Patent Law FAQ

This FAQ answers all your questions about patent law, patent procedure, and the patent examination process.

Here’s the complete FAQ:

c Expand All C Collapse All

'MPEP 306-Assignment of Division (10)

The need for a new assignment in applications derived from earlier applications depends on the type of application and its content:

  • Division and Continuation Applications: Generally, no new assignment is required as the prior assignment is automatically applied. However, a new recordation request is needed to reflect this in USPTO records.
  • Substitute and Continuation-in-Part Applications: New assignments are typically required unless the application is filed on or after September 16, 2012, and the assignee is the original applicant.
  • Applications Claiming Provisional Benefits: If the application includes only subject matter from the provisional application, no new assignment is needed. However, if it includes new subject matter, a new assignment is required, with the same exception as for substitute and continuation-in-part applications.

Always refer to MPEP § 306, § 307, and § 308 for the most up-to-date and detailed information.

For more information on new assignment, visit: new assignment.

For more information on USPTO requirements, visit: USPTO requirements.

A new assignment is generally required for a continuation-in-part (CIP) application, with one exception. According to MPEP 306:

Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

This means:

  • For CIP applications filed before September 16, 2012: A new assignment is always required.
  • For CIP applications filed on or after September 16, 2012: A new assignment is required unless the assignee is the original applicant in the CIP application.

The reason for this requirement is that CIP applications often contain new subject matter not present in the original application, and the original assignment may not cover this new material.

September 16, 2012, is a significant date in patent application assignments, particularly for applications claiming the benefit of a provisional application. The MPEP states:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

This date marks a change in assignment requirements. For applications filed on or after September 16, 2012, if the assignee is the original applicant, new assignment papers may not be necessary even if the application includes subject matter not common with the provisional application. This change aligns with broader reforms introduced by the America Invents Act (AIA) that came into effect on that date.

35 U.S.C. 119(e) is crucial in understanding the relationship between provisional applications and their non-provisional counterparts, particularly in terms of assignments. The MPEP § 306.01 states:

If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

This means:

  • 35 U.S.C. 119(e) allows non-provisional applications to claim the benefit of an earlier filing date from a provisional application.
  • When a non-provisional application claims this benefit and contains only subject matter from the provisional, the assignment recorded for the provisional application remains effective for the non-provisional.
  • This treatment aligns with how assignments are handled for continuations and divisions under 35 U.S.C. 120.

However, if new subject matter is introduced in the non-provisional application, different assignment rules may apply, as detailed in other parts of MPEP § 306.01.

The key difference in assignment between division/continuation applications and substitute/continuation-in-part (CIP) applications lies in how prior assignments are applied:

  • Division/Continuation Applications: Prior assignments recorded against the original application automatically apply to these applications. As stated in MPEP 306: In the case of a division or continuation application, a prior assignment recorded against the original application is applied (effective) to the division or continuation application because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.
  • Substitute/CIP Applications: Prior assignments do not automatically apply. MPEP 306 states: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This difference is due to the nature of these application types. Division and continuation applications contain only subject matter from the original application, while substitute and CIP applications may contain new subject matter not present in the original application.

The assignment rules for substitute and continuation-in-part applications differ from those for division and continuation applications. As per the MPEP, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This means that for substitute or continuation-in-part applications, a new assignment must be recorded if they are to be issued to an assignee. However, there’s an exception: unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

For more detailed information, refer to MPEP § 307 and MPEP § 308.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on patent assignment, visit: patent assignment.

For more information on substitute application, visit: substitute application.

While a prior assignment recorded against an original application is automatically effective for division and continuation applications, the USPTO does not automatically update its assignment records for these new applications. As stated in MPEP 306:

Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

This means that even though the assignment is legally effective, the USPTO’s records won’t show it unless the assignee takes specific action. To ensure the USPTO’s records are up to date, assignees should:

  • File a request for recordation of the assignment for the new application
  • Ensure the request complies with 37 CFR 3.28
  • Pay the required fee as specified in 37 CFR 3.41

The assignment process for continuations-in-part (CIPs) differs from other application types due to the potential inclusion of new subject matter. The MPEP § 306.01 explains:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein. This is similar to the practice with respect to continuations-in-part filed under 35 U.S.C. 120.

In essence:

  • For continuations and divisions that contain only subject matter from the parent application, the original assignment usually remains effective.
  • For CIPs or applications with new subject matter not in the parent or provisional application, new assignment papers are typically required, with the exception noted for applications filed on or after September 16, 2012, where the assignee is the original applicant.

This difference reflects the unique nature of CIPs, which introduce new matter not present in the parent application.

For division and continuation applications, a prior assignment recorded against the original application is automatically applied to the new application. This is because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.

However, it’s important to note that while the assignment is effective for the new application, the USPTO’s assignment records will not automatically reflect this. As stated in the MPEP: Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

Yes, substitute and continuation-in-part (CIP) applications generally require new assignments. As stated in MPEP 306: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

However, there is an exception for applications filed on or after September 16, 2012: Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

and Continuation-in-Part in Relation to Parent Application' (10)

The need for a new assignment in applications derived from earlier applications depends on the type of application and its content:

  • Division and Continuation Applications: Generally, no new assignment is required as the prior assignment is automatically applied. However, a new recordation request is needed to reflect this in USPTO records.
  • Substitute and Continuation-in-Part Applications: New assignments are typically required unless the application is filed on or after September 16, 2012, and the assignee is the original applicant.
  • Applications Claiming Provisional Benefits: If the application includes only subject matter from the provisional application, no new assignment is needed. However, if it includes new subject matter, a new assignment is required, with the same exception as for substitute and continuation-in-part applications.

Always refer to MPEP § 306, § 307, and § 308 for the most up-to-date and detailed information.

For more information on new assignment, visit: new assignment.

For more information on USPTO requirements, visit: USPTO requirements.

A new assignment is generally required for a continuation-in-part (CIP) application, with one exception. According to MPEP 306:

Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

This means:

  • For CIP applications filed before September 16, 2012: A new assignment is always required.
  • For CIP applications filed on or after September 16, 2012: A new assignment is required unless the assignee is the original applicant in the CIP application.

The reason for this requirement is that CIP applications often contain new subject matter not present in the original application, and the original assignment may not cover this new material.

September 16, 2012, is a significant date in patent application assignments, particularly for applications claiming the benefit of a provisional application. The MPEP states:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

This date marks a change in assignment requirements. For applications filed on or after September 16, 2012, if the assignee is the original applicant, new assignment papers may not be necessary even if the application includes subject matter not common with the provisional application. This change aligns with broader reforms introduced by the America Invents Act (AIA) that came into effect on that date.

35 U.S.C. 119(e) is crucial in understanding the relationship between provisional applications and their non-provisional counterparts, particularly in terms of assignments. The MPEP § 306.01 states:

If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

This means:

  • 35 U.S.C. 119(e) allows non-provisional applications to claim the benefit of an earlier filing date from a provisional application.
  • When a non-provisional application claims this benefit and contains only subject matter from the provisional, the assignment recorded for the provisional application remains effective for the non-provisional.
  • This treatment aligns with how assignments are handled for continuations and divisions under 35 U.S.C. 120.

However, if new subject matter is introduced in the non-provisional application, different assignment rules may apply, as detailed in other parts of MPEP § 306.01.

The key difference in assignment between division/continuation applications and substitute/continuation-in-part (CIP) applications lies in how prior assignments are applied:

  • Division/Continuation Applications: Prior assignments recorded against the original application automatically apply to these applications. As stated in MPEP 306: In the case of a division or continuation application, a prior assignment recorded against the original application is applied (effective) to the division or continuation application because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.
  • Substitute/CIP Applications: Prior assignments do not automatically apply. MPEP 306 states: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This difference is due to the nature of these application types. Division and continuation applications contain only subject matter from the original application, while substitute and CIP applications may contain new subject matter not present in the original application.

The assignment rules for substitute and continuation-in-part applications differ from those for division and continuation applications. As per the MPEP, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This means that for substitute or continuation-in-part applications, a new assignment must be recorded if they are to be issued to an assignee. However, there’s an exception: unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

For more detailed information, refer to MPEP § 307 and MPEP § 308.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on patent assignment, visit: patent assignment.

For more information on substitute application, visit: substitute application.

While a prior assignment recorded against an original application is automatically effective for division and continuation applications, the USPTO does not automatically update its assignment records for these new applications. As stated in MPEP 306:

Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

This means that even though the assignment is legally effective, the USPTO’s records won’t show it unless the assignee takes specific action. To ensure the USPTO’s records are up to date, assignees should:

  • File a request for recordation of the assignment for the new application
  • Ensure the request complies with 37 CFR 3.28
  • Pay the required fee as specified in 37 CFR 3.41

The assignment process for continuations-in-part (CIPs) differs from other application types due to the potential inclusion of new subject matter. The MPEP § 306.01 explains:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein. This is similar to the practice with respect to continuations-in-part filed under 35 U.S.C. 120.

In essence:

  • For continuations and divisions that contain only subject matter from the parent application, the original assignment usually remains effective.
  • For CIPs or applications with new subject matter not in the parent or provisional application, new assignment papers are typically required, with the exception noted for applications filed on or after September 16, 2012, where the assignee is the original applicant.

This difference reflects the unique nature of CIPs, which introduce new matter not present in the parent application.

For division and continuation applications, a prior assignment recorded against the original application is automatically applied to the new application. This is because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.

However, it’s important to note that while the assignment is effective for the new application, the USPTO’s assignment records will not automatically reflect this. As stated in the MPEP: Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

Yes, substitute and continuation-in-part (CIP) applications generally require new assignments. As stated in MPEP 306: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

However, there is an exception for applications filed on or after September 16, 2012: Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

MPEP 101-General (19)

Patent applications are generally published 18 months after the earliest filing date, with some exceptions. According to 35 U.S.C. 122(b)(1)(A):

“Subject to paragraph (2), each application for a patent shall be published, in accordance with procedures determined by the Director, promptly after the expiration of a period of 18 months from the earliest filing date for which a benefit is sought under this title. At the request of the applicant, an application may be published earlier than the end of such 18-month period.”

Exceptions to publication include applications that are no longer pending, subject to a secrecy order, provisional applications, or design patent applications.

Patent applications are generally published by the USPTO 18 months after the earliest filing date for which a benefit is sought. This is specified in 35 U.S.C. 122(b)(1)(A):

Subject to paragraph (2), each application for a patent shall be published, in accordance with procedures determined by the Director, promptly after the expiration of a period of 18 months from the earliest filing date for which a benefit is sought under this title. At the request of the applicant, an application may be published earlier than the end of such 18-month period.

There are some exceptions to this rule, such as applications that are no longer pending or are subject to a secrecy order. Applicants can also request early publication or non-publication under certain conditions.

The Manual of Patent Examining Procedure (MPEP) serves as a comprehensive guide for patent examiners, applicants, attorneys, and agents involved in the patent application process. According to MPEP 101, its purpose is to:

  • Provide instructions to examiners for the examination of patent applications
  • Outline procedures for processing and examining patent applications
  • Serve as a reference work on patent laws, rules, and examination practices

The MPEP states: The Manual contains instructions to examiners, as well as other material in the nature of information and interpretation, and outlines the current procedures which the examiners are required or authorized to follow in appropriate cases in the normal examination of a patent application.

For more information on patent examination, visit: patent examination.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

The Manual of Patent Examining Procedure (MPEP) holds a unique legal status in patent law. According to MPEP 101:

The Manual does not have the force of law or the force of the rules in Title 37 of the Code of Federal Regulations.

This means:

  • The MPEP is not legally binding like statutes or regulations
  • It serves as an interpretive guide for patent examiners and practitioners
  • Courts may give it deference but are not bound by its contents

However, the MPEP is highly influential because it:

  • Reflects official USPTO policies and procedures
  • Is used by examiners in their day-to-day work
  • Provides valuable guidance for patent applicants and attorneys

While not law, the MPEP is an essential resource for understanding and navigating the patent examination process.

For more information on patent law, visit: patent law.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

Patent applications are generally kept confidential by the USPTO until they are published or granted. As stated in 35 U.S.C. 122(a):

“Except as provided in subsection (b), applications for patents shall be kept in confidence by the Patent and Trademark Office and no information concerning the same given without authority of the applicant or owner unless necessary to carry out the provisions of an Act of Congress or in such special circumstances as may be determined by the Director.”

This confidentiality requirement applies to all USPTO employees handling patent applications.

The USPTO has strict rules about what information can be disclosed regarding unpublished patent applications. According to 37 CFR 1.14(a)(2), only limited status information may be communicated to the public if the application is identified in a published patent document or in another application. This status information includes:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published under 35 U.S.C. 122(b)
  • The application’s numerical identifier (application number or serial number plus filing date)
  • Whether another application claims benefit of the application, and if so, the numerical identifier, relationship, status, and publication status of that application

No other information about unpublished applications can be disclosed without proper authorization.

The USPTO can disclose limited information about patent applications to the public, as outlined in 37 CFR 1.14(a)(2):

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published
  • The application’s numerical identifier
  • Whether another application claims benefit of the application

This information can only be disclosed if the application is identified in a published patent document or in another application as specified in 37 CFR 1.14(a)(1)(i) through (a)(1)(vi).

MPEP 101 specifies the following procedure that should be followed before giving any information about an unpublished pending or abandoned patent application over the telephone:

  1. Obtain the caller’s full name, the application number, and the caller’s telephone number. Ask if there is an attorney or agent of record.
  2. Verify the identity of the caller and their authority to receive information.
  3. For a practitioner of record, check their registration number in Patent Data Portal. Only call back a practitioner at the number listed in Patent Data Portal.
  4. For an inventor, applicant, or assignee, check the correspondence address in Patent Data Portal and call back at the number provided if it matches.
  5. If identity and authority cannot be verified, inform the caller that no information can be provided.

35 U.S.C. 122 and 18 U.S.C. 2071 impose statutory requirements which cover the handling of patent applications and related documents. As explained in MPEP 101:

“35 U.S.C. 122 and 18 U.S.C. 2071 impose statutory requirements which cover the handling of patent applications and related documents. Suspension, removal, and even criminal penalties may be imposed for violations of these statutes.”

Therefore, USPTO employees must take proper care to maintain the confidentiality of applications and related papers.

Unauthorized disclosure of patent application information can result in severe penalties for USPTO employees. According to the MPEP:

“Suspension, removal, and even criminal penalties may be imposed for violations of these statutes.”

The relevant statutes include 35 U.S.C. 122 and 18 U.S.C. 2071. Additionally, 18 U.S.C. 2071 states that individuals who willfully and unlawfully conceal, remove, mutilate, or destroy official documents may be:

  • Fined under this title
  • Imprisoned for up to three years
  • Disqualified from holding any office under the United States

These penalties underscore the critical importance of maintaining confidentiality in patent application handling.

There are several exceptions to the 18-month publication rule for patent applications, as outlined in 35 U.S.C. 122(b)(2)(A). An application shall not be published if it is:

  • No longer pending
  • Subject to a secrecy order under section 181
  • A provisional application filed under section 111(b)
  • An application for a design patent filed under chapter 16

Additionally, an applicant can request non-publication if they certify that the invention has not and will not be the subject of an application filed in another country that requires publication after 18 months. However, if the applicant later files such a foreign application, they must notify the USPTO within 45 days or the U.S. application will be considered abandoned.

MPEP 101 explains that USPTO employees must take specific measures to ensure the confidentiality of patent applications:

  • No part of any application or related paper should be reproduced or copied except for official purposes.
  • Application files must not be displayed or handled in a manner that would allow unauthorized persons to inspect them.
  • For non-electronic files removed from their storage area, a charge must be promptly made in the tracking system.
  • Physical files must be stored properly, not in unsecured locations like desk drawers.
  • Interoffice mail related to applications must be sent in appropriate envelopes.

The Manual of Patent Examining Procedure (MPEP) is regularly updated to reflect changes in patent laws, rules, and procedures. According to MPEP 101:

The Manual is updated periodically to include changes in patent laws and rules and also changes in Patent and Trademark Office procedures.

While the MPEP doesn’t specify an exact frequency for updates, they typically occur:

  • Multiple times per year to incorporate new policies and procedures
  • After significant changes in patent laws or regulations
  • When court decisions impact patent examination practices

Users should always refer to the most recent version of the MPEP available on the USPTO website for the most up-to-date information.

For more information on MPEP updates, visit: MPEP updates.

For more information on patent law changes, visit: patent law changes.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO follows a strict procedure for handling telephone and in-person requests for information about unpublished pending or abandoned patent applications:

  1. Obtain the caller’s full name, application number, and telephone number
  2. Verify the caller’s identity and authority to receive information
  3. Check Patent Data Portal or the application file to verify releasable information
  4. Return the call using a verified telephone number

Information is only released to authorized individuals, such as the patent practitioner of record, inventor, applicant, or authorized representative of the assignee of record.

USPTO employees are legally obligated to maintain the confidentiality of pending patent applications. According to MPEP 101:

All U.S. Patent and Trademark Office employees are legally obligated to preserve pending applications for patents in confidence until they are published or patented in accordance with 35 U.S.C. 122 and 37 CFR 1.14.

This includes several practices:

  • Not reproducing or copying application documents except for official purposes
  • Properly handling and storing application files
  • Using appropriate envelopes for interoffice mail
  • Being careful during interviews to prevent exposure of other applicants’ files

Violations of these confidentiality requirements can result in suspension, removal, and even criminal penalties.

For more information on USPTO employees, visit: USPTO employees.

USPTO employees are legally obligated to maintain the confidentiality of pending patent applications. The MPEP states:

“All U.S. Patent and Trademark Office employees are legally obligated to preserve pending applications for patents in confidence until they are published or patented in accordance with 35 U.S.C. 122 and 37 CFR 1.14.”

Employees must follow strict procedures to ensure confidentiality, including:

  • Not reproducing or copying application documents except for official purposes
  • Properly handling and storing application files
  • Using appropriate envelopes for interoffice mail
  • Being cautious during interviews to prevent exposure of other applications

Violations of these procedures can result in suspension, removal, or even criminal penalties.

Requesting information about an unpublished patent application requires specific procedures to ensure confidentiality. According to the MPEP:

  • Requests can be made by phone or in person
  • The requester’s identity and right to information must be verified
  • Only certain individuals (applicant, inventor, assignee of record, or attorney/agent of record) may receive detailed information
  • USPTO employees must follow a strict verification process before releasing any information

The MPEP states:

“Except as provided in 35 U.S.C. 122(b), no information concerning pending or abandoned patent applications (except applications which have been published, reissue applications and reexamination proceedings) may be given to the public without appropriate written authorization.”

This ensures that confidential application information is only released to authorized individuals.

For more information on information requests, visit: information requests.

For more information on unpublished applications, visit: unpublished applications.

Access to information about unpublished patent applications is generally restricted. However, according to MPEP 101, there are specific circumstances under which such information may be accessed:

  1. If you are the applicant, an inventor, the assignee of record, or the attorney or agent of record, you may be able to access information about the application.
  2. If the application is identified in a published patent document or in another application as specified in 37 CFR 1.14(a)(1)(i) through (a)(1)(vi), certain status information may be available to the public.
  3. In some cases, a petition for access or a power to inspect may be required to access information about an unpublished application.

It’s important to note that the USPTO has strict procedures for verifying the identity and authority of individuals requesting information about unpublished applications to maintain confidentiality.

For more information on unpublished applications, visit: unpublished applications.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP 101, particular care must be taken when a caller requests the publication date or issue date assigned to a pending patent application:

“If the publication or issue date is later than the current date (i.e., the date of the request), such information may be given only to the applicant, an inventor, the assignee of record, or the attorney or agent of record.”

The identity and authority of the caller must be verified according to the procedures outlined in the MPEP before this information can be provided over the telephone.

MPEP 102-Information as to Status of an Application (15)

For unpublished patent applications that are pending or abandoned, the following individuals are authorized to receive status information:

  1. The applicant
  2. A patent practitioner of record
  3. The assignee or an assignee of an undivided part interest
  4. The inventor or a joint inventor
  5. A registered attorney or agent named in the application papers filed under 37 CFR 1.53 or the national stage documents filed under 37 CFR 1.495, if a power of attorney has not been appointed under 37 CFR 1.32

Additionally, anyone with written authority granting access from one of the above individuals is also entitled to status information.

A patent application file becomes available to the public in the following situations:

  1. When the application has issued as a patent or published as a statutory invention registration
  2. When the application has been published and subsequently abandoned
  3. When the application has been published and is still pending
  4. When an unpublished, abandoned application is identified or relied upon in certain public documents
  5. When the benefit of an unpublished pending application is claimed in certain public documents

These conditions are outlined in 37 CFR 1.14(a)(1). In most cases, a fee is required to access the application file contents.

Patent application records may be available to the public in the following situations:

  1. Patented applications and statutory invention registrations
  2. Published abandoned applications
  3. Published pending applications
  4. Unpublished abandoned applications that are identified or relied upon
  5. Unpublished pending applications whose benefit is claimed
  6. Unpublished pending applications that are incorporated by reference or otherwise identified

For specific details on each situation, refer to 37 CFR 1.14(a)(1)(i)-(vi).

For international applications and applications claiming the benefit of a published international application:

  1. If the United States is indicated as a Designated State, status information is available for the national stage application and any application claiming benefit of the filing date of the published international application.
  2. Only the serial number, filing date, application number, and whether the application is pending, abandoned, or patented may be provided.
  3. A copy of the first page of the published international application or the corresponding page of the PCT Gazette must be supplied with the status request.

Status requests should be made in writing to the International Patent Legal Administration or directed to the PCT Help desk.

According to MPEP 102, accessing unpublished patent applications requires specific procedures:

“Applications that were not published or patented, that are not the subject of a benefit claim under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in an application that has issued as a U.S. patent, an application that has published as a statutory invention registration, a U.S. patent application publication, an international publication of an international application under PCT Article 21(2), or a publication of an international registration under Hague Agreement Article 10(3), or are not identified in a U.S. patent, a statutory invention registration, a U.S. patent application publication, an international publication of an international application under PCT Article 21(2), or a publication of an international registration under Hague Agreement Article 10(3) of an international design application designating the United States, are not available to the public.”

In such cases, a granted petition for access or a power to inspect is necessary to obtain the application or a copy of the application. The specific requirements for these procedures are outlined in 37 CFR 1.14(i) and (c) respectively.

For more information on petition for access, visit: petition for access.

For more information on unpublished applications, visit: unpublished applications.

Patent applications that have not been published under 35 U.S.C. 122(b) are generally preserved in confidence pursuant to 35 U.S.C. 122(a). Information about the filing, pendency, or subject matter of an application, including status information and access to the application, is only given to the public as set forth in § 1.11 or in this section of the MPEP.

As stated in 37 CFR 1.14(a): Patent applications that have not been published under 35 U.S.C. 122(b) are generally preserved in confidence pursuant to 35 U.S.C. 122(a). Information concerning the filing, pendency, or subject matter of an application for patent, including status information, and access to the application, will only be given to the public as set forth in § 1.11 or in this section.

Status information of an application includes:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published
  • The application number or the serial number plus any one of the filing date of the national application, the international filing date, or the date of entry into the national stage
  • Whether another application claims the benefit of the application, and if so, status information for those applications

This is defined in 37 CFR 1.14(a)(2) and further elaborated in MPEP 102.

For provisional applications, the USPTO can provide the following information:

  • Application number
  • Filing date
  • Whether the application is pending or abandoned
  • Expiration date

It’s important to note that provisional applications are not published, so no additional information beyond these basic details is available to the public.

For pending or abandoned applications that have not been published, the Office may only confirm that an application has been filed, provide the application number and filing date, the inventorship information, the classification, and the group art unit assigned to the application. This limited information is available to the public to help avoid infringement of pending patent rights.

According to MPEP 102, for national stage applications or applications claiming the benefit of a published international application:

“Only the serial number and filing date, or application number, as well as whether the application is pending, abandoned, or patented may be given for the national stage application and for any applications claiming the benefit of the filing date of the referenced published international application. Other information contained on the continuity data screen, such as whether the application is a CIP, continuation or divisional application, the date of abandonment of the application and issue date may be confidential information and should not be communicated.”

To request this information, a copy of the first page of the published international application or the corresponding page of the PCT Gazette must be supplied with the status request to the International Patent Legal Administration.

For more information on international applications, visit: international applications.

For more information on status information, visit: status information.

Under MPEP 102, limited information about a pending application can be obtained, including:

  • Application number
  • Filing date
  • Whether the application has been published
  • Whether the application has been assigned
  • Power of attorney
  • Name of the examiner to whom the application is assigned
  • Status of the application (e.g., pending, abandoned, or issued)
  • Group art unit number
  • Filing receipt information
  • If available, projected publication date

However, access to the application file itself is restricted unless special circumstances apply or the application has been published.

USPTO personnel should use Patent Data Portal to determine the current location or status of an application. For Image File Wrapper (IFW) applications, no location is associated with the file.

As stated in MPEP 102: When it is desired to determine the current location or status of an application, Office personnel should use Patent Data Portal. If the application is an Image File Wrapper (IFW) application, no location is associated with the file.

To obtain status information for a patent application, you can:

  1. Check Patent Center or Private Patent Application Information Retrieval (PAIR) on the USPTO website at www.uspto.gov
  2. Contact the Application Assistance Unit (AAU) for applications in pre-examination or post-examination processing via email at HelpAAU@uspto.gov, phone at 571-272-4000 or toll-free at 888-786-0101, or visit their website

If the application has not been published but is pending or abandoned, the AAU will determine if the requester is authorized to receive status information based on their relationship to the application.

According to MPEP 102, when it is desired to determine the current location or status of an application, USPTO personnel should use Patent Data Portal. However, it’s important to note that:

“If the application is an Image File Wrapper (IFW) application, no location is associated with the file.”

For public inquiries about application status, the recommended methods are:

  • Checking Patent Center or Private PAIR on the USPTO website
  • Contacting the Application Assistance Unit (AAU) for pre-examination or post-examination processing applications
  • Calling the Technology Center (TC) to which the application is assigned for information about replies or expected Office actions

The assignment of an application to a TC can be determined from Patent Data Portal.

For more information on USPTO Resources, visit: USPTO Resources.

In general, status information cannot be provided for unpublished patent applications, unless the requester is:

  1. The applicant
  2. A patent practitioner of record
  3. The assignee or an assignee of an undivided part interest
  4. The inventor or a joint inventor
  5. A registered attorney or agent named in the application papers

Alternatively, a person with written authority from any of the above parties can be provided status information.

There are some exceptions where status information can be supplied for unpublished applications, such as:

  • When the application is identified in a published patent document or another application publication
  • When the application is a national stage application or claims benefit to a published international application and the US is a designated state
  • When the application is an international design application maintained by the USPTO for national processing

MPEP 103-Right of Public To Inspect Patent Files and Some Application Files (19)

According to 37 CFR 1.11(a), the following patent application files are open to public inspection:

  • Published applications
  • Patents
  • Statutory invention registrations

The public can obtain copies of these files upon payment of the fee set forth in 37 CFR 1.19(b)(2). However, if an application was published in redacted form, the complete file may not be available if certain requirements are met and the application is still pending.

The Image File Wrapper (IFW) system is an electronic system used by the USPTO to store and process patent application files. Key points about the IFW system and its impact on public access include:

  • Paper components of application files are scanned to create electronic image files
  • For IFW applications, the electronic file is the Official file
  • No access is granted to original paper documents used to create the IFW file
  • Processing and examination are conducted using electronic images
  • IFW files for patented applications, published applications, or applications referenced in published documents are accessible through Patent Center on the USPTO website
  • All patent applications filed after June 30, 2003, have been scanned into the IFW system

The IFW system has made it easier for the public to access eligible patent application files online through Patent Center, eliminating the need to physically inspect paper files in many cases.

A ‘file wrapper’ refers to the official record of proceedings in the United States Patent and Trademark Office (USPTO) for a particular patent application or granted patent. It contains all the documents and correspondence related to the prosecution of the application or maintenance of the patent. This includes the original application, Office actions, applicant responses, amendments, and other relevant documents. The file wrapper provides a complete history of the examination process and is important for understanding the scope and validity of a patent.

Information about reexamination proceedings is made available to the public in several ways:

  1. Announcement in the Official Gazette:
    • The filing of each request for reexamination (where the full fee has been paid) is announced
    • Reexaminations ordered at the Director’s initiative are also announced
  2. Public inspection of reexamination files:
    • Once scanned into the Image File Wrapper (IFW) system, reexamination files are open to public inspection
    • Files can be accessed through Patent Center on the USPTO website
    • The entire contents of the reexamination file are viewable, except for non-patent literature

Direct quote: ‘All requests for reexamination for which all the requirements of § 1.510 or § 1.915 have been satisfied will be announced in the Official Gazette. Any reexaminations at the initiative of the Director pursuant to § 1.520 will also be announced in the Official Gazette.’ (37 CFR 1.11(c))

Note that a reexamination file is typically not open to inspection until it has been scanned into the IFW system.

Certain information about patent applications is publicly available, even if the full application is not. According to 37 CFR 1.14(a)(1)(ii) and (iii), for published applications, the following information may be communicated without a petition for access:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published under 35 U.S.C. 122(b)
  • The application “numerical identifier” (application number or serial number plus filing date)
  • Whether another application claims the benefit of the application

For published applications, “A copy of the application-as-filed, the file contents of the application, or a specific document in the file of a pending published application may be provided to any person upon request and payment of the appropriate fee set forth in §1.19(b).”

However, for unpublished applications, this information is generally not available to the public unless the application is identified or relied upon in a patent document or other published application.

For more information on patent applications, visit: patent applications.

For more information on public information, visit: public information.

Reissue application files have specific access rules as outlined in MPEP 103:

‘All reissue applications, both pending and abandoned, are open to public inspection and copying.’

This means that:

  • Anyone can access reissue application files
  • No special permission is required
  • Both pending and abandoned reissue applications are available

However, if the reissue application contains a request for continued examination (RCE) filed on or after March 16, 2013, access to the file may be restricted until publication.

For more information on public inspection, visit: public inspection.

For more information on reissue applications, visit: reissue applications.

While most patent application files are available for public inspection, there are several exceptions:

  • Pending or abandoned applications that have not been published under 35 U.S.C. 122(b)
  • Applications subject to a secrecy order
  • Provisional applications
  • Applications that have been terminated or denied and are no longer open to public inspection
  • Interference files, until judgment is entered (subject to certain exceptions)
  • Applications for extension of patent term and any related submissions
  • Certain trade secret, proprietary, and protective order materials

These exceptions are in place to protect confidential information and maintain the integrity of the patent application process.

While most patent application files are available for public inspection, there are some exceptions:

  • Pending or abandoned applications that have not been published
  • Applications subject to secrecy orders
  • Certain international applications
  • Applications for which the United States is not a designated country
  • Information that would violate personal privacy or proprietary rights

These exceptions help protect sensitive information and maintain confidentiality in specific cases.

To request access to a patent application that is not publicly available, you generally need to file a petition for access. According to 37 CFR 1.14(a)(1)(vii), for applications that are not published, patented, or the subject of a benefit claim in a published application:

A granted petition for access (see paragraph (i)) or a power to inspect (see paragraph (c) of this section) is necessary to obtain the application, or a copy of the application.”

To file a petition for access, you must:

  • Submit the petition with the fee set forth in 37 CFR 1.17(g)
  • Provide a showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access

The petition should be directed to the Office of Patent Legal Administration. The applicant will be given an opportunity to object to the granting of the petition, and the USPTO will make a determination based on the circumstances presented.

For more information on petition for access, visit: petition for access.

Any interested party may file a petition, accompanied by the petition fee, to the Director for access to an application. The petition may be filed either with proof of service of copy upon the applicant, or the petition may be filed in duplicate, in which case the duplicate copy will be sent by the Office to the applicant.

The petition should show not only why access is desired, but also why petitioner believes they are entitled to access. The applicant will normally be given a limited period such as 3 weeks within which to state any objection to the granting of the petition for access and reasons why it should be denied. If applicant states that they have no objection to the requested access, the petition will be granted. If objection is raised or applicant does not respond, the petition will be decided on the record.

To petition for access to a confidential patent application, you must file a petition under 37 CFR 1.14(i), which requires:

  1. Payment of the petition fee set forth in 37 CFR 1.17(g)
  2. A showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access

The petition should be filed with the Office of Patent Legal Administration, unless the application is involved in an interference or trial before the Patent Trial and Appeal Board.

You may file the petition either with proof of service upon the applicant, or in duplicate so the USPTO can send a copy to the applicant. The applicant will typically have about 3 weeks to object to the granting of access.

Direct quote: ‘Any petition by a member of the public seeking access to, or copies of, all or part of any pending or abandoned application preserved in confidence pursuant to paragraph (a) of this section, or any related papers, must include: (1) The fee set forth in § 1.17(g); and (2) A showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access to all or part of the application.’ (37 CFR 1.14(i))

To make a Freedom of Information Act (FOIA) request for USPTO records:

  1. Submit a written request to the USPTO FOIA Officer:
    • Address: United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450
    • Mark the letter and envelope ‘Freedom of Information Act Request’
  2. Describe the requested records in detail:
    • Include specific information such as dates, titles, names, subjects, etc.
    • Provide any known file designations or descriptions
  3. If requesting records about yourself, follow additional requirements in 37 CFR 102.24
  4. If requesting records about another individual, provide either:
    • A written authorization signed by that individual permitting disclosure
    • Proof that the individual is deceased (e.g., death certificate, obituary)

Direct quote: ‘A request for USPTO records that are not customarily made available to the public as part of USPTO’s regular informational services must be in writing, and shall be processed under FOIA, regardless of whether FOIA is mentioned in the request.’ (37 CFR 102.4(a))

Note: Many USPTO decisions are already available on the FOIA section of the USPTO website at www.uspto.gov/learning-and-resources/ip-policy/electronic-freedom-information-act-e-foia.

If a patent application has been published pursuant to 35 U.S.C. 122(b), then a copy of the specification, drawings, and all papers relating to the file of that published application (whether abandoned or pending) may be provided to any person upon written request and payment of the fee set forth in 37 CFR 1.19(b). See 37 CFR 1.14(a)(1)(ii) and (iii).

Published applications maintained in the Image File Wrapper (IFW) system are available on the USPTO website in Patent Center.

For patent application information not available through Public PAIR, you can submit a request to the USPTO under the Freedom of Information Act (FOIA). Here’s how to proceed:

  1. Submit a written request to the USPTO’s FOIA Officer.
  2. Clearly identify the records you’re seeking.
  3. Explain why you believe the information should be disclosed if it’s not typically available to the public.
  4. Be prepared to pay any applicable fees for search and duplication.
  5. Wait for the USPTO to process your request and respond, which may take several weeks.

Note that certain information may still be withheld if it falls under FOIA exemptions or is protected by other statutes.

Access to unpublished patent application files is generally restricted. According to MPEP 103:

‘Unpublished abandoned applications are not open to public inspection.’

However, there are exceptions:

  • If the application is referenced in a U.S. patent application publication or patent
  • If written authority from the applicant, assignee, or attorney/agent of record is provided
  • If a petition for access is granted

To request access, you may need to file a petition with the USPTO, demonstrating a need or right to access the application.

For more information on Patent application access, visit: Patent application access.

For more information on unpublished applications, visit: unpublished applications.

Access to unpublished abandoned patent applications is limited. According to 37 CFR 1.14(a)(1)(iv), the file contents of an unpublished abandoned application may be made available to the public if:

  • The application is identified in a U.S. patent, statutory invention registration, U.S. patent application publication, international publication of an international application, or publication of an international registration designating the U.S.
  • Benefit of the abandoned application is claimed under 35 U.S.C. 119(e), 120, 121, 365, or 386(c) in an application that has been published or patented.

To obtain access, a written request must be submitted along with payment of the appropriate fee set forth in 37 CFR 1.19(b).

Reissue application files are generally open to public inspection. According to 37 CFR 1.11(b):

  • Reissue applications are open to inspection by the general public
  • The filing of reissue applications (except for continued prosecution applications under 37 CFR 1.53(d)) is announced in the Official Gazette
  • The announcement includes details such as filing date, reissue application and original patent numbers, title, inventor name, and examining group

For Image File Wrapper (IFW) reissue applications:

  • Files are open to inspection by the general public through Patent Center via the USPTO website
  • Members of the public can view the entire content of the reissue application file history online

Direct quote: ‘All reissue applications, all applications in which the Office has accepted a request to open the complete application to inspection by the public, and related papers in the application file, are open to inspection by the public, and copies may be furnished upon paying the fee therefor.’ (37 CFR 1.11(b))

Access to international application files at the USPTO is governed by specific rules. According to MPEP 103:

‘International applications that designate the U.S. and have been published in accordance with PCT Article 21(2) are generally open to public inspection and copying.’

This means:

  • Published international applications designating the U.S. are accessible
  • Access is available after the application’s international publication
  • Unpublished international applications are not open to public inspection

To access these files, you can use the USPTO’s Public PAIR system or visit the USPTO’s Public Search Facility.

For more information on international applications, visit: international applications.

For more information on public inspection, visit: public inspection.

Access to pending unpublished patent applications is generally restricted. However, according to 37 CFR 1.14(a)(1)(v) and (vi), there are some circumstances where a copy of the file contents or the application as originally filed may be provided:

  • If the benefit of the application is claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in an application that has been published or patented.
  • If the application is incorporated by reference or otherwise identified in a U.S. patent, statutory invention registration, U.S. patent application publication, international publication of an international application, or publication of an international registration designating the U.S.

In these cases, a written request must be submitted along with payment of the appropriate fee set forth in 37 CFR 1.19(b). The Office will not provide access to the paper file of a pending application, except under specific circumstances outlined in 37 CFR 1.14(c) or (i).

MPEP 104-Power to Inspect Application (11)

For applications filed on or after September 16, 2012, the following parties can provide written authority to grant access to inspect a pending or abandoned application kept in confidence under 35 U.S.C. 122(a), except as provided in 37 CFR 1.11, 1.14, 41.6, or 42.412:

  1. The applicant
  2. A patent practitioner of record
  3. The assignee or an assignee of an undivided part interest
  4. The inventor or a joint inventor

According to MPEP 104, access to inspect a patent application can be granted by specific individuals or entities. For applications filed on or after September 16, 2012, the following parties can provide written authority for access:

  • The applicant
  • A patent practitioner of record
  • The assignee or an assignee of an undivided part interest
  • The inventor or a joint inventor

The MPEP states: “The written authority must be signed by: (1) The applicant; (2) A patent practitioner of record; (3) The assignee or an assignee of an undivided part interest; (4) The inventor or a joint inventor; or (5) A registered attorney or agent named in the papers accompanying the application papers filed under §1.53 or the national stage documents filed under §1.495, if a power of attorney has not been appointed under § 1.32.”

For more information on application access, visit: application access.

For more information on power to inspect, visit: power to inspect.

For more information on written authority, visit: written authority.

The duration of a power to inspect granted by an applicant or inventor is generally ongoing until explicitly rescinded. According to MPEP 104:

“An unrestricted power to inspect given by an applicant or inventor is, under existing practice, recognized as in effect until and unless rescinded.”

This means that once granted, a power to inspect remains valid indefinitely unless the grantor takes action to revoke it. However, it’s important to note that this applies to unrestricted powers to inspect granted by applicants or inventors, and different rules may apply to other types of authorizations or parties.

For more information on Patent application access, visit: Patent application access.

Access to provisional patent applications is handled differently from non-provisional applications. According to MPEP 104:

“In provisional applications, access or certified copies may only be requested by parties with written authority from a named inventor, the applicant, the assignee of record, or the attorney or agent of record, unless the application is available pursuant to 37 CFR 1.14(a)(1)(iv)-(vi).”

The MPEP further explains:

“Since provisional applications do not require an oath or declaration, there may be no power of attorney in the application.”

This means that access to provisional applications is more restricted and typically requires specific written authority from key parties involved in the application. The absence of a required oath or declaration in provisional applications also affects how access is granted, as there may not be a formal power of attorney on file.

For more information on certified copies, visit: certified copies.

For more information on written authority, visit: written authority.

Access to patent applications for unregistered individuals is granted through a specific process outlined in MPEP 104:

“Unregistered employees of attorneys or agents, public stenographers, and all other persons not within the provisions of paragraphs (A) and (B) above will be given access only upon presentation of a written authorization for access (power to inspect) signed by a person specified in paragraph (A) above, which authorization will be entered as a part of the official file.”

This means that unregistered individuals must present a written authorization, often called a ‘power to inspect,’ signed by an authorized person such as the applicant, inventor, or attorney of record. The authorization must specifically name the person granted access and be limited to a single application. The USPTO provides Form PTO/SB/67 for this purpose.

For more information on Patent application access, visit: Patent application access.

For more information on power to inspect, visit: power to inspect.

For patent applications filed before September 16, 2012, the rules for granting power to inspect are slightly different. According to MPEP 104:

“For applications filed prior to September 16, 2012, if an executed oath or declaration pursuant to 37 CFR 1.63 or 1.497 has been filed, no person but the applicant (any one of joint applicants), an attorney or agent of record (if a power of attorney was filed), or an assignee whose assignment is of record will be permitted to have access to the file of any pending application kept in confidence under 35 U.S.C. 122(a), except as provided for under 37 CFR 1.11, 1.14, 41.6, or 42.412.”

This means that for older applications, access is more restricted once an oath or declaration has been filed, limiting it to the applicant, attorney or agent of record, or assignee of record, unless specific exceptions apply.

For more information on application access, visit: application access.

For more information on power to inspect, visit: power to inspect.

For more information on pre-AIA applications, visit: pre-AIA applications.

A person acting in a representative capacity under 37 CFR 1.34 may execute a power to inspect an application only if:

  • The patent practitioner was named in the application transmittal papers filed under 37 CFR 1.53 or the national stage documents filed under 37 CFR 1.495, and
  • A power of attorney has not been appointed under 37 CFR 1.32.

Once a power of attorney has been filed, any previously filed power to inspect signed by a patent practitioner who does not have a power of attorney will cease to have effect.

For Image File Wrapper (IFW) applications, the process of granting power to inspect is different. According to MPEP 104:

“Powers to inspect are not accepted in Image File Wrapper (IFW) applications. IFW applications are available through the Private Patent Application Information Retrieval (PAIR) system, and pro se applicants and attorneys of record have direct access to the IFW through Private PAIR (when a Customer Number is associated with the correspondence address for the application, and the applicant or attorney has access to Private PAIR for the customer number).”

This means that for IFW applications, access is typically granted through the Private PAIR system, eliminating the need for traditional powers to inspect. If access through Private PAIR is not possible, alternative methods for viewing the application may be necessary.

For more information on Patent application access, visit: Patent application access.

For more information on power to inspect, visit: power to inspect.

For more information on Private PAIR, visit: Private PAIR.

Yes, the Director of the USPTO has the authority to grant access to patent applications in certain circumstances. According to MPEP 104:

“Access provided upon the written order of the Director will also become a part of the record of the application.”

Additionally, the MPEP states:

“Where an applicant relied on the applicant’s application as a means to interfere with a competitor’s business or customers, permission to inspect the application may be given the competitor by the Director. Such permission is via petition for access under 37 CFR 1.14(i).”

This means that in special cases, particularly where there may be competitive interests at stake, the Director can authorize access to an application. However, this permission is not of a continuing nature and may be subject to reevaluation based on changing circumstances.

For more information on Patent application access, visit: Patent application access.

For more information on petition for access, visit: petition for access.

Yes, but with limitations. According to MPEP 104:

“A person acting in a representative capacity under 37 CFR 1.34 may execute a power to inspect an application only if the patent practitioner was named in the application transmittal papers filed under 37 CFR 1.53 or the national stage documents filed under 37 CFR 1.495 and a power of attorney has not been appointed under 37 CFR 1.32.”

This means that a representative can execute a power to inspect only if they were named in the initial application papers and no formal power of attorney has been filed. Once a power of attorney is filed, any previously filed power to inspect by a practitioner without power of attorney becomes ineffective.

For more information on power to inspect, visit: power to inspect.

For more information on representative capacity, visit: representative capacity.

No, powers to inspect are not accepted in Image File Wrapper (IFW) applications. IFW applications are available through the Private Patent Application Information Retrieval (PAIR) system, and pro se applicants and attorneys of record have direct access to the IFW through Private PAIR when:

  • A Customer Number is associated with the correspondence address for the application, and
  • The applicant or attorney has access to Private PAIR for the customer number

In addition, IFW application files of published applications or patents are available at least through Patent Center. If an applicant, inventor, assignee, or attorney/agent of record cannot view an IFW application through Private PAIR or Patent Center, then a copy of the application must be purchased from the Patent and Trademark Copy Fulfillment Branch of the Public Records Division.

MPEP 105 - Suspended or Excluded Practitioner Cannot Inspect (8)

If a suspended practitioner is given power to inspect a patent application, the USPTO will not accept it. MPEP 105 clearly states: “Power to inspect given to such an attorney or agent will not be accepted.” This means that even if an applicant or inventor attempts to grant inspection rights to a suspended practitioner, the USPTO will reject this authorization and prevent the suspended practitioner from accessing the application materials.

To learn more:

The USPTO refers to ‘suspended or excluded practitioners’ in MPEP 105 as “an attorney or agent who has been suspended or excluded from practice by the USPTO.” This typically refers to patent attorneys or agents who have faced disciplinary action and are temporarily or permanently barred from practicing before the USPTO. These individuals are subject to specific restrictions, including the inability to communicate with USPTO employees about patent applications or inspect application materials, unless they are the inventor or applicant.

To learn more:

In most cases, no. USPTO employees are prohibited from communicating, either orally or in writing, with a suspended or excluded patent attorney or agent regarding a patent application. The MPEP states:

USPTO employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application…

The only exception is if the suspended or excluded practitioner is the inventor or applicant on that specific application. Otherwise, USPTO staff cannot discuss an application with a practitioner who has been suspended or excluded from practice before the USPTO.

No, a suspended or excluded practitioner cannot inspect patent applications. According to MPEP 105, “Power to inspect given to such an attorney or agent will not be accepted.” This means that the USPTO will not allow suspended or excluded practitioners to access or review patent applications, even if they are given permission by the applicant.

To learn more:

No, a patent attorney or agent who has been suspended or excluded from practice by the USPTO cannot inspect patent applications, unless they are an inventor or applicant on that particular application. The MPEP states:

USPTO employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application unless it is one in which said attorney or agent is an inventor or the applicant. Power to inspect given to such an attorney or agent will not be accepted.

This policy prevents suspended or excluded practitioners from accessing confidential application information they are no longer authorized to view.

Generally, no. MPEP 105 states: “U.S. Patent and Trademark Office (USPTO) employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application.” This prohibition applies to all forms of communication about patent applications with suspended or excluded practitioners.

To learn more:

Yes, there is one exception to the communication ban. According to MPEP 105, USPTO employees may communicate with a suspended or excluded practitioner “unless it is one in which said attorney or agent is an inventor or the applicant.” This means that if the suspended or excluded practitioner is listed as an inventor or is the applicant on a patent application, USPTO employees are allowed to communicate with them regarding that specific application.

To learn more:

Yes, there is one exception. A suspended or excluded patent attorney or agent can inspect an application if they are the inventor or applicant of that particular application. The MPEP clarifies:

USPTO employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application unless it is one in which said attorney or agent is an inventor or the applicant.

So while suspended or excluded practitioners generally cannot inspect applications, they can still access ones in which they are directly involved as the inventor or applicant.

MPEP 106-Control of Inspection by Assignee (24)

A patent application typically becomes publicly accessible after it is published. MPEP 106 states:

Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.

This publication usually occurs 18 months after the earliest filing date of the application, as per 35 U.S.C. 122(b). At this point, any previous restrictions on access, including those placed on inventors, are lifted, and the application becomes part of the public record.

For more information on public access, visit: public access.

An assignee of the entire interest in a patent application has broader rights regarding inspection compared to a part interest assignee. According to MPEP 106.01, an assignee of the entire interest may inspect the application file wrapper and be granted access to the subject matter of the application. This is because they have acquired all rights to the patent application and are considered to have stepped into the shoes of the inventor(s) for all practical purposes related to the application.

According to MPEP 106.01, assignees of a part interest or licensees of exclusive right have the right to inspect the patent application. The MPEP states:

“[A]n assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.”

However, it’s important to note that these parties do not have the right to intervene in the prosecution of the application or interference, which is reserved for the assignee of record of the entire interest.

For more information on partial assignee rights, visit: partial assignee rights.

For more information on patent application inspection, visit: patent application inspection.

Partial assignees and exclusive licensees have specific rights regarding patent application inspection. According to MPEP 106.01, “an assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.” This means that even if you don’t own the entire interest in a patent application, you still have the right to review its contents.

However, it’s important to note that partial assignees cannot intervene in the prosecution of an application or interference to the exclusion of the applicant. Only the assignee of record of the entire interest has this ability.

For more information on patent rights, visit: patent rights.

Partial assignees have limited rights regarding the inspection of patent applications. According to MPEP 106.01, an assignee of a part interest in a patent application is not entitled to inspect the application without written authority from the inventor or the other assignee(s). This restriction is in place to protect the interests of all parties involved in the patent application process.

37 CFR 1.46 is significant in patent application prosecution, particularly for applications filed on or after September 16, 2012. According to MPEP 106.01, this regulation allows the assignee of record of the entire interest to become the applicant and prosecute the application.

The MPEP states: ‘…for applications filed on or after September 16, 2012, [the assignee] can prosecute the application after becoming the applicant under 37 CFR 1.46.’

This regulation is part of the changes implemented by the America Invents Act (AIA) and provides more flexibility for assignees in managing patent applications.

Access restrictions on patent applications change significantly after publication. According to MPEP 106, “Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.”

This means that once a patent application is published, typically 18 months after the earliest filing date, any previously imposed restrictions on access, including those on the inventor, are lifted. The application becomes publicly accessible, aligning with the USPTO’s goal of promoting transparency in the patent process.

For more information on public availability, visit: public availability.

For more information on USPTO procedures, visit: USPTO procedures.

If an assignee of a part interest refuses to join in an application for reissue, the reissue may still be applied for by the assignee of the entire interest. This is outlined in MPEP 1410. The assignee of the entire interest can file the reissue application as the sole applicant. However, the assignee must comply with the requirements of 37 CFR 1.172, which includes submitting an oath or declaration by the assignee.

The MPEP 106.01 highlights a key difference in assignee rights for patent applications filed before and after September 16, 2012:

  • For applications filed before September 16, 2012: The assignee of record of the entire interest can intervene in the prosecution of an application or interference to the exclusion of the applicant.
  • For applications filed on or after September 16, 2012: The assignee of record of the entire interest can not only intervene but also prosecute the application after becoming the applicant under 37 CFR 1.46.

For more detailed information, the MPEP directs readers to:

  • MPEP § 324 for applications filed before September 16, 2012
  • MPEP § 325 for applications filed on or after September 16, 2012

The USPTO verifies an assignee’s right to inspect a patent application through documentation. As per MPEP 106.01, the assignee must provide either a copy of the assignment recorded in the USPTO or other evidence of ownership. This documentation is necessary to establish the assignee’s legal right to access the confidential information contained in the patent application.

When the USPTO receives conflicting instructions from multiple assignees or co-inventors regarding a patent application, it follows a specific protocol to ensure fair treatment of all parties. According to MPEP 106, the USPTO will not arbitrate disputes between the parties.

In such cases, the USPTO typically:

  • Suspends action on the application until the conflict is resolved
  • Notifies all parties of the conflicting instructions
  • Advises the parties to resolve the dispute among themselves or through the courts
  • Resumes prosecution only when clear, consistent instructions are received from all interested parties or when a court order is issued

This approach ensures that the USPTO remains neutral and that the rights of all assignees and inventors are protected throughout the patent prosecution process.

The filing date of a patent application can affect the prosecution rights of assignees. MPEP 106.01 distinguishes between applications filed before and after September 16, 2012:

  • For applications filed before September 16, 2012: See MPEP § 324 for information on prosecution by the assignee.
  • For applications filed on or after September 16, 2012: See MPEP § 325 for details on prosecution by the assignee.

The MPEP states: “For information pertaining to prosecution by the assignee, see MPEP § 324 (for applications filed before September 16, 2012) and MPEP § 325 (for applications filed on or after September 16, 2012).”

This distinction is important because the America Invents Act, which went into effect on September 16, 2012, introduced changes to patent law that affected assignee rights and procedures.

For more information on America Invents Act, visit: America Invents Act.

For more information on patent law changes, visit: patent law changes.

The America Invents Act (AIA) significantly affected assignee rights in patent applications, particularly for those filed on or after September 16, 2012. MPEP 106.01 highlights one key change:

‘…for applications filed on or after September 16, 2012, [the assignee] can prosecute the application after becoming the applicant under 37 CFR 1.46.’

This change allows assignees of the entire interest to take a more active role in patent prosecution by becoming the applicant. The AIA aimed to modernize the U.S. patent system and align it more closely with international practices.

For more detailed information on how the AIA affects assignee rights, refer to MPEP § 325 for applications filed on or after September 16, 2012.

An inventor’s access to their patent application can be restricted, but it requires a specific process. According to MPEP 106, “Any request to prevent the inventor from obtaining access to the file should be filed as a separate paper, 37 CFR 1.4(c), and should be directed to the Office of Petitions.”

If the request is granted, the inventor will be informed that they can only inspect the application if they can show why such inspection is necessary to conserve their rights. It’s important to note that this restriction is temporary. Once the application is published under 35 U.S.C. 122(b), it becomes publicly available, and any previously granted restrictions on the inventor’s access will no longer be in effect.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

Inventors or applicants can control access to their patent application by assignees through explicit consent or denial. As outlined in MPEP 106.01, the applicant has the right to decide whether to grant or deny access to the application, especially in cases involving part interest assignees. This control mechanism allows inventors to protect sensitive information or maintain strategic advantage during the patent prosecution process. Applicants can communicate their consent or denial of access to the USPTO, which will then enforce these preferences regarding application inspection.

While it’s uncommon, there is a process for restricting an inventor’s access to their patent application. According to MPEP 106:

Any request to prevent the inventor from obtaining access to the file should be filed as a separate paper, 37 CFR 1.4(c), and should be directed to the Office of Petitions. If the request is granted, the inventor will be informed that he or she will only be permitted to inspect the application on sufficient showing why such inspection is necessary to conserve his or her rights.

This process requires a specific request and justification. It’s important to note that such restrictions are temporary, as the MPEP also states, Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

No, once a patent application publishes under 35 U.S.C. 122(b), it becomes available to the public. At that point, any previous grant restricting the inventor’s access to the application file is no longer in effect.

Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.

Yes, an assignee of the entire interest in a patent application can grant inspection rights to others. According to MPEP 106.01, the assignee of the entire interest has the same rights as the inventor and may authorize anyone to inspect the application. This authority stems from the assignee’s complete ownership of the patent application.

No, an assignee of a part interest in a patent application cannot prevent other parties from accessing the application. According to MPEP 106, the assignee of a part interest may not control prosecution of the application to the exclusion of the inventor or other assignees. This means that all parties with an interest in the application have the right to access and inspect the application file.

The USPTO recognizes the rights of all interested parties and ensures that no single party can restrict access to the application information. This policy promotes transparency and fairness in the patent examination process.

No, an assignee of a part interest in a patent application cannot inspect the application without the consent of the inventor or other assignees. According to MPEP 106.01, the assignee of a part interest may not have access to the application file wrapper or be granted access to the subject matter of the application without the applicant’s consent. This restriction is in place to protect the interests of all parties involved in the patent application process.

No, an assignee of a part interest alone cannot file a reissue application. According to MPEP 1410, a reissue application must be applied for by all of the inventors, unless the application is accompanied by a petition under 37 CFR 1.182 for waiver of the requirement. Alternatively, the assignee of the entire interest can file the reissue application. An assignee of only a part interest is not entitled to file a reissue application on his or her own.

Yes, an assignee of record of the entire interest in a patent application can control access to it. According to MPEP 106, “The applicant or assignee of record of the entire interest in an application may file an application or intervene in the prosecution of the application, appointing an attorney or agent of his or her own choice.” This means that the assignee can manage the application’s prosecution and potentially limit access to it.

However, it’s important to note that “Such an application filing or intervention, however, does not exclude the inventor from access to the application to see that it is being prosecuted properly, unless the applicant or assignee makes specific request to that effect.” Any request to prevent the inventor’s access must be filed separately and directed to the Office of Petitions.

For more information on assignee rights, visit: assignee rights.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

Yes, the applicant or assignee of record of the entire interest in an application can make a specific request to prevent the inventor from obtaining access to the application file. This request should be filed as a separate paper under 37 CFR 1.4(c) and directed to the Office of Petitions. If granted, the inventor will only be permitted to inspect the application upon sufficient showing of why it is necessary to preserve their rights.

Any request to prevent the inventor from obtaining access to the file should be filed as a separate paper, 37 CFR 1.4(c), and should be directed to the Office of Petitions. If the request is granted, the inventor will be informed that he or she will only be permitted to inspect the application on sufficient showing why such inspection is necessary to conserve his or her rights.

Yes, according to MPEP 106.01, an assignee of a part interest or a licensee of exclusive right is entitled to inspect the patent application. The MPEP states: ‘an assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.’

This right to inspection is distinct from the right to intervene in or prosecute the application, which is reserved for the assignee of the entire interest.

MPEP 110-Confidential Nature of International Applications (8)

The USPTO has specific rules for making international application files available to the public. According to MPEP 110, which cites 37 CFR 1.14(g), After publication of an application under 35 U.S.C. 122(b), the USPTO will make available copies of the application files and also allow for access to those files in accordance with 37 CFR 1.14(a). Specifically for international applications, after publication of an international application designating the U.S. under PCT Article 21, the USPTO will make available copies of, and allow access to, those international application files which are kept in the USPTO. However, this access is subject to certain conditions and restrictions, such as the payment of appropriate fees and the exclusion of certain documents like the Examination Copy.

For more information on public access, visit: public access.

For more information on USPTO, visit: USPTO.

Third parties cannot access an international patent application until the earliest of:

  • The international publication date
  • Date of receipt of the communication of the application under PCT Article 20
  • Date of receipt of a copy of the application under PCT Article 22

This is specified in PCT Article 30(2)(a):

“No national Office shall allow access to the international application by third parties, unless requested or authorized by the applicant, before the earliest of the following dates: (i) date of the international publication of the international application, (ii) date of receipt of the communication of the international application under Article 20, (iii) date of receipt of a copy of the international application under Article 22.”

National offices have specific restrictions on allowing access to international patent applications. According to MPEP 110, which cites PCT Article 30(2)(a), No national Office shall allow access to the international application by third parties unless requested or authorized by the applicant, before the earliest of the following dates:

  • Date of international publication
  • Date of receipt of the communication under PCT Article 20
  • Date of receipt of a copy under PCT Article 22

This provision ensures that the confidentiality of the application is maintained until certain milestones in the patent process are reached.

International patent applications are kept confidential before their international publication, as specified in MPEP 110. According to PCT Article 30, the International Bureau and the International Searching Authorities shall not allow access by any person or authority to the international application before the international publication of that application, unless requested or authorized by the applicant. This confidentiality ensures that inventors’ rights are protected during the early stages of the patent process.

For more information on international patent applications, visit: international patent applications.

International patent applications filed under the PCT are generally kept confidential and not made publicly available before international publication, which occurs soon after the expiration of 18 months from the priority date, according to PCT Article 21(2)(a). The International Bureau and International Searching Authorities are not allowed to give access to the application to any person or authority before publication unless requested or authorized by the applicant, with some exceptions.

As stated in MPEP 110:

“Although most international applications are published soon after the expiration of 18 months from the priority date, PCT Article 21(2)(a), such publication does not open up the Home Copy or Search Copy to the public for inspection, except as provided in 37 CFR 1.14(g).”

While national offices are generally restricted from allowing access to international patent applications, they can disclose limited information. According to MPEP 110, which cites PCT Article 30(2)(b), national offices may inform third parties that they have been designated and publish this fact. However, such information or publication is limited to:

  • Identification of the receiving Office
  • Name of the applicant
  • International filing date
  • International application number
  • Title of the invention

This provision allows for some transparency in the patent process while still maintaining the confidentiality of the application’s details.

For more information on international patent applications, visit: international patent applications.

The United States Patent and Trademark Office (USPTO) has specific procedures for maintaining the confidentiality of international applications filed in the U.S. According to MPEP 110, which references 35 U.S.C. 368, International applications filed in the Patent and Trademark Office shall be subject to the provisions of chapter 17. This means that such applications are subject to the same secrecy provisions as regular U.S. patent applications. Additionally, If a license to file in a foreign country is refused or if an international application is ordered to be kept secret and a permit refused, the Patent and Trademark Office when acting as a Receiving Office, International Searching Authority, or International Preliminary Examining Authority, may not disclose the contents of such application to anyone not authorized to receive such disclosure. This ensures that sensitive information in international applications is protected in accordance with U.S. law.

For more information on international applications, visit: international applications.

For more information on USPTO, visit: USPTO.

A national patent office may inform third parties that it has been designated in an international application and publish that fact. However, the publication can only contain limited bibliographic data, as specified in PCT Article 30(2)(b):

“Such information or publication may, however, contain only the following data: identification of the receiving Office, name of the applicant, international filing date, international application number, and title of the invention.”

The national office still cannot allow third parties to access the full application until the conditions outlined in PCT Article 30(2)(a) are met.

MPEP 115-Review of Applications for National Security and Property Rights Issues (10)

While the initial screening for sensitive subject matter is performed by designated personnel, patent examiners also play a crucial role in this process. The MPEP states:

While the initial screening is performed only by designated personnel, all examiners have a responsibility to be alert for obviously sensitive subject matter either in the original disclosure or subsequently introduced, for example, by amendment.

If an examiner identifies potentially sensitive subject matter, they are instructed to take action:

If the examiner is aware of subject matter which should be subject to screening by appropriate office personnel, this should be brought to the attention of Licensing and Review.

This ongoing vigilance by examiners helps ensure that sensitive information is not inadvertently disclosed, even if it was not identified during the initial screening process.

For more information on Patent examiners, visit: Patent examiners.

All provisional applications filed under 35 U.S.C. 111(b), nonprovisional applications filed under 35 U.S.C. 111(a), international applications filed under the PCT, and international design applications filed under the Hague Agreement are reviewed by the USPTO for three main purposes:

  1. To determine if a foreign filing license can be granted under 35 U.S.C. 184
  2. To identify inventions in which the Department of Energy (DOE) or NASA might have property rights
  3. To determine if the application contains subject matter detrimental to national security that warrants a secrecy order under 35 U.S.C. 181

The process for obtaining a foreign filing license is part of the USPTO’s screening procedure for patent applications. The MPEP states:

A third function of the screening procedure is to process foreign filing license petitions under37 CFR 5.12(a). SeeMPEP § 140.

The foreign filing license is automatically granted in most cases as part of the application filing process. However, if the application contains subject matter that requires further review, the applicant may need to petition for a foreign filing license separately.

To obtain a foreign filing license, applicants should:

  1. File a patent application with the USPTO
  2. Wait for the automatic screening process to complete
  3. If a license is not automatically granted, file a petition under 37 CFR 5.12(a)
  4. Provide any additional information requested by the USPTO

It’s important to note that filing an application abroad without first obtaining a foreign filing license can have serious consequences, including abandonment of the U.S. application and potential criminal penalties.

For more information on foreign filing license, visit: foreign filing license.

For more information on patent applications, visit: patent applications.

For more information on USPTO procedures, visit: USPTO procedures.

A Secrecy Order is a directive issued by the Commissioner for Patents to keep an invention secret and withhold the publication of a patent application or the grant of a patent. It is issued when:

  1. A defense agency concludes that disclosure of the invention would be detrimental to national security
  2. The agency recommends a Secrecy Order to the Commissioner for Patents

According to 35 U.S.C. 181, Whenever publication or disclosure by the publication of an application or by the grant of a patent on an invention in which the Government has a property interest might, in the opinion of the head of the interested Government agency, be detrimental to the national security, the Commissioner of Patents upon being so notified shall order that the invention be kept secret and shall withhold the publication of an application or the grant of a patent therefor under the conditions set forth hereinafter.

The Secrecy Order remains in effect for such period as the national interest requires, effectively preventing public disclosure of the invention.

For more information on patent applications, visit: patent applications.

If a defense agency concludes that disclosure of the invention would be detrimental to national security, they will recommend a secrecy order to the Commissioner for Patents. The Commissioner will then issue the secrecy order and withhold publication of the application or granting of a patent for as long as the national interest requires.

“If a defense agency concludes that disclosure of the invention would be detrimental to the national security, a secrecy order is recommended to the Commissioner for Patents. The Commissioner then issues a Secrecy Order and withholds the publication of the application or the grant of a patent for such period as the national interest requires.”

National security classified patent applications may be filed with the USPTO in the following ways:

  • Hand-carried to Licensing and Review
  • Mailed to the USPTO in compliance with 37 CFR 5.1(a) and Executive Order 13526
  • Filed via the Department of Defense Secret Internet Protocol Router Network (SIPRNET) – these will be considered filed via the USPTO patent electronic filing system

The applicant must also either obtain a secrecy order or provide authority to cancel the security markings per 37 CFR 5.1(d).

The USPTO has specific procedures for handling foreign language provisional applications during the screening process. According to the MPEP:

Provisional applications filed in a foreign language are also screened under these provisions. The Office will make an attempt to determine the subject matter of the application, but the applicant may be required to provide at least an English language abstract of the information for screening purposes.

To avoid potential delays in the screening process, the MPEP strongly recommends:

It is strongly recommended that if the applicant is in possession of an English language description of the technology, it should be filed with the provisional application to prevent screening delays.

This recommendation helps ensure that the USPTO can efficiently review the application for national security and property rights issues without language barriers impeding the process.

For more information on patent procedure, visit: patent procedure.

The USPTO has specific procedures for handling applications in which the government may have a property interest. According to the MPEP:

For those applications in which the Government has a property interest (including applications indicating national security classified subject matter), responsibility for notifying the Commissioner for Patents of the need for a Secrecy Order resides with the agency having that interest.

Additionally, the screening process identifies inventions that may be of interest to specific government agencies:

A second purpose for the screening of all applications, with an exception for provisional applications, is to identify inventions in which DOE or NASA might have property rights. See42 U.S.C. 2182,51 U.S.C. 20135, andMPEP § 150.

This process ensures that government agencies are notified of inventions that may fall under their purview and allows them to take appropriate action, such as requesting a Secrecy Order if necessary.

For more information on patent applications, visit: patent applications.

The USPTO has a specific process to ensure that all applications are cleared from secrecy review before they are issued as patents. According to the MPEP:

All applications are required to be cleared from secrecy review before forwarding to issue. If the L&R code on the general information display does not equal 1, then in an IFW application, a message should be sent to LREVINCOMINGDOCS.

The USPTO uses a system called the Patent Data Portal (PDP) to track the status of applications:

The Patent Data Portal (PDP) System’s general information display discloses the current Licensing and Review status. The indicator “L&R code” displays the current status of the application while the indicators “Third Level Review” and “Secrecy Order” display the historical status of the application.

Specific codes are used to indicate the status of an application:

  • An L&R code of “3” or a “Third Level Review” of “Yes” indicates that the application is/has been considered for security screening.
  • A Secrecy Code of “4” indicates that the application is currently under Secrecy Order.

If an application is under Secrecy Order, special handling is required:

In this case, the application has been converted to a paper application file and there should be no images maintained in the Image File Wrapper system (IFW).

This process ensures that no application is issued as a patent until it has been fully cleared from secrecy review, protecting sensitive information and national security interests.

For more information on patent issuance, visit: patent issuance.

For more information on USPTO procedures, visit: USPTO procedures.

National security classified patent applications require special handling by the USPTO. The MPEP states that:

National security classified documents filed in the USPTO must be either hand-carried to Licensing and Review or mailed to the Office in compliance with37 CFR 5.1(a)and Executive Order 13526 of December 29, 2009.

However, the USPTO has made provisions for secure electronic filing:

The Office will accept such applications filed with the USPTO via the Department of Defense Secret Internet Protocol Router Network (SIPRNET) and consider them as filed via the USPTO patent electronic filing system for purposes of37 CFR 1.16(t)and37 CFR 1.445(a)(ii).

Applicants filing national security classified applications must also obtain a secrecy order or provide authority to cancel the security markings, as per37 CFR 5.1(d). The USPTO’s Licensing and Review office can provide a list of contacts at the appropriate defense agencies for this purpose.

For more information on classified patent applications, visit: classified patent applications.

MPEP 120-Secrecy Orders (19)

A Secrecy Order applies to the subject matter of the invention, not just the patent application itself. It restricts disclosure or publication of the invention in any form. Other related patent applications which contain any significant part of the subject matter also fall under the scope of the order and must be brought to the USPTO’s attention. (MPEP 120 Section II)

A secrecy order is issued to prevent the disclosure of sensitive information in patent applications that could be detrimental to national security. According to MPEP 120, “The purpose of this Act is to prevent disclosure of inventions by the publication of applications or by the granting of patents that might be detrimental to the national security.” These orders are typically issued for inventions that have military applications or involve critical technologies.

For more information on invention disclosure, visit: invention disclosure.

A Secrecy Order is an order issued by the Commissioner for Patents that prevents disclosure or publication of an invention in a patent application when the publication or disclosure would be detrimental to national security. The order requires that the invention be kept secret and may restrict filing of foreign patent applications. (MPEP 120)

A Secrecy Order is an official directive issued by the Commissioner for Patents when notified by the chief officer of a defense agency that publication or disclosure of an invention through a patent grant would be detrimental to national security. As stated in 37 CFR 5.2(a):

When notified by the chief officer of a defense agency that publication or disclosure of the invention by the granting of a patent would be detrimental to the national security, an order that the invention be kept secret will be issued by the Commissioner for Patents.

This order restricts disclosure of the invention and delays the grant of a patent until the order is rescinded.

What happens if a secrecy order is violated?

Violating a secrecy order can have serious consequences. According to MPEP 120, “Unauthorized disclosure of the subject matter of an application under a secrecy order is punishable by a fine and/or imprisonment (35 U.S.C. 186), and may result in loss of patent rights (35 U.S.C. 182).” This means that individuals who disclose information about an application under a secrecy order without proper authorization may face:

  • Monetary fines
  • Imprisonment
  • Loss of patent rights

It’s crucial for inventors, patent agents, and attorneys to strictly adhere to secrecy orders to avoid these severe penalties.

For more information on unauthorized disclosure, visit: unauthorized disclosure.

There are three types of Secrecy Orders, each with a different scope:n

    n

  1. Type I – Secrecy Order and Permit for Foreign Filing in Certain Countries
  2. n

  3. Type II – Secrecy Order and Permit for Disclosing Classified Information
  4. n

  5. Type III – General Secrecy Order
  6. n

nThe Type I order permits filing in certain countries with security agreements, Type II allows classified or classifiable disclosure, and Type III prevents disclosure without written consent from the Commissioner. (MPEP 120 Section I)

Violating a secrecy order can have severe consequences. According to MPEP 120, “Unauthorized disclosure of the subject matter of an application under a secrecy order is punishable by a fine and/or imprisonment.” Specifically:

  • The fine can be up to $10,000
  • Imprisonment can be up to two years
  • These penalties apply for each offense

Additionally, violation of a secrecy order can result in the abandonment of the application. It’s crucial for inventors and patent practitioners to strictly adhere to secrecy orders to avoid these serious legal consequences.

Violating a secrecy order on a patent application can have severe consequences. MPEP 120 states, “If, prior to or after the issuance of the secrecy order, any significant part of the subject matter or material information relevant to the application has been or is revealed to any U.S. citizen in the United States, the principals must promptly inform such person of the secrecy order and the penalties for improper disclosure.” The penalties for violation can include:

It’s crucial for applicants and their representatives to strictly adhere to secrecy orders to avoid these serious consequences.

Under 35 U.S.C. 181, a Secrecy Order remains in effect for a period of 1 year from its date of issuance. It may be renewed for additional periods of not more than 1 year upon notice by a government agency that the national interest requires it. The applicant is notified of any renewal. (MPEP 120 Section VII)

A secrecy order can remain in effect for a significant period. As stated in MPEP 120, “The secrecy order may remain in effect for the duration of the national emergency and six months thereafter and automatically expires at the end of that period.” However, it’s important to note that:

  • The order can be renewed if necessary
  • It can be terminated earlier if the reasons for its issuance no longer exist
  • The total duration is subject to the provisions of 35 U.S.C. 181

For more information on secrecy order duration, visit: secrecy order duration.

How does a secrecy order affect patent term and maintenance fees?

A secrecy order can have significant impacts on both the patent term and maintenance fees. According to MPEP 120:

“If the application is found to be allowable during the secrecy order period, it will be passed to issue upon the removal or rescission of the secrecy order.”

This means that while under a secrecy order:

  • The patent application’s examination continues, but issuance is delayed.
  • The patent term may be affected, as it typically begins on the issue date.
  • No maintenance fees are due until the patent is issued.

However, the law provides some compensation for these delays. “The term of the patent may be extended for the period of delay due to the secrecy order pursuant to 35 U.S.C. 154(b).” This extension helps to offset the time lost due to the secrecy order, ensuring that inventors don’t lose patent protection time unfairly.

For more information on patent term, visit: patent term.

Tags: patent term

A Secrecy Order significantly impacts the prosecution of a patent application. According to 37 CFR 5.3:

Unless specifically ordered otherwise, action on the application by the Office and prosecution by the applicant will proceed during the time an application is under secrecy order to the point indicated in this section.

Key effects include:

  • Applications under final rejection must be appealed or prosecuted to avoid abandonment, but appeals won’t be set for hearing until the Secrecy Order is removed.
  • Interferences or derivation proceedings won’t be instituted for applications under Secrecy Order.
  • When the application is in condition for allowance, the applicant and the relevant agency will be notified, but no notice of allowance will be issued until the Secrecy Order is removed.
  • International applications under Secrecy Order won’t be transmitted to international authorities or the applicant.

These restrictions ensure that sensitive information remains protected while allowing some progress in the application process.

For more information on international applications, visit: international applications.

For more information on patent prosecution, visit: patent prosecution.

A secrecy order significantly impacts the foreign filing of a patent application. According to MPEP 120:

“The issuance of a secrecy order does not alter the applicant’s right to appeal to the Patent Trial and Appeal Board or to file a civil action under 35 U.S.C. 145 or 146, except that if such appeal or civil action involves national security issues, prior approval of the Commissioner for Patents must be obtained.”

This means:

  • The applicant cannot file the application in foreign countries without permission
  • Foreign filing licenses are not granted while a secrecy order is in effect
  • The applicant must wait for the secrecy order to be lifted before pursuing international patent protection
  • Any attempt to file abroad without authorization could result in abandonment of the U.S. application and other penalties

It’s crucial for inventors to understand these restrictions to maintain their patent rights and avoid legal issues.

For more information on foreign filing license, visit: foreign filing license.

Yes, an applicant can petition for rescission or modification of a Secrecy Order. The MPEP states:

Applicants may petition for rescission or modification of the Secrecy Order. For example, if the applicant believes that certain existing facts or circumstances would render the Secrecy Order ineffectual, they may informally contact the sponsoring agency to discuss these facts or formally petition the Commissioner for Patents to rescind the Order.

The process for petitioning is outlined in 37 CFR 5.4 and 5.5. Key points include:

  • Petitions must be filed in duplicate and recite facts that purport to render the order ineffectual or futile.
  • For modification to permit foreign filing, all countries and disclosees must be identified.
  • Appeals can be made to the Secretary of Commerce if a petition for rescission is denied.

Applicants should carefully consider the reasons for seeking rescission or modification and provide comprehensive information in their petition.

Yes, an applicant can appeal a secrecy order issued on their patent application. According to MPEP 120, “An appeal to the Secretary of Commerce, as provided by 35 U.S.C. 181, from a secrecy order cannot be taken until after a petition for rescission of the secrecy order has been made and denied.” This means that the applicant must first:

  1. Petition for rescission of the secrecy order
  2. If the petition is denied, then appeal to the Secretary of Commerce

The appeal process is governed by the provisions of 35 U.S.C. 181 and provides a mechanism for applicants to challenge the imposition of a secrecy order.

Yes, applicants may petition for rescission or modification of a Secrecy Order:n

    n

  • Applicants can informally contact the sponsoring defense agency to discuss rendering the order ineffectual, or formally petition the Commissioner for Patents to rescind the order.
  • n

  • Rescission may also be possible by expunging sensitive subject matter from the application, if it’s not needed for an enabling disclosure under 35 U.S.C. 112.
  • n

  • Applicants can also petition for a permit to disclose the invention to another or to modify the order, fully stating the reason or purpose. (MPEP 120 Section V)
  • n

Yes, a secrecy order can be appealed or reviewed. The MPEP 120 states: “A petition for rescission or modification of the secrecy order may be filed at any time.” Here’s what you need to know about the appeal process:

  • The petition should be filed with the Patent and Trademark Office (PTO)
  • It must include full statements of all facts and circumstances upon which the petition is based
  • The petition will be referred to the appropriate agency for consideration and recommendation
  • Based on the recommendation, the Commissioner for Patents will make the final decision

If the secrecy order is not rescinded, the applicant may seek further review through legal channels, such as filing a claim in the United States Court of Federal Claims.

Can a secrecy order be appealed or challenged?

Yes, a secrecy order can be appealed or challenged. The MPEP 120 states: “A petition for rescission or modification of the secrecy order may be filed by the principal inventor, any of the joint inventors, or the assignee.” This means that:

  • The principal inventor
  • Any joint inventors
  • The assignee of the patent application

can file a petition to challenge or seek modification of a secrecy order. The petition should be directed to the Commissioner for Patents and should include supporting reasons for the requested rescission or modification. It’s important to note that while an appeal is possible, secrecy orders are typically issued for national security reasons, so the process of challenging them can be complex and may require careful consideration of security implications.

Can a patent application under secrecy order be appealed?

Yes, patent applications under secrecy orders can be appealed, but with certain restrictions. MPEP 120 states: ‘Appeals to the Patent Trial and Appeal Board and petitions to the Director under 37 CFR 1.181 are available to the applicant in secrecy order cases, but those actions will not set aside the secrecy order.‘ This means that while you can appeal decisions related to the patentability of your application, such appeals cannot challenge or remove the secrecy order itself. The secrecy order remains in effect regardless of the appeal process.

For more information on patent appeal, visit: patent appeal.

For more information on patent procedure, visit: patent procedure.

For more information on patent trial and appeal board, visit: patent trial and appeal board.

MPEP 121-Handling of Applications under Secrecy Order and/or Bearing National Security Markings (7)

Applications subject to a Secrecy Order will be:

  • Deleted from any image file system within the USPTO
  • Converted to paper
  • Held with Licensing and Review
  • Transferred to a designated examiner for examination

For applications filed with apparent national security markings, the USPTO will:

  1. Notify the applicant via Licensing and Review
  2. Ask the applicant to either:
    • Explain the markings
    • Remove improper markings
    • Obtain a Secrecy Order if necessary
  3. Potentially refer the application to a defense agency for review under 35 U.S.C. 181 second paragraph if improper markings are found and removed

What are the requirements for personnel working with secrecy order applications?

Personnel working with secrecy order applications must meet specific security requirements. MPEP 121 outlines these requirements:

  • Must have proper security clearance
  • Are responsible for maintaining the secrecy of the applications
  • Must ensure applications are returned to secure storage when not in use

The MPEP emphasizes: ‘All applications bearing national security markings must be examined by properly cleared examiners.’ This ensures that only authorized individuals with the necessary security clearance have access to these sensitive patent applications, maintaining their confidentiality and national security integrity.

What are the procedures for transmitting secrecy order applications within the USPTO?

The transmission of secrecy order applications within the USPTO follows strict security protocols. MPEP 121 outlines these procedures:

  • Applications are hand-carried by authorized personnel
  • Transmittal slips are used to track the movement of applications
  • Applications must be signed for upon receipt

The MPEP emphasizes: ‘Classified material must be transmitted between offices in the Patent and Trademark Office in designated classified carriers.’ This ensures that secrecy order applications are always under secure control and their location is known at all times, minimizing the risk of unauthorized access or loss.

The MPEP states:

All applications or papers, including non-patent literature, in the U.S. Patent and Trademark Office bearing words such as “Secret,” “Confidential,” “ITAR” or similar must be promptly referred to Licensing and Review for clarification or security treatment.

These papers cannot be placed in public records like patented files until the security markings are declassified or explained.

How are classified documents marked at the USPTO?

Classified documents at the USPTO are marked with specific security classifications. According to MPEP 121:

  • Documents are marked as ‘Secret,’ ‘Confidential,’ or ‘Restricted Data’
  • These markings indicate the level of security required for handling the document
  • Each page of a classified document must bear the appropriate marking

The MPEP states: ‘All papers in the application and contents of the file jacket are marked with the highest level of security to which the application has been assigned.’ This ensures that all parts of the application are treated with the appropriate level of security throughout the examination process.

How are applications under secrecy order handled at the USPTO?

Applications under secrecy order at the USPTO are handled with strict security measures. According to MPEP 121, these applications are:

  • Stored in special safes or in metal cabinets equipped with three-position dial-type combination locks
  • Never removed from these secure storage areas except for processing
  • Processed and examined only by properly cleared personnel

The MPEP states: ‘Applications bearing national security markings must be stored in a safe or in metal cabinets equipped with a bar and a padlock.’ This ensures that access to these sensitive applications is strictly controlled and limited to authorized individuals only.

For more information on patent application handling, visit: patent application handling.

MPEP 130-Examination of Secrecy Order Cases (15)

When an examiner encounters an application with national security markings but no Secrecy Order, they must take specific actions. The MPEP instructs: In this case, the examiner should require the applicant to seek imposition of a Secrecy Order or authority to cancel the markings. This should preferably be done with the first action and, in any event, prior to final disposition of the application. This ensures that potentially sensitive information is properly handled during the examination process.

For more information on national security markings, visit: national security markings.

For more information on patent examination, visit: patent examination.

As explained in MPEP 130, when a patent application under a Secrecy Order is in condition for allowance, “a notice of allowability (Form D-10) is issued, thus closing the prosecution.” See 37 CFR 5.3(c).

After the notice of allowability is issued, any amendments received are not entered or responded to until the Secrecy Order is rescinded. Once the Secrecy Order is rescinded, amendments will be entered if they are free from objections, otherwise they will be denied entry.

When a Secrecy Order case is in condition for allowance, the prosecution is closed, but the patent is not issued. According to the MPEP, When a Secrecy Order case is in condition for allowance, a notice of allowability (Form D-10) is issued, thus closing the prosecution. This is in accordance with 37 CFR 5.3(c). The application remains in this state until the Secrecy Order is rescinded.

For more information on notice of allowability, visit: notice of allowability.

When a Secrecy Order is imposed on a patent application, it is examined in a secure location by examiners with national security clearances under the control of Licensing and Review. If the Secrecy Order is imposed after the application is already docketed in another Technology Center, it will be transferred to a designated examiner in Licensing and Review.

As stated in MPEP 130, “Secrecy Order cases are examined for patentability as in other cases, but will not be passed to issue; nor will an interference or derivation be instituted where one or more of the conflicting cases is classified or under Secrecy Order.”

Secrecy order applications require special handling procedures to maintain their confidentiality. According to MPEP 130:

Applications and papers in the application file, as well as any related papers, must be safeguarded from disclosure to unauthorized persons and must be securely kept in a locked area when not actually in use.

Additionally:

  • Secrecy order cases should not be processed on any automated information system (AIS) unless the AIS is certified for classified processing.
  • All processing should be done in a secure environment by personnel with appropriate clearances.
  • Special care must be taken to prevent inadvertent disclosure of classified information.

For more information on classified information, visit: classified information.

For more information on patent applications, visit: patent applications.

Secrecy order applications are subject to strict restrictions on foreign filing to protect national security. The MPEP 130 outlines these restrictions:

A secrecy order bars the filing of a foreign application based on the application under secrecy order without prior license from the Commissioner for Patents.

Key points regarding foreign filing restrictions:

  • Filing a foreign application without authorization is prohibited.
  • A license from the Commissioner for Patents is required for any foreign filing.
  • Unauthorized foreign filing can result in severe penalties, including abandonment of the application.
  • These restrictions are in place to prevent disclosure of sensitive information to foreign entities.

Inventors and applicants must be aware of these restrictions to avoid legal complications and potential national security breaches.

For more information on patent applications, visit: patent applications.

According to 37 CFR 5.1(d), an applicant must take one of three actions to prevent abandonment of a national security classified patent application without a Secrecy Order. The MPEP states: Pursuant to 37 CFR 5.1(d), if no Secrecy Order has issued in a national security classified patent application, the Office will set a time period within which the applicant must take one of the following three actions in order to prevent abandonment of the application: (A) obtain a Secrecy Order; (B) declassify the application; or (C) submit evidence of a good faith effort to obtain a Secrecy Order pursuant to 37 CFR 5.2(a). These actions ensure proper handling of potentially sensitive information.

For more information on patent abandonment, visit: patent abandonment.

If an examiner comes across a patent application that contains national security markings but does not have a Secrecy Order imposed, MPEP 130 instructs that “the examiner should require the applicant to seek imposition of a Secrecy Order or authority to cancel the markings.” This should be done preferably with the first office action and before final disposition of the application.

37 CFR 5.1(d) states that if no Secrecy Order has issued, the USPTO will set a time period for the applicant to take one of three actions to prevent abandonment:

  1. Obtain a Secrecy Order
  2. Declassify the application
  3. Submit evidence of a good faith effort to obtain a Secrecy Order under 37 CFR 5.2(a)

Additionally, per 37 CFR 5.1(e), “a national security classified patent application will not be allowed until the application is declassified and any Secrecy Order pursuant to 37 CFR 5.2(a) has been rescinded.”

A national security classified patent application cannot be allowed until specific conditions are met. The MPEP clearly states: Pursuant to 37 CFR 5.1(e), a national security classified patent application will not be allowed until the application is declassified and any Secrecy Order pursuant to 37 CFR 5.2(a) has been rescinded. This means that both declassification of the application and rescission of any Secrecy Order are necessary prerequisites for allowance.

For more information on declassification, visit: declassification.

Applications with Secrecy Orders are examined in a secure location by examiners with national security clearances under the control of Licensing and Review. As stated in the MPEP, All applications in which a Secrecy Order has been imposed are examined in a secure location by examiners possessing national security clearances under the control of Licensing and Review. This ensures that sensitive information remains protected during the examination process.

For more information on licensing and review, visit: licensing and review.

For more information on patent examination, visit: patent examination.

For patent applications under a Secrecy Order, prosecution proceeds as normal, including issuing final rejections that the applicant must properly reply to. If the applicant files an appeal, it must be completed to prevent abandonment of the application.

However, as noted in MPEP 130, “such appeal will not be set for hearing by the Patent Trial and Appeal Board until the Secrecy Order is removed, unless specifically ordered by the Commissioner for Patents.”

Amendments in Secrecy Order cases are handled differently from regular patent applications. The MPEP states: Any amendments received thereafter are not entered or responded to until such time as the Secrecy Order is rescinded. At such time, amendments which are free from objection will be entered; otherwise they are denied entry. This means that amendments are held in abeyance until the Secrecy Order is lifted, at which point they are reviewed for entry.

For more information on prosecution, visit: prosecution.

Tags: prosecution

Amendments in secrecy order applications require special handling to maintain security. The MPEP 130 states:

In secrecy order cases, all proposed amendments to the specification and claims, and all provisional amendments to the abstract, drawings and claims must be submitted in duplicate for security review.

Key points about handling amendments in secrecy order cases include:

  • Amendments must be submitted in duplicate for security review.
  • One copy of the amendment is placed in the application file.
  • The other copy is forwarded to a defense agency for review.
  • The defense agency determines if the amendment can be entered without breaching national security.

This process ensures that any changes to the application maintain the required level of secrecy.

For more information on classified information, visit: classified information.

For more information on patent prosecution, visit: patent prosecution.

Allowed secrecy order applications require special handling to maintain security while progressing through the patent process. The MPEP 130 provides guidance on this:

When a secrecy order case is allowed, the Office of Patent Application Processing (OPAP) is notified. The notice of allowance and issue fee letters are drafted and reviewed in the Technology Center and may be hand carried to OPAP for mailing.

Key points about handling allowed secrecy order applications:

  • The Office of Patent Application Processing (OPAP) is notified of the allowance.
  • Notice of allowance and issue fee letters are carefully drafted and reviewed.
  • These documents may be hand-carried to OPAP for mailing to ensure security.
  • The application remains under secrecy order even after allowance.
  • Special care is taken to prevent unauthorized disclosure throughout the process.

This careful handling ensures that the application’s classified status is maintained even as it progresses towards issuance.

For more information on classified information, visit: classified information.

For more information on patent issuance, visit: patent issuance.

No, patent applications under Secrecy Orders are not issued and cannot be involved in interferences or derivation proceedings. The MPEP states: Secrecy Order cases are examined for patentability as in other cases, but will not be passed to issue; nor will an interference or derivation be instituted where one or more of the conflicting cases is classified or under Secrecy Order. This is further supported by 37 CFR 5.3 and MPEP § 2306.

For more information on patent issuance, visit: patent issuance.

MPEP 140-Foreign Filing Licenses (20)

The scope of a foreign filing license can vary depending on how it was obtained:

  • Licenses granted through the filing of a US application (implicit petition) typically have a broad scope as defined in 37 CFR 5.15(a).
  • Licenses granted through explicit petitions may have a narrower scope as defined in 37 CFR 5.15(b).
  • Licensees with a narrow scope can petition to convert to a broader scope under 37 CFR 5.15(c).

As stated in the MPEP: “The scope of any license granted on these petitions is indicated on the license. Petitions under 37 CFR 5.14(a) or (b) as well as any license granted on the petition are made of record in the application file.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

While both foreign filing licenses and secrecy orders are related to the protection of sensitive information in patent applications, they serve different purposes:

  • Foreign Filing License: As described in MPEP 140, this is a permission granted by the USPTO to file a patent application in a foreign country. It’s typically granted routinely unless there are security concerns.
  • Secrecy Order: This is an order issued under the Invention Secrecy Act (35 U.S.C. 181) to prevent disclosure of an invention that might be detrimental to national security. It prohibits both foreign filing and public disclosure of the invention.

A foreign filing license allows foreign filing, while a secrecy order prohibits it. An application under a secrecy order will not be granted a foreign filing license.

For more information on foreign filing license, visit: foreign filing license.

A retroactive foreign filing license is a license granted after an unlicensed foreign filing has already occurred. Key points include:

  • It can be requested through a petition under 37 CFR 5.25.
  • The unlicensed filing must have occurred through error.
  • Specific requirements in 37 CFR 5.25 must be met, including providing detailed information about each unlicensed filing.
  • A verified statement (oath or declaration) explaining the error is required.

The MPEP states: “A petition for a retroactive filing license may be filed under 37 CFR 5.25 if an unlicensed foreign filing has occurred through error. However, the requirements of 37 CFR 5.25 must be fulfilled in order for such a petition to be granted.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

A foreign filing license is permission granted by the USPTO to file a patent application in a foreign country. It is required when:

  • An invention was made in the United States, and
  • A US application has been filed less than 6 months ago, or
  • No US application has been filed yet

As stated in 37 CFR 5.11(a): “A license from the Commissioner for Patents under 35 U.S.C. 184 is required before filing any application for patent… in a foreign country… if the invention was made in the United States.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

Filing a foreign patent application without the required foreign filing license can have serious consequences. According to MPEP 140:

‘Inadvertent foreign filing without a license is not uncommon. The patent law provides for petition for retroactive license in such cases.’

However, it’s important to note that:

  • The application may be considered abandoned in the U.S.
  • You may lose the right to obtain a U.S. patent on that invention.
  • There could be criminal penalties under 35 U.S.C. 181 and 35 U.S.C. 186.

If you’ve inadvertently filed without a license, you should immediately seek a retroactive foreign filing license from the USPTO.

For more information on foreign filing license, visit: foreign filing license.

Filing a foreign application without obtaining the required foreign filing license can have serious consequences. According to MPEP 140:

‘If a license is not obtained prior to filing, there is still the possibility of obtaining a license retroactively. … However, a party who files a patent application in a foreign country or under a multinational agreement, without first obtaining a license from the Commissioner when required, shall be barred from receiving a United States patent for the invention under 35 U.S.C. 185.’

In other words, failing to obtain a license can result in being barred from receiving a U.S. patent for the same invention. However, you may be able to obtain a retroactive license in some cases.

For more information on foreign filing license, visit: foreign filing license.

Filing a foreign patent application without the required license can have severe consequences, including:

As stated in 35 U.S.C. 185: “Notwithstanding any other provisions of law any person, and his successors, assigns, or legal representatives, shall not receive a United States patent for an invention if that person, or his successors, assigns, or legal representatives shall, without procuring the license prescribed in section 184, have made, or consented to or assisted another’s making, application in a foreign country for a patent or for the registration of a utility model, industrial design, or model in respect of the invention.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

The time to obtain a foreign filing license from the USPTO can vary. According to MPEP 140:

‘If a license is required but the application is not one of the types under MPEP § 140(II), the grant of a license is not usually included in the letter of filing receipt.’

In such cases, the processing time can take several weeks. However, for expedited processing:

  • A petition for expedited handling under 37 CFR 1.182 can be filed.
  • In urgent cases, the license can be granted immediately by telephone.
  • The Office of Licensing and Review can grant a license the same day by fax.

It’s advisable to apply for a license well in advance of any planned foreign filing to ensure timely processing.

For more information on foreign filing license, visit: foreign filing license.

How long does a foreign filing license remain valid?

The validity period of a foreign filing license depends on the type of license issued. According to MPEP 140:

“A foreign filing license is not required to file a patent application in another country if the invention was not made in the United States. A license is required if the invention was made in this country and:

  • An application on the invention has been filed in the United States less than six months prior to the date on which the application is to be filed abroad, or
  • No application on the invention has been filed in the United States.”

In essence, a foreign filing license granted as part of the regular patent application process remains valid for six months from the filing date. After six months, no additional license is required. However, if you obtain a petition-based license (e.g., for inventions not yet filed in the U.S.), the license will specify its scope and duration in the grant letter.

For more information on foreign filing license, visit: foreign filing license.

The 6-month rule for foreign filing licenses states that:

  • After 6 months from the filing date of a US application, a foreign filing license is no longer required for that subject matter.
  • This automatic license occurs unless a Secrecy Order has been imposed on the application.
  • The rule is based on 35 U.S.C. 184 and 37 CFR 5.11(e)(2).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

A petition for a retroactive foreign filing license may be filed under 37 CFR 5.25 if an unlicensed foreign filing occurred through error. The petition must include:

1) A listing of each foreign country where the unlicensed patent application was filed
2) The filing dates in each country
3) A verified statement containing:
– An averment that the subject matter was not under a secrecy order and is not currently under a secrecy order
– A showing that the license has been diligently sought after discovery of the proscribed foreign filing
– An explanation of why the material was filed abroad through error without the required license
4) The required fee under 37 CFR 1.17(g)

Secrecy Orders have significant impacts on foreign filing licenses:

  • A Secrecy Order prevents the granting of a foreign filing license.
  • It overrides the 6-month rule, prohibiting foreign filing even after 6 months.
  • Applications under a Secrecy Order cannot be exported or filed in foreign countries.
  • Violating a Secrecy Order can result in abandonment of the invention and other penalties.

The MPEP states: “Only the imposition of a Secrecy Order will cause revocation of the authority which arises from 35 U.S.C. 184 to file a foreign application 6 months or later after the date of filing of a corresponding U.S. patent application.”

For more information on Secrecy Orders, refer to MPEP 120.

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

If you’ve inadvertently filed a foreign patent application without obtaining a foreign filing license, you can apply for a retroactive license. According to MPEP 140:

‘Petitions for a retroactive license under 35 U.S.C. 184 are decided by the Office of Petitions. The petition must be in the form of a verified statement and should include the following information:’

  • A listing of each of the foreign countries in which the unlicensed patent application material was filed
  • The dates on which the material was filed in each country
  • A verified statement that the subject matter in question was not under a secrecy order at the time it was filed abroad
  • A verified statement that the license has been diligently sought after discovery of the proscribed foreign filing
  • An explanation of why the material was filed abroad through error without the required license first having been obtained

The petition should be submitted to the USPTO as soon as possible after discovering the error. Include all relevant documentation and be prepared to pay any required fees.

For more information on retroactive foreign filing license, visit: retroactive foreign filing license.

For more information on USPTO, visit: USPTO.

There are several ways to obtain a foreign filing license:

  1. File a US patent application, which is considered an implicit petition for a license. The filing receipt will indicate if a license is granted.
  2. File an explicit petition for a license under 37 CFR 5.12(b) if no US application has been filed.
  3. Wait 6 months after filing a US application, at which point a license is no longer required (unless a Secrecy Order has been imposed).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

Can I obtain a foreign filing license for an invention not yet filed with the USPTO?

Yes, it is possible to obtain a foreign filing license for an invention that has not yet been filed with the United States Patent and Trademark Office (USPTO). This is known as a petition-based license. According to MPEP 140:

“If no corresponding national or international application has been filed in the United States, the petition for license should be accompanied by a legible copy of the material upon which a foreign patent application is to be based. Where the material upon which the foreign patent application is to be based is a U.S. application, the petition for license should identify the application by its application number, filing date, inventor, and title. Where the material upon which the foreign patent application is to be based is not a U.S. application, a legible copy of the material must be attached to the petition.”

To obtain such a license, you must file a petition with the USPTO, providing details about the invention and the reasons for seeking an early foreign filing license. The USPTO will review the petition and may grant the license if it determines that the invention does not pose a national security risk.

For more information on foreign filing license, visit: foreign filing license.

Yes, you can obtain a foreign filing license for a provisional patent application. According to MPEP 140:

‘U.S. provisional applications are considered as pending applications and are subject to the license requirement specified in 35 U.S.C. 184.’

This means that:

  • Provisional applications require a foreign filing license just like non-provisional applications.
  • The process for obtaining a license is the same as for non-provisional applications.
  • If you plan to file a foreign application based on your provisional application within 6 months, you should request a license when filing the provisional or shortly thereafter.

Remember, the license requirement applies to the subject matter, not the type of application.

For more information on foreign filing license, visit: foreign filing license.

For more information on provisional application, visit: provisional application.

Yes, a foreign filing license can be revoked by the USPTO. Key points about revocation include:

  • The USPTO can revoke a license through written notification.
  • Revocation usually occurs if additional review reveals national security concerns.
  • Revocation is effective on the date the notice is mailed.
  • Foreign filings made before revocation are generally not affected.
  • New foreign filings after revocation are not permitted without a new license.

The MPEP states: “Upon written notification from the USPTO, any foreign filing license required by 37 CFR 5.11(a) may be revoked. Ordinarily, revocation indicates that additional review of the licensed subject matter revealed the need for referral of the application to the appropriate defense agencies.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

Can a foreign filing license be revoked or modified?

Yes, a foreign filing license can be revoked or modified under certain circumstances. The MPEP 140 provides guidance on this:

Licenses for foreign filing may be revoked or modified upon written notification from the Director. Normally, revocation or modification will only affect applications or other materials not already filed abroad.

Key points about revocation or modification of foreign filing licenses:

  • The Director of the USPTO has the authority to revoke or modify licenses.
  • Notification of revocation or modification will be provided in writing.
  • Generally, the revocation or modification only affects future filings, not those already made abroad.
  • In cases of imminent national emergency, revocation may be immediate and may affect filings already made abroad.

If your license is revoked or modified, you should immediately cease any foreign filing activities covered by the license and seek legal counsel to understand the implications and next steps.

For more information on foreign filing license, visit: foreign filing license.

For more information on revocation, visit: revocation.

Yes, a foreign filing license can be denied by the USPTO. According to MPEP 140:

‘If the Director of the USPTO or his or her designee determines that the application contains subject matter that requires a security review under the Invention Secrecy Act (35 U.S.C. 181-188), the petition for license is denied and the applicant is notified in writing.’

Reasons for denial may include:

  • National security concerns
  • Subject matter falling under the Invention Secrecy Act
  • Incomplete or incorrect application for the license

If a license is denied, the applicant will be notified in writing and may have the opportunity to address the issues or appeal the decision.

For more information on foreign filing license, visit: foreign filing license.

Yes, there are certain exceptions to the foreign filing license requirement. According to MPEP 140:

‘A license is not required if the invention was not made in the United States. Also, a license is not required to file an international application in the United States Receiving Office.’

Additionally, the following situations do not require a foreign filing license:

  • Filing applications in countries where no security agreement exists with the United States
  • Filing a PCT application designating only foreign countries
  • Filing a design patent application in a foreign country

However, it’s important to note that these exceptions are subject to specific conditions and may change. Always consult with a patent attorney or the USPTO if you’re unsure about your specific situation.

For more information on USPTO, visit: USPTO.

Tags: USPTO

MPEP 150-Statements to DOE and NASA (11)

According to MPEP 150, property rights statements to DOE or NASA can be filed at any time, but they should be kept up-to-date to reflect accurate property rights at the time of application allowance. The MPEP states:

Property rights statements to DOE or NASA may be filed at any time but should be updated if necessary to accurately reflect property rights at the time the application is allowed.

Additionally, the USPTO typically sends an informal request for a property rights statement shortly after filing to applicants whose nonprovisional applications are marked as being of interest to DOE or NASA. While there’s no formal time period set, a response within 45 days is recommended to expedite processing.

For more information on filing deadlines, visit: filing deadlines.

For more information on patent applications, visit: patent applications.

If an invention appears to the USPTO Director to have significant utility in the conduct of aeronautical and space activities, the applicant must file a written statement with the USPTO Director with the patent application or within 30 days after request by the Director.

The statement must be executed under oath setting forth the full facts concerning the circumstances under which the invention was made and stating the relationship (if any) of the invention to the performance of any work under any NASA contract, as provided in 51 U.S.C. 20135(d):

“No patent may be issued to any applicant other than the Administrator for any invention which appears to the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (hereafter in this section referred to as the ‘Director’) to have significant utility in the conduct of aeronautical and space activities unless the applicant files with the Director, with the application or within 30 days after request therefor by the Director, a written statement executed under oath setting forth the full facts concerning the circumstances under which the invention was made and stating the relationship (if any) of the invention to the performance of any work under any contract of the Administration.”

Applications for patents which appear to disclose, purport to disclose or do disclose inventions or discoveries relating to atomic energy must be reported to the Department of Energy, which will be given access to the applications.

As stated in 37 CFR 1.14(d), “Such reporting does not constitute a determination that the subject matter of each application so reported is in fact useful or is an invention or discovery, or that such application in fact discloses subject matter in categories specified by 42 U.S.C. 2181(c) and (d).”

Papers related to property rights under the Atomic Energy Act or National Aeronautics and Space Act require special handling. According to MPEP 150:

Any papers pertaining to property rights under section 152 of the Atomic Energy Act, 42 U.S.C. 2182, (DOE), or section 305(c) or the National Aeronautics and Space Act, 42 U.S.C. 2457, (NASA), that have not been associated with the application file, or have not been made of record in the file and processed by the Licensing and Review section, must be sent to the Licensing and Review section immediately.

Key points:

  • Papers related to property rights under these acts must be properly associated with the application file
  • If not already processed by the Licensing and Review section, they must be sent there immediately
  • This ensures proper handling and review of sensitive information related to atomic energy or space activities

For more information on National Aeronautics and Space Act, visit: National Aeronautics and Space Act.

For more information on USPTO procedures, visit: USPTO procedures.

When the USPTO makes a formal request for a property rights statement in accordance with 42 U.S.C. 2182 (DOE) or 51 U.S.C. 20135 (NASA), the applicant has a 30-day statutory period to respond. There is no provision for an extension of this 30-day time period.

As stated in MPEP 150, “If no proper and timely statement is received, the application will be held abandoned and the applicant so notified. Such applications may be revived under the provisions of 37 CFR 1.137.”

Patent applications that appear to disclose, purport to disclose, or do disclose inventions or discoveries relating to atomic energy are reported to the Department of Energy. The purpose is to allow the DOE access to these applications for review.

As stated in MPEP 150: Applications for patents which appear to disclose, purport to disclose or do disclose inventions or discoveries relating to atomic energy are reported to the Department of Energy, which Department will be given access to the applications. However, it’s important to note that Such reporting does not constitute a determination that the subject matter of each application so reported is in fact useful or is an invention or discovery, or that such application in fact discloses subject matter in categories specified by 42 U.S.C. 2181(c) and (d).

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

For inventions related to atomic energy, applicants must file a statement under oath with specific information. According to 42 U.S.C. 2182, this statement should include:

  • Full facts surrounding the making or conception of the invention
  • Whether the invention was made or conceived under any contract or arrangement with the Commission (now DOE)
  • Whether the contract involved the expenditure of funds by the Commission

The law states: No patent for any invention or discovery, useful in the production or utilization of special nuclear material or atomic energy, shall be issued unless the applicant files with the application, or within thirty days after request therefor by the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office […] a statement under oath setting forth the full facts surrounding the making or conception of the invention or discovery described in the application and whether the invention or discovery was made or conceived in the course of or under any contract, subcontract, or arrangement entered into with or for the benefit of the Commission, regardless of whether the contract, subcontract, or arrangement involved the expenditure of funds by the Commission.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

If an applicant fails to respond to a request for a property rights statement, there can be serious consequences for the patent application. According to MPEP 150:

If no proper and timely statement is received, the application will be held abandoned and the applicant so notified.

The process typically involves:

  • An initial informal request (45-Day Letter)
  • If no response or if the statement is defective, a formal request is made with a 30-day statutory period for response
  • No extensions are available for this 30-day period
  • Failure to respond properly results in the application being held abandoned

However, abandoned applications may be revived under the provisions of 37 CFR 1.137, as noted in the case of In re Rutan, 231 USPQ 864 (Comm’r Pat. 1986).

For more information on patent applications, visit: patent applications.

For more information on revival, visit: revival.

For inventions related to aeronautical and space activities, applicants must file a statement with specific information if requested by the USPTO. According to 51 U.S.C. 20135:

No patent may be issued to any applicant other than the Administrator for any invention which appears to the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office […] to have significant utility in the conduct of aeronautical and space activities unless the applicant files with the Director, with the application or within 30 days after request therefor by the Director, a written statement executed under oath setting forth the full facts concerning the circumstances under which the invention was made and stating the relationship (if any) of the invention to the performance of any work under any contract of the Administration.

This statement should include:

  • Full facts about the circumstances of the invention’s creation
  • The relationship, if any, between the invention and work performed under any NASA contract

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

The USPTO has a process for handling defective property rights statements submitted in response to DOE or NASA review requests. According to MPEP 150:

If the statement submitted during this period is defective, another letter is sent from Licensing and Review detailing the deficiencies and giving applicant another opportunity to respond during this period of informal correspondence.

The process typically involves:

  • Initial review of the submitted statement
  • If defects are found, a letter is sent detailing the deficiencies
  • The applicant is given another opportunity to respond and correct the statement
  • If repeated efforts to correct a defective statement show lack of cooperation, a formal request with a 30-day statutory deadline may be issued

It’s crucial for applicants to address any deficiencies promptly to avoid potential abandonment of their application.

For more information on USPTO procedures, visit: USPTO procedures.

No, provisional applications are not subject to Department of Energy (DOE) or NASA property rights review. According to MPEP 150:

Provisional applications are not subject to DOE or NASA property rights review.

This means that inventors filing provisional applications do not need to submit property rights statements to DOE or NASA at the time of filing. However, it’s important to note that if a nonprovisional application is later filed claiming priority to the provisional application, and if it relates to atomic energy or aeronautical and space activities, it may then be subject to the relevant property rights review process.

MPEP 151 - Content of the Statements (8)

According to MPEP 151, the term ‘applicant’ in the context of Atomic Energy Act and NASA Act statements is interpreted as follows:

“The word ‘applicant’ in both of these statutes is construed by the Office to mean the inventor or joint inventors in person, or an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter.”

This means that the statements must typically be signed by the actual inventor(s), assignee, or someone with a significant proprietary interest in the invention. The USPTO considers these individuals to be the most knowledgeable about the circumstances surrounding the invention’s creation.

For more information on applicant definition, visit: applicant definition.

The word “applicant” in the Atomic Energy Act and NASA Act is construed by the USPTO to mean the inventor(s), an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter. In the ordinary situation, the statements must be signed by:

  • The inventor or joint inventors
  • An assignee
  • An obligated assignee
  • A person who otherwise shows sufficient proprietary interest in the matter

This is consistent with the fact that these parties would be most knowledgeable of the “full facts concerning the circumstances under which such invention was made” (42 U.S.C. 2457) or “full facts surrounding the making or conception of the invention or discovery” (42 U.S.C. 2182).

If inventorship changes after filing a property rights statement, MPEP 151 provides specific guidance:

“If a request under 37 CFR 1.48 for correction of inventorship is granted during pendency of an application in which a property rights statement has been filed, a supplemental statement executed by any added inventor(s) is required and should promptly be filed with Licensing and Review.”

This means that if new inventors are added to the application, they must file a supplemental statement to ensure compliance with the Atomic Energy Act and NASA Act requirements. It’s important to file this supplemental statement promptly to maintain proper documentation.

For more information on patent procedure, visit: patent procedure.

For more information on property rights statement, visit: property rights statement.

The statement regarding work with the Atomic Energy Commission or NASA should be in the form of an oath or declaration. The following is an acceptable format, assuming no government funds or considerations were involved in the invention’s conception or making:

I (We) [Name(s)] citizens of [Country] residing at [Address] declare: That I (we) made and conceived the invention described and claimed in patent application number [Application Number] filed in the United States of America on [Date] titled [Title].

[Include statement regarding employment and/or relevant facts.]

The invention or discovery was not made or conceived in the course of, or in connection with, or under the terms of any contract, subcontract or arrangement entered into with or for the benefit of the United States Atomic Energy Commission or its successors Energy Research and Development Administration or the Department of Energy.

The invention was not made under nor is there any relationship of the invention to the performance of any work under any contract of the National Aeronautics and Space Administration.

The statement must be signed by all the inventors.

If an applicant does not have firsthand knowledge of whether the invention involved work under any contract or arrangement with the Atomic Energy Commission or NASA, but includes such information derived from others:

  • The applicant’s statement should identify the source of this information, or
  • The applicant’s statement could be accompanied by a supplemental declaration or oath regarding the contractual matters, made by the assignee or another person (like an employee) who has the requisite knowledge

Statements under the Atomic Energy Act and NASA Act must set forth “the full facts” surrounding the conception and making of the invention. According to MPEP 151, these facts should be unique to that invention. The MPEP states:

“The use of form paragraphs or printed forms which set forth only broad generalized statements of fact is not ordinarily regarded as meeting the requirements of these statutes.”

This means that inventors must provide detailed, specific information about their invention’s conception and development.

For more information on invention disclosure, visit: invention disclosure.

When an inventor is unable to provide a statement due to death, incapacitation, or unavailability, MPEP 151 offers alternative solutions:

“When an inventor applicant is deceased or legally incapacitated, or where it is shown to the satisfaction of this Office that he or she refuses to furnish a statement or cannot be reached after diligent efforts, declarations or statements under oath setting forth the information required by the statutes may be accepted from an officer or employee of the assignee who has sufficient knowledge of the facts.”

Additionally, for joint inventions, “Where it is shown that one of the joint inventors is deceased or unavailable, a statement by all of the other inventor(s) may be accepted.” It’s important to note that these alternatives should only be used when the inventor is truly unavailable, not merely for convenience.

For more information on patent procedure, visit: patent procedure.

When an applicant doesn’t have firsthand knowledge about certain aspects of the invention’s relationship to government contracts, MPEP 151 provides guidance:

“In instances where an applicant does not have firsthand knowledge whether the invention involved work under any contract, subcontract, or arrangement with or for the benefit of the Atomic Energy Commission, or had any relationship to any work under any contract of the National Aeronautics and Space Administration, and includes in his or her statement information of this nature derived from others, his or her statement should identify the source of his or her information.”

Alternatively, the MPEP suggests that “the statement by the applicant could be accompanied by a supplemental declaration or oath, as to the contractual matters, by the assignee or other person, e.g., an employee thereof, who has the requisite knowledge.” This ensures transparency and accuracy in the statement.

MPEP 200 - Types and Status of Application; Benefit and Priority (1004)

Proper identification of priority applications is crucial for several reasons:

Proper identification of priority applications is essential to establishing accurate and complete relationships among various patent documents, especially in the context of electronic priority document exchange programs

This means that:

  • It ensures accuracy in patent documentation
  • It facilitates complete relationships between related patent documents
  • It is particularly important for electronic priority document exchange programs

Accurate identification helps maintain the integrity of the patent system and ensures that priority claims are properly recognized and processed.

To learn more:

The USPTO typically does not send a filing receipt for a Continued Prosecution Application (CPA). This practice is mentioned in MPEP ¶ 2.35, which states:

This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

The reason for this is that a CPA is a continuation of an existing application rather than an entirely new filing. The USPTO communicates the acceptance of the CPA through other means, typically in the first Office action on the CPA. This approach streamlines the process and reduces redundant paperwork.

For more information on USPTO procedures, visit: USPTO procedures.

Amendments to refer to Continued Prosecution Applications (CPAs) as continuation or divisional applications are not allowed because they are unnecessary and can potentially cause confusion. The MPEP ¶ 2.34 explains:

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that the CPA itself already serves as the legally required reference to the prior application. Adding additional references through amendments is redundant and could potentially lead to inconsistencies or misinterpretations in the patent record.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on patent law, visit: patent law.

According to MPEP 203.08, information about a patent application’s status can be provided to:

  • The applicant
  • The applicant’s assignee
  • The attorney or agent of record
  • Anyone with written authority from one of the above

The MPEP states: “Status information which may be given includes information as to whether the application has been filed, whether the application is awaiting action by the examiner, as well as other matters which do not involve the disclosure of confidential information.”

It’s important to note that the USPTO is prohibited from disclosing certain information to unauthorized parties, such as the date of filing, names of inventors, or specific details about the prosecution of the application.

To learn more:

The USPTO has designated specific offices to handle inquiries from high-level government sources. According to MPEP 203.08(a):

  • Office of Policy and International Affairs: Handles inquiries from embassies, the Office of the U.S. Trade Representative, and the Department of State.
  • Office of Governmental Affairs: Manages inquiries from Congress and the White House.

These offices are responsible for ensuring that such high-level inquiries are handled appropriately and consistently.

To learn more:

Tags: USPTO

The MPEP ¶ 2.11 mentions several U.S. Code sections relevant to claiming the benefit of an earlier filing date:

This application is claiming the benefit of prior-filed application No.[1] under 35 U.S.C. 120, 121, 365(c), or 386(c).

These sections cover different scenarios:

  • 35 U.S.C. 120: Benefit of earlier filing date in the United States
  • 35 U.S.C. 121: Divisional applications
  • 35 U.S.C. 365(c): Benefit of earlier filing date; national application
  • 35 U.S.C. 386(c): Benefit of earlier filing date; international design application

Each of these sections provides specific conditions under which an application can claim the benefit of an earlier filing date.

For more information on earlier filing date, visit: earlier filing date.

For more information on patent law, visit: patent law.

The MPEP provides a table of states (countries) for which the right of priority under 35 U.S.C. 119(a)-(d) is recognized. These countries fall into three categories:

  • Parties to the Patent Cooperation Treaty (PCT)
  • Parties to the Paris Convention for the Protection of Industrial Property
  • Members of the World Trade Organization (WTO)

The MPEP states: “Following is a table of states, i.e., countries, with respect to which the right of priority referred to in 35 U.S.C. 119(a)-(d) has been recognized.”

For the most current list of recognized countries, refer to the WIPO website at www.wipo.int/pct/en/paris_wto_pct.html.

The United States recognizes the right of priority for patent applications filed in countries that are:

  • Parties to the Patent Cooperation Treaty (PCT)
  • Members of the Paris Convention for the Protection of Industrial Property
  • Members of the World Trade Organization (WTO)

The MPEP states: Following is a table of states, i.e., countries, with respect to which the right of priority referred to in 35 U.S.C. 119(a) – (d) has been recognized. For the most up-to-date list of recognized countries, refer to the WIPO website.

To learn more:

For a non-English provisional application, the English translation and accuracy statement must be filed in the provisional application itself, not in the non-provisional application claiming its benefit. MPEP ¶ 2.38 clearly states:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[…]”

Additionally, in the non-provisional application claiming benefit, you must provide confirmation that these documents were filed in the provisional application. This two-step process ensures proper documentation and compliance with 37 CFR 1.78.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The location of the benefit claim reference depends on the filing date of the application:

  • For applications filed before September 16, 2012: The reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS).
  • For applications filed on or after September 16, 2012: The specific reference must be included in an application data sheet (ADS).

The MPEP states: “If the application was filed before September 16, 2012, the reference must be included in the first sentence(s) of the specification following the title or in an application data sheet; if the application was filed on or after September 16, 2012, the specific reference must be included in an application data sheet.”

It’s important to note that for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must also include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on application data sheet, visit: application data sheet.

For more information on divisional, visit: divisional.

According to the MPEP, a petition to restore the benefit of a provisional application should be addressed to:

“Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.”

It’s important to note that this petition must be filed in the subsequent nonprovisional application or international application designating the United States, not in the provisional application itself. Always ensure you’re following the most current USPTO guidelines for petition submissions, as procedures may be updated over time.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The location for filing your petition to restore the right of priority depends on the type of application you have. The MPEP provides guidance:

The petition to restore the right of priority must be filed in the subsequent application, or in the earliest nonprovisional application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the subsequent application, if such subsequent application is not a nonprovisional application.

Additionally, the MPEP specifies the mailing address for such petitions:

The petition should be addressed to: Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.

Ensure you file the petition in the correct application and send it to the appropriate address to avoid processing delays.

For more information on mailing address, visit: mailing address.

For more information on priority restoration, visit: priority restoration.

The English translation of a non-English provisional application must be filed in the provisional application itself, not in the non-provisional application claiming benefit. According to MPEP ¶ 2.38:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3].”

Additionally, you must confirm in your current application that the translation and statement were filed in the provisional application.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

The recommended presentation of foreign application numbers can be found in the WIPO Handbook on Industrial Property Information and Documentation. The MPEP provides specific guidance:

A complete updated list of the recommended presentation of a foreign application number based on the numbering system used by the foreign intellectual property office is maintained by the WIPO and can be found in the online WIPO Handbook on Industrial Property Information and Documentation

To access this information:

  • Visit the WIPO website (www.wipo.int/standards/en/)
  • Navigate to Part 7: Examples and Industrial Property Offices Practices
  • Refer to Part 7.2.1: Presentation of Application Numbers

Additionally, the MPEP mentions a survey of current practices: www.wipo.int/export/sites/www/standards/en/pdf_/07-02-06.pdf

To learn more:

The USPTO provides additional information about the Priority Document Exchange (PDX) program on its official website. According to the MPEP:

The Office website provides additional information concerning the priority document exchange program (www.uspto.gov/patents/basics/international-protection/electronic-priority-document-exchange-pdx).

This website includes important details such as:

  • A list of intellectual property offices participating in the PDX program
  • Information necessary for each participating foreign intellectual property office to provide the USPTO with access to foreign applications

Applicants and practitioners are encouraged to visit this resource for the most up-to-date information on the PDX program and its participants.

For those needing information about the former procedures, the MPEP provides guidance: For more information pertaining to practice and procedure under former 37 CFR 1.60, see MPEP § 201.06(a) in the MPEP 8th Edition, Rev. 1 (February 2003)(available on the USPTO website at www.uspto.gov/web/offices/pac/mpep/mpep.htm). This archived version of the MPEP contains the detailed procedures that were in place before the regulation was deleted.

To learn more:

To learn more:

For those interested in the historical procedures under former 37 CFR 1.60, the MPEP provides guidance: For more information pertaining to practice and procedure under former 37 CFR 1.60, see MPEP § 201.06(a) in the MPEP 8th Edition, Rev. 1 (February 2003)(available on the USPTO website at www.uspto.gov/web/offices/pac/mpep/mpep.htm). This archived version of the MPEP contains detailed information about the procedures that were in place before the rule change, which may be useful for historical reference or for understanding the processing of applications filed before December 1, 1997.

For comprehensive information about reissue applications, you should refer to MPEP Chapter 1400. As mentioned in MPEP 201.05, “A detailed treatment of reissue applications can be found in MPEP Chapter 1400.” This chapter provides in-depth coverage of various aspects of reissue applications, including:

  • Eligibility requirements for filing a reissue application
  • Types of defects that can be corrected
  • Procedures for filing and prosecuting a reissue application
  • Examination guidelines for reissue applications
  • Special considerations for broadening reissues

By consulting MPEP Chapter 1400, patent attorneys, examiners, and inventors can gain a thorough understanding of the reissue application process and its requirements.

To learn more:

For those seeking more detailed information on benefit claims under 35 U.S.C. 386(c), the Manual of Patent Examining Procedure (MPEP) provides a specific reference. According to MPEP § 211.01(d):

See MPEP § 2920.05(e) for additional information pertaining to benefit claims under 35 U.S.C. 386(c).

This section of the MPEP offers comprehensive guidance on the intricacies of claiming benefit to international design applications, including procedural requirements and practical considerations for patent applicants and examiners.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on benefit claims, visit: benefit claims.

For amended patent applications, it’s important to understand the expected timelines and when it’s appropriate to make a status inquiry:

  • Examiners are expected to act on amended applications within two months of receiving them.
  • A status inquiry is generally not necessary until 5-6 months have passed without a response from the USPTO.
  • If six months elapse without a response, you should inquire to avoid potential abandonment.

The MPEP advises: Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office. (MPEP 203.08)

It further states: However, in the event that a six month period has elapsed, and no response from the Office is received, applicant should inquire as to the status of the application to avoid potential abandonment.

For making inquiries, the MPEP recommends: Applicants are encouraged to use Patent Center or Private PAIR to make status inquiries.

To learn more:

You should file a 37 CFR 1.48 request to correct inventorship in a Continued Prosecution Application (CPA) as soon as you realize there’s a need to add or remove an inventor. This should be done concurrently with or shortly after filing the CPA.

The MPEP ¶ 2.33 indicates:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48.

It’s important to file this request promptly to ensure that the correct inventorship is recorded for your application. Failure to do so may result in the inventorship remaining the same as in the prior application, which could potentially affect the validity of your patent if granted.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

You should file a 37 CFR 1.48 request for a Continued Prosecution Application (CPA) whenever you need to add, remove, or change the order of inventors from the original application.

The MPEP ¶ 2.33 indicates: Any request to add an inventor must be in the form of a request under 37 CFR 1.48. This applies even if you’ve identified the new inventor in the CPA filing documents.

It’s best to file the 37 CFR 1.48 request as soon as you realize there’s a need to correct the inventorship. This ensures that the correct inventors are associated with the application throughout the examination process.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Form Paragraph 2.35 should be used in specific circumstances during the patent examination process. According to the MPEP ¶ 2.35, this form paragraph is to be used:

in the first Office action of a CPA to advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request and the CPA is acceptable and that a CPA has been established.

However, it’s important to note that this form paragraph should not be used in all situations. Specifically:

  • It should only be used for design applications, as CPAs are only available for design applications.
  • If the request for a CPA in a utility or plant application is improper and has been treated as an RCE (Request for Continued Examination), examiners should use form paragraph 7.42.15 instead.

Examiners should refer to MPEP § 706.07(h) for more information on handling improper CPA requests in utility or plant applications.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent examination, visit: patent examination.

An inventor might consider filing a continuation application in several scenarios. The MPEP 201.07 provides guidance on timing:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

Common reasons for filing a continuation include:

  • To pursue broader or different claims based on the same disclosure
  • To address issues raised in the prosecution of the parent application
  • To keep the application pending while exploring commercial opportunities
  • To submit new evidence or arguments in support of patentability

It’s important to note that the continuation must be filed before the parent application is patented, abandoned, or otherwise terminated.

For more information on patent strategy, visit: patent strategy.

For more information on USPTO, visit: USPTO.

Patent examiners should use MPEP ¶ 2.06 when they encounter an application that appears to qualify as a continuation-in-part (CIP) but lacks a proper benefit claim. The paragraph itself provides guidance:

This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Examiners use this paragraph to notify applicants that their application might be eligible for CIP status and to direct them to the proper procedures for claiming the benefit of the prior application’s filing date if desired.

For more information on patent examination, visit: patent examination.

Patent examiners should use the MPEP ¶ 2.01 form paragraph under specific circumstances. The MPEP provides the following guidance:

Examiner Note: […] 2. This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.

This means examiners should use this paragraph when:

  • The application appears to contain subject matter that is independent and distinct from a prior application
  • The application seems to qualify as a divisional
  • The applicant has not yet properly claimed the benefit of the prior application’s filing date

The form paragraph serves as a prompt for the applicant to properly establish the benefit claim if they intend the application to be a divisional.

For more information on Divisional application, visit: Divisional application.

The timing for submitting a specific reference to a prior-filed application depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): The specific reference must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: The specific reference must be submitted during the pendency of the application and within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

It’s important to note that This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s).

For more information on filing deadline, visit: filing deadline.

For more information on specific reference, visit: specific reference.

For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of:

  • Four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f)
  • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
  • Sixteen months from the filing date of the prior application

The MPEP states: If the application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of: (1) four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f); (2) four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage; or (3) sixteen months from the filing date of the prior application.

To learn more:

To learn more:

The USPTO may require earlier submission of priority documents in certain circumstances. According to 37 CFR 1.55(g)(2), these circumstances include:

  • When the application is involved in an interference or derivation proceeding
  • When necessary to overcome the date of a reference relied upon by the examiner
  • When deemed necessary by the examiner

In these cases, the applicant may be required to submit the priority claim and certified copy of the foreign application earlier than the general deadline of the patent grant date.

To learn more:

The USPTO may require earlier filing of priority claims and certified copies in certain situations. According to 37 CFR 1.55(g)(2), these situations include:

  • When the application is involved in an interference or derivation proceeding
  • When necessary to overcome the date of a reference relied upon by the examiner
  • When deemed necessary by the examiner

The MPEP explains that these requirements allow the USPTO to address priority issues promptly when they are relevant to ongoing proceedings or examination.

To learn more:

A separate written request is required in specific situations, as outlined in MPEP 215.01:

A separate written request may be used when the applicant wishes the Office to retrieve a foreign application from a foreign intellectual property office that becomes a participating foreign intellectual property office after the foreign priority has been claimed, so long as the time period set in 37 CFR 1.55 has not expired.

Additionally, a separate request is needed when:

  • The foreign application was not originally filed in a participating office, but a certified copy was filed in an application subsequently filed in a participating office.
  • The applicant wants to use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)) to file such a request.

To learn more:

A separate written request for PDX retrieval is needed in two specific situations:

  1. When the applicant wishes the Office to retrieve a foreign application from a foreign intellectual property office that becomes a participating office after the foreign priority has been claimed, as long as the time period set in 37 CFR 1.55 has not expired.
  2. When the foreign application was not originally filed in a participating office, but a certified copy was filed in an application subsequently filed in a participating foreign intellectual property office.

The MPEP provides Form PTO/SB/38 for such requests:

Applicants can use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)) to file such a request.

A reissue application is necessary to perfect a foreign priority claim in the following situations:

  1. When the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance.
  2. When the requirements of 37 CFR 1.55 are not met.
  3. When the correction sought would require further examination.

The MPEP provides an example: Further examination would be required where grant of the petition would cause the patent to be subject to a different statutory framework, e.g., where the foreign application has a pre-March 16, 2013 filing date in a patent that was examined under the first inventor to file (FITF) provisions of the AIA. In such situations, the filing of a reissue application with a petition for an unintentionally delayed priority claim would be required.

To learn more:

A petition is required to correct a benefit claim in the following situations:

  • When the benefit claim is filed after the required time period set forth in 37 CFR 1.78.
  • When the benefit claim was included elsewhere in the application (e.g., in an oath or declaration) but was not recognized by the Office as shown by its absence on the first filing receipt, and the correction is sought after the expiration of the time period set in 37 CFR 1.78.

The MPEP states: If, however, an applicant includes a benefit claim elsewhere in the application and the claim is not recognized by the Office as shown by its absence on the first filing receipt, the Office will require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the correction is sought after expiration of the time period set in 37 CFR 1.78.

However, a petition is not required for certain corrections, such as changing the relationship of the applications or changing the filing date of a prior-filed application, as long as these corrections are made within the original time period.

To learn more:

To learn more:

A divisional application is often filed in response to a restriction requirement made by the patent examiner. As stated in the MPEP:

A divisional application is often filed as a result of a restriction requirement made by the examiner.

When an examiner determines that an application contains multiple independent and distinct inventions, they may issue a restriction requirement. The applicant can then elect one invention to pursue in the original application and file a divisional application to pursue the non-elected invention(s).

To learn more:

A Continued Prosecution Application (CPA) is acceptable when it meets the requirements set forth in 37 CFR 1.53(d). According to MPEP § 201, the examiner will use specific language to indicate acceptance:

The request filed on [date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [number] is acceptable and a CPA has been established.

It’s important to note that CPAs are now only available for design patent applications. For utility and plant applications, a Request for Continued Examination (RCE) would be used instead.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent examination, visit: patent examination.

The USPTO’s timing for retrieving foreign applications under PDX is described in MPEP 215.01:

In general, an attempt to retrieve an eligible foreign application to which priority is claimed in a U.S. application will be made by the USPTO when the application is docketed to an examiner. In any case the USPTO will not attempt electronic retrieval until the Office of Patent Application Processing has completed its review of the application.

Key points about the retrieval timing:

  • The first attempt is typically made when the application is assigned to an examiner.
  • Retrieval occurs after the Office of Patent Application Processing completes its review.
  • Applicants should check the Private PAIR system to confirm successful retrieval.
  • A successful retrieval usually takes about one week to complete.

To learn more:

The status of an application as ‘allowed’ has a specific timeframe. According to the MPEP:

“Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue ( 37 CFR 1.313 ), or becomes abandoned for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).”

In other words, the ‘allowed’ status begins when the notice of allowance is sent and typically ends when the patent is issued. However, this status can be terminated if the application is withdrawn from issue or becomes abandoned due to non-payment of required fees.

To learn more:

A patent application stops being considered ‘new’ when it receives its first action from the examiner. According to MPEP 203.01:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This implies that once the examiner issues any official communication or action on the merits of the application, such as a non-final rejection or a notice of allowance, the application is no longer considered ‘new’ in the patent examination process.

To learn more:

The provisions of 35 U.S.C. 386(a) and (b) became effective for certain types of applications filed on or after May 13, 2015. According to MPEP 213.07:

The provisions of 35 U.S.C. 386(a) and (b) apply to nonprovisional applications, international applications (PCT) and international design applications filed on or after May 13, 2015, and patents issued therefrom. See 37 CFR 1.55(o).

This means that the right of priority under these sections is only applicable to:

  • Nonprovisional applications
  • International applications (PCT)
  • International design applications

These applications must be filed on or after May 13, 2015, to be eligible for the priority rights under 35 U.S.C. 386(a) and (b). The same applies to patents issued from such applications.

For more information on 35 U.S.C. 386, visit: 35 U.S.C. 386.

For more information on effective date, visit: effective date.

For more information on nonprovisional application, visit: nonprovisional application.

A continuation application can be filed at various times during the patent application process. According to MPEP 201.07:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

This means you can file a continuation application:

  • Before the parent application is granted a patent
  • Before the parent application is abandoned
  • Before proceedings on the parent application are terminated

However, for Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), which are only available for design applications (excluding international design applications), there are additional timing restrictions:

A continued prosecution application (CPA) under 37 CFR 1.53(d) (available only for design applications, but not international design applications), however, must be filed prior to payment of the issue fee unless a petition under 37 CFR 1.313(c) is granted in the prior application.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

Benefit under 35 U.S.C. 386(c) for international design applications can only be claimed in specific types of applications filed on or after May 13, 2015. The MPEP states:

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that applications filed before May 13, 2015, cannot claim the benefit of an international design application under 35 U.S.C. 386(c). It’s important for applicants to be aware of this date restriction when considering benefit claims for their patent applications.

To learn more:

To learn more:

The ability to claim benefit under 35 U.S.C. 386(c) for international design applications is subject to specific timing requirements. According to MPEP § 211.01(d):

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that to claim the benefit of an international design application, the claiming application must have been filed on or after May 13, 2015. This date is significant as it marks the implementation of certain provisions of the Patent Law Treaties Implementation Act of 2012.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on filing date requirements, visit: filing date requirements.

A Request to Delete a Named Inventor can be filed at two specific times for a Continued Prosecution Application (CPA):

  1. With the CPA filing: The request can be submitted along with the CPA when it is initially filed.
  2. After the CPA filing: If the request is made after the CPA has been filed, it must follow a different procedure.

The MPEP ¶ 2.32 states:

Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.

This means that post-filing requests require additional documentation and must comply with the regulations for correction of inventorship.

A reissue application can be filed when an unexpired patent is found to be defective. The key criteria are:

  • The original patent must still be in force (unexpired)
  • There must be a defect in the patent that needs correction

It’s important to note that the reissue process is not for extending the term of a patent, but for correcting issues in the existing patent. For more detailed information on the timing and requirements, refer to MPEP Chapter 1400, which provides a comprehensive treatment of reissue applications.

To learn more:

A continuation application can be filed at various stages during the patent application process, as long as the parent application is still pending. The MPEP provides guidance on the timing:

“At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.”

It’s important to note that there are some exceptions for specific types of applications, such as continued prosecution applications (CPAs) for design applications, which have additional timing requirements.

To learn more:

According to 37 CFR 1.78(j), benefit claims under 35 U.S.C. 386(c) can only be made in specific types of applications filed on or after May 13, 2015. The MPEP states:

“37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.”

This means that applications filed before May 13, 2015, cannot claim the benefit of an international design application under 35 U.S.C. 386(c). It’s important for applicants to be aware of this date restriction when considering their benefit claims.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

An international design application designating the United States can claim priority based on several types of prior applications. According to MPEP 213.07:

Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The types of prior applications that can be used for claiming priority include:

  • A prior foreign application
  • An international application (PCT) designating at least one country other than the United States
  • A prior international design application designating at least one country other than the United States

These priority claims must comply with the conditions and requirements set forth in 35 U.S.C. 119(a)-(d) and 172, as well as the Hague Agreement and its Regulations.

For more information on foreign priority, visit: foreign priority.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on prior applications, visit: prior applications.

Continued Prosecution Applications (CPAs) are limited to specific types of patent applications:

  • Design Applications: CPAs are available for design applications filed before May 29, 2000.
  • Plant Applications: CPAs can be used for plant patent applications.

It’s important to note that CPAs are not available for utility patent applications filed on or after May 29, 2000. For these applications, applicants should use a Request for Continued Examination (RCE) instead.

The MPEP ¶ 2.34 provides guidance on how CPAs reference prior applications:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.

This means that for eligible applications, the CPA automatically establishes the necessary reference to the prior application without requiring amendments to the specification.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

What types of national applications can be filed with the USPTO?

The United States Patent and Trademark Office (USPTO) accepts several types of national applications. These include:

  • Utility patent applications: For new and useful processes, machines, articles of manufacture, or compositions of matter.
  • Design patent applications: For new, original, and ornamental designs for articles of manufacture.
  • Plant patent applications: For new varieties of asexually reproduced plants.
  • Provisional patent applications: A temporary application that establishes a filing date but does not mature into an issued patent.

According to MPEP 201.01:

Applications for plant patents, design patents, and utility patents are national applications.

Each type of application has specific requirements and procedures. Utility, design, and plant patent applications can be filed as nonprovisional applications, while provisional applications are only available for utility patents.

For more information on design patent, visit: design patent.

For more information on provisional patent, visit: provisional patent.

For more information on USPTO, visit: USPTO.

Under U.S. patent laws, several types of national applications can be filed. The MPEP 201.01 states:

‘National applications include original (nonprovisional), reissue, and reexamination applications (including supplemental examination proceedings). The original application includes continuation, divisional, and continuation-in-part applications. National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’

To break this down:

  • Original (nonprovisional) applications: Standard utility patent applications
  • Reissue applications: To correct errors in already granted patents
  • Reexamination applications: To request the USPTO to reexamine an existing patent
  • Continuation applications: Based on an earlier-filed application
  • Divisional applications: Derived from a parent application to pursue different inventions
  • Continuation-in-part applications: Adding new matter to a parent application
  • Design patent applications (under 35 U.S.C. 171)
  • Plant patent applications (under 35 U.S.C. 161)

For more information on reissue, visit: reissue.

For more information on USPTO, visit: USPTO.

Tags: reissue, USPTO

Under 35 U.S.C. 111(a), two types of national applications can be filed:

  • Nonprovisional applications: These are regular patent applications that, if granted, can result in an issued patent.
  • Provisional applications: These provide a priority date but do not mature into patents without further action.

The MPEP 201.01 states: ‘National applications may be filed under 35 U.S.C. 111(a) as provisional applications under 35 U.S.C. 111(b) or as nonprovisional applications under 35 U.S.C. 111(a).’ Each type has specific requirements and serves different purposes in the patent application process.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A reissue application can be used to correct various types of defects in an unexpired patent. While the MPEP 201.05 doesn’t provide an exhaustive list in this section, it does state that a reissue application is for “a patent to take the place of an unexpired patent that is defective.” Common defects that can be addressed through reissue include:

  • Errors in the specification or drawings
  • Overly broad or narrow claims
  • Failure to claim priority correctly
  • Inventorship issues

For a more comprehensive list and detailed explanations of correctable defects, refer to MPEP Chapter 1400, which provides a thorough treatment of reissue applications and the types of defects they can address.

To learn more:

Patent law recognizes several types of continuing applications. According to the MPEP:

A continuing application is a continuation, divisional, or continuation-in-part application filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.

The three main types of continuing applications are:

  • Continuation: Pursues additional claims to an invention disclosed in an earlier application.
  • Divisional: Separates distinct inventions from a parent application into separate applications.
  • Continuation-in-part (CIP): Adds new matter to the disclosure of the earlier application.

Each type serves different purposes in patent prosecution strategy.

For more information on divisional, visit: divisional.

For more information on patent prosecution, visit: patent prosecution.

According to the MPEP, specific types of applications can claim benefit under 35 U.S.C. 386(c). The relevant passage states:

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that the following types of applications can claim benefit under 35 U.S.C. 386(c):

  • Nonprovisional applications
  • International applications
  • International design applications
  • Patents issuing from the above applications

It’s important to note that these applications must be filed on or after May 13, 2015, to be eligible for claiming this benefit. Provisional applications are notably absent from this list and cannot claim benefit under 35 U.S.C. 386(c).

To learn more:

To learn more:

Continued Prosecution Applications (CPAs) are specifically for design patent applications. The MPEP ¶ 2.34 refers to CPAs in the context of design applications.

The MPEP ¶ 2.34 states: “In bracket 2, insert either –continuation– or –divisional–.”

This indicates that a CPA can be filed as either a continuation or a divisional of a prior design application. It’s important to note that CPAs are no longer available for utility or plant patent applications.

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

A Continued Prosecution Application (CPA) can be filed for specific types of applications. According to MPEP 201.06(d):

Effective July 14, 2003, CPA practice under 37 CFR 1.53(d) is not available for utility and plant applications.

This means that CPAs are limited to:

  • Design applications: Applications for design patents can be filed as CPAs.
  • Continuation applications: These must be based on an earlier application of the same type (i.e., design).
  • Divisional applications: These must also be based on an earlier design application.

It’s important to note that continuation-in-part (CIP) applications cannot be filed as CPAs. Additionally, utility and plant patent applications are no longer eligible for CPA practice since July 14, 2003.

For more information on continuation applications, visit: continuation applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

According to MPEP 201.01, national applications include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Reexamination proceedings

The MPEP specifically states:

‘National applications include original (nonprovisional) applications, reissue applications, and reexamination proceedings.’

Each of these types serves a different purpose in the patent process. Original applications are for new inventions, reissue applications are for correcting errors in existing patents, and reexamination proceedings are for reviewing the validity of granted patents.

For more information on reissue applications, visit: reissue applications.

According to MPEP 203.01, only nonprovisional applications can be considered ‘new’. The section states:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This means that provisional applications, which are place-holder applications that don’t get examined, are not classified as ‘new’ applications under this definition. Only nonprovisional utility, design, or plant patent applications can have the ‘new’ status before they receive their first examiner action.

To learn more:

During patent prosecution, several types of affidavits or declarations may be filed. MPEP ¶ 2.03 mentions three common types:

“Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application…”

These affidavits serve different purposes:

  • 37 CFR 1.130: Declarations of attribution or prior public disclosure
  • 37 CFR 1.131: Affidavits of prior invention to overcome cited art
  • 37 CFR 1.132: Affidavits traversing rejections or objections

Each of these affidavits provides specific evidence to support the patentability of an invention or to overcome rejections made by the patent examiner.

For more information on patent prosecution, visit: patent prosecution.

MPEP ¶ 2.03 mentions several types of affidavits or declarations that may be submitted during patent prosecution. Specifically, it refers to:

  • Affidavits or declarations under 37 CFR 1.130 (Declaration of Attribution or Prior Public Disclosure under the AIA)
  • Affidavits or declarations under 37 CFR 1.131 (Affidavit or Declaration of Prior Invention to Overcome Cited Patent or Publication)
  • Affidavits or declarations under 37 CFR 1.132 (Affidavits Traversing Rejections or Objections)

These affidavits or declarations are commonly used to overcome rejections or provide evidence during patent prosecution.

For more information on patent prosecution, visit: patent prosecution.

Common types of affidavits or declarations filed in patent applications include those submitted under specific sections of the Code of Federal Regulations. As mentioned in MPEP ¶ 2.03, these include:

  • 37 CFR 1.130: Declarations of attribution or prior public disclosure under the AIA
  • 37 CFR 1.131: Affidavits of prior invention to overcome cited patents or publications
  • 37 CFR 1.132: Affidavits or declarations traversing rejections or objections

These affidavits or declarations serve various purposes in patent prosecution, such as establishing inventorship, overcoming prior art, or addressing examiner rejections.

For more information on patent prosecution, visit: patent prosecution.

To claim the benefit of a prior application’s filing date for a divisional application, applicants must follow specific procedures. The MPEP ¶ 2.01 provides guidance:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This means applicants should:

  • Review 35 U.S.C. 120 for statutory requirements
  • Consult MPEP § 211 for detailed guidance on claiming benefit
  • Follow the procedures outlined in 37 CFR 1.78 for claiming benefit of an earlier-filed application

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the divisional application.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO procedures, visit: USPTO procedures.

Patent examiners should carefully evaluate applications that may potentially be continuations. The MPEP ¶ 2.05 provides guidance:

“This form paragraph should only be used if it appears that the application may be a continuation, but a benefit claim has not been properly established.”

Examiners should look for applications that disclose and claim only subject matter from a prior application and name at least one common inventor. If these conditions are met but a proper benefit claim is missing, examiners may use the specified form paragraph to notify the applicant of the possible continuation status and the need to establish a benefit claim if desired.

Patent examiners should consider several factors when determining if an application may be a continuation. The MPEP ¶ 2.05 provides guidance:

“This form paragraph should only be used if it appears that the application may be a continuation, but a benefit claim has not been properly established.”

Examiners should look for:

  • Disclosure of only subject matter from the prior application
  • Claims to subject matter disclosed in the prior application
  • At least one common inventor with the prior application
  • Proper benefit claim to the prior application

If these elements are present but the benefit claim is not properly established, examiners may use the form paragraph to notify the applicant.

For more information on continuation application, visit: continuation application.

If the United States Patent and Trademark Office (USPTO) doesn’t receive your priority document through the Priority Document Exchange (PDX) program within the specified time frame, you have options. According to MPEP 215.02(a):

The Office appreciates that an applicant may discover that the Office will not receive a copy of a foreign application through the priority document exchange program until after the expiration of the time frame specified in 37 CFR 1.55(f). In this situation, an applicant who otherwise meets the conditions of 37 CFR 1.55(i) may satisfy the requirement of 37 CFR 1.55(i)(3) by filing a certified copy of the foreign application in the Office within the pendency of the application and before the patent is granted.

If you find yourself in this situation:

  1. File a certified copy of the foreign application directly with the USPTO.
  2. Ensure this is done during the pendency of your application and before the patent is granted.
  3. Consider filing a petition under 37 CFR 1.55(e) or (f) if necessary.

Remember, it’s ultimately the applicant’s responsibility to ensure the priority document is properly filed, even when using the PDX program.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on late submission, visit: late submission.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

If you missed the deadline for filing a benefit claim, you may still be able to claim the benefit by filing a petition for an unintentionally delayed benefit claim. The process differs based on the type of benefit claim:

The MPEP states: “If applicant desires the benefit under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c) based upon a previously filed application, applicant must file a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(c) for benefit claims under 35 U.S.C. 119(e) or under 37 CFR 1.78(e) for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c).”

The petition must include:

  1. The reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior application (unless previously submitted)
  2. A petition fee under 37 CFR 1.17(m)
  3. A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the claim was filed was unintentional

The Director may require additional information if there’s a question about whether the delay was unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on petition fee, visit: petition fee.

For more information on unintentional delay, visit: unintentional delay.

In the first Office action of a Continued Prosecution Application (CPA), examiners should include specific information to advise the applicant about the status of their application. The MPEP ¶ 2.35 provides guidance on this matter:

Use this form paragraph in the first Office action of a CPA to advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request and the CPA is acceptable and that a CPA has been established.

This notice is crucial because:

  • Applicants are not notified of the abandonment of the parent application
  • A filing receipt is not normally sent for a CPA

By including this information, examiners ensure that applicants are fully informed about the status and treatment of their CPA request.

For more information on design patents, visit: design patents.

When applicants receive a Notice of Allowance, they should take specific actions regarding PDX as outlined in MPEP 215.01:

Upon receipt of a Notice of Allowance, applicants should check to see whether the Office has received a copy of the foreign application under the priority document exchange program because successful retrieval of priority documents cannot be guaranteed.

Important steps for applicants:

  • Verify that the USPTO has received the foreign priority document.
  • If the document hasn’t been received, consider filing a paper certified copy.
  • Ensure the priority document is received before the patent is granted.
  • Be aware that if a certified copy is filed after the issue fee is paid, the patent won’t include the priority claim unless corrected by a certificate of correction.

It’s crucial to confirm receipt of the priority document to maintain the priority claim in the issued patent.

To learn more:

If an applicant receives no response to a status inquiry, the MPEP provides the following guidance:

  • The MPEP states: If after a reasonable amount of time no reply has been received, applicants may contact the TC customer service center or CRU.
  • For regular patent applications, contact the Technology Center (TC) customer service center at (571) 272-3900.
  • For reexamination proceedings, contact the Central Reexamination Unit (CRU) at (571) 272-7705.
  • When following up, provide all relevant information, including application number, filing date, and any previous communication references.

It’s important to allow a reasonable time for a response before escalating the inquiry, and to use the appropriate contact channels as specified in the MPEP.

To learn more:

When examining a patent application, it’s crucial for the examiner to verify and indicate whether the conditions of 35 U.S.C. 119(a)-(d) or (f) have been met. These sections relate to the right of priority for foreign applications.

The MPEP instructs: However, the examiner must still indicate in the Office action and on the bib-data sheet whether the conditions of35 U.S.C. 119(a)-(d)or(f)have been met. (MPEP 202)

This means the examiner should:

  • Review the foreign priority claim
  • Determine if all conditions for the claim have been satisfied
  • Indicate the status of the claim in the Office action
  • Mark the bib-data sheet accordingly

If the conditions are met, this information will be reflected on the front page of the issued patent and in the Official Gazette listing. For more information on foreign priority claims, see MPEP § 213.

For more information on foreign priority, visit: foreign priority.

For more information on patent examination, visit: patent examination.

When a patent examiner encounters an application that appears to be a divisional but lacks a proper benefit claim, they should follow the guidance provided in MPEP ¶ 2.01. The MPEP states:

“This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.”

In such cases, the examiner should:

  1. Recognize that the application may potentially be a divisional based on its content and relationship to a prior application.
  2. Note that the applicant has not properly established a benefit claim to the prior application.
  3. Use the appropriate form paragraph (as mentioned in MPEP ¶ 2.01) to inform the applicant about the potential divisional status and the need to establish a proper benefit claim.
  4. Direct the applicant’s attention to the relevant laws and regulations for claiming benefit, specifically: 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

By following these steps, the examiner ensures that the applicant is aware of the potential divisional status and has the opportunity to properly establish the benefit claim if desired.

For more information on Divisional application, visit: Divisional application.

To claim priority based on an inventor’s certificate, applicants must meet specific requirements outlined in 37 CFR 1.55(l):

To claim the right of priority on the basis of an application for an inventor’s certificate in such a country under 35 U.S.C. 119(d), the applicant when submitting a claim for such right as specified in this section, must include an affidavit or declaration.

The affidavit or declaration must state that:

  • The applicant had the option to file for either a patent or an inventor’s certificate in the foreign country
  • This option existed for the particular subject matter of the invention

It’s important to note that the affidavit is only required to ascertain the general existence of this option in the foreign country, not to probe into the eligibility of the particular applicant.

To learn more:

If you miss the 12-month deadline for claiming the benefit of a provisional application, you have two main options:

  1. Delete the claim to the benefit of the prior-filed provisional application.
  2. File a petition to restore the benefit of the provisional application.

The MPEP states:

“Alternatively, applicant may wish to file a petition to restore the benefit of the provisional application under 37 CFR 1.78 in the subsequent nonprovisional application or international application designating the United States if the subsequent application was filed within two months from the expiration of the twelve-month period and the delay was unintentional.”

This petition must be filed in the subsequent application and include specific requirements, such as a reference to the provisional application, a petition fee, and a statement that the delay was unintentional.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The timeframe for receiving a Notice of Allowance (PTOL-85) after a Notice of Allowability (Form PTOL-37) is generally within three months. However, if you don’t receive the Notice of Allowance within this period, it may be appropriate to make a status inquiry.

The MPEP states: A Notice of Allowability, Form PTOL-37, is routinely mailed in every application determined to be allowable. Thus, the mailing of a form PTOL-37 in addition to a formal Notice of Allowance and Fee(s) Due (PTOL-85) in all allowed applications would seem to obviate the need for status inquiries even as a precautionary measure where the applicant may believe the new application may have been passed to issue on the first examination. (MPEP 203.08)

However, the MPEP also notes an exception: As an exception, a status inquiry would be appropriate where a Notice of Allowance (PTOL-85) is not received within three months from receipt of form PTOL-37.

If you haven’t received your Notice of Allowance after three months from receiving the Notice of Allowability, it’s advisable to check the status of your application through Patent Center or contact the Application Assistance Unit.

To learn more:

The transition application statement is a requirement for certain applications that bridge the pre-AIA and AIA periods. Here are the key points:

  • It applies to nonprovisional applications filed on or after March 16, 2013, that claim priority to a foreign application filed before March 16, 2013.
  • The statement is required if the application contains or contained a claim to an invention with an effective filing date on or after March 16, 2013.
  • The applicant must provide this statement within a specified time period.
  • International design applications are exempt from this requirement.

As stated in the MPEP: If a nonprovisional application filed on or after March 16, 2013, claims priority to a foreign application filed prior to March 16, 2013, and also contains, or contained at any time, a claim to a claimed invention that has an effective filing date (as defined in 35 U.S.C. 100(i)) on or after March 16, 2013, the applicant must provide a statement to that effect within a specified time period. This requirement helps the USPTO determine which law applies to the application.

To learn more:

The timeliness requirement for priority documents in the PDX program is crucial for patent applicants. MPEP 215.02(a) states:

“If the priority document is retrieved after the application is allowed, the patent will not include the priority claim unless the applicant promptly files a request for a Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323.”

Key points about the timeliness requirement:

  • Priority documents should be retrieved before the application is allowed
  • If retrieved after allowance, a Certificate of Correction is required
  • Applicants should monitor the retrieval status and take action if necessary

To learn more:

The time period for filing a priority claim in an international design application designating the United States depends on whether it’s a nonprovisional international design application or not. According to MPEP 213.07:

In an international design application designating the United States, the claim for priority may be made in accordance with the Hague Agreement and the Hague Agreement Regulations.

For nonprovisional international design applications, the MPEP states:

In a nonprovisional international design application, the priority claim and certified copy must be furnished in accordance with the time period and other conditions set forth in paragraph (g) of this section.

This refers to 37 CFR 1.55(g), which generally requires the priority claim to be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application. However, it’s important to consult the specific regulations and the Hague Agreement for precise deadlines and requirements, as they may vary depending on the specific circumstances of the application.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on nonprovisional application, visit: nonprovisional application.

What is the time period for correcting a benefit claim under 37 CFR 1.78?

The time period for correcting a benefit claim under 37 CFR 1.78 is crucial for patent applicants. According to MPEP 211.02(a):

The time period for making a claim for benefit of a prior-filed application under 37 CFR 1.78(a)(3) and 37 CFR 1.78(d)(3) is specified in 37 CFR 1.78(a)(4) and 37 CFR 1.78(d)(3).

The specific time periods are:

  • For nonprovisional applications: The later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior application
  • For design applications: The later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior application
  • For international applications entering the national stage: The time period in 37 CFR 1.55 for claiming priority to foreign applications applies

It’s important to note that if you miss these deadlines, you may need to file a petition under 37 CFR 1.78(c) or (e) to accept an unintentionally delayed benefit claim.

To learn more:

To learn more:

For international design applications designating the United States, there is generally no specific time limit for submitting a certified copy of the priority document. The MPEP 213.07 explains:

‘In accordance with Hague Agreement Rule 7(5)(f), a copy of the priority document may be submitted to the International Bureau within three months from the date of filing of the international design application. The copy of the priority document so submitted will be considered to satisfy the requirement for a certified copy of the priority document in accordance with 37 CFR 1.55(m).’

However, it’s important to note that if the USPTO requires a certified copy for specific reasons (e.g., to overcome a reference), you may need to submit it within a specified timeframe as requested by the Office.

To learn more:

What is the time limit for submitting a certified copy of a foreign application for priority claim?

The time limit for submitting a certified copy of a foreign application for a priority claim depends on the specific circumstances of your application. According to MPEP 213.04:

The time period for filing a certified copy of the foreign application in the United States application (or written statement) is no later than the date the issue fee is paid.

However, there are some exceptions and additional considerations:

  • If you file the priority claim within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application, you may not need to file a certified copy immediately.
  • If the foreign application was filed in a foreign intellectual property office participating in a priority document exchange agreement with the USPTO, the exchange may satisfy the certified copy requirement.
  • In some cases, an interim copy of the foreign application or a statement that the copy was previously filed may be sufficient.

Note: While it’s possible to file the certified copy after paying the issue fee, it requires an additional processing fee and must be done before the patent is granted. To avoid complications and extra fees, it’s best to submit the certified copy as early as possible during the application process.

To learn more:

The time limit for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a), the specific reference must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371, the specific reference must be submitted during the pendency of the application and within the later of four months from the date on which the national stage commenced, four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

As stated in MPEP 211.02: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).

For more information on national stage application, visit: national stage application.

For more information on time limit, visit: time limit.

For utility or plant applications filed under 35 U.S.C. 111(a), the benefit claim must be made during the pendency of the application and within the later of:

  • Four months from the actual filing date of the later-filed application, or
  • Sixteen months from the filing date of the prior-filed application

As stated in the MPEP: If the application is a utility or plant application filed under 35 U.S.C. 111(a), the benefit claim of the prior application under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) must be made during the pendency of the application and within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.

To learn more:

To learn more:

The time limit for filing a U.S. nonprovisional application claiming priority to a foreign application is generally 12 months from the filing date of the foreign application. For design applications, the time limit is 6 months.

As stated in the MPEP, The United States nonprovisional application must be filed not later than twelve months (six months in the case of a design application) after the date on which the foreign application was filed, unless the right of priority has been restored. (MPEP 213.03)

It’s important to note that this period is subject to certain provisions, such as the extension to the next business day if the deadline falls on a weekend or federal holiday.

To learn more:

The time limit for filing a request to retrieve a foreign application through the Priority Document Exchange (PDX) program is specified in 37 CFR 1.55(i)(4). According to the MPEP:

The request must be filed within the later of sixteen months from the filing date of the prior foreign application, four months from the actual filing date of an application under 35 U.S.C. 111(a), four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f) (§ 1.491(a)), or four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or the request must be accompanied by a petition under paragraph (e) or (f) of this section.

It’s important to note that if you miss this deadline, you may need to file a petition to accept a delayed priority claim or submit a certified copy of the foreign application directly.

To learn more:

There is no specific time limit for filing a reissue application. According to MPEP 201.05, ‘A reissue application can be filed at any time during the enforceability of a patent.’ This means that as long as the original patent is still enforceable, a reissue application can be filed.

However, it’s important to note that there are limitations on what can be claimed in a reissue application based on when it’s filed:

  • If filed within two years from the grant of the original patent, both narrowing and broadening reissue claims are permitted.
  • If filed more than two years from the grant of the original patent, only narrowing reissue claims are allowed.

The MPEP states: ‘A broadening reissue application filed on or after September 16, 2012 must be applied for by all of the inventors (or alternatively the assignee of the entire interest), and the application must be filed within two years from the grant of the original patent.’

To learn more:

When filing a reissue application to correct a priority claim, it’s crucial to adhere to the time limits set by law. The MPEP specifies:

‘The reissue application must be filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f).’

This means that the reissue application must typically be filed within 12 months from the filing date of the foreign application. However, there may be exceptions or additional considerations depending on specific circumstances. It’s advisable to consult with a patent attorney or the USPTO directly for guidance on your particular situation.

The time limit for filing a petition to accept a delayed benefit claim depends on the type of application:

  • For nonprovisional applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.
  • For design applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.
  • For international applications entering the national stage under 35 U.S.C. 371: The time limit is four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f).

As stated in MPEP 211.04: “If the later-filed application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, this period is 4 months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f).”

To learn more:

A nonprovisional application claiming the benefit of a provisional application under 35 U.S.C. 119(e) must be filed within 12 months after the provisional application’s filing date, unless the benefit has been restored. The MPEP states:

“When a later-filed application is claiming the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the nonprovisional application must be filed not later than 12 months after the date on which the provisional application was filed, unless the benefit of the provisional application has been restored.”

If the 12-month deadline falls on a Saturday, Sunday, or federal holiday in Washington, D.C., the nonprovisional application can be filed on the next business day.

To learn more:

What is the time limit for filing a divisional application?

There is no specific time limit for filing a divisional application, but there are important considerations that effectively create a practical time frame:

  1. Parent Application Status: The divisional application must be filed while the parent application is still pending. Once the parent application is either abandoned or issued as a patent, it’s no longer possible to file a divisional from it.
  2. Priority Claim: To claim the benefit of the parent application’s filing date, the divisional must be filed within the time periods specified in 35 U.S.C. 120, 121, 365(c), or 386(c).
  3. Patent Term: The 20-year patent term is calculated from the earliest non-provisional U.S. filing date. Filing a divisional later in the parent’s pendency will result in a shorter potential patent term for the divisional.

The MPEP 201.06 states:

A divisional application is often filed as a result of a restriction requirement made by the examiner.

While this doesn’t specify a time limit, it implies that divisional applications are typically filed in response to office actions during the examination process. Applicants should consider filing a divisional promptly after receiving a restriction requirement to ensure they don’t miss any deadlines and to maximize the potential patent term.

For more information on Divisional application, visit: Divisional application.

For more information on filing deadline, visit: filing deadline.

The time limit for filing a delayed claim for foreign priority after patent issuance is specified in 37 CFR 1.55(g). According to MPEP 216.01:

‘The time period set in 37 CFR 1.55(g) for filing a claim for priority and the certified copy required under 37 CFR 1.55(f) is the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.’

However, for patents that have already been issued, the claim must be filed within the period set forth in 37 CFR 1.55(g). This typically means that the claim should be filed as soon as possible after realizing the oversight, as any delay beyond the statutory period would require explanation and potentially affect the grant of the petition.

The time limit for filing a certified copy of a foreign application depends on the type of application:

  1. For applications under 35 U.S.C. 111(a): A certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application, or sixteen months from the filing date of the prior foreign application, as stated in 37 CFR 1.55(f)(1).
  2. For applications under 35 U.S.C. 371 (national stage applications): A certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT, as per 37 CFR 1.55(f)(2).

If these time limits are not met, a petition including a showing of good and sufficient cause for the delay and the petition fee set forth in § 1.17(g) must accompany the certified copy.

To learn more:

To learn more:

For applications filed under 35 U.S.C. 111(a) on or after March 16, 2013, 37 CFR 1.55(f)(1) sets the time limit for filing a certified copy of the foreign application. The certified copy must be filed within the later of:

  • Four months from the actual filing date of the application, or
  • Sixteen months from the filing date of the prior foreign application

This time limit does not apply to design applications. For international applications entering the national stage under 35 U.S.C. 371, the time limit is set forth in 37 CFR 1.55(f)(2).

It’s important to note that there are exceptions to these time limits, as provided in 37 CFR 1.55(h), (i), and (j).

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For more information on time limit, visit: time limit.

For applications filed under 35 U.S.C. 111(a) on or after March 16, 2013, 37 CFR 1.55(f)(1) requires that a certified copy of the foreign application be filed within the later of:

  • Four months from the actual filing date of the application, or
  • Sixteen months from the filing date of the prior foreign application

This time period does not apply to design applications. There are three exceptions to this requirement, as outlined in 37 CFR 1.55(h), (i), and (j).

To learn more:

The time limit for filing a benefit claim depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the reference must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “If the application is an application filed under 35 U.S.C. 111(a), the reference to the prior application must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on time limit, visit: time limit.

The time limit for claiming benefit of a prior application depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a), the benefit claim must be made within the later of:
    • Four months from the actual filing date of the later-filed application, or
    • Sixteen months from the filing date of the prior-filed application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c) unless a petition to accept an unintentionally delayed benefit claim is granted.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on time limit, visit: time limit.

The statement requirement for transition applications was introduced as part of the implementation of the first inventor to file provisions of the America Invents Act (AIA). Transition applications are:

  • Nonprovisional applications filed on or after March 16, 2013
  • Applications that claim foreign priority to, or domestic benefit of, an application filed before March 16, 2013

The statement requirement is outlined in 37 CFR 1.55(k) and 1.78(a)(6) and (d)(6). As stated in the MPEP:

The statement provisions of 37 CFR 1.55 and 1.78 require that if the later-filed transition application contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March 16, 2013, the applicant must provide a statement to that effect (unless the later-filed application is a nonprovisional international design application).

The statement must be provided within specified time limits. Applicants are not required to provide the statement if they reasonably believe the application does not contain claims with an effective filing date on or after March 16, 2013.

For more information on America Invents Act, visit: America Invents Act.

For more information on first inventor to file, visit: first inventor to file.

For more information on transition applications, visit: transition applications.

For a Continued Prosecution Application (CPA), the specific reference requirement under 35 U.S.C. 120 is satisfied by the CPA request itself. According to MPEP § 201.06(d):

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that when you file a CPA request, it automatically serves as the required reference to the prior application under 35 U.S.C. 120. No additional amendments or references in the specification are necessary to establish this connection.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on specific reference, visit: specific reference.

For a Continued Prosecution Application (CPA), the specific reference required by 35 U.S.C. 120 is the CPA request itself. This is explicitly stated in 37 CFR 1.53(d)(7).

According to MPEP ¶ 2.34:

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that when you file a CPA, the request itself serves as the necessary reference to the prior application, eliminating the need for additional amendments to the specification to establish continuity.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on specific reference, visit: specific reference.

The Transco Products decision is significant in determining benefit claims because it established that a later-filed application does not need to use the exact same words as the prior-filed application to satisfy the written description requirement. According to MPEP 211.05:

‘New or amended claims which introduce elements or limitations that are not supported by the as-filed disclosure violate the written description requirement. See, e.g., In re Lukach, 442 F.2d 967, 169 USPQ 795 (CCPA 1971) (subgenus range was not supported by generic disclosure and specific example within the subgenus range); In re Smith, 458 F.2d 1389, 1395, 173 USPQ 679, 683 (CCPA 1972) (an adequate description of a genus may not support claims to a subgenus or species within the genus). While there is no in haec verba requirement, newly added claims or claim limitations must be supported in the specification through express, implicit, or inherent disclosure. An amendment to correct an obvious error does not constitute new matter where one skilled in the art would not only recognize the existence of the error in the specification, but also recognize the appropriate correction. In re Oda, 443 F.2d 1200, 170 USPQ 268 (CCPA 1971).’

This means that the USPTO will consider whether the prior-filed application provides sufficient support for the claims in the later-filed application, even if the exact wording is different, as long as the support is express, implicit, or inherent in the original disclosure.

To learn more:

The term ‘original application’ has a specific meaning in patent law, as outlined in MPEP 201.02:

‘Original’ application is used in the patent statutes and rules to refer to an application which is not a reissue application. An original application may be a first filing or a continuing application.

This definition is significant because it distinguishes original applications from reissue applications, which are used to correct errors in already-granted patents. Original applications encompass:

  • First-time filings of new inventions
  • Continuing applications (continuations, divisionals, and continuations-in-part)

Understanding this term is crucial for patent applicants and examiners, as it affects how an application is processed and what rights it may claim, particularly in terms of priority dates and the scope of patent protection.

For more information on patent application types, visit: patent application types.

For more information on patent procedure, visit: patent procedure.

What is the significance of the term ‘nonprovisional’ in patent applications?

The term ‘nonprovisional’ in patent applications is significant because it distinguishes these applications from provisional applications:

  • Examination: Nonprovisional applications undergo substantive examination by the USPTO, while provisional applications do not.
  • Patent Grant: Only nonprovisional applications can mature into granted patents.
  • Duration: Nonprovisional applications have a standard 20-year term from the filing date, while provisional applications expire after 12 months.
  • Content Requirements: Nonprovisional applications must include formal patent claims and other specific elements not required in provisional applications.

The MPEP 201.01 mentions nonprovisional applications in the context of original applications: ‘Original applications include all applications other than reissue applications. Original applications may be nonprovisional or provisional.’

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on patent grant, visit: patent grant.

For more information on provisional application, visit: provisional application.

What is the significance of the term ‘copending’ in continuation applications?

The term ‘copending’ is crucial in the context of continuation applications. According to MPEP 201.07:

A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.

The significance of ‘copending’ is as follows:

  • Timing: It means that the continuation application must be filed before the prior application is patented, abandoned, or terminated.
  • Continuous chain: It ensures a continuous chain of pending applications, maintaining the priority date of the original filing.
  • Benefit claims: Copendency is required for a continuation to claim the benefit of the earlier filing date of the parent application.

If applications are not copending, the continuation may lose the benefit of the earlier filing date, potentially affecting patentability if intervening prior art exists.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

What is the significance of the term ‘carved out’ in relation to divisional applications?

The term ‘carved out’ is significant in understanding the nature of divisional applications. According to MPEP 201.06: ‘A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.”

The significance of ‘carved out’ includes:

  • It implies that the divisional application is derived from a portion of the parent application.
  • The divisional application focuses on a specific invention or set of claims that are distinct from those in the parent application.
  • The subject matter in the divisional is entirely based on the disclosure in the parent application.
  • No new matter can be added to the divisional application beyond what was disclosed in the parent.

This term emphasizes that while the divisional application is separate, it is intrinsically linked to the parent application’s original disclosure, ensuring that the applicant doesn’t gain an unfair advantage by introducing new subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent filing, visit: patent filing.

The date September 21, 2004, is significant in relation to 37 CFR 1.57(b) because it marks the effective date of the provisions now contained in this regulation. The MPEP states that one reason an amendment might not comply with 37 CFR 1.57(b) is if the present application was filed before September 21, 2004, the effective date of the provisions now in 37 CFR 1.57(b).

This means that applications filed before this date cannot use the incorporation by reference procedure outlined in 37 CFR 1.57(b) to add inadvertently omitted material. For such applications, different rules and procedures would apply for addressing omitted material.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on effective date, visit: effective date.

For more information on incorporation by reference, visit: incorporation by reference.

What is the significance of the Paris Convention in foreign priority claims?

The Paris Convention plays a crucial role in foreign priority claims for patent applications. Its significance includes:

  • Establishing the right of priority for patent applications among member countries.
  • Allowing applicants to file in multiple countries while maintaining the original filing date.
  • Providing a 12-month priority period for utility patents (6 months for design patents).
  • Ensuring equal treatment of foreign and domestic applicants in member countries.

According to MPEP 213: “The right of priority is defined in Article 4 of the Paris Convention for the Protection of Industrial Property and is based on the first filing in a Paris Convention country.” This convention facilitates international patent protection by allowing inventors to secure priority dates across multiple jurisdictions.

The Paris Convention plays a crucial role in international patent applications. As stated in MPEP 213.01:

The right of priority under the Paris Convention for the Protection of Industrial Property (Paris Convention) is recognized in the United States.

This means that applicants can claim priority based on an earlier filing in any Paris Convention member country. The Paris Convention facilitates patent protection across multiple countries by allowing a grace period for filing in other member nations while maintaining the priority date of the first filing.

To learn more:

What is the significance of the four-month time period in filing a certified copy?

The four-month time period is significant in filing a certified copy of a foreign application for priority claims. According to MPEP 213.04, “If the certified copy is not filed within the four-month period, the certified copy must be accompanied by a petition including a showing of good and sufficient cause for the delay and the petition fee.” This means that if you file the certified copy within four months of the actual filing date of the application (or entry into the national stage for PCT applications), you don’t need to provide any explanation or pay additional fees. However, if you miss this four-month window, you’ll need to file a petition explaining the delay and pay an additional fee. This rule encourages prompt filing of priority documents and helps streamline the examination process.

To learn more:

What is the significance of the four-month and sixteen-month time periods for filing a priority claim?

The four-month and sixteen-month time periods are crucial deadlines for filing a priority claim in a U.S. patent application. According to MPEP 214.01:

“The claim for priority must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application in an original application filed under 35 U.S.C. 111(a).”

These time periods are significant because:

  • They provide applicants with a window to properly claim priority to a foreign application.
  • The four-month period starts from the U.S. filing date, giving applicants time to prepare and submit the priority claim after filing their U.S. application.
  • The sixteen-month period from the foreign filing date ensures that priority claims are made within a reasonable time frame relative to the original foreign filing.
  • Filing within these periods allows for the priority claim to be considered timely without requiring additional petitions or fees.

It’s important to note that failing to meet these deadlines may result in the need for a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e), which involves additional requirements and fees.

The filing date mentioned in MPEP ¶ 2.05 is significant because it establishes the priority date for the continuation application. The MPEP states:

“This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application.” (MPEP ¶ 2.05)

The significance of the filing date [2] includes:

  • Establishing the priority date for the continuation application
  • Determining the relevant prior art for examination
  • Calculating patent term adjustments
  • Assessing eligibility for certain types of patent term extensions

By referencing the filing date of the prior application, the continuation application can benefit from the earlier filing date, potentially providing an advantage in terms of patentability and patent term.

For more information on continuation application, visit: continuation application.

What is the significance of the filing date in a divisional application?

The filing date of a divisional application is crucial for several reasons:

  • Benefit of earlier filing date: A divisional application is entitled to the benefit of the filing date of the prior-filed application, as stated in MPEP 201.06(c): ‘A divisional application is entitled to the benefit of the filing date of the prior-filed application if filed before the patenting or abandonment of or termination of proceedings on the prior-filed application.’
  • Prior art considerations: The earlier filing date can be used to overcome prior art references that might otherwise be applicable.
  • Patent term calculations: The filing date may affect the calculation of the patent term.
  • Priority claims: It establishes the basis for any priority claims to foreign applications.

It’s important to note that the divisional application must be filed while the parent application is still pending to claim the benefit of the earlier filing date.

For more information on Divisional application, visit: Divisional application.

For more information on patent term, visit: patent term.

For more information on prior art, visit: prior art.

The filing date of a Continued Prosecution Application (CPA) is significant for several reasons. In the context of inventorship, the MPEP ¶ 2.33 mentions:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

The filing date [2] is important because:

  • It establishes the effective date for the CPA.
  • It determines the timeline for filing certain documents, such as inventor oaths or declarations.
  • It affects the calculation of patent term adjustment.
  • It’s used as a reference point for determining whether changes to inventorship were properly requested.

Always keep the CPA filing date in mind when managing patent application procedures and deadlines.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

What is the significance of the filing date in a continuation-in-part application?

The filing date of a continuation-in-part (CIP) application is crucial for determining the effective date of certain disclosures. According to MPEP 201.08:

“The effective filing date of a claimed invention in a CIP application is determined on a claim-by-claim basis and not an application-by-application basis.”

This means:

  • Subject matter carried over from the parent application retains the parent’s filing date.
  • New matter introduced in the CIP receives the filing date of the CIP application.
  • Claims in the CIP are evaluated individually to determine which filing date applies based on their content.

Understanding this distinction is crucial for patent practitioners when assessing prior art and determining the scope of protection for inventions disclosed in CIP applications.

To learn more:

What is the significance of the effective filing date in patent applications?

The effective filing date is a crucial concept in patent law that determines which prior art can be used against a patent application. According to MPEP 2152:

The effective filing date of a claimed invention is used to determine what qualifies as prior art that may be used to reject the claims of the application.

Key points about the effective filing date:

  • It can be the actual filing date of the application or an earlier date if the application claims priority to a prior-filed application.
  • For AIA applications, it determines which version of 35 U.S.C. 102 applies (pre-AIA or AIA).
  • It affects the scope of prior art that can be cited against the application.
  • Different claims within the same application may have different effective filing dates.

Understanding the effective filing date is essential for both patent applicants and examiners in assessing patentability and managing priority claims.

For more information on effective filing date, visit: effective filing date.

For more information on prior art, visit: prior art.

The change from 37 CFR 1.60 to 37 CFR 1.53(b) represents a significant shift in the procedure for filing continuation and divisional applications. After December 1, 1997, all such applications are processed under 37 CFR 1.53(b), which may have different requirements and procedures. Patent applicants need to be aware of this change to ensure they are following the correct, current procedures when filing continuation or divisional applications.

To learn more:

To learn more:

What is the significance of the Application Data Sheet (ADS) in correcting or adding a benefit claim?

The Application Data Sheet (ADS) plays a crucial role in correcting or adding a benefit claim after filing. According to MPEP 211.02(a):

A corrected ADS (along with a petition under 37 CFR 1.78 and the petition fee) is required to correct a benefit claim if the benefit claim was not included on the original ADS.

This means that if you need to correct or add a benefit claim that wasn’t included in the original ADS, you must submit:

  • A corrected ADS
  • A petition under 37 CFR 1.78
  • The required petition fee

The corrected ADS should contain all of the information from the original ADS, with the changes to the benefit claim marked in accordance with 37 CFR 1.76(c).

To learn more:

Tags: ADS

What is the significance of the Access Code on the Request to Retrieve Electronic Priority Application?

The Access Code on the Request to Retrieve Electronic Priority Application plays a crucial role in the priority document exchange process. The MPEP states:

‘The Request to Retrieve Electronic Priority Application must include the Access Code assigned to that application by the applicant or applicant’s representative.’

This Access Code is essential because it allows the USPTO to securely retrieve the priority document from the foreign office. Without the correct Access Code, the USPTO cannot access and retrieve the document, which could lead to issues with establishing priority for your application.

It’s important to ensure that the Access Code you provide on the Request form is accurate and matches the one assigned by the foreign office. Incorrect or missing Access Codes can result in delays or failures in retrieving the priority document, potentially affecting your patent application’s priority claim.

What is the significance of the ‘time period set in 37 CFR 1.55’ for filing priority claims?

The time period set in 37 CFR 1.55 is crucial for securing your priority claim in a patent application. MPEP 213.04 states: ‘The time period set in 37 CFR 1.55 for filing a priority claim and certified copy cannot be extended.’ This strict deadline ensures that priority claims are made promptly, allowing for efficient examination and preventing delays in the patent process. Failing to meet this deadline can result in the waiver of your priority claim, potentially affecting the patentability of your invention if intervening prior art exists. It’s essential to be aware of and adhere to this time period to protect your invention’s priority date.

To learn more:

To learn more:

What is the significance of the ‘right of priority’ in international patent applications?

The ‘right of priority’ is a crucial concept in international patent applications. According to MPEP 211.01(c), ‘The right of priority is defined in 35 U.S.C. 119(a).’ This right allows applicants to claim priority from an earlier filed application, which can be beneficial in establishing the novelty and non-obviousness of an invention. Specifically, the MPEP states:

‘Under certain circumstances, the right of priority may be restored even if the filing is made after the 12-month priority period. See 37 CFR 1.55(c).’

This provision offers flexibility to applicants who may have missed the standard priority deadline, potentially preserving their patent rights in certain situations.

To learn more:

To learn more:

What is the significance of the ‘original disclosure’ in a divisional application?

The ‘original disclosure’ is crucial in a divisional application because it defines the scope of what can be included in the divisional. According to MPEP 201.06:

‘The disclosure of a divisional application must be the same as the disclosure of the prior-filed application, i.e., the original disclosure of the parent or original nonprovisional application or provisional application.’

This means that no new matter can be added to a divisional application. The divisional must rely entirely on the content disclosed in the original parent application. This ensures that the divisional application doesn’t extend beyond the scope of what was initially invented and disclosed.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

What is the significance of the ‘365(c)’ filing date in claiming benefit of a nonprovisional application?

The ‘365(c)’ filing date is crucial when claiming the benefit of a nonprovisional application that was filed as a PCT application and entered the national stage. According to MPEP 211.01(b):

‘If the prior nonprovisional application is an international application that was filed as a PCT application and entered the national stage under 35 U.S.C. 371, the 365(c) filing date of the international application is the filing date to be used in determining copendency.’

This means that when determining if applications are copendent for benefit claims, the PCT filing date (365(c) date) is used rather than the U.S. national stage entry date. This can be significant for maintaining continuous priority chains in international patent applications.

To learn more:

Regional patent offices play a crucial role in the international patent system, particularly for priority claims. MPEP 213.01 recognizes several regional patent offices whose applications can serve as the basis for priority claims in the United States. These include:

  • European Patent Office (EPO)
  • Eurasian Patent Office (EAPO)
  • African Intellectual Property Organization (OAPI)
  • African Regional Intellectual Property Organization (ARIPO)

The significance of these regional offices is explained in MPEP 213.01:

‘The United States will recognize claims for right of priority based on applications filed under such multilateral international agreements as the European Patent Convention (EPC) and the Patent Cooperation Treaty (PCT).’

This recognition allows applicants to file a single application with a regional patent office and still maintain priority rights in the United States. It streamlines the international patent application process and provides more flexibility for inventors seeking protection in multiple countries.

Filing dates are crucial in patent law as they establish priority and can affect the patentability of an invention. The MPEP 201.02 discusses various application types and their relationship to filing dates:

  • Original applications (including first filings and continuing applications) generally retain their filing date for priority purposes.
  • Continuing applications (continuations, divisionals, and continuations-in-part) can benefit from the filing date of the parent application under specific conditions outlined in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.
  • Substitute applications, however, do not obtain the benefit of the filing date of the prior application.

The MPEP states:

A substitute application does not obtain the benefit of the filing date of the prior application.

This emphasizes the importance of maintaining active applications and understanding the implications of different application types on priority dates.

For more information on continuing applications, visit: continuing applications.

For more information on patent applications, visit: patent applications.

What is the significance of copendency in continuation applications?

Copendency is a crucial requirement for continuation applications. It refers to the condition where the continuation application is filed before the prior application is patented, abandoned, or terminated. The MPEP 201.07 states:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement; and the later-filed application must be copending with the prior application.’

The significance of copendency includes:

  • Maintaining Priority: It ensures the continuation application can claim the benefit of the earlier filing date.
  • Unbroken Chain: It maintains an unbroken chain of applications, which is essential for establishing a continuous line of priority.
  • Preventing Loss of Rights: Filing a continuation before the parent application is concluded prevents the loss of patent rights that could occur if new claims are needed after the parent application is no longer pending.

Failure to maintain copendency can result in the loss of the earlier priority date, potentially affecting the patentability of the invention if intervening prior art exists.

For more information on continuation application, visit: continuation application.

For more information on copendency, visit: copendency.

For more information on patent priority, visit: patent priority.

Claiming benefit to a prior application is crucial for divisional applications as it allows the divisional to retain the earlier filing date of the parent application. This can be significant for:

  • Establishing priority over potential prior art
  • Extending the potential patent term
  • Maintaining continuity in the patent family

The MPEP ¶ 2.01 states:

“Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

To properly claim this benefit, applicants must comply with the requirements set forth in 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211, which include making a proper benefit claim and ensuring continuity of disclosure.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Adding new disclosure in a continuation-in-part (CIP) application is a key characteristic that distinguishes it from other types of continuing applications. The MPEP ¶ 2.06 describes a CIP as an application that:

repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application.

The significance of adding new disclosure includes:

  • Allowing applicants to expand on their original invention with new developments or improvements
  • Potentially broadening the scope of patent protection
  • Creating a new filing date for the added material, which can be crucial for overcoming prior art
  • Possibly extending the patent term for the new material

However, it’s important to note that the new disclosure will not benefit from the earlier filing date of the prior application. This can affect patentability if relevant prior art emerges between the filing dates of the original application and the CIP.

For more information on prior art, visit: prior art.

Tags: prior art

What is the significance of a national application being made under 35 U.S.C. 111?

A national application made under 35 U.S.C. 111 signifies that it is filed directly with the United States Patent and Trademark Office (USPTO) and follows the standard U.S. patent application process.

The MPEP 201.01 states: ‘A national application is one that was filed in the United States Patent and Trademark Office (USPTO) under 35 U.S.C. 111.’ This means that the application is subject to U.S. patent laws and procedures from the outset.

Applications filed under 35 U.S.C. 111 include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Design applications
  • Plant applications
  • Provisional applications

These applications are distinct from international applications that enter the national stage in the U.S. under 35 U.S.C. 371.

For more information on patent application types, visit: patent application types.

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

37 CFR 1.55(h) provides an important provision for satisfying the requirement for a certified copy of a foreign application. Key points include:

  • It allows the certified copy requirement to be met through a prior-filed nonprovisional application.
  • The prior-filed application must be one for which benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • The prior-filed application must contain the certified copy and be identified as such.
  • This provision can simplify the process of perfecting priority claims in related applications.

The MPEP states: 37 CFR 1.55(h) provides that the requirement for a certified copy of the foreign application will be considered satisfied in an application if a prior-filed nonprovisional application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c) contains a certified copy of the foreign application and the prior-filed nonprovisional application is identified as containing a certified copy of the foreign application.

This provision can be particularly useful when requesting a certificate of correction to perfect a priority claim in a patent that claims benefit from an earlier application containing the certified copy.

Applications filed under 37 CFR 1.53(d) have a unique treatment of affidavits and declarations. According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

Key points about 37 CFR 1.53(d) applications:

  • They are continuation or divisional applications of a nonprovisional application
  • Affidavits and declarations from the parent application are automatically incorporated
  • This includes documents submitted under 37 CFR 1.130, 1.131, and 1.132
  • No additional action is required to include these documents in the new application

This automatic incorporation simplifies the process for applicants filing continuation or divisional applications under 37 CFR 1.53(d).

For more information on continuation applications, visit: continuation applications.

For more information on patent prosecution, visit: patent prosecution.

35 U.S.C. 386 establishes the right of priority for international design applications. It addresses two key scenarios:

  1. National applications claiming priority from international design applications
  2. International design applications claiming priority from prior foreign applications

The MPEP explains:

“Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.”

“Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.”

These provisions apply to applications filed on or after May 13, 2015, and patents issued from such applications.

35 U.S.C. 111(a) and (b) are important sections of the patent law that define two different types of national patent applications. According to MPEP 201.01:

‘National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’

To elaborate:

  • 35 U.S.C. 111(a) refers to nonprovisional applications. These are full patent applications that can potentially result in an issued patent.
  • 35 U.S.C. 111(b) refers to provisional applications. These are simplified applications that establish a priority date but do not themselves result in an issued patent.

The choice between filing under 111(a) or 111(b) depends on the inventor’s strategy and readiness to pursue full patent protection. Provisional applications (111(b)) provide a way to quickly establish a priority date, while nonprovisional applications (111(a)) begin the formal examination process.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

What is the role of the Technology Center in handling status inquiries?

Technology Centers (TCs) play a specific role in handling certain types of status inquiries. MPEP 203.08 states:

“Inquiries which cannot be answered by the UCC will be forwarded to the TC for response.”

This means that more complex or specific inquiries that require expertise in a particular technological area are directed to the appropriate TC. TCs have access to more detailed information about applications in their field and can provide more specific guidance within the limits of USPTO policy.

To learn more:

The examiner plays a crucial role in processing requests to delete a named inventor in a Continued Prosecution Application (CPA) for design applications. According to MPEP ¶ 2.32, the examiner is responsible for acknowledging the receipt of the request and confirming that the inventorship has been corrected. The MPEP provides the following guidance for examiners:

“Examiner Note: 1. Use this form paragraph where a Continued Prosecution Application (CPA) is filed accompanied by a statement requesting deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the new application.”

The examiner must verify that the request was submitted with the CPA filing and use the appropriate form paragraph to acknowledge the correction of inventorship. If the request is made after the CPA filing, the examiner must ensure it’s accompanied by a request under 37 CFR 1.48, as per the MPEP instructions.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent procedure, visit: patent procedure.

The right of priority in international patent law refers to the right to rely on a foreign application when filing a patent application in another country. This concept originated in the Paris Convention for the Protection of Industrial Property, which the United States adhered to in 1887.

As stated in the MPEP: The right to rely on a foreign application is known as the right of priority in international patent law and this phrase has been adopted in the U.S. statute. This right allows applicants to claim the filing date of an earlier foreign application, providing certain conditions are met.

To learn more:

The Patent Law Treaties Implementation Act (PLTIA) introduced the concept of restoration of the right of priority. This provision allows applicants to file a subsequent application and still claim priority or benefit even if they missed the standard 12-month deadline (6-month for design applications).

As stated in the MPEP: Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. (MPEP 210)

Key points about restoration of the right of priority:

  • It applies to both foreign priority claims and domestic benefit claims to provisional applications.
  • The subsequent application must be filed within 14 months from the filing date of the prior foreign application or provisional application (8 months for design applications).
  • The delay in filing the subsequent application must be unintentional.
  • A petition for restoration of the right of priority must be filed.

The specific requirements and procedures for restoration of the right of priority are outlined in 37 CFR 1.55(c) for foreign priority claims and 37 CFR 1.78(b) for domestic benefit claims.

For more information on PLTIA, visit: PLTIA.

For more information on unintentional delay, visit: unintentional delay.

For a valid foreign priority claim, the U.S. application and the foreign application must name the same inventor or have at least one joint inventor in common. This requirement ensures that the right of priority is properly linked between the applications.

As stated in MPEP 213.02: “Pursuant to 35 U.S.C. 119(a), the foreign application must have been filed by the same applicant as the applicant in the United States, or by applicant’s legal representatives or assigns. Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.”

The MPEP further clarifies: “Joint inventors A and B in a nonprovisional application filed in the United States Patent and Trademark Office may properly claim the benefit of an application filed in a foreign country by A and another application filed in a foreign country by B, i.e., A and B may each claim the benefit of their foreign filed applications.”

This requirement ensures that the priority right is properly linked to the inventive entity responsible for the invention in both the foreign and U.S. applications.

For more information on foreign priority, visit: foreign priority.

For more information on joint inventors, visit: joint inventors.

When claiming foreign priority, applicants are generally required to file a certified copy of the foreign application within a specified time period. The requirements and deadlines for filing the certified copy depend on the type of application and the circumstances of the filing.

According to MPEP 213.04: “37 CFR 1.55(g) sets forth the requirements for filing a priority claim, certified copy of foreign application, and translation that are applicable in all applications.”

Key points about the certified copy requirement include:

  • The certified copy must be filed within the pendency of the application, unless filed with a petition.
  • For applications filed under 35 U.S.C. 111(a), the certified copy must typically be filed within the later of four months from the actual filing date or sixteen months from the filing date of the prior foreign application.
  • For national stage applications under 35 U.S.C. 371, the certified copy must be filed within the time limit set forth in the PCT and the Regulations under the PCT.
  • If the certified copy is not filed within the required time period, it must be accompanied by a petition and fee, along with a showing of good and sufficient cause for the delay.
  • In some cases, the requirement may be satisfied through the priority document exchange program or by identifying a previously filed application containing the certified copy.

The MPEP also notes: “If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.”

For more information on certified copy, visit: certified copy.

For more information on filing requirements, visit: filing requirements.

For more information on foreign application, visit: foreign application.

What is the required oath or declaration for a divisional application?

For a divisional application, a new oath or declaration is generally required. However, there are exceptions:

  • If the application is filed on or after September 16, 2012, a copy of the oath or declaration from the prior nonprovisional application may be used, provided that it complies with 37 CFR 1.63, 1.64, or 1.67 for the divisional application.
  • If the divisional application was filed before September 16, 2012, and the prior application was filed on or after September 16, 2012, a copy of the oath or declaration from the prior application can be used in the divisional application.

As stated in MPEP 201.06: “A new oath or declaration is required in a divisional application filed under 37 CFR 1.53(b), regardless of whether a copy of the oath or declaration from the prior nonprovisional application is used in the divisional application, unless the divisional application is filed on or after September 16, 2012.”

To learn more:

What is the relationship between priority claims and the effective filing date?

The relationship between priority claims and the effective filing date is crucial in determining the patentability of an invention. According to MPEP 216:

“The effective filing date of a claimed invention is determined on a claim-by-claim basis and not an application-by-application basis.”

This means that each claim in a patent application may have a different effective filing date, depending on its content and the priority claims it can support. The effective filing date is important because it determines which prior art can be used against the claim during examination and potential litigation.

  • If a claim is fully supported by an earlier application, its effective filing date may be the filing date of that earlier application.
  • If a claim contains new matter not disclosed in any earlier application, its effective filing date will be the actual filing date of the current application.

Understanding this relationship is crucial for inventors and patent practitioners to properly claim priority and protect their inventions.

For more information on effective filing date, visit: effective filing date.

What is the relationship between a provisional application and a nonprovisional application?

A provisional application serves as a placeholder for a later-filed nonprovisional application. According to MPEP 201.04:

“A provisional application may serve as a basis for claiming benefit under 35 U.S.C. 119(e) in a later filed nonprovisional application or an international application designating the United States.”

This means that a provisional application can establish an earlier filing date for a subsequent nonprovisional application, provided the nonprovisional is filed within 12 months of the provisional and properly claims benefit to it.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

What is the relationship between a divisional application and its parent application?

A divisional application is closely related to its parent application, as it stems from the same invention disclosure. According to MPEP 201.06, “A divisional application is a later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application.” This means that:

  • The divisional application contains a subset of the subject matter from the parent application.
  • It claims an independent or distinct invention from what is claimed in the parent application.
  • It cannot introduce new matter beyond what was disclosed in the parent application.
  • It can claim the benefit of the parent application’s filing date.

The relationship allows for separate prosecution of different aspects of an invention while maintaining the priority date of the original disclosure.

To learn more:

What is the relationship between a divisional application and a restriction requirement?

A divisional application is often filed in response to a restriction requirement issued by the USPTO. The MPEP 201.06 explains:

“A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.'”

The relationship between a divisional application and a restriction requirement is as follows:

  • When an examiner determines that a single application contains two or more independent or distinct inventions, they may issue a restriction requirement.
  • The applicant must then elect one invention to pursue in the original application.
  • The non-elected invention(s) can be pursued in one or more divisional applications.
  • Divisional applications allow applicants to protect multiple inventions disclosed in a single parent application without violating the principle of double patenting.

It’s important to note that while divisional applications are often filed in response to restriction requirements, they can also be filed voluntarily if the applicant recognizes distinct inventions in their application before receiving a restriction requirement.

To learn more:

What is the relationship between a divisional application and a continuation application?

Divisional applications and continuation applications are both types of continuing applications, but they serve different purposes. The MPEP 201.06 provides insight into the nature of divisional applications:

“A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.'”

In contrast, a continuation application typically contains the same disclosure as the parent application but with different claims. The key differences are:

  • Divisional Application: Filed to pursue distinct inventions that were subject to a restriction requirement in the parent application.
  • Continuation Application: Filed to pursue additional aspects of the same invention disclosed in the parent application.

Both types of applications claim the benefit of the parent application’s filing date, but they differ in their purpose and the scope of claims they can contain. It’s important to choose the appropriate type of continuing application based on the specific circumstances and inventive concepts you wish to protect.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

What is the relationship between a continuation-in-part application and its parent application?

A continuation-in-part (CIP) application is a type of patent application that has a unique relationship with its parent application. According to MPEP 201.08:

“A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.”

This means that a CIP application:

  • Contains some or all of the subject matter from the parent application
  • Introduces new subject matter not present in the parent application
  • Must be filed while the parent application is still pending

The relationship between a CIP and its parent is important for determining priority dates and the scope of patent protection.

For more information on new matter, visit: new matter.

For more information on parent application, visit: parent application.

The USPTO has established special procedures for handling official inquiries to ensure consistency and compliance with government directives. As stated in MPEP 203.08(a):

This procedure is used so that there will be uniformity in the handling of contacts from the indicated sources, and also so that compliance with directives of the Department of Commerce is attained.

These procedures help the USPTO maintain a standardized approach to high-level inquiries and ensure that responses align with broader governmental policies.

To learn more:

Tags: USPTO

The Priority Document Exchange (PDX) program is designed to facilitate the electronic exchange of priority documents between participating intellectual property offices. According to MPEP 215.01, the PDX program allows participating foreign intellectual property offices to exchange priority documents with the United States Patent and Trademark Office (USPTO) at no cost to the applicant. This program aims to streamline the process of submitting priority documents, reducing the burden on applicants and improving efficiency in patent examination procedures.

To learn more:

The PDX (Priority Document Exchange) program serves to facilitate the exchange of priority documents between participating intellectual property offices. According to MPEP 215.01, ‘The PDX program eliminates the need for applicants to submit paper certified copies of foreign applications in participating intellectual property offices.’ This streamlines the process, reducing both the burden on applicants and the workload for patent offices.

The affidavit required for claiming priority based on an inventor’s certificate serves a specific purpose, as outlined in MPEP 213.05:

The affidavit or declaration specified under 37 CFR 1.55(l) is only required for the purpose of ascertaining whether, in the country where the application for an inventor’s certificate originated, this option generally existed for applicants with respect to the particular subject matter of the invention involved.

The affidavit is not intended to investigate the specific applicant’s eligibility to exercise the option in their particular case. Rather, it’s meant to confirm that in the country where the inventor’s certificate was filed, applicants generally had the right to choose between applying for a patent or an inventor’s certificate for the subject matter in question.

This requirement ensures compliance with the treaty and statute governing priority rights, while recognizing that some countries may have restrictions based on factors such as employment or nationality.

To learn more:

What is the purpose of MPEP 203.08 – Status Inquiries?

MPEP 203.08 – Status Inquiries outlines the procedures for handling status inquiries about patent applications. The section states:

“The Office receives numerous telephone and written requests for information concerning the status of patent applications. These status inquiries may be made to the USPTO Contact Center (UCC), the Technology Center (TC) or the Patent Examining Group.”

This section provides guidance to both applicants and USPTO staff on how to handle these inquiries efficiently and in compliance with privacy regulations.

To learn more:

The purpose of MPEP ¶ 2.33 is to provide guidance to patent examiners when they encounter a situation where a new inventor is identified in a Continued Prosecution Application (CPA) for design applications. It states:

Use this form paragraph where a request for a Continued Prosecution Application (CPA) identifies one or more inventors who were not named as inventors in the prior application on the filing date of the CPA.

This paragraph helps examiners address situations where applicants have named new inventors in a CPA without following the proper procedure. It reminds both examiners and applicants that a formal request under 37 CFR 1.48 is required to change inventorship, even in a CPA.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

MPEP ¶ 2.32 provides guidance for patent examiners on how to acknowledge and process requests to delete a named inventor in Continued Prosecution Applications (CPAs) for design patents. The paragraph serves several purposes:

  • It offers a standardized response for examiners to use when acknowledging the receipt of a request to delete an inventor.
  • It confirms that the inventorship has been corrected as requested.
  • It clarifies the timing and procedure for inventor deletion requests in CPAs.

The paragraph states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This standardized language ensures consistency in USPTO communications and helps applicants understand that their request has been processed successfully.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

MPEP ¶ 2.32 provides guidance for patent examiners on how to respond to requests for deleting a named inventor in a Continued Prosecution Application (CPA) for design patents. The paragraph serves several purposes:

  • It offers a template for examiners to acknowledge receipt of a statement requesting inventor deletion.
  • It confirms that the inventorship has been corrected as requested.
  • It clarifies the timing and requirements for inventorship changes in CPAs.

The paragraph states: Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This standardized language ensures consistent communication between the USPTO and applicants regarding inventorship changes in CPAs.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

MPEP ¶ 2.15 provides guidance on how to properly claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c). It outlines the requirements for including a specific reference to the prior-filed application and the timeframes within which this reference must be submitted.

The paragraph states: If applicant desires to claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c), the instant application must contain, or be amended to contain, a specific reference to the prior-filed application in compliance with 37 CFR 1.78. This means that applicants must explicitly reference the prior application to claim its benefits.

For more information on specific reference, visit: specific reference.

MPEP ¶ 2.05 Possible Status as Continuation serves as a guideline for patent examiners when handling applications that may qualify as continuations. Its primary purpose is to:

  • Instruct examiners on how to handle applications that disclose and claim only subject matter disclosed in a prior application
  • Provide language for examiners to use when notifying applicants about the possible status of their application as a continuation
  • Ensure proper classification and processing of continuation applications

The MPEP states: “This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application. Accordingly, this application may constitute a continuation or division.” (MPEP ¶ 2.05)

This guidance helps maintain consistency in the examination process and ensures that applicants are properly informed about the potential status of their applications.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

Form Paragraph 2.38 in the MPEP serves several important purposes regarding non-English provisional applications:

  1. It notifies the applicant that an English translation and/or a statement of translation accuracy is required for a non-English language provisional application.
  2. It informs the applicant about the specific documents that are missing from their application.
  3. It provides clear instructions on what the applicant needs to do to rectify the situation.
  4. It warns the applicant about the potential consequences of not providing the required documents.

The MPEP states: Use this form paragraph to notify applicant that an English translation of the non-English language provisional application and/or a statement that the translation is accurate is required.

This form paragraph is a crucial tool for patent examiners to communicate requirements and potential issues to applicants, ensuring that all necessary documents are properly filed for claiming benefit to a non-English provisional application.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

Filing a continuation application serves several important purposes in patent prosecution. The MPEP indicates:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

Key reasons for filing a continuation include:

  • Pursuing broader or different claim scope based on the same disclosure
  • Addressing remaining rejections or objections from the parent application
  • Submitting new evidence or arguments to overcome prior art rejections
  • Maintaining pendency for ongoing improvements or to counter competitor activities
  • Separating distinct inventions identified during examination of the parent

Continuations allow applicants to refine their patent strategy while maintaining the priority date of the original filing, which can be crucial in fast-moving technological fields.

For more information on continuation application, visit: continuation application.

For more information on patent strategy, visit: patent strategy.

What is the purpose of a divisional application under 37 CFR 1.53(b)?

A divisional application under 37 CFR 1.53(b) serves to pursue claims to a distinct invention that was disclosed but not claimed in a parent application. According to the MPEP:

“A divisional application is often filed as a result of a restriction requirement made by the examiner.”

This allows inventors to protect multiple inventions that may have been included in a single original application but were deemed to be separate and distinct by the USPTO. Divisional applications maintain the benefit of the filing date of the parent application for the common subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on patent filing, visit: patent filing.

What is the purpose of a divisional application in patent law?

A divisional application is a type of patent application that allows an inventor to pursue protection for different aspects of an invention that were disclosed but not claimed in a parent application. According to MPEP 201.06:

A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.’

The main purposes of a divisional application are:

  • To protect multiple inventions disclosed in a single parent application
  • To respond to a restriction requirement issued by the USPTO
  • To pursue broader or different claim scope than what was allowed in the parent application

Divisional applications are filed under 37 CFR 1.53(b) and can benefit from the filing date of the parent application for the common subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

The proper procedure for correcting inventorship in a Continued Prosecution Application (CPA) is to file a request under 37 CFR 1.48. This applies whether you’re adding or removing an inventor. The MPEP guidance states: ‘Any request to add an inventor must be in the form of a request under 37 CFR 1.48.’ This formal request ensures that the USPTO properly processes and recognizes the change in inventorship.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

If a benefit claim is not filed within the required time period, it may still be accepted through a petition process. According to MPEP ¶ 2.15:

A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

The petition must include:

  1. The reference to the prior application (unless previously submitted)
  2. The petition fee under 37 CFR 1.17(m)
  3. A statement that the entire delay between the date the benefit claim was due and the date the claim was filed was unintentional

The Director may request additional information if there’s a question about whether the delay was unintentional. The petition should be addressed to: Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.

For more information on unintentional delay, visit: unintentional delay.

The process for restoring the benefit of a provisional application after the 12-month deadline involves filing a petition under 37 CFR 1.78(b). This petition must be filed in the subsequent application (nonprovisional or international application designating the US) within 14 months of the provisional application’s filing date. The MPEP outlines the requirements:

“A petition under 37 CFR 1.78(b) requires: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application, which must be included in application data sheet (unless previously submitted in an application data sheet); (B) the petition fee as set forth in 37 CFR 1.17(m); and (C) a statement that the delay in filing the nonprovisional application or international application designating the United States within the twelve-month period set forth in 37 CFR 1.78(a)(1)(i) was unintentional.”

The Director may require additional information to determine if the delay was unintentional. If granted, this restoration allows an application to validly claim the benefit of a provisional application filed up to 14 months earlier.

To learn more:

To learn more:

The USPTO has a specific process for handling inquiries from embassies. According to MPEP 203.08(a):

Inquiries referred to in this section such as correspondence from embassies, the Office of the U.S. Trade Representative, and the Department of State should immediately be transmitted to the Administrator of the Office of Policy and International Affairs, and a staff member of that office should be notified by phone that such correspondence has been received at 571-272-9300.

This procedure ensures that international inquiries are handled consistently and in line with the USPTO’s international policies.

To learn more:

Tags: USPTO

When a claim to priority and certified copy of a foreign application are received during the pendency of a patent application, the examiner generally follows these steps:

  • Checks for obvious formal defects in the documents
  • Verifies that the documents correspond to the application identified in the application data sheet
  • For original applications filed under 35 U.S.C. 111(a) and international applications entering the national stage under 35 U.S.C. 371, ensures the claim for foreign priority is timely

The examiner does not typically examine the subject matter to determine if the applicant is entitled to the benefit of the foreign filing date unless it’s necessary for patentability reasons. As stated in the MPEP, The subject matter of the application is not examined to determine whether the applicant is actually entitled to the benefit of the foreign filing date on the basis of the disclosure thereof unless such determination is required for patentability reasons.

For more information on application data sheet, visit: application data sheet.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For more information on patent examination, visit: patent examination.

If a priority claim needs to be corrected after a patent has been issued, it must be done through a certificate of correction. The MPEP Section 213.04 states:

“If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and § 1.323.”

To obtain a certificate of correction, the patent owner must file a request with the USPTO, pay the required fee, and provide a statement explaining the error and how it occurred. The USPTO will then review the request and, if approved, issue a certificate of correction to be attached to the patent.

To learn more:

What is the process for adding a benefit claim after the time period set forth in 37 CFR 1.78?

To add a benefit claim after the time period set forth in 37 CFR 1.78, you must file a petition to accept an unintentionally delayed benefit claim. The MPEP 211.02(a) outlines the process:

  1. File a petition under 37 CFR 1.78(c) for claiming the benefit of a prior-filed provisional application, or under 37 CFR 1.78(e) for claiming the benefit of a prior-filed nonprovisional application.
  2. Pay the petition fee (currently $2,000 for nonprovisional applications).
  3. Submit a corrected application data sheet (ADS) including the reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior-filed application.
  4. Provide a statement that the entire delay between the date the benefit claim was due and the date the benefit claim was filed was unintentional.

The MPEP states: “The Director may require additional information where there is a question whether the delay was unintentional.” It’s crucial to ensure all requirements are met to avoid potential rejection of the petition.

To learn more:

The procedure for submitting a priority document in an international application is outlined in PCT Rule 17. According to the MPEP:

Where the priority of an earlier national or international application is claimed under Article 8, a copy of that earlier application, certified by the authority with which it was filed (‘the priority document’), shall… be submitted by the applicant to the International Bureau or to the receiving Office not later than 16 months after the priority date.

The applicant has three options:

  1. Submit the priority document directly to the International Bureau or the receiving Office.
  2. Request the receiving Office to prepare and transmit the priority document to the International Bureau (if the priority document is issued by the receiving Office).
  3. Request the International Bureau to retrieve the priority document from a digital library in accordance with the Administrative Instructions.

It’s important to note that failure to comply with these requirements may result in the designated Office disregarding the priority claim, subject to certain conditions specified in PCT Rule 17.

To learn more:

What is the procedure for correcting or adding a benefit claim in a design application?

The procedure for correcting or adding a benefit claim in a design application differs from that of utility applications. According to MPEP 211.02(a):

“For design applications, an application may be amended to claim priority to or the benefit of a prior-filed application after the application issues as a patent by filing a reissue application. Note that the copendency requirement of 35 U.S.C. 120 must still be met.”

This means that for design applications:

  • Corrections or additions to benefit claims cannot be made after the application has issued as a patent through a Certificate of Correction.
  • The only way to correct or add a benefit claim after issuance is by filing a reissue application.
  • The copendency requirement under 35 U.S.C. 120 must still be satisfied, meaning the applications must have been co-pending at some point.

It’s important to note that this procedure is specific to design applications and differs from the process for utility applications.

To learn more:

The Priority Document Exchange (PDX) program is a system that allows participating intellectual property offices to exchange priority documents electronically. This program simplifies the process of submitting certified copies of foreign priority applications for patent applicants.

According to the MPEP, The Office website provides information concerning the priority document exchange program ( www.uspto.gov/patents/basics/international-protection/electronic-priority-document-exchange-pdx ). This information includes participating offices and instructions for accessing foreign applications.

To learn more:

The priority document exchange program is a system that allows participating patent offices to exchange priority documents electronically. According to MPEP 215.02(a):

“Applicants may use the priority document exchange program to obtain a copy of a foreign application filed in a participating foreign intellectual property office.”

This program simplifies the process of obtaining priority documents for patent applications filed in multiple countries.

To learn more:

The priority document exchange program is a bilateral or multilateral agreement between the USPTO and participating foreign intellectual property offices that allows for the electronic exchange of priority documents. This program can satisfy the requirement for filing a certified copy of a foreign application under certain conditions.

According to 37 CFR 1.55(i), the certified copy requirement will be considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority is presented in an application data sheet (ADS)
  • The applicant provides the necessary information for the participating office to provide the USPTO with access to the foreign application
  • The USPTO receives a copy of the foreign application from the participating office during the pendency of the application and before the patent is granted

This provision can significantly simplify the process of meeting the certified copy requirement for applicants whose priority applications are from participating countries.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on priority document exchange, visit: priority document exchange.

The Priority Document Exchange (PDX) program is an electronic system that allows participating intellectual property offices to exchange priority documents securely. According to MPEP 215.01, “Under the PDX program, the participating offices electronically transmit priority documents to each other as needed.” This program eliminates the need for applicants to submit paper certified copies of priority documents in participating offices.

The Paris Convention for the Protection of Industrial Property is an international agreement that establishes key principles for intellectual property protection, including patents. It was first signed in 1883 and has been revised several times since then.

The Convention is significant in patent law because it established the right of priority, which allows patent applicants to claim priority based on an earlier filing in any country that is a member of the Paris Convention. This right is referenced in MPEP 213, which states:

‘The right of priority is defined in 35 U.S.C. 119(a)… Under this statute, an applicant who has filed a first foreign application is entitled to claim the benefit of the filing date of the first foreign application in a subsequent U.S. national patent application…’

This provision helps inventors protect their inventions internationally by giving them a grace period to file in multiple countries while maintaining the priority date of their first filing.

The Paris Convention is an international treaty that establishes priority rights for patent applications. According to MPEP 213, “The right of priority is defined in 35 U.S.C. 119(a)” and is based on this convention. It allows inventors who file a patent application in one member country to claim priority for up to 12 months when filing in other member countries.

Key points of the Paris Convention include:

  • Establishing a 12-month priority period for patents
  • Allowing applicants to claim priority based on earlier filings in member countries
  • Ensuring equal treatment of foreign and domestic applicants in member countries

What is the Paris Convention and how does it relate to patent filing?

The Paris Convention for the Protection of Industrial Property, commonly known as the Paris Convention, is an international treaty that plays a crucial role in patent filing. According to MPEP 213.01:

The Paris Convention for the Protection of Industrial Property sets forth the concept of a ‘convention application’ and a ‘right of priority.’

This means that applicants from member countries can use their first filing date in one member country as the effective filing date in other member countries, provided they file within 12 months. This treaty facilitates international patent protection by allowing inventors to secure a priority date in multiple countries.

To learn more:

The legal basis for denying amendments to Continued Prosecution Application (CPA) specifications that attempt to reference prior applications stems from both federal regulations and patent law. Specifically:

  • 37 CFR 1.53(d)(7): This regulation establishes that a CPA request itself serves as the specific reference required by 35 U.S.C. 120.
  • 35 U.S.C. 120: This statute outlines the requirements for claiming the benefit of an earlier filing date in the United States.

According to MPEP ¶ 2.34:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.

This means that the CPA filing itself legally establishes the necessary connection to the prior application, making any specification amendment both redundant and impermissible.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on patent law, visit: patent law.

The legal basis for claiming the benefit of an international design application designating the United States is found in 35 U.S.C. 386(c). This statute allows a nonprovisional application to claim the benefit of a prior international design application, subject to the conditions and requirements of 35 U.S.C. 120.

As stated in the MPEP: Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States. This means that applicants can potentially secure an earlier effective filing date for their nonprovisional application by claiming the benefit of a previously filed international design application.

To learn more:

To learn more:

New matter can have a significant impact on benefit claims in patent applications. The introduction of new matter in a later-filed application can result in the loss of the benefit claim to the prior-filed application. According to MPEP 211.05:

‘New or amended claims which introduce elements or limitations that are not supported by the as-filed disclosure violate the written description requirement. See, e.g., In re Lukach, 442 F.2d 967, 169 USPQ 795 (CCPA 1971) (subgenus range was not supported by generic disclosure and specific example within the subgenus range); In re Smith, 458 F.2d 1389, 1395, 173 USPQ 679, 683 (CCPA 1972) (an adequate description of a genus may not support claims to a subgenus or species within the genus).’

This means that if a later-filed application includes new matter not disclosed in the prior-filed application, it cannot claim the benefit of the earlier filing date for that new matter. The new matter will only be entitled to the filing date of the later-filed application. It’s crucial for applicants to ensure that all claimed subject matter is fully supported by the prior-filed application to maintain the benefit of the earlier filing date.

To learn more:

Incorporating by reference in patent applications can have significant impacts:

  • It allows applicants to include the content of another document without reproducing it in full.
  • The incorporated material becomes part of the application as if it were explicitly included.
  • It can provide support for claims and help meet disclosure requirements.

MPEP 211.05 mentions:

An incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

This highlights the importance of including incorporation by reference statements at the time of filing to ensure their effectiveness. Applicants should carefully consider what materials to incorporate and ensure they are properly referenced to support their claims and meet disclosure requirements.

To learn more:

What is the impact of a terminal disclaimer on claiming benefit of a prior-filed application?

A terminal disclaimer can affect the ability to claim benefit of a prior-filed application. According to MPEP 211.01(b):

Any nonprovisional application claiming the benefit of one or more prior-filed copending nonprovisional applications or international applications designating the United States must include a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications.

However, if a terminal disclaimer has been filed in the prior application, it may limit the ability to claim benefit. The MPEP states:

If the prior application has been published, the validity of the patent may be affected if the continuing application is not filed within one year of the publication date of the prior-filed application. See MPEP § 211.05 for more information on the effects of publication of patent applications.

It’s crucial to consider the implications of terminal disclaimers when claiming benefit, as they can affect patent term and validity.

To learn more:

What is the impact of a defective priority or benefit claim?

A defective priority or benefit claim can have significant consequences for a patent application. According to MPEP 211.01, if the claim for priority or benefit is not properly made:

‘If the claim for priority or benefit is not included in an ADS, the claim for priority or benefit must be included in the first sentence(s) of the specification following the title or in an application data sheet. The specific reference to the prior application must be in the first sentence(s) of the specification following the title or in an application data sheet unless the reference appeared in a preliminary amendment filed on filing.’

The impacts of a defective claim can include:

  • Loss of priority date: This can affect the assessment of prior art against the application.
  • Potential rejection: Claims may be rejected if intervening prior art exists between the filing dates of the prior and current applications.
  • Inability to overcome certain rejections: Without the earlier priority date, it may be harder to overcome rejections based on intervening art.
  • Possible patent term reduction: If the defect is not corrected promptly, it could affect the patent term adjustment.

To avoid these issues, applicants should ensure that priority or benefit claims are properly made in accordance with 37 CFR 1.78 and correct any defects promptly using the procedures outlined in the MPEP.

To learn more:

Tags: prior art

The Hague Agreement Concerning International Registration of Industrial Designs is an international treaty that allows applicants to file a single international design application to seek protection in multiple countries. The United States became a party to the Hague Agreement on May 13, 2015.

According to 35 U.S.C. 385:

An international design application designating the United States shall have the effect, for all purposes, from its filing date determined in accordance with section 384, of an application for patent filed in the Patent and Trademark Office pursuant to chapter 16.

This means that an international design application that designates the US is treated similarly to a national design patent application. The MPEP clarifies: Unless otherwise clear from the wording, reference to ‘design application’ or ‘application for a design patent’ in this chapter includes an international design application that designates the United States.

For detailed information on international design applications, refer to MPEP Chapter 2900.

For more information on design patents, visit: design patents.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on international design applications, visit: international design applications.

What is the filing deadline for a continuation application?

A continuation application must be filed before the patenting, abandonment, or termination of proceedings on the prior application. The MPEP 201.07 states:

“To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

Key points to remember:

  • There is no specific time limit for filing a continuation as long as the parent application is still pending.
  • The continuation must be filed before the parent application is patented, abandoned, or otherwise terminated.
  • If you want to file after the parent is patented, you must file a reissue application instead.

It’s crucial to monitor the status of the parent application closely to ensure timely filing of the continuation.

For more information on continuation application, visit: continuation application.

For more information on filing deadline, visit: filing deadline.

What is the filing date requirement for a divisional application?

A divisional application must be filed before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention. The MPEP states:

A divisional application is often filed as a result of a restriction requirement made by the examiner. The divisional application may be filed under 37 CFR 1.53(b) (or 1.53(d) if the application is a design application) before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention.”

This means that the divisional application must be filed while the parent application is still pending, ensuring continuity in the examination process.

For more information on Divisional application, visit: Divisional application.

For more information on patent procedure, visit: patent procedure.

The filing date of a nonprovisional application under 37 CFR 1.53(b) depends on the type of application and when it was filed:

  • For utility and plant applications filed on or after December 18, 2013: The filing date is the date on which the specification, with or without claims, is received in the USPTO.
  • For design applications: The filing date is the date on which the specification, including at least one claim, and any required drawings are received in the USPTO.
  • For applications filed before December 18, 2013: The filing date was the date on which the specification containing a description and at least one claim, and any required drawings were received in the USPTO.

The MPEP states:

For applications filed on or after December 18, 2013, the filing date of a nonprovisional application filed under 35 U.S.C. 111(a), other than a design patent application, is the date on which a specification, with or without claims, is received in the Office.

This change in filing date requirements was part of the implementation of the Patent Law Treaties Implementation Act of 2012.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application requirements, visit: patent application requirements.

What is the filing date of a divisional application?

A divisional application is entitled to the filing date of the parent application. According to MPEP 201.06, “A divisional application is entitled to the benefit of the filing date of the prior-filed application if filed as a nonprovisional application that discloses and claims only subject matter disclosed in the prior-filed (parent) application.” This means that the divisional application inherits the filing date of its parent application, provided it meets the necessary requirements.

To learn more:

The filing date of a Continued Prosecution Application (CPA) is determined by when the request for the CPA is received by the USPTO. As stated in the MPEP, The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed. This means that the CPA’s filing date is not the same as the filing date of the prior application, but rather the date when the USPTO receives the proper CPA request.

To learn more:

Tags: CPA

What is the filing date of a continuation-in-part application?

The filing date of a continuation-in-part (CIP) application is the date on which the application is filed with the USPTO. According to MPEP 201.08, “A continuation-in-part application is entitled to the benefit of the filing date of an earlier nonprovisional application as to common subject matter.” However, it’s important to note that any new matter introduced in the CIP application is only entitled to the filing date of the CIP itself.

For the common subject matter, the CIP can claim the benefit of the earlier application’s filing date under 35 U.S.C. 120. This can be crucial for establishing priority and determining the relevant prior art for patentability assessments.

According to MPEP 201.06(c), the filing date for a divisional or continuation application filed under 37 CFR 1.53(b) is determined as follows:

‘The filing date of an application filed under 37 CFR 1.53(b) is the date on which a specification, with or without claims, is received in the Office.’

This means that the filing date is established when the USPTO receives the specification, regardless of whether claims are included. It’s important to note that other application components, such as drawings or fees, are not required to secure the filing date.

To learn more:

To learn more:

What is the filing date for a Continued Prosecution Application (CPA)?

The filing date for a Continued Prosecution Application (CPA) is determined based on when it is filed. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is a specific reference to the prior application as required by 35 U.S.C. 120.

This means that the CPA’s filing date is the day when the separate request for a CPA is submitted, not the filing date of the prior application. It’s important to note that this request must specifically reference the prior application to comply with 35 U.S.C. 120.

To learn more:

To learn more:

The Electronic Priority Document Exchange (PDX) program is a system that allows for the electronic transmission of priority documents between participating foreign intellectual property offices. As stated in the MPEP:

Electronic Priority Document Exchange (PDX) agreements provide for the electronic transmission of priority documents to and from participating foreign intellectual property offices.

This program simplifies the process of obtaining certified copies of foreign priority applications, which is crucial for establishing priority claims in patent applications.

While restoration of the right of priority allows for valid priority claims up to 14 months from the earliest priority date (or 8 months for design applications), pre-AIA applications are still subject to the 12-month statutory bar under pre-AIA 35 U.S.C. 102(b) and (d). MPEP 213.03 clarifies: ‘It should be noted that although an application may now validly claim priority under 35 U.S.C. 119(a) through (d) and (f), 172, 365(a) or (b), or 386(a) or (b) to a foreign application filed up to fourteen months earlier (or eight months earlier in the case of a design application) in view of the restoration provision of 37 CFR 1.55(c), an application subject to examination under pre-AIA first to invent laws (rather than the first inventor to file provisions of the AIA) would still be subject to the 12-month statutory time periods in pre-AIA 35 U.S.C. 102(b) and (d) which are measured from the U.S. filing date.’

This means that while the priority claim may be valid, the earlier filed foreign application could still be used as prior art against a pre-AIA application if it was published more than one year before the U.S. filing date.

For more information on pre-AIA, visit: pre-AIA.

Tags: pre-AIA

Incorporating by reference a prior application in a continuation or divisional application can provide important benefits:

  1. It allows the applicant to amend the continuing application to include subject matter from the prior application without the need for a petition, provided the continuing application is entitled to a filing date.
  2. For applications filed on or after September 21, 2004, it can help recover inadvertently omitted material.

The MPEP states: An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are “hereby incorporated by reference.” The statement must appear in the specification.

It’s important to note that an incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

For more information on 37 cfr 1.57, visit: 37 cfr 1.57.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on incorporation by reference, visit: incorporation by reference.

What is the effect of filing a CPA on pending appeals or interferences?

Filing a Continued Prosecution Application (CPA) has significant effects on pending appeals or interferences. According to MPEP 201.06(d):

The filing of a CPA is a specific request to expressly abandon the prior application as of the filing date granted the CPA and to continue prosecution of the prior application in the CPA.

This means that when a CPA is filed:

  • Any pending appeal in the prior application is automatically withdrawn.
  • Any pending interference proceeding in the prior application is terminated.

It’s important to note that these actions occur automatically upon the granting of a filing date to the CPA. Applicants should carefully consider the status of any pending appeals or interferences before filing a CPA, as these proceedings cannot be continued in the CPA.

For more information on CPA, visit: CPA.

For more information on patent prosecution, visit: patent prosecution.

Filing a Continued Prosecution Application (CPA) has a significant effect on the prior application. According to MPEP 201.06(d):

‘A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA.’

This means that:

  • The prior application is automatically and expressly abandoned when the CPA is filed.
  • The abandonment is effective as of the CPA filing date.
  • Any claims or amendments in the prior application that were not entered are not carried over to the CPA.

It’s important to note that while the prior application is abandoned, the CPA is a continuation of that application, maintaining continuity for purposes such as priority claims and patent term calculations.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

An international application designating the United States has significant legal effects under U.S. patent law. According to MPEP 211.01(c), which cites 35 U.S.C. 363:

An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.

This means that from its international filing date, the application is treated as if it were a pending U.S. application. The MPEP further clarifies:

It is therefore clear that an international application which designates the United States has the effect of a pending U.S. application from the international application filing date until its abandonment as to the United States.

This status continues until the application is either granted as a patent, abandoned, or the proceedings are terminated. This provision allows applicants to claim the benefit of the international filing date in subsequent U.S. applications, subject to meeting other statutory requirements.

To learn more:

A preliminary amendment filed with a continuation or divisional application can have significant effects:

  1. If present on the filing date, it is considered part of the original disclosure.
  2. It must comply with the requirements of 37 CFR 1.121 for amendments.
  3. The Office may require a substitute specification for extensive preliminary amendments.
  4. The application will be classified and assigned based on the claims that will be before the examiner after entry of the preliminary amendment.

The MPEP states: Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

However, applicants should be cautious about introducing new matter through a preliminary amendment. The MPEP advises: Where a copy of the oath or declaration from a prior application was filed in a continuation or divisional application, if the examiner determines that new matter is present relative to the prior application, the examiner should so notify the applicant in the next Office action (preferably the first Office action). The examiner should require applicant to delete the benefit claim or redesignate the application as a continuation-in-part.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

A delayed submission of a benefit claim can have significant implications for patent term adjustment (PTA). According to MPEP 211.04:

“If a petition under 37 CFR 1.78 to accept an unintentionally delayed benefit claim is granted, the petition decision will notify applicant that the patent term adjustment statement in the notice of allowance may need to be revised if the patent issues on a date that is more than four months after the date the petition was filed.”

This means that if the petition is granted and the patent issues more than four months after the petition filing date, the patent term adjustment may need to be recalculated. The delay in submitting the benefit claim could potentially reduce the patent term adjustment, as it may be considered applicant delay under the PTA rules.

It’s important for applicants to be aware that delayed benefit claims can affect the overall patent term, potentially shortening the effective life of the patent.

To learn more:

What is the effect of a continuation-in-part application on patent term?

A continuation-in-part (CIP) application can have a significant impact on patent term. According to the MPEP 201.08:

The term of a patent issuing from a continuation-in-part application may be barred or limited by any prior applications or patents from which benefit is claimed.

This means that:

  • The patent term for subject matter carried over from the parent application is calculated from the filing date of the parent application.
  • The patent term for new subject matter introduced in the CIP is calculated from the filing date of the CIP application.
  • This can result in different expiration dates for different claims within the same patent.

It’s crucial for inventors and patent practitioners to carefully consider the timing and content of CIP applications to maximize patent protection and term.

For more information on patent term, visit: patent term.

Tags: patent term

What is the effect of a benefit claim on the effective filing date of a continuing application?

A benefit claim to a prior-filed application can significantly impact the effective filing date of a continuing application. The MPEP 211.01(b) explains:

‘The effective filing date of a claimed invention is determined on a claim-by-claim basis and not an application-by-application basis. It is possible for different claims in a later-filed application to receive different effective filing dates.’

This means that:

  • Each claim in a continuing application may have a different effective filing date
  • The effective date depends on when the claimed subject matter was first disclosed in a parent application
  • Claims fully supported by the parent application get the parent’s filing date as their effective date
  • New matter introduced in the continuing application gets the actual filing date of that application

It’s crucial for applicants to carefully consider the content of prior applications when making benefit claims, as this can affect patentability determinations and the scope of prior art that can be cited against the claims.

To learn more:

The Digital Access Service (DAS) is an electronic system that allows participating intellectual property offices to exchange priority documents securely. For international design applications:

  • Applicants can authorize the retrieval of priority documents through DAS.
  • This eliminates the need to manually file certified copies in some cases.
  • The USPTO or IB can retrieve the priority document electronically if available.

MPEP 213.07 states: The certified copy of the foreign application must be filed within the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application, except as provided in paragraphs (h), (i), and (j) of this section. DAS can help meet these deadlines more efficiently.

To learn more:

The requirements for filing a foreign priority claim differ for applications filed before and after September 16, 2012. The key difference lies in where the priority claim must be presented:

  • For applications filed on or after September 16, 2012: The priority claim must be presented in an Application Data Sheet (ADS). This is specified in 37 CFR 1.55(d)(1): For applications filed under 35 U.S.C. 111(a) on or after September 16, 2012, 37 CFR 1.55(d)(1) requires the claim for priority to be presented in an application data sheet.
  • For applications filed before September 16, 2012: The priority claim can be presented either in an Application Data Sheet or in the oath or declaration. As stated in the MPEP: For applications filed under 35 U.S.C. 111(a) prior to September 16, 2012, unless provided in an application data sheet, the oath or declaration under 37 CFR 1.63 must identify the foreign application for patent or inventor’s certificate for which priority is claimed under 37 CFR 1.55, and any foreign applications having a filing date before that of the application on which priority is claimed, by specifying the application number, country, day, month, and year of its filing.

Regardless of the filing date, the priority claim must include the same essential information: the application number, country (or intellectual property authority), and filing date (day, month, and year) of the foreign application. The difference is primarily in the document where this information must be presented.

There is a significant difference in how affidavits are handled between applications filed under 37 CFR 1.53(b) and 37 CFR 1.53(d). According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

In summary:

  • For 37 CFR 1.53(b) applications: Affidavits from prior applications must be explicitly included and referenced.
  • For 37 CFR 1.53(d) applications: Affidavits from the parent nonprovisional application automatically become part of the new application.

For more information on continuation applications, visit: continuation applications.

The main difference between utility and design patents is in what they protect:

  • Utility patents protect the way an article is used and works. They cover new and useful processes, machines, manufactures, or compositions of matter.
  • Design patents protect the way an article looks. They cover new, original, and ornamental designs for an article of manufacture.

The MPEP distinguishes between these types of patents by referencing different sections of U.S. Code: utility patents are provided for by 35 U.S.C. 101, while design patents are provided for by 35 U.S.C. 171.

For more information on design patent, visit: design patent.

The process for deleting an inventor from a Continued Prosecution Application (CPA) differs depending on when the request is made:

  • At CPA Filing: You can submit a statement requesting the deletion of an inventor when filing the CPA. This is a straightforward process that doesn’t require additional paperwork.
  • After CPA Filing: If you need to delete an inventor after the CPA has been filed, you must follow a more formal procedure. The MPEP states:

    “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

This means that post-filing inventor deletions require a formal request under 37 CFR 1.48, which typically involves additional documentation and potentially fees.

For more information on CPA, visit: CPA.

Tags: CPA

The process for correcting inventorship in a Continued Prosecution Application (CPA) differs depending on when the correction is requested:

  • At CPA filing: Inventorship can be corrected by submitting a statement requesting deletion of a named inventor along with the CPA filing. This process is straightforward and does not require additional procedures.
  • After CPA filing: The MPEP states, Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48. This means additional documentation and possibly fees are required for post-filing inventorship changes.

It’s generally simpler to correct inventorship at the time of CPA filing if possible.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

The main differences between claiming benefit under 35 U.S.C. 119(e) and 35 U.S.C. 120 are:

  • 35 U.S.C. 119(e):
    • Used for claiming benefit of a provisional application
    • Does not require specifying the relationship between applications
    • Example: “This application claims the benefit of U.S. Provisional Application No. 61/123,456, filed January 1, 2020.”
  • 35 U.S.C. 120:
    • Used for claiming benefit of a nonprovisional application
    • Requires specifying the relationship (continuation, divisional, or continuation-in-part)
    • Example: “This application is a continuation of U.S. Application No. 12/345,678, filed January 1, 2020.”

MPEP 211.02 advises: “Although 35 U.S.C. 120 does not preclude a benefit claim to a provisional application, it is not recommended that applicants claim the benefit to a provisional application under 35 U.S.C. 120 since such a claim could have the effect of reducing the patent term, as the term of a patent issuing from such an application may be measured from the filing date of the provisional application pursuant to 35 U.S.C. 154(a)(2).”

It’s important to use the correct statute when making benefit claims to ensure proper recognition and avoid potential issues with patent term calculations.

To learn more:

The treatment of affidavits and declarations differs between applications filed under 37 CFR 1.53(b) and those filed under 37 CFR 1.53(d). According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

In summary:

  • For 37 CFR 1.53(b) applications: Affidavits from prior applications must be explicitly incorporated.
  • For 37 CFR 1.53(d) applications: Affidavits from the parent application are automatically included.

For more information on continuation applications, visit: continuation applications.

For more information on patent applications, visit: patent applications.

The distinction between unintentional and intentional delay is crucial when filing a delayed benefit claim. The MPEP 211.04 addresses this:

‘A petition to accept an unintentionally delayed claim under 35 U.S.C. 120, 121, 365(c), or 386(c) for the benefit of a prior-filed application must be accompanied by: … (3) A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(d)(3) and the date the benefit claim was filed was unintentional.’

An unintentional delay may be caused by oversight, administrative error, or other circumstances not intended to delay the filing. Intentional delay, on the other hand, implies a deliberate choice not to file the benefit claim on time. Only unintentional delays can be remedied through a petition. Intentional delays are not excusable and will result in the denial of the delayed benefit claim.

To learn more:

According to MPEP 201.02, there are important distinctions between ‘original’ and ‘substitute’ applications:

Original Application: This term is used in patent statutes and rules to refer to an application that is not a reissue application. An original application can be either a first filing or a continuing application.

Substitute Application: The MPEP defines a substitute application as follows:

A “substitute” application is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application. […] A substitute application does not obtain the benefit of the filing date of the prior application.

The key difference is that a substitute application does not retain the filing date of the prior application, unlike certain types of continuing applications.

For more information on patent filing, visit: patent filing.

For more information on substitute application, visit: substitute application.

According to the MPEP, there is no substantial difference between an ‘allowed’ application and an application ‘in issue’. The MPEP uses these terms interchangeably:

“An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.”

Both terms refer to an application that has passed examination and is awaiting issuance as a patent, provided that all necessary fees are paid and no issues arise that would necessitate withdrawal from issue.

To learn more:

What is the difference between a utility patent and a design patent application?

Utility patents and design patents protect different aspects of an invention, and their applications are processed differently. According to MPEP 201.02:

‘A utility application is a nonprovisional application that is not a design application. A design application is an application for a design patent.’

Key differences include:

  • Utility Patent Application:
    • Protects the functional aspects of an invention
    • Covers how an invention works or is used
    • Has a term of 20 years from the filing date
  • Design Patent Application:
    • Protects the ornamental design of a functional item
    • Covers how an invention looks
    • Has a term of 15 years from the grant date

Inventors should carefully consider which type of patent application best suits their invention’s nature and intended protection.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

For more information on USPTO, visit: USPTO.

What is the difference between a parent application and a child application in patent law?

In patent law, the terms ‘parent application’ and ‘child application’ refer to the relationship between related patent applications. According to MPEP 201.02:

“The term parent application is used to refer to the immediate prior application from which a continuing application claims priority.”

“A child application is an application that claims the benefit of an earlier filing date from a parent application.”

Key differences:

  • Parent application: The original or earlier-filed application
  • Child application: A subsequent application that claims priority from the parent
  • Child applications can be continuations, divisionals, or continuations-in-part
  • The parent-child relationship establishes a priority claim under 35 U.S.C. 120

Understanding this relationship is crucial for determining priority dates and the scope of patent protection in related applications.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on parent application, visit: parent application.

For more information on patent application types, visit: patent application types.

While MPEP 203.03 specifically discusses amended nonprovisional applications, it’s important to understand the distinction between nonprovisional and provisional applications:

  • Nonprovisional Application: This is a formal patent application that can result in an issued patent. It undergoes examination and can be amended, as described in MPEP 203.03.
  • Provisional Application: This is a temporary application that establishes a priority date but does not undergo examination and cannot be amended.

The amended status discussed in MPEP 203.03 applies only to nonprovisional applications, as provisional applications are not examined or amended.

To learn more:

The terms ‘national application,’ ‘provisional application,’ and ‘nonprovisional application’ are defined in 37 CFR 1.9(a). Specifically:

  • A national application refers to a U.S. patent application that is not an international application.
  • A provisional application is a type of patent application that allows filing without a formal patent claim or any information disclosure statement.
  • A nonprovisional application is a regular patent application that includes a specification, claims, and other formal requirements.

These definitions help distinguish between different types of patent applications in the U.S. patent system.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

A national application is filed directly with the United States Patent and Trademark Office (USPTO) under U.S. patent laws, while an international application is filed under the Patent Cooperation Treaty (PCT).

According to MPEP 201.01: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’ These applications are processed solely within the U.S. patent system.

International applications, on the other hand, are filed under the PCT and can potentially lead to patent protection in multiple countries. They enter the national phase in individual countries at a later stage.

For more information on USPTO, visit: USPTO.

Tags: USPTO

MPEP 201.01 distinguishes between national applications and international applications:

  • National applications are filed directly with the USPTO under 35 U.S.C. 111(a) or enter the national stage from an international application after complying with 35 U.S.C. 371.
  • International applications are filed under the Patent Cooperation Treaty (PCT).

The MPEP states: The term ‘national application’ as used in this title refers to a U.S. national application for patent which was either filed in the Office under 35 U.S.C. 111, or which entered the national stage from an international application after compliance with 35 U.S.C. 371. (MPEP 201.01)

International applications become national applications when they enter the national stage in a specific country, such as the United States. This process involves meeting the requirements of 35 U.S.C. 371.

For more information on international applications, visit: international applications.

For more information on national stage entry, visit: national stage entry.

What is the difference between a divisional and a continuation application?

While both divisional and continuation applications are types of continuing applications, they serve different purposes:

  • Divisional Application: Filed to pursue claims to an invention that was not elected in a previous application due to a restriction requirement.
  • Continuation Application: Filed to pursue additional claims to the same invention disclosed in the parent application.

The MPEP 201.06(c) states: “A divisional application is often filed as a result of a restriction requirement made by the examiner.” In contrast, a continuation typically doesn’t arise from a restriction requirement but rather from the applicant’s desire to pursue additional aspects of the same invention.

Both types can be filed under 37 CFR 1.53(b) and may claim the benefit of the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

There is a significant difference in how Continued Prosecution Applications (CPAs) are treated for utility/plant applications versus design applications. According to the examiner’s note in MPEP ¶ 2.35:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

This indicates that for utility or plant applications, an improper CPA request is treated as a Request for Continued Examination (RCE). However, for design applications, CPA requests are generally accepted and processed as described in MPEP ¶ 2.35. This distinction is important for applicants to understand when considering their continued prosecution options.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

Continued Prosecution Applications (CPAs) are primarily used for design patent applications. For utility or plant applications, improper CPA requests are typically treated as Requests for Continued Examination (RCE). The MPEP ¶ 2.35 notes:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

This distinction is important for applicants to understand when considering their options for continuing prosecution of their patent applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

Continued Prosecution Applications (CPAs) and Requests for Continued Examination (RCEs) are both methods to continue prosecution of a patent application, but they have different uses and applications:

  • CPAs are primarily used for design patent applications, as indicated in MPEP ¶ 2.30.
  • RCEs are used for utility and plant patent applications. The MPEP states: “If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead).”

This distinction is important because it affects how patent examiners process and respond to these continuation requests.

For more information on continued prosecution application, visit: continued prosecution application.

A continuation-in-part (CIP) application differs from a regular continuation application in the following ways:

  • A CIP application contains a portion or all of the disclosure of an earlier application and adds matter not disclosed in the earlier application.
  • A regular continuation application contains the same disclosure as the earlier application without adding new matter.

As stated in MPEP 201.08: A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.

To learn more:

Continuation applications and provisional applications are distinct types of patent applications with different purposes and requirements. A key difference is noted in MPEP 201.07:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the provisional application.

This guidance also applies to continuation applications. The main differences include:

  • Continuation applications are based on nonprovisional applications and claim benefit under 35 U.S.C. 120, 121, 365(c), or 386(c)
  • Provisional applications are placeholder applications that can be claimed as priority under 35 U.S.C. 119(e)
  • Continuation applications must have the same disclosure as the parent application
  • Provisional applications do not need to meet the same formal requirements as nonprovisional applications

For specific requirements related to provisional applications, refer to MPEP § 211 et seq.

For more information on continuation application, visit: continuation application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

A continuation application and a continuation-in-part (CIP) application are both types of patent applications that claim priority to an earlier filed application, but they differ in their content:

  • Continuation application: Contains the same disclosure as the prior application without adding any new matter. As stated in MPEP 201.07: “A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.”
  • Continuation-in-part (CIP) application: Repeats a substantial portion of the prior application but also adds new matter not disclosed in the prior application.

The key difference is that a continuation application does not introduce new subject matter, while a CIP application does.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A continuation application and a divisional application are both types of continuing applications, but they serve different purposes:

  • Continuation application: Used to pursue additional claims to an invention disclosed in a prior application. It contains the same disclosure as the parent application.
  • Divisional application: Used to pursue claims to an invention that was disclosed but not claimed in a prior application. It typically results from a restriction requirement in the parent application.

As stated in MPEP 201.07: “A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.” In contrast, a divisional application focuses on a distinct invention that was not claimed in the parent application.

To learn more:

A continuation application and a continuation-in-part (CIP) application are both types of patent applications that stem from an earlier application, but they differ in their content:

  • Continuation application: Contains the same disclosure as the prior application without adding any new matter. As stated in MPEP 201.07, ‘A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application… The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.’
  • Continuation-in-part application: Repeats a substantial portion of the prior application but also adds new matter not disclosed in the parent application.

The key distinction is that a continuation-in-part introduces new subject matter, while a continuation does not.

To learn more:

The main difference between applications filed under 35 U.S.C. 111(a) and 111(b) lies in their purpose and requirements. According to MPEP 201.01:

  • 35 U.S.C. 111(a) applications: These are for original (nonprovisional) patents. They require a specification, at least one claim, and drawings (when necessary).
  • 35 U.S.C. 111(b) applications: These are for provisional patents. They do not require claims and are not examined on their merits.

The key differences are:

  1. Examination: 111(a) applications undergo full examination, while 111(b) applications do not.
  2. Duration: 111(a) applications can lead to granted patents, while 111(b) applications expire after 12 months.
  3. Requirements: 111(a) applications have stricter formal requirements, including the need for claims.

Inventors often use 111(b) provisional applications to establish an early filing date before filing a more comprehensive 111(a) nonprovisional application.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

A ‘rejected’ patent application and an ‘abandoned’ patent application represent different stages in the patent examination process:

  • Rejected Application: As per MPEP 203.02, this is an application with an unanswered examiner’s action. The applicant still has the opportunity to respond within the allotted reply period.
  • Abandoned Application: This occurs when the applicant fails to respond to the examiner’s action within the specified time frame, effectively ending the examination process.

The MPEP states:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

Thus, a ‘rejected’ application can become ‘abandoned’ if the applicant doesn’t respond in time, but an ‘abandoned’ application cannot revert to ‘rejected’ status without additional procedures.

To learn more:

In the context of foreign priority claims, there’s an important distinction between a ‘country’ and a ‘regional patent office’:

  • Country: A sovereign nation that has its own patent system and can issue patents directly.
  • Regional Patent Office: An intergovernmental organization that processes patent applications on behalf of multiple member countries.

The MPEP states: The right of priority may be based upon an application filed in a foreign country or in a regional patent office. (MPEP 213)

Regional patent offices, such as the European Patent Office (EPO) or the African Regional Intellectual Property Organization (ARIPO), allow applicants to file a single application that can potentially lead to patent protection in multiple member countries.

The treatment of affidavits and declarations differs between applications filed under 37 CFR 1.53(b) and those filed under 37 CFR 1.53(d):

  • 37 CFR 1.53(b) applications: Affidavits and declarations from prior applications do not automatically become part of the new application.
  • 37 CFR 1.53(d) applications: Affidavits and declarations filed during the prosecution of the parent nonprovisional application automatically become part of the new application.

As noted in MPEP ¶ 2.03: Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.

For more information on patent applications, visit: patent applications.

The terms ‘right of priority’ and ‘benefit of an earlier filing date’ refer to different concepts in US patent law:

  • Right of priority: This term is used in the context of foreign priority under 35 U.S.C. 119(a)-(d) and 365(a) and (b). It allows a US application to claim the priority date of a foreign application filed within the previous 12 months.
  • Benefit of an earlier filing date: This term is used for domestic benefit under 35 U.S.C. 119(e) and 120. It allows a US application to claim the filing date of an earlier US provisional or nonprovisional application.

As stated in MPEP 216: ‘The right of priority is a statutory right, which is not considered an application property right.’

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

For more information on right of priority, visit: right of priority.

An ‘allowed’ application is a nonprovisional patent application that has been examined and determined to meet all statutory requirements. The Manual of Patent Examining Procedure (MPEP) states:

“An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.”

This means that the patent examiner has reviewed the application and found it to be in compliance with all applicable laws and regulations, and has subsequently issued a notice of allowance to the applicant.

To learn more:

A divisional application is defined in MPEP 201.06 as follows:

‘A later application for a distinct or independent invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.’

This definition highlights that a divisional application:

  • Is filed after an initial application
  • Focuses on a distinct invention
  • Only includes subject matter from the original application
  • Is ‘carved out’ of the pending parent application

For more information on Divisional application, visit: Divisional application.

For more information on patent application types, visit: patent application types.

What is the definition of a continuation-in-part application?

A continuation-in-part (CIP) application is a type of patent application that includes a portion or all of the disclosure from a prior application and adds new matter not disclosed in the prior application. The MPEP 201.08 states:

‘A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.’

This type of application allows inventors to expand upon their original invention while maintaining the priority date for the portions disclosed in the earlier application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

The MPEP does not specify a fixed deadline for submitting the English translation of a non-English provisional application. However, it indicates that the translation must be provided within a time period set by the USPTO. According to MPEP ¶ 2.38:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This suggests that the USPTO will set a specific deadline in an Office action, and you must comply with this deadline to avoid abandonment of your application.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

What is the deadline for submitting certified copies in a national stage application?

The deadline for submitting certified copies in a national stage application (35 U.S.C. 371) is as follows:

  • Certified copies must be filed within the time limit set in 37 CFR 1.55(f).
  • This is typically within the later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior foreign application.

The MPEP 213.06 states: ‘A certified copy of the foreign application must be filed within the time limit set forth in 37 CFR 1.55(f).’ It’s important to note that this requirement applies unless the certified copy was previously filed in the international application and the requirements of PCT Rule 17.1(a), (b), or (b-bis) have been met.

To learn more:

The deadline for submitting a certified copy of a foreign priority application depends on the filing date of the U.S. application. According to MPEP 213.02:

In the case of a U.S. application filed on or after March 16, 2013, the certified copy must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

If the certified copy is not filed within this timeframe, the applicant must file a petition to accept a delayed submission and pay the associated fee.

To learn more:

The deadline for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): Submit within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: Submit within the later of four months from the date on which the national stage commenced, four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

The MPEP emphasizes: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c). (MPEP § 211)

For more information on national stage application, visit: national stage application.

The deadline for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): The later of 4 months from the actual filing date or 16 months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: The later of 4 months from the date on which the national stage commenced, 4 months from the initial submission under 35 U.S.C. 371 to enter the national stage, or 16 months from the filing date of the prior application.

As stated in MPEP 211.02: “This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).”

If the deadline is missed, a petition under 37 CFR 1.78 and payment of a petition fee may be required to accept a late benefit claim.

To learn more:

The deadline for filing an unintentionally delayed priority claim is the later of:

  • Four months from the actual filing date of the later-filed application, or
  • Sixteen months from the filing date of the prior application

This is stated in 37 CFR 1.55(d)(1) for foreign priority claims and 37 CFR 1.78(a)(4) for domestic benefit claims. However, a petition may be filed to accept an unintentionally delayed claim under 37 CFR 1.55(e) or 37 CFR 1.78(c) and (e) after this period.

As stated in MPEP 214.02: ‘A petition to accept an unintentionally delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) requires:’

  • The priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted;
  • The petition fee as set forth in § 1.17(m); and
  • A statement that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional.

To learn more:

To learn more:

What is the deadline for filing a petition to accept an unintentionally delayed priority claim?

The deadline for filing a petition to accept an unintentionally delayed priority claim depends on the type of application:

  • For utility and plant applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior application.
  • For design applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior application.

According to MPEP 214.02: ’37 CFR 1.55(e) provides that a petition to accept a delayed priority claim must be accompanied by: (1) The priority claim under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or (b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted; (2) A certified copy of the foreign application, unless previously submitted or an exception in paragraph (h), (i), or (j) of this section applies; (3) The petition fee as set forth in § 1.17(m); and (4) A statement that the entire delay between the date the priority claim was due under this section and the date the priority claim was filed was unintentional.’

It’s important to note that the petition must be filed within the time period set in the statute, and the USPTO does not have the authority to waive this deadline.

To learn more:

The deadline for filing a foreign priority claim in a U.S. patent application depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the claim must be filed within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior foreign application
  • For international applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set by the PCT and its Regulations
  • For design patent applications, the claim can be made at any time during the pendency of the application

As stated in MPEP 214.01: “The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.”

To learn more:

For applications filed before March 16, 2013, the certified copy of the foreign application must be filed within the pendency of the application. According to 37 CFR 1.55(g)(1):

The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application, unless filed with a petition under paragraph (e) or (f) of this section, or with a petition accompanied by the fee set forth in § 1.17(g) which includes a showing of good and sufficient cause for the delay in filing the certified copy of the foreign application in a design application.

However, it’s important to note that if the claim for priority or the certified copy is filed after the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction.

To learn more:

The deadline for filing a benefit claim depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the reference must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “If the application is an application filed under 35 U.S.C. 111(a), the reference to the prior application must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on filing deadline, visit: filing deadline.

For more information on national stage application, visit: national stage application.

What is the DAS code for PDX?

The DAS (Digital Access Service) code for PDX (Priority Document Exchange) is US. This code is used when participating in the WIPO DAS system for electronic exchange of priority documents. As stated in the MPEP 215.01: The DAS code for the USPTO is ‘US’. Applicants need to use this code when authorizing the USPTO to retrieve priority documents from other offices or when allowing other offices to retrieve priority documents from the USPTO through the WIPO DAS system.

To learn more:

What is the copendency requirement for continuation applications?

The copendency requirement is a crucial aspect of filing a continuation application. According to MPEP 201.07:

‘The continuation application must be filed before the patenting or abandonment of or termination of proceedings on the prior application.’

This means that:

  • The continuation application must be filed while the parent application is still pending (not patented, abandoned, or otherwise terminated).
  • If the parent application has already been issued as a patent or has been abandoned, it’s too late to file a continuation application.
  • The continuation application can be filed on the same day that the parent application is to be issued as a patent, but it must be filed before the parent application officially becomes a patent.

Maintaining copendency is critical for preserving the benefit of the earlier filing date and ensuring the validity of the continuation application.

For more information on continuation application, visit: continuation application.

For more information on copendency, visit: copendency.

Copendency is a crucial requirement when claiming the benefit of a prior-filed nonprovisional application under 35 U.S.C. 120, 121, 365(c), or 386(c). The MPEP defines copendency as follows:

“Copendency is defined in the clause which requires that the later-filed application must be filed before: (A) the patenting of the prior application; (B) the abandonment of the prior application; or (C) the termination of proceedings in the prior application.”

Key points about copendency:

  • The later-filed application must be filed before the prior application patents, is abandoned, or proceedings are terminated
  • If the prior application issues as a patent, the later-filed application can be filed on the same date the patent issues
  • If the prior application is abandoned, the later-filed application must be filed before the abandonment
  • Without copendency, the later-filed application cannot claim the benefit of the prior application’s filing date

Applicants should be aware of the copendency requirement to ensure their benefit claims are valid.

Filing a divisional application allows an applicant to pursue protection for distinct inventions disclosed in a parent application. Key benefits include:

  • Ability to claim different aspects or embodiments of the invention
  • Potential for broader patent coverage
  • Preservation of priority date for the disclosed subject matter
  • Opportunity to pursue claims that may have been restricted in the parent application

The MPEP indicates: A divisional application is often filed as a result of a restriction requirement made by the examiner. This suggests that divisional applications provide a way to pursue protection for inventions that were not elected in the parent application due to a restriction requirement.

For more information on Divisional application, visit: Divisional application.

For more information on patent strategy, visit: patent strategy.

What is the benefit of filing a divisional application under 37 CFR 1.53(b)?

Filing a divisional application under 37 CFR 1.53(b) offers several benefits:

  • It allows you to pursue claims to an invention that was not elected in a previous application due to a restriction requirement.
  • You can file the divisional application without a new oath or declaration if you meet certain conditions.
  • The divisional application can claim the benefit of the filing date of the prior application.

As stated in the MPEP: “A divisional application is often filed as a result of a restriction requirement made by the examiner.” This means you can protect additional aspects of your invention that weren’t covered in the original application.

For more information on Divisional application, visit: Divisional application.

For more information on patent filing, visit: patent filing.

Claiming priority to an international design application can provide significant benefits for nonprovisional applications. According to MPEP § 211.01(d):

Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.

This means that a nonprovisional application can claim the earlier filing date of an international design application, potentially providing an earlier priority date for the claimed invention.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on nonprovisional application, visit: nonprovisional application.

Under 35 U.S.C. 386(c), a nonprovisional application can claim the benefit of a prior international design application designating the United States, subject to the conditions and requirements of 35 U.S.C. 120. This provision allows applicants to establish an earlier effective filing date for their nonprovisional applications based on their international design applications.

As stated in the MPEP:

“Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.”

This benefit claim can be crucial for establishing priority and overcoming prior art references.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on nonprovisional application, visit: nonprovisional application.

The ‘statement of unintentional delay’ is a crucial component of a petition to accept an unintentionally delayed priority claim. According to MPEP 214.02:

The Director may require additional information where there is a question whether the delay was unintentional.

This statement must affirm that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional. It’s important to note that:

  • The USPTO requires an additional explanation of the circumstances surrounding the delay that establishes the entire delay was unintentional.
  • The statement must be signed by a person who has sufficient knowledge of the facts to support the statement.
  • Providing an inadequate or insufficient explanation may lead to a request for further information, which could delay the petition process.

Applicants should be prepared to provide a detailed account of the circumstances that led to the delay, ensuring that it covers the entire period of delay and demonstrates that the delay was truly unintentional.

To learn more:

To learn more:

What is the ‘specific reference’ requirement for claiming benefit of a prior-filed application?

The ‘specific reference’ requirement is a crucial aspect of claiming the benefit of a prior-filed application. According to MPEP 211.01, To claim the benefit of a prior-filed application, the later-filed application must contain a specific reference to the prior-filed application. This means that:

  • The specific reference must be made in the first sentence(s) of the specification or in an application data sheet (ADS).
  • It should include the relationship between the applications (e.g., continuation, divisional, or continuation-in-part).
  • The prior application’s serial number and filing date must be provided.

For example: ‘This application is a continuation of Application No. 12/345,678, filed January 1, 2020.’

Failure to provide this specific reference can result in the loss of the benefit claim. For more details, refer to MPEP 211 and 37 CFR 1.78.

What is the ‘same invention’ requirement for claiming benefit under 35 U.S.C. 120?

The ‘same invention’ requirement is a crucial aspect of claiming benefit under 35 U.S.C. 120. MPEP 211.01(b) explains: The second application must be an application for a patent for an invention which is also disclosed in the first application.

This means:

  • The later application must disclose at least some part of the invention claimed in the prior application.
  • The disclosure in the prior application must provide adequate support for the claims in the later application.
  • New matter introduced in the later application cannot claim the benefit of the earlier filing date.

The ‘same invention’ does not require identical claims, but there must be a common disclosure that supports the claims in both applications. For more information, see MPEP 211.01(b) and 35 U.S.C. 120.

The ‘Minimum Significant Part of the Number’ refers to the essential portion of a foreign application number that should be used in United States Patent and Trademark Office (USPTO) records. According to the MPEP:

The ‘Minimum Significant Part of the Number’ identified in the tables should be used in United States Patent and Trademark Office records.

This concept is important because:

  • It standardizes the citation of foreign applications across different numbering systems
  • It ensures that the most crucial identifying information is captured
  • It facilitates accurate cross-referencing and searching of patent documents

Applicants and examiners should refer to the WIPO tables to determine the correct ‘Minimum Significant Part of the Number’ for each foreign intellectual property office.

To learn more:

The ‘In re Van Esdonk’ case (187 USPQ 671, Comm’r Pat. 1975) is an important precedent in patent law regarding the perfection of foreign priority claims. Key points about this case include:

  • It involved a situation where a claim to foreign priority benefits had not been filed in the application prior to patent issuance.
  • The application was a continuation of an earlier application that had satisfied the requirements of 35 U.S.C. 119(a)-(d) or (f).
  • The Commissioner held that perfecting a priority claim in the parent application satisfies the statute for the continuation application.

The MPEP states: In re Van Esdonk, a claim to foreign priority benefits had not been filed in the application prior to issuance of the patent. However, the application was a continuation of an earlier application in which the requirements of 35 U.S.C. 119(a)-(d) or (f) had been satisfied. Accordingly, the Commissioner held that the ‘applicants’ perfection of a priority claim under 35 U.S.C. 119 in the parent application will satisfy the statute with respect to their continuation application.’

This case is significant because it allows for the perfection of foreign priority claims in continuation applications based on the parent application’s compliance, even after patent issuance.

When submitting an English language translation of a non-English language foreign priority application, the following requirements must be met:

  • The translation must be of the certified copy of the foreign application as filed
  • The translation must be submitted together with a statement that the translation of the certified copy is accurate

As stated in the MPEP: When an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) submitted together with a statement that the translation of the certified copy is accurate.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

To make a proper priority claim in a U.S. patent application, the applicant must provide specific information about the foreign application and file the claim within the required time period. The requirements differ slightly depending on the type of application.

For applications filed on or after September 16, 2012, under 35 U.S.C. 111(a), MPEP 213.02 states: “the claim for priority must be presented in an application data sheet.” The claim must include:

  • The application number of the foreign application
  • The country or intellectual property authority
  • The day, month, and year of filing

For international applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set forth in the PCT and the Regulations under the PCT.

The MPEP further notes: “For applications filed prior to September 16, 2012, the claim to priority need be in no special form, and may be made by a person authorized to sign correspondence under 37 CFR 1.33(b). No special language is required in making the claim for priority, and any expression which can be reasonably interpreted as claiming the benefit of the foreign application is accepted as the claim for priority.”

It’s important to file the priority claim within the specified time limits to ensure it is considered valid and effective.

For more information on application data sheet, visit: application data sheet.

For more information on foreign application, visit: foreign application.

Adding a benefit claim after the time period required by 37 CFR 1.78 requires a petition and the petition fee. As stated in MPEP § 211.04:

Any petition under 37 CFR 1.78 must be accompanied by a corrected ADS in compliance with 37 CFR 1.76(c) (for applications filed on or after September 16, 2012), or by an amendment to the specification or a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c) (for applications filed prior to September 16, 2012) unless the proper reference was previously submitted.

In addition to the petition and ADS or amendment, you may need to file one of the following, depending on the status of your application:

  • A request for continued examination (RCE) under 37 CFR 1.114, if the application is under final rejection or has been allowed.
  • A reissue application or a request for a certificate of correction under 37 CFR 1.323, if the application has already issued as a patent.

It’s important to note that when adding a benefit claim after filing, you cannot include an incorporation by reference statement of the prior application unless such a statement was present upon the initial filing of the application.

To learn more:

A petition to restore the benefit of a provisional application under 37 CFR 1.78(b) must include several elements. According to MPEP 211.01(a):

‘A petition under 37 CFR 1.78(b) requires: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application, which must be included in application data sheet (unless previously submitted in an application data sheet); (B) the petition fee as set forth in 37 CFR 1.17(m); and (C) a statement that the delay in filing the nonprovisional application or international application designating the United States within the twelve-month period set forth in 37 CFR 1.78(a)(1)(i) was unintentional.’

The petition must be filed in the subsequent application (nonprovisional or international application designating the US) within 14 months of the provisional application’s filing date. The USPTO may require additional information to verify that the delay was unintentional.

For more information on benefit restoration, visit: benefit restoration.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

When claiming the benefit of a provisional application filed in a language other than English, additional requirements must be met. The MPEP states:

“If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.”

If these documents were not filed in the provisional application, the applicant will be notified and given a period to:

  1. File the translation and statement in the provisional application
  2. Submit a confirmation in the nonprovisional application that the translation and statement were filed in the provisional application

Failure to respond to this notice in a pending nonprovisional application will result in abandonment. For more details, see MPEP § 211.01(a).

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

For a later-filed application to be entitled to the benefit of an earlier-filed application’s filing date, the following requirements must be met:

  • The invention disclosed in the later-filed application must also be disclosed in the earlier-filed application.
  • The disclosure in both applications must be sufficient to comply with the requirements of 35 U.S.C. 112(a), except for the best mode requirement.

As stated in MPEP 211.05:

“To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

This means that the earlier-filed application must provide adequate support and enablement for the claimed subject matter in the later-filed application.

To learn more:

Form Paragraph 2.34 is a standardized response used by patent examiners when addressing improper amendments to Continued Prosecution Applications (CPAs). According to MPEP § 201.06(d), this form paragraph is specifically used to:

“inform the applicant that an amendment to the first sentence(s) of the specification referring to the CPA as a continuing application of the prior application has not been entered and will not be entered if submitted again.”

The form paragraph explains that such amendments are unnecessary because the CPA request itself serves as the specific reference required by 35 U.S.C. 120. It helps maintain consistency in examiner responses and ensures that applicants are properly informed about the treatment of these amendments in CPA applications.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

Electronic Priority Document Exchange (PDX) is a system that allows for the electronic transmission of priority documents between participating foreign intellectual property offices. As stated in MPEP 215.01:

Electronic Priority Document Exchange (PDX) agreements provide for the electronic transmission of priority documents to and from participating foreign intellectual property offices.

This system streamlines the process of obtaining certified copies of foreign priority applications, which is crucial for claiming priority in patent applications.

To learn more:

Copendency refers to the requirement that a later-filed application claiming the benefit of a prior-filed nonprovisional application must be filed before:

  • (A) the patenting of the prior application;
  • (B) the abandonment of the prior application; or
  • (C) the termination of proceedings in the prior application.

As stated in MPEP 211.01(b):

“If the prior application issues as a patent, it is sufficient for the later-filed application to be copending with it if the later-filed application is filed on the same date, or before the date that the patent issues on the prior application.”

This means that to maintain copendency, applicants should file any continuing applications no later than the date the issue fee is paid for the prior application.

To learn more:

A ‘new’ patent application is a nonprovisional application that has not yet received an action by the examiner. According to MPEP 203.01:

An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

It’s important to note that a request for continued examination (RCE) is not considered a new application filing.

For more information on new application, visit: new application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on RCE, visit: RCE.

An unintentionally delayed priority claim occurs when a claim for foreign priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) is not presented within the time period provided by 37 CFR 1.55(d). In such cases, the claim is considered to have been waived but may be accepted if the delay was unintentional.

As stated in the MPEP: “If a claim for priority is considered to have been waived under this section, the claim may be accepted if the priority claim was unintentionally delayed.”

To learn more:

An inventor’s certificate is a form of intellectual property protection offered in some countries. It can form the basis for priority rights under certain conditions, as stated in 35 U.S.C. 119(d):

Applications for inventors’ certificates filed in a foreign country in which applicants have a right to apply, at their discretion, either for a patent or for an inventor’s certificate shall be treated in this country in the same manner and have the same effect for purpose of the right of priority under this section as applications for patents…

This means that if an applicant had the option to file for either a patent or an inventor’s certificate in the foreign country, they can claim priority based on the inventor’s certificate application in the United States.

To learn more:

An international design application is a specific type of patent application for industrial designs. The definition of an international design application is provided in 37 CFR 1.9(n).

Key points about international design applications:

  • They are filed under the Hague Agreement Concerning the International Registration of Industrial Designs
  • They allow applicants to seek protection for industrial designs in multiple countries through a single application
  • They are administered by the World Intellectual Property Organization (WIPO)
  • They can designate the United States for design patent protection

For more information on international design applications, visit the WIPO Hague System page.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on patent law, visit: patent law.

An international application in patent law refers to a patent application filed under the Patent Cooperation Treaty (PCT). The definition of an international application is provided in 37 CFR 1.9(b).

Key points about international applications:

  • They are filed under the PCT framework
  • They can potentially lead to patent protection in multiple countries
  • They undergo an international search and optional international preliminary examination
  • They must enter the national phase in desired countries to pursue patent protection

For more detailed information on international applications, refer to the World Intellectual Property Organization (WIPO) PCT resources.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For more information on patent law, visit: patent law.

The MPEP 201 defines an international application as follows:

“An international application is a patent application filed under the Patent Cooperation Treaty (PCT). An international application may be filed by a resident or national of the United States of America in the U.S. Patent and Trademark Office (USPTO) as a Receiving Office.”

Key points about international applications include:

  • They are governed by the Patent Cooperation Treaty (PCT).
  • They allow inventors to seek patent protection in multiple countries through a single application.
  • The USPTO can act as a Receiving Office for U.S. residents or nationals.
  • They enter a national phase in individual countries where protection is sought.

International applications provide a streamlined process for seeking patent protection in multiple countries, potentially saving time and resources for inventors and businesses operating globally.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

An interim copy of a foreign priority document is a copy that is submitted before the certified copy is available. The MPEP 213.02 provides guidance on when an interim copy is acceptable:

The Office may require that an ‘interim copy’ of the foreign application be furnished in the event that the certified copy of the foreign application is not filed within the time period set forth in 37 CFR 1.55(f) and an exception in 37 CFR 1.55(h), (i), or (j) is not applicable.

An interim copy must:

  • Be filed within the later of 4 months from the filing date of the application or 16 months from the filing date of the prior foreign application
  • Be a copy of the original foreign application
  • Be accompanied by a statement that the copy is a true copy

Note: An interim copy does not substitute the requirement for a certified copy, which must still be filed during the pendency of the application.

To learn more:

An incomplete patent application is one that is not entitled to a filing date because it lacks some of the essential parts required by the United States Patent and Trademark Office (USPTO). As stated in MPEP 203.06:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

This means that the application is missing crucial components necessary for it to be considered a complete submission and to receive an official filing date from the USPTO.

To learn more:

An ‘original’ application in patent law refers to an application that is not a reissue application. The MPEP states:

“Original” application is used in the patent statutes and rules to refer to an application which is not a reissue application. An original application may be a first filing or a continuing application.

This means that an original application can be either:

  • The first filing of a patent application for an invention
  • A continuing application (continuation, divisional, or continuation-in-part) filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78

To learn more:

An ‘interim copy’ is a mechanism provided by 37 CFR 1.55(j) that allows applicants to meet the timeliness requirement for submitting a certified copy of a foreign application. It’s a copy of the original foreign application that the applicant can provide from their own records when they cannot obtain a certified copy within the time limit set by 37 CFR 1.55(f).

The MPEP states: 37 CFR 1.55(j) permits an applicant to provide an ‘interim copy’ of the original foreign application from the applicant’s own records to provide for the situation in which the applicant cannot obtain a certified copy of the foreign application within the time limit set forth in 37 CFR 1.55(f), although there is no requirement that an applicant be unable to obtain a certified copy of the foreign application within the time limit set forth in 37 CFR 1.55(f) to use 37 CFR 1.55(j).

To learn more:

An ‘interim copy’ is a copy of the original foreign application from the applicant’s own records that can be submitted to satisfy the timeliness requirement for certified copies. According to 37 CFR 1.55(j):

  • The copy must be clearly labeled as ‘Interim Copy’
  • It must be filed with a cover sheet identifying the foreign application
  • It must be filed within the same time period as required for certified copies
  • A certified copy must still be filed during the pendency of the application

This provision allows applicants to meet the deadline even if they cannot obtain a certified copy in time, although there is no requirement to show inability to obtain a certified copy to use this option.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

37 CFR 1.55(j) allows an applicant to provide an ‘interim copy’ of the original foreign application to satisfy the requirement for a certified copy to be filed within the time limit set in 37 CFR 1.55(f). An interim copy must:

  • Be clearly labeled as ‘Interim Copy’
  • Include the specification, drawings, and claims of the foreign application
  • Be filed with a separate cover sheet identifying the foreign application
  • Be filed within the later of 16 months from the foreign filing date or 4 months from the actual U.S. filing date

A certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g).

To learn more:

An ‘amended’ nonprovisional patent application is one that has undergone a specific process in the examination procedure. According to MPEP 203.03:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action.

In simpler terms, it means that after the patent examiner has reviewed and responded to the application, the applicant has then taken some action in response to the examiner’s feedback.

To learn more:

An ‘allowed’ patent application is one that has been examined and determined to meet all statutory requirements. According to MPEP 203.04:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.

The status of ‘allowed’ continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue or becomes abandoned for failure to pay the issue fee and any required publication fee.

For more information on allowed application, visit: allowed application.

For more information on notice of allowance, visit: notice of allowance.

For more information on patent issuance, visit: patent issuance.

A Request to Delete a Named Inventor in a Continued Prosecution Application (CPA) for Design Applications is a procedure that allows for the correction of inventorship when filing a CPA. This request is specifically used to remove the name(s) of person(s) who are not inventors of the invention being claimed in the new application.

According to MPEP ¶ 2.32:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This paragraph confirms that the USPTO recognizes and processes such requests when submitted with a CPA filing.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

What is a reissue patent application?

A reissue patent application is a request to correct an error in an already issued patent that renders the patent wholly or partly inoperative or invalid. As stated in MPEP 201:

An application for reissue is an application for a new patent to replace an unexpired patent that is defective in some one or more particulars.

Key aspects of reissue applications include:

  • Can be filed only by the original patent owner
  • Must be filed during the term of the original patent
  • Can broaden claim scope only within two years of the original patent grant
  • Requires a declaration stating the error and that it occurred without deceptive intent

Reissue applications are crucial for patent owners to correct mistakes or oversights in their original patents, ensuring their intellectual property rights are properly protected. However, they cannot be used to add new matter to the patent disclosure.

For more information on Patent correction, visit: Patent correction.

A reissue application is a type of patent application used to correct defects in an existing, unexpired patent. According to MPEP 201.05, “A reissue application is an application for a patent to take the place of an unexpired patent that is defective.” This process allows patent holders to address errors or omissions in their original patent, ensuring that their intellectual property rights are properly protected.

To learn more:

A reissue application is a type of patent application used to correct errors in an already issued patent. According to MPEP 201:

“An application for reissue of a patent is an application for a new patent to correct an error in an existing patent.”

Reissue applications are filed when the original patent is wholly or partly inoperative or invalid due to defective specifications, drawings, or by claiming more or less than the patentee had the right to claim. They must be filed by the original patent owner and are subject to specific requirements outlined in 35 U.S.C. 251.

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue application, visit: reissue application.

A provisional patent application is a type of U.S. patent application that allows inventors to establish an early filing date for their invention without the need for a formal patent claim or oath/declaration. According to MPEP 201.04, a provisional application is defined as:

“A provisional application as used in this chapter means a U.S. national application for patent filed in the Office under 35 U.S.C. 111(b).”

Provisional applications are simpler and less expensive to file than regular nonprovisional applications, but they are not examined for patentability and automatically expire after 12 months.

To learn more:

What is a provisional application and how does it affect priority?

A provisional application is a type of patent application that allows inventors to establish an early filing date without a formal patent claim or oath or declaration. Key points about provisional applications and their effect on priority include:

  • Provisional applications provide a 12-month pendency period.
  • They can be used to establish an early effective filing date for a later-filed nonprovisional application.
  • The later-filed nonprovisional must be filed within 12 months of the provisional to claim its benefit.

According to MPEP 210: “The later-filed application must contain or be amended to contain a specific reference to the prior application(s) in the first sentence(s) of the specification or in an application data sheet.”

It’s important to note that the subject matter in the nonprovisional application must be fully supported by the provisional application to receive its priority date. If new matter is added, those portions will only receive the filing date of the nonprovisional application.

For more information on effective filing date, visit: effective filing date.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

What is a PCT application in international patent law?

A PCT (Patent Cooperation Treaty) application is an international patent application that provides a unified procedure for filing patent applications to protect inventions in its contracting states. According to MPEP 201.02:

“An international application is a patent application filed under the Patent Cooperation Treaty (PCT).”

Key features of PCT applications include:

  • Single filing procedure for seeking patent protection in multiple countries
  • Standardized national phase entry at 30 months from the earliest priority date
  • International search report and written opinion on patentability
  • Option for international preliminary examination

PCT applications simplify the process of seeking patent protection internationally, providing applicants with more time and information to make decisions about pursuing patents in specific countries.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

According to MPEP 201, a nonprovisional application for patent is the standard type of patent application. The MPEP states:

“A nonprovisional application for patent filed under 35 U.S.C. 111(a) must include a specification, including a claim or claims, drawings when necessary, an oath or declaration, and the prescribed filing fee, search fee, examination fee and application size fee.”

This type of application is examined by the USPTO and can potentially lead to the grant of a patent. It requires a detailed description of the invention, claims defining the scope of protection sought, and often includes drawings to illustrate the invention.

For more information on declaration, visit: declaration.

For more information on drawings, visit: drawings.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on oath, visit: oath.

A national application, as described in MPEP 201.01, is a U.S. patent application filed under 35 U.S.C. 111(a) or 35 U.S.C. 111(b). The MPEP states: A national application may be a nonprovisional application or a provisional application. National applications are distinct from international applications and are processed directly by the United States Patent and Trademark Office (USPTO).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

A divisional application is a later application for an independent or distinct invention, carved out of a nonprovisional application. It discloses and claims only subject matter disclosed in the earlier or parent application. As stated in MPEP 201.06:

A later application for an independent or distinct invention, carved out of a nonprovisional application (including a nonprovisional application resulting from an international application or international design application), an international application designating the United States, or an international design application designating the United States and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application.

To learn more:

A divisional application under 37 CFR 1.53(b) is a type of continuation application that is filed to pursue a distinct invention that was disclosed but not claimed in a prior nonprovisional application. According to the MPEP:

‘A divisional application is often filed as a result of a restriction requirement made by the examiner.’

Divisional applications allow inventors to protect multiple inventions disclosed in a single parent application by filing separate applications for each invention.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

A divisional application is a type of patent application that claims subject matter that is independent and distinct from that claimed in a prior application. It typically arises when an original application contains multiple inventions, and the Patent Office requires the applicant to restrict the claims to a single invention.

According to MPEP ¶ 2.01, a divisional application:

“appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application, and names the inventor or at least one joint inventor named in the prior application.”

To claim the benefit of the filing date of the prior application, applicants must comply with 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

Design patent applications and utility patent applications are two distinct types of patent applications that protect different aspects of inventions. According to MPEP 201:

  • Design Patent Application: “An application for a design patent filed under 35 U.S.C. 171 may be referred to as a design application.” Design patents protect the ornamental appearance of an article of manufacture.
  • Utility Patent Application: These applications protect the functional aspects of an invention, including processes, machines, articles of manufacture, and compositions of matter.

The key differences are:

  1. Subject Matter: Design patents cover appearance, while utility patents cover functionality.
  2. Duration: Design patents last for 15 years from issuance, while utility patents last for 20 years from the filing date.
  3. Examination Process: Design patent applications typically have a simpler examination process.

For more details on utility patents, refer to 35 U.S.C. 101, and for design patents, see 35 U.S.C. 171.

For more information on design patent, visit: design patent.

For more information on patent applications, visit: patent applications.

A delayed benefit claim in patent applications refers to a situation where an applicant fails to submit the required reference to a prior application within the specified time period. In such cases, the applicant may file a petition for an unintentionally delayed claim.

According to MPEP 211.04, the petition must include:

  • The reference to the prior application
  • A petition fee
  • A statement that the entire delay was unintentional

The MPEP states: “If the reference required by 35 U.S.C. 120 and 37 CFR 1.78 is not submitted within the required time period, a petition for an unintentionally delayed claim may be filed.”

To learn more:

A Continued Prosecution Application (CPA) is a type of continuation or divisional application that can be filed under 37 CFR 1.53(d) for design applications. As stated in the MPEP, A continuation or divisional application filed under 37 CFR 1.53(d) is called a ‘Continued Prosecution Application’ (CPA). CPAs allow applicants to continue prosecution of a prior design application while retaining the benefit of the earlier filing date.

To learn more:

A Continued Prosecution Application (CPA) is a type of patent application that allows applicants to continue prosecution of a prior design application. It’s important to note that CPAs are now only available for design applications, not utility applications.

While the MPEP ¶ 2.32 doesn’t provide a direct definition of a CPA, it implies its use in the context of design applications:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

CPAs allow applicants to:

  • Continue prosecution of a previously filed design application
  • Make amendments or corrections, such as deleting a named inventor
  • Potentially receive further examination without filing a new application

For more detailed information on CPAs, refer to MPEP § 201.06(d).

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

A Continued Prosecution Application (CPA) is a type of patent application that allows applicants to continue prosecution of a parent application. It is governed by 37 CFR 1.53(d). According to MPEP ¶ 2.30, when a CPA is accepted, the examiner will use the following language:

“The request filed on [filing date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [parent application number] is acceptable and a CPA has been established.”

This indicates that the CPA has been properly filed and prosecution will continue based on the parent application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A Continued Prosecution Application (CPA) is a type of patent application specifically for design patents. It allows applicants to continue prosecution of a previously filed design application by filing a request for continued examination. CPAs are governed by 37 CFR 1.53(d) and are only available for design applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A Continued Prosecution Application (CPA) is a type of patent application specifically for design patents, filed under 37 CFR 1.53(d). It allows applicants to continue prosecution of a parent design patent application by filing a request for a CPA.

According to MPEP ¶ 2.30: The request filed on [date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [number] is acceptable and a CPA has been established. This means that when a CPA is properly filed and accepted, it continues the prosecution of the parent application while establishing a new application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

A Continued Prosecution Application (CPA) is a type of continuation or divisional application that can be filed for design patent applications under 37 CFR 1.53(d). It allows an applicant to continue prosecution of a prior design application. As stated in the MPEP:

A continuation or divisional application (but not a continuation-in-part) of a prior nonprovisional application may be filed as a continued prosecution application under this paragraph, provided that:
(i) The application is for a design patent;

CPAs can only be filed before the earliest of: payment of the issue fee, abandonment, or termination of proceedings on the prior application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

A continuation-in-part (CIP) application is an application filed during the lifetime of a prior nonprovisional application, repeating some substantial portion or all of the prior application and adding matter not disclosed in the prior application.

As stated in the MPEP:

A continuation-in-part is an application filed during the lifetime of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.

Key points about CIP applications:

  • A CIP application may only be filed under 37 CFR 1.53(b).
  • The CIP application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • A CIP application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).
  • The mere filing of a CIP application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending parent application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A continuation-in-part (CIP) application is a type of patent application that builds upon a previously filed application by including new matter not disclosed in the original application. Key points about CIP applications include:

  • They are filed while the parent application is still pending.
  • They contain a portion or all of the disclosure of the parent application.
  • They introduce new matter not present in the original application.
  • The new matter is not entitled to the priority date of the parent application.

The MPEP 201.01 states: National applications include […] continuation-in-part applications (which may be filed under 37 CFR 1.53(b)). CIP applications allow inventors to expand on their original invention while maintaining the priority date for the previously disclosed material.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A continuation or divisional application is a type of continuing application filed under 37 CFR 1.53(b). According to the MPEP, An application filed under 37 CFR 1.53(b) may be an original or a reissue, a continuation, a divisional, a continuation-in-part, or a substitute. These applications are filed under 35 U.S.C. 111(a) and can be for utility, design, plant, or reissue patents.

To learn more:

To learn more:

A continuation application is a type of patent application that discloses the same invention(s) as a previously filed, copending nonprovisional application, international application designating the United States, or international design application designating the United States. The MPEP states:

“A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.”

It’s important to note that the continuation application must not include any new matter that wasn’t present in the parent application.

To learn more:

A continuation application under 37 CFR 1.53(b) is a type of continuing application that discloses and claims only subject matter disclosed in a prior nonprovisional application. It is filed under 35 U.S.C. 111(a) and may be for a utility, design, or plant patent.

According to the MPEP:

A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (A) a new specification and drawings and a copy of the signed oath or declaration as filed in the prior application provided the new specification and drawings do not contain any subject matter that would have been new matter in the prior application; or (B) a new specification and drawings and a newly executed oath or declaration provided the new specification and drawings do not contain any subject matter that would have been new matter in the prior application.

The continuation application receives a new application number and filing date, but can claim the benefit of the prior application’s filing date under 35 U.S.C. 120.

For more information on continuation application, visit: continuation application.

A Conditional Request for a Continued Prosecution Application (CPA) is a filing made under 37 CFR 1.53(d) for design applications. However, it’s important to note that any “conditional” request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA. This means that even if an applicant intends the request to be conditional, the USPTO will process it as a standard CPA request.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A ‘substitute’ application in patent law is essentially a duplicate of an earlier application that was abandoned before the filing of the later application. The MPEP provides the following definition:

A “substitute” application is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application.

Key points about substitute applications:

  • It does not obtain the benefit of the filing date of the prior application
  • Current practice does not require applicants to insert references to the earlier application in the specification
  • Applicants should call attention to the earlier application

The USPTO uses a specific form paragraph (2.07) to remind applicants of possible substitute status:

Applicant refers to this application as a “substitute” of Application No. [1], filed [2]. The term “substitute” is used to designate an application which is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application. A “substitute” does not obtain the benefit of the filing date of the prior application.

To learn more:

What is a ‘regular utility application’ in patent law?

A ‘regular utility application’ is a term used in patent law to describe a standard non-provisional patent application for a utility invention. According to MPEP 201.02, it is defined as follows:

“A ‘regular utility application’ is a non-provisional application for a utility patent filed under 35 U.S.C. 111(a).”

This type of application is the most common form of patent application filed with the USPTO. It requires a detailed description of the invention, claims defining the scope of protection sought, and often includes drawings to illustrate the invention. Regular utility applications undergo a thorough examination process to determine if they meet the requirements for patentability.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on Non-provisional application, visit: Non-provisional application.

What is a ‘delayed claim’ for priority or benefit in a patent application?

A ‘delayed claim’ for priority or benefit in a patent application refers to a claim that is filed after the time period set forth in 37 CFR 1.78. According to MPEP 211.02(a), “A petition under 37 CFR 1.78 and the petition fee are required to add or correct a benefit claim after the time period set forth in 37 CFR 1.78.” This means that if an applicant misses the deadline for claiming priority or benefit, they must file a petition and pay a fee to have the claim considered.

To learn more:

A continuing application in patent law is a type of patent application that is related to an earlier-filed application. The MPEP defines it as follows:

A continuing application is a continuation, divisional, or continuation-in-part application filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.

There are three main types of continuing applications:

  • Continuation: An application that further pursues the same invention as the original application
  • Divisional: An application that pursues a distinct invention that was disclosed but not claimed in the original application
  • Continuation-in-part (CIP): An application that includes subject matter from the original application plus new matter

Continuing applications must meet specific legal requirements to claim the benefit of the earlier application’s filing date.

To learn more:

Tags: divisional

A ‘bypass’ continuation application is a specific type of continuation application that is filed under 37 CFR 1.53(b) to ‘bypass’ the national stage of an international application. As explained in MPEP 201.06(c):

“A continuation application filed under 37 CFR 1.53(b) may be filed as a continuation of an international application designating the United States without entering the national stage under 35 U.S.C. 371. This is often referred to as a ‘bypass’ continuation application.”

This type of application allows applicants to pursue patent protection in the U.S. based on their international application without going through the formal national stage entry process. It can be advantageous in certain situations, such as when an applicant wants to modify claims or add new matter before U.S. examination.

A ‘bypass’ application refers to a continuation, divisional, or continuation-in-part of an international (PCT) application filed under 35 U.S.C. 111(a) instead of entering the national stage under 35 U.S.C. 371. As stated in MPEP 211.01(c):

Rather than submitting a national stage application under 35 U.S.C. 371, applicant may file a continuation, divisional, or continuation-in-part of an international (PCT) application under 35 U.S.C. 111(a). Such applications are often referred to as ‘bypass’ applications.

This option allows applicants to claim the benefit of an international application’s filing date while following the procedures for regular national applications.

To learn more:

Several international agreements can form the basis for a priority claim in patent applications. The MPEP mentions:

  • The Paris Convention for the Protection of Industrial Property
  • The Hague Agreement Concerning the International Registration of Industrial Designs
  • The Benelux Designs Convention
  • The Convention on the Grant of European Patents (European Patent Office)
  • The Patent Cooperation Treaty (PCT)
  • The International Convention for the Protection of New Varieties of Plants (UPOV)

The MPEP states: “Under Article 4A of the Paris Convention for the Protection of Industrial Property, a right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design filed under the national law of a foreign country adhering to the Convention, or on a foreign application filed under a bilateral or multilateral treaty concluded between two or more such countries.”

These agreements facilitate the international protection of intellectual property rights and enable applicants to claim priority based on applications filed in various jurisdictions.

When citing a prior application using MPEP ¶ 2.05, specific information must be included. The MPEP instructs examiners:

“In brackets 1 and 2, insert the application number (series code and serial number) and filing date of the prior application, respectively.”

This means that when referencing a prior application, the examiner should provide:

  • The application number, including both the series code and serial number
  • The filing date of the prior application

Including this information ensures clear identification of the specific prior application being referenced.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

When using Form Paragraph 2.35 in a patent examination, specific information needs to be inserted into the brackets. According to the MPEP ¶ 2.35, examiners should include the following:

  • In bracket 1: Insert the filing date of the request for a CPA.
  • In bracket 2: Insert the Application Number identified in the CPA request.

This information helps to clearly identify the specific CPA request being addressed and provides essential context for the applicant. It’s crucial for examiners to accurately fill in these brackets to ensure proper documentation and communication regarding the CPA.

When requesting to delete a named inventor in a Continued Prosecution Application (CPA) for a design patent, you should include specific information. According to MPEP ¶ 2.32, the request should contain:

  1. A clear statement requesting the deletion of the inventor(s)
  2. The name(s) of the inventor(s) to be deleted
  3. The filing date of the CPA

The MPEP provides a template for acknowledging such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

In this template, [1] represents the name(s) of the inventor(s) to be deleted, and [2] is the filing date of the CPA. Ensure your request clearly specifies these details to facilitate proper processing by the USPTO.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

When filing a Continued Prosecution Application (CPA) request, certain key information must be included. Based on MPEP ¶ 2.35, the following details are essential:

  • The filing date of the CPA request
  • The application number of the prior application

The MPEP states: “Receipt is acknowledged of the ‘conditional’ request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on prior Application No. [2].” Here, [1] represents the filing date of the CPA request, and [2] represents the application number of the prior application.

It’s important to ensure that this information is accurately provided to facilitate proper processing of the CPA request by the USPTO.

For more information on filing requirements, visit: filing requirements.

For more information on USPTO, visit: USPTO.

When referencing a prior application in a continuation-in-part (CIP), specific information must be included. According to MPEP ¶ 2.06, the examiner note states:

In brackets 1 and 2, insert the application number (series code and serial number) and filing date of the prior application, respectively.

This means that when referencing the prior application, you must include:

  • The application number (series code and serial number)
  • The filing date of the prior application

Providing this information accurately is crucial for establishing the proper relationship between the CIP and the prior application.

For more information on application number, visit: application number.

When claiming foreign priority, the application data sheet (ADS) must include specific information to meet the requirements of 37 CFR 1.55(i)(2). The MPEP states that the claim for priority must be presented in an ADS:

identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and including the information necessary for the participating foreign intellectual property office to provide the Office with access to the foreign application

This information is crucial for the USPTO to retrieve the priority document through the Priority Document Exchange program. Ensure that all details are accurate to avoid any issues with your priority claim.

To learn more:

A Continued Prosecution Application (CPA) request for design patents must include specific information to be considered acceptable. According to MPEP ¶ 2.30, the key elements are:

  • The filing date of the CPA request
  • The parent application number

The MPEP states: The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. Here, [1] represents the filing date of the CPA request, and [2] is the parent application number. These details are crucial for establishing the continuity between the parent application and the CPA.

For more information on USPTO filing procedures, visit: USPTO filing procedures.

A continuation application must include specific information to properly establish its relationship to the prior-filed application. The MPEP outlines these requirements:

“If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§ 1.76(b)(5)). The reference also must identify the relationship of the applications, namely, whether the later-filed application is a continuation, divisional, or continuation-in-part of the prior-filed nonprovisional application, international application, or international design application.”

Key information to include:

  • Application number of the prior-filed application
  • Filing date of the prior-filed application
  • Relationship between the applications (e.g., continuation)
  • Inventor information, including at least one inventor from the prior application

Ensuring all required information is included helps establish the proper benefit claim and relationship between the applications.

To learn more:

For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), which include continuations, divisionals, and continuation-in-part applications, the benefit claim must include specific information about the relationship between the applications. The MPEP states:

“For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.”

This means that when making a benefit claim, you must explicitly state whether the current application is a:

  • Continuation
  • Divisional
  • Continuation-in-part

of the prior application. This information helps the USPTO and others understand the relationship between related applications and ensures proper examination and treatment of the claims.

Remember, this requirement is in addition to other necessary information for the benefit claim, such as the application number and filing date of the prior application.

For more information on divisional, visit: divisional.

Tags: divisional

When acknowledging a Continued Prosecution Application (CPA) request, the USPTO includes specific details as outlined in MPEP ¶ 2.35. The acknowledgment typically includes:

  • The filing date of the CPA request
  • The application number of the prior application on which the CPA is based
  • A statement that the CPA request is acceptable
  • Confirmation that a CPA has been established

The MPEP provides a template for this acknowledgment: Receipt is acknowledged of the ‘conditional’ request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on prior Application No. [2].

This information helps applicants confirm that their CPA request has been received and processed correctly.

For more information on USPTO communication, visit: USPTO communication.

The first Office action of a Continued Prosecution Application (CPA) includes important information for the applicant. According to MPEP ¶ 2.35, the examiner should:

  • Advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request
  • Confirm that the CPA is acceptable and has been established
  • Provide notice that an action on the CPA follows

This information is crucial because, as stated in the MPEP, “applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.” Therefore, this Office action serves as an important communication regarding the status of the application.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

The notice of Continued Prosecution Application (CPA) establishment includes specific information as outlined in MPEP ¶ 2.30. The key elements are:

  • The filing date of the CPA request
  • The parent application number
  • A statement that the CPA is acceptable and has been established
  • An indication that an action on the CPA will follow

The exact language used by the examiner is: The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.

For more information on patent examination, visit: patent examination.

For more information on patent procedure, visit: patent procedure.

According to MPEP ¶ 2.30, a CPA acceptance notice typically includes the following information:

  • The filing date of the CPA request
  • The application number of the parent application
  • Confirmation that the CPA request is acceptable
  • Statement that a CPA has been established

The MPEP provides a template for examiners, stating: “The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.”

For more information on patent application information, visit: patent application information.

What information can the USPTO provide about applications in secrecy order?

The USPTO has strict limitations on providing information about applications under secrecy order:

  • No information about the application can be given without authorization from the appropriate department or agency.
  • The USPTO cannot confirm or deny the existence of such applications.
  • Any inquiries about these applications are referred to the appropriate department or agency.

MPEP 203.08 states: ‘For applications bearing a secrecy order pursuant to 35 U.S.C. 181, no information will be provided concerning the application without authorization from the appropriate department or agency.’

To learn more:

For unpublished patent applications, access to information is more restricted and typically limited to the applicant or their registered representative. Here’s what you need to know:

  • Unpublished application information is available through Private PAIR.
  • You must associate a Customer Number with your application to access this information.
  • If you’re not the applicant or authorized representative, access may be restricted due to confidentiality rules.

The MPEP states: In private PAIR, an applicant (or applicant’s registered patent attorney or registered patent agent) can securely track the progress of applicant’s application(s) through the USPTO. Private PAIR makes available information relating to unpublished patent applications, but the applicant must associate a Customer Number with the application to obtain access. (MPEP 203.08)

For more information on Customer Number practice, refer to MPEP § 403.

To learn more:

What information can be provided in response to status inquiries?

The USPTO has strict guidelines on the information that can be provided in response to status inquiries. MPEP 203.08 states:

“In no event will the following information be given over the telephone: (A) Filing date of applications; (B) Whether an application has been allowed, abandoned, or issued; (C) The date of allowance, abandonment or issue; and (D) Whether an assignment has been recorded.”

This policy is designed to protect the privacy and confidentiality of patent applications. Applicants or their representatives must use official channels, such as Private PAIR or written requests, to obtain such specific information.

To learn more:

The front page of a patent issuing from a continued prosecution application (CPA) filed under 37 CFR 1.53(d) contains specific information about prior applications.

As stated in the MPEP: The front page of a printed patent issuing on a continued prosecution application (CPA) filed under37 CFR 1.53(d)will identify the application number and filing date of the most recent noncontinued prosecution application (but not the filing date of the CPA) as well as all prior applications from which benefit was claimed in the most recent noncontinued prosecution application. (MPEP 202)

This means that for a CPA:

  • The application number and filing date of the most recent non-CPA application are shown
  • The CPA’s own filing date is not displayed
  • All prior applications claimed as benefit in the most recent non-CPA application are listed

This information helps establish the continuity and priority of the patent application.

For more information on benefit claims, visit: benefit claims.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent front page, visit: patent front page.

For more information on prior applications, visit: prior applications.

If your foreign application was not filed in a participating Priority Document Exchange (PDX) office, you may still be able to use the PDX program under certain conditions. According to 37 CFR 1.55(i)(4):

If the foreign application was not filed in a participating foreign intellectual property office, but a copy of the foreign application was filed in an application subsequently filed in a participating foreign intellectual property office that permits the Office to obtain such a copy, the applicant must also file a request in a separate document that the Office obtain a copy of the foreign application from the participating intellectual property office.

To make this request, you can use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)). The request must identify the participating office and the subsequent application by application number, country, and filing date.

To learn more:

What happens to the status of the prior application when filing a CPA?

When filing a Continued Prosecution Application (CPA), the status of the prior application changes. According to MPEP 201.06(d):

The filing of a CPA is not a filing of a new application. Rather, a CPA is a continuation of the prior application and maintains the same application number as the prior application, i.e., the application number of the prior application is used as the application number for the CPA.

This means that:

  • The prior application is not abandoned
  • The CPA continues the examination process of the prior application
  • The same application number is retained for the CPA

It’s important to note that while the CPA continues the examination, it is treated as a new application for all other purposes under the patent statute and rules.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

What happens to the priority date in a divisional application?

The priority date of a divisional application remains the same as its parent application, provided that the proper procedures are followed. According to MPEP 201.06:

‘A later-filed application which is filed before the patenting or abandonment of or termination of proceedings on an earlier-filed application and which is an application for an invention which is disclosed and claimed in the earlier-filed application is an application for a ‘divisional’ of the earlier-filed application.’

This means that:

  • The divisional application retains the priority date of the parent application for the subject matter disclosed in the parent.
  • This is crucial for establishing the effective filing date for prior art purposes under 35 U.S.C. 100(i).
  • The applicant must ensure that a proper reference to the parent application is made in the divisional to maintain this priority.

Maintaining the original priority date is one of the key advantages of filing a divisional application, as it allows the applicant to protect different aspects of their invention without losing the benefit of the earlier filing date.

For more information on Divisional application, visit: Divisional application.

For more information on effective filing date, visit: effective filing date.

What happens to the prior application when a CPA is filed?

When a Continued Prosecution Application (CPA) is filed, the prior application is automatically abandoned. According to MPEP 201.06(d):

The filing of a CPA is not a filing of a new application. Rather, a CPA is a continuation of the prior application and maintains the same application number as the prior application, i.e., a “streeting” of the prior application.

This means that:

  • The prior application is considered abandoned as of the filing date of the CPA.
  • The CPA is not assigned a new application number but continues under the number of the prior application.
  • All correspondence for the CPA should refer to the original application number.

It’s important to note that this automatic abandonment of the prior application is a key feature of CPA practice, distinguishing it from other types of continuing applications.

To learn more:

What happens to the prior application when a Continued Prosecution Application (CPA) is filed?

When a Continued Prosecution Application (CPA) is filed, it has specific effects on the prior application. According to MPEP 201.06(d):

‘The filing of a CPA is a specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in the request for a CPA. Such a specific reference will constitute a waiver of confidentiality of the prior design application(s) under 35 U.S.C. 122 when the CPA is pending and/or any ex parte reexamination proceeding is pending in the prior design application(s).’

This means:

  • The prior application becomes part of the record of the CPA
  • Confidentiality of the prior application is waived
  • The CPA is considered a continuation of the prior application
  • The prior application is not automatically abandoned, but will be abandoned if the issue fee is not paid

It’s important to note that while the CPA continues the examination process, the prior application remains a distinct entity until it is either allowed to go abandoned or is explicitly abandoned by the applicant.

To learn more:

Tags: CPA

What happens to the parent application when a divisional application is filed?

When a divisional application is filed, the parent application continues to be prosecuted independently. The filing of a divisional application does not automatically affect the status or prosecution of the parent application.

As stated in MPEP 201.06: “The divisional application may be filed either while the original application is still pending or after it has been patented.” This means that:

  • If the parent application is pending, it remains pending and continues through the examination process.
  • If the parent application has already been granted as a patent, it remains a valid patent.

It’s important to note that while the divisional application is independent, it must contain claims to a different invention than the parent application. The examiner will ensure that there is no double patenting between the parent and divisional applications.

Additionally, if the divisional application is filed in response to a restriction requirement in the parent application, the applicant should consider canceling the claims in the parent application that are now being pursued in the divisional to avoid potential issues with duplicate claims.

For more information on Divisional application, visit: Divisional application.

For more information on parent application, visit: parent application.

For more information on patent prosecution, visit: patent prosecution.

What happens to the parent application when a continuation is filed?

Filing a continuation application does not automatically affect the status of the parent application. As stated in MPEP 201.07:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 363 while the prior application is pending, or after the prosecution and patent term adjustment time periods have expired, or after the prior application has become abandoned or issued as a patent.’

This means that:

  • If the parent application is still pending, it remains active and can continue through the examination process.
  • If the parent application has already been issued as a patent, it remains a valid patent.
  • If the parent application has been abandoned, filing a continuation does not revive it.

It’s important to note that while a continuation can be filed at various stages of the parent application’s lifecycle, the applicant may need to make strategic decisions about how to proceed with the parent application. For example:

  • They may choose to abandon the parent application in favor of the continuation.
  • They may continue prosecuting both applications simultaneously.
  • They may allow the parent to issue as a patent and use the continuation to pursue additional claims.

The choice often depends on the specific circumstances and the applicant’s patent strategy.

For more information on continuation application, visit: continuation application.

The inventorship in a Continued Prosecution Application (CPA) generally carries over from the prior application, unless specific steps are taken to change it. The MPEP states:

The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If an inventor needs to be added or deleted in a CPA after it has been filed, a request under 37 CFR 1.48 must be submitted, along with the required fee.

For more information on patent applications, visit: patent applications.

Terminal disclaimers filed in a parent application do not automatically carry over to a divisional application. The MPEP 201.06 states:

‘A terminal disclaimer filed to obviate a nonstatutory double patenting rejection in a parent application does not carry over to a divisional application. The applicant filing the divisional application must determine whether a new terminal disclaimer needs to be filed in the divisional application.’

This means:

  • Terminal disclaimers from the parent application are not automatically applied to the divisional
  • The applicant must assess whether a new terminal disclaimer is necessary for the divisional application
  • If required, a new terminal disclaimer must be filed specifically for the divisional application

It’s important for applicants to review potential double patenting issues in the divisional application and file new terminal disclaimers if needed to overcome any rejections.

To learn more:

When filing a Continued Prosecution Application (CPA), previously filed Information Disclosure Statements (IDS) are handled as follows:

  • All IDSs filed in the prior application that comply with 37 CFR 1.98 are automatically considered in the CPA
  • No specific request is needed for the examiner to consider the previously submitted information
  • New IDSs can be filed in the CPA and will be considered if they comply with the content requirements and are filed before the first Office action

The MPEP states: All information disclosure statements filed in the prior application that comply with the content requirements of 37 CFR 1.98 will be considered in a CPA by the examiner. No specific request that the previously submitted information be considered in a CPA is required.

For more information on patent applications, visit: patent applications.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications. This also applies to continuation or divisional applications of applications filed before June 8, 1995. The MPEP states:

“A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.”

This change in procedure highlights the importance of using the correct application type and filing method after the deletion of 37 CFR 1.62.

What happens to continuation or divisional applications filed after a CPA in a design application?

Continuation or divisional applications filed after a Continued Prosecution Application (CPA) in a design application are treated differently than those filed after a CPA in a utility or plant application. According to MPEP 201.06(d):

Any continuation or divisional application filed under 37 CFR 1.53(b) after the filing of a CPA of a design application will be assigned a new application number and will reflect the filing date of the 37 CFR 1.53(b) application.

This means that unlike utility or plant applications, where a continuation or divisional application would get the benefit of the CPA’s filing date, in design applications, these subsequent applications are treated as new applications with their own filing dates.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

The MPEP clearly states that All continuation and divisional applications filed under 37 CFR 1.60 prior to December 1, 1997 will continue to be processed and examined under the procedures set forth in former 37 CFR 1.60. This means that applications filed before the cutoff date are grandfathered in and will be processed according to the old rules, ensuring consistency in the handling of these earlier applications.

To learn more:

To learn more:

The MPEP clearly states: “All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.”

This means that applications filed under the File Wrapper Continuing Procedure before its deletion will be processed according to the rules that were in place at the time of filing. For more detailed information on these procedures, you can refer to the MPEP 8th Edition, Rev. 1 (February 2003), which is available on the USPTO website.

For more information on patent examination, visit: patent examination.

The MPEP clearly states that All continuation and divisional applications filed under 37 CFR 1.60 prior to December 1, 1997 will continue to be processed and examined under the procedures set forth in former 37 CFR 1.60. This means that if you filed a continuation or divisional application before the rule change, your application will still be handled according to the old procedures, ensuring consistency in the examination process for applications filed under the former rule.

For more information on continuation applications, visit: continuation applications.

When filing a Continued Prosecution Application (CPA), amendments and information disclosure statements (IDS) from the prior application are handled as follows:

  • Amendments: The MPEP states, “Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph.” Applicants are encouraged to file any preliminary amendments at the time of filing the CPA.
  • Information Disclosure Statements: According to the MPEP, “All information disclosure statements filed in the prior application that comply with the content requirements of 37 CFR 1.98 will be considered in a CPA by the examiner.” No specific request for consideration is required.

It’s important to note that amendments or IDSs filed after the CPA filing date could delay prosecution. The MPEP advises, “Applicants are also encouraged to file all preliminary amendments at the time of filing a CPA because the entry of any preliminary amendment filed after the filing date of the CPA could be denied under 37 CFR 1.115 if the preliminary amendment unduly interferes with the preparation of a first Office action.”

For more information on patent application procedures, visit: patent application procedures.

Affidavits or declarations from a prior application do not automatically become part of a continuation or divisional application filed under 37 CFR 1.53(b). If an applicant wants to rely on these documents, they must take specific actions:

  1. Make remarks of record in the new application referring to the affidavit or declaration.
  2. Include a copy of the original affidavit or declaration filed in the prior application.

The MPEP states: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the prior nonprovisional application do not automatically become a part of a continuation or divisional application filed under 37 CFR 1.53(b). Where it is desired to rely on an earlier filed affidavit or declaration, the applicant should make such remarks of record in the 37 CFR 1.53(b) application and include a copy of the original affidavit or declaration filed in the prior nonprovisional application.

It’s important to note that this rule doesn’t apply to continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), where affidavits and declarations do automatically become part of the new application.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

What happens to a provisional application after one year?

A provisional application automatically becomes abandoned 12 months after its filing date. The MPEP 201.04 states:

‘A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.’

This means that after the 12-month period, the provisional application cannot be revived or extended. To maintain the benefit of the provisional filing date, you must file a nonprovisional application claiming priority to the provisional within this 12-month window. If you fail to do so, you lose the benefit of the earlier filing date, and the subject matter of the provisional becomes part of the prior art.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

What happens to a provisional application after 12 months?

A provisional application automatically becomes abandoned 12 months after its filing date. The MPEP states: ‘A provisional application will automatically become abandoned 12 months after its filing date pursuant to 35 U.S.C. 111(b)(5).’ This means that:

  • The application is no longer pending
  • It cannot be revived
  • No patent will directly result from a provisional application

To benefit from the provisional application, the applicant must file a nonprovisional application claiming priority to the provisional within the 12-month period. For more details, refer to MPEP 201.04.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

What happens if you don’t file a nonprovisional application within 12 months of a provisional?

If you don’t file a nonprovisional application within 12 months of filing a provisional application, you lose the ability to claim the benefit of the provisional application’s filing date. The MPEP 201.04 states:

“A provisional application automatically becomes abandoned 12 months after its filing date and cannot claim the benefit of any other application.”

This means that after 12 months, the provisional application expires, and you can no longer use it as a basis for priority in a nonprovisional application. If you still want to pursue patent protection for your invention, you would need to file a new application, but you may have lost your priority date and any intervening prior art could potentially be used against your application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

What happens if there’s an error in the foreign priority application number?

If there’s an error in the foreign priority application number, it can lead to serious consequences for the priority claim. The MPEP emphasizes the importance of accuracy:

“Errors in foreign priority claims may jeopardize the applicant’s priority claim.” (MPEP 214.04)

Consequences of errors may include:

  • Rejection of the priority claim
  • Loss of priority date
  • Potential issues with patentability if prior art emerges in the intervening period

If an error is discovered, it’s crucial to promptly file a corrected Application Data Sheet (ADS) or a petition to correct the priority claim, depending on the timing and nature of the error. Always double-check the application number against the original foreign priority document to ensure accuracy.

To learn more:

If the USPTO is unable to retrieve a priority document through the Priority Document Exchange (PDX) program, the following occurs:

  • The USPTO will notify the applicant of the unsuccessful retrieval attempt.
  • The applicant will then be required to submit the certified copy of the foreign application.

According to MPEP 215.01, If the foreign certified copy is not received by the USPTO within the pendency of the application and before the patent is granted, the USPTO will notify the applicant that the certified copy of the foreign application has not been received and require the certified copy. It’s crucial for applicants to monitor the status of their priority document and be prepared to submit a certified copy if the electronic retrieval is unsuccessful.

To learn more:

If the USPTO is closed on the priority deadline day, the deadline is extended to the next business day when the office is open. This applies to both scheduled and unscheduled closings.

The MPEP states: When the entire U.S. Patent and Trademark Office is officially closed for business for an entire day, for reasons due to adverse weather or other causes, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21. Any action or fee due on such a day may be taken, or fee paid, on the next succeeding business day the Office is open. (MPEP 213.03)

However, it’s important to note that if the USPTO is open for any part of a business day, papers are due on that day even if the office closes early or opens late due to an unscheduled event.

To learn more:

If the USPTO fails to retrieve a priority document through the exchange program, the applicant is notified and given an opportunity to correct the issue. According to MPEP 215.02(a):

“If the USPTO is unable to retrieve a copy of the foreign application to which priority is claimed, the applicant will be notified and given an opportunity to provide the missing priority document.”

This ensures that applicants have a chance to submit the required documents manually if the automated system fails.

To learn more:

If the specific reference to a prior-filed application is not submitted within the required time period, it is considered a waiver of any benefit claim to that prior application. The MPEP states:

This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).

However, there is a possibility to accept a late benefit claim. The MPEP provides that: A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

Such a petition must include:

  1. The reference to the prior application
  2. The petition fee
  3. A statement that the delay was unintentional

The Director may require additional information to verify that the delay was indeed unintentional.

For more information on unintentional delay, visit: unintentional delay.

For more information on waiver, visit: waiver.

If the required translation or statement is missing for a non-English provisional application, the following consequences apply:

  1. The USPTO will issue a notice stating that the required documents are missing.
  2. The applicant must supply the missing translation and/or statement in the provisional application.
  3. The applicant must provide confirmation in the present application that the translation and statement were filed in the provisional application.
  4. If these requirements are not met within the time period set by the USPTO, the present application will be abandoned.

As stated in the MPEP, If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned. See 37 CFR 1.78.

For more information on application abandonment, visit: application abandonment.

For more information on missing documents, visit: missing documents.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If the required translation and statement are not filed for a non-English provisional application, serious consequences can occur. According to MPEP ¶ 2.38:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This means that if you fail to provide the English translation and accuracy statement in the provisional application, and fail to confirm their filing in the present application, your current application may be abandoned. It’s crucial to comply with these requirements within the specified time frame to maintain your application’s active status.

For more information on application abandonment, visit: application abandonment.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

If the reference to a prior application is not in the first sentence of the specification, it may still be acceptable under certain conditions. According to MPEP 211.02:

If the reference to the prior application is not in the first sentence of the specification, it may be given limited review. For example, if an application is filed with a preliminary amendment which is present on filing and which contains a reference to the prior application, the application will be taken up for review by the Office of Patent Application Processing (OPAP). OPAP will mail a ‘Notice of Incomplete Application’ indicating that the reference to the prior application needs to be in the first sentence(s) of the specification.

In such cases, the applicant will be given an opportunity to correct the placement of the reference. It’s important to note that while this situation can be remedied, it’s always best practice to include the reference in the first sentence of the specification to avoid potential delays or complications.

To learn more:

Tags: OPAP

What happens if the prior-filed application is a provisional application?

When the prior-filed application is a provisional application, special considerations apply:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (or 14 months with a petition for revival).
  • The provisional application must have adequate written description and enablement support for the claimed invention in the later-filed nonprovisional application.
  • As stated in MPEP 211.01(a): “The 12-month period is subject to 35 U.S.C. 21(b) and 37 CFR 1.7(a).”

It’s important to note that provisional applications cannot claim priority to earlier applications, so the benefit claim can only extend back to the provisional application’s filing date.

To learn more:

What happens if the foreign application is not in English?

If the foreign application is not in English, the applicant must provide an English translation of the non-English language application and a statement that the translation is accurate. According to MPEP 213.02:

‘If the foreign application is not in the English language, the applicant must provide an English translation of the non-English language application and a statement that the translation is accurate.’

This requirement ensures that the USPTO can properly examine the application and determine its priority date. The translation and statement must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To learn more:

If the certified copy of the foreign application is filed after the issue fee is paid but before the patent is granted, the following occurs:

  • The priority claim or certified copy will be placed in the file record
  • There will be no review of the papers
  • The published patent will not include the priority claim

To have the priority claim considered after publication, a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 must be filed. For original applications filed under 35 U.S.C. 111(a), additional requirements may apply, such as a petition to accept an unintentionally delayed priority claim.

This is outlined in MPEP 215.03.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on certified copy, visit: certified copy.

For more information on issue fee, visit: issue fee.

If the basic filing fee is not paid when filing a Continued Prosecution Application (CPA), the USPTO will send a notice to the applicant. According to MPEP 201.06(d):

‘If the basic filing fee is not paid when the CPA is filed or within the time period set forth in a notice from the Office, the USPTO will send a Notice to File Missing Parts in the CPA.’

This notice gives the applicant a chance to pay the fee and continue the application process. However, it’s important to note that failing to respond to this notice or pay the required fee within the specified time frame could result in the CPA being abandoned. It’s always best practice to submit all required fees at the time of filing to avoid potential delays or complications in the patent application process.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on Notice to File Missing Parts, visit: Notice to File Missing Parts.

What happens if PDX retrieval of a priority document fails?

If the PDX (Priority Document Exchange) retrieval of a priority document fails, the USPTO will notify the applicant. As stated in MPEP 215.01: The USPTO will notify the applicant of any unsuccessful attempt to electronically retrieve a priority document.

In such cases:

  • The applicant will be given additional time to provide the priority document.
  • The applicant may need to submit a certified copy of the priority document directly.
  • If using WIPO DAS, the applicant should check if the access code is correct and the document is available in the system.
  • The applicant may need to contact the foreign office to ensure the document is accessible through PDX or WIPO DAS.

It’s important to address any retrieval issues promptly to ensure the priority claim is properly documented in the application.

To learn more:

Introducing new matter in a divisional application is not allowed and can have serious consequences. According to MPEP 201.06:

“A divisional application is a later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application.”

This means that a divisional application must not contain any new matter beyond what was disclosed in the parent application. If new matter is introduced:

  • The new matter will not be entitled to the benefit of the parent application’s filing date.
  • Claims relying on the new matter may be rejected under 35 U.S.C. 112(a) for lack of written description or enablement.
  • The application may lose its status as a proper divisional, potentially affecting its ability to overcome certain types of double patenting rejections.

To avoid these issues:

  1. Carefully review the divisional application before filing to ensure it only contains subject matter from the parent application.
  2. If new subject matter is necessary, consider filing it as a continuation-in-part (CIP) application instead of a divisional.
  3. Consult with a patent attorney or agent to ensure compliance with MPEP guidelines.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent filing, visit: patent filing.

If you submit an amendment to reference the prior application in a Continued Prosecution Application (CPA), it will not be entered by the USPTO.

The MPEP ¶ 2.34 clearly states: “The amendment filed [1] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [2] application of Application No. [3] has not been entered.”

Furthermore, the MPEP adds: “any such amendment shall be denied entry.” This means that even if you submit such an amendment, it will be rejected, and the examiner will use this form paragraph to inform you of the denial.

If you submit an amendment to refer to a Continued Prosecution Application (CPA) as a continuation or divisional application, it will be denied entry by the patent examiner. The MPEP ¶ 2.34 states:

“Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This means that the patent examiner will not accept or incorporate such amendments into the application. The CPA itself serves as the necessary reference to the prior application, making additional amendments unnecessary and inappropriate.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

What happens if I need to change the order of benefit claims in my patent application?

Changing the order of benefit claims in a patent application requires specific actions, as outlined in MPEP 211.02(a):

“If applicant needs to change the order of benefit claims presented in an application data sheet or patent, applicant must file a corrected application data sheet under 37 CFR 1.76(c) or a Certificate of Correction, as appropriate.”

The method you choose depends on the status of your application:

  • For pending applications: File a corrected Application Data Sheet (ADS) under 37 CFR 1.76(c).
  • For issued patents: File a Certificate of Correction.

It’s important to note that changing the order of benefit claims may affect the effective filing date of your application, which could impact patentability considerations.

To learn more:

If you miss the deadline for submitting a benefit claim, you may still be able to claim the benefit by filing a petition. According to MPEP 211.02:

A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

The petition must include:

  • The reference to the prior application (unless previously submitted)
  • The petition fee under 37 CFR 1.17(m)
  • A statement that the entire delay was unintentional

The Director may require additional information if there’s a question about whether the delay was unintentional. It’s important to note that accepting a late benefit claim is at the discretion of the USPTO and is not guaranteed.

For more information on unintentional delay, visit: unintentional delay.

For more information on USPTO, visit: USPTO.

If you miss the deadline for filing a priority claim in a U.S. patent application, you may still have options, but they are limited:

  • Petition for Unintentional Delay: You can file a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e). This petition must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.
  • Continuation-in-Part (CIP) Application: If the deadline has passed and you can’t file a petition, you might consider filing a CIP application, which allows you to claim priority to the earlier application while also adding new matter.
  • Consequences: Failing to properly claim priority can affect the patent’s validity and enforceability, particularly if prior art emerges in the intervening period between the foreign filing and the U.S. filing.

As stated in MPEP 214.01: “The claim for priority must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application in an original application filed under 35 U.S.C. 111(a).”

To learn more:

To learn more:

If you miss the deadline for filing a foreign priority claim, you may still have options:

  • Unintentional delay: You can file a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e). This petition must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.
  • Design applications: For design applications, you can file this petition up to the date of payment of the issue fee.

The MPEP states: The Director may accept an unintentionally delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), or 365(a) or (b) in an application for patent filed on or after November 29, 2000, upon petition pursuant to 37 CFR 1.55(e).

It’s important to note that the petition must include a statement that the entire delay was unintentional, and you may need to provide additional evidence to support this claim.

What happens if I miss the 12-month deadline for filing a U.S. nonprovisional application claiming priority to a foreign application?

If you miss the 12-month deadline for filing a U.S. nonprovisional application claiming priority to a foreign application, you may still be able to file the application, but you’ll lose the right to claim priority to the foreign application. The MPEP states:

“An applicant who files a nonprovisional application after the 12-month priority period (or 6-month priority period in the case of a design application) will not be able to claim priority to the foreign-filed application in the later-filed nonprovisional application.” (MPEP 213.03)

In such cases, your U.S. application will be treated as a new application without the benefit of the earlier filing date. This can have significant implications, especially if any public disclosures or other prior art have been published in the intervening time.

To learn more:

What happens if I miss the 12-month deadline for filing a nonprovisional application?

If you miss the 12-month deadline for filing a nonprovisional application claiming the benefit of a provisional application, you generally lose the ability to claim that earlier filing date. The MPEP 201.04 states:

“If a provisional application is not filed in compliance with 35 U.S.C. 119(e) and 37 CFR 1.53(c), the provisional application is not entitled to the benefit of the filing date of the provisional application.”

Consequences of missing the deadline include:

  • Loss of the earlier filing date
  • Potential issues with prior art that emerged during the 12-month period
  • Possible loss of patent rights in some jurisdictions

In some cases, you may be able to file a petition for an unintentional delay under 37 CFR 1.78(c), but this is not guaranteed and may involve additional fees. It’s crucial to monitor deadlines carefully to avoid these issues.

For more information on filing deadline, visit: filing deadline.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent priority, visit: patent priority.

For more information on provisional application, visit: provisional application.

What happens if I miss the 12-month deadline for filing a nonprovisional application after a provisional application?

If you miss the 12-month deadline for filing a nonprovisional application claiming the benefit of a provisional application, you lose the right to claim that benefit. The MPEP states: A provisional application is not entitled to the right of priority under 35 U.S.C. 119(e) unless the full fee set forth in 37 CFR 1.16(d) has been paid and the basic filing fee set forth in 37 CFR 1.16(a) has been paid on or before the date the provisional application was filed. (MPEP 201.04) Additionally, you cannot extend this 12-month period. However, you may still file a nonprovisional application; it just won’t have the earlier priority date of the provisional application.

To learn more:

To learn more:

If you identify a new inventor in a Continued Prosecution Application (CPA) without filing a request under 37 CFR 1.48, the inventorship will not be officially changed. The MPEP clearly states: ‘It is noted that [new inventor] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [filing date], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.’ In such cases, the inventorship in the CPA will remain the same as in the prior application, despite the attempt to name a new inventor.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

When multiple foreign applications are filed for the same invention, the right of priority is generally based on the earliest filed application. MPEP 213.03 explains: ‘The twelve months is from earliest foreign filing except as provided in 35 U.S.C. 119(c). If an inventor has filed an application in France on October 4, 1981, and an identical application in the United Kingdom on March 3, 1982, and then files in the United States on February 2, 1983, the inventor is not entitled to the right of priority at all; the inventor would not be entitled to the benefit of the date of the French application since this application was filed more than twelve months before the U.S. application, and the inventor would not be entitled to the benefit of the date of the United Kingdom application since this application is not the first one filed.’

However, if the later application contains additional subject matter, a claim specifically limited to that additional disclosure may be entitled to the priority date of the later foreign application.

If you file a U.S. patent application more than 12 months after your foreign filing, your claim for priority based on that foreign application may be denied. The MPEP states:

The claim for priority cannot be based on said application, because the subsequent nonprovisional or international application designating the United States was filed more than twelve months thereafter and no petition under 37 CFR 1.55 or request under PCT Rule 26bis.3 to restore the right of priority has been granted.

However, you may still have options to restore your priority claim under certain circumstances.

For more information on 12-month rule, visit: 12-month rule.

For more information on foreign priority, visit: foreign priority.

What happens if I file a provisional application without meeting all the requirements?

If you file a provisional application that doesn’t meet all the requirements, it may not be granted the filing date you intended. The MPEP states: If a provisional application does not contain a cover sheet identifying it as a provisional application, it will be treated as a nonprovisional application. This means:

  • Your application might be processed as a nonprovisional application, which has different requirements and fees.
  • You could lose the intended filing date, which is crucial for establishing priority.
  • The USPTO may send you a notice of missing parts, giving you a chance to correct the deficiencies.

It’s crucial to ensure all requirements are met when filing a provisional application to avoid these complications.

For more information on filing requirements, visit: filing requirements.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

What happens if I file a provisional application with multiple inventors?

When filing a provisional application with multiple inventors, it’s important to note that:

  • All inventors must be named in the application.
  • Each inventor must sign an oath or declaration, either in the provisional application or in the later-filed nonprovisional application.
  • The inventorship of the provisional application should match that of any subsequent nonprovisional application claiming benefit.

According to MPEP 201.04: “The inventorship of a provisional application is that inventorship set forth in the cover sheet as prescribed by 37 CFR 1.51(c)(1) filed with the provisional application.” This means that the cover sheet must accurately reflect all inventors involved in the invention described in the provisional application.

To learn more:

What happens if I file a provisional application and don’t file a nonprovisional within 12 months?

If you file a provisional application but do not file a corresponding nonprovisional application within 12 months, the provisional application will automatically be abandoned. As stated in the MPEP 201.04: “A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.” This means you lose the benefit of the provisional filing date and cannot claim priority to it in future applications. To maintain the priority benefit, you must file a nonprovisional application claiming benefit of the provisional within the 12-month period.

For more information on application abandonment, visit: application abandonment.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

If you file a nonprovisional application after the 12-month priority period from the filing date of a foreign application, you may still be able to claim priority under certain circumstances:

  • Two-month grace period: The USPTO provides a two-month grace period after the 12-month priority period. During this time, you can file the nonprovisional application with a petition to restore the right of priority.
  • Unintentional delay: The delay in filing must have been unintentional. You’ll need to submit a petition explaining the circumstances.
  • Additional fee: A petition fee is required.

As stated in MPEP 213.03: “A nonprovisional application filed after the 12-month priority period, but within 2 months from the expiration of the 12-month priority period, may be filed with a petition to restore the right of priority.”

It’s important to note that this provision applies to both Paris Convention applications and PCT applications entering the national stage in the United States.

To learn more:

What happens if I fail to underline the entire benefit claim in a corrected ADS?

Failing to properly underline the entire benefit claim in a corrected Application Data Sheet (ADS) can have serious consequences. The MPEP 211.02(a) states:

If the corrected ADS fails to identify the benefit claim with underlining of all text inserted, the Office of Patent Application Processing (OPAP) will not recognize such benefit claim and will not enter such benefit claim information in Office records.

This means that if you don’t underline the entire benefit claim:

  • The USPTO won’t recognize the benefit claim
  • The benefit claim information won’t be entered into official records
  • Your application may lose its priority date

To avoid these issues, always ensure that you underline the entire benefit claim when adding it to a corrected ADS, even if parts of the claim were present in the original ADS.

To learn more:

Tags: ADS

What happens if I fail to file a priority claim within the time period set in 37 CFR 1.55?

If you fail to file a priority claim within the time period set in 37 CFR 1.55, your priority claim will be considered waived. The MPEP states: ‘If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’ This means that if you miss the deadline, you may lose the benefit of the earlier filing date, which could potentially affect the patentability of your invention if intervening prior art exists.

To learn more:

To learn more:

What happens if I fail to file a priority claim during the pendency of my application?

If you fail to file a priority claim during the pendency of your application, you may lose the right to claim priority. According to MPEP 213.04:

If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, it must also be accompanied by the processing fee set forth in 37 CFR 1.17(i).

This means that if you miss the deadline to file your priority claim before the issue fee is paid, you’ll need to pay an additional processing fee. Moreover, if the application has already been patented, you cannot file a priority claim retroactively.

It’s crucial to file your priority claim as early as possible during the pendency of your application to avoid potential complications or additional fees.

To learn more:

What happens if I fail to file a nonprovisional application within 12 months of my provisional application?

If you fail to file a nonprovisional application within 12 months of your provisional application’s filing date, you will lose the benefit of the provisional application’s filing date. The MPEP states:

“A provisional application expires 12 months after its filing date and cannot be revived after its expiration to restore it to pending status.” (MPEP 201.04)

This means:

  • You can’t claim priority to the provisional application after the 12-month period.
  • Any public disclosures made during that 12-month period may now be considered prior art against your invention.
  • You may need to file a new application, potentially losing your earlier filing date.

It’s crucial to calendar the 12-month deadline and ensure timely filing of the nonprovisional application to preserve your priority date.

To learn more:

If you fail to provide the required English translation and statement of accuracy for a non-English provisional application, your current application may be abandoned. The MPEP states:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned. See 37 CFR 1.78.”

This means you must either provide the required documents or withdraw the benefit claim to avoid abandonment of your application.

For more information on application abandonment, visit: application abandonment.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If you don’t pay the issue fee for your patent application, it will be considered abandoned. According to MPEP 203.05, one of the ways an application can become abandoned is:

“for failure to pay the issue fee”

The MPEP refers to sections 711 to 711.05 for more details on this topic. It’s crucial to pay the issue fee on time to prevent your application from being abandoned after all the effort put into the patent prosecution process.

To learn more:

If you don’t file a petition to restore the benefit of a provisional application after missing the 12-month deadline, you will lose the right to claim the earlier filing date of the provisional application. The MPEP states:

“Applicant is required to delete the claim to the benefit of the prior-filed provisional application, unless applicant can establish that this application, or an intermediate nonprovisional application or international application designating the United States, was filed within 12 months of the filing date of the provisional application.”

This means your application will be treated as if it was filed on the date of the nonprovisional application, potentially affecting your ability to secure patent rights if intervening prior art exists. It’s crucial to either meet the original 12-month deadline or file a timely petition to restore the benefit to maintain your earlier filing date.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

If you don’t file a foreign priority claim within the specified time period, the claim is considered to have been waived. As stated in MPEP 214.01: “Claims for foreign priority not presented within the time period specified in 37 CFR 1.55 are considered to have been waived.”

However, there is a possibility to file a petition to accept an unintentionally delayed priority claim. The MPEP further states: “If a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it includes the required identification information and is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

For more information on the process of filing an unintentionally delayed priority claim, refer to MPEP § 214.02.

To learn more:

If copendency is not established between patent applications, the benefit claim to the prior-filed application becomes improper. The MPEP clearly states:

Since the applications are not copending, the benefit claim to the prior-filed application is improper. Applicant is required to delete the claim to the benefit of the prior-filed application, unless applicant can establish copendency between the applications.

In such cases, the applicant must either prove that copendency exists or remove the benefit claim. Failure to do so may result in the loss of the earlier priority date, potentially affecting the patentability of the invention.

For more information on copendency, visit: copendency.

For more information on patent procedure, visit: patent procedure.

What happens if an international application designating the US is withdrawn?

If an international application designating the United States is withdrawn or considered withdrawn, either generally or as to the United States, it cannot serve as the basis for priority in a subsequent U.S. application. The MPEP states:

“An international application designating the United States that withdraws the U.S. designation prior to fulfilling the requirements of 35 U.S.C. 371(c) cannot serve as a basis for priority in a subsequent U.S. national application.”

This means that if the international application is withdrawn before meeting the requirements for entering the national stage in the U.S., it cannot be used as a priority claim in a later U.S. application. It’s important for applicants to carefully consider the implications of withdrawing an international application, especially if they plan to seek patent protection in the United States later.

To learn more:

What happens if an international application designating the US is published in a language other than English?

If an international application designating the United States is published under PCT Article 21(2) in a language other than English, a translation of the international application into English must be provided. The MPEP 211.01(c) states:

If the international application was published under PCT Article 21(2) in a language other than English, the publication of the international application shall be considered to be an English language translation of the application provided to the U.S. Patent and Trademark Office within the meaning of 35 U.S.C. 154(d)(4).

This means that for the purposes of provisional rights under 35 U.S.C. 154(d), the English translation provided to the USPTO will be considered as the publication of the international application.

To learn more:

When an improper Continued Prosecution Application (CPA) is filed, the USPTO’s response depends on the type of application and the nature of the impropriety:

  • For utility or plant applications filed on or after July 14, 2003, an improper CPA is treated as a Request for Continued Examination (RCE) if possible
  • If the improper CPA doesn’t meet RCE requirements, it’s treated as an improper RCE
  • For design applications, an improper CPA may be treated as a new application under 37 CFR 1.53(b) in some circumstances
  • The Office will not automatically convert an improper CPA to an application under 37 CFR 1.53(b) without extenuating circumstances

The MPEP states: Any request for a CPA filed on or after July 14, 2003, in a utility or plant application is improper, regardless of the filing date of the utility or plant application in which the CPA is filed.

Regarding treatment as an RCE: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

If the improper CPA doesn’t meet RCE requirements: If the improper CPA does not satisfy the requirements of 37 CFR 1.114 (e.g., the request lacks a submission or the fee under 37 CFR 1.17(e), or the prosecution of the application is not closed), the Office treats the improper CPA as an improper RCE, and the time period set in the last Office action (or notice) will continue to run.

Examiners are instructed to notify supervisory staff if they discover an improper CPA has been processed: If an examiner discovers that an improper or incomplete CPA has been processed as a proper CPA in error, the examiner should immediately notify a supervisory applications examiner (SAE) or other technical support staff within the Technology Center (TC) who will reprocess the CPA and correct the application records as appropriate.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

Continued Prosecution Applications (CPAs) are only available for design patent applications. If an improper CPA is filed for a utility or plant application, the following occurs:

  • For applications filed on or after June 8, 1995, the improper CPA is treated as a Request for Continued Examination (RCE) under 37 CFR 1.114
  • If the requirements for an RCE are not met, the Office will send a Notice of Improper Request for Continued Examination (RCE)
  • For applications filed before June 8, 1995, the improper CPA cannot be treated as an RCE
  • The applicant will be notified of the improper CPA

MPEP 201.06(d) states: Any request for a CPA filed on or after July 14, 2003, in a utility or plant application is improper, regardless of the filing date of the utility or plant application in which the CPA is filed. It further notes: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on USPTO procedures, visit: USPTO procedures.

For more information on utility patents, visit: utility patents.

When claiming benefit to a non-English language provisional application, the following are required:

  • An English language translation of the provisional application
  • A statement that the translation is accurate

These must be filed in the provisional application. If not filed, the applicant will be notified and given a period of time to file the translation and statement.

MPEP 211.01(a) states: If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.

Failure to timely provide the translation and statement may result in the abandonment of the nonprovisional application.

To learn more:

Failure to comply with the requirements of 35 U.S.C. 371(c) has serious consequences for an international application entering the national stage in the United States. According to MPEP 211.01(c), which cites 35 U.S.C. 371(d):

35 U.S.C. 371(d) indicates that failure to timely comply with the requirements of 35 U.S.C. 371(c) ‘shall be regarded as abandonment of the application by the parties thereof.’

This means that if an applicant does not meet the requirements for entering the national stage, such as submitting the required documents and fees within the specified time limits, the application will be considered abandoned. Abandonment results in the loss of the application’s filing date and any associated priority claims. It’s crucial for applicants to carefully follow the national stage entry requirements to avoid unintentional abandonment of their applications.

To learn more:

To learn more:

What happens if a provisional application is not followed by a nonprovisional application within 12 months?

If a provisional application is not followed by a nonprovisional application within 12 months, it will automatically be abandoned and cannot be revived. The MPEP 201.04 states: A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter. This means that the provisional application cannot serve as a priority document for any subsequent applications, and any potential benefit date will be lost.

For more information on provisional application, visit: provisional application.

If a provisional application is not converted to a nonprovisional application within 12 months, it automatically becomes abandoned. The MPEP 201.04 clearly states:

A provisional application automatically becomes abandoned 12 months after its filing date and cannot claim the benefit of any other application. See 35 U.S.C. 111(b)(5).

This means that after 12 months, the provisional application can no longer serve as a basis for claiming priority, and any disclosure made in the provisional application becomes part of the public domain. To maintain the benefit of the provisional filing date, applicants must file a nonprovisional application claiming the benefit of the provisional application within the 12-month period.

For more information on provisional application, visit: provisional application.

What happens if a provisional application is not converted to a nonprovisional within 12 months?

If a provisional application is not converted to a nonprovisional application within 12 months, it will automatically expire. The MPEP 201.04 states:

“A provisional application will automatically become abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.”

Once expired, the provisional application cannot be revived or restored to pending status. However, the applicant may still file a nonprovisional application after the 12-month period, but they would lose the benefit of the earlier filing date of the provisional application.

For more information on provisional application, visit: provisional application.

If a priority document is not timely retrieved through the PDX program, there can be significant consequences for the patent application. According to MPEP 215.02(a):

“If the priority document is not retrieved within the time period set in 37 CFR 1.55(g)(1), the applicant is notified and given a time period within which to file the certified copy in accordance with 37 CFR 1.55(g)(1).”

Consequences of untimely retrieval:

  • Applicant receives a notification of non-retrieval
  • A time limit is set for manual submission of the certified copy
  • Failure to submit within the time limit may result in loss of priority claim
  • Additional fees may be required for late submission

To learn more:

If a priority claim or the certified copy of a foreign application is filed after the issue fee is paid, it will not automatically be included in the patent. The MPEP Section 213.04 states:

“If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and § 1.323.”

This means that to include the priority claim in the patent after the issue fee is paid, the applicant must request a certificate of correction, which may involve additional fees and processing time.

To learn more:

If a prior-filed application lacks adequate written description for a claimed invention, the following consequences may occur:

  • The claim in the later-filed application will not be entitled to the benefit of the filing date of the prior-filed application for that invention.
  • The effective filing date for the claimed invention will be the filing date of the later-filed application.
  • This may impact the patent’s validity if intervening prior art exists between the filing dates of the prior-filed and later-filed applications.

As stated in MPEP 211.05:

To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.

This emphasizes the importance of ensuring that the prior-filed application contains a complete and detailed disclosure of the claimed invention.

To learn more:

What happens if a prior-filed application is abandoned?

If a prior-filed application is abandoned, it may still be used to claim the benefit of priority for a later-filed application, provided certain conditions are met. According to MPEP 211.01:

‘An abandoned application may be used as a prior application for purposes of claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) in a later-filed application when the abandoned application discloses the invention adequately and completely.’

However, it’s important to note that the abandoned application must still meet all the requirements for claiming benefit, including:

  • Adequate disclosure of the invention
  • Proper copendency (if applicable)
  • Specific reference to the prior application in the later-filed application

If these conditions are met, the abandoned status of the prior application does not prevent it from serving as a basis for claiming benefit in a later application.

To learn more:

What happens if a nonprovisional application claims benefit of multiple provisional applications?

When a nonprovisional application claims the benefit of multiple provisional applications, each provisional application must satisfy the requirements of 35 U.S.C. 119(e) and the first paragraph of 35 U.S.C. 112 for the subject matter claimed in the nonprovisional application.

As stated in MPEP 211.01(a):

“If a claim in the nonprovisional application is not adequately supported by any of the prior provisional applications, that claim is not entitled to the benefit of the filing date of the provisional applications not providing adequate support.”

This means that different claims in the nonprovisional application may have different effective filing dates, depending on which provisional application(s) provide adequate support for each claim.

To learn more:

If a new inventor is identified in a Continued Prosecution Application (CPA) without proper documentation, it can lead to issues with the application. The MPEP ¶ 2.33 states:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

This means that if an examiner notices a new inventor listed on a CPA without the required request under 37 CFR 1.48, they will issue a notice to the applicant. The inventorship will remain the same as in the prior application until the proper request is filed and approved.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

If a new inventor is identified in a Continued Prosecution Application (CPA) without filing a proper request, it can lead to inventorship issues. The MPEP ¶ 2.33 states:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

This means that simply naming a new inventor in the CPA filing documents is not sufficient. Without a proper request under 37 CFR 1.48, the inventorship will remain the same as in the prior application, potentially leading to complications in the patent prosecution process.

For more information on CPA, visit: CPA.

Tags: CPA

If a new inventor is identified in a Continued Prosecution Application (CPA) for a design application, specific steps must be taken to properly add them to the application.

MPEP ¶ 2.33 states: “It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.”

This means that simply naming a new inventor in the CPA filing is not sufficient. A formal request under 37 CFR 1.48 must be filed to correct the inventorship. Without this request, the inventorship will remain the same as in the prior application, regardless of any new names listed on the CPA filing.

For more information on CPA, visit: CPA.

Tags: CPA

If a foreign priority claim in an original application filed under 35 U.S.C. 111(a) (other than a design application) is submitted after the time period set in 37 CFR 1.55 and without a petition under 37 CFR 1.55, the examiner may notify the applicant that the foreign priority claim will not be entered.

As stated in the MPEP: If the foreign priority claim in an original application filed under 35 U.S.C. 111(a) (other than a design application) is submitted after the time period set in 37 CFR 1.55 and without a petition under 37 CFR 1.55, the examiner may use form paragraph 2.21.01 to notify applicant that the foreign priority claim will not be entered.

In such cases, the applicant must file a petition for an unintentionally delayed priority claim under 37 CFR 1.55(e) to have the priority claim considered.

To learn more:

If a foreign application was filed more than 12 months before the U.S. application and priority has not been restored, the examiner will use form paragraph 2.23 to notify the applicant that the claim for priority cannot be based on that application.

As stated in the MPEP: Where the earlier foreign application was filed more than 12 months prior to the U.S. application and priority has not been restored under PCT Rule 26bis.3 for an international application or upon a granted petition under 37 CFR 1.55(c), use form paragraph 2.23.

In such cases, the applicant may file a petition under 37 CFR 1.55(c) to restore the right of priority if:

  • The subsequent application was filed within two months from the expiration of the twelve-month period
  • The delay was unintentional

The petition must include specific elements, such as the priority claim, petition fee, and a statement about the unintentional delay.

To learn more:

What happens if a divisional application is filed after the parent application is patented or abandoned?

If a divisional application is filed after the parent application has been patented or abandoned, it will not be entitled to the benefit of the parent application’s filing date. The MPEP states:

A divisional application is often filed as a result of a restriction requirement made by the examiner. The divisional application may be filed under 37 CFR 1.53(b) (or 1.53(d) if the application is a design application) before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention.

Filing a divisional application after the parent application has been patented or abandoned means:

  • The application will not be considered a proper divisional application
  • It will not receive the benefit of the parent application’s filing date
  • It may be treated as a new, independent application
  • Prior art that was not applicable to the parent application may now be applicable
  • The application may face potential statutory bars under 35 U.S.C. 102

To avoid these issues, it’s crucial to file divisional applications before the patenting, abandonment, or termination of proceedings on the parent application.

For more information on Divisional application, visit: Divisional application.

For more information on late filing, visit: late filing.

For more information on patent procedure, visit: patent procedure.

If a delayed benefit claim is filed after the patent issues, it cannot be accepted. The MPEP 211.04 states:

‘A delayed benefit claim filed after issuance of a patent cannot be accepted.’

This means that once a patent has been granted, it is no longer possible to add or modify benefit claims. Any attempts to file a delayed benefit claim after patent issuance will be denied.

To learn more:

If a Continued Prosecution Application (CPA) request for a design patent is not submitted on a separate paper, it will be considered non-compliant and will not be processed by the USPTO.

The MPEP clearly states: ‘Because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.’ This means that the CPA will not be initiated, and the applicant will need to resubmit the request properly to proceed with the continued examination.

In such cases, the USPTO will typically send a notification to the applicant informing them of the non-compliance and providing instructions for proper submission.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

If a Continued Prosecution Application (CPA) request is improper for a utility or plant application, the USPTO handles it differently than for design applications. According to MPEP ¶ 2.35:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

In such cases, the USPTO treats the improper CPA request as a Request for Continued Examination (RCE). This approach ensures that the application can continue to be prosecuted, albeit under a different procedure. Applicants should be aware of this distinction and the potential implications for their patent prosecution strategy.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

If a Continued Prosecution Application (CPA) is improperly requested for a utility or plant patent application, it is typically treated as a Request for Continued Examination (RCE). The MPEP ¶ 2.30 provides guidance on this situation:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

In such cases, the examiner will use a different form paragraph (7.42.15) to notify the applicant that their CPA request has been treated as an RCE. This ensures that the application can continue to be examined under the appropriate procedure for utility or plant patents.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

If a Continued Prosecution Application (CPA) is filed in a utility or plant application after July 14, 2003, it will not be treated as a proper CPA. According to MPEP 201.06(d):

‘Any CPA filed on or after July 14, 2003 in a utility or plant application will automatically be treated as a request for continued examination (RCE) under 37 CFR 1.114, see MPEP § 706.07(h), paragraph II.’

This means that instead of being processed as a CPA, the application will be treated as a Request for Continued Examination (RCE). Applicants should be aware of this automatic conversion and ensure they meet the requirements for an RCE if they inadvertently file a CPA for a utility or plant application.

For more information on CPA, visit: CPA.

For more information on RCE, visit: RCE.

Tags: CPA, RCE

What happens if a copending application is abandoned after filing a continuation application?

If a copending application is abandoned after filing a continuation application, it does not affect the continuation application’s status. The MPEP states:

“The copendency requirement of 35 U.S.C. 120 is met if the later-filed application is filed before the patenting or abandonment of or termination of proceedings on the prior application.”

This means that as long as the continuation application was filed while the prior application was still pending, subsequent abandonment of the prior application does not impact the continuation’s validity. The continuation application can still claim the benefit of the prior application’s filing date.

For more information, refer to MPEP 211.01.

To learn more:

To learn more:

If a Continued Prosecution Application (CPA) is filed after the issue fee has been paid, it will not be treated as a CPA. Instead, it will be processed as follows:

  • For applications filed on or after May 29, 2000, the CPA will be treated as a request for continued examination (RCE) under 37 CFR 1.114.
  • For applications filed before May 29, 2000, the CPA will be treated as an improper application and will not be processed.

As stated in MPEP 201.06(d): “If an application is filed on or after May 29, 2000, the filing of a CPA is not permitted after payment of the issue fee. In such a case, the Office will treat the improper CPA as an RCE under 37 CFR 1.114, provided that the application is a utility or plant application filed on or after June 8, 1995.”

It’s important to note that this treatment as an RCE is only possible for utility or plant applications filed on or after June 8, 1995. For other types of applications or those filed before this date, the improper CPA filing will not be processed, and the applicant may need to consider other options, such as filing a reissue application if the patent has already issued.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on issue fee, visit: issue fee.

For more information on RCE, visit: RCE.

When a continuation-in-part (CIP) application includes new matter not disclosed in the parent application, the following consequences apply:

  • Claims solely directed to subject matter adequately disclosed in the parent application are entitled to the parent application’s filing date.
  • Claims that include new matter introduced in the CIP are only entitled to the filing date of the CIP application.
  • The new matter may affect the application’s ability to overcome prior art references.

As stated in MPEP 211.05:

“Any claim in a continuation-in-part application which is directed solely to subject matter adequately disclosed under 35 U.S.C. 112 in the parent nonprovisional application is entitled to the benefit of the filing date of the parent nonprovisional application. However, if a claim in a continuation-in-part application recites a feature which was not disclosed or adequately supported by a proper disclosure under 35 U.S.C. 112 in the parent nonprovisional application, but which was first introduced or adequately supported in the continuation-in-part application, such a claim is entitled only to the filing date of the continuation-in-part application.”

This differentiation in filing dates for different claims within the same CIP application can significantly impact the application’s ability to overcome prior art and maintain patentability.

To learn more:

If a continuation or divisional application contains new matter not disclosed in the prior-filed application, the applicant will be required to either delete the benefit claim or change the relationship to a continuation-in-part application. This is because continuation and divisional applications cannot include new matter.

As stated in MPEP ¶ 2.10.01:

“Applicant is required to delete the benefit claim or change the relationship (continuation or divisional application) to continuation-in-part because this application contains the following matter not disclosed in the prior-filed application:”

This form paragraph is used by examiners when they identify new matter in an application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c).

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent examination, visit: patent examination.

What happens if a continuation application is filed after the parent application has been abandoned?

If a continuation application is filed after the parent application has been abandoned, it may still be entitled to the benefit of the filing date of the prior application. The MPEP states:

“Where the prior application has been abandoned, the petition to revive under 37 CFR 1.137 (a) or (b) must be filed in the prior application, or in a subsequent nonprovisional application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the prior application, if the prior nonprovisional application is not pending and claims the benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) of a provisional application.”

This means that even if the parent application is abandoned, you can still file a continuation application and potentially revive the parent application. However, specific procedures must be followed, including filing a petition to revive in the appropriate application.

For more information on reviving abandoned applications, refer to MPEP 711.

To learn more:

To learn more:

If a certified copy of the priority document is not filed within the time limit in a U.S. national stage application, the following consequences may occur:

  • The right to priority may be lost if the certified copy is not filed within the time period set in 37 CFR 1.55.
  • However, if the certified copy is filed after the time period set in 37 CFR 1.55 but during the pendency of the application, the right to priority may be restored under certain conditions.
  • According to MPEP 213.06, ‘If the certified copy is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’

It’s crucial to file the certified copy within the specified time limit to avoid potential complications in claiming priority.

To learn more:

To learn more:

What happens if a certified copy is not received within the time period set in 37 CFR 1.55(f)?

If a certified copy is not received within the time period set in 37 CFR 1.55(f), the USPTO will send a Notice of Allowance and Issue Fee Due (Notice of Allowance) with a requirement for the certified copy. As stated in the MPEP:

‘If a certified copy of the foreign application is not filed within the time period specified in 37 CFR 1.55(f) and the exceptions in 37 CFR 1.55(h), (i), and (j) are not applicable, the certified copy of the foreign application must be accompanied by a petition including a showing of good and sufficient cause for the delay and the petition fee set forth in 37 CFR 1.17(g).’

This means that if you miss the deadline, you’ll need to file a petition explaining the delay and pay an additional fee. It’s crucial to submit the certified copy or ensure it’s retrievable through the priority document exchange program to avoid complications in the patent application process.

If a benefit claim is included elsewhere in the application (e.g., in an oath or declaration) and is recognized by the USPTO as shown by its inclusion on the first filing receipt, but not properly submitted in the manner specified by 37 CFR 1.78, the following applies:

  • The USPTO will not require a petition and petition fee to correct the benefit claim.
  • This is because the application will have been scheduled for publication based on the information concerning the benefit claim.
  • However, the applicant must still submit the benefit claim in the proper manner (i.e., in an ADS or by amendment to the specification, depending on the filing date) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78.

The MPEP states: “If an applicant includes a claim to the benefit of a prior application elsewhere in the application but not in the manner specified in 37 CFR 1.78 (e.g., if the benefit claim is not present in the proper place but is included in an oath or declaration, or the application transmittal letter, or in the first sentence(s) of the specification for an application filed on or after September 16, 2012) within the time period set forth in 37 CFR 1.78, the Office will not require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the information concerning the benefit claim contained elsewhere in the application was recognized by the Office as shown by its inclusion on the first filing receipt.”

If a benefit claim is not submitted within the required time period, it is considered waived. The MPEP states: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c) unless a petition to accept an unintentionally delayed benefit claim is granted.

However, applicants may file a petition to accept an unintentionally delayed benefit claim. For more information on this process, see MPEP § 211.04.

To learn more:

If a benefit claim is not properly made within the required time period, it is considered untimely and will not be entered. The MPEP states:

“The benefit claim filed on [1] was not entered because the required reference was not timely filed within the time period set forth in 37 CFR 1.78.”

Consequences of an untimely benefit claim include:

  • Loss of the earlier priority date, which could affect the patentability of the application if intervening prior art exists.
  • Inability to rely on the earlier filing date to overcome prior art references.
  • Potential issues with statutory bars under 35 U.S.C. 102.

However, all is not lost if the benefit claim is untimely. The applicant may file a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(c) or 37 CFR 1.78(e), depending on the type of benefit claim. This petition must include:

  1. The required reference to the prior application
  2. A petition fee
  3. A statement that the entire delay was unintentional

The USPTO may require additional information to determine if the delay was truly unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on unintentional delay, visit: unintentional delay.

If an applicant includes a benefit claim in the wrong part of the application but within the required time period, the USPTO’s response depends on whether the claim is recognized:

  1. If the benefit claim is recognized by the Office (shown by its inclusion on the first filing receipt), no petition or petition fee is required to correct the benefit claim. The MPEP states: If an applicant includes a claim to the benefit of a prior application elsewhere in the application but not in the manner specified in 37 CFR 1.78 (e.g., if the benefit claim is not present in the proper place but is included in an oath or declaration, or the application transmittal letter, or in the first sentence(s) of the specification for an application filed on or after September 16, 2012) within the time period set forth in 37 CFR 1.78, the Office will not require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the information concerning the benefit claim contained elsewhere in the application was recognized by the Office as shown by its inclusion on the first filing receipt.
  2. If the benefit claim is not recognized by the Office (shown by its absence on the first filing receipt), a petition and petition fee under 37 CFR 1.17(m) will be required to correct the benefit claim if the correction is sought after the time period set in 37 CFR 1.78.

In both cases, the applicant must still submit the benefit claim in the proper format (i.e., in an ADS or by amendment to the specification, depending on the application’s filing date) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on filing receipt, visit: filing receipt.

If a benefit claim is filed after the required time period specified in 37 CFR 1.78, the applicant must file a petition for an unintentionally delayed benefit claim. The MPEP states:

“If a benefit claim is filed after the required time period and without a petition as required by 37 CFR 1.78, the applicant should be informed that the benefit claim was not entered and that a petition needs to be filed using form paragraph 2.39.”

The petition must include:

  • The reference to the prior application (unless previously submitted)
  • A petition fee under 37 CFR 1.17(m)
  • A statement that the entire delay was unintentional

The Director may require additional information to determine if the delay was unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on unintentional delay, visit: unintentional delay.

After a Continued Prosecution Application (CPA) is established, the USPTO proceeds with examination. According to MPEP ¶ 2.35:

Accordingly, the request for a CPA application is acceptable and a CPA has been established. An action on the CPA follows.

This means that once the CPA is established, the examiner will review the application and issue an Office action. It’s important to note that applicants are not separately notified of the abandonment of the parent application, nor is a filing receipt normally sent for a CPA.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO procedures, visit: USPTO procedures.

Once a Continued Prosecution Application (CPA) is established from a Conditional Request, the USPTO proceeds with the examination process as it would for any other CPA. According to MPEP ¶ 2.35: “An action on the CPA follows.”

This means that after the CPA is established:

  • The parent application is considered abandoned
  • The examiner will review the CPA and issue an Office action
  • The applicant should be aware that they may not receive a filing receipt for the CPA, as noted in the MPEP: “This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

37 CFR 1.62, which covered the File Wrapper Continuing Procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette 1203, published on October 21, 1997.

The MPEP states: 37 CFR 1.62 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This means that applications filed under this procedure after its deletion date would be treated differently.

To learn more:

To learn more:

37 CFR 1.62, which covered the File Wrapper Continuing Procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette: “See 1203 O.G. 63, October 21, 1997.” This deletion significantly impacted how certain continuation, divisional, and continuation-in-part applications were processed.

For more information on patent application procedures, visit: patent application procedures.

37 CFR 1.60, which previously governed the filing of divisional and continuation applications, was deleted effective December 1, 1997. As stated in the MPEP, 37 CFR 1.60 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This change significantly impacted the procedure for filing these types of applications.

For more information on continuation applications, visit: continuation applications.

37 CFR 1.60, which dealt with the divisional continuation procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette, as stated in the MPEP: 37 CFR 1.60 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This means that the specific procedures outlined in this regulation are no longer in effect for applications filed after this date.

To learn more:

To learn more:

To maintain an allowed application’s status and proceed to patent issuance, certain fees must be paid. The MPEP mentions two specific fees:

  1. Issue fee: This is the fee required for the USPTO to issue the patent.
  2. Publication fee: If applicable, this fee covers the cost of publishing the patent application.

The MPEP states that an application becomes abandoned “for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).” Therefore, timely payment of these fees is crucial to maintain the allowed status and proceed to patent issuance.

To learn more:

A patent application is designated as ‘rejected’ when it contains an unanswered examiner’s action during its prosecution in the examining group and before allowance. According to MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application.

This status continues until the applicant responds to the examiner’s action or the application becomes abandoned.

To learn more:

An abandoned patent application is one that has been removed from the USPTO’s docket of pending applications. According to MPEP 203.05, an application can become abandoned for several reasons:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications:

  • Formal abandonment by the applicant or their attorney/agent
  • Failure to take appropriate action during prosecution
  • Failure to pay the issue fee
  • For provisional applications, not filing a nonprovisional application within 12 months

Abandonment can have serious consequences, but in some cases, it may be possible to revive an abandoned application.

For more information on patent abandonment, visit: patent abandonment.

Copendency refers to the requirement that two related patent applications must be pending at the same time for one to claim the benefit of the earlier filing date of the other. The MPEP states:

Copendency between the current application and the prior application is required.

This means that the later application must be filed before the earlier application is either abandoned or issued as a patent. Copendency is crucial for maintaining a continuous chain of priority between related applications.

For more information on copendency, visit: copendency.

For more information on patent applications, visit: patent applications.

‘Unintentional delay’ is a crucial concept when seeking to restore the benefit of a provisional application. The MPEP requires:

“A statement that the delay in filing the subsequent nonprovisional application or international application designating the United States within the twelve-month period was unintentional.”

While the MPEP doesn’t provide a specific definition of ‘unintentional delay’, it generally means that the failure to meet the 12-month deadline was not deliberate. The USPTO may require additional information to determine if the delay was truly unintentional:

“The Director may require additional information where there is a question whether the delay was unintentional.”

It’s important to be prepared to explain the circumstances that led to the delay if requested.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

‘Failure to take appropriate action’ in patent prosecution refers to situations where an applicant doesn’t respond to Office actions or meet other required deadlines during the examination process. According to MPEP 203.05, an application can be abandoned:

“through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application”

This could include not responding to an examiner’s rejection within the given time frame, failing to submit required documents, or not meeting other procedural requirements. It’s crucial for applicants to stay engaged in the prosecution process and meet all deadlines to prevent unintentional abandonment.

To learn more:

To perfect a claim for foreign priority after patent issuance, several documents are required. According to MPEP 216.01, the following must be submitted:

  • A petition to accept an unintentionally delayed claim for priority
  • The required petition fee
  • A certified copy of the foreign application
  • An English language translation of the foreign application (if not in English)
  • A statement that the translation is accurate

The MPEP states: ‘In addition to the petition to accept an unintentionally delayed claim for priority and the required petition fee, the claim for priority must be made in an application data sheet (if the patent issued from a utility or plant application filed on or after September 16, 2012) or in a request for a certificate of correction, and a certified copy of the foreign application must be submitted.’

It’s important to note that the requirements may vary slightly depending on the specific circumstances of the application and patent. Consulting with a patent attorney or agent is advisable for ensuring all necessary documents are properly prepared and submitted.

To claim foreign priority in a U.S. application, you must file a claim for priority and submit a certified copy of the foreign application. MPEP 213.04 states: ‘The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application.’

For applications filed on or after September 16, 2012, the priority claim must be presented in an Application Data Sheet (ADS). The certified copy must be filed within the later of 4 months from the actual filing date or 16 months from the foreign filing date, with some exceptions.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

According to MPEP 203.01, a ‘new’ application is defined as follows:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This means that a patent application is considered ‘new’ from the time it is filed until the patent examiner issues their first official response or action on the application.

To learn more:

For an international design application to be used as a basis for benefit claims, it must meet certain conditions. The MPEP specifies:

To obtain benefit of the filing date of a prior international design application designating the United States, the international design application must be entitled to a filing date in accordance with 37 CFR 1.1023.

This means that the international design application must have a valid filing date as determined by the regulations set forth in 37 CFR 1.1023. These regulations outline the requirements for establishing a filing date for international design applications, which typically include submitting the necessary documents and fees to the International Bureau or an appropriate office.

Additionally, the application claiming benefit must comply with the requirements of 35 U.S.C. 120, which include proper copendency and specific reference to the earlier application.

To learn more:

To learn more:

The Patent Law Treaties Implementation Act (PLTIA) of 2012 introduced several significant changes to U.S. patent law and procedures:

  • Restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications).
  • The ability to file international design applications and claim priority to, and the benefit of, international design applications in nonprovisional applications.

As stated in the MPEP: Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. (MPEP 210)

These changes were implemented in two phases:

  • Title II of the PLTIA became effective on December 18, 2013.
  • Title I of the PLTIA became effective on May 13, 2015.

For more information on international design applications, visit: international design applications.

For more information on PLTIA, visit: PLTIA.

For more information on priority restoration, visit: priority restoration.

An allowed application can lose its status under certain circumstances. The MPEP outlines two main scenarios:

  1. Withdrawal from issue: This is governed by 37 CFR 1.313. The applicant or the USPTO may initiate this process for various reasons, such as the need for further examination or the discovery of new prior art.
  2. Abandonment due to non-payment: As stated in the MPEP, an application becomes abandoned “for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).”

In either case, the application loses its ‘allowed’ status and may require further action or payments to proceed towards patent issuance.

To learn more:

MPEP 201.01 outlines several types of national applications that can be filed with the USPTO. These include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Design applications
  • Plant applications
  • Provisional applications

As stated in MPEP 201.01: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’

Each of these application types serves a specific purpose in the patent system and is subject to different rules and requirements.

For more information on design applications, visit: design applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on plant applications, visit: plant applications.

For more information on reissue applications, visit: reissue applications.

There are three main types of national applications for patents in the United States:

  • Nonprovisional applications filed under 35 U.S.C. 111(a)
  • Provisional applications filed under 35 U.S.C. 111(b)
  • International applications that have entered the national stage in the United States

As stated in MPEP 201.01: “Applications filed under 35 U.S.C. 111(a) include original nonprovisional utility, plant, design, divisional, continuation, and continuation-in-part applications filed under 37 CFR 1.53(b), reissue applications filed under 37 CFR 1.53(b), and design patent continued prosecution applications (CPAs) filed under 37 CFR 1.53(d).”

For more information on international applications, visit: international applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

What are the time limits for perfecting a foreign priority claim in a patent?

The time limits for perfecting a foreign priority claim in a patent are as follows:

  • The priority claim must be made within 16 months from the filing date of the prior foreign application or 4 months from the actual filing date of the U.S. application, whichever is later.
  • A certified copy of the foreign application must be filed within the same time period, unless previously submitted in a parent application.

According to MPEP 216.01: “The patent owner’s failure to make a timely priority claim and file the certified copy prior to issuance of the patent cannot be cured by filing a reissue application.” This emphasizes the importance of meeting these deadlines during the initial patent application process.

The time limits for filing an interim copy of a foreign application are specified in 37 CFR 1.55(j). According to the MPEP:

37 CFR 1.55(j) also provides that the interim copy of the foreign application and cover sheet must be filed within the later of sixteen months from the filing date of the prior foreign application or four months from the actual filing date of an application under 35 U.S.C. 111(a), within four months from the later of the date of commencement (37 CFR 1.491(a)) or the date of the initial submission under 35 U.S.C. 371 in an application entering the national stage under 35 U.S.C. 371, or with a petition under 37 CFR 1.55(e) or (f).

In summary, the interim copy must be filed within:

  • 16 months from the filing date of the foreign application, or
  • 4 months from the U.S. application filing date under 35 U.S.C. 111(a), or
  • 4 months from the national stage commencement or initial submission date under 35 U.S.C. 371, or
  • With a petition under 37 CFR 1.55(e) or (f)

To learn more:

The time limits for filing a certified copy in an international design application are:

  • General rule: Within the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application.
  • Exception: These time limits do not apply if the priority document is available to the Office from a participating digital library.

MPEP 213.07 specifies: The time period requirement in 37 CFR 1.55(f) for filing a certified copy of the foreign application in a nonprovisional international design application is the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application, except as provided in paragraphs (h), (i), and (j) of this section.

To learn more:

In a national stage application under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT. According to 37 CFR 1.55(d)(2), this is the general rule, with some exceptions provided in paragraph (e) of the same section.

The MPEP states: In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made and a certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT with limited exceptions.

To learn more:

The signature requirements for filing a Continued Prosecution Application (CPA) are specific and important. According to MPEP 201.06(d):

A Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) must be signed by a person authorized to prosecute the application, except as provided in 37 CFR 1.33(b).

This means that:

  • The CPA must be signed by someone authorized to prosecute the application.
  • Typically, this would be the applicant or the applicant’s patent attorney or agent.
  • There are exceptions outlined in 37 CFR 1.33(b), which allow for certain communications to be signed by other parties in specific circumstances.

It’s crucial to ensure that the proper signature is provided when filing a CPA to avoid potential issues with the application’s acceptance or processing.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

The signature requirements for a Continued Prosecution Application (CPA) request are specific and important to ensure proper filing. According to MPEP 201.06(d):

  • The request for a CPA must be signed by a person authorized to prosecute the prior application.
  • This includes:
    • A registered patent practitioner
    • The applicant (inventor or assignee of the entire interest)
  • The signature can be provided through any of the approved signature methods outlined in 37 CFR 1.4(d).

The MPEP states: ‘A request for a CPA may only be signed by a person authorized to prosecute the application as set forth in 37 CFR 1.33(b).’ This ensures that only authorized individuals can initiate the CPA process, maintaining the integrity of the application.

It’s crucial to note that if the CPA request is not properly signed, it may not be granted a filing date, potentially affecting the continuity of the application.

For more information on CPA, visit: CPA.

Tags: CPA

What are the restrictions on filing a continuation-in-part application?

n

While continuation-in-part (CIP) applications offer flexibility in adding new matter to existing patent applications, there are several important restrictions to consider. The MPEP 201.08 outlines some key points:

n

“A continuation-in-part application can be filed as a new application claiming benefit under 35 U.S.C. 120 to a prior nonprovisional application or under 35 U.S.C. 119(e) to a prior provisional application, provided the conditions set forth under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 are met.”

n

Key restrictions include:

n

    n

  • The CIP must be filed while the parent application is still pending (not abandoned or issued).
  • n

  • At least one inventor named in the CIP must also be named in the parent application.
  • n

  • The CIP must include a specific reference to the parent application.
  • n

  • New matter in the CIP does not benefit from the parent application’s filing date.
  • n

  • The CIP must be filed within the time limits specified in 37 CFR 1.78 to claim priority.
  • n

n

Additionally, applicants should be aware that filing a CIP may affect the patent term and the assessment of prior art for the new subject matter. Careful consideration of these restrictions is essential for effective patent strategy.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on filing requirements, visit: filing requirements.

To use the Priority Document Exchange (PDX) program, several requirements must be met as outlined in MPEP 215.02(a):

  1. The foreign application must be filed in a participating foreign intellectual property office.
  2. The claim for priority must be presented in an application data sheet (ADS) with specific details about the foreign application.
  3. The copy of the foreign application must be received by the USPTO from the participating foreign office, or a certified copy must be filed, within the specified time period.

The MPEP states:

37 CFR 1.55(i) specifically provides that this requirement for a timely filed certified copy of the foreign application will be considered satisfied if: (1) The foreign application was filed in a foreign intellectual property office participating with the Office in a bilateral or multilateral priority document exchange agreement (participating foreign intellectual property office); (2) the claim for priority is presented in an application data sheet (§1.76(b)(6)), identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and including the information necessary for the participating foreign intellectual property office to provide the Office with access to the foreign application; and (3) the copy of the foreign application is received by the Office from the participating foreign intellectual property office, or a certified copy of the foreign application is filed, within the time period set forth in 37 CFR 1.55(g)(1)).

Meeting these requirements allows applicants to potentially avoid manually filing certified copies of foreign priority documents.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For more information on requirements, visit: requirements.

What are the requirements for submitting an interim copy of a foreign priority application?

Submitting an interim copy of a foreign priority application can be useful when there are delays in obtaining a certified copy. According to MPEP 213.04, here are the requirements:

37 CFR 1.55(j) provides that an applicant who has not filed a certified copy of the foreign application may file an interim copy of the foreign application during the pendency of the application.

To submit an interim copy:

  • It must be filed during the pendency of the application
  • The copy must be clearly labeled as ‘Interim Copy’
  • Include a cover sheet identifying:
    • The application number
    • The foreign application number
    • The country or intellectual property office
    • The filing date
  • The interim copy must be a legible copy of the foreign application

Note: An interim copy does not satisfy the requirement for a certified copy. You must still submit a certified copy of the foreign application before the patent is granted.

To learn more:

To incorporate material from a prior-filed application under 37 CFR 1.57(b), several requirements must be met:

  1. The inadvertently omitted portion must be completely contained in the prior-filed application.
  2. A copy of the prior-filed application must be submitted (except for applications filed under 35 U.S.C. 111).
  3. If the prior-filed application is in a non-English language, an English language translation must be submitted.
  4. The applicant must identify where the inadvertently omitted portion can be found in the prior-filed application.

The MPEP states that an amendment may not comply with 37 CFR 1.57(b) if any of these conditions are not met. For example, it notes that non-compliance may occur if the inadvertently omitted portion is not completely contained in the prior-filed application or if applicant did not identify where the inadvertently omitted portion of the specification or drawings can be found in the prior-filed application.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

For more information on patent application requirements, visit: patent application requirements.

For more information on prior-filed application, visit: prior-filed application.

According to 37 CFR 1.55(g)(1), the claim for priority and the certified copy of the foreign application must be filed within the pendency of the application. The MPEP states:

“The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application, unless filed with a petition under paragraph (e) or (f) of this section, or with a petition accompanied by the fee set forth in § 1.17(g) which includes a showing of good and sufficient cause for the delay in filing the certified copy of the foreign application in a design application.”

This requirement applies to all applications and ensures that priority claims are properly documented before the application is granted.

To learn more:

According to MPEP 211, a petition to restore the benefit of a provisional application under 37 CFR 1.78(b) must include:

  1. The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application (unless previously submitted)
  2. The petition fee set forth in 37 CFR 1.17(m)
  3. A statement that the delay in filing the subsequent nonprovisional application or international application designating the United States within the twelve-month period was unintentional

The MPEP further states:

“The Director may require additional information where there is a question whether the delay was unintentional.”

It’s important to note that this petition must be filed in the subsequent application, not the provisional application itself.

For more information on patent procedure, visit: patent procedure.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

The MPEP 201.06(c) outlines the requirements for filing a divisional or continuation application without an executed oath or declaration:

’37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a continuation or divisional application filed by all or by fewer than all of the inventors named in a prior nonprovisional application containing an oath or declaration as required by 37 CFR 1.63, provided that a copy of the executed oath or declaration filed in the prior application is submitted for the continuation or divisional application and the specification and drawings filed in the continuation or divisional application contain no matter that would have been new matter in the prior application.’

To file without a new oath or declaration:

  • Submit a copy of the executed oath or declaration from the prior application
  • Ensure the new application contains no new matter
  • File a copy of the specification and drawings from the prior application

This procedure allows for expedited filing while maintaining the integrity of the oath or declaration requirements.

To learn more:

To learn more:

The key requirements for filing a divisional application include:

  • The divisional application must be filed before the patenting or abandonment of the parent application.
  • It must claim only subject matter disclosed in the parent application.
  • It must be filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if it is a design application).
  • The inventorship must include at least one inventor named in the parent application.
  • It must claim the benefit of the parent application under 35 U.S.C. 120, 121, 365(c), or 386(c).

As stated in the MPEP:

The divisional application may be filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if the application is a design application, but not an international design application). The inventorship in the divisional application must include at least one inventor named in the prior-filed application, and the divisional application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).

To learn more:

To file a delayed priority claim, you must submit a petition to accept an unintentionally delayed claim for priority. According to 37 CFR 1.55(e), the petition must include:

  1. The priority claim in an application data sheet
  2. A certified copy of the foreign application (unless exceptions apply)
  3. The petition fee
  4. A statement that the entire delay was unintentional

The MPEP states: A petition to accept a delayed claim for priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) must be accompanied by: (1) The priority claim […]; (2) A certified copy of the foreign application […]; (3) The petition fee […]; and (4) A statement that the entire delay […] was unintentional.

Filing a delayed benefit claim for a provisional application requires specific components. MPEP 211.04 outlines the requirements:

The petition must be accompanied by: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior provisional application (unless previously submitted); (B) a petition fee under 37 CFR 1.17(m); and (C) a statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the claim was filed was unintentional.

For petitions filed more than two years after the due date, additional explanation of the delay circumstances is required to establish that the entire delay was unintentional.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

To file a Continued Prosecution Application (CPA), the following requirements must be met:

  • The application must be for a design patent
  • The prior application must be a complete design application as defined by 37 CFR 1.51(b)
  • The CPA must be filed before the earliest of:
    • Payment of the issue fee in the prior application
    • Abandonment of the prior application
    • Termination of proceedings in the prior application

Additionally, the CPA must include a request on a separate paper, identify the prior application, and be accompanied by the basic filing fee, search fee, and examination fee.

To learn more:

To file a valid Continued Prosecution Application (CPA) request for a design patent application, you must adhere to specific requirements outlined in 37 CFR 1.53(d). Key requirements include:

  • The request must be for a design application only.
  • The request must be submitted on a separate paper, as stated in MPEP ¶ 2.31: “because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.”
  • The application being continued must be a design application that is complete as defined by 37 CFR 1.51(b).

Failure to meet these requirements may result in the CPA request being deemed unacceptable.

To file a Continued Prosecution Application (CPA) in a design application, the following requirements must be met:

  • The application must be a design application.
  • The prior application must be a nonprovisional application.
  • The application must be filed before the earliest of:
    • Payment of the issue fee on the prior application, unless a petition under § 1.313(c) is granted in the prior application;
    • Abandonment of the prior application; or
    • Termination of proceedings on the prior application.

As stated in the MPEP 201.06(d): “A continuation or divisional application that is a nonprovisional application may be filed as a CPA under 37 CFR 1.53(d) if the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).”

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on filing requirements, visit: filing requirements.

To file a continuation-in-part (CIP) application, several requirements must be met according to MPEP 201.08 and 37 CFR 1.78:

  1. The CIP must be filed while the prior nonprovisional application is still pending (before patenting, abandonment, or termination of proceedings).
  2. The CIP must claim benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  3. The CIP must contain a specific reference to the prior application, including the application number.
  4. For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet (ADS).
  5. The CIP must have at least one common inventor with the prior application.

It’s important to note that a CIP can only be filed under 37 CFR 1.53(b) and cannot be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).

For more information on filing requirements, visit: filing requirements.

For more information on USPTO, visit: USPTO.

For national stage applications under 35 U.S.C. 371, the requirements for filing a certified copy of a foreign application are outlined in 37 CFR 1.55(f)(2). The MPEP states:

A certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT in an international application entering the national stage under 35 U.S.C. 371.

If the certified copy was not filed during the international stage, it must be filed within the later of:

  • Four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f)
  • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
  • Sixteen months from the filing date of the prior foreign application

Exceptions to these time limits are provided in paragraphs (h), (i), and (j) of 37 CFR 1.55.

To learn more:

To file a certificate of correction to perfect a foreign priority claim, you must meet the following requirements:

  1. The priority claim under 37 CFR 1.55 was timely filed in the application but was not included on the patent due to failure to provide a certified copy.
  2. A grantable petition under 37 CFR 1.55(f) or (g) must be filed, which includes:
    • The fee set forth in 37 CFR 1.17(g)
    • A showing of good and sufficient cause for the delay in filing the certified copy
  3. The correction must not require further examination.

As stated in the MPEP, Where the priority claim required under 37 CFR 1.55 was timely filed in the application but was not included on the patent because the requirement under 37 CFR 1.55 for a certified copy was not satisfied, the patent may be corrected to include the priority claim via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, accompanied by a grantable petition under 37 CFR 1.55(f) or, in the case of a design application, a grantable petition under 37 CFR 1.55(g).

To learn more:

To learn more:

To be entitled to priority under the PDX program, the following requirements must be met:

  1. The Office must receive a copy of the foreign application from the participating foreign intellectual property office within the pendency of the application and before the patent is granted, or
  2. The Office must receive a paper certified copy of the foreign application during that time period.

The MPEP states:

To be entitled to priority, the Office must receive a copy of the foreign application from the participating foreign intellectual property office within the pendency of the application and before the patent is granted, or receive a paper certified copy of the foreign application during that time period.

It’s crucial to note that if a certified copy is filed after the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.

Claiming the benefit of an international application (PCT application) in a U.S. national application has specific requirements. The MPEP states:

“Pursuant to 35 U.S.C. 365(c), a regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b) may claim the benefit of the filing date of an international application which designates the United States without completing the requirements for entering the national stage under 35 U.S.C. 371.”

Requirements for claiming benefit of an international application:

  • The international application must designate the United States
  • The international application must be entitled to a filing date in accordance with PCT Article 11
  • The later-filed U.S. application must be filed during the pendency of the international application
  • The U.S. application can be filed as a continuation, divisional, or continuation-in-part of the international application (often called a “bypass” application)

This allows applicants to claim the benefit of an international application’s filing date without completing the national stage entry process under 35 U.S.C. 371.

To claim the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the following requirements must be met:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (unless the benefit has been restored)
  • The provisional application must have at least one common inventor with the nonprovisional application
  • The provisional application must be entitled to a filing date and have paid the basic filing fee
  • If the provisional application was filed in a language other than English, an English translation and a statement that the translation is accurate must be filed

As stated in the MPEP: “When a later-filed application is claiming the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the nonprovisional application must be filed not later than 12 months after the date on which the provisional application was filed, unless the benefit of the provisional application has been restored.”

To claim the benefit of a prior application’s filing date, applicants must meet specific requirements. The MPEP ¶ 2.05 advises:

“Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

Key requirements include:

  • The application must be filed before the patenting or abandonment of the prior application.
  • The application must contain a specific reference to the prior application.
  • The application must have at least one common inventor with the prior application.
  • The application must disclose the invention claimed in the manner provided by 35 U.S.C. 112(a).

For more information on patent law, visit: patent law.

Tags: patent law

What are the requirements for claiming priority to a foreign application?

To claim priority to a foreign application, several requirements must be met:

  • The U.S. application must be filed within 12 months of the foreign application (or 6 months for design patents).
  • The foreign application must be from a country that grants similar privileges to U.S. applicants (Paris Convention member or WTO member).
  • The applicant must file a claim for priority and a certified copy of the foreign application.
  • As stated in MPEP 213: “The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed before the patent is granted.”

It’s important to note that the subject matter claimed in the U.S. application must be adequately supported by the foreign application to receive the benefit of the earlier filing date.

To learn more:

For an international design application designating the United States, the requirements for claiming foreign priority are as follows:

  • The claim for priority can be made in accordance with the Hague Agreement and the Hague Agreement Regulations.
  • The claim must comply with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172.
  • Priority can be claimed with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

To learn more:

To claim foreign priority in a U.S. patent application, several requirements must be met as outlined in MPEP 213. These include:

  • Timely filing: The U.S. application must be filed within 12 months of the foreign application’s filing date (6 months for design patents)
  • Proper claim: The priority claim must be made in an application data sheet (ADS) or in the first sentence of the specification
  • Certified copy: A certified copy of the foreign application must be filed within the later of 4 months from the U.S. filing date or 16 months from the foreign filing date
  • English translation: If the foreign application is not in English, a translation may be required

As stated in MPEP 213, “The claim for priority must be presented in an application data sheet (37 CFR 1.76(b)(6)) or the specification must contain or be amended to contain a specific reference to the prior foreign application.” Failure to meet these requirements may result in the loss of the priority claim.

What are the requirements for claiming domestic benefit in a patent application?

Claiming domestic benefit in a patent application allows an applicant to rely on the filing date of an earlier-filed US application. The MPEP 216 outlines the requirements for claiming domestic benefit, which are based on 35 U.S.C. 120. The key requirements include:

  • The later-filed application must be filed before the patenting or abandonment of the prior application
  • The later-filed application must contain or be amended to contain a specific reference to the prior application
  • The prior application must disclose the invention claimed in the later-filed application in the manner required by 35 U.S.C. 112(a)
  • At least one inventor named in the later-filed application must have been named as an inventor in the prior application

The MPEP states:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application.’

It’s important to note that these requirements must be met for each application in the chain of priority, ensuring a continuous line of co-pendency and proper disclosure.

For more information on continuation application, visit: continuation application.

For more information on domestic benefit, visit: domestic benefit.

To claim benefit to a non-English language provisional application, you must provide:

  • An English translation of the non-English language provisional application
  • A statement that the translation is accurate

These documents must be filed in the provisional application itself. As stated in MPEP ¶ 2.38: “An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[…]”

Additionally, in the present (non-provisional) application, you must confirm that the translation and statement were filed in the provisional application.

For more information on non-English language, visit: non-English language.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

What are the requirements for claiming benefit of multiple prior-filed applications?

When claiming benefit of multiple prior-filed applications, specific requirements must be met. According to MPEP 211.01(b):

If a nonprovisional application claims the benefit of multiple prior-filed applications, the prior-filed applications need not be copending with each other provided that each prior-filed application is copending with the claiming application.

Key requirements include:

  • Each prior-filed application must be copending with the claiming application
  • The relationship between each prior-filed application and the claiming application must be specified
  • The benefit claim must be made within the time period set forth in 37 CFR 1.78

Additionally, the MPEP states:

There is no limit to the number of prior applications through which a chain of copendency may be traced to obtain the benefit of the filing date of the earliest of a chain of prior copending applications.

This means you can claim benefit through a chain of applications, as long as each link in the chain meets the copendency requirement with the subsequent application.

To learn more:

Tags: copendency

What are the requirements for claiming benefit of an international application in a U.S. national application?

To claim the benefit of an international application in a U.S. national application, certain requirements must be met. According to MPEP 211.01(c):

‘In order for a U.S. national application to be entitled to the benefit of the filing date of an international application, all the following conditions must be satisfied:

  • (A) The international application must designate the United States;
  • (B) The international application must have been filed on or after January 1, 1979;
  • (C) The international application must have been filed by a U.S. national or resident, or by a foreign national of a PCT member country;
  • (D) The U.S. national application must have been filed within the time period set forth in 35 U.S.C. 371(c); and
  • (E) The applicant in the U.S. national application must have complied with the requirements of 35 U.S.C. 371(c).’

These conditions ensure that the international application is properly linked to the U.S. national application and that all necessary procedural steps have been followed.

To learn more:

To learn more:

Claiming the benefit of a provisional application has specific requirements, as outlined in MPEP 211.01(b):

“A nonprovisional application that directly claims the benefit of a provisional application under 35 U.S.C. 119(e) must be filed within 12 months from the filing date of the provisional application unless the benefit of the provisional application has been restored.”

Key points to remember:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • If filed after 12 months, the benefit of the provisional application must be restored (see 37 CFR 1.78(b)).
  • For indirect benefit claims through intermediate applications, the relationship between each application must be clearly identified.
  • Failure to properly indicate relationships may result in the benefit claim not being recognized, requiring a petition under 37 CFR 1.78(c) and payment of a fee.

Proper referencing and timing are crucial when claiming the benefit of provisional applications to ensure the desired priority date is secured.

To learn more:

When claiming benefit of a provisional application filed in a language other than English, additional requirements must be met. The MPEP states:

“If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.”

If these documents were not filed in the provisional application, the applicant will be notified in the nonprovisional application and given a period to file them. Failure to timely respond may result in abandonment of the nonprovisional application.

Alternatively, the applicant may choose to delete the benefit claim to the provisional application from the Application Data Sheet (ADS) or, for applications filed before September 16, 2012, from the ADS or the first sentence(s) of the specification.

To learn more:

To claim the benefit of a prior-filed application in a continuation-in-part (CIP), several requirements must be met as outlined in MPEP 201.08 and 35 U.S.C. 120:

  • The CIP must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  • The CIP must contain or be amended to contain a specific reference to the earlier filed application.
  • For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet.
  • The CIP must have at least one common inventor with the prior-filed application.

Additionally, the MPEP notes:

“The continuation-in-part application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).”

It’s important to note that the USPTO does not typically scrutinize whether the earlier application fully supports the CIP’s claims unless this becomes relevant in a proceeding before the Office.

For more information on patent procedure, visit: patent procedure.

For more information on prior-filed application, visit: prior-filed application.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP), applicants must meet specific requirements. According to MPEP ¶ 2.06:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

These requirements typically include:

  • Filing the CIP application while the prior application is still pending
  • Naming at least one inventor in common with the prior application
  • Including a specific reference to the prior application in the CIP
  • Ensuring the CIP application contains a substantial portion of the prior application’s disclosure
  • Complying with the time limits and procedures outlined in 37 CFR 1.78

It’s important to note that only the subject matter shared with the prior application will benefit from its earlier filing date. New matter added in the CIP will have the filing date of the CIP application.

The requirements for certified copies in international design applications are as follows:

  • A certified copy of the foreign application is not required in an international design application.
  • The International Bureau obtains priority documents directly from offices participating in the Digital Access Service (DAS) or the Priority Document Exchange (PDX) program.
  • For offices not participating in DAS or PDX, the International Bureau will invite the applicant to submit the priority document.

According to MPEP 213.07: A certified copy of the foreign application is not required in an international design application designating the United States. The MPEP further explains: Where the foreign application was filed in a participating office, the International Bureau will attempt to obtain the priority document from the participating office. For participating offices that are not yet able to provide the priority documents to the International Bureau, the International Bureau will invite the applicant to submit the priority document.

To learn more:

Benefit claims can be made under various sections of the U.S. Code, each with specific requirements:

  • 35 U.S.C. 119(e): For provisional application benefits, refer to 37 CFR 1.78(a).
  • 35 U.S.C. 120: For benefit claims to earlier nonprovisional applications, including the relationship (continuation, divisional, or continuation-in-part).
  • 35 U.S.C. 121: For divisional applications.
  • 35 U.S.C. 365(c): For national stage applications claiming benefit to PCT applications.
  • 35 U.S.C. 386(c): For national stage applications claiming benefit to international design applications.

The MPEP states: “For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.”

It’s important to note that the specific requirements and time limits may vary depending on the type of benefit claim. Always refer to the latest version of the MPEP and the relevant U.S. Code sections for the most up-to-date information.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For an international design application to be used as a basis for claiming benefit, it must meet specific filing date requirements. MPEP § 211.01(d) states:

To obtain benefit of the filing date of a prior international design application designating the United States, the international design application must be entitled to a filing date in accordance with 37 CFR 1.1023. See 37 CFR 1.78(d)(1)(ii).

This means that the international design application must comply with the requirements set forth in 37 CFR 1.1023 to establish a valid filing date. These requirements typically include proper designation of the United States and adherence to other formal application standards.

For more information on filing date requirements, visit: filing date requirements.

For an application to be considered a divisional, it must meet several requirements as outlined in MPEP ¶ 2.01:

  1. It must disclose and claim only subject matter disclosed in the prior application.
  2. It must claim subject matter that is independent and distinct from that claimed in the prior application.
  3. It must name the inventor or at least one joint inventor named in the prior application.

The MPEP states:

This application, which discloses and claims only subject matter disclosed in prior Application No.[1], filed [2], appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application, and names the inventor or at least one joint inventor named in the prior application.

Meeting these requirements helps ensure that the divisional application is properly derived from the prior application while claiming a distinct invention.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO, visit: USPTO.

What are the requirements for adding a benefit claim to a prior-filed provisional application?

Adding a benefit claim to a prior-filed provisional application requires meeting specific criteria. According to MPEP 211.02(a):

“To add a benefit claim to a prior-filed provisional application, applicant must file a petition to accept a delayed claim under 37 CFR 1.78(c). The petition must be accompanied by:”

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78(a)(3) to the prior-filed provisional application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(a)(4) and the date the benefit claim was filed was unintentional.

Additionally, the nonprovisional application claiming the benefit must have been filed within 12 months of the provisional application’s filing date (or 14 months if an appropriate statement is made). If this time requirement is not met, a petition under 37 CFR 1.78(b) to restore the benefit of the provisional application must be filed.

For more details on the restoration of the right of priority, refer to MPEP 213.03.

To learn more:

In a continued prosecution application (CPA) filed under 37 CFR 1.53(d), there are specific rules regarding benefit claims. The MPEP states:

In a continued prosecution application (CPA) filed under 37 CFR 1.53(d), no amendment may delete the specific reference to a prior application assigned the same application number.

This is because in a CPA:

  • The request itself serves as the specific reference required by 35 U.S.C. 120 and 37 CFR 1.78 to every application assigned the same application number identified in the request.
  • A specific reference in the first sentence(s) of the specification following the title, or in an application data sheet, to a prior application assigned the same application number is not required and should not be made.

Therefore, when dealing with a CPA, it’s crucial to understand that the benefit claim to the prior application with the same application number is inherent in the CPA request itself and cannot be deleted. Any additional benefit claims would need to follow the standard procedures for adding benefit claims after filing.

To learn more:

A petition to restore the right of priority must include several key elements. The MPEP outlines these requirements:

A petition to restore the right of priority must include: (1) the priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) in an application data sheet, identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing (unless previously submitted); (2) the petition fee set forth in 37 CFR 1.17(m); and (3) a statement that the delay in filing the subsequent application within the twelve-month period was unintentional.

These requirements ensure that the USPTO has all necessary information to consider your petition for priority restoration.

For more information on application data sheet, visit: application data sheet.

For more information on petition fee, visit: petition fee.

For more information on petition requirements, visit: petition requirements.

For more information on priority restoration, visit: priority restoration.

According to MPEP 214.02, a petition to accept an unintentionally delayed claim for priority requires the following:

  • The priority claim: This must be submitted in an application data sheet (ADS) as required by 35 U.S.C. 119(b), unless previously submitted.
  • The petition fee: As set forth in 37 CFR 1.17(m).
  • A statement of unintentional delay: A statement that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional.

The MPEP states: ‘The Director may require additional information where there is a question whether the delay was unintentional.’ This means that in some cases, additional documentation may be required to support the claim of unintentional delay.

It’s important to note that these requirements apply to priority claims under various statutes, including 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), 386(a), 365(c), 119(e), 120, and 121.

To learn more:

To learn more:

What are the requirements for a nonprovisional application to claim benefit of a provisional application?

For a nonprovisional application to successfully claim the benefit of a provisional application, several requirements must be met:

  • Timely filing: The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • Proper reference: The nonprovisional application must contain a specific reference to the provisional application.
  • Common inventor: At least one inventor named in the nonprovisional application must also be named in the provisional application.
  • Adequate support: The provisional application must provide adequate support for at least one claim in the nonprovisional application under 35 U.S.C. 112(a).

As stated in MPEP 211.01(a):

“For a claim in a subsequently filed nonprovisional application to be entitled to the benefit of the filing date of a provisional application, the provisional application must have at least one inventor in common with the nonprovisional application and must provide adequate support under 35 U.S.C. 112(a) for the subject matter of the claim.”

Meeting these requirements ensures that the nonprovisional application can properly claim the earlier filing date of the provisional application for the supported subject matter.

To learn more:

According to MPEP 201.04, the required components of a provisional patent application are:

  • A specification as prescribed by 35 U.S.C. 112(a)
  • Any drawings required by 37 CFR 1.81(a)
  • A cover sheet as required by 37 CFR 1.51(c)(1), which may be an application data sheet, form SB/16, or a cover letter identifying the application as provisional

The MPEP states, No amendment, other than to make the provisional application comply with the patent statute and all applicable regulations, may be made to the provisional application after the filing date of the provisional application.

For more information on patent drawings, visit: patent drawings.

For more information on provisional application, visit: provisional application.

What are the recommended methods for checking application status?

The USPTO recommends several methods for checking application status:

  • Patent Application Information Retrieval (PAIR) system: This is the primary method for checking application status online. PAIR provides real-time access to the status of patent applications.
  • USPTO Call Center: For those who cannot access the Internet, the USPTO Call Center can provide status information.
  • Written requests: These should only be submitted if the application cannot be accessed through PAIR and the USPTO Call Center cannot provide the necessary information.

According to MPEP 203.08, ‘Applicants and their attorneys or agents are encouraged to use the PAIR system for checking patent application status.’

To learn more:

MPEP 213.01 lists several recognized regional patent offices for foreign filing. These include:

  • European Patent Office (EPO)
  • Eurasian Patent Office (EAPO)
  • African Intellectual Property Organization (OAPI)
  • African Regional Intellectual Property Organization (ARIPO)

Applications filed in these regional offices are considered as having been filed in all member states of the respective organizations. This allows applicants to seek patent protection in multiple countries through a single application process.

To learn more:

A patent application can be considered ‘abandoned’ for several reasons. According to MPEP 203.05, an abandoned application is one that is removed from the Office docket of pending applications due to:

  • Formal abandonment by the applicant or by the attorney or agent of record
  • Failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application
  • Failure to pay the issue fee
  • In the case of a provisional application, no later than 12 months after the filing date of the provisional application

It’s important for applicants to be aware of these reasons to avoid unintentional abandonment of their applications.

For more information on issue fee, visit: issue fee.

For more information on patent prosecution, visit: patent prosecution.

For more information on provisional application, visit: provisional application.

There are two primary methods for requesting the deletion of a named inventor in a Continued Prosecution Application (CPA) for design applications:

  • Letter to the examiner: You can submit a letter directly to the patent examiner handling your application.
  • Request for corrected filing receipt: You can file a formal request for a corrected filing receipt with the USPTO.

These methods are outlined in MPEP § 201, ¶ 2.32, which states:

In a continued prosecution application (CPA) for a design application (37 CFR 1.53(d)), a request to delete a named inventor from the prior application may be submitted by way of a letter to the examiner or a request for corrected filing receipt.

It’s important to note that this procedure is specific to design applications and is not applicable to utility patents.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent examination, visit: patent examination.

For more information on USPTO procedures, visit: USPTO procedures.

The MPEP 201 outlines several main types of patent applications:

  • Nonprovisional applications for patent
  • Provisional applications for patent
  • International applications
  • Design applications
  • Plant applications
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

Each type serves a specific purpose in the patent application process and has its own requirements and procedures.

For more information on divisional, visit: divisional.

For more information on patent applications, visit: patent applications.

For more information on reissue, visit: reissue.

There are several types of patent applications in the United States:

  • Nonprovisional applications filed under 35 U.S.C. 111(a), including utility, plant, and design patent applications
  • Provisional applications filed under 35 U.S.C. 111(b)
  • International applications filed under the Patent Cooperation Treaty (PCT)
  • International design applications filed under the Hague Agreement

The MPEP states: Applications filed under 35 U.S.C. 111(a) include original nonprovisional utility, plant, design, divisional, continuation, and continuation-in-part applications filed under 37 CFR 1.53(b), reissue applications filed under 37 CFR 1.53(b), and design patent continued prosecution applications (CPAs) filed under 37 CFR 1.53(d).

For more information on Hague Agreement, visit: Hague Agreement.

For more information on international applications, visit: international applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent applications, visit: patent applications.

The main types of national applications under U.S. patent law are:

  • Original (non-provisional) applications
  • Provisional applications
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

As stated in MPEP 201.01: National applications include original (non-provisional), provisional, plant, design, reissue, divisional, and continuation applications (which may be filed under 37 CFR 1.53(b)), as well as continuation-in-part applications (which may be filed under 37 CFR 1.53(b)).

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

To learn more:

A nonprovisional patent application filed under 35 U.S.C. 111(a) must include several key components. According to the MPEP, these include:

The MPEP states: Such application shall include— (A) a specification as prescribed by section 112; (B) a drawing as prescribed by section 113; and (C) an oath or declaration as prescribed by section 115.

It’s important to note that while claims and drawings are not required for obtaining a filing date (except for design applications), they are necessary for a complete application and must be submitted to avoid abandonment.

For more information on filing requirements, visit: filing requirements.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent drawings, visit: patent drawings.

Continued Prosecution Applications (CPAs) have several key differences from regular continuation applications filed under 37 CFR 1.53(b):

  • CPAs are only available for design applications, not utility or plant applications
  • CPAs use the same application number as the prior application
  • CPAs do not require a new specification or drawings to be filed
  • The filing requirements for a CPA are minimal compared to a regular continuation
  • CPAs are typically processed faster than regular continuations
  • Filing a CPA automatically abandons the prior application

MPEP 201.06(d) states: A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on USPTO procedures, visit: USPTO procedures.

While both continuation and continuation-in-part (CIP) applications are related to a prior application, there are key differences:

  • Continuation: Repeats the entire disclosure of the prior application without adding new matter.
  • Continuation-in-Part (CIP): According to MPEP ¶ 2.06, a CIP “repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application.”

The main difference is that a CIP introduces new subject matter not present in the original application. This new matter receives the filing date of the CIP, while the repeated portions may claim the earlier filing date of the prior application if properly claimed under 35 U.S.C. 120.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A divisional application has several key characteristics as outlined in MPEP ¶ 2.01:

  1. Independent and Distinct Subject Matter: It ‘appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application.’
  2. Disclosure in Prior Application: It ‘discloses and claims only subject matter disclosed in prior Application No.[1],filed[2].’
  3. Inventor Continuity: It ‘names the inventor or at least one joint inventor named in the prior application.’
  4. Potential Benefit Claim: It may claim the benefit of the filing date of the prior application, subject to meeting certain requirements.

These characteristics ensure that divisional applications properly separate distinct inventions while maintaining a connection to the original disclosure and inventorship.

For more information on Divisional application, visit: Divisional application.

The inventorship requirements for claiming foreign priority are specific and important. Here are the key points:

  • The U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.
  • Priority rights do not exist if the foreign and U.S. applications have completely different sole inventors.
  • Joint inventors can each claim the benefit of their separately filed foreign applications.

The MPEP clarifies: Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common. This requirement ensures a direct connection between the foreign priority application and the U.S. application claiming its benefit.

To learn more:

Failing to properly claim benefit in a potential continuation-in-part (CIP) application can have significant implications for patent protection. The MPEP cautions: This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established. (MPEP ¶ 2.06)

Implications of not properly claiming benefit include:

  • Loss of earlier filing date for common subject matter, potentially affecting patentability
  • Increased vulnerability to prior art that could have been excluded with the earlier filing date
  • Possible issues with patent term calculation
  • Risk of unintentionally abandoning the application if statutory deadlines are missed

To avoid these issues, applicants should carefully follow the requirements outlined in 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq when filing a CIP application.

For more information on prior art, visit: prior art.

Tags: prior art

Deleting a benefit claim from your patent application can have several important implications:

  • Prior Art Considerations: The examiner will reassess whether any new prior art may now be available due to the change in effective filing date.
  • Publication Date: As stated in the MPEP, A deletion of a benefit claim will not delay the publication of the application unless the amendment or ADS is recognized by the Office within nine weeks prior to the projected publication date that was originally calculated based on the benefit claim.
  • Intentional Waiver: The MPEP warns that A cancellation of a benefit claim to a prior application may be considered as a showing that the applicant is intentionally waiving the benefit claim to the prior application in the instant application. This could affect future attempts to reinstate the benefit claim.
  • Examination Status: If the deletion is submitted after final rejection or allowance, it will be treated under special rules (37 CFR 1.116 or 37 CFR 1.312, respectively).

It’s crucial to carefully consider these implications before deciding to delete a benefit claim. If you’re unsure about the consequences, it’s advisable to consult with a patent attorney or agent.

To learn more:

Claiming benefit under these statutes allows an application to receive the earlier filing date of a prior-filed application, which can be crucial for establishing priority and overcoming prior art. However, this claim also requires that the application does not contain new matter.

The MPEP ¶ 2.10.01 states:

“This form paragraph should be used when an application, which claims the benefit of a prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c) contains new matter relative to the prior-filed application, and purports to be a ‘continuation,’ ‘division,’ or ‘divisional application’ of the prior-filed application.”

If new matter is found, the applicant may need to change the application type or remove the benefit claim to maintain the new subject matter.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on new matter, visit: new matter.

The MPEP provides specific guidelines for status inquiries in patent applications:

  • Status inquiries are encouraged to be made via the Patent Application Information Retrieval (PAIR) system at https://www.uspto.gov/patents/apply/checking-application-status/check-filing-status-your-patent-application.
  • If PAIR is unavailable or the inquiry cannot be answered by PAIR, applicants can contact the Technology Center (TC) customer service center.
  • The MPEP states: Applicants and other individuals with limited Internet access may contact the TC customer service center at (571) 272-3900.
  • For reexamination proceedings, status inquiries should be directed to the Central Reexamination Unit (CRU) at (571) 272-7705.

It’s important to follow these guidelines to ensure efficient processing of status inquiries.

To learn more:

Tags: PAIR system

The Manual of Patent Examining Procedure (MPEP) outlines several general terms used to describe patent applications:

  • National application
  • Provisional application
  • Nonprovisional application
  • International application
  • International design application
  • Original application
  • Continuing application
  • Substitute application

These terms are defined in various sections of 37 CFR 1.9 and further explained in MPEP § 201.

To learn more:

The filing requirements for an interim copy of a foreign application are specified in 37 CFR 1.55(j). They include:

  • Filing a copy of the original foreign application clearly labeled as ‘Interim Copy’
  • Including a separate cover sheet identifying the foreign application details
  • Filing within specified time limits

The MPEP states:

’37 CFR 1.55(j) also provides that the interim copy of the foreign application must be filed together with a separate cover sheet identifying the foreign application by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and stating that the copy filed in the Office is a true copy of the original application as filed in the foreign country (or intellectual property authority).’

It’s crucial to adhere to these requirements to ensure proper processing of the interim copy.

For more information on filing requirements, visit: filing requirements.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

The filing requirements for a divisional application under 37 CFR 1.53(b) are similar to those for a new nonprovisional application. According to the MPEP:

‘A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (1) a specification complying with 35 U.S.C. 112, including a claim or claims; (2) drawings, where necessary; and (3) the inventorship named on filing.’

Additionally, you must include:

  • The appropriate filing fees
  • An Application Data Sheet (ADS) specifying that the application is a divisional
  • A proper benefit claim to the parent application

It’s important to note that while a new oath or declaration may not be required under 37 CFR 1.63(d), you must still comply with all other filing requirements.

For more information on Divisional application, visit: Divisional application.

For more information on drawings, visit: drawings.

For more information on filing requirements, visit: filing requirements.

For more information on inventorship, visit: inventorship.

To file a CPA for a design patent application, the following requirements must be met:

  • The prior application must be a design application that is complete under 37 CFR 1.51(b)
  • The CPA must be filed before the earliest of: payment of the issue fee, abandonment, or termination of proceedings in the prior application
  • The CPA must be filed with a request on a separate paper
  • The proper filing fee, search fee, and examination fee must be paid
  • The CPA must only disclose and claim subject matter disclosed in the prior application

As stated in the MPEP: “The filing date of a CPA is the date on which a request on a separate paper for an application under this paragraph is filed.”

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

The filing requirements for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) are as follows:

  • The CPA must be filed before the earliest of:
    • Payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted;
    • Abandonment of the prior application; or
    • Termination of proceedings on the prior application.
  • The CPA must include a request to initiate proceedings under 37 CFR 1.53(d).
  • The prior application must be a design application eligible for CPA practice.

As stated in the MPEP 201.06(d): ‘A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).’

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on filing requirements, visit: filing requirements.

A continuation-in-part (CIP) application has specific filing requirements. Key points include:

  • A CIP application can only be filed under 37 CFR 1.53(b).
  • It must be filed during the lifetime of the prior-filed application (before its abandonment or issuance).
  • The CIP must claim the benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • For applications filed on or after September 16, 2012, the benefit claim must be in an application data sheet (ADS).
  • The CIP must have at least one common inventor with the prior application.
  • New matter can be added to the specification, but claims relying on this new matter will not get the benefit of the earlier filing date.

As stated in the MPEP:

A continuation-in-part application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).

It’s important to note that while a CIP allows for the addition of new matter, any claims that rely on this new matter will only be entitled to the filing date of the CIP application, not the earlier filing date of the parent application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on filing requirements, visit: filing requirements.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

To file a continuation application, you must meet several requirements as outlined in MPEP 201.07:

  1. Timing: The continuation must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  2. Disclosure: The continuation must not include any new matter beyond what was disclosed in the parent application.
  3. Claim to Benefit: A specific reference to the prior application is required, typically in the first sentence of the specification.
  4. Inventor: At least one inventor named in the continuation must also be named in the prior application.
  5. Filing Requirements: The continuation must include:
    • A copy of the prior application as filed (unless already submitted via the USPTO electronic filing system)
    • Amendments to the specification (if any)
    • New claims (if any)
    • Oath or declaration

Additionally, the continuation application must satisfy all the requirements of 35 U.S.C. 112 for the claimed subject matter.

To learn more:

The filing date requirements for nonprovisional applications filed under 35 U.S.C. 111(a) have changed due to the Patent Law Treaties Implementation Act of 2012 (PLTIA). For applications filed on or after December 18, 2013:

  • Non-design applications no longer require at least one claim or any drawings to receive a filing date
  • Design patent applications still require at least one claim and any required drawings to receive a filing date

The MPEP states: Unless the application is for a design patent, nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013, are no longer required to include at least one claim or any drawings in order to receive a filing date for the application.

Additionally, applications may now be filed by reference to a previously filed application: A nonprovisional application filed under 35 U.S.C. 111(a) on or after December 18, 2013, may be filed by a reference to a previously filed application (foreign, international, provisional, or nonprovisional) indicating that the specification and any drawings of the application are replaced by the reference to the previously filed application.

For more information on filing date requirements, visit: filing date requirements.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent drawings, visit: patent drawings.

For more information on PLTIA, visit: PLTIA.

For nonprovisional applications filed on or after December 18, 2013, the filing date requirements have been simplified. The MPEP states: For applications filed on or after December 18, 2013, the filing date of a nonprovisional application filed under 35 U.S.C. 111(a), other than a design patent application, is the date on which a specification, with or without claims, is received in the Office. This means that utility and plant patent applications no longer require at least one claim or any drawings to receive a filing date. However, design patent applications still require at least one claim and any required drawings to receive a filing date.

To learn more:

What are the filing date requirements for a CPA?

The filing date requirements for a Continued Prosecution Application (CPA) are specific and must be adhered to. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is a paper filing, even though it may be submitted via EFS-Web.

Key points about CPA filing date requirements include:

  • The CPA must be filed before the payment of the issue fee for the prior application
  • It must be filed before abandonment of the prior application
  • The request for a CPA must be made on a separate paper
  • The filing date is based on when the CPA request is received, not when other application documents are submitted

It’s crucial to meet these requirements to ensure the CPA is properly filed and receives the correct filing date.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

To receive a filing date for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d), the following requirements must be met:

  • The application must be for a design patent;
  • The prior application must be a design application that is complete as defined by 37 CFR 1.51(b);
  • The application must be submitted before the payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted in the prior application;
  • The application must be filed within the period set forth in 37 CFR 1.53(d)(1)(ii); and
  • The application must be filed with a request for a CPA.

As stated in the MPEP: ‘A CPA may be filed under 37 CFR 1.53(d) only if the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).’

For more information on CPA, visit: CPA.

For more information on design patent, visit: design patent.

For more information on filing requirements, visit: filing requirements.

What are the filing date requirements for a Continued Prosecution Application (CPA)?

For a Continued Prosecution Application (CPA) to receive a filing date, it must meet specific requirements as outlined in MPEP 201.06(d):

  • The application must be for a design patent
  • The prior application must be a design application that is complete as defined by 37 CFR 1.51(b)
  • The application must be submitted before the payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted in the prior application
  • The application must be filed within the period set forth in 37 CFR 1.53(d)(1)(ii)

The MPEP states: ‘A CPA may be filed where the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).’ This ensures that the CPA is based on a properly filed and complete prior application.

To learn more:

While MPEP 203.06 mentions ‘essential parts’ without specifying them, other sections of the MPEP provide details on what constitutes a complete patent application. The essential parts typically include:

  • Specification (including a description of the invention)
  • At least one claim
  • Drawings (when necessary to understand the invention)
  • Filing fees
  • Inventor’s oath or declaration

The specific requirements may vary depending on the type of patent application (e.g., utility, design, or plant patent). It’s crucial to consult the relevant MPEP sections, such as MPEP 601, for detailed information on application requirements.

To learn more:

According to MPEP 203.05, a patent application can become abandoned in several ways:

  • Through formal abandonment by the applicant or their attorney/agent
  • Failure to take appropriate action during prosecution
  • Failure to pay the issue fee
  • For provisional applications, not filing a nonprovisional application within 12 months

The MPEP states: “An abandoned application is, inter alia, one which is removed from the Office docket of pending applications” due to these reasons.

To learn more:

According to MPEP 201.02, there are several types of patent applications:

  • National applications
  • Provisional applications
  • Nonprovisional applications
  • International applications
  • International design applications

The definitions for these terms can be found in 37 CFR 1.9. Additionally, applications can be classified as ‘original’ or ‘continuing’ applications. An original application may be a first filing or a continuing application, while a continuing application can be a continuation, divisional, or continuation-in-part application.

For more information on continuing applications, visit: continuing applications.

For more information on international applications, visit: international applications.

For more information on international design applications, visit: international design applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent applications, visit: patent applications.

The United States Patent and Trademark Office (USPTO) recognizes several types of patent applications. According to MPEP 201, these include:

  • Nonprovisional applications for patent, including utility, design, and plant patent applications
  • Provisional applications for patent
  • International applications filed under the Patent Cooperation Treaty (PCT)
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

Each type of application serves a specific purpose in the patent process and has its own requirements and procedures.

For more information on divisional, visit: divisional.

For more information on patent applications, visit: patent applications.

For more information on reissue, visit: reissue.

For more information on USPTO, visit: USPTO.

According to MPEP 201.01, there are three main types of national applications in U.S. patent law:

  • Original applications: These include both provisional and nonprovisional applications.
  • Reissue applications: Filed to correct an error in an already issued patent.
  • Reexamination applications: Used to request a review of an existing patent.

The MPEP states: National applications include original (nonprovisional and provisional), reissue, and reexamination applications. Each type serves a specific purpose in the patent application process.

For more information on reissue applications, visit: reissue applications.

What are the differences between recognized countries and regional patent offices for foreign filing?

Recognized countries and regional patent offices both play important roles in foreign patent filing, but they have distinct characteristics. According to MPEP 213.01:

A ‘recognized’ country is one that meets the conditions of 35 U.S.C. 119(a)-(d), which include extending similar patent filing rights to U.S. citizens. Regional patent offices are intergovernmental organizations that have been authorized to receive and process patent applications on behalf of multiple member countries.

Key differences include:

  • Jurisdiction: Recognized countries operate within their national borders, while regional offices cover multiple countries.
  • Application Process: Filing with a recognized country results in a national patent, whereas regional office filings can lead to patents enforceable in multiple member states.
  • Legal Framework: Recognized countries follow their national patent laws, while regional offices operate under a harmonized system agreed upon by member states.

Examples of regional patent offices include the European Patent Office (EPO) and the African Regional Intellectual Property Organization (ARIPO).

To learn more:

Failing to file a 37 CFR 1.48 request when adding a new inventor to a Continued Prosecution Application (CPA) can have significant consequences.

MPEP ¶ 2.33 states: “Otherwise, the inventorship in the CPA shall be the same as in the prior application.” This means that without a proper 37 CFR 1.48 request:

  • The new inventor will not be officially recognized on the application.
  • The inventorship will remain unchanged from the prior application.
  • This discrepancy could potentially affect the validity of the patent if granted.
  • It may lead to complications in future patent proceedings or enforcement efforts.

It’s crucial to follow proper procedures to ensure all inventors are correctly listed and legally recognized on the patent application.

For more information on CPA, visit: CPA.

For more information on patent validity, visit: patent validity.

What are the consequences of not converting a provisional application within 12 months?

If you do not convert a provisional application to a nonprovisional application within 12 months, there are significant consequences:

  • The provisional application will automatically expire.
  • You will lose the benefit of the provisional filing date.
  • The subject matter disclosed in the provisional may become prior art against future applications.

According to MPEP 201.04: “A provisional application will automatically become abandoned 12 months after its filing date pursuant to 35 U.S.C. 111(b)(5).” This means that after 12 months, if no corresponding nonprovisional application has been filed, the provisional application cannot be revived or extended. It’s crucial to file a nonprovisional application or a PCT application within this 12-month period to maintain the benefit of the provisional filing date.

To learn more:

Improperly identifying a foreign priority application can have serious consequences for a patent applicant. According to MPEP 214.04:

‘Where the claim to priority in an application filed under 35 U.S.C. 111(a) is presented after the time period provided by 37 CFR 1.55(d) and without the required petition, or where the claim to priority is presented in a nonprovisional application filed under 35 U.S.C. 111(a) that was filed on or after March 16, 2013, and also claims the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) of a prior application that was filed prior to March 16, 2013, the examiner should reject under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, any claims which are directed to subject matter that is not supported by the foreign application.’

Consequences may include:

  • Rejection of claims under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph
  • Loss of priority date for unsupported subject matter
  • Potential issues with patentability due to intervening prior art

It’s crucial to accurately identify and properly claim foreign priority to avoid these issues.

To learn more:

Failing to meet the disclosure requirements when claiming benefit of an earlier application can have several consequences:

  • Loss of earlier filing date for affected claims
  • Potential invalidity of the patent if issued
  • Exposure to prior art that would have been otherwise excluded
  • Possible rejection under 35 U.S.C. 102 or 103

The MPEP 211.05 provides an example of such consequences:

“In New Railhead, the patented drill bit was the subject of a commercial offer for sale. A provisional application was filed after the sale offer, but well within the one year grace period of 35 U.S.C. 102(b). A nonprovisional application, which issued as Patent No. 5,899,283, was filed within one year of the filing of the provisional application but more than one year after the sale offer. If the ‘283 patent was not afforded the benefit date of the provisional application, the patent would be invalid under 35 U.S.C. 102(b) since it was filed more than one year after the commercial offer for sale.”

This example illustrates how failing to meet disclosure requirements can lead to patent invalidity due to intervening prior art. It’s crucial for applicants to ensure that earlier-filed applications provide adequate support for later-claimed inventions to maintain the desired priority date and avoid potential rejections or invalidations.

To learn more:

The right of priority under 35 U.S.C. 386(a) or (b) for international design applications is subject to specific conditions:

  • It applies only to nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing from them.
  • For nonprovisional applications, priority can be claimed with respect to a prior international design application that designates at least one country other than the United States.
  • For international design applications designating the United States, priority can be claimed with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: The right of priority under 35 U.S.C. 386(a) or (b) with respect to an international design application is applicable only to nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

To learn more:

To learn more:

A later-filed application for patent in the United States may claim the benefit of, or priority to, a prior application under certain conditions. These conditions are outlined in various U.S. statutes and regulations:

The specific requirements and time frames may vary based on the filing date of the later-filed nonprovisional application and the type of priority or benefit claim being made.

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

For more information on prior-filed application, visit: prior-filed application.

When filing a Continued Prosecution Application (CPA), there are specific conditions under which the prior application may be automatically abandoned. According to MPEP 201.06(d):

A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA. See 37 CFR 1.53(d)(2)(v).

However, it’s important to note that:

  • The prior application is only expressly abandoned if the CPA is properly filed.
  • If the CPA is improper (e.g., filed in a utility application), the express abandonment of the prior application will not be effective.
  • The abandonment of the prior application is automatic upon the filing date of the properly filed CPA.

This automatic abandonment provision ensures a clear transition from the prior application to the CPA, which is particularly relevant for design applications where CPAs are permitted.

For more information on CPA, visit: CPA.

Tags: CPA

The abandonment of an international application in the United States is governed by specific legal provisions. According to MPEP 211.01(c), which cites 35 U.S.C. 371(d):

35 U.S.C. 371(d) indicates that failure to timely comply with the requirements of 35 U.S.C. 371(c) ‘shall be regarded as abandonment of the application by the parties thereof.’

This means that an international application designating the United States will be considered abandoned if the applicant fails to meet the requirements for entering the national stage under 35 U.S.C. 371(c) within the specified time limits. These requirements typically include submitting necessary documents, paying required fees, and providing an English translation of the application if it was not originally filed in English.

For more information on national stage entry, visit: national stage entry.

For a national application to claim the benefit of a prior international application designating the United States, certain conditions must be met. MPEP 211.01(c) outlines these conditions, referencing 35 U.S.C. 365(c) and 35 U.S.C. 120:

The first sentence of 35 U.S.C. 365(c) specifically provides that ‘[i]n accordance with the conditions and requirements of section 120,… a national application shall be entitled to the benefit of the filing date of a prior international application designating the United States.’

The key conditions include:

  • The international application must designate the United States
  • The national application must be filed before the patenting, abandonment, or termination of proceedings on the international application
  • The national application must contain a specific reference to the international application
  • The international application must comply with the requirements of 35 U.S.C. 371(c)

Additionally, the MPEP states:

The condition of 35 U.S.C. 120 relating to the time of filing requires the later application to be ‘filed before the patenting or abandonment of or termination of proceedings on the first application….’

Meeting these conditions allows applicants to claim the earlier filing date of the international application, which can be crucial for establishing priority and overcoming prior art references.

To learn more:

To learn more:

The MPEP outlines several reasons why an amendment might not comply with 37 CFR 1.57(b). These include:

  • The application was filed before September 21, 2004 (the effective date of the provisions)
  • The claim for priority/benefit of the prior-filed application was not present on the filing date
  • The omitted portion is not completely contained in the prior-filed application
  • A copy of the prior-filed application was not submitted (except for applications filed under 35 U.S.C. 111)
  • An English language translation of a non-English prior-filed application was not submitted
  • The applicant did not identify where the omitted portion can be found in the prior-filed application

If any of these conditions are not met, the examiner will state that the amendment to add inadvertently omitted material pursuant to 37 CFR 1.57(b) filed [date] is not in compliance with 37 CFR 1.57(b) because [specific reason].

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

Filing a CPA for a design patent application offers several benefits:

  • Minimal filing requirements compared to a regular continuation application
  • No new filing receipt is normally issued
  • Faster processing time, as it uses the same application number and file wrapper
  • For examination priority, CPAs are treated as “amended” applications rather than “new” applications, potentially resulting in faster examination
  • The prior application is automatically abandoned, simplifying the process

As stated in the MPEP: “A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).”

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

Filing a continuation application offers several benefits to patent applicants:

  1. Pursuing additional claims: As stated in MPEP 201.07, “The disclosure presented in the continuation must be the same as that of the original application; i.e., the continuation should not include anything which would constitute new matter if inserted in the original application.” This allows applicants to pursue different or broader claims based on the same disclosure.
  2. Extending prosecution: A continuation application provides more time to negotiate with the USPTO, potentially leading to stronger patent protection.
  3. Maintaining pendency: It keeps the application pending, which can be strategically important in fast-evolving technologies or competitive markets.
  4. Addressing new prior art: If new prior art emerges during the prosecution of the parent application, a continuation allows for claim adjustments to overcome this art.
  5. Commercial considerations: As products evolve or market conditions change, continuation applications allow for tailoring claims to cover new aspects of the invention or competitor products.

By utilizing continuation applications strategically, inventors and businesses can build a stronger patent portfolio and maintain flexibility in their intellectual property protection strategy.

For more information on patent strategy, visit: patent strategy.

Filing a provisional patent application offers several benefits but also has limitations:

Benefits:

  • Establishes an early filing date quickly and inexpensively
  • Allows use of ‘Patent Pending’ for up to 12 months
  • Provides time to assess commercial potential before filing a nonprovisional application
  • Does not require claims or an oath/declaration

Limitations:

  • Limited 12-month pendency
  • Cannot directly mature into a patent
  • Not examined for patentability
  • Cannot claim priority to any earlier applications

The MPEP notes: A provisional application is not entitled to the right of priority of any other application under 35 U.S.C. 119 or 365(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121 or 365(c) or § 1.78 of any other application.

Additionally, No claim for priority under 35 U.S.C. 119(e) or § 1.78(a)(4) may be made in a design application based on a provisional application. This limits the use of provisional applications in certain contexts.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

Filing a continuation-in-part (CIP) application has several benefits and potential drawbacks:

Benefits:

  • Allows addition of new subject matter to an existing invention
  • Maintains the priority date of the original application for common subject matter
  • Provides an opportunity to strengthen the patent application with new data or improvements
  • Allows for changes in inventorship to reflect new contributions

Drawbacks:

  • New subject matter only gets the filing date of the CIP, potentially exposing it to more prior art
  • Can complicate the patent term calculation
  • May result in multiple patents with overlapping subject matter, requiring terminal disclaimers
  • Increases overall costs due to additional filing and prosecution fees

The MPEP notes: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

Inventors and patent attorneys should carefully consider these factors when deciding whether to file a CIP or a new application.

For more information on new subject matter, visit: new subject matter.

For more information on patent strategy, visit: patent strategy.

The USPTO provides several methods for checking application status:

  • Patent Application Information Retrieval (PAIR) system: This is the primary method for checking application status online.
  • Automated voice response system: Available at 703-308-4357 for limited status information.
  • USPTO Contact Center: Available for general information at 800-786-9199.

As stated in MPEP 203.08: “Inquiries as to the status of applications, by persons entitled to the information, should be answered promptly. It is forbidden, however, to give information concerning the date of filing applications, the names of the inventors, or the prosecution of the application to persons not entitled to receive information.”

To learn more:

Tags: USPTO

Filing a provisional patent application offers several advantages, as outlined in the MPEP:

  1. Establishing Priority: It allows applicants to quickly and inexpensively file provisional applications and establish a priority date for their invention.
  2. Paris Convention Priority: It starts the Paris Convention priority year, allowing foreign filings within 12 months while maintaining the U.S. filing date.
  3. Simplified Filing: As stated in the MPEP, No claim is required in a provisional application and No oath or declaration is required in a provisional application.
  4. Patent Term: The MPEP notes, The domestic priority period will not count in the measurement of the 20-year patent term. This puts domestic applicants… on equal footing with foreign applicants with respect to the patent term.
  5. Time for Development: It provides a 12-month period to further develop the invention before filing a nonprovisional application.

These advantages make provisional applications a useful tool for inventors to secure an early filing date while allowing time for further development and market assessment.

For more information on patent strategy, visit: patent strategy.

For more information on patent term, visit: patent term.

For more information on provisional application, visit: provisional application.

Filing a Continued Prosecution Application (CPA) for design patents has several advantages over filing a regular continuation application under 37 CFR 1.53(b):

  • Minimal filing requirements – only a request on a separate paper and the filing fee are needed
  • No new oath or declaration is required
  • Faster processing – the CPA uses the file and contents of the prior application
  • Potentially faster examination – CPAs are often treated as “amended” applications for examination priority
  • No need for a new specification or drawings

The MPEP notes: “A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).”

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

Reissue applications are used to correct errors in already issued patents. According to MPEP 201:

‘An application for reissue is made by the patentee when the patent is, through error without any deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent.’

Key points about reissue applications:

  • They are filed under 35 U.S.C. 251.
  • They can be used to broaden or narrow the scope of patent claims.
  • There are time limitations for broadening reissues (within two years from the grant of the original patent).

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue application, visit: reissue application.

MPEP 201.01 briefly mentions reissue applications as one of the types of national applications. Specifically, it states:

‘National applications include original applications and reissue applications (filed under 35 U.S.C. 251).’

Reissue applications are a specialized type of patent application used to correct errors in an already issued patent. They are governed by 35 U.S.C. 251, which allows a patentee to apply for a reissue of their patent if it is deemed to be wholly or partly inoperative or invalid due to certain types of errors.

For more detailed information on reissue applications, refer to MPEP 1400 – Correction of Patents.

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue applications, visit: reissue applications.

Provisional applications are a type of patent application that allows inventors to establish an early filing date without the formal requirements of a non-provisional application. According to MPEP 201:

‘A provisional application is a U.S. national application for patent filed in the USPTO under 35 U.S.C. 111(b).’

Key differences between provisional and non-provisional applications:

  • Provisional applications have a simplified filing process and lower fees.
  • They do not require formal patent claims or an oath or declaration.
  • Provisional applications are not examined and automatically expire after 12 months.
  • To obtain patent protection, a non-provisional application claiming benefit of the provisional must be filed within 12 months.

Non-provisional applications, on the other hand, are formal patent applications that are examined by the USPTO and can result in an issued patent if approved.

For more information on Non-provisional application, visit: Non-provisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

International applications under the Patent Cooperation Treaty (PCT) are a type of patent application that provides a unified procedure for filing patent applications in its contracting states. According to MPEP 201:

‘An international application is a national application for patent which is filed under the Patent Cooperation Treaty (PCT).’

Key aspects of PCT applications:

  • Allow seeking patent protection in multiple countries simultaneously
  • Provide a streamlined filing process for international patent protection
  • Include an international search and optional international preliminary examination
  • Must enter the national phase in desired countries within specified timeframes
  • Do not result in an ‘international patent’ but facilitate national/regional patent grants

PCT applications are particularly useful for inventors seeking broad international patent protection.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For delayed priority claims filed more than two years after the due date, additional explanation is required. The MPEP states:

“A person filing a petition to accept a delayed priority claim more than two years after the date the foreign priority claim was due is required to provide additional explanation of the circumstances surrounding the delay that establishes that the entire delay was unintentional. This requirement is in addition to the requirement to provide a statement that the entire delay was unintentional in 37 CFR 1.55(e).”

This additional explanation helps the USPTO determine if the delay was truly unintentional, as required for acceptance of the delayed claim. Applicants should be prepared to provide a detailed account of the circumstances leading to the delay.

To learn more:

After receiving a MPEP ¶ 2.05 notification, an applicant should take the following actions:

  1. Review the notification carefully: Understand the examiner’s assessment that the application may constitute a continuation or division.
  2. Verify the information: Confirm that the prior application number and filing date mentioned in the notification are correct.
  3. Assess the application’s status: Determine if the application should indeed be treated as a continuation, division, or both.
  4. File appropriate documents: If the application is intended to be a continuation or division, ensure that all necessary documents, such as a reference to the prior application under 35 U.S.C. 120, 121, or 365(c), are properly filed.
  5. Respond to the examiner: Provide any necessary clarifications or corrections regarding the application’s status.

The MPEP ¶ 2.05 notification states: “Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.” (MPEP ¶ 2.05)

It’s crucial to follow these steps promptly to ensure proper processing of the application and to secure any potential benefits of the earlier filing date.

For more information on applicant actions, visit: applicant actions.

For more information on continuation application, visit: continuation application.

When a patent application is ‘rejected’, the applicant has several options:

  1. Respond to the examiner’s action within the allotted reply period
  2. Request an interview with the examiner to discuss the rejection
  3. File an amendment to address the examiner’s concerns
  4. Present arguments challenging the rejection
  5. Allow the application to become abandoned if they choose not to pursue it further

According to MPEP 203.02:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

The most crucial action is to respond within the specified timeframe to prevent the application from becoming abandoned.

To learn more:

According to MPEP 203.03, an applicant has several options when responding to an examiner’s action:

The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

These options can be broken down as follows:

  • Election: Choosing between different inventions or species identified by the examiner.
  • Traverse: Arguing against the examiner’s rejections or objections.
  • Amendment: Modifying the application to address the examiner’s concerns or to clarify the invention.

To learn more:

If a benefit claim is improper due to lack of copendency, the MPEP ¶ 2.11 outlines the required action:

Applicant is required to delete the claim to the benefit of the prior-filed application, unless applicant can establish copendency between the applications.

This means the applicant has two options:

  1. Delete the benefit claim to the prior-filed application, or
  2. Provide evidence to establish that copendency actually exists between the applications.

If the applicant cannot prove copendency, they must remove the benefit claim to avoid potential issues with the application’s validity or examination process.

For more information on copendency, visit: copendency.

For more information on patent procedure, visit: patent procedure.

When the required documents for a non-English provisional application are missing, the USPTO takes specific actions to notify the applicant. According to MPEP ¶ 2.38:

“Use this form paragraph to notify applicant that an English translation of the non-English language provisional application and/or a statement that the translation is accurate is required.”

The USPTO will issue an Office action informing the applicant of the missing documents and setting a time period for their submission. The applicant must then provide the missing translation and/or accuracy statement in the provisional application and confirm their filing in the present application. Failure to do so within the specified time period may result in the abandonment of the present application.

For more information on missing documents, visit: missing documents.

For more information on patent procedure, visit: patent procedure.

All relevant information from MPEP ¶ 2.33 New Inventor Identified in CPA (for Design Applications) has been covered in the previous FAQs. No additional meaningful questions can be generated without redundancy.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

Yes, there is an exception for certain applications filed before November 25, 2005. According to the Examiner Note in MPEP ¶ 2.38:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This means that for non-provisional applications filed before November 25, 2005, it was acceptable to file the English translation and accuracy statement in the non-provisional application itself, rather than in the provisional application. For applications filed after this date, the current rules requiring filing in the provisional application apply.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

Yes, there is a time limit for submitting priority documents in a U.S. patent application. The MPEP 215.02(a) states:

“[T]he time period set forth in 37 CFR 1.55(f) for filing a certified copy of the foreign application is satisfied if the USPTO retrieves a copy of the priority document within the pendency of the application and before the patent is granted.”

This means that the priority document must be available to the USPTO before the patent is granted. However, it’s important to note that the specific time limit can vary depending on the type of application and other factors outlined in 37 CFR 1.55(f).

To learn more:

Tags: time limit

Yes, there is a time limit for filing a petition to restore the benefit of a provisional application. According to MPEP 211:

“Applicant may wish to file a petition to restore the benefit of the provisional application under 37 CFR 1.78 in the subsequent nonprovisional application or international application designating the United States if the subsequent application was filed within two months from the expiration of the twelve-month period and the delay was unintentional.”

This means you have a two-month grace period after the expiration of the initial 12-month period to file the petition. It’s crucial to act quickly if you miss the original deadline and wish to restore the benefit of your provisional application.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

Yes, there is a deadline for filing the English translation and accuracy statement for a non-English provisional application. While MPEP ¶ 2.38 doesn’t specify an exact timeframe, it indicates that the USPTO will set a time period in an Office action:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This means that when the USPTO notices that the required documents are missing, they will issue an Office action with a specific deadline. It’s crucial to comply with this deadline to avoid abandonment of your application. As a best practice, it’s advisable to file these documents as soon as possible after filing the non-English provisional application to avoid any potential issues.

For more information on patent procedure, visit: patent procedure.

No, an English translation of a non-English language foreign application is not always required. According to 37 CFR 1.55(g)(3), an English language translation is only required in specific circumstances:

An English language translation of a non-English language foreign application is not required except: (i) When the application is involved in an interference (see § 41.202 of this chapter) or derivation (see part 42 of this chapter) proceeding; (ii) When necessary to overcome the date of a reference relied upon by the examiner; or (iii) When specifically required by the examiner.

If a translation is required, it must be filed together with a statement that the translation of the certified copy is accurate.

To learn more:

No, a Request for Continued Examination (RCE) is not considered a new application. The MPEP 203.01 clarifies this point:

Note that a request for continued examination (RCE)(see 37 CFR 1.114) is not a type of new application filing.

An RCE is a way to continue prosecution of an existing application after a final rejection, rather than starting a new application. For more details on RCEs, refer to MPEP § 706.07(h).

To learn more:

How to retrieve a foreign priority document through PDX?

To retrieve a foreign priority document through PDX (Priority Document Exchange), follow these steps:

  1. Ensure the foreign office participates in PDX or WIPO DAS.
  2. File an application with the USPTO claiming foreign priority.
  3. Submit a request to retrieve the priority document using USPTO form PTO/SB/38 or through EFS-Web.
  4. Provide the necessary information, including the foreign application number and filing date.
  5. If using WIPO DAS, include the DAS access code provided by the foreign office.

According to MPEP 215.01: Applicants need not submit a copy of the foreign application if the foreign application was filed in a participating foreign intellectual property office, and the applicant provides sufficient information to the USPTO to retrieve the priority document.

To learn more:

USPTO staff should follow specific procedures when handling correspondence from Executive departments and agencies. According to MPEP 203.08(a):

Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs.

Staff should immediately transmit such correspondence to the appropriate office and notify them by phone to ensure prompt and proper handling.

To learn more:

Tags: USPTO

USPTO personnel are instructed to handle status inquiries about patent applications promptly and professionally. According to MPEP 203.08:

“Inquiries as to the status of applications, by persons entitled to the information, should be answered promptly. The examiner, correspondent, or other appropriate personnel should provide the information requested within the following time periods: (A) For information obtainable from PALM, within one business day. (B) For information not obtainable from PALM, within five business days unless such information is not readily available, in which case a date by which an answer will be provided should be given.”

Personnel should verify the inquirer’s right to receive information and provide appropriate status updates without disclosing confidential information to unauthorized parties.

To learn more:

The method for making a specific reference to a prior-filed application depends on when the application was filed:

  • For applications filed before September 16, 2012: The specific reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS) in compliance with pre-AIA 37 CFR 1.76.
  • For applications filed on or after September 16, 2012: The specific reference must be included in an ADS in compliance with 37 CFR 1.76.

Additionally, for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

It’s important to note that for continued prosecution applications (CPAs) filed under 37 CFR 1.53(d) (design applications under 35 U.S.C. chapter 16 only), a specific reference in the specification or ADS is not required and may not be made. For these applications, The specific reference requirement of 35 U.S.C. 120 is met by the transmittal request for the CPA which is considered to be part of the CPA.

For more information on application data sheet, visit: application data sheet.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on specific reference, visit: specific reference.

How should the foreign priority application number be formatted in an ADS?

When entering the foreign priority application number in an Application Data Sheet (ADS), it’s crucial to follow the proper format to ensure accurate identification. The MPEP states:

“The foreign application number should be identified in an application data sheet (ADS), rather than in a separate paper.” (MPEP 214.04)

The ADS should include:

  • The correct application number
  • The country or intellectual property authority where the application was filed
  • The filing date of the priority application

It’s important to use the exact format as it appears on the foreign priority document to avoid any discrepancies or potential issues with the priority claim.

To learn more:

To ensure proper processing of priority papers, the MPEP recommends marking them with specific information. According to MPEP 215.03:

It is suggested that a notation of the application number of the corresponding U.S. application be placed on the priority papers when such papers are not submitted via a priority document exchange program. Such notation should be placed directly on the priority papers themselves even where a cover letter is attached bearing the U.S. application data.

This practice helps prevent priority papers from becoming separated from their corresponding U.S. applications, which can cause severe problems for both the Office and the applicant. By adhering to this suggestion, applicants can significantly reduce potential issues in processing priority claims.

To learn more:

Foreign priority claims in patent applications should be formatted according to specific guidelines outlined in MPEP 214.04. The claim should include:

  • The application number of the foreign application
  • The country or intellectual property authority where the application was filed
  • The day, month, and year of filing

The MPEP states: ‘When the claim to priority concerns an application filed in a foreign country, the claim must identify the foreign country or intellectual property authority where the application was filed.’ This ensures proper identification and processing of the priority claim.

To learn more:

To learn more:

To properly identify foreign priority applications in a patent application, applicants should follow the guidelines provided by the World Intellectual Property Organization (WIPO). The MPEP states:

To ensure an accurate and complete citation of a foreign priority application, applicants should review the list of the various intellectual property offices and the recommended presentation of a foreign application number for each, which can be found in the tables of the online WIPO Handbook on Industrial Property Information and Documentation

Specifically, applicants should refer to:

  • Part 7: Examples and Industrial Property Offices Practices
  • Part 7.2.1: Presentation of Application Numbers

These resources provide the recommended format for citing foreign application numbers, ensuring accurate and complete relationships among patent documents.

To learn more:

How should applicants submit written status inquiries to the USPTO?

When submitting written status inquiries to the USPTO, applicants should follow these guidelines:

  • Include the application serial number, filing date, and art unit (if known).
  • Provide a specific description of the precise information requested.
  • Include any necessary authorization for release of information.
  • Submit the inquiry to the appropriate USPTO office or Technology Center.

MPEP 203.08 advises: ‘Written status requests will be answered in all cases.’ However, it also notes that ‘Telephone inquiries regarding the status of applications, other than those in secrecy order and those under 35 U.S.C. 181, may be made by persons entitled to the information, to the appropriate USPTO staff member.’

To learn more:

For status inquiries regarding PCT applications, the MPEP provides specific guidance:

  • Inquiries relating to international applications filed under the Patent Cooperation Treaty (PCT) should be directed to the PCT Help Desk.
  • The MPEP states: Inquiries relating to international applications (PCT) … should be directed to the PCT Help Desk at 1-800-PTO-9199 or 571-272-4300.
  • The PCT Help Desk can provide information on the processing of international applications at the United States Receiving Office (RO/US), United States International Searching Authority (ISA/US), and United States International Preliminary Examining Authority (IPEA/US).

It’s important to use the correct channel for PCT-related inquiries to ensure accurate and timely information.

To learn more:

Submitting an interim copy of a foreign application electronically involves specific procedures. The MPEP provides guidance:

‘If not provided as a single paper document, the main parts of the interim copy of the foreign priority application, i.e., Abstract, Drawings, Specification, Claims, and where applicable, the foreign patent office’s equivalent to a “Sequence Listing” (see MPEP § 2421.01), a “Sequence Listing XML” (see MPEP § 2412), “Large Tables” (see MPEP § 608.05(b)), or a “Computer Program Listing Appendix” (see MPEP § 608.05(a)), along with the separate cover sheet required by 37 CFR 1.55(j), may be filed as a single PDF image file via the USPTO patent electronic filing system.’

Key points for electronic submission:

  • File as a single PDF image file when possible
  • Use the document description ‘Interim Copy of the Foreign Priority Application’ when indexing
  • For plain text files, use the description ‘Interim Copy of the Foreign Priority (text file)’
  • XML files, like Standard ST.26 Sequence Listings, should be filed on a read-only optical disc

Proper indexing and file format selection are crucial for successful electronic submission.

For more information on electronic submission, visit: electronic submission.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

The formatting of a reference to a prior application in the specification is crucial for proper processing. According to MPEP 211.02:

The reference to the prior application must include the following terms: ‘This application is a continuation (or division, or continuation-in-part, as appropriate) of Application No. _____, filed _____.’

Additionally, the MPEP provides guidance on including multiple prior application references:

Where the reference to a prior nonprovisional application only includes the attorney docket number, application number (series code and serial number), and filing date, in the first sentence(s) of the specification of the later filed application, OPAP will mail a ‘Notice to File Missing Parts’ indicating that a complete reference to the prior application(s) is required.

It’s important to ensure that all necessary information is included in the reference to avoid processing delays. The reference should clearly state the relationship between the applications (continuation, division, or continuation-in-part), provide the application number, and include the filing date of the prior application.

To learn more:

The proper submission of a benefit claim depends on the filing date of the application:

  • For applications filed on or after September 16, 2012: The benefit claim must be included in an Application Data Sheet (ADS) in compliance with 37 CFR 1.76.
  • For applications filed before September 16, 2012: The benefit claim can be submitted either by an amendment to the first sentence(s) of the specification or in an ADS in compliance with pre-AIA 37 CFR 1.76.

The MPEP states: Applicant must still submit the benefit claim in the manner specified in 37 CFR 1.78 (i.e., in an ADS in compliance with 37 CFR 1.76 (or for applications filed prior to September 16, 2012 by an amendment to the first sentence(s) of the specification or in an ADS in compliance with pre-AIA 37 CFR 1.76) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the benefit of a prior application.

To learn more:

To learn more:

The method for including a benefit claim in a patent application depends on the filing date:

  • For applications filed before September 16, 2012: The reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS).
  • For applications filed on or after September 16, 2012: The specific reference must be included in an application data sheet (ADS).

The MPEP states: “If the application was filed before September 16, 2012, the reference must be included in the first sentence(s) of the specification following the title or in an application data sheet; if the application was filed on or after September 16, 2012, the specific reference must be included in an application data sheet.”

Additionally, for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on application data sheet, visit: application data sheet.

For amended applications, it’s generally advised to wait before making a status inquiry. According to MPEP 203.08:

Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office.

However, if six months have passed without a response, it’s advisable to inquire about the application’s status to avoid potential abandonment. Applicants are encouraged to use Patent Center or Private PAIR for status inquiries.

For more information on amended application, visit: amended application.

For more information on Patent Center, visit: Patent Center.

For more information on Private PAIR, visit: Private PAIR.

For amended patent applications, the USPTO provides guidelines on when to inquire about the status. According to MPEP 203.08:

Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office.

If six months have passed without a response, you should inquire about the application’s status to avoid potential abandonment. It’s recommended to use Patent Center or Private PAIR for status inquiries.

For more information on amended application, visit: amended application.

A provisional patent application has a limited lifespan. According to MPEP 201.04:

“A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter. See 35 U.S.C. 111(b)(5).”

However, there is a provision for extending this period in certain circumstances:

“The period of pendency of a provisional application is extended to the next succeeding business day if the day that is 12 months after the filing date of a provisional application falls on a Saturday, Sunday, or federal holiday within the District of Columbia. See 35 U.S.C. 119(e)(3) and 37 CFR 1.7(b).”

It’s crucial to file a nonprovisional application claiming the benefit of the provisional application within this 12-month period to maintain the priority date.

For more information on patent validity, visit: patent validity.

For more information on provisional patent, visit: provisional patent.

For more information on USPTO, visit: USPTO.

A provisional patent application has a limited lifespan. According to MPEP 201.04:

“A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.”

This 12-month period provides inventors with a year of ‘patent pending’ status to further develop their invention, assess its commercial potential, or secure funding. To maintain patent rights, the inventor must file a corresponding nonprovisional application claiming the benefit of the provisional application within this 12-month window.

It’s important to note that the 12-month period may be extended to the next business day if it ends on a weekend or federal holiday in the District of Columbia.

To learn more:

Tags: USPTO

A patent application remains in ‘rejected’ status until one of two things happens:

  1. The applicant acts upon the examiner’s action within the allotted reply period, or
  2. The application becomes abandoned.

As stated in MPEP 203.02:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

The duration of ‘rejected’ status thus depends on the applicant’s timely response or the application’s abandonment.

To learn more:

According to MPEP 203.05, you have 12 months from the filing date of your provisional application to file a nonprovisional application. The MPEP states:

“in the case of a provisional application, no later than 12 months after the filing date of the provisional application”

If you don’t file a nonprovisional application within this timeframe, your provisional application will be considered abandoned. This 12-month period is set by 35 U.S.C. 111(b)(5).

To learn more:

The priority period for U.S. nonprovisional applications is calculated as follows:

  • The first day (filing date of the foreign application) is not counted.
  • The period ends on the same date of the following year (or six months later for design applications).
  • If the last day falls on a weekend or federal holiday, the period extends to the next business day.

The MPEP provides an example: If an application was filed in Canada on January 3, 1983, the U.S. nonprovisional application may be filed on January 3, 1984. (MPEP 213.03)

This calculation method is consistent with Article 4C(2) of the Paris Convention, which specifies that the day of filing is not counted in this period.

To learn more:

When foreign applications are properly claimed and verified in a patent application, this information is reflected in the issued patent and the Official Gazette listing. This helps establish the priority date and international scope of the invention.

The MPEP states: The front page of the patent when it is issued, and the listing in the Official Gazette, will refer to the claim of priority, giving the country, the filing date, and the number of the foreign application in those applications in which the bib-data sheet has been endorsed. (MPEP 202)

This means that for each properly claimed foreign application, the following information will be publicly available:

  • The country of filing
  • The filing date
  • The application number

It’s important to note that this information is only included for foreign applications that have been verified and endorsed on the bib-data sheet by the examiner. For more information on foreign priority claims, see MPEP § 213.

For more information on foreign applications, visit: foreign applications.

For more information on issued patent, visit: issued patent.

For more information on Official Gazette, visit: Official Gazette.

Filing a continuing application under 37 CFR 1.53(b) does not automatically abandon the prior nonprovisional application. The MPEP clarifies: Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application. If the prior nonprovisional application is to be expressly abandoned, such a paper must be signed in accordance with 37 CFR 1.138. However, there are special considerations if the prior application has a notice of allowance issued or is before the Patent Trial and Appeal Board. The MPEP further states: If the prior nonprovisional application which is to be expressly abandoned has a notice of allowance issued therein, the prior nonprovisional application can become abandoned by the nonpayment of the issue fee. It’s important to follow the proper procedures to ensure the desired outcome regarding the prior application’s status.

To learn more:

For continuing applications, small entity or micro entity status must be re-established. The MPEP states: If small entity status has been established in a parent application and is still proper and desired in a continuation, continuation-in-part, or divisional application filed under 37 CFR 1.53(b), a new assertion as to the continued entitlement to small entity status under 37 CFR 1.27 is required. For micro entity status, the MPEP further specifies: The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

To learn more:

Inventorship in a Continued Prosecution Application (CPA) is generally maintained from the prior application. However, if there’s a need to add or change inventors, specific procedures must be followed.

According to MPEP ¶ 2.33: “Any request to add an inventor must be in the form of a request under 37 CFR 1.48. Otherwise, the inventorship in the CPA shall be the same as in the prior application.”

This means that if you want to add or change inventors in a CPA, you must file a formal request under 37 CFR 1.48, which outlines the procedure for correction of inventorship in patent applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

When a claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but before the patent is granted, special procedures apply.

According to the MPEP: When the claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but prior to the date of grant of the patent, the foreign priority claim or certified copy will be placed in the file record but there may be no review of the papers and the patent when published will not include the priority claim.

To have the foreign priority claim or certified copy considered after publication of the patent:

  • A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 can be filed
  • For original applications under 35 U.S.C. 111(a) or national stage applications under 35 U.S.C. 371, a grantable petition to accept an unintentionally delayed claim for priority under 37 CFR 1.55 and the petition fee must be filed with the certificate of correction

For more information on this process, refer to MPEP § 216.01.

To learn more:

An international application is defined in 37 CFR 1.9(b). While the specific definition is not provided in the given MPEP excerpt, it generally refers to a patent application filed under the Patent Cooperation Treaty (PCT). International applications allow inventors to seek patent protection in multiple countries through a single filing process.

For more detailed information on international applications, you can refer to the full text of 37 CFR 1.9(b) and related sections of the MPEP.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For more information on patent law, visit: patent law.

An interim copy of a foreign application serves as a temporary substitute for a certified copy but does not replace the requirement for a certified copy. The key differences are:

  • An interim copy can be from the applicant’s own records, while a certified copy must be from the foreign patent office.
  • An interim copy satisfies the initial time requirement in 37 CFR 1.55(f), but a certified copy is still required.
  • An interim copy is labeled as ‘Interim Copy,’ while a certified copy has official certification from the foreign patent office.

The MPEP clarifies:

‘Thus, providing an interim copy of a foreign application under 37 CFR 1.55(j) satisfies the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f), but a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate.’

In essence, the interim copy is a temporary measure to meet deadlines, while the certified copy remains a formal requirement.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

According to MPEP ¶ 2.30, the applicant is typically notified that their CPA request has been accepted through the first Office action on the CPA. The MPEP states: “Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established.” This notification is important because, as the MPEP notes, “applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

Unlike regular patent applications, applicants are not typically notified when a Continued Prosecution Application (CPA) has been established. The MPEP ¶ 2.30 states: “This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

Instead, the first notification an applicant usually receives is in the first Office action of the CPA. The examiner will use specific language to advise the applicant that the CPA request was acceptable and has been established.

According to MPEP ¶ 2.35, the USPTO treats ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. The MPEP explicitly states:

Any ‘conditional’ request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.

This means that even if an applicant submits a CPA request with conditions attached, the USPTO will process it as a standard, unconditional CPA request. This policy ensures clarity and consistency in the application process.

For more information on CPA, visit: CPA.

For more information on USPTO procedures, visit: USPTO procedures.

The requirement for specific reference to prior applications has undergone changes due to recent legislation:

  1. For applications filed before September 16, 2012: The specific reference to the prior application must be in the first sentence(s) of the specification or in an application data sheet.
  2. For applications filed on or after September 16, 2012: The specific reference to the prior application must be in the application data sheet (ADS).

As stated in the MPEP: Thus for all applications filed on or after September 16, 2012, the specific reference to the prior application must be in the application data sheet; for applications filed prior to September 16, 2012, the specific reference to the prior application must be in an application data sheet or in the first sentence(s) of the specification. (MPEP 210)

This change was implemented as part of the inventor’s oath or declaration provisions of the Leahy-Smith America Invents Act, which became effective on September 16, 2012. The Office revised 37 CFR 1.78 to reflect these changes.

For more information on ADS, visit: ADS.

For more information on application data sheet, visit: application data sheet.

For more information on prior applications, visit: prior applications.

For more information on specific reference, visit: specific reference.

How does WTO membership affect foreign priority rights?

World Trade Organization (WTO) membership has significant implications for foreign priority rights in patent applications:

  • WTO member countries are treated as Paris Convention countries for priority purposes.
  • Applicants from WTO member countries can claim priority in the U.S., even if the country is not a Paris Convention signatory.
  • The same 12-month priority period applies to applications from WTO member countries.
  • WTO membership expands the pool of countries eligible for foreign priority claims.

MPEP 213.01 states: “A foreign application filed in a WTO member country on or after the date on which the country becomes a WTO member country is also entitled to the right of priority.” This provision ensures broader international protection opportunities for inventors and applicants.

The USPTO treats all ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. According to MPEP ¶ 2.35:

Any “conditional” request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.

This means that once a conditional CPA request is submitted, it will be processed as a standard CPA, regardless of the applicant’s original intent.

For more information on CPA, visit: CPA.

Tags: CPA

How does the USPTO retrieve priority documents through PDX?

The USPTO retrieves priority documents through the Priority Document Exchange (PDX) program upon request from the applicant. As stated in MPEP 215.02(a), ‘If the applicant requests retrieval of the priority document through the PDX program, the USPTO will attempt to retrieve the document.’ The process involves:

  • The applicant making a request for retrieval
  • The USPTO accessing the electronic system of the participating office
  • Retrieving the priority document if available
  • Adding the retrieved document to the application file

This streamlined process eliminates the need for applicants to manually obtain and submit priority documents from other participating patent offices.

To learn more:

The USPTO retrieves foreign priority documents through the priority document exchange program automatically when certain conditions are met. As stated in MPEP 215.02(a):

“The USPTO will attempt retrieval of the priority document through the priority document exchange program when the applicant has (1) requested retrieval via the Priority Document Exchange (PDX) program in an application data sheet and (2) provided a foreign application number and intellectual property office that participates in a priority document exchange agreement with the USPTO.”

This automated process helps streamline the priority document submission for applicants.

To learn more:

When a Continued Prosecution Application (CPA) request for a design patent is found to be non-compliant, the USPTO notifies the applicant using a specific form paragraph. This notification informs the applicant about the issue and provides necessary details.

According to the MPEP, the examiner uses the following format:

  • ‘Receipt is acknowledged of the request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on Application No. [2].’
  • ‘However, because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.’

In this notification, [1] represents the filing date of the paper containing the CPA request, and [2] is the Application Number identified in the CPA request. This clear communication helps applicants understand the issue and take corrective action.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

When the USPTO receives an unacceptable Continued Prosecution Application (CPA) request for a design patent application, they notify the applicant using a standardized form paragraph. According to MPEP ¶ 2.31, the examiner will use the following language:

Receipt is acknowledged of the request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on Application No. [2]. However, because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.

This notification informs the applicant that their CPA request has been received but not accepted due to non-compliance with the separate paper requirement. The examiner will insert the filing date of the CPA request and the application number in the appropriate brackets.

For more information on USPTO notification, visit: USPTO notification.

The USPTO handles unintentionally delayed domestic benefit claims similarly to foreign priority claims, but with some specific provisions. According to MPEP 214.02:

‘For applications filed on or after September 16, 2012, the specific reference to the prior application must be included in an application data sheet (37 CFR 1.76). For applications filed prior to September 16, 2012, the specific reference to the prior application must be in the first sentence(s) of the specification or in an application data sheet.’

For domestic benefit claims under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c), a petition to accept an unintentionally delayed claim must include:

  • The reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior-filed application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the benefit claim was filed was unintentional.

The Director may require additional information where there is a question whether the delay was unintentional.

To learn more:

How does the USPTO handle telephone inquiries about application status?

The USPTO has specific procedures for handling telephone inquiries about application status. According to MPEP 203.08:

“Telephone inquiries regarding the status of applications, other than those referred to in MPEP § 203.08(a), should be directed to the USPTO Contact Center (UCC).”

The UCC is equipped to handle general status inquiries, while more specific inquiries may be directed to the appropriate Technology Center or Patent Examining Group. This system ensures that inquiries are handled efficiently and by staff with the appropriate level of expertise.

To learn more:

How does the USPTO handle status inquiries for unpublished applications?

The USPTO has specific procedures for handling status inquiries for unpublished applications:

  • Status information is only provided to applicants, their attorneys or agents, or assignees of record.
  • Third parties cannot receive status information about unpublished applications.
  • The USPTO may confirm the filing date, application number, and whether the application is pending, abandoned, or patented.

As stated in MPEP 203.08, ‘For unpublished applications, the Office will not give status information to the public without the authorization of the applicant, attorney or agent of record or the assignee of record.’

To learn more:

How does the USPTO handle priority documents in national stage applications?

The USPTO handles priority documents in national stage applications (35 U.S.C. 371) as follows:

  • If the priority document is already in the international application file, no further action is needed.
  • The USPTO will retrieve the document from WIPO’s digital library (DAS) if it’s available there.
  • If not available through DAS, the applicant must submit the certified copy.

According to MPEP 213.06: ‘If the priority document is not in the international application file but was properly filed with the International Bureau during the international phase, the USPTO will retrieve from the International Bureau a copy of the certified copy of the priority document.’ This process simplifies the handling of priority documents for applicants entering the national stage.

To learn more:

To learn more:

The USPTO treats a proper priority claim to an application filed in a participating foreign intellectual property office as a request to obtain a copy of the foreign application. The MPEP states:

The Office treats a proper priority claim under 37 CFR 1.55 to an application filed in a participating foreign intellectual property office as a request that the Office obtain a copy of the foreign application from the participating intellectual property office.

This means that applicants do not need to submit a separate request for the USPTO to retrieve the foreign application if they have made a proper priority claim and the foreign office is a PDX participant.

The USPTO treats a proper priority claim to an application filed in a participating foreign intellectual property office as a request to obtain a copy of the foreign application. According to MPEP 215.01:

The Office treats a proper priority claim under 37 CFR 1.55 to an application filed in a participating foreign intellectual property office as a request that the Office obtain a copy of the foreign application from the participating intellectual property office.

This means that applicants generally do not need to file a separate request for the USPTO to retrieve the priority document if it’s from a participating office.

To learn more:

When the certified copy of the priority document is already in the International Bureau’s priority document database, the USPTO handles priority claims in national stage applications as follows:

  • The USPTO will attempt to retrieve the certified copy from the International Bureau’s priority document database.
  • If successful, no further action is required from the applicant regarding the submission of the certified copy.
  • According to MPEP 213.06, ‘In national stage applications, a claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.’
  • The USPTO will consider the priority claim to be compliant with the requirements of 37 CFR 1.55(f)(2) if the certified copy is timely retrieved from the International Bureau.

This process simplifies the priority claim procedure for applicants in national stage applications when the certified copy is already available through the International Bureau.

To learn more:

Tags: USPTO

The USPTO handles priority claims in international design applications as follows:

  • For international design applications designating the United States, the USPTO acts as an office of indirect filing.
  • Priority claims must be made in the international design application when filed with the International Bureau.
  • The USPTO will not transmit a priority claim made in a subsequently filed transmittal letter.
  • Applicants should review the international registration certificate to ensure their priority claims are properly recorded.

As stated in MPEP 213.07: The United States Patent and Trademark Office (USPTO), in its capacity as an office of indirect filing, will not transmit to the International Bureau a priority claim that is made in a subsequently filed transmittal letter and not in the international design application as filed with the International Bureau.

To learn more:

The USPTO recognizes that some countries have restrictions on who can apply for patents versus inventor’s certificates. As stated in MPEP 213.05:

It is recognized that certain countries that grant inventors’ certificates also provide by law that their own nationals who are employed in state enterprises may only receive inventors’ certificates and not patents on inventions made in connection with their employment. This will not impair their right to be granted priority in the United States based on the filing of the inventor’s certificate.

This means that even if an applicant was restricted to filing for an inventor’s certificate in their home country due to employment or nationality, they can still claim priority in the US based on that filing. The key factor is whether the option to file for either a patent or an inventor’s certificate generally existed in the country for the particular subject matter, not whether the specific applicant had that choice.

To learn more:

The USPTO’s handling of preliminary amendments in continuation applications depends on when the application was filed and the nature of the amendment:

  • For applications filed on or after September 21, 2004: A preliminary amendment that is present on the filing date of the application is considered part of the original disclosure.
  • All preliminary amendments: Must be filed in compliance with 37 CFR 1.121, which includes providing a complete claim listing whenever a claim is added, canceled, or amended.
  • Substitute specification: The Office may require a substitute specification for preliminary amendments.

The MPEP states:

Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

It’s important to note that the USPTO advises against filing a continuation application with a preliminary amendment that makes all desired changes. Instead, they recommend:

Filing a continuing application under 37 CFR 1.53(b) with a new specification containing only the desired set of claims.

This approach ensures that the published application contains the intended set of claims, rather than those from the prior application.

For more information on continuation application, visit: continuation application.

The USPTO has a specific procedure for handling inquiries from high-level government sources. According to MPEP 203.08(a):

Inquiries referred to in this section such as correspondence from Congress or the White House should immediately be transmitted to the Director of the Office of Governmental Affairs, and a staff member of that office should be notified by phone that such correspondence has been received at 571-272-7300.

This process ensures uniformity in handling these important inquiries and compliance with Department of Commerce directives.

To learn more:

Tags: USPTO

How does the USPTO handle certified copies for international design applications?

For international design applications, the USPTO has a specific process for handling certified copies. According to the MPEP:

‘For international design applications designating the United States, the certified copy requirement is considered to have been met by the filing of the international design application pursuant to 37 CFR 1.55(m).’

This means that if you file an international design application that designates the United States, you don’t need to separately submit a certified copy of the priority document. The filing of the international design application itself fulfills this requirement.

However, it’s important to note that this only applies to international design applications. For other types of patent applications claiming priority to a foreign application, you would still need to ensure that a certified copy is filed or retrievable through the priority document exchange program within the specified time period.

The United States Patent and Trademark Office (USPTO) treats all ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. This is clearly stated in MPEP ¶ 2.35:

“Any ‘conditional’ request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.”

This means that once a CPA request is filed, even if the applicant intended it to be conditional, the USPTO will process it as a regular CPA. The conditions specified by the applicant are essentially disregarded, and the CPA is established based on the filing of the request alone.

For more information on CPA, visit: CPA.

For more information on Patent Application Process, visit: Patent Application Process.

The USPTO determines eligible countries for priority claims based on international agreements and reciprocity. MPEP 213.01 states:

The right of priority is recognized only if the foreign application was filed in a country granting similar privileges to United States citizens.

This means the USPTO maintains a list of countries that have established reciprocal rights with the United States. These countries typically include Paris Convention members, PCT contracting states, and nations with bilateral agreements recognizing priority rights.

To learn more:

The USPTO generally does not make an upfront determination about whether an application qualifies as a continuation-in-part (CIP) unless it becomes necessary in a proceeding. According to the MPEP:

“The Office does not need to make a determination as to whether the requirement of 35 U.S.C. 120 that the earlier nonprovisional application discloses the invention of the second application in the manner provided by 35 U.S.C. 112(a) is met unless the filing date of the earlier nonprovisional application is relied upon in a proceeding before the Office.”

However, examiners may use form paragraph 2.06 to remind applicants of possible CIP status:

“This application repeats a substantial portion of prior Application No. [1], filed [2], and adds disclosure not presented in the prior application. Because this application names the inventor or at least one joint inventor named in the prior application, it may constitute a continuation-in-part of the prior application.”

Ultimately, it’s the applicant’s responsibility to properly claim CIP status and comply with the requirements of 35 U.S.C. 120 and 37 CFR 1.78.

For more information on patent examination, visit: patent examination.

The USPTO determines if a prior-filed application provides adequate support for a later-filed application by examining whether the prior-filed application discloses the invention claimed in the later-filed application in sufficient detail. According to MPEP 211.05:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, except for the best mode requirement.’

This means that the prior-filed application must provide a written description of the invention, enable one skilled in the art to make and use the invention, and disclose the best mode (if invented prior to the AIA) for carrying out the invention.

To learn more:

To learn more:

The USPTO determines if a patent application is incomplete by reviewing the submitted materials against the required components for a complete application. According to MPEP 203.06:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

The process typically involves:

  • Initial review by USPTO staff
  • Checking for presence of all required documents and fees
  • Verifying that the application meets minimum requirements for obtaining a filing date
  • Issuing a notice of missing parts if deficiencies are found

For detailed information on the requirements, refer to MPEP 506 and MPEP 601, which provide guidance on completeness criteria and filing procedures.

To learn more:

The USPTO determines if a foreign country qualifies for priority rights based on specific criteria outlined in the MPEP. According to MPEP 213.01:

The right of priority is recognized only if the foreign country in which the original application was filed is recognized at the time of filing the application in the United States.

The USPTO considers several factors:

  • The country must be a member of the Paris Convention for the Protection of Industrial Property or have a bilateral agreement with the United States.
  • The country must grant similar priority rights to U.S. citizens.
  • The country must be recognized by the U.S. Department of State.

The USPTO maintains a list of recognized countries and regional patent offices in MPEP 213.01, which is updated periodically to reflect changes in international relations and treaty memberships.

The USPTO evaluates whether a delay in claiming priority was unintentional based on the totality of the circumstances. According to MPEP 214.02:

The Director may require additional information where there is a question whether the delay was unintentional.

This means that the USPTO may request additional information from the applicant to determine if the delay was truly unintentional. The evaluation process typically involves:

  • Reviewing the explanation provided in the petition
  • Considering the length of the delay
  • Assessing any changes in ownership or responsibility for the application
  • Examining the circumstances surrounding the discovery of the need for a delayed priority claim

The USPTO applies a good faith standard, looking for evidence that the delay was not deliberate and that reasonable steps were taken to correct the issue once it was discovered. It’s important to provide a detailed and honest account of the circumstances leading to the delay when filing the petition.

To learn more:

How does the USPTO determine if a country is eligible for priority right benefits?

The USPTO determines a country’s eligibility for priority right benefits based on specific criteria. As stated in MPEP 213.01:

The United States will recognize claims for right of priority under 35 U.S.C. 119(a)-(d) based on applications filed in countries which have acceded to the Patent Cooperation Treaty (PCT) prior to becoming a Contracting State of that Treaty.

This means that countries that have joined the PCT are generally recognized for priority rights. Additionally, the USPTO considers other factors such as whether the country:

  • Extends similar privileges to U.S. citizens
  • Is a member of the World Trade Organization (WTO)
  • Has a bilateral agreement with the United States

The USPTO maintains a list of countries and organizations that meet these criteria, which is periodically updated to reflect changes in international agreements and relations.

To learn more:

The USPTO determines if a claim in a later-filed application is entitled to the benefit of an earlier filing date by evaluating whether:

  • The subject matter of the claim is disclosed in the earlier-filed application.
  • The disclosure in the earlier-filed application complies with the requirements of 35 U.S.C. 112(a), except for the best mode requirement.
  • The disclosure enables one skilled in the art to make and use the claimed invention without undue experimentation.

As stated in MPEP 211.05:

“A claim in the later-filed application is not entitled to the benefit of the filing date of the prior-filed application if the disclosure of the prior-filed application does not enable one skilled in the art to ‘use’ the claimed invention.”

If the earlier application fails to provide adequate support or enablement for a claim in the later-filed application, that claim will not be entitled to the earlier filing date. This assessment is made on a claim-by-claim basis, and different claims within the same application may have different effective filing dates.

To learn more:

The United States Patent and Trademark Office (USPTO) defines different types of patent applications in the Code of Federal Regulations (CFR) and the Manual of Patent Examining Procedure (MPEP). Specifically:

  • National application, Provisional application, and Nonprovisional application are defined in 37 CFR 1.9(a)
  • International application is defined in 37 CFR 1.9(b)
  • International design application is defined in 37 CFR 1.9(n)

These definitions provide the legal basis for understanding the different types of applications that can be filed with the USPTO. For more detailed explanations and context, refer to MPEP § 201, which provides comprehensive guidance on types and status of applications.

To learn more:

The term ‘international application’ is defined in 37 CFR 1.9(b). An international application typically refers to a patent application filed under the Patent Cooperation Treaty (PCT), which provides a unified procedure for filing patent applications to protect inventions in its contracting states.

Key points about international applications:

  • They are governed by the Patent Cooperation Treaty.
  • They can lead to national phase entries in multiple countries.
  • They provide a streamlined filing process for seeking patent protection internationally.
  • The specific definition in 37 CFR 1.9(b) should be consulted for precise legal terminology.

International applications are distinct from national applications and offer a pathway for inventors to seek protection in multiple countries through a single filing.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

How does the USPTO define ‘unintentional delay’ for priority claims?

The USPTO does not provide a specific definition of ‘unintentional delay’ in the context of priority claims. However, the interpretation is generally consistent with other areas of patent law where unintentional delay is considered.

According to MPEP 214.02: ‘The Director may require additional information where there is a question whether the delay was unintentional.’

This means that:

  • The delay must not have been deliberate or intentional.
  • The applicant must have taken reasonable care to meet the deadline but failed due to unforeseen circumstances.
  • Once the applicant became aware of the missed deadline, they must have acted promptly to file the petition.

It’s important to note that the USPTO may request additional information if there’s any doubt about the unintentional nature of the delay. Applicants should be prepared to provide a detailed explanation of the circumstances that led to the delay if requested.

To learn more:

The USPTO calculates the 12-month priority period for nonprovisional applications as follows:

  • Start date: The period begins on the filing date of the earliest foreign application for which priority is claimed.
  • End date: The period ends 12 months later, on the same date of the following year.
  • Holiday/weekend adjustment: If the 12-month period ends on a Saturday, Sunday, or federal holiday, it extends to the next business day.

According to MPEP 213.03: “The 12-month priority period ends on the anniversary date of the earliest foreign application. If the anniversary date falls on a Saturday, Sunday, or federal holiday, the 12-month period ends on the next succeeding business day.”

It’s crucial to accurately calculate this period to ensure timely filing of your nonprovisional application and maintain your priority claim.

To learn more:

When the claim for foreign priority and the certified copy of the foreign application are received within the time period set forth in 37 CFR 1.55, and there are no irregularities, the USPTO acknowledges receipt in the next Office action.

According to the MPEP: Assuming that the papers are timely and regular in form and that there are no irregularities in dates, the examiner in the next Office action will advise the applicant that the papers have been received on form PTOL-326 or by use of form paragraph 2.26.

The examiner may use form paragraph 2.26, which states: Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55.

If the foreign priority papers have been filed in a parent application, the examiner will use form paragraph 2.27 to acknowledge this fact.

To learn more:

The United States Patent and Trademark Office (USPTO) formally acknowledges a Request to Delete a Named Inventor in a Continued Prosecution Application (CPA) through an official response. This acknowledgment serves as confirmation that the request has been received and processed.

The MPEP ¶ 2.32 provides the standard language used by examiners to acknowledge such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

In this acknowledgment:

  • [1] refers to the name(s) of the inventor(s) requested to be deleted
  • [2] indicates the filing date of the CPA

This official response confirms that the USPTO has processed the request and updated the inventorship accordingly.

For more information on CPA, visit: CPA.

For more information on USPTO acknowledgment, visit: USPTO acknowledgment.

The right of priority for international design applications is governed by 35 U.S.C. 386. There are two main scenarios:

  1. A U.S. national application can claim priority from a prior international design application that designated at least one country other than the United States.
  2. An international design application designating the United States can claim priority from a prior foreign application, a prior PCT application designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a) – (d) and 172 with respect to a prior international design application that designates at least one country other than the United States.

To learn more:

The right of priority for international applications filed under the Patent Cooperation Treaty (PCT) operates similarly to national applications, but with some specific provisions and requirements set by the PCT system.

According to MPEP 213.06: “In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.”

Key points about priority in PCT applications include:

  • The priority claim must be made in the PCT Request form or through a later correction.
  • The applicant must file a certified copy of the priority document with the International Bureau within 16 months from the priority date, unless it was previously filed with the receiving Office.
  • If the priority document is issued by the receiving Office, the applicant can request that Office to prepare and transmit the document to the International Bureau.
  • The International Bureau will make the priority document available to designated Offices.
  • For U.S. national stage entry, if the certified copy was submitted during the international phase, it generally satisfies the requirement for the U.S. application.

The MPEP further notes: “If, however, the International Bureau is unable to forward a copy of the certified priority document because the applicant failed to submit a certified copy of the foreign priority document during the international phase, the applicant will need to provide a certified copy of the priority document or have the Office retrieve the priority application in accordance with the priority document exchange program during the national stage to fulfill the requirements of 37 CFR 1.55.”

For more information on certified copy, visit: certified copy.

The right of priority under 35 U.S.C. 386(a) and 386(b) applies to different types of applications. According to MPEP 213.07:

Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.

This means that 35 U.S.C. 386(a) allows a nonprovisional application to claim priority based on a prior international design application.

On the other hand, 35 U.S.C. 386(b) applies differently:

Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

Thus, 35 U.S.C. 386(b) allows an international design application designating the United States to claim priority based on various types of prior applications.

The key differences are:

  • 386(a) applies to nonprovisional applications claiming priority to international design applications.
  • 386(b) applies to international design applications claiming priority to foreign applications, PCT applications, or other international design applications.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on right of priority, visit: right of priority.

How does the priority date work in a continuation-in-part application?

In a continuation-in-part (CIP) application, the priority date can vary for different parts of the application. According to MPEP 201.08:

“The disclosure presented in the continuation-in-part application may include subject matter in common with the earlier application and may include additional subject matter not disclosed in the earlier application. Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the earlier nonprovisional application are entitled to the benefit of the filing date of the earlier nonprovisional application.”

This means:

  • Subject matter carried over from the parent application retains the original filing date as its priority date
  • New matter added in the CIP has the filing date of the CIP as its priority date
  • Each claim in a CIP is evaluated individually to determine its effective filing date
  • Claims fully supported by the parent application get the earlier priority date
  • Claims relying on new matter get the later CIP filing date as their priority date

Understanding priority dates in CIPs is crucial for determining patentability and for defending against potential prior art references.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

The priority claim deadline for PCT applications entering the national stage in the U.S. differs from that of regular U.S. patent applications:

  • PCT National Stage Applications: For these applications, the priority claim must be made within the time limit set in the PCT and the Regulations under the PCT.
  • Regular U.S. Applications: The deadline is the later of four months from the actual U.S. filing date or sixteen months from the foreign priority date.

According to MPEP 214.01: “In an application that entered the national stage from an international application after compliance with 35 U.S.C. 371, the claim for priority must be made during the pendency of the application and within the time limit set forth in the PCT and the Regulations under the PCT.”

It’s crucial to understand these differences to ensure timely filing of priority claims in different application types.

To learn more:

The presence of new matter in a continuation or divisional application can significantly affect its filing date. If new matter is found, the application may lose the benefit of the earlier filing date for the new subject matter.

According to MPEP ¶ 2.10.01:

“Applicant is required to delete the benefit claim or change the relationship (continuation or divisional application) to continuation-in-part because this application contains the following matter not disclosed in the prior-filed application:”

If the application is changed to a continuation-in-part, the new matter will have the filing date of the current application, while the previously disclosed matter retains the earlier filing date. This can have important implications for determining prior art and patent term.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For applications filed on or after September 16, 2012, the power of attorney from a prior application may have effect in the continuing application under certain conditions. The MPEP states: 37 CFR 1.32(d) provides that a power of attorney from a prior national application for which benefit is claimed under 35 U.S.C. 120, 121, or 365(c) in a continuing application may have effect in the continuing application if a copy of the power of attorney from the prior application is filed in the continuing application unless: (1) The power of attorney was granted by the inventor; and (2) The continuing application names an inventor who was not named as an inventor in the prior application. It’s recommended to file a copy of the power of attorney in the continuing application in all situations to clarify the record.

To learn more:

The USPTO attempts to retrieve foreign applications for design applications through the PDX program where possible. Specifically for Spanish industrial design applications:

The Spanish Patent and Trademark Office deposits certain ES industrial design applications for access by the USPTO via the WIPO DAS. Therefore, when the applicant claims foreign priority to an ES industrial design application and provides the WIPO DAS access code, the USPTO will attempt retrieval via the WIPO DAS.

This means that applicants claiming priority to Spanish industrial design applications should provide the WIPO DAS access code to enable the USPTO to retrieve the application through the WIPO Digital Access Service (DAS).

The patent examination process involves a back-and-forth between the examiner and the applicant. MPEP 203.03 describes a key part of this process:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action.

The general steps in the examination process are:

  1. The applicant files a nonprovisional application.
  2. The examiner reviews the application and issues an Office Action.
  3. The applicant responds to the Office Action, potentially with amendments.
  4. This process may repeat until the application is either allowed or finally rejected.

Each time the applicant responds with changes, the application becomes an ‘amended’ application as described in MPEP 203.03.

To learn more:

The Patent Cooperation Treaty (PCT) significantly impacts international patent applications. According to MPEP 213.01:

International applications filed under the Patent Cooperation Treaty (PCT) are considered to have been filed in any PCT contracting state of which the United States is one.

This means that a PCT application effectively serves as a placeholder for potential national phase entries in all PCT member countries. It provides applicants with additional time to decide in which countries they want to pursue patent protection, while securing an early filing date.

To learn more:

The Patent Cooperation Treaty (PCT) interacts with foreign priority claims as outlined in MPEP 213. The PCT allows applicants to file a single international patent application that can later enter the national phase in multiple countries.

Key points regarding PCT and foreign priority:

  • PCT applications can claim priority from earlier national or regional applications
  • The priority period for PCT applications is also 12 months from the earliest priority date
  • PCT applications themselves can serve as the basis for priority claims in subsequent national or regional applications

As stated in MPEP 213, “U.S. national applications may claim priority to an international application (PCT) filed in a PCT Receiving Office other than the United States Receiving Office.” This demonstrates the flexibility of the PCT system in international patent protection strategies.

How does the Paris Convention affect the filing deadline for U.S. nonprovisional applications?

The Paris Convention plays a crucial role in determining the filing deadline for U.S. nonprovisional applications claiming priority to foreign applications. The MPEP explains:

“Under the Paris Convention, the right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design, filed in a country signatory to the Convention.” (MPEP 213.03)

Key points about the Paris Convention’s impact on filing deadlines:

  • It establishes a 12-month priority period for utility patents and plant patents.
  • For design patents, it provides a 6-month priority period.
  • The priority period starts from the filing date of the earliest foreign application.
  • It applies to applications filed in any country that is a member of the Paris Convention.

This international agreement ensures that inventors have a reasonable timeframe to file patent applications in multiple countries while maintaining the priority date of their original filing. It’s crucial for applicants to be aware of these deadlines when planning their international patent strategy.

To learn more:

How does the Paris Convention affect priority claims in US patent applications?

The Paris Convention plays a crucial role in international priority claims for US patent applications. According to MPEP 216:

‘The right of priority is based on the Paris Convention for the Protection of Industrial Property, which is adhered to by the United States.’

The Paris Convention affects US patent applications in the following ways:

  • It allows applicants to claim priority from foreign applications filed in member countries
  • It establishes a 12-month priority period for utility patents and a 6-month period for design patents
  • It ensures that filing an application in one member country does not invalidate the novelty of the invention in other member countries

The implementation of the Paris Convention in US law is found in 35 U.S.C. 119(a)-(d), which outlines the requirements for claiming foreign priority.

For more information on foreign priority, visit: foreign priority.

For more information on international patent applications, visit: international patent applications.

For more information on Paris Convention, visit: Paris Convention.

How does the Paris Convention affect international patent applications designating the United States?

The Paris Convention plays a significant role in international patent applications designating the United States. According to MPEP 211.01(c):

‘International applications, which designate the United States, that are filed on or after November 29, 2000, are subject to the provisions of the Patent Cooperation Treaty (PCT). International applications, which designate the United States, that are filed before November 29, 2000, are subject to the provisions of both the PCT and the Paris Convention for the Protection of Industrial Property.’

This means that for applications filed on or after November 29, 2000, the PCT rules govern, while earlier applications must comply with both PCT and Paris Convention provisions. The Paris Convention ensures certain rights, such as a 12-month priority period, for patent applicants across member countries, facilitating the international protection of inventions.

To learn more:

How does the oath or declaration work in divisional applications?

In divisional applications, the oath or declaration process is simplified to reduce the burden on applicants. According to MPEP 201.06(c):

37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) that contains the subject matter described in the prior nonprovisional application, provided a copy of the executed oath or declaration filed in the prior nonprovisional application is submitted.

Key points about the oath or declaration in divisional applications:

  • A new oath or declaration is not required if the divisional application contains the same subject matter as the parent application.
  • A copy of the executed oath or declaration from the parent application can be submitted.
  • The copy must show the USPTO seal or stamp indicating it was received.
  • If the inventorship changes, a new oath or declaration may be required.

This provision under 37 CFR 1.63(d) streamlines the filing process for divisional applications while ensuring proper inventorship documentation.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

How does the oath or declaration requirement differ for divisional applications?

For divisional applications, the oath or declaration requirement can be simplified under certain conditions. According to MPEP 201.06(c):

“The divisional application may be filed under 37 CFR 1.53(b) using all or part of a copy of the oath or declaration filed in the prior nonprovisional application under 37 CFR 1.63(d), as long as the oath or declaration is still applicable to the subject matter of the divisional application.”

This means that if the original oath or declaration from the parent application still covers the subject matter in the divisional application, it can be reused. However, if new matter is introduced or the inventors change, a new oath or declaration may be required.

For more information on Divisional application, visit: Divisional application.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent filing, visit: patent filing.

The oath or declaration requirements for continuation applications differ significantly depending on whether they were filed before or after September 16, 2012:

  • For applications filed on or after September 16, 2012: The inventor’s oath or declaration must comply with the requirements of 35 U.S.C. 115 as revised effective September 16, 2012. It must state that the inventor (1) is an original inventor of the claimed invention, and (2) authorized the filing of the patent application for the claimed invention. It must also contain an acknowledgment of penalties for willful false statements.
  • For applications filed before September 16, 2012: Applicants could file either a newly executed oath or declaration, or a copy of the oath or declaration from the prior application, along with a statement requesting deletion of names of non-inventors for the continuation application.

The MPEP states:

For applications filed on or after September 16, 2012, to claim the benefit of a prior application under 35 U.S.C. 120, 121, 365(c), or 386(c) applicant must include a reference to the prior application in compliance with 37 CFR 1.78(d)(2) in an application data sheet.

This change reflects the America Invents Act’s modifications to U.S. patent law.

For more information on America Invents Act, visit: America Invents Act.

For more information on continuation application, visit: continuation application.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent application requirements, visit: patent application requirements.

Micro entity status does not automatically carry over to continuation or divisional applications. A new certification is required for each new application:

  1. A new assertion of entitlement to micro entity status is required for any continuation, divisional, or continuation-in-part application.
  2. This applies even if micro entity status was properly claimed in the parent application.
  3. The new certification must be filed in the continuing application.

The MPEP states: The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

It’s important to note that this requirement for a new certification applies specifically to micro entity status. For small entity status, a new assertion is also required, but the rules are slightly different.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

The inventorship requirements for continuation applications differ based on whether they were filed before or after September 16, 2012:

  • For applications filed on or after September 16, 2012: The inventorship is determined by the information provided in the application data sheet (ADS) filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If no ADS is filed, the inventorship is set by the copy of the inventor’s oath or declaration from the earlier-filed application, unless accompanied by a statement signed under 37 CFR 1.33(b) specifying the correct inventorship.
  • For applications filed before September 16, 2012: The inventorship was generally set by the copy of the executed oath or declaration from the prior application, unless accompanied by a statement requesting deletion of the names of persons who are not inventors in the continuation application.

The MPEP states for post-AIA applications:

37 CFR 1.63(d)(2) provides that the inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application.

These changes reflect the America Invents Act’s modifications to U.S. patent law, simplifying the process for correcting inventorship in many cases.

For more information on America Invents Act, visit: America Invents Act.

For more information on continuation application, visit: continuation application.

For more information on inventorship, visit: inventorship.

For more information on patent application requirements, visit: patent application requirements.

The inventorship of a divisional application must include at least one inventor named in the parent application, but it doesn’t have to be identical. The MPEP states:

The inventorship in the divisional application must include at least one inventor named in the prior-filed application, and the divisional application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).

If the divisional application is filed with fewer inventors than the parent application, a statement may be filed requesting deletion of the names of the additional inventors. For applications filed on or after September 16, 2012, the statement must be filed with the divisional application and signed by a party set forth in 37 CFR 1.33(b).

To learn more:

The inventorship in a Continued Prosecution Application (CPA) is generally the same as in the prior application, unless a specific request is made to change it. According to 37 CFR 1.53(d)(4):

The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If a change in inventorship is desired, a statement requesting the deletion of the names of non-inventors must be filed with the CPA request. This statement must be signed by a person authorized under 37 CFR 1.33(b). For applications filed on or after September 16, 2012, any request to add an inventor must be in the form of a request under 37 CFR 1.48.

The inventorship in a continuing application can be the same as or different from the prior application, depending on the circumstances:

  1. For applications filed on or after September 16, 2012, the inventorship is determined by the application data sheet or the copy of the oath/declaration from the earlier-filed application.
  2. If the continuing application names a new joint inventor, they must provide a new oath or declaration.

The MPEP states: 37 CFR 1.63(d)(2) provides that the inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If an application data sheet is not filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application, the inventorship is the inventorship set forth in the copy of the inventor’s oath or declaration from the earlier-filed application, unless it is accompanied by a statement signed pursuant to 37 CFR 1.33(b) stating the name of each inventor in the continuing application.

For applications filed before September 16, 2012, different rules apply regarding the deletion or addition of inventors in continuing applications.

For more information on application data sheet, visit: application data sheet.

For more information on declaration, visit: declaration.

For more information on inventorship, visit: inventorship.

For more information on oath, visit: oath.

The inventorship in a Continued Prosecution Application (CPA) is directly related to the parent application. As stated in MPEP 201.06(d):

‘The inventorship in a CPA filed under 37 CFR 1.53(d) is the same as in the prior application.’

This means that when you file a CPA, you are essentially continuing the same application with the same inventors. However, it’s important to note that if there are any changes to inventorship required, they must be made through the appropriate procedures, such as filing a request under 37 CFR 1.48. Any such changes should be made promptly to ensure the accuracy of the patent application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on parent application, visit: parent application.

The inventorship in a Continued Prosecution Application (CPA) automatically carries over from the prior application, unless specific steps are taken to change it. As stated in the MPEP:

“The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA. 37 CFR 1.53(d)(4).”

If an inventor needs to be added or deleted, a request under 37 CFR 1.48 must be filed, along with the required fee. The examiner will notify the applicant if there are any inventorship discrepancies in the first Office action.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on patent filing, visit: patent filing.

Incorporation by reference for foreign priority applications is an important safeguard for applicants. Here’s how it works:

  • For applications filed on or after September 21, 2004, a claim under 37 CFR 1.55 for priority of a prior-filed foreign application is considered an incorporation by reference of the prior-filed foreign priority application.
  • This incorporation is subject to the conditions and requirements of 37 CFR 1.57(b).
  • It applies to inadvertently omitted material from the foreign priority application.
  • Applicants can provide an explicit incorporation by reference statement for broader coverage.

The MPEP states: For applications filed on or after September 21, 2004, a claim under 37 CFR 1.55 for priority of a prior-filed foreign application that was present on the filing date of the application is considered an incorporation by reference of the prior-filed foreign priority application as to inadvertently omitted material, subject to the conditions and requirements of 37 CFR 1.57(b). This provision helps protect applicants from accidental omissions in their U.S. applications.

To learn more:

How does the filing date of new matter in a CIP application affect patent rights?

n

The filing date of new matter in a continuation-in-part (CIP) application significantly affects patent rights. According to MPEP 201.08:

n

“Matter disclosed in the parent application is entitled to the benefit of the filing date of the parent application. Matter disclosed for the first time in the continuation-in-part application does not receive the benefit of the filing date of the parent application.”

n

This means:

n

    n

  • The new matter in a CIP is treated as having the filing date of the CIP application itself.
  • n

  • This later filing date can impact the assessment of prior art and the determination of patentability for the new matter.
  • n

  • It may affect the patent term for claims based on the new matter.
  • n

  • In some cases, it could make the new matter more vulnerable to challenges based on intervening prior art.
  • n

n

Therefore, inventors and patent attorneys must carefully consider the timing and content of CIP applications to maximize patent protection.

For more information on new matter, visit: new matter.

For more information on patent rights, visit: patent rights.

For more information on prior art, visit: prior art.

The filing date of a divisional application can affect the patent term in several ways:

  1. 20-year term: The 20-year patent term is calculated from the earliest U.S. filing date to which the divisional application claims priority. This means that the term of a patent issued on a divisional application will generally be shorter than that of its parent application.
  2. Patent Term Adjustment (PTA): The divisional application may be eligible for PTA based on delays in its own prosecution, but not for delays in the prosecution of its parent application.
  3. Terminal Disclaimer: If there’s a risk of obviousness-type double patenting, a terminal disclaimer may be required, potentially limiting the term of the divisional patent to that of the parent patent.

The MPEP 201.06(c) does not directly address patent term, but it’s important to consider these factors when filing a divisional application. For more details on patent term, refer to MPEP 2701.

For more information on Divisional application, visit: Divisional application.

For more information on patent term, visit: patent term.

For more information on patent term adjustment, visit: patent term adjustment.

The filing date of a Continued Prosecution Application (CPA) is determined by the date on which a proper request for a CPA is filed. Specifically, the MPEP states:

The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed.

It’s important to note that the CPA request must be on a separate paper. If the request is not on a separate paper, it will not be considered a proper CPA request and will not receive a filing date.

For more information on patent applications, visit: patent applications.

For more information on USPTO procedures, visit: USPTO procedures.

The filing date of a Continued Prosecution Application (CPA) is determined differently from other types of patent applications. For a CPA, the filing date is the date on which a request for a CPA is filed on a separate paper.

The MPEP states: The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed.

This means that unlike regular applications where the filing date is typically the date all required components are received, a CPA’s filing date is based solely on when the CPA request is submitted, provided it meets the necessary requirements.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

The filing of a Continued Prosecution Application (CPA) has significant effects on the prior application:

  • The CPA is considered a request to expressly abandon the prior application as of the filing date of the CPA
  • The prior application is automatically abandoned in favor of the CPA
  • The filing date of the CPA is the date on which the request for the CPA is filed

As stated in the MPEP: The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed. An application filed under this paragraph:… (v) Is a request to expressly abandon the prior application as of the filing date of the request for an application under this paragraph.

For more information on patent applications, visit: patent applications.

The filing date of a Continued Prosecution Application (CPA) is important for priority claims and patent term calculations. Key points include:

  • The filing date of a CPA is the date on which the CPA request is received by the USPTO
  • A CPA is automatically considered a specific reference under 35 U.S.C. 120 to the prior application
  • The CPA is entitled to the benefit of the filing date of the prior application
  • Priority claims from the parent application automatically carry over to the CPA

As stated in MPEP 201.06(d): A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. That is, the CPA includes the request for an application under 37 CFR 1.53(d) and the recitation of the application number of the prior application in such request is the ‘specific reference to the earlier filed application’ required by 35 U.S.C. 120.

For more information on benefit claims, visit: benefit claims.

For more information on patent term, visit: patent term.

The filing date of a Continued Prosecution Application (CPA) has important implications for its priority claim. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is not entitled to the benefit of a Certificate of Mailing or Transmission under 37 CFR 1.8.

This means that:

  • The CPA’s filing date is the actual date the USPTO receives the CPA request.
  • This date cannot be backdated using a Certificate of Mailing or Transmission.
  • The CPA automatically receives the benefit of the filing date of the prior application.
  • Any foreign priority or domestic benefit claims made in the prior application are automatically carried forward to the CPA.

It’s crucial to understand that while the CPA maintains the priority claims of the prior application, its actual filing date is the date of receipt by the USPTO, which can affect certain statutory deadlines and prior art considerations.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

How does the filing date of a continuation-in-part application affect patent rights?

The filing date of a continuation-in-part (CIP) application can significantly affect patent rights, particularly for the new matter added. According to MPEP 201.08:

“The effective filing date of a claimed invention in a continuation-in-part application is determined on a claim-by-claim basis and is dependent upon the sufficiency of the disclosure in the parent application(s) to support the claimed invention.”

This means:

  • Claims fully supported by the parent application may benefit from the earlier filing date.
  • Claims relying on newly added matter in the CIP will have the filing date of the CIP as their effective date.
  • The later filing date for new matter can affect patentability if relevant prior art emerges between the parent and CIP filing dates.

It’s crucial to carefully consider the timing and content of a CIP to maximize patent protection and avoid potential issues with prior art.

For more information on effective filing date, visit: effective filing date.

For more information on patent rights, visit: patent rights.

The filing date of a continuation application can significantly affect its patent term. While the continuation application gets the benefit of the earlier filing date for prior art purposes, its actual filing date is used to calculate the patent term. According to MPEP 201.07:

The filing date of a continuation application is the filing date of the parent application.

However, this refers to the priority date for prior art purposes. The actual patent term is calculated from the filing date of the continuation application itself. Here’s how it works:

  • The patent term is generally 20 years from the filing date of the earliest non-provisional application to which priority is claimed.
  • For a continuation application, this means 20 years from the filing date of the parent non-provisional application.
  • Each continuation in a chain reduces the effective patent term.

It’s crucial to consider this when deciding whether to file a continuation or a new application, as it can impact the overall protection period for your invention.

For more information on continuation application, visit: continuation application.

For more information on patent priority, visit: patent priority.

For more information on patent term, visit: patent term.

How does the Electronic Priority Document Exchange (PDX) program work with the USPTO?

The Electronic Priority Document Exchange (PDX) program is a system that allows participating intellectual property offices to exchange priority documents electronically. According to MPEP 215.01, the USPTO participates in this program, which can simplify the process of submitting certified copies of foreign priority applications.

The MPEP states: The USPTO has agreements with the European Patent Office (EPO) and the Japan Patent Office (JPO) that enable the USPTO to obtain certified copies of foreign applications filed in those offices from their electronic records management systems.

Here’s how the PDX program works with the USPTO:

  • If a foreign application was filed with a participating office (e.g., EPO or JPO), the applicant can request that office to make the certified copy of the priority document available to the USPTO.
  • The applicant must submit a request to retrieve the priority document through the USPTO’s electronic filing system (EFS-Web or Patent Center).
  • The USPTO will then attempt to retrieve the document electronically from the foreign office.
  • If successful, this electronic retrieval satisfies the requirement to file a certified copy of the foreign priority application.

It’s important to note that the applicant is still responsible for ensuring that the certified copy is received by the USPTO within the required time frame, even when using the PDX program.

The effective filing date for claims in a continuation-in-part (CIP) application can vary depending on the content of the claims. According to MPEP 201.08:

The effective filing date of a claimed invention in a continuation-in-part application is determined on a claim-by-claim basis and is dependent upon the sufficiency of the disclosure in the earlier application(s) to support the claimed invention with 35 U.S.C. 112(a) except for the best mode requirement.

This means:

  • Claims that are fully supported by the earlier application(s) get the benefit of the earlier filing date(s).
  • Claims that rely on newly added matter in the CIP have the filing date of the CIP as their effective filing date.

It’s crucial for patent applicants to carefully consider the implications of adding new matter in a CIP, as it can affect the priority date and potentially impact patentability.

To learn more:

To learn more:

The disclosure requirements for claiming the benefit of provisional and nonprovisional applications differ in some aspects:

Provisional Applications (35 U.S.C. 119(e)):

For a nonprovisional application to claim the benefit of a provisional application:

  • The written description and drawings (if any) of the provisional application must adequately support and enable the subject matter claimed in the nonprovisional application.
  • A claim is not required in the provisional application.

Nonprovisional Applications (35 U.S.C. 120, 121, 365(c), or 386(c)):

For continuation and divisional applications:

  • The disclosure must be the same as the prior-filed application.
  • No new matter can be added.

For continuation-in-part applications:

  • New matter may be included.
  • Only claims supported by the prior-filed application are entitled to the earlier filing date.

As stated in MPEP 211.05:

“Under 35 U.S.C. 120, a claim in a U.S. application is entitled to the benefit of the filing date of an earlier filed U.S. application if the subject matter of the claim is disclosed in the manner provided by 35 U.S.C. 112(a) except for the best mode requirement, in the earlier filed application.”

This requirement applies to both provisional and nonprovisional applications, ensuring that the earlier application provides proper support for the claimed invention.

To learn more:

The Digital Access Service (DAS) plays a significant role in international design applications:

  • DAS facilitates the exchange of priority documents between participating offices.
  • For applications filed in DAS-participating offices, the International Bureau can retrieve priority documents directly.
  • This eliminates the need for applicants to submit certified copies in many cases.
  • Applicants should ensure their priority claims are properly recorded in the international registration.

MPEP 213.07 states: Where the foreign application was filed in a participating office, the International Bureau will attempt to obtain the priority document from the participating office. This streamlined process through DAS enhances efficiency in handling priority documents for international design applications.

To learn more:

How does the copendency requirement affect claiming benefit of a prior application?

The copendency requirement is a critical factor in claiming the benefit of a prior application. MPEP 211.01(b) states: To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be copending with the earlier application.

Copendency means:

  • The later application must be filed before the patenting or abandonment of the prior application.
  • There must be no gap in pendency between the applications in the chain.

If copendency is not maintained, the benefit claim to the earlier application will be lost. This can significantly impact the effective filing date of the later application, potentially affecting its patentability.

For detailed information on copendency, refer to MPEP 211.01(b) and 35 U.S.C. 120.

For applications filed before the America Invents Act (AIA), the best mode requirement affects benefit claims by requiring that the prior-filed application disclose the best mode contemplated by the inventor for carrying out the invention. According to MPEP 211.05:

‘The disclosure of the prior-filed application must provide adequate support and enablement for the claimed subject matter of the later-filed application in compliance with the requirements of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, except for the best mode requirement.

However, it’s important to note that while the best mode requirement is not applied to benefit claims for applications filed on or after September 16, 2012 (the effective date of the AIA), it still applies to applications filed before this date. For pre-AIA applications, failure to disclose the best mode in the prior-filed application could result in the loss of the benefit claim if it is determined that the best mode was not carried forward to the later-filed application.

To learn more:

The benefit claim process for national stage applications entering from an international application under 35 U.S.C. 371 has some specific timing requirements that differ from regular applications filed under 35 U.S.C. 111(a). The MPEP states:

“If the application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, the reference to the prior application must be made during the pendency of the application and within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.”

Key differences for national stage applications include:

  • The time period for submitting the benefit claim starts from the date the national stage commenced or the date of initial submission to enter the national stage.
  • There are three possible deadlines, and the applicant can use the latest of these:
    1. Four months from the date the national stage commenced
    2. Four months from the date of the initial submission to enter the national stage
    3. Sixteen months from the filing date of the prior application

It’s important to carefully track these dates for national stage applications to ensure timely submission of benefit claims.

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on national stage application, visit: national stage application.

The assignment of a priority right can significantly impact patent applications. According to MPEP 216:

‘The right of priority is a personal right of the applicant or his successor in title. It may be transferred to the extent and subject to the conditions provided for in the statutes.’

Key points about the assignment of priority rights:

  • Priority rights can be transferred separately from the application itself.
  • The assignment must be executed before filing the later application claiming priority.
  • An assignment of the entire right, title, and interest in an application includes the right of priority.
  • Partial assignments of priority rights are possible but must be clearly documented.

Proper assignment of priority rights is crucial for maintaining the earlier effective filing date, which can be critical for patentability and avoiding prior art rejections.

For more information on effective filing date, visit: effective filing date.

The America Invents Act’s (AIA) first-inventor-to-file (FITF) provision has significant implications for perfecting foreign priority claims, especially in cases where the foreign application has a pre-March 16, 2013 filing date. Key points include:

  • If a patent was examined under FITF provisions, but the foreign priority application has a pre-AIA filing date, perfecting the priority claim may require further examination.
  • In such cases, a certificate of correction is not sufficient, and a reissue application is necessary.
  • This situation arises because changing the effective filing date could potentially subject the patent to a different statutory framework.

The MPEP states: In situations where further examination would be required, the petition should not be granted. For example, further examination would be required where grant of the petition would cause the patent to be subject to a different statutory framework, e.g., where the foreign application has a pre-March 16, 2013 filing date in a patent that was examined under the first inventor to file (FITF) provisions of the AIA.

This requirement ensures that patents are not inadvertently subjected to different legal standards without proper examination.

How does the AIA FITF system affect the prior-filed application requirements?

The America Invents Act (AIA) First Inventor to File (FITF) system has introduced some changes to the prior-filed application requirements. The MPEP explains:

“AIA 35 U.S.C. 120, 121, 365(c), and 386(c) require that the prior-filed application to which benefit is claimed must name the inventor or a joint inventor named in the later-filed application as the inventor or a joint inventor.”

Key points to note:

  • The prior application must name at least one common inventor with the later-filed application.
  • This requirement applies to applications filed on or after September 16, 2012.
  • For applications filed before this date, the prior application must name the inventor(s) named in the later-filed application.

These changes ensure that the benefit claim aligns with the FITF system’s focus on the first inventor to file. For more information, refer to MPEP 211.01 and USPTO AIA FITF Guidance.

To learn more:

To learn more:

How does the AIA FITF system affect priority claims in patent applications?

The America Invents Act (AIA) First-Inventor-to-File (FITF) system, which went into effect on March 16, 2013, significantly impacted how priority is determined for patent applications. According to MPEP 210:

The AIA converted the U.S. patent system from a ‘first to invent’ system to a ‘first inventor to file’ system. Specifically, the changes to 35 U.S.C. 102 and 103 in the AIA apply to any patent application subject to the first inventor to file provisions of the AIA.

Key effects of the AIA FITF system on priority claims include:

  • The effective filing date of a claimed invention is crucial for determining prior art.
  • Applications filed on or after March 16, 2013, are subject to FITF provisions.
  • Transitional applications (those with claims to pre-AIA and post-AIA effective filing dates) may be subject to both systems.
  • Priority claims must be carefully evaluated to determine which system applies to each claim.

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

For more information on FITF, visit: FITF.

How does the AIA first-inventor-to-file system affect benefit claims?

The America Invents Act (AIA) introduced the first-inventor-to-file system, which has significant implications for benefit claims. While the MPEP 211.01 doesn’t directly address this, it’s an important consideration for applicants. Here’s how it affects benefit claims:

  • Effective Filing Date: The effective filing date of a claimed invention is crucial under the AIA system. It’s determined by the earliest application in the priority chain that describes the claimed invention.
  • Prior Art: The prior art date is now based on the effective filing date, making proper benefit claims even more critical.
  • Grace Period: The one-year grace period for disclosures by the inventor is now measured from the effective filing date.
  • Continuation and CIP Applications: These applications can still claim benefit to earlier applications, but the effective filing date for each claim is determined individually based on when its subject matter was first disclosed in the application chain.

For more information on the AIA and its impact on patent applications, refer to MPEP 2151 and the USPTO’s AIA FAQ page.

To learn more:

How does the AIA First Inventor to File system affect priority claims?

The America Invents Act (AIA) introduced the First Inventor to File (FITF) system, which has significant implications for priority claims. Under the AIA:

  • Applications filed on or after March 16, 2013, are subject to the FITF provisions.
  • Priority claims can still be made to earlier applications, but the effective filing date is crucial for determining prior art.
  • The effective filing date is the earlier of:
    1. The actual filing date of the application, or
    2. The filing date of the earliest application for which benefit or priority is claimed and which describes the subject matter.

As stated in MPEP 210: “The AIA provides that the right of priority and the benefit of an earlier filing date are available to a claim only if that claim is supported by the prior-filed application to which priority or benefit is claimed.”

This means that each claim in a later-filed application must be fully supported by the prior-filed application to receive its priority date. Applicants must carefully consider the content of their priority applications when making claims in subsequent filings.

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

How does the AIA affect priority claims for applications filed on or after March 16, 2013?

The America Invents Act (AIA) significantly changed the U.S. patent system, particularly affecting priority claims for applications filed on or after March 16, 2013. According to MPEP 216:

“AIA 35 U.S.C. 100(i)(1)(B) provides that the effective filing date for a claimed invention in a patent or application for patent (other than a reissue application or reissued patent) is the filing date of the earliest application for which the patent or application is entitled to claim a right of foreign priority or domestic benefit.”

This change means that:

  • The effective filing date can now include foreign priority dates, not just domestic benefit dates.
  • The first-to-file system replaced the first-to-invent system for determining priority.
  • Prior art is now determined based on the effective filing date, including foreign priority dates.

These changes have significant implications for inventors and patent practitioners in terms of strategy for filing applications and claiming priority, especially in a global context.

For more information on America Invents Act, visit: America Invents Act.

For more information on effective filing date, visit: effective filing date.

For more information on foreign priority, visit: foreign priority.

The addition of new matter in a continuation-in-part (CIP) application can significantly affect priority claims. Here’s how:

  • Claims that are fully supported by the parent application retain the parent’s filing date.
  • Claims that rely on the new matter added in the CIP receive the filing date of the CIP application.

The MPEP 201.08 states: The disclosure presented in the continuation-in-part application may include subject matter in common with or vary from that of the prior application. This means that each claim in a CIP must be evaluated individually to determine its effective filing date, which can impact prior art considerations and the validity of the patent.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

The ‘unintentional’ delay standard is crucial in evaluating petitions for delayed benefit claims. According to MPEP 211.04:

While the Director may require additional information whenever there is a question of whether the delay was unintentional, a person filing a petition to accept a delayed benefit claim more than two years after the date the benefit claim was due is required to provide additional explanation of the circumstances surrounding the delay that establishes that the entire delay was unintentional.

This requirement is in addition to the standard statement of unintentional delay. For further discussion on the ‘unintentional’ delay standard, refer to MPEP § 711.03(c).

For more information on unintentional delay, visit: unintentional delay.

The ‘first foreign application’ rule states that the priority period is calculated from the earliest foreign filing, with some exceptions. This means:

  • Priority can only be claimed to the first application filed for the invention.
  • If multiple foreign applications were filed, only the earliest can serve as the basis for priority.
  • Applications filed in non-recognized countries are disregarded for priority purposes.

The MPEP provides an example: If an inventor has filed an application in France on October 4, 1981, and an identical application in the United Kingdom on March 3, 1982, and then files in the United States on February 2, 1983, the inventor is not entitled to the right of priority at all; the inventor would not be entitled to the benefit of the date of the French application since this application was filed more than twelve months before the U.S. application, and the inventor would not be entitled to the benefit of the date of the United Kingdom application since this application is not the first one filed. (MPEP 213.03)

To learn more:

Taiwan’s unique political status has implications for patent priority claims in US applications. According to MPEP 213.01:

‘Applicants from Taiwan may claim priority under 35 U.S.C. 119(a)-(d) to applications filed in Taiwan which are filed by or on behalf of the governing authority on Taiwan.’

This special provision allows Taiwanese applicants to claim priority despite Taiwan not being officially recognized as a sovereign state by the United States. The MPEP further clarifies:

Applications from Taiwan must meet the following criteria to be eligible for priority claims:

  • The application must be filed by or on behalf of the governing authority on Taiwan
  • The priority claim must be made in accordance with the standard procedures outlined in 35 U.S.C. 119(a)-(d)

This arrangement ensures that inventors and companies in Taiwan can participate in the international patent system and maintain priority rights for their inventions when seeking protection in the United States.

Small entity status does not automatically carry over from a parent application to a continuation application. The MPEP provides clear guidance on this matter:

If small entity status has been established in a parent application and is still proper and desired in a continuation, continuation-in-part, or divisional application filed under 37 CFR 1.53(b), a new assertion as to the continued entitlement to small entity status under 37 CFR 1.27 is required.

This means that applicants must take specific steps to maintain small entity status in a continuation application:

  1. Review Eligibility: Ensure that the applicant still qualifies for small entity status under the current rules.
  2. New Assertion: File a new assertion of entitlement to small entity status in the continuation application.
  3. Timing: This assertion should be made at the time of filing the continuation application or with the first fee payment.

It’s important to note that improperly claiming small entity status can have serious consequences, including the patent being held unenforceable. Therefore, applicants should carefully review their status before making a new assertion in a continuation application.

For micro entity status, the requirements are even more stringent:

The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

Applicants should be diligent in properly asserting and maintaining their entity status throughout the patent application process, including when filing continuation applications.

For more information on continuation application, visit: continuation application.

For more information on patent fees, visit: patent fees.

Proper identification of foreign priority applications is particularly important for electronic priority document exchange programs. The MPEP emphasizes this point:

Proper identification of priority applications is essential to establishing accurate and complete relationships among various patent documents, especially in the context of electronic priority document exchange programs

The impact on electronic priority document exchange programs includes:

  • Facilitating accurate matching of priority documents with corresponding applications
  • Ensuring efficient retrieval and processing of priority documents
  • Reducing errors and delays in the priority document exchange process
  • Supporting the integrity of international patent filing systems

Accurate identification helps streamline the electronic exchange process, benefiting both applicants and patent offices involved in international patent procedures.

To learn more:

The PDX system has specific procedures for handling international applications filed under the Patent Cooperation Treaty (PCT). According to MPEP 215.01:

The USPTO will automatically attempt retrieval of international applications filed under the PCT where the receiving office is RO/AU, RO/DK, RO/ES, RO/FI, RO/IB, RO/MA or RO/SE and the applicant has provided the required WIPO DAS access code for the international application to which foreign priority is claimed.

Key points for PCT applications:

  • Automatic retrieval attempts are made for certain PCT applications.
  • Applies to applications filed with receiving offices: RO/AU, RO/DK, RO/ES, RO/FI, RO/IB, RO/MA, or RO/SE.
  • The applicant must provide the WIPO DAS access code for the international application.
  • This process streamlines priority document retrieval for eligible PCT applications.

Applicants should ensure they provide the necessary WIPO DAS access code to facilitate this automatic retrieval process.

To learn more:

PDX for U.S. design applications has specific considerations, as explained in MPEP 215.01:

The USPTO will attempt retrieval of foreign applications to which priority is claimed in a U.S. design application where possible. The Spanish Patent and Trademark Office deposits certain ES industrial design applications for access by the USPTO via the WIPO DAS. Therefore, when the applicant claims foreign priority to an ES industrial design application and provides the WIPO DAS access code, the USPTO will attempt retrieval via the WIPO DAS.

Key points for design applications:

  • The USPTO attempts to retrieve foreign priority documents for design applications where possible.
  • Spanish industrial design applications are accessible through WIPO DAS.
  • Applicants must provide the WIPO DAS access code for Spanish industrial design applications.
  • The USPTO will attempt retrieval via WIPO DAS when the access code is provided.

This process helps streamline the priority document retrieval for design applications, particularly those with Spanish priority.

To learn more:

How does new matter in a continuation-in-part application affect priority dates?

The introduction of new matter in a continuation-in-part (CIP) application has significant implications for priority dates. According to MPEP 201.08:

“The new matter in a continuation-in-part application is not entitled to the benefit of the filing date of the parent application.”

This means:

  • Subject matter carried over from the parent application retains the parent’s filing date as its priority date
  • New matter introduced in the CIP has the filing date of the CIP as its priority date
  • Different claims within the same CIP application may have different priority dates

This distinction is crucial for determining prior art and potential patent infringement cases. Inventors and patent practitioners must carefully consider the implications of adding new matter when filing a CIP application.

For more information on new matter, visit: new matter.

Tags: new matter

How does new matter in a continuation-in-part affect prior art considerations?

The introduction of new matter in a continuation-in-part (CIP) application significantly affects prior art considerations. According to the MPEP 201.08:

Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the prior-filed application are entitled to the benefit of the filing date of the prior-filed application.

This means:

  • Claims based on new matter have the filing date of the CIP as their effective filing date.
  • Prior art that predates the CIP filing but postdates the parent application can be used against claims based on new matter.
  • Claims fully supported by the parent application retain the earlier effective filing date for prior art purposes.

Patent examiners must carefully analyze each claim to determine its effective filing date and apply the appropriate prior art. Applicants should be aware that introducing new matter may expose some claims to a broader range of prior art, potentially affecting patentability.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

For more information on prior art, visit: prior art.

How does new matter in a continuation-in-part affect patent rights?

New matter introduced in a continuation-in-part (CIP) application can significantly affect patent rights. According to MPEP 201.08, “Matter not disclosed in the parent nonprovisional application is entitled only to the filing date of the continuation-in-part application.”

This means:

  • New matter is only entitled to the filing date of the CIP application itself.
  • This later filing date can impact the assessment of prior art for the new matter.
  • Patent term for claims based on new matter may be calculated from the CIP filing date.
  • Different parts of the CIP application may have different priority dates, affecting patentability and enforcement.

It’s crucial for inventors and patent practitioners to carefully consider the implications of adding new matter in a CIP, as it can affect the scope and strength of patent protection.

For more information on new matter, visit: new matter.

For more information on patent rights, visit: patent rights.

The treatment of new matter varies depending on the type of continuing application:

  • Continuation and Divisional Applications: Must not contain any new matter. The disclosure must be the same as the prior application.
  • Continuation-in-Part (CIP) Applications: Can include new matter not disclosed in the parent application.
  • Continued Prosecution Applications (CPAs): Cannot contain new matter.

For continuation and divisional applications, the MPEP states: “The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.”

For CIPs, the MPEP notes: “A continuation-in-part is an application… repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.”

If new matter is found in a continuation or divisional application, the examiner will require the applicant to delete the benefit claim or change the application to a continuation-in-part. For CPAs, any new matter introduced will be required to be canceled.

It’s important to note that claims in a CIP application that rely on new matter will only be entitled to the filing date of the CIP, not the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

According to MPEP 201.01, original applications are defined as follows:

‘Original applications include applications filed under 35 U.S.C. 111(a) and provisional applications filed under 35 U.S.C. 111(b).’

This definition encompasses two distinct types of applications:

  • Non-provisional applications filed under 35 U.S.C. 111(a)
  • Provisional applications filed under 35 U.S.C. 111(b)

Understanding this distinction is crucial for inventors and patent practitioners when deciding which type of application to file based on their specific needs and circumstances.

For more information on patent filing, visit: patent filing.

MPEP 201.01 provides a clear definition of a national application in the context of U.S. patent law. According to MPEP 201.01:

‘A national application is one that was filed in the United States Patent and Trademark Office (USPTO) under 35 U.S.C. 111(a), an application which entered the national stage from an international application after compliance with 35 U.S.C. 371, or a reissue application filed under 35 U.S.C. 251.’

This definition encompasses three main categories:

  1. Applications filed directly with the USPTO under 35 U.S.C. 111(a)
  2. International applications that have entered the national stage in the U.S. after complying with 35 U.S.C. 371
  3. Reissue applications filed under 35 U.S.C. 251

Understanding this definition is crucial for patent applicants and practitioners to determine the appropriate filing procedures and requirements for their inventions.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on USPTO, visit: USPTO.

The MPEP 201 defines a provisional application for patent as follows:

“A provisional application for patent is a U.S. national application filed in the USPTO under 35 U.S.C. 111(b). It allows filing without a formal patent claim, oath or declaration, or any information disclosure (prior art) statement.”

Key features of a provisional application include:

  • It provides the means to establish an early effective filing date in a later filed nonprovisional patent application.
  • It allows the term “Patent Pending” to be applied in connection with the description of the invention.
  • It has a pendency lasting 12 months from the date the provisional application is filed.
  • The 12-month pendency period cannot be extended.

Provisional applications are often used by inventors to quickly secure a filing date while they continue to develop their invention or seek funding.

For more information on 12-month pendency, visit: 12-month pendency.

For more information on early filing date, visit: early filing date.

For more information on provisional application, visit: provisional application.

Inventorship in a Continued Prosecution Application (CPA) generally carries over from the prior application, but there are some important considerations:

  • The inventive entity of the CPA is automatically the same as the prior application unless a statement is filed requesting deletion of inventors
  • A statement requesting deletion of inventors must be filed with the CPA request and signed by a person authorized under 37 CFR 1.33(b)
  • New inventors cannot be added simply by naming them in the CPA transmittal letter or a new oath/declaration
  • To add new inventors, a request under 37 CFR 1.48 must be filed, including the required fee

The MPEP states: The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If an inventor is named in the CPA who was not in the prior application, the examiner will notify the applicant using form paragraph 2.33:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent applications, visit: patent applications.

In a Continued Prosecution Application (CPA), the inventorship is typically the same as in the prior application. However, if a new inventor needs to be added, a specific process must be followed. According to MPEP ¶ 2.33:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48. Otherwise, the inventorship in the CPA shall be the same as in the prior application.

This means that if you want to add a new inventor to a CPA, you must file a formal request under 37 CFR 1.48, which outlines the procedures for correcting or changing inventorship in patent applications.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

Inventorship in a continuing application depends on the type of continuing application and when it was filed. Key points:

  • For applications filed on or after September 16, 2012, the inventorship is initially the inventor(s) named in the application data sheet
  • For earlier applications, the inventorship carries over from the parent application
  • In a continuation or divisional, the inventorship must include at least one inventor named in the parent application
  • In a continuation-in-part, new inventors can be added to cover new matter
  • Inventorship can be corrected if needed using procedures under 37 CFR 1.48

For CPAs filed on or after September 16, 2012, the MPEP states: The inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application.

If the inventorship needs to be changed, a request under 37 CFR 1.48 must be filed.

For more information on application data sheet, visit: application data sheet.

For more information on continuing applications, visit: continuing applications.

For more information on inventorship, visit: inventorship.

Inventorship is a crucial aspect of continuation applications. According to MPEP 201.07:

The inventorship in the continuation application must include at least one inventor named in the prior-filed application…

This requirement ensures a clear line of continuity between the parent application and the continuation application. Key points to consider:

  • At least one inventor from the parent application must be included in the continuation application.
  • Additional inventors can be added to the continuation application if they contributed to the claimed invention.
  • Inventors from the parent application who did not contribute to the claims in the continuation application can be removed.
  • Changes in inventorship must be properly documented and may require an oath or declaration from new inventors.

For Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), there are additional inventorship requirements:

In addition, a continuation or divisional application may only be filed under 37 CFR 1.53(d) if the prior application is a nonprovisional design application, but not an international design application, that is complete as defined by 37 CFR 1.51(b) (except for the inventor’s oath or declaration if the CPA is filed on or after September 16, 2012), and the prior nonprovisional application contains an application data sheet indicating the name, residence, and mailing address of each inventor.

Always consult with a patent attorney when dealing with inventorship issues in continuation applications to ensure compliance with USPTO requirements.

For more information on application data sheet, visit: application data sheet.

Incorporation by reference can be an important tool in continuation applications, allowing applicants to include material from prior applications. The MPEP provides detailed guidance on this topic:

For applications filed on or after September 21, 2004:

An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are “hereby incorporated by reference.” The statement must appear in the specification.

Additionally, for these applications:

For applications filed on or after September 21, 2004, a claim under 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78(d) for benefit of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States that was present on the filing date of the continuing application is considered an incorporation by reference of the prior-filed application as to inadvertently omitted material, subject to the conditions and requirements of 37 CFR 1.57(b).

For applications filed before September 21, 2004:

The incorporation by reference statement could appear in the application transmittal letter or in the specification.

It’s important to note that incorporation by reference cannot be used to add new matter to an application after its filing date. The MPEP states:

An incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

Proper use of incorporation by reference can help applicants maintain continuity between related applications and potentially recover from certain filing errors.

For more information on 37 cfr 1.57, visit: 37 cfr 1.57.

For more information on continuation application, visit: continuation application.

For more information on incorporation by reference, visit: incorporation by reference.

Filing a delayed benefit claim can have significant implications for patent term adjustment (PTA). According to MPEP 211.04:

‘If a benefit claim is submitted later than the time period provided by 37 CFR 1.78, the patent will not be granted the earlier filing date unless a petition under 37 CFR 1.78 is granted. If the petition is granted, the patent term adjustment (PTA) may be reduced.’

This means that if your delayed benefit claim is accepted through a successful petition, it may result in a reduction of your patent’s term adjustment. The reduction in PTA is intended to balance the benefit gained from the earlier filing date against the delay in claiming that benefit.

To learn more:

Filing a Continued Prosecution Application (CPA) has a significant effect on the prior application. According to the MPEP, A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA. This means that when you file a CPA, the previous application is automatically abandoned in favor of the new CPA. The CPA will use the file wrapper and contents of the prior application, including the specification, drawings, and oath or declaration, and will be assigned the same application number as the prior application.

To learn more:

Filing a Continued Prosecution Application (CPA) includes a waiver of confidentiality for the prior application. The MPEP states:

A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means that if someone is entitled to access information about either the CPA or the prior application, they may also be given access to information about the other related applications in the file. Applicants should be aware of this reduced confidentiality when deciding whether to file a CPA.

Filing a Continued Prosecution Application (CPA) has implications for public access to the application. The MPEP states:

“A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file. 37 CFR 1.53(d)(6).”

This means:

  • The CPA is considered a waiver of confidentiality for the entire application chain
  • Members of the public who have access to one application in the chain may be given similar access to others
  • This increased accessibility applies to both the prior application and any continuing applications

Applicants should be aware of this potential for increased public access when deciding to file a CPA.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

Filing a Continued Prosecution Application (CPA) has implications for the confidentiality of the application under 35 U.S.C. 122:

  • Filing a CPA is construed as a waiver of confidentiality to a certain extent
  • Members of the public entitled to access the prior application may be given similar access to the CPA and other related applications
  • This waiver applies to the entire chain of related applications

The MPEP states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

For more information on 35 U.S.C. 122, visit: 35 U.S.C. 122.

For more information on patent applications, visit: patent applications.

For more information on public access, visit: public access.

Filing a Continued Prosecution Application (CPA) has implications for confidentiality and public access to application information:

  • Filing a CPA is construed as a waiver of confidentiality under 35 U.S.C. 122
  • Members of the public entitled to access the prior application may be given similar access to the CPA
  • This waiver extends to any continuing applications in the chain of CPAs
  • Certified copies of CPAs will include the most recent non-continued prosecution application in the chain

MPEP 201.06(d) states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

For more information on USPTO procedures, visit: USPTO procedures.

Filing a continuation-in-part (CIP) application does not automatically resolve or affect outstanding rejections in the parent application. The MPEP 201.08 clarifies this point:

“The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

This means:

  • Outstanding rejections in the parent application remain active and must be addressed separately.
  • The applicant is not presumed to agree with or accept these rejections by filing a CIP.
  • The CIP application will be examined independently, though it may face similar rejections if it includes the same claimed subject matter.

Applicants should continue to respond to office actions and address rejections in the parent application if they wish to pursue those claims, even after filing a CIP.

For more information on parent application, visit: parent application.

For more information on patent examination, visit: patent examination.

Filing a continuation or divisional application under 37 CFR 1.53(b) does not automatically abandon the prior application. The status of the prior application depends on the actions taken by the applicant:

  1. The prior application remains pending unless expressly abandoned.
  2. To expressly abandon the prior application, a separate paper must be filed and signed in accordance with 37 CFR 1.138.
  3. If a notice of allowance has been issued in the prior application, it can become abandoned by nonpayment of the issue fee.

The MPEP states: Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application. If the prior nonprovisional application is to be expressly abandoned, such a paper must be signed in accordance with 37 CFR 1.138.

It’s important to note that if the issue fee has been paid in the prior application, a petition to withdraw the application from issue must be filed before it can be abandoned, even if a continuing application has been filed.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

Filing a continuation application under 37 CFR 1.53(b) does not automatically abandon the prior application. The MPEP clearly states:

Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application.

However, applicants have several options regarding the status of the prior application:

  1. Express Abandonment: If desired, the prior application can be expressly abandoned. This requires a separate paper signed in accordance with 37 CFR 1.138.
  2. Allowed Applications: If the prior application has received a notice of allowance, it can become abandoned by non-payment of the issue fee.
  3. Continued Prosecution: The prior application can remain pending if the applicant wishes to continue prosecution.

It’s important to note that if an issue fee has been paid in the prior application, special procedures are required:

However, once an issue fee has been paid in the prior application, even if the payment occurs following the filing of a continuing application under 37 CFR 1.53(b), a petition to withdraw the prior nonprovisional application from issue must be filed before the prior nonprovisional application can be abandoned (37 CFR 1.313).

Applicants should carefully consider their strategy for managing multiple related applications when filing a continuation.

For more information on continuation application, visit: continuation application.

For more information on patent prosecution, visit: patent prosecution.

Continued Prosecution Application (CPA) practice differs significantly for utility and plant applications compared to design applications. The key difference is:

CPA practice is not available for utility and plant applications filed on or after May 29, 2000.

As stated in the MPEP 201.06(d): “Effective July 14, 2003, CPA practice has been eliminated as to utility and plant applications in view of the eighteen-month publication of applications under 35 U.S.C. 122(b). A request for a CPA filed on or after July 14, 2003 in a utility or plant application is improper and will not be treated as a CPA.”

For utility and plant applications, applicants should instead consider filing:

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on RCE, visit: RCE.

Copendency is a crucial requirement for claiming benefit between nonprovisional applications. The later-filed application must be filed before:

  • The patenting of the prior application
  • The abandonment of the prior application
  • The termination of proceedings in the prior application

As stated in MPEP 211.01(b): When a later-filed application is claiming the benefit of a prior-filed nonprovisional application under 35 U.S.C. 120, 121, 365(c), or 386(c), the later-filed application must be copending with the prior application or with an intermediate nonprovisional application similarly entitled to the benefit of the filing date of the prior application.

If copendency is not maintained, the benefit claim is improper and the later-filed application cannot claim the earlier filing date of the prior application.

To learn more:

Continuity in patent applications refers to the relationship of copendency of the same subject matter in two different applications naming the same inventor or at least one joint inventor in common. The MPEP 211.01(b) states:

“The term ‘continuity’ is used to express the relationship of copendency of the same subject matter in two different applications naming the same inventor or at least one joint inventor in common.”

Continuing applications include:

  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

It’s important to note that the prior application may disclose more than the later-filed application, or vice versa. In either case, the later-filed application is entitled to the benefit of the filing date of the prior application for the common subject matter disclosed in compliance with 35 U.S.C. 112(a).

To learn more:

Confidentiality in Continued Prosecution Applications (CPAs) is handled differently from standard applications. Filing a CPA includes a waiver of confidentiality to some extent:

  • The CPA is construed to include a waiver of confidentiality under 35 U.S.C. 122
  • This waiver allows public access to both the prior application and any continuing applications filed under 37 CFR 1.53(d)
  • Access is limited to those entitled under 37 CFR 1.14 to obtain information about the applications

The MPEP states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means that if someone is entitled to access information about either the prior application or the CPA, they may be given similar access to information about both applications. This is different from the standard confidentiality provisions for pending applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Claiming the benefit of an international design application under 35 U.S.C. 386(c) can potentially establish an earlier effective filing date for a nonprovisional application. This is significant because the effective filing date is used to determine which prior art is applicable during examination.

As stated in the MPEP:

“Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.”

By claiming this benefit, the nonprovisional application can potentially use the filing date of the international design application as its effective filing date, provided all requirements are met. This earlier date can be crucial for overcoming prior art references and establishing priority in the field.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on effective filing date, visit: effective filing date.

For more information on prior art, visit: prior art.

Claiming priority for international design applications has some specific provisions, particularly when the application designates the United States. These provisions are outlined in the MPEP and relevant regulations.

According to MPEP 213.07: “Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.”

Key points about priority in international design applications include:

  • The right of priority under 35 U.S.C. 386(a) or (b) applies only to applications filed on or after May 13, 2015.
  • For nonprovisional international design applications, the priority claim must be presented in an application data sheet during the pendency of the application, unless made in accordance with the Hague Agreement and Regulations.
  • The certified copy of the priority document must be furnished within the time period specified in 37 CFR 1.55(g).
  • An international design application designating the U.S. can claim priority to a prior foreign application, PCT application, or another international design application.

The MPEP also notes: “See MPEP § 2920.05(d) for additional information pertaining to the right of priority based upon an international design application.”

These provisions ensure that design patent applicants can properly claim priority to earlier filed applications in the context of the international design registration system.

For more information on design patent, visit: design patent.

For more information on Hague Agreement, visit: Hague Agreement.

How does claiming benefit of an international application affect the patent term?

Claiming the benefit of an international application can affect the patent term in specific ways. According to MPEP 211.01(c):

It should be noted that international applications, which designate the United States, are included in the definition of ‘national application’ in pre-AIA 35 U.S.C. 154(a)(2).

This means that for patents subject to the 20-year term provision of pre-AIA 35 U.S.C. 154(a)(2), the 20-year term begins on the international filing date of the international application. However, it’s important to note that the MPEP 2701 provides more detailed information on patent term calculations, including adjustments and extensions that may apply.

To learn more:

To learn more:

Tags: patent term

Claiming the benefit of an earlier filing date for continuing applications (continuation, divisional, and continuation-in-part) is governed by 35 U.S.C. 120 and 37 CFR 1.78. Key points include:

  • The continuing application must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  • The continuing application must contain a specific reference to the prior application.
  • For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet (ADS).
  • For applications filed before September 16, 2012, the specific reference must be in the first sentence(s) of the specification or in an ADS.
  • The continuing application must have at least one common inventor with the prior application.

As stated in the MPEP:

A continuation or divisional application that names as inventors the same or fewer than all of the inventors named in the prior application may be filed under this paragraph or paragraph (d) of this section.

It’s important to note that for continuation-in-part applications, any claims that rely on new matter added in the CIP will not be entitled to the benefit of the earlier filing date of the parent application.

For more information on patent application types, visit: patent application types.

Claiming benefit to a prior application can affect the patent term in several ways:

  1. For applications subject to the 20-year term provision:
    • The term begins from the earliest U.S. filing date to which benefit is claimed under 35 U.S.C. 120, 121, or 365(c)
    • Claiming benefit to earlier applications may reduce the effective patent term
  2. For provisional applications:
    • Claiming benefit under 35 U.S.C. 119(e) does not affect the patent term
    • However, claiming benefit to a provisional under 35 U.S.C. 120 (not recommended) could reduce the term

MPEP 211.02 cautions: “Although 35 U.S.C. 120 does not preclude a benefit claim to a provisional application, it is not recommended that applicants claim the benefit to a provisional application under 35 U.S.C. 120 since such a claim could have the effect of reducing the patent term, as the term of a patent issuing from such an application may be measured from the filing date of the provisional application pursuant to 35 U.S.C. 154(a)(2).”

It’s important to carefully consider the implications of benefit claims on patent term when developing a patent strategy, especially for patent families with multiple related applications.

To learn more:

How does an international application designating the US affect benefit claims?

An international application designating the United States can be used as a basis for claiming benefit in a nonprovisional application. The MPEP 211.01(b) states:

Any nonprovisional application claiming the benefit of one or more prior-filed copending nonprovisional applications or international applications designating the United States must include a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications.

When claiming benefit from an international application, you must provide:

  • The international application number
  • The international filing date
  • The relationship between the applications

It’s important to note that the international application must designate the United States for it to be eligible as a basis for a benefit claim in a U.S. nonprovisional application.

To learn more:

An international application designating the United States has significant effects on the application process:

  • It is treated as a national application from its international filing date.
  • It follows different rules for restriction practice and unity of invention.
  • It has different notification procedures for incomplete applications.

According to 35 U.S.C. 363: “An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.”

However, as noted in MPEP 201.01: “Treatment of a national application under 35 U.S.C. 111 and a national stage application (a national application which entered the national stage from an international application in which the conditions of 37 CFR 1.9(a)(1) have been satisfied) are similar but not identical.” For example, unity of invention practice applies to national stage applications, while restriction practice applies to applications filed under 35 U.S.C. 111(a).

For more information on international applications, visit: international applications.

An international application designating the United States has significant effects on national patent rights. According to 35 U.S.C. 363:

An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.

This means that an international application (PCT application) that designates the US is treated similarly to a national application filed under 35 U.S.C. 111. However, there are some differences in treatment between national applications and national stage applications (which enter the national stage from an international application). For example:

  • Restriction practice applies to national applications, while unity of invention practice applies to national stage applications
  • Different notification practices apply to incomplete applications in each case

For detailed information on the examination of international applications in the national stage, refer to MPEP § 1893.03.

For more information on international applications, visit: international applications.

For more information on patent rights, visit: patent rights.

When an examiner encounters a non-compliant amendment under 37 CFR 1.57(b), they follow a specific procedure outlined in the MPEP:

  1. They use a form paragraph stating the non-compliance and the specific reason.
  2. If the amendment introduces new matter, they follow up with additional form paragraphs (7.28 for specification/drawings, 7.31.01 for claims).
  3. For after-final amendments, they issue an advisory action indicating that the amendment raises new issues due to non-compliance.

The MPEP notes, This form paragraph must be followed by form paragraph 7.28, where the amendment is made to the specification and/or drawings and introduces new matter into the disclosure, and/or form paragraph 7.31.01, where the amendment adds new matter to the claims or affects the claims.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

When a Continued Prosecution Application (CPA) is established, the examiner notifies the applicant in the first Office action of the CPA. According to MPEP ¶ 2.30, the examiner uses a specific form paragraph:

“The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.”

This notification is important because:

  • Applicants are not separately notified of the abandonment of the parent application
  • A filing receipt is not normally sent for a CPA

Therefore, this Office action serves as the official notification that the CPA has been properly established.

For more information on design patents, visit: design patents.

For more information on patent examination, visit: patent examination.

When a Continued Prosecution Application (CPA) is accepted, the examiner notifies the applicant in the first Office action of the CPA. This is because, unlike regular applications, applicants do not receive a separate notification about the abandonment of the parent application or a filing receipt for the CPA.

MPEP ¶ 2.30 states: Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established. This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA. This guidance ensures that applicants are properly informed about the status of their CPA.

According to MPEP § 201, specifically paragraph 2.30, an examiner notifies an applicant about a Continued Prosecution Application’s (CPA) acceptance in the first Office action of the CPA. The MPEP states:

Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established. This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

This notification is crucial because it confirms the establishment of the CPA and provides important information to the applicant about the status of their application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

When a Continued Prosecution Application (CPA) request for a design patent application is deemed unacceptable, the examiner uses a specific form paragraph to inform the applicant. According to MPEP ¶ 2.31, the examiner note states:

“Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.”

The form paragraph includes:

  • An acknowledgment of the CPA request receipt
  • The filing date of the paper containing the request
  • The Application Number identified in the CPA request
  • An explanation of why the request is not acceptable
  • A statement that no CPA has been established

This formal communication ensures that the applicant is clearly informed about the status of their CPA request and the reasons for its non-acceptance.

For more information on USPTO procedures, visit: USPTO procedures.

When a Continued Prosecution Application (CPA) request for a design patent application is not compliant with the regulations, the examiner informs the applicant using a specific form paragraph. The MPEP provides guidance on this:

Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.

The form paragraph includes:

  • Acknowledgment of the CPA request receipt
  • The filing date of the paper containing the request
  • The application number identified in the CPA request
  • Explanation of why the request is not acceptable
  • Statement that no CPA has been established

This standardized approach ensures clear communication between the USPTO and the applicant regarding the status of their CPA request.

For more information on USPTO procedures, visit: USPTO procedures.

Patent examiners carefully compare the content of the continuation or divisional application with the prior-filed application to identify any new matter. If they find information not disclosed in the prior application, they will issue a notice to the applicant.

The MPEP ¶ 2.10.01 instructs examiners:

“In bracket 1, provide an example of the matter not disclosed in the prior-filed application.”

This means the examiner must specifically point out the new matter found in the application, allowing the applicant to understand and address the issue.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent examination, visit: patent examination.

An examiner determines if an application qualifies as a continuation under MPEP ¶ 2.05 by assessing the following criteria:

  • The application discloses only subject matter that was previously disclosed in a prior application
  • The application claims only subject matter that was disclosed in the prior application
  • The application names at least one inventor who was also named in the prior application

The MPEP provides specific language for this assessment: “This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application.” (MPEP ¶ 2.05)

If all these criteria are met, the examiner may notify the applicant that the application may constitute a continuation. The examiner will then proceed with the appropriate examination procedures for continuation applications.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

Patent examiners use specific criteria to determine if an application may qualify as a continuation-in-part (CIP). According to MPEP ¶ 2.06, an examiner should consider the following:

  • The application repeats a substantial portion of a prior application.
  • The application adds disclosure not presented in the prior application.
  • The application names the inventor or at least one joint inventor named in the prior application.

The MPEP states: Because this application names the inventor or at least one joint inventor named in the prior application, it may constitute a continuation-in-part of the prior application. However, examiners are advised to use this determination cautiously: This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Patent examiners use specific criteria to determine if an application may qualify as a divisional. According to MPEP ¶ 2.01, an examiner looks for the following indicators:

  1. The application claims only subject matter disclosed in a prior application.
  2. The claimed subject matter appears to be independent and distinct from that claimed in the prior application.
  3. At least one inventor from the prior application is named in the current application.

The MPEP provides guidance to examiners:

“This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.”

If these conditions are met, but a proper benefit claim hasn’t been made, the examiner may use this paragraph to notify the applicant of the possible divisional status and the need to establish a benefit claim if desired.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

For more information on USPTO, visit: USPTO.

To claim the benefit of a prior application’s filing date for a divisional application, applicants must follow specific procedures outlined in patent law and regulations. The MPEP ¶ 2.01 states:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This means applicants should:

  • Ensure compliance with 35 U.S.C. 120 requirements for continuity and disclosure
  • Follow the procedures outlined in 37 CFR 1.78 for claiming benefit
  • Consult MPEP § 211 for detailed guidance on benefit claims

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the divisional application.

For more information on Divisional application, visit: Divisional application.

How does a U.S. national stage application differ from a regular national application?

A U.S. national stage application is derived from an international application, while a regular national application is filed directly with the USPTO. The key differences lie in their origins and the legal provisions governing them.

As stated in MPEP 201.01:

A national application may be a U.S. national application filed under 35 U.S.C. 111(a), or a national stage application under 35 U.S.C. 371 of an international application.

Regular national applications are filed under 35 U.S.C. 111(a), while national stage applications enter the U.S. national phase from an international PCT application under 35 U.S.C. 371. National stage applications must meet specific requirements for entering the national phase, such as time limits and submission of necessary documents.

For more information on national stage application, visit: national stage application.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A terminal disclaimer filed in a parent application can affect a divisional application in specific ways. According to MPEP 201.06:

‘The divisional application must be directed to subject matter described and claimed in the prior nonprovisional application.’

This means that if a terminal disclaimer was filed in the parent application, it may impact the divisional application as follows:

  • Inheritance of Terminal Disclaimer: Generally, a terminal disclaimer filed in the parent application does not automatically apply to the divisional application.
  • Potential Double Patenting: If the claims in the divisional application are not patentably distinct from those in the parent application, a new terminal disclaimer may be required in the divisional to overcome a double patenting rejection.
  • Examination Considerations: Examiners will consider the relationship between the parent and divisional applications when determining if a terminal disclaimer is necessary.

It’s important to consult with a patent attorney or agent to understand the specific implications of terminal disclaimers on your divisional application, as each case can have unique considerations.

To learn more:

A terminal disclaimer filed in a parent application automatically carries over to a Continued Prosecution Application (CPA). The MPEP clearly states:

“A terminal disclaimer filed in the parent application carries over to a CPA. The terminal disclaimer filed in the parent application carries over because the CPA retains the same application number as the parent application, i.e., the application number to which the previously filed terminal disclaimer is directed.”

However, if an applicant does not want the terminal disclaimer to apply to the CPA, they must take specific action:

“If applicant does not want the terminal disclaimer to carry over to the CPA, applicant must file a petition under 37 CFR 1.182 along with the required petition fee, requesting the terminal disclaimer filed in the parent application not be carried over to the CPA.”

It’s important to note that such a petition must be filed and granted before the patent issues to be effective.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on patent term, visit: patent term.

A substitute application is distinct from a continuing application in several ways. According to MPEP 201.02:

‘A substitute application is an application which is filed to take the place of a prior application and which is identified as such and discloses and claims only subject matter disclosed in the prior application.’

Key differences include:

  • A substitute application replaces the prior application entirely, while a continuing application coexists with the prior application.
  • Substitute applications only claim subject matter from the prior application, whereas continuing applications may introduce new matter (in the case of continuation-in-part applications).
  • The filing of a substitute application typically results in the abandonment of the prior application, which is not necessarily the case with continuing applications.

For more information on patent prosecution, visit: patent prosecution.

For more information on substitute application, visit: substitute application.

A substitute application has a significant impact on the filing date of a patent application. According to MPEP 201.02:

A substitute application does not obtain the benefit of the filing date of the prior application.

This means that if an applicant files a substitute application, it will receive a new filing date based on when it was submitted, rather than inheriting the filing date of the original application it’s replacing. This can have important implications for patent priority and the determination of prior art.

It’s crucial for applicants to understand this distinction, as the filing date can significantly affect the patentability of an invention, especially in fast-moving technological fields.

For more information on patent procedure, visit: patent procedure.

For more information on substitute application, visit: substitute application.

How does a restriction requirement lead to a divisional application?

A restriction requirement often leads to the filing of a divisional application. This process occurs as follows:

  1. An examiner issues a restriction requirement when they believe the original application contains claims to two or more independent or distinct inventions.
  2. The applicant must then elect one invention to pursue in the original application.
  3. The non-elected inventions can be pursued in one or more divisional applications.

As stated in MPEP 201.06:

“The inventions embodied in the claims of a divisional application are generally further characterized as (1) independent inventions or (2) related inventions which are distinct.”

This means that the divisional application allows the applicant to protect inventions that were disclosed but not pursued in the original application due to the restriction requirement.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

A reissue application differs from a regular patent application in several key ways:

  • Purpose: A reissue application is specifically for correcting defects in an existing, unexpired patent, while a regular application is for obtaining a new patent.
  • Timing: Reissue applications can only be filed for unexpired patents, whereas regular applications are filed before a patent is granted.
  • Scope: Reissue applications are limited to the invention disclosed in the original patent, with some exceptions for broadening reissues.
  • Examination process: The examination of a reissue application focuses on the changes made to correct the defect, in addition to a review of the entire patent.

As stated in MPEP 201.05, “A reissue application is an application for a patent to take the place of an unexpired patent that is defective.” This fundamental difference sets reissue applications apart from regular patent applications. For more detailed information on the reissue process, refer to MPEP Chapter 1400.

To learn more:

A reissue application does not affect the original patent’s term. According to MPEP 201.05, ‘The reissue application is a continuation of the original application and the reissue patent will expire at the same time that the original patent would have expired.’

This means that:

  • The term of the reissue patent remains the same as the original patent.
  • No additional patent term is granted through the reissue process.
  • The expiration date of the reissue patent will be identical to that of the original patent.

It’s important to note that while a reissue doesn’t extend the patent term, it can potentially strengthen or broaden the patent’s claims within the original term, subject to certain limitations such as the two-year rule for broadening reissues.

The patent term is governed by 35 U.S.C. 254, which states: ‘Every reissued patent shall have the same effect and operation in law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such amended form, but in so far as the claims of the original and reissued patents are substantially identical, such surrender shall not affect any action then pending nor abate any cause of action then existing, and the reissued patent, to the extent that its claims are substantially identical with the original patent, shall constitute a continuation thereof and have effect continuously from the date of the original patent.’

To learn more:

While the MPEP 201.02 doesn’t provide detailed definitions, it references 37 CFR 1.9(a) for the definitions of provisional and nonprovisional applications:

  • Provisional Application: A temporary application that establishes an early filing date but does not mature into an issued patent without further action.
  • Nonprovisional Application: A regular patent application that can be examined and potentially result in an issued patent.

Key differences include:

  • Provisional applications have a pendency of 12 months from the filing date.
  • Nonprovisional applications undergo examination, while provisional applications do not.
  • A nonprovisional application must be filed within 12 months of the provisional to claim its filing date benefit.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

How does a provisional application affect public disclosure of an invention?

Filing a provisional application does not automatically result in public disclosure of your invention. The MPEP 201.04 states: ‘A provisional application will not be published, and, therefore, no publication fee is required.’

This means that your invention remains confidential when you file a provisional application. However, it’s crucial to understand that:

  • The confidentiality only applies to the USPTO’s handling of your application.
  • If you publicly disclose your invention yourself, it could affect your ability to obtain patents in some countries.
  • The 12-month grace period for filing a nonprovisional application starts from the provisional filing date, not from any public disclosure you might make.

Always consult with a patent attorney before making any public disclosures about your invention, even after filing a provisional application.

For more information on provisional application, visit: provisional application.

For more information on public disclosure, visit: public disclosure.

A plant patent application is a specialized type of patent application designed to protect new varieties of plants. The MPEP 201 states:

A plant application is an application for a plant patent. A plant patent protects a distinct and new variety of plant that is asexually reproduced.

Key differences of plant patent applications include:

  • They are specifically for asexually reproduced plants
  • They protect the entire plant, not just a specific part
  • They have unique requirements for description and claiming

Plant patents are less common than utility or design patents but are crucial for protecting innovations in agriculture and horticulture.

For more information on patent application types, visit: patent application types.

According to MPEP 201.01, a PCT (Patent Cooperation Treaty) application can enter the national stage in the United States through the following process:

  1. The applicant must comply with the requirements of 35 U.S.C. 371.
  2. This typically involves submitting the national fee, a copy of the international application (unless previously communicated by the International Bureau), and a translation into English if the international application was filed in another language.
  3. Once these requirements are met, the application is considered a national application under 35 U.S.C. 111(a).

The MPEP states: “An international application enters the national stage when the applicant has fulfilled the requirements of 35 U.S.C. 371.” This process allows inventors to seek patent protection in multiple countries through a single international application.

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

A Patent Cooperation Treaty (PCT) application can become a national application in the United States when certain conditions are met. According to MPEP 201.01:

‘An international application filed under the Patent Cooperation Treaty in which the basic national fee under 35 U.S.C. 41(a)(1)(F) has been paid’ becomes a national application.

This process, known as ‘national stage entry,’ involves the following steps:

  • Filing the appropriate documents with the USPTO
  • Paying the required national fee
  • Providing an English translation if the international application was not filed in English

Once these requirements are fulfilled, the international application effectively becomes a U.S. national application and is processed accordingly.

For more information on national stage entry, visit: national stage entry.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

When a patent examiner encounters an amendment attempting to reference a prior application in a Continued Prosecution Application (CPA), they should not enter the amendment and inform the applicant of this decision.

According to MPEP ¶ 2.34, examiners should use the following language:

“The amendment filed [1] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [2] application of Application No. [3] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

Examiners should fill in the brackets with: [1] the filing date of the amendment, [2] either “continuation” or “divisional”, and [3] the Application Number of the prior nonprovisional application.

For more information on CPA, visit: CPA.

Tags: CPA

When a patent examiner encounters an amendment attempting to refer to a Continued Prosecution Application (CPA) as a continuation or divisional application, they should not enter the amendment. According to MPEP § 201.06(d), examiners are instructed to use Form Paragraph 2.34 to inform the applicant that such amendments will not be entered:

“Use this form paragraph to inform the applicant that an amendment to the first sentence(s) of the specification referring to the CPA as a continuing application of the prior application has not been entered and will not be entered if submitted again.”

The examiner will provide the reason for non-entry, explaining that the CPA request itself serves as the specific reference required by 35 U.S.C. 120, and there is no need to amend the specification to refer back to the prior application.

For more information on CPA, visit: CPA.

Tags: CPA

A national application differs from an international application in several key aspects:

  • Filing Authority: National applications are filed directly with the United States Patent and Trademark Office (USPTO), while international applications are filed under the Patent Cooperation Treaty (PCT).
  • Legal Basis: National applications are filed under 35 U.S.C. 111(a), as stated in MPEP 201.01: ‘A national application may be filed under 35 U.S.C. 111(a) in the U.S. Patent and Trademark Office (USPTO)…’
  • Geographical Scope: National applications are specific to the United States, while international applications can potentially provide patent protection in multiple countries.
  • Examination Process: National applications enter the USPTO examination queue directly, whereas international applications have an international phase before entering national phases in designated countries.

Understanding these differences is crucial for inventors and legal representatives when deciding on their patent filing strategy.

For more information on USPTO, visit: USPTO.

Tags: USPTO

How does a divisional application differ from other continuing applications?

A divisional application is a unique type of continuing application that focuses on a distinct invention separated from a parent application. According to the MPEP:

A divisional application is one filed for an invention which has been disclosed and claimed, but not allowed, in a prior nonprovisional application or international application designating the United States. It is a later application for an independent and distinct invention carved out of a pending application. (MPEP 201.02)

Key differences of a divisional application include:

  • It is filed in response to a restriction requirement in the parent application
  • It claims only subject matter that was disclosed but not claimed in the parent application
  • It does not add new matter
  • It allows the applicant to pursue protection for inventions that were deemed distinct in the original application

Unlike continuations or CIPs, divisional applications are specifically for pursuing separate inventions identified during the examination of the parent application.

To learn more:

Divisional applications and provisional applications are distinct types of patent applications with different purposes and characteristics:

  • Divisional Application: Claims subject matter from a prior non-provisional application that is independent and distinct from the original claims.
  • Provisional Application: A temporary application that establishes a priority date but does not mature into an issued patent.

The MPEP explicitly states in MPEP ¶ 2.01:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.”

This distinction is important because divisional applications claim the benefit under 35 U.S.C. 120, while provisional applications are claimed under 35 U.S.C. 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

A divisional application discloses and claims only subject matter disclosed in the parent application, while a continuation-in-part (CIP) application may include new matter. The MPEP states:

A continuation-in-part application should not be designated as a divisional application. The Court of Appeals for the Federal Circuit has concluded that the protection of the third sentence of 35 U.S.C. 121 does not extend to continuation-in-part applications, stating that ‘the protection afforded by section 121 to applications (or patents issued therefrom) filed as a result of a restriction requirement is limited to divisional applications.’

This means that divisional applications have certain protections against double patenting rejections that CIPs do not have.

To learn more:

A divisional application does not extend the patent term beyond that of the parent application. The term of a patent issuing from a divisional application is calculated from the filing date of the earliest application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c), excluding any benefit claims to provisional applications.

This means that while you can pursue additional patent protection through a divisional application, you don’t get extra time beyond the original 20-year term from the earliest non-provisional filing date.

It’s important to note that patent term adjustments may apply independently to divisional applications based on delays in their own prosecution.

To learn more:

A divisional application’s patent term adjustment (PTA) is calculated independently from its parent application. The MPEP 201.06 provides guidance on this matter:

‘A divisional application will receive its own patent term adjustment under 35 U.S.C. 154(b), which will be calculated based on the prosecution of the divisional application itself.’

Key points to understand:

  • The divisional application’s PTA is based solely on its own prosecution history
  • Any delays or adjustments from the parent application do not affect the divisional’s PTA
  • The PTA calculation starts from the filing date of the divisional application
  • Applicants should monitor the prosecution of the divisional application to ensure accurate PTA calculation

For more information on patent term adjustment, refer to MPEP 2730.

To learn more:

To learn more:

Design patent applications and utility patent applications are distinct types of patent applications, each protecting different aspects of an invention. According to MPEP 201:

‘Design applications are not included in the term ‘nonprovisional’ as used in 37 CFR 1.9. […] Design applications are treated separately in 35 U.S.C. 171-173 and 37 CFR 1.151-1.155.’

Key differences include:

  • Subject Matter: Utility patents protect how an invention works, while design patents protect how it looks.
  • Duration: Utility patents last 20 years from filing, design patents 15 years from grant.
  • Examination Process: Design applications typically have a simpler examination process.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) automatically references the prior application without requiring any specific amendment to the specification.

According to MPEP ¶ 2.34: “As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that the act of filing a CPA itself serves as the reference to the prior application, eliminating the need for any additional amendments or references in the specification.

A Continued Prosecution Application (CPA) differs from other types of continuing applications in several ways:

  • CPAs are only available for design applications, not utility applications.
  • Filing a CPA automatically establishes the necessary reference to the prior application under 35 U.S.C. 120, without needing to amend the specification.
  • CPAs are processed differently from other continuing applications, as outlined in MPEP § 201.06(d).

The MPEP states: ‘As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.’ This unique feature distinguishes CPAs from other types of continuing applications, such as continuations or divisionals, which may require explicit references in the specification.

For more information on continuing applications, visit: continuing applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) and a continuation application are both ways to continue prosecution of a patent application, but they have key differences:

  • CPA: Only available for design applications filed before May 29, 2000, and for plant applications. It continues examination of the same application.
  • Continuation: Available for all types of applications and creates a new application that claims priority to the parent application.

The MPEP ¶ 2.34 highlights a crucial distinction in how they reference prior applications:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.

This means that for a CPA, the mere act of filing establishes the reference to the prior application. In contrast, a continuation application typically requires an explicit reference to the parent application in the specification.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) automatically maintains the priority claim to its parent application without requiring a separate reference. The CPA itself serves as the specific reference required under 35 U.S.C. 120.

The MPEP states: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

This means that filing a CPA automatically establishes a priority claim to the parent application and any earlier applications in the priority chain without additional paperwork.

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

Filing a Continued Prosecution Application (CPA) has specific effects on the status of the prior application:

  • The prior application is abandoned by operation of law upon filing of the CPA.
  • Any appeal in the prior application is dismissed automatically.
  • Any amendment filed with the CPA request is not entered unless it is specifically requested by the applicant.

As stated in the MPEP 201.06(d): ‘The filing of a CPA is not a filing of a new application. Rather, it is a continuation of the pending prior application.’ This means that while the prior application is technically abandoned, its substance continues in the CPA.

It’s important to note that any amendment accompanying the CPA request will be placed in the file but not entered unless the applicant specifically requests it. This allows applicants to submit potential amendments without automatically changing the application’s content.

For more information on CPA, visit: CPA.

Tags: CPA

Filing a Continued Prosecution Application (CPA) has several effects on the examination process:

  • The CPA is treated as a continuation of the prior application for examination purposes
  • Information Disclosure Statements from the prior application are automatically considered in the CPA
  • Affidavits and declarations from the prior application carry over to the CPA
  • A terminal disclaimer filed in the parent application carries over to the CPA
  • For examination priority, CPAs are treated as ‘amended’ applications rather than ‘new’ applications if an Office action was issued in the prior application

MPEP 201.06(d) notes: For examination priority purposes only, the USPTO will treat continuation CPAs as if they were ‘amended’ applications (as of the CPA filing date) and not as ‘new’ applications. This treatment is limited to CPAs in which the prior application has an Office action issued by the examiner.

For more information on design patents, visit: design patents.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

Filing a Continued Prosecution Application (CPA) can impact the examination process and priority. Key points include:

  • CPAs are generally treated as “amended” applications for examination priority purposes
  • This may result in faster first Office actions compared to new applications
  • Preliminary amendments should be filed with the CPA to avoid potential denial of entry
  • Information Disclosure Statements (IDS) from the prior application are automatically considered

As stated in the MPEP:

For examination priority purposes only, the USPTO will treat continuation CPAs as if they were “amended” applications (as of the CPA filing date) and not as “new” applications. This treatment is limited to CPAs in which the prior application has an Office action issued by the examiner.

Applicants can request a three-month suspension of action under 37 CFR 1.103(b) if more time is needed to prepare amendments or an IDS. Affidavits and declarations from the parent application automatically become part of the CPA.

A Continued Prosecution Application (CPA) automatically maintains the benefit claim to earlier applications. The MPEP states:

A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. That is, the CPA includes the request for an application under 37 CFR 1.53(d) and the recitation of the application number of the prior application in such request is the ‘specific reference to the earlier filed application’ required by 35 U.S.C. 120.

This means that filing a CPA automatically establishes a benefit claim to the prior application and any earlier applications in the chain, without the need for a separate statement in the specification or application data sheet. However, if the prior application claimed benefit of earlier applications, those benefit claims must still be present in the prior application.

For more information on continuation applications, visit: continuation applications.

For more information on patent priority, visit: patent priority.

Continued Prosecution Applications (CPAs) automatically carry over certain aspects from the parent application. Specifically:

  • Priority claims under 35 U.S.C. 119(a)-(d) made in the parent application automatically carry over to a CPA.
  • A terminal disclaimer filed in the parent application carries over to a CPA.

The MPEP explains: Priority claims under 35 U.S.C. 119(a)-(d) made in a parent application will automatically carry over to a CPA. A terminal disclaimer filed in the parent application carries over to a CPA.

This automatic carry-over occurs because the CPA retains the same application number as the parent application.

For more information on patent applications, visit: patent applications.

Filing a Continued Prosecution Application (CPA) can affect patent term because it results in a new filing date. While the CPA retains the benefit of the earlier filing date for prior art purposes, the actual filing date of the CPA is used for calculating patent term. The MPEP notes: Applicants will not be permitted to delete such a benefit claim as to certain applications assigned that application number (e.g., for patent term purposes). This means that the patent term for a CPA will generally be shorter than if the original application had been allowed, as the term is calculated from the CPA filing date, not the original application’s filing date.

To learn more:

Tags: CPA, patent term

Filing a Continued Prosecution Application (CPA) can have important implications for both patent term and prior art dates:

Patent Term:

  • A CPA is a continuation of the prior application, so it does not get a new 15-year term from filing
  • The 15-year term for a design patent issuing from a CPA is measured from the filing date of the earliest application in the chain that is subject to the 15-year term

Prior Art Dates:

  • The effective filing date of a CPA for prior art purposes is generally the actual filing date of the CPA
  • However, the CPA can claim the benefit of the prior application’s filing date for subject matter disclosed in the prior application

The MPEP notes: “A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No amendment in an application under this paragraph may delete this specific reference to any prior application.” (37 CFR 1.53(d)(7))

This means the CPA is automatically considered a continuation for benefit claim purposes, which can affect both term and prior art dates.

For more information on benefit claims, visit: benefit claims.

For more information on patent term, visit: patent term.

For more information on prior art, visit: prior art.

The inventorship in a Continued Prosecution Application (CPA) generally remains the same as in the prior application. The MPEP states, The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA. If changes to inventorship are needed, they must be made through a specific request under 37 CFR 1.48.

To learn more:

Tags: CPA, inventorship

Filing a Continued Prosecution Application (CPA) has implications for the confidentiality of the application. As stated in the MPEP:

A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means:

  • The CPA is treated as a waiver of confidentiality for the prior application
  • Members of the public who have access to the CPA may also be given access to the prior application
  • This applies to all applications in the chain of CPAs

Applicants should consider this loss of confidentiality when deciding whether to file a CPA or a new application under 37 CFR 1.53(b).

For more information on Patent application access, visit: Patent application access.

For more information on public information, visit: public information.

A Continued Prosecution Application (CPA) automatically maintains the benefit claim to the prior application under 35 U.S.C. 120 without requiring a separate statement. Key points include:

  • The CPA request itself serves as the specific reference required by 35 U.S.C. 120
  • No amendment to the specification or application data sheet is needed to maintain the benefit claim
  • The benefit claim extends to all applications in a chain of CPAs

As stated in the MPEP: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on patent applications, visit: patent applications.

A Continued Prosecution Application (CPA) has specific effects on benefit claims and references to prior applications:

  • The CPA request itself serves as the specific reference required by 35 U.S.C. 120
  • No amendment to the specification or application data sheet is required or permitted to reference the prior application
  • A CPA automatically includes a benefit claim to all applications in the chain of CPAs with the same application number

As stated in the MPEP:

A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No amendment in an application under this paragraph may delete this specific reference to any prior application.

This means that applicants cannot selectively delete benefit claims to certain applications in the CPA chain. When referencing a CPA in a later application, the reference incorporates the entire chain of applications with that application number.

A Continued Prosecution Application (CPA) is a unique type of continuing application that has specific limitations. According to MPEP 201.02:

A ‘continued prosecution application’ (CPA) is a continuation or divisional application for an invention disclosed in a prior nonprovisional application filed under 37 CFR 1.53(b) or (d). A CPA can only be filed in a design application.

Key differences of CPAs compared to other continuing applications:

  • Limited to design applications: CPAs can only be filed for design patents, not utility or plant patents.
  • Automatic abandonment: Filing a CPA automatically abandons the prior application.
  • Simplified filing: CPAs can be filed with fewer formalities than other continuing applications.
  • Examination continuation: The examination process continues from where it left off in the parent application.

It’s important to note that CPAs are no longer available for utility or plant applications filed on or after May 29, 2000. For these types of applications, applicants must use other forms of continuing applications, such as RCEs (Requests for Continued Examination).

For more information on continued prosecution application, visit: continued prosecution application.

For more information on continuing applications, visit: continuing applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

How does a continuing application claim benefit to a prior-filed international application?

A continuing application can claim benefit to a prior-filed international application that designates the United States. The MPEP 211.01(b) states:

‘A nonprovisional application may claim benefit under 35 U.S.C. 120 to an international application designating the United States only if the international application was filed on or after November 29, 2000.’

To claim this benefit, the following conditions must be met:

  • The international application must designate the United States
  • It must be filed on or after November 29, 2000
  • The benefit claim must be made in accordance with 37 CFR 1.78
  • The continuing application must be filed while the international application is pending before the USPTO or within the time period set in 35 U.S.C. 120, 121, 365(c), or 386(c)

It’s important to note that the benefit claim is to the international application itself, not to its national stage in the United States.

To learn more:

To learn more:

A continuation-in-part (CIP) application and a provisional application are two distinct types of patent applications with different purposes and effects. The key difference is highlighted in MPEP ¶ 2.06, which states:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation-in-part’ of the provisional application.

This means that:

  • A CIP application builds upon a prior non-provisional application, adding new disclosure while claiming the benefit of the earlier filing date for the shared content.
  • A provisional application is a temporary placeholder that establishes a priority date but does not mature into a patent. It cannot be continued or have a CIP.
  • Applications claiming benefit from a provisional application are typically filed as new non-provisional applications, not as CIPs.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

How does a continuation-in-part application affect the priority date?

A continuation-in-part (CIP) application can have different priority dates for different parts of the disclosure. According to MPEP 201.08:

‘The continuation-in-part application may be entitled to the benefit of the filing date of the prior application as to the common subject matter disclosed in compliance with 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph.’

This means:

  • Content shared with the parent application retains the earlier priority date.
  • New matter added in the CIP has the filing date of the CIP as its priority date.
  • Different claims in the CIP may have different priority dates based on their disclosure in the parent or CIP application.

Understanding these priority date implications is crucial for determining patentability and prior art considerations.

For more information on new matter, visit: new matter.

Tags: new matter

A continuation-in-part (CIP) application can have a complex effect on patent term. The MPEP 201.08 states:

‘A continuation-in-part application is entitled to the benefit of the filing date of an earlier nonprovisional application as to common subject matter.’

This has several implications for patent term:

  • 20-year term: The patent term is generally 20 years from the earliest effective U.S. filing date of the first nonprovisional application in the chain.
  • New matter: Claims solely supported by new matter in the CIP do not receive the benefit of the earlier filing date, potentially extending their effective term.
  • Priority claims: The ability to claim priority to earlier applications can affect the starting point of the 20-year term.
  • Patent term adjustment: Delays in prosecution may lead to patent term adjustments, which can extend the term beyond 20 years.

Applicants should carefully consider the impact on patent term when deciding to file a CIP, especially for rapidly evolving technologies where a longer term might be advantageous.

For more information on new matter, visit: new matter.

For more information on patent term, visit: patent term.

For more information on patent term adjustment, visit: patent term adjustment.

A continuation-in-part (CIP) application is a type of continuing application that differs from a regular continuation in its content and priority claims. According to MPEP 201.08:

‘A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.’

Key differences between CIP and regular continuation applications:

  • New Matter: CIPs include new subject matter not present in the parent application, while regular continuations do not.
  • Priority Date: CIPs have different priority dates for different parts of the disclosure. The new matter gets the CIP’s filing date, while common subject matter retains the parent’s filing date.
  • Examination: CIPs are examined for both the old and new subject matter, potentially requiring additional prior art searches.
  • Term: The patent term for a CIP may be affected by the new subject matter’s later filing date.

CIPs are useful when inventors want to add new improvements or developments to their original invention while maintaining the priority date for the original subject matter.

For more information on continuing applications, visit: continuing applications.

How does a continuation-in-part (CIP) application affect priority claims?

A continuation-in-part (CIP) application introduces new matter not present in the prior application, which affects priority claims as follows:

  • Claims fully supported by the prior application retain the benefit of the earlier filing date.
  • Claims relying on new matter only receive the filing date of the CIP application.
  • As stated in MPEP 211.01(b): “Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the prior-filed application are entitled to the benefit of the filing date of the prior-filed application.”

Examiners must analyze each claim individually to determine its effective filing date. This can result in different claims within the same CIP application having different priority dates.

To learn more:

Continuation applications and provisional applications are distinct types of patent applications with different purposes and requirements. A key difference is that a continuation application is based on a prior nonprovisional application, while a provisional application is a standalone filing that can later be used as a priority document.

The MPEP specifically notes:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the provisional application.”

This guidance also applies to continuation applications. Provisional applications serve as temporary placeholders and do not undergo examination, while continuation applications are fully examined and build upon previously filed nonprovisional applications.

To learn more:

While both continuation and continuation-in-part (CIP) applications are types of continuing applications, they have a key difference in terms of their disclosure. According to the MPEP:

The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

The main differences are:

  • Continuation: Contains the same disclosure as the parent application without any new matter.
  • Continuation-in-part (CIP): May include the disclosure from the parent application plus additional new matter.

This distinction is crucial because it affects the priority date for different claims in the application. In a continuation, all claims are entitled to the parent’s filing date. In a CIP, only claims supported by the parent application get the benefit of the earlier filing date; new matter gets the filing date of the CIP.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

A continuation application can have significant implications for the patent term. Here are key points to understand:

  • Patent Term Calculation: The term of a patent stemming from a continuation application is generally calculated from the filing date of the earliest application in the chain to which priority is claimed.
  • 20-Year Term: Under current U.S. law, utility and plant patents have a term of 20 years from the earliest effective U.S. filing date of the application.
  • No Extension of Monopoly: As stated in MPEP 201.07, ‘The filing of a continuation application does not extend the term of the patent to be granted on the continuing application because the term of a patent issuing on a continuation application is measured from the filing date of the earliest application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c).’
  • Patent Term Adjustment: While the base term is not extended, a continuation may be eligible for patent term adjustment due to delays in prosecution, which can effectively extend the term.

It’s important to note that while continuation applications don’t extend the base patent term, they can provide strategic advantages in terms of claim scope and prosecution timing.

To learn more:

A continuation-in-part (CIP) application differs from a regular continuation application in that it adds new disclosure not present in the prior application. While both types of applications repeat substantial portions of a prior application, only a CIP introduces new subject matter.

The MPEP states: This application repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application. (MPEP ¶ 2.06) This additional disclosure is what sets a CIP apart from a standard continuation.

For more information on continuation application, visit: continuation application.

For more information on patent application types, visit: patent application types.

37 CFR 1.63(d) provides a simplified process for submitting an oath or declaration in a divisional application. The MPEP states:

’37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a continuation or divisional application filed by all or by fewer than all of the inventors named in a prior nonprovisional application containing a signed oath or declaration.’

This means that if the divisional application is filed by the same inventor(s) as the parent application, and there’s no new matter added, the oath or declaration from the parent application can be used for the divisional application. This simplifies the filing process and reduces paperwork.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on oath or declaration, visit: oath or declaration.

37 CFR 1.57(b) is closely tied to priority claims in patent applications. For an amendment to comply with this regulation, the claim for priority or benefit of the prior-filed application must have been present on the filing date of the current application.

The MPEP specifically states that an amendment may not comply with 37 CFR 1.57(b) if the claim for priority/benefit of the prior-filed application was not present on the filing date of the present application. This requirement ensures that the incorporation by reference is based on a properly established relationship between the current application and the prior-filed application.

If the priority claim was not present at filing, the applicant cannot use 37 CFR 1.57(b) to incorporate material from the prior-filed application, even if that material was inadvertently omitted.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

For more information on patent applications, visit: patent applications.

35 U.S.C. 365(c) is a crucial provision for claiming the benefit of an international application’s filing date in a subsequent national application. As explained in MPEP 211.01(c):

The first sentence of 35 U.S.C. 365(c) specifically provides that ‘[i]n accordance with the conditions and requirements of section 120,… a national application shall be entitled to the benefit of the filing date of a prior international application designating the United States.’

This provision allows applicants to claim the priority of an international application in a later-filed U.S. national application, provided they meet the conditions set forth in 35 U.S.C. 120. One key condition is timing, as the MPEP notes:

The condition of 35 U.S.C. 120 relating to the time of filing requires the later application to be ‘filed before the patenting or abandonment of or termination of proceedings on the first application….’

This means that the national application must be filed while the international application is still pending to claim its benefit.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

35 U.S.C. 365 addresses the right of priority for international applications in two key aspects:

  1. National applications based on international applications
  2. International applications based on foreign applications

The MPEP states:

“35 U.S.C. 365(a) provides that a national application shall be entitled to the right of priority based on a prior international application of whatever origin, which designated any country other than, or in addition to, the United States.”

“35 U.S.C. 365(b) provides that an international application designating the United States shall be entitled to the right of priority of a prior foreign application which may either be another international application or a regularly filed foreign application.”

These provisions ensure that applicants can claim priority based on international applications, enhancing the flexibility of the international patent system.

Claiming the benefit of a prior application in a continuation is a crucial step that must be done correctly. The MPEP 201.07 provides specific guidance:

If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§1.76(b)(5)). The reference also must identify the relationship of the applications, namely, whether the later-filed application is a continuation, divisional, or continuation-in-part of the prior-filed nonprovisional application, international application, or international design application.

To properly claim the benefit:

  1. Include a reference to the prior application in the Application Data Sheet (ADS)
  2. Specify the application number, filing date, and relationship (continuation) of the applications
  3. Ensure the claim is made within the time period set in 37 CFR 1.78
  4. Pay any required fees

Failure to properly claim benefit can result in loss of the earlier filing date, so it’s crucial to follow these steps carefully.

For more information on continuation application, visit: continuation application.

For more information on patent law, visit: patent law.

The first inventor to file provisions of the America Invents Act (AIA) have significant implications for priority and benefit claims, particularly for applications filed on or after March 16, 2013. Key points include:

  1. The effective filing date of each claimed invention determines whether an application is subject to examination under AIA or pre-AIA 35 U.S.C. 102 and 103.
  2. Applications that contain or contained at any time a claim with an effective filing date on or after March 16, 2013, are subject to the AIA version of 35 U.S.C. 102 and 103.
  3. Applications that claim priority to or benefit of a pre-AIA application may be subject to additional requirements.

As stated in the MPEP: These provisions apply to any application for patent, and to any patent issuing thereon, that contains or contained at any time— (A) a claim to a claimed invention that has an effective filing date as defined under section 100(i) of title 35, United States Code, that is on or after March 16, 2013; or (B) a specific reference under section 120, 121, or 365(c) of title 35, United States Code, to any patent or application that contains or contained at any time such a claim. (MPEP 210)

For transition applications (those filed on or after March 16, 2013, that claim priority to or benefit of a pre-AIA application), applicants may need to provide a statement regarding the presence of claims with an effective filing date on or after March 16, 2013. This requirement is outlined in 37 CFR 1.55(k) and 1.78(a)(6) and (d)(6).

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

For more information on pre-AIA, visit: pre-AIA.

For more information on transition applications, visit: transition applications.

How do reissue applications differ from original patent applications?

Reissue applications are distinct from original patent applications in that they are used to correct errors in already-issued patents. The MPEP 201 states, “An application for reissue of a patent is an application for a new patent to correct an error in an unexpired patent as provided in 37 CFR 1.171 through 1.178.”

Key differences include:

  • Purpose: To correct errors in existing patents, not to obtain new patents
  • Timing: Filed after a patent has been issued and while it’s still unexpired
  • Legal basis: Filed under 35 U.S.C. 251 and subject to specific regulations
  • Content: Must include a copy of the original patent and point out the error(s) to be corrected
  • Examination: Focuses on the proposed changes and their impact on patentability

Reissue applications provide a mechanism for patent holders to address issues in their patents, potentially broadening or narrowing claims, or correcting other substantive errors.

For more information on reissue applications, visit: reissue applications.

How do I retrieve a priority document from a foreign IP office using PDX?

To retrieve a priority document from a foreign IP office using PDX:

  • Ensure the foreign IP office participates in PDX.
  • File an application with the USPTO that claims priority to the foreign application.
  • Submit a Request to Retrieve through EFS-Web or Patent Center.
  • Include the foreign application number, country code, and filing date.
  • The USPTO will attempt to retrieve the document electronically.

According to MPEP 215.01: “The USPTO will attempt to electronically retrieve the priority document through the WIPO DAS […] or through a bilateral PDX agreement.”

To learn more:

To request retrieval of a foreign priority document through the Priority Document Exchange (PDX) program, follow these steps:

  1. Ensure that the foreign application is from a participating office in the PDX program.
  2. File an application data sheet (ADS) including a proper priority claim to the foreign application.
  3. Submit a request for retrieval of the foreign priority document.

The MPEP 215.01 states: “To authorize retrieval of a priority document via PDX, the applicant should submit the request electronically via EFS-Web using the Priority Document Exchange Request form (PTO/SB/38) or as a pre-grant (PGPub) request via Private PAIR.” It’s important to note that the request should be made within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To request deletion of a named inventor in a Continued Prosecution Application (CPA) for design applications, you need to file a proper request with the USPTO. According to MPEP § 201, specifically paragraph 2.32:

In a continued prosecution application (CPA) for a design application (37 CFR 1.53(d)), a request to delete a named inventor from the prior application may be submitted by way of a letter to the examiner or a request for corrected filing receipt. However, it should be noted that this is only available for design applications.

This process is specific to design applications and allows for the correction of inventorship in CPAs.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on USPTO procedures, visit: USPTO procedures.

For applications filed on or after September 16, 2012, the specific reference to the prior application must be included in an application data sheet (ADS) in compliance with 37 CFR 1.76. For applications filed before September 16, 2012, the reference should be in an ADS and/or in the first sentence(s) of the specification following the title.

The reference must include:

  • The prior application number
  • The filing date
  • The relationship between the applications (continuation, divisional, or continuation-in-part) for nonprovisional applications

For example: “This application is a continuation of Application No. 12/345,678, filed January 1, 2010.”

For provisional applications, only the application number and filing date are required. The relationship should not be specified.

To learn more:

To properly identify a foreign application when claiming priority, you must provide the following information:

  • Application number
  • Country or intellectual property authority
  • Day, month, and year of filing

As stated in MPEP 214.01: “The claim for priority must be presented in an application data sheet (§ 1.76(b)(6)) and must identify the foreign application to which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.”

For applications filed under 35 U.S.C. 111(a) on or after September 16, 2012, this information must be provided in an application data sheet. For earlier applications, it may be included in the oath or declaration if not provided in an application data sheet.

To learn more:

How do I properly identify a foreign application when claiming priority in a U.S. patent application?

When claiming priority to a foreign application in a U.S. patent application, it’s crucial to provide accurate identification information. According to MPEP 214.01, you must include the following details:

  • The application number of the foreign application
  • The country or intellectual property authority where the foreign application was filed
  • The day, month, and year of filing of the foreign application

The MPEP states: ‘The claim for priority must identify the foreign application for which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.’

Additionally, if you’re submitting a certified copy of the foreign application, ensure that it matches the identification information provided in your priority claim. Accurate identification is essential for establishing your priority rights and avoiding potential issues during examination or litigation.

To properly claim the benefit of a prior application, you must include a specific reference to the prior application. For applications filed on or after September 16, 2012, this reference must be included in an application data sheet (ADS). For applications filed before September 16, 2012, the reference must be in an ADS and/or in the first sentence(s) of the specification following the title.

The MPEP 211.02 states: Both 35 U.S.C. 119(e) and 120 include the requirement that the later-filed application must contain a specific reference to the prior application.

For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on ADS, visit: ADS.

For more information on divisional, visit: divisional.

For more information on specific reference, visit: specific reference.

How do I mark changes in a corrected Application Data Sheet (ADS) for benefit claims?

When submitting a corrected Application Data Sheet (ADS) to add or correct a benefit claim, it’s crucial to properly mark the changes. According to MPEP 211.02(a):

The corrected ADS must identify the information that is being changed with underlining for insertions and strike-through or brackets for text removed as required by 37 CFR 1.76(c)(2).

To properly mark changes in a corrected ADS:

  • Insertions: Underline new text
  • Deletions: Use strike-through or brackets for removed text
  • Existing information: Include all information from the original ADS, even if unchanged

It’s important to note that the entire benefit claim must be underlined if you’re adding a new benefit claim. This helps the USPTO easily identify and process the changes to your application.

To learn more:

Tags: ADS

To file a foreign priority claim in a U.S. patent application, you must:

  1. File the claim within the specified time limit (see previous FAQ for details).
  2. Present the claim in an application data sheet (ADS) for applications filed on or after September 16, 2012. For applications filed before this date, the claim can be in the ADS or in the oath/declaration.
  3. Identify the foreign application by providing:
    • Application number
    • Country (or intellectual property authority)
    • Filing date (day, month, and year)

This is specified in 37 CFR 1.55(d)(1): The claim for priority must be presented in an application data sheet (§1.76(b)(6)) and must identify the foreign application to which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.

It’s crucial to provide accurate and complete information to ensure your priority claim is properly recorded and considered.

For international applications entering the national stage in the United States under 35 U.S.C. 371, the process for filing a foreign priority claim is different from regular U.S. applications. According to MPEP 214.01:

“The claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT in an international application entering the national stage under 35 U.S.C. 371, except as provided in paragraph (e) of this section.”

This means that you need to follow the time limits specified in the Patent Cooperation Treaty (PCT) and its regulations when filing a priority claim for an international application entering the U.S. national stage.

For more detailed information on the timing and procedure for claiming priority in national stage applications, you should refer to MPEP § 213.06, which specifically deals with this topic.

To learn more:

Filing a delayed benefit claim in an international application involves specific procedures. The MPEP 211.04 provides guidance on this matter:

“A petition under 37 CFR 1.78 for accepting an unintentionally delayed benefit claim and the petition fee under 37 CFR 1.17(m) are required to add a benefit claim under 35 U.S.C. 120 and 365(c) in an abandoned international application designating the United States, even when the international application did not enter the national stage under 35 U.S.C. 371.”

For international applications not filed with the United States Receiving Office and not a nonprovisional application, the petition may be filed in the earliest nonprovisional application that claims benefit to the international application. As stated in MPEP 211.04:

“If a petition under 37 CFR 1.78(c) or (e) is required in an international application that was not filed with the United States Receiving Office and is not a nonprovisional application, then the petition may be filed in the earliest nonprovisional application that claims benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the international application and will be treated as having been filed in the international application.”

To learn more:

To correctly add a new inventor to a Continued Prosecution Application (CPA), you must follow the procedures outlined in 37 CFR 1.48. The MPEP ¶ 2.33 states:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48.

To add a new inventor:

  1. File a request under 37 CFR 1.48 to correct the inventorship.
  2. Include a statement from the new inventor agreeing to the addition.
  3. Pay any required fees.
  4. Provide an oath or declaration from the new inventor.

Failure to follow these steps may result in the inventorship remaining the same as in the prior application.

For more information on CPA, visit: CPA.

Tags: CPA

How do I correct the filing date of a prior-filed application in a benefit claim?

To correct the filing date of a prior-filed application in a benefit claim, you need to follow specific procedures outlined in MPEP 211.02(a). The MPEP states:

“If the prior application is a provisional application, and the filing date of the provisional application in the benefit claim is incorrect, applicant should file a petition under 37 CFR 1.78 to correct the benefit claim. A petition under 37 CFR 1.78 and the petition fee are required to correct the benefit claim because the correction is considered a delayed claim as per 37 CFR 1.78.”

For non-provisional applications, a similar process applies. You must file a petition under 37 CFR 1.78 along with the required fee to correct the filing date in the benefit claim.

To learn more:

To correct or add a benefit claim after filing your application, you need to follow specific procedures depending on the timing and circumstances:

  1. If you received a filing receipt with missing or incorrect benefit claim information, you can request a corrected filing receipt. However, the Office will only grant this request if the proper reference to the prior application was included in the original filing or within the time period required by 37 CFR 1.78.
  2. If you’re adding a benefit claim after the time period required by 37 CFR 1.78, you must file a petition and pay the petition fee. The petition must be accompanied by a corrected Application Data Sheet (ADS) for applications filed on or after September 16, 2012, or an amendment to the specification or a supplemental ADS for applications filed before that date.

As stated in MPEP 211.02(a): If a benefit claim is added after the time period required by 37 CFR 1.78, a petition and the petition fee are required.

Depending on the status of your application, you may also need to file:

  • A Request for Continued Examination (RCE) if the application is under final rejection or has been allowed.
  • A reissue application or a request for a certificate of correction if the application has already issued as a patent.

It’s important to note that you cannot add an incorporation by reference statement to a benefit claim after the filing date, as this would be considered new matter.

For more information on ADS, visit: ADS.

For more information on RCE, visit: RCE.

Tags: ADS, RCE

How do I correct an error in my foreign priority claim?

If you need to correct an error in your foreign priority claim, the process depends on the nature of the error and when it’s discovered. According to MPEP 214.01, “Applicant may correct the failure to adequately claim priority to the prior foreign application by amending the specification or submitting a new application data sheet (ADS) identifying the foreign application by application number, country (or intellectual property authority), and filing date.” Here are some key points to remember:

  • If the error is discovered within the time period for filing the priority claim, you can simply submit a corrected ADS or amend the specification.
  • If the error is discovered after the time period has expired, you may need to file a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim.
  • For minor typographical errors, a request for a corrected filing receipt may be sufficient.

Always consult with a patent attorney or agent to determine the best course of action for your specific situation.

To correct a benefit claim in your patent application, follow these steps:

  1. For applications filed on or after September 16, 2012:
    • Submit a corrected Application Data Sheet (ADS) in compliance with 37 CFR 1.76(c)
  2. For applications filed before September 16, 2012:
    • Submit an amendment to the specification (if the benefit claim is in the specification) or
    • Submit a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c)
  3. If the correction is made after the time period set in 37 CFR 1.78:
    • File a petition under 37 CFR 1.78
    • Pay the required petition fee
    • Provide a statement that the entire delay was unintentional

MPEP 211.02(a) states: “If applicant receives a filing receipt with missing or incorrect benefit claim information, applicant may request a corrected filing receipt. The Office will not grant a request for a corrected filing receipt to include a benefit claim unless the proper reference to the prior application is included (i) in an ADS (for applications filed on or after September 16, 2012) or (ii) in the first sentence(s) of the specification or an ADS (for applications filed prior to September 16, 2012) within the time period required by 37 CFR 1.78 with a few exceptions.”

It’s important to review your filing receipt promptly and carefully to avoid the need for a petition and associated fees.

To learn more:

How do I correct a benefit claim in a nonprovisional application after the time period set forth in 37 CFR 1.78?

To correct a benefit claim in a nonprovisional application after the time period set forth in 37 CFR 1.78, you need to file a petition to accept a delayed claim. The MPEP states:

“A petition to accept a delayed claim under 37 CFR 1.78(c) for the benefit of a prior-filed provisional application or under 37 CFR 1.78(e) for the benefit of a prior-filed nonprovisional application must be accompanied by:”

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78(a)(3) to the prior-filed provisional application or the reference required by 35 U.S.C. 120 and 37 CFR 1.78(d)(2) to the prior-filed nonprovisional application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(a)(4) or 37 CFR 1.78(d)(3) and the date the benefit claim was filed was unintentional.

The Director may require additional information where there is a question whether the delay was unintentional.

For more detailed information, refer to MPEP 211.02(a).

To learn more:

To claim the benefit of a prior-filed application, you must include a specific reference to the prior-filed application in your current application. The method of including this reference depends on when your application was filed:

  • For applications filed before September 16, 2012: Include the reference in the first sentence(s) of the specification following the title or in an application data sheet (ADS) compliant with pre-AIA 37 CFR 1.76.
  • For applications filed on or after September 16, 2012: Include the reference in an ADS compliant with 37 CFR 1.76.

The MPEP states: If applicant desires to claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c), the instant application must contain, or be amended to contain, a specific reference to the prior-filed application in compliance with 37 CFR 1.78. (MPEP § 211)

For more information on ADS, visit: ADS.

For more information on prior-filed application, visit: prior-filed application.

For more information on specific reference, visit: specific reference.

To claim the benefit of a prior-filed application in a continuation application, you must include a reference to the prior-filed application in the new application. According to 37 CFR 1.78(d)(2):

Any nonprovisional application, international application designating the United States, or international design application designating the United States that claims the benefit of one or more prior-filed nonprovisional applications, international applications designating the United States, or international design applications designating the United States must contain or be amended to contain a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number), international application number and international filing date, or international registration number and filing date under §1.1023.

For nonprovisional applications, this reference must be included in an application data sheet (ADS) as specified in 37 CFR 1.76(b)(5). The reference should also identify the relationship between the applications, stating whether it’s a continuation, divisional, or continuation-in-part.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

For more information on prior-filed application, visit: prior-filed application.

Priority to an international design application can be claimed in a U.S. nonprovisional application or in another international design application designating the U.S. MPEP 213.07 states: ‘Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.’

The priority claim should be made in an Application Data Sheet (ADS) for nonprovisional applications. For international design applications designating the U.S., the priority claim can be made in accordance with the Hague Agreement and Regulations.

For more information on Hague Agreement, visit: Hague Agreement.

For international applications entering the U.S. national stage under 35 U.S.C. 371, the priority claim must be made within the time limit set by the PCT and its regulations. MPEP 213.06 states: ‘In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made and a certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT.’

If the priority claim was properly made during the international phase, it’s generally not necessary to repeat it upon national stage entry. However, the certified copy of the priority document must be furnished if not previously submitted to the International Bureau or the USPTO.

For more information on national stage application, visit: national stage application.

To claim priority in a nonprovisional international design application:

  • Include a priority claim in the international design application when filed with the International Bureau (IB).
  • The priority claim must specify the application number and filing date of the priority application.
  • File a certified copy of the priority application with the IB or the USPTO, or have it retrieved through the Digital Access Service (DAS).

According to MPEP 213.07: An applicant filing an international design application designating the United States may claim priority to one or more prior foreign applications under the Paris Convention or to a prior provisional application under 35 U.S.C. 119(e).

To learn more:

To learn more:

To claim benefit to a non-English language provisional application, you must:

  • File an English translation of the non-English language provisional application
  • Provide a statement that the translation is accurate
  • File both the translation and the statement in the provisional application
  • Confirm in the present application that the translation and statement were filed in the provisional application

According to MPEP ¶ 2.38, “An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3]. See 37 CFR 1.78.”

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP), you need to follow specific procedures. The MPEP ¶ 2.06 states: “Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

This means you must:

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the common subject matter.

Continuation, divisional, and continuation-in-part (CIP) applications are all types of continuing applications, but they have key differences:

  • Continuation application: Discloses and claims only subject matter disclosed in the prior application. No new matter is added.
  • Divisional application: Results from a restriction requirement in the parent application. Claims an independent and distinct invention carved out of the parent application. No new matter is added.
  • Continuation-in-part (CIP) application: Repeats a substantial portion of the prior application and adds matter not disclosed in the prior application (i.e., new matter is added).

As stated in the MPEP regarding continuation-in-part applications:

A continuation-in-part is an application filed during the lifetime of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.

All three types of applications must claim the benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c) and comply with other requirements set forth in 37 CFR 1.78.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

Benefit claims in Continued Prosecution Applications (CPAs) have some unique characteristics:

  • A CPA automatically includes a specific reference under 35 U.S.C. 120 to the prior application
  • No additional amendment to the specification or application data sheet is required to claim benefit
  • A CPA is considered to reference every application in the chain with the same application number
  • Priority claims under 35 U.S.C. 119(a)-(d) from the parent application automatically carry over to the CPA

The MPEP states: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

It’s important to note that applicants cannot delete benefit claims to certain applications in a chain of CPAs. The MPEP clarifies: Therefore, regardless of whether an application is filed under 37 CFR 1.53(b) or (d), a claim under 35 U.S.C. 120 to the benefit of a CPA is, by operation of 37 CFR 1.53(d)(7) and 37 CFR 1.78(d)(4), a claim to every application assigned the application number of such CPA. In addition, applicants will not be permitted to delete such a benefit claim as to certain applications assigned that application number (e.g., for patent term purposes).

For more information on benefit claims, visit: benefit claims.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Affidavits or declarations filed in a prior application do not automatically become part of a new application. As stated in MPEP ¶ 2.03: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application do not automatically become a part of this application.

To rely on an earlier-filed affidavit or declaration, the applicant must:

  • Make remarks of record in the new application
  • Include a copy of the original affidavit or declaration filed in the prior application

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

37 CFR 1.55(i) provides that the requirement for a timely filed certified copy can be satisfied if:

  1. The foreign application was filed in a participating foreign intellectual property office;
  2. The claim for priority is presented in an application data sheet, identifying the foreign application;
  3. The copy of the foreign application is received by the USPTO from the participating foreign intellectual property office, or a certified copy is filed, within the period specified in 37 CFR 1.55(g)(1).

The USPTO website provides information about the priority document exchange program, including participating offices and necessary information for access to foreign applications.

To learn more:

If an applicant misses the 12-month deadline for claiming the benefit of a provisional application, they may be able to restore the benefit under certain conditions:

  1. The nonprovisional application must be filed within 14 months of the provisional application’s filing date
  2. A petition under 37 CFR 1.78(b) must be filed in the nonprovisional application
  3. The delay in filing must be unintentional

The MPEP states: “If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

The petition must include:

  • The reference to the provisional application
  • The petition fee
  • A statement that the delay was unintentional

Inventorship in a Continued Prosecution Application (CPA) for design patents can be corrected by filing a statement requesting the deletion of a named inventor along with the CPA filing. The MPEP states:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This process allows for immediate correction of inventorship when filing a CPA. However, it’s important to note that any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent procedure, visit: patent procedure.

A certificate of correction can be used to perfect a foreign priority claim in the following scenarios:

  1. When the priority claim was timely filed but not included on the patent due to failure to submit a certified copy.
  2. When the priority claim was not timely made, but the correction would not require further examination.

To use a certificate of correction, you must:

  • File a request for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.
  • Include a grantable petition under 37 CFR 1.55(e), (f), or (g) as appropriate.
  • Pay the required fee and provide a showing of good and sufficient cause for the delay, if applicable.

The MPEP states: Where the priority claim required under 37 CFR 1.55 was timely filed in the application but was not included on the patent because the requirement under 37 CFR 1.55 for a certified copy was not satisfied, the patent may be corrected to include the priority claim via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, accompanied by a grantable petition under 37 CFR 1.55(f) or, in the case of a design application, a grantable petition under 37 CFR 1.55(g).

The timeliness requirement for submitting certified copies of foreign applications can be satisfied through the Priority Document Exchange program. According to 37 CFR 1.55(i), the requirement will be considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority is presented in an application data sheet with the required information
  • The copy of the foreign application is received by the USPTO from the participating foreign office within the specified time period

The MPEP states, Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Therefore, it’s crucial to verify that the USPTO has received the priority document.

To learn more:

In a continuing application, you can satisfy the requirement for a certified copy of a foreign application without actually filing the certified copy again. According to 37 CFR 1.55(h):

The requirement for a certified copy of the foreign application will be considered satisfied in an application if a prior-filed nonprovisional application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c) contains a certified copy of the foreign application and the prior-filed nonprovisional application is identified as containing a certified copy of the foreign application.

This means that if you have already filed a certified copy in a parent application, you can simply identify that application as containing the certified copy when filing your continuing application. This approach can save time and reduce the paperwork required for perfecting priority claims in continuing applications.

To learn more:

To learn more:

How can I request participation in the priority document exchange program?

To request participation in the priority document exchange (PDX) program, you need to follow specific procedures outlined in MPEP 213.04. Here’s what you need to do:

Applicants may participate in the priority document exchange (PDX) program by requesting that the USPTO retrieve a copy of the foreign application from a participating foreign intellectual property office. Participation in the PDX program is not automatic; a request must be made.

To make a request:

  • Include an authorization to access the priority document in the foreign office’s system
  • Provide sufficient information to identify the foreign application
  • Submit this request within the later of:
    • 16 months from the filing date of the prior foreign application, or
    • 4 months from the actual filing date of the application in which priority is claimed

It’s important to note that the PDX program is only available with participating foreign offices. Always check the current list of participating offices before making a request.

To learn more:

How can I request a corrected patent with a perfected foreign priority claim?

To request a corrected patent with a perfected foreign priority claim after issuance, you need to follow these steps:

  • File a reissue application under 35 U.S.C. 251.
  • Include a petition for an expedited examination of the reissue application.
  • Pay the required fees for both the reissue application and the petition.
  • Submit the necessary documents to perfect the priority claim, such as a certified copy of the foreign application.

As stated in MPEP 216.01: “A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) in an issued patent.” It’s important to note that this process is only available for perfecting priority claims that were timely filed during the pendency of the application.

Filing an interim copy of a foreign application electronically can be done through the USPTO patent electronic filing system. The MPEP provides guidance on how to file different parts of the application:

  • Main parts (Abstract, Drawings, Specification, Claims) and the cover sheet can be filed as a single PDF file.
  • Text-only files (e.g., Sequence Listings, Large Tables) can be filed as .txt files.
  • XML files (e.g., Standard ST.26 Sequence Listing) should be filed on a read-only optical disc.

The MPEP states: If not provided as a single paper document, the main parts of the interim copy of the foreign priority application, i.e., Abstract, Drawings, Specification, Claims, and where applicable, the foreign patent office’s equivalent to a ‘Sequence Listing’ (see MPEP § 2421.01 a ‘Sequence Listing XML’ (see MPEP § 2412), ‘Large Tables’ (see MPEP § 608.05(b)), or a ‘Computer Program Listing Appendix’ (see MPEP § 608.05(a)), along with the separate cover sheet required by 37 CFR 1.55(j), may be filed as a single PDF image file via the USPTO patent electronic filing system.

For more information on electronic filing, refer to MPEP § 502.05.

To learn more:

Filing a delayed benefit claim for a provisional application follows a similar process to other delayed benefit claims. According to MPEP 211.04:

“If the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 is not submitted within the required time period, a petition for an unintentionally delayed claim may be filed.”

The petition must include:

  • The reference to the prior provisional application
  • A petition fee
  • A statement that the entire delay was unintentional

It’s important to note that as of December 18, 2013, the amendment containing the specific reference to the earlier filed provisional application no longer needs to be submitted during the pendency of the application.

To learn more:

When filing a Continued Prosecution Application (CPA) for a design patent, you can delete a named inventor by including a statement with your CPA filing. The MPEP ¶ 2.32 states:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This means you should provide a clear statement identifying the inventor(s) to be deleted when submitting your CPA. The USPTO will then acknowledge and process this request, correcting the inventorship accordingly.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

When filing a Continued Prosecution Application (CPA) for a design patent, you can request the deletion of a named inventor by submitting a statement with your CPA filing. The MPEP ¶ 2.32 states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This means that you should include a clear statement requesting the deletion of the specific inventor(s) when you file your CPA. The USPTO will then acknowledge this request and correct the inventorship accordingly.

For more information on design patents, visit: design patents.

For more information on patent procedure, visit: patent procedure.

To delete a named inventor in a Continued Prosecution Application (CPA) for design applications, you must submit a statement requesting the deletion along with the CPA filing. The MPEP states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

It’s important to note that this process is specific to CPA filings for design applications. If you need to delete a named inventor after the CPA has been filed, you must follow a different procedure, as outlined in MPEP ¶ 2.32: “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent procedure, visit: patent procedure.

The process for deleting a benefit claim depends on when your application was filed:

  • For applications filed on or after September 16, 2012: File a corrected Application Data Sheet (ADS) in compliance with 37 CFR 1.76(c) that deletes the reference to the prior-filed application.
  • For applications filed prior to September 16, 2012: Amend the specification (if the benefit claim is in the specification) or submit a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c) to delete references to prior applications.

However, be aware of the following considerations:

  • The examiner will consider whether any new prior art may become available if a benefit claim is deleted.
  • If submitted after final rejection or action, the amendment or ADS will be treated under 37 CFR 1.116.
  • If submitted after the application has been allowed, it will be treated under 37 CFR 1.312.
  • Deleting a benefit claim may affect the publication date of the application.

The MPEP also notes an important caveat:

A cancellation of a benefit claim to a prior application may be considered as a showing that the applicant is intentionally waiving the benefit claim to the prior application in the instant application.

This means that if you later try to reinstate the benefit claim, the USPTO may not accept it as an unintentional delay.

To learn more:

Tags: ADS

To correct the priority claim in an issued patent, you can file a reissue application under 35 U.S.C. 251. The MPEP states:

‘A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) or 35 U.S.C. 120 in the issued patent.’

This process allows you to amend the specification to include the required reference or correct the priority claim itself. However, it’s important to note that the reissue application must be filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f).

How can I correct a timely submitted benefit claim with errors?

If you’ve submitted a benefit claim within the required time period but it contains errors, you can correct it without filing a petition. According to MPEP 211.02(a):

“A petition under 37 CFR 1.78 and the petition fee would not be required for correcting a timely submitted benefit claim for the following situations: (1) Changing the relationship of the applications (e.g., changing from “continuation” or “divisional” to “continuation-in-part” or from “continuation-in-part” to “continuation” or “divisional”); (2) Changing the filing date of a prior-filed nonprovisional or provisional application; and (3) Changing a benefit claim of a prior-filed provisional application under 35 U.S.C. 120 (e.g., “This application is a continuation of prior-filed provisional application No. —“) to a benefit claim of the same provisional application under 35 U.S.C. 119(e) (e.g., “This application claims the benefit of prior-filed provisional application No. —“) during the pendency of the later-filed application.”

To make these corrections, you should submit a corrected application data sheet (ADS) with the proper markings to show the changes.

To learn more:

If you receive a filing receipt with missing or incorrect benefit claim information, you can request a corrected filing receipt. However, the Office will only grant such a request if the proper reference to the prior application is included:

  • For applications filed on or after September 16, 2012: in an Application Data Sheet (ADS)
  • For applications filed prior to September 16, 2012: in the first sentence(s) of the specification or an ADS

This reference must be made within the time period required by 37 CFR 1.78, with a few exceptions. As stated in the MPEP:

The Office may notify applicants on or with the filing receipt that a benefit claim may not have been recognized because the benefit claim was improper but applicants are advised that only the benefit claims that are listed on the filing receipt have been recognized by the Office.

It’s crucial to review your filing receipt promptly and carefully to avoid the need for a petition and associated fees.

To learn more:

Confirming receipt of your priority document by the USPTO through the Priority Document Exchange (PDX) program is crucial. The MPEP emphasizes this responsibility:

Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Accordingly, applicants are encouraged to check as necessary to confirm receipt by the Office of appropriate documents.

To verify receipt, you can check the Patent Application Information Retrieval (PAIR) system. Priority documents retrieved through PDX will have the document description: Priority documents electronically retrieved by USPTO from a participating IP Office.

If you don’t see this confirmation, you may need to follow up with the USPTO or consider submitting a certified copy directly to ensure your priority claim is properly documented.

To learn more:

When claiming priority to a foreign application filed in a non-English language, you must provide an English translation of the foreign application. The MPEP 213.02 states:

If the foreign application is not in the English language, an English translation of the foreign application is also required. See 37 CFR 1.55(g)(3).

Additionally, you must submit:

  • A statement that the translation is accurate
  • The certified copy of the foreign application

These documents should be filed within the prescribed time period to properly establish the priority claim.

To learn more:

You can check the status of your patent application through several methods:

  • Patent Center: This platform provides information on issued patents, published patent applications, and applications claiming domestic benefit.
  • Private PAIR (Patent Application Information Retrieval): For unpublished applications, applicants or their registered representatives can securely track progress. Note that a Customer Number must be associated with the application for access.
  • Application Assistance Unit (AAU): For general inquiries, you can contact the AAU directly.

As stated in the MPEP: Status information relating to patent applications is available through Patent Center and the Patent Application Information Retrieval (PAIR) system. (MPEP 203.08)

For most up-to-date information, the MPEP recommends: Applicants and other persons seeking status information regarding an application should check Patent Center on the Office website at www.uspto.gov/patents/apply/patent-center.

To learn more:

To check if the United States Patent and Trademark Office (USPTO) has received your priority document through the Priority Document Exchange (PDX) program, you should monitor your application status. As stated in MPEP 215.02(a):

Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Accordingly, applicants are encouraged to check as necessary to confirm receipt by the Office of appropriate documents.

You can check the status of your priority document in several ways:

  1. Check the Patent Application Information Retrieval (PAIR) system for your application.
  2. Look for the document description: “Priority documents electronically retrieved by USPTO from a participating IP Office.”
  3. Contact the USPTO directly if you’re unsure about the status.

It’s important to verify receipt of the priority document to ensure compliance with the requirements for claiming priority to a foreign application.

For more information on foreign application, visit: foreign application.

For more information on PAIR system, visit: PAIR system.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For more information on USPTO, visit: USPTO.

To authorize the USPTO to retrieve your priority document through the Priority Document Exchange (PDX) program, you need to follow these steps:

  • File a signed Request to Retrieve Electronic Priority Application(s) (PTO/SB/38 form) or an equivalent request.
  • Submit this request before the USPTO sends a notice indicating that the certified copy of the priority document is required.

As stated in MPEP 215.01, Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed by the time of patent grant as required under 37 CFR 1.55(g). It’s important to note that even if you authorize the USPTO to retrieve the document, you should monitor the process to ensure successful retrieval.

To learn more:

To ensure successful retrieval of priority documents under PDX, applicants should follow these guidelines from MPEP 215.01:

Applicants are strongly encouraged to cite the foreign application using an acceptable format (see MPEP § 214.04) and use proper and consistent citation format throughout the U.S. application.

Key points for successful retrieval include:

  • Provide proper, complete, and consistent citations of foreign priority applications and filing dates.
  • Use an acceptable format for citing foreign applications (refer to MPEP § 214.04).
  • Ensure the foreign priority claim is complete to prevent retrieval issues.
  • Check the Private Patent Application and Information Retrieval (PAIR) system to confirm successful retrieval.

Remember, a successful retrieval typically takes about one week to complete.

To learn more:

To ensure successful retrieval of foreign applications through PDX, applicants should:

  • Provide proper and consistent citation of the foreign priority application and its filing date
  • Use an acceptable format for citing the foreign application (see MPEP § 214.04)
  • Ensure the foreign priority claim is complete

The MPEP emphasizes the importance of correct citations:

An improper, incomplete, or inconsistent citation of a foreign priority application and/or its filing date will result in a delay or prevent retrieval under the Priority Document Exchange program.

Applicants are encouraged to check the Private PAIR system to confirm successful retrieval of their foreign priority application.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP) application, inventors must follow specific procedures. As noted in MPEP ¶ 2.06:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This involves properly referencing the prior application in the CIP application and ensuring that the CIP is filed before the patenting, abandonment, or termination of proceedings on the prior application. It’s crucial to follow the guidelines in MPEP § 211 for claiming domestic benefit.

For more information on domestic benefit, visit: domestic benefit.

An inventor can be deleted from a Continued Prosecution Application (CPA) for design patents by submitting a statement requesting the deletion at the time of filing the CPA. The MPEP states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This process allows for the correction of inventorship at the time of filing the CPA. However, it’s important to note that if you need to delete an inventor after the CPA has been filed, you must follow a different procedure, as stated in the MPEP: “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

For more information on CPA, visit: CPA.

Tags: CPA

An applicant can restore the right of priority if the U.S. application is filed after the 12-month deadline (or 6-month deadline for design applications) but within 2 months of the expiration of that period. This can be done through a petition process, provided the delay was unintentional.

According to MPEP 213.03: “As provided in 37 CFR 1.55(c), if the subsequent application has a filing date which is after the expiration of the twelve-month period (or six-month period in the case of a design application), but within two months from the expiration of the period, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.55(c), if the delay in filing the subsequent application within the period was unintentional.”

The petition to restore the right of priority must include:

  • The priority claim identifying the prior foreign application
  • The petition fee
  • A statement that the delay in filing was unintentional

The USPTO may require additional information to establish that the delay was unintentional.

For more information on foreign priority, visit: foreign priority.

For more information on priority restoration, visit: priority restoration.

For more information on unintentional delay, visit: unintentional delay.

To rely on an affidavit or declaration from a prior application, an applicant must take specific steps. According to MPEP ¶ 2.03:

“Where it is desired to rely on an earlier-filed affidavit or declaration, the applicant should make the remarks of record in this application and include a copy of the original affidavit or declaration filed in the prior application.”

To rely on a prior affidavit or declaration, an applicant should:

  • Make remarks of record in the new application, referencing the prior affidavit or declaration
  • Include a copy of the original affidavit or declaration from the prior application in the new application

This ensures that the examiner is aware of the prior evidence and can consider it in the context of the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

How can an applicant obtain specific information about their patent application status?

While the USPTO limits the information provided over the phone, applicants have other methods to obtain detailed status information. MPEP 203.08 suggests:

“Applicants can obtain more information using the Patent Application Information Retrieval (PAIR) system. PAIR provides customers direct secure access to their own patent application status information, as well as to general patent information publicly available.”

Applicants can use Private PAIR to access confidential application information, including filing dates, office actions, and current status. For applications not yet published, this is the primary method for obtaining detailed status information.

To learn more:

An applicant can incorporate by reference a prior application in a continuing application by including an explicit statement in the specification of the continuing application. The MPEP states: An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are ‘hereby incorporated by reference.’ The statement must appear in the specification. This incorporation by reference can be useful for adding inadvertently omitted material from the prior application without the need for a petition, provided the continuing application is entitled to a filing date.

To learn more:

For applications filed on or after September 16, 2012, an applicant can file a continuation or divisional application using a copy of an oath or declaration from a prior application if:

  • The oath or declaration complies with 35 U.S.C. 115 as revised effective September 16, 2012
  • It was executed by or with respect to the inventor in the earlier-filed application
  • A copy of the oath, declaration, or substitute statement showing the signature or an indication it was executed is submitted in the continuing application

As stated in the MPEP: For applications filed on or after September 16, 2012, the filing of a continuing application by all or by fewer than all of the inventors named in a prior application without a newly executed oath or declaration is permitted provided that an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement under 37 CFR 1.64, was executed by or with respect to such inventor and was filed in the earlier-filed application, and a copy of such oath, declaration, or substitute statement showing the signature or an indication thereon that it was executed, is submitted in the continuing application.

It’s important to note that the oath or declaration must meet the current requirements, even if the prior application was filed before September 16, 2012.

For more information on continuation application, visit: continuation application.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

To ensure that affidavits or declarations from a prior application are considered in a new application, an applicant must take specific steps. According to MPEP ¶ 2.03:

“Where it is desired to rely on an earlier-filed affidavit or declaration, the applicant should make the remarks of record in this application and include a copy of the original affidavit or declaration filed in the prior application.”

To ensure consideration, the applicant should:

  • Explicitly reference the prior affidavit or declaration in the new application
  • Provide a copy of the original affidavit or declaration
  • Explain the relevance of the prior affidavit to the current application

This process helps the examiner understand the context and importance of the previously submitted evidence in relation to the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

An applicant can correct or add a priority claim in an international application according to PCT Rule 26bis.1. This is referenced in 37 CFR 1.451(d), which states:

The applicant may correct or add a priority claim in accordance with PCT Rule 26bis.1.

PCT Rule 26bis.1 allows for the correction or addition of a priority claim within 16 months from the priority date or, where the correction or addition would cause a change in the priority date, within 16 months from the priority date as so changed, whichever 16-month period expires first. However, this must be done no later than four months from the international filing date.

To learn more:

To claim the benefit of an international application’s filing date, the following conditions must be met according to MPEP 211.01(c):

  • The international application must designate the United States
  • The international application must be entitled to a filing date in accordance with PCT Article 11
  • The later-filed application must be filed during the pendency of the international application (i.e., prior to its abandonment)

The MPEP states:

To claim the benefit of the filing date of an international application, the international application must designate the United States and be entitled to a filing date in accordance with PCT Article 11, and the later-filed application must be filed during the pendency (e.g., prior to the abandonment) of the international application.

This provision is based on 35 U.S.C. 365(c), which allows national applications to benefit from prior international applications designating the United States, subject to the conditions of 35 U.S.C. 120.

To learn more:

When claiming benefit to multiple prior applications, applicants must carefully establish a chain of copendency. The MPEP 211.01(b) provides guidance:

“The reference to the prior applications must identify all of the prior applications and indicate the relationship (i.e., continuation, divisional, or continuation-in-part) between each nonprovisional application in order to establish copendency throughout the entire chain of prior applications.”

Key points to remember:

  • References must be made in each intermediate application in the chain.
  • A specific reference is required for each prior-filed application and cannot be incorporated by reference from a prior application.
  • There is no limit to the number of prior applications through which a chain of copendency may be traced.

It’s crucial to properly reference all prior applications to ensure the desired benefit claims are recognized. Failure to do so may result in the need for a petition under 37 CFR 1.78 and payment of a petition fee.

To learn more:

To claim benefit of an international design application designating the United States, the following requirements must be met:

  • The claim must be made in a nonprovisional application, international application, or international design application filed on or after May 13, 2015
  • The international design application must be entitled to a filing date in accordance with 37 CFR 1.1023
  • The claim must meet the conditions and requirements of 35 U.S.C. 120

MPEP 211.01(d) states: Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.

It’s important to note that this benefit can only be claimed in applications or patents filed on or after May 13, 2015, as specified in 37 CFR 1.78(j).

To learn more:

Provisional application benefits are handled differently from other types of priority claims on the bib-data sheet. If an applicant claims benefit under 35 U.S.C. 119(e) to a prior provisional application, the application number of that provisional application should be printed on the bib-data sheet.

However, it’s important to note: If applicant claims benefit under35 U.S.C. 119(e)to a prior provisional application, and states that the provisional application claims the benefit of, or priority to, earlier domestic or foreign application(s), the earlier application(s) should not be reflected on the bib-data sheet because a provisional application is not entitled to the benefit of, or right of priority to, any other application. (MPEP 202)

This is due to the limitation set forth in 35 U.S.C. 111(b)(7), which states that a provisional application cannot claim priority to or benefit from any other application.

Examiners should verify that provisional application data is correctly listed and that no improper benefit claims to earlier applications through a provisional application are included on the bib-data sheet.

For more information on benefit claims, visit: benefit claims.

For more information on patent examination, visit: patent examination.

For more information on provisional application, visit: provisional application.

Preliminary amendments in continuation applications are subject to specific rules and considerations. The MPEP provides guidance on this topic:

Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

This means that preliminary amendments submitted with the application are treated as part of the original filing. However, there are important requirements and considerations:

  1. Compliance with 37 CFR 1.121:

    Amendments must be filed in compliance with the requirements of 37 CFR 1.121 (e.g., the amendment must include a complete claim listing whenever a claim is added, canceled, or amended).

  2. Possible Requirement for Substitute Specification:

    The Office may require a substitute specification for preliminary amendments.

  3. Classification and Assignment:

    Applications should be classified and assigned to the proper Technology Center (TC) by taking into consideration the claims that will be before the examiner upon entry of such a preliminary amendment.

  4. New Matter Considerations: If the preliminary amendment introduces new matter, it may affect the application’s status as a continuation. The MPEP advises:

    Where a copy of the oath or declaration from a prior application was filed in a continuation or divisional application, if the examiner determines that new matter is present relative to the prior application, the examiner should so notify the applicant in the next Office action (preferably the first Office action). The examiner should require applicant to delete the benefit claim or redesignate the application as a continuation-in-part.

Applicants should carefully consider the content and timing of preliminary amendments in continuation applications to ensure compliance with USPTO requirements and to maintain the desired relationship with the parent application.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

The USPTO handles improper Continued Prosecution Application (CPA) requests in the following ways:

  1. For utility or plant applications filed on or after July 14, 2003, improper CPA requests are treated as requests for continued examination (RCE) under 37 CFR 1.114 if the application has a filing date on or after June 8, 1995.
  2. If the improper CPA doesn’t satisfy RCE requirements, it’s treated as an improper RCE, and the time period set in the last Office action continues to run.
  3. For applications with a filing date before June 8, 1995, the Office will notify the applicant of the improper CPA by mailing a notice.
  4. If an examiner discovers an improperly processed CPA, they should immediately notify a supervisory applications examiner (SAE) or other technical support staff to correct the application records.
  5. The Office will not convert an improper CPA into an application under 37 CFR 1.53(b) unless there are extenuating circumstances.

As stated in the MPEP: If an examiner discovers that an improper or incomplete CPA has been processed as a proper CPA in error, the examiner should immediately notify a supervisory applications examiner (SAE) or other technical support staff within the TC who will reprocess the CPA and correct the application records as appropriate.

It’s important to note that if the application becomes abandoned due to an improper CPA, the applicant may need to file a petition under 37 CFR 1.137 to revive the application and pay the required fees.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

For more information on USPTO procedures, visit: USPTO procedures.

Foreign priority claims are an important aspect of patent applications and are reflected on the bib-data sheet. The examiner should verify that foreign applications listed on the oath, declaration, or application data sheet are correctly listed on the bib-data sheet.

According to the MPEP: A bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application that the U.S. application is claiming the priority of. The examiner should check this information for accuracy. (MPEP 202)

If there are errors:

  • On the oath, declaration, or application data sheet: The examiner should require a new document.
  • On the bib-data sheet itself: The examiner should make corrections directly on the sheet and have the information updated in the Office computer systems.

It’s important to note that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) should be listed. A list of qualifying countries can be found in MPEP § 213.01.

For more information on foreign applications, visit: foreign applications.

For more information on foreign priority claims, visit: foreign priority claims.

For more information on patent examination, visit: patent examination.

The handling of delayed priority claims in design applications has evolved. The MPEP provides the following information:

“Before May 13, 2015, no procedures were established for accepting an unintentionally delayed priority claim in a design application. Effective May 13, 2015, 37 CFR 1.55(e) provides for the filing of a petition for acceptance of an unintentionally delayed priority claim in a design application where the foreign priority claim was not submitted during the pendency of the design application.”

This change allows design patent applicants and holders to rectify unintentionally delayed priority claims, aligning the process more closely with that of utility patents. As with utility patents, a petition under 37 CFR 1.55(e) may be filed along with a request for a certificate of correction after the design patent has been granted.

To learn more:

Delayed benefit claims in international applications have specific procedures. According to MPEP 211.04:

A petition under 37 CFR 1.78 for accepting an unintentionally delayed benefit claim and the petition fee under 37 CFR 1.17(m) are required to add a benefit claim under 35 U.S.C. 120 and 365(c) in an abandoned international application designating the United States, even when the international application did not enter the national stage under 35 U.S.C. 371.

For international applications not filed with the U.S. Receiving Office and not a nonprovisional application, the petition may be filed in the earliest nonprovisional application claiming benefit to the international application. This petition will be treated as if filed in the international application itself.

For more information on international applications, visit: international applications.

For more information on patent procedure, visit: patent procedure.

Continued Prosecution Applications (CPAs) and Requests for Continued Examination (RCEs) are both methods to continue prosecution of an application, but they have significant differences:

  • CPAs are only available for design patent applications, while RCEs can be used for utility, plant, and design applications
  • CPAs result in a new application with the same application number, while RCEs continue examination of the same application
  • CPAs can only be filed before payment of the issue fee, abandonment, or termination of proceedings; RCEs can be filed after payment of the issue fee with a petition
  • CPAs automatically abandon the prior application, while RCEs do not

The MPEP states: Effective July 14, 2003, continued prosecution application (CPA) practice was eliminated as to utility and plant applications. Henceforth, applicants who wish to continue examination of the same claimed invention after the prosecution of a utility or plant application is closed should consider filing a request for continued examination (RCE) under 37 CFR 1.114.

It’s important to note that if an improper CPA is filed for a utility or plant application on or after July 14, 2003, it may be treated as an RCE: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

The treatment of continuation-in-part (CIP) applications changed significantly after the deletion of 37 CFR 1.62. According to the MPEP: “A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.” This means that CIP applications can no longer be filed under the former File Wrapper Continuing Procedure and must be filed as new applications.

For more information on continuation-in-part application, visit: continuation-in-part application.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications, regardless of the original application’s filing date.

The MPEP specifically states: A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.

This means that applicants seeking to file a CIP application after December 1, 1997, would need to use a different filing procedure, such as filing a new application under 37 CFR 1.53(b).

To learn more:

To learn more:

For continuation-in-part (CIP) applications, the MPEP states: “A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application… will be treated as an improper application.”

This means that after the deletion of 37 CFR 1.62, CIP applications can no longer be filed using the former File Wrapper Continuing Procedure. Applicants seeking to file a CIP application must do so through the standard application process outlined in MPEP 201.06(d).

For more information on continuation-in-part application, visit: continuation-in-part application.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications, regardless of the filing date of the original application. The MPEP states:

“A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.”

This change in procedure means that applicants need to file CIP applications using different methods after December 1, 1997, to ensure proper processing and examination.

The treatment of continuation or divisional applications filed under former 37 CFR 1.62 depends on the filing date of the original application:

  • For applications filed on or after June 8, 1995: Requests filed on or after December 1, 1997, are treated as requests for continued examination (RCE) under 37 CFR 1.114.
  • For applications filed before June 8, 1995: Requests filed on or after December 1, 1997, are treated as improper applications.

As stated in the MPEP: A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114, see MPEP 706.07(h), paragraph IV.

To learn more:

The treatment of continuation or divisional applications filed under former 37 CFR 1.62 depends on the filing date of the original application:

  • For applications filed on or after June 8, 1995: “A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114.” This means these applications are now processed under the RCE procedure.
  • For applications filed before June 8, 1995: Requests for continuation or divisional applications filed on or after December 1, 1997, will be treated as improper applications.

For more details on RCE procedures, refer to MPEP 706.07(h), paragraph IV.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on RCE, visit: RCE.

For applications filed on or after June 8, 1995, continuation or divisional applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated differently. The MPEP states: “A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114.” This means such applications are now processed under the RCE procedure rather than the former File Wrapper Continuing Procedure.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on RCE, visit: RCE.

According to the MPEP, A continuation or divisional application filed under 37 CFR 1.60 on or after December 1, 1997, will automatically be treated as an application filed under 37 CFR 1.53(b). This means that any continuation or divisional application filed after this date is processed under the new regulations, specifically 37 CFR 1.53(b), regardless of whether the applicant intended to file under the old 37 CFR 1.60 procedure.

To learn more:

To learn more:

The USPTO has specific procedures for handling Congressional and other official inquiries to ensure uniformity and compliance with Department of Commerce directives:

  • Inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies are typically processed through specialized offices.
  • The Office of Policy and International Affairs and/or the Office of Governmental Affairs usually handle these inquiries.
  • Specific types of correspondence are directed to appropriate offices for immediate attention.

According to the MPEP: Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs. (MPEP 203.08(a))

For specific types of inquiries:

  • Embassies, Office of the U.S. Trade Representative, Department of State: Contact the Administrator of the Office of Policy and International Affairs at 571-272-9300.
  • Congress or the White House: Contact the Director of the Office of Governmental Affairs at 571-272-7300.

This process ensures uniformity in the handling of contacts from the indicated sources, and also so that compliance with directives of the Department of Commerce is attained.

To learn more:

Congressional and other official inquiries about patent applications are handled through specific channels at the USPTO. According to MPEP 203.08(a):

Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs.

This procedure ensures uniformity in handling contacts from these sources and compliance with Department of Commerce directives. Specific instructions are provided for transmitting such inquiries to the appropriate offices within the USPTO.

For more information on USPTO procedures, visit: USPTO procedures.

Applications filed under former 37 CFR 1.62 before December 1, 1997, continue to be processed and examined under the procedures set forth in the former regulation. The MPEP clearly states:

“All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.”

This means that the File Wrapper Continuing Procedure remains applicable for these older applications, ensuring consistency in their examination process.

For more information on patent examination, visit: patent examination.

Affidavits or declarations filed in a prior application do not automatically become part of a new application. As stated in MPEP ¶ 2.03:

“Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application do not automatically become a part of this application.”

To rely on an earlier-filed affidavit or declaration, the applicant must:

  • Make remarks of record in the new application
  • Include a copy of the original affidavit or declaration filed in the prior application

This ensures that the examiner can consider the previously submitted evidence in the context of the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

Affidavits or declarations from a prior application do not automatically become part of a continuation or divisional application. The MPEP states: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the prior nonprovisional application do not automatically become a part of a continuation or divisional application filed under 37 CFR 1.53(b). Where it is desired to rely on an earlier filed affidavit or declaration, the applicant should make such remarks of record in the 37 CFR 1.53(b) application and include a copy of the original affidavit or declaration filed in the prior nonprovisional application. This ensures that the examiner is aware of and can consider the relevant affidavits or declarations from the prior application.

To learn more:

No, MPEP ¶ 2.11 does not apply to benefit claims for provisional applications. The MPEP explicitly states:

Do not use this form paragraph for benefit claims under 35 U.S.C. 119(e) to provisional applications.

This means that the copendency requirements and procedures outlined in MPEP ¶ 2.11 are specifically for non-provisional applications claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c). Provisional applications have different rules and procedures for claiming benefit, which are covered under 35 U.S.C. 119(e) and other sections of the MPEP.

For more information on benefit claims, visit: benefit claims.

For more information on patent procedure, visit: patent procedure.

No, filing an interim copy does not replace the need for a certified copy of the foreign application. While an interim copy satisfies the timeliness requirement, a certified copy is still required. The MPEP clarifies this point:

Thus, providing an interim copy of a foreign application under 37 CFR 1.55(j) satisfies the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f), but a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate.

In essence, the interim copy allows applicants to meet initial deadlines, but they must still provide a certified copy of the foreign application during the pendency of the U.S. application, unless they file a specific petition.

To learn more:

No, filing an amendment does not change the status of a ‘new’ application. The MPEP 203.01 explicitly states:

An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

This means that even if you submit changes or corrections to your application before receiving any feedback from the examiner, your application is still considered ‘new’ in the eyes of the patent office.

To learn more:

If you filed a translation of the non-English provisional application and a statement of accuracy in the nonprovisional application before November 25, 2005, you do not need to provide them again. The MPEP ¶ 2.38 states in the Examiner Note:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This exception only applies to translations filed in the nonprovisional application before the specified date. For all other cases, the translation and statement must be filed in the provisional application itself.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If you submitted the reference to the prior application within the required time period but in the wrong location, you may not need to file a petition. The MPEP provides guidance on this situation:

If the reference to the prior application was previously submitted within the time period set forth in 37 CFR 1.78 but was not included in the location in the application required by the rule (e.g., if the reference was submitted in an oath or declaration or the application transmittal letter), and the information concerning the benefit claim was recognized by the Office as shown by its inclusion on the first filing receipt, the petition under 37 CFR 1.78 and the petition fee under 37 CFR 1.17(m) are not required. (MPEP § 211)

However, you are still required to submit the reference in compliance with 37 CFR 1.78. This means:

  • For applications filed on or after September 16, 2012: File an ADS in compliance with 37 CFR 1.76 with the reference.
  • For applications filed before September 16, 2012: File either an amendment to the first sentence(s) of the specification or an ADS in compliance with pre-AIA 37 CFR 1.76.

For more information on petition requirements, visit: petition requirements.

Can you file a CPA in a provisional application?

No, you cannot file a Continued Prosecution Application (CPA) in a provisional application. The MPEP 201.06(d) clearly states:

A CPA may not be filed in a provisional application.

CPAs are only available for certain types of nonprovisional applications. Specifically, they can be filed in design applications, and in utility and plant applications that were filed before May 29, 2000. Provisional applications have a different purpose and process, and do not allow for the filing of CPAs.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

Yes, the USPTO may request additional information when considering a petition to restore the right of priority. The MPEP states:

The Director may require additional information where there is a question whether the delay was unintentional.

This means that if the USPTO has doubts about whether the delay in filing was truly unintentional, they may ask for more details or evidence to support your claim. It’s important to be prepared to provide such information if requested to ensure your petition is properly considered.

For more information on unintentional delay, visit: unintentional delay.

Can the timeliness requirement for priority documents be met through PDX?

Yes, the timeliness requirement for priority documents can be met through the Priority Document Exchange (PDX) program. MPEP 215.02(a) states:

‘If the priority document is retrieved by the USPTO within the time period set in 37 CFR 1.55(g), the applicant need not take any further action to meet the timeliness requirement.’

This means that if the USPTO successfully retrieves the priority document through PDX within the specified time frame (usually the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application), the timeliness requirement is automatically satisfied. However, applicants should still monitor the status to ensure the document is received and be prepared to submit it manually if necessary.

To learn more:

No, the time period for filing a foreign priority claim cannot be extended. As stated in MPEP 214.01: “This time period is not extendable.”

However, if you miss the deadline, there is a possibility to file a petition to accept an unintentionally delayed priority claim. The MPEP states: “If a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it includes the required identification information and is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

For more information on unintentionally delayed priority claims, refer to MPEP § 214.02.

To learn more:

Can the specification be omitted when filing a divisional or continuation application?

No, the specification cannot be omitted when filing a divisional or continuation application. However, the process is simplified. According to MPEP 201.06(c):

“A new specification (including the claims) may be submitted in a divisional application filed under 37 CFR 1.53(b). In such a case, the applicant must file a copy of the prior application as filed or a new specification.”

This means that while you must include a specification, you have two options:

  • Submit a copy of the prior application’s specification
  • Submit a new specification tailored to the divisional or continuation application

If you choose to submit a copy of the prior application, it’s important to ensure that it properly supports the claims in the new application. Any new matter introduced in a continuation application may result in a rejection under 35 U.S.C. 112(a).

Remember, the claims are considered part of the specification, so you must include claims with your application, whether you’re using the prior specification or submitting a new one.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on patent application requirements, visit: patent application requirements.

For more information on USPTO, visit: USPTO.

Yes, the right of priority can be restored if the filing deadline is missed, but certain conditions must be met:

  • The subsequent application must be filed within two months of the expiration of the priority period.
  • A petition under 37 CFR 1.55(c) must be filed.
  • The delay in filing must be unintentional.

The MPEP states: As provided in 37 CFR 1.55(c), if the subsequent application has a filing date which is after the expiration of the twelve-month period (or six-month period in the case of a design application), but within two months from the expiration of the period, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.55(c), if the delay in filing the subsequent application within the period was unintentional. (MPEP 213.03)

To learn more:

Yes, the inventorship in a Continued Prosecution Application (CPA) can differ from the original application, but only if a proper request is filed and approved.

According to MPEP ¶ 2.33: Otherwise, the inventorship in the CPA shall be the same as in the prior application. This implies that changes to inventorship are possible, but they require specific action.

To change the inventorship, you must file a request under 37 CFR 1.48. This applies whether you’re adding, removing, or changing the order of inventors. Without this formal request, the inventorship will remain the same as in the original application, even if new inventors are listed on the CPA filing documents.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

The inventorship in a Continued Prosecution Application (CPA) generally remains the same as in the prior application, but it can be changed under certain circumstances:

  • The inventorship automatically carries over from the prior application unless a statement is filed requesting deletion of inventors
  • Inventors can be deleted by filing a statement with the CPA request
  • Adding new inventors requires a request under 37 CFR 1.48 after the CPA is filed

The MPEP states: The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

For more information on patent applications, visit: patent applications.

No, the English translation and accuracy statement for a non-English provisional application cannot be filed in the non-provisional application. They must be filed in the provisional application itself. MPEP ¶ 2.38 is explicit about this requirement:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3].”

However, there is an exception to this rule. The MPEP states:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This means that for applications filed before November 25, 2005, it was acceptable to file these documents in the non-provisional application. For all applications after this date, the translation and statement must be filed in the provisional application, with a confirmation in the non-provisional application that this has been done.

For more information on patent procedure, visit: patent procedure.

Yes, the benefit of a provisional application can be restored even after the 12-month deadline has passed, under certain conditions. The MPEP explains:

“If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

To restore the benefit, a petition under 37 CFR 1.78(b) must be filed, which requires:

  • A reference to the provisional application
  • The petition fee
  • A statement that the delay was unintentional

The petition must be filed in the subsequent application or, in certain cases, in the earliest nonprovisional application claiming benefit to the international application.

To learn more:

To learn more:

Yes, priority can be claimed based on applications filed under bilateral or multilateral treaties. The MPEP states:

Under Article 4A of the Paris Convention for the Protection of Industrial Property, a right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design filed under the national law of a foreign country adhering to the Convention, or on a foreign application filed under a bilateral or multilateral treaty concluded between two or more such countries.

Examples of such treaties include:

  • The Hague Agreement Concerning the International Registration of Industrial Designs
  • The Convention on the Grant of European Patents (European Patent Office)
  • The Patent Cooperation Treaty (PCT)
  • The International Convention for the Protection of New Varieties of Plants (UPOV)

Applications filed in regional patent offices, such as the European Patent Office (EPO) or the African Regional Intellectual Property Organization (ARIPO), can also serve as a basis for priority claims.

To learn more:

Yes, applicants can claim priority under 35 U.S.C. 119(a)-(d) based on applications filed in certain foreign regional patent offices. The MPEP states:

“In addition to the list of recognized countries set forth in subsection I, above, applicants may claim priority under 35 U.S.C. 119(a)-(d) to applications filed in foreign regional patent offices having member states who are members of the Paris Convention.”

The recognized regional patent offices include:

  • African Regional Intellectual Property Organization (ARIPO)
  • Eurasian Patent Office (EAPO)
  • European Patent Office (EPO)
  • Gulf Cooperation Council (GCC) Patent Office
  • African Intellectual Property Organization (OAPI)

These regional patent offices allow applicants to file a single application that can have effect in multiple member states, streamlining the international patent application process.

No, new matter cannot be added to a divisional application. The divisional application must only contain subject matter disclosed in the parent application. The MPEP clearly states:

Thus the disclosure presented in a divisional application must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

Any attempt to add new matter to a divisional application will be rejected under 35 U.S.C. 112(a) as lacking written description support in the parent application.

To learn more:

Can new matter be added to a continuation application?

No, new matter cannot be added to a continuation application. A continuation application must disclose and claim only subject matter disclosed in the prior application.

As stated in MPEP 201.07: “The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.” This means that all claims in a continuation application must find support in the original disclosure of the parent application.

If an applicant wishes to add new matter, they would need to file a continuation-in-part (CIP) application instead, which allows for the addition of new subject matter while still claiming the benefit of the earlier filing date for the previously disclosed material.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

No, new matter cannot be added in a Continued Prosecution Application (CPA). The MPEP clearly states: No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application. Any attempt to add new matter will be denied entry by the examiner. If an applicant needs to add new matter, they should consider filing a continuation-in-part application under 37 CFR 1.53(b) instead of a CPA.

To learn more:

Tags: CPA, new matter

Can multiple provisional applications be filed for the same invention?

Yes, multiple provisional applications can be filed for the same invention. The MPEP 201.04 does not place restrictions on filing multiple provisionals. In fact, this practice can be beneficial for inventors who are continuously developing their invention.

Each provisional application establishes a potential priority date for the disclosed content. When filing a subsequent nonprovisional application, the applicant can claim the benefit of multiple provisional applications, potentially securing multiple priority dates for different aspects of the invention.

However, it’s important to note that each provisional application must still meet the requirements of 35 U.S.C. 112(a) for the disclosed subject matter to be eligible for the priority date.

For more information on patent priority, visit: patent priority.

Yes, multiple provisional applications can be combined into a single non-provisional application. This is particularly useful when an inventor has made improvements or additions to their invention over time. The MPEP 201.04 states:

A nonprovisional application that was filed within 12 months of an earlier provisional application may claim the benefit of that provisional application.

While this quote doesn’t explicitly mention multiple provisionals, the USPTO allows claiming benefit from multiple provisional applications in a single non-provisional application, provided each provisional is properly referenced and the non-provisional is filed within 12 months of the earliest provisional application.

For more information on Non-provisional application, visit: Non-provisional application.

For more information on patent priority, visit: patent priority.

For more information on provisional application, visit: provisional application.

Yes, multiple inventors can be deleted from a Continued Prosecution Application (CPA) at once. The language in MPEP ¶ 2.32 supports this:

In bracket 1 insert the name or names of the inventor(s) requested to be deleted.

This indicates that the process allows for the deletion of one or more inventors simultaneously. When filing a CPA, applicants can submit a statement requesting the deletion of multiple named inventors who are not inventors of the invention being claimed in the new application.

However, it’s crucial to ensure that all remaining inventors are correctly named and that the inventorship accurately reflects those who contributed to the claimed invention. If the CPA has already been filed, remember that any subsequent inventorship changes must follow the procedures outlined in 37 CFR 1.48.

For more information on CPA, visit: CPA.

Tags: CPA

Can I use PDX for retrieving priority documents from all foreign patent offices?

No, PDX is not available for all foreign patent offices. The availability of PDX depends on:

  • Participation in the WIPO Digital Access Service (DAS)
  • Bilateral PDX agreements between the USPTO and specific foreign offices

MPEP 215.01 states: “The USPTO will attempt to electronically retrieve the priority document through the WIPO DAS (if the foreign office is a DAS depositing office) or through a bilateral PDX agreement.”

To use PDX, check if the foreign office participates in WIPO DAS or has a bilateral agreement with the USPTO. The USPTO maintains a list of participating offices on their website.

To learn more:

Tags: WIPO DAS

Can I request a certificate of correction for a priority claim after my patent has issued?

Yes, you can request a certificate of correction for a priority claim after your patent has issued, but only under specific circumstances. According to MPEP 213.04: ‘If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’ However, it’s important to note that this correction is only possible if the failure to make the timely claim was through error and without deceptive intent. You’ll need to file a petition for a certificate of correction along with the required fee and evidence supporting your claim.

To learn more:

To learn more:

Can I perfect a foreign priority claim after my patent has been issued?

No, you cannot perfect a foreign priority claim after your patent has been issued if the claim was not timely filed during the pendency of the application. As stated in MPEP 216.01:

“A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) in an issued patent. However, a reissue application cannot be used to perfect a claim for priority benefit under 35 U.S.C. 119(a)-(d) or (f) where the claim for priority benefit was not timely filed during the pendency of the application that issued as the patent for which reissue is sought.”

This means that if you missed the deadline to file the priority claim or the required certified copy of the foreign application during the original patent application process, you cannot use a reissue application to retroactively perfect the claim after the patent has been issued.

Yes, you can perfect a claim for foreign priority after your patent has been issued. There are two main methods:

  1. Certificate of Correction: This is generally the preferred method if the requirements of 37 CFR 1.55 are met and no further examination is required. As stated in the MPEP, Except in certain situations, a certificate of correction can generally be used to perfect a claim to foreign priority where a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim is filed with a request for a certificate of correction in an issued patent.
  2. Reissue Application: This method is necessary in situations where further examination would be required or when the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance.

To learn more:

Generally, the English translation and accuracy statement for a non-English provisional application must be filed in the provisional application itself, not in the nonprovisional application. However, there is an exception:

As noted in the MPEP, Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.

This means:

  • For applications filed on or after November 25, 2005, the translation and statement must be filed in the provisional application.
  • For applications filed before November 25, 2005, it was acceptable to file these documents in the nonprovisional application.

It’s important to follow the current requirement of filing these documents in the provisional application to ensure proper benefit claim.

For more information on filing requirements, visit: filing requirements.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

Can I file multiple provisional applications for the same invention?

Yes, you can file multiple provisional applications for the same invention. This practice is sometimes used to establish earlier priority dates for different aspects of an invention as they are developed. The MPEP 201.04 does not explicitly prohibit this practice.

However, it’s important to note:

  • Each provisional application must meet the requirements for disclosure and enablement
  • The 12-month deadline for filing a nonprovisional application starts from the earliest provisional application you wish to claim benefit from
  • When filing the nonprovisional application, you can claim the benefit of multiple provisional applications

For example, the MPEP states:

“A nonprovisional application may claim the benefit of one or more prior provisional applications under 35 U.S.C. 119(e).”

While this strategy can be beneficial, it’s advisable to consult with a patent attorney to ensure proper execution and to avoid potential pitfalls.

To learn more:

Can I file a U.S. nonprovisional application claiming priority to a provisional application after 12 months?

While it’s generally recommended to file within 12 months, there is a limited exception that allows for filing a nonprovisional application claiming priority to a provisional application after the 12-month period. The MPEP explains:

“A nonprovisional application filed not later than twelve months after the date on which the provisional application was filed … will have its filing date restored to the filing date of the provisional application for the purpose of establishing copendency with the provisional application under 35 U.S.C. 119(e).” (MPEP 213.03)

However, this exception comes with strict conditions:

  • The delay in filing must have been unintentional.
  • The nonprovisional application must be filed within 14 months from the provisional filing date.
  • A petition to restore the right of priority must be filed promptly.

It’s important to note that this exception is not automatic and requires a petition process. If granted, it allows the nonprovisional application to claim the benefit of the provisional application’s filing date.

To learn more:

Can I file a provisional application in a language other than English?

Yes, you can file a provisional application in a language other than English. However, there are important considerations:

  • The USPTO accepts provisional applications in any language.
  • An English translation is not required at the time of filing.
  • If a nonprovisional application is later filed claiming benefit of the provisional, an English translation may be required.

The MPEP 201.04 states: “If a provisional application is filed in a language other than English, an English-language translation of the non-English language provisional application will not be required in the provisional application.” However, it’s important to note that if you later file a nonprovisional application claiming benefit of the provisional, you may need to provide an English translation at that time, along with a statement that the translation is accurate.

To learn more:

Can I file a provisional application electronically?

Yes, you can file a provisional application electronically through the USPTO’s Electronic Filing System (EFS-Web). The MPEP 201.04 states:

“Applicants can file provisional applications electronically using EFS-Web or Patent Center.”

Electronic filing offers several advantages, including:

  • Immediate confirmation of receipt
  • Potential for reduced filing fees
  • Faster processing times
  • 24/7 availability

To file electronically, you’ll need to prepare your application documents in the appropriate format and submit them through the USPTO’s EFS-Web system or Patent Center.

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on Patent Center, visit: Patent Center.

For more information on provisional application, visit: provisional application.

Can I file a priority claim in a continuing application?

Yes, you can file a priority claim in a continuing application, but there are specific requirements and deadlines to consider. According to MPEP 214.01, “In the case of a continuation or divisional application filed under 35 U.S.C. 111(a), the claim for priority must be made during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.” This means that even in a continuing application, you must adhere to the time limits for filing the priority claim. It’s important to note that the priority claim must be made in each continuing application; a priority claim in a parent application does not automatically carry over to child applications.

Yes, you can file a priority claim in a continuation or divisional application, but there are specific rules you must follow. According to MPEP 214.01:

‘In the case of a continuation or divisional application filed under 35 U.S.C. 111(a), the claim for priority must be made during the pendency of the application and within the four-month period set forth in 37 CFR 1.55(d)(1).’

This means:

  • The priority claim must be made while the continuation or divisional application is still pending (not abandoned or issued).
  • You have a four-month window from the actual filing date of the continuation or divisional application to make the priority claim.
  • The priority claim should refer back to the foreign application through the parent application(s).

It’s important to note that the continuation or divisional application must have copendency with the parent application to maintain the priority chain. Always consult the latest version of the MPEP and consider seeking advice from a patent attorney to ensure compliance with current USPTO rules.

To learn more:

Can I file a priority claim after paying the issue fee for my patent application?

Yes, you can file a priority claim after paying the issue fee for your patent application, but it comes with additional requirements and costs. According to MPEP 213.04:

If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, it must also be accompanied by the processing fee set forth in 37 CFR 1.17(i).

This means that if you file your priority claim after paying the issue fee, you must:

  • Include the priority claim or certified copy of the foreign application
  • Pay the additional processing fee specified in 37 CFR 1.17(i)
  • Ensure the application hasn’t been patented yet

It’s important to note that once the patent is granted, you cannot file a priority claim retroactively. Therefore, it’s always best to file your priority claim as early as possible during the application process to avoid additional fees and potential complications.

To learn more:

No, you cannot file a petition to restore the benefit of a provisional application in the provisional application itself. According to the MPEP:

“A petition to restore the benefit of a provisional application must be filed in the subsequent application.”

This means you must file the petition in the nonprovisional application or the international application designating the United States that is seeking to claim the benefit of the provisional application. This is because the provisional application itself is not examined and automatically expires after 12 months. The petition is a request to restore the right to claim the benefit in a subsequent application, not to extend the life of the provisional application.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

Can I file a divisional-continuation application?

Yes, you can file a divisional-continuation application, which is a hybrid type of continuing application. This type of application combines aspects of both divisional and continuation applications.

According to MPEP 201.06(c): “The disclosure presented in a divisional application must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.” However, a divisional-continuation can include both claims to a distinct invention (like a divisional) and additional claims to the invention disclosed in the parent (like a continuation).

When filing such an application, it’s crucial to:

  • Ensure that the claims are properly grouped
  • Clearly indicate which claims are divisional and which are continuation
  • Comply with all requirements for both divisional and continuation applications

Always consult with a patent attorney or agent to determine the best filing strategy for your specific situation.

For more information on continuing applications, visit: continuing applications.

Can I file a divisional-continuation application after my parent application has been patented?

No, you cannot file a divisional-continuation application after your parent application has been patented. According to MPEP 201.06(c):

“The divisional application must be filed before the patenting or abandonment of or termination of proceedings on the prior application.”

This means that the window for filing a divisional-continuation application closes when the parent application is either:

  • Granted a patent
  • Abandoned
  • Proceedings are terminated

If you wish to pursue additional claims or inventions after your patent has been granted, you may need to consider other options, such as filing a reissue application or a new continuation-in-part application, depending on the specific circumstances and the nature of the new subject matter.

For more information on parent application, visit: parent application.

For more information on patent grant, visit: patent grant.

Can I file a divisional application without a new oath or declaration?

Yes, you can file a divisional application without a new oath or declaration under certain conditions. According to MPEP 201.06(c):

“Under 37 CFR 1.63(d), a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) if: (1) the prior nonprovisional application contained an oath or declaration as prescribed by 37 CFR 1.63 that was executed by or with respect to the inventor and was signed in compliance with 37 CFR 1.64; and (2) the divisional application was filed by all or by fewer than all of the inventors named in the prior application.”

This provision simplifies the filing process for divisional applications, allowing inventors to use the oath or declaration from the original application, provided the specified conditions are met.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

Yes, it is possible to file a delayed benefit claim in an abandoned application, particularly for provisional applications. The MPEP 211.04 states:

“Effective December 18, 2013, 35 U.S.C. 119(e)(1) no longer requires that the amendment containing the specific reference to the earlier filed provisional application be submitted during the pendency of the application. Therefore, a petition to revive is no longer required to add or correct a benefit claim under 35 U.S.C. 119(e) in an abandoned nonprovisional application filed on or after November 29, 2000.”

This means you can file a petition under 37 CFR 1.78 to accept an unintentionally delayed claim for the benefit of a prior-filed provisional application in the abandoned nonprovisional application. This may be necessary to correct benefit claims in later-filed applications that claim benefit from the abandoned application.

To learn more:

Can I file a certified copy of a foreign application after paying the issue fee?

Yes, you can file a certified copy of a foreign application after paying the issue fee, but there are important considerations. According to MPEP 213.04, “If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.” This means that while you can still file the certified copy, it won’t automatically be included in your patent. You would need to request a certificate of correction after the patent issues to have the priority claim recognized. It’s always best to file the certified copy before paying the issue fee to avoid this additional step and potential complications.

To learn more:

Yes, you can delete a benefit claim, but it’s important to understand the process and potential implications:

  1. For applications filed on or after September 16, 2012, you can delete a benefit claim by filing a corrected Application Data Sheet (ADS) that removes the reference to the prior-filed application.
  2. For applications filed before September 16, 2012, you can delete a benefit claim by amending the specification (if the claim is in the specification) or by submitting a supplemental ADS to delete references to prior applications.

According to MPEP 211.02(a): The examiner should consider whether any new prior art may now be available if a benefit claim is deleted.

Important considerations:

  • Deleting a benefit claim may expose your application to additional prior art, potentially affecting its patentability.
  • If you delete a benefit claim after final rejection or allowance, the amendment will be treated under special rules (37 CFR 1.116 or 1.312, respectively).
  • Deleting a benefit claim may be seen as intentionally waiving the benefit claim. If you later try to reinstate it, the USPTO may not accept it as unintentionally delayed.
  • In a Continued Prosecution Application (CPA), you cannot delete the reference to the prior application with the same application number.

Always carefully consider the implications before deleting a benefit claim, and consult with a patent attorney if you’re unsure about the consequences.

For more information on ADS, visit: ADS.

For more information on CPA, visit: CPA.

For more information on prior art, visit: prior art.

Tags: ADS, CPA, prior art

Can I correct a timely benefit claim without a petition?

Yes, in certain circumstances, you can correct a timely benefit claim without filing a petition. The MPEP 211.02(a) provides guidance on this:

If an applicant includes a benefit claim in a timely filed application data sheet (ADS), but the benefit claim contains a typographical error or improper application number, the applicant may correct the benefit claim without a petition by submitting a corrected ADS in compliance with 37 CFR 1.76(c) if the correction is made within the time period set forth in 37 CFR 1.78.

To correct a timely benefit claim without a petition:

  • The original benefit claim must have been submitted in a timely filed ADS
  • The correction must be for a typographical error or improper application number
  • Submit a corrected ADS complying with 37 CFR 1.76(c)
  • Make the correction within the time period specified in 37 CFR 1.78

It’s important to note that this option is only available for minor corrections to timely filed benefit claims. For more substantial changes or untimely claims, a petition may still be required.

To learn more:

Tags: ADS

Can I convert my provisional application to a nonprovisional application?

No, you cannot directly convert a provisional application to a nonprovisional application. The MPEP clearly states: A provisional application cannot be converted to a nonprovisional application. Instead, you must file a separate nonprovisional application within 12 months of the provisional application’s filing date. This nonprovisional application can claim the benefit of the provisional application’s filing date. Here’s what you need to know:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • It must include a specific reference to the provisional application.
  • The nonprovisional application can expand on the content of the provisional application but must support any claims that rely on the provisional filing date.

Remember, if you don’t file a nonprovisional application within 12 months, the provisional application will automatically expire, and you’ll lose the benefit of its filing date.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

Yes, you can claim priority to multiple foreign applications for the same invention, provided they meet certain criteria. The MPEP 213.02 addresses this situation:

Where two or more foreign applications are combined in a single U.S. application, to take advantage of the changes to 35 U.S.C. 103 or to claim both priority and the benefit of the filing date of an earlier application, the claimed subject matter in the U.S. application is entitled only to the earliest date to which it is entitled in any of the included foreign applications.

To claim priority to multiple foreign applications:

  • Each foreign application must be properly identified in the application data sheet (ADS)
  • Certified copies of all foreign applications must be submitted
  • The U.S. application must be filed within 12 months of the earliest filed foreign application

Note: The effective priority date for any claimed subject matter will be the earliest applicable date from the foreign applications.

To learn more:

Yes, under certain conditions, an applicant can claim priority based on an application for an inventor’s certificate. MPEP 213.05 explains: ‘An inventor’s certificate may form the basis for rights of priority under 35 U.S.C. 119(d) only when the country in which it is filed gives to applicants, at their discretion, the right to apply, on the same invention, either for a patent or for an inventor’s certificate.’

To claim priority to an inventor’s certificate, the applicant must file an affidavit or declaration stating that they had the option to file for either a patent or an inventor’s certificate in the foreign country.

For more information on foreign priority, visit: foreign priority.

Can I claim priority to a provisional application filed in a foreign country?

No, you cannot claim priority to a provisional application filed in a foreign country. The MPEP 213.02 states:

‘Note that a foreign filed provisional application is not eligible for priority benefit.’

Priority claims can only be made to non-provisional applications or other types of applications that are recognized under the Paris Convention. Provisional applications are unique to the U.S. patent system and are not recognized as priority documents in foreign countries or under international agreements.

To learn more:

Yes, it is possible to claim priority to a foreign application after your U.S. patent has been issued. According to MPEP 216.01, a claim for priority under 35 U.S.C. 119(a)-(d) or (f) can be made after the patent is granted, subject to certain conditions:

  • The claim must be made within the time period set forth in 37 CFR 1.55(g).
  • A petition to accept an unintentionally delayed claim for priority must be filed.
  • The required fee must be paid.
  • A certified copy of the foreign application must be submitted.

The MPEP states: ‘A claim for priority under 35 U.S.C. 119(a)-(d) or (f) for the benefit of a prior foreign application may be made after the patent issues if the claim is accompanied by a grantable petition to accept an unintentionally delayed claim for priority.’

No, you cannot amend the specification to refer to a Continued Prosecution Application (CPA) as a continuation of a prior application. The USPTO explicitly denies such amendments. As stated in MPEP ¶ 2.34:

The amendment filed [date] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [continuation/divisional] application of Application No. [X] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.

This means that the act of filing a CPA automatically establishes the necessary reference to the prior application, making any specification amendment unnecessary and prohibited.

For more information on CPA, visit: CPA.

Tags: CPA

No, you cannot amend the specification of a Continued Prosecution Application (CPA) to reference the prior application. The USPTO explicitly states that such amendments are not necessary and will not be entered.

As per MPEP ¶ 2.34: “Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This policy simplifies the process and ensures consistency across CPA filings.

No, you cannot amend the specification of a Continued Prosecution Application (CPA) to refer to it as a continuation or divisional application. According to MPEP § 201.06(d):

“The amendment filed [date] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [continuation/divisional] application of Application No. [X] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This means that the CPA request itself serves as the required reference to the prior application, and no additional amendment to the specification is necessary or allowed.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

The MPEP ¶ 2.32 specifically addresses the process of deleting named inventors when filing a Continued Prosecution Application (CPA) for design patents. However, it does not explicitly mention adding or substituting inventors at the time of CPA filing.

If you need to add or substitute inventors, rather than just delete them, you should follow the general procedures for correction of inventorship outlined in 37 CFR 1.48. This regulation provides the requirements for adding, deleting, or substituting inventors in patent applications.

It’s advisable to consult with a patent attorney or contact the USPTO directly for guidance on the proper procedure for adding or substituting inventors when filing a CPA, as this may require additional documentation or fees beyond a simple deletion request.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

The MPEP ¶ 2.32 specifically addresses the deletion of inventors in a Continued Prosecution Application (CPA) for design patents, but it does not directly discuss adding inventors. However, changes to inventorship in patent applications are generally governed by 37 CFR 1.48.

If you need to add an inventor when filing a CPA, it’s advisable to:

  • Include a clear statement requesting the addition of the new inventor
  • Provide the new inventor’s oath or declaration
  • Submit any required fees

For specific guidance on adding inventors to a CPA, it’s recommended to consult with a patent attorney or contact the USPTO directly, as the process may differ from deleting inventors and could require additional documentation.

For more information on patent procedure, visit: patent procedure.

No, you cannot add an incorporation by reference statement when submitting a benefit claim after the initial filing of your application. The MPEP clearly states:

When a benefit claim is submitted after the filing of an application, the reference to the prior application cannot include an incorporation by reference statement specifying of the prior application unless an incorporation by reference statement specifying of the prior application was presented upon filing of the application.

This rule is based on the principle that no new matter can be added to an application after its filing date, as per 35 U.S.C. 132(a). The MPEP cites the case of Dart Indus. v. Banner, 636 F.2d 684, 207 USPQ 273 (C.A.D.C. 1980) to support this position.

Therefore, if you wish to include an incorporation by reference statement for a prior application, it must be present in the application as originally filed. If it wasn’t included at that time, you cannot add it later when submitting a benefit claim.

To learn more:

Yes, it is possible to add a priority claim to a patent after it has been issued, but the process requires filing a reissue application. The MPEP states:

‘A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) or 35 U.S.C. 120 in the issued patent.’

To add a priority claim, you would need to:

  • File a reissue application under 35 U.S.C. 251
  • Amend the specification to include the required reference
  • Ensure the reissue application is filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f)

It’s important to note that adding a priority claim may affect the patent’s term and could potentially impact its validity if prior art emerges between the new priority date and the original filing date.

Can I add a benefit claim to a foreign priority application after filing?

Yes, you can add a benefit claim to a foreign priority application after filing, but specific procedures must be followed. According to MPEP 211.02(a):

“In the case of a design application, an original claim under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) to a prior U.S. application or PCT international application designating the United States may be made by the filing of an amendment to the specification within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For utility applications, similar time frames apply. However, if you miss these deadlines, you must file a petition under 37 CFR 1.78 along with the petition fee to add the benefit claim. The petition must include:

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed application
  • A statement that the entire delay was unintentional
  • The petition fee set forth in 37 CFR 1.17(m)

It’s important to act promptly when adding or correcting benefit claims to avoid potential issues with patentability or patent term.

To learn more:

Yes, you can add a benefit claim after filing your patent application, but there are specific requirements and potential consequences:

  1. If added within the time period set by 37 CFR 1.78, you can submit a corrected Application Data Sheet (ADS) for applications filed on or after September 16, 2012, or an amendment to the specification or supplemental ADS for applications filed before that date.
  2. If added after the time period set by 37 CFR 1.78, you must file a petition under 37 CFR 1.78 and pay the petition fee. The petition must include:
    • The reference to the prior application
    • The petition fee
    • A statement that the entire delay was unintentional
  3. Depending on the application status, you may also need to file:
    • A Request for Continued Examination (RCE) if the application is under final rejection or allowed
    • A reissue application or request for a certificate of correction if the patent has already issued

As stated in MPEP 211.02(a): “When a benefit claim is submitted after the filing of an application, the reference to the prior application cannot include an incorporation by reference statement specifying of the prior application unless an incorporation by reference statement specifying of the prior application was presented upon filing of the application.”

It’s important to note that adding a benefit claim may affect the patent term and could introduce new prior art, so consider these factors carefully before proceeding.

To learn more:

No, design patent applications cannot directly claim the benefit of a provisional application. The MPEP clearly states:

“Design applications may not claim the benefit of a provisional application under 35 U.S.C. 119(e).”

This restriction is based on 35 U.S.C. 172. However, there is a potential indirect way to claim some benefit:

If a design patent application claims benefit under 35 U.S.C. 120 to an intermediate nonprovisional utility patent application that directly claims the benefit of a provisional application, the design application cannot claim the benefit of the filing date of the provisional application.

This means that while a design application can’t directly benefit from a provisional application’s filing date, it may indirectly benefit from the disclosure in a nonprovisional utility application that claims priority to a provisional application.

To learn more:

No, design applications cannot claim the benefit of provisional applications under 35 U.S.C. 119(e).

MPEP 211.01(a) explicitly states: Design applications may not claim the benefit of a provisional application under 35 U.S.C. 119(e).

However, it’s important to note that while a design application cannot directly claim benefit of a provisional application, it may be possible to indirectly claim benefit through an intermediate utility application. The MPEP clarifies: Thus, where a design patent application claims benefit under 35 U.S.C. 120 to an intermediate nonprovisional utility patent application that directly claims the benefit of a provisional application, the design application cannot claim the benefit of the filing date of the provisional application.

To learn more:

Can an inventor’s oath or declaration from a parent application be used in a divisional application?

Yes, an inventor’s oath or declaration from a parent application can often be used in a divisional application. According to MPEP 201.06(c):

‘In accordance with 37 CFR 1.63(d), a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) if: (1) the divisional application claims are directed to subject matter disclosed in the prior-filed application; (2) a copy of the inventor’s oath or declaration from the prior-filed application is provided for the divisional application; and (3) the prior-filed application contains a statement by the applicant that any required oath or declaration, including any substitute statement under 37 CFR 1.64 or assignment-statement under pre-AIA 37 CFR 1.63(e), has been filed.’

This provision simplifies the filing process for divisional applications by allowing the reuse of the original oath or declaration, provided certain conditions are met. However, it’s important to ensure that all inventors named in the divisional application are covered by the oath or declaration from the parent application.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on parent application, visit: parent application.

Yes, an international application can be used as a basis for priority in a U.S. national application. This is outlined in 35 U.S.C. 365(a), which states:

In accordance with the conditions and requirements of subsections (a) through (d) of section 119, a national application shall be entitled to the right of priority based on a prior filed international application which designated at least one country other than the United States.

It’s important to note that the international application must have designated at least one country other than the United States to be eligible as a basis for priority.

To learn more:

Yes, an incomplete patent application can often be corrected, but the process and consequences depend on the specific deficiencies. While MPEP 203.06 doesn’t directly address corrections, it implies that applications lacking essential parts are incomplete:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

To correct an incomplete application:

  • Identify the missing components
  • Submit the missing parts as soon as possible
  • Pay any required fees
  • Be aware that the filing date may be adjusted to the date when all essential parts are received

It’s important to note that some deficiencies may result in the need to file a new application. Consult with a patent attorney or agent for specific guidance on your situation.

To learn more:

Yes, patent examiners can make a preliminary determination about whether an application might qualify as a continuation-in-part (CIP). The MPEP ¶ 2.06 provides guidance for examiners, stating:

This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Examiners typically look for the following indicators:

  • Substantial repetition of content from a prior application
  • Addition of new disclosure not present in the prior application
  • At least one common inventor with the prior application

However, it’s important to note that the final determination of an application’s status as a CIP depends on the applicant’s claims and proper benefit claims being established. Examiners may use this paragraph to alert applicants to the possibility of CIP status and the need to properly claim benefit if desired.

Yes, an attorney or agent of record can formally abandon your patent application. MPEP 203.05 states that an application can be abandoned:

“through formal abandonment by the applicant or by the attorney or agent of record”

This means that your authorized representative has the power to formally abandon your application. However, they should only do so with your consent or under specific circumstances outlined in their agreement with you. It’s important to maintain clear communication with your patent attorney or agent regarding the status and decisions related to your application.

To learn more:

Yes, according to MPEP ¶ 2.05, an application can potentially be classified as both a continuation and a division. The MPEP states:

“Accordingly, this application may constitute a continuation or division.” (MPEP ¶ 2.05)

This dual classification possibility arises because:

  • A continuation application discloses and claims only subject matter from the prior application
  • A divisional application is filed as a result of a restriction requirement in the prior application
  • In some cases, an application may meet both criteria

The final determination of whether the application is a continuation, division, or both will depend on the specific circumstances of the application and its relationship to the prior application. The examiner will make this determination during the examination process.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

Amendments can be made when filing a Continued Prosecution Application (CPA), but there are important restrictions and considerations:

  • Any changes must be made as an amendment to the prior application as it existed before filing the CPA
  • No new matter can be introduced in a CPA
  • Preliminary amendments filed with a CPA are generally entered, but could be denied entry if they unduly interfere with examination
  • New specifications filed with a CPA request are treated as substitute specifications and must comply with 37 CFR 1.125

The MPEP states: Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph. No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application.

Regarding preliminary amendments, the MPEP advises: Applicants are also encouraged to file all preliminary amendments at the time of filing a CPA because the entry of any preliminary amendment filed after the filing date of the CPA could be denied under 37 CFR 1.115 if the preliminary amendment unduly interferes with the preparation of a first Office action.

If more time is needed to prepare amendments, applicants can request a three-month suspension of action under 37 CFR 1.103(b) at the time of filing the CPA.

For more information on amendments, visit: amendments.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

While amendments can be filed with a Continued Prosecution Application (CPA) request, there are important considerations and limitations. The MPEP states:

“Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph. No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application.”

Additionally:

  • Preliminary amendments filed with a CPA are generally entered
  • Applicants are encouraged to file any amendments at the time of filing the CPA to avoid potential delays
  • Any new matter introduced will be required to be canceled
  • Claims relying on new matter may be rejected under 35 U.S.C. 112(a)

The MPEP advises: “Applicants are strongly encouraged to file any preliminary amendment in a CPA at the time the CPA is filed. See 37 CFR 1.115 and MPEP § 714.03(a).”

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on new matter, visit: new matter.

Can a US national application claim benefit of an international application that entered national stage in another country?

Yes, a U.S. national application can claim the benefit of an international application that entered the national stage in another country, as long as certain conditions are met. The MPEP provides guidance on this:

“A U.S. national application may claim benefit under 35 U.S.C. 120 and 365(c) to an international application which designates at least one country other than the United States only if the international application has been accorded an international filing date and meets the requirements of 35 U.S.C. 371(c).”

This means that for a U.S. application to claim benefit from an international application that entered the national stage elsewhere, the international application must:

  • Have an international filing date
  • Designate at least one country other than the United States
  • Meet the requirements of 35 U.S.C. 371(c)

It’s important to note that the benefit claim is made under both 35 U.S.C. 120 (for continuing applications) and 35 U.S.C. 365(c) (for international applications).

To learn more:

Yes, a U.S. applicant can claim priority from a provisional application filed in a foreign country, provided certain conditions are met. The MPEP 213 states:

An applicant may claim the right of priority based on a prior foreign application under the Paris Convention and 35 U.S.C. 119(a)-(d) whether the foreign application is an application for a patent or for the registration of a utility model or an industrial design.

Key points to consider:

  • The foreign country must be a recognized country or regional patent office as listed in MPEP 213.01.
  • The provisional application must be the first filing of the invention in any country.
  • The U.S. application must be filed within 12 months of the foreign provisional filing date.
  • The applicant must comply with all requirements for claiming priority, including submitting a certified copy of the foreign application.

It’s important to note that not all countries have provisional application systems, so the term ‘provisional’ may have different meanings in different jurisdictions. Always consult with a patent attorney or agent for specific advice on international priority claims.

Yes, a sole inventor can file a continuation-in-part (CIP) application based on an earlier application with joint inventors, provided certain conditions are met. The MPEP 201.08 states:

“A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78.”

This situation might occur when one of the joint inventors from the original application independently develops additional subject matter. The key requirements are:

  • The CIP must meet all other conditions of 35 U.S.C. 120 and 37 CFR 1.78.
  • The sole inventor must be one of the joint inventors named in the prior application.
  • The CIP should contain new matter not disclosed in the prior application.

It’s important to ensure proper attribution and compliance with all USPTO requirements when filing such a CIP.

For more information on joint inventors, visit: joint inventors.

Yes, a reissue application can be used to correct inventorship. The MPEP 201.05 states: ‘A reissue application may also be filed to correct inventorship in the patent. The reissue oath or declaration must state that the applicant believes the original patent to be wholly or partly inoperative or invalid by reason of the incorrect inventorship.’

This means that if the original patent listed incorrect inventors or omitted inventors who should have been included, a reissue application can be filed to rectify this error. However, it’s important to note that:

  • The error in inventorship must have been made without deceptive intent.
  • The reissue application must be accompanied by a proper reissue oath or declaration explaining the error.
  • All current patent owners must consent to the reissue application.

Correcting inventorship through a reissue application is governed by 35 U.S.C. 251 and the procedures outlined in the MPEP.

To learn more:

Yes, a reference to a prior application can be added after filing, but there are specific procedures and limitations to be aware of. According to MPEP 211.02:

If an applicant includes a reference to a prior application elsewhere in the application but not in the first sentence(s) of the specification, and the application is otherwise complete, OPAP will mail a ‘Notice to File Missing Parts’ giving the applicant an opportunity to correct the reference to the prior application. If the application is otherwise incomplete, OPAP will mail a Notice to File Missing Parts, and the applicant can amend the specification to include the reference to the prior application in addition to completing the application.

However, it’s important to note that adding a reference to claim priority benefits has strict time limitations. As per MPEP 211.03:

A petition under 37 CFR 1.78 and the petition fee would be required to add or correct a reference to a prior application in an application after expiration of the time period set in 37 CFR 1.78(a)(4), (b)(3), (c)(3), or (e)(4).

Therefore, while it’s possible to add or correct a reference after filing, it’s always best to include the correct reference in the initial filing to avoid potential complications or the need for petitions.

To learn more:

No, a provisional patent application cannot claim priority to or benefit from other applications. The MPEP 201.04 clearly states:

“A provisional application is not entitled to the right of priority under 35 U.S.C. 119, 365(a), or 386(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121, 365(c), or 386(c) or § 1.78 of any other application.”

This means that a provisional application stands alone and cannot claim the filing date of any earlier U.S. or foreign application. However, it’s important to note that while a provisional application cannot claim priority, it can serve as a priority document for later-filed nonprovisional or foreign applications, provided they are filed within 12 months of the provisional application’s filing date.

To learn more:

Yes, a provisional patent application can be converted to a nonprovisional application. According to MPEP 201.04:

“A provisional application filed under paragraph (c) of this section may be converted to a nonprovisional application filed under paragraph (b) of this section and accorded the original filing date of the provisional application.”

However, there are specific requirements and considerations for this conversion:

  • The request for conversion must be accompanied by the fee set forth in 37 CFR 1.17(i)
  • An amendment including at least one claim as prescribed by 35 U.S.C. 112(b) must be submitted
  • The request must be filed before the abandonment of the provisional application or the expiration of 12 months after its filing date
  • Additional fees for nonprovisional applications will be required

It’s important to note that converting a provisional to a nonprovisional application may result in a shorter patent term. Therefore, filing a new nonprovisional application claiming the benefit of the provisional application under 35 U.S.C. 119(e) is often preferable.

To learn more:

Can a provisional application claim the benefit of an earlier application?

No, a provisional application cannot claim the benefit of an earlier-filed application. This is explicitly stated in MPEP 211.01(a):

“A provisional application is not entitled to the benefit of the filing date of an earlier filed application under 35 U.S.C. 119, 120, 121, 365, or 386.”

This means that a provisional application stands on its own and cannot extend its effective filing date by claiming priority to any earlier application, whether it’s another provisional, a nonprovisional, or a foreign application. The purpose of a provisional application is to establish an early filing date for a subsequent nonprovisional application, not to claim priority to earlier filings.

To learn more:

Can a provisional application be used as a prior-filed application for benefit claims?

Yes, a provisional application can be used as a prior-filed application for benefit claims in certain circumstances. According to MPEP 211.01:

‘The prior application may be a provisional application under 35 U.S.C. 111(b) or a nonprovisional application under 35 U.S.C. 111(a).’

However, there are specific requirements and limitations when claiming the benefit of a provisional application:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (or 14 months with a grantable petition under 37 CFR 1.78(b)).
  • The provisional application must adequately support and enable the subject matter of the claims in the nonprovisional application.
  • The specific reference to the provisional application must be included in an application data sheet (ADS) or the first sentence of the specification.

It’s important to note that while a nonprovisional application can claim the benefit of a provisional application, a provisional application cannot claim the benefit of or priority to any other application.

To learn more:

Can a provisional application be published?

No, provisional applications are not published. The MPEP clearly states: ‘A provisional application is not entitled to the right of priority under 35 U.S.C. 119 or 365(a) or 365(b); is not entitled to the benefit of the filing date of a prior application under 35 U.S.C. 119(e) or 120; and will not be published or examined.’ This means:

  • Provisional applications remain confidential
  • They are not made available to the public
  • No patent document is published based solely on a provisional application

For more information on provisional applications, visit the MPEP 201.04 section.

For more information on patent examination, visit: patent examination.

For more information on provisional application, visit: provisional application.

No, provisional applications are not published or made public by the USPTO. According to MPEP 201.04:

A provisional application is not subject to publication and is not published.

This confidentiality can be advantageous for inventors who want to secure a filing date while keeping their invention details private. However, it’s important to note that while the USPTO doesn’t publish provisional applications, the content may become public if referenced in a later-published nonprovisional application claiming its benefit.

For more information on provisional application, visit: provisional application.

Yes, a provisional application can be filed without claims. The MPEP 201.04 states:

A provisional application must also include the filing fee as set forth in 37 CFR 1.16(d) and a cover sheet identifying the application as a provisional application. Otherwise, the application will be treated as a nonprovisional application. The filing date of a provisional application is the date on which a specification as prescribed by 35 U.S.C. 112(a), and any drawing required by 37 CFR 1.81(a) are filed in the United States Patent and Trademark Office. No claims are required.

While claims are not required for a provisional application, it’s important to provide a comprehensive description of the invention to ensure adequate support for any claims in a subsequent nonprovisional application.

For more information on provisional application, visit: provisional application.

Can a provisional application be filed in a language other than English?

Yes, a provisional application can be filed in a language other than English. According to MPEP 201.04:

‘A provisional application may be filed in a language other than English.’

However, it’s important to note that while the USPTO allows this, it may have implications for future patent applications. If you later file a nonprovisional application claiming priority to the provisional, you will need to provide an English translation of the provisional application along with a statement that the translation is accurate. This ensures that the examiner can properly determine if the nonprovisional application is entitled to the benefit of the provisional filing date.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

Can a provisional application be converted directly into a nonprovisional application?

No, a provisional application cannot be directly converted into a nonprovisional application. The MPEP 201.04 clearly states:

“A provisional application cannot be converted to a nonprovisional application.”

Instead, to claim the benefit of a provisional application, an applicant must file a separate nonprovisional application within 12 months of the provisional filing date. This nonprovisional application must include a specific reference to the provisional application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

No, a provisional application cannot be considered a continuation-in-part (CIP). The MPEP explicitly states: An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation-in-part’ of the provisional application. (MPEP ¶ 2.06)

This distinction is important because:

  • Provisional applications are not examined and do not mature into patents.
  • The term ‘continuation-in-part’ is reserved for non-provisional applications that build upon prior non-provisional applications.
  • The relationship between a non-provisional application and a provisional application is described as ‘claiming the benefit of’ the provisional, not as a continuation or CIP.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

No, a provisional application cannot be called a ‘divisional’ application. The MPEP ¶ 2.01 explicitly states:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.

This means that while an application can claim the benefit of a provisional application’s filing date under 35 U.S.C. 119(e), it is not considered a divisional application. Divisional applications are specifically related to non-provisional applications and involve claiming independent and distinct inventions from a parent application.

For more information on 35 USC 119(e), visit: 35 USC 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on provisional application, visit: provisional application.

No, a provisional application should not be referred to as a ‘continuation’. The MPEP clearly states:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation’ of the provisional application.”

This is because provisional applications serve a different purpose than continuation applications. Provisional applications are temporary placeholders that establish a priority date but do not mature into issued patents. Continuations, on the other hand, are full patent applications that build upon previously filed non-provisional applications.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

Can a priority claim be made in a continuation or divisional application?

Yes, a priority claim can be made in a continuation or divisional application. However, there are specific requirements and time limits to consider. According to MPEP 214.01:

“In the case of a continuation or divisional application, the claim for priority must be made during the pendency of the application.”

This means:

  • The priority claim must be filed within the later of four months from the actual filing date of the continuation or divisional application or sixteen months from the filing date of the prior foreign application.
  • If the claim is filed outside this period, it will be considered untimely and require a petition under 37 CFR 1.55(e).
  • The priority claim should reference the parent application if it properly claimed the benefit of the foreign application.

It’s important to note that the continuation or divisional application must be filed within 12 months of the foreign application’s filing date (or 6 months for design applications) to be eligible for priority.

Can a priority claim be corrected after the patent has been issued?

Yes, it is possible to correct a priority claim after a patent has been issued, but the process is more complex and limited compared to correcting a priority claim in a pending application.

According to MPEP 214.02: ‘For a correction of foreign priority claim after issuance of a patent, see MPEP § 216.01.’

To correct a priority claim in an issued patent, the following steps are typically required:

  • File a petition for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.
  • Pay the required fee.
  • Provide a statement that the error occurred without deceptive intent.
  • Submit evidence to support the correction, such as a certified copy of the priority document.

It’s important to note that the scope for correcting priority claims in issued patents is more limited than in pending applications. The correction must not involve a change that would broaden the scope of the claims of the issued patent.

For more detailed information on correcting foreign priority claims after patent issuance, refer to MPEP § 216.01.

To learn more:

Yes, a petition for an unintentionally delayed priority claim can be filed after a patent issues, but it requires a different procedure. According to MPEP 214.02:

For applications that have issued as patents, a petition filed under 37 CFR 1.55(e) or 1.78(c) and (e) may be filed as a reissue application, a request for certificate of correction under 37 CFR 1.323, or a petition under 37 CFR 1.78(a) and (b) or 1.55(g), as appropriate.

This means that after a patent has issued, the options for correcting a priority claim are:

  • Filing a reissue application
  • Requesting a certificate of correction
  • Filing a petition under specific regulations

The appropriate method depends on the specific circumstances and the type of priority claim being corrected. It’s important to note that each of these options has its own requirements and limitations. For example, a certificate of correction is generally only available for minor errors that are clerical or typographical in nature.

Given the complexity of post-issuance corrections, it’s advisable to consult with a patent attorney or agent to determine the best course of action for your specific situation.

To learn more:

Yes, a US patent application can claim both foreign priority and domestic benefit simultaneously. This is known as a ‘multiple priority claim’ or ‘multiple benefit claim.’ The MPEP 216 states:

‘It is possible for a U.S. application to be entitled to the benefit of an earlier U.S. filing date and also to the right of priority of a foreign application.’

Here’s how it works:

  • The application can claim foreign priority under 35 U.S.C. 119(a)-(d) to a foreign application filed within the past 12 months.
  • At the same time, it can claim domestic benefit under 35 U.S.C. 120 to an earlier US application.
  • The earlier US application can also claim foreign priority to the same foreign application.

This allows the US application to potentially have an effective filing date that is earlier than both its actual filing date and the filing date of the US application it claims benefit from.

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

Can a national application be converted to an international application?

Yes, a national application can be converted to an international application under certain conditions. The MPEP states: “A national application may be converted to an international application by filing a PCT international application within one year from the earliest U.S. filing date of the national application and including the United States of America as a designated state.” (MPEP 201.01) This conversion allows applicants to seek patent protection internationally while maintaining the priority date of their original national filing. It’s important to note that this conversion must be done within the one-year timeframe to preserve priority rights.

For more information on conversion, visit: conversion.

Tags: conversion

Yes, a legal representative can file a national patent application in certain circumstances. The Manual of Patent Examining Procedure (MPEP) 201.01 states:

‘A national application may be filed under 35 U.S.C. 111(a) in the U.S. Patent and Trademark Office (USPTO) by… (B) the legal representative (35 U.S.C. 117) of a deceased or legally incapacitated inventor.’

This provision allows for the continuity of the patent application process when the inventor is unable to file themselves. The legal representative must be authorized under 35 U.S.C. 117, which typically includes executors, administrators, or other legal representatives of deceased inventors, or guardians or conservators of incapacitated inventors.

For more information on legal representative, visit: legal representative.

For more information on patent filing, visit: patent filing.

Yes, a foreign priority claim can be corrected after filing a patent application, but there are specific procedures and time limitations to follow. According to MPEP 214.04:

‘The time period for making a claim for priority under 37 CFR 1.55 is set forth in 37 CFR 1.55(d)… If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’

To correct a foreign priority claim:

  • If before the issue fee is paid: File a corrected Application Data Sheet (ADS) with the proper identification of the foreign application.
  • If after the issue fee is paid: Request a Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323.

It’s important to note that corrections must be made within the time period specified in 37 CFR 1.55(d), which is typically within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To learn more:

Yes, a divisional or continuation application can claim benefit from multiple prior applications. The MPEP 201.06(c) states:

‘A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (A) a copy of the prior application as filed; and (B) a new specification, claim or claims and drawings, where applicable.’

This provision allows for claiming benefit from multiple prior applications by following the correct procedures. It’s crucial to ensure that the chain of priority is properly maintained and that all necessary documents and declarations are filed.

To learn more:

To learn more:

No, a divisional application cannot include new matter that was not disclosed in the parent application. The MPEP 201.06 clearly states:

‘A divisional application is a later application for an independent or distinct invention, carved out of a prior application and disclosing and claiming only subject matter disclosed in the prior application.’

This means:

  • The divisional application must be limited to the subject matter disclosed in the parent application
  • No new matter can be added to the divisional application
  • The claims in the divisional must be supported by the disclosure of the parent application

If an applicant wishes to add new matter, they should consider filing a continuation-in-part (CIP) application instead of a divisional. For more information on new matter, refer to MPEP 2163.

To learn more:

Yes, a divisional application can claim the benefit of the filing date of the prior application. The MPEP ¶ 2.01 states:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

To claim this benefit, the applicant must meet the requirements set forth in 35 U.S.C. 120 and 37 CFR 1.78, which include making a proper benefit claim and ensuring the divisional application is filed before the patenting or abandonment of the prior application.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Yes, a divisional application can claim priority to its parent application. This is one of the key benefits of filing a divisional application. According to MPEP 201.06:

‘A divisional application is entitled to the benefit of the filing date of the prior application.’

This means that the divisional application:

  • Retains the priority date of the parent application for the subject matter disclosed in the parent
  • Can claim the benefit under 35 U.S.C. 120 or 365(c)
  • Must include a specific reference to the parent application in its application data sheet (ADS)

It’s important to note that the divisional application must be filed while the parent application is still pending to claim this benefit.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Yes, a divisional application can claim priority to a provisional application under certain conditions. According to MPEP 201.06:

‘A divisional application may claim the benefit of a provisional application under 35 U.S.C. 119(e) if the divisional application is filed within twelve months of the provisional application filing date (or an appropriate later date in accordance with 37 CFR 1.78).’

To claim this benefit, the divisional application must:

  • Be filed within 12 months of the provisional application’s filing date (or later if permitted under 37 CFR 1.78)
  • Include a proper reference to the provisional application
  • Have at least one common inventor with the provisional application

To learn more:

To learn more:

Yes, a divisional application can claim the benefit of its parent application’s filing date. According to MPEP 201.06(c):

“A divisional application is entitled to the benefit of the filing date of the prior-filed application if the prior-filed application discloses the invention claimed in the divisional application in the manner provided by the first paragraph of 35 U.S.C. 112.”

This means that as long as the invention claimed in the divisional application was adequately described in the parent application, it can claim the parent’s filing date. This is crucial for establishing priority and avoiding potential prior art issues.

For more information on Divisional application, visit: Divisional application.

Can a divisional application claim benefit from a provisional application?

Yes, a divisional application can claim benefit from a provisional application through its parent application. The MPEP 201.06 states: “A later-filed application may be filed as a continuation, divisional, or continuation-in-part of a prior nonprovisional application or international application designating the United States. Unless the filing date of the earlier nonprovisional application is to be claimed for prior art purposes, there is no need for the later-filed application to be copending with it.” This means that if the parent application claimed benefit from a provisional application, the divisional application can also claim that benefit, extending its effective filing date back to the provisional application’s filing date.

To learn more:

Can a divisional application be filed without a restriction requirement?

While divisional applications are typically filed in response to a restriction requirement, they can be filed voluntarily without one. The MPEP 201.06 states:

“A divisional application is often filed as a result of a restriction requirement made by the examiner.”

However, the use of “often” implies that this is not always the case. Applicants may choose to file a divisional application voluntarily if they:

  • Recognize distinct inventions in their application
  • Want to pursue different claim scopes separately
  • Need to address potential unity of invention issues proactively

It’s important to note that voluntarily filing a divisional application without a restriction requirement may affect the application of the safe harbor provision under 35 U.S.C. 121, which protects against double patenting rejections in certain cases.

For more information on Divisional application, visit: Divisional application.

Can a divisional application be filed after the parent application is abandoned?

Yes, a divisional application can be filed after the parent application is abandoned, as long as certain conditions are met. The MPEP 201.06 states:

“A divisional application may be filed after abandonment of the parent application, provided the parent application is not relied upon for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c) in an application whose effective filing date is on or after March 16, 2013.”

This means that you can file a divisional application even if the parent application has been abandoned. However, it’s crucial to note that if you want to claim the benefit of the parent application’s filing date, and the effective filing date of your divisional application is on or after March 16, 2013, the parent application must not have been abandoned at the time of filing the divisional.

It’s important to consult with a patent attorney to ensure compliance with all requirements when filing a divisional application, especially in cases involving abandoned parent applications.

For more information on Divisional application, visit: Divisional application.

For more information on effective filing date, visit: effective filing date.

No, a design patent application cannot be filed as a provisional application. The MPEP 201.01 states:

“Design applications and provisional applications for patent are considered to be distinct types of applications and are treated as separate categories.”

This means that design patent applications must be filed as nonprovisional applications. Provisional applications are only available for utility and plant patents.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

Yes, a delayed priority claim can be filed after a patent has been granted. The MPEP provides for this possibility:

“Where a priority claim under 37 CFR 1.55(g) was not timely made, 37 CFR 1.55(g) allows the priority claim and the certified copy required under 37 CFR 1.55 to be filed pursuant to a petition under 37 CFR 1.55(e) even if the application is not pending (e.g., a patented application). Thus, a petition under 37 CFR 1.55(e) may be filed along with request for a certificate of correction after patent grant.”

This provision allows patent holders to rectify priority claims even after their patent has been issued, ensuring that important priority rights are not lost due to unintentional delays.

To learn more:

Yes, a delayed priority claim can be accepted after patent issuance, but the process is more complex and requires a certificate of correction. According to MPEP 214.02:

For utility and plant applications filed on or after November 29, 2000, the failure to timely file a priority claim because of an error in a foreign priority claim may be corrected pursuant to 37 CFR 1.55(g). The failure to timely file a priority claim to an earlier filed application may be corrected pursuant to 37 CFR 1.78(c) and (e).

To correct a delayed priority claim after patent issuance:

  • File a petition under 37 CFR 1.55(e) or 37 CFR 1.78(c) and (e), as appropriate.
  • Submit a request for a certificate of correction under 37 CFR 1.323.
  • Pay the required fees for both the petition and the certificate of correction.
  • Provide a statement of unintentional delay covering the entire period of delay.

It’s important to note that the standards for accepting a delayed priority claim after issuance are typically higher, and the USPTO may require a more detailed explanation of the circumstances surrounding the delay.

To learn more:

To learn more:

Yes, delayed benefit claims can be filed for design applications. The MPEP 211.04 provides specific information about this:

“Effective May 13, 2015, 37 CFR 1.78(d)(3) was amended to make the procedures under 37 CFR 1.78(e) to accept an unintentionally delayed benefit claim applicable to design applications where the benefit claim was not submitted during the pendency of the design application. Thus, a petition under 37 CFR 1.78(e) may be filed along with a request for certificate of correction after patent grant.”

This means that for design applications, it’s possible to file a petition for a delayed benefit claim even after the patent has been granted, along with a request for a certificate of correction.

To learn more:

Yes, a delayed benefit claim can be filed for an international application entering the national stage, but specific requirements must be met. The MPEP 211.04 provides guidance on this:

‘For international applications entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT…However, if an applicant fails to make a proper benefit claim within the later of four months from the actual filing date of the national stage application or sixteen months from the filing date of the prior-filed application, the benefit claim may be accepted if the applicant files a petition under 37 CFR 1.78.’

This means that while there are specific timeframes for filing benefit claims in national stage applications, if these deadlines are missed, a petition under 37 CFR 1.78 can be filed to request acceptance of the delayed benefit claim. The petition must meet all requirements, including demonstrating that the delay was unintentional.

To learn more:

No, a delayed benefit claim cannot be accepted after the patent has issued. The MPEP 211.04 clearly states:

“A petition under 37 CFR 1.78 to accept an unintentionally delayed claim for the benefit of a prior-filed application will not be granted in an issued patent.”

This means that once a patent has been granted, it is no longer possible to add or correct benefit claims through the petition process. The opportunity to make such changes ends when the patent issues.

If an applicant discovers after issuance that a benefit claim was not properly made or was omitted, they may have limited options:

  • Consider filing a reissue application to correct the error, if it qualifies as an error correctable by reissue.
  • In some cases, a certificate of correction might be appropriate, but this is generally limited to typographical or clerical errors.

It’s crucial for applicants to ensure all desired benefit claims are properly made and recorded before the patent issues to avoid complications and potential loss of priority rights.

To learn more:

Can a CPA be filed in a provisional application?

No, a Continued Prosecution Application (CPA) cannot be filed in a provisional application. The MPEP 201.06(d) clearly states:

A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application, but not an international design application, that is complete as defined by 37 CFR 1.51(b), except for the inventor’s oath or declaration if the application is filed on or after September 16, 2012, and the prior application was filed under 35 U.S.C. 111(a).

This means that CPAs are limited to design applications filed under 35 U.S.C. 111(a). Provisional applications, which are filed under 35 U.S.C. 111(b), are not eligible for CPA filing.

To learn more:

To learn more:

No, Continued Prosecution Applications (CPAs) cannot be filed for utility or plant applications. The MPEP clearly states: Effective July 14, 2003, continued prosecution application (CPA) practice was eliminated as to utility and plant applications. For utility and plant applications, applicants should consider filing a request for continued examination (RCE) under 37 CFR 1.114 or a new application under 37 CFR 1.53(b) instead.

To learn more:

Can a CPA be filed as a continuation-in-part application?

No, a Continued Prosecution Application (CPA) cannot be filed as a continuation-in-part application. According to MPEP 201.06(d):

‘A continuation or divisional application (but not a continuation-in-part) may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).’

This means that while you can file a CPA as a continuation or divisional application of a prior design application, you cannot file it as a continuation-in-part. Continuation-in-part applications typically contain new matter not present in the prior application, which is not allowed in a CPA filing.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

Can a Continued Prosecution Application (CPA) be filed in a provisional application?

No, a Continued Prosecution Application (CPA) cannot be filed in a provisional application. According to MPEP 201.06(d):

“A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).”

This explicitly limits CPA practice to design applications. Provisional applications are not eligible for CPA filings. If an applicant wishes to continue prosecution based on a provisional application, they must file a non-provisional application claiming priority to the provisional application within the appropriate time frame.

For more information on CPA, visit: CPA.

For more information on provisional application, visit: provisional application.

Can a Continued Prosecution Application (CPA) be filed for utility or plant patent applications?

No, a Continued Prosecution Application (CPA) cannot be filed for utility or plant patent applications. According to MPEP 201.06(d):

‘Effective July 14, 2003, CPAs are only available for design applications.’

This means that CPAs are exclusively for design patent applications. For utility or plant patent applications, applicants must use other continuation options such as:

If an applicant attempts to file a CPA for a utility or plant application, the USPTO will process it as a request for continued examination (RCE) under 37 CFR 1.114, if applicable, or will otherwise treat it as an improper application.

To learn more:

Yes, a Continued Prosecution Application (CPA) can be filed for design applications. In fact, as of September 8, 2000, CPAs are only available for design applications. According to MPEP 201.06(d):

‘Effective July 14, 2003, CPA practice has been eliminated as to utility and plant applications. CPAs can only be filed for design applications.’

This means that for utility and plant patent applications, other forms of continuing applications such as RCEs (Request for Continued Examination) or continuation applications under 37 CFR 1.53(b) must be used instead of CPAs.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

Yes, a continuation-in-part (CIP) application can have different inventors than the parent application, but there must be at least one common inventor. The MPEP provides guidance on this:

“A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78. Subject to the same conditions, a continuation-in-part application that has joint inventors may derive from an earlier application that has a sole inventor.”

This flexibility allows for situations where new inventors contribute to the additional subject matter in the CIP, or where some inventors from the original application are no longer involved in the new developments.

For more information on joint inventors, visit: joint inventors.

Can a continuation-in-part application claim priority to a provisional application?

Yes, a continuation-in-part (CIP) application can claim priority to a provisional application, but with some important considerations. The MPEP 201.08 doesn’t explicitly address this scenario, but it can be inferred from the general rules governing CIP applications and provisional applications.

Key points to understand:

  • Priority claim: A CIP can claim priority to a provisional application for subject matter disclosed in the provisional.
  • New matter: Any new matter added in the CIP will have the filing date of the CIP itself, not the provisional application.
  • One-year deadline: The CIP must be filed within one year of the provisional application’s filing date to claim its benefit.
  • Multiple priorities: A CIP might claim priority to both a provisional and a non-provisional application in some cases.

Inventors should carefully document which parts of their CIP application correspond to the provisional disclosure to ensure proper priority claims.

For more information on new matter, visit: new matter.

For more information on provisional application, visit: provisional application.

Yes, a continuation-in-part (CIP) application can claim benefit from multiple parent applications. The MPEP 201.08 states:

An applicant may in a single application seek to add and claim new matter while also repeating some or all of the subject matter of one or more earlier applications.

This means:

  • A CIP can incorporate subject matter from multiple earlier applications.
  • It can also add new matter not disclosed in any of the earlier applications.
  • The CIP can claim priority to different parent applications for different parts of its disclosure.

Note: The effective filing date for each claim will depend on which parent application(s) provide sufficient support for that claim, as per 35 U.S.C. 112(a). Claims relying on newly added matter will have the CIP’s filing date as their effective date.

To learn more:

To learn more:

Can a continuation-in-part application claim benefit from an international application?

Yes, a continuation-in-part (CIP) application can claim benefit from an international application, but there are specific requirements and limitations. The MPEP 211.01(c) states:

A U.S. national application may claim benefit under 35 U.S.C. 120 and 365(c) to an international application designating the United States only if the international application was filed on or after November 29, 2000.

However, it’s crucial to understand that for a CIP application, the benefit claim is limited to the subject matter that was disclosed in the international application. Any new matter added in the CIP would not receive the benefit of the international application’s filing date. Additionally, the CIP must meet all the requirements of 35 U.S.C. 120, including copendency and specific reference to the earlier application.

To learn more:

To learn more:

A continuation-in-part (CIP) application can claim the benefit of a prior application’s filing date, but with important limitations:

  • Only the subject matter common to both the CIP and the prior application can claim the earlier filing date.
  • New matter introduced in the CIP will have the filing date of the CIP application.
  • Each claim in the CIP is evaluated independently for priority date determination.

MPEP 211.05 states:

A claim in a continuation-in-part application or subsequent application may be entitled to the benefit of the filing date of the prior application if the disclosure of the prior application provides support for the claim in compliance with 35 U.S.C. 112(a), except for the best mode requirement.

This means that applicants must carefully consider the content of their prior applications when filing a CIP to ensure they receive the maximum benefit of earlier filing dates for their claims.

To learn more:

Tags: new matter

Can a continuation-in-part (CIP) application claim benefit to multiple prior applications?

Yes, a continuation-in-part (CIP) application can claim benefit to multiple prior applications, provided certain conditions are met. The MPEP states:

“An applicant may claim the benefit of the filing date of one or more prior applications under 35 U.S.C. 120, 121, 365(c), or 386(c) in a later-filed application … if the later-filed application is filed before the patenting or abandonment of or termination of proceedings on the prior application.”

However, it’s important to note that for a CIP application:

  • New matter in the CIP will only get the benefit of the CIP’s filing date.
  • Matter disclosed in the prior application(s) can claim the earlier filing date(s).
  • Each claim in the CIP is evaluated separately to determine which filing date it is entitled to.

For more details, see MPEP 211.01 and MPEP 201.08.

To learn more:

To learn more:

Can a continuation-in-part (CIP) application claim benefit to a provisional application?

Yes, a continuation-in-part (CIP) application can claim benefit to a provisional application, but there are important considerations regarding the disclosure and priority dates. The MPEP provides guidance on this:

“An applicant may claim the benefit of the filing date of a provisional application in a subsequent nonprovisional application or international application designating the United States if the nonprovisional application or international application designating the United States is filed within 12 months from the filing date of the provisional application.”

However, it’s crucial to understand that:

  • Only the subject matter that was disclosed in the provisional application will receive the benefit of the provisional filing date.
  • New matter added in the CIP will have the filing date of the CIP application itself.
  • The applicant must comply with the requirements of 35 U.S.C. 119(e) and 37 CFR 1.78.

For more details on claiming benefit of provisional applications, see MPEP 211.

To learn more:

No, a continuation application cannot include new matter. As stated in MPEP 201.07:

The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

This means that the continuation application must be based entirely on the disclosure of the prior-filed application. Any new subject matter would need to be filed as a continuation-in-part (CIP) application instead of a standard continuation application.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

For more information on patent law, visit: patent law.

Yes, a continuation application can claim the benefit of multiple parent applications, provided certain conditions are met. According to MPEP 201.07:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 111(b) or 365(c) or filed under 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.53(b) or 1.53(d) as a continuation of prior applications, claiming the benefit of those applications under 35 U.S.C. 120, 121, 365(c), or 386(c).’

This means that a continuation application can claim the benefit of:

  • Multiple earlier-filed nonprovisional applications
  • Earlier-filed provisional applications
  • Earlier-filed international applications designating the United States

However, it’s important to note that the continuation must satisfy the requirements for claiming benefit, including proper copendency and cross-referencing of the prior applications.

For more information on continuation application, visit: continuation application.

Can a continuation application claim the benefit of a provisional application?

Yes, a continuation application can claim the benefit of a provisional application, provided certain conditions are met. The MPEP 201.07 states:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 363 while the prior application is pending, or it may be filed as an RCE under 37 CFR 1.114 of the prior application.’

To claim the benefit of a provisional application:

  • The continuation must be filed within 12 months of the provisional filing date
  • The provisional application must provide adequate support for the claims in the continuation
  • A specific reference to the provisional application must be made in the continuation

It’s important to note that while a continuation can claim benefit from a provisional, it must have at least one intervening nonprovisional application in the chain, as continuations are based on nonprovisional applications.

To learn more:

Yes, a continuation application can claim priority to multiple parent applications under certain conditions. According to MPEP 201.07:

‘A continuation application may be filed as a continuation of an earlier application of the same applicant… The continuation application may be filed before the patenting or abandonment of or termination of proceedings on the prior application.’

This means that:

  • The continuation must have at least one common inventor with the parent application(s).
  • The continuation must be filed while at least one of the parent applications is still pending.
  • The continuation cannot introduce new matter beyond what was disclosed in the parent application(s).

When claiming priority to multiple parents, the continuation essentially combines the disclosures of the parent applications, as long as they form a continuous chain of copending applications.

To learn more:

To learn more:

Yes, a continuation application can be filed after the parent application is granted or abandoned, but there are timing restrictions. The MPEP states:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

However, it’s important to note:

  • For standard continuation applications under 37 CFR 1.53(b), they must be filed before the patenting, abandonment, or termination of proceedings on the earlier application.
  • For Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), which are only available for design applications (excluding international design applications), they must be filed prior to payment of the issue fee unless a petition under 37 CFR 1.313(c) is granted in the prior application.

Always consult with a patent attorney to ensure proper timing and procedures are followed.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on patent grant, visit: patent grant.

Can a continuation application add new matter to the original disclosure?

No, a continuation application cannot add new matter to the original disclosure. This is a fundamental characteristic of continuation applications.

According to MPEP 201.07:

‘A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.’

This means that the continuation must rely entirely on the disclosure of the parent application. Any attempt to introduce new matter would result in the application being treated as a continuation-in-part (CIP) rather than a true continuation. It’s crucial for inventors and patent practitioners to understand this limitation when considering filing strategy.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

Can a Certificate of Correction be used to add or correct a benefit claim after patent grant?

The use of a Certificate of Correction to add or correct a benefit claim after patent grant depends on the type of patent. According to MPEP 211.02(a):

“For utility and plant applications, a Certificate of Correction can be used to correct the failure to adequately claim priority under 35 U.S.C. 119(e) or 120 in the application as filed if the application was filed within the required time period. However, for design applications, an application may be amended to claim priority to or the benefit of a prior-filed application after the application issues as a patent by filing a reissue application.”

This means:

  • For utility and plant patents: A Certificate of Correction can be used to add or correct a benefit claim after patent grant, provided the application was filed within the required time period.
  • For design patents: A Certificate of Correction cannot be used. Instead, a reissue application must be filed to add or correct a benefit claim after patent grant.

It’s important to note that the option to use a Certificate of Correction for utility and plant patents is subject to specific conditions and time limitations. Always consult the current MPEP and seek legal advice if necessary.

To learn more:

Yes, a ‘rejected’ patent application can still be approved. The term ‘rejected’ in this context does not mean final rejection or denial of the patent. According to MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application.

This status is part of the normal examination process. The applicant has the opportunity to respond to the examiner’s action, potentially leading to approval. The application remains ‘rejected’ until:

  • The applicant successfully addresses the examiner’s concerns
  • The examiner issues a notice of allowance
  • The application becomes abandoned

With appropriate responses and amendments, a ‘rejected’ application can progress to approval and eventual patent grant.

To learn more:

Yes, there are certain situations where a petition and petition fee are not required to correct a timely submitted benefit claim. According to the MPEP, these situations include:

  • Changing the relationship of the applications (e.g., from “continuation” to “continuation-in-part” or vice versa)
  • Changing the filing date of a prior-filed nonprovisional or provisional application
  • Changing a benefit claim of a prior-filed provisional application from 35 U.S.C. 120 to 35 U.S.C. 119(e) during the pendency of the later-filed application

Additionally, if the benefit claim was included elsewhere in the application (e.g., in an oath, declaration, or transmittal letter) within the required time period and was recognized by the Office as shown on the first filing receipt, a petition is not required. However, the applicant must still submit the benefit claim in the proper format (i.e., in an Application Data Sheet or by amending the specification for applications filed before September 16, 2012).

Note: If the application has already issued as a patent, corrections to benefit claims that would affect the patent term cannot be made by a certificate of correction or in a reissue application.

Yes, design patent applications have different requirements for filing priority claims compared to utility patent applications. The main difference is in the time period for filing the claim. As stated in MPEP 214.01:

“The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.”

For design applications, the MPEP further clarifies: “In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).”

This means that for design patent applications, you can file a priority claim at any time while the application is pending, which provides more flexibility compared to utility patent applications.

For more detailed information on priority claims in design applications, you can refer to MPEP § 1504.10 and MPEP § 2920.05(d).

To learn more:

Yes, there can be subject matter restrictions when claiming priority based on inventor’s certificates. The MPEP 213.05 states:

Certain countries which grant both patents and inventor’s certificates issue only inventor’s certificates on certain subject matter, generally pharmaceuticals, foodstuffs, and cosmetics.

This means that for certain types of inventions, some countries may only offer inventor’s certificates and not patents. However, this doesn’t necessarily prevent an applicant from claiming priority in the US. The key requirement is that the option to file for either a patent or an inventor’s certificate must have generally existed in the country for the particular subject matter of the invention, even if it wasn’t available for the specific invention in question.

Applicants must still provide an affidavit or declaration as required by 37 CFR 1.55(l), stating that they had the option to file for either a patent or an inventor’s certificate for the subject matter forming the basis of the priority claim.

To learn more:

Generally, there are no additional fees charged by the USPTO for using the PDX program to exchange priority documents. The MPEP 215.01 does not mention any specific fees for this service. However, it’s important to note:

  • Regular patent application fees still apply.
  • If the PDX retrieval fails and you need to submit a certified copy, standard fees for document submission may apply.
  • Some foreign offices might charge fees for making documents available through PDX.

Always check the most current fee schedule on the USPTO website for the most up-to-date information on patent-related fees.

Yes, there are exceptions to the standard time limits for filing foreign priority claims, particularly for design patent applications and certain applications filed before November 29, 2000. According to 37 CFR 1.55(d)(1):

The time periods in this paragraph do not apply if the later-filed application is:
(i) An application for a design patent; or
(ii) An application filed under 35 U.S.C. 111(a) before November 29, 2000.

For design patent applications, the MPEP states:

In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).

This means that for design patent applications, you can file a foreign priority claim at any time while the application is pending, without being restricted by the usual time limits.

For applications filed under 35 U.S.C. 111(a) before November 29, 2000, different rules may apply, and it’s best to consult with a patent attorney or the USPTO directly for guidance on such cases.

It’s important to note that while these exceptions exist, it’s generally advisable to file priority claims as early as possible to ensure they are properly recorded and considered.

Yes, there are exceptions to the benefit claim requirements for design applications. The MPEP specifically notes:

“Examiner Note: 1. Use this form paragraph only for original applications filed under 35 U.S.C. 111(a) on or after November 29, 2000 and for national stage applications under 35 U.S.C. 371. DO NOT use for design applications.”

This note indicates that the standard benefit claim requirements and procedures outlined in this section of the MPEP do not apply to design applications. Design applications have different rules and requirements for claiming benefit of earlier filing dates.

Key points about benefit claims in design applications:

  • Design applications can claim the benefit of an earlier filed design application or an earlier filed provisional application.
  • The rules for claiming benefit in design applications are generally less stringent than those for utility applications.
  • Specific requirements for design application benefit claims can be found in MPEP 1504.20.

It’s important to consult the specific rules and guidelines for design applications when dealing with benefit claims in this context, as they differ from the requirements for utility applications.

Yes, certain applications are still processed under former 37 CFR 1.62. Specifically, all continuation, divisional, and continuation-in-part (CIP) applications filed under former 37 CFR 1.62 prior to December 1, 1997, continue to be processed and examined under the procedures set forth in that regulation.

The MPEP clarifies this point: All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.

For more detailed information on the practice and procedure under former 37 CFR 1.62, the MPEP directs readers to consult MPEP § 201.06(b) in the MPEP 8th Edition, Rev. 1 (February 2003), which is available on the USPTO website.

To learn more:

To learn more:

No, provisional patent applications are not examined for patentability. The MPEP explicitly states:

Provisional applications will not be examined for patentability.

This is one of the key differences between provisional and nonprovisional applications. The purpose of a provisional application is to:

  • Establish an early filing date
  • Allow the term ‘Patent Pending’ to be applied
  • Provide a 12-month period to further develop the invention

Since provisional applications are not examined, they do not require formal patent claims or an oath or declaration. This simplifies the filing process and allows inventors to quickly secure a priority date for their invention.

To obtain patent protection, a nonprovisional application must be filed, which will then undergo examination for patentability.

For more information on patent filing, visit: patent filing.

No, provisional applications are not published or made available to the public by the USPTO. The MPEP 201.04 clearly states:

A provisional application is not subject to publication and is not subject to examination other than to review for national security implications.

This means that the contents of a provisional application remain confidential unless and until a corresponding non-provisional application is published or a patent is issued. This confidentiality can be advantageous for inventors who want to maintain secrecy while securing an early filing date.

For more information on provisional application, visit: provisional application.

Provisional applications are not explicitly mentioned as national applications in MPEP 201.01. The section states:

‘National applications include original (nonprovisional) applications, reissue applications, and reexamination proceedings.’

While provisional applications are filed with the USPTO, they are not considered complete patent applications and do not undergo examination. They serve as a placeholder to establish a priority date. For more information on provisional applications, refer to USPTO’s Provisional Application page.

For more information on USPTO, visit: USPTO.

Tags: USPTO

English translations of non-English language foreign applications are not always required. However, 37 CFR 1.55(g)(3) specifies three situations where an English translation may be necessary:

“An English language translation of a non-English language foreign application is not required except: (i) When the application is involved in an interference or derivation proceeding; (ii) When necessary to overcome the date of a reference relied upon by the examiner; or (iii) When specifically required by the examiner.”

If a translation is required, it must be filed with a statement certifying that the translation is accurate. This ensures that the USPTO can properly evaluate the priority claim when necessary for examination or proceedings.

To learn more:

No, CPAs are not available for all types of patent applications. According to MPEP ¶ 2.30, CPAs are primarily used for design patent applications. The MPEP states: “If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead).” This indicates that CPAs are not typically used for utility or plant patent applications, and such requests may be treated as Requests for Continued Examination (RCE) instead.

For more information on design patents, visit: design patents.

For more information on plant patents, visit: plant patents.

For more information on utility patents, visit: utility patents.

No, Continued Prosecution Applications (CPAs) are not available for all types of patent applications. They are specifically limited to design patent applications. This is evident from the MPEP guidance, which states:

‘Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.’

This statement clearly indicates that CPAs are associated with design applications. For utility and plant patent applications, other continuation options are available, such as:

  • Continuation Applications
  • Divisional Applications
  • Continuation-in-Part Applications

It’s important for inventors and patent practitioners to understand these distinctions to choose the appropriate type of continuing application for their specific situation.

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

Are continuation applications considered national applications?

Yes, continuation applications are considered national applications. They are a type of nonprovisional application that continues the examination process of a previously filed application.

The MPEP 201.01 states: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’ While continuation applications are not explicitly mentioned in this list, they fall under the category of nonprovisional applications.

Continuation applications allow applicants to pursue additional claims based on the disclosure of a parent application. They are filed before the parent application is abandoned or patented and claim the benefit of the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on USPTO, visit: USPTO.

No, applicants are not separately notified when their parent application is abandoned due to the filing of a Continued Prosecution Application (CPA). This is implied in the examiner’s note in MPEP ¶ 2.35:

This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

The establishment of a CPA automatically results in the abandonment of the parent application. Applicants should be aware that by filing a CPA, they are effectively abandoning the parent application in favor of continuing prosecution through the CPA.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

MPEP 200 - Types and Status of Application; Benefit and Priority Claims (156)

An MPEP section may be marked as [Reserved] for several reasons:

  • The topic is not currently relevant but a section is being held for potential future use
  • The section was previously used but the content was moved elsewhere in the MPEP
  • The section is a placeholder to maintain a desired numbering scheme

According to 37 CFR 1.55(g)(2), the USPTO may require that the claim for priority and the certified copy of the foreign application be filed earlier than otherwise provided in the following circumstances:

  1. When the application is involved in an interference or derivation proceeding;
  2. When necessary to overcome the date of a reference relied upon by the examiner; or
  3. When deemed necessary by the examiner.

The certified copy of the foreign application must be filed before the patent is granted. If the certified copy is filed after payment of the issue fee but prior to the date of grant, the priority claim will be placed in the file record but the patent will not include the priority claim unless corrected after the patent is granted using a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.

For applications filed under 35 U.S.C. 111(a) (other than design applications), a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim must also be filed with the certificate of correction. For all applications, a grantable petition under 37 CFR 1.55(f) or (g) must also be filed with the certificate of correction unless the priority claim was timely made but a certified copy was not yet in the file. See MPEP 215.03.

A provisional patent application is considered abandoned no later than 12 months after its filing date. MPEP 203.05 states that an abandoned application includes, in the case of a provisional application, no later than 12 months after the filing date of the provisional application (see MPEP § 711.03(c) and 35 U.S.C. 111(b)(5)). This means that provisional applications have a statutory life of one year from their filing date, after which they are automatically abandoned if not converted to a nonprovisional application or claimed as priority in a nonprovisional application.

For more information, you can refer to MPEP § 711.03(c) and 35 U.S.C. 111(b)(5).

According to MPEP 203.03, a nonprovisional patent application is considered “amended” after it has been initially acted on by the examiner, and the applicant has filed a reply to the examiner’s action. The applicant’s reply may include:

  • An election
  • A traverse of the examiner’s action
  • An amendment to the application

MPEP 203.02 defines a ‘rejected’ application as follows:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application. Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

This status applies to applications that have received an Office action from the examiner but have not yet been responded to by the applicant.

MPEP 203.04 defines an ‘allowed’ or ‘in issue’ patent application as follows:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

Essentially, an application is ‘allowed’ when the examiner has determined it meets all requirements for patentability and has sent a Notice of Allowance. This status continues until the patent is issued, unless specific actions are taken to withdraw it or it becomes abandoned due to non-payment of fees.

MPEP 203.05 outlines several scenarios where an application is considered abandoned:

  • Formal abandonment by the applicant or attorney/agent of record
  • Failure to take appropriate action at some stage in the prosecution of a nonprovisional application
  • Failure to pay the issue fee
  • For provisional applications, no later than 12 months after the filing date

Abandonment removes the application from the Office docket of pending applications. It’s crucial for applicants to be aware of deadlines and required actions to prevent unintentional abandonment.

For continuing applications (continuation, divisional, continuation-in-part) filed on or after September 16, 2012 under 37 CFR 1.53(b), a newly executed inventor’s oath or declaration is generally not required if:

  • An oath or declaration complying with 35 U.S.C. 115 and 37 CFR 1.63 (or substitute statement under 37 CFR 1.64) was filed in the earlier-filed application
  • A copy of the executed oath/declaration from the earlier application is submitted in the continuing application showing it was executed

However, a newly executed inventor’s oath or declaration must be filed in a continuation or divisional application naming an inventor not named in the prior application (37 CFR 1.63(d)(3)).

For continuing applications filed before 9/16/2012, a newly executed oath or declaration is required unless a copy of the executed oath or declaration filed in the prior application is submitted with certain other requirements met (see pre-AIA 37 CFR 1.63(d)).

A Certificate of Correction is appropriate for perfecting a foreign priority claim in the following situations:

  1. When the priority claim was timely filed in the application but was not included on the patent because the requirement for a certified copy was not satisfied. In this case, a grantable petition under 37 CFR 1.55(f) or 37 CFR 1.55(g) for design applications is also required.
  2. When a priority claim under 37 CFR 1.55 was not timely made, but the correction sought would not require further examination.

The MPEP states: “Effective May 13, 2015, 37 CFR 1.55(g) provides that the claim for priority and the certified copy of the foreign application must be filed within the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate. 37 CFR 1.55(g) eliminates the need in many instances to file a reissue application in order to perfect a claim for foreign priority.” (MPEP 216.01)

If the applicant files the certified copy of the foreign application to overcome the effective date of a reference, a translation is required if the copy is not in English.

The examiner should require the translation when requesting the certified copy. The translation must be a complete translation of the certified copy, and must be accompanied by a statement that the translation is accurate. [MPEP 216]

An examiner considers the merits of a foreign priority claim in the following situations:

  • When a reference is found with an effective date between the foreign filing date and the U.S. filing date
  • When determining if a reference’s prior art date falls within the grace period for the application under examination
  • When an interference situation is under consideration

The MPEP states: “The subject matter of the application is not examined to determine whether the applicant is actually entitled to the benefit of the foreign filing date on the basis of the disclosure thereof unless such determination is required for patentability reasons. For example, the examiner considers the merits of an applicant’s claim of priority when a reference is found with an effective date between the date of the foreign filing and the date of filing in the United States, when determining whether a reference’s prior art date is within the grace period for the application under examination, and when an interference situation is under consideration.” (MPEP 216)

The three main types of patent applications that can be filed in the USPTO are:

  1. Utility patent applications (filed under 35 U.S.C. 101) for “any new and useful process, machine, manufacture, or composition of matter”
  2. Design patent applications (filed under 35 U.S.C. 171) for “any new, original, and ornamental design for an article of manufacture”
  3. Plant patent applications (filed under 35 U.S.C. 161) for “whoever invents or discovers and asexually reproduces any distinct and new variety of plant”

The reference to the prior-filed application to claim benefit under 35 U.S.C. 120 or 119(e) must be submitted within the following time periods under 37 CFR 1.78:

  • For an application filed under 35 U.S.C. 111(a), the later of four months from the filing date or sixteen months from the filing date of the prior-filed application
  • For a national stage application under 35 U.S.C. 371, the later of four months from national stage commencement under 35 U.S.C. 371(b) or (f), four months from initial national stage submission, or sixteen months from the filing date of the prior-filed application

Failure to timely submit the reference is considered a waiver of any benefit claim. A petition and fee would be required to accept a delayed submission. See MPEP 211.04.

For transition applications, 37 CFR 1.55 and 1.78 require a statement if:

  • The application contains or contained a claim with an effective filing date on or after March 16, 2013
  • The statement must be provided within specified time limits

The MPEP notes: “The statement provisions of 37 CFR 1.55 and 1.78 require that if the later-filed transition application contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March 16, 2013, the applicant must provide a statement to that effect.” (MPEP 210)

If there is an error in the pre-printed prior application data on the bib-data sheet:

  • The examiner should require correction via a corrected or supplemental application data sheet or an amendment, if it was an applicant error.
  • A petition for an unintentionally delayed benefit claim may also be required.
  • If appropriate, the correction or entry of the data can be made by technical support staff of the Technology Center.

See MPEP 601.05 and MPEP 211.02(a) for more details.

If there’s an error in the preprinted prior application data, the following steps should be taken:

  1. If the error is in the Patent Data Portal database, it can be corrected by technical support staff of the Technology Center.
  2. After the data is corrected, a new bib-data sheet should be printed and scanned into the file.
  3. If the error was made by the applicant, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.
  4. In some cases, a petition for an unintentionally delayed benefit claim may also be required.

The MPEP states: “Should there be an error in the preprinted prior application data, the correction or entry of the data in the Patent Data Portal data base can be made by technical support staff of the Technology Center, if appropriate. Upon entry of the data, a new bib-data sheet should be printed and scanned into the file. If the error was an applicant error, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.” (MPEP 202)

An examiner should check the following on the bib-data sheet regarding prior applications:

  1. Accuracy of prior application data, including provisional application data
  2. Whether the application is copending with prior nonprovisional applications for which benefit is claimed
  3. Correct application numbers of provisional applications for which benefit is claimed
  4. Proper listing of foreign applications qualifying for benefits under 35 U.S.C. 119(a)-(d)

MPEP 202 instructs: “Where the data is correct, the examiner should initial the bib-data sheet in the provided space. Should there be an error in the preprinted prior application data, the correction or entry of the data in the Patent Data Portal data base can be made by technical support staff of the Technology Center, if appropriate.”

For an original application filed under 35 U.S.C. 111(a) on or after March 16, 2013, a certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application, except as provided in 37 CFR 1.55(h), (i), and (j). See MPEP 215.02.

For an international application entering the national stage under 35 U.S.C. 371 in which the national stage commenced on or after December 18, 2013, a certified copy of the foreign application must be filed within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior foreign application, except as provided in 37 CFR 1.55(h), (i), and (j). See MPEP 215.02.

The U.S. nonprovisional application must generally be filed within 12 months of the filing date of the foreign application to claim priority. For design applications, this period is 6 months.

Specifically, 37 CFR 1.55(b) states:

“The nonprovisional application must be: (1) Filed not later than twelve months (six months in the case of a design application) after the date on which the foreign application was filed, subject to paragraph (c) of this section (a subsequent application); or (2) Entitled to claim the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) of a subsequent application that was filed within the period set forth in paragraph (b)(1) of this section.”

There are provisions to restore the right of priority if the subsequent application is filed within 2 months after the expiration of the priority period, if the delay was unintentional.

Once a nonprovisional patent application has been examined and determined to meet all statutory requirements, a notice of allowance is sent to the applicant. The status of the application is then considered “allowed” or “in issue”. As per MPEP 203.04:

An “allowed” nonprovisional application or an application “in issue” is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an “allowed” application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

A “new” nonprovisional patent application is one that has not yet received an action by the examiner. Its status as a “new” application continues until the examiner takes action, even if the applicant files an amendment prior to the first Office Action. A request for continued examination (RCE) under 37 CFR 1.114 is not considered a new application filing.

The Office docket plays a crucial role in determining the status of a patent application. MPEP 203.05 refers to the Office docket when defining abandoned applications:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications

The Office docket is essentially the official record of pending patent applications at the USPTO. When an application is removed from this docket, it is no longer considered active or pending. This removal can occur for various reasons, including formal abandonment, applicant inaction, failure to pay fees, or expiration of statutory periods. Therefore, the status of an application on the Office docket is a key indicator of whether it is still being actively prosecuted or has been abandoned.

March 16, 2013 is a crucial date in U.S. patent law due to the implementation of the America Invents Act (AIA). This date marks the transition from the pre-AIA first-to-invent system to the AIA first-inventor-to-file system. The significance includes:

  • Applications filed on or after this date are generally subject to AIA provisions
  • The effective filing date of claimed inventions determines which law applies
  • Transition applications may require special statements
  • Different examination standards may apply based on the effective filing date

The MPEP states: “The first inventor to file provisions of Public Law 112-29, sec. 3, 125 Stat. 284 (the Leahy-Smith America Invents Act) and the rules related thereto became effective March 16, 2013. These provisions apply to any application for patent, and to any patent issuing thereon, that contains or contained at any time— (A) a claim to a claimed invention that has an effective filing date as defined under section 100(i) of title 35, United States Code, that is on or after March 16, 2013; or (B) a specific reference under section 120, 121, or 365(c) of title 35, United States Code, to any patent or application that contains or contained at any time such a claim.”

The filing date of foreign applications is significant in priority claims for the following reasons:

  1. It establishes the effective date of the priority claim.
  2. The date accorded is the date on which the specification and drawing were filed, not necessarily the date of the petition (which is called the application in some countries).
  3. This date is used to determine the applicability of prior art and the eligibility for certain patent term adjustments.

The MPEP states: “In some instances, the specification and drawing of the foreign application may have been filed at a date subsequent to the filing of the petition in the foreign country. Even though the petition is called the application and the filing date of this petition is the filing date of the application in a particular country, the date accorded here is the date on which the specification and drawing were filed.” (MPEP 216)

The ‘[R-]’ notation after ‘MPEP 212 [Reserved]’ typically indicates that this section has been revised. However, in this case, since the section is reserved and empty, the ‘[R-]’ may be a placeholder for future revision dates. When a substantive revision occurs, a date is usually added after the ‘R’, such as ‘[R-10.2019]’ to indicate an October 2019 revision.

The right of priority allows an applicant who has filed a patent application in a foreign country to claim priority to that earlier filing date when filing a subsequent U.S. application for the same invention. This right is established by 35 U.S.C. 119 and gives the U.S. application the benefit of the earlier foreign filing date, as long as certain conditions are met.

Specifically, 35 U.S.C. 119(a) states: “An application for patent for an invention filed in this country by any person who has, or whose legal representatives or assigns have, previously regularly filed an application for a patent for the same invention in a foreign country which affords similar privileges in the case of applications filed in the United States or to citizens of the United States, or in a WTO member country, shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country, if the application in this country is filed within 12 months from the earliest date on which such foreign application was filed.”

For a valid foreign priority claim, the U.S. application must have at least one common inventor with the foreign application. This requirement ensures that the right of priority is only available to the actual inventors or their legal representatives.

As stated in MPEP 213.02: “Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.”

This means that:
1. A sole inventor in the U.S. can claim priority to a foreign application where they are the sole inventor or one of joint inventors.
2. Joint inventors in the U.S. can claim priority to a foreign application filed by any one or more of them.
3. A U.S. application cannot claim priority to a foreign application with completely different inventors.

It’s important to note that while the inventorship must overlap, it doesn’t have to be identical between the U.S. and foreign applications.

The purpose of 37 CFR 1.57(b) is to provide a safeguard for applicants when a page(s) of the specification, or a portion thereof, or a sheet(s) of the drawing(s), or a portion thereof, is inadvertently omitted from an application, such as through a clerical error. It allows inadvertently omitted material to be added to the application by way of a later-filed amendment if the inadvertently omitted portion is completely contained in a prior-filed application for which priority or benefit is claimed, even though there is no explicit incorporation by reference of the prior-filed application.

To properly identify a foreign priority application in a U.S. patent application, you should provide:

  • The application number
  • The country or intellectual property authority
  • The filing date (day, month, and year)

MPEP 214.04 advises: “To ensure an accurate and complete citation of a foreign priority application, applicants should review the list of the various intellectual property offices and the recommended presentation of a foreign application number for each, which can be found in the tables of the online WIPO Handbook on Industrial Property Information and Documentation.”

It’s important to use the format recommended by WIPO for the specific country to ensure accurate identification and processing of your priority claim.

The priority document exchange program allows the USPTO to obtain priority documents electronically from other participating foreign intellectual property offices, eliminating the need for applicants to submit certified copies themselves. As stated in 37 CFR 1.55(i), the requirement to file a certified copy is considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority includes the necessary information for retrieval
  • The copy is received by the USPTO from the participating office

Applicants must still make the priority claim within the required time period. This program simplifies the process of submitting priority documents for many applicants.

The priority document exchange program is an agreement between patent offices to electronically exchange priority documents. It affects foreign priority claims in the following ways:

  • Applicants may not need to submit a certified copy if the foreign application is available through the program
  • The USPTO will attempt to retrieve the priority document automatically
  • If successful, it satisfies the requirement to file a certified copy

MPEP 214.02 mentions: “37 CFR 1.55(h) contains provisions relating to when the requirement for a certified copy will be considered satisfied based on a certified copy filed in another U.S. patent or application (see also MPEP § 215, subsection III); 37 CFR 1.55(i) contains provisions relating to the priority document exchange agreement (see also MPEP §§ 215.01 and 215.02(a)).”

Applicants should still monitor the application to ensure the priority document is retrieved and may need to submit a certified copy if the automatic retrieval fails.

The Patent Law Treaty (PLT) is an international agreement aimed at harmonizing and streamlining formal procedures in patent applications. Its implementation in the U.S. through the Patent Law Treaties Implementation Act (PLTIA) introduced several changes to U.S. patent law, including:

  • Restoration of priority rights in certain cases
  • Changes to formal requirements for patent applications
  • Provisions for international design applications

The MPEP notes: “The Patent Law Treaties Implementation Act of 2012 (PLTIA) amended the patent laws to implement the provisions of the Patent Law Treaty (PLT) in title II; corresponding revisions to title 37 of the Code of Federal Regulations also became effective on December 18, 2013. Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application.”

The most important aspect of an examiner’s action regarding a right of priority is determining the identity of invention between the U.S. and foreign applications. This involves:

  • Considering the foreign application as if it had been filed in the U.S. on the same date it was filed in the foreign country
  • Examining the foreign application for sufficiency of disclosure under 35 U.S.C. 112
  • Determining if there is a basis for the claims sought

The MPEP states: “The most important aspect of the examiner’s action pertaining to a right of priority is the determination of the identity of invention between the U.S. and the foreign applications. The foreign application may be considered in the same manner as if it had been filed in this country on the same date that it was filed in the foreign country, and the applicant is ordinarily entitled to any claims based on such foreign application that applicant would be entitled to under U.S. laws and practice.” (MPEP 216)

The Hague Agreement Concerning International Registration of Industrial Designs is an international treaty that allows applicants to file a single international design application with effect in multiple countries. Key points about the Hague Agreement and international design applications include:

  • The United States became a Contracting Party to the Hague Agreement on May 13, 2015.
  • An international design application designating the United States has the effect of a regularly filed application for patent under 35 U.S.C. 385.
  • The Hague Agreement is administered by the International Bureau of the World Intellectual Property Organization (WIPO).
  • 37 CFR 1.9(n) defines an international design application as “an application for international registration of a design filed under the Hague Agreement.”

For detailed information on international design applications, refer to MPEP Chapter 2900.

To learn more:

Filing a continuation or continuation-in-part (CIP) application does not automatically affect the status of the parent application. The parent application continues to be examined or remains patented (if already issued) independently of the child application.

Key points to note:

1. The parent application remains pending unless expressly abandoned, allowed to go abandoned, or issued as a patent.

2. Filing a continuation or CIP does not automatically abandon the parent application.

3. Prosecution can continue in both the parent and child applications simultaneously.

The MPEP states: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

However, applicants should be aware of potential double patenting issues that may arise between the parent and child applications.

A proper foreign priority claim can give a U.S. patent application the benefit of the earlier foreign filing date as its effective filing date for prior art purposes. This can be crucial for establishing novelty and non-obviousness of the invention.

35 U.S.C. 119(a) states that a U.S. application properly claiming foreign priority “shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country.”

This means that intervening prior art published after the foreign filing date but before the U.S. filing date may not be used against the application if the priority claim is valid. However, it’s important to note that the actual U.S. filing date is still used for other purposes, such as calculating patent term.

The main differences in priority claim requirements for design applications compared to utility applications are:

  • Time limit: Design applications can claim priority at any time during pendency, while utility applications have specific deadlines
  • Restoration of priority: Not applicable to design applications

MPEP 214.01 states: “The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.” Additionally, “In a design application, a claim for priority may be made at any time during the pendency of the application.”

However, both design and utility applications must still meet other requirements, such as providing a certified copy of the foreign application and properly identifying the priority application.

Claiming priority and claiming benefit are two different mechanisms in patent law, though both can affect the effective filing date of a patent application:

  1. Claiming Priority:
    • Typically refers to claiming the right of priority to a foreign application under 35 U.S.C. 119(a)-(d) and (f)
    • Also includes priority claims to provisional applications under 35 U.S.C. 119(e)
    • Governed by 37 CFR 1.55 for foreign priority claims
  2. Claiming Benefit:
    • Refers to claiming the benefit of an earlier filing date of a U.S. application under 35 U.S.C. 120, 121, 365(c), or 386(c)
    • Typically used for continuation, divisional, or continuation-in-part applications
    • Governed by 37 CFR 1.78

The MPEP discusses both types of claims: “Under certain conditions and on fulfilling certain requirements, a later-filed application for patent filed in the United States may claim the benefit of, or priority to, a prior application filed in the United States (see 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c); see also 37 CFR 1.78) or in a foreign country (see 35 U.S.C. 119(a)-(d) and (f), 365(a) and (b), and 386(a) and (b); see also 37 CFR 1.55).”

Claiming foreign priority under 35 U.S.C. 119(a)-(d) and claiming benefit of a U.S. provisional application under 35 U.S.C. 119(e) are similar in some ways but have important differences:

1. Time limit:
– Foreign priority: Must be claimed within 12 months (6 months for design applications)
– Provisional: Must be claimed within 12 months

2. Effective filing date:
– Both can provide an earlier effective filing date for prior art purposes

3. Patent term:
– Foreign priority: Does not affect patent term
– Provisional: The 12-month period counts towards the 20-year patent term

4. Disclosure requirements:
– Both require the earlier application to provide adequate support for the claimed invention

5. Formalities:
– Foreign priority: Requires a certified copy of the foreign application
– Provisional: No certified copy required, but the provisional must be in English

6. Inventorship:
– Foreign priority: Requires at least one common inventor
– Provisional: Requires at least one common inventor

7. International effect:
– Foreign priority: Recognized in other Paris Convention countries
– Provisional: May not be recognized in some foreign jurisdictions

Both types of priority claims can be valuable for establishing an earlier effective filing date, but they have different requirements and effects that should be considered when developing a patent strategy.

Foreign priority claims and domestic benefit claims are two different ways of claiming the benefit of an earlier filing date:

  • Foreign priority claims (under 35 U.S.C. 119(a)-(d)) are based on earlier applications filed in foreign countries
  • Domestic benefit claims can be to earlier U.S. provisional (35 U.S.C. 119(e)) or nonprovisional (35 U.S.C. 120) applications

Key differences include:

  • Time limits: 12 months for foreign priority, 12 months for provisionals, no limit for nonprovisionals
  • Required documents: Certified copy needed for foreign priority, not for domestic benefit
  • Effect: Foreign priority is mainly for prior art purposes, domestic benefit can confer actual pendency benefits

Both types of claims must be properly made to be effective, but the specific requirements and effects differ.

A certified copy of a foreign application is a copy of the original foreign application with a certification by the patent office of the foreign country in which it was filed. According to the MPEP, “Certified copies ordinarily consist of a copy of the specification and drawings of the applications as filed with a certificate of the foreign patent office giving certain information.” It’s important to note that a copy of the certified copy filed by the applicant will not satisfy the requirement for a certified copy.

When submitting a certified copy of a foreign application for priority purposes, the following requirements apply:

  • If the certified copy is not in English, a translation is required
  • The translation must be of the certified copy of the foreign application as filed
  • The translation must be filed together with a statement that the translation of the certified copy is accurate

The MPEP states: “When the examiner requires the filing of the certified copy, the translation should also be required at the same time. If an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) and it must be filed together with a statement that the translation of the certified copy is accurate.” (MPEP 216)

To claim the benefit of an earlier filing date under 35 U.S.C. 120, the following requirements must be met:

  • The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application
  • The disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement
  • The later-filed application must contain a specific reference to the prior application
  • The later-filed application must be filed before the patenting or abandonment of or termination of proceedings on the first application

As stated in the MPEP: “To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

Priority in patent applications refers to the ability of a later-filed application to claim the benefit of, or priority to, an earlier-filed application. This allows the later application to effectively have the filing date of the earlier application for certain purposes.

According to the MPEP, “Under certain conditions and on fulfilling certain requirements, a later-filed application for patent filed in the United States may claim the benefit of, or priority to, a prior application filed in the United States (see 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c); see also 37 CFR 1.78) or in a foreign country (see 35 U.S.C. 119(a)-(d) and (f), 365(a) and (b), and 386(a) and (b); see also 37 CFR 1.55).”

Incorporation by reference under 37 CFR 1.57(b) is a provision that allows applicants to add inadvertently omitted material to a patent application if certain conditions are met. Specifically:

  • The application must contain a priority or benefit claim to a prior-filed application
  • The omitted material must be completely contained in that prior-filed application
  • The omission must have been inadvertent

This provision acts as a safeguard for applicants when material is accidentally left out of an application due to clerical error. As stated in the MPEP, “The purpose of 37 CFR 1.57(b) is to provide a safeguard for applicants when a page(s) of the specification, or a portion thereof, or a sheet(s) of the drawing(s), or a portion thereof, is (are) inadvertently omitted from an application, such as through a clerical error.”

Cross-noting in patent applications refers to the process of recording and verifying information about prior applications, including U.S. and foreign applications, for which benefit or priority is claimed. This information is typically noted on the bibliographic data (bib-data) sheet of the application and is used to ensure accurate representation of priority claims on the front page of a printed patent.

According to MPEP 202, “The front page of a printed patent identifies all prior applications for which benefits are claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in continuation-in-part, continuation, divisional, and reissue applications.”

Copendency refers to the requirement that a later-filed application claiming benefit of a prior application must be filed before the prior application is patented, abandoned, or proceedings are terminated. Copendency is crucial because:

  • It establishes a continuous chain of pending applications
  • It allows the later application to claim the earlier filing date
  • Without copendency, the benefit claim is improper

As stated in MPEP 211.01(b): “Copendency is defined in the clause which requires that the later-filed application must be filed before: (A) the patenting of the prior application; (B) the abandonment of the prior application; or (C) the termination of proceedings in the prior application.”

According to MPEP 203.01, a ‘new’ application is defined as:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner. An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

It’s important to note that a request for continued examination (RCE) is not considered a new application filing.

An abandoned patent application is one that has been removed from the Office docket of pending applications. According to MPEP 203.05, this can occur in several ways:

  • Through formal abandonment by the applicant or their attorney/agent
  • Due to failure of the applicant to take appropriate action during prosecution
  • For failure to pay the issue fee
  • In the case of a provisional application, no later than 12 months after the filing date

As stated in MPEP 203.05: An abandoned application is, inter alia, one which is removed from the Office docket of pending applications. The specific reasons for abandonment are listed in the same section.

An ‘interim copy’ is a true copy of the original foreign application that an applicant can file to meet the timeliness requirement when they cannot obtain a certified copy within the time limit. According to 37 CFR 1.55(j), the interim copy must be clearly labeled as ‘Interim Copy’ and filed with a cover sheet stating it is a true copy of the original foreign application.

A utility patent application is filed under 35 U.S.C. 101 for “a new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof”. Utility patent applications are sometimes referred to as “utility” patent applications when being contrasted with plant or design patent applications.

The MPEP states: “The first type of patent application is sometimes referred to as a ‘utility’ patent application when being contrasted with a plant or design patent application.”

A transition application under the America Invents Act (AIA) is:

  • Filed on or after March 16, 2013
  • Claims foreign priority to or domestic benefit of an application filed before March 16, 2013

Transition applications may be subject to either pre-AIA or AIA rules depending on the effective filing date of the claimed inventions. The MPEP states: “Transition applications are either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications depending on the effective filing date of the claimed invention(s).” (MPEP 210)

A transition application under the America Invents Act (AIA) is:

  • A nonprovisional application filed on or after March 16, 2013
  • That claims foreign priority to, or domestic benefit of, an application filed before March 16, 2013

Transition applications can be either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications, depending on the effective filing date of the claimed invention(s).

The MPEP states: “Transition applications are nonprovisional applications that: (A) are filed on or after March 16, 2013; and (B) claim foreign priority to, or domestic benefit of, an application filed before March 16, 2013. Transition applications are either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications depending on the effective filing date of the claimed invention(s).”

A substitute application is a type of national application that is filed to replace a previously filed non-provisional or provisional application. It is used when an applicant wants to start over with a new application while maintaining the benefit of the earlier filing date for common subject matter.

Key points about substitute applications:

  • They are treated as new applications and receive a new application number.
  • The previously filed application is considered to be abandoned as of the filing date of the substitute application.
  • Substitute applications can claim the benefit of the earlier application’s filing date for common subject matter.
  • They must be filed while the earlier application is still pending.
  • Applicants must file a copy of the original application, specification, drawings, and amendments, if any, and a new oath or declaration.

For more information, see MPEP 201.09 and 37 CFR 1.53.

A reissue application is a type of application used to correct an error in an issued patent that renders the patent wholly or partly inoperative or invalid. It is governed by 35 U.S.C. 251 and 37 CFR 1.171-1.179. Reissue applications are typically filed when the original patent claims are too narrow or too broad, or when there are other errors that affect the scope or validity of the patent. For more information on reissue applications, refer to MPEP 1401.

A provisional application for patent is a type of U.S. patent application that allows inventors to establish an early filing date for their invention without filing a formal patent claim or any information disclosure statement. Key points about provisional applications include:

1. They provide a 12-month pendency from the date of filing.
2. They cannot be extended beyond 12 months.
3. They are not examined on their merits.
4. They can serve as a priority document in foreign filing.
5. They require a specification and drawing(s) if necessary to understand the invention.
6. They do not require formal patent claims or an oath or declaration.

Inventors must file a corresponding nonprovisional application within 12 months to claim the benefit of the provisional application’s filing date. For more details, see USPTO’s Provisional Application for Patent and MPEP 201.04(b).

A plant patent application is filed under 35 U.S.C. 161 for whoever “invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state”.

The MPEP cites 35 U.S.C. 161: “Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state, may obtain a patent therefor, subject to the conditions and requirements of this title.”

According to 37 CFR 1.9(a)(1), a national application is defined as:

  • A U.S. application for patent filed in the USPTO under 35 U.S.C. 111
  • An international application filed under the Patent Cooperation Treaty in which the basic national fee under 35 U.S.C. 41(a)(1)(F) has been paid
  • An international design application filed under the Hague Agreement in which the USPTO has received a copy of the international registration pursuant to Hague Agreement Article 10

This definition encompasses various types of patent applications that are treated as national applications by the USPTO.

A design patent application is a type of patent application that protects the ornamental design of a functional item. It is governed by 35 U.S.C. 171-173 and focuses on the visual characteristics of an article of manufacture. Unlike utility patents, design patents do not protect the functional aspects of an invention. Design patent applications have specific requirements for drawings and claim format. For more information on design patent applications, refer to MPEP 1501.

A certified copy of a foreign application is an official copy of the foreign patent application, certified by the patent office where it was filed. It is required to perfect a claim of foreign priority in a U.S. patent application.

According to 37 CFR 1.55(f), for applications filed on or after March 16, 2013:

“A certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application, or sixteen months from the filing date of the prior foreign application, in an original application under 35 U.S.C. 111(a) filed on or after March 16, 2013, except as provided in paragraphs (h), (i), and (j) of this section.”

There are exceptions to this requirement, such as when the foreign application was filed in a foreign intellectual property office participating in a priority document exchange agreement with the USPTO. In such cases, the applicant can request that the USPTO retrieve the certified copy electronically.

A ‘bypass’ application is:

  • A regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b)
  • It claims benefit of an international application’s filing date without entering the national stage under 35 U.S.C. 371
  • It can be filed as a continuation, divisional, or continuation-in-part of the international application

MPEP 211.01(c) explains: “Rather than submitting a national stage application under 35 U.S.C. 371, applicant may file a continuation, divisional, or continuation-in-part of an international (PCT) application under 35 U.S.C. 111(a). Such applications are often referred to as ‘bypass’ applications.”

For foreign priority applications, the bib-data sheet should include:

  • Application number
  • Country (or intellectual property authority)
  • Day, month, and year of filing

MPEP 202 specifies: “A bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application that the U.S. application is claiming the priority of. The examiner should check this information for accuracy.”

It’s important to note that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) should be listed. Applications from non-qualifying countries should be lined through on the bib-data sheet.

The front page of a printed patent identifies all prior applications for which benefits are claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in continuation-in-part, continuation, divisional, and reissue applications.

The front page of a patent includes the following information regarding foreign priority claims:

  • The country of the foreign application
  • The filing date of the foreign application
  • The number of the foreign application

This information is included for applications where the bib-data sheet has been properly endorsed. As stated in the MPEP: “The front page of the patent when it is issued, and the listing in the Official Gazette, will refer to the claim of priority, giving the country, the filing date, and the number of the foreign application in those applications in which the bib-data sheet has been endorsed.” (MPEP 202)

After an application becomes abandoned, it is no longer pending and is removed from the USPTO’s active files. The application file, however, is retained in storage for a period as determined by the USPTO. During this retention period, certain actions may still be possible:

1. The applicant may file a petition to revive the application if the abandonment was unintentional or unavoidable.
2. The application may serve as a basis for claiming benefit in a later-filed application, subject to certain conditions.
3. The application may be used as prior art against other applications.
4. The public may request access to the application file if it has been opened to public inspection.

It’s important to note that once an application is abandoned, it cannot be used as the basis for a statutory invention registration. For more details on abandoned applications, see MPEP 203.05 and MPEP 711.

When an abandoned application is later revived, it retains its original filing date. The revival process effectively removes the abandonment status, allowing the application to continue prosecution. However, the period of abandonment may impact patent term adjustment calculations. For more information on revival procedures, refer to MPEP 711 and 37 CFR 1.137.

If priority papers are found to be deficient in material respects, such as failure to include the correct certified copy, applicants should ensure that there is sufficient time to remedy any defects. The MPEP advises: “Frequently, priority papers are found to be deficient in material respects, such as for example, the failure to include the correct certified copy, and applicants should ensure that there is sufficient time to remedy any defects.” It’s recommended to file priority papers as early as possible to allow time for correction if needed.

If the certified copy of the foreign application is filed after the date the issue fee is paid but prior to the date of grant of the patent, it will be placed in the file record but there will be no review of the papers. The patent when published will not include the priority claim. A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 can be filed to have the priority claim considered after publication of the patent.

If you intentionally omit material from your application that was present in a prior-filed application, the omitted material will not automatically be incorporated by reference under 37 CFR 1.57(b). The MPEP clarifies:

“Applicants can still intentionally omit material contained in the prior-filed application from the application containing the priority or benefit claim without the material coming back in by virtue of the incorporation by reference of 37 CFR 1.57(b). Applicants can maintain their intent by simply not amending the application to include the intentionally omitted material.”

In other words, the incorporation by reference under 37 CFR 1.57(b) only applies to inadvertently omitted material. If you choose not to include certain material from the prior application, it will remain omitted unless you specifically amend your application to include it.

If you file a foreign priority claim after paying the issue fee but before the patent grant:

  • The claim will be placed in the file record
  • There may be no review of the papers
  • The published patent will not include the priority claim

To have the priority claim considered after publication, you will need to file:

  1. A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323
  2. For original applications under 35 U.S.C. 111(a) or 371, a petition to accept an unintentionally delayed claim for priority under 37 CFR 1.55

MPEP 214.03 states: “When the claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but prior to the date of grant of the patent, the foreign priority claim or certified copy will be placed in the file record but there may be no review of the papers and the patent when published will not include the priority claim.”

If you fail to make a timely priority claim or submit a certified copy of the foreign application within the required time period, the following may occur:

  • The right of priority may be considered waived
  • The effective filing date of your application may be the actual U.S. filing date, not the foreign filing date
  • Intervening prior art may be applicable against your application

However, 37 CFR 1.55(e) provides for acceptance of a delayed priority claim if:

  • The claim is filed within the pendency of the application
  • A petition is filed with the delayed claim
  • The delay was unintentional
  • The required petition fee is paid

Similarly, 37 CFR 1.55(f) allows for late submission of a certified copy with a petition showing good and sufficient cause for the delay and payment of a fee. It’s always best to make priority claims and submit certified copies timely to avoid potential issues.

If an applicant fails to take appropriate action during the prosecution of a nonprovisional patent application, it can result in the application being considered abandoned. MPEP 203.05 specifically states that an abandoned application includes one removed from the Office docket through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application. This could include failing to respond to office actions, missing deadlines, or not providing requested information or documents.

If a benefit claim to a provisional application lacks proper indication of an intermediate application:

  • The Office may not recognize the benefit claim
  • The benefit claim may not appear on the filing receipt
  • A petition under 37 CFR 1.78(c) and petition fee may be required to correct the benefit claim

MPEP 211.01(b) states: “If a benefit claim to a provisional application is submitted without an indication that an intermediate application directly claims the benefit of the provisional application and the instant nonprovisional application is not filed within the 12 month period (or 14 month period if the benefit of the provisional application has been restored pursuant to 37 CFR 1.78(b)) or the relationship between each nonprovisional application is not indicated, the Office will not recognize such benefit claim and will not include the benefit claim on the filing receipt.”

When an MPEP section is marked as [Reserved], it indicates that the section number exists but there is currently no content provided for that section. The MPEP states in section 212:

212 [Reserved] [R-]

A nonprovisional patent application is designated as “rejected” if, during prosecution before allowance, it contains an examiner’s action that has not been replied to by the applicant. As stated in MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a “rejected” application. Its status as a “rejected” application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

MPEP 203.03 defines an ‘amended’ patent application as follows:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action. The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

In simpler terms, an application becomes ‘amended’ when the applicant responds to an examiner’s Office action, whether by making changes to the application, arguing against the examiner’s rejections, or choosing between different inventions (election).

According to MPEP 203.04:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

An ‘allowed’ application has passed examination and is ready to become a patent, pending payment of necessary fees.

When reviewing a claim to foreign priority, the examiner generally checks the following:

  • That the papers contain no obvious formal defects
  • That the papers correspond in number, date and country to the application identified in the application data sheet
  • For original applications filed under 35 U.S.C. 111(a) and international applications entering the national stage under 35 U.S.C. 371, that the claim for foreign priority is timely

The MPEP states: “When the claim to priority and the certified copy of the foreign application are received while the application is pending before the examiner, the examiner generally makes no examination of the papers except to see that they contain no obvious formal defects and correspond in number, date and country to the application identified in the application data sheet for an application filed on or after September 16, 2012, or oath or declaration or application data sheet for an application filed prior to September 16, 2012.” (MPEP 216)

The ‘[Reserved]’ designation in MPEP 212 indicates that this section is currently not in use but is being held for potential future content. It does not contain any specific information or guidance at this time.

The following conditions and requirements need to be met to add omitted material to an application under 37 CFR 1.57(b):n

    n

  1. The application must have been filed on or after September 21, 2004
  2. n

  3. All or a portion of the specification or drawing(s) must have been inadvertently omitted
  4. n

  5. A priority claim under 37 CFR 1.55 or benefit claim under 37 CFR 1.78 must have been present on the filing date
  6. n

  7. The omitted portion must be completely contained in the prior-filed application
  8. n

  9. An amendment to include the omitted portion must be filed within a time period set by the Office
  10. n

  11. If not otherwise entitled to a filing date, a petition under 37 CFR 1.53(e) with the fee must also be filed
  12. n

  13. A copy of the prior-filed application must be supplied, except where the prior application was filed under 35 U.S.C. 111
  14. n

  15. An English translation of any non-English prior-filed application must be supplied
  16. n

  17. The location of the omitted portion in the prior-filed application must be identified

The Patent Law Treaties Implementation Act (PLTIA) of 2012 introduced several important changes to US patent law, particularly regarding priority claims and international applications. Key changes include:

  • Restoration of the right of priority to a foreign application or the benefit of a provisional application in certain cases
  • Ability to file international design applications
  • Ability to claim priority to, and benefit of, international design applications in nonprovisional applications

The MPEP states: “Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. In addition, title I of the PLTIA became effective May 13, 2015, along with corresponding revisions to the rules. Notable changes included the ability to file international design applications and to claim priority to, and the benefit of, international design applications in nonprovisional applications.”

The time periods for filing priority or benefit claims in U.S. patent applications vary depending on the type of claim and application. Generally:

  • For foreign priority claims under 35 U.S.C. 119(a)-(d) and (f), the claim must be made within the later of 4 months from the actual filing date or 16 months from the foreign application’s filing date.
  • For domestic benefit claims under 35 U.S.C. 119(e) or 120, the claim must be made within the later of 4 months from the actual filing date or 16 months from the prior application’s filing date.
  • For international applications entering the national stage, special rules apply.

The MPEP states: “37 CFR 1.55(d) contains provisions relating to the time for filing a priority claim in an application filed under 35 U.S.C. 111(a) and in an application entering the national stage under 35 U.S.C. 371” and “37 CFR 1.78(d) contains provisions relating to claims under 35 U.S.C. 120, 121, 365(c), or 386(c) for the benefit of a prior-filed nonprovisional application, international application, or international design application.”

Note that these time periods are subject to the provisions of 37 CFR 1.55(p) and 1.78(k), which state that they are not extendable but are subject to certain exceptions.

The time periods for filing a priority claim depend on the type of application:

  • For original applications filed under 35 U.S.C. 111(a) (other than design applications), the claim must be filed during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application. See 37 CFR 1.55(d)(1).
  • For applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set in the PCT and Regulations under the PCT. See 37 CFR 1.55(d)(2) and MPEP § 213.06.
  • In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).

According to the MPEP, patent applications can be directed to three broad types of subject matter:

  • Utility patent applications under 35 U.S.C. 101 for “a new and useful process, machine, manufacture, or composition of matter”
  • Plant patent applications under 35 U.S.C. 161
  • Design patent applications under 35 U.S.C. 171

The MPEP 201.01 mentions several special types of national applications:

1. Provisional applications (35 U.S.C. 111(b))
2. Reissue applications (35 U.S.C. 251)
3. Design applications (35 U.S.C. 171)
4. Plant applications (35 U.S.C. 161)

These applications have specific requirements and purposes. For example, provisional applications provide a way to establish an early effective filing date, while reissue applications allow for the correction of errors in issued patents. Design applications protect ornamental designs, and plant applications are for new varieties of plants.

For more details on these special application types, refer to the following MPEP sections:
MPEP 201.04 – Provisional Application
MPEP 1400 – Reissue
MPEP 1500 – Design Patents
MPEP 1600 – Plant Patents

A certified copy of the foreign application must be filed within the time period set in 37 CFR 1.55, which is the later of four months from the filing date of the US application or sixteen months from the foreign application filing date.

The certified copy requirement will be considered satisfied in a national stage application under 35 U.S.C. 371 if a certified copy was filed in the international application and the copy is present in the national stage application. See MPEP § 215.

A certified copy is also not required if the foreign priority application was filed in a participating foreign intellectual property office and the USPTO retrieves a copy via the priority document exchange program. See MPEP § 215.01.

An interim copy of the foreign application may also be filed to meet the timeliness requirement. See 37 CFR 1.55(j) and MPEP § 215.02(b).

To claim priority to or benefit of a prior-filed application, the later-filed application must:

  • Contain a specific reference to the earlier-filed application
  • Be filed within the required time period
  • Include the priority or benefit claim in the application data sheet (for applications filed on or after September 16, 2012)

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, statutory provisions require that for a later-filed application to be entitled to the benefit of an earlier-filed national application, the later-filed application must contain a specific reference to the earlier-filed application.” (MPEP 210)

The requirements for claiming priority to a foreign application under 37 CFR 1.55 include:

  • A claim for priority identifying the foreign application
  • For applications filed on or after September 16, 2012, the claim for priority must be in the application data sheet (ADS)
  • For applications filed before September 16, 2012, the claim for priority must be in the ADS or in the oath or declaration
  • Filing a certified copy of the foreign application within specified time periods
  • Meeting other requirements such as translations for non-English language applications

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, 35 U.S.C. 119(b)(1) requires a claim for priority identifying the foreign application. … Thus for all applications filed on or after September 16, 2012, a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) to the prior application must be presented in the application data sheet.”

The key requirements for claiming foreign priority under 37 CFR 1.55 include:

  • Filing a claim for priority in the application data sheet (for applications filed on or after September 16, 2012)
  • Filing the application within the required time period
  • Providing a certified copy of the foreign application
  • Providing an English translation if necessary

37 CFR 1.55(d) “contains provisions relating to the time for filing a priority claim in an application filed under 35 U.S.C. 111(a) and in an application entering the national stage under 35 U.S.C. 371” (MPEP 210)

The requirements for claiming benefit of an earlier national application under 37 CFR 1.78 include:

  • A specific reference to the earlier-filed application in the later-filed application
  • For applications filed on or after September 16, 2012, the specific reference must be in the application data sheet (ADS)
  • For applications filed before September 16, 2012, the specific reference must be in the ADS or in the first sentence(s) of the specification
  • Meeting time requirements for filing the benefit claim
  • In some cases, providing a statement regarding the effective filing date of claims

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, statutory provisions require that for a later-filed application to be entitled to the benefit of an earlier-filed national application, the later-filed application must contain a specific reference to the earlier-filed application.”

To claim the benefit of a prior-filed application in a continuation or continuation-in-part application, several requirements must be met:

1. The application must be filed before the patenting, abandonment, or termination of proceedings on the prior application.

2. The application must contain or be amended to contain a specific reference to the prior application. For applications filed on or after September 16, 2012, this reference must be in an application data sheet.

3. The application must have at least one common inventor with the prior application.

4. The application must comply with the requirements of 35 U.S.C. 120 and 37 CFR 1.78.

As stated in the MPEP: “An applicant in a nonprovisional application (including a nonprovisional application resulting from an international application or international design application), an international application designating the United States, or an international design application designating the United States may claim the benefit of one or more prior-filed copending nonprovisional applications, international applications designating the United States, or international design applications designating the United States under the conditions set forth in 35 U.S.C. 120, 121, 365(c), or 386(c) and this section.”

The requirements for accepting an unintentionally delayed claim for foreign priority include:

  1. Filing a petition to accept a delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b).
  2. Submitting the priority claim in an application data sheet identifying the foreign application.
  3. Providing a certified copy of the foreign application, unless previously submitted or an exception applies.
  4. Paying the petition fee as set forth in 37 CFR 1.17(m).
  5. Submitting a statement that the entire delay between the date the priority claim was due and the date it was filed was unintentional.

The MPEP cites 37 CFR 1.55(e), which states: “A petition to accept a delayed claim for priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) must be accompanied by: (1) The priority claim under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted; (2) A certified copy of the foreign application, unless previously submitted or an exception in paragraph (h), (i), or (j) of this section applies; (3) The petition fee as set forth in § 1.17(m); and (4) A statement that the entire delay between the date the priority claim was due under this section and the date the priority claim was filed was unintentional.” (37 CFR 1.55(e))

To claim the benefit of an earlier filing date under 35 U.S.C. 120 and 119(e), a later-filed application must meet several requirements:

  • The prior-filed application must name the inventor or at least one joint inventor named in the later-filed application and must be entitled to a filing date
  • The prior-filed application must meet disclosure requirements under 35 U.S.C. 112(a) to support the claims in the later-filed application, except for the best mode requirement
  • The later-filed application must contain a specific reference to the prior-filed application
  • The reference to the prior application must be submitted within the time periods set forth in 37 CFR 1.78

Filing a continuation-in-part (CIP) application can present several risks and potential drawbacks:

1. Different Effective Filing Dates: New matter in the CIP only gets the benefit of the CIP filing date, potentially exposing those claims to more prior art.

2. Reduced Patent Term: The patent term is measured from the filing date of the earliest application to which the CIP claims priority, potentially reducing the overall protection period for new matter.

3. Double Patenting Issues: Claims in the CIP may be subject to obviousness-type double patenting rejections based on the claims of the parent application.

4. Complexity in Litigation: The varying effective filing dates can complicate patent litigation, particularly when determining relevant prior art.

5. Difficulty in Claiming Priority: International applications may have difficulty claiming priority to a CIP due to the new matter.

While not explicitly stated in the provided MPEP section, these are important considerations derived from patent law and practice. The MPEP does note: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

Applicants should carefully consider these factors when deciding whether to file a CIP or a new application.

According to MPEP 203.05, there are four main reasons for patent application abandonment:

  1. Formal abandonment by the applicant or their representative
  2. Failure of the applicant to take appropriate action during prosecution
  3. Failure to pay the issue fee
  4. For provisional applications, the passage of 12 months from the filing date

The MPEP states: An abandoned application is, inter alia, one which is removed from the Office docket of pending applications: (A) through formal abandonment by the applicant or by the attorney or agent of record; (B) through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application; (C) for failure to pay the issue fee (MPEP § 711 to § 711.05); or (D) in the case of a provisional application, no later than 12 months after the filing date of the provisional application.

The Patent Law Treaties Implementation Act of 2012 (PLTIA) amended the filing date requirements for nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013. The key changes are:

  • Nonprovisional applications (except for design patent applications) no longer require at least one claim or any drawings to receive a filing date.
  • For design patent applications, the filing date is the date on which the USPTO receives the specification including at least one claim and any required drawings.
  • As provided in 35 U.S.C. 111(c), a nonprovisional application may be filed by reference to a previously filed application (foreign, international, provisional, or nonprovisional).

These changes simplified the filing process for most nonprovisional applications while maintaining specific requirements for design patent applications.

Design and plant patent applications are two distinct types of patent applications, each protecting different aspects of inventions:

Design Patent Applications:
1. Protect the ornamental design of a functional item.
2. Cover the visual appearance of an article of manufacture.
3. Have a term of 15 years from the date of grant.
4. Require drawings or photographs of the design.
5. Do not require a written description of the invention.

Plant Patent Applications:
1. Protect new varieties of asexually reproduced plants.
2. Cover the entire plant, not just a specific part.
3. Have a term of 20 years from the filing date.
4. Require a detailed botanical description of the plant.
5. May include drawings or photographs to illustrate the plant’s characteristics.

For more information, refer to MPEP 201.06 for design patents and MPEP 201.07 for plant patents.

Failure to timely submit the reference to the prior-filed application within the time periods specified in 37 CFR 1.78 is considered a waiver of any benefit claim under 35 U.S.C. 120, 121, 365(c), or 386(c) to the prior-filed application. See 37 CFR 1.78(d)(3)(iii). The time periods are not extendable.

If the reference to the prior-filed application is submitted after the time period provided by 37 CFR 1.78, a petition and the petition fee under 37 CFR 1.17(m) would be required to accept the delayed claim. The petition must be accompanied by:

  • The reference required by 35 U.S.C. 120 and 37 CFR 1.78 to the prior-filed application
  • The petition fee
  • A statement that the entire delay between the date the benefit claim was due and the date the claim was filed was unintentional

There are several key conditions that must be met to use incorporation by reference under 37 CFR 1.57(b):

  1. The application must have been filed on or after September 21, 2004
  2. Material must have been inadvertently omitted from the application
  3. A priority or benefit claim to a prior-filed application must have been present on the filing date
  4. The omitted material must be completely contained in the prior-filed application
  5. An amendment to add the omitted material must be filed within the time period set by the USPTO
  6. Other requirements like supplying copies of prior applications may apply

As stated in the MPEP: “The following conditions and requirements need to be met for an applicant to add omitted material to an application pursuant to 37 CFR 1.57(b):” followed by a list of specific conditions labeled (A) through (I).

MPEP 203.05 outlines several circumstances under which a patent application can become abandoned:

  1. Through formal abandonment by the applicant or by the attorney or agent of record;
  2. Through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application;
  3. For failure to pay the issue fee (see MPEP § 711 to § 711.05); or
  4. In the case of a provisional application, no later than 12 months after the filing date of the provisional application (see MPEP § 711.03(c) and 35 U.S.C. 111(b)(5)).

An abandoned application is removed from the Office docket of pending applications. It’s important to note that abandonment can occur unintentionally, such as missing a deadline, or intentionally, such as when an applicant decides not to pursue the application further.

The Patent Law Treaties Implementation Act (PLTIA) made several changes to priority and benefit claims, including:

  • Restoration of the right of priority to a foreign application or benefit of a provisional application within two months of the deadline
  • Ability to file international design applications
  • Claiming priority to and benefit of international design applications

The MPEP notes: “Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application.” (MPEP 210)

To obtain a filing date for a nonprovisional utility patent application filed on or after 12/18/2013, the application must include:

  • A specification with or without claims (35 U.S.C. 111(a)(2)(A))
  • Drawings, if necessary for an understanding of the invention (35 U.S.C. 111(a)(2)(B)), but see 37 CFR 1.81(a) for applications filed before 12/18/2013 requiring drawings where they are necessary for the understanding of the invention
  • The inventor’s oath or declaration, which may be filed later if an application data sheet (ADS) is submitted identifying the inventor(s) (35 U.S.C. 111(a)(2)(C) and 115)
  • The applicable filing fees (basic filing fee, search fee, examination fee, any required excess claims fees) (35 U.S.C. 41 and 37 CFR 1.16)

An application missing any of the above items will be treated as incomplete and no filing date will be granted until the missing item(s) are submitted.

Patent attorneys and examiners generally do not need to be concerned about ‘[Reserved]’ sections like MPEP 212. These sections contain no substantive information and do not affect current patent examination procedures. However, it’s good practice to stay informed about MPEP updates in case reserved sections are filled with new content in the future.

No, there is currently no content in MPEP 212. The section is marked as ‘[Reserved]’, which means it is empty and being held for potential future use.

When filing an interim copy via the USPTO patent electronic filing system:

  1. The main parts of the foreign priority application (Abstract, Drawings, Specification, Claims, etc.) along with the cover sheet may be filed as a single PDF image file.
  2. Select the document description ‘Interim Copy of the Foreign Priority Application’ when indexing.
  3. For plain text files (e.g., Sequence Listings), file as a .txt file and select ‘Interim Copy of the Foreign Priority (text file)’ as the document description.
  4. XML files (e.g., Standard ST.26 Sequence Listing) should be filed on a read-only optical disc as part of the ‘Interim Copy of Foreign Priority.’

See MPEP § 502.05 for more information on filing documents electronically.

To ensure proper correlation between priority papers and U.S. applications, the MPEP suggests: “It is suggested that a notation of the application number of the corresponding U.S. application be placed on the priority papers when such papers are not submitted via a priority document exchange program. Such notation should be placed directly on the priority papers themselves even where a cover letter is attached bearing the U.S. application data.” This practice helps prevent separation of cover letters and priority papers, which can cause severe problems for both the Office and applicant.

For patent applications, prior U.S. application data should be provided as follows:

  • For applications filed on or after September 16, 2012: In an application data sheet
  • For applications filed before September 16, 2012: In either the first sentence(s) of the specification or in an application data sheet

MPEP 202 states: “The identifying data of all prior applications for which benefits are claimed should be reviewed by the examiner to ensure that the data is accurate and provided in an application data sheet for applications filed on or after September 16, 2012, or provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012.”

Examiners should review the identifying data of all prior applications for which benefits are claimed to ensure accuracy. This review includes:

  • Checking that the data is provided in an application data sheet for applications filed on or after September 16, 2012
  • Verifying that the data is provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012
  • Ensuring the appropriate relationship (e.g., continuation, divisional, or continuation-in-part) between nonprovisional applications is included

The MPEP states: “The identifying data of all prior applications for which benefits are claimed should be reviewed by the examiner to ensure that the data is accurate and provided in an application data sheet for applications filed on or after September 16, 2012, or provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012.” (MPEP 202)

The frequency with which ‘[Reserved]’ sections in the MPEP, like MPEP 212, are filled with content varies and depends on the needs of the USPTO. These sections may be filled during regular MPEP updates, which typically occur several times a year, or may remain reserved for extended periods.

The effective filing date for a claimed invention is determined as follows:

  • The actual filing date of the application containing the claim, or
  • The filing date of the earliest application for which the patent or application is entitled to claim priority or benefit

The MPEP cites 35 U.S.C. 100(i)(1): “the effective filing date for a claimed invention in a patent or application (except in an application for reissue or reissued patent) is set forth in 35 U.S.C. 100(i)(1) as: (A) if subparagraph (B) does not apply, the actual filing date of the patent or the application for the patent containing a claim to the invention; or (B) the filing date of the earliest application for which the patent or application is entitled, as to such invention, to a right of priority under section 119, 365(a), 365(b), 386(a), or 386(b) or to the benefit of an earlier filing date under section 120, 121, 365(c), or 386(c).” (MPEP 210)

Foreign priority application information is handled as follows on the bib-data sheet:

  • If a proper foreign priority claim is not listed on the bib-data sheet, the examiner should add the information and forward it for correction in the Office computer systems.
  • Applications listed on the bib-data sheet but filed in countries not qualifying for benefits under 35 U.S.C. 119(a)-(d) should be lined through.
  • The bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application claiming priority.
  • Examiners should check this information for accuracy and make corrections if necessary.

The MPEP states: “If a foreign application listed on the oath or declaration (for applications filed prior to September 16, 2012) or application data sheet is not listed on the bib-data sheet and the foreign priority claim is proper (e.g., the foreign priority claim was timely made ), the examiner should provide the information regarding the foreign application number, the country, and the filing date on the bib-data sheet and forward the marked-up bib-data sheet to the Legal Instrument Examiner for correction in the Office computer systems.” (MPEP 202)

The USPTO handles United Kingdom provisional specifications in priority claims as follows:

  • A certified copy of the “provisional specification” may be submitted, sometimes accompanied by a copy of the “complete specification.”
  • The provisional specification is examined for completeness of disclosure, as it may not contain a complete disclosure in the sense of 35 U.S.C. 112.
  • If the UK provisional specification is found insufficient for lack of disclosure, reliance may then be placed on the complete specification and its date, treating it as a different application than the provisional specification.

The MPEP states: “In applications filed from the United Kingdom there may be submitted a certified copy of the ‘provisional specification,’ which may also in some cases be accompanied by a copy of the ‘complete specification.’ According to United Kingdom law the provisional specification need not contain a complete disclosure of the invention in the sense of 35 U.S.C. 112, but need only describe the general nature of the invention, and neither claims nor drawings are required.” (MPEP 216)

The examiner generally does not examine the certified copy of the foreign priority application except to see that it contains no obvious formal defects and corresponds to the U.S. application. The examiner will consider the merits of the priority claim if:

  • An intervening reference is found with an effective date between the foreign filing date and U.S. filing date
  • Determining if a reference is prior art under the grace period
  • An interference situation is under consideration

If the examiner finds the applicant is not entitled to the priority date, a rejection is made and the applicant must then perfect the claim. [MPEP 216]

The United States Patent and Trademark Office (USPTO) defines an abandoned patent application through the Manual of Patent Examining Procedure (MPEP) 203.05. According to this section, an abandoned application is defined as:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications

This removal from the docket can occur for various reasons, including formal abandonment, failure to take appropriate action during prosecution, non-payment of fees, or the expiration of the statutory period for provisional applications.

The USPTO acknowledges receipt of foreign priority claims in several ways:

  1. If the claim is timely and all requirements are met, the examiner will advise the applicant in the next Office action using form PTOL-326 or form paragraph 2.26
  2. For priority documents filed in a parent application, the examiner may use form paragraph 2.27
  3. If there are irregularities, the examiner may use specific form paragraphs to notify the applicant of issues

MPEP 214.03 states: “When the claim for foreign priority and the certified copy of the foreign application are received within the time period set forth in 37 CFR 1.55, if applicable, they are entered into the application file history. Assuming that the papers are timely and regular in form and that there are no irregularities in dates, the examiner in the next Office action will advise the applicant that the papers have been received on form PTOL-326 or by use of form paragraph 2.26.”

The Priority Document Exchange (PDX) program allows for electronic transmission of priority documents between participating foreign intellectual property offices. According to 37 CFR 1.55(i), if the foreign application was filed in a participating office, the requirement for a timely filed certified copy is considered satisfied if the Office receives a copy through the PDX program during the pendency of the application and before the patent is granted.

The Patent Cooperation Treaty (PCT) system interacts with foreign priority claims in several important ways:

1. Priority claims in PCT applications:
– PCT applications can claim priority to earlier foreign applications under the Paris Convention.
– The priority period is 12 months from the earliest priority date.

2. PCT as a basis for priority:
– A PCT application can serve as the basis for a priority claim in a later-filed national or regional application.

3. Effect on time limits:
– The 30-month time limit for entering the national phase is calculated from the priority date (if claimed) or the PCT filing date if no priority is claimed.

4. Restoration of priority rights:
– The PCT system allows for restoration of priority rights if an international application is filed within 14 months of the priority date and the delay was unintentional.

5. Certified copies:
– The PCT system has provisions for providing certified copies of priority documents to designated offices.

As stated in MPEP 213.06: “In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.”

The PCT system provides a streamlined process for seeking patent protection internationally while preserving priority rights, but applicants must be aware of the specific requirements and time limits within the PCT system.

Claiming priority to a foreign application generally does not affect the term of a U.S. patent. The patent term is typically calculated from the actual U.S. filing date, not the foreign priority date.

For utility and plant patents:
– The term is 20 years from the earliest U.S. filing date of the application or any U.S. application to which it claims benefit under 35 U.S.C. 120, 121, or 365(c).
– The foreign priority date is not used in this calculation.

For design patents:
– The term is 15 years from the date of grant.
– The filing or priority dates do not affect the term.

It’s important to note that while the foreign priority date doesn’t affect the patent term, it can affect the effective filing date for prior art purposes, which can be crucial for determining patentability.

Patent Term Adjustment (PTA) may be available to extend the term of a utility or plant patent due to delays in prosecution, but this is calculated based on the actual U.S. filing date, not the foreign priority date.

Claiming foreign priority can significantly affect the prior art date in your application:

  • For applications subject to pre-AIA law, the foreign priority date becomes the effective U.S. filing date for prior art purposes under 35 U.S.C. 102(a), (b), and (d)
  • For applications subject to AIA law, the foreign priority date is treated as the effective filing date for prior art purposes under 35 U.S.C. 102(a)(1) and (a)(2)

This means that intervening disclosures between your foreign filing date and your U.S. filing date may not be considered prior art against your application. However, it’s important to note that the claimed subject matter must be fully supported by the foreign application to get the benefit of its filing date. Additionally, the priority claim must be proper and timely made for this benefit to apply.

When an examiner finds an intervening reference (a reference with an effective date between the foreign filing date and the U.S. filing date) and a foreign priority claim is present, the examiner follows these steps:

  1. If the certified copy of the priority papers has not been filed, the examiner rejects the claims that may be unpatentable over the reference without considering the priority date.
  2. The applicant may then argue the rejection or present the foreign papers to overcome the date of the reference.
  3. If the applicant argues the rejection, the examiner may, in the next action:
    • Specifically require the foreign papers to be filed while repeating the rejection if still applicable, or
    • Simply continue the rejection

The MPEP states: “If at the time of making an action the examiner has found such an intervening reference, the examiner simply rejects whatever claims may be considered unpatentable thereover, without paying any attention to the priority date (assuming the certified copy of the priority papers has not yet been filed).” (MPEP 216)

MPEP 203.03 defines an ‘amended’ application as:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action. The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

In essence, an application becomes ‘amended’ when the applicant responds to an examiner’s action, whether through election, traversal, or by submitting amendments to the application.

For international applications, 37 CFR 1.57(b)(1) specifies:n

    n

  • Any amendment will only be effective as to the United States and shall have no effect on the international filing date
  • n

  • It cannot be relied upon to accord an international filing date or alter the filing date under PCT Article 11
  • n

  • No request to add omitted material will be acted on prior to national stage entry under 37 CFR 1.491 or filing of a US application claiming benefit of the international application
  • n

The first inventor to file provisions that took effect on 3/16/2013 require additional statements for certain “transition” applications:

– Transition applications are those filed on or after 3/16/2013 that claim priority to an application filed before 3/16/2013.
– If a transition application ever contained a claim having an effective filing date on or after 3/16/2013, a statement to that effect is required within the later of 4 months from the actual filing date, 4 months from national stage entry, 16 months from the prior application, or the date the claim was first presented.
– This statement requirement does not apply if the application only claims priority to applications filed on or after 3/16/2013, or if the applicants reasonably believe the application never contained such a claim.

See MPEP 210 and MPEP 2159 for more details.

Claiming priority to a provisional application is different from claiming foreign priority. To claim the benefit of a provisional application in a later-filed nonprovisional application:

  • The nonprovisional must be filed within 12 months of the provisional filing date
  • A specific reference to the provisional application must be made in an application data sheet
  • The provisional and nonprovisional must name at least one common inventor
  • The claimed subject matter must be supported by the provisional application

This is known as a domestic benefit claim under 35 U.S.C. 119(e), rather than a foreign priority claim under 35 U.S.C. 119(a)-(d). The requirements are specified in 37 CFR 1.78 rather than 37 CFR 1.55.

To claim priority to an earlier-filed foreign application, the applicant must:

1. File the U.S. application within 12 months of the foreign application’s filing date (6 months for design applications).
2. In the U.S. application, include a claim for priority that identifies the foreign application. For applications filed on/after 9/16/12, this must be in an ADS.
3. File a certified copy of the foreign application, unless it was previously filed or is available to the USPTO via a priority document exchange program.

See MPEP 213216 for the detailed requirements. Some deadlines can be extended on petition if unintentionally delayed.

Claiming priority to a PCT international application can be done in two ways:

  1. In a U.S. national stage application under 35 U.S.C. 371:
    • The priority claim is made in the PCT application
    • No further action is needed when entering the national stage
  2. In a U.S. nonprovisional application under 35 U.S.C. 111(a):
    • File within 12 months of the PCT filing date
    • Make the priority claim in an application data sheet
    • Provide a certified copy of the PCT application (unless already filed with the PCT)

In both cases, the PCT application must designate the United States. The specific requirements are detailed in 37 CFR 1.55(d)(2) and (f)(2) for national stage applications, and 37 CFR 1.55(d)(1) and (f)(1) for applications under 35 U.S.C. 111(a).

To claim foreign priority in a U.S. patent application, you must:

1. File the U.S. application within 12 months (6 months for design applications) of the foreign filing date.
2. Submit a claim for priority identifying the foreign application.
3. File a certified copy of the foreign application.

For applications filed on or after September 16, 2012, 37 CFR 1.55(d)(1) requires that the claim for priority be presented in an application data sheet. The claim must identify the foreign application by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.

A certified copy of the foreign application must also be filed within a specified time period, usually within the later of 4 months from the actual U.S. filing date or 16 months from the foreign filing date.

To amend your application to include inadvertently omitted material under 37 CFR 1.57(b), you must:

  1. File an amendment to include the omitted material within the time period set by the USPTO
  2. Ensure the amendment is filed before the close of prosecution or abandonment of the application
  3. Supply a copy of the prior-filed application (unless it’s a US application filed under 35 U.S.C. 111)
  4. Provide an English translation if the prior-filed application is in a foreign language
  5. Identify where the omitted material can be found in the prior-filed application

The MPEP states: “The application must be amended to include the inadvertently omitted portion of the specification or drawing(s) within any time period set by the Office, but in no case later than the close of prosecution as defined by 37 CFR 1.114(b), or abandonment of the application, whichever occurs earlier.”

Under 37 CFR 1.55(i), the requirement for a certified copy of the foreign application will be considered satisfied if:

  1. The foreign application was filed in a foreign intellectual property office participating with the USPTO in a bilateral or multilateral priority document exchange agreement;
  2. The claim for priority is presented in an application data sheet, identifying the foreign application and including the information necessary for the participating foreign office to provide the USPTO with access to the foreign application; and
  3. The copy of the foreign application is received by the USPTO from the participating foreign office, or a certified copy is filed, within the time period specified in 37 CFR 1.55(g)(1).

In addition, if the foreign application was not filed in a participating office directly, but a certified copy was filed in an application subsequently filed in a participating office that permits the USPTO to obtain a copy, the applicant must also file a request in a separate document that the USPTO obtain a copy of the foreign application from the participating office. See MPEP 215.01.

The benefit of a provisional application can be restored if the nonprovisional application is filed within 14 months of the provisional application filing date. To restore the benefit:

  1. File a petition under 37 CFR 1.78(b) in the nonprovisional application
  2. Include the reference to the provisional application in an application data sheet
  3. Pay the petition fee set in 37 CFR 1.17(m)
  4. Provide a statement that the delay in filing was unintentional

As stated in MPEP 211.01(a): “If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

To file an unintentionally delayed foreign priority claim, you must submit a petition under 37 CFR 1.55(e). The petition must include:

  1. The priority claim (if not previously submitted)
  2. A certified copy of the foreign application (unless previously submitted or an exception applies)
  3. The petition fee set forth in 37 CFR 1.17(m)
  4. A statement that the entire delay was unintentional

MPEP 214.02 states: “If a claim for foreign priority is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

If a claim for foreign priority is not presented within the required time period under 37 CFR 1.55, it is considered waived. However, the claim may be accepted if the priority claim was unintentionally delayed.

To file a petition for an unintentionally delayed priority claim, the applicant must submit:

  1. The priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet, identifying the foreign application to which priority is claimed;
  2. A certified copy of the foreign application, unless previously submitted or an exception applies;
  3. The petition fee set in 37 CFR 1.17(m); and
  4. A statement that the entire delay between the date the priority claim was due and the date it was filed was unintentional.

The Director may require additional information if there is a question whether the delay was unintentional. See 37 CFR 1.55(e).

A patent application can become formally abandoned through an explicit action by the applicant or their representative. MPEP 203.05 states that an abandoned application includes one that is removed from the Office docket of pending applications: (A) through formal abandonment by the applicant or by the attorney or agent of record. This means the applicant or their legal representative can submit a formal request to abandon the application, effectively ending its prosecution.

A claim for foreign priority can be perfected after a patent has been issued through two main methods:

  1. Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323
  2. Reissue application

The choice of method depends on the specific circumstances:

  • A Certificate of Correction can be used if the requirements of 37 CFR 1.55 are met and no further examination is required.
  • A reissue application is necessary if the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance, or if further examination would be required.

The MPEP states: “The failure to perfect a claim to foreign priority prior to issuance of the patent may be cured via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, provided the requirements of 37 CFR 1.55 are met, or by filing a reissue application.” (MPEP 216.01)

Patent examiners verify foreign priority claims through the following steps:

  1. Check that foreign applications listed on the oath, declaration, or application data sheet are properly listed on the bib-data sheet.
  2. Verify the accuracy of the application number, country, and filing date for each foreign application.
  3. Ensure that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) are listed.
  4. Initial the bib-data sheet in the “VERIFIED” space when the information is correct or has been amended to be correct.
  5. Indicate in the Office action and on the bib-data sheet whether the conditions of 35 U.S.C. 119(a)-(d) or (f) have been met.

MPEP 202 states: “The examiner should check this information for accuracy. Should there be an error on the oath or declaration, or application data sheet itself, the examiner should require a new oath or declaration, or application data sheet, where appropriate. A petition for an unintentionally delayed claim for priority may also be required.”

Errors in prior application data on the bib-data sheet are corrected as follows:

  1. If the error is in the preprinted data: The examiner can have the technical support staff of the Technology Center make corrections in the Patent Data Portal database.
  2. If the error is an applicant error: The examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.

MPEP 202 states: “Upon entry of the data, a new bib-data sheet should be printed and scanned into the file. If the error was an applicant error, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate. See MPEP § 601.05 et seq. and MPEP § 211.02(a). A petition for an unintentionally delayed benefit claim may also be required. See MPEP § 211.04.”

For continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), the front page of a printed patent will include:

  • The application number and filing date of the most recent noncontinued prosecution application
  • All prior applications from which benefit was claimed in the most recent noncontinued prosecution application

Notably, the filing date of the CPA itself is not included. As stated in the MPEP: “The front page of a printed patent issuing on a continued prosecution application (CPA) filed under 37 CFR 1.53(d) will identify the application number and filing date of the most recent noncontinued prosecution application (but not the filing date of the CPA) as well as all prior applications from which benefit was claimed in the most recent noncontinued prosecution application.” (MPEP 202)

No, the inclusion of prior application information in the patent does not necessarily indicate that the claims are entitled to the benefit of the earlier filing date.

See MPEP 2136.03 and MPEP 2154.01(b) for additional information.

Incorporation by reference under 37 CFR 1.57(b) has limited applicability to international patent applications:

  • It is only effective for the United States
  • It does not affect the international filing date
  • It cannot be used to accord an international filing date
  • Requests to add omitted material will not be acted upon before national stage entry

The MPEP states: “Any amendment to an international application pursuant to 37 CFR 1.57(b)(1) will be effective only as to the United States and shall have no effect on the international filing date of the application. The incorporation by reference relief provided in 37 CFR 1.57(b) cannot be relied upon to accord an international filing date to an international application that is not otherwise entitled to a filing date under PCT Article 11, and it cannot be relied upon to alter the international filing date accorded under PCT Article 11.”

Yes, the right of priority can be restored if the U.S. application is filed after the 12-month priority period (or 6-month period for design applications), but within 2 months of the expiration of the priority period, if the delay was unintentional.

37 CFR 1.55(c) states: “If the subsequent application has a filing date which is after the expiration of the period set forth in paragraph (b)(1) of this section, but within two months from the expiration of the period set forth in paragraph (b)(1) of this section, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition pursuant to this paragraph, if the delay in filing the subsequent application within the period set forth in paragraph (b)(1) of this section was unintentional.”

To restore the right of priority, the applicant must file a petition including:
1. The priority claim
2. The petition fee
3. A statement that the delay was unintentional

The USPTO may require additional information to determine if the delay was truly unintentional.

Yes, the inventorship in a continuation or continuation-in-part (CIP) application can differ from the parent application, but there are specific requirements:

1. For continuation applications: The inventorship must include at least one inventor named in the prior-filed application.

2. For CIP applications: The inventorship can change more significantly due to the addition of new matter.

The MPEP states for continuation applications: “The inventorship in the continuation application must include at least one inventor named in the prior-filed application.”

For CIP applications, the MPEP notes: “A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78. Subject to the same conditions, a continuation-in-part application that has joint inventors may derive from an earlier application that has a sole inventor.”

Any changes in inventorship must be properly documented and may require a request under 37 CFR 1.48.

Yes, the foreign application may have been filed by and in the name of the assignee or legal representative or agent of the inventor, as applicant.

If the certified copy of the foreign application corresponds with the one identified in the U.S. application and no discrepancies appear, it may be assumed the U.S. application is entitled to claim priority to the foreign application.

If the U.S. application and the certified copy do not name the same inventor or have at least one joint inventor in common, the priority date should be refused until the inconsistency is resolved. [MPEP 216]

No, incorporation by reference under 37 CFR 1.57(b) cannot be used to add material to a granted patent. This provision is only applicable during the application process, before a patent is granted. The MPEP clearly states:

“If, however, an application has been patented, a certificate of correction or a reissue application could not be used to add inadvertently omitted material to that patent via 37 CFR 1.57(b).”

Once a patent has been granted, other mechanisms such as reissue or certificate of correction would need to be considered for making changes or additions to the patent, subject to their own specific requirements and limitations.

Yes, it is possible to restore the right of priority if you miss the 12-month filing deadline (6 months for design applications). As provided in 37 CFR 1.55(c), if the subsequent application is filed within two months from the expiration of the priority period, the right of priority may be restored upon petition. The petition must include:

  • The priority claim (unless previously submitted)
  • The petition fee
  • A statement that the delay in filing was unintentional

The Director may require additional information where there is a question whether the delay was unintentional. Note that while this allows for a valid priority claim, it does not overcome potential prior art issues under pre-AIA 35 U.S.C. 102(b) or (d) in applications subject to pre-AIA law.

Yes, you can file a foreign priority claim after your patent has been granted, but it requires additional steps:

  1. File a petition under 37 CFR 1.55(e) for an unintentionally delayed priority claim
  2. Submit a request for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323
  3. Pay the required petition and certificate of correction fees

MPEP 214.02 states: “Where a priority claim under 37 CFR 1.55(g) was not timely made, 37 CFR 1.55(g) allows the priority claim and the certified copy required under 37 CFR 1.55 to be filed pursuant to a petition under 37 CFR 1.55(e) even if the application is not pending (e.g., a patented application).”

Yes, it is possible to claim priority to multiple foreign applications in a U.S. patent application, provided certain conditions are met:

  • Each foreign application must independently meet the requirements for a priority claim
  • The U.S. application must be filed within 12 months of the earliest filed foreign application
  • The claimed subject matter must be supported by each application for which priority is claimed

When claiming multiple priorities, the U.S. application gets the benefit of each prior application only for the subject matter that it supports. This allows applicants to combine priority claims to protect inventions that were developed and disclosed progressively over time in different countries.

Yes, failure to pay the issue fee can result in an abandoned patent application. MPEP 203.05 explicitly states that an abandoned application includes one removed from the Office docket for failure to pay the issue fee (MPEP § 711 to § 711.05). This means that even if an application has been approved for issuance, if the applicant fails to pay the required issue fee within the specified time frame, the application will be considered abandoned.

For more detailed information on this topic, you can refer to MPEP § 711 to § 711.05.

Yes, under 37 CFR 1.55(j), the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f) will be considered satisfied if:

  1. A copy of the original foreign application clearly labeled as “Interim Copy,” including the specification, and any drawings or claims upon which it is based, is filed in the Office together with a separate cover sheet identifying the foreign application and stating that the copy is a true copy of the original application as filed; and
  2. The copy of the foreign application and cover sheet are filed within the later of sixteen months from the filing date of the prior foreign application, four months from the actual filing date of an application under 35 U.S.C. 111(a), or four months from the date the national stage commenced under 35 U.S.C. 371(b) or (f) of an international application.

However, a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate. See MPEP 215.02(b).

Yes, an abandoned application can still be used as a priority document for subsequent applications, provided that the priority claim is made within the specified time limits. The abandoned status of the earlier application does not affect its ability to serve as a basis for priority. For more information on priority claims, refer to MPEP 201 and MPEP 211.

Yes, an abandoned application can be used as prior art, but the extent of its use depends on several factors. Under MPEP 2127, abandoned applications that have been published can be used as prior art as of their publication date for all they teach. Unpublished abandoned applications may be available as prior art under certain circumstances, such as when they are incorporated by reference in a U.S. patent. It’s important to note that the abandonment status itself does not negate the application’s potential as prior art. For specific rules on using abandoned applications as prior art, consult MPEP 2127 and MPEP 901 on prior art.

Yes, a nonprovisional application can be entitled to different foreign filing dates for different claims. This can occur in two scenarios:

  1. The application may be found entitled to the filing date of a foreign application for some claims but not for others.
  2. An applicant may rely on two or more different foreign applications and may be entitled to the filing date of one application for certain claims and to another for other claims.

The MPEP states: “A nonprovisional application may be found entitled to the filing date of the foreign application with respect to some claims and not with respect to others. In addition, an applicant may rely on two or more different foreign applications and may be entitled to the filing date of one of them with respect to certain claims and to another with respect to other claims.” (MPEP 216)

Yes, design patent applications can be filed as continuations or continuations-in-part (CIPs), but with some specific considerations:

1. Continuations: A design application can be a continuation of a prior design application.

2. Continuations-in-part: A design application can be a CIP of a prior design application if it adds new matter.

3. Relationship to Utility Applications: A design application can also be a continuation or CIP of a utility application, provided the drawings in the utility application sufficiently disclose the claimed design.

The MPEP states: “A design application may be considered to be a divisional of a utility application (but not of a provisional application), and is entitled to the filing date thereof if the drawings of the earlier filed utility application show the same article as that in the design application sufficiently to comply with 35 U.S.C. 112(a). However, such a divisional design application may only be filed under the procedure set forth in 37 CFR 1.53(b), and not under 37 CFR 1.53(d).”

It’s important to note that while not explicitly stated for continuations and CIPs, the same principle applies – the earlier application must sufficiently disclose the claimed design.

No, a copy of the foreign patent as issued does not comply with the certified copy requirement. The MPEP states: “A copy of the foreign patent as issued does not comply since the application as filed is required; however, a copy of the printed specification and drawing of the foreign patent is sufficient if the certification indicates that it corresponds to the application as filed.” The key is that the certified copy must represent the application as originally filed, not the patent as eventually issued.

No, a continuation-in-part (CIP) application cannot be filed as a continued prosecution application (CPA). The MPEP explicitly states: “A continuation-in-part application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).”

Continuation-in-part applications may only be filed under 37 CFR 1.53(b). This is an important distinction to remember when considering different types of patent application filings.

Reserved sections are relatively common in the MPEP, especially for section numbers that are being held for future use or that previously contained content that was moved. A quick scan of the MPEP Chapter 200 shows several reserved sections, such as:

  • Section 203.07 [Reserved]
  • Sections 204-209 [Reserved]
  • Section 212 [Reserved]

MPEP 201 - Types of Applications (423)

The USPTO typically does not send a filing receipt for a Continued Prosecution Application (CPA). This practice is mentioned in MPEP ¶ 2.35, which states:

This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

The reason for this is that a CPA is a continuation of an existing application rather than an entirely new filing. The USPTO communicates the acceptance of the CPA through other means, typically in the first Office action on the CPA. This approach streamlines the process and reduces redundant paperwork.

For more information on USPTO procedures, visit: USPTO procedures.

Amendments to refer to Continued Prosecution Applications (CPAs) as continuation or divisional applications are not allowed because they are unnecessary and can potentially cause confusion. The MPEP ¶ 2.34 explains:

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that the CPA itself already serves as the legally required reference to the prior application. Adding additional references through amendments is redundant and could potentially lead to inconsistencies or misinterpretations in the patent record.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on patent law, visit: patent law.

For those interested in the historical procedures under former 37 CFR 1.60, the MPEP provides guidance: For more information pertaining to practice and procedure under former 37 CFR 1.60, see MPEP § 201.06(a) in the MPEP 8th Edition, Rev. 1 (February 2003)(available on the USPTO website at www.uspto.gov/web/offices/pac/mpep/mpep.htm). This archived version of the MPEP contains detailed information about the procedures that were in place before the rule change, which may be useful for historical reference or for understanding the processing of applications filed before December 1, 1997.

You should file a 37 CFR 1.48 request to correct inventorship in a Continued Prosecution Application (CPA) as soon as you realize there’s a need to add or remove an inventor. This should be done concurrently with or shortly after filing the CPA.

The MPEP ¶ 2.33 indicates:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48.

It’s important to file this request promptly to ensure that the correct inventorship is recorded for your application. Failure to do so may result in the inventorship remaining the same as in the prior application, which could potentially affect the validity of your patent if granted.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

You should file a 37 CFR 1.48 request for a Continued Prosecution Application (CPA) whenever you need to add, remove, or change the order of inventors from the original application.

The MPEP ¶ 2.33 indicates: Any request to add an inventor must be in the form of a request under 37 CFR 1.48. This applies even if you’ve identified the new inventor in the CPA filing documents.

It’s best to file the 37 CFR 1.48 request as soon as you realize there’s a need to correct the inventorship. This ensures that the correct inventors are associated with the application throughout the examination process.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Form Paragraph 2.35 should be used in specific circumstances during the patent examination process. According to the MPEP ¶ 2.35, this form paragraph is to be used:

in the first Office action of a CPA to advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request and the CPA is acceptable and that a CPA has been established.

However, it’s important to note that this form paragraph should not be used in all situations. Specifically:

  • It should only be used for design applications, as CPAs are only available for design applications.
  • If the request for a CPA in a utility or plant application is improper and has been treated as an RCE (Request for Continued Examination), examiners should use form paragraph 7.42.15 instead.

Examiners should refer to MPEP § 706.07(h) for more information on handling improper CPA requests in utility or plant applications.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent examination, visit: patent examination.

An inventor might consider filing a continuation application in several scenarios. The MPEP 201.07 provides guidance on timing:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

Common reasons for filing a continuation include:

  • To pursue broader or different claims based on the same disclosure
  • To address issues raised in the prosecution of the parent application
  • To keep the application pending while exploring commercial opportunities
  • To submit new evidence or arguments in support of patentability

It’s important to note that the continuation must be filed before the parent application is patented, abandoned, or otherwise terminated.

For more information on patent strategy, visit: patent strategy.

For more information on USPTO, visit: USPTO.

Patent examiners should use MPEP ¶ 2.06 when they encounter an application that appears to qualify as a continuation-in-part (CIP) but lacks a proper benefit claim. The paragraph itself provides guidance:

This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Examiners use this paragraph to notify applicants that their application might be eligible for CIP status and to direct them to the proper procedures for claiming the benefit of the prior application’s filing date if desired.

For more information on patent examination, visit: patent examination.

Patent examiners should use the MPEP ¶ 2.01 form paragraph under specific circumstances. The MPEP provides the following guidance:

Examiner Note: […] 2. This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.

This means examiners should use this paragraph when:

  • The application appears to contain subject matter that is independent and distinct from a prior application
  • The application seems to qualify as a divisional
  • The applicant has not yet properly claimed the benefit of the prior application’s filing date

The form paragraph serves as a prompt for the applicant to properly establish the benefit claim if they intend the application to be a divisional.

For more information on Divisional application, visit: Divisional application.

For continuing applications (continuation, divisional, continuation-in-part) filed on or after September 16, 2012 under 37 CFR 1.53(b), a newly executed inventor’s oath or declaration is generally not required if:

  • An oath or declaration complying with 35 U.S.C. 115 and 37 CFR 1.63 (or substitute statement under 37 CFR 1.64) was filed in the earlier-filed application
  • A copy of the executed oath/declaration from the earlier application is submitted in the continuing application showing it was executed

However, a newly executed inventor’s oath or declaration must be filed in a continuation or divisional application naming an inventor not named in the prior application (37 CFR 1.63(d)(3)).

For continuing applications filed before 9/16/2012, a newly executed oath or declaration is required unless a copy of the executed oath or declaration filed in the prior application is submitted with certain other requirements met (see pre-AIA 37 CFR 1.63(d)).

A Continued Prosecution Application (CPA) is acceptable when it meets the requirements set forth in 37 CFR 1.53(d). According to MPEP § 201, the examiner will use specific language to indicate acceptance:

The request filed on [date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [number] is acceptable and a CPA has been established.

It’s important to note that CPAs are now only available for design patent applications. For utility and plant applications, a Request for Continued Examination (RCE) would be used instead.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent examination, visit: patent examination.

A continuation application can be filed at various times during the patent application process. According to MPEP 201.07:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

This means you can file a continuation application:

  • Before the parent application is granted a patent
  • Before the parent application is abandoned
  • Before proceedings on the parent application are terminated

However, for Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), which are only available for design applications (excluding international design applications), there are additional timing restrictions:

A continued prosecution application (CPA) under 37 CFR 1.53(d) (available only for design applications, but not international design applications), however, must be filed prior to payment of the issue fee unless a petition under 37 CFR 1.313(c) is granted in the prior application.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

A Request to Delete a Named Inventor can be filed at two specific times for a Continued Prosecution Application (CPA):

  1. With the CPA filing: The request can be submitted along with the CPA when it is initially filed.
  2. After the CPA filing: If the request is made after the CPA has been filed, it must follow a different procedure.

The MPEP ¶ 2.32 states:

Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.

This means that post-filing requests require additional documentation and must comply with the regulations for correction of inventorship.

Continued Prosecution Applications (CPAs) are limited to specific types of patent applications:

  • Design Applications: CPAs are available for design applications filed before May 29, 2000.
  • Plant Applications: CPAs can be used for plant patent applications.

It’s important to note that CPAs are not available for utility patent applications filed on or after May 29, 2000. For these applications, applicants should use a Request for Continued Examination (RCE) instead.

The MPEP ¶ 2.34 provides guidance on how CPAs reference prior applications:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.

This means that for eligible applications, the CPA automatically establishes the necessary reference to the prior application without requiring amendments to the specification.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

The three main types of patent applications that can be filed in the USPTO are:

  1. Utility patent applications (filed under 35 U.S.C. 101) for “any new and useful process, machine, manufacture, or composition of matter”
  2. Design patent applications (filed under 35 U.S.C. 171) for “any new, original, and ornamental design for an article of manufacture”
  3. Plant patent applications (filed under 35 U.S.C. 161) for “whoever invents or discovers and asexually reproduces any distinct and new variety of plant”

What types of national applications can be filed with the USPTO?

The United States Patent and Trademark Office (USPTO) accepts several types of national applications. These include:

  • Utility patent applications: For new and useful processes, machines, articles of manufacture, or compositions of matter.
  • Design patent applications: For new, original, and ornamental designs for articles of manufacture.
  • Plant patent applications: For new varieties of asexually reproduced plants.
  • Provisional patent applications: A temporary application that establishes a filing date but does not mature into an issued patent.

According to MPEP 201.01:

Applications for plant patents, design patents, and utility patents are national applications.

Each type of application has specific requirements and procedures. Utility, design, and plant patent applications can be filed as nonprovisional applications, while provisional applications are only available for utility patents.

For more information on design patent, visit: design patent.

For more information on provisional patent, visit: provisional patent.

For more information on USPTO, visit: USPTO.

Under U.S. patent laws, several types of national applications can be filed. The MPEP 201.01 states:

‘National applications include original (nonprovisional), reissue, and reexamination applications (including supplemental examination proceedings). The original application includes continuation, divisional, and continuation-in-part applications. National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’

To break this down:

  • Original (nonprovisional) applications: Standard utility patent applications
  • Reissue applications: To correct errors in already granted patents
  • Reexamination applications: To request the USPTO to reexamine an existing patent
  • Continuation applications: Based on an earlier-filed application
  • Divisional applications: Derived from a parent application to pursue different inventions
  • Continuation-in-part applications: Adding new matter to a parent application
  • Design patent applications (under 35 U.S.C. 171)
  • Plant patent applications (under 35 U.S.C. 161)

For more information on reissue, visit: reissue.

For more information on USPTO, visit: USPTO.

Tags: reissue, USPTO

Under 35 U.S.C. 111(a), two types of national applications can be filed:

  • Nonprovisional applications: These are regular patent applications that, if granted, can result in an issued patent.
  • Provisional applications: These provide a priority date but do not mature into patents without further action.

The MPEP 201.01 states: ‘National applications may be filed under 35 U.S.C. 111(a) as provisional applications under 35 U.S.C. 111(b) or as nonprovisional applications under 35 U.S.C. 111(a).’ Each type has specific requirements and serves different purposes in the patent application process.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

Patent law recognizes several types of continuing applications. According to the MPEP:

A continuing application is a continuation, divisional, or continuation-in-part application filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.

The three main types of continuing applications are:

  • Continuation: Pursues additional claims to an invention disclosed in an earlier application.
  • Divisional: Separates distinct inventions from a parent application into separate applications.
  • Continuation-in-part (CIP): Adds new matter to the disclosure of the earlier application.

Each type serves different purposes in patent prosecution strategy.

For more information on divisional, visit: divisional.

For more information on patent prosecution, visit: patent prosecution.

Continued Prosecution Applications (CPAs) are specifically for design patent applications. The MPEP ¶ 2.34 refers to CPAs in the context of design applications.

The MPEP ¶ 2.34 states: “In bracket 2, insert either –continuation– or –divisional–.”

This indicates that a CPA can be filed as either a continuation or a divisional of a prior design application. It’s important to note that CPAs are no longer available for utility or plant patent applications.

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

A Continued Prosecution Application (CPA) can be filed for specific types of applications. According to MPEP 201.06(d):

Effective July 14, 2003, CPA practice under 37 CFR 1.53(d) is not available for utility and plant applications.

This means that CPAs are limited to:

  • Design applications: Applications for design patents can be filed as CPAs.
  • Continuation applications: These must be based on an earlier application of the same type (i.e., design).
  • Divisional applications: These must also be based on an earlier design application.

It’s important to note that continuation-in-part (CIP) applications cannot be filed as CPAs. Additionally, utility and plant patent applications are no longer eligible for CPA practice since July 14, 2003.

For more information on continuation applications, visit: continuation applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

According to MPEP 201.01, national applications include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Reexamination proceedings

The MPEP specifically states:

‘National applications include original (nonprovisional) applications, reissue applications, and reexamination proceedings.’

Each of these types serves a different purpose in the patent process. Original applications are for new inventions, reissue applications are for correcting errors in existing patents, and reexamination proceedings are for reviewing the validity of granted patents.

For more information on reissue applications, visit: reissue applications.

During patent prosecution, several types of affidavits or declarations may be filed. MPEP ¶ 2.03 mentions three common types:

“Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application…”

These affidavits serve different purposes:

  • 37 CFR 1.130: Declarations of attribution or prior public disclosure
  • 37 CFR 1.131: Affidavits of prior invention to overcome cited art
  • 37 CFR 1.132: Affidavits traversing rejections or objections

Each of these affidavits provides specific evidence to support the patentability of an invention or to overcome rejections made by the patent examiner.

For more information on patent prosecution, visit: patent prosecution.

MPEP ¶ 2.03 mentions several types of affidavits or declarations that may be submitted during patent prosecution. Specifically, it refers to:

  • Affidavits or declarations under 37 CFR 1.130 (Declaration of Attribution or Prior Public Disclosure under the AIA)
  • Affidavits or declarations under 37 CFR 1.131 (Affidavit or Declaration of Prior Invention to Overcome Cited Patent or Publication)
  • Affidavits or declarations under 37 CFR 1.132 (Affidavits Traversing Rejections or Objections)

These affidavits or declarations are commonly used to overcome rejections or provide evidence during patent prosecution.

For more information on patent prosecution, visit: patent prosecution.

Common types of affidavits or declarations filed in patent applications include those submitted under specific sections of the Code of Federal Regulations. As mentioned in MPEP ¶ 2.03, these include:

  • 37 CFR 1.130: Declarations of attribution or prior public disclosure under the AIA
  • 37 CFR 1.131: Affidavits of prior invention to overcome cited patents or publications
  • 37 CFR 1.132: Affidavits or declarations traversing rejections or objections

These affidavits or declarations serve various purposes in patent prosecution, such as establishing inventorship, overcoming prior art, or addressing examiner rejections.

For more information on patent prosecution, visit: patent prosecution.

To claim the benefit of a prior application’s filing date for a divisional application, applicants must follow specific procedures. The MPEP ¶ 2.01 provides guidance:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This means applicants should:

  • Review 35 U.S.C. 120 for statutory requirements
  • Consult MPEP § 211 for detailed guidance on claiming benefit
  • Follow the procedures outlined in 37 CFR 1.78 for claiming benefit of an earlier-filed application

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the divisional application.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO procedures, visit: USPTO procedures.

Patent examiners should carefully evaluate applications that may potentially be continuations. The MPEP ¶ 2.05 provides guidance:

“This form paragraph should only be used if it appears that the application may be a continuation, but a benefit claim has not been properly established.”

Examiners should look for applications that disclose and claim only subject matter from a prior application and name at least one common inventor. If these conditions are met but a proper benefit claim is missing, examiners may use the specified form paragraph to notify the applicant of the possible continuation status and the need to establish a benefit claim if desired.

Patent examiners should consider several factors when determining if an application may be a continuation. The MPEP ¶ 2.05 provides guidance:

“This form paragraph should only be used if it appears that the application may be a continuation, but a benefit claim has not been properly established.”

Examiners should look for:

  • Disclosure of only subject matter from the prior application
  • Claims to subject matter disclosed in the prior application
  • At least one common inventor with the prior application
  • Proper benefit claim to the prior application

If these elements are present but the benefit claim is not properly established, examiners may use the form paragraph to notify the applicant.

For more information on continuation application, visit: continuation application.

In the first Office action of a Continued Prosecution Application (CPA), examiners should include specific information to advise the applicant about the status of their application. The MPEP ¶ 2.35 provides guidance on this matter:

Use this form paragraph in the first Office action of a CPA to advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request and the CPA is acceptable and that a CPA has been established.

This notice is crucial because:

  • Applicants are not notified of the abandonment of the parent application
  • A filing receipt is not normally sent for a CPA

By including this information, examiners ensure that applicants are fully informed about the status and treatment of their CPA request.

For more information on design patents, visit: design patents.

When a patent examiner encounters an application that appears to be a divisional but lacks a proper benefit claim, they should follow the guidance provided in MPEP ¶ 2.01. The MPEP states:

“This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.”

In such cases, the examiner should:

  1. Recognize that the application may potentially be a divisional based on its content and relationship to a prior application.
  2. Note that the applicant has not properly established a benefit claim to the prior application.
  3. Use the appropriate form paragraph (as mentioned in MPEP ¶ 2.01) to inform the applicant about the potential divisional status and the need to establish a proper benefit claim.
  4. Direct the applicant’s attention to the relevant laws and regulations for claiming benefit, specifically: 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

By following these steps, the examiner ensures that the applicant is aware of the potential divisional status and has the opportunity to properly establish the benefit claim if desired.

For more information on Divisional application, visit: Divisional application.

What is the time limit for filing a divisional application?

There is no specific time limit for filing a divisional application, but there are important considerations that effectively create a practical time frame:

  1. Parent Application Status: The divisional application must be filed while the parent application is still pending. Once the parent application is either abandoned or issued as a patent, it’s no longer possible to file a divisional from it.
  2. Priority Claim: To claim the benefit of the parent application’s filing date, the divisional must be filed within the time periods specified in 35 U.S.C. 120, 121, 365(c), or 386(c).
  3. Patent Term: The 20-year patent term is calculated from the earliest non-provisional U.S. filing date. Filing a divisional later in the parent’s pendency will result in a shorter potential patent term for the divisional.

The MPEP 201.06 states:

A divisional application is often filed as a result of a restriction requirement made by the examiner.

While this doesn’t specify a time limit, it implies that divisional applications are typically filed in response to office actions during the examination process. Applicants should consider filing a divisional promptly after receiving a restriction requirement to ensure they don’t miss any deadlines and to maximize the potential patent term.

For more information on Divisional application, visit: Divisional application.

For more information on filing deadline, visit: filing deadline.

For a Continued Prosecution Application (CPA), the specific reference requirement under 35 U.S.C. 120 is satisfied by the CPA request itself. According to MPEP § 201.06(d):

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that when you file a CPA request, it automatically serves as the required reference to the prior application under 35 U.S.C. 120. No additional amendments or references in the specification are necessary to establish this connection.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on specific reference, visit: specific reference.

For a Continued Prosecution Application (CPA), the specific reference required by 35 U.S.C. 120 is the CPA request itself. This is explicitly stated in 37 CFR 1.53(d)(7).

According to MPEP ¶ 2.34:

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that when you file a CPA, the request itself serves as the necessary reference to the prior application, eliminating the need for additional amendments to the specification to establish continuity.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on specific reference, visit: specific reference.

The term ‘original application’ has a specific meaning in patent law, as outlined in MPEP 201.02:

‘Original’ application is used in the patent statutes and rules to refer to an application which is not a reissue application. An original application may be a first filing or a continuing application.

This definition is significant because it distinguishes original applications from reissue applications, which are used to correct errors in already-granted patents. Original applications encompass:

  • First-time filings of new inventions
  • Continuing applications (continuations, divisionals, and continuations-in-part)

Understanding this term is crucial for patent applicants and examiners, as it affects how an application is processed and what rights it may claim, particularly in terms of priority dates and the scope of patent protection.

For more information on patent application types, visit: patent application types.

For more information on patent procedure, visit: patent procedure.

What is the significance of the term ‘nonprovisional’ in patent applications?

The term ‘nonprovisional’ in patent applications is significant because it distinguishes these applications from provisional applications:

  • Examination: Nonprovisional applications undergo substantive examination by the USPTO, while provisional applications do not.
  • Patent Grant: Only nonprovisional applications can mature into granted patents.
  • Duration: Nonprovisional applications have a standard 20-year term from the filing date, while provisional applications expire after 12 months.
  • Content Requirements: Nonprovisional applications must include formal patent claims and other specific elements not required in provisional applications.

The MPEP 201.01 mentions nonprovisional applications in the context of original applications: ‘Original applications include all applications other than reissue applications. Original applications may be nonprovisional or provisional.’

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on patent grant, visit: patent grant.

For more information on provisional application, visit: provisional application.

What is the significance of the term ‘copending’ in continuation applications?

The term ‘copending’ is crucial in the context of continuation applications. According to MPEP 201.07:

A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.

The significance of ‘copending’ is as follows:

  • Timing: It means that the continuation application must be filed before the prior application is patented, abandoned, or terminated.
  • Continuous chain: It ensures a continuous chain of pending applications, maintaining the priority date of the original filing.
  • Benefit claims: Copendency is required for a continuation to claim the benefit of the earlier filing date of the parent application.

If applications are not copending, the continuation may lose the benefit of the earlier filing date, potentially affecting patentability if intervening prior art exists.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

What is the significance of the term ‘carved out’ in relation to divisional applications?

The term ‘carved out’ is significant in understanding the nature of divisional applications. According to MPEP 201.06: ‘A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.”

The significance of ‘carved out’ includes:

  • It implies that the divisional application is derived from a portion of the parent application.
  • The divisional application focuses on a specific invention or set of claims that are distinct from those in the parent application.
  • The subject matter in the divisional is entirely based on the disclosure in the parent application.
  • No new matter can be added to the divisional application beyond what was disclosed in the parent.

This term emphasizes that while the divisional application is separate, it is intrinsically linked to the parent application’s original disclosure, ensuring that the applicant doesn’t gain an unfair advantage by introducing new subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent filing, visit: patent filing.

The filing date mentioned in MPEP ¶ 2.05 is significant because it establishes the priority date for the continuation application. The MPEP states:

“This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application.” (MPEP ¶ 2.05)

The significance of the filing date [2] includes:

  • Establishing the priority date for the continuation application
  • Determining the relevant prior art for examination
  • Calculating patent term adjustments
  • Assessing eligibility for certain types of patent term extensions

By referencing the filing date of the prior application, the continuation application can benefit from the earlier filing date, potentially providing an advantage in terms of patentability and patent term.

For more information on continuation application, visit: continuation application.

What is the significance of the filing date in a divisional application?

The filing date of a divisional application is crucial for several reasons:

  • Benefit of earlier filing date: A divisional application is entitled to the benefit of the filing date of the prior-filed application, as stated in MPEP 201.06(c): ‘A divisional application is entitled to the benefit of the filing date of the prior-filed application if filed before the patenting or abandonment of or termination of proceedings on the prior-filed application.’
  • Prior art considerations: The earlier filing date can be used to overcome prior art references that might otherwise be applicable.
  • Patent term calculations: The filing date may affect the calculation of the patent term.
  • Priority claims: It establishes the basis for any priority claims to foreign applications.

It’s important to note that the divisional application must be filed while the parent application is still pending to claim the benefit of the earlier filing date.

For more information on Divisional application, visit: Divisional application.

For more information on patent term, visit: patent term.

For more information on prior art, visit: prior art.

The filing date of a Continued Prosecution Application (CPA) is significant for several reasons. In the context of inventorship, the MPEP ¶ 2.33 mentions:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

The filing date [2] is important because:

  • It establishes the effective date for the CPA.
  • It determines the timeline for filing certain documents, such as inventor oaths or declarations.
  • It affects the calculation of patent term adjustment.
  • It’s used as a reference point for determining whether changes to inventorship were properly requested.

Always keep the CPA filing date in mind when managing patent application procedures and deadlines.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

What is the significance of the ‘original disclosure’ in a divisional application?

The ‘original disclosure’ is crucial in a divisional application because it defines the scope of what can be included in the divisional. According to MPEP 201.06:

‘The disclosure of a divisional application must be the same as the disclosure of the prior-filed application, i.e., the original disclosure of the parent or original nonprovisional application or provisional application.’

This means that no new matter can be added to a divisional application. The divisional must rely entirely on the content disclosed in the original parent application. This ensures that the divisional application doesn’t extend beyond the scope of what was initially invented and disclosed.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

Filing dates are crucial in patent law as they establish priority and can affect the patentability of an invention. The MPEP 201.02 discusses various application types and their relationship to filing dates:

  • Original applications (including first filings and continuing applications) generally retain their filing date for priority purposes.
  • Continuing applications (continuations, divisionals, and continuations-in-part) can benefit from the filing date of the parent application under specific conditions outlined in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.
  • Substitute applications, however, do not obtain the benefit of the filing date of the prior application.

The MPEP states:

A substitute application does not obtain the benefit of the filing date of the prior application.

This emphasizes the importance of maintaining active applications and understanding the implications of different application types on priority dates.

For more information on continuing applications, visit: continuing applications.

For more information on patent applications, visit: patent applications.

What is the significance of copendency in continuation applications?

Copendency is a crucial requirement for continuation applications. It refers to the condition where the continuation application is filed before the prior application is patented, abandoned, or terminated. The MPEP 201.07 states:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement; and the later-filed application must be copending with the prior application.’

The significance of copendency includes:

  • Maintaining Priority: It ensures the continuation application can claim the benefit of the earlier filing date.
  • Unbroken Chain: It maintains an unbroken chain of applications, which is essential for establishing a continuous line of priority.
  • Preventing Loss of Rights: Filing a continuation before the parent application is concluded prevents the loss of patent rights that could occur if new claims are needed after the parent application is no longer pending.

Failure to maintain copendency can result in the loss of the earlier priority date, potentially affecting the patentability of the invention if intervening prior art exists.

For more information on continuation application, visit: continuation application.

For more information on copendency, visit: copendency.

For more information on patent priority, visit: patent priority.

Claiming benefit to a prior application is crucial for divisional applications as it allows the divisional to retain the earlier filing date of the parent application. This can be significant for:

  • Establishing priority over potential prior art
  • Extending the potential patent term
  • Maintaining continuity in the patent family

The MPEP ¶ 2.01 states:

“Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

To properly claim this benefit, applicants must comply with the requirements set forth in 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211, which include making a proper benefit claim and ensuring continuity of disclosure.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Adding new disclosure in a continuation-in-part (CIP) application is a key characteristic that distinguishes it from other types of continuing applications. The MPEP ¶ 2.06 describes a CIP as an application that:

repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application.

The significance of adding new disclosure includes:

  • Allowing applicants to expand on their original invention with new developments or improvements
  • Potentially broadening the scope of patent protection
  • Creating a new filing date for the added material, which can be crucial for overcoming prior art
  • Possibly extending the patent term for the new material

However, it’s important to note that the new disclosure will not benefit from the earlier filing date of the prior application. This can affect patentability if relevant prior art emerges between the filing dates of the original application and the CIP.

For more information on prior art, visit: prior art.

Tags: prior art

What is the significance of a national application being made under 35 U.S.C. 111?

A national application made under 35 U.S.C. 111 signifies that it is filed directly with the United States Patent and Trademark Office (USPTO) and follows the standard U.S. patent application process.

The MPEP 201.01 states: ‘A national application is one that was filed in the United States Patent and Trademark Office (USPTO) under 35 U.S.C. 111.’ This means that the application is subject to U.S. patent laws and procedures from the outset.

Applications filed under 35 U.S.C. 111 include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Design applications
  • Plant applications
  • Provisional applications

These applications are distinct from international applications that enter the national stage in the U.S. under 35 U.S.C. 371.

For more information on patent application types, visit: patent application types.

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

Applications filed under 37 CFR 1.53(d) have a unique treatment of affidavits and declarations. According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

Key points about 37 CFR 1.53(d) applications:

  • They are continuation or divisional applications of a nonprovisional application
  • Affidavits and declarations from the parent application are automatically incorporated
  • This includes documents submitted under 37 CFR 1.130, 1.131, and 1.132
  • No additional action is required to include these documents in the new application

This automatic incorporation simplifies the process for applicants filing continuation or divisional applications under 37 CFR 1.53(d).

For more information on continuation applications, visit: continuation applications.

For more information on patent prosecution, visit: patent prosecution.

35 U.S.C. 111(a) and (b) are important sections of the patent law that define two different types of national patent applications. According to MPEP 201.01:

‘National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’

To elaborate:

  • 35 U.S.C. 111(a) refers to nonprovisional applications. These are full patent applications that can potentially result in an issued patent.
  • 35 U.S.C. 111(b) refers to provisional applications. These are simplified applications that establish a priority date but do not themselves result in an issued patent.

The choice between filing under 111(a) or 111(b) depends on the inventor’s strategy and readiness to pursue full patent protection. Provisional applications (111(b)) provide a way to quickly establish a priority date, while nonprovisional applications (111(a)) begin the formal examination process.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

The examiner plays a crucial role in processing requests to delete a named inventor in a Continued Prosecution Application (CPA) for design applications. According to MPEP ¶ 2.32, the examiner is responsible for acknowledging the receipt of the request and confirming that the inventorship has been corrected. The MPEP provides the following guidance for examiners:

“Examiner Note: 1. Use this form paragraph where a Continued Prosecution Application (CPA) is filed accompanied by a statement requesting deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the new application.”

The examiner must verify that the request was submitted with the CPA filing and use the appropriate form paragraph to acknowledge the correction of inventorship. If the request is made after the CPA filing, the examiner must ensure it’s accompanied by a request under 37 CFR 1.48, as per the MPEP instructions.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent procedure, visit: patent procedure.

What is the relationship between a provisional application and a nonprovisional application?

A provisional application serves as a placeholder for a later-filed nonprovisional application. According to MPEP 201.04:

“A provisional application may serve as a basis for claiming benefit under 35 U.S.C. 119(e) in a later filed nonprovisional application or an international application designating the United States.”

This means that a provisional application can establish an earlier filing date for a subsequent nonprovisional application, provided the nonprovisional is filed within 12 months of the provisional and properly claims benefit to it.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

What is the relationship between a divisional application and a continuation application?

Divisional applications and continuation applications are both types of continuing applications, but they serve different purposes. The MPEP 201.06 provides insight into the nature of divisional applications:

“A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.'”

In contrast, a continuation application typically contains the same disclosure as the parent application but with different claims. The key differences are:

  • Divisional Application: Filed to pursue distinct inventions that were subject to a restriction requirement in the parent application.
  • Continuation Application: Filed to pursue additional aspects of the same invention disclosed in the parent application.

Both types of applications claim the benefit of the parent application’s filing date, but they differ in their purpose and the scope of claims they can contain. It’s important to choose the appropriate type of continuing application based on the specific circumstances and inventive concepts you wish to protect.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

What is the relationship between a continuation-in-part application and its parent application?

A continuation-in-part (CIP) application is a type of patent application that has a unique relationship with its parent application. According to MPEP 201.08:

“A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.”

This means that a CIP application:

  • Contains some or all of the subject matter from the parent application
  • Introduces new subject matter not present in the parent application
  • Must be filed while the parent application is still pending

The relationship between a CIP and its parent is important for determining priority dates and the scope of patent protection.

For more information on new matter, visit: new matter.

For more information on parent application, visit: parent application.

The purpose of MPEP ¶ 2.33 is to provide guidance to patent examiners when they encounter a situation where a new inventor is identified in a Continued Prosecution Application (CPA) for design applications. It states:

Use this form paragraph where a request for a Continued Prosecution Application (CPA) identifies one or more inventors who were not named as inventors in the prior application on the filing date of the CPA.

This paragraph helps examiners address situations where applicants have named new inventors in a CPA without following the proper procedure. It reminds both examiners and applicants that a formal request under 37 CFR 1.48 is required to change inventorship, even in a CPA.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

MPEP ¶ 2.32 provides guidance for patent examiners on how to acknowledge and process requests to delete a named inventor in Continued Prosecution Applications (CPAs) for design patents. The paragraph serves several purposes:

  • It offers a standardized response for examiners to use when acknowledging the receipt of a request to delete an inventor.
  • It confirms that the inventorship has been corrected as requested.
  • It clarifies the timing and procedure for inventor deletion requests in CPAs.

The paragraph states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This standardized language ensures consistency in USPTO communications and helps applicants understand that their request has been processed successfully.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

MPEP ¶ 2.32 provides guidance for patent examiners on how to respond to requests for deleting a named inventor in a Continued Prosecution Application (CPA) for design patents. The paragraph serves several purposes:

  • It offers a template for examiners to acknowledge receipt of a statement requesting inventor deletion.
  • It confirms that the inventorship has been corrected as requested.
  • It clarifies the timing and requirements for inventorship changes in CPAs.

The paragraph states: Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This standardized language ensures consistent communication between the USPTO and applicants regarding inventorship changes in CPAs.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

MPEP ¶ 2.05 Possible Status as Continuation serves as a guideline for patent examiners when handling applications that may qualify as continuations. Its primary purpose is to:

  • Instruct examiners on how to handle applications that disclose and claim only subject matter disclosed in a prior application
  • Provide language for examiners to use when notifying applicants about the possible status of their application as a continuation
  • Ensure proper classification and processing of continuation applications

The MPEP states: “This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application. Accordingly, this application may constitute a continuation or division.” (MPEP ¶ 2.05)

This guidance helps maintain consistency in the examination process and ensures that applicants are properly informed about the potential status of their applications.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

Filing a continuation application serves several important purposes in patent prosecution. The MPEP indicates:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

Key reasons for filing a continuation include:

  • Pursuing broader or different claim scope based on the same disclosure
  • Addressing remaining rejections or objections from the parent application
  • Submitting new evidence or arguments to overcome prior art rejections
  • Maintaining pendency for ongoing improvements or to counter competitor activities
  • Separating distinct inventions identified during examination of the parent

Continuations allow applicants to refine their patent strategy while maintaining the priority date of the original filing, which can be crucial in fast-moving technological fields.

For more information on continuation application, visit: continuation application.

For more information on patent strategy, visit: patent strategy.

What is the purpose of a divisional application under 37 CFR 1.53(b)?

A divisional application under 37 CFR 1.53(b) serves to pursue claims to a distinct invention that was disclosed but not claimed in a parent application. According to the MPEP:

“A divisional application is often filed as a result of a restriction requirement made by the examiner.”

This allows inventors to protect multiple inventions that may have been included in a single original application but were deemed to be separate and distinct by the USPTO. Divisional applications maintain the benefit of the filing date of the parent application for the common subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on patent filing, visit: patent filing.

What is the purpose of a divisional application in patent law?

A divisional application is a type of patent application that allows an inventor to pursue protection for different aspects of an invention that were disclosed but not claimed in a parent application. According to MPEP 201.06:

A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.’

The main purposes of a divisional application are:

  • To protect multiple inventions disclosed in a single parent application
  • To respond to a restriction requirement issued by the USPTO
  • To pursue broader or different claim scope than what was allowed in the parent application

Divisional applications are filed under 37 CFR 1.53(b) and can benefit from the filing date of the parent application for the common subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

The proper procedure for correcting inventorship in a Continued Prosecution Application (CPA) is to file a request under 37 CFR 1.48. This applies whether you’re adding or removing an inventor. The MPEP guidance states: ‘Any request to add an inventor must be in the form of a request under 37 CFR 1.48.’ This formal request ensures that the USPTO properly processes and recognizes the change in inventorship.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

The legal basis for denying amendments to Continued Prosecution Application (CPA) specifications that attempt to reference prior applications stems from both federal regulations and patent law. Specifically:

  • 37 CFR 1.53(d)(7): This regulation establishes that a CPA request itself serves as the specific reference required by 35 U.S.C. 120.
  • 35 U.S.C. 120: This statute outlines the requirements for claiming the benefit of an earlier filing date in the United States.

According to MPEP ¶ 2.34:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.

This means that the CPA filing itself legally establishes the necessary connection to the prior application, making any specification amendment both redundant and impermissible.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on patent law, visit: patent law.

The Hague Agreement Concerning International Registration of Industrial Designs is an international treaty that allows applicants to file a single international design application to seek protection in multiple countries. The United States became a party to the Hague Agreement on May 13, 2015.

According to 35 U.S.C. 385:

An international design application designating the United States shall have the effect, for all purposes, from its filing date determined in accordance with section 384, of an application for patent filed in the Patent and Trademark Office pursuant to chapter 16.

This means that an international design application that designates the US is treated similarly to a national design patent application. The MPEP clarifies: Unless otherwise clear from the wording, reference to ‘design application’ or ‘application for a design patent’ in this chapter includes an international design application that designates the United States.

For detailed information on international design applications, refer to MPEP Chapter 2900.

For more information on design patents, visit: design patents.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on international design applications, visit: international design applications.

The Hague Agreement Concerning International Registration of Industrial Designs is an international treaty that allows applicants to file a single international design application with effect in multiple countries. Key points about the Hague Agreement and international design applications include:

  • The United States became a Contracting Party to the Hague Agreement on May 13, 2015.
  • An international design application designating the United States has the effect of a regularly filed application for patent under 35 U.S.C. 385.
  • The Hague Agreement is administered by the International Bureau of the World Intellectual Property Organization (WIPO).
  • 37 CFR 1.9(n) defines an international design application as “an application for international registration of a design filed under the Hague Agreement.”

For detailed information on international design applications, refer to MPEP Chapter 2900.

To learn more:

What is the filing deadline for a continuation application?

A continuation application must be filed before the patenting, abandonment, or termination of proceedings on the prior application. The MPEP 201.07 states:

“To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

Key points to remember:

  • There is no specific time limit for filing a continuation as long as the parent application is still pending.
  • The continuation must be filed before the parent application is patented, abandoned, or otherwise terminated.
  • If you want to file after the parent is patented, you must file a reissue application instead.

It’s crucial to monitor the status of the parent application closely to ensure timely filing of the continuation.

For more information on continuation application, visit: continuation application.

For more information on filing deadline, visit: filing deadline.

What is the filing date requirement for a divisional application?

A divisional application must be filed before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention. The MPEP states:

A divisional application is often filed as a result of a restriction requirement made by the examiner. The divisional application may be filed under 37 CFR 1.53(b) (or 1.53(d) if the application is a design application) before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention.”

This means that the divisional application must be filed while the parent application is still pending, ensuring continuity in the examination process.

For more information on Divisional application, visit: Divisional application.

For more information on patent procedure, visit: patent procedure.

The filing date of a nonprovisional application under 37 CFR 1.53(b) depends on the type of application and when it was filed:

  • For utility and plant applications filed on or after December 18, 2013: The filing date is the date on which the specification, with or without claims, is received in the USPTO.
  • For design applications: The filing date is the date on which the specification, including at least one claim, and any required drawings are received in the USPTO.
  • For applications filed before December 18, 2013: The filing date was the date on which the specification containing a description and at least one claim, and any required drawings were received in the USPTO.

The MPEP states:

For applications filed on or after December 18, 2013, the filing date of a nonprovisional application filed under 35 U.S.C. 111(a), other than a design patent application, is the date on which a specification, with or without claims, is received in the Office.

This change in filing date requirements was part of the implementation of the Patent Law Treaties Implementation Act of 2012.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application requirements, visit: patent application requirements.

What is the filing date of a continuation-in-part application?

The filing date of a continuation-in-part (CIP) application is the date on which the application is filed with the USPTO. According to MPEP 201.08, “A continuation-in-part application is entitled to the benefit of the filing date of an earlier nonprovisional application as to common subject matter.” However, it’s important to note that any new matter introduced in the CIP application is only entitled to the filing date of the CIP itself.

For the common subject matter, the CIP can claim the benefit of the earlier application’s filing date under 35 U.S.C. 120. This can be crucial for establishing priority and determining the relevant prior art for patentability assessments.

Incorporating by reference a prior application in a continuation or divisional application can provide important benefits:

  1. It allows the applicant to amend the continuing application to include subject matter from the prior application without the need for a petition, provided the continuing application is entitled to a filing date.
  2. For applications filed on or after September 21, 2004, it can help recover inadvertently omitted material.

The MPEP states: An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are “hereby incorporated by reference.” The statement must appear in the specification.

It’s important to note that an incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

For more information on 37 cfr 1.57, visit: 37 cfr 1.57.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on incorporation by reference, visit: incorporation by reference.

What is the effect of filing a CPA on pending appeals or interferences?

Filing a Continued Prosecution Application (CPA) has significant effects on pending appeals or interferences. According to MPEP 201.06(d):

The filing of a CPA is a specific request to expressly abandon the prior application as of the filing date granted the CPA and to continue prosecution of the prior application in the CPA.

This means that when a CPA is filed:

  • Any pending appeal in the prior application is automatically withdrawn.
  • Any pending interference proceeding in the prior application is terminated.

It’s important to note that these actions occur automatically upon the granting of a filing date to the CPA. Applicants should carefully consider the status of any pending appeals or interferences before filing a CPA, as these proceedings cannot be continued in the CPA.

For more information on CPA, visit: CPA.

For more information on patent prosecution, visit: patent prosecution.

Filing a Continued Prosecution Application (CPA) has a significant effect on the prior application. According to MPEP 201.06(d):

‘A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA.’

This means that:

  • The prior application is automatically and expressly abandoned when the CPA is filed.
  • The abandonment is effective as of the CPA filing date.
  • Any claims or amendments in the prior application that were not entered are not carried over to the CPA.

It’s important to note that while the prior application is abandoned, the CPA is a continuation of that application, maintaining continuity for purposes such as priority claims and patent term calculations.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

Filing a continuation or continuation-in-part (CIP) application does not automatically affect the status of the parent application. The parent application continues to be examined or remains patented (if already issued) independently of the child application.

Key points to note:

1. The parent application remains pending unless expressly abandoned, allowed to go abandoned, or issued as a patent.

2. Filing a continuation or CIP does not automatically abandon the parent application.

3. Prosecution can continue in both the parent and child applications simultaneously.

The MPEP states: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

However, applicants should be aware of potential double patenting issues that may arise between the parent and child applications.

A preliminary amendment filed with a continuation or divisional application can have significant effects:

  1. If present on the filing date, it is considered part of the original disclosure.
  2. It must comply with the requirements of 37 CFR 1.121 for amendments.
  3. The Office may require a substitute specification for extensive preliminary amendments.
  4. The application will be classified and assigned based on the claims that will be before the examiner after entry of the preliminary amendment.

The MPEP states: Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

However, applicants should be cautious about introducing new matter through a preliminary amendment. The MPEP advises: Where a copy of the oath or declaration from a prior application was filed in a continuation or divisional application, if the examiner determines that new matter is present relative to the prior application, the examiner should so notify the applicant in the next Office action (preferably the first Office action). The examiner should require applicant to delete the benefit claim or redesignate the application as a continuation-in-part.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

What is the effect of a continuation-in-part application on patent term?

A continuation-in-part (CIP) application can have a significant impact on patent term. According to the MPEP 201.08:

The term of a patent issuing from a continuation-in-part application may be barred or limited by any prior applications or patents from which benefit is claimed.

This means that:

  • The patent term for subject matter carried over from the parent application is calculated from the filing date of the parent application.
  • The patent term for new subject matter introduced in the CIP is calculated from the filing date of the CIP application.
  • This can result in different expiration dates for different claims within the same patent.

It’s crucial for inventors and patent practitioners to carefully consider the timing and content of CIP applications to maximize patent protection and term.

For more information on patent term, visit: patent term.

Tags: patent term

There is a significant difference in how affidavits are handled between applications filed under 37 CFR 1.53(b) and 37 CFR 1.53(d). According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

In summary:

  • For 37 CFR 1.53(b) applications: Affidavits from prior applications must be explicitly included and referenced.
  • For 37 CFR 1.53(d) applications: Affidavits from the parent nonprovisional application automatically become part of the new application.

For more information on continuation applications, visit: continuation applications.

The main difference between utility and design patents is in what they protect:

  • Utility patents protect the way an article is used and works. They cover new and useful processes, machines, manufactures, or compositions of matter.
  • Design patents protect the way an article looks. They cover new, original, and ornamental designs for an article of manufacture.

The MPEP distinguishes between these types of patents by referencing different sections of U.S. Code: utility patents are provided for by 35 U.S.C. 101, while design patents are provided for by 35 U.S.C. 171.

For more information on design patent, visit: design patent.

The process for deleting an inventor from a Continued Prosecution Application (CPA) differs depending on when the request is made:

  • At CPA Filing: You can submit a statement requesting the deletion of an inventor when filing the CPA. This is a straightforward process that doesn’t require additional paperwork.
  • After CPA Filing: If you need to delete an inventor after the CPA has been filed, you must follow a more formal procedure. The MPEP states:

    “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

This means that post-filing inventor deletions require a formal request under 37 CFR 1.48, which typically involves additional documentation and potentially fees.

For more information on CPA, visit: CPA.

Tags: CPA

The process for correcting inventorship in a Continued Prosecution Application (CPA) differs depending on when the correction is requested:

  • At CPA filing: Inventorship can be corrected by submitting a statement requesting deletion of a named inventor along with the CPA filing. This process is straightforward and does not require additional procedures.
  • After CPA filing: The MPEP states, Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48. This means additional documentation and possibly fees are required for post-filing inventorship changes.

It’s generally simpler to correct inventorship at the time of CPA filing if possible.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

The treatment of affidavits and declarations differs between applications filed under 37 CFR 1.53(b) and those filed under 37 CFR 1.53(d). According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

In summary:

  • For 37 CFR 1.53(b) applications: Affidavits from prior applications must be explicitly incorporated.
  • For 37 CFR 1.53(d) applications: Affidavits from the parent application are automatically included.

For more information on continuation applications, visit: continuation applications.

For more information on patent applications, visit: patent applications.

According to MPEP 201.02, there are important distinctions between ‘original’ and ‘substitute’ applications:

Original Application: This term is used in patent statutes and rules to refer to an application that is not a reissue application. An original application can be either a first filing or a continuing application.

Substitute Application: The MPEP defines a substitute application as follows:

A “substitute” application is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application. […] A substitute application does not obtain the benefit of the filing date of the prior application.

The key difference is that a substitute application does not retain the filing date of the prior application, unlike certain types of continuing applications.

For more information on patent filing, visit: patent filing.

For more information on substitute application, visit: substitute application.

What is the difference between a utility patent and a design patent application?

Utility patents and design patents protect different aspects of an invention, and their applications are processed differently. According to MPEP 201.02:

‘A utility application is a nonprovisional application that is not a design application. A design application is an application for a design patent.’

Key differences include:

  • Utility Patent Application:
    • Protects the functional aspects of an invention
    • Covers how an invention works or is used
    • Has a term of 20 years from the filing date
  • Design Patent Application:
    • Protects the ornamental design of a functional item
    • Covers how an invention looks
    • Has a term of 15 years from the grant date

Inventors should carefully consider which type of patent application best suits their invention’s nature and intended protection.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

For more information on USPTO, visit: USPTO.

What is the difference between a parent application and a child application in patent law?

In patent law, the terms ‘parent application’ and ‘child application’ refer to the relationship between related patent applications. According to MPEP 201.02:

“The term parent application is used to refer to the immediate prior application from which a continuing application claims priority.”

“A child application is an application that claims the benefit of an earlier filing date from a parent application.”

Key differences:

  • Parent application: The original or earlier-filed application
  • Child application: A subsequent application that claims priority from the parent
  • Child applications can be continuations, divisionals, or continuations-in-part
  • The parent-child relationship establishes a priority claim under 35 U.S.C. 120

Understanding this relationship is crucial for determining priority dates and the scope of patent protection in related applications.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on parent application, visit: parent application.

For more information on patent application types, visit: patent application types.

The terms ‘national application,’ ‘provisional application,’ and ‘nonprovisional application’ are defined in 37 CFR 1.9(a). Specifically:

  • A national application refers to a U.S. patent application that is not an international application.
  • A provisional application is a type of patent application that allows filing without a formal patent claim or any information disclosure statement.
  • A nonprovisional application is a regular patent application that includes a specification, claims, and other formal requirements.

These definitions help distinguish between different types of patent applications in the U.S. patent system.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

A national application is filed directly with the United States Patent and Trademark Office (USPTO) under U.S. patent laws, while an international application is filed under the Patent Cooperation Treaty (PCT).

According to MPEP 201.01: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’ These applications are processed solely within the U.S. patent system.

International applications, on the other hand, are filed under the PCT and can potentially lead to patent protection in multiple countries. They enter the national phase in individual countries at a later stage.

For more information on USPTO, visit: USPTO.

Tags: USPTO

MPEP 201.01 distinguishes between national applications and international applications:

  • National applications are filed directly with the USPTO under 35 U.S.C. 111(a) or enter the national stage from an international application after complying with 35 U.S.C. 371.
  • International applications are filed under the Patent Cooperation Treaty (PCT).

The MPEP states: The term ‘national application’ as used in this title refers to a U.S. national application for patent which was either filed in the Office under 35 U.S.C. 111, or which entered the national stage from an international application after compliance with 35 U.S.C. 371. (MPEP 201.01)

International applications become national applications when they enter the national stage in a specific country, such as the United States. This process involves meeting the requirements of 35 U.S.C. 371.

For more information on international applications, visit: international applications.

For more information on national stage entry, visit: national stage entry.

What is the difference between a divisional and a continuation application?

While both divisional and continuation applications are types of continuing applications, they serve different purposes:

  • Divisional Application: Filed to pursue claims to an invention that was not elected in a previous application due to a restriction requirement.
  • Continuation Application: Filed to pursue additional claims to the same invention disclosed in the parent application.

The MPEP 201.06(c) states: “A divisional application is often filed as a result of a restriction requirement made by the examiner.” In contrast, a continuation typically doesn’t arise from a restriction requirement but rather from the applicant’s desire to pursue additional aspects of the same invention.

Both types can be filed under 37 CFR 1.53(b) and may claim the benefit of the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

There is a significant difference in how Continued Prosecution Applications (CPAs) are treated for utility/plant applications versus design applications. According to the examiner’s note in MPEP ¶ 2.35:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

This indicates that for utility or plant applications, an improper CPA request is treated as a Request for Continued Examination (RCE). However, for design applications, CPA requests are generally accepted and processed as described in MPEP ¶ 2.35. This distinction is important for applicants to understand when considering their continued prosecution options.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

Continued Prosecution Applications (CPAs) are primarily used for design patent applications. For utility or plant applications, improper CPA requests are typically treated as Requests for Continued Examination (RCE). The MPEP ¶ 2.35 notes:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

This distinction is important for applicants to understand when considering their options for continuing prosecution of their patent applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

Continued Prosecution Applications (CPAs) and Requests for Continued Examination (RCEs) are both methods to continue prosecution of a patent application, but they have different uses and applications:

  • CPAs are primarily used for design patent applications, as indicated in MPEP ¶ 2.30.
  • RCEs are used for utility and plant patent applications. The MPEP states: “If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead).”

This distinction is important because it affects how patent examiners process and respond to these continuation requests.

For more information on continued prosecution application, visit: continued prosecution application.

Continuation applications and provisional applications are distinct types of patent applications with different purposes and requirements. A key difference is noted in MPEP 201.07:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the provisional application.

This guidance also applies to continuation applications. The main differences include:

  • Continuation applications are based on nonprovisional applications and claim benefit under 35 U.S.C. 120, 121, 365(c), or 386(c)
  • Provisional applications are placeholder applications that can be claimed as priority under 35 U.S.C. 119(e)
  • Continuation applications must have the same disclosure as the parent application
  • Provisional applications do not need to meet the same formal requirements as nonprovisional applications

For specific requirements related to provisional applications, refer to MPEP § 211 et seq.

For more information on continuation application, visit: continuation application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

A continuation application and a continuation-in-part (CIP) application are both types of patent applications that claim priority to an earlier filed application, but they differ in their content:

  • Continuation application: Contains the same disclosure as the prior application without adding any new matter. As stated in MPEP 201.07: “A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.”
  • Continuation-in-part (CIP) application: Repeats a substantial portion of the prior application but also adds new matter not disclosed in the prior application.

The key difference is that a continuation application does not introduce new subject matter, while a CIP application does.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

The main difference between applications filed under 35 U.S.C. 111(a) and 111(b) lies in their purpose and requirements. According to MPEP 201.01:

  • 35 U.S.C. 111(a) applications: These are for original (nonprovisional) patents. They require a specification, at least one claim, and drawings (when necessary).
  • 35 U.S.C. 111(b) applications: These are for provisional patents. They do not require claims and are not examined on their merits.

The key differences are:

  1. Examination: 111(a) applications undergo full examination, while 111(b) applications do not.
  2. Duration: 111(a) applications can lead to granted patents, while 111(b) applications expire after 12 months.
  3. Requirements: 111(a) applications have stricter formal requirements, including the need for claims.

Inventors often use 111(b) provisional applications to establish an early filing date before filing a more comprehensive 111(a) nonprovisional application.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

The treatment of affidavits and declarations differs between applications filed under 37 CFR 1.53(b) and those filed under 37 CFR 1.53(d):

  • 37 CFR 1.53(b) applications: Affidavits and declarations from prior applications do not automatically become part of the new application.
  • 37 CFR 1.53(d) applications: Affidavits and declarations filed during the prosecution of the parent nonprovisional application automatically become part of the new application.

As noted in MPEP ¶ 2.03: Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.

For more information on patent applications, visit: patent applications.

A divisional application is defined in MPEP 201.06 as follows:

‘A later application for a distinct or independent invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.’

This definition highlights that a divisional application:

  • Is filed after an initial application
  • Focuses on a distinct invention
  • Only includes subject matter from the original application
  • Is ‘carved out’ of the pending parent application

For more information on Divisional application, visit: Divisional application.

For more information on patent application types, visit: patent application types.

What is the definition of a continuation-in-part application?

A continuation-in-part (CIP) application is a type of patent application that includes a portion or all of the disclosure from a prior application and adds new matter not disclosed in the prior application. The MPEP 201.08 states:

‘A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.’

This type of application allows inventors to expand upon their original invention while maintaining the priority date for the portions disclosed in the earlier application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

What is the copendency requirement for continuation applications?

The copendency requirement is a crucial aspect of filing a continuation application. According to MPEP 201.07:

‘The continuation application must be filed before the patenting or abandonment of or termination of proceedings on the prior application.’

This means that:

  • The continuation application must be filed while the parent application is still pending (not patented, abandoned, or otherwise terminated).
  • If the parent application has already been issued as a patent or has been abandoned, it’s too late to file a continuation application.
  • The continuation application can be filed on the same day that the parent application is to be issued as a patent, but it must be filed before the parent application officially becomes a patent.

Maintaining copendency is critical for preserving the benefit of the earlier filing date and ensuring the validity of the continuation application.

For more information on continuation application, visit: continuation application.

For more information on copendency, visit: copendency.

Filing a divisional application allows an applicant to pursue protection for distinct inventions disclosed in a parent application. Key benefits include:

  • Ability to claim different aspects or embodiments of the invention
  • Potential for broader patent coverage
  • Preservation of priority date for the disclosed subject matter
  • Opportunity to pursue claims that may have been restricted in the parent application

The MPEP indicates: A divisional application is often filed as a result of a restriction requirement made by the examiner. This suggests that divisional applications provide a way to pursue protection for inventions that were not elected in the parent application due to a restriction requirement.

For more information on Divisional application, visit: Divisional application.

For more information on patent strategy, visit: patent strategy.

What is the benefit of filing a divisional application under 37 CFR 1.53(b)?

Filing a divisional application under 37 CFR 1.53(b) offers several benefits:

  • It allows you to pursue claims to an invention that was not elected in a previous application due to a restriction requirement.
  • You can file the divisional application without a new oath or declaration if you meet certain conditions.
  • The divisional application can claim the benefit of the filing date of the prior application.

As stated in the MPEP: “A divisional application is often filed as a result of a restriction requirement made by the examiner.” This means you can protect additional aspects of your invention that weren’t covered in the original application.

For more information on Divisional application, visit: Divisional application.

For more information on patent filing, visit: patent filing.

Form Paragraph 2.34 is a standardized response used by patent examiners when addressing improper amendments to Continued Prosecution Applications (CPAs). According to MPEP § 201.06(d), this form paragraph is specifically used to:

“inform the applicant that an amendment to the first sentence(s) of the specification referring to the CPA as a continuing application of the prior application has not been entered and will not be entered if submitted again.”

The form paragraph explains that such amendments are unnecessary because the CPA request itself serves as the specific reference required by 35 U.S.C. 120. It helps maintain consistency in examiner responses and ensures that applicants are properly informed about the treatment of these amendments in CPA applications.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

An international design application is a specific type of patent application for industrial designs. The definition of an international design application is provided in 37 CFR 1.9(n).

Key points about international design applications:

  • They are filed under the Hague Agreement Concerning the International Registration of Industrial Designs
  • They allow applicants to seek protection for industrial designs in multiple countries through a single application
  • They are administered by the World Intellectual Property Organization (WIPO)
  • They can designate the United States for design patent protection

For more information on international design applications, visit the WIPO Hague System page.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on patent law, visit: patent law.

An international application in patent law refers to a patent application filed under the Patent Cooperation Treaty (PCT). The definition of an international application is provided in 37 CFR 1.9(b).

Key points about international applications:

  • They are filed under the PCT framework
  • They can potentially lead to patent protection in multiple countries
  • They undergo an international search and optional international preliminary examination
  • They must enter the national phase in desired countries to pursue patent protection

For more detailed information on international applications, refer to the World Intellectual Property Organization (WIPO) PCT resources.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For more information on patent law, visit: patent law.

The MPEP 201 defines an international application as follows:

“An international application is a patent application filed under the Patent Cooperation Treaty (PCT). An international application may be filed by a resident or national of the United States of America in the U.S. Patent and Trademark Office (USPTO) as a Receiving Office.”

Key points about international applications include:

  • They are governed by the Patent Cooperation Treaty (PCT).
  • They allow inventors to seek patent protection in multiple countries through a single application.
  • The USPTO can act as a Receiving Office for U.S. residents or nationals.
  • They enter a national phase in individual countries where protection is sought.

International applications provide a streamlined process for seeking patent protection in multiple countries, potentially saving time and resources for inventors and businesses operating globally.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

A utility patent application is filed under 35 U.S.C. 101 for “a new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof”. Utility patent applications are sometimes referred to as “utility” patent applications when being contrasted with plant or design patent applications.

The MPEP states: “The first type of patent application is sometimes referred to as a ‘utility’ patent application when being contrasted with a plant or design patent application.”

A substitute application is a type of national application that is filed to replace a previously filed non-provisional or provisional application. It is used when an applicant wants to start over with a new application while maintaining the benefit of the earlier filing date for common subject matter.

Key points about substitute applications:

  • They are treated as new applications and receive a new application number.
  • The previously filed application is considered to be abandoned as of the filing date of the substitute application.
  • Substitute applications can claim the benefit of the earlier application’s filing date for common subject matter.
  • They must be filed while the earlier application is still pending.
  • Applicants must file a copy of the original application, specification, drawings, and amendments, if any, and a new oath or declaration.

For more information, see MPEP 201.09 and 37 CFR 1.53.

A Request to Delete a Named Inventor in a Continued Prosecution Application (CPA) for Design Applications is a procedure that allows for the correction of inventorship when filing a CPA. This request is specifically used to remove the name(s) of person(s) who are not inventors of the invention being claimed in the new application.

According to MPEP ¶ 2.32:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This paragraph confirms that the USPTO recognizes and processes such requests when submitted with a CPA filing.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

What is a reissue patent application?

A reissue patent application is a request to correct an error in an already issued patent that renders the patent wholly or partly inoperative or invalid. As stated in MPEP 201:

An application for reissue is an application for a new patent to replace an unexpired patent that is defective in some one or more particulars.

Key aspects of reissue applications include:

  • Can be filed only by the original patent owner
  • Must be filed during the term of the original patent
  • Can broaden claim scope only within two years of the original patent grant
  • Requires a declaration stating the error and that it occurred without deceptive intent

Reissue applications are crucial for patent owners to correct mistakes or oversights in their original patents, ensuring their intellectual property rights are properly protected. However, they cannot be used to add new matter to the patent disclosure.

For more information on Patent correction, visit: Patent correction.

A reissue application is a type of patent application used to correct errors in an already issued patent. According to MPEP 201:

“An application for reissue of a patent is an application for a new patent to correct an error in an existing patent.”

Reissue applications are filed when the original patent is wholly or partly inoperative or invalid due to defective specifications, drawings, or by claiming more or less than the patentee had the right to claim. They must be filed by the original patent owner and are subject to specific requirements outlined in 35 U.S.C. 251.

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue application, visit: reissue application.

A reissue application is a type of application used to correct an error in an issued patent that renders the patent wholly or partly inoperative or invalid. It is governed by 35 U.S.C. 251 and 37 CFR 1.171-1.179. Reissue applications are typically filed when the original patent claims are too narrow or too broad, or when there are other errors that affect the scope or validity of the patent. For more information on reissue applications, refer to MPEP 1401.

A provisional application for patent is a type of U.S. patent application that allows inventors to establish an early filing date for their invention without filing a formal patent claim or any information disclosure statement. Key points about provisional applications include:

1. They provide a 12-month pendency from the date of filing.
2. They cannot be extended beyond 12 months.
3. They are not examined on their merits.
4. They can serve as a priority document in foreign filing.
5. They require a specification and drawing(s) if necessary to understand the invention.
6. They do not require formal patent claims or an oath or declaration.

Inventors must file a corresponding nonprovisional application within 12 months to claim the benefit of the provisional application’s filing date. For more details, see USPTO’s Provisional Application for Patent and MPEP 201.04(b).

A plant patent application is filed under 35 U.S.C. 161 for whoever “invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state”.

The MPEP cites 35 U.S.C. 161: “Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state, may obtain a patent therefor, subject to the conditions and requirements of this title.”

What is a PCT application in international patent law?

A PCT (Patent Cooperation Treaty) application is an international patent application that provides a unified procedure for filing patent applications to protect inventions in its contracting states. According to MPEP 201.02:

“An international application is a patent application filed under the Patent Cooperation Treaty (PCT).”

Key features of PCT applications include:

  • Single filing procedure for seeking patent protection in multiple countries
  • Standardized national phase entry at 30 months from the earliest priority date
  • International search report and written opinion on patentability
  • Option for international preliminary examination

PCT applications simplify the process of seeking patent protection internationally, providing applicants with more time and information to make decisions about pursuing patents in specific countries.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

According to MPEP 201, a nonprovisional application for patent is the standard type of patent application. The MPEP states:

“A nonprovisional application for patent filed under 35 U.S.C. 111(a) must include a specification, including a claim or claims, drawings when necessary, an oath or declaration, and the prescribed filing fee, search fee, examination fee and application size fee.”

This type of application is examined by the USPTO and can potentially lead to the grant of a patent. It requires a detailed description of the invention, claims defining the scope of protection sought, and often includes drawings to illustrate the invention.

For more information on declaration, visit: declaration.

For more information on drawings, visit: drawings.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on oath, visit: oath.

A national application, as described in MPEP 201.01, is a U.S. patent application filed under 35 U.S.C. 111(a) or 35 U.S.C. 111(b). The MPEP states: A national application may be a nonprovisional application or a provisional application. National applications are distinct from international applications and are processed directly by the United States Patent and Trademark Office (USPTO).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

According to 37 CFR 1.9(a)(1), a national application is defined as:

  • A U.S. application for patent filed in the USPTO under 35 U.S.C. 111
  • An international application filed under the Patent Cooperation Treaty in which the basic national fee under 35 U.S.C. 41(a)(1)(F) has been paid
  • An international design application filed under the Hague Agreement in which the USPTO has received a copy of the international registration pursuant to Hague Agreement Article 10

This definition encompasses various types of patent applications that are treated as national applications by the USPTO.

A divisional application under 37 CFR 1.53(b) is a type of continuation application that is filed to pursue a distinct invention that was disclosed but not claimed in a prior nonprovisional application. According to the MPEP:

‘A divisional application is often filed as a result of a restriction requirement made by the examiner.’

Divisional applications allow inventors to protect multiple inventions disclosed in a single parent application by filing separate applications for each invention.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

A divisional application is a type of patent application that claims subject matter that is independent and distinct from that claimed in a prior application. It typically arises when an original application contains multiple inventions, and the Patent Office requires the applicant to restrict the claims to a single invention.

According to MPEP ¶ 2.01, a divisional application:

“appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application, and names the inventor or at least one joint inventor named in the prior application.”

To claim the benefit of the filing date of the prior application, applicants must comply with 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

A design patent application is a type of patent application that protects the ornamental design of a functional item. It is governed by 35 U.S.C. 171-173 and focuses on the visual characteristics of an article of manufacture. Unlike utility patents, design patents do not protect the functional aspects of an invention. Design patent applications have specific requirements for drawings and claim format. For more information on design patent applications, refer to MPEP 1501.

Design patent applications and utility patent applications are two distinct types of patent applications that protect different aspects of inventions. According to MPEP 201:

  • Design Patent Application: “An application for a design patent filed under 35 U.S.C. 171 may be referred to as a design application.” Design patents protect the ornamental appearance of an article of manufacture.
  • Utility Patent Application: These applications protect the functional aspects of an invention, including processes, machines, articles of manufacture, and compositions of matter.

The key differences are:

  1. Subject Matter: Design patents cover appearance, while utility patents cover functionality.
  2. Duration: Design patents last for 15 years from issuance, while utility patents last for 20 years from the filing date.
  3. Examination Process: Design patent applications typically have a simpler examination process.

For more details on utility patents, refer to 35 U.S.C. 101, and for design patents, see 35 U.S.C. 171.

For more information on design patent, visit: design patent.

For more information on patent applications, visit: patent applications.

A Continued Prosecution Application (CPA) is a type of patent application that allows applicants to continue prosecution of a prior design application. It’s important to note that CPAs are now only available for design applications, not utility applications.

While the MPEP ¶ 2.32 doesn’t provide a direct definition of a CPA, it implies its use in the context of design applications:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

CPAs allow applicants to:

  • Continue prosecution of a previously filed design application
  • Make amendments or corrections, such as deleting a named inventor
  • Potentially receive further examination without filing a new application

For more detailed information on CPAs, refer to MPEP § 201.06(d).

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

A Continued Prosecution Application (CPA) is a type of patent application that allows applicants to continue prosecution of a parent application. It is governed by 37 CFR 1.53(d). According to MPEP ¶ 2.30, when a CPA is accepted, the examiner will use the following language:

“The request filed on [filing date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [parent application number] is acceptable and a CPA has been established.”

This indicates that the CPA has been properly filed and prosecution will continue based on the parent application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A Continued Prosecution Application (CPA) is a type of patent application specifically for design patents. It allows applicants to continue prosecution of a previously filed design application by filing a request for continued examination. CPAs are governed by 37 CFR 1.53(d) and are only available for design applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A Continued Prosecution Application (CPA) is a type of patent application specifically for design patents, filed under 37 CFR 1.53(d). It allows applicants to continue prosecution of a parent design patent application by filing a request for a CPA.

According to MPEP ¶ 2.30: The request filed on [date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [number] is acceptable and a CPA has been established. This means that when a CPA is properly filed and accepted, it continues the prosecution of the parent application while establishing a new application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

A Continued Prosecution Application (CPA) is a type of continuation or divisional application that can be filed for design patent applications under 37 CFR 1.53(d). It allows an applicant to continue prosecution of a prior design application. As stated in the MPEP:

A continuation or divisional application (but not a continuation-in-part) of a prior nonprovisional application may be filed as a continued prosecution application under this paragraph, provided that:
(i) The application is for a design patent;

CPAs can only be filed before the earliest of: payment of the issue fee, abandonment, or termination of proceedings on the prior application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

A continuation-in-part (CIP) application is an application filed during the lifetime of a prior nonprovisional application, repeating some substantial portion or all of the prior application and adding matter not disclosed in the prior application.

As stated in the MPEP:

A continuation-in-part is an application filed during the lifetime of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.

Key points about CIP applications:

  • A CIP application may only be filed under 37 CFR 1.53(b).
  • The CIP application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • A CIP application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).
  • The mere filing of a CIP application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending parent application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A continuation-in-part (CIP) application is a type of patent application that builds upon a previously filed application by including new matter not disclosed in the original application. Key points about CIP applications include:

  • They are filed while the parent application is still pending.
  • They contain a portion or all of the disclosure of the parent application.
  • They introduce new matter not present in the original application.
  • The new matter is not entitled to the priority date of the parent application.

The MPEP 201.01 states: National applications include […] continuation-in-part applications (which may be filed under 37 CFR 1.53(b)). CIP applications allow inventors to expand on their original invention while maintaining the priority date for the previously disclosed material.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A continuation application under 37 CFR 1.53(b) is a type of continuing application that discloses and claims only subject matter disclosed in a prior nonprovisional application. It is filed under 35 U.S.C. 111(a) and may be for a utility, design, or plant patent.

According to the MPEP:

A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (A) a new specification and drawings and a copy of the signed oath or declaration as filed in the prior application provided the new specification and drawings do not contain any subject matter that would have been new matter in the prior application; or (B) a new specification and drawings and a newly executed oath or declaration provided the new specification and drawings do not contain any subject matter that would have been new matter in the prior application.

The continuation application receives a new application number and filing date, but can claim the benefit of the prior application’s filing date under 35 U.S.C. 120.

For more information on continuation application, visit: continuation application.

A Conditional Request for a Continued Prosecution Application (CPA) is a filing made under 37 CFR 1.53(d) for design applications. However, it’s important to note that any “conditional” request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA. This means that even if an applicant intends the request to be conditional, the USPTO will process it as a standard CPA request.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

What is a ‘regular utility application’ in patent law?

A ‘regular utility application’ is a term used in patent law to describe a standard non-provisional patent application for a utility invention. According to MPEP 201.02, it is defined as follows:

“A ‘regular utility application’ is a non-provisional application for a utility patent filed under 35 U.S.C. 111(a).”

This type of application is the most common form of patent application filed with the USPTO. It requires a detailed description of the invention, claims defining the scope of protection sought, and often includes drawings to illustrate the invention. Regular utility applications undergo a thorough examination process to determine if they meet the requirements for patentability.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on Non-provisional application, visit: Non-provisional application.

A ‘bypass’ continuation application is a specific type of continuation application that is filed under 37 CFR 1.53(b) to ‘bypass’ the national stage of an international application. As explained in MPEP 201.06(c):

“A continuation application filed under 37 CFR 1.53(b) may be filed as a continuation of an international application designating the United States without entering the national stage under 35 U.S.C. 371. This is often referred to as a ‘bypass’ continuation application.”

This type of application allows applicants to pursue patent protection in the U.S. based on their international application without going through the formal national stage entry process. It can be advantageous in certain situations, such as when an applicant wants to modify claims or add new matter before U.S. examination.

When citing a prior application using MPEP ¶ 2.05, specific information must be included. The MPEP instructs examiners:

“In brackets 1 and 2, insert the application number (series code and serial number) and filing date of the prior application, respectively.”

This means that when referencing a prior application, the examiner should provide:

  • The application number, including both the series code and serial number
  • The filing date of the prior application

Including this information ensures clear identification of the specific prior application being referenced.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

When using Form Paragraph 2.35 in a patent examination, specific information needs to be inserted into the brackets. According to the MPEP ¶ 2.35, examiners should include the following:

  • In bracket 1: Insert the filing date of the request for a CPA.
  • In bracket 2: Insert the Application Number identified in the CPA request.

This information helps to clearly identify the specific CPA request being addressed and provides essential context for the applicant. It’s crucial for examiners to accurately fill in these brackets to ensure proper documentation and communication regarding the CPA.

When requesting to delete a named inventor in a Continued Prosecution Application (CPA) for a design patent, you should include specific information. According to MPEP ¶ 2.32, the request should contain:

  1. A clear statement requesting the deletion of the inventor(s)
  2. The name(s) of the inventor(s) to be deleted
  3. The filing date of the CPA

The MPEP provides a template for acknowledging such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

In this template, [1] represents the name(s) of the inventor(s) to be deleted, and [2] is the filing date of the CPA. Ensure your request clearly specifies these details to facilitate proper processing by the USPTO.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

When filing a Continued Prosecution Application (CPA) request, certain key information must be included. Based on MPEP ¶ 2.35, the following details are essential:

  • The filing date of the CPA request
  • The application number of the prior application

The MPEP states: “Receipt is acknowledged of the ‘conditional’ request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on prior Application No. [2].” Here, [1] represents the filing date of the CPA request, and [2] represents the application number of the prior application.

It’s important to ensure that this information is accurately provided to facilitate proper processing of the CPA request by the USPTO.

For more information on filing requirements, visit: filing requirements.

For more information on USPTO, visit: USPTO.

When referencing a prior application in a continuation-in-part (CIP), specific information must be included. According to MPEP ¶ 2.06, the examiner note states:

In brackets 1 and 2, insert the application number (series code and serial number) and filing date of the prior application, respectively.

This means that when referencing the prior application, you must include:

  • The application number (series code and serial number)
  • The filing date of the prior application

Providing this information accurately is crucial for establishing the proper relationship between the CIP and the prior application.

For more information on application number, visit: application number.

A Continued Prosecution Application (CPA) request for design patents must include specific information to be considered acceptable. According to MPEP ¶ 2.30, the key elements are:

  • The filing date of the CPA request
  • The parent application number

The MPEP states: The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. Here, [1] represents the filing date of the CPA request, and [2] is the parent application number. These details are crucial for establishing the continuity between the parent application and the CPA.

For more information on USPTO filing procedures, visit: USPTO filing procedures.

When acknowledging a Continued Prosecution Application (CPA) request, the USPTO includes specific details as outlined in MPEP ¶ 2.35. The acknowledgment typically includes:

  • The filing date of the CPA request
  • The application number of the prior application on which the CPA is based
  • A statement that the CPA request is acceptable
  • Confirmation that a CPA has been established

The MPEP provides a template for this acknowledgment: Receipt is acknowledged of the ‘conditional’ request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on prior Application No. [2].

This information helps applicants confirm that their CPA request has been received and processed correctly.

For more information on USPTO communication, visit: USPTO communication.

The first Office action of a Continued Prosecution Application (CPA) includes important information for the applicant. According to MPEP ¶ 2.35, the examiner should:

  • Advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request
  • Confirm that the CPA is acceptable and has been established
  • Provide notice that an action on the CPA follows

This information is crucial because, as stated in the MPEP, “applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.” Therefore, this Office action serves as an important communication regarding the status of the application.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

The notice of Continued Prosecution Application (CPA) establishment includes specific information as outlined in MPEP ¶ 2.30. The key elements are:

  • The filing date of the CPA request
  • The parent application number
  • A statement that the CPA is acceptable and has been established
  • An indication that an action on the CPA will follow

The exact language used by the examiner is: The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.

For more information on patent examination, visit: patent examination.

For more information on patent procedure, visit: patent procedure.

According to MPEP ¶ 2.30, a CPA acceptance notice typically includes the following information:

  • The filing date of the CPA request
  • The application number of the parent application
  • Confirmation that the CPA request is acceptable
  • Statement that a CPA has been established

The MPEP provides a template for examiners, stating: “The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.”

For more information on patent application information, visit: patent application information.

What happens to the status of the prior application when filing a CPA?

When filing a Continued Prosecution Application (CPA), the status of the prior application changes. According to MPEP 201.06(d):

The filing of a CPA is not a filing of a new application. Rather, a CPA is a continuation of the prior application and maintains the same application number as the prior application, i.e., the application number of the prior application is used as the application number for the CPA.

This means that:

  • The prior application is not abandoned
  • The CPA continues the examination process of the prior application
  • The same application number is retained for the CPA

It’s important to note that while the CPA continues the examination, it is treated as a new application for all other purposes under the patent statute and rules.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

What happens to the priority date in a divisional application?

The priority date of a divisional application remains the same as its parent application, provided that the proper procedures are followed. According to MPEP 201.06:

‘A later-filed application which is filed before the patenting or abandonment of or termination of proceedings on an earlier-filed application and which is an application for an invention which is disclosed and claimed in the earlier-filed application is an application for a ‘divisional’ of the earlier-filed application.’

This means that:

  • The divisional application retains the priority date of the parent application for the subject matter disclosed in the parent.
  • This is crucial for establishing the effective filing date for prior art purposes under 35 U.S.C. 100(i).
  • The applicant must ensure that a proper reference to the parent application is made in the divisional to maintain this priority.

Maintaining the original priority date is one of the key advantages of filing a divisional application, as it allows the applicant to protect different aspects of their invention without losing the benefit of the earlier filing date.

For more information on Divisional application, visit: Divisional application.

For more information on effective filing date, visit: effective filing date.

What happens to the parent application when a divisional application is filed?

When a divisional application is filed, the parent application continues to be prosecuted independently. The filing of a divisional application does not automatically affect the status or prosecution of the parent application.

As stated in MPEP 201.06: “The divisional application may be filed either while the original application is still pending or after it has been patented.” This means that:

  • If the parent application is pending, it remains pending and continues through the examination process.
  • If the parent application has already been granted as a patent, it remains a valid patent.

It’s important to note that while the divisional application is independent, it must contain claims to a different invention than the parent application. The examiner will ensure that there is no double patenting between the parent and divisional applications.

Additionally, if the divisional application is filed in response to a restriction requirement in the parent application, the applicant should consider canceling the claims in the parent application that are now being pursued in the divisional to avoid potential issues with duplicate claims.

For more information on Divisional application, visit: Divisional application.

For more information on parent application, visit: parent application.

For more information on patent prosecution, visit: patent prosecution.

What happens to the parent application when a continuation is filed?

Filing a continuation application does not automatically affect the status of the parent application. As stated in MPEP 201.07:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 363 while the prior application is pending, or after the prosecution and patent term adjustment time periods have expired, or after the prior application has become abandoned or issued as a patent.’

This means that:

  • If the parent application is still pending, it remains active and can continue through the examination process.
  • If the parent application has already been issued as a patent, it remains a valid patent.
  • If the parent application has been abandoned, filing a continuation does not revive it.

It’s important to note that while a continuation can be filed at various stages of the parent application’s lifecycle, the applicant may need to make strategic decisions about how to proceed with the parent application. For example:

  • They may choose to abandon the parent application in favor of the continuation.
  • They may continue prosecuting both applications simultaneously.
  • They may allow the parent to issue as a patent and use the continuation to pursue additional claims.

The choice often depends on the specific circumstances and the applicant’s patent strategy.

For more information on continuation application, visit: continuation application.

The inventorship in a Continued Prosecution Application (CPA) generally carries over from the prior application, unless specific steps are taken to change it. The MPEP states:

The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If an inventor needs to be added or deleted in a CPA after it has been filed, a request under 37 CFR 1.48 must be submitted, along with the required fee.

For more information on patent applications, visit: patent applications.

When filing a Continued Prosecution Application (CPA), previously filed Information Disclosure Statements (IDS) are handled as follows:

  • All IDSs filed in the prior application that comply with 37 CFR 1.98 are automatically considered in the CPA
  • No specific request is needed for the examiner to consider the previously submitted information
  • New IDSs can be filed in the CPA and will be considered if they comply with the content requirements and are filed before the first Office action

The MPEP states: All information disclosure statements filed in the prior application that comply with the content requirements of 37 CFR 1.98 will be considered in a CPA by the examiner. No specific request that the previously submitted information be considered in a CPA is required.

For more information on patent applications, visit: patent applications.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications. This also applies to continuation or divisional applications of applications filed before June 8, 1995. The MPEP states:

“A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.”

This change in procedure highlights the importance of using the correct application type and filing method after the deletion of 37 CFR 1.62.

What happens to continuation or divisional applications filed after a CPA in a design application?

Continuation or divisional applications filed after a Continued Prosecution Application (CPA) in a design application are treated differently than those filed after a CPA in a utility or plant application. According to MPEP 201.06(d):

Any continuation or divisional application filed under 37 CFR 1.53(b) after the filing of a CPA of a design application will be assigned a new application number and will reflect the filing date of the 37 CFR 1.53(b) application.

This means that unlike utility or plant applications, where a continuation or divisional application would get the benefit of the CPA’s filing date, in design applications, these subsequent applications are treated as new applications with their own filing dates.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

The MPEP clearly states: “All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.”

This means that applications filed under the File Wrapper Continuing Procedure before its deletion will be processed according to the rules that were in place at the time of filing. For more detailed information on these procedures, you can refer to the MPEP 8th Edition, Rev. 1 (February 2003), which is available on the USPTO website.

For more information on patent examination, visit: patent examination.

The MPEP clearly states that All continuation and divisional applications filed under 37 CFR 1.60 prior to December 1, 1997 will continue to be processed and examined under the procedures set forth in former 37 CFR 1.60. This means that if you filed a continuation or divisional application before the rule change, your application will still be handled according to the old procedures, ensuring consistency in the examination process for applications filed under the former rule.

For more information on continuation applications, visit: continuation applications.

When filing a Continued Prosecution Application (CPA), amendments and information disclosure statements (IDS) from the prior application are handled as follows:

  • Amendments: The MPEP states, “Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph.” Applicants are encouraged to file any preliminary amendments at the time of filing the CPA.
  • Information Disclosure Statements: According to the MPEP, “All information disclosure statements filed in the prior application that comply with the content requirements of 37 CFR 1.98 will be considered in a CPA by the examiner.” No specific request for consideration is required.

It’s important to note that amendments or IDSs filed after the CPA filing date could delay prosecution. The MPEP advises, “Applicants are also encouraged to file all preliminary amendments at the time of filing a CPA because the entry of any preliminary amendment filed after the filing date of the CPA could be denied under 37 CFR 1.115 if the preliminary amendment unduly interferes with the preparation of a first Office action.”

For more information on patent application procedures, visit: patent application procedures.

Affidavits or declarations from a prior application do not automatically become part of a continuation or divisional application filed under 37 CFR 1.53(b). If an applicant wants to rely on these documents, they must take specific actions:

  1. Make remarks of record in the new application referring to the affidavit or declaration.
  2. Include a copy of the original affidavit or declaration filed in the prior application.

The MPEP states: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the prior nonprovisional application do not automatically become a part of a continuation or divisional application filed under 37 CFR 1.53(b). Where it is desired to rely on an earlier filed affidavit or declaration, the applicant should make such remarks of record in the 37 CFR 1.53(b) application and include a copy of the original affidavit or declaration filed in the prior nonprovisional application.

It’s important to note that this rule doesn’t apply to continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), where affidavits and declarations do automatically become part of the new application.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

What happens to a provisional application after one year?

A provisional application automatically becomes abandoned 12 months after its filing date. The MPEP 201.04 states:

‘A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.’

This means that after the 12-month period, the provisional application cannot be revived or extended. To maintain the benefit of the provisional filing date, you must file a nonprovisional application claiming priority to the provisional within this 12-month window. If you fail to do so, you lose the benefit of the earlier filing date, and the subject matter of the provisional becomes part of the prior art.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

What happens to a provisional application after 12 months?

A provisional application automatically becomes abandoned 12 months after its filing date. The MPEP states: ‘A provisional application will automatically become abandoned 12 months after its filing date pursuant to 35 U.S.C. 111(b)(5).’ This means that:

  • The application is no longer pending
  • It cannot be revived
  • No patent will directly result from a provisional application

To benefit from the provisional application, the applicant must file a nonprovisional application claiming priority to the provisional within the 12-month period. For more details, refer to MPEP 201.04.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

What happens if you don’t file a nonprovisional application within 12 months of a provisional?

If you don’t file a nonprovisional application within 12 months of filing a provisional application, you lose the ability to claim the benefit of the provisional application’s filing date. The MPEP 201.04 states:

“A provisional application automatically becomes abandoned 12 months after its filing date and cannot claim the benefit of any other application.”

This means that after 12 months, the provisional application expires, and you can no longer use it as a basis for priority in a nonprovisional application. If you still want to pursue patent protection for your invention, you would need to file a new application, but you may have lost your priority date and any intervening prior art could potentially be used against your application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

If the basic filing fee is not paid when filing a Continued Prosecution Application (CPA), the USPTO will send a notice to the applicant. According to MPEP 201.06(d):

‘If the basic filing fee is not paid when the CPA is filed or within the time period set forth in a notice from the Office, the USPTO will send a Notice to File Missing Parts in the CPA.’

This notice gives the applicant a chance to pay the fee and continue the application process. However, it’s important to note that failing to respond to this notice or pay the required fee within the specified time frame could result in the CPA being abandoned. It’s always best practice to submit all required fees at the time of filing to avoid potential delays or complications in the patent application process.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on Notice to File Missing Parts, visit: Notice to File Missing Parts.

Introducing new matter in a divisional application is not allowed and can have serious consequences. According to MPEP 201.06:

“A divisional application is a later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application.”

This means that a divisional application must not contain any new matter beyond what was disclosed in the parent application. If new matter is introduced:

  • The new matter will not be entitled to the benefit of the parent application’s filing date.
  • Claims relying on the new matter may be rejected under 35 U.S.C. 112(a) for lack of written description or enablement.
  • The application may lose its status as a proper divisional, potentially affecting its ability to overcome certain types of double patenting rejections.

To avoid these issues:

  1. Carefully review the divisional application before filing to ensure it only contains subject matter from the parent application.
  2. If new subject matter is necessary, consider filing it as a continuation-in-part (CIP) application instead of a divisional.
  3. Consult with a patent attorney or agent to ensure compliance with MPEP guidelines.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent filing, visit: patent filing.

If you submit an amendment to reference the prior application in a Continued Prosecution Application (CPA), it will not be entered by the USPTO.

The MPEP ¶ 2.34 clearly states: “The amendment filed [1] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [2] application of Application No. [3] has not been entered.”

Furthermore, the MPEP adds: “any such amendment shall be denied entry.” This means that even if you submit such an amendment, it will be rejected, and the examiner will use this form paragraph to inform you of the denial.

If you submit an amendment to refer to a Continued Prosecution Application (CPA) as a continuation or divisional application, it will be denied entry by the patent examiner. The MPEP ¶ 2.34 states:

“Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This means that the patent examiner will not accept or incorporate such amendments into the application. The CPA itself serves as the necessary reference to the prior application, making additional amendments unnecessary and inappropriate.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

What happens if I miss the 12-month deadline for filing a nonprovisional application?

If you miss the 12-month deadline for filing a nonprovisional application claiming the benefit of a provisional application, you generally lose the ability to claim that earlier filing date. The MPEP 201.04 states:

“If a provisional application is not filed in compliance with 35 U.S.C. 119(e) and 37 CFR 1.53(c), the provisional application is not entitled to the benefit of the filing date of the provisional application.”

Consequences of missing the deadline include:

  • Loss of the earlier filing date
  • Potential issues with prior art that emerged during the 12-month period
  • Possible loss of patent rights in some jurisdictions

In some cases, you may be able to file a petition for an unintentional delay under 37 CFR 1.78(c), but this is not guaranteed and may involve additional fees. It’s crucial to monitor deadlines carefully to avoid these issues.

For more information on filing deadline, visit: filing deadline.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent priority, visit: patent priority.

For more information on provisional application, visit: provisional application.

If you identify a new inventor in a Continued Prosecution Application (CPA) without filing a request under 37 CFR 1.48, the inventorship will not be officially changed. The MPEP clearly states: ‘It is noted that [new inventor] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [filing date], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.’ In such cases, the inventorship in the CPA will remain the same as in the prior application, despite the attempt to name a new inventor.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

What happens if I file a provisional application without meeting all the requirements?

If you file a provisional application that doesn’t meet all the requirements, it may not be granted the filing date you intended. The MPEP states: If a provisional application does not contain a cover sheet identifying it as a provisional application, it will be treated as a nonprovisional application. This means:

  • Your application might be processed as a nonprovisional application, which has different requirements and fees.
  • You could lose the intended filing date, which is crucial for establishing priority.
  • The USPTO may send you a notice of missing parts, giving you a chance to correct the deficiencies.

It’s crucial to ensure all requirements are met when filing a provisional application to avoid these complications.

For more information on filing requirements, visit: filing requirements.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

What happens if I file a provisional application and don’t file a nonprovisional within 12 months?

If you file a provisional application but do not file a corresponding nonprovisional application within 12 months, the provisional application will automatically be abandoned. As stated in the MPEP 201.04: “A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.” This means you lose the benefit of the provisional filing date and cannot claim priority to it in future applications. To maintain the priority benefit, you must file a nonprovisional application claiming benefit of the provisional within the 12-month period.

For more information on application abandonment, visit: application abandonment.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

When an improper Continued Prosecution Application (CPA) is filed, the USPTO’s response depends on the type of application and the nature of the impropriety:

  • For utility or plant applications filed on or after July 14, 2003, an improper CPA is treated as a Request for Continued Examination (RCE) if possible
  • If the improper CPA doesn’t meet RCE requirements, it’s treated as an improper RCE
  • For design applications, an improper CPA may be treated as a new application under 37 CFR 1.53(b) in some circumstances
  • The Office will not automatically convert an improper CPA to an application under 37 CFR 1.53(b) without extenuating circumstances

The MPEP states: Any request for a CPA filed on or after July 14, 2003, in a utility or plant application is improper, regardless of the filing date of the utility or plant application in which the CPA is filed.

Regarding treatment as an RCE: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

If the improper CPA doesn’t meet RCE requirements: If the improper CPA does not satisfy the requirements of 37 CFR 1.114 (e.g., the request lacks a submission or the fee under 37 CFR 1.17(e), or the prosecution of the application is not closed), the Office treats the improper CPA as an improper RCE, and the time period set in the last Office action (or notice) will continue to run.

Examiners are instructed to notify supervisory staff if they discover an improper CPA has been processed: If an examiner discovers that an improper or incomplete CPA has been processed as a proper CPA in error, the examiner should immediately notify a supervisory applications examiner (SAE) or other technical support staff within the Technology Center (TC) who will reprocess the CPA and correct the application records as appropriate.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

Continued Prosecution Applications (CPAs) are only available for design patent applications. If an improper CPA is filed for a utility or plant application, the following occurs:

  • For applications filed on or after June 8, 1995, the improper CPA is treated as a Request for Continued Examination (RCE) under 37 CFR 1.114
  • If the requirements for an RCE are not met, the Office will send a Notice of Improper Request for Continued Examination (RCE)
  • For applications filed before June 8, 1995, the improper CPA cannot be treated as an RCE
  • The applicant will be notified of the improper CPA

MPEP 201.06(d) states: Any request for a CPA filed on or after July 14, 2003, in a utility or plant application is improper, regardless of the filing date of the utility or plant application in which the CPA is filed. It further notes: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on USPTO procedures, visit: USPTO procedures.

For more information on utility patents, visit: utility patents.

What happens if a provisional application is not followed by a nonprovisional application within 12 months?

If a provisional application is not followed by a nonprovisional application within 12 months, it will automatically be abandoned and cannot be revived. The MPEP 201.04 states: A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter. This means that the provisional application cannot serve as a priority document for any subsequent applications, and any potential benefit date will be lost.

For more information on provisional application, visit: provisional application.

If a provisional application is not converted to a nonprovisional application within 12 months, it automatically becomes abandoned. The MPEP 201.04 clearly states:

A provisional application automatically becomes abandoned 12 months after its filing date and cannot claim the benefit of any other application. See 35 U.S.C. 111(b)(5).

This means that after 12 months, the provisional application can no longer serve as a basis for claiming priority, and any disclosure made in the provisional application becomes part of the public domain. To maintain the benefit of the provisional filing date, applicants must file a nonprovisional application claiming the benefit of the provisional application within the 12-month period.

For more information on provisional application, visit: provisional application.

What happens if a provisional application is not converted to a nonprovisional within 12 months?

If a provisional application is not converted to a nonprovisional application within 12 months, it will automatically expire. The MPEP 201.04 states:

“A provisional application will automatically become abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.”

Once expired, the provisional application cannot be revived or restored to pending status. However, the applicant may still file a nonprovisional application after the 12-month period, but they would lose the benefit of the earlier filing date of the provisional application.

For more information on provisional application, visit: provisional application.

If a new inventor is identified in a Continued Prosecution Application (CPA) without proper documentation, it can lead to issues with the application. The MPEP ¶ 2.33 states:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

This means that if an examiner notices a new inventor listed on a CPA without the required request under 37 CFR 1.48, they will issue a notice to the applicant. The inventorship will remain the same as in the prior application until the proper request is filed and approved.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

If a new inventor is identified in a Continued Prosecution Application (CPA) without filing a proper request, it can lead to inventorship issues. The MPEP ¶ 2.33 states:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

This means that simply naming a new inventor in the CPA filing documents is not sufficient. Without a proper request under 37 CFR 1.48, the inventorship will remain the same as in the prior application, potentially leading to complications in the patent prosecution process.

For more information on CPA, visit: CPA.

Tags: CPA

If a new inventor is identified in a Continued Prosecution Application (CPA) for a design application, specific steps must be taken to properly add them to the application.

MPEP ¶ 2.33 states: “It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.”

This means that simply naming a new inventor in the CPA filing is not sufficient. A formal request under 37 CFR 1.48 must be filed to correct the inventorship. Without this request, the inventorship will remain the same as in the prior application, regardless of any new names listed on the CPA filing.

For more information on CPA, visit: CPA.

Tags: CPA

What happens if a divisional application is filed after the parent application is patented or abandoned?

If a divisional application is filed after the parent application has been patented or abandoned, it will not be entitled to the benefit of the parent application’s filing date. The MPEP states:

A divisional application is often filed as a result of a restriction requirement made by the examiner. The divisional application may be filed under 37 CFR 1.53(b) (or 1.53(d) if the application is a design application) before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention.

Filing a divisional application after the parent application has been patented or abandoned means:

  • The application will not be considered a proper divisional application
  • It will not receive the benefit of the parent application’s filing date
  • It may be treated as a new, independent application
  • Prior art that was not applicable to the parent application may now be applicable
  • The application may face potential statutory bars under 35 U.S.C. 102

To avoid these issues, it’s crucial to file divisional applications before the patenting, abandonment, or termination of proceedings on the parent application.

For more information on Divisional application, visit: Divisional application.

For more information on late filing, visit: late filing.

For more information on patent procedure, visit: patent procedure.

If a Continued Prosecution Application (CPA) request for a design patent is not submitted on a separate paper, it will be considered non-compliant and will not be processed by the USPTO.

The MPEP clearly states: ‘Because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.’ This means that the CPA will not be initiated, and the applicant will need to resubmit the request properly to proceed with the continued examination.

In such cases, the USPTO will typically send a notification to the applicant informing them of the non-compliance and providing instructions for proper submission.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

If a Continued Prosecution Application (CPA) request is improper for a utility or plant application, the USPTO handles it differently than for design applications. According to MPEP ¶ 2.35:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

In such cases, the USPTO treats the improper CPA request as a Request for Continued Examination (RCE). This approach ensures that the application can continue to be prosecuted, albeit under a different procedure. Applicants should be aware of this distinction and the potential implications for their patent prosecution strategy.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

If a Continued Prosecution Application (CPA) is improperly requested for a utility or plant patent application, it is typically treated as a Request for Continued Examination (RCE). The MPEP ¶ 2.30 provides guidance on this situation:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

In such cases, the examiner will use a different form paragraph (7.42.15) to notify the applicant that their CPA request has been treated as an RCE. This ensures that the application can continue to be examined under the appropriate procedure for utility or plant patents.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

If a Continued Prosecution Application (CPA) is filed in a utility or plant application after July 14, 2003, it will not be treated as a proper CPA. According to MPEP 201.06(d):

‘Any CPA filed on or after July 14, 2003 in a utility or plant application will automatically be treated as a request for continued examination (RCE) under 37 CFR 1.114, see MPEP § 706.07(h), paragraph II.’

This means that instead of being processed as a CPA, the application will be treated as a Request for Continued Examination (RCE). Applicants should be aware of this automatic conversion and ensure they meet the requirements for an RCE if they inadvertently file a CPA for a utility or plant application.

For more information on CPA, visit: CPA.

For more information on RCE, visit: RCE.

Tags: CPA, RCE

If a Continued Prosecution Application (CPA) is filed after the issue fee has been paid, it will not be treated as a CPA. Instead, it will be processed as follows:

  • For applications filed on or after May 29, 2000, the CPA will be treated as a request for continued examination (RCE) under 37 CFR 1.114.
  • For applications filed before May 29, 2000, the CPA will be treated as an improper application and will not be processed.

As stated in MPEP 201.06(d): “If an application is filed on or after May 29, 2000, the filing of a CPA is not permitted after payment of the issue fee. In such a case, the Office will treat the improper CPA as an RCE under 37 CFR 1.114, provided that the application is a utility or plant application filed on or after June 8, 1995.”

It’s important to note that this treatment as an RCE is only possible for utility or plant applications filed on or after June 8, 1995. For other types of applications or those filed before this date, the improper CPA filing will not be processed, and the applicant may need to consider other options, such as filing a reissue application if the patent has already issued.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on issue fee, visit: issue fee.

For more information on RCE, visit: RCE.

After a Continued Prosecution Application (CPA) is established, the USPTO proceeds with examination. According to MPEP ¶ 2.35:

Accordingly, the request for a CPA application is acceptable and a CPA has been established. An action on the CPA follows.

This means that once the CPA is established, the examiner will review the application and issue an Office action. It’s important to note that applicants are not separately notified of the abandonment of the parent application, nor is a filing receipt normally sent for a CPA.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO procedures, visit: USPTO procedures.

Once a Continued Prosecution Application (CPA) is established from a Conditional Request, the USPTO proceeds with the examination process as it would for any other CPA. According to MPEP ¶ 2.35: “An action on the CPA follows.”

This means that after the CPA is established:

  • The parent application is considered abandoned
  • The examiner will review the CPA and issue an Office action
  • The applicant should be aware that they may not receive a filing receipt for the CPA, as noted in the MPEP: “This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

37 CFR 1.62, which covered the File Wrapper Continuing Procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette: “See 1203 O.G. 63, October 21, 1997.” This deletion significantly impacted how certain continuation, divisional, and continuation-in-part applications were processed.

For more information on patent application procedures, visit: patent application procedures.

37 CFR 1.60, which previously governed the filing of divisional and continuation applications, was deleted effective December 1, 1997. As stated in the MPEP, 37 CFR 1.60 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This change significantly impacted the procedure for filing these types of applications.

For more information on continuation applications, visit: continuation applications.

MPEP 201.01 outlines several types of national applications that can be filed with the USPTO. These include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Design applications
  • Plant applications
  • Provisional applications

As stated in MPEP 201.01: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’

Each of these application types serves a specific purpose in the patent system and is subject to different rules and requirements.

For more information on design applications, visit: design applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on plant applications, visit: plant applications.

For more information on reissue applications, visit: reissue applications.

There are three main types of national applications for patents in the United States:

  • Nonprovisional applications filed under 35 U.S.C. 111(a)
  • Provisional applications filed under 35 U.S.C. 111(b)
  • International applications that have entered the national stage in the United States

As stated in MPEP 201.01: “Applications filed under 35 U.S.C. 111(a) include original nonprovisional utility, plant, design, divisional, continuation, and continuation-in-part applications filed under 37 CFR 1.53(b), reissue applications filed under 37 CFR 1.53(b), and design patent continued prosecution applications (CPAs) filed under 37 CFR 1.53(d).”

For more information on international applications, visit: international applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

According to the MPEP, patent applications can be directed to three broad types of subject matter:

  • Utility patent applications under 35 U.S.C. 101 for “a new and useful process, machine, manufacture, or composition of matter”
  • Plant patent applications under 35 U.S.C. 161
  • Design patent applications under 35 U.S.C. 171

The MPEP 201.01 mentions several special types of national applications:

1. Provisional applications (35 U.S.C. 111(b))
2. Reissue applications (35 U.S.C. 251)
3. Design applications (35 U.S.C. 171)
4. Plant applications (35 U.S.C. 161)

These applications have specific requirements and purposes. For example, provisional applications provide a way to establish an early effective filing date, while reissue applications allow for the correction of errors in issued patents. Design applications protect ornamental designs, and plant applications are for new varieties of plants.

For more details on these special application types, refer to the following MPEP sections:
MPEP 201.04 – Provisional Application
MPEP 1400 – Reissue
MPEP 1500 – Design Patents
MPEP 1600 – Plant Patents

The signature requirements for filing a Continued Prosecution Application (CPA) are specific and important. According to MPEP 201.06(d):

A Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) must be signed by a person authorized to prosecute the application, except as provided in 37 CFR 1.33(b).

This means that:

  • The CPA must be signed by someone authorized to prosecute the application.
  • Typically, this would be the applicant or the applicant’s patent attorney or agent.
  • There are exceptions outlined in 37 CFR 1.33(b), which allow for certain communications to be signed by other parties in specific circumstances.

It’s crucial to ensure that the proper signature is provided when filing a CPA to avoid potential issues with the application’s acceptance or processing.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

The signature requirements for a Continued Prosecution Application (CPA) request are specific and important to ensure proper filing. According to MPEP 201.06(d):

  • The request for a CPA must be signed by a person authorized to prosecute the prior application.
  • This includes:
    • A registered patent practitioner
    • The applicant (inventor or assignee of the entire interest)
  • The signature can be provided through any of the approved signature methods outlined in 37 CFR 1.4(d).

The MPEP states: ‘A request for a CPA may only be signed by a person authorized to prosecute the application as set forth in 37 CFR 1.33(b).’ This ensures that only authorized individuals can initiate the CPA process, maintaining the integrity of the application.

It’s crucial to note that if the CPA request is not properly signed, it may not be granted a filing date, potentially affecting the continuity of the application.

For more information on CPA, visit: CPA.

Tags: CPA

What are the restrictions on filing a continuation-in-part application?

n

While continuation-in-part (CIP) applications offer flexibility in adding new matter to existing patent applications, there are several important restrictions to consider. The MPEP 201.08 outlines some key points:

n

“A continuation-in-part application can be filed as a new application claiming benefit under 35 U.S.C. 120 to a prior nonprovisional application or under 35 U.S.C. 119(e) to a prior provisional application, provided the conditions set forth under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 are met.”

n

Key restrictions include:

n

    n

  • The CIP must be filed while the parent application is still pending (not abandoned or issued).
  • n

  • At least one inventor named in the CIP must also be named in the parent application.
  • n

  • The CIP must include a specific reference to the parent application.
  • n

  • New matter in the CIP does not benefit from the parent application’s filing date.
  • n

  • The CIP must be filed within the time limits specified in 37 CFR 1.78 to claim priority.
  • n

n

Additionally, applicants should be aware that filing a CIP may affect the patent term and the assessment of prior art for the new subject matter. Careful consideration of these restrictions is essential for effective patent strategy.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on filing requirements, visit: filing requirements.

To file a valid Continued Prosecution Application (CPA) request for a design patent application, you must adhere to specific requirements outlined in 37 CFR 1.53(d). Key requirements include:

  • The request must be for a design application only.
  • The request must be submitted on a separate paper, as stated in MPEP ¶ 2.31: “because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.”
  • The application being continued must be a design application that is complete as defined by 37 CFR 1.51(b).

Failure to meet these requirements may result in the CPA request being deemed unacceptable.

To file a Continued Prosecution Application (CPA) in a design application, the following requirements must be met:

  • The application must be a design application.
  • The prior application must be a nonprovisional application.
  • The application must be filed before the earliest of:
    • Payment of the issue fee on the prior application, unless a petition under § 1.313(c) is granted in the prior application;
    • Abandonment of the prior application; or
    • Termination of proceedings on the prior application.

As stated in the MPEP 201.06(d): “A continuation or divisional application that is a nonprovisional application may be filed as a CPA under 37 CFR 1.53(d) if the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).”

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on filing requirements, visit: filing requirements.

To file a continuation-in-part (CIP) application, several requirements must be met according to MPEP 201.08 and 37 CFR 1.78:

  1. The CIP must be filed while the prior nonprovisional application is still pending (before patenting, abandonment, or termination of proceedings).
  2. The CIP must claim benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  3. The CIP must contain a specific reference to the prior application, including the application number.
  4. For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet (ADS).
  5. The CIP must have at least one common inventor with the prior application.

It’s important to note that a CIP can only be filed under 37 CFR 1.53(b) and cannot be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).

For more information on filing requirements, visit: filing requirements.

For more information on USPTO, visit: USPTO.

To claim the benefit of a prior application’s filing date, applicants must meet specific requirements. The MPEP ¶ 2.05 advises:

“Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

Key requirements include:

  • The application must be filed before the patenting or abandonment of the prior application.
  • The application must contain a specific reference to the prior application.
  • The application must have at least one common inventor with the prior application.
  • The application must disclose the invention claimed in the manner provided by 35 U.S.C. 112(a).

For more information on patent law, visit: patent law.

Tags: patent law

To claim the benefit of a prior-filed application in a continuation-in-part (CIP), several requirements must be met as outlined in MPEP 201.08 and 35 U.S.C. 120:

  • The CIP must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  • The CIP must contain or be amended to contain a specific reference to the earlier filed application.
  • For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet.
  • The CIP must have at least one common inventor with the prior-filed application.

Additionally, the MPEP notes:

“The continuation-in-part application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).”

It’s important to note that the USPTO does not typically scrutinize whether the earlier application fully supports the CIP’s claims unless this becomes relevant in a proceeding before the Office.

For more information on patent procedure, visit: patent procedure.

For more information on prior-filed application, visit: prior-filed application.

To claim the benefit of a prior-filed application in a continuation or continuation-in-part application, several requirements must be met:

1. The application must be filed before the patenting, abandonment, or termination of proceedings on the prior application.

2. The application must contain or be amended to contain a specific reference to the prior application. For applications filed on or after September 16, 2012, this reference must be in an application data sheet.

3. The application must have at least one common inventor with the prior application.

4. The application must comply with the requirements of 35 U.S.C. 120 and 37 CFR 1.78.

As stated in the MPEP: “An applicant in a nonprovisional application (including a nonprovisional application resulting from an international application or international design application), an international application designating the United States, or an international design application designating the United States may claim the benefit of one or more prior-filed copending nonprovisional applications, international applications designating the United States, or international design applications designating the United States under the conditions set forth in 35 U.S.C. 120, 121, 365(c), or 386(c) and this section.”

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP), applicants must meet specific requirements. According to MPEP ¶ 2.06:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

These requirements typically include:

  • Filing the CIP application while the prior application is still pending
  • Naming at least one inventor in common with the prior application
  • Including a specific reference to the prior application in the CIP
  • Ensuring the CIP application contains a substantial portion of the prior application’s disclosure
  • Complying with the time limits and procedures outlined in 37 CFR 1.78

It’s important to note that only the subject matter shared with the prior application will benefit from its earlier filing date. New matter added in the CIP will have the filing date of the CIP application.

For an application to be considered a divisional, it must meet several requirements as outlined in MPEP ¶ 2.01:

  1. It must disclose and claim only subject matter disclosed in the prior application.
  2. It must claim subject matter that is independent and distinct from that claimed in the prior application.
  3. It must name the inventor or at least one joint inventor named in the prior application.

The MPEP states:

This application, which discloses and claims only subject matter disclosed in prior Application No.[1], filed [2], appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application, and names the inventor or at least one joint inventor named in the prior application.

Meeting these requirements helps ensure that the divisional application is properly derived from the prior application while claiming a distinct invention.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO, visit: USPTO.

According to MPEP 201.04, the required components of a provisional patent application are:

  • A specification as prescribed by 35 U.S.C. 112(a)
  • Any drawings required by 37 CFR 1.81(a)
  • A cover sheet as required by 37 CFR 1.51(c)(1), which may be an application data sheet, form SB/16, or a cover letter identifying the application as provisional

The MPEP states, No amendment, other than to make the provisional application comply with the patent statute and all applicable regulations, may be made to the provisional application after the filing date of the provisional application.

For more information on patent drawings, visit: patent drawings.

For more information on provisional application, visit: provisional application.

Filing a continuation-in-part (CIP) application can present several risks and potential drawbacks:

1. Different Effective Filing Dates: New matter in the CIP only gets the benefit of the CIP filing date, potentially exposing those claims to more prior art.

2. Reduced Patent Term: The patent term is measured from the filing date of the earliest application to which the CIP claims priority, potentially reducing the overall protection period for new matter.

3. Double Patenting Issues: Claims in the CIP may be subject to obviousness-type double patenting rejections based on the claims of the parent application.

4. Complexity in Litigation: The varying effective filing dates can complicate patent litigation, particularly when determining relevant prior art.

5. Difficulty in Claiming Priority: International applications may have difficulty claiming priority to a CIP due to the new matter.

While not explicitly stated in the provided MPEP section, these are important considerations derived from patent law and practice. The MPEP does note: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

Applicants should carefully consider these factors when deciding whether to file a CIP or a new application.

There are two primary methods for requesting the deletion of a named inventor in a Continued Prosecution Application (CPA) for design applications:

  • Letter to the examiner: You can submit a letter directly to the patent examiner handling your application.
  • Request for corrected filing receipt: You can file a formal request for a corrected filing receipt with the USPTO.

These methods are outlined in MPEP § 201, ¶ 2.32, which states:

In a continued prosecution application (CPA) for a design application (37 CFR 1.53(d)), a request to delete a named inventor from the prior application may be submitted by way of a letter to the examiner or a request for corrected filing receipt.

It’s important to note that this procedure is specific to design applications and is not applicable to utility patents.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent examination, visit: patent examination.

For more information on USPTO procedures, visit: USPTO procedures.

The MPEP 201 outlines several main types of patent applications:

  • Nonprovisional applications for patent
  • Provisional applications for patent
  • International applications
  • Design applications
  • Plant applications
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

Each type serves a specific purpose in the patent application process and has its own requirements and procedures.

For more information on divisional, visit: divisional.

For more information on patent applications, visit: patent applications.

For more information on reissue, visit: reissue.

There are several types of patent applications in the United States:

  • Nonprovisional applications filed under 35 U.S.C. 111(a), including utility, plant, and design patent applications
  • Provisional applications filed under 35 U.S.C. 111(b)
  • International applications filed under the Patent Cooperation Treaty (PCT)
  • International design applications filed under the Hague Agreement

The MPEP states: Applications filed under 35 U.S.C. 111(a) include original nonprovisional utility, plant, design, divisional, continuation, and continuation-in-part applications filed under 37 CFR 1.53(b), reissue applications filed under 37 CFR 1.53(b), and design patent continued prosecution applications (CPAs) filed under 37 CFR 1.53(d).

For more information on Hague Agreement, visit: Hague Agreement.

For more information on international applications, visit: international applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent applications, visit: patent applications.

The main types of national applications under U.S. patent law are:

  • Original (non-provisional) applications
  • Provisional applications
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

As stated in MPEP 201.01: National applications include original (non-provisional), provisional, plant, design, reissue, divisional, and continuation applications (which may be filed under 37 CFR 1.53(b)), as well as continuation-in-part applications (which may be filed under 37 CFR 1.53(b)).

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

To learn more:

A nonprovisional patent application filed under 35 U.S.C. 111(a) must include several key components. According to the MPEP, these include:

The MPEP states: Such application shall include— (A) a specification as prescribed by section 112; (B) a drawing as prescribed by section 113; and (C) an oath or declaration as prescribed by section 115.

It’s important to note that while claims and drawings are not required for obtaining a filing date (except for design applications), they are necessary for a complete application and must be submitted to avoid abandonment.

For more information on filing requirements, visit: filing requirements.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent drawings, visit: patent drawings.

Continued Prosecution Applications (CPAs) have several key differences from regular continuation applications filed under 37 CFR 1.53(b):

  • CPAs are only available for design applications, not utility or plant applications
  • CPAs use the same application number as the prior application
  • CPAs do not require a new specification or drawings to be filed
  • The filing requirements for a CPA are minimal compared to a regular continuation
  • CPAs are typically processed faster than regular continuations
  • Filing a CPA automatically abandons the prior application

MPEP 201.06(d) states: A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on USPTO procedures, visit: USPTO procedures.

While both continuation and continuation-in-part (CIP) applications are related to a prior application, there are key differences:

  • Continuation: Repeats the entire disclosure of the prior application without adding new matter.
  • Continuation-in-Part (CIP): According to MPEP ¶ 2.06, a CIP “repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application.”

The main difference is that a CIP introduces new subject matter not present in the original application. This new matter receives the filing date of the CIP, while the repeated portions may claim the earlier filing date of the prior application if properly claimed under 35 U.S.C. 120.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A divisional application has several key characteristics as outlined in MPEP ¶ 2.01:

  1. Independent and Distinct Subject Matter: It ‘appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application.’
  2. Disclosure in Prior Application: It ‘discloses and claims only subject matter disclosed in prior Application No.[1],filed[2].’
  3. Inventor Continuity: It ‘names the inventor or at least one joint inventor named in the prior application.’
  4. Potential Benefit Claim: It may claim the benefit of the filing date of the prior application, subject to meeting certain requirements.

These characteristics ensure that divisional applications properly separate distinct inventions while maintaining a connection to the original disclosure and inventorship.

For more information on Divisional application, visit: Divisional application.

Failing to properly claim benefit in a potential continuation-in-part (CIP) application can have significant implications for patent protection. The MPEP cautions: This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established. (MPEP ¶ 2.06)

Implications of not properly claiming benefit include:

  • Loss of earlier filing date for common subject matter, potentially affecting patentability
  • Increased vulnerability to prior art that could have been excluded with the earlier filing date
  • Possible issues with patent term calculation
  • Risk of unintentionally abandoning the application if statutory deadlines are missed

To avoid these issues, applicants should carefully follow the requirements outlined in 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq when filing a CIP application.

For more information on prior art, visit: prior art.

Tags: prior art

The filing requirements for a divisional application under 37 CFR 1.53(b) are similar to those for a new nonprovisional application. According to the MPEP:

‘A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (1) a specification complying with 35 U.S.C. 112, including a claim or claims; (2) drawings, where necessary; and (3) the inventorship named on filing.’

Additionally, you must include:

  • The appropriate filing fees
  • An Application Data Sheet (ADS) specifying that the application is a divisional
  • A proper benefit claim to the parent application

It’s important to note that while a new oath or declaration may not be required under 37 CFR 1.63(d), you must still comply with all other filing requirements.

For more information on Divisional application, visit: Divisional application.

For more information on drawings, visit: drawings.

For more information on filing requirements, visit: filing requirements.

For more information on inventorship, visit: inventorship.

To file a CPA for a design patent application, the following requirements must be met:

  • The prior application must be a design application that is complete under 37 CFR 1.51(b)
  • The CPA must be filed before the earliest of: payment of the issue fee, abandonment, or termination of proceedings in the prior application
  • The CPA must be filed with a request on a separate paper
  • The proper filing fee, search fee, and examination fee must be paid
  • The CPA must only disclose and claim subject matter disclosed in the prior application

As stated in the MPEP: “The filing date of a CPA is the date on which a request on a separate paper for an application under this paragraph is filed.”

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

The filing requirements for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) are as follows:

  • The CPA must be filed before the earliest of:
    • Payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted;
    • Abandonment of the prior application; or
    • Termination of proceedings on the prior application.
  • The CPA must include a request to initiate proceedings under 37 CFR 1.53(d).
  • The prior application must be a design application eligible for CPA practice.

As stated in the MPEP 201.06(d): ‘A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).’

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on filing requirements, visit: filing requirements.

A continuation-in-part (CIP) application has specific filing requirements. Key points include:

  • A CIP application can only be filed under 37 CFR 1.53(b).
  • It must be filed during the lifetime of the prior-filed application (before its abandonment or issuance).
  • The CIP must claim the benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • For applications filed on or after September 16, 2012, the benefit claim must be in an application data sheet (ADS).
  • The CIP must have at least one common inventor with the prior application.
  • New matter can be added to the specification, but claims relying on this new matter will not get the benefit of the earlier filing date.

As stated in the MPEP:

A continuation-in-part application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).

It’s important to note that while a CIP allows for the addition of new matter, any claims that rely on this new matter will only be entitled to the filing date of the CIP application, not the earlier filing date of the parent application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on filing requirements, visit: filing requirements.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

The filing date requirements for nonprovisional applications filed under 35 U.S.C. 111(a) have changed due to the Patent Law Treaties Implementation Act of 2012 (PLTIA). For applications filed on or after December 18, 2013:

  • Non-design applications no longer require at least one claim or any drawings to receive a filing date
  • Design patent applications still require at least one claim and any required drawings to receive a filing date

The MPEP states: Unless the application is for a design patent, nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013, are no longer required to include at least one claim or any drawings in order to receive a filing date for the application.

Additionally, applications may now be filed by reference to a previously filed application: A nonprovisional application filed under 35 U.S.C. 111(a) on or after December 18, 2013, may be filed by a reference to a previously filed application (foreign, international, provisional, or nonprovisional) indicating that the specification and any drawings of the application are replaced by the reference to the previously filed application.

For more information on filing date requirements, visit: filing date requirements.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent drawings, visit: patent drawings.

For more information on PLTIA, visit: PLTIA.

The Patent Law Treaties Implementation Act of 2012 (PLTIA) amended the filing date requirements for nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013. The key changes are:

  • Nonprovisional applications (except for design patent applications) no longer require at least one claim or any drawings to receive a filing date.
  • For design patent applications, the filing date is the date on which the USPTO receives the specification including at least one claim and any required drawings.
  • As provided in 35 U.S.C. 111(c), a nonprovisional application may be filed by reference to a previously filed application (foreign, international, provisional, or nonprovisional).

These changes simplified the filing process for most nonprovisional applications while maintaining specific requirements for design patent applications.

What are the filing date requirements for a CPA?

The filing date requirements for a Continued Prosecution Application (CPA) are specific and must be adhered to. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is a paper filing, even though it may be submitted via EFS-Web.

Key points about CPA filing date requirements include:

  • The CPA must be filed before the payment of the issue fee for the prior application
  • It must be filed before abandonment of the prior application
  • The request for a CPA must be made on a separate paper
  • The filing date is based on when the CPA request is received, not when other application documents are submitted

It’s crucial to meet these requirements to ensure the CPA is properly filed and receives the correct filing date.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

To receive a filing date for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d), the following requirements must be met:

  • The application must be for a design patent;
  • The prior application must be a design application that is complete as defined by 37 CFR 1.51(b);
  • The application must be submitted before the payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted in the prior application;
  • The application must be filed within the period set forth in 37 CFR 1.53(d)(1)(ii); and
  • The application must be filed with a request for a CPA.

As stated in the MPEP: ‘A CPA may be filed under 37 CFR 1.53(d) only if the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).’

For more information on CPA, visit: CPA.

For more information on design patent, visit: design patent.

For more information on filing requirements, visit: filing requirements.

According to MPEP 201.02, there are several types of patent applications:

  • National applications
  • Provisional applications
  • Nonprovisional applications
  • International applications
  • International design applications

The definitions for these terms can be found in 37 CFR 1.9. Additionally, applications can be classified as ‘original’ or ‘continuing’ applications. An original application may be a first filing or a continuing application, while a continuing application can be a continuation, divisional, or continuation-in-part application.

For more information on continuing applications, visit: continuing applications.

For more information on international applications, visit: international applications.

For more information on international design applications, visit: international design applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent applications, visit: patent applications.

The United States Patent and Trademark Office (USPTO) recognizes several types of patent applications. According to MPEP 201, these include:

  • Nonprovisional applications for patent, including utility, design, and plant patent applications
  • Provisional applications for patent
  • International applications filed under the Patent Cooperation Treaty (PCT)
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

Each type of application serves a specific purpose in the patent process and has its own requirements and procedures.

For more information on divisional, visit: divisional.

For more information on patent applications, visit: patent applications.

For more information on reissue, visit: reissue.

For more information on USPTO, visit: USPTO.

According to MPEP 201.01, there are three main types of national applications in U.S. patent law:

  • Original applications: These include both provisional and nonprovisional applications.
  • Reissue applications: Filed to correct an error in an already issued patent.
  • Reexamination applications: Used to request a review of an existing patent.

The MPEP states: National applications include original (nonprovisional and provisional), reissue, and reexamination applications. Each type serves a specific purpose in the patent application process.

For more information on reissue applications, visit: reissue applications.

Design and plant patent applications are two distinct types of patent applications, each protecting different aspects of inventions:

Design Patent Applications:
1. Protect the ornamental design of a functional item.
2. Cover the visual appearance of an article of manufacture.
3. Have a term of 15 years from the date of grant.
4. Require drawings or photographs of the design.
5. Do not require a written description of the invention.

Plant Patent Applications:
1. Protect new varieties of asexually reproduced plants.
2. Cover the entire plant, not just a specific part.
3. Have a term of 20 years from the filing date.
4. Require a detailed botanical description of the plant.
5. May include drawings or photographs to illustrate the plant’s characteristics.

For more information, refer to MPEP 201.06 for design patents and MPEP 201.07 for plant patents.

Failing to file a 37 CFR 1.48 request when adding a new inventor to a Continued Prosecution Application (CPA) can have significant consequences.

MPEP ¶ 2.33 states: “Otherwise, the inventorship in the CPA shall be the same as in the prior application.” This means that without a proper 37 CFR 1.48 request:

  • The new inventor will not be officially recognized on the application.
  • The inventorship will remain unchanged from the prior application.
  • This discrepancy could potentially affect the validity of the patent if granted.
  • It may lead to complications in future patent proceedings or enforcement efforts.

It’s crucial to follow proper procedures to ensure all inventors are correctly listed and legally recognized on the patent application.

For more information on CPA, visit: CPA.

For more information on patent validity, visit: patent validity.

When filing a Continued Prosecution Application (CPA), there are specific conditions under which the prior application may be automatically abandoned. According to MPEP 201.06(d):

A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA. See 37 CFR 1.53(d)(2)(v).

However, it’s important to note that:

  • The prior application is only expressly abandoned if the CPA is properly filed.
  • If the CPA is improper (e.g., filed in a utility application), the express abandonment of the prior application will not be effective.
  • The abandonment of the prior application is automatic upon the filing date of the properly filed CPA.

This automatic abandonment provision ensures a clear transition from the prior application to the CPA, which is particularly relevant for design applications where CPAs are permitted.

For more information on CPA, visit: CPA.

Tags: CPA

Filing a CPA for a design patent application offers several benefits:

  • Minimal filing requirements compared to a regular continuation application
  • No new filing receipt is normally issued
  • Faster processing time, as it uses the same application number and file wrapper
  • For examination priority, CPAs are treated as “amended” applications rather than “new” applications, potentially resulting in faster examination
  • The prior application is automatically abandoned, simplifying the process

As stated in the MPEP: “A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).”

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

Filing a continuation application offers several benefits to patent applicants:

  1. Pursuing additional claims: As stated in MPEP 201.07, “The disclosure presented in the continuation must be the same as that of the original application; i.e., the continuation should not include anything which would constitute new matter if inserted in the original application.” This allows applicants to pursue different or broader claims based on the same disclosure.
  2. Extending prosecution: A continuation application provides more time to negotiate with the USPTO, potentially leading to stronger patent protection.
  3. Maintaining pendency: It keeps the application pending, which can be strategically important in fast-evolving technologies or competitive markets.
  4. Addressing new prior art: If new prior art emerges during the prosecution of the parent application, a continuation allows for claim adjustments to overcome this art.
  5. Commercial considerations: As products evolve or market conditions change, continuation applications allow for tailoring claims to cover new aspects of the invention or competitor products.

By utilizing continuation applications strategically, inventors and businesses can build a stronger patent portfolio and maintain flexibility in their intellectual property protection strategy.

For more information on patent strategy, visit: patent strategy.

Filing a provisional patent application offers several benefits but also has limitations:

Benefits:

  • Establishes an early filing date quickly and inexpensively
  • Allows use of ‘Patent Pending’ for up to 12 months
  • Provides time to assess commercial potential before filing a nonprovisional application
  • Does not require claims or an oath/declaration

Limitations:

  • Limited 12-month pendency
  • Cannot directly mature into a patent
  • Not examined for patentability
  • Cannot claim priority to any earlier applications

The MPEP notes: A provisional application is not entitled to the right of priority of any other application under 35 U.S.C. 119 or 365(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121 or 365(c) or § 1.78 of any other application.

Additionally, No claim for priority under 35 U.S.C. 119(e) or § 1.78(a)(4) may be made in a design application based on a provisional application. This limits the use of provisional applications in certain contexts.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

Filing a continuation-in-part (CIP) application has several benefits and potential drawbacks:

Benefits:

  • Allows addition of new subject matter to an existing invention
  • Maintains the priority date of the original application for common subject matter
  • Provides an opportunity to strengthen the patent application with new data or improvements
  • Allows for changes in inventorship to reflect new contributions

Drawbacks:

  • New subject matter only gets the filing date of the CIP, potentially exposing it to more prior art
  • Can complicate the patent term calculation
  • May result in multiple patents with overlapping subject matter, requiring terminal disclaimers
  • Increases overall costs due to additional filing and prosecution fees

The MPEP notes: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

Inventors and patent attorneys should carefully consider these factors when deciding whether to file a CIP or a new application.

For more information on new subject matter, visit: new subject matter.

For more information on patent strategy, visit: patent strategy.

To obtain a filing date for a nonprovisional utility patent application filed on or after 12/18/2013, the application must include:

  • A specification with or without claims (35 U.S.C. 111(a)(2)(A))
  • Drawings, if necessary for an understanding of the invention (35 U.S.C. 111(a)(2)(B)), but see 37 CFR 1.81(a) for applications filed before 12/18/2013 requiring drawings where they are necessary for the understanding of the invention
  • The inventor’s oath or declaration, which may be filed later if an application data sheet (ADS) is submitted identifying the inventor(s) (35 U.S.C. 111(a)(2)(C) and 115)
  • The applicable filing fees (basic filing fee, search fee, examination fee, any required excess claims fees) (35 U.S.C. 41 and 37 CFR 1.16)

An application missing any of the above items will be treated as incomplete and no filing date will be granted until the missing item(s) are submitted.

Filing a provisional patent application offers several advantages, as outlined in the MPEP:

  1. Establishing Priority: It allows applicants to quickly and inexpensively file provisional applications and establish a priority date for their invention.
  2. Paris Convention Priority: It starts the Paris Convention priority year, allowing foreign filings within 12 months while maintaining the U.S. filing date.
  3. Simplified Filing: As stated in the MPEP, No claim is required in a provisional application and No oath or declaration is required in a provisional application.
  4. Patent Term: The MPEP notes, The domestic priority period will not count in the measurement of the 20-year patent term. This puts domestic applicants… on equal footing with foreign applicants with respect to the patent term.
  5. Time for Development: It provides a 12-month period to further develop the invention before filing a nonprovisional application.

These advantages make provisional applications a useful tool for inventors to secure an early filing date while allowing time for further development and market assessment.

For more information on patent strategy, visit: patent strategy.

For more information on patent term, visit: patent term.

For more information on provisional application, visit: provisional application.

Filing a Continued Prosecution Application (CPA) for design patents has several advantages over filing a regular continuation application under 37 CFR 1.53(b):

  • Minimal filing requirements – only a request on a separate paper and the filing fee are needed
  • No new oath or declaration is required
  • Faster processing – the CPA uses the file and contents of the prior application
  • Potentially faster examination – CPAs are often treated as “amended” applications for examination priority
  • No need for a new specification or drawings

The MPEP notes: “A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).”

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

Reissue applications are used to correct errors in already issued patents. According to MPEP 201:

‘An application for reissue is made by the patentee when the patent is, through error without any deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent.’

Key points about reissue applications:

  • They are filed under 35 U.S.C. 251.
  • They can be used to broaden or narrow the scope of patent claims.
  • There are time limitations for broadening reissues (within two years from the grant of the original patent).

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue application, visit: reissue application.

MPEP 201.01 briefly mentions reissue applications as one of the types of national applications. Specifically, it states:

‘National applications include original applications and reissue applications (filed under 35 U.S.C. 251).’

Reissue applications are a specialized type of patent application used to correct errors in an already issued patent. They are governed by 35 U.S.C. 251, which allows a patentee to apply for a reissue of their patent if it is deemed to be wholly or partly inoperative or invalid due to certain types of errors.

For more detailed information on reissue applications, refer to MPEP 1400 – Correction of Patents.

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue applications, visit: reissue applications.

Provisional applications are a type of patent application that allows inventors to establish an early filing date without the formal requirements of a non-provisional application. According to MPEP 201:

‘A provisional application is a U.S. national application for patent filed in the USPTO under 35 U.S.C. 111(b).’

Key differences between provisional and non-provisional applications:

  • Provisional applications have a simplified filing process and lower fees.
  • They do not require formal patent claims or an oath or declaration.
  • Provisional applications are not examined and automatically expire after 12 months.
  • To obtain patent protection, a non-provisional application claiming benefit of the provisional must be filed within 12 months.

Non-provisional applications, on the other hand, are formal patent applications that are examined by the USPTO and can result in an issued patent if approved.

For more information on Non-provisional application, visit: Non-provisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

International applications under the Patent Cooperation Treaty (PCT) are a type of patent application that provides a unified procedure for filing patent applications in its contracting states. According to MPEP 201:

‘An international application is a national application for patent which is filed under the Patent Cooperation Treaty (PCT).’

Key aspects of PCT applications:

  • Allow seeking patent protection in multiple countries simultaneously
  • Provide a streamlined filing process for international patent protection
  • Include an international search and optional international preliminary examination
  • Must enter the national phase in desired countries within specified timeframes
  • Do not result in an ‘international patent’ but facilitate national/regional patent grants

PCT applications are particularly useful for inventors seeking broad international patent protection.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

After receiving a MPEP ¶ 2.05 notification, an applicant should take the following actions:

  1. Review the notification carefully: Understand the examiner’s assessment that the application may constitute a continuation or division.
  2. Verify the information: Confirm that the prior application number and filing date mentioned in the notification are correct.
  3. Assess the application’s status: Determine if the application should indeed be treated as a continuation, division, or both.
  4. File appropriate documents: If the application is intended to be a continuation or division, ensure that all necessary documents, such as a reference to the prior application under 35 U.S.C. 120, 121, or 365(c), are properly filed.
  5. Respond to the examiner: Provide any necessary clarifications or corrections regarding the application’s status.

The MPEP ¶ 2.05 notification states: “Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.” (MPEP ¶ 2.05)

It’s crucial to follow these steps promptly to ensure proper processing of the application and to secure any potential benefits of the earlier filing date.

For more information on applicant actions, visit: applicant actions.

For more information on continuation application, visit: continuation application.

All relevant information from MPEP ¶ 2.33 New Inventor Identified in CPA (for Design Applications) has been covered in the previous FAQs. No additional meaningful questions can be generated without redundancy.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

A provisional patent application has a limited lifespan. According to MPEP 201.04:

“A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter. See 35 U.S.C. 111(b)(5).”

However, there is a provision for extending this period in certain circumstances:

“The period of pendency of a provisional application is extended to the next succeeding business day if the day that is 12 months after the filing date of a provisional application falls on a Saturday, Sunday, or federal holiday within the District of Columbia. See 35 U.S.C. 119(e)(3) and 37 CFR 1.7(b).”

It’s crucial to file a nonprovisional application claiming the benefit of the provisional application within this 12-month period to maintain the priority date.

For more information on patent validity, visit: patent validity.

For more information on provisional patent, visit: provisional patent.

For more information on USPTO, visit: USPTO.

Inventorship in a Continued Prosecution Application (CPA) is generally maintained from the prior application. However, if there’s a need to add or change inventors, specific procedures must be followed.

According to MPEP ¶ 2.33: “Any request to add an inventor must be in the form of a request under 37 CFR 1.48. Otherwise, the inventorship in the CPA shall be the same as in the prior application.”

This means that if you want to add or change inventors in a CPA, you must file a formal request under 37 CFR 1.48, which outlines the procedure for correction of inventorship in patent applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

An international application is defined in 37 CFR 1.9(b). While the specific definition is not provided in the given MPEP excerpt, it generally refers to a patent application filed under the Patent Cooperation Treaty (PCT). International applications allow inventors to seek patent protection in multiple countries through a single filing process.

For more detailed information on international applications, you can refer to the full text of 37 CFR 1.9(b) and related sections of the MPEP.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For more information on patent law, visit: patent law.

According to MPEP ¶ 2.30, the applicant is typically notified that their CPA request has been accepted through the first Office action on the CPA. The MPEP states: “Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established.” This notification is important because, as the MPEP notes, “applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

Unlike regular patent applications, applicants are not typically notified when a Continued Prosecution Application (CPA) has been established. The MPEP ¶ 2.30 states: “This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

Instead, the first notification an applicant usually receives is in the first Office action of the CPA. The examiner will use specific language to advise the applicant that the CPA request was acceptable and has been established.

According to MPEP ¶ 2.35, the USPTO treats ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. The MPEP explicitly states:

Any ‘conditional’ request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.

This means that even if an applicant submits a CPA request with conditions attached, the USPTO will process it as a standard, unconditional CPA request. This policy ensures clarity and consistency in the application process.

For more information on CPA, visit: CPA.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO treats all ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. According to MPEP ¶ 2.35:

Any “conditional” request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.

This means that once a conditional CPA request is submitted, it will be processed as a standard CPA, regardless of the applicant’s original intent.

For more information on CPA, visit: CPA.

Tags: CPA

When a Continued Prosecution Application (CPA) request for a design patent is found to be non-compliant, the USPTO notifies the applicant using a specific form paragraph. This notification informs the applicant about the issue and provides necessary details.

According to the MPEP, the examiner uses the following format:

  • ‘Receipt is acknowledged of the request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on Application No. [2].’
  • ‘However, because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.’

In this notification, [1] represents the filing date of the paper containing the CPA request, and [2] is the Application Number identified in the CPA request. This clear communication helps applicants understand the issue and take corrective action.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

When the USPTO receives an unacceptable Continued Prosecution Application (CPA) request for a design patent application, they notify the applicant using a standardized form paragraph. According to MPEP ¶ 2.31, the examiner will use the following language:

Receipt is acknowledged of the request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on Application No. [2]. However, because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.

This notification informs the applicant that their CPA request has been received but not accepted due to non-compliance with the separate paper requirement. The examiner will insert the filing date of the CPA request and the application number in the appropriate brackets.

For more information on USPTO notification, visit: USPTO notification.

The USPTO’s handling of preliminary amendments in continuation applications depends on when the application was filed and the nature of the amendment:

  • For applications filed on or after September 21, 2004: A preliminary amendment that is present on the filing date of the application is considered part of the original disclosure.
  • All preliminary amendments: Must be filed in compliance with 37 CFR 1.121, which includes providing a complete claim listing whenever a claim is added, canceled, or amended.
  • Substitute specification: The Office may require a substitute specification for preliminary amendments.

The MPEP states:

Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

It’s important to note that the USPTO advises against filing a continuation application with a preliminary amendment that makes all desired changes. Instead, they recommend:

Filing a continuing application under 37 CFR 1.53(b) with a new specification containing only the desired set of claims.

This approach ensures that the published application contains the intended set of claims, rather than those from the prior application.

For more information on continuation application, visit: continuation application.

The United States Patent and Trademark Office (USPTO) treats all ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. This is clearly stated in MPEP ¶ 2.35:

“Any ‘conditional’ request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.”

This means that once a CPA request is filed, even if the applicant intended it to be conditional, the USPTO will process it as a regular CPA. The conditions specified by the applicant are essentially disregarded, and the CPA is established based on the filing of the request alone.

For more information on CPA, visit: CPA.

For more information on Patent Application Process, visit: Patent Application Process.

The USPTO generally does not make an upfront determination about whether an application qualifies as a continuation-in-part (CIP) unless it becomes necessary in a proceeding. According to the MPEP:

“The Office does not need to make a determination as to whether the requirement of 35 U.S.C. 120 that the earlier nonprovisional application discloses the invention of the second application in the manner provided by 35 U.S.C. 112(a) is met unless the filing date of the earlier nonprovisional application is relied upon in a proceeding before the Office.”

However, examiners may use form paragraph 2.06 to remind applicants of possible CIP status:

“This application repeats a substantial portion of prior Application No. [1], filed [2], and adds disclosure not presented in the prior application. Because this application names the inventor or at least one joint inventor named in the prior application, it may constitute a continuation-in-part of the prior application.”

Ultimately, it’s the applicant’s responsibility to properly claim CIP status and comply with the requirements of 35 U.S.C. 120 and 37 CFR 1.78.

For more information on patent examination, visit: patent examination.

The term ‘international application’ is defined in 37 CFR 1.9(b). An international application typically refers to a patent application filed under the Patent Cooperation Treaty (PCT), which provides a unified procedure for filing patent applications to protect inventions in its contracting states.

Key points about international applications:

  • They are governed by the Patent Cooperation Treaty.
  • They can lead to national phase entries in multiple countries.
  • They provide a streamlined filing process for seeking patent protection internationally.
  • The specific definition in 37 CFR 1.9(b) should be consulted for precise legal terminology.

International applications are distinct from national applications and offer a pathway for inventors to seek protection in multiple countries through a single filing.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

The United States Patent and Trademark Office (USPTO) formally acknowledges a Request to Delete a Named Inventor in a Continued Prosecution Application (CPA) through an official response. This acknowledgment serves as confirmation that the request has been received and processed.

The MPEP ¶ 2.32 provides the standard language used by examiners to acknowledge such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

In this acknowledgment:

  • [1] refers to the name(s) of the inventor(s) requested to be deleted
  • [2] indicates the filing date of the CPA

This official response confirms that the USPTO has processed the request and updated the inventorship accordingly.

For more information on CPA, visit: CPA.

For more information on USPTO acknowledgment, visit: USPTO acknowledgment.

How does the priority date work in a continuation-in-part application?

In a continuation-in-part (CIP) application, the priority date can vary for different parts of the application. According to MPEP 201.08:

“The disclosure presented in the continuation-in-part application may include subject matter in common with the earlier application and may include additional subject matter not disclosed in the earlier application. Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the earlier nonprovisional application are entitled to the benefit of the filing date of the earlier nonprovisional application.”

This means:

  • Subject matter carried over from the parent application retains the original filing date as its priority date
  • New matter added in the CIP has the filing date of the CIP as its priority date
  • Each claim in a CIP is evaluated individually to determine its effective filing date
  • Claims fully supported by the parent application get the earlier priority date
  • Claims relying on new matter get the later CIP filing date as their priority date

Understanding priority dates in CIPs is crucial for determining patentability and for defending against potential prior art references.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

How does the oath or declaration work in divisional applications?

In divisional applications, the oath or declaration process is simplified to reduce the burden on applicants. According to MPEP 201.06(c):

37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) that contains the subject matter described in the prior nonprovisional application, provided a copy of the executed oath or declaration filed in the prior nonprovisional application is submitted.

Key points about the oath or declaration in divisional applications:

  • A new oath or declaration is not required if the divisional application contains the same subject matter as the parent application.
  • A copy of the executed oath or declaration from the parent application can be submitted.
  • The copy must show the USPTO seal or stamp indicating it was received.
  • If the inventorship changes, a new oath or declaration may be required.

This provision under 37 CFR 1.63(d) streamlines the filing process for divisional applications while ensuring proper inventorship documentation.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

How does the oath or declaration requirement differ for divisional applications?

For divisional applications, the oath or declaration requirement can be simplified under certain conditions. According to MPEP 201.06(c):

“The divisional application may be filed under 37 CFR 1.53(b) using all or part of a copy of the oath or declaration filed in the prior nonprovisional application under 37 CFR 1.63(d), as long as the oath or declaration is still applicable to the subject matter of the divisional application.”

This means that if the original oath or declaration from the parent application still covers the subject matter in the divisional application, it can be reused. However, if new matter is introduced or the inventors change, a new oath or declaration may be required.

For more information on Divisional application, visit: Divisional application.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent filing, visit: patent filing.

The oath or declaration requirements for continuation applications differ significantly depending on whether they were filed before or after September 16, 2012:

  • For applications filed on or after September 16, 2012: The inventor’s oath or declaration must comply with the requirements of 35 U.S.C. 115 as revised effective September 16, 2012. It must state that the inventor (1) is an original inventor of the claimed invention, and (2) authorized the filing of the patent application for the claimed invention. It must also contain an acknowledgment of penalties for willful false statements.
  • For applications filed before September 16, 2012: Applicants could file either a newly executed oath or declaration, or a copy of the oath or declaration from the prior application, along with a statement requesting deletion of names of non-inventors for the continuation application.

The MPEP states:

For applications filed on or after September 16, 2012, to claim the benefit of a prior application under 35 U.S.C. 120, 121, 365(c), or 386(c) applicant must include a reference to the prior application in compliance with 37 CFR 1.78(d)(2) in an application data sheet.

This change reflects the America Invents Act’s modifications to U.S. patent law.

For more information on America Invents Act, visit: America Invents Act.

For more information on continuation application, visit: continuation application.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent application requirements, visit: patent application requirements.

Micro entity status does not automatically carry over to continuation or divisional applications. A new certification is required for each new application:

  1. A new assertion of entitlement to micro entity status is required for any continuation, divisional, or continuation-in-part application.
  2. This applies even if micro entity status was properly claimed in the parent application.
  3. The new certification must be filed in the continuing application.

The MPEP states: The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

It’s important to note that this requirement for a new certification applies specifically to micro entity status. For small entity status, a new assertion is also required, but the rules are slightly different.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

The inventorship requirements for continuation applications differ based on whether they were filed before or after September 16, 2012:

  • For applications filed on or after September 16, 2012: The inventorship is determined by the information provided in the application data sheet (ADS) filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If no ADS is filed, the inventorship is set by the copy of the inventor’s oath or declaration from the earlier-filed application, unless accompanied by a statement signed under 37 CFR 1.33(b) specifying the correct inventorship.
  • For applications filed before September 16, 2012: The inventorship was generally set by the copy of the executed oath or declaration from the prior application, unless accompanied by a statement requesting deletion of the names of persons who are not inventors in the continuation application.

The MPEP states for post-AIA applications:

37 CFR 1.63(d)(2) provides that the inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application.

These changes reflect the America Invents Act’s modifications to U.S. patent law, simplifying the process for correcting inventorship in many cases.

For more information on America Invents Act, visit: America Invents Act.

For more information on continuation application, visit: continuation application.

For more information on inventorship, visit: inventorship.

For more information on patent application requirements, visit: patent application requirements.

The inventorship in a Continued Prosecution Application (CPA) is generally the same as in the prior application, unless a specific request is made to change it. According to 37 CFR 1.53(d)(4):

The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If a change in inventorship is desired, a statement requesting the deletion of the names of non-inventors must be filed with the CPA request. This statement must be signed by a person authorized under 37 CFR 1.33(b). For applications filed on or after September 16, 2012, any request to add an inventor must be in the form of a request under 37 CFR 1.48.

The inventorship in a continuing application can be the same as or different from the prior application, depending on the circumstances:

  1. For applications filed on or after September 16, 2012, the inventorship is determined by the application data sheet or the copy of the oath/declaration from the earlier-filed application.
  2. If the continuing application names a new joint inventor, they must provide a new oath or declaration.

The MPEP states: 37 CFR 1.63(d)(2) provides that the inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If an application data sheet is not filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application, the inventorship is the inventorship set forth in the copy of the inventor’s oath or declaration from the earlier-filed application, unless it is accompanied by a statement signed pursuant to 37 CFR 1.33(b) stating the name of each inventor in the continuing application.

For applications filed before September 16, 2012, different rules apply regarding the deletion or addition of inventors in continuing applications.

For more information on application data sheet, visit: application data sheet.

For more information on declaration, visit: declaration.

For more information on inventorship, visit: inventorship.

For more information on oath, visit: oath.

The inventorship in a Continued Prosecution Application (CPA) is directly related to the parent application. As stated in MPEP 201.06(d):

‘The inventorship in a CPA filed under 37 CFR 1.53(d) is the same as in the prior application.’

This means that when you file a CPA, you are essentially continuing the same application with the same inventors. However, it’s important to note that if there are any changes to inventorship required, they must be made through the appropriate procedures, such as filing a request under 37 CFR 1.48. Any such changes should be made promptly to ensure the accuracy of the patent application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on parent application, visit: parent application.

The inventorship in a Continued Prosecution Application (CPA) automatically carries over from the prior application, unless specific steps are taken to change it. As stated in the MPEP:

“The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA. 37 CFR 1.53(d)(4).”

If an inventor needs to be added or deleted, a request under 37 CFR 1.48 must be filed, along with the required fee. The examiner will notify the applicant if there are any inventorship discrepancies in the first Office action.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on patent filing, visit: patent filing.

How does the filing date of new matter in a CIP application affect patent rights?

n

The filing date of new matter in a continuation-in-part (CIP) application significantly affects patent rights. According to MPEP 201.08:

n

“Matter disclosed in the parent application is entitled to the benefit of the filing date of the parent application. Matter disclosed for the first time in the continuation-in-part application does not receive the benefit of the filing date of the parent application.”

n

This means:

n

    n

  • The new matter in a CIP is treated as having the filing date of the CIP application itself.
  • n

  • This later filing date can impact the assessment of prior art and the determination of patentability for the new matter.
  • n

  • It may affect the patent term for claims based on the new matter.
  • n

  • In some cases, it could make the new matter more vulnerable to challenges based on intervening prior art.
  • n

n

Therefore, inventors and patent attorneys must carefully consider the timing and content of CIP applications to maximize patent protection.

For more information on new matter, visit: new matter.

For more information on patent rights, visit: patent rights.

For more information on prior art, visit: prior art.

The filing date of a divisional application can affect the patent term in several ways:

  1. 20-year term: The 20-year patent term is calculated from the earliest U.S. filing date to which the divisional application claims priority. This means that the term of a patent issued on a divisional application will generally be shorter than that of its parent application.
  2. Patent Term Adjustment (PTA): The divisional application may be eligible for PTA based on delays in its own prosecution, but not for delays in the prosecution of its parent application.
  3. Terminal Disclaimer: If there’s a risk of obviousness-type double patenting, a terminal disclaimer may be required, potentially limiting the term of the divisional patent to that of the parent patent.

The MPEP 201.06(c) does not directly address patent term, but it’s important to consider these factors when filing a divisional application. For more details on patent term, refer to MPEP 2701.

For more information on Divisional application, visit: Divisional application.

For more information on patent term, visit: patent term.

For more information on patent term adjustment, visit: patent term adjustment.

The filing date of a Continued Prosecution Application (CPA) is determined by the date on which a proper request for a CPA is filed. Specifically, the MPEP states:

The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed.

It’s important to note that the CPA request must be on a separate paper. If the request is not on a separate paper, it will not be considered a proper CPA request and will not receive a filing date.

For more information on patent applications, visit: patent applications.

For more information on USPTO procedures, visit: USPTO procedures.

The filing date of a Continued Prosecution Application (CPA) is determined differently from other types of patent applications. For a CPA, the filing date is the date on which a request for a CPA is filed on a separate paper.

The MPEP states: The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed.

This means that unlike regular applications where the filing date is typically the date all required components are received, a CPA’s filing date is based solely on when the CPA request is submitted, provided it meets the necessary requirements.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

The filing of a Continued Prosecution Application (CPA) has significant effects on the prior application:

  • The CPA is considered a request to expressly abandon the prior application as of the filing date of the CPA
  • The prior application is automatically abandoned in favor of the CPA
  • The filing date of the CPA is the date on which the request for the CPA is filed

As stated in the MPEP: The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed. An application filed under this paragraph:… (v) Is a request to expressly abandon the prior application as of the filing date of the request for an application under this paragraph.

For more information on patent applications, visit: patent applications.

The filing date of a Continued Prosecution Application (CPA) is important for priority claims and patent term calculations. Key points include:

  • The filing date of a CPA is the date on which the CPA request is received by the USPTO
  • A CPA is automatically considered a specific reference under 35 U.S.C. 120 to the prior application
  • The CPA is entitled to the benefit of the filing date of the prior application
  • Priority claims from the parent application automatically carry over to the CPA

As stated in MPEP 201.06(d): A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. That is, the CPA includes the request for an application under 37 CFR 1.53(d) and the recitation of the application number of the prior application in such request is the ‘specific reference to the earlier filed application’ required by 35 U.S.C. 120.

For more information on benefit claims, visit: benefit claims.

For more information on patent term, visit: patent term.

The filing date of a Continued Prosecution Application (CPA) has important implications for its priority claim. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is not entitled to the benefit of a Certificate of Mailing or Transmission under 37 CFR 1.8.

This means that:

  • The CPA’s filing date is the actual date the USPTO receives the CPA request.
  • This date cannot be backdated using a Certificate of Mailing or Transmission.
  • The CPA automatically receives the benefit of the filing date of the prior application.
  • Any foreign priority or domestic benefit claims made in the prior application are automatically carried forward to the CPA.

It’s crucial to understand that while the CPA maintains the priority claims of the prior application, its actual filing date is the date of receipt by the USPTO, which can affect certain statutory deadlines and prior art considerations.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

How does the filing date of a continuation-in-part application affect patent rights?

The filing date of a continuation-in-part (CIP) application can significantly affect patent rights, particularly for the new matter added. According to MPEP 201.08:

“The effective filing date of a claimed invention in a continuation-in-part application is determined on a claim-by-claim basis and is dependent upon the sufficiency of the disclosure in the parent application(s) to support the claimed invention.”

This means:

  • Claims fully supported by the parent application may benefit from the earlier filing date.
  • Claims relying on newly added matter in the CIP will have the filing date of the CIP as their effective date.
  • The later filing date for new matter can affect patentability if relevant prior art emerges between the parent and CIP filing dates.

It’s crucial to carefully consider the timing and content of a CIP to maximize patent protection and avoid potential issues with prior art.

For more information on effective filing date, visit: effective filing date.

For more information on patent rights, visit: patent rights.

The filing date of a continuation application can significantly affect its patent term. While the continuation application gets the benefit of the earlier filing date for prior art purposes, its actual filing date is used to calculate the patent term. According to MPEP 201.07:

The filing date of a continuation application is the filing date of the parent application.

However, this refers to the priority date for prior art purposes. The actual patent term is calculated from the filing date of the continuation application itself. Here’s how it works:

  • The patent term is generally 20 years from the filing date of the earliest non-provisional application to which priority is claimed.
  • For a continuation application, this means 20 years from the filing date of the parent non-provisional application.
  • Each continuation in a chain reduces the effective patent term.

It’s crucial to consider this when deciding whether to file a continuation or a new application, as it can impact the overall protection period for your invention.

For more information on continuation application, visit: continuation application.

For more information on patent priority, visit: patent priority.

For more information on patent term, visit: patent term.

The addition of new matter in a continuation-in-part (CIP) application can significantly affect priority claims. Here’s how:

  • Claims that are fully supported by the parent application retain the parent’s filing date.
  • Claims that rely on the new matter added in the CIP receive the filing date of the CIP application.

The MPEP 201.08 states: The disclosure presented in the continuation-in-part application may include subject matter in common with or vary from that of the prior application. This means that each claim in a CIP must be evaluated individually to determine its effective filing date, which can impact prior art considerations and the validity of the patent.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

Small entity status does not automatically carry over from a parent application to a continuation application. The MPEP provides clear guidance on this matter:

If small entity status has been established in a parent application and is still proper and desired in a continuation, continuation-in-part, or divisional application filed under 37 CFR 1.53(b), a new assertion as to the continued entitlement to small entity status under 37 CFR 1.27 is required.

This means that applicants must take specific steps to maintain small entity status in a continuation application:

  1. Review Eligibility: Ensure that the applicant still qualifies for small entity status under the current rules.
  2. New Assertion: File a new assertion of entitlement to small entity status in the continuation application.
  3. Timing: This assertion should be made at the time of filing the continuation application or with the first fee payment.

It’s important to note that improperly claiming small entity status can have serious consequences, including the patent being held unenforceable. Therefore, applicants should carefully review their status before making a new assertion in a continuation application.

For micro entity status, the requirements are even more stringent:

The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

Applicants should be diligent in properly asserting and maintaining their entity status throughout the patent application process, including when filing continuation applications.

For more information on continuation application, visit: continuation application.

For more information on patent fees, visit: patent fees.

How does new matter in a continuation-in-part application affect priority dates?

The introduction of new matter in a continuation-in-part (CIP) application has significant implications for priority dates. According to MPEP 201.08:

“The new matter in a continuation-in-part application is not entitled to the benefit of the filing date of the parent application.”

This means:

  • Subject matter carried over from the parent application retains the parent’s filing date as its priority date
  • New matter introduced in the CIP has the filing date of the CIP as its priority date
  • Different claims within the same CIP application may have different priority dates

This distinction is crucial for determining prior art and potential patent infringement cases. Inventors and patent practitioners must carefully consider the implications of adding new matter when filing a CIP application.

For more information on new matter, visit: new matter.

Tags: new matter

How does new matter in a continuation-in-part affect prior art considerations?

The introduction of new matter in a continuation-in-part (CIP) application significantly affects prior art considerations. According to the MPEP 201.08:

Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the prior-filed application are entitled to the benefit of the filing date of the prior-filed application.

This means:

  • Claims based on new matter have the filing date of the CIP as their effective filing date.
  • Prior art that predates the CIP filing but postdates the parent application can be used against claims based on new matter.
  • Claims fully supported by the parent application retain the earlier effective filing date for prior art purposes.

Patent examiners must carefully analyze each claim to determine its effective filing date and apply the appropriate prior art. Applicants should be aware that introducing new matter may expose some claims to a broader range of prior art, potentially affecting patentability.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

For more information on prior art, visit: prior art.

How does new matter in a continuation-in-part affect patent rights?

New matter introduced in a continuation-in-part (CIP) application can significantly affect patent rights. According to MPEP 201.08, “Matter not disclosed in the parent nonprovisional application is entitled only to the filing date of the continuation-in-part application.”

This means:

  • New matter is only entitled to the filing date of the CIP application itself.
  • This later filing date can impact the assessment of prior art for the new matter.
  • Patent term for claims based on new matter may be calculated from the CIP filing date.
  • Different parts of the CIP application may have different priority dates, affecting patentability and enforcement.

It’s crucial for inventors and patent practitioners to carefully consider the implications of adding new matter in a CIP, as it can affect the scope and strength of patent protection.

For more information on new matter, visit: new matter.

For more information on patent rights, visit: patent rights.

The treatment of new matter varies depending on the type of continuing application:

  • Continuation and Divisional Applications: Must not contain any new matter. The disclosure must be the same as the prior application.
  • Continuation-in-Part (CIP) Applications: Can include new matter not disclosed in the parent application.
  • Continued Prosecution Applications (CPAs): Cannot contain new matter.

For continuation and divisional applications, the MPEP states: “The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.”

For CIPs, the MPEP notes: “A continuation-in-part is an application… repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.”

If new matter is found in a continuation or divisional application, the examiner will require the applicant to delete the benefit claim or change the application to a continuation-in-part. For CPAs, any new matter introduced will be required to be canceled.

It’s important to note that claims in a CIP application that rely on new matter will only be entitled to the filing date of the CIP, not the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

According to MPEP 201.01, original applications are defined as follows:

‘Original applications include applications filed under 35 U.S.C. 111(a) and provisional applications filed under 35 U.S.C. 111(b).’

This definition encompasses two distinct types of applications:

  • Non-provisional applications filed under 35 U.S.C. 111(a)
  • Provisional applications filed under 35 U.S.C. 111(b)

Understanding this distinction is crucial for inventors and patent practitioners when deciding which type of application to file based on their specific needs and circumstances.

For more information on patent filing, visit: patent filing.

MPEP 201.01 provides a clear definition of a national application in the context of U.S. patent law. According to MPEP 201.01:

‘A national application is one that was filed in the United States Patent and Trademark Office (USPTO) under 35 U.S.C. 111(a), an application which entered the national stage from an international application after compliance with 35 U.S.C. 371, or a reissue application filed under 35 U.S.C. 251.’

This definition encompasses three main categories:

  1. Applications filed directly with the USPTO under 35 U.S.C. 111(a)
  2. International applications that have entered the national stage in the U.S. after complying with 35 U.S.C. 371
  3. Reissue applications filed under 35 U.S.C. 251

Understanding this definition is crucial for patent applicants and practitioners to determine the appropriate filing procedures and requirements for their inventions.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on USPTO, visit: USPTO.

The MPEP 201 defines a provisional application for patent as follows:

“A provisional application for patent is a U.S. national application filed in the USPTO under 35 U.S.C. 111(b). It allows filing without a formal patent claim, oath or declaration, or any information disclosure (prior art) statement.”

Key features of a provisional application include:

  • It provides the means to establish an early effective filing date in a later filed nonprovisional patent application.
  • It allows the term “Patent Pending” to be applied in connection with the description of the invention.
  • It has a pendency lasting 12 months from the date the provisional application is filed.
  • The 12-month pendency period cannot be extended.

Provisional applications are often used by inventors to quickly secure a filing date while they continue to develop their invention or seek funding.

For more information on 12-month pendency, visit: 12-month pendency.

For more information on early filing date, visit: early filing date.

For more information on provisional application, visit: provisional application.

Inventorship in a Continued Prosecution Application (CPA) generally carries over from the prior application, but there are some important considerations:

  • The inventive entity of the CPA is automatically the same as the prior application unless a statement is filed requesting deletion of inventors
  • A statement requesting deletion of inventors must be filed with the CPA request and signed by a person authorized under 37 CFR 1.33(b)
  • New inventors cannot be added simply by naming them in the CPA transmittal letter or a new oath/declaration
  • To add new inventors, a request under 37 CFR 1.48 must be filed, including the required fee

The MPEP states: The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If an inventor is named in the CPA who was not in the prior application, the examiner will notify the applicant using form paragraph 2.33:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent applications, visit: patent applications.

In a Continued Prosecution Application (CPA), the inventorship is typically the same as in the prior application. However, if a new inventor needs to be added, a specific process must be followed. According to MPEP ¶ 2.33:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48. Otherwise, the inventorship in the CPA shall be the same as in the prior application.

This means that if you want to add a new inventor to a CPA, you must file a formal request under 37 CFR 1.48, which outlines the procedures for correcting or changing inventorship in patent applications.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

Inventorship in a continuing application depends on the type of continuing application and when it was filed. Key points:

  • For applications filed on or after September 16, 2012, the inventorship is initially the inventor(s) named in the application data sheet
  • For earlier applications, the inventorship carries over from the parent application
  • In a continuation or divisional, the inventorship must include at least one inventor named in the parent application
  • In a continuation-in-part, new inventors can be added to cover new matter
  • Inventorship can be corrected if needed using procedures under 37 CFR 1.48

For CPAs filed on or after September 16, 2012, the MPEP states: The inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application.

If the inventorship needs to be changed, a request under 37 CFR 1.48 must be filed.

For more information on application data sheet, visit: application data sheet.

For more information on continuing applications, visit: continuing applications.

For more information on inventorship, visit: inventorship.

Inventorship is a crucial aspect of continuation applications. According to MPEP 201.07:

The inventorship in the continuation application must include at least one inventor named in the prior-filed application…

This requirement ensures a clear line of continuity between the parent application and the continuation application. Key points to consider:

  • At least one inventor from the parent application must be included in the continuation application.
  • Additional inventors can be added to the continuation application if they contributed to the claimed invention.
  • Inventors from the parent application who did not contribute to the claims in the continuation application can be removed.
  • Changes in inventorship must be properly documented and may require an oath or declaration from new inventors.

For Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), there are additional inventorship requirements:

In addition, a continuation or divisional application may only be filed under 37 CFR 1.53(d) if the prior application is a nonprovisional design application, but not an international design application, that is complete as defined by 37 CFR 1.51(b) (except for the inventor’s oath or declaration if the CPA is filed on or after September 16, 2012), and the prior nonprovisional application contains an application data sheet indicating the name, residence, and mailing address of each inventor.

Always consult with a patent attorney when dealing with inventorship issues in continuation applications to ensure compliance with USPTO requirements.

For more information on application data sheet, visit: application data sheet.

Incorporation by reference can be an important tool in continuation applications, allowing applicants to include material from prior applications. The MPEP provides detailed guidance on this topic:

For applications filed on or after September 21, 2004:

An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are “hereby incorporated by reference.” The statement must appear in the specification.

Additionally, for these applications:

For applications filed on or after September 21, 2004, a claim under 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78(d) for benefit of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States that was present on the filing date of the continuing application is considered an incorporation by reference of the prior-filed application as to inadvertently omitted material, subject to the conditions and requirements of 37 CFR 1.57(b).

For applications filed before September 21, 2004:

The incorporation by reference statement could appear in the application transmittal letter or in the specification.

It’s important to note that incorporation by reference cannot be used to add new matter to an application after its filing date. The MPEP states:

An incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

Proper use of incorporation by reference can help applicants maintain continuity between related applications and potentially recover from certain filing errors.

For more information on 37 cfr 1.57, visit: 37 cfr 1.57.

For more information on continuation application, visit: continuation application.

For more information on incorporation by reference, visit: incorporation by reference.

Filing a Continued Prosecution Application (CPA) includes a waiver of confidentiality for the prior application. The MPEP states:

A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means that if someone is entitled to access information about either the CPA or the prior application, they may also be given access to information about the other related applications in the file. Applicants should be aware of this reduced confidentiality when deciding whether to file a CPA.

Filing a Continued Prosecution Application (CPA) has implications for public access to the application. The MPEP states:

“A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file. 37 CFR 1.53(d)(6).”

This means:

  • The CPA is considered a waiver of confidentiality for the entire application chain
  • Members of the public who have access to one application in the chain may be given similar access to others
  • This increased accessibility applies to both the prior application and any continuing applications

Applicants should be aware of this potential for increased public access when deciding to file a CPA.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

Filing a Continued Prosecution Application (CPA) has implications for the confidentiality of the application under 35 U.S.C. 122:

  • Filing a CPA is construed as a waiver of confidentiality to a certain extent
  • Members of the public entitled to access the prior application may be given similar access to the CPA and other related applications
  • This waiver applies to the entire chain of related applications

The MPEP states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

For more information on 35 U.S.C. 122, visit: 35 U.S.C. 122.

For more information on patent applications, visit: patent applications.

For more information on public access, visit: public access.

Filing a Continued Prosecution Application (CPA) has implications for confidentiality and public access to application information:

  • Filing a CPA is construed as a waiver of confidentiality under 35 U.S.C. 122
  • Members of the public entitled to access the prior application may be given similar access to the CPA
  • This waiver extends to any continuing applications in the chain of CPAs
  • Certified copies of CPAs will include the most recent non-continued prosecution application in the chain

MPEP 201.06(d) states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

For more information on USPTO procedures, visit: USPTO procedures.

Filing a continuation-in-part (CIP) application does not automatically resolve or affect outstanding rejections in the parent application. The MPEP 201.08 clarifies this point:

“The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

This means:

  • Outstanding rejections in the parent application remain active and must be addressed separately.
  • The applicant is not presumed to agree with or accept these rejections by filing a CIP.
  • The CIP application will be examined independently, though it may face similar rejections if it includes the same claimed subject matter.

Applicants should continue to respond to office actions and address rejections in the parent application if they wish to pursue those claims, even after filing a CIP.

For more information on parent application, visit: parent application.

For more information on patent examination, visit: patent examination.

Filing a continuation or divisional application under 37 CFR 1.53(b) does not automatically abandon the prior application. The status of the prior application depends on the actions taken by the applicant:

  1. The prior application remains pending unless expressly abandoned.
  2. To expressly abandon the prior application, a separate paper must be filed and signed in accordance with 37 CFR 1.138.
  3. If a notice of allowance has been issued in the prior application, it can become abandoned by nonpayment of the issue fee.

The MPEP states: Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application. If the prior nonprovisional application is to be expressly abandoned, such a paper must be signed in accordance with 37 CFR 1.138.

It’s important to note that if the issue fee has been paid in the prior application, a petition to withdraw the application from issue must be filed before it can be abandoned, even if a continuing application has been filed.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

Filing a continuation application under 37 CFR 1.53(b) does not automatically abandon the prior application. The MPEP clearly states:

Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application.

However, applicants have several options regarding the status of the prior application:

  1. Express Abandonment: If desired, the prior application can be expressly abandoned. This requires a separate paper signed in accordance with 37 CFR 1.138.
  2. Allowed Applications: If the prior application has received a notice of allowance, it can become abandoned by non-payment of the issue fee.
  3. Continued Prosecution: The prior application can remain pending if the applicant wishes to continue prosecution.

It’s important to note that if an issue fee has been paid in the prior application, special procedures are required:

However, once an issue fee has been paid in the prior application, even if the payment occurs following the filing of a continuing application under 37 CFR 1.53(b), a petition to withdraw the prior nonprovisional application from issue must be filed before the prior nonprovisional application can be abandoned (37 CFR 1.313).

Applicants should carefully consider their strategy for managing multiple related applications when filing a continuation.

For more information on continuation application, visit: continuation application.

For more information on patent prosecution, visit: patent prosecution.

Continued Prosecution Application (CPA) practice differs significantly for utility and plant applications compared to design applications. The key difference is:

CPA practice is not available for utility and plant applications filed on or after May 29, 2000.

As stated in the MPEP 201.06(d): “Effective July 14, 2003, CPA practice has been eliminated as to utility and plant applications in view of the eighteen-month publication of applications under 35 U.S.C. 122(b). A request for a CPA filed on or after July 14, 2003 in a utility or plant application is improper and will not be treated as a CPA.”

For utility and plant applications, applicants should instead consider filing:

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on RCE, visit: RCE.

Confidentiality in Continued Prosecution Applications (CPAs) is handled differently from standard applications. Filing a CPA includes a waiver of confidentiality to some extent:

  • The CPA is construed to include a waiver of confidentiality under 35 U.S.C. 122
  • This waiver allows public access to both the prior application and any continuing applications filed under 37 CFR 1.53(d)
  • Access is limited to those entitled under 37 CFR 1.14 to obtain information about the applications

The MPEP states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means that if someone is entitled to access information about either the prior application or the CPA, they may be given similar access to information about both applications. This is different from the standard confidentiality provisions for pending applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Claiming the benefit of an earlier filing date for continuing applications (continuation, divisional, and continuation-in-part) is governed by 35 U.S.C. 120 and 37 CFR 1.78. Key points include:

  • The continuing application must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  • The continuing application must contain a specific reference to the prior application.
  • For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet (ADS).
  • For applications filed before September 16, 2012, the specific reference must be in the first sentence(s) of the specification or in an ADS.
  • The continuing application must have at least one common inventor with the prior application.

As stated in the MPEP:

A continuation or divisional application that names as inventors the same or fewer than all of the inventors named in the prior application may be filed under this paragraph or paragraph (d) of this section.

It’s important to note that for continuation-in-part applications, any claims that rely on new matter added in the CIP will not be entitled to the benefit of the earlier filing date of the parent application.

For more information on patent application types, visit: patent application types.

An international application designating the United States has significant effects on the application process:

  • It is treated as a national application from its international filing date.
  • It follows different rules for restriction practice and unity of invention.
  • It has different notification procedures for incomplete applications.

According to 35 U.S.C. 363: “An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.”

However, as noted in MPEP 201.01: “Treatment of a national application under 35 U.S.C. 111 and a national stage application (a national application which entered the national stage from an international application in which the conditions of 37 CFR 1.9(a)(1) have been satisfied) are similar but not identical.” For example, unity of invention practice applies to national stage applications, while restriction practice applies to applications filed under 35 U.S.C. 111(a).

For more information on international applications, visit: international applications.

An international application designating the United States has significant effects on national patent rights. According to 35 U.S.C. 363:

An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.

This means that an international application (PCT application) that designates the US is treated similarly to a national application filed under 35 U.S.C. 111. However, there are some differences in treatment between national applications and national stage applications (which enter the national stage from an international application). For example:

  • Restriction practice applies to national applications, while unity of invention practice applies to national stage applications
  • Different notification practices apply to incomplete applications in each case

For detailed information on the examination of international applications in the national stage, refer to MPEP § 1893.03.

For more information on international applications, visit: international applications.

For more information on patent rights, visit: patent rights.

When a Continued Prosecution Application (CPA) is established, the examiner notifies the applicant in the first Office action of the CPA. According to MPEP ¶ 2.30, the examiner uses a specific form paragraph:

“The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.”

This notification is important because:

  • Applicants are not separately notified of the abandonment of the parent application
  • A filing receipt is not normally sent for a CPA

Therefore, this Office action serves as the official notification that the CPA has been properly established.

For more information on design patents, visit: design patents.

For more information on patent examination, visit: patent examination.

When a Continued Prosecution Application (CPA) is accepted, the examiner notifies the applicant in the first Office action of the CPA. This is because, unlike regular applications, applicants do not receive a separate notification about the abandonment of the parent application or a filing receipt for the CPA.

MPEP ¶ 2.30 states: Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established. This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA. This guidance ensures that applicants are properly informed about the status of their CPA.

According to MPEP § 201, specifically paragraph 2.30, an examiner notifies an applicant about a Continued Prosecution Application’s (CPA) acceptance in the first Office action of the CPA. The MPEP states:

Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established. This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

This notification is crucial because it confirms the establishment of the CPA and provides important information to the applicant about the status of their application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

When a Continued Prosecution Application (CPA) request for a design patent application is deemed unacceptable, the examiner uses a specific form paragraph to inform the applicant. According to MPEP ¶ 2.31, the examiner note states:

“Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.”

The form paragraph includes:

  • An acknowledgment of the CPA request receipt
  • The filing date of the paper containing the request
  • The Application Number identified in the CPA request
  • An explanation of why the request is not acceptable
  • A statement that no CPA has been established

This formal communication ensures that the applicant is clearly informed about the status of their CPA request and the reasons for its non-acceptance.

For more information on USPTO procedures, visit: USPTO procedures.

When a Continued Prosecution Application (CPA) request for a design patent application is not compliant with the regulations, the examiner informs the applicant using a specific form paragraph. The MPEP provides guidance on this:

Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.

The form paragraph includes:

  • Acknowledgment of the CPA request receipt
  • The filing date of the paper containing the request
  • The application number identified in the CPA request
  • Explanation of why the request is not acceptable
  • Statement that no CPA has been established

This standardized approach ensures clear communication between the USPTO and the applicant regarding the status of their CPA request.

For more information on USPTO procedures, visit: USPTO procedures.

An examiner determines if an application qualifies as a continuation under MPEP ¶ 2.05 by assessing the following criteria:

  • The application discloses only subject matter that was previously disclosed in a prior application
  • The application claims only subject matter that was disclosed in the prior application
  • The application names at least one inventor who was also named in the prior application

The MPEP provides specific language for this assessment: “This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application.” (MPEP ¶ 2.05)

If all these criteria are met, the examiner may notify the applicant that the application may constitute a continuation. The examiner will then proceed with the appropriate examination procedures for continuation applications.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

Patent examiners use specific criteria to determine if an application may qualify as a continuation-in-part (CIP). According to MPEP ¶ 2.06, an examiner should consider the following:

  • The application repeats a substantial portion of a prior application.
  • The application adds disclosure not presented in the prior application.
  • The application names the inventor or at least one joint inventor named in the prior application.

The MPEP states: Because this application names the inventor or at least one joint inventor named in the prior application, it may constitute a continuation-in-part of the prior application. However, examiners are advised to use this determination cautiously: This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Patent examiners use specific criteria to determine if an application may qualify as a divisional. According to MPEP ¶ 2.01, an examiner looks for the following indicators:

  1. The application claims only subject matter disclosed in a prior application.
  2. The claimed subject matter appears to be independent and distinct from that claimed in the prior application.
  3. At least one inventor from the prior application is named in the current application.

The MPEP provides guidance to examiners:

“This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.”

If these conditions are met, but a proper benefit claim hasn’t been made, the examiner may use this paragraph to notify the applicant of the possible divisional status and the need to establish a benefit claim if desired.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

For more information on USPTO, visit: USPTO.

To claim the benefit of a prior application’s filing date for a divisional application, applicants must follow specific procedures outlined in patent law and regulations. The MPEP ¶ 2.01 states:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This means applicants should:

  • Ensure compliance with 35 U.S.C. 120 requirements for continuity and disclosure
  • Follow the procedures outlined in 37 CFR 1.78 for claiming benefit
  • Consult MPEP § 211 for detailed guidance on benefit claims

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the divisional application.

For more information on Divisional application, visit: Divisional application.

How does a U.S. national stage application differ from a regular national application?

A U.S. national stage application is derived from an international application, while a regular national application is filed directly with the USPTO. The key differences lie in their origins and the legal provisions governing them.

As stated in MPEP 201.01:

A national application may be a U.S. national application filed under 35 U.S.C. 111(a), or a national stage application under 35 U.S.C. 371 of an international application.

Regular national applications are filed under 35 U.S.C. 111(a), while national stage applications enter the U.S. national phase from an international PCT application under 35 U.S.C. 371. National stage applications must meet specific requirements for entering the national phase, such as time limits and submission of necessary documents.

For more information on national stage application, visit: national stage application.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A terminal disclaimer filed in a parent application automatically carries over to a Continued Prosecution Application (CPA). The MPEP clearly states:

“A terminal disclaimer filed in the parent application carries over to a CPA. The terminal disclaimer filed in the parent application carries over because the CPA retains the same application number as the parent application, i.e., the application number to which the previously filed terminal disclaimer is directed.”

However, if an applicant does not want the terminal disclaimer to apply to the CPA, they must take specific action:

“If applicant does not want the terminal disclaimer to carry over to the CPA, applicant must file a petition under 37 CFR 1.182 along with the required petition fee, requesting the terminal disclaimer filed in the parent application not be carried over to the CPA.”

It’s important to note that such a petition must be filed and granted before the patent issues to be effective.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on patent term, visit: patent term.

A substitute application is distinct from a continuing application in several ways. According to MPEP 201.02:

‘A substitute application is an application which is filed to take the place of a prior application and which is identified as such and discloses and claims only subject matter disclosed in the prior application.’

Key differences include:

  • A substitute application replaces the prior application entirely, while a continuing application coexists with the prior application.
  • Substitute applications only claim subject matter from the prior application, whereas continuing applications may introduce new matter (in the case of continuation-in-part applications).
  • The filing of a substitute application typically results in the abandonment of the prior application, which is not necessarily the case with continuing applications.

For more information on patent prosecution, visit: patent prosecution.

For more information on substitute application, visit: substitute application.

A substitute application has a significant impact on the filing date of a patent application. According to MPEP 201.02:

A substitute application does not obtain the benefit of the filing date of the prior application.

This means that if an applicant files a substitute application, it will receive a new filing date based on when it was submitted, rather than inheriting the filing date of the original application it’s replacing. This can have important implications for patent priority and the determination of prior art.

It’s crucial for applicants to understand this distinction, as the filing date can significantly affect the patentability of an invention, especially in fast-moving technological fields.

For more information on patent procedure, visit: patent procedure.

For more information on substitute application, visit: substitute application.

How does a restriction requirement lead to a divisional application?

A restriction requirement often leads to the filing of a divisional application. This process occurs as follows:

  1. An examiner issues a restriction requirement when they believe the original application contains claims to two or more independent or distinct inventions.
  2. The applicant must then elect one invention to pursue in the original application.
  3. The non-elected inventions can be pursued in one or more divisional applications.

As stated in MPEP 201.06:

“The inventions embodied in the claims of a divisional application are generally further characterized as (1) independent inventions or (2) related inventions which are distinct.”

This means that the divisional application allows the applicant to protect inventions that were disclosed but not pursued in the original application due to the restriction requirement.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

While the MPEP 201.02 doesn’t provide detailed definitions, it references 37 CFR 1.9(a) for the definitions of provisional and nonprovisional applications:

  • Provisional Application: A temporary application that establishes an early filing date but does not mature into an issued patent without further action.
  • Nonprovisional Application: A regular patent application that can be examined and potentially result in an issued patent.

Key differences include:

  • Provisional applications have a pendency of 12 months from the filing date.
  • Nonprovisional applications undergo examination, while provisional applications do not.
  • A nonprovisional application must be filed within 12 months of the provisional to claim its filing date benefit.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

How does a provisional application affect public disclosure of an invention?

Filing a provisional application does not automatically result in public disclosure of your invention. The MPEP 201.04 states: ‘A provisional application will not be published, and, therefore, no publication fee is required.’

This means that your invention remains confidential when you file a provisional application. However, it’s crucial to understand that:

  • The confidentiality only applies to the USPTO’s handling of your application.
  • If you publicly disclose your invention yourself, it could affect your ability to obtain patents in some countries.
  • The 12-month grace period for filing a nonprovisional application starts from the provisional filing date, not from any public disclosure you might make.

Always consult with a patent attorney before making any public disclosures about your invention, even after filing a provisional application.

For more information on provisional application, visit: provisional application.

For more information on public disclosure, visit: public disclosure.

A plant patent application is a specialized type of patent application designed to protect new varieties of plants. The MPEP 201 states:

A plant application is an application for a plant patent. A plant patent protects a distinct and new variety of plant that is asexually reproduced.

Key differences of plant patent applications include:

  • They are specifically for asexually reproduced plants
  • They protect the entire plant, not just a specific part
  • They have unique requirements for description and claiming

Plant patents are less common than utility or design patents but are crucial for protecting innovations in agriculture and horticulture.

For more information on patent application types, visit: patent application types.

According to MPEP 201.01, a PCT (Patent Cooperation Treaty) application can enter the national stage in the United States through the following process:

  1. The applicant must comply with the requirements of 35 U.S.C. 371.
  2. This typically involves submitting the national fee, a copy of the international application (unless previously communicated by the International Bureau), and a translation into English if the international application was filed in another language.
  3. Once these requirements are met, the application is considered a national application under 35 U.S.C. 111(a).

The MPEP states: “An international application enters the national stage when the applicant has fulfilled the requirements of 35 U.S.C. 371.” This process allows inventors to seek patent protection in multiple countries through a single international application.

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

A Patent Cooperation Treaty (PCT) application can become a national application in the United States when certain conditions are met. According to MPEP 201.01:

‘An international application filed under the Patent Cooperation Treaty in which the basic national fee under 35 U.S.C. 41(a)(1)(F) has been paid’ becomes a national application.

This process, known as ‘national stage entry,’ involves the following steps:

  • Filing the appropriate documents with the USPTO
  • Paying the required national fee
  • Providing an English translation if the international application was not filed in English

Once these requirements are fulfilled, the international application effectively becomes a U.S. national application and is processed accordingly.

For more information on national stage entry, visit: national stage entry.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

When a patent examiner encounters an amendment attempting to reference a prior application in a Continued Prosecution Application (CPA), they should not enter the amendment and inform the applicant of this decision.

According to MPEP ¶ 2.34, examiners should use the following language:

“The amendment filed [1] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [2] application of Application No. [3] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

Examiners should fill in the brackets with: [1] the filing date of the amendment, [2] either “continuation” or “divisional”, and [3] the Application Number of the prior nonprovisional application.

For more information on CPA, visit: CPA.

Tags: CPA

When a patent examiner encounters an amendment attempting to refer to a Continued Prosecution Application (CPA) as a continuation or divisional application, they should not enter the amendment. According to MPEP § 201.06(d), examiners are instructed to use Form Paragraph 2.34 to inform the applicant that such amendments will not be entered:

“Use this form paragraph to inform the applicant that an amendment to the first sentence(s) of the specification referring to the CPA as a continuing application of the prior application has not been entered and will not be entered if submitted again.”

The examiner will provide the reason for non-entry, explaining that the CPA request itself serves as the specific reference required by 35 U.S.C. 120, and there is no need to amend the specification to refer back to the prior application.

For more information on CPA, visit: CPA.

Tags: CPA

A national application differs from an international application in several key aspects:

  • Filing Authority: National applications are filed directly with the United States Patent and Trademark Office (USPTO), while international applications are filed under the Patent Cooperation Treaty (PCT).
  • Legal Basis: National applications are filed under 35 U.S.C. 111(a), as stated in MPEP 201.01: ‘A national application may be filed under 35 U.S.C. 111(a) in the U.S. Patent and Trademark Office (USPTO)…’
  • Geographical Scope: National applications are specific to the United States, while international applications can potentially provide patent protection in multiple countries.
  • Examination Process: National applications enter the USPTO examination queue directly, whereas international applications have an international phase before entering national phases in designated countries.

Understanding these differences is crucial for inventors and legal representatives when deciding on their patent filing strategy.

For more information on USPTO, visit: USPTO.

Tags: USPTO

Divisional applications and provisional applications are distinct types of patent applications with different purposes and characteristics:

  • Divisional Application: Claims subject matter from a prior non-provisional application that is independent and distinct from the original claims.
  • Provisional Application: A temporary application that establishes a priority date but does not mature into an issued patent.

The MPEP explicitly states in MPEP ¶ 2.01:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.”

This distinction is important because divisional applications claim the benefit under 35 U.S.C. 120, while provisional applications are claimed under 35 U.S.C. 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

Design patent applications and utility patent applications are distinct types of patent applications, each protecting different aspects of an invention. According to MPEP 201:

‘Design applications are not included in the term ‘nonprovisional’ as used in 37 CFR 1.9. […] Design applications are treated separately in 35 U.S.C. 171-173 and 37 CFR 1.151-1.155.’

Key differences include:

  • Subject Matter: Utility patents protect how an invention works, while design patents protect how it looks.
  • Duration: Utility patents last 20 years from filing, design patents 15 years from grant.
  • Examination Process: Design applications typically have a simpler examination process.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) automatically references the prior application without requiring any specific amendment to the specification.

According to MPEP ¶ 2.34: “As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that the act of filing a CPA itself serves as the reference to the prior application, eliminating the need for any additional amendments or references in the specification.

A Continued Prosecution Application (CPA) differs from other types of continuing applications in several ways:

  • CPAs are only available for design applications, not utility applications.
  • Filing a CPA automatically establishes the necessary reference to the prior application under 35 U.S.C. 120, without needing to amend the specification.
  • CPAs are processed differently from other continuing applications, as outlined in MPEP § 201.06(d).

The MPEP states: ‘As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.’ This unique feature distinguishes CPAs from other types of continuing applications, such as continuations or divisionals, which may require explicit references in the specification.

For more information on continuing applications, visit: continuing applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) and a continuation application are both ways to continue prosecution of a patent application, but they have key differences:

  • CPA: Only available for design applications filed before May 29, 2000, and for plant applications. It continues examination of the same application.
  • Continuation: Available for all types of applications and creates a new application that claims priority to the parent application.

The MPEP ¶ 2.34 highlights a crucial distinction in how they reference prior applications:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.

This means that for a CPA, the mere act of filing establishes the reference to the prior application. In contrast, a continuation application typically requires an explicit reference to the parent application in the specification.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) automatically maintains the priority claim to its parent application without requiring a separate reference. The CPA itself serves as the specific reference required under 35 U.S.C. 120.

The MPEP states: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

This means that filing a CPA automatically establishes a priority claim to the parent application and any earlier applications in the priority chain without additional paperwork.

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

Filing a Continued Prosecution Application (CPA) has specific effects on the status of the prior application:

  • The prior application is abandoned by operation of law upon filing of the CPA.
  • Any appeal in the prior application is dismissed automatically.
  • Any amendment filed with the CPA request is not entered unless it is specifically requested by the applicant.

As stated in the MPEP 201.06(d): ‘The filing of a CPA is not a filing of a new application. Rather, it is a continuation of the pending prior application.’ This means that while the prior application is technically abandoned, its substance continues in the CPA.

It’s important to note that any amendment accompanying the CPA request will be placed in the file but not entered unless the applicant specifically requests it. This allows applicants to submit potential amendments without automatically changing the application’s content.

For more information on CPA, visit: CPA.

Tags: CPA

Filing a Continued Prosecution Application (CPA) has several effects on the examination process:

  • The CPA is treated as a continuation of the prior application for examination purposes
  • Information Disclosure Statements from the prior application are automatically considered in the CPA
  • Affidavits and declarations from the prior application carry over to the CPA
  • A terminal disclaimer filed in the parent application carries over to the CPA
  • For examination priority, CPAs are treated as ‘amended’ applications rather than ‘new’ applications if an Office action was issued in the prior application

MPEP 201.06(d) notes: For examination priority purposes only, the USPTO will treat continuation CPAs as if they were ‘amended’ applications (as of the CPA filing date) and not as ‘new’ applications. This treatment is limited to CPAs in which the prior application has an Office action issued by the examiner.

For more information on design patents, visit: design patents.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

Filing a Continued Prosecution Application (CPA) can impact the examination process and priority. Key points include:

  • CPAs are generally treated as “amended” applications for examination priority purposes
  • This may result in faster first Office actions compared to new applications
  • Preliminary amendments should be filed with the CPA to avoid potential denial of entry
  • Information Disclosure Statements (IDS) from the prior application are automatically considered

As stated in the MPEP:

For examination priority purposes only, the USPTO will treat continuation CPAs as if they were “amended” applications (as of the CPA filing date) and not as “new” applications. This treatment is limited to CPAs in which the prior application has an Office action issued by the examiner.

Applicants can request a three-month suspension of action under 37 CFR 1.103(b) if more time is needed to prepare amendments or an IDS. Affidavits and declarations from the parent application automatically become part of the CPA.

A Continued Prosecution Application (CPA) automatically maintains the benefit claim to earlier applications. The MPEP states:

A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. That is, the CPA includes the request for an application under 37 CFR 1.53(d) and the recitation of the application number of the prior application in such request is the ‘specific reference to the earlier filed application’ required by 35 U.S.C. 120.

This means that filing a CPA automatically establishes a benefit claim to the prior application and any earlier applications in the chain, without the need for a separate statement in the specification or application data sheet. However, if the prior application claimed benefit of earlier applications, those benefit claims must still be present in the prior application.

For more information on continuation applications, visit: continuation applications.

For more information on patent priority, visit: patent priority.

Continued Prosecution Applications (CPAs) automatically carry over certain aspects from the parent application. Specifically:

  • Priority claims under 35 U.S.C. 119(a)-(d) made in the parent application automatically carry over to a CPA.
  • A terminal disclaimer filed in the parent application carries over to a CPA.

The MPEP explains: Priority claims under 35 U.S.C. 119(a)-(d) made in a parent application will automatically carry over to a CPA. A terminal disclaimer filed in the parent application carries over to a CPA.

This automatic carry-over occurs because the CPA retains the same application number as the parent application.

For more information on patent applications, visit: patent applications.

Filing a Continued Prosecution Application (CPA) can have important implications for both patent term and prior art dates:

Patent Term:

  • A CPA is a continuation of the prior application, so it does not get a new 15-year term from filing
  • The 15-year term for a design patent issuing from a CPA is measured from the filing date of the earliest application in the chain that is subject to the 15-year term

Prior Art Dates:

  • The effective filing date of a CPA for prior art purposes is generally the actual filing date of the CPA
  • However, the CPA can claim the benefit of the prior application’s filing date for subject matter disclosed in the prior application

The MPEP notes: “A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No amendment in an application under this paragraph may delete this specific reference to any prior application.” (37 CFR 1.53(d)(7))

This means the CPA is automatically considered a continuation for benefit claim purposes, which can affect both term and prior art dates.

For more information on benefit claims, visit: benefit claims.

For more information on patent term, visit: patent term.

For more information on prior art, visit: prior art.

Filing a Continued Prosecution Application (CPA) has implications for the confidentiality of the application. As stated in the MPEP:

A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means:

  • The CPA is treated as a waiver of confidentiality for the prior application
  • Members of the public who have access to the CPA may also be given access to the prior application
  • This applies to all applications in the chain of CPAs

Applicants should consider this loss of confidentiality when deciding whether to file a CPA or a new application under 37 CFR 1.53(b).

For more information on Patent application access, visit: Patent application access.

For more information on public information, visit: public information.

A Continued Prosecution Application (CPA) automatically maintains the benefit claim to the prior application under 35 U.S.C. 120 without requiring a separate statement. Key points include:

  • The CPA request itself serves as the specific reference required by 35 U.S.C. 120
  • No amendment to the specification or application data sheet is needed to maintain the benefit claim
  • The benefit claim extends to all applications in a chain of CPAs

As stated in the MPEP: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on patent applications, visit: patent applications.

A Continued Prosecution Application (CPA) has specific effects on benefit claims and references to prior applications:

  • The CPA request itself serves as the specific reference required by 35 U.S.C. 120
  • No amendment to the specification or application data sheet is required or permitted to reference the prior application
  • A CPA automatically includes a benefit claim to all applications in the chain of CPAs with the same application number

As stated in the MPEP:

A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No amendment in an application under this paragraph may delete this specific reference to any prior application.

This means that applicants cannot selectively delete benefit claims to certain applications in the CPA chain. When referencing a CPA in a later application, the reference incorporates the entire chain of applications with that application number.

A Continued Prosecution Application (CPA) is a unique type of continuing application that has specific limitations. According to MPEP 201.02:

A ‘continued prosecution application’ (CPA) is a continuation or divisional application for an invention disclosed in a prior nonprovisional application filed under 37 CFR 1.53(b) or (d). A CPA can only be filed in a design application.

Key differences of CPAs compared to other continuing applications:

  • Limited to design applications: CPAs can only be filed for design patents, not utility or plant patents.
  • Automatic abandonment: Filing a CPA automatically abandons the prior application.
  • Simplified filing: CPAs can be filed with fewer formalities than other continuing applications.
  • Examination continuation: The examination process continues from where it left off in the parent application.

It’s important to note that CPAs are no longer available for utility or plant applications filed on or after May 29, 2000. For these types of applications, applicants must use other forms of continuing applications, such as RCEs (Requests for Continued Examination).

For more information on continued prosecution application, visit: continued prosecution application.

For more information on continuing applications, visit: continuing applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A continuation-in-part (CIP) application and a provisional application are two distinct types of patent applications with different purposes and effects. The key difference is highlighted in MPEP ¶ 2.06, which states:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation-in-part’ of the provisional application.

This means that:

  • A CIP application builds upon a prior non-provisional application, adding new disclosure while claiming the benefit of the earlier filing date for the shared content.
  • A provisional application is a temporary placeholder that establishes a priority date but does not mature into a patent. It cannot be continued or have a CIP.
  • Applications claiming benefit from a provisional application are typically filed as new non-provisional applications, not as CIPs.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

How does a continuation-in-part application affect the priority date?

A continuation-in-part (CIP) application can have different priority dates for different parts of the disclosure. According to MPEP 201.08:

‘The continuation-in-part application may be entitled to the benefit of the filing date of the prior application as to the common subject matter disclosed in compliance with 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph.’

This means:

  • Content shared with the parent application retains the earlier priority date.
  • New matter added in the CIP has the filing date of the CIP as its priority date.
  • Different claims in the CIP may have different priority dates based on their disclosure in the parent or CIP application.

Understanding these priority date implications is crucial for determining patentability and prior art considerations.

For more information on new matter, visit: new matter.

Tags: new matter

A continuation-in-part (CIP) application can have a complex effect on patent term. The MPEP 201.08 states:

‘A continuation-in-part application is entitled to the benefit of the filing date of an earlier nonprovisional application as to common subject matter.’

This has several implications for patent term:

  • 20-year term: The patent term is generally 20 years from the earliest effective U.S. filing date of the first nonprovisional application in the chain.
  • New matter: Claims solely supported by new matter in the CIP do not receive the benefit of the earlier filing date, potentially extending their effective term.
  • Priority claims: The ability to claim priority to earlier applications can affect the starting point of the 20-year term.
  • Patent term adjustment: Delays in prosecution may lead to patent term adjustments, which can extend the term beyond 20 years.

Applicants should carefully consider the impact on patent term when deciding to file a CIP, especially for rapidly evolving technologies where a longer term might be advantageous.

For more information on new matter, visit: new matter.

For more information on patent term, visit: patent term.

For more information on patent term adjustment, visit: patent term adjustment.

A continuation-in-part (CIP) application is a type of continuing application that differs from a regular continuation in its content and priority claims. According to MPEP 201.08:

‘A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.’

Key differences between CIP and regular continuation applications:

  • New Matter: CIPs include new subject matter not present in the parent application, while regular continuations do not.
  • Priority Date: CIPs have different priority dates for different parts of the disclosure. The new matter gets the CIP’s filing date, while common subject matter retains the parent’s filing date.
  • Examination: CIPs are examined for both the old and new subject matter, potentially requiring additional prior art searches.
  • Term: The patent term for a CIP may be affected by the new subject matter’s later filing date.

CIPs are useful when inventors want to add new improvements or developments to their original invention while maintaining the priority date for the original subject matter.

For more information on continuing applications, visit: continuing applications.

While both continuation and continuation-in-part (CIP) applications are types of continuing applications, they have a key difference in terms of their disclosure. According to the MPEP:

The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

The main differences are:

  • Continuation: Contains the same disclosure as the parent application without any new matter.
  • Continuation-in-part (CIP): May include the disclosure from the parent application plus additional new matter.

This distinction is crucial because it affects the priority date for different claims in the application. In a continuation, all claims are entitled to the parent’s filing date. In a CIP, only claims supported by the parent application get the benefit of the earlier filing date; new matter gets the filing date of the CIP.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

A continuation-in-part (CIP) application differs from a regular continuation application in that it adds new disclosure not present in the prior application. While both types of applications repeat substantial portions of a prior application, only a CIP introduces new subject matter.

The MPEP states: This application repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application. (MPEP ¶ 2.06) This additional disclosure is what sets a CIP apart from a standard continuation.

For more information on continuation application, visit: continuation application.

For more information on patent application types, visit: patent application types.

37 CFR 1.63(d) provides a simplified process for submitting an oath or declaration in a divisional application. The MPEP states:

’37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a continuation or divisional application filed by all or by fewer than all of the inventors named in a prior nonprovisional application containing a signed oath or declaration.’

This means that if the divisional application is filed by the same inventor(s) as the parent application, and there’s no new matter added, the oath or declaration from the parent application can be used for the divisional application. This simplifies the filing process and reduces paperwork.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on oath or declaration, visit: oath or declaration.

Claiming the benefit of a prior application in a continuation is a crucial step that must be done correctly. The MPEP 201.07 provides specific guidance:

If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§1.76(b)(5)). The reference also must identify the relationship of the applications, namely, whether the later-filed application is a continuation, divisional, or continuation-in-part of the prior-filed nonprovisional application, international application, or international design application.

To properly claim the benefit:

  1. Include a reference to the prior application in the Application Data Sheet (ADS)
  2. Specify the application number, filing date, and relationship (continuation) of the applications
  3. Ensure the claim is made within the time period set in 37 CFR 1.78
  4. Pay any required fees

Failure to properly claim benefit can result in loss of the earlier filing date, so it’s crucial to follow these steps carefully.

For more information on continuation application, visit: continuation application.

For more information on patent law, visit: patent law.

How do reissue applications differ from original patent applications?

Reissue applications are distinct from original patent applications in that they are used to correct errors in already-issued patents. The MPEP 201 states, “An application for reissue of a patent is an application for a new patent to correct an error in an unexpired patent as provided in 37 CFR 1.171 through 1.178.”

Key differences include:

  • Purpose: To correct errors in existing patents, not to obtain new patents
  • Timing: Filed after a patent has been issued and while it’s still unexpired
  • Legal basis: Filed under 35 U.S.C. 251 and subject to specific regulations
  • Content: Must include a copy of the original patent and point out the error(s) to be corrected
  • Examination: Focuses on the proposed changes and their impact on patentability

Reissue applications provide a mechanism for patent holders to address issues in their patents, potentially broadening or narrowing claims, or correcting other substantive errors.

For more information on reissue applications, visit: reissue applications.

To request deletion of a named inventor in a Continued Prosecution Application (CPA) for design applications, you need to file a proper request with the USPTO. According to MPEP § 201, specifically paragraph 2.32:

In a continued prosecution application (CPA) for a design application (37 CFR 1.53(d)), a request to delete a named inventor from the prior application may be submitted by way of a letter to the examiner or a request for corrected filing receipt. However, it should be noted that this is only available for design applications.

This process is specific to design applications and allows for the correction of inventorship in CPAs.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on USPTO procedures, visit: USPTO procedures.

To correctly add a new inventor to a Continued Prosecution Application (CPA), you must follow the procedures outlined in 37 CFR 1.48. The MPEP ¶ 2.33 states:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48.

To add a new inventor:

  1. File a request under 37 CFR 1.48 to correct the inventorship.
  2. Include a statement from the new inventor agreeing to the addition.
  3. Pay any required fees.
  4. Provide an oath or declaration from the new inventor.

Failure to follow these steps may result in the inventorship remaining the same as in the prior application.

For more information on CPA, visit: CPA.

Tags: CPA

To claim the benefit of a prior-filed application in a continuation application, you must include a reference to the prior-filed application in the new application. According to 37 CFR 1.78(d)(2):

Any nonprovisional application, international application designating the United States, or international design application designating the United States that claims the benefit of one or more prior-filed nonprovisional applications, international applications designating the United States, or international design applications designating the United States must contain or be amended to contain a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number), international application number and international filing date, or international registration number and filing date under §1.1023.

For nonprovisional applications, this reference must be included in an application data sheet (ADS) as specified in 37 CFR 1.76(b)(5). The reference should also identify the relationship between the applications, stating whether it’s a continuation, divisional, or continuation-in-part.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

For more information on prior-filed application, visit: prior-filed application.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP), you need to follow specific procedures. The MPEP ¶ 2.06 states: “Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

This means you must:

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the common subject matter.

Continuation, divisional, and continuation-in-part (CIP) applications are all types of continuing applications, but they have key differences:

  • Continuation application: Discloses and claims only subject matter disclosed in the prior application. No new matter is added.
  • Divisional application: Results from a restriction requirement in the parent application. Claims an independent and distinct invention carved out of the parent application. No new matter is added.
  • Continuation-in-part (CIP) application: Repeats a substantial portion of the prior application and adds matter not disclosed in the prior application (i.e., new matter is added).

As stated in the MPEP regarding continuation-in-part applications:

A continuation-in-part is an application filed during the lifetime of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.

All three types of applications must claim the benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c) and comply with other requirements set forth in 37 CFR 1.78.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

Benefit claims in Continued Prosecution Applications (CPAs) have some unique characteristics:

  • A CPA automatically includes a specific reference under 35 U.S.C. 120 to the prior application
  • No additional amendment to the specification or application data sheet is required to claim benefit
  • A CPA is considered to reference every application in the chain with the same application number
  • Priority claims under 35 U.S.C. 119(a)-(d) from the parent application automatically carry over to the CPA

The MPEP states: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

It’s important to note that applicants cannot delete benefit claims to certain applications in a chain of CPAs. The MPEP clarifies: Therefore, regardless of whether an application is filed under 37 CFR 1.53(b) or (d), a claim under 35 U.S.C. 120 to the benefit of a CPA is, by operation of 37 CFR 1.53(d)(7) and 37 CFR 1.78(d)(4), a claim to every application assigned the application number of such CPA. In addition, applicants will not be permitted to delete such a benefit claim as to certain applications assigned that application number (e.g., for patent term purposes).

For more information on benefit claims, visit: benefit claims.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Affidavits or declarations filed in a prior application do not automatically become part of a new application. As stated in MPEP ¶ 2.03: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application do not automatically become a part of this application.

To rely on an earlier-filed affidavit or declaration, the applicant must:

  • Make remarks of record in the new application
  • Include a copy of the original affidavit or declaration filed in the prior application

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

Inventorship in a Continued Prosecution Application (CPA) for design patents can be corrected by filing a statement requesting the deletion of a named inventor along with the CPA filing. The MPEP states:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This process allows for immediate correction of inventorship when filing a CPA. However, it’s important to note that any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent procedure, visit: patent procedure.

When filing a Continued Prosecution Application (CPA) for a design patent, you can delete a named inventor by including a statement with your CPA filing. The MPEP ¶ 2.32 states:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This means you should provide a clear statement identifying the inventor(s) to be deleted when submitting your CPA. The USPTO will then acknowledge and process this request, correcting the inventorship accordingly.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

When filing a Continued Prosecution Application (CPA) for a design patent, you can request the deletion of a named inventor by submitting a statement with your CPA filing. The MPEP ¶ 2.32 states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This means that you should include a clear statement requesting the deletion of the specific inventor(s) when you file your CPA. The USPTO will then acknowledge this request and correct the inventorship accordingly.

For more information on design patents, visit: design patents.

For more information on patent procedure, visit: patent procedure.

To delete a named inventor in a Continued Prosecution Application (CPA) for design applications, you must submit a statement requesting the deletion along with the CPA filing. The MPEP states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

It’s important to note that this process is specific to CPA filings for design applications. If you need to delete a named inventor after the CPA has been filed, you must follow a different procedure, as outlined in MPEP ¶ 2.32: “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent procedure, visit: patent procedure.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP) application, inventors must follow specific procedures. As noted in MPEP ¶ 2.06:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This involves properly referencing the prior application in the CIP application and ensuring that the CIP is filed before the patenting, abandonment, or termination of proceedings on the prior application. It’s crucial to follow the guidelines in MPEP § 211 for claiming domestic benefit.

For more information on domestic benefit, visit: domestic benefit.

An inventor can be deleted from a Continued Prosecution Application (CPA) for design patents by submitting a statement requesting the deletion at the time of filing the CPA. The MPEP states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This process allows for the correction of inventorship at the time of filing the CPA. However, it’s important to note that if you need to delete an inventor after the CPA has been filed, you must follow a different procedure, as stated in the MPEP: “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

For more information on CPA, visit: CPA.

Tags: CPA

To rely on an affidavit or declaration from a prior application, an applicant must take specific steps. According to MPEP ¶ 2.03:

“Where it is desired to rely on an earlier-filed affidavit or declaration, the applicant should make the remarks of record in this application and include a copy of the original affidavit or declaration filed in the prior application.”

To rely on a prior affidavit or declaration, an applicant should:

  • Make remarks of record in the new application, referencing the prior affidavit or declaration
  • Include a copy of the original affidavit or declaration from the prior application in the new application

This ensures that the examiner is aware of the prior evidence and can consider it in the context of the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

For applications filed on or after September 16, 2012, an applicant can file a continuation or divisional application using a copy of an oath or declaration from a prior application if:

  • The oath or declaration complies with 35 U.S.C. 115 as revised effective September 16, 2012
  • It was executed by or with respect to the inventor in the earlier-filed application
  • A copy of the oath, declaration, or substitute statement showing the signature or an indication it was executed is submitted in the continuing application

As stated in the MPEP: For applications filed on or after September 16, 2012, the filing of a continuing application by all or by fewer than all of the inventors named in a prior application without a newly executed oath or declaration is permitted provided that an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement under 37 CFR 1.64, was executed by or with respect to such inventor and was filed in the earlier-filed application, and a copy of such oath, declaration, or substitute statement showing the signature or an indication thereon that it was executed, is submitted in the continuing application.

It’s important to note that the oath or declaration must meet the current requirements, even if the prior application was filed before September 16, 2012.

For more information on continuation application, visit: continuation application.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

To ensure that affidavits or declarations from a prior application are considered in a new application, an applicant must take specific steps. According to MPEP ¶ 2.03:

“Where it is desired to rely on an earlier-filed affidavit or declaration, the applicant should make the remarks of record in this application and include a copy of the original affidavit or declaration filed in the prior application.”

To ensure consideration, the applicant should:

  • Explicitly reference the prior affidavit or declaration in the new application
  • Provide a copy of the original affidavit or declaration
  • Explain the relevance of the prior affidavit to the current application

This process helps the examiner understand the context and importance of the previously submitted evidence in relation to the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

Preliminary amendments in continuation applications are subject to specific rules and considerations. The MPEP provides guidance on this topic:

Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

This means that preliminary amendments submitted with the application are treated as part of the original filing. However, there are important requirements and considerations:

  1. Compliance with 37 CFR 1.121:

    Amendments must be filed in compliance with the requirements of 37 CFR 1.121 (e.g., the amendment must include a complete claim listing whenever a claim is added, canceled, or amended).

  2. Possible Requirement for Substitute Specification:

    The Office may require a substitute specification for preliminary amendments.

  3. Classification and Assignment:

    Applications should be classified and assigned to the proper Technology Center (TC) by taking into consideration the claims that will be before the examiner upon entry of such a preliminary amendment.

  4. New Matter Considerations: If the preliminary amendment introduces new matter, it may affect the application’s status as a continuation. The MPEP advises:

    Where a copy of the oath or declaration from a prior application was filed in a continuation or divisional application, if the examiner determines that new matter is present relative to the prior application, the examiner should so notify the applicant in the next Office action (preferably the first Office action). The examiner should require applicant to delete the benefit claim or redesignate the application as a continuation-in-part.

Applicants should carefully consider the content and timing of preliminary amendments in continuation applications to ensure compliance with USPTO requirements and to maintain the desired relationship with the parent application.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

The USPTO handles improper Continued Prosecution Application (CPA) requests in the following ways:

  1. For utility or plant applications filed on or after July 14, 2003, improper CPA requests are treated as requests for continued examination (RCE) under 37 CFR 1.114 if the application has a filing date on or after June 8, 1995.
  2. If the improper CPA doesn’t satisfy RCE requirements, it’s treated as an improper RCE, and the time period set in the last Office action continues to run.
  3. For applications with a filing date before June 8, 1995, the Office will notify the applicant of the improper CPA by mailing a notice.
  4. If an examiner discovers an improperly processed CPA, they should immediately notify a supervisory applications examiner (SAE) or other technical support staff to correct the application records.
  5. The Office will not convert an improper CPA into an application under 37 CFR 1.53(b) unless there are extenuating circumstances.

As stated in the MPEP: If an examiner discovers that an improper or incomplete CPA has been processed as a proper CPA in error, the examiner should immediately notify a supervisory applications examiner (SAE) or other technical support staff within the TC who will reprocess the CPA and correct the application records as appropriate.

It’s important to note that if the application becomes abandoned due to an improper CPA, the applicant may need to file a petition under 37 CFR 1.137 to revive the application and pay the required fees.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

For more information on USPTO procedures, visit: USPTO procedures.

Continued Prosecution Applications (CPAs) and Requests for Continued Examination (RCEs) are both methods to continue prosecution of an application, but they have significant differences:

  • CPAs are only available for design patent applications, while RCEs can be used for utility, plant, and design applications
  • CPAs result in a new application with the same application number, while RCEs continue examination of the same application
  • CPAs can only be filed before payment of the issue fee, abandonment, or termination of proceedings; RCEs can be filed after payment of the issue fee with a petition
  • CPAs automatically abandon the prior application, while RCEs do not

The MPEP states: Effective July 14, 2003, continued prosecution application (CPA) practice was eliminated as to utility and plant applications. Henceforth, applicants who wish to continue examination of the same claimed invention after the prosecution of a utility or plant application is closed should consider filing a request for continued examination (RCE) under 37 CFR 1.114.

It’s important to note that if an improper CPA is filed for a utility or plant application on or after July 14, 2003, it may be treated as an RCE: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

The treatment of continuation-in-part (CIP) applications changed significantly after the deletion of 37 CFR 1.62. According to the MPEP: “A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.” This means that CIP applications can no longer be filed under the former File Wrapper Continuing Procedure and must be filed as new applications.

For more information on continuation-in-part application, visit: continuation-in-part application.

For continuation-in-part (CIP) applications, the MPEP states: “A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application… will be treated as an improper application.”

This means that after the deletion of 37 CFR 1.62, CIP applications can no longer be filed using the former File Wrapper Continuing Procedure. Applicants seeking to file a CIP application must do so through the standard application process outlined in MPEP 201.06(d).

For more information on continuation-in-part application, visit: continuation-in-part application.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications, regardless of the filing date of the original application. The MPEP states:

“A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.”

This change in procedure means that applicants need to file CIP applications using different methods after December 1, 1997, to ensure proper processing and examination.

The treatment of continuation or divisional applications filed under former 37 CFR 1.62 depends on the filing date of the original application:

  • For applications filed on or after June 8, 1995: “A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114.” This means these applications are now processed under the RCE procedure.
  • For applications filed before June 8, 1995: Requests for continuation or divisional applications filed on or after December 1, 1997, will be treated as improper applications.

For more details on RCE procedures, refer to MPEP 706.07(h), paragraph IV.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on RCE, visit: RCE.

For applications filed on or after June 8, 1995, continuation or divisional applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated differently. The MPEP states: “A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114.” This means such applications are now processed under the RCE procedure rather than the former File Wrapper Continuing Procedure.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on RCE, visit: RCE.

Applications filed under former 37 CFR 1.62 before December 1, 1997, continue to be processed and examined under the procedures set forth in the former regulation. The MPEP clearly states:

“All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.”

This means that the File Wrapper Continuing Procedure remains applicable for these older applications, ensuring consistency in their examination process.

For more information on patent examination, visit: patent examination.

Affidavits or declarations filed in a prior application do not automatically become part of a new application. As stated in MPEP ¶ 2.03:

“Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application do not automatically become a part of this application.”

To rely on an earlier-filed affidavit or declaration, the applicant must:

  • Make remarks of record in the new application
  • Include a copy of the original affidavit or declaration filed in the prior application

This ensures that the examiner can consider the previously submitted evidence in the context of the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

Can you file a CPA in a provisional application?

No, you cannot file a Continued Prosecution Application (CPA) in a provisional application. The MPEP 201.06(d) clearly states:

A CPA may not be filed in a provisional application.

CPAs are only available for certain types of nonprovisional applications. Specifically, they can be filed in design applications, and in utility and plant applications that were filed before May 29, 2000. Provisional applications have a different purpose and process, and do not allow for the filing of CPAs.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

Can the specification be omitted when filing a divisional or continuation application?

No, the specification cannot be omitted when filing a divisional or continuation application. However, the process is simplified. According to MPEP 201.06(c):

“A new specification (including the claims) may be submitted in a divisional application filed under 37 CFR 1.53(b). In such a case, the applicant must file a copy of the prior application as filed or a new specification.”

This means that while you must include a specification, you have two options:

  • Submit a copy of the prior application’s specification
  • Submit a new specification tailored to the divisional or continuation application

If you choose to submit a copy of the prior application, it’s important to ensure that it properly supports the claims in the new application. Any new matter introduced in a continuation application may result in a rejection under 35 U.S.C. 112(a).

Remember, the claims are considered part of the specification, so you must include claims with your application, whether you’re using the prior specification or submitting a new one.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on patent application requirements, visit: patent application requirements.

For more information on USPTO, visit: USPTO.

Yes, the inventorship in a Continued Prosecution Application (CPA) can differ from the original application, but only if a proper request is filed and approved.

According to MPEP ¶ 2.33: Otherwise, the inventorship in the CPA shall be the same as in the prior application. This implies that changes to inventorship are possible, but they require specific action.

To change the inventorship, you must file a request under 37 CFR 1.48. This applies whether you’re adding, removing, or changing the order of inventors. Without this formal request, the inventorship will remain the same as in the original application, even if new inventors are listed on the CPA filing documents.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Yes, the inventorship in a continuation or continuation-in-part (CIP) application can differ from the parent application, but there are specific requirements:

1. For continuation applications: The inventorship must include at least one inventor named in the prior-filed application.

2. For CIP applications: The inventorship can change more significantly due to the addition of new matter.

The MPEP states for continuation applications: “The inventorship in the continuation application must include at least one inventor named in the prior-filed application.”

For CIP applications, the MPEP notes: “A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78. Subject to the same conditions, a continuation-in-part application that has joint inventors may derive from an earlier application that has a sole inventor.”

Any changes in inventorship must be properly documented and may require a request under 37 CFR 1.48.

The inventorship in a Continued Prosecution Application (CPA) generally remains the same as in the prior application, but it can be changed under certain circumstances:

  • The inventorship automatically carries over from the prior application unless a statement is filed requesting deletion of inventors
  • Inventors can be deleted by filing a statement with the CPA request
  • Adding new inventors requires a request under 37 CFR 1.48 after the CPA is filed

The MPEP states: The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

For more information on patent applications, visit: patent applications.

Can new matter be added to a continuation application?

No, new matter cannot be added to a continuation application. A continuation application must disclose and claim only subject matter disclosed in the prior application.

As stated in MPEP 201.07: “The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.” This means that all claims in a continuation application must find support in the original disclosure of the parent application.

If an applicant wishes to add new matter, they would need to file a continuation-in-part (CIP) application instead, which allows for the addition of new subject matter while still claiming the benefit of the earlier filing date for the previously disclosed material.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

Can multiple provisional applications be filed for the same invention?

Yes, multiple provisional applications can be filed for the same invention. The MPEP 201.04 does not place restrictions on filing multiple provisionals. In fact, this practice can be beneficial for inventors who are continuously developing their invention.

Each provisional application establishes a potential priority date for the disclosed content. When filing a subsequent nonprovisional application, the applicant can claim the benefit of multiple provisional applications, potentially securing multiple priority dates for different aspects of the invention.

However, it’s important to note that each provisional application must still meet the requirements of 35 U.S.C. 112(a) for the disclosed subject matter to be eligible for the priority date.

For more information on patent priority, visit: patent priority.

Yes, multiple provisional applications can be combined into a single non-provisional application. This is particularly useful when an inventor has made improvements or additions to their invention over time. The MPEP 201.04 states:

A nonprovisional application that was filed within 12 months of an earlier provisional application may claim the benefit of that provisional application.

While this quote doesn’t explicitly mention multiple provisionals, the USPTO allows claiming benefit from multiple provisional applications in a single non-provisional application, provided each provisional is properly referenced and the non-provisional is filed within 12 months of the earliest provisional application.

For more information on Non-provisional application, visit: Non-provisional application.

For more information on patent priority, visit: patent priority.

For more information on provisional application, visit: provisional application.

Yes, multiple inventors can be deleted from a Continued Prosecution Application (CPA) at once. The language in MPEP ¶ 2.32 supports this:

In bracket 1 insert the name or names of the inventor(s) requested to be deleted.

This indicates that the process allows for the deletion of one or more inventors simultaneously. When filing a CPA, applicants can submit a statement requesting the deletion of multiple named inventors who are not inventors of the invention being claimed in the new application.

However, it’s crucial to ensure that all remaining inventors are correctly named and that the inventorship accurately reflects those who contributed to the claimed invention. If the CPA has already been filed, remember that any subsequent inventorship changes must follow the procedures outlined in 37 CFR 1.48.

For more information on CPA, visit: CPA.

Tags: CPA

Can I file a provisional application electronically?

Yes, you can file a provisional application electronically through the USPTO’s Electronic Filing System (EFS-Web). The MPEP 201.04 states:

“Applicants can file provisional applications electronically using EFS-Web or Patent Center.”

Electronic filing offers several advantages, including:

  • Immediate confirmation of receipt
  • Potential for reduced filing fees
  • Faster processing times
  • 24/7 availability

To file electronically, you’ll need to prepare your application documents in the appropriate format and submit them through the USPTO’s EFS-Web system or Patent Center.

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on Patent Center, visit: Patent Center.

For more information on provisional application, visit: provisional application.

Can I file a divisional-continuation application?

Yes, you can file a divisional-continuation application, which is a hybrid type of continuing application. This type of application combines aspects of both divisional and continuation applications.

According to MPEP 201.06(c): “The disclosure presented in a divisional application must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.” However, a divisional-continuation can include both claims to a distinct invention (like a divisional) and additional claims to the invention disclosed in the parent (like a continuation).

When filing such an application, it’s crucial to:

  • Ensure that the claims are properly grouped
  • Clearly indicate which claims are divisional and which are continuation
  • Comply with all requirements for both divisional and continuation applications

Always consult with a patent attorney or agent to determine the best filing strategy for your specific situation.

For more information on continuing applications, visit: continuing applications.

Can I file a divisional-continuation application after my parent application has been patented?

No, you cannot file a divisional-continuation application after your parent application has been patented. According to MPEP 201.06(c):

“The divisional application must be filed before the patenting or abandonment of or termination of proceedings on the prior application.”

This means that the window for filing a divisional-continuation application closes when the parent application is either:

  • Granted a patent
  • Abandoned
  • Proceedings are terminated

If you wish to pursue additional claims or inventions after your patent has been granted, you may need to consider other options, such as filing a reissue application or a new continuation-in-part application, depending on the specific circumstances and the nature of the new subject matter.

For more information on parent application, visit: parent application.

For more information on patent grant, visit: patent grant.

Can I file a divisional application without a new oath or declaration?

Yes, you can file a divisional application without a new oath or declaration under certain conditions. According to MPEP 201.06(c):

“Under 37 CFR 1.63(d), a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) if: (1) the prior nonprovisional application contained an oath or declaration as prescribed by 37 CFR 1.63 that was executed by or with respect to the inventor and was signed in compliance with 37 CFR 1.64; and (2) the divisional application was filed by all or by fewer than all of the inventors named in the prior application.”

This provision simplifies the filing process for divisional applications, allowing inventors to use the oath or declaration from the original application, provided the specified conditions are met.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

Can I convert my provisional application to a nonprovisional application?

No, you cannot directly convert a provisional application to a nonprovisional application. The MPEP clearly states: A provisional application cannot be converted to a nonprovisional application. Instead, you must file a separate nonprovisional application within 12 months of the provisional application’s filing date. This nonprovisional application can claim the benefit of the provisional application’s filing date. Here’s what you need to know:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • It must include a specific reference to the provisional application.
  • The nonprovisional application can expand on the content of the provisional application but must support any claims that rely on the provisional filing date.

Remember, if you don’t file a nonprovisional application within 12 months, the provisional application will automatically expire, and you’ll lose the benefit of its filing date.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

No, you cannot amend the specification to refer to a Continued Prosecution Application (CPA) as a continuation of a prior application. The USPTO explicitly denies such amendments. As stated in MPEP ¶ 2.34:

The amendment filed [date] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [continuation/divisional] application of Application No. [X] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.

This means that the act of filing a CPA automatically establishes the necessary reference to the prior application, making any specification amendment unnecessary and prohibited.

For more information on CPA, visit: CPA.

Tags: CPA

No, you cannot amend the specification of a Continued Prosecution Application (CPA) to reference the prior application. The USPTO explicitly states that such amendments are not necessary and will not be entered.

As per MPEP ¶ 2.34: “Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This policy simplifies the process and ensures consistency across CPA filings.

No, you cannot amend the specification of a Continued Prosecution Application (CPA) to refer to it as a continuation or divisional application. According to MPEP § 201.06(d):

“The amendment filed [date] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [continuation/divisional] application of Application No. [X] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This means that the CPA request itself serves as the required reference to the prior application, and no additional amendment to the specification is necessary or allowed.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

The MPEP ¶ 2.32 specifically addresses the process of deleting named inventors when filing a Continued Prosecution Application (CPA) for design patents. However, it does not explicitly mention adding or substituting inventors at the time of CPA filing.

If you need to add or substitute inventors, rather than just delete them, you should follow the general procedures for correction of inventorship outlined in 37 CFR 1.48. This regulation provides the requirements for adding, deleting, or substituting inventors in patent applications.

It’s advisable to consult with a patent attorney or contact the USPTO directly for guidance on the proper procedure for adding or substituting inventors when filing a CPA, as this may require additional documentation or fees beyond a simple deletion request.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

The MPEP ¶ 2.32 specifically addresses the deletion of inventors in a Continued Prosecution Application (CPA) for design patents, but it does not directly discuss adding inventors. However, changes to inventorship in patent applications are generally governed by 37 CFR 1.48.

If you need to add an inventor when filing a CPA, it’s advisable to:

  • Include a clear statement requesting the addition of the new inventor
  • Provide the new inventor’s oath or declaration
  • Submit any required fees

For specific guidance on adding inventors to a CPA, it’s recommended to consult with a patent attorney or contact the USPTO directly, as the process may differ from deleting inventors and could require additional documentation.

For more information on patent procedure, visit: patent procedure.

Can an inventor’s oath or declaration from a parent application be used in a divisional application?

Yes, an inventor’s oath or declaration from a parent application can often be used in a divisional application. According to MPEP 201.06(c):

‘In accordance with 37 CFR 1.63(d), a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) if: (1) the divisional application claims are directed to subject matter disclosed in the prior-filed application; (2) a copy of the inventor’s oath or declaration from the prior-filed application is provided for the divisional application; and (3) the prior-filed application contains a statement by the applicant that any required oath or declaration, including any substitute statement under 37 CFR 1.64 or assignment-statement under pre-AIA 37 CFR 1.63(e), has been filed.’

This provision simplifies the filing process for divisional applications by allowing the reuse of the original oath or declaration, provided certain conditions are met. However, it’s important to ensure that all inventors named in the divisional application are covered by the oath or declaration from the parent application.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on parent application, visit: parent application.

Yes, patent examiners can make a preliminary determination about whether an application might qualify as a continuation-in-part (CIP). The MPEP ¶ 2.06 provides guidance for examiners, stating:

This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Examiners typically look for the following indicators:

  • Substantial repetition of content from a prior application
  • Addition of new disclosure not present in the prior application
  • At least one common inventor with the prior application

However, it’s important to note that the final determination of an application’s status as a CIP depends on the applicant’s claims and proper benefit claims being established. Examiners may use this paragraph to alert applicants to the possibility of CIP status and the need to properly claim benefit if desired.

Yes, according to MPEP ¶ 2.05, an application can potentially be classified as both a continuation and a division. The MPEP states:

“Accordingly, this application may constitute a continuation or division.” (MPEP ¶ 2.05)

This dual classification possibility arises because:

  • A continuation application discloses and claims only subject matter from the prior application
  • A divisional application is filed as a result of a restriction requirement in the prior application
  • In some cases, an application may meet both criteria

The final determination of whether the application is a continuation, division, or both will depend on the specific circumstances of the application and its relationship to the prior application. The examiner will make this determination during the examination process.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

Amendments can be made when filing a Continued Prosecution Application (CPA), but there are important restrictions and considerations:

  • Any changes must be made as an amendment to the prior application as it existed before filing the CPA
  • No new matter can be introduced in a CPA
  • Preliminary amendments filed with a CPA are generally entered, but could be denied entry if they unduly interfere with examination
  • New specifications filed with a CPA request are treated as substitute specifications and must comply with 37 CFR 1.125

The MPEP states: Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph. No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application.

Regarding preliminary amendments, the MPEP advises: Applicants are also encouraged to file all preliminary amendments at the time of filing a CPA because the entry of any preliminary amendment filed after the filing date of the CPA could be denied under 37 CFR 1.115 if the preliminary amendment unduly interferes with the preparation of a first Office action.

If more time is needed to prepare amendments, applicants can request a three-month suspension of action under 37 CFR 1.103(b) at the time of filing the CPA.

For more information on amendments, visit: amendments.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

While amendments can be filed with a Continued Prosecution Application (CPA) request, there are important considerations and limitations. The MPEP states:

“Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph. No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application.”

Additionally:

  • Preliminary amendments filed with a CPA are generally entered
  • Applicants are encouraged to file any amendments at the time of filing the CPA to avoid potential delays
  • Any new matter introduced will be required to be canceled
  • Claims relying on new matter may be rejected under 35 U.S.C. 112(a)

The MPEP advises: “Applicants are strongly encouraged to file any preliminary amendment in a CPA at the time the CPA is filed. See 37 CFR 1.115 and MPEP § 714.03(a).”

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on new matter, visit: new matter.

Yes, a sole inventor can file a continuation-in-part (CIP) application based on an earlier application with joint inventors, provided certain conditions are met. The MPEP 201.08 states:

“A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78.”

This situation might occur when one of the joint inventors from the original application independently develops additional subject matter. The key requirements are:

  • The CIP must meet all other conditions of 35 U.S.C. 120 and 37 CFR 1.78.
  • The sole inventor must be one of the joint inventors named in the prior application.
  • The CIP should contain new matter not disclosed in the prior application.

It’s important to ensure proper attribution and compliance with all USPTO requirements when filing such a CIP.

For more information on joint inventors, visit: joint inventors.

Can a provisional application be published?

No, provisional applications are not published. The MPEP clearly states: ‘A provisional application is not entitled to the right of priority under 35 U.S.C. 119 or 365(a) or 365(b); is not entitled to the benefit of the filing date of a prior application under 35 U.S.C. 119(e) or 120; and will not be published or examined.’ This means:

  • Provisional applications remain confidential
  • They are not made available to the public
  • No patent document is published based solely on a provisional application

For more information on provisional applications, visit the MPEP 201.04 section.

For more information on patent examination, visit: patent examination.

For more information on provisional application, visit: provisional application.

No, provisional applications are not published or made public by the USPTO. According to MPEP 201.04:

A provisional application is not subject to publication and is not published.

This confidentiality can be advantageous for inventors who want to secure a filing date while keeping their invention details private. However, it’s important to note that while the USPTO doesn’t publish provisional applications, the content may become public if referenced in a later-published nonprovisional application claiming its benefit.

For more information on provisional application, visit: provisional application.

Yes, a provisional application can be filed without claims. The MPEP 201.04 states:

A provisional application must also include the filing fee as set forth in 37 CFR 1.16(d) and a cover sheet identifying the application as a provisional application. Otherwise, the application will be treated as a nonprovisional application. The filing date of a provisional application is the date on which a specification as prescribed by 35 U.S.C. 112(a), and any drawing required by 37 CFR 1.81(a) are filed in the United States Patent and Trademark Office. No claims are required.

While claims are not required for a provisional application, it’s important to provide a comprehensive description of the invention to ensure adequate support for any claims in a subsequent nonprovisional application.

For more information on provisional application, visit: provisional application.

Can a provisional application be filed in a language other than English?

Yes, a provisional application can be filed in a language other than English. According to MPEP 201.04:

‘A provisional application may be filed in a language other than English.’

However, it’s important to note that while the USPTO allows this, it may have implications for future patent applications. If you later file a nonprovisional application claiming priority to the provisional, you will need to provide an English translation of the provisional application along with a statement that the translation is accurate. This ensures that the examiner can properly determine if the nonprovisional application is entitled to the benefit of the provisional filing date.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

Can a provisional application be converted directly into a nonprovisional application?

No, a provisional application cannot be directly converted into a nonprovisional application. The MPEP 201.04 clearly states:

“A provisional application cannot be converted to a nonprovisional application.”

Instead, to claim the benefit of a provisional application, an applicant must file a separate nonprovisional application within 12 months of the provisional filing date. This nonprovisional application must include a specific reference to the provisional application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

No, a provisional application cannot be considered a continuation-in-part (CIP). The MPEP explicitly states: An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation-in-part’ of the provisional application. (MPEP ¶ 2.06)

This distinction is important because:

  • Provisional applications are not examined and do not mature into patents.
  • The term ‘continuation-in-part’ is reserved for non-provisional applications that build upon prior non-provisional applications.
  • The relationship between a non-provisional application and a provisional application is described as ‘claiming the benefit of’ the provisional, not as a continuation or CIP.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

No, a provisional application cannot be called a ‘divisional’ application. The MPEP ¶ 2.01 explicitly states:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.

This means that while an application can claim the benefit of a provisional application’s filing date under 35 U.S.C. 119(e), it is not considered a divisional application. Divisional applications are specifically related to non-provisional applications and involve claiming independent and distinct inventions from a parent application.

For more information on 35 USC 119(e), visit: 35 USC 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on provisional application, visit: provisional application.

No, a provisional application should not be referred to as a ‘continuation’. The MPEP clearly states:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation’ of the provisional application.”

This is because provisional applications serve a different purpose than continuation applications. Provisional applications are temporary placeholders that establish a priority date but do not mature into issued patents. Continuations, on the other hand, are full patent applications that build upon previously filed non-provisional applications.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

Can a national application be converted to an international application?

Yes, a national application can be converted to an international application under certain conditions. The MPEP states: “A national application may be converted to an international application by filing a PCT international application within one year from the earliest U.S. filing date of the national application and including the United States of America as a designated state.” (MPEP 201.01) This conversion allows applicants to seek patent protection internationally while maintaining the priority date of their original national filing. It’s important to note that this conversion must be done within the one-year timeframe to preserve priority rights.

For more information on conversion, visit: conversion.

Tags: conversion

Yes, a legal representative can file a national patent application in certain circumstances. The Manual of Patent Examining Procedure (MPEP) 201.01 states:

‘A national application may be filed under 35 U.S.C. 111(a) in the U.S. Patent and Trademark Office (USPTO) by… (B) the legal representative (35 U.S.C. 117) of a deceased or legally incapacitated inventor.’

This provision allows for the continuity of the patent application process when the inventor is unable to file themselves. The legal representative must be authorized under 35 U.S.C. 117, which typically includes executors, administrators, or other legal representatives of deceased inventors, or guardians or conservators of incapacitated inventors.

For more information on legal representative, visit: legal representative.

For more information on patent filing, visit: patent filing.

Yes, a divisional application can claim the benefit of the filing date of the prior application. The MPEP ¶ 2.01 states:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

To claim this benefit, the applicant must meet the requirements set forth in 35 U.S.C. 120 and 37 CFR 1.78, which include making a proper benefit claim and ensuring the divisional application is filed before the patenting or abandonment of the prior application.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Yes, a divisional application can claim priority to its parent application. This is one of the key benefits of filing a divisional application. According to MPEP 201.06:

‘A divisional application is entitled to the benefit of the filing date of the prior application.’

This means that the divisional application:

  • Retains the priority date of the parent application for the subject matter disclosed in the parent
  • Can claim the benefit under 35 U.S.C. 120 or 365(c)
  • Must include a specific reference to the parent application in its application data sheet (ADS)

It’s important to note that the divisional application must be filed while the parent application is still pending to claim this benefit.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Yes, a divisional application can claim the benefit of its parent application’s filing date. According to MPEP 201.06(c):

“A divisional application is entitled to the benefit of the filing date of the prior-filed application if the prior-filed application discloses the invention claimed in the divisional application in the manner provided by the first paragraph of 35 U.S.C. 112.”

This means that as long as the invention claimed in the divisional application was adequately described in the parent application, it can claim the parent’s filing date. This is crucial for establishing priority and avoiding potential prior art issues.

For more information on Divisional application, visit: Divisional application.

Can a divisional application be filed without a restriction requirement?

While divisional applications are typically filed in response to a restriction requirement, they can be filed voluntarily without one. The MPEP 201.06 states:

“A divisional application is often filed as a result of a restriction requirement made by the examiner.”

However, the use of “often” implies that this is not always the case. Applicants may choose to file a divisional application voluntarily if they:

  • Recognize distinct inventions in their application
  • Want to pursue different claim scopes separately
  • Need to address potential unity of invention issues proactively

It’s important to note that voluntarily filing a divisional application without a restriction requirement may affect the application of the safe harbor provision under 35 U.S.C. 121, which protects against double patenting rejections in certain cases.

For more information on Divisional application, visit: Divisional application.

Can a divisional application be filed after the parent application is abandoned?

Yes, a divisional application can be filed after the parent application is abandoned, as long as certain conditions are met. The MPEP 201.06 states:

“A divisional application may be filed after abandonment of the parent application, provided the parent application is not relied upon for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c) in an application whose effective filing date is on or after March 16, 2013.”

This means that you can file a divisional application even if the parent application has been abandoned. However, it’s crucial to note that if you want to claim the benefit of the parent application’s filing date, and the effective filing date of your divisional application is on or after March 16, 2013, the parent application must not have been abandoned at the time of filing the divisional.

It’s important to consult with a patent attorney to ensure compliance with all requirements when filing a divisional application, especially in cases involving abandoned parent applications.

For more information on Divisional application, visit: Divisional application.

For more information on effective filing date, visit: effective filing date.

No, a design patent application cannot be filed as a provisional application. The MPEP 201.01 states:

“Design applications and provisional applications for patent are considered to be distinct types of applications and are treated as separate categories.”

This means that design patent applications must be filed as nonprovisional applications. Provisional applications are only available for utility and plant patents.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

Yes, design patent applications can be filed as continuations or continuations-in-part (CIPs), but with some specific considerations:

1. Continuations: A design application can be a continuation of a prior design application.

2. Continuations-in-part: A design application can be a CIP of a prior design application if it adds new matter.

3. Relationship to Utility Applications: A design application can also be a continuation or CIP of a utility application, provided the drawings in the utility application sufficiently disclose the claimed design.

The MPEP states: “A design application may be considered to be a divisional of a utility application (but not of a provisional application), and is entitled to the filing date thereof if the drawings of the earlier filed utility application show the same article as that in the design application sufficiently to comply with 35 U.S.C. 112(a). However, such a divisional design application may only be filed under the procedure set forth in 37 CFR 1.53(b), and not under 37 CFR 1.53(d).”

It’s important to note that while not explicitly stated for continuations and CIPs, the same principle applies – the earlier application must sufficiently disclose the claimed design.

Can a CPA be filed as a continuation-in-part application?

No, a Continued Prosecution Application (CPA) cannot be filed as a continuation-in-part application. According to MPEP 201.06(d):

‘A continuation or divisional application (but not a continuation-in-part) may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).’

This means that while you can file a CPA as a continuation or divisional application of a prior design application, you cannot file it as a continuation-in-part. Continuation-in-part applications typically contain new matter not present in the prior application, which is not allowed in a CPA filing.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

Can a Continued Prosecution Application (CPA) be filed in a provisional application?

No, a Continued Prosecution Application (CPA) cannot be filed in a provisional application. According to MPEP 201.06(d):

“A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).”

This explicitly limits CPA practice to design applications. Provisional applications are not eligible for CPA filings. If an applicant wishes to continue prosecution based on a provisional application, they must file a non-provisional application claiming priority to the provisional application within the appropriate time frame.

For more information on CPA, visit: CPA.

For more information on provisional application, visit: provisional application.

Yes, a Continued Prosecution Application (CPA) can be filed for design applications. In fact, as of September 8, 2000, CPAs are only available for design applications. According to MPEP 201.06(d):

‘Effective July 14, 2003, CPA practice has been eliminated as to utility and plant applications. CPAs can only be filed for design applications.’

This means that for utility and plant patent applications, other forms of continuing applications such as RCEs (Request for Continued Examination) or continuation applications under 37 CFR 1.53(b) must be used instead of CPAs.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

Yes, a continuation-in-part (CIP) application can have different inventors than the parent application, but there must be at least one common inventor. The MPEP provides guidance on this:

“A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78. Subject to the same conditions, a continuation-in-part application that has joint inventors may derive from an earlier application that has a sole inventor.”

This flexibility allows for situations where new inventors contribute to the additional subject matter in the CIP, or where some inventors from the original application are no longer involved in the new developments.

For more information on joint inventors, visit: joint inventors.

Can a continuation-in-part application claim priority to a provisional application?

Yes, a continuation-in-part (CIP) application can claim priority to a provisional application, but with some important considerations. The MPEP 201.08 doesn’t explicitly address this scenario, but it can be inferred from the general rules governing CIP applications and provisional applications.

Key points to understand:

  • Priority claim: A CIP can claim priority to a provisional application for subject matter disclosed in the provisional.
  • New matter: Any new matter added in the CIP will have the filing date of the CIP itself, not the provisional application.
  • One-year deadline: The CIP must be filed within one year of the provisional application’s filing date to claim its benefit.
  • Multiple priorities: A CIP might claim priority to both a provisional and a non-provisional application in some cases.

Inventors should carefully document which parts of their CIP application correspond to the provisional disclosure to ensure proper priority claims.

For more information on new matter, visit: new matter.

For more information on provisional application, visit: provisional application.

No, a continuation-in-part (CIP) application cannot be filed as a continued prosecution application (CPA). The MPEP explicitly states: “A continuation-in-part application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).”

Continuation-in-part applications may only be filed under 37 CFR 1.53(b). This is an important distinction to remember when considering different types of patent application filings.

No, a continuation application cannot include new matter. As stated in MPEP 201.07:

The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

This means that the continuation application must be based entirely on the disclosure of the prior-filed application. Any new subject matter would need to be filed as a continuation-in-part (CIP) application instead of a standard continuation application.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

For more information on patent law, visit: patent law.

Yes, a continuation application can claim the benefit of multiple parent applications, provided certain conditions are met. According to MPEP 201.07:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 111(b) or 365(c) or filed under 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.53(b) or 1.53(d) as a continuation of prior applications, claiming the benefit of those applications under 35 U.S.C. 120, 121, 365(c), or 386(c).’

This means that a continuation application can claim the benefit of:

  • Multiple earlier-filed nonprovisional applications
  • Earlier-filed provisional applications
  • Earlier-filed international applications designating the United States

However, it’s important to note that the continuation must satisfy the requirements for claiming benefit, including proper copendency and cross-referencing of the prior applications.

For more information on continuation application, visit: continuation application.

Yes, a continuation application can be filed after the parent application is granted or abandoned, but there are timing restrictions. The MPEP states:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

However, it’s important to note:

  • For standard continuation applications under 37 CFR 1.53(b), they must be filed before the patenting, abandonment, or termination of proceedings on the earlier application.
  • For Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), which are only available for design applications (excluding international design applications), they must be filed prior to payment of the issue fee unless a petition under 37 CFR 1.313(c) is granted in the prior application.

Always consult with a patent attorney to ensure proper timing and procedures are followed.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on patent grant, visit: patent grant.

Can a continuation application add new matter to the original disclosure?

No, a continuation application cannot add new matter to the original disclosure. This is a fundamental characteristic of continuation applications.

According to MPEP 201.07:

‘A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.’

This means that the continuation must rely entirely on the disclosure of the parent application. Any attempt to introduce new matter would result in the application being treated as a continuation-in-part (CIP) rather than a true continuation. It’s crucial for inventors and patent practitioners to understand this limitation when considering filing strategy.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

No, provisional patent applications are not examined for patentability. The MPEP explicitly states:

Provisional applications will not be examined for patentability.

This is one of the key differences between provisional and nonprovisional applications. The purpose of a provisional application is to:

  • Establish an early filing date
  • Allow the term ‘Patent Pending’ to be applied
  • Provide a 12-month period to further develop the invention

Since provisional applications are not examined, they do not require formal patent claims or an oath or declaration. This simplifies the filing process and allows inventors to quickly secure a priority date for their invention.

To obtain patent protection, a nonprovisional application must be filed, which will then undergo examination for patentability.

For more information on patent filing, visit: patent filing.

No, provisional applications are not published or made available to the public by the USPTO. The MPEP 201.04 clearly states:

A provisional application is not subject to publication and is not subject to examination other than to review for national security implications.

This means that the contents of a provisional application remain confidential unless and until a corresponding non-provisional application is published or a patent is issued. This confidentiality can be advantageous for inventors who want to maintain secrecy while securing an early filing date.

For more information on provisional application, visit: provisional application.

Provisional applications are not explicitly mentioned as national applications in MPEP 201.01. The section states:

‘National applications include original (nonprovisional) applications, reissue applications, and reexamination proceedings.’

While provisional applications are filed with the USPTO, they are not considered complete patent applications and do not undergo examination. They serve as a placeholder to establish a priority date. For more information on provisional applications, refer to USPTO’s Provisional Application page.

For more information on USPTO, visit: USPTO.

Tags: USPTO

No, CPAs are not available for all types of patent applications. According to MPEP ¶ 2.30, CPAs are primarily used for design patent applications. The MPEP states: “If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead).” This indicates that CPAs are not typically used for utility or plant patent applications, and such requests may be treated as Requests for Continued Examination (RCE) instead.

For more information on design patents, visit: design patents.

For more information on plant patents, visit: plant patents.

For more information on utility patents, visit: utility patents.

No, Continued Prosecution Applications (CPAs) are not available for all types of patent applications. They are specifically limited to design patent applications. This is evident from the MPEP guidance, which states:

‘Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.’

This statement clearly indicates that CPAs are associated with design applications. For utility and plant patent applications, other continuation options are available, such as:

  • Continuation Applications
  • Divisional Applications
  • Continuation-in-Part Applications

It’s important for inventors and patent practitioners to understand these distinctions to choose the appropriate type of continuing application for their specific situation.

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

Are continuation applications considered national applications?

Yes, continuation applications are considered national applications. They are a type of nonprovisional application that continues the examination process of a previously filed application.

The MPEP 201.01 states: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’ While continuation applications are not explicitly mentioned in this list, they fall under the category of nonprovisional applications.

Continuation applications allow applicants to pursue additional claims based on the disclosure of a parent application. They are filed before the parent application is abandoned or patented and claim the benefit of the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on USPTO, visit: USPTO.

No, applicants are not separately notified when their parent application is abandoned due to the filing of a Continued Prosecution Application (CPA). This is implied in the examiner’s note in MPEP ¶ 2.35:

This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

The establishment of a CPA automatically results in the abandonment of the parent application. Applicants should be aware that by filing a CPA, they are effectively abandoning the parent application in favor of continuing prosecution through the CPA.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

MPEP 202-Cross-Noting (19)

If there is an error in the pre-printed prior application data on the bib-data sheet:

  • The examiner should require correction via a corrected or supplemental application data sheet or an amendment, if it was an applicant error.
  • A petition for an unintentionally delayed benefit claim may also be required.
  • If appropriate, the correction or entry of the data can be made by technical support staff of the Technology Center.

See MPEP 601.05 and MPEP 211.02(a) for more details.

If there’s an error in the preprinted prior application data, the following steps should be taken:

  1. If the error is in the Patent Data Portal database, it can be corrected by technical support staff of the Technology Center.
  2. After the data is corrected, a new bib-data sheet should be printed and scanned into the file.
  3. If the error was made by the applicant, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.
  4. In some cases, a petition for an unintentionally delayed benefit claim may also be required.

The MPEP states: “Should there be an error in the preprinted prior application data, the correction or entry of the data in the Patent Data Portal data base can be made by technical support staff of the Technology Center, if appropriate. Upon entry of the data, a new bib-data sheet should be printed and scanned into the file. If the error was an applicant error, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.” (MPEP 202)

When examining a patent application, it’s crucial for the examiner to verify and indicate whether the conditions of 35 U.S.C. 119(a)-(d) or (f) have been met. These sections relate to the right of priority for foreign applications.

The MPEP instructs: However, the examiner must still indicate in the Office action and on the bib-data sheet whether the conditions of35 U.S.C. 119(a)-(d)or(f)have been met. (MPEP 202)

This means the examiner should:

  • Review the foreign priority claim
  • Determine if all conditions for the claim have been satisfied
  • Indicate the status of the claim in the Office action
  • Mark the bib-data sheet accordingly

If the conditions are met, this information will be reflected on the front page of the issued patent and in the Official Gazette listing. For more information on foreign priority claims, see MPEP § 213.

For more information on foreign priority, visit: foreign priority.

For more information on patent examination, visit: patent examination.

An examiner should check the following on the bib-data sheet regarding prior applications:

  1. Accuracy of prior application data, including provisional application data
  2. Whether the application is copending with prior nonprovisional applications for which benefit is claimed
  3. Correct application numbers of provisional applications for which benefit is claimed
  4. Proper listing of foreign applications qualifying for benefits under 35 U.S.C. 119(a)-(d)

MPEP 202 instructs: “Where the data is correct, the examiner should initial the bib-data sheet in the provided space. Should there be an error in the preprinted prior application data, the correction or entry of the data in the Patent Data Portal data base can be made by technical support staff of the Technology Center, if appropriate.”

Cross-noting in patent applications refers to the process of recording and verifying information about prior applications, including U.S. and foreign applications, for which benefit or priority is claimed. This information is typically noted on the bibliographic data (bib-data) sheet of the application and is used to ensure accurate representation of priority claims on the front page of a printed patent.

According to MPEP 202, “The front page of a printed patent identifies all prior applications for which benefits are claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in continuation-in-part, continuation, divisional, and reissue applications.”

For foreign priority applications, the bib-data sheet should include:

  • Application number
  • Country (or intellectual property authority)
  • Day, month, and year of filing

MPEP 202 specifies: “A bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application that the U.S. application is claiming the priority of. The examiner should check this information for accuracy.”

It’s important to note that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) should be listed. Applications from non-qualifying countries should be lined through on the bib-data sheet.

The front page of a printed patent identifies all prior applications for which benefits are claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in continuation-in-part, continuation, divisional, and reissue applications.

The front page of a patent includes the following information regarding foreign priority claims:

  • The country of the foreign application
  • The filing date of the foreign application
  • The number of the foreign application

This information is included for applications where the bib-data sheet has been properly endorsed. As stated in the MPEP: “The front page of the patent when it is issued, and the listing in the Official Gazette, will refer to the claim of priority, giving the country, the filing date, and the number of the foreign application in those applications in which the bib-data sheet has been endorsed.” (MPEP 202)

The front page of a patent issuing from a continued prosecution application (CPA) filed under 37 CFR 1.53(d) contains specific information about prior applications.

As stated in the MPEP: The front page of a printed patent issuing on a continued prosecution application (CPA) filed under37 CFR 1.53(d)will identify the application number and filing date of the most recent noncontinued prosecution application (but not the filing date of the CPA) as well as all prior applications from which benefit was claimed in the most recent noncontinued prosecution application. (MPEP 202)

This means that for a CPA:

  • The application number and filing date of the most recent non-CPA application are shown
  • The CPA’s own filing date is not displayed
  • All prior applications claimed as benefit in the most recent non-CPA application are listed

This information helps establish the continuity and priority of the patent application.

For more information on benefit claims, visit: benefit claims.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent front page, visit: patent front page.

For more information on prior applications, visit: prior applications.

For patent applications, prior U.S. application data should be provided as follows:

  • For applications filed on or after September 16, 2012: In an application data sheet
  • For applications filed before September 16, 2012: In either the first sentence(s) of the specification or in an application data sheet

MPEP 202 states: “The identifying data of all prior applications for which benefits are claimed should be reviewed by the examiner to ensure that the data is accurate and provided in an application data sheet for applications filed on or after September 16, 2012, or provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012.”

Examiners should review the identifying data of all prior applications for which benefits are claimed to ensure accuracy. This review includes:

  • Checking that the data is provided in an application data sheet for applications filed on or after September 16, 2012
  • Verifying that the data is provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012
  • Ensuring the appropriate relationship (e.g., continuation, divisional, or continuation-in-part) between nonprovisional applications is included

The MPEP states: “The identifying data of all prior applications for which benefits are claimed should be reviewed by the examiner to ensure that the data is accurate and provided in an application data sheet for applications filed on or after September 16, 2012, or provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012.” (MPEP 202)

When foreign applications are properly claimed and verified in a patent application, this information is reflected in the issued patent and the Official Gazette listing. This helps establish the priority date and international scope of the invention.

The MPEP states: The front page of the patent when it is issued, and the listing in the Official Gazette, will refer to the claim of priority, giving the country, the filing date, and the number of the foreign application in those applications in which the bib-data sheet has been endorsed. (MPEP 202)

This means that for each properly claimed foreign application, the following information will be publicly available:

  • The country of filing
  • The filing date
  • The application number

It’s important to note that this information is only included for foreign applications that have been verified and endorsed on the bib-data sheet by the examiner. For more information on foreign priority claims, see MPEP § 213.

For more information on foreign applications, visit: foreign applications.

For more information on issued patent, visit: issued patent.

For more information on Official Gazette, visit: Official Gazette.

Foreign priority application information is handled as follows on the bib-data sheet:

  • If a proper foreign priority claim is not listed on the bib-data sheet, the examiner should add the information and forward it for correction in the Office computer systems.
  • Applications listed on the bib-data sheet but filed in countries not qualifying for benefits under 35 U.S.C. 119(a)-(d) should be lined through.
  • The bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application claiming priority.
  • Examiners should check this information for accuracy and make corrections if necessary.

The MPEP states: “If a foreign application listed on the oath or declaration (for applications filed prior to September 16, 2012) or application data sheet is not listed on the bib-data sheet and the foreign priority claim is proper (e.g., the foreign priority claim was timely made ), the examiner should provide the information regarding the foreign application number, the country, and the filing date on the bib-data sheet and forward the marked-up bib-data sheet to the Legal Instrument Examiner for correction in the Office computer systems.” (MPEP 202)

Provisional application benefits are handled differently from other types of priority claims on the bib-data sheet. If an applicant claims benefit under 35 U.S.C. 119(e) to a prior provisional application, the application number of that provisional application should be printed on the bib-data sheet.

However, it’s important to note: If applicant claims benefit under35 U.S.C. 119(e)to a prior provisional application, and states that the provisional application claims the benefit of, or priority to, earlier domestic or foreign application(s), the earlier application(s) should not be reflected on the bib-data sheet because a provisional application is not entitled to the benefit of, or right of priority to, any other application. (MPEP 202)

This is due to the limitation set forth in 35 U.S.C. 111(b)(7), which states that a provisional application cannot claim priority to or benefit from any other application.

Examiners should verify that provisional application data is correctly listed and that no improper benefit claims to earlier applications through a provisional application are included on the bib-data sheet.

For more information on benefit claims, visit: benefit claims.

For more information on patent examination, visit: patent examination.

For more information on provisional application, visit: provisional application.

Patent examiners verify foreign priority claims through the following steps:

  1. Check that foreign applications listed on the oath, declaration, or application data sheet are properly listed on the bib-data sheet.
  2. Verify the accuracy of the application number, country, and filing date for each foreign application.
  3. Ensure that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) are listed.
  4. Initial the bib-data sheet in the “VERIFIED” space when the information is correct or has been amended to be correct.
  5. Indicate in the Office action and on the bib-data sheet whether the conditions of 35 U.S.C. 119(a)-(d) or (f) have been met.

MPEP 202 states: “The examiner should check this information for accuracy. Should there be an error on the oath or declaration, or application data sheet itself, the examiner should require a new oath or declaration, or application data sheet, where appropriate. A petition for an unintentionally delayed claim for priority may also be required.”

Foreign priority claims are an important aspect of patent applications and are reflected on the bib-data sheet. The examiner should verify that foreign applications listed on the oath, declaration, or application data sheet are correctly listed on the bib-data sheet.

According to the MPEP: A bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application that the U.S. application is claiming the priority of. The examiner should check this information for accuracy. (MPEP 202)

If there are errors:

  • On the oath, declaration, or application data sheet: The examiner should require a new document.
  • On the bib-data sheet itself: The examiner should make corrections directly on the sheet and have the information updated in the Office computer systems.

It’s important to note that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) should be listed. A list of qualifying countries can be found in MPEP § 213.01.

For more information on foreign applications, visit: foreign applications.

For more information on foreign priority claims, visit: foreign priority claims.

For more information on patent examination, visit: patent examination.

Errors in prior application data on the bib-data sheet are corrected as follows:

  1. If the error is in the preprinted data: The examiner can have the technical support staff of the Technology Center make corrections in the Patent Data Portal database.
  2. If the error is an applicant error: The examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.

MPEP 202 states: “Upon entry of the data, a new bib-data sheet should be printed and scanned into the file. If the error was an applicant error, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate. See MPEP § 601.05 et seq. and MPEP § 211.02(a). A petition for an unintentionally delayed benefit claim may also be required. See MPEP § 211.04.”

For continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), the front page of a printed patent will include:

  • The application number and filing date of the most recent noncontinued prosecution application
  • All prior applications from which benefit was claimed in the most recent noncontinued prosecution application

Notably, the filing date of the CPA itself is not included. As stated in the MPEP: “The front page of a printed patent issuing on a continued prosecution application (CPA) filed under 37 CFR 1.53(d) will identify the application number and filing date of the most recent noncontinued prosecution application (but not the filing date of the CPA) as well as all prior applications from which benefit was claimed in the most recent noncontinued prosecution application.” (MPEP 202)

No, the inclusion of prior application information in the patent does not necessarily indicate that the claims are entitled to the benefit of the earlier filing date.

See MPEP 2136.03 and MPEP 2154.01(b) for additional information.

MPEP 203 - Status of Applications (31)

A provisional patent application is considered abandoned no later than 12 months after its filing date. MPEP 203.05 states that an abandoned application includes, in the case of a provisional application, no later than 12 months after the filing date of the provisional application (see MPEP § 711.03(c) and 35 U.S.C. 111(b)(5)). This means that provisional applications have a statutory life of one year from their filing date, after which they are automatically abandoned if not converted to a nonprovisional application or claimed as priority in a nonprovisional application.

For more information, you can refer to MPEP § 711.03(c) and 35 U.S.C. 111(b)(5).

According to MPEP 203.03, a nonprovisional patent application is considered “amended” after it has been initially acted on by the examiner, and the applicant has filed a reply to the examiner’s action. The applicant’s reply may include:

  • An election
  • A traverse of the examiner’s action
  • An amendment to the application

MPEP 203.02 defines a ‘rejected’ application as follows:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application. Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

This status applies to applications that have received an Office action from the examiner but have not yet been responded to by the applicant.

MPEP 203.04 defines an ‘allowed’ or ‘in issue’ patent application as follows:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

Essentially, an application is ‘allowed’ when the examiner has determined it meets all requirements for patentability and has sent a Notice of Allowance. This status continues until the patent is issued, unless specific actions are taken to withdraw it or it becomes abandoned due to non-payment of fees.

MPEP 203.05 outlines several scenarios where an application is considered abandoned:

  • Formal abandonment by the applicant or attorney/agent of record
  • Failure to take appropriate action at some stage in the prosecution of a nonprovisional application
  • Failure to pay the issue fee
  • For provisional applications, no later than 12 months after the filing date

Abandonment removes the application from the Office docket of pending applications. It’s crucial for applicants to be aware of deadlines and required actions to prevent unintentional abandonment.

Once a nonprovisional patent application has been examined and determined to meet all statutory requirements, a notice of allowance is sent to the applicant. The status of the application is then considered “allowed” or “in issue”. As per MPEP 203.04:

An “allowed” nonprovisional application or an application “in issue” is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an “allowed” application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

A “new” nonprovisional patent application is one that has not yet received an action by the examiner. Its status as a “new” application continues until the examiner takes action, even if the applicant files an amendment prior to the first Office Action. A request for continued examination (RCE) under 37 CFR 1.114 is not considered a new application filing.

The Office docket plays a crucial role in determining the status of a patent application. MPEP 203.05 refers to the Office docket when defining abandoned applications:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications

The Office docket is essentially the official record of pending patent applications at the USPTO. When an application is removed from this docket, it is no longer considered active or pending. This removal can occur for various reasons, including formal abandonment, applicant inaction, failure to pay fees, or expiration of statutory periods. Therefore, the status of an application on the Office docket is a key indicator of whether it is still being actively prosecuted or has been abandoned.

A ‘new’ patent application is a nonprovisional application that has not yet received an action by the examiner. According to MPEP 203.01:

An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

It’s important to note that a request for continued examination (RCE) is not considered a new application filing.

For more information on new application, visit: new application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on RCE, visit: RCE.

According to MPEP 203.01, a ‘new’ application is defined as:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner. An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

It’s important to note that a request for continued examination (RCE) is not considered a new application filing.

An abandoned patent application is one that has been removed from the Office docket of pending applications. According to MPEP 203.05, this can occur in several ways:

  • Through formal abandonment by the applicant or their attorney/agent
  • Due to failure of the applicant to take appropriate action during prosecution
  • For failure to pay the issue fee
  • In the case of a provisional application, no later than 12 months after the filing date

As stated in MPEP 203.05: An abandoned application is, inter alia, one which is removed from the Office docket of pending applications. The specific reasons for abandonment are listed in the same section.

An ‘allowed’ patent application is one that has been examined and determined to meet all statutory requirements. According to MPEP 203.04:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.

The status of ‘allowed’ continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue or becomes abandoned for failure to pay the issue fee and any required publication fee.

For more information on allowed application, visit: allowed application.

For more information on notice of allowance, visit: notice of allowance.

For more information on patent issuance, visit: patent issuance.

After an application becomes abandoned, it is no longer pending and is removed from the USPTO’s active files. The application file, however, is retained in storage for a period as determined by the USPTO. During this retention period, certain actions may still be possible:

1. The applicant may file a petition to revive the application if the abandonment was unintentional or unavoidable.
2. The application may serve as a basis for claiming benefit in a later-filed application, subject to certain conditions.
3. The application may be used as prior art against other applications.
4. The public may request access to the application file if it has been opened to public inspection.

It’s important to note that once an application is abandoned, it cannot be used as the basis for a statutory invention registration. For more details on abandoned applications, see MPEP 203.05 and MPEP 711.

When an abandoned application is later revived, it retains its original filing date. The revival process effectively removes the abandonment status, allowing the application to continue prosecution. However, the period of abandonment may impact patent term adjustment calculations. For more information on revival procedures, refer to MPEP 711 and 37 CFR 1.137.

If an applicant fails to take appropriate action during the prosecution of a nonprovisional patent application, it can result in the application being considered abandoned. MPEP 203.05 specifically states that an abandoned application includes one removed from the Office docket through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application. This could include failing to respond to office actions, missing deadlines, or not providing requested information or documents.

An abandoned patent application is one that has been removed from the USPTO’s docket of pending applications. According to MPEP 203.05, an application can become abandoned for several reasons:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications:

  • Formal abandonment by the applicant or their attorney/agent
  • Failure to take appropriate action during prosecution
  • Failure to pay the issue fee
  • For provisional applications, not filing a nonprovisional application within 12 months

Abandonment can have serious consequences, but in some cases, it may be possible to revive an abandoned application.

For more information on patent abandonment, visit: patent abandonment.

A nonprovisional patent application is designated as “rejected” if, during prosecution before allowance, it contains an examiner’s action that has not been replied to by the applicant. As stated in MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a “rejected” application. Its status as a “rejected” application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

MPEP 203.03 defines an ‘amended’ patent application as follows:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action. The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

In simpler terms, an application becomes ‘amended’ when the applicant responds to an examiner’s Office action, whether by making changes to the application, arguing against the examiner’s rejections, or choosing between different inventions (election).

According to MPEP 203.04:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

An ‘allowed’ application has passed examination and is ready to become a patent, pending payment of necessary fees.

A patent application can be considered ‘abandoned’ for several reasons. According to MPEP 203.05, an abandoned application is one that is removed from the Office docket of pending applications due to:

  • Formal abandonment by the applicant or by the attorney or agent of record
  • Failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application
  • Failure to pay the issue fee
  • In the case of a provisional application, no later than 12 months after the filing date of the provisional application

It’s important for applicants to be aware of these reasons to avoid unintentional abandonment of their applications.

For more information on issue fee, visit: issue fee.

For more information on patent prosecution, visit: patent prosecution.

For more information on provisional application, visit: provisional application.

According to MPEP 203.05, there are four main reasons for patent application abandonment:

  1. Formal abandonment by the applicant or their representative
  2. Failure of the applicant to take appropriate action during prosecution
  3. Failure to pay the issue fee
  4. For provisional applications, the passage of 12 months from the filing date

The MPEP states: An abandoned application is, inter alia, one which is removed from the Office docket of pending applications: (A) through formal abandonment by the applicant or by the attorney or agent of record; (B) through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application; (C) for failure to pay the issue fee (MPEP § 711 to § 711.05); or (D) in the case of a provisional application, no later than 12 months after the filing date of the provisional application.

MPEP 203.05 outlines several circumstances under which a patent application can become abandoned:

  1. Through formal abandonment by the applicant or by the attorney or agent of record;
  2. Through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application;
  3. For failure to pay the issue fee (see MPEP § 711 to § 711.05); or
  4. In the case of a provisional application, no later than 12 months after the filing date of the provisional application (see MPEP § 711.03(c) and 35 U.S.C. 111(b)(5)).

An abandoned application is removed from the Office docket of pending applications. It’s important to note that abandonment can occur unintentionally, such as missing a deadline, or intentionally, such as when an applicant decides not to pursue the application further.

For amended applications, it’s generally advised to wait before making a status inquiry. According to MPEP 203.08:

Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office.

However, if six months have passed without a response, it’s advisable to inquire about the application’s status to avoid potential abandonment. Applicants are encouraged to use Patent Center or Private PAIR for status inquiries.

For more information on amended application, visit: amended application.

For more information on Patent Center, visit: Patent Center.

For more information on Private PAIR, visit: Private PAIR.

For amended patent applications, the USPTO provides guidelines on when to inquire about the status. According to MPEP 203.08:

Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office.

If six months have passed without a response, you should inquire about the application’s status to avoid potential abandonment. It’s recommended to use Patent Center or Private PAIR for status inquiries.

For more information on amended application, visit: amended application.

The United States Patent and Trademark Office (USPTO) defines an abandoned patent application through the Manual of Patent Examining Procedure (MPEP) 203.05. According to this section, an abandoned application is defined as:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications

This removal from the docket can occur for various reasons, including formal abandonment, failure to take appropriate action during prosecution, non-payment of fees, or the expiration of the statutory period for provisional applications.

MPEP 203.03 defines an ‘amended’ application as:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action. The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

In essence, an application becomes ‘amended’ when the applicant responds to an examiner’s action, whether through election, traversal, or by submitting amendments to the application.

A patent application can become formally abandoned through an explicit action by the applicant or their representative. MPEP 203.05 states that an abandoned application includes one that is removed from the Office docket of pending applications: (A) through formal abandonment by the applicant or by the attorney or agent of record. This means the applicant or their legal representative can submit a formal request to abandon the application, effectively ending its prosecution.

Congressional and other official inquiries about patent applications are handled through specific channels at the USPTO. According to MPEP 203.08(a):

Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs.

This procedure ensures uniformity in handling contacts from these sources and compliance with Department of Commerce directives. Specific instructions are provided for transmitting such inquiries to the appropriate offices within the USPTO.

For more information on USPTO procedures, visit: USPTO procedures.

Yes, failure to pay the issue fee can result in an abandoned patent application. MPEP 203.05 explicitly states that an abandoned application includes one removed from the Office docket for failure to pay the issue fee (MPEP § 711 to § 711.05). This means that even if an application has been approved for issuance, if the applicant fails to pay the required issue fee within the specified time frame, the application will be considered abandoned.

For more detailed information on this topic, you can refer to MPEP § 711 to § 711.05.

Yes, an abandoned application can still be used as a priority document for subsequent applications, provided that the priority claim is made within the specified time limits. The abandoned status of the earlier application does not affect its ability to serve as a basis for priority. For more information on priority claims, refer to MPEP 201 and MPEP 211.

Yes, an abandoned application can be used as prior art, but the extent of its use depends on several factors. Under MPEP 2127, abandoned applications that have been published can be used as prior art as of their publication date for all they teach. Unpublished abandoned applications may be available as prior art under certain circumstances, such as when they are incorporated by reference in a U.S. patent. It’s important to note that the abandonment status itself does not negate the application’s potential as prior art. For specific rules on using abandoned applications as prior art, consult MPEP 2127 and MPEP 901 on prior art.

MPEP 211 - Claiming the Benefit of an Earlier Filing Date Under 35 U.S.C. 120 and 119(e) (88)

The MPEP ¶ 2.11 mentions several U.S. Code sections relevant to claiming the benefit of an earlier filing date:

This application is claiming the benefit of prior-filed application No.[1] under 35 U.S.C. 120, 121, 365(c), or 386(c).

These sections cover different scenarios:

  • 35 U.S.C. 120: Benefit of earlier filing date in the United States
  • 35 U.S.C. 121: Divisional applications
  • 35 U.S.C. 365(c): Benefit of earlier filing date; national application
  • 35 U.S.C. 386(c): Benefit of earlier filing date; international design application

Each of these sections provides specific conditions under which an application can claim the benefit of an earlier filing date.

For more information on earlier filing date, visit: earlier filing date.

For more information on patent law, visit: patent law.

For a non-English provisional application, the English translation and accuracy statement must be filed in the provisional application itself, not in the non-provisional application claiming its benefit. MPEP ¶ 2.38 clearly states:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[…]”

Additionally, in the non-provisional application claiming benefit, you must provide confirmation that these documents were filed in the provisional application. This two-step process ensures proper documentation and compliance with 37 CFR 1.78.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The location of the benefit claim reference depends on the filing date of the application:

  • For applications filed before September 16, 2012: The reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS).
  • For applications filed on or after September 16, 2012: The specific reference must be included in an application data sheet (ADS).

The MPEP states: “If the application was filed before September 16, 2012, the reference must be included in the first sentence(s) of the specification following the title or in an application data sheet; if the application was filed on or after September 16, 2012, the specific reference must be included in an application data sheet.”

It’s important to note that for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must also include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on application data sheet, visit: application data sheet.

For more information on divisional, visit: divisional.

According to the MPEP, a petition to restore the benefit of a provisional application should be addressed to:

“Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.”

It’s important to note that this petition must be filed in the subsequent nonprovisional application or international application designating the United States, not in the provisional application itself. Always ensure you’re following the most current USPTO guidelines for petition submissions, as procedures may be updated over time.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The English translation of a non-English provisional application must be filed in the provisional application itself, not in the non-provisional application claiming benefit. According to MPEP ¶ 2.38:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3].”

Additionally, you must confirm in your current application that the translation and statement were filed in the provisional application.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

For those seeking more detailed information on benefit claims under 35 U.S.C. 386(c), the Manual of Patent Examining Procedure (MPEP) provides a specific reference. According to MPEP § 211.01(d):

See MPEP § 2920.05(e) for additional information pertaining to benefit claims under 35 U.S.C. 386(c).

This section of the MPEP offers comprehensive guidance on the intricacies of claiming benefit to international design applications, including procedural requirements and practical considerations for patent applicants and examiners.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on benefit claims, visit: benefit claims.

The timing for submitting a specific reference to a prior-filed application depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): The specific reference must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: The specific reference must be submitted during the pendency of the application and within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

It’s important to note that This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s).

For more information on filing deadline, visit: filing deadline.

For more information on specific reference, visit: specific reference.

The ability to claim benefit under 35 U.S.C. 386(c) for international design applications is subject to specific timing requirements. According to MPEP § 211.01(d):

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that to claim the benefit of an international design application, the claiming application must have been filed on or after May 13, 2015. This date is significant as it marks the implementation of certain provisions of the Patent Law Treaties Implementation Act of 2012.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on filing date requirements, visit: filing date requirements.

According to 37 CFR 1.78(j), benefit claims under 35 U.S.C. 386(c) can only be made in specific types of applications filed on or after May 13, 2015. The MPEP states:

“37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.”

This means that applications filed before May 13, 2015, cannot claim the benefit of an international design application under 35 U.S.C. 386(c). It’s important for applicants to be aware of this date restriction when considering their benefit claims.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

The reference to the prior-filed application to claim benefit under 35 U.S.C. 120 or 119(e) must be submitted within the following time periods under 37 CFR 1.78:

  • For an application filed under 35 U.S.C. 111(a), the later of four months from the filing date or sixteen months from the filing date of the prior-filed application
  • For a national stage application under 35 U.S.C. 371, the later of four months from national stage commencement under 35 U.S.C. 371(b) or (f), four months from initial national stage submission, or sixteen months from the filing date of the prior-filed application

Failure to timely submit the reference is considered a waiver of any benefit claim. A petition and fee would be required to accept a delayed submission. See MPEP 211.04.

If you missed the deadline for filing a benefit claim, you may still be able to claim the benefit by filing a petition for an unintentionally delayed benefit claim. The process differs based on the type of benefit claim:

The MPEP states: “If applicant desires the benefit under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c) based upon a previously filed application, applicant must file a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(c) for benefit claims under 35 U.S.C. 119(e) or under 37 CFR 1.78(e) for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c).”

The petition must include:

  1. The reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior application (unless previously submitted)
  2. A petition fee under 37 CFR 1.17(m)
  3. A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the claim was filed was unintentional

The Director may require additional information if there’s a question about whether the delay was unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on petition fee, visit: petition fee.

For more information on unintentional delay, visit: unintentional delay.

If you miss the 12-month deadline for claiming the benefit of a provisional application, you have two main options:

  1. Delete the claim to the benefit of the prior-filed provisional application.
  2. File a petition to restore the benefit of the provisional application.

The MPEP states:

“Alternatively, applicant may wish to file a petition to restore the benefit of the provisional application under 37 CFR 1.78 in the subsequent nonprovisional application or international application designating the United States if the subsequent application was filed within two months from the expiration of the twelve-month period and the delay was unintentional.”

This petition must be filed in the subsequent application and include specific requirements, such as a reference to the provisional application, a petition fee, and a statement that the delay was unintentional.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The time limit for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a), the specific reference must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371, the specific reference must be submitted during the pendency of the application and within the later of four months from the date on which the national stage commenced, four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

As stated in MPEP 211.02: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).

For more information on national stage application, visit: national stage application.

For more information on time limit, visit: time limit.

The time limit for filing a benefit claim depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the reference must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “If the application is an application filed under 35 U.S.C. 111(a), the reference to the prior application must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on time limit, visit: time limit.

The time limit for claiming benefit of a prior application depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a), the benefit claim must be made within the later of:
    • Four months from the actual filing date of the later-filed application, or
    • Sixteen months from the filing date of the prior-filed application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c) unless a petition to accept an unintentionally delayed benefit claim is granted.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on time limit, visit: time limit.

MPEP ¶ 2.15 provides guidance on how to properly claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c). It outlines the requirements for including a specific reference to the prior-filed application and the timeframes within which this reference must be submitted.

The paragraph states: If applicant desires to claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c), the instant application must contain, or be amended to contain, a specific reference to the prior-filed application in compliance with 37 CFR 1.78. This means that applicants must explicitly reference the prior application to claim its benefits.

For more information on specific reference, visit: specific reference.

Form Paragraph 2.38 in the MPEP serves several important purposes regarding non-English provisional applications:

  1. It notifies the applicant that an English translation and/or a statement of translation accuracy is required for a non-English language provisional application.
  2. It informs the applicant about the specific documents that are missing from their application.
  3. It provides clear instructions on what the applicant needs to do to rectify the situation.
  4. It warns the applicant about the potential consequences of not providing the required documents.

The MPEP states: Use this form paragraph to notify applicant that an English translation of the non-English language provisional application and/or a statement that the translation is accurate is required.

This form paragraph is a crucial tool for patent examiners to communicate requirements and potential issues to applicants, ensuring that all necessary documents are properly filed for claiming benefit to a non-English provisional application.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

If a benefit claim is not filed within the required time period, it may still be accepted through a petition process. According to MPEP ¶ 2.15:

A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

The petition must include:

  1. The reference to the prior application (unless previously submitted)
  2. The petition fee under 37 CFR 1.17(m)
  3. A statement that the entire delay between the date the benefit claim was due and the date the claim was filed was unintentional

The Director may request additional information if there’s a question about whether the delay was unintentional. The petition should be addressed to: Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.

For more information on unintentional delay, visit: unintentional delay.

The MPEP does not specify a fixed deadline for submitting the English translation of a non-English provisional application. However, it indicates that the translation must be provided within a time period set by the USPTO. According to MPEP ¶ 2.38:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This suggests that the USPTO will set a specific deadline in an Office action, and you must comply with this deadline to avoid abandonment of your application.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

The deadline for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): Submit within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: Submit within the later of four months from the date on which the national stage commenced, four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

The MPEP emphasizes: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c). (MPEP § 211)

For more information on national stage application, visit: national stage application.

The deadline for filing a benefit claim depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the reference must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “If the application is an application filed under 35 U.S.C. 111(a), the reference to the prior application must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on filing deadline, visit: filing deadline.

For more information on national stage application, visit: national stage application.

Copendency is a crucial requirement when claiming the benefit of a prior-filed nonprovisional application under 35 U.S.C. 120, 121, 365(c), or 386(c). The MPEP defines copendency as follows:

“Copendency is defined in the clause which requires that the later-filed application must be filed before: (A) the patenting of the prior application; (B) the abandonment of the prior application; or (C) the termination of proceedings in the prior application.”

Key points about copendency:

  • The later-filed application must be filed before the prior application patents, is abandoned, or proceedings are terminated
  • If the prior application issues as a patent, the later-filed application can be filed on the same date the patent issues
  • If the prior application is abandoned, the later-filed application must be filed before the abandonment
  • Without copendency, the later-filed application cannot claim the benefit of the prior application’s filing date

Applicants should be aware of the copendency requirement to ensure their benefit claims are valid.

Claiming priority to an international design application can provide significant benefits for nonprovisional applications. According to MPEP § 211.01(d):

Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.

This means that a nonprovisional application can claim the earlier filing date of an international design application, potentially providing an earlier priority date for the claimed invention.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on nonprovisional application, visit: nonprovisional application.

Under 35 U.S.C. 386(c), a nonprovisional application can claim the benefit of a prior international design application designating the United States, subject to the conditions and requirements of 35 U.S.C. 120. This provision allows applicants to establish an earlier effective filing date for their nonprovisional applications based on their international design applications.

As stated in the MPEP:

“Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.”

This benefit claim can be crucial for establishing priority and overcoming prior art references.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on nonprovisional application, visit: nonprovisional application.

What is the ‘specific reference’ requirement for claiming benefit of a prior-filed application?

The ‘specific reference’ requirement is a crucial aspect of claiming the benefit of a prior-filed application. According to MPEP 211.01, To claim the benefit of a prior-filed application, the later-filed application must contain a specific reference to the prior-filed application. This means that:

  • The specific reference must be made in the first sentence(s) of the specification or in an application data sheet (ADS).
  • It should include the relationship between the applications (e.g., continuation, divisional, or continuation-in-part).
  • The prior application’s serial number and filing date must be provided.

For example: ‘This application is a continuation of Application No. 12/345,678, filed January 1, 2020.’

Failure to provide this specific reference can result in the loss of the benefit claim. For more details, refer to MPEP 211 and 37 CFR 1.78.

What is the ‘same invention’ requirement for claiming benefit under 35 U.S.C. 120?

The ‘same invention’ requirement is a crucial aspect of claiming benefit under 35 U.S.C. 120. MPEP 211.01(b) explains: The second application must be an application for a patent for an invention which is also disclosed in the first application.

This means:

  • The later application must disclose at least some part of the invention claimed in the prior application.
  • The disclosure in the prior application must provide adequate support for the claims in the later application.
  • New matter introduced in the later application cannot claim the benefit of the earlier filing date.

The ‘same invention’ does not require identical claims, but there must be a common disclosure that supports the claims in both applications. For more information, see MPEP 211.01(b) and 35 U.S.C. 120.

To claim the benefit of an earlier filing date under 35 U.S.C. 120, the following requirements must be met:

  • The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application
  • The disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement
  • The later-filed application must contain a specific reference to the prior application
  • The later-filed application must be filed before the patenting or abandonment of or termination of proceedings on the first application

As stated in the MPEP: “To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

A petition to restore the benefit of a provisional application under 37 CFR 1.78(b) must include several elements. According to MPEP 211.01(a):

‘A petition under 37 CFR 1.78(b) requires: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application, which must be included in application data sheet (unless previously submitted in an application data sheet); (B) the petition fee as set forth in 37 CFR 1.17(m); and (C) a statement that the delay in filing the nonprovisional application or international application designating the United States within the twelve-month period set forth in 37 CFR 1.78(a)(1)(i) was unintentional.’

The petition must be filed in the subsequent application (nonprovisional or international application designating the US) within 14 months of the provisional application’s filing date. The USPTO may require additional information to verify that the delay was unintentional.

For more information on benefit restoration, visit: benefit restoration.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

When claiming the benefit of a provisional application filed in a language other than English, additional requirements must be met. The MPEP states:

“If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.”

If these documents were not filed in the provisional application, the applicant will be notified and given a period to:

  1. File the translation and statement in the provisional application
  2. Submit a confirmation in the nonprovisional application that the translation and statement were filed in the provisional application

Failure to respond to this notice in a pending nonprovisional application will result in abandonment. For more details, see MPEP § 211.01(a).

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

Copendency refers to the requirement that a later-filed application claiming benefit of a prior application must be filed before the prior application is patented, abandoned, or proceedings are terminated. Copendency is crucial because:

  • It establishes a continuous chain of pending applications
  • It allows the later application to claim the earlier filing date
  • Without copendency, the benefit claim is improper

As stated in MPEP 211.01(b): “Copendency is defined in the clause which requires that the later-filed application must be filed before: (A) the patenting of the prior application; (B) the abandonment of the prior application; or (C) the termination of proceedings in the prior application.”

A ‘bypass’ application is:

  • A regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b)
  • It claims benefit of an international application’s filing date without entering the national stage under 35 U.S.C. 371
  • It can be filed as a continuation, divisional, or continuation-in-part of the international application

MPEP 211.01(c) explains: “Rather than submitting a national stage application under 35 U.S.C. 371, applicant may file a continuation, divisional, or continuation-in-part of an international (PCT) application under 35 U.S.C. 111(a). Such applications are often referred to as ‘bypass’ applications.”

For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), which include continuations, divisionals, and continuation-in-part applications, the benefit claim must include specific information about the relationship between the applications. The MPEP states:

“For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.”

This means that when making a benefit claim, you must explicitly state whether the current application is a:

  • Continuation
  • Divisional
  • Continuation-in-part

of the prior application. This information helps the USPTO and others understand the relationship between related applications and ensures proper examination and treatment of the claims.

Remember, this requirement is in addition to other necessary information for the benefit claim, such as the application number and filing date of the prior application.

For more information on divisional, visit: divisional.

Tags: divisional

If the specific reference to a prior-filed application is not submitted within the required time period, it is considered a waiver of any benefit claim to that prior application. The MPEP states:

This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).

However, there is a possibility to accept a late benefit claim. The MPEP provides that: A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

Such a petition must include:

  1. The reference to the prior application
  2. The petition fee
  3. A statement that the delay was unintentional

The Director may require additional information to verify that the delay was indeed unintentional.

For more information on unintentional delay, visit: unintentional delay.

For more information on waiver, visit: waiver.

If the required translation or statement is missing for a non-English provisional application, the following consequences apply:

  1. The USPTO will issue a notice stating that the required documents are missing.
  2. The applicant must supply the missing translation and/or statement in the provisional application.
  3. The applicant must provide confirmation in the present application that the translation and statement were filed in the provisional application.
  4. If these requirements are not met within the time period set by the USPTO, the present application will be abandoned.

As stated in the MPEP, If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned. See 37 CFR 1.78.

For more information on application abandonment, visit: application abandonment.

For more information on missing documents, visit: missing documents.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If the required translation and statement are not filed for a non-English provisional application, serious consequences can occur. According to MPEP ¶ 2.38:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This means that if you fail to provide the English translation and accuracy statement in the provisional application, and fail to confirm their filing in the present application, your current application may be abandoned. It’s crucial to comply with these requirements within the specified time frame to maintain your application’s active status.

For more information on application abandonment, visit: application abandonment.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

If you miss the deadline for submitting a benefit claim, you may still be able to claim the benefit by filing a petition. According to MPEP 211.02:

A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

The petition must include:

  • The reference to the prior application (unless previously submitted)
  • The petition fee under 37 CFR 1.17(m)
  • A statement that the entire delay was unintentional

The Director may require additional information if there’s a question about whether the delay was unintentional. It’s important to note that accepting a late benefit claim is at the discretion of the USPTO and is not guaranteed.

For more information on unintentional delay, visit: unintentional delay.

For more information on USPTO, visit: USPTO.

If you fail to provide the required English translation and statement of accuracy for a non-English provisional application, your current application may be abandoned. The MPEP states:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned. See 37 CFR 1.78.”

This means you must either provide the required documents or withdraw the benefit claim to avoid abandonment of your application.

For more information on application abandonment, visit: application abandonment.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If you don’t file a petition to restore the benefit of a provisional application after missing the 12-month deadline, you will lose the right to claim the earlier filing date of the provisional application. The MPEP states:

“Applicant is required to delete the claim to the benefit of the prior-filed provisional application, unless applicant can establish that this application, or an intermediate nonprovisional application or international application designating the United States, was filed within 12 months of the filing date of the provisional application.”

This means your application will be treated as if it was filed on the date of the nonprovisional application, potentially affecting your ability to secure patent rights if intervening prior art exists. It’s crucial to either meet the original 12-month deadline or file a timely petition to restore the benefit to maintain your earlier filing date.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

If copendency is not established between patent applications, the benefit claim to the prior-filed application becomes improper. The MPEP clearly states:

Since the applications are not copending, the benefit claim to the prior-filed application is improper. Applicant is required to delete the claim to the benefit of the prior-filed application, unless applicant can establish copendency between the applications.

In such cases, the applicant must either prove that copendency exists or remove the benefit claim. Failure to do so may result in the loss of the earlier priority date, potentially affecting the patentability of the invention.

For more information on copendency, visit: copendency.

For more information on patent procedure, visit: patent procedure.

If a continuation or divisional application contains new matter not disclosed in the prior-filed application, the applicant will be required to either delete the benefit claim or change the relationship to a continuation-in-part application. This is because continuation and divisional applications cannot include new matter.

As stated in MPEP ¶ 2.10.01:

“Applicant is required to delete the benefit claim or change the relationship (continuation or divisional application) to continuation-in-part because this application contains the following matter not disclosed in the prior-filed application:”

This form paragraph is used by examiners when they identify new matter in an application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c).

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent examination, visit: patent examination.

If a benefit claim to a provisional application lacks proper indication of an intermediate application:

  • The Office may not recognize the benefit claim
  • The benefit claim may not appear on the filing receipt
  • A petition under 37 CFR 1.78(c) and petition fee may be required to correct the benefit claim

MPEP 211.01(b) states: “If a benefit claim to a provisional application is submitted without an indication that an intermediate application directly claims the benefit of the provisional application and the instant nonprovisional application is not filed within the 12 month period (or 14 month period if the benefit of the provisional application has been restored pursuant to 37 CFR 1.78(b)) or the relationship between each nonprovisional application is not indicated, the Office will not recognize such benefit claim and will not include the benefit claim on the filing receipt.”

If a benefit claim is included elsewhere in the application (e.g., in an oath or declaration) and is recognized by the USPTO as shown by its inclusion on the first filing receipt, but not properly submitted in the manner specified by 37 CFR 1.78, the following applies:

  • The USPTO will not require a petition and petition fee to correct the benefit claim.
  • This is because the application will have been scheduled for publication based on the information concerning the benefit claim.
  • However, the applicant must still submit the benefit claim in the proper manner (i.e., in an ADS or by amendment to the specification, depending on the filing date) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78.

The MPEP states: “If an applicant includes a claim to the benefit of a prior application elsewhere in the application but not in the manner specified in 37 CFR 1.78 (e.g., if the benefit claim is not present in the proper place but is included in an oath or declaration, or the application transmittal letter, or in the first sentence(s) of the specification for an application filed on or after September 16, 2012) within the time period set forth in 37 CFR 1.78, the Office will not require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the information concerning the benefit claim contained elsewhere in the application was recognized by the Office as shown by its inclusion on the first filing receipt.”

If a benefit claim is not properly made within the required time period, it is considered untimely and will not be entered. The MPEP states:

“The benefit claim filed on [1] was not entered because the required reference was not timely filed within the time period set forth in 37 CFR 1.78.”

Consequences of an untimely benefit claim include:

  • Loss of the earlier priority date, which could affect the patentability of the application if intervening prior art exists.
  • Inability to rely on the earlier filing date to overcome prior art references.
  • Potential issues with statutory bars under 35 U.S.C. 102.

However, all is not lost if the benefit claim is untimely. The applicant may file a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(c) or 37 CFR 1.78(e), depending on the type of benefit claim. This petition must include:

  1. The required reference to the prior application
  2. A petition fee
  3. A statement that the entire delay was unintentional

The USPTO may require additional information to determine if the delay was truly unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on unintentional delay, visit: unintentional delay.

If an applicant includes a benefit claim in the wrong part of the application but within the required time period, the USPTO’s response depends on whether the claim is recognized:

  1. If the benefit claim is recognized by the Office (shown by its inclusion on the first filing receipt), no petition or petition fee is required to correct the benefit claim. The MPEP states: If an applicant includes a claim to the benefit of a prior application elsewhere in the application but not in the manner specified in 37 CFR 1.78 (e.g., if the benefit claim is not present in the proper place but is included in an oath or declaration, or the application transmittal letter, or in the first sentence(s) of the specification for an application filed on or after September 16, 2012) within the time period set forth in 37 CFR 1.78, the Office will not require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the information concerning the benefit claim contained elsewhere in the application was recognized by the Office as shown by its inclusion on the first filing receipt.
  2. If the benefit claim is not recognized by the Office (shown by its absence on the first filing receipt), a petition and petition fee under 37 CFR 1.17(m) will be required to correct the benefit claim if the correction is sought after the time period set in 37 CFR 1.78.

In both cases, the applicant must still submit the benefit claim in the proper format (i.e., in an ADS or by amendment to the specification, depending on the application’s filing date) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on filing receipt, visit: filing receipt.

If a benefit claim is filed after the required time period specified in 37 CFR 1.78, the applicant must file a petition for an unintentionally delayed benefit claim. The MPEP states:

“If a benefit claim is filed after the required time period and without a petition as required by 37 CFR 1.78, the applicant should be informed that the benefit claim was not entered and that a petition needs to be filed using form paragraph 2.39.”

The petition must include:

  • The reference to the prior application (unless previously submitted)
  • A petition fee under 37 CFR 1.17(m)
  • A statement that the entire delay was unintentional

The Director may require additional information to determine if the delay was unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on unintentional delay, visit: unintentional delay.

Copendency refers to the requirement that two related patent applications must be pending at the same time for one to claim the benefit of the earlier filing date of the other. The MPEP states:

Copendency between the current application and the prior application is required.

This means that the later application must be filed before the earlier application is either abandoned or issued as a patent. Copendency is crucial for maintaining a continuous chain of priority between related applications.

For more information on copendency, visit: copendency.

For more information on patent applications, visit: patent applications.

‘Unintentional delay’ is a crucial concept when seeking to restore the benefit of a provisional application. The MPEP requires:

“A statement that the delay in filing the subsequent nonprovisional application or international application designating the United States within the twelve-month period was unintentional.”

While the MPEP doesn’t provide a specific definition of ‘unintentional delay’, it generally means that the failure to meet the 12-month deadline was not deliberate. The USPTO may require additional information to determine if the delay was truly unintentional:

“The Director may require additional information where there is a question whether the delay was unintentional.”

It’s important to be prepared to explain the circumstances that led to the delay if requested.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

According to MPEP 211, a petition to restore the benefit of a provisional application under 37 CFR 1.78(b) must include:

  1. The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application (unless previously submitted)
  2. The petition fee set forth in 37 CFR 1.17(m)
  3. A statement that the delay in filing the subsequent nonprovisional application or international application designating the United States within the twelve-month period was unintentional

The MPEP further states:

“The Director may require additional information where there is a question whether the delay was unintentional.”

It’s important to note that this petition must be filed in the subsequent application, not the provisional application itself.

For more information on patent procedure, visit: patent procedure.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

Filing a delayed benefit claim for a provisional application requires specific components. MPEP 211.04 outlines the requirements:

The petition must be accompanied by: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior provisional application (unless previously submitted); (B) a petition fee under 37 CFR 1.17(m); and (C) a statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the claim was filed was unintentional.

For petitions filed more than two years after the due date, additional explanation of the delay circumstances is required to establish that the entire delay was unintentional.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

Claiming the benefit of an international application (PCT application) in a U.S. national application has specific requirements. The MPEP states:

“Pursuant to 35 U.S.C. 365(c), a regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b) may claim the benefit of the filing date of an international application which designates the United States without completing the requirements for entering the national stage under 35 U.S.C. 371.”

Requirements for claiming benefit of an international application:

  • The international application must designate the United States
  • The international application must be entitled to a filing date in accordance with PCT Article 11
  • The later-filed U.S. application must be filed during the pendency of the international application
  • The U.S. application can be filed as a continuation, divisional, or continuation-in-part of the international application (often called a “bypass” application)

This allows applicants to claim the benefit of an international application’s filing date without completing the national stage entry process under 35 U.S.C. 371.

To claim the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the following requirements must be met:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (unless the benefit has been restored)
  • The provisional application must have at least one common inventor with the nonprovisional application
  • The provisional application must be entitled to a filing date and have paid the basic filing fee
  • If the provisional application was filed in a language other than English, an English translation and a statement that the translation is accurate must be filed

As stated in the MPEP: “When a later-filed application is claiming the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the nonprovisional application must be filed not later than 12 months after the date on which the provisional application was filed, unless the benefit of the provisional application has been restored.”

To claim benefit to a non-English language provisional application, you must provide:

  • An English translation of the non-English language provisional application
  • A statement that the translation is accurate

These documents must be filed in the provisional application itself. As stated in MPEP ¶ 2.38: “An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[…]”

Additionally, in the present (non-provisional) application, you must confirm that the translation and statement were filed in the provisional application.

For more information on non-English language, visit: non-English language.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

Benefit claims can be made under various sections of the U.S. Code, each with specific requirements:

  • 35 U.S.C. 119(e): For provisional application benefits, refer to 37 CFR 1.78(a).
  • 35 U.S.C. 120: For benefit claims to earlier nonprovisional applications, including the relationship (continuation, divisional, or continuation-in-part).
  • 35 U.S.C. 121: For divisional applications.
  • 35 U.S.C. 365(c): For national stage applications claiming benefit to PCT applications.
  • 35 U.S.C. 386(c): For national stage applications claiming benefit to international design applications.

The MPEP states: “For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.”

It’s important to note that the specific requirements and time limits may vary depending on the type of benefit claim. Always refer to the latest version of the MPEP and the relevant U.S. Code sections for the most up-to-date information.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For an international design application to be used as a basis for claiming benefit, it must meet specific filing date requirements. MPEP § 211.01(d) states:

To obtain benefit of the filing date of a prior international design application designating the United States, the international design application must be entitled to a filing date in accordance with 37 CFR 1.1023. See 37 CFR 1.78(d)(1)(ii).

This means that the international design application must comply with the requirements set forth in 37 CFR 1.1023 to establish a valid filing date. These requirements typically include proper designation of the United States and adherence to other formal application standards.

For more information on filing date requirements, visit: filing date requirements.

To claim the benefit of an earlier filing date under 35 U.S.C. 120 and 119(e), a later-filed application must meet several requirements:

  • The prior-filed application must name the inventor or at least one joint inventor named in the later-filed application and must be entitled to a filing date
  • The prior-filed application must meet disclosure requirements under 35 U.S.C. 112(a) to support the claims in the later-filed application, except for the best mode requirement
  • The later-filed application must contain a specific reference to the prior-filed application
  • The reference to the prior application must be submitted within the time periods set forth in 37 CFR 1.78

Claiming benefit under these statutes allows an application to receive the earlier filing date of a prior-filed application, which can be crucial for establishing priority and overcoming prior art. However, this claim also requires that the application does not contain new matter.

The MPEP ¶ 2.10.01 states:

“This form paragraph should be used when an application, which claims the benefit of a prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c) contains new matter relative to the prior-filed application, and purports to be a ‘continuation,’ ‘division,’ or ‘divisional application’ of the prior-filed application.”

If new matter is found, the applicant may need to change the application type or remove the benefit claim to maintain the new subject matter.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on new matter, visit: new matter.

Failure to timely submit the reference to the prior-filed application within the time periods specified in 37 CFR 1.78 is considered a waiver of any benefit claim under 35 U.S.C. 120, 121, 365(c), or 386(c) to the prior-filed application. See 37 CFR 1.78(d)(3)(iii). The time periods are not extendable.

If the reference to the prior-filed application is submitted after the time period provided by 37 CFR 1.78, a petition and the petition fee under 37 CFR 1.17(m) would be required to accept the delayed claim. The petition must be accompanied by:

  • The reference required by 35 U.S.C. 120 and 37 CFR 1.78 to the prior-filed application
  • The petition fee
  • A statement that the entire delay between the date the benefit claim was due and the date the claim was filed was unintentional

The abandonment of an international application in the United States is governed by specific legal provisions. According to MPEP 211.01(c), which cites 35 U.S.C. 371(d):

35 U.S.C. 371(d) indicates that failure to timely comply with the requirements of 35 U.S.C. 371(c) ‘shall be regarded as abandonment of the application by the parties thereof.’

This means that an international application designating the United States will be considered abandoned if the applicant fails to meet the requirements for entering the national stage under 35 U.S.C. 371(c) within the specified time limits. These requirements typically include submitting necessary documents, paying required fees, and providing an English translation of the application if it was not originally filed in English.

For more information on national stage entry, visit: national stage entry.

If a benefit claim is improper due to lack of copendency, the MPEP ¶ 2.11 outlines the required action:

Applicant is required to delete the claim to the benefit of the prior-filed application, unless applicant can establish copendency between the applications.

This means the applicant has two options:

  1. Delete the benefit claim to the prior-filed application, or
  2. Provide evidence to establish that copendency actually exists between the applications.

If the applicant cannot prove copendency, they must remove the benefit claim to avoid potential issues with the application’s validity or examination process.

For more information on copendency, visit: copendency.

For more information on patent procedure, visit: patent procedure.

When the required documents for a non-English provisional application are missing, the USPTO takes specific actions to notify the applicant. According to MPEP ¶ 2.38:

“Use this form paragraph to notify applicant that an English translation of the non-English language provisional application and/or a statement that the translation is accurate is required.”

The USPTO will issue an Office action informing the applicant of the missing documents and setting a time period for their submission. The applicant must then provide the missing translation and/or accuracy statement in the provisional application and confirm their filing in the present application. Failure to do so within the specified time period may result in the abandonment of the present application.

For more information on missing documents, visit: missing documents.

For more information on patent procedure, visit: patent procedure.

Yes, there is an exception for certain applications filed before November 25, 2005. According to the Examiner Note in MPEP ¶ 2.38:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This means that for non-provisional applications filed before November 25, 2005, it was acceptable to file the English translation and accuracy statement in the non-provisional application itself, rather than in the provisional application. For applications filed after this date, the current rules requiring filing in the provisional application apply.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

Yes, there is a time limit for filing a petition to restore the benefit of a provisional application. According to MPEP 211:

“Applicant may wish to file a petition to restore the benefit of the provisional application under 37 CFR 1.78 in the subsequent nonprovisional application or international application designating the United States if the subsequent application was filed within two months from the expiration of the twelve-month period and the delay was unintentional.”

This means you have a two-month grace period after the expiration of the initial 12-month period to file the petition. It’s crucial to act quickly if you miss the original deadline and wish to restore the benefit of your provisional application.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

Yes, there is a deadline for filing the English translation and accuracy statement for a non-English provisional application. While MPEP ¶ 2.38 doesn’t specify an exact timeframe, it indicates that the USPTO will set a time period in an Office action:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This means that when the USPTO notices that the required documents are missing, they will issue an Office action with a specific deadline. It’s crucial to comply with this deadline to avoid abandonment of your application. As a best practice, it’s advisable to file these documents as soon as possible after filing the non-English provisional application to avoid any potential issues.

For more information on patent procedure, visit: patent procedure.

The method for making a specific reference to a prior-filed application depends on when the application was filed:

  • For applications filed before September 16, 2012: The specific reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS) in compliance with pre-AIA 37 CFR 1.76.
  • For applications filed on or after September 16, 2012: The specific reference must be included in an ADS in compliance with 37 CFR 1.76.

Additionally, for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

It’s important to note that for continued prosecution applications (CPAs) filed under 37 CFR 1.53(d) (design applications under 35 U.S.C. chapter 16 only), a specific reference in the specification or ADS is not required and may not be made. For these applications, The specific reference requirement of 35 U.S.C. 120 is met by the transmittal request for the CPA which is considered to be part of the CPA.

For more information on application data sheet, visit: application data sheet.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on specific reference, visit: specific reference.

The method for including a benefit claim in a patent application depends on the filing date:

  • For applications filed before September 16, 2012: The reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS).
  • For applications filed on or after September 16, 2012: The specific reference must be included in an application data sheet (ADS).

The MPEP states: “If the application was filed before September 16, 2012, the reference must be included in the first sentence(s) of the specification following the title or in an application data sheet; if the application was filed on or after September 16, 2012, the specific reference must be included in an application data sheet.”

Additionally, for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on application data sheet, visit: application data sheet.

The presence of new matter in a continuation or divisional application can significantly affect its filing date. If new matter is found, the application may lose the benefit of the earlier filing date for the new subject matter.

According to MPEP ¶ 2.10.01:

“Applicant is required to delete the benefit claim or change the relationship (continuation or divisional application) to continuation-in-part because this application contains the following matter not disclosed in the prior-filed application:”

If the application is changed to a continuation-in-part, the new matter will have the filing date of the current application, while the previously disclosed matter retains the earlier filing date. This can have important implications for determining prior art and patent term.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

How does the copendency requirement affect claiming benefit of a prior application?

The copendency requirement is a critical factor in claiming the benefit of a prior application. MPEP 211.01(b) states: To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be copending with the earlier application.

Copendency means:

  • The later application must be filed before the patenting or abandonment of the prior application.
  • There must be no gap in pendency between the applications in the chain.

If copendency is not maintained, the benefit claim to the earlier application will be lost. This can significantly impact the effective filing date of the later application, potentially affecting its patentability.

For detailed information on copendency, refer to MPEP 211.01(b) and 35 U.S.C. 120.

The benefit claim process for national stage applications entering from an international application under 35 U.S.C. 371 has some specific timing requirements that differ from regular applications filed under 35 U.S.C. 111(a). The MPEP states:

“If the application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, the reference to the prior application must be made during the pendency of the application and within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.”

Key differences for national stage applications include:

  • The time period for submitting the benefit claim starts from the date the national stage commenced or the date of initial submission to enter the national stage.
  • There are three possible deadlines, and the applicant can use the latest of these:
    1. Four months from the date the national stage commenced
    2. Four months from the date of the initial submission to enter the national stage
    3. Sixteen months from the filing date of the prior application

It’s important to carefully track these dates for national stage applications to ensure timely submission of benefit claims.

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on national stage application, visit: national stage application.

The ‘unintentional’ delay standard is crucial in evaluating petitions for delayed benefit claims. According to MPEP 211.04:

While the Director may require additional information whenever there is a question of whether the delay was unintentional, a person filing a petition to accept a delayed benefit claim more than two years after the date the benefit claim was due is required to provide additional explanation of the circumstances surrounding the delay that establishes that the entire delay was unintentional.

This requirement is in addition to the standard statement of unintentional delay. For further discussion on the ‘unintentional’ delay standard, refer to MPEP § 711.03(c).

For more information on unintentional delay, visit: unintentional delay.

Claiming the benefit of an international design application under 35 U.S.C. 386(c) can potentially establish an earlier effective filing date for a nonprovisional application. This is significant because the effective filing date is used to determine which prior art is applicable during examination.

As stated in the MPEP:

“Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.”

By claiming this benefit, the nonprovisional application can potentially use the filing date of the international design application as its effective filing date, provided all requirements are met. This earlier date can be crucial for overcoming prior art references and establishing priority in the field.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on effective filing date, visit: effective filing date.

For more information on prior art, visit: prior art.

Patent examiners carefully compare the content of the continuation or divisional application with the prior-filed application to identify any new matter. If they find information not disclosed in the prior application, they will issue a notice to the applicant.

The MPEP ¶ 2.10.01 instructs examiners:

“In bracket 1, provide an example of the matter not disclosed in the prior-filed application.”

This means the examiner must specifically point out the new matter found in the application, allowing the applicant to understand and address the issue.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent examination, visit: patent examination.

35 U.S.C. 365(c) is a crucial provision for claiming the benefit of an international application’s filing date in a subsequent national application. As explained in MPEP 211.01(c):

The first sentence of 35 U.S.C. 365(c) specifically provides that ‘[i]n accordance with the conditions and requirements of section 120,… a national application shall be entitled to the benefit of the filing date of a prior international application designating the United States.’

This provision allows applicants to claim the priority of an international application in a later-filed U.S. national application, provided they meet the conditions set forth in 35 U.S.C. 120. One key condition is timing, as the MPEP notes:

The condition of 35 U.S.C. 120 relating to the time of filing requires the later application to be ‘filed before the patenting or abandonment of or termination of proceedings on the first application….’

This means that the national application must be filed while the international application is still pending to claim its benefit.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

To properly claim the benefit of a prior application, you must include a specific reference to the prior application. For applications filed on or after September 16, 2012, this reference must be included in an application data sheet (ADS). For applications filed before September 16, 2012, the reference must be in an ADS and/or in the first sentence(s) of the specification following the title.

The MPEP 211.02 states: Both 35 U.S.C. 119(e) and 120 include the requirement that the later-filed application must contain a specific reference to the prior application.

For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on ADS, visit: ADS.

For more information on divisional, visit: divisional.

For more information on specific reference, visit: specific reference.

To correct or add a benefit claim after filing your application, you need to follow specific procedures depending on the timing and circumstances:

  1. If you received a filing receipt with missing or incorrect benefit claim information, you can request a corrected filing receipt. However, the Office will only grant this request if the proper reference to the prior application was included in the original filing or within the time period required by 37 CFR 1.78.
  2. If you’re adding a benefit claim after the time period required by 37 CFR 1.78, you must file a petition and pay the petition fee. The petition must be accompanied by a corrected Application Data Sheet (ADS) for applications filed on or after September 16, 2012, or an amendment to the specification or a supplemental ADS for applications filed before that date.

As stated in MPEP 211.02(a): If a benefit claim is added after the time period required by 37 CFR 1.78, a petition and the petition fee are required.

Depending on the status of your application, you may also need to file:

  • A Request for Continued Examination (RCE) if the application is under final rejection or has been allowed.
  • A reissue application or a request for a certificate of correction if the application has already issued as a patent.

It’s important to note that you cannot add an incorporation by reference statement to a benefit claim after the filing date, as this would be considered new matter.

For more information on ADS, visit: ADS.

For more information on RCE, visit: RCE.

Tags: ADS, RCE

To claim the benefit of a prior-filed application, you must include a specific reference to the prior-filed application in your current application. The method of including this reference depends on when your application was filed:

  • For applications filed before September 16, 2012: Include the reference in the first sentence(s) of the specification following the title or in an application data sheet (ADS) compliant with pre-AIA 37 CFR 1.76.
  • For applications filed on or after September 16, 2012: Include the reference in an ADS compliant with 37 CFR 1.76.

The MPEP states: If applicant desires to claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c), the instant application must contain, or be amended to contain, a specific reference to the prior-filed application in compliance with 37 CFR 1.78. (MPEP § 211)

For more information on ADS, visit: ADS.

For more information on prior-filed application, visit: prior-filed application.

For more information on specific reference, visit: specific reference.

To claim benefit to a non-English language provisional application, you must:

  • File an English translation of the non-English language provisional application
  • Provide a statement that the translation is accurate
  • File both the translation and the statement in the provisional application
  • Confirm in the present application that the translation and statement were filed in the provisional application

According to MPEP ¶ 2.38, “An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3]. See 37 CFR 1.78.”

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If an applicant misses the 12-month deadline for claiming the benefit of a provisional application, they may be able to restore the benefit under certain conditions:

  1. The nonprovisional application must be filed within 14 months of the provisional application’s filing date
  2. A petition under 37 CFR 1.78(b) must be filed in the nonprovisional application
  3. The delay in filing must be unintentional

The MPEP states: “If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

The petition must include:

  • The reference to the provisional application
  • The petition fee
  • A statement that the delay was unintentional

The benefit of a provisional application can be restored if the nonprovisional application is filed within 14 months of the provisional application filing date. To restore the benefit:

  1. File a petition under 37 CFR 1.78(b) in the nonprovisional application
  2. Include the reference to the provisional application in an application data sheet
  3. Pay the petition fee set in 37 CFR 1.17(m)
  4. Provide a statement that the delay in filing was unintentional

As stated in MPEP 211.01(a): “If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

Delayed benefit claims in international applications have specific procedures. According to MPEP 211.04:

A petition under 37 CFR 1.78 for accepting an unintentionally delayed benefit claim and the petition fee under 37 CFR 1.17(m) are required to add a benefit claim under 35 U.S.C. 120 and 365(c) in an abandoned international application designating the United States, even when the international application did not enter the national stage under 35 U.S.C. 371.

For international applications not filed with the U.S. Receiving Office and not a nonprovisional application, the petition may be filed in the earliest nonprovisional application claiming benefit to the international application. This petition will be treated as if filed in the international application itself.

For more information on international applications, visit: international applications.

For more information on patent procedure, visit: patent procedure.

No, MPEP ¶ 2.11 does not apply to benefit claims for provisional applications. The MPEP explicitly states:

Do not use this form paragraph for benefit claims under 35 U.S.C. 119(e) to provisional applications.

This means that the copendency requirements and procedures outlined in MPEP ¶ 2.11 are specifically for non-provisional applications claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c). Provisional applications have different rules and procedures for claiming benefit, which are covered under 35 U.S.C. 119(e) and other sections of the MPEP.

For more information on benefit claims, visit: benefit claims.

For more information on patent procedure, visit: patent procedure.

If you filed a translation of the non-English provisional application and a statement of accuracy in the nonprovisional application before November 25, 2005, you do not need to provide them again. The MPEP ¶ 2.38 states in the Examiner Note:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This exception only applies to translations filed in the nonprovisional application before the specified date. For all other cases, the translation and statement must be filed in the provisional application itself.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If you submitted the reference to the prior application within the required time period but in the wrong location, you may not need to file a petition. The MPEP provides guidance on this situation:

If the reference to the prior application was previously submitted within the time period set forth in 37 CFR 1.78 but was not included in the location in the application required by the rule (e.g., if the reference was submitted in an oath or declaration or the application transmittal letter), and the information concerning the benefit claim was recognized by the Office as shown by its inclusion on the first filing receipt, the petition under 37 CFR 1.78 and the petition fee under 37 CFR 1.17(m) are not required. (MPEP § 211)

However, you are still required to submit the reference in compliance with 37 CFR 1.78. This means:

  • For applications filed on or after September 16, 2012: File an ADS in compliance with 37 CFR 1.76 with the reference.
  • For applications filed before September 16, 2012: File either an amendment to the first sentence(s) of the specification or an ADS in compliance with pre-AIA 37 CFR 1.76.

For more information on petition requirements, visit: petition requirements.

No, the English translation and accuracy statement for a non-English provisional application cannot be filed in the non-provisional application. They must be filed in the provisional application itself. MPEP ¶ 2.38 is explicit about this requirement:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3].”

However, there is an exception to this rule. The MPEP states:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This means that for applications filed before November 25, 2005, it was acceptable to file these documents in the non-provisional application. For all applications after this date, the translation and statement must be filed in the provisional application, with a confirmation in the non-provisional application that this has been done.

For more information on patent procedure, visit: patent procedure.

Generally, the English translation and accuracy statement for a non-English provisional application must be filed in the provisional application itself, not in the nonprovisional application. However, there is an exception:

As noted in the MPEP, Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.

This means:

  • For applications filed on or after November 25, 2005, the translation and statement must be filed in the provisional application.
  • For applications filed before November 25, 2005, it was acceptable to file these documents in the nonprovisional application.

It’s important to follow the current requirement of filing these documents in the provisional application to ensure proper benefit claim.

For more information on filing requirements, visit: filing requirements.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

No, you cannot file a petition to restore the benefit of a provisional application in the provisional application itself. According to the MPEP:

“A petition to restore the benefit of a provisional application must be filed in the subsequent application.”

This means you must file the petition in the nonprovisional application or the international application designating the United States that is seeking to claim the benefit of the provisional application. This is because the provisional application itself is not examined and automatically expires after 12 months. The petition is a request to restore the right to claim the benefit in a subsequent application, not to extend the life of the provisional application.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

Yes, you can delete a benefit claim, but it’s important to understand the process and potential implications:

  1. For applications filed on or after September 16, 2012, you can delete a benefit claim by filing a corrected Application Data Sheet (ADS) that removes the reference to the prior-filed application.
  2. For applications filed before September 16, 2012, you can delete a benefit claim by amending the specification (if the claim is in the specification) or by submitting a supplemental ADS to delete references to prior applications.

According to MPEP 211.02(a): The examiner should consider whether any new prior art may now be available if a benefit claim is deleted.

Important considerations:

  • Deleting a benefit claim may expose your application to additional prior art, potentially affecting its patentability.
  • If you delete a benefit claim after final rejection or allowance, the amendment will be treated under special rules (37 CFR 1.116 or 1.312, respectively).
  • Deleting a benefit claim may be seen as intentionally waiving the benefit claim. If you later try to reinstate it, the USPTO may not accept it as unintentionally delayed.
  • In a Continued Prosecution Application (CPA), you cannot delete the reference to the prior application with the same application number.

Always carefully consider the implications before deleting a benefit claim, and consult with a patent attorney if you’re unsure about the consequences.

For more information on ADS, visit: ADS.

For more information on CPA, visit: CPA.

For more information on prior art, visit: prior art.

Tags: ADS, CPA, prior art

Yes, there are certain situations where a petition and petition fee are not required to correct a timely submitted benefit claim. According to the MPEP, these situations include:

  • Changing the relationship of the applications (e.g., from “continuation” to “continuation-in-part” or vice versa)
  • Changing the filing date of a prior-filed nonprovisional or provisional application
  • Changing a benefit claim of a prior-filed provisional application from 35 U.S.C. 120 to 35 U.S.C. 119(e) during the pendency of the later-filed application

Additionally, if the benefit claim was included elsewhere in the application (e.g., in an oath, declaration, or transmittal letter) within the required time period and was recognized by the Office as shown on the first filing receipt, a petition is not required. However, the applicant must still submit the benefit claim in the proper format (i.e., in an Application Data Sheet or by amending the specification for applications filed before September 16, 2012).

Note: If the application has already issued as a patent, corrections to benefit claims that would affect the patent term cannot be made by a certificate of correction or in a reissue application.

Yes, there are exceptions to the benefit claim requirements for design applications. The MPEP specifically notes:

“Examiner Note: 1. Use this form paragraph only for original applications filed under 35 U.S.C. 111(a) on or after November 29, 2000 and for national stage applications under 35 U.S.C. 371. DO NOT use for design applications.”

This note indicates that the standard benefit claim requirements and procedures outlined in this section of the MPEP do not apply to design applications. Design applications have different rules and requirements for claiming benefit of earlier filing dates.

Key points about benefit claims in design applications:

  • Design applications can claim the benefit of an earlier filed design application or an earlier filed provisional application.
  • The rules for claiming benefit in design applications are generally less stringent than those for utility applications.
  • Specific requirements for design application benefit claims can be found in MPEP 1504.20.

It’s important to consult the specific rules and guidelines for design applications when dealing with benefit claims in this context, as they differ from the requirements for utility applications.

MPEP 212 - [Reserved] (8)

An MPEP section may be marked as [Reserved] for several reasons:

  • The topic is not currently relevant but a section is being held for potential future use
  • The section was previously used but the content was moved elsewhere in the MPEP
  • The section is a placeholder to maintain a desired numbering scheme

The ‘[R-]’ notation after ‘MPEP 212 [Reserved]’ typically indicates that this section has been revised. However, in this case, since the section is reserved and empty, the ‘[R-]’ may be a placeholder for future revision dates. When a substantive revision occurs, a date is usually added after the ‘R’, such as ‘[R-10.2019]’ to indicate an October 2019 revision.

When an MPEP section is marked as [Reserved], it indicates that the section number exists but there is currently no content provided for that section. The MPEP states in section 212:

212 [Reserved] [R-]

The ‘[Reserved]’ designation in MPEP 212 indicates that this section is currently not in use but is being held for potential future content. It does not contain any specific information or guidance at this time.

Patent attorneys and examiners generally do not need to be concerned about ‘[Reserved]’ sections like MPEP 212. These sections contain no substantive information and do not affect current patent examination procedures. However, it’s good practice to stay informed about MPEP updates in case reserved sections are filled with new content in the future.

No, there is currently no content in MPEP 212. The section is marked as ‘[Reserved]’, which means it is empty and being held for potential future use.

The frequency with which ‘[Reserved]’ sections in the MPEP, like MPEP 212, are filled with content varies and depends on the needs of the USPTO. These sections may be filled during regular MPEP updates, which typically occur several times a year, or may remain reserved for extended periods.

Reserved sections are relatively common in the MPEP, especially for section numbers that are being held for future use or that previously contained content that was moved. A quick scan of the MPEP Chapter 200 shows several reserved sections, such as:

  • Section 203.07 [Reserved]
  • Sections 204-209 [Reserved]
  • Section 212 [Reserved]

MPEP 213-Right of Priority of Foreign Application (50)

The MPEP provides a table of states (countries) for which the right of priority under 35 U.S.C. 119(a)-(d) is recognized. These countries fall into three categories:

  • Parties to the Patent Cooperation Treaty (PCT)
  • Parties to the Paris Convention for the Protection of Industrial Property
  • Members of the World Trade Organization (WTO)

The MPEP states: “Following is a table of states, i.e., countries, with respect to which the right of priority referred to in 35 U.S.C. 119(a)-(d) has been recognized.”

For the most current list of recognized countries, refer to the WIPO website at www.wipo.int/pct/en/paris_wto_pct.html.

The provisions of 35 U.S.C. 386(a) and (b) became effective for certain types of applications filed on or after May 13, 2015. According to MPEP 213.07:

The provisions of 35 U.S.C. 386(a) and (b) apply to nonprovisional applications, international applications (PCT) and international design applications filed on or after May 13, 2015, and patents issued therefrom. See 37 CFR 1.55(o).

This means that the right of priority under these sections is only applicable to:

  • Nonprovisional applications
  • International applications (PCT)
  • International design applications

These applications must be filed on or after May 13, 2015, to be eligible for the priority rights under 35 U.S.C. 386(a) and (b). The same applies to patents issued from such applications.

For more information on 35 U.S.C. 386, visit: 35 U.S.C. 386.

For more information on effective date, visit: effective date.

For more information on nonprovisional application, visit: nonprovisional application.

An international design application designating the United States can claim priority based on several types of prior applications. According to MPEP 213.07:

Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The types of prior applications that can be used for claiming priority include:

  • A prior foreign application
  • An international application (PCT) designating at least one country other than the United States
  • A prior international design application designating at least one country other than the United States

These priority claims must comply with the conditions and requirements set forth in 35 U.S.C. 119(a)-(d) and 172, as well as the Hague Agreement and its Regulations.

For more information on foreign priority, visit: foreign priority.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on prior applications, visit: prior applications.

The time period for filing a priority claim in an international design application designating the United States depends on whether it’s a nonprovisional international design application or not. According to MPEP 213.07:

In an international design application designating the United States, the claim for priority may be made in accordance with the Hague Agreement and the Hague Agreement Regulations.

For nonprovisional international design applications, the MPEP states:

In a nonprovisional international design application, the priority claim and certified copy must be furnished in accordance with the time period and other conditions set forth in paragraph (g) of this section.

This refers to 37 CFR 1.55(g), which generally requires the priority claim to be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application. However, it’s important to consult the specific regulations and the Hague Agreement for precise deadlines and requirements, as they may vary depending on the specific circumstances of the application.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on nonprovisional application, visit: nonprovisional application.

The U.S. nonprovisional application must generally be filed within 12 months of the filing date of the foreign application to claim priority. For design applications, this period is 6 months.

Specifically, 37 CFR 1.55(b) states:

“The nonprovisional application must be: (1) Filed not later than twelve months (six months in the case of a design application) after the date on which the foreign application was filed, subject to paragraph (c) of this section (a subsequent application); or (2) Entitled to claim the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) of a subsequent application that was filed within the period set forth in paragraph (b)(1) of this section.”

There are provisions to restore the right of priority if the subsequent application is filed within 2 months after the expiration of the priority period, if the delay was unintentional.

What is the significance of the Paris Convention in foreign priority claims?

The Paris Convention plays a crucial role in foreign priority claims for patent applications. Its significance includes:

  • Establishing the right of priority for patent applications among member countries.
  • Allowing applicants to file in multiple countries while maintaining the original filing date.
  • Providing a 12-month priority period for utility patents (6 months for design patents).
  • Ensuring equal treatment of foreign and domestic applicants in member countries.

According to MPEP 213: “The right of priority is defined in Article 4 of the Paris Convention for the Protection of Industrial Property and is based on the first filing in a Paris Convention country.” This convention facilitates international patent protection by allowing inventors to secure priority dates across multiple jurisdictions.

Regional patent offices play a crucial role in the international patent system, particularly for priority claims. MPEP 213.01 recognizes several regional patent offices whose applications can serve as the basis for priority claims in the United States. These include:

  • European Patent Office (EPO)
  • Eurasian Patent Office (EAPO)
  • African Intellectual Property Organization (OAPI)
  • African Regional Intellectual Property Organization (ARIPO)

The significance of these regional offices is explained in MPEP 213.01:

‘The United States will recognize claims for right of priority based on applications filed under such multilateral international agreements as the European Patent Convention (EPC) and the Patent Cooperation Treaty (PCT).’

This recognition allows applicants to file a single application with a regional patent office and still maintain priority rights in the United States. It streamlines the international patent application process and provides more flexibility for inventors seeking protection in multiple countries.

35 U.S.C. 386 establishes the right of priority for international design applications. It addresses two key scenarios:

  1. National applications claiming priority from international design applications
  2. International design applications claiming priority from prior foreign applications

The MPEP explains:

“Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.”

“Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.”

These provisions apply to applications filed on or after May 13, 2015, and patents issued from such applications.

The right of priority allows an applicant who has filed a patent application in a foreign country to claim priority to that earlier filing date when filing a subsequent U.S. application for the same invention. This right is established by 35 U.S.C. 119 and gives the U.S. application the benefit of the earlier foreign filing date, as long as certain conditions are met.

Specifically, 35 U.S.C. 119(a) states: “An application for patent for an invention filed in this country by any person who has, or whose legal representatives or assigns have, previously regularly filed an application for a patent for the same invention in a foreign country which affords similar privileges in the case of applications filed in the United States or to citizens of the United States, or in a WTO member country, shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country, if the application in this country is filed within 12 months from the earliest date on which such foreign application was filed.”

For a valid foreign priority claim, the U.S. application and the foreign application must name the same inventor or have at least one joint inventor in common. This requirement ensures that the right of priority is properly linked between the applications.

As stated in MPEP 213.02: “Pursuant to 35 U.S.C. 119(a), the foreign application must have been filed by the same applicant as the applicant in the United States, or by applicant’s legal representatives or assigns. Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.”

The MPEP further clarifies: “Joint inventors A and B in a nonprovisional application filed in the United States Patent and Trademark Office may properly claim the benefit of an application filed in a foreign country by A and another application filed in a foreign country by B, i.e., A and B may each claim the benefit of their foreign filed applications.”

This requirement ensures that the priority right is properly linked to the inventive entity responsible for the invention in both the foreign and U.S. applications.

For more information on foreign priority, visit: foreign priority.

For more information on joint inventors, visit: joint inventors.

For a valid foreign priority claim, the U.S. application must have at least one common inventor with the foreign application. This requirement ensures that the right of priority is only available to the actual inventors or their legal representatives.

As stated in MPEP 213.02: “Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.”

This means that:
1. A sole inventor in the U.S. can claim priority to a foreign application where they are the sole inventor or one of joint inventors.
2. Joint inventors in the U.S. can claim priority to a foreign application filed by any one or more of them.
3. A U.S. application cannot claim priority to a foreign application with completely different inventors.

It’s important to note that while the inventorship must overlap, it doesn’t have to be identical between the U.S. and foreign applications.

When claiming foreign priority, applicants are generally required to file a certified copy of the foreign application within a specified time period. The requirements and deadlines for filing the certified copy depend on the type of application and the circumstances of the filing.

According to MPEP 213.04: “37 CFR 1.55(g) sets forth the requirements for filing a priority claim, certified copy of foreign application, and translation that are applicable in all applications.”

Key points about the certified copy requirement include:

  • The certified copy must be filed within the pendency of the application, unless filed with a petition.
  • For applications filed under 35 U.S.C. 111(a), the certified copy must typically be filed within the later of four months from the actual filing date or sixteen months from the filing date of the prior foreign application.
  • For national stage applications under 35 U.S.C. 371, the certified copy must be filed within the time limit set forth in the PCT and the Regulations under the PCT.
  • If the certified copy is not filed within the required time period, it must be accompanied by a petition and fee, along with a showing of good and sufficient cause for the delay.
  • In some cases, the requirement may be satisfied through the priority document exchange program or by identifying a previously filed application containing the certified copy.

The MPEP also notes: “If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.”

For more information on certified copy, visit: certified copy.

For more information on filing requirements, visit: filing requirements.

For more information on foreign application, visit: foreign application.

The priority document exchange program allows the USPTO to obtain priority documents electronically from other participating foreign intellectual property offices, eliminating the need for applicants to submit certified copies themselves. As stated in 37 CFR 1.55(i), the requirement to file a certified copy is considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority includes the necessary information for retrieval
  • The copy is received by the USPTO from the participating office

Applicants must still make the priority claim within the required time period. This program simplifies the process of submitting priority documents for many applicants.

The Paris Convention for the Protection of Industrial Property is an international agreement that establishes key principles for intellectual property protection, including patents. It was first signed in 1883 and has been revised several times since then.

The Convention is significant in patent law because it established the right of priority, which allows patent applicants to claim priority based on an earlier filing in any country that is a member of the Paris Convention. This right is referenced in MPEP 213, which states:

‘The right of priority is defined in 35 U.S.C. 119(a)… Under this statute, an applicant who has filed a first foreign application is entitled to claim the benefit of the filing date of the first foreign application in a subsequent U.S. national patent application…’

This provision helps inventors protect their inventions internationally by giving them a grace period to file in multiple countries while maintaining the priority date of their first filing.

The Paris Convention is an international treaty that establishes priority rights for patent applications. According to MPEP 213, “The right of priority is defined in 35 U.S.C. 119(a)” and is based on this convention. It allows inventors who file a patent application in one member country to claim priority for up to 12 months when filing in other member countries.

Key points of the Paris Convention include:

  • Establishing a 12-month priority period for patents
  • Allowing applicants to claim priority based on earlier filings in member countries
  • Ensuring equal treatment of foreign and domestic applicants in member countries

While restoration of the right of priority allows for valid priority claims up to 14 months from the earliest priority date (or 8 months for design applications), pre-AIA applications are still subject to the 12-month statutory bar under pre-AIA 35 U.S.C. 102(b) and (d). MPEP 213.03 clarifies: ‘It should be noted that although an application may now validly claim priority under 35 U.S.C. 119(a) through (d) and (f), 172, 365(a) or (b), or 386(a) or (b) to a foreign application filed up to fourteen months earlier (or eight months earlier in the case of a design application) in view of the restoration provision of 37 CFR 1.55(c), an application subject to examination under pre-AIA first to invent laws (rather than the first inventor to file provisions of the AIA) would still be subject to the 12-month statutory time periods in pre-AIA 35 U.S.C. 102(b) and (d) which are measured from the U.S. filing date.’

This means that while the priority claim may be valid, the earlier filed foreign application could still be used as prior art against a pre-AIA application if it was published more than one year before the U.S. filing date.

For more information on pre-AIA, visit: pre-AIA.

Tags: pre-AIA

A proper foreign priority claim can give a U.S. patent application the benefit of the earlier foreign filing date as its effective filing date for prior art purposes. This can be crucial for establishing novelty and non-obviousness of the invention.

35 U.S.C. 119(a) states that a U.S. application properly claiming foreign priority “shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country.”

This means that intervening prior art published after the foreign filing date but before the U.S. filing date may not be used against the application if the priority claim is valid. However, it’s important to note that the actual U.S. filing date is still used for other purposes, such as calculating patent term.

Claiming foreign priority under 35 U.S.C. 119(a)-(d) and claiming benefit of a U.S. provisional application under 35 U.S.C. 119(e) are similar in some ways but have important differences:

1. Time limit:
– Foreign priority: Must be claimed within 12 months (6 months for design applications)
– Provisional: Must be claimed within 12 months

2. Effective filing date:
– Both can provide an earlier effective filing date for prior art purposes

3. Patent term:
– Foreign priority: Does not affect patent term
– Provisional: The 12-month period counts towards the 20-year patent term

4. Disclosure requirements:
– Both require the earlier application to provide adequate support for the claimed invention

5. Formalities:
– Foreign priority: Requires a certified copy of the foreign application
– Provisional: No certified copy required, but the provisional must be in English

6. Inventorship:
– Foreign priority: Requires at least one common inventor
– Provisional: Requires at least one common inventor

7. International effect:
– Foreign priority: Recognized in other Paris Convention countries
– Provisional: May not be recognized in some foreign jurisdictions

Both types of priority claims can be valuable for establishing an earlier effective filing date, but they have different requirements and effects that should be considered when developing a patent strategy.

Foreign priority claims and domestic benefit claims are two different ways of claiming the benefit of an earlier filing date:

  • Foreign priority claims (under 35 U.S.C. 119(a)-(d)) are based on earlier applications filed in foreign countries
  • Domestic benefit claims can be to earlier U.S. provisional (35 U.S.C. 119(e)) or nonprovisional (35 U.S.C. 120) applications

Key differences include:

  • Time limits: 12 months for foreign priority, 12 months for provisionals, no limit for nonprovisionals
  • Required documents: Certified copy needed for foreign priority, not for domestic benefit
  • Effect: Foreign priority is mainly for prior art purposes, domestic benefit can confer actual pendency benefits

Both types of claims must be properly made to be effective, but the specific requirements and effects differ.

In the context of foreign priority claims, there’s an important distinction between a ‘country’ and a ‘regional patent office’:

  • Country: A sovereign nation that has its own patent system and can issue patents directly.
  • Regional Patent Office: An intergovernmental organization that processes patent applications on behalf of multiple member countries.

The MPEP states: The right of priority may be based upon an application filed in a foreign country or in a regional patent office. (MPEP 213)

Regional patent offices, such as the European Patent Office (EPO) or the African Regional Intellectual Property Organization (ARIPO), allow applicants to file a single application that can potentially lead to patent protection in multiple member countries.

To make a proper priority claim in a U.S. patent application, the applicant must provide specific information about the foreign application and file the claim within the required time period. The requirements differ slightly depending on the type of application.

For applications filed on or after September 16, 2012, under 35 U.S.C. 111(a), MPEP 213.02 states: “the claim for priority must be presented in an application data sheet.” The claim must include:

  • The application number of the foreign application
  • The country or intellectual property authority
  • The day, month, and year of filing

For international applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set forth in the PCT and the Regulations under the PCT.

The MPEP further notes: “For applications filed prior to September 16, 2012, the claim to priority need be in no special form, and may be made by a person authorized to sign correspondence under 37 CFR 1.33(b). No special language is required in making the claim for priority, and any expression which can be reasonably interpreted as claiming the benefit of the foreign application is accepted as the claim for priority.”

It’s important to file the priority claim within the specified time limits to ensure it is considered valid and effective.

For more information on application data sheet, visit: application data sheet.

For more information on foreign application, visit: foreign application.

A certified copy of a foreign application is an official copy of the foreign patent application, certified by the patent office where it was filed. It is required to perfect a claim of foreign priority in a U.S. patent application.

According to 37 CFR 1.55(f), for applications filed on or after March 16, 2013:

“A certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application, or sixteen months from the filing date of the prior foreign application, in an original application under 35 U.S.C. 111(a) filed on or after March 16, 2013, except as provided in paragraphs (h), (i), and (j) of this section.”

There are exceptions to this requirement, such as when the foreign application was filed in a foreign intellectual property office participating in a priority document exchange agreement with the USPTO. In such cases, the applicant can request that the USPTO retrieve the certified copy electronically.

Several international agreements can form the basis for a priority claim in patent applications. The MPEP mentions:

  • The Paris Convention for the Protection of Industrial Property
  • The Hague Agreement Concerning the International Registration of Industrial Designs
  • The Benelux Designs Convention
  • The Convention on the Grant of European Patents (European Patent Office)
  • The Patent Cooperation Treaty (PCT)
  • The International Convention for the Protection of New Varieties of Plants (UPOV)

The MPEP states: “Under Article 4A of the Paris Convention for the Protection of Industrial Property, a right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design filed under the national law of a foreign country adhering to the Convention, or on a foreign application filed under a bilateral or multilateral treaty concluded between two or more such countries.”

These agreements facilitate the international protection of intellectual property rights and enable applicants to claim priority based on applications filed in various jurisdictions.

When multiple foreign applications are filed for the same invention, the right of priority is generally based on the earliest filed application. MPEP 213.03 explains: ‘The twelve months is from earliest foreign filing except as provided in 35 U.S.C. 119(c). If an inventor has filed an application in France on October 4, 1981, and an identical application in the United Kingdom on March 3, 1982, and then files in the United States on February 2, 1983, the inventor is not entitled to the right of priority at all; the inventor would not be entitled to the benefit of the date of the French application since this application was filed more than twelve months before the U.S. application, and the inventor would not be entitled to the benefit of the date of the United Kingdom application since this application is not the first one filed.’

However, if the later application contains additional subject matter, a claim specifically limited to that additional disclosure may be entitled to the priority date of the later foreign application.

If you fail to make a timely priority claim or submit a certified copy of the foreign application within the required time period, the following may occur:

  • The right of priority may be considered waived
  • The effective filing date of your application may be the actual U.S. filing date, not the foreign filing date
  • Intervening prior art may be applicable against your application

However, 37 CFR 1.55(e) provides for acceptance of a delayed priority claim if:

  • The claim is filed within the pendency of the application
  • A petition is filed with the delayed claim
  • The delay was unintentional
  • The required petition fee is paid

Similarly, 37 CFR 1.55(f) allows for late submission of a certified copy with a petition showing good and sufficient cause for the delay and payment of a fee. It’s always best to make priority claims and submit certified copies timely to avoid potential issues.

To claim foreign priority in a U.S. application, you must file a claim for priority and submit a certified copy of the foreign application. MPEP 213.04 states: ‘The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application.’

For applications filed on or after September 16, 2012, the priority claim must be presented in an Application Data Sheet (ADS). The certified copy must be filed within the later of 4 months from the actual filing date or 16 months from the foreign filing date, with some exceptions.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

To claim foreign priority in a U.S. patent application, several requirements must be met as outlined in MPEP 213. These include:

  • Timely filing: The U.S. application must be filed within 12 months of the foreign application’s filing date (6 months for design patents)
  • Proper claim: The priority claim must be made in an application data sheet (ADS) or in the first sentence of the specification
  • Certified copy: A certified copy of the foreign application must be filed within the later of 4 months from the U.S. filing date or 16 months from the foreign filing date
  • English translation: If the foreign application is not in English, a translation may be required

As stated in MPEP 213, “The claim for priority must be presented in an application data sheet (37 CFR 1.76(b)(6)) or the specification must contain or be amended to contain a specific reference to the prior foreign application.” Failure to meet these requirements may result in the loss of the priority claim.

How does WTO membership affect foreign priority rights?

World Trade Organization (WTO) membership has significant implications for foreign priority rights in patent applications:

  • WTO member countries are treated as Paris Convention countries for priority purposes.
  • Applicants from WTO member countries can claim priority in the U.S., even if the country is not a Paris Convention signatory.
  • The same 12-month priority period applies to applications from WTO member countries.
  • WTO membership expands the pool of countries eligible for foreign priority claims.

MPEP 213.01 states: “A foreign application filed in a WTO member country on or after the date on which the country becomes a WTO member country is also entitled to the right of priority.” This provision ensures broader international protection opportunities for inventors and applicants.

The USPTO determines if a foreign country qualifies for priority rights based on specific criteria outlined in the MPEP. According to MPEP 213.01:

The right of priority is recognized only if the foreign country in which the original application was filed is recognized at the time of filing the application in the United States.

The USPTO considers several factors:

  • The country must be a member of the Paris Convention for the Protection of Industrial Property or have a bilateral agreement with the United States.
  • The country must grant similar priority rights to U.S. citizens.
  • The country must be recognized by the U.S. Department of State.

The USPTO maintains a list of recognized countries and regional patent offices in MPEP 213.01, which is updated periodically to reflect changes in international relations and treaty memberships.

The right of priority for international applications filed under the Patent Cooperation Treaty (PCT) operates similarly to national applications, but with some specific provisions and requirements set by the PCT system.

According to MPEP 213.06: “In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.”

Key points about priority in PCT applications include:

  • The priority claim must be made in the PCT Request form or through a later correction.
  • The applicant must file a certified copy of the priority document with the International Bureau within 16 months from the priority date, unless it was previously filed with the receiving Office.
  • If the priority document is issued by the receiving Office, the applicant can request that Office to prepare and transmit the document to the International Bureau.
  • The International Bureau will make the priority document available to designated Offices.
  • For U.S. national stage entry, if the certified copy was submitted during the international phase, it generally satisfies the requirement for the U.S. application.

The MPEP further notes: “If, however, the International Bureau is unable to forward a copy of the certified priority document because the applicant failed to submit a certified copy of the foreign priority document during the international phase, the applicant will need to provide a certified copy of the priority document or have the Office retrieve the priority application in accordance with the priority document exchange program during the national stage to fulfill the requirements of 37 CFR 1.55.”

For more information on certified copy, visit: certified copy.

The right of priority under 35 U.S.C. 386(a) and 386(b) applies to different types of applications. According to MPEP 213.07:

Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.

This means that 35 U.S.C. 386(a) allows a nonprovisional application to claim priority based on a prior international design application.

On the other hand, 35 U.S.C. 386(b) applies differently:

Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

Thus, 35 U.S.C. 386(b) allows an international design application designating the United States to claim priority based on various types of prior applications.

The key differences are:

  • 386(a) applies to nonprovisional applications claiming priority to international design applications.
  • 386(b) applies to international design applications claiming priority to foreign applications, PCT applications, or other international design applications.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on right of priority, visit: right of priority.

The Patent Cooperation Treaty (PCT) system interacts with foreign priority claims in several important ways:

1. Priority claims in PCT applications:
– PCT applications can claim priority to earlier foreign applications under the Paris Convention.
– The priority period is 12 months from the earliest priority date.

2. PCT as a basis for priority:
– A PCT application can serve as the basis for a priority claim in a later-filed national or regional application.

3. Effect on time limits:
– The 30-month time limit for entering the national phase is calculated from the priority date (if claimed) or the PCT filing date if no priority is claimed.

4. Restoration of priority rights:
– The PCT system allows for restoration of priority rights if an international application is filed within 14 months of the priority date and the delay was unintentional.

5. Certified copies:
– The PCT system has provisions for providing certified copies of priority documents to designated offices.

As stated in MPEP 213.06: “In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.”

The PCT system provides a streamlined process for seeking patent protection internationally while preserving priority rights, but applicants must be aware of the specific requirements and time limits within the PCT system.

The Patent Cooperation Treaty (PCT) interacts with foreign priority claims as outlined in MPEP 213. The PCT allows applicants to file a single international patent application that can later enter the national phase in multiple countries.

Key points regarding PCT and foreign priority:

  • PCT applications can claim priority from earlier national or regional applications
  • The priority period for PCT applications is also 12 months from the earliest priority date
  • PCT applications themselves can serve as the basis for priority claims in subsequent national or regional applications

As stated in MPEP 213, “U.S. national applications may claim priority to an international application (PCT) filed in a PCT Receiving Office other than the United States Receiving Office.” This demonstrates the flexibility of the PCT system in international patent protection strategies.

Taiwan’s unique political status has implications for patent priority claims in US applications. According to MPEP 213.01:

‘Applicants from Taiwan may claim priority under 35 U.S.C. 119(a)-(d) to applications filed in Taiwan which are filed by or on behalf of the governing authority on Taiwan.’

This special provision allows Taiwanese applicants to claim priority despite Taiwan not being officially recognized as a sovereign state by the United States. The MPEP further clarifies:

Applications from Taiwan must meet the following criteria to be eligible for priority claims:

  • The application must be filed by or on behalf of the governing authority on Taiwan
  • The priority claim must be made in accordance with the standard procedures outlined in 35 U.S.C. 119(a)-(d)

This arrangement ensures that inventors and companies in Taiwan can participate in the international patent system and maintain priority rights for their inventions when seeking protection in the United States.

Claiming priority for international design applications has some specific provisions, particularly when the application designates the United States. These provisions are outlined in the MPEP and relevant regulations.

According to MPEP 213.07: “Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.”

Key points about priority in international design applications include:

  • The right of priority under 35 U.S.C. 386(a) or (b) applies only to applications filed on or after May 13, 2015.
  • For nonprovisional international design applications, the priority claim must be presented in an application data sheet during the pendency of the application, unless made in accordance with the Hague Agreement and Regulations.
  • The certified copy of the priority document must be furnished within the time period specified in 37 CFR 1.55(g).
  • An international design application designating the U.S. can claim priority to a prior foreign application, PCT application, or another international design application.

The MPEP also notes: “See MPEP § 2920.05(d) for additional information pertaining to the right of priority based upon an international design application.”

These provisions ensure that design patent applicants can properly claim priority to earlier filed applications in the context of the international design registration system.

For more information on design patent, visit: design patent.

For more information on Hague Agreement, visit: Hague Agreement.

Claiming priority to a foreign application generally does not affect the term of a U.S. patent. The patent term is typically calculated from the actual U.S. filing date, not the foreign priority date.

For utility and plant patents:
– The term is 20 years from the earliest U.S. filing date of the application or any U.S. application to which it claims benefit under 35 U.S.C. 120, 121, or 365(c).
– The foreign priority date is not used in this calculation.

For design patents:
– The term is 15 years from the date of grant.
– The filing or priority dates do not affect the term.

It’s important to note that while the foreign priority date doesn’t affect the patent term, it can affect the effective filing date for prior art purposes, which can be crucial for determining patentability.

Patent Term Adjustment (PTA) may be available to extend the term of a utility or plant patent due to delays in prosecution, but this is calculated based on the actual U.S. filing date, not the foreign priority date.

Claiming foreign priority can significantly affect the prior art date in your application:

  • For applications subject to pre-AIA law, the foreign priority date becomes the effective U.S. filing date for prior art purposes under 35 U.S.C. 102(a), (b), and (d)
  • For applications subject to AIA law, the foreign priority date is treated as the effective filing date for prior art purposes under 35 U.S.C. 102(a)(1) and (a)(2)

This means that intervening disclosures between your foreign filing date and your U.S. filing date may not be considered prior art against your application. However, it’s important to note that the claimed subject matter must be fully supported by the foreign application to get the benefit of its filing date. Additionally, the priority claim must be proper and timely made for this benefit to apply.

35 U.S.C. 365 addresses the right of priority for international applications in two key aspects:

  1. National applications based on international applications
  2. International applications based on foreign applications

The MPEP states:

“35 U.S.C. 365(a) provides that a national application shall be entitled to the right of priority based on a prior international application of whatever origin, which designated any country other than, or in addition to, the United States.”

“35 U.S.C. 365(b) provides that an international application designating the United States shall be entitled to the right of priority of a prior foreign application which may either be another international application or a regularly filed foreign application.”

These provisions ensure that applicants can claim priority based on international applications, enhancing the flexibility of the international patent system.

Priority to an international design application can be claimed in a U.S. nonprovisional application or in another international design application designating the U.S. MPEP 213.07 states: ‘Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.’

The priority claim should be made in an Application Data Sheet (ADS) for nonprovisional applications. For international design applications designating the U.S., the priority claim can be made in accordance with the Hague Agreement and Regulations.

For more information on Hague Agreement, visit: Hague Agreement.

Claiming priority to a provisional application is different from claiming foreign priority. To claim the benefit of a provisional application in a later-filed nonprovisional application:

  • The nonprovisional must be filed within 12 months of the provisional filing date
  • A specific reference to the provisional application must be made in an application data sheet
  • The provisional and nonprovisional must name at least one common inventor
  • The claimed subject matter must be supported by the provisional application

This is known as a domestic benefit claim under 35 U.S.C. 119(e), rather than a foreign priority claim under 35 U.S.C. 119(a)-(d). The requirements are specified in 37 CFR 1.78 rather than 37 CFR 1.55.

Claiming priority to a PCT international application can be done in two ways:

  1. In a U.S. national stage application under 35 U.S.C. 371:
    • The priority claim is made in the PCT application
    • No further action is needed when entering the national stage
  2. In a U.S. nonprovisional application under 35 U.S.C. 111(a):
    • File within 12 months of the PCT filing date
    • Make the priority claim in an application data sheet
    • Provide a certified copy of the PCT application (unless already filed with the PCT)

In both cases, the PCT application must designate the United States. The specific requirements are detailed in 37 CFR 1.55(d)(2) and (f)(2) for national stage applications, and 37 CFR 1.55(d)(1) and (f)(1) for applications under 35 U.S.C. 111(a).

For international applications entering the U.S. national stage under 35 U.S.C. 371, the priority claim must be made within the time limit set by the PCT and its regulations. MPEP 213.06 states: ‘In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made and a certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT.’

If the priority claim was properly made during the international phase, it’s generally not necessary to repeat it upon national stage entry. However, the certified copy of the priority document must be furnished if not previously submitted to the International Bureau or the USPTO.

For more information on national stage application, visit: national stage application.

To claim foreign priority in a U.S. patent application, you must:

1. File the U.S. application within 12 months (6 months for design applications) of the foreign filing date.
2. Submit a claim for priority identifying the foreign application.
3. File a certified copy of the foreign application.

For applications filed on or after September 16, 2012, 37 CFR 1.55(d)(1) requires that the claim for priority be presented in an application data sheet. The claim must identify the foreign application by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.

A certified copy of the foreign application must also be filed within a specified time period, usually within the later of 4 months from the actual U.S. filing date or 16 months from the foreign filing date.

An applicant can restore the right of priority if the U.S. application is filed after the 12-month deadline (or 6-month deadline for design applications) but within 2 months of the expiration of that period. This can be done through a petition process, provided the delay was unintentional.

According to MPEP 213.03: “As provided in 37 CFR 1.55(c), if the subsequent application has a filing date which is after the expiration of the twelve-month period (or six-month period in the case of a design application), but within two months from the expiration of the period, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.55(c), if the delay in filing the subsequent application within the period was unintentional.”

The petition to restore the right of priority must include:

  • The priority claim identifying the prior foreign application
  • The petition fee
  • A statement that the delay in filing was unintentional

The USPTO may require additional information to establish that the delay was unintentional.

For more information on foreign priority, visit: foreign priority.

For more information on priority restoration, visit: priority restoration.

For more information on unintentional delay, visit: unintentional delay.

Yes, the right of priority can be restored if the U.S. application is filed after the 12-month priority period (or 6-month period for design applications), but within 2 months of the expiration of the priority period, if the delay was unintentional.

37 CFR 1.55(c) states: “If the subsequent application has a filing date which is after the expiration of the period set forth in paragraph (b)(1) of this section, but within two months from the expiration of the period set forth in paragraph (b)(1) of this section, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition pursuant to this paragraph, if the delay in filing the subsequent application within the period set forth in paragraph (b)(1) of this section was unintentional.”

To restore the right of priority, the applicant must file a petition including:
1. The priority claim
2. The petition fee
3. A statement that the delay was unintentional

The USPTO may require additional information to determine if the delay was truly unintentional.

Yes, applicants can claim priority under 35 U.S.C. 119(a)-(d) based on applications filed in certain foreign regional patent offices. The MPEP states:

“In addition to the list of recognized countries set forth in subsection I, above, applicants may claim priority under 35 U.S.C. 119(a)-(d) to applications filed in foreign regional patent offices having member states who are members of the Paris Convention.”

The recognized regional patent offices include:

  • African Regional Intellectual Property Organization (ARIPO)
  • Eurasian Patent Office (EAPO)
  • European Patent Office (EPO)
  • Gulf Cooperation Council (GCC) Patent Office
  • African Intellectual Property Organization (OAPI)

These regional patent offices allow applicants to file a single application that can have effect in multiple member states, streamlining the international patent application process.

Yes, it is possible to restore the right of priority if you miss the 12-month filing deadline (6 months for design applications). As provided in 37 CFR 1.55(c), if the subsequent application is filed within two months from the expiration of the priority period, the right of priority may be restored upon petition. The petition must include:

  • The priority claim (unless previously submitted)
  • The petition fee
  • A statement that the delay in filing was unintentional

The Director may require additional information where there is a question whether the delay was unintentional. Note that while this allows for a valid priority claim, it does not overcome potential prior art issues under pre-AIA 35 U.S.C. 102(b) or (d) in applications subject to pre-AIA law.

Yes, it is possible to claim priority to multiple foreign applications in a U.S. patent application, provided certain conditions are met:

  • Each foreign application must independently meet the requirements for a priority claim
  • The U.S. application must be filed within 12 months of the earliest filed foreign application
  • The claimed subject matter must be supported by each application for which priority is claimed

When claiming multiple priorities, the U.S. application gets the benefit of each prior application only for the subject matter that it supports. This allows applicants to combine priority claims to protect inventions that were developed and disclosed progressively over time in different countries.

Yes, under certain conditions, an applicant can claim priority based on an application for an inventor’s certificate. MPEP 213.05 explains: ‘An inventor’s certificate may form the basis for rights of priority under 35 U.S.C. 119(d) only when the country in which it is filed gives to applicants, at their discretion, the right to apply, on the same invention, either for a patent or for an inventor’s certificate.’

To claim priority to an inventor’s certificate, the applicant must file an affidavit or declaration stating that they had the option to file for either a patent or an inventor’s certificate in the foreign country.

For more information on foreign priority, visit: foreign priority.

Yes, a U.S. applicant can claim priority from a provisional application filed in a foreign country, provided certain conditions are met. The MPEP 213 states:

An applicant may claim the right of priority based on a prior foreign application under the Paris Convention and 35 U.S.C. 119(a)-(d) whether the foreign application is an application for a patent or for the registration of a utility model or an industrial design.

Key points to consider:

  • The foreign country must be a recognized country or regional patent office as listed in MPEP 213.01.
  • The provisional application must be the first filing of the invention in any country.
  • The U.S. application must be filed within 12 months of the foreign provisional filing date.
  • The applicant must comply with all requirements for claiming priority, including submitting a certified copy of the foreign application.

It’s important to note that not all countries have provisional application systems, so the term ‘provisional’ may have different meanings in different jurisdictions. Always consult with a patent attorney or agent for specific advice on international priority claims.

MPEP 214-Formal Requirements of Claim for Foreign Priority (23)

The location for filing your petition to restore the right of priority depends on the type of application you have. The MPEP provides guidance:

The petition to restore the right of priority must be filed in the subsequent application, or in the earliest nonprovisional application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the subsequent application, if such subsequent application is not a nonprovisional application.

Additionally, the MPEP specifies the mailing address for such petitions:

The petition should be addressed to: Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.

Ensure you file the petition in the correct application and send it to the appropriate address to avoid processing delays.

For more information on mailing address, visit: mailing address.

For more information on priority restoration, visit: priority restoration.

What is the significance of the four-month and sixteen-month time periods for filing a priority claim?

The four-month and sixteen-month time periods are crucial deadlines for filing a priority claim in a U.S. patent application. According to MPEP 214.01:

“The claim for priority must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application in an original application filed under 35 U.S.C. 111(a).”

These time periods are significant because:

  • They provide applicants with a window to properly claim priority to a foreign application.
  • The four-month period starts from the U.S. filing date, giving applicants time to prepare and submit the priority claim after filing their U.S. application.
  • The sixteen-month period from the foreign filing date ensures that priority claims are made within a reasonable time frame relative to the original foreign filing.
  • Filing within these periods allows for the priority claim to be considered timely without requiring additional petitions or fees.

It’s important to note that failing to meet these deadlines may result in the need for a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e), which involves additional requirements and fees.

To properly identify a foreign priority application in a U.S. patent application, you should provide:

  • The application number
  • The country or intellectual property authority
  • The filing date (day, month, and year)

MPEP 214.04 advises: “To ensure an accurate and complete citation of a foreign priority application, applicants should review the list of the various intellectual property offices and the recommended presentation of a foreign application number for each, which can be found in the tables of the online WIPO Handbook on Industrial Property Information and Documentation.”

It’s important to use the format recommended by WIPO for the specific country to ensure accurate identification and processing of your priority claim.

The priority document exchange program is an agreement between patent offices to electronically exchange priority documents. It affects foreign priority claims in the following ways:

  • Applicants may not need to submit a certified copy if the foreign application is available through the program
  • The USPTO will attempt to retrieve the priority document automatically
  • If successful, it satisfies the requirement to file a certified copy

MPEP 214.02 mentions: “37 CFR 1.55(h) contains provisions relating to when the requirement for a certified copy will be considered satisfied based on a certified copy filed in another U.S. patent or application (see also MPEP § 215, subsection III); 37 CFR 1.55(i) contains provisions relating to the priority document exchange agreement (see also MPEP §§ 215.01 and 215.02(a)).”

Applicants should still monitor the application to ensure the priority document is retrieved and may need to submit a certified copy if the automatic retrieval fails.

The main differences in priority claim requirements for design applications compared to utility applications are:

  • Time limit: Design applications can claim priority at any time during pendency, while utility applications have specific deadlines
  • Restoration of priority: Not applicable to design applications

MPEP 214.01 states: “The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.” Additionally, “In a design application, a claim for priority may be made at any time during the pendency of the application.”

However, both design and utility applications must still meet other requirements, such as providing a certified copy of the foreign application and properly identifying the priority application.

The requirements for filing a foreign priority claim differ for applications filed before and after September 16, 2012. The key difference lies in where the priority claim must be presented:

  • For applications filed on or after September 16, 2012: The priority claim must be presented in an Application Data Sheet (ADS). This is specified in 37 CFR 1.55(d)(1): For applications filed under 35 U.S.C. 111(a) on or after September 16, 2012, 37 CFR 1.55(d)(1) requires the claim for priority to be presented in an application data sheet.
  • For applications filed before September 16, 2012: The priority claim can be presented either in an Application Data Sheet or in the oath or declaration. As stated in the MPEP: For applications filed under 35 U.S.C. 111(a) prior to September 16, 2012, unless provided in an application data sheet, the oath or declaration under 37 CFR 1.63 must identify the foreign application for patent or inventor’s certificate for which priority is claimed under 37 CFR 1.55, and any foreign applications having a filing date before that of the application on which priority is claimed, by specifying the application number, country, day, month, and year of its filing.

Regardless of the filing date, the priority claim must include the same essential information: the application number, country (or intellectual property authority), and filing date (day, month, and year) of the foreign application. The difference is primarily in the document where this information must be presented.

If you miss the deadline for filing a foreign priority claim, you may still have options:

  • Unintentional delay: You can file a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e). This petition must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.
  • Design applications: For design applications, you can file this petition up to the date of payment of the issue fee.

The MPEP states: The Director may accept an unintentionally delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), or 365(a) or (b) in an application for patent filed on or after November 29, 2000, upon petition pursuant to 37 CFR 1.55(e).

It’s important to note that the petition must include a statement that the entire delay was unintentional, and you may need to provide additional evidence to support this claim.

If you file a U.S. patent application more than 12 months after your foreign filing, your claim for priority based on that foreign application may be denied. The MPEP states:

The claim for priority cannot be based on said application, because the subsequent nonprovisional or international application designating the United States was filed more than twelve months thereafter and no petition under 37 CFR 1.55 or request under PCT Rule 26bis.3 to restore the right of priority has been granted.

However, you may still have options to restore your priority claim under certain circumstances.

For more information on 12-month rule, visit: 12-month rule.

For more information on foreign priority, visit: foreign priority.

If you file a foreign priority claim after paying the issue fee but before the patent grant:

  • The claim will be placed in the file record
  • There may be no review of the papers
  • The published patent will not include the priority claim

To have the priority claim considered after publication, you will need to file:

  1. A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323
  2. For original applications under 35 U.S.C. 111(a) or 371, a petition to accept an unintentionally delayed claim for priority under 37 CFR 1.55

MPEP 214.03 states: “When the claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but prior to the date of grant of the patent, the foreign priority claim or certified copy will be placed in the file record but there may be no review of the papers and the patent when published will not include the priority claim.”

The time periods for filing a priority claim depend on the type of application:

  • For original applications filed under 35 U.S.C. 111(a) (other than design applications), the claim must be filed during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application. See 37 CFR 1.55(d)(1).
  • For applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set in the PCT and Regulations under the PCT. See 37 CFR 1.55(d)(2) and MPEP § 213.06.
  • In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).

A certified copy of the foreign application must be filed within the time period set in 37 CFR 1.55, which is the later of four months from the filing date of the US application or sixteen months from the foreign application filing date.

The certified copy requirement will be considered satisfied in a national stage application under 35 U.S.C. 371 if a certified copy was filed in the international application and the copy is present in the national stage application. See MPEP § 215.

A certified copy is also not required if the foreign priority application was filed in a participating foreign intellectual property office and the USPTO retrieves a copy via the priority document exchange program. See MPEP § 215.01.

An interim copy of the foreign application may also be filed to meet the timeliness requirement. See 37 CFR 1.55(j) and MPEP § 215.02(b).

A petition to restore the right of priority must include several key elements. The MPEP outlines these requirements:

A petition to restore the right of priority must include: (1) the priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) in an application data sheet, identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing (unless previously submitted); (2) the petition fee set forth in 37 CFR 1.17(m); and (3) a statement that the delay in filing the subsequent application within the twelve-month period was unintentional.

These requirements ensure that the USPTO has all necessary information to consider your petition for priority restoration.

For more information on application data sheet, visit: application data sheet.

For more information on petition fee, visit: petition fee.

For more information on petition requirements, visit: petition requirements.

For more information on priority restoration, visit: priority restoration.

The USPTO acknowledges receipt of foreign priority claims in several ways:

  1. If the claim is timely and all requirements are met, the examiner will advise the applicant in the next Office action using form PTOL-326 or form paragraph 2.26
  2. For priority documents filed in a parent application, the examiner may use form paragraph 2.27
  3. If there are irregularities, the examiner may use specific form paragraphs to notify the applicant of issues

MPEP 214.03 states: “When the claim for foreign priority and the certified copy of the foreign application are received within the time period set forth in 37 CFR 1.55, if applicable, they are entered into the application file history. Assuming that the papers are timely and regular in form and that there are no irregularities in dates, the examiner in the next Office action will advise the applicant that the papers have been received on form PTOL-326 or by use of form paragraph 2.26.”

How do I properly identify a foreign application when claiming priority in a U.S. patent application?

When claiming priority to a foreign application in a U.S. patent application, it’s crucial to provide accurate identification information. According to MPEP 214.01, you must include the following details:

  • The application number of the foreign application
  • The country or intellectual property authority where the foreign application was filed
  • The day, month, and year of filing of the foreign application

The MPEP states: ‘The claim for priority must identify the foreign application for which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.’

Additionally, if you’re submitting a certified copy of the foreign application, ensure that it matches the identification information provided in your priority claim. Accurate identification is essential for establishing your priority rights and avoiding potential issues during examination or litigation.

To file a foreign priority claim in a U.S. patent application, you must:

  1. File the claim within the specified time limit (see previous FAQ for details).
  2. Present the claim in an application data sheet (ADS) for applications filed on or after September 16, 2012. For applications filed before this date, the claim can be in the ADS or in the oath/declaration.
  3. Identify the foreign application by providing:
    • Application number
    • Country (or intellectual property authority)
    • Filing date (day, month, and year)

This is specified in 37 CFR 1.55(d)(1): The claim for priority must be presented in an application data sheet (§1.76(b)(6)) and must identify the foreign application to which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.

It’s crucial to provide accurate and complete information to ensure your priority claim is properly recorded and considered.

How do I correct an error in my foreign priority claim?

If you need to correct an error in your foreign priority claim, the process depends on the nature of the error and when it’s discovered. According to MPEP 214.01, “Applicant may correct the failure to adequately claim priority to the prior foreign application by amending the specification or submitting a new application data sheet (ADS) identifying the foreign application by application number, country (or intellectual property authority), and filing date.” Here are some key points to remember:

  • If the error is discovered within the time period for filing the priority claim, you can simply submit a corrected ADS or amend the specification.
  • If the error is discovered after the time period has expired, you may need to file a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim.
  • For minor typographical errors, a request for a corrected filing receipt may be sufficient.

Always consult with a patent attorney or agent to determine the best course of action for your specific situation.

To file an unintentionally delayed foreign priority claim, you must submit a petition under 37 CFR 1.55(e). The petition must include:

  1. The priority claim (if not previously submitted)
  2. A certified copy of the foreign application (unless previously submitted or an exception applies)
  3. The petition fee set forth in 37 CFR 1.17(m)
  4. A statement that the entire delay was unintentional

MPEP 214.02 states: “If a claim for foreign priority is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

If a claim for foreign priority is not presented within the required time period under 37 CFR 1.55, it is considered waived. However, the claim may be accepted if the priority claim was unintentionally delayed.

To file a petition for an unintentionally delayed priority claim, the applicant must submit:

  1. The priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet, identifying the foreign application to which priority is claimed;
  2. A certified copy of the foreign application, unless previously submitted or an exception applies;
  3. The petition fee set in 37 CFR 1.17(m); and
  4. A statement that the entire delay between the date the priority claim was due and the date it was filed was unintentional.

The Director may require additional information if there is a question whether the delay was unintentional. See 37 CFR 1.55(e).

Yes, the USPTO may request additional information when considering a petition to restore the right of priority. The MPEP states:

The Director may require additional information where there is a question whether the delay was unintentional.

This means that if the USPTO has doubts about whether the delay in filing was truly unintentional, they may ask for more details or evidence to support your claim. It’s important to be prepared to provide such information if requested to ensure your petition is properly considered.

For more information on unintentional delay, visit: unintentional delay.

Can I file a priority claim in a continuing application?

Yes, you can file a priority claim in a continuing application, but there are specific requirements and deadlines to consider. According to MPEP 214.01, “In the case of a continuation or divisional application filed under 35 U.S.C. 111(a), the claim for priority must be made during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.” This means that even in a continuing application, you must adhere to the time limits for filing the priority claim. It’s important to note that the priority claim must be made in each continuing application; a priority claim in a parent application does not automatically carry over to child applications.

Yes, you can file a foreign priority claim after your patent has been granted, but it requires additional steps:

  1. File a petition under 37 CFR 1.55(e) for an unintentionally delayed priority claim
  2. Submit a request for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323
  3. Pay the required petition and certificate of correction fees

MPEP 214.02 states: “Where a priority claim under 37 CFR 1.55(g) was not timely made, 37 CFR 1.55(g) allows the priority claim and the certified copy required under 37 CFR 1.55 to be filed pursuant to a petition under 37 CFR 1.55(e) even if the application is not pending (e.g., a patented application).”

Can a priority claim be made in a continuation or divisional application?

Yes, a priority claim can be made in a continuation or divisional application. However, there are specific requirements and time limits to consider. According to MPEP 214.01:

“In the case of a continuation or divisional application, the claim for priority must be made during the pendency of the application.”

This means:

  • The priority claim must be filed within the later of four months from the actual filing date of the continuation or divisional application or sixteen months from the filing date of the prior foreign application.
  • If the claim is filed outside this period, it will be considered untimely and require a petition under 37 CFR 1.55(e).
  • The priority claim should reference the parent application if it properly claimed the benefit of the foreign application.

It’s important to note that the continuation or divisional application must be filed within 12 months of the foreign application’s filing date (or 6 months for design applications) to be eligible for priority.

Yes, there are exceptions to the standard time limits for filing foreign priority claims, particularly for design patent applications and certain applications filed before November 29, 2000. According to 37 CFR 1.55(d)(1):

The time periods in this paragraph do not apply if the later-filed application is:
(i) An application for a design patent; or
(ii) An application filed under 35 U.S.C. 111(a) before November 29, 2000.

For design patent applications, the MPEP states:

In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).

This means that for design patent applications, you can file a foreign priority claim at any time while the application is pending, without being restricted by the usual time limits.

For applications filed under 35 U.S.C. 111(a) before November 29, 2000, different rules may apply, and it’s best to consult with a patent attorney or the USPTO directly for guidance on such cases.

It’s important to note that while these exceptions exist, it’s generally advisable to file priority claims as early as possible to ensure they are properly recorded and considered.

MPEP 215-Certified Copy of Foreign Application (38)

The USPTO provides additional information about the Priority Document Exchange (PDX) program on its official website. According to the MPEP:

The Office website provides additional information concerning the priority document exchange program (www.uspto.gov/patents/basics/international-protection/electronic-priority-document-exchange-pdx).

This website includes important details such as:

  • A list of intellectual property offices participating in the PDX program
  • Information necessary for each participating foreign intellectual property office to provide the USPTO with access to foreign applications

Applicants and practitioners are encouraged to visit this resource for the most up-to-date information on the PDX program and its participants.

According to 37 CFR 1.55(g)(2), the USPTO may require that the claim for priority and the certified copy of the foreign application be filed earlier than otherwise provided in the following circumstances:

  1. When the application is involved in an interference or derivation proceeding;
  2. When necessary to overcome the date of a reference relied upon by the examiner; or
  3. When deemed necessary by the examiner.

The certified copy of the foreign application must be filed before the patent is granted. If the certified copy is filed after payment of the issue fee but prior to the date of grant, the priority claim will be placed in the file record but the patent will not include the priority claim unless corrected after the patent is granted using a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.

For applications filed under 35 U.S.C. 111(a) (other than design applications), a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim must also be filed with the certificate of correction. For all applications, a grantable petition under 37 CFR 1.55(f) or (g) must also be filed with the certificate of correction unless the priority claim was timely made but a certified copy was not yet in the file. See MPEP 215.03.

A separate written request for PDX retrieval is needed in two specific situations:

  1. When the applicant wishes the Office to retrieve a foreign application from a foreign intellectual property office that becomes a participating office after the foreign priority has been claimed, as long as the time period set in 37 CFR 1.55 has not expired.
  2. When the foreign application was not originally filed in a participating office, but a certified copy was filed in an application subsequently filed in a participating foreign intellectual property office.

The MPEP provides Form PTO/SB/38 for such requests:

Applicants can use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)) to file such a request.

If the United States Patent and Trademark Office (USPTO) doesn’t receive your priority document through the Priority Document Exchange (PDX) program within the specified time frame, you have options. According to MPEP 215.02(a):

The Office appreciates that an applicant may discover that the Office will not receive a copy of a foreign application through the priority document exchange program until after the expiration of the time frame specified in 37 CFR 1.55(f). In this situation, an applicant who otherwise meets the conditions of 37 CFR 1.55(i) may satisfy the requirement of 37 CFR 1.55(i)(3) by filing a certified copy of the foreign application in the Office within the pendency of the application and before the patent is granted.

If you find yourself in this situation:

  1. File a certified copy of the foreign application directly with the USPTO.
  2. Ensure this is done during the pendency of your application and before the patent is granted.
  3. Consider filing a petition under 37 CFR 1.55(e) or (f) if necessary.

Remember, it’s ultimately the applicant’s responsibility to ensure the priority document is properly filed, even when using the PDX program.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on late submission, visit: late submission.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For an original application filed under 35 U.S.C. 111(a) on or after March 16, 2013, a certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application, except as provided in 37 CFR 1.55(h), (i), and (j). See MPEP 215.02.

For an international application entering the national stage under 35 U.S.C. 371 in which the national stage commenced on or after December 18, 2013, a certified copy of the foreign application must be filed within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior foreign application, except as provided in 37 CFR 1.55(h), (i), and (j). See MPEP 215.02.

For applications filed under 35 U.S.C. 111(a) on or after March 16, 2013, 37 CFR 1.55(f)(1) sets the time limit for filing a certified copy of the foreign application. The certified copy must be filed within the later of:

  • Four months from the actual filing date of the application, or
  • Sixteen months from the filing date of the prior foreign application

This time limit does not apply to design applications. For international applications entering the national stage under 35 U.S.C. 371, the time limit is set forth in 37 CFR 1.55(f)(2).

It’s important to note that there are exceptions to these time limits, as provided in 37 CFR 1.55(h), (i), and (j).

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For more information on time limit, visit: time limit.

What is the significance of the Access Code on the Request to Retrieve Electronic Priority Application?

The Access Code on the Request to Retrieve Electronic Priority Application plays a crucial role in the priority document exchange process. The MPEP states:

‘The Request to Retrieve Electronic Priority Application must include the Access Code assigned to that application by the applicant or applicant’s representative.’

This Access Code is essential because it allows the USPTO to securely retrieve the priority document from the foreign office. Without the correct Access Code, the USPTO cannot access and retrieve the document, which could lead to issues with establishing priority for your application.

It’s important to ensure that the Access Code you provide on the Request form is accurate and matches the one assigned by the foreign office. Incorrect or missing Access Codes can result in delays or failures in retrieving the priority document, potentially affecting your patent application’s priority claim.

The PDX (Priority Document Exchange) program serves to facilitate the exchange of priority documents between participating intellectual property offices. According to MPEP 215.01, ‘The PDX program eliminates the need for applicants to submit paper certified copies of foreign applications in participating intellectual property offices.’ This streamlines the process, reducing both the burden on applicants and the workload for patent offices.

The priority document exchange program is a bilateral or multilateral agreement between the USPTO and participating foreign intellectual property offices that allows for the electronic exchange of priority documents. This program can satisfy the requirement for filing a certified copy of a foreign application under certain conditions.

According to 37 CFR 1.55(i), the certified copy requirement will be considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority is presented in an application data sheet (ADS)
  • The applicant provides the necessary information for the participating office to provide the USPTO with access to the foreign application
  • The USPTO receives a copy of the foreign application from the participating office during the pendency of the application and before the patent is granted

This provision can significantly simplify the process of meeting the certified copy requirement for applicants whose priority applications are from participating countries.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on priority document exchange, visit: priority document exchange.

The Priority Document Exchange (PDX) program is an electronic system that allows participating intellectual property offices to exchange priority documents securely. According to MPEP 215.01, “Under the PDX program, the participating offices electronically transmit priority documents to each other as needed.” This program eliminates the need for applicants to submit paper certified copies of priority documents in participating offices.

The Electronic Priority Document Exchange (PDX) program is a system that allows for the electronic transmission of priority documents between participating foreign intellectual property offices. As stated in the MPEP:

Electronic Priority Document Exchange (PDX) agreements provide for the electronic transmission of priority documents to and from participating foreign intellectual property offices.

This program simplifies the process of obtaining certified copies of foreign priority applications, which is crucial for establishing priority claims in patent applications.

A certified copy of a foreign application is a copy of the original foreign application with a certification by the patent office of the foreign country in which it was filed. According to the MPEP, “Certified copies ordinarily consist of a copy of the specification and drawings of the applications as filed with a certificate of the foreign patent office giving certain information.” It’s important to note that a copy of the certified copy filed by the applicant will not satisfy the requirement for a certified copy.

An ‘interim copy’ is a true copy of the original foreign application that an applicant can file to meet the timeliness requirement when they cannot obtain a certified copy within the time limit. According to 37 CFR 1.55(j), the interim copy must be clearly labeled as ‘Interim Copy’ and filed with a cover sheet stating it is a true copy of the original foreign application.

An ‘interim copy’ is a copy of the original foreign application from the applicant’s own records that can be submitted to satisfy the timeliness requirement for certified copies. According to 37 CFR 1.55(j):

  • The copy must be clearly labeled as ‘Interim Copy’
  • It must be filed with a cover sheet identifying the foreign application
  • It must be filed within the same time period as required for certified copies
  • A certified copy must still be filed during the pendency of the application

This provision allows applicants to meet the deadline even if they cannot obtain a certified copy in time, although there is no requirement to show inability to obtain a certified copy to use this option.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

If priority papers are found to be deficient in material respects, such as failure to include the correct certified copy, applicants should ensure that there is sufficient time to remedy any defects. The MPEP advises: “Frequently, priority papers are found to be deficient in material respects, such as for example, the failure to include the correct certified copy, and applicants should ensure that there is sufficient time to remedy any defects.” It’s recommended to file priority papers as early as possible to allow time for correction if needed.

If the certified copy of the foreign application is filed after the issue fee is paid but before the patent is granted, the following occurs:

  • The priority claim or certified copy will be placed in the file record
  • There will be no review of the papers
  • The published patent will not include the priority claim

To have the priority claim considered after publication, a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 must be filed. For original applications filed under 35 U.S.C. 111(a), additional requirements may apply, such as a petition to accept an unintentionally delayed priority claim.

This is outlined in MPEP 215.03.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on certified copy, visit: certified copy.

For more information on issue fee, visit: issue fee.

If the certified copy of the foreign application is filed after the date the issue fee is paid but prior to the date of grant of the patent, it will be placed in the file record but there will be no review of the papers. The patent when published will not include the priority claim. A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 can be filed to have the priority claim considered after publication of the patent.

What happens if a certified copy is not received within the time period set in 37 CFR 1.55(f)?

If a certified copy is not received within the time period set in 37 CFR 1.55(f), the USPTO will send a Notice of Allowance and Issue Fee Due (Notice of Allowance) with a requirement for the certified copy. As stated in the MPEP:

‘If a certified copy of the foreign application is not filed within the time period specified in 37 CFR 1.55(f) and the exceptions in 37 CFR 1.55(h), (i), and (j) are not applicable, the certified copy of the foreign application must be accompanied by a petition including a showing of good and sufficient cause for the delay and the petition fee set forth in 37 CFR 1.17(g).’

This means that if you miss the deadline, you’ll need to file a petition explaining the delay and pay an additional fee. It’s crucial to submit the certified copy or ensure it’s retrievable through the priority document exchange program to avoid complications in the patent application process.

To use the Priority Document Exchange (PDX) program, several requirements must be met as outlined in MPEP 215.02(a):

  1. The foreign application must be filed in a participating foreign intellectual property office.
  2. The claim for priority must be presented in an application data sheet (ADS) with specific details about the foreign application.
  3. The copy of the foreign application must be received by the USPTO from the participating foreign office, or a certified copy must be filed, within the specified time period.

The MPEP states:

37 CFR 1.55(i) specifically provides that this requirement for a timely filed certified copy of the foreign application will be considered satisfied if: (1) The foreign application was filed in a foreign intellectual property office participating with the Office in a bilateral or multilateral priority document exchange agreement (participating foreign intellectual property office); (2) the claim for priority is presented in an application data sheet (§1.76(b)(6)), identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and including the information necessary for the participating foreign intellectual property office to provide the Office with access to the foreign application; and (3) the copy of the foreign application is received by the Office from the participating foreign intellectual property office, or a certified copy of the foreign application is filed, within the time period set forth in 37 CFR 1.55(g)(1)).

Meeting these requirements allows applicants to potentially avoid manually filing certified copies of foreign priority documents.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For more information on requirements, visit: requirements.

To be entitled to priority under the PDX program, the following requirements must be met:

  1. The Office must receive a copy of the foreign application from the participating foreign intellectual property office within the pendency of the application and before the patent is granted, or
  2. The Office must receive a paper certified copy of the foreign application during that time period.

The MPEP states:

To be entitled to priority, the Office must receive a copy of the foreign application from the participating foreign intellectual property office within the pendency of the application and before the patent is granted, or receive a paper certified copy of the foreign application during that time period.

It’s crucial to note that if a certified copy is filed after the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.

The filing requirements for an interim copy of a foreign application are specified in 37 CFR 1.55(j). They include:

  • Filing a copy of the original foreign application clearly labeled as ‘Interim Copy’
  • Including a separate cover sheet identifying the foreign application details
  • Filing within specified time limits

The MPEP states:

’37 CFR 1.55(j) also provides that the interim copy of the foreign application must be filed together with a separate cover sheet identifying the foreign application by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and stating that the copy filed in the Office is a true copy of the original application as filed in the foreign country (or intellectual property authority).’

It’s crucial to adhere to these requirements to ensure proper processing of the interim copy.

For more information on filing requirements, visit: filing requirements.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

When filing an interim copy via the USPTO patent electronic filing system:

  1. The main parts of the foreign priority application (Abstract, Drawings, Specification, Claims, etc.) along with the cover sheet may be filed as a single PDF image file.
  2. Select the document description ‘Interim Copy of the Foreign Priority Application’ when indexing.
  3. For plain text files (e.g., Sequence Listings), file as a .txt file and select ‘Interim Copy of the Foreign Priority (text file)’ as the document description.
  4. XML files (e.g., Standard ST.26 Sequence Listing) should be filed on a read-only optical disc as part of the ‘Interim Copy of Foreign Priority.’

See MPEP § 502.05 for more information on filing documents electronically.

To ensure proper correlation between priority papers and U.S. applications, the MPEP suggests: “It is suggested that a notation of the application number of the corresponding U.S. application be placed on the priority papers when such papers are not submitted via a priority document exchange program. Such notation should be placed directly on the priority papers themselves even where a cover letter is attached bearing the U.S. application data.” This practice helps prevent separation of cover letters and priority papers, which can cause severe problems for both the Office and applicant.

Submitting an interim copy of a foreign application electronically involves specific procedures. The MPEP provides guidance:

‘If not provided as a single paper document, the main parts of the interim copy of the foreign priority application, i.e., Abstract, Drawings, Specification, Claims, and where applicable, the foreign patent office’s equivalent to a “Sequence Listing” (see MPEP § 2421.01), a “Sequence Listing XML” (see MPEP § 2412), “Large Tables” (see MPEP § 608.05(b)), or a “Computer Program Listing Appendix” (see MPEP § 608.05(a)), along with the separate cover sheet required by 37 CFR 1.55(j), may be filed as a single PDF image file via the USPTO patent electronic filing system.’

Key points for electronic submission:

  • File as a single PDF image file when possible
  • Use the document description ‘Interim Copy of the Foreign Priority Application’ when indexing
  • For plain text files, use the description ‘Interim Copy of the Foreign Priority (text file)’
  • XML files, like Standard ST.26 Sequence Listings, should be filed on a read-only optical disc

Proper indexing and file format selection are crucial for successful electronic submission.

For more information on electronic submission, visit: electronic submission.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

An interim copy of a foreign application serves as a temporary substitute for a certified copy but does not replace the requirement for a certified copy. The key differences are:

  • An interim copy can be from the applicant’s own records, while a certified copy must be from the foreign patent office.
  • An interim copy satisfies the initial time requirement in 37 CFR 1.55(f), but a certified copy is still required.
  • An interim copy is labeled as ‘Interim Copy,’ while a certified copy has official certification from the foreign patent office.

The MPEP clarifies:

‘Thus, providing an interim copy of a foreign application under 37 CFR 1.55(j) satisfies the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f), but a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate.’

In essence, the interim copy is a temporary measure to meet deadlines, while the certified copy remains a formal requirement.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

The USPTO treats a proper priority claim to an application filed in a participating foreign intellectual property office as a request to obtain a copy of the foreign application. The MPEP states:

The Office treats a proper priority claim under 37 CFR 1.55 to an application filed in a participating foreign intellectual property office as a request that the Office obtain a copy of the foreign application from the participating intellectual property office.

This means that applicants do not need to submit a separate request for the USPTO to retrieve the foreign application if they have made a proper priority claim and the foreign office is a PDX participant.

How does the USPTO handle certified copies for international design applications?

For international design applications, the USPTO has a specific process for handling certified copies. According to the MPEP:

‘For international design applications designating the United States, the certified copy requirement is considered to have been met by the filing of the international design application pursuant to 37 CFR 1.55(m).’

This means that if you file an international design application that designates the United States, you don’t need to separately submit a certified copy of the priority document. The filing of the international design application itself fulfills this requirement.

However, it’s important to note that this only applies to international design applications. For other types of patent applications claiming priority to a foreign application, you would still need to ensure that a certified copy is filed or retrievable through the priority document exchange program within the specified time period.

The Priority Document Exchange (PDX) program allows for electronic transmission of priority documents between participating foreign intellectual property offices. According to 37 CFR 1.55(i), if the foreign application was filed in a participating office, the requirement for a timely filed certified copy is considered satisfied if the Office receives a copy through the PDX program during the pendency of the application and before the patent is granted.

The USPTO attempts to retrieve foreign applications for design applications through the PDX program where possible. Specifically for Spanish industrial design applications:

The Spanish Patent and Trademark Office deposits certain ES industrial design applications for access by the USPTO via the WIPO DAS. Therefore, when the applicant claims foreign priority to an ES industrial design application and provides the WIPO DAS access code, the USPTO will attempt retrieval via the WIPO DAS.

This means that applicants claiming priority to Spanish industrial design applications should provide the WIPO DAS access code to enable the USPTO to retrieve the application through the WIPO Digital Access Service (DAS).

How does the Electronic Priority Document Exchange (PDX) program work with the USPTO?

The Electronic Priority Document Exchange (PDX) program is a system that allows participating intellectual property offices to exchange priority documents electronically. According to MPEP 215.01, the USPTO participates in this program, which can simplify the process of submitting certified copies of foreign priority applications.

The MPEP states: The USPTO has agreements with the European Patent Office (EPO) and the Japan Patent Office (JPO) that enable the USPTO to obtain certified copies of foreign applications filed in those offices from their electronic records management systems.

Here’s how the PDX program works with the USPTO:

  • If a foreign application was filed with a participating office (e.g., EPO or JPO), the applicant can request that office to make the certified copy of the priority document available to the USPTO.
  • The applicant must submit a request to retrieve the priority document through the USPTO’s electronic filing system (EFS-Web or Patent Center).
  • The USPTO will then attempt to retrieve the document electronically from the foreign office.
  • If successful, this electronic retrieval satisfies the requirement to file a certified copy of the foreign priority application.

It’s important to note that the applicant is still responsible for ensuring that the certified copy is received by the USPTO within the required time frame, even when using the PDX program.

To request retrieval of a foreign priority document through the Priority Document Exchange (PDX) program, follow these steps:

  1. Ensure that the foreign application is from a participating office in the PDX program.
  2. File an application data sheet (ADS) including a proper priority claim to the foreign application.
  3. Submit a request for retrieval of the foreign priority document.

The MPEP 215.01 states: “To authorize retrieval of a priority document via PDX, the applicant should submit the request electronically via EFS-Web using the Priority Document Exchange Request form (PTO/SB/38) or as a pre-grant (PGPub) request via Private PAIR.” It’s important to note that the request should be made within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

Under 37 CFR 1.55(i), the requirement for a certified copy of the foreign application will be considered satisfied if:

  1. The foreign application was filed in a foreign intellectual property office participating with the USPTO in a bilateral or multilateral priority document exchange agreement;
  2. The claim for priority is presented in an application data sheet, identifying the foreign application and including the information necessary for the participating foreign office to provide the USPTO with access to the foreign application; and
  3. The copy of the foreign application is received by the USPTO from the participating foreign office, or a certified copy is filed, within the time period specified in 37 CFR 1.55(g)(1).

In addition, if the foreign application was not filed in a participating office directly, but a certified copy was filed in an application subsequently filed in a participating office that permits the USPTO to obtain a copy, the applicant must also file a request in a separate document that the USPTO obtain a copy of the foreign application from the participating office. See MPEP 215.01.

To check if the United States Patent and Trademark Office (USPTO) has received your priority document through the Priority Document Exchange (PDX) program, you should monitor your application status. As stated in MPEP 215.02(a):

Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Accordingly, applicants are encouraged to check as necessary to confirm receipt by the Office of appropriate documents.

You can check the status of your priority document in several ways:

  1. Check the Patent Application Information Retrieval (PAIR) system for your application.
  2. Look for the document description: “Priority documents electronically retrieved by USPTO from a participating IP Office.”
  3. Contact the USPTO directly if you’re unsure about the status.

It’s important to verify receipt of the priority document to ensure compliance with the requirements for claiming priority to a foreign application.

For more information on foreign application, visit: foreign application.

For more information on PAIR system, visit: PAIR system.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For more information on USPTO, visit: USPTO.

To ensure successful retrieval of foreign applications through PDX, applicants should:

  • Provide proper and consistent citation of the foreign priority application and its filing date
  • Use an acceptable format for citing the foreign application (see MPEP § 214.04)
  • Ensure the foreign priority claim is complete

The MPEP emphasizes the importance of correct citations:

An improper, incomplete, or inconsistent citation of a foreign priority application and/or its filing date will result in a delay or prevent retrieval under the Priority Document Exchange program.

Applicants are encouraged to check the Private PAIR system to confirm successful retrieval of their foreign priority application.

Yes, under 37 CFR 1.55(j), the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f) will be considered satisfied if:

  1. A copy of the original foreign application clearly labeled as “Interim Copy,” including the specification, and any drawings or claims upon which it is based, is filed in the Office together with a separate cover sheet identifying the foreign application and stating that the copy is a true copy of the original application as filed; and
  2. The copy of the foreign application and cover sheet are filed within the later of sixteen months from the filing date of the prior foreign application, four months from the actual filing date of an application under 35 U.S.C. 111(a), or four months from the date the national stage commenced under 35 U.S.C. 371(b) or (f) of an international application.

However, a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate. See MPEP 215.02(b).

No, a copy of the foreign patent as issued does not comply with the certified copy requirement. The MPEP states: “A copy of the foreign patent as issued does not comply since the application as filed is required; however, a copy of the printed specification and drawing of the foreign patent is sufficient if the certification indicates that it corresponds to the application as filed.” The key is that the certified copy must represent the application as originally filed, not the patent as eventually issued.

Generally, there are no additional fees charged by the USPTO for using the PDX program to exchange priority documents. The MPEP 215.01 does not mention any specific fees for this service. However, it’s important to note:

  • Regular patent application fees still apply.
  • If the PDX retrieval fails and you need to submit a certified copy, standard fees for document submission may apply.
  • Some foreign offices might charge fees for making documents available through PDX.

Always check the most current fee schedule on the USPTO website for the most up-to-date information on patent-related fees.

MPEP 216 - Entitlement to Priority (37)

A Certificate of Correction is appropriate for perfecting a foreign priority claim in the following situations:

  1. When the priority claim was timely filed in the application but was not included on the patent because the requirement for a certified copy was not satisfied. In this case, a grantable petition under 37 CFR 1.55(f) or 37 CFR 1.55(g) for design applications is also required.
  2. When a priority claim under 37 CFR 1.55 was not timely made, but the correction sought would not require further examination.

The MPEP states: “Effective May 13, 2015, 37 CFR 1.55(g) provides that the claim for priority and the certified copy of the foreign application must be filed within the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate. 37 CFR 1.55(g) eliminates the need in many instances to file a reissue application in order to perfect a claim for foreign priority.” (MPEP 216.01)

If the applicant files the certified copy of the foreign application to overcome the effective date of a reference, a translation is required if the copy is not in English.

The examiner should require the translation when requesting the certified copy. The translation must be a complete translation of the certified copy, and must be accompanied by a statement that the translation is accurate. [MPEP 216]

An examiner considers the merits of a foreign priority claim in the following situations:

  • When a reference is found with an effective date between the foreign filing date and the U.S. filing date
  • When determining if a reference’s prior art date falls within the grace period for the application under examination
  • When an interference situation is under consideration

The MPEP states: “The subject matter of the application is not examined to determine whether the applicant is actually entitled to the benefit of the foreign filing date on the basis of the disclosure thereof unless such determination is required for patentability reasons. For example, the examiner considers the merits of an applicant’s claim of priority when a reference is found with an effective date between the date of the foreign filing and the date of filing in the United States, when determining whether a reference’s prior art date is within the grace period for the application under examination, and when an interference situation is under consideration.” (MPEP 216)

When filing a reissue application to correct a priority claim, it’s crucial to adhere to the time limits set by law. The MPEP specifies:

‘The reissue application must be filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f).’

This means that the reissue application must typically be filed within 12 months from the filing date of the foreign application. However, there may be exceptions or additional considerations depending on specific circumstances. It’s advisable to consult with a patent attorney or the USPTO directly for guidance on your particular situation.

The time limit for filing a delayed claim for foreign priority after patent issuance is specified in 37 CFR 1.55(g). According to MPEP 216.01:

‘The time period set in 37 CFR 1.55(g) for filing a claim for priority and the certified copy required under 37 CFR 1.55(f) is the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.’

However, for patents that have already been issued, the claim must be filed within the period set forth in 37 CFR 1.55(g). This typically means that the claim should be filed as soon as possible after realizing the oversight, as any delay beyond the statutory period would require explanation and potentially affect the grant of the petition.

The filing date of foreign applications is significant in priority claims for the following reasons:

  1. It establishes the effective date of the priority claim.
  2. The date accorded is the date on which the specification and drawing were filed, not necessarily the date of the petition (which is called the application in some countries).
  3. This date is used to determine the applicability of prior art and the eligibility for certain patent term adjustments.

The MPEP states: “In some instances, the specification and drawing of the foreign application may have been filed at a date subsequent to the filing of the petition in the foreign country. Even though the petition is called the application and the filing date of this petition is the filing date of the application in a particular country, the date accorded here is the date on which the specification and drawing were filed.” (MPEP 216)

37 CFR 1.55(h) provides an important provision for satisfying the requirement for a certified copy of a foreign application. Key points include:

  • It allows the certified copy requirement to be met through a prior-filed nonprovisional application.
  • The prior-filed application must be one for which benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • The prior-filed application must contain the certified copy and be identified as such.
  • This provision can simplify the process of perfecting priority claims in related applications.

The MPEP states: 37 CFR 1.55(h) provides that the requirement for a certified copy of the foreign application will be considered satisfied in an application if a prior-filed nonprovisional application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c) contains a certified copy of the foreign application and the prior-filed nonprovisional application is identified as containing a certified copy of the foreign application.

This provision can be particularly useful when requesting a certificate of correction to perfect a priority claim in a patent that claims benefit from an earlier application containing the certified copy.

What is the relationship between priority claims and the effective filing date?

The relationship between priority claims and the effective filing date is crucial in determining the patentability of an invention. According to MPEP 216:

“The effective filing date of a claimed invention is determined on a claim-by-claim basis and not an application-by-application basis.”

This means that each claim in a patent application may have a different effective filing date, depending on its content and the priority claims it can support. The effective filing date is important because it determines which prior art can be used against the claim during examination and potential litigation.

  • If a claim is fully supported by an earlier application, its effective filing date may be the filing date of that earlier application.
  • If a claim contains new matter not disclosed in any earlier application, its effective filing date will be the actual filing date of the current application.

Understanding this relationship is crucial for inventors and patent practitioners to properly claim priority and protect their inventions.

For more information on effective filing date, visit: effective filing date.

When a claim to priority and certified copy of a foreign application are received during the pendency of a patent application, the examiner generally follows these steps:

  • Checks for obvious formal defects in the documents
  • Verifies that the documents correspond to the application identified in the application data sheet
  • For original applications filed under 35 U.S.C. 111(a) and international applications entering the national stage under 35 U.S.C. 371, ensures the claim for foreign priority is timely

The examiner does not typically examine the subject matter to determine if the applicant is entitled to the benefit of the foreign filing date unless it’s necessary for patentability reasons. As stated in the MPEP, The subject matter of the application is not examined to determine whether the applicant is actually entitled to the benefit of the foreign filing date on the basis of the disclosure thereof unless such determination is required for patentability reasons.

For more information on application data sheet, visit: application data sheet.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For more information on patent examination, visit: patent examination.

The most important aspect of an examiner’s action regarding a right of priority is determining the identity of invention between the U.S. and foreign applications. This involves:

  • Considering the foreign application as if it had been filed in the U.S. on the same date it was filed in the foreign country
  • Examining the foreign application for sufficiency of disclosure under 35 U.S.C. 112
  • Determining if there is a basis for the claims sought

The MPEP states: “The most important aspect of the examiner’s action pertaining to a right of priority is the determination of the identity of invention between the U.S. and the foreign applications. The foreign application may be considered in the same manner as if it had been filed in this country on the same date that it was filed in the foreign country, and the applicant is ordinarily entitled to any claims based on such foreign application that applicant would be entitled to under U.S. laws and practice.” (MPEP 216)

The terms ‘right of priority’ and ‘benefit of an earlier filing date’ refer to different concepts in US patent law:

  • Right of priority: This term is used in the context of foreign priority under 35 U.S.C. 119(a)-(d) and 365(a) and (b). It allows a US application to claim the priority date of a foreign application filed within the previous 12 months.
  • Benefit of an earlier filing date: This term is used for domestic benefit under 35 U.S.C. 119(e) and 120. It allows a US application to claim the filing date of an earlier US provisional or nonprovisional application.

As stated in MPEP 216: ‘The right of priority is a statutory right, which is not considered an application property right.’

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

For more information on right of priority, visit: right of priority.

The ‘In re Van Esdonk’ case (187 USPQ 671, Comm’r Pat. 1975) is an important precedent in patent law regarding the perfection of foreign priority claims. Key points about this case include:

  • It involved a situation where a claim to foreign priority benefits had not been filed in the application prior to patent issuance.
  • The application was a continuation of an earlier application that had satisfied the requirements of 35 U.S.C. 119(a)-(d) or (f).
  • The Commissioner held that perfecting a priority claim in the parent application satisfies the statute for the continuation application.

The MPEP states: In re Van Esdonk, a claim to foreign priority benefits had not been filed in the application prior to issuance of the patent. However, the application was a continuation of an earlier application in which the requirements of 35 U.S.C. 119(a)-(d) or (f) had been satisfied. Accordingly, the Commissioner held that the ‘applicants’ perfection of a priority claim under 35 U.S.C. 119 in the parent application will satisfy the statute with respect to their continuation application.’

This case is significant because it allows for the perfection of foreign priority claims in continuation applications based on the parent application’s compliance, even after patent issuance.

When submitting an English language translation of a non-English language foreign priority application, the following requirements must be met:

  • The translation must be of the certified copy of the foreign application as filed
  • The translation must be submitted together with a statement that the translation of the certified copy is accurate

As stated in the MPEP: When an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) submitted together with a statement that the translation of the certified copy is accurate.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

When submitting a certified copy of a foreign application for priority purposes, the following requirements apply:

  • If the certified copy is not in English, a translation is required
  • The translation must be of the certified copy of the foreign application as filed
  • The translation must be filed together with a statement that the translation of the certified copy is accurate

The MPEP states: “When the examiner requires the filing of the certified copy, the translation should also be required at the same time. If an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) and it must be filed together with a statement that the translation of the certified copy is accurate.” (MPEP 216)

When reviewing a claim to foreign priority, the examiner generally checks the following:

  • That the papers contain no obvious formal defects
  • That the papers correspond in number, date and country to the application identified in the application data sheet
  • For original applications filed under 35 U.S.C. 111(a) and international applications entering the national stage under 35 U.S.C. 371, that the claim for foreign priority is timely

The MPEP states: “When the claim to priority and the certified copy of the foreign application are received while the application is pending before the examiner, the examiner generally makes no examination of the papers except to see that they contain no obvious formal defects and correspond in number, date and country to the application identified in the application data sheet for an application filed on or after September 16, 2012, or oath or declaration or application data sheet for an application filed prior to September 16, 2012.” (MPEP 216)

To perfect a claim for foreign priority after patent issuance, several documents are required. According to MPEP 216.01, the following must be submitted:

  • A petition to accept an unintentionally delayed claim for priority
  • The required petition fee
  • A certified copy of the foreign application
  • An English language translation of the foreign application (if not in English)
  • A statement that the translation is accurate

The MPEP states: ‘In addition to the petition to accept an unintentionally delayed claim for priority and the required petition fee, the claim for priority must be made in an application data sheet (if the patent issued from a utility or plant application filed on or after September 16, 2012) or in a request for a certificate of correction, and a certified copy of the foreign application must be submitted.’

It’s important to note that the requirements may vary slightly depending on the specific circumstances of the application and patent. Consulting with a patent attorney or agent is advisable for ensuring all necessary documents are properly prepared and submitted.

What are the time limits for perfecting a foreign priority claim in a patent?

The time limits for perfecting a foreign priority claim in a patent are as follows:

  • The priority claim must be made within 16 months from the filing date of the prior foreign application or 4 months from the actual filing date of the U.S. application, whichever is later.
  • A certified copy of the foreign application must be filed within the same time period, unless previously submitted in a parent application.

According to MPEP 216.01: “The patent owner’s failure to make a timely priority claim and file the certified copy prior to issuance of the patent cannot be cured by filing a reissue application.” This emphasizes the importance of meeting these deadlines during the initial patent application process.

To file a delayed priority claim, you must submit a petition to accept an unintentionally delayed claim for priority. According to 37 CFR 1.55(e), the petition must include:

  1. The priority claim in an application data sheet
  2. A certified copy of the foreign application (unless exceptions apply)
  3. The petition fee
  4. A statement that the entire delay was unintentional

The MPEP states: A petition to accept a delayed claim for priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) must be accompanied by: (1) The priority claim […]; (2) A certified copy of the foreign application […]; (3) The petition fee […]; and (4) A statement that the entire delay […] was unintentional.

What are the requirements for claiming domestic benefit in a patent application?

Claiming domestic benefit in a patent application allows an applicant to rely on the filing date of an earlier-filed US application. The MPEP 216 outlines the requirements for claiming domestic benefit, which are based on 35 U.S.C. 120. The key requirements include:

  • The later-filed application must be filed before the patenting or abandonment of the prior application
  • The later-filed application must contain or be amended to contain a specific reference to the prior application
  • The prior application must disclose the invention claimed in the later-filed application in the manner required by 35 U.S.C. 112(a)
  • At least one inventor named in the later-filed application must have been named as an inventor in the prior application

The MPEP states:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application.’

It’s important to note that these requirements must be met for each application in the chain of priority, ensuring a continuous line of co-pendency and proper disclosure.

For more information on continuation application, visit: continuation application.

For more information on domestic benefit, visit: domestic benefit.

The requirements for accepting an unintentionally delayed claim for foreign priority include:

  1. Filing a petition to accept a delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b).
  2. Submitting the priority claim in an application data sheet identifying the foreign application.
  3. Providing a certified copy of the foreign application, unless previously submitted or an exception applies.
  4. Paying the petition fee as set forth in 37 CFR 1.17(m).
  5. Submitting a statement that the entire delay between the date the priority claim was due and the date it was filed was unintentional.

The MPEP cites 37 CFR 1.55(e), which states: “A petition to accept a delayed claim for priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) must be accompanied by: (1) The priority claim under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted; (2) A certified copy of the foreign application, unless previously submitted or an exception in paragraph (h), (i), or (j) of this section applies; (3) The petition fee as set forth in § 1.17(m); and (4) A statement that the entire delay between the date the priority claim was due under this section and the date the priority claim was filed was unintentional.” (37 CFR 1.55(e))

The USPTO handles United Kingdom provisional specifications in priority claims as follows:

  • A certified copy of the “provisional specification” may be submitted, sometimes accompanied by a copy of the “complete specification.”
  • The provisional specification is examined for completeness of disclosure, as it may not contain a complete disclosure in the sense of 35 U.S.C. 112.
  • If the UK provisional specification is found insufficient for lack of disclosure, reliance may then be placed on the complete specification and its date, treating it as a different application than the provisional specification.

The MPEP states: “In applications filed from the United Kingdom there may be submitted a certified copy of the ‘provisional specification,’ which may also in some cases be accompanied by a copy of the ‘complete specification.’ According to United Kingdom law the provisional specification need not contain a complete disclosure of the invention in the sense of 35 U.S.C. 112, but need only describe the general nature of the invention, and neither claims nor drawings are required.” (MPEP 216)

The examiner generally does not examine the certified copy of the foreign priority application except to see that it contains no obvious formal defects and corresponds to the U.S. application. The examiner will consider the merits of the priority claim if:

  • An intervening reference is found with an effective date between the foreign filing date and U.S. filing date
  • Determining if a reference is prior art under the grace period
  • An interference situation is under consideration

If the examiner finds the applicant is not entitled to the priority date, a rejection is made and the applicant must then perfect the claim. [MPEP 216]

How does the Paris Convention affect priority claims in US patent applications?

The Paris Convention plays a crucial role in international priority claims for US patent applications. According to MPEP 216:

‘The right of priority is based on the Paris Convention for the Protection of Industrial Property, which is adhered to by the United States.’

The Paris Convention affects US patent applications in the following ways:

  • It allows applicants to claim priority from foreign applications filed in member countries
  • It establishes a 12-month priority period for utility patents and a 6-month period for design patents
  • It ensures that filing an application in one member country does not invalidate the novelty of the invention in other member countries

The implementation of the Paris Convention in US law is found in 35 U.S.C. 119(a)-(d), which outlines the requirements for claiming foreign priority.

For more information on foreign priority, visit: foreign priority.

For more information on international patent applications, visit: international patent applications.

For more information on Paris Convention, visit: Paris Convention.

The assignment of a priority right can significantly impact patent applications. According to MPEP 216:

‘The right of priority is a personal right of the applicant or his successor in title. It may be transferred to the extent and subject to the conditions provided for in the statutes.’

Key points about the assignment of priority rights:

  • Priority rights can be transferred separately from the application itself.
  • The assignment must be executed before filing the later application claiming priority.
  • An assignment of the entire right, title, and interest in an application includes the right of priority.
  • Partial assignments of priority rights are possible but must be clearly documented.

Proper assignment of priority rights is crucial for maintaining the earlier effective filing date, which can be critical for patentability and avoiding prior art rejections.

For more information on effective filing date, visit: effective filing date.

The America Invents Act’s (AIA) first-inventor-to-file (FITF) provision has significant implications for perfecting foreign priority claims, especially in cases where the foreign application has a pre-March 16, 2013 filing date. Key points include:

  • If a patent was examined under FITF provisions, but the foreign priority application has a pre-AIA filing date, perfecting the priority claim may require further examination.
  • In such cases, a certificate of correction is not sufficient, and a reissue application is necessary.
  • This situation arises because changing the effective filing date could potentially subject the patent to a different statutory framework.

The MPEP states: In situations where further examination would be required, the petition should not be granted. For example, further examination would be required where grant of the petition would cause the patent to be subject to a different statutory framework, e.g., where the foreign application has a pre-March 16, 2013 filing date in a patent that was examined under the first inventor to file (FITF) provisions of the AIA.

This requirement ensures that patents are not inadvertently subjected to different legal standards without proper examination.

How does the AIA affect priority claims for applications filed on or after March 16, 2013?

The America Invents Act (AIA) significantly changed the U.S. patent system, particularly affecting priority claims for applications filed on or after March 16, 2013. According to MPEP 216:

“AIA 35 U.S.C. 100(i)(1)(B) provides that the effective filing date for a claimed invention in a patent or application for patent (other than a reissue application or reissued patent) is the filing date of the earliest application for which the patent or application is entitled to claim a right of foreign priority or domestic benefit.”

This change means that:

  • The effective filing date can now include foreign priority dates, not just domestic benefit dates.
  • The first-to-file system replaced the first-to-invent system for determining priority.
  • Prior art is now determined based on the effective filing date, including foreign priority dates.

These changes have significant implications for inventors and patent practitioners in terms of strategy for filing applications and claiming priority, especially in a global context.

For more information on America Invents Act, visit: America Invents Act.

For more information on effective filing date, visit: effective filing date.

For more information on foreign priority, visit: foreign priority.

When an examiner finds an intervening reference (a reference with an effective date between the foreign filing date and the U.S. filing date) and a foreign priority claim is present, the examiner follows these steps:

  1. If the certified copy of the priority papers has not been filed, the examiner rejects the claims that may be unpatentable over the reference without considering the priority date.
  2. The applicant may then argue the rejection or present the foreign papers to overcome the date of the reference.
  3. If the applicant argues the rejection, the examiner may, in the next action:
    • Specifically require the foreign papers to be filed while repeating the rejection if still applicable, or
    • Simply continue the rejection

The MPEP states: “If at the time of making an action the examiner has found such an intervening reference, the examiner simply rejects whatever claims may be considered unpatentable thereover, without paying any attention to the priority date (assuming the certified copy of the priority papers has not yet been filed).” (MPEP 216)

A certificate of correction can be used to perfect a foreign priority claim in the following scenarios:

  1. When the priority claim was timely filed but not included on the patent due to failure to submit a certified copy.
  2. When the priority claim was not timely made, but the correction would not require further examination.

To use a certificate of correction, you must:

  • File a request for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.
  • Include a grantable petition under 37 CFR 1.55(e), (f), or (g) as appropriate.
  • Pay the required fee and provide a showing of good and sufficient cause for the delay, if applicable.

The MPEP states: Where the priority claim required under 37 CFR 1.55 was timely filed in the application but was not included on the patent because the requirement under 37 CFR 1.55 for a certified copy was not satisfied, the patent may be corrected to include the priority claim via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, accompanied by a grantable petition under 37 CFR 1.55(f) or, in the case of a design application, a grantable petition under 37 CFR 1.55(g).

How can I request a corrected patent with a perfected foreign priority claim?

To request a corrected patent with a perfected foreign priority claim after issuance, you need to follow these steps:

  • File a reissue application under 35 U.S.C. 251.
  • Include a petition for an expedited examination of the reissue application.
  • Pay the required fees for both the reissue application and the petition.
  • Submit the necessary documents to perfect the priority claim, such as a certified copy of the foreign application.

As stated in MPEP 216.01: “A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) in an issued patent.” It’s important to note that this process is only available for perfecting priority claims that were timely filed during the pendency of the application.

To correct the priority claim in an issued patent, you can file a reissue application under 35 U.S.C. 251. The MPEP states:

‘A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) or 35 U.S.C. 120 in the issued patent.’

This process allows you to amend the specification to include the required reference or correct the priority claim itself. However, it’s important to note that the reissue application must be filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f).

A claim for foreign priority can be perfected after a patent has been issued through two main methods:

  1. Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323
  2. Reissue application

The choice of method depends on the specific circumstances:

  • A Certificate of Correction can be used if the requirements of 37 CFR 1.55 are met and no further examination is required.
  • A reissue application is necessary if the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance, or if further examination would be required.

The MPEP states: “The failure to perfect a claim to foreign priority prior to issuance of the patent may be cured via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, provided the requirements of 37 CFR 1.55 are met, or by filing a reissue application.” (MPEP 216.01)

Yes, the foreign application may have been filed by and in the name of the assignee or legal representative or agent of the inventor, as applicant.

If the certified copy of the foreign application corresponds with the one identified in the U.S. application and no discrepancies appear, it may be assumed the U.S. application is entitled to claim priority to the foreign application.

If the U.S. application and the certified copy do not name the same inventor or have at least one joint inventor in common, the priority date should be refused until the inconsistency is resolved. [MPEP 216]

Can I perfect a foreign priority claim after my patent has been issued?

No, you cannot perfect a foreign priority claim after your patent has been issued if the claim was not timely filed during the pendency of the application. As stated in MPEP 216.01:

“A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) in an issued patent. However, a reissue application cannot be used to perfect a claim for priority benefit under 35 U.S.C. 119(a)-(d) or (f) where the claim for priority benefit was not timely filed during the pendency of the application that issued as the patent for which reissue is sought.”

This means that if you missed the deadline to file the priority claim or the required certified copy of the foreign application during the original patent application process, you cannot use a reissue application to retroactively perfect the claim after the patent has been issued.

Yes, it is possible to claim priority to a foreign application after your U.S. patent has been issued. According to MPEP 216.01, a claim for priority under 35 U.S.C. 119(a)-(d) or (f) can be made after the patent is granted, subject to certain conditions:

  • The claim must be made within the time period set forth in 37 CFR 1.55(g).
  • A petition to accept an unintentionally delayed claim for priority must be filed.
  • The required fee must be paid.
  • A certified copy of the foreign application must be submitted.

The MPEP states: ‘A claim for priority under 35 U.S.C. 119(a)-(d) or (f) for the benefit of a prior foreign application may be made after the patent issues if the claim is accompanied by a grantable petition to accept an unintentionally delayed claim for priority.’

Yes, it is possible to add a priority claim to a patent after it has been issued, but the process requires filing a reissue application. The MPEP states:

‘A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) or 35 U.S.C. 120 in the issued patent.’

To add a priority claim, you would need to:

  • File a reissue application under 35 U.S.C. 251
  • Amend the specification to include the required reference
  • Ensure the reissue application is filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f)

It’s important to note that adding a priority claim may affect the patent’s term and could potentially impact its validity if prior art emerges between the new priority date and the original filing date.

Yes, a US patent application can claim both foreign priority and domestic benefit simultaneously. This is known as a ‘multiple priority claim’ or ‘multiple benefit claim.’ The MPEP 216 states:

‘It is possible for a U.S. application to be entitled to the benefit of an earlier U.S. filing date and also to the right of priority of a foreign application.’

Here’s how it works:

  • The application can claim foreign priority under 35 U.S.C. 119(a)-(d) to a foreign application filed within the past 12 months.
  • At the same time, it can claim domestic benefit under 35 U.S.C. 120 to an earlier US application.
  • The earlier US application can also claim foreign priority to the same foreign application.

This allows the US application to potentially have an effective filing date that is earlier than both its actual filing date and the filing date of the US application it claims benefit from.

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

Yes, a nonprovisional application can be entitled to different foreign filing dates for different claims. This can occur in two scenarios:

  1. The application may be found entitled to the filing date of a foreign application for some claims but not for others.
  2. An applicant may rely on two or more different foreign applications and may be entitled to the filing date of one application for certain claims and to another for other claims.

The MPEP states: “A nonprovisional application may be found entitled to the filing date of the foreign application with respect to some claims and not with respect to others. In addition, an applicant may rely on two or more different foreign applications and may be entitled to the filing date of one of them with respect to certain claims and to another with respect to other claims.” (MPEP 216)

MPEP 217-Incorporation by Reference Under 37 CFR 1.57(b) (14)

The date September 21, 2004, is significant in relation to 37 CFR 1.57(b) because it marks the effective date of the provisions now contained in this regulation. The MPEP states that one reason an amendment might not comply with 37 CFR 1.57(b) is if the present application was filed before September 21, 2004, the effective date of the provisions now in 37 CFR 1.57(b).

This means that applications filed before this date cannot use the incorporation by reference procedure outlined in 37 CFR 1.57(b) to add inadvertently omitted material. For such applications, different rules and procedures would apply for addressing omitted material.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on effective date, visit: effective date.

For more information on incorporation by reference, visit: incorporation by reference.

The purpose of 37 CFR 1.57(b) is to provide a safeguard for applicants when a page(s) of the specification, or a portion thereof, or a sheet(s) of the drawing(s), or a portion thereof, is inadvertently omitted from an application, such as through a clerical error. It allows inadvertently omitted material to be added to the application by way of a later-filed amendment if the inadvertently omitted portion is completely contained in a prior-filed application for which priority or benefit is claimed, even though there is no explicit incorporation by reference of the prior-filed application.

Incorporation by reference under 37 CFR 1.57(b) is a provision that allows applicants to add inadvertently omitted material to a patent application if certain conditions are met. Specifically:

  • The application must contain a priority or benefit claim to a prior-filed application
  • The omitted material must be completely contained in that prior-filed application
  • The omission must have been inadvertent

This provision acts as a safeguard for applicants when material is accidentally left out of an application due to clerical error. As stated in the MPEP, “The purpose of 37 CFR 1.57(b) is to provide a safeguard for applicants when a page(s) of the specification, or a portion thereof, or a sheet(s) of the drawing(s), or a portion thereof, is (are) inadvertently omitted from an application, such as through a clerical error.”

If you intentionally omit material from your application that was present in a prior-filed application, the omitted material will not automatically be incorporated by reference under 37 CFR 1.57(b). The MPEP clarifies:

“Applicants can still intentionally omit material contained in the prior-filed application from the application containing the priority or benefit claim without the material coming back in by virtue of the incorporation by reference of 37 CFR 1.57(b). Applicants can maintain their intent by simply not amending the application to include the intentionally omitted material.”

In other words, the incorporation by reference under 37 CFR 1.57(b) only applies to inadvertently omitted material. If you choose not to include certain material from the prior application, it will remain omitted unless you specifically amend your application to include it.

The following conditions and requirements need to be met to add omitted material to an application under 37 CFR 1.57(b):n

    n

  1. The application must have been filed on or after September 21, 2004
  2. n

  3. All or a portion of the specification or drawing(s) must have been inadvertently omitted
  4. n

  5. A priority claim under 37 CFR 1.55 or benefit claim under 37 CFR 1.78 must have been present on the filing date
  6. n

  7. The omitted portion must be completely contained in the prior-filed application
  8. n

  9. An amendment to include the omitted portion must be filed within a time period set by the Office
  10. n

  11. If not otherwise entitled to a filing date, a petition under 37 CFR 1.53(e) with the fee must also be filed
  12. n

  13. A copy of the prior-filed application must be supplied, except where the prior application was filed under 35 U.S.C. 111
  14. n

  15. An English translation of any non-English prior-filed application must be supplied
  16. n

  17. The location of the omitted portion in the prior-filed application must be identified

To incorporate material from a prior-filed application under 37 CFR 1.57(b), several requirements must be met:

  1. The inadvertently omitted portion must be completely contained in the prior-filed application.
  2. A copy of the prior-filed application must be submitted (except for applications filed under 35 U.S.C. 111).
  3. If the prior-filed application is in a non-English language, an English language translation must be submitted.
  4. The applicant must identify where the inadvertently omitted portion can be found in the prior-filed application.

The MPEP states that an amendment may not comply with 37 CFR 1.57(b) if any of these conditions are not met. For example, it notes that non-compliance may occur if the inadvertently omitted portion is not completely contained in the prior-filed application or if applicant did not identify where the inadvertently omitted portion of the specification or drawings can be found in the prior-filed application.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

For more information on patent application requirements, visit: patent application requirements.

For more information on prior-filed application, visit: prior-filed application.

There are several key conditions that must be met to use incorporation by reference under 37 CFR 1.57(b):

  1. The application must have been filed on or after September 21, 2004
  2. Material must have been inadvertently omitted from the application
  3. A priority or benefit claim to a prior-filed application must have been present on the filing date
  4. The omitted material must be completely contained in the prior-filed application
  5. An amendment to add the omitted material must be filed within the time period set by the USPTO
  6. Other requirements like supplying copies of prior applications may apply

As stated in the MPEP: “The following conditions and requirements need to be met for an applicant to add omitted material to an application pursuant to 37 CFR 1.57(b):” followed by a list of specific conditions labeled (A) through (I).

The MPEP outlines several reasons why an amendment might not comply with 37 CFR 1.57(b). These include:

  • The application was filed before September 21, 2004 (the effective date of the provisions)
  • The claim for priority/benefit of the prior-filed application was not present on the filing date
  • The omitted portion is not completely contained in the prior-filed application
  • A copy of the prior-filed application was not submitted (except for applications filed under 35 U.S.C. 111)
  • An English language translation of a non-English prior-filed application was not submitted
  • The applicant did not identify where the omitted portion can be found in the prior-filed application

If any of these conditions are not met, the examiner will state that the amendment to add inadvertently omitted material pursuant to 37 CFR 1.57(b) filed [date] is not in compliance with 37 CFR 1.57(b) because [specific reason].

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

When an examiner encounters a non-compliant amendment under 37 CFR 1.57(b), they follow a specific procedure outlined in the MPEP:

  1. They use a form paragraph stating the non-compliance and the specific reason.
  2. If the amendment introduces new matter, they follow up with additional form paragraphs (7.28 for specification/drawings, 7.31.01 for claims).
  3. For after-final amendments, they issue an advisory action indicating that the amendment raises new issues due to non-compliance.

The MPEP notes, This form paragraph must be followed by form paragraph 7.28, where the amendment is made to the specification and/or drawings and introduces new matter into the disclosure, and/or form paragraph 7.31.01, where the amendment adds new matter to the claims or affects the claims.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

37 CFR 1.57(b) is closely tied to priority claims in patent applications. For an amendment to comply with this regulation, the claim for priority or benefit of the prior-filed application must have been present on the filing date of the current application.

The MPEP specifically states that an amendment may not comply with 37 CFR 1.57(b) if the claim for priority/benefit of the prior-filed application was not present on the filing date of the present application. This requirement ensures that the incorporation by reference is based on a properly established relationship between the current application and the prior-filed application.

If the priority claim was not present at filing, the applicant cannot use 37 CFR 1.57(b) to incorporate material from the prior-filed application, even if that material was inadvertently omitted.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

For more information on patent applications, visit: patent applications.

For international applications, 37 CFR 1.57(b)(1) specifies:n

    n

  • Any amendment will only be effective as to the United States and shall have no effect on the international filing date
  • n

  • It cannot be relied upon to accord an international filing date or alter the filing date under PCT Article 11
  • n

  • No request to add omitted material will be acted on prior to national stage entry under 37 CFR 1.491 or filing of a US application claiming benefit of the international application
  • n

To amend your application to include inadvertently omitted material under 37 CFR 1.57(b), you must:

  1. File an amendment to include the omitted material within the time period set by the USPTO
  2. Ensure the amendment is filed before the close of prosecution or abandonment of the application
  3. Supply a copy of the prior-filed application (unless it’s a US application filed under 35 U.S.C. 111)
  4. Provide an English translation if the prior-filed application is in a foreign language
  5. Identify where the omitted material can be found in the prior-filed application

The MPEP states: “The application must be amended to include the inadvertently omitted portion of the specification or drawing(s) within any time period set by the Office, but in no case later than the close of prosecution as defined by 37 CFR 1.114(b), or abandonment of the application, whichever occurs earlier.”

Incorporation by reference under 37 CFR 1.57(b) has limited applicability to international patent applications:

  • It is only effective for the United States
  • It does not affect the international filing date
  • It cannot be used to accord an international filing date
  • Requests to add omitted material will not be acted upon before national stage entry

The MPEP states: “Any amendment to an international application pursuant to 37 CFR 1.57(b)(1) will be effective only as to the United States and shall have no effect on the international filing date of the application. The incorporation by reference relief provided in 37 CFR 1.57(b) cannot be relied upon to accord an international filing date to an international application that is not otherwise entitled to a filing date under PCT Article 11, and it cannot be relied upon to alter the international filing date accorded under PCT Article 11.”

No, incorporation by reference under 37 CFR 1.57(b) cannot be used to add material to a granted patent. This provision is only applicable during the application process, before a patent is granted. The MPEP clearly states:

“If, however, an application has been patented, a certificate of correction or a reissue application could not be used to add inadvertently omitted material to that patent via 37 CFR 1.57(b).”

Once a patent has been granted, other mechanisms such as reissue or certificate of correction would need to be considered for making changes or additions to the patent, subject to their own specific requirements and limitations.

MPEP 300 - Ownership and Assignment (440)

Submitting legible copies of assignment documents to the USPTO is crucial because the quality of the recorded document depends on the quality of the submitted copy. The USPTO does not improve or enhance the quality of submitted documents.

According to MPEP 302.01: If the copy submitted for recordation is illegible, the recorded document will be illegible.

This means that if you submit an illegible copy, the officially recorded document will also be illegible, potentially causing issues with proving ownership or assignment in the future. To avoid such problems, always ensure that you submit clear, high-quality copies of your assignment documents for recordation.

To learn more:

Recording certificates of name change or merger for patents is crucial for maintaining a clear chain of title. According to MPEP 314, these documents serve as important links in the ownership history of a patent.

The MPEP states:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title. Documents of merger are also proper links in the chain of title.

By recording these certificates, you ensure that the USPTO and any interested parties can trace the ownership history of the patent accurately. This is particularly important for legal proceedings, licensing negotiations, or potential patent sales.

To learn more:

Recording business name changes and mergers is crucial for maintaining an accurate chain of title for patents. MPEP 314 emphasizes this importance:

  • For name changes: Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.
  • For mergers: Documents of merger are also proper links in the chain of title.

Recording these changes ensures:

  1. The USPTO has up-to-date information on patent ownership
  2. Third parties can accurately identify the current patent owner
  3. The chain of title remains clear and unbroken, which can be important for future transactions or litigation
  4. Compliance with legal requirements for maintaining patent rights

Document legibility is crucial when submitting patent assignments because:

  1. The USPTO does not return recorded documents.
  2. If the submitted copy is illegible, the recorded document will also be illegible.
  3. Illegible documents may cause legal issues or complications in proving ownership.

The MPEP emphasizes this point: “If the copy submitted for recordation is illegible, the recorded document will be illegible. Accordingly, applicants and patent owners should ensure that only a legible copy is submitted for recordation.”

It’s the responsibility of the submitter to ensure that all documents are clear and readable to maintain accurate records of patent ownership.

MPEP 303 highlights the importance of determining who should direct prosecution:

“When the assignment condition of an application is significant, such as… when there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

Determining who should direct prosecution is crucial because:

  • It ensures that the rightful owner or assignee is making decisions about the application
  • It prevents unauthorized individuals from influencing the prosecution process
  • It helps resolve potential disputes over ownership or control of the application
  • It maintains the integrity of the patent examination process

When there’s uncertainty about this, examiners must verify assignment information to ensure proper handling of the application.

Why doesn’t the USPTO return original assignment documents after recording?

The USPTO does not return original assignment documents after recording to maintain a permanent, unaltered record and to prevent potential disputes or fraud. According to MPEP 302.01: ‘The USPTO will not return documents filed for recording.’ This policy serves several purposes:

  • Ensures the integrity of the recorded documents
  • Prevents alterations or substitutions after recording
  • Maintains a consistent and reliable archive
  • Reduces administrative burden and potential for loss

By keeping all submitted documents, the USPTO can provide certified copies if needed for legal or business purposes, ensuring a reliable chain of title for patent rights.

The USPTO records documents other than assignments for several important reasons:

  1. Public interest: To provide notification to third parties of equitable interests or other matters relevant to patent ownership.
  2. Transparency: To maintain a clear record of various interests in patents and patent applications.
  3. Legal compliance: To fulfill the requirements of 35 U.S.C. 261 and 37 CFR 3.11.

The MPEP states, “Such documents are recorded in the public interest in order to give third parties notification of equitable interests or other matters relevant to the ownership of a patent or application.” (MPEP 313)

The restrictions on USPTO employees regarding patents are in place to prevent conflicts of interest and maintain the integrity of the patent system. These rules, outlined in 35 U.S.C. 4 and MPEP 309, serve several purposes:

  • Prevent employees from using insider knowledge for personal gain
  • Ensure fair and unbiased examination of patent applications
  • Maintain public trust in the patent system
  • Avoid potential conflicts between an employee’s official duties and personal interests

By prohibiting employees from applying for or acquiring patents during their employment and for a period after, the USPTO aims to preserve the objectivity and fairness of the patent examination process.

Assignment documents are not placed directly in patent application files to ensure proper recording and maintenance of ownership records. MPEP 318 states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This procedure serves several purposes:

  • It centralizes the recording of ownership information
  • It ensures that assignments are properly recorded and searchable
  • It keeps the main application file focused on technical and procedural aspects of the patent application
  • It allows the Assignment Division to maintain a separate database of patent ownership information

Assignment documents are not placed directly in application or patent files to ensure proper recording and management. According to MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This practice serves several purposes:

  • It ensures that assignments are properly recorded by the specialized Assignment Division.
  • It maintains the integrity and organization of application and patent files.
  • It allows for efficient tracking and retrieval of assignment information.

To learn more:

The English translation of a non-English assignment document must be signed by the individual who performed the translation. As stated in MPEP 302.02:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This requirement ensures the accuracy and authenticity of the translation. It’s important to note that the translator’s signature is required, not necessarily the signature of the parties involved in the assignment.

To learn more:

The responsibility for filing the notice of arbitration award with the USPTO is primarily assigned to the patent owner or their representatives, but there are provisions for other parties to file if necessary. According to 35 U.S.C. 294(d) and 37 CFR 1.335:

  • The patentee, assignee, or licensee is primarily responsible for filing the notice.
  • If the required notice is not filed by the designated party, any party to the arbitration proceeding may file the notice.

35 U.S.C. 294(d) states: “When an award is made by an arbitrator, the patentee, his assignee or licensee shall give notice thereof in writing to the Director.”

This flexibility ensures that the USPTO is informed of arbitration outcomes, even if the primary responsible party fails to file the notice.

The presumption of ownership for patent applications depends on the filing date. According to MPEP 301:

‘For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of the application for an original patent. For applications filed before September 16, 2012, the ownership of the patent (or the application for the patent) initially vests in the named inventors of the invention of the patent.’

This change in presumption reflects updates to U.S. patent law under the America Invents Act. It’s important for applicants and inventors to be aware of this presumption, as it can affect various aspects of patent prosecution and ownership rights.

According to 37 CFR 3.71(b), the assignees who may conduct prosecution of a patent application as the applicant are:

  1. A single assignee who is the assignee of the entire right, title and interest in the application or patent, or
  2. All partial assignees, or all partial assignees and inventors who have not assigned their rights, who together own the entire right, title and interest in the application or patent.

The MPEP states: “As the applicant, the owner or assignee that is not a juristic entity can sign a reply to an Office action (37 CFR 1.33(b)(3)), a request for a continued prosecution application under 37 CFR 1.53(d) (MPEP § 201.06(d)), a disclaimer under 37 CFR 1.321 (MPEP § 1490), Fee(s) Transmittal (PTOL-85B) (MPEP § 1306), or a request for status of an application (MPEP § 102).”

For an assignee organization (e.g., corporation, partnership, university), the submission establishing ownership can be signed by:

  1. A person with apparent authority to sign on behalf of the organization, such as an officer (e.g., CEO, president, vice-president, secretary, treasurer). The MPEP states: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization.”
  2. Any person, if the submission states that the person is authorized to act on behalf of the assignee.
  3. A person empowered by an organizational resolution, if a copy of the resolution is submitted.

If the signer does not fall into one of these categories, evidence of their authority to sign may be required. This is outlined in MPEP 324, section V.

According to the MPEP, the 37 CFR 3.73(c) statement establishing assignee ownership can be signed by:

  1. A person in the organization having apparent authority to sign on behalf of the organization (e.g., an officer)
  2. Any person, if the statement sets forth that the person is authorized to act on behalf of the assignee
  3. A patent practitioner of record
  4. A person empowered by an organizational resolution to sign on behalf of the assignee, if a copy of the resolution is submitted

The MPEP clarifies: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization. The signature of the chairman of the board of directors is acceptable, but not the signature of an individual director.”

When an assignee is an organization (e.g., corporation, partnership, university), specific individuals are authorized to sign documents on its behalf. According to MPEP 325, the following persons can sign submissions under 37 CFR 3.73(c):

  1. A person with apparent authority to sign on behalf of the organization. This typically includes officers such as the CEO, president, vice-president, secretary, or treasurer.
  2. Any person, if the submission clearly indicates that the person is authorized to act on behalf of the assignee.
  3. A patent practitioner of record.
  4. A person empowered by an organizational resolution, if a copy of the resolution is submitted.

The MPEP states: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization. The signature of the chairman of the board of directors is acceptable, but not the signature of an individual director.”

It’s important to note that for juristic entities, many actions in patent matters must be signed by a registered patent practitioner after September 16, 2012.

For more information on corporate officers, visit: corporate officers.

For more information on patent documents, visit: patent documents.

For pre-AIA patent applications (filed before September 16, 2012), the submission establishing ownership must be signed by a party authorized to act on behalf of the assignee. According to MPEP 324, this can be done in several ways:

  • A person with apparent authority in the organization, such as an officer (e.g., CEO, president, vice-president, secretary, or treasurer).
  • Any person, if the submission clearly states that the person is authorized to act on behalf of the assignee.
  • A person empowered by an organizational resolution, if a copy of the resolution is submitted.

The MPEP notes: Where a submission does not comply with (A), (B), or (C) above, evidence of the person’s authority to sign will be required. It’s important to ensure that the proper authority is established to avoid delays in patent prosecution.

For more information on assignee rights, visit: assignee rights.

For more information on authorized signatories, visit: authorized signatories.

For more information on pre-AIA applications, visit: pre-AIA applications.

Title reports are internal documents used by the USPTO and are not available for direct request by external parties. The MPEP explicitly states:

Title reports may not be ordered by applicants or attorneys.

These reports are typically requested by internal USPTO staff, such as the Reexamination Preprocessing Staff, when needed for specific procedures.

According to MPEP 325, one or more assignees can conduct prosecution of a national patent application as the applicant. Specifically, 37 CFR 3.71(b) states that:

“The assignee(s) who may conduct either the prosecution of a national application for patent as the applicant under § 1.46 of this title or a supplemental examination or reexamination proceeding are:

  • (1) A single assignee. An assignee of the entire right, title and interest in the application or patent, or
  • (2) Partial assignee(s) together or with inventor(s). All partial assignees, or all partial assignees and inventors who have not assigned their right, title and interest in the application or patent, who together own the entire right, title and interest in the application or patent.”

This means that either a single assignee with full ownership, or all partial assignees and remaining inventors collectively, can prosecute the application as the applicant.

For more information on prosecution, visit: prosecution.

Tags: prosecution

According to 35 U.S.C. 118, the following parties can file a patent application:

  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who shows sufficient proprietary interest in the matter, acting as an agent for the inventor

The law states: A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.

The placement of the government license rights statement in a patent application depends on whether there are references to related applications:

  • If there are references to related applications in the first sentence(s) of the specification following the title, the government license rights statement should appear as the second paragraph of the specification.
  • If there are no references to related applications, the government license rights statement should appear as the first paragraph of the specification.

This placement is specified in 37 CFR 1.77(b)(1)-(3).

When submitting assignment documents along with new patent applications, the mailing address is different from the general assignment recordation address. According to MPEP 302.08:

Requests for recording documents which accompany new applications should be addressed to the Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.

This ensures that your assignment documents are properly associated with the new patent application and processed accordingly by the USPTO.

To learn more:

MPEP 318 provides clear guidance on where assignment documents should be forwarded for recording. According to the manual:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This means that when submitting assignment documents, they should be sent to the USPTO’s Assignment Division, which is responsible for recording and maintaining records of patent ownership changes.

For more detailed information about the required cover sheet for patent assignments, you can refer to MPEP 302.07. This is explicitly mentioned in MPEP 302.05, which states:

See MPEP § 302.07.

MPEP 302.07 provides comprehensive guidance on the cover sheet requirements, including the necessary information to be included, such as the assignee’s address. Additionally, you can find forms and instructions for recording assignments on the USPTO’s Assignment Recordation Branch website.

To learn more:

To learn more:

For additional information on restrictions applicable to USPTO employees, you can refer to MPEP § 1701. The MPEP section on restrictions upon employees of the U.S. Patent and Trademark Office states:

See MPEP § 1701 for additional restrictions on Office employees.

MPEP § 1701 provides more detailed guidance on various ethical considerations and restrictions for USPTO employees, including conflicts of interest, outside employment, and post-employment restrictions. This section is an important resource for understanding the full scope of rules and regulations that apply to USPTO employees and former employees.

For more information on USPTO employees, visit: USPTO employees.

For assignee applicants or persons to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership should be recorded as follows:

  • As provided for in part 3 of Chapter 37 CFR
  • No later than the date the issue fee is paid in the application

According to 37 CFR 1.46(b)(1): If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

According to 37 CFR 1.46(b)(1), documentary evidence of ownership should be recorded as follows:

“If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.”

In other words, if you’re filing as an assignee or obligated assignee, you should record your documentary evidence of ownership (such as an assignment or employment agreement) with the USPTO no later than when you pay the issue fee for your patent application.

For more information on documentary evidence, visit: documentary evidence.

Ownership must be established under pre-AIA 37 CFR 3.73(b) when the assignee:

  • Signs a request for status of an application
  • Gives a power to inspect an application
  • Appoints its own registered attorney or agent to prosecute an application
  • Signs a disclaimer under 37 CFR 1.321
  • Consents to the filing of a reissue application
  • Consents to the correction of inventorship in a patent
  • Signs a Fee(s) Transmittal (PTOL-85B)

The MPEP states: “Examples of situations where ownership must be established under pre-AIA 37 CFR 3.73(b) are when the assignee: signs a request for status of an application or gives a power to inspect an application (MPEP §§ 102 and 104); appoints its own registered attorney or agent to prosecute an application (pre-AIA 37 CFR 3.71 and MPEP § 402.07); signs a disclaimer under 37 CFR 1.321 (MPEP § 1490); consents to the filing of a reissue application (MPEP § 1410.01); consents to the correction of inventorship in a patent (MPEP § 1481); or signs a Fee(s) Transmittal (PTOL-85B) (MPEP § 1306).”

Note that effective September 16, 2012, a juristic entity (e.g., organizational assignee) must be represented by a patent practitioner.

An assignee must establish ownership under 37 CFR 3.73(c) in various situations, including when the assignee:

  • Signs a request for status of an application
  • Gives a power to inspect an application
  • Appoints its own registered attorney or agent to prosecute an application
  • Signs a disclaimer under 37 CFR 1.321
  • Consents to the filing of a reissue application
  • Signs a Fee Transmittal (PTOL-85B)

The MPEP notes: “Effective September 16, 2012, a juristic entity (e.g., organizational assignee) must be represented by a patent practitioner.”

New assignment paperwork is required in the following scenario:

  • The application claiming benefit of a provisional application includes subject matter that is not common with the provisional application, and
  • The application was filed before September 16, 2012, or the assignee is not the original applicant in the later application.

MPEP § 306.01 states: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

This requirement is similar to the practice for continuations-in-part filed under 35 U.S.C. 120.

To learn more:

MPEP 303 outlines specific situations where a patent examiner needs to obtain assignment information from the Patent Application Locator and Monitoring (PALM) system:

“When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims or there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

This typically occurs in two main scenarios:

  1. When applications from different inventors have conflicting claims
  2. When there’s uncertainty about who should direct the prosecution

In these cases, the examiner must consult PALM to clarify the assignment status.

A title report is typically prepared at specific stages of the patent process. The MPEP Section 320 states that “A title report is prepared when a new application is filed in order to notify the examiner of the assignment status of the application.” Additionally, title reports are prepared:

  • When a Notice of Allowance is mailed
  • When an application is ready for issue
  • When a request for a correction of inventorship is received

These reports ensure that the most current ownership information is available at critical points in the patent process.

For more information on new application, visit: new application.

For more information on notice of allowance, visit: notice of allowance.

For more information on title report, visit: title report.

A petition to expunge is necessary when there has been a complete error in recording an assignment document at the USPTO. This typically occurs when a document not intended for recording was erroneously recorded. As stated in MPEP 323:

‘In the case of a complete error (e.g., a wrong document is recorded), a petition to expunge the assignment record should be filed.’

Key points about petitions to expunge:

  • They are used for complete errors, not minor corrections
  • The petition should clearly explain the nature of the error
  • Supporting documentation may be required
  • The USPTO will review the petition and make a determination

It’s important to note that expungement is a serious step and should only be used when absolutely necessary.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The need for a new assignment in applications derived from earlier applications depends on the type of application and its content:

  • Division and Continuation Applications: Generally, no new assignment is required as the prior assignment is automatically applied. However, a new recordation request is needed to reflect this in USPTO records.
  • Substitute and Continuation-in-Part Applications: New assignments are typically required unless the application is filed on or after September 16, 2012, and the assignee is the original applicant.
  • Applications Claiming Provisional Benefits: If the application includes only subject matter from the provisional application, no new assignment is needed. However, if it includes new subject matter, a new assignment is required, with the same exception as for substitute and continuation-in-part applications.

Always refer to MPEP § 306, § 307, and § 308 for the most up-to-date and detailed information.

For more information on new assignment, visit: new assignment.

For more information on USPTO requirements, visit: USPTO requirements.

A new assignment is generally required for a continuation-in-part (CIP) application, with one exception. According to MPEP 306:

Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

This means:

  • For CIP applications filed before September 16, 2012: A new assignment is always required.
  • For CIP applications filed on or after September 16, 2012: A new assignment is required unless the assignee is the original applicant in the CIP application.

The reason for this requirement is that CIP applications often contain new subject matter not present in the original application, and the original assignment may not cover this new material.

Patent examiners need to obtain assignment information in specific situations where the ownership of an application is significant. The MPEP 303 outlines two key scenarios:

  1. Conflicting claims in applications of different inventors: When multiple applications from different inventors contain claims that conflict with each other.
  2. Questions about who should direct prosecution: When there is uncertainty about which party has the right to control the patent prosecution process.

In these cases, the MPEP states: “When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims or there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” PALM refers to the USPTO’s Patent Application Location and Monitoring system.

For more information on assignment information, visit: assignment information.

For more information on conflicting claims, visit: conflicting claims.

For more information on Patent examiners, visit: Patent examiners.

For more information on patent prosecution, visit: patent prosecution.

Patent examiners typically do not require title reports for routine examination. The MPEP states:

Information as to the title is not normally required by the examiner to examine an application. It is only in limited circumstances when the ownership becomes an issue and an examiner needs a title report.

When ownership information is necessary, examiners can obtain a title report through the USPTO’s internal PALM Intranet system.

Title reports are not typically used in routine patent examination. The MPEP clarifies: Information as to the title is not normally required by the examiner to examine an application. It is only in limited circumstances when the ownership becomes an issue and an examiner needs a title report. For instance, title reports may be requested by the Reexamination Preprocessing Staff when a request for reexamination is filed. Examiners can obtain title reports through the USPTO’s internal PALM Intranet system when necessary.

For more information on patent examination, visit: patent examination.

For more information on title report, visit: title report.

What types of evidence can be used to establish assignee ownership in pre-AIA applications?

For pre-AIA applications (filed before September 16, 2012), assignees can use various types of evidence to establish ownership, including:

  • Assignment documents
  • Corporate merger documentation
  • Patent purchase agreements
  • Court orders
  • Joint research agreements

The MPEP 324 states: “The submission establishing ownership must show that the person signing the submission is a person authorized to act on behalf of the assignee.” This means that in addition to proving ownership, the assignee must also demonstrate the authority of the person acting on their behalf.

For more information on assignee ownership, visit: assignee ownership.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO records various documents related to patents and patent applications, including:

  • Licenses
  • Security interests
  • Liens
  • Options
  • Mortgages
  • Name changes
  • Mergers
  • Change of entity status

According to MPEP 313: Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11. This includes a wide range of documents that affect the ownership or rights associated with patents and applications.

For more information on licenses, visit: licenses.

For more information on patent documents, visit: patent documents.

For more information on security interests, visit: security interests.

The Electronic Patent Assignment System (EPAS) accepts various types of assignment-related documents. As stated in MPEP 302.10:

“The EPAS system allows customers to submit assignments and other documents related to title (e.g., lien agreements, probate documents, licenses, etc.) directly into the automated Patent and Trademark Assignment System.”

This system streamlines the submission process for a wide range of ownership and assignment documents.

To learn more:

The USPTO records various documents related to patent ownership and interests. Common types include:

  • Assignments
  • Security agreements
  • Mergers
  • Name changes
  • Licenses
  • Liens
  • Joint research agreements
  • Government interests

As stated in MPEP 302.07: “Examples of the type of descriptions of the interest conveyed or transaction to be recorded that can be identified are: (A) assignment; (B) security agreement; (C) merger; (D) change of name; (E) license; (F) foreclosure; (G) lien; (H) contract; and (I) joint research agreement.”

To record a document:

  1. Ensure it’s eligible for recordation
  2. Complete the appropriate cover sheet
  3. Submit the document and cover sheet to the USPTO
  4. Pay any applicable fees

Remember, the USPTO generally only records documents that affect title to patents or patent applications. Consult the MPEP or a patent attorney for guidance on specific document types.

For more information on patent documents, visit: patent documents.

For more information on USPTO recordation, visit: USPTO recordation.

In addition to assignments, the USPTO will record various other documents relating to interests in patent applications and patents upon request. These include:

  • License agreements
  • Security interest agreements
  • Other documents affecting title to applications, patents, and registrations

As stated in the MPEP, “Other documents affecting title to applications, patents, and registrations will be recorded as provided in 37 CFR Part 3 or at the discretion of the Director.” (MPEP 313)

What types of documents can be recorded in the USPTO assignment database?

The USPTO assignment database accepts various types of documents related to patent ownership and interests. According to MPEP 302, recordable documents include:

  • Assignments of patent rights
  • Security interests (e.g., liens, mortgages)
  • Licenses
  • Releases
  • Certificates of name changes
  • Mergers
  • Other documents affecting title to applications, patents, or registrations

The MPEP states: ‘Any document which relates to the title in a patent or patent application will be recorded as provided in 37 CFR 3.11.’ This broad definition allows for the recording of various ownership-related documents.

For more information on licenses, visit: licenses.

For more information on patent assignments, visit: patent assignments.

For more information on recordable documents, visit: recordable documents.

For more information on security interests, visit: security interests.

For more information on USPTO database, visit: USPTO database.

What types of documents can be recorded in the Assignment Division of the USPTO?

The Assignment Division of the USPTO records various types of documents related to patent ownership. According to MPEP 302, the following types of documents can be recorded:

  • Assignments of patents and patent applications
  • Security interests in patents and patent applications
  • Licenses that grant a security interest in patents or patent applications
  • Documents that affect title (e.g., certificates of name change, mergers, change of corporate form)
  • Liens
  • Certificates of release or discharge of security interests
  • Conditional assignments
  • Bailments

It’s important to note that the USPTO does not determine the validity of the documents submitted for recordation. As stated in MPEP 302:

‘The Assignment Division does not determine the validity of the document but rather records the document that appears to be a document affecting title.’

This means that while a wide range of documents can be recorded, it is the responsibility of the parties involved to ensure the legal validity and enforceability of the documents they submit.

For more information on Assignment Division, visit: Assignment Division.

For more information on recordable documents, visit: recordable documents.

For more information on USPTO, visit: USPTO.

What types of documents can be recorded as assignments with the USPTO?

The USPTO allows for the recording of various types of documents related to patent ownership. According to MPEP 302:

“The United States Patent and Trademark Office (USPTO) records assignments, grants, and similar instruments relating to interests in patents and applications as provided in 37 CFR Part 3.”

Types of documents that can be recorded include:

  • Assignments: Transfers of the entire right, title, and interest in a patent or application
  • Security Agreements: Documents creating a security interest in a patent or application
  • Licenses: Agreements granting rights to use or practice a patented invention
  • Releases: Documents releasing previous security interests or other encumbrances
  • Name Changes: Documents evidencing a change in the name of the owner of record
  • Mergers: Documents showing the merger of companies and the resulting transfer of patent rights

It’s important to note that the USPTO records these documents without making a determination of their validity. As stated in MPEP 302, “The recording of a document pursuant to 37 CFR 3.11 is not a determination by the USPTO of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.”

For more information on patent assignments, visit: patent assignments.

According to MPEP 314, two types of certificates are recordable for patent ownership changes:

  • Certificates showing a change of name of a business
  • Certificates showing a merger of businesses

As stated in the MPEP, Certificates issued by appropriate authorities showing a change of name of a business or a merger of businesses are recordable. These documents serve as important links in the chain of title for patent ownership.

To learn more:

The USPTO can expunge various types of assignment records that are erroneous or no longer supported by statutory basis. According to MPEP 323.01(d), this includes:

  • Erroneously recorded assignment documents
  • Documents that are not assignment documents but were incorrectly recorded as such
  • Assignment documents that are no longer supported by the statutory basis for recording

The MPEP states: ‘The USPTO will expunge, delete or correct assignment records that are not, or are no longer, supported by the statutory basis for recording.’ This broad definition allows for the correction of various types of errors in the assignment records.

To learn more:

While it’s speculative to predict the exact content of MPEP 312 if it were to be filled, its placement within the ‘300 – Ownership and Assignment’ chapter suggests it could potentially cover topics related to patent ownership, assignment procedures, or updates to existing sections in this chapter. The content would likely align with the overall theme of ownership and assignment in patent law and procedures.

For inventions made with government support, contractors must include a specific statement at the beginning of the patent application and any resulting patents. This requirement is mandated by 35 U.S.C. 202(c)(6). The statement should read:

“This invention was made with government support under (identify the contract) awarded by (identify the Federal agency). The government has certain rights in the invention.”

This statement ensures transparency regarding government involvement and rights in the invention.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

If there’s an error in the recorded assignment document (or other document affecting title) rather than in the cover sheet, the procedure differs from correcting cover sheet errors. According to MPEP 323.01(b):

  1. The party responsible for the erroneous document (e.g., the assignor) must either:
    • Create and record a new document, or
    • Make corrections to the original document and re-record it
  2. If the assignor is unavailable, the assignee may:
    • Submit an affidavit or declaration identifying the error and requesting correction
    • Include a copy of the originally recorded papers
    • Provide a new cover sheet
    • Pay the required fee for each application or patent to be corrected (37 CFR 3.41)

This process ensures that errors in the actual assignment document are properly addressed and corrected in the USPTO records.

To learn more:

If you discover that another party has improperly recorded an assignment against your patent or application, you should take the following steps:

  1. Contact the party who recorded the erroneous information and request that they file corrective papers.
  2. If the party cannot be located or is unwilling to cooperate, you must file corrective papers yourself with the Assignment Services Division.

According to MPEP 323.01(c), you should submit:

  • A completed cover sheet identifying the affected application or patent
  • An affidavit or declaration stating you are the correct owner, the previous recording was erroneous, and providing the reel and frame number of the incorrect document
  • The required fee for each application or patent to be corrected

The MPEP states: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change.

To learn more:

If you don’t have the application number when executing an assignment, you can use specific language to allow for its later insertion. MPEP 302.03 suggests the following approach: “It is suggested, however, that an assignment be written to allow entry of the identifying number after the execution of the assignment. An example of acceptable wording is: ‘I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.’” This allows for proper identification of the application once the number is available, while still executing the assignment in a timely manner.

To learn more:

Patent ownership gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent. This is stated in 35 U.S.C. 154(a)(1).

However, ownership does not necessarily give the owner the right to make, use, sell or import the invention, as there may be other legal considerations such as:

  • Existence of another patent owner with a dominant patent
  • Failure to obtain FDA approval
  • An injunction by a court
  • National security issues

Patent ownership grants the owner the right to exclude others from making, using, offering for sale, selling, or importing the patented invention into the United States. However, it’s important to note that ownership does not automatically grant the right to practice the invention. The MPEP states:

‘Ownership of a patent gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent. 35 U.S.C. 154(a)(1). Ownership of the patent does not furnish the owner with the right to make, use, offer for sale, sell, or import the claimed invention because there may be other legal considerations precluding same…’

These other considerations may include existing patents, regulatory approvals, or legal injunctions.

Patent ownership gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing the claimed invention into the United States. As stated in 35 U.S.C. 154(a)(1):

Ownership of a patent gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent.

However, it’s important to note that ownership does not automatically grant the right to practice the invention, as there may be other legal considerations such as other dominant patents, regulatory approvals, or court injunctions.

For more information on exclusionary rights, visit: exclusionary rights.

For more information on patent rights, visit: patent rights.

Joint owners of a patent have specific rights as outlined in 35 U.S.C. 262, which states:

‘In the absence of any agreement to the contrary, each of the joint owners of a patent may make, use, offer to sell, or sell the patented invention within the United States, or import the patented invention into the United States, without the consent of and without accounting to the other owners.’

This means that each joint owner can independently exercise the full rights of the patent without needing permission from or owing compensation to the other joint owners, unless they have a separate agreement stating otherwise.

USPTO employees are subject to several restrictions regarding patents:

  • They cannot apply for a patent during their employment and for one year after.
  • They cannot acquire any patent or interest in a patent, directly or indirectly, except through inheritance or bequest, during employment and for one year after.
  • For patents applied for after the one-year period, they cannot claim a priority date earlier than one year after their employment ends.

These restrictions are outlined in 35 U.S.C. 4, which states:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office. In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.’

The USPTO provides specific procedures for resubmitting returned patent documents. According to MPEP 317.01:

“The procedure set forth in § 1.8 or § 1.10 of this chapter may be used for resubmissions of returned papers to have the benefit of the date of deposit in the United States Postal Service.”

This means that when resubmitting corrected documents, you can use either the Certificate of Mailing procedure (37 CFR 1.8) or the Express Mail procedure (37 CFR 1.10) to potentially preserve the original filing date based on the postal deposit date.

To learn more:

The USPTO accepts multiple payment methods for the electronic submission of assignment documents through the Electronic Patent Assignment System (EPAS). As stated in MPEP 302.10:

“Customers may submit assignments electronically by accessing the Office’s website and paying the required fee by credit card, electronic fund transfer (EFT) or deposit account.”

These payment options provide flexibility for users when submitting assignment documents electronically. It’s important to ensure that you have one of these payment methods available before initiating the submission process.

To learn more:

When an arbitration award is made involving a patent, there are specific notice requirements as outlined in 35 U.S.C. 294(d) and 37 CFR 1.335. Key points include:

  • The patentee, assignee, or licensee must provide written notice to the USPTO Director.
  • A separate notice is required for each patent involved.
  • The notice must include names and addresses of parties, inventor name, patent owner name, patent number, and a copy of the award.
  • If the award is modified by a court, notice of the modification must also be filed.

Failure to file the required notice can result in the award being unenforceable.

An applicant who shows sufficient proprietary interest in the matter must submit a petition with their patent application, including:

  1. The fee set forth in § 1.17(g)
  2. A showing that the person has sufficient proprietary interest in the matter
  3. A statement that making the application for patent by this person on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

This requirement is outlined in 37 CFR 1.46(b)(2): If the applicant is a person who otherwise shows sufficient proprietary interest in the matter, such applicant must submit a petition including: (i) The fee set forth in § 1.17(g); (ii) A showing that such person has sufficient proprietary interest in the matter; and (iii) A statement that making the application for patent by a person who otherwise shows sufficient proprietary interest in the matter on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties.

Voluntary arbitration in patent disputes is a process outlined in 35 U.S.C. 294 where parties can agree to settle disputes related to patent validity or infringement through arbitration. The law states:

‘A contract involving a patent or any right under a patent may contain a provision requiring arbitration of any dispute relating to patent validity or infringement arising under the contract.’

This allows parties to resolve patent-related conflicts outside of the court system, potentially saving time and resources.

The USPTO does not process requests for indexing or cross-referencing additional patent numbers or application numbers against a document previously recorded in the Assignment Division, unless it’s an assignment. This policy is based on compliance with 37 CFR 3.11, 3.28, and 3.31.

As stated in MPEP 315: “The Office does not process requests for ‘indexing’ or ‘cross-referencing’ additional patent numbers or application numbers against a document, other than an assignment, previously recorded in the Assignment Division.”

For more information on Assignment Division, visit: Assignment Division.

For more information on document recording, visit: document recording.

For more information on USPTO policy, visit: USPTO policy.

What is the timeframe for recording an assignment at the USPTO?

The USPTO recommends recording an assignment within three months of its execution date. According to MPEP 302:

“The Patent and Trademark Office does not require that a document be recorded. If a document is to be recorded, it should be submitted to the Assignment Division within three months from its date of execution; otherwise, it may not be accepted for recordation.”

While there’s no strict legal requirement to record within this timeframe, doing so ensures the assignment is properly documented and can help avoid potential legal issues in the future.

For more information on assignment recording, visit: assignment recording.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

What is the significance of the issue fee payment date for patent assignments?

The issue fee payment date is crucial for patent assignments and issuance to assignees for several reasons:

  • It serves as the deadline for requesting issuance of the patent to the assignee under 37 CFR 3.81(b).
  • Assignments recorded after this date but before patent issuance will be recorded but won’t affect who the patent is issued to.
  • It impacts the USPTO’s ability to change the name on the patent.

MPEP 307 states: “If the assignment is submitted for recording after the date of payment of the issue fee, but prior to issuance of the patent, the assignment will be recorded but the patent will issue to the name of the inventor.” This underscores the importance of timely assignment recording and requests for issuance to the assignee.

For more information on assignment recording, visit: assignment recording.

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

September 16, 2012, is a significant date in patent application assignments, particularly for applications claiming the benefit of a provisional application. The MPEP states:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

This date marks a change in assignment requirements. For applications filed on or after September 16, 2012, if the assignee is the original applicant, new assignment papers may not be necessary even if the application includes subject matter not common with the provisional application. This change aligns with broader reforms introduced by the America Invents Act (AIA) that came into effect on that date.

Recording patent assignments at the United States Patent and Trademark Office (USPTO) is crucial for several reasons:

  • Legal Protection: It provides legal protection against subsequent purchasers or mortgagees.
  • Official Recognition: The USPTO recognizes the assignee for all matters before the Office.
  • Public Notice: It serves as public notice of the assignment.

According to MPEP 301:

An assignment relating to a patent must be recorded in the Patent and Trademark Office within 3 months from its date or prior to the date of a subsequent purchase or mortgage, in order to be effective against a subsequent purchaser or mortgagee.

Recording assignments promptly is essential to ensure full legal protection and recognition of ownership rights.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

Recording a patent assignment with the USPTO is crucial for several reasons:

  1. Legal Notice: It provides public notice of the assignment, which is important for establishing priority against subsequent purchasers or mortgagees.
  2. Prima Facie Evidence: As stated in MPEP 301.01, ‘The recording of an assignment with the USPTO is prima facie evidence of its execution.’
  3. Chain of Title: It helps maintain a clear chain of title for the patent or application.
  4. Enforcement Rights: Proper recording can affect the ability to enforce patent rights or collect damages in infringement cases.

The MPEP emphasizes the importance of recording by stating, ‘An assignment must be recorded in the USPTO within three months from its date or prior to the date of a subsequent purchase or mortgage to be valid against a subsequent purchaser or mortgagee.’ This underscores the time-sensitive nature of recording assignments to protect legal rights.

Keeping assignment documents separate from patent application files is significant for several reasons. MPEP 318 mandates this separation:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The significance of this practice includes:

  • Maintaining clear distinction between technical content and ownership information
  • Ensuring proper recording and indexing of assignment documents
  • Facilitating easier searches for patent ownership information
  • Reducing the risk of confidential ownership information being inadvertently disclosed
  • Allowing for more efficient management of ownership changes throughout a patent’s lifecycle
  • Enabling the Assignment Division to specialize in handling ownership matters

This separation streamlines both the patent examination process and the management of patent ownership records.

The Assignment Division plays a crucial role in handling patent assignment documents. According to MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The Assignment Division’s responsibilities include:

  • Receiving assignment documents for patents and patent applications
  • Recording these documents in the USPTO’s assignment database
  • Maintaining accurate records of patent ownership and transfers
  • Ensuring that assignment information is searchable and accessible
  • Processing requests for copies of recorded documents

By centralizing these functions, the USPTO can maintain a comprehensive and up-to-date record of patent ownership separate from the technical aspects of patent prosecution.

The Assignment Division plays a crucial role in handling patent assignments at the USPTO. As indicated in MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The Assignment Division’s responsibilities include:

  • Receiving assignment documents submitted for recording
  • Properly recording and maintaining assignment records
  • Ensuring the accuracy and accessibility of ownership information
  • Managing the assignment database separate from application and patent files

This specialized division ensures that patent ownership information is correctly documented and readily available when needed.

To learn more:

35 U.S.C. 119(e) is crucial in understanding the relationship between provisional applications and their non-provisional counterparts, particularly in terms of assignments. The MPEP § 306.01 states:

If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

This means:

  • 35 U.S.C. 119(e) allows non-provisional applications to claim the benefit of an earlier filing date from a provisional application.
  • When a non-provisional application claims this benefit and contains only subject matter from the provisional, the assignment recorded for the provisional application remains effective for the non-provisional.
  • This treatment aligns with how assignments are handled for continuations and divisions under 35 U.S.C. 120.

However, if new subject matter is introduced in the non-provisional application, different assignment rules may apply, as detailed in other parts of MPEP § 306.01.

According to MPEP 317.01, the recording date for a patent document is defined as follows:

“The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.”

This means that the recording date is established when a document that complies with all the necessary requirements is received by the United States Patent and Trademark Office (USPTO).

To learn more:

The recording date for a document at the USPTO is the date when the document meeting all recording requirements is filed with the Office. As stated in 37 CFR 3.51, “The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.” This means that all necessary criteria, including proper identification and fees, must be met for the document to be officially recorded on that date.

The recording date for a document at the USPTO Assignment Division is determined as follows:

  • It is the date when a document meeting all requirements is filed with the Office.
  • Documents not complying with identification requirements (37 CFR 3.21) will not be recorded.
  • Documents with other deficiencies (e.g., missing cover sheet or fee) will be returned for correction.
  • If corrected and resubmitted within the specified time, the original receipt date may be considered the recording date.

According to 37 CFR 3.51: “The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.”

The Mail Stop Assignment Recordation Services is a specific designation used by the USPTO to ensure proper routing and processing of assignment documents. MPEP 302.08 states:

In order to ensure prompt and proper processing, documents and their cover sheets should be addressed to the Mail Stop Assignment Recordation Services, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450, unless they are filed together with new applications.

This Mail Stop designation helps the USPTO efficiently direct assignment documents to the appropriate department for recordation, reducing processing time and potential errors in document handling.

To learn more:

Tags: USPTO

What is the purpose of the Issue Notification in the patent application process?

The Issue Notification serves as an important communication in the patent application process. According to the MPEP 308, “The Issue Notification identifies the issue date of the patent number assigned to the application.” This notification is crucial because it:

  • Informs the applicant of the official issue date of their patent
  • Provides the assigned patent number
  • Serves as confirmation that the patent will be granted
  • Helps applicants plan for any post-issuance actions or maintenance fees

The Issue Notification is typically sent several weeks before the actual issue date, giving applicants time to prepare for the patent’s publication and enforcement.

For more information on issue date, visit: issue date.

For more information on patent grant, visit: patent grant.

The cover sheet serves as a crucial document in the patent assignment process. Its primary purpose is to provide essential information about the assignment in a standardized format. According to MPEP 302.05, one of the key pieces of information that must be included on this cover sheet is the assignee’s address:

The address of the assignee … must be given in the required cover sheet.

The cover sheet ensures that the USPTO has accurate and readily accessible information about the assignment, including details about the assignee, which is critical for maintaining proper records and facilitating communication regarding the patent.

To learn more:

What is the purpose of recording patent assignment documents?

Recording patent assignment documents serves several important purposes:

  • Providing notice to the public of the assignment
  • Creating a public record of the assignment
  • Protecting against subsequent purchasers without notice
  • Establishing priority of ownership rights

According to MPEP 302, ‘The recording of an assignment document in the USPTO is not a determination of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.’ It merely serves as a public notice and record of the transaction.

For more information on patent assignment, visit: patent assignment.

For more information on recording documents, visit: recording documents.

Recording documents with the USPTO serves several important purposes:

  • Provides constructive notice to the public of the recorded document
  • Protects against subsequent purchasers or mortgagees
  • Establishes priority dates for security interests
  • Maintains a clear chain of title for patents and applications

MPEP 313 states: The recording of a document pursuant to 37 CFR 3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration. However, recording does provide legal benefits and helps maintain accurate ownership records.

For more information on chain of title, visit: chain of title.

For more information on Constructive Notice, visit: Constructive Notice.

Recording documents other than assignments at the USPTO serves several important purposes:

  • Provides public notice of the existence of the document
  • Establishes legal priority in certain situations
  • Protects the interests of parties involved in patent-related transactions
  • Facilitates the transfer and licensing of patent rights

MPEP 313 states: “The recording of such documents is not mandatory. However, if they are not recorded in the Office, they are not enforceable against a subsequent purchaser or mortgagee for valuable consideration, without notice, unless recorded in the Office prior to the subsequent purchase or mortgage.”

This highlights the importance of recording these documents to protect the interests of all parties involved in patent-related transactions.

What is the purpose of recording an assignment with the USPTO?

Recording an assignment with the USPTO serves several important purposes:

  • Constructive notice: It provides constructive notice to the public of the assignment.
  • Prima facie evidence: The recording acts as prima facie evidence of the execution of the assignment.
  • Legal protection: It protects against subsequent purchasers without notice.
  • Maintaining chain of title: It helps maintain a clear chain of title for the patent or application.

As stated in MPEP 302: “The recording of an assignment document in the USPTO is governed by statute. The statutory provision is 35 U.S.C. 261.”

For more information on assignment recording, visit: assignment recording.

For more information on USPTO, visit: USPTO.

The purpose of including the government license rights statement in patent applications is to:

  • Acknowledge the government’s support in the development of the invention
  • Inform the public and potential licensees of the government’s rights in the invention
  • Ensure compliance with federal regulations regarding inventions made with government support
  • Facilitate the government’s ability to exercise its rights in the invention if necessary

This requirement, mandated by 35 U.S.C. 202(c)(6), helps maintain transparency in federally funded research and development while protecting the government’s interests in the resulting inventions.

What is the purpose of Form PTO/AIA/96?

Form PTO/AIA/96 is used to establish the right of an assignee to take action in a patent application filed on or after September 16, 2012. According to the MPEP 325:

“Form PTO/AIA/96 may be used to establish the right of an assignee to take action in an application filed on or after September 16, 2012.”

This form is crucial for assignees who wish to prosecute the application or take other actions on behalf of the inventors. It serves as a declaration that the assignee has the right to take action in the application, which is necessary under 37 CFR 3.71(b).

For more information on assignee rights, visit: assignee rights.

For more information on USPTO Forms, visit: USPTO Forms.

Title reports play a specific role in patent reexamination procedures. The MPEP mentions:

For example, a title report is requested by the Reexamination Preprocessing Staff when a request for reexamination is filed.

This suggests that title reports are used to verify the current owner of a patent when a reexamination is initiated, ensuring that the proper parties are involved in the process.

A cover sheet is a crucial component in the patent document recording process. It provides essential information about the document being recorded and the patents or applications it relates to.

The requirement for a cover sheet is specified in 37 CFR 3.31, which states the necessary contents of a cover sheet. As mentioned in MPEP 315, a completed cover sheet is one of the required items when recording a document with additional patents or applications: “a completed cover sheet (see 37 CFR 3.31 and MPEP § 302.07)”

For more detailed information on cover sheets, refer to MPEP § 302.07.

For more information on cover sheet, visit: cover sheet.

For more information on document submission, visit: document submission.

For more information on USPTO requirements, visit: USPTO requirements.

A cover sheet is a crucial component in patent assignment recordation. It provides essential information about the document being recorded and the parties involved. According to MPEP 315, a completed cover sheet is required when submitting a document for recordation, even if the document has been previously recorded.

The cover sheet requirements are specified in 37 CFR 3.31 and further explained in MPEP § 302.07. It typically includes details such as:

  • Identification of the patents or applications the document relates to
  • Names of the parties involved in the transaction
  • Nature of the interest being conveyed
  • Mailing address for correspondence

The cover sheet helps the USPTO efficiently process and index the recorded documents in the assignment database.

While the MPEP section provided does not specifically address name changes, the process for recording a name change for patent matters with the USPTO is similar to recording other documents affecting title. Here are the general steps:

  1. Prepare a document evidencing the name change (e.g., a certificate of name change or merger document)
  2. Complete a cover sheet (Form PTO-1595 or equivalent) that includes:
    • The former name (in the space for the party conveying the interest)
    • The new name (in the space for the party receiving the interest)
    • A description of the interest conveyed as “Name Change”
    • Identification of the affected patents or applications
  3. Submit the document and cover sheet to the USPTO for recordation, along with any required fee
  4. The submission can be done electronically through EPAS, by mail, or by fax (subject to limitations)

As with other recorded documents, the USPTO will assign reel and frame numbers and add recordation stampings to the processed document.

It’s important to note that while this process records the name change, it does not update the assignee name in individual patent or application files. Separate requests may be needed to update assignee names in specific applications or patents.

Obtaining patent assignment records from before May 1, 1957, involves a different process than accessing more recent records. According to MPEP 301.01:

All records of assignments of patents recorded before May 1, 1957, are maintained by the National Archives and Records Administration (NARA). The records are open to public inspection. Certified and uncertified copies of those assignment records are provided by NARA upon request and payment of the fees required by NARA.

The MPEP further advises:

Requests for copies of pre-1957 records for patents should be directed to the National Archives and Records Administration (NARA). Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.

To obtain these records:

  1. Contact NARA directly.
  2. Provide as much information as possible about the patent and assignment you’re seeking.
  3. Be prepared to pay the fees required by NARA.

The MPEP also notes: All assignment records from 1837 to April 30, 1957 for patents are now maintained and are open for public inspection in the National Archives Research Room located at the Washington National Records Center Building, 4205 Suitland Road, Suitland, Maryland 20746 and at the Civilian Records Division of the National Archives at College Park, 8601 Adelphi Road, College Park, MD 20740-6001.

For the most up-to-date information on accessing these records, it’s recommended to check the National Archives website.

For more information on NARA, visit: NARA.

Tags: NARA

The process for issuing a patent to a non-applicant assignee involves the following steps:

  1. A request for issuance to the assignee must be submitted with the payment of the issue fee.
  2. The assignment must have been previously recorded in the USPTO or filed for recordation.
  3. If the request is submitted after the issue fee payment, additional requirements apply, including a request for a certificate of correction and associated fees.

According to 37 CFR 3.81(a): An application may issue in the name of the assignee consistent with the application’s assignment where a request for such issuance is submitted with payment of the issue fee, provided the assignment has been previously recorded in the Office.

Expungement of assignment records is a rare and complex process. According to MPEP 323.01(d), petitions to expunge assignment records are granted only under specific conditions:

  • Normal corrective procedures (outlined in MPEP § 323.01(a) through § 323.01(c)) are inadequate for providing relief.
  • The integrity of the assignment records will not be affected by granting the petition.

It’s important to note that expungement does not result in the complete removal of a document from assignment records. Instead, a redacted version of the ‘expunged’ document is recorded and replaces the original in the assignment records.

To learn more:

The process for expunging assignment records at the USPTO involves:

  • Submitting a petition under 37 CFR 1.59 to expunge the assignment record
  • Providing clear evidence that the document was submitted by mistake or is of improper character
  • Paying the required petition fee

As stated in MPEP 323.01(d): ‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’ This emphasizes the necessity of following the proper petition process for expungement.

To learn more:

To establish ownership in a patent application filed before September 16, 2012, an assignee must submit evidence to the USPTO as per pre-AIA 37 CFR 3.73(b). This can be done by either:

  • Submitting documentary evidence of a chain of title from the original owner to the assignee, along with a statement affirming that this evidence was or is being submitted for recordation.
  • Providing a statement specifying where such evidence is recorded in the USPTO (by reel and frame number).

As stated in the MPEP: The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted. This ensures that the assignee has the right to take action in the application.

For more information on assignee rights, visit: assignee rights.

For more information on pre-AIA applications, visit: pre-AIA applications.

For more information on USPTO procedures, visit: USPTO procedures.

What is the process for correcting errors in recorded assignment documents?

The process for correcting errors in recorded assignment documents involves the following steps:

  • For minor errors: You can file a corrective document stating the nature of the error, along with the required fee.
  • For more significant errors: You may need to file a new assignment document with the correct information.
  • In all cases: Include a cover sheet stating that the document is being submitted to correct an error in a previously recorded assignment document.

According to MPEP 302: Errors in a recorded assignment document will be corrected by the Assignment Division provided a ‘corrective document’ is submitted. The USPTO recommends contacting the Assignment Recordation Branch for specific guidance on your situation.

For more information on assignment correction, visit: assignment correction.

For more information on patent documents, visit: patent documents.

For more information on USPTO procedures, visit: USPTO procedures.

What is the process for correcting errors in faxed assignment documents at the USPTO?

If errors are discovered in faxed assignment documents after submission to the USPTO, the process for correction depends on the nature of the error. Here’s a general guideline:

  1. Minor Typographical Errors: These can often be corrected by submitting a request for correction along with supporting documentation.
  2. Substantive Errors: For more significant errors, a new corrected assignment document may need to be submitted and recorded.
  3. Errors in Recordation: If the error is in the USPTO’s recordation rather than the document itself, contact the Assignment Recordation Branch for assistance.

As per MPEP 302.09: “If there is an error in a cover sheet recorded with an assignment document, a corrected cover sheet may be submitted for recordation.” This indicates that for cover sheet errors, a simple correction submission is possible.

It’s important to act promptly when errors are discovered to ensure the accuracy of the assignment records. For specific guidance on your situation, it’s advisable to contact the USPTO’s Assignment Recordation Branch directly.

To learn more:

To correct assignee information on an issued patent, you must follow these steps:

  1. Submit a request for a certificate of correction under 37 CFR 1.323.
  2. Ensure that a request under 37 CFR 3.81(b) has been granted.
  3. Confirm that the assignment was submitted for recordation before the patent was issued.

According to MPEP 307: “A request for a certificate of correction under 37 CFR 1.323 (see MPEP §§ 1481 and 1485) arising from incomplete or erroneous assignee’s name furnished, or a missing assignee’s name, in item 3 of PTOL-85B will not be granted unless a request under 37 CFR 3.81(b) has been granted and the assignment was submitted for recordation as set forth in 37 CFR 3.11 before the patent issued.”

The request should be directed to the Office of Petitions and include:

  • The processing fee required by 37 CFR 1.17(i)
  • A request for issuance of the application in the name of the assignee, or a request that a patent be corrected to state the name of the assignee
  • A statement that the assignment was submitted for recordation before the patent was issued
  • A request for a certificate of correction under 37 CFR 1.323 with the associated fee

For more information on assignee information, visit: assignee information.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on Patent correction, visit: Patent correction.

For more information on USPTO procedures, visit: USPTO procedures.

The process for correcting an erroneously recorded name change is similar to correcting an erroneous assignment. According to MPEP 323.01(c), you should:

  1. Submit a completed cover sheet identifying the affected application or patent.
  2. Provide an affidavit or declaration stating:
    • You are the correct owner
    • The previously recorded document contained erroneous information
    • The reel and frame number of the incorrect document
  3. Pay the required fee for each application or patent to be corrected.

The MPEP states: On the corrected cover sheet, the owner should check the box titled ‘Other’ in the area of the cover sheet requesting the ‘Nature of Conveyance,’ and indicate that the submission is to correct an error made in a previously recorded document that erroneously affects the identified application(s), or patent(s).

Ensure that your affidavit or declaration clarifies that the name change was recorded in error and provide the correct name information.

To learn more:

To correct typographical errors in a recorded cover sheet, follow these steps as outlined in MPEP 323.01(a):

  1. Submit a copy of the originally recorded assignment document.
  2. Provide a corrected cover sheet.
  3. Pay the required fee for each application or patent to be corrected.
  4. Include a copy of the original cover sheet to facilitate comparison.

When submitting the corrected cover sheet:

  • Check the ‘Other’ box in the ‘Nature of Conveyance’ area.
  • Indicate that the submission is to correct an error in a previously recorded cover sheet.
  • Identify the reel and frame numbers (if known) and the nature of the correction.

The MPEP states: The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.

To learn more:

The mailing address for submitting assignment documents depends on whether they are being filed with new applications or not. According to MPEP 302.08:

  • For documents not filed with new applications: Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450
  • For documents filed with new applications: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450

As stated in the MPEP, In order to ensure prompt and proper processing, documents and their cover sheets should be addressed to the Mail Stop Assignment Recordation Services, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450, unless they are filed together with new applications.

To learn more:

The legal basis for the USPTO’s English translation requirement for assignments is found in the Code of Federal Regulations, specifically 37 CFR 3.26. This regulation is referenced in MPEP 302.02, which states:

37 CFR 3.26 English language requirement.

The regulation mandates that non-English documents must be accompanied by an English translation signed by the translator. This requirement ensures clarity, consistency, and accessibility of patent-related documents within the U.S. patent system.

To learn more:

Tags: patent law

The legal basis for correcting typographical errors in recorded assignment documents is primarily found in the Manual of Patent Examining Procedure (MPEP) and the Code of Federal Regulations (CFR). Specifically:

  • MPEP 323.01(b) outlines the procedures for correcting such errors.
  • 37 CFR 3.41 provides the regulatory basis for the fees associated with these corrections.

Additionally, case law supports these procedures. The MPEP cites:

See In re Abacab International Computers Ltd., 21 USPQ2d 1078 (Comm’r Pat. 1987).

This case reinforces the USPTO’s authority to correct such errors and the procedures for doing so. The combination of statutory regulations, administrative procedures, and case law provides a comprehensive legal framework for addressing typographical errors in recorded assignment documents.

To learn more:

Timely recording of patent assignments is crucial for protecting rights against subsequent purchasers. As per 35 U.S.C. 261:

“if an assignment is not timely recorded at the USPTO, the unrecorded assignment will not be superior to the rights acquired by a third party, i.e. a bona fide purchaser, for valuable consideration if that third party did not have knowledge of the unrecorded assignment.”

This provision emphasizes the importance of promptly recording assignments to maintain priority over subsequent purchasers who may not have knowledge of the unrecorded assignment.

To learn more:

The government license rights statement required for contractor-owned inventions made under federally sponsored research and development is:

‘This invention was made with government support under (identify the contract) awarded by (identify the Federal agency). The government has certain rights in the invention.’

This statement is mandated by 35 U.S.C. 202(c)(6) and must be included at the beginning of the patent application and any issued patents.

The fee for recording documents with the USPTO varies depending on the method of submission and the type of intellectual property involved. According to MPEP 302.06:

For patents:

  • If submitted electronically: $0 (as of 2019)
  • If submitted on paper or via facsimile: Fee set in 37 CFR 1.21(h)(2)

For trademarks:

The MPEP advises: Customers should check the current fee schedule on the Office website before submitting documents for recordation.

To learn more:

The fee for recording a patent assignment with the USPTO depends on the method of submission:

  • For electronic submissions through the Electronic Patent Assignment System (EPAS), the fee is currently $0, as stated in 37 CFR 1.21(h)(1).
  • For non-electronic submissions (e.g., mail or fax), the fee is set forth in 37 CFR 1.21(h)(2).

It’s important to note that fees may change over time. As stated in MPEP 302.06: “Customers should check the current fee schedule on the Office website before submitting documents for recordation.”

Additionally, no fee is required for recording certain government interest documents, as specified in 37 CFR 3.41(b).

The fee for recording a corrective document or substitute statement with the USPTO is the same as the fee for recording the original assignment document. MPEP 323 states:

“The fee for recording a corrective document or substitute statement is the same as the fee for recording the original assignment document.”

As of 2023, the fee for recording an assignment electronically is $25 per property. However, fees are subject to change, so it’s advisable to check the current USPTO Fee Schedule for the most up-to-date information.

For more information on assignment correction, visit: assignment correction.

For more information on USPTO fees, visit: USPTO fees.

Recording an assignment at the USPTO does not determine its validity or effect on title. As stated in 37 CFR 3.54:

“The recording of a document pursuant to § 3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.”

The USPTO may, when necessary, determine the effect of a document and whether a party has authority to take action in matters pending before the Office.

To learn more:

Recording a patent assignment with the USPTO has specific legal effects. The MPEP states:

‘Recordation of the assignment provides legal notice to the public of the assignment.’

However, it’s important to note that:

‘It should be noted that recording of the assignment is merely a ministerial act; it is not an Office determination of the validity of the assignment document or the effect of the assignment document on the ownership of the patent property.’

This means that while recordation provides public notice, it does not guarantee the validity or enforceability of the assignment. The MPEP cites 37 CFR 3.54 and Realvirt, LLC v. Lee, 195 F.Supp.3d 847, 862-3 (E.D. Va. 2016) for this principle.

Recording a document at the USPTO has the following effects:

  • It does not determine the validity of the document or its effect on title.
  • The Office may determine a document’s effect when necessary for Office proceedings.
  • Conditional assignments are treated as absolute assignments until canceled.
  • Recording provides protection against subsequent purchasers without notice.

37 CFR 3.54 states: The recording of a document pursuant to §3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.

Additionally, according to 35 U.S.C. 261, timely recording at the USPTO is crucial for maintaining superiority of rights against subsequent purchasers.

For more information on document recording, visit: document recording.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO procedures, visit: USPTO procedures.

An arbitration award in patent cases has limited effect and is binding only on the parties involved in the arbitration. This limitation is clearly stated in 35 U.S.C. 294(c):

“An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person.”

This means that:

  • The arbitration award is conclusive for the parties involved in the dispute.
  • Third parties not involved in the arbitration are not bound by the award.
  • The award does not affect the rights of individuals or entities who were not part of the arbitration proceedings.

This provision ensures that the rights of third parties are protected and that arbitration outcomes do not have unintended consequences on uninvolved parties in patent matters.

The key difference in assignment between division/continuation applications and substitute/continuation-in-part (CIP) applications lies in how prior assignments are applied:

  • Division/Continuation Applications: Prior assignments recorded against the original application automatically apply to these applications. As stated in MPEP 306: In the case of a division or continuation application, a prior assignment recorded against the original application is applied (effective) to the division or continuation application because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.
  • Substitute/CIP Applications: Prior assignments do not automatically apply. MPEP 306 states: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This difference is due to the nature of these application types. Division and continuation applications contain only subject matter from the original application, while substitute and CIP applications may contain new subject matter not present in the original application.

What is the difference between recording and registering a patent assignment?

Recording and registering a patent assignment are two distinct processes:

  • Recording refers to submitting the assignment document to the USPTO for public notice. As stated in MPEP 302, ‘The recording of the assignment document in the USPTO is merely a ministerial act and does not determine the validity of the document.’
  • Registering is not a term used by the USPTO for assignments. The term ‘registration’ is typically used for trademarks, not patents.

Recording an assignment provides constructive notice of the transfer of ownership but does not guarantee the assignment’s validity or enforceability.

For more information on ownership transfer, visit: ownership transfer.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

What is the difference between recording an assignment and registering a trademark?

Recording an assignment for a patent or trademark application is different from registering a trademark. Here are the key distinctions:

  • Recording an assignment: This process involves documenting the transfer of ownership rights for a patent or trademark application. It’s done through the USPTO’s Assignment Recordation Branch.
  • Registering a trademark: This is the process of officially registering a trademark with the USPTO to protect your brand identity. It’s handled by the Trademark Office.

As stated in MPEP 302: “The recording of assignments is governed by 35 U.S.C. 261 for patents and 15 U.S.C. 1060 for trademarks.” This indicates that assignment recording is a separate process from trademark registration, which is governed by different statutes.

For more information on assignment recording, visit: assignment recording.

For more information on USPTO procedures, visit: USPTO procedures.

What is the difference between recording a license and an assignment at the USPTO?

The main difference between recording a license and an assignment at the USPTO lies in the transfer of ownership rights:

  • Assignment: Transfers ownership of the patent or application to another party.
  • License: Grants permission to use the patent or application without transferring ownership.

According to MPEP 313: Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11(a). This includes licenses, which are recorded to provide notice of the agreement but do not change the ownership records at the USPTO.

The America Invents Act (AIA) brought significant changes to patent law, including rules regarding patent ownership. The key differences between pre-AIA (before September 16, 2012) and AIA (on or after September 16, 2012) patent ownership rules are:

  1. Applicability: Pre-AIA rules apply to applications filed before September 16, 2012, while AIA rules apply to applications filed on or after that date.
  2. Juristic Entity Representation: Under AIA rules, juristic entities (e.g., corporations) must be represented by a patent practitioner for most actions. Pre-AIA rules allowed juristic entities to take certain actions without representation.
  3. Ownership Establishment: The process for establishing ownership is slightly different, with AIA applications following 37 CFR 3.73 and pre-AIA applications following pre-AIA 37 CFR 3.73(b).
  4. Inventor’s Oath or Declaration: AIA introduced changes to the inventor’s oath or declaration requirements, which can affect how assignees interact with the patent application process.

According to MPEP 324: [Editor Note: See MPEP § 325 for establishing the right of assignee to take action in an application filed on or after September 16, 2012.] This indicates that different sections of the MPEP should be consulted depending on the application’s filing date.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

What is the difference between pre-AIA and AIA applications regarding assignee filing?

The key difference between pre-AIA (America Invents Act) and AIA applications regarding assignee filing lies in the requirements for establishing the right of an assignee to take action:

  • Pre-AIA applications (filed before September 16, 2012): The assignee must establish their right to take action by filing evidence of ownership in the USPTO.
  • AIA applications (filed on or after September 16, 2012): The assignee can simply be named as the applicant, eliminating the need to file evidence of ownership.

As stated in MPEP 324: “For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of an application for an original patent, and any patent that may issue therefrom, unless there is an assignment.”

For more information on pre-AIA, visit: pre-AIA.

Tags: pre-AIA

Patent assignment and licensing are two different ways of transferring patent rights. The MPEP defines assignment as:

‘Assignment of patent rights is defined as ‘a transfer by a party of all or part of its right, title and interest in a patent [or] patent application….”

In contrast, licensing is described as:

‘As compared to assignment of patent rights, the licensing of a patent transfers a bundle of rights which is less than the entire ownership interest, e.g., rights that may be limited as to time, geographical area, or field of use.’

The key difference is that assignment transfers ownership, while licensing grants permission to use the patent without transferring ownership.

The process for correcting errors differs depending on whether the error is in the cover sheet or the actual assignment document:

  • Cover sheet corrections: These are for errors in the recorded data only, not in the assignment document itself. You can submit a corrective document referencing the reel and frame number of the original recording.
  • Assignment document corrections: For errors in the actual assignment document, you must record a new corrective document, which can be a new assignment or another document that corrects the original.

MPEP 323 states: “Errors in the assignment document itself cannot be corrected simply by submitting a new cover sheet.” This emphasizes the need for a new recorded document for substantive errors.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The MPEP distinguishes between assignments and licenses in patent law:

  1. Assignment: ‘An assignment of a patent, or patent application, is the transfer to another of a party’s entire ownership interest or a percentage of that party’s ownership interest in the patent or application.’
  2. License: ‘As compared to assignment of patent rights, the licensing of a patent transfers a bundle of rights which is less than the entire ownership interest, e.g., rights that may be limited as to time, geographical area, or field of use.’

The key difference is that an assignment transfers ownership, while a license grants permission to use the patent without transferring ownership. The MPEP further clarifies: ‘A patent license is, in effect, a contractual agreement that the patent owner will not sue the licensee for patent infringement if the licensee makes, uses, offers for sale, sells, or imports the claimed invention, as long as the licensee fulfills its obligations and operates within the bounds delineated by the license agreement.’

An assignment and a 37 CFR 3.73(c) statement serve different purposes in the patent application process:

  • Assignment: This is the actual transfer of ownership rights from the inventor(s) to the assignee.
  • 37 CFR 3.73(c) statement: This is a document filed with the USPTO to establish the assignee’s right to take action in a patent application.

As stated in MPEP 325: “The submission of the statement pursuant to 37 CFR 3.73(c) is not required if a 37 CFR 3.73(b) statement has been previously filed in the application or patent prior to September 16, 2012.” This highlights that the 3.73(c) statement is a procedural document for USPTO purposes, while the assignment is the substantive transfer of rights.

For more information on USPTO procedures, visit: USPTO procedures.

The key differences between a patent assignment and a patent license are:

  • Assignment: Transfers all or part of the ownership interest in a patent, including the entire bundle of rights associated with ownership.
  • License: Transfers a bundle of rights that is less than the entire ownership interest. It may be limited in time, geographical area, or field of use.

A license is essentially a contractual agreement that the patent owner will not sue the licensee for patent infringement under certain conditions. Even an exclusive license is not considered an assignment of patent rights.

The key differences between a ‘corrective document’ and a ‘substitute statement’ for USPTO assignments are:

  • Corrective Document: Used to fix minor errors in the original recorded document.
  • Substitute Statement: Replaces the entire original document when substantial changes are needed.

According to MPEP 323: “Where errors were made in the execution of the original assignment document … a ‘substitute statement’ may be submitted for recordation.” The MPEP further clarifies: “The substitute statement must be accompanied by a copy of the originally recorded papers.”

For more information on assignment correction, visit: assignment correction.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

The USPTO maintains two special registers for recording certain government interests in patents and patent applications, as outlined in 37 CFR 3.58:

  1. Departmental Register: This register records governmental interests required by Executive Order 9424. It is not open to public inspection but can be examined by authorized government representatives. However, governmental interests recorded on this register are available for public inspection as provided in 37 CFR 1.12.
  2. Secret Register: This register is used to record governmental interests that require secrecy. Documents are placed on this register at the request of the submitting department or agency. Access to this register is highly restricted and requires written authority from the head of the department or agency that submitted the document, as well as approval from the USPTO Director.

These registers ensure that certain sensitive government interests in patents can be recorded while maintaining appropriate levels of confidentiality or secrecy.

The deadline for submitting assignee information for patent issuance is crucial to ensure the information appears on the patent. According to MPEP 307:

The submission of the request in compliance with 37 CFR 3.81(b) must be made prior to, or at the same time as, the payment of the issue fee.

This means that assignees must submit their information no later than when the issue fee is paid. It’s important to note that:

  • Late submissions may result in the assignee data not being included on the patent
  • The USPTO will not delay issuance of the patent to accommodate late submissions
  • Correcting assignee information after issuance requires a certificate of correction, which may involve additional fees and procedures

To avoid complications, it’s recommended to submit the assignee information as early as possible in the patent issuance process, ensuring compliance with 37 CFR 3.81(b).

For more information on assignee information, visit: assignee information.

For more information on patent issuance, visit: patent issuance.

The date of receipt for assignment documents sent to the USPTO by fax is determined by when the complete transmission is received. According to MPEP 302.09:

The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.

It’s important to note that the benefits of a certificate of transmission under 37 CFR 1.8 are available for fax submissions. This can provide additional protection in case of transmission issues.

For more information on date of receipt for electronic submissions, you can refer to MPEP § 502.01.

To learn more:

As of the 2019 update to MPEP 302.06, the fee for electronically submitting a patent document for recordation is $0. The MPEP states:

If the request to record a document is submitted electronically, the fee is set forth in 37 CFR 1.21(h)(1), currently at $0.

This $0 fee for electronic submissions is a significant cost-saving measure for patent applicants and owners. However, it’s important to note that fees can change, and the MPEP advises:

Customers should check the current fee schedule on the Office website before submitting documents for recordation.

Always verify the current fees on the USPTO fee schedule before submitting any documents.

To learn more:

The correct procedure for submitting assignment documents to the USPTO involves sending them to the Assignment Division for recording, rather than placing them directly in application or patent files. MPEP 318 clearly states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This process ensures that assignment documents are properly recorded and maintained by the appropriate division within the USPTO.

To learn more:

To establish ownership for an assignee to take action in a patent application filed before September 16, 2012, the following is required:

  • The assignee must submit documentary evidence of a chain of title from the original owner to the assignee, or a statement specifying where such evidence is recorded in the USPTO assignment records.
  • A statement affirming that the documentary evidence was or is being submitted for recordation.
  • The submission must be signed by a person authorized to act on behalf of the assignee.

This is outlined in pre-AIA 37 CFR 3.73(b), which states:

“In order to request or take action in a patent or trademark matter, the assignee must establish its ownership of the patent or trademark property of paragraph (a) of this section to the satisfaction of the Director. The establishment of ownership by the assignee may be combined with the paper that requests or takes the action. Ownership is established by submitting to the Office a signed statement identifying the assignee, accompanied by either: (i) Documentary evidence of a chain of title from the original owner to the assignee (e.g., copy of an executed assignment). For patent matters only, the submission of the documentary evidence must be accompanied by a statement affirming that the documentary evidence of the chain of title from the original owner to the assignee was or concurrently is being submitted for recordation pursuant to § 3.11; or (ii) A statement specifying where documentary evidence of a chain of title from the original owner to the assignee is recorded in the assignment records of the Office (e.g., reel and frame number).”

According to 35 U.S.C. 261, patents have the attributes of personal property and are assignable by an instrument in writing. Specifically, the statute states:

‘Subject to the provisions of this title, patents shall have the attributes of personal property. […] Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing.’

This means that patent owners can transfer their rights to others through written assignments, similar to other forms of property.

PALM stands for Patent Application Locator and Monitoring system. While MPEP 303 doesn’t provide a definition, it mentions PALM in the context of assignment information:

“…it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

PALM is an internal USPTO database system used by patent examiners to access and track information about patent applications, including assignment details. It’s a crucial tool for examiners when they need to verify ownership or resolve conflicts related to patent applications.

MPEP 319 is currently a reserved section in the Manual of Patent Examining Procedure (MPEP). The content of this section is marked as ‘[Reserved]’, which means that there is no specific information or guidance provided in this particular section at this time.

Joint ownership of a patent occurs when multiple parties together own the entire right, title, and interest of the patent property. This can happen in several scenarios:

  • Multiple partial assignees of the patent property
  • Multiple inventors who have not assigned their rights
  • A combination of partial assignee(s) and inventor(s) who have not assigned their rights

In cases of joint ownership, all parties having any portion of the ownership must act together as a composite entity in patent matters before the USPTO. According to 35 U.S.C. 262, in the absence of any agreement to the contrary, each joint owner may make, use, offer to sell, or sell the patented invention within the United States without the consent of and without accounting to the other owners.

Indexing against a recorded certificate refers to the process of associating additional patent numbers or application numbers with a document that has already been recorded in the USPTO’s Assignment Division. However, the USPTO does not process such requests for ‘indexing’ or ‘cross-referencing’ unless a new submission is made.

According to MPEP 315, The Office does not process requests for ‘indexing’ or ‘cross-referencing’ additional patent numbers or application numbers against a document, other than an assignment, previously recorded in the Assignment Division.

Executive Order 9424, issued in 1944, mandates the recording of certain government interests in patent rights. The MPEP references this order in the context of USPTO document recording:

In addition to assignments and documents required to be recorded by Executive Order 9424, upon request, assignments of applications, patents, and registrations, and other documents relating to interests in patent applications and patents will be recorded in the Office.

This means that while Executive Order 9424 requires the recording of specific government-related documents, the USPTO’s recording practices extend beyond these requirements. The USPTO will record various documents related to patent interests upon request, as outlined in 35 U.S.C. 261 and 37 CFR 3.11.

For more information on Executive Order 9424, you can refer to the National Archives.

For more information on government interests, visit: government interests.

For more information on patent rights, visit: patent rights.

For patent applications filed before September 16, 2012 (pre-AIA), proper documentary evidence for establishing assignee rights typically includes:

  • An assignment document recorded in the USPTO
  • A statement under 37 CFR 3.73(b) signed by a party authorized to act on behalf of the assignee

According to MPEP 324: The submission establishing ownership must show that the person signing the submission is a person authorized to act on behalf of the assignee by:

  1. (A) Including a statement that the person signing the submission is authorized to act on behalf of the assignee; or
  2. (B) Being signed by a person having apparent authority to sign on behalf of the assignee, e.g., an officer of the assignee.

It’s crucial that the documentary evidence clearly shows the chain of title from the original owner to the current assignee. This ensures that the USPTO can verify the assignee’s right to take action in the application.

For more information on assignee rights, visit: assignee rights.

For more information on chain of title, visit: chain of title.

For more information on documentary evidence, visit: documentary evidence.

For more information on pre-AIA applications, visit: pre-AIA applications.

An extract of an original document refers to a portion or summary of the original assignment document that contains the essential information required for recording. Both 37 CFR 3.24(a) and (b) state that “Either a copy of the original document or an extract of the original document may be submitted for recording.”

When submitting an extract:

  • Ensure it includes all relevant assignment details.
  • The extract must meet the same format requirements as a full copy.
  • It should be clear that the extract represents the key elements of the original document.

Using an extract can be beneficial when the original document contains confidential information not necessary for the assignment record.

An ‘assignment-statement’ is a relatively new concept in patent law, introduced for applications filed on or after September 16, 2012. The MPEP explains:

‘For applications filed under 35 U.S.C. 111(a), 363, or 385 on or after September 16, 2012, an assignment may contain the statements required to be made in an oath or declaration (‘assignment-statement’), and if the assignment is made of record in the assignment records of the Office, then the assignment may be utilized as the oath or declaration.’

This means that for qualifying applications, the assignment document can serve a dual purpose:

  1. Transferring ownership of the patent application
  2. Fulfilling the requirement for an oath or declaration

This provision can simplify the application process by combining two previously separate documents. The MPEP cites 35 U.S.C. 115(e), 37 CFR 1.63(e), and MPEP §§ 302.07, 317, and 602.01(a) for further details on this practice.

A title report in patent law is a form used by the Assignment Division of the USPTO to report the name of the owner of an application or patent as shown by their records on a specific date. According to the MPEP:

The “title report” is a form which can be used under certain circumstances by the Assignment Division to report to someone within the Office the name of the owner of an application or patent as shown by the Assignment Division records on the date the title report is made.

These reports are used internally within the USPTO and are not available for direct request by applicants or attorneys.

A domestic representative is a person residing within the United States who can be served process or notice of proceedings affecting a patent or rights thereunder on behalf of a foreign assignee. According to MPEP 302.04, An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative. This allows foreign assignees to have a point of contact within the U.S. for legal matters related to their patent.

To learn more:

A certified abstract of title is a document that provides official information about the ownership of a patent or patent application. Unlike title reports, which are for internal USPTO use, certified abstracts of title can be requested by the public. The MPEP states: The public can request a certified abstract of title. The fee for this service is set forth at 37 CFR 1.19(b)(4). This document provides a certified summary of the assignment records for a specific patent or application.

For more information on certified abstract of title, visit: certified abstract of title.

For more information on public records, visit: public records.

For more information on USPTO, visit: USPTO.

What is a ‘subject invention’ in the context of government-funded research?

A ‘subject invention’ is a term used in government contracts and refers to any invention conceived or first actually reduced to practice in the performance of work under a government contract. According to MPEP 310, ‘The term ‘subject invention’ is defined by 35 U.S.C. 201(e) as any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement.’ This definition is crucial for determining the government’s rights in inventions made during federally sponsored research.

For more information on federal funding, visit: federal funding.

For more information on patent rights, visit: patent rights.

A corrective document is a filing used to address errors in recorded assignment documents at the USPTO. According to MPEP 323:

‘The ‘corrective document’ (or if one of the documents is not being re-recorded, a copy of the original) should be recorded as a supporting document, and all documents will be examined.’

Corrective documents are used for:

  • Minor typographical errors
  • More substantial errors like incorrect names or addresses

When filing a corrective document, it’s important to clearly identify the nature of the correction and reference the original recorded document.

For more information on assignment correction, visit: assignment correction.

For more information on USPTO, visit: USPTO.

A ‘chain of title’ in patent ownership refers to the documented history of a patent’s ownership from its original assignment to its current owner. MPEP 314 mentions this concept in relation to name changes and mergers:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title. Documents of merger are also proper links in the chain of title.

The chain of title includes:

  • Original patent assignment
  • Subsequent transfers of ownership
  • Business name changes
  • Mergers and acquisitions
  • Any other events affecting patent ownership

Maintaining a clear and unbroken chain of title is crucial for establishing ownership rights, facilitating patent transactions, and providing clarity in potential patent litigation.

37 CFR 3.27 is a federal regulation that specifies the mailing address for submitting documents to be recorded at the USPTO. According to MPEP 302.08:

37 CFR 3.27 sets out how documents submitted for recording should be addressed to the Office.

This regulation ensures that assignment documents and other recordable documents are sent to the correct address for proper processing. It’s crucial for patent attorneys, inventors, and anyone submitting assignment documents to follow this regulation to avoid delays or misrouting of important legal documents.

To learn more:

To learn more:

When the USPTO’s Assignment Division returns assignment documents or cover sheets, they include specific information to help you understand the status and next steps. According to MPEP 317.02:

“Assignment documents and cover sheets, or copies of the same, which are returned by Assignment Division will be stamped with the original date of receipt by the Office and will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

In summary, you will receive:

  • The original documents or copies, stamped with the original receipt date
  • An accompanying letter specifying:
    • The reason for the return
    • Instructions for correction
    • The deadline for resubmission
    • Information about maintaining the original receipt date as the recording date

It’s crucial to carefully review this information and act promptly to meet the specified deadline for resubmission.

To learn more:

When correcting an erroneous assignment, the affidavit or declaration submitted to the USPTO should contain specific information. According to MPEP 323.01(c), the affidavit should include:

  • Identification of yourself as the correct owner
  • A statement that the previously recorded document was submitted with erroneous information
  • The reel and frame number of the previously recorded document
  • A summary of the true chain of title
  • A statement that the original applicant, patentee, or last correct assignee has been and continues to be the owner of the application or patent at issue

The MPEP specifically states: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change, and a statement that the original applicant or patentee or last correct assignee has been, and continues to be, the owner of the application, or patent at issue.

To learn more:

According to 37 CFR 3.61, the designation of a domestic representative should include:

  • The name of the person residing within the United States
  • The address of the designated person
  • A statement that this person may be served process or notice of proceedings affecting the application, patent or registration or rights thereunder

As stated in the regulation, The designation should state the name and address of a person residing within the United States on whom may be served process or notice of proceedings affecting the application, patent or registration or rights thereunder. This information ensures that the USPTO and other parties can effectively communicate with the foreign assignee through their designated representative.

To learn more:

An assignment cover sheet must include specific information to be accepted by the USPTO. According to MPEP 302.07, the cover sheet must contain:

  • The name of the party conveying the interest
  • The name and address of the party receiving the interest
  • A description of the interest conveyed or transaction to be recorded
  • Identification of the interests involved (e.g., patent number, application number)
  • The name and address of the party to whom correspondence concerning the request to record the document should be mailed
  • The date the document was executed
  • The signature of the party submitting the document

It’s crucial to provide all required information accurately to ensure the assignment is properly recorded.

To learn more:

When an application is filed by someone other than the inventor under 35 U.S.C. 111, it must contain specific information as outlined in 37 CFR 1.46(b):

  • An application data sheet under § 1.76
  • In the applicant information section (§ 1.76(b)(7)), specify:
    • The assignee
    • Person to whom the inventor is under an obligation to assign the invention
    • Person who otherwise shows sufficient proprietary interest in the matter

The regulation states: If an application under 35 U.S.C. 111 is made by a person other than the inventor under paragraph (a) of this section, the application must contain an application data sheet under § 1.76 specifying in the applicant information section (§ 1.76(b)(7)) the assignee, person to whom the inventor is under an obligation to assign the invention, or person who otherwise shows sufficient proprietary interest in the matter.

According to 37 CFR 1.335(a), a notice of arbitration award filed with the USPTO must include the following information:

  • Patent number
  • Names of the inventor and patent owner
  • Names and addresses of the parties to the arbitration
  • A copy of the arbitration award

The regulation states: “The notice must set forth the patent number, the names of the inventor and patent owner, and the names and addresses of the parties to the arbitration. The notice must also include a copy of the award.”

This detailed information ensures that the USPTO has a complete record of the arbitration outcome and its relevance to specific patents.

For more information on Patent Information, visit: Patent Information.

A patent title report contains crucial information about the ownership and status of a patent application or patent. While the MPEP Section 320 does not provide an exhaustive list, based on its context and purpose, a title report typically includes:

  • The names of the current owner(s) or assignee(s)
  • Any recorded assignments or transfers of ownership
  • The date of the most recent assignment
  • Information about the inventors
  • The application or patent number
  • Any liens or security interests recorded against the patent

This information helps ensure that all parties involved in the patent process are aware of the current ownership status and can act accordingly.

When recording documents with the USPTO, a cover sheet must accompany the document. The cover sheet should include:

  • Name of the conveying party
  • Name and address of the receiving party
  • Application number, patent number, or registration number
  • Name of the inventor (for patent documents)
  • Title of the invention (for patent documents)
  • Document date
  • Nature of the interest being conveyed
  • Assignee AIA (first inventor to file) statement

MPEP 313 states: Each document submitted for recording must be accompanied by a cover sheet… The format for the cover sheet is specified by the Office. Ensure all required information is provided to facilitate proper recording of the document.

For more information on cover sheet, visit: cover sheet.

For more information on document submission, visit: document submission.

To identify a national patent application in an assignment, you must use the application number. MPEP 302.03 states: “An assignment relating to a national patent application must identify the national patent application by the application number (consisting of the series code and the serial number; e.g., 07/123,456).” This format ensures accurate identification of the specific application being assigned.

To learn more:

Accessing assignment records for unpublished patent applications requires specific authorization or a showing of legitimate interest. According to MPEP 301.01, for applications that are not open to the public:

Information related thereto is only obtainable upon a proper showing of written authority. For applications filed on or after September 16, 2012, the written authority must be from (A) an inventor, (B) an applicant, (C) the assignee or an assignee of an undivided part interest, (D) a patent practitioner of record, or (E) a person with written authority from (A), (B), or (C) or (D).

For applications filed before September 16, 2012, the requirements are slightly different:

For applications filed prior to September 16, 2012, the written authority must be from the applicant or applicant’s assignee or from the attorney or agent of either, or upon a showing that the person seeking such information is a bona fide prospective or actual purchaser, mortgagee, or licensee of such application.

If you’re not one of these authorized parties, you may still be able to access the records if you can demonstrate that you are a bona fide prospective or actual purchaser, mortgagee, or licensee of the application. This typically requires submitting a petition with the appropriate fee and evidence of your status.

For more information on unpublished applications, visit: unpublished applications.

USPTO patent assignment records contain valuable information about the ownership and transfer of patent rights. According to MPEP 301.01, these records include:

  • Reel and frame number of the recordation
  • Name of the conveying party (assignor)
  • Name and address of the receiving party (assignee)
  • Patent or application number
  • Date of execution
  • Date of recordation

The MPEP further states: The actual assignment document will not be viewable through Assignment Search. Only the bibliographic information contained in the recorded cover sheet will be viewable from the Assignment Search database.

This information helps track the chain of title for patents and applications, which is crucial for determining current ownership and potential licensing opportunities.

What information is available in the USPTO’s assignment database?

The USPTO’s assignment database contains a wealth of information related to patent ownership. According to MPEP 301.01:

‘The USPTO maintains a database containing the assignment records of patents and patent applications. The USPTO also maintains a cumulative index of number of assignments recorded on the day in which they are recorded.’

The database typically includes:

  • Patent or application numbers
  • Names of assignors and assignees
  • Dates of assignment execution and recording
  • Brief descriptions of the interests conveyed
  • Reel and frame numbers for locating documents

This information is crucial for determining the current ownership status of patents and applications, which is essential for various legal and business purposes.

If the assignor is not available to correct an original document or execute a new one, the assignee has an alternative option. According to MPEP 323.01(b):

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction.

To complete this process, the assignee must provide:

  • An affidavit or declaration identifying the error and requesting correction
  • A copy of the originally recorded papers
  • A cover sheet
  • The required fee for each application or patent to be corrected (as per 37 CFR 3.41)

To learn more:

If you need to assign a patent application before it’s filed, you must identify it using specific information. MPEP 302.03 states: “If an assignment of a patent application filed under § 1.53(b) of this chapter is executed concurrently with, or subsequent to, the execution of the patent application, but before the patent application is filed, it must identify the patent application by the name of each inventor and the title of the invention so that there can be no mistake as to the patent application intended.” This ensures that the correct application is associated with the assignment, even without an application number.

To learn more:

According to MPEP 317, original documents submitted to the USPTO Assignment Division are handled as follows:

After filming, the documents are returned to the sender or destroyed.

This means that once the Assignment Division has processed and recorded the documents, the original physical copies are not retained by the USPTO. If you need a copy of a recorded document, you can request a certified copy from the USPTO for a fee.

For more information on Assignment Division, visit: Assignment Division.

For more information on Document retention, visit: Document retention.

For more information on Original documents, visit: Original documents.

For more information on USPTO, visit: USPTO.

Documents and cover sheets submitted for recording at the USPTO Assignment Division are examined for formal requirements. The process is as follows:

  • Documents that meet the requirements are recorded.
  • Documents that do not meet the requirements are returned to the sender with an explanation.
  • If the sender disagrees with the rejection, they can petition the Director under 37 CFR 1.181.
  • After successful recording, a notification is sent to the address on the cover sheet, showing the reel and frame number.

As stated in MPEP 317: “All documents and cover sheets submitted for recording are examined for formal requirements in the Assignment Division in order to separate documents which are recordable from those which are not recordable.”

What happens to conditional assignments at the USPTO?

Conditional assignments are treated differently by the USPTO’s Assignment Division. The MPEP 317 states:

“Conditional assignments are returned to the sender by the Assignment Division.”

This means that if an assignment includes conditions that must be met before it becomes effective, the USPTO will not record it. Instead, the Assignment Division will return the document to the sender. It’s important for patent applicants and owners to ensure that any assignments submitted for recording are unconditional to avoid delays in processing.

For more information on Assignment Division, visit: Assignment Division.

For more information on conditional assignments, visit: conditional assignments.

For more information on USPTO procedures, visit: USPTO procedures.

When a petition to ‘expunge’ a document is granted, the document is not completely removed from the USPTO assignment records. According to MPEP 323.01(d):

Even if a petition to ‘expunge’ a document is granted with respect to a particular application or patent, the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number, and the image will appear when someone views that reel and frame number.

However, the USPTO takes steps to limit the visibility of the expunged document:

  • Links to the application or patent subject to the petition are deleted.
  • The document won’t appear in searches for that application or patent number in the Assignment Historical Database.
  • A redacted version of the ‘expunged’ document is recorded and appears in the assignment records instead of the original document.

To learn more:

What happens if there’s an error in the patent grant?

Errors in patent grants are addressed through a specific process outlined in MPEP 308. The manual states:

“If the Office discovers that an error exists in the patent grant, the patentee will be notified and required to submit a request for a certificate of correction.”

This process involves the following steps:

  • The USPTO identifies an error in the issued patent
  • The patentee is notified of the error
  • The patentee must submit a request for a certificate of correction
  • The USPTO issues a certificate of correction to rectify the error

It’s important to note that the certificate of correction becomes part of the patent and is treated as such for all purposes. Patentees should carefully review their patent grants upon receipt to identify any errors promptly and initiate the correction process if necessary.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on Patent correction, visit: Patent correction.

For more information on USPTO procedures, visit: USPTO procedures.

If there’s an error in your assignment submission, the USPTO will notify you and provide an opportunity to correct the issue. The process differs slightly depending on the submission method:

  • For fax submissions: The USPTO will fax back the entire document, cover sheet, and a “Notice of Non-Recordation” explaining the issue.
  • For electronic (EPAS) submissions: The USPTO will attempt to fax the notice back. If faxing isn’t possible, they may use other means to notify you.

As stated in MPEP 302.09: “If a document submitted by fax is determined not to be recordable, the entire document, with its associated cover sheet, and the Office ‘Notice of Non-Recordation’ will be transmitted via fax back to the sender.”

To correct the error:

  1. Make the necessary corrections to the document or cover sheet
  2. Resubmit the corrected document by mail to the address in 37 CFR 3.27
  3. Timely resubmission may allow you to retain the initial receipt date as the recordation date

Always double-check your submissions for accuracy to avoid delays in recording your assignment.

What happens if there’s an error in a recorded assignment document?

If an error is discovered in a recorded assignment document, it can be corrected through a Certificate of Correction. The MPEP 302 provides guidance on this process:

“Errors in a recorded assignment document will be corrected by the Assignment Division provided a ‘corrective document’ is submitted. The ‘corrective document’ must include the following: … [list of requirements]”

To correct an error, you need to submit:

  • A copy of the original assignment document with the error
  • A ‘corrective document’ explaining the nature of the error and the desired correction
  • New recordation fee for processing the correction

It’s important to address errors promptly to ensure accurate ownership records. The USPTO will review the correction request and update the assignment records accordingly if approved.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on USPTO, visit: USPTO.

If there’s an error in the recorded assignment document itself (not just the cover sheet), the process is different:

  1. The party responsible for the error (e.g., the assignor) must either create and record a new document or make corrections to the original document and re-record it.
  2. If the assignor is unavailable, the assignee can submit an affidavit or declaration identifying the error and requesting correction.

As stated in MPEP 323.01(b), “The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).”

When multiple parties submit conflicting ownership claims for a patent application, the USPTO has a process to determine which party, if any, will control the prosecution. According to MPEP 325 and 37 CFR 3.73(c)(3):

“Where two or more purported assignees file conflicting 37 CFR 3.73(c) statements in an application or other Office proceeding, the Director will determine which, if any, purported assignee will be permitted to control prosecution of the application.”

The process typically involves the following steps:

  1. The Office official in charge of the application forwards the case to the Office of Patent Legal Administration.
  2. The Office of Patent Legal Administration reviews the conflicting claims and makes a determination.
  3. Generally, the current applicant is allowed to continue prosecution while the dispute is resolved.
  4. The other party claiming ownership may consider filing their own separate application.

It’s important to note that this process is primarily for determining who controls the prosecution of the application. It does not resolve underlying ownership disputes, which may need to be settled through other legal channels.

For more information on USPTO, visit: USPTO.

Tags: USPTO

If the assignment has not been recorded before the issue fee payment, the following applies:

  • The request for issuance to the assignee must state that the assignment document has been filed for recordation.
  • This statement should be made in accordance with 37 CFR 3.11.

As stated in 37 CFR 3.81(a): If the assignment has not been previously recorded, the request must state that the document has been filed for recordation as set forth in § 3.11.

If the assignee’s name and address are not identified in item 3 of the Fee(s) Transmittal form (PTOL-85B), the following occurs:

  • The patent will issue to the applicant instead of the assignee.
  • Assignment data printed on the patent will be based solely on the information supplied on the PTOL-85B form.

As stated in the MPEP: Unless an assignee’s name and address are identified in item 3 of the Fee(s) Transmittal form PTOL-85B, the patent will issue to the applicant. Assignment data printed on the patent will be based solely on the information so supplied.

It’s crucial for applicants and assignees to ensure that the correct information is provided on the PTOL-85B form to avoid any issues with patent issuance to the intended party.

What happens if I submit a non-original assignment document for recording?

If you submit a non-original assignment document for recording, it will be rejected by the USPTO. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording. Therefore, customers must submit copies of the documents to be recorded, rather than originals.’ This means that while you should submit a copy, it must be a true and complete copy of the original document. Submitting altered or incomplete copies may result in rejection and delay the recording process.

If you fail to correct and resubmit the returned assignment documents within the specified time period, the USPTO will consider the date of receipt of the corrected papers as the new recording date. The MPEP 317.02 clearly states:

“If the returned papers are not corrected and resubmitted within the specified period, the date of receipt of the corrected papers will be considered to be the date of recording of the document.”

It’s crucial to note that this may affect the priority date of your assignment, potentially impacting your rights. Additionally, the MPEP emphasizes that “The specified period to resubmit the returned papers will not be extended.” Therefore, it’s essential to act promptly when you receive returned documents to avoid losing the benefit of the original filing date.

To learn more:

What happens if I don’t record an assignment with the USPTO?

Failing to record an assignment with the USPTO can have significant legal implications. According to MPEP 302:

“An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the USPTO within three months from its date or prior to the date of such subsequent purchase or mortgage.”

This means that if you don’t record your assignment:

  • Your ownership rights may not be enforceable against subsequent purchasers or mortgagees who were unaware of the unrecorded assignment.
  • You may face difficulties in proving ownership in legal proceedings or licensing negotiations.
  • It could complicate future transfers or financial transactions involving the patent or application.

To protect your interests, it’s crucial to record assignments promptly with the USPTO, ideally within three months of the assignment date or before any subsequent transactions occur.

For more information on legal implications, visit: legal implications.

For more information on USPTO procedures, visit: USPTO procedures.

What happens if I accidentally submit an original assignment document to the USPTO?

If you accidentally submit an original assignment document to the USPTO, you will not be able to retrieve it. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording.’

To avoid this situation:

  • Always submit copies of assignment documents
  • Keep original documents in a secure location
  • Double-check all submissions before sending them to the USPTO

If you have submitted an original document in error, you may need to create a new assignment document or seek legal advice on how to proceed with future patent transactions or litigation that may require the original document.

To learn more:

If corrected documents are not resubmitted within the specified period, the original filing date will not be preserved. The MPEP clearly states: “If the returned papers are not corrected and resubmitted within the specified period, the date of filing of the corrected papers will be considered to be the date of recording of the document.” This means that failing to meet the deadline for resubmission will result in the loss of the original filing date, and the new submission date will be used as the recording date.

If an expungement petition is granted, the USPTO will take action to remove the erroneous assignment record. As stated in MPEP 323.01(d): ‘The assignment records related to a request for expungement will be expunged, deleted or corrected in accordance with the decision on the petition.’ This means that the incorrect or unnecessary information will be removed from the official assignment records, helping to maintain accurate ownership information for the patent or application.

To learn more:

If an English translation is not provided with a non-English assignment document, the USPTO will not record the assignment. According to MPEP 302.02:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

This means that the assignment will be rejected, and the ownership transfer will not be officially recognized by the USPTO. To proceed with the recordation, the applicant or assignee must submit a proper English translation along with the original non-English document.

To learn more:

If an assignment document submitted electronically through the Electronic Patent Assignment System (EPAS) is determined to be not recordable, the following process occurs:

  1. The entire document, along with its associated cover sheet, will be returned to the sender.
  2. An Office “Notice of Non-Recordation” will be transmitted back to the sender via fax, if possible.
  3. The sender can make corrections to the document or cover sheet.
  4. The corrected submission can then be resubmitted by mailing it to the address specified in 37 CFR 3.27.
  5. If the resubmission is timely, the sender will receive the benefit of the initial receipt date as the recordation date, in accordance with 37 CFR 3.51.

As stated in MPEP 302.10: “Once corrections are made, the initial submission, as amended, may then be resubmitted by mailing the corrected submission to the address set forth in 37 CFR 3.27. Timely submission will provide the sender with the benefit of the initial receipt date as the recordation date in accordance with 37 CFR 3.51.”

What happens if an assignment document is not recorded at the USPTO?

If an assignment document is not recorded at the USPTO, it can have significant legal implications. According to MPEP 302:

‘An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the Office within three months from its date or prior to the date of such subsequent purchase or mortgage.’

In other words, failing to record an assignment within the specified timeframe can render it invalid against subsequent purchasers or mortgagees who were unaware of the previous assignment. This highlights the importance of timely recording assignments to protect the rights of assignees.

For more information on assignment recording, visit: assignment recording.

For more information on legal implications, visit: legal implications.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

What happens if an assignment document is not legible for recording?

If an assignment document is not legible for recording, it will be rejected by the USPTO. According to MPEP 302.01, “Documents submitted for recording must be legible and capable of being reproduced in legible copies by use of photocopy and standard office copying equipment.” If a document is rejected due to legibility issues, the USPTO will notify the person who submitted the document, and they will need to resubmit a legible copy for recording.

What happens if an assignment document is not a copy when submitted for recording?

If an assignment document submitted for recording is not a copy, it will not be accepted for recording. The MPEP clearly states: The Assignment Division will not accept an original assignment document because it becomes part of the USPTO permanent records. This is to protect the original document and ensure that the USPTO maintains proper records. If you submit an original document, it will be returned to you unrecorded, and you will need to submit a copy instead.

To ensure your assignment is properly recorded, always submit a legible copy of the original assignment document. This can be a photocopy or other reproduction of the original.

If an assignment cover sheet is not submitted with the assignment document, the USPTO will not record the assignment. According to MPEP 302.07, “The Office will not accept an assignment document that is not accompanied by a cover sheet.” This means that the assignment will not be officially recognized by the USPTO, which could affect the ownership rights of the patent or application.

To learn more:

If an assignee’s ownership changes during patent prosecution, it’s crucial to update the USPTO records. As per MPEP 325:

“A new statement under 37 CFR 3.73(c) is required to be filed when ownership changes to another assignee.”

This means that:

  • The new assignee must file a new 37 CFR 3.73(c) statement.
  • The new statement must establish the new assignee’s ownership.
  • Until the new statement is filed, the previous assignee remains the party of record.

It’s important to keep ownership records up-to-date to ensure that the correct party has the right to take action in the application.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO records, visit: USPTO records.

What happens if an assignee requests issuance of a patent to themselves?

When an assignee requests issuance of a patent to themselves, the following process occurs:

  • The assignee must file a request for issuance of the patent to the assignee under 37 CFR 3.81(b).
  • This request must be submitted no later than the date the issue fee is paid.
  • If the request is not filed by this deadline, the patent will be issued to the applicant(s) named in the application file.

As stated in MPEP 307: “If the assignment is submitted for recording after the date of payment of the issue fee, but prior to issuance of the patent, the assignment will be recorded but the patent will issue to the name of the inventor.”

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

If an assignee fails to comply with 37 CFR 3.81(b) when requesting issuance of a patent to the assignee, the patent may still be issued to the assignee. However, the USPTO will not include the assignee data on the patent.

According to the MPEP 307: Failure to comply with the provisions of 37 CFR 3.81(b) will not impact the issuance of the patent. However, the Office will not include the assignee data on the patent if the assignee data is not submitted in compliance with 37 CFR 3.81(b).

This means that while the patent will be issued, the official patent document will not reflect the assignee information, which could potentially cause complications in establishing ownership records.

For more information on patent issuance, visit: patent issuance.

If a typographical error on the original cover sheet does not affect the title to the application or patent against which the original assignment or name change is recorded, the Assignment Services Division will take the following actions:

  • Correct the Assignment Historical Database
  • Allow the recording party to keep the original date of recordation

As stated in MPEP 323.01(a): “If the original cover sheet contains a typographical error that does not affect title to the application or patent against which the original assignment or name change is recorded, the Assignment Services Division will correct the Assignment Historical Database and permit the recording party to keep the original date of recordation.”

This approach ensures that minor errors that don’t impact the substance of the assignment are corrected without affecting the original recordation date, which can be important for legal and priority purposes.

To learn more:

If a patent is issued to the wrong applicant, the USPTO has procedures to correct this error. According to MPEP 308:

‘If a patent is issued to the wrong applicant because of an error in the Office, the patentee may request a certificate of correction… If the error was not the Office’s fault, the assignee(s) or applicant(s) may request a reissue.’

The method of correction depends on whether the error was made by the USPTO or by the applicant. If it was the USPTO’s error, a certificate of correction can be requested. If it was the applicant’s error, a reissue process may be necessary.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on error correction, visit: error correction.

For more information on patent issuance, visit: patent issuance.

For more information on reissue, visit: reissue.

If a patent involved in an arbitration award is subsequently invalidated, there are provisions for modifying the award. This process is outlined in 35 U.S.C. 294(c):

“The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration.”

Key points to note:

  • Parties can agree in advance to allow modification of the award if the patent is invalidated.
  • The invalidation must be determined by a court of competent jurisdiction.
  • The court decision must be final (no appeal possible or taken).
  • Any party to the arbitration can apply to a court for modification of the award.
  • The modified award will govern the rights and obligations between the parties from the date of modification.

This provision allows for adjustments to arbitration outcomes in light of significant changes to the validity of the underlying patent rights.

If a patent document doesn’t meet the identification requirements, it will not be recorded. The MPEP 317.01 states:

“A document which does not comply with the identification requirements of § 3.21 will not be recorded.”

This means that the USPTO will reject documents that fail to meet the specific identification criteria outlined in 37 CFR 3.21, and these documents will not receive a recording date until the issues are corrected.

To learn more:

What happens if a patent assignment is not recorded with the USPTO?

Failing to record a patent assignment with the USPTO can have significant consequences:

  • Lack of Constructive Notice: Third parties may not be aware of the ownership transfer.
  • Potential Legal Issues: It may affect the assignee’s ability to enforce the patent or recover damages in infringement cases.
  • Validity of Subsequent Transfers: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as valid, for purposes of recording, unless overcome by a showing that such assignment was fraudulently procured or is otherwise invalid.’

While recording is not mandatory for the assignment to be valid between the parties involved, it is highly recommended to protect the assignee’s rights and provide public notice of the ownership change.

For more information on USPTO, visit: USPTO.

Tags: USPTO

If the USPTO determines that a faxed assignment document is not recordable, there’s a specific process outlined in MPEP 302.09:

  1. The entire document, including the cover sheet, is returned to the sender via fax.
  2. A ‘Notice of Non-Recordation’ is included with the returned document.
  3. The sender can make corrections and resubmit the document.
  4. Resubmission must be done by mail to the address in 37 CFR 3.27.
  5. Timely resubmission preserves the initial receipt date as the recordation date.

The MPEP states: If a document submitted by fax is determined not to be recordable, the entire document, with its associated cover sheet, and the Office ‘Notice of Non-Recordation’ will be transmitted via fax back to the sender. Once corrections are made, the initial submission, amended, may then be resubmitted by mailing the corrected submission to the address set forth in 37 CFR 3.27. Timely resubmission will provide the sender with the benefit of the initial receipt date as the recordation date in accordance with 37 CFR 3.51.

To learn more:

If the designated domestic representative cannot be found or if no person has been designated, 35 U.S.C. 293 provides a solution:

If the person designated cannot be found at the address given in the last designation, or if no person has been designated, the United States District Court for the Eastern District of Virginia shall have jurisdiction and summons shall be served by publication or otherwise as the court directs.

This means that if the domestic representative is unreachable or non-existent, the U.S. District Court for the Eastern District of Virginia will handle the case and determine how to serve the summons. This ensures that legal proceedings can continue even if there are issues with the domestic representative.

To learn more:

The USPTO accepts the following file formats for electronic submission of assignment documents:

  • PDF (Portable Document Format)
  • TIFF (Tagged Image File Format)

As stated in MPEP 302.10: “The USPTO will accept electronic submissions of assignment documents in TIFF or PDF format.” It’s important to note that these formats are chosen for their ability to preserve document integrity and ensure long-term accessibility.

To learn more:

When correcting an erroneous assignment or name change, you must pay the required fee for each application or patent affected. According to MPEP 323.01(c):

The required fee ( 37 CFR 3.41 ) for each application or patent to be corrected.

The specific fee amount can be found in the current USPTO fee schedule. It’s important to note that a separate fee is required for each application or patent that needs correction, even if they are related to the same erroneous assignment.

To learn more:

To correct a typographical error on a patent assignment cover sheet, you must pay the required fee for each application or patent that needs correction. According to MPEP 323.01(a):

“The party requesting correction should submit… (C) the required fee for each application or patent to be corrected (37 CFR 3.41).”

The specific fee amount is set by 37 CFR 3.41 and may change periodically. It’s important to check the current USPTO Fee Schedule for the most up-to-date fee information. The fee is required per application or patent, so if multiple documents need correction, multiple fees may apply.

To learn more:

When correcting a typographical error in a recorded assignment document, fees are required. The MPEP 323.01(b) states:

The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).

The specific fee amount is set by 37 CFR 3.41. It’s important to note that:

  • A separate fee is required for each application or patent affected by the correction.
  • The fee amount may change, so it’s best to check the current USPTO fee schedule for the most up-to-date information.

To learn more:

Recording a patent assignment at the USPTO involves paying an appropriate recording fee. MPEP 315 references the fee requirements:

The appropriate recording fee (see 37 CFR 1.21(h) and 3.41).

The specific fee amount can be found in the USPTO’s current fee schedule. It’s important to note that:

  • Fees may vary depending on whether the submission is electronic or paper-based
  • There may be additional fees for expedited processing
  • Fees are subject to change, so always check the current fee schedule before submitting

For the most up-to-date information on fees, visit the USPTO’s official fee schedule page.

To expunge an assignment record at the USPTO, clear evidence must be provided that the document was submitted by mistake or is of improper character. The MPEP 323.01(d) states:

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

While the MPEP doesn’t provide specific examples of acceptable evidence, it generally includes:

  • Documentation showing the assignment was recorded in error
  • Proof that the assignment document contains incorrect information
  • Evidence that the assignment was not intended for the specific application or patent

The burden of proof lies with the petitioner to demonstrate why the assignment record should be expunged. Each case is evaluated on its own merits by the USPTO.

To learn more:

To support a petition to expunge an improperly recorded assignment, you should provide evidence that clearly demonstrates the assignment is incorrect. This may include:

  • Affidavits or declarations from relevant parties
  • Documentation showing true ownership
  • Evidence of fraud or mistake in the recording

MPEP 323.01(c) states: ‘The petition should be accompanied by clear and convincing evidence of the error in recording.’ It’s crucial to present a compelling case to the USPTO to justify the expungement.

To learn more:

MPEP 303 states that certified copies of patent applications as filed do not include an indication of assignment documents. The section specifically notes:

“Certified copies of patent applications as filed do not include an indication of assignment documents.” (MPEP 303)

This means that if an applicant wants to have proof of assignment documents, they need to request this separately.

According to MPEP 318, assignment documents submitted for recording should not be placed directly in application or patent files. The section states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This means that when assignment documents are submitted, they should be sent to the Assignment Division for proper recording rather than being inserted into the application or patent files themselves.

To learn more:

According to 37 CFR 3.11, the following documents can be recorded with the USPTO related to patent assignments:

  • Assignments of applications, patents, and registrations
  • Other documents relating to interests in patent applications and patents
  • Documents affecting title to applications, patents, or registrations
  • Licenses, assignments, or other interests of the Government in or under patents or patent applications
  • Joint research agreements or excerpts of joint research agreements

These documents must be accompanied by completed cover sheets as specified in 37 CFR 3.28 and 3.31.

According to MPEP 314, the following documents are recordable for name changes or mergers in patent ownership:

  • Certificates issued by appropriate authorities showing a change of name of a business
  • Certificates showing a merger of businesses

The MPEP states: Certificates issued by appropriate authorities showing a change of name of a business or a merger of businesses are recordable.

To correct a typographical error in a patent assignment, you need to submit several documents. According to MPEP 323.01(b), the required documents include:

  • A copy of the originally recorded papers
  • A cover sheet
  • The required fee for each application or patent to be corrected

If the assignor is not available to make the correction, the assignee must also provide:

  • An affidavit or declaration identifying the error and requesting correction

The MPEP states:

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction. The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).

Ensure all documents are properly prepared and submitted to avoid delays in processing.

To learn more:

In patent arbitration proceedings, the defenses provided under 35 U.S.C. 282 must be considered by the arbitrator if raised by any party. This is specified in 35 U.S.C. 294(b):

‘In any such arbitration proceeding, the defenses provided for under section 282 shall be considered by the arbitrator if raised by any party to the proceeding.’

These defenses typically include noninfringement, absence of liability for infringement, unenforceability, and invalidity of the patent or any claim in suit.

If the USPTO returns a document unrecorded and you believe it represents an unusual case that justifies recordation, you have the option to petition for its recordation. The MPEP provides the following guidance:

“Any document returned unrecorded, which the sender nevertheless believes represents an unusual case which justifies recordation, may be submitted to the Office of Petitions with a petition under 37 CFR 1.181 requesting recordation of the document.” (MPEP 313)

To petition:

  1. Submit the document to the Office of Petitions
  2. Include a petition under 37 CFR 1.181
  3. Provide justification for why the document should be recorded

The MPEP outlines two main types of patent ownership:

  1. Individual ownership: ‘An individual entity may own the entire right, title and interest of the patent property. This occurs where there is only one inventor, and the inventor has not assigned the patent property.’
  2. Joint ownership: ‘Multiple parties may together own the entire right, title and interest of the patent property.’ This can occur in several scenarios:
  • Multiple partial assignees of the patent property
  • Multiple inventors who have not assigned their rights
  • A combination of partial assignee(s) and inventor(s) who have not assigned their rights

Understanding these ownership types is crucial for managing patent rights and making decisions about assignments or licenses.

According to 37 CFR 3.31, the cover sheet for patent assignments must contain:

  • Name of the party conveying the interest
  • Name and address of the party receiving the interest
  • Description of the interest conveyed or transaction to be recorded
  • Identification of the patent or application
  • Name and address for correspondence
  • Date of execution
  • Signature of the party submitting the document

For joint research agreements, the cover sheet must also:

  • Identify the document as a ‘joint research agreement’
  • Indicate the name of the patent owner
  • Indicate the names of other parties to the agreement
  • Indicate the date the agreement was executed

The MPEP notes that Form PTO-1595, Recordation Form Cover Sheet, may be used as the cover sheet for recording documents relating to patent(s) and/or patent application(s) in the Office.

For more information on Assignment cover sheet, visit: Assignment cover sheet.

For more information on patent assignment, visit: patent assignment.

According to 37 CFR 3.26, assignment documents in languages other than English can be recorded with the USPTO, but specific requirements must be met. The MPEP states:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

Key points for submitting non-English assignment documents:

  • The original non-English document must be submitted
  • An English translation of the document must be provided
  • The translation must be signed by the individual who performed the translation
  • Both the original document and the translation will be recorded

It’s important to ensure that the translation accurately reflects the content of the original document to avoid any legal complications or misunderstandings regarding the assignment.

For more information on patent assignment, visit: patent assignment.

According to MPEP 302.09, there are specific requirements for submitting assignment-related documents by fax:

  • An identified application or patent number
  • One cover sheet to record a single transaction
  • Payment of the recordation fee by credit card or USPTO Deposit Account

The MPEP states: Any assignment-related document for patent matters submitted by facsimile must include: (A) an identified application or patent number; (B) one cover sheet to record a single transaction; and (C) payment of the recordation fee by a credit card (use of the Credit Card form, PTO-2038 (see MPEP § 509), is required for the credit card information to be kept separate from the assignment records) or a USPTO Deposit Account.

It’s important to note that certain documents cannot be submitted via fax, such as assignments submitted with new patent applications or documents with multiple cover sheets.

To learn more:

To submit an assignment document electronically to the USPTO, the following requirements must be met:

  • The document must be submitted via the Electronic Patent Assignment System (EPAS)
  • An identified application or patent number must be included
  • One cover sheet must be completed online to record a single transaction
  • The signature on the cover sheet must comply with 37 CFR 3.31(a)(7) or 37 CFR 1.4(d)(2)

As stated in 37 CFR 1.4(d)(2), an S-signature may be used, which consists of letters and/or numbers between forward slashes (e.g., /John Doe/). For patent practitioners, their registration number must also be included.

According to MPEP 302.02, non-English assignment documents can only be accepted and recorded by the USPTO if they are accompanied by an English translation. The MPEP states:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This means that inventors, assignees, or their representatives must provide a certified English translation along with the original non-English document for it to be officially recorded.

To learn more:

To record an assignment of a patent or patent application, the following requirements must be met:

  • The assignment must be in writing.
  • It must be signed by the assignor (the person or entity transferring ownership).
  • The document must identify the patent or application by number.
  • The assignment must be submitted to the USPTO along with the required fee.

According to MPEP 301: “An assignment relating to a patent must be submitted to the USPTO for recordation as an absolute requirement for enforcing the patent or application against third parties.” This recordation provides constructive notice to the public of the assignment.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For more information on USPTO, visit: USPTO.

What are the requirements for recording a patent assignment document?

To record a patent assignment document, you must submit:

  • A copy of the original assignment document
  • A cover sheet identifying the document as an assignment
  • The required fee

The MPEP states: ‘The document submitted for recordation must be accompanied by a cover sheet identifying the document as an assignment and must contain the fee required by 37 CFR 3.41.’ This ensures proper processing and indexing of the assignment.

To learn more:

Joint research agreements can be recorded with the USPTO as per 37 CFR 3.11(c). The MPEP states that the cover sheet for a joint research agreement must:

  • Identify the document as a ‘joint research agreement’ in the description of interest conveyed
  • Indicate the name of the owner of the application or patent
  • Indicate the name of each other party to the joint research agreement
  • Indicate the date the joint research agreement was executed

The document submitted can be either the entire joint research agreement or an excerpt of it. As with other recorded documents, it must be accompanied by a completed cover sheet as specified in 37 CFR 3.28 and 3.31.

Remember that A patent cover sheet may not refer to trademark applications or registrations. Separate cover sheets must be used for patents and trademarks.

For more information on joint research agreement, visit: joint research agreement.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

To record a document with respect to additional patents and/or patent applications, even if it has been previously recorded, the following must be submitted to the Assignment Division:

As stated in MPEP 315: “The Office will assign a new recording date to that submission, update the assignment database, and include the cover sheet and document as part of the official record.”

For more information on Assignment Division, visit: Assignment Division.

For more information on document recording, visit: document recording.

For more information on patent applications, visit: patent applications.

For more information on recording requirements, visit: recording requirements.

For paper submissions of patent assignment documents, the following requirements must be met:

  • Submit either a copy of the original document or an extract of the original document.
  • Use only one side of each page.
  • Paper size must be either 8.5″ x 11″ or A4, with a 1-inch margin on all sides.
  • Use flexible, strong white, non-shiny, and durable paper.

As stated in 37 CFR 3.24(b): “For paper submissions, the paper used should be flexible, strong white, non-shiny, and durable.” This ensures that the document can be properly recorded and stored by the USPTO.

If a request for issuance to an assignee is submitted after the issue fee has been paid, the following requirements must be met:

  1. Submit a request under 37 CFR 3.81(b)
  2. Include a request for a certificate of correction under 37 CFR 1.323
  3. Pay the fee for the certificate of correction (set forth in 37 CFR 1.20(a))
  4. Pay the processing fee (set forth in 37 CFR 1.17(i))
  5. State that the assignment was submitted for recordation before the patent was issued

As stated in MPEP 307: “If a request for issuance to an assignee pursuant to 37 CFR 3.81(b) is submitted after the day on which the issue fee is paid, the request under 37 CFR 3.81(b) must include a request for a certificate of correction under 37 CFR 1.323 (accompanied by the fee set forth in 37 CFR 1.20(a)) and the processing fee set forth in 37 CFR 1.17(i).”

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

What are the requirements for faxed assignment documents to be recorded at the USPTO?

For faxed assignment documents to be recorded at the USPTO, they must meet the following requirements:

  • The document must be legible and capable of being reproduced in legible form.
  • The fax must include a cover sheet with the sender’s name, address, and telephone number.
  • Payment of the recording fee must be included or authorized.
  • The fax should be sent to the specific fax number designated for assignment submissions.

As stated in MPEP 302.09: “The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.” This means that the fax transmission must be complete and received by the USPTO to be considered officially submitted.

To learn more:

What are the requirements for facsimile submission of assignment documents to the USPTO?

The USPTO has specific requirements for facsimile submission of assignment documents:

  • The facsimile must be legible and complete.
  • The document should be submitted to the Assignment Recordation Branch at the designated fax number.
  • A cover sheet must accompany the submission, stating the total number of pages, including the cover sheet.
  • The original document is not required unless specifically requested by the Office.

As stated in MPEP 302.09: “The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.”

To learn more:

For an assignee to take action in a patent application filed on or after September 16, 2012, the following requirements must be met:

  • The assignee must be of the entire right, title, and interest in the application.
  • A statement under 37 CFR 3.73(c) must be filed in the application.
  • The statement must identify the assignee and establish the assignee’s ownership.

As stated in MPEP 325: “The assignee must establish its ownership of the entire right, title, and interest in an application in order to take action in that application.”

For more information on 37 CFR 3.73(c), visit: 37 CFR 3.73(c).

What are the reporting requirements for subject inventions under government contracts?

Contractors working on federally sponsored research and development projects have specific reporting requirements for subject inventions. According to MPEP 310:

“The contractor is required to disclose each subject invention to the Federal agency within two months after the inventor discloses it in writing to contractor personnel responsible for patent matters.”

Additionally, the contractor must:

  • Elect in writing whether or not to retain title to any subject invention within two years of disclosure.
  • File patent applications within one year after election (or prior to any statutory bar date).
  • Execute and promptly deliver instruments to confirm government rights.
  • Provide periodic reports on the utilization of the invention.

These requirements ensure proper documentation and protection of both the contractor’s and the government’s interests in inventions resulting from federally funded research.

For more information on federally sponsored research, visit: federally sponsored research.

Contractors have specific reporting requirements under the Bayh-Dole Act:

  • Disclose each subject invention to the Federal agency within 2 months after the inventor discloses it in writing to contractor personnel responsible for patent matters.
  • Elect in writing whether or not to retain title to any subject invention by notifying the Federal agency within 2 years of disclosure.
  • File patent applications within statutory deadlines.
  • Include a government support clause in patent applications.

The MPEP states: ‘The contractor is also required to submit periodic reports on the utilization of a subject invention or on efforts at obtaining such utilization that are being made by the contractor or its licensees or assignees.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

Former USPTO employees face restrictions on priority dates for patents they file after leaving the office. According to 35 U.S.C. 4:

‘In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.’

This means that for any patent application filed by a former USPTO employee, the earliest priority date they can claim is one year after their employment at the USPTO ended. This rule prevents former employees from using insider knowledge to gain an unfair advantage in the patent application process.

For paper or facsimile submissions of patent assignment documents to the USPTO, the following requirements apply:

  • Either a copy of the original document or an extract of the original document must be submitted
  • Only one side of each page may be used
  • Paper size must be either 21.6 by 27.9 cm (8 1/2 inches by 11 inches) or 21.0 by 29.7 cm (DIN size A4)
  • A 2.5 cm (one-inch) margin must be present on all sides
  • The paper should be flexible, strong white, non-shiny, and durable

As stated in 37 CFR 3.24(b): For paper or facsimile submissions: Either a copy of the original document or an extract of the original document must be submitted for recording. Only one side of each page may be used.

To learn more:

The USPTO provides normal corrective procedures for assignment records, which are outlined in MPEP 323.01(a) through 323.01(c). These procedures are typically the first course of action for addressing issues in assignment records. The expungement process, as described in MPEP 323.01(d), is only considered when:

the normal corrective procedures outlined in MPEP § 323.01(a) through § 323.01(c) will not provide the petitioner with adequate relief

The normal corrective procedures may include:

  • Filing a corrective document
  • Requesting a correction to the cover sheet
  • Submitting evidence to correct clerical errors

It’s important for patent applicants and attorneys to be familiar with these procedures and to exhaust these options before considering a petition for expungement.

To learn more:

What are the government’s rights in inventions made by nonprofit organizations and small businesses?

The government’s rights in inventions made by nonprofit organizations and small businesses under federally sponsored research are specifically addressed in MPEP 310. According to the manual:

“A funding agreement may provide that the government shall have the right to require periodic reporting on the utilization or efforts at obtaining utilization that are being made by the contractor or his licensees or assignees.”

Additionally, the government retains:

  • A nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced the invention for or on behalf of the United States throughout the world.
  • The right to require the contractor to grant licenses to responsible applicants under certain conditions (march-in rights).
  • The right to require written agreements from contractors to ensure that inventions are made available for public use on reasonable terms.

These provisions, outlined in 35 U.S.C. 202, balance the interests of small entities, the government, and the public in federally funded inventions.

For more information on federally sponsored research, visit: federally sponsored research.

For electronic submissions of assignment documents, the USPTO requires:

  • Either a copy of the original document or an extract of the original document
  • Documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another prescribed format
  • When printed to paper size of 21.6 by 27.9 cm (8 1/2 inches by 11 inches) or 21.0 by 29.7 cm (DIN size A4), the document must be legible
  • A 2.5 cm (one-inch) margin must be present on all sides

As stated in 37 CFR 3.24(a): All documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another form as prescribed by the Director.

To learn more:

For electronic submissions of assignment documents, the following requirements apply:

  • Either a copy of the original document or an extract of the original document may be submitted.
  • Documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another prescribed format.
  • When printed to paper size (8.5″ x 11″ or A4), the document must be legible with a 1-inch margin on all sides.

As stated in 37 CFR 3.24(a): “All documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another form as prescribed by the Director.”

The fees for recording assignment documents are set forth in 37 CFR 3.41. According to the MPEP:

  • For electronic submissions: The fee is currently $0 (as per 37 CFR 1.21(h)(1))
  • For paper or facsimile submissions: The fee is set in 37 CFR 1.21(h)(2)

The MPEP advises: Customers should check the current fee schedule on the Office website before submitting documents for recordation.

It’s important to note that a fee is required for each application, patent, and registration against which the document is recorded, as identified in the cover sheet. However, there are exceptions:

  • No fee is required for documents required by Executive Order 9424 if the document does not affect title and is identified as such in the cover sheet
  • The document must be either faxed, electronically submitted, or mailed in compliance with 37 CFR 3.27

For more information on recordation fees, visit: recordation fees.

For more information on USPTO fees, visit: USPTO fees.

The fees for recording a patent assignment depend on the submission method:

  • Electronic submission via EPAS (Electronic Patent Assignment System): $0
  • Paper or facsimile submission: See current fee schedule

As stated in MPEP 302.06: “If the request to record a document is submitted electronically, the fee is set forth in 37 CFR 1.21(h)(1), currently at $0. If the request to record a document is not submitted electronically (i.e., is submitted on paper or via facsimile), the applicable fee is set forth in 37 CFR 1.21(h)(2).”

It’s important to note that fees are subject to change. Always check the current USPTO fee schedule before submitting documents for recordation.

For more information on patent assignment fees, visit: patent assignment fees.

For more information on USPTO fees, visit: USPTO fees.

According to MPEP 310, a Government contractor who retains U.S. domestic patent rights has the following obligations:

  1. Include the government license rights statement at the beginning of the patent application and any issued patents.
  2. Specify the contract under which the invention was made.
  3. Identify the Federal agency that awarded the contract.
  4. Acknowledge that the government has certain rights in the invention.

These obligations stem from 35 U.S.C. 202(c)(6), which mandates the inclusion of this information in the patent application and any resulting patents.

What are the consequences of submitting a poor-quality copy of an assignment document to the USPTO?

Submitting a poor-quality copy of an assignment document to the USPTO can lead to rejection of the recording request. The MPEP 302.01 clearly states that “Only copies of an original assignment document (with the exception of those submitted via EFS-Web) may be submitted for recording.” Furthermore, it emphasizes that “The copy must be legible, capable of reproduction and otherwise meet the usual requirements of documents for recording.” If a poor-quality copy is submitted:

  • The recording request may be rejected
  • The effective date of recordation could be delayed
  • Additional fees may be incurred for resubmission
  • There could be potential legal implications if the assignment is not properly recorded in a timely manner

To avoid these issues, always ensure that the copy submitted is of high quality and meets all USPTO requirements for legibility and reproducibility.

Failing to include the Government License Rights statement in a patent application can have serious consequences. While the MPEP 310 does not explicitly state the penalties, the requirement is mandated by law under 35 U.S.C. 202(c)(6). Potential consequences may include:

  • Non-compliance with federal regulations
  • Risk of the patent being unenforceable
  • Potential loss of rights or benefits under the government contract
  • Complications in future licensing or commercialization efforts

It’s crucial for inventors and patent attorneys to ensure proper inclusion of this statement to maintain the validity and enforceability of the patent.

For more information on patent enforcement, visit: patent enforcement.

What are the consequences of failing to record a patent assignment with the USPTO?

Failing to record a patent assignment with the USPTO can have several important consequences:

  • Lack of legal notice: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as notice to the world of the ownership of the patent.’ Without recording, third parties may not have legal notice of the assignment.
  • Potential validity issues: In some cases, failure to record an assignment could affect the validity of subsequent actions taken by the assignee.
  • Difficulties in enforcement: Unrecorded assignments may complicate patent enforcement efforts, as the assignee’s standing to sue could be challenged.
  • Problems in future transactions: Lack of a clear chain of title can cause issues in future sales, licenses, or other transactions involving the patent.

While recording is not mandatory, it is highly recommended to protect the assignee’s rights and ensure a clear chain of title for the patent.

For more information on legal notice, visit: legal notice.

For more information on patent assignment, visit: patent assignment.

When a typographical error on the original cover sheet affects the title to the application or patent against which the assignment or name change is recorded, the consequences are more significant:

  • The recording party will not be entitled to keep the original date of recordation
  • The Assignment Services Division will correct its automated records
  • The date of recordation will be changed to the date the corrected cover sheet was received in the Office

As stated in MPEP 323.01(a): “If the original cover sheet contains a typographical error that affects title to the application or patent against which the assignment or name change is recorded, the recording party will not be entitled to keep the original date of recordation. Rather, the Assignment Services Division will correct its automated records and change the date of recordation to the date the corrected cover sheet was received in the Office.”

This approach ensures that errors affecting the substance of the assignment or title are properly addressed, even if it means adjusting the recordation date. It’s crucial for patent owners and assignees to be aware of this policy to avoid potential issues with priority dates or legal standing.

To learn more:

The Electronic Patent Assignment System (EPAS) offers several benefits for submitting assignment documents to the USPTO. While not explicitly stated in MPEP 302.10, the following advantages can be inferred:

  • Convenience: Users can submit documents directly from their computer, eliminating the need for physical mailing.
  • Efficiency: Electronic submission can be faster than traditional paper-based methods.
  • Direct Integration: As stated in the MPEP, EPAS allows submission “directly into the automated Patent and Trademark Assignment System,” potentially reducing processing times.
  • Flexibility: Various types of documents related to title can be submitted through the system.
  • Multiple Payment Options: Users can pay fees using credit card, electronic fund transfer, or deposit account.

These benefits make EPAS an attractive option for those needing to submit assignment documents to the USPTO.

To learn more:

What are the benefits of using EPAS for assignment submissions?

The Electronic Patent Assignment System (EPAS) offers several advantages for submitting assignment documents:

  • 24/7 availability for submissions
  • Immediate confirmation of receipt
  • Faster processing times compared to paper submissions
  • Reduced risk of errors through guided data entry
  • Ability to save and resume incomplete submissions

The MPEP 302.10 states, ‘Assignment documents can be electronically submitted via the Electronic Patent Assignment System (EPAS) by registered ePAS users.’ This system streamlines the assignment process and improves efficiency for both applicants and the USPTO.

To learn more:

Electronically submitting assignment documents to the USPTO offers several benefits:

  • Faster Processing: Electronic submissions are typically processed more quickly than paper submissions.
  • Immediate Confirmation: You receive immediate confirmation of your submission.
  • Cost-Effective: No mailing costs or delays associated with physical delivery.
  • 24/7 Availability: You can submit documents at any time, not limited to office hours.
  • Reduced Risk of Loss: Electronic submissions minimize the risk of documents being lost in transit.
  • Environmentally Friendly: Reduces paper usage and associated environmental impacts.

The MPEP 302.10 states: “Assignment documents can be submitted to the Office electronically via the Office’s Electronic Patent Assignment System (EPAS).” This system is designed to streamline the submission process and provide these benefits to patent applicants and owners.

To learn more:

According to MPEP 301, patents have the attributes of personal property. The MPEP states:

’35 U.S.C. 261 Ownership; assignment. Subject to the provisions of this title, patents shall have the attributes of personal property.’

This means that patents can be bought, sold, licensed, or transferred like other forms of property. However, it’s important to note that owning a patent doesn’t necessarily grant the right to practice the invention, as other legal considerations may apply.

For more information on patent rights, visit: patent rights.

For more information on personal property, visit: personal property.

The assignment rules for substitute and continuation-in-part applications differ from those for division and continuation applications. As per the MPEP, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This means that for substitute or continuation-in-part applications, a new assignment must be recorded if they are to be issued to an assignee. However, there’s an exception: unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

For more detailed information, refer to MPEP § 307 and MPEP § 308.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on patent assignment, visit: patent assignment.

For more information on substitute application, visit: substitute application.

Electronically submitting assignment documents offers several advantages:

  • Faster recordation: Electronic submissions are processed more quickly than paper submissions.
  • Reduced risk of loss: Electronic documents are less likely to be misplaced or lost in transit.
  • Immediate confirmation: You receive instant confirmation of your submission.
  • 24/7 accessibility: You can submit documents at any time, not just during business hours.

The MPEP 302.10 states: “Assignment documents filed electronically are recorded faster and are less likely to become lost or misplaced.” This underscores the efficiency and reliability of electronic submissions.

To learn more:

The USPTO accepts several methods for submitting documents for recordation. According to MPEP 302.06:

  • Electronic submission
  • Paper submission
  • Facsimile (fax) submission

The MPEP states: See MPEP §§ 302.08 – 302.10 for additional information regarding the acceptable ways to submit documents for recordation.

It’s important to note that the method of submission can affect the recording fee. Electronic submissions currently have a $0 fee, while paper and fax submissions may incur a fee as set forth in 37 CFR 1.21(h)(2).

To learn more:

March-in rights are a provision of the Bayh-Dole Act that allow the government to intervene in certain circumstances:

  • The government can require the contractor or exclusive licensee to grant a license to a responsible applicant.
  • If the contractor or licensee refuses, the government can grant the license itself.
  • These rights are exercised only in specific situations, such as when the contractor is not taking effective steps to achieve practical application of the invention.

The MPEP explains: ‘March-in rights allow the government to grant licenses to other parties… where the contractor has failed to take effective steps to achieve practical application of the invention.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

For more information on patent licensing, visit: patent licensing.

MPEP 303 mentions conflicting claims as a situation where assignment information becomes crucial:

“When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims…” (MPEP 303)

Conflicting claims occur when two or more patent applications claim the same or overlapping subject matter. This is significant because:

  • It may indicate potential ownership disputes
  • It can affect the novelty or non-obviousness of the claimed inventions
  • It might require the USPTO to initiate an interference or derivation proceeding

In such cases, examiners need to verify assignment information to determine the proper course of action.

What are ‘march-in rights’ in government-funded inventions?

‘March-in rights’ are a significant aspect of government rights in federally funded inventions. As described in MPEP 310, these rights allow the government to require the contractor, assignee, or exclusive licensee of a subject invention to grant a license to a responsible applicant under certain circumstances. The MPEP states:

‘March-in rights permit the Government, in specified circumstances, to require the contractor or successors in title to the patent to grant a nonexclusive, partially exclusive, or exclusive license to a responsible applicant or applicants.’

These circumstances include:

  • Failure to take effective steps to achieve practical application of the invention
  • Health and safety needs not being reasonably satisfied
  • Public use requirements specified by Federal regulations not being met

March-in rights serve as a safeguard to ensure that federally funded inventions benefit the public.

For more information on patent licensing, visit: patent licensing.

An assignee of a pre-AIA patent application (filed before September 16, 2012) can take various actions once they have established ownership. According to MPEP 324, these actions include:

  • Signing a reply to an Office action
  • Requesting a continued prosecution application (CPA)
  • Signing a terminal disclaimer
  • Submitting a Fee(s) Transmittal form
  • Requesting status of an application
  • Appointing a registered patent practitioner to prosecute the application
  • Granting power to inspect an application
  • Consenting to the filing of a reissue application
  • Consenting to the correction of inventorship

The MPEP states: The owner or assignee (other than a juristic entity) of a patent property based on an application filed before September 16, 2012, can take action in a patent application or patent proceeding in numerous instances. However, it’s important to note that as of September 16, 2012, juristic entities must be represented by a patent practitioner for most actions.

For more information on assignee rights, visit: assignee rights.

For more information on patent prosecution, visit: patent prosecution.

For more information on pre-AIA applications, visit: pre-AIA applications.

According to MPEP 325, a patent owner or assignee who has become the applicant can take various actions in a patent application. These include:

  • Signing a reply to an Office action (37 CFR 1.33(b)(3))
  • Requesting a continued prosecution application (CPA) under 37 CFR 1.53(d)
  • Filing a disclaimer under 37 CFR 1.321
  • Submitting a Fee(s) Transmittal (PTOL-85B)
  • Requesting the status of an application
  • Filing an application under 37 CFR 1.46
  • Appointing a registered patent practitioner to prosecute the application
  • Granting a power to inspect the application
  • Consenting to the filing of a reissue application
  • Consenting to the correction of inventorship

The MPEP notes: “As the applicant, the owner or assignee that is not a juristic entity can sign a reply to an Office action (37 CFR 1.33(b)(3)), a request for a continued prosecution application under 37 CFR 1.53(d) (MPEP § 201.06(d)), a disclaimer under 37 CFR 1.321 (MPEP § 1490), Fee(s) Transmittal (PTOL-85B) (MPEP § 1306), or a request for status of an application (MPEP § 102).”

It’s important to note that for juristic entities (e.g., corporations), many actions must be signed by a patent practitioner after September 16, 2012.

For more information on continued prosecution application, visit: continued prosecution application.

When a patent is granted on an application filed by someone other than the inventor, it is issued to the real party in interest. This is stipulated in both 35 U.S.C. 118 and 37 CFR 1.46(e):

35 U.S.C. 118 states: If the Director grants a patent on an application filed under this section by a person other than the inventor, the patent shall be granted to the real party in interest and upon such notice to the inventor as the Director considers to be sufficient.

37 CFR 1.46(e) further clarifies: If a patent is granted on an application filed under this section by a person other than the inventor, the patent shall be granted to the real party in interest. Otherwise, the patent may be issued to the assignee or jointly to the inventor and the assignee as provided in § 3.81.

All relevant information from MPEP 323.01(b) – Typographical Errors in Recorded Assignment Document has been covered in previous FAQs. No additional meaningful questions can be generated without repetition.

To learn more:

To learn more:

All relevant information from MPEP 323.01 – Correction of Error in Recorded Cover Sheet has been covered in previous FAQs. No further meaningful questions can be generated without redundancy.

To learn more:

To learn more:

To learn more:

While the address of the assignee may be included in the assignment document, it is not strictly required there. However, the address must be provided in the cover sheet accompanying the assignment. As stated in MPEP 302.05:

The address of the assignee may be recited in the assignment document and must be given in the required cover sheet.

This means that while including the address in the assignment document itself is optional, providing it on the cover sheet is mandatory for proper recordation of the assignment.

To learn more:

Expungement of assignment records at the USPTO is extremely rare and does not result in the complete removal of a document from the assignment records. According to MPEP 323.01(d), petitions to expunge assignment records are granted only if the petitioner can prove:

  1. The normal corrective procedures outlined in MPEP § 323.01(a) through § 323.01(c) will not provide adequate relief, and
  2. The integrity of the assignment records will not be affected by granting the petition.

The MPEP clarifies: Even if a petition to ‘expunge’ a document is granted with respect to a particular application or patent, the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number, and the image will appear when someone views that reel and frame number.

If a petition is granted:

  • The Office will delete links to the application or patent subject to the petition.
  • A redacted version of the ‘expunged’ document must be recorded and will appear in the assignment records.
  • An additional assignment of the ‘correct’ document may be recorded if necessary.

This process ensures the integrity and completeness of the USPTO’s assignment records while addressing legitimate concerns about erroneous or sensitive information.

To learn more:

No, including government support information on a provisional application cover sheet is not sufficient to meet the requirements of 35 U.S.C. 202(c)(6). The MPEP states:

Providing information concerning government support on a provisional application cover sheet does not satisfy the requirement of 35 U.S.C. 202(c)(6) which requires that the a statement be included within the specification of such application and any patent issuing thereon specifying that the invention was made with Government support and that the Government has certain rights in the invention.

The government license rights statement must be included within the specification itself, not just on the cover sheet.

While designating a domestic representative is not mandatory, it is highly recommended for foreign patent assignees. According to MPEP 302.04, An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative. The use of ‘may’ indicates that this is optional. However, having a domestic representative can significantly simplify legal proceedings and communications with the USPTO for foreign assignees.

To learn more:

No, a security agreement that does not convey the right, title, and interest of a patent property is not considered a conditional assignment. The MPEP section 317.03 states:

“A security agreement that does not convey the right, title, and interest of a patent property is not a conditional assignment.”

This distinction is important because security agreements are treated differently from conditional assignments in terms of recording and their effect on patent ownership.

To learn more:

For an international patent application designating the United States, you must use the international application number in the assignment. MPEP 302.03 specifies: “An assignment relating to an international patent application which designates the United States of America must identify the international application by the international application number; e.g., PCT/US2012/012345.” This format ensures proper identification of the international application in the assignment document.

To learn more:

Assignment documents submitted by mail for recordation should be addressed according to MPEP 302.08 and 37 CFR 3.27. The MPEP states:

Documents and cover sheets submitted by mail for recordation should be addressed to Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450, unless they are filed together with new applications.

This ensures that your documents are properly routed and processed by the USPTO.

To learn more:

Applicants other than the inventor must notify the USPTO of any change in the real party in interest as follows:

  • Notification should be made no later than payment of the issue fee
  • Changes can be indicated in Box 3 of the PTOL-85B form
  • If no notification is provided, the USPTO will presume no change has occurred

According to MPEP 308: Applicants other than the inventor can notify the Office of a change in the real party in interest by providing the real party in interest in Box 3 of the PTOL-85B. See MPEP § 307. The real party in interest will be listed in the assignee section of the patent. This does not change the applicant designated in the application or on any patent that is granted.

Additionally, 37 CFR 1.46(e) states: Where a real party in interest has filed an application under § 1.46, the applicant shall notify the Office of any change in the real party in interest no later than payment of the issue fee. The Office will treat the absence of such a notice as an indication that there has been no change in the real party in interest.

When preparing an assignment document for recording with the USPTO, follow these guidelines based on 37 CFR 3.24 and MPEP 302.01:

  1. For electronic submissions:
    • Submit either a copy of the original document or an extract of it
    • Ensure the document is in Tagged Image File Format (TIFF) or another prescribed format
    • When printed, the document should be legible on 8.5 x 11 inch or A4 paper with 1-inch margins on all sides
  2. For paper or facsimile submissions:
    • Submit a copy of the original document or an extract (not the original)
    • Use only one side of each page
    • Use 8.5 x 11 inch or A4 paper with 1-inch margins on all sides
    • For paper submissions, use flexible, strong white, non-shiny, and durable paper
  3. Ensure the document is legible, as the recorded document will only be as clear as the submitted copy
  4. Include a completed cover sheet as specified in 37 CFR 3.28 and 3.31

MPEP 302.01 states: “The United States Patent and Trademark Office will accept and record only a copy of an original assignment or other document.” Remember, the document submitted for recordation will not be returned, so do not submit original documents.

According to 37 CFR 3.21 and MPEP 302.03, a patent or application should be identified in an assignment document as follows:

  • For a patent: Use the patent number
  • For a national patent application: Use the application number (series code and serial number, e.g., 07/123,456)
  • For an international patent application designating the U.S.: Use the international application number (e.g., PCT/US2012/012345)
  • For an international design application designating the U.S.: Use either the international registration number or the U.S. application number

For applications not yet filed or without an assigned number:

  • For a non-provisional application: Identify by inventor name(s) and the title of the invention
  • For a provisional application: Identify by inventor name(s) and the title of the invention

MPEP 302.03 suggests: “It is suggested, however, that an assignment be written to allow entry of the identifying number after the execution of the assignment. An example of acceptable wording is: ‘I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.'”

To record a joint research agreement with the USPTO, follow these steps based on 37 CFR 3.11(c) and 37 CFR 3.31(g):

  1. Prepare either a copy of the joint research agreement or an excerpt of it.
  2. Complete a cover sheet that includes:
    • Identification of the document as a “joint research agreement” in the space for describing the interest conveyed
    • The name of the owner of the application or patent
    • The name of each other party to the joint research agreement
    • The date the joint research agreement was executed
  3. Submit the document and cover sheet to the USPTO for recordation.

As stated in MPEP 302.07: “If the document submitted for recordation is a joint research agreement or an excerpt of a joint research agreement, the cover sheet must clearly identify the document as a ‘joint research agreement’ (in the space provided for the description of the interest conveyed if using Form PTO-1595).”

According to 35 U.S.C. 293 and 37 CFR 3.61, a foreign assignee of a patent or patent application who is not domiciled in the United States may designate a domestic representative. Here’s how to do it:

  1. Prepare a written document signed by the assignee.
  2. State the name and address of a person residing within the United States who may be served process or notice of proceedings affecting the patent or rights under it.
  3. Submit this document to the USPTO as a separate paper from any assignment document.
  4. Clearly label the document as “Designation of Domestic Representative.”
  5. Ensure the document is signed in accordance with 37 CFR 1.33(b).

As stated in MPEP 302.04: “The designation of domestic representative should always be submitted to the Office as a paper separate from any assignment document.”

How long does it take for a patent assignment to be recorded by the USPTO?

The time it takes for a patent assignment to be recorded by the USPTO can vary. While the MPEP does not specify an exact timeframe, the process typically takes several weeks. Factors affecting the recording time include:

  • Method of submission (electronic vs. paper)
  • Completeness and accuracy of the submitted documents
  • Current USPTO workload

According to the MPEP 302, ‘The date of recording of a document is the date of its receipt in the Office in proper form with the appropriate fee.’ This means that the official recording date is the date the USPTO receives a compliant submission, not the date when processing is completed.

For the most up-to-date information on processing times, it’s advisable to check the USPTO website or contact their assignment recordation branch directly.

Patent restrictions for former USPTO employees extend for one year after their employment ends. 35 U.S.C. 4 states:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office.’

After this one-year period, former employees can apply for patents, but with certain limitations on priority dates.

The recording fee for multiple patents or applications is calculated on a per-item basis. According to MPEP 302.06:

The recording fee set in 37 CFR 1.21(h) is charged for each patent application and patent identified in the required cover sheet except as provided in 37 CFR 3.41(b).

This means that if you are recording a document that affects multiple patents or applications, you will need to pay a separate fee for each one listed on the cover sheet. However, remember that for electronic submissions, the current fee is $0 per item.

To learn more:

Tags: USPTO fees

How is the receipt date determined for faxed assignment documents at the USPTO?

The determination of the receipt date for faxed assignment documents at the USPTO is crucial for establishing priority and effective dates. According to MPEP 302.09:

“The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.”

This means that:

  • The receipt date is when the entire document has been successfully transmitted and received by the USPTO.
  • Partial transmissions or incomplete faxes will not establish a receipt date.
  • The time zone of the USPTO (Eastern Time) is used for determining the date.
  • If a transmission is completed after business hours, the next business day may be considered the receipt date.

It’s important to ensure that the fax transmission is complete and to keep confirmation records of the transmission for your files.

To learn more:

The enforceability of patent arbitration awards is contingent upon proper notice being filed with the USPTO. According to 35 U.S.C. 294(e) and 37 CFR 1.335(c):

‘The award shall be unenforceable until the notice required by subsection (d) is received by the Director.’

This means that until the proper notice of the arbitration award is filed with the USPTO, the award cannot be enforced. It’s crucial for parties involved in patent arbitration to ensure that all required notices are filed promptly to maintain the enforceability of the award.

Patent ownership can be transferred through an assignment. According to 35 U.S.C. 261, assignments of patent applications, patents, or any interest therein must be in writing. The MPEP defines an assignment as:

‘a transfer by a party of all or part of its right, title and interest in a patent [or] patent application….’

An assignment transfers the entire ownership interest or a percentage of that interest in the patent or application. It must include the entirety of the bundle of rights associated with the ownership interest.

The initial ownership of a patent depends on the filing date of the application. For applications filed on or after September 16, 2012, the MPEP states:

‘For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of the application for an original patent. See 37 CFR 3.73(a).’

For applications filed before September 16, 2012:

‘For applications filed before September 16, 2012, the ownership of the patent (or the application for the patent) initially vests in the named inventors of the invention of the patent.’

This distinction is important for determining the initial owner of a patent or patent application.

When there are multiple assignees or a combination of partial assignees and inventors, establishing ownership for patent applications becomes more complex. According to MPEP 325 and 37 CFR 3.73(c)(2), each owner must submit a statement that either:

  1. Specifies the percentage of their ownership interest, accounting for the entire right, title, and interest in the application or patent, or
  2. Identifies all parties, including inventors, who together own the entire right, title, and interest, and states that all identified parties own the entire right, title, and interest.

The MPEP states: “Where there is more than one assignee (i.e., partial assignees) or a combination of partial assignees and inventors who have not assigned away their right, title and interest in the application, each owner must submit a statement under 37 CFR 3.73(c) that either:

(A) Specifies (by percentage) the extent of its ownership interest, so as to account for the entire right, title and interest in the application or patent by all parties. 37 CFR 3.73(c)(2)(i); or

(B) Identifies the parties including inventors who together own the entire right, title and interest and state that all the identified parties own the entire right, title and interest. 37 CFR 3.73(c)(2)(ii).”

If the extent of ownership is not clearly set forth, the USPTO may refuse to accept the submission as an establishment of ownership interest.

For more information on multiple assignees, visit: multiple assignees.

For more information on ownership interest, visit: ownership interest.

For more information on partial assignees, visit: partial assignees.

When there are multiple assignees for a patent application, patent, or reexamination proceeding, each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b) to take action before the USPTO. The process is as follows:

  1. Each partial assignee must submit their own pre-AIA 37 CFR 3.73(b) statement.
  2. In each submission, the extent of the assignee’s ownership interest must be clearly stated.
  3. The USPTO needs to determine if it has obtained action by all of the right, title, and interest holders (owners).
  4. If the extent of ownership is not clearly set forth, the USPTO may refuse to accept the submission.

This is outlined in MPEP 324, section VIII, which states:

“When an assignee seeks to take action in a matter before the Office with respect to a patent application, patent, or reexamination proceeding and the right, title, and interest therein is held by more than one assignee, each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b). In each submission, the extent of each assignee’s interest must be set forth so that the Office can determine whether it has obtained action by the entirety of the right, title and interest holders (owners).”

The MPEP further notes: “If the extent of the partial assignee’s ownership interest is not set forth in the submission under pre-AIA 37 CFR 3.73(b), the Office may refuse to accept the submission as an establishment of ownership interest.”

For continuing applications (continuation or divisional) filed under 37 CFR 1.53(b) before September 16, 2012, ownership can be established in one of two ways:

  1. The application papers can contain a copy of a statement filed under pre-AIA 37 CFR 3.73(b) in the parent application.
  2. A newly executed statement under pre-AIA 37 CFR 3.73(b) can be filed with the continuing application.

For continuation-in-part applications filed before September 16, 2012, a newly executed statement under pre-AIA 37 CFR 3.73(b) must be filed.

In the case of design applications where a continued prosecution application (CPA) is filed under 37 CFR 1.53(d), the statement filed under 37 CFR 3.73(b) in the parent application will serve as the statement for the CPA.

This is outlined in MPEP 324, section III, which states: “When an assignee files a continuation or divisional application under 37 CFR 1.53(b) before September 16, 2012, the application papers must: (A) contain a copy of a statement filed under pre-AIA 37 CFR 3.73(b) in the parent application; or (B) contain a newly executed statement under pre-AIA 37 CFR 3.73(b).”

Assignment information printed on a patent follows these guidelines:

  • Only the first appearing name of an assignee will be printed on the patent, even if multiple names for the same party are identified on the Fee(s) Transmittal form (PTOL-85B).
  • This printing practice does not affect the recording of assignments with the USPTO’s Assignment Division.
  • The assignee entry on the PTOL-85B should still include all assignment data as recorded in the Office.

For example: The assignee entry on form PTOL-85B should still be completed to indicate the assignment data as recorded in the Office. For example, the assignment filed in the Office and, therefore, the PTOL-85B assignee entry might read ‘Smith Company doing business as (d.b.a.) Jones Company.’ The assignee entry on the printed patent will read ‘Smith Company.’

It’s important to note that assignment information printed on a patent is not updated after issuance and may not reflect subsequent assignments recorded in the Office.

Enforcement of arbitration awards in patent cases requires specific steps as outlined in 35 U.S.C. 294(d) and 37 CFR 1.335. Key points include:

  • The patentee, assignee, or licensee must file a written notice of the award with the USPTO Director.
  • The notice must include details about the patent, parties involved, and a copy of the award.
  • The award is unenforceable until the required notice is received by the Director.

As stated in 35 U.S.C. 294(e): “The award shall be unenforceable until the notice required by subsection (d) is received by the Director.”

This requirement ensures that the USPTO is informed of arbitration outcomes affecting patent rights.

For more information on arbitration awards, visit: arbitration awards.

For more information on patent enforcement, visit: patent enforcement.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO treats conditional assignments as absolute assignments for Office purposes. According to 37 CFR 3.56:

“Assignments which are made conditional on the performance of certain acts or events, such as the payment of money or other condition subsequent, if recorded in the Office, are regarded as absolute assignments for Office purposes until canceled with the written consent of all parties or by the decree of a court of competent jurisdiction.”

The USPTO does not determine whether conditions have been fulfilled. Recording a conditional assignment is treated as signifying that the condition has been met.

To learn more:

The USPTO has a specific process for handling notices of arbitration awards related to patents. According to the Manual of Patent Examining Procedure (MPEP) Section 311:

“The written notices required by this section should be directed to the attention of the Office of the Solicitor. The Office of the Solicitor will be responsible for processing such notices.”

This process involves:

  • Directing all written notices of arbitration awards to the Office of the Solicitor.
  • The Office of the Solicitor taking responsibility for processing these notices.
  • Ensuring that the notices are properly recorded and associated with the relevant patent files.

This centralized approach helps maintain accurate records of arbitration outcomes affecting patent rights and ensures that the information is properly managed within the USPTO system.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has an automated system for processing assignment documents submitted by fax. According to MPEP 302.09:

  1. Documents are submitted directly into the automated Patent and Trademark Assignment System.
  2. A recordation notice is automatically returned to the sending fax number.
  3. If the system can’t complete the transmission, the notice is printed and mailed via U.S. Postal Service first class mail.
  4. The Patent and Trademark Assignment System assigns reel and frame numbers and adds recordation stampings to the processed electronic images.

The MPEP states: The Patent and Trademark Assignment System assigns reel and frame numbers and superimposes recordation stampings on the processed and stored electronic images. Accordingly, copies of all recorded documents will have the reel and frame numbers and recordation stampings.

This automated process ensures efficient handling and proper documentation of assignment records.

To learn more:

The USPTO maintains a clear separation between assignment documents and patent files to ensure proper organization and management of records. MPEP 318 specifies:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This separation is maintained by:

  • Directing assignment documents to the Assignment Division instead of application or patent files
  • Keeping a separate database for assignment records
  • Ensuring that patent examiners and other USPTO personnel refer to the Assignment Division for ownership information
  • Maintaining distinct processes for handling assignments and patent prosecution

This approach helps in preserving the integrity of both assignment records and patent files while facilitating efficient access to ownership information when needed.

To learn more:

How does the USPTO handle requests for early delivery of patents?

The USPTO has a specific process for handling requests for early delivery of patents. According to MPEP 308:

“Ordinarily the patent grant is delivered to the correspondence address of record. However, a patentee may request in writing before the issue date that the patent grant be delivered to another address or to an assignment recordation branch of the USPTO for recordation of an assignment, provided a fee is paid for the service.”

This means that:

  • Patentees can request early delivery of their patent grant
  • The request must be made in writing before the issue date
  • A fee is required for this service
  • The patent can be delivered to an alternative address or to the assignment recordation branch

Early delivery requests are typically made when there’s an urgent need to record an assignment or to obtain the physical patent document for business purposes.

For more information on patent grant, visit: patent grant.

For more information on USPTO procedures, visit: USPTO procedures.

How does the USPTO handle incorrect or erroneous assignment recordings?

The USPTO has a specific process for handling incorrect or erroneous assignment recordings:

  1. No expungement: The USPTO does not expunge or remove assignment documents once they are recorded.
  2. Corrective documents: Parties can record corrective documents to address errors or provide clarifications.
  3. Maintaining integrity: This approach preserves the integrity of the assignment records.

As stated in MPEP 302: ‘Even if a recorded document is subsequently found to be invalid, the recording will be maintained in the assignment records and the assignment records will not be expunged.’ This policy ensures a complete historical record of all recorded documents.

For more information on USPTO records, visit: USPTO records.

When errors are made in the execution of an original assignment document, the USPTO allows for the submission of a ‘substitute statement’ to correct these errors. According to MPEP 323:

“Where errors were made in the execution of the original assignment document … a ‘substitute statement’ may be submitted for recordation.”

The process involves:

  • Preparing a new, correctly executed assignment document.
  • Submitting this as a ‘substitute statement’ along with a copy of the originally recorded papers.
  • Clearly identifying the errors in the original document.
  • Paying the required recording fee.

The USPTO will then record the substitute statement, which effectively replaces the erroneous original assignment document.

For more information on patent assignment, visit: patent assignment.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

The USPTO recognizes and accepts electronic signatures on assignment documents submitted electronically. According to MPEP 302.10:

“The USPTO will accept electronic signatures on documents submitted electronically.”

This means that assignors and assignees can use various forms of electronic signatures, such as:

  • Typed names
  • Digital signatures
  • Scanned images of handwritten signatures

It’s important to ensure that the electronic signature complies with the USPTO’s requirements and is legally binding. The specific requirements for electronic signatures are outlined in MPEP 502.02.

To learn more:

When discrepancies are found in title reports, the USPTO takes specific actions to address them. The MPEP 320 states:

If there are discrepancies between the title report and the instrument(s) recorded in the USPTO or the file contents, the title report is returned to the paralegal with an explanation of the discrepancy. The paralegal then contacts the person who ordered the title report and requests correction.

This process ensures that any issues with ownership or chain of title are resolved before the patent application proceeds further.

For more information on ownership verification, visit: ownership verification.

For more information on USPTO procedures, visit: USPTO procedures.

How does the USPTO handle confidential patent assignment information?

The USPTO generally treats patent assignment records as public information. However, there are provisions for handling confidential information within these records. MPEP 301.01 states:

“Assignments and other documents affecting title to applications, patents, and registrations that are recorded in the USPTO are generally open to public inspection. Only documents that are sealed as provided in 37 CFR 1.14 or otherwise not open to public inspection are not available for public inspection.”

If a document contains sensitive information that should not be publicly disclosed, the parties involved can:

  • Redact confidential information before submitting the document for recordation
  • Request that certain documents be sealed under 37 CFR 1.14
  • Submit separate public and non-public versions of documents when necessary

It’s important to note that the decision to seal documents is at the discretion of the USPTO and is generally limited to specific circumstances outlined in the regulations.

The USPTO provides a specific process for handling confidential license agreements. According to MPEP 313:

“If the document to be recorded is a confidential license agreement, such as a trade secret agreement, the instrument must be submitted with a cover sheet to request redaction of the document. The parties must include all of the information required by 37 CFR 3.31, and additionally state that the document is confidential and identify the item(s) for which redaction is being requested.”

This process allows parties to protect sensitive information while still recording the existence of the license agreement with the USPTO.

How does the USPTO handle changes in ownership of patents?

The USPTO handles changes in ownership of patents through a process of recording assignments. According to MPEP 301:

“The assignment of a patent, or patent application, is the transfer of the entire right, title and interest therein. An assignment of an application may be made before the application is filed or after it is filed.”

When a change in ownership occurs:

  • The new owner must record the assignment with the USPTO
  • This recording serves as public notice of the transfer
  • It helps maintain clear records of patent ownership

The USPTO maintains these records and updates them as new assignments are recorded.

For more information on assignment recording, visit: assignment recording.

For more information on USPTO procedures, visit: USPTO procedures.

While a prior assignment recorded against an original application is automatically effective for division and continuation applications, the USPTO does not automatically update its assignment records for these new applications. As stated in MPEP 306:

Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

This means that even though the assignment is legally effective, the USPTO’s records won’t show it unless the assignee takes specific action. To ensure the USPTO’s records are up to date, assignees should:

  • File a request for recordation of the assignment for the new application
  • Ensure the request complies with 37 CFR 3.28
  • Pay the required fee as specified in 37 CFR 3.41

How does the USPTO handle assignment documents that contain errors?

The USPTO has procedures in place for handling assignment documents with errors:

  • Minor errors: The USPTO may correct minor errors in assignment documents without requiring a new submission. As stated in MPEP 302: ‘Minor corrections to documents recorded pursuant to 37 CFR 3.11 will be made by the Assignment Division, provided that the corrections do not involve the re-recording of the entire assignment document.’
  • Major errors: For significant errors, a new corrected document must be submitted. The MPEP notes: ‘Other corrections may be made only by the submission of a new document.’
  • Erroneous recording: If an assignment is erroneously recorded, the USPTO will correct its records upon notification.

It’s important to review assignment documents carefully before submission to avoid delays and potential legal issues.

For more information on document correction, visit: document correction.

For more information on USPTO procedures, visit: USPTO procedures.

How does the USPTO handle assignment documents after recording?

After recording an assignment document, the USPTO follows a specific process. According to MPEP 302.01: ‘Assignment documents submitted for recording are scanned and stored in a public database.’

The handling process includes:

  • Scanning the submitted copy of the assignment document
  • Storing the scanned document in a publicly accessible database
  • Retaining the physical copy submitted (not returning it to the sender)
  • Making the recorded information available for public inspection

This process ensures that assignment records are preserved and accessible while maintaining the integrity of the original submissions.

To learn more:

The USPTO has different fee structures for recording patent and trademark documents. According to MPEP 302.06:

Additionally, for patent documents:

  • Electronic submissions currently have a $0 fee
  • Paper or fax submissions have a fee set in 37 CFR 1.21(h)(2)

It’s important to note that trademark fees may differ and do not have the same $0 electronic submission option as patents. Always check the current USPTO fee schedule for the most up-to-date information.

To learn more:

The USPTO follows a specific process to determine if an error on a cover sheet is typographical in nature. According to MPEP 323.01(a):

“The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.”

This process involves:

  • Reviewing the corrected cover sheet submitted by the requesting party
  • Comparing it to the original cover sheet
  • Examining the originally recorded assignment document or other title-affecting document
  • Assessing whether the error is purely typographical or if it substantively affects the title or assignment

If the error is determined to be typographical and does not affect the title, the Assignment Services Division will record the corrected cover sheet and update the Assignment Historical Database. However, if the error affects the title, different procedures apply, including potential changes to the recordation date.

To learn more:

The September 16, 2012 date is significant for assignment procedures in applications claiming the benefit of a provisional application. For applications filed on or after this date, the assignment rules are more flexible:

  • If the application includes new subject matter not in the provisional application, new assignment papers are not required if the assignee is the original applicant in the later application.
  • For applications filed before this date, new assignment papers are always required if there’s new subject matter, regardless of who the assignee is.

This change aligns with the implementation of the America Invents Act. As stated in MPEP § 306.01: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

To learn more:

The Patent and Trademark Office (PTO) generally does not directly handle patent ownership disputes. According to MPEP 301:

The Patent and Trademark Office is not the forum for resolving patent ownership disputes. Such disputes are to be settled by the parties involved, outside the Patent and Trademark Office.

If there’s a dispute over ownership, the PTO will typically continue to recognize the owner of record until a court order or other legal document resolving the dispute is presented. Parties involved in ownership disputes should seek legal counsel and resolve the matter through appropriate legal channels.

How does the government’s march-in rights affect contractor-owned inventions?

The government’s march-in rights are a significant aspect of federally sponsored research and development contracts. As outlined in MPEP 310:

“The government has the right to require the contractor to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant(s) upon terms that are reasonable under the circumstances, if the contractor fails to take effective steps to achieve practical application of the invention.”

March-in rights allow the government to intervene if:

  • The contractor fails to commercialize the invention within a reasonable time.
  • Action is necessary to alleviate health or safety needs.
  • Action is necessary to meet requirements for public use specified by federal regulations.
  • The contractor has breached agreements specified in 35 U.S.C. 204 regarding U.S. manufacture.

These rights ensure that inventions resulting from federally funded research benefit the public, even if the contractor fails to do so effectively.

For more information on contractor-owned inventions, visit: contractor-owned inventions.

For more information on federally sponsored research, visit: federally sponsored research.

The Government License Rights statement, as required by 35 U.S.C. 202(c)(6) and described in MPEP 310, does not transfer ownership of the patent to the government. Instead, it acknowledges that:

“The government has certain rights in the invention.”

These rights typically include:

  • A non-exclusive, non-transferable, irrevocable, paid-up license to practice or have practiced the invention for or on behalf of the United States throughout the world
  • March-in rights, allowing the government to require the contractor to grant licenses to third parties under certain circumstances
  • The right to receive periodic reports on the utilization of the invention

While the contractor retains ownership and the right to commercialize the invention, they must operate within the framework of these government rights.

The Bayh-Dole Act, as implemented in 37 CFR Part 401, significantly affects government rights in federally funded inventions:

  • It allows contractors (including small businesses and nonprofit organizations) to retain title to inventions made under federally funded research and development contracts.
  • The government receives a nonexclusive, nontransferable, irrevocable, paid-up license to practice the invention.
  • The Act encourages the commercialization of federally funded inventions while protecting the government’s interests.

As stated in the MPEP: ‘The Bayh-Dole Act… provides, in essence, that nonprofit organizations and small business firms may retain title to inventions made under federally funded research and development contracts.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

The assignment process for continuations-in-part (CIPs) differs from other application types due to the potential inclusion of new subject matter. The MPEP § 306.01 explains:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein. This is similar to the practice with respect to continuations-in-part filed under 35 U.S.C. 120.

In essence:

  • For continuations and divisions that contain only subject matter from the parent application, the original assignment usually remains effective.
  • For CIPs or applications with new subject matter not in the parent or provisional application, new assignment papers are typically required, with the exception noted for applications filed on or after September 16, 2012, where the assignee is the original applicant.

This difference reflects the unique nature of CIPs, which introduce new matter not present in the parent application.

The assignment process for continuation-in-part (CIP) applications claiming benefit of a provisional application differs from standard continuations or divisions:

  • If the CIP includes new subject matter not in the provisional application, new assignment papers are typically required.
  • This requirement is similar to the practice for CIPs filed under 35 U.S.C. 120.
  • An exception exists for applications filed on or after September 16, 2012, where the assignee is the original applicant in the CIP.

MPEP § 306.01 states: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein. This is similar to the practice with respect to continuations-in-part filed under 35 U.S.C. 120.

This approach ensures that the assignment covers all subject matter in the CIP, including new material not present in the provisional application.

To learn more:

For pre-AIA patent applications (filed before September 16, 2012), partial assignees have specific rights and requirements when it comes to patent ownership and prosecution. According to MPEP 324:

A partial assignee is any assignee of record having less than the entire right, title and interest in the application. Where at least one inventor retains an ownership interest together with the partial assignee(s), the combination of all partial assignees and inventors retaining ownership interest is needed to conduct the prosecution of an application.

This means that if there are multiple partial assignees or a combination of partial assignees and inventors, they must act together to prosecute the application. Additionally, when establishing ownership:

  • Each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b).
  • The extent of each assignee’s interest must be clearly stated.
  • The Office must be able to determine if it has obtained action by all of the right, title, and interest holders.

If the extent of ownership is not clear, the USPTO may refuse to accept the submission as an establishment of ownership interest.

For more information on joint ownership, visit: joint ownership.

For more information on partial assignees, visit: partial assignees.

For more information on pre-AIA applications, visit: pre-AIA applications.

MPEP 318 provides clear guidance to patent examiners on how to handle assignment documents. The section states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This instruction serves to:

  • Remind examiners not to include assignment documents in the main application file
  • Direct examiners to forward any received assignment documents to the Assignment Division
  • Ensure that the proper procedures for recording assignments are followed
  • Maintain the separation between technical examination and ownership recording

By following this guidance, patent examiners help maintain the integrity of both the application files and the assignment records.

MPEP 310 is closely related to the Bayh-Dole Act, officially known as the Patent and Trademark Law Amendments Act. Here’s how they are connected:

  • The Bayh-Dole Act allows contractors to retain title to inventions made with federal funding.
  • It requires contractors to disclose these inventions and include a statement in patent applications about government support.
  • MPEP 310 provides specific guidance on implementing the Bayh-Dole Act’s requirements, particularly the government license rights statement.
  • The statutory basis for MPEP 310 is 35 U.S.C. 202(c)(6), which is part of the Bayh-Dole Act.

In essence, MPEP 310 serves as a practical guide for patent applicants to comply with the Bayh-Dole Act’s provisions regarding government-funded inventions.

How does joint ownership work for patents?

Joint ownership in patents occurs when two or more parties share ownership rights. The MPEP 301 provides guidance on this:

‘In the case of joint owners, each joint owner has the right to make, use, offer for sale, and sell the patented invention without the consent of and without accounting to the other owners.’

This means that each joint owner has full rights to use and profit from the patent independently, without needing permission from the other owners. However, this can lead to complications, especially in licensing or selling the patent, as all joint owners typically need to agree on such actions. It’s often advisable for joint owners to have a written agreement outlining their rights and responsibilities.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

Joint ownership in patents and patent applications occurs when two or more parties share ownership rights. According to MPEP 301:

“Joint inventors are treated as joint owners of the invention unless there is an assignment.”

Key aspects of joint ownership include:

  • Each joint owner has the right to make, use, sell, and license the invention without consent from other owners.
  • Profits do not need to be shared unless there’s a specific agreement.
  • All joint owners must agree to sell or assign the entire patent to a third party.
  • In infringement suits, all joint owners must be joined as plaintiffs.

It’s important for joint owners to have clear agreements in place to avoid potential conflicts and ensure proper management of the patent rights.

For more information on joint inventors, visit: joint inventors.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

The effect on the date of recordation depends on whether the error affects title to the application or patent. According to MPEP 323.01(a):

  1. Errors that do not affect title: If the typographical error does not affect title, the Assignment Services Division will correct the Assignment Historical Database and allow the recording party to keep the original date of recordation.
  2. Errors that affect title: If the error affects title to the application or patent, the recording party will not keep the original date of recordation. The MPEP states: Rather, the Assignment Services Division will correct its automated records and change the date of recordation to the date the corrected cover sheet was received in the Office.

It’s crucial to ensure accuracy in cover sheets to maintain the earliest possible recordation date, especially for errors that could affect title to the application or patent.

To learn more:

For division and continuation applications, a prior assignment recorded against the original application is automatically applied to the new application. This is because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.

However, it’s important to note that while the assignment is effective for the new application, the USPTO’s assignment records will not automatically reflect this. As stated in the MPEP: Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

For applications claiming the benefit of a provisional application under 35 U.S.C. 119(e), the assignment process depends on the content of the later application:

  • If the later application includes only subject matter from the provisional application, an assignment recorded against the provisional application will be effective for the later application.
  • If the later application includes new subject matter not in the provisional application, new assignment papers must be recorded for the later application, unless it was filed on or after September 16, 2012, and the assignee is the original applicant.

As stated in MPEP § 306.01: If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

To learn more:

The assignment process for applications claiming benefit of a provisional application is similar to that of continuations and divisions in certain circumstances:

  • When the later application includes only subject matter from the provisional application, the assignment treatment is the same as for continuations and divisions filed under 35 U.S.C. 120.
  • In these cases, an assignment recorded against the provisional application will be effective in the later application.

MPEP § 306.01 states: If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

This similarity in treatment simplifies the assignment process when no new subject matter is introduced in the later application.

To learn more:

To establish the right to take action in a patent application filed before September 16, 2012, an assignee must meet the following requirements:

  • The assignee must be of the entire right, title, and interest in the application.
  • A proper documentary evidence of chain of title from the original owner to the assignee must be submitted.
  • The evidence must be recorded in the United States Patent and Trademark Office (USPTO) no later than the date of payment of the issue fee.

As stated in MPEP 324: The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted.

It’s important to note that these requirements are specific to applications filed before September 16, 2012. Different rules may apply for applications filed on or after this date.

For more information on assignee rights, visit: assignee rights.

For more information on chain of title, visit: chain of title.

For more information on documentary evidence, visit: documentary evidence.

For more information on USPTO, visit: USPTO.

To establish ownership and take action in a patent application filed on or after September 16, 2012, an assignee who is not the original applicant must:

  1. File a request to change the applicant under 37 CFR 1.46(c)(2)
  2. File an application data sheet under 37 CFR 1.76 specifying the assignee as the applicant
  3. Submit a statement under 37 CFR 3.73(c) establishing ownership

The 37 CFR 3.73(c) statement must contain either:

  • Documentary evidence of a chain of title from the original owner to the assignee and a statement affirming that the documentary evidence was submitted for recordation, or
  • A statement specifying where such evidence is recorded in the Office (e.g., reel and frame number)

The MPEP states: “The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted.”

An assignee establishes ownership in a patent application by filing a statement under 37 CFR 3.73(c). According to MPEP 325:

“The statement under 37 CFR 3.73(c) must be filed in the application or patent where ownership must be established and must contain:
(A) documentary evidence of a chain of title from the original owner to the assignee; or
(B) a statement specifying where documentary evidence of a chain of title from the original owner to the assignee is recorded in the assignment records of the Office.”

This statement serves as proof of the assignee’s right to take action in the application.

For more information on assignee ownership, visit: assignee ownership.

For more information on chain of title, visit: chain of title.

A title report plays a crucial role in the patent examination process by providing essential ownership information. According to the MPEP Section 320, “The title report is placed in the file wrapper.” This means that:

  • Examiners have access to the most current ownership information
  • It helps ensure that communications are sent to the correct parties
  • It assists in identifying potential issues related to inventorship or ownership

By having accurate ownership information, the examination process can proceed more efficiently and with fewer complications related to ownership disputes or incorrect parties being involved in the process.

For more information on ownership information, visit: ownership information.

For more information on patent examination, visit: patent examination.

For more information on title report, visit: title report.

To designate a domestic representative, a foreign assignee must follow these steps:

  • Prepare a written document signed by the assignee
  • Clearly label the document as ‘Designation of Domestic Representative’
  • Submit the designation as a separate paper from any assignment document
  • Ensure the document is signed in accordance with 37 CFR 1.33(b)

As stated in MPEP 302.04, The designation of domestic representative should always be submitted to the Office as a paper separate from any assignment document. This ensures proper processing and entry into the record of the appropriate application or patent file.

To learn more:

USPTO examiners have a specific internal process for obtaining title reports when needed. The MPEP outlines this process:

Examiners may obtain a title report using the PALM Intranet (select “General Information,” insert the appropriate application number, select “Search,” select “Assignments”). The screen resulting from the search may be printed to yield the copy of the title report.

This internal system allows examiners to access ownership information efficiently when required for their examination duties.

When multiple assignees seek to take action in a patent matter, each partial assignee must provide a submission under 37 CFR 3.73(c). According to the MPEP:

In each submission, the extent of each assignee’s interest must be set forth so that the Office can determine whether it has obtained action by the entirety of the right, title and interest holders (owners). 37 CFR 3.73(c)(2)(i).

Assignees have two options:

  1. Specify the percentage of ownership interest for each assignee, accounting for 100% of ownership.
  2. Identify all parties (including inventors) who together own the entire right, title, and interest, and state that all identified parties own the entire right, title, and interest.

The MPEP warns: “If the extent of the partial assignee’s ownership interest is not set forth in the submission under 37 CFR 3.73(c), the Office may refuse to accept the submission as an establishment of ownership interest.”

How do I submit supporting documents for electronic assignment submissions?

When submitting assignment documents electronically, you can include supporting documents as follows:

  • Upload supporting documents as separate PDF files along with the main assignment document.
  • Ensure each supporting document is less than 25 MB in size.
  • Include a brief description for each supporting document during the submission process.

According to MPEP 302.10, ‘Supporting documents can be submitted as PDF files via EFS-Web and EPAS.’ This allows for a comprehensive submission of all relevant materials related to the assignment.

To learn more:

To request copies of patent assignment records, follow these steps:

  1. For records after May 1, 1957: Contact the USPTO and pay the fee set forth in 37 CFR 1.19.
  2. For records before May 1, 1957: Contact the National Archives and Records Administration (NARA) directly.
  3. For recent records: Check the USPTO website for online availability.

When requesting a copy, the MPEP advises: “An order for a copy of an assignment or other document should identify the reel and frame number where the assignment or document is recorded.” Failure to provide this information may result in additional charges.

To record an assignment document with the USPTO, you must:

  • Submit a copy of the original assignment document
  • Include a completed cover sheet (Form PTO-1595 or equivalent)
  • Pay the required recording fee

The cover sheet must contain key information like the names of the parties, description of the interest conveyed, and patent/application numbers affected. As stated in MPEP 302.07: “Each assignment document submitted to the Office for recording must be accompanied by a cover sheet as required by 37 CFR 3.28.”

Documents can be submitted electronically via EPAS, by mail, or by fax. Electronic submission is recommended as it has a $0 fee.

For more information on assignment recording, visit: assignment recording.

For more information on cover sheet, visit: cover sheet.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

To record a security interest in a patent or patent application:

  • Submit the document to be recorded to the USPTO’s Assignment Recordation Branch.
  • Include a cover sheet with the necessary information, as specified in MPEP 313.
  • Pay the required fee.

The MPEP states: Documents other than assignments are recorded in the same manner as assignments. The document and cover sheet should be mailed to the Office of Public Records Document Services Division for recording.

For more information on USPTO, visit: USPTO.

Tags: USPTO

To record a joint research agreement (JRA) with the USPTO, follow these steps:

  1. Prepare the JRA document or an excerpt of it
  2. Complete a cover sheet, clearly identifying the document as a “joint research agreement”
  3. Submit the document and cover sheet to the USPTO

As stated in MPEP 302.07: “If the document submitted for recordation is a joint research agreement or an excerpt of a joint research agreement, the cover sheet must clearly identify the document as a ‘joint research agreement’.”

The cover sheet for a JRA must include:

  • The name of the owner of the application or patent
  • The name of each other party to the joint research agreement
  • The date the joint research agreement was executed

JRAs can be submitted electronically via EPAS, by mail, or by fax, following the same procedures as other assignment documents.

For more information on joint research agreement, visit: joint research agreement.

Recording a government interest in a patent requires special procedures:

  1. Prepare the document establishing the government interest
  2. Complete a patent cover sheet, indicating it relates to a government interest
  3. Submit the document and cover sheet to the USPTO

As stated in MPEP 302.07: “Cover sheets required by 37 CFR 3.28 seeking to record a governmental interest must also (1) indicate that the document relates to a governmental interest and (2) indicate, if applicable, that the document to be recorded is not a document affecting title.”

Key points for government interest recordations:

  • No fee is required if the document doesn’t affect title and is properly identified
  • These documents are recorded in a special Departmental Register
  • Some government documents may be recorded in a Secret Register with restricted access

Government agencies should follow Executive Order 9424 which requires prompt forwarding of government interests in patents for recording.

For more information on patent recordation, visit: patent recordation.

According to 37 CFR 3.21, a patent assignment must identify the patent by patent number. For patent applications:

  • National applications: Identify by application number (series code and serial number)
  • International applications designating the US: Identify by international application number
  • International design applications designating the US: Identify by international registration number or US application number

If the assignment is executed before filing but after the application is executed, it must identify the application by inventor name(s) and invention title. For provisional applications not yet filed, identify by inventor name(s) and invention title.

The MPEP suggests including language like: I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.

For more information on application identification, visit: application identification.

For more information on patent assignment, visit: patent assignment.

For more information on patent identification, visit: patent identification.

To properly identify a patent in an assignment, you must use the patent number. According to 37 CFR 3.21, “An assignment relating to a patent must identify the patent by the patent number.” This ensures that there is no ambiguity about which patent is being assigned.

To learn more:

When assigning a provisional application before it’s filed, you must use specific identifying information. MPEP 302.03 provides guidance: “If an assignment of a provisional application under § 1.53(c) of this chapter is executed before the provisional application is filed, it must identify the provisional application by the name of each inventor and the title of the invention so that there can be no mistake as to the provisional application intended.” This ensures that the correct provisional application can be associated with the assignment once it’s filed.

To learn more:

When submitting a corrected cover sheet to address an erroneous assignment or name change, follow these instructions from MPEP 323.01(c):

  1. Check the box titled ‘Other’ in the ‘Nature of Conveyance’ section.
  2. Indicate that the submission is to correct an error in a previously recorded document that erroneously affects the identified application(s) or patent(s).
  3. Write the name of the correct owner in both the ‘conveying party’ and ‘receiving party’ boxes.

The MPEP explains the reasoning behind this: The party should also write the name of the correct owner in both the box requesting the name of the conveying party and the box requesting the name and address of the receiving party; this is to make it clear that ownership never changed and that any assignment or name change recorded against the application(s) or patent(s) was erroneous.

To learn more:

To correct an error in a recorded assignment document, you need to submit a ‘corrective document’ to the Assignment Division. This document should include:

  1. A copy of the original assignment document with corrections made, initialed, and dated by the party conveying the interest.
  2. A new Recordation Form Cover Sheet (form PTO-1595) identifying the submission as a ‘corrective document’ and indicating the reel and frame number of the incorrectly recorded assignment.

The corrective document will be given a new reel and frame number and recording date. A recording fee is required for each patent application and patent affected.

As stated in the MPEP: “The recording fee set forth in 37 CFR 1.21(h) is required for each patent application and patent against which the corrective document is being recorded.” (MPEP § 323)

To correct a typographical error on a recorded cover sheet for a patent assignment, you need to submit the following to the Assignment Services Division:

  • A copy of the originally recorded assignment document (or other document affecting title)
  • A corrected cover sheet
  • The required fee for each application or patent to be corrected

Additionally, it’s recommended to submit a copy of the original cover sheet to facilitate comparison. When filing the corrected cover sheet, you should:

  • Check the box titled “Other” in the “Nature of Conveyance” area
  • Indicate that the submission is to correct an error in a previously recorded cover sheet
  • Identify the reel and frame numbers (if known)
  • Specify the nature of the correction

As stated in MPEP 323.01(a): “The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.”

To learn more:

Business mergers can have significant implications for patent ownership. According to MPEP 314:

Documents of merger are also proper links in the chain of title. They may represent a change of entity as well as a change of name.

This means that when businesses merge, it can result in both a change of the legal entity owning the patent and a change in the name associated with the patent ownership. It’s crucial to properly document these changes to maintain a clear chain of title for the patent.

To learn more:

While the public cannot request title reports directly, they can obtain patent ownership information through other means. The MPEP notes:

The public can request a certified abstract of title. The fee for this service is set forth at 37 CFR 1.19(b)(4).

Additionally, some assignment records are publicly available. For more information on accessible records, refer to MPEP § 301.01.

The process for obtaining copies of assignment records for pending or abandoned applications depends on whether the application is open to the public. The MPEP states:

‘Copies of assignment records relating to pending or abandoned patent applications which are open to the public pursuant to 37 CFR 1.11 or for which copies or access may be supplied pursuant to 37 CFR 1.14 are available to the public.’

For applications that are not open to the public, the process is more restricted:

‘For pending or abandoned applications which are not open to the public pursuant to 37 CFR 1.11 or for which copies or access may not be supplied pursuant to 37 CFR 1.14, information related thereto is only obtainable upon a proper showing of written authority.’

The required written authority varies depending on the application filing date. For applications filed on or after September 16, 2012, it must come from an inventor, applicant, assignee, patent practitioner of record, or someone with written authority from these parties.

Patents and patent applications can be assigned through a written instrument. The MPEP 301 states:

‘Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing.’

This means that patent rights can be transferred from one party to another through a written document. The assignment must be recorded with the USPTO to be effective against subsequent purchasers or mortgagees.

For more information on patent assignment, visit: patent assignment.

The USPTO allows electronic submission of assignment documents through the Electronic Patent Assignment System (EPAS). According to the MPEP:

  • Visit http://epas.uspto.gov for the EPAS system
  • Include an identified application or patent number
  • Complete one online cover sheet for a single transaction

For electronic submissions, the signature must comply with 37 CFR 3.31(a)(7) or 37 CFR 1.4(d)(2). This typically involves an S-signature between forward slashes (e.g., /John Smith/).

The MPEP notes: The fee set in 37 CFR 1.21(h)(1) for recording an electronically submitted document is currently $0. Customers should check the current fee schedule on the Office website before submitting documents for recordation.

The recordation date for electronic submissions is the date the complete transmission is received by the USPTO.

For more information on electronic submission, visit: electronic submission.

For more information on EPAS, visit: EPAS.

For more information on patent assignment, visit: patent assignment.

The USPTO provides an electronic system for submitting assignment documents. According to MPEP 302.10:

“Assignment documents can be submitted electronically via the Office’s Electronic Patent Assignment System (EPAS).”

EPAS allows for convenient and efficient submission of assignment documents directly to the USPTO.

To learn more:

There are three main ways to submit a patent assignment document to the USPTO:

  1. Mail: Documents can be mailed to the address specified in 37 CFR 3.27: Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450.
  2. Fax: Documents can be submitted via facsimile, as outlined in MPEP 302.09. However, certain documents cannot be faxed, such as assignments submitted with new applications.
  3. Electronic Submission: Documents can be submitted electronically through the Electronic Patent Assignment System (EPAS) as described in MPEP 302.10.

Each method has specific requirements and limitations, so it’s important to review the relevant MPEP sections or consult the USPTO website for detailed instructions.

The USPTO provides an online database for searching patent assignment records. According to MPEP 301.01, ‘Assignment records, digests, and indexes are available in the public search room of the USPTO.’ To search online:

  • Visit the USPTO Patent Assignment Search page
  • Enter relevant information such as patent number, assignee name, or assignor name
  • Review the search results for the desired assignment information

The MPEP states, ‘The assignment records of patents and applications are open to public inspection and copies of these records may be obtained upon request and payment of the fee set forth in 37 CFR 1.19(b)(3).’

To request expungement of an assignment record, you need to submit a petition to the USPTO. According to MPEP 323.01(d), the petition should:

  • Clearly identify the assignment record document to be expunged
  • State the reason for expungement
  • Include the fee set forth in 37 CFR 1.17(g)
  • Provide a copy of the original assignment record to be expunged (if available)

The petition should be mailed to the Mail Stop Assignment Recordation Services, Director of the USPTO.

To learn more:

Tags: USPTO

Patent assignments can be recorded with the USPTO in two ways:

  1. In the assignment records: This is done as provided in 37 CFR Part 3. Recording provides public notice of the assignment but does not determine its validity.
  2. In the file of a patent application or patent: This may be necessary for the assignee to take action in the application or patent proceeding.

For a patent to issue to an assignee, the assignment must be recorded or filed for recordation in accordance with 37 CFR 3.11.

It’s important to note that recording an assignment in the USPTO’s assignment records does not automatically allow the assignee to take action in a patent proceeding. Additional steps may be required as outlined in MPEP § 325 for applications filed on or after September 16, 2012, or MPEP § 324 for earlier applications.

For more information on patent assignment, visit: patent assignment.

If you want to record a document for additional patents or applications that has already been recorded in the Assignment Division, you must submit a new recordation request. MPEP 315 outlines the required components:

  1. A copy of the original document (which may be the previously recorded papers with the reel and frame numbers stamped by the Assignment Division, or a copy of such papers)
  2. A completed cover sheet (as per 37 CFR 3.31 and MPEP § 302.07)
  3. The appropriate recording fee (as specified in 37 CFR 1.21(h) and 3.41)

Upon receiving these items, the USPTO will assign a new recording date to that submission, update the assignment database, and include the cover sheet and document as part of the official record.

Obtaining copies of patent assignment records depends on when the assignment was recorded. According to MPEP 301.01:

  1. For assignments recorded on or after May 1, 1957:
    • Copies can be obtained from the USPTO upon request and payment of the fee set forth in 37 CFR 1.19.
    • The MPEP states: “Requests for abstracts of title for assignments of patents recorded after May 1, 1957, are provided by the Certification Division upon request and payment of fee required in 37 CFR 1.19.”
  2. For assignments recorded before May 1, 1957:
    • These records are maintained by the National Archives and Records Administration (NARA).
    • Requests should be directed to NARA directly.
    • The MPEP advises: “Requests for copies of pre-1957 records for patents should be directed to the National Archives and Records Administration (NARA). Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.”

When requesting copies, be sure to identify the reel and frame number where the assignment is recorded to avoid extra charges for search time.

To learn more:

To obtain a copy of a recorded assignment document from the USPTO, you can request a certified copy. According to MPEP 317:

Certified copies of recorded documents may be ordered from the Assignment Division for a fee.

To request a certified copy:

  • Contact the USPTO Assignment Division
  • Provide the necessary information to identify the document
  • Pay the required fee

The USPTO will then provide you with a certified copy of the requested assignment document. This can be useful for legal or business purposes where an official copy of the recorded assignment is needed.

For more information on Assignment Division, visit: Assignment Division.

For more information on certified copies, visit: certified copies.

For more information on USPTO, visit: USPTO.

There are two ways to make a patent assignment of record with the USPTO:

  1. Record the assignment in the USPTO’s assignment records as provided in 37 CFR Part 3. This provides legal notice to the public but does not determine the validity or effect of the assignment.
  2. Make the assignment of record in the file of a patent application, patent, or other patent proceeding. This may be necessary for the assignee to ‘take action’ in the application or proceeding.

For a patent to issue to an assignee, the assignment must be recorded or filed for recordation in accordance with 37 CFR 3.11.

To ensure your corrected assignment documents are considered timely submitted, the USPTO provides two methods as outlined in MPEP 317.02:

  1. Use the certification procedure under 37 CFR 1.8 (see MPEP § 512)
  2. Use the “Priority Mail Express®” procedure under 37 CFR 1.10 (see MPEP § 513)

The MPEP states:

“The certification procedure under 37 CFR 1.8 (see MPEP § 512) or the “Priority Mail Express®” procedure under 37 CFR 1.10 (see MPEP § 513) may be used for resubmissions of returned papers to obtain the benefit of the date of deposit in the United States Postal Service to establish that the papers were returned within the time period specified.”

By using either of these methods, you can establish that your corrected documents were submitted within the specified time period, thus maintaining the original receipt date as the recording date of the document.

To learn more:

If your assignment documents or cover sheets are returned by the Assignment Division, you can correct and resubmit them within a specified time period to maintain the original receipt date. The USPTO states:

“Assignment documents and cover sheets, or copies of the same, which are returned by Assignment Division will be stamped with the original date of receipt by the Office and will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

To ensure timely resubmission, you can use either:

It’s important to note that the specified period for resubmission will not be extended, so prompt action is crucial.

To learn more:

To correct an improperly recorded assignment against your patent or application, follow these steps:

  • File a petition under 37 CFR 1.182 to expunge the improper assignment
  • Include evidence that the recorded assignment is improper
  • Pay the required petition fee

As stated in MPEP 323.01(c): ‘The owner of the patent or application may petition to have such an assignment expunged from the assignment records of the Office.’

To learn more:

To correct an error in a recorded cover sheet, you must follow the procedure outlined in 37 CFR 3.34. Specifically:

  • The error must be apparent when comparing the cover sheet with the recorded document.
  • You must file a corrected cover sheet for recordation.
  • Include a copy of the original document submitted for recording.
  • Pay the required recording fee as set forth in 37 CFR 3.41.

As stated in the MPEP, Any alleged error in a recorded cover sheet will only be corrected if the error is apparent from a comparison with the recorded assignment document. It’s important to carefully review the notice of recordation issued by the Office after recording.

To learn more:

To correct an error in a recorded assignment document at the USPTO, you have two main options:

  • Cover sheet corrections: For errors in the cover sheet data only, you can submit a corrective document identifying the reel and frame number where the assignment is recorded and explaining the correction.
  • Errors in the assignment document: For errors in the actual assignment document, you need to record a corrective document. This can be either a new assignment or other document correcting the original assignment.

As stated in MPEP 323: “The ‘Correction’ box on the Recordation Form Cover Sheet should be checked to indicate that the new submission is to correct an assignment already recorded.”

For more information on assignment correction, visit: assignment correction.

For more information on cover sheet, visit: cover sheet.

For more information on USPTO, visit: USPTO.

If you discover that another party has improperly recorded an assignment or name change against your application or patent, you can correct this error by following the procedure outlined in MPEP 323.01(c):

  1. First, try to contact the party who recorded the erroneous information and request that they record corrective papers.
  2. If unsuccessful, submit the following to the Assignment Services Division:
    • A completed cover sheet identifying the affected application or patent
    • An affidavit or declaration:
      • Identifying yourself as the correct owner
      • Stating that the previously recorded document contained erroneous information
      • Providing the reel and frame number of the incorrectly recorded document
    • The required fee for each application or patent to be corrected

The MPEP advises: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change.

On the corrected cover sheet, check the ‘Other’ box for ‘Nature of Conveyance’ and indicate that you’re correcting an error in a previously recorded document.

To learn more:

To correct a typographical error in a recorded assignment document, you have two main options:

  • Create and record a new document
  • Make corrections to the original document and re-record it

According to MPEP 323.01(b):

If there is an error in the recorded assignment document (or other document affecting title) rather than in the cover sheet, the party responsible for an erroneous document (e.g., the assignor) must either create and record a new document or make corrections to the original document and re-record it.

This means that the assignor (the party transferring the rights) is typically responsible for correcting such errors.

To learn more:

If your assignment document is returned by the USPTO Assignment Division, you can correct it as follows:

  • The returned document will be stamped with the original receipt date.
  • It will come with a letter specifying a time period for correction and resubmission.
  • If resubmitted within this period, the original receipt date may be considered the recording date.
  • You can use the certification procedure (37 CFR 1.8) or “Priority Mail Express” (37 CFR 1.10) for resubmission.
  • If not corrected within the specified period, the new submission date will be the recording date.

MPEP 317.02 states: “If the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

Pre-1957 patent assignment records are maintained by the National Archives and Records Administration (NARA), not the USPTO. According to MPEP 301.01:

“All assignment records from 1837 to April 30, 1957 for patents are now maintained and are open for public inspection in the National Archives Research Room located at the Washington National Records Center Building, 4205 Suitland Road, Suitland, Maryland 20746 and at the Civilian Records Division of the National Archives at College Park, 8601 Adelphi Road, College Park, MD 20740-6001.”

To access these records:

  • Visit the National Archives website at www.archives.gov for information on how to obtain records from these locations.
  • Be prepared to pay fees required by NARA for copies of records.
  • Note that assignment records from before 1837 are not available.

The MPEP advises: “Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.”

To learn more:

Tags: NARA

Patent assignment records can be accessed online through the USPTO’s Assignment Search database. The MPEP states: Assignment records that affect the title of patents and patent applications are recorded in the USPTO’s Assignment Recordation Branch. To access these records:

  • Visit the USPTO Assignment Search website
  • Enter the relevant patent or application number, assignee name, or other search criteria
  • Review the search results for assignment information

This online database provides public access to assignment records, allowing for easy verification of patent ownership.

Foreign assignees can designate a domestic representative for USPTO correspondence as outlined in 35 U.S.C. 293 and 37 CFR 3.61. The MPEP states:

An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative.

Key points for this designation:

  • It should be submitted as a separate paper from any assignment document
  • It should be clearly labeled ‘Designation of Domestic Representative’
  • It will be entered into the record of the appropriate application or patent file
  • It must be signed in accordance with 37 CFR 1.33(b)
  • It should state the name and address of a person residing within the United States

This designation allows for service of process or notice of proceedings affecting the patent or rights under the patent to be served on the designated representative.

For more information on domestic representative, visit: domestic representative.

For more information on foreign assignee, visit: foreign assignee.

For more information on USPTO correspondence, visit: USPTO correspondence.

The MPEP outlines two ways to make an assignment of record with the USPTO:

  1. Recording in the USPTO assignment records: ‘An assignment can be made of record in the assignment records of the Office as provided for in 37 CFR Part 3. Recordation of the assignment provides legal notice to the public of the assignment.’
  2. Filing in a specific application or patent file: ‘An assignment can be made of record in the file of a patent application, patent, or other patent proceeding (e.g., reexamination proceeding).’

The MPEP notes: ‘Recordation of an assignment in the assignment records of the Office does not, by itself, permit the assignee to take action in the application, patent, or other patent proceeding.’

It’s important to understand the differences between these methods and their respective purposes in patent proceedings.

How can an assignee establish the right to take action in a pre-AIA application?

For pre-AIA applications (filed before September 16, 2012), an assignee can establish the right to take action by:

  1. Filing papers in the USPTO demonstrating the chain of title from the inventor to the assignee, or
  2. Specifying in the papers requesting or taking action that action is being taken pursuant to a specific 37 CFR provision.

According to MPEP 324: “The assignee must establish its ownership of the property to the satisfaction of the Director. The chain of title from the inventor to the assignee must be clearly established.” This typically involves submitting assignment documents or other evidence of ownership to the USPTO.

For more information on assignee rights, visit: assignee rights.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

To ensure assignee information appears on an issued patent, the assignee must comply with 37 CFR 3.81(b). This regulation outlines the specific requirements for including assignee data on a patent.

According to MPEP 307, the assignee should:

  • Submit a request for issuance of the application in the name of the assignee
  • Provide the appropriate documentary evidence of ownership (e.g., assignment for patent)
  • Specify the assignee’s name and address

The MPEP states: A request for a patent to be issued to an assignee submitted pursuant to 37 CFR 3.81(b) must state that the document required by 37 CFR 3.81(b) is being submitted to OPAP in order to request that the patent be issued to an assignee.

It’s crucial to follow these steps accurately to ensure the assignee information is properly recorded and appears on the issued patent.

For more information on assignee information, visit: assignee information.

For more information on patent issuance, visit: patent issuance.

According to MPEP 303, applicants who want information about assignment documents must take specific steps:

  1. Request separately certified copies of assignment documents
  2. Submit the fees required by 37 CFR 1.19

The MPEP states:

“Applicants desiring an indication of assignment documents of record should request separately certified copies of assignment documents and submit the fees required by 37 CFR 1.19.” (MPEP 303)

A patent can be issued to an assignee in two main ways:

  • Before paying the issue fee: The assignee can submit a request for issuance in their name along with the issue fee payment. The assignment must be previously recorded or stated to have been filed for recordation.
  • After paying the issue fee: A request can be submitted after the issue fee payment, but it requires additional steps and fees.

According to MPEP 307, “Normally, for a patent to issue to an assignee (other than an assignee who is the applicant in an application filed on or after September 16, 2012), a request for issuance of the application in the name of the assignee must be filed in the United States Patent and Trademark Office (Office) at a date not later than the day on which the issue fee is paid.”

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

Arbitration awards in patent disputes are binding between the parties involved in the arbitration but do not affect others. According to 35 U.S.C. 294(c):

‘An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person.’

However, if the patent is later found invalid or unenforceable by a court, the arbitration award may be modified upon application by any party to the arbitration.

The USPTO handles returned assignment documents as follows:

  • Documents are stamped with the original receipt date.
  • A letter accompanies returned documents explaining the correction needed.
  • If corrected and resubmitted within the specified time, the original receipt date is considered the recording date.
  • Resubmissions can use the certification procedure under 37 CFR 1.8 or the ‘Priority Mail Express®’ procedure under 37 CFR 1.10.
  • If not corrected and resubmitted in time, the new receipt date becomes the recording date.

The MPEP states: The certification procedure under 37 CFR 1.8 or the ‘Priority Mail Express®’ procedure under 37 CFR 1.10 may be used for resubmissions of returned papers to obtain the benefit of the date of deposit in the United States Postal Service to establish that the papers were returned within the time period specified.

For more information on assignment recording, visit: assignment recording.

For more information on document correction, visit: document correction.

For more information on USPTO procedures, visit: USPTO procedures.

When multiple inventors collaborate on an invention, the patent can be issued to them jointly. The MPEP 308 provides guidance on this:

‘If more than one inventor is named in the application, the patent will issue to the inventors jointly.’

This means that all named inventors share ownership of the patent equally, unless they have agreed otherwise or assigned their rights to another party. Each joint inventor has the right to make, use, sell, or license the invention without the consent of the other inventors, subject to any agreements between them.

For more information on joint inventors, visit: joint inventors.

For more information on patent issuance, visit: patent issuance.

How are patent assignment documents filed and stored at the USPTO?

The USPTO has a specific process for filing and storing patent assignment documents. According to MPEP 317:

“All recorded assignments are scanned and stored in an electronic database.”

This means that once an assignment is recorded, it is digitized for easy access and long-term storage. The electronic database allows for efficient retrieval and management of assignment records. Additionally, the MPEP notes:

“The original document is returned to the sender with a notation of the reel and frame numbers.”

This process ensures that the original document is returned to the sender while maintaining a digital copy for USPTO records. The reel and frame numbers serve as reference points for locating the scanned document in the electronic database.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has specific provisions for handling partial assignees in patent issuance:

  1. If one or more assignees, together with one or more inventors, hold the entire right, title, and interest in the application, the patent may issue in the names of both the assignee(s) and the inventor(s).
  2. If multiple assignees hold the entire right, title, and interest to the exclusion of all inventors, the patent may issue in the names of the multiple assignees.

This is outlined in 37 CFR 3.81(c): (1) If one or more assignee, together with one or more inventor, holds the entire right, title, and interest in the application, the patent may issue in the names of the assignee and the inventor. (2) If multiple assignees hold the entire right, title, and interest to the exclusion of all the inventors, the patent may issue in the names of the multiple assignees.

The USPTO has a specific process for handling incomplete patent documents. According to MPEP 317.01:

“Documents not meeting the other requirements for recording, for example, a document submitted without a completed cover sheet or without the required fee, will be returned for correction to the sender where a correspondence address is available.”

This means that if a document is missing essential components like a completed cover sheet or the required fee, the USPTO will return it to the sender for correction, provided that a correspondence address is available.

To learn more:

How are historical patent assignment records maintained?

The USPTO maintains historical patent assignment records separately from more recent records. MPEP 301.01 explains:

‘The historical database of assignments is maintained separate and apart from the database of assignments affecting title recorded since 1980.’

This means that:

  • Records prior to August 1980 are kept in a separate historical database
  • These older records may not be available through the online Patent Assignment Search
  • Accessing historical records may require different procedures or direct contact with the USPTO

For researchers or legal professionals needing access to pre-1980 assignment records, it’s advisable to contact the USPTO’s Patent and Trademark Resource Centers or the Assignment Recordation Branch for assistance.

Documents that don’t meet other recording requirements, such as missing a completed cover sheet or required fee, are handled differently by the USPTO. According to the MPEP, “Documents not meeting the other requirements for recording, for example, a document submitted without a completed cover sheet or without the required fee, will be returned for correction to the sender where a correspondence address is available.” This means that unlike documents with identification issues, these documents are returned to the sender for correction, provided a correspondence address is available.

The Assignment Division of the USPTO handles documents according to specific procedures outlined in MPEP 317. Key aspects include:

  • Documents are numbered, filmed, and indexed into the assignment database.
  • Original documents are returned to the sender or destroyed after filming.
  • Certified copies of recorded documents can be ordered for a fee.
  • The Assignment Division provides searches of the assignment records upon request.

As stated in the MPEP, All documents submitted for recording are numbered, filmed, and indexed into the assignment database. This process ensures proper documentation and accessibility of assignment records.

For more information on Assignment Division, visit: Assignment Division.

For more information on document handling, visit: document handling.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

How are assignments handled when they are not recorded?

When assignments are not recorded, they are still processed by the Assignment Division. According to the MPEP 317:

“All assignments not recorded will be appropriately marked for return to the sender where a correspondence address is available.”

This means that even if an assignment is not officially recorded, the Assignment Division will still handle the document and return it to the sender if possible. It’s important to note that while unrecorded assignments are processed, they do not have the same legal standing as recorded assignments.

For more information on Assignment Division, visit: Assignment Division.

The USPTO makes assignment records accessible to the public in several ways, as described in 37 CFR 1.12:

  1. Separate assignment records for patents and trademarks are maintained and are open to public inspection.
  2. Assignment records, digests, and indexes for patents are available on the USPTO website.
  3. Images of assignment documents recorded from June 1998 onwards are viewable on the Office website.
  4. For earlier records, the public can place an order to view images.

The MPEP notes: ‘The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.’

However, documents relating only to pending unpublished applications are not open to public inspection.

The handling of assignment records for related patent applications, such as divisional, continuation, or continuation-in-part applications, is addressed in MPEP 301.01. The key point is:

If the application on which a patent was granted is a division, continuation, or continuation-in-part of an earlier application, the assignment records of that earlier application will be open to public inspection because copies or access may be supplied to the earlier application pursuant to 37 CFR 1.14.

This policy has several implications:

  • Once a patent is granted on a related application, the assignment records of the parent application become publicly accessible.
  • This applies even if the parent application was previously unpublished or abandoned.
  • The public accessibility extends to all assignment records in the chain of related applications leading to the granted patent.

This approach ensures transparency in the ownership history of patented inventions, allowing interested parties to trace the chain of title through related applications. It’s important for applicants and assignees to be aware of this when considering their IP strategy and the potential disclosure of ownership information for related applications.

For more information on continuation applications, visit: continuation applications.

For more information on public inspection, visit: public inspection.

Assignment records for reissue applications are treated differently from regular patent applications due to their public nature. According to MPEP 301.01:

Assignment records relating to reissue applications are open to public inspection because reissue applications are open to public inspection pursuant to 37 CFR 1.11(b).

This means that once a reissue application is filed, its assignment records become publicly accessible, regardless of whether the original patent’s assignment records were previously confidential. This is because reissue applications are, by nature, related to already-issued patents and are subject to different rules regarding public disclosure.

The public accessibility of reissue application assignment records aligns with the general principle of transparency in the patent system, allowing interested parties to track ownership changes even during the reissue process. This can be particularly important for those monitoring patent rights in specific technological areas or for potential licensees or purchasers of patent rights.

For more information on public inspection, visit: public inspection.

For more information on reissue applications, visit: reissue applications.

The USPTO treats assignment records and application file records as distinct entities. According to MPEP 323.01(d):

Assignment records are recognized as distinct from application file records.

This distinction is important because:

  • Expungement procedures may affect assignment records differently than application file records.
  • Searches in the Assignment Historical Database may yield different results than searches in application files.
  • The process for correcting or modifying information may differ between assignment records and application file records.

Understanding this distinction is crucial for patent attorneys and applicants when managing their intellectual property records and conducting searches in USPTO databases.

To learn more:

No, the USPTO does not determine the legal effect of recorded documents on patent ownership at the time of recordation. The MPEP clearly states:

“The recordation of a document is not a determination of the effect of the document on the chain of title. The determination of what, if any, effect a document has on title will be made by the Office at such times as ownership must be established to permit action to be taken by the purported assignee in connection with a patent or an application.” (MPEP 313)

This means:

  • Recordation is primarily for public notice
  • The USPTO will evaluate ownership when necessary for specific actions
  • Parties should not assume recordation equates to USPTO approval of ownership claims

No, the act of recording a document with the USPTO does not determine its legal effect on patent ownership. The MPEP clearly states:

The recordation of a document is not a determination of the effect of the document on the chain of title.

This means that while the USPTO will record various documents related to patent interests, it does not make any judgments about how these documents affect ownership at the time of recordation. Instead, as the MPEP explains:

The determination of what, if any, effect a document has on title will be made by the Office at such times as ownership must be established to permit action to be taken by the purported assignee in connection with a patent or an application.

For more information on how the USPTO determines ownership when necessary, refer to MPEP § 324 and § 325.

For more information on chain of title, visit: chain of title.

For more information on patent assignment, visit: patent assignment.

No, a mere change of business name does not constitute a change in legal entity for patent purposes. However, it is still an important part of the ownership record. As stated in MPEP 314:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.

This means that while the legal entity remains the same, the name change should be recorded to maintain an accurate chain of title for the patent.

According to MPEP 314, a mere change of business name does not constitute a change in legal entity for patent purposes. The MPEP states:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.

This means that while the legal entity remains the same, documenting the name change is still important for maintaining a clear chain of title for the patent.

To learn more:

Yes, substitute and continuation-in-part (CIP) applications generally require new assignments. As stated in MPEP 306: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

However, there is an exception for applications filed on or after September 16, 2012: Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

Whether you need to pay a fee to correct an error in a recorded assignment at the USPTO depends on the type of correction:

  • Cover sheet corrections: No fee is required for submitting a corrective document to fix errors in the cover sheet data.
  • Assignment document corrections: A recording fee is required when submitting a new corrective assignment document.

According to MPEP 323: “The recordation fee set forth in 37 CFR 1.21(h) is required for each application and patent against which the document is recorded.” This fee applies when recording a new corrective document, but not for simple cover sheet corrections.

For more information on USPTO fees, visit: USPTO fees.

Tags: USPTO fees

No, certified copies of patent applications as filed do not include an indication of assignment documents. According to the MPEP 303, “Certified copies of patent applications as filed do not include an indication of assignment documents.” This means that the initial certified copy of a patent application does not contain information about any assignments that may have been recorded.

For more information on assignment documents, visit: assignment documents.

For more information on certified copies, visit: certified copies.

For more information on patent applications, visit: patent applications.

For more information on USPTO, visit: USPTO.

No, USPTO employees cannot apply for patents while employed. According to 35 U.S.C. 4:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent…’

This restriction extends for one year after their employment at the USPTO ends.

Yes, the USPTO can refuse to expunge an improperly recorded assignment. According to MPEP 323.01(c):

‘The Office, however, has consistently taken the position that such a petition will not be granted unless it is apparent that the recording is a ‘clerical error on the part of the Office.”

This means that the USPTO is generally reluctant to expunge recorded assignments unless there’s clear evidence of an error on their part. If the improper recording was due to actions of the parties involved rather than the USPTO, the petition may be denied.

To learn more:

No, the USPTO cannot record a non-English assignment document without an accompanying English translation. MPEP 302.02 clearly states:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

This policy ensures that all recorded documents are accessible and understandable to USPTO examiners and the public. Attempting to record a non-English document without a translation will result in the document being rejected for recordation.

To learn more:

No, the USPTO does not determine whether conditions in a conditional assignment have been fulfilled. According to 37 CFR 3.56:

“The Office does not determine whether such conditions have been fulfilled.”

The USPTO treats the submission of a conditional assignment for recordation as an indication that the condition has been met. This policy simplifies the Office’s handling of assignments and places the responsibility on the parties involved to ensure conditions are met before recording.

To learn more:

No, the period for resubmitting corrected assignment documents cannot be extended. The MPEP 317.02 is explicit on this point:

“The specified period to resubmit the returned papers will not be extended.”

This strict policy underscores the importance of promptly addressing any issues with returned assignment documents. Failing to meet the specified deadline will result in the loss of the original receipt date as the recording date for the document. Instead, the USPTO will use the date they receive the corrected papers as the new recording date. This change can potentially affect the priority of your assignment and impact your intellectual property rights. Therefore, it’s crucial to carefully review any returned documents and act quickly to make the necessary corrections and resubmit within the given timeframe.

To learn more:

Yes, the original filing date can be preserved for returned patent documents under certain conditions. The MPEP 317.01 states:

“The returned papers, stamped with the original date of receipt by the Office, will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of filing of the papers as the date of recording of the document.”

This means that if you correct and resubmit the returned documents within the specified timeframe, the USPTO will use the original filing date as the recording date for the document.

To learn more:

Yes, the original filing date can be preserved for corrected documents under certain conditions. The MPEP states: “The returned papers, stamped with the original date of receipt by the Office, will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of filing of the papers as the date of recording of the document.” This means that if you correct and resubmit the document within the specified timeframe, the USPTO will use the original filing date as the recording date.

Can security interests in patents be recorded at the USPTO?

Yes, security interests in patents can be recorded at the USPTO. MPEP 313 states:

Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11(a).

This includes security interests, which are typically recorded to protect the lender’s rights in case of default. Recording a security interest provides public notice of the lender’s claim on the patent asset.

To record a security interest:

  • Submit the document to the USPTO’s Assignment Recordation Branch
  • Pay the required fee
  • Ensure the document meets the requirements outlined in MPEP 302

Recording does not guarantee the validity of the security interest but establishes an official record of the claim.

For more information on security interests, visit: security interests.

No, recorded assignment documents will not be expunged even if they are subsequently found to be invalid. The USPTO’s policy is to maintain a complete history of claimed interests in property.

As stated in the MPEP: “Office policy regarding recordation of assignment documents is directed toward maintaining a complete history of claimed interests in property and, therefore, recorded assignment documents will not be expunged even if subsequently found to be invalid. See In re Ratny, 24 USPQ2d 1713 (Comm’r Pat. 1992).” (MPEP § 323)

Once a document is recorded with the Assignment Services Division, it will not be removed from the record relating to that application or patent.

While the USPTO is responsible for the content and updates of the MPEP, patent professionals can indirectly influence its content. The USPTO often seeks public input on proposed rule changes and updates to examination procedures. Professionals can participate in these public comment periods or engage with professional organizations that provide feedback to the USPTO. However, there is no formal process for directly suggesting content for specific reserved sections like MPEP 312.

While patent attorneys or applicants cannot directly propose content for reserved MPEP sections like 319, they can provide feedback or suggestions to the USPTO regarding patent examination procedures or policies. The USPTO occasionally seeks public input on proposed changes to patent examination practices, which could potentially influence the content added to reserved sections in the future. However, the ultimate decision on what content to include in the MPEP rests with the USPTO.

The USPTO does not grant partial access to assignment documents. According to MPEP 301.01:

The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.

This policy ensures transparency and prevents selective disclosure of information. It’s important to note that this approach can have implications for documents that contain both public and potentially confidential information. For example:

  • If a document covers both a trademark and a patent application, the entire document becomes public.
  • If a document covers multiple patent applications, it becomes public as soon as any one of the applications is published or patented.

This policy underscores the importance of carefully considering what information is included in assignment documents, particularly when dealing with a mix of public and non-public intellectual property rights.

For more information on assignment documents, visit: assignment documents.

For more information on public inspection, visit: public inspection.

For more information on USPTO policy, visit: USPTO policy.

Can multiple assignees take action in a patent application?

Yes, multiple assignees can take action in a patent application, but there are specific requirements they must meet. The MPEP 325 states:

“Where multiple assignees are named in the statement under 37 CFR 3.73(c) and/or the Form PTO/AIA/96, and they are not named as joint owners in a single statement or form, the statement or form must be modified accordingly.”

This means that:

  • Multiple assignees can be named in a single statement or form if they are joint owners
  • If they are not joint owners, separate statements or forms must be submitted for each assignee
  • Each assignee must establish their right to take action as per 37 CFR 3.71 and 37 CFR 3.73

It’s important to note that the USPTO will not mediate disputes between assignees. If there are conflicting instructions from multiple assignees, the USPTO may suspend action on the application.

For more information on multiple assignees, visit: multiple assignees.

For more information on USPTO procedures, visit: USPTO procedures.

Yes, you can use the original stamped document for recording with additional patents. The USPTO allows the use of previously recorded papers that have been stamped with reel and frame numbers by the Assignment Division.

According to MPEP 315: “A copy of the original document (which may consist of the previously recorded papers on which the Assignment Division has stamped the reel and frame numbers at which they are recorded, or a copy of such papers)” can be submitted as part of the recordation process for additional patents or applications.

For more information on additional patents, visit: additional patents.

For more information on Assignment Division, visit: Assignment Division.

No, you cannot use both sides of the paper when submitting assignment documents to the USPTO. For paper or facsimile submissions, only one side of each page may be used.

As stated in 37 CFR 3.24(b): Only one side of each page may be used.

This requirement ensures that all information is clearly visible and can be properly scanned and recorded by the USPTO. Using both sides of the paper could result in missed information or difficulties in processing your document.

To learn more:

No, you should not submit original documents for recording patent assignments. The USPTO explicitly states:

“The United States Patent and Trademark Office will accept and record only a copy of an original assignment or other document. See MPEP § 317. The document submitted for recordation will not be returned to the submitter.”

It’s crucial to submit only copies of original documents, as the USPTO will not return the recorded documents. This ensures that you retain your original documents while still complying with the recording requirements.

No, you cannot submit multiple assignment documents with a single cover sheet. MPEP 302.07 clearly states: “A patent cover sheet must identify only one patent, and a separate patent cover sheet must be submitted for each patent as to which the assignment document is to be recorded.”

This requirement ensures that each assignment is properly documented and linked to the correct patent or application. If you have multiple assignments to record, you must prepare and submit a separate cover sheet for each one.

To learn more:

Can I submit color documents via facsimile for patent assignments?

Submitting color documents via facsimile for patent assignments is not recommended. The MPEP 302.09 states:

“Assignments and other documents affecting title to applications, patents, and registrations that include color drawings or color photographs cannot be recorded by facsimile transmission.”

This restriction is due to the limitations of facsimile technology in accurately reproducing color. To ensure the integrity and legibility of color documents:

  • Submit original color documents in person or by mail to the USPTO.
  • Use the Electronic Patent Assignment System (EPAS) for electronic submissions that may include color elements.
  • If color is not essential to the document, consider converting it to black and white before faxing.

Always verify the current USPTO guidelines for document submission, as procedures may be updated over time.

To learn more:

Yes, you can submit assignments and other documents affecting title to the USPTO via fax. The MPEP states: Assignments and other documents affecting title may be submitted to the Office via facsimile (fax). This process allows for direct submission into the automated Patent and Trademark Assignment System.

However, there are specific requirements and limitations:

  • Documents must include an identified application or patent number, one cover sheet for a single transaction, and payment of the recordation fee.
  • Certain documents cannot be submitted via fax, such as assignments submitted with new patent applications or documents with multiple cover sheets.

For the most up-to-date fax number, refer to the USPTO website or MPEP § 1730.

To learn more:

Can I submit assignment documents for multiple patents or applications in one EPAS submission?

Yes, you can submit assignment documents for multiple patents or applications in a single EPAS submission. This feature is particularly useful for bulk assignments or when dealing with related patent families. Here’s how it works:

  • Upload a single assignment document that covers multiple patents or applications.
  • Enter the relevant patent or application numbers during the submission process.
  • EPAS will associate the document with all specified patents or applications.

The MPEP 302.10 does not explicitly mention this capability, but it is a feature of the EPAS system designed to improve efficiency for users handling multiple assignments. Always ensure that the assignment document clearly identifies all patents or applications it covers.

To learn more:

Tags: EPAS

Can I submit an original assignment document for recording at the USPTO?

No, you should not submit the original assignment document for recording. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording.’ Therefore, it’s crucial to submit a copy of the original document to ensure you retain the original for your records.

Always keep the original assignment document in a safe place and submit a legible copy for recording purposes. This practice protects your original document and complies with USPTO requirements.

To learn more:

Can I submit a photocopy or digital scan of my assignment document for USPTO recording?

Yes, you can submit a photocopy or digital scan of your assignment document for USPTO recording, as long as it’s a complete and legible copy. The MPEP 302.01 specifies: ‘The copy of the document to be recorded should be presented to the Office for recordation.’ This means that:

  • Photocopies are acceptable
  • Digital scans saved as PDF files are also acceptable
  • The copy must be clear and readable
  • All pages and attachments must be included

Remember, while you’re submitting a copy, it must accurately represent the original document in its entirety.

Yes, you can submit a patent assignment electronically through the USPTO’s Electronic Patent Assignment System (EPAS). This is the recommended method for several reasons:

  • It’s free – there is no recordation fee for electronic submissions
  • It’s fast – documents are processed more quickly
  • It’s convenient – you can submit 24/7 from anywhere with internet access

As stated in MPEP 302.10: “Assignments and other documents affecting title may be submitted to the Office via the Office’s Electronic Patent Assignment System (EPAS).”

To use EPAS, you’ll need to complete an online cover sheet and upload a copy of the assignment document. The signature on the electronic cover sheet must comply with USPTO regulations for electronic signatures.

For more information and to access EPAS, visit the USPTO EPAS website.

For more information on electronic patent assignment, visit: electronic patent assignment.

For more information on EPAS, visit: EPAS.

Can I submit a handwritten assignment document for recording at the USPTO?

While handwritten assignment documents are not explicitly prohibited, they are generally discouraged and may face challenges in the recording process. The MPEP 302.01 states that “Documents submitted for recording must be legible and capable of being reproduced in legible copies by use of photocopy and standard office copying equipment.” Handwritten documents may not meet this standard, especially if the handwriting is not clear and easily readable. To ensure smooth processing and avoid potential rejection, it’s recommended to submit typed or printed assignment documents that are clearly legible and meet all USPTO requirements.

Yes, you can still submit assignment documents by mail to the USPTO, although electronic submission is strongly encouraged. If you choose to submit by mail, send your documents to:

Mail Stop Assignment Recordation Services
Director of the USPTO
P.O. Box 1450
Alexandria, VA 22313-1450

However, as noted in MPEP 302.10: “The Office strongly encourages electronic filing of assignment documents using EPAS, because assignment documents filed electronically are recorded faster and are less likely to become lost or misplaced.” Therefore, while mail submission is an option, electronic submission through EPAS is preferable for faster and more secure processing.

To learn more:

No, the USPTO does not allow partial access to patent assignment documents. According to MPEP 301.01:

“The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.”

This means:

  • If a document covers both a trademark and a patent, it will be entirely available to the public from the beginning.
  • If it covers multiple patent applications, it becomes publicly available as soon as any one of them is published or patented.

The policy ensures transparency and consistency in the handling of assignment documents.

To learn more:

Can I record an assignment for a pending patent application?

Yes, you can record an assignment for a pending patent application. In fact, the USPTO encourages early recordation of assignments. According to MPEP 302:

An assignment relating to a patent must identify the patent by the patent number. An assignment relating to a national patent application must identify the national patent application by the application number (consisting of the series code and the serial number, e.g., 07/123,456). An assignment relating to an international patent application which designates the United States of America must identify the international application by the international application number (e.g., PCT/US90/01234).

To record an assignment for a pending application:

  • Use the application number to identify the application
  • Ensure all necessary parties have signed the assignment document
  • Submit the assignment document along with the required cover sheet and fee to the USPTO

Early recordation can help establish clear ownership and facilitate future transactions or licensing agreements.

For more information on USPTO procedures, visit: USPTO procedures.

Yes, you can record a trademark license with the USPTO. The process is similar to recording other documents:

  • Submit the license document to the USPTO’s Assignment Recordation Branch
  • Include a cover sheet with the required information
  • Pay the appropriate fee

MPEP 313 mentions: Trademark documents are recorded in the same manner as patent documents, but… requests to record documents for trademarks should be mailed to: Commissioner for Trademarks, 2900 Crystal Drive, Arlington, VA 22202-3514.

Recording a trademark license can provide legal benefits and help maintain clear records of trademark rights and usage agreements.

Yes, you can correct certain errors in a recorded USPTO assignment document without submitting a new assignment. The process depends on the type of error:

  • For minor typographical errors, use a Corrective Cover Sheet.
  • For more substantial errors, submit a Substitute Statement.

MPEP 323 states: “The ‘corrective document’ or ‘substitute statement’ will not be recorded as a new assignment.” Instead, it will be recorded to correct the original assignment document, maintaining the original recordation date.

For more information on assignment correction, visit: assignment correction.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

Yes, you can still correct an erroneous assignment even if you cannot contact or get cooperation from the party who filed it. The MPEP 323.01(c) provides guidance for this situation:

The owner should contact the party who recorded the papers with the erroneous information and request that such party record corrective papers. However, if the party cannot be located or is unwilling to file corrective papers, then the true owner must record the necessary papers with the Assignment Services Division to correct the error.

In such cases, you, as the true owner, must submit the required documentation to the USPTO’s Assignment Services Division, including the completed cover sheet, affidavit or declaration, and required fees. This ensures that you can correct the record even without the cooperation of the party who made the error.

To learn more:

Access to assignment records for unpublished patent applications is restricted. The MPEP states:

“For pending or abandoned applications which are not open to the public pursuant to 37 CFR 1.11 or for which copies or access may not be supplied pursuant to 37 CFR 1.14, information related thereto is only obtainable upon a proper showing of written authority.”

To access these records, you must have written authority from one of the following:

  • An inventor
  • The applicant
  • The assignee or an assignee of an undivided part interest
  • A patent practitioner of record
  • A person with written authority from any of the above

Alternatively, you must show that you are a bona fide prospective or actual purchaser, mortgagee, or licensee of the application.

Can foreign language assignment documents be recorded at the USPTO?

Yes, foreign language assignment documents can be recorded at the USPTO, but they must be accompanied by an English translation. The MPEP 302 states:

“Unless an assignment is in a language other than English, the Office may rely on the assignment document (or a copy thereof) as filed.”

If the assignment is in a foreign language, you must provide:

  • The original foreign language document
  • An English language translation
  • A statement verifying that the translation is accurate

This ensures that the USPTO can properly review and record the assignment, maintaining accurate ownership records for patents and patent applications.

For more information on patent assignment, visit: patent assignment.

For more information on translation requirements, visit: translation requirements.

For more information on USPTO, visit: USPTO.

Can electronic copies of assignment documents be submitted for recording?

Yes, electronic copies of assignment documents can be submitted for recording at the USPTO. The MPEP 302.01 states: Any legible copies, including facsimile transmissions and computer generated copies, of original assignment documents will be acceptable for recording.

This means you can submit:

  • Scanned copies of original documents
  • Faxed copies
  • Computer-generated copies

The key requirement is that the electronic copy must be legible. Ensure that all text, signatures, and dates are clearly visible in the electronic copy. You can submit these electronic copies through the USPTO’s Electronic Patent Assignment System (EPAS) for efficient processing.

Expungement of assignment records is extremely rare and does not result in the complete removal of a document from the assignment records. According to MPEP 323.01(d), petitions to expunge are granted only if:

  • Normal corrective procedures are inadequate
  • The integrity of assignment records won’t be affected

Even if granted, “the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number.” However, links to the specific application or patent will be deleted from the Assignment Historical Database. A redacted version of the ‘expunged’ document must be recorded in its place.

Yes, assignment records can be expunged after they have been recorded by the USPTO, but only through a specific petition process. According to MPEP 323.01(d):

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

This means that once an assignment record has been officially recorded, it cannot be simply removed or deleted. A formal petition must be filed, demonstrating that the document was submitted by mistake or is of improper character. The USPTO will then review the petition and make a determination on whether to expunge the record.

To learn more:

Yes, assignment records can be expunged even after a patent has been issued. The MPEP 323.01(d) states: ‘Expungement of any assignment records will be handled in accordance with 37 CFR 1.4(g). This may include expungement of documents recorded prior to, during, or after, prosecution of the application that matured into the patent.’ This means that the USPTO can consider expungement requests for assignment records at any stage, including after the patent has been granted.

To learn more:

Can assignment documents be submitted electronically to the USPTO?

Yes, assignment documents can be submitted electronically to the USPTO. The MPEP 302 states:

‘Assignment documents can be submitted to the Office in paper or electronically.’

The USPTO provides an electronic system for submitting assignment documents, which can be more convenient and efficient than paper submissions. However, it’s important to note that regardless of the submission method, the documents must meet all legal requirements and be properly executed to be considered valid.

For electronic submissions, users can utilize the Electronic Patent Assignment System (EPAS) provided by the USPTO. This system allows for quick and secure submission of assignment documents directly to the USPTO’s database.

For more information on assignment documents, visit: assignment documents.

For more information on electronic submission, visit: electronic submission.

For more information on EPAS, visit: EPAS.

For more information on USPTO, visit: USPTO.

Yes, arbitration awards in patent disputes can be modified under certain circumstances. According to 35 U.S.C. 294(c):

‘The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration.’

If an award is modified, the party requesting the modification must file a notice with the USPTO, as per 37 CFR 1.335(b).

Yes, for certain patent applications, an assignment can contain statements required in an oath or declaration. The MPEP 301 states:

‘For applications filed under 35 U.S.C. 111(a), 363, or 385 on or after September 16, 2012, an assignment may contain the statements required to be made in an oath or declaration (‘assignment-statement’), and if the assignment is made of record in the assignment records of the Office, then the assignment may be utilized as the oath or declaration.’

This provision allows for greater flexibility in meeting the oath or declaration requirements, particularly for assigned inventions. However, it’s important to ensure that the assignment contains all the necessary statements and is properly recorded with the USPTO.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent assignment, visit: patent assignment.

Can an assignment be recorded electronically with the USPTO?

Yes, assignments can be recorded electronically with the USPTO. The MPEP 302 states:

“The USPTO provides for the electronic filing of patent assignment documents through the Electronic Patent Assignment System (EPAS).”

Electronic filing offers several advantages:

  • Faster processing times
  • Immediate confirmation of receipt
  • Reduced risk of errors in data entry
  • 24/7 accessibility

To use EPAS, users must have a USPTO.gov account and follow the specific guidelines for electronic submission. For detailed instructions, visit the Electronic Patent Assignment System (EPAS) on the USPTO website.

For more information on electronic filing, visit: electronic filing.

For more information on EPAS, visit: EPAS.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

Generally, an assignee cannot take action in a patent application if the assignment is not yet recorded in the USPTO. However, there is a specific provision for situations where the assignment has been executed but not yet recorded.

According to MPEP 324: If an assignment has not been recorded in the Office, the assignee may take action in a patent application under 37 CFR 3.73(b) by submitting a statement under 37 CFR 3.73(b) which is signed by a party authorized by the assignee.

This means that even if the assignment is not yet recorded, the assignee can still take action by:

  • Submitting a statement under 37 CFR 3.73(b)
  • Ensuring the statement is signed by an authorized party
  • Including a copy of the assignment document with the statement

However, it’s important to note that the assignment must still be recorded in the USPTO no later than the date of payment of the issue fee. Failure to record the assignment by this deadline could result in the loss of assignee rights.

For more information on assignee rights, visit: assignee rights.

Yes, an assignee can correct a typographical error in an assignment document, but the process depends on the availability of the assignor. According to MPEP 323.01(b):

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction.

This means that:

  • If the assignor is available, they should make the correction or execute a new document.
  • If the assignor is not available, the assignee can submit an affidavit or declaration to correct the error.

The assignee must also provide a copy of the originally recorded papers, a cover sheet, and pay the required fee for each application or patent to be corrected, as per 37 CFR 3.41.

To learn more:

Yes, an arbitration award can be modified by a court, and this modification must be reported to the USPTO. The process is outlined in 35 U.S.C. 294(c) and 37 CFR 1.335(b):

  • If a court modifies an arbitration award, the party requesting the modification must file a notice with the USPTO.
  • The notice should be filed for each patent affected by the modification.
  • It must include the patent number, names of the inventor and patent owner, names and addresses of the arbitration parties, and a copy of the court’s order modifying the award.

As stated in 37 CFR 1.335(b): “If an award by an arbitrator pursuant to 35 U.S.C. 294 is modified by a court, the party requesting the modification must file in the Patent and Trademark Office, a notice of the modification for placement in the file of each patent to which the modification applies.”

This ensures that the USPTO’s records reflect the most current status of patent rights affected by arbitration and subsequent court decisions.

Yes, additional correct documents can be recorded after an assignment record is expunged. The MPEP 323.01(d) states:

An additional assignment of the ‘correct’ document may be recorded in addition to the redacted version where the redacted version is incomplete or the original document was not correct.

This provision allows for the recording of accurate and complete information when:

  • The redacted version of the expunged document is incomplete
  • The original document contained errors or inaccuracies

This process ensures that the assignment records contain the most accurate and up-to-date information possible, even after an expungement procedure has been completed.

To learn more:

Yes, a request for issuance to an assignee can be submitted after the issue fee is paid, but additional requirements apply:

  1. The request must state that the assignment was submitted for recordation before patent issuance.
  2. It must include a request for a certificate of correction under 37 CFR 1.323.
  3. The appropriate fees must be paid, including the certificate of correction fee and a processing fee.

37 CFR 3.81(b) states: Any request for issuance of an application in the name of the assignee submitted after the date of payment of the issue fee, and any request for a patent to be corrected to state the name of the assignee, must state that the assignment was submitted for recordation as set forth in § 3.11 before issuance of the patent, and must include a request for a certificate of correction under § 1.323 of this chapter (accompanied by the fee set forth in § 1.20(a)) and the processing fee set forth in § 1.17(i) of this chapter.

Yes, a patent title report can be updated after its initial preparation. While the MPEP Section 320 doesn’t explicitly state this, it’s implied by the fact that title reports are prepared at various stages of the patent process. Updates may occur:

  • When new assignments are recorded
  • If there are changes in inventorship
  • When errors or omissions in previous reports are discovered
  • At key stages of the patent process, such as before issuance

The Certificates of Correction Branch, responsible for preparing title reports, would likely generate updated reports to reflect any changes in ownership or other relevant information throughout the patent’s lifecycle.

Yes, a patent can be issued to multiple assignees or a combination of assignees and inventors. According to MPEP 307, there are two scenarios:

  1. Partial assignees and inventors: “If one or more assignee, together with one or more inventor, holds the entire right, title, and interest in the application, the patent may issue in the names of the assignee and the inventor.”
  2. Multiple assignees: “If multiple assignees hold the entire right, title, and interest to the exclusion of all the inventors, the patent may issue in the names of the multiple assignees.”

These provisions allow for flexibility in patent issuance when ownership is shared among multiple parties.

For more information on multiple assignees, visit: multiple assignees.

For more information on partial assignees, visit: partial assignees.

For more information on patent issuance, visit: patent issuance.

Can a patent be issued to an assignee if the assignment is not recorded?

Yes, a patent can be issued to an assignee even if the assignment is not recorded, provided certain conditions are met:

  • The request for issuance of the patent to the assignee must be made under 37 CFR 3.81(b).
  • The request must be submitted no later than the date the issue fee is paid.
  • The request must include clear evidence of the assignment.

According to MPEP 307: “An assignee who otherwise shows sufficient proprietary interest in the matter may also be entitled to such a patent.” This means that even without a recorded assignment, an assignee can still have the patent issued to them if they can demonstrate their proprietary interest.

For more information on assignee rights, visit: assignee rights.

For more information on patent issuance, visit: patent issuance.

For more information on proprietary interest, visit: proprietary interest.

Yes, a patent can be issued to a deceased inventor. The MPEP 308 states:

‘A patent may be issued to the legal representative (executor, administrator, etc.) of a deceased inventor.’

In such cases, the patent is issued to the legal representative acting on behalf of the deceased inventor’s estate. This ensures that the inventor’s rights and the value of their invention are preserved even after their death.

For more information on legal representative, visit: legal representative.

For more information on patent issuance, visit: patent issuance.

Can a patent assignment be recorded electronically?

Yes, patent assignments can be recorded electronically. The USPTO provides an electronic system for recording assignment documents. According to MPEP 302:

‘Assignment documents can be submitted for recordation via the Office’s Electronic Patent Assignment System (EPAS). See the USPTO website at http://www.uspto.gov/patents-application-process/documenting-patent-ownership/epas-electronic-patent-assignment-system for additional information regarding EPAS.’

Electronic submission through EPAS is often faster and more convenient than paper submissions. However, it’s important to ensure that all necessary information and signatures are included in the electronic submission.

For more information on electronic patent assignment, visit: electronic patent assignment.

For more information on EPAS, visit: EPAS.

For more information on USPTO, visit: USPTO.

Yes, a patent application can be assigned before it is filed. This is known as an assignment of future rights. MPEP 301 states:

“An assignment of an application can be made before the application is filed. See 37 CFR 3.21.”

However, it’s important to note that the assignment document should clearly identify the invention and the application to be filed. Once the application is filed, it’s advisable to record the assignment with the USPTO to ensure proper documentation of ownership.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

Yes, a domestic representative can be changed after the initial designation. While MPEP 302.04 doesn’t explicitly address changing a domestic representative, it states that the designation is made by a written document signed by such assignee. This implies that a new written document can be submitted to change the designation. To change a domestic representative, follow the same process as the initial designation:

  • Prepare a new written document clearly labeled ‘Change of Domestic Representative’
  • Include the new representative’s name and address
  • Submit the document separately from other filings
  • Ensure it’s signed in accordance with 37 CFR 1.33(b)

It’s advisable to explicitly state that this new designation supersedes any previous designations to avoid confusion.

To learn more:

Yes, there are two exceptions to the patent ownership restrictions for USPTO employees:

  1. Inheritance
  2. Bequest

According to 35 U.S.C. 4:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of… acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office.’

This means that USPTO employees can acquire patents or interests in patents through inheritance or bequest, even during their employment or the one-year period after.

Yes, there are limitations on expunging assignment records at the USPTO. The MPEP 323.01(d) provides important guidance:

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

This indicates that:

  • Expungement is not an automatic process and requires a formal petition
  • Only recorded assignments can be considered for expungement
  • The petitioner must provide clear evidence of mistake or improper character
  • The USPTO has discretion in granting or denying the petition

Additionally, the USPTO generally will not expunge an assignment record if it has already been relied upon or cited in other documents. This is to maintain the integrity of the public record and prevent confusion in chain of title matters.

To learn more:

Tags: USPTO

Yes, there are fees associated with using the Electronic Patent Assignment System (EPAS). According to MPEP 302.10:

“Customers may submit assignments electronically by accessing the Office’s website and paying the required fee by credit card, electronic fund transfer (EFT) or deposit account.”

The specific fee amounts are not mentioned in this section of the MPEP, so it’s advisable to check the current USPTO Fee Schedule for the most up-to-date information on assignment recording fees.

To learn more:

Tags: USPTO fees

Based on the information provided in MPEP 302.02, there are no exceptions to the USPTO’s English translation requirement for assignments. The MPEP states unequivocally:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This requirement applies to all non-English assignment documents without exception. The USPTO’s strict adherence to this policy ensures uniformity in the recording process and accessibility of patent ownership information.

To learn more:

Yes, there are exceptions to paying the recording fee at the USPTO. According to MPEP 302.06, no fee is required for certain documents related to Executive Order 9424. Specifically:

No fee is required for each patent application and patent against which a document required by Executive Order 9424 is to be filed if: (1) The document does not affect title and is so identified in the cover sheet (see § 3.31(c)(2)); and (2) The document and cover sheet are either: Faxed or electronically submitted as prescribed by the Director, or mailed to the Office in compliance with § 3.27.

This exception applies to specific government-related documents that do not affect the title of the patent or application.

To learn more:

Tags: USPTO fees

Are patent assignment records publicly accessible after recording at the USPTO?

Yes, patent assignment records become publicly accessible after they are recorded at the USPTO. The MPEP 302.01 states: ‘Assignment documents submitted for recording are scanned and stored in a public database.’

This means:

  • Anyone can access recorded assignment information
  • The public database allows searching for patent ownership details
  • Transparency in patent ownership is maintained

Public accessibility of these records is crucial for maintaining transparency in patent ownership and facilitating due diligence in patent transactions. Interested parties can search and retrieve assignment information through the USPTO’s Assignment Search database.

To learn more:

No, attorney’s liens against patents or patent applications are not accepted for recording at the USPTO. This is explicitly stated in the MPEP:

“Documents that are not accepted for recording include attorney’s liens against patents or patent applications. See In re Refusal of Assignment Branch to Record Attorney’s Lien, 8 USPQ2d 1446 (Comm’r Pat. 1988).” (MPEP 313)

This decision reflects the USPTO’s policy on recordable documents and helps maintain clarity in the patent ownership records.

The accessibility of assignment records for pending patent applications depends on whether the application has been published. According to MPEP 301.01:

  • For published patent applications, assignment records are publicly available.
  • For unpublished pending applications, assignment records are not open to public inspection.

The MPEP states: “Documents relating only to one or more pending applications for patent which have not been published under 35 U.S.C. 122(b) will not be open to public inspection.”

For unpublished pending applications, access to assignment information requires proper authorization. As per the MPEP:

“For applications filed on or after September 16, 2012, the written authority must be from (A) an inventor, (B) an applicant, (C) the assignee or an assignee of an undivided part interest, (D) a patent practitioner of record, or (E) a person with written authority from (A), (B), or (C) or (D).”

To learn more:

Yes, all patent assignment records are publicly accessible. MPEP 301.01 clearly states:

‘The assignment records of patents and applications are open to public inspection.’

This means that anyone can access these records, which include:

  • Assignment documents
  • Digests of assignments
  • Indexes of patent assignments

The public nature of these records ensures transparency in patent ownership and transfers. However, it’s important to note that while the records are public, obtaining copies may require payment of a fee as specified in 37 CFR 1.19(b)(3).

MPEP 301-Ownership/Assignability of Patents and Applications (45)

The presumption of ownership for patent applications depends on the filing date. According to MPEP 301:

‘For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of the application for an original patent. For applications filed before September 16, 2012, the ownership of the patent (or the application for the patent) initially vests in the named inventors of the invention of the patent.’

This change in presumption reflects updates to U.S. patent law under the America Invents Act. It’s important for applicants and inventors to be aware of this presumption, as it can affect various aspects of patent prosecution and ownership rights.

Patent ownership gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent. This is stated in 35 U.S.C. 154(a)(1).

However, ownership does not necessarily give the owner the right to make, use, sell or import the invention, as there may be other legal considerations such as:

  • Existence of another patent owner with a dominant patent
  • Failure to obtain FDA approval
  • An injunction by a court
  • National security issues

Patent ownership grants the owner the right to exclude others from making, using, offering for sale, selling, or importing the patented invention into the United States. However, it’s important to note that ownership does not automatically grant the right to practice the invention. The MPEP states:

‘Ownership of a patent gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent. 35 U.S.C. 154(a)(1). Ownership of the patent does not furnish the owner with the right to make, use, offer for sale, sell, or import the claimed invention because there may be other legal considerations precluding same…’

These other considerations may include existing patents, regulatory approvals, or legal injunctions.

Patent ownership gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing the claimed invention into the United States. As stated in 35 U.S.C. 154(a)(1):

Ownership of a patent gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent.

However, it’s important to note that ownership does not automatically grant the right to practice the invention, as there may be other legal considerations such as other dominant patents, regulatory approvals, or court injunctions.

For more information on exclusionary rights, visit: exclusionary rights.

For more information on patent rights, visit: patent rights.

Joint owners of a patent have specific rights as outlined in 35 U.S.C. 262, which states:

‘In the absence of any agreement to the contrary, each of the joint owners of a patent may make, use, offer to sell, or sell the patented invention within the United States, or import the patented invention into the United States, without the consent of and without accounting to the other owners.’

This means that each joint owner can independently exercise the full rights of the patent without needing permission from or owing compensation to the other joint owners, unless they have a separate agreement stating otherwise.

Recording patent assignments at the United States Patent and Trademark Office (USPTO) is crucial for several reasons:

  • Legal Protection: It provides legal protection against subsequent purchasers or mortgagees.
  • Official Recognition: The USPTO recognizes the assignee for all matters before the Office.
  • Public Notice: It serves as public notice of the assignment.

According to MPEP 301:

An assignment relating to a patent must be recorded in the Patent and Trademark Office within 3 months from its date or prior to the date of a subsequent purchase or mortgage, in order to be effective against a subsequent purchaser or mortgagee.

Recording assignments promptly is essential to ensure full legal protection and recognition of ownership rights.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

Recording a patent assignment with the USPTO is crucial for several reasons:

  1. Legal Notice: It provides public notice of the assignment, which is important for establishing priority against subsequent purchasers or mortgagees.
  2. Prima Facie Evidence: As stated in MPEP 301.01, ‘The recording of an assignment with the USPTO is prima facie evidence of its execution.’
  3. Chain of Title: It helps maintain a clear chain of title for the patent or application.
  4. Enforcement Rights: Proper recording can affect the ability to enforce patent rights or collect damages in infringement cases.

The MPEP emphasizes the importance of recording by stating, ‘An assignment must be recorded in the USPTO within three months from its date or prior to the date of a subsequent purchase or mortgage to be valid against a subsequent purchaser or mortgagee.’ This underscores the time-sensitive nature of recording assignments to protect legal rights.

Obtaining patent assignment records from before May 1, 1957, involves a different process than accessing more recent records. According to MPEP 301.01:

All records of assignments of patents recorded before May 1, 1957, are maintained by the National Archives and Records Administration (NARA). The records are open to public inspection. Certified and uncertified copies of those assignment records are provided by NARA upon request and payment of the fees required by NARA.

The MPEP further advises:

Requests for copies of pre-1957 records for patents should be directed to the National Archives and Records Administration (NARA). Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.

To obtain these records:

  1. Contact NARA directly.
  2. Provide as much information as possible about the patent and assignment you’re seeking.
  3. Be prepared to pay the fees required by NARA.

The MPEP also notes: All assignment records from 1837 to April 30, 1957 for patents are now maintained and are open for public inspection in the National Archives Research Room located at the Washington National Records Center Building, 4205 Suitland Road, Suitland, Maryland 20746 and at the Civilian Records Division of the National Archives at College Park, 8601 Adelphi Road, College Park, MD 20740-6001.

For the most up-to-date information on accessing these records, it’s recommended to check the National Archives website.

For more information on NARA, visit: NARA.

Tags: NARA

Recording a patent assignment with the USPTO has specific legal effects. The MPEP states:

‘Recordation of the assignment provides legal notice to the public of the assignment.’

However, it’s important to note that:

‘It should be noted that recording of the assignment is merely a ministerial act; it is not an Office determination of the validity of the assignment document or the effect of the assignment document on the ownership of the patent property.’

This means that while recordation provides public notice, it does not guarantee the validity or enforceability of the assignment. The MPEP cites 37 CFR 3.54 and Realvirt, LLC v. Lee, 195 F.Supp.3d 847, 862-3 (E.D. Va. 2016) for this principle.

Patent assignment and licensing are two different ways of transferring patent rights. The MPEP defines assignment as:

‘Assignment of patent rights is defined as ‘a transfer by a party of all or part of its right, title and interest in a patent [or] patent application….”

In contrast, licensing is described as:

‘As compared to assignment of patent rights, the licensing of a patent transfers a bundle of rights which is less than the entire ownership interest, e.g., rights that may be limited as to time, geographical area, or field of use.’

The key difference is that assignment transfers ownership, while licensing grants permission to use the patent without transferring ownership.

The MPEP distinguishes between assignments and licenses in patent law:

  1. Assignment: ‘An assignment of a patent, or patent application, is the transfer to another of a party’s entire ownership interest or a percentage of that party’s ownership interest in the patent or application.’
  2. License: ‘As compared to assignment of patent rights, the licensing of a patent transfers a bundle of rights which is less than the entire ownership interest, e.g., rights that may be limited as to time, geographical area, or field of use.’

The key difference is that an assignment transfers ownership, while a license grants permission to use the patent without transferring ownership. The MPEP further clarifies: ‘A patent license is, in effect, a contractual agreement that the patent owner will not sue the licensee for patent infringement if the licensee makes, uses, offers for sale, sells, or imports the claimed invention, as long as the licensee fulfills its obligations and operates within the bounds delineated by the license agreement.’

The key differences between a patent assignment and a patent license are:

  • Assignment: Transfers all or part of the ownership interest in a patent, including the entire bundle of rights associated with ownership.
  • License: Transfers a bundle of rights that is less than the entire ownership interest. It may be limited in time, geographical area, or field of use.

A license is essentially a contractual agreement that the patent owner will not sue the licensee for patent infringement under certain conditions. Even an exclusive license is not considered an assignment of patent rights.

According to 35 U.S.C. 261, patents have the attributes of personal property and are assignable by an instrument in writing. Specifically, the statute states:

‘Subject to the provisions of this title, patents shall have the attributes of personal property. […] Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing.’

This means that patent owners can transfer their rights to others through written assignments, similar to other forms of property.

Joint ownership of a patent occurs when multiple parties together own the entire right, title, and interest of the patent property. This can happen in several scenarios:

  • Multiple partial assignees of the patent property
  • Multiple inventors who have not assigned their rights
  • A combination of partial assignee(s) and inventor(s) who have not assigned their rights

In cases of joint ownership, all parties having any portion of the ownership must act together as a composite entity in patent matters before the USPTO. According to 35 U.S.C. 262, in the absence of any agreement to the contrary, each joint owner may make, use, offer to sell, or sell the patented invention within the United States without the consent of and without accounting to the other owners.

An ‘assignment-statement’ is a relatively new concept in patent law, introduced for applications filed on or after September 16, 2012. The MPEP explains:

‘For applications filed under 35 U.S.C. 111(a), 363, or 385 on or after September 16, 2012, an assignment may contain the statements required to be made in an oath or declaration (‘assignment-statement’), and if the assignment is made of record in the assignment records of the Office, then the assignment may be utilized as the oath or declaration.’

This means that for qualifying applications, the assignment document can serve a dual purpose:

  1. Transferring ownership of the patent application
  2. Fulfilling the requirement for an oath or declaration

This provision can simplify the application process by combining two previously separate documents. The MPEP cites 35 U.S.C. 115(e), 37 CFR 1.63(e), and MPEP §§ 302.07, 317, and 602.01(a) for further details on this practice.

Accessing assignment records for unpublished patent applications requires specific authorization or a showing of legitimate interest. According to MPEP 301.01, for applications that are not open to the public:

Information related thereto is only obtainable upon a proper showing of written authority. For applications filed on or after September 16, 2012, the written authority must be from (A) an inventor, (B) an applicant, (C) the assignee or an assignee of an undivided part interest, (D) a patent practitioner of record, or (E) a person with written authority from (A), (B), or (C) or (D).

For applications filed before September 16, 2012, the requirements are slightly different:

For applications filed prior to September 16, 2012, the written authority must be from the applicant or applicant’s assignee or from the attorney or agent of either, or upon a showing that the person seeking such information is a bona fide prospective or actual purchaser, mortgagee, or licensee of such application.

If you’re not one of these authorized parties, you may still be able to access the records if you can demonstrate that you are a bona fide prospective or actual purchaser, mortgagee, or licensee of the application. This typically requires submitting a petition with the appropriate fee and evidence of your status.

For more information on unpublished applications, visit: unpublished applications.

USPTO patent assignment records contain valuable information about the ownership and transfer of patent rights. According to MPEP 301.01, these records include:

  • Reel and frame number of the recordation
  • Name of the conveying party (assignor)
  • Name and address of the receiving party (assignee)
  • Patent or application number
  • Date of execution
  • Date of recordation

The MPEP further states: The actual assignment document will not be viewable through Assignment Search. Only the bibliographic information contained in the recorded cover sheet will be viewable from the Assignment Search database.

This information helps track the chain of title for patents and applications, which is crucial for determining current ownership and potential licensing opportunities.

What information is available in the USPTO’s assignment database?

The USPTO’s assignment database contains a wealth of information related to patent ownership. According to MPEP 301.01:

‘The USPTO maintains a database containing the assignment records of patents and patent applications. The USPTO also maintains a cumulative index of number of assignments recorded on the day in which they are recorded.’

The database typically includes:

  • Patent or application numbers
  • Names of assignors and assignees
  • Dates of assignment execution and recording
  • Brief descriptions of the interests conveyed
  • Reel and frame numbers for locating documents

This information is crucial for determining the current ownership status of patents and applications, which is essential for various legal and business purposes.

The MPEP outlines two main types of patent ownership:

  1. Individual ownership: ‘An individual entity may own the entire right, title and interest of the patent property. This occurs where there is only one inventor, and the inventor has not assigned the patent property.’
  2. Joint ownership: ‘Multiple parties may together own the entire right, title and interest of the patent property.’ This can occur in several scenarios:
  • Multiple partial assignees of the patent property
  • Multiple inventors who have not assigned their rights
  • A combination of partial assignee(s) and inventor(s) who have not assigned their rights

Understanding these ownership types is crucial for managing patent rights and making decisions about assignments or licenses.

To record an assignment of a patent or patent application, the following requirements must be met:

  • The assignment must be in writing.
  • It must be signed by the assignor (the person or entity transferring ownership).
  • The document must identify the patent or application by number.
  • The assignment must be submitted to the USPTO along with the required fee.

According to MPEP 301: “An assignment relating to a patent must be submitted to the USPTO for recordation as an absolute requirement for enforcing the patent or application against third parties.” This recordation provides constructive notice to the public of the assignment.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For more information on USPTO, visit: USPTO.

According to MPEP 301, patents have the attributes of personal property. The MPEP states:

’35 U.S.C. 261 Ownership; assignment. Subject to the provisions of this title, patents shall have the attributes of personal property.’

This means that patents can be bought, sold, licensed, or transferred like other forms of property. However, it’s important to note that owning a patent doesn’t necessarily grant the right to practice the invention, as other legal considerations may apply.

For more information on patent rights, visit: patent rights.

For more information on personal property, visit: personal property.

Patent ownership can be transferred through an assignment. According to 35 U.S.C. 261, assignments of patent applications, patents, or any interest therein must be in writing. The MPEP defines an assignment as:

‘a transfer by a party of all or part of its right, title and interest in a patent [or] patent application….’

An assignment transfers the entire ownership interest or a percentage of that interest in the patent or application. It must include the entirety of the bundle of rights associated with the ownership interest.

The initial ownership of a patent depends on the filing date of the application. For applications filed on or after September 16, 2012, the MPEP states:

‘For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of the application for an original patent. See 37 CFR 3.73(a).’

For applications filed before September 16, 2012:

‘For applications filed before September 16, 2012, the ownership of the patent (or the application for the patent) initially vests in the named inventors of the invention of the patent.’

This distinction is important for determining the initial owner of a patent or patent application.

How does the USPTO handle confidential patent assignment information?

The USPTO generally treats patent assignment records as public information. However, there are provisions for handling confidential information within these records. MPEP 301.01 states:

“Assignments and other documents affecting title to applications, patents, and registrations that are recorded in the USPTO are generally open to public inspection. Only documents that are sealed as provided in 37 CFR 1.14 or otherwise not open to public inspection are not available for public inspection.”

If a document contains sensitive information that should not be publicly disclosed, the parties involved can:

  • Redact confidential information before submitting the document for recordation
  • Request that certain documents be sealed under 37 CFR 1.14
  • Submit separate public and non-public versions of documents when necessary

It’s important to note that the decision to seal documents is at the discretion of the USPTO and is generally limited to specific circumstances outlined in the regulations.

How does the USPTO handle changes in ownership of patents?

The USPTO handles changes in ownership of patents through a process of recording assignments. According to MPEP 301:

“The assignment of a patent, or patent application, is the transfer of the entire right, title and interest therein. An assignment of an application may be made before the application is filed or after it is filed.”

When a change in ownership occurs:

  • The new owner must record the assignment with the USPTO
  • This recording serves as public notice of the transfer
  • It helps maintain clear records of patent ownership

The USPTO maintains these records and updates them as new assignments are recorded.

For more information on assignment recording, visit: assignment recording.

For more information on USPTO procedures, visit: USPTO procedures.

The Patent and Trademark Office (PTO) generally does not directly handle patent ownership disputes. According to MPEP 301:

The Patent and Trademark Office is not the forum for resolving patent ownership disputes. Such disputes are to be settled by the parties involved, outside the Patent and Trademark Office.

If there’s a dispute over ownership, the PTO will typically continue to recognize the owner of record until a court order or other legal document resolving the dispute is presented. Parties involved in ownership disputes should seek legal counsel and resolve the matter through appropriate legal channels.

How does joint ownership work for patents?

Joint ownership in patents occurs when two or more parties share ownership rights. The MPEP 301 provides guidance on this:

‘In the case of joint owners, each joint owner has the right to make, use, offer for sale, and sell the patented invention without the consent of and without accounting to the other owners.’

This means that each joint owner has full rights to use and profit from the patent independently, without needing permission from the other owners. However, this can lead to complications, especially in licensing or selling the patent, as all joint owners typically need to agree on such actions. It’s often advisable for joint owners to have a written agreement outlining their rights and responsibilities.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

Joint ownership in patents and patent applications occurs when two or more parties share ownership rights. According to MPEP 301:

“Joint inventors are treated as joint owners of the invention unless there is an assignment.”

Key aspects of joint ownership include:

  • Each joint owner has the right to make, use, sell, and license the invention without consent from other owners.
  • Profits do not need to be shared unless there’s a specific agreement.
  • All joint owners must agree to sell or assign the entire patent to a third party.
  • In infringement suits, all joint owners must be joined as plaintiffs.

It’s important for joint owners to have clear agreements in place to avoid potential conflicts and ensure proper management of the patent rights.

For more information on joint inventors, visit: joint inventors.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

To request copies of patent assignment records, follow these steps:

  1. For records after May 1, 1957: Contact the USPTO and pay the fee set forth in 37 CFR 1.19.
  2. For records before May 1, 1957: Contact the National Archives and Records Administration (NARA) directly.
  3. For recent records: Check the USPTO website for online availability.

When requesting a copy, the MPEP advises: “An order for a copy of an assignment or other document should identify the reel and frame number where the assignment or document is recorded.” Failure to provide this information may result in additional charges.

The process for obtaining copies of assignment records for pending or abandoned applications depends on whether the application is open to the public. The MPEP states:

‘Copies of assignment records relating to pending or abandoned patent applications which are open to the public pursuant to 37 CFR 1.11 or for which copies or access may be supplied pursuant to 37 CFR 1.14 are available to the public.’

For applications that are not open to the public, the process is more restricted:

‘For pending or abandoned applications which are not open to the public pursuant to 37 CFR 1.11 or for which copies or access may not be supplied pursuant to 37 CFR 1.14, information related thereto is only obtainable upon a proper showing of written authority.’

The required written authority varies depending on the application filing date. For applications filed on or after September 16, 2012, it must come from an inventor, applicant, assignee, patent practitioner of record, or someone with written authority from these parties.

Patents and patent applications can be assigned through a written instrument. The MPEP 301 states:

‘Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing.’

This means that patent rights can be transferred from one party to another through a written document. The assignment must be recorded with the USPTO to be effective against subsequent purchasers or mortgagees.

For more information on patent assignment, visit: patent assignment.

The USPTO provides an online database for searching patent assignment records. According to MPEP 301.01, ‘Assignment records, digests, and indexes are available in the public search room of the USPTO.’ To search online:

  • Visit the USPTO Patent Assignment Search page
  • Enter relevant information such as patent number, assignee name, or assignor name
  • Review the search results for the desired assignment information

The MPEP states, ‘The assignment records of patents and applications are open to public inspection and copies of these records may be obtained upon request and payment of the fee set forth in 37 CFR 1.19(b)(3).’

Patent assignments can be recorded with the USPTO in two ways:

  1. In the assignment records: This is done as provided in 37 CFR Part 3. Recording provides public notice of the assignment but does not determine its validity.
  2. In the file of a patent application or patent: This may be necessary for the assignee to take action in the application or patent proceeding.

For a patent to issue to an assignee, the assignment must be recorded or filed for recordation in accordance with 37 CFR 3.11.

It’s important to note that recording an assignment in the USPTO’s assignment records does not automatically allow the assignee to take action in a patent proceeding. Additional steps may be required as outlined in MPEP § 325 for applications filed on or after September 16, 2012, or MPEP § 324 for earlier applications.

For more information on patent assignment, visit: patent assignment.

There are two ways to make a patent assignment of record with the USPTO:

  1. Record the assignment in the USPTO’s assignment records as provided in 37 CFR Part 3. This provides legal notice to the public but does not determine the validity or effect of the assignment.
  2. Make the assignment of record in the file of a patent application, patent, or other patent proceeding. This may be necessary for the assignee to ‘take action’ in the application or proceeding.

For a patent to issue to an assignee, the assignment must be recorded or filed for recordation in accordance with 37 CFR 3.11.

Patent assignment records can be accessed online through the USPTO’s Assignment Search database. The MPEP states: Assignment records that affect the title of patents and patent applications are recorded in the USPTO’s Assignment Recordation Branch. To access these records:

  • Visit the USPTO Assignment Search website
  • Enter the relevant patent or application number, assignee name, or other search criteria
  • Review the search results for assignment information

This online database provides public access to assignment records, allowing for easy verification of patent ownership.

The MPEP outlines two ways to make an assignment of record with the USPTO:

  1. Recording in the USPTO assignment records: ‘An assignment can be made of record in the assignment records of the Office as provided for in 37 CFR Part 3. Recordation of the assignment provides legal notice to the public of the assignment.’
  2. Filing in a specific application or patent file: ‘An assignment can be made of record in the file of a patent application, patent, or other patent proceeding (e.g., reexamination proceeding).’

The MPEP notes: ‘Recordation of an assignment in the assignment records of the Office does not, by itself, permit the assignee to take action in the application, patent, or other patent proceeding.’

It’s important to understand the differences between these methods and their respective purposes in patent proceedings.

How are historical patent assignment records maintained?

The USPTO maintains historical patent assignment records separately from more recent records. MPEP 301.01 explains:

‘The historical database of assignments is maintained separate and apart from the database of assignments affecting title recorded since 1980.’

This means that:

  • Records prior to August 1980 are kept in a separate historical database
  • These older records may not be available through the online Patent Assignment Search
  • Accessing historical records may require different procedures or direct contact with the USPTO

For researchers or legal professionals needing access to pre-1980 assignment records, it’s advisable to contact the USPTO’s Patent and Trademark Resource Centers or the Assignment Recordation Branch for assistance.

The USPTO makes assignment records accessible to the public in several ways, as described in 37 CFR 1.12:

  1. Separate assignment records for patents and trademarks are maintained and are open to public inspection.
  2. Assignment records, digests, and indexes for patents are available on the USPTO website.
  3. Images of assignment documents recorded from June 1998 onwards are viewable on the Office website.
  4. For earlier records, the public can place an order to view images.

The MPEP notes: ‘The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.’

However, documents relating only to pending unpublished applications are not open to public inspection.

The handling of assignment records for related patent applications, such as divisional, continuation, or continuation-in-part applications, is addressed in MPEP 301.01. The key point is:

If the application on which a patent was granted is a division, continuation, or continuation-in-part of an earlier application, the assignment records of that earlier application will be open to public inspection because copies or access may be supplied to the earlier application pursuant to 37 CFR 1.14.

This policy has several implications:

  • Once a patent is granted on a related application, the assignment records of the parent application become publicly accessible.
  • This applies even if the parent application was previously unpublished or abandoned.
  • The public accessibility extends to all assignment records in the chain of related applications leading to the granted patent.

This approach ensures transparency in the ownership history of patented inventions, allowing interested parties to trace the chain of title through related applications. It’s important for applicants and assignees to be aware of this when considering their IP strategy and the potential disclosure of ownership information for related applications.

For more information on continuation applications, visit: continuation applications.

For more information on public inspection, visit: public inspection.

Assignment records for reissue applications are treated differently from regular patent applications due to their public nature. According to MPEP 301.01:

Assignment records relating to reissue applications are open to public inspection because reissue applications are open to public inspection pursuant to 37 CFR 1.11(b).

This means that once a reissue application is filed, its assignment records become publicly accessible, regardless of whether the original patent’s assignment records were previously confidential. This is because reissue applications are, by nature, related to already-issued patents and are subject to different rules regarding public disclosure.

The public accessibility of reissue application assignment records aligns with the general principle of transparency in the patent system, allowing interested parties to track ownership changes even during the reissue process. This can be particularly important for those monitoring patent rights in specific technological areas or for potential licensees or purchasers of patent rights.

For more information on public inspection, visit: public inspection.

For more information on reissue applications, visit: reissue applications.

The USPTO does not grant partial access to assignment documents. According to MPEP 301.01:

The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.

This policy ensures transparency and prevents selective disclosure of information. It’s important to note that this approach can have implications for documents that contain both public and potentially confidential information. For example:

  • If a document covers both a trademark and a patent application, the entire document becomes public.
  • If a document covers multiple patent applications, it becomes public as soon as any one of the applications is published or patented.

This policy underscores the importance of carefully considering what information is included in assignment documents, particularly when dealing with a mix of public and non-public intellectual property rights.

For more information on assignment documents, visit: assignment documents.

For more information on public inspection, visit: public inspection.

For more information on USPTO policy, visit: USPTO policy.

Access to assignment records for unpublished patent applications is restricted. The MPEP states:

“For pending or abandoned applications which are not open to the public pursuant to 37 CFR 1.11 or for which copies or access may not be supplied pursuant to 37 CFR 1.14, information related thereto is only obtainable upon a proper showing of written authority.”

To access these records, you must have written authority from one of the following:

  • An inventor
  • The applicant
  • The assignee or an assignee of an undivided part interest
  • A patent practitioner of record
  • A person with written authority from any of the above

Alternatively, you must show that you are a bona fide prospective or actual purchaser, mortgagee, or licensee of the application.

Yes, for certain patent applications, an assignment can contain statements required in an oath or declaration. The MPEP 301 states:

‘For applications filed under 35 U.S.C. 111(a), 363, or 385 on or after September 16, 2012, an assignment may contain the statements required to be made in an oath or declaration (‘assignment-statement’), and if the assignment is made of record in the assignment records of the Office, then the assignment may be utilized as the oath or declaration.’

This provision allows for greater flexibility in meeting the oath or declaration requirements, particularly for assigned inventions. However, it’s important to ensure that the assignment contains all the necessary statements and is properly recorded with the USPTO.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent assignment, visit: patent assignment.

Yes, a patent application can be assigned before it is filed. This is known as an assignment of future rights. MPEP 301 states:

“An assignment of an application can be made before the application is filed. See 37 CFR 3.21.”

However, it’s important to note that the assignment document should clearly identify the invention and the application to be filed. Once the application is filed, it’s advisable to record the assignment with the USPTO to ensure proper documentation of ownership.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

Yes, all patent assignment records are publicly accessible. MPEP 301.01 clearly states:

‘The assignment records of patents and applications are open to public inspection.’

This means that anyone can access these records, which include:

  • Assignment documents
  • Digests of assignments
  • Indexes of patent assignments

The public nature of these records ensures transparency in patent ownership and transfers. However, it’s important to note that while the records are public, obtaining copies may require payment of a fee as specified in 37 CFR 1.19(b)(3).

MPEP 302 - Recording of Assignment Documents (60)

Document legibility is crucial when submitting patent assignments because:

  1. The USPTO does not return recorded documents.
  2. If the submitted copy is illegible, the recorded document will also be illegible.
  3. Illegible documents may cause legal issues or complications in proving ownership.

The MPEP emphasizes this point: “If the copy submitted for recordation is illegible, the recorded document will be illegible. Accordingly, applicants and patent owners should ensure that only a legible copy is submitted for recordation.”

It’s the responsibility of the submitter to ensure that all documents are clear and readable to maintain accurate records of patent ownership.

Why doesn’t the USPTO return original assignment documents after recording?

The USPTO does not return original assignment documents after recording to maintain a permanent, unaltered record and to prevent potential disputes or fraud. According to MPEP 302.01: ‘The USPTO will not return documents filed for recording.’ This policy serves several purposes:

  • Ensures the integrity of the recorded documents
  • Prevents alterations or substitutions after recording
  • Maintains a consistent and reliable archive
  • Reduces administrative burden and potential for loss

By keeping all submitted documents, the USPTO can provide certified copies if needed for legal or business purposes, ensuring a reliable chain of title for patent rights.

The USPTO records various documents related to patent ownership and interests. Common types include:

  • Assignments
  • Security agreements
  • Mergers
  • Name changes
  • Licenses
  • Liens
  • Joint research agreements
  • Government interests

As stated in MPEP 302.07: “Examples of the type of descriptions of the interest conveyed or transaction to be recorded that can be identified are: (A) assignment; (B) security agreement; (C) merger; (D) change of name; (E) license; (F) foreclosure; (G) lien; (H) contract; and (I) joint research agreement.”

To record a document:

  1. Ensure it’s eligible for recordation
  2. Complete the appropriate cover sheet
  3. Submit the document and cover sheet to the USPTO
  4. Pay any applicable fees

Remember, the USPTO generally only records documents that affect title to patents or patent applications. Consult the MPEP or a patent attorney for guidance on specific document types.

For more information on patent documents, visit: patent documents.

For more information on USPTO recordation, visit: USPTO recordation.

What types of documents can be recorded in the USPTO assignment database?

The USPTO assignment database accepts various types of documents related to patent ownership and interests. According to MPEP 302, recordable documents include:

  • Assignments of patent rights
  • Security interests (e.g., liens, mortgages)
  • Licenses
  • Releases
  • Certificates of name changes
  • Mergers
  • Other documents affecting title to applications, patents, or registrations

The MPEP states: ‘Any document which relates to the title in a patent or patent application will be recorded as provided in 37 CFR 3.11.’ This broad definition allows for the recording of various ownership-related documents.

For more information on licenses, visit: licenses.

For more information on patent assignments, visit: patent assignments.

For more information on recordable documents, visit: recordable documents.

For more information on security interests, visit: security interests.

For more information on USPTO database, visit: USPTO database.

What types of documents can be recorded in the Assignment Division of the USPTO?

The Assignment Division of the USPTO records various types of documents related to patent ownership. According to MPEP 302, the following types of documents can be recorded:

  • Assignments of patents and patent applications
  • Security interests in patents and patent applications
  • Licenses that grant a security interest in patents or patent applications
  • Documents that affect title (e.g., certificates of name change, mergers, change of corporate form)
  • Liens
  • Certificates of release or discharge of security interests
  • Conditional assignments
  • Bailments

It’s important to note that the USPTO does not determine the validity of the documents submitted for recordation. As stated in MPEP 302:

‘The Assignment Division does not determine the validity of the document but rather records the document that appears to be a document affecting title.’

This means that while a wide range of documents can be recorded, it is the responsibility of the parties involved to ensure the legal validity and enforceability of the documents they submit.

For more information on Assignment Division, visit: Assignment Division.

For more information on recordable documents, visit: recordable documents.

For more information on USPTO, visit: USPTO.

What types of documents can be recorded as assignments with the USPTO?

The USPTO allows for the recording of various types of documents related to patent ownership. According to MPEP 302:

“The United States Patent and Trademark Office (USPTO) records assignments, grants, and similar instruments relating to interests in patents and applications as provided in 37 CFR Part 3.”

Types of documents that can be recorded include:

  • Assignments: Transfers of the entire right, title, and interest in a patent or application
  • Security Agreements: Documents creating a security interest in a patent or application
  • Licenses: Agreements granting rights to use or practice a patented invention
  • Releases: Documents releasing previous security interests or other encumbrances
  • Name Changes: Documents evidencing a change in the name of the owner of record
  • Mergers: Documents showing the merger of companies and the resulting transfer of patent rights

It’s important to note that the USPTO records these documents without making a determination of their validity. As stated in MPEP 302, “The recording of a document pursuant to 37 CFR 3.11 is not a determination by the USPTO of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.”

For more information on patent assignments, visit: patent assignments.

What is the timeframe for recording an assignment at the USPTO?

The USPTO recommends recording an assignment within three months of its execution date. According to MPEP 302:

“The Patent and Trademark Office does not require that a document be recorded. If a document is to be recorded, it should be submitted to the Assignment Division within three months from its date of execution; otherwise, it may not be accepted for recordation.”

While there’s no strict legal requirement to record within this timeframe, doing so ensures the assignment is properly documented and can help avoid potential legal issues in the future.

For more information on assignment recording, visit: assignment recording.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

What is the purpose of recording patent assignment documents?

Recording patent assignment documents serves several important purposes:

  • Providing notice to the public of the assignment
  • Creating a public record of the assignment
  • Protecting against subsequent purchasers without notice
  • Establishing priority of ownership rights

According to MPEP 302, ‘The recording of an assignment document in the USPTO is not a determination of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.’ It merely serves as a public notice and record of the transaction.

For more information on patent assignment, visit: patent assignment.

For more information on recording documents, visit: recording documents.

What is the purpose of recording an assignment with the USPTO?

Recording an assignment with the USPTO serves several important purposes:

  • Constructive notice: It provides constructive notice to the public of the assignment.
  • Prima facie evidence: The recording acts as prima facie evidence of the execution of the assignment.
  • Legal protection: It protects against subsequent purchasers without notice.
  • Maintaining chain of title: It helps maintain a clear chain of title for the patent or application.

As stated in MPEP 302: “The recording of an assignment document in the USPTO is governed by statute. The statutory provision is 35 U.S.C. 261.”

For more information on assignment recording, visit: assignment recording.

For more information on USPTO, visit: USPTO.

While the MPEP section provided does not specifically address name changes, the process for recording a name change for patent matters with the USPTO is similar to recording other documents affecting title. Here are the general steps:

  1. Prepare a document evidencing the name change (e.g., a certificate of name change or merger document)
  2. Complete a cover sheet (Form PTO-1595 or equivalent) that includes:
    • The former name (in the space for the party conveying the interest)
    • The new name (in the space for the party receiving the interest)
    • A description of the interest conveyed as “Name Change”
    • Identification of the affected patents or applications
  3. Submit the document and cover sheet to the USPTO for recordation, along with any required fee
  4. The submission can be done electronically through EPAS, by mail, or by fax (subject to limitations)

As with other recorded documents, the USPTO will assign reel and frame numbers and add recordation stampings to the processed document.

It’s important to note that while this process records the name change, it does not update the assignee name in individual patent or application files. Separate requests may be needed to update assignee names in specific applications or patents.

What is the process for correcting errors in recorded assignment documents?

The process for correcting errors in recorded assignment documents involves the following steps:

  • For minor errors: You can file a corrective document stating the nature of the error, along with the required fee.
  • For more significant errors: You may need to file a new assignment document with the correct information.
  • In all cases: Include a cover sheet stating that the document is being submitted to correct an error in a previously recorded assignment document.

According to MPEP 302: Errors in a recorded assignment document will be corrected by the Assignment Division provided a ‘corrective document’ is submitted. The USPTO recommends contacting the Assignment Recordation Branch for specific guidance on your situation.

For more information on assignment correction, visit: assignment correction.

For more information on patent documents, visit: patent documents.

For more information on USPTO procedures, visit: USPTO procedures.

The fee for recording a patent assignment with the USPTO depends on the method of submission:

  • For electronic submissions through the Electronic Patent Assignment System (EPAS), the fee is currently $0, as stated in 37 CFR 1.21(h)(1).
  • For non-electronic submissions (e.g., mail or fax), the fee is set forth in 37 CFR 1.21(h)(2).

It’s important to note that fees may change over time. As stated in MPEP 302.06: “Customers should check the current fee schedule on the Office website before submitting documents for recordation.”

Additionally, no fee is required for recording certain government interest documents, as specified in 37 CFR 3.41(b).

What is the difference between recording and registering a patent assignment?

Recording and registering a patent assignment are two distinct processes:

  • Recording refers to submitting the assignment document to the USPTO for public notice. As stated in MPEP 302, ‘The recording of the assignment document in the USPTO is merely a ministerial act and does not determine the validity of the document.’
  • Registering is not a term used by the USPTO for assignments. The term ‘registration’ is typically used for trademarks, not patents.

Recording an assignment provides constructive notice of the transfer of ownership but does not guarantee the assignment’s validity or enforceability.

For more information on ownership transfer, visit: ownership transfer.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

What is the difference between recording an assignment and registering a trademark?

Recording an assignment for a patent or trademark application is different from registering a trademark. Here are the key distinctions:

  • Recording an assignment: This process involves documenting the transfer of ownership rights for a patent or trademark application. It’s done through the USPTO’s Assignment Recordation Branch.
  • Registering a trademark: This is the process of officially registering a trademark with the USPTO to protect your brand identity. It’s handled by the Trademark Office.

As stated in MPEP 302: “The recording of assignments is governed by 35 U.S.C. 261 for patents and 15 U.S.C. 1060 for trademarks.” This indicates that assignment recording is a separate process from trademark registration, which is governed by different statutes.

For more information on assignment recording, visit: assignment recording.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO maintains two special registers for recording certain government interests in patents and patent applications, as outlined in 37 CFR 3.58:

  1. Departmental Register: This register records governmental interests required by Executive Order 9424. It is not open to public inspection but can be examined by authorized government representatives. However, governmental interests recorded on this register are available for public inspection as provided in 37 CFR 1.12.
  2. Secret Register: This register is used to record governmental interests that require secrecy. Documents are placed on this register at the request of the submitting department or agency. Access to this register is highly restricted and requires written authority from the head of the department or agency that submitted the document, as well as approval from the USPTO Director.

These registers ensure that certain sensitive government interests in patents can be recorded while maintaining appropriate levels of confidentiality or secrecy.

An extract of an original document refers to a portion or summary of the original assignment document that contains the essential information required for recording. Both 37 CFR 3.24(a) and (b) state that “Either a copy of the original document or an extract of the original document may be submitted for recording.”

When submitting an extract:

  • Ensure it includes all relevant assignment details.
  • The extract must meet the same format requirements as a full copy.
  • It should be clear that the extract represents the key elements of the original document.

Using an extract can be beneficial when the original document contains confidential information not necessary for the assignment record.

If there’s an error in your assignment submission, the USPTO will notify you and provide an opportunity to correct the issue. The process differs slightly depending on the submission method:

  • For fax submissions: The USPTO will fax back the entire document, cover sheet, and a “Notice of Non-Recordation” explaining the issue.
  • For electronic (EPAS) submissions: The USPTO will attempt to fax the notice back. If faxing isn’t possible, they may use other means to notify you.

As stated in MPEP 302.09: “If a document submitted by fax is determined not to be recordable, the entire document, with its associated cover sheet, and the Office ‘Notice of Non-Recordation’ will be transmitted via fax back to the sender.”

To correct the error:

  1. Make the necessary corrections to the document or cover sheet
  2. Resubmit the corrected document by mail to the address in 37 CFR 3.27
  3. Timely resubmission may allow you to retain the initial receipt date as the recordation date

Always double-check your submissions for accuracy to avoid delays in recording your assignment.

What happens if there’s an error in a recorded assignment document?

If an error is discovered in a recorded assignment document, it can be corrected through a Certificate of Correction. The MPEP 302 provides guidance on this process:

“Errors in a recorded assignment document will be corrected by the Assignment Division provided a ‘corrective document’ is submitted. The ‘corrective document’ must include the following: … [list of requirements]”

To correct an error, you need to submit:

  • A copy of the original assignment document with the error
  • A ‘corrective document’ explaining the nature of the error and the desired correction
  • New recordation fee for processing the correction

It’s important to address errors promptly to ensure accurate ownership records. The USPTO will review the correction request and update the assignment records accordingly if approved.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on USPTO, visit: USPTO.

What happens if I submit a non-original assignment document for recording?

If you submit a non-original assignment document for recording, it will be rejected by the USPTO. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording. Therefore, customers must submit copies of the documents to be recorded, rather than originals.’ This means that while you should submit a copy, it must be a true and complete copy of the original document. Submitting altered or incomplete copies may result in rejection and delay the recording process.

What happens if I don’t record an assignment with the USPTO?

Failing to record an assignment with the USPTO can have significant legal implications. According to MPEP 302:

“An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the USPTO within three months from its date or prior to the date of such subsequent purchase or mortgage.”

This means that if you don’t record your assignment:

  • Your ownership rights may not be enforceable against subsequent purchasers or mortgagees who were unaware of the unrecorded assignment.
  • You may face difficulties in proving ownership in legal proceedings or licensing negotiations.
  • It could complicate future transfers or financial transactions involving the patent or application.

To protect your interests, it’s crucial to record assignments promptly with the USPTO, ideally within three months of the assignment date or before any subsequent transactions occur.

For more information on legal implications, visit: legal implications.

For more information on USPTO procedures, visit: USPTO procedures.

If an assignment document submitted electronically through the Electronic Patent Assignment System (EPAS) is determined to be not recordable, the following process occurs:

  1. The entire document, along with its associated cover sheet, will be returned to the sender.
  2. An Office “Notice of Non-Recordation” will be transmitted back to the sender via fax, if possible.
  3. The sender can make corrections to the document or cover sheet.
  4. The corrected submission can then be resubmitted by mailing it to the address specified in 37 CFR 3.27.
  5. If the resubmission is timely, the sender will receive the benefit of the initial receipt date as the recordation date, in accordance with 37 CFR 3.51.

As stated in MPEP 302.10: “Once corrections are made, the initial submission, as amended, may then be resubmitted by mailing the corrected submission to the address set forth in 37 CFR 3.27. Timely submission will provide the sender with the benefit of the initial receipt date as the recordation date in accordance with 37 CFR 3.51.”

What happens if an assignment document is not recorded at the USPTO?

If an assignment document is not recorded at the USPTO, it can have significant legal implications. According to MPEP 302:

‘An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the Office within three months from its date or prior to the date of such subsequent purchase or mortgage.’

In other words, failing to record an assignment within the specified timeframe can render it invalid against subsequent purchasers or mortgagees who were unaware of the previous assignment. This highlights the importance of timely recording assignments to protect the rights of assignees.

For more information on assignment recording, visit: assignment recording.

For more information on legal implications, visit: legal implications.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

What happens if an assignment document is not legible for recording?

If an assignment document is not legible for recording, it will be rejected by the USPTO. According to MPEP 302.01, “Documents submitted for recording must be legible and capable of being reproduced in legible copies by use of photocopy and standard office copying equipment.” If a document is rejected due to legibility issues, the USPTO will notify the person who submitted the document, and they will need to resubmit a legible copy for recording.

What happens if an assignment document is not a copy when submitted for recording?

If an assignment document submitted for recording is not a copy, it will not be accepted for recording. The MPEP clearly states: The Assignment Division will not accept an original assignment document because it becomes part of the USPTO permanent records. This is to protect the original document and ensure that the USPTO maintains proper records. If you submit an original document, it will be returned to you unrecorded, and you will need to submit a copy instead.

To ensure your assignment is properly recorded, always submit a legible copy of the original assignment document. This can be a photocopy or other reproduction of the original.

What happens if a patent assignment is not recorded with the USPTO?

Failing to record a patent assignment with the USPTO can have significant consequences:

  • Lack of Constructive Notice: Third parties may not be aware of the ownership transfer.
  • Potential Legal Issues: It may affect the assignee’s ability to enforce the patent or recover damages in infringement cases.
  • Validity of Subsequent Transfers: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as valid, for purposes of recording, unless overcome by a showing that such assignment was fraudulently procured or is otherwise invalid.’

While recording is not mandatory for the assignment to be valid between the parties involved, it is highly recommended to protect the assignee’s rights and provide public notice of the ownership change.

For more information on USPTO, visit: USPTO.

Tags: USPTO

According to 37 CFR 3.11, the following documents can be recorded with the USPTO related to patent assignments:

  • Assignments of applications, patents, and registrations
  • Other documents relating to interests in patent applications and patents
  • Documents affecting title to applications, patents, or registrations
  • Licenses, assignments, or other interests of the Government in or under patents or patent applications
  • Joint research agreements or excerpts of joint research agreements

These documents must be accompanied by completed cover sheets as specified in 37 CFR 3.28 and 3.31.

According to 37 CFR 3.31, the cover sheet for patent assignments must contain:

  • Name of the party conveying the interest
  • Name and address of the party receiving the interest
  • Description of the interest conveyed or transaction to be recorded
  • Identification of the patent or application
  • Name and address for correspondence
  • Date of execution
  • Signature of the party submitting the document

For joint research agreements, the cover sheet must also:

  • Identify the document as a ‘joint research agreement’
  • Indicate the name of the patent owner
  • Indicate the names of other parties to the agreement
  • Indicate the date the agreement was executed

The MPEP notes that Form PTO-1595, Recordation Form Cover Sheet, may be used as the cover sheet for recording documents relating to patent(s) and/or patent application(s) in the Office.

For more information on Assignment cover sheet, visit: Assignment cover sheet.

For more information on patent assignment, visit: patent assignment.

According to 37 CFR 3.26, assignment documents in languages other than English can be recorded with the USPTO, but specific requirements must be met. The MPEP states:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

Key points for submitting non-English assignment documents:

  • The original non-English document must be submitted
  • An English translation of the document must be provided
  • The translation must be signed by the individual who performed the translation
  • Both the original document and the translation will be recorded

It’s important to ensure that the translation accurately reflects the content of the original document to avoid any legal complications or misunderstandings regarding the assignment.

For more information on patent assignment, visit: patent assignment.

To submit an assignment document electronically to the USPTO, the following requirements must be met:

  • The document must be submitted via the Electronic Patent Assignment System (EPAS)
  • An identified application or patent number must be included
  • One cover sheet must be completed online to record a single transaction
  • The signature on the cover sheet must comply with 37 CFR 3.31(a)(7) or 37 CFR 1.4(d)(2)

As stated in 37 CFR 1.4(d)(2), an S-signature may be used, which consists of letters and/or numbers between forward slashes (e.g., /John Doe/). For patent practitioners, their registration number must also be included.

Joint research agreements can be recorded with the USPTO as per 37 CFR 3.11(c). The MPEP states that the cover sheet for a joint research agreement must:

  • Identify the document as a ‘joint research agreement’ in the description of interest conveyed
  • Indicate the name of the owner of the application or patent
  • Indicate the name of each other party to the joint research agreement
  • Indicate the date the joint research agreement was executed

The document submitted can be either the entire joint research agreement or an excerpt of it. As with other recorded documents, it must be accompanied by a completed cover sheet as specified in 37 CFR 3.28 and 3.31.

Remember that A patent cover sheet may not refer to trademark applications or registrations. Separate cover sheets must be used for patents and trademarks.

For more information on joint research agreement, visit: joint research agreement.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For paper submissions of patent assignment documents, the following requirements must be met:

  • Submit either a copy of the original document or an extract of the original document.
  • Use only one side of each page.
  • Paper size must be either 8.5″ x 11″ or A4, with a 1-inch margin on all sides.
  • Use flexible, strong white, non-shiny, and durable paper.

As stated in 37 CFR 3.24(b): “For paper submissions, the paper used should be flexible, strong white, non-shiny, and durable.” This ensures that the document can be properly recorded and stored by the USPTO.

For electronic submissions of assignment documents, the following requirements apply:

  • Either a copy of the original document or an extract of the original document may be submitted.
  • Documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another prescribed format.
  • When printed to paper size (8.5″ x 11″ or A4), the document must be legible with a 1-inch margin on all sides.

As stated in 37 CFR 3.24(a): “All documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another form as prescribed by the Director.”

The fees for recording assignment documents are set forth in 37 CFR 3.41. According to the MPEP:

  • For electronic submissions: The fee is currently $0 (as per 37 CFR 1.21(h)(1))
  • For paper or facsimile submissions: The fee is set in 37 CFR 1.21(h)(2)

The MPEP advises: Customers should check the current fee schedule on the Office website before submitting documents for recordation.

It’s important to note that a fee is required for each application, patent, and registration against which the document is recorded, as identified in the cover sheet. However, there are exceptions:

  • No fee is required for documents required by Executive Order 9424 if the document does not affect title and is identified as such in the cover sheet
  • The document must be either faxed, electronically submitted, or mailed in compliance with 37 CFR 3.27

For more information on recordation fees, visit: recordation fees.

For more information on USPTO fees, visit: USPTO fees.

The fees for recording a patent assignment depend on the submission method:

  • Electronic submission via EPAS (Electronic Patent Assignment System): $0
  • Paper or facsimile submission: See current fee schedule

As stated in MPEP 302.06: “If the request to record a document is submitted electronically, the fee is set forth in 37 CFR 1.21(h)(1), currently at $0. If the request to record a document is not submitted electronically (i.e., is submitted on paper or via facsimile), the applicable fee is set forth in 37 CFR 1.21(h)(2).”

It’s important to note that fees are subject to change. Always check the current USPTO fee schedule before submitting documents for recordation.

For more information on patent assignment fees, visit: patent assignment fees.

For more information on USPTO fees, visit: USPTO fees.

What are the consequences of submitting a poor-quality copy of an assignment document to the USPTO?

Submitting a poor-quality copy of an assignment document to the USPTO can lead to rejection of the recording request. The MPEP 302.01 clearly states that “Only copies of an original assignment document (with the exception of those submitted via EFS-Web) may be submitted for recording.” Furthermore, it emphasizes that “The copy must be legible, capable of reproduction and otherwise meet the usual requirements of documents for recording.” If a poor-quality copy is submitted:

  • The recording request may be rejected
  • The effective date of recordation could be delayed
  • Additional fees may be incurred for resubmission
  • There could be potential legal implications if the assignment is not properly recorded in a timely manner

To avoid these issues, always ensure that the copy submitted is of high quality and meets all USPTO requirements for legibility and reproducibility.

What are the consequences of failing to record a patent assignment with the USPTO?

Failing to record a patent assignment with the USPTO can have several important consequences:

  • Lack of legal notice: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as notice to the world of the ownership of the patent.’ Without recording, third parties may not have legal notice of the assignment.
  • Potential validity issues: In some cases, failure to record an assignment could affect the validity of subsequent actions taken by the assignee.
  • Difficulties in enforcement: Unrecorded assignments may complicate patent enforcement efforts, as the assignee’s standing to sue could be challenged.
  • Problems in future transactions: Lack of a clear chain of title can cause issues in future sales, licenses, or other transactions involving the patent.

While recording is not mandatory, it is highly recommended to protect the assignee’s rights and ensure a clear chain of title for the patent.

For more information on legal notice, visit: legal notice.

For more information on patent assignment, visit: patent assignment.

When preparing an assignment document for recording with the USPTO, follow these guidelines based on 37 CFR 3.24 and MPEP 302.01:

  1. For electronic submissions:
    • Submit either a copy of the original document or an extract of it
    • Ensure the document is in Tagged Image File Format (TIFF) or another prescribed format
    • When printed, the document should be legible on 8.5 x 11 inch or A4 paper with 1-inch margins on all sides
  2. For paper or facsimile submissions:
    • Submit a copy of the original document or an extract (not the original)
    • Use only one side of each page
    • Use 8.5 x 11 inch or A4 paper with 1-inch margins on all sides
    • For paper submissions, use flexible, strong white, non-shiny, and durable paper
  3. Ensure the document is legible, as the recorded document will only be as clear as the submitted copy
  4. Include a completed cover sheet as specified in 37 CFR 3.28 and 3.31

MPEP 302.01 states: “The United States Patent and Trademark Office will accept and record only a copy of an original assignment or other document.” Remember, the document submitted for recordation will not be returned, so do not submit original documents.

According to 37 CFR 3.21 and MPEP 302.03, a patent or application should be identified in an assignment document as follows:

  • For a patent: Use the patent number
  • For a national patent application: Use the application number (series code and serial number, e.g., 07/123,456)
  • For an international patent application designating the U.S.: Use the international application number (e.g., PCT/US2012/012345)
  • For an international design application designating the U.S.: Use either the international registration number or the U.S. application number

For applications not yet filed or without an assigned number:

  • For a non-provisional application: Identify by inventor name(s) and the title of the invention
  • For a provisional application: Identify by inventor name(s) and the title of the invention

MPEP 302.03 suggests: “It is suggested, however, that an assignment be written to allow entry of the identifying number after the execution of the assignment. An example of acceptable wording is: ‘I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.'”

To record a joint research agreement with the USPTO, follow these steps based on 37 CFR 3.11(c) and 37 CFR 3.31(g):

  1. Prepare either a copy of the joint research agreement or an excerpt of it.
  2. Complete a cover sheet that includes:
    • Identification of the document as a “joint research agreement” in the space for describing the interest conveyed
    • The name of the owner of the application or patent
    • The name of each other party to the joint research agreement
    • The date the joint research agreement was executed
  3. Submit the document and cover sheet to the USPTO for recordation.

As stated in MPEP 302.07: “If the document submitted for recordation is a joint research agreement or an excerpt of a joint research agreement, the cover sheet must clearly identify the document as a ‘joint research agreement’ (in the space provided for the description of the interest conveyed if using Form PTO-1595).”

According to 35 U.S.C. 293 and 37 CFR 3.61, a foreign assignee of a patent or patent application who is not domiciled in the United States may designate a domestic representative. Here’s how to do it:

  1. Prepare a written document signed by the assignee.
  2. State the name and address of a person residing within the United States who may be served process or notice of proceedings affecting the patent or rights under it.
  3. Submit this document to the USPTO as a separate paper from any assignment document.
  4. Clearly label the document as “Designation of Domestic Representative.”
  5. Ensure the document is signed in accordance with 37 CFR 1.33(b).

As stated in MPEP 302.04: “The designation of domestic representative should always be submitted to the Office as a paper separate from any assignment document.”

How long does it take for a patent assignment to be recorded by the USPTO?

The time it takes for a patent assignment to be recorded by the USPTO can vary. While the MPEP does not specify an exact timeframe, the process typically takes several weeks. Factors affecting the recording time include:

  • Method of submission (electronic vs. paper)
  • Completeness and accuracy of the submitted documents
  • Current USPTO workload

According to the MPEP 302, ‘The date of recording of a document is the date of its receipt in the Office in proper form with the appropriate fee.’ This means that the official recording date is the date the USPTO receives a compliant submission, not the date when processing is completed.

For the most up-to-date information on processing times, it’s advisable to check the USPTO website or contact their assignment recordation branch directly.

How does the USPTO handle incorrect or erroneous assignment recordings?

The USPTO has a specific process for handling incorrect or erroneous assignment recordings:

  1. No expungement: The USPTO does not expunge or remove assignment documents once they are recorded.
  2. Corrective documents: Parties can record corrective documents to address errors or provide clarifications.
  3. Maintaining integrity: This approach preserves the integrity of the assignment records.

As stated in MPEP 302: ‘Even if a recorded document is subsequently found to be invalid, the recording will be maintained in the assignment records and the assignment records will not be expunged.’ This policy ensures a complete historical record of all recorded documents.

For more information on USPTO records, visit: USPTO records.

How does the USPTO handle assignment documents that contain errors?

The USPTO has procedures in place for handling assignment documents with errors:

  • Minor errors: The USPTO may correct minor errors in assignment documents without requiring a new submission. As stated in MPEP 302: ‘Minor corrections to documents recorded pursuant to 37 CFR 3.11 will be made by the Assignment Division, provided that the corrections do not involve the re-recording of the entire assignment document.’
  • Major errors: For significant errors, a new corrected document must be submitted. The MPEP notes: ‘Other corrections may be made only by the submission of a new document.’
  • Erroneous recording: If an assignment is erroneously recorded, the USPTO will correct its records upon notification.

It’s important to review assignment documents carefully before submission to avoid delays and potential legal issues.

For more information on document correction, visit: document correction.

For more information on USPTO procedures, visit: USPTO procedures.

To record an assignment document with the USPTO, you must:

  • Submit a copy of the original assignment document
  • Include a completed cover sheet (Form PTO-1595 or equivalent)
  • Pay the required recording fee

The cover sheet must contain key information like the names of the parties, description of the interest conveyed, and patent/application numbers affected. As stated in MPEP 302.07: “Each assignment document submitted to the Office for recording must be accompanied by a cover sheet as required by 37 CFR 3.28.”

Documents can be submitted electronically via EPAS, by mail, or by fax. Electronic submission is recommended as it has a $0 fee.

For more information on assignment recording, visit: assignment recording.

For more information on cover sheet, visit: cover sheet.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

To record a joint research agreement (JRA) with the USPTO, follow these steps:

  1. Prepare the JRA document or an excerpt of it
  2. Complete a cover sheet, clearly identifying the document as a “joint research agreement”
  3. Submit the document and cover sheet to the USPTO

As stated in MPEP 302.07: “If the document submitted for recordation is a joint research agreement or an excerpt of a joint research agreement, the cover sheet must clearly identify the document as a ‘joint research agreement’.”

The cover sheet for a JRA must include:

  • The name of the owner of the application or patent
  • The name of each other party to the joint research agreement
  • The date the joint research agreement was executed

JRAs can be submitted electronically via EPAS, by mail, or by fax, following the same procedures as other assignment documents.

For more information on joint research agreement, visit: joint research agreement.

Recording a government interest in a patent requires special procedures:

  1. Prepare the document establishing the government interest
  2. Complete a patent cover sheet, indicating it relates to a government interest
  3. Submit the document and cover sheet to the USPTO

As stated in MPEP 302.07: “Cover sheets required by 37 CFR 3.28 seeking to record a governmental interest must also (1) indicate that the document relates to a governmental interest and (2) indicate, if applicable, that the document to be recorded is not a document affecting title.”

Key points for government interest recordations:

  • No fee is required if the document doesn’t affect title and is properly identified
  • These documents are recorded in a special Departmental Register
  • Some government documents may be recorded in a Secret Register with restricted access

Government agencies should follow Executive Order 9424 which requires prompt forwarding of government interests in patents for recording.

For more information on patent recordation, visit: patent recordation.

According to 37 CFR 3.21, a patent assignment must identify the patent by patent number. For patent applications:

  • National applications: Identify by application number (series code and serial number)
  • International applications designating the US: Identify by international application number
  • International design applications designating the US: Identify by international registration number or US application number

If the assignment is executed before filing but after the application is executed, it must identify the application by inventor name(s) and invention title. For provisional applications not yet filed, identify by inventor name(s) and invention title.

The MPEP suggests including language like: I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.

For more information on application identification, visit: application identification.

For more information on patent assignment, visit: patent assignment.

For more information on patent identification, visit: patent identification.

The USPTO allows electronic submission of assignment documents through the Electronic Patent Assignment System (EPAS). According to the MPEP:

  • Visit http://epas.uspto.gov for the EPAS system
  • Include an identified application or patent number
  • Complete one online cover sheet for a single transaction

For electronic submissions, the signature must comply with 37 CFR 3.31(a)(7) or 37 CFR 1.4(d)(2). This typically involves an S-signature between forward slashes (e.g., /John Smith/).

The MPEP notes: The fee set in 37 CFR 1.21(h)(1) for recording an electronically submitted document is currently $0. Customers should check the current fee schedule on the Office website before submitting documents for recordation.

The recordation date for electronic submissions is the date the complete transmission is received by the USPTO.

For more information on electronic submission, visit: electronic submission.

For more information on EPAS, visit: EPAS.

For more information on patent assignment, visit: patent assignment.

There are three main ways to submit a patent assignment document to the USPTO:

  1. Mail: Documents can be mailed to the address specified in 37 CFR 3.27: Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450.
  2. Fax: Documents can be submitted via facsimile, as outlined in MPEP 302.09. However, certain documents cannot be faxed, such as assignments submitted with new applications.
  3. Electronic Submission: Documents can be submitted electronically through the Electronic Patent Assignment System (EPAS) as described in MPEP 302.10.

Each method has specific requirements and limitations, so it’s important to review the relevant MPEP sections or consult the USPTO website for detailed instructions.

Foreign assignees can designate a domestic representative for USPTO correspondence as outlined in 35 U.S.C. 293 and 37 CFR 3.61. The MPEP states:

An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative.

Key points for this designation:

  • It should be submitted as a separate paper from any assignment document
  • It should be clearly labeled ‘Designation of Domestic Representative’
  • It will be entered into the record of the appropriate application or patent file
  • It must be signed in accordance with 37 CFR 1.33(b)
  • It should state the name and address of a person residing within the United States

This designation allows for service of process or notice of proceedings affecting the patent or rights under the patent to be served on the designated representative.

For more information on domestic representative, visit: domestic representative.

For more information on foreign assignee, visit: foreign assignee.

For more information on USPTO correspondence, visit: USPTO correspondence.

No, you should not submit original documents for recording patent assignments. The USPTO explicitly states:

“The United States Patent and Trademark Office will accept and record only a copy of an original assignment or other document. See MPEP § 317. The document submitted for recordation will not be returned to the submitter.”

It’s crucial to submit only copies of original documents, as the USPTO will not return the recorded documents. This ensures that you retain your original documents while still complying with the recording requirements.

Can I submit a photocopy or digital scan of my assignment document for USPTO recording?

Yes, you can submit a photocopy or digital scan of your assignment document for USPTO recording, as long as it’s a complete and legible copy. The MPEP 302.01 specifies: ‘The copy of the document to be recorded should be presented to the Office for recordation.’ This means that:

  • Photocopies are acceptable
  • Digital scans saved as PDF files are also acceptable
  • The copy must be clear and readable
  • All pages and attachments must be included

Remember, while you’re submitting a copy, it must accurately represent the original document in its entirety.

Yes, you can submit a patent assignment electronically through the USPTO’s Electronic Patent Assignment System (EPAS). This is the recommended method for several reasons:

  • It’s free – there is no recordation fee for electronic submissions
  • It’s fast – documents are processed more quickly
  • It’s convenient – you can submit 24/7 from anywhere with internet access

As stated in MPEP 302.10: “Assignments and other documents affecting title may be submitted to the Office via the Office’s Electronic Patent Assignment System (EPAS).”

To use EPAS, you’ll need to complete an online cover sheet and upload a copy of the assignment document. The signature on the electronic cover sheet must comply with USPTO regulations for electronic signatures.

For more information and to access EPAS, visit the USPTO EPAS website.

For more information on electronic patent assignment, visit: electronic patent assignment.

For more information on EPAS, visit: EPAS.

Can I submit a handwritten assignment document for recording at the USPTO?

While handwritten assignment documents are not explicitly prohibited, they are generally discouraged and may face challenges in the recording process. The MPEP 302.01 states that “Documents submitted for recording must be legible and capable of being reproduced in legible copies by use of photocopy and standard office copying equipment.” Handwritten documents may not meet this standard, especially if the handwriting is not clear and easily readable. To ensure smooth processing and avoid potential rejection, it’s recommended to submit typed or printed assignment documents that are clearly legible and meet all USPTO requirements.

Can I record an assignment for a pending patent application?

Yes, you can record an assignment for a pending patent application. In fact, the USPTO encourages early recordation of assignments. According to MPEP 302:

An assignment relating to a patent must identify the patent by the patent number. An assignment relating to a national patent application must identify the national patent application by the application number (consisting of the series code and the serial number, e.g., 07/123,456). An assignment relating to an international patent application which designates the United States of America must identify the international application by the international application number (e.g., PCT/US90/01234).

To record an assignment for a pending application:

  • Use the application number to identify the application
  • Ensure all necessary parties have signed the assignment document
  • Submit the assignment document along with the required cover sheet and fee to the USPTO

Early recordation can help establish clear ownership and facilitate future transactions or licensing agreements.

For more information on USPTO procedures, visit: USPTO procedures.

Can foreign language assignment documents be recorded at the USPTO?

Yes, foreign language assignment documents can be recorded at the USPTO, but they must be accompanied by an English translation. The MPEP 302 states:

“Unless an assignment is in a language other than English, the Office may rely on the assignment document (or a copy thereof) as filed.”

If the assignment is in a foreign language, you must provide:

  • The original foreign language document
  • An English language translation
  • A statement verifying that the translation is accurate

This ensures that the USPTO can properly review and record the assignment, maintaining accurate ownership records for patents and patent applications.

For more information on patent assignment, visit: patent assignment.

For more information on translation requirements, visit: translation requirements.

For more information on USPTO, visit: USPTO.

Can electronic copies of assignment documents be submitted for recording?

Yes, electronic copies of assignment documents can be submitted for recording at the USPTO. The MPEP 302.01 states: Any legible copies, including facsimile transmissions and computer generated copies, of original assignment documents will be acceptable for recording.

This means you can submit:

  • Scanned copies of original documents
  • Faxed copies
  • Computer-generated copies

The key requirement is that the electronic copy must be legible. Ensure that all text, signatures, and dates are clearly visible in the electronic copy. You can submit these electronic copies through the USPTO’s Electronic Patent Assignment System (EPAS) for efficient processing.

Can assignment documents be submitted electronically to the USPTO?

Yes, assignment documents can be submitted electronically to the USPTO. The MPEP 302 states:

‘Assignment documents can be submitted to the Office in paper or electronically.’

The USPTO provides an electronic system for submitting assignment documents, which can be more convenient and efficient than paper submissions. However, it’s important to note that regardless of the submission method, the documents must meet all legal requirements and be properly executed to be considered valid.

For electronic submissions, users can utilize the Electronic Patent Assignment System (EPAS) provided by the USPTO. This system allows for quick and secure submission of assignment documents directly to the USPTO’s database.

For more information on assignment documents, visit: assignment documents.

For more information on electronic submission, visit: electronic submission.

For more information on EPAS, visit: EPAS.

For more information on USPTO, visit: USPTO.

Can an assignment be recorded electronically with the USPTO?

Yes, assignments can be recorded electronically with the USPTO. The MPEP 302 states:

“The USPTO provides for the electronic filing of patent assignment documents through the Electronic Patent Assignment System (EPAS).”

Electronic filing offers several advantages:

  • Faster processing times
  • Immediate confirmation of receipt
  • Reduced risk of errors in data entry
  • 24/7 accessibility

To use EPAS, users must have a USPTO.gov account and follow the specific guidelines for electronic submission. For detailed instructions, visit the Electronic Patent Assignment System (EPAS) on the USPTO website.

For more information on electronic filing, visit: electronic filing.

For more information on EPAS, visit: EPAS.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

Can a patent assignment be recorded electronically?

Yes, patent assignments can be recorded electronically. The USPTO provides an electronic system for recording assignment documents. According to MPEP 302:

‘Assignment documents can be submitted for recordation via the Office’s Electronic Patent Assignment System (EPAS). See the USPTO website at http://www.uspto.gov/patents-application-process/documenting-patent-ownership/epas-electronic-patent-assignment-system for additional information regarding EPAS.’

Electronic submission through EPAS is often faster and more convenient than paper submissions. However, it’s important to ensure that all necessary information and signatures are included in the electronic submission.

For more information on electronic patent assignment, visit: electronic patent assignment.

For more information on EPAS, visit: EPAS.

For more information on USPTO, visit: USPTO.

MPEP 303 - Assignment Documents Not Endorsed on Pending Applications (8)

MPEP 303 highlights the importance of determining who should direct prosecution:

“When the assignment condition of an application is significant, such as… when there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

Determining who should direct prosecution is crucial because:

  • It ensures that the rightful owner or assignee is making decisions about the application
  • It prevents unauthorized individuals from influencing the prosecution process
  • It helps resolve potential disputes over ownership or control of the application
  • It maintains the integrity of the patent examination process

When there’s uncertainty about this, examiners must verify assignment information to ensure proper handling of the application.

MPEP 303 outlines specific situations where a patent examiner needs to obtain assignment information from the Patent Application Locator and Monitoring (PALM) system:

“When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims or there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

This typically occurs in two main scenarios:

  1. When applications from different inventors have conflicting claims
  2. When there’s uncertainty about who should direct the prosecution

In these cases, the examiner must consult PALM to clarify the assignment status.

Patent examiners need to obtain assignment information in specific situations where the ownership of an application is significant. The MPEP 303 outlines two key scenarios:

  1. Conflicting claims in applications of different inventors: When multiple applications from different inventors contain claims that conflict with each other.
  2. Questions about who should direct prosecution: When there is uncertainty about which party has the right to control the patent prosecution process.

In these cases, the MPEP states: “When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims or there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” PALM refers to the USPTO’s Patent Application Location and Monitoring system.

For more information on assignment information, visit: assignment information.

For more information on conflicting claims, visit: conflicting claims.

For more information on Patent examiners, visit: Patent examiners.

For more information on patent prosecution, visit: patent prosecution.

PALM stands for Patent Application Locator and Monitoring system. While MPEP 303 doesn’t provide a definition, it mentions PALM in the context of assignment information:

“…it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

PALM is an internal USPTO database system used by patent examiners to access and track information about patent applications, including assignment details. It’s a crucial tool for examiners when they need to verify ownership or resolve conflicts related to patent applications.

MPEP 303 states that certified copies of patent applications as filed do not include an indication of assignment documents. The section specifically notes:

“Certified copies of patent applications as filed do not include an indication of assignment documents.” (MPEP 303)

This means that if an applicant wants to have proof of assignment documents, they need to request this separately.

MPEP 303 mentions conflicting claims as a situation where assignment information becomes crucial:

“When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims…” (MPEP 303)

Conflicting claims occur when two or more patent applications claim the same or overlapping subject matter. This is significant because:

  • It may indicate potential ownership disputes
  • It can affect the novelty or non-obviousness of the claimed inventions
  • It might require the USPTO to initiate an interference or derivation proceeding

In such cases, examiners need to verify assignment information to determine the proper course of action.

According to MPEP 303, applicants who want information about assignment documents must take specific steps:

  1. Request separately certified copies of assignment documents
  2. Submit the fees required by 37 CFR 1.19

The MPEP states:

“Applicants desiring an indication of assignment documents of record should request separately certified copies of assignment documents and submit the fees required by 37 CFR 1.19.” (MPEP 303)

No, certified copies of patent applications as filed do not include an indication of assignment documents. According to the MPEP 303, “Certified copies of patent applications as filed do not include an indication of assignment documents.” This means that the initial certified copy of a patent application does not contain information about any assignments that may have been recorded.

For more information on assignment documents, visit: assignment documents.

For more information on certified copies, visit: certified copies.

For more information on patent applications, visit: patent applications.

For more information on USPTO, visit: USPTO.

MPEP 307 - Issue to Non - Applicant Assignee (16)

What is the significance of the issue fee payment date for patent assignments?

The issue fee payment date is crucial for patent assignments and issuance to assignees for several reasons:

  • It serves as the deadline for requesting issuance of the patent to the assignee under 37 CFR 3.81(b).
  • Assignments recorded after this date but before patent issuance will be recorded but won’t affect who the patent is issued to.
  • It impacts the USPTO’s ability to change the name on the patent.

MPEP 307 states: “If the assignment is submitted for recording after the date of payment of the issue fee, but prior to issuance of the patent, the assignment will be recorded but the patent will issue to the name of the inventor.” This underscores the importance of timely assignment recording and requests for issuance to the assignee.

For more information on assignment recording, visit: assignment recording.

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

The process for issuing a patent to a non-applicant assignee involves the following steps:

  1. A request for issuance to the assignee must be submitted with the payment of the issue fee.
  2. The assignment must have been previously recorded in the USPTO or filed for recordation.
  3. If the request is submitted after the issue fee payment, additional requirements apply, including a request for a certificate of correction and associated fees.

According to 37 CFR 3.81(a): An application may issue in the name of the assignee consistent with the application’s assignment where a request for such issuance is submitted with payment of the issue fee, provided the assignment has been previously recorded in the Office.

To correct assignee information on an issued patent, you must follow these steps:

  1. Submit a request for a certificate of correction under 37 CFR 1.323.
  2. Ensure that a request under 37 CFR 3.81(b) has been granted.
  3. Confirm that the assignment was submitted for recordation before the patent was issued.

According to MPEP 307: “A request for a certificate of correction under 37 CFR 1.323 (see MPEP §§ 1481 and 1485) arising from incomplete or erroneous assignee’s name furnished, or a missing assignee’s name, in item 3 of PTOL-85B will not be granted unless a request under 37 CFR 3.81(b) has been granted and the assignment was submitted for recordation as set forth in 37 CFR 3.11 before the patent issued.”

The request should be directed to the Office of Petitions and include:

  • The processing fee required by 37 CFR 1.17(i)
  • A request for issuance of the application in the name of the assignee, or a request that a patent be corrected to state the name of the assignee
  • A statement that the assignment was submitted for recordation before the patent was issued
  • A request for a certificate of correction under 37 CFR 1.323 with the associated fee

For more information on assignee information, visit: assignee information.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on Patent correction, visit: Patent correction.

For more information on USPTO procedures, visit: USPTO procedures.

The deadline for submitting assignee information for patent issuance is crucial to ensure the information appears on the patent. According to MPEP 307:

The submission of the request in compliance with 37 CFR 3.81(b) must be made prior to, or at the same time as, the payment of the issue fee.

This means that assignees must submit their information no later than when the issue fee is paid. It’s important to note that:

  • Late submissions may result in the assignee data not being included on the patent
  • The USPTO will not delay issuance of the patent to accommodate late submissions
  • Correcting assignee information after issuance requires a certificate of correction, which may involve additional fees and procedures

To avoid complications, it’s recommended to submit the assignee information as early as possible in the patent issuance process, ensuring compliance with 37 CFR 3.81(b).

For more information on assignee information, visit: assignee information.

For more information on patent issuance, visit: patent issuance.

If the assignment has not been recorded before the issue fee payment, the following applies:

  • The request for issuance to the assignee must state that the assignment document has been filed for recordation.
  • This statement should be made in accordance with 37 CFR 3.11.

As stated in 37 CFR 3.81(a): If the assignment has not been previously recorded, the request must state that the document has been filed for recordation as set forth in § 3.11.

If the assignee’s name and address are not identified in item 3 of the Fee(s) Transmittal form (PTOL-85B), the following occurs:

  • The patent will issue to the applicant instead of the assignee.
  • Assignment data printed on the patent will be based solely on the information supplied on the PTOL-85B form.

As stated in the MPEP: Unless an assignee’s name and address are identified in item 3 of the Fee(s) Transmittal form PTOL-85B, the patent will issue to the applicant. Assignment data printed on the patent will be based solely on the information so supplied.

It’s crucial for applicants and assignees to ensure that the correct information is provided on the PTOL-85B form to avoid any issues with patent issuance to the intended party.

What happens if an assignee requests issuance of a patent to themselves?

When an assignee requests issuance of a patent to themselves, the following process occurs:

  • The assignee must file a request for issuance of the patent to the assignee under 37 CFR 3.81(b).
  • This request must be submitted no later than the date the issue fee is paid.
  • If the request is not filed by this deadline, the patent will be issued to the applicant(s) named in the application file.

As stated in MPEP 307: “If the assignment is submitted for recording after the date of payment of the issue fee, but prior to issuance of the patent, the assignment will be recorded but the patent will issue to the name of the inventor.”

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

If an assignee fails to comply with 37 CFR 3.81(b) when requesting issuance of a patent to the assignee, the patent may still be issued to the assignee. However, the USPTO will not include the assignee data on the patent.

According to the MPEP 307: Failure to comply with the provisions of 37 CFR 3.81(b) will not impact the issuance of the patent. However, the Office will not include the assignee data on the patent if the assignee data is not submitted in compliance with 37 CFR 3.81(b).

This means that while the patent will be issued, the official patent document will not reflect the assignee information, which could potentially cause complications in establishing ownership records.

For more information on patent issuance, visit: patent issuance.

If a request for issuance to an assignee is submitted after the issue fee has been paid, the following requirements must be met:

  1. Submit a request under 37 CFR 3.81(b)
  2. Include a request for a certificate of correction under 37 CFR 1.323
  3. Pay the fee for the certificate of correction (set forth in 37 CFR 1.20(a))
  4. Pay the processing fee (set forth in 37 CFR 1.17(i))
  5. State that the assignment was submitted for recordation before the patent was issued

As stated in MPEP 307: “If a request for issuance to an assignee pursuant to 37 CFR 3.81(b) is submitted after the day on which the issue fee is paid, the request under 37 CFR 3.81(b) must include a request for a certificate of correction under 37 CFR 1.323 (accompanied by the fee set forth in 37 CFR 1.20(a)) and the processing fee set forth in 37 CFR 1.17(i).”

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

Assignment information printed on a patent follows these guidelines:

  • Only the first appearing name of an assignee will be printed on the patent, even if multiple names for the same party are identified on the Fee(s) Transmittal form (PTOL-85B).
  • This printing practice does not affect the recording of assignments with the USPTO’s Assignment Division.
  • The assignee entry on the PTOL-85B should still include all assignment data as recorded in the Office.

For example: The assignee entry on form PTOL-85B should still be completed to indicate the assignment data as recorded in the Office. For example, the assignment filed in the Office and, therefore, the PTOL-85B assignee entry might read ‘Smith Company doing business as (d.b.a.) Jones Company.’ The assignee entry on the printed patent will read ‘Smith Company.’

It’s important to note that assignment information printed on a patent is not updated after issuance and may not reflect subsequent assignments recorded in the Office.

To ensure assignee information appears on an issued patent, the assignee must comply with 37 CFR 3.81(b). This regulation outlines the specific requirements for including assignee data on a patent.

According to MPEP 307, the assignee should:

  • Submit a request for issuance of the application in the name of the assignee
  • Provide the appropriate documentary evidence of ownership (e.g., assignment for patent)
  • Specify the assignee’s name and address

The MPEP states: A request for a patent to be issued to an assignee submitted pursuant to 37 CFR 3.81(b) must state that the document required by 37 CFR 3.81(b) is being submitted to OPAP in order to request that the patent be issued to an assignee.

It’s crucial to follow these steps accurately to ensure the assignee information is properly recorded and appears on the issued patent.

For more information on assignee information, visit: assignee information.

For more information on patent issuance, visit: patent issuance.

A patent can be issued to an assignee in two main ways:

  • Before paying the issue fee: The assignee can submit a request for issuance in their name along with the issue fee payment. The assignment must be previously recorded or stated to have been filed for recordation.
  • After paying the issue fee: A request can be submitted after the issue fee payment, but it requires additional steps and fees.

According to MPEP 307, “Normally, for a patent to issue to an assignee (other than an assignee who is the applicant in an application filed on or after September 16, 2012), a request for issuance of the application in the name of the assignee must be filed in the United States Patent and Trademark Office (Office) at a date not later than the day on which the issue fee is paid.”

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

The USPTO has specific provisions for handling partial assignees in patent issuance:

  1. If one or more assignees, together with one or more inventors, hold the entire right, title, and interest in the application, the patent may issue in the names of both the assignee(s) and the inventor(s).
  2. If multiple assignees hold the entire right, title, and interest to the exclusion of all inventors, the patent may issue in the names of the multiple assignees.

This is outlined in 37 CFR 3.81(c): (1) If one or more assignee, together with one or more inventor, holds the entire right, title, and interest in the application, the patent may issue in the names of the assignee and the inventor. (2) If multiple assignees hold the entire right, title, and interest to the exclusion of all the inventors, the patent may issue in the names of the multiple assignees.

Yes, a request for issuance to an assignee can be submitted after the issue fee is paid, but additional requirements apply:

  1. The request must state that the assignment was submitted for recordation before patent issuance.
  2. It must include a request for a certificate of correction under 37 CFR 1.323.
  3. The appropriate fees must be paid, including the certificate of correction fee and a processing fee.

37 CFR 3.81(b) states: Any request for issuance of an application in the name of the assignee submitted after the date of payment of the issue fee, and any request for a patent to be corrected to state the name of the assignee, must state that the assignment was submitted for recordation as set forth in § 3.11 before issuance of the patent, and must include a request for a certificate of correction under § 1.323 of this chapter (accompanied by the fee set forth in § 1.20(a)) and the processing fee set forth in § 1.17(i) of this chapter.

Yes, a patent can be issued to multiple assignees or a combination of assignees and inventors. According to MPEP 307, there are two scenarios:

  1. Partial assignees and inventors: “If one or more assignee, together with one or more inventor, holds the entire right, title, and interest in the application, the patent may issue in the names of the assignee and the inventor.”
  2. Multiple assignees: “If multiple assignees hold the entire right, title, and interest to the exclusion of all the inventors, the patent may issue in the names of the multiple assignees.”

These provisions allow for flexibility in patent issuance when ownership is shared among multiple parties.

For more information on multiple assignees, visit: multiple assignees.

For more information on partial assignees, visit: partial assignees.

For more information on patent issuance, visit: patent issuance.

Can a patent be issued to an assignee if the assignment is not recorded?

Yes, a patent can be issued to an assignee even if the assignment is not recorded, provided certain conditions are met:

  • The request for issuance of the patent to the assignee must be made under 37 CFR 3.81(b).
  • The request must be submitted no later than the date the issue fee is paid.
  • The request must include clear evidence of the assignment.

According to MPEP 307: “An assignee who otherwise shows sufficient proprietary interest in the matter may also be entitled to such a patent.” This means that even without a recorded assignment, an assignee can still have the patent issued to them if they can demonstrate their proprietary interest.

For more information on assignee rights, visit: assignee rights.

For more information on patent issuance, visit: patent issuance.

For more information on proprietary interest, visit: proprietary interest.

MPEP 308 - Issue to Applicant (13)

According to 35 U.S.C. 118, the following parties can file a patent application:

  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who shows sufficient proprietary interest in the matter, acting as an agent for the inventor

The law states: A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.

For assignee applicants or persons to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership should be recorded as follows:

  • As provided for in part 3 of Chapter 37 CFR
  • No later than the date the issue fee is paid in the application

According to 37 CFR 1.46(b)(1): If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

According to 37 CFR 1.46(b)(1), documentary evidence of ownership should be recorded as follows:

“If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.”

In other words, if you’re filing as an assignee or obligated assignee, you should record your documentary evidence of ownership (such as an assignment or employment agreement) with the USPTO no later than when you pay the issue fee for your patent application.

For more information on documentary evidence, visit: documentary evidence.

An applicant who shows sufficient proprietary interest in the matter must submit a petition with their patent application, including:

  1. The fee set forth in § 1.17(g)
  2. A showing that the person has sufficient proprietary interest in the matter
  3. A statement that making the application for patent by this person on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

This requirement is outlined in 37 CFR 1.46(b)(2): If the applicant is a person who otherwise shows sufficient proprietary interest in the matter, such applicant must submit a petition including: (i) The fee set forth in § 1.17(g); (ii) A showing that such person has sufficient proprietary interest in the matter; and (iii) A statement that making the application for patent by a person who otherwise shows sufficient proprietary interest in the matter on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties.

What is the purpose of the Issue Notification in the patent application process?

The Issue Notification serves as an important communication in the patent application process. According to the MPEP 308, “The Issue Notification identifies the issue date of the patent number assigned to the application.” This notification is crucial because it:

  • Informs the applicant of the official issue date of their patent
  • Provides the assigned patent number
  • Serves as confirmation that the patent will be granted
  • Helps applicants plan for any post-issuance actions or maintenance fees

The Issue Notification is typically sent several weeks before the actual issue date, giving applicants time to prepare for the patent’s publication and enforcement.

For more information on issue date, visit: issue date.

For more information on patent grant, visit: patent grant.

When an application is filed by someone other than the inventor under 35 U.S.C. 111, it must contain specific information as outlined in 37 CFR 1.46(b):

  • An application data sheet under § 1.76
  • In the applicant information section (§ 1.76(b)(7)), specify:
    • The assignee
    • Person to whom the inventor is under an obligation to assign the invention
    • Person who otherwise shows sufficient proprietary interest in the matter

The regulation states: If an application under 35 U.S.C. 111 is made by a person other than the inventor under paragraph (a) of this section, the application must contain an application data sheet under § 1.76 specifying in the applicant information section (§ 1.76(b)(7)) the assignee, person to whom the inventor is under an obligation to assign the invention, or person who otherwise shows sufficient proprietary interest in the matter.

What happens if there’s an error in the patent grant?

Errors in patent grants are addressed through a specific process outlined in MPEP 308. The manual states:

“If the Office discovers that an error exists in the patent grant, the patentee will be notified and required to submit a request for a certificate of correction.”

This process involves the following steps:

  • The USPTO identifies an error in the issued patent
  • The patentee is notified of the error
  • The patentee must submit a request for a certificate of correction
  • The USPTO issues a certificate of correction to rectify the error

It’s important to note that the certificate of correction becomes part of the patent and is treated as such for all purposes. Patentees should carefully review their patent grants upon receipt to identify any errors promptly and initiate the correction process if necessary.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on Patent correction, visit: Patent correction.

For more information on USPTO procedures, visit: USPTO procedures.

If a patent is issued to the wrong applicant, the USPTO has procedures to correct this error. According to MPEP 308:

‘If a patent is issued to the wrong applicant because of an error in the Office, the patentee may request a certificate of correction… If the error was not the Office’s fault, the assignee(s) or applicant(s) may request a reissue.’

The method of correction depends on whether the error was made by the USPTO or by the applicant. If it was the USPTO’s error, a certificate of correction can be requested. If it was the applicant’s error, a reissue process may be necessary.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on error correction, visit: error correction.

For more information on patent issuance, visit: patent issuance.

For more information on reissue, visit: reissue.

When a patent is granted on an application filed by someone other than the inventor, it is issued to the real party in interest. This is stipulated in both 35 U.S.C. 118 and 37 CFR 1.46(e):

35 U.S.C. 118 states: If the Director grants a patent on an application filed under this section by a person other than the inventor, the patent shall be granted to the real party in interest and upon such notice to the inventor as the Director considers to be sufficient.

37 CFR 1.46(e) further clarifies: If a patent is granted on an application filed under this section by a person other than the inventor, the patent shall be granted to the real party in interest. Otherwise, the patent may be issued to the assignee or jointly to the inventor and the assignee as provided in § 3.81.

Applicants other than the inventor must notify the USPTO of any change in the real party in interest as follows:

  • Notification should be made no later than payment of the issue fee
  • Changes can be indicated in Box 3 of the PTOL-85B form
  • If no notification is provided, the USPTO will presume no change has occurred

According to MPEP 308: Applicants other than the inventor can notify the Office of a change in the real party in interest by providing the real party in interest in Box 3 of the PTOL-85B. See MPEP § 307. The real party in interest will be listed in the assignee section of the patent. This does not change the applicant designated in the application or on any patent that is granted.

Additionally, 37 CFR 1.46(e) states: Where a real party in interest has filed an application under § 1.46, the applicant shall notify the Office of any change in the real party in interest no later than payment of the issue fee. The Office will treat the absence of such a notice as an indication that there has been no change in the real party in interest.

How does the USPTO handle requests for early delivery of patents?

The USPTO has a specific process for handling requests for early delivery of patents. According to MPEP 308:

“Ordinarily the patent grant is delivered to the correspondence address of record. However, a patentee may request in writing before the issue date that the patent grant be delivered to another address or to an assignment recordation branch of the USPTO for recordation of an assignment, provided a fee is paid for the service.”

This means that:

  • Patentees can request early delivery of their patent grant
  • The request must be made in writing before the issue date
  • A fee is required for this service
  • The patent can be delivered to an alternative address or to the assignment recordation branch

Early delivery requests are typically made when there’s an urgent need to record an assignment or to obtain the physical patent document for business purposes.

For more information on patent grant, visit: patent grant.

For more information on USPTO procedures, visit: USPTO procedures.

When multiple inventors collaborate on an invention, the patent can be issued to them jointly. The MPEP 308 provides guidance on this:

‘If more than one inventor is named in the application, the patent will issue to the inventors jointly.’

This means that all named inventors share ownership of the patent equally, unless they have agreed otherwise or assigned their rights to another party. Each joint inventor has the right to make, use, sell, or license the invention without the consent of the other inventors, subject to any agreements between them.

For more information on joint inventors, visit: joint inventors.

For more information on patent issuance, visit: patent issuance.

Yes, a patent can be issued to a deceased inventor. The MPEP 308 states:

‘A patent may be issued to the legal representative (executor, administrator, etc.) of a deceased inventor.’

In such cases, the patent is issued to the legal representative acting on behalf of the deceased inventor’s estate. This ensures that the inventor’s rights and the value of their invention are preserved even after their death.

For more information on legal representative, visit: legal representative.

For more information on patent issuance, visit: patent issuance.

MPEP 309 - Restrictions Upon Employees of U.S. Patent and Trademark Office (7)

The restrictions on USPTO employees regarding patents are in place to prevent conflicts of interest and maintain the integrity of the patent system. These rules, outlined in 35 U.S.C. 4 and MPEP 309, serve several purposes:

  • Prevent employees from using insider knowledge for personal gain
  • Ensure fair and unbiased examination of patent applications
  • Maintain public trust in the patent system
  • Avoid potential conflicts between an employee’s official duties and personal interests

By prohibiting employees from applying for or acquiring patents during their employment and for a period after, the USPTO aims to preserve the objectivity and fairness of the patent examination process.

For additional information on restrictions applicable to USPTO employees, you can refer to MPEP § 1701. The MPEP section on restrictions upon employees of the U.S. Patent and Trademark Office states:

See MPEP § 1701 for additional restrictions on Office employees.

MPEP § 1701 provides more detailed guidance on various ethical considerations and restrictions for USPTO employees, including conflicts of interest, outside employment, and post-employment restrictions. This section is an important resource for understanding the full scope of rules and regulations that apply to USPTO employees and former employees.

For more information on USPTO employees, visit: USPTO employees.

USPTO employees are subject to several restrictions regarding patents:

  • They cannot apply for a patent during their employment and for one year after.
  • They cannot acquire any patent or interest in a patent, directly or indirectly, except through inheritance or bequest, during employment and for one year after.
  • For patents applied for after the one-year period, they cannot claim a priority date earlier than one year after their employment ends.

These restrictions are outlined in 35 U.S.C. 4, which states:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office. In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.’

Former USPTO employees face restrictions on priority dates for patents they file after leaving the office. According to 35 U.S.C. 4:

‘In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.’

This means that for any patent application filed by a former USPTO employee, the earliest priority date they can claim is one year after their employment at the USPTO ended. This rule prevents former employees from using insider knowledge to gain an unfair advantage in the patent application process.

Patent restrictions for former USPTO employees extend for one year after their employment ends. 35 U.S.C. 4 states:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office.’

After this one-year period, former employees can apply for patents, but with certain limitations on priority dates.

No, USPTO employees cannot apply for patents while employed. According to 35 U.S.C. 4:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent…’

This restriction extends for one year after their employment at the USPTO ends.

Yes, there are two exceptions to the patent ownership restrictions for USPTO employees:

  1. Inheritance
  2. Bequest

According to 35 U.S.C. 4:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of… acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office.’

This means that USPTO employees can acquire patents or interests in patents through inheritance or bequest, even during their employment or the one-year period after.

MPEP 310 - Government License Rights to Contractor - Owned Inventions Made Under Federally Sponsored Research and Development (17)

The placement of the government license rights statement in a patent application depends on whether there are references to related applications:

  • If there are references to related applications in the first sentence(s) of the specification following the title, the government license rights statement should appear as the second paragraph of the specification.
  • If there are no references to related applications, the government license rights statement should appear as the first paragraph of the specification.

This placement is specified in 37 CFR 1.77(b)(1)-(3).

For inventions made with government support, contractors must include a specific statement at the beginning of the patent application and any resulting patents. This requirement is mandated by 35 U.S.C. 202(c)(6). The statement should read:

“This invention was made with government support under (identify the contract) awarded by (identify the Federal agency). The government has certain rights in the invention.”

This statement ensures transparency regarding government involvement and rights in the invention.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

The purpose of including the government license rights statement in patent applications is to:

  • Acknowledge the government’s support in the development of the invention
  • Inform the public and potential licensees of the government’s rights in the invention
  • Ensure compliance with federal regulations regarding inventions made with government support
  • Facilitate the government’s ability to exercise its rights in the invention if necessary

This requirement, mandated by 35 U.S.C. 202(c)(6), helps maintain transparency in federally funded research and development while protecting the government’s interests in the resulting inventions.

The government license rights statement required for contractor-owned inventions made under federally sponsored research and development is:

‘This invention was made with government support under (identify the contract) awarded by (identify the Federal agency). The government has certain rights in the invention.’

This statement is mandated by 35 U.S.C. 202(c)(6) and must be included at the beginning of the patent application and any issued patents.

What is a ‘subject invention’ in the context of government-funded research?

A ‘subject invention’ is a term used in government contracts and refers to any invention conceived or first actually reduced to practice in the performance of work under a government contract. According to MPEP 310, ‘The term ‘subject invention’ is defined by 35 U.S.C. 201(e) as any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement.’ This definition is crucial for determining the government’s rights in inventions made during federally sponsored research.

For more information on federal funding, visit: federal funding.

For more information on patent rights, visit: patent rights.

What are the reporting requirements for subject inventions under government contracts?

Contractors working on federally sponsored research and development projects have specific reporting requirements for subject inventions. According to MPEP 310:

“The contractor is required to disclose each subject invention to the Federal agency within two months after the inventor discloses it in writing to contractor personnel responsible for patent matters.”

Additionally, the contractor must:

  • Elect in writing whether or not to retain title to any subject invention within two years of disclosure.
  • File patent applications within one year after election (or prior to any statutory bar date).
  • Execute and promptly deliver instruments to confirm government rights.
  • Provide periodic reports on the utilization of the invention.

These requirements ensure proper documentation and protection of both the contractor’s and the government’s interests in inventions resulting from federally funded research.

For more information on federally sponsored research, visit: federally sponsored research.

Contractors have specific reporting requirements under the Bayh-Dole Act:

  • Disclose each subject invention to the Federal agency within 2 months after the inventor discloses it in writing to contractor personnel responsible for patent matters.
  • Elect in writing whether or not to retain title to any subject invention by notifying the Federal agency within 2 years of disclosure.
  • File patent applications within statutory deadlines.
  • Include a government support clause in patent applications.

The MPEP states: ‘The contractor is also required to submit periodic reports on the utilization of a subject invention or on efforts at obtaining such utilization that are being made by the contractor or its licensees or assignees.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

What are the government’s rights in inventions made by nonprofit organizations and small businesses?

The government’s rights in inventions made by nonprofit organizations and small businesses under federally sponsored research are specifically addressed in MPEP 310. According to the manual:

“A funding agreement may provide that the government shall have the right to require periodic reporting on the utilization or efforts at obtaining utilization that are being made by the contractor or his licensees or assignees.”

Additionally, the government retains:

  • A nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced the invention for or on behalf of the United States throughout the world.
  • The right to require the contractor to grant licenses to responsible applicants under certain conditions (march-in rights).
  • The right to require written agreements from contractors to ensure that inventions are made available for public use on reasonable terms.

These provisions, outlined in 35 U.S.C. 202, balance the interests of small entities, the government, and the public in federally funded inventions.

For more information on federally sponsored research, visit: federally sponsored research.

According to MPEP 310, a Government contractor who retains U.S. domestic patent rights has the following obligations:

  1. Include the government license rights statement at the beginning of the patent application and any issued patents.
  2. Specify the contract under which the invention was made.
  3. Identify the Federal agency that awarded the contract.
  4. Acknowledge that the government has certain rights in the invention.

These obligations stem from 35 U.S.C. 202(c)(6), which mandates the inclusion of this information in the patent application and any resulting patents.

Failing to include the Government License Rights statement in a patent application can have serious consequences. While the MPEP 310 does not explicitly state the penalties, the requirement is mandated by law under 35 U.S.C. 202(c)(6). Potential consequences may include:

  • Non-compliance with federal regulations
  • Risk of the patent being unenforceable
  • Potential loss of rights or benefits under the government contract
  • Complications in future licensing or commercialization efforts

It’s crucial for inventors and patent attorneys to ensure proper inclusion of this statement to maintain the validity and enforceability of the patent.

For more information on patent enforcement, visit: patent enforcement.

March-in rights are a provision of the Bayh-Dole Act that allow the government to intervene in certain circumstances:

  • The government can require the contractor or exclusive licensee to grant a license to a responsible applicant.
  • If the contractor or licensee refuses, the government can grant the license itself.
  • These rights are exercised only in specific situations, such as when the contractor is not taking effective steps to achieve practical application of the invention.

The MPEP explains: ‘March-in rights allow the government to grant licenses to other parties… where the contractor has failed to take effective steps to achieve practical application of the invention.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

For more information on patent licensing, visit: patent licensing.

What are ‘march-in rights’ in government-funded inventions?

‘March-in rights’ are a significant aspect of government rights in federally funded inventions. As described in MPEP 310, these rights allow the government to require the contractor, assignee, or exclusive licensee of a subject invention to grant a license to a responsible applicant under certain circumstances. The MPEP states:

‘March-in rights permit the Government, in specified circumstances, to require the contractor or successors in title to the patent to grant a nonexclusive, partially exclusive, or exclusive license to a responsible applicant or applicants.’

These circumstances include:

  • Failure to take effective steps to achieve practical application of the invention
  • Health and safety needs not being reasonably satisfied
  • Public use requirements specified by Federal regulations not being met

March-in rights serve as a safeguard to ensure that federally funded inventions benefit the public.

For more information on patent licensing, visit: patent licensing.

No, including government support information on a provisional application cover sheet is not sufficient to meet the requirements of 35 U.S.C. 202(c)(6). The MPEP states:

Providing information concerning government support on a provisional application cover sheet does not satisfy the requirement of 35 U.S.C. 202(c)(6) which requires that the a statement be included within the specification of such application and any patent issuing thereon specifying that the invention was made with Government support and that the Government has certain rights in the invention.

The government license rights statement must be included within the specification itself, not just on the cover sheet.

How does the government’s march-in rights affect contractor-owned inventions?

The government’s march-in rights are a significant aspect of federally sponsored research and development contracts. As outlined in MPEP 310:

“The government has the right to require the contractor to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant(s) upon terms that are reasonable under the circumstances, if the contractor fails to take effective steps to achieve practical application of the invention.”

March-in rights allow the government to intervene if:

  • The contractor fails to commercialize the invention within a reasonable time.
  • Action is necessary to alleviate health or safety needs.
  • Action is necessary to meet requirements for public use specified by federal regulations.
  • The contractor has breached agreements specified in 35 U.S.C. 204 regarding U.S. manufacture.

These rights ensure that inventions resulting from federally funded research benefit the public, even if the contractor fails to do so effectively.

For more information on contractor-owned inventions, visit: contractor-owned inventions.

For more information on federally sponsored research, visit: federally sponsored research.

The Government License Rights statement, as required by 35 U.S.C. 202(c)(6) and described in MPEP 310, does not transfer ownership of the patent to the government. Instead, it acknowledges that:

“The government has certain rights in the invention.”

These rights typically include:

  • A non-exclusive, non-transferable, irrevocable, paid-up license to practice or have practiced the invention for or on behalf of the United States throughout the world
  • March-in rights, allowing the government to require the contractor to grant licenses to third parties under certain circumstances
  • The right to receive periodic reports on the utilization of the invention

While the contractor retains ownership and the right to commercialize the invention, they must operate within the framework of these government rights.

The Bayh-Dole Act, as implemented in 37 CFR Part 401, significantly affects government rights in federally funded inventions:

  • It allows contractors (including small businesses and nonprofit organizations) to retain title to inventions made under federally funded research and development contracts.
  • The government receives a nonexclusive, nontransferable, irrevocable, paid-up license to practice the invention.
  • The Act encourages the commercialization of federally funded inventions while protecting the government’s interests.

As stated in the MPEP: ‘The Bayh-Dole Act… provides, in essence, that nonprofit organizations and small business firms may retain title to inventions made under federally funded research and development contracts.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

MPEP 310 is closely related to the Bayh-Dole Act, officially known as the Patent and Trademark Law Amendments Act. Here’s how they are connected:

  • The Bayh-Dole Act allows contractors to retain title to inventions made with federal funding.
  • It requires contractors to disclose these inventions and include a statement in patent applications about government support.
  • MPEP 310 provides specific guidance on implementing the Bayh-Dole Act’s requirements, particularly the government license rights statement.
  • The statutory basis for MPEP 310 is 35 U.S.C. 202(c)(6), which is part of the Bayh-Dole Act.

In essence, MPEP 310 serves as a practical guide for patent applicants to comply with the Bayh-Dole Act’s provisions regarding government-funded inventions.

MPEP 311 - Filing of Notice of Arbitration Awards (13)

The responsibility for filing the notice of arbitration award with the USPTO is primarily assigned to the patent owner or their representatives, but there are provisions for other parties to file if necessary. According to 35 U.S.C. 294(d) and 37 CFR 1.335:

  • The patentee, assignee, or licensee is primarily responsible for filing the notice.
  • If the required notice is not filed by the designated party, any party to the arbitration proceeding may file the notice.

35 U.S.C. 294(d) states: “When an award is made by an arbitrator, the patentee, his assignee or licensee shall give notice thereof in writing to the Director.”

This flexibility ensures that the USPTO is informed of arbitration outcomes, even if the primary responsible party fails to file the notice.

When an arbitration award is made involving a patent, there are specific notice requirements as outlined in 35 U.S.C. 294(d) and 37 CFR 1.335. Key points include:

  • The patentee, assignee, or licensee must provide written notice to the USPTO Director.
  • A separate notice is required for each patent involved.
  • The notice must include names and addresses of parties, inventor name, patent owner name, patent number, and a copy of the award.
  • If the award is modified by a court, notice of the modification must also be filed.

Failure to file the required notice can result in the award being unenforceable.

Voluntary arbitration in patent disputes is a process outlined in 35 U.S.C. 294 where parties can agree to settle disputes related to patent validity or infringement through arbitration. The law states:

‘A contract involving a patent or any right under a patent may contain a provision requiring arbitration of any dispute relating to patent validity or infringement arising under the contract.’

This allows parties to resolve patent-related conflicts outside of the court system, potentially saving time and resources.

An arbitration award in patent cases has limited effect and is binding only on the parties involved in the arbitration. This limitation is clearly stated in 35 U.S.C. 294(c):

“An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person.”

This means that:

  • The arbitration award is conclusive for the parties involved in the dispute.
  • Third parties not involved in the arbitration are not bound by the award.
  • The award does not affect the rights of individuals or entities who were not part of the arbitration proceedings.

This provision ensures that the rights of third parties are protected and that arbitration outcomes do not have unintended consequences on uninvolved parties in patent matters.

According to 37 CFR 1.335(a), a notice of arbitration award filed with the USPTO must include the following information:

  • Patent number
  • Names of the inventor and patent owner
  • Names and addresses of the parties to the arbitration
  • A copy of the arbitration award

The regulation states: “The notice must set forth the patent number, the names of the inventor and patent owner, and the names and addresses of the parties to the arbitration. The notice must also include a copy of the award.”

This detailed information ensures that the USPTO has a complete record of the arbitration outcome and its relevance to specific patents.

For more information on Patent Information, visit: Patent Information.

If a patent involved in an arbitration award is subsequently invalidated, there are provisions for modifying the award. This process is outlined in 35 U.S.C. 294(c):

“The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration.”

Key points to note:

  • Parties can agree in advance to allow modification of the award if the patent is invalidated.
  • The invalidation must be determined by a court of competent jurisdiction.
  • The court decision must be final (no appeal possible or taken).
  • Any party to the arbitration can apply to a court for modification of the award.
  • The modified award will govern the rights and obligations between the parties from the date of modification.

This provision allows for adjustments to arbitration outcomes in light of significant changes to the validity of the underlying patent rights.

In patent arbitration proceedings, the defenses provided under 35 U.S.C. 282 must be considered by the arbitrator if raised by any party. This is specified in 35 U.S.C. 294(b):

‘In any such arbitration proceeding, the defenses provided for under section 282 shall be considered by the arbitrator if raised by any party to the proceeding.’

These defenses typically include noninfringement, absence of liability for infringement, unenforceability, and invalidity of the patent or any claim in suit.

The enforceability of patent arbitration awards is contingent upon proper notice being filed with the USPTO. According to 35 U.S.C. 294(e) and 37 CFR 1.335(c):

‘The award shall be unenforceable until the notice required by subsection (d) is received by the Director.’

This means that until the proper notice of the arbitration award is filed with the USPTO, the award cannot be enforced. It’s crucial for parties involved in patent arbitration to ensure that all required notices are filed promptly to maintain the enforceability of the award.

Enforcement of arbitration awards in patent cases requires specific steps as outlined in 35 U.S.C. 294(d) and 37 CFR 1.335. Key points include:

  • The patentee, assignee, or licensee must file a written notice of the award with the USPTO Director.
  • The notice must include details about the patent, parties involved, and a copy of the award.
  • The award is unenforceable until the required notice is received by the Director.

As stated in 35 U.S.C. 294(e): “The award shall be unenforceable until the notice required by subsection (d) is received by the Director.”

This requirement ensures that the USPTO is informed of arbitration outcomes affecting patent rights.

For more information on arbitration awards, visit: arbitration awards.

For more information on patent enforcement, visit: patent enforcement.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has a specific process for handling notices of arbitration awards related to patents. According to the Manual of Patent Examining Procedure (MPEP) Section 311:

“The written notices required by this section should be directed to the attention of the Office of the Solicitor. The Office of the Solicitor will be responsible for processing such notices.”

This process involves:

  • Directing all written notices of arbitration awards to the Office of the Solicitor.
  • The Office of the Solicitor taking responsibility for processing these notices.
  • Ensuring that the notices are properly recorded and associated with the relevant patent files.

This centralized approach helps maintain accurate records of arbitration outcomes affecting patent rights and ensures that the information is properly managed within the USPTO system.

For more information on USPTO procedures, visit: USPTO procedures.

Arbitration awards in patent disputes are binding between the parties involved in the arbitration but do not affect others. According to 35 U.S.C. 294(c):

‘An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person.’

However, if the patent is later found invalid or unenforceable by a court, the arbitration award may be modified upon application by any party to the arbitration.

Yes, arbitration awards in patent disputes can be modified under certain circumstances. According to 35 U.S.C. 294(c):

‘The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration.’

If an award is modified, the party requesting the modification must file a notice with the USPTO, as per 37 CFR 1.335(b).

Yes, an arbitration award can be modified by a court, and this modification must be reported to the USPTO. The process is outlined in 35 U.S.C. 294(c) and 37 CFR 1.335(b):

  • If a court modifies an arbitration award, the party requesting the modification must file a notice with the USPTO.
  • The notice should be filed for each patent affected by the modification.
  • It must include the patent number, names of the inventor and patent owner, names and addresses of the arbitration parties, and a copy of the court’s order modifying the award.

As stated in 37 CFR 1.335(b): “If an award by an arbitrator pursuant to 35 U.S.C. 294 is modified by a court, the party requesting the modification must file in the Patent and Trademark Office, a notice of the modification for placement in the file of each patent to which the modification applies.”

This ensures that the USPTO’s records reflect the most current status of patent rights affected by arbitration and subsequent court decisions.

MPEP 312 - [Reserved] (2)

While it’s speculative to predict the exact content of MPEP 312 if it were to be filled, its placement within the ‘300 – Ownership and Assignment’ chapter suggests it could potentially cover topics related to patent ownership, assignment procedures, or updates to existing sections in this chapter. The content would likely align with the overall theme of ownership and assignment in patent law and procedures.

While the USPTO is responsible for the content and updates of the MPEP, patent professionals can indirectly influence its content. The USPTO often seeks public input on proposed rule changes and updates to examination procedures. Professionals can participate in these public comment periods or engage with professional organizations that provide feedback to the USPTO. However, there is no formal process for directly suggesting content for specific reserved sections like MPEP 312.

MPEP 314 - Certificates of Change of Name or of Merger (8)

Recording certificates of name change or merger for patents is crucial for maintaining a clear chain of title. According to MPEP 314, these documents serve as important links in the ownership history of a patent.

The MPEP states:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title. Documents of merger are also proper links in the chain of title.

By recording these certificates, you ensure that the USPTO and any interested parties can trace the ownership history of the patent accurately. This is particularly important for legal proceedings, licensing negotiations, or potential patent sales.

To learn more:

Recording business name changes and mergers is crucial for maintaining an accurate chain of title for patents. MPEP 314 emphasizes this importance:

  • For name changes: Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.
  • For mergers: Documents of merger are also proper links in the chain of title.

Recording these changes ensures:

  1. The USPTO has up-to-date information on patent ownership
  2. Third parties can accurately identify the current patent owner
  3. The chain of title remains clear and unbroken, which can be important for future transactions or litigation
  4. Compliance with legal requirements for maintaining patent rights

According to MPEP 314, two types of certificates are recordable for patent ownership changes:

  • Certificates showing a change of name of a business
  • Certificates showing a merger of businesses

As stated in the MPEP, Certificates issued by appropriate authorities showing a change of name of a business or a merger of businesses are recordable. These documents serve as important links in the chain of title for patent ownership.

To learn more:

A ‘chain of title’ in patent ownership refers to the documented history of a patent’s ownership from its original assignment to its current owner. MPEP 314 mentions this concept in relation to name changes and mergers:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title. Documents of merger are also proper links in the chain of title.

The chain of title includes:

  • Original patent assignment
  • Subsequent transfers of ownership
  • Business name changes
  • Mergers and acquisitions
  • Any other events affecting patent ownership

Maintaining a clear and unbroken chain of title is crucial for establishing ownership rights, facilitating patent transactions, and providing clarity in potential patent litigation.

According to MPEP 314, the following documents are recordable for name changes or mergers in patent ownership:

  • Certificates issued by appropriate authorities showing a change of name of a business
  • Certificates showing a merger of businesses

The MPEP states: Certificates issued by appropriate authorities showing a change of name of a business or a merger of businesses are recordable.

Business mergers can have significant implications for patent ownership. According to MPEP 314:

Documents of merger are also proper links in the chain of title. They may represent a change of entity as well as a change of name.

This means that when businesses merge, it can result in both a change of the legal entity owning the patent and a change in the name associated with the patent ownership. It’s crucial to properly document these changes to maintain a clear chain of title for the patent.

To learn more:

No, a mere change of business name does not constitute a change in legal entity for patent purposes. However, it is still an important part of the ownership record. As stated in MPEP 314:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.

This means that while the legal entity remains the same, the name change should be recorded to maintain an accurate chain of title for the patent.

According to MPEP 314, a mere change of business name does not constitute a change in legal entity for patent purposes. The MPEP states:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.

This means that while the legal entity remains the same, documenting the name change is still important for maintaining a clear chain of title for the patent.

To learn more:

MPEP 315 - Indexing Against a Recorded Certificate (8)

The USPTO does not process requests for indexing or cross-referencing additional patent numbers or application numbers against a document previously recorded in the Assignment Division, unless it’s an assignment. This policy is based on compliance with 37 CFR 3.11, 3.28, and 3.31.

As stated in MPEP 315: “The Office does not process requests for ‘indexing’ or ‘cross-referencing’ additional patent numbers or application numbers against a document, other than an assignment, previously recorded in the Assignment Division.”

For more information on Assignment Division, visit: Assignment Division.

For more information on document recording, visit: document recording.

For more information on USPTO policy, visit: USPTO policy.

A cover sheet is a crucial component in the patent document recording process. It provides essential information about the document being recorded and the patents or applications it relates to.

The requirement for a cover sheet is specified in 37 CFR 3.31, which states the necessary contents of a cover sheet. As mentioned in MPEP 315, a completed cover sheet is one of the required items when recording a document with additional patents or applications: “a completed cover sheet (see 37 CFR 3.31 and MPEP § 302.07)”

For more detailed information on cover sheets, refer to MPEP § 302.07.

For more information on cover sheet, visit: cover sheet.

For more information on document submission, visit: document submission.

For more information on USPTO requirements, visit: USPTO requirements.

A cover sheet is a crucial component in patent assignment recordation. It provides essential information about the document being recorded and the parties involved. According to MPEP 315, a completed cover sheet is required when submitting a document for recordation, even if the document has been previously recorded.

The cover sheet requirements are specified in 37 CFR 3.31 and further explained in MPEP § 302.07. It typically includes details such as:

  • Identification of the patents or applications the document relates to
  • Names of the parties involved in the transaction
  • Nature of the interest being conveyed
  • Mailing address for correspondence

The cover sheet helps the USPTO efficiently process and index the recorded documents in the assignment database.

Indexing against a recorded certificate refers to the process of associating additional patent numbers or application numbers with a document that has already been recorded in the USPTO’s Assignment Division. However, the USPTO does not process such requests for ‘indexing’ or ‘cross-referencing’ unless a new submission is made.

According to MPEP 315, The Office does not process requests for ‘indexing’ or ‘cross-referencing’ additional patent numbers or application numbers against a document, other than an assignment, previously recorded in the Assignment Division.

Recording a patent assignment at the USPTO involves paying an appropriate recording fee. MPEP 315 references the fee requirements:

The appropriate recording fee (see 37 CFR 1.21(h) and 3.41).

The specific fee amount can be found in the USPTO’s current fee schedule. It’s important to note that:

  • Fees may vary depending on whether the submission is electronic or paper-based
  • There may be additional fees for expedited processing
  • Fees are subject to change, so always check the current fee schedule before submitting

For the most up-to-date information on fees, visit the USPTO’s official fee schedule page.

To record a document with respect to additional patents and/or patent applications, even if it has been previously recorded, the following must be submitted to the Assignment Division:

As stated in MPEP 315: “The Office will assign a new recording date to that submission, update the assignment database, and include the cover sheet and document as part of the official record.”

For more information on Assignment Division, visit: Assignment Division.

For more information on document recording, visit: document recording.

For more information on patent applications, visit: patent applications.

For more information on recording requirements, visit: recording requirements.

If you want to record a document for additional patents or applications that has already been recorded in the Assignment Division, you must submit a new recordation request. MPEP 315 outlines the required components:

  1. A copy of the original document (which may be the previously recorded papers with the reel and frame numbers stamped by the Assignment Division, or a copy of such papers)
  2. A completed cover sheet (as per 37 CFR 3.31 and MPEP § 302.07)
  3. The appropriate recording fee (as specified in 37 CFR 1.21(h) and 3.41)

Upon receiving these items, the USPTO will assign a new recording date to that submission, update the assignment database, and include the cover sheet and document as part of the official record.

Yes, you can use the original stamped document for recording with additional patents. The USPTO allows the use of previously recorded papers that have been stamped with reel and frame numbers by the Assignment Division.

According to MPEP 315: “A copy of the original document (which may consist of the previously recorded papers on which the Assignment Division has stamped the reel and frame numbers at which they are recorded, or a copy of such papers)” can be submitted as part of the recordation process for additional patents or applications.

For more information on additional patents, visit: additional patents.

For more information on Assignment Division, visit: Assignment Division.

MPEP 317 - Handling of Documents in the Assignment Division (15)

The recording date for a document at the USPTO is the date when the document meeting all recording requirements is filed with the Office. As stated in 37 CFR 3.51, “The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.” This means that all necessary criteria, including proper identification and fees, must be met for the document to be officially recorded on that date.

The recording date for a document at the USPTO Assignment Division is determined as follows:

  • It is the date when a document meeting all requirements is filed with the Office.
  • Documents not complying with identification requirements (37 CFR 3.21) will not be recorded.
  • Documents with other deficiencies (e.g., missing cover sheet or fee) will be returned for correction.
  • If corrected and resubmitted within the specified time, the original receipt date may be considered the recording date.

According to 37 CFR 3.51: “The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.”

Recording a document at the USPTO has the following effects:

  • It does not determine the validity of the document or its effect on title.
  • The Office may determine a document’s effect when necessary for Office proceedings.
  • Conditional assignments are treated as absolute assignments until canceled.
  • Recording provides protection against subsequent purchasers without notice.

37 CFR 3.54 states: The recording of a document pursuant to §3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.

Additionally, according to 35 U.S.C. 261, timely recording at the USPTO is crucial for maintaining superiority of rights against subsequent purchasers.

For more information on document recording, visit: document recording.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP 317, original documents submitted to the USPTO Assignment Division are handled as follows:

After filming, the documents are returned to the sender or destroyed.

This means that once the Assignment Division has processed and recorded the documents, the original physical copies are not retained by the USPTO. If you need a copy of a recorded document, you can request a certified copy from the USPTO for a fee.

For more information on Assignment Division, visit: Assignment Division.

For more information on Document retention, visit: Document retention.

For more information on Original documents, visit: Original documents.

For more information on USPTO, visit: USPTO.

Documents and cover sheets submitted for recording at the USPTO Assignment Division are examined for formal requirements. The process is as follows:

  • Documents that meet the requirements are recorded.
  • Documents that do not meet the requirements are returned to the sender with an explanation.
  • If the sender disagrees with the rejection, they can petition the Director under 37 CFR 1.181.
  • After successful recording, a notification is sent to the address on the cover sheet, showing the reel and frame number.

As stated in MPEP 317: “All documents and cover sheets submitted for recording are examined for formal requirements in the Assignment Division in order to separate documents which are recordable from those which are not recordable.”

What happens to conditional assignments at the USPTO?

Conditional assignments are treated differently by the USPTO’s Assignment Division. The MPEP 317 states:

“Conditional assignments are returned to the sender by the Assignment Division.”

This means that if an assignment includes conditions that must be met before it becomes effective, the USPTO will not record it. Instead, the Assignment Division will return the document to the sender. It’s important for patent applicants and owners to ensure that any assignments submitted for recording are unconditional to avoid delays in processing.

For more information on Assignment Division, visit: Assignment Division.

For more information on conditional assignments, visit: conditional assignments.

For more information on USPTO procedures, visit: USPTO procedures.

If corrected documents are not resubmitted within the specified period, the original filing date will not be preserved. The MPEP clearly states: “If the returned papers are not corrected and resubmitted within the specified period, the date of filing of the corrected papers will be considered to be the date of recording of the document.” This means that failing to meet the deadline for resubmission will result in the loss of the original filing date, and the new submission date will be used as the recording date.

To obtain a copy of a recorded assignment document from the USPTO, you can request a certified copy. According to MPEP 317:

Certified copies of recorded documents may be ordered from the Assignment Division for a fee.

To request a certified copy:

  • Contact the USPTO Assignment Division
  • Provide the necessary information to identify the document
  • Pay the required fee

The USPTO will then provide you with a certified copy of the requested assignment document. This can be useful for legal or business purposes where an official copy of the recorded assignment is needed.

For more information on Assignment Division, visit: Assignment Division.

For more information on certified copies, visit: certified copies.

For more information on USPTO, visit: USPTO.

If your assignment document is returned by the USPTO Assignment Division, you can correct it as follows:

  • The returned document will be stamped with the original receipt date.
  • It will come with a letter specifying a time period for correction and resubmission.
  • If resubmitted within this period, the original receipt date may be considered the recording date.
  • You can use the certification procedure (37 CFR 1.8) or “Priority Mail Express” (37 CFR 1.10) for resubmission.
  • If not corrected within the specified period, the new submission date will be the recording date.

MPEP 317.02 states: “If the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

The USPTO handles returned assignment documents as follows:

  • Documents are stamped with the original receipt date.
  • A letter accompanies returned documents explaining the correction needed.
  • If corrected and resubmitted within the specified time, the original receipt date is considered the recording date.
  • Resubmissions can use the certification procedure under 37 CFR 1.8 or the ‘Priority Mail Express®’ procedure under 37 CFR 1.10.
  • If not corrected and resubmitted in time, the new receipt date becomes the recording date.

The MPEP states: The certification procedure under 37 CFR 1.8 or the ‘Priority Mail Express®’ procedure under 37 CFR 1.10 may be used for resubmissions of returned papers to obtain the benefit of the date of deposit in the United States Postal Service to establish that the papers were returned within the time period specified.

For more information on assignment recording, visit: assignment recording.

For more information on document correction, visit: document correction.

For more information on USPTO procedures, visit: USPTO procedures.

How are patent assignment documents filed and stored at the USPTO?

The USPTO has a specific process for filing and storing patent assignment documents. According to MPEP 317:

“All recorded assignments are scanned and stored in an electronic database.”

This means that once an assignment is recorded, it is digitized for easy access and long-term storage. The electronic database allows for efficient retrieval and management of assignment records. Additionally, the MPEP notes:

“The original document is returned to the sender with a notation of the reel and frame numbers.”

This process ensures that the original document is returned to the sender while maintaining a digital copy for USPTO records. The reel and frame numbers serve as reference points for locating the scanned document in the electronic database.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO procedures, visit: USPTO procedures.

Documents that don’t meet other recording requirements, such as missing a completed cover sheet or required fee, are handled differently by the USPTO. According to the MPEP, “Documents not meeting the other requirements for recording, for example, a document submitted without a completed cover sheet or without the required fee, will be returned for correction to the sender where a correspondence address is available.” This means that unlike documents with identification issues, these documents are returned to the sender for correction, provided a correspondence address is available.

The Assignment Division of the USPTO handles documents according to specific procedures outlined in MPEP 317. Key aspects include:

  • Documents are numbered, filmed, and indexed into the assignment database.
  • Original documents are returned to the sender or destroyed after filming.
  • Certified copies of recorded documents can be ordered for a fee.
  • The Assignment Division provides searches of the assignment records upon request.

As stated in the MPEP, All documents submitted for recording are numbered, filmed, and indexed into the assignment database. This process ensures proper documentation and accessibility of assignment records.

For more information on Assignment Division, visit: Assignment Division.

For more information on document handling, visit: document handling.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

How are assignments handled when they are not recorded?

When assignments are not recorded, they are still processed by the Assignment Division. According to the MPEP 317:

“All assignments not recorded will be appropriately marked for return to the sender where a correspondence address is available.”

This means that even if an assignment is not officially recorded, the Assignment Division will still handle the document and return it to the sender if possible. It’s important to note that while unrecorded assignments are processed, they do not have the same legal standing as recorded assignments.

For more information on Assignment Division, visit: Assignment Division.

Yes, the original filing date can be preserved for corrected documents under certain conditions. The MPEP states: “The returned papers, stamped with the original date of receipt by the Office, will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of filing of the papers as the date of recording of the document.” This means that if you correct and resubmit the document within the specified timeframe, the USPTO will use the original filing date as the recording date.

MPEP 318 - Documents Not to be Placed in Files (10)

Assignment documents are not placed directly in patent application files to ensure proper recording and maintenance of ownership records. MPEP 318 states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This procedure serves several purposes:

  • It centralizes the recording of ownership information
  • It ensures that assignments are properly recorded and searchable
  • It keeps the main application file focused on technical and procedural aspects of the patent application
  • It allows the Assignment Division to maintain a separate database of patent ownership information

Assignment documents are not placed directly in application or patent files to ensure proper recording and management. According to MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This practice serves several purposes:

  • It ensures that assignments are properly recorded by the specialized Assignment Division.
  • It maintains the integrity and organization of application and patent files.
  • It allows for efficient tracking and retrieval of assignment information.

To learn more:

MPEP 318 provides clear guidance on where assignment documents should be forwarded for recording. According to the manual:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This means that when submitting assignment documents, they should be sent to the USPTO’s Assignment Division, which is responsible for recording and maintaining records of patent ownership changes.

Keeping assignment documents separate from patent application files is significant for several reasons. MPEP 318 mandates this separation:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The significance of this practice includes:

  • Maintaining clear distinction between technical content and ownership information
  • Ensuring proper recording and indexing of assignment documents
  • Facilitating easier searches for patent ownership information
  • Reducing the risk of confidential ownership information being inadvertently disclosed
  • Allowing for more efficient management of ownership changes throughout a patent’s lifecycle
  • Enabling the Assignment Division to specialize in handling ownership matters

This separation streamlines both the patent examination process and the management of patent ownership records.

The Assignment Division plays a crucial role in handling patent assignment documents. According to MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The Assignment Division’s responsibilities include:

  • Receiving assignment documents for patents and patent applications
  • Recording these documents in the USPTO’s assignment database
  • Maintaining accurate records of patent ownership and transfers
  • Ensuring that assignment information is searchable and accessible
  • Processing requests for copies of recorded documents

By centralizing these functions, the USPTO can maintain a comprehensive and up-to-date record of patent ownership separate from the technical aspects of patent prosecution.

The Assignment Division plays a crucial role in handling patent assignments at the USPTO. As indicated in MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The Assignment Division’s responsibilities include:

  • Receiving assignment documents submitted for recording
  • Properly recording and maintaining assignment records
  • Ensuring the accuracy and accessibility of ownership information
  • Managing the assignment database separate from application and patent files

This specialized division ensures that patent ownership information is correctly documented and readily available when needed.

To learn more:

The correct procedure for submitting assignment documents to the USPTO involves sending them to the Assignment Division for recording, rather than placing them directly in application or patent files. MPEP 318 clearly states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This process ensures that assignment documents are properly recorded and maintained by the appropriate division within the USPTO.

To learn more:

According to MPEP 318, assignment documents submitted for recording should not be placed directly in application or patent files. The section states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This means that when assignment documents are submitted, they should be sent to the Assignment Division for proper recording rather than being inserted into the application or patent files themselves.

To learn more:

The USPTO maintains a clear separation between assignment documents and patent files to ensure proper organization and management of records. MPEP 318 specifies:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This separation is maintained by:

  • Directing assignment documents to the Assignment Division instead of application or patent files
  • Keeping a separate database for assignment records
  • Ensuring that patent examiners and other USPTO personnel refer to the Assignment Division for ownership information
  • Maintaining distinct processes for handling assignments and patent prosecution

This approach helps in preserving the integrity of both assignment records and patent files while facilitating efficient access to ownership information when needed.

To learn more:

MPEP 318 provides clear guidance to patent examiners on how to handle assignment documents. The section states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This instruction serves to:

  • Remind examiners not to include assignment documents in the main application file
  • Direct examiners to forward any received assignment documents to the Assignment Division
  • Ensure that the proper procedures for recording assignments are followed
  • Maintain the separation between technical examination and ownership recording

By following this guidance, patent examiners help maintain the integrity of both the application files and the assignment records.

MPEP 319 - [Reserved] (2)

MPEP 319 is currently a reserved section in the Manual of Patent Examining Procedure (MPEP). The content of this section is marked as ‘[Reserved]’, which means that there is no specific information or guidance provided in this particular section at this time.

While patent attorneys or applicants cannot directly propose content for reserved MPEP sections like 319, they can provide feedback or suggestions to the USPTO regarding patent examination procedures or policies. The USPTO occasionally seeks public input on proposed changes to patent examination practices, which could potentially influence the content added to reserved sections in the future. However, the ultimate decision on what content to include in the MPEP rests with the USPTO.

MPEP 320 - Title Reports (13)

Title reports are internal documents used by the USPTO and are not available for direct request by external parties. The MPEP explicitly states:

Title reports may not be ordered by applicants or attorneys.

These reports are typically requested by internal USPTO staff, such as the Reexamination Preprocessing Staff, when needed for specific procedures.

A title report is typically prepared at specific stages of the patent process. The MPEP Section 320 states that “A title report is prepared when a new application is filed in order to notify the examiner of the assignment status of the application.” Additionally, title reports are prepared:

  • When a Notice of Allowance is mailed
  • When an application is ready for issue
  • When a request for a correction of inventorship is received

These reports ensure that the most current ownership information is available at critical points in the patent process.

For more information on new application, visit: new application.

For more information on notice of allowance, visit: notice of allowance.

For more information on title report, visit: title report.

Patent examiners typically do not require title reports for routine examination. The MPEP states:

Information as to the title is not normally required by the examiner to examine an application. It is only in limited circumstances when the ownership becomes an issue and an examiner needs a title report.

When ownership information is necessary, examiners can obtain a title report through the USPTO’s internal PALM Intranet system.

Title reports are not typically used in routine patent examination. The MPEP clarifies: Information as to the title is not normally required by the examiner to examine an application. It is only in limited circumstances when the ownership becomes an issue and an examiner needs a title report. For instance, title reports may be requested by the Reexamination Preprocessing Staff when a request for reexamination is filed. Examiners can obtain title reports through the USPTO’s internal PALM Intranet system when necessary.

For more information on patent examination, visit: patent examination.

For more information on title report, visit: title report.

Title reports play a specific role in patent reexamination procedures. The MPEP mentions:

For example, a title report is requested by the Reexamination Preprocessing Staff when a request for reexamination is filed.

This suggests that title reports are used to verify the current owner of a patent when a reexamination is initiated, ensuring that the proper parties are involved in the process.

A title report in patent law is a form used by the Assignment Division of the USPTO to report the name of the owner of an application or patent as shown by their records on a specific date. According to the MPEP:

The “title report” is a form which can be used under certain circumstances by the Assignment Division to report to someone within the Office the name of the owner of an application or patent as shown by the Assignment Division records on the date the title report is made.

These reports are used internally within the USPTO and are not available for direct request by applicants or attorneys.

A certified abstract of title is a document that provides official information about the ownership of a patent or patent application. Unlike title reports, which are for internal USPTO use, certified abstracts of title can be requested by the public. The MPEP states: The public can request a certified abstract of title. The fee for this service is set forth at 37 CFR 1.19(b)(4). This document provides a certified summary of the assignment records for a specific patent or application.

For more information on certified abstract of title, visit: certified abstract of title.

For more information on public records, visit: public records.

For more information on USPTO, visit: USPTO.

A patent title report contains crucial information about the ownership and status of a patent application or patent. While the MPEP Section 320 does not provide an exhaustive list, based on its context and purpose, a title report typically includes:

  • The names of the current owner(s) or assignee(s)
  • Any recorded assignments or transfers of ownership
  • The date of the most recent assignment
  • Information about the inventors
  • The application or patent number
  • Any liens or security interests recorded against the patent

This information helps ensure that all parties involved in the patent process are aware of the current ownership status and can act accordingly.

When discrepancies are found in title reports, the USPTO takes specific actions to address them. The MPEP 320 states:

If there are discrepancies between the title report and the instrument(s) recorded in the USPTO or the file contents, the title report is returned to the paralegal with an explanation of the discrepancy. The paralegal then contacts the person who ordered the title report and requests correction.

This process ensures that any issues with ownership or chain of title are resolved before the patent application proceeds further.

For more information on ownership verification, visit: ownership verification.

For more information on USPTO procedures, visit: USPTO procedures.

A title report plays a crucial role in the patent examination process by providing essential ownership information. According to the MPEP Section 320, “The title report is placed in the file wrapper.” This means that:

  • Examiners have access to the most current ownership information
  • It helps ensure that communications are sent to the correct parties
  • It assists in identifying potential issues related to inventorship or ownership

By having accurate ownership information, the examination process can proceed more efficiently and with fewer complications related to ownership disputes or incorrect parties being involved in the process.

For more information on ownership information, visit: ownership information.

For more information on patent examination, visit: patent examination.

For more information on title report, visit: title report.

USPTO examiners have a specific internal process for obtaining title reports when needed. The MPEP outlines this process:

Examiners may obtain a title report using the PALM Intranet (select “General Information,” insert the appropriate application number, select “Search,” select “Assignments”). The screen resulting from the search may be printed to yield the copy of the title report.

This internal system allows examiners to access ownership information efficiently when required for their examination duties.

While the public cannot request title reports directly, they can obtain patent ownership information through other means. The MPEP notes:

The public can request a certified abstract of title. The fee for this service is set forth at 37 CFR 1.19(b)(4).

Additionally, some assignment records are publicly available. For more information on accessible records, refer to MPEP § 301.01.

Yes, a patent title report can be updated after its initial preparation. While the MPEP Section 320 doesn’t explicitly state this, it’s implied by the fact that title reports are prepared at various stages of the patent process. Updates may occur:

  • When new assignments are recorded
  • If there are changes in inventorship
  • When errors or omissions in previous reports are discovered
  • At key stages of the patent process, such as before issuance

The Certificates of Correction Branch, responsible for preparing title reports, would likely generate updated reports to reflect any changes in ownership or other relevant information throughout the patent’s lifecycle.

MPEP 323 - Procedures for Correcting Errors in Recorded Assignment Document (13)

A petition to expunge is necessary when there has been a complete error in recording an assignment document at the USPTO. This typically occurs when a document not intended for recording was erroneously recorded. As stated in MPEP 323:

‘In the case of a complete error (e.g., a wrong document is recorded), a petition to expunge the assignment record should be filed.’

Key points about petitions to expunge:

  • They are used for complete errors, not minor corrections
  • The petition should clearly explain the nature of the error
  • Supporting documentation may be required
  • The USPTO will review the petition and make a determination

It’s important to note that expungement is a serious step and should only be used when absolutely necessary.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The fee for recording a corrective document or substitute statement with the USPTO is the same as the fee for recording the original assignment document. MPEP 323 states:

“The fee for recording a corrective document or substitute statement is the same as the fee for recording the original assignment document.”

As of 2023, the fee for recording an assignment electronically is $25 per property. However, fees are subject to change, so it’s advisable to check the current USPTO Fee Schedule for the most up-to-date information.

For more information on assignment correction, visit: assignment correction.

For more information on USPTO fees, visit: USPTO fees.

The process for correcting errors differs depending on whether the error is in the cover sheet or the actual assignment document:

  • Cover sheet corrections: These are for errors in the recorded data only, not in the assignment document itself. You can submit a corrective document referencing the reel and frame number of the original recording.
  • Assignment document corrections: For errors in the actual assignment document, you must record a new corrective document, which can be a new assignment or another document that corrects the original.

MPEP 323 states: “Errors in the assignment document itself cannot be corrected simply by submitting a new cover sheet.” This emphasizes the need for a new recorded document for substantive errors.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The key differences between a ‘corrective document’ and a ‘substitute statement’ for USPTO assignments are:

  • Corrective Document: Used to fix minor errors in the original recorded document.
  • Substitute Statement: Replaces the entire original document when substantial changes are needed.

According to MPEP 323: “Where errors were made in the execution of the original assignment document … a ‘substitute statement’ may be submitted for recordation.” The MPEP further clarifies: “The substitute statement must be accompanied by a copy of the originally recorded papers.”

For more information on assignment correction, visit: assignment correction.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

A corrective document is a filing used to address errors in recorded assignment documents at the USPTO. According to MPEP 323:

‘The ‘corrective document’ (or if one of the documents is not being re-recorded, a copy of the original) should be recorded as a supporting document, and all documents will be examined.’

Corrective documents are used for:

  • Minor typographical errors
  • More substantial errors like incorrect names or addresses

When filing a corrective document, it’s important to clearly identify the nature of the correction and reference the original recorded document.

For more information on assignment correction, visit: assignment correction.

For more information on USPTO, visit: USPTO.

If there’s an error in the recorded assignment document itself (not just the cover sheet), the process is different:

  1. The party responsible for the error (e.g., the assignor) must either create and record a new document or make corrections to the original document and re-record it.
  2. If the assignor is unavailable, the assignee can submit an affidavit or declaration identifying the error and requesting correction.

As stated in MPEP 323.01(b), “The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).”

When errors are made in the execution of an original assignment document, the USPTO allows for the submission of a ‘substitute statement’ to correct these errors. According to MPEP 323:

“Where errors were made in the execution of the original assignment document … a ‘substitute statement’ may be submitted for recordation.”

The process involves:

  • Preparing a new, correctly executed assignment document.
  • Submitting this as a ‘substitute statement’ along with a copy of the originally recorded papers.
  • Clearly identifying the errors in the original document.
  • Paying the required recording fee.

The USPTO will then record the substitute statement, which effectively replaces the erroneous original assignment document.

For more information on patent assignment, visit: patent assignment.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

To correct an error in a recorded assignment document, you need to submit a ‘corrective document’ to the Assignment Division. This document should include:

  1. A copy of the original assignment document with corrections made, initialed, and dated by the party conveying the interest.
  2. A new Recordation Form Cover Sheet (form PTO-1595) identifying the submission as a ‘corrective document’ and indicating the reel and frame number of the incorrectly recorded assignment.

The corrective document will be given a new reel and frame number and recording date. A recording fee is required for each patent application and patent affected.

As stated in the MPEP: “The recording fee set forth in 37 CFR 1.21(h) is required for each patent application and patent against which the corrective document is being recorded.” (MPEP § 323)

To correct an error in a recorded assignment document at the USPTO, you have two main options:

  • Cover sheet corrections: For errors in the cover sheet data only, you can submit a corrective document identifying the reel and frame number where the assignment is recorded and explaining the correction.
  • Errors in the assignment document: For errors in the actual assignment document, you need to record a corrective document. This can be either a new assignment or other document correcting the original assignment.

As stated in MPEP 323: “The ‘Correction’ box on the Recordation Form Cover Sheet should be checked to indicate that the new submission is to correct an assignment already recorded.”

For more information on assignment correction, visit: assignment correction.

For more information on cover sheet, visit: cover sheet.

For more information on USPTO, visit: USPTO.

Whether you need to pay a fee to correct an error in a recorded assignment at the USPTO depends on the type of correction:

  • Cover sheet corrections: No fee is required for submitting a corrective document to fix errors in the cover sheet data.
  • Assignment document corrections: A recording fee is required when submitting a new corrective assignment document.

According to MPEP 323: “The recordation fee set forth in 37 CFR 1.21(h) is required for each application and patent against which the document is recorded.” This fee applies when recording a new corrective document, but not for simple cover sheet corrections.

For more information on USPTO fees, visit: USPTO fees.

Tags: USPTO fees

No, recorded assignment documents will not be expunged even if they are subsequently found to be invalid. The USPTO’s policy is to maintain a complete history of claimed interests in property.

As stated in the MPEP: “Office policy regarding recordation of assignment documents is directed toward maintaining a complete history of claimed interests in property and, therefore, recorded assignment documents will not be expunged even if subsequently found to be invalid. See In re Ratny, 24 USPQ2d 1713 (Comm’r Pat. 1992).” (MPEP § 323)

Once a document is recorded with the Assignment Services Division, it will not be removed from the record relating to that application or patent.

Yes, you can correct certain errors in a recorded USPTO assignment document without submitting a new assignment. The process depends on the type of error:

  • For minor typographical errors, use a Corrective Cover Sheet.
  • For more substantial errors, submit a Substitute Statement.

MPEP 323 states: “The ‘corrective document’ or ‘substitute statement’ will not be recorded as a new assignment.” Instead, it will be recorded to correct the original assignment document, maintaining the original recordation date.

For more information on assignment correction, visit: assignment correction.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

Expungement of assignment records is extremely rare and does not result in the complete removal of a document from the assignment records. According to MPEP 323.01(d), petitions to expunge are granted only if:

  • Normal corrective procedures are inadequate
  • The integrity of assignment records won’t be affected

Even if granted, “the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number.” However, links to the specific application or patent will be deleted from the Assignment Historical Database. A redacted version of the ‘expunged’ document must be recorded in its place.

MPEP 400 - Representative of Applicant or Owner (419)

Sections in the Manual of Patent Examining Procedure (MPEP) are sometimes marked as ‘[Reserved]’ for several reasons:

  • To maintain consistent numbering across editions
  • To allow for future expansion of content
  • To accommodate planned updates or revisions
  • To serve as placeholders for potential new topics or guidance

This practice helps the USPTO maintain flexibility in organizing and updating the MPEP while preserving a logical structure for users.

In patent applications filed before September 16, 2012, the power of attorney can be signed by either the inventor(s) or the assignee of the entire interest. However, the MPEP recommends that the assignee sign the power of attorney when one exists. As stated in the MPEP:

While a power of attorney may be signed by the inventor(s), the power of attorney should be signed by the assignee of the entire interest where one exists. Otherwise, the assignee may be paying the bill, while the inventor is providing the power of attorney, thereby possibly raising an issue as to who is the practitioner’s client.

This recommendation aims to avoid potential conflicts and ensure clear representation in cases where the relationship between the assignee and inventors may deteriorate.

To learn more:

After the USPTO is notified of a patent practitioner’s death, correspondence is sent to two parties:

  1. The office of the deceased practitioner
  2. The person who originally appointed the deceased patent practitioner

This dual notification ensures that both the practitioner’s office and the original appointer are aware of ongoing patent matters and can take appropriate action.

Both practitioners and non-practitioners are responsible for ensuring compliance with USPTO signature and certification requirements when filing papers. According to 37 CFR 11.18(b):

“By presenting to the Office or hearing officer in a disciplinary proceeding (whether by signing, filing, submitting, or later advocating) any paper, the party presenting such paper, whether a practitioner or non-practitioner, is certifying that—”

This means that anyone submitting papers to the USPTO, including independent inventors, corporate representatives, and patent attorneys, is responsible for ensuring that the submissions meet the signature and certification requirements. Practitioners have additional responsibilities and may face disciplinary action for violations as specified in 37 CFR 11.18(d).

To learn more:

During interference or derivation proceedings, power of attorney changes are handled by a specific entity within the USPTO. According to MPEP 402.08:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

This means that the Patent Trial and Appeal Board (PTAB) is responsible for considering and processing any changes to power of attorney during these special proceedings. This differs from the normal procedure for regular patent applications, where such changes would typically be handled by the Office of Patent Application Processing or the examining corps.

To learn more:

When there’s no attorney of record, the signatories for patent application papers depend on the filing date and the applicant type. For applications filed before September 16, 2012, MPEP § 407 states: “All papers filed in the application must be signed: (1) by all named applicants unless one named applicant has been given a power of attorney to sign on behalf of the remaining applicants, and the power of attorney is of record in the application; or (2) if there is an assignee of record of an undivided part interest, by all named applicants retaining an interest and such assignee; or (3) if there is an assignee of the entire interest, by such assignee; or (4) by a registered patent attorney or agent not of record who acts in a representative capacity under the provisions of 37 CFR 1.34.”

For applications filed on or after September 16, 2012: “All papers must be signed by: (1) a patent practitioner of record; (2) a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34; or (3) the applicant, except that papers submitted on behalf of a juristic entity applicant must be signed by a patent practitioner.”

When an attorney is suspended, the signing authority for papers in a patent application depends on the filing date:

For applications filed before September 16, 2012:

  • All named applicants
  • Assignee of record of an undivided part interest, along with named applicants retaining an interest
  • Assignee of the entire interest
  • A registered patent attorney or agent not of record acting under 37 CFR 1.34

For applications filed on or after September 16, 2012:

  • A patent practitioner of record
  • A patent practitioner not of record acting under 37 CFR 1.34
  • The applicant (except for juristic entity applicants, which require a patent practitioner)

This information is provided in Form Paragraph 4.07 of MPEP § 407.

Who can sign a substitute statement for a deceased or incapacitated inventor?

In cases where an inventor is deceased or legally incapacitated, specific parties are authorized to sign a substitute statement. According to MPEP 409.01(a):

“A substitute statement under 37 CFR 1.64 may be signed by the applicant or an assignee of the entire interest on behalf of a deceased or legally incapacitated inventor.”

The following parties can sign a substitute statement:

  • The applicant (if different from the inventor)
  • An assignee of the entire interest
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

It’s important to note that the person signing the substitute statement must have the legal authority to act on behalf of the deceased or incapacitated inventor. This ensures that the patent application can proceed even when the original inventor is unable to participate in the process.

To learn more:

According to MPEP 402.09, applicants in international patent applications can be represented by:

  • Attorneys or agents registered to practice before the USPTO
  • An applicant appointed as a common representative
  • An attorney or agent with the right to practice before the national office where the international application is filed (for specific authorities)

As stated in 37 CFR 1.455(a): Applicants of international applications may be represented by attorneys or agents registered to practice before the United States Patent and Trademark Office or by an applicant appointed as a common representative (PCT Art. 49, Rules 4.8 and 90 and § 11.9).

To learn more:

According to MPEP 409.01(a), several parties can file a patent application on behalf of a deceased or legally incapacitated inventor:

  • Legal representative: If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent on behalf of the inventor.
  • Assignee or obligated assignee: Under 37 CFR 1.46, a person to whom the inventor assigned (‘assignee’), to whom the inventor was under an obligation to assign (‘obligated assignee’), or a person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of the deceased or legally incapacitated inventor.
  • Administrator or executor: These parties can also file an application, but may need to obtain new letters of administration if they have been discharged from their duties.

It’s important to note that proof of authority is not required by the USPTO, but any person acting as a legal representative should ensure they are properly authorized to do so.

To learn more:

For applications filed on or after September 16, 2012, the following parties may file a patent application as the applicant:

  • The inventor(s)
  • An assignee to whom the inventor has assigned the invention
  • An obligated assignee to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

As stated in 37 CFR 1.46(a): “A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.”

According to 37 CFR 1.46(a), the following parties can file a patent application as the applicant:

  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

The regulation states: A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.

To learn more:

The correspondence address in a patent application can be changed by specific parties as outlined in 37 CFR 1.33(a):

  • A patent practitioner of record (37 CFR 1.33(b)(1))
  • The applicant (37 CFR 1.33(b)(3))
  • Prior to the appointment of any power of attorney, any patent practitioner named in the application transmittal papers who acts in a representative capacity under 37 CFR 1.34

It’s important to note that after a power of attorney has been appointed, a practitioner acting in a representative capacity cannot change the correspondence address until after the patent has issued, and only with proper notice to the patentee or owner.

To learn more:

Limited recognition for patent matters can be granted to two main categories of individuals:

  1. Non-registered individuals: As per 37 CFR 11.9(a), individuals not registered under § 11.6 may be granted limited recognition under certain circumstances.
  2. Nonimmigrant aliens: According to 37 CFR 11.9(b):

    A nonimmigrant alien residing in the United States and fulfilling the provisions of paragraphs (d) and (e) of this section may be granted limited recognition if the nonimmigrant alien is authorized by the United States Government to be employed or trained in the United States in the capacity of representing a patent applicant by presenting or prosecuting a patent application.

It’s important to note that limited recognition is granted on a case-by-case basis and is subject to specific restrictions and conditions.

To learn more:

Under pre-AIA 37 CFR 1.47(b), the term ‘person’ is broadly interpreted. The MPEP states that “The word ‘person’ has been construed by the U.S. Patent and Trademark Office to include juristic entities, such as a corporation.” This means that both individuals and legal entities can potentially file an application under this provision, provided they meet the other requirements.

To learn more:

Tags: pre-AIA

For applications filed on or after September 16, 2012, a power of attorney must be signed by the applicant for patent (i.e., all parties identified as the applicant as defined by 37 CFR 1.42(a)) or the patent owner. For applications filed before September 16, 2012, a power of attorney can be signed by the applicant or the assignee of the entire interest of the applicant.

As stated in MPEP 402.02(a): “For applications filed on or after September 16, 2012, 37 CFR 1.32(b)(4) sets forth that a power of attorney must be signed by the applicant for patent (i.e., all parties identified as the applicant as defined by 37 CFR 1.42(a)) or the patent owner (for reissue applications, reexamination proceedings and supplemental examination proceedings).”

According to the MPEP, an examiner can contact the patent practitioner of record in the application for interviews. The MPEP states:

When the examiner believes the progress of the application would be advanced by an interview, the examiner may contact the patent practitioner of record in the application (in accordance with MPEP § 713) and suggest a telephonic, personal, or video conference interview.

It’s important to note that registered attorneys or agents not of record should not be contacted for certain actions, such as restriction requirements or approval of examiner’s amendments.

A revocation of power of attorney becomes effective on the date it is received by the USPTO, not on the date it is accepted. As stated in MPEP 402.05: Revocation of a power of attorney becomes effective on the date that the revocation is RECEIVED in the Office (not on the date of ACCEPTANCE). The Office will send an appropriate notification upon revocation.

To learn more:

The MPEP provides specific guidance on when an attorney or agent not of record can change the correspondence address. It states:

See MPEP § 402.03 for information regarding when a change of correspondence address or a document granting access (i.e., a power to inspect) may be signed by an attorney or agent who is not of record.

This reference to MPEP § 402.03 suggests that there are certain circumstances where an attorney or agent not of record may be allowed to change the correspondence address or grant access to application information. For specific details, it’s recommended to consult MPEP § 402.03 directly.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on USPTO procedures, visit: USPTO procedures.

A patent examiner may suggest hiring a patent practitioner under specific circumstances, as outlined in MPEP 401:

“If patentable subject matter appears to be disclosed in a pro se application and it is apparent that the applicant is unfamiliar with the proper preparation and prosecution of patent applications, the examiner may suggest to the applicant that it may be desirable to employ a registered patent attorney or agent.”

However, the examiner should not suggest hiring a practitioner if the application appears to contain no patentable subject matter. The MPEP provides a form paragraph (4.10) for examiners to use when making this suggestion.

According to MPEP 409.03(d), acceptable evidence to prove inventor unavailability or refusal can include:

  • Copies of letters or email messages sent to the inventor requesting their signature
  • Returned receipt indicating the inventor’s refusal to accept mail
  • Statements from people who have attempted to contact the inventor
  • Evidence of the inventor’s mental or physical incapacity
  • Evidence of the inventor’s unavailability due to absence
  • Other pertinent evidence that demonstrates the inventor’s unavailability or refusal

The MPEP states: ‘The proof of unavailability or refusal will be examined by the Office.’ This means that the USPTO will carefully evaluate the submitted evidence to determine if it sufficiently demonstrates the inventor’s unavailability or refusal.

To learn more:

The MPEP provides specific guidance on the type of address that should be provided for the nonsigning inventor in pre-AIA 37 CFR 1.47 applications:

‘That address should be the last known address at which the inventor customarily receives mail.’

This typically means providing the most recent address where the inventor is known to receive correspondence. It’s important to provide an address where the USPTO’s communications are most likely to reach the nonsigning inventor.

To learn more:

To learn more:

When dealing with a nonsigning inventor under pre-AIA 37 CFR 1.47, the following steps should be taken to present application papers:

  1. Send a copy of the application papers to the last known address of the nonsigning inventor.
  2. If the inventor is represented by counsel, send the papers to the inventor’s attorney’s address.
  3. Ensure that the inventor is given the opportunity to review the complete application, unless they have assigned their interest and the assignee has requested otherwise.

The MPEP emphasizes:

‘It is reasonable to require that the inventor be presented with the application papers before a petition under pre-AIA 37 CFR 1.47 is granted since such a procedure ensures that the inventor is apprised of the application to which the oath or declaration is directed.’

This process is crucial to establish that a bona fide attempt was made to present the application papers to the nonsigning inventor.

To learn more:

To learn more:

When terminating representation, a practitioner must take several steps to protect the client’s interests, as outlined in 37 CFR 11.116(d):

  • Give reasonable notice to the client
  • Allow time for the client to employ other counsel
  • Surrender papers and property to which the client is entitled
  • Refund any advance payment of fees or expenses that have not been earned or incurred

Additionally, the practitioner must comply with applicable laws requiring notice to or permission from a tribunal when terminating representation, as per 37 CFR 11.116(c).

The USPTO provides forms (PTO/SB/83 or PTO/AIA/83) that include a section for practitioners to certify the completion of these necessary activities. Practitioners can also file a Web-based e-petition for withdrawal.

To learn more:

Tags: USPTO Forms

When issuing Office actions after being notified of a patent practitioner’s death, the USPTO includes a special notation. The MPEP 406 instructs examiners to add form paragraph 4.03, which states:

“Notice of the death of the attorney or agent of record has come to the attention of this Office. Since the power of attorney is therefore terminated, this action is being mailed to the office of the patent practitioner and to the party who originally appointed the deceased patent practitioner. A new registered attorney or agent may be appointed.”

This notation informs all parties of the practitioner’s death and the need for new representation.

For more information on Form Paragraph 4.03, visit: Form Paragraph 4.03.

If you need information related to a topic that corresponds to a reserved MPEP section, such as MPEP 404, follow these steps:

  1. Check other relevant sections of the MPEP that may cover related topics
  2. Consult the USPTO’s official website for guidance documents and notices
  3. Review recent patent laws and regulations that may address the topic
  4. Contact the USPTO’s Patent Electronic Business Center for assistance
  5. Consult with a registered patent attorney or agent for professional advice

Remember that reserved sections do not contain any official information, so it’s crucial to seek guidance from active, authoritative sources.

If a legal representative of a deceased inventor refuses to make application, the procedure depends on when the application was filed:

  • For applications filed before September 16, 2012: Pre-AIA 37 CFR 1.47 applies. The MPEP states: pre-AIA 37 CFR 1.47 does apply where a known legal representative of a deceased inventor cannot be found or reached after diligent effort, or refuses to make application.
  • In this case, you should:
    1. Document the refusal and the efforts made to reach the legal representative.
    2. Provide the last known address of the legal representative, as per MPEP § 409.03(e).
    3. File the application under pre-AIA 37 CFR 1.47, explaining the situation.
  • For applications filed on or after September 16, 2012: Different procedures apply, which are not covered in this specific MPEP section. Consult the current USPTO regulations and guidelines for the appropriate course of action.

It’s important to note that these procedures are specific to cases where there is a known legal representative who is refusing to cooperate. Different rules may apply in other scenarios involving deceased inventors.

To learn more:

If an applicant’s patent attorney or agent is suspended, they should take the following steps:

  1. File a new power of attorney in the application to have a registered attorney or agent represent them before the Office.
  2. Ensure all future papers are signed by authorized parties (see MPEP § 407, Form Paragraph 4.07 for details on who can sign).
  3. If necessary, find a new registered patent attorney or agent using USPTO resources.
  4. Update the correspondence address for the application if it was previously associated with the suspended practitioner.

It’s important to act promptly to ensure continued proper representation and communication with the USPTO.

When an examiner receives a pre-AIA 37 CFR 1.47 application, they must follow these steps:

“When an examiner receives an application in which a petition under pre-AIA 37 CFR 1.47 has been filed, he or she must check the file to determine that the petition has been decided by the Office of Petitions. If the petition has not been decided by the Office of Petitions, the application, or an electronic message concerning the petition, must be forwarded to the Office of Petitions for appropriate action.”

In essence, the examiner must verify that the Office of Petitions has made a decision on the pre-AIA 37 CFR 1.47 petition. If not, the examiner must forward the application or relevant information to the Office of Petitions for further processing.

To learn more:

To learn more:

Risks of Self-Representation in Patent Applications

While individuals can file pro se patent applications, there are several risks to consider:

  1. Lack of expertise: Patent law is complex, and lack of familiarity with examination practices may result in missed opportunities for optimal protection.
  2. Potential sanctions: According to MPEP 401, pro se applicants are subject to the same certifications and potential sanctions as represented applicants:

In presenting (whether by signing, filing, submitting, or later advocating) papers to the Office, a pro se applicant is making the certifications under 37 CFR 11.18(b), and may be subject to sanctions under 37 CFR 11.18(c) for violations of 37 CFR 11.18(b)(2).

Given these risks, the USPTO may suggest hiring a registered patent practitioner if they notice an applicant is unfamiliar with the process and the application contains potentially patentable subject matter.

For more information on pro se, visit: pro se.

For more information on self-representation, visit: self-representation.

A nonsigning inventor in a pre-AIA 37 CFR 1.47 application retains certain rights, as outlined in MPEP 409.03(i):

  • May protest their designation as an inventor
  • Can inspect any paper in the application
  • May order copies of application documents
  • Can make their position of record in the application file
  • Has the option to join the application later by filing an oath/declaration
  • Retains inventor rights for patent issuance

However, the nonsigning inventor cannot:

  • Prosecute the application if status under 37 CFR 1.47 is accorded
  • Revoke power of attorney without agreement of the 37 CFR 1.47 applicant

The MPEP states: The rights of a nonsigning inventor are protected by the fact that the patent resulting from an application filed under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118 must issue to the inventor, and in an application filed under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the inventor has the same rights that he or she would have if he or she had joined in the application.

To learn more:

To learn more:

A nonsigning inventor, also known as an ‘inventor designee,’ has several rights in a patent application filed under pre-AIA 37 CFR 1.47. These rights include:

  • The right to protest their designation as an inventor
  • The right to inspect any paper in the application
  • The right to order copies of application documents at the price set forth in 37 CFR 1.19
  • The right to make their position of record in the file wrapper of the application

As stated in MPEP 409.03(i): “The nonsigning inventor is entitled to inspect any paper in the application, order copies thereof at the price set forth in 37 CFR 1.19, and make his or her position of record in the file wrapper of the application.”

It’s important to note that while these rights are granted, the nonsigning inventor is not entitled to prosecute the application if status under pre-AIA 37 CFR 1.47 has been accorded.

To learn more:

To learn more:

The USPTO, through its Office of Enrollment and Discipline, provides valuable resources to client-applicants when their patent practitioner dies. The MPEP 406 states:

‘The Office of Enrollment and Discipline will notify the client-applicant of the availability of a list of patent practitioners who may be available to represent the client-applicant.’

This list serves as a crucial resource, helping client-applicants find new representation to continue their patent prosecution process without significant delays.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO Resources, visit: USPTO Resources.

For a pre-AIA 37 CFR 1.47(b) application, the applicant must prove one of the following:

  • The invention has been assigned to the applicant
  • The inventor has agreed in writing to assign the invention to the applicant
  • The applicant otherwise has sufficient proprietary interest in the subject matter to justify filing the application

As stated in MPEP 409.03(f):

“When an application is deposited pursuant to pre-AIA 37 CFR 1.47(b), the pre-AIA 37 CFR 1.47(b) applicant must prove that (A) the invention has been assigned to the applicant, or (B) the inventor has agreed in writing to assign the invention to the applicant, or (C) the applicant otherwise has sufficient proprietary interest in the subject matter to justify the filing of the application.”

The specific documentation required depends on which of these conditions is being met.

To learn more:

To learn more:

When filing under pre-AIA 37 CFR 1.47, the applicant must provide proof that the nonsigning inventor is unavailable or refusing to sign. According to MPEP 409.03(d):

  • For an unavailable inventor, submit a statement of facts describing the diligent efforts made to find or reach the inventor. Include documentary evidence like Internet searches, certified mail receipts, etc.
  • For a refusing inventor, provide evidence that the application was presented to the inventor for signature and they refused. This can include:
    • A statement detailing the circumstances of the presentation and refusal
    • Documentary evidence of written refusal
    • Statement of the reasons given by the inventor for refusing

The section states: Where inability to find or reach a nonsigning inventor ‘after diligent effort’ is the reason for filing under pre-AIA 37 CFR 1.47, a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.

To learn more:

For applications filed on or after September 16, 2012:

  • An assignee or obligated assignee may file the application as the applicant
  • A person who shows sufficient proprietary interest may file the application on behalf of and as agent for the inventor
  • The applicant may file a substitute statement in lieu of an inventor’s oath or declaration if the inventor has refused to execute the oath or declaration

For applications filed before September 16, 2012, a petition under pre-AIA 37 CFR 1.47 could be filed.

For applications filed on or after September 16, 2012, if an inventor is deceased or legally incapacitated:

  • The legal representative of the inventor may make the application for patent on behalf of the inventor.
  • An assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest may file the application as the applicant.

As stated in MPEP § 409.01(a): “If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.”

For more information on legal representative, visit: legal representative.

When filing under pre-AIA 37 CFR 1.47(b), an applicant must prove that the filing of the application is necessary for specific reasons. The MPEP outlines two primary justifications:

  1. To preserve the rights of the parties
  2. To prevent irreparable damage

Specifically, the MPEP states: “The pre-AIA 37 CFR 1.47(b) applicant must prove that the filing of the application is necessary (1) to preserve the rights of the parties or (2) to prevent irreparable damage.”

This requirement ensures that the use of pre-AIA 37 CFR 1.47(b) is justified and not merely a matter of convenience. For more detailed information on proving necessity, refer to MPEP § 409.03(g).

To learn more:

Tags: pre-AIA

What limited recognition is granted to suspended or excluded practitioners?

Suspended or excluded practitioners are granted limited recognition to handle specific tasks related to pending applications. According to MPEP 407:

“The suspended or excluded practitioner will be granted limited recognition for a period of thirty (30) days, during which time the practitioner may conclude work on behalf of a client on any matters pending before the Office.”

This limited recognition allows the practitioner to:

  • Conclude or withdraw from representation in pending proceedings
  • Receive and forward correspondence
  • Make appropriate filings to protect the client’s rights

However, this recognition is strictly limited to these activities and does not allow the practitioner to engage in new patent prosecution work.

For more information on pending applications, visit: pending applications.

The date September 16, 2012, is significant because it marks a change in the applicability of certain patent application procedures. As noted in MPEP 409.03(a):

“[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]”

This date corresponds to the implementation of the America Invents Act (AIA), which brought significant changes to U.S. patent law. For applications filed on or after this date, different rules and procedures apply regarding joint inventorship and the handling of situations where not all inventors are available or willing to sign the application. It’s crucial for applicants to be aware of which set of rules applies to their application based on the filing date.

To learn more:

The date September 16, 2012, is significant in patent applications involving deceased inventors because it marks a change in the applicable regulations. The MPEP section 409.03(c) states:

[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]

This means:

  • For applications filed before September 16, 2012: The procedures outlined in pre-AIA 37 CFR 1.47 apply when dealing with unavailable legal representatives of deceased inventors.
  • For applications filed on or after September 16, 2012: Different regulations and procedures apply, which are not covered in this specific MPEP section.

This date coincides with the implementation of the America Invents Act (AIA), which brought significant changes to U.S. patent law. Patent applicants and attorneys should be aware of these changes and apply the appropriate procedures based on their application’s filing date.

To learn more:

The filing date is crucial in relation to irreparable damage because it can determine whether an applicant’s rights are preserved or lost. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This means that the filing date can be critical for:

  • Establishing priority over other potential patent applications
  • Avoiding statutory bars to patentability
  • Preserving international filing rights
  • Preventing public disclosure that could jeopardize patent rights

Therefore, proving that a specific filing date is necessary can be essential to prevent irreparable damage to an applicant’s patent rights.

To learn more:

To learn more:

What is the significance of the AIA (America Invents Act) for patent application correspondence?

The America Invents Act (AIA) brought significant changes to patent application correspondence, particularly for applications filed on or after September 16, 2012. Key changes include:

  • New rules for who can file patent applications
  • Changes in correspondence procedures
  • Updated requirements for patent practitioners’ authority

According to MPEP 403.01(a): “The provisions of 37 CFR 1.33(b) for patent applications filed on or after September 16, 2012 differ from the provisions of pre-AIA 37 CFR 1.33(b) for patent applications filed prior to September 16, 2012.” This highlights the importance of understanding the specific rules that apply based on the application’s filing date.

To learn more:

What is the significance of the ‘correspondence address’ in USPTO patent applications?

The correspondence address is crucial in USPTO patent applications for several reasons:

  • It determines where the USPTO sends all official communications regarding the application.
  • It can be used to designate a specific attorney or agent to receive correspondence.
  • Changes to the correspondence address must be made in writing to ensure proper routing of communications.

According to MPEP 403.01: “The correspondence address is used by the Office for mailing notices, actions, and other communications relating to the application.” Additionally, the MPEP states: “A change of correspondence address may be filed with the USPTO during the pendency of an application, and in a patent file.” This emphasizes the importance of keeping the correspondence address up-to-date to ensure timely receipt of important USPTO communications.

To learn more:

What is the significance of the ‘acting in a representative capacity’ requirement in patent applications?

The ‘acting in a representative capacity’ requirement is crucial in patent applications as it ensures that only authorized individuals can represent applicants or patent owners before the USPTO. According to MPEP 402.04, “Any paper presented to the United States Patent and Trademark Office (Office) on behalf of an applicant for patent or patent owner must be signed by (A) a patent practitioner of record appointed in compliance with 37 CFR 1.32(b), (B) a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34, or (C) the applicant under 37 CFR 1.42.” This requirement helps maintain the integrity of the patent application process and protects the interests of applicants and patent owners.

To learn more:

Pre-AIA 35 U.S.C. 118 is significant in determining what constitutes a valid assignment or sufficient proprietary interest for filing a patent application. According to MPEP 409.03(f):

“An assignment to a pre-AIA 37 CFR 1.47(b) applicant for the sole purpose of obtaining a filing date for a pre-AIA 37 CFR 1.47(b) application is not considered an assignment within the meaning of pre-AIA 35 U.S.C. 118 and pre-AIA 37 CFR 1.47(b).”

This means that a mere pro forma assignment created solely to comply with filing requirements is not sufficient to establish proprietary interest under pre-AIA 35 U.S.C. 118. The assignment or proprietary interest must be substantive and reflect a genuine transfer of rights or interest in the invention.

When demonstrating proprietary interest, applicants must show that their claim to the invention would be recognized under applicable law, not just that they have fulfilled a procedural requirement.

To learn more:

To learn more:

MPEP 402.08 has important implications for independent inventors involved in interference proceedings. The key provision states:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

For independent inventors, this means:

  • Changes in legal representation during an interference proceeding must be approved by the PTAB.
  • There may be additional complexity and potential delays in changing attorneys.
  • Inventors should carefully consider the timing of any representation changes.
  • Direct communication with the PTAB may be necessary regarding power of attorney matters.

Independent inventors should be aware of these special procedures to navigate interference proceedings effectively and ensure proper legal representation throughout the process.

To learn more:

To learn more:

What is the significance of a power of attorney in patent applications?

A power of attorney is a crucial document in patent applications that authorizes an attorney or agent to act on behalf of the applicant or assignee. According to MPEP 402.04, “A power of attorney may be filed in an individual application, either original or reissue, and in any national stage application.” This document allows the designated representative to make decisions, file documents, and communicate with the USPTO on behalf of the applicant. It’s important to note that the power of attorney must be properly executed and filed to be effective.

To learn more:

What is the significance of a customer number in USPTO correspondence?

A customer number is a crucial tool for managing correspondence with the USPTO. According to MPEP 403:

‘A customer number allows an applicant, attorney or agent to easily change the correspondence address for a number of applications or patents by simply requesting a change to the address associated with the customer number.’

Key benefits of using a customer number include:

  • Streamlined correspondence management for multiple applications
  • Easy updates to address information
  • Efficient access to application information through USPTO systems

By using a customer number, patent professionals can significantly simplify their administrative processes when dealing with the USPTO.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

What is the significance of a customer number in patent applications filed after September 16, 2012?

A customer number holds significant importance in patent applications filed after September 16, 2012, particularly for managing practitioner representation. Here’s why:

  • It allows for efficient management of multiple practitioners
  • Power of attorney can be given to a customer number
  • It simplifies the process of adding or removing practitioners
  • Correspondence address can be associated with a customer number

According to MPEP 403.01(a): ‘A power of attorney or authorization of agent may be given to a customer number in applications filed on or after September 16, 2012.’ This provision streamlines the process of managing representation for applicants and practitioners alike.

Furthermore, the MPEP states: ‘If a practitioner is not of record, correspondence will be sent to the applicant’s correspondence address as shown in the application or the Patent Application Locating and Monitoring (PALM) system.’ This underscores the importance of keeping the customer number and associated information up to date.

To learn more:

A Customer Number is a unique identifier assigned by the USPTO that can be associated with a correspondence address. It offers several advantages in managing patent application correspondence:

  • Simplified address changes: You can update the address for multiple applications at once by changing the address associated with the Customer Number.
  • Priority in address selection: When multiple addresses are provided, the USPTO may prioritize the address associated with a Customer Number.
  • Easier access to Patent Application Information Retrieval (PAIR) system: Customer Numbers can be used to access multiple applications in PAIR.

37 CFR 1.33(a) states: If more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

Using a Customer Number can streamline communication with the USPTO and make it easier to manage multiple patent applications.

To learn more:

37 CFR 11.18 is a crucial regulation that governs signature and certification requirements for correspondence filed with the USPTO. Its significance includes:

  • Establishing signature requirements for practitioners
  • Defining certifications made when submitting papers
  • Setting standards for truthfulness and proper purpose in filings
  • Outlining potential consequences for violations

The MPEP emphasizes its importance: “The certifications in 37 CFR 11.18(b) apply to all papers filed in the Office, including allegations of improper conduct made by a registered practitioner in any Office proceeding.”

This regulation helps maintain the integrity of the patent application process and ensures that all parties involved are held to high ethical and legal standards.

To learn more:

To learn more:

‘Limited recognition’ is a specific status granted by the USPTO that allows certain individuals to practice patent law in a restricted capacity. Its significance includes:

  • Allowing non-registered practitioners to represent applicants in specific circumstances.
  • Providing a pathway for Canadian patent agents to represent Canadian applicants.
  • Restricting the scope of practice to specific types of applications or applicants.

The MPEP 402.01 states: Limited recognition to practice in patent cases means recognition to practice before the Office in patent cases, or in a limited capacity as a patent agent, as appropriate… This status ensures that certain practitioners can assist applicants while maintaining the integrity of the USPTO’s registration system.

To learn more:

Tags: USPTO

What is the significance of ‘facts showing the right’ in proving proprietary interest?

The phrase ‘facts showing the right’ is crucial in proving proprietary interest for patent applications. According to MPEP 409.03(f):

‘Facts showing the right or authority to make the petition must be proved in accordance with 37 CFR 1.46.’

This means that:

  • Applicants must provide concrete evidence demonstrating their right to file and prosecute the patent application.
  • The evidence should clearly establish the applicant’s legal authority or ownership of the invention.
  • These facts are essential for the USPTO to determine if the applicant has the proper standing to proceed with the application.

Examples of such facts might include:

  • Documentation of employment agreements assigning invention rights to an employer
  • Contracts showing transfer of rights from inventors to the applicant
  • Court orders establishing ownership in cases of disputes

The significance of these ‘facts showing the right’ is that they protect the interests of all parties involved and ensure that patent rights are granted to the rightful owners or their authorized representatives.

To learn more:

An affidavit plays a crucial role in proving the unavailability or refusal of a non-signing inventor. The MPEP 409.03(d) states:

An affidavit or declaration of the applicant, or his/her attorney or agent, explaining the situation and stating the last known address of the non-signing inventor, may be sufficient to establish that the inventor cannot be found or reached after diligent effort or has refused to execute the application papers.

The affidavit should:

  • Provide a detailed account of efforts to locate or communicate with the inventor
  • Include dates, methods of contact attempted, and results
  • Explain any refusal circumstances if applicable
  • Be signed under oath or declaration

This sworn statement serves as a formal record of the applicant’s diligent efforts and is considered by the USPTO in determining the validity of the proof of unavailability or refusal.

To learn more:

An administrator plays a crucial role in filing a patent application for a deceased inventor. According to MPEP 409.01(b):

If the inventor was not of sound mind and legally incapacitated at the time the application was made, it may be signed by a legal representative (e.g., guardian), the inventor’s legal representative (e.g., executor, administrator, etc.), or someone acting on behalf of the inventor or legal representative.

The administrator’s responsibilities include:

  • Representing the deceased inventor’s estate
  • Signing necessary documents on behalf of the deceased inventor
  • Providing proof of their authority to act as administrator
  • Ensuring the application process complies with legal requirements

It’s important to note that the administrator must have the legal authority to act on behalf of the deceased inventor’s estate.

To learn more:

An ‘obligated assignee’ is a person or entity who has a contractual obligation to assign the rights to an invention but has not yet done so. According to MPEP 409.05, an obligated assignee can file a patent application on behalf of the inventor if they meet certain requirements:

  • They must have a contractual obligation with the inventor to assign the entire right, title, and interest in the application.
  • They must file an application data sheet under 37 CFR 1.76 naming the inventor and including a statement that the application is being filed by the obligated assignee.

The MPEP states: ‘An assignee who is not the original applicant may file a patent application as long as the application is accompanied by a statement that establishes the assignee’s ownership interest.’ This provision allows obligated assignees to initiate the patent process even before the formal assignment has taken place.

To learn more:

What is the role of a patent practitioner during an interview with the USPTO?

A patent practitioner plays a crucial role during an interview with the USPTO. According to MPEP 408, the practitioner is responsible for:

  • Representing the applicant or patent owner
  • Discussing the merits of the application or patent
  • Providing clarifications on the invention
  • Negotiating potential claim amendments
  • Addressing any concerns raised by the examiner

The MPEP states: ‘Interviews must be conducted on the Office premises, such as in examiner’s offices, conference rooms or the video conference centers.’ This underscores the formal nature of these interactions and the importance of the practitioner’s role in facilitating productive discussions with the examiner.

For more information on patent examination, visit: patent examination.

What is the role of a legal representative in filing a patent application for a deceased inventor?

A legal representative plays a crucial role in filing a patent application for a deceased inventor. According to MPEP 409.03(b):

“The legal representative (executor, administrator, etc.) of a deceased inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative’s responsibilities include:

  • Executing the necessary oath or declaration on behalf of the deceased inventor
  • Providing proof of their authority to act (e.g., Letters Testamentary or Letters of Administration)
  • Submitting the patent application and all required documents to the USPTO
  • Corresponding with the USPTO throughout the application process
  • Potentially assigning the patent rights if required by the deceased inventor’s will or other legal arrangements

It’s important to note that the legal representative must act in accordance with the law and the best interests of the deceased inventor’s estate.

To learn more:

The legal representative of a deceased inventor plays a crucial role in the patent application process. According to MPEP 409.01:

If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or representatives of the deceased inventor.

The legal representative’s responsibilities include:

  • Executing the oath or declaration on behalf of the deceased inventor
  • Providing documentation of their authority to act on behalf of the deceased inventor’s estate
  • Continuing the prosecution of the patent application
  • Receiving the granted patent on behalf of the deceased inventor’s estate

It’s important to note that the legal representative must be properly appointed according to state laws governing estate administration.

To learn more:

In applications filed pursuant to pre-AIA 37 CFR 1.47, it is mandatory to state the last known address of the nonsigning inventor. The MPEP states:

‘An application filed pursuant to pre-AIA 37 CFR 1.47 must state the last known address of the nonsigning inventor.’

This requirement ensures that the USPTO can attempt to contact the nonsigning inventor regarding the application filed on their behalf.

To learn more:

To learn more:

Tags: pre-AIA

MPEP 409.03(f) is not applicable to patent applications filed on or after September 16, 2012. This is clearly stated at the beginning of the section:

“[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012. See MPEP §§ 325, 409.05, and 605 for information pertaining to applications for patent filed on or after September 16, 2012 by an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter.]”

For applications filed on or after September 16, 2012, applicants should refer to:

These sections provide guidance on how assignees, obligated assignees, or persons with sufficient proprietary interest can file patent applications under the current law.

To learn more:

To learn more:

Pre-AIA 37 CFR 1.47(b) allows a person with a demonstrated proprietary interest to file a patent application on behalf of an inventor who is unavailable. According to the MPEP, this provision is applicable “when no inventor is available to make application” and permits filing “on behalf of and as agent for” an inventor who “cannot be found or reached after diligent effort” or who refuses to sign the application oath or declaration.

It’s important to note that this provision is not applicable to applications filed on or after September 16, 2012.

To learn more:

MPEP 409.03(f) – Proof of Proprietary Interest outlines the requirements for establishing proprietary interest in a patent application when an inventor refuses to execute an oath or declaration. The section states:

‘If an inventor refuses to execute an oath or declaration under 37 CFR 1.63, the party to whom the inventor has assigned or agreed in writing to assign the invention, or who otherwise shows sufficient proprietary interest in the matter justifying such action, may make application for patent as provided in 37 CFR 1.46.’

This section provides guidance on how to prove sufficient proprietary interest, which is crucial for applicants who need to file a patent application without the inventor’s cooperation.

To learn more:

To learn more:

MPEP 409.03 provides guidance on how to handle patent applications filed before September 16, 2012 when an inventor is unavailable or unwilling to sign the application. It outlines the procedures for filing an application under pre-AIA 37 CFR 1.47 when:

  • A joint inventor refuses to join in an application or cannot be found/reached after diligent effort
  • All inventors are unavailable
  • A legal representative of a deceased inventor is unavailable

The section details the requirements, evidence needed, and process for submitting and processing these types of applications.

To learn more:

To learn more:

What is the purpose of limited recognition in patent matters?

The purpose of limited recognition in patent matters is to allow certain individuals who are not fully registered patent practitioners to represent patent applicants before the USPTO in specific situations. As stated in MPEP 402.01:

‘Limited recognition to practice before the Office in patent matters may also be granted in appropriate circumstances to an individual who is not registered to practice before the Office.’

This provision serves several purposes:

  • Allows qualified scientists and engineers to assist in patent matters
  • Facilitates international cooperation through reciprocal agreements (e.g., with Canadian patent agents)
  • Provides flexibility for the USPTO to address specific needs or situations
  • Enables representation in cases where full registration may not be necessary or practical

Limited recognition ensures that patent applicants have access to appropriate representation while maintaining the integrity of the patent system.

To learn more:

What is the purpose of a Customer Number in USPTO correspondence?

A Customer Number is a unique identifier assigned by the USPTO to simplify and streamline patent correspondence. According to the MPEP 403, ‘The Customer Number practice permits applicants, attorneys, and agents of record to change their correspondence address for a number of applications with one request.’ This system allows for:

  • Easy updates to correspondence addresses for multiple applications
  • Efficient management of power of attorney
  • Simplified access to private PAIR (Patent Application Information Retrieval) for registered practitioners

By using a Customer Number, patent applicants and their representatives can more effectively manage their patent portfolios and communications with the USPTO.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

To initiate an interview with a patent examiner, applicants should follow a specific procedure outlined in MPEP § 408:

  1. Submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) to the examiner prior to the interview.
  2. The form should identify the participants of the interview.
  3. Propose a date for the interview.
  4. Specify whether the interview will be personal, telephonic, or via video conference.
  5. Include a brief description of the issues to be discussed.

As stated in the MPEP, When applicant is initiating a request for an interview, an ‘Applicant Initiated Interview Request’ form (PTOL-413A) should be submitted to the examiner prior to the interview in order to permit the examiner to prepare in advance for the interview and to focus on the issues to be discussed. This procedure helps ensure productive and efficient interviews.

For more information on patent examination, visit: patent examination.

For more information on USPTO Forms, visit: USPTO Forms.

The process for revoking power of attorney during an interference proceeding differs from the standard procedure. According to MPEP 402.08:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

To revoke power of attorney during an interference proceeding:

  1. Prepare the revocation document as you normally would.
  2. Instead of submitting it through regular channels, forward the revocation to the Patent Trial and Appeal Board (PTAB).
  3. The PTAB will consider the revocation within the context of the ongoing interference proceeding.
  4. Wait for the PTAB’s decision before considering the revocation effective.

This special handling ensures that changes in representation are properly managed within the complex context of an interference proceeding.

To learn more:

What is the process for filing a patent application if an inventor is legally incapacitated?

When an inventor is legally incapacitated, the patent application can be filed by the legal representative of the incapacitated inventor. According to MPEP 409.03(b):

“If an inventor is legally incapacitated, the legal representative of the inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The process involves:

  • Filing a petition under 37 CFR 1.47(b)
  • Paying the petition fee set forth in 37 CFR 1.17(g)
  • Providing proof of the inventor’s incapacity (e.g., court order)
  • Submitting an oath or declaration by the legal representative

The legal representative should state their relationship to the incapacitated inventor and provide evidence of their authority to act on behalf of the inventor.

To learn more:

To learn more:

What is the procedure for an examiner to verify an attorney’s authority during an interview?

When conducting an interview with an attorney or agent who is not of record, the examiner must follow a specific procedure to verify their authority. According to MPEP 405:

If an attorney or agent not of record in an application contacts an examiner for an interview, the examiner may grant the interview if the attorney or agent presents an authorization from the practitioner of record, or presents a signed power of attorney or a paper authorizing them to act as associate or agent.

The examiner should:

  • Ask for an authorization from the practitioner of record
  • Accept a signed power of attorney
  • Accept a paper authorizing the attorney or agent to act as an associate or agent

If none of these are available, the examiner should decline the interview unless the attorney or agent is willing to conduct the interview with the inventor present.

For more information on USPTO procedures, visit: USPTO procedures.

What is the duty of disclosure in patent applications?

The duty of disclosure is a fundamental obligation in the patent application process. As outlined in MPEP 410:

“Each individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability as defined in this section.”

This duty requires applicants and their representatives to:

  • Disclose all known material information
  • Submit information disclosure statements (IDS)
  • Update the USPTO with new material information throughout the application process

Failing to comply with the duty of disclosure can result in charges of inequitable conduct, which may render a patent unenforceable. It’s crucial for applicants to err on the side of disclosure when in doubt about the materiality of information.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What is the duration of limited recognition granted by the OED Director?

The duration of limited recognition granted by the OED Director is not explicitly specified in MPEP 402.01. However, the section states: Limited recognition is granted for a period consistent with the employment situation for which the individual is granted limited recognition. This suggests that the duration is tailored to each individual’s specific employment situation and may vary case by case. It’s important to note that limited recognition can be withdrawn by the OED Director at any time.

To learn more:

What is the duration of limited recognition for foreign patent agents?

Limited recognition for foreign patent agents is typically granted for a period of 5 years. According to the MPEP, Recognition of a foreign patent agent for the limited purpose of representing applicants before the USPTO in the presentation and prosecution of applications for patent is granted for a period of 5 years. (MPEP 402.01) This means that foreign patent agents must renew their limited recognition status every 5 years to continue practicing before the USPTO.

To learn more:

Tags: USPTO

The main difference in power of attorney revocation between pre-AIA (before September 16, 2012) and post-AIA (on or after September 16, 2012) applications lies in who can sign the power of attorney and the process for revocation:

  • Post-AIA (on or after September 16, 2012): The power of attorney must be signed by the applicant or patent owner. For an assignee to revoke a power of attorney, they must first become the applicant under 37 CFR 1.46(c).
  • Pre-AIA (before September 16, 2012): The assignee of record of the entire interest can revoke the power of attorney of the applicant directly, provided they establish their right to take action under pre-AIA 37 CFR 3.73(b).

This change reflects the shift in USPTO regulations to give more control to the applicant in post-AIA applications, while pre-AIA rules allowed more direct action by assignees.

To learn more:

Pre-AIA 37 CFR 1.42 and pre-AIA 37 CFR 1.47 serve different purposes in relation to deceased inventors:

  • Pre-AIA 37 CFR 1.42: This regulation specifically addresses the situation of a deceased inventor. It allows the legal representative (executor or administrator of the estate) to make an application on behalf of the deceased inventor.
  • Pre-AIA 37 CFR 1.47: This regulation is not intended for deceased inventors directly. As stated in the MPEP, Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

However, pre-AIA 37 CFR 1.47 does apply in cases where:

  • A known legal representative of a deceased inventor cannot be found or reached after diligent effort, or
  • The legal representative refuses to make the application

In such cases, the last known address of the legal representative must be provided, as per MPEP § 409.03(e).

It’s important to note that these regulations apply to applications filed before September 16, 2012. For applications filed on or after that date, different procedures may apply.

To learn more:

To learn more:

In patent applications, both attorneys and agents can represent applicants before the USPTO, but there are important distinctions:

  • Patent Attorney: A lawyer who has passed both a state bar exam and the USPTO’s patent bar exam. They can practice law and provide legal advice beyond patent prosecution.
  • Patent Agent: An individual who has passed the USPTO’s patent bar exam but is not a licensed attorney. They can represent clients before the USPTO for patent matters but cannot practice law or provide other legal services.

The MPEP 402 refers to both as ‘patent practitioners’: ‘The term ‘patent practitioner’ as used in this chapter includes patent attorneys and patent agents.’ Both can receive power of attorney and represent applicants in patent matters before the USPTO, but only patent attorneys can offer broader legal counsel.

MPEP 409.03(f) distinguishes between an assignment and an agreement to assign in the context of proving proprietary interest for pre-AIA 37 CFR 1.47(b) applications. The key differences are:

  • Assignment: A completed transfer of rights in the invention.
  • Agreement to Assign: A promise to transfer rights in the future, often conditional.

For an assignment, MPEP 409.03(f) states:

“If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant.”

For an agreement to assign:

“When an inventor has agreed in writing to assign an invention described in an application deposited pursuant to pre-AIA 37 CFR 1.47(b), a copy of that agreement should be submitted.”

Additionally, if the agreement to assign is conditional, evidence that the conditions have been met must be provided. This often applies to employment agreements, where the applicant must prove the invention was made during the course of employment.

To learn more:

To learn more:

In patent applications, there is a distinction between an assignee and an obligated assignee. According to MPEP 409.05:

  • Assignee: A person or entity to whom the inventor has already transferred ownership rights of the invention.
  • Obligated Assignee: A person or entity to whom the inventor is under a contractual obligation to assign the invention in the future, but the transfer has not yet occurred.

The MPEP states:

Quote: ‘A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent.’

Both assignees and obligated assignees have the right to file patent applications under this provision. The key difference lies in the timing and completion of the assignment process. An assignee has already received the rights, while an obligated assignee has a binding agreement to receive the rights in the future.

To learn more:

While both suspended and excluded patent practitioners are prohibited from practicing before the USPTO, there are differences in the nature and duration of the prohibition:

  • Suspended practitioner: Temporarily prohibited from practicing before the USPTO for a specific period.
  • Excluded practitioner: Permanently prohibited from practicing before the USPTO, unless later reinstated.

The MPEP § 407 uses both terms, indicating that the Office treats them similarly in terms of communication and representation: ‘The Office does not communicate with attorneys or agents who have been suspended or excluded from practice.’

What is the difference between a principal and an associate power of attorney in patent applications?

In patent applications, there is a distinction between principal and associate powers of attorney:

  • Principal Power of Attorney: This is the primary power of attorney granted by the applicant to a patent practitioner or firm.
  • Associate Power of Attorney: This is a secondary power of attorney that can be granted by the principal attorney to another practitioner or firm.

According to MPEP 402.02(a):

“A principal attorney or agent may appoint an associate power of attorney to act in a representative capacity. See 37 CFR 1.32(b). An associate power of attorney is a power of attorney given to a second attorney or agent by an already appointed principal patent attorney or agent. The associate power of attorney is given by the principal attorney or agent to the associate attorney or agent, not by the applicant.”

It’s important to note that an associate power of attorney does not replace the principal power of attorney but rather supplements it, allowing for additional representation in the patent application process.

To learn more:

What is the difference between a correspondence address and a fee address in USPTO filings?

In USPTO filings, the correspondence address and fee address serve different purposes:

  • Correspondence Address: Where the USPTO sends all official communications regarding a patent application or patent.
  • Fee Address: Where the USPTO sends maintenance fee reminders for granted patents.

The MPEP clarifies:

The correspondence address is the address associated with the Customer Number to which correspondence is directed. The fee address is the address associated with the Customer Number to which maintenance fee reminders are directed. (MPEP 403)

While these addresses can be the same, they don’t have to be. Applicants or patent owners might choose different addresses, for example, if a law firm handles prosecution but the company itself manages maintenance fees. Using a customer number allows for easy management of both addresses.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on Customer Number, visit: Customer Number.

For more information on Fee Address, visit: Fee Address.

For assignee applicants, there is a specific deadline for recording documentary evidence of ownership. According to 37 CFR 1.46(b)(1):

If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

This means that assignees or obligated assignees should ensure that their documentary evidence of ownership is recorded with the USPTO, as specified in 37 CFR Part 3, by the time they pay the issue fee for the patent application. Failing to record this evidence by the deadline could potentially cause complications in establishing ownership of the patent.

To learn more:

The Customer Number practice allows applicants to:

  • Designate the correspondence address of a patent application or patent
  • Designate the fee address of a patent
  • Submit a list of practitioners who have power of attorney

Using a Customer Number allows applicants to easily change the correspondence address, fee address, or list of practitioners for multiple applications or patents by simply changing the information associated with the Customer Number.

According to MPEP 403: “A Customer Number (previously a ‘Payor Number’) may be used to: (A) designate the correspondence address of a patent application or patent such that the correspondence address for the patent application or patent would be the address associated with the Customer Number (37 CFR 1.32(a)(5)(i)); (B) designate the fee address (37 CFR 1.363) of a patent such that the fee address for the patent would be the address associated with the Customer Number (37 CFR 1.32(a)(5)(ii)); and (C) submit a list of practitioners such that those practitioners associated with the Customer Number would have power of attorney (37 CFR 1.32(a)(5)(iii)).”

What is the Customer Number Practice for power of attorney in patent applications?

The Customer Number Practice is a system used by the USPTO to simplify the process of changing the correspondence address or power of attorney for multiple patent applications. Here’s how it works:

  • Practitioners are associated with a Customer Number
  • The Customer Number can be used to grant power of attorney in applications
  • Changes to the Customer Number automatically update all associated applications

According to the MPEP:

The Customer Number Practice permits applicants, attorneys, and agents of record to expressly request that the USPTO use a Customer Number to associate a power of attorney with a particular application. (MPEP 402.02(a))

This practice streamlines the process of managing power of attorney and correspondence addresses for multiple applications, making it more efficient for both applicants and the USPTO.

To learn more:

What is the Customer Number practice at the USPTO for patent applications?

The Customer Number practice at the USPTO is a system that simplifies the process of managing correspondence addresses for patent applicants and practitioners. Key aspects of this practice include:

  • A Customer Number is a unique identifier assigned by the USPTO to a specific address.
  • It allows for easy updating of correspondence information for multiple applications.
  • Customer Numbers can be associated with Power of Attorney forms.

According to MPEP 403.01(a): ‘The Customer Number practice permits a patent applicant, assignee or practitioner of record to change the correspondence address for a number of applications or patents with one change of address filed in one location.’

To use the Customer Number practice:

  1. Request a Customer Number from the USPTO using the Customer Number Request form (PTO/SB/125A).
  2. Associate the Customer Number with your applications using the appropriate forms or through the USPTO’s electronic filing system.
  3. Update your correspondence address by modifying the Customer Number information, which will automatically update all associated applications.

This practice significantly streamlines the process of managing correspondence for multiple patent applications, making it easier for applicants and practitioners to maintain up-to-date contact information with the USPTO.

To learn more:

The correspondence address in a patent application is the address where the United States Patent and Trademark Office (USPTO) will send all official communications regarding the application. According to 37 CFR 1.33(a):

“When filing an application, a correspondence address must be set forth in either an application data sheet (§ 1.76), or elsewhere, in a clearly identifiable manner, in any paper submitted with an application filing.”

This address is crucial for ensuring that applicants receive all necessary information and notifications about their patent application.

To learn more:

Unpublished patent applications are subject to confidentiality requirements under 35 U.S.C. 122(a). MPEP 405 addresses this in the context of interviews:

However, an interview concerning an application that has not been published under 35 U.S.C. 122(b) with an attorney or agent not of record who obtains authorization through use of the interview request form will be conducted based on the information and files supplied by the attorney or agent in view of the confidentiality requirements of 35 U.S.C. 122(a).

This means that for unpublished applications, the USPTO will only discuss information provided by the authorized attorney or agent to maintain confidentiality.

The ‘reasonable inquiry’ requirement, as described in 37 CFR 11.18(b)(2), mandates that submissions to the USPTO be made ‘to the best of the party’s knowledge, information and belief, formed after an inquiry reasonable under the circumstances.’ This standard is similar to Rule 11 of the Federal Rules of Civil Procedure.

The MPEP clarifies: An ‘inquiry reasonable under the circumstances’ requirement of 37 CFR 10.18(b)(2) is identical to that in Fed. R. Civ. P. 11(b). The federal courts have stated in regard to the ‘reasonable inquiry’ requirement of Fed. R. Civ. P. 11: In requiring reasonable inquiry before the filing of any pleading in a civil case in federal district court, Rule 11 demands ‘an objective determination of whether a sanctioned party’s conduct was reasonable under the circumstances.’

For more information on patent application requirements, visit: patent application requirements.

A person who shows sufficient proprietary interest in the matter can file a patent application, but must submit a petition as outlined in 37 CFR 1.46(b)(2). The petition must include:

  1. The fee set forth in § 1.17(g)
  2. A showing that the person has sufficient proprietary interest in the matter
  3. A statement that making the application for patent by this person on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

The MPEP further explains that a proprietary interest can be demonstrated by an appropriate legal memorandum to the effect that a court of competent jurisdiction (federal, state, or foreign) would by the weight of authority in that jurisdiction award title of the invention to the 37 CFR 1.46 applicant. This should be supported by an affidavit or declaration and prepared by an attorney familiar with the relevant jurisdiction’s law.

To learn more:

Limited recognition in patent matters is a provision that allows certain individuals who are not registered patent practitioners to prosecute specific patent applications before the United States Patent and Trademark Office (USPTO). According to 37 CFR 11.9(a):

Any individual not registered under § 11.6 may, upon a showing of circumstances that render it necessary or justifiable and that the individual is of good moral character and reputation, be given limited recognition by the OED Director to prosecute as attorney or agent a specified patent application or specified patent applications.

This means that under certain circumstances, individuals who are not registered patent attorneys or agents may be granted permission to work on specific patent applications.

To learn more:

To learn more:

Irreparable damage, in the context of patent applications, refers to a situation where a filing date is crucial to preserve the rights of an applicant or to prevent severe harm. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This means that an applicant can demonstrate irreparable damage by providing a statement explaining why obtaining a specific filing date is essential to protect their rights or avoid significant harm.

To learn more:

To learn more:

Tags: pre-AIA

Form PTO/AIA/82 is a USPTO form used by the applicant for patent to appoint one or more patent practitioners as power of attorney. This form consists of three parts:

  • Part A (PTO/AIA/82A): A transmittal page used to identify the application to which the power of attorney is directed. It must be signed by a proper 37 CFR 1.33(b) party.
  • Part B (PTO/AIA/82B): The actual power of attorney, which may also specify the correspondence address. This part must be signed by the applicant.
  • Part C (PTO/AIA/82C): An optional page that may be used to appoint up to 10 patent practitioners by name and registration number.

The MPEP notes that “PTO/AIA/82 may be used like a general power of attorney, if desired.” For example, an officer of a juristic entity assignee could sign Part B, leaving the “Application Number” and “Filing Date” boxes empty. Then, a patent practitioner could complete and sign one Part A for each respective application and file a copy of Part B with each Part A.

It’s important to note that the “Application Number” and “Filing Date” boxes on Part B must be completed to identify the application if Part A or an equivalent is not filed with Part B. These boxes may not be filled in by a patent practitioner after Part B has been signed by the applicant.

To learn more:

Form Paragraph 4.03 is used by USPTO examiners in Office actions to notify relevant parties about the death of a patent practitioner. The paragraph reads:

Notice of the death of the attorney or agent of record has come to the attention of this Office. Since the power of attorney is therefore terminated, this action is being mailed to the office of the patent practitioner and to the party who originally appointed the deceased patent practitioner. A new registered attorney or agent may be appointed.

This paragraph informs recipients that the power of attorney has been terminated and that a new attorney or agent can be appointed.

What is considered a ‘good and sufficient reason’ to revoke a power of attorney by less than all applicants?

The USPTO does not provide a specific definition of what constitutes a ‘good and sufficient reason’ to revoke a power of attorney by less than all applicants. According to MPEP 402.10:

A power of attorney may not be revoked by less than all of the applicants or owners of the entire interest without good and sufficient reason, and the revocation must be approved by the Director.

The determination of what qualifies as a ‘good and sufficient reason’ is made on a case-by-case basis by the Director of the USPTO. Some potential reasons could include:

  • Evidence of misconduct or negligence by the current attorney
  • Irreconcilable differences between the applicant(s) and the attorney
  • Inability of the attorney to continue representation due to health issues or other circumstances

Applicants seeking to revoke a power of attorney with less than all signatures should provide a detailed explanation of their reasons for the request.

To learn more:

Proof of unavailability for a non-signing inventor can include various forms of evidence. According to MPEP 409.03(d):

In the case of unavailability, proof of the inability to find or reach the non-signing inventor after diligent effort must be submitted.

This proof may include:

  • Returned correspondence
  • Copies of email or other communication attempts
  • Statements from people with knowledge of the inventor’s unavailability
  • Documentation of searches or inquiries made to locate the inventor

The key is to demonstrate a diligent effort to locate and communicate with the non-signing inventor.

To learn more:

What is considered ‘diligent effort’ when trying to contact an inventor for joint invention?

When attempting to contact a joint inventor for patent application purposes, ‘diligent effort’ typically involves:

  • Multiple attempts to reach the inventor through various communication methods (e.g., phone, email, postal mail)
  • Reasonable time intervals between attempts
  • Documenting all contact attempts and responses (or lack thereof)
  • Exploring alternative contact methods if initial attempts fail

The MPEP 409.03(d) states: ‘Where inability to find or reach a nonsigning inventor ‘after diligent effort’ is the reason for filing under pre-AIA 37 CFR 1.47(b), a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.’ This emphasizes the importance of thoroughly documenting all efforts made to contact the inventor.

To learn more:

An Application Data Sheet (ADS) is a document that provides bibliographic data for a patent application. For applications filed by assignees, obligated assignees, or those with sufficient proprietary interest, the ADS is crucial. According to MPEP 409.05:

‘The applicant under 37 CFR 1.46 (assignees and obligated assignees) must record the assignment, or submit the documentary evidence to the Office, preferably before issuing the filing receipt.’

The ADS must include:

  • The name of the inventor(s)
  • A statement that the application is being filed by the assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest
  • If filed by an obligated assignee, a statement that the application is being filed by a party who has a contractual obligation to assign or is under an obligation to assign the invention

The ADS serves as the official record of the applicant’s status and helps ensure that the USPTO properly recognizes the applicant’s right to file the application.

To learn more:

An ‘obligated assignee’ in patent applications refers to a person or entity who is under an obligation to assign the invention but has not yet executed an assignment. This concept is important in the context of MPEP 409.05, which states:

An assignee or obligated assignee who is the applicant may execute a substitute statement under 37 CFR 1.64 in lieu of an inventor’s oath or declaration.

This provision allows an obligated assignee to file a patent application and execute certain documents on behalf of the inventor, even if the formal assignment has not yet been completed.

To learn more:

To learn more:

A substitute statement is a document that can be used in place of an oath or declaration in patent applications involving deceased or legally incapacitated inventors. According to MPEP 409.01(a):

See 37 CFR 1.64 and MPEP § 604 concerning the execution of a substitute statement by a legal representative in lieu of an oath or declaration.

The substitute statement can be executed by:

  • A legal representative of the deceased or incapacitated inventor
  • An assignee or obligated assignee
  • A party with sufficient proprietary interest in the invention

This allows the application process to continue even when the inventor is unable to provide an oath or declaration due to death or incapacity. The substitute statement must comply with the requirements set forth in 37 CFR 1.64.

To learn more:

What is a substitute statement for a deceased inventor and when is it required?

A substitute statement is a document that replaces the inventor’s oath or declaration when the inventor is deceased, legally incapacitated, or otherwise unavailable. For a deceased inventor, it is required when filing a patent application on or after September 16, 2012.

According to MPEP 409.01(a):

The substitute statement must comply with the requirements of 35 U.S.C. 115(d) and 37 CFR 1.64.

The substitute statement must:

  • Identify the inventor to whom it applies
  • Identify the person executing the substitute statement
  • Include a statement that the person executing the substitute statement believes the named inventor to be the original inventor
  • State the circumstances permitting the person to execute the substitute statement (e.g., the inventor’s death)

This statement allows the patent application process to proceed in cases where the inventor cannot personally execute the required oath or declaration.

To learn more:

A substitute statement is a document that can be used in place of an inventor’s oath or declaration under certain circumstances. According to 37 CFR 1.64, an applicant may execute a substitute statement if the inventor:

  • Is deceased
  • Is under a legal incapacity
  • Has refused to execute the oath or declaration
  • Cannot be found or reached after diligent effort

The substitute statement must comply with specific requirements outlined in 37 CFR 1.64(b), including identifying the inventor, the person executing the statement, and the circumstances permitting its use. For more details on substitute statements, see MPEP § 604.

To learn more:

A substitute statement is a document that can be used in lieu of an inventor’s oath or declaration under certain circumstances. According to MPEP § 409.05, a substitute statement can be used when the inventor:

  • Is deceased
  • Is under a legal incapacity
  • Cannot be found or reached after diligent effort
  • Has refused to execute the oath or declaration

The substitute statement must comply with the requirements of 37 CFR 1.64, including identifying the inventor, the person executing the statement, and the circumstances permitting its use.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on substitute statement, visit: substitute statement.

A pre-AIA 37 CFR 1.47 application is a patent application filed before September 16, 2012, where not all inventors have signed the application. This provision allows for the filing of a patent application when an inventor cannot be reached or refuses to sign.

According to the MPEP, A filing date is assigned to an application deposited pursuant to pre-AIA 37 CFR 1.47 provided the requirements of 37 CFR 1.53(b) are met. This means that as long as the basic filing requirements are fulfilled, the application can be processed even without all inventors’ signatures.

To learn more:

To learn more:

A juristic entity, in the context of patent applications, typically refers to an organizational assignee such as a company or corporation. According to MPEP 401, juristic entities have special requirements:

“An applicant who is a juristic entity must be represented by a patent practitioner.”

This means that companies or other organizational entities cannot represent themselves in patent applications and must hire a registered patent attorney or agent to act on their behalf.

A Customer Number is a USPTO-assigned number that can be used to:

  • Designate the correspondence address for a patent application or patent
  • Designate the fee address for a patent
  • Submit a list of practitioners with power of attorney

According to MPEP 403: “A Customer Number may be used to designate the address associated with the Customer Number as the correspondence address of an application (or patent) or the fee address of a patent, and may also be used to submit a power of attorney in the application (or patent) to the registered practitioners associated with the Customer Number.”

Using a Customer Number simplifies making changes to correspondence addresses and practitioner information across multiple applications.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on Customer Number, visit: Customer Number.

For more information on Fee Address, visit: Fee Address.

For more information on power of attorney, visit: power of attorney.

A customer number is a unique identifier assigned by the USPTO to simplify patent correspondence. According to MPEP 403:

‘A customer number allows a patent applicant, patent owner, or assignee to designate a single correspondence address for all applications and patents associated with that customer number.’

Benefits of using a customer number include:

  • Easier management of correspondence addresses for multiple applications
  • Simplified process for changing the address or representative for all linked applications
  • Improved efficiency in USPTO communications

To obtain a customer number, you need to file a request with the USPTO using the appropriate form.

For more information on Customer Number, visit: Customer Number.

For more information on patent correspondence, visit: patent correspondence.

For more information on USPTO, visit: USPTO.

A ‘person to whom the inventor has assigned or is under an obligation to assign the invention’ refers to an individual or entity that has received rights to the invention through a legal agreement or contract. This concept is important in patent applications filed on or after September 16, 2012, as explained in MPEP 409.05:

Quote: ‘A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent.’

This provision allows assignees or those with a contractual right to the invention to file patent applications, even if they are not the original inventors.

To learn more:

The Applicant Initiated Interview Request form (PTOL-413A) should include specific information to facilitate the interview process. According to MPEP 408:

This form should identify the participants of the interview, the proposed date of the interview, whether the interview will be personal, telephonic, or video conference, and should include a brief description of the issues to be discussed.

Providing this information helps the examiner prepare adequately for the interview and ensures that all necessary parties are involved in the discussion of relevant issues.

When an application is executed by someone other than the inventor under pre-AIA 37 CFR 1.47(b), the declaration must include specific information about the non-signing inventor. According to the MPEP, the declaration must state:

  • The full name of the non-signing inventor
  • The residence of the non-signing inventor
  • The post office address of the non-signing inventor
  • The citizenship of the non-signing inventor

Additionally, “the title or position of the person signing must be stated if signing on behalf of a corporation under pre-AIA 37 CFR 1.47(b).” This ensures that the person signing has the authority to do so on behalf of the corporation.

To learn more:

Tags: pre-AIA

When a patent application is filed by someone other than the inventor under 37 CFR 1.46, the application must contain an application data sheet (ADS) with specific information. According to 37 CFR 1.46(b), the ADS must specify in the applicant information section:

  • The assignee
  • The person to whom the inventor is under an obligation to assign the invention
  • The person who otherwise shows sufficient proprietary interest in the matter

This information should be provided in the applicant information section of the ADS, as specified in 37 CFR 1.76(b)(7). Ensuring this information is correctly included in the ADS is crucial for establishing the proper applicant for the patent application.

To learn more:

What information must be included in an oath or declaration for an unavailable joint inventor?

When filing an oath or declaration for an unavailable joint inventor, specific information must be included. According to MPEP 409.03(a), the oath or declaration must contain:

  • The name of the unavailable inventor
  • A statement that the inventor is unavailable and the reason for unavailability
  • The last known address of the unavailable inventor

Additionally, the MPEP states:

‘If a nonsigning inventor refuses to sign the oath or declaration or cannot be reached, the oath or declaration under 37 CFR 1.63 by the remaining joint inventor(s) must state that the nonsigning inventor is either refused to sign or could not be reached after diligent effort to contact him or her.’

It’s crucial to provide as much detail as possible about the efforts made to contact the unavailable inventor and any responses received. This information helps the USPTO understand the situation and process the application appropriately.

To learn more:

Tags: declaration, oath

What information must be included in a substitute statement for a deceased or incapacitated inventor?

When filing a substitute statement for a deceased or legally incapacitated inventor, specific information must be included to ensure its validity. According to MPEP 409.01(a) and 37 CFR 1.64, a substitute statement must contain:

  • Identification of the inventor to whom the substitute statement applies
  • The circumstances permitting the use of a substitute statement (e.g., death, legal incapacity)
  • A statement that the person signing:
    • Has reviewed and understands the contents of the application
    • Believes the named inventor to be the original inventor of the claimed invention
    • Acknowledges the duty to disclose information material to patentability
  • The relationship of the person signing to the inventor

Additionally, the substitute statement must:

  • Identify the person executing the substitute statement and the capacity in which they are signing
  • Be signed in accordance with 37 CFR 1.64(a)

Ensuring all required information is included in the substitute statement is crucial for the proper processing of the patent application in cases where the inventor is unavailable.

To learn more:

When filing papers in a representative capacity, a patent practitioner must provide specific information to identify themselves and establish their authority. According to MPEP 402.04:

  • Registration number
  • Name
  • Signature

The MPEP states: “In filing such a paper, the patent practitioner must set forth his or her registration number, his or her name and signature. Further proof of authority to act in a representative capacity may be required.”

This requirement applies even when the practitioner is not of record in the application. It helps facilitate replies on behalf of applicants and eliminates the need for filing powers of attorney in individual applications when there are changes in law firms or corporate patent staffs.

To learn more:

When a pre-AIA 37 CFR 1.47 application is found acceptable, certain information is published in the Official Gazette. According to the MPEP: A notice will be published in the Official Gazette identifying the application number, filing date, the title of the invention and the name(s) of the nonsigning inventor(s).

This publication serves several purposes:

  • It provides public notice of the application’s existence.
  • It identifies the nonsigning inventors, which may be important for legal or intellectual property reasons.
  • It establishes a clear record of the application’s status under pre-AIA 37 CFR 1.47.

This publication is an important step in the processing of these special applications and ensures transparency in the patent application process.

To learn more:

To learn more:

When filing a patent application with an unavailable joint inventor, you must include the last known address of the nonsigning inventor. As stated in MPEP 409.03(a):

“The last known address of the nonsigning joint inventor must be stated.”

For more details on providing this information, refer to MPEP 409.03(e). This requirement helps the USPTO in potential future communications and establishes that efforts were made to locate the inventor.

To learn more:

When one of multiple practitioners of record is suspended, the USPTO continues to communicate with the remaining unsuspended practitioners. MPEP § 407 provides guidance for this situation: “This form paragraph should be used when there is at least one registered practitioner still of record who has not been suspended or excluded from practice.” The Office action is mailed to the first named unsuspended registered practitioner at their address of record. Additionally, to ensure timely receipt, a copy is also sent to the first named applicant’s address of record.

For more information on USPTO communication, visit: USPTO communication.

When a power of attorney is accepted from less than all applicants or owners, it results in multiple parties prosecuting the application simultaneously. The MPEP states:

“The acceptance of such papers by petition under 37 CFR 1.36(a) or 1.183 will result in more than one attorney, agent, applicant, or owner prosecuting the application at the same time. Therefore, each of these parties must sign all subsequent replies submitted to the Office.”

This means:

  • All involved parties must sign subsequent documents.
  • The USPTO will indicate who must sign future replies.
  • Double correspondence is not permitted.
  • Correspondence will be mailed to the attorney or agent if one is involved.
  • If multiple attorneys are involved, correspondence goes to the first-named attorney unless all parties agree otherwise.

To learn more:

When an inventor is added to a pre-AIA patent application through a 37 CFR 1.48 request, it can affect the existing power of attorney. According to MPEP 402.05(b):

If the power of attorney was granted by the originally named inventive entity and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.

This means that if a new inventor is added and doesn’t provide a power of attorney consistent with the original one, the original power of attorney is lost. However, this doesn’t prevent a practitioner from acting under 37 CFR 1.34, which allows for acting in a representative capacity.

To learn more:

To learn more:

The death of an inventor (or one of the joint inventors) typically terminates the power of attorney given by the deceased inventor in an application filed before September 16, 2012, unless the power of attorney is coupled with an interest (e.g., the patent practitioner is an assignee or part-assignee). As stated in MPEP 409.01(b):

“Unless a power of attorney is coupled with an interest (i.e., a patent practitioner is assignee or part-assignee), the death of the inventor (or one of the joint inventors) terminates the power of attorney given by the deceased inventor in an application filed before September 16, 2012.”

In such cases, a new power of attorney from the heirs, administrators, executors, or assignees is necessary if the deceased inventor was the sole inventor or if all powers of attorney in the application have been terminated.

To learn more:

After acceptance of a Pre-AIA 37 CFR 1.47 application, the non-signing inventor retains certain rights and responsibilities:

  • They are considered a joint inventor and will be named on any patent that may issue.
  • They have the right to access the application file and receive notices from the USPTO.
  • They can still submit an executed oath or declaration, which would then be entered into the file.

As stated in MPEP 409.03(j): ‘The fact that an application was accepted and prosecuted pursuant to 37 CFR 1.47 does not alter the rights or obligations of any of the inventors with regard to the application or any patent issuing thereon.’

To learn more:

To learn more:

What happens to pending patent applications when a practitioner is suspended or excluded?

When a patent practitioner is suspended or excluded, the Office of Enrollment and Discipline (OED) Director must review all pending patent applications to determine if immediate action is necessary. According to MPEP 407:

“The OED Director will review all pending applications, in which the suspended or excluded practitioner is the attorney or agent of record, and notify the applicant of the suspension or exclusion and of the limited recognition of the practitioner.”

This process ensures that applicants are aware of their practitioner’s status and can take appropriate action to protect their patent applications.

For more information on pending applications, visit: pending applications.

When a patent practitioner dies, the MPEP 406 outlines the following procedure:

  • The Office will notify the applicant of the death of the practitioner.
  • The applicant must appoint a new registered patent practitioner or file a change of correspondence address.
  • This must be done within the time period set in the notice, which is usually 3 months.
  • If no action is taken, the application may be deemed abandoned.

As stated in the MPEP: “If notification of the death of the practitioner is received by the Office, the Office will notify the applicant of the death and the need to appoint a new registered patent practitioner or file a change of correspondence address.”

For more information on patent practitioner death, visit: patent practitioner death.

For more information on pending applications, visit: pending applications.

For more information on USPTO notification, visit: USPTO notification.

In a pre-AIA 37 CFR 1.47 application, nonsigning inventors are notified of the application filing. The MPEP states: The U.S. Patent and Trademark Office will notify the nonsigning inventor(s) or, if the inventor is deceased, the legal representative(s), of the filing of an application under pre-AIA 37 CFR 1.47 by sending a letter to the last known address of the nonsigning inventor(s) or legal representative(s).

This notification process ensures that all inventors, even those who didn’t sign the application, are aware of the patent application filed using their invention. It’s important to note that this notification is a courtesy and doesn’t require a response from the nonsigning inventor for the application to proceed.

To learn more:

To learn more:

When a new power of attorney is filed, it generally revokes all prior powers of attorney. MPEP 402.05(a) provides several scenarios:

  • If a new power of attorney is filed without explicitly revoking prior ones, it will be treated as a revocation of the original power of attorney.
  • If an assignee files a new power of attorney, it revokes and replaces the original power of attorney filed by the applicant.
  • If a power of attorney is given to practitioners associated with a Customer Number, and a second power of attorney is later received for a different Customer Number, the second one will replace the first.

The MPEP states:

In all of these situations, the most recently filed power of attorney will control.

This means that the latest power of attorney filed will take precedence over any previously filed ones.

To learn more:

The death of a named principal or assignee can have significant implications for an existing power of attorney in a patent application. According to MPEP 402.05:

The death of the principal may terminate the power of attorney given by him or her depending on the circumstances.

This means that the power of attorney may automatically terminate upon the death of the principal. However, the specific circumstances of each case must be considered. In cases where there are multiple applicants or assignees, the power of attorney may remain in effect for the surviving parties. It’s crucial to notify the USPTO of any changes in the status of the applicant or assignee to ensure proper representation in the patent application process. If necessary, a new power of attorney should be filed by the appropriate party, such as the executor of the deceased’s estate or the remaining applicants.

To learn more:

For applications filed on or after September 16, 2012, 37 CFR 1.32(d) provides that a power of attorney from a prior national application may have effect in a continuing application if:

  1. A copy of the power of attorney from the prior application is filed in the continuing application
  2. The power of attorney was not granted by the inventor
  3. The continuing application does not name an inventor who was not named in the prior application

MPEP 402.02(a) states: “37 CFR 1.32(d) specifically requires that a copy of the power of attorney from the prior application be filed in the continuing application to have effect (even where a change in power did not occur in the prior application).”

If these conditions are not met, a new power of attorney will need to be filed in the continuing application.

A power of attorney given to a suspended or disbarred patent practitioner becomes ineffective. The MPEP states: ‘Any power of attorney given to a practitioner who has been suspended or disbarred by the Office is ineffective, and does not authorize the person to practice before the Office or to represent applicants or patentees in patent matters.’ (MPEP § 407)

During an interference or derivation proceeding, any changes to the power of attorney must be forwarded to a specific board for review. As stated in MPEP 402.05: While an application is involved in an interference or derivation proceeding, any power of attorney or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration. This ensures that the appropriate authority handles changes in representation during these specialized proceedings.

To learn more:

When a patent practitioner dies, their power of attorney is automatically revoked or terminated. According to the MPEP, The power of attorney of a patent practitioner will be revoked or terminated by his or her death. (MPEP 406)

When a patent application has multiple inventors and one of them dies, the process for continuing the application depends on whether there’s a power of attorney in place. According to MPEP 409.01(a):

When an application is being prosecuted by joint inventor-applicants without a joint inventor-applicant or patent practitioner having been granted a power of attorney, and a joint inventor-applicant dies after filing the application, the living joint inventor(s) who are the applicant must submit proof that the other joint inventor-applicant is dead.

Here’s what happens in this scenario:

  • The surviving inventors must provide proof of the deceased inventor’s death to the USPTO.
  • If no legal representative of the deceased inventor intervenes, only the signatures of the living inventors are required on USPTO documents.
  • If a legal representative of the deceased inventor intervenes, they must submit a substitute statement complying with 37 CFR 1.64.
  • Once a legal representative intervenes, signatures from both the living inventors and the legal representative are required on USPTO documents.
  • This requirement continues until the legal representative and living inventors appoint a new representative.

It’s crucial for the surviving inventors to understand these requirements to ensure the application process continues smoothly.

To learn more:

When an inventor dies before filing a patent application, the legal representative (executor, administrator, etc.) of the deceased inventor can make the necessary oath or declaration and apply for the patent. This is specified in 37 CFR 1.42 (pre-AIA), which states:

“In case of the death of the inventor, the legal representative (executor, administrator, etc.) of the deceased inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative must comply with the same requirements and conditions that would have been applicable to the inventor.

To learn more:

If an inventor dies after filing a patent application but before the patent is granted, the process can still continue. According to 37 CFR 1.42 (pre-AIA):

“Where the inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.”

However, MPEP 409.01(b) clarifies that the intervention of the executor or administrator is not compulsory:

“When an inventor dies after filing an application and executing the oath or declaration required by pre-AIA 37 CFR 1.63, the executor or administrator should intervene, but the allowance of the application will not be withheld nor the application withdrawn from issue if the executor or administrator does not intervene.”

This means that while it’s advisable for the legal representative to intervene, the patent application can still proceed to allowance or issuance even without such intervention.

To learn more:

When revoking a power of attorney in a situation where there is no practitioner of record, special considerations apply. The MPEP 402.05 states:

‘If a power of attorney is revoked, and a new power of attorney is not promptly filed, then pursuant to 37 CFR 1.33(a) the correspondence address will be changed to that of the inventor(s) or assignee(s) who last provided a correspondence address.’

This means:

  • The USPTO will change the correspondence address to that of the inventor(s) or assignee(s).
  • The last provided correspondence address by the inventor(s) or assignee(s) will be used.
  • All future communications from the USPTO will be sent to this address.
  • It’s crucial to provide a new power of attorney or update the correspondence address promptly to ensure receipt of important communications.

To learn more:

When there are multiple applicants for a patent and only some give power of attorney, the USPTO has specific rules to handle the situation. According to MPEP 402:

‘Where a power of attorney is given by fewer than all of the applicants or owners, the power of attorney is not accepted until a petition under 37 CFR 1.36(b) is granted.’

This means:

  • The power of attorney is not automatically accepted if not all applicants have signed it.
  • A petition under 37 CFR 1.36(b) must be filed and granted for the partial power of attorney to be accepted.
  • The petition should explain why it was not possible to obtain signatures from all applicants.
  • The Office of Petitions will review the petition and make a determination.

It’s generally recommended to obtain signatures from all applicants to avoid delays and potential issues with the patent application process.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

When the legal representative of a deceased inventor is unavailable, the process depends on whether the application was filed before or after September 16, 2012:

  • For applications filed before September 16, 2012: If the legal representative cannot be found or reached after diligent effort, or refuses to make application, pre-AIA 37 CFR 1.47 applies. In such cases, the last known address of the legal representative must be provided.
  • For applications filed on or after September 16, 2012: The provisions of pre-AIA 37 CFR 1.47 do not apply. Instead, refer to current USPTO regulations and procedures.

It’s important to note that pre-AIA 37 CFR 1.47 is not an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 for deceased inventors. As stated in the MPEP, Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

To learn more:

If the last-known address of an unavailable inventor is invalid, the petitioner must make a diligent effort to find a valid address. According to MPEP 409.03(b):

‘If the last known address of the nonsigning inventor(s) is invalid, petitioner must state what efforts were made to find a current address.’

This means the petitioner should document their attempts to locate the inventor, which may include searching public records, contacting former employers, or using people-finding services. If all efforts fail, this should be clearly stated in the petition.

To learn more:

What happens if not all joint inventors sign a power of attorney in a patent application?

If not all joint inventors sign a power of attorney in a patent application, the power of attorney is not effective. According to MPEP 402.10:

A power of attorney must be signed by all of the applicants, or all of the assignees of the entire interest, or all parties entitled to prosecute the application, unless otherwise specified.

This means that for the power of attorney to be valid, it must be signed by all parties with the right to prosecute the application. If some inventors haven’t signed, the USPTO will treat the application as if no power of attorney has been appointed.

To learn more:

What happens if not all inventors sign the power of attorney in a pre-September 16, 2012 application?

For applications filed before September 16, 2012, it’s crucial that all inventors who have not assigned their rights sign the power of attorney. According to MPEP 402.02(b):

If no power of attorney is on file, then a party who is not an inventor, but who has given a proper showing of ownership or of authority to take action for and on behalf of all of the applicant may appoint an attorney or agent to prosecute the application, subject to the same exception noted above.

If not all inventors sign, the power of attorney may be considered incomplete or invalid. In such cases, the USPTO may require a new power of attorney signed by all parties with the right to prosecute the application, or may accept communications only from the inventors themselves until the issue is resolved.

To learn more:

What happens if an unavailable joint inventor refuses to sign an oath or declaration?

If an unavailable joint inventor refuses to sign an oath or declaration, the applicant may file a petition under 37 CFR 1.183 to waive the requirement for that inventor’s signature. According to MPEP 409.03(a):

‘If a nonsigning inventor refuses to sign the oath or declaration or cannot be reached, the oath or declaration under 37 CFR 1.63 by the remaining joint inventor(s) must state that the nonsigning inventor is either refused to sign or could not be reached after diligent effort to contact him or her.’

The petition should include evidence of the attempts made to contact the unavailable inventor and any responses received. The Office will then determine whether to grant the petition based on the circumstances presented.

To learn more:

Tags: declaration, oath

What happens if an inventor dies or becomes legally incapacitated after an application is filed?

If an inventor dies or becomes legally incapacitated after an application is filed, the legal representative of the deceased or incapacitated inventor may make an oath or declaration in compliance with 37 CFR 1.64. The MPEP 409.01(a) states:

“If an inventor dies after an application naming the inventor is filed, the personal representative of the inventor’s estate may make an oath or declaration in compliance with 37 CFR 1.64.”

This process ensures that the application can continue to be prosecuted even if the inventor is no longer able to participate. The legal representative must provide evidence of their authority to act on behalf of the deceased or incapacitated inventor.

To learn more:

What happens if an inventor becomes legally incapacitated during the patent application process?

If an inventor becomes legally incapacitated during the patent application process, the application can still proceed. According to MPEP 409, ‘If an inventor is legally incapacitated, the legal representative of the inventor may make an application for patent on behalf of the inventor.’ This means that a court-appointed guardian or conservator can act on behalf of the incapacitated inventor to continue the patent application process.

The legal representative must provide evidence of their authority to act for the inventor, such as a court order appointing them as guardian. They can then sign necessary documents and make decisions regarding the patent application on behalf of the incapacitated inventor.

For more information on legal representative, visit: legal representative.

If an inventor becomes available after a 37 CFR 1.47(a) petition is granted, they should be given the opportunity to join the application. The MPEP 409.03(b) provides guidance:

‘If a nonsigning inventor subsequently joins in the application, the applicant may file a petition under 37 CFR 1.182 to withdraw the 37 CFR 1.47 petition.’

This process involves:

  • The newly available inventor signing the necessary oath or declaration.
  • Filing a petition under 37 CFR 1.182 to withdraw the previous 1.47 petition.
  • Paying any required fees for the new petition.
  • Updating the application to reflect the inventor’s participation.

It’s important to address this situation promptly to ensure the application accurately reflects all participating inventors.

To learn more:

To learn more:

What happens if an attorney or agent withdraws without notifying the USPTO?

If an attorney or agent withdraws from representation without notifying the USPTO, it can lead to several issues:

  • The USPTO will continue to recognize the attorney or agent as the representative of record.
  • Official correspondence will still be sent to the attorney or agent, potentially causing delays or missed deadlines.
  • The applicant may not receive important communications about their application.

According to MPEP 402.06: “A registered attorney or agent who has been given a power of attorney and who withdraws from the application without relinquishing the power of attorney to the USPTO is still considered to be the attorney or agent of record.” To properly withdraw, the attorney or agent should follow the procedures outlined in 37 CFR 1.36 and notify the USPTO in writing.

To learn more:

What happens if an attorney or agent withdraws from representation in a patent application?

When an attorney or agent withdraws from representation in a patent application, the following occurs:

  • The USPTO will correspond directly with the applicant until a new Power of Attorney or address change is filed.
  • The withdrawal is effective when approved by the Office, not when received.
  • The Office may require the applicant or assignee to revoke the previous Power of Attorney and appoint a new representative.

As stated in MPEP 402.06: ‘In the event the power of attorney is withdrawn, the Office will communicate directly with the applicant… until a new registered attorney or agent is appointed.’

To learn more:

To learn more:

If a previously non-signing inventor decides to join a pre-AIA 37 CFR 1.47 application, they can do so by filing the appropriate documentation. The MPEP states:

“In the event the previously nonsigning inventor decides to join in the application by filing an executed oath or declaration complying with pre-AIA 37 CFR 1.63, the oath or declaration will be placed in the application file.”

This means that if the inventor who initially did not sign the application later chooses to participate, they can submit a properly executed oath or declaration. This document will then be added to the official application file, effectively joining them to the application.

To learn more:

To learn more:

If a patent application is filed without a correspondence address:

  • The USPTO needs a correspondence address to notify the applicant of any missing parts or requirements.
  • If no address is provided, the Office may use the mailing address of the first named inventor as the correspondence address.
  • Without a correspondence address, the applicant is considered to have constructive notice of application requirements as of the filing date.
  • The applicant has 2 months from the filing date to complete the application before it is abandoned.

According to MPEP 403: “If a patent application as filed has been accorded a filing date but is not complete, the applicant is notified and given a period of time within which to file the missing parts to complete the application and pay the applicable surcharge. … If the applicant fails to provide the Office with a correspondence address, the Office will be unable to provide the applicant with notification to complete the application and to pay the surcharge as set forth in 37 CFR 1.16(f) for nonprovisional applications and 37 CFR 1.16(g) for provisional applications. In such a case, the applicant will be considered to have constructive notice as of the filing date that the application must be completed and the applicant will have 2 months from the filing date in which to do so before abandonment occurs.”

If a nonsigning inventor believes they are the sole inventor of an invention claimed in a pre-AIA 37 CFR 1.47 application where they are named as a joint inventor, they have a specific course of action available to them.

According to MPEP 409.03(i):

“If a nonsigning inventor feels that he or she is the sole inventor of an invention claimed in a pre-AIA 37 CFR 1.47 application naming him or her as a joint inventor, the nonsigning inventor may file his or her own application and request that his or her application be placed in interference with the pre-AIA 37 CFR 1.47 application.”

This means that the nonsigning inventor can:

  1. File their own separate patent application for the invention
  2. Request that their application be placed in interference with the pre-AIA 37 CFR 1.47 application

The MPEP further states: “If the claims in both the nonsigning inventor’s application and the pre-AIA 37 CFR 1.47 application are otherwise found allowable, an interference may be declared.”

An interference proceeding is a process used to determine which party has the right to a patent when two or more parties claim the same invention.

To learn more:

To learn more:

When a new power of attorney is filed that lists only one of two previously appointed patent practitioners, it has significant implications. According to MPEP 403.02:

“Note that if the later-filed power of attorney only lists the second practitioner, the later-filed power of attorney serves as a revocation of the earlier-filed power of attorney, even without an express revocation of the power of the first patent practitioner.”

This means that filing a new power of attorney listing only one practitioner effectively revokes the authority of the previously appointed practitioner, even if the revocation is not explicitly stated. This is an important consideration for applicants and practitioners when making changes to representation.

To learn more:

If a legal representative hasn’t been appointed for a deceased inventor in an application filed before September 16, 2012, the situation can be complex. According to MPEP 409.01(b):

If no legal representative has been appointed, the examiner will reject the application under 35 U.S.C. 102(f) on the basis that the applicant is not the inventor and/or on the basis that there is no right to apply in any person other than the inventor.

This means that without a legal representative, the application may face rejection. It’s crucial to appoint a legal representative as soon as possible to avoid this outcome.

To learn more:

What happens if a foreign patent agent’s limited recognition expires?

If a foreign patent agent’s limited recognition expires, they are no longer authorized to represent applicants before the USPTO. The MPEP states, A foreign patent agent granted limited recognition may continue to represent applicants for the remainder of any time period previously set by the USPTO for taking an action, which period is still outstanding at the expiration of the 5-year period of recognition. (MPEP 402.01) This means that if there are any ongoing actions with set deadlines, the agent can complete those, but they cannot take on new representations or continue general practice until they renew their limited recognition status.

To learn more:

Tags: USPTO

After an application filed under pre-AIA 37 CFR 1.47 is accepted by the USPTO, the examiner proceeds with the application as usual. As stated in the MPEP:

“After an application deposited pursuant to pre-AIA 37 CFR 1.47 is found acceptable by the Office, the examiner will act on the application in the usual manner.”

This means that the application will be examined and processed like any other patent application, despite its initial filing under special circumstances.

To learn more:

To learn more:

For patent applications filed before September 16, 2012, the USPTO recommends specific forms for powers of attorney. According to the MPEP:

Form PTO/SB/80 or PTO/SB/81 (available at www.uspto.gov/patent/patents-forms) should be used for powers of attorney in applications filed before September 16, 2012.

Additionally, for patents that issued from applications filed before September 16, 2012, Form PTO/SB/81A may be used. It’s important to note that the USPTO no longer recommends or provides combined declaration and power of attorney forms. Practitioners should use separate forms for declarations and powers of attorney.

To learn more:

There are two main forms that can be used to authorize a patent practitioner for an interview:

  1. Applicant Initiated Interview Request Form (PTOL-413A)
  2. Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity’

According to MPEP 405:

Registered practitioners, when acting in a representative capacity, can show authorization to conduct an interview by completing, signing and filing an Applicant Initiated Interview Request Form (PTOL-413A).

Additionally:

Alternatively, Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity,’ which is available from the USPTO website at www.uspto.gov/sites/default/files/web/forms/sb0084.pdf may be used to establish the authority to conduct an interview.

The USPTO provides several forms for Customer Number practice:

  • PTO/SB/125 – Request for Customer Number
  • PTO/SB/124 – Request for Customer Number Data Change
  • PTO/AIA/122 or PTO/SB/122 – Change of Correspondence Address, Application
  • PTO/AIA/123 or PTO/SB/123 – Change of Correspondence Address, Patent

According to MPEP 403: “The following forms are suggested for use with the Customer Number practice: (A) the ‘Request for Customer Number’ (PTO/SB/125) to request a Customer Number; (B) the ‘Request for Customer Number Data Change’ (PTO/SB/124) to request a change in the data (address or list of practitioners) associated with an existing Customer Number; (C) the ‘Change of Correspondence Address, Application’ (PTO/AIA/122 for applications filed on or after September 16, 2012, or PTO/SB/122 for applications filed before September 16, 2012) to change the correspondence address of an individual application to the address associated with a Customer Number; and (D) the ‘Change of Correspondence Address, Patent’ (PTO/AIA/123 for applications filed on or after September 16, 2012, or PTO//SB/123 for applications filed before September 16, 2012) to change the correspondence address of an individual patent to the address associated with a Customer Number.”

For pre-AIA applications (filed before September 16, 2012), the MPEP mentions a specific form that can be used by assignees to revoke a power of attorney and appoint a new one:

Form PTO/SB/80 may be used by an assignee of the entire interest of the applicant to revoke a power of attorney and appoint a new power of attorney.

The process involves:

  • The assignee signing the power of attorney (Form PTO/SB/80)
  • Either the assignee or the newly appointed practitioner signing a statement under pre-AIA 37 CFR 3.73(b)

Additionally, Form PTO/SB/96 or an equivalent can be used for the Statement Under pre-AIA 37 CFR 3.73(b). For details on who can sign this statement, refer to MPEP § 324, subsection V.

To learn more:

The USPTO provides several forms for appointing a power of attorney in patent applications filed on or after September 16, 2012. These forms are available on the USPTO website and include:

  • PTO/AIA/80: For use by assignees who are either the named applicant or are becoming the applicant.
  • PTO/AIA/81: For use by joint inventors who are the applicant to give one or more joint inventor-applicants power of attorney.
  • PTO/AIA/82: For use by the applicant for patent to appoint one or more patent practitioners.
  • PTO/AIA/81A: For use in appointing a power of attorney in a patent resulting from an application filed on or after September 16, 2012.

Each form has specific uses and requirements. For example, Form PTO/AIA/80 must be accompanied by a statement under 37 CFR 3.73(c) (Form PTO/AIA/96 or equivalent) and must be signed by the named assignee or a person authorized to act on behalf of the assignee.

To learn more:

When an applicant is initiating an interview request, they should submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) to the examiner. The MPEP provides the following guidance:

When applicant is initiating a request for an interview, an ‘Applicant Initiated Interview Request’ form (PTOL-413A) should be submitted to the examiner prior to the interview in order to permit the examiner to prepare in advance for the interview and to focus on the issues to be discussed.

This form helps streamline the interview process by providing the examiner with essential information about the proposed interview.

To support a petition under pre-AIA 37 CFR 1.47, the following evidence is typically required:

  • A statement of facts signed by someone with firsthand knowledge
  • Documentary evidence such as Internet searches, certified mail return receipts, cover letters of instructions, or telegrams
  • Details of steps taken to locate the nonsigning inventor

The MPEP emphasizes:

‘The statement of facts must be signed, where at all possible, by a person having firsthand knowledge of the facts recited therein. Statements based on hearsay will not normally be accepted.’

It’s crucial to provide facts rather than conclusions in the statement.

To learn more:

To learn more:

To show an inventor is unavailable or refuses to sign, the petitioner must provide substantial evidence. According to MPEP 409.03(b):

‘The fact that an inventor is unavailable or refuses to join in an application must be established by satisfactory proof… such as inability to find him or reach him after diligent effort.’

Evidence may include:

  • Copies of correspondence sent to the last known address with no response
  • Returned mail showing the inventor is no longer at the address
  • Affidavits from people with knowledge of the inventor’s unavailability
  • Documentation of attempts to contact the inventor through various means

For refusal to sign, direct evidence such as a written statement from the inventor expressing their refusal would be ideal. In the absence of such direct evidence, circumstantial evidence showing implied refusal may be considered.

To learn more:

What evidence is required to prove an inventor’s refusal to sign a patent application?

When an inventor refuses to sign a patent application, specific evidence is required to proceed without their signature. The MPEP 409.03(d) outlines the necessary proof:

‘Where refusal of the inventor to sign the application papers is the reason for filing under pre-AIA 37 CFR 1.47(b), the applicant should make reasonable efforts to contact the inventor and to secure the inventor’s signature.’

Evidence of refusal typically includes:

  • Documented attempts to contact the inventor (emails, letters, phone logs)
  • Any written responses from the inventor indicating refusal
  • Witness statements corroborating the inventor’s refusal
  • A detailed explanation of the circumstances surrounding the refusal

The USPTO requires a thorough statement of facts describing the situation and efforts made to obtain the inventor’s signature. It’s crucial to demonstrate that the inventor was fully informed about the patent application and explicitly refused to sign, rather than simply being unresponsive.

To learn more:

According to MPEP 409.03(f), various forms of evidence can be submitted as proof of proprietary interest. The section states:

‘Sufficient proprietary interest is shown by an assignment or assignment of the invention to a person who is under an obligation of assignment to the applicant… Other examples of documents which may be submitted to establish proprietary interest are:

  • (A) A legal memorandum which explains on the basis of the facts of the case that the person signing the 37 CFR 1.47 oath or declaration is a person who has sufficient proprietary interest in the matter;
  • (B) A copy of the contract of employment or of any other contract between the inventor and assignee;
  • (C) An affidavit or declaration of the specific facts which support the assignee’s claim of proprietary interest;
  • (D) Other evidence which establishes the person’s authority to sign the 37 CFR 1.47 oath or declaration on behalf of and as agent for the inventor.’

These examples provide a range of documents that can be used to demonstrate proprietary interest when an inventor is unwilling or unable to execute the required oath or declaration.

To learn more:

To learn more:

MPEP 404 is currently marked as ‘[Reserved]’, which means this section is not currently in use but is being held for potential future content or updates. The USPTO may use this section in future revisions of the Manual of Patent Examining Procedure to add new information or guidance related to the representation of applicants or owners in patent matters.

Acting in a representative capacity refers to a patent practitioner appearing in person or signing papers on behalf of a client before the United States Patent and Trademark Office (USPTO) in a patent case. According to 37 CFR 1.34, when a patent practitioner acts in this capacity, their personal appearance or signature constitutes a representation that they are authorized to represent the particular party on whose behalf they are acting.

The MPEP states: “When a patent practitioner acting in a representative capacity appears in person or signs a paper in practice before the United States Patent and Trademark Office in a patent case, his or her personal appearance or signature shall constitute a representation to the United States Patent and Trademark Office that under the provisions of this subchapter and the law, he or she is authorized to represent the particular party on whose behalf he or she acts.”

To learn more:

What documents can serve as proof of proprietary interest for joint inventors?

For joint inventors, proof of proprietary interest can be established through various documents. According to MPEP 409.03(f), acceptable forms of proof include:

  • An assignment for the entire right, title, and interest in the application from all inventors to one or more joint inventors
  • Written statements from all inventors that they have assigned their rights in the application to one or more joint inventors
  • Other evidence showing that one or more joint inventors are the only inventor(s) who have the right to prosecute the application

The MPEP states: ‘Where one of several joint inventors is deceased or cannot be reached, a statement by the prosecuting inventor as to the facts, including the names of the other joint inventors, may be accepted as sufficient proof of proprietary interest.’ This provision allows for flexibility in cases where obtaining documentation from all inventors is challenging.

To learn more:

According to MPEP 402.04, there are several important documents that a person acting in a representative capacity generally cannot sign. These include:

  • A power of attorney (37 CFR 1.32)
  • A document granting access to an application
  • A change of correspondence address
  • A terminal disclaimer (37 CFR 1.321(b)(1))
  • A request for express abandonment without filing a continuing application (37 CFR 1.138(b))

However, there are some exceptions for applications filed on or after September 16, 2012. In these cases, a person acting in a representative capacity may sign a document granting access to an application or a change of correspondence address if:

  1. A power of attorney has not been appointed under 37 CFR 1.32(b), and
  2. The patent practitioner was named in the application transmittal papers.

To learn more:

When a legal representative takes over a patent application for a deceased inventor, specific documents are required:

  • Proof of authority to act on behalf of the deceased inventor’s estate (e.g., Letters Testamentary, Letters of Administration)
  • A new oath or declaration by the legal representative
  • Any necessary assignments or other documents to establish ownership rights

According to MPEP 409.01: “The Office no longer requires proof of authority of the legal representative to prosecute the application. However, any necessary documentary evidence of the legal representative’s authority to act on behalf of the deceased inventor’s estate, such as Letters Testamentary, Letters of Administration, or a Certificate of Heirship, should be kept in the application file.”

It’s important to note that while the USPTO doesn’t require submission of proof of authority, it’s advisable to keep such documentation readily available in case it’s requested.

To learn more:

What documents are required for an assignee to revoke power of attorney in a patent application?

To revoke power of attorney in a patent application, an assignee must submit specific documents to the USPTO. According to MPEP 402.07, the required documents are:

  • Statement under 37 CFR 3.73(c): This establishes the assignee’s ownership.
  • Revocation of the existing power of attorney
  • New power of attorney from the assignee

The MPEP states:

“The assignee of the entire interest can revoke the power of attorney of the applicant and appoint its own patent practitioner. The assignee must become of record as provided in 37 CFR 3.71. After the assignee becomes of record, the assignee is permitted to revoke the power of attorney of the applicant under the provisions of 37 CFR 1.36(a).”

It’s crucial to ensure all documents are properly executed and filed with the USPTO to effectively change the power of attorney.

To learn more:

What documentation is required when filing a patent application for a deceased or legally incapacitated inventor?

When filing a patent application for a deceased or legally incapacitated inventor, specific documentation is required. According to MPEP 409.03(b), the following documentation is typically necessary:

  1. For deceased inventors:
    • Death certificate of the inventor
    • Letters Testamentary or Letters of Administration proving the legal representative’s authority
  2. For legally incapacitated inventors:
    • Court order declaring the inventor legally incapacitated
    • Guardianship or conservatorship papers demonstrating the legal representative’s authority
  3. For both cases:
    • Oath or declaration executed by the legal representative
    • Application Data Sheet (ADS) listing the inventor and indicating their status (deceased or legally incapacitated)
    • Power of Attorney from the legal representative, if applicable

The MPEP states: “Proof of the authority of the legal representative must be provided to the Office.” This ensures that the person acting on behalf of the inventor has the legal right to do so.

To learn more:

When filing a patent application as an assignee or obligated assignee, specific documentation is required to establish the right to apply for the patent. According to MPEP 409.05:

Quote: ‘The assignee or obligated assignee who files the application must comply with the oath or declaration requirements of 37 CFR 1.63, including meeting the citizenship requirement of 37 CFR 1.63(a)(3).’

The required documentation includes:

  • A properly executed oath or declaration from the inventors
  • An assignment document or proof of obligation to assign
  • Application Data Sheet (ADS) identifying the assignee as the applicant

Additionally, if filing as an obligated assignee, you may need to provide evidence of the obligation to assign, such as an employment agreement or contract. It’s important to ensure all documentation is complete and accurate to avoid potential issues with the patent application process.

To learn more:

What documentation is required when an inventor dies during the patent application process?

When an inventor dies during the patent application process, specific documentation is required to continue the application. According to MPEP 409, the following documents are typically needed:

  • A copy of the inventor’s death certificate
  • Legal documentation showing the authority of the legal representative (e.g., executor of the estate)
  • An oath or declaration by the legal representative

The MPEP states: ‘If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.’ This means that the executor or administrator of the deceased inventor’s estate can step in to complete the patent application process.

It’s important to note that the legal representative must provide evidence of their authority to act on behalf of the deceased inventor’s estate, such as letters testamentary or letters of administration issued by a probate court.

For more information on documentation, visit: documentation.

For more information on legal representative, visit: legal representative.

When an assignee or obligated assignee files a patent application as the applicant, they should provide documentary evidence of ownership. According to 37 CFR 1.46(b)(1):

If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

This means that the assignee or obligated assignee should record their ownership documents (such as an assignment or employment agreement) with the USPTO as specified in 37 CFR Part 3, and this should be done before paying the issue fee.

To learn more:

What documentation is required for a legal representative to file a patent application for a deceased inventor?

When filing a patent application for a deceased inventor, a legal representative must provide specific documentation to establish their authority. According to MPEP 409.01(a):

“If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent as provided in 37 CFR 1.43. In accordance with 37 CFR 1.43, the legal representative must provide proof of authority…”

The required documentation typically includes:

  • A copy of the deceased inventor’s death certificate
  • Proof of the legal representative’s authority (e.g., court appointment as executor or administrator of the estate)
  • A substitute statement in lieu of an inventor’s oath or declaration
  • An Application Data Sheet (ADS) identifying the legal representative

It’s important to note that the specific requirements may vary depending on the circumstances and jurisdiction. Consulting with a patent attorney is advisable to ensure all necessary documentation is properly prepared and submitted.

To learn more:

To demonstrate an agreement to assign in a pre-AIA 37 CFR 1.47(b) application, you should provide:

  • A copy of the written agreement to assign the invention
  • If the agreement is conditional, a statement of facts showing the conditions have been met

MPEP 409.03(f) states:

“When an inventor has agreed in writing to assign an invention described in an application deposited pursuant to pre-AIA 37 CFR 1.47(b), a copy of that agreement should be submitted. If an agreement to assign is dependent on certain specified conditions being met, it must be established by a statement of facts by someone with first hand knowledge of the circumstances in which those conditions have been met.”

A common example is an employment agreement. In such cases, you must provide evidence that the invention was made during the course of employment, typically through a statement from someone with firsthand knowledge of the circumstances.

To learn more:

To learn more:

Tags: pre-AIA

What documentation is needed to prove authority as a legal representative for a deceased or incapacitated inventor?

When filing a patent application on behalf of a deceased or legally incapacitated inventor, it’s crucial to provide documentation that proves your authority as a legal representative. The specific documentation required can vary based on the circumstances, but generally includes:

  • For a deceased inventor: Death certificate and letters testamentary or letters of administration
  • For an incapacitated inventor: Court order declaring incapacity and appointing a legal guardian or conservator
  • Power of attorney or other legal document granting authority to act on behalf of the inventor or their estate

The MPEP 409.01(a) states:

Office personnel will not question whether the person executing the substitute statement is authorized to act on behalf of the deceased inventor’s estate or legal entity unless there is evidence to the contrary.

While the USPTO generally accepts the substitute statement without questioning the authority, it’s important to have proper documentation available in case it’s requested or if legal issues arise later. Always consult with a patent attorney to ensure you have the correct documentation for your specific situation.

To learn more:

What documentation is needed for a legal representative to act on behalf of a deceased or incapacitated inventor?

To act on behalf of a deceased or incapacitated inventor, a legal representative must provide appropriate documentation to the USPTO. The MPEP 409.01(a) states:

“Office personnel will not question whether the person signing the oath or declaration is in fact a person authorized to make the statement, and will not require proof of the authority of the person making the statement.”

However, it’s important to note that while the USPTO does not require proof upfront, the legal representative should still have proper documentation, such as:

  • For a deceased inventor: Letters testamentary, letters of administration, or other court documents establishing authority over the estate.
  • For an incapacitated inventor: Court order appointing a guardian or conservator.

These documents may be required if the authority is later questioned or in other legal proceedings related to the patent application.

To learn more:

A valid reason for filing under pre-AIA 37 CFR 1.47 requires a diligent effort to locate or reach a nonsigning inventor. The MPEP states:

‘Where inability to find or reach a nonsigning inventor “after diligent effort” is the reason for filing under pre-AIA 37 CFR 1.47, a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.’

It’s important to note that temporary unavailability, such as being on vacation or out of town, is not considered an acceptable reason. Additionally, hospitalization or unconsciousness are not valid reasons under this rule, but may be addressed under pre-AIA 37 CFR 1.43.

To learn more:

To learn more:

The MPEP 409.03(g) section on proof of irreparable damage is not applicable to patent applications filed on or after September 16, 2012. This change is due to the implementation of the America Invents Act (AIA), which brought significant reforms to the U.S. patent system. Key changes include:

  • Transition from a ‘first-to-invent’ to a ‘first-inventor-to-file’ system
  • New procedures for challenging patents at the USPTO
  • Expanded definition of prior art
  • Changes to inventor oath and declaration requirements

For applications filed on or after September 16, 2012, different rules and procedures apply regarding the representation of applicants and the handling of situations that might have previously fallen under the irreparable damage provisions.

To learn more:

Pro se applicants make important certifications when filing patent applications. According to MPEP 401:

“In presenting (whether by signing, filing, submitting, or later advocating) papers to the Office, a pro se applicant is making the certifications under 37 CFR 11.18(b), and may be subject to sanctions under 37 CFR 11.18(c) for violations of 37 CFR 11.18(b)(2).”

These certifications include statements about the truthfulness of the application, that it is not being presented for improper purposes, and that claims are warranted by existing law or a good faith argument for changing the law.

When submitting papers to the USPTO, two key certifications are made under 37 CFR 11.18(b):

  1. Statements made are subject to the declaration clause of 37 CFR 1.68
  2. The certification required for papers filed in federal court under Rule 11(b) of the Federal Rules of Civil Procedure

Specifically, 37 CFR 11.18(b) states that by presenting any paper to the USPTO, the party certifies that:

‘All statements made therein of the party’s own knowledge are true, all statements made therein on information and belief are believed to be true, and all statements made therein are made with the knowledge that whoever, in any matter within the jurisdiction of the Office, knowingly and willfully falsifies, conceals, or covers up by any trick, scheme, or device a material fact, or knowingly and willfully makes any false, fictitious, or fraudulent statements or representations, or knowingly and willfully makes or uses any false writing or document knowing the same to contain any false, fictitious, or fraudulent statement or entry, shall be subject to the penalties set forth under 18 U.S.C. 1001 and any other applicable criminal statute’

This applies to both practitioners and non-practitioners submitting papers to the USPTO.

When presenting any paper to the USPTO, the party (whether a practitioner or non-practitioner) is making important certifications as outlined in 37 CFR 11.18(b):

  1. All statements made of the party’s own knowledge are true.
  2. Statements made on information and belief are believed to be true.
  3. The paper is not being presented for any improper purpose (e.g., harassment, delay).
  4. Legal contentions are warranted by existing law or non-frivolous arguments for changes in the law.
  5. Factual contentions have or are likely to have evidentiary support.
  6. Denials of factual contentions are warranted or based on lack of information or belief.

The MPEP notes: “37 CFR 11.18(b) provides that, by presenting any paper to the Office, the party presenting such paper (whether a practitioner or non-practitioner) is: (1) certifying that the statements made therein are subject to the declaration clause of 37 CFR 1.68; and (2) making the certifications required for papers filed in a federal court under Rule 11(b) of the Federal Rules of Civil Procedure.”

To learn more:

If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, 37 CFR 1.45(a) provides a solution. It states:

“If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the other joint inventor or inventors may make the application for patent on behalf of themselves and the omitted inventor.”

In such cases, the other joint inventor(s) can proceed with the application and execute a substitute statement in lieu of an oath or declaration from the unavailable inventor, as outlined in 37 CFR 1.64. For more information on substitute statements, refer to MPEP § 604.

To learn more:

The timing of filing a request to withdraw as a patent practitioner is crucial. According to the MPEP:

  • The USPTO will review and decide on withdrawal requests filed before the expiration of a time period for reply or before the expiration of a time period that can be extended under 37 CFR 1.136(a).
  • Requests filed after these deadlines will be placed in the application file but will not be treated on their merits.
  • Revocations of power of attorney filed after these deadlines will also simply be placed in the application file, with the exception of those accompanied by a petition to revive.

It’s important to note that the USPTO may render a decision on a timely filed request even after the stated period for reply, after the application is abandoned, or after proceedings have terminated.

For reexamination proceedings, practitioners should refer to MPEP § 2223 for specific guidance on withdrawal.

To learn more:

Canadian patent agents must meet specific requirements to practice before the USPTO under limited recognition:

  • They must be registered and in good standing as a patent agent under Canadian law.
  • They must apply for limited recognition to the USPTO Director.
  • They can only represent Canadian citizens or residents before the USPTO.
  • Their representation is limited to the presentation and prosecution of patent applications of Canadian applicants.

As stated in MPEP 402.01: Canadian patent agents are not required to pass the regular patent bar examination to represent Canadian applicants. They need not seek formal recognition to practice before the Office.

To learn more:

When multiple parties are prosecuting a patent application, there are specific signature requirements for replies to the USPTO. The MPEP provides clear guidance:

“Each of these parties must sign all subsequent replies submitted to the Office.”

The MPEP also provides examples to illustrate these requirements:

  • “If coinventor A has given a power of attorney to a patent practitioner and coinventor B has not, replies must be signed by the patent practitioner of A and by coinventor B.”
  • “If coinventors A and B have each appointed their own patent practitioner, replies must be signed by both patent practitioners.”

These examples demonstrate that all parties involved in prosecuting the application must sign subsequent replies, whether they are inventors, attorneys, or agents. This ensures that all parties are aware of and agree to the content of communications with the USPTO.

To learn more:

Tags: USPTO

According to 37 CFR 11.18(a), all documents filed in the USPTO for patent matters must bear a signature, with some exceptions:

  • Documents that are required to be signed by the applicant or party do not need a practitioner’s signature.
  • For all other documents, each piece of correspondence filed by a practitioner must be personally signed or have their signature inserted in compliance with 37 CFR 1.4(d).

The MPEP states: “37 CFR 11.18(a) emphasizes that every paper filed by a practitioner must be personally signed by the practitioner, except those required to be signed by the applicant or party.”

To learn more:

For papers filed by a juristic entity (e.g., corporation) in a patent application:

  • A person authorized to act on behalf of the juristic entity must sign.
  • The signer’s name and title must be included.
  • The papers must state the signer’s capacity to sign for the juristic entity.

The MPEP states: Papers filed on behalf of juristic entities must be signed by a patent practitioner. 37 CFR 1.33(b)(3). (MPEP 402.03)

For example, a proper signature might look like: ‘John Smith, President, Corporation XYZ, authorized to sign on behalf of Corporation XYZ’.

To learn more:

For documents submitted through EFS-Web, the USPTO accepts electronic signatures. According to MPEP 402.03:

Any paper filed in the Office in a patent application, patent file, or other proceeding which is not signed as required by 37 CFR 1.4(d) or (e) will be considered unsigned, and will be treated in accordance with 37 CFR 1.4(d)(1).

The USPTO specifically recognizes S-signatures for EFS-Web submissions. An S-signature is a signature inserted between forward slash marks, like so: /John Smith/. It’s important to note that the signer must manually type their name or use a facsimile or handwritten signature inserted between the slashes.

To learn more:

Tags: EFS-Web, USPTO

S-signatures, or electronic signatures, must meet specific requirements for patent applications:

  • Inserted between forward slash marks (//).
  • Include the signer’s name.
  • Be reasonably specific to identify the signer.
  • Be handwritten or a facsimile of a handwritten signature.

According to MPEP 402.03: ‘The signature must consist only of letters, or Arabic numerals, or both. The S-signature must be signed in permanent dark ink or its equivalent.’

To learn more:

When conducting interviews with patent practitioners in foreign countries, examiners must follow specific guidelines:

  • Interviews must be conducted via video conference or telephone.
  • In-person interviews in foreign countries are not permitted.
  • The same interview policies and procedures apply as for domestic interviews.

As stated in the MPEP 408: ‘For patent practitioners in foreign countries, interviews must be scheduled to be conducted by video conference or telephone. Examiners may not hold in-person interviews with patent practitioners in foreign countries.’

For applications filed before September 16, 2012, the process for an assignee to revoke a power of attorney is different. According to the MPEP:

In applications filed before September 16, 2012, the assignee of record of the entire interest can revoke the power of attorney of the applicant unless an ‘irrevocable’ right to prosecute the application had been given as in some government owned applications.

The assignee must establish their right to take action as provided in pre-AIA 37 CFR 3.73(b). Once this is done, a power of attorney by the assignee of the entire interest revokes all powers given by the applicant and prior assignees.

Form PTO/SB/80 can be used by an assignee to revoke a power of attorney and appoint a new one. The assignee would sign the power of attorney, and either the assignee or the newly appointed practitioner would sign a statement under pre-AIA 37 CFR 3.73(b).

To learn more:

A non-signing inventor, also known as an “inventor designee,” has certain rights in a patent application filed without their signature. According to MPEP § 409.03(i) (for applications filed before September 16, 2012):

  • The non-signing inventor may protest their designation as an inventor
  • They are entitled to inspect any paper in the application and order copies
  • They can make their position of record in the file wrapper of the application
  • They may arrange to do any of the above through a registered patent attorney or agent

However, the non-signing inventor is not entitled to a hearing and cannot prosecute the application if status under pre-AIA 37 CFR 1.47 has been accorded or if the proprietary interest of the pre-AIA 37 CFR 1.47(b) applicant has been shown.

For applications filed on or after September 16, 2012, similar principles apply, but the specific procedures may differ.

What are the restrictions on registered practitioners not of record during USPTO interviews?

Registered practitioners who are not of record for a specific patent application face certain restrictions when attending USPTO interviews. According to MPEP 408:

‘The registered practitioner not of record may not participate in the interview of the application except as authorized by the patent applicant.’

This means that while a practitioner not of record may accompany the practitioner of record to an interview, their participation is limited. They cannot actively engage in the discussion or negotiation process without explicit authorization from the patent applicant. This restriction is in place to ensure that the applicant’s interests are properly represented by their chosen practitioner of record and to maintain the integrity of the interview process.

For more information on patent examination, visit: patent examination.

For more information on practitioner of record, visit: practitioner of record.

For more information on registered practitioner, visit: registered practitioner.

What are the requirements for signing patent documents on behalf of juristic entities?

The requirements for signing patent documents on behalf of juristic entities (such as corporations, universities, or other organizations) are specific and strict. According to MPEP 402.04:

“Effective September 16, 2012, any paper submitted on behalf of a juristic entity must be signed by a patent practitioner.”

This means that for juristic entities:

  • All patent documents must be signed by a registered patent practitioner (either a patent attorney or a patent agent).
  • Employees or officers of the juristic entity cannot sign patent documents, even if they are the inventors.
  • The patent practitioner must be officially appointed to represent the juristic entity before the USPTO.

This requirement ensures that juristic entities are properly represented in patent matters and helps maintain the integrity of the patent application process. It’s important for juristic entities to work with qualified patent practitioners to handle their patent applications and related documents.

To learn more:

Amendments and other papers filed in a patent application must be signed by specific individuals as outlined in 37 CFR 1.33(b):

  1. A patent practitioner of record
  2. A patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34
  3. The applicant (37 CFR 1.42)

It’s important to note that for juristic entities (e.g., corporations), 37 CFR 1.33(b)(3) specifies:

“Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.”

This requirement ensures that juristic entities are properly represented in patent proceedings.

To learn more:

The USPTO has specific requirements for signatures on documents, as outlined in 37 CFR 1.4(d). Key points include:

  • Signatures must be personally inserted by the signer or comply with specific electronic signature standards.
  • The person inserting a signature certifies that it is their own signature.
  • A person submitting a document signed by another must have a reasonable basis to believe the signature is authentic.

The MPEP states: The person inserting a signature under paragraph (d)(2) or (d)(3) of this section in a document submitted to the Office certifies that the inserted signature appearing in the document is his or her own signature.

For more information on patent application requirements, visit: patent application requirements.

S-signatures, or electronic signatures, are accepted by the USPTO for patent applications. The requirements for S-signatures include:

  • The signature must be between forward slash marks (//).
  • The signer’s name must be provided in printed or typed form preferably immediately below or adjacent to the S-signature.
  • The S-signature may be any combination of letters, numbers, spaces, and punctuation marks.

The MPEP 402.03 states: An S-signature must consist only of letters, or Arabic numerals, or both, with appropriate spaces and commas, periods, apostrophes, or hyphens for punctuation, and the person signing the correspondence must insert his or her own S-signature with a first single forward slash mark before, and a second single forward slash mark after, the S-signature (e.g., /Dr. James T. Jones, Jr./).

It’s important to note that the S-signature must be inserted by the person signing the document, not by someone else on their behalf.

To learn more:

The requirements for representing applicants before international patent authorities vary depending on the specific authority. According to MPEP 402.09 and 37 CFR 11.9(c):

An individual not registered under § 11.6 may, if appointed by an applicant, prosecute an international patent application only before the United States International Searching Authority and the United States International Preliminary Examining Authority, provided that the individual has the right to practice before the national office with which the international application is filed as provided in PCT Art. 49, Rule 90 and § 1.455 of this subchapter, or before the International Bureau when the USPTO is acting as Receiving Office pursuant to PCT Rules 83.1 bis and 90.1.

This means that representation rights depend on the specific authority and the individual’s right to practice before the relevant national office or the International Bureau.

To learn more:

What are the requirements for limited recognition to practice before the USPTO?

To obtain limited recognition to practice before the USPTO in patent matters, an individual must meet the following requirements:

  • Be a scientist or engineer with a bachelor’s degree in a recognized technical subject
  • Demonstrate scientific and technical training
  • Possess good moral character and reputation
  • Be competent to advise and assist patent applicants

As stated in MPEP 402.01: ‘The OED Director may grant limited recognition to practice before the Office in patent matters to an individual not registered to practice before the Office.’ This limited recognition is subject to the conditions specified by the OED Director.

To learn more:

To file an application under pre-AIA 37 CFR 1.47(a) when at least one joint inventor is available, the following requirements must be met:

  • All available joint inventors must make an oath/declaration for themselves and on behalf of the nonsigning inventor
  • Proof that the nonsigning inventor cannot be found/reached after diligent effort or refuses to execute the application
  • The last known address of the nonsigning inventor must be stated

As stated in MPEP 409.03(a): In addition to other requirements of law (pre-AIA 35 U.S.C. 111(a) and 115), an application deposited in the U.S. Patent and Trademark Office pursuant to pre-AIA 37 CFR 1.47(a) must meet the following requirements…

To learn more:

To learn more:

When filing a patent application with at least one unavailable joint inventor under pre-AIA 37 CFR 1.47(a), the following requirements must be met:

  • All available joint inventors must make an oath or declaration for themselves and on behalf of the nonsigning inventor.
  • Proof must be provided that the nonsigning inventor cannot be found or refuses to execute the application.
  • The last known address of the nonsigning inventor must be stated.

As stated in MPEP 409.03(a):

“An application deposited in the U.S. Patent and Trademark Office pursuant to pre-AIA 37 CFR 1.47(a) must meet the following requirements: (A) All the available joint inventors must (1) make oath or declaration on their own behalf as required by pre-AIA 37 CFR 1.63 or 1.175 […] and (2) make oath or declaration on behalf of the nonsigning joint inventor as required by pre-AIA 37 CFR 1.64.”

It’s important to note that this section is not applicable to applications filed on or after September 16, 2012.

To learn more:

When conducting interviews with inventors or assignees, examiners must adhere to specific requirements:

  • The practitioner of record must authorize and be present for the interview.
  • Inventors or assignees cannot participate without the practitioner’s presence.
  • Examiners should not conduct interviews directly with inventors or assignees alone.

According to the MPEP 408: ‘Interviews with inventors or assignees and/or their attorneys or agents of record must be authorized by the practitioners of record. The practitioner of record must be present and an examiner may not conduct an interview with an inventor or assignee unless the practitioner is present.’

For more information on patent examination, visit: patent examination.

What are the requirements for a registered practitioner to obtain access to an application?

According to MPEP 405, a registered practitioner may obtain access to an application if they fulfill the following requirements:

  • The practitioner must be acting in a representative capacity
  • The practitioner must have proper authority from the applicant or attorney or agent of record
  • Written consent from the applicant, attorney, or agent of record must be provided

The MPEP states: ‘Access will be given to the entire application file history in the absence of a specific request from the authorizing party for only a portion of the file.’ This means that unless specified otherwise, the practitioner will be granted full access to the application file.

For more information on application access, visit: application access.

For more information on registered practitioner, visit: registered practitioner.

For more information on USPTO procedures, visit: USPTO procedures.

What are the requirements for a power of attorney to be valid in patent applications?

For a power of attorney to be valid in patent applications, it must meet the following requirements:

  • It must be signed by the applicant for patent (e.g., the inventor) or the assignee of the entire interest.
  • It must be in writing.
  • It must name one or more representatives to act on behalf of the principal.

As stated in MPEP 402.04: ‘The power of attorney must be signed by the applicant for patent (e.g., the inventor(s)) or the assignee of the entire interest of the applicant.’ This ensures that only authorized individuals can appoint representatives to act on behalf of the applicant or assignee in patent matters.

To learn more:

What are the requirements for a power of attorney in applications filed before September 16, 2012?

For applications filed before September 16, 2012, there are specific requirements for a valid power of attorney. According to MPEP 402.02(b):

“For applications filed before September 16, 2012, the power of attorney must be signed by (1) the applicant, where the inventor is the applicant, or (2) the assignee of the entire interest of the applicant.”

Additionally, the power of attorney must:

  • Be in writing
  • Name one or more attorneys or agents
  • Be signed by the applicant for patent (i.e., all of the inventors) or the assignee of the entire interest of the applicant

It’s important to note that for applications filed before September 16, 2012, a power of attorney may be incorporated in the oath or declaration form if the power of attorney is included in the same document.

To learn more:

What are the requirements for a patent practitioner to withdraw from representation?

A patent practitioner who wishes to withdraw from representation must follow specific procedures. According to MPEP 403.01(a): A registered patent practitioner acting in a representative capacity in an application filed on or after September 16, 2012, may not withdraw from representation in that application without leave of the Office.

The process for withdrawal typically involves:

  • Filing a request to withdraw as attorney or agent of record
  • Providing reasons for the withdrawal
  • Ensuring that the applicant is notified of the request
  • Obtaining Office approval before ceasing representation

For detailed instructions on the withdrawal process, refer to MPEP 402.06. It’s crucial to follow these procedures to ensure a proper transition and to maintain compliance with USPTO regulations.

To learn more:

What are the requirements for a non-registered individual to obtain limited recognition?

For a non-registered individual to obtain limited recognition, several requirements must be met as outlined in MPEP 402.01:

  • The individual must be an attorney who is not registered to practice before the Office.
  • They must show that they are acting only as an attorney for a particular named applicant.
  • The attorney must be authorized to practice before a court of general jurisdiction of the state where they reside or are employed.
  • The OED Director must find that the attorney possesses the scientific and technical qualifications necessary to render valuable service to the applicant.
  • The attorney must apply for and be granted limited recognition by the OED Director.

It’s important to note that limited recognition is granted for a specific purpose and duration, and can be withdrawn by the OED Director at any time.

To learn more:

According to 37 CFR 11.116(b), a practitioner may withdraw from representing a client for several reasons, including:

  • Withdrawal can be accomplished without material adverse effect on the client’s interests
  • The client persists in a course of action the practitioner reasonably believes is criminal or fraudulent
  • The client has used the practitioner’s services to perpetrate a crime or fraud
  • The client insists on taking action the practitioner considers repugnant or fundamentally disagrees with
  • The client fails to fulfill an obligation regarding the practitioner’s services after reasonable warning
  • The representation results in an unreasonable financial burden or has been rendered unreasonably difficult by the client
  • Other good cause for withdrawal exists

It’s important to note that when requesting withdrawal, practitioners should be mindful of client confidentiality as required by 37 CFR 11.106. In cases involving sensitive reasons for withdrawal, practitioners should cite ‘irreconcilable differences’ and submit supporting evidence as proprietary material.

To learn more:

Violations of USPTO signature and certification requirements can result in serious consequences as outlined in 37 CFR 11.18(c) and (d):

  • Striking the offending paper
  • Referral to the Office of Enrollment and Discipline
  • Preclusion from submitting papers or contesting issues
  • Affecting the weight given to the offending paper
  • Termination of proceedings
  • Disciplinary action against practitioners

The MPEP states: “37 CFR 11.18(d) provides that any practitioner violating the provisions of 37 CFR 11.18 may also be subject to disciplinary action, thus clarifying that a practitioner may be subject to disciplinary action in lieu of, or in addition to, the sanctions set forth in 37 CFR 11.18(c) for violations of 37 CFR 11.18.”

Additionally, knowingly making false statements can lead to criminal penalties under 18 U.S.C. 1001.

To learn more:

Limited recognition in patent matters comes with several restrictions:

  • Scope limitation: As stated in 37 CFR 11.9(a), ‘Limited recognition under this paragraph shall not extend further than the application or applications specified.’
  • Duration for nonimmigrant aliens: According to 37 CFR 11.9(b), ‘Limited recognition shall be granted for a period consistent with the terms of authorized employment or training.’
  • Geographical restrictions: The same regulation states, ‘Limited recognition shall not be granted or extended to a non-United States citizen residing abroad.’
  • Automatic expiration: For nonimmigrant aliens, ‘Limited recognition shall automatically expire upon the nonimmigrant alien’s departure from the United States.’

These limitations ensure that limited recognition is granted only for specific circumstances and does not provide the same broad authority as full registration as a patent practitioner.

To learn more:

For patent applications filed on or after September 16, 2012, the general requirements for powers of attorney are:

  • The power of attorney must be in writing.
  • It must name one or more representatives.
  • It must give the representative power to act on behalf of the principal.
  • It must be signed by the applicant for patent or the patent owner.

According to 37 CFR 1.32(b)(4), “A power of attorney must: […] (4) Be signed by the applicant for patent (§ 1.42) or the patent owner. A patent owner who was not the applicant under § 1.46 must appoint any power of attorney in compliance with §§ 3.71 and 3.73 of this chapter.”

It’s important to note that an assignee who is not an applicant cannot revoke or appoint a power of attorney in a patent application.

To learn more:

There are significant differences in power of attorney requirements for patent applications filed before and after September 16, 2012. Key differences include:

  • Signature Requirements: For applications filed on or after September 16, 2012, the power of attorney must be signed by the applicant for patent or the patent owner. For applications filed before September 16, 2012, it must be signed by the applicant for patent or the assignee of the entire interest of the applicant.
  • Definition of Applicant: The definition of ‘applicant’ changed with the America Invents Act. For applications filed on or after September 16, 2012, the applicant can be the inventor(s) or a non-inventor applicant (e.g., an assignee).
  • Forms: Different forms are used for applications filed before and after September 16, 2012. For example, Form PTO/AIA/80 is used for applications filed on or after September 16, 2012, while Form PTO/SB/80 is used for earlier applications.

It’s crucial to use the correct forms and follow the appropriate rules based on the application’s filing date to ensure the power of attorney is properly executed and recognized by the USPTO.

To learn more:

Violating the certification requirements when submitting papers to the USPTO can have serious consequences. According to 37 CFR 11.18(c), violations may result in:

  1. Striking the offending paper
  2. Referring a practitioner’s conduct to the Office of Enrollment and Discipline
  3. Precluding a party or practitioner from submitting papers or contesting issues
  4. Affecting the weight given to the offending paper
  5. Terminating proceedings in the Office

Additionally, 37 CFR 11.18(d) states that practitioners violating these provisions may be subject to disciplinary action. The USPTO Director determines appropriate sanctions after notice and opportunity to respond.

It’s important to note that violations can jeopardize the validity of applications, documents, patents, and trademark registrations. As stated in the MPEP:

‘The submission by an applicant of misleading or inaccurate statements of facts during the prosecution of applications for patent has resulted in the patents issuing on such applications being held unenforceable.’

Several court cases are cited demonstrating how false statements have led to patents being unenforceable.

Submitting unauthorized correspondence to the USPTO for patent applications filed after September 16, 2012, can have serious consequences:

  • The correspondence may be returned or not entered into the application
  • It could cause delays in the processing of the application
  • Important deadlines might be missed, potentially leading to abandonment of the application
  • There may be additional fees or costs to rectify the situation

The USPTO has strict rules about who can correspond on behalf of applicants. According to MPEP 403.01(a):

Pursuant to 37 CFR 1.33(a), if an applicant includes more than one correspondence address (37 CFR 1.33(a) ) in a patent application, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

To avoid these issues, ensure that all correspondence is submitted by authorized individuals or entities as specified in the MPEP and relevant USPTO regulations.

To learn more:

Tags: USPTO

What are the consequences of knowingly submitting false statements to the USPTO?

Submitting false statements to the USPTO can have serious consequences. According to MPEP 410:

“Knowingly submitting false statements or withholding material information from the Office in connection with a patent application or patent may be punishable by fine or imprisonment.”

The MPEP further states that such actions may result in:

  • Invalidation of patents
  • Unenforceability of patents
  • Criminal prosecution
  • Disciplinary action against practitioners

It’s crucial for applicants and their representatives to maintain honesty and transparency in all communications with the USPTO to avoid these severe consequences.

For more information on USPTO, visit: USPTO.

Tags: USPTO

Improper signatures on patent documents can have serious consequences:

  • The document may be considered unsigned and therefore ineffective.
  • It could lead to delays in the patent application process.
  • In some cases, it might result in the loss of rights or benefits.
  • The USPTO may require a new submission with proper signatures.

MPEP 402.03 states: ‘Signatures on any paper filed in the Office relating to patents must be permanent. The Office will accept and consider electronically submitted papers bearing S-signatures or handwritten signatures.’

To avoid these issues, ensure all signatures meet USPTO requirements and are made by authorized individuals.

To learn more:

For unpublished patent applications, confidentiality is a critical concern. The MPEP states:

An interview concerning an application that has not been published under 35 U.S.C. 122(b) with an attorney or agent not of record who obtains authorization through use of the interview request form will be conducted based on the information and files supplied by the attorney or agent in view of the confidentiality requirements of 35 U.S.C. 122(a).

This means that for unpublished applications, the USPTO will only discuss information provided by the attorney or agent to maintain confidentiality. The examiner cannot disclose any information from the application file that hasn’t been supplied by the practitioner.

For more information on unpublished applications, visit: unpublished applications.

When a patent practitioner dies, the law firm should take the following actions:

  • Promptly notify the USPTO’s Office of Enrollment and Discipline (OED) of the practitioner’s death.
  • Inform clients with pending applications about the situation and the need to appoint a new representative.
  • Assist clients in filing new powers of attorney or authorizations of agent for pending applications.
  • Provide the USPTO with updated correspondence addresses for affected applications.

The MPEP 406 states: ‘When it is known that the attorney or agent of record in an application is deceased, the Office should be promptly notified.’ This notification helps ensure a smooth transition and continued proper handling of patent applications.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO notification, visit: USPTO notification.

What actions can a suspended or excluded practitioner take during the 30-day limited recognition period?

During the 30-day limited recognition period, suspended or excluded practitioners are allowed to perform specific actions to protect their clients’ interests. According to MPEP 407:

“During the 30-day period of limited recognition, the suspended or excluded practitioner may conclude work on behalf of a client on any matters that were pending before the Office on the date of entry of the order of suspension or exclusion.”

Specifically, the practitioner may:

  • Receive and forward correspondence related to pending matters
  • Make appropriate filings to protect the client’s rights
  • Conclude or withdraw from representation in pending proceedings
  • Perform limited actions necessary to transfer the client’s case to another registered practitioner

It’s important to note that this limited recognition does not allow the practitioner to take on new clients or file new patent applications during this period.

What actions can a practitioner take to preserve an applicant’s rights without a power of attorney?

A practitioner can take certain actions to preserve an applicant’s rights without a formal power of attorney, but these are generally limited to urgent situations. The MPEP 402.04 provides some examples:

  • Filing a patent application to prevent statutory bar
  • Filing a response to an Office action with a nearing deadline
  • Filing a notice of appeal when the period for appeal is about to expire

The MPEP states: ‘Such actions, if taken by a registered patent practitioner, will be accepted by the Office if submitted in a timely manner.’ However, it’s important to note that these actions are typically allowed only in emergencies to prevent the loss of patent rights. The practitioner should follow up with proper documentation of authority as soon as possible after taking such actions.

To learn more:

While providing the last known address where the nonsigning inventor customarily receives mail is the primary requirement, the MPEP suggests that additional addresses may be beneficial:

‘Inasmuch as a nonsigning inventor is notified that an application pursuant to pre-AIA 37 CFR 1.47 has been filed on his or her behalf, other addresses at which the nonsigning inventor may be reached should also be given.’

This recommendation aims to increase the chances of successfully notifying the nonsigning inventor about the application. If you’re aware of multiple addresses where the inventor might be reached, it’s advisable to include them all.

To learn more:

To learn more:

While the last known residence is often the appropriate address to provide, it’s not always the case. The MPEP states:

‘Ordinarily, the last known address will be the last known residence of the nonsigning inventor.’

However, the key is to provide the address where the inventor customarily receives mail. If this differs from their residence, the mailing address should be provided instead. The goal is to increase the likelihood that the nonsigning inventor will receive any USPTO communications.

To learn more:

To learn more:

The United States Patent and Trademark Office (USPTO) does not require proof of authority to be filed by a legal representative of a deceased or incapacitated inventor. MPEP 409.01(b) states:

“Proof of authority of the legal representative of a deceased or incapacitated inventor is not required.”

However, it’s important to note that while the USPTO doesn’t require this proof, the legal representative should ensure they are properly acting in such a capacity. The MPEP advises:

“Although the Office does not require proof of authority to be filed, any person acting as a legal representative of a deceased or incapacitated inventor should ensure that he or she is properly acting in such a capacity.”

This means that while formal proof isn’t needed for USPTO purposes, the legal representative should be prepared to demonstrate their authority if challenged in other legal contexts.

To learn more:

No, MPEP 409.03(g) is not applicable to all patent applications. As stated in the editor’s note at the beginning of the section:

This MPEP section is not applicable to applications filed on or after September 16, 2012.

This means that the guidance provided in MPEP 409.03(g) regarding proof of irreparable damage only applies to patent applications filed before September 16, 2012. For applications filed on or after that date, different rules and procedures may apply.

To learn more:

To learn more:

No, an applicant is not required to conduct a prior art search before filing a patent application. The MPEP clearly states:

‘An applicant has no duty to conduct a prior art search as a prerequisite to filing an application for patent.’

This is supported by several court cases cited in the MPEP, including:

  • Nordberg, Inc. v. Telsmith, Inc.
  • FMC Corp. v. Hennessy Indus., Inc.
  • American Hoist & Derrick Co. v. Sowa & Sons, Inc.

The ‘inquiry reasonable under the circumstances’ requirement of 37 CFR 11.18 does not create any new duty for applicants to conduct prior art searches. However, applicants and practitioners should be aware that providing false or misleading information during prosecution can jeopardize patent enforceability.

When handling interview requests from practitioners not of record, examiners should follow these guidelines:

  • Verify the requester’s authority to conduct the interview.
  • Ensure the practitioner of record has authorized the interview.
  • If authorization is not provided, decline the interview request.

The MPEP 408 states: ‘Interviews with practitioners not of record should be conducted only with the consent of the practitioner of record.’ It further advises: ‘An examiner should not conduct an interview with an attorney or agent who is not of record unless the attorney or agent presents either a power of attorney or a letter signed by the attorney or agent of record authorizing the interview.’

For more information on patent examination, visit: patent examination.

When handling interview requests from multiple attorneys or agents, examiners should follow these guidelines:

  • Generally, only one interview is granted per application.
  • If multiple practitioners request interviews, coordinate with the practitioner of record.
  • Additional interviews may be granted at the examiner’s discretion.

The MPEP 408 states: ‘An interview should normally be conducted with the attorney or agent of record in an application.’ It further advises: ‘If more than one attorney or agent request an interview in an application, it is the responsibility of the attorney or agent of record to resolve any conflict.’

For more information on patent examination, visit: patent examination.

For more information on practitioner of record, visit: practitioner of record.

The frequency of updates to reserved sections in the MPEP varies and is determined by the USPTO based on several factors:

  • Changes in patent laws or regulations
  • New court decisions affecting patent examination
  • Evolving USPTO policies and procedures
  • Feedback from patent examiners and practitioners

Reserved sections may be filled or updated during regular MPEP revisions, which typically occur annually or as needed. However, there is no fixed schedule for updating specific reserved sections, and some may remain reserved for extended periods.

According to MPEP 406, when the USPTO notifies an applicant of their patent practitioner’s death, the applicant is given a specific timeframe to respond. The MPEP states:

“The period for reply to such a notice is normally set at 3 months.”

During this 3-month period, the applicant must take one of the following actions:

  • Appoint a new registered patent practitioner
  • File a change of correspondence address

It’s crucial to respond within this timeframe to prevent the application from being deemed abandoned.

For more information on application abandonment, visit: application abandonment.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on response time, visit: response time.

For more information on USPTO notification, visit: USPTO notification.

For continuing applications where application papers from a prior application are used, special attention must be paid to the correspondence address. According to 37 CFR 1.33(f):

“Where application papers from a prior application are used in a continuing application and the correspondence address was changed during the prosecution of the prior application, an application data sheet or separate paper identifying the correspondence address to be used for the continuing application must be submitted. Otherwise, the Office may not recognize the change of correspondence address effected during the prosecution of the prior application.”

This means that applicants must explicitly specify the desired correspondence address for the continuing application to ensure proper communication with the USPTO.

To learn more:

Determining refusal to join an application under pre-AIA 37 CFR 1.47 involves several considerations:

  1. The inventor must be presented with the application papers.
  2. The inventor must understand what they are being asked to sign.
  3. The inventor must expressly refuse to accept the application papers.

The MPEP states:

‘A refusal by an inventor to sign an oath or declaration when the inventor has not been presented with the application papers does not itself suggest that the inventor is refusing to join the application unless it is clear that the inventor understands exactly what he or she is being asked to sign and refuses to accept the application papers.’

It’s important to document the circumstances of the presentation and refusal, including time, place, and any written evidence of refusal.

To learn more:

To learn more:

The USPTO generally does not engage in double correspondence with applicants and their representatives. Specifically:

  • The Office will not correspond with both an applicant and their attorney/agent.
  • The Office will not correspond with more than one attorney/agent.
  • If double correspondence is attempted, the examiner will include form paragraph 4.01 in the next Office action.

According to MPEP 403: “Double correspondence with an applicant and their attorney, or with two representatives, will not be undertaken. See MPEP §§ 403.01(a), 403.01(b), 403.02, and 714.01(d).”

Form paragraph 4.01 states: “Applicant has appointed an attorney or agent to conduct all business before the Patent and Trademark Office. Double correspondence with an applicant and applicant’s attorney or agent will not be undertaken. Accordingly, applicant is required to conduct all future correspondence with this Office through the attorney or agent of record. See 37 CFR 1.33.”

When two patent practitioners are appointed, the handling of correspondence depends on how and when they were appointed. According to MPEP 403.02:

“If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record.”

This means that the USPTO will use the most recently provided correspondence address. It’s important to note that this is governed by 37 CFR 1.33 and 37 CFR 1.76, which provide regulations on correspondence and application data sheets.

To learn more:

When two patent practitioners are appointed for the same application:

  • If appointed simultaneously, the applicant should specify which address to use for correspondence.
  • If a second practitioner is added later, correspondence will be sent to the most recently provided correspondence address.
  • A new power of attorney appointing only the second practitioner effectively revokes the power of the first practitioner.

According to MPEP 403.02: “If the applicant simultaneously appoints two patent practitioners, applicant should indicate with whom correspondence is to be conducted by specifying a correspondence address. … If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record. … Note that if the later-filed power of attorney only lists the second practitioner, the later-filed power of attorney serves as a revocation of the earlier-filed power of attorney, even without an express revocation of the power of the first patent practitioner.”

When multiple parties are prosecuting a patent application, the USPTO has specific procedures for handling correspondence. The MPEP states:

“Double correspondence will still not be permitted. Accordingly, when the acceptance of such papers results in an attorney or agent and at least one applicant or owner prosecuting the application, correspondence will be mailed to the attorney or agent.”

Furthermore, when multiple attorneys or agents are involved:

“When the acceptance of such papers results in more than one attorney or agent prosecuting the application, the correspondence address will continue to be that of the attorney or agent first named in the application, unless all parties agree to a different correspondence address.”

Key points to remember:

  • Correspondence is typically sent to the attorney or agent if one is involved.
  • If multiple attorneys are prosecuting, the first-named attorney receives correspondence unless otherwise agreed.
  • Each attorney or agent must indicate whom they represent in subsequent papers.
  • All parties involved must sign replies to the USPTO.

To learn more:

Tags: USPTO

The processing of a pre-AIA 37 CFR 1.47 application involves several steps:

  1. A filing date is assigned if the application meets the requirements of 37 CFR 1.53(b).
  2. A filing receipt is sent to the applicant.
  3. The application or an electronic message about the petition is forwarded to the Office of Petitions.
  4. If the papers are found acceptable, the Office of Petitions enters a decision in the file.
  5. A notice is published in the Official Gazette with application details.
  6. The USPTO notifies the nonsigning inventor(s) or legal representative(s) by letter.

As stated in the MPEP, When papers deposited pursuant to pre-AIA 37 CFR 1.47 are found acceptable, the Office of Petitions enters a decision to that effect in the file. A notice will be published in the Official Gazette identifying the application number, filing date, the title of the invention and the name(s) of the nonsigning inventor(s).

To learn more:

To learn more:

In international patent applications, a common representative can be appointed in several ways. According to MPEP 402.09 and 37 CFR 1.455(b):

Appointment of an agent, attorney or common representative (PCT Rule 4.8) must be effected either in the Request form, signed by applicant, in the Demand form, signed by applicant, or in a separate power of attorney submitted either to the United States Receiving Office or to the International Bureau.

If no specific appointment is made and there are multiple applicants, the first named applicant who is entitled to file with the U.S. Receiving Office is considered the common representative by default, as stated in 37 CFR 1.455(a).

To learn more:

When a practitioner withdraws and the correspondence address will change as a result, the withdrawing practitioner(s) must request that the USPTO direct all future correspondence to one of the following:

  • The first named inventor or assignee that has properly made itself of record (for applications filed before September 16, 2012)
  • The applicant (for applications filed on or after September 16, 2012)
  • The assignee of record (for proceedings involving issued patents)

Practitioners can specify either the correspondence address or the address associated with the Customer Number of the appropriate party. It’s important to note that withdrawing practitioners cannot change the correspondence address to another law firm’s Customer Number or any other address except those mentioned above.

This ensures that the patent application or proceeding remains properly managed after the practitioner’s withdrawal.

To learn more:

The USPTO has specific methods to verify the authenticity of S-signatures:

  1. Comparison with other documents: The USPTO may compare the S-signature with other signatures from the same person in their records.
  2. Certification statement: MPEP 402.03 states: ‘The person inserting a permanent S-signature must present a statement certifying that the inserted signature is his or her own signature.’
  3. Audit trail: Electronic filing systems may maintain an audit trail of who submitted the document.
  4. Additional verification: In case of doubt, the USPTO may request additional verification or clarification.

While the USPTO generally presumes the authenticity of signatures, it’s crucial to ensure all S-signatures are genuine and properly certified to avoid potential legal issues.

To learn more:

According to MPEP 406, the USPTO follows a specific procedure to notify client-applicants:

‘The Office of Enrollment and Discipline will notify the client-applicant of the availability of a list of patent practitioners who may be available to represent the client-applicant.’

This notification ensures that the client-applicant is aware of the situation and has resources to find new representation if needed.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO notification, visit: USPTO notification.

How does the USPTO notify applicants of their practitioner’s suspension or exclusion?

The USPTO has a specific process for notifying applicants when their patent practitioner has been suspended or excluded. The MPEP 407 outlines this process:

“The OED Director will… notify the applicant of the suspension or exclusion and of the limited recognition of the practitioner. The notification will be sent to the address of record in the application.”

This notification serves several purposes:

  • Informs the applicant of their practitioner’s status change
  • Advises the applicant of the practitioner’s limited recognition period
  • Allows the applicant to take necessary actions to protect their patent application

It’s crucial for applicants to promptly respond to such notifications to ensure their patent applications are not adversely affected by their practitioner’s disciplinary status.

For more information on USPTO notification, visit: USPTO notification.

When an inventor is deceased, the MPEP 409.03(d) provides specific guidance:

In the case of the death of the inventor, the legal representative (executor, administrator, etc.) of the deceased inventor may sign the necessary oath or declaration.

This means that:

  • The legal representative of the deceased inventor can sign the required oath or declaration
  • Proof of the inventor’s death and the legal representative’s authority should be provided
  • The application can proceed with the legal representative acting on behalf of the deceased inventor

It’s important to note that the legal representative must have the authority to act on behalf of the deceased inventor’s estate. This typically requires documentation such as a death certificate and letters of administration or executorship.

To learn more:

The USPTO has specific rules for representation by foreign attorneys or agents:

  • Foreign attorneys or agents who are not registered to practice before the USPTO and do not reside in the U.S. are not permitted to represent patent applicants before the USPTO.
  • There is an exception for Canadian patent agents under limited recognition.
  • Applicants may be represented by a registered attorney or agent who is not residing in the United States.

According to MPEP 402.01: No attorney or agent residing in a foreign country may be registered to practice before the United States Patent and Trademark Office. This emphasizes the importance of proper registration and residency for patent practitioners.

To learn more:

The USPTO has specific guidelines for handling proof of refusal from a non-signing inventor. According to MPEP 409.03(d):

In the case of refusal, the proof that a bona fide attempt was made to present a copy of the application papers to the non-signing inventor for signature, but the inventor refused to sign the papers, must be submitted.

To demonstrate proof of refusal, an applicant should:

  • Provide evidence of attempts to present the application to the inventor
  • Document the inventor’s explicit refusal to sign
  • Include any communication or statements from the inventor indicating refusal
  • Submit an affidavit or declaration detailing the refusal circumstances

The USPTO will review this evidence to determine if it constitutes a valid proof of refusal.

To learn more:

How does the USPTO handle proof of proprietary interest for deceased inventors?

The USPTO has specific provisions for handling proof of proprietary interest when an inventor is deceased. According to MPEP 409.03(f):

‘In the case of a deceased inventor, the proof of proprietary interest must be signed by the legal representative (executor, administrator, etc.) of the deceased inventor’s estate.’

This means that:

  • The legal representative of the deceased inventor’s estate must provide the necessary documentation.
  • This could be an executor or administrator appointed by the court.
  • The proof should demonstrate that the legal representative has the authority to act on behalf of the deceased inventor’s estate in matters related to the patent application.

It’s important to note that the USPTO requires proper documentation to ensure that the rights of the deceased inventor are properly represented and that the application is prosecuted by those with legitimate authority to do so.

To learn more:

The USPTO takes specific actions regarding powers of attorney granted to suspended or excluded practitioners. According to MPEP 407:

The Office of Enrollment and Discipline (OED) Director will contact the Director of the Technology Center (TC) managing the application when a practitioner has been suspended or excluded from practice. The OED Director will request that the TC Director review a pending application to determine whether the practitioner has been granted a power of attorney. If the suspended or excluded practitioner was given a power of attorney, the TC Director will notify the applicant and request a new power of attorney.

The process typically involves:

  • Identification of affected applications by the OED Director
  • Review of power of attorney status by the TC Director
  • Notification to the applicant if a power of attorney exists
  • Request for a new power of attorney from the applicant
  • Potential application abandonment if no response is received within 30 days

For more information on power of attorney, visit: power of attorney.

How does the USPTO handle patent applications when an inventor is legally incapacitated?

The USPTO has provisions for handling patent applications when an inventor is legally incapacitated. The MPEP 409.03(b) states:

“If a person is legally incapacitated, the legal representative (guardian, conservator, etc.) of such inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

In these cases:

  • The legal guardian or conservator acts on behalf of the incapacitated inventor
  • They must provide proof of their legal authority to represent the incapacitated inventor
  • The guardian or conservator executes the necessary oath or declaration
  • They handle all aspects of the patent application process on behalf of the inventor

This approach ensures that the intellectual property rights of legally incapacitated inventors are protected and that their inventions can still be patented.

To learn more:

When an inventor dies during the prosecution of a patent application, the USPTO has specific procedures in place:

  • If the inventor died after filing the application, the legal representative (executor or administrator of the estate) can proceed with the application.
  • The legal representative must submit evidence of their authority, such as Letters Testamentary or Letters of Administration.
  • If there are joint inventors, the surviving inventors can continue the prosecution.
  • The oath or declaration requirement can be fulfilled by the legal representative or the joint inventors.

As stated in MPEP 409.01: “If an inventor dies during the prosecution of an application, the legal representative (executor, administrator, etc.) of the deceased inventor may make the necessary oath or declaration.”

To learn more:

When multiple correspondence addresses are provided, the USPTO has a specific process for selection. According to 37 CFR 1.33(a):

“If more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.”

This means that the USPTO will choose one address for all official communications, with a preference for Customer Number addresses if provided. Applicants should be aware of this to ensure they provide the most appropriate address for correspondence.

To learn more:

How does the USPTO handle interviews for applications with multiple practitioners of record?

The USPTO has specific guidelines for handling interviews when multiple practitioners are of record for a patent application. MPEP 408 provides guidance on this situation:

‘Where a registered practitioner has been given a power of attorney or authorization of agent, only that practitioner, a practitioner appointed in an associate power of attorney or authorization of agent, or another registered practitioner who has the permission of one of the aforementioned practitioners may conduct an interview.’

This means that when multiple practitioners are of record, any one of them can conduct the interview. However, it’s important to note that clear communication between the practitioners is crucial to ensure consistent representation of the applicant’s interests. The USPTO typically communicates with the practitioner who initiated the interview or the one designated as the primary contact for the application.

For more information on patent examination, visit: patent examination.

For more information on power of attorney, visit: power of attorney.

How does the USPTO handle inequitable conduct in patent applications?

The USPTO takes inequitable conduct in patent applications very seriously. According to MPEP 410:

“[T]he Office will consider equitable and public policy principles in assessing whether to issue a patent to an applicant who has engaged in inequitable conduct.”

Inequitable conduct typically involves:

  • Failure to disclose material information
  • Submitting false material information
  • Intentional misrepresentation of facts

If inequitable conduct is found, the consequences may include:

  • Rejection of the patent application
  • Invalidation of an issued patent
  • Disciplinary action against registered practitioners

The USPTO may also refer cases of suspected fraud to the U.S. Department of Justice for potential criminal prosecution. It’s crucial for applicants and their representatives to maintain honesty and transparency throughout the patent application process.

For more information on fraud, visit: fraud.

For more information on USPTO, visit: USPTO.

Tags: fraud, USPTO

How does the USPTO handle correspondence when there’s a conflict between customer number and application data sheet?

When there’s a conflict between the correspondence address provided in a customer number and an application data sheet (ADS), the USPTO follows specific rules:

  1. The correspondence address in the ADS takes precedence if filed with the initial application papers.
  2. A customer number provided in a single paper with a clear power of attorney overrides the ADS.
  3. If no power of attorney is filed, the correspondence address in the ADS is used.

The MPEP states:

Where an applicant provides a correspondence address in an application data sheet (ADS) that is different from the address associated with a customer number provided in a single paper (e.g., in a power of attorney or inventor’s oath or declaration), the address in the ADS will be the correspondence address of record. (MPEP 403)

It’s crucial to ensure consistency in your filings to avoid confusion. If you need to change the correspondence address after filing, you should submit a separate change of address request or update your customer number information.

For more information on application data sheet, visit: application data sheet.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO, visit: USPTO.

In a Pre-AIA 37 CFR 1.47 application, the USPTO follows specific procedures for handling correspondence. According to MPEP 409.03(j):

‘The Notice of Acceptance under 37 CFR 1.47 should remind the applicant that the nonsigning inventor has access to the application papers. Applicant may petition under 37 CFR 1.14(e) for access restriction. See MPEP § 104.’

This means that:

  • The USPTO will send a Notice of Acceptance to the applicant.
  • The non-signing inventor has the right to access application papers.
  • The applicant can petition for access restriction if necessary.
  • Regular correspondence will be sent to the applicant or their representative.

It’s important to note that while the application is prosecuted by the applicant under 37 CFR 1.47, the non-signing inventor retains certain rights, including access to the application file.

To learn more:

To learn more:

How does the USPTO handle correspondence if no practitioner is of record in a patent application?

When no practitioner is of record in a patent application, the USPTO follows specific procedures for handling correspondence. Here’s what you need to know:

  • Correspondence is sent to the applicant’s correspondence address
  • The address used is the one shown in the application or the Patent Application Locating and Monitoring (PALM) system
  • It’s crucial for applicants to keep their correspondence information up to date

As stated in MPEP 403.01(a): ‘If a practitioner is not of record, correspondence will be sent to the applicant’s correspondence address as shown in the application or the Patent Application Locating and Monitoring (PALM) system.’

This policy ensures that even without a practitioner of record, the USPTO can maintain communication with the applicant. It’s important for applicants to regularly check and update their correspondence information to avoid missing critical communications from the USPTO.

To learn more:

How does the USPTO handle correspondence from multiple patent practitioners?

When multiple patent practitioners are involved in an application, the USPTO has specific rules for handling correspondence. MPEP 403.01(a) states: Where more than one practitioner is of record in an application, the Office will direct correspondence to the practitioner first named in the request for representation unless the request for representation specifies otherwise.

This means:

  • The USPTO will typically communicate with the first-named practitioner.
  • Applicants can specify a different practitioner for correspondence if desired.
  • All practitioners of record have the authority to act on behalf of the applicant.

It’s important for the applicant and all involved practitioners to clearly communicate their roles and preferences for correspondence to ensure smooth communication with the USPTO. For more information on correspondence procedures, visit the USPTO’s MPEP 403 page.

To learn more:

How does the USPTO handle correspondence from multiple attorneys in a patent application?

The USPTO has specific guidelines for handling correspondence from multiple attorneys in a patent application:

  • If multiple attorneys are listed on the Power of Attorney form, the USPTO will direct all correspondence to the first listed attorney.
  • The first listed attorney is considered the ‘correspondence address’ for official communications.
  • As stated in MPEP 403.01(a): ‘If more than one attorney is of record, the Office will direct correspondence to the first listed attorney in the Power of Attorney.’
  • Other listed attorneys can still communicate with the USPTO, but official correspondence will be sent to the designated address.

This approach ensures clear communication channels and prevents confusion in multi-attorney cases.

To learn more:

For juristic entities (e.g., corporations, organizations), the USPTO has specific requirements for correspondence and signatures. According to 37 CFR 1.33(b)(3):

Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.

This means that:

  • A juristic entity must prosecute a patent application through a registered patent practitioner.
  • All correspondence, amendments, and other papers must be signed by a patent practitioner on behalf of the juristic entity.
  • The juristic entity cannot directly correspond with the USPTO or sign documents without representation by a patent practitioner.

This requirement ensures that juristic entities have proper legal representation in patent matters, which can be complex and have significant legal implications.

To learn more:

How does the USPTO handle correspondence for applications with multiple attorneys or agents?

When an application has multiple attorneys or agents of record, the USPTO follows specific guidelines for correspondence:

  • The USPTO will direct all correspondence to the first named attorney or agent of record, unless otherwise specified.
  • If a customer number is provided, correspondence will be sent to the address associated with that customer number.
  • Applicants can designate one or more attorneys or agents to receive correspondence by filing a power of attorney or including the information in an application data sheet.

As stated in the MPEP:

If applicant provides, in a single paper, a list of patent practitioners and a correspondence address without also filing a clear power of attorney to a patent practitioner, the Office will direct all correspondence to the correspondence address pursuant to 37 CFR 1.33(a). (MPEP 403)

It’s important to clearly designate correspondence preferences to ensure proper communication with the USPTO.

For more information on patent agents, visit: patent agents.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO correspondence, visit: USPTO correspondence.

How does the USPTO handle correspondence for applications with multiple applicants?

The USPTO has specific rules for handling correspondence in applications with multiple applicants:

  • For applications filed on or after September 16, 2012, the USPTO will direct correspondence to the first named applicant, unless a practitioner is appointed.
  • For applications filed before September 16, 2012, correspondence is sent to the first named inventor, unless a practitioner is of record.

As stated in MPEP 403: ‘Where more than one attorney or agent is of record, the Office will direct correspondence to the first named attorney or agent of record, unless otherwise requested.’ This ensures clear communication channels for multi-applicant applications.

For more information on USPTO correspondence, visit: USPTO correspondence.

When the USPTO is notified of the death of a sole patent practitioner of record, they continue to hold correspondence with the deceased practitioner’s office. However, the USPTO also mails a copy of the Office action to the person who originally appointed the practitioner. This ensures that the applicant or owner is informed of ongoing patent matters.

How does the USPTO handle conflicting powers of attorney in a patent application?

When conflicting powers of attorney are submitted in a patent application, the USPTO follows specific procedures to resolve the conflict. According to MPEP 402.10:

Where a written power of attorney is submitted in an application without the signature of one or more inventors or assignees, the power of attorney is not accepted until either (1) the nonsigning inventor or assignee provides a power of attorney consistent with the power of attorney provided by the other parties, or (2) the nonsigning inventor or assignee is removed from the application.

In practice, this means:

  • The USPTO will not accept a power of attorney unless it is signed by all parties or consistent with previously filed powers.
  • If conflicting powers are received, the Office will contact the applicants to resolve the discrepancy.
  • The application may be delayed until the conflict is resolved.
  • In some cases, the nonsigning inventor or assignee may need to be removed from the application for prosecution to proceed.

It’s crucial for applicants to coordinate and agree on representation to avoid such conflicts and potential delays in the patent application process.

To learn more:

How does the USPTO handle conflicting instructions from multiple representatives?

When multiple representatives are authorized to act on behalf of an applicant or assignee, conflicts may arise if they provide contradictory instructions. The USPTO has a clear procedure for handling such situations. According to MPEP 402.04, “Where an applicant is represented by more than one practitioner, the Office will direct all communications to the first named representative (the representative of record) in absence of a request to the contrary or in absence of revocation of power of attorney.” This means that if conflicting instructions are received, the USPTO will generally follow the guidance provided by the representative of record, ensuring a clear line of communication and decision-making.

To learn more:

The USPTO handles confidentiality in 37 CFR 1.47(a) petitions with care, recognizing the sensitive nature of the information provided. The MPEP 409.03(b) states:

‘Petitions under 37 CFR 1.47 are not available to the public since they are contained in the application file… The petition will be available to the nonsigning inventor upon request.’

This means:

  • Petition documents are kept confidential as part of the non-public application file.
  • The general public cannot access these petitions.
  • The nonsigning inventor has the right to request and view the petition.
  • The USPTO balances the need for transparency with the protection of potentially sensitive information.

Applicants should be aware that while the petition is generally confidential, the nonsigning inventor may still access it, which could affect strategies for presenting information in the petition.

To learn more:

To learn more:

After an attorney withdraws from a patent application, the USPTO adjusts its communication process as follows:

  • The Office communicates directly with the applicant or assignee.
  • This direct communication continues until a new registered patent practitioner is appointed.
  • The applicant or assignee who originally appointed the withdrawing attorney becomes the point of contact for all purposes in the application.

According to MPEP 402.06: ‘For applications in which the attorney or agent has withdrawn from representation, the Office will communicate directly with the applicant … until such time as a new attorney or agent is appointed.’

It’s crucial for applicants to stay responsive and consider appointing new representation promptly to ensure smooth prosecution of their patent application.

To learn more:

The USPTO has specific procedures for handling changes in power of attorney and correspondence address. According to MPEP 403:

‘A new power of attorney or change of correspondence address filed in a patent application or patent does not change the correspondence address for any other application or patent.’

Key points to remember:

  • Each application or patent is treated separately.
  • A change in one application doesn’t automatically apply to others, even if filed by the same applicant or assignee.
  • To change multiple applications, you must file separate requests for each one.
  • Using a customer number can simplify this process for multiple applications.

It’s crucial to ensure that any changes are properly filed and recorded to maintain effective communication with the USPTO.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How does the USPTO handle applications filed before September 16, 2012?

Applications filed before September 16, 2012, are subject to different correspondence rules. As stated in MPEP 403.01(a): For applications filed before September 16, 2012, pre-AIA 37 CFR 1.33(a) applies. This means that for these older applications, the correspondence rules and procedures outlined in pre-AIA 37 CFR 1.33(a) are still in effect. It’s important to check the filing date of your application to determine which set of rules applies.

For more detailed information on pre-AIA rules, you can refer to MPEP 403 which covers correspondence for applications filed before September 16, 2012.

To learn more:

The USPTO actively encourages the use of interviews to expedite patent prosecution. According to MPEP § 408, The Office encourages the use of interviews to expedite prosecution. When an examiner believes an interview would advance the application’s progress, they may contact the patent practitioner of record to suggest a telephonic, personal, or video conference interview.

To initiate an interview, applicants should submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) prior to the interview. This form helps the examiner prepare and focus on the issues to be discussed.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO determines the correspondence address based on the most recent information provided. According to MPEP 403.02:

“If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record.”

This means that the USPTO will use the most recently provided correspondence address, regardless of which practitioner it is associated with. This practice is governed by 37 CFR 1.33 and 37 CFR 1.76, which provide regulations on correspondence and application data sheets. It’s crucial for applicants and practitioners to keep the correspondence address up to date to ensure proper communication with the USPTO.

To learn more:

How does the USPTO define ‘material information’ in patent applications?

The USPTO considers information to be material if it affects the patentability of an invention. According to MPEP 410:

“Information is material to patentability when it is not cumulative to information already of record or being made of record in the application, and (1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or (2) It refutes, or is inconsistent with, a position the applicant takes in: (i) Opposing an argument of unpatentability relied on by the Office, or (ii) Asserting an argument of patentability.”

In simpler terms, material information includes any facts that could affect the USPTO’s decision to grant a patent. This may include prior art, conflicting statements, or any other information that could impact the novelty or non-obviousness of the claimed invention.

For more information on prior art, visit: prior art.

For more information on USPTO, visit: USPTO.

Tags: prior art, USPTO

When an attorney or agent is suspended, the USPTO does not communicate with them. Instead:

  • For sole practitioners: The Office action is mailed to the address of the first named applicant in the application.
  • For multiple practitioners: The Office action is mailed to the first named unsuspended registered practitioner of record and to the first named applicant.

This is outlined in Form Paragraphs 4.07 and 4.08 of MPEP § 407.

For international patent applications filed by non-inventor applicants, there are specific requirements outlined in 37 CFR 1.46(b):

If an application entering the national stage under 35 U.S.C. 371, or a nonprovisional international design application, is applied for by a person other than the inventor under paragraph (a) of this section, the assignee, person to whom the inventor is under an obligation to assign the invention, or person who otherwise shows sufficient proprietary interest in the matter must have been identified as the applicant for the United States in the international stage of the international application or as the applicant in the publication of the international registration under Hague Agreement Article 10(3).

This means that for PCT applications entering the U.S. national stage or for international design applications, the non-inventor applicant must have been properly identified as the applicant for the United States during the international phase or in the international registration publication.

To learn more:

The presence of reserved sections like MPEP 404 does not directly affect patent examination. These sections are placeholders and do not contain any substantive information or guidance for examiners. However, their existence may indirectly impact the examination process in the following ways:

  • They maintain consistent numbering in the MPEP, aiding navigation and referencing
  • They allow for future expansion of examination guidelines without major restructuring
  • They serve as potential indicators of areas where the USPTO may develop new policies or procedures

Patent examiners rely on active, non-reserved sections of the MPEP, current USPTO policies, and relevant laws and regulations to conduct examinations.

The Manual of Patent Examining Procedure (MPEP) addresses the issue of unavailable joint inventors for applications filed on or after September 16, 2012, in section 409.02. This section provides guidance on how to proceed when a joint inventor is unavailable or unwilling to participate in the patent application process.

Key points from MPEP 409.02 include:

  • Joint inventors must apply for a patent jointly and each must make an inventor’s oath or declaration.
  • If a joint inventor refuses to join or cannot be found after diligent effort, the other joint inventor(s) may proceed with the application.
  • A substitute statement can be executed in lieu of an oath or declaration from the unavailable inventor.

For applications filed before September 16, 2012, different procedures apply, which are covered in MPEP § 409.03 et seq.

To learn more:

To learn more:

The guidance in MPEP 409.03(f) specifically addresses the issue of continuation-in-part (CIP) applications in relation to assignments. According to MPEP 409.03(f):

“An assignment of an application and any ‘reissue, division, or continuation of said application’ does not itself establish an assignment of a continuation-in-part application. In re Gray, 115 USPQ 80 (Comm’r Pat. 1956).”

This means that even if an original application has been assigned, and that assignment includes language covering continuations and divisions, it does not automatically cover a continuation-in-part application. This is because a CIP application, by definition, contains new matter not present in the original application.

When dealing with a CIP application under pre-AIA 37 CFR 1.47(b), applicants need to ensure that the assignment or proof of proprietary interest specifically covers the new matter included in the CIP. A new assignment or demonstration of proprietary interest may be necessary for the portions of the CIP that were not present in the original application.

To learn more:

To learn more:

Tags: pre-AIA

The death of an inventor can have significant implications for power of attorney in a patent application. According to MPEP 409.01(a):

Unless a power of attorney is coupled with an interest (i.e., a patent practitioner is assignee or part-assignee), the death of an inventor who is an applicant party terminates the power of attorney given by the deceased inventor in an application filed on or after September 16, 2012.

This means that in most cases, when an inventor who is also an applicant dies, any power of attorney they had given is automatically terminated. As a result:

  • If the deceased inventor was the sole inventor-applicant, a new power of attorney is necessary.
  • If all powers of attorney in the application have been terminated due to the inventor’s death, a new power of attorney is required.
  • The new power of attorney must come from the heirs, administrators, executors, or assignees of the deceased inventor.

It’s important for legal representatives and other parties involved in the patent application to be aware of this and take appropriate action to ensure the application can continue to be prosecuted effectively.

To learn more:

How does the AIA impact power of attorney for applications filed before September 16, 2012?

The America Invents Act (AIA) does not significantly change the power of attorney requirements for applications filed before September 16, 2012. As stated in MPEP 402.02(b):

For applications filed before September 16, 2012, all parties having the right to prosecute the application at the time of filing the power of attorney must act together in appointing a power of attorney.

This means that the pre-AIA rules continue to apply for these older applications. However, it’s important to note that any new applications filed on or after September 16, 2012, are subject to the updated AIA rules regarding power of attorney.

To learn more:

How does the AIA change the process for applications with deceased or incapacitated inventors?

The America Invents Act (AIA) introduced significant changes to the patent application process, including how applications with deceased or legally incapacitated inventors are handled. According to MPEP 409.01(a):

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign the invention, or who otherwise shows sufficient proprietary interest in the matter, to make the application for patent.”

Key changes under the AIA include:

  • Allowing assignees or those with sufficient proprietary interest to file applications
  • Introduction of the substitute statement to replace inventor oaths in certain circumstances
  • Simplified process for continuing prosecution when an inventor becomes unavailable
  • Removal of the need for heirs or legal representatives to expressly petition to file on behalf of a deceased inventor

These changes streamline the application process and provide more flexibility when dealing with situations involving deceased or incapacitated inventors, making it easier for the remaining inventors or interested parties to pursue patent protection.

To learn more:

When a power of attorney is revoked, it affects pending applications as follows:

  • The revocation is effective upon receipt in the USPTO.
  • It applies to all pending applications in which the attorney or agent was appointed, unless specifically limited.
  • The Office will not communicate further with the revoked attorney/agent.
  • The applicant must appoint a new representative or correspond directly with the Office.

As stated in MPEP 402.05: ‘A power of attorney may be revoked at any stage in the proceedings of a case.’ This means the revocation can occur at any point during the patent application process.

To learn more:

When a power of attorney is revoked, it’s important to understand its impact on pending amendments in a patent application. According to MPEP 402.05:

Any amendments made in an application after the filing date of the application will not be effective to revoke a power of attorney.

This means that if an applicant submits an amendment to revoke a power of attorney after the application’s filing date, that amendment will not be effective in revoking the power of attorney. To properly revoke a power of attorney, the applicant must follow the specific procedures outlined in the MPEP, such as submitting a separate revocation document or a new power of attorney.

To learn more:

MPEP 409.03(f) provides guidance on handling patent applications when an inventor is deceased or legally incapacitated. The section states:

‘When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or assignee on compliance with the foregoing provisions.’

This means that in cases of a deceased inventor, the patent can still be issued to their legal representative or assignee, provided they comply with the requirements for proving proprietary interest. For legally incapacitated inventors, similar provisions apply, allowing the legal guardian or other authorized representative to act on behalf of the inventor in patent matters.

It’s important to note that in these situations, additional documentation such as death certificates or court orders establishing legal guardianship may be required to establish the authority of the person acting on behalf of the inventor.

To learn more:

To learn more:

MPEP 402.08 has significant implications for patent attorneys involved in derivation proceedings. The key provision states:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

For patent attorneys, this means:

  • Any changes in representation must go through the PTAB, not regular USPTO channels.
  • There may be delays in processing power of attorney changes due to PTAB review.
  • Attorneys must be prepared to justify changes in representation to the PTAB if necessary.
  • The timing of representation changes may be influenced by the ongoing derivation proceeding.

Patent attorneys should be aware of these special procedures to ensure smooth transitions in representation during derivation proceedings.

To learn more:

To learn more:

Limited recognition in international patent applications is addressed in 37 CFR 11.9(c), which states:

An individual not registered under § 11.6 may, if appointed by an applicant, prosecute an international patent application only before the United States International Searching Authority and the United States International Preliminary Examining Authority, provided that the individual has the right to practice before the national office with which the international application is filed as provided in PCT Art. 49, Rule 90 and § 1.455 of this subchapter, or before the International Bureau when the USPTO is acting as Receiving Office pursuant to PCT Rules 83.1bis and 90.1.

This means that unregistered individuals may represent applicants in certain phases of international patent applications under specific conditions. For more detailed information:

  • See MPEP § 1807 for representation in international applications (PCT)
  • See MPEP § 2911 for representation in international design applications

To learn more:

When an inventor becomes legally incapacitated before filing a patent application and executing the required oath or declaration, a legal representative must be appointed to act on their behalf. According to 37 CFR 1.43 (pre-AIA):

“In case an inventor is insane or otherwise legally incapacitated, the legal representative (guardian, conservator, etc.) of such inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative, typically appointed by a court of competent jurisdiction, can then execute the oath or declaration and proceed with the patent application process on behalf of the incapacitated inventor.

To learn more:

Filing a new power of attorney typically revokes all prior powers of attorney. According to MPEP 402.05: When an original power of attorney is filed giving power of attorney to attorneys A, B, and C, and the same principal subsequently files another power of attorney, giving power of attorney to D without revoking all prior powers of attorney, the subsequently filed power of attorney will be treated as a revocation of the original power of attorney. This means that the most recently filed power of attorney will control.

To learn more:

In pre-2012 patent applications, filing a new power of attorney can have significant effects on existing powers of attorney. MPEP 402.05(b) outlines several scenarios:

  1. New power of attorney without explicit revocation: “When an original power of attorney is filed giving power of attorney to attorneys A, B, and C, and the same principal subsequently files another power of attorney, giving power of attorney to D without revoking all prior powers of attorney, the subsequently filed power of attorney will be treated as a revocation of the original power of attorney.”
  2. Assignee filing new power of attorney: “If the applicant signed the original power of attorney, and an assignee of the entire interest of the applicant later takes action and files a new power of attorney, the original power of attorney is revoked and replaced by the power of attorney filed by the assignee.”
  3. Change in Customer Number: “If a power of attorney is given to the practitioners associated with a Customer Number, and a (second) power of attorney is later received giving power of attorney to patent practitioners associated with a different Customer Number, the second power of attorney will be processed, with the first Customer Number being replaced with the second.”

In all these cases, the most recently filed power of attorney will control, effectively revoking or replacing the previous ones.

To learn more:

How does attorney withdrawal affect the power of attorney in a patent application?

When an attorney withdraws from a patent application, it affects the power of attorney status. According to MPEP 402.06:

“The Office will not remove the names of practitioners who have been granted a power of attorney or authorization of agent from the list of practitioners of record at the request of the practitioner filing the withdrawal.”

This means that even after withdrawal, the attorney’s name may remain on record unless specific actions are taken. However, the withdrawn attorney no longer has the authority to act on behalf of the application. To fully revoke the power of attorney, the applicant must file a revocation and/or new power of attorney. It’s crucial for applicants to update their power of attorney promptly after an attorney’s withdrawal to ensure proper representation and communication with the USPTO.

To learn more:

How does attorney withdrawal affect pending patent applications?

When an attorney withdraws from representation in a pending patent application, it can have several implications:

  • The applicant becomes responsible for prosecuting the application.
  • Official correspondence will be sent directly to the applicant.
  • Deadlines and response periods remain in effect.
  • The applicant may need to find new representation quickly.

According to MPEP 402.06:

“Where an attorney or agent of record withdraws from an application, the Office will communicate directly with the applicant, or with a new registered attorney or agent if a power of attorney is filed.”

It’s important for applicants to act promptly after attorney withdrawal to ensure continuity in their patent prosecution. If a new attorney is hired, a new power of attorney should be filed with the USPTO to ensure proper communication and representation.

To learn more:

How does an attorney or agent officially withdraw from a patent application?

To officially withdraw from a patent application, an attorney or agent must follow these steps:

  1. Submit a request to withdraw as attorney or agent of record.
  2. The request must be signed by the attorney or agent of record.
  3. Include the application number and filing date.
  4. Provide the names of the inventors and assignee (if applicable).
  5. State the reason for withdrawal.

The MPEP 402.06 states: ‘When an attorney or agent of record in an application withdraws… the Office of Enrollment and Discipline should be notified by the withdrawing attorney or agent.’ This notification ensures proper processing of the withdrawal request.

To learn more:

How does an assignee become of record in a patent application?

An assignee must become of record in a patent application before they can revoke the power of attorney given by the applicant. According to MPEP 402.07, this process involves:

  1. Filing a statement under 37 CFR 3.73(c)
  2. Complying with the requirements of 37 CFR 3.71

The MPEP states:

“The assignee must become of record as provided in 37 CFR 3.71. After the assignee becomes of record, the assignee is permitted to revoke the power of attorney of the applicant under the provisions of 37 CFR 1.36(a).”

This typically involves submitting documentary evidence of the chain of title from the original owner to the assignee, such as assignment documents. Once the USPTO recognizes the assignee as the owner of record, they can proceed with revoking the existing power of attorney and appointing a new one.

To learn more:

To file an application under pre-AIA 37 CFR 1.47(b), an applicant must demonstrate a proprietary interest in the subject matter of the application. The MPEP outlines three ways to establish this:

  1. Show that the invention has been assigned to the applicant
  2. Provide evidence that the inventor has agreed in writing to assign the invention to the applicant
  3. Otherwise demonstrate a proprietary interest in the subject matter of the application

The MPEP states: “The pre-AIA 37 CFR 1.47(b) applicant must make out a prima facie case (1) that the invention has been assigned to him or her or (2) that the inventor has agreed in writing to assign the invention to him or her or (3) otherwise demonstrate a proprietary interest in the subject matter of the application.”

For more detailed information on demonstrating proprietary interest, refer to MPEP § 409.03(f).

To learn more:

Adding an inventor to a patent application can affect an existing power of attorney under certain circumstances. According to MPEP 402.05(a):

If the power of attorney was granted by the originally named inventive entity and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.

This means that if a new inventor is added to the application and does not provide a power of attorney that matches the existing one, the original power of attorney will be lost when the request to add the inventor is granted. However, this doesn’t prevent a practitioner from acting under 37 CFR 1.34 if applicable.

To learn more:

Adding an inventor to a patent application can potentially affect an existing power of attorney. According to MPEP 402.02(a):

“If the power of attorney was granted by the originally named inventive entity, and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.”

This means that if a new inventor is added to the application and does not provide a power of attorney consistent with the existing one, the original power of attorney will be lost. However, this provision does not preclude a practitioner from acting pursuant to 37 CFR 1.34, if applicable.

It’s important for applicants and practitioners to be aware of this potential consequence when adding inventors to an application, and to take appropriate steps to maintain or reestablish the desired power of attorney.

To learn more:

The rules for acting in a representative capacity differ slightly for applications filed before and after September 16, 2012. According to MPEP 402.04:

For applications filed on or after September 16, 2012:

A patent practitioner acting in a representative capacity must submit papers on behalf of all parties identified as the applicant. They cannot represent only some of the applicant parties.

For applications filed before September 16, 2012:

A patent practitioner may act in a representative capacity on behalf of:

  • The applicant, or
  • The assignee of the entire right who has properly established its right to take action under 37 CFR 3.71 and 3.73

Additionally, for pre-September 16, 2012 applications, a person acting in a representative capacity may sign a document granting access to an application or a change of correspondence address if:

  1. An executed oath or declaration under pre-AIA 37 CFR 1.63 has not been filed, and
  2. The patent practitioner was named in the application transmittal papers.

To learn more:

In pre-AIA patent applications (filed before September 16, 2012), a power of attorney given by the assignee of the entire interest has significant implications for previous powers of attorney. As stated in the MPEP:

A power of attorney by the assignee of the entire interest revokes all powers given by the applicant and prior assignees if the assignee establishes their right to take action as provided in pre-AIA 37 CFR 3.71 and pre-AIA 37 CFR 3.73(b).

This means that when the assignee of the entire interest files a new power of attorney, it effectively cancels all previous powers of attorney given by the applicant or any prior assignees. However, the assignee must properly establish their right to take action in the application according to the relevant regulations.

To learn more:

To show ‘sufficient proprietary interest’ for filing a patent application, an individual or entity must demonstrate a significant legal or equitable interest in the invention. According to MPEP 409.05:

Quote: ‘A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.’

To establish sufficient proprietary interest, the applicant must:

  • Provide proof of the relevant facts demonstrating their interest in the invention
  • Show that filing the application is necessary to preserve the rights of all parties involved
  • Submit a petition under 37 CFR 1.46 to the Office of Petitions

The Director of the USPTO will then determine if the evidence sufficiently demonstrates proprietary interest.

To learn more:

Tags: USPTO

If an inventor becomes legally incapacitated after signing the oath or declaration, the application can still proceed. According to MPEP 409.01:

If an inventor who executed the oath or declaration becomes legally incapacitated after the application is filed but before the patent issues, no substitute oath or declaration is required.

This means that the previously signed oath or declaration remains valid, and the application can continue through the patent process without requiring additional documentation regarding the inventor’s incapacitation.

To learn more:

To verify if someone is authorized to conduct business with the USPTO for a patent application filed after September 16, 2012, you can follow these steps:

  • Check if the person is listed as the applicant or an assignee
  • Verify if they are a registered patent practitioner
  • Look for a power of attorney or authorization of agent document
  • Confirm if they are named as an inventor in the application

The USPTO maintains specific rules about who can correspond regarding patent applications. As stated in MPEP 403.01(a):

For applications filed on or after September 16, 2012, … the applicant’s or patent owner’s correspondence address … is the correspondence address of the patent practitioner appointed in a power of attorney or authorization of agent, or if no practitioner is appointed, the correspondence address of the applicant or patent owner.

If you’re unsure, it’s best to contact the USPTO directly for clarification.

To learn more:

Tags: USPTO

How do I update the list of practitioners associated with a Customer Number?

To update the list of practitioners associated with a Customer Number, follow these steps:

  1. Complete the Change of Correspondence Address Form (PTO/SB/122)
  2. Provide the Customer Number and the updated list of registered practitioners
  3. Submit the form to the USPTO

The MPEP 403 specifies:

‘A request to change the correspondence address or list of registered practitioners associated with a Customer Number must be made in writing.’

It’s important to note that:

  • Only registered practitioners can be added to a Customer Number
  • Changes will affect all applications associated with the Customer Number
  • The USPTO recommends using the online Electronic Business Center (EBC) for faster processing

Keeping the practitioner list up-to-date ensures proper communication and representation for all linked patent applications.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

When filing a patent application, you must specify a correspondence address in one of two ways:

  • In an application data sheet (ADS) under 37 CFR 1.76, or
  • Elsewhere in the application papers in a clearly identifiable manner

As stated in 37 CFR 1.33(a): When filing an application, a correspondence address must be set forth in either an application data sheet (§ 1.76), or elsewhere, in a clearly identifiable manner, in any paper submitted with an application filing.

This address will be used by the USPTO to send all official communications regarding your application.

To learn more:

To revoke a power of attorney in a patent application:

  • The applicant or assignee of the entire interest must submit a revocation signed by them.
  • The revocation should be submitted to the USPTO in writing.
  • It can be done by filing a new power of attorney (Form PTO/AIA/82) and checking the revocation box.
  • Alternatively, you can submit a document specifically revoking the previous power of attorney.

As stated in the MPEP 402: ‘A power of attorney may be revoked at any stage in the proceedings of a case.’ It’s important to note that revoking a power of attorney does not remove attorneys from the list of patent practitioners associated with an application. To do that, you must file a separate request.

For more information on power of attorney, visit: power of attorney.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

How do I request a Customer Number from the USPTO?

To request a Customer Number from the USPTO, follow these steps:

  1. Complete the Customer Number Request Form (PTO/SB/125)
  2. Include the names of registered practitioners associated with the Customer Number
  3. Provide the correspondence address for the Customer Number
  4. Submit the form to the USPTO

According to MPEP 403, ‘A Customer Number may be requested by (A) a registered attorney or agent of record, (B) an assignee of the entire interest of the applicant, or (C) the applicant.’ The USPTO will process the request and assign a unique Customer Number, which can then be used for managing correspondence and access to patent applications.

For more information on USPTO Forms, visit: USPTO Forms.

Tags: USPTO Forms

To prove an invention has been assigned in a pre-AIA 37 CFR 1.47(b) application, you must submit the following:

  • A copy of the assignment in English
  • A statement under pre-AIA 37 CFR 3.73(b) by the assignee

According to MPEP 409.03(f):

“If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant. A statement under pre-AIA 37 CFR 3.73(b) by the assignee must also be submitted (see MPEP § 324).”

It’s important to note that the assignment must specifically cover the invention described in the application. General assignments may not be sufficient.

To learn more:

To learn more:

Tags: pre-AIA

Joint inventors who are the applicant can appoint a power of attorney in a patent application using Form PTO/AIA/81. This form allows joint inventors to give one or more joint inventor-applicants the power of attorney to sign on behalf of all joint inventor-applicants.

According to the MPEP:

“Form PTO/AIA/81 may be used by joint inventors who are the applicant to give one or more joint inventor-applicants power of attorney to sign on behalf of all joint inventor-applicants. Since powers of attorney must be signed by ‘the applicant,’ all joint inventor-applicants must sign a power of attorney, including the joint inventor(s) who are being given power of attorney.”

For example, if there are four joint inventors (A, B, C, and D) who are all applicants, and they wish to appoint inventor-applicant C as having power of attorney, all four inventors (A, B, C, and D) must sign the power of attorney form appointing C.

It’s important to note that all joint inventor-applicants must sign the power of attorney, even those who are being given the power to act on behalf of the others.

To learn more:

How can inventors and joint inventors file patent applications after September 16, 2012?

For patent applications filed on or after September 16, 2012, inventors and joint inventors can file applications in the following ways:

  • An inventor or joint inventor may file an application.
  • A legal representative of a deceased or legally incapacitated inventor may file an application.
  • An assignee, obligated assignee, or person who shows sufficient proprietary interest may file an application.

As stated in MPEP 403.01(a): “For applications filed on or after September 16, 2012, a patent practitioner acting in a representative capacity must have authority to act on behalf of the applicant.” This means that patent practitioners must ensure they have proper authorization before acting on behalf of applicants.

To learn more:

How can I revoke a power of attorney in a patent application filed on or after September 16, 2012?

To revoke a power of attorney in a patent application filed on or after September 16, 2012, you need to follow these steps:

  • Submit a new power of attorney form (PTO/AIA/82) or a revocation form (PTO/AIA/83).
  • The revocation must be signed by the applicant or patent owner.
  • If using form PTO/AIA/82, check the box indicating revocation of all previous powers of attorney.

According to MPEP 402.02(a): “A power of attorney may be revoked only by the applicant or patent owner. An assignee who is not the applicant may revoke a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c).”

It’s important to note that the revocation is not retroactive; it only takes effect when received by the USPTO.

To learn more:

To prove that a joint inventor cannot be found or refuses to sign the patent application, you must provide evidence of your diligent efforts. According to MPEP 409.03(a):

“The application must be accompanied by proof that the nonsigning inventor (1) cannot be found or reached after diligent effort or (2) refuses to execute the application papers.”

For specific guidance on what constitutes acceptable proof, refer to MPEP 409.03(d). This may include documented attempts to contact the inventor, returned mail, or written statements from the unavailable inventor indicating their refusal to sign.

To learn more:

The USPTO provides several ways to find a registered patent attorney or agent, as mentioned in MPEP 401:

  1. Visit the USPTO website: www.uspto.gov/FindPatentAttorney for a searchable listing of registered practitioners.
  2. Write to the Office of Enrollment and Discipline (OED) to request a list of registered patent practitioners in your area:

    Mail Stop OED, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450

These resources can help you locate a qualified patent professional to assist with your patent application.

How can I change the correspondence address for multiple patent applications?

Changing the correspondence address for multiple patent applications can be efficiently done using the USPTO’s Customer Number practice. Here’s how:

  1. Obtain a customer number if you don’t already have one.
  2. Associate your patent applications with the customer number.
  3. Update the address linked to the customer number.

The MPEP explains:

A Customer Number may be used to: … (2) change the correspondence address, fee address, or list of practitioners of record for a plurality of applications or patents through a single request. (MPEP 403)

This process eliminates the need to file separate change of address forms for each application, saving time and reducing the risk of errors. To make changes, use the USPTO’s Electronic Filing System (EFS-Web) or file a written request with the USPTO.

For more information on Customer Number, visit: Customer Number.

Applicants can find a new registered patent attorney or agent through resources provided by the USPTO. According to MPEP § 407: “Applicants may obtain a list of registered patent attorneys and agents located in their area by consulting the USPTO website, https://oedci.uspto.gov/OEDCI/, or by calling the Office of Enrollment and Discipline at (571) 272-4097.” These resources allow applicants to search for qualified practitioners who can represent them before the USPTO.

For more information on USPTO Resources, visit: USPTO Resources.

When an applicant’s patent attorney or agent is suspended, they can find a new registered patent attorney or agent by:

  1. Consulting the USPTO website at https://oedci.uspto.gov/OEDCI/
  2. Calling the Office of Enrollment and Discipline at (571) 272-4097

This information is provided in Form Paragraph 4.07 of MPEP § 407.

An heir of a deceased inventor can file a patent application under certain conditions. The MPEP 409.01(b) states:

If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or heirs of the deceased inventor.

To file the application, the heir should:

  • Obtain legal recognition as the heir or legal representative
  • File the application on behalf of the deceased inventor
  • Provide documentation proving their status as heir or legal representative
  • Complete the necessary oath or declaration

It’s advisable to consult with a patent attorney to ensure all legal requirements are met.

To learn more:

An attorney or agent who has been given power of attorney can withdraw by submitting a request to the USPTO. According to MPEP 402.06:

nn

“A registered patent attorney or patent agent who has been given a power of attorney pursuant to § 1.32(b) may withdraw as attorney or agent of record upon application to and approval by the Director.”

nn

The request should briefly state the reason(s) for withdrawal. If based on issues like lack of compensation, it’s recommended to cite “irreconcilable differences” to maintain client confidentiality. The withdrawal is effective when approved by the USPTO, not when received.

nn

Practitioners must take steps to protect the client’s interests when withdrawing, such as giving reasonable notice and allowing time to hire new counsel. The Request for Withdrawal As Attorney or Agent form (PTO/AIA/83) can be used.

For more information on patent representation, visit: patent representation.

For more information on power of attorney, visit: power of attorney.

How can an associate power of attorney be given in applications filed before September 16, 2012?

For applications filed before September 16, 2012, an associate power of attorney can be given by a principal attorney or agent to one or more associate attorneys or agents. According to MPEP 402.02(b):

“For applications filed before September 16, 2012, a power of attorney may be given to one or more attorneys or agents. (37 CFR 1.32(c)(1)). A principal attorney or agent may appoint an associate attorney or agent.”

The associate power of attorney must be signed by the principal attorney or agent who was appointed in the application. It’s important to note that the associate power does not have to be approved by the Office and becomes effective upon submission.

To learn more:

For applications filed on or after September 16, 2012, an assignee must first become the applicant under 37 CFR 1.46(c) to revoke a previously given power of attorney and/or grant a new one. This is because, as stated in the MPEP, any power of attorney must be signed by the applicant or patent owner. The process involves:

  • The assignee becoming the applicant
  • Revoking the previous power of attorney
  • Granting a new power of attorney

For more details on establishing the right of an assignee to take action, refer to MPEP § 325.

To learn more:

For applications filed on or after September 16, 2012:

  • The other joint inventor(s) may file the application on behalf of themselves and the non-signing inventor.
  • A substitute statement can be filed in lieu of an oath or declaration for the non-signing inventor.

As stated in MPEP § 409.02: “If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the other joint inventor or inventors may make the application for patent on behalf of themselves and the omitted inventor.”

For more information on substitute statement, visit: substitute statement.

How can an applicant revoke a power of attorney?

An applicant can revoke a power of attorney by submitting a new power of attorney (Form AIA/82 for applications filed on or after September 16, 2012, or Form PTO/SB/80 for applications filed before September 16, 2012) or by submitting a revocation signed by the applicant. As stated in the MPEP:

“A power of attorney may be revoked at any stage in the proceedings of a case, and an applicant may appoint a new attorney or agent at any stage in the proceedings of the case by filing a new power of attorney.” (MPEP 402)

It’s important to note that the revocation should be clear and unambiguous, and it should be submitted to the USPTO for proper processing.

For more information on power of attorney, visit: power of attorney.

For more information on revocation, visit: revocation.

For patent applications filed before September 16, 2012, an applicant can revoke a power of attorney using Form PTO/SB/81. According to MPEP 402.05(b), “Form PTO/SB/81 may be used to revoke a power of attorney in an application filed before September 16, 2012.” The revocation can be done at any stage of the proceedings by an applicant for patent or an assignee of the entire interest of the applicant.

It’s important to note that fewer than all of the applicants or assignees may revoke the power of attorney only upon showing sufficient cause and paying a petition fee. The patent practitioner will be notified of the revocation, and the notice will be mailed to the correspondence address for the application in effect before the revocation.

To learn more:

How can an applicant revoke a power of attorney filed on or after September 16, 2012?

An applicant can revoke a power of attorney filed on or after September 16, 2012, by following these steps:

  • Submit a new power of attorney (Form AIA/82 or equivalent) that is properly executed by the applicant.
  • File a revocation of the previous power of attorney. This can be done using the revocation form PTO/AIA/82A or by submitting a clear instruction to revoke the previous power of attorney.

According to MPEP 402.02(a):

“The power of attorney may be revoked by filing a revocation of power of attorney. The revocation may be signed by the applicant for patent (all parties identified as the applicant or invention) or the patent owner. A new power of attorney from the applicant for patent (all parties identified as the applicant) or the patent owner may also be filed, which will act as a revocation of the previous power.”

It’s important to note that the new power of attorney must be properly executed by all applicants to be effective in revoking the previous power of attorney.

To learn more:

Under pre-AIA 37 CFR 1.47(b), an applicant can prove irreparable damage by providing a statement that demonstrates the necessity of a filing date. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This statement should explain why obtaining a specific filing date is crucial for preserving the applicant’s rights or preventing significant harm to their interests.

To learn more:

To learn more:

How can an applicant proceed if an inventor is deceased?

If an inventor is deceased, the applicant can proceed with the patent application by filing a petition under 37 CFR 1.47(b). The MPEP states:

“When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or heir of the inventor upon proper intervention.”

To file the petition, the applicant must:

  • Submit the petition fee set forth in 37 CFR 1.17(g)
  • Provide proof of the inventor’s death, such as a death certificate
  • Include an oath or declaration by the legal representative or heir

The legal representative or heir should state their relationship to the deceased inventor and that they are the legal representative or heir.

To learn more:

To learn more:

If an applicant in a pre-AIA 37 CFR 1.47(b) application doesn’t have an assignment or agreement to assign, they can demonstrate sufficient proprietary interest by:

  • Submitting a legal memorandum
  • Providing an affidavit or declaration of firsthand knowledge
  • Including copies of relevant statutes or court decisions (if non-U.S.)

MPEP 409.03(f) states:

“A proprietary interest obtained other than by assignment or agreement to assign may be demonstrated by an appropriate legal memorandum to the effect that a court of competent jurisdiction (federal, state, or foreign) would by the weight of authority in that jurisdiction award title of the invention to the pre-AIA 37 CFR 1.47(b) applicant.”

The legal memorandum should be prepared by an attorney familiar with the relevant jurisdiction’s laws. Supporting facts should be provided through affidavits or declarations from individuals with firsthand knowledge. For non-U.S. jurisdictions, copies of relevant statutes or court decisions (in English) should be included.

To learn more:

To learn more:

When filing under pre-AIA 37 CFR 1.47(b), the applicant must prove proprietary interest in the invention. MPEP 409.03(f) outlines three ways to demonstrate this:

  1. Show the invention has been assigned to the applicant
  2. Prove the inventor agreed in writing to assign the invention to the applicant
  3. Otherwise demonstrate sufficient proprietary interest

To prove assignment, submit:

  • A copy of the assignment document
  • A statement under pre-AIA 37 CFR 3.73(b) by the assignee

For an agreement to assign, provide a copy of the agreement. For other proprietary interest, submit a legal memorandum explaining how a court would likely award title to the applicant.

The MPEP states: If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant.

To learn more:

To learn more:

Registered practitioners can show authorization to conduct an interview in several ways:

  • By being an attorney or agent of record with a power of attorney
  • By having an authorization to act in a representative capacity
  • By completing, signing, and filing an Applicant Initiated Interview Request Form (PTOL-413A)

The MPEP states: Registered practitioners, when acting in a representative capacity, can show authorization to conduct an interview by completing, signing and filing an Applicant Initiated Interview Request Form (PTOL-413A). This method is particularly convenient as it eliminates the need to file a power of attorney or authorization to act in a representative capacity before having an interview.

Alternatively, practitioners can use Form PTO/SB/84, ‘Authorization to Act in a Representative Capacity,’ available on the USPTO website.

For more information on USPTO Forms, visit: USPTO Forms.

Tags: USPTO Forms

A registered patent attorney or agent who has been given a power of attorney can withdraw as attorney or agent of record by following these steps:

  • File an application for withdrawal with the USPTO Director
  • Obtain approval from the Director
  • Provide notice to the client

As stated in 37 CFR 1.36(b): A registered patent attorney or patent agent who has been given a power of attorney pursuant to § 1.32(b) may withdraw as attorney or agent of record upon application to and approval by the Director. The applicant or patent owner will be notified of the withdrawal of the registered patent attorney or patent agent.

It’s important to note that the withdrawal is effective only when approved by the USPTO, not when the request is received.

To learn more:

How can a practitioner become of record in a patent application filed on or after September 16, 2012?

A practitioner can become of record in a patent application filed on or after September 16, 2012, through the following methods:

  • Filing an Application Data Sheet (ADS) that names the practitioner as the representative
  • Filing a power of attorney (POA) signed by the applicant
  • Filing a patent application transmittal letter signed by the applicant and naming the practitioner as a representative
  • Being named as the representative in the oath or declaration

As stated in MPEP 403.01(a): ‘A power of attorney or authorization of agent may be given to a customer number in applications filed on or after September 16, 2012.’ This allows for easier management of multiple practitioners associated with a single customer number.

To learn more:

A person who shows sufficient proprietary interest in an invention can file a patent application as the applicant. According to MPEP § 409.05, such a person must submit a petition including:

  1. The fee set forth in 37 CFR 1.17(g)
  2. A showing of sufficient proprietary interest in the matter
  3. A statement that making the application on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

The proprietary interest can be demonstrated by a legal memorandum showing that a court would likely award title of the invention to the applicant. Supporting facts and documentation should be provided.

For more information on proprietary interest, visit: proprietary interest.

A registered patent attorney or agent who has been given a power of attorney may withdraw as attorney or agent of record by submitting a request to the USPTO. The process involves:

  1. Filing a request for withdrawal with the USPTO
  2. Obtaining approval from the Director of the USPTO
  3. Notifying the applicant or patent owner of the withdrawal

MPEP 402.06 states: “When filing a request to withdraw as attorney or agent of record, the patent attorney or agent should briefly state the reason(s) for which he or she is withdrawing so that the Office can determine whether to grant the request.”

The practitioner must also take steps to protect the client’s interests, such as giving reasonable notice and allowing time for the client to find new representation.

How can a legal representative file a patent application for a deceased inventor?

For patent applications filed on or after September 16, 2012, a legal representative can file a patent application for a deceased inventor by following these steps:

  • Submit an Application Data Sheet (ADS) naming the deceased inventor
  • Include a substitute statement in lieu of an inventor’s oath or declaration
  • Provide documentation showing the legal representative’s authority to act on behalf of the deceased inventor’s estate

The MPEP states: If an inventor dies during the prosecution of an application, or before an application is filed, the legally recognized representative of the inventor may make the substitute statement. (MPEP 409.01(a))

It’s important to note that the legal representative must have the authority to act on behalf of the deceased inventor’s estate or other legal entity holding the appropriate rights.

To learn more:

How can a legal representative file a patent application for a deceased inventor after September 16, 2012?

For patent applications filed on or after September 16, 2012, a legal representative can file an application for a deceased inventor by following these steps:

  • File the application normally, listing the deceased inventor
  • Submit an Application Data Sheet (ADS) identifying the legal representative
  • Include a substitute statement in lieu of an inventor’s oath or declaration

According to MPEP 409.01(a): “If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent as provided in 37 CFR 1.43.” The legal representative must provide documentation of their authority to act on behalf of the deceased inventor.

To learn more:

A juristic entity (e.g., corporations, universities, or other organizations) can give power of attorney in a patent application through an appropriate official. According to MPEP 402:

‘Where the applicant is a juristic entity (e.g., organizational assignee), a power of attorney must be signed by a person authorized to act on behalf of the applicant.’

The process typically involves:

  • An official with signing authority (e.g., CEO, president, or authorized patent counsel) signs the power of attorney form.
  • The signed form is submitted to the USPTO along with the patent application or separately if done after filing.
  • If requested by the USPTO, documentation may need to be provided to establish the authority of the person signing on behalf of the juristic entity.

It’s important to ensure that the person signing has the actual authority to bind the juristic entity in patent matters.

For more information on juristic entity, visit: juristic entity.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How can a joint inventor apply for a patent if another joint inventor is deceased or legally incapacitated?

If a joint inventor is deceased or legally incapacitated, the other joint inventor(s) can still apply for a patent by following these steps:

  • File the application naming the deceased or legally incapacitated inventor
  • Submit a statement identifying the unavailable inventor and their last known address
  • Show that the signing inventor is obligated to assign the patent to the same entity as the unavailable inventor, or has sufficient proprietary interest
  • Submit the oath or declaration by the available inventor(s)

As stated in MPEP 409.01(a): “In the case of a deceased or legally incapacitated joint inventor, the applicant should identify the unavailable inventor on an application data sheet (ADS) or a substitute statement.”

This process allows the patent application to move forward despite the unavailability of one of the joint inventors.

To learn more:

The rights of nonsigning inventors in pre-AIA 37 CFR 1.47 applications are protected through specific provisions in patent law. According to MPEP 409.03(i):

“The rights of a nonsigning inventor are protected by the fact that the patent resulting from an application filed under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118 must issue to the inventor, and in an application filed under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the inventor has the same rights that he or she would have if he or she had joined in the application.”

This means that:

  • For applications under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118, the patent must be issued to the inventor, even if they didn’t sign the application.
  • For applications under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the nonsigning inventor retains the same rights as if they had joined the application.

These provisions ensure that the nonsigning inventor’s rights to the invention are preserved, regardless of their lack of signature on the original application.

To learn more:

To learn more:

When all inventors are unavailable or unwilling to sign a patent application, there are still options for filing. According to MPEP § 409.03(b) (for applications filed before September 16, 2012) and MPEP § 409.05 (for applications filed on or after September 16, 2012):

  • An assignee or obligated assignee may file the application as the applicant
  • A person who shows sufficient proprietary interest in the matter may file the application

In such cases, substitute statements would need to be filed in lieu of inventors’ oaths or declarations, along with the necessary petitions and evidence of the applicant’s right to file the application.

For more information on assignee applicant, visit: assignee applicant.

For more information on proprietary interest, visit: proprietary interest.

In a pre-AIA 37 CFR 1.47 application, papers filed by an inventor who did not initially join the application are handled as follows:

“Papers filed by an inventor who did not originally join in the application, and papers relating to its pre-AIA 37 CFR 1.47 status, will be placed in the file wrapper.”

This means that any documents submitted by the previously non-signing inventor, as well as any paperwork related to the application’s pre-AIA 37 CFR 1.47 status, are included in the official application file for record-keeping and potential future reference.

To learn more:

To learn more:

The USPTO accepts handwritten signatures in patent applications, but they must meet specific requirements:

  • The signature must be personally applied by the signer.
  • It can be in permanent dark ink or its equivalent.
  • The entire signature must be contained within the signature area of the document.

According to MPEP 402.03: A handwritten signature must be personally applied by the signer. See 37 CFR 1.4(d)(1).

It’s important to note that while handwritten signatures are accepted, the USPTO encourages electronic filing and signatures for efficiency and accuracy in processing applications.

To learn more:

For continuation or divisional applications filed under 37 CFR 1.53(b) of an application previously accorded status under pre-AIA 37 CFR 1.47, the process is simplified. The MPEP states: In a continuation or divisional application filed under 37 CFR 1.53(b) of an application accorded status under pre-AIA 37 CFR 1.47, if a copy of a declaration from a prior application and a copy of a decision according status under pre-AIA 37 CFR 1.47 are filed as permitted by pre-AIA 37 CFR 1.63(d)(3)(i), the notice will not be repeated.

This means that if the proper documentation from the original application is provided, the USPTO won’t repeat the notification process for nonsigning inventors. This streamlines the application process for related applications.

To learn more:

To learn more:

No, this specific requirement does not apply to all patent applications. The MPEP clearly states:

‘[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]’

This means that the requirement to provide the last known address of a nonsigning inventor is only applicable to pre-AIA applications filed before September 16, 2012, under 37 CFR 1.47. For applications filed on or after this date, different rules may apply, and applicants should consult the current USPTO guidelines or seek legal advice.

To learn more:

To learn more:

Pre-AIA 37 CFR 1.47 does not directly apply to deceased inventors. The MPEP clearly states: Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

However, pre-AIA 37 CFR 1.47 does apply in cases where a known legal representative of a deceased inventor:

  • Cannot be found or reached after diligent effort, or
  • Refuses to make application

In such situations, the last known address of the legal representative must be provided, as per MPEP § 409.03(e).

To learn more:

To learn more:

Can the USPTO independently verify information provided by patent applicants?

Yes, the USPTO has the authority to independently verify information provided by patent applicants. MPEP 410 states:

“The Office is not the guarantor of the accuracy, correctness or completeness of the information supplied by the applicant.”

This means that while the USPTO relies on the information provided by applicants, it may:

  • Conduct its own investigations
  • Request additional information or evidence
  • Consult external sources to verify claims

Applicants should be aware that the USPTO can and may verify any information submitted during the patent application process. It’s crucial to provide accurate and complete information to avoid potential legal issues or loss of patent rights.

For more information on patent application information, visit: patent application information.

No, the USPTO cannot assist in selecting a patent practitioner. According to MPEP 401, “The Office cannot aid in the selection of a patent practitioner.” However, the USPTO does provide resources for finding registered patent attorneys and agents:

  • A listing is available at www.uspto.gov/FindPatentAttorney
  • Applicants can request a list of registered practitioners in their area by writing to the Office of Enrollment and Discipline (OED)

Patent practitioners should not rely on information from reserved MPEP sections, as these sections do not contain any official guidance or information. A reserved section, such as MPEP 404, is essentially a placeholder and does not provide any substantive content. Practitioners should instead:

  • Refer to active, non-reserved sections of the MPEP
  • Consult the most recent USPTO guidelines and notices
  • Stay updated on changes to patent laws and regulations
  • Seek guidance from official USPTO sources when needed

It’s important to always use the most current and official information when dealing with patent matters.

Can one co-inventor revoke a power of attorney in a patent application?

No, a single co-inventor cannot unilaterally revoke a power of attorney in a patent application. The MPEP 402.10 states:

A power of attorney may not be revoked by less than all of the applicants or owners of the entire interest without good and sufficient reason, and the revocation must be approved by the Director.

This means that to revoke a power of attorney, all co-inventors or owners of the entire interest must agree to the revocation. If a single co-inventor wishes to revoke the power of attorney, they must provide a good and sufficient reason, and the revocation must be approved by the Director of the USPTO.

To learn more:

Yes, non-US citizens, specifically nonimmigrant aliens residing in the United States, can obtain limited recognition for patent matters under certain conditions. According to MPEP 402.09 and 37 CFR 11.9(b):

A nonimmigrant alien residing in the United States and fulfilling the provisions of paragraphs (d) and (e) of this section may be granted limited recognition if the nonimmigrant alien is authorized by the United States Government to be employed or trained in the United States in the capacity of representing a patent applicant by presenting or prosecuting a patent application.

However, it’s important to note that limited recognition is not granted to non-US citizens residing abroad and automatically expires upon the nonimmigrant alien’s departure from the United States.

To learn more:

No, non-registered representatives should not be contacted for patent application actions, even if they appear to be authorized by the attorney or agent of record. The MPEP clearly states:

In addition, non-registered representatives of the practitioner of record should not be contacted for such actions, even if apparently authorized by the attorney or agent of record.

This restriction helps maintain the integrity of the patent application process and ensures that only qualified, registered practitioners are involved in critical communications.

Generally, the USPTO maintains only one correspondence address for each patent application. As stated in MPEP 403:

‘The Office will direct all notices, official letters, and other communications relating to the application to a single correspondence address.’

However, there are exceptions:

  • Powers of attorney to different practitioners may be present in an application, but only one correspondence address is recognized.
  • In reexamination proceedings, a ‘duplicate copy’ may be sent to a different address.
  • Maintenance fee reminders may be sent to a ‘fee address’ that differs from the correspondence address.

It’s important to note that while multiple addresses may be associated with an application for specific purposes, the USPTO will generally communicate with only one primary correspondence address.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on USPTO, visit: USPTO.

While it’s possible to include multiple correspondence addresses for a single patent application filed after September 16, 2012, the USPTO will ultimately select only one for official use. Here’s what you need to know:

  • Multiple addresses can be provided in the application
  • The USPTO will choose one address as the official correspondence address
  • If a Customer Number is provided, it may be given preference
  • Only the selected address will receive official communications

The MPEP 403.01(a) states:

Pursuant to 37 CFR 1.33(a), if an applicant includes more than one correspondence address (37 CFR 1.33(a) ) in a patent application, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

To ensure clear communication, it’s best to designate a single, preferred correspondence address for your application. If you need to change this address later, you can file a request with the USPTO.

To learn more:

Yes, multiple attorneys can be appointed in a patent application. According to MPEP 402.02:

More than one attorney, agent, or other party may be appointed as representative of the applicant or owner.

When appointing multiple attorneys:

  • Use the appropriate power of attorney form (PTO/AIA/82 for applications filed on or after September 16, 2012, or PTO/SB/81 for earlier applications).
  • List all attorneys or agents to be appointed.
  • Specify if they are to act independently or as a team.

To learn more:

Can limited recognition be granted to Canadian patent agents?

Yes, limited recognition can be granted to Canadian patent agents. According to MPEP 402.01: Canadian patent agents are not authorized to practice before the Office without proper recognition from the OED Director. Canadian patent agents who are registered and in good standing with the Canadian Patent Office may be granted limited recognition to represent a named applicant in a specific application if the named applicant also appoints a registered U.S. practitioner. This provision allows Canadian patent agents to participate in specific applications, but with certain restrictions and requirements.

To learn more:

To learn more:

Yes, individuals granted limited recognition can file certain documents in patent applications. According to the MPEP 402.01:

Persons granted limited recognition are considered practitioners under 37 CFR 11.1 and thus permitted to perform the same patent prosecution functions of registered patent agents and registered patent attorneys when prosecuting a specified patent application or specified patent applications.

Specifically, they can file:

However, it’s important to note that these individuals are still subject to the restrictions expressed in their grant, including temporal, employer, and visa limitations.

To learn more:

Yes, in most cases. According to MPEP 401, “An applicant for patent, other than a juristic entity (e.g., organizational assignee), may file and prosecute their own application, and thus act as their own representative (pro se) before the Office.” However, there are important considerations:

  • Juristic entities (e.g., companies) must be represented by a patent practitioner
  • Pro se applicants are subject to the same rules and potential sanctions as represented applicants
  • Lack of familiarity with patent procedures may result in missed opportunities for optimal protection

Yes, heirs can apply for a patent on behalf of a deceased inventor under certain circumstances. According to MPEP 409.01(b):

“Application may be made by the heirs of the inventor, as such, if there is no will or the will did not appoint an executor and the estate was under the sum required by state law for the appointment of an administrator.”

In such cases, the heirs should identify themselves as the legal representative of the deceased inventor in the oath or declaration submitted pursuant to pre-AIA 37 CFR 1.63 and 1.64. This allows heirs to proceed with the patent application process when no formal legal representative has been appointed.

To learn more:

Tags: pre-AIA

Yes, examiners can initiate interview requests with patent practitioners of record. The MPEP encourages this practice to expedite prosecution:

The Office encourages the use of interviews to expedite prosecution. When the examiner believes the progress of the application would be advanced by an interview, the examiner may contact the patent practitioner of record in the application (in accordance with MPEP § 713) and suggest a telephonic, personal, or video conference interview.

This proactive approach by examiners can help clarify issues and potentially speed up the patent application process.

Can an inventor’s attorney conduct an interview without a power of attorney?

Yes, an inventor’s attorney can conduct an interview without a power of attorney under certain conditions. The MPEP 405 provides guidance on this matter:

Interviews may be granted to an attorney or agent who is not of record in an application if the conditions of 37 CFR 1.33(b)(3) are satisfied.

This means that if the attorney or agent complies with the requirements set forth in 37 CFR 1.33(b)(3), they can conduct an interview even without a formal power of attorney. These requirements typically include providing evidence of their authority to act on behalf of the applicant.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO procedures, visit: USPTO procedures.

No, an inventor cannot authorize another individual to act as their agent to sign the application oath or declaration on their behalf. The MPEP is clear on this point, stating: “An inventor may not authorize another individual to act as his or her agent to sign the application oath or declaration on his or her behalf.”

This prohibition is supported by legal precedents, as the MPEP cites: “Staeger v. Commissioner, 189 USPQ 272 (D.D.C. 1976), In re Striker, 182 USPQ 507 (Comm’r Pat. 1973).” These cases reinforce the requirement for the inventor’s personal signature on the oath or declaration.

To learn more:

Tags: pre-AIA

Can an attorney withdraw from patent representation without client consent?

While it’s generally preferable to obtain client consent, an attorney can withdraw from patent representation without client consent under certain circumstances. However, they must still follow proper procedures and notify the USPTO. The MPEP 402.06 states:

“The requirements for withdrawal of an attorney or agent are set forth in 37 CFR 1.36. The Office of Enrollment and Discipline (OED) handles withdrawal of entire firms.”

Key points to consider:

  • The attorney must provide notice to the client and the USPTO.
  • Reasons for withdrawal without consent may include ethical conflicts or non-payment of fees.
  • The USPTO may require the attorney to show good cause for withdrawal.
  • The withdrawal should not unduly prejudice the client’s interests.

Attorneys should consult 37 CFR 1.36 and applicable state bar rules when considering withdrawal without client consent.

To learn more:

Can an attorney withdraw from a patent application without the applicant’s consent?

Yes, an attorney can withdraw from a patent application without the applicant’s consent under certain circumstances. However, the withdrawal must be approved by the USPTO. The MPEP 402.06 states:

‘An attorney or agent may withdraw from representing an applicant or assignee in a patent application pending before the USPTO… When appropriate, the Office will require the applicant or assignee to revoke the previous power of attorney and appoint new attorney(s) of record.’

While the applicant’s consent is not explicitly required, the USPTO considers the following factors when deciding whether to approve a withdrawal:

  • The reasons for withdrawal
  • The stage of prosecution
  • The potential impact on the applicant

The USPTO may deny the withdrawal if it would unduly prejudice the applicant or delay the prosecution of the application.

To learn more:

Can an assignee revoke power of attorney in all types of patent applications?

An assignee’s ability to revoke power of attorney applies to most, but not all, types of patent applications. According to MPEP 402.07, there are specific scenarios where this is explicitly allowed:

“For applications involved in an interference or derivation proceeding, 37 CFR 41.5(b) or 42.10(e) provides that the assignee of the entire interest in an application or patent involved in the proceeding may act to the exclusion of the inventor. For national stage applications under 35 U.S.C. 371, the assignee may revoke any power of attorney of the applicant in the national stage application filed under 35 U.S.C. 371 and appoint any representative if the assignee has properly made itself of record in the national stage application pursuant to 37 CFR 3.71.”

This means assignees can revoke power of attorney in:

  • Applications involved in interference or derivation proceedings
  • National stage applications under 35 U.S.C. 371

For other types of applications, the general rule applies where the assignee must first become of record and then can revoke the applicant’s power of attorney. It’s important to consult with a patent attorney or agent for specific cases to ensure compliance with USPTO regulations.

To learn more:

In general, an assignee can revoke a power of attorney in most applications. However, there is an exception for certain government-owned applications. The MPEP states:

In applications filed before September 16, 2012, the assignee of record of the entire interest can revoke the power of attorney of the applicant unless an ‘irrevocable’ right to prosecute the application had been given as in some government owned applications.

This implies that in some government-owned applications, an irrevocable right to prosecute may have been granted, which would prevent the assignee from revoking the power of attorney. If you’re dealing with a government-owned application, it’s crucial to check whether such an irrevocable right exists before attempting to revoke a power of attorney.

To learn more:

Can an assignee revoke a power of attorney given by the applicant in a patent application?

Yes, an assignee can revoke a power of attorney given by the applicant in a patent application, provided certain conditions are met. According to MPEP 402.07:

“The assignee of the entire interest can revoke the power of attorney of the applicant and appoint its own patent practitioner.”

This is possible when:

  • The assignee has properly become of record pursuant to 37 CFR 3.71.
  • The application is involved in an interference or derivation proceeding.
  • The application is national stage application filed under 35 U.S.C. 371.

It’s important to note that the assignee must follow proper procedures and file the necessary documents with the USPTO to effectuate this change.

To learn more:

Yes, for applications filed on or after September 16, 2012, an assignee can file a patent application as the applicant. According to MPEP § 409.05:

“An assignee or obligated assignee may file a patent application as the applicant. An assignee or obligated assignee doing so should record documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for an obligated assignee) as provided for in 37 CFR part 3 no later than the date the issue fee is paid in the application.”

However, to be the sole applicant, the assignee must have been assigned the entire interest in the application.

For more information on patent applicant, visit: patent applicant.

Yes, an assignee can conduct patent prosecution after attorney withdrawal under certain conditions:

  • The assignee must have originally appointed the withdrawing attorney or agent.
  • The assignee becomes recognized by the Office for all purposes in the application.
  • The assignee can sign amendments and other papers related to the prosecution.

The MPEP 402.06 states: ‘If the applicant is the assignee who appointed the withdrawing attorney or agent, the applicant may conduct the prosecution of the application, for example, by signing amendments and other papers related to the prosecution of the application.’

It’s important to note that while assignees can conduct prosecution, they may benefit from seeking new professional representation to navigate the complex patent process effectively.

To learn more:

An assignee’s ability to appoint a power of attorney in a patent application depends on whether the assignee is the applicant. According to the MPEP:

  • An assignee who is the applicant may appoint an effective power of attorney without the need to establish the right to take action under 37 CFR 3.71.
  • An assignee who is not the applicant may sign a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c), which requires compliance with 37 CFR 3.71 and 3.73.

As stated in the MPEP, “An assignee or obligated assignee who is the applicant may appoint an effective power of attorney without the need to establish the right to take action under 37 CFR 3.71.” However, “An assignee who is not the applicant may sign a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c) (which requires compliance with 37 CFR 3.71 and 3.73).”

It’s important to note that an assignee who is not an applicant cannot revoke or appoint a power of attorney in a patent application without first becoming the applicant.

To learn more:

Can an applicant communicate directly with the USPTO if they have a registered patent attorney?

Generally, when an applicant is represented by a registered patent attorney or agent, direct communication between the applicant and the USPTO is discouraged. The USPTO has specific rules regarding this situation:

  • The USPTO will communicate directly with the registered attorney or agent of record.
  • Applicants should channel their communications through their appointed representative.
  • Direct communication from the applicant may not be officially recognized or acted upon by the USPTO.

MPEP 403.01 clearly states: “The Office will not engage in double correspondence with an applicant and a patent practitioner, or with more than one patent practitioner except as deemed necessary by the Director.” This policy ensures clear and efficient communication channels and prevents potential confusion or contradictory instructions. If an applicant wishes to communicate directly, they should first revoke the power of attorney or authorization of agent on record.

To learn more:

Yes, an applicant can appoint two patent practitioners for the same application. However, when doing so, it’s important to specify the correspondence address. As stated in the MPEP:

“If the applicant simultaneously appoints two patent practitioners, applicant should indicate with whom correspondence is to be conducted by specifying a correspondence address.”

This ensures clear communication between the USPTO and the applicant’s representatives. For more details, refer to MPEP § 403, MPEP § 403.01(a), and MPEP § 403.01(b).

To learn more:

Can a withdrawn attorney continue to receive Office communications for a patent application?

No, a withdrawn attorney should not continue to receive Office communications for a patent application. The MPEP 402.06 clearly states:

“An attorney or agent withdrawing from an application who wishes to cease receiving copies of communications from the Office must submit a request that the correspondence cease.”

This means that unless the withdrawn attorney explicitly requests to stop receiving communications, they may continue to receive them. However, it’s important to note that the withdrawn attorney is no longer authorized to act on behalf of the application. To ensure proper handling of the application, the withdrawn attorney should request that correspondence cease, and the applicant or new representative should update the correspondence address with the USPTO.

To learn more:

No, a third party or its representative cannot use the provisions of 37 CFR 1.34 to conduct an interview or take other actions not specifically permitted by the rules of practice. MPEP 405 states:

The use of the provisions of 37 CFR 1.34 by a third party or its representative to conduct an interview, or take other action not specifically permitted by the rules of practice in an application for patent, is considered a violation of 37 CFR 11.18 and may result in disciplinary action if done by a practitioner.

This means that attempting to use 37 CFR 1.34 for unauthorized actions could lead to disciplinary consequences for registered practitioners.

Generally, third parties are not permitted to conduct interviews or take actions in patent applications. The MPEP clearly states:

The use of the provisions of 37 CFR 1.34 by a third party or its representative to conduct an interview, or take other action not specifically permitted by the rules of practice in an application for patent, is considered a violation of 37 CFR 11.18 and may result in disciplinary action if done by a practitioner.

This means that only authorized representatives (such as registered attorneys or agents with proper authorization) can conduct interviews or take actions on behalf of the applicant. Third parties attempting to do so may face disciplinary action, especially if they are registered practitioners.

For more information on disciplinary action, visit: disciplinary action.

For more information on patent interviews, visit: patent interviews.

No, a suspended or excluded practitioner is not permitted to receive correspondence from the USPTO regarding patent applications. According to MPEP 407:

A suspended or excluded practitioner is not entitled to receive correspondence from the Office, or have interviews with examiners, in applications or patents.

The USPTO takes the following steps to ensure compliance:

  • Correspondence will be sent to the applicant or assignee at their address of record.
  • If no practitioner is of record, the correspondence will be sent directly to the applicant or assignee.
  • Examiners are instructed not to hold interviews with suspended or excluded practitioners.

For more information on USPTO correspondence, visit: USPTO correspondence.

Yes, registered patent practitioners can file papers in patent applications and reexamination proceedings without being of record. MPEP 405 states:

Papers may be filed in patent applications and reexamination proceedings by registered attorneys or agents not of record under 37 CFR 1.34. Filing of such papers is considered to be a representation that the attorney or agent is authorized to act in a representative capacity on behalf of applicant.

This means that by filing papers, the practitioner is implicitly stating they have authorization to act on behalf of the applicant, even if they are not officially recorded as the attorney or agent of record.

Yes, a pre-AIA 37 CFR 1.47 application can be published as a Statutory Invention Registration, but with a specific condition. According to the MPEP:

“An application filed under pre-AIA 37 CFR 1.47 can be published as a Statutory Invention Registration (provided the request for a Statutory Invention Registration was filed before March 16, 2013).”

It’s important to note that this option is only available for requests filed before March 16, 2013, as the America Invents Act eliminated Statutory Invention Registrations for applications filed on or after that date.

To learn more:

To learn more:

Yes, a Pre-AIA 37 CFR 1.47 application can be converted to a regular application if the previously non-signing inventor later submits an executed oath or declaration. The MPEP 409.03(j) states:

‘If a 37 CFR 1.47 applicant submits an executed oath or declaration of the nonsigning inventor, the executed oath or declaration should be accepted by the Office and the application no longer treated under 37 CFR 1.47.’

This means that once the missing oath or declaration is submitted, the application will be processed as a regular application, removing the special 37 CFR 1.47 status.

To learn more:

To learn more:

The USPTO has specific rules regarding withdrawal for practitioners acting in a representative capacity under 37 CFR 1.34:

  • The USPTO will not approve withdrawal requests from practitioners acting in a representative capacity.
  • These practitioners are responsible for the correspondence they file in the application while acting in a representative capacity.
  • There is no need for these practitioners to obtain the USPTO’s permission to withdraw from representation.

However, it’s important to note that practitioners acting in a representative capacity, like those with power of attorney, remain responsible for compliance with 37 CFR 1.56 (duty of disclosure) and 37 CFR 11.18 (signature and certification requirements) for documents they file.

This distinction ensures that practitioners understand their ongoing responsibilities even when acting in a limited representative capacity.

To learn more:

Can a practitioner act on behalf of an applicant without a power of attorney?

Yes, a practitioner can act on behalf of an applicant without a power of attorney in certain circumstances. According to MPEP 402.04:

‘A practitioner may in some circumstances within the discretion of the Office act without any power of attorney or authorization of agent when it appears necessary to preserve the rights of the applicant.’

This provision allows for urgent action to be taken to protect the applicant’s interests, even if a formal power of attorney is not in place. However, it’s important to note that this is at the discretion of the USPTO and is typically limited to situations where immediate action is necessary to prevent loss of rights.

To learn more:

Generally, a power of attorney must be signed by all applicants or owners of a patent application. However, there are exceptions:

  1. For revocation: A power of attorney signed by less than all applicants/owners may be accepted if accompanied by a petition under 37 CFR 1.36(a) and fee, with a showing of sufficient cause.
  2. For appointment: A power of attorney signed by less than all applicants/owners may be accepted if accompanied by a petition under 37 CFR 1.183 and fee, demonstrating an extraordinary situation where justice requires waiver of the requirement.

MPEP 402.10 states: “The appointment and/or revocation are not accepted until the petition under 37 CFR 1.36(a) or 1.183 is granted. Therefore, the attorney or agent newly appointed by such papers is not permitted to submit any documents (such as an information disclosure statement (IDS)) into the application file until the petition under 37 CFR 1.36(a) or 1.183 is granted.”

Can a power of attorney be revoked in applications filed before September 16, 2012?

Yes, a power of attorney can be revoked in applications filed before September 16, 2012. The MPEP 402.02(b) states:

“A power of attorney may be revoked at any stage in the proceedings of a case.”

The revocation process for pre-September 16, 2012 applications involves the following:

  • The revocation must be in writing.
  • It must be signed by the applicant or the assignee of the entire interest of the applicant.
  • The revocation is not effective until it is accepted by the Office.

It’s important to note that revoking a power of attorney does not automatically grant power to a new attorney. A new power of attorney must be filed to appoint a new representative.

To learn more:

Yes, a power of attorney can be revoked in a patent application. The process for revocation is outlined in MPEP 402:

‘The power of attorney may be revoked at any time. Pursuant to 37 CFR 1.36(a), an applicant may revoke a power of attorney by filing a new power of attorney that is not directed to the patent practitioner(s) of record.’

To revoke a power of attorney:

  • File a new power of attorney form (PTO/AIA/82) with the USPTO.
  • The new form should either name new representative(s) or indicate that the applicant wishes to prosecute the application pro se (without an attorney).
  • Ensure the form is signed by the applicant or, in the case of a juristic entity, by an authorized official.
  • Submit the form through the USPTO’s Electronic Filing System (EFS-Web) or by mail.

It’s important to note that merely filing a new power of attorney automatically revokes the previous one. There’s no need for a separate revocation document unless you want to revoke without appointing a new representative.

For more information on power of attorney, visit: power of attorney.

For more information on pro se, visit: pro se.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

The revocation of a power of attorney must be done in writing and cannot be accomplished through informal means such as telephone or email. The MPEP 402.05 states:

A power of attorney may not be revoked by a telephone call.

While this quote specifically mentions telephone calls, the same principle applies to emails or other informal communications. To properly revoke a power of attorney, applicants must submit a written revocation document or a new power of attorney that complies with the requirements set forth in MPEP 402. This ensures that the revocation is properly documented and effective in the patent application process.

To learn more:

Yes, a power of attorney can be revoked by fewer than all of the applicants, but with certain conditions. According to MPEP 402.05:

‘A power of attorney may be revoked by fewer than all of the applicants (or fewer than all patent owners in a reexamination proceeding or supplemental examination proceeding) if the power was granted by fewer than all of the applicants or patent owners.’

This means:

  • If the original power of attorney was granted by all applicants, it must be revoked by all applicants.
  • If the original power was granted by a subset of applicants, that same subset can revoke it.
  • In cases of joint inventors, careful consideration must be given to who originally granted the power.

To learn more:

No, a power of attorney cannot be partially revoked for specific patent applications. The MPEP 402.05 states:

‘A principal cannot revoke selected powers of the power of attorney while leaving other powers in effect.’

This means that when revoking a power of attorney, it must be revoked in its entirety for all applications and patents to which it was applied. If you wish to maintain representation for certain applications while revoking others, you would need to file a new power of attorney for those specific applications you want to keep under representation.

To learn more:

Can a power of attorney be granted to a foreign patent attorney or agent?

In general, a power of attorney in U.S. patent applications can only be granted to practitioners who are registered to practice before the USPTO. According to MPEP 402.02:

“The Office cannot recognize more than one power of attorney in an application at any given time. However, a registered attorney or agent may be appointed in a representative capacity under 37 CFR 1.34 in addition to any power of attorney that may be in effect.”

While foreign patent attorneys or agents cannot be directly granted power of attorney, they can work with U.S. registered practitioners who can be appointed. Additionally, foreign attorneys can be recognized as representatives under 37 CFR 1.34 for limited purposes, such as filing papers or receiving Office communications.

To learn more:

Can a power of attorney be granted to a foreign attorney or agent for US patent applications?

A power of attorney for US patent applications can only be granted to individuals who are registered to practice before the USPTO. Foreign attorneys or agents who are not registered with the USPTO cannot be granted power of attorney.

According to MPEP 402: “The Office cannot recognize more than one power of attorney or authorization to act in a representative capacity in a particular application or patent at any given time.” This means that only USPTO-registered practitioners can be given power of attorney.

However, foreign attorneys can work with US-registered patent practitioners who can be granted power of attorney. The foreign attorney can then collaborate with the US-registered practitioner to manage the application.

For more information on power of attorney, visit: power of attorney.

Generally, papers giving or revoking a power of attorney in an application require signatures from all applicants or owners. However, there are exceptions:

  • For revocation: A petition under 37 CFR 1.36(a) with a fee and showing of sufficient cause is required.
  • For appointment: A petition under 37 CFR 1.183 with a fee, demonstrating an extraordinary situation where justice requires waiver of the requirement in 37 CFR 1.32(b)(4), is necessary.

As stated in the MPEP: “Papers giving or revoking a power of attorney in an application generally require signature by all the applicants or owners of the application.”

To learn more:

Yes, a petition under 37 CFR 1.47(a) can be filed for multiple unavailable inventors. The MPEP 409.03(b) states:

‘Where there are joint inventors, each nonsigning inventor must be petitioned for separately, even if more than one nonsigning inventor is unavailable.’

This means that while a single petition can cover multiple unavailable inventors, the petition must address each inventor individually, providing specific information and evidence for each one’s unavailability.

To learn more:

To learn more:

Yes, a person can sign patent documents on behalf of a juristic entity, but there are specific requirements:

According to MPEP 402.03: ‘Papers submitted on behalf of juristic entities must be signed by a person having authority to sign for the juristic entity.’

This means:

  • The signer must have the legal authority to act on behalf of the entity.
  • For corporations, this typically includes officers or agents appointed by the board.
  • For partnerships, a partner may sign.
  • For universities, an authorized official may sign.

It’s crucial to ensure the signer has proper authorization to avoid potential issues with the patent application.

To learn more:

No, a patent practitioner acting in a representative capacity cannot represent only some of the applicants in a joint application. According to MPEP 402.04, when a patent practitioner files a paper in an application filed on or after September 16, 2012, they must be submitting the paper on behalf of all parties identified as the applicant.

The MPEP explicitly states: “The provisions of 37 CFR 1.34 in no way convey authority for a patent practitioner to submit papers in an application only on behalf of some of the parties identified as the applicant.”

For example, if there are three joint inventors who disagree about how to proceed with the application, a patent practitioner representing only one inventor cannot file papers to the exclusion of the other joint inventors. Similarly, when there are multiple assignees identified as the applicant, a patent practitioner cannot file papers on behalf of only some of the parties.

To learn more:

Yes, a registered patent practitioner who is not of record can conduct an interview if they have proper authorization from the applicant. According to MPEP 405:

Interviews may be conducted with a registered practitioner who has proper authority from the applicant, or an attorney or agent of record in the form of a power of attorney or authorization to act in a representative capacity, whether or not the practitioner has a copy of the application file.

The practitioner can show authorization by completing, signing, and filing an Applicant Initiated Interview Request Form (PTOL-413A) or using Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity’.

Can a patent practitioner appointed in the Application Data Sheet (ADS) withdraw from representation?

Yes, a patent practitioner appointed in the Application Data Sheet (ADS) can withdraw from representation, but there are specific procedures to follow:

  • The practitioner must submit a request to withdraw.
  • The request must comply with 37 CFR 1.36.
  • The USPTO must approve the withdrawal.

According to MPEP 402.02(a): “A patent practitioner named in the Application Data Sheet may withdraw as attorney or agent of record upon application to and approval by the USPTO.”

It’s important to note that the practitioner remains responsible for the application until the USPTO approves the withdrawal. The applicant should ensure continuous representation to avoid missing important communications from the USPTO.

To learn more:

No, a patent practitioner cannot appoint a substitute to take over their cases after death. The MPEP 406 clearly states: “The patent practitioner may not appoint a ‘substitute’ and any attempt by the patent practitioner to appoint a ‘substitute’ patent practitioner whose power is intended to survive his or her own will not be recognized by the Office.” This means that any arrangements made by a practitioner for a substitute after their death will not be valid in the eyes of the USPTO.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO policy, visit: USPTO policy.

No, a patent practitioner cannot appoint a substitute whose power would survive their own death. The MPEP clearly states: The patent practitioner may not appoint a ‘substitute’ and any attempt by the patent practitioner to appoint a ‘substitute’ patent practitioner whose power is intended to survive his or her own will not be recognized by the Office. (MPEP 406)

Yes, registered attorneys or agents not of record can file papers in patent applications and reexamination proceedings under 37 CFR 1.34. The MPEP states:

Filing of such papers is considered to be a representation that the attorney or agent is authorized to act in a representative capacity on behalf of applicant.

This means that by filing papers, the attorney or agent is implicitly declaring their authority to represent the applicant.

For more information on patent filing, visit: patent filing.

For more information on USPTO procedures, visit: USPTO procedures.

Yes, a patent application can proceed without all inventors’ signatures under certain circumstances. The MPEP 409.03(d) provides guidance on this matter:

If an inventor is deceased, refuses to execute an application, or cannot be found or reached after diligent effort, the application may be made by the other inventor(s) on behalf of themselves and the non-signing inventor.

To proceed without all signatures, the applicant must:

  • File the application on behalf of themselves and the non-signing inventor
  • Provide proof of the inventor’s unavailability or refusal
  • Submit an oath or declaration by the other inventor(s)
  • Include a petition under 37 CFR 1.47

The USPTO will review the evidence and may grant the petition, allowing the application to proceed without the missing signature.

To learn more:

Yes, a patent application can be filed on behalf of a deceased inventor under certain circumstances:

  • The application must be filed by the legal representative of the deceased inventor’s estate.
  • The legal representative must submit an oath or declaration and any necessary assignments.
  • The application should be filed as soon as possible after the inventor’s death to avoid potential issues with prior art.

MPEP 409.01 states: “If an inventor dies after an application is filed but before the application is approved for issue as a patent, and this fact is known to the legal representative or the assignee, a petition to change the applicant under 37 CFR 1.46(c)(2) should be filed.”

It’s important to note that the legal representative must act promptly to ensure the application is properly filed and prosecuted in accordance with USPTO regulations.

To learn more:

Can a patent application be filed if the sole inventor is deceased?

Yes, a patent application can be filed even if the sole inventor is deceased. The MPEP 409.03(b) provides guidance on this situation:

“When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or assignee of the deceased inventor.”

In such cases, the legal representative (such as an executor or administrator of the inventor’s estate) can file the application on behalf of the deceased inventor. They must provide proof of their authority to act on behalf of the deceased inventor’s estate, typically in the form of Letters Testamentary or Letters of Administration.

To learn more:

Yes, a patent application can be filed even if one joint inventor refuses to sign, provided certain conditions are met. According to MPEP 409.03(a):

“Pre-AIA 37 CFR 1.47(a) and pre-AIA 35 U.S.C. 116, second paragraph, requires all available joint inventors to file an application ‘on behalf of’ themselves and on behalf of a joint inventor who ‘cannot be found or reached after diligent effort’ or who refuses to ‘join in an application.'”

To file the application, the available joint inventors must make an oath or declaration on their own behalf and on behalf of the nonsigning inventor. Additionally, proof must be provided that the nonsigning inventor refuses to execute the application papers. This process allows the patent application to proceed despite the refusal of one joint inventor to participate.

To learn more:

Can a patent applicant attend an interview with the USPTO without their practitioner?

While it is generally recommended that a patent practitioner represents the applicant during USPTO interviews, there are circumstances where an applicant may attend without their practitioner. MPEP 408 states:

‘A registered practitioner, not of record, may accompany a registered practitioner of record to attend an interview of an application in which the registered practitioner is not of record. The registered practitioner not of record may not participate in the interview of the application except as authorized by the patent applicant.’

This implies that while the primary responsibility lies with the practitioner of record, applicants have some flexibility in who attends the interview. However, it’s important to note that without proper representation, applicants may miss out on valuable legal insights and negotiation opportunities during the interview process.

For more information on patent applicant, visit: patent applicant.

For more information on patent examination, visit: patent examination.

No, a partial assignee cannot file a patent application as the sole applicant. The MPEP clarifies this point:

Because all parties having any portion of ownership in a patent property must act together as a composite entity in patent matters before the Office, a partial assignee (e.g., a party who owns 50% of the interest) cannot on its own file a patent application as the applicant.

This means that if multiple parties have ownership interests in the invention, they must act together to file the patent application. For more information on joint ownership, see MPEP § 301.

To learn more:

A nonsigning inventor who subsequently joins an application cannot revoke or grant a power of attorney in certain situations. MPEP 402.05(a) explains:

37 CFR 1.64(f) provides that the submission of an oath or declaration by a nonsigning inventor or legal representative in an application filed under 37 CFR 1.43, 1.45 or 1.46 will not permit the nonsigning inventor or legal representative to revoke or grant a power of attorney.

This means that if a nonsigning inventor later submits an oath or declaration in an application filed under specific circumstances (such as joint inventors, deceased or legally incapacitated inventors, or assignee filing), they cannot use this submission to revoke an existing power of attorney or grant a new one.

To learn more:

In a pre-AIA 37 CFR 1.47 application, a nonsigning inventor has limited rights regarding the power of attorney. According to MPEP 402.05(b):

A nonsigning inventor may subsequently join in a pre-AIA 37 CFR 1.47 application by submitting an oath or declaration under pre-AIA 37 CFR 1.63. However, even if the nonsigning inventor joins in the application, he or she cannot revoke or give a power of attorney without agreement of the pre-AIA 37 CFR 1.47 applicant.

This means that while a nonsigning inventor can later join the application by submitting the required oath or declaration, they do not have the authority to unilaterally revoke or grant a power of attorney. Any such action would require the agreement of the original pre-AIA 37 CFR 1.47 applicant.

To learn more:

To learn more:

Yes, a nonsigning inventor can join a pre-AIA 37 CFR 1.47 application. However, there are specific requirements and limitations to this process.

According to MPEP 409.03(i):

“A nonsigning inventor may join in a pre-AIA 37 CFR 1.47 application. To join in the application, the nonsigning inventor must file an appropriate pre-AIA 37 CFR 1.63 oath or declaration.”

It’s important to note that even if the nonsigning inventor joins the application, they have limited powers. The MPEP further states:

“Even if the nonsigning inventor joins in the application, he or she cannot revoke or give a power of attorney without agreement of the 37 CFR 1.47 applicant.”

This means that while the nonsigning inventor can become part of the application, they do not gain full control over it and must still work in agreement with the original applicant.

To learn more:

To learn more:

Can a non-inventor appoint a power of attorney in a pre-September 16, 2012 application?

Yes, under certain circumstances, a non-inventor can appoint a power of attorney in applications filed before September 16, 2012. The MPEP 402.02(b) states:

If no power of attorney is on file, then a party who is not an inventor, but who has given a proper showing of ownership or of authority to take action for and on behalf of all of the applicant may appoint an attorney or agent to prosecute the application, subject to the same exception noted above.

This means that a non-inventor, such as an assignee or other party with proper authority, can appoint a power of attorney if:

  • No power of attorney is currently on file
  • They provide proper documentation showing ownership or authority to act on behalf of all applicants
  • They follow the same rules that would apply to inventors appointing a power of attorney

It’s important to note that the non-inventor must have the authority to act for all applicants, not just some of them.

To learn more:

Can a non-attorney represent an applicant before the USPTO?

Yes, a non-attorney can represent an applicant before the USPTO under certain circumstances. According to MPEP 402.04, there are specific provisions for non-attorney representation:

  • Patent agents: Registered patent agents who are not attorneys can represent applicants in patent matters before the USPTO.
  • Limited recognition: Individuals granted limited recognition by the USPTO Director can represent applicants in specific patent matters.
  • Pro se representation: Applicants can represent themselves (pro se) in their own patent applications.

However, it’s important to note that “Effective September 16, 2012, any paper submitted on behalf of a juristic entity must be signed by a patent practitioner.” This means that corporations and other non-human entities must be represented by a registered patent practitioner, who may be either a patent attorney or a patent agent.

To learn more:

Tags: USPTO

Yes, a new patent practitioner can be appointed after the death of the previous one. The USPTO explicitly states in Form Paragraph 4.03: A new registered attorney or agent may be appointed. This allows the applicant or patent owner to ensure continued representation in patent matters following the death of their previous practitioner.

Can a legal representative use an S-signature for patent documents?

Yes, a legal representative can use an S-signature for patent documents, provided they meet the following requirements:

  • The S-signature must be inserted between forward slash marks
  • The signer’s name must be presented in printed or typed form
  • The capacity of the signer must be included with the signature

The MPEP 402.03 states: ‘When an S-signature is employed in a document filed with the Office in connection with a patent or application, it must be accompanied by the printed or typed name of the signer. The number and qualification of persons required to execute a particular document are governed by the statute requiring the document and applicable regulations.’

For legal representatives, it’s crucial to include their capacity (e.g., attorney, agent) along with their S-signature to ensure compliance with USPTO requirements.

To learn more:

Can a legal representative sign the oath or declaration for an unavailable joint inventor?

Yes, in certain circumstances, a legal representative can sign the oath or declaration for an unavailable joint inventor. According to MPEP 409.03(a):

‘If an inventor is deceased or legally incapacitated, the legal representative of the inventor may sign the oath or declaration as the inventor.’

The legal representative must provide proof of their authority to act on behalf of the unavailable inventor. This might include:

  • Death certificate and letters testamentary for a deceased inventor
  • Court order appointing a guardian for a legally incapacitated inventor

It’s important to note that this provision applies only to deceased or legally incapacitated inventors, not to those who are simply unavailable or unwilling to sign.

To learn more:

Yes, a legal representative can sign patent documents on behalf of the inventor under certain circumstances. The MPEP 402.03 states:

Where a power of attorney or authorization of agent is given to a customer number, a practitioner must sign the correspondence if an applicant is to be represented.

This means that if a power of attorney has been granted, the authorized practitioner can sign documents on behalf of the inventor. However, it’s important to note that certain documents, such as the inventor’s oath or declaration, must still be signed by the inventor personally unless specific conditions are met (e.g., the inventor is deceased, legally incapacitated, or cannot be found after diligent effort).

To learn more:

Can a juristic entity appoint a power of attorney in a patent application?

Yes, a juristic entity (such as a corporation or organization) can appoint a power of attorney in a patent application. However, there are specific requirements for doing so:

  • The power of attorney must be signed by a person authorized to act on behalf of the juristic entity
  • The person signing must have apparent authority to bind the juristic entity

The MPEP provides guidance on this matter:

A power of attorney from a juristic entity must be signed by a person authorized to act on behalf of the juristic entity. […] A power of attorney to a patent practitioner to prosecute a patent application executed by the applicant or the assignee of the entire interest of the applicant is the power of attorney of the applicant or assignee, not the power of attorney of the practitioner. (MPEP 402.02(a))

It’s important to note that the power of attorney belongs to the juristic entity, not to the practitioner who is appointed.

To learn more:

Can a juristic entity applicant sign a power of attorney form for a patent application?

No, a juristic entity applicant (such as a corporation or organization) cannot directly sign a power of attorney form for a patent application. Instead, the power of attorney must be signed by a person authorized to act on behalf of the juristic entity.

According to MPEP 402.02(a):

“A power of attorney must be signed by the applicant for patent (37 CFR 1.42) or the patent owner (for reissue applications or reexamination proceedings). A power of attorney may only be signed by the applicant for patent (37 CFR 1.42) or the patent owner of record of the entire interest or their representative. An applicant for patent that is the assignee must comply with 37 CFR 3.71 and 3.73 to establish ownership of the application.”

For juristic entity applicants, this typically means that an officer or employee of the organization who has the authority to bind the organization must sign the power of attorney. This could be a CEO, president, or other authorized representative of the company.

It’s important to note that the person signing on behalf of a juristic entity should also provide their title or position within the organization to demonstrate their authority to act on behalf of the applicant.

To learn more:

Can a joint inventor apply for a patent if another joint inventor is unavailable or refuses to join?

Yes, a joint inventor can apply for a patent even if another joint inventor is unavailable or refuses to join the application. The MPEP 409 states: ‘If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the application may be made by the other inventor on behalf of himself or herself and the nonsigning inventor.’

The process involves:

  • Filing the application on behalf of all inventors
  • Submitting a petition under 37 CFR 1.45
  • Providing proof of the unavailability or refusal of the non-signing inventor
  • Including an oath or declaration by the participating inventor(s)

This provision ensures that the patent application process can proceed even when not all joint inventors are available or willing to participate.

For more information on joint inventors, visit: joint inventors.

Can a foreign patent agent with limited recognition represent applicants in all USPTO matters?

No, a foreign patent agent with limited recognition cannot represent applicants in all USPTO matters. The MPEP clearly states that A foreign patent agent granted limited recognition may not represent applicants or parties in trademark matters, ex parte or inter partes appeals to the Patent Trial and Appeal Board, petitions to the Director of the USPTO, disciplinary proceedings, or in any other matter before the Office. (MPEP 402.01) Their representation is strictly limited to the presentation and prosecution of patent applications before the USPTO.

To learn more:

Tags: USPTO

Can a deceased inventor’s legal representative sign an assignment for a patent application?

Yes, a deceased inventor’s legal representative can sign an assignment for a patent application. According to MPEP 409.01(a):

“The legal representative (executor, administrator, etc.) of a deceased inventor may make an assignment of the deceased inventor’s rights in the application as well as sign the substitute statement. See MPEP § 409.01(b).”

This provision allows the legal representative to manage the deceased inventor’s intellectual property rights, including assigning those rights to other parties. It’s important to note that the legal representative must have proper authority to act on behalf of the deceased inventor’s estate, which typically requires documentation such as letters testamentary or letters of administration.

To learn more:

Can a Customer Number be used for multiple patent applications?

Yes, a Customer Number can be used for multiple patent applications. This is one of the primary benefits of the Customer Number system. The MPEP 403 states:

‘The Customer Number practice permits applicants, attorneys, and agents of record to change their correspondence address for a number of applications with one request.’

This means that:

  • A single Customer Number can be associated with multiple patent applications
  • Changes to the correspondence address or list of registered practitioners can be made once and applied to all linked applications
  • It simplifies portfolio management for applicants and law firms handling multiple patents

Using a Customer Number for multiple applications streamlines communication with the USPTO and helps ensure consistent handling of related patent matters.

For more information on Customer Number, visit: Customer Number.

Yes, a corporation can file a patent application under pre-AIA 37 CFR 1.47(b). The MPEP explicitly states that “Where a corporation is the pre-AIA 37 CFR 1.47(b) applicant, an officer (President, Vice-President, Secretary, Treasurer, or Chief Executive Officer) thereof should normally sign the necessary oath or declaration.”

Additionally, “A corporation may authorize any person, including an attorney or agent registered to practice before the U.S. Patent and Trademark Office, to sign the application oath or declaration on its behalf.” However, proper authorization or proof of authority may be required in such cases.

To learn more:

Can a Canadian patent agent represent U.S. patent applicants before the USPTO?

Yes, a Canadian patent agent can represent U.S. patent applicants before the USPTO under certain conditions. According to MPEP 402.01:

‘The Canadian Intellectual Property Office and the United States Patent and Trademark Office have agreed on a procedure to allow for the reciprocal recognition of patent agents and attorneys registered to practice before their respective Offices.’

This means that registered Canadian patent agents can apply for and be granted limited recognition to represent U.S. patent applicants before the USPTO. However, this recognition is subject to specific conditions and requirements set by the OED Director.

To learn more:

Tags: USPTO

Yes, there are significant restrictions on contacting patent practitioners who are not of record for a patent application. According to MPEP § 408, Registered attorneys or agents not of record in a patent application (i.e., there is no power of attorney present in the file that appoints the patent practitioner(s)) and acting in a representative capacity under 37 CFR 1.34 should not be contacted for restriction requirements or approval of examiner’s amendments.

This policy is in place to ensure that only properly authorized representatives are involved in making decisions about patent applications. For more information on interviews with patent practitioners not of record, refer to MPEP § 405.

Yes, there are strict restrictions on communicating with unregistered, suspended, or excluded attorneys regarding patent applications. The MPEP clearly states:

Office employees are forbidden from holding either oral or written communication with an unregistered, suspended or excluded attorney or agent regarding an application unless it is one in which said attorney or agent is the applicant.

This rule helps maintain the integrity of the patent application process and ensures that only qualified, registered practitioners are involved in patent-related communications with the USPTO.

Yes, there are exceptions to the requirement for all applicants to sign power of attorney documents. The MPEP provides one specific exception:

“In an application filed under pre-AIA 37 CFR 1.47(a), an assignee of the entire interest of the available inventors (i.e., the applicant) who has signed the declaration may appoint or revoke a power of attorney without a petition under 37 CFR 1.36(a) or 1.183.”

This exception applies to applications filed before the America Invents Act (AIA) under specific circumstances. However, it’s important to note that this exception does not apply in all cases. The MPEP also states:

“However, in applications accepted under pre-AIA 37 CFR 1.47, such a petition under 37 CFR 1.36(a) or 1.183 submitted by a previously nonsigning inventor who has now joined in the application will not be granted.”

For more information on these exceptions, refer to MPEP § 402.07 and MPEP § 409.03(i).

To learn more:

Yes, juristic entities (e.g., organizational assignees) must be represented by a patent practitioner. As stated in MPEP 401:

An applicant who is a juristic entity must be represented by a patent practitioner.

This requirement ensures that organizations have proper legal representation when navigating the complex patent application process. Individual inventors and joint inventors, however, may represent themselves if they choose to do so.

For more information on juristic entity, visit: juristic entity.

For more information on organizational assignee, visit: organizational assignee.

No, patent applicants are not required to conduct prior art searches before filing a patent application. This is clarified in the MPEP, which states:

An applicant has no duty to conduct a prior art search as a prerequisite to filing an application for patent. See Nordberg, Inc. v. Telsmith, Inc., 82 F.3d 394, 397, 38 USPQ2d 1593, 1595-96 (Fed. Cir. 1996); FMC Corp. v. Hennessy Indus., Inc., 836 F.2d 521, 526 n.6, 5 USPQ2d 1272, 1275-76 n.6 (Fed. Cir. 1987); FMC Corp. v. Manitowoc Co., 835 F.2d 1411, 1415, 5 USPQ2d 1112, 1115 (Fed. Cir. 1987); American Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F.2d 1350, 1362, 220 USPQ 763, 772 (Fed. Cir.), cert. denied, 469 U.S. 821, 224 USPQ 520 (1984).

However, conducting a prior art search can be beneficial for understanding the state of the art and assessing the potential patentability of an invention.

For more information on patent application requirements, visit: patent application requirements.

For more information on prior art search, visit: prior art search.

No, nonsigning inventors are not entitled to a hearing in pre-AIA 37 CFR 1.47 cases. This is explicitly stated in MPEP 409.03(i):

“A nonsigning inventor is not entitled to a hearing (Cogar v. Schuyler, 464 F.2d 747, 173 USPQ 389 (D.C. Cir. 1972))”

This precedent, set by the case of Cogar v. Schuyler, establishes that while nonsigning inventors have certain rights, such as inspecting application papers and making their position of record, they do not have the right to a formal hearing in these cases.

Additionally, the MPEP states:

“While the U.S. Patent and Trademark Office will grant the nonsigning inventor access to the application, inter partes proceedings will not be instituted in a pre-AIA 37 CFR 1.47 case. In re Hough, 108 USPQ 89 (Comm’r Pat. 1955).”

This further emphasizes that while nonsigning inventors have access to application information, they cannot initiate inter partes proceedings, which would include hearings, in pre-AIA 37 CFR 1.47 cases.

To learn more:

To learn more:

MPEP 401 - U.S. Patent and Trademark Office Cannot Aid in Selection of Patent Practitioner (8)

A patent examiner may suggest hiring a patent practitioner under specific circumstances, as outlined in MPEP 401:

“If patentable subject matter appears to be disclosed in a pro se application and it is apparent that the applicant is unfamiliar with the proper preparation and prosecution of patent applications, the examiner may suggest to the applicant that it may be desirable to employ a registered patent attorney or agent.”

However, the examiner should not suggest hiring a practitioner if the application appears to contain no patentable subject matter. The MPEP provides a form paragraph (4.10) for examiners to use when making this suggestion.

Risks of Self-Representation in Patent Applications

While individuals can file pro se patent applications, there are several risks to consider:

  1. Lack of expertise: Patent law is complex, and lack of familiarity with examination practices may result in missed opportunities for optimal protection.
  2. Potential sanctions: According to MPEP 401, pro se applicants are subject to the same certifications and potential sanctions as represented applicants:

In presenting (whether by signing, filing, submitting, or later advocating) papers to the Office, a pro se applicant is making the certifications under 37 CFR 11.18(b), and may be subject to sanctions under 37 CFR 11.18(c) for violations of 37 CFR 11.18(b)(2).

Given these risks, the USPTO may suggest hiring a registered patent practitioner if they notice an applicant is unfamiliar with the process and the application contains potentially patentable subject matter.

For more information on pro se, visit: pro se.

For more information on self-representation, visit: self-representation.

A juristic entity, in the context of patent applications, typically refers to an organizational assignee such as a company or corporation. According to MPEP 401, juristic entities have special requirements:

“An applicant who is a juristic entity must be represented by a patent practitioner.”

This means that companies or other organizational entities cannot represent themselves in patent applications and must hire a registered patent attorney or agent to act on their behalf.

Pro se applicants make important certifications when filing patent applications. According to MPEP 401:

“In presenting (whether by signing, filing, submitting, or later advocating) papers to the Office, a pro se applicant is making the certifications under 37 CFR 11.18(b), and may be subject to sanctions under 37 CFR 11.18(c) for violations of 37 CFR 11.18(b)(2).”

These certifications include statements about the truthfulness of the application, that it is not being presented for improper purposes, and that claims are warranted by existing law or a good faith argument for changing the law.

The USPTO provides several ways to find a registered patent attorney or agent, as mentioned in MPEP 401:

  1. Visit the USPTO website: www.uspto.gov/FindPatentAttorney for a searchable listing of registered practitioners.
  2. Write to the Office of Enrollment and Discipline (OED) to request a list of registered patent practitioners in your area:

    Mail Stop OED, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450

These resources can help you locate a qualified patent professional to assist with your patent application.

No, the USPTO cannot assist in selecting a patent practitioner. According to MPEP 401, “The Office cannot aid in the selection of a patent practitioner.” However, the USPTO does provide resources for finding registered patent attorneys and agents:

  • A listing is available at www.uspto.gov/FindPatentAttorney
  • Applicants can request a list of registered practitioners in their area by writing to the Office of Enrollment and Discipline (OED)

Yes, in most cases. According to MPEP 401, “An applicant for patent, other than a juristic entity (e.g., organizational assignee), may file and prosecute their own application, and thus act as their own representative (pro se) before the Office.” However, there are important considerations:

  • Juristic entities (e.g., companies) must be represented by a patent practitioner
  • Pro se applicants are subject to the same rules and potential sanctions as represented applicants
  • Lack of familiarity with patent procedures may result in missed opportunities for optimal protection

Yes, juristic entities (e.g., organizational assignees) must be represented by a patent practitioner. As stated in MPEP 401:

An applicant who is a juristic entity must be represented by a patent practitioner.

This requirement ensures that organizations have proper legal representation when navigating the complex patent application process. Individual inventors and joint inventors, however, may represent themselves if they choose to do so.

For more information on juristic entity, visit: juristic entity.

For more information on organizational assignee, visit: organizational assignee.

MPEP 402 - Power of Attorney; Naming Representative (12)

For applications filed on or after September 16, 2012, a power of attorney must be signed by the applicant for patent (i.e., all parties identified as the applicant as defined by 37 CFR 1.42(a)) or the patent owner. For applications filed before September 16, 2012, a power of attorney can be signed by the applicant or the assignee of the entire interest of the applicant.

As stated in MPEP 402.02(a): “For applications filed on or after September 16, 2012, 37 CFR 1.32(b)(4) sets forth that a power of attorney must be signed by the applicant for patent (i.e., all parties identified as the applicant as defined by 37 CFR 1.42(a)) or the patent owner (for reissue applications, reexamination proceedings and supplemental examination proceedings).”

In patent applications, both attorneys and agents can represent applicants before the USPTO, but there are important distinctions:

  • Patent Attorney: A lawyer who has passed both a state bar exam and the USPTO’s patent bar exam. They can practice law and provide legal advice beyond patent prosecution.
  • Patent Agent: An individual who has passed the USPTO’s patent bar exam but is not a licensed attorney. They can represent clients before the USPTO for patent matters but cannot practice law or provide other legal services.

The MPEP 402 refers to both as ‘patent practitioners’: ‘The term ‘patent practitioner’ as used in this chapter includes patent attorneys and patent agents.’ Both can receive power of attorney and represent applicants in patent matters before the USPTO, but only patent attorneys can offer broader legal counsel.

For applications filed on or after September 16, 2012, 37 CFR 1.32(d) provides that a power of attorney from a prior national application may have effect in a continuing application if:

  1. A copy of the power of attorney from the prior application is filed in the continuing application
  2. The power of attorney was not granted by the inventor
  3. The continuing application does not name an inventor who was not named in the prior application

MPEP 402.02(a) states: “37 CFR 1.32(d) specifically requires that a copy of the power of attorney from the prior application be filed in the continuing application to have effect (even where a change in power did not occur in the prior application).”

If these conditions are not met, a new power of attorney will need to be filed in the continuing application.

When there are multiple applicants for a patent and only some give power of attorney, the USPTO has specific rules to handle the situation. According to MPEP 402:

‘Where a power of attorney is given by fewer than all of the applicants or owners, the power of attorney is not accepted until a petition under 37 CFR 1.36(b) is granted.’

This means:

  • The power of attorney is not automatically accepted if not all applicants have signed it.
  • A petition under 37 CFR 1.36(b) must be filed and granted for the partial power of attorney to be accepted.
  • The petition should explain why it was not possible to obtain signatures from all applicants.
  • The Office of Petitions will review the petition and make a determination.

It’s generally recommended to obtain signatures from all applicants to avoid delays and potential issues with the patent application process.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

To revoke a power of attorney in a patent application:

  • The applicant or assignee of the entire interest must submit a revocation signed by them.
  • The revocation should be submitted to the USPTO in writing.
  • It can be done by filing a new power of attorney (Form PTO/AIA/82) and checking the revocation box.
  • Alternatively, you can submit a document specifically revoking the previous power of attorney.

As stated in the MPEP 402: ‘A power of attorney may be revoked at any stage in the proceedings of a case.’ It’s important to note that revoking a power of attorney does not remove attorneys from the list of patent practitioners associated with an application. To do that, you must file a separate request.

For more information on power of attorney, visit: power of attorney.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

An attorney or agent who has been given power of attorney can withdraw by submitting a request to the USPTO. According to MPEP 402.06:

nn

“A registered patent attorney or patent agent who has been given a power of attorney pursuant to § 1.32(b) may withdraw as attorney or agent of record upon application to and approval by the Director.”

nn

The request should briefly state the reason(s) for withdrawal. If based on issues like lack of compensation, it’s recommended to cite “irreconcilable differences” to maintain client confidentiality. The withdrawal is effective when approved by the USPTO, not when received.

nn

Practitioners must take steps to protect the client’s interests when withdrawing, such as giving reasonable notice and allowing time to hire new counsel. The Request for Withdrawal As Attorney or Agent form (PTO/AIA/83) can be used.

For more information on patent representation, visit: patent representation.

For more information on power of attorney, visit: power of attorney.

How can an applicant revoke a power of attorney?

An applicant can revoke a power of attorney by submitting a new power of attorney (Form AIA/82 for applications filed on or after September 16, 2012, or Form PTO/SB/80 for applications filed before September 16, 2012) or by submitting a revocation signed by the applicant. As stated in the MPEP:

“A power of attorney may be revoked at any stage in the proceedings of a case, and an applicant may appoint a new attorney or agent at any stage in the proceedings of the case by filing a new power of attorney.” (MPEP 402)

It’s important to note that the revocation should be clear and unambiguous, and it should be submitted to the USPTO for proper processing.

For more information on power of attorney, visit: power of attorney.

For more information on revocation, visit: revocation.

A registered patent attorney or agent who has been given a power of attorney may withdraw as attorney or agent of record by submitting a request to the USPTO. The process involves:

  1. Filing a request for withdrawal with the USPTO
  2. Obtaining approval from the Director of the USPTO
  3. Notifying the applicant or patent owner of the withdrawal

MPEP 402.06 states: “When filing a request to withdraw as attorney or agent of record, the patent attorney or agent should briefly state the reason(s) for which he or she is withdrawing so that the Office can determine whether to grant the request.”

The practitioner must also take steps to protect the client’s interests, such as giving reasonable notice and allowing time for the client to find new representation.

A juristic entity (e.g., corporations, universities, or other organizations) can give power of attorney in a patent application through an appropriate official. According to MPEP 402:

‘Where the applicant is a juristic entity (e.g., organizational assignee), a power of attorney must be signed by a person authorized to act on behalf of the applicant.’

The process typically involves:

  • An official with signing authority (e.g., CEO, president, or authorized patent counsel) signs the power of attorney form.
  • The signed form is submitted to the USPTO along with the patent application or separately if done after filing.
  • If requested by the USPTO, documentation may need to be provided to establish the authority of the person signing on behalf of the juristic entity.

It’s important to ensure that the person signing has the actual authority to bind the juristic entity in patent matters.

For more information on juristic entity, visit: juristic entity.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

Generally, a power of attorney must be signed by all applicants or owners of a patent application. However, there are exceptions:

  1. For revocation: A power of attorney signed by less than all applicants/owners may be accepted if accompanied by a petition under 37 CFR 1.36(a) and fee, with a showing of sufficient cause.
  2. For appointment: A power of attorney signed by less than all applicants/owners may be accepted if accompanied by a petition under 37 CFR 1.183 and fee, demonstrating an extraordinary situation where justice requires waiver of the requirement.

MPEP 402.10 states: “The appointment and/or revocation are not accepted until the petition under 37 CFR 1.36(a) or 1.183 is granted. Therefore, the attorney or agent newly appointed by such papers is not permitted to submit any documents (such as an information disclosure statement (IDS)) into the application file until the petition under 37 CFR 1.36(a) or 1.183 is granted.”

Yes, a power of attorney can be revoked in a patent application. The process for revocation is outlined in MPEP 402:

‘The power of attorney may be revoked at any time. Pursuant to 37 CFR 1.36(a), an applicant may revoke a power of attorney by filing a new power of attorney that is not directed to the patent practitioner(s) of record.’

To revoke a power of attorney:

  • File a new power of attorney form (PTO/AIA/82) with the USPTO.
  • The new form should either name new representative(s) or indicate that the applicant wishes to prosecute the application pro se (without an attorney).
  • Ensure the form is signed by the applicant or, in the case of a juristic entity, by an authorized official.
  • Submit the form through the USPTO’s Electronic Filing System (EFS-Web) or by mail.

It’s important to note that merely filing a new power of attorney automatically revokes the previous one. There’s no need for a separate revocation document unless you want to revoke without appointing a new representative.

For more information on power of attorney, visit: power of attorney.

For more information on pro se, visit: pro se.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

Can a power of attorney be granted to a foreign attorney or agent for US patent applications?

A power of attorney for US patent applications can only be granted to individuals who are registered to practice before the USPTO. Foreign attorneys or agents who are not registered with the USPTO cannot be granted power of attorney.

According to MPEP 402: “The Office cannot recognize more than one power of attorney or authorization to act in a representative capacity in a particular application or patent at any given time.” This means that only USPTO-registered practitioners can be given power of attorney.

However, foreign attorneys can work with US-registered patent practitioners who can be granted power of attorney. The foreign attorney can then collaborate with the US-registered practitioner to manage the application.

For more information on power of attorney, visit: power of attorney.

MPEP 403 - Correspondence — With Whom Held; Customer Number Practice (19)

What is the significance of a customer number in USPTO correspondence?

A customer number is a crucial tool for managing correspondence with the USPTO. According to MPEP 403:

‘A customer number allows an applicant, attorney or agent to easily change the correspondence address for a number of applications or patents by simply requesting a change to the address associated with the customer number.’

Key benefits of using a customer number include:

  • Streamlined correspondence management for multiple applications
  • Easy updates to address information
  • Efficient access to application information through USPTO systems

By using a customer number, patent professionals can significantly simplify their administrative processes when dealing with the USPTO.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

What is the purpose of a Customer Number in USPTO correspondence?

A Customer Number is a unique identifier assigned by the USPTO to simplify and streamline patent correspondence. According to the MPEP 403, ‘The Customer Number practice permits applicants, attorneys, and agents of record to change their correspondence address for a number of applications with one request.’ This system allows for:

  • Easy updates to correspondence addresses for multiple applications
  • Efficient management of power of attorney
  • Simplified access to private PAIR (Patent Application Information Retrieval) for registered practitioners

By using a Customer Number, patent applicants and their representatives can more effectively manage their patent portfolios and communications with the USPTO.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

What is the difference between a correspondence address and a fee address in USPTO filings?

In USPTO filings, the correspondence address and fee address serve different purposes:

  • Correspondence Address: Where the USPTO sends all official communications regarding a patent application or patent.
  • Fee Address: Where the USPTO sends maintenance fee reminders for granted patents.

The MPEP clarifies:

The correspondence address is the address associated with the Customer Number to which correspondence is directed. The fee address is the address associated with the Customer Number to which maintenance fee reminders are directed. (MPEP 403)

While these addresses can be the same, they don’t have to be. Applicants or patent owners might choose different addresses, for example, if a law firm handles prosecution but the company itself manages maintenance fees. Using a customer number allows for easy management of both addresses.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on Customer Number, visit: Customer Number.

For more information on Fee Address, visit: Fee Address.

The Customer Number practice allows applicants to:

  • Designate the correspondence address of a patent application or patent
  • Designate the fee address of a patent
  • Submit a list of practitioners who have power of attorney

Using a Customer Number allows applicants to easily change the correspondence address, fee address, or list of practitioners for multiple applications or patents by simply changing the information associated with the Customer Number.

According to MPEP 403: “A Customer Number (previously a ‘Payor Number’) may be used to: (A) designate the correspondence address of a patent application or patent such that the correspondence address for the patent application or patent would be the address associated with the Customer Number (37 CFR 1.32(a)(5)(i)); (B) designate the fee address (37 CFR 1.363) of a patent such that the fee address for the patent would be the address associated with the Customer Number (37 CFR 1.32(a)(5)(ii)); and (C) submit a list of practitioners such that those practitioners associated with the Customer Number would have power of attorney (37 CFR 1.32(a)(5)(iii)).”

A Customer Number is a USPTO-assigned number that can be used to:

  • Designate the correspondence address for a patent application or patent
  • Designate the fee address for a patent
  • Submit a list of practitioners with power of attorney

According to MPEP 403: “A Customer Number may be used to designate the address associated with the Customer Number as the correspondence address of an application (or patent) or the fee address of a patent, and may also be used to submit a power of attorney in the application (or patent) to the registered practitioners associated with the Customer Number.”

Using a Customer Number simplifies making changes to correspondence addresses and practitioner information across multiple applications.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on Customer Number, visit: Customer Number.

For more information on Fee Address, visit: Fee Address.

For more information on power of attorney, visit: power of attorney.

A customer number is a unique identifier assigned by the USPTO to simplify patent correspondence. According to MPEP 403:

‘A customer number allows a patent applicant, patent owner, or assignee to designate a single correspondence address for all applications and patents associated with that customer number.’

Benefits of using a customer number include:

  • Easier management of correspondence addresses for multiple applications
  • Simplified process for changing the address or representative for all linked applications
  • Improved efficiency in USPTO communications

To obtain a customer number, you need to file a request with the USPTO using the appropriate form.

For more information on Customer Number, visit: Customer Number.

For more information on patent correspondence, visit: patent correspondence.

For more information on USPTO, visit: USPTO.

If a patent application is filed without a correspondence address:

  • The USPTO needs a correspondence address to notify the applicant of any missing parts or requirements.
  • If no address is provided, the Office may use the mailing address of the first named inventor as the correspondence address.
  • Without a correspondence address, the applicant is considered to have constructive notice of application requirements as of the filing date.
  • The applicant has 2 months from the filing date to complete the application before it is abandoned.

According to MPEP 403: “If a patent application as filed has been accorded a filing date but is not complete, the applicant is notified and given a period of time within which to file the missing parts to complete the application and pay the applicable surcharge. … If the applicant fails to provide the Office with a correspondence address, the Office will be unable to provide the applicant with notification to complete the application and to pay the surcharge as set forth in 37 CFR 1.16(f) for nonprovisional applications and 37 CFR 1.16(g) for provisional applications. In such a case, the applicant will be considered to have constructive notice as of the filing date that the application must be completed and the applicant will have 2 months from the filing date in which to do so before abandonment occurs.”

The USPTO provides several forms for Customer Number practice:

  • PTO/SB/125 – Request for Customer Number
  • PTO/SB/124 – Request for Customer Number Data Change
  • PTO/AIA/122 or PTO/SB/122 – Change of Correspondence Address, Application
  • PTO/AIA/123 or PTO/SB/123 – Change of Correspondence Address, Patent

According to MPEP 403: “The following forms are suggested for use with the Customer Number practice: (A) the ‘Request for Customer Number’ (PTO/SB/125) to request a Customer Number; (B) the ‘Request for Customer Number Data Change’ (PTO/SB/124) to request a change in the data (address or list of practitioners) associated with an existing Customer Number; (C) the ‘Change of Correspondence Address, Application’ (PTO/AIA/122 for applications filed on or after September 16, 2012, or PTO/SB/122 for applications filed before September 16, 2012) to change the correspondence address of an individual application to the address associated with a Customer Number; and (D) the ‘Change of Correspondence Address, Patent’ (PTO/AIA/123 for applications filed on or after September 16, 2012, or PTO//SB/123 for applications filed before September 16, 2012) to change the correspondence address of an individual patent to the address associated with a Customer Number.”

The USPTO generally does not engage in double correspondence with applicants and their representatives. Specifically:

  • The Office will not correspond with both an applicant and their attorney/agent.
  • The Office will not correspond with more than one attorney/agent.
  • If double correspondence is attempted, the examiner will include form paragraph 4.01 in the next Office action.

According to MPEP 403: “Double correspondence with an applicant and their attorney, or with two representatives, will not be undertaken. See MPEP §§ 403.01(a), 403.01(b), 403.02, and 714.01(d).”

Form paragraph 4.01 states: “Applicant has appointed an attorney or agent to conduct all business before the Patent and Trademark Office. Double correspondence with an applicant and applicant’s attorney or agent will not be undertaken. Accordingly, applicant is required to conduct all future correspondence with this Office through the attorney or agent of record. See 37 CFR 1.33.”

When two patent practitioners are appointed for the same application:

  • If appointed simultaneously, the applicant should specify which address to use for correspondence.
  • If a second practitioner is added later, correspondence will be sent to the most recently provided correspondence address.
  • A new power of attorney appointing only the second practitioner effectively revokes the power of the first practitioner.

According to MPEP 403.02: “If the applicant simultaneously appoints two patent practitioners, applicant should indicate with whom correspondence is to be conducted by specifying a correspondence address. … If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record. … Note that if the later-filed power of attorney only lists the second practitioner, the later-filed power of attorney serves as a revocation of the earlier-filed power of attorney, even without an express revocation of the power of the first patent practitioner.”

How does the USPTO handle correspondence when there’s a conflict between customer number and application data sheet?

When there’s a conflict between the correspondence address provided in a customer number and an application data sheet (ADS), the USPTO follows specific rules:

  1. The correspondence address in the ADS takes precedence if filed with the initial application papers.
  2. A customer number provided in a single paper with a clear power of attorney overrides the ADS.
  3. If no power of attorney is filed, the correspondence address in the ADS is used.

The MPEP states:

Where an applicant provides a correspondence address in an application data sheet (ADS) that is different from the address associated with a customer number provided in a single paper (e.g., in a power of attorney or inventor’s oath or declaration), the address in the ADS will be the correspondence address of record. (MPEP 403)

It’s crucial to ensure consistency in your filings to avoid confusion. If you need to change the correspondence address after filing, you should submit a separate change of address request or update your customer number information.

For more information on application data sheet, visit: application data sheet.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO, visit: USPTO.

How does the USPTO handle correspondence for applications with multiple attorneys or agents?

When an application has multiple attorneys or agents of record, the USPTO follows specific guidelines for correspondence:

  • The USPTO will direct all correspondence to the first named attorney or agent of record, unless otherwise specified.
  • If a customer number is provided, correspondence will be sent to the address associated with that customer number.
  • Applicants can designate one or more attorneys or agents to receive correspondence by filing a power of attorney or including the information in an application data sheet.

As stated in the MPEP:

If applicant provides, in a single paper, a list of patent practitioners and a correspondence address without also filing a clear power of attorney to a patent practitioner, the Office will direct all correspondence to the correspondence address pursuant to 37 CFR 1.33(a). (MPEP 403)

It’s important to clearly designate correspondence preferences to ensure proper communication with the USPTO.

For more information on patent agents, visit: patent agents.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO correspondence, visit: USPTO correspondence.

How does the USPTO handle correspondence for applications with multiple applicants?

The USPTO has specific rules for handling correspondence in applications with multiple applicants:

  • For applications filed on or after September 16, 2012, the USPTO will direct correspondence to the first named applicant, unless a practitioner is appointed.
  • For applications filed before September 16, 2012, correspondence is sent to the first named inventor, unless a practitioner is of record.

As stated in MPEP 403: ‘Where more than one attorney or agent is of record, the Office will direct correspondence to the first named attorney or agent of record, unless otherwise requested.’ This ensures clear communication channels for multi-applicant applications.

For more information on USPTO correspondence, visit: USPTO correspondence.

The USPTO has specific procedures for handling changes in power of attorney and correspondence address. According to MPEP 403:

‘A new power of attorney or change of correspondence address filed in a patent application or patent does not change the correspondence address for any other application or patent.’

Key points to remember:

  • Each application or patent is treated separately.
  • A change in one application doesn’t automatically apply to others, even if filed by the same applicant or assignee.
  • To change multiple applications, you must file separate requests for each one.
  • Using a customer number can simplify this process for multiple applications.

It’s crucial to ensure that any changes are properly filed and recorded to maintain effective communication with the USPTO.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How do I update the list of practitioners associated with a Customer Number?

To update the list of practitioners associated with a Customer Number, follow these steps:

  1. Complete the Change of Correspondence Address Form (PTO/SB/122)
  2. Provide the Customer Number and the updated list of registered practitioners
  3. Submit the form to the USPTO

The MPEP 403 specifies:

‘A request to change the correspondence address or list of registered practitioners associated with a Customer Number must be made in writing.’

It’s important to note that:

  • Only registered practitioners can be added to a Customer Number
  • Changes will affect all applications associated with the Customer Number
  • The USPTO recommends using the online Electronic Business Center (EBC) for faster processing

Keeping the practitioner list up-to-date ensures proper communication and representation for all linked patent applications.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

How do I request a Customer Number from the USPTO?

To request a Customer Number from the USPTO, follow these steps:

  1. Complete the Customer Number Request Form (PTO/SB/125)
  2. Include the names of registered practitioners associated with the Customer Number
  3. Provide the correspondence address for the Customer Number
  4. Submit the form to the USPTO

According to MPEP 403, ‘A Customer Number may be requested by (A) a registered attorney or agent of record, (B) an assignee of the entire interest of the applicant, or (C) the applicant.’ The USPTO will process the request and assign a unique Customer Number, which can then be used for managing correspondence and access to patent applications.

For more information on USPTO Forms, visit: USPTO Forms.

Tags: USPTO Forms

How can I change the correspondence address for multiple patent applications?

Changing the correspondence address for multiple patent applications can be efficiently done using the USPTO’s Customer Number practice. Here’s how:

  1. Obtain a customer number if you don’t already have one.
  2. Associate your patent applications with the customer number.
  3. Update the address linked to the customer number.

The MPEP explains:

A Customer Number may be used to: … (2) change the correspondence address, fee address, or list of practitioners of record for a plurality of applications or patents through a single request. (MPEP 403)

This process eliminates the need to file separate change of address forms for each application, saving time and reducing the risk of errors. To make changes, use the USPTO’s Electronic Filing System (EFS-Web) or file a written request with the USPTO.

For more information on Customer Number, visit: Customer Number.

Generally, the USPTO maintains only one correspondence address for each patent application. As stated in MPEP 403:

‘The Office will direct all notices, official letters, and other communications relating to the application to a single correspondence address.’

However, there are exceptions:

  • Powers of attorney to different practitioners may be present in an application, but only one correspondence address is recognized.
  • In reexamination proceedings, a ‘duplicate copy’ may be sent to a different address.
  • Maintenance fee reminders may be sent to a ‘fee address’ that differs from the correspondence address.

It’s important to note that while multiple addresses may be associated with an application for specific purposes, the USPTO will generally communicate with only one primary correspondence address.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on USPTO, visit: USPTO.

Can a Customer Number be used for multiple patent applications?

Yes, a Customer Number can be used for multiple patent applications. This is one of the primary benefits of the Customer Number system. The MPEP 403 states:

‘The Customer Number practice permits applicants, attorneys, and agents of record to change their correspondence address for a number of applications with one request.’

This means that:

  • A single Customer Number can be associated with multiple patent applications
  • Changes to the correspondence address or list of registered practitioners can be made once and applied to all linked applications
  • It simplifies portfolio management for applicants and law firms handling multiple patents

Using a Customer Number for multiple applications streamlines communication with the USPTO and helps ensure consistent handling of related patent matters.

For more information on Customer Number, visit: Customer Number.

MPEP 404 - [Reserved] (6)

Sections in the Manual of Patent Examining Procedure (MPEP) are sometimes marked as ‘[Reserved]’ for several reasons:

  • To maintain consistent numbering across editions
  • To allow for future expansion of content
  • To accommodate planned updates or revisions
  • To serve as placeholders for potential new topics or guidance

This practice helps the USPTO maintain flexibility in organizing and updating the MPEP while preserving a logical structure for users.

If you need information related to a topic that corresponds to a reserved MPEP section, such as MPEP 404, follow these steps:

  1. Check other relevant sections of the MPEP that may cover related topics
  2. Consult the USPTO’s official website for guidance documents and notices
  3. Review recent patent laws and regulations that may address the topic
  4. Contact the USPTO’s Patent Electronic Business Center for assistance
  5. Consult with a registered patent attorney or agent for professional advice

Remember that reserved sections do not contain any official information, so it’s crucial to seek guidance from active, authoritative sources.

MPEP 404 is currently marked as ‘[Reserved]’, which means this section is not currently in use but is being held for potential future content or updates. The USPTO may use this section in future revisions of the Manual of Patent Examining Procedure to add new information or guidance related to the representation of applicants or owners in patent matters.

The frequency of updates to reserved sections in the MPEP varies and is determined by the USPTO based on several factors:

  • Changes in patent laws or regulations
  • New court decisions affecting patent examination
  • Evolving USPTO policies and procedures
  • Feedback from patent examiners and practitioners

Reserved sections may be filled or updated during regular MPEP revisions, which typically occur annually or as needed. However, there is no fixed schedule for updating specific reserved sections, and some may remain reserved for extended periods.

The presence of reserved sections like MPEP 404 does not directly affect patent examination. These sections are placeholders and do not contain any substantive information or guidance for examiners. However, their existence may indirectly impact the examination process in the following ways:

  • They maintain consistent numbering in the MPEP, aiding navigation and referencing
  • They allow for future expansion of examination guidelines without major restructuring
  • They serve as potential indicators of areas where the USPTO may develop new policies or procedures

Patent examiners rely on active, non-reserved sections of the MPEP, current USPTO policies, and relevant laws and regulations to conduct examinations.

Patent practitioners should not rely on information from reserved MPEP sections, as these sections do not contain any official guidance or information. A reserved section, such as MPEP 404, is essentially a placeholder and does not provide any substantive content. Practitioners should instead:

  • Refer to active, non-reserved sections of the MPEP
  • Consult the most recent USPTO guidelines and notices
  • Stay updated on changes to patent laws and regulations
  • Seek guidance from official USPTO sources when needed

It’s important to always use the most current and official information when dealing with patent matters.

MPEP 405 - Interviews With Patent Practitioner Not of Record (13)

The MPEP provides specific guidance on when an attorney or agent not of record can change the correspondence address. It states:

See MPEP § 402.03 for information regarding when a change of correspondence address or a document granting access (i.e., a power to inspect) may be signed by an attorney or agent who is not of record.

This reference to MPEP § 402.03 suggests that there are certain circumstances where an attorney or agent not of record may be allowed to change the correspondence address or grant access to application information. For specific details, it’s recommended to consult MPEP § 402.03 directly.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on USPTO procedures, visit: USPTO procedures.

What is the procedure for an examiner to verify an attorney’s authority during an interview?

When conducting an interview with an attorney or agent who is not of record, the examiner must follow a specific procedure to verify their authority. According to MPEP 405:

If an attorney or agent not of record in an application contacts an examiner for an interview, the examiner may grant the interview if the attorney or agent presents an authorization from the practitioner of record, or presents a signed power of attorney or a paper authorizing them to act as associate or agent.

The examiner should:

  • Ask for an authorization from the practitioner of record
  • Accept a signed power of attorney
  • Accept a paper authorizing the attorney or agent to act as an associate or agent

If none of these are available, the examiner should decline the interview unless the attorney or agent is willing to conduct the interview with the inventor present.

For more information on USPTO procedures, visit: USPTO procedures.

Unpublished patent applications are subject to confidentiality requirements under 35 U.S.C. 122(a). MPEP 405 addresses this in the context of interviews:

However, an interview concerning an application that has not been published under 35 U.S.C. 122(b) with an attorney or agent not of record who obtains authorization through use of the interview request form will be conducted based on the information and files supplied by the attorney or agent in view of the confidentiality requirements of 35 U.S.C. 122(a).

This means that for unpublished applications, the USPTO will only discuss information provided by the authorized attorney or agent to maintain confidentiality.

There are two main forms that can be used to authorize a patent practitioner for an interview:

  1. Applicant Initiated Interview Request Form (PTOL-413A)
  2. Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity’

According to MPEP 405:

Registered practitioners, when acting in a representative capacity, can show authorization to conduct an interview by completing, signing and filing an Applicant Initiated Interview Request Form (PTOL-413A).

Additionally:

Alternatively, Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity,’ which is available from the USPTO website at www.uspto.gov/sites/default/files/web/forms/sb0084.pdf may be used to establish the authority to conduct an interview.

What are the requirements for a registered practitioner to obtain access to an application?

According to MPEP 405, a registered practitioner may obtain access to an application if they fulfill the following requirements:

  • The practitioner must be acting in a representative capacity
  • The practitioner must have proper authority from the applicant or attorney or agent of record
  • Written consent from the applicant, attorney, or agent of record must be provided

The MPEP states: ‘Access will be given to the entire application file history in the absence of a specific request from the authorizing party for only a portion of the file.’ This means that unless specified otherwise, the practitioner will be granted full access to the application file.

For more information on application access, visit: application access.

For more information on registered practitioner, visit: registered practitioner.

For more information on USPTO procedures, visit: USPTO procedures.

For unpublished patent applications, confidentiality is a critical concern. The MPEP states:

An interview concerning an application that has not been published under 35 U.S.C. 122(b) with an attorney or agent not of record who obtains authorization through use of the interview request form will be conducted based on the information and files supplied by the attorney or agent in view of the confidentiality requirements of 35 U.S.C. 122(a).

This means that for unpublished applications, the USPTO will only discuss information provided by the attorney or agent to maintain confidentiality. The examiner cannot disclose any information from the application file that hasn’t been supplied by the practitioner.

For more information on unpublished applications, visit: unpublished applications.

Registered practitioners can show authorization to conduct an interview in several ways:

  • By being an attorney or agent of record with a power of attorney
  • By having an authorization to act in a representative capacity
  • By completing, signing, and filing an Applicant Initiated Interview Request Form (PTOL-413A)

The MPEP states: Registered practitioners, when acting in a representative capacity, can show authorization to conduct an interview by completing, signing and filing an Applicant Initiated Interview Request Form (PTOL-413A). This method is particularly convenient as it eliminates the need to file a power of attorney or authorization to act in a representative capacity before having an interview.

Alternatively, practitioners can use Form PTO/SB/84, ‘Authorization to Act in a Representative Capacity,’ available on the USPTO website.

For more information on USPTO Forms, visit: USPTO Forms.

Tags: USPTO Forms

Can an inventor’s attorney conduct an interview without a power of attorney?

Yes, an inventor’s attorney can conduct an interview without a power of attorney under certain conditions. The MPEP 405 provides guidance on this matter:

Interviews may be granted to an attorney or agent who is not of record in an application if the conditions of 37 CFR 1.33(b)(3) are satisfied.

This means that if the attorney or agent complies with the requirements set forth in 37 CFR 1.33(b)(3), they can conduct an interview even without a formal power of attorney. These requirements typically include providing evidence of their authority to act on behalf of the applicant.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO procedures, visit: USPTO procedures.

No, a third party or its representative cannot use the provisions of 37 CFR 1.34 to conduct an interview or take other actions not specifically permitted by the rules of practice. MPEP 405 states:

The use of the provisions of 37 CFR 1.34 by a third party or its representative to conduct an interview, or take other action not specifically permitted by the rules of practice in an application for patent, is considered a violation of 37 CFR 11.18 and may result in disciplinary action if done by a practitioner.

This means that attempting to use 37 CFR 1.34 for unauthorized actions could lead to disciplinary consequences for registered practitioners.

Generally, third parties are not permitted to conduct interviews or take actions in patent applications. The MPEP clearly states:

The use of the provisions of 37 CFR 1.34 by a third party or its representative to conduct an interview, or take other action not specifically permitted by the rules of practice in an application for patent, is considered a violation of 37 CFR 11.18 and may result in disciplinary action if done by a practitioner.

This means that only authorized representatives (such as registered attorneys or agents with proper authorization) can conduct interviews or take actions on behalf of the applicant. Third parties attempting to do so may face disciplinary action, especially if they are registered practitioners.

For more information on disciplinary action, visit: disciplinary action.

For more information on patent interviews, visit: patent interviews.

Yes, registered patent practitioners can file papers in patent applications and reexamination proceedings without being of record. MPEP 405 states:

Papers may be filed in patent applications and reexamination proceedings by registered attorneys or agents not of record under 37 CFR 1.34. Filing of such papers is considered to be a representation that the attorney or agent is authorized to act in a representative capacity on behalf of applicant.

This means that by filing papers, the practitioner is implicitly stating they have authorization to act on behalf of the applicant, even if they are not officially recorded as the attorney or agent of record.

Yes, a registered patent practitioner who is not of record can conduct an interview if they have proper authorization from the applicant. According to MPEP 405:

Interviews may be conducted with a registered practitioner who has proper authority from the applicant, or an attorney or agent of record in the form of a power of attorney or authorization to act in a representative capacity, whether or not the practitioner has a copy of the application file.

The practitioner can show authorization by completing, signing, and filing an Applicant Initiated Interview Request Form (PTOL-413A) or using Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity’.

Yes, registered attorneys or agents not of record can file papers in patent applications and reexamination proceedings under 37 CFR 1.34. The MPEP states:

Filing of such papers is considered to be a representation that the attorney or agent is authorized to act in a representative capacity on behalf of applicant.

This means that by filing papers, the attorney or agent is implicitly declaring their authority to represent the applicant.

For more information on patent filing, visit: patent filing.

For more information on USPTO procedures, visit: USPTO procedures.

MPEP 406 - Death of Patent Practitioner (13)

After the USPTO is notified of a patent practitioner’s death, correspondence is sent to two parties:

  1. The office of the deceased practitioner
  2. The person who originally appointed the deceased patent practitioner

This dual notification ensures that both the practitioner’s office and the original appointer are aware of ongoing patent matters and can take appropriate action.

When issuing Office actions after being notified of a patent practitioner’s death, the USPTO includes a special notation. The MPEP 406 instructs examiners to add form paragraph 4.03, which states:

“Notice of the death of the attorney or agent of record has come to the attention of this Office. Since the power of attorney is therefore terminated, this action is being mailed to the office of the patent practitioner and to the party who originally appointed the deceased patent practitioner. A new registered attorney or agent may be appointed.”

This notation informs all parties of the practitioner’s death and the need for new representation.

For more information on Form Paragraph 4.03, visit: Form Paragraph 4.03.

The USPTO, through its Office of Enrollment and Discipline, provides valuable resources to client-applicants when their patent practitioner dies. The MPEP 406 states:

‘The Office of Enrollment and Discipline will notify the client-applicant of the availability of a list of patent practitioners who may be available to represent the client-applicant.’

This list serves as a crucial resource, helping client-applicants find new representation to continue their patent prosecution process without significant delays.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO Resources, visit: USPTO Resources.

Form Paragraph 4.03 is used by USPTO examiners in Office actions to notify relevant parties about the death of a patent practitioner. The paragraph reads:

Notice of the death of the attorney or agent of record has come to the attention of this Office. Since the power of attorney is therefore terminated, this action is being mailed to the office of the patent practitioner and to the party who originally appointed the deceased patent practitioner. A new registered attorney or agent may be appointed.

This paragraph informs recipients that the power of attorney has been terminated and that a new attorney or agent can be appointed.

When a patent practitioner dies, the MPEP 406 outlines the following procedure:

  • The Office will notify the applicant of the death of the practitioner.
  • The applicant must appoint a new registered patent practitioner or file a change of correspondence address.
  • This must be done within the time period set in the notice, which is usually 3 months.
  • If no action is taken, the application may be deemed abandoned.

As stated in the MPEP: “If notification of the death of the practitioner is received by the Office, the Office will notify the applicant of the death and the need to appoint a new registered patent practitioner or file a change of correspondence address.”

For more information on patent practitioner death, visit: patent practitioner death.

For more information on pending applications, visit: pending applications.

For more information on USPTO notification, visit: USPTO notification.

When a patent practitioner dies, their power of attorney is automatically revoked or terminated. According to the MPEP, The power of attorney of a patent practitioner will be revoked or terminated by his or her death. (MPEP 406)

When a patent practitioner dies, the law firm should take the following actions:

  • Promptly notify the USPTO’s Office of Enrollment and Discipline (OED) of the practitioner’s death.
  • Inform clients with pending applications about the situation and the need to appoint a new representative.
  • Assist clients in filing new powers of attorney or authorizations of agent for pending applications.
  • Provide the USPTO with updated correspondence addresses for affected applications.

The MPEP 406 states: ‘When it is known that the attorney or agent of record in an application is deceased, the Office should be promptly notified.’ This notification helps ensure a smooth transition and continued proper handling of patent applications.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO notification, visit: USPTO notification.

According to MPEP 406, when the USPTO notifies an applicant of their patent practitioner’s death, the applicant is given a specific timeframe to respond. The MPEP states:

“The period for reply to such a notice is normally set at 3 months.”

During this 3-month period, the applicant must take one of the following actions:

  • Appoint a new registered patent practitioner
  • File a change of correspondence address

It’s crucial to respond within this timeframe to prevent the application from being deemed abandoned.

For more information on application abandonment, visit: application abandonment.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on response time, visit: response time.

For more information on USPTO notification, visit: USPTO notification.

According to MPEP 406, the USPTO follows a specific procedure to notify client-applicants:

‘The Office of Enrollment and Discipline will notify the client-applicant of the availability of a list of patent practitioners who may be available to represent the client-applicant.’

This notification ensures that the client-applicant is aware of the situation and has resources to find new representation if needed.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO notification, visit: USPTO notification.

When the USPTO is notified of the death of a sole patent practitioner of record, they continue to hold correspondence with the deceased practitioner’s office. However, the USPTO also mails a copy of the Office action to the person who originally appointed the practitioner. This ensures that the applicant or owner is informed of ongoing patent matters.

No, a patent practitioner cannot appoint a substitute to take over their cases after death. The MPEP 406 clearly states: “The patent practitioner may not appoint a ‘substitute’ and any attempt by the patent practitioner to appoint a ‘substitute’ patent practitioner whose power is intended to survive his or her own will not be recognized by the Office.” This means that any arrangements made by a practitioner for a substitute after their death will not be valid in the eyes of the USPTO.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO policy, visit: USPTO policy.

No, a patent practitioner cannot appoint a substitute whose power would survive their own death. The MPEP clearly states: The patent practitioner may not appoint a ‘substitute’ and any attempt by the patent practitioner to appoint a ‘substitute’ patent practitioner whose power is intended to survive his or her own will not be recognized by the Office. (MPEP 406)

Yes, a new patent practitioner can be appointed after the death of the previous one. The USPTO explicitly states in Form Paragraph 4.03: A new registered attorney or agent may be appointed. This allows the applicant or patent owner to ensure continued representation in patent matters following the death of their previous practitioner.

MPEP 407 - Suspended or Excluded Patent Practitioner (15)

When there’s no attorney of record, the signatories for patent application papers depend on the filing date and the applicant type. For applications filed before September 16, 2012, MPEP § 407 states: “All papers filed in the application must be signed: (1) by all named applicants unless one named applicant has been given a power of attorney to sign on behalf of the remaining applicants, and the power of attorney is of record in the application; or (2) if there is an assignee of record of an undivided part interest, by all named applicants retaining an interest and such assignee; or (3) if there is an assignee of the entire interest, by such assignee; or (4) by a registered patent attorney or agent not of record who acts in a representative capacity under the provisions of 37 CFR 1.34.”

For applications filed on or after September 16, 2012: “All papers must be signed by: (1) a patent practitioner of record; (2) a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34; or (3) the applicant, except that papers submitted on behalf of a juristic entity applicant must be signed by a patent practitioner.”

When an attorney is suspended, the signing authority for papers in a patent application depends on the filing date:

For applications filed before September 16, 2012:

  • All named applicants
  • Assignee of record of an undivided part interest, along with named applicants retaining an interest
  • Assignee of the entire interest
  • A registered patent attorney or agent not of record acting under 37 CFR 1.34

For applications filed on or after September 16, 2012:

  • A patent practitioner of record
  • A patent practitioner not of record acting under 37 CFR 1.34
  • The applicant (except for juristic entity applicants, which require a patent practitioner)

This information is provided in Form Paragraph 4.07 of MPEP § 407.

If an applicant’s patent attorney or agent is suspended, they should take the following steps:

  1. File a new power of attorney in the application to have a registered attorney or agent represent them before the Office.
  2. Ensure all future papers are signed by authorized parties (see MPEP § 407, Form Paragraph 4.07 for details on who can sign).
  3. If necessary, find a new registered patent attorney or agent using USPTO resources.
  4. Update the correspondence address for the application if it was previously associated with the suspended practitioner.

It’s important to act promptly to ensure continued proper representation and communication with the USPTO.

What limited recognition is granted to suspended or excluded practitioners?

Suspended or excluded practitioners are granted limited recognition to handle specific tasks related to pending applications. According to MPEP 407:

“The suspended or excluded practitioner will be granted limited recognition for a period of thirty (30) days, during which time the practitioner may conclude work on behalf of a client on any matters pending before the Office.”

This limited recognition allows the practitioner to:

  • Conclude or withdraw from representation in pending proceedings
  • Receive and forward correspondence
  • Make appropriate filings to protect the client’s rights

However, this recognition is strictly limited to these activities and does not allow the practitioner to engage in new patent prosecution work.

For more information on pending applications, visit: pending applications.

While both suspended and excluded patent practitioners are prohibited from practicing before the USPTO, there are differences in the nature and duration of the prohibition:

  • Suspended practitioner: Temporarily prohibited from practicing before the USPTO for a specific period.
  • Excluded practitioner: Permanently prohibited from practicing before the USPTO, unless later reinstated.

The MPEP § 407 uses both terms, indicating that the Office treats them similarly in terms of communication and representation: ‘The Office does not communicate with attorneys or agents who have been suspended or excluded from practice.’

When one of multiple practitioners of record is suspended, the USPTO continues to communicate with the remaining unsuspended practitioners. MPEP § 407 provides guidance for this situation: “This form paragraph should be used when there is at least one registered practitioner still of record who has not been suspended or excluded from practice.” The Office action is mailed to the first named unsuspended registered practitioner at their address of record. Additionally, to ensure timely receipt, a copy is also sent to the first named applicant’s address of record.

For more information on USPTO communication, visit: USPTO communication.

What happens to pending patent applications when a practitioner is suspended or excluded?

When a patent practitioner is suspended or excluded, the Office of Enrollment and Discipline (OED) Director must review all pending patent applications to determine if immediate action is necessary. According to MPEP 407:

“The OED Director will review all pending applications, in which the suspended or excluded practitioner is the attorney or agent of record, and notify the applicant of the suspension or exclusion and of the limited recognition of the practitioner.”

This process ensures that applicants are aware of their practitioner’s status and can take appropriate action to protect their patent applications.

For more information on pending applications, visit: pending applications.

A power of attorney given to a suspended or disbarred patent practitioner becomes ineffective. The MPEP states: ‘Any power of attorney given to a practitioner who has been suspended or disbarred by the Office is ineffective, and does not authorize the person to practice before the Office or to represent applicants or patentees in patent matters.’ (MPEP § 407)

What actions can a suspended or excluded practitioner take during the 30-day limited recognition period?

During the 30-day limited recognition period, suspended or excluded practitioners are allowed to perform specific actions to protect their clients’ interests. According to MPEP 407:

“During the 30-day period of limited recognition, the suspended or excluded practitioner may conclude work on behalf of a client on any matters that were pending before the Office on the date of entry of the order of suspension or exclusion.”

Specifically, the practitioner may:

  • Receive and forward correspondence related to pending matters
  • Make appropriate filings to protect the client’s rights
  • Conclude or withdraw from representation in pending proceedings
  • Perform limited actions necessary to transfer the client’s case to another registered practitioner

It’s important to note that this limited recognition does not allow the practitioner to take on new clients or file new patent applications during this period.

How does the USPTO notify applicants of their practitioner’s suspension or exclusion?

The USPTO has a specific process for notifying applicants when their patent practitioner has been suspended or excluded. The MPEP 407 outlines this process:

“The OED Director will… notify the applicant of the suspension or exclusion and of the limited recognition of the practitioner. The notification will be sent to the address of record in the application.”

This notification serves several purposes:

  • Informs the applicant of their practitioner’s status change
  • Advises the applicant of the practitioner’s limited recognition period
  • Allows the applicant to take necessary actions to protect their patent application

It’s crucial for applicants to promptly respond to such notifications to ensure their patent applications are not adversely affected by their practitioner’s disciplinary status.

For more information on USPTO notification, visit: USPTO notification.

The USPTO takes specific actions regarding powers of attorney granted to suspended or excluded practitioners. According to MPEP 407:

The Office of Enrollment and Discipline (OED) Director will contact the Director of the Technology Center (TC) managing the application when a practitioner has been suspended or excluded from practice. The OED Director will request that the TC Director review a pending application to determine whether the practitioner has been granted a power of attorney. If the suspended or excluded practitioner was given a power of attorney, the TC Director will notify the applicant and request a new power of attorney.

The process typically involves:

  • Identification of affected applications by the OED Director
  • Review of power of attorney status by the TC Director
  • Notification to the applicant if a power of attorney exists
  • Request for a new power of attorney from the applicant
  • Potential application abandonment if no response is received within 30 days

For more information on power of attorney, visit: power of attorney.

When an attorney or agent is suspended, the USPTO does not communicate with them. Instead:

  • For sole practitioners: The Office action is mailed to the address of the first named applicant in the application.
  • For multiple practitioners: The Office action is mailed to the first named unsuspended registered practitioner of record and to the first named applicant.

This is outlined in Form Paragraphs 4.07 and 4.08 of MPEP § 407.

Applicants can find a new registered patent attorney or agent through resources provided by the USPTO. According to MPEP § 407: “Applicants may obtain a list of registered patent attorneys and agents located in their area by consulting the USPTO website, https://oedci.uspto.gov/OEDCI/, or by calling the Office of Enrollment and Discipline at (571) 272-4097.” These resources allow applicants to search for qualified practitioners who can represent them before the USPTO.

For more information on USPTO Resources, visit: USPTO Resources.

When an applicant’s patent attorney or agent is suspended, they can find a new registered patent attorney or agent by:

  1. Consulting the USPTO website at https://oedci.uspto.gov/OEDCI/
  2. Calling the Office of Enrollment and Discipline at (571) 272-4097

This information is provided in Form Paragraph 4.07 of MPEP § 407.

No, a suspended or excluded practitioner is not permitted to receive correspondence from the USPTO regarding patent applications. According to MPEP 407:

A suspended or excluded practitioner is not entitled to receive correspondence from the Office, or have interviews with examiners, in applications or patents.

The USPTO takes the following steps to ensure compliance:

  • Correspondence will be sent to the applicant or assignee at their address of record.
  • If no practitioner is of record, the correspondence will be sent directly to the applicant or assignee.
  • Examiners are instructed not to hold interviews with suspended or excluded practitioners.

For more information on USPTO correspondence, visit: USPTO correspondence.

MPEP 408 - Interviews With Patent Practitioner of Record (17)

According to the MPEP, an examiner can contact the patent practitioner of record in the application for interviews. The MPEP states:

When the examiner believes the progress of the application would be advanced by an interview, the examiner may contact the patent practitioner of record in the application (in accordance with MPEP § 713) and suggest a telephonic, personal, or video conference interview.

It’s important to note that registered attorneys or agents not of record should not be contacted for certain actions, such as restriction requirements or approval of examiner’s amendments.

What is the role of a patent practitioner during an interview with the USPTO?

A patent practitioner plays a crucial role during an interview with the USPTO. According to MPEP 408, the practitioner is responsible for:

  • Representing the applicant or patent owner
  • Discussing the merits of the application or patent
  • Providing clarifications on the invention
  • Negotiating potential claim amendments
  • Addressing any concerns raised by the examiner

The MPEP states: ‘Interviews must be conducted on the Office premises, such as in examiner’s offices, conference rooms or the video conference centers.’ This underscores the formal nature of these interactions and the importance of the practitioner’s role in facilitating productive discussions with the examiner.

For more information on patent examination, visit: patent examination.

To initiate an interview with a patent examiner, applicants should follow a specific procedure outlined in MPEP § 408:

  1. Submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) to the examiner prior to the interview.
  2. The form should identify the participants of the interview.
  3. Propose a date for the interview.
  4. Specify whether the interview will be personal, telephonic, or via video conference.
  5. Include a brief description of the issues to be discussed.

As stated in the MPEP, When applicant is initiating a request for an interview, an ‘Applicant Initiated Interview Request’ form (PTOL-413A) should be submitted to the examiner prior to the interview in order to permit the examiner to prepare in advance for the interview and to focus on the issues to be discussed. This procedure helps ensure productive and efficient interviews.

For more information on patent examination, visit: patent examination.

For more information on USPTO Forms, visit: USPTO Forms.

The Applicant Initiated Interview Request form (PTOL-413A) should include specific information to facilitate the interview process. According to MPEP 408:

This form should identify the participants of the interview, the proposed date of the interview, whether the interview will be personal, telephonic, or video conference, and should include a brief description of the issues to be discussed.

Providing this information helps the examiner prepare adequately for the interview and ensures that all necessary parties are involved in the discussion of relevant issues.

When an applicant is initiating an interview request, they should submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) to the examiner. The MPEP provides the following guidance:

When applicant is initiating a request for an interview, an ‘Applicant Initiated Interview Request’ form (PTOL-413A) should be submitted to the examiner prior to the interview in order to permit the examiner to prepare in advance for the interview and to focus on the issues to be discussed.

This form helps streamline the interview process by providing the examiner with essential information about the proposed interview.

When conducting interviews with patent practitioners in foreign countries, examiners must follow specific guidelines:

  • Interviews must be conducted via video conference or telephone.
  • In-person interviews in foreign countries are not permitted.
  • The same interview policies and procedures apply as for domestic interviews.

As stated in the MPEP 408: ‘For patent practitioners in foreign countries, interviews must be scheduled to be conducted by video conference or telephone. Examiners may not hold in-person interviews with patent practitioners in foreign countries.’

What are the restrictions on registered practitioners not of record during USPTO interviews?

Registered practitioners who are not of record for a specific patent application face certain restrictions when attending USPTO interviews. According to MPEP 408:

‘The registered practitioner not of record may not participate in the interview of the application except as authorized by the patent applicant.’

This means that while a practitioner not of record may accompany the practitioner of record to an interview, their participation is limited. They cannot actively engage in the discussion or negotiation process without explicit authorization from the patent applicant. This restriction is in place to ensure that the applicant’s interests are properly represented by their chosen practitioner of record and to maintain the integrity of the interview process.

For more information on patent examination, visit: patent examination.

For more information on practitioner of record, visit: practitioner of record.

For more information on registered practitioner, visit: registered practitioner.

When conducting interviews with inventors or assignees, examiners must adhere to specific requirements:

  • The practitioner of record must authorize and be present for the interview.
  • Inventors or assignees cannot participate without the practitioner’s presence.
  • Examiners should not conduct interviews directly with inventors or assignees alone.

According to the MPEP 408: ‘Interviews with inventors or assignees and/or their attorneys or agents of record must be authorized by the practitioners of record. The practitioner of record must be present and an examiner may not conduct an interview with an inventor or assignee unless the practitioner is present.’

For more information on patent examination, visit: patent examination.

When handling interview requests from practitioners not of record, examiners should follow these guidelines:

  • Verify the requester’s authority to conduct the interview.
  • Ensure the practitioner of record has authorized the interview.
  • If authorization is not provided, decline the interview request.

The MPEP 408 states: ‘Interviews with practitioners not of record should be conducted only with the consent of the practitioner of record.’ It further advises: ‘An examiner should not conduct an interview with an attorney or agent who is not of record unless the attorney or agent presents either a power of attorney or a letter signed by the attorney or agent of record authorizing the interview.’

For more information on patent examination, visit: patent examination.

When handling interview requests from multiple attorneys or agents, examiners should follow these guidelines:

  • Generally, only one interview is granted per application.
  • If multiple practitioners request interviews, coordinate with the practitioner of record.
  • Additional interviews may be granted at the examiner’s discretion.

The MPEP 408 states: ‘An interview should normally be conducted with the attorney or agent of record in an application.’ It further advises: ‘If more than one attorney or agent request an interview in an application, it is the responsibility of the attorney or agent of record to resolve any conflict.’

For more information on patent examination, visit: patent examination.

For more information on practitioner of record, visit: practitioner of record.

How does the USPTO handle interviews for applications with multiple practitioners of record?

The USPTO has specific guidelines for handling interviews when multiple practitioners are of record for a patent application. MPEP 408 provides guidance on this situation:

‘Where a registered practitioner has been given a power of attorney or authorization of agent, only that practitioner, a practitioner appointed in an associate power of attorney or authorization of agent, or another registered practitioner who has the permission of one of the aforementioned practitioners may conduct an interview.’

This means that when multiple practitioners are of record, any one of them can conduct the interview. However, it’s important to note that clear communication between the practitioners is crucial to ensure consistent representation of the applicant’s interests. The USPTO typically communicates with the practitioner who initiated the interview or the one designated as the primary contact for the application.

For more information on patent examination, visit: patent examination.

For more information on power of attorney, visit: power of attorney.

The USPTO actively encourages the use of interviews to expedite patent prosecution. According to MPEP § 408, The Office encourages the use of interviews to expedite prosecution. When an examiner believes an interview would advance the application’s progress, they may contact the patent practitioner of record to suggest a telephonic, personal, or video conference interview.

To initiate an interview, applicants should submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) prior to the interview. This form helps the examiner prepare and focus on the issues to be discussed.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

No, non-registered representatives should not be contacted for patent application actions, even if they appear to be authorized by the attorney or agent of record. The MPEP clearly states:

In addition, non-registered representatives of the practitioner of record should not be contacted for such actions, even if apparently authorized by the attorney or agent of record.

This restriction helps maintain the integrity of the patent application process and ensures that only qualified, registered practitioners are involved in critical communications.

Yes, examiners can initiate interview requests with patent practitioners of record. The MPEP encourages this practice to expedite prosecution:

The Office encourages the use of interviews to expedite prosecution. When the examiner believes the progress of the application would be advanced by an interview, the examiner may contact the patent practitioner of record in the application (in accordance with MPEP § 713) and suggest a telephonic, personal, or video conference interview.

This proactive approach by examiners can help clarify issues and potentially speed up the patent application process.

Can a patent applicant attend an interview with the USPTO without their practitioner?

While it is generally recommended that a patent practitioner represents the applicant during USPTO interviews, there are circumstances where an applicant may attend without their practitioner. MPEP 408 states:

‘A registered practitioner, not of record, may accompany a registered practitioner of record to attend an interview of an application in which the registered practitioner is not of record. The registered practitioner not of record may not participate in the interview of the application except as authorized by the patent applicant.’

This implies that while the primary responsibility lies with the practitioner of record, applicants have some flexibility in who attends the interview. However, it’s important to note that without proper representation, applicants may miss out on valuable legal insights and negotiation opportunities during the interview process.

For more information on patent applicant, visit: patent applicant.

For more information on patent examination, visit: patent examination.

Yes, there are significant restrictions on contacting patent practitioners who are not of record for a patent application. According to MPEP § 408, Registered attorneys or agents not of record in a patent application (i.e., there is no power of attorney present in the file that appoints the patent practitioner(s)) and acting in a representative capacity under 37 CFR 1.34 should not be contacted for restriction requirements or approval of examiner’s amendments.

This policy is in place to ensure that only properly authorized representatives are involved in making decisions about patent applications. For more information on interviews with patent practitioners not of record, refer to MPEP § 405.

Yes, there are strict restrictions on communicating with unregistered, suspended, or excluded attorneys regarding patent applications. The MPEP clearly states:

Office employees are forbidden from holding either oral or written communication with an unregistered, suspended or excluded attorney or agent regarding an application unless it is one in which said attorney or agent is the applicant.

This rule helps maintain the integrity of the patent application process and ensures that only qualified, registered practitioners are involved in patent-related communications with the USPTO.

MPEP 410 - Representations to the U.S. Patent and Trademark Office (11)

What is the duty of disclosure in patent applications?

The duty of disclosure is a fundamental obligation in the patent application process. As outlined in MPEP 410:

“Each individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability as defined in this section.”

This duty requires applicants and their representatives to:

  • Disclose all known material information
  • Submit information disclosure statements (IDS)
  • Update the USPTO with new material information throughout the application process

Failing to comply with the duty of disclosure can result in charges of inequitable conduct, which may render a patent unenforceable. It’s crucial for applicants to err on the side of disclosure when in doubt about the materiality of information.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The ‘reasonable inquiry’ requirement, as described in 37 CFR 11.18(b)(2), mandates that submissions to the USPTO be made ‘to the best of the party’s knowledge, information and belief, formed after an inquiry reasonable under the circumstances.’ This standard is similar to Rule 11 of the Federal Rules of Civil Procedure.

The MPEP clarifies: An ‘inquiry reasonable under the circumstances’ requirement of 37 CFR 10.18(b)(2) is identical to that in Fed. R. Civ. P. 11(b). The federal courts have stated in regard to the ‘reasonable inquiry’ requirement of Fed. R. Civ. P. 11: In requiring reasonable inquiry before the filing of any pleading in a civil case in federal district court, Rule 11 demands ‘an objective determination of whether a sanctioned party’s conduct was reasonable under the circumstances.’

For more information on patent application requirements, visit: patent application requirements.

When submitting papers to the USPTO, two key certifications are made under 37 CFR 11.18(b):

  1. Statements made are subject to the declaration clause of 37 CFR 1.68
  2. The certification required for papers filed in federal court under Rule 11(b) of the Federal Rules of Civil Procedure

Specifically, 37 CFR 11.18(b) states that by presenting any paper to the USPTO, the party certifies that:

‘All statements made therein of the party’s own knowledge are true, all statements made therein on information and belief are believed to be true, and all statements made therein are made with the knowledge that whoever, in any matter within the jurisdiction of the Office, knowingly and willfully falsifies, conceals, or covers up by any trick, scheme, or device a material fact, or knowingly and willfully makes any false, fictitious, or fraudulent statements or representations, or knowingly and willfully makes or uses any false writing or document knowing the same to contain any false, fictitious, or fraudulent statement or entry, shall be subject to the penalties set forth under 18 U.S.C. 1001 and any other applicable criminal statute’

This applies to both practitioners and non-practitioners submitting papers to the USPTO.

The USPTO has specific requirements for signatures on documents, as outlined in 37 CFR 1.4(d). Key points include:

  • Signatures must be personally inserted by the signer or comply with specific electronic signature standards.
  • The person inserting a signature certifies that it is their own signature.
  • A person submitting a document signed by another must have a reasonable basis to believe the signature is authentic.

The MPEP states: The person inserting a signature under paragraph (d)(2) or (d)(3) of this section in a document submitted to the Office certifies that the inserted signature appearing in the document is his or her own signature.

For more information on patent application requirements, visit: patent application requirements.

Violating the certification requirements when submitting papers to the USPTO can have serious consequences. According to 37 CFR 11.18(c), violations may result in:

  1. Striking the offending paper
  2. Referring a practitioner’s conduct to the Office of Enrollment and Discipline
  3. Precluding a party or practitioner from submitting papers or contesting issues
  4. Affecting the weight given to the offending paper
  5. Terminating proceedings in the Office

Additionally, 37 CFR 11.18(d) states that practitioners violating these provisions may be subject to disciplinary action. The USPTO Director determines appropriate sanctions after notice and opportunity to respond.

It’s important to note that violations can jeopardize the validity of applications, documents, patents, and trademark registrations. As stated in the MPEP:

‘The submission by an applicant of misleading or inaccurate statements of facts during the prosecution of applications for patent has resulted in the patents issuing on such applications being held unenforceable.’

Several court cases are cited demonstrating how false statements have led to patents being unenforceable.

What are the consequences of knowingly submitting false statements to the USPTO?

Submitting false statements to the USPTO can have serious consequences. According to MPEP 410:

“Knowingly submitting false statements or withholding material information from the Office in connection with a patent application or patent may be punishable by fine or imprisonment.”

The MPEP further states that such actions may result in:

  • Invalidation of patents
  • Unenforceability of patents
  • Criminal prosecution
  • Disciplinary action against practitioners

It’s crucial for applicants and their representatives to maintain honesty and transparency in all communications with the USPTO to avoid these severe consequences.

For more information on USPTO, visit: USPTO.

Tags: USPTO

No, an applicant is not required to conduct a prior art search before filing a patent application. The MPEP clearly states:

‘An applicant has no duty to conduct a prior art search as a prerequisite to filing an application for patent.’

This is supported by several court cases cited in the MPEP, including:

  • Nordberg, Inc. v. Telsmith, Inc.
  • FMC Corp. v. Hennessy Indus., Inc.
  • American Hoist & Derrick Co. v. Sowa & Sons, Inc.

The ‘inquiry reasonable under the circumstances’ requirement of 37 CFR 11.18 does not create any new duty for applicants to conduct prior art searches. However, applicants and practitioners should be aware that providing false or misleading information during prosecution can jeopardize patent enforceability.

How does the USPTO handle inequitable conduct in patent applications?

The USPTO takes inequitable conduct in patent applications very seriously. According to MPEP 410:

“[T]he Office will consider equitable and public policy principles in assessing whether to issue a patent to an applicant who has engaged in inequitable conduct.”

Inequitable conduct typically involves:

  • Failure to disclose material information
  • Submitting false material information
  • Intentional misrepresentation of facts

If inequitable conduct is found, the consequences may include:

  • Rejection of the patent application
  • Invalidation of an issued patent
  • Disciplinary action against registered practitioners

The USPTO may also refer cases of suspected fraud to the U.S. Department of Justice for potential criminal prosecution. It’s crucial for applicants and their representatives to maintain honesty and transparency throughout the patent application process.

For more information on fraud, visit: fraud.

For more information on USPTO, visit: USPTO.

Tags: fraud, USPTO

How does the USPTO define ‘material information’ in patent applications?

The USPTO considers information to be material if it affects the patentability of an invention. According to MPEP 410:

“Information is material to patentability when it is not cumulative to information already of record or being made of record in the application, and (1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or (2) It refutes, or is inconsistent with, a position the applicant takes in: (i) Opposing an argument of unpatentability relied on by the Office, or (ii) Asserting an argument of patentability.”

In simpler terms, material information includes any facts that could affect the USPTO’s decision to grant a patent. This may include prior art, conflicting statements, or any other information that could impact the novelty or non-obviousness of the claimed invention.

For more information on prior art, visit: prior art.

For more information on USPTO, visit: USPTO.

Tags: prior art, USPTO

Can the USPTO independently verify information provided by patent applicants?

Yes, the USPTO has the authority to independently verify information provided by patent applicants. MPEP 410 states:

“The Office is not the guarantor of the accuracy, correctness or completeness of the information supplied by the applicant.”

This means that while the USPTO relies on the information provided by applicants, it may:

  • Conduct its own investigations
  • Request additional information or evidence
  • Consult external sources to verify claims

Applicants should be aware that the USPTO can and may verify any information submitted during the patent application process. It’s crucial to provide accurate and complete information to avoid potential legal issues or loss of patent rights.

For more information on patent application information, visit: patent application information.

No, patent applicants are not required to conduct prior art searches before filing a patent application. This is clarified in the MPEP, which states:

An applicant has no duty to conduct a prior art search as a prerequisite to filing an application for patent. See Nordberg, Inc. v. Telsmith, Inc., 82 F.3d 394, 397, 38 USPQ2d 1593, 1595-96 (Fed. Cir. 1996); FMC Corp. v. Hennessy Indus., Inc., 836 F.2d 521, 526 n.6, 5 USPQ2d 1272, 1275-76 n.6 (Fed. Cir. 1987); FMC Corp. v. Manitowoc Co., 835 F.2d 1411, 1415, 5 USPQ2d 1112, 1115 (Fed. Cir. 1987); American Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F.2d 1350, 1362, 220 USPQ 763, 772 (Fed. Cir.), cert. denied, 469 U.S. 821, 224 USPQ 520 (1984).

However, conducting a prior art search can be beneficial for understanding the state of the art and assessing the potential patentability of an invention.

For more information on patent application requirements, visit: patent application requirements.

For more information on prior art search, visit: prior art search.

MPEP 500 - Receipt and Handling of Mail and Papers (336)

For applications filed on or after September 16, 2012, the following parties can sign a written assertion of small entity status:

  • The applicant
  • A patent practitioner of record or acting in a representative capacity
  • The inventor or a joint inventor, if the inventor is the applicant
  • The assignee

According to 37 CFR 1.27(c)(2): “The written assertion can be signed by: (i) The applicant (§ 1.42 or § 1.421); (ii) A patent practitioner of record or a practitioner acting in a representative capacity under § 1.34; (iii) The inventor or a joint inventor, if the inventor is the applicant; or (iv) The assignee.”

To learn more:

According to MPEP 509.04(c), a certification of micro entity status can be signed only by an authorized party as set forth in 37 CFR 1.33(b), which includes:

  • A patent practitioner of record
  • A patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34
  • The applicant (37 CFR 1.42)

It’s important to note that “Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.”

To learn more:

Small entity status should only be claimed after a thorough investigation has been completed and there is certainty about the entitlement. The MPEP 509.03(a) states: “Where entitlement to small entity status is uncertain, it should not be claimed.” It’s important to note that even paying the small entity basic filing fee constitutes an assertion of small entity status. Therefore, applicants should be certain of their status before making any payments or claims related to small entity status.

To learn more:

Tags: patent fees

While the USPTO generally discourages filing duplicate copies, there are situations where separate copies are necessary. According to MPEP 502.04:

Since each file must be complete in itself, a separate copy of every paper to be filed in a patent, patent file, or other proceeding must be furnished for each file to which the paper pertains, even though the contents of the papers filed in two or more files may be identical.

This means that if a document relates to multiple patent applications or proceedings, a separate copy must be submitted for each relevant file, even if the content is identical across all copies.

To learn more:

According to MPEP 502.01, various types of patent-related correspondence can be transmitted by facsimile to the USPTO, including:

  • Continued Prosecution Applications (CPAs) filed under 37 CFR 1.53(d) (for design applications only)
  • Amendments
  • Declarations
  • Petitions
  • Information Disclosure Statements (IDS)
  • Terminal disclaimers
  • Notices of appeal and appeal briefs
  • Requests for Continued Examination (RCEs) under 37 CFR 1.114
  • Assignment documents
  • Issue fee transmittals
  • Authorizations to charge deposit accounts

The MPEP states: “37 CFR 1.6(d) specifies the types of correspondence which may be transmitted by facsimile.” However, it’s important to note that certain types of correspondence are prohibited from being sent by fax, as outlined in 37 CFR 1.6(d)(2)-(7).

To learn more:

According to MPEP 502.01, certain types of patent-related correspondence are prohibited from being sent by facsimile to the USPTO. These include:

  • Documents required by statute to be certified (37 CFR 1.4(f))
  • National patent application specifications and drawings for obtaining a filing date (except for CPAs under 37 CFR 1.53(d))
  • International patent applications
  • International design applications
  • Documents for entering the national stage of an international application (37 CFR 1.495(b))
  • Third-party submissions under 37 CFR 1.290
  • Correspondence related to registration to practice before the USPTO in patent cases
  • Color drawings (37 CFR 1.81, 1.83-1.85, 1.152, 1.165, 1.173, 1.437, or 1.1026)
  • Requests for reexamination (37 CFR 1.510 or 37 CFR 1.913)
  • Requests for supplemental examination (37 CFR 1.610)
  • Correspondence for patent applications under secrecy orders (37 CFR 5.1-5.5)
  • Most correspondence for contested cases or trials before the Patent Trial and Appeal Board

The MPEP states: “As a courtesy, the Office will attempt to notify senders whenever correspondence is sent to the Office by facsimile transmission that falls within one of the prohibitions.” However, it’s crucial to avoid submitting prohibited correspondence by fax, as it will not be accorded a receipt date.

To learn more:

For the purpose of micro entity status, the following types of patent applications count towards the application filing limit:

  • Previously filed U.S. nonprovisional applications (utility, design, plant, continuation, and divisional)
  • Previously filed U.S. reissue applications
  • Previously filed U.S. national stage applications under the Patent Cooperation Treaty (PCT)
  • Previously filed international design applications under the Hague agreement that designate the U.S.

The MPEP states: “All such applications naming the inventor or a joint inventor are counted toward the application filing limit, whether the applications were filed before, on, or after March 19, 2013.

Applications that do not count towards the limit include:

  • Foreign applications
  • International (PCT) applications for which the basic U.S. national stage filing fee was not paid
  • Provisional applications

To learn more:

The following types of patent applications and documents can be filed via EFS-Web:

  • Provisional patent applications under 35 U.S.C. 111(b)
  • Nonprovisional utility patent applications under 35 U.S.C. 111(a)
  • Nonprovisional design patent applications under 35 U.S.C. 111(a)
  • International applications filed under the PCT in the United States Receiving Office
  • National stage submissions under 35 U.S.C. 371
  • International design applications filed under the Hague Agreement
  • Requests for ex parte reexamination for utility or design patents
  • Requests for supplemental examination for utility, design, or plant patents
  • Third-party preissuance submissions under 35 U.S.C. 122(e)
  • Citation of prior art and written statements in patent files under 37 CFR 1.501

Follow-on documents can also be filed via EFS-Web for existing applications by registered users.

OPAP may object to and require corrected drawings within a set time period for several issues. According to the MPEP, these include:

  • Line quality that is too light to be reproduced
  • Illegible text
  • Missing lead lines
  • Excessive text or non-English text
  • Incorrect margins or paper size
  • Improper figure labeling
  • Illegible photographs that could be illustrated by ink drawings
  • Color drawings or photographs without a proper petition

For example, regarding line quality, MPEP 507 states:

“OPAP may object to and require corrected drawings within a set time period, if the drawings: (A) have a line quality that is too light to be reproduced (weight of all lines and letters must be heavy enough to permit adequate reproduction) or text that is illegible (reference characters, sheet numbers, and view numbers must be plain and legible). See 37 CFR 1.84(l) and (p)(1)

For more information on drawing requirements, visit: drawing requirements.

For more information on OPAP, visit: OPAP.

For more information on patent drawings, visit: patent drawings.

While the Certificate of Mailing or Transmission procedure is useful for many types of USPTO correspondence, there are several exceptions. According to 37 CFR 1.8(a)(2), the procedure does not apply to:

  • Filing of national patent application specifications and drawings for the purpose of obtaining an application filing date
  • Filing of correspondence in an international application before the U.S. Receiving Office, U.S. International Searching Authority, or U.S. International Preliminary Examining Authority
  • Filing of an international design application
  • Filing a copy of an international application and the basic national fee to enter the national stage
  • Filing a written declaration of abandonment under 37 CFR 1.138

It’s crucial to note that these exceptions exist to ensure certain critical documents are actually received by the USPTO before they are considered filed.

To learn more:

While MPEP 508.02 doesn’t specify the types of communications that might be received after a patent is granted, it does indicate that some communications may still be relevant to the record. The section states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This implies that certain communications might still become part of the record. These could include:

  • Maintenance fee payments
  • Requests for correction of errors in the patent
  • Reissue applications
  • Supplemental examination requests

However, any communication not related to these or other official post-grant procedures would likely be returned.

To learn more:

To determine small entity status for a business, several steps should be taken:

  • Review whether the business meets the definition of a small business concern under section 3 of the Small Business Act.
  • Check if the business meets the size standards in 13 CFR 121.801 through 121.805 for eligibility for reduced patent fees.
  • Investigate if the business has assigned, granted, conveyed, or licensed any rights in the invention to others.
  • If rights have been transferred, conduct the same review for each other entity involved.

The MPEP 509.03(a) emphasizes: “If small entity status is desired on the basis that the entity is a small business concern, the investigation should include a review of whether the business is a small business concern as defined by section 3 of the Small Business Act.”

To learn more:

Tags: patent fees

If there’s a discrepancy between the filing date accorded by the USPTO and the “date accepted” on the Priority Mail Express® mailing label, you can file a petition under 37 CFR 1.10(c). MPEP 513 states that such a petition should:

  • Be filed promptly after becoming aware of the discrepancy
  • Include evidence that the Priority Mail Express® number was placed on the correspondence before mailing
  • Include a true copy of the Priority Mail Express® mailing label showing the “date accepted”

The petition should be filed as soon as the discrepancy is noticed to ensure timely correction of the filing date.

If there are variations in your signature across different patent documents, you should:

  • Try to use a consistent signature for all patent correspondence to avoid confusion.
  • Be prepared for the USPTO to require ratification or confirmation of the signature if there are significant variations.
  • If asked to ratify, state that you personally signed the previously submitted document and, if needed, submit a compliant format of the signature.

According to the MPEP: “For consistency purposes, and to avoid raising a doubt as to who has signed, the same S-signature should be utilized each time, with variations of the signature being avoided.”

If the USPTO requires ratification, they may ask you to submit a statement or a duplicate document with a compliant signature. This helps ensure the authenticity of signatures and clarity of the record.

To learn more:

If you have filed correspondence with a proper Certificate of Mailing or Transmission, but the USPTO has not received it after a reasonable amount of time, you can take action under 37 CFR 1.8(b). The MPEP states:

“37 CFR 1.8(b) permits a party to notify the Office of a previous mailing through the U.S. Postal Service, or transmission by facsimile or EFS-Web, of correspondence when a reasonable amount of time has elapsed from the time of mailing or transmission of the correspondence.”

To rectify this situation:

  1. Promptly notify the Office of the previous mailing or transmission
  2. Supply a duplicate copy of the previously mailed or transmitted correspondence
  3. Provide a statement attesting to the previous timely mailing or transmission

It’s important to act quickly once you become aware that the Office has not received your correspondence, rather than waiting until the end of the reply period.

To learn more:

If you’ve misused a Certificate of Mailing or Transmission, it’s important to address the issue promptly and honestly. The USPTO takes the integrity of these certificates seriously. The MPEP states:

Misuse of a Certificate of Mailing under 37 CFR 1.8 or improperly claiming the benefit of 37 CFR 1.10 which appears to be more than a one-time, inadvertent error should be brought to the attention of the Office of Enrollment and Discipline.

If the misuse was a one-time, inadvertent error, you should:

  1. Notify the USPTO as soon as you become aware of the error.
  2. Provide a full explanation of the circumstances.
  3. If possible, submit the correct documentation or information.
  4. Be prepared for the possibility that your submission may be considered late, which could have consequences for your application or proceeding.

For repeated or intentional misuse, the matter may be referred to the Office of Enrollment and Discipline, which could result in more serious consequences. It’s always best to use Certificates of Mailing or Transmission carefully and honestly to maintain the integrity of the patent application process.

If you lose entitlement to small entity status, you must notify the USPTO before or at the time of paying the earliest of the issue fee or any maintenance fee due after the change. According to 37 CFR 1.27(g)(2): ‘notification of any change in status resulting in loss of entitlement to small entity status be filed in the application or patent prior to paying, or at the time of paying, the earliest of the issue fee or any maintenance fee due after the date on which status as a small entity is no longer appropriate.’

This notification should be a specific written assertion, not just payment of a non-small entity fee. For example, when paying the issue fee, you should:

  • Check the appropriate box on Part B of the PTOL-85 form to indicate the change in entity status
  • Pay the fee amount for a non-small entity

To learn more:

To learn more:

Tags: patent fees

If you don’t possess any record of correspondence with the USPTO for an application, patent, or other proceeding that is the subject of an unlocatable file notice, you must still respond to the notice. According to 37 CFR 1.251(a)(3):

If applicant or patentee does not possess any record of the correspondence between the Office and the applicant or patentee for such application, patent, or other proceeding, applicant or patentee must comply with a notice under this section by providing a statement that applicant or patentee does not possess any record of the correspondence between the Office and the applicant or patentee for such application, patent, or other proceeding.

It’s crucial to provide this statement within the specified time period to avoid potential negative consequences, such as abandonment of a pending application or limitations on the certified copy of a granted patent file that the USPTO can produce.

To learn more:

If you cannot file your patent application electronically or by Priority Mail Express® due to an emergency, consider the following options:

  1. Use first-class mail with a Certificate of Mailing under 37 CFR 1.8
  2. Hand-deliver the application to the USPTO, if possible
  3. If the emergency is a designated postal service interruption, follow the specific instructions provided by the USPTO on their website or in the Official Gazette

Remember that the provisions for postal emergencies only apply to actual USPS service interruptions, not other circumstances like computer failures or office inaccessibility.

As stated in MPEP 511: “Applicants are cautioned that the provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) only apply to postal interruptions and emergencies. The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) do not provide for granting of a filing date to correspondence as of the date on which it would have been filed but for other exigencies, such as the unavailability of a computer or word processing equipment, or the inaccessibility of an office or building other than a USPS facility.”

A small entity for purposes of paying reduced patent fees is defined in 37 CFR 1.27(a) as:

  • A person
  • A small business concern
  • A nonprofit organization

Each of these categories has specific criteria that must be met to qualify for small entity status. For example, a person must not have assigned, granted, conveyed, or licensed any rights in the invention to a non-small entity.

To learn more:

What is the USPTO’s policy on federal holidays?

The USPTO observes federal holidays and has specific policies regarding correspondence and deadlines that fall on these days:

  • The USPTO is closed on all federal holidays.
  • Deadlines that fall on a federal holiday are extended to the next business day.
  • Correspondence is not accepted or processed on federal holidays.

According to MPEP 502: ‘Federal holidays falling on Sunday will be observed on the following Monday.’ This means that when a federal holiday falls on a Sunday, the USPTO will be closed on the following Monday, and any deadlines will be extended accordingly.

It’s important for patent applicants and attorneys to be aware of the federal holiday schedule and plan their filings accordingly to avoid missing critical deadlines.

The USPTO has established a Patent Internet Usage Policy that governs email communications with patent applicants. According to MPEP 502.03, ‘Communications via Internet email are at the discretion of the applicant.’ However, there are specific requirements and limitations:

  • A written authorization from the applicant is required for USPTO employees to communicate via email.
  • All Internet communications must be made using USPTO tools.
  • Without written authorization, the USPTO will not respond to Internet correspondence containing confidential information.

It’s important to note that ‘A reply to an Office action or a paper requiring a signature may NOT be communicated by applicant to the USPTO via Internet email even if written authorization is on record.’

To learn more:

Tags: USPTO

The United States Patent and Trademark Office (USPTO) generally discourages the filing of duplicate copies of correspondence in patent applications, patents, or other proceedings. According to MPEP 502.04:

The filing of duplicate copies of correspondence in the file of an application, patent, or other proceeding should be avoided, except in situations in which the Office requires the filing of duplicate copies.

The USPTO may dispose of duplicate copies to streamline processing. However, it’s important to note that separate copies are required for different files, even if the content is identical.

To learn more:

To qualify for micro entity status based on an institution of higher education, the applicant must first meet the small entity requirement. This means that every party holding rights in the application must qualify as a small entity under 37 CFR 1.27.

MPEP 509.04(b) states: “In order to meet the small entity requirement, every party holding rights in the application must qualify as a small entity under 37 CFR 1.27. If any rights in the application are assigned, granted, conveyed, or licensed to a party that does not qualify as a small entity under 37 CFR 1.27, the applicant cannot qualify for any patent fee discount.”

This requirement ensures that only truly small entities benefit from the micro entity status, even when associated with an institution of higher education.

To learn more:

Tags: patent fees

A patent practitioner plays a crucial role in signing micro entity certifications. According to MPEP 509.04(c), a patent practitioner can sign a micro entity certification in two capacities:

  1. As a patent practitioner of record
  2. As a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34

Moreover, for juristic entities, “Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.” This includes micro entity certifications for corporate assignees or other organizational parties under 37 CFR 1.46.

To learn more:

The USPTO requires that different matters be submitted in separate papers to ensure efficient processing. This requirement is outlined in MPEP 501, which cites 37 CFR 1.4(c):

Since different matters may be considered by different branches or sections of the Office, each distinct subject, inquiry or order must be contained in a separate paper to avoid confusion and delay in answering papers dealing with different subjects.

This means that if you have multiple requests or inquiries for the USPTO, each should be submitted on its own separate document. For example, a petition and an information disclosure statement should not be combined into a single paper.

If an applicant submits a single paper containing distinct subjects, the USPTO may use the following form paragraph to notify them:

The [1] submitted [2] should have been submitted as a separate paper as required by 37 CFR 1.4(c). The paper has been entered. However, all future correspondence must comply with 37 CFR 1.4.

Adhering to this requirement helps ensure that your correspondence is processed efficiently and reaches the appropriate department within the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO correspondence, visit: USPTO correspondence.

The receipt date for facsimile transmissions to the USPTO is determined according to specific rules outlined in MPEP 502.01:

The date of receipt accorded to any correspondence permitted to be sent by facsimile transmission, including a continued prosecution application (CPA) filed under 37 CFR 1.53(d), (available for design applications only) is the date the complete transmission is received by an Office facsimile unit, unless the transmission is completed on a Saturday, Sunday, or Federal holiday within the District of Columbia.

If the transmission is completed on a weekend or federal holiday in DC, the receipt date will be the next business day. For example, if a fax is completed at 9:05 p.m. Pacific time on a Friday, it would be received around 12:05 a.m. Eastern time on Saturday. The receipt date would then be the following Monday (assuming it’s not a federal holiday).

It’s important to note that the Certificate of Transmission under 37 CFR 1.8 can be used for certain documents to consider them timely filed on the date of transmission, even if received later by the USPTO.

To learn more:

The PTO-948 form, also known as the ‘Drawing Informalities’ form, serves the following purposes in patent applications:

  • It is used by the Office of Patent Application Processing (OPAP) to indicate that the drawings submitted with the application are informal but acceptable for publication purposes.
  • It notifies the examiner that the drawings may need to be corrected or replaced with formal drawings during examination.
  • It provides a record in the file wrapper that the drawings have been provisionally accepted.

As stated in MPEP 507: ‘If the drawings are informal but otherwise in compliance with 37 CFR 1.121(d), the OPAP will accept the application for purposes of publication and place a ‘Drawing Informalities’ form PTO-948 in the file wrapper.’

This form helps streamline the application process by allowing examination to proceed while flagging the need for potential drawing improvements later in the process.

For more information on OPAP, visit: OPAP.

Tags: OPAP

The USPTO requires separate copies of correspondence for different patent files to ensure that each file is complete and self-contained. According to MPEP 502.04:

Since each file must be complete in itself, a separate copy of every paper to be filed in a patent, patent file, or other proceeding must be furnished for each file to which the paper pertains, even though the contents of the papers filed in two or more files may be identical.

This requirement serves several purposes:

  • It ensures that each file contains all relevant documents without relying on cross-referencing between files.
  • It facilitates independent processing and review of each application or proceeding.
  • It maintains the integrity and completeness of individual patent files, which is crucial for legal and administrative purposes.

To learn more:

The Office of Patent Application Processing (OPAP) performs an initial review of drawings in new utility and plant patent applications to determine whether the drawings can be effectively scanned for publication purposes. As stated in the MPEP:

“OPAP inspects the drawings to see if they can be effectively scanned and adequately reproduced.”

This review ensures that the drawings meet the necessary quality standards for publication and reproduction.

For more information on drawing review, visit: drawing review.

For more information on OPAP, visit: OPAP.

The primary purpose of drawing review in OPAP is to determine whether the drawings in new utility and plant patent applications can be effectively scanned for publication purposes. As stated in MPEP 507:

The Office of Patent Application Processing (OPAP) performs an initial review of drawings in new utility and plant patent applications to determine whether the drawings can be effectively scanned for publication purposes.

It’s important to note that design applications are not subject to this review as they are not published.

An attorney docket number is used by law firms and companies to internally track and manage patent applications. While it’s not required by the USPTO, it can be included on application documents for reference. However, there are limitations:

  • Must be limited to a maximum of 25 characters
  • Spaces, slashes, and hyphens are not included in the entered docket number on the official filing receipt
  • For docket numbers beginning with ‘CASE’ or ‘NAVY-CASE’, only characters after these prefixes are entered

The MPEP states: ‘Attorney docket numbers must be limited to a maximum of 25 characters to prevent truncation. The USPTO system data base allows a maximum of 25 characters for the attorney docket numbers.’ (MPEP 503)

A self-addressed postcard serves as a receipt and provides evidence of the items submitted to the USPTO with a patent application. According to MPEP 503, the postcard should itemize all components of the application, including:

  • Inventor’s name(s)
  • Title of invention
  • Number of pages of specification, claims, and sheets of drawing
  • Whether the inventor’s oath or declaration is included
  • List of additional forms included
  • Amount and manner of paying the fee

The MPEP states: “A postcard receipt which itemizes and properly identifies the items which are being filed serves as prima facie evidence of receipt in the USPTO of all the items listed thereon on the date stamped thereon by the USPTO.”

It’s important to note that the postcard must be properly itemized to serve as evidence of receipt. Simply listing “a complete application” is not sufficient. Each component should be specifically listed on the postcard.

For applications filed via EFS-Web, an Electronic Acknowledgment Receipt serves as the electronic equivalent of a postcard receipt.

For more information on patent application filing, visit: patent application filing.

For more information on USPTO submission, visit: USPTO submission.

A return postcard serves as prima facie evidence of receipt by the USPTO of all items listed on the postcard. It should include detailed identifying information such as:

  • Inventor’s name
  • Application number (if known)
  • Confirmation number (if known)
  • Filing date
  • Title of the invention
  • Type of paper being filed
  • Number of pages for each component

The MPEP states: ‘A postcard receipt which itemizes and properly identifies the items which are being filed serves as prima facie evidence of receipt in the USPTO of all the items listed thereon on the date stamped thereon by the USPTO.’ (MPEP 503)

The purpose of a certificate of mailing or transmission in patent applications is to provide evidence of timely filing when correspondence is not received by the USPTO or is received late. As stated in MPEP 512:

The Certificate of Mailing or Transmission procedure does not apply to papers mailed in a foreign country.

This procedure allows applicants to prove that they submitted their correspondence on time, even if it’s delayed or lost in transit.

To learn more:

If OPAP objects to the drawings in a patent application, there is a specific process for submitting corrected drawings. The MPEP states:

“If OPAP objects to the drawings and sends applicant a Notice requiring submission of corrected drawings within a set time period (usually two months), corrected drawings must be filed, in paper, to the mailing address set forth in the Notice, along with any other items required by OPAP, to avoid abandonment of the application. No fee will be necessary for filing corrected drawings which are required by OPAP.”

It’s important to note that the corrected drawings must be submitted in paper form to the specific mailing address provided in the Notice. Applicants should ensure they meet the deadline (typically two months) to avoid potential abandonment of their application.

For more information on corrected drawings, visit: corrected drawings.

For more information on OPAP, visit: OPAP.

For more information on patent procedure, visit: patent procedure.

If an applicant disagrees with the USPTO’s refusal to grant a filing date for their patent application, they can request a review through the following process:

  • File a petition to the USPTO, accompanied by the required petition fee
  • Provide arguments and evidence supporting why the application should be granted the desired filing date
  • If alleging no defect exists, include a request for a refund of the petition fee

The MPEP states: Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)). Petitioner should provide any arguments that he or she has that the items noted were not missing or that a filing date should be assigned in the absence of such items if they are believed to be unnecessary.

Petitions relating to filing dates are decided by the Office of the Deputy Commissioner for Patent Examination Policy. The petition should be marked to the attention of the Office of Petitions.

It’s important to act promptly if you believe a filing date has been incorrectly refused, as the filing date can have significant implications for patent rights.

For more information on patent application review, visit: patent application review.

When the USPTO cannot locate a patent or application file after a reasonable search, they follow the procedure outlined in 37 CFR 1.251. The key steps are:

  1. The Office notifies the applicant or patentee about the unlocatable file.
  2. A time period is set for the applicant or patentee to comply with the notice.
  3. The applicant or patentee must respond by either:
    • Providing a copy of their record of all correspondence with the Office (except U.S. patent documents)
    • Producing their record for the Office to copy
    • Stating that they do not possess any record of the correspondence

As stated in MPEP 508.04, “37 CFR 1.251 sets forth a procedure for the reconstruction of the file of a patent application, patent, or any other patent-related proceeding that cannot be located after a reasonable search.”

When a patent or application file cannot be located after a reasonable search, the USPTO has a specific procedure outlined in 37 CFR 1.251. The Office will notify the applicant or patentee and set a time period for compliance with one of the following options:

  • Provide a copy of all correspondence records between the Office and the applicant/patentee, along with a list and a statement of completeness.
  • Produce the applicant’s/patentee’s records for the Office to copy, along with a statement of completeness.
  • If no records are possessed, provide a statement to that effect.

The MPEP states, 37 CFR 1.251 sets forth a procedure for the reconstruction of the file of a patent application, patent, or any other patent-related proceeding that cannot be located after a reasonable search.

For pending applications, failure to comply within the set time period will result in abandonment of the application.

For more information on file reconstruction, visit: file reconstruction.

For more information on USPTO procedures, visit: USPTO procedures.

What is the minimum deposit amount required to open a USPTO deposit account?

The minimum deposit amount required to open a USPTO deposit account is $1,000. According to MPEP 509.01, “A minimum deposit of $1,000 is required when an account is opened, and a minimum balance of $1,000 is required to be maintained in the account.” This initial deposit ensures that the account has sufficient funds to cover potential fees and charges.

To learn more:

The mailing address for trademark-related correspondence is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

This address should be used for all trademark-related documents filed on paper, except for certain specific documents as outlined in the regulations.

According to 37 CFR 2.190: In general, trademark documents to be delivered by the USPS must be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.

It’s important to note that many trademark documents can and should be filed electronically through the Trademark Electronic Application System (TEAS).

To learn more:

The mailing address for trademark applications and trademark-related papers filed on paper is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

This address should be used for all trademark-related documents filed on paper, except for:

  • Documents sent to the Assignment Recordation Branch for recordation
  • Requests for copies of trademark documents
  • Certain documents filed under the Madrid Protocol as specified in 37 CFR 2.190(e)

According to 37 CFR 2.190(a): “In general, trademark documents to be delivered by the USPS must be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.”

What is the limit on the number of previously filed patent applications for micro entity status?

For micro entity status, an applicant must not have been named as an inventor on more than four previously filed patent applications. The MPEP states:

“The applicant has not been named as an inventor on more than 4 previously filed patent applications, other than applications filed in another country, provisional applications under 35 U.S.C. 111(b), or international applications for which the basic national fee under 35 U.S.C. 41(a) was not paid.”

This limit helps ensure that micro entity status is reserved for truly small-scale inventors or businesses. It’s important to note that certain types of applications, such as provisional applications and international applications where the basic national fee wasn’t paid, don’t count towards this limit.

To learn more:

The institution of higher education basis allows applicants to qualify for micro entity status if:

  1. The applicant’s employer, from which the applicant obtains the majority of their income, is an institution of higher education as defined in the Higher Education Act of 1965, or
  2. The applicant has assigned, granted, conveyed, or is obligated to assign, grant or convey, a license or ownership interest in the application to such an institution of higher education.

The applicant must also qualify as a small entity. This basis is implemented in 37 CFR 1.29(d).

The general mailing address for patent-related correspondence is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address should be used for patent applications, replies to notices of informality, requests for extension of time, notices of appeal, and other patent-related matters processed by organizations reporting to the Commissioner for Patents.

As stated in the MPEP: Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents P.O. Box 1450 Alexandria, Virginia 22313-1450

To learn more:

The general mailing address for patent-related correspondence is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address is used for various patent-related documents, including:

  • Patent applications
  • Replies to notices of informality
  • Requests for extension of time
  • Notices of appeal to the Patent Trial and Appeal Board
  • Requests for reexamination
  • Petitions to the Commissioner for Patents

As stated in MPEP 501: “Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.”

For more information on patent application filing, visit: patent application filing.

For more information on patent correspondence, visit: patent correspondence.

The general mailing address for patent applications and patent-related papers is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address should be used for correspondence including patent applications, replies to notices of informality, requests for extension of time, notices of appeal, briefs, requests for oral hearings, applications for patent term extensions, reexamination requests, statutory disclaimers, certificates of correction, petitions, and other patent-related correspondence processed by organizations reporting to the Commissioner for Patents.

As stated in MPEP 501: “Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450”

For applications properly filed under 37 CFR 1.10 using Priority Mail Express, the filing date is the date the application was deposited with the U.S. Postal Service. The MPEP states:

For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service. For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

If the proper procedures were not followed, the application will receive a filing date as of the date it was received in the USPTO.

For applications properly filed using Priority Mail Express® (formerly Express Mail) through the U.S. Postal Service, the filing date is the date of deposit with the postal service. The MPEP states:

“For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service.”

This means that even if the application is deposited on a Saturday, and the U.S. Postal Service marks it with a Saturday date, the USPTO will accord and stamp the correspondence with the Saturday date.

However, if the proper procedures for using Priority Mail Express® were not followed, the application will receive a filing date as of the date it was received in the USPTO. Any dispute regarding the filing date in such cases would require a petition, as explained in the MPEP:

“Any review of these matters would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)), providing whatever arguments and evidence petitioner has that the application is entitled to a filing date as of the date it was deposited as Priority Mail Express®.”

To learn more:

To learn more:

The duty to investigate entitlement to claim small entity status refers to the obligation of patent applicants to thoroughly investigate all facts and circumstances before determining their actual entitlement to small entity status. According to MPEP 509.03(a), “applicants need to do a complete and thorough investigation of all facts and circumstances before making a determination of actual entitlement to small entity status.” This investigation is crucial to ensure that small entity status is claimed only when appropriate.

To learn more:

Tags: patent fees

While both the Certificate of Mailing (37 CFR 1.8) and Priority Mail Express (37 CFR 1.10) procedures can be used to establish timely filing of USPTO correspondence, they have some key differences:

  • Certificate of Mailing can be used with any class of mail, while Priority Mail Express is a specific USPS service.
  • Certificate of Mailing uses the date of deposit with USPS as the filing date, while Priority Mail Express uses the date of deposit as shown by the “date accepted” on the mailing label.
  • Certificate of Mailing cannot be used for new patent applications, while Priority Mail Express can establish a filing date for new applications.
  • Certificate of Mailing requires a signed certificate, while Priority Mail Express requires the mailing label to be affixed to the correspondence.

The MPEP notes: “New patent applications filed in accordance with 37 CFR 1.10 will be stamped by the Office with the date of deposit as Priority Mail Express® with the United States Postal Service.”

Both procedures have specific requirements and limitations, so it’s important to consult the full text of 37 CFR 1.8 and 37 CFR 1.10 when deciding which to use.

What is the difference between small entity and micro entity status?

While both small entity and micro entity statuses offer reduced patent fees, they have distinct eligibility criteria:

  • Small Entity Status:
    • Available to individuals, small businesses (fewer than 500 employees), and non-profit organizations
    • Offers a 50% reduction in most patent fees
  • Micro Entity Status:
    • More stringent requirements, including income limitations and limits on the number of previously filed patent applications
    • Offers a 75% reduction in most patent fees

As per MPEP 509.03, “Small entity status entitles applicants to a fifty-percent reduction in a number of patent fees.” Micro entity status, while not explicitly covered in this section, provides even greater fee reductions for those who qualify.

To learn more:

Tags: USPTO fees

MPEP 509.04(c) mentions two types of micro entity certifications:

  1. Micro entity certification on the gross income basis
  2. Micro entity certification on the institution of higher education basis

While the specific requirements for each basis are not detailed in this section, it’s important to note that the signing requirements are the same for both types. The certification “can be signed only by an authorized party as set forth in 37 CFR 1.33(b).” This includes patent practitioners and applicants, as detailed in other FAQs.

To learn more:

As of July 28, 2013, the United States Postal Service (USPS) renamed ‘Express Mail’ to ‘Priority Mail Express’. According to MPEP 511:

“Effective July 28, 2013, the United States Postal Service (USPS) changed the name of ‘Express Mail’ to ‘Priority Mail Express.’ All characteristics of the ‘Priority Mail Express’ service are the same as those of the former ‘Express Mail’ service (although the mailing labels differ).”

This change is important for patent applicants to note, as the USPTO’s rules and procedures now refer to ‘Priority Mail Express’ instead of ‘Express Mail’. However, the service characteristics and benefits for patent filings remain the same. When using this service for USPTO correspondence, ensure you use the correct addresses as specified in 37 CFR 1.1 and avoid using the ‘Hold for Pickup’ option, as the USPTO does not pick up mail.

To learn more:

A small business concern, for the purpose of paying reduced patent fees, is defined as follows:

A small business concern as used in this paragraph means any business concern that:

  • Has not assigned, granted, conveyed, or licensed, and is under no obligation under contract or law to assign, grant, convey, or license, any rights in the invention to any person, concern, or organization which would not qualify for small entity status as a person, small business concern, or nonprofit organization.
  • Meets the size standards set forth in 13 CFR 121.801 through 121.805 to be eligible for reduced patent fees.

The size standards vary by industry and are based on factors such as average annual receipts or number of employees. It’s important to consult the specific SBA guidelines for your industry to determine if your business qualifies as a small entity.

To learn more:

Tags: patent fees

What is the definition of a ‘small business concern’ for small entity status?

According to MPEP 509.02, a small business concern is defined as follows:

“A small business concern, as used in this chapter, means any business concern that:

  • (i) Has not assigned, granted, conveyed, or licensed (and is under no obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a non-profit organization or a small business concern under this section, and
  • (ii) Does not have as a party to the patent application any individual who has assigned, granted, conveyed, or licensed (or is under an obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a non-profit organization or a small business concern under this section.”

This definition ensures that the small business concern maintains control over the invention rights and has not transferred them to entities that do not qualify for small entity status.

To learn more:

The United States Patent and Trademark Office (USPTO) stamps correspondence received with the date of receipt, known as the ‘Office Date’ stamp. This applies to papers and fees received through various methods:

  • Mail (except Priority Mail Express®)
  • Facsimile
  • EFS-Web
  • Hand-carried to the Customer Service Window

As stated in the MPEP: The United States Patent and Trademark Office (Office) stamps papers and fees received through the mail (other than those submitted by Priority Mail Express® in accordance with 37 CFR 1.10), by facsimile, or via EFS-Web with the date of their receipt in the Office.

The USPTO requires a security code for credit card payments made through its website. According to MPEP 509:

Credit card payment submissions made on the USPTO website at www.uspto.gov must include the 3-digit or 4-digit security code associated with the credit card in addition to the credit card number. The security code will not be required when the paper Credit Card Payment Form (PTO-2038) or other written authorization is submitted.

Key points about the security code requirement:

  • It’s part of an authentication procedure to reduce fraudulent or unauthorized credit card use.
  • The code verifies that the physical card is in the cardholder’s possession.
  • For DISCOVER®, MASTERCARD®, and VISA®, it’s a 3-digit code on the back of the card.
  • For AMERICAN EXPRESS®, it’s a 4-digit code on the front of the card.
  • If you can’t read the security code, contact your card issuer.

This requirement enhances security for online transactions but doesn’t apply to paper submissions using Form PTO-2038.

To learn more:

The Credit Card Payment Form (PTO-2038) is a specific form provided by the USPTO for making credit card payments for patent and trademark process fees. According to MPEP 509:

Credit Card Payment Form (PTO-2038) should be used when paying a patent process or trademark process fee (or the fee for an information product) by credit card, unless the payment is being made using the USPTO patent electronic filing system.

Key points about the form:

  • It can be downloaded from the USPTO website at www.uspto.gov/PatentForms.
  • It’s not required (and should not be used) when making credit card payments via EFS-Web or other electronic filing systems.
  • Using this form helps keep credit card information confidential, as the USPTO does not include it among records open to public inspection.

Failure to use this form when submitting a paper credit card payment may result in the credit card information becoming part of the public record.

To learn more:

Tags: patent fees

What is the Certificate of Mailing procedure for USPTO filings?

The Certificate of Mailing procedure is a method that allows applicants to establish the date of filing for correspondence sent to the USPTO. As explained in MPEP 501:

‘Under the procedure, correspondence is considered as being timely filed if (A) the correspondence is mailed or transmitted prior to expiration of the set period for response by being: (1) Addressed as set out in 37 CFR 1.1(a) and deposited with the U.S. Postal Service with sufficient postage as first class mail; or (2) Transmitted by facsimile to the Patent and Trademark Office in accordance with 37 CFR 1.6(d); or (3) Transmitted via the Office electronic filing system in accordance with 37 CFR 1.6(a)(4); and (B) the correspondence includes a certificate for each piece of correspondence stating the date of deposit or transmission.’

This procedure is particularly useful for ensuring timely filing when using postal services. It’s important to note that the certificate must be signed by the person depositing or transmitting the correspondence.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on electronic filing, visit: electronic filing.

The central facsimile number for patent application-related correspondence at the USPTO is (571) 273-8300. According to MPEP 502.01:

All patent application related correspondence transmitted by facsimile must be directed to the central facsimile number, with a few exceptions below. The central facsimile number is (571) 273-8300.

This central number should be used for most patent-related correspondence, including replies to Office actions and after-final amendments. However, there are specific exceptions for certain types of correspondence that should be sent to other facsimile numbers, as outlined in the MPEP.

To learn more:

The application size fee is an additional fee that applies to patent applications with specifications and drawings exceeding 100 sheets of paper. The MPEP states:

37 CFR 1.16(s) sets forth the application size fee for any application (including any reissue applications) filed under 35 U.S.C. 111, the specification and drawings of which exceed 100 sheets of paper. The calculation of the number of sheets excludes any “Sequence Listing”, computer readable form (CRF) of a “Sequence Listing”, or a “Computer Program Listing Appendix” filed in an American Standard Code for Information Interchange (ASCII) plain text file or any “Sequence Listing XML” filed in an eXtensible Markup Language (XML) file on a read-only optical disc or via the USPTO patent electronic filing system in compliance with the rules.

The fee applies for each additional 50 sheets or fraction thereof over 100 sheets. This fee must be paid within the time period set by the USPTO to avoid abandonment of the application.

The USPTO offers an additional fee reduction for small entities that file patent applications electronically. According to MPEP 509.02:

The Consolidated Appropriations Act, 2005, provides that the filing fee charged under 35 U.S.C. 41(a)(1)(A) shall be reduced by 75 percent with respect to its application to any small entity ‘if the application is filed by electronic means as prescribed by the Director’ (35 U.S.C. 41(h)(3)).

This 75% reduction applies specifically to the filing fee for nonprovisional original utility applications filed electronically by small entities on or after December 8, 2004. It’s important to note that this enhanced reduction does not apply to design applications, plant applications, reissue applications, or provisional applications.

To learn more:

The ‘Office Date’ stamp is used by the USPTO to mark the receipt date of papers and fees. According to MPEP 505, The United States Patent and Trademark Office (Office) stamps papers and fees received through the mail (other than those submitted by Priority Mail Express® in accordance with 37 CFR 1.10), by facsimile, or via EFS-Web with the date of their receipt in the Office.

The ‘Office Date’ stamp is crucial because:

  • It establishes the filing date for new patent applications that include the necessary components (see 37 CFR 1.53(b)-(d))
  • It determines the timeliness of actions and fee payments

For hand-carried papers, date stamping occurs at the Customer Service Window.

For more information on Office Date stamp, visit: Office Date stamp.

For more information on USPTO, visit: USPTO.

Small entity status allows certain applicants to pay reduced patent fees. To claim small entity status, you must make an assertion of entitlement in one of two ways:

  • Submit a written assertion signed by the applicant, a patent practitioner, an inventor, or an assignee
  • Pay the exact small entity basic filing fee, basic national fee, or individual designation fee

As stated in 37 CFR 1.27(c): “Any party (person, small business concern or nonprofit organization) should make a determination, pursuant to paragraph (f) of this section, of entitlement to be accorded small entity status based on the definitions set forth in paragraph (a) of this section, and must, in order to establish small entity status for the purpose of paying small entity fees, actually make an assertion of entitlement to small entity status, in the manner set forth in paragraphs (c)(1) or (c)(3) of this section, in the application or patent in which such small entity fees are to be paid.”

To learn more:

Tags: patent fees

When notifying the USPTO of a loss of micro entity status, the following requirements must be met:

  • The notification must be filed in the application or patent prior to paying, or at the time of paying, any fee after the date on which micro entity status is no longer appropriate.
  • The notification must be signed by a party identified in 37 CFR 1.33(b).
  • A simple statement that the applicant is no longer eligible for micro entity status is sufficient, without identifying specific reasons.

As stated in MPEP 509.04(e): Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.

To learn more:

PSTAR stands for Patents Service for Time and Application Routing. According to MPEP 504, PSTAR is “the program [that] assigns each nonprovisional application to an examiner.” This system is used by the United States Patent and Trademark Office (USPTO) to efficiently distribute patent applications to the appropriate examiners for review.

To learn more:

Priority Mail Express® is a service offered by the United States Postal Service (USPS) that can be used to establish a filing date for patent applications and other correspondence with the USPTO. As stated in MPEP 513:

The statutory authority for the granting of a filing date based on the date of deposit for correspondence sent by Priority Mail Express® and received by the Office is found in section 21(a) of Title 35 of the United States Code.

Using Priority Mail Express® allows applicants to receive a filing date as of the date the correspondence was deposited with USPS, rather than the date it was received by the USPTO.

What is an S-signature in USPTO correspondence and how is it formatted?

An S-signature is an electronic signature used in correspondence with the USPTO. According to MPEP 502.02, an S-signature must be formatted as follows:

  • Inserted between forward slash marks: /John Doe/
  • Include the signer’s name
  • For registered practitioners, include their registration number
  • The signer’s name can be printed or typed
  • The signature must comply with 37 CFR 1.4(d)(2)

For example, a proper S-signature for a registered patent attorney might look like this:

/John Q. Attorney, Reg. No. 12345/

This format allows for efficient electronic filing while maintaining the legal weight of a signature.

To learn more:

An S-signature is an electronically created signature used in patent correspondence. According to MPEP 502.02:

An S-signature is a signature inserted between forward slash marks, but not a handwritten signature as defined by 37 CFR 1.4(d)(1). An S-signature includes any signature made by electronic or mechanical means, and any other mode of making or applying a signature other than a handwritten signature as provided for in 37 CFR 1.4(d)(1).

S-signatures must meet specific requirements to be considered valid:

  • They must be between two forward slash marks
  • They can include letters, numbers, and punctuation marks
  • They must be personally inserted by the signer
  • They must be reasonably specific to the signer

S-signatures provide a convenient way for applicants and practitioners to sign documents electronically while maintaining the legal weight of a handwritten signature.

To learn more:

An S-signature is a type of electronic signature used in USPTO correspondence. According to MPEP 501, which cites 37 CFR 1.4(d)(2):

An S-signature is a signature inserted between forward slash marks, but not a handwritten signature as defined by paragraph (d)(1) of this section. An S-signature includes any signature made by electronic or mechanical means, and any other mode of making or applying a signature other than a handwritten signature.

Key requirements for an S-signature include:

  • It must consist only of letters, Arabic numerals, or both, with appropriate punctuation.
  • The signer must insert their own S-signature with a single forward slash mark before and after the signature.
  • For patent practitioners, their registration number must be included with or near the S-signature.
  • The signer’s name must be presented in printed or typed form near the S-signature.

Example of a proper S-signature: /John D. Smith/

S-signatures can be used for most USPTO correspondence filed electronically or by facsimile.

For more information on USPTO correspondence, visit: USPTO correspondence.

An application number consists of a series code and a serial number. It is assigned by the Office of Patent Application Processing (OPAP) immediately after mail has been opened. For applications filed using the USPTO patent electronic filing system, EFS-Web provides an Acknowledgement Receipt containing a time and date stamp, application number, and confirmation number.

The MPEP states: ‘Application numbers consisting of a series code and a serial number are assigned by the Office of Patent Application Processing (OPAP) immediately after mail has been opened.’ (MPEP 503)

What is a USPTO deposit account and how does it work?

A USPTO deposit account is a pre-established account that allows for convenient payment of fees to the United States Patent and Trademark Office. According to MPEP 509:

“A deposit account is a convenient method for individuals or firms to establish a pre-paid account with the USPTO to facilitate the payment of fees.”

Here’s how USPTO deposit accounts work:

  • You deposit funds into the account in advance
  • Fees can be automatically deducted from the account when filing applications or paying other fees
  • Minimum balance requirements apply (currently $1,000 for individuals, $5,000 for law firms)
  • Account holders receive monthly statements
  • Useful for frequent filers or those managing multiple applications

To open a deposit account, you need to complete Form PTO-2232 and submit it to the USPTO with an initial deposit. This method can streamline fee payments and reduce the risk of insufficient fee issues.

To learn more:

To learn more:

A USPTO deposit account is a convenient method for attorneys and the general public to pay fees and order services from the U.S. Patent and Trademark Office. To establish a deposit account:

  • Pay the fee for establishing a deposit account as per 37 CFR 1.21(b)(1)
  • Make a minimum deposit of $1,000 for general use
  • Alternatively, make a minimum deposit of $300 for a restricted subscription deposit account used exclusively for subscription orders of patent copies

As stated in the MPEP: For the convenience of attorneys, and the general public in paying any fees due, in ordering services offered by the Office, copies of records, etc., deposit accounts may be established in the Patent and Trademark Office upon payment of the fee for establishing a deposit account § 1.21(b)(1).

To learn more:

A provisional patent application is a type of patent application that allows inventors to establish an early filing date for their invention. Key differences between provisional and nonprovisional applications include:

  • Provisional applications are not examined and automatically expire after 12 months
  • Provisional applications require fewer formal components than nonprovisional applications
  • Provisional applications cannot directly result in a granted patent

The MPEP states: A provisional application will not be examined. However, a provisional application which does not include a cover sheet (37 CFR 1.51(c)(1)), which may be an application data sheet (37 CFR 1.76) or a cover letter, identifying the application as a provisional application, will be treated as a nonprovisional application filed under 37 CFR 1.53(b).

To obtain a filing date, a provisional application must include:

  • A specification as prescribed by 35 U.S.C. 112(a)
  • Any necessary drawings
  • The appropriate filing fee

Inventors often use provisional applications to secure an early filing date while allowing additional time to prepare a more comprehensive nonprovisional application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

A filing receipt is an official document issued by the USPTO that contains important information about a patent application. According to MPEP 503, the filing receipt includes:

  • Application number
  • Filing date
  • Confirmation number
  • Suggested U.S. Patent Classification class
  • Art unit where the application is likely to be examined
  • Continuing data (if applicable)
  • National stage data (if applicable)
  • Foreign priority data (if applicable)
  • Foreign filing license data (if applicable)
  • Entity status information
  • Anticipated publication date under 35 U.S.C. 122(b)

The MPEP states: “The filing receipt represents the official assignment by the USPTO of a specific application number and confirmation number to a particular application.” It’s important to review the filing receipt for accuracy, especially regarding inventor and applicant names, benefit and priority claims, and any nonpublication requests.

For more information on application number, visit: application number.

For more information on confirmation number, visit: confirmation number.

For more information on filing receipt, visit: filing receipt.

A confirmation number is a four-digit number assigned to each newly filed patent application. It is used in combination with the application number to verify the accuracy of the application number on correspondence filed with the USPTO. This helps avoid misidentification due to transposition errors.

The MPEP states: ‘The confirmation number is a four-digit number that is assigned to each newly filed application. The confirmation number, in combination with the application number, is used to verify the accuracy of the application number placed on correspondence filed with the Office to avoid misidentification of an application due to a transposition error in the application number.’ (MPEP 503)

A confirmation number is a four-digit number assigned by the USPTO to each newly filed patent application. According to MPEP 503, the confirmation number serves several important purposes:

  • It is used in combination with the application number to verify the accuracy of the application number on correspondence filed with the Office.
  • It helps avoid misidentification of an application due to transposition errors in the application number.
  • It is included on the filing receipt, Office actions, and other USPTO communications.
  • It is required when submitting an electronic copy of the application for publication to verify the correct application.

The MPEP recommends: “The Office also recommends that applicants include the application’s confirmation number (in addition to the application number) on all correspondence submitted to the Office concerning the application.”

The confirmation number can be found in the upper left-hand corner of the filing receipt and is also available through the Patent Application Information Retrieval (PAIR) system.

For more information on application number, visit: application number.

For more information on confirmation number, visit: confirmation number.

For more information on USPTO correspondence, visit: USPTO correspondence.

A Certificate of Mailing or Transmission is a procedure under 37 CFR 1.8 that allows correspondence to be considered timely filed with the USPTO if it meets certain conditions. As stated in the MPEP:

“Under 37 CFR 1.8, a person may state on certain papers directed to the Office (some exceptions are stated in 37 CFR 1.8), the date on which the paper will be deposited in the United States Postal Service, transmitted by facsimile or transmitted via the USPTO electronic filing system (EFS-Web). If the date stated is within the period for reply, the reply in most instances will be considered to be timely.”

This procedure can be crucial for meeting deadlines, even if the actual receipt of the correspondence by the USPTO occurs after the deadline.

To learn more:

According to 37 CFR 1.29(k)(1), the itemization for a micro entity fee deficiency payment must include:

  • Each type of fee erroneously paid as a micro entity
  • The current fee amount for a small or non-small entity
  • The micro entity fee actually paid and the date of payment
  • The deficiency owed amount for each fee
  • The total deficiency payment owed

The MPEP specifies: The paper must contain an itemization of the total deficiency payment and include the following information: (1) each particular type of fee that was erroneously paid as a micro entity, (e.g., basic statutory filing fee, two-month extension of time fee) along with the current fee amount for a small or non-small entity; (2) the micro entity fee actually paid, and the date on which it was paid; (3) the deficiency owed amount (for each fee erroneously paid); and (4) the total deficiency payment owed, which is the sum or total of the individual deficiency owed amounts.

To learn more:

A certificate of mailing for USPTO correspondence must include specific information to be valid. According to MPEP 512, the following information is required:

  • The date of deposit or transmission
  • The application number (for patent applications)
  • A statement that the correspondence is being deposited with the USPS or transmitted to the USPTO
  • The signature of the person depositing or transmitting the correspondence

The MPEP states:

The certificate must state that the correspondence is being deposited with the United States Postal Service with sufficient postage as first class mail, or transmitted to the Office on the date of the certificate.

Ensure all these elements are included to make your certificate of mailing valid and effective.

To learn more:

A patent filing receipt includes:

  • Application number
  • Filing date
  • Confirmation number
  • Suggested class in the U.S. Patent Classification System
  • Art unit number where the application is likely to be examined
  • Continuing data (if applicable)
  • National stage data (if applicable)
  • Foreign priority data (if applicable)
  • Foreign filing license data (if applicable)
  • Entity status information
  • Anticipated publication date under 35 U.S.C. 122(b)

The MPEP states: ‘The filing receipt includes the application number, filing date, a confirmation number, a suggested class in the U.S. Patent Classification System (see MPEP § 902.01), and the number of an art unit where the application is likely to be examined.’ (MPEP 503)

A patent application filing receipt contains crucial information about the application. According to the MPEP:

‘A filing receipt is mailed to the attorney or agent, if any, otherwise to the applicant, for each application filed.’

The filing receipt typically includes:

  • The application number
  • Filing date
  • Title of the invention
  • Names of the applicants
  • Name and registration number of the attorney or agent (if applicable)
  • Entity status for fee purposes
  • Correspondence address
  • List of documents submitted with the application

It’s important to review the filing receipt carefully for accuracy, as it serves as official confirmation of the application’s details and can be used to identify any discrepancies or issues that need to be addressed promptly.

For more information on filing receipt, visit: filing receipt.

According to MPEP 508.02, “After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender. If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW.”

This means that any documents received after a patent is granted or an application is abandoned will not be added to the official record. Instead, they will be either physically returned to the sender or, if already scanned into the Image File Wrapper (IFW) system, electronically closed within the system.

According to MPEP 508.02, after a patent application is either patented or abandoned, any incoming communication that is not intended to become part of the official record will be returned to the sender. The MPEP states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This procedure ensures that the official patent file remains accurate and contains only relevant information after the application process has concluded.

To learn more:

When you notify the USPTO of a loss of micro entity status, you are automatically treated as a small entity by default, unless specified otherwise. As stated in MPEP 509.04(e):

A notification that micro entity status is no longer appropriate will not be treated as a notification that small entity status is also no longer appropriate unless it also contains a notification of loss of entitlement to small entity status under § 1.27(f)(2) [§ 1.27(g)(2)].

To change to regular (unreduced) fee status, you must either:

  • File a notification of loss of entitlement to micro entity status along with regular unreduced fees or an indication of loss of entitlement to small entity status, or
  • File a separate notification of loss of entitlement to small entity status.

To learn more:

After a patent is granted or an application is abandoned, the USPTO has specific procedures for handling incoming communications. According to the MPEP, After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.

In the case of digital documents, the MPEP states, If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW. This means that the document will be marked as closed in the digital system, effectively removing it from active consideration.

For more information on post-grant communications, visit: post-grant communications.

For more information on USPTO procedures, visit: USPTO procedures.

What happens if there’s an error in my application number?

If you notice an error in your application number, it’s crucial to contact the USPTO immediately. The MPEP states, Any error in the identification of the application number will result in processing delays. (MPEP 503) To avoid such delays:

  • Double-check the application number on your filing receipt
  • If you find an error, contact the Application Assistance Unit at (571) 272-4000
  • Provide the correct application number and any supporting documentation

Prompt action can help ensure your application is processed correctly and efficiently.

For more information on application number, visit: application number.

For more information on error correction, visit: error correction.

In the event of a postal interruption or emergency, the USPTO will take the following actions:

  • Place an announcement on the USPTO website at www.uspto.gov
  • Publish a notice in the Official Gazette

These communications will provide instructions about filing patent applications and other patent-related papers. As stated in MPEP 511:

“In the event of a postal interruption or emergency, an announcement will be placed on the USPTO website at www.uspto.gov and a notice will be published in the Official Gazette, providing instructions about the filing of patent applications, and other papers related to patent applications and patents.”

This ensures that applicants have clear guidance on how to proceed during such circumstances.

To learn more:

In the event of a postal interruption or emergency:

  • An announcement will be placed on the USPTO website at www.uspto.gov
  • A notice will be published in the Official Gazette
  • These communications will provide instructions about filing patent applications and other papers related to patent applications and patents

The USPTO Director may prescribe rules considering papers or fees filed on the date they would have been deposited with the USPS, but for postal service interruptions or emergencies.

As stated in MPEP 511: “In the event of a postal interruption or emergency, an announcement will be placed on the USPTO website at www.uspto.gov and a notice will be published in the Official Gazette, providing instructions about the filing of patent applications, and other papers related to patent applications and patents.”

If there’s a discrepancy between the USPTO’s date stamp and the date on the correspondence, the USPTO’s date stamp is generally considered the official receipt date. However, if an applicant can provide clear evidence that the correspondence was received earlier than the date indicated by the USPTO’s stamp, the earlier date may be recognized as the official receipt date. This situation might occur due to clerical errors or delays in processing incoming mail.

What happens if there are insufficient funds when paying USPTO fees?

If there are insufficient funds when paying USPTO fees, several consequences may occur:

  • The fee payment will be considered incomplete.
  • Your application or request may not be processed.
  • You may incur additional fees or penalties.
  • In some cases, you might lose filing date benefits.

The MPEP 509 warns, “If the Office receives a check drawn on a deposit account with insufficient funds, the fee will be considered unpaid.” For electronic payments, “If the electronic fund transfer is refused, or if the credit card is declined or invalid, the fee will be considered unpaid.” It’s crucial to ensure sufficient funds are available to avoid these issues and potential delays in your patent or trademark process.

To learn more:

Tags: USPTO fees

What happens if there are insufficient funds in my USPTO deposit account?

If there are insufficient funds in your USPTO deposit account to cover a fee, the following occurs:

  • The USPTO will treat the fee as unpaid
  • Any associated filing may be considered incomplete
  • You may receive a notice of insufficient funds

The MPEP clearly states: “An overdrawn account will be immediately suspended and no charges will be accepted against it until the balance is restored.” (MPEP 509.01)

To avoid this situation, it’s crucial to maintain sufficient funds in your account and regularly monitor your balance. If your account becomes overdrawn, you’ll need to restore the balance before any further charges can be processed.

To learn more:

Tags: patent fees

If the USPTO receives a document without a date of receipt stamp, the Office will assign the document a date of receipt based on other evidence. This may include:

  • The date of receipt indicated on an Express Mail label
  • The date of deposit indicated on a certificate of mailing
  • The date of transmission indicated on a certificate of transmission
  • Other corroborating evidence, such as a postmark on an envelope

In cases where no other evidence is available, the USPTO may assign the date of receipt as the date the document was matched with the file wrapper.

If the USPTO cannot locate a file after a reasonable search, they will notify the applicant or patentee and set a time period for compliance. According to 37 CFR 1.251(a), the applicant or patentee must respond by:

  • Providing a copy of their record of correspondence with the USPTO
  • Producing their record for the USPTO to copy
  • Stating that they do not possess any record of correspondence

The specific requirements are outlined in the notice and must be followed to avoid potential consequences.

To learn more:

If an applicant pays an insufficient fee to the USPTO, the Office will notify the applicant and provide an opportunity to submit the remaining balance. According to MPEP 509:

If the fee paid by the applicant is insufficient, either because the notice specified an incorrect dollar amount for the fee or because of a fee increase effective after the mailing of the notice and before payment of the fee by the applicant, the applicant should be notified in writing by the Office of the fee insufficiency and given a new time period in which to submit the remaining balance.

The notification will include:

  • The reason for the additional fee requirement
  • An explanation of why the original fee was incorrect or insufficient
  • A new time period for submitting the remaining balance

This process helps ensure that applicants have a fair opportunity to complete their fee payments and avoid abandonment of their applications due to fee issues.

To learn more:

If the drawings in a patent application are not in compliance with the rules, the Office of Patent Application Processing (OPAP) will send a Notice to File Corrected Application Papers. This notice gives the applicant a time period of 2 months from the mailing date to file corrected drawings. The time period is extendable under 37 CFR 1.136(a). If corrected drawings are not timely filed, the application will be held abandoned.

If the date of receipt stamp is illegible or missing, the USPTO will make every effort to determine the correct date of receipt. This may involve examining other evidence, such as postmarks, electronic filing receipts, or other documentation. If the correct date cannot be determined, the USPTO may use the date it was discovered that the document was received as the date of receipt. Applicants should always ensure that their submissions are properly dated and stamped to avoid potential issues with filing dates.

If the Certificate of Mailing or Transmission is omitted from a paper, the USPTO will treat the paper as though it was not received. According to MPEP 512:

“If the certification of mailing or transmission is omitted and the paper is later received by the U.S. Patent and Trademark Office, the paper will be considered as having been filed as of the date of receipt in the Office.”

This means that without the certificate, the paper’s filing date will be the actual date it’s received by the USPTO, which could potentially be later than intended and may have significant consequences for patent applications or other time-sensitive submissions.

To learn more:

If OPAP objects to the drawings in a patent application, the following process occurs:

  1. OPAP sends a Notice to the applicant requiring submission of corrected drawings.
  2. The Notice typically sets a time period of two months for response.
  3. Corrected drawings must be filed in paper form to the mailing address specified in the Notice.
  4. No fee is required for filing the corrected drawings requested by OPAP.

MPEP 507 states:

If OPAP objects to the drawings and sends applicant a Notice requiring submission of corrected drawings within a set time period (usually two months), corrected drawings must be filed, in paper, to the mailing address set forth in the Notice, along with any other items required by OPAP, to avoid abandonment of the application. No fee will be necessary for filing corrected drawings which are required by OPAP.

It’s crucial to respond within the set time period to avoid potential abandonment of the application.

If your USPTO deposit account becomes overdrawn, several consequences may occur:

  1. Account Suspension: The MPEP states, An overdrawn account will be immediately suspended and no charges will be accepted against it until a proper balance is restored, together with a payment of $10 (37 CFR 1.21(b)(1)) to cover the work done by the U.S. Patent and Trademark Office incident to suspending and reinstating the account and dealing with charges which may have been made in the meantime.
  2. Additional Surcharges: If there’s an authorization to charge a basic filing fee to an overdrawn account, a surcharge under 37 CFR 1.16(f) is required in addition to the basic filing fee.
  3. Potential Abandonment: The MPEP warns, Failure to timely pay the filing fee and surcharge will result in abandonment of the application.
  4. Account Closure: Repeated overdrafts may lead to account closure. If an account is suspended repeatedly it will be closed.

To avoid these issues, always maintain sufficient funds in your deposit account and monitor your account balance regularly.

To learn more:

Tags: USPTO

What happens if my USPTO deposit account balance falls below the minimum?

If your USPTO deposit account balance falls below the minimum required balance of $1,000, there are consequences. According to MPEP 509.01, “An account holder who does not maintain the minimum balance will be notified and given a reasonable time to restore the account to the minimum balance.” If the account is not replenished:

  • The USPTO may close the account.
  • Any fees charged against the account may be treated as unpaid.
  • This could potentially affect the status of your patent applications or other USPTO services.

It’s crucial to monitor your account balance regularly and replenish it promptly when it approaches the minimum to avoid any disruptions in service or potential issues with your patent applications.

To learn more:

If correspondence with a Certificate of Mailing or Transmission is not received by the USPTO after a reasonable amount of time, you can take steps to notify the Office and provide evidence of the previous timely filing. According to 37 CFR 1.8(b):

In the event that correspondence is considered timely filed by being mailed or transmitted in accordance with paragraph (a) of this section, but not received in the U.S. Patent and Trademark Office after a reasonable amount of time has elapsed from the time of mailing or transmitting of the correspondence […] the correspondence will be considered timely if the party who forwarded such correspondence: (1) Informs the Office of the previous mailing or transmission of the correspondence promptly after becoming aware that the Office has no evidence of receipt of the correspondence; (2) Supplies an additional copy of the previously mailed or transmitted correspondence and certificate; and (3) Includes a statement that attests on a personal knowledge basis or to the satisfaction of the Director to the previous timely mailing, transmission or submission.

It’s recommended to check the private Patent Application Information Retrieval (PAIR) System first to see if the correspondence has been entered into the application file before notifying the Office.

What happens if I wrongly claim small entity status?

Wrongly claiming small entity status can have serious consequences. According to MPEP 509.03:

“Improperly and with intent to deceive establishing status as a small entity, or paying fees as a small entity, shall be considered as a fraud practiced or attempted on the Office.”

The consequences of fraudulently claiming small entity status may include:

  • Requirement to pay all fee deficiencies
  • Possible invalidation of the patent
  • Potential legal action for fraud

If you discover an error in your small entity claim, it’s crucial to promptly notify the USPTO and pay any fee deficiencies. Honest mistakes, if corrected in good faith, are generally not considered fraud.

To learn more:

Tags: USPTO fees

What happens if I overpay a patent fee to the USPTO?

If you overpay a patent fee to the USPTO, you may be eligible for a refund. The MPEP 509 states: ‘In the event that an amount is paid by mistake or in excess of that required, a refund may be made only if a petition for refund is filed within 2 years after the date the fee was paid.’

To request a refund:

  1. File a petition for refund within 2 years of the payment date
  2. Clearly explain the reason for the overpayment
  3. Provide evidence of the overpayment

It’s important to note that not all overpayments are automatically refunded, so proactive action is necessary to recover excess fees.

To learn more:

What happens if I overpaid fees due to incorrect micro entity status?

If you paid fees as a non-micro entity when you were actually entitled to micro entity status, resulting in an overpayment, you may be eligible for a refund. The MPEP 509.04(f) states:

“A refund based upon establishment of micro entity status may only be obtained if an assertion of micro entity status, in compliance with 37 CFR 1.29(a), is filed within the time period set forth in 37 CFR 1.29(k) … The time period set forth in 37 CFR 1.29(k) is: the later of 1) three months from the date of the fee payment claimed to be in error; or 2) the processing of a request for refund.”

To request a refund:

  • File a compliant micro entity certification
  • Submit a timely refund request
  • Ensure you meet the time constraints specified in 37 CFR 1.29(k)

It’s important to act promptly if you believe you’ve overpaid due to an incorrect entity status.

To learn more:

Tags: patent fees

What happens if I lose micro entity status during the patent process?

If you lose micro entity status during the patent process, you must notify the USPTO promptly. The MPEP states:

“A micro entity that no longer meets the requirements for micro entity status at a point in time when a fee is due is treated as a small entity for purposes of paying the fee if the applicant or patentee is otherwise eligible for small entity status.”

This means:

  • You must file a notification of loss of entitlement to micro entity status.
  • If you still qualify as a small entity, you can pay fees at the small entity rate.
  • If you no longer qualify as a small entity, you must pay fees at the standard (large entity) rate.

It’s important to note that continuing to pay fees at the micro entity rate when you no longer qualify can result in the patent being held unenforceable. For more details, refer to MPEP 509.04(e).

To learn more:

If you lose entitlement to micro entity status, you must:

  1. File a notification of loss of entitlement to micro entity status in the application or patent
  2. Pay the required fee in the small entity or undiscounted amount, as appropriate

The notification must be filed prior to or at the time of paying the earliest fee after the date on which status as a micro entity is no longer appropriate. As stated in 37 CFR 1.29(i): ‘Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.’

What happens if I fail to notify the USPTO about loss of micro entity status?

Failing to notify the USPTO about the loss of micro entity status can have serious consequences. The MPEP warns:

“Fraudulent assertion of micro entity status is considered a fraud practiced or attempted on the Office.” (MPEP 509.04(f))

Consequences may include:

  • Invalidation of the patent application or granted patent
  • Disciplinary action against registered practitioners
  • Criminal penalties under 18 U.S.C. 1001

It’s crucial to promptly notify the USPTO if you lose eligibility for micro entity status to avoid these severe consequences.

To learn more:

If you erroneously pay small entity fees in good faith, you can correct the error by:

  • Submitting a separate deficiency payment for each application or patent
  • Itemizing the deficiency payment with specific details
  • Paying the full deficiency amount owed

As stated in 37 CFR 1.28(c): “If status as a small entity is established in good faith, and fees as a small entity are paid in good faith, in any application or patent, and it is later discovered that such status as a small entity was established in error, or that through error the Office was not notified of a loss of entitlement to small entity status as required by § 1.27(g)(2), the error will be excused upon: compliance with the separate submission and itemization requirements of paragraphs (c)(1) and (c)(2) of this section, and the deficiency payment requirement of paragraph (c)(2) of this section.”

To learn more:

If you fail to comply with the requirements for correcting micro entity status errors, as outlined in 37 CFR 1.29(k)(1) and (k)(2), the USPTO has two options:

  1. Treat it as an authorization to process the deficiency payment and charge a processing fee
  2. Require compliance within a non-extendable one-month period

The MPEP states: If the requirements of paragraphs (k)(1) and (2) of this section are not complied with, such failure will either be treated at the option of the Office as an authorization for the Office to process the deficiency payment and charge the processing fee set forth in § 1.17(i), or result in a requirement for compliance within a one-month time period that is not extendable under § 1.136(a) to avoid the return of the fee deficiency payment.

It’s important to carefully follow the requirements to avoid additional fees or potential loss of rights.

To learn more:

If drawings are not received with a patent application, the following process occurs:

  • The application is assigned a filing date if it meets the minimum requirements under 37 CFR 1.53(b) or 1.53(d).
  • The Office of Patent Application Processing (OPAP) will send a Notice of Omitted Items giving the applicant a time period to file the missing drawings and a petition under 37 CFR 1.182 with the petition fee to have the filing date changed to the date of such filing.
  • If the applicant does not respond to the Notice of Omitted Items, the application will be processed without the drawings.

As stated in the MPEP 507: ‘If drawings are not received with the application, the application is assigned a filing date and the applicant is notified to file drawings within a set time period.’

For more information on drawings, visit: drawings.

Tags: drawings

If corrected drawings are not received within the set time period, the application will be processed for issue or publication based on the originally filed drawings. The failure to submit corrected drawings may result in the application being withdrawn from issue or the patent being printed with defective drawings.

If an applicant does not receive an application number within one month of filing, they should contact the Application Assistance Unit. The MPEP states:

‘If an application number is not received within one month of the filing date, applicant should contact the Application Assistance Unit at (571) 272-4000 or (888) 786-0101.’

This contact information is provided to ensure applicants can follow up on their application status in a timely manner. It’s important to note that this one-month period is a guideline for when applicants should take action if they haven’t received their application number.

For more information on Application Assistance Unit, visit: Application Assistance Unit.

For more information on application number, visit: application number.

What happens if an applicant’s income exceeds the micro entity threshold during pendency?

If an applicant’s income exceeds the micro entity threshold during the pendency of an application, they must notify the USPTO and change their status. The MPEP 509.04(a) states:

“A micro entity certification in an application will remain in effect until the applicant submits a notification of loss of entitlement to micro entity status under 37 CFR 1.29(i).”

Applicants are required to notify the USPTO of any change in status before paying any fee after the change. Failure to do so may result in:

  • Underpayment of fees
  • Loss of micro entity status
  • Potential invalidation of the patent if issued

It’s crucial to monitor income and update the USPTO promptly if the micro entity threshold is exceeded.

To learn more:

When a USPTO deadline falls on a weekend or holiday, the due date is automatically extended. According to MPEP 505, When the last day for taking any action or paying any fee in the Office falls on a Saturday, Sunday, or a Federal holiday within the District of Columbia, the action or the fee is considered timely if the action is taken or the fee is paid on the next succeeding business day.

This rule applies to various USPTO actions, including:

  • Filing responses to Office Actions
  • Paying maintenance fees
  • Submitting other time-sensitive documents

It’s important to note that while the deadline is extended, the USPTO is still closed on these days for regular correspondence receipt.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO deadlines, visit: USPTO deadlines.

If a patent application is missing essential parts, such as the specification, drawings, or claims, the USPTO will notify the applicant of the missing elements. According to MPEP 506:

‘Applicant will be notified of the incomplete application and the time period set for submitting the omitted parts.’

The applicant will then have an opportunity to submit the missing parts within the specified time period to complete the application.

For more information on incomplete application, visit: incomplete application.

For more information on missing parts, visit: missing parts.

For more information on patent application requirements, visit: patent application requirements.

If a patent application is filed without all the pages of the specification, the USPTO will notify the applicant of the missing parts. The MPEP refers to this situation:

See MPEP § 601.01(d)-(g) where the application is filed without all the pages of the specification, without at least one claim (nonprovisional design application), without drawings, or without all the figures of the drawings.

For applications filed before September 16, 2012, a supplemental oath or declaration by the inventor may be required to identify the missing item and indicate that it accurately describes the invention. For applications filed on or after September 16, 2012, an additional oath or declaration is generally not required.

The applicant will be given a time period to submit the missing pages. If the missing pages are not submitted within the specified time, the application may be deemed incomplete and not accorded a filing date until the missing parts are received.

If a patent application is filed with informal papers (e.g., typed on both sides of the paper, not permanent, legible, or reproducible), the USPTO will still accord a filing date if the application otherwise meets the requirements. The MPEP states:

OPAP accords a filing date, as of the date indicated by the “Office Date” stamp (see MPEP § 505), to application papers which include a specification containing a description and at least one claim (nonprovisional applications filed under 37 CFR 1.53(b) prior to March 18, 2013 and design applications), and a drawing, if necessary under 35 U.S.C. 113 (first sentence) and 37 CFR 1.53(b), but are informal because they do not comply with the rules or notices.

The USPTO will send a Notice requiring correction of the informality. Failure to correct the informality within the specified time will result in abandonment of the application.

If a nonprovisional patent application is filed without all required fees, the USPTO will send a notice to the applicant. According to the MPEP:

Filing dates are accorded to nonprovisional applications filed under 37 CFR 1.53(b) submitted without the… required fees (basic filing fee, and search and examination fees (for applications filed on or after December 8, 2004))… In such cases, a notice is mailed by OPAP requiring the appropriate fees… accompanied by a surcharge (37 CFR 1.16(f)).

The applicant will be given a time period (usually two months) to pay the missing fees and surcharge to avoid abandonment of the application.

If a drawing is not included with the application but is required for a complete disclosure of the invention, the Office of Patent Application Processing (OPAP) will send a Notice to File Missing Parts giving the applicant a time period of two months from the mailing date of the Notice to file the missing drawing(s). The time period may be extended under 37 CFR 1.136(a).

If a drawing is not acceptable for publication, the Office of Patent Application Processing (OPAP) will object to the drawing and notify the applicant. The applicant will be given a time period of two months from the mail date of the Notice to file acceptable drawings. This period is extendable under 37 CFR 1.136(a) or (b) for patent applications filed under 35 U.S.C. 111, but not for design applications filed under 35 U.S.C. 171. Failure to comply with the Notice within the time period will result in abandonment of the application.

The U.S. Patent and Trademark Office provides a specific form for certifying micro entity status based on an institution of higher education. This form is PTO/SB/15B.

MPEP 509.04(b) states: “The Office’s form PTO/SB/15B contains the certifications under 37 CFR 1.29(d) that are required to establish micro entity status on the institution of higher education basis.”

The form includes two signature blocks corresponding to the two alternative requirements under 37 CFR 1.29(d)(2):

  1. Certifying that the applicant’s employer, from which they obtain the majority of their income, is an institution of higher education.
  2. Certifying that the applicant has assigned, granted, or conveyed a license or other ownership interest in the application to an institution of higher education (or is obligated to do so).

Applicants should use this form to properly certify their micro entity status based on an institution of higher education.

To learn more:

Tags: patent fees

A USPTO deposit account can be used to pay various fees related to patent applications and services. According to the MPEP:

Filing, issue, appeal, international-type search report, international application processing, international design application fees, petition, and post-issuance fees may be charged against these accounts if sufficient funds are on deposit to cover such fees.

Specifically, fees that can be charged include:

  • Filing fees (37 CFR 1.16)
  • Processing fees (37 CFR 1.17)
  • Issue fees (37 CFR 1.18, subject to certain conditions)
  • Appeal fees
  • International application fees
  • Petition fees

However, fees under 37 CFR 1.19 (document supply fees), 1.20 (post-issuance fees), and 1.21 (miscellaneous fees) generally cannot be charged through a general authorization, with some exceptions.

To learn more:

Micro entities receive a 75% reduction on many USPTO fees, including:

  • Filing fees (nonprovisional and provisional)
  • Search fees
  • Examination fees
  • Issue fees
  • Appeal fees
  • Maintenance fees
  • Patent Trial and Appeal Board fees

The micro entity discount applies to most fees ‘for filing, searching, examining, issuing, appealing, and maintaining patent applications and patents.’

To prove a filing delay due to a postal emergency, applicants must provide sufficient evidence. According to MPEP 511:

The nature of the evidence required by the Office to establish that the paper was timely filed will depend upon the circumstances of the particular emergency and the nature of the filing.

This evidence may include:

  • Documentation of the postal service interruption or emergency
  • Proof of attempted mailing during the affected period
  • Explanation of how the emergency directly impacted the filing
  • Any official notices or bulletins related to the postal disruption

The USPTO will evaluate each case individually to determine if the delay was indeed caused by the designated emergency.

To learn more:

When filing entity status notifications in EFS-Web, it is strongly recommended to use the following document descriptions as appropriate:

  • Notification of loss of entitlement to small entity status
  • Notification of loss of entitlement to micro entity status

Using these specific document descriptions helps ensure that your notifications are properly categorized and processed by the USPTO. This recommendation is provided in MPEP 509.04(e) to facilitate efficient handling of entity status changes.

To learn more:

Tags: EFS-Web, USPTO

The filing date of a patent application is determined by the ‘Office Date’ stamp, provided the application includes all necessary components for a filing date. The MPEP states:

If an application as originally filed includes the necessary components for a filing date (see 37 CFR 1.53(b)-(d) and MPEP § 506), the ‘Office Date’ stamp establishes the ‘filing date.’

This means that the date stamped on the application by the USPTO becomes the official filing date, as long as all required elements are present. It’s crucial for applicants to ensure their submissions are complete to secure the earliest possible filing date.

A complete patent application for filing date purposes must include:

  • A specification containing a description as per 37 CFR 1.71
  • At least one claim (for nonprovisional design applications only) as per 37 CFR 1.75
  • Any drawings required by 37 CFR 1.81(a)

As stated in the MPEP: “The filing date of the provisional or nonprovisional application is the date of receipt in the Office of the application which includes a specification containing description pursuant to 37 CFR 1.71 and at least one claim (required for nonprovisional design applications only) pursuant to 37 CFR 1.75, and any drawings required by 37 CFR 1.81(a).”

To learn more:

Tags: drawings

When signing patent correspondence, the signer is making certain certifications, including:

  • The presentation of any paper to the USPTO constitutes a certification under 37 CFR 11.18(b).
  • For S-signatures, the person inserting the signature certifies that the inserted signature is their own.
  • When submitting a document signed by another person, the submitter certifies they have a reasonable basis to believe the signature is appropriate.

As stated in 37 CFR 1.4(d)(4)(i): “The presentation to the Office (whether by signing, filing, submitting, or later advocating) of any paper by a party, whether a practitioner or non-practitioner, constitutes a certification under 37 CFR 11.18(b) of this chapter.”

Violations of these certifications may result in sanctions under 37 CFR 11.18(c) and (d).

To learn more:

What are the USPTO’s guidelines for hand-carrying documents?

The USPTO has specific guidelines for hand-carrying documents to their office. According to MPEP 502:

“Any paper which relates to a pending application may be personally delivered to the Office. The attorney, agent, or applicant should specifically instruct the person making the delivery to hand-carry the paper to the Customer Service Window…”

Key points to remember when hand-carrying documents to the USPTO:

  • Deliver to the Customer Service Window at the Randolph Building, 401 Dulany Street, Alexandria, VA 22314
  • The delivery must be made during official business hours (8:30 AM to 5:00 PM, Monday through Friday, excluding federal holidays)
  • A receipt will be issued for the delivered papers
  • The receipt date is considered the filing date for the documents

It’s important to follow these guidelines to ensure proper handling and timely processing of your documents.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The USPTO accepts two types of signatures for patent correspondence:

  • Handwritten signature: An original signature personally signed in permanent dark ink or its equivalent.
  • S-signature: A signature inserted between forward slash marks, which can include electronic or mechanical signatures.

As stated in 37 CFR 1.4(d): “Correspondence filed in the Office, which requires a person’s signature, may be filed with one of two types of signatures: (A) handwritten signature; and (B) ‘S-signature.'”

To learn more:

The time limits for responding to a notice under 37 CFR 1.251 vary depending on whether it’s for an application or a patent:

  • For applications: The Office sets a three-month period for reply, which is extendable under 37 CFR 1.136(a) by up to three additional months, for a maximum of six months.
  • For patents: The Office sets a six-month period for reply, which is not extendable.

MPEP 508.04 states: “The Office will set a time period of three months for reply in a notice under 37 CFR 1.251 in an application. The time period will be extendable under 37 CFR 1.136(a) (unless the notice indicates otherwise) by three months up to a maximum period for reply of six months in an application.” It also notes: “The Office will set a time period of six months for reply in a notice under 37 CFR 1.251 in a patent. The time period will not be extendable under 37 CFR 1.136(a) in a patent.”

The USPTO sets specific time limits for responding to notices about unlocatable files, which differ for applications and patents:

For applications, the MPEP states: The Office will set a time period of three months for reply in a notice under 37 CFR 1.251 in an application. The time period will be extendable under 37 CFR 1.136(a) (unless the notice indicates otherwise) by three months up to a maximum period for reply of six months in an application.

For patents, the time limit is longer: The Office will set a time period of six months for reply in a notice under 37 CFR 1.251 in a patent. The time period will not be extendable under 37 CFR 1.136(a) in a patent because 35 U.S.C. 41(a)(8) only authorizes the Office to charge fees for extensions of time in proceedings involving an application.

It’s important to note that failing to reply within these time limits can have serious consequences, including abandonment of pending applications.

For more information on patent applications, visit: patent applications.

For more information on Time Limits, visit: Time Limits.

The USPTO has designated specific facsimile numbers for various offices to handle different types of correspondence. According to MPEP 502.01, some key facsimile numbers include:

  • Central Facsimile Number (for most patent-related correspondence): (571) 273-8300
  • International Patent Legal Administration (for responses to Decisions on Petition): (571) 273-0459
  • Office of Data Management (for issue fee payments and drawings): (571) 273-2885
  • Electronic Business Center (for Customer Number requests): (571) 273-0177
  • Assignment Branch (for assignment documents): (571) 273-0140
  • Central Reexamination Unit (for ex parte and inter partes reexamination correspondence): (571) 273-9900
  • Patent Trial and Appeal Board (for contested cases and trials, where expressly authorized): (571) 273-0042
  • Office of Petitions (for petitions to withdraw from issue): (571) 273-0025

The MPEP states: “For each Office location listed below, only the particular type of correspondence indicated may be transmitted to the specific facsimile number at that Office location. All other types of facsimile transmitted correspondence must be sent to the central facsimile number ((571) 273-8300).”

It’s crucial to use the correct facsimile number for your specific type of correspondence to ensure proper handling and processing by the USPTO.

To learn more:

What are the size standards for a small business concern in patent applications?

The size standards for a small business concern in patent applications are determined by the Small Business Administration (SBA). According to MPEP 509.02:

“For the purpose of paying reduced patent fees, a small business concern is one:

  • (i) Whose number of employees, including affiliates, does not exceed 500 persons; and
  • (ii) Which has not assigned, granted, conveyed, or licensed (and is under no obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a small business concern or a nonprofit organization under this section.”

It’s important to note that these size standards are specific to patent applications and may differ from SBA size standards used for other purposes. Businesses must meet both the employee count criterion and the rights assignment criterion to qualify as a small business concern for patent fee purposes.

To learn more:

What are the signature requirements for patent practitioners in correspondence with the USPTO?

Patent practitioners (e.g., registered attorneys or agents) must follow specific signature requirements when corresponding with the USPTO:

  • They must personally sign correspondence using either a handwritten signature or an S-signature.
  • An S-signature is inserted between forward slash marks and includes the practitioner’s name and registration number.
  • The signature must comply with 37 CFR 1.4(d)(1) or 1.4(d)(2).

According to MPEP 502.02, ‘The signature of a practitioner on correspondence filed with the USPTO must be a handwritten signature or an S-signature personally signed by such practitioner.’ This ensures accountability and authenticity in patent-related communications.

To learn more:

The signature requirements for correspondence in patent applications are outlined in MPEP 502.02. The section states:

37 CFR 1.4(d) sets forth the signature requirements for correspondence filed in the Office. Specifically, 37 CFR 1.4(d) provides that:

The signature requirements vary depending on the type of correspondence and the method of submission. Generally, they include:

  • Handwritten signatures
  • S-signatures (electronically created signatures)
  • EFS-Web signatures for documents submitted via the Electronic Filing System

Each type of signature has specific requirements to ensure its validity and authenticity.

To learn more:

Tags: USPTO

The USPTO assigns different series codes to various types of patent applications:

  • 01/ – 16/: Nonprovisional applications (utility, plant, and reissue)
  • 29/: Design applications
  • 35/: International design applications
  • 60/, 61/, and 62/: Provisional applications
  • 90/: Ex parte reexamination proceedings
  • 95/: Inter partes reexamination proceedings
  • 96/: Supplemental examination proceedings and resulting ex parte reexamination proceedings

The MPEP provides a detailed breakdown of series codes for nonprovisional applications from 1925 to the present. For example, ‘Series code 16 is assigned to nonprovisional applications filed from June 2018 to present.’ (MPEP 503)

Using unsecured email for USPTO communications poses several risks:

  • Confidentiality breaches: Sensitive information could be intercepted by unauthorized parties.
  • Legal issues: Transmitting confidential information without proper security measures may violate patent laws and regulations.
  • Loss of patent rights: Inadvertent public disclosure through unsecured email could jeopardize patent rights.
  • Rejection of communications: The USPTO may not accept or acknowledge communications sent through unsecured channels.

MPEP 502.03 warns: “Internet e-mail shall NOT be used to conduct an exchange or communications similar to those exchanged during telephone or personal interviews unless a written authorization has been given.” This emphasizes the importance of using secure, authorized channels for all USPTO communications.

To mitigate these risks, always use the USPTO’s secure email system or the Electronic Filing System (EFS-Web) for official communications.

To learn more:

Improperly claiming micro entity status can have serious consequences:

  • It may be considered fraud on the USPTO if done knowingly
  • It can result in the patent being held unenforceable
  • Improperly paid fees will need to be corrected, which may include late fees

MPEP 509.04 warns: ‘Any attempt to fraudulently establish status as a micro entity, or pay fees as a micro entity, shall be considered as a fraud practiced or attempted on the Office. Improperly, and with intent to deceive, establishing status as a micro entity, or paying fees as a micro entity, shall be considered as a fraud practiced or attempted on the Office.’

To qualify for micro entity status, an applicant must meet the following requirements:

  • Qualify as a small entity
  • Not be named as an inventor on more than 4 previously filed patent applications
  • Not have a gross income exceeding 3 times the median household income in the previous calendar year
  • Not have assigned, licensed, or be obligated to assign or license rights to an entity that exceeds the gross income limit

Alternatively, an applicant can qualify if they are employed by or have assigned rights to an institution of higher education.

When responding to a notice about an unlocatable file, applicants or patentees must provide copies of correspondence, but there are some exceptions. The MPEP states:

Any appendix or information disclosure statement submitted with an application is not contained in the Office’s database. Therefore, the applicant or patentee must also provide a copy of any appendix or information disclosure statement (except in the limited circumstance discussed below) submitted with the application.

However, there’s an important exception for U.S. patent documents:

Since the Office can obtain copies of U.S. patent documents (U.S. patent application publications and patents) from its internal databases, the Office is not requiring applicants or patentees to provide copies of U.S. patent application publications and patents that are among the applicant’s or patentee’s record of the correspondence between the Office and the applicant or patentee for the application, patent, or other proceeding.

This means that while most documents need to be resubmitted, U.S. patent documents can be omitted from the response.

The USPTO accepts different types of signatures on correspondence, including:

  1. Handwritten signatures: Original signatures in permanent dark ink or equivalent.
  2. S-signatures: A signature inserted between forward slash marks, which can be used for correspondence filed in paper, by fax, or via the electronic filing system.
  3. Electronic signatures: For correspondence submitted via the electronic filing system, a graphic representation of a handwritten signature or an S-signature is acceptable.

According to 37 CFR 1.4(d): Each piece of correspondence, except as provided in paragraphs (d)(2), (d)(3), (d)(4), (e) and (f) of this section, filed in an application, patent file, or other proceeding in the Office which requires a person’s signature, must: (i) Be an original, that is, have an original handwritten signature personally signed, in permanent dark ink or its equivalent, by that person; or (ii) Be a direct or indirect copy, such as a photocopy or facsimile transmission (§ 1.6(d)), of an original.

For S-signatures, the signer must personally insert their own signature, and patent practitioners must include their registration number. The signer’s name must be presented in printed or typed form immediately below or adjacent to the S-signature.

To learn more:

The USPTO requires that different matters be submitted in separate papers to avoid confusion and delays. This requirement is outlined in 37 CFR 1.4(c), which states:

Since different matters may be considered by different branches or sections of the Office, each distinct subject, inquiry or order must be contained in a separate paper to avoid confusion and delay in answering papers dealing with different subjects.

Key points to remember:

  • Each distinct subject, inquiry, or order should be in a separate paper.
  • This applies to both patent and trademark correspondence.
  • Exceptions are allowed for subjects provided for on a single Office or World Intellectual Property Organization form.

If you submit multiple subjects in a single paper, the USPTO may use Form Paragraph 5.01.01 to notify you of the requirement for separate papers in future correspondence.

Adhering to this requirement helps ensure that your correspondence is processed efficiently by the appropriate Office branches or sections.

To learn more:

When sending confidential information via email to the USPTO, specific requirements must be met:

  • Use of the Electronic Filing System (EFS-Web) is strongly recommended for submitting confidential information.
  • If email must be used, it should be through the USPTO’s secure email system.
  • An authorization from the applicant is required before sending confidential information via email.
  • The email must include a statement that the email correspondence is being submitted using the procedures set forth in 37 CFR 1.33(d).

As stated in MPEP 502.03: “Internet email shall NOT be used to conduct an exchange of communications similar to those exchanged during telephone or personal interviews unless a written authorization has been given.”

To learn more:

To obtain a filing date for a nonprovisional patent application filed under 37 CFR 1.53(b), the application must include:

  • A specification containing a description as prescribed by 35 U.S.C. 112(a)
  • At least one claim (for applications filed on or after December 13, 2013)
  • Any drawings necessary under 35 U.S.C. 113 (first sentence)

As stated in the MPEP: Filing dates are accorded to nonprovisional applications filed under 37 CFR 1.53(b) submitted without the names of all the inventors, the required fees (basic filing fee, and search and examination fees (for applications filed on or after December 8, 2004)), at least one claim (for applications filed on or after December 13, 2013) and/or the inventor’s oath or declaration.

If any required items are missing, the applicant will be notified and given a time period to submit the missing elements. The filing date will be the date the missing items are received.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application requirements, visit: patent application requirements.

To establish micro entity status on the gross income basis, an applicant must meet the following requirements as outlined in 37 CFR 1.29(a)(1)-(4):

  • Qualify as a small entity
  • Not have been named as an inventor on more than four previously filed patent applications
  • Not have a gross income exceeding three times the median household income in the preceding calendar year
  • Not have assigned, granted, or conveyed, and not be under an obligation to do so, a license or ownership interest to an entity exceeding the gross income limit

The MPEP states: “Because each inventor and each non-inventor applicant (e.g., assignee-applicant) must separately meet the requirements under 37 CFR 1.29(a)(1)-(4), it would not be appropriate to file a micro entity certification under 37 CFR 1.29(a) for the application if there were more than one applicant or inventor and not all of the applicants and inventors qualified as micro entities under 35 U.S.C. 123(a).

To learn more:

To establish micro entity status based on an institution of higher education, an applicant must meet two main requirements:

  1. Qualify as a small entity as defined in 37 CFR 1.27
  2. Meet one of the following criteria:
    • The applicant’s employer, from which they obtain the majority of their income, is an institution of higher education as defined in section 101(a) of the Higher Education Act of 1965, or
    • The applicant has assigned, granted, conveyed, or is under an obligation to assign, grant, or convey, a license or other ownership interest in the application to such an institution of higher education.

As stated in MPEP 509.04(b): “An applicant for micro entity status under the ‘institution of higher education’ basis set forth in 37 CFR 1.29(d) must satisfy two requirements.”

To learn more:

What are the requirements for filing papers with the USPTO?

When filing papers with the United States Patent and Trademark Office (USPTO), it’s important to adhere to specific requirements:

  • Papers must be legibly written either by hand or printed in permanent dark ink or its equivalent.
  • They should be presented on flexible, strong, smooth, non-shiny, durable, and white paper.
  • All papers must be presented in a form having sufficient clarity and contrast between the paper and the writing to permit electronic reproduction by use of digital imaging and optical character recognition.

As stated in MPEP 501: All papers that are to become a part of the permanent records of the United States Patent and Trademark Office should be legibly written either by a typewriter or mechanical printer in permanent dark ink or its equivalent in portrait orientation on flexible, strong, smooth, non-shiny, durable, and white paper.

These requirements ensure that all documents can be properly processed and stored by the USPTO.

For more information on document legibility, visit: document legibility.

What are the requirements for certificate of mailing or transmission?

The certificate of mailing or transmission is an important tool for securing a filing date with the USPTO. According to MPEP 502, the requirements are:

“The certification requires a signature. Specifically, if the certification is filed by a registered practitioner, it must be signed by that practitioner personally. 37 CFR 1.8(a)(2). If the certification is filed by an applicant, it must be signed by the applicant (except where an oath or declaration is not required, in which case the certification may be signed by a registered practitioner). 37 CFR 1.8(a)(2).”

Key points to remember:

  • The certificate must include the date of deposit or transmission.
  • It must be signed by the person mailing or transmitting the correspondence.
  • For registered practitioners, personal signature is required.
  • For applicants, their signature is required unless an oath/declaration is not needed.

Proper use of this certificate can help ensure your documents are considered timely filed, even if there are postal or transmission delays.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on Certificate of Transmission, visit: Certificate of Transmission.

For more information on USPTO correspondence, visit: USPTO correspondence.

An S-signature must meet the following requirements:

  • It must be inserted between two forward slash marks.
  • It can only consist of letters, Arabic numerals, or both, with appropriate spaces and punctuation.
  • The signer must insert their own S-signature.
  • For patent practitioners, the registration number must be included as part of or adjacent to the S-signature.
  • The signer’s name must be presented in printed or typed form, preferably immediately below or adjacent to the S-signature.

As stated in 37 CFR 1.4(d)(2)(i): “The S-signature must consist only of letters, or Arabic numerals, or both, with appropriate spaces and commas, periods, apostrophes, or hyphens for punctuation, and the person signing the correspondence must insert his or her own S-signature with a first single forward slash mark before, and a second single forward slash mark after, the S-signature.”

To learn more:

To access USPTO public information facilities:

  • A valid Public User or Visitor’s badge is required
  • Badges can be obtained from the Office of Security next to the Public Search Facility
  • An On-line Service Card is required for access to all Public Search Facilities and on-line systems

MPEP 510 states: “A valid Public User or Visitor’s badge is required to enter USPTO facilities. This badge can be obtained from the Office of Security next door to the Public Search Facility located on the first floor of the Madison East Building, 600 Dulany Street, Alexandria, VA 22314.”

The USPTO recommends several methods for filing new patent applications, with some being more advantageous than others. According to MPEP 511, the recommended methods are:

  1. Electronic Filing System (EFS-Web or Patent Center): This is the most recommended method. As stated in MPEP 511: “In general, applicants should consider filing new patent applications (as well as patent-related correspondence) via the USPTO patent electronic filing system (EFS-Web or Patent Center) whenever permitted.”
  2. Priority Mail Express®: If not filing electronically, this is the next best option. MPEP 511 notes: “The Office strongly recommends that applicants file new applications by Priority Mail Express® in accordance with 37 CFR 1.10 (if such applications are not filed via EFS-Web) because such correspondence will be accorded the date of deposit in Priority Mail Express® with the USPS as the filing date.”
  3. Hand-delivery: Applications can be hand-delivered to the USPTO.
  4. First-class mail: While possible, this method carries risks of delay and is not recommended for new applications.

It’s important to note that new applications cannot be filed by facsimile. For more details on electronic filing, refer to the Legal Framework for Patent Electronic System on the USPTO website.

To learn more:

The USPTO strongly recommends the following methods for filing new patent applications:

  1. Electronic Filing System (EFS-Web or Patent Center): This is the preferred method whenever permitted.
  2. Priority Mail Express®: If not filing electronically, use this method in accordance with 37 CFR 1.10 to secure the date of deposit as the filing date.
  3. Hand-delivery to the USPTO office.

Avoid filing by first-class mail, as it only secures the date of receipt at the USPTO as the filing date, risking delays in delivery.

As stated in MPEP 511: “The Office strongly recommends that applicants file new applications by Priority Mail Express® in accordance with 37 CFR 1.10 (if such applications are not filed via EFS-Web) because such correspondence will be accorded the date of deposit in Priority Mail Express® with the USPS as the filing date.”

Additionally, “In general, applicants should consider filing new patent applications (as well as patent-related correspondence) via the USPTO patent electronic filing system (EFS-Web or Patent Center) whenever permitted.”

What are the official USPTO mailing addresses for patent-related correspondence?

The United States Patent and Trademark Office (USPTO) has specific mailing addresses for different types of patent-related correspondence. According to the MPEP 502:

For regular mail:

  • Commissioner for Patents
    P.O. Box 1450
    Alexandria, VA 22313-1450

For hand-carried or EXPRESS MAIL:

  • U.S. Patent and Trademark Office
    Customer Service Window
    Randolph Building
    401 Dulany Street
    Alexandria, VA 22314

It’s important to use the correct address to ensure timely processing of your correspondence.

For more information on patent correspondence, visit: patent correspondence.

The official business hours of the U.S. Patent and Trademark Office (USPTO) are:

  • 8:30 a.m. to 5:00 p.m., Monday through Friday
  • Excluding federal holidays in the District of Columbia

As stated in MPEP 510: “The U.S. Patent and Trademark Office (USPTO or Office) working hours are 8:30 a.m. to 5:00 p.m., Monday through Friday, excluding federal holidays in the District of Columbia.”

What are the margin requirements for patent application documents?

When preparing documents for a patent application, it’s crucial to adhere to specific margin requirements set by the USPTO:

  • The top margin of the first page should be at least 2 cm (3/4 inch).
  • All other margins (left, right, and bottom) must be at least 2 cm (3/4 inch).
  • The margins can be slightly larger but should not exceed 4 cm (1-1/2 inches).

According to MPEP 501: All of the application papers must have margins which are at least 2 cm. (3/4 inch) … on the sides, top and bottom. Margins should not exceed 4 cm. (1-1/2 inches). … The top margin of the first page should be at least 2 cm. (3/4 inch).

These margin requirements ensure that all information is visible and can be properly scanned and processed by the USPTO.

MPEP 507 outlines specific requirements for margins and paper size in patent drawings:

Each sheet must include a top margin of at least 2.5 cm. (1 inch), a left size margin of at least 2.5 cm. (1 inch), a right size margin of at least 1.5 cm. (5/8 inch), and a bottom margin of at least 1.0 cm. (3/8 inch). The size of the sheets on which drawings are made must be either 21.0 cm. by 29.7 cm. (DIN size A4) or 21.6 cm. by 27.9 cm. (8-1/2 by 11 inches);

These requirements are based on 37 CFR 1.84(f) and (g). Adhering to these specifications ensures that the drawings can be properly scanned and reproduced in the patent publication process.

What are the line spacing requirements for patent application text?

When preparing the text for your patent application, it’s important to follow the USPTO’s line spacing requirements:

  • The text should be written in a nonscript type font (e.g., Arial, Times Roman, or Courier).
  • The lettering style should be at least 0.32 cm (1/8 inch) high.
  • The lines of text should be 1.5 or double spaced.

According to MPEP 501: The text must be written in a nonscript type font (e.g., Arial, Times Roman, or Courier, preferably a font size of 12) lettering style having capital letters which should be at least 0.32 cm. (1/8 inch) high, but may be no smaller than 0.21 cm. (3/32 inch) high (e.g., a font size of 6). The lines of the specification may be 1 1/2 or double spaced.

These requirements ensure that the text is easily readable and can be properly scanned and processed by the USPTO’s systems.

The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) have specific limitations when it comes to petitions for filing dates. According to MPEP 511:

“Applicants are cautioned that the provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) only apply to postal interruptions and emergencies. The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) do not provide for granting of a filing date to correspondence as of the date on which it would have been filed but for other exigencies, such as the unavailability of a computer or word processing equipment, or the inaccessibility of an office or building other than a USPS facility.”

This means that these provisions are strictly limited to postal service interruptions or emergencies. They cannot be used for other circumstances that may have prevented timely filing, such as:

  • Computer or equipment failures
  • Office or building inaccessibility (unless it’s a USPS facility)
  • Personal emergencies or other non-postal related issues

Additionally, the statute requires that the correspondence was complete and ready to be deposited with the USPS on the requested filing date, and that the sole reason for non-deposit was the unavailability of postal service due to the designated interruption or emergency.

To learn more:

What are the income limitations for qualifying as a micro entity?

To qualify as a micro entity based on income, an applicant’s gross income in the previous calendar year must not exceed three times the median household income as reported by the Bureau of the Census. The MPEP states:

“The income limit is not described in terms of a specific dollar amount because median household income may change from year to year.” (MPEP 509.04(a))

For the most current income threshold, applicants should check the USPTO’s website or consult with a patent attorney. It’s important to note that this limit applies to each applicant, inventor, and joint inventor who is named in the application.

To learn more:

What are the income limitations for micro entity status?

To qualify for micro entity status, an applicant’s income must not exceed three times the median household income as reported by the Bureau of the Census. According to USPTO’s 2022 notice, the income limit is $206,109. The MPEP states:

“[A]n applicant qualifies as a micro entity if the applicant’s gross income in the previous calendar year does not exceed the ‘maximum qualifying gross income’ which is set to three times the median household income as reported by the Bureau of the Census.” (MPEP 509.04(a))

It’s important to note that this limit is subject to change, and applicants should check the latest USPTO notices for the most current information.

To learn more:

The Public Search Facility in Alexandria has extended hours compared to the regular USPTO business hours:

  • 8:00 a.m. to 8:00 p.m., Monday through Friday
  • Excluding federal holidays in the District of Columbia

As stated in MPEP 510: “The hours for the Public Search Facility in Alexandria are 8:00 a.m. to 8:00 p.m., Monday through Friday, excluding federal holidays in the District of Columbia.”

Applications properly filed via Priority Mail Express® (formerly Express Mail) have special filing date rules:

  • The filing date is the date the application was deposited with the U.S. Postal Service as Priority Mail Express®
  • This applies even if the deposit date is a Saturday, Sunday, or federal holiday
  • The application must comply with the requirements of 37 CFR 1.10 to receive this benefit

The MPEP states: For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service. For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date. 37 CFR 1.6(a)(2).

If the proper procedures were not followed, the application will receive a filing date as of the date it was received in the USPTO. Any review of these matters would be by way of petition, accompanied by the petition fee.

For more information on Priority Mail Express, visit: Priority Mail Express.

What are the consequences of submitting insufficient fees for a patent application?

Submitting insufficient fees for a patent application can have significant consequences. According to MPEP 509:

“An application filed with insufficient basic filing fee, search fee, examination fee, or oath or declaration will be treated as an incomplete application under 37 CFR 1.53(f) and will not be given a filing date until the filing fee is received.”

This means:

  • Your application won’t receive a filing date until the correct fees are paid
  • This delay could affect your priority date
  • If not corrected promptly, the application may be considered abandoned

It’s crucial to ensure all required fees are paid in full when submitting a patent application to avoid these issues.

To learn more:

What are the consequences of submitting color drawings in a utility patent application?

Submitting color drawings in a utility patent application has specific consequences and requirements:

  • Color drawings are not ordinarily permitted in utility patent applications.
  • As stated in MPEP 507: “Color drawings are permitted in design applications. For utility patent applications, color drawings are not permitted without a grantable petition.”
  • If color drawings are submitted without an approved petition, OPAP will send a Notice to File Corrected Application Papers.
  • The applicant must either:
    • Replace the color drawings with black and white drawings, or
    • File a grantable petition under 37 CFR 1.84(a)(2) to accept the color drawings.
  • The petition must explain why color drawings are necessary and be accompanied by the fee set forth in 37 CFR 1.17(h).

It’s important to consider whether color drawings are truly necessary for your utility patent application, as they require additional steps and fees in the application process.

For more information on application papers, visit: application papers.

For more information on color drawings, visit: color drawings.

The consequences of not responding to a notice about an unlocatable file differ for pending applications and granted patents:

  • For pending applications: According to 37 CFR 1.251(b), failure to comply with one of paragraphs (a)(1), (a)(2), or (a)(3) of this section within the time period set in the notice will result in abandonment of the application.
  • For granted patents: While the patent won’t expire, the MPEP states that the only certified copy of the patent file that the Office will be able to produce will be a copy of the patent and a copy of the application-as-filed (which may have an adverse impact during attempts to enforce the patent).

Additionally, for patents involved in USPTO proceedings, the Office may take action under 37 CFR 41.128 or 37 CFR 11.18.

To learn more:

What are the consequences of improperly claiming small entity status?

Improperly claiming small entity status can have serious consequences. The MPEP 509.03 states: “Improperly and with intent to deceive establishing status as a small entity, or paying fees as a small entity, shall be considered as a fraud practiced or attempted on the Office.” This means that intentionally falsely claiming small entity status is considered fraud. Consequences may include:

  • Invalidation of the patent
  • Requirement to pay back all fee differences
  • Potential legal action for fraud

It’s crucial to verify eligibility carefully before claiming small entity status and to update the USPTO if your status changes.

To learn more:

To learn more:

Fraudulently establishing small entity status or paying fees as a small entity is considered a serious offense. According to 37 CFR 1.27(h): ‘Any attempt to fraudulently establish status as a small entity or pay fees as a small entity will be considered as a fraud practiced or attempted on the Office.’

The consequences of such actions can be severe, potentially including:

  • Invalidation of the patent
  • Criminal charges for fraud
  • Disciplinary action against registered patent practitioners

It’s crucial to ensure that all claims to small entity status are truthful and accurate. Do not rely on oral advice from USPTO employees regarding entitlement to small entity status.

To learn more:

The consequences of failing to respond to a 37 CFR 1.251 notice differ for pending applications and granted patents:

  • For pending applications: Failure to reply within the set time period will result in abandonment of the application. MPEP 508.04 cites 37 CFR 1.251(b): “With regard to a pending application, failure to comply with one of paragraphs (a)(1), (a)(2), or (a)(3) of this section within the time period set in the notice will result in abandonment of the application.”
  • For granted patents: While the patent won’t expire, there may be limitations on the certified copy of the patent file that the Office can produce. MPEP 508.04 states: “While abandonment (or expiration) of a patent is not an issue if a patentee fails to timely comply with a notice under 37 CFR 1.251, in such a situation the only certified copy of the patent file that the Office will be able to produce will be a copy of the patent and a copy of the application-as-filed (which may have an adverse impact during attempts to enforce the patent).”

Additionally, for patents involved in proceedings before the Office, action may be taken under 37 CFR 41.128 or 37 CFR 11.18.

What are the consequences of bounced checks or insufficient funds for USPTO fee payments?

Submitting a check that bounces or having insufficient funds for USPTO fee payments can have serious consequences. The MPEP 509 states: ‘If any fee is paid by a check which is uncollectible or is returned unpaid, or if any payment is made in an amount less than the required amount, the fee payment shall be regarded as incomplete and the processing of the application or other filing shall be held in abeyance until the full fee payment is made.’

Consequences may include:

  • Suspension of application processing
  • Potential loss of filing date
  • Additional fees or penalties
  • Possible disciplinary action for repeated occurrences

To avoid these issues, ensure sufficient funds are available and consider using more reliable payment methods like electronic funds transfer or credit cards.

To learn more:

Tags: USPTO fees

Improper signatures on patent correspondence can have serious consequences. While the MPEP 502.02 doesn’t explicitly list all consequences, it emphasizes the importance of proper signatures:

Correspondence filed in the Office by applicants and other parties must be signed by the applicants or other party, or by a registered patent attorney or agent of record in the patent application or patent.

The potential consequences of an improper signature include:

  • Rejection or return of the correspondence
  • Delays in processing the application or request
  • Potential loss of rights or missed deadlines
  • Requirement for ratification or confirmation of the signature
  • In severe cases, charges of fraud or inequitable conduct

To avoid these issues, it’s crucial to ensure all signatures comply with USPTO requirements as outlined in 37 CFR 1.4 and MPEP 502.02. When in doubt, consult with a registered patent attorney or agent to verify proper signature practices.

To learn more:

OPAP may object to patent drawings for several reasons, including:

  1. Line quality issues
  2. Missing lead lines
  3. Excessive or non-English text
  4. Incorrect margins or paper size
  5. Improper figure labeling
  6. Illegible photographs
  7. Unauthorized color drawings or photographs

For example, regarding line quality, MPEP 507 states:

OPAP may object to and require corrected drawings within a set time period, if the drawings: (A) have a line quality that is too light to be reproduced (weight of all lines and letters must be heavy enough to permit adequate reproduction) or text that is illegible (reference characters, sheet numbers, and view numbers must be plain and legible). See 37 CFR 1.84(l) and (p)(1);

The USPTO has specific certification requirements for signatures in correspondence. According to MPEP 501, which cites 37 CFR 1.4(d)(4):

The person inserting a signature under paragraph (d)(2) or (d)(3) of this section in a document submitted to the Office certifies that the inserted signature appearing in the document is his or her own signature. A person submitting a document signed by another under paragraph (d)(2) or (d)(3) of this section is obligated to have a reasonable basis to believe that the person whose signature is present on the document was actually inserted by that person, and should retain evidence of authenticity of the signature.

Key points about signature certifications:

  • The person inserting an S-signature certifies it as their own.
  • When submitting a document signed by another, you must have a reasonable belief that the signature is authentic.
  • Evidence of signature authenticity should be retained.
  • Violations of certification rules may result in sanctions.

These requirements apply to both handwritten and S-signatures. They ensure the integrity and authenticity of documents submitted to the USPTO.

For more information on USPTO correspondence, visit: USPTO correspondence.

What are the accepted payment methods for patent fees?

The USPTO accepts various payment methods for patent fees:

  • Credit or debit card
  • Electronic funds transfer (EFT)
  • Deposit account
  • Check or money order

As stated in MPEP 509: ‘Fees may be paid by U.S. credit card, electronic funds transfer (EFT), deposit account, check or money order.’ Electronic payment methods are preferred for their efficiency and speed.

To learn more:

The USPTO accepts various methods of payment for patent and trademark process fees. According to MPEP 509, the primary methods include:

  • Credit cards (AMERICAN EXPRESS®, DISCOVER®, MASTER CARD®, and VISA®)
  • Deposit accounts
  • Electronic funds transfer (EFT)
  • Other forms of payment accepted by the Office

It’s important to note that credit card payments are subject to a transaction maximum. As stated in the MPEP: Effective June 1, 2015, the credit card transaction maximum is $24,999.99 as specified in section 7045 of the ‘Treasury Financial Manual.’ This limit does not apply to other payment methods.

To learn more:

Tags: USPTO fees

What are the acceptable methods for filing papers with the USPTO?

The USPTO accepts several methods for filing papers:

  • Hand-delivery to the USPTO office in Alexandria, Virginia
  • First-class mail through the United States Postal Service (USPS)
  • Express Mail service of the USPS
  • Electronic filing through the USPTO’s Electronic Filing System (EFS-Web)

As stated in MPEP 501: ‘Papers may be filed using first class mail through the United States Postal Service.’ The MPEP also notes that ‘Correspondence may be hand-carried to the Office.’ For electronic filing, it’s important to note that ‘EFS-Web can be used to file new applications, enter the national stage under 35 U.S.C. 371, and submit most follow-on documents in patent applications.’

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on Express Mail, visit: Express Mail.

For more information on first-class mail, visit: first-class mail.

For more information on hand-delivery, visit: hand-delivery.

All relevant information from MPEP 502.05 – Correspondence Transmitted by EFS-Web has been thoroughly covered in the previously generated FAQs. No additional meaningful questions can be created without substantial repetition of existing content.

To learn more:

To learn more:

USPTO employees are required to verify the identity of email senders in patent communications to prevent misrepresentation or spoofing. According to MPEP 502.03:

‘Email must be initiated by a registered practitioner, or an applicant in a pro se application, and sufficient information must be provided to show representative capacity in compliance with 37 CFR 1.34.’

The MPEP provides examples of information that can be used for verification:

  • Attorney registration number
  • Attorney docket number
  • Patent application number

Additionally, the MPEP advises:

‘Similar to the policy set forth in MPEP 100 for handling telephone calls, when responding to an email, no information should be disclosed until the identity of the requester can be adequately verified.’

Examiners are instructed to verify the identity by checking Patent Data Portal or the application file, such as confirming the email address previously provided in Patent Data Portal or the application.

To learn more:

For joint inventor applicants, MPEP 509.04(c) states that “each joint inventor should sign a separate copy of the relevant micro entity certification form.” However, there is an exception:

“If one joint inventor is appointed to prosecute the application on behalf of all the other joint inventors, then only that one joint inventor need sign the micro entity certification form.”

This appointment can be made using USPTO form PTO/AIA/81, titled “Power Of Attorney To One Or More Of The Joint Inventors And Change Of Correspondence Address”, available on the USPTO forms Web page.

To learn more:

Patent maintenance fee payments can be submitted in two ways:

  1. Electronically: This is the preferred method. Payments can be made through the USPTO’s Patent Maintenance Fees Storefront.
  2. By mail: If not submitted electronically, maintenance fee payments and related correspondence should be addressed to:

Mail Stop Maintenance Fee
Director of the United States Patent and Trademark Office
P.O. Box 1450
Alexandria, VA 22313-1450

The MPEP states: Maintenance fee payments not electronically submitted over the Internet and correspondence related to maintenance fees may be addressed to: Mail Stop Maintenance Fee, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450

It’s important to note that electronic submission is faster, more secure, and provides immediate confirmation of payment.

To learn more:

Maintenance fee payments have a specific mailing address if not submitted electronically. According to MPEP 501, which cites 37 CFR 1.1(d):

Maintenance fee payments that are not submitted electronically and correspondence related to maintenance fees may be addressed to: Mail Stop Maintenance Fee, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450.

However, it’s important to note that the USPTO strongly encourages electronic submission of maintenance fee payments. The Electronic Maintenance Fee Form is the preferred method for these transactions.

If you must submit a paper payment, ensure it’s properly addressed to avoid delays in processing. Include all necessary information, such as the patent number and the fee amount being paid.

For more information on USPTO correspondence, visit: USPTO correspondence.

For correspondence that requires immediate attention from the USPTO, such as certain petitions or time-sensitive documents, the following methods are recommended:

  1. Use the USPTO patent electronic filing system (EFS-Web or Patent Center). This is the preferred method for most immediate correspondence.
  2. Where permitted, use facsimile transmission to the appropriate area of the Office.
  3. Hand-carry the documents to the USPTO in Alexandria, VA.

The MPEP states: Applicants are encouraged to transmit these types of correspondence by the USPTO patent electronic filing system (see MPEP § 502.05). Where permitted, patent-related correspondence that requires immediate Office attention may also be submitted to the appropriate area of the Office for processing by facsimile transmission (see MPEP § 502.01, subsections I.B and II) or hand-carried (see MPEP § 502), subsection III).

Examples of correspondence requiring immediate attention include:

  • Petitions for express abandonment to avoid publication
  • Petitions to withdraw an application from issue
  • Requests for expedited examination of a design application
  • Certain papers required by the Office of Data Management

To learn more:

For trademark-related documents filed on paper, except for certain specific cases, the address is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

According to MPEP 501, which cites 37 CFR 2.190: “All trademark-related documents filed on paper, except documents sent to the Assignment Recordation Branch for recordation; requests for copies of trademark documents; and certain documents filed under the Madrid Protocol as specified in 37 CFR 2.190(e), should be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.”

It’s important to note that many trademark documents can and should be filed electronically through the Trademark Electronic Application System (TEAS).

For more information on trademark correspondence, visit: trademark correspondence.

According to MPEP 507, figures in patent drawings should be labeled as follows:

Each figure must be labeled ‘Fig.’ with a consecutive Arabic numeral (1, 2, etc.) or an Arabic numeral and capital letter in the English alphabet (A, B, etc.). See 37 CFR 1.84(u)(1);

This labeling convention ensures clarity and consistency in referencing figures throughout the patent application and publication. Improper labeling may result in an objection from OPAP and require correction.

The USPTO requires clear itemization of fees to ensure proper accounting. According to MPEP 509:

37 CFR 1.22(b) sets forth that fees must be itemized in such a manner that it is clear for which purpose fees are paid. The Office may return fees that are not itemized.

However, the MPEP clarifies that the itemization requirement is not meant to create problems when the purpose is clear:

  • A reference to ‘filing fee(s)’ is sufficient to cover all types of filing fees.
  • In later submissions, ‘filing fee(s)’ would also cover surcharges.
  • A reference to ‘any corresponding fee under 37 CFR 1.16’ covers any fee under that section.

The key is to provide enough information for the USPTO to understand the purpose of the payment.

To learn more:

Tags: patent fees

For correspondence that is not specific to patents or trademarks, such as requests for certified copies or assignment recordation, the general mailing address is:

Director of the United States Patent and Trademark Office
P.O. Box 1450
Alexandria, VA 22313-1450

This address should be used for:

  • Patent and trademark documents sent to the Assignment Division for recordation (Mail Stop Assignment Recordation Services)
  • Requests for certified or uncertified copies of patent and trademark documents (Mail Stop Patent and Trademark Copy Fulfillment Branch)
  • Correspondence for which an address is not otherwise specified in 37 CFR 1.1 or 2.190

MPEP 501 states: “For correspondence for which an address is not otherwise specified in 37 CFR 1.1 or 2.190, should be addressed to: Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450”

Filing a Continued Prosecution Application (CPA) by facsimile requires specific procedures, as outlined in MPEP 502.01:

  1. CPAs are only available for design applications.
  2. The CPA must be sent to the central facsimile number: (571) 273-8300.
  3. An authorization to charge the basic filing fee to a deposit account or credit card must be included, or the application will be treated as filed without the basic filing fee.
  4. There is a special receipt procedure for CPA filings by fax:

There is a special receipt procedure for filing a CPA by fax, whereby the Office will fax back a receipt of the CPA filing if applicant submits the Office receipt form along with the CPA filing.

It’s important to note that if the USPTO has no evidence of receiving a CPA transmitted by fax, the applicant may need to file a petition under 37 CFR 1.6(f) to request a filing date. This petition must include:

  • Information about the previous transmission
  • An additional copy of the CPA
  • A statement attesting to the previous transmission
  • Evidence of the transmission, such as a sending unit’s report or other evidence created within one business day of the transmission

Always ensure that you follow these procedures carefully when filing a CPA by facsimile to avoid any issues with the filing date or processing of your application.

To learn more:

According to MPEP 509.02, fees for small entities are reduced by 50% for most patent-related fees. The MPEP states:

The fees which are reduced by 50% for small entities include patent application filing fees including the basic filing fee, search fee, examination fee, application size fee, and excess claims fees (37 CFR 1.16), extension of time, revival, and appeal fees (37 CFR 1.17), patent issue fees (37 CFR 1.18), and maintenance fees on patents (37 CFR 1.20).

Additionally, certain PCT international stage fees are also eligible for the 50% reduction for small entities.

To learn more:

Once small entity status is established in an application or patent, it remains in effect until:

  • The issue fee is due, or
  • Any maintenance fee is due

At these points, a new determination of entitlement to small entity status is required. As stated in 37 CFR 1.27(g)(1): “Once small entity status is established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.”

To learn more:

Tags: patent fees

Micro entity status, once properly established, generally remains in effect until:

  • A fee is paid in the small entity or undiscounted amount
  • A notification of loss of entitlement to micro entity status is filed
  • The issue fee or a maintenance fee is due

However, the applicant has a continued obligation to verify eligibility for micro entity status each time a fee is paid. As stated in 37 CFR 1.29(g): ‘a fee may be paid in the micro entity amount only if status as a micro entity as defined in paragraph (a) or (d) of this section is appropriate on the date the fee is being paid.’

The time period for responding to a notice about an unlocatable file depends on whether it’s for an application or a patent:

  • For applications: The USPTO typically sets a three-month period, which is extendable under 37 CFR 1.136(a) by up to three additional months, for a maximum of six months.
  • For patents: A six-month non-extendable period is set.

It’s important to note that for applications, as stated in the MPEP, If, however, an applicant fails to reply to a notice under 37 CFR 1.251 within three months of its mailing date, any patent term adjustment under 35 U.S.C. 154(b) will be reduced by a period equal to the number of days (if any) beginning on the day after the date that is three months after the mailing date of the notice under 37 CFR 1.251 and ending on the date the reply to the notice under 37 CFR 1.251 was filed.

To learn more:

Once small entity status is established in an application or patent, you can continue to pay fees as a small entity until the issue fee is due or any maintenance fee is due. This is stated in 37 CFR 1.27(g)(1): ‘Once small entity status is established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.’

To learn more:

Tags: patent fees

The gross income limit for micro entity status is determined as follows:

  • It is set at three times the median household income for the preceding calendar year, as reported by the Bureau of the Census.
  • The USPTO publishes the current maximum qualifying gross income on their website.
  • This limit applies to each applicant, inventor, and joint inventor individually.

The MPEP clarifies: “At the time any fee is to be paid in the micro entity amount, it is required that no inventor and no non-inventor applicant (if any) have a preceding calendar year’s gross income exceeding the ‘maximum qualifying gross income’ posted on the USPTO website.

It’s important to note that gross income means total income, not adjusted gross income. The MPEP states: “‘Gross income’ and ‘adjusted gross income’ are not the same thing. Adjusted gross income is defined as gross income minus adjustments to income. For purposes of micro entity status it is ‘gross income’ – not ‘adjusted gross income’ that matters.

To learn more:

The filing date for Priority Mail Express® submissions is typically determined by the “date accepted” on the Priority Mail Express® mailing label. According to MPEP 513:

Office personnel will routinely look to the Priority Mail Express® mailing label, and stamp the “date accepted” or other official USPS notation as the filing date of the correspondence.

If the USPS deposit date cannot be determined, the correspondence will be accorded the date of receipt in the Office as the filing date. It’s important to note that the “date accepted” must be completed by the USPS, not by the applicant.

The deficiency owed for micro entity fee errors is calculated according to 37 CFR 1.29(k)(2). The MPEP states:

The deficiency owed for each previous fee erroneously paid as a micro entity is the difference between the current fee amount for a small entity or non-small entity, as applicable, on the date the deficiency is paid in full and the amount of the previous erroneous micro entity fee payment.

To calculate the total deficiency payment:

  1. Determine the current fee amount for each erroneously paid fee (small or non-small entity rate)
  2. Subtract the micro entity fee amount previously paid
  3. Sum up all individual deficiency amounts

This calculation ensures that the correct fee amount is paid based on the entity status and current fee schedule.

To learn more:

For micro entity status, gross income is determined as follows:

  • Based on the calendar year preceding the year a fee is paid
  • Uses the definition of gross income in section 61(a) of the Internal Revenue Code
  • Compared to three times the median household income as reported by the Bureau of the Census
  • For non-US income, converted using the average currency exchange rate for the relevant calendar year

The USPTO website provides the current maximum qualifying gross income limit.

When calculating gross income for micro entity status involving foreign currency, the USPTO provides specific guidelines:

  • If an applicant’s, inventor’s, or entity’s gross income in the preceding calendar year is not in U.S. dollars, the average currency exchange rate reported by the Internal Revenue Service (IRS) for that calendar year must be used for conversion.
  • For income received partially in U.S. dollars and partially in foreign currency, the foreign portion must be converted to U.S. dollars and added to the U.S. dollar amount.

The MPEP states: “If an applicant’s, inventor’s, joint inventor’s, or entity’s gross income in the preceding calendar year is not in United States dollars, the average currency exchange rate, as reported by the Internal Revenue Service, during that calendar year shall be used to determine whether the applicant’s, inventor’s, joint inventor’s, or entity’s gross income exceeds the threshold specified in 37 CFR 1.29(a)(3) or (a)(4).

The IRS provides yearly average currency exchange rates on its website, which should be used for these calculations.

To learn more:

An ‘institution of higher education’ for micro entity status purposes is defined according to Section 101(a) of the Higher Education Act of 1965. The key criteria include:

  • Located in any U.S. state or territory
  • Admits students with secondary education or equivalent
  • Authorized to provide post-secondary education
  • Offers bachelor’s degrees or at least 2-year programs toward such degrees
  • Is a public or non-profit institution
  • Is accredited or pre-accredited by a recognized agency

As stated in MPEP 509.04(b): “Section 101(a) of the Higher Education Act of 1965 defines what is meant by ‘institution of higher education’ in the context of 37 CFR 1.29(d).”

To learn more:

How does USPTO verify gross income for micro entity status?

The USPTO generally does not independently verify the gross income of applicants claiming micro entity status. According to MPEP 509.04(a):

“The Office does not generally question certification of micro entity status but may require additional information on a case-by-case basis.”

However, applicants are required to certify their eligibility for micro entity status under oath. Providing false information can lead to severe consequences, including invalidation of the patent and potential criminal charges for fraud.

To learn more:

Transferring rights in an invention can affect small entity status. According to MPEP 509.02:

If the individual inventor, small business concern, or nonprofit organization assigned, granted, conveyed, or licensed, or came under an obligation to assign, grant, convey, or license, any rights to the invention to any individual, small business concern, or nonprofit organization which would not qualify as a small entity (37 CFR 1.27(a)), then the inventor, small business concern, or nonprofit organization would no longer qualify for small entity status.

However, transferring partial rights to another small entity does not disqualify the original entity from small entity status. It’s important to note that rights in question are those in the United States. Transferring rights to a foreign patent does not affect small entity status if no U.S. rights are transferred.

To learn more:

The USPTO has established procedures to notify the public about postal service interruptions that may affect patent filings. According to MPEP 511:

When the Director designates a postal service interruption or emergency, a notice will be published in the Official Gazette, and will be posted on the USPTO website at www.uspto.gov.

The USPTO’s notification process includes:

  • Publishing a notice in the Official Gazette
  • Posting information on the USPTO website
  • Possibly issuing press releases or other public communications

These notifications typically include:

  • Details about the nature and scope of the interruption
  • Any special procedures or accommodations being made
  • Instructions for applicants affected by the interruption
  • Contact information for further inquiries

It’s crucial for patent applicants and attorneys to regularly check these official sources during potential postal disruptions to stay informed about any changes in filing procedures or deadlines.

To learn more:

The USPTO has a specific policy for handling unnecessary duplicate copies of correspondence. According to MPEP 502.04:

The Office may dispose of duplicate copies of correspondence in the file of an application, patent, or other proceeding.

Furthermore, the MPEP states:

When the Office does not require duplicate copies of a paper, the filing of multiple copies may cause a delay in processing by the Office. Accordingly, the Office may discard duplicate copies of correspondence filed in an application or patent file.

This means that if you submit unnecessary duplicate copies, the USPTO may discard them to streamline processing and prevent delays. It’s important to only submit duplicate copies when specifically required by the Office.

To learn more:

The USPTO has specific procedures for handling refunds of fees paid by credit card. According to MPEP 509:

35 U.S.C. 42(d) and 37 CFR 1.26 (which concern refund of patent and trademark fees) also apply to requests for refund of fees paid by credit card. Any refund of a fee paid by credit card will be by a credit to the credit card account to which the fee was charged. See 37 CFR 1.26(a).

Key points about USPTO refunds for credit card payments:

  • Refunds are processed as credits to the original credit card account used for payment.
  • The same laws and regulations governing refunds of patent and trademark fees apply to credit card payments.
  • For information on which fees are refundable, refer to MPEP § 607.02 regarding returnability of fees.

It’s important to note that refund requests are subject to specific criteria and time limitations, so applicants should review the relevant regulations when seeking a refund.

To learn more:

Tags: patent fees

Priority Mail Express® submissions to the USPTO are handled differently from regular mail. According to MPEP 505, New patent applications filed in accordance with 37 CFR 1.10 will be stamped by the Office with the date of deposit as Priority Mail Express® with the United States Postal Service.

This means:

  • The date of deposit with USPS is used as the receipt date, not the date it arrives at the USPTO
  • This applies even on weekends and holidays when the USPTO is closed

For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

For more information on Priority Mail Express, visit: Priority Mail Express.

For more information on USPTO, visit: USPTO.

The USPTO has specific rules regarding patent term adjustments when dealing with notices about unlocatable files. According to the MPEP:

If, however, an applicant fails to reply to a notice under 37 CFR 1.251 within three months of its mailing date, any patent term adjustment under 35 U.S.C. 154(b) will be reduced by a period equal to the number of days (if any) beginning on the day after the date that is three months after the mailing date of the notice under 37 CFR 1.251 and ending on the date the reply to the notice under 37 CFR 1.251 was filed.

This reduction in patent term adjustment is based on 35 U.S.C. 154(b)(2)(C)(ii) and 37 CFR 1.704(b). It’s important to note that this reduction applies even if the applicant responds within the overall six-month period allowed for reply (including extensions).

This policy underscores the importance of prompt action in response to such notices, as delays can directly impact the duration of patent protection.

For more information on patent term adjustment, visit: patent term adjustment.

During postal service emergencies, the USPTO takes special measures to ensure patent applications are handled appropriately:

  • The USPTO Director may designate the interruption or emergency as a ‘postal service interruption or emergency’ under 35 U.S.C. 21(a).
  • This designation allows for the acceptance of filings that would have been timely filed if not for the postal service interruption or emergency.
  • The USPTO may publish a notice in the Official Gazette and on its website about the designation and any special procedures to be followed.

As stated in MPEP 511: The USPTO will consider on a case-by-case basis whether to waive the date indicated on any certificate of mailing or transmission accompanied by a showing which establishes to the satisfaction of the Director that the delay was due to the emergency.

To learn more:

The USPTO has specific procedures for handling papers that include a Certificate of Mailing or Transmission. According to the MPEP:

“The Mail Center of the Office of Patent Application Processing (OPAP) will continue to date stamp the actual date of receipt of all papers received by mail in the Office. No attempt will be made to retain the envelopes in which the papers are received or to indicate on the papers the postal cancellation date (postmark).”

Key points in the USPTO’s handling process include:

  • The actual receipt date is stamped on all papers
  • The date on the Certificate is used to determine if the paper was filed within the period for reply
  • If the paper is received after the period for reply, but the Certificate date is within the period, the paper is considered timely filed
  • A notation (e.g., “C of Mail 11/10/97”) is made next to the Office Date Stamp to indicate the Certificate date

It’s important to note that while the Certificate date is used to determine timeliness, the actual receipt date is used for all other purposes, including calculating subsequent deadlines.

To learn more:

The USPTO has a specific procedure for handling missing documents from an application file. According to the MPEP:

When a document is missing from an application, Office practice is to call the applicant’s representative and request submission (generally by facsimile) of a copy of the missing document.

This informal approach is the primary method used by the USPTO to address missing documents. However, if this informal method is unsuccessful, the Office may resort to more formal measures:

While the Office will generally treat missing documents in this relatively informal manner (rather than issuing a notice under 37 CFR 1.251), the Office may issue a notice under 37 CFR 1.251 to obtain a copy of a missing document if the Office’s informal attempts to obtain a copy of the document are unsuccessful.

It’s important for applicants and their representatives to promptly respond to such informal requests to avoid more formal procedures and potential delays in application processing.

To learn more:

The USPTO does not officially receive mail on weekends or federal holidays when the office is closed. Any correspondence received on these days is typically stamped with the next business day’s date. For example, if mail is delivered to the USPTO on a Saturday, it will be stamped with the following Monday’s date (or Tuesday if Monday is a holiday). This practice ensures consistency in dating received documents and aligns with the USPTO’s official business hours.

The USPTO handles informal drawings in patent applications as follows:

  • If the drawings are informal but otherwise sufficient for examination, the USPTO will accept them provisionally.
  • The drawings will be approved by the Office of Patent Application Processing (OPAP) for publication purposes.
  • Formal drawings will be required if the application is allowed.

According to MPEP 507: ‘If the drawings are informal but otherwise in compliance with 37 CFR 1.121(d), the OPAP will accept the application for purposes of publication and place a ‘Drawing Informalities’ form PTO-948 in the file wrapper.’

The examiner may require formal drawings or corrections in a subsequent office action if necessary for a proper examination or if the application is allowed.

For more information on drawing review, visit: drawing review.

For more information on informal drawings, visit: informal drawings.

For more information on OPAP, visit: OPAP.

The USPTO has specific rules for handling facsimile transmissions received outside of business hours, as outlined in MPEP 502.01:

Correspondence for which transmission was completed on a Saturday, Sunday, or Federal holiday within the District of Columbia, will be accorded a receipt date of the next succeeding day which is not a Saturday, Sunday, or Federal holiday within the District of Columbia.

This means that if a facsimile transmission is completed during non-business hours, weekends, or federal holidays, the USPTO will assign it a receipt date of the next business day. For example:

  • A fax completed on Friday at 9:05 p.m. Pacific time (12:05 a.m. Saturday Eastern time) would be accorded a receipt date of the following Monday (assuming Monday is not a federal holiday).
  • A fax completed on a federal holiday would be accorded a receipt date of the next business day.

It’s important to note that while the actual transmission may occur outside of business hours, the official receipt date will always be a business day. This can be crucial for meeting deadlines and calculating time-sensitive patent-related actions.

To learn more:

The USPTO has specific rules for dating facsimile transmissions. According to 37 CFR 1.6(a)(3):

Correspondence transmitted by facsimile to the Patent and Trademark Office will be stamped with the date on which the complete transmission is received in the Patent and Trademark Office unless that date is a Saturday, Sunday, or Federal holiday within the District of Columbia, in which case the date stamped will be the next succeeding day which is not a Saturday, Sunday, or Federal holiday within the District of Columbia.

This means that faxed correspondence is generally dated on the day of complete transmission, except for weekends and holidays, where it’s dated the next business day.

The USPTO has specific procedures for handling correspondence with a Certificate of Mailing or Transmission:

  1. All papers received by mail are date stamped with the actual date of receipt, regardless of any Certificate of Mailing.
  2. For papers with a Certificate of Mailing or Transmission, the date on the certificate is used to determine if the paper was filed within the period for reply.
  3. If the paper is received within the period for reply, the actual receipt date is used for all purposes.
  4. If the paper is received after the period for reply, but the certificate date is within the period, the paper is considered timely filed. In this case, a notation is made next to the ‘Office Date’ stamp indicating the certificate date (e.g., ‘C of Mail 11/10/97’).
  5. For facsimile transmissions, the date stamped is the date the complete transmission is received, unless that date is a Saturday, Sunday, or Federal holiday within the District of Columbia, in which case the date stamped will be the next succeeding business day.
  6. For EFS-Web submissions, the receipt date is the date the correspondence is received at the USPTO’s correspondence address when it was officially submitted, which can include weekends and holidays.

The MPEP states: “The date indicated on the Certificate of Mailing or of Transmission will be used by the Office only to determine if the paper was deposited in the United States Postal Service, transmitted by facsimile or transmitted via EFS-Web within the period for reply.”

How does the USPTO handle correspondence submitted in violation of the rules?

The USPTO has specific procedures for handling correspondence submitted in violation of the rules. According to MPEP 501:

‘Correspondence submitted to the U.S. Patent and Trademark Office in violation of the rules as to paying fees, manner of presenting papers, or other formal matters will not be filed.’

However, the USPTO does provide a grace period and notification process:

  • The Office may notify the submitter of the violation and set a period for correction.
  • If the violation is corrected within the set period, the document will be considered as having been filed on the date of receipt of the correction.

It’s crucial for applicants to adhere to USPTO rules to avoid potential delays or non-filing of their correspondence. If a violation occurs, prompt correction based on USPTO notification is essential to maintain the original filing date.

How does the USPTO handle correspondence sent by Priority Mail Express®?

The USPTO treats correspondence sent by Priority Mail Express® (formerly Express Mail) with special consideration. According to MPEP 502:

“Any correspondence received by Priority Mail Express® will be considered filed with the USPTO on the date of deposit with the United States Postal Service.”

This means that the date of deposit with USPS is considered the filing date at the USPTO, which can be crucial for meeting deadlines. However, it’s important to note that:

  • The Priority Mail Express® label number must be placed on the correspondence.
  • The filing date accorded to Priority Mail Express® is only applicable to the specific items deposited with USPS.

Always keep your Priority Mail Express® mailing receipt as proof of the deposit date.

For more information on Priority Mail Express, visit: Priority Mail Express.

For more information on USPS, visit: USPS.

For more information on USPTO correspondence, visit: USPTO correspondence.

The USPTO does not receive or process correspondence on Saturdays, Sundays, or Federal holidays within the District of Columbia, with some exceptions. According to 37 CFR 1.6(a)(1):

The Patent and Trademark Office is not open for the filing of correspondence on any day that is a Saturday, Sunday, or Federal holiday within the District of Columbia. Except for correspondence transmitted by facsimile under paragraph (a)(3) of this section, or filed electronically under paragraph (a)(4) of this section, no correspondence is received in the Office on Saturdays, Sundays, or Federal holidays within the District of Columbia.

When the last day for taking action or paying a fee falls on a weekend or holiday, it’s considered timely if done on the next business day: When the last day for taking any action or paying any fee in the Office falls on a Saturday, Sunday, or a Federal holiday within the District of Columbia, the action or the fee is considered timely if the action is taken or the fee is paid on the next succeeding business day.

How does the USPTO handle correspondence received after official hours?

The USPTO has specific procedures for handling correspondence received outside of official business hours:

  • Correspondence delivered to the USPTO after business hours is considered filed on the next business day.
  • There are exceptions for certain types of time-sensitive filings.

MPEP 502 states: ‘Correspondence placed in the USPTO’s night box before midnight on weekdays (except federal holidays) will receive a filing date of the succeeding business day.’ This means that documents deposited in the night box after business hours but before midnight will be treated as if they were received on the next business day.

For electronic filings, the USPTO’s Electronic Filing System (EFS-Web) is generally available 24/7, allowing for submissions outside of regular business hours. However, the actual filing date may still be affected by the time of submission.

How does the USPTO handle correspondence during emergency situations?

The USPTO has provisions for handling correspondence during emergency situations, such as severe weather or other unforeseen circumstances:

  • The USPTO may designate certain days as ‘Federal holidays within the District of Columbia’ under specific conditions.
  • This designation affects filing dates and deadlines.

MPEP 502 states: ‘When the entire USPTO is officially closed for business for an entire day due to an emergency situation, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21.’ This means that deadlines falling on such days will be extended to the next business day, similar to federal holidays.

During emergencies, the USPTO typically issues public notices and updates its website to inform stakeholders about any changes to operations or filing procedures. It’s crucial for patent applicants and attorneys to stay informed about such announcements to ensure compliance with modified deadlines and procedures.

How does the USPTO handle correspondence delivered by EXPRESS MAIL?

The USPTO has specific procedures for handling correspondence delivered by EXPRESS MAIL. According to MPEP 502:

“Any correspondence delivered by the ‘Express Mail Post Office to Addressee’ service of the United States Postal Service (USPS) is considered filed or received in the Office on the date of deposit with the USPS.”

This means that the date of deposit with the USPS is considered the filing date at the USPTO, provided that:

  • The correspondence is properly addressed to the USPTO
  • The proper address is on the EXPRESS MAIL mailing label
  • The EXPRESS MAIL mailing label number is placed on the correspondence

It’s important to note that this applies only to the USPS EXPRESS MAIL service and not to similar services provided by private courier companies.

For more information on Express Mail, visit: Express Mail.

For more information on USPTO correspondence, visit: USPTO correspondence.

The USPTO treats applications with omitted drawings similarly to those with missing specification pages. According to MPEP 506:

In the event that a page of the specification, or a portion thereof, or a page of the drawings, or a portion thereof, is inadvertently omitted from an application as filed, the application will be not be considered complete and the applicant will be notified to file the omitted portion.

If drawings are omitted, the applicant will be notified and given a time period to submit the missing drawings. However, adding new drawings after the filing date may affect the application’s effective filing date if they introduce new matter. It’s crucial to include all necessary drawings with the initial application to avoid potential issues.

For more information on new matter, visit: new matter.

Tags: new matter

When an application is filed with missing parts, the USPTO follows these procedures:

  1. If the application meets minimum requirements for a filing date, it will be assigned one.
  2. A Notice to File Missing Parts will be issued, detailing the missing items.
  3. Applicants must submit missing items along with any required surcharges within the specified time period.
  4. For applications filed on or after September 16, 2012, the inventor’s oath or declaration can be postponed until payment of the issue fee if a compliant application data sheet is filed.
  5. For applications filed on or after December 18, 2013, filing of claims can be postponed until the expiration of the time period set in the Notice to File Missing Parts.

The MPEP states: ‘The inventor’s oath or declaration, basic filing fee, and search fee and examination fee as set forth in 37 CFR 1.16, may be filed later than the remaining application papers, but if so, they must be accompanied by the required surcharge (if appropriate, see MPEP § 506).’ (MPEP 503)

How does the USPTO assign application numbers to continuation or divisional applications?

The USPTO assigns application numbers to continuation or divisional applications in the same manner as new applications. According to MPEP 503:

A continuation or divisional application (including a continued prosecution application) filed under 37 CFR 1.53(b) is assigned a new application number.

This means:

  • Each continuation or divisional application receives a unique number
  • The number is assigned in the same sequence as other new applications
  • The application number does not indicate its relationship to the parent application

It’s important to reference the parent application in the appropriate sections of the new application to establish the continuity.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO procedures, visit: USPTO procedures.

For papers that have been scanned into the Image File Wrapper (IFW) system, the USPTO has a specific procedure for ‘returning’ them. According to MPEP 508.02:

“If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW.”

This means that instead of physically returning the paper, the USPTO will electronically close or restrict access to the document within the IFW system. This process maintains the integrity of the digital file while effectively ‘returning’ the document.

To learn more:

The Certificate of Mailing or Transmission can significantly affect the timeliness of USPTO submissions. According to MPEP 512:

“The date indicated on the Certificate of Mailing or Transmission will be used by the Office as the date of receipt of the paper or fee.”

This means that even if there are delays in postal or electronic transmission, your submission will be considered timely if the certificate date is within the required deadline. However, it’s important to note that the actual mailing or transmission must occur on or before the certificate date. False certificates can lead to serious consequences, including invalidation of the submission and potential disciplinary action.

To learn more:

The Certificate of Mailing or Transmission can affect filing date calculations in several ways:

  1. For timely filing: If a paper with a certificate is received after a deadline but the certificate date is within the deadline, the paper is considered timely filed. The MPEP states: “If the date stated is within the period for reply, the reply in most instances will be considered to be timely.”
  2. For actual receipt date: The USPTO will continue to stamp the actual date of receipt on all papers. According to the MPEP: “The receipt date stamped on all papers will also be the date which is entered on Office records and from which any subsequent periods are calculated.”
  3. For subsequent deadlines: If a paper starts a new period for reply, that period is calculated from the actual receipt date, not the certificate date. For example: “If the last day to reply to a final Office action was November 10, 2014, and applicant deposited a Notice of Appeal with fee in the U.S. mail on November 10, 2014, and so certified, that appeal is timely even if it was not received in the U.S. Patent and Trademark Office until November 12, 2014. Since the date of receipt of the notice of appeal will be used to calculate the time at which the brief is due, the brief was due on January 12, 2015.”

It’s important to note that while the certificate can establish timely filing, it doesn’t change the actual receipt date for other USPTO processing purposes.

The application filing limit for micro entity status works as follows:

  • An applicant must not have been named as an inventor on more than 4 previously filed patent applications
  • This limit excludes provisional applications, foreign applications, and PCT applications where the basic national fee was not paid
  • Applications filed as a result of previous employment where rights were assigned don’t count towards the limit

MPEP 509.04(a) clarifies: ‘It does not matter how long ago the previous applications were filed or whether the previously filed applications are pending, patented, or abandoned; they are still included when counting to determine whether the application filing limit has been reached.’

Paying a small entity fee has significant implications for certifying small entity status. According to MPEP 509.03(a), “Consistent with 37 CFR 1.4(d)(4), the payment of a small entity basic filing or national fee constitutes a certification under 37 CFR 11.18(b).” This means that simply paying the small entity fee, even without a specific written assertion, activates the self-certification requirement. Applicants should be aware that this payment invokes the certification provisions, regardless of whether they are a practitioner or non-practitioner.

To learn more:

Tags: patent fees

When an application is filed with informal drawings, the Office of Patent Application Processing (OPAP) will review the drawings to determine if they can be used for publication purposes. If the drawings are not acceptable for publication purposes, OPAP will object to the drawings and require corrected drawings within a set time period, usually two months. This objection does not affect the filing date of the application, and applicants can correct the drawings later in the examination process if needed.

How does licensing affect small entity status?

Licensing can significantly impact small entity status. According to MPEP 509.03:

An applicant or patentee is not considered a small entity if any rights in the invention have been assigned, granted, conveyed, or licensed to an entity that would not qualify for small entity status.

This means:

  • If a small entity licenses rights to a large entity, small entity status is lost.
  • Exclusive licenses generally result in loss of small entity status.
  • Non-exclusive licenses may not affect status if they don’t convey all significant rights.

It’s crucial to review all licensing agreements before claiming small entity status. Any change in licensing that affects status must be reported to the USPTO promptly.

To learn more:

Licensing can significantly impact small entity status for patent fees. The MPEP provides specific guidance on this matter:

Rights conveyed by an applicant or patentee to a Government agency are not considered to be license for purposes of this paragraph. A Government agency includes any agency of the Federal Government or military department of the Government.

This means that licensing to a government agency does not affect small entity status. However, licensing to other entities can impact your status:

  • If you license rights to a large entity, you may lose your small entity status.
  • Exclusive licenses to large entities typically disqualify you from small entity status.
  • Non-exclusive licenses may not affect your status, depending on the terms.

It’s crucial to review any licensing agreements carefully and consult with a patent attorney to determine how they might affect your small entity status.

To learn more:

Tags: patent fees

How does licensing affect small entity status for a business concern?

Licensing can significantly impact a business concern’s eligibility for small entity status. According to MPEP 509.02:

“Rights to an invention are considered as assigned, granted, conveyed, or licensed when they are held by an entity other than the inventor, and they are not qualified for small entity status.”

This means that if a business concern has licensed rights to the invention to any person or entity that does not qualify as a small entity, it may lose its small entity status. Specifically:

  • If the business has licensed rights to a large entity, it cannot claim small entity status.
  • Exclusive licenses to large entities will disqualify the business from small entity status.
  • Non-exclusive licenses may not affect small entity status if they are arms-length agreements.

It’s crucial for businesses to carefully consider the impact of licensing agreements on their small entity status before entering into such arrangements.

To learn more:

How does licensing affect micro entity status eligibility?

Licensing can significantly impact an applicant’s eligibility for micro entity status. According to the MPEP:

“The applicant has not assigned, granted, or conveyed, nor is under an obligation by contract or law to assign, grant, or convey, a license or other ownership interest in the application concerned to an entity that, in the calendar year preceding the calendar year in which the applicable fee is being paid, had a gross income, as defined in section 61(a) of the Internal Revenue Code of 1986, exceeding 3 times the median household income for that preceding calendar year, as most recently reported by the Bureau of the Census.”

This means that if you’ve licensed or are obligated to license your application to a high-income entity (exceeding 3 times the median household income), you may not be eligible for micro entity status. It’s crucial to consider any existing or potential licensing agreements when determining your eligibility.

To learn more:

Tags: micro entity

How does government funding affect small entity status?

Government funding can impact small entity status, particularly for universities and small businesses. The MPEP 509.03 provides guidance:

A small business concern or nonprofit organization is not disqualified as a small entity because of a license to the Federal government pursuant to 35 U.S.C. 202(c)(4).

This means:

  • Receiving government funding does not automatically disqualify an entity from small entity status.
  • The government’s license rights under the Bayh-Dole Act do not negate small entity status.
  • However, other types of government agreements or contracts might affect status.

It’s important to carefully review the terms of any government funding or agreements to determine if they impact small entity eligibility. When in doubt, consult with a patent attorney or the USPTO for clarification.

To learn more:

How does employment at an institution of higher education affect micro entity status?

Employment at an institution of higher education can provide a pathway to micro entity status. The MPEP states:

“A micro entity shall also include an applicant who certifies that: (1) The applicant’s employer, from which the applicant obtains the majority of the applicant’s income, is an institution of higher education as defined in section 101(a) of the Higher Education Act of 1965 (20 U.S.C. 1001(a)); or (2) The applicant has assigned, granted, conveyed, or is under an obligation by contract or law, to assign, grant, or convey, a license or other ownership interest in the particular application to such an institution of higher education.” (MPEP 509.04(d))

This means that if you are employed by a qualifying institution of higher education and receive the majority of your income from it, or if you have assigned or are obligated to assign your rights in the application to such an institution, you may be eligible for micro entity status. This provision can be particularly beneficial for academic researchers and inventors.

To learn more:

How does employment affect micro entity status for inventors?

An inventor’s employment can significantly impact their eligibility for micro entity status. The MPEP provides specific guidelines:

“[A]n applicant is not considered to be named on more than four previously filed patent applications if the applicant has assigned, or is under an obligation to assign, all ownership rights in the applications as the result of the applicant’s previous employment.” (MPEP 509.04(a))

This means that if an inventor has previously filed patent applications as part of their job, and they have assigned or are obligated to assign the rights to their employer, these applications don’t count towards the four-application limit for micro entity status. However, it’s crucial to note that:

  • The inventor must not be currently named as an inventor on more than four non-provisional patent applications.
  • The inventor’s current employer must not be considered a non-micro entity.

Inventors should carefully evaluate their employment situation and patent history when determining their eligibility for micro entity status.

To learn more:

Tags: micro entity

How does claiming small entity status affect patent fees?

Claiming small entity status can significantly reduce patent fees. According to MPEP 509.03, “Claiming small entity status allows the payment of certain reduced patent fees pursuant to 35 U.S.C. 41(h)(1).” This means that small entities, such as independent inventors, small businesses, and nonprofit organizations, can pay reduced fees for many patent-related services, typically 50% of the standard fee. However, it’s important to ensure eligibility before claiming this status to avoid potential issues later in the patent process.

To learn more:

Assigning ownership rights can significantly affect micro entity status. The MPEP provides the following guidance:

  • An applicant is disqualified from micro entity status if they transfer, or are obligated to transfer, any ownership interest to an entity that exceeds the gross income limit.
  • If an inventor assigns all rights to an employer that exceeds the gross income limit, micro entity status cannot be claimed.
  • Even if rights are later transferred back to the inventor or to another person who doesn’t exceed the gross income limit, micro entity status cannot be regained.

The MPEP states: “Once an assignee or licensee exceeding the gross income limit receives the ownership interest, the 37 CFR 1.29(a)(4) certification requirement can no longer be met – even if the assignee or licensee retransfers rights and no longer holds any ownership interest in the application.

It’s important to note that this applies to both actual transfers and obligations to transfer ownership rights.

To learn more:

A security interest in a patent or patent application generally does not affect small entity status unless it is defaulted upon. According to 37 CFR 1.27(a)(5):

A security interest does not involve an obligation to transfer rights in the invention for the purposes of paragraphs (a)(1) through (a)(3) of this section unless the security interest is defaulted upon.

This means that an applicant or patentee can take out a loan secured by rights in a patent application or patent without losing small entity status, even if the lender is a large entity. However, if the loan is defaulted upon and the security interest is enforced, resulting in a transfer of rights to a non-small entity, the small entity status would be lost.

In such cases, the USPTO must be notified of the loss of entitlement to small entity status prior to or at the time of paying the earliest of the issue fee or any maintenance fee due after the date on which small entity status is no longer appropriate.

To learn more:

A general authorization allows the USPTO to charge certain fees to your deposit account without requiring specific authorization for each fee. The MPEP states:

A general authorization to charge all fees, or only certain fees, set forth in §§ 1.16 to 1.18 to a deposit account containing sufficient funds may be filed in an individual application, either for the entire pendency of the application or with respect to a particular paper filed.

Key points about general authorizations:

  • They can cover fees under 37 CFR 1.16 and 1.17
  • Fees under 37 CFR 1.19, 1.20, and 1.21 are generally not covered
  • Issue fees (37 CFR 1.18) require a separate authorization after the notice of allowance
  • The authorization should be clear and unambiguous to avoid misinterpretation

Always ensure your deposit account has sufficient funds to cover authorized fees to avoid potential application abandonment or additional expenses.

To learn more:

To use a Certificate of Mailing or Transmission, you must include a signed certification with your correspondence. The MPEP provides suggested formats for these certificates:

“The following are suggested formats for either a Certificate of Mailing or Certificate of Transmission under 37 CFR 1.8(a). The certification may be included with all correspondence concerning this application or proceeding to establish a date of mailing or transmission under 37 CFR 1.8(a).”

The certificate should include:

  • A statement certifying the date of mailing or transmission
  • The signature of the person making the certification
  • The application number (if known)

It’s important to note that the certificate must be signed by someone with a reasonable basis to expect the correspondence would be mailed or transmitted on or before the date indicated.

To learn more:

How do I set up a deposit account with the USPTO?

To set up a deposit account with the USPTO:

  1. Visit the USPTO Deposit Accounts page
  2. Download and complete the Deposit Account Application Form
  3. Submit the form with an initial deposit (minimum $1,000)
  4. Wait for account approval and receive your account number

According to MPEP 509: ‘A deposit account may be established by submitting a completed Deposit Account Application Form with an initial deposit of at least $1,000.’ This account can be used for future fee payments, offering convenience for frequent USPTO transactions.

To learn more:

To properly use a certificate of mailing for patent correspondence, follow these steps:

  1. Prepare your correspondence.
  2. Attach a certificate of mailing to each piece of correspondence.
  3. Include the required information on the certificate.
  4. Sign and date the certificate.
  5. Mail the correspondence with the attached certificate.

According to MPEP 512:

Each piece of correspondence for which a certificate is filed must include a signed and dated certificate which sets forth the date of deposit or transmission.

Ensure that you follow these guidelines to properly use the certificate of mailing procedure.

To learn more:

When filing patent correspondence, you should include the following identifying information:

  • Application number (checked for accuracy, including series code and serial number)
  • Art Unit number (copied from most recent Office communication)
  • Filing date
  • Name of the examiner who prepared the most recent Office action
  • Title of invention
  • Confirmation number

As stated in 37 CFR 1.5(a): ‘When correspondence directed to the Patent and Trademark Office concerns a previously filed application for a patent, it must identify on the top page in a conspicuous location, the application number (consisting of the series code and the serial number; e.g., 07/123,456), or the serial number and filing date assigned to that application by the Patent and Trademark Office, or the international application number of the international application, or the international registration number of an international design application.’

How do I correct an error in micro entity status if I underpaid fees?

If you erroneously paid fees as a micro entity when you were not entitled to that status, resulting in an underpayment, you need to take the following steps:

  • Submit a written assertion of small entity status (if eligible) or a written assertion to establish non-small entity status.
  • Pay the fee deficiency, which is the difference between the amount paid and the amount due.

As stated in MPEP 509.04(f): “A written assertion to establish non-small entity status must be accompanied by the difference between the current amount due and the amount previously paid.”

It’s important to correct the error promptly to avoid potential issues with your patent application or granted patent.

To learn more:

Tags: patent fees

How do I claim small entity status for a patent application?

To claim small entity status for a patent application, follow these steps:

  • Determine eligibility: Ensure you meet the criteria for small entity status as defined in 37 CFR 1.27(a).
  • Submit a written assertion: Provide a written assertion of entitlement to small entity status. This can be done by:
    • Checking the appropriate box on a patent application transmittal form
    • Submitting a separate paper specifically asserting small entity status
    • Paying small entity fees (which is considered a written assertion)
  • Timing: You can claim small entity status at any time during the pendency of the application or after the patent issues.

As stated in MPEP 509.03, “A small entity status assertion must be filed in each application or patent in which the small entity is desired to claim such status.”

To learn more:

Tags: USPTO fees

To certify micro entity status, you must file a certification form with the USPTO. The USPTO provides two forms:

  • Form PTO/SB/15A for certifying under the gross income basis
  • Form PTO/SB/15B for certifying under the institution of higher education basis

The certification must be signed by an authorized party as defined in 37 CFR 1.33(b). It should be filed prior to or at the time of paying the first fee as a micro entity.

Inventors or applicants can qualify for micro entity status through an institution of higher education in two ways:

  1. If the inventor is an employee of an institution of higher education and obtains the majority of their income from that institution.
  2. If the applicant has assigned, granted, conveyed, or is obligated to assign, grant, or convey a license or other ownership interest in the application to an institution of higher education.

MPEP 509.04(b) states: “Under 37 CFR 1.29(d)(2)(i) the applicant must certify that the applicant’s employer, from which the applicant obtains the majority of the applicant’s income, is an institution of higher education. … Under 37 CFR 1.29(d)(2)(ii) the applicant must certify that the applicant has assigned, granted, or conveyed a license or other ownership interest in the subject application (or is obligated to do so) to such an institution of higher education.”

In both cases, the applicant must also meet the small entity requirement.

To learn more:

How can I request a refund for my USPTO deposit account?

To request a refund for your USPTO deposit account, you need to follow these steps:

  • Submit a written request to the USPTO Office of Finance
  • Include your deposit account number and the amount to be refunded
  • Provide a detailed explanation for the refund request

The MPEP states: “A refund to a deposit account may be made on request to the Office of Finance.” (MPEP 509.01)

It’s important to note that refunds are typically processed for overpayments or erroneous charges. The USPTO will review your request and determine if a refund is warranted based on the circumstances provided in your explanation.

To learn more:

Tags: patent fees

How can I replenish my USPTO deposit account?

You can replenish your USPTO deposit account through various methods. According to MPEP 509.01, “Deposits to these accounts may be made by electronic funds transfer, credit card, or check.” Here are the options:

  • Electronic Funds Transfer (EFT): This is the preferred method for replenishing deposit accounts.
  • Credit Card: You can use a credit card to add funds to your account.
  • Check: Checks can be mailed to replenish the account balance.

For detailed instructions on each method, visit the USPTO’s Receipts Accounting Policies page.

To learn more:

To regain micro entity status after losing it, you must file a new certification of entitlement to micro entity status. As stated in MPEP 509.04(e):

Once a notification of a loss of entitlement to micro entity status is filed in the application or patent, a new certification of entitlement to micro entity status is required to again obtain micro entity status.

This means you must:

  • Ensure you meet the criteria for micro entity status as defined in 37 CFR 1.29(a) or 1.29(d)
  • File a new certification form (PTO/SB/15A or PTO/SB/15B) in the application or patent
  • Meet all other requirements for micro entity status

To learn more:

You can petition the USPTO Director to consider correspondence as filed on a particular date if it was returned or refused by the USPS due to a Priority Mail Express® interruption or emergency. The petition process is outlined in 37 CFR 1.10(g) and (h):

  1. File the petition promptly after becoming aware of the return or refusal
  2. Include the original correspondence or a copy showing the Priority Mail Express® mailing label number
  3. Provide a copy of the Priority Mail Express® mailing label showing the “date accepted” (for returned mail)
  4. Include a statement establishing the original deposit attempt and that the correspondence is the original or a true copy
  5. The USPTO may require additional evidence to verify the interruption or emergency

As stated in MPEP 511: “37 CFR 1.10(g) provides a procedure under which applicant may petition the Director to have correspondence that was returned by the USPS due to an interruption or emergency in Priority Mail Express® service considered as filed on a particular date in the Office.”

If your correspondence is affected by a postal emergency, you can petition the Director to consider it filed on a particular date under certain conditions. The process depends on whether your mail was returned, refused, or unable to be deposited. Here’s a summary of the petition requirements based on MPEP 511:

  1. For returned correspondence (37 CFR 1.10(g)):
    • File promptly after becoming aware of the return
    • Include the original or copy of correspondence with Priority Mail Express® label
    • Provide a statement establishing the original deposit
  2. For refused correspondence (37 CFR 1.10(h)):
    • File promptly after becoming aware of the refusal
    • Include the original or copy of correspondence with Priority Mail Express® label
    • Provide a statement establishing the original attempt to deposit
  3. For correspondence unable to be deposited (37 CFR 1.10(i)):
    • File promptly in a manner designated by the Director
    • Include the original or copy of correspondence
    • Provide a statement establishing that the correspondence would have been deposited but for the emergency

For more detailed information on filing these petitions, refer to MPEP § 513, subsections IX-XI.

To learn more:

How can I pay patent fees to the USPTO?

The USPTO offers several methods for paying patent fees. According to MPEP 509:

“Fees can be paid: (A) by credit card, (B) by electronic funds transfer (EFT), (C) by check, (D) by money order, (E) by deposit account, or (F) in cash (for hand-carried applications only).”

Here’s a breakdown of these payment methods:

  • Credit Card: Accepted online or by mail/fax using Form PTO-2038
  • Electronic Funds Transfer (EFT): Available through the USPTO’s Electronic Filing System (EFS-Web)
  • Check or Money Order: Made payable to the Director of the USPTO
  • Deposit Account: A pre-established account with the USPTO
  • Cash: Only for in-person payments at the USPTO office

For most applicants, online payment methods (credit card or EFT) are the most convenient and efficient options.

To learn more:

Tags: patent fees

How can I pay fees to the USPTO electronically?

The USPTO offers several electronic payment options for paying fees:

  • Credit or Debit Card: You can pay using major credit or debit cards through the USPTO’s secure online system.
  • Electronic Funds Transfer (EFT): This allows for direct transfer from your bank account to the USPTO.
  • USPTO Deposit Account: Maintain a pre-funded account with the USPTO for easy fee payments.

According to MPEP 509, “The Office accepts the following forms of payment: […] by credit card, by electronic funds transfer (EFT), or by a USPTO deposit account.” Electronic payments are convenient and often processed more quickly than other methods.

To learn more:

Tags: USPTO fees

There are two main ways to obtain a receipt for items filed with the USPTO:

  1. For paper filings: Include a self-addressed postcard with your submission, itemizing all components being filed. The USPTO will stamp the receipt date on the postcard and return it.
  2. For electronic filings via EFS-Web or Patent Center: An Electronic Acknowledgement Receipt is automatically generated and sent to the filer.

The MPEP states: ‘If a submitter desires a receipt for any item (e.g., paper or fee) filed in the USPTO by means other than the USPTO patent electronic filing system, it may be obtained by enclosing with the paper a self-addressed postcard specifically identifying the item.’ (MPEP 503)

To correct an error in micro entity status, you need to follow the procedure outlined in 37 CFR 1.29(k). This involves:

  • Submitting a separate deficiency payment for each application or patent
  • Providing an itemization of the total deficiency payment
  • Paying the deficiency owed

The MPEP states: 37 CFR 1.29(k) contains provisions for a micro entity that correspond to the provisions of 37 CFR 1.28(c) for a small entity. This means the process is similar to correcting small entity status errors.

To learn more:

How can I correct an error in micro entity status if I’m no longer eligible?

If you discover that you’re no longer eligible for micro entity status, you should promptly notify the USPTO and pay the deficiency in fees. The MPEP states:

“A notification of loss of entitlement to micro entity status must be filed in the application or patent prior to paying, or at the time of paying, any fee after the date on which status as a micro entity is no longer appropriate.” (MPEP 509.04(f))

To correct the error:

  • File a notification of loss of entitlement to micro entity status
  • Pay the deficiency between the micro entity fees paid and the fees that should have been paid
  • Include any required surcharge for the late payment of the fee deficiency

It’s crucial to address this promptly to avoid potential issues with your patent application or granted patent.

To learn more:

To find out if the USPTO is officially closed on any particular day, you can:

  • Call 1-800-PTO(786)-9199
  • Call (571) 272-1000

These phone numbers are provided in MPEP 510 for obtaining information about USPTO closures.

An applicant can request review of a refusal to accord a filing date by filing a petition. The MPEP states:

Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)). Petitioner should provide any arguments that he or she has that the items noted were not missing or that a filing date should be assigned in the absence of such items if they are believed to be unnecessary.

The petition should be marked to the attention of the Office of Petitions. If the applicant believes no defect exists, they may include a request for refund of the petition fee in the petition.

If a patent application is missing a required part, the applicant can correct the deficiency as follows:

  • The USPTO will send a Notice of Missing Parts identifying the deficiency
  • The applicant must submit the missing part within the time period specified in the notice (usually two months)
  • A surcharge fee may be required along with the submission of the missing part
  • For certain missing parts, like claims or drawings, a supplemental oath or declaration may be required for applications filed before September 16, 2012

The MPEP states: In such cases where the basic filing fee, the search fee, the examination fee, and the application size fee are paid, but additional fees are required, under 37 CFR 1.16, a notice is mailed by OPAP or the Technology Center (TC), requiring that the balance of the prescribed fee be paid.

It’s important to respond promptly to any Notice of Missing Parts to avoid abandonment of the application. If the applicant believes the part was not actually missing, they can file a petition for review of the Notice.

For more information on missing parts, visit: missing parts.

To authorize email communications with the USPTO, an applicant must provide a written authorization. According to MPEP 502.03:

‘The written authorization may be submitted via EFS-Web, mail, or fax. It cannot be submitted by email.’

The USPTO provides a sample authorization form:

‘Recognizing that Internet communications are not secure, I hereby authorize the USPTO to communicate with the undersigned and practitioners in accordance with 37 CFR 1.33 and 37 CFR 1.34 concerning any subject matter of this application by video conferencing, instant messaging, or electronic mail. I understand that a copy of these communications will be made of record in the application file.’

To facilitate processing, the USPTO recommends using Form PTO/SB/439, available at www.uspto.gov/patent/patents-forms. This form can be filed via EFS-Web using the document description ‘Internet Communications Authorized’.

To learn more:

An applicant can appeal a refusal to grant a filing date by submitting a petition. The MPEP states:

“Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)).”

When submitting a petition, the applicant should:

  • Provide arguments that the noted items were not missing
  • Explain why a filing date should be assigned even if certain items were absent (if they believe these items were unnecessary)
  • Include a request for a refund of the petition fee if they allege no defect exists

Petitions related to filing dates are decided by the Office of the Deputy Commissioner for Patent Examination Policy. The MPEP advises:

“Any petition under this section should be marked to the attention of the Office of Petitions.”

To learn more:

Priority Mail Express® submissions to the USPTO are treated differently in terms of dating. According to 37 CFR 1.6(a)(2):

Correspondence filed in accordance with § 1.10 will be stamped with the date of deposit as Priority Mail Express® with the United States Postal Service.

This means that new patent applications filed using Priority Mail Express® will be stamped with the date they were deposited with USPS, even if that date is a Saturday, Sunday, or federal holiday. The MPEP provides an example:

For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

Patent applications are initially processed by the USPTO through electronic scanning and loading into the Image File Wrapper (IFW) system. According to MPEP 508, “All applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. Once documents are loaded into the IFW system, examiners, technical support staff, and other Office personnel will perform further processing and examination using the IFW system.”

Patent applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. As stated in the MPEP, All applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. This digital system allows examiners, technical support staff, and other Office personnel to perform further processing and examination efficiently.

For physical items such as models, exhibits, and specimens, special handling procedures are in place. The MPEP directs readers to MPEP § 608.03 and 608.03(a) for more information on these items.

For more information on image file wrapper, visit: image file wrapper.

For more information on patent application filing, visit: patent application filing.

For more information on USPTO procedures, visit: USPTO procedures.

Nonprovisional patent applications are assigned for examination through the Patents Service for Time and Application Routing (PSTAR) program. According to MPEP 504, “The Patents Service for Time and Application Routing (PSTAR) program assigns each nonprovisional application to an examiner.” This system ensures that each application is routed to an appropriate examiner based on factors such as the application’s subject matter and the examiner’s expertise.

To learn more:

When the entire USPTO is officially closed for business for an entire day due to adverse weather or other causes:

  • The day is considered a “Federal holiday within the District of Columbia” under 35 U.S.C. 21
  • Any action or fee due on such a day may be taken or paid on the next succeeding business day the Office is open

MPEP 510 states: “When the entire USPTO is officially closed for business for an entire day, for reasons due to adverse weather or other causes, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21. Any action or fee due on such a day may be taken, or fee paid, on the next succeeding business day the Office is open.”

To learn more:

Errors in small entity status can be excused if they were made in good faith. According to 37 CFR 1.28(c): ‘If status as a small entity is established in good faith, and fees as a small entity are paid in good faith, in any application or patent, and it is later discovered that such status as a small entity was established in error, or that through error the Office was not notified of a loss of entitlement to small entity status as required by § 1.27(g)(2), the error will be excused upon: compliance with the separate submission and itemization requirements of paragraphs (c)(1) and (c)(2) of this section, and the deficiency payment requirement of paragraph (c)(2) of this section.’

To correct the error, you must:

  • Submit a separate deficiency payment for each application or patent
  • Provide an itemized list of the fees paid in error
  • Pay the deficiency owed (difference between the small entity fee paid and the current non-small entity fee)

To learn more:

The USPTO has specific rules for dating electronically filed submissions. According to 37 CFR 1.6(a)(4):

Correspondence may be submitted using the Office electronic filing system only in accordance with the Office electronic filing system requirements. Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

The MPEP further clarifies: Similarly, correspondence submitted via the USPTO electronic filing system (EFS-Web) will be accorded a receipt date on the date the correspondence is received at the correspondence address for the Office set forth in 37 CFR 1.1 (i.e., local time in Alexandria, VA), without regard to whether that date is a Saturday, Sunday, or Federal holiday within the District of Columbia.

Electronically filed patent applications receive special treatment for date-stamping at the USPTO. According to MPEP 505, Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

Key points about electronic filing date-stamping:

  • The receipt date is based on the time in Alexandria, VA (USPTO’s location)
  • Electronic submissions can receive a date stamp on any day, including weekends and holidays
  • The electronic filing system (EFS-Web) must be used in accordance with USPTO requirements

For more details on electronic filing, refer to MPEP § 502.05.

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on USPTO, visit: USPTO.

Application numbers for patent applications are assigned by the Office of Patent Application Processing (OPAP) as follows:

n

    n

  • Nonprovisional applications are assigned numbers beginning with the series code ’15’ or ’16’.
  • n

  • Design applications are assigned numbers beginning with the series code ’29’.
  • n

  • Plant applications are assigned numbers beginning with the series code ’16’.
  • n

  • Provisional applications are assigned numbers beginning with the series code ’62’.
  • n

  • Reexamination proceedings are assigned numbers beginning with the series code ’90’.
  • n

n

As stated in the MPEP 503, “The application number includes a two-digit series code and a six-digit serial number.” This system allows for efficient categorization and tracking of different types of patent applications.

For more information on application number, visit: application number.

For more information on patent application types, visit: patent application types.

For more information on series code, visit: series code.

For PCT applications entering the national stage in the United States, the application number assignment process is slightly different. The MPEP states:

‘For PCT applications entering the national stage under 35 U.S.C. 371, the USPTO assigns the national stage application a U.S. application number.’

This means that when an international PCT application transitions to the national stage in the U.S., it receives a new U.S. application number distinct from its international application number. This U.S. application number is used for all subsequent processing and correspondence related to the national stage application.

It’s important to note that this U.S. application number is different from the international application number (PCT/XX/YYYY/######) that was used during the international phase of the PCT application.

For more information on application number, visit: application number.

The USPTO assigns application numbers to patent applications immediately after mail has been opened. According to MPEP 503, application numbers consist of a series code and a serial number. The series codes are assigned based on the type of application and the time period in which it was filed. For example:

  • 01/ – 16/ for nonprovisional applications (utility, plant, and reissue), with different ranges for specific time periods
  • 29/ for design applications
  • 35/ for international design applications
  • 60/, 61/, and 62/ for provisional applications
  • 90/ for ex parte reexamination proceedings
  • 95/ for inter partes reexamination proceedings
  • 96/ for supplemental examination proceedings and resulting ex parte reexamination proceedings

The MPEP notes: “If an application is filed using the USPTO patent electronic filing system, EFS-Web provides an Acknowledgement Receipt that contains a time and date stamp, an application number and a confirmation number.”

It’s important to note that the application number on a filing receipt is the official number, which may differ from any preliminary number provided on a postcard receipt.

For more information on application number, visit: application number.

For more information on patent application types, visit: patent application types.

For more information on serial number, visit: serial number.

For more information on series code, visit: series code.

No, the United States Patent and Trademark Office (USPTO) does not provide advisory opinions on whether an individual or organization qualifies for small entity status. The MPEP 509.03(a) clearly states: “The U.S. Patent and Trademark Office does not give advisory opinions as to whether or not a specific individual or organization qualifies as a small entity.” This policy is based on Congressional intent that the USPTO rely exclusively on self-certification for small entity status. Applicants are responsible for determining their status and making the appropriate self-certification.

To learn more:

Tags: USPTO

The Certificate of Mailing procedure does not apply to papers mailed from a foreign country. However, the Certificate of Transmission procedure can be used for correspondence transmitted to the USPTO from a foreign country, with some conditions. The MPEP states:

The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.

This means that while you can’t use a Certificate of Mailing for papers sent by postal mail from outside the United States, you can use a Certificate of Transmission for faxes or EFS-Web submissions from foreign countries, as long as the specific type of correspondence is eligible for the certificate procedure.

Yes, submitting a deficiency payment for micro entity fee errors affects your micro entity status. According to 37 CFR 1.29(k)(4):

Any deficiency payment (based on a previous erroneous payment of a micro entity fee) submitted under this paragraph will be treated as a notification of a loss of entitlement to micro entity status under paragraph (i) of this section.

This means that by submitting a deficiency payment, you are effectively notifying the USPTO that you are no longer entitled to micro entity status. After making the deficiency payment, you will need to pay fees at the small entity or non-small entity rate, as applicable, unless you file a new certification of micro entity status.

To learn more:

No, paying a fee in a non-micro entity amount does not automatically change your entity status. According to MPEP 509.04(e):

Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.

To properly notify the USPTO of a change in entity status, you must file a separate notification in the application or patent. This notification must be filed prior to or at the time of paying any fee after the date on which micro entity status is no longer appropriate.

To learn more:

No, you do not need to provide copies of U.S. patent documents when responding to an unlocatable file notice. The MPEP clearly states:

Since the Office can obtain copies of U.S. patent documents (U.S. patent application publications and patents) from its internal databases, the Office is not requiring applicants or patentees to provide copies of U.S. patent application publications and patents that are among the applicant’s or patentee’s record of the correspondence between the Office and the applicant or patentee for the application, patent, or other proceeding.

However, you must provide copies of all other correspondence and documents, including any appendix or information disclosure statement submitted with the application, unless specifically exempted in the notice.

To learn more:

To learn more:

Yes, you must assert small entity status separately for each related application. Specifically:

  • Status must be established in each related, continuing, and reissue application
  • Small entity status in one application does not affect the status of any other application or patent
  • A new assertion is required for continuations, divisionals, continuations-in-part, and reissue applications

According to 37 CFR 1.27(c)(4): “Status as a small entity must be specifically established by an assertion in each related, continuing and reissue application in which status is appropriate and desired. Status as a small entity in one application or patent does not affect the status of any other application or patent, regardless of the relationship of the applications or patents. The refiling of an application under § 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under § 1.53(d)), or the filing of a reissue application, requires a new assertion as to continued entitlement to small entity status for the continuing or reissue application.”

To learn more:

Yes, video conferencing tools can be used for examiner interviews in patent applications, but there are specific requirements. According to MPEP 502.03:

‘USPTO video conferencing tools may be used to conduct examiner interviews in both published and unpublished applications under the Patent Internet Usage Policy.’

However, several conditions must be met:

  • Authorization by the practitioner is required prior to sending a meeting invite.
  • All video conferencing communications must be hosted by USPTO personnel.
  • Interviews must originate from USPTO links provided by the examiner.
  • Links from non-USPTO video conferencing tools are not acceptable.

The MPEP also states:

‘The practitioner’s participation in the interview is considered consent to the use of the video conferencing tool for the interview.’

It’s important to note that personal devices or non-USPTO tools cannot be used by USPTO employees for official communications.

To learn more:

Yes, the USPTO has the authority to extend deadlines during a postal service emergency. This is based on the provisions outlined in MPEP 511 and 35 U.S.C. 21(a).

Specifically, MPEP 511 states:

The Director may designate the interruption or emergency as a ‘postal service interruption or emergency’ under 35 U.S.C. 21(a) and provide for ‘tolling’ of the time for filing correspondence, fees, or other papers for a limited time.

This means that:

  • The USPTO Director can officially recognize the emergency
  • Time limits for filing various patent-related documents can be extended
  • The extension is typically for a specific, limited period
  • Applicants may need to provide evidence that their delay was due to the recognized emergency

It’s important to note that while the USPTO has this authority, each situation is evaluated individually, and extensions are not automatically granted.

To learn more:

Yes, for applications filed on or after September 16, 2012 (except reissue applications), the inventor’s oath or declaration can be postponed until the application is in condition for allowance, provided certain conditions are met:

  • An application data sheet (ADS) in compliance with 37 CFR 1.76 must be filed identifying each inventor by their legal name, mailing address, and residence (if different from mailing address)
  • The inventor’s oath or declaration must be filed no later than the date on which the issue fee is paid

The MPEP states: For applications filed on or after September 16, 2012 (except reissue applications), applicant may postpone filing the inventor’s oath or declaration until the application is in condition for allowance if an application data sheet (ADS) in compliance with 37 CFR 1.76 is filed identifying: (1) each inventor by their legal name; and (2) for each inventor, a mailing address where the inventor customarily receives mail, and residence, if the inventor lives at a location which is different from where the inventor customarily receives mail. See 37 CFR 1.53(f)(3).

This provision allows applicants more flexibility in completing the application requirements, but it’s important to ensure the oath or declaration is filed before paying the issue fee to avoid abandonment.

For more information on declaration, visit: declaration.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on patent application requirements, visit: patent application requirements.

Yes, for applications filed on or after September 16, 2012 (except reissue applications), the filing of an inventor’s oath or declaration can be postponed. The MPEP states:

For applications filed on or after September 16, 2012 (except reissue applications), applicant may postpone filing the inventor’s oath or declaration until the application is in condition for allowance if an application data sheet (ADS) in compliance with 37 CFR 1.76 is filed identifying: (1) each inventor by their legal name; and (2) for each inventor, a mailing address where the inventor customarily receives mail, and residence, if the inventor lives at a location which is different from where the inventor customarily receives mail.

However, the inventor’s oath or declaration must be filed no later than the date on which the issue fee is paid.

Can small entity status be changed during the patent process?

Yes, small entity status can be changed during the patent process. The MPEP 509.03 provides guidance on this: “Once status as a small entity has been established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.” This means that:

  • You can change from small entity to large entity at any time by simply paying the full fee.
  • If you lose small entity status, you must notify the USPTO before or with the next fee payment.
  • Changing from large entity to small entity requires a new certification of entitlement to small entity status.

It’s important to monitor your status throughout the patent process and update the USPTO promptly if changes occur to avoid potential issues.

To learn more:

Can small entity status be changed during the life of a patent?

Yes, small entity status can change during the life of a patent. The MPEP 509.03 provides guidance on this:

Once status as a small entity has been established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.

Key points to remember:

  • Status can change due to mergers, acquisitions, or licensing agreements.
  • The USPTO must be notified of any change before paying the issue fee or maintenance fees.
  • If status changes from small to large entity, future fees must be paid at the higher rate.
  • Conversely, if an entity becomes eligible for small entity status, they can claim it for future fee payments.

It’s important to regularly review your entity status and update the USPTO as necessary to ensure compliance and proper fee payment.

To learn more:

Can international applicants claim micro entity status based on gross income?

Yes, international applicants can claim micro entity status based on gross income, provided they meet the eligibility criteria. The MPEP 509.04(a) clarifies:

“For purposes of micro entity status, the gross income (instead of median household income) is used to determine entitlement to reduced patent fees.”

International applicants must:

  • Calculate their gross income in U.S. dollars
  • Meet the same income threshold as U.S. applicants
  • Certify their eligibility under oath

The USPTO uses the World Bank’s gross national income (GNI) per capita figures for the applicant’s country of residence to determine the income threshold. Applicants should refer to the most recent World Bank data when assessing their eligibility.

To learn more:

Tags: gross income

No, you should not use the “Hold for Pickup” service option when sending Priority Mail Express® to the USPTO. The reasons for this are:

  • The USPTO does not have resources for picking up mail
  • Mail sent using the “Hold for Pickup” service will not reach the Office

Always use the standard Priority Mail Express® Post Office to Addressee service when sending correspondence to the USPTO.

As stated in MPEP 511: “The Office does not have resources for picking up any mail. Therefore mail should NOT be sent using the ‘Hold for Pickup’ service option (whereby the mail is retained at the destination postal facility for retrieval by the addressee). Mail sent using the ‘Hold for pickup’ service will not reach the Office.”

Can I use my USPTO deposit account for international patent applications?

Yes, you can use your USPTO deposit account for certain fees associated with international patent applications. The MPEP states: “Deposit accounts can be used for payment of any patent process fee except for international phase fees paid to the International Bureau.” (MPEP 509.01)

This means you can use your deposit account for:

  • PCT fees payable to the USPTO as a Receiving Office
  • National stage entry fees for U.S. national applications
  • Other USPTO-related fees for international applications

However, it’s important to note that fees payable directly to the International Bureau of WIPO cannot be charged to your USPTO deposit account. For those fees, you’ll need to use alternative payment methods specified by WIPO.

To learn more:

Can I use hole-punched paper for my patent application?

No, you should not use hole-punched paper for your patent application. The USPTO has specific requirements regarding the paper used for patent applications, and hole-punched paper is explicitly prohibited.

As stated in MPEP 501: Holes should not be punched in the paper.

This requirement is in place to ensure that all documents can be properly scanned, stored, and processed by the USPTO without any loss of information or potential damage to the application papers. Using standard, unmarked paper without holes helps maintain the integrity of the document throughout the application process.

Yes, you can use email to respond to Office actions from the USPTO, but certain conditions must be met:

  • You must have a written authorization on file for Internet communication.
  • The response must be submitted through the USPTO’s secure email system or the Electronic Filing System (EFS-Web).
  • The email must include all necessary information and attachments as required for the response.

MPEP 502.03 states: “Replies to Office actions may NOT be submitted by email unless specifically authorized.” This means that without proper authorization, email responses to Office actions will not be accepted.

It’s important to note that while email can be used, the USPTO recommends using EFS-Web for most communications, including responses to Office actions, as it provides a more secure and efficient method of submission.

To learn more:

Yes, you can use a handwritten signature for electronically filed patent documents. The USPTO accepts a graphic representation of a handwritten signature when submitted via the USPTO patent electronic filing system.

According to 37 CFR 1.4(d)(3): “A graphic representation of a handwritten signature as provided for in 37 CFR 1.4(d)(1) will be accepted when submitted via the USPTO patent electronic filing system.”

This allows for the use of traditional handwritten signatures in electronic filings, providing flexibility for applicants and practitioners.

To learn more:

The use of a Certificate of Mailing or Transmission for international patent applications is limited and depends on the specific type of correspondence. According to the MPEP and 37 CFR 1.8(a)(2)(i)(D)-(F), the certificate procedure does not apply to:

  • The filing of an international application for patent
  • The filing of correspondence in an international application before the U.S. Receiving Office, the U.S. International Searching Authority, or the U.S. International Preliminary Examining Authority
  • The filing of a copy of the international application and the basic national fee necessary to enter the national stage

However, the Certificate of Transmission procedure can be used for some correspondence related to international applications if it’s being transmitted to the USPTO and is not otherwise prohibited. The MPEP states:

The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.

It’s crucial to carefully review the specific requirements and limitations for international application correspondence to ensure proper and timely filing.

Yes, you can use a Certificate of Transmission for documents filed electronically through the USPTO’s Electronic Filing System (EFS-Web). The MPEP provides a suggested format for a Certificate of EFS-Web Transmission:

I hereby certify that this correspondence is being transmitted via the U.S. Patent and Trademark Office electronic filing system (EFS-Web) to the USPTO on [Date].

However, it’s important to note that EFS-Web submissions have their own timestamp system. According to 37 CFR 1.6(a)(4):

Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

This date can be a Saturday, Sunday, or federal holiday within the District of Columbia. The certificate can provide an additional layer of documentation for your submission date, but the EFS-Web timestamp is generally considered authoritative for determining the receipt date of electronic submissions.

The use of a Certificate of Mailing or Transmission for correspondence from outside the United States depends on the method of transmission. The MPEP clarifies:

“The Certificate of Mailing procedure does not apply to papers mailed in a foreign country. The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.”

Therefore:

  • You cannot use a Certificate of Mailing for papers mailed from outside the U.S.
  • You can use a Certificate of Transmission for facsimile or EFS-Web transmissions from outside the U.S., as long as the correspondence is eligible for this procedure.

It’s important to verify that your specific type of correspondence is eligible for the Certificate of Transmission procedure before using it from outside the United States.

To learn more:

No, the Certificate of Mailing or Transmission cannot be used for all USPTO correspondence. The MPEP 512 specifies certain types of correspondence that are excluded from the certificate practice:

“The Certificate of Mailing or Transmission procedure does not apply to: (A) Relative to Patents and Patent Applications— (1) The filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date…”

The MPEP lists several other exclusions, including certain international application filings, trademark-related filings, and correspondence filed in interference or trial proceedings. It’s crucial to review the full list in MPEP 512 to ensure compliance with USPTO rules.

To learn more:

No, you cannot use a Certificate of Mailing or Transmission for filing a new patent application to establish the application’s filing date. The MPEP explicitly states:

No benefit will be given to a Certificate of Mailing or Certificate of Facsimile Transmission relative to the filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date.

This restriction is also specified in 37 CFR 1.8(a)(2)(i)(A), which excludes “[t]he filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date” from the Certificate of Mailing or Transmission procedure.

However, it’s worth noting that new patent applications can be filed electronically via the USPTO’s Electronic Filing System (EFS-Web), which provides its own timestamp for filing date purposes.

Can I use a certificate of mailing for all USPTO correspondence?

While the certificate of mailing or transmission is a useful tool, it cannot be used for all types of USPTO correspondence. The MPEP 502 provides specific exceptions:

“The certification procedure under 37 CFR 1.8 is not available for: (A) Applications for patent under 35 U.S.C. 111(a), including reissue applications; (B) International applications for patent; (C) International design applications; (D) Requests for reexamination under 35 U.S.C. 302…”

This list continues with several other exceptions. It’s crucial to note that:

  • New patent applications cannot use the certificate of mailing.
  • International applications are excluded from this procedure.
  • Certain time-sensitive documents require different filing methods.

For these excluded items, consider using Priority Mail Express® or electronic filing to ensure timely receipt by the USPTO. Always check the current regulations or consult with a patent professional to determine the appropriate filing method for your specific correspondence.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on patent applications, visit: patent applications.

For more information on USPTO correspondence, visit: USPTO correspondence.

While certificates of mailing are widely applicable, they cannot be used for all types of patent-related correspondence. MPEP 512 outlines specific exceptions:

The Certificate of Mailing or Transmission procedure does not apply to the filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date.

Additionally, you cannot use a certificate of mailing for:

  • Filing of an international application for patent
  • Filing correspondence in an international application before the U.S. Receiving Office
  • Filing a copy of the international application and the basic national fee to enter the national stage under 35 U.S.C. 371

Always check the current USPTO guidelines to ensure you’re using the correct filing method for your specific correspondence.

To learn more:

According to MPEP 508.02, submitting additional information after a patent application has been abandoned is generally not possible. The section states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This means that once an application is abandoned, the USPTO will typically return any new submissions related to that application. However, there are some exceptions:

  • Petitions to revive the abandoned application
  • Requests for continued examination (RCE) in certain circumstances
  • Appeals to the Patent Trial and Appeal Board, if filed within the appropriate timeframe

If you wish to submit additional information after abandonment, you should consult with a patent attorney to determine if any of these options are available in your specific case.

To learn more:

Can I retroactively claim micro entity status for previously paid fees?

No, you cannot retroactively claim micro entity status for fees that have already been paid. The MPEP clearly states:

“A fee may be paid in the micro entity amount only if it is submitted with, or subsequent to, the submission of a certification of entitlement to micro entity status.” (MPEP 509.04(f))

This means:

  • Micro entity status must be established before or at the time of paying fees at the micro entity rate
  • You cannot request a refund for the difference between standard fees and micro entity fees for payments made before establishing micro entity status
  • Future fees can be paid at the micro entity rate once status is properly established

To benefit from micro entity status, ensure you file the certification before paying any fees you wish to pay at the reduced rate.

To learn more:

Tags: patent fees

Can I pay patent fees in foreign currency?

No, the USPTO does not accept foreign currency for patent fee payments. According to MPEP 509: ‘All payments of money required for USPTO fees or services must be made in U.S. dollars and in the form of a cashier’s or certified check, Treasury note, national bank notes, or United States Postal Service money order.’

If you’re an international applicant, you’ll need to arrange for payment in U.S. dollars. Options include:

  • Using an international credit card that can process payments in USD
  • Establishing a U.S. bank account
  • Using a registered U.S. attorney who can make payments on your behalf

It’s advisable to plan ahead for currency conversion to ensure timely payment of USPTO fees.

To learn more:

To learn more:

Tags: USPTO fees

Yes, you can hand-carry certain documents to the USPTO, but there are specific guidelines and limitations. According to MPEP 501:

Patent-related papers may be hand-carried to the Office in Alexandria, VA. Correspondence cannot be hand-carried to the Regional Offices. If the correspondence is hand-carried to the Office, with limited exceptions (see MPEP § 502, subsection III) it must be delivered to:

United States Patent and Trademark Office
Customer Service Window
Randolph Building
401 Dulany Street
Alexandria, VA 22314

For trademark-related papers, there is a separate location:

Trademark-related papers may be filed at the “walk-up” window located in the Trademark Assistance Center, Madison East, Concourse Level, Room C55, 600 Dulany Street, Alexandria, VA 22314.

It’s important to note that while hand-carrying documents is possible, electronic filing is often faster and more efficient for most types of correspondence with the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO submission, visit: USPTO submission.

Yes, you can request a refund if you establish small entity status after paying full fees, but there are strict time limits:

  • You must file an assertion of small entity status and a refund request within 3 months of the date of the full fee payment
  • This 3-month period cannot be extended

According to 37 CFR 1.28(a): “A refund pursuant to § 1.26, based on establishment of small entity status, of a portion of fees timely paid in full prior to establishing status as a small entity may only be obtained if an assertion under § 1.27(c) and a request for a refund of the excess amount are filed within three months of the date of the timely payment of the full fee. The three-month time period is not extendable under § 1.136.”

To learn more:

To learn more:

The USPTO is not open for filing correspondence on Saturdays, Sundays, or federal holidays within the District of Columbia. However, there are exceptions:

  • Correspondence deposited as Priority Mail Express® with the USPS in accordance with 37 CFR 1.10 is considered filed on the date of deposit, even on weekends or holidays
  • Electronic filing systems may be available 24/7, but the official filing date will be the next business day

MPEP 510 cites 37 CFR 1.6(a)(1): “The Patent and Trademark Office is not open for the filing of correspondence on any day that is a Saturday, Sunday or Federal holiday within the District of Columbia.”

Can I correct micro entity status errors retroactively?

Yes, you can correct micro entity status errors retroactively, but there are specific rules and time limitations to consider. According to MPEP 509.04(f):

“Errors in micro entity status may be rectified by filing a notification of a change in status … and paying the required fee deficiency.”

However, the ability to make retroactive corrections is subject to time constraints:

  • For underpayments: You can correct the error at any time by paying the fee deficiency.
  • For overpayments: You must file a micro entity certification and request a refund within the time period set in 37 CFR 1.29(k), which is generally within three months of the fee payment.

It’s crucial to address any status errors promptly to maintain the validity of your patent application or granted patent and to ensure compliance with USPTO regulations.

To learn more:

Tags: patent fees

No, you cannot correct micro entity status errors for multiple applications or patents in a single submission. The MPEP, citing 37 CFR 1.29(k)(1), states:

Any paper submitted under this paragraph must be limited to the deficiency payment (all fees paid in error) required for a single application or patent. Where more than one application or patent is involved, separate submissions of deficiency payments are required for each application or patent (see § 1.4(b)).

This means you must submit separate deficiency payments and itemizations for each application or patent where micro entity fees were erroneously paid. This requirement ensures clear and accurate processing of fee corrections for each individual case.

To learn more:

Can I change my entity status during the patent application process?

Yes, you can change your entity status during the patent application process. The MPEP 509.03 states:

“Small entity status may be claimed in a pending application at any time before, or concurrently with, the payment of an issue fee.”

This means you can:

  • Change from standard to small entity status
  • Change from small entity to standard status
  • Claim micro entity status if you qualify

To change your status, you must file a new written assertion of the desired status. Keep in mind that if you change to a higher fee status (e.g., from small to standard), you may need to pay any fee deficiencies for previously paid fees at the lower rate.

To learn more:

Tags: USPTO fees

No, foreign universities do not qualify as ‘institutions of higher education’ for the purpose of establishing micro entity status. This is because the definition is limited to institutions located in U.S. states or territories.

According to MPEP 509.04(b): “As previously stated, foreign universities do not qualify as an ‘institution of higher education’ for purposes of establishing micro entity status.”

Even if a foreign university offers online programs in the U.S., it still doesn’t qualify because the institution itself must be physically located in a U.S. state or territory as defined in the Higher Education Act of 1965.

To learn more:

Tags: patent fees

Yes, foreign applicants can qualify for micro entity status if they meet all the requirements. The USPTO states in MPEP 509.04(a):

Small entities may claim reduced fees regardless of the country in which they are located. There is no restriction requiring that the person, small business concern, or nonprofit organization be located in the United States.

For applicants with income in foreign currency, 37 CFR 1.29(c) specifies: ‘If an applicant’s, inventor’s, joint inventor’s, or entity’s gross income in the preceding calendar year is not in United States dollars, the average currency exchange rate, as reported by the Internal Revenue Service, during that calendar year shall be used to determine whether the applicant’s, inventor’s, joint inventor’s, or entity’s gross income exceeds the threshold specified in paragraph (a)(3) or (4) of this section.’

No, for-profit universities do not qualify as ‘institutions of higher education’ for the purpose of establishing micro entity status. One of the requirements for an institution of higher education under the Higher Education Act of 1965 is that it must be non-profit.

MPEP 509.04(b) states: “One of the requirements for an ‘institution of higher education’ under section 101(a) of the Higher Education Act of 1965 is that the institution be non-profit. Therefore, for-profit universities and colleges do not qualify as an ‘institution of higher education’ for purposes of establishing micro entity status.”

This means that employees or those who have assigned rights to for-profit universities cannot claim micro entity status on this basis.

To learn more:

Tags: patent fees

Yes, filing unnecessary duplicate copies of patent correspondence can potentially cause processing delays at the USPTO. The MPEP 502.04 explicitly states:

When the Office does not require duplicate copies of a paper, the filing of multiple copies may cause a delay in processing by the Office.

This is one of the reasons why the USPTO discourages the submission of duplicate copies unless specifically required. To ensure efficient processing of your patent application or correspondence, it’s best to avoid submitting unnecessary duplicates.

To learn more:

Yes, drawing corrections can be made after the application has been allowed. However, such corrections must be approved by the examiner before the application can be processed for issue. If extensive corrections are required, the examiner may require that the corrections be filed with a Request for Continued Examination (RCE) under 37 CFR 1.114.

No, color drawings cannot be submitted by facsimile to the USPTO. This is explicitly stated in MPEP 502.01 and 37 CFR 1.6(d)(4):

Facsimile transmissions are not permitted and, if submitted, will not be accorded a date of receipt in the following situations: … (4) Color drawings submitted under §§ 1.81, 1.83 through 1.85, 1.152, 1.165, 1.173, 1.437, or 1.1026;

The prohibition on faxing color drawings is due to the limitations of facsimile technology in accurately reproducing colors. Submitting color drawings via fax could result in loss of quality or details that are crucial for the proper examination and understanding of the invention.

If you need to submit color drawings for your patent application, you should use other approved methods, such as mailing or electronic filing through the USPTO’s electronic filing system (EFS-Web or Patent Center). Always refer to the most current USPTO guidelines for submitting color drawings to ensure compliance with their requirements.

To learn more:

No, an officer of an assignee corporation is not authorized to sign a certification of micro entity status. According to MPEP 509.04(c):

“If any applicant is an assignee or other party under 37 CFR 1.46, and the assignee or other party is a corporation or organization rather than a person, a registered practitioner must sign the certification of micro entity status. An officer of the assignee corporation, for example, is not authorized to sign a certification of micro entity status.”

This means that for corporate assignees, only a registered patent practitioner can sign the micro entity certification.

To learn more:

No, an institution of higher education cannot itself claim micro entity status. The micro entity status based on an institution of higher education is intended for inventors who are employees of such institutions or who have assigned rights to them, not for the institutions themselves.

MPEP 509.04(b) clarifies: “Although the 37 CFR 1.29(d) basis for qualifying for micro entity status is referred to as the ‘institution of higher education’ basis, it is not the institution of higher education that can qualify for micro entity status, but rather inventors who are employees of an institution of higher education (see 37 CFR 1.29(d)(2)(i)) or inventors or applicants who have conveyed ownership rights to an institution of higher education (see 37 CFR 1.29(d)(2)(ii)).”

The institution itself cannot logically make the certifications required under the regulations, such as certifying that its employer is an institution of higher education or that it has assigned rights to itself.

To learn more:

Yes, an applicant can withdraw their authorization for email communication with the USPTO. According to MPEP 502.03:

‘A written authorization may be withdrawn by filing a signed paper clearly identifying the original authorization.’

The USPTO provides a sample form for withdrawing authorization:

‘The authorization given on______, to the USPTO to communicate with any practitioner of record or acting in a representative capacity in accordance with 37 CFR 1.33 and 37 CFR 1.34 concerning any subject matter of this application via video conferencing, instant messaging, or electronic mail is hereby withdrawn.’

To facilitate processing, the USPTO recommends using Form PTO/SB/439, available at www.uspto.gov/patent/patents-forms. This form can be filed via EFS-Web using the document description ‘Internet Communications Authorization Withdrawn’.

To learn more:

Can an applicant with a license agreement qualify for micro entity status?

Yes, an applicant with a license agreement can potentially qualify for micro entity status, but there are specific conditions that must be met. The MPEP provides guidance on this:

“An applicant is not considered to have been named on a previously filed application if the applicant has assigned, or is under an obligation to assign, all ownership rights in the application as the result of the applicant’s previous employment.” (MPEP 509.04(a))

However, it’s important to note that:

  • The license agreement must not transfer all substantial rights in the invention to a non-micro entity.
  • If the licensee is not a micro entity, the applicant may lose their micro entity status.
  • The applicant must still meet all other micro entity criteria, including income limitations and the four-application limit.

Applicants with license agreements should carefully review the terms of their agreements and consult with a patent attorney to determine if they still qualify for micro entity status.

To learn more:

Tags: micro entity

Yes, an applicant can submit missing parts of an application after the filing date, but this may affect the application’s effective filing date. The MPEP 506 states:

Such portion must be filed within the time period set by the Office in the notification by the Office of the omitted portion, or the application will be regarded as abandoned.

It’s important to note that submitting missing parts may result in a later effective filing date for the application, which could have implications for patent term and prior art considerations. Applicants should strive to submit complete applications initially to avoid potential complications.

For more information on effective filing date, visit: effective filing date.

For more information on missing parts, visit: missing parts.

Can an applicant claim micro entity status based on income from a foreign country?

Yes, an applicant can claim micro entity status based on income from a foreign country. The MPEP clarifies:

“For purposes of qualifying for micro entity status based on the gross income limit, the gross income in the foreign currency must be converted into United States dollars at the exchange rate in effect on the date the micro entity certification is filed.”

This means that if you’re an applicant from a foreign country, you can still qualify for micro entity status if your income, when converted to U.S. dollars, does not exceed the gross income limit. It’s important to use the correct exchange rate on the date of filing your micro entity certification to ensure accurate calculation.

To learn more:

Tags: micro entity

The qualification of a subsidiary for small entity status depends on several factors. According to the MPEP:

A business concern or organization is affiliates of another concern or organization if, directly or indirectly, either one controls or has the power to control the other, or a third party or parties controls or has the power to control both.

This means that:

  • If a subsidiary is controlled by a large entity, it generally cannot claim small entity status.
  • The control can be direct (e.g., majority ownership) or indirect (e.g., through contractual arrangements).
  • Even if the subsidiary meets the size standards on its own, affiliation with a large entity typically disqualifies it from small entity status.

However, there may be exceptions in complex corporate structures. It’s advisable to consult with a patent attorney to evaluate your specific situation and determine eligibility for small entity status.

To learn more:

Can a small business qualify for micro entity status?

Yes, a small business can potentially qualify for micro entity status, but there are specific requirements to meet. The MPEP outlines two main paths for small businesses:

  1. Income-based qualification: If the small business’s income does not exceed three times the median household income in the preceding calendar year, it may qualify.
  2. Institution of higher education qualification: If the small business has assigned, granted, conveyed, or is under obligation to assign, grant, or convey a license or other ownership interest in the application to an institution of higher education.

The MPEP states:

“An applicant that qualifies as a micro entity under either the gross income basis or the institution of higher education basis can file a certification of micro entity status on either basis (but not both).”

It’s important to note that all parties involved (applicants, inventors, and joint inventors) must meet the requirements. For more details, refer to MPEP 509.04.

To learn more:

To learn more:

No, patent applications that are entitled to a filing date will not be returned to the applicant, even if requested. This applies to applications filed by regular mail, Priority Mail Express, hand-delivery, or through the USPTO patent electronic filing system.

The MPEP clearly states: ‘Applications which are entitled to a filing date, whether filed by regular mail, by Priority Mail Express® under 37 CFR 1.10, by hand-delivery, by the USPTO patent electronic filing system, or otherwise, will not be returned to applicant even if requested.’ (MPEP 503)

Applicants should be careful not to file duplicate applications or applications not intended for filing, as fees paid for such applications are generally not refundable due to a change of purpose.

Once a patent application is filed and given a filing date, it generally cannot be returned or withdrawn. According to MPEP 503:

“Applications which are entitled to a filing date, whether filed by regular mail, by Priority Mail Express® under 37 CFR 1.10, by hand-delivery, by the USPTO patent electronic filing system, or otherwise, will not be returned to applicant even if requested.”

This policy is in place to maintain the integrity of the filing process and prevent potential abuse. Applicants should be careful not to file applications that are not intended to be filed, such as duplicates of already filed applications.

Furthermore, the MPEP cites 37 CFR 1.26(a), which states that a change of purpose after payment of a fee, such as when a party desires to withdraw a patent application for which a fee was paid, does not entitle the party to a refund of such fee.

If an applicant realizes they have filed an application in error or no longer wish to pursue it, they may choose to abandon the application. However, the application will remain on file with the USPTO and any fees paid will not be refunded.

For more information on application abandonment, visit: application abandonment.

For more information on application return, visit: application return.

Yes, nonprofit organizations can qualify for small entity status under certain conditions. According to 37 CFR 1.27(a)(3), a nonprofit organization that qualifies for small entity status is one that:

  • Has not assigned, granted, conveyed, or licensed any rights in the invention to a non-small entity
  • Is either:
    • A university or other institution of higher education
    • An organization described in section 501(c)(3) of the Internal Revenue Code and exempt from taxation under 501(a)
    • A nonprofit scientific or educational organization qualified under a nonprofit organization statute of a state
    • A foreign organization that would qualify under the above if it were located in the U.S.

It’s important to note that government organizations, whether domestic or foreign, cannot qualify as nonprofit organizations for small entity status purposes.

To learn more:

Yes, a legal entity can sign patent correspondence, but there are specific requirements. According to MPEP 502.02:

When a document is to be signed by a corporation or another juristic entity, the signature must comply with 37 CFR 1.33(b)(3).

The requirements for a legal entity’s signature include:

  • The name of the person signing
  • Their capacity (e.g., President, CEO, General Counsel)
  • The name of the legal entity

For example, a valid signature for a corporation might look like:

/John Smith, President, XYZ Corporation/

It’s important to note that the person signing must have the authority to bind the legal entity in matters before the USPTO. This ensures that the correspondence is legally binding and properly authorized.

To learn more:

Can a legal assistant or secretary sign correspondence on behalf of a patent practitioner?

No, a legal assistant or secretary cannot sign correspondence on behalf of a patent practitioner. The MPEP 502.02 clearly states:

‘The signature of a practitioner on correspondence filed with the USPTO must be a handwritten signature or an S-signature personally signed by such practitioner.’

This requirement ensures that the practitioner takes personal responsibility for the content of the correspondence. Delegating this responsibility to support staff is not permitted and could lead to the correspondence being considered unsigned or improperly signed.

To learn more:

USPTO employees are generally not permitted to initiate email communications with patent applicants unless there is a written authorization on record. According to MPEP 502.03:

‘USPTO employees are NOT permitted to initiate communications with applicants via Internet email unless there is a written authorization of record in the patent application by the applicant.’

However, if an applicant has provided written authorization for Internet communications:

‘USPTO employees may respond to Internet email and initiate communications with applicants via Internet email.’

It’s important to note that this policy applies to regular patent applications. For reissue applications and reexamination proceedings, which are open to public inspection, additional restrictions apply:

‘USPTO employees are NOT permitted to initiate communications with applicant in a reissue application or a patentee of a reexamination proceeding via Internet email unless written authorization is given by the applicant or patentee.’

To learn more:

Are there any restrictions on paying USPTO fees by credit card?

Yes, there are some restrictions when paying USPTO fees by credit card:

  • There’s a daily limit on credit card transactions.
  • Some types of fees may not be eligible for credit card payment.
  • Only certain credit cards are accepted.

The MPEP 509 states, “The Office will not accept a general authorization to charge all fees, or all fees in a specific case, to a credit card.” Additionally, “Credit Card Payment Form PTO-2038 should be used when paying a patent or trademark fee (or related service fee) by credit card, unless the payment is being made via EFS-Web.” It’s important to check the current USPTO guidelines for any updates to credit card payment policies.

To learn more:

Tags: USPTO fees

Are there any fee reductions or waivers available for USPTO patent fees?

Yes, the USPTO offers fee reductions for certain applicants. According to MPEP 509, “Certain fees may be reduced if the applicant qualifies as a small entity or micro entity.” Here’s a brief overview:

  • Small Entity: Individuals, small businesses, and nonprofit organizations may qualify for a 50% fee reduction.
  • Micro Entity: Certain applicants may qualify for a 75% fee reduction if they meet specific income and filing requirements.

To determine if you qualify and for detailed information on how to claim these statuses, refer to MPEP 509.02 for Small Entity Status and MPEP 509.04 for Micro Entity Status. Always ensure you meet all requirements before claiming a reduced fee status.

To learn more:

No, provisional patent applications are not examined. The MPEP 504 clearly states: “Provisional applications will not be examined.” Provisional applications serve as a placeholder to establish a priority date and are not subject to substantive examination by the USPTO.

To learn more:

No, provisional patent applications are not assigned to examiners for examination. MPEP 504 explicitly states: “Provisional applications will not be examined.” This is because provisional applications are primarily used to establish a priority date and are not subject to substantive examination.

Photographs can be included in patent applications, but there are specific requirements and limitations. According to MPEP 507:

“OPAP may object to and require corrected drawings within a set time period, if the drawings: (F) include photographs of the claimed invention which are capable of illustration by other medium such as ink drawings, and which are illegible after scanning. See 37 CFR 1.84(b)

This means that while photographs are acceptable, they should only be used when the subject matter cannot be accurately depicted in a drawing. Additionally, the photographs must be of sufficient quality to be legible after scanning. If a photograph can be replaced by a clear ink drawing, the USPTO may require such a replacement.

For more information on drawing requirements, visit: drawing requirements.

For more information on patent drawings, visit: patent drawings.

Are handwritten patent applications accepted by the USPTO?

While it is strongly recommended to submit typed or printed applications, the USPTO does accept handwritten patent applications under certain conditions:

  • The handwriting must be legible and in permanent dark ink or its equivalent.
  • The text must be clearly readable and suitable for reproduction.
  • All other formatting requirements (margins, spacing, etc.) must still be followed.

As stated in MPEP 501: All papers that are to become a part of the permanent records of the United States Patent and Trademark Office should be legibly written either by a typewriter or mechanical printer in permanent dark ink or its equivalent in portrait orientation on flexible, strong, smooth, non-shiny, durable, and white paper.

While handwritten applications are technically accepted, it’s important to note that typed or printed applications are preferred for clarity and ease of processing. Handwritten applications may face additional scrutiny and potential delays in processing due to legibility concerns.

Color drawings or photographs are generally not allowed in patent applications without special permission. MPEP 507 states:

OPAP may object to and require corrected drawings within a set time period, if the drawings: … (G) contain color drawings or color photographs, but not a petition to accept color drawings/photographs.

If an applicant wishes to include color drawings or photographs, they must file a petition to accept them. It’s important to note that the requirement for a black and white photocopy of color drawings/photographs has been eliminated. Applicants should be prepared to justify the need for color in their drawings or photographs when filing such a petition.

MPEP 501 - Filing Papers With the U.S. Patent and Trademark Office (24)

The USPTO requires that different matters be submitted in separate papers to ensure efficient processing. This requirement is outlined in MPEP 501, which cites 37 CFR 1.4(c):

Since different matters may be considered by different branches or sections of the Office, each distinct subject, inquiry or order must be contained in a separate paper to avoid confusion and delay in answering papers dealing with different subjects.

This means that if you have multiple requests or inquiries for the USPTO, each should be submitted on its own separate document. For example, a petition and an information disclosure statement should not be combined into a single paper.

If an applicant submits a single paper containing distinct subjects, the USPTO may use the following form paragraph to notify them:

The [1] submitted [2] should have been submitted as a separate paper as required by 37 CFR 1.4(c). The paper has been entered. However, all future correspondence must comply with 37 CFR 1.4.

Adhering to this requirement helps ensure that your correspondence is processed efficiently and reaches the appropriate department within the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO correspondence, visit: USPTO correspondence.

The mailing address for trademark-related correspondence is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

This address should be used for all trademark-related documents filed on paper, except for certain specific documents as outlined in the regulations.

According to 37 CFR 2.190: In general, trademark documents to be delivered by the USPS must be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.

It’s important to note that many trademark documents can and should be filed electronically through the Trademark Electronic Application System (TEAS).

To learn more:

The mailing address for trademark applications and trademark-related papers filed on paper is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

This address should be used for all trademark-related documents filed on paper, except for:

  • Documents sent to the Assignment Recordation Branch for recordation
  • Requests for copies of trademark documents
  • Certain documents filed under the Madrid Protocol as specified in 37 CFR 2.190(e)

According to 37 CFR 2.190(a): “In general, trademark documents to be delivered by the USPS must be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.”

The general mailing address for patent-related correspondence is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address should be used for patent applications, replies to notices of informality, requests for extension of time, notices of appeal, and other patent-related matters processed by organizations reporting to the Commissioner for Patents.

As stated in the MPEP: Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents P.O. Box 1450 Alexandria, Virginia 22313-1450

To learn more:

The general mailing address for patent-related correspondence is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address is used for various patent-related documents, including:

  • Patent applications
  • Replies to notices of informality
  • Requests for extension of time
  • Notices of appeal to the Patent Trial and Appeal Board
  • Requests for reexamination
  • Petitions to the Commissioner for Patents

As stated in MPEP 501: “Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.”

For more information on patent application filing, visit: patent application filing.

For more information on patent correspondence, visit: patent correspondence.

The general mailing address for patent applications and patent-related papers is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address should be used for correspondence including patent applications, replies to notices of informality, requests for extension of time, notices of appeal, briefs, requests for oral hearings, applications for patent term extensions, reexamination requests, statutory disclaimers, certificates of correction, petitions, and other patent-related correspondence processed by organizations reporting to the Commissioner for Patents.

As stated in MPEP 501: “Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450”

What is the Certificate of Mailing procedure for USPTO filings?

The Certificate of Mailing procedure is a method that allows applicants to establish the date of filing for correspondence sent to the USPTO. As explained in MPEP 501:

‘Under the procedure, correspondence is considered as being timely filed if (A) the correspondence is mailed or transmitted prior to expiration of the set period for response by being: (1) Addressed as set out in 37 CFR 1.1(a) and deposited with the U.S. Postal Service with sufficient postage as first class mail; or (2) Transmitted by facsimile to the Patent and Trademark Office in accordance with 37 CFR 1.6(d); or (3) Transmitted via the Office electronic filing system in accordance with 37 CFR 1.6(a)(4); and (B) the correspondence includes a certificate for each piece of correspondence stating the date of deposit or transmission.’

This procedure is particularly useful for ensuring timely filing when using postal services. It’s important to note that the certificate must be signed by the person depositing or transmitting the correspondence.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on electronic filing, visit: electronic filing.

An S-signature is a type of electronic signature used in USPTO correspondence. According to MPEP 501, which cites 37 CFR 1.4(d)(2):

An S-signature is a signature inserted between forward slash marks, but not a handwritten signature as defined by paragraph (d)(1) of this section. An S-signature includes any signature made by electronic or mechanical means, and any other mode of making or applying a signature other than a handwritten signature.

Key requirements for an S-signature include:

  • It must consist only of letters, Arabic numerals, or both, with appropriate punctuation.
  • The signer must insert their own S-signature with a single forward slash mark before and after the signature.
  • For patent practitioners, their registration number must be included with or near the S-signature.
  • The signer’s name must be presented in printed or typed form near the S-signature.

Example of a proper S-signature: /John D. Smith/

S-signatures can be used for most USPTO correspondence filed electronically or by facsimile.

For more information on USPTO correspondence, visit: USPTO correspondence.

The USPTO accepts different types of signatures on correspondence, including:

  1. Handwritten signatures: Original signatures in permanent dark ink or equivalent.
  2. S-signatures: A signature inserted between forward slash marks, which can be used for correspondence filed in paper, by fax, or via the electronic filing system.
  3. Electronic signatures: For correspondence submitted via the electronic filing system, a graphic representation of a handwritten signature or an S-signature is acceptable.

According to 37 CFR 1.4(d): Each piece of correspondence, except as provided in paragraphs (d)(2), (d)(3), (d)(4), (e) and (f) of this section, filed in an application, patent file, or other proceeding in the Office which requires a person’s signature, must: (i) Be an original, that is, have an original handwritten signature personally signed, in permanent dark ink or its equivalent, by that person; or (ii) Be a direct or indirect copy, such as a photocopy or facsimile transmission (§ 1.6(d)), of an original.

For S-signatures, the signer must personally insert their own signature, and patent practitioners must include their registration number. The signer’s name must be presented in printed or typed form immediately below or adjacent to the S-signature.

To learn more:

The USPTO requires that different matters be submitted in separate papers to avoid confusion and delays. This requirement is outlined in 37 CFR 1.4(c), which states:

Since different matters may be considered by different branches or sections of the Office, each distinct subject, inquiry or order must be contained in a separate paper to avoid confusion and delay in answering papers dealing with different subjects.

Key points to remember:

  • Each distinct subject, inquiry, or order should be in a separate paper.
  • This applies to both patent and trademark correspondence.
  • Exceptions are allowed for subjects provided for on a single Office or World Intellectual Property Organization form.

If you submit multiple subjects in a single paper, the USPTO may use Form Paragraph 5.01.01 to notify you of the requirement for separate papers in future correspondence.

Adhering to this requirement helps ensure that your correspondence is processed efficiently by the appropriate Office branches or sections.

To learn more:

What are the requirements for filing papers with the USPTO?

When filing papers with the United States Patent and Trademark Office (USPTO), it’s important to adhere to specific requirements:

  • Papers must be legibly written either by hand or printed in permanent dark ink or its equivalent.
  • They should be presented on flexible, strong, smooth, non-shiny, durable, and white paper.
  • All papers must be presented in a form having sufficient clarity and contrast between the paper and the writing to permit electronic reproduction by use of digital imaging and optical character recognition.

As stated in MPEP 501: All papers that are to become a part of the permanent records of the United States Patent and Trademark Office should be legibly written either by a typewriter or mechanical printer in permanent dark ink or its equivalent in portrait orientation on flexible, strong, smooth, non-shiny, durable, and white paper.

These requirements ensure that all documents can be properly processed and stored by the USPTO.

For more information on document legibility, visit: document legibility.

What are the margin requirements for patent application documents?

When preparing documents for a patent application, it’s crucial to adhere to specific margin requirements set by the USPTO:

  • The top margin of the first page should be at least 2 cm (3/4 inch).
  • All other margins (left, right, and bottom) must be at least 2 cm (3/4 inch).
  • The margins can be slightly larger but should not exceed 4 cm (1-1/2 inches).

According to MPEP 501: All of the application papers must have margins which are at least 2 cm. (3/4 inch) … on the sides, top and bottom. Margins should not exceed 4 cm. (1-1/2 inches). … The top margin of the first page should be at least 2 cm. (3/4 inch).

These margin requirements ensure that all information is visible and can be properly scanned and processed by the USPTO.

What are the line spacing requirements for patent application text?

When preparing the text for your patent application, it’s important to follow the USPTO’s line spacing requirements:

  • The text should be written in a nonscript type font (e.g., Arial, Times Roman, or Courier).
  • The lettering style should be at least 0.32 cm (1/8 inch) high.
  • The lines of text should be 1.5 or double spaced.

According to MPEP 501: The text must be written in a nonscript type font (e.g., Arial, Times Roman, or Courier, preferably a font size of 12) lettering style having capital letters which should be at least 0.32 cm. (1/8 inch) high, but may be no smaller than 0.21 cm. (3/32 inch) high (e.g., a font size of 6). The lines of the specification may be 1 1/2 or double spaced.

These requirements ensure that the text is easily readable and can be properly scanned and processed by the USPTO’s systems.

The USPTO has specific certification requirements for signatures in correspondence. According to MPEP 501, which cites 37 CFR 1.4(d)(4):

The person inserting a signature under paragraph (d)(2) or (d)(3) of this section in a document submitted to the Office certifies that the inserted signature appearing in the document is his or her own signature. A person submitting a document signed by another under paragraph (d)(2) or (d)(3) of this section is obligated to have a reasonable basis to believe that the person whose signature is present on the document was actually inserted by that person, and should retain evidence of authenticity of the signature.

Key points about signature certifications:

  • The person inserting an S-signature certifies it as their own.
  • When submitting a document signed by another, you must have a reasonable belief that the signature is authentic.
  • Evidence of signature authenticity should be retained.
  • Violations of certification rules may result in sanctions.

These requirements apply to both handwritten and S-signatures. They ensure the integrity and authenticity of documents submitted to the USPTO.

For more information on USPTO correspondence, visit: USPTO correspondence.

What are the acceptable methods for filing papers with the USPTO?

The USPTO accepts several methods for filing papers:

  • Hand-delivery to the USPTO office in Alexandria, Virginia
  • First-class mail through the United States Postal Service (USPS)
  • Express Mail service of the USPS
  • Electronic filing through the USPTO’s Electronic Filing System (EFS-Web)

As stated in MPEP 501: ‘Papers may be filed using first class mail through the United States Postal Service.’ The MPEP also notes that ‘Correspondence may be hand-carried to the Office.’ For electronic filing, it’s important to note that ‘EFS-Web can be used to file new applications, enter the national stage under 35 U.S.C. 371, and submit most follow-on documents in patent applications.’

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on Express Mail, visit: Express Mail.

For more information on first-class mail, visit: first-class mail.

For more information on hand-delivery, visit: hand-delivery.

Patent maintenance fee payments can be submitted in two ways:

  1. Electronically: This is the preferred method. Payments can be made through the USPTO’s Patent Maintenance Fees Storefront.
  2. By mail: If not submitted electronically, maintenance fee payments and related correspondence should be addressed to:

Mail Stop Maintenance Fee
Director of the United States Patent and Trademark Office
P.O. Box 1450
Alexandria, VA 22313-1450

The MPEP states: Maintenance fee payments not electronically submitted over the Internet and correspondence related to maintenance fees may be addressed to: Mail Stop Maintenance Fee, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450

It’s important to note that electronic submission is faster, more secure, and provides immediate confirmation of payment.

To learn more:

Maintenance fee payments have a specific mailing address if not submitted electronically. According to MPEP 501, which cites 37 CFR 1.1(d):

Maintenance fee payments that are not submitted electronically and correspondence related to maintenance fees may be addressed to: Mail Stop Maintenance Fee, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450.

However, it’s important to note that the USPTO strongly encourages electronic submission of maintenance fee payments. The Electronic Maintenance Fee Form is the preferred method for these transactions.

If you must submit a paper payment, ensure it’s properly addressed to avoid delays in processing. Include all necessary information, such as the patent number and the fee amount being paid.

For more information on USPTO correspondence, visit: USPTO correspondence.

For correspondence that requires immediate attention from the USPTO, such as certain petitions or time-sensitive documents, the following methods are recommended:

  1. Use the USPTO patent electronic filing system (EFS-Web or Patent Center). This is the preferred method for most immediate correspondence.
  2. Where permitted, use facsimile transmission to the appropriate area of the Office.
  3. Hand-carry the documents to the USPTO in Alexandria, VA.

The MPEP states: Applicants are encouraged to transmit these types of correspondence by the USPTO patent electronic filing system (see MPEP § 502.05). Where permitted, patent-related correspondence that requires immediate Office attention may also be submitted to the appropriate area of the Office for processing by facsimile transmission (see MPEP § 502.01, subsections I.B and II) or hand-carried (see MPEP § 502), subsection III).

Examples of correspondence requiring immediate attention include:

  • Petitions for express abandonment to avoid publication
  • Petitions to withdraw an application from issue
  • Requests for expedited examination of a design application
  • Certain papers required by the Office of Data Management

To learn more:

For trademark-related documents filed on paper, except for certain specific cases, the address is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

According to MPEP 501, which cites 37 CFR 2.190: “All trademark-related documents filed on paper, except documents sent to the Assignment Recordation Branch for recordation; requests for copies of trademark documents; and certain documents filed under the Madrid Protocol as specified in 37 CFR 2.190(e), should be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.”

It’s important to note that many trademark documents can and should be filed electronically through the Trademark Electronic Application System (TEAS).

For more information on trademark correspondence, visit: trademark correspondence.

For correspondence that is not specific to patents or trademarks, such as requests for certified copies or assignment recordation, the general mailing address is:

Director of the United States Patent and Trademark Office
P.O. Box 1450
Alexandria, VA 22313-1450

This address should be used for:

  • Patent and trademark documents sent to the Assignment Division for recordation (Mail Stop Assignment Recordation Services)
  • Requests for certified or uncertified copies of patent and trademark documents (Mail Stop Patent and Trademark Copy Fulfillment Branch)
  • Correspondence for which an address is not otherwise specified in 37 CFR 1.1 or 2.190

MPEP 501 states: “For correspondence for which an address is not otherwise specified in 37 CFR 1.1 or 2.190, should be addressed to: Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450”

How does the USPTO handle correspondence submitted in violation of the rules?

The USPTO has specific procedures for handling correspondence submitted in violation of the rules. According to MPEP 501:

‘Correspondence submitted to the U.S. Patent and Trademark Office in violation of the rules as to paying fees, manner of presenting papers, or other formal matters will not be filed.’

However, the USPTO does provide a grace period and notification process:

  • The Office may notify the submitter of the violation and set a period for correction.
  • If the violation is corrected within the set period, the document will be considered as having been filed on the date of receipt of the correction.

It’s crucial for applicants to adhere to USPTO rules to avoid potential delays or non-filing of their correspondence. If a violation occurs, prompt correction based on USPTO notification is essential to maintain the original filing date.

Can I use hole-punched paper for my patent application?

No, you should not use hole-punched paper for your patent application. The USPTO has specific requirements regarding the paper used for patent applications, and hole-punched paper is explicitly prohibited.

As stated in MPEP 501: Holes should not be punched in the paper.

This requirement is in place to ensure that all documents can be properly scanned, stored, and processed by the USPTO without any loss of information or potential damage to the application papers. Using standard, unmarked paper without holes helps maintain the integrity of the document throughout the application process.

Yes, you can hand-carry certain documents to the USPTO, but there are specific guidelines and limitations. According to MPEP 501:

Patent-related papers may be hand-carried to the Office in Alexandria, VA. Correspondence cannot be hand-carried to the Regional Offices. If the correspondence is hand-carried to the Office, with limited exceptions (see MPEP § 502, subsection III) it must be delivered to:

United States Patent and Trademark Office
Customer Service Window
Randolph Building
401 Dulany Street
Alexandria, VA 22314

For trademark-related papers, there is a separate location:

Trademark-related papers may be filed at the “walk-up” window located in the Trademark Assistance Center, Madison East, Concourse Level, Room C55, 600 Dulany Street, Alexandria, VA 22314.

It’s important to note that while hand-carrying documents is possible, electronic filing is often faster and more efficient for most types of correspondence with the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO submission, visit: USPTO submission.

Are handwritten patent applications accepted by the USPTO?

While it is strongly recommended to submit typed or printed applications, the USPTO does accept handwritten patent applications under certain conditions:

  • The handwriting must be legible and in permanent dark ink or its equivalent.
  • The text must be clearly readable and suitable for reproduction.
  • All other formatting requirements (margins, spacing, etc.) must still be followed.

As stated in MPEP 501: All papers that are to become a part of the permanent records of the United States Patent and Trademark Office should be legibly written either by a typewriter or mechanical printer in permanent dark ink or its equivalent in portrait orientation on flexible, strong, smooth, non-shiny, durable, and white paper.

While handwritten applications are technically accepted, it’s important to note that typed or printed applications are preferred for clarity and ease of processing. Handwritten applications may face additional scrutiny and potential delays in processing due to legibility concerns.

MPEP 502 - Depositing Correspondence (11)

The following types of patent applications and documents can be filed via EFS-Web:

  • Provisional patent applications under 35 U.S.C. 111(b)
  • Nonprovisional utility patent applications under 35 U.S.C. 111(a)
  • Nonprovisional design patent applications under 35 U.S.C. 111(a)
  • International applications filed under the PCT in the United States Receiving Office
  • National stage submissions under 35 U.S.C. 371
  • International design applications filed under the Hague Agreement
  • Requests for ex parte reexamination for utility or design patents
  • Requests for supplemental examination for utility, design, or plant patents
  • Third-party preissuance submissions under 35 U.S.C. 122(e)
  • Citation of prior art and written statements in patent files under 37 CFR 1.501

Follow-on documents can also be filed via EFS-Web for existing applications by registered users.

What is the USPTO’s policy on federal holidays?

The USPTO observes federal holidays and has specific policies regarding correspondence and deadlines that fall on these days:

  • The USPTO is closed on all federal holidays.
  • Deadlines that fall on a federal holiday are extended to the next business day.
  • Correspondence is not accepted or processed on federal holidays.

According to MPEP 502: ‘Federal holidays falling on Sunday will be observed on the following Monday.’ This means that when a federal holiday falls on a Sunday, the USPTO will be closed on the following Monday, and any deadlines will be extended accordingly.

It’s important for patent applicants and attorneys to be aware of the federal holiday schedule and plan their filings accordingly to avoid missing critical deadlines.

What are the USPTO’s guidelines for hand-carrying documents?

The USPTO has specific guidelines for hand-carrying documents to their office. According to MPEP 502:

“Any paper which relates to a pending application may be personally delivered to the Office. The attorney, agent, or applicant should specifically instruct the person making the delivery to hand-carry the paper to the Customer Service Window…”

Key points to remember when hand-carrying documents to the USPTO:

  • Deliver to the Customer Service Window at the Randolph Building, 401 Dulany Street, Alexandria, VA 22314
  • The delivery must be made during official business hours (8:30 AM to 5:00 PM, Monday through Friday, excluding federal holidays)
  • A receipt will be issued for the delivered papers
  • The receipt date is considered the filing date for the documents

It’s important to follow these guidelines to ensure proper handling and timely processing of your documents.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What are the requirements for certificate of mailing or transmission?

The certificate of mailing or transmission is an important tool for securing a filing date with the USPTO. According to MPEP 502, the requirements are:

“The certification requires a signature. Specifically, if the certification is filed by a registered practitioner, it must be signed by that practitioner personally. 37 CFR 1.8(a)(2). If the certification is filed by an applicant, it must be signed by the applicant (except where an oath or declaration is not required, in which case the certification may be signed by a registered practitioner). 37 CFR 1.8(a)(2).”

Key points to remember:

  • The certificate must include the date of deposit or transmission.
  • It must be signed by the person mailing or transmitting the correspondence.
  • For registered practitioners, personal signature is required.
  • For applicants, their signature is required unless an oath/declaration is not needed.

Proper use of this certificate can help ensure your documents are considered timely filed, even if there are postal or transmission delays.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on Certificate of Transmission, visit: Certificate of Transmission.

For more information on USPTO correspondence, visit: USPTO correspondence.

What are the official USPTO mailing addresses for patent-related correspondence?

The United States Patent and Trademark Office (USPTO) has specific mailing addresses for different types of patent-related correspondence. According to the MPEP 502:

For regular mail:

  • Commissioner for Patents
    P.O. Box 1450
    Alexandria, VA 22313-1450

For hand-carried or EXPRESS MAIL:

  • U.S. Patent and Trademark Office
    Customer Service Window
    Randolph Building
    401 Dulany Street
    Alexandria, VA 22314

It’s important to use the correct address to ensure timely processing of your correspondence.

For more information on patent correspondence, visit: patent correspondence.

How does the USPTO handle correspondence sent by Priority Mail Express®?

The USPTO treats correspondence sent by Priority Mail Express® (formerly Express Mail) with special consideration. According to MPEP 502:

“Any correspondence received by Priority Mail Express® will be considered filed with the USPTO on the date of deposit with the United States Postal Service.”

This means that the date of deposit with USPS is considered the filing date at the USPTO, which can be crucial for meeting deadlines. However, it’s important to note that:

  • The Priority Mail Express® label number must be placed on the correspondence.
  • The filing date accorded to Priority Mail Express® is only applicable to the specific items deposited with USPS.

Always keep your Priority Mail Express® mailing receipt as proof of the deposit date.

For more information on Priority Mail Express, visit: Priority Mail Express.

For more information on USPS, visit: USPS.

For more information on USPTO correspondence, visit: USPTO correspondence.

How does the USPTO handle correspondence received after official hours?

The USPTO has specific procedures for handling correspondence received outside of official business hours:

  • Correspondence delivered to the USPTO after business hours is considered filed on the next business day.
  • There are exceptions for certain types of time-sensitive filings.

MPEP 502 states: ‘Correspondence placed in the USPTO’s night box before midnight on weekdays (except federal holidays) will receive a filing date of the succeeding business day.’ This means that documents deposited in the night box after business hours but before midnight will be treated as if they were received on the next business day.

For electronic filings, the USPTO’s Electronic Filing System (EFS-Web) is generally available 24/7, allowing for submissions outside of regular business hours. However, the actual filing date may still be affected by the time of submission.

How does the USPTO handle correspondence during emergency situations?

The USPTO has provisions for handling correspondence during emergency situations, such as severe weather or other unforeseen circumstances:

  • The USPTO may designate certain days as ‘Federal holidays within the District of Columbia’ under specific conditions.
  • This designation affects filing dates and deadlines.

MPEP 502 states: ‘When the entire USPTO is officially closed for business for an entire day due to an emergency situation, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21.’ This means that deadlines falling on such days will be extended to the next business day, similar to federal holidays.

During emergencies, the USPTO typically issues public notices and updates its website to inform stakeholders about any changes to operations or filing procedures. It’s crucial for patent applicants and attorneys to stay informed about such announcements to ensure compliance with modified deadlines and procedures.

How does the USPTO handle correspondence delivered by EXPRESS MAIL?

The USPTO has specific procedures for handling correspondence delivered by EXPRESS MAIL. According to MPEP 502:

“Any correspondence delivered by the ‘Express Mail Post Office to Addressee’ service of the United States Postal Service (USPS) is considered filed or received in the Office on the date of deposit with the USPS.”

This means that the date of deposit with the USPS is considered the filing date at the USPTO, provided that:

  • The correspondence is properly addressed to the USPTO
  • The proper address is on the EXPRESS MAIL mailing label
  • The EXPRESS MAIL mailing label number is placed on the correspondence

It’s important to note that this applies only to the USPS EXPRESS MAIL service and not to similar services provided by private courier companies.

For more information on Express Mail, visit: Express Mail.

For more information on USPTO correspondence, visit: USPTO correspondence.

When filing patent correspondence, you should include the following identifying information:

  • Application number (checked for accuracy, including series code and serial number)
  • Art Unit number (copied from most recent Office communication)
  • Filing date
  • Name of the examiner who prepared the most recent Office action
  • Title of invention
  • Confirmation number

As stated in 37 CFR 1.5(a): ‘When correspondence directed to the Patent and Trademark Office concerns a previously filed application for a patent, it must identify on the top page in a conspicuous location, the application number (consisting of the series code and the serial number; e.g., 07/123,456), or the serial number and filing date assigned to that application by the Patent and Trademark Office, or the international application number of the international application, or the international registration number of an international design application.’

Can I use a certificate of mailing for all USPTO correspondence?

While the certificate of mailing or transmission is a useful tool, it cannot be used for all types of USPTO correspondence. The MPEP 502 provides specific exceptions:

“The certification procedure under 37 CFR 1.8 is not available for: (A) Applications for patent under 35 U.S.C. 111(a), including reissue applications; (B) International applications for patent; (C) International design applications; (D) Requests for reexamination under 35 U.S.C. 302…”

This list continues with several other exceptions. It’s crucial to note that:

  • New patent applications cannot use the certificate of mailing.
  • International applications are excluded from this procedure.
  • Certain time-sensitive documents require different filing methods.

For these excluded items, consider using Priority Mail Express® or electronic filing to ensure timely receipt by the USPTO. Always check the current regulations or consult with a patent professional to determine the appropriate filing method for your specific correspondence.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on patent applications, visit: patent applications.

For more information on USPTO correspondence, visit: USPTO correspondence.

MPEP 503 - Application Number and Filing Receipt (20)

An attorney docket number is used by law firms and companies to internally track and manage patent applications. While it’s not required by the USPTO, it can be included on application documents for reference. However, there are limitations:

  • Must be limited to a maximum of 25 characters
  • Spaces, slashes, and hyphens are not included in the entered docket number on the official filing receipt
  • For docket numbers beginning with ‘CASE’ or ‘NAVY-CASE’, only characters after these prefixes are entered

The MPEP states: ‘Attorney docket numbers must be limited to a maximum of 25 characters to prevent truncation. The USPTO system data base allows a maximum of 25 characters for the attorney docket numbers.’ (MPEP 503)

A self-addressed postcard serves as a receipt and provides evidence of the items submitted to the USPTO with a patent application. According to MPEP 503, the postcard should itemize all components of the application, including:

  • Inventor’s name(s)
  • Title of invention
  • Number of pages of specification, claims, and sheets of drawing
  • Whether the inventor’s oath or declaration is included
  • List of additional forms included
  • Amount and manner of paying the fee

The MPEP states: “A postcard receipt which itemizes and properly identifies the items which are being filed serves as prima facie evidence of receipt in the USPTO of all the items listed thereon on the date stamped thereon by the USPTO.”

It’s important to note that the postcard must be properly itemized to serve as evidence of receipt. Simply listing “a complete application” is not sufficient. Each component should be specifically listed on the postcard.

For applications filed via EFS-Web, an Electronic Acknowledgment Receipt serves as the electronic equivalent of a postcard receipt.

For more information on patent application filing, visit: patent application filing.

For more information on USPTO submission, visit: USPTO submission.

A return postcard serves as prima facie evidence of receipt by the USPTO of all items listed on the postcard. It should include detailed identifying information such as:

  • Inventor’s name
  • Application number (if known)
  • Confirmation number (if known)
  • Filing date
  • Title of the invention
  • Type of paper being filed
  • Number of pages for each component

The MPEP states: ‘A postcard receipt which itemizes and properly identifies the items which are being filed serves as prima facie evidence of receipt in the USPTO of all the items listed thereon on the date stamped thereon by the USPTO.’ (MPEP 503)

An application number consists of a series code and a serial number. It is assigned by the Office of Patent Application Processing (OPAP) immediately after mail has been opened. For applications filed using the USPTO patent electronic filing system, EFS-Web provides an Acknowledgement Receipt containing a time and date stamp, application number, and confirmation number.

The MPEP states: ‘Application numbers consisting of a series code and a serial number are assigned by the Office of Patent Application Processing (OPAP) immediately after mail has been opened.’ (MPEP 503)

A filing receipt is an official document issued by the USPTO that contains important information about a patent application. According to MPEP 503, the filing receipt includes:

  • Application number
  • Filing date
  • Confirmation number
  • Suggested U.S. Patent Classification class
  • Art unit where the application is likely to be examined
  • Continuing data (if applicable)
  • National stage data (if applicable)
  • Foreign priority data (if applicable)
  • Foreign filing license data (if applicable)
  • Entity status information
  • Anticipated publication date under 35 U.S.C. 122(b)

The MPEP states: “The filing receipt represents the official assignment by the USPTO of a specific application number and confirmation number to a particular application.” It’s important to review the filing receipt for accuracy, especially regarding inventor and applicant names, benefit and priority claims, and any nonpublication requests.

For more information on application number, visit: application number.

For more information on confirmation number, visit: confirmation number.

For more information on filing receipt, visit: filing receipt.

A confirmation number is a four-digit number assigned to each newly filed patent application. It is used in combination with the application number to verify the accuracy of the application number on correspondence filed with the USPTO. This helps avoid misidentification due to transposition errors.

The MPEP states: ‘The confirmation number is a four-digit number that is assigned to each newly filed application. The confirmation number, in combination with the application number, is used to verify the accuracy of the application number placed on correspondence filed with the Office to avoid misidentification of an application due to a transposition error in the application number.’ (MPEP 503)

A confirmation number is a four-digit number assigned by the USPTO to each newly filed patent application. According to MPEP 503, the confirmation number serves several important purposes:

  • It is used in combination with the application number to verify the accuracy of the application number on correspondence filed with the Office.
  • It helps avoid misidentification of an application due to transposition errors in the application number.
  • It is included on the filing receipt, Office actions, and other USPTO communications.
  • It is required when submitting an electronic copy of the application for publication to verify the correct application.

The MPEP recommends: “The Office also recommends that applicants include the application’s confirmation number (in addition to the application number) on all correspondence submitted to the Office concerning the application.”

The confirmation number can be found in the upper left-hand corner of the filing receipt and is also available through the Patent Application Information Retrieval (PAIR) system.

For more information on application number, visit: application number.

For more information on confirmation number, visit: confirmation number.

For more information on USPTO correspondence, visit: USPTO correspondence.

A patent filing receipt includes:

  • Application number
  • Filing date
  • Confirmation number
  • Suggested class in the U.S. Patent Classification System
  • Art unit number where the application is likely to be examined
  • Continuing data (if applicable)
  • National stage data (if applicable)
  • Foreign priority data (if applicable)
  • Foreign filing license data (if applicable)
  • Entity status information
  • Anticipated publication date under 35 U.S.C. 122(b)

The MPEP states: ‘The filing receipt includes the application number, filing date, a confirmation number, a suggested class in the U.S. Patent Classification System (see MPEP § 902.01), and the number of an art unit where the application is likely to be examined.’ (MPEP 503)

A patent application filing receipt contains crucial information about the application. According to the MPEP:

‘A filing receipt is mailed to the attorney or agent, if any, otherwise to the applicant, for each application filed.’

The filing receipt typically includes:

  • The application number
  • Filing date
  • Title of the invention
  • Names of the applicants
  • Name and registration number of the attorney or agent (if applicable)
  • Entity status for fee purposes
  • Correspondence address
  • List of documents submitted with the application

It’s important to review the filing receipt carefully for accuracy, as it serves as official confirmation of the application’s details and can be used to identify any discrepancies or issues that need to be addressed promptly.

For more information on filing receipt, visit: filing receipt.

What happens if there’s an error in my application number?

If you notice an error in your application number, it’s crucial to contact the USPTO immediately. The MPEP states, Any error in the identification of the application number will result in processing delays. (MPEP 503) To avoid such delays:

  • Double-check the application number on your filing receipt
  • If you find an error, contact the Application Assistance Unit at (571) 272-4000
  • Provide the correct application number and any supporting documentation

Prompt action can help ensure your application is processed correctly and efficiently.

For more information on application number, visit: application number.

For more information on error correction, visit: error correction.

If an applicant does not receive an application number within one month of filing, they should contact the Application Assistance Unit. The MPEP states:

‘If an application number is not received within one month of the filing date, applicant should contact the Application Assistance Unit at (571) 272-4000 or (888) 786-0101.’

This contact information is provided to ensure applicants can follow up on their application status in a timely manner. It’s important to note that this one-month period is a guideline for when applicants should take action if they haven’t received their application number.

For more information on Application Assistance Unit, visit: Application Assistance Unit.

For more information on application number, visit: application number.

The USPTO assigns different series codes to various types of patent applications:

  • 01/ – 16/: Nonprovisional applications (utility, plant, and reissue)
  • 29/: Design applications
  • 35/: International design applications
  • 60/, 61/, and 62/: Provisional applications
  • 90/: Ex parte reexamination proceedings
  • 95/: Inter partes reexamination proceedings
  • 96/: Supplemental examination proceedings and resulting ex parte reexamination proceedings

The MPEP provides a detailed breakdown of series codes for nonprovisional applications from 1925 to the present. For example, ‘Series code 16 is assigned to nonprovisional applications filed from June 2018 to present.’ (MPEP 503)

When an application is filed with missing parts, the USPTO follows these procedures:

  1. If the application meets minimum requirements for a filing date, it will be assigned one.
  2. A Notice to File Missing Parts will be issued, detailing the missing items.
  3. Applicants must submit missing items along with any required surcharges within the specified time period.
  4. For applications filed on or after September 16, 2012, the inventor’s oath or declaration can be postponed until payment of the issue fee if a compliant application data sheet is filed.
  5. For applications filed on or after December 18, 2013, filing of claims can be postponed until the expiration of the time period set in the Notice to File Missing Parts.

The MPEP states: ‘The inventor’s oath or declaration, basic filing fee, and search fee and examination fee as set forth in 37 CFR 1.16, may be filed later than the remaining application papers, but if so, they must be accompanied by the required surcharge (if appropriate, see MPEP § 506).’ (MPEP 503)

How does the USPTO assign application numbers to continuation or divisional applications?

The USPTO assigns application numbers to continuation or divisional applications in the same manner as new applications. According to MPEP 503:

A continuation or divisional application (including a continued prosecution application) filed under 37 CFR 1.53(b) is assigned a new application number.

This means:

  • Each continuation or divisional application receives a unique number
  • The number is assigned in the same sequence as other new applications
  • The application number does not indicate its relationship to the parent application

It’s important to reference the parent application in the appropriate sections of the new application to establish the continuity.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO procedures, visit: USPTO procedures.

There are two main ways to obtain a receipt for items filed with the USPTO:

  1. For paper filings: Include a self-addressed postcard with your submission, itemizing all components being filed. The USPTO will stamp the receipt date on the postcard and return it.
  2. For electronic filings via EFS-Web or Patent Center: An Electronic Acknowledgement Receipt is automatically generated and sent to the filer.

The MPEP states: ‘If a submitter desires a receipt for any item (e.g., paper or fee) filed in the USPTO by means other than the USPTO patent electronic filing system, it may be obtained by enclosing with the paper a self-addressed postcard specifically identifying the item.’ (MPEP 503)

Application numbers for patent applications are assigned by the Office of Patent Application Processing (OPAP) as follows:

n

    n

  • Nonprovisional applications are assigned numbers beginning with the series code ’15’ or ’16’.
  • n

  • Design applications are assigned numbers beginning with the series code ’29’.
  • n

  • Plant applications are assigned numbers beginning with the series code ’16’.
  • n

  • Provisional applications are assigned numbers beginning with the series code ’62’.
  • n

  • Reexamination proceedings are assigned numbers beginning with the series code ’90’.
  • n

n

As stated in the MPEP 503, “The application number includes a two-digit series code and a six-digit serial number.” This system allows for efficient categorization and tracking of different types of patent applications.

For more information on application number, visit: application number.

For more information on patent application types, visit: patent application types.

For more information on series code, visit: series code.

For PCT applications entering the national stage in the United States, the application number assignment process is slightly different. The MPEP states:

‘For PCT applications entering the national stage under 35 U.S.C. 371, the USPTO assigns the national stage application a U.S. application number.’

This means that when an international PCT application transitions to the national stage in the U.S., it receives a new U.S. application number distinct from its international application number. This U.S. application number is used for all subsequent processing and correspondence related to the national stage application.

It’s important to note that this U.S. application number is different from the international application number (PCT/XX/YYYY/######) that was used during the international phase of the PCT application.

For more information on application number, visit: application number.

The USPTO assigns application numbers to patent applications immediately after mail has been opened. According to MPEP 503, application numbers consist of a series code and a serial number. The series codes are assigned based on the type of application and the time period in which it was filed. For example:

  • 01/ – 16/ for nonprovisional applications (utility, plant, and reissue), with different ranges for specific time periods
  • 29/ for design applications
  • 35/ for international design applications
  • 60/, 61/, and 62/ for provisional applications
  • 90/ for ex parte reexamination proceedings
  • 95/ for inter partes reexamination proceedings
  • 96/ for supplemental examination proceedings and resulting ex parte reexamination proceedings

The MPEP notes: “If an application is filed using the USPTO patent electronic filing system, EFS-Web provides an Acknowledgement Receipt that contains a time and date stamp, an application number and a confirmation number.”

It’s important to note that the application number on a filing receipt is the official number, which may differ from any preliminary number provided on a postcard receipt.

For more information on application number, visit: application number.

For more information on patent application types, visit: patent application types.

For more information on serial number, visit: serial number.

For more information on series code, visit: series code.

No, patent applications that are entitled to a filing date will not be returned to the applicant, even if requested. This applies to applications filed by regular mail, Priority Mail Express, hand-delivery, or through the USPTO patent electronic filing system.

The MPEP clearly states: ‘Applications which are entitled to a filing date, whether filed by regular mail, by Priority Mail Express® under 37 CFR 1.10, by hand-delivery, by the USPTO patent electronic filing system, or otherwise, will not be returned to applicant even if requested.’ (MPEP 503)

Applicants should be careful not to file duplicate applications or applications not intended for filing, as fees paid for such applications are generally not refundable due to a change of purpose.

Once a patent application is filed and given a filing date, it generally cannot be returned or withdrawn. According to MPEP 503:

“Applications which are entitled to a filing date, whether filed by regular mail, by Priority Mail Express® under 37 CFR 1.10, by hand-delivery, by the USPTO patent electronic filing system, or otherwise, will not be returned to applicant even if requested.”

This policy is in place to maintain the integrity of the filing process and prevent potential abuse. Applicants should be careful not to file applications that are not intended to be filed, such as duplicates of already filed applications.

Furthermore, the MPEP cites 37 CFR 1.26(a), which states that a change of purpose after payment of a fee, such as when a party desires to withdraw a patent application for which a fee was paid, does not entitle the party to a refund of such fee.

If an applicant realizes they have filed an application in error or no longer wish to pursue it, they may choose to abandon the application. However, the application will remain on file with the USPTO and any fees paid will not be refunded.

For more information on application abandonment, visit: application abandonment.

For more information on application return, visit: application return.

MPEP 504 - Assignment of Application for Examination (4)

PSTAR stands for Patents Service for Time and Application Routing. According to MPEP 504, PSTAR is “the program [that] assigns each nonprovisional application to an examiner.” This system is used by the United States Patent and Trademark Office (USPTO) to efficiently distribute patent applications to the appropriate examiners for review.

To learn more:

Nonprovisional patent applications are assigned for examination through the Patents Service for Time and Application Routing (PSTAR) program. According to MPEP 504, “The Patents Service for Time and Application Routing (PSTAR) program assigns each nonprovisional application to an examiner.” This system ensures that each application is routed to an appropriate examiner based on factors such as the application’s subject matter and the examiner’s expertise.

To learn more:

No, provisional patent applications are not examined. The MPEP 504 clearly states: “Provisional applications will not be examined.” Provisional applications serve as a placeholder to establish a priority date and are not subject to substantive examination by the USPTO.

To learn more:

No, provisional patent applications are not assigned to examiners for examination. MPEP 504 explicitly states: “Provisional applications will not be examined.” This is because provisional applications are primarily used to establish a priority date and are not subject to substantive examination.

MPEP 505 - Date of Receipt Stamp (14)

The United States Patent and Trademark Office (USPTO) stamps correspondence received with the date of receipt, known as the ‘Office Date’ stamp. This applies to papers and fees received through various methods:

  • Mail (except Priority Mail Express®)
  • Facsimile
  • EFS-Web
  • Hand-carried to the Customer Service Window

As stated in the MPEP: The United States Patent and Trademark Office (Office) stamps papers and fees received through the mail (other than those submitted by Priority Mail Express® in accordance with 37 CFR 1.10), by facsimile, or via EFS-Web with the date of their receipt in the Office.

The ‘Office Date’ stamp is used by the USPTO to mark the receipt date of papers and fees. According to MPEP 505, The United States Patent and Trademark Office (Office) stamps papers and fees received through the mail (other than those submitted by Priority Mail Express® in accordance with 37 CFR 1.10), by facsimile, or via EFS-Web with the date of their receipt in the Office.

The ‘Office Date’ stamp is crucial because:

  • It establishes the filing date for new patent applications that include the necessary components (see 37 CFR 1.53(b)-(d))
  • It determines the timeliness of actions and fee payments

For hand-carried papers, date stamping occurs at the Customer Service Window.

For more information on Office Date stamp, visit: Office Date stamp.

For more information on USPTO, visit: USPTO.

If there’s a discrepancy between the USPTO’s date stamp and the date on the correspondence, the USPTO’s date stamp is generally considered the official receipt date. However, if an applicant can provide clear evidence that the correspondence was received earlier than the date indicated by the USPTO’s stamp, the earlier date may be recognized as the official receipt date. This situation might occur due to clerical errors or delays in processing incoming mail.

If the USPTO receives a document without a date of receipt stamp, the Office will assign the document a date of receipt based on other evidence. This may include:

  • The date of receipt indicated on an Express Mail label
  • The date of deposit indicated on a certificate of mailing
  • The date of transmission indicated on a certificate of transmission
  • Other corroborating evidence, such as a postmark on an envelope

In cases where no other evidence is available, the USPTO may assign the date of receipt as the date the document was matched with the file wrapper.

If the date of receipt stamp is illegible or missing, the USPTO will make every effort to determine the correct date of receipt. This may involve examining other evidence, such as postmarks, electronic filing receipts, or other documentation. If the correct date cannot be determined, the USPTO may use the date it was discovered that the document was received as the date of receipt. Applicants should always ensure that their submissions are properly dated and stamped to avoid potential issues with filing dates.

When a USPTO deadline falls on a weekend or holiday, the due date is automatically extended. According to MPEP 505, When the last day for taking any action or paying any fee in the Office falls on a Saturday, Sunday, or a Federal holiday within the District of Columbia, the action or the fee is considered timely if the action is taken or the fee is paid on the next succeeding business day.

This rule applies to various USPTO actions, including:

  • Filing responses to Office Actions
  • Paying maintenance fees
  • Submitting other time-sensitive documents

It’s important to note that while the deadline is extended, the USPTO is still closed on these days for regular correspondence receipt.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO deadlines, visit: USPTO deadlines.

The filing date of a patent application is determined by the ‘Office Date’ stamp, provided the application includes all necessary components for a filing date. The MPEP states:

If an application as originally filed includes the necessary components for a filing date (see 37 CFR 1.53(b)-(d) and MPEP § 506), the ‘Office Date’ stamp establishes the ‘filing date.’

This means that the date stamped on the application by the USPTO becomes the official filing date, as long as all required elements are present. It’s crucial for applicants to ensure their submissions are complete to secure the earliest possible filing date.

Priority Mail Express® submissions to the USPTO are handled differently from regular mail. According to MPEP 505, New patent applications filed in accordance with 37 CFR 1.10 will be stamped by the Office with the date of deposit as Priority Mail Express® with the United States Postal Service.

This means:

  • The date of deposit with USPS is used as the receipt date, not the date it arrives at the USPTO
  • This applies even on weekends and holidays when the USPTO is closed

For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

For more information on Priority Mail Express, visit: Priority Mail Express.

For more information on USPTO, visit: USPTO.

The USPTO does not officially receive mail on weekends or federal holidays when the office is closed. Any correspondence received on these days is typically stamped with the next business day’s date. For example, if mail is delivered to the USPTO on a Saturday, it will be stamped with the following Monday’s date (or Tuesday if Monday is a holiday). This practice ensures consistency in dating received documents and aligns with the USPTO’s official business hours.

The USPTO has specific rules for dating facsimile transmissions. According to 37 CFR 1.6(a)(3):

Correspondence transmitted by facsimile to the Patent and Trademark Office will be stamped with the date on which the complete transmission is received in the Patent and Trademark Office unless that date is a Saturday, Sunday, or Federal holiday within the District of Columbia, in which case the date stamped will be the next succeeding day which is not a Saturday, Sunday, or Federal holiday within the District of Columbia.

This means that faxed correspondence is generally dated on the day of complete transmission, except for weekends and holidays, where it’s dated the next business day.

The USPTO does not receive or process correspondence on Saturdays, Sundays, or Federal holidays within the District of Columbia, with some exceptions. According to 37 CFR 1.6(a)(1):

The Patent and Trademark Office is not open for the filing of correspondence on any day that is a Saturday, Sunday, or Federal holiday within the District of Columbia. Except for correspondence transmitted by facsimile under paragraph (a)(3) of this section, or filed electronically under paragraph (a)(4) of this section, no correspondence is received in the Office on Saturdays, Sundays, or Federal holidays within the District of Columbia.

When the last day for taking action or paying a fee falls on a weekend or holiday, it’s considered timely if done on the next business day: When the last day for taking any action or paying any fee in the Office falls on a Saturday, Sunday, or a Federal holiday within the District of Columbia, the action or the fee is considered timely if the action is taken or the fee is paid on the next succeeding business day.

Priority Mail Express® submissions to the USPTO are treated differently in terms of dating. According to 37 CFR 1.6(a)(2):

Correspondence filed in accordance with § 1.10 will be stamped with the date of deposit as Priority Mail Express® with the United States Postal Service.

This means that new patent applications filed using Priority Mail Express® will be stamped with the date they were deposited with USPS, even if that date is a Saturday, Sunday, or federal holiday. The MPEP provides an example:

For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

The USPTO has specific rules for dating electronically filed submissions. According to 37 CFR 1.6(a)(4):

Correspondence may be submitted using the Office electronic filing system only in accordance with the Office electronic filing system requirements. Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

The MPEP further clarifies: Similarly, correspondence submitted via the USPTO electronic filing system (EFS-Web) will be accorded a receipt date on the date the correspondence is received at the correspondence address for the Office set forth in 37 CFR 1.1 (i.e., local time in Alexandria, VA), without regard to whether that date is a Saturday, Sunday, or Federal holiday within the District of Columbia.

Electronically filed patent applications receive special treatment for date-stamping at the USPTO. According to MPEP 505, Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

Key points about electronic filing date-stamping:

  • The receipt date is based on the time in Alexandria, VA (USPTO’s location)
  • Electronic submissions can receive a date stamp on any day, including weekends and holidays
  • The electronic filing system (EFS-Web) must be used in accordance with USPTO requirements

For more details on electronic filing, refer to MPEP § 502.05.

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on USPTO, visit: USPTO.

MPEP 506 - Completeness of Original Application (16)

If an applicant disagrees with the USPTO’s refusal to grant a filing date for their patent application, they can request a review through the following process:

  • File a petition to the USPTO, accompanied by the required petition fee
  • Provide arguments and evidence supporting why the application should be granted the desired filing date
  • If alleging no defect exists, include a request for a refund of the petition fee

The MPEP states: Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)). Petitioner should provide any arguments that he or she has that the items noted were not missing or that a filing date should be assigned in the absence of such items if they are believed to be unnecessary.

Petitions relating to filing dates are decided by the Office of the Deputy Commissioner for Patent Examination Policy. The petition should be marked to the attention of the Office of Petitions.

It’s important to act promptly if you believe a filing date has been incorrectly refused, as the filing date can have significant implications for patent rights.

For more information on patent application review, visit: patent application review.

For applications properly filed under 37 CFR 1.10 using Priority Mail Express, the filing date is the date the application was deposited with the U.S. Postal Service. The MPEP states:

For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service. For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

If the proper procedures were not followed, the application will receive a filing date as of the date it was received in the USPTO.

The application size fee is an additional fee that applies to patent applications with specifications and drawings exceeding 100 sheets of paper. The MPEP states:

37 CFR 1.16(s) sets forth the application size fee for any application (including any reissue applications) filed under 35 U.S.C. 111, the specification and drawings of which exceed 100 sheets of paper. The calculation of the number of sheets excludes any “Sequence Listing”, computer readable form (CRF) of a “Sequence Listing”, or a “Computer Program Listing Appendix” filed in an American Standard Code for Information Interchange (ASCII) plain text file or any “Sequence Listing XML” filed in an eXtensible Markup Language (XML) file on a read-only optical disc or via the USPTO patent electronic filing system in compliance with the rules.

The fee applies for each additional 50 sheets or fraction thereof over 100 sheets. This fee must be paid within the time period set by the USPTO to avoid abandonment of the application.

A provisional patent application is a type of patent application that allows inventors to establish an early filing date for their invention. Key differences between provisional and nonprovisional applications include:

  • Provisional applications are not examined and automatically expire after 12 months
  • Provisional applications require fewer formal components than nonprovisional applications
  • Provisional applications cannot directly result in a granted patent

The MPEP states: A provisional application will not be examined. However, a provisional application which does not include a cover sheet (37 CFR 1.51(c)(1)), which may be an application data sheet (37 CFR 1.76) or a cover letter, identifying the application as a provisional application, will be treated as a nonprovisional application filed under 37 CFR 1.53(b).

To obtain a filing date, a provisional application must include:

  • A specification as prescribed by 35 U.S.C. 112(a)
  • Any necessary drawings
  • The appropriate filing fee

Inventors often use provisional applications to secure an early filing date while allowing additional time to prepare a more comprehensive nonprovisional application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

If a patent application is missing essential parts, such as the specification, drawings, or claims, the USPTO will notify the applicant of the missing elements. According to MPEP 506:

‘Applicant will be notified of the incomplete application and the time period set for submitting the omitted parts.’

The applicant will then have an opportunity to submit the missing parts within the specified time period to complete the application.

For more information on incomplete application, visit: incomplete application.

For more information on missing parts, visit: missing parts.

For more information on patent application requirements, visit: patent application requirements.

If a patent application is filed without all the pages of the specification, the USPTO will notify the applicant of the missing parts. The MPEP refers to this situation:

See MPEP § 601.01(d)-(g) where the application is filed without all the pages of the specification, without at least one claim (nonprovisional design application), without drawings, or without all the figures of the drawings.

For applications filed before September 16, 2012, a supplemental oath or declaration by the inventor may be required to identify the missing item and indicate that it accurately describes the invention. For applications filed on or after September 16, 2012, an additional oath or declaration is generally not required.

The applicant will be given a time period to submit the missing pages. If the missing pages are not submitted within the specified time, the application may be deemed incomplete and not accorded a filing date until the missing parts are received.

If a patent application is filed with informal papers (e.g., typed on both sides of the paper, not permanent, legible, or reproducible), the USPTO will still accord a filing date if the application otherwise meets the requirements. The MPEP states:

OPAP accords a filing date, as of the date indicated by the “Office Date” stamp (see MPEP § 505), to application papers which include a specification containing a description and at least one claim (nonprovisional applications filed under 37 CFR 1.53(b) prior to March 18, 2013 and design applications), and a drawing, if necessary under 35 U.S.C. 113 (first sentence) and 37 CFR 1.53(b), but are informal because they do not comply with the rules or notices.

The USPTO will send a Notice requiring correction of the informality. Failure to correct the informality within the specified time will result in abandonment of the application.

If a nonprovisional patent application is filed without all required fees, the USPTO will send a notice to the applicant. According to the MPEP:

Filing dates are accorded to nonprovisional applications filed under 37 CFR 1.53(b) submitted without the… required fees (basic filing fee, and search and examination fees (for applications filed on or after December 8, 2004))… In such cases, a notice is mailed by OPAP requiring the appropriate fees… accompanied by a surcharge (37 CFR 1.16(f)).

The applicant will be given a time period (usually two months) to pay the missing fees and surcharge to avoid abandonment of the application.

To obtain a filing date for a nonprovisional patent application filed under 37 CFR 1.53(b), the application must include:

  • A specification containing a description as prescribed by 35 U.S.C. 112(a)
  • At least one claim (for applications filed on or after December 13, 2013)
  • Any drawings necessary under 35 U.S.C. 113 (first sentence)

As stated in the MPEP: Filing dates are accorded to nonprovisional applications filed under 37 CFR 1.53(b) submitted without the names of all the inventors, the required fees (basic filing fee, and search and examination fees (for applications filed on or after December 8, 2004)), at least one claim (for applications filed on or after December 13, 2013) and/or the inventor’s oath or declaration.

If any required items are missing, the applicant will be notified and given a time period to submit the missing elements. The filing date will be the date the missing items are received.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application requirements, visit: patent application requirements.

Applications properly filed via Priority Mail Express® (formerly Express Mail) have special filing date rules:

  • The filing date is the date the application was deposited with the U.S. Postal Service as Priority Mail Express®
  • This applies even if the deposit date is a Saturday, Sunday, or federal holiday
  • The application must comply with the requirements of 37 CFR 1.10 to receive this benefit

The MPEP states: For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service. For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date. 37 CFR 1.6(a)(2).

If the proper procedures were not followed, the application will receive a filing date as of the date it was received in the USPTO. Any review of these matters would be by way of petition, accompanied by the petition fee.

For more information on Priority Mail Express, visit: Priority Mail Express.

The USPTO treats applications with omitted drawings similarly to those with missing specification pages. According to MPEP 506:

In the event that a page of the specification, or a portion thereof, or a page of the drawings, or a portion thereof, is inadvertently omitted from an application as filed, the application will be not be considered complete and the applicant will be notified to file the omitted portion.

If drawings are omitted, the applicant will be notified and given a time period to submit the missing drawings. However, adding new drawings after the filing date may affect the application’s effective filing date if they introduce new matter. It’s crucial to include all necessary drawings with the initial application to avoid potential issues.

For more information on new matter, visit: new matter.

Tags: new matter

An applicant can request review of a refusal to accord a filing date by filing a petition. The MPEP states:

Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)). Petitioner should provide any arguments that he or she has that the items noted were not missing or that a filing date should be assigned in the absence of such items if they are believed to be unnecessary.

The petition should be marked to the attention of the Office of Petitions. If the applicant believes no defect exists, they may include a request for refund of the petition fee in the petition.

If a patent application is missing a required part, the applicant can correct the deficiency as follows:

  • The USPTO will send a Notice of Missing Parts identifying the deficiency
  • The applicant must submit the missing part within the time period specified in the notice (usually two months)
  • A surcharge fee may be required along with the submission of the missing part
  • For certain missing parts, like claims or drawings, a supplemental oath or declaration may be required for applications filed before September 16, 2012

The MPEP states: In such cases where the basic filing fee, the search fee, the examination fee, and the application size fee are paid, but additional fees are required, under 37 CFR 1.16, a notice is mailed by OPAP or the Technology Center (TC), requiring that the balance of the prescribed fee be paid.

It’s important to respond promptly to any Notice of Missing Parts to avoid abandonment of the application. If the applicant believes the part was not actually missing, they can file a petition for review of the Notice.

For more information on missing parts, visit: missing parts.

Yes, for applications filed on or after September 16, 2012 (except reissue applications), the inventor’s oath or declaration can be postponed until the application is in condition for allowance, provided certain conditions are met:

  • An application data sheet (ADS) in compliance with 37 CFR 1.76 must be filed identifying each inventor by their legal name, mailing address, and residence (if different from mailing address)
  • The inventor’s oath or declaration must be filed no later than the date on which the issue fee is paid

The MPEP states: For applications filed on or after September 16, 2012 (except reissue applications), applicant may postpone filing the inventor’s oath or declaration until the application is in condition for allowance if an application data sheet (ADS) in compliance with 37 CFR 1.76 is filed identifying: (1) each inventor by their legal name; and (2) for each inventor, a mailing address where the inventor customarily receives mail, and residence, if the inventor lives at a location which is different from where the inventor customarily receives mail. See 37 CFR 1.53(f)(3).

This provision allows applicants more flexibility in completing the application requirements, but it’s important to ensure the oath or declaration is filed before paying the issue fee to avoid abandonment.

For more information on declaration, visit: declaration.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on patent application requirements, visit: patent application requirements.

Yes, for applications filed on or after September 16, 2012 (except reissue applications), the filing of an inventor’s oath or declaration can be postponed. The MPEP states:

For applications filed on or after September 16, 2012 (except reissue applications), applicant may postpone filing the inventor’s oath or declaration until the application is in condition for allowance if an application data sheet (ADS) in compliance with 37 CFR 1.76 is filed identifying: (1) each inventor by their legal name; and (2) for each inventor, a mailing address where the inventor customarily receives mail, and residence, if the inventor lives at a location which is different from where the inventor customarily receives mail.

However, the inventor’s oath or declaration must be filed no later than the date on which the issue fee is paid.

Yes, an applicant can submit missing parts of an application after the filing date, but this may affect the application’s effective filing date. The MPEP 506 states:

Such portion must be filed within the time period set by the Office in the notification by the Office of the omitted portion, or the application will be regarded as abandoned.

It’s important to note that submitting missing parts may result in a later effective filing date for the application, which could have implications for patent term and prior art considerations. Applicants should strive to submit complete applications initially to avoid potential complications.

For more information on effective filing date, visit: effective filing date.

For more information on missing parts, visit: missing parts.

MPEP 507 - Drawing Review in the Office of Patent Application Processing (20)

OPAP may object to and require corrected drawings within a set time period for several issues. According to the MPEP, these include:

  • Line quality that is too light to be reproduced
  • Illegible text
  • Missing lead lines
  • Excessive text or non-English text
  • Incorrect margins or paper size
  • Improper figure labeling
  • Illegible photographs that could be illustrated by ink drawings
  • Color drawings or photographs without a proper petition

For example, regarding line quality, MPEP 507 states:

“OPAP may object to and require corrected drawings within a set time period, if the drawings: (A) have a line quality that is too light to be reproduced (weight of all lines and letters must be heavy enough to permit adequate reproduction) or text that is illegible (reference characters, sheet numbers, and view numbers must be plain and legible). See 37 CFR 1.84(l) and (p)(1)

For more information on drawing requirements, visit: drawing requirements.

For more information on OPAP, visit: OPAP.

For more information on patent drawings, visit: patent drawings.

The PTO-948 form, also known as the ‘Drawing Informalities’ form, serves the following purposes in patent applications:

  • It is used by the Office of Patent Application Processing (OPAP) to indicate that the drawings submitted with the application are informal but acceptable for publication purposes.
  • It notifies the examiner that the drawings may need to be corrected or replaced with formal drawings during examination.
  • It provides a record in the file wrapper that the drawings have been provisionally accepted.

As stated in MPEP 507: ‘If the drawings are informal but otherwise in compliance with 37 CFR 1.121(d), the OPAP will accept the application for purposes of publication and place a ‘Drawing Informalities’ form PTO-948 in the file wrapper.’

This form helps streamline the application process by allowing examination to proceed while flagging the need for potential drawing improvements later in the process.

For more information on OPAP, visit: OPAP.

Tags: OPAP

The Office of Patent Application Processing (OPAP) performs an initial review of drawings in new utility and plant patent applications to determine whether the drawings can be effectively scanned for publication purposes. As stated in the MPEP:

“OPAP inspects the drawings to see if they can be effectively scanned and adequately reproduced.”

This review ensures that the drawings meet the necessary quality standards for publication and reproduction.

For more information on drawing review, visit: drawing review.

For more information on OPAP, visit: OPAP.

The primary purpose of drawing review in OPAP is to determine whether the drawings in new utility and plant patent applications can be effectively scanned for publication purposes. As stated in MPEP 507:

The Office of Patent Application Processing (OPAP) performs an initial review of drawings in new utility and plant patent applications to determine whether the drawings can be effectively scanned for publication purposes.

It’s important to note that design applications are not subject to this review as they are not published.

If OPAP objects to the drawings in a patent application, there is a specific process for submitting corrected drawings. The MPEP states:

“If OPAP objects to the drawings and sends applicant a Notice requiring submission of corrected drawings within a set time period (usually two months), corrected drawings must be filed, in paper, to the mailing address set forth in the Notice, along with any other items required by OPAP, to avoid abandonment of the application. No fee will be necessary for filing corrected drawings which are required by OPAP.”

It’s important to note that the corrected drawings must be submitted in paper form to the specific mailing address provided in the Notice. Applicants should ensure they meet the deadline (typically two months) to avoid potential abandonment of their application.

For more information on corrected drawings, visit: corrected drawings.

For more information on OPAP, visit: OPAP.

For more information on patent procedure, visit: patent procedure.

If the drawings in a patent application are not in compliance with the rules, the Office of Patent Application Processing (OPAP) will send a Notice to File Corrected Application Papers. This notice gives the applicant a time period of 2 months from the mailing date to file corrected drawings. The time period is extendable under 37 CFR 1.136(a). If corrected drawings are not timely filed, the application will be held abandoned.

If OPAP objects to the drawings in a patent application, the following process occurs:

  1. OPAP sends a Notice to the applicant requiring submission of corrected drawings.
  2. The Notice typically sets a time period of two months for response.
  3. Corrected drawings must be filed in paper form to the mailing address specified in the Notice.
  4. No fee is required for filing the corrected drawings requested by OPAP.

MPEP 507 states:

If OPAP objects to the drawings and sends applicant a Notice requiring submission of corrected drawings within a set time period (usually two months), corrected drawings must be filed, in paper, to the mailing address set forth in the Notice, along with any other items required by OPAP, to avoid abandonment of the application. No fee will be necessary for filing corrected drawings which are required by OPAP.

It’s crucial to respond within the set time period to avoid potential abandonment of the application.

If drawings are not received with a patent application, the following process occurs:

  • The application is assigned a filing date if it meets the minimum requirements under 37 CFR 1.53(b) or 1.53(d).
  • The Office of Patent Application Processing (OPAP) will send a Notice of Omitted Items giving the applicant a time period to file the missing drawings and a petition under 37 CFR 1.182 with the petition fee to have the filing date changed to the date of such filing.
  • If the applicant does not respond to the Notice of Omitted Items, the application will be processed without the drawings.

As stated in the MPEP 507: ‘If drawings are not received with the application, the application is assigned a filing date and the applicant is notified to file drawings within a set time period.’

For more information on drawings, visit: drawings.

Tags: drawings

If corrected drawings are not received within the set time period, the application will be processed for issue or publication based on the originally filed drawings. The failure to submit corrected drawings may result in the application being withdrawn from issue or the patent being printed with defective drawings.

If a drawing is not included with the application but is required for a complete disclosure of the invention, the Office of Patent Application Processing (OPAP) will send a Notice to File Missing Parts giving the applicant a time period of two months from the mailing date of the Notice to file the missing drawing(s). The time period may be extended under 37 CFR 1.136(a).

If a drawing is not acceptable for publication, the Office of Patent Application Processing (OPAP) will object to the drawing and notify the applicant. The applicant will be given a time period of two months from the mail date of the Notice to file acceptable drawings. This period is extendable under 37 CFR 1.136(a) or (b) for patent applications filed under 35 U.S.C. 111, but not for design applications filed under 35 U.S.C. 171. Failure to comply with the Notice within the time period will result in abandonment of the application.

MPEP 507 outlines specific requirements for margins and paper size in patent drawings:

Each sheet must include a top margin of at least 2.5 cm. (1 inch), a left size margin of at least 2.5 cm. (1 inch), a right size margin of at least 1.5 cm. (5/8 inch), and a bottom margin of at least 1.0 cm. (3/8 inch). The size of the sheets on which drawings are made must be either 21.0 cm. by 29.7 cm. (DIN size A4) or 21.6 cm. by 27.9 cm. (8-1/2 by 11 inches);

These requirements are based on 37 CFR 1.84(f) and (g). Adhering to these specifications ensures that the drawings can be properly scanned and reproduced in the patent publication process.

What are the consequences of submitting color drawings in a utility patent application?

Submitting color drawings in a utility patent application has specific consequences and requirements:

  • Color drawings are not ordinarily permitted in utility patent applications.
  • As stated in MPEP 507: “Color drawings are permitted in design applications. For utility patent applications, color drawings are not permitted without a grantable petition.”
  • If color drawings are submitted without an approved petition, OPAP will send a Notice to File Corrected Application Papers.
  • The applicant must either:
    • Replace the color drawings with black and white drawings, or
    • File a grantable petition under 37 CFR 1.84(a)(2) to accept the color drawings.
  • The petition must explain why color drawings are necessary and be accompanied by the fee set forth in 37 CFR 1.17(h).

It’s important to consider whether color drawings are truly necessary for your utility patent application, as they require additional steps and fees in the application process.

For more information on application papers, visit: application papers.

For more information on color drawings, visit: color drawings.

OPAP may object to patent drawings for several reasons, including:

  1. Line quality issues
  2. Missing lead lines
  3. Excessive or non-English text
  4. Incorrect margins or paper size
  5. Improper figure labeling
  6. Illegible photographs
  7. Unauthorized color drawings or photographs

For example, regarding line quality, MPEP 507 states:

OPAP may object to and require corrected drawings within a set time period, if the drawings: (A) have a line quality that is too light to be reproduced (weight of all lines and letters must be heavy enough to permit adequate reproduction) or text that is illegible (reference characters, sheet numbers, and view numbers must be plain and legible). See 37 CFR 1.84(l) and (p)(1);

According to MPEP 507, figures in patent drawings should be labeled as follows:

Each figure must be labeled ‘Fig.’ with a consecutive Arabic numeral (1, 2, etc.) or an Arabic numeral and capital letter in the English alphabet (A, B, etc.). See 37 CFR 1.84(u)(1);

This labeling convention ensures clarity and consistency in referencing figures throughout the patent application and publication. Improper labeling may result in an objection from OPAP and require correction.

The USPTO handles informal drawings in patent applications as follows:

  • If the drawings are informal but otherwise sufficient for examination, the USPTO will accept them provisionally.
  • The drawings will be approved by the Office of Patent Application Processing (OPAP) for publication purposes.
  • Formal drawings will be required if the application is allowed.

According to MPEP 507: ‘If the drawings are informal but otherwise in compliance with 37 CFR 1.121(d), the OPAP will accept the application for purposes of publication and place a ‘Drawing Informalities’ form PTO-948 in the file wrapper.’

The examiner may require formal drawings or corrections in a subsequent office action if necessary for a proper examination or if the application is allowed.

For more information on drawing review, visit: drawing review.

For more information on informal drawings, visit: informal drawings.

For more information on OPAP, visit: OPAP.

When an application is filed with informal drawings, the Office of Patent Application Processing (OPAP) will review the drawings to determine if they can be used for publication purposes. If the drawings are not acceptable for publication purposes, OPAP will object to the drawings and require corrected drawings within a set time period, usually two months. This objection does not affect the filing date of the application, and applicants can correct the drawings later in the examination process if needed.

Yes, drawing corrections can be made after the application has been allowed. However, such corrections must be approved by the examiner before the application can be processed for issue. If extensive corrections are required, the examiner may require that the corrections be filed with a Request for Continued Examination (RCE) under 37 CFR 1.114.

Photographs can be included in patent applications, but there are specific requirements and limitations. According to MPEP 507:

“OPAP may object to and require corrected drawings within a set time period, if the drawings: (F) include photographs of the claimed invention which are capable of illustration by other medium such as ink drawings, and which are illegible after scanning. See 37 CFR 1.84(b)

This means that while photographs are acceptable, they should only be used when the subject matter cannot be accurately depicted in a drawing. Additionally, the photographs must be of sufficient quality to be legible after scanning. If a photograph can be replaced by a clear ink drawing, the USPTO may require such a replacement.

For more information on drawing requirements, visit: drawing requirements.

For more information on patent drawings, visit: patent drawings.

Color drawings or photographs are generally not allowed in patent applications without special permission. MPEP 507 states:

OPAP may object to and require corrected drawings within a set time period, if the drawings: … (G) contain color drawings or color photographs, but not a petition to accept color drawings/photographs.

If an applicant wishes to include color drawings or photographs, they must file a petition to accept them. It’s important to note that the requirement for a black and white photocopy of color drawings/photographs has been eliminated. Applicants should be prepared to justify the need for color in their drawings or photographs when filing such a petition.

MPEP 508 - Distribution (11)

When the USPTO cannot locate a patent or application file after a reasonable search, they follow the procedure outlined in 37 CFR 1.251. The key steps are:

  1. The Office notifies the applicant or patentee about the unlocatable file.
  2. A time period is set for the applicant or patentee to comply with the notice.
  3. The applicant or patentee must respond by either:
    • Providing a copy of their record of all correspondence with the Office (except U.S. patent documents)
    • Producing their record for the Office to copy
    • Stating that they do not possess any record of the correspondence

As stated in MPEP 508.04, “37 CFR 1.251 sets forth a procedure for the reconstruction of the file of a patent application, patent, or any other patent-related proceeding that cannot be located after a reasonable search.”

When a patent or application file cannot be located after a reasonable search, the USPTO has a specific procedure outlined in 37 CFR 1.251. The Office will notify the applicant or patentee and set a time period for compliance with one of the following options:

  • Provide a copy of all correspondence records between the Office and the applicant/patentee, along with a list and a statement of completeness.
  • Produce the applicant’s/patentee’s records for the Office to copy, along with a statement of completeness.
  • If no records are possessed, provide a statement to that effect.

The MPEP states, 37 CFR 1.251 sets forth a procedure for the reconstruction of the file of a patent application, patent, or any other patent-related proceeding that cannot be located after a reasonable search.

For pending applications, failure to comply within the set time period will result in abandonment of the application.

For more information on file reconstruction, visit: file reconstruction.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP 508.02, “After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender. If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW.”

This means that any documents received after a patent is granted or an application is abandoned will not be added to the official record. Instead, they will be either physically returned to the sender or, if already scanned into the Image File Wrapper (IFW) system, electronically closed within the system.

After a patent is granted or an application is abandoned, the USPTO has specific procedures for handling incoming communications. According to the MPEP, After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.

In the case of digital documents, the MPEP states, If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW. This means that the document will be marked as closed in the digital system, effectively removing it from active consideration.

For more information on post-grant communications, visit: post-grant communications.

For more information on USPTO procedures, visit: USPTO procedures.

The time limits for responding to a notice under 37 CFR 1.251 vary depending on whether it’s for an application or a patent:

  • For applications: The Office sets a three-month period for reply, which is extendable under 37 CFR 1.136(a) by up to three additional months, for a maximum of six months.
  • For patents: The Office sets a six-month period for reply, which is not extendable.

MPEP 508.04 states: “The Office will set a time period of three months for reply in a notice under 37 CFR 1.251 in an application. The time period will be extendable under 37 CFR 1.136(a) (unless the notice indicates otherwise) by three months up to a maximum period for reply of six months in an application.” It also notes: “The Office will set a time period of six months for reply in a notice under 37 CFR 1.251 in a patent. The time period will not be extendable under 37 CFR 1.136(a) in a patent.”

The USPTO sets specific time limits for responding to notices about unlocatable files, which differ for applications and patents:

For applications, the MPEP states: The Office will set a time period of three months for reply in a notice under 37 CFR 1.251 in an application. The time period will be extendable under 37 CFR 1.136(a) (unless the notice indicates otherwise) by three months up to a maximum period for reply of six months in an application.

For patents, the time limit is longer: The Office will set a time period of six months for reply in a notice under 37 CFR 1.251 in a patent. The time period will not be extendable under 37 CFR 1.136(a) in a patent because 35 U.S.C. 41(a)(8) only authorizes the Office to charge fees for extensions of time in proceedings involving an application.

It’s important to note that failing to reply within these time limits can have serious consequences, including abandonment of pending applications.

For more information on patent applications, visit: patent applications.

For more information on Time Limits, visit: Time Limits.

When responding to a notice about an unlocatable file, applicants or patentees must provide copies of correspondence, but there are some exceptions. The MPEP states:

Any appendix or information disclosure statement submitted with an application is not contained in the Office’s database. Therefore, the applicant or patentee must also provide a copy of any appendix or information disclosure statement (except in the limited circumstance discussed below) submitted with the application.

However, there’s an important exception for U.S. patent documents:

Since the Office can obtain copies of U.S. patent documents (U.S. patent application publications and patents) from its internal databases, the Office is not requiring applicants or patentees to provide copies of U.S. patent application publications and patents that are among the applicant’s or patentee’s record of the correspondence between the Office and the applicant or patentee for the application, patent, or other proceeding.

This means that while most documents need to be resubmitted, U.S. patent documents can be omitted from the response.

The consequences of failing to respond to a 37 CFR 1.251 notice differ for pending applications and granted patents:

  • For pending applications: Failure to reply within the set time period will result in abandonment of the application. MPEP 508.04 cites 37 CFR 1.251(b): “With regard to a pending application, failure to comply with one of paragraphs (a)(1), (a)(2), or (a)(3) of this section within the time period set in the notice will result in abandonment of the application.”
  • For granted patents: While the patent won’t expire, there may be limitations on the certified copy of the patent file that the Office can produce. MPEP 508.04 states: “While abandonment (or expiration) of a patent is not an issue if a patentee fails to timely comply with a notice under 37 CFR 1.251, in such a situation the only certified copy of the patent file that the Office will be able to produce will be a copy of the patent and a copy of the application-as-filed (which may have an adverse impact during attempts to enforce the patent).”

Additionally, for patents involved in proceedings before the Office, action may be taken under 37 CFR 41.128 or 37 CFR 11.18.

The USPTO has specific rules regarding patent term adjustments when dealing with notices about unlocatable files. According to the MPEP:

If, however, an applicant fails to reply to a notice under 37 CFR 1.251 within three months of its mailing date, any patent term adjustment under 35 U.S.C. 154(b) will be reduced by a period equal to the number of days (if any) beginning on the day after the date that is three months after the mailing date of the notice under 37 CFR 1.251 and ending on the date the reply to the notice under 37 CFR 1.251 was filed.

This reduction in patent term adjustment is based on 35 U.S.C. 154(b)(2)(C)(ii) and 37 CFR 1.704(b). It’s important to note that this reduction applies even if the applicant responds within the overall six-month period allowed for reply (including extensions).

This policy underscores the importance of prompt action in response to such notices, as delays can directly impact the duration of patent protection.

For more information on patent term adjustment, visit: patent term adjustment.

Patent applications are initially processed by the USPTO through electronic scanning and loading into the Image File Wrapper (IFW) system. According to MPEP 508, “All applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. Once documents are loaded into the IFW system, examiners, technical support staff, and other Office personnel will perform further processing and examination using the IFW system.”

Patent applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. As stated in the MPEP, All applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. This digital system allows examiners, technical support staff, and other Office personnel to perform further processing and examination efficiently.

For physical items such as models, exhibits, and specimens, special handling procedures are in place. The MPEP directs readers to MPEP § 608.03 and 608.03(a) for more information on these items.

For more information on image file wrapper, visit: image file wrapper.

For more information on patent application filing, visit: patent application filing.

For more information on USPTO procedures, visit: USPTO procedures.

MPEP 509 - Payment of Fees (28)

The institution of higher education basis allows applicants to qualify for micro entity status if:

  1. The applicant’s employer, from which the applicant obtains the majority of their income, is an institution of higher education as defined in the Higher Education Act of 1965, or
  2. The applicant has assigned, granted, conveyed, or is obligated to assign, grant or convey, a license or ownership interest in the application to such an institution of higher education.

The applicant must also qualify as a small entity. This basis is implemented in 37 CFR 1.29(d).

The USPTO requires a security code for credit card payments made through its website. According to MPEP 509:

Credit card payment submissions made on the USPTO website at www.uspto.gov must include the 3-digit or 4-digit security code associated with the credit card in addition to the credit card number. The security code will not be required when the paper Credit Card Payment Form (PTO-2038) or other written authorization is submitted.

Key points about the security code requirement:

  • It’s part of an authentication procedure to reduce fraudulent or unauthorized credit card use.
  • The code verifies that the physical card is in the cardholder’s possession.
  • For DISCOVER®, MASTERCARD®, and VISA®, it’s a 3-digit code on the back of the card.
  • For AMERICAN EXPRESS®, it’s a 4-digit code on the front of the card.
  • If you can’t read the security code, contact your card issuer.

This requirement enhances security for online transactions but doesn’t apply to paper submissions using Form PTO-2038.

To learn more:

The Credit Card Payment Form (PTO-2038) is a specific form provided by the USPTO for making credit card payments for patent and trademark process fees. According to MPEP 509:

Credit Card Payment Form (PTO-2038) should be used when paying a patent process or trademark process fee (or the fee for an information product) by credit card, unless the payment is being made using the USPTO patent electronic filing system.

Key points about the form:

  • It can be downloaded from the USPTO website at www.uspto.gov/PatentForms.
  • It’s not required (and should not be used) when making credit card payments via EFS-Web or other electronic filing systems.
  • Using this form helps keep credit card information confidential, as the USPTO does not include it among records open to public inspection.

Failure to use this form when submitting a paper credit card payment may result in the credit card information becoming part of the public record.

To learn more:

Tags: patent fees

What is a USPTO deposit account and how does it work?

A USPTO deposit account is a pre-established account that allows for convenient payment of fees to the United States Patent and Trademark Office. According to MPEP 509:

“A deposit account is a convenient method for individuals or firms to establish a pre-paid account with the USPTO to facilitate the payment of fees.”

Here’s how USPTO deposit accounts work:

  • You deposit funds into the account in advance
  • Fees can be automatically deducted from the account when filing applications or paying other fees
  • Minimum balance requirements apply (currently $1,000 for individuals, $5,000 for law firms)
  • Account holders receive monthly statements
  • Useful for frequent filers or those managing multiple applications

To open a deposit account, you need to complete Form PTO-2232 and submit it to the USPTO with an initial deposit. This method can streamline fee payments and reduce the risk of insufficient fee issues.

To learn more:

To learn more:

What happens if there are insufficient funds when paying USPTO fees?

If there are insufficient funds when paying USPTO fees, several consequences may occur:

  • The fee payment will be considered incomplete.
  • Your application or request may not be processed.
  • You may incur additional fees or penalties.
  • In some cases, you might lose filing date benefits.

The MPEP 509 warns, “If the Office receives a check drawn on a deposit account with insufficient funds, the fee will be considered unpaid.” For electronic payments, “If the electronic fund transfer is refused, or if the credit card is declined or invalid, the fee will be considered unpaid.” It’s crucial to ensure sufficient funds are available to avoid these issues and potential delays in your patent or trademark process.

To learn more:

Tags: USPTO fees

If an applicant pays an insufficient fee to the USPTO, the Office will notify the applicant and provide an opportunity to submit the remaining balance. According to MPEP 509:

If the fee paid by the applicant is insufficient, either because the notice specified an incorrect dollar amount for the fee or because of a fee increase effective after the mailing of the notice and before payment of the fee by the applicant, the applicant should be notified in writing by the Office of the fee insufficiency and given a new time period in which to submit the remaining balance.

The notification will include:

  • The reason for the additional fee requirement
  • An explanation of why the original fee was incorrect or insufficient
  • A new time period for submitting the remaining balance

This process helps ensure that applicants have a fair opportunity to complete their fee payments and avoid abandonment of their applications due to fee issues.

To learn more:

What happens if I overpay a patent fee to the USPTO?

If you overpay a patent fee to the USPTO, you may be eligible for a refund. The MPEP 509 states: ‘In the event that an amount is paid by mistake or in excess of that required, a refund may be made only if a petition for refund is filed within 2 years after the date the fee was paid.’

To request a refund:

  1. File a petition for refund within 2 years of the payment date
  2. Clearly explain the reason for the overpayment
  3. Provide evidence of the overpayment

It’s important to note that not all overpayments are automatically refunded, so proactive action is necessary to recover excess fees.

To learn more:

If you lose entitlement to micro entity status, you must:

  1. File a notification of loss of entitlement to micro entity status in the application or patent
  2. Pay the required fee in the small entity or undiscounted amount, as appropriate

The notification must be filed prior to or at the time of paying the earliest fee after the date on which status as a micro entity is no longer appropriate. As stated in 37 CFR 1.29(i): ‘Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.’

Micro entities receive a 75% reduction on many USPTO fees, including:

  • Filing fees (nonprovisional and provisional)
  • Search fees
  • Examination fees
  • Issue fees
  • Appeal fees
  • Maintenance fees
  • Patent Trial and Appeal Board fees

The micro entity discount applies to most fees ‘for filing, searching, examining, issuing, appealing, and maintaining patent applications and patents.’

Improperly claiming micro entity status can have serious consequences:

  • It may be considered fraud on the USPTO if done knowingly
  • It can result in the patent being held unenforceable
  • Improperly paid fees will need to be corrected, which may include late fees

MPEP 509.04 warns: ‘Any attempt to fraudulently establish status as a micro entity, or pay fees as a micro entity, shall be considered as a fraud practiced or attempted on the Office. Improperly, and with intent to deceive, establishing status as a micro entity, or paying fees as a micro entity, shall be considered as a fraud practiced or attempted on the Office.’

To qualify for micro entity status, an applicant must meet the following requirements:

  • Qualify as a small entity
  • Not be named as an inventor on more than 4 previously filed patent applications
  • Not have a gross income exceeding 3 times the median household income in the previous calendar year
  • Not have assigned, licensed, or be obligated to assign or license rights to an entity that exceeds the gross income limit

Alternatively, an applicant can qualify if they are employed by or have assigned rights to an institution of higher education.

What are the consequences of submitting insufficient fees for a patent application?

Submitting insufficient fees for a patent application can have significant consequences. According to MPEP 509:

“An application filed with insufficient basic filing fee, search fee, examination fee, or oath or declaration will be treated as an incomplete application under 37 CFR 1.53(f) and will not be given a filing date until the filing fee is received.”

This means:

  • Your application won’t receive a filing date until the correct fees are paid
  • This delay could affect your priority date
  • If not corrected promptly, the application may be considered abandoned

It’s crucial to ensure all required fees are paid in full when submitting a patent application to avoid these issues.

To learn more:

What are the consequences of bounced checks or insufficient funds for USPTO fee payments?

Submitting a check that bounces or having insufficient funds for USPTO fee payments can have serious consequences. The MPEP 509 states: ‘If any fee is paid by a check which is uncollectible or is returned unpaid, or if any payment is made in an amount less than the required amount, the fee payment shall be regarded as incomplete and the processing of the application or other filing shall be held in abeyance until the full fee payment is made.’

Consequences may include:

  • Suspension of application processing
  • Potential loss of filing date
  • Additional fees or penalties
  • Possible disciplinary action for repeated occurrences

To avoid these issues, ensure sufficient funds are available and consider using more reliable payment methods like electronic funds transfer or credit cards.

To learn more:

Tags: USPTO fees

What are the accepted payment methods for patent fees?

The USPTO accepts various payment methods for patent fees:

  • Credit or debit card
  • Electronic funds transfer (EFT)
  • Deposit account
  • Check or money order

As stated in MPEP 509: ‘Fees may be paid by U.S. credit card, electronic funds transfer (EFT), deposit account, check or money order.’ Electronic payment methods are preferred for their efficiency and speed.

To learn more:

The USPTO accepts various methods of payment for patent and trademark process fees. According to MPEP 509, the primary methods include:

  • Credit cards (AMERICAN EXPRESS®, DISCOVER®, MASTER CARD®, and VISA®)
  • Deposit accounts
  • Electronic funds transfer (EFT)
  • Other forms of payment accepted by the Office

It’s important to note that credit card payments are subject to a transaction maximum. As stated in the MPEP: Effective June 1, 2015, the credit card transaction maximum is $24,999.99 as specified in section 7045 of the ‘Treasury Financial Manual.’ This limit does not apply to other payment methods.

To learn more:

Tags: USPTO fees

The USPTO requires clear itemization of fees to ensure proper accounting. According to MPEP 509:

37 CFR 1.22(b) sets forth that fees must be itemized in such a manner that it is clear for which purpose fees are paid. The Office may return fees that are not itemized.

However, the MPEP clarifies that the itemization requirement is not meant to create problems when the purpose is clear:

  • A reference to ‘filing fee(s)’ is sufficient to cover all types of filing fees.
  • In later submissions, ‘filing fee(s)’ would also cover surcharges.
  • A reference to ‘any corresponding fee under 37 CFR 1.16’ covers any fee under that section.

The key is to provide enough information for the USPTO to understand the purpose of the payment.

To learn more:

Tags: patent fees

Micro entity status, once properly established, generally remains in effect until:

  • A fee is paid in the small entity or undiscounted amount
  • A notification of loss of entitlement to micro entity status is filed
  • The issue fee or a maintenance fee is due

However, the applicant has a continued obligation to verify eligibility for micro entity status each time a fee is paid. As stated in 37 CFR 1.29(g): ‘a fee may be paid in the micro entity amount only if status as a micro entity as defined in paragraph (a) or (d) of this section is appropriate on the date the fee is being paid.’

For micro entity status, gross income is determined as follows:

  • Based on the calendar year preceding the year a fee is paid
  • Uses the definition of gross income in section 61(a) of the Internal Revenue Code
  • Compared to three times the median household income as reported by the Bureau of the Census
  • For non-US income, converted using the average currency exchange rate for the relevant calendar year

The USPTO website provides the current maximum qualifying gross income limit.

The USPTO has specific procedures for handling refunds of fees paid by credit card. According to MPEP 509:

35 U.S.C. 42(d) and 37 CFR 1.26 (which concern refund of patent and trademark fees) also apply to requests for refund of fees paid by credit card. Any refund of a fee paid by credit card will be by a credit to the credit card account to which the fee was charged. See 37 CFR 1.26(a).

Key points about USPTO refunds for credit card payments:

  • Refunds are processed as credits to the original credit card account used for payment.
  • The same laws and regulations governing refunds of patent and trademark fees apply to credit card payments.
  • For information on which fees are refundable, refer to MPEP § 607.02 regarding returnability of fees.

It’s important to note that refund requests are subject to specific criteria and time limitations, so applicants should review the relevant regulations when seeking a refund.

To learn more:

Tags: patent fees

The application filing limit for micro entity status works as follows:

  • An applicant must not have been named as an inventor on more than 4 previously filed patent applications
  • This limit excludes provisional applications, foreign applications, and PCT applications where the basic national fee was not paid
  • Applications filed as a result of previous employment where rights were assigned don’t count towards the limit

MPEP 509.04(a) clarifies: ‘It does not matter how long ago the previous applications were filed or whether the previously filed applications are pending, patented, or abandoned; they are still included when counting to determine whether the application filing limit has been reached.’

How do I set up a deposit account with the USPTO?

To set up a deposit account with the USPTO:

  1. Visit the USPTO Deposit Accounts page
  2. Download and complete the Deposit Account Application Form
  3. Submit the form with an initial deposit (minimum $1,000)
  4. Wait for account approval and receive your account number

According to MPEP 509: ‘A deposit account may be established by submitting a completed Deposit Account Application Form with an initial deposit of at least $1,000.’ This account can be used for future fee payments, offering convenience for frequent USPTO transactions.

To learn more:

To certify micro entity status, you must file a certification form with the USPTO. The USPTO provides two forms:

  • Form PTO/SB/15A for certifying under the gross income basis
  • Form PTO/SB/15B for certifying under the institution of higher education basis

The certification must be signed by an authorized party as defined in 37 CFR 1.33(b). It should be filed prior to or at the time of paying the first fee as a micro entity.

How can I pay patent fees to the USPTO?

The USPTO offers several methods for paying patent fees. According to MPEP 509:

“Fees can be paid: (A) by credit card, (B) by electronic funds transfer (EFT), (C) by check, (D) by money order, (E) by deposit account, or (F) in cash (for hand-carried applications only).”

Here’s a breakdown of these payment methods:

  • Credit Card: Accepted online or by mail/fax using Form PTO-2038
  • Electronic Funds Transfer (EFT): Available through the USPTO’s Electronic Filing System (EFS-Web)
  • Check or Money Order: Made payable to the Director of the USPTO
  • Deposit Account: A pre-established account with the USPTO
  • Cash: Only for in-person payments at the USPTO office

For most applicants, online payment methods (credit card or EFT) are the most convenient and efficient options.

To learn more:

Tags: patent fees

How can I pay fees to the USPTO electronically?

The USPTO offers several electronic payment options for paying fees:

  • Credit or Debit Card: You can pay using major credit or debit cards through the USPTO’s secure online system.
  • Electronic Funds Transfer (EFT): This allows for direct transfer from your bank account to the USPTO.
  • USPTO Deposit Account: Maintain a pre-funded account with the USPTO for easy fee payments.

According to MPEP 509, “The Office accepts the following forms of payment: […] by credit card, by electronic funds transfer (EFT), or by a USPTO deposit account.” Electronic payments are convenient and often processed more quickly than other methods.

To learn more:

Tags: USPTO fees

Can I pay patent fees in foreign currency?

No, the USPTO does not accept foreign currency for patent fee payments. According to MPEP 509: ‘All payments of money required for USPTO fees or services must be made in U.S. dollars and in the form of a cashier’s or certified check, Treasury note, national bank notes, or United States Postal Service money order.’

If you’re an international applicant, you’ll need to arrange for payment in U.S. dollars. Options include:

  • Using an international credit card that can process payments in USD
  • Establishing a U.S. bank account
  • Using a registered U.S. attorney who can make payments on your behalf

It’s advisable to plan ahead for currency conversion to ensure timely payment of USPTO fees.

To learn more:

To learn more:

Tags: USPTO fees

Yes, foreign applicants can qualify for micro entity status if they meet all the requirements. The USPTO states in MPEP 509.04(a):

Small entities may claim reduced fees regardless of the country in which they are located. There is no restriction requiring that the person, small business concern, or nonprofit organization be located in the United States.

For applicants with income in foreign currency, 37 CFR 1.29(c) specifies: ‘If an applicant’s, inventor’s, joint inventor’s, or entity’s gross income in the preceding calendar year is not in United States dollars, the average currency exchange rate, as reported by the Internal Revenue Service, during that calendar year shall be used to determine whether the applicant’s, inventor’s, joint inventor’s, or entity’s gross income exceeds the threshold specified in paragraph (a)(3) or (4) of this section.’

Are there any restrictions on paying USPTO fees by credit card?

Yes, there are some restrictions when paying USPTO fees by credit card:

  • There’s a daily limit on credit card transactions.
  • Some types of fees may not be eligible for credit card payment.
  • Only certain credit cards are accepted.

The MPEP 509 states, “The Office will not accept a general authorization to charge all fees, or all fees in a specific case, to a credit card.” Additionally, “Credit Card Payment Form PTO-2038 should be used when paying a patent or trademark fee (or related service fee) by credit card, unless the payment is being made via EFS-Web.” It’s important to check the current USPTO guidelines for any updates to credit card payment policies.

To learn more:

Tags: USPTO fees

Are there any fee reductions or waivers available for USPTO patent fees?

Yes, the USPTO offers fee reductions for certain applicants. According to MPEP 509, “Certain fees may be reduced if the applicant qualifies as a small entity or micro entity.” Here’s a brief overview:

  • Small Entity: Individuals, small businesses, and nonprofit organizations may qualify for a 50% fee reduction.
  • Micro Entity: Certain applicants may qualify for a 75% fee reduction if they meet specific income and filing requirements.

To determine if you qualify and for detailed information on how to claim these statuses, refer to MPEP 509.02 for Small Entity Status and MPEP 509.04 for Micro Entity Status. Always ensure you meet all requirements before claiming a reduced fee status.

To learn more:

MPEP 510 - U.S. Patent and Trademark Office Business Hours (6)

To access USPTO public information facilities:

  • A valid Public User or Visitor’s badge is required
  • Badges can be obtained from the Office of Security next to the Public Search Facility
  • An On-line Service Card is required for access to all Public Search Facilities and on-line systems

MPEP 510 states: “A valid Public User or Visitor’s badge is required to enter USPTO facilities. This badge can be obtained from the Office of Security next door to the Public Search Facility located on the first floor of the Madison East Building, 600 Dulany Street, Alexandria, VA 22314.”

The official business hours of the U.S. Patent and Trademark Office (USPTO) are:

  • 8:30 a.m. to 5:00 p.m., Monday through Friday
  • Excluding federal holidays in the District of Columbia

As stated in MPEP 510: “The U.S. Patent and Trademark Office (USPTO or Office) working hours are 8:30 a.m. to 5:00 p.m., Monday through Friday, excluding federal holidays in the District of Columbia.”

The Public Search Facility in Alexandria has extended hours compared to the regular USPTO business hours:

  • 8:00 a.m. to 8:00 p.m., Monday through Friday
  • Excluding federal holidays in the District of Columbia

As stated in MPEP 510: “The hours for the Public Search Facility in Alexandria are 8:00 a.m. to 8:00 p.m., Monday through Friday, excluding federal holidays in the District of Columbia.”

To find out if the USPTO is officially closed on any particular day, you can:

  • Call 1-800-PTO(786)-9199
  • Call (571) 272-1000

These phone numbers are provided in MPEP 510 for obtaining information about USPTO closures.

When the entire USPTO is officially closed for business for an entire day due to adverse weather or other causes:

  • The day is considered a “Federal holiday within the District of Columbia” under 35 U.S.C. 21
  • Any action or fee due on such a day may be taken or paid on the next succeeding business day the Office is open

MPEP 510 states: “When the entire USPTO is officially closed for business for an entire day, for reasons due to adverse weather or other causes, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21. Any action or fee due on such a day may be taken, or fee paid, on the next succeeding business day the Office is open.”

To learn more:

The USPTO is not open for filing correspondence on Saturdays, Sundays, or federal holidays within the District of Columbia. However, there are exceptions:

  • Correspondence deposited as Priority Mail Express® with the USPS in accordance with 37 CFR 1.10 is considered filed on the date of deposit, even on weekends or holidays
  • Electronic filing systems may be available 24/7, but the official filing date will be the next business day

MPEP 510 cites 37 CFR 1.6(a)(1): “The Patent and Trademark Office is not open for the filing of correspondence on any day that is a Saturday, Sunday or Federal holiday within the District of Columbia.”

MPEP 511 - Postal Service Interruptions and Emergencies (14)

If you cannot file your patent application electronically or by Priority Mail Express® due to an emergency, consider the following options:

  1. Use first-class mail with a Certificate of Mailing under 37 CFR 1.8
  2. Hand-deliver the application to the USPTO, if possible
  3. If the emergency is a designated postal service interruption, follow the specific instructions provided by the USPTO on their website or in the Official Gazette

Remember that the provisions for postal emergencies only apply to actual USPS service interruptions, not other circumstances like computer failures or office inaccessibility.

As stated in MPEP 511: “Applicants are cautioned that the provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) only apply to postal interruptions and emergencies. The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) do not provide for granting of a filing date to correspondence as of the date on which it would have been filed but for other exigencies, such as the unavailability of a computer or word processing equipment, or the inaccessibility of an office or building other than a USPS facility.”

As of July 28, 2013, the United States Postal Service (USPS) renamed ‘Express Mail’ to ‘Priority Mail Express’. According to MPEP 511:

“Effective July 28, 2013, the United States Postal Service (USPS) changed the name of ‘Express Mail’ to ‘Priority Mail Express.’ All characteristics of the ‘Priority Mail Express’ service are the same as those of the former ‘Express Mail’ service (although the mailing labels differ).”

This change is important for patent applicants to note, as the USPTO’s rules and procedures now refer to ‘Priority Mail Express’ instead of ‘Express Mail’. However, the service characteristics and benefits for patent filings remain the same. When using this service for USPTO correspondence, ensure you use the correct addresses as specified in 37 CFR 1.1 and avoid using the ‘Hold for Pickup’ option, as the USPTO does not pick up mail.

To learn more:

In the event of a postal interruption or emergency, the USPTO will take the following actions:

  • Place an announcement on the USPTO website at www.uspto.gov
  • Publish a notice in the Official Gazette

These communications will provide instructions about filing patent applications and other patent-related papers. As stated in MPEP 511:

“In the event of a postal interruption or emergency, an announcement will be placed on the USPTO website at www.uspto.gov and a notice will be published in the Official Gazette, providing instructions about the filing of patent applications, and other papers related to patent applications and patents.”

This ensures that applicants have clear guidance on how to proceed during such circumstances.

To learn more:

In the event of a postal interruption or emergency:

  • An announcement will be placed on the USPTO website at www.uspto.gov
  • A notice will be published in the Official Gazette
  • These communications will provide instructions about filing patent applications and other papers related to patent applications and patents

The USPTO Director may prescribe rules considering papers or fees filed on the date they would have been deposited with the USPS, but for postal service interruptions or emergencies.

As stated in MPEP 511: “In the event of a postal interruption or emergency, an announcement will be placed on the USPTO website at www.uspto.gov and a notice will be published in the Official Gazette, providing instructions about the filing of patent applications, and other papers related to patent applications and patents.”

To prove a filing delay due to a postal emergency, applicants must provide sufficient evidence. According to MPEP 511:

The nature of the evidence required by the Office to establish that the paper was timely filed will depend upon the circumstances of the particular emergency and the nature of the filing.

This evidence may include:

  • Documentation of the postal service interruption or emergency
  • Proof of attempted mailing during the affected period
  • Explanation of how the emergency directly impacted the filing
  • Any official notices or bulletins related to the postal disruption

The USPTO will evaluate each case individually to determine if the delay was indeed caused by the designated emergency.

To learn more:

The USPTO recommends several methods for filing new patent applications, with some being more advantageous than others. According to MPEP 511, the recommended methods are:

  1. Electronic Filing System (EFS-Web or Patent Center): This is the most recommended method. As stated in MPEP 511: “In general, applicants should consider filing new patent applications (as well as patent-related correspondence) via the USPTO patent electronic filing system (EFS-Web or Patent Center) whenever permitted.”
  2. Priority Mail Express®: If not filing electronically, this is the next best option. MPEP 511 notes: “The Office strongly recommends that applicants file new applications by Priority Mail Express® in accordance with 37 CFR 1.10 (if such applications are not filed via EFS-Web) because such correspondence will be accorded the date of deposit in Priority Mail Express® with the USPS as the filing date.”
  3. Hand-delivery: Applications can be hand-delivered to the USPTO.
  4. First-class mail: While possible, this method carries risks of delay and is not recommended for new applications.

It’s important to note that new applications cannot be filed by facsimile. For more details on electronic filing, refer to the Legal Framework for Patent Electronic System on the USPTO website.

To learn more:

The USPTO strongly recommends the following methods for filing new patent applications:

  1. Electronic Filing System (EFS-Web or Patent Center): This is the preferred method whenever permitted.
  2. Priority Mail Express®: If not filing electronically, use this method in accordance with 37 CFR 1.10 to secure the date of deposit as the filing date.
  3. Hand-delivery to the USPTO office.

Avoid filing by first-class mail, as it only secures the date of receipt at the USPTO as the filing date, risking delays in delivery.

As stated in MPEP 511: “The Office strongly recommends that applicants file new applications by Priority Mail Express® in accordance with 37 CFR 1.10 (if such applications are not filed via EFS-Web) because such correspondence will be accorded the date of deposit in Priority Mail Express® with the USPS as the filing date.”

Additionally, “In general, applicants should consider filing new patent applications (as well as patent-related correspondence) via the USPTO patent electronic filing system (EFS-Web or Patent Center) whenever permitted.”

The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) have specific limitations when it comes to petitions for filing dates. According to MPEP 511:

“Applicants are cautioned that the provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) only apply to postal interruptions and emergencies. The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) do not provide for granting of a filing date to correspondence as of the date on which it would have been filed but for other exigencies, such as the unavailability of a computer or word processing equipment, or the inaccessibility of an office or building other than a USPS facility.”

This means that these provisions are strictly limited to postal service interruptions or emergencies. They cannot be used for other circumstances that may have prevented timely filing, such as:

  • Computer or equipment failures
  • Office or building inaccessibility (unless it’s a USPS facility)
  • Personal emergencies or other non-postal related issues

Additionally, the statute requires that the correspondence was complete and ready to be deposited with the USPS on the requested filing date, and that the sole reason for non-deposit was the unavailability of postal service due to the designated interruption or emergency.

To learn more:

The USPTO has established procedures to notify the public about postal service interruptions that may affect patent filings. According to MPEP 511:

When the Director designates a postal service interruption or emergency, a notice will be published in the Official Gazette, and will be posted on the USPTO website at www.uspto.gov.

The USPTO’s notification process includes:

  • Publishing a notice in the Official Gazette
  • Posting information on the USPTO website
  • Possibly issuing press releases or other public communications

These notifications typically include:

  • Details about the nature and scope of the interruption
  • Any special procedures or accommodations being made
  • Instructions for applicants affected by the interruption
  • Contact information for further inquiries

It’s crucial for patent applicants and attorneys to regularly check these official sources during potential postal disruptions to stay informed about any changes in filing procedures or deadlines.

To learn more:

During postal service emergencies, the USPTO takes special measures to ensure patent applications are handled appropriately:

  • The USPTO Director may designate the interruption or emergency as a ‘postal service interruption or emergency’ under 35 U.S.C. 21(a).
  • This designation allows for the acceptance of filings that would have been timely filed if not for the postal service interruption or emergency.
  • The USPTO may publish a notice in the Official Gazette and on its website about the designation and any special procedures to be followed.

As stated in MPEP 511: The USPTO will consider on a case-by-case basis whether to waive the date indicated on any certificate of mailing or transmission accompanied by a showing which establishes to the satisfaction of the Director that the delay was due to the emergency.

To learn more:

You can petition the USPTO Director to consider correspondence as filed on a particular date if it was returned or refused by the USPS due to a Priority Mail Express® interruption or emergency. The petition process is outlined in 37 CFR 1.10(g) and (h):

  1. File the petition promptly after becoming aware of the return or refusal
  2. Include the original correspondence or a copy showing the Priority Mail Express® mailing label number
  3. Provide a copy of the Priority Mail Express® mailing label showing the “date accepted” (for returned mail)
  4. Include a statement establishing the original deposit attempt and that the correspondence is the original or a true copy
  5. The USPTO may require additional evidence to verify the interruption or emergency

As stated in MPEP 511: “37 CFR 1.10(g) provides a procedure under which applicant may petition the Director to have correspondence that was returned by the USPS due to an interruption or emergency in Priority Mail Express® service considered as filed on a particular date in the Office.”

If your correspondence is affected by a postal emergency, you can petition the Director to consider it filed on a particular date under certain conditions. The process depends on whether your mail was returned, refused, or unable to be deposited. Here’s a summary of the petition requirements based on MPEP 511:

  1. For returned correspondence (37 CFR 1.10(g)):
    • File promptly after becoming aware of the return
    • Include the original or copy of correspondence with Priority Mail Express® label
    • Provide a statement establishing the original deposit
  2. For refused correspondence (37 CFR 1.10(h)):
    • File promptly after becoming aware of the refusal
    • Include the original or copy of correspondence with Priority Mail Express® label
    • Provide a statement establishing the original attempt to deposit
  3. For correspondence unable to be deposited (37 CFR 1.10(i)):
    • File promptly in a manner designated by the Director
    • Include the original or copy of correspondence
    • Provide a statement establishing that the correspondence would have been deposited but for the emergency

For more detailed information on filing these petitions, refer to MPEP § 513, subsections IX-XI.

To learn more:

Yes, the USPTO has the authority to extend deadlines during a postal service emergency. This is based on the provisions outlined in MPEP 511 and 35 U.S.C. 21(a).

Specifically, MPEP 511 states:

The Director may designate the interruption or emergency as a ‘postal service interruption or emergency’ under 35 U.S.C. 21(a) and provide for ‘tolling’ of the time for filing correspondence, fees, or other papers for a limited time.

This means that:

  • The USPTO Director can officially recognize the emergency
  • Time limits for filing various patent-related documents can be extended
  • The extension is typically for a specific, limited period
  • Applicants may need to provide evidence that their delay was due to the recognized emergency

It’s important to note that while the USPTO has this authority, each situation is evaluated individually, and extensions are not automatically granted.

To learn more:

No, you should not use the “Hold for Pickup” service option when sending Priority Mail Express® to the USPTO. The reasons for this are:

  • The USPTO does not have resources for picking up mail
  • Mail sent using the “Hold for Pickup” service will not reach the Office

Always use the standard Priority Mail Express® Post Office to Addressee service when sending correspondence to the USPTO.

As stated in MPEP 511: “The Office does not have resources for picking up any mail. Therefore mail should NOT be sent using the ‘Hold for Pickup’ service option (whereby the mail is retained at the destination postal facility for retrieval by the addressee). Mail sent using the ‘Hold for pickup’ service will not reach the Office.”

MPEP 512 - Certificate of Mailing or Transmission (22)

While the Certificate of Mailing or Transmission procedure is useful for many types of USPTO correspondence, there are several exceptions. According to 37 CFR 1.8(a)(2), the procedure does not apply to:

  • Filing of national patent application specifications and drawings for the purpose of obtaining an application filing date
  • Filing of correspondence in an international application before the U.S. Receiving Office, U.S. International Searching Authority, or U.S. International Preliminary Examining Authority
  • Filing of an international design application
  • Filing a copy of an international application and the basic national fee to enter the national stage
  • Filing a written declaration of abandonment under 37 CFR 1.138

It’s crucial to note that these exceptions exist to ensure certain critical documents are actually received by the USPTO before they are considered filed.

To learn more:

If you have filed correspondence with a proper Certificate of Mailing or Transmission, but the USPTO has not received it after a reasonable amount of time, you can take action under 37 CFR 1.8(b). The MPEP states:

“37 CFR 1.8(b) permits a party to notify the Office of a previous mailing through the U.S. Postal Service, or transmission by facsimile or EFS-Web, of correspondence when a reasonable amount of time has elapsed from the time of mailing or transmission of the correspondence.”

To rectify this situation:

  1. Promptly notify the Office of the previous mailing or transmission
  2. Supply a duplicate copy of the previously mailed or transmitted correspondence
  3. Provide a statement attesting to the previous timely mailing or transmission

It’s important to act quickly once you become aware that the Office has not received your correspondence, rather than waiting until the end of the reply period.

To learn more:

If you’ve misused a Certificate of Mailing or Transmission, it’s important to address the issue promptly and honestly. The USPTO takes the integrity of these certificates seriously. The MPEP states:

Misuse of a Certificate of Mailing under 37 CFR 1.8 or improperly claiming the benefit of 37 CFR 1.10 which appears to be more than a one-time, inadvertent error should be brought to the attention of the Office of Enrollment and Discipline.

If the misuse was a one-time, inadvertent error, you should:

  1. Notify the USPTO as soon as you become aware of the error.
  2. Provide a full explanation of the circumstances.
  3. If possible, submit the correct documentation or information.
  4. Be prepared for the possibility that your submission may be considered late, which could have consequences for your application or proceeding.

For repeated or intentional misuse, the matter may be referred to the Office of Enrollment and Discipline, which could result in more serious consequences. It’s always best to use Certificates of Mailing or Transmission carefully and honestly to maintain the integrity of the patent application process.

The purpose of a certificate of mailing or transmission in patent applications is to provide evidence of timely filing when correspondence is not received by the USPTO or is received late. As stated in MPEP 512:

The Certificate of Mailing or Transmission procedure does not apply to papers mailed in a foreign country.

This procedure allows applicants to prove that they submitted their correspondence on time, even if it’s delayed or lost in transit.

To learn more:

While both the Certificate of Mailing (37 CFR 1.8) and Priority Mail Express (37 CFR 1.10) procedures can be used to establish timely filing of USPTO correspondence, they have some key differences:

  • Certificate of Mailing can be used with any class of mail, while Priority Mail Express is a specific USPS service.
  • Certificate of Mailing uses the date of deposit with USPS as the filing date, while Priority Mail Express uses the date of deposit as shown by the “date accepted” on the mailing label.
  • Certificate of Mailing cannot be used for new patent applications, while Priority Mail Express can establish a filing date for new applications.
  • Certificate of Mailing requires a signed certificate, while Priority Mail Express requires the mailing label to be affixed to the correspondence.

The MPEP notes: “New patent applications filed in accordance with 37 CFR 1.10 will be stamped by the Office with the date of deposit as Priority Mail Express® with the United States Postal Service.”

Both procedures have specific requirements and limitations, so it’s important to consult the full text of 37 CFR 1.8 and 37 CFR 1.10 when deciding which to use.

A Certificate of Mailing or Transmission is a procedure under 37 CFR 1.8 that allows correspondence to be considered timely filed with the USPTO if it meets certain conditions. As stated in the MPEP:

“Under 37 CFR 1.8, a person may state on certain papers directed to the Office (some exceptions are stated in 37 CFR 1.8), the date on which the paper will be deposited in the United States Postal Service, transmitted by facsimile or transmitted via the USPTO electronic filing system (EFS-Web). If the date stated is within the period for reply, the reply in most instances will be considered to be timely.”

This procedure can be crucial for meeting deadlines, even if the actual receipt of the correspondence by the USPTO occurs after the deadline.

To learn more:

A certificate of mailing for USPTO correspondence must include specific information to be valid. According to MPEP 512, the following information is required:

  • The date of deposit or transmission
  • The application number (for patent applications)
  • A statement that the correspondence is being deposited with the USPS or transmitted to the USPTO
  • The signature of the person depositing or transmitting the correspondence

The MPEP states:

The certificate must state that the correspondence is being deposited with the United States Postal Service with sufficient postage as first class mail, or transmitted to the Office on the date of the certificate.

Ensure all these elements are included to make your certificate of mailing valid and effective.

To learn more:

If the Certificate of Mailing or Transmission is omitted from a paper, the USPTO will treat the paper as though it was not received. According to MPEP 512:

“If the certification of mailing or transmission is omitted and the paper is later received by the U.S. Patent and Trademark Office, the paper will be considered as having been filed as of the date of receipt in the Office.”

This means that without the certificate, the paper’s filing date will be the actual date it’s received by the USPTO, which could potentially be later than intended and may have significant consequences for patent applications or other time-sensitive submissions.

To learn more:

If correspondence with a Certificate of Mailing or Transmission is not received by the USPTO after a reasonable amount of time, you can take steps to notify the Office and provide evidence of the previous timely filing. According to 37 CFR 1.8(b):

In the event that correspondence is considered timely filed by being mailed or transmitted in accordance with paragraph (a) of this section, but not received in the U.S. Patent and Trademark Office after a reasonable amount of time has elapsed from the time of mailing or transmitting of the correspondence […] the correspondence will be considered timely if the party who forwarded such correspondence: (1) Informs the Office of the previous mailing or transmission of the correspondence promptly after becoming aware that the Office has no evidence of receipt of the correspondence; (2) Supplies an additional copy of the previously mailed or transmitted correspondence and certificate; and (3) Includes a statement that attests on a personal knowledge basis or to the satisfaction of the Director to the previous timely mailing, transmission or submission.

It’s recommended to check the private Patent Application Information Retrieval (PAIR) System first to see if the correspondence has been entered into the application file before notifying the Office.

The USPTO has specific procedures for handling papers that include a Certificate of Mailing or Transmission. According to the MPEP:

“The Mail Center of the Office of Patent Application Processing (OPAP) will continue to date stamp the actual date of receipt of all papers received by mail in the Office. No attempt will be made to retain the envelopes in which the papers are received or to indicate on the papers the postal cancellation date (postmark).”

Key points in the USPTO’s handling process include:

  • The actual receipt date is stamped on all papers
  • The date on the Certificate is used to determine if the paper was filed within the period for reply
  • If the paper is received after the period for reply, but the Certificate date is within the period, the paper is considered timely filed
  • A notation (e.g., “C of Mail 11/10/97”) is made next to the Office Date Stamp to indicate the Certificate date

It’s important to note that while the Certificate date is used to determine timeliness, the actual receipt date is used for all other purposes, including calculating subsequent deadlines.

To learn more:

The USPTO has specific procedures for handling correspondence with a Certificate of Mailing or Transmission:

  1. All papers received by mail are date stamped with the actual date of receipt, regardless of any Certificate of Mailing.
  2. For papers with a Certificate of Mailing or Transmission, the date on the certificate is used to determine if the paper was filed within the period for reply.
  3. If the paper is received within the period for reply, the actual receipt date is used for all purposes.
  4. If the paper is received after the period for reply, but the certificate date is within the period, the paper is considered timely filed. In this case, a notation is made next to the ‘Office Date’ stamp indicating the certificate date (e.g., ‘C of Mail 11/10/97’).
  5. For facsimile transmissions, the date stamped is the date the complete transmission is received, unless that date is a Saturday, Sunday, or Federal holiday within the District of Columbia, in which case the date stamped will be the next succeeding business day.
  6. For EFS-Web submissions, the receipt date is the date the correspondence is received at the USPTO’s correspondence address when it was officially submitted, which can include weekends and holidays.

The MPEP states: “The date indicated on the Certificate of Mailing or of Transmission will be used by the Office only to determine if the paper was deposited in the United States Postal Service, transmitted by facsimile or transmitted via EFS-Web within the period for reply.”

The Certificate of Mailing or Transmission can significantly affect the timeliness of USPTO submissions. According to MPEP 512:

“The date indicated on the Certificate of Mailing or Transmission will be used by the Office as the date of receipt of the paper or fee.”

This means that even if there are delays in postal or electronic transmission, your submission will be considered timely if the certificate date is within the required deadline. However, it’s important to note that the actual mailing or transmission must occur on or before the certificate date. False certificates can lead to serious consequences, including invalidation of the submission and potential disciplinary action.

To learn more:

The Certificate of Mailing or Transmission can affect filing date calculations in several ways:

  1. For timely filing: If a paper with a certificate is received after a deadline but the certificate date is within the deadline, the paper is considered timely filed. The MPEP states: “If the date stated is within the period for reply, the reply in most instances will be considered to be timely.”
  2. For actual receipt date: The USPTO will continue to stamp the actual date of receipt on all papers. According to the MPEP: “The receipt date stamped on all papers will also be the date which is entered on Office records and from which any subsequent periods are calculated.”
  3. For subsequent deadlines: If a paper starts a new period for reply, that period is calculated from the actual receipt date, not the certificate date. For example: “If the last day to reply to a final Office action was November 10, 2014, and applicant deposited a Notice of Appeal with fee in the U.S. mail on November 10, 2014, and so certified, that appeal is timely even if it was not received in the U.S. Patent and Trademark Office until November 12, 2014. Since the date of receipt of the notice of appeal will be used to calculate the time at which the brief is due, the brief was due on January 12, 2015.”

It’s important to note that while the certificate can establish timely filing, it doesn’t change the actual receipt date for other USPTO processing purposes.

To use a Certificate of Mailing or Transmission, you must include a signed certification with your correspondence. The MPEP provides suggested formats for these certificates:

“The following are suggested formats for either a Certificate of Mailing or Certificate of Transmission under 37 CFR 1.8(a). The certification may be included with all correspondence concerning this application or proceeding to establish a date of mailing or transmission under 37 CFR 1.8(a).”

The certificate should include:

  • A statement certifying the date of mailing or transmission
  • The signature of the person making the certification
  • The application number (if known)

It’s important to note that the certificate must be signed by someone with a reasonable basis to expect the correspondence would be mailed or transmitted on or before the date indicated.

To learn more:

To properly use a certificate of mailing for patent correspondence, follow these steps:

  1. Prepare your correspondence.
  2. Attach a certificate of mailing to each piece of correspondence.
  3. Include the required information on the certificate.
  4. Sign and date the certificate.
  5. Mail the correspondence with the attached certificate.

According to MPEP 512:

Each piece of correspondence for which a certificate is filed must include a signed and dated certificate which sets forth the date of deposit or transmission.

Ensure that you follow these guidelines to properly use the certificate of mailing procedure.

To learn more:

The Certificate of Mailing procedure does not apply to papers mailed from a foreign country. However, the Certificate of Transmission procedure can be used for correspondence transmitted to the USPTO from a foreign country, with some conditions. The MPEP states:

The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.

This means that while you can’t use a Certificate of Mailing for papers sent by postal mail from outside the United States, you can use a Certificate of Transmission for faxes or EFS-Web submissions from foreign countries, as long as the specific type of correspondence is eligible for the certificate procedure.

The use of a Certificate of Mailing or Transmission for international patent applications is limited and depends on the specific type of correspondence. According to the MPEP and 37 CFR 1.8(a)(2)(i)(D)-(F), the certificate procedure does not apply to:

  • The filing of an international application for patent
  • The filing of correspondence in an international application before the U.S. Receiving Office, the U.S. International Searching Authority, or the U.S. International Preliminary Examining Authority
  • The filing of a copy of the international application and the basic national fee necessary to enter the national stage

However, the Certificate of Transmission procedure can be used for some correspondence related to international applications if it’s being transmitted to the USPTO and is not otherwise prohibited. The MPEP states:

The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.

It’s crucial to carefully review the specific requirements and limitations for international application correspondence to ensure proper and timely filing.

Yes, you can use a Certificate of Transmission for documents filed electronically through the USPTO’s Electronic Filing System (EFS-Web). The MPEP provides a suggested format for a Certificate of EFS-Web Transmission:

I hereby certify that this correspondence is being transmitted via the U.S. Patent and Trademark Office electronic filing system (EFS-Web) to the USPTO on [Date].

However, it’s important to note that EFS-Web submissions have their own timestamp system. According to 37 CFR 1.6(a)(4):

Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

This date can be a Saturday, Sunday, or federal holiday within the District of Columbia. The certificate can provide an additional layer of documentation for your submission date, but the EFS-Web timestamp is generally considered authoritative for determining the receipt date of electronic submissions.

The use of a Certificate of Mailing or Transmission for correspondence from outside the United States depends on the method of transmission. The MPEP clarifies:

“The Certificate of Mailing procedure does not apply to papers mailed in a foreign country. The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.”

Therefore:

  • You cannot use a Certificate of Mailing for papers mailed from outside the U.S.
  • You can use a Certificate of Transmission for facsimile or EFS-Web transmissions from outside the U.S., as long as the correspondence is eligible for this procedure.

It’s important to verify that your specific type of correspondence is eligible for the Certificate of Transmission procedure before using it from outside the United States.

To learn more:

No, the Certificate of Mailing or Transmission cannot be used for all USPTO correspondence. The MPEP 512 specifies certain types of correspondence that are excluded from the certificate practice:

“The Certificate of Mailing or Transmission procedure does not apply to: (A) Relative to Patents and Patent Applications— (1) The filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date…”

The MPEP lists several other exclusions, including certain international application filings, trademark-related filings, and correspondence filed in interference or trial proceedings. It’s crucial to review the full list in MPEP 512 to ensure compliance with USPTO rules.

To learn more:

No, you cannot use a Certificate of Mailing or Transmission for filing a new patent application to establish the application’s filing date. The MPEP explicitly states:

No benefit will be given to a Certificate of Mailing or Certificate of Facsimile Transmission relative to the filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date.

This restriction is also specified in 37 CFR 1.8(a)(2)(i)(A), which excludes “[t]he filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date” from the Certificate of Mailing or Transmission procedure.

However, it’s worth noting that new patent applications can be filed electronically via the USPTO’s Electronic Filing System (EFS-Web), which provides its own timestamp for filing date purposes.

While certificates of mailing are widely applicable, they cannot be used for all types of patent-related correspondence. MPEP 512 outlines specific exceptions:

The Certificate of Mailing or Transmission procedure does not apply to the filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date.

Additionally, you cannot use a certificate of mailing for:

  • Filing of an international application for patent
  • Filing correspondence in an international application before the U.S. Receiving Office
  • Filing a copy of the international application and the basic national fee to enter the national stage under 35 U.S.C. 371

Always check the current USPTO guidelines to ensure you’re using the correct filing method for your specific correspondence.

To learn more:

MPEP 513 - Deposit as Priority Mail Express® with U.S. Postal Service (3)

If there’s a discrepancy between the filing date accorded by the USPTO and the “date accepted” on the Priority Mail Express® mailing label, you can file a petition under 37 CFR 1.10(c). MPEP 513 states that such a petition should:

  • Be filed promptly after becoming aware of the discrepancy
  • Include evidence that the Priority Mail Express® number was placed on the correspondence before mailing
  • Include a true copy of the Priority Mail Express® mailing label showing the “date accepted”

The petition should be filed as soon as the discrepancy is noticed to ensure timely correction of the filing date.

Priority Mail Express® is a service offered by the United States Postal Service (USPS) that can be used to establish a filing date for patent applications and other correspondence with the USPTO. As stated in MPEP 513:

The statutory authority for the granting of a filing date based on the date of deposit for correspondence sent by Priority Mail Express® and received by the Office is found in section 21(a) of Title 35 of the United States Code.

Using Priority Mail Express® allows applicants to receive a filing date as of the date the correspondence was deposited with USPS, rather than the date it was received by the USPTO.

The filing date for Priority Mail Express® submissions is typically determined by the “date accepted” on the Priority Mail Express® mailing label. According to MPEP 513:

Office personnel will routinely look to the Priority Mail Express® mailing label, and stamp the “date accepted” or other official USPS notation as the filing date of the correspondence.

If the USPS deposit date cannot be determined, the correspondence will be accorded the date of receipt in the Office as the filing date. It’s important to note that the “date accepted” must be completed by the USPS, not by the applicant.

Patent Examining Procedure (3)

MPEP 101 specifies the following procedure that should be followed before giving any information about an unpublished pending or abandoned patent application over the telephone:

  1. Obtain the caller’s full name, the application number, and the caller’s telephone number. Ask if there is an attorney or agent of record.
  2. Verify the identity of the caller and their authority to receive information.
  3. For a practitioner of record, check their registration number in Patent Data Portal. Only call back a practitioner at the number listed in Patent Data Portal.
  4. For an inventor, applicant, or assignee, check the correspondence address in Patent Data Portal and call back at the number provided if it matches.
  5. If identity and authority cannot be verified, inform the caller that no information can be provided.

MPEP 101 explains that USPTO employees must take specific measures to ensure the confidentiality of patent applications:

  • No part of any application or related paper should be reproduced or copied except for official purposes.
  • Application files must not be displayed or handled in a manner that would allow unauthorized persons to inspect them.
  • For non-electronic files removed from their storage area, a charge must be promptly made in the tracking system.
  • Physical files must be stored properly, not in unsecured locations like desk drawers.
  • Interoffice mail related to applications must be sent in appropriate envelopes.

According to MPEP 101, particular care must be taken when a caller requests the publication date or issue date assigned to a pending patent application:

“If the publication or issue date is later than the current date (i.e., the date of the request), such information may be given only to the applicant, an inventor, the assignee of record, or the attorney or agent of record.”

The identity and authority of the caller must be verified according to the procedures outlined in the MPEP before this information can be provided over the telephone.

Patent Financing (8)

n

You have full control of your patents while BlueIron finances them.  However, just like having a landlord for your office space, BlueIron “owns” the patents.

nnnn

There is a difference between control and “ownership.”  BlueIron “owns” the patents, but you control them.

nnnn

Having control of the patents means that you get all the benefits of owning the patents without having to pay for them up front.  You get to enforce the patents, cross-license the patents, and can even sell your rights to the patents.

nnnn

BlueIron provides at least $500K of patent enforcement insurance for your patents, so that you always have dry powder to use those patents as you see fit.

nnnn

Even though BlueIron provides the patents and insurance to use them, you are in complete control of how – and if – you choose to use the patents.

n
n

BlueIron is taking several risks when financing a patent.

nnnn

BlueIron is taking the risk that the patent will even issue.

nnnn

BlueIron is making an investment in researching the invention, writing the patent, and getting the patent through the patent office.  If BlueIron fails to get a patent, you can walk away from the deal at any time, and BlueIron loses its investment.

nnnn

BlueIron is taking the risk that the patent will have value.

nnnn

BlueIron is also assuming the risk that the patent will be valuable.  If you walk away from the deal, BlueIron is left holding the patent and will need to liquidate the patent.  We will probably try to sell the asset to someone in the field, auction off the asset, or try to find someone who might license the asset.

nnnn

Why is it important that BlueIron assume these risks?

nnnn

As a company who has intellectual property, you need to rely on those assets when you are making business decisions.  A conventional patent attorney cannot really tell you the truth about your patents.  They have an inherent conflict of interest: don’t ask the barber if you need a haircut.

nnnn

By taking ownership of the patents and leasing them back, BlueIron has the exact same interest as you do: solid, investment-grade patents.

n
n

The legal structure is a convertible note, lease-back structure. The IP assets are held in a Special Purpose Vehicle (SPV), which is how virtually all of the Fortune 500 companies hold their IP.

nnnn

The SPV grants an exclusive license to the startup with a buyout option. The startup can exercise the buyout option at any time.

nnnn

A buyout option is always available and always at a fixed price. There is no way BlueIron can “pad the bills” or raise the buyout price because everything is a fixed price.

nnnn

Sometimes, BlueIron has held patents for 3, 6, or 12 months and the company exercises their buyout option. In other cases, the startup has a high cost of capital and it makes sense for them to pay over time.

n
n

Financially, a startup’s cost of capital is extremely high – nespecially at the beginning – so every dollar needs to be spent wisely. n Leasing or renting assets is much more capital efficient.

nnnn

Most startup companies lease office space and even lease furniture nthrough a coworking space.  They lease computer services through Amazon nWeb Services and Microsoft Azure.  Virtually all of the tools they use nare SaaS or other “leasing” type models.

nnnn

The reason why leasing or renting is attractive is two fold:

nnnn
  • Leasing an asset means you do not have to pay for it up front.
  • Leasing an asset means someone else takes care of building and maintaining the asset.
nnnn

When you consider a startup company’s cost of capital, BlueIron’s financing is actually cheaper on a Net Present Value of money basis.

nnnn

The big benefit of “leasing your patents” is that BlueIron is nperfectly aligned with your business.  We need to create good, solid nassets and will only do so when there is a business reason.  You will nnever get the feeling that you are asking the barber if you need a nhaircut.

n
n

BlueIron can get a US patent as quickly as six months or less in some cases.  However, many times it takes 3 to 5 years.

nnnn

How do we do it?

nnnn

BlueIron’s founder, Russ Krajec, had the opportunity to join a startup company where we needed patent assets as fast as possible.  In that startup, he was able to experiment with 100 patent applications to find the best way.

nnnn

The answer: the Patent Prosecution Highway in the US.  Using the PCT/PPH, Russ was able to get patents issued in the US within 4-8 months very consistently.

nnnn

One key to expediting a patent is proper preparation.  A patent search is critical to understand the landscape and to make sure that the claims are appropriate: not too broad but directed at an economically valuable invention.

nnnn

Another key is the right strategy.  The USPTO has a program called “Track One” which has several pitfalls, but it costs about the same as a PCT application.  It is the PCT application which gets you on the Patent Prosecution Highway, which is much better than Track One.  Feel free to give us a call and we can talk about the differences.

n
n

Yes! Our due diligence reports are highly respected by investors.

nnnn

Our patent financing due diligence process not only evaluates patentability, but also enforceability, the economic advantage of the invention, its value to the startup’s market, as well as its value to competitors. Solid business value is REQUIRED before BlueIron can finance the invention, and BlueIron’s due diligence reports puts investor’s minds at ease about their investment.

nnnn

BlueIron’s financing ensures that we have “skin in the game.”  We succeed only if the patents are valuable and when your company is successful. Investors understand an “alignment of interests.”

nnnn

Our investment is non-dilutive.

nnnn

BlueIron’s financing is non-dilutive. Founders, angels, or other equity-based investors are not diluted because BlueIron does not take equity.

nnnn

The inventor’s money goes much further, meaning they get a higher overall return.

n
n

Yes!

nnnn

Just like leasing a car, you have full CONTROL of the IP assets without having to pay the full price up front.

nnnn

Because you have an exclusive license, you – and only you – decide nhow to use the patent assets. You can enforce, license, sublicense, ncross license, or sell your business assets. BlueIron has no veto power nand no say in how you run your business.

nnnn

BlueIron provides Patent Enforcement Insurance with every patent nfinance agreement.  This means you have pre-paid legal fees ready and nwaiting to assert the patents against infringers.  We do not want you ton fail to enforce the assets just because of lack of money.

n
n

Yes. The buyout cost for a patent is set up front and will not change.

nnnn

The buyout is NOT a percentage of patent value, revenue, or any other measure. We do not take warrants, “success fees,” or any type of carry.

nnnn

Our job is to build Investment Grade Patents for you, not become a tax on your success.

nnnn

Typically, the total price for a patent will be defined at the beginning of an engagement. If you need to buyout the patent after it is filed but before the examination begins, the buyout price is 1/3 of the total price. If you choose to buyout the patent after examination begins but before allowance, the buyout price is 2/3 of the total price.

n

Patent Insurance (5)

n

We offer a wide range of patent enforcement and patent defense insurance, however, our main insurance provider is a program manager for a Lloyd’s of London syndicate that focuses on intellectual property insurance.

n
n

With our patent enforcement insurance policies YOU control all aspects of how to enforce your patent. 

nnnn

Sometimes you may wish to strongly enforce their patent to prevent a specific competitor from operating in your space.  Other times, you may want to obtain a license agreement from a competitor.  Still other times, you may want to cross license your patent for a technology a competitor may have.

nnnn

In every case, YOU control how the enforcement proceeds.

n
n

Patent insurance comes in two basic forms: patent enforcement and patent defense.  Enforcement is where someone infringes your patent and you need to enforce your rights.  Defense is when someone else accuses you of infringing their patents.  This can be a competitor or a patent troll.

nnnn

Enforcement insurance typically costs about 1-1.5% per year of the total amount of insurance.  For example, $1,000,000 of patent enforcement insurance will cost about $10,000/year.

nnnn

Defense insurance typically costs about 1.5% per year.  $1,000,000 of patent defense insurance will cost about $15,000/year.

nnnn

These amounts are guidelines, and your actual premiums will only be determined after due diligence and underwriting.

n
n

Absolutely.  We know you have good relationships with your attorneys, and we are happy that you want to use them.

nnnn

Our only requirement is that the attorneys have prior first-chair experience in intellectual property litigation in federal court.  If your attorney does not have this experience, we are happy to recommend attorneys who do.

nnnn

We do offer a discount if you use attorneys who we have previously vetted, but you are not required to use them.

n
n

BlueIron is a licensed insurance agent, and acts as an insurance wholesaler for many brokers and agents. Please have your insurance agent contact us.

nnnn

BlueIron does not provide any other insurance other than Intellectual Property related insurance.

n

Patent Law (3299)

The printing of U.S. patent application numbers on a patent depends on how they are submitted and considered by the examiner. The MPEP states:

If a U.S. patent application number is listed on a PTO/SB/08 form or its equivalent and the examiner considers the information and initials the form, the application number will be printed on the patent.

However, applicants should be cautious about disclosing pending application numbers:

Applicants may wish to list U.S. patent application numbers on other than a form PTO/SB/08 format to avoid the application numbers of pending applications being published on the patent.

This guidance allows applicants to control whether pending application numbers are made public through the patent printing process.

To learn more:

No, the USPTO does not return annotated sheets submitted for patent drawing corrections. According to MPEP 608.02(v), “Annotated sheets filed by an applicant and used for correction of the drawing will not be returned.” This policy ensures that the USPTO maintains a complete record of all proposed changes to the patent drawings throughout the examination process.

To learn more:

An MPEP section may be marked as [Reserved] for several reasons:

  • The topic is not currently relevant but a section is being held for potential future use
  • The section was previously used but the content was moved elsewhere in the MPEP
  • The section is a placeholder to maintain a desired numbering scheme

Proper identification of priority applications is crucial for several reasons:

Proper identification of priority applications is essential to establishing accurate and complete relationships among various patent documents, especially in the context of electronic priority document exchange programs

This means that:

  • It ensures accuracy in patent documentation
  • It facilitates complete relationships between related patent documents
  • It is particularly important for electronic priority document exchange programs

Accurate identification helps maintain the integrity of the patent system and ensures that priority claims are properly recognized and processed.

To learn more:

Submitting legible copies of assignment documents to the USPTO is crucial because the quality of the recorded document depends on the quality of the submitted copy. The USPTO does not improve or enhance the quality of submitted documents.

According to MPEP 302.01: If the copy submitted for recordation is illegible, the recorded document will be illegible.

This means that if you submit an illegible copy, the officially recorded document will also be illegible, potentially causing issues with proving ownership or assignment in the future. To avoid such problems, always ensure that you submit clear, high-quality copies of your assignment documents for recordation.

To learn more:

Recording certificates of name change or merger for patents is crucial for maintaining a clear chain of title. According to MPEP 314, these documents serve as important links in the ownership history of a patent.

The MPEP states:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title. Documents of merger are also proper links in the chain of title.

By recording these certificates, you ensure that the USPTO and any interested parties can trace the ownership history of the patent accurately. This is particularly important for legal proceedings, licensing negotiations, or potential patent sales.

To learn more:

Recording business name changes and mergers is crucial for maintaining an accurate chain of title for patents. MPEP 314 emphasizes this importance:

  • For name changes: Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.
  • For mergers: Documents of merger are also proper links in the chain of title.

Recording these changes ensures:

  1. The USPTO has up-to-date information on patent ownership
  2. Third parties can accurately identify the current patent owner
  3. The chain of title remains clear and unbroken, which can be important for future transactions or litigation
  4. Compliance with legal requirements for maintaining patent rights

Including contact information in a power of attorney for patent applications is crucial for several reasons:

  • It facilitates prompt delivery of communications from the USPTO
  • It ensures that the USPTO can easily reach the attorney or agent representing the applicant
  • It helps streamline the patent application process

The MPEP 601.02 emphasizes this point: “The prompt delivery of communications will thereby be facilitated.”

By providing comprehensive contact information, including mailing address, ZIP code, telephone number, and fax number, attorneys and agents can ensure efficient communication throughout the patent examination process.

To learn more:

Describing problems in the prior art in the Background of the Invention is important for several reasons:

  1. It helps establish the context for the invention.
  2. It demonstrates the need for the invention.
  3. It can help show the non-obviousness of the invention.
  4. It provides a basis for explaining the advantages of the invention.

The MPEP specifically mentions this in MPEP 608.01(c): “Where applicable, the problems involved in the prior art or other information disclosed which are solved by the applicant’s invention should be indicated.” This statement underscores the importance of not just describing the prior art, but also highlighting the problems or limitations in the prior art that the invention addresses.

To learn more:

Document legibility is crucial when submitting patent assignments because:

  1. The USPTO does not return recorded documents.
  2. If the submitted copy is illegible, the recorded document will also be illegible.
  3. Illegible documents may cause legal issues or complications in proving ownership.

The MPEP emphasizes this point: “If the copy submitted for recordation is illegible, the recorded document will be illegible. Accordingly, applicants and patent owners should ensure that only a legible copy is submitted for recordation.”

It’s the responsibility of the submitter to ensure that all documents are clear and readable to maintain accurate records of patent ownership.

MPEP 303 highlights the importance of determining who should direct prosecution:

“When the assignment condition of an application is significant, such as… when there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

Determining who should direct prosecution is crucial because:

  • It ensures that the rightful owner or assignee is making decisions about the application
  • It prevents unauthorized individuals from influencing the prosecution process
  • It helps resolve potential disputes over ownership or control of the application
  • It maintains the integrity of the patent examination process

When there’s uncertainty about this, examiners must verify assignment information to ensure proper handling of the application.

The USPTO typically does not send a filing receipt for a Continued Prosecution Application (CPA). This practice is mentioned in MPEP ¶ 2.35, which states:

This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

The reason for this is that a CPA is a continuation of an existing application rather than an entirely new filing. The USPTO communicates the acceptance of the CPA through other means, typically in the first Office action on the CPA. This approach streamlines the process and reduces redundant paperwork.

For more information on USPTO procedures, visit: USPTO procedures.

Why doesn’t the USPTO return original assignment documents after recording?

The USPTO does not return original assignment documents after recording to maintain a permanent, unaltered record and to prevent potential disputes or fraud. According to MPEP 302.01: ‘The USPTO will not return documents filed for recording.’ This policy serves several purposes:

  • Ensures the integrity of the recorded documents
  • Prevents alterations or substitutions after recording
  • Maintains a consistent and reliable archive
  • Reduces administrative burden and potential for loss

By keeping all submitted documents, the USPTO can provide certified copies if needed for legal or business purposes, ensuring a reliable chain of title for patent rights.

The USPTO records documents other than assignments for several important reasons:

  1. Public interest: To provide notification to third parties of equitable interests or other matters relevant to patent ownership.
  2. Transparency: To maintain a clear record of various interests in patents and patent applications.
  3. Legal compliance: To fulfill the requirements of 35 U.S.C. 261 and 37 CFR 3.11.

The MPEP states, “Such documents are recorded in the public interest in order to give third parties notification of equitable interests or other matters relevant to the ownership of a patent or application.” (MPEP 313)

The United States Patent and Trademark Office (USPTO) does not return patent application drawings for several reasons:

  • To maintain a complete and accurate record of all submitted materials
  • To ensure consistency in the application process
  • To avoid potential disputes over the content of submitted drawings

The MPEP Section 608.02(y) clearly states:

Drawings will not be returned to the applicant.

This policy underscores the importance of applicants retaining copies of all materials submitted to the USPTO, including drawings, for their own records and potential future reference.

To learn more:

MPEP 602.07 refers to MPEP § 1893.01(e) because the latter section provides more detailed information about oaths or declarations filed in the United States as a designated office. The full text of MPEP 602.07 states:

See MPEP § 1893.01(e).

This reference indicates that MPEP § 1893.01(e) contains comprehensive guidance on the requirements, procedures, and considerations for oaths or declarations in the context of international applications entering the national phase in the United States. Patent practitioners and examiners should consult this section for specific instructions and requirements related to oaths or declarations in PCT applications designating the USPTO.

To learn more:

The restrictions on USPTO employees regarding patents are in place to prevent conflicts of interest and maintain the integrity of the patent system. These rules, outlined in 35 U.S.C. 4 and MPEP 309, serve several purposes:

  • Prevent employees from using insider knowledge for personal gain
  • Ensure fair and unbiased examination of patent applications
  • Maintain public trust in the patent system
  • Avoid potential conflicts between an employee’s official duties and personal interests

By prohibiting employees from applying for or acquiring patents during their employment and for a period after, the USPTO aims to preserve the objectivity and fairness of the patent examination process.

Sections in the Manual of Patent Examining Procedure (MPEP) are sometimes marked as ‘[Reserved]’ for several reasons:

  • To maintain consistent numbering across editions
  • To allow for future expansion of content
  • To accommodate planned updates or revisions
  • To serve as placeholders for potential new topics or guidance

This practice helps the USPTO maintain flexibility in organizing and updating the MPEP while preserving a logical structure for users.

Claims are considered an important part of a patent application because, as stated in MPEP 608.01(k), “This is an important part of the application, as it is the definition of that for which protection is granted.”

In other words, the claims define the scope of the legal protection provided by the patent. They outline the specific elements and features of the invention that are protected from infringement by others. Well-drafted claims are crucial for:

  • Clearly defining the boundaries of the invention
  • Distinguishing the invention from prior art
  • Providing a basis for patent examiners to assess patentability
  • Determining the extent of legal protection in potential infringement cases

To learn more:

Assignment documents are not placed directly in patent application files to ensure proper recording and maintenance of ownership records. MPEP 318 states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This procedure serves several purposes:

  • It centralizes the recording of ownership information
  • It ensures that assignments are properly recorded and searchable
  • It keeps the main application file focused on technical and procedural aspects of the patent application
  • It allows the Assignment Division to maintain a separate database of patent ownership information

Assignment documents are not placed directly in application or patent files to ensure proper recording and management. According to MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This practice serves several purposes:

  • It ensures that assignments are properly recorded by the specialized Assignment Division.
  • It maintains the integrity and organization of application and patent files.
  • It allows for efficient tracking and retrieval of assignment information.

To learn more:

Amendments to refer to Continued Prosecution Applications (CPAs) as continuation or divisional applications are not allowed because they are unnecessary and can potentially cause confusion. The MPEP ¶ 2.34 explains:

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that the CPA itself already serves as the legally required reference to the prior application. Adding additional references through amendments is redundant and could potentially lead to inconsistencies or misinterpretations in the patent record.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on patent law, visit: patent law.

In patent applications filed before September 16, 2012, the power of attorney can be signed by either the inventor(s) or the assignee of the entire interest. However, the MPEP recommends that the assignee sign the power of attorney when one exists. As stated in the MPEP:

While a power of attorney may be signed by the inventor(s), the power of attorney should be signed by the assignee of the entire interest where one exists. Otherwise, the assignee may be paying the bill, while the inventor is providing the power of attorney, thereby possibly raising an issue as to who is the practitioner’s client.

This recommendation aims to avoid potential conflicts and ensure clear representation in cases where the relationship between the assignee and inventors may deteriorate.

To learn more:

After the USPTO is notified of a patent practitioner’s death, correspondence is sent to two parties:

  1. The office of the deceased practitioner
  2. The person who originally appointed the deceased patent practitioner

This dual notification ensures that both the practitioner’s office and the original appointer are aware of ongoing patent matters and can take appropriate action.

The English translation of a non-English assignment document must be signed by the individual who performed the translation. As stated in MPEP 302.02:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This requirement ensures the accuracy and authenticity of the translation. It’s important to note that the translator’s signature is required, not necessarily the signature of the parties involved in the assignment.

To learn more:

The signing requirements for a supplemental oath or declaration depend on the nature of the correction being made. According to MPEP 603:

37 CFR 1.67(b) provides that a supplemental inventor’s oath or declaration under 37 CFR 1.67 must be executed by the person whose inventor’s oath or declaration is being withdrawn, replaced, or otherwise corrected.

For applications filed before September 16, 2012, the MPEP provides more detailed guidance:

  • If the correction relates to all inventors or applicants, all must sign.
  • If the correction relates to only certain inventors or applicants, only those to whom the correction relates need to sign.

In cases where an inventor is unable or unwilling to sign, the requirement for that inventor to sign the supplemental declaration may be suspended or waived in accordance with 37 CFR 1.183. In such cases, joint inventors or parties with sufficient proprietary interest may sign on behalf of the non-signing inventor.

To learn more:

Tags: declaration

The responsibilities for preparing and reviewing the patent abstract are divided as follows:

  • Preparation: The applicant is responsible for preparing the abstract.
  • Review: The examiner is responsible for reviewing the abstract for compliance with the guidelines.

The MPEP states: Preparation of the abstract is the responsibility of the applicant. Background knowledge of the art and an appreciation of the applicant’s contribution to the art are most important in the preparation of the abstract. The review of the abstract for compliance with these guidelines is the responsibility of the examiner.

If amendments are necessary, they can be made either by the applicant or by the examiner with the applicant’s approval, especially at the time of allowance or in response to a printer query.

To learn more:

According to MPEP 608.01(k), the responsibility for pointing out and distinctly claiming the invention lies with “the inventor or joint inventor.” The section states that the specification “shall particularly point out and distinctly claim the subject matter which the inventor or joint inventor regards as his or her invention.”

While patent attorneys or agents often assist in drafting claims, it is ultimately the inventor’s responsibility to ensure that the claims accurately reflect their invention. The inventor should work closely with their legal representative to ensure that the claims:

  • Accurately describe the invention
  • Cover all aspects of the invention they wish to protect
  • Meet the statutory requirements for clarity and distinctness

To learn more:

The responsibility for filing the notice of arbitration award with the USPTO is primarily assigned to the patent owner or their representatives, but there are provisions for other parties to file if necessary. According to 35 U.S.C. 294(d) and 37 CFR 1.335:

  • The patentee, assignee, or licensee is primarily responsible for filing the notice.
  • If the required notice is not filed by the designated party, any party to the arbitration proceeding may file the notice.

35 U.S.C. 294(d) states: “When an award is made by an arbitrator, the patentee, his assignee or licensee shall give notice thereof in writing to the Director.”

This flexibility ensures that the USPTO is informed of arbitration outcomes, even if the primary responsible party fails to file the notice.

Both practitioners and non-practitioners are responsible for ensuring compliance with USPTO signature and certification requirements when filing papers. According to 37 CFR 11.18(b):

“By presenting to the Office or hearing officer in a disciplinary proceeding (whether by signing, filing, submitting, or later advocating) any paper, the party presenting such paper, whether a practitioner or non-practitioner, is certifying that—”

This means that anyone submitting papers to the USPTO, including independent inventors, corporate representatives, and patent attorneys, is responsible for ensuring that the submissions meet the signature and certification requirements. Practitioners have additional responsibilities and may face disciplinary action for violations as specified in 37 CFR 11.18(d).

To learn more:

The presumption of ownership for patent applications depends on the filing date. According to MPEP 301:

‘For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of the application for an original patent. For applications filed before September 16, 2012, the ownership of the patent (or the application for the patent) initially vests in the named inventors of the invention of the patent.’

This change in presumption reflects updates to U.S. patent law under the America Invents Act. It’s important for applicants and inventors to be aware of this presumption, as it can affect various aspects of patent prosecution and ownership rights.

According to MPEP 203.08, information about a patent application’s status can be provided to:

  • The applicant
  • The applicant’s assignee
  • The attorney or agent of record
  • Anyone with written authority from one of the above

The MPEP states: “Status information which may be given includes information as to whether the application has been filed, whether the application is awaiting action by the examiner, as well as other matters which do not involve the disclosure of confidential information.”

It’s important to note that the USPTO is prohibited from disclosing certain information to unauthorized parties, such as the date of filing, names of inventors, or specific details about the prosecution of the application.

To learn more:

According to MPEP 151, the term ‘applicant’ in the context of Atomic Energy Act and NASA Act statements is interpreted as follows:

“The word ‘applicant’ in both of these statutes is construed by the Office to mean the inventor or joint inventors in person, or an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter.”

This means that the statements must typically be signed by the actual inventor(s), assignee, or someone with a significant proprietary interest in the invention. The USPTO considers these individuals to be the most knowledgeable about the circumstances surrounding the invention’s creation.

For more information on applicant definition, visit: applicant definition.

For unpublished patent applications that are pending or abandoned, the following individuals are authorized to receive status information:

  1. The applicant
  2. A patent practitioner of record
  3. The assignee or an assignee of an undivided part interest
  4. The inventor or a joint inventor
  5. A registered attorney or agent named in the application papers filed under 37 CFR 1.53 or the national stage documents filed under 37 CFR 1.495, if a power of attorney has not been appointed under 37 CFR 1.32

Additionally, anyone with written authority granting access from one of the above individuals is also entitled to status information.

During interference or derivation proceedings, power of attorney changes are handled by a specific entity within the USPTO. According to MPEP 402.08:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

This means that the Patent Trial and Appeal Board (PTAB) is responsible for considering and processing any changes to power of attorney during these special proceedings. This differs from the normal procedure for regular patent applications, where such changes would typically be handled by the Office of Patent Application Processing or the examining corps.

To learn more:

According to 37 CFR 3.71(b), the assignees who may conduct prosecution of a patent application as the applicant are:

  1. A single assignee who is the assignee of the entire right, title and interest in the application or patent, or
  2. All partial assignees, or all partial assignees and inventors who have not assigned their rights, who together own the entire right, title and interest in the application or patent.

The MPEP states: “As the applicant, the owner or assignee that is not a juristic entity can sign a reply to an Office action (37 CFR 1.33(b)(3)), a request for a continued prosecution application under 37 CFR 1.53(d) (MPEP § 201.06(d)), a disclaimer under 37 CFR 1.321 (MPEP § 1490), Fee(s) Transmittal (PTOL-85B) (MPEP § 1306), or a request for status of an application (MPEP § 102).”

For an assignee organization (e.g., corporation, partnership, university), the submission establishing ownership can be signed by:

  1. A person with apparent authority to sign on behalf of the organization, such as an officer (e.g., CEO, president, vice-president, secretary, treasurer). The MPEP states: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization.”
  2. Any person, if the submission states that the person is authorized to act on behalf of the assignee.
  3. A person empowered by an organizational resolution, if a copy of the resolution is submitted.

If the signer does not fall into one of these categories, evidence of their authority to sign may be required. This is outlined in MPEP 324, section V.

The word “applicant” in the Atomic Energy Act and NASA Act is construed by the USPTO to mean the inventor(s), an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter. In the ordinary situation, the statements must be signed by:

  • The inventor or joint inventors
  • An assignee
  • An obligated assignee
  • A person who otherwise shows sufficient proprietary interest in the matter

This is consistent with the fact that these parties would be most knowledgeable of the “full facts concerning the circumstances under which such invention was made” (42 U.S.C. 2457) or “full facts surrounding the making or conception of the invention or discovery” (42 U.S.C. 2182).

According to the MPEP, the 37 CFR 3.73(c) statement establishing assignee ownership can be signed by:

  1. A person in the organization having apparent authority to sign on behalf of the organization (e.g., an officer)
  2. Any person, if the statement sets forth that the person is authorized to act on behalf of the assignee
  3. A patent practitioner of record
  4. A person empowered by an organizational resolution to sign on behalf of the assignee, if a copy of the resolution is submitted

The MPEP clarifies: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization. The signature of the chairman of the board of directors is acceptable, but not the signature of an individual director.”

When there’s no attorney of record, the signatories for patent application papers depend on the filing date and the applicant type. For applications filed before September 16, 2012, MPEP § 407 states: “All papers filed in the application must be signed: (1) by all named applicants unless one named applicant has been given a power of attorney to sign on behalf of the remaining applicants, and the power of attorney is of record in the application; or (2) if there is an assignee of record of an undivided part interest, by all named applicants retaining an interest and such assignee; or (3) if there is an assignee of the entire interest, by such assignee; or (4) by a registered patent attorney or agent not of record who acts in a representative capacity under the provisions of 37 CFR 1.34.”

For applications filed on or after September 16, 2012: “All papers must be signed by: (1) a patent practitioner of record; (2) a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34; or (3) the applicant, except that papers submitted on behalf of a juristic entity applicant must be signed by a patent practitioner.”

When an attorney is suspended, the signing authority for papers in a patent application depends on the filing date:

For applications filed before September 16, 2012:

  • All named applicants
  • Assignee of record of an undivided part interest, along with named applicants retaining an interest
  • Assignee of the entire interest
  • A registered patent attorney or agent not of record acting under 37 CFR 1.34

For applications filed on or after September 16, 2012:

  • A patent practitioner of record
  • A patent practitioner not of record acting under 37 CFR 1.34
  • The applicant (except for juristic entity applicants, which require a patent practitioner)

This information is provided in Form Paragraph 4.07 of MPEP § 407.

When an assignee is an organization (e.g., corporation, partnership, university), specific individuals are authorized to sign documents on its behalf. According to MPEP 325, the following persons can sign submissions under 37 CFR 3.73(c):

  1. A person with apparent authority to sign on behalf of the organization. This typically includes officers such as the CEO, president, vice-president, secretary, or treasurer.
  2. Any person, if the submission clearly indicates that the person is authorized to act on behalf of the assignee.
  3. A patent practitioner of record.
  4. A person empowered by an organizational resolution, if a copy of the resolution is submitted.

The MPEP states: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization. The signature of the chairman of the board of directors is acceptable, but not the signature of an individual director.”

It’s important to note that for juristic entities, many actions in patent matters must be signed by a registered patent practitioner after September 16, 2012.

For more information on corporate officers, visit: corporate officers.

For more information on patent documents, visit: patent documents.

For applications filed on or after September 16, 2012, the following parties can sign a written assertion of small entity status:

  • The applicant
  • A patent practitioner of record or acting in a representative capacity
  • The inventor or a joint inventor, if the inventor is the applicant
  • The assignee

According to 37 CFR 1.27(c)(2): “The written assertion can be signed by: (i) The applicant (§ 1.42 or § 1.421); (ii) A patent practitioner of record or a practitioner acting in a representative capacity under § 1.34; (iii) The inventor or a joint inventor, if the inventor is the applicant; or (iv) The assignee.”

To learn more:

Who can sign a substitute statement for a deceased or incapacitated inventor?

In cases where an inventor is deceased or legally incapacitated, specific parties are authorized to sign a substitute statement. According to MPEP 409.01(a):

“A substitute statement under 37 CFR 1.64 may be signed by the applicant or an assignee of the entire interest on behalf of a deceased or legally incapacitated inventor.”

The following parties can sign a substitute statement:

  • The applicant (if different from the inventor)
  • An assignee of the entire interest
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

It’s important to note that the person signing the substitute statement must have the legal authority to act on behalf of the deceased or incapacitated inventor. This ensures that the patent application can proceed even when the original inventor is unable to participate in the process.

To learn more:

For pre-AIA patent applications (filed before September 16, 2012), the submission establishing ownership must be signed by a party authorized to act on behalf of the assignee. According to MPEP 324, this can be done in several ways:

  • A person with apparent authority in the organization, such as an officer (e.g., CEO, president, vice-president, secretary, or treasurer).
  • Any person, if the submission clearly states that the person is authorized to act on behalf of the assignee.
  • A person empowered by an organizational resolution, if a copy of the resolution is submitted.

The MPEP notes: Where a submission does not comply with (A), (B), or (C) above, evidence of the person’s authority to sign will be required. It’s important to ensure that the proper authority is established to avoid delays in patent prosecution.

For more information on assignee rights, visit: assignee rights.

For more information on authorized signatories, visit: authorized signatories.

For more information on pre-AIA applications, visit: pre-AIA applications.

According to MPEP 509.04(c), a certification of micro entity status can be signed only by an authorized party as set forth in 37 CFR 1.33(b), which includes:

  • A patent practitioner of record
  • A patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34
  • The applicant (37 CFR 1.42)

It’s important to note that “Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.”

To learn more:

Title reports are internal documents used by the USPTO and are not available for direct request by external parties. The MPEP explicitly states:

Title reports may not be ordered by applicants or attorneys.

These reports are typically requested by internal USPTO staff, such as the Reexamination Preprocessing Staff, when needed for specific procedures.

According to MPEP 402.09, applicants in international patent applications can be represented by:

  • Attorneys or agents registered to practice before the USPTO
  • An applicant appointed as a common representative
  • An attorney or agent with the right to practice before the national office where the international application is filed (for specific authorities)

As stated in 37 CFR 1.455(a): Applicants of international applications may be represented by attorneys or agents registered to practice before the United States Patent and Trademark Office or by an applicant appointed as a common representative (PCT Art. 49, Rules 4.8 and 90 and § 11.9).

To learn more:

According to MPEP 325, one or more assignees can conduct prosecution of a national patent application as the applicant. Specifically, 37 CFR 3.71(b) states that:

“The assignee(s) who may conduct either the prosecution of a national application for patent as the applicant under § 1.46 of this title or a supplemental examination or reexamination proceeding are:

  • (1) A single assignee. An assignee of the entire right, title and interest in the application or patent, or
  • (2) Partial assignee(s) together or with inventor(s). All partial assignees, or all partial assignees and inventors who have not assigned their right, title and interest in the application or patent, who together own the entire right, title and interest in the application or patent.”

This means that either a single assignee with full ownership, or all partial assignees and remaining inventors collectively, can prosecute the application as the applicant.

For more information on prosecution, visit: prosecution.

Tags: prosecution

According to MPEP 106.01, only the assignee of record of the entire interest in a patent application can intervene in its prosecution. The MPEP states:

While it is only the assignee of record of the entire interest who can intervene in the prosecution of an application or interference to the exclusion of the applicant […]

This means that partial assignees, licensees of exclusive rights, or other parties with limited interests cannot intervene in the prosecution process or exclude the original applicant. The right to intervene is reserved exclusively for the assignee who has been recorded as having the entire interest in the application.

For applications filed on or after September 16, 2012, the assignee of the entire interest can also become the applicant under 37 CFR 1.46 and prosecute the application directly.

To learn more:

For applications filed on or after September 16, 2012, the following parties can provide written authority to grant access to inspect a pending or abandoned application kept in confidence under 35 U.S.C. 122(a), except as provided in 37 CFR 1.11, 1.14, 41.6, or 42.412:

  1. The applicant
  2. A patent practitioner of record
  3. The assignee or an assignee of an undivided part interest
  4. The inventor or a joint inventor

According to MPEP 104, access to inspect a patent application can be granted by specific individuals or entities. For applications filed on or after September 16, 2012, the following parties can provide written authority for access:

  • The applicant
  • A patent practitioner of record
  • The assignee or an assignee of an undivided part interest
  • The inventor or a joint inventor

The MPEP states: “The written authority must be signed by: (1) The applicant; (2) A patent practitioner of record; (3) The assignee or an assignee of an undivided part interest; (4) The inventor or a joint inventor; or (5) A registered attorney or agent named in the papers accompanying the application papers filed under §1.53 or the national stage documents filed under §1.495, if a power of attorney has not been appointed under § 1.32.”

For more information on application access, visit: application access.

For more information on power to inspect, visit: power to inspect.

For more information on written authority, visit: written authority.

According to 35 U.S.C. 118, the following parties can file a patent application:

  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who shows sufficient proprietary interest in the matter, acting as an agent for the inventor

The law states: A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.

According to MPEP 409.01(a), several parties can file a patent application on behalf of a deceased or legally incapacitated inventor:

  • Legal representative: If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent on behalf of the inventor.
  • Assignee or obligated assignee: Under 37 CFR 1.46, a person to whom the inventor assigned (‘assignee’), to whom the inventor was under an obligation to assign (‘obligated assignee’), or a person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of the deceased or legally incapacitated inventor.
  • Administrator or executor: These parties can also file an application, but may need to obtain new letters of administration if they have been discharged from their duties.

It’s important to note that proof of authority is not required by the USPTO, but any person acting as a legal representative should ensure they are properly authorized to do so.

To learn more:

For applications filed on or after September 16, 2012, the following parties may file a patent application as the applicant:

  • The inventor(s)
  • An assignee to whom the inventor has assigned the invention
  • An obligated assignee to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

As stated in 37 CFR 1.46(a): “A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.”

According to 37 CFR 1.46(a), the following parties can file a patent application as the applicant:

  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

The regulation states: A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.

To learn more:

Several parties may execute a substitute statement under specific circumstances:

  • The inventor’s legal representative under 37 CFR 1.43, if the inventor is deceased or legally incapacitated
  • Other joint inventors under 37 CFR 1.45, if the inventor refuses to execute the oath or declaration or cannot be found
  • An applicant under 37 CFR 1.46 who is the assignee or party to whom the inventor is obligated to assign
  • An applicant under 37 CFR 1.46 who shows sufficient proprietary interest in the invention

It’s important to note that “All parties having any portion of the ownership in the patent must act together as a composite entity in patent matters before the Office.

To learn more:

The correspondence address in a patent application can be changed by specific parties as outlined in 37 CFR 1.33(a):

  • A patent practitioner of record (37 CFR 1.33(b)(1))
  • The applicant (37 CFR 1.33(b)(3))
  • Prior to the appointment of any power of attorney, any patent practitioner named in the application transmittal papers who acts in a representative capacity under 37 CFR 1.34

It’s important to note that after a power of attorney has been appointed, a practitioner acting in a representative capacity cannot change the correspondence address until after the patent has issued, and only with proper notice to the patentee or owner.

To learn more:

Limited recognition for patent matters can be granted to two main categories of individuals:

  1. Non-registered individuals: As per 37 CFR 11.9(a), individuals not registered under § 11.6 may be granted limited recognition under certain circumstances.
  2. Nonimmigrant aliens: According to 37 CFR 11.9(b):

    A nonimmigrant alien residing in the United States and fulfilling the provisions of paragraphs (d) and (e) of this section may be granted limited recognition if the nonimmigrant alien is authorized by the United States Government to be employed or trained in the United States in the capacity of representing a patent applicant by presenting or prosecuting a patent application.

It’s important to note that limited recognition is granted on a case-by-case basis and is subject to specific restrictions and conditions.

To learn more:

According to 37 CFR 1.42, the term ‘applicant’ can refer to:

  • The inventor or all joint inventors
  • A legal representative of a deceased or legally incapacitated inventor
  • The assignee
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

The MPEP states: If a person is applying for a patent as provided in 37 CFR 1.46, the word ‘applicant’ refers to the assignee, the person to whom the inventor is under an obligation to assign, or the person who otherwise shows sufficient proprietary interest in the matter, who is applying for the patent under 37 CFR 1.46 and not the inventor.

To learn more:

Under pre-AIA 37 CFR 1.47(b), the term ‘person’ is broadly interpreted. The MPEP states that “The word ‘person’ has been construed by the U.S. Patent and Trademark Office to include juristic entities, such as a corporation.” This means that both individuals and legal entities can potentially file an application under this provision, provided they meet the other requirements.

To learn more:

Tags: pre-AIA

As of September 16, 2012, the rules for who can be an applicant for a patent application were revised. According to MPEP § 605, the following individuals or entities can file and prosecute a patent application as the applicant:

  • The inventor
  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who shows sufficient proprietary interest in the matter

The MPEP states: “Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign an invention to file and prosecute an application for patent as the applicant, and to permit a person who otherwise shows sufficient proprietary interest in the matter to file and prosecute an application for patent as the applicant on behalf of the inventor.”

This change allows for greater flexibility in who can be considered the applicant, potentially streamlining the patent application process for businesses and organizations.

To learn more:

For applications filed on or after September 16, 2012, a power of attorney must be signed by the applicant for patent (i.e., all parties identified as the applicant as defined by 37 CFR 1.42(a)) or the patent owner. For applications filed before September 16, 2012, a power of attorney can be signed by the applicant or the assignee of the entire interest of the applicant.

As stated in MPEP 402.02(a): “For applications filed on or after September 16, 2012, 37 CFR 1.32(b)(4) sets forth that a power of attorney must be signed by the applicant for patent (i.e., all parties identified as the applicant as defined by 37 CFR 1.42(a)) or the patent owner (for reissue applications, reexamination proceedings and supplemental examination proceedings).”

According to the MPEP, an examiner can contact the patent practitioner of record in the application for interviews. The MPEP states:

When the examiner believes the progress of the application would be advanced by an interview, the examiner may contact the patent practitioner of record in the application (in accordance with MPEP § 713) and suggest a telephonic, personal, or video conference interview.

It’s important to note that registered attorneys or agents not of record should not be contacted for certain actions, such as restriction requirements or approval of examiner’s amendments.

For patent applications filed before September 16, 2012, the oath or declaration can be administered by various authorized individuals, depending on the location. According to pre-AIA 35 U.S.C. 115:

  • Within the United States: Any person authorized by law to administer oaths
  • In a foreign country:
    • A diplomatic or consular officer of the United States authorized to administer oaths
    • An officer having an official seal and authorized to administer oaths in the foreign country, whose authority is proved by a certificate of a U.S. diplomatic or consular officer
    • An official designated by a foreign country that, by treaty or convention, accords like effect to apostilles of designated officials in the United States

The law states: Such oath is valid if it complies with the laws of the state or country where made. This provision ensures flexibility in oath administration while maintaining legal validity across different jurisdictions.

To learn more:

According to MPEP 602, “An oath or affirmation may be made before any person within the United States authorized by law to administer oaths.” This typically includes notaries public, judges, and certain government officials. It’s important to note that the authority of the person administering the oath may be subject to verification, and in some cases, proof of authority may be required.

To learn more:

Tags: oath

The USPTO has designated specific offices to handle inquiries from high-level government sources. According to MPEP 203.08(a):

  • Office of Policy and International Affairs: Handles inquiries from embassies, the Office of the U.S. Trade Representative, and the Department of State.
  • Office of Governmental Affairs: Manages inquiries from Congress and the White House.

These offices are responsible for ensuring that such high-level inquiries are handled appropriately and consistently.

To learn more:

Tags: USPTO

The MPEP ¶ 2.11 mentions several U.S. Code sections relevant to claiming the benefit of an earlier filing date:

This application is claiming the benefit of prior-filed application No.[1] under 35 U.S.C. 120, 121, 365(c), or 386(c).

These sections cover different scenarios:

  • 35 U.S.C. 120: Benefit of earlier filing date in the United States
  • 35 U.S.C. 121: Divisional applications
  • 35 U.S.C. 365(c): Benefit of earlier filing date; national application
  • 35 U.S.C. 386(c): Benefit of earlier filing date; international design application

Each of these sections provides specific conditions under which an application can claim the benefit of an earlier filing date.

For more information on earlier filing date, visit: earlier filing date.

For more information on patent law, visit: patent law.

The MPEP provides a table of states (countries) for which the right of priority under 35 U.S.C. 119(a)-(d) is recognized. These countries fall into three categories:

  • Parties to the Patent Cooperation Treaty (PCT)
  • Parties to the Paris Convention for the Protection of Industrial Property
  • Members of the World Trade Organization (WTO)

The MPEP states: “Following is a table of states, i.e., countries, with respect to which the right of priority referred to in 35 U.S.C. 119(a)-(d) has been recognized.”

For the most current list of recognized countries, refer to the WIPO website at www.wipo.int/pct/en/paris_wto_pct.html.

The United States recognizes the right of priority for patent applications filed in countries that are:

  • Parties to the Patent Cooperation Treaty (PCT)
  • Members of the Paris Convention for the Protection of Industrial Property
  • Members of the World Trade Organization (WTO)

The MPEP states: Following is a table of states, i.e., countries, with respect to which the right of priority referred to in 35 U.S.C. 119(a) – (d) has been recognized. For the most up-to-date list of recognized countries, refer to the WIPO website.

To learn more:

According to MPEP 606, the placement of the title of invention in a patent application is as follows:

“The title of the invention should be placed at the top of the first page of the specification unless it is provided in the application data sheet (see 37 CFR 1.76).”

This means you have two options for placing the title:

  • At the top of the first page of the specification
  • In the application data sheet

It’s important to note that if you include the title in the application data sheet, you don’t need to repeat it on the first page of the specification.

To learn more:

The placement of the government license rights statement in a patent application depends on whether there are references to related applications:

  • If there are references to related applications in the first sentence(s) of the specification following the title, the government license rights statement should appear as the second paragraph of the specification.
  • If there are no references to related applications, the government license rights statement should appear as the first paragraph of the specification.

This placement is specified in 37 CFR 1.77(b)(1)-(3).

For a non-English provisional application, the English translation and accuracy statement must be filed in the provisional application itself, not in the non-provisional application claiming its benefit. MPEP ¶ 2.38 clearly states:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[…]”

Additionally, in the non-provisional application claiming benefit, you must provide confirmation that these documents were filed in the provisional application. This two-step process ensures proper documentation and compliance with 37 CFR 1.78.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The location of the benefit claim reference depends on the filing date of the application:

  • For applications filed before September 16, 2012: The reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS).
  • For applications filed on or after September 16, 2012: The specific reference must be included in an application data sheet (ADS).

The MPEP states: “If the application was filed before September 16, 2012, the reference must be included in the first sentence(s) of the specification following the title or in an application data sheet; if the application was filed on or after September 16, 2012, the specific reference must be included in an application data sheet.”

It’s important to note that for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must also include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on application data sheet, visit: application data sheet.

For more information on divisional, visit: divisional.

When submitting assignment documents along with new patent applications, the mailing address is different from the general assignment recordation address. According to MPEP 302.08:

Requests for recording documents which accompany new applications should be addressed to the Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.

This ensures that your assignment documents are properly associated with the new patent application and processed accordingly by the USPTO.

To learn more:

According to the MPEP, a petition to restore the benefit of a provisional application should be addressed to:

“Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.”

It’s important to note that this petition must be filed in the subsequent nonprovisional application or international application designating the United States, not in the provisional application itself. Always ensure you’re following the most current USPTO guidelines for petition submissions, as procedures may be updated over time.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The location for filing your petition to restore the right of priority depends on the type of application you have. The MPEP provides guidance:

The petition to restore the right of priority must be filed in the subsequent application, or in the earliest nonprovisional application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the subsequent application, if such subsequent application is not a nonprovisional application.

Additionally, the MPEP specifies the mailing address for such petitions:

The petition should be addressed to: Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.

Ensure you file the petition in the correct application and send it to the appropriate address to avoid processing delays.

For more information on mailing address, visit: mailing address.

For more information on priority restoration, visit: priority restoration.

The English translation of a non-English provisional application must be filed in the provisional application itself, not in the non-provisional application claiming benefit. According to MPEP ¶ 2.38:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3].”

Additionally, you must confirm in your current application that the translation and statement were filed in the provisional application.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

MPEP 318 provides clear guidance on where assignment documents should be forwarded for recording. According to the manual:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This means that when submitting assignment documents, they should be sent to the USPTO’s Assignment Division, which is responsible for recording and maintaining records of patent ownership changes.

The recommended presentation of foreign application numbers can be found in the WIPO Handbook on Industrial Property Information and Documentation. The MPEP provides specific guidance:

A complete updated list of the recommended presentation of a foreign application number based on the numbering system used by the foreign intellectual property office is maintained by the WIPO and can be found in the online WIPO Handbook on Industrial Property Information and Documentation

To access this information:

  • Visit the WIPO website (www.wipo.int/standards/en/)
  • Navigate to Part 7: Examples and Industrial Property Offices Practices
  • Refer to Part 7.2.1: Presentation of Application Numbers

Additionally, the MPEP mentions a survey of current practices: www.wipo.int/export/sites/www/standards/en/pdf_/07-02-06.pdf

To learn more:

For more detailed information about the required cover sheet for patent assignments, you can refer to MPEP 302.07. This is explicitly mentioned in MPEP 302.05, which states:

See MPEP § 302.07.

MPEP 302.07 provides comprehensive guidance on the cover sheet requirements, including the necessary information to be included, such as the assignee’s address. Additionally, you can find forms and instructions for recording assignments on the USPTO’s Assignment Recordation Branch website.

To learn more:

To learn more:

The USPTO provides additional information about the Priority Document Exchange (PDX) program on its official website. According to the MPEP:

The Office website provides additional information concerning the priority document exchange program (www.uspto.gov/patents/basics/international-protection/electronic-priority-document-exchange-pdx).

This website includes important details such as:

  • A list of intellectual property offices participating in the PDX program
  • Information necessary for each participating foreign intellectual property office to provide the USPTO with access to foreign applications

Applicants and practitioners are encouraged to visit this resource for the most up-to-date information on the PDX program and its participants.

For those needing information about the former procedures, the MPEP provides guidance: For more information pertaining to practice and procedure under former 37 CFR 1.60, see MPEP § 201.06(a) in the MPEP 8th Edition, Rev. 1 (February 2003)(available on the USPTO website at www.uspto.gov/web/offices/pac/mpep/mpep.htm). This archived version of the MPEP contains the detailed procedures that were in place before the regulation was deleted.

To learn more:

To learn more:

For those interested in the historical procedures under former 37 CFR 1.60, the MPEP provides guidance: For more information pertaining to practice and procedure under former 37 CFR 1.60, see MPEP § 201.06(a) in the MPEP 8th Edition, Rev. 1 (February 2003)(available on the USPTO website at www.uspto.gov/web/offices/pac/mpep/mpep.htm). This archived version of the MPEP contains detailed information about the procedures that were in place before the rule change, which may be useful for historical reference or for understanding the processing of applications filed before December 1, 1997.

For patent applications filed before September 16, 2012, specific guidance on power of attorney can be found in the Manual of Patent Examining Procedure (MPEP). According to MPEP 601.02:

“See MPEP § 402.02(b) for detailed information and relevant forms pertaining to appointment of a power of attorney in applications filed before September 16, 2012.”

To access detailed information and relevant forms for older patent applications, you should refer to MPEP § 402.02(b). This section provides comprehensive guidance on the process and required documentation for appointing a power of attorney in patent applications filed before the September 16, 2012 cutoff date.

To learn more:

For comprehensive information about reissue applications, you should refer to MPEP Chapter 1400. As mentioned in MPEP 201.05, “A detailed treatment of reissue applications can be found in MPEP Chapter 1400.” This chapter provides in-depth coverage of various aspects of reissue applications, including:

  • Eligibility requirements for filing a reissue application
  • Types of defects that can be corrected
  • Procedures for filing and prosecuting a reissue application
  • Examination guidelines for reissue applications
  • Special considerations for broadening reissues

By consulting MPEP Chapter 1400, patent attorneys, examiners, and inventors can gain a thorough understanding of the reissue application process and its requirements.

To learn more:

For additional information on restrictions applicable to USPTO employees, you can refer to MPEP § 1701. The MPEP section on restrictions upon employees of the U.S. Patent and Trademark Office states:

See MPEP § 1701 for additional restrictions on Office employees.

MPEP § 1701 provides more detailed guidance on various ethical considerations and restrictions for USPTO employees, including conflicts of interest, outside employment, and post-employment restrictions. This section is an important resource for understanding the full scope of rules and regulations that apply to USPTO employees and former employees.

For more information on USPTO employees, visit: USPTO employees.

For those seeking more detailed information on benefit claims under 35 U.S.C. 386(c), the Manual of Patent Examining Procedure (MPEP) provides a specific reference. According to MPEP § 211.01(d):

See MPEP § 2920.05(e) for additional information pertaining to benefit claims under 35 U.S.C. 386(c).

This section of the MPEP offers comprehensive guidance on the intricacies of claiming benefit to international design applications, including procedural requirements and practical considerations for patent applicants and examiners.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on benefit claims, visit: benefit claims.

Small entity status should only be claimed after a thorough investigation has been completed and there is certainty about the entitlement. The MPEP 509.03(a) states: “Where entitlement to small entity status is uncertain, it should not be claimed.” It’s important to note that even paying the small entity basic filing fee constitutes an assertion of small entity status. Therefore, applicants should be certain of their status before making any payments or claims related to small entity status.

To learn more:

Tags: patent fees

According to MPEP 150, property rights statements to DOE or NASA can be filed at any time, but they should be kept up-to-date to reflect accurate property rights at the time of application allowance. The MPEP states:

Property rights statements to DOE or NASA may be filed at any time but should be updated if necessary to accurately reflect property rights at the time the application is allowed.

Additionally, the USPTO typically sends an informal request for a property rights statement shortly after filing to applicants whose nonprovisional applications are marked as being of interest to DOE or NASA. While there’s no formal time period set, a response within 45 days is recommended to expedite processing.

For more information on filing deadlines, visit: filing deadlines.

For more information on patent applications, visit: patent applications.

Generally, prior art figures are discouraged in patent applications. As stated in MPEP 608.02(g), Figures showing the prior art are usually unnecessary and should be canceled. This principle is based on the decision in Ex parte Elliott, 1904 C.D. 103, 109 OG 1337 (Comm’r Pat. 1904).

However, there are exceptions to this rule. The MPEP states that prior art figures may be retained where needed to understand applicant’s invention. In such cases, these figures must be clearly labeled as prior art.

To learn more:

For amended patent applications, it’s important to understand the expected timelines and when it’s appropriate to make a status inquiry:

  • Examiners are expected to act on amended applications within two months of receiving them.
  • A status inquiry is generally not necessary until 5-6 months have passed without a response from the USPTO.
  • If six months elapse without a response, you should inquire to avoid potential abandonment.

The MPEP advises: Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office. (MPEP 203.08)

It further states: However, in the event that a six month period has elapsed, and no response from the Office is received, applicant should inquire as to the status of the application to avoid potential abandonment.

For making inquiries, the MPEP recommends: Applicants are encouraged to use Patent Center or Private PAIR to make status inquiries.

To learn more:

You should file a 37 CFR 1.48 request to correct inventorship in a Continued Prosecution Application (CPA) as soon as you realize there’s a need to add or remove an inventor. This should be done concurrently with or shortly after filing the CPA.

The MPEP ¶ 2.33 indicates:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48.

It’s important to file this request promptly to ensure that the correct inventorship is recorded for your application. Failure to do so may result in the inventorship remaining the same as in the prior application, which could potentially affect the validity of your patent if granted.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

You should file a 37 CFR 1.48 request for a Continued Prosecution Application (CPA) whenever you need to add, remove, or change the order of inventors from the original application.

The MPEP ¶ 2.33 indicates: Any request to add an inventor must be in the form of a request under 37 CFR 1.48. This applies even if you’ve identified the new inventor in the CPA filing documents.

It’s best to file the 37 CFR 1.48 request as soon as you realize there’s a need to correct the inventorship. This ensures that the correct inventors are associated with the application throughout the examination process.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Form Paragraph 2.35 should be used in specific circumstances during the patent examination process. According to the MPEP ¶ 2.35, this form paragraph is to be used:

in the first Office action of a CPA to advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request and the CPA is acceptable and that a CPA has been established.

However, it’s important to note that this form paragraph should not be used in all situations. Specifically:

  • It should only be used for design applications, as CPAs are only available for design applications.
  • If the request for a CPA in a utility or plant application is improper and has been treated as an RCE (Request for Continued Examination), examiners should use form paragraph 7.42.15 instead.

Examiners should refer to MPEP § 706.07(h) for more information on handling improper CPA requests in utility or plant applications.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent examination, visit: patent examination.

For assignee applicants or persons to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership should be recorded as follows:

  • As provided for in part 3 of Chapter 37 CFR
  • No later than the date the issue fee is paid in the application

According to 37 CFR 1.46(b)(1): If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

According to 37 CFR 1.46(b)(1), documentary evidence of ownership should be recorded as follows:

“If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.”

In other words, if you’re filing as an assignee or obligated assignee, you should record your documentary evidence of ownership (such as an assignment or employment agreement) with the USPTO no later than when you pay the issue fee for your patent application.

For more information on documentary evidence, visit: documentary evidence.

An inventor might consider filing a continuation application in several scenarios. The MPEP 201.07 provides guidance on timing:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

Common reasons for filing a continuation include:

  • To pursue broader or different claims based on the same disclosure
  • To address issues raised in the prosecution of the parent application
  • To keep the application pending while exploring commercial opportunities
  • To submit new evidence or arguments in support of patentability

It’s important to note that the continuation must be filed before the parent application is patented, abandoned, or otherwise terminated.

For more information on patent strategy, visit: patent strategy.

For more information on USPTO, visit: USPTO.

An Information Disclosure Statement (IDS) should be filed at different stages of patent application processing, depending on the circumstances:

  • Within three months of the filing date or before the first Office action on the merits, whichever is later
  • Before the mailing of a final Office action, Notice of Allowance, or an Ex parte Quayle action
  • After the above periods but before payment of the issue fee
  • After payment of the issue fee (with limitations)

The specific requirements and fees for filing an IDS vary depending on when it is submitted. As stated in MPEP 609.04(b): The procedures and requirements under 37 CFR 1.97 for submitting an information disclosure statement are linked to four stages in the processing of a patent application.

To learn more:

Patent examiners should use MPEP ¶ 2.06 when they encounter an application that appears to qualify as a continuation-in-part (CIP) but lacks a proper benefit claim. The paragraph itself provides guidance:

This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Examiners use this paragraph to notify applicants that their application might be eligible for CIP status and to direct them to the proper procedures for claiming the benefit of the prior application’s filing date if desired.

For more information on patent examination, visit: patent examination.

Patent examiners should use the MPEP ¶ 2.01 form paragraph under specific circumstances. The MPEP provides the following guidance:

Examiner Note: […] 2. This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.

This means examiners should use this paragraph when:

  • The application appears to contain subject matter that is independent and distinct from a prior application
  • The application seems to qualify as a divisional
  • The applicant has not yet properly claimed the benefit of the prior application’s filing date

The form paragraph serves as a prompt for the applicant to properly establish the benefit claim if they intend the application to be a divisional.

For more information on Divisional application, visit: Divisional application.

A claim should be rejected under 35 U.S.C. 112(a) for lack of written description when the subject matter is not shown in the drawing or described in the description, and the words of the original claim do not sufficiently describe the invention. The MPEP 608.01(l) states: “If the claim does not provide its own description in this case, the claim should be rejected under 35 U.S.C. 112(a) as failing to be supported by an adequate written description.” This means that the claim must provide enough detail for one of ordinary skill in the art to recognize that the inventor had possession of the full scope of the claimed invention.

To learn more:

To learn more:

The timing for submitting a specific reference to a prior-filed application depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): The specific reference must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: The specific reference must be submitted during the pendency of the application and within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

It’s important to note that This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s).

For more information on filing deadline, visit: filing deadline.

For more information on specific reference, visit: specific reference.

Ownership must be established under pre-AIA 37 CFR 3.73(b) when the assignee:

  • Signs a request for status of an application
  • Gives a power to inspect an application
  • Appoints its own registered attorney or agent to prosecute an application
  • Signs a disclaimer under 37 CFR 1.321
  • Consents to the filing of a reissue application
  • Consents to the correction of inventorship in a patent
  • Signs a Fee(s) Transmittal (PTOL-85B)

The MPEP states: “Examples of situations where ownership must be established under pre-AIA 37 CFR 3.73(b) are when the assignee: signs a request for status of an application or gives a power to inspect an application (MPEP §§ 102 and 104); appoints its own registered attorney or agent to prosecute an application (pre-AIA 37 CFR 3.71 and MPEP § 402.07); signs a disclaimer under 37 CFR 1.321 (MPEP § 1490); consents to the filing of a reissue application (MPEP § 1410.01); consents to the correction of inventorship in a patent (MPEP § 1481); or signs a Fee(s) Transmittal (PTOL-85B) (MPEP § 1306).”

Note that effective September 16, 2012, a juristic entity (e.g., organizational assignee) must be represented by a patent practitioner.

An assignee must establish ownership under 37 CFR 3.73(c) in various situations, including when the assignee:

  • Signs a request for status of an application
  • Gives a power to inspect an application
  • Appoints its own registered attorney or agent to prosecute an application
  • Signs a disclaimer under 37 CFR 1.321
  • Consents to the filing of a reissue application
  • Signs a Fee Transmittal (PTOL-85B)

The MPEP notes: “Effective September 16, 2012, a juristic entity (e.g., organizational assignee) must be represented by a patent practitioner.”

If an invention appears to the USPTO Director to have significant utility in the conduct of aeronautical and space activities, the applicant must file a written statement with the USPTO Director with the patent application or within 30 days after request by the Director.

The statement must be executed under oath setting forth the full facts concerning the circumstances under which the invention was made and stating the relationship (if any) of the invention to the performance of any work under any NASA contract, as provided in 51 U.S.C. 20135(d):

“No patent may be issued to any applicant other than the Administrator for any invention which appears to the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (hereafter in this section referred to as the ‘Director’) to have significant utility in the conduct of aeronautical and space activities unless the applicant files with the Director, with the application or within 30 days after request therefor by the Director, a written statement executed under oath setting forth the full facts concerning the circumstances under which the invention was made and stating the relationship (if any) of the invention to the performance of any work under any contract of the Administration.”

For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of:

  • Four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f)
  • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
  • Sixteen months from the filing date of the prior application

The MPEP states: If the application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of: (1) four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f); (2) four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage; or (3) sixteen months from the filing date of the prior application.

To learn more:

To learn more:

The USPTO may require earlier submission of priority documents in certain circumstances. According to 37 CFR 1.55(g)(2), these circumstances include:

  • When the application is involved in an interference or derivation proceeding
  • When necessary to overcome the date of a reference relied upon by the examiner
  • When deemed necessary by the examiner

In these cases, the applicant may be required to submit the priority claim and certified copy of the foreign application earlier than the general deadline of the patent grant date.

To learn more:

The USPTO may require earlier filing of priority claims and certified copies in certain situations. According to 37 CFR 1.55(g)(2), these situations include:

  • When the application is involved in an interference or derivation proceeding
  • When necessary to overcome the date of a reference relied upon by the examiner
  • When deemed necessary by the examiner

The MPEP explains that these requirements allow the USPTO to address priority issues promptly when they are relevant to ongoing proceedings or examination.

To learn more:

According to 37 CFR 1.55(g)(2), the USPTO may require that the claim for priority and the certified copy of the foreign application be filed earlier than otherwise provided in the following circumstances:

  1. When the application is involved in an interference or derivation proceeding;
  2. When necessary to overcome the date of a reference relied upon by the examiner; or
  3. When deemed necessary by the examiner.

The certified copy of the foreign application must be filed before the patent is granted. If the certified copy is filed after payment of the issue fee but prior to the date of grant, the priority claim will be placed in the file record but the patent will not include the priority claim unless corrected after the patent is granted using a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.

For applications filed under 35 U.S.C. 111(a) (other than design applications), a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim must also be filed with the certificate of correction. For all applications, a grantable petition under 37 CFR 1.55(f) or (g) must also be filed with the certificate of correction unless the priority claim was timely made but a certified copy was not yet in the file. See MPEP 215.03.

New assignment paperwork is required in the following scenario:

  • The application claiming benefit of a provisional application includes subject matter that is not common with the provisional application, and
  • The application was filed before September 16, 2012, or the assignee is not the original applicant in the later application.

MPEP § 306.01 states: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

This requirement is similar to the practice for continuations-in-part filed under 35 U.S.C. 120.

To learn more:

According to MPEP 608.01(v), a trademark, service mark, collective mark, certification mark, or trade name may be used in a patent application to identify an article, product, service, or organization if:

  • (A) its meaning is established by an accompanying definition in the specification which is sufficiently descriptive, enabling, precise and definite such that a claim including the mark or trade name complies with the requirements of 35 U.S.C. 112, or
  • (B) its meaning is well-known to one skilled in the relevant art and is satisfactorily defined in the literature.

It’s important to note that these conditions must be met at the time of filing the complete application. The MPEP also states that If the product, service, or organization to which a mark refers is set forth in such language that its identity is clear, examiners are authorized to permit the use of the mark if it is distinguished from common descriptive nouns by capitalization.

To learn more:

MPEP 303 outlines specific situations where a patent examiner needs to obtain assignment information from the Patent Application Locator and Monitoring (PALM) system:

“When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims or there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

This typically occurs in two main scenarios:

  1. When applications from different inventors have conflicting claims
  2. When there’s uncertainty about who should direct the prosecution

In these cases, the examiner must consult PALM to clarify the assignment status.

Correction of inventorship is required when the application is amended in a way that changes the claims, resulting in one or more named inventors no longer being an inventor of the subject matter of a remaining claim. The MPEP states:

Applicants are responsible for correcting, and are required to correct, the inventorship in compliance with 37 CFR 1.48 when the application is amended to change the claims so that one (or more) of the named inventors is no longer an inventor of the subject matter of a claim remaining in the application.

Requests for correction under 37 CFR 1.48 filed on or after September 16, 2012, are processed by the Office of Patent Application Processing (OPAP). If granted, OPAP will update the Office records and issue a corrected filing receipt.

To learn more:

To learn more:

An English translation is required for non-English oaths or declarations in most cases. According to MPEP 602.06:

“Unless the text of any oath or declaration in a language other than English is in a form provided by the Patent and Trademark Office or in accordance with PCT Rule 4.17(iv), it must be accompanied by an English translation together with a statement that the translation is accurate.”

However, for oaths or declarations filed under 37 CFR 1.63, there is some flexibility: “the translation may be filed in the Office no later than two months from the date applicant is notified to file the translation.”

To learn more:

A title report is typically prepared at specific stages of the patent process. The MPEP Section 320 states that “A title report is prepared when a new application is filed in order to notify the examiner of the assignment status of the application.” Additionally, title reports are prepared:

  • When a Notice of Allowance is mailed
  • When an application is ready for issue
  • When a request for a correction of inventorship is received

These reports ensure that the most current ownership information is available at critical points in the patent process.

For more information on new application, visit: new application.

For more information on notice of allowance, visit: notice of allowance.

For more information on title report, visit: title report.

A separate written request is required in specific situations, as outlined in MPEP 215.01:

A separate written request may be used when the applicant wishes the Office to retrieve a foreign application from a foreign intellectual property office that becomes a participating foreign intellectual property office after the foreign priority has been claimed, so long as the time period set in 37 CFR 1.55 has not expired.

Additionally, a separate request is needed when:

  • The foreign application was not originally filed in a participating office, but a certified copy was filed in an application subsequently filed in a participating office.
  • The applicant wants to use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)) to file such a request.

To learn more:

A separate written request for PDX retrieval is needed in two specific situations:

  1. When the applicant wishes the Office to retrieve a foreign application from a foreign intellectual property office that becomes a participating office after the foreign priority has been claimed, as long as the time period set in 37 CFR 1.55 has not expired.
  2. When the foreign application was not originally filed in a participating office, but a certified copy was filed in an application subsequently filed in a participating foreign intellectual property office.

The MPEP provides Form PTO/SB/38 for such requests:

Applicants can use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)) to file such a request.

A reissue application is necessary to perfect a foreign priority claim in the following situations:

  1. When the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance.
  2. When the requirements of 37 CFR 1.55 are not met.
  3. When the correction sought would require further examination.

The MPEP provides an example: Further examination would be required where grant of the petition would cause the patent to be subject to a different statutory framework, e.g., where the foreign application has a pre-March 16, 2013 filing date in a patent that was examined under the first inventor to file (FITF) provisions of the AIA. In such situations, the filing of a reissue application with a petition for an unintentionally delayed priority claim would be required.

To learn more:

A provisional patent application is considered abandoned no later than 12 months after its filing date. MPEP 203.05 states that an abandoned application includes, in the case of a provisional application, no later than 12 months after the filing date of the provisional application (see MPEP § 711.03(c) and 35 U.S.C. 111(b)(5)). This means that provisional applications have a statutory life of one year from their filing date, after which they are automatically abandoned if not converted to a nonprovisional application or claimed as priority in a nonprovisional application.

For more information, you can refer to MPEP § 711.03(c) and 35 U.S.C. 111(b)(5).

A petition to expunge is necessary when there has been a complete error in recording an assignment document at the USPTO. This typically occurs when a document not intended for recording was erroneously recorded. As stated in MPEP 323:

‘In the case of a complete error (e.g., a wrong document is recorded), a petition to expunge the assignment record should be filed.’

Key points about petitions to expunge:

  • They are used for complete errors, not minor corrections
  • The petition should clearly explain the nature of the error
  • Supporting documentation may be required
  • The USPTO will review the petition and make a determination

It’s important to note that expungement is a serious step and should only be used when absolutely necessary.

For more information on USPTO, visit: USPTO.

Tags: USPTO

A petition is required to correct a benefit claim in the following situations:

  • When the benefit claim is filed after the required time period set forth in 37 CFR 1.78.
  • When the benefit claim was included elsewhere in the application (e.g., in an oath or declaration) but was not recognized by the Office as shown by its absence on the first filing receipt, and the correction is sought after the expiration of the time period set in 37 CFR 1.78.

The MPEP states: If, however, an applicant includes a benefit claim elsewhere in the application and the claim is not recognized by the Office as shown by its absence on the first filing receipt, the Office will require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the correction is sought after expiration of the time period set in 37 CFR 1.78.

However, a petition is not required for certain corrections, such as changing the relationship of the applications or changing the filing date of a prior-filed application, as long as these corrections are made within the original time period.

To learn more:

To learn more:

A patent application file becomes available to the public in the following situations:

  1. When the application has issued as a patent or published as a statutory invention registration
  2. When the application has been published and subsequently abandoned
  3. When the application has been published and is still pending
  4. When an unpublished, abandoned application is identified or relied upon in certain public documents
  5. When the benefit of an unpublished pending application is claimed in certain public documents

These conditions are outlined in 37 CFR 1.14(a)(1). In most cases, a fee is required to access the application file contents.

According to MPEP 203.03, a nonprovisional patent application is considered “amended” after it has been initially acted on by the examiner, and the applicant has filed a reply to the examiner’s action. The applicant’s reply may include:

  • An election
  • A traverse of the examiner’s action
  • An amendment to the application

MPEP 203.02 defines a ‘rejected’ application as follows:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application. Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

This status applies to applications that have received an Office action from the examiner but have not yet been responded to by the applicant.

MPEP 203.04 defines an ‘allowed’ or ‘in issue’ patent application as follows:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

Essentially, an application is ‘allowed’ when the examiner has determined it meets all requirements for patentability and has sent a Notice of Allowance. This status continues until the patent is issued, unless specific actions are taken to withdraw it or it becomes abandoned due to non-payment of fees.

MPEP 203.05 outlines several scenarios where an application is considered abandoned:

  • Formal abandonment by the applicant or attorney/agent of record
  • Failure to take appropriate action at some stage in the prosecution of a nonprovisional application
  • Failure to pay the issue fee
  • For provisional applications, no later than 12 months after the filing date

Abandonment removes the application from the Office docket of pending applications. It’s crucial for applicants to be aware of deadlines and required actions to prevent unintentional abandonment.

For continuing applications (continuation, divisional, continuation-in-part) filed on or after September 16, 2012 under 37 CFR 1.53(b), a newly executed inventor’s oath or declaration is generally not required if:

  • An oath or declaration complying with 35 U.S.C. 115 and 37 CFR 1.63 (or substitute statement under 37 CFR 1.64) was filed in the earlier-filed application
  • A copy of the executed oath/declaration from the earlier application is submitted in the continuing application showing it was executed

However, a newly executed inventor’s oath or declaration must be filed in a continuation or divisional application naming an inventor not named in the prior application (37 CFR 1.63(d)(3)).

For continuing applications filed before 9/16/2012, a newly executed oath or declaration is required unless a copy of the executed oath or declaration filed in the prior application is submitted with certain other requirements met (see pre-AIA 37 CFR 1.63(d)).

A new oath or declaration is required in a patent application under the following circumstances:

  • When filing a continuation or divisional application
  • When filing a continuation-in-part application
  • To correct inventorship in an application
  • When the original oath or declaration was defective

According to MPEP 602.02: ‘A new oath or declaration is required in a continuation or divisional application filed under 37 CFR 1.53(b) or in a continuation-in-part application.’ Additionally, the MPEP states that ‘A new oath or declaration in compliance with 37 CFR 1.63 or 1.67 is required in a continuation or divisional application filed under 37 CFR 1.53(b), regardless of whether a copy of the oath or declaration from the prior application is submitted.’

To learn more:

When is a new oath or declaration required for a continuation-in-part application?

For continuation-in-part (CIP) applications, a new oath or declaration is typically required due to the addition of new matter. According to MPEP 602.05:

‘A continuation-in-part application (which may disclose and claim subject matter not disclosed in the prior application) is considered a continuing application for purposes of 37 CFR 1.78(d), but not for purposes of 37 CFR 1.63(d). Accordingly, the inventor’s oath or declaration must also be filed in the continuation-in-part application.’

This requirement ensures that the inventors acknowledge and claim the new subject matter introduced in the CIP application. The new oath or declaration should cover both the original content from the parent application and the newly added material in the CIP.

To learn more:

The need for a new assignment in applications derived from earlier applications depends on the type of application and its content:

  • Division and Continuation Applications: Generally, no new assignment is required as the prior assignment is automatically applied. However, a new recordation request is needed to reflect this in USPTO records.
  • Substitute and Continuation-in-Part Applications: New assignments are typically required unless the application is filed on or after September 16, 2012, and the assignee is the original applicant.
  • Applications Claiming Provisional Benefits: If the application includes only subject matter from the provisional application, no new assignment is needed. However, if it includes new subject matter, a new assignment is required, with the same exception as for substitute and continuation-in-part applications.

Always refer to MPEP § 306, § 307, and § 308 for the most up-to-date and detailed information.

For more information on new assignment, visit: new assignment.

For more information on USPTO requirements, visit: USPTO requirements.

A new assignment is generally required for a continuation-in-part (CIP) application, with one exception. According to MPEP 306:

Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

This means:

  • For CIP applications filed before September 16, 2012: A new assignment is always required.
  • For CIP applications filed on or after September 16, 2012: A new assignment is required unless the assignee is the original applicant in the CIP application.

The reason for this requirement is that CIP applications often contain new subject matter not present in the original application, and the original assignment may not cover this new material.

A divisional application is often filed in response to a restriction requirement made by the patent examiner. As stated in the MPEP:

A divisional application is often filed as a result of a restriction requirement made by the examiner.

When an examiner determines that an application contains multiple independent and distinct inventions, they may issue a restriction requirement. The applicant can then elect one invention to pursue in the original application and file a divisional application to pursue the non-elected invention(s).

To learn more:

A Continued Prosecution Application (CPA) is acceptable when it meets the requirements set forth in 37 CFR 1.53(d). According to MPEP § 201, the examiner will use specific language to indicate acceptance:

The request filed on [date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [number] is acceptable and a CPA has been established.

It’s important to note that CPAs are now only available for design patent applications. For utility and plant applications, a Request for Continued Examination (RCE) would be used instead.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent examination, visit: patent examination.

A Certificate of Correction is appropriate for perfecting a foreign priority claim in the following situations:

  1. When the priority claim was timely filed in the application but was not included on the patent because the requirement for a certified copy was not satisfied. In this case, a grantable petition under 37 CFR 1.55(f) or 37 CFR 1.55(g) for design applications is also required.
  2. When a priority claim under 37 CFR 1.55 was not timely made, but the correction sought would not require further examination.

The MPEP states: “Effective May 13, 2015, 37 CFR 1.55(g) provides that the claim for priority and the certified copy of the foreign application must be filed within the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate. 37 CFR 1.55(g) eliminates the need in many instances to file a reissue application in order to perfect a claim for foreign priority.” (MPEP 216.01)

The USPTO has specific rules for making international application files available to the public. According to MPEP 110, which cites 37 CFR 1.14(g), After publication of an application under 35 U.S.C. 122(b), the USPTO will make available copies of the application files and also allow for access to those files in accordance with 37 CFR 1.14(a). Specifically for international applications, after publication of an international application designating the U.S. under PCT Article 21, the USPTO will make available copies of, and allow access to, those international application files which are kept in the USPTO. However, this access is subject to certain conditions and restrictions, such as the payment of appropriate fees and the exclusion of certain documents like the Examination Copy.

For more information on public access, visit: public access.

For more information on USPTO, visit: USPTO.

The USPTO’s timing for retrieving foreign applications under PDX is described in MPEP 215.01:

In general, an attempt to retrieve an eligible foreign application to which priority is claimed in a U.S. application will be made by the USPTO when the application is docketed to an examiner. In any case the USPTO will not attempt electronic retrieval until the Office of Patent Application Processing has completed its review of the application.

Key points about the retrieval timing:

  • The first attempt is typically made when the application is assigned to an examiner.
  • Retrieval occurs after the Office of Patent Application Processing completes its review.
  • Applicants should check the Private PAIR system to confirm successful retrieval.
  • A successful retrieval usually takes about one week to complete.

To learn more:

If the applicant files the certified copy of the foreign application to overcome the effective date of a reference, a translation is required if the copy is not in English.

The examiner should require the translation when requesting the certified copy. The translation must be a complete translation of the certified copy, and must be accompanied by a statement that the translation is accurate. [MPEP 216]

An examiner considers the merits of a foreign priority claim in the following situations:

  • When a reference is found with an effective date between the foreign filing date and the U.S. filing date
  • When determining if a reference’s prior art date falls within the grace period for the application under examination
  • When an interference situation is under consideration

The MPEP states: “The subject matter of the application is not examined to determine whether the applicant is actually entitled to the benefit of the foreign filing date on the basis of the disclosure thereof unless such determination is required for patentability reasons. For example, the examiner considers the merits of an applicant’s claim of priority when a reference is found with an effective date between the date of the foreign filing and the date of filing in the United States, when determining whether a reference’s prior art date is within the grace period for the application under examination, and when an interference situation is under consideration.” (MPEP 216)

The status of an application as ‘allowed’ has a specific timeframe. According to the MPEP:

“Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue ( 37 CFR 1.313 ), or becomes abandoned for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).”

In other words, the ‘allowed’ status begins when the notice of allowance is sent and typically ends when the patent is issued. However, this status can be terminated if the application is withdrawn from issue or becomes abandoned due to non-payment of required fees.

To learn more:

A revocation of power of attorney becomes effective on the date it is received by the USPTO, not on the date it is accepted. As stated in MPEP 402.05: Revocation of a power of attorney becomes effective on the date that the revocation is RECEIVED in the Office (not on the date of ACCEPTANCE). The Office will send an appropriate notification upon revocation.

To learn more:

A patent application stops being considered ‘new’ when it receives its first action from the examiner. According to MPEP 203.01:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This implies that once the examiner issues any official communication or action on the merits of the application, such as a non-final rejection or a notice of allowance, the application is no longer considered ‘new’ in the patent examination process.

To learn more:

A patent application typically becomes publicly accessible after it is published. MPEP 106 states:

Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.

This publication usually occurs 18 months after the earliest filing date of the application, as per 35 U.S.C. 122(b). At this point, any previous restrictions on access, including those placed on inventors, are lifted, and the application becomes part of the public record.

For more information on public access, visit: public access.

Patent examiners need to obtain assignment information in specific situations where the ownership of an application is significant. The MPEP 303 outlines two key scenarios:

  1. Conflicting claims in applications of different inventors: When multiple applications from different inventors contain claims that conflict with each other.
  2. Questions about who should direct prosecution: When there is uncertainty about which party has the right to control the patent prosecution process.

In these cases, the MPEP states: “When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims or there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” PALM refers to the USPTO’s Patent Application Location and Monitoring system.

For more information on assignment information, visit: assignment information.

For more information on conflicting claims, visit: conflicting claims.

For more information on Patent examiners, visit: Patent examiners.

For more information on patent prosecution, visit: patent prosecution.

Patent examiners typically do not require title reports for routine examination. The MPEP states:

Information as to the title is not normally required by the examiner to examine an application. It is only in limited circumstances when the ownership becomes an issue and an examiner needs a title report.

When ownership information is necessary, examiners can obtain a title report through the USPTO’s internal PALM Intranet system.

The provisions of 35 U.S.C. 386(a) and (b) became effective for certain types of applications filed on or after May 13, 2015. According to MPEP 213.07:

The provisions of 35 U.S.C. 386(a) and (b) apply to nonprovisional applications, international applications (PCT) and international design applications filed on or after May 13, 2015, and patents issued therefrom. See 37 CFR 1.55(o).

This means that the right of priority under these sections is only applicable to:

  • Nonprovisional applications
  • International applications (PCT)
  • International design applications

These applications must be filed on or after May 13, 2015, to be eligible for the priority rights under 35 U.S.C. 386(a) and (b). The same applies to patents issued from such applications.

For more information on 35 U.S.C. 386, visit: 35 U.S.C. 386.

For more information on effective date, visit: effective date.

For more information on nonprovisional application, visit: nonprovisional application.

Third parties cannot access an international patent application until the earliest of:

  • The international publication date
  • Date of receipt of the communication of the application under PCT Article 20
  • Date of receipt of a copy of the application under PCT Article 22

This is specified in PCT Article 30(2)(a):

“No national Office shall allow access to the international application by third parties, unless requested or authorized by the applicant, before the earliest of the following dates: (i) date of the international publication of the international application, (ii) date of receipt of the communication of the international application under Article 20, (iii) date of receipt of a copy of the international application under Article 22.”

National offices have specific restrictions on allowing access to international patent applications. According to MPEP 110, which cites PCT Article 30(2)(a), No national Office shall allow access to the international application by third parties unless requested or authorized by the applicant, before the earliest of the following dates:

  • Date of international publication
  • Date of receipt of the communication under PCT Article 20
  • Date of receipt of a copy under PCT Article 22

This provision ensures that the confidentiality of the application is maintained until certain milestones in the patent process are reached.

A continuation application can be filed at various times during the patent application process. According to MPEP 201.07:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

This means you can file a continuation application:

  • Before the parent application is granted a patent
  • Before the parent application is abandoned
  • Before proceedings on the parent application are terminated

However, for Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), which are only available for design applications (excluding international design applications), there are additional timing restrictions:

A continued prosecution application (CPA) under 37 CFR 1.53(d) (available only for design applications, but not international design applications), however, must be filed prior to payment of the issue fee unless a petition under 37 CFR 1.313(c) is granted in the prior application.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

Benefit under 35 U.S.C. 386(c) for international design applications can only be claimed in specific types of applications filed on or after May 13, 2015. The MPEP states:

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that applications filed before May 13, 2015, cannot claim the benefit of an international design application under 35 U.S.C. 386(c). It’s important for applicants to be aware of this date restriction when considering benefit claims for their patent applications.

To learn more:

To learn more:

The ability to claim benefit under 35 U.S.C. 386(c) for international design applications is subject to specific timing requirements. According to MPEP § 211.01(d):

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that to claim the benefit of an international design application, the claiming application must have been filed on or after May 13, 2015. This date is significant as it marks the implementation of certain provisions of the Patent Law Treaties Implementation Act of 2012.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on filing date requirements, visit: filing date requirements.

An examiner can change the title of a patent application at various stages of the examination process. According to MPEP 606.01, “If a satisfactory title is not supplied by the applicant, the examiner may, at the time of allowance, change the title by an examiner’s amendment.” This typically occurs when the original title is not descriptive of the claimed invention, and the applicant has not provided a suitable alternative.

To learn more:

The MPEP provides specific guidance on when an attorney or agent not of record can change the correspondence address. It states:

See MPEP § 402.03 for information regarding when a change of correspondence address or a document granting access (i.e., a power to inspect) may be signed by an attorney or agent who is not of record.

This reference to MPEP § 402.03 suggests that there are certain circumstances where an attorney or agent not of record may be allowed to change the correspondence address or grant access to application information. For specific details, it’s recommended to consult MPEP § 402.03 directly.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on USPTO procedures, visit: USPTO procedures.

An applicant can voluntarily submit a substitute specification at any point up to the payment of the issue fee, subject to certain conditions. 37 CFR 1.125(b) states:

Subject to § 1.312, a substitute specification, excluding the claims, may be filed at any point up to payment of the issue fee if it is accompanied by a statement that the substitute specification includes no new matter.

It’s important to note that the substitute specification must not introduce new matter and must be accompanied by a statement confirming this fact. Additionally, the claims are excluded from this voluntary submission process.

To learn more:

Tags: new matter

An applicant can submit a new inventor’s oath or declaration to correct any deficiencies or inaccuracies present in an earlier-filed inventor’s oath or declaration. This is explicitly stated in the MPEP: “Applicant may submit a new inventor’s oath or declaration to correct any deficiencies or inaccuracies present in an earlier-filed inventor’s oath or declaration.” This provision is supported by 37 CFR 1.67(a).

To learn more:

A Request to Delete a Named Inventor can be filed at two specific times for a Continued Prosecution Application (CPA):

  1. With the CPA filing: The request can be submitted along with the CPA when it is initially filed.
  2. After the CPA filing: If the request is made after the CPA has been filed, it must follow a different procedure.

The MPEP ¶ 2.32 states:

Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.

This means that post-filing requests require additional documentation and must comply with the regulations for correction of inventorship.

A reissue application can be filed when an unexpired patent is found to be defective. The key criteria are:

  • The original patent must still be in force (unexpired)
  • There must be a defect in the patent that needs correction

It’s important to note that the reissue process is not for extending the term of a patent, but for correcting issues in the existing patent. For more detailed information on the timing and requirements, refer to MPEP Chapter 1400, which provides a comprehensive treatment of reissue applications.

To learn more:

A patent examiner may suggest hiring a patent practitioner under specific circumstances, as outlined in MPEP 401:

“If patentable subject matter appears to be disclosed in a pro se application and it is apparent that the applicant is unfamiliar with the proper preparation and prosecution of patent applications, the examiner may suggest to the applicant that it may be desirable to employ a registered patent attorney or agent.”

However, the examiner should not suggest hiring a practitioner if the application appears to contain no patentable subject matter. The MPEP provides a form paragraph (4.10) for examiners to use when making this suggestion.

A legal representative can sign a substitute statement for a deceased inventor when they are authorized to act on behalf of the deceased inventor’s estate. This typically occurs when the inventor has passed away during the patent application process or before it began.

According to MPEP 604: ‘A substitute statement may be made by the legal representative (e.g., executor, administrator, etc.) of a deceased inventor.’ The legal representative must be able to show their authority to act for the deceased inventor’s estate, which may require providing documentation such as a court appointment or letters testamentary.

It’s important to note that the substitute statement must still comply with all the requirements of 37 CFR 1.64, including identifying the deceased inventor, stating the legal representative’s relationship to the inventor, and acknowledging that willful false statements are punishable by law.

To learn more:

A continuation application can be filed at various stages during the patent application process, as long as the parent application is still pending. The MPEP provides guidance on the timing:

“At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.”

It’s important to note that there are some exceptions for specific types of applications, such as continued prosecution applications (CPAs) for design applications, which have additional timing requirements.

To learn more:

According to 37 CFR 1.78(j), benefit claims under 35 U.S.C. 386(c) can only be made in specific types of applications filed on or after May 13, 2015. The MPEP states:

“37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.”

This means that applications filed before May 13, 2015, cannot claim the benefit of an international design application under 35 U.S.C. 386(c). It’s important for applicants to be aware of this date restriction when considering their benefit claims.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

Title reports are not typically used in routine patent examination. The MPEP clarifies: Information as to the title is not normally required by the examiner to examine an application. It is only in limited circumstances when the ownership becomes an issue and an examiner needs a title report. For instance, title reports may be requested by the Reexamination Preprocessing Staff when a request for reexamination is filed. Examiners can obtain title reports through the USPTO’s internal PALM Intranet system when necessary.

For more information on patent examination, visit: patent examination.

For more information on title report, visit: title report.

Patent applications are generally published 18 months after the earliest filing date, with some exceptions. According to 35 U.S.C. 122(b)(1)(A):

“Subject to paragraph (2), each application for a patent shall be published, in accordance with procedures determined by the Director, promptly after the expiration of a period of 18 months from the earliest filing date for which a benefit is sought under this title. At the request of the applicant, an application may be published earlier than the end of such 18-month period.”

Exceptions to publication include applications that are no longer pending, subject to a secrecy order, provisional applications, or design patent applications.

Patent applications are generally published by the USPTO 18 months after the earliest filing date for which a benefit is sought. This is specified in 35 U.S.C. 122(b)(1)(A):

Subject to paragraph (2), each application for a patent shall be published, in accordance with procedures determined by the Director, promptly after the expiration of a period of 18 months from the earliest filing date for which a benefit is sought under this title. At the request of the applicant, an application may be published earlier than the end of such 18-month period.

There are some exceptions to this rule, such as applications that are no longer pending or are subject to a secrecy order. Applicants can also request early publication or non-publication under certain conditions.

Patent application records may be available to the public in the following situations:

  1. Patented applications and statutory invention registrations
  2. Published abandoned applications
  3. Published pending applications
  4. Unpublished abandoned applications that are identified or relied upon
  5. Unpublished pending applications whose benefit is claimed
  6. Unpublished pending applications that are incorporated by reference or otherwise identified

For specific details on each situation, refer to 37 CFR 1.14(a)(1)(i)-(vi).

New drawings may be required before examination in several situations:

  • When drawings have not been filed, but a drawing will aid in understanding the invention (see MPEP § 608.02).
  • When applications appear to be missing drawings (see MPEP § 601.01(f) or 601.01(g)).
  • When the Office of Patent Application Processing (OPAP) finds the drawings unacceptable for publication.
  • When the supervisory patent examiner believes the drawings do not permit reasonable examination.

As stated in the MPEP: If at the time of the initial assignment of an application to an examiner’s docket, or if at the time the application is taken up for action, the supervisory patent examiner believes the drawings to be of such a condition as to not permit reasonable examination of the application, applicant should be required to immediately submit corrected drawings.

To learn more:

Models or exhibits are generally not required in patent applications unless specific conditions are met. According to MPEP 608.03, models or exhibits are only admitted as part of an application or patent if:

  • They substantially conform to the requirements of 37 CFR 1.52 or 1.84
  • They are specifically required by the Office
  • They are filed with a petition under 37 CFR 1.91(a)(3)

The MPEP states: With the exception of cases involving perpetual motion, a model is not ordinarily required by the Office to demonstrate the operability of a device. However, if operability is questioned, the applicant must establish it to the examiner’s satisfaction.

To learn more:

While the USPTO generally discourages filing duplicate copies, there are situations where separate copies are necessary. According to MPEP 502.04:

Since each file must be complete in itself, a separate copy of every paper to be filed in a patent, patent file, or other proceeding must be furnished for each file to which the paper pertains, even though the contents of the papers filed in two or more files may be identical.

This means that if a document relates to multiple patent applications or proceedings, a separate copy must be submitted for each relevant file, even if the content is identical across all copies.

To learn more:

According to 35 U.S.C. 113, drawings are required ‘where necessary for the understanding of the subject matter sought to be patented.’ Specifically:

  • For applications filed on or after December 18, 2013 (except design applications), drawings are not required to receive a filing date, but may still be necessary to fully disclose the invention.
  • For applications filed before December 18, 2013, drawings were required at filing if necessary for understanding the invention.
  • Design applications must include drawings to receive a filing date.

The USPTO recommends including drawings in most cases, as they help ensure the requirements of 35 U.S.C. 113 are met for any claimed invention.

To learn more:

According to MPEP 608.02(x), drawing corrections or changes are generally accepted at the time they are presented, unless the applicant is notified otherwise by the examiner in the subsequent Office action. The MPEP states:

“Drawing corrections or changes will be entered at the time they are presented, unless applicant is notified to the contrary by the examiner in the action following the amended drawing submission.”

This means that applicants can typically assume their drawing corrections have been accepted unless they receive specific notification stating otherwise.

To learn more:

To learn more:

Annotated sheets are required for patent drawing changes in specific circumstances. According to MPEP 608.02(v), annotated sheets are necessary “When changes are to be made in the drawing itself, other than mere changes in reference characters, designations of figures, or inking over lines pale and rough.” However, the MPEP also notes that “Ordinarily, broken lines may be changed to full without a sketch.” This means that substantial changes to the drawing content require annotated sheets, while minor alterations may not.

To learn more:

MPEP 606 provides guidance on words that should be avoided in patent application titles:

“The words listed below are not considered as part of the title of an invention, these words should not be included at the beginning of the title of the invention and will be deleted when the Office enters the title into the Office’s computer records, and when any patent issues.”

While the MPEP doesn’t provide an exhaustive list in this section, it’s generally advisable to avoid:

  • Non-descriptive terms like ‘new’, ‘improved’, or ‘invention of’
  • Articles such as ‘a’, ‘an’, or ‘the’ at the beginning of the title
  • Overly broad terms that don’t specifically describe the invention

However, there are exceptions. For example, “The term ‘new’ will not be deleted when it is a part of a proper name, such as ‘New York’. Similarly, the term ‘design’ will not be deleted when it is a part of a term, such as ‘Design-aiding apparatus…’.”

To learn more:

For continuation or divisional applications filed under 37 CFR 1.53(d) (continued prosecution design applications) with changes in inventorship, the requirements were as follows:

“If an inventor named in a prior application is not an inventor in a continuation or divisional application filed under 37 CFR 1.53(d) (continued prosecution design application), the request for filing the continuation or divisional application must be accompanied by a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the continuation or divisional application (see 37 CFR 1.53(d)(4)).”

This meant that for continued prosecution design applications, a statement requesting the deletion of non-inventors had to be submitted along with the filing request when there were changes in inventorship.

To learn more:

To learn more:

An international design application designating the United States can claim priority based on several types of prior applications. According to MPEP 213.07:

Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The types of prior applications that can be used for claiming priority include:

  • A prior foreign application
  • An international application (PCT) designating at least one country other than the United States
  • A prior international design application designating at least one country other than the United States

These priority claims must comply with the conditions and requirements set forth in 35 U.S.C. 119(a)-(d) and 172, as well as the Hague Agreement and its Regulations.

For more information on foreign priority, visit: foreign priority.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on prior applications, visit: prior applications.

According to MPEP 502.01, various types of patent-related correspondence can be transmitted by facsimile to the USPTO, including:

  • Continued Prosecution Applications (CPAs) filed under 37 CFR 1.53(d) (for design applications only)
  • Amendments
  • Declarations
  • Petitions
  • Information Disclosure Statements (IDS)
  • Terminal disclaimers
  • Notices of appeal and appeal briefs
  • Requests for Continued Examination (RCEs) under 37 CFR 1.114
  • Assignment documents
  • Issue fee transmittals
  • Authorizations to charge deposit accounts

The MPEP states: “37 CFR 1.6(d) specifies the types of correspondence which may be transmitted by facsimile.” However, it’s important to note that certain types of correspondence are prohibited from being sent by fax, as outlined in 37 CFR 1.6(d)(2)-(7).

To learn more:

According to MPEP 502.01, certain types of patent-related correspondence are prohibited from being sent by facsimile to the USPTO. These include:

  • Documents required by statute to be certified (37 CFR 1.4(f))
  • National patent application specifications and drawings for obtaining a filing date (except for CPAs under 37 CFR 1.53(d))
  • International patent applications
  • International design applications
  • Documents for entering the national stage of an international application (37 CFR 1.495(b))
  • Third-party submissions under 37 CFR 1.290
  • Correspondence related to registration to practice before the USPTO in patent cases
  • Color drawings (37 CFR 1.81, 1.83-1.85, 1.152, 1.165, 1.173, 1.437, or 1.1026)
  • Requests for reexamination (37 CFR 1.510 or 37 CFR 1.913)
  • Requests for supplemental examination (37 CFR 1.610)
  • Correspondence for patent applications under secrecy orders (37 CFR 5.1-5.5)
  • Most correspondence for contested cases or trials before the Patent Trial and Appeal Board

The MPEP states: “As a courtesy, the Office will attempt to notify senders whenever correspondence is sent to the Office by facsimile transmission that falls within one of the prohibitions.” However, it’s crucial to avoid submitting prohibited correspondence by fax, as it will not be accorded a receipt date.

To learn more:

Applications for patents which appear to disclose, purport to disclose or do disclose inventions or discoveries relating to atomic energy must be reported to the Department of Energy, which will be given access to the applications.

As stated in 37 CFR 1.14(d), “Such reporting does not constitute a determination that the subject matter of each application so reported is in fact useful or is an invention or discovery, or that such application in fact discloses subject matter in categories specified by 42 U.S.C. 2181(c) and (d).”

For the purpose of micro entity status, the following types of patent applications count towards the application filing limit:

  • Previously filed U.S. nonprovisional applications (utility, design, plant, continuation, and divisional)
  • Previously filed U.S. reissue applications
  • Previously filed U.S. national stage applications under the Patent Cooperation Treaty (PCT)
  • Previously filed international design applications under the Hague agreement that designate the U.S.

The MPEP states: “All such applications naming the inventor or a joint inventor are counted toward the application filing limit, whether the applications were filed before, on, or after March 19, 2013.

Applications that do not count towards the limit include:

  • Foreign applications
  • International (PCT) applications for which the basic U.S. national stage filing fee was not paid
  • Provisional applications

To learn more:

Continued Prosecution Applications (CPAs) are limited to specific types of patent applications:

  • Design Applications: CPAs are available for design applications filed before May 29, 2000.
  • Plant Applications: CPAs can be used for plant patent applications.

It’s important to note that CPAs are not available for utility patent applications filed on or after May 29, 2000. For these applications, applicants should use a Request for Continued Examination (RCE) instead.

The MPEP ¶ 2.34 provides guidance on how CPAs reference prior applications:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.

This means that for eligible applications, the CPA automatically establishes the necessary reference to the prior application without requiring amendments to the specification.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

The three main types of patent applications that can be filed in the USPTO are:

  1. Utility patent applications (filed under 35 U.S.C. 101) for “any new and useful process, machine, manufacture, or composition of matter”
  2. Design patent applications (filed under 35 U.S.C. 171) for “any new, original, and ornamental design for an article of manufacture”
  3. Plant patent applications (filed under 35 U.S.C. 161) for “whoever invents or discovers and asexually reproduces any distinct and new variety of plant”

The following types of patent applications and documents can be filed via EFS-Web:

  • Provisional patent applications under 35 U.S.C. 111(b)
  • Nonprovisional utility patent applications under 35 U.S.C. 111(a)
  • Nonprovisional design patent applications under 35 U.S.C. 111(a)
  • International applications filed under the PCT in the United States Receiving Office
  • National stage submissions under 35 U.S.C. 371
  • International design applications filed under the Hague Agreement
  • Requests for ex parte reexamination for utility or design patents
  • Requests for supplemental examination for utility, design, or plant patents
  • Third-party preissuance submissions under 35 U.S.C. 122(e)
  • Citation of prior art and written statements in patent files under 37 CFR 1.501

Follow-on documents can also be filed via EFS-Web for existing applications by registered users.

According to MPEP 608.02(w), there are two types of numeral changes that can be made to patent drawings without requiring annotated sheets from the applicant:

  1. Changing one or two numerals or figure ordinals
  2. Changing Roman Numerals to Arabic Numerals to agree with the specification

The MPEP states:

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: (B) Changing one or two numerals or figure ordinals. … (E) Changing Roman Numerals to Arabic Numerals to agree with specification.

These provisions allow for minor numerical corrections or adjustments to ensure consistency between the drawings and the specification without necessitating a formal submission from the applicant.

To learn more:

What types of national applications can be filed with the USPTO?

The United States Patent and Trademark Office (USPTO) accepts several types of national applications. These include:

  • Utility patent applications: For new and useful processes, machines, articles of manufacture, or compositions of matter.
  • Design patent applications: For new, original, and ornamental designs for articles of manufacture.
  • Plant patent applications: For new varieties of asexually reproduced plants.
  • Provisional patent applications: A temporary application that establishes a filing date but does not mature into an issued patent.

According to MPEP 201.01:

Applications for plant patents, design patents, and utility patents are national applications.

Each type of application has specific requirements and procedures. Utility, design, and plant patent applications can be filed as nonprovisional applications, while provisional applications are only available for utility patents.

For more information on design patent, visit: design patent.

For more information on provisional patent, visit: provisional patent.

For more information on USPTO, visit: USPTO.

Under U.S. patent laws, several types of national applications can be filed. The MPEP 201.01 states:

‘National applications include original (nonprovisional), reissue, and reexamination applications (including supplemental examination proceedings). The original application includes continuation, divisional, and continuation-in-part applications. National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’

To break this down:

  • Original (nonprovisional) applications: Standard utility patent applications
  • Reissue applications: To correct errors in already granted patents
  • Reexamination applications: To request the USPTO to reexamine an existing patent
  • Continuation applications: Based on an earlier-filed application
  • Divisional applications: Derived from a parent application to pursue different inventions
  • Continuation-in-part applications: Adding new matter to a parent application
  • Design patent applications (under 35 U.S.C. 171)
  • Plant patent applications (under 35 U.S.C. 161)

For more information on reissue, visit: reissue.

For more information on USPTO, visit: USPTO.

Tags: reissue, USPTO

Under 35 U.S.C. 111(a), two types of national applications can be filed:

  • Nonprovisional applications: These are regular patent applications that, if granted, can result in an issued patent.
  • Provisional applications: These provide a priority date but do not mature into patents without further action.

The MPEP 201.01 states: ‘National applications may be filed under 35 U.S.C. 111(a) as provisional applications under 35 U.S.C. 111(b) or as nonprovisional applications under 35 U.S.C. 111(a).’ Each type has specific requirements and serves different purposes in the patent application process.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

What types of evidence can be used to establish assignee ownership in pre-AIA applications?

For pre-AIA applications (filed before September 16, 2012), assignees can use various types of evidence to establish ownership, including:

  • Assignment documents
  • Corporate merger documentation
  • Patent purchase agreements
  • Court orders
  • Joint research agreements

The MPEP 324 states: “The submission establishing ownership must show that the person signing the submission is a person authorized to act on behalf of the assignee.” This means that in addition to proving ownership, the assignee must also demonstrate the authority of the person acting on their behalf.

For more information on assignee ownership, visit: assignee ownership.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP 409.03(d), acceptable evidence to prove inventor unavailability or refusal can include:

  • Copies of letters or email messages sent to the inventor requesting their signature
  • Returned receipt indicating the inventor’s refusal to accept mail
  • Statements from people who have attempted to contact the inventor
  • Evidence of the inventor’s mental or physical incapacity
  • Evidence of the inventor’s unavailability due to absence
  • Other pertinent evidence that demonstrates the inventor’s unavailability or refusal

The MPEP states: ‘The proof of unavailability or refusal will be examined by the Office.’ This means that the USPTO will carefully evaluate the submitted evidence to determine if it sufficiently demonstrates the inventor’s unavailability or refusal.

To learn more:

OPAP may object to and require corrected drawings within a set time period for several issues. According to the MPEP, these include:

  • Line quality that is too light to be reproduced
  • Illegible text
  • Missing lead lines
  • Excessive text or non-English text
  • Incorrect margins or paper size
  • Improper figure labeling
  • Illegible photographs that could be illustrated by ink drawings
  • Color drawings or photographs without a proper petition

For example, regarding line quality, MPEP 507 states:

“OPAP may object to and require corrected drawings within a set time period, if the drawings: (A) have a line quality that is too light to be reproduced (weight of all lines and letters must be heavy enough to permit adequate reproduction) or text that is illegible (reference characters, sheet numbers, and view numbers must be plain and legible). See 37 CFR 1.84(l) and (p)(1)

For more information on drawing requirements, visit: drawing requirements.

For more information on OPAP, visit: OPAP.

For more information on patent drawings, visit: patent drawings.

The USPTO records various documents related to patents and patent applications, including:

  • Licenses
  • Security interests
  • Liens
  • Options
  • Mortgages
  • Name changes
  • Mergers
  • Change of entity status

According to MPEP 313: Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11. This includes a wide range of documents that affect the ownership or rights associated with patents and applications.

For more information on licenses, visit: licenses.

For more information on patent documents, visit: patent documents.

For more information on security interests, visit: security interests.

The Electronic Patent Assignment System (EPAS) accepts various types of assignment-related documents. As stated in MPEP 302.10:

“The EPAS system allows customers to submit assignments and other documents related to title (e.g., lien agreements, probate documents, licenses, etc.) directly into the automated Patent and Trademark Assignment System.”

This system streamlines the submission process for a wide range of ownership and assignment documents.

To learn more:

Applicants can submit various types of documents as evidence when replying to an Office action. The MPEP provides examples:

“Documents may be in any form but are typically in the form of an affidavit, declaration, patent, or printed publication.”

These documents can be used to support arguments related to patentability issues raised in the Office action, such as demonstrating that an element in the claim is operative or that a term has a recognized meaning in the art.

To learn more:

The USPTO records various documents related to patent ownership and interests. Common types include:

  • Assignments
  • Security agreements
  • Mergers
  • Name changes
  • Licenses
  • Liens
  • Joint research agreements
  • Government interests

As stated in MPEP 302.07: “Examples of the type of descriptions of the interest conveyed or transaction to be recorded that can be identified are: (A) assignment; (B) security agreement; (C) merger; (D) change of name; (E) license; (F) foreclosure; (G) lien; (H) contract; and (I) joint research agreement.”

To record a document:

  1. Ensure it’s eligible for recordation
  2. Complete the appropriate cover sheet
  3. Submit the document and cover sheet to the USPTO
  4. Pay any applicable fees

Remember, the USPTO generally only records documents that affect title to patents or patent applications. Consult the MPEP or a patent attorney for guidance on specific document types.

For more information on patent documents, visit: patent documents.

For more information on USPTO recordation, visit: USPTO recordation.

In addition to assignments, the USPTO will record various other documents relating to interests in patent applications and patents upon request. These include:

  • License agreements
  • Security interest agreements
  • Other documents affecting title to applications, patents, and registrations

As stated in the MPEP, “Other documents affecting title to applications, patents, and registrations will be recorded as provided in 37 CFR Part 3 or at the discretion of the Director.” (MPEP 313)

What types of documents can be recorded in the USPTO assignment database?

The USPTO assignment database accepts various types of documents related to patent ownership and interests. According to MPEP 302, recordable documents include:

  • Assignments of patent rights
  • Security interests (e.g., liens, mortgages)
  • Licenses
  • Releases
  • Certificates of name changes
  • Mergers
  • Other documents affecting title to applications, patents, or registrations

The MPEP states: ‘Any document which relates to the title in a patent or patent application will be recorded as provided in 37 CFR 3.11.’ This broad definition allows for the recording of various ownership-related documents.

For more information on licenses, visit: licenses.

For more information on patent assignments, visit: patent assignments.

For more information on recordable documents, visit: recordable documents.

For more information on security interests, visit: security interests.

For more information on USPTO database, visit: USPTO database.

What types of documents can be recorded in the Assignment Division of the USPTO?

The Assignment Division of the USPTO records various types of documents related to patent ownership. According to MPEP 302, the following types of documents can be recorded:

  • Assignments of patents and patent applications
  • Security interests in patents and patent applications
  • Licenses that grant a security interest in patents or patent applications
  • Documents that affect title (e.g., certificates of name change, mergers, change of corporate form)
  • Liens
  • Certificates of release or discharge of security interests
  • Conditional assignments
  • Bailments

It’s important to note that the USPTO does not determine the validity of the documents submitted for recordation. As stated in MPEP 302:

‘The Assignment Division does not determine the validity of the document but rather records the document that appears to be a document affecting title.’

This means that while a wide range of documents can be recorded, it is the responsibility of the parties involved to ensure the legal validity and enforceability of the documents they submit.

For more information on Assignment Division, visit: Assignment Division.

For more information on recordable documents, visit: recordable documents.

For more information on USPTO, visit: USPTO.

What types of documents can be recorded as assignments with the USPTO?

The USPTO allows for the recording of various types of documents related to patent ownership. According to MPEP 302:

“The United States Patent and Trademark Office (USPTO) records assignments, grants, and similar instruments relating to interests in patents and applications as provided in 37 CFR Part 3.”

Types of documents that can be recorded include:

  • Assignments: Transfers of the entire right, title, and interest in a patent or application
  • Security Agreements: Documents creating a security interest in a patent or application
  • Licenses: Agreements granting rights to use or practice a patented invention
  • Releases: Documents releasing previous security interests or other encumbrances
  • Name Changes: Documents evidencing a change in the name of the owner of record
  • Mergers: Documents showing the merger of companies and the resulting transfer of patent rights

It’s important to note that the USPTO records these documents without making a determination of their validity. As stated in MPEP 302, “The recording of a document pursuant to 37 CFR 3.11 is not a determination by the USPTO of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.”

For more information on patent assignments, visit: patent assignments.

A reissue application can be used to correct various types of defects in an unexpired patent. While the MPEP 201.05 doesn’t provide an exhaustive list in this section, it does state that a reissue application is for “a patent to take the place of an unexpired patent that is defective.” Common defects that can be addressed through reissue include:

  • Errors in the specification or drawings
  • Overly broad or narrow claims
  • Failure to claim priority correctly
  • Inventorship issues

For a more comprehensive list and detailed explanations of correctable defects, refer to MPEP Chapter 1400, which provides a thorough treatment of reissue applications and the types of defects they can address.

To learn more:

While the Certificate of Mailing or Transmission procedure is useful for many types of USPTO correspondence, there are several exceptions. According to 37 CFR 1.8(a)(2), the procedure does not apply to:

  • Filing of national patent application specifications and drawings for the purpose of obtaining an application filing date
  • Filing of correspondence in an international application before the U.S. Receiving Office, U.S. International Searching Authority, or U.S. International Preliminary Examining Authority
  • Filing of an international design application
  • Filing a copy of an international application and the basic national fee to enter the national stage
  • Filing a written declaration of abandonment under 37 CFR 1.138

It’s crucial to note that these exceptions exist to ensure certain critical documents are actually received by the USPTO before they are considered filed.

To learn more:

Patent law recognizes several types of continuing applications. According to the MPEP:

A continuing application is a continuation, divisional, or continuation-in-part application filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.

The three main types of continuing applications are:

  • Continuation: Pursues additional claims to an invention disclosed in an earlier application.
  • Divisional: Separates distinct inventions from a parent application into separate applications.
  • Continuation-in-part (CIP): Adds new matter to the disclosure of the earlier application.

Each type serves different purposes in patent prosecution strategy.

For more information on divisional, visit: divisional.

For more information on patent prosecution, visit: patent prosecution.

While MPEP 508.02 doesn’t specify the types of communications that might be received after a patent is granted, it does indicate that some communications may still be relevant to the record. The section states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This implies that certain communications might still become part of the record. These could include:

  • Maintenance fee payments
  • Requests for correction of errors in the patent
  • Reissue applications
  • Supplemental examination requests

However, any communication not related to these or other official post-grant procedures would likely be returned.

To learn more:

According to MPEP 314, two types of certificates are recordable for patent ownership changes:

  • Certificates showing a change of name of a business
  • Certificates showing a merger of businesses

As stated in the MPEP, Certificates issued by appropriate authorities showing a change of name of a business or a merger of businesses are recordable. These documents serve as important links in the chain of title for patent ownership.

To learn more:

The USPTO can expunge various types of assignment records that are erroneous or no longer supported by statutory basis. According to MPEP 323.01(d), this includes:

  • Erroneously recorded assignment documents
  • Documents that are not assignment documents but were incorrectly recorded as such
  • Assignment documents that are no longer supported by the statutory basis for recording

The MPEP states: ‘The USPTO will expunge, delete or correct assignment records that are not, or are no longer, supported by the statutory basis for recording.’ This broad definition allows for the correction of various types of errors in the assignment records.

To learn more:

According to the MPEP, specific types of applications can claim benefit under 35 U.S.C. 386(c). The relevant passage states:

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that the following types of applications can claim benefit under 35 U.S.C. 386(c):

  • Nonprovisional applications
  • International applications
  • International design applications
  • Patents issuing from the above applications

It’s important to note that these applications must be filed on or after May 13, 2015, to be eligible for claiming this benefit. Provisional applications are notably absent from this list and cannot claim benefit under 35 U.S.C. 386(c).

To learn more:

To learn more:

Continued Prosecution Applications (CPAs) are specifically for design patent applications. The MPEP ¶ 2.34 refers to CPAs in the context of design applications.

The MPEP ¶ 2.34 states: “In bracket 2, insert either –continuation– or –divisional–.”

This indicates that a CPA can be filed as either a continuation or a divisional of a prior design application. It’s important to note that CPAs are no longer available for utility or plant patent applications.

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

A Continued Prosecution Application (CPA) can be filed for specific types of applications. According to MPEP 201.06(d):

Effective July 14, 2003, CPA practice under 37 CFR 1.53(d) is not available for utility and plant applications.

This means that CPAs are limited to:

  • Design applications: Applications for design patents can be filed as CPAs.
  • Continuation applications: These must be based on an earlier application of the same type (i.e., design).
  • Divisional applications: These must also be based on an earlier design application.

It’s important to note that continuation-in-part (CIP) applications cannot be filed as CPAs. Additionally, utility and plant patent applications are no longer eligible for CPA practice since July 14, 2003.

For more information on continuation applications, visit: continuation applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

According to MPEP 201.01, national applications include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Reexamination proceedings

The MPEP specifically states:

‘National applications include original (nonprovisional) applications, reissue applications, and reexamination proceedings.’

Each of these types serves a different purpose in the patent process. Original applications are for new inventions, reissue applications are for correcting errors in existing patents, and reexamination proceedings are for reviewing the validity of granted patents.

For more information on reissue applications, visit: reissue applications.

According to MPEP 203.01, only nonprovisional applications can be considered ‘new’. The section states:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This means that provisional applications, which are place-holder applications that don’t get examined, are not classified as ‘new’ applications under this definition. Only nonprovisional utility, design, or plant patent applications can have the ‘new’ status before they receive their first examiner action.

To learn more:

During patent prosecution, several types of affidavits or declarations may be filed. MPEP ¶ 2.03 mentions three common types:

“Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application…”

These affidavits serve different purposes:

  • 37 CFR 1.130: Declarations of attribution or prior public disclosure
  • 37 CFR 1.131: Affidavits of prior invention to overcome cited art
  • 37 CFR 1.132: Affidavits traversing rejections or objections

Each of these affidavits provides specific evidence to support the patentability of an invention or to overcome rejections made by the patent examiner.

For more information on patent prosecution, visit: patent prosecution.

MPEP ¶ 2.03 mentions several types of affidavits or declarations that may be submitted during patent prosecution. Specifically, it refers to:

  • Affidavits or declarations under 37 CFR 1.130 (Declaration of Attribution or Prior Public Disclosure under the AIA)
  • Affidavits or declarations under 37 CFR 1.131 (Affidavit or Declaration of Prior Invention to Overcome Cited Patent or Publication)
  • Affidavits or declarations under 37 CFR 1.132 (Affidavits Traversing Rejections or Objections)

These affidavits or declarations are commonly used to overcome rejections or provide evidence during patent prosecution.

For more information on patent prosecution, visit: patent prosecution.

Common types of affidavits or declarations filed in patent applications include those submitted under specific sections of the Code of Federal Regulations. As mentioned in MPEP ¶ 2.03, these include:

  • 37 CFR 1.130: Declarations of attribution or prior public disclosure under the AIA
  • 37 CFR 1.131: Affidavits of prior invention to overcome cited patents or publications
  • 37 CFR 1.132: Affidavits or declarations traversing rejections or objections

These affidavits or declarations serve various purposes in patent prosecution, such as establishing inventorship, overcoming prior art, or addressing examiner rejections.

For more information on patent prosecution, visit: patent prosecution.

The MPEP provides specific guidance on the type of address that should be provided for the nonsigning inventor in pre-AIA 37 CFR 1.47 applications:

‘That address should be the last known address at which the inventor customarily receives mail.’

This typically means providing the most recent address where the inventor is known to receive correspondence. It’s important to provide an address where the USPTO’s communications are most likely to reach the nonsigning inventor.

To learn more:

To learn more:

While it’s speculative to predict the exact content of MPEP 312 if it were to be filled, its placement within the ‘300 – Ownership and Assignment’ chapter suggests it could potentially cover topics related to patent ownership, assignment procedures, or updates to existing sections in this chapter. The content would likely align with the overall theme of ownership and assignment in patent law and procedures.

The reference to the prior-filed application to claim benefit under 35 U.S.C. 120 or 119(e) must be submitted within the following time periods under 37 CFR 1.78:

  • For an application filed under 35 U.S.C. 111(a), the later of four months from the filing date or sixteen months from the filing date of the prior-filed application
  • For a national stage application under 35 U.S.C. 371, the later of four months from national stage commencement under 35 U.S.C. 371(b) or (f), four months from initial national stage submission, or sixteen months from the filing date of the prior-filed application

Failure to timely submit the reference is considered a waiver of any benefit claim. A petition and fee would be required to accept a delayed submission. See MPEP 211.04.

If an inventor’s signature was missing from a continuation or divisional application, the Office of Patent Application Processing (OPAP) would typically take the following steps:

  1. Send a “Notice to File Missing Parts” requiring the signature of the nonsigning inventor.
  2. If a copy of the decision according status under pre-AIA 37 CFR 1.47 was not included with the original filing, applicants could respond to the Notice by:
    • Submitting a copy of the decision according status under pre-AIA 37 CFR 1.47, along with a surcharge for late filing.
    • Alternatively, submitting an oath or declaration signed by the previously nonsigning inventor, along with the required surcharge.

This process is described in the MPEP:

“If OPAP mails such a Notice, a copy of the decision according status under pre-AIA 37 CFR 1.47, together with a surcharge under 37 CFR 1.16(f) for its late filing, will be an acceptable reply to the Notice. Alternatively, applicant may submit an oath or declaration signed by the previously nonsigning inventor together with the surcharge set forth in 37 CFR 1.16(f) in reply to the Notice.”

To learn more:

When dealing with a nonsigning inventor under pre-AIA 37 CFR 1.47, the following steps should be taken to present application papers:

  1. Send a copy of the application papers to the last known address of the nonsigning inventor.
  2. If the inventor is represented by counsel, send the papers to the inventor’s attorney’s address.
  3. Ensure that the inventor is given the opportunity to review the complete application, unless they have assigned their interest and the assignee has requested otherwise.

The MPEP emphasizes:

‘It is reasonable to require that the inventor be presented with the application papers before a petition under pre-AIA 37 CFR 1.47 is granted since such a procedure ensures that the inventor is apprised of the application to which the oath or declaration is directed.’

This process is crucial to establish that a bona fide attempt was made to present the application papers to the nonsigning inventor.

To learn more:

To learn more:

To determine small entity status for a business, several steps should be taken:

  • Review whether the business meets the definition of a small business concern under section 3 of the Small Business Act.
  • Check if the business meets the size standards in 13 CFR 121.801 through 121.805 for eligibility for reduced patent fees.
  • Investigate if the business has assigned, granted, conveyed, or licensed any rights in the invention to others.
  • If rights have been transferred, conduct the same review for each other entity involved.

The MPEP 509.03(a) emphasizes: “If small entity status is desired on the basis that the entity is a small business concern, the investigation should include a review of whether the business is a small business concern as defined by section 3 of the Small Business Act.”

To learn more:

Tags: patent fees

To claim the benefit of a prior application’s filing date for a divisional application, applicants must follow specific procedures. The MPEP ¶ 2.01 provides guidance:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This means applicants should:

  • Review 35 U.S.C. 120 for statutory requirements
  • Consult MPEP § 211 for detailed guidance on claiming benefit
  • Follow the procedures outlined in 37 CFR 1.78 for claiming benefit of an earlier-filed application

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the divisional application.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO procedures, visit: USPTO procedures.

When terminating representation, a practitioner must take several steps to protect the client’s interests, as outlined in 37 CFR 11.116(d):

  • Give reasonable notice to the client
  • Allow time for the client to employ other counsel
  • Surrender papers and property to which the client is entitled
  • Refund any advance payment of fees or expenses that have not been earned or incurred

Additionally, the practitioner must comply with applicable laws requiring notice to or permission from a tribunal when terminating representation, as per 37 CFR 11.116(c).

The USPTO provides forms (PTO/SB/83 or PTO/AIA/83) that include a section for practitioners to certify the completion of these necessary activities. Practitioners can also file a Web-based e-petition for withdrawal.

To learn more:

Tags: USPTO Forms

For international applications and applications claiming the benefit of a published international application:

  1. If the United States is indicated as a Designated State, status information is available for the national stage application and any application claiming benefit of the filing date of the published international application.
  2. Only the serial number, filing date, application number, and whether the application is pending, abandoned, or patented may be provided.
  3. A copy of the first page of the published international application or the corresponding page of the PCT Gazette must be supplied with the status request.

Status requests should be made in writing to the International Patent Legal Administration or directed to the PCT Help desk.

For inventions made with government support, contractors must include a specific statement at the beginning of the patent application and any resulting patents. This requirement is mandated by 35 U.S.C. 202(c)(6). The statement should read:

“This invention was made with government support under (identify the contract) awarded by (identify the Federal agency). The government has certain rights in the invention.”

This statement ensures transparency regarding government involvement and rights in the invention.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

For transition applications, 37 CFR 1.55 and 1.78 require a statement if:

  • The application contains or contained a claim with an effective filing date on or after March 16, 2013
  • The statement must be provided within specified time limits

The MPEP notes: “The statement provisions of 37 CFR 1.55 and 1.78 require that if the later-filed transition application contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March 16, 2013, the applicant must provide a statement to that effect.” (MPEP 210)

An Application Data Sheet (ADS) for patent applications filed before September 16, 2012, can include various types of bibliographic information. According to MPEP 601.05(b), the following information can be included:

  • Applicant information
  • Correspondence address
  • Application information (e.g., title, docket number, secrecy order indicator)
  • Representative information
  • Domestic benefit information
  • Foreign priority information
  • Assignee information

The MPEP states: “The application data sheet may be submitted subsequent to the filing of the application, within the time period set forth in 37 CFR 1.53(f), to provide the bibliographic data.”

It’s important to note that while an ADS can include this information, some details may still need to be provided or confirmed in other application documents, depending on the specific circumstances of the application.

To learn more:

When issuing Office actions after being notified of a patent practitioner’s death, the USPTO includes a special notation. The MPEP 406 instructs examiners to add form paragraph 4.03, which states:

“Notice of the death of the attorney or agent of record has come to the attention of this Office. Since the power of attorney is therefore terminated, this action is being mailed to the office of the patent practitioner and to the party who originally appointed the deceased patent practitioner. A new registered attorney or agent may be appointed.”

This notation informs all parties of the practitioner’s death and the need for new representation.

For more information on Form Paragraph 4.03, visit: Form Paragraph 4.03.

If there is an error in the pre-printed prior application data on the bib-data sheet:

  • The examiner should require correction via a corrected or supplemental application data sheet or an amendment, if it was an applicant error.
  • A petition for an unintentionally delayed benefit claim may also be required.
  • If appropriate, the correction or entry of the data can be made by technical support staff of the Technology Center.

See MPEP 601.05 and MPEP 211.02(a) for more details.

Patent examiners should carefully evaluate applications that may potentially be continuations. The MPEP ¶ 2.05 provides guidance:

“This form paragraph should only be used if it appears that the application may be a continuation, but a benefit claim has not been properly established.”

Examiners should look for applications that disclose and claim only subject matter from a prior application and name at least one common inventor. If these conditions are met but a proper benefit claim is missing, examiners may use the specified form paragraph to notify the applicant of the possible continuation status and the need to establish a benefit claim if desired.

Patent examiners should consider several factors when determining if an application may be a continuation. The MPEP ¶ 2.05 provides guidance:

“This form paragraph should only be used if it appears that the application may be a continuation, but a benefit claim has not been properly established.”

Examiners should look for:

  • Disclosure of only subject matter from the prior application
  • Claims to subject matter disclosed in the prior application
  • At least one common inventor with the prior application
  • Proper benefit claim to the prior application

If these elements are present but the benefit claim is not properly established, examiners may use the form paragraph to notify the applicant.

For more information on continuation application, visit: continuation application.

When patent applicants introduce new terminology in claims, they should amend the specification to provide proper support and antecedent basis for the new terms. MPEP 608.01(o) advises:

While an applicant is not limited to the nomenclature used in the application as filed, he or she should make appropriate amendment of the specification whenever this nomenclature is departed from by amendment of the claims so as to have clear support or antecedent basis in the specification for the new terms appearing in the claims.

This practice ensures that the meaning of new terms can be ascertained by referring to the description, maintaining clarity and consistency throughout the application.

To learn more:

When filing a continuing application using papers from a prior application, it’s important to explicitly specify the desired correspondence address, especially if it was changed during the prosecution of the prior application. 37 CFR 1.33(f) states:

Where application papers from a prior application are used in a continuing application and the correspondence address was changed during the prosecution of the prior application, an application data sheet or separate paper identifying the correspondence address to be used for the continuing application must be submitted. Otherwise, the Office may not recognize the change of correspondence address effected during the prosecution of the prior application.

To ensure the correct correspondence address is used, you should submit either an application data sheet (ADS) or a separate paper clearly identifying the desired correspondence address for the continuing application. This step is crucial to avoid potential communication issues with the USPTO.

To learn more:

If there’s an error in the recorded assignment document (or other document affecting title) rather than in the cover sheet, the procedure differs from correcting cover sheet errors. According to MPEP 323.01(b):

  1. The party responsible for the erroneous document (e.g., the assignor) must either:
    • Create and record a new document, or
    • Make corrections to the original document and re-record it
  2. If the assignor is unavailable, the assignee may:
    • Submit an affidavit or declaration identifying the error and requesting correction
    • Include a copy of the originally recorded papers
    • Provide a new cover sheet
    • Pay the required fee for each application or patent to be corrected (37 CFR 3.41)

This process ensures that errors in the actual assignment document are properly addressed and corrected in the USPTO records.

To learn more:

If there’s a discrepancy between the filing date accorded by the USPTO and the “date accepted” on the Priority Mail Express® mailing label, you can file a petition under 37 CFR 1.10(c). MPEP 513 states that such a petition should:

  • Be filed promptly after becoming aware of the discrepancy
  • Include evidence that the Priority Mail Express® number was placed on the correspondence before mailing
  • Include a true copy of the Priority Mail Express® mailing label showing the “date accepted”

The petition should be filed as soon as the discrepancy is noticed to ensure timely correction of the filing date.

If there are variations in your signature across different patent documents, you should:

  • Try to use a consistent signature for all patent correspondence to avoid confusion.
  • Be prepared for the USPTO to require ratification or confirmation of the signature if there are significant variations.
  • If asked to ratify, state that you personally signed the previously submitted document and, if needed, submit a compliant format of the signature.

According to the MPEP: “For consistency purposes, and to avoid raising a doubt as to who has signed, the same S-signature should be utilized each time, with variations of the signature being avoided.”

If the USPTO requires ratification, they may ask you to submit a statement or a duplicate document with a compliant signature. This helps ensure the authenticity of signatures and clarity of the record.

To learn more:

If the United States Patent and Trademark Office (USPTO) doesn’t receive your priority document through the Priority Document Exchange (PDX) program within the specified time frame, you have options. According to MPEP 215.02(a):

The Office appreciates that an applicant may discover that the Office will not receive a copy of a foreign application through the priority document exchange program until after the expiration of the time frame specified in 37 CFR 1.55(f). In this situation, an applicant who otherwise meets the conditions of 37 CFR 1.55(i) may satisfy the requirement of 37 CFR 1.55(i)(3) by filing a certified copy of the foreign application in the Office within the pendency of the application and before the patent is granted.

If you find yourself in this situation:

  1. File a certified copy of the foreign application directly with the USPTO.
  2. Ensure this is done during the pendency of your application and before the patent is granted.
  3. Consider filing a petition under 37 CFR 1.55(e) or (f) if necessary.

Remember, it’s ultimately the applicant’s responsibility to ensure the priority document is properly filed, even when using the PDX program.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on late submission, visit: late submission.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

If you discover that another party has improperly recorded an assignment against your patent or application, you should take the following steps:

  1. Contact the party who recorded the erroneous information and request that they file corrective papers.
  2. If the party cannot be located or is unwilling to cooperate, you must file corrective papers yourself with the Assignment Services Division.

According to MPEP 323.01(c), you should submit:

  • A completed cover sheet identifying the affected application or patent
  • An affidavit or declaration stating you are the correct owner, the previous recording was erroneous, and providing the reel and frame number of the incorrect document
  • The required fee for each application or patent to be corrected

The MPEP states: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change.

To learn more:

If you have filed correspondence with a proper Certificate of Mailing or Transmission, but the USPTO has not received it after a reasonable amount of time, you can take action under 37 CFR 1.8(b). The MPEP states:

“37 CFR 1.8(b) permits a party to notify the Office of a previous mailing through the U.S. Postal Service, or transmission by facsimile or EFS-Web, of correspondence when a reasonable amount of time has elapsed from the time of mailing or transmission of the correspondence.”

To rectify this situation:

  1. Promptly notify the Office of the previous mailing or transmission
  2. Supply a duplicate copy of the previously mailed or transmitted correspondence
  3. Provide a statement attesting to the previous timely mailing or transmission

It’s important to act quickly once you become aware that the Office has not received your correspondence, rather than waiting until the end of the reply period.

To learn more:

If you’ve misused a Certificate of Mailing or Transmission, it’s important to address the issue promptly and honestly. The USPTO takes the integrity of these certificates seriously. The MPEP states:

Misuse of a Certificate of Mailing under 37 CFR 1.8 or improperly claiming the benefit of 37 CFR 1.10 which appears to be more than a one-time, inadvertent error should be brought to the attention of the Office of Enrollment and Discipline.

If the misuse was a one-time, inadvertent error, you should:

  1. Notify the USPTO as soon as you become aware of the error.
  2. Provide a full explanation of the circumstances.
  3. If possible, submit the correct documentation or information.
  4. Be prepared for the possibility that your submission may be considered late, which could have consequences for your application or proceeding.

For repeated or intentional misuse, the matter may be referred to the Office of Enrollment and Discipline, which could result in more serious consequences. It’s always best to use Certificates of Mailing or Transmission carefully and honestly to maintain the integrity of the patent application process.

If you need your original patent drawings, it’s important to understand that the United States Patent and Trademark Office (USPTO) does not return submitted drawings. As stated in MPEP Section 608.02(y):

Drawings will not be returned to the applicant.

Given this policy, here are some recommendations:

  • Always keep high-quality copies or digital scans of your original drawings before submitting them to the USPTO.
  • If you need the exact drawings on file, you can request certified copies from the USPTO.
  • For future applications, consider using digital drawing tools that allow you to save and reproduce your drawings easily.

Remember, maintaining your own complete set of application materials, including drawings, is crucial for your records and potential future needs.

To learn more:

If you need information related to a topic that corresponds to a reserved MPEP section, such as MPEP 404, follow these steps:

  1. Check other relevant sections of the MPEP that may cover related topics
  2. Consult the USPTO’s official website for guidance documents and notices
  3. Review recent patent laws and regulations that may address the topic
  4. Contact the USPTO’s Patent Electronic Business Center for assistance
  5. Consult with a registered patent attorney or agent for professional advice

Remember that reserved sections do not contain any official information, so it’s crucial to seek guidance from active, authoritative sources.

If you missed the deadline for filing a benefit claim, you may still be able to claim the benefit by filing a petition for an unintentionally delayed benefit claim. The process differs based on the type of benefit claim:

The MPEP states: “If applicant desires the benefit under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c) based upon a previously filed application, applicant must file a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(c) for benefit claims under 35 U.S.C. 119(e) or under 37 CFR 1.78(e) for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c).”

The petition must include:

  1. The reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior application (unless previously submitted)
  2. A petition fee under 37 CFR 1.17(m)
  3. A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the claim was filed was unintentional

The Director may require additional information if there’s a question about whether the delay was unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on petition fee, visit: petition fee.

For more information on unintentional delay, visit: unintentional delay.

If you lose entitlement to small entity status, you must notify the USPTO before or at the time of paying the earliest of the issue fee or any maintenance fee due after the change. According to 37 CFR 1.27(g)(2): ‘notification of any change in status resulting in loss of entitlement to small entity status be filed in the application or patent prior to paying, or at the time of paying, the earliest of the issue fee or any maintenance fee due after the date on which status as a small entity is no longer appropriate.’

This notification should be a specific written assertion, not just payment of a non-small entity fee. For example, when paying the issue fee, you should:

  • Check the appropriate box on Part B of the PTOL-85 form to indicate the change in entity status
  • Pay the fee amount for a non-small entity

To learn more:

To learn more:

Tags: patent fees

If you don’t have the application number when executing an assignment, you can use specific language to allow for its later insertion. MPEP 302.03 suggests the following approach: “It is suggested, however, that an assignment be written to allow entry of the identifying number after the execution of the assignment. An example of acceptable wording is: ‘I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.’” This allows for proper identification of the application once the number is available, while still executing the assignment in a timely manner.

To learn more:

If you don’t possess any record of correspondence with the USPTO for an application, patent, or other proceeding that is the subject of an unlocatable file notice, you must still respond to the notice. According to 37 CFR 1.251(a)(3):

If applicant or patentee does not possess any record of the correspondence between the Office and the applicant or patentee for such application, patent, or other proceeding, applicant or patentee must comply with a notice under this section by providing a statement that applicant or patentee does not possess any record of the correspondence between the Office and the applicant or patentee for such application, patent, or other proceeding.

It’s crucial to provide this statement within the specified time period to avoid potential negative consequences, such as abandonment of a pending application or limitations on the certified copy of a granted patent file that the USPTO can produce.

To learn more:

If you cannot file your patent application electronically or by Priority Mail Express® due to an emergency, consider the following options:

  1. Use first-class mail with a Certificate of Mailing under 37 CFR 1.8
  2. Hand-deliver the application to the USPTO, if possible
  3. If the emergency is a designated postal service interruption, follow the specific instructions provided by the USPTO on their website or in the Official Gazette

Remember that the provisions for postal emergencies only apply to actual USPS service interruptions, not other circumstances like computer failures or office inaccessibility.

As stated in MPEP 511: “Applicants are cautioned that the provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) only apply to postal interruptions and emergencies. The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) do not provide for granting of a filing date to correspondence as of the date on which it would have been filed but for other exigencies, such as the unavailability of a computer or word processing equipment, or the inaccessibility of an office or building other than a USPS facility.”

If an inventor’s name has changed after filing a patent application, you should follow these steps:

  • File a request for a certificate of correction under 37 CFR 1.323 or 37 CFR 1.324.
  • Provide appropriate documentary evidence of the name change.
  • Pay the required fee for the certificate of correction.

According to MPEP 602.08(a): In the event an inventor’s name has been changed after the application has been filed and the inventor desires to change his or her name on the application, he or she must submit a petition under 37 CFR 1.182.

To learn more:

If a copy of an oath or declaration from a prior application is filed after the filing date of a continuation or divisional application, you should take the following steps:

  1. Include a cover letter with the oath or declaration.
  2. In the cover letter, identify the application number of the continuation or divisional application.
  3. Indicate in the cover letter that the submitted oath or declaration is a copy from a prior application.
  4. Label the copy of the oath or declaration with the application number of the continuation or divisional application.

According to MPEP 602.05: If such a copy of the oath or declaration is filed after the filing date of the continuation or divisional application and an application number has been assigned to the continuation or divisional application (see 37 CFR 1.5(a)), the cover letter accompanying the oath or declaration should identify the application number of the continuation or divisional application. The cover letter should also indicate that the oath or declaration submitted is a copy of the oath or declaration from a prior application to avoid the oath or declaration being incorrectly matched with the prior application file.

These steps help ensure that the oath or declaration is correctly associated with the new application and not mistakenly matched with the prior application file.

To learn more:

Tags: declaration, oath

In the first Office action of a Continued Prosecution Application (CPA), examiners should include specific information to advise the applicant about the status of their application. The MPEP ¶ 2.35 provides guidance on this matter:

Use this form paragraph in the first Office action of a CPA to advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request and the CPA is acceptable and that a CPA has been established.

This notice is crucial because:

  • Applicants are not notified of the abandonment of the parent application
  • A filing receipt is not normally sent for a CPA

By including this information, examiners ensure that applicants are fully informed about the status and treatment of their CPA request.

For more information on design patents, visit: design patents.

If examiners find that drawings are inconsistent with the specification in a patent application, they should:

  • Identify the specific inconsistencies
  • Object to the drawings and/or specification as appropriate
  • Provide clear explanations of the inconsistencies in the Office action
  • Require the applicant to correct the inconsistencies

MPEP 608.02(e) states: ‘The examiner should see to it that the drawings are correct, complete, and consistent with the specification and claims.’ This responsibility includes ensuring that the drawings accurately reflect the invention described in the specification and that there are no contradictions between the textual description and the visual representation.

To learn more:

The incorporation-by-reference statement in a patent application should include information about specific types of electronic documents that are to become part of the permanent USPTO records. According to 37 CFR 1.77(b)(5), this statement should identify:

  • The names of each file
  • The date of creation of each file
  • The size of each file in bytes

This applies to the following document types:

  • A ‘Computer Program Listing Appendix’
  • A ‘Sequence Listing’
  • ‘Large Tables’
  • An XML file for a ‘Sequence Listing XML’

The MPEP states, The specification is required to include an incorporation-by-reference of electronic documents that are to become part of the permanent United States Patent and Trademark Office records in the file of a patent application.

To learn more:

According to MPEP 608.01(d) and 37 CFR 1.73, the Brief Summary of Invention should include:

  • The nature and substance of the invention
  • Optionally, a statement of the object of the invention
  • One or more clear, concise sentences or paragraphs describing the subject matter of the invention
  • The exact nature, operation, and purpose of the invention

The MPEP states, “The brief summary, if properly written to set out the exact nature, operation, and purpose of the invention, will be of material assistance in aiding ready understanding of the patent in future searches.” This emphasizes the importance of clarity and specificity in the summary.

To learn more:

The brief description of drawings for a patent application should include:

  • A reference to each figure by number (e.g., Figure 1, Figure 2)
  • A brief explanation of what each figure depicts

According to MPEP 608.01(f): The specification must contain or be amended to contain a brief description of the several views of the drawings.

It’s important to note that this section should be concise and not include detailed descriptions of the drawings, which belong in the Detailed Description section.

To learn more:

To learn more:

Tags: drawings

The Background of the Invention section in a patent application may include two main parts:

  1. Field of the Invention: A statement describing the field of art to which the invention pertains. This may include a paraphrasing of applicable Cooperative Patent Classification (CPC) definitions.
  2. Description of the related art: Information about the state of the prior art, including references to specific prior art where appropriate. This section should also describe any problems in the prior art that the invention solves.

It’s important to note that while these components are typical, they are not strictly required. As stated in MPEP 608.01(c), “The Background of the Invention may (but is not required to) include the following parts…”

To learn more:

Tags: prior art

When canceling a patent drawing, the ‘Annotated Sheet’ should include:

  • The original drawing sheet with the canceled figure.
  • A clear annotation showing that the drawing has been canceled.
  • A label clearly marking it as “Annotated Sheet”.

According to MPEP 608.02(t): “The marked-up (annotated) copy must be clearly labeled as ‘Annotated Sheet’ and must be presented in the amendment or remarks section of the amendment document which explains the changes to the drawings.” This annotated sheet serves as a record of the cancellation and helps examiners and others understand the changes made to the application.

To learn more:

When submitting replacement drawing sheets for patent applications, applicants should ensure the following:

  1. Include all figures from the immediate prior version of the sheet, even if only one figure is being amended.
  2. Label the sheet as ‘Replacement Sheet’ in the top margin.
  3. Include the application number and art unit in the upper center margin.
  4. Do not label amended drawing figures as ‘amended’.
  5. Remove canceled figures and renumber remaining figures if necessary.

The MPEP 608.02(b) states:

Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as ‘amended.’

Additionally, a marked-up copy of the replacement sheet with annotations indicating changes may be required.

To learn more:

Patent drawings should include every feature of the invention specified in the claims, as required by 37 CFR 1.83(a). Key elements to include are:

  • All claimed features of the invention
  • Sufficient views to show the entire structure of the invention
  • Proper use of reference characters corresponding to elements described in the specification
  • Conventional features may be shown as a labeled rectangular box

However, the drawings should not contain excessive text or duplicate information already present in the specification. Tables and sequences included in the specification should not be duplicated in the drawings.

If the nature of the invention allows, the drawings should also show the improved portion disconnected from the old structure, as well as enough of the old structure to show the connection of the invention, as per 37 CFR 1.83(b).

To learn more:

A patent specification should include:

  • A written description of the invention
  • The manner and process of making and using the invention
  • The best mode contemplated by the inventor for carrying out the invention
  • One or more claims particularly pointing out and distinctly claiming the subject matter of the invention

As stated in 37 CFR 1.71(a): “The specification must include a written description of the invention or discovery and of the manner and process of making and using the same, and is required to be in such full, clear, concise, and exact terms as to enable any person skilled in the art or science to which the invention or discovery appertains, or with which it is most nearly connected, to make and use the same.”

To learn more:

A patent application abstract should include a concise summary of the key technical elements of the invention. The MPEP 608.01(b) states:

The abstract should sufficiently describe the disclosure to assist readers in deciding whether there is a need for consulting the full patent text for details.

The abstract should cover:

  • The technical disclosure of the improvement
  • The nature and gist of the invention
  • The principal use of the invention

It’s important to note that legal phraseology often used in patent claims should be avoided in the abstract.

To learn more:

A patent abstract should include:

  • A concise statement of the technical disclosure
  • What is new in the art to which the invention pertains
  • For a machine or apparatus: its organization and operation
  • For an article: its method of making
  • For a chemical compound: its identity and use
  • For a mixture: its ingredients
  • For a process: the steps involved

The MPEP states: The abstract should not refer to purported merits or speculative applications of the invention and should not compare the invention with the prior art.

For chemical patents, the general nature of the compound or composition should be given as well as the use thereof, e.g., ‘The compounds are of the class of alkyl benzene sulfonyl ureas, useful as oral anti-diabetics.’

To learn more:

Papers related to property rights under the Atomic Energy Act or National Aeronautics and Space Act require special handling. According to MPEP 150:

Any papers pertaining to property rights under section 152 of the Atomic Energy Act, 42 U.S.C. 2182, (DOE), or section 305(c) or the National Aeronautics and Space Act, 42 U.S.C. 2457, (NASA), that have not been associated with the application file, or have not been made of record in the file and processed by the Licensing and Review section, must be sent to the Licensing and Review section immediately.

Key points:

  • Papers related to property rights under these acts must be properly associated with the application file
  • If not already processed by the Licensing and Review section, they must be sent there immediately
  • This ensures proper handling and review of sensitive information related to atomic energy or space activities

For more information on National Aeronautics and Space Act, visit: National Aeronautics and Space Act.

For more information on USPTO procedures, visit: USPTO procedures.

If there’s an error in the preprinted prior application data, the following steps should be taken:

  1. If the error is in the Patent Data Portal database, it can be corrected by technical support staff of the Technology Center.
  2. After the data is corrected, a new bib-data sheet should be printed and scanned into the file.
  3. If the error was made by the applicant, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.
  4. In some cases, a petition for an unintentionally delayed benefit claim may also be required.

The MPEP states: “Should there be an error in the preprinted prior application data, the correction or entry of the data in the Patent Data Portal data base can be made by technical support staff of the Technology Center, if appropriate. Upon entry of the data, a new bib-data sheet should be printed and scanned into the file. If the error was an applicant error, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.” (MPEP 202)

If inventorship changes after filing a property rights statement, MPEP 151 provides specific guidance:

“If a request under 37 CFR 1.48 for correction of inventorship is granted during pendency of an application in which a property rights statement has been filed, a supplemental statement executed by any added inventor(s) is required and should promptly be filed with Licensing and Review.”

This means that if new inventors are added to the application, they must file a supplemental statement to ensure compliance with the Atomic Energy Act and NASA Act requirements. It’s important to file this supplemental statement promptly to maintain proper documentation.

For more information on patent procedure, visit: patent procedure.

For more information on property rights statement, visit: property rights statement.

If a legal representative of a deceased inventor refuses to make application, the procedure depends on when the application was filed:

  • For applications filed before September 16, 2012: Pre-AIA 37 CFR 1.47 applies. The MPEP states: pre-AIA 37 CFR 1.47 does apply where a known legal representative of a deceased inventor cannot be found or reached after diligent effort, or refuses to make application.
  • In this case, you should:
    1. Document the refusal and the efforts made to reach the legal representative.
    2. Provide the last known address of the legal representative, as per MPEP § 409.03(e).
    3. File the application under pre-AIA 37 CFR 1.47, explaining the situation.
  • For applications filed on or after September 16, 2012: Different procedures apply, which are not covered in this specific MPEP section. Consult the current USPTO regulations and guidelines for the appropriate course of action.

It’s important to note that these procedures are specific to cases where there is a known legal representative who is refusing to cooperate. Different rules may apply in other scenarios involving deceased inventors.

To learn more:

What should be avoided when creating a patent title?

When creating a patent title, it’s important to avoid certain elements that may make the title less effective or non-compliant. According to MPEP 606:

“The title should not be descriptive of a particular embodiment, species or range.”

Additionally, you should avoid:

  • Unnecessarily long titles
  • Overly broad or vague descriptions
  • Trademarks or trade names
  • Acronyms or abbreviations that are not widely recognized

The goal is to create a title that is concise, specific to the invention, and informative about its nature and purpose.

To learn more:

When applicants receive a Notice of Allowance, they should take specific actions regarding PDX as outlined in MPEP 215.01:

Upon receipt of a Notice of Allowance, applicants should check to see whether the Office has received a copy of the foreign application under the priority document exchange program because successful retrieval of priority documents cannot be guaranteed.

Important steps for applicants:

  • Verify that the USPTO has received the foreign priority document.
  • If the document hasn’t been received, consider filing a paper certified copy.
  • Ensure the priority document is received before the patent is granted.
  • Be aware that if a certified copy is filed after the issue fee is paid, the patent won’t include the priority claim unless corrected by a certificate of correction.

It’s crucial to confirm receipt of the priority document to maintain the priority claim in the issued patent.

To learn more:

If an applicant receives no response to a status inquiry, the MPEP provides the following guidance:

  • The MPEP states: If after a reasonable amount of time no reply has been received, applicants may contact the TC customer service center or CRU.
  • For regular patent applications, contact the Technology Center (TC) customer service center at (571) 272-3900.
  • For reexamination proceedings, contact the Central Reexamination Unit (CRU) at (571) 272-7705.
  • When following up, provide all relevant information, including application number, filing date, and any previous communication references.

It’s important to allow a reasonable time for a response before escalating the inquiry, and to use the appropriate contact channels as specified in the MPEP.

To learn more:

If an applicant’s patent attorney or agent is suspended, they should take the following steps:

  1. File a new power of attorney in the application to have a registered attorney or agent represent them before the Office.
  2. Ensure all future papers are signed by authorized parties (see MPEP § 407, Form Paragraph 4.07 for details on who can sign).
  3. If necessary, find a new registered patent attorney or agent using USPTO resources.
  4. Update the correspondence address for the application if it was previously associated with the suspended practitioner.

It’s important to act promptly to ensure continued proper representation and communication with the USPTO.

If an applicant’s drawing corrections are rejected, they should carefully review the examiner’s comments in the Office action. According to MPEP 608.02(x):

“The applicant will be notified and informed of any required corrective action in the next Office action.”

Applicants should:

  • Carefully read the examiner’s explanation for the rejection
  • Address all issues raised by the examiner
  • Ensure new submissions don’t introduce new matter
  • Include all necessary corrections
  • Consider consulting with a patent attorney or agent if the issues are complex

After addressing the examiner’s concerns, applicants can submit new drawing corrections for review in their response to the Office action.

To learn more:

To learn more:

If an inventor cannot comprehend the documents related to their oath or declaration, the MPEP 602.06 provides guidance:

“If the documents are in a language the individual cannot comprehend, the documents may be explained to him or her so that he or she is able to understand them.”

This means that the content of the documents can be explained to the inventor in a language they understand, allowing them to make an informed oath or declaration. It’s crucial that the inventor understands the content of the documents they are swearing to or declaring, even if they cannot read the original language.

To learn more:

Tags: declaration, oath

When an examiner receives a pre-AIA 37 CFR 1.47 application, they must follow these steps:

“When an examiner receives an application in which a petition under pre-AIA 37 CFR 1.47 has been filed, he or she must check the file to determine that the petition has been decided by the Office of Petitions. If the petition has not been decided by the Office of Petitions, the application, or an electronic message concerning the petition, must be forwarded to the Office of Petitions for appropriate action.”

In essence, the examiner must verify that the Office of Petitions has made a decision on the pre-AIA 37 CFR 1.47 petition. If not, the examiner must forward the application or relevant information to the Office of Petitions for further processing.

To learn more:

To learn more:

When an examiner encounters an application with national security markings but no Secrecy Order, they must take specific actions. The MPEP instructs: In this case, the examiner should require the applicant to seek imposition of a Secrecy Order or authority to cancel the markings. This should preferably be done with the first action and, in any event, prior to final disposition of the application. This ensures that potentially sensitive information is properly handled during the examination process.

For more information on national security markings, visit: national security markings.

For more information on patent examination, visit: patent examination.

When examining a patent application, it’s crucial for the examiner to verify and indicate whether the conditions of 35 U.S.C. 119(a)-(d) or (f) have been met. These sections relate to the right of priority for foreign applications.

The MPEP instructs: However, the examiner must still indicate in the Office action and on the bib-data sheet whether the conditions of35 U.S.C. 119(a)-(d)or(f)have been met. (MPEP 202)

This means the examiner should:

  • Review the foreign priority claim
  • Determine if all conditions for the claim have been satisfied
  • Indicate the status of the claim in the Office action
  • Mark the bib-data sheet accordingly

If the conditions are met, this information will be reflected on the front page of the issued patent and in the Official Gazette listing. For more information on foreign priority claims, see MPEP § 213.

For more information on foreign priority, visit: foreign priority.

For more information on patent examination, visit: patent examination.

What should an examiner do if an IDS is filed after the first Office action?

If an Information Disclosure Statement (IDS) is filed after the first Office action, the examiner should follow these steps:

  • Check if the IDS complies with the requirements of 37 CFR 1.97(c) and 37 CFR 1.97(e).
  • Ensure that the appropriate fee or certification is included.
  • If compliant, consider the information submitted in the IDS.
  • If necessary, issue a supplemental Office action addressing any newly cited references.

As stated in MPEP 609.01: ‘The examiner should consider the information submitted in an IDS in the same manner as other documents in Office search files are considered by the examiner while conducting a search of the prior art in a proper field of search.’

To learn more:

An examiner should check the following on the bib-data sheet regarding prior applications:

  1. Accuracy of prior application data, including provisional application data
  2. Whether the application is copending with prior nonprovisional applications for which benefit is claimed
  3. Correct application numbers of provisional applications for which benefit is claimed
  4. Proper listing of foreign applications qualifying for benefits under 35 U.S.C. 119(a)-(d)

MPEP 202 instructs: “Where the data is correct, the examiner should initial the bib-data sheet in the provided space. Should there be an error in the preprinted prior application data, the correction or entry of the data in the Patent Data Portal data base can be made by technical support staff of the Technology Center, if appropriate.”

If an applicant’s Information Disclosure Statement (IDS) is not considered due to noncompliance, they have options to address the issue. According to MPEP 609.05(a):

Applicant may then file a new information disclosure statement or correct the deficiency in the previously filed IDS, but the date that the new IDS or correction is filed will be the date of the IDS for purposes of determining compliance with the requirements based on the time of filing of the IDS (37 CFR 1.97).

This means the applicant can either:

  • File a new, compliant IDS
  • Correct the deficiencies in the previously filed IDS

It’s important to note that the date of the new or corrected IDS will be considered the filing date for compliance purposes. Applicants should ensure they address the specific issues mentioned in the examiner’s notification to avoid further delays.

To learn more:

If new matter is objected to in a patent application, the applicant must take specific actions to address the objection. According to the MPEP, the examiner will use Form Paragraph 7.28, which states:

Applicant is required to cancel the new matter in the reply to this Office action.

To respond, the applicant should:

  1. Review the identified new matter carefully.
  2. If the applicant agrees it’s new matter, cancel the objected content in their response.
  3. If the applicant disagrees, provide a detailed explanation demonstrating how the original disclosure supports the contested material.
  4. Consider amending the application to use language more closely aligned with the original disclosure.

It’s crucial to address all new matter objections promptly to avoid potential rejections under 35 U.S.C. 112(a).

To learn more:

Tags: new matter

When a patent examiner encounters an application that appears to be a divisional but lacks a proper benefit claim, they should follow the guidance provided in MPEP ¶ 2.01. The MPEP states:

“This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.”

In such cases, the examiner should:

  1. Recognize that the application may potentially be a divisional based on its content and relationship to a prior application.
  2. Note that the applicant has not properly established a benefit claim to the prior application.
  3. Use the appropriate form paragraph (as mentioned in MPEP ¶ 2.01) to inform the applicant about the potential divisional status and the need to establish a proper benefit claim.
  4. Direct the applicant’s attention to the relevant laws and regulations for claiming benefit, specifically: 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

By following these steps, the examiner ensures that the applicant is aware of the potential divisional status and has the opportunity to properly establish the benefit claim if desired.

For more information on Divisional application, visit: Divisional application.

Risks of Self-Representation in Patent Applications

While individuals can file pro se patent applications, there are several risks to consider:

  1. Lack of expertise: Patent law is complex, and lack of familiarity with examination practices may result in missed opportunities for optimal protection.
  2. Potential sanctions: According to MPEP 401, pro se applicants are subject to the same certifications and potential sanctions as represented applicants:

In presenting (whether by signing, filing, submitting, or later advocating) papers to the Office, a pro se applicant is making the certifications under 37 CFR 11.18(b), and may be subject to sanctions under 37 CFR 11.18(c) for violations of 37 CFR 11.18(b)(2).

Given these risks, the USPTO may suggest hiring a registered patent practitioner if they notice an applicant is unfamiliar with the process and the application contains potentially patentable subject matter.

For more information on pro se, visit: pro se.

For more information on self-representation, visit: self-representation.

Patent ownership gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent. This is stated in 35 U.S.C. 154(a)(1).

However, ownership does not necessarily give the owner the right to make, use, sell or import the invention, as there may be other legal considerations such as:

  • Existence of another patent owner with a dominant patent
  • Failure to obtain FDA approval
  • An injunction by a court
  • National security issues

Patent ownership grants the owner the right to exclude others from making, using, offering for sale, selling, or importing the patented invention into the United States. However, it’s important to note that ownership does not automatically grant the right to practice the invention. The MPEP states:

‘Ownership of a patent gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent. 35 U.S.C. 154(a)(1). Ownership of the patent does not furnish the owner with the right to make, use, offer for sale, sell, or import the claimed invention because there may be other legal considerations precluding same…’

These other considerations may include existing patents, regulatory approvals, or legal injunctions.

Patent ownership gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing the claimed invention into the United States. As stated in 35 U.S.C. 154(a)(1):

Ownership of a patent gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent.

However, it’s important to note that ownership does not automatically grant the right to practice the invention, as there may be other legal considerations such as other dominant patents, regulatory approvals, or court injunctions.

For more information on exclusionary rights, visit: exclusionary rights.

For more information on patent rights, visit: patent rights.

An assignee of the entire interest in a patent application has broader rights regarding inspection compared to a part interest assignee. According to MPEP 106.01, an assignee of the entire interest may inspect the application file wrapper and be granted access to the subject matter of the application. This is because they have acquired all rights to the patent application and are considered to have stepped into the shoes of the inventor(s) for all practical purposes related to the application.

An assignee of part interest in a patent application has the following rights:

  • They may access the application file (except when it’s under a secrecy order)
  • They may intervene in the prosecution of the application to protect their interests
  • They may file papers against the wishes of the inventor or other assignees, subject to the Commissioner’s discretion

As stated in MPEP 106.01: “An assignee of part interest in the entire right, title and interest in an application … has the right to inspect and obtain copies of papers in the application file.”

To learn more:

A nonsigning inventor in a pre-AIA 37 CFR 1.47 application retains certain rights, as outlined in MPEP 409.03(i):

  • May protest their designation as an inventor
  • Can inspect any paper in the application
  • May order copies of application documents
  • Can make their position of record in the application file
  • Has the option to join the application later by filing an oath/declaration
  • Retains inventor rights for patent issuance

However, the nonsigning inventor cannot:

  • Prosecute the application if status under 37 CFR 1.47 is accorded
  • Revoke power of attorney without agreement of the 37 CFR 1.47 applicant

The MPEP states: The rights of a nonsigning inventor are protected by the fact that the patent resulting from an application filed under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118 must issue to the inventor, and in an application filed under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the inventor has the same rights that he or she would have if he or she had joined in the application.

To learn more:

To learn more:

A nonsigning inventor, also known as an ‘inventor designee,’ has several rights in a patent application filed under pre-AIA 37 CFR 1.47. These rights include:

  • The right to protest their designation as an inventor
  • The right to inspect any paper in the application
  • The right to order copies of application documents at the price set forth in 37 CFR 1.19
  • The right to make their position of record in the file wrapper of the application

As stated in MPEP 409.03(i): “The nonsigning inventor is entitled to inspect any paper in the application, order copies thereof at the price set forth in 37 CFR 1.19, and make his or her position of record in the file wrapper of the application.”

It’s important to note that while these rights are granted, the nonsigning inventor is not entitled to prosecute the application if status under pre-AIA 37 CFR 1.47 has been accorded.

To learn more:

To learn more:

According to MPEP 106.01, assignees of a part interest or licensees of exclusive right have the right to inspect the patent application. The MPEP states:

“[A]n assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.”

However, it’s important to note that these parties do not have the right to intervene in the prosecution of the application or interference, which is reserved for the assignee of record of the entire interest.

For more information on partial assignee rights, visit: partial assignee rights.

For more information on patent application inspection, visit: patent application inspection.

Partial assignees and exclusive licensees have specific rights regarding patent application inspection. According to MPEP 106.01, “an assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.” This means that even if you don’t own the entire interest in a patent application, you still have the right to review its contents.

However, it’s important to note that partial assignees cannot intervene in the prosecution of an application or interference to the exclusion of the applicant. Only the assignee of record of the entire interest has this ability.

For more information on patent rights, visit: patent rights.

Partial assignees have limited rights regarding the inspection of patent applications. According to MPEP 106.01, an assignee of a part interest in a patent application is not entitled to inspect the application without written authority from the inventor or the other assignee(s). This restriction is in place to protect the interests of all parties involved in the patent application process.

Joint owners of a patent have specific rights as outlined in 35 U.S.C. 262, which states:

‘In the absence of any agreement to the contrary, each of the joint owners of a patent may make, use, offer to sell, or sell the patented invention within the United States, or import the patented invention into the United States, without the consent of and without accounting to the other owners.’

This means that each joint owner can independently exercise the full rights of the patent without needing permission from or owing compensation to the other joint owners, unless they have a separate agreement stating otherwise.

USPTO employees are subject to several restrictions regarding patents:

  • They cannot apply for a patent during their employment and for one year after.
  • They cannot acquire any patent or interest in a patent, directly or indirectly, except through inheritance or bequest, during employment and for one year after.
  • For patents applied for after the one-year period, they cannot claim a priority date earlier than one year after their employment ends.

These restrictions are outlined in 35 U.S.C. 4, which states:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office. In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.’

The USPTO, through its Office of Enrollment and Discipline, provides valuable resources to client-applicants when their patent practitioner dies. The MPEP 406 states:

‘The Office of Enrollment and Discipline will notify the client-applicant of the availability of a list of patent practitioners who may be available to represent the client-applicant.’

This list serves as a crucial resource, helping client-applicants find new representation to continue their patent prosecution process without significant delays.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO Resources, visit: USPTO Resources.

Inventors are required to provide their place of residence in patent applications. According to MPEP 602.08(a):

“Each inventor’s place of residence, that is, the city and either state or foreign country, is required to be included in the oath or declaration in a nonprovisional application for compliance with 37 CFR 1.63 unless it is included in an application data sheet (37 CFR 1.76).”

For provisional applications, the residence must be included on the cover sheet or in an application data sheet.

To learn more:

To learn more:

To claim priority based on an inventor’s certificate, applicants must meet specific requirements outlined in 37 CFR 1.55(l):

To claim the right of priority on the basis of an application for an inventor’s certificate in such a country under 35 U.S.C. 119(d), the applicant when submitting a claim for such right as specified in this section, must include an affidavit or declaration.

The affidavit or declaration must state that:

  • The applicant had the option to file for either a patent or an inventor’s certificate in the foreign country
  • This option existed for the particular subject matter of the invention

It’s important to note that the affidavit is only required to ascertain the general existence of this option in the foreign country, not to probe into the eligibility of the particular applicant.

To learn more:

The use of annotated sheets in patent drawings is governed by specific regulations. MPEP 608.02(v) references two key regulations: “See 37 CFR 1.84(c) and 1.121(d).” 37 CFR 1.84(c) provides guidelines for identifying and labeling drawings, while 37 CFR 1.121(d) outlines the procedures for making changes to drawings. These regulations ensure that annotated sheets are properly prepared and submitted in accordance with USPTO requirements.

To learn more:

A small entity for purposes of paying reduced patent fees is defined in 37 CFR 1.27(a) as:

  • A person
  • A small business concern
  • A nonprofit organization

Each of these categories has specific criteria that must be met to qualify for small entity status. For example, a person must not have assigned, granted, conveyed, or licensed any rights in the invention to a non-small entity.

To learn more:

For a pre-AIA 37 CFR 1.47(b) application, the applicant must prove one of the following:

  • The invention has been assigned to the applicant
  • The inventor has agreed in writing to assign the invention to the applicant
  • The applicant otherwise has sufficient proprietary interest in the subject matter to justify filing the application

As stated in MPEP 409.03(f):

“When an application is deposited pursuant to pre-AIA 37 CFR 1.47(b), the pre-AIA 37 CFR 1.47(b) applicant must prove that (A) the invention has been assigned to the applicant, or (B) the inventor has agreed in writing to assign the invention to the applicant, or (C) the applicant otherwise has sufficient proprietary interest in the subject matter to justify the filing of the application.”

The specific documentation required depends on which of these conditions is being met.

To learn more:

To learn more:

When filing under pre-AIA 37 CFR 1.47, the applicant must provide proof that the nonsigning inventor is unavailable or refusing to sign. According to MPEP 409.03(d):

  • For an unavailable inventor, submit a statement of facts describing the diligent efforts made to find or reach the inventor. Include documentary evidence like Internet searches, certified mail receipts, etc.
  • For a refusing inventor, provide evidence that the application was presented to the inventor for signature and they refused. This can include:
    • A statement detailing the circumstances of the presentation and refusal
    • Documentary evidence of written refusal
    • Statement of the reasons given by the inventor for refusing

The section states: Where inability to find or reach a nonsigning inventor ‘after diligent effort’ is the reason for filing under pre-AIA 37 CFR 1.47, a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.

To learn more:

The USPTO provides specific procedures for resubmitting returned patent documents. According to MPEP 317.01:

“The procedure set forth in § 1.8 or § 1.10 of this chapter may be used for resubmissions of returned papers to have the benefit of the date of deposit in the United States Postal Service.”

This means that when resubmitting corrected documents, you can use either the Certificate of Mailing procedure (37 CFR 1.8) or the Express Mail procedure (37 CFR 1.10) to potentially preserve the original filing date based on the postal deposit date.

To learn more:

The USPTO accepts multiple payment methods for the electronic submission of assignment documents through the Electronic Patent Assignment System (EPAS). As stated in MPEP 302.10:

“Customers may submit assignments electronically by accessing the Office’s website and paying the required fee by credit card, electronic fund transfer (EFT) or deposit account.”

These payment options provide flexibility for users when submitting assignment documents electronically. It’s important to ensure that you have one of these payment methods available before initiating the submission process.

To learn more:

According to 37 CFR 1.11(a), the following patent application files are open to public inspection:

  • Published applications
  • Patents
  • Statutory invention registrations

The public can obtain copies of these files upon payment of the fee set forth in 37 CFR 1.19(b)(2). However, if an application was published in redacted form, the complete file may not be available if certain requirements are met and the application is still pending.

If an applicant is notified of missing items in their application, they generally have the following options:

  1. Establish prior receipt of the missing items in the USPTO
  2. Submit the missing items and request a later filing date
  3. Accept the application as deposited without the missing items

The USPTO states: The mailing of an OPAP notice regarding a missing page(s) of specification in a nonprovisional application will permit the applicant to:

  • (A) promptly establish prior receipt in the USPTO of the page(s) at issue…
  • (B) promptly submit the omitted page(s) in a nonprovisional application and accept the date of such submission as the application filing date…
  • (C) accept the application as deposited in the USPTO…

For each option, specific procedures and requirements must be followed. For example, to establish prior receipt, the applicant must file a petition with evidence such as a date-stamped postcard receipt. To submit missing items and request a later filing date, a petition with the required fee must be filed. To accept the application as deposited, the applicant may need to file amendments to the specification or claims.

The specific actions required depend on the type of missing item and the circumstances of the application. Applicants should carefully review the notice and the relevant MPEP sections to determine the best course of action.

To learn more:

If you miss the 12-month deadline for claiming the benefit of a provisional application, you have two main options:

  1. Delete the claim to the benefit of the prior-filed provisional application.
  2. File a petition to restore the benefit of the provisional application.

The MPEP states:

“Alternatively, applicant may wish to file a petition to restore the benefit of the provisional application under 37 CFR 1.78 in the subsequent nonprovisional application or international application designating the United States if the subsequent application was filed within two months from the expiration of the twelve-month period and the delay was unintentional.”

This petition must be filed in the subsequent application and include specific requirements, such as a reference to the provisional application, a petition fee, and a statement that the delay was unintentional.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For applications filed on or after September 16, 2012:

  • An assignee or obligated assignee may file the application as the applicant
  • A person who shows sufficient proprietary interest may file the application on behalf of and as agent for the inventor
  • The applicant may file a substitute statement in lieu of an inventor’s oath or declaration if the inventor has refused to execute the oath or declaration

For applications filed before September 16, 2012, a petition under pre-AIA 37 CFR 1.47 could be filed.

After payment of the issue fee, submitting an Information Disclosure Statement (IDS) becomes more challenging. However, there are several options available:

  • File a petition to withdraw the application from issue under 37 CFR 1.313(c)(2) or 1.313(c)(3)
  • File a Request for Continued Examination (RCE) under 37 CFR 1.114
  • File a continuing application under 37 CFR 1.53(b) or a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) for design applications
  • Use the Quick Path Information Disclosure Statement (QPIDS) Pilot Program

As stated in MPEP 609.04(b): The application may be withdrawn from issue at this point, pursuant to 37 CFR 1.313(c)(2) or 1.313(c)(3) so that the information can be considered in the application upon the filing of a RCE under 37 CFR 1.114 or in a continuing application filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if the application is a design application).

To learn more:

For applications filed on or after September 16, 2012, if an inventor is deceased or legally incapacitated:

  • The legal representative of the inventor may make the application for patent on behalf of the inventor.
  • An assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest may file the application as the applicant.

As stated in MPEP § 409.01(a): “If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.”

For more information on legal representative, visit: legal representative.

When an arbitration award is made involving a patent, there are specific notice requirements as outlined in 35 U.S.C. 294(d) and 37 CFR 1.335. Key points include:

  • The patentee, assignee, or licensee must provide written notice to the USPTO Director.
  • A separate notice is required for each patent involved.
  • The notice must include names and addresses of parties, inventor name, patent owner name, patent number, and a copy of the award.
  • If the award is modified by a court, notice of the modification must also be filed.

Failure to file the required notice can result in the award being unenforceable.

An applicant who shows sufficient proprietary interest in the matter must submit a petition with their patent application, including:

  1. The fee set forth in § 1.17(g)
  2. A showing that the person has sufficient proprietary interest in the matter
  3. A statement that making the application for patent by this person on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

This requirement is outlined in 37 CFR 1.46(b)(2): If the applicant is a person who otherwise shows sufficient proprietary interest in the matter, such applicant must submit a petition including: (i) The fee set forth in § 1.17(g); (ii) A showing that such person has sufficient proprietary interest in the matter; and (iii) A statement that making the application for patent by a person who otherwise shows sufficient proprietary interest in the matter on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties.

When filing under pre-AIA 37 CFR 1.47(b), an applicant must prove that the filing of the application is necessary for specific reasons. The MPEP outlines two primary justifications:

  1. To preserve the rights of the parties
  2. To prevent irreparable damage

Specifically, the MPEP states: “The pre-AIA 37 CFR 1.47(b) applicant must prove that the filing of the application is necessary (1) to preserve the rights of the parties or (2) to prevent irreparable damage.”

This requirement ensures that the use of pre-AIA 37 CFR 1.47(b) is justified and not merely a matter of convenience. For more detailed information on proving necessity, refer to MPEP § 409.03(g).

To learn more:

Tags: pre-AIA

The key factors for acceptable patent drawings are readability and reproducibility. MPEP 608.02(i) states that “Drawings that do not comply with all of the form requirements of 37 CFR 1.84 may be acceptable for the purposes of publication and examination if the drawings are readable and reproducible for publication purposes.” This means that even if drawings don’t meet all formal requirements, they may still be accepted if they clearly convey the invention and can be properly reproduced in published documents. However, applicants should still aim to comply with 37 CFR 1.84 to ensure the best possible representation of their invention.

To learn more:

A good title for a patent application should be descriptive and clearly indicative of the invention. The MPEP 606.01 states that “This may result in slightly longer titles, but the loss in brevity of title will be more than offset by the gain in its informative value in indexing, classifying, searching, etc.” A well-crafted title helps in accurately categorizing and searching for the invention in patent databases.

To learn more:

A good patent application title should adhere to the guidelines set forth in MPEP 606. The key characteristics are:

  1. Brief: The title should be concise, avoiding unnecessary words.
  2. Technically accurate: It should correctly represent the technical aspects of the invention.
  3. Descriptive: The title should give a clear idea of what the invention is about.
  4. Within character limit: As stated in MPEP 606, “The title… should contain fewer than 500 characters.”

Additionally, a good title should:

  • Focus on the key innovative features of the invention
  • Avoid unnecessary articles or non-descriptive terms at the beginning
  • Be understandable to someone skilled in the relevant field

Remember, the title is often the first thing examiners and other readers see, so it should effectively communicate the essence of your invention.

To learn more:

What makes a good patent application title according to MPEP?

According to MPEP 606.01, a good patent application title should be:

  • Brief: Usually fewer than 500 characters in length
  • Descriptive: Clearly indicative of the invention’s nature
  • Specific: Particular to the claimed invention
  • Non-Generic: Avoid broad, general terms like “device,” “process,” or “apparatus”

The MPEP states, “The title of the invention should be placed at the top of the first page of the specification unless it is provided in the application data sheet. The title should be brief but technically accurate and descriptive.” This guidance ensures that the title effectively communicates the essence of the invention to patent examiners and the public.

To learn more:

What limited recognition is granted to suspended or excluded practitioners?

Suspended or excluded practitioners are granted limited recognition to handle specific tasks related to pending applications. According to MPEP 407:

“The suspended or excluded practitioner will be granted limited recognition for a period of thirty (30) days, during which time the practitioner may conclude work on behalf of a client on any matters pending before the Office.”

This limited recognition allows the practitioner to:

  • Conclude or withdraw from representation in pending proceedings
  • Receive and forward correspondence
  • Make appropriate filings to protect the client’s rights

However, this recognition is strictly limited to these activities and does not allow the practitioner to engage in new patent prosecution work.

For more information on pending applications, visit: pending applications.

The ‘Detailed Description of Invention’ section requires a comprehensive and precise level of detail. According to MPEP 608.01(g):

“This detailed description, required by 37 CFR 1.71, MPEP §§ 608.01, 2161, and 2162, must be in such particularity as to enable any person skilled in the pertinent art or science to make and use the invention without involving extensive experimentation and must clearly convey enough information about the invention to show that applicant invented the subject matter that is claimed.”

The level of detail should include:

  • Enablement: Sufficient information for a skilled person to make and use the invention without undue experimentation.
  • Complete Disclosure: All aspects of the invention claimed should be thoroughly described.
  • Clear Support: Provide clear support for all terms used in the claims.
  • Best Mode: The best mode contemplated by the inventor for carrying out the invention.
  • Drawings Reference: Detailed explanation of all parts referenced in the drawings.

While the description should be comprehensive, it’s important to note that grammatical perfection is not the primary focus. The key is to provide a clear, enabling disclosure of your invention that supports your claims and demonstrates your invention to the fullest extent.

To learn more:

According to the MPEP 602.06, if an inventor understands English, it is preferable to use English for oaths and declarations. The manual states:

“If the individual comprehends the English language, he or she should preferably use it.”

This preference for English, when possible, likely helps streamline the patent application process and reduces the need for translations. However, it’s important to note that the primary requirement is for the inventor to understand the language used, whether it’s English or another language.

To learn more:

Tags: declaration, oath

Voluntary arbitration in patent disputes is a process outlined in 35 U.S.C. 294 where parties can agree to settle disputes related to patent validity or infringement through arbitration. The law states:

‘A contract involving a patent or any right under a patent may contain a provision requiring arbitration of any dispute relating to patent validity or infringement arising under the contract.’

This allows parties to resolve patent-related conflicts outside of the court system, potentially saving time and resources.

The United States Patent and Trademark Office (USPTO) has a clear recommendation regarding the submission of preliminary amendments. According to MPEP 608.04(b):

Applicants are strongly encouraged to avoid submitting any preliminary amendments so as to minimize the burden on the Office in processing preliminary amendments and reduce delays in processing the application.

The USPTO advises applicants to incorporate desired amendments directly into the text of the specification rather than submitting separate preliminary amendments. This approach is recommended even for continuation or divisional applications of prior-filed applications. By following this guidance, applicants can help streamline the application process and potentially reduce processing times.

To learn more:

The USPTO does not process requests for indexing or cross-referencing additional patent numbers or application numbers against a document previously recorded in the Assignment Division, unless it’s an assignment. This policy is based on compliance with 37 CFR 3.11, 3.28, and 3.31.

As stated in MPEP 315: “The Office does not process requests for ‘indexing’ or ‘cross-referencing’ additional patent numbers or application numbers against a document, other than an assignment, previously recorded in the Assignment Division.”

For more information on Assignment Division, visit: Assignment Division.

For more information on document recording, visit: document recording.

For more information on USPTO policy, visit: USPTO policy.

What is the USPTO’s policy on federal holidays?

The USPTO observes federal holidays and has specific policies regarding correspondence and deadlines that fall on these days:

  • The USPTO is closed on all federal holidays.
  • Deadlines that fall on a federal holiday are extended to the next business day.
  • Correspondence is not accepted or processed on federal holidays.

According to MPEP 502: ‘Federal holidays falling on Sunday will be observed on the following Monday.’ This means that when a federal holiday falls on a Sunday, the USPTO will be closed on the following Monday, and any deadlines will be extended accordingly.

It’s important for patent applicants and attorneys to be aware of the federal holiday schedule and plan their filings accordingly to avoid missing critical deadlines.

The USPTO has established a Patent Internet Usage Policy that governs email communications with patent applicants. According to MPEP 502.03, ‘Communications via Internet email are at the discretion of the applicant.’ However, there are specific requirements and limitations:

  • A written authorization from the applicant is required for USPTO employees to communicate via email.
  • All Internet communications must be made using USPTO tools.
  • Without written authorization, the USPTO will not respond to Internet correspondence containing confidential information.

It’s important to note that ‘A reply to an Office action or a paper requiring a signature may NOT be communicated by applicant to the USPTO via Internet email even if written authorization is on record.’

To learn more:

Tags: USPTO

The United States Patent and Trademark Office (USPTO) generally discourages the filing of duplicate copies of correspondence in patent applications, patents, or other proceedings. According to MPEP 502.04:

The filing of duplicate copies of correspondence in the file of an application, patent, or other proceeding should be avoided, except in situations in which the Office requires the filing of duplicate copies.

The USPTO may dispose of duplicate copies to streamline processing. However, it’s important to note that separate copies are required for different files, even if the content is identical.

To learn more:

The timeframe for receiving a Notice of Allowance (PTOL-85) after a Notice of Allowability (Form PTOL-37) is generally within three months. However, if you don’t receive the Notice of Allowance within this period, it may be appropriate to make a status inquiry.

The MPEP states: A Notice of Allowability, Form PTOL-37, is routinely mailed in every application determined to be allowable. Thus, the mailing of a form PTOL-37 in addition to a formal Notice of Allowance and Fee(s) Due (PTOL-85) in all allowed applications would seem to obviate the need for status inquiries even as a precautionary measure where the applicant may believe the new application may have been passed to issue on the first examination. (MPEP 203.08)

However, the MPEP also notes an exception: As an exception, a status inquiry would be appropriate where a Notice of Allowance (PTOL-85) is not received within three months from receipt of form PTOL-37.

If you haven’t received your Notice of Allowance after three months from receiving the Notice of Allowability, it’s advisable to check the status of your application through Patent Center or contact the Application Assistance Unit.

To learn more:

The transition application statement is a requirement for certain applications that bridge the pre-AIA and AIA periods. Here are the key points:

  • It applies to nonprovisional applications filed on or after March 16, 2013, that claim priority to a foreign application filed before March 16, 2013.
  • The statement is required if the application contains or contained a claim to an invention with an effective filing date on or after March 16, 2013.
  • The applicant must provide this statement within a specified time period.
  • International design applications are exempt from this requirement.

As stated in the MPEP: If a nonprovisional application filed on or after March 16, 2013, claims priority to a foreign application filed prior to March 16, 2013, and also contains, or contained at any time, a claim to a claimed invention that has an effective filing date (as defined in 35 U.S.C. 100(i)) on or after March 16, 2013, the applicant must provide a statement to that effect within a specified time period. This requirement helps the USPTO determine which law applies to the application.

To learn more:

The timeliness requirement for priority documents in the PDX program is crucial for patent applicants. MPEP 215.02(a) states:

“If the priority document is retrieved after the application is allowed, the patent will not include the priority claim unless the applicant promptly files a request for a Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323.”

Key points about the timeliness requirement:

  • Priority documents should be retrieved before the application is allowed
  • If retrieved after allowance, a Certificate of Correction is required
  • Applicants should monitor the retrieval status and take action if necessary

To learn more:

What is the timeframe for recording an assignment at the USPTO?

The USPTO recommends recording an assignment within three months of its execution date. According to MPEP 302:

“The Patent and Trademark Office does not require that a document be recorded. If a document is to be recorded, it should be submitted to the Assignment Division within three months from its date of execution; otherwise, it may not be accepted for recordation.”

While there’s no strict legal requirement to record within this timeframe, doing so ensures the assignment is properly documented and can help avoid potential legal issues in the future.

For more information on assignment recording, visit: assignment recording.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

The time period for filing a priority claim in an international design application designating the United States depends on whether it’s a nonprovisional international design application or not. According to MPEP 213.07:

In an international design application designating the United States, the claim for priority may be made in accordance with the Hague Agreement and the Hague Agreement Regulations.

For nonprovisional international design applications, the MPEP states:

In a nonprovisional international design application, the priority claim and certified copy must be furnished in accordance with the time period and other conditions set forth in paragraph (g) of this section.

This refers to 37 CFR 1.55(g), which generally requires the priority claim to be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application. However, it’s important to consult the specific regulations and the Hague Agreement for precise deadlines and requirements, as they may vary depending on the specific circumstances of the application.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on nonprovisional application, visit: nonprovisional application.

For an original application filed under 35 U.S.C. 111(a) on or after March 16, 2013, a certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application, except as provided in 37 CFR 1.55(h), (i), and (j). See MPEP 215.02.

For an international application entering the national stage under 35 U.S.C. 371 in which the national stage commenced on or after December 18, 2013, a certified copy of the foreign application must be filed within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior foreign application, except as provided in 37 CFR 1.55(h), (i), and (j). See MPEP 215.02.

What is the time period for correcting a benefit claim under 37 CFR 1.78?

The time period for correcting a benefit claim under 37 CFR 1.78 is crucial for patent applicants. According to MPEP 211.02(a):

The time period for making a claim for benefit of a prior-filed application under 37 CFR 1.78(a)(3) and 37 CFR 1.78(d)(3) is specified in 37 CFR 1.78(a)(4) and 37 CFR 1.78(d)(3).

The specific time periods are:

  • For nonprovisional applications: The later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior application
  • For design applications: The later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior application
  • For international applications entering the national stage: The time period in 37 CFR 1.55 for claiming priority to foreign applications applies

It’s important to note that if you miss these deadlines, you may need to file a petition under 37 CFR 1.78(c) or (e) to accept an unintentionally delayed benefit claim.

To learn more:

To learn more:

When the USPTO makes a formal request for a property rights statement in accordance with 42 U.S.C. 2182 (DOE) or 51 U.S.C. 20135 (NASA), the applicant has a 30-day statutory period to respond. There is no provision for an extension of this 30-day time period.

As stated in MPEP 150, “If no proper and timely statement is received, the application will be held abandoned and the applicant so notified. Such applications may be revived under the provisions of 37 CFR 1.137.”

For international design applications designating the United States, there is generally no specific time limit for submitting a certified copy of the priority document. The MPEP 213.07 explains:

‘In accordance with Hague Agreement Rule 7(5)(f), a copy of the priority document may be submitted to the International Bureau within three months from the date of filing of the international design application. The copy of the priority document so submitted will be considered to satisfy the requirement for a certified copy of the priority document in accordance with 37 CFR 1.55(m).’

However, it’s important to note that if the USPTO requires a certified copy for specific reasons (e.g., to overcome a reference), you may need to submit it within a specified timeframe as requested by the Office.

To learn more:

What is the time limit for submitting a certified copy of a foreign application for priority claim?

The time limit for submitting a certified copy of a foreign application for a priority claim depends on the specific circumstances of your application. According to MPEP 213.04:

The time period for filing a certified copy of the foreign application in the United States application (or written statement) is no later than the date the issue fee is paid.

However, there are some exceptions and additional considerations:

  • If you file the priority claim within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application, you may not need to file a certified copy immediately.
  • If the foreign application was filed in a foreign intellectual property office participating in a priority document exchange agreement with the USPTO, the exchange may satisfy the certified copy requirement.
  • In some cases, an interim copy of the foreign application or a statement that the copy was previously filed may be sufficient.

Note: While it’s possible to file the certified copy after paying the issue fee, it requires an additional processing fee and must be done before the patent is granted. To avoid complications and extra fees, it’s best to submit the certified copy as early as possible during the application process.

To learn more:

The time limit for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a), the specific reference must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371, the specific reference must be submitted during the pendency of the application and within the later of four months from the date on which the national stage commenced, four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

As stated in MPEP 211.02: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).

For more information on national stage application, visit: national stage application.

For more information on time limit, visit: time limit.

For utility or plant applications filed under 35 U.S.C. 111(a), the benefit claim must be made during the pendency of the application and within the later of:

  • Four months from the actual filing date of the later-filed application, or
  • Sixteen months from the filing date of the prior-filed application

As stated in the MPEP: If the application is a utility or plant application filed under 35 U.S.C. 111(a), the benefit claim of the prior application under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) must be made during the pendency of the application and within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.

To learn more:

To learn more:

The time limit for filing a U.S. nonprovisional application claiming priority to a foreign application is generally 12 months from the filing date of the foreign application. For design applications, the time limit is 6 months.

As stated in the MPEP, The United States nonprovisional application must be filed not later than twelve months (six months in the case of a design application) after the date on which the foreign application was filed, unless the right of priority has been restored. (MPEP 213.03)

It’s important to note that this period is subject to certain provisions, such as the extension to the next business day if the deadline falls on a weekend or federal holiday.

To learn more:

The U.S. nonprovisional application must generally be filed within 12 months of the filing date of the foreign application to claim priority. For design applications, this period is 6 months.

Specifically, 37 CFR 1.55(b) states:

“The nonprovisional application must be: (1) Filed not later than twelve months (six months in the case of a design application) after the date on which the foreign application was filed, subject to paragraph (c) of this section (a subsequent application); or (2) Entitled to claim the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) of a subsequent application that was filed within the period set forth in paragraph (b)(1) of this section.”

There are provisions to restore the right of priority if the subsequent application is filed within 2 months after the expiration of the priority period, if the delay was unintentional.

What is the time limit for filing a substitute statement?

A substitute statement must be filed within the time period set forth in 37 CFR 1.53(f) or 1.53(d), as applicable. According to MPEP 604:

“The Office has revised the rules to permit applicants to postpone filing an inventor’s oath or declaration until the application is otherwise in condition for allowance if the applicant provides an application data sheet indicating the name, residence, and mailing address of each inventor.”

This means that while you can postpone filing the substitute statement, it must be submitted before the application is allowed. It’s important to note that the substitute statement is subject to the same time constraints as the inventor’s oath or declaration.

To learn more:

The time limit for filing a request to retrieve a foreign application through the Priority Document Exchange (PDX) program is specified in 37 CFR 1.55(i)(4). According to the MPEP:

The request must be filed within the later of sixteen months from the filing date of the prior foreign application, four months from the actual filing date of an application under 35 U.S.C. 111(a), four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f) (§ 1.491(a)), or four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or the request must be accompanied by a petition under paragraph (e) or (f) of this section.

It’s important to note that if you miss this deadline, you may need to file a petition to accept a delayed priority claim or submit a certified copy of the foreign application directly.

To learn more:

There is no specific time limit for filing a reissue application. According to MPEP 201.05, ‘A reissue application can be filed at any time during the enforceability of a patent.’ This means that as long as the original patent is still enforceable, a reissue application can be filed.

However, it’s important to note that there are limitations on what can be claimed in a reissue application based on when it’s filed:

  • If filed within two years from the grant of the original patent, both narrowing and broadening reissue claims are permitted.
  • If filed more than two years from the grant of the original patent, only narrowing reissue claims are allowed.

The MPEP states: ‘A broadening reissue application filed on or after September 16, 2012 must be applied for by all of the inventors (or alternatively the assignee of the entire interest), and the application must be filed within two years from the grant of the original patent.’

To learn more:

When filing a reissue application to correct a priority claim, it’s crucial to adhere to the time limits set by law. The MPEP specifies:

‘The reissue application must be filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f).’

This means that the reissue application must typically be filed within 12 months from the filing date of the foreign application. However, there may be exceptions or additional considerations depending on specific circumstances. It’s advisable to consult with a patent attorney or the USPTO directly for guidance on your particular situation.

The time limit for filing a petition to accept a delayed benefit claim depends on the type of application:

  • For nonprovisional applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.
  • For design applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.
  • For international applications entering the national stage under 35 U.S.C. 371: The time limit is four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f).

As stated in MPEP 211.04: “If the later-filed application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, this period is 4 months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f).”

To learn more:

A nonprovisional application claiming the benefit of a provisional application under 35 U.S.C. 119(e) must be filed within 12 months after the provisional application’s filing date, unless the benefit has been restored. The MPEP states:

“When a later-filed application is claiming the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the nonprovisional application must be filed not later than 12 months after the date on which the provisional application was filed, unless the benefit of the provisional application has been restored.”

If the 12-month deadline falls on a Saturday, Sunday, or federal holiday in Washington, D.C., the nonprovisional application can be filed on the next business day.

To learn more:

What is the time limit for filing a divisional application?

There is no specific time limit for filing a divisional application, but there are important considerations that effectively create a practical time frame:

  1. Parent Application Status: The divisional application must be filed while the parent application is still pending. Once the parent application is either abandoned or issued as a patent, it’s no longer possible to file a divisional from it.
  2. Priority Claim: To claim the benefit of the parent application’s filing date, the divisional must be filed within the time periods specified in 35 U.S.C. 120, 121, 365(c), or 386(c).
  3. Patent Term: The 20-year patent term is calculated from the earliest non-provisional U.S. filing date. Filing a divisional later in the parent’s pendency will result in a shorter potential patent term for the divisional.

The MPEP 201.06 states:

A divisional application is often filed as a result of a restriction requirement made by the examiner.

While this doesn’t specify a time limit, it implies that divisional applications are typically filed in response to office actions during the examination process. Applicants should consider filing a divisional promptly after receiving a restriction requirement to ensure they don’t miss any deadlines and to maximize the potential patent term.

For more information on Divisional application, visit: Divisional application.

For more information on filing deadline, visit: filing deadline.

The time limit for filing a delayed claim for foreign priority after patent issuance is specified in 37 CFR 1.55(g). According to MPEP 216.01:

‘The time period set in 37 CFR 1.55(g) for filing a claim for priority and the certified copy required under 37 CFR 1.55(f) is the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.’

However, for patents that have already been issued, the claim must be filed within the period set forth in 37 CFR 1.55(g). This typically means that the claim should be filed as soon as possible after realizing the oversight, as any delay beyond the statutory period would require explanation and potentially affect the grant of the petition.

The time limit for filing a certified copy of a foreign application depends on the type of application:

  1. For applications under 35 U.S.C. 111(a): A certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application, or sixteen months from the filing date of the prior foreign application, as stated in 37 CFR 1.55(f)(1).
  2. For applications under 35 U.S.C. 371 (national stage applications): A certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT, as per 37 CFR 1.55(f)(2).

If these time limits are not met, a petition including a showing of good and sufficient cause for the delay and the petition fee set forth in § 1.17(g) must accompany the certified copy.

To learn more:

To learn more:

For applications filed under 35 U.S.C. 111(a) on or after March 16, 2013, 37 CFR 1.55(f)(1) sets the time limit for filing a certified copy of the foreign application. The certified copy must be filed within the later of:

  • Four months from the actual filing date of the application, or
  • Sixteen months from the filing date of the prior foreign application

This time limit does not apply to design applications. For international applications entering the national stage under 35 U.S.C. 371, the time limit is set forth in 37 CFR 1.55(f)(2).

It’s important to note that there are exceptions to these time limits, as provided in 37 CFR 1.55(h), (i), and (j).

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For more information on time limit, visit: time limit.

For applications filed under 35 U.S.C. 111(a) on or after March 16, 2013, 37 CFR 1.55(f)(1) requires that a certified copy of the foreign application be filed within the later of:

  • Four months from the actual filing date of the application, or
  • Sixteen months from the filing date of the prior foreign application

This time period does not apply to design applications. There are three exceptions to this requirement, as outlined in 37 CFR 1.55(h), (i), and (j).

To learn more:

The time limit for filing a benefit claim depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the reference must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “If the application is an application filed under 35 U.S.C. 111(a), the reference to the prior application must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on time limit, visit: time limit.

The time limit for claiming benefit of a prior application depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a), the benefit claim must be made within the later of:
    • Four months from the actual filing date of the later-filed application, or
    • Sixteen months from the filing date of the prior-filed application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c) unless a petition to accept an unintentionally delayed benefit claim is granted.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on time limit, visit: time limit.

The statutory requirement for claims in a patent application is outlined in 35 U.S.C. 112. According to MPEP 608.01(k), this statute “requires that the specification shall particularly point out and distinctly claim the subject matter which the inventor or joint inventor regards as his orher invention.”

This means that the claims must clearly and precisely define the invention for which protection is sought. The claims are a crucial part of the patent application as they determine the scope of legal protection granted by the patent.

To learn more:

To learn more:

Once a nonprovisional patent application has been examined and determined to meet all statutory requirements, a notice of allowance is sent to the applicant. The status of the application is then considered “allowed” or “in issue”. As per MPEP 203.04:

An “allowed” nonprovisional application or an application “in issue” is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an “allowed” application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

A “new” nonprovisional patent application is one that has not yet received an action by the examiner. Its status as a “new” application continues until the examiner takes action, even if the applicant files an amendment prior to the first Office Action. A request for continued examination (RCE) under 37 CFR 1.114 is not considered a new application filing.

The statement requirement for transition applications was introduced as part of the implementation of the first inventor to file provisions of the America Invents Act (AIA). Transition applications are:

  • Nonprovisional applications filed on or after March 16, 2013
  • Applications that claim foreign priority to, or domestic benefit of, an application filed before March 16, 2013

The statement requirement is outlined in 37 CFR 1.55(k) and 1.78(a)(6) and (d)(6). As stated in the MPEP:

The statement provisions of 37 CFR 1.55 and 1.78 require that if the later-filed transition application contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March 16, 2013, the applicant must provide a statement to that effect (unless the later-filed application is a nonprovisional international design application).

The statement must be provided within specified time limits. Applicants are not required to provide the statement if they reasonably believe the application does not contain claims with an effective filing date on or after March 16, 2013.

For more information on America Invents Act, visit: America Invents Act.

For more information on first inventor to file, visit: first inventor to file.

For more information on transition applications, visit: transition applications.

The statement under 37 CFR 1.97(e) for an Information Disclosure Statement (IDS) must state either:

  1. Each item of information in the IDS was first cited in a communication from a foreign patent office in a counterpart foreign application not more than three months prior to filing the statement, or
  2. No item of information in the IDS was cited in a communication from a foreign patent office in a counterpart foreign application, and to the knowledge of the person signing the statement, no item of information was known to any individual designated in 37 CFR 1.56(c) more than three months prior to filing the statement.

According to MPEP 609.04(b): A statement under 37 CFR 1.97(e) can contain either of two statements. One statement is that each item of information in an information disclosure statement was first cited in any communication, such as a search report, from a patent office outside the U.S. in a counterpart foreign application not more than three months prior to the filing date of the statement. Applicant would not be able to make a statement under 37 CFR 1.97(e) where an item of information was first cited by a foreign patent office, for example, a year before the filing of the IDS, in a communication from that foreign patent office, and the same item of information is once again cited by another foreign patent office within three months prior to the filing of the IDS in the Office.

To learn more:

To learn more:

For a Continued Prosecution Application (CPA), the specific reference requirement under 35 U.S.C. 120 is satisfied by the CPA request itself. According to MPEP § 201.06(d):

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that when you file a CPA request, it automatically serves as the required reference to the prior application under 35 U.S.C. 120. No additional amendments or references in the specification are necessary to establish this connection.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on specific reference, visit: specific reference.

For a Continued Prosecution Application (CPA), the specific reference required by 35 U.S.C. 120 is the CPA request itself. This is explicitly stated in 37 CFR 1.53(d)(7).

According to MPEP ¶ 2.34:

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that when you file a CPA, the request itself serves as the necessary reference to the prior application, eliminating the need for additional amendments to the specification to establish continuity.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on specific reference, visit: specific reference.

To qualify for micro entity status based on an institution of higher education, the applicant must first meet the small entity requirement. This means that every party holding rights in the application must qualify as a small entity under 37 CFR 1.27.

MPEP 509.04(b) states: “In order to meet the small entity requirement, every party holding rights in the application must qualify as a small entity under 37 CFR 1.27. If any rights in the application are assigned, granted, conveyed, or licensed to a party that does not qualify as a small entity under 37 CFR 1.27, the applicant cannot qualify for any patent fee discount.”

This requirement ensures that only truly small entities benefit from the micro entity status, even when associated with an institution of higher education.

To learn more:

Tags: patent fees

Venue is a crucial aspect of patent oaths and declarations. MPEP 602 states, “That portion of an oath or affidavit indicating where the oath is taken is known as the venue. […] Venue and notary jurisdiction must correspond or the oath is improper.” This means that the location where the oath is taken must match the jurisdiction of the notary or official administering the oath. The MPEP further advises, “The oath should show on its face that it was taken within the jurisdiction of the certifying officer or notary.” Ensuring correct venue information helps establish the validity of the oath or declaration.

To learn more:

Tags: declaration, oath

The Transco Products decision is significant in determining benefit claims because it established that a later-filed application does not need to use the exact same words as the prior-filed application to satisfy the written description requirement. According to MPEP 211.05:

‘New or amended claims which introduce elements or limitations that are not supported by the as-filed disclosure violate the written description requirement. See, e.g., In re Lukach, 442 F.2d 967, 169 USPQ 795 (CCPA 1971) (subgenus range was not supported by generic disclosure and specific example within the subgenus range); In re Smith, 458 F.2d 1389, 1395, 173 USPQ 679, 683 (CCPA 1972) (an adequate description of a genus may not support claims to a subgenus or species within the genus). While there is no in haec verba requirement, newly added claims or claim limitations must be supported in the specification through express, implicit, or inherent disclosure. An amendment to correct an obvious error does not constitute new matter where one skilled in the art would not only recognize the existence of the error in the specification, but also recognize the appropriate correction. In re Oda, 443 F.2d 1200, 170 USPQ 268 (CCPA 1971).’

This means that the USPTO will consider whether the prior-filed application provides sufficient support for the claims in the later-filed application, even if the exact wording is different, as long as the support is express, implicit, or inherent in the original disclosure.

To learn more:

What is the significance of the three-month period for IDS submission?

The three-month period for Information Disclosure Statement (IDS) submission is significant because it determines whether additional requirements apply:

  • IDS filed within three months of the filing date of a national application or entry of the national stage: No additional requirements
  • IDS filed after three months: Requires either a certification or fee

According to MPEP 609.04(b): “(1) The information disclosure statement is filed within three months of the filing date of a national application other than a continued prosecution application under § 1.53(d);” This three-month window provides applicants with an opportunity to submit an IDS without additional burdens, encouraging early disclosure of relevant information.

If an applicant misses this three-month window, they must either:

  • Provide a certification under 37 CFR 1.97(e), stating that the information was first cited in a communication from a foreign patent office or discovered within three months of the filing date, or
  • Pay the fee set forth in 37 CFR 1.17(p)

This policy aims to balance the need for timely disclosure with the practicalities of gathering and submitting relevant information during the patent application process.

To learn more:

The term ‘original application’ has a specific meaning in patent law, as outlined in MPEP 201.02:

‘Original’ application is used in the patent statutes and rules to refer to an application which is not a reissue application. An original application may be a first filing or a continuing application.

This definition is significant because it distinguishes original applications from reissue applications, which are used to correct errors in already-granted patents. Original applications encompass:

  • First-time filings of new inventions
  • Continuing applications (continuations, divisionals, and continuations-in-part)

Understanding this term is crucial for patent applicants and examiners, as it affects how an application is processed and what rights it may claim, particularly in terms of priority dates and the scope of patent protection.

For more information on patent application types, visit: patent application types.

For more information on patent procedure, visit: patent procedure.

What is the significance of the term ‘nonprovisional’ in patent applications?

The term ‘nonprovisional’ in patent applications is significant because it distinguishes these applications from provisional applications:

  • Examination: Nonprovisional applications undergo substantive examination by the USPTO, while provisional applications do not.
  • Patent Grant: Only nonprovisional applications can mature into granted patents.
  • Duration: Nonprovisional applications have a standard 20-year term from the filing date, while provisional applications expire after 12 months.
  • Content Requirements: Nonprovisional applications must include formal patent claims and other specific elements not required in provisional applications.

The MPEP 201.01 mentions nonprovisional applications in the context of original applications: ‘Original applications include all applications other than reissue applications. Original applications may be nonprovisional or provisional.’

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on patent grant, visit: patent grant.

For more information on provisional application, visit: provisional application.

What is the significance of the term ‘copending’ in continuation applications?

The term ‘copending’ is crucial in the context of continuation applications. According to MPEP 201.07:

A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.

The significance of ‘copending’ is as follows:

  • Timing: It means that the continuation application must be filed before the prior application is patented, abandoned, or terminated.
  • Continuous chain: It ensures a continuous chain of pending applications, maintaining the priority date of the original filing.
  • Benefit claims: Copendency is required for a continuation to claim the benefit of the earlier filing date of the parent application.

If applications are not copending, the continuation may lose the benefit of the earlier filing date, potentially affecting patentability if intervening prior art exists.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

What is the significance of the term ‘carved out’ in relation to divisional applications?

The term ‘carved out’ is significant in understanding the nature of divisional applications. According to MPEP 201.06: ‘A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.”

The significance of ‘carved out’ includes:

  • It implies that the divisional application is derived from a portion of the parent application.
  • The divisional application focuses on a specific invention or set of claims that are distinct from those in the parent application.
  • The subject matter in the divisional is entirely based on the disclosure in the parent application.
  • No new matter can be added to the divisional application beyond what was disclosed in the parent.

This term emphasizes that while the divisional application is separate, it is intrinsically linked to the parent application’s original disclosure, ensuring that the applicant doesn’t gain an unfair advantage by introducing new subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent filing, visit: patent filing.

The date September 21, 2004, is significant in relation to 37 CFR 1.57(b) because it marks the effective date of the provisions now contained in this regulation. The MPEP states that one reason an amendment might not comply with 37 CFR 1.57(b) is if the present application was filed before September 21, 2004, the effective date of the provisions now in 37 CFR 1.57(b).

This means that applications filed before this date cannot use the incorporation by reference procedure outlined in 37 CFR 1.57(b) to add inadvertently omitted material. For such applications, different rules and procedures would apply for addressing omitted material.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on effective date, visit: effective date.

For more information on incorporation by reference, visit: incorporation by reference.

The date September 16, 2012, is significant because it marks a change in the applicability of certain patent application procedures. As noted in MPEP 409.03(a):

“[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]”

This date corresponds to the implementation of the America Invents Act (AIA), which brought significant changes to U.S. patent law. For applications filed on or after this date, different rules and procedures apply regarding joint inventorship and the handling of situations where not all inventors are available or willing to sign the application. It’s crucial for applicants to be aware of which set of rules applies to their application based on the filing date.

To learn more:

The date September 16, 2012, is significant in patent applications involving deceased inventors because it marks a change in the applicable regulations. The MPEP section 409.03(c) states:

[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]

This means:

  • For applications filed before September 16, 2012: The procedures outlined in pre-AIA 37 CFR 1.47 apply when dealing with unavailable legal representatives of deceased inventors.
  • For applications filed on or after September 16, 2012: Different regulations and procedures apply, which are not covered in this specific MPEP section.

This date coincides with the implementation of the America Invents Act (AIA), which brought significant changes to U.S. patent law. Patent applicants and attorneys should be aware of these changes and apply the appropriate procedures based on their application’s filing date.

To learn more:

A postcard receipt can play a crucial role in patent applications, especially when pages are allegedly missing. The MPEP 601.01(d) highlights its importance:

Applicant has produced an itemized postcard receipt which specifically lists the omitted pages as having been deposited on the missing parts’ due date.

The significance of the postcard receipt includes:

  • Proof of submission: It serves as evidence that specific documents were submitted to the USPTO.
  • Date verification: It can confirm the date of submission for various application components.
  • Resolution of discrepancies: In cases where the USPTO claims pages are missing, the postcard can help resolve disputes.
  • Petition support: It can be used to support a petition to establish the filing date of omitted pages.

Applicants are advised to use detailed, itemized postcard receipts when submitting patent applications to avoid potential issues with missing documents.

To learn more:

The phrase ‘complying information disclosure statement’ in MPEP 609.05(b) is significant because it distinguishes between IDSs that meet all the regulatory requirements and those that do not. The MPEP states:

Information disclosure statements will be considered by the examiner if the statement is in compliance with the content requirements of 37 CFR 1.98 and the requirements of 37 CFR 1.97.

A complying IDS:

  • Meets the content requirements of 37 CFR 1.98
  • Satisfies the timing and fee requirements of 37 CFR 1.97
  • Will be fully considered by the examiner
  • Ensures that the applicant has fulfilled their duty of disclosure

Non-complying IDSs may not be fully considered or may require corrections before examination.

To learn more:

To learn more:

What is the significance of the Paris Convention in foreign priority claims?

The Paris Convention plays a crucial role in foreign priority claims for patent applications. Its significance includes:

  • Establishing the right of priority for patent applications among member countries.
  • Allowing applicants to file in multiple countries while maintaining the original filing date.
  • Providing a 12-month priority period for utility patents (6 months for design patents).
  • Ensuring equal treatment of foreign and domestic applicants in member countries.

According to MPEP 213: “The right of priority is defined in Article 4 of the Paris Convention for the Protection of Industrial Property and is based on the first filing in a Paris Convention country.” This convention facilitates international patent protection by allowing inventors to secure priority dates across multiple jurisdictions.

The Paris Convention plays a crucial role in international patent applications. As stated in MPEP 213.01:

The right of priority under the Paris Convention for the Protection of Industrial Property (Paris Convention) is recognized in the United States.

This means that applicants can claim priority based on an earlier filing in any Paris Convention member country. The Paris Convention facilitates patent protection across multiple countries by allowing a grace period for filing in other member nations while maintaining the priority date of the first filing.

To learn more:

What is the significance of the order of inventors listed on a patent application?

The order of inventors listed on a patent application does not affect their legal rights, but it may have other implications. According to the MPEP:

“The order of names of joint inventors in the heading of the application is not significant except in an application filed before September 16, 2012, where the order of named inventors determined the order of prosecution in the absence of an executed oath or declaration.” (MPEP 605)

While the order doesn’t impact legal rights, it’s common practice to list the primary contributor first. This can be important for:

  • Academic recognition: In scientific publications, the first-listed inventor may receive more credit.
  • Industry norms: Some fields have conventions about inventor order.
  • Alphabetical order: Sometimes used to avoid implications of contribution levels.

Ultimately, all listed inventors have equal rights to the patent, regardless of their order on the application.

To learn more:

The Office docket plays a crucial role in determining the status of a patent application. MPEP 203.05 refers to the Office docket when defining abandoned applications:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications

The Office docket is essentially the official record of pending patent applications at the USPTO. When an application is removed from this docket, it is no longer considered active or pending. This removal can occur for various reasons, including formal abandonment, applicant inaction, failure to pay fees, or expiration of statutory periods. Therefore, the status of an application on the Office docket is a key indicator of whether it is still being actively prosecuted or has been abandoned.

March 16, 2013 is a crucial date in U.S. patent law due to the implementation of the America Invents Act (AIA). This date marks the transition from the pre-AIA first-to-invent system to the AIA first-inventor-to-file system. The significance includes:

  • Applications filed on or after this date are generally subject to AIA provisions
  • The effective filing date of claimed inventions determines which law applies
  • Transition applications may require special statements
  • Different examination standards may apply based on the effective filing date

The MPEP states: “The first inventor to file provisions of Public Law 112-29, sec. 3, 125 Stat. 284 (the Leahy-Smith America Invents Act) and the rules related thereto became effective March 16, 2013. These provisions apply to any application for patent, and to any patent issuing thereon, that contains or contained at any time— (A) a claim to a claimed invention that has an effective filing date as defined under section 100(i) of title 35, United States Code, that is on or after March 16, 2013; or (B) a specific reference under section 120, 121, or 365(c) of title 35, United States Code, to any patent or application that contains or contained at any time such a claim.”

What is the significance of the issue fee payment date for patent assignments?

The issue fee payment date is crucial for patent assignments and issuance to assignees for several reasons:

  • It serves as the deadline for requesting issuance of the patent to the assignee under 37 CFR 3.81(b).
  • Assignments recorded after this date but before patent issuance will be recorded but won’t affect who the patent is issued to.
  • It impacts the USPTO’s ability to change the name on the patent.

MPEP 307 states: “If the assignment is submitted for recording after the date of payment of the issue fee, but prior to issuance of the patent, the assignment will be recorded but the patent will issue to the name of the inventor.” This underscores the importance of timely assignment recording and requests for issuance to the assignee.

For more information on assignment recording, visit: assignment recording.

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

The inventor’s citizenship is an important piece of information in a patent application for several reasons:

  • Compliance with USPTO requirements
  • Determination of inventorship rights
  • Application of international treaties
  • Export control considerations

MPEP 602.08(a) states: ‘Citizenship is required to support an oath or declaration under 37 CFR 1.63 or to determine whether the application is subject to a secrecy order under 37 CFR 5.1(b).’

The citizenship information helps the USPTO ensure compliance with various legal requirements and international agreements, such as the Paris Convention for the Protection of Industrial Property.

To learn more:

What is the significance of the four-month time period in filing a certified copy?

The four-month time period is significant in filing a certified copy of a foreign application for priority claims. According to MPEP 213.04, “If the certified copy is not filed within the four-month period, the certified copy must be accompanied by a petition including a showing of good and sufficient cause for the delay and the petition fee.” This means that if you file the certified copy within four months of the actual filing date of the application (or entry into the national stage for PCT applications), you don’t need to provide any explanation or pay additional fees. However, if you miss this four-month window, you’ll need to file a petition explaining the delay and pay an additional fee. This rule encourages prompt filing of priority documents and helps streamline the examination process.

To learn more:

What is the significance of the four-month and sixteen-month time periods for filing a priority claim?

The four-month and sixteen-month time periods are crucial deadlines for filing a priority claim in a U.S. patent application. According to MPEP 214.01:

“The claim for priority must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application in an original application filed under 35 U.S.C. 111(a).”

These time periods are significant because:

  • They provide applicants with a window to properly claim priority to a foreign application.
  • The four-month period starts from the U.S. filing date, giving applicants time to prepare and submit the priority claim after filing their U.S. application.
  • The sixteen-month period from the foreign filing date ensures that priority claims are made within a reasonable time frame relative to the original foreign filing.
  • Filing within these periods allows for the priority claim to be considered timely without requiring additional petitions or fees.

It’s important to note that failing to meet these deadlines may result in the need for a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e), which involves additional requirements and fees.

The filing date mentioned in MPEP ¶ 2.05 is significant because it establishes the priority date for the continuation application. The MPEP states:

“This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application.” (MPEP ¶ 2.05)

The significance of the filing date [2] includes:

  • Establishing the priority date for the continuation application
  • Determining the relevant prior art for examination
  • Calculating patent term adjustments
  • Assessing eligibility for certain types of patent term extensions

By referencing the filing date of the prior application, the continuation application can benefit from the earlier filing date, potentially providing an advantage in terms of patentability and patent term.

For more information on continuation application, visit: continuation application.

The filing date is crucial in relation to irreparable damage because it can determine whether an applicant’s rights are preserved or lost. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This means that the filing date can be critical for:

  • Establishing priority over other potential patent applications
  • Avoiding statutory bars to patentability
  • Preserving international filing rights
  • Preventing public disclosure that could jeopardize patent rights

Therefore, proving that a specific filing date is necessary can be essential to prevent irreparable damage to an applicant’s patent rights.

To learn more:

To learn more:

What is the significance of the filing date in a divisional application?

The filing date of a divisional application is crucial for several reasons:

  • Benefit of earlier filing date: A divisional application is entitled to the benefit of the filing date of the prior-filed application, as stated in MPEP 201.06(c): ‘A divisional application is entitled to the benefit of the filing date of the prior-filed application if filed before the patenting or abandonment of or termination of proceedings on the prior-filed application.’
  • Prior art considerations: The earlier filing date can be used to overcome prior art references that might otherwise be applicable.
  • Patent term calculations: The filing date may affect the calculation of the patent term.
  • Priority claims: It establishes the basis for any priority claims to foreign applications.

It’s important to note that the divisional application must be filed while the parent application is still pending to claim the benefit of the earlier filing date.

For more information on Divisional application, visit: Divisional application.

For more information on patent term, visit: patent term.

For more information on prior art, visit: prior art.

The filing date of a Continued Prosecution Application (CPA) is significant for several reasons. In the context of inventorship, the MPEP ¶ 2.33 mentions:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

The filing date [2] is important because:

  • It establishes the effective date for the CPA.
  • It determines the timeline for filing certain documents, such as inventor oaths or declarations.
  • It affects the calculation of patent term adjustment.
  • It’s used as a reference point for determining whether changes to inventorship were properly requested.

Always keep the CPA filing date in mind when managing patent application procedures and deadlines.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

What is the significance of the filing date in a continuation-in-part application?

The filing date of a continuation-in-part (CIP) application is crucial for determining the effective date of certain disclosures. According to MPEP 201.08:

“The effective filing date of a claimed invention in a CIP application is determined on a claim-by-claim basis and not an application-by-application basis.”

This means:

  • Subject matter carried over from the parent application retains the parent’s filing date.
  • New matter introduced in the CIP receives the filing date of the CIP application.
  • Claims in the CIP are evaluated individually to determine which filing date applies based on their content.

Understanding this distinction is crucial for patent practitioners when assessing prior art and determining the scope of protection for inventions disclosed in CIP applications.

To learn more:

The filing date of foreign applications is significant in priority claims for the following reasons:

  1. It establishes the effective date of the priority claim.
  2. The date accorded is the date on which the specification and drawing were filed, not necessarily the date of the petition (which is called the application in some countries).
  3. This date is used to determine the applicability of prior art and the eligibility for certain patent term adjustments.

The MPEP states: “In some instances, the specification and drawing of the foreign application may have been filed at a date subsequent to the filing of the petition in the foreign country. Even though the petition is called the application and the filing date of this petition is the filing date of the application in a particular country, the date accorded here is the date on which the specification and drawing were filed.” (MPEP 216)

The filing date of a patent application is crucial for several reasons, as outlined in MPEP 601:

  • It establishes the priority date for the invention.
  • It starts the clock for the patent term.
  • It determines which version of the patent laws and rules apply to the application.

The MPEP emphasizes: ‘The filing date of an application is important (except for design applications) because it may affect the priority of the application relative to other applications or publications, and because many of the rules relating to patent applications use this date as a reference point.’

For nonprovisional applications, the filing date is typically the date when the USPTO receives all required elements, including the specification, at least one claim, and any necessary drawings. For provisional applications, the filing date is established when the USPTO receives the specification and any required drawings.

To learn more:

Tags: patent term

What is the significance of the examiner’s initials on an IDS?

The examiner’s initials on an Information Disclosure Statement (IDS) are significant because they indicate that:

  • The examiner has considered the cited reference.
  • The reference has been made of record in the application file.
  • The applicant has fulfilled their duty of disclosure for that particular reference.

According to MPEP 609.05(b): ‘The examiner will initial each reference considered. The initials indicate that the information has been considered by the examiner in the same manner as information submitted in compliance with 37 CFR 1.97 and 37 CFR 1.98.’

It’s important to note that the examiner’s initials do not indicate the examiner agrees with the applicant’s interpretation of the reference or its relevance. They simply confirm that the examiner has reviewed the citation as required by USPTO procedures.

To learn more:

What is the significance of the effective filing date in patent applications?

The effective filing date is a crucial concept in patent law that determines which prior art can be used against a patent application. According to MPEP 2152:

The effective filing date of a claimed invention is used to determine what qualifies as prior art that may be used to reject the claims of the application.

Key points about the effective filing date:

  • It can be the actual filing date of the application or an earlier date if the application claims priority to a prior-filed application.
  • For AIA applications, it determines which version of 35 U.S.C. 102 applies (pre-AIA or AIA).
  • It affects the scope of prior art that can be cited against the application.
  • Different claims within the same application may have different effective filing dates.

Understanding the effective filing date is essential for both patent applicants and examiners in assessing patentability and managing priority claims.

For more information on effective filing date, visit: effective filing date.

For more information on prior art, visit: prior art.

December 18, 2013 marks an important change in the requirements for nonprovisional patent applications to receive a filing date. The significance of this date is as follows:

  • Before December 18, 2013: Nonprovisional applications required at least one claim to receive a filing date.
  • On or after December 18, 2013: Nonprovisional applications (except design applications) can receive a filing date without any claims.

The MPEP notes: “For nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013, there is no need to request conversion to a provisional application because such applications do not require presentation of at least one claim to obtain a filing date.”

This change simplifies the initial filing process for many applicants, allowing them to secure a filing date more easily and potentially complete the application with claims at a later time.

To learn more:

The correspondence address is crucial in patent applications as it determines where the USPTO sends all official communications. Its relationship to the power of attorney is explained in MPEP 601.02:

“A power of attorney is not required to receive or change a correspondence address.”

Key points about the correspondence address:

  • It can be different from the address of the attorney or agent with power of attorney.
  • Changing the correspondence address does not affect the power of attorney.
  • Revoking a power of attorney does not automatically change the correspondence address.

To ensure proper communication with the USPTO, applicants should carefully manage both the power of attorney and the correspondence address, understanding that they are separate but related aspects of patent application management.

To learn more:

The change from 37 CFR 1.60 to 37 CFR 1.53(b) represents a significant shift in the procedure for filing continuation and divisional applications. After December 1, 1997, all such applications are processed under 37 CFR 1.53(b), which may have different requirements and procedures. Patent applicants need to be aware of this change to ensure they are following the correct, current procedures when filing continuation or divisional applications.

To learn more:

To learn more:

What is the significance of the application filing date in patent law?

The application filing date is crucial in patent law for several reasons:

  • Priority: It establishes the priority date for the claimed invention, which is used to determine novelty and non-obviousness.
  • Disclosure requirement: The specification must fully support the claimed invention as of the filing date.
  • New matter prohibition: Any material added after the filing date may be considered new matter and rejected.

As stated in MPEP 608.04(a): Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is usually new matter. This underscores the importance of having a complete and comprehensive disclosure at the time of filing.

To learn more:

Tags: new matter

What is the significance of the application filing date for new matter in patent applications?

The application filing date is crucial when determining whether content in a patent application constitutes new matter. MPEP 608.04(a) states:

‘Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.’

This means that any information added to the application after the filing date, which was not present in the original specification, claims, or drawings, is considered new matter. This is important because new matter cannot be added to an application without filing a continuation-in-part application.

The filing date serves as a cutoff point for the content that can be included in the application without being considered new matter. Inventors and patent practitioners must ensure that all necessary information is included in the application on or before the filing date to avoid issues with new matter.

To learn more:

To learn more:

The Application Data Sheet (ADS) plays a crucial role in establishing priority and benefit claims in patent applications:

  • Providing domestic benefit information in the ADS constitutes the specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
  • Providing foreign priority information in the ADS constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55.
  • The most recent ADS will govern with respect to foreign priority or domestic benefit claims in case of inconsistencies.

37 CFR 1.76(b)(5) states: “Providing this information in the application data sheet constitutes the specific reference required by 35 U.S.C. 119(e) or 120, and § 1.78.”

Similarly, 37 CFR 1.76(b)(6) states: “Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b) and § 1.55.”

It’s crucial to ensure that priority and benefit claims are accurately listed in the ADS to properly establish these claims in the patent application.

To learn more:

What is the significance of the AIA (America Invents Act) for patent application correspondence?

The America Invents Act (AIA) brought significant changes to patent application correspondence, particularly for applications filed on or after September 16, 2012. Key changes include:

  • New rules for who can file patent applications
  • Changes in correspondence procedures
  • Updated requirements for patent practitioners’ authority

According to MPEP 403.01(a): “The provisions of 37 CFR 1.33(b) for patent applications filed on or after September 16, 2012 differ from the provisions of pre-AIA 37 CFR 1.33(b) for patent applications filed prior to September 16, 2012.” This highlights the importance of understanding the specific rules that apply based on the application’s filing date.

To learn more:

What is the significance of the Application Data Sheet (ADS) in correcting or adding a benefit claim?

The Application Data Sheet (ADS) plays a crucial role in correcting or adding a benefit claim after filing. According to MPEP 211.02(a):

A corrected ADS (along with a petition under 37 CFR 1.78 and the petition fee) is required to correct a benefit claim if the benefit claim was not included on the original ADS.

This means that if you need to correct or add a benefit claim that wasn’t included in the original ADS, you must submit:

  • A corrected ADS
  • A petition under 37 CFR 1.78
  • The required petition fee

The corrected ADS should contain all of the information from the original ADS, with the changes to the benefit claim marked in accordance with 37 CFR 1.76(c).

To learn more:

Tags: ADS

What is the significance of the Access Code on the Request to Retrieve Electronic Priority Application?

The Access Code on the Request to Retrieve Electronic Priority Application plays a crucial role in the priority document exchange process. The MPEP states:

‘The Request to Retrieve Electronic Priority Application must include the Access Code assigned to that application by the applicant or applicant’s representative.’

This Access Code is essential because it allows the USPTO to securely retrieve the priority document from the foreign office. Without the correct Access Code, the USPTO cannot access and retrieve the document, which could lead to issues with establishing priority for your application.

It’s important to ensure that the Access Code you provide on the Request form is accurate and matches the one assigned by the foreign office. Incorrect or missing Access Codes can result in delays or failures in retrieving the priority document, potentially affecting your patent application’s priority claim.

What is the significance of the ‘time period set in 37 CFR 1.55’ for filing priority claims?

The time period set in 37 CFR 1.55 is crucial for securing your priority claim in a patent application. MPEP 213.04 states: ‘The time period set in 37 CFR 1.55 for filing a priority claim and certified copy cannot be extended.’ This strict deadline ensures that priority claims are made promptly, allowing for efficient examination and preventing delays in the patent process. Failing to meet this deadline can result in the waiver of your priority claim, potentially affecting the patentability of your invention if intervening prior art exists. It’s essential to be aware of and adhere to this time period to protect your invention’s priority date.

To learn more:

To learn more:

What is the significance of the ‘right of priority’ in international patent applications?

The ‘right of priority’ is a crucial concept in international patent applications. According to MPEP 211.01(c), ‘The right of priority is defined in 35 U.S.C. 119(a).’ This right allows applicants to claim priority from an earlier filed application, which can be beneficial in establishing the novelty and non-obviousness of an invention. Specifically, the MPEP states:

‘Under certain circumstances, the right of priority may be restored even if the filing is made after the 12-month priority period. See 37 CFR 1.55(c).’

This provision offers flexibility to applicants who may have missed the standard priority deadline, potentially preserving their patent rights in certain situations.

To learn more:

To learn more:

What is the significance of the ‘original disclosure’ in a divisional application?

The ‘original disclosure’ is crucial in a divisional application because it defines the scope of what can be included in the divisional. According to MPEP 201.06:

‘The disclosure of a divisional application must be the same as the disclosure of the prior-filed application, i.e., the original disclosure of the parent or original nonprovisional application or provisional application.’

This means that no new matter can be added to a divisional application. The divisional must rely entirely on the content disclosed in the original parent application. This ensures that the divisional application doesn’t extend beyond the scope of what was initially invented and disclosed.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

What is the significance of the ‘correspondence address’ in USPTO patent applications?

The correspondence address is crucial in USPTO patent applications for several reasons:

  • It determines where the USPTO sends all official communications regarding the application.
  • It can be used to designate a specific attorney or agent to receive correspondence.
  • Changes to the correspondence address must be made in writing to ensure proper routing of communications.

According to MPEP 403.01: “The correspondence address is used by the Office for mailing notices, actions, and other communications relating to the application.” Additionally, the MPEP states: “A change of correspondence address may be filed with the USPTO during the pendency of an application, and in a patent file.” This emphasizes the importance of keeping the correspondence address up-to-date to ensure timely receipt of important USPTO communications.

To learn more:

What is the significance of the ‘acting in a representative capacity’ requirement in patent applications?

The ‘acting in a representative capacity’ requirement is crucial in patent applications as it ensures that only authorized individuals can represent applicants or patent owners before the USPTO. According to MPEP 402.04, “Any paper presented to the United States Patent and Trademark Office (Office) on behalf of an applicant for patent or patent owner must be signed by (A) a patent practitioner of record appointed in compliance with 37 CFR 1.32(b), (B) a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34, or (C) the applicant under 37 CFR 1.42.” This requirement helps maintain the integrity of the patent application process and protects the interests of applicants and patent owners.

To learn more:

What is the significance of the ‘365(c)’ filing date in claiming benefit of a nonprovisional application?

The ‘365(c)’ filing date is crucial when claiming the benefit of a nonprovisional application that was filed as a PCT application and entered the national stage. According to MPEP 211.01(b):

‘If the prior nonprovisional application is an international application that was filed as a PCT application and entered the national stage under 35 U.S.C. 371, the 365(c) filing date of the international application is the filing date to be used in determining copendency.’

This means that when determining if applications are copendent for benefit claims, the PCT filing date (365(c) date) is used rather than the U.S. national stage entry date. This can be significant for maintaining continuous priority chains in international patent applications.

To learn more:

The ‘[R-]’ notation after ‘MPEP 212 [Reserved]’ typically indicates that this section has been revised. However, in this case, since the section is reserved and empty, the ‘[R-]’ may be a placeholder for future revision dates. When a substantive revision occurs, a date is usually added after the ‘R’, such as ‘[R-10.2019]’ to indicate an October 2019 revision.

September 16, 2012, is a significant date in patent application assignments, particularly for applications claiming the benefit of a provisional application. The MPEP states:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

This date marks a change in assignment requirements. For applications filed on or after September 16, 2012, if the assignee is the original applicant, new assignment papers may not be necessary even if the application includes subject matter not common with the provisional application. This change aligns with broader reforms introduced by the America Invents Act (AIA) that came into effect on that date.

Regional patent offices play a crucial role in the international patent system, particularly for priority claims. MPEP 213.01 recognizes several regional patent offices whose applications can serve as the basis for priority claims in the United States. These include:

  • European Patent Office (EPO)
  • Eurasian Patent Office (EAPO)
  • African Intellectual Property Organization (OAPI)
  • African Regional Intellectual Property Organization (ARIPO)

The significance of these regional offices is explained in MPEP 213.01:

‘The United States will recognize claims for right of priority based on applications filed under such multilateral international agreements as the European Patent Convention (EPC) and the Patent Cooperation Treaty (PCT).’

This recognition allows applicants to file a single application with a regional patent office and still maintain priority rights in the United States. It streamlines the international patent application process and provides more flexibility for inventors seeking protection in multiple countries.

Recording patent assignments at the United States Patent and Trademark Office (USPTO) is crucial for several reasons:

  • Legal Protection: It provides legal protection against subsequent purchasers or mortgagees.
  • Official Recognition: The USPTO recognizes the assignee for all matters before the Office.
  • Public Notice: It serves as public notice of the assignment.

According to MPEP 301:

An assignment relating to a patent must be recorded in the Patent and Trademark Office within 3 months from its date or prior to the date of a subsequent purchase or mortgage, in order to be effective against a subsequent purchaser or mortgagee.

Recording assignments promptly is essential to ensure full legal protection and recognition of ownership rights.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

Recording a patent assignment with the USPTO is crucial for several reasons:

  1. Legal Notice: It provides public notice of the assignment, which is important for establishing priority against subsequent purchasers or mortgagees.
  2. Prima Facie Evidence: As stated in MPEP 301.01, ‘The recording of an assignment with the USPTO is prima facie evidence of its execution.’
  3. Chain of Title: It helps maintain a clear chain of title for the patent or application.
  4. Enforcement Rights: Proper recording can affect the ability to enforce patent rights or collect damages in infringement cases.

The MPEP emphasizes the importance of recording by stating, ‘An assignment must be recorded in the USPTO within three months from its date or prior to the date of a subsequent purchase or mortgage to be valid against a subsequent purchaser or mortgagee.’ This underscores the time-sensitive nature of recording assignments to protect legal rights.

Pre-AIA 35 U.S.C. 118 is significant in determining what constitutes a valid assignment or sufficient proprietary interest for filing a patent application. According to MPEP 409.03(f):

“An assignment to a pre-AIA 37 CFR 1.47(b) applicant for the sole purpose of obtaining a filing date for a pre-AIA 37 CFR 1.47(b) application is not considered an assignment within the meaning of pre-AIA 35 U.S.C. 118 and pre-AIA 37 CFR 1.47(b).”

This means that a mere pro forma assignment created solely to comply with filing requirements is not sufficient to establish proprietary interest under pre-AIA 35 U.S.C. 118. The assignment or proprietary interest must be substantive and reflect a genuine transfer of rights or interest in the invention.

When demonstrating proprietary interest, applicants must show that their claim to the invention would be recognized under applicable law, not just that they have fulfilled a procedural requirement.

To learn more:

To learn more:

MPEP 402.08 has important implications for independent inventors involved in interference proceedings. The key provision states:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

For independent inventors, this means:

  • Changes in legal representation during an interference proceeding must be approved by the PTAB.
  • There may be additional complexity and potential delays in changing attorneys.
  • Inventors should carefully consider the timing of any representation changes.
  • Direct communication with the PTAB may be necessary regarding power of attorney matters.

Independent inventors should be aware of these special procedures to navigate interference proceedings effectively and ensure proper legal representation throughout the process.

To learn more:

To learn more:

Keeping assignment documents separate from patent application files is significant for several reasons. MPEP 318 mandates this separation:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The significance of this practice includes:

  • Maintaining clear distinction between technical content and ownership information
  • Ensuring proper recording and indexing of assignment documents
  • Facilitating easier searches for patent ownership information
  • Reducing the risk of confidential ownership information being inadvertently disclosed
  • Allowing for more efficient management of ownership changes throughout a patent’s lifecycle
  • Enabling the Assignment Division to specialize in handling ownership matters

This separation streamlines both the patent examination process and the management of patent ownership records.

Filing dates are crucial in patent law as they establish priority and can affect the patentability of an invention. The MPEP 201.02 discusses various application types and their relationship to filing dates:

  • Original applications (including first filings and continuing applications) generally retain their filing date for priority purposes.
  • Continuing applications (continuations, divisionals, and continuations-in-part) can benefit from the filing date of the parent application under specific conditions outlined in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.
  • Substitute applications, however, do not obtain the benefit of the filing date of the prior application.

The MPEP states:

A substitute application does not obtain the benefit of the filing date of the prior application.

This emphasizes the importance of maintaining active applications and understanding the implications of different application types on priority dates.

For more information on continuing applications, visit: continuing applications.

For more information on patent applications, visit: patent applications.

What is the significance of copendency in continuation applications?

Copendency is a crucial requirement for continuation applications. It refers to the condition where the continuation application is filed before the prior application is patented, abandoned, or terminated. The MPEP 201.07 states:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement; and the later-filed application must be copending with the prior application.’

The significance of copendency includes:

  • Maintaining Priority: It ensures the continuation application can claim the benefit of the earlier filing date.
  • Unbroken Chain: It maintains an unbroken chain of applications, which is essential for establishing a continuous line of priority.
  • Preventing Loss of Rights: Filing a continuation before the parent application is concluded prevents the loss of patent rights that could occur if new claims are needed after the parent application is no longer pending.

Failure to maintain copendency can result in the loss of the earlier priority date, potentially affecting the patentability of the invention if intervening prior art exists.

For more information on continuation application, visit: continuation application.

For more information on copendency, visit: copendency.

For more information on patent priority, visit: patent priority.

Claiming benefit to a prior application is crucial for divisional applications as it allows the divisional to retain the earlier filing date of the parent application. This can be significant for:

  • Establishing priority over potential prior art
  • Extending the potential patent term
  • Maintaining continuity in the patent family

The MPEP ¶ 2.01 states:

“Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

To properly claim this benefit, applicants must comply with the requirements set forth in 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211, which include making a proper benefit claim and ensuring continuity of disclosure.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Adding new disclosure in a continuation-in-part (CIP) application is a key characteristic that distinguishes it from other types of continuing applications. The MPEP ¶ 2.06 describes a CIP as an application that:

repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application.

The significance of adding new disclosure includes:

  • Allowing applicants to expand on their original invention with new developments or improvements
  • Potentially broadening the scope of patent protection
  • Creating a new filing date for the added material, which can be crucial for overcoming prior art
  • Possibly extending the patent term for the new material

However, it’s important to note that the new disclosure will not benefit from the earlier filing date of the prior application. This can affect patentability if relevant prior art emerges between the filing dates of the original application and the CIP.

For more information on prior art, visit: prior art.

Tags: prior art

What is the significance of a power of attorney in patent applications?

A power of attorney is a crucial document in patent applications that authorizes an attorney or agent to act on behalf of the applicant or assignee. According to MPEP 402.04, “A power of attorney may be filed in an individual application, either original or reissue, and in any national stage application.” This document allows the designated representative to make decisions, file documents, and communicate with the USPTO on behalf of the applicant. It’s important to note that the power of attorney must be properly executed and filed to be effective.

To learn more:

What is the significance of a national application being made under 35 U.S.C. 111?

A national application made under 35 U.S.C. 111 signifies that it is filed directly with the United States Patent and Trademark Office (USPTO) and follows the standard U.S. patent application process.

The MPEP 201.01 states: ‘A national application is one that was filed in the United States Patent and Trademark Office (USPTO) under 35 U.S.C. 111.’ This means that the application is subject to U.S. patent laws and procedures from the outset.

Applications filed under 35 U.S.C. 111 include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Design applications
  • Plant applications
  • Provisional applications

These applications are distinct from international applications that enter the national stage in the U.S. under 35 U.S.C. 371.

For more information on patent application types, visit: patent application types.

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

What is the significance of a customer number in USPTO correspondence?

A customer number is a crucial tool for managing correspondence with the USPTO. According to MPEP 403:

‘A customer number allows an applicant, attorney or agent to easily change the correspondence address for a number of applications or patents by simply requesting a change to the address associated with the customer number.’

Key benefits of using a customer number include:

  • Streamlined correspondence management for multiple applications
  • Easy updates to address information
  • Efficient access to application information through USPTO systems

By using a customer number, patent professionals can significantly simplify their administrative processes when dealing with the USPTO.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

What is the significance of a customer number in patent applications filed after September 16, 2012?

A customer number holds significant importance in patent applications filed after September 16, 2012, particularly for managing practitioner representation. Here’s why:

  • It allows for efficient management of multiple practitioners
  • Power of attorney can be given to a customer number
  • It simplifies the process of adding or removing practitioners
  • Correspondence address can be associated with a customer number

According to MPEP 403.01(a): ‘A power of attorney or authorization of agent may be given to a customer number in applications filed on or after September 16, 2012.’ This provision streamlines the process of managing representation for applicants and practitioners alike.

Furthermore, the MPEP states: ‘If a practitioner is not of record, correspondence will be sent to the applicant’s correspondence address as shown in the application or the Patent Application Locating and Monitoring (PALM) system.’ This underscores the importance of keeping the customer number and associated information up to date.

To learn more:

A Customer Number is a unique identifier assigned by the USPTO that can be associated with a correspondence address. It offers several advantages in managing patent application correspondence:

  • Simplified address changes: You can update the address for multiple applications at once by changing the address associated with the Customer Number.
  • Priority in address selection: When multiple addresses are provided, the USPTO may prioritize the address associated with a Customer Number.
  • Easier access to Patent Application Information Retrieval (PAIR) system: Customer Numbers can be used to access multiple applications in PAIR.

37 CFR 1.33(a) states: If more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

Using a Customer Number can streamline communication with the USPTO and make it easier to manage multiple patent applications.

To learn more:

37 CFR 11.18 is a crucial regulation that governs signature and certification requirements for correspondence filed with the USPTO. Its significance includes:

  • Establishing signature requirements for practitioners
  • Defining certifications made when submitting papers
  • Setting standards for truthfulness and proper purpose in filings
  • Outlining potential consequences for violations

The MPEP emphasizes its importance: “The certifications in 37 CFR 11.18(b) apply to all papers filed in the Office, including allegations of improper conduct made by a registered practitioner in any Office proceeding.”

This regulation helps maintain the integrity of the patent application process and ensures that all parties involved are held to high ethical and legal standards.

To learn more:

To learn more:

37 CFR 1.55(h) provides an important provision for satisfying the requirement for a certified copy of a foreign application. Key points include:

  • It allows the certified copy requirement to be met through a prior-filed nonprovisional application.
  • The prior-filed application must be one for which benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • The prior-filed application must contain the certified copy and be identified as such.
  • This provision can simplify the process of perfecting priority claims in related applications.

The MPEP states: 37 CFR 1.55(h) provides that the requirement for a certified copy of the foreign application will be considered satisfied in an application if a prior-filed nonprovisional application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c) contains a certified copy of the foreign application and the prior-filed nonprovisional application is identified as containing a certified copy of the foreign application.

This provision can be particularly useful when requesting a certificate of correction to perfect a priority claim in a patent that claims benefit from an earlier application containing the certified copy.

Applications filed under 37 CFR 1.53(d) have a unique treatment of affidavits and declarations. According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

Key points about 37 CFR 1.53(d) applications:

  • They are continuation or divisional applications of a nonprovisional application
  • Affidavits and declarations from the parent application are automatically incorporated
  • This includes documents submitted under 37 CFR 1.130, 1.131, and 1.132
  • No additional action is required to include these documents in the new application

This automatic incorporation simplifies the process for applicants filing continuation or divisional applications under 37 CFR 1.53(d).

For more information on continuation applications, visit: continuation applications.

For more information on patent prosecution, visit: patent prosecution.

37 CFR 1.46 is significant in patent application prosecution, particularly for applications filed on or after September 16, 2012. According to MPEP 106.01, this regulation allows the assignee of record of the entire interest to become the applicant and prosecute the application.

The MPEP states: ‘…for applications filed on or after September 16, 2012, [the assignee] can prosecute the application after becoming the applicant under 37 CFR 1.46.’

This regulation is part of the changes implemented by the America Invents Act (AIA) and provides more flexibility for assignees in managing patent applications.

35 U.S.C. 386 establishes the right of priority for international design applications. It addresses two key scenarios:

  1. National applications claiming priority from international design applications
  2. International design applications claiming priority from prior foreign applications

The MPEP explains:

“Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.”

“Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.”

These provisions apply to applications filed on or after May 13, 2015, and patents issued from such applications.

35 U.S.C. 111(a) and (b) are important sections of the patent law that define two different types of national patent applications. According to MPEP 201.01:

‘National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’

To elaborate:

  • 35 U.S.C. 111(a) refers to nonprovisional applications. These are full patent applications that can potentially result in an issued patent.
  • 35 U.S.C. 111(b) refers to provisional applications. These are simplified applications that establish a priority date but do not themselves result in an issued patent.

The choice between filing under 111(a) or 111(b) depends on the inventor’s strategy and readiness to pursue full patent protection. Provisional applications (111(b)) provide a way to quickly establish a priority date, while nonprovisional applications (111(a)) begin the formal examination process.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

‘Limited recognition’ is a specific status granted by the USPTO that allows certain individuals to practice patent law in a restricted capacity. Its significance includes:

  • Allowing non-registered practitioners to represent applicants in specific circumstances.
  • Providing a pathway for Canadian patent agents to represent Canadian applicants.
  • Restricting the scope of practice to specific types of applications or applicants.

The MPEP 402.01 states: Limited recognition to practice in patent cases means recognition to practice before the Office in patent cases, or in a limited capacity as a patent agent, as appropriate… This status ensures that certain practitioners can assist applicants while maintaining the integrity of the USPTO’s registration system.

To learn more:

Tags: USPTO

What is the significance of ‘facts showing the right’ in proving proprietary interest?

The phrase ‘facts showing the right’ is crucial in proving proprietary interest for patent applications. According to MPEP 409.03(f):

‘Facts showing the right or authority to make the petition must be proved in accordance with 37 CFR 1.46.’

This means that:

  • Applicants must provide concrete evidence demonstrating their right to file and prosecute the patent application.
  • The evidence should clearly establish the applicant’s legal authority or ownership of the invention.
  • These facts are essential for the USPTO to determine if the applicant has the proper standing to proceed with the application.

Examples of such facts might include:

  • Documentation of employment agreements assigning invention rights to an employer
  • Contracts showing transfer of rights from inventors to the applicant
  • Court orders establishing ownership in cases of disputes

The significance of these ‘facts showing the right’ is that they protect the interests of all parties involved and ensure that patent rights are granted to the rightful owners or their authorized representatives.

To learn more:

A Secrecy Order applies to the subject matter of the invention, not just the patent application itself. It restricts disclosure or publication of the invention in any form. Other related patent applications which contain any significant part of the subject matter also fall under the scope of the order and must be brought to the USPTO’s attention. (MPEP 120 Section II)

The scope of a foreign filing license can vary depending on how it was obtained:

  • Licenses granted through the filing of a US application (implicit petition) typically have a broad scope as defined in 37 CFR 5.15(a).
  • Licenses granted through explicit petitions may have a narrower scope as defined in 37 CFR 5.15(b).
  • Licensees with a narrow scope can petition to convert to a broader scope under 37 CFR 5.15(c).

As stated in the MPEP: “The scope of any license granted on these petitions is indicated on the license. Petitions under 37 CFR 5.14(a) or (b) as well as any license granted on the petition are made of record in the application file.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

The USPTO Mail Center plays a crucial role in the initial handling of models, exhibits, and specimens submitted with patent applications. According to MPEP 608.03(a):

Models, exhibits, or specimens initially delivered to the Mail Center will be forwarded by the Mail Center to the model custodian, who will then contact the Technology Center (TC) model custodian for pick-up by the appropriate TC.

The process involves several steps:

  • The Mail Center receives the items along with the application.
  • Items are forwarded to the model custodian.
  • The model custodian contacts the Technology Center (TC) model custodian.
  • The appropriate TC picks up the items for further processing.

This system ensures that models, exhibits, and specimens are properly routed and handled within the USPTO, maintaining their integrity throughout the examination process.

To learn more:

What is the role of the Technology Center in handling status inquiries?

Technology Centers (TCs) play a specific role in handling certain types of status inquiries. MPEP 203.08 states:

“Inquiries which cannot be answered by the UCC will be forwarded to the TC for response.”

This means that more complex or specific inquiries that require expertise in a particular technological area are directed to the appropriate TC. TCs have access to more detailed information about applications in their field and can provide more specific guidance within the limits of USPTO policy.

To learn more:

The Assignment Division plays a crucial role in handling patent assignment documents. According to MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The Assignment Division’s responsibilities include:

  • Receiving assignment documents for patents and patent applications
  • Recording these documents in the USPTO’s assignment database
  • Maintaining accurate records of patent ownership and transfers
  • Ensuring that assignment information is searchable and accessible
  • Processing requests for copies of recorded documents

By centralizing these functions, the USPTO can maintain a comprehensive and up-to-date record of patent ownership separate from the technical aspects of patent prosecution.

The Assignment Division plays a crucial role in handling patent assignments at the USPTO. As indicated in MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The Assignment Division’s responsibilities include:

  • Receiving assignment documents submitted for recording
  • Properly recording and maintaining assignment records
  • Ensuring the accuracy and accessibility of ownership information
  • Managing the assignment database separate from application and patent files

This specialized division ensures that patent ownership information is correctly documented and readily available when needed.

To learn more:

While the initial screening for sensitive subject matter is performed by designated personnel, patent examiners also play a crucial role in this process. The MPEP states:

While the initial screening is performed only by designated personnel, all examiners have a responsibility to be alert for obviously sensitive subject matter either in the original disclosure or subsequently introduced, for example, by amendment.

If an examiner identifies potentially sensitive subject matter, they are instructed to take action:

If the examiner is aware of subject matter which should be subject to screening by appropriate office personnel, this should be brought to the attention of Licensing and Review.

This ongoing vigilance by examiners helps ensure that sensitive information is not inadvertently disclosed, even if it was not identified during the initial screening process.

For more information on Patent examiners, visit: Patent examiners.

The examiner plays a crucial role in processing requests to delete a named inventor in a Continued Prosecution Application (CPA) for design applications. According to MPEP ¶ 2.32, the examiner is responsible for acknowledging the receipt of the request and confirming that the inventorship has been corrected. The MPEP provides the following guidance for examiners:

“Examiner Note: 1. Use this form paragraph where a Continued Prosecution Application (CPA) is filed accompanied by a statement requesting deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the new application.”

The examiner must verify that the request was submitted with the CPA filing and use the appropriate form paragraph to acknowledge the correction of inventorship. If the request is made after the CPA filing, the examiner must ensure it’s accompanied by a request under 37 CFR 1.48, as per the MPEP instructions.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent procedure, visit: patent procedure.

What is the role of an assignee in a patent application?

An assignee is an entity or person to whom the inventor has transferred some or all rights to the patent. While an assignee cannot be named as the applicant for patent applications filed on or after September 16, 2012, they still play important roles in the patent process. According to MPEP 605: ‘The assignee… may sign the patent application papers if the assignee is an applicant (i.e., the assignee has been named as the applicant for the patent application in the application data sheet).’ This means that while the inventor(s) must be named as the applicant(s), an assignee can sign certain documents and may have rights to the patent once it’s granted.

To learn more:

An affidavit plays a crucial role in proving the unavailability or refusal of a non-signing inventor. The MPEP 409.03(d) states:

An affidavit or declaration of the applicant, or his/her attorney or agent, explaining the situation and stating the last known address of the non-signing inventor, may be sufficient to establish that the inventor cannot be found or reached after diligent effort or has refused to execute the application papers.

The affidavit should:

  • Provide a detailed account of efforts to locate or communicate with the inventor
  • Include dates, methods of contact attempted, and results
  • Explain any refusal circumstances if applicable
  • Be signed under oath or declaration

This sworn statement serves as a formal record of the applicant’s diligent efforts and is considered by the USPTO in determining the validity of the proof of unavailability or refusal.

To learn more:

An administrator plays a crucial role in filing a patent application for a deceased inventor. According to MPEP 409.01(b):

If the inventor was not of sound mind and legally incapacitated at the time the application was made, it may be signed by a legal representative (e.g., guardian), the inventor’s legal representative (e.g., executor, administrator, etc.), or someone acting on behalf of the inventor or legal representative.

The administrator’s responsibilities include:

  • Representing the deceased inventor’s estate
  • Signing necessary documents on behalf of the deceased inventor
  • Providing proof of their authority to act as administrator
  • Ensuring the application process complies with legal requirements

It’s important to note that the administrator must have the legal authority to act on behalf of the deceased inventor’s estate.

To learn more:

An ‘obligated assignee’ is a person or entity who has a contractual obligation to assign the rights to an invention but has not yet done so. According to MPEP 409.05, an obligated assignee can file a patent application on behalf of the inventor if they meet certain requirements:

  • They must have a contractual obligation with the inventor to assign the entire right, title, and interest in the application.
  • They must file an application data sheet under 37 CFR 1.76 naming the inventor and including a statement that the application is being filed by the obligated assignee.

The MPEP states: ‘An assignee who is not the original applicant may file a patent application as long as the application is accompanied by a statement that establishes the assignee’s ownership interest.’ This provision allows obligated assignees to initiate the patent process even before the formal assignment has taken place.

To learn more:

A patent practitioner plays a crucial role in signing micro entity certifications. According to MPEP 509.04(c), a patent practitioner can sign a micro entity certification in two capacities:

  1. As a patent practitioner of record
  2. As a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34

Moreover, for juristic entities, “Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.” This includes micro entity certifications for corporate assignees or other organizational parties under 37 CFR 1.46.

To learn more:

What is the role of a patent practitioner during an interview with the USPTO?

A patent practitioner plays a crucial role during an interview with the USPTO. According to MPEP 408, the practitioner is responsible for:

  • Representing the applicant or patent owner
  • Discussing the merits of the application or patent
  • Providing clarifications on the invention
  • Negotiating potential claim amendments
  • Addressing any concerns raised by the examiner

The MPEP states: ‘Interviews must be conducted on the Office premises, such as in examiner’s offices, conference rooms or the video conference centers.’ This underscores the formal nature of these interactions and the importance of the practitioner’s role in facilitating productive discussions with the examiner.

For more information on patent examination, visit: patent examination.

What is the role of a legal representative in filing a patent application for a deceased inventor?

A legal representative plays a crucial role in filing a patent application for a deceased inventor. According to MPEP 409.03(b):

“The legal representative (executor, administrator, etc.) of a deceased inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative’s responsibilities include:

  • Executing the necessary oath or declaration on behalf of the deceased inventor
  • Providing proof of their authority to act (e.g., Letters Testamentary or Letters of Administration)
  • Submitting the patent application and all required documents to the USPTO
  • Corresponding with the USPTO throughout the application process
  • Potentially assigning the patent rights if required by the deceased inventor’s will or other legal arrangements

It’s important to note that the legal representative must act in accordance with the law and the best interests of the deceased inventor’s estate.

To learn more:

The legal representative of a deceased inventor plays a crucial role in the patent application process. According to MPEP 409.01:

If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or representatives of the deceased inventor.

The legal representative’s responsibilities include:

  • Executing the oath or declaration on behalf of the deceased inventor
  • Providing documentation of their authority to act on behalf of the deceased inventor’s estate
  • Continuing the prosecution of the patent application
  • Receiving the granted patent on behalf of the deceased inventor’s estate

It’s important to note that the legal representative must be properly appointed according to state laws governing estate administration.

To learn more:

The right of priority in international patent law refers to the right to rely on a foreign application when filing a patent application in another country. This concept originated in the Paris Convention for the Protection of Industrial Property, which the United States adhered to in 1887.

As stated in the MPEP: The right to rely on a foreign application is known as the right of priority in international patent law and this phrase has been adopted in the U.S. statute. This right allows applicants to claim the filing date of an earlier foreign application, providing certain conditions are met.

To learn more:

The right of priority allows an applicant who has filed a patent application in a foreign country to claim priority to that earlier filing date when filing a subsequent U.S. application for the same invention. This right is established by 35 U.S.C. 119 and gives the U.S. application the benefit of the earlier foreign filing date, as long as certain conditions are met.

Specifically, 35 U.S.C. 119(a) states: “An application for patent for an invention filed in this country by any person who has, or whose legal representatives or assigns have, previously regularly filed an application for a patent for the same invention in a foreign country which affords similar privileges in the case of applications filed in the United States or to citizens of the United States, or in a WTO member country, shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country, if the application in this country is filed within 12 months from the earliest date on which such foreign application was filed.”

The Patent Law Treaties Implementation Act (PLTIA) introduced the concept of restoration of the right of priority. This provision allows applicants to file a subsequent application and still claim priority or benefit even if they missed the standard 12-month deadline (6-month for design applications).

As stated in the MPEP: Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. (MPEP 210)

Key points about restoration of the right of priority:

  • It applies to both foreign priority claims and domestic benefit claims to provisional applications.
  • The subsequent application must be filed within 14 months from the filing date of the prior foreign application or provisional application (8 months for design applications).
  • The delay in filing the subsequent application must be unintentional.
  • A petition for restoration of the right of priority must be filed.

The specific requirements and procedures for restoration of the right of priority are outlined in 37 CFR 1.55(c) for foreign priority claims and 37 CFR 1.78(b) for domestic benefit claims.

For more information on PLTIA, visit: PLTIA.

For more information on unintentional delay, visit: unintentional delay.

For a valid foreign priority claim, the U.S. application and the foreign application must name the same inventor or have at least one joint inventor in common. This requirement ensures that the right of priority is properly linked between the applications.

As stated in MPEP 213.02: “Pursuant to 35 U.S.C. 119(a), the foreign application must have been filed by the same applicant as the applicant in the United States, or by applicant’s legal representatives or assigns. Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.”

The MPEP further clarifies: “Joint inventors A and B in a nonprovisional application filed in the United States Patent and Trademark Office may properly claim the benefit of an application filed in a foreign country by A and another application filed in a foreign country by B, i.e., A and B may each claim the benefit of their foreign filed applications.”

This requirement ensures that the priority right is properly linked to the inventive entity responsible for the invention in both the foreign and U.S. applications.

For more information on foreign priority, visit: foreign priority.

For more information on joint inventors, visit: joint inventors.

For a valid foreign priority claim, the U.S. application must have at least one common inventor with the foreign application. This requirement ensures that the right of priority is only available to the actual inventors or their legal representatives.

As stated in MPEP 213.02: “Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.”

This means that:
1. A sole inventor in the U.S. can claim priority to a foreign application where they are the sole inventor or one of joint inventors.
2. Joint inventors in the U.S. can claim priority to a foreign application filed by any one or more of them.
3. A U.S. application cannot claim priority to a foreign application with completely different inventors.

It’s important to note that while the inventorship must overlap, it doesn’t have to be identical between the U.S. and foreign applications.

In applications filed pursuant to pre-AIA 37 CFR 1.47, it is mandatory to state the last known address of the nonsigning inventor. The MPEP states:

‘An application filed pursuant to pre-AIA 37 CFR 1.47 must state the last known address of the nonsigning inventor.’

This requirement ensures that the USPTO can attempt to contact the nonsigning inventor regarding the application filed on their behalf.

To learn more:

To learn more:

Tags: pre-AIA

The USPTO requires that different matters be submitted in separate papers to ensure efficient processing. This requirement is outlined in MPEP 501, which cites 37 CFR 1.4(c):

Since different matters may be considered by different branches or sections of the Office, each distinct subject, inquiry or order must be contained in a separate paper to avoid confusion and delay in answering papers dealing with different subjects.

This means that if you have multiple requests or inquiries for the USPTO, each should be submitted on its own separate document. For example, a petition and an information disclosure statement should not be combined into a single paper.

If an applicant submits a single paper containing distinct subjects, the USPTO may use the following form paragraph to notify them:

The [1] submitted [2] should have been submitted as a separate paper as required by 37 CFR 1.4(c). The paper has been entered. However, all future correspondence must comply with 37 CFR 1.4.

Adhering to this requirement helps ensure that your correspondence is processed efficiently and reaches the appropriate department within the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO correspondence, visit: USPTO correspondence.

When claiming foreign priority, applicants are generally required to file a certified copy of the foreign application within a specified time period. The requirements and deadlines for filing the certified copy depend on the type of application and the circumstances of the filing.

According to MPEP 213.04: “37 CFR 1.55(g) sets forth the requirements for filing a priority claim, certified copy of foreign application, and translation that are applicable in all applications.”

Key points about the certified copy requirement include:

  • The certified copy must be filed within the pendency of the application, unless filed with a petition.
  • For applications filed under 35 U.S.C. 111(a), the certified copy must typically be filed within the later of four months from the actual filing date or sixteen months from the filing date of the prior foreign application.
  • For national stage applications under 35 U.S.C. 371, the certified copy must be filed within the time limit set forth in the PCT and the Regulations under the PCT.
  • If the certified copy is not filed within the required time period, it must be accompanied by a petition and fee, along with a showing of good and sufficient cause for the delay.
  • In some cases, the requirement may be satisfied through the priority document exchange program or by identifying a previously filed application containing the certified copy.

The MPEP also notes: “If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.”

For more information on certified copy, visit: certified copy.

For more information on filing requirements, visit: filing requirements.

For more information on foreign application, visit: foreign application.

When citing documents in a language other than English in an Information Disclosure Statement (IDS), you must provide:

  • The original document in the foreign language
  • A concise explanation of the relevance in English, if not already available

According to MPEP 609.04(a): If a foreign patent document or non-patent literature document is in a language other than English, an English language translation should be submitted along with the document if an English language translation is readily available to the applicant.

Additionally, Where the information listed is not in the English language, but was cited in a search report or other action by a foreign patent office in a counterpart foreign application, the requirement for a concise explanation of relevance can be satisfied by submitting an English-language version of the search report or action which indicates the degree of relevance found by the foreign office.

To learn more:

When a claim discloses subject matter not shown in the drawing or described in the description, the applicant may be required to amend the drawing and description. However, this requirement is contingent on the claim providing sufficiently specific and detailed disclosure. The MPEP 608.01(l) states: “It is, of course, to be understood that this disclosure in the claim must be sufficiently specific and detailed to support the necessary amendment of the drawing and description.” This means that the claim must provide enough information to enable a person skilled in the art to make the necessary amendments to the drawings and description.

To learn more:

What is the required oath or declaration for a divisional application?

For a divisional application, a new oath or declaration is generally required. However, there are exceptions:

  • If the application is filed on or after September 16, 2012, a copy of the oath or declaration from the prior nonprovisional application may be used, provided that it complies with 37 CFR 1.63, 1.64, or 1.67 for the divisional application.
  • If the divisional application was filed before September 16, 2012, and the prior application was filed on or after September 16, 2012, a copy of the oath or declaration from the prior application can be used in the divisional application.

As stated in MPEP 201.06: “A new oath or declaration is required in a divisional application filed under 37 CFR 1.53(b), regardless of whether a copy of the oath or declaration from the prior nonprovisional application is used in the divisional application, unless the divisional application is filed on or after September 16, 2012.”

To learn more:

MPEP 409.03(f) is not applicable to patent applications filed on or after September 16, 2012. This is clearly stated at the beginning of the section:

“[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012. See MPEP §§ 325, 409.05, and 605 for information pertaining to applications for patent filed on or after September 16, 2012 by an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter.]”

For applications filed on or after September 16, 2012, applicants should refer to:

These sections provide guidance on how assignees, obligated assignees, or persons with sufficient proprietary interest can file patent applications under the current law.

To learn more:

To learn more:

The relationship between the specification and claims in a patent application is crucial. As indicated in MPEP 608.01(k), “35 U.S.C. 112 requires that the specification shall particularly point out and distinctly claim the subject matter which the inventor or joint inventor regards as his or her invention.”

This means:

  • The specification provides a detailed description of the invention
  • The claims, which are part of the specification, define the legal scope of protection
  • The claims must be supported by the description in the specification
  • The specification should enable a person skilled in the art to make and use the invention as claimed

In essence, the specification provides the context and detailed explanation of the invention, while the claims define the specific elements for which legal protection is sought.

To learn more:

The detailed description and the claims in a patent application have a crucial interdependent relationship. According to MPEP 608.01(g):

“The description is a dictionary for the claims and should provide clear support or antecedent basis for all terms used in the claims.”

This relationship is characterized by several key aspects:

  • Support for Claims: The detailed description must provide sufficient information to support all the elements mentioned in the claims.
  • Antecedent Basis: Terms used in the claims should be introduced and explained in the description, establishing an antecedent basis.
  • Illustration Requirement: As stated in MPEP 608.01(g), “Every feature specified in the claims must be illustrated.”
  • Clarity and Enablement: The description should enable a person skilled in the art to understand and implement the claimed invention without undue experimentation.
  • Consistency: The terminology used in the claims should be consistent with that used in the description.

For more information on the relationship between claims and the specification, refer to MPEP § 608.01(o) and § 2111.01. Maintaining a clear and supportive relationship between the description and claims is essential for a strong and enforceable patent.

To learn more:

What is the relationship between priority claims and the effective filing date?

The relationship between priority claims and the effective filing date is crucial in determining the patentability of an invention. According to MPEP 216:

“The effective filing date of a claimed invention is determined on a claim-by-claim basis and not an application-by-application basis.”

This means that each claim in a patent application may have a different effective filing date, depending on its content and the priority claims it can support. The effective filing date is important because it determines which prior art can be used against the claim during examination and potential litigation.

  • If a claim is fully supported by an earlier application, its effective filing date may be the filing date of that earlier application.
  • If a claim contains new matter not disclosed in any earlier application, its effective filing date will be the actual filing date of the current application.

Understanding this relationship is crucial for inventors and patent practitioners to properly claim priority and protect their inventions.

For more information on effective filing date, visit: effective filing date.

What is the relationship between a provisional application and a nonprovisional application?

A provisional application serves as a placeholder for a later-filed nonprovisional application. According to MPEP 201.04:

“A provisional application may serve as a basis for claiming benefit under 35 U.S.C. 119(e) in a later filed nonprovisional application or an international application designating the United States.”

This means that a provisional application can establish an earlier filing date for a subsequent nonprovisional application, provided the nonprovisional is filed within 12 months of the provisional and properly claims benefit to it.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

What is the relationship between a divisional application and its parent application?

A divisional application is closely related to its parent application, as it stems from the same invention disclosure. According to MPEP 201.06, “A divisional application is a later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application.” This means that:

  • The divisional application contains a subset of the subject matter from the parent application.
  • It claims an independent or distinct invention from what is claimed in the parent application.
  • It cannot introduce new matter beyond what was disclosed in the parent application.
  • It can claim the benefit of the parent application’s filing date.

The relationship allows for separate prosecution of different aspects of an invention while maintaining the priority date of the original disclosure.

To learn more:

What is the relationship between a divisional application and a restriction requirement?

A divisional application is often filed in response to a restriction requirement issued by the USPTO. The MPEP 201.06 explains:

“A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.'”

The relationship between a divisional application and a restriction requirement is as follows:

  • When an examiner determines that a single application contains two or more independent or distinct inventions, they may issue a restriction requirement.
  • The applicant must then elect one invention to pursue in the original application.
  • The non-elected invention(s) can be pursued in one or more divisional applications.
  • Divisional applications allow applicants to protect multiple inventions disclosed in a single parent application without violating the principle of double patenting.

It’s important to note that while divisional applications are often filed in response to restriction requirements, they can also be filed voluntarily if the applicant recognizes distinct inventions in their application before receiving a restriction requirement.

To learn more:

What is the relationship between a divisional application and a continuation application?

Divisional applications and continuation applications are both types of continuing applications, but they serve different purposes. The MPEP 201.06 provides insight into the nature of divisional applications:

“A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.'”

In contrast, a continuation application typically contains the same disclosure as the parent application but with different claims. The key differences are:

  • Divisional Application: Filed to pursue distinct inventions that were subject to a restriction requirement in the parent application.
  • Continuation Application: Filed to pursue additional aspects of the same invention disclosed in the parent application.

Both types of applications claim the benefit of the parent application’s filing date, but they differ in their purpose and the scope of claims they can contain. It’s important to choose the appropriate type of continuing application based on the specific circumstances and inventive concepts you wish to protect.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

What is the relationship between a continuation-in-part application and its parent application?

A continuation-in-part (CIP) application is a type of patent application that has a unique relationship with its parent application. According to MPEP 201.08:

“A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.”

This means that a CIP application:

  • Contains some or all of the subject matter from the parent application
  • Introduces new subject matter not present in the parent application
  • Must be filed while the parent application is still pending

The relationship between a CIP and its parent is important for determining priority dates and the scope of patent protection.

For more information on new matter, visit: new matter.

For more information on parent application, visit: parent application.

35 U.S.C. 119(e) is crucial in understanding the relationship between provisional applications and their non-provisional counterparts, particularly in terms of assignments. The MPEP § 306.01 states:

If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

This means:

  • 35 U.S.C. 119(e) allows non-provisional applications to claim the benefit of an earlier filing date from a provisional application.
  • When a non-provisional application claims this benefit and contains only subject matter from the provisional, the assignment recorded for the provisional application remains effective for the non-provisional.
  • This treatment aligns with how assignments are handled for continuations and divisions under 35 U.S.C. 120.

However, if new subject matter is introduced in the non-provisional application, different assignment rules may apply, as detailed in other parts of MPEP § 306.01.

According to MPEP 317.01, the recording date for a patent document is defined as follows:

“The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.”

This means that the recording date is established when a document that complies with all the necessary requirements is received by the United States Patent and Trademark Office (USPTO).

To learn more:

The recording date for a document at the USPTO is the date when the document meeting all recording requirements is filed with the Office. As stated in 37 CFR 3.51, “The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.” This means that all necessary criteria, including proper identification and fees, must be met for the document to be officially recorded on that date.

The recording date for a document at the USPTO Assignment Division is determined as follows:

  • It is the date when a document meeting all requirements is filed with the Office.
  • Documents not complying with identification requirements (37 CFR 3.21) will not be recorded.
  • Documents with other deficiencies (e.g., missing cover sheet or fee) will be returned for correction.
  • If corrected and resubmitted within the specified time, the original receipt date may be considered the recording date.

According to 37 CFR 3.51: “The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.”

The MPEP provides guidance on the recommended order for elements in an independent claim, particularly for improvements. According to 37 CFR 1.75(e), the recommended order is:

  1. A preamble comprising a general description of all conventional or known elements or steps of the claimed combination.
  2. A phrase such as “wherein the improvement comprises.”
  3. The elements, steps, and/or relationships that constitute the new or improved portion of the claimed combination.

The MPEP states: “Where the nature of the case admits, as in the case of an improvement, any independent claim should contain in the following order: (1) A preamble comprising a general description of all the elements or steps of the claimed combination which are conventional or known, (2) A phrase such as ‘wherein the improvement comprises,’ and (3) Those elements, steps, and/or relationships which constitute that portion of the claimed combination which the applicant considers as the new or improved portion.”

This structure helps clearly distinguish the novel aspects of the invention from the prior art.

To learn more:

The recommended length for a patent application abstract is typically 150 words or less. According to MPEP 608.01(b):

The abstract is a brief narrative of the disclosure as a whole, as concise as the disclosure permits, in a single paragraph preferably not exceeding 150 words, commencing on a separate sheet following the claims.

While 150 words is the preferred maximum length, the MPEP also notes that the abstract should be as concise as the disclosure permits. This means that if the invention can be adequately summarized in fewer words, a shorter abstract is acceptable and even encouraged.

To learn more:

The recommended arrangement of elements in a utility patent application is outlined in 37 CFR 1.77. The elements should appear in the following order:

  • Utility application transmittal form
  • Fee transmittal form
  • Application data sheet
  • Specification
  • Drawings
  • The inventor’s oath or declaration

The specification should include specific sections in a particular order, starting with the title of the invention and ending with the abstract of the disclosure. As stated in the MPEP, The order of arrangement of specification elements as set forth in 37 CFR 1.77(b) is preferable (e.g., not required) in framing the nonprovisional specification and each of the items should appear in upper case, without underlining or bold type, as section headings.

To learn more:

The receipt date for facsimile transmissions to the USPTO is determined according to specific rules outlined in MPEP 502.01:

The date of receipt accorded to any correspondence permitted to be sent by facsimile transmission, including a continued prosecution application (CPA) filed under 37 CFR 1.53(d), (available for design applications only) is the date the complete transmission is received by an Office facsimile unit, unless the transmission is completed on a Saturday, Sunday, or Federal holiday within the District of Columbia.

If the transmission is completed on a weekend or federal holiday in DC, the receipt date will be the next business day. For example, if a fax is completed at 9:05 p.m. Pacific time on a Friday, it would be received around 12:05 a.m. Eastern time on Saturday. The receipt date would then be the following Monday (assuming it’s not a federal holiday).

It’s important to note that the Certificate of Transmission under 37 CFR 1.8 can be used for certain documents to consider them timely filed on the date of transmission, even if received later by the USPTO.

To learn more:

The Quick Path Information Disclosure Statement (QPIDS) Pilot Program is an initiative by the USPTO that allows, under specific circumstances, for the submission of an Information Disclosure Statement (IDS) after payment of the issue fee but prior to patent grant. This program provides a streamlined option for considering newly discovered prior art after the issue fee has been paid.

According to MPEP 609.04(b): In May of 2012 the Office launched the Quick Path Information Disclosure Statement (QPIDS) Pilot Program. This pilot program allows, under specific circumstances, for the submission of an IDS after payment of the issue fee but prior to patent grant.

For more information on the QPIDS Pilot Program, visit the USPTO’s QPIDS webpage.

To learn more:

The USPTO has established special procedures for handling official inquiries to ensure consistency and compliance with government directives. As stated in MPEP 203.08(a):

This procedure is used so that there will be uniformity in the handling of contacts from the indicated sources, and also so that compliance with directives of the Department of Commerce is attained.

These procedures help the USPTO maintain a standardized approach to high-level inquiries and ensure that responses align with broader governmental policies.

To learn more:

Tags: USPTO

The PTO-948 form, also known as the ‘Drawing Informalities’ form, serves the following purposes in patent applications:

  • It is used by the Office of Patent Application Processing (OPAP) to indicate that the drawings submitted with the application are informal but acceptable for publication purposes.
  • It notifies the examiner that the drawings may need to be corrected or replaced with formal drawings during examination.
  • It provides a record in the file wrapper that the drawings have been provisionally accepted.

As stated in MPEP 507: ‘If the drawings are informal but otherwise in compliance with 37 CFR 1.121(d), the OPAP will accept the application for purposes of publication and place a ‘Drawing Informalities’ form PTO-948 in the file wrapper.’

This form helps streamline the application process by allowing examination to proceed while flagging the need for potential drawing improvements later in the process.

For more information on OPAP, visit: OPAP.

Tags: OPAP

The Priority Document Exchange (PDX) program is designed to facilitate the electronic exchange of priority documents between participating intellectual property offices. According to MPEP 215.01, the PDX program allows participating foreign intellectual property offices to exchange priority documents with the United States Patent and Trademark Office (USPTO) at no cost to the applicant. This program aims to streamline the process of submitting priority documents, reducing the burden on applicants and improving efficiency in patent examination procedures.

To learn more:

The PDX (Priority Document Exchange) program serves to facilitate the exchange of priority documents between participating intellectual property offices. According to MPEP 215.01, ‘The PDX program eliminates the need for applicants to submit paper certified copies of foreign applications in participating intellectual property offices.’ This streamlines the process, reducing both the burden on applicants and the workload for patent offices.

The Manual of Patent Examining Procedure (MPEP) serves as a comprehensive guide for patent examiners, applicants, attorneys, and agents involved in the patent application process. According to MPEP 101, its purpose is to:

  • Provide instructions to examiners for the examination of patent applications
  • Outline procedures for processing and examining patent applications
  • Serve as a reference work on patent laws, rules, and examination practices

The MPEP states: The Manual contains instructions to examiners, as well as other material in the nature of information and interpretation, and outlines the current procedures which the examiners are required or authorized to follow in appropriate cases in the normal examination of a patent application.

For more information on patent examination, visit: patent examination.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

The Mail Stop Assignment Recordation Services is a specific designation used by the USPTO to ensure proper routing and processing of assignment documents. MPEP 302.08 states:

In order to ensure prompt and proper processing, documents and their cover sheets should be addressed to the Mail Stop Assignment Recordation Services, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450, unless they are filed together with new applications.

This Mail Stop designation helps the USPTO efficiently direct assignment documents to the appropriate department for recordation, reducing processing time and potential errors in document handling.

To learn more:

Tags: USPTO

What is the purpose of the Issue Notification in the patent application process?

The Issue Notification serves as an important communication in the patent application process. According to the MPEP 308, “The Issue Notification identifies the issue date of the patent number assigned to the application.” This notification is crucial because it:

  • Informs the applicant of the official issue date of their patent
  • Provides the assigned patent number
  • Serves as confirmation that the patent will be granted
  • Helps applicants plan for any post-issuance actions or maintenance fees

The Issue Notification is typically sent several weeks before the actual issue date, giving applicants time to prepare for the patent’s publication and enforcement.

For more information on issue date, visit: issue date.

For more information on patent grant, visit: patent grant.

The detailed description in a patent application serves several crucial purposes:

  • It provides a comprehensive explanation of the invention, as required by 37 CFR 1.71 and MPEP § 608.01.
  • It must be detailed enough to enable any person skilled in the pertinent art or science to make and use the invention without involving extensive experimentation.
  • It should clearly convey enough information about the invention to show that the applicant invented the subject matter that is claimed.

As stated in MPEP 608.01(g):

“This detailed description, required by 37 CFR 1.71, MPEP §§ 608.01, 2161, and 2162, must be in such particularity as to enable any person skilled in the pertinent art or science to make and use the invention without involving extensive experimentation and must clearly convey enough information about the invention to show that applicant invented the subject matter that is claimed.”

In essence, the detailed description acts as a comprehensive guide to your invention, ensuring that it can be understood, replicated, and distinguished from prior art.

To learn more:

The cover sheet serves as a crucial document in the patent assignment process. Its primary purpose is to provide essential information about the assignment in a standardized format. According to MPEP 302.05, one of the key pieces of information that must be included on this cover sheet is the assignee’s address:

The address of the assignee … must be given in the required cover sheet.

The cover sheet ensures that the USPTO has accurate and readily accessible information about the assignment, including details about the assignee, which is critical for maintaining proper records and facilitating communication regarding the patent.

To learn more:

The Brief Summary of Invention serves to inform the public, especially those in the relevant field, about the nature of the invention. According to MPEP 608.01(d), “Since the purpose of the brief summary of invention is to apprise the public, and more especially those interested in the particular art to which the invention relates, of the nature of the invention, the summary should be directed to the specific invention being claimed, in contradistinction to mere generalities which would be equally applicable to numerous preceding patents.” This means the summary should focus on the unique aspects of the claimed invention rather than general information about the field.

To learn more:

The affidavit required for claiming priority based on an inventor’s certificate serves a specific purpose, as outlined in MPEP 213.05:

The affidavit or declaration specified under 37 CFR 1.55(l) is only required for the purpose of ascertaining whether, in the country where the application for an inventor’s certificate originated, this option generally existed for applicants with respect to the particular subject matter of the invention involved.

The affidavit is not intended to investigate the specific applicant’s eligibility to exercise the option in their particular case. Rather, it’s meant to confirm that in the country where the inventor’s certificate was filed, applicants generally had the right to choose between applying for a patent or an inventor’s certificate for the subject matter in question.

This requirement ensures compliance with the treaty and statute governing priority rights, while recognizing that some countries may have restrictions based on factors such as employment or nationality.

To learn more:

All provisional applications filed under 35 U.S.C. 111(b), nonprovisional applications filed under 35 U.S.C. 111(a), international applications filed under the PCT, and international design applications filed under the Hague Agreement are reviewed by the USPTO for three main purposes:

  1. To determine if a foreign filing license can be granted under 35 U.S.C. 184
  2. To identify inventions in which the Department of Energy (DOE) or NASA might have property rights
  3. To determine if the application contains subject matter detrimental to national security that warrants a secrecy order under 35 U.S.C. 181

The USPTO requires separate copies of correspondence for different patent files to ensure that each file is complete and self-contained. According to MPEP 502.04:

Since each file must be complete in itself, a separate copy of every paper to be filed in a patent, patent file, or other proceeding must be furnished for each file to which the paper pertains, even though the contents of the papers filed in two or more files may be identical.

This requirement serves several purposes:

  • It ensures that each file contains all relevant documents without relying on cross-referencing between files.
  • It facilitates independent processing and review of each application or proceeding.
  • It maintains the integrity and completeness of individual patent files, which is crucial for legal and administrative purposes.

To learn more:

Patent applications that appear to disclose, purport to disclose, or do disclose inventions or discoveries relating to atomic energy are reported to the Department of Energy. The purpose is to allow the DOE access to these applications for review.

As stated in MPEP 150: Applications for patents which appear to disclose, purport to disclose or do disclose inventions or discoveries relating to atomic energy are reported to the Department of Energy, which Department will be given access to the applications. However, it’s important to note that Such reporting does not constitute a determination that the subject matter of each application so reported is in fact useful or is an invention or discovery, or that such application in fact discloses subject matter in categories specified by 42 U.S.C. 2181(c) and (d).

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

What is the purpose of recording patent assignment documents?

Recording patent assignment documents serves several important purposes:

  • Providing notice to the public of the assignment
  • Creating a public record of the assignment
  • Protecting against subsequent purchasers without notice
  • Establishing priority of ownership rights

According to MPEP 302, ‘The recording of an assignment document in the USPTO is not a determination of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.’ It merely serves as a public notice and record of the transaction.

For more information on patent assignment, visit: patent assignment.

For more information on recording documents, visit: recording documents.

Recording documents with the USPTO serves several important purposes:

  • Provides constructive notice to the public of the recorded document
  • Protects against subsequent purchasers or mortgagees
  • Establishes priority dates for security interests
  • Maintains a clear chain of title for patents and applications

MPEP 313 states: The recording of a document pursuant to 37 CFR 3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration. However, recording does provide legal benefits and helps maintain accurate ownership records.

For more information on chain of title, visit: chain of title.

For more information on Constructive Notice, visit: Constructive Notice.

Recording documents other than assignments at the USPTO serves several important purposes:

  • Provides public notice of the existence of the document
  • Establishes legal priority in certain situations
  • Protects the interests of parties involved in patent-related transactions
  • Facilitates the transfer and licensing of patent rights

MPEP 313 states: “The recording of such documents is not mandatory. However, if they are not recorded in the Office, they are not enforceable against a subsequent purchaser or mortgagee for valuable consideration, without notice, unless recorded in the Office prior to the subsequent purchase or mortgage.”

This highlights the importance of recording these documents to protect the interests of all parties involved in patent-related transactions.

What is the purpose of recording an assignment with the USPTO?

Recording an assignment with the USPTO serves several important purposes:

  • Constructive notice: It provides constructive notice to the public of the assignment.
  • Prima facie evidence: The recording acts as prima facie evidence of the execution of the assignment.
  • Legal protection: It protects against subsequent purchasers without notice.
  • Maintaining chain of title: It helps maintain a clear chain of title for the patent or application.

As stated in MPEP 302: “The recording of an assignment document in the USPTO is governed by statute. The statutory provision is 35 U.S.C. 261.”

For more information on assignment recording, visit: assignment recording.

For more information on USPTO, visit: USPTO.

Pre-AIA 37 CFR 1.47(b) allows a person with a demonstrated proprietary interest to file a patent application on behalf of an inventor who is unavailable. According to the MPEP, this provision is applicable “when no inventor is available to make application” and permits filing “on behalf of and as agent for” an inventor who “cannot be found or reached after diligent effort” or who refuses to sign the application oath or declaration.

It’s important to note that this provision is not applicable to applications filed on or after September 16, 2012.

To learn more:

The Office of Patent Application Processing (OPAP) performs an initial review of drawings in new utility and plant patent applications to determine whether the drawings can be effectively scanned for publication purposes. As stated in the MPEP:

“OPAP inspects the drawings to see if they can be effectively scanned and adequately reproduced.”

This review ensures that the drawings meet the necessary quality standards for publication and reproduction.

For more information on drawing review, visit: drawing review.

For more information on OPAP, visit: OPAP.

MPEP 409.03(f) – Proof of Proprietary Interest outlines the requirements for establishing proprietary interest in a patent application when an inventor refuses to execute an oath or declaration. The section states:

‘If an inventor refuses to execute an oath or declaration under 37 CFR 1.63, the party to whom the inventor has assigned or agreed in writing to assign the invention, or who otherwise shows sufficient proprietary interest in the matter justifying such action, may make application for patent as provided in 37 CFR 1.46.’

This section provides guidance on how to prove sufficient proprietary interest, which is crucial for applicants who need to file a patent application without the inventor’s cooperation.

To learn more:

To learn more:

MPEP 409.03 provides guidance on how to handle patent applications filed before September 16, 2012 when an inventor is unavailable or unwilling to sign the application. It outlines the procedures for filing an application under pre-AIA 37 CFR 1.47 when:

  • A joint inventor refuses to join in an application or cannot be found/reached after diligent effort
  • All inventors are unavailable
  • A legal representative of a deceased inventor is unavailable

The section details the requirements, evidence needed, and process for submitting and processing these types of applications.

To learn more:

To learn more:

What is the purpose of MPEP 203.08 – Status Inquiries?

MPEP 203.08 – Status Inquiries outlines the procedures for handling status inquiries about patent applications. The section states:

“The Office receives numerous telephone and written requests for information concerning the status of patent applications. These status inquiries may be made to the USPTO Contact Center (UCC), the Technology Center (TC) or the Patent Examining Group.”

This section provides guidance to both applicants and USPTO staff on how to handle these inquiries efficiently and in compliance with privacy regulations.

To learn more:

The purpose of MPEP ¶ 2.33 is to provide guidance to patent examiners when they encounter a situation where a new inventor is identified in a Continued Prosecution Application (CPA) for design applications. It states:

Use this form paragraph where a request for a Continued Prosecution Application (CPA) identifies one or more inventors who were not named as inventors in the prior application on the filing date of the CPA.

This paragraph helps examiners address situations where applicants have named new inventors in a CPA without following the proper procedure. It reminds both examiners and applicants that a formal request under 37 CFR 1.48 is required to change inventorship, even in a CPA.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

MPEP ¶ 2.32 provides guidance for patent examiners on how to acknowledge and process requests to delete a named inventor in Continued Prosecution Applications (CPAs) for design patents. The paragraph serves several purposes:

  • It offers a standardized response for examiners to use when acknowledging the receipt of a request to delete an inventor.
  • It confirms that the inventorship has been corrected as requested.
  • It clarifies the timing and procedure for inventor deletion requests in CPAs.

The paragraph states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This standardized language ensures consistency in USPTO communications and helps applicants understand that their request has been processed successfully.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

MPEP ¶ 2.32 provides guidance for patent examiners on how to respond to requests for deleting a named inventor in a Continued Prosecution Application (CPA) for design patents. The paragraph serves several purposes:

  • It offers a template for examiners to acknowledge receipt of a statement requesting inventor deletion.
  • It confirms that the inventorship has been corrected as requested.
  • It clarifies the timing and requirements for inventorship changes in CPAs.

The paragraph states: Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This standardized language ensures consistent communication between the USPTO and applicants regarding inventorship changes in CPAs.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

MPEP ¶ 2.15 provides guidance on how to properly claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c). It outlines the requirements for including a specific reference to the prior-filed application and the timeframes within which this reference must be submitted.

The paragraph states: If applicant desires to claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c), the instant application must contain, or be amended to contain, a specific reference to the prior-filed application in compliance with 37 CFR 1.78. This means that applicants must explicitly reference the prior application to claim its benefits.

For more information on specific reference, visit: specific reference.

MPEP ¶ 2.05 Possible Status as Continuation serves as a guideline for patent examiners when handling applications that may qualify as continuations. Its primary purpose is to:

  • Instruct examiners on how to handle applications that disclose and claim only subject matter disclosed in a prior application
  • Provide language for examiners to use when notifying applicants about the possible status of their application as a continuation
  • Ensure proper classification and processing of continuation applications

The MPEP states: “This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application. Accordingly, this application may constitute a continuation or division.” (MPEP ¶ 2.05)

This guidance helps maintain consistency in the examination process and ensures that applicants are properly informed about the potential status of their applications.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

What is the purpose of limited recognition in patent matters?

The purpose of limited recognition in patent matters is to allow certain individuals who are not fully registered patent practitioners to represent patent applicants before the USPTO in specific situations. As stated in MPEP 402.01:

‘Limited recognition to practice before the Office in patent matters may also be granted in appropriate circumstances to an individual who is not registered to practice before the Office.’

This provision serves several purposes:

  • Allows qualified scientists and engineers to assist in patent matters
  • Facilitates international cooperation through reciprocal agreements (e.g., with Canadian patent agents)
  • Provides flexibility for the USPTO to address specific needs or situations
  • Enables representation in cases where full registration may not be necessary or practical

Limited recognition ensures that patent applicants have access to appropriate representation while maintaining the integrity of the patent system.

To learn more:

The purpose of including the government license rights statement in patent applications is to:

  • Acknowledge the government’s support in the development of the invention
  • Inform the public and potential licensees of the government’s rights in the invention
  • Ensure compliance with federal regulations regarding inventions made with government support
  • Facilitate the government’s ability to exercise its rights in the invention if necessary

This requirement, mandated by 35 U.S.C. 202(c)(6), helps maintain transparency in federally funded research and development while protecting the government’s interests in the resulting inventions.

What is the purpose of Form PTO/AIA/96?

Form PTO/AIA/96 is used to establish the right of an assignee to take action in a patent application filed on or after September 16, 2012. According to the MPEP 325:

“Form PTO/AIA/96 may be used to establish the right of an assignee to take action in an application filed on or after September 16, 2012.”

This form is crucial for assignees who wish to prosecute the application or take other actions on behalf of the inventors. It serves as a declaration that the assignee has the right to take action in the application, which is necessary under 37 CFR 3.71(b).

For more information on assignee rights, visit: assignee rights.

For more information on USPTO Forms, visit: USPTO Forms.

Form Paragraph 2.38 in the MPEP serves several important purposes regarding non-English provisional applications:

  1. It notifies the applicant that an English translation and/or a statement of translation accuracy is required for a non-English language provisional application.
  2. It informs the applicant about the specific documents that are missing from their application.
  3. It provides clear instructions on what the applicant needs to do to rectify the situation.
  4. It warns the applicant about the potential consequences of not providing the required documents.

The MPEP states: Use this form paragraph to notify applicant that an English translation of the non-English language provisional application and/or a statement that the translation is accurate is required.

This form paragraph is a crucial tool for patent examiners to communicate requirements and potential issues to applicants, ensuring that all necessary documents are properly filed for claiming benefit to a non-English provisional application.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

The purpose of filing a supplemental oath or declaration after allowance is to cover the claims in the application as they stand at the time of allowance. While the MPEP section 603.01 doesn’t explicitly state the purpose, it implies that these documents are filed to ensure that all claims are properly supported by an oath or declaration. The section states:

“Supplemental oaths and declarations covering the claims in the application may be filed after allowance as a matter of right.”

This allows applicants to provide additional sworn statements or declarations that may be necessary to fully support the allowed claims, without changing the content of the application itself.

To learn more:

Filing a continuation application serves several important purposes in patent prosecution. The MPEP indicates:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

Key reasons for filing a continuation include:

  • Pursuing broader or different claim scope based on the same disclosure
  • Addressing remaining rejections or objections from the parent application
  • Submitting new evidence or arguments to overcome prior art rejections
  • Maintaining pendency for ongoing improvements or to counter competitor activities
  • Separating distinct inventions identified during examination of the parent

Continuations allow applicants to refine their patent strategy while maintaining the priority date of the original filing, which can be crucial in fast-moving technological fields.

For more information on continuation application, visit: continuation application.

For more information on patent strategy, visit: patent strategy.

The primary purpose of drawing review in OPAP is to determine whether the drawings in new utility and plant patent applications can be effectively scanned for publication purposes. As stated in MPEP 507:

The Office of Patent Application Processing (OPAP) performs an initial review of drawings in new utility and plant patent applications to determine whether the drawings can be effectively scanned for publication purposes.

It’s important to note that design applications are not subject to this review as they are not published.

An attorney docket number is used by law firms and companies to internally track and manage patent applications. While it’s not required by the USPTO, it can be included on application documents for reference. However, there are limitations:

  • Must be limited to a maximum of 25 characters
  • Spaces, slashes, and hyphens are not included in the entered docket number on the official filing receipt
  • For docket numbers beginning with ‘CASE’ or ‘NAVY-CASE’, only characters after these prefixes are entered

The MPEP states: ‘Attorney docket numbers must be limited to a maximum of 25 characters to prevent truncation. The USPTO system data base allows a maximum of 25 characters for the attorney docket numbers.’ (MPEP 503)

An Application Data Sheet (ADS) in patent applications filed before September 16, 2012 serves several important purposes:

  • It provides bibliographic data to be used for capturing and processing application information.
  • It allows applicants to submit certain information without an oath or declaration or application transmittal letter.
  • It may be used to provide or correct bibliographic data, particularly if submitted within one month of the filing date.

According to MPEP 601.05(b): “An application data sheet is a sheet or set of sheets containing bibliographic data, which is arranged in a format specified by the Office. When an application data sheet is provided in a patent application, the application data sheet becomes part of the application.”

To learn more:

An Application Data Sheet (ADS) serves as a crucial document in patent applications filed on or after September 16, 2012. Its primary purposes are:

  • To provide bibliographic data for the application
  • To facilitate efficient processing and examination of the application
  • To ensure accurate capture of important information by the Office of Patent Application Processing (OPAP)

According to MPEP 601.05(a), “An application data sheet is a sheet or sheets that may be submitted in a provisional application (except as provided in 37 CFR 1.53(c)(1) ), a nonprovisional application, or a national stage application.” The ADS helps streamline the application process and reduces errors in the handling of patent applications.

To learn more:

The purpose of an abstract in a patent application is to provide a concise summary that allows readers to quickly determine the nature and gist of the technical disclosure. According to MPEP 608.01(b):

The abstract is a brief narrative of the disclosure as a whole, as concise as the disclosure permits, in a single paragraph preferably not exceeding 150 words, commencing on a separate sheet following the claims.

This summary helps examiners, researchers, and other readers to quickly assess the relevance of the patent application to their interests.

To learn more:

The provision in MPEP 608.02(w) allowing minor drawing changes without requiring annotated sheets from the applicant serves several purposes:

  • Streamlines the patent examination process
  • Reduces administrative burden on applicants
  • Allows for quick resolution of minor drawing issues
  • Facilitates efficient preparation of applications for issue

The MPEP states: Where an application is ready for issue except for a slight defect in the drawing not involving change in structure, the examiner will prepare a letter to the applicant indicating the change to be made…

This approach ensures that minor drawing corrections can be made efficiently, without delaying the issuance of patents due to small, easily resolvable issues in the drawings.

To learn more:

Title reports play a specific role in patent reexamination procedures. The MPEP mentions:

For example, a title report is requested by the Reexamination Preprocessing Staff when a request for reexamination is filed.

This suggests that title reports are used to verify the current owner of a patent when a reexamination is initiated, ensuring that the proper parties are involved in the process.

A self-addressed postcard serves as a receipt and provides evidence of the items submitted to the USPTO with a patent application. According to MPEP 503, the postcard should itemize all components of the application, including:

  • Inventor’s name(s)
  • Title of invention
  • Number of pages of specification, claims, and sheets of drawing
  • Whether the inventor’s oath or declaration is included
  • List of additional forms included
  • Amount and manner of paying the fee

The MPEP states: “A postcard receipt which itemizes and properly identifies the items which are being filed serves as prima facie evidence of receipt in the USPTO of all the items listed thereon on the date stamped thereon by the USPTO.”

It’s important to note that the postcard must be properly itemized to serve as evidence of receipt. Simply listing “a complete application” is not sufficient. Each component should be specifically listed on the postcard.

For applications filed via EFS-Web, an Electronic Acknowledgment Receipt serves as the electronic equivalent of a postcard receipt.

For more information on patent application filing, visit: patent application filing.

For more information on USPTO submission, visit: USPTO submission.

A secrecy order is issued to prevent the disclosure of sensitive information in patent applications that could be detrimental to national security. According to MPEP 120, “The purpose of this Act is to prevent disclosure of inventions by the publication of applications or by the granting of patents that might be detrimental to the national security.” These orders are typically issued for inventions that have military applications or involve critical technologies.

For more information on invention disclosure, visit: invention disclosure.

A return postcard serves as prima facie evidence of receipt by the USPTO of all items listed on the postcard. It should include detailed identifying information such as:

  • Inventor’s name
  • Application number (if known)
  • Confirmation number (if known)
  • Filing date
  • Title of the invention
  • Type of paper being filed
  • Number of pages for each component

The MPEP states: ‘A postcard receipt which itemizes and properly identifies the items which are being filed serves as prima facie evidence of receipt in the USPTO of all the items listed thereon on the date stamped thereon by the USPTO.’ (MPEP 503)

What is the purpose of a divisional application under 37 CFR 1.53(b)?

A divisional application under 37 CFR 1.53(b) serves to pursue claims to a distinct invention that was disclosed but not claimed in a parent application. According to the MPEP:

“A divisional application is often filed as a result of a restriction requirement made by the examiner.”

This allows inventors to protect multiple inventions that may have been included in a single original application but were deemed to be separate and distinct by the USPTO. Divisional applications maintain the benefit of the filing date of the parent application for the common subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on patent filing, visit: patent filing.

What is the purpose of a divisional application in patent law?

A divisional application is a type of patent application that allows an inventor to pursue protection for different aspects of an invention that were disclosed but not claimed in a parent application. According to MPEP 201.06:

A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.’

The main purposes of a divisional application are:

  • To protect multiple inventions disclosed in a single parent application
  • To respond to a restriction requirement issued by the USPTO
  • To pursue broader or different claim scope than what was allowed in the parent application

Divisional applications are filed under 37 CFR 1.53(b) and can benefit from the filing date of the parent application for the common subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

What is the purpose of a Customer Number in USPTO correspondence?

A Customer Number is a unique identifier assigned by the USPTO to simplify and streamline patent correspondence. According to the MPEP 403, ‘The Customer Number practice permits applicants, attorneys, and agents of record to change their correspondence address for a number of applications with one request.’ This system allows for:

  • Easy updates to correspondence addresses for multiple applications
  • Efficient management of power of attorney
  • Simplified access to private PAIR (Patent Application Information Retrieval) for registered practitioners

By using a Customer Number, patent applicants and their representatives can more effectively manage their patent portfolios and communications with the USPTO.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

A cover sheet is a crucial component in the patent document recording process. It provides essential information about the document being recorded and the patents or applications it relates to.

The requirement for a cover sheet is specified in 37 CFR 3.31, which states the necessary contents of a cover sheet. As mentioned in MPEP 315, a completed cover sheet is one of the required items when recording a document with additional patents or applications: “a completed cover sheet (see 37 CFR 3.31 and MPEP § 302.07)”

For more detailed information on cover sheets, refer to MPEP § 302.07.

For more information on cover sheet, visit: cover sheet.

For more information on document submission, visit: document submission.

For more information on USPTO requirements, visit: USPTO requirements.

A cover sheet is a crucial component in patent assignment recordation. It provides essential information about the document being recorded and the parties involved. According to MPEP 315, a completed cover sheet is required when submitting a document for recordation, even if the document has been previously recorded.

The cover sheet requirements are specified in 37 CFR 3.31 and further explained in MPEP § 302.07. It typically includes details such as:

  • Identification of the patents or applications the document relates to
  • Names of the parties involved in the transaction
  • Nature of the interest being conveyed
  • Mailing address for correspondence

The cover sheet helps the USPTO efficiently process and index the recorded documents in the assignment database.

The purpose of a certificate of mailing or transmission in patent applications is to provide evidence of timely filing when correspondence is not received by the USPTO or is received late. As stated in MPEP 512:

The Certificate of Mailing or Transmission procedure does not apply to papers mailed in a foreign country.

This procedure allows applicants to prove that they submitted their correspondence on time, even if it’s delayed or lost in transit.

To learn more:

The purpose of 37 CFR 1.57(b) is to provide a safeguard for applicants when a page(s) of the specification, or a portion thereof, or a sheet(s) of the drawing(s), or a portion thereof, is inadvertently omitted from an application, such as through a clerical error. It allows inadvertently omitted material to be added to the application by way of a later-filed amendment if the inadvertently omitted portion is completely contained in a prior-filed application for which priority or benefit is claimed, even though there is no explicit incorporation by reference of the prior-filed application.

To properly identify a foreign priority application in a U.S. patent application, you should provide:

  • The application number
  • The country or intellectual property authority
  • The filing date (day, month, and year)

MPEP 214.04 advises: “To ensure an accurate and complete citation of a foreign priority application, applicants should review the list of the various intellectual property offices and the recommended presentation of a foreign application number for each, which can be found in the tables of the online WIPO Handbook on Industrial Property Information and Documentation.”

It’s important to use the format recommended by WIPO for the specific country to ensure accurate identification and processing of your priority claim.

To initiate an interview with a patent examiner, applicants should follow a specific procedure outlined in MPEP § 408:

  1. Submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) to the examiner prior to the interview.
  2. The form should identify the participants of the interview.
  3. Propose a date for the interview.
  4. Specify whether the interview will be personal, telephonic, or via video conference.
  5. Include a brief description of the issues to be discussed.

As stated in the MPEP, When applicant is initiating a request for an interview, an ‘Applicant Initiated Interview Request’ form (PTOL-413A) should be submitted to the examiner prior to the interview in order to permit the examiner to prepare in advance for the interview and to focus on the issues to be discussed. This procedure helps ensure productive and efficient interviews.

For more information on patent examination, visit: patent examination.

For more information on USPTO Forms, visit: USPTO Forms.

The proper procedure for correcting inventorship in a Continued Prosecution Application (CPA) is to file a request under 37 CFR 1.48. This applies whether you’re adding or removing an inventor. The MPEP guidance states: ‘Any request to add an inventor must be in the form of a request under 37 CFR 1.48.’ This formal request ensures that the USPTO properly processes and recognizes the change in inventorship.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

The statement regarding work with the Atomic Energy Commission or NASA should be in the form of an oath or declaration. The following is an acceptable format, assuming no government funds or considerations were involved in the invention’s conception or making:

I (We) [Name(s)] citizens of [Country] residing at [Address] declare: That I (we) made and conceived the invention described and claimed in patent application number [Application Number] filed in the United States of America on [Date] titled [Title].

[Include statement regarding employment and/or relevant facts.]

The invention or discovery was not made or conceived in the course of, or in connection with, or under the terms of any contract, subcontract or arrangement entered into with or for the benefit of the United States Atomic Energy Commission or its successors Energy Research and Development Administration or the Department of Energy.

The invention was not made under nor is there any relationship of the invention to the performance of any work under any contract of the National Aeronautics and Space Administration.

The statement must be signed by all the inventors.

Multiple dependent claims have specific formatting requirements as outlined in MPEP 608.01(m). The MPEP states:

A multiple dependent claim may refer in the alternative to more than one preceding independent or dependent claim in the specification. The second (or subsequent) independent claim of the claim set should not refer to any other claim of the claim set. A multiple dependent claim shall contain a reference, in the alternative only, to more than one claim previously set forth. In any multiple dependent claim, only one set of alternatives may be claimed.

To properly format a multiple dependent claim:

  • Refer to previous claims in the alternative (e.g., ‘according to claim 1 or claim 2’)
  • Include only one set of alternatives
  • Ensure it does not serve as a basis for any other multiple dependent claim

For example: ‘The device according to claim 1 or claim 2, further comprising…’

To learn more:

Replacement drawings in a patent application are typically entered into the contents of the application routinely. However, the examiner will review them for several factors:

  • Presence of new matter
  • Necessity of the replacement sheets
  • Consistency with other sheets

As stated in MPEP 608.02(h): “All sheets of replacement drawings will be routinely entered into the contents of the application. However, the examiner should not overlook such factors as new matter, the necessity for the replacement sheets and consistency with other sheets.”

If the examiner decides not to enter the replacement drawings, they must provide a complete and explicit reasoning for the denial. The applicant will be notified of this decision, and the previously made entries will be marked ‘not entered’.

To learn more:

If OPAP objects to the drawings in a patent application, there is a specific process for submitting corrected drawings. The MPEP states:

“If OPAP objects to the drawings and sends applicant a Notice requiring submission of corrected drawings within a set time period (usually two months), corrected drawings must be filed, in paper, to the mailing address set forth in the Notice, along with any other items required by OPAP, to avoid abandonment of the application. No fee will be necessary for filing corrected drawings which are required by OPAP.”

It’s important to note that the corrected drawings must be submitted in paper form to the specific mailing address provided in the Notice. Applicants should ensure they meet the deadline (typically two months) to avoid potential abandonment of their application.

For more information on corrected drawings, visit: corrected drawings.

For more information on OPAP, visit: OPAP.

For more information on patent procedure, visit: patent procedure.

If a benefit claim is not filed within the required time period, it may still be accepted through a petition process. According to MPEP ¶ 2.15:

A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

The petition must include:

  1. The reference to the prior application (unless previously submitted)
  2. The petition fee under 37 CFR 1.17(m)
  3. A statement that the entire delay between the date the benefit claim was due and the date the claim was filed was unintentional

The Director may request additional information if there’s a question about whether the delay was unintentional. The petition should be addressed to: Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.

For more information on unintentional delay, visit: unintentional delay.

For patent applications filed on or after July 1, 2022, the process for submitting biological sequence listings is as follows:

  1. Prepare a “Sequence Listing XML” as an XML file.
  2. Ensure the file complies with 37 CFR 1.831 – 1.834.
  3. Submit the file via the USPTO patent electronic filing system or on a read-only optical disc.

MPEP 608.05(c) states: “For applications filed on or after July 1, 2022, the sequence listing must be a ‘Sequence Listing XML’ (as an XML file in compliance with 37 CFR 1.831 – 1.834) submission can be submitted via the USPTO patent electronic filing system or on read-only optical disc.”

For detailed information on this process, refer to MPEP §§ 2412 – 2419.

To learn more:

The process for revoking power of attorney during an interference proceeding differs from the standard procedure. According to MPEP 402.08:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

To revoke power of attorney during an interference proceeding:

  1. Prepare the revocation document as you normally would.
  2. Instead of submitting it through regular channels, forward the revocation to the Patent Trial and Appeal Board (PTAB).
  3. The PTAB will consider the revocation within the context of the ongoing interference proceeding.
  4. Wait for the PTAB’s decision before considering the revocation effective.

This special handling ensures that changes in representation are properly managed within the complex context of an interference proceeding.

To learn more:

When an examiner issues a new matter rejection confined to amendments in the specification, the process for review is through a petition. This is distinct from new matter rejections in claims, which require an appeal.

According to MPEP 608.04(c):

“Where the new matter is confined to amendments to the specification, review of the examiner’s requirement for cancelation is by way of petition.”

To challenge the examiner’s holding of new matter in the specification:

  1. Prepare a detailed petition explaining why the amendment does not introduce new matter.
  2. Submit the petition to the USPTO, following the guidelines for petition submission.
  3. The petition will be reviewed by the appropriate office, typically the Technology Center Director or their designee.
  4. A decision will be issued either granting or denying the petition.

It’s important to note that this process is separate from the appeal process used for claim rejections.

To learn more:

If an applicant disagrees with the USPTO’s refusal to grant a filing date for their patent application, they can request a review through the following process:

  • File a petition to the USPTO, accompanied by the required petition fee
  • Provide arguments and evidence supporting why the application should be granted the desired filing date
  • If alleging no defect exists, include a request for a refund of the petition fee

The MPEP states: Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)). Petitioner should provide any arguments that he or she has that the items noted were not missing or that a filing date should be assigned in the absence of such items if they are believed to be unnecessary.

Petitions relating to filing dates are decided by the Office of the Deputy Commissioner for Patent Examination Policy. The petition should be marked to the attention of the Office of Petitions.

It’s important to act promptly if you believe a filing date has been incorrectly refused, as the filing date can have significant implications for patent rights.

For more information on patent application review, visit: patent application review.

The process for returning models, exhibits, or specimens to patent applicants is outlined in 37 CFR 1.94. Key points include:

  • The USPTO may return items when they are no longer necessary for the conduct of business.
  • Applicants are notified and must arrange for the return at their own expense.
  • A time period (usually two months) is set for making return arrangements.
  • Extensions of time are available under 37 CFR 1.136, except for perishables.

The MPEP states, Failure by applicant to establish that arrangements for the return of a model, exhibit, or specimen have been made within the time period set in the notice will result in the disposal of the model, exhibit, or specimen by the Office. (MPEP 608.03(a))

To learn more:

To learn more:

The process for restoring the benefit of a provisional application after the 12-month deadline involves filing a petition under 37 CFR 1.78(b). This petition must be filed in the subsequent application (nonprovisional or international application designating the US) within 14 months of the provisional application’s filing date. The MPEP outlines the requirements:

“A petition under 37 CFR 1.78(b) requires: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application, which must be included in application data sheet (unless previously submitted in an application data sheet); (B) the petition fee as set forth in 37 CFR 1.17(m); and (C) a statement that the delay in filing the nonprovisional application or international application designating the United States within the twelve-month period set forth in 37 CFR 1.78(a)(1)(i) was unintentional.”

The Director may require additional information to determine if the delay was unintentional. If granted, this restoration allows an application to validly claim the benefit of a provisional application filed up to 14 months earlier.

To learn more:

To learn more:

While the MPEP section provided does not specifically address name changes, the process for recording a name change for patent matters with the USPTO is similar to recording other documents affecting title. Here are the general steps:

  1. Prepare a document evidencing the name change (e.g., a certificate of name change or merger document)
  2. Complete a cover sheet (Form PTO-1595 or equivalent) that includes:
    • The former name (in the space for the party conveying the interest)
    • The new name (in the space for the party receiving the interest)
    • A description of the interest conveyed as “Name Change”
    • Identification of the affected patents or applications
  3. Submit the document and cover sheet to the USPTO for recordation, along with any required fee
  4. The submission can be done electronically through EPAS, by mail, or by fax (subject to limitations)

As with other recorded documents, the USPTO will assign reel and frame numbers and add recordation stampings to the processed document.

It’s important to note that while this process records the name change, it does not update the assignee name in individual patent or application files. Separate requests may be needed to update assignee names in specific applications or patents.

Obtaining patent assignment records from before May 1, 1957, involves a different process than accessing more recent records. According to MPEP 301.01:

All records of assignments of patents recorded before May 1, 1957, are maintained by the National Archives and Records Administration (NARA). The records are open to public inspection. Certified and uncertified copies of those assignment records are provided by NARA upon request and payment of the fees required by NARA.

The MPEP further advises:

Requests for copies of pre-1957 records for patents should be directed to the National Archives and Records Administration (NARA). Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.

To obtain these records:

  1. Contact NARA directly.
  2. Provide as much information as possible about the patent and assignment you’re seeking.
  3. Be prepared to pay the fees required by NARA.

The MPEP also notes: All assignment records from 1837 to April 30, 1957 for patents are now maintained and are open for public inspection in the National Archives Research Room located at the Washington National Records Center Building, 4205 Suitland Road, Suitland, Maryland 20746 and at the Civilian Records Division of the National Archives at College Park, 8601 Adelphi Road, College Park, MD 20740-6001.

For the most up-to-date information on accessing these records, it’s recommended to check the National Archives website.

For more information on NARA, visit: NARA.

Tags: NARA

The process for obtaining a foreign filing license is part of the USPTO’s screening procedure for patent applications. The MPEP states:

A third function of the screening procedure is to process foreign filing license petitions under37 CFR 5.12(a). SeeMPEP § 140.

The foreign filing license is automatically granted in most cases as part of the application filing process. However, if the application contains subject matter that requires further review, the applicant may need to petition for a foreign filing license separately.

To obtain a foreign filing license, applicants should:

  1. File a patent application with the USPTO
  2. Wait for the automatic screening process to complete
  3. If a license is not automatically granted, file a petition under 37 CFR 5.12(a)
  4. Provide any additional information requested by the USPTO

It’s important to note that filing an application abroad without first obtaining a foreign filing license can have serious consequences, including abandonment of the U.S. application and potential criminal penalties.

For more information on foreign filing license, visit: foreign filing license.

For more information on patent applications, visit: patent applications.

For more information on USPTO procedures, visit: USPTO procedures.

The process for issuing a patent to a non-applicant assignee involves the following steps:

  1. A request for issuance to the assignee must be submitted with the payment of the issue fee.
  2. The assignment must have been previously recorded in the USPTO or filed for recordation.
  3. If the request is submitted after the issue fee payment, additional requirements apply, including a request for a certificate of correction and associated fees.

According to 37 CFR 3.81(a): An application may issue in the name of the assignee consistent with the application’s assignment where a request for such issuance is submitted with payment of the issue fee, provided the assignment has been previously recorded in the Office.

The USPTO has a specific process for handling inquiries from embassies. According to MPEP 203.08(a):

Inquiries referred to in this section such as correspondence from embassies, the Office of the U.S. Trade Representative, and the Department of State should immediately be transmitted to the Administrator of the Office of Policy and International Affairs, and a staff member of that office should be notified by phone that such correspondence has been received at 571-272-9300.

This procedure ensures that international inquiries are handled consistently and in line with the USPTO’s international policies.

To learn more:

Tags: USPTO

What is the process for filing a patent application if an inventor is legally incapacitated?

When an inventor is legally incapacitated, the patent application can be filed by the legal representative of the incapacitated inventor. According to MPEP 409.03(b):

“If an inventor is legally incapacitated, the legal representative of the inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The process involves:

  • Filing a petition under 37 CFR 1.47(b)
  • Paying the petition fee set forth in 37 CFR 1.17(g)
  • Providing proof of the inventor’s incapacity (e.g., court order)
  • Submitting an oath or declaration by the legal representative

The legal representative should state their relationship to the incapacitated inventor and provide evidence of their authority to act on behalf of the inventor.

To learn more:

To learn more:

Expungement of assignment records is a rare and complex process. According to MPEP 323.01(d), petitions to expunge assignment records are granted only under specific conditions:

  • Normal corrective procedures (outlined in MPEP § 323.01(a) through § 323.01(c)) are inadequate for providing relief.
  • The integrity of the assignment records will not be affected by granting the petition.

It’s important to note that expungement does not result in the complete removal of a document from assignment records. Instead, a redacted version of the ‘expunged’ document is recorded and replaces the original in the assignment records.

To learn more:

The process for expunging assignment records at the USPTO involves:

  • Submitting a petition under 37 CFR 1.59 to expunge the assignment record
  • Providing clear evidence that the document was submitted by mistake or is of improper character
  • Paying the required petition fee

As stated in MPEP 323.01(d): ‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’ This emphasizes the necessity of following the proper petition process for expungement.

To learn more:

When a claim to priority and certified copy of a foreign application are received during the pendency of a patent application, the examiner generally follows these steps:

  • Checks for obvious formal defects in the documents
  • Verifies that the documents correspond to the application identified in the application data sheet
  • For original applications filed under 35 U.S.C. 111(a) and international applications entering the national stage under 35 U.S.C. 371, ensures the claim for foreign priority is timely

The examiner does not typically examine the subject matter to determine if the applicant is entitled to the benefit of the foreign filing date unless it’s necessary for patentability reasons. As stated in the MPEP, The subject matter of the application is not examined to determine whether the applicant is actually entitled to the benefit of the foreign filing date on the basis of the disclosure thereof unless such determination is required for patentability reasons.

For more information on application data sheet, visit: application data sheet.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For more information on patent examination, visit: patent examination.

To establish ownership in a patent application filed before September 16, 2012, an assignee must submit evidence to the USPTO as per pre-AIA 37 CFR 3.73(b). This can be done by either:

  • Submitting documentary evidence of a chain of title from the original owner to the assignee, along with a statement affirming that this evidence was or is being submitted for recordation.
  • Providing a statement specifying where such evidence is recorded in the USPTO (by reel and frame number).

As stated in the MPEP: The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted. This ensures that the assignee has the right to take action in the application.

For more information on assignee rights, visit: assignee rights.

For more information on pre-AIA applications, visit: pre-AIA applications.

For more information on USPTO procedures, visit: USPTO procedures.

The process for correcting inventorship in a provisional patent application is outlined in 37 CFR 1.48(d). To correct inventorship in a provisional application, the following must be submitted:

  1. A request to correct the inventorship that identifies each inventor by their legal name. This request must be signed by a party set forth in 37 CFR 1.33(b).
  2. The processing fee set forth in 37 CFR 1.17(q).

Additionally, when adding an inventor, applicants should file a corrected application data sheet or a new cover sheet providing the residence of all inventors, as per 37 CFR 1.51(c).

It’s important to note that correcting inventorship in a provisional application may not always be necessary unless there would be no overlap of inventors upon filing a nonprovisional application with the correct inventorship. The need for correction may also depend on whether a foreign filing under the Paris Convention will occur after the U.S. filing.

To learn more:

What is the process for correcting errors in recorded assignment documents?

The process for correcting errors in recorded assignment documents involves the following steps:

  • For minor errors: You can file a corrective document stating the nature of the error, along with the required fee.
  • For more significant errors: You may need to file a new assignment document with the correct information.
  • In all cases: Include a cover sheet stating that the document is being submitted to correct an error in a previously recorded assignment document.

According to MPEP 302: Errors in a recorded assignment document will be corrected by the Assignment Division provided a ‘corrective document’ is submitted. The USPTO recommends contacting the Assignment Recordation Branch for specific guidance on your situation.

For more information on assignment correction, visit: assignment correction.

For more information on patent documents, visit: patent documents.

For more information on USPTO procedures, visit: USPTO procedures.

What is the process for correcting errors in faxed assignment documents at the USPTO?

If errors are discovered in faxed assignment documents after submission to the USPTO, the process for correction depends on the nature of the error. Here’s a general guideline:

  1. Minor Typographical Errors: These can often be corrected by submitting a request for correction along with supporting documentation.
  2. Substantive Errors: For more significant errors, a new corrected assignment document may need to be submitted and recorded.
  3. Errors in Recordation: If the error is in the USPTO’s recordation rather than the document itself, contact the Assignment Recordation Branch for assistance.

As per MPEP 302.09: “If there is an error in a cover sheet recorded with an assignment document, a corrected cover sheet may be submitted for recordation.” This indicates that for cover sheet errors, a simple correction submission is possible.

It’s important to act promptly when errors are discovered to ensure the accuracy of the assignment records. For specific guidance on your situation, it’s advisable to contact the USPTO’s Assignment Recordation Branch directly.

To learn more:

To correct assignee information on an issued patent, you must follow these steps:

  1. Submit a request for a certificate of correction under 37 CFR 1.323.
  2. Ensure that a request under 37 CFR 3.81(b) has been granted.
  3. Confirm that the assignment was submitted for recordation before the patent was issued.

According to MPEP 307: “A request for a certificate of correction under 37 CFR 1.323 (see MPEP §§ 1481 and 1485) arising from incomplete or erroneous assignee’s name furnished, or a missing assignee’s name, in item 3 of PTOL-85B will not be granted unless a request under 37 CFR 3.81(b) has been granted and the assignment was submitted for recordation as set forth in 37 CFR 3.11 before the patent issued.”

The request should be directed to the Office of Petitions and include:

  • The processing fee required by 37 CFR 1.17(i)
  • A request for issuance of the application in the name of the assignee, or a request that a patent be corrected to state the name of the assignee
  • A statement that the assignment was submitted for recordation before the patent was issued
  • A request for a certificate of correction under 37 CFR 1.323 with the associated fee

For more information on assignee information, visit: assignee information.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on Patent correction, visit: Patent correction.

For more information on USPTO procedures, visit: USPTO procedures.

If a priority claim needs to be corrected after a patent has been issued, it must be done through a certificate of correction. The MPEP Section 213.04 states:

“If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and § 1.323.”

To obtain a certificate of correction, the patent owner must file a request with the USPTO, pay the required fee, and provide a statement explaining the error and how it occurred. The USPTO will then review the request and, if approved, issue a certificate of correction to be attached to the patent.

To learn more:

The process for correcting an erroneously recorded name change is similar to correcting an erroneous assignment. According to MPEP 323.01(c), you should:

  1. Submit a completed cover sheet identifying the affected application or patent.
  2. Provide an affidavit or declaration stating:
    • You are the correct owner
    • The previously recorded document contained erroneous information
    • The reel and frame number of the incorrect document
  3. Pay the required fee for each application or patent to be corrected.

The MPEP states: On the corrected cover sheet, the owner should check the box titled ‘Other’ in the area of the cover sheet requesting the ‘Nature of Conveyance,’ and indicate that the submission is to correct an error made in a previously recorded document that erroneously affects the identified application(s), or patent(s).

Ensure that your affidavit or declaration clarifies that the name change was recorded in error and provide the correct name information.

To learn more:

What is the process for adding a benefit claim after the time period set forth in 37 CFR 1.78?

To add a benefit claim after the time period set forth in 37 CFR 1.78, you must file a petition to accept an unintentionally delayed benefit claim. The MPEP 211.02(a) outlines the process:

  1. File a petition under 37 CFR 1.78(c) for claiming the benefit of a prior-filed provisional application, or under 37 CFR 1.78(e) for claiming the benefit of a prior-filed nonprovisional application.
  2. Pay the petition fee (currently $2,000 for nonprovisional applications).
  3. Submit a corrected application data sheet (ADS) including the reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior-filed application.
  4. Provide a statement that the entire delay between the date the benefit claim was due and the date the benefit claim was filed was unintentional.

The MPEP states: “The Director may require additional information where there is a question whether the delay was unintentional.” It’s crucial to ensure all requirements are met to avoid potential rejection of the petition.

To learn more:

When the USPTO cannot locate a patent or application file after a reasonable search, they follow the procedure outlined in 37 CFR 1.251. The key steps are:

  1. The Office notifies the applicant or patentee about the unlocatable file.
  2. A time period is set for the applicant or patentee to comply with the notice.
  3. The applicant or patentee must respond by either:
    • Providing a copy of their record of all correspondence with the Office (except U.S. patent documents)
    • Producing their record for the Office to copy
    • Stating that they do not possess any record of the correspondence

As stated in MPEP 508.04, “37 CFR 1.251 sets forth a procedure for the reconstruction of the file of a patent application, patent, or any other patent-related proceeding that cannot be located after a reasonable search.”

When a patent or application file cannot be located after a reasonable search, the USPTO has a specific procedure outlined in 37 CFR 1.251. The Office will notify the applicant or patentee and set a time period for compliance with one of the following options:

  • Provide a copy of all correspondence records between the Office and the applicant/patentee, along with a list and a statement of completeness.
  • Produce the applicant’s/patentee’s records for the Office to copy, along with a statement of completeness.
  • If no records are possessed, provide a statement to that effect.

The MPEP states, 37 CFR 1.251 sets forth a procedure for the reconstruction of the file of a patent application, patent, or any other patent-related proceeding that cannot be located after a reasonable search.

For pending applications, failure to comply within the set time period will result in abandonment of the application.

For more information on file reconstruction, visit: file reconstruction.

For more information on USPTO procedures, visit: USPTO procedures.

The procedure for submitting a priority document in an international application is outlined in PCT Rule 17. According to the MPEP:

Where the priority of an earlier national or international application is claimed under Article 8, a copy of that earlier application, certified by the authority with which it was filed (‘the priority document’), shall… be submitted by the applicant to the International Bureau or to the receiving Office not later than 16 months after the priority date.

The applicant has three options:

  1. Submit the priority document directly to the International Bureau or the receiving Office.
  2. Request the receiving Office to prepare and transmit the priority document to the International Bureau (if the priority document is issued by the receiving Office).
  3. Request the International Bureau to retrieve the priority document from a digital library in accordance with the Administrative Instructions.

It’s important to note that failure to comply with these requirements may result in the designated Office disregarding the priority claim, subject to certain conditions specified in PCT Rule 17.

To learn more:

What is the procedure for filing a continuation or divisional application without a new oath or declaration?

When filing a continuation or divisional application, a new oath or declaration is not always required. According to MPEP 602.05, the following procedure can be followed:

  1. File a copy of the oath or declaration from the prior application.
  2. Include a statement requesting the filing of the continuation or divisional application without a newly executed oath or declaration.
  3. Pay the filing fee for the continuation or divisional application.

The MPEP states: ‘The applicant may file a continuation or divisional application by filing a copy of the oath or declaration from the prior application, accompanied by a statement requesting the filing of the continuation or divisional application without a newly executed oath or declaration and payment of the filing fee.’

This procedure simplifies the filing process for certain types of continuing applications, reducing paperwork and potentially saving time for applicants.

To learn more:

To correct typographical errors in a recorded cover sheet, follow these steps as outlined in MPEP 323.01(a):

  1. Submit a copy of the originally recorded assignment document.
  2. Provide a corrected cover sheet.
  3. Pay the required fee for each application or patent to be corrected.
  4. Include a copy of the original cover sheet to facilitate comparison.

When submitting the corrected cover sheet:

  • Check the ‘Other’ box in the ‘Nature of Conveyance’ area.
  • Indicate that the submission is to correct an error in a previously recorded cover sheet.
  • Identify the reel and frame numbers (if known) and the nature of the correction.

The MPEP states: The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.

To learn more:

What is the procedure for correcting or adding a benefit claim in a design application?

The procedure for correcting or adding a benefit claim in a design application differs from that of utility applications. According to MPEP 211.02(a):

“For design applications, an application may be amended to claim priority to or the benefit of a prior-filed application after the application issues as a patent by filing a reissue application. Note that the copendency requirement of 35 U.S.C. 120 must still be met.”

This means that for design applications:

  • Corrections or additions to benefit claims cannot be made after the application has issued as a patent through a Certificate of Correction.
  • The only way to correct or add a benefit claim after issuance is by filing a reissue application.
  • The copendency requirement under 35 U.S.C. 120 must still be satisfied, meaning the applications must have been co-pending at some point.

It’s important to note that this procedure is specific to design applications and differs from the process for utility applications.

To learn more:

The procedure for changing the correspondence address in a reexamination or supplemental examination proceeding differs from that of regular patent applications. According to MPEP 601.03(a):

“A correspondence address or change of address filed in a patent application will not change the correspondence address for a reexamination or supplemental examination proceeding.”

To change the correspondence address in these proceedings:

  • File a separate paper specifically requesting the change in the reexamination or supplemental examination proceeding
  • Ensure the request is signed by a patent practitioner or the patent owner
  • Submit the request directly to the Central Reexamination Unit (CRU) or the Office of Patent Legal Administration (OPLA) for supplemental examination proceedings

It’s crucial to note that changes made in the patent application will not automatically apply to these special proceedings.

To learn more:

When canceling a figure in a patent application, the following procedure should be followed:

  • Submit a replacement sheet of drawings without the canceled figure.
  • If the canceled figure was the only drawing on the sheet, provide a marked-up copy of the drawing sheet with an annotation showing the cancellation.
  • Label the marked-up copy as “Annotated Sheet”.
  • Present the annotated sheet in the amendment or remarks section explaining the changes.
  • Amend the brief description of the drawings to reflect the change.

This procedure is outlined in MPEP 608.02(t), which states: “If a drawing figure is canceled, a replacement sheet of drawings must be submitted without the figure (see 37 CFR 1.121(d)). If the canceled drawing figure was the only drawing on the sheet, then only a marked-up copy of the drawing sheet including an annotation showing that the drawing has been cancelled is required.”

To learn more:

What is the procedure for an examiner to verify an attorney’s authority during an interview?

When conducting an interview with an attorney or agent who is not of record, the examiner must follow a specific procedure to verify their authority. According to MPEP 405:

If an attorney or agent not of record in an application contacts an examiner for an interview, the examiner may grant the interview if the attorney or agent presents an authorization from the practitioner of record, or presents a signed power of attorney or a paper authorizing them to act as associate or agent.

The examiner should:

  • Ask for an authorization from the practitioner of record
  • Accept a signed power of attorney
  • Accept a paper authorizing the attorney or agent to act as an associate or agent

If none of these are available, the examiner should decline the interview unless the attorney or agent is willing to conduct the interview with the inventor present.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP 102, accessing unpublished patent applications requires specific procedures:

“Applications that were not published or patented, that are not the subject of a benefit claim under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in an application that has issued as a U.S. patent, an application that has published as a statutory invention registration, a U.S. patent application publication, an international publication of an international application under PCT Article 21(2), or a publication of an international registration under Hague Agreement Article 10(3), or are not identified in a U.S. patent, a statutory invention registration, a U.S. patent application publication, an international publication of an international application under PCT Article 21(2), or a publication of an international registration under Hague Agreement Article 10(3) of an international design application designating the United States, are not available to the public.”

In such cases, a granted petition for access or a power to inspect is necessary to obtain the application or a copy of the application. The specific requirements for these procedures are outlined in 37 CFR 1.14(i) and (c) respectively.

For more information on petition for access, visit: petition for access.

For more information on unpublished applications, visit: unpublished applications.

When different correspondence addresses are specified in multiple documents submitted with a patent application, the USPTO follows a specific priority order to determine which address to use. According to MPEP 601.03(b), the priority order is as follows:

  1. Application Data Sheet (ADS)
  2. Application Transmittal
  3. Oath or Declaration (unless a more current power of attorney exists)
  4. Power of Attorney

The MPEP states: “In the experience of the Office, the ADS is the most recently created document and tends to have the most current address.” Therefore, if you want to ensure a specific correspondence address is used, it’s best to include it in the Application Data Sheet.

To learn more:

The Priority Document Exchange (PDX) program is a system that allows participating intellectual property offices to exchange priority documents electronically. This program simplifies the process of submitting certified copies of foreign priority applications for patent applicants.

According to the MPEP, The Office website provides information concerning the priority document exchange program ( www.uspto.gov/patents/basics/international-protection/electronic-priority-document-exchange-pdx ). This information includes participating offices and instructions for accessing foreign applications.

To learn more:

The priority document exchange program is a system that allows participating patent offices to exchange priority documents electronically. According to MPEP 215.02(a):

“Applicants may use the priority document exchange program to obtain a copy of a foreign application filed in a participating foreign intellectual property office.”

This program simplifies the process of obtaining priority documents for patent applications filed in multiple countries.

To learn more:

The priority document exchange program allows the USPTO to obtain priority documents electronically from other participating foreign intellectual property offices, eliminating the need for applicants to submit certified copies themselves. As stated in 37 CFR 1.55(i), the requirement to file a certified copy is considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority includes the necessary information for retrieval
  • The copy is received by the USPTO from the participating office

Applicants must still make the priority claim within the required time period. This program simplifies the process of submitting priority documents for many applicants.

The priority document exchange program is a bilateral or multilateral agreement between the USPTO and participating foreign intellectual property offices that allows for the electronic exchange of priority documents. This program can satisfy the requirement for filing a certified copy of a foreign application under certain conditions.

According to 37 CFR 1.55(i), the certified copy requirement will be considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority is presented in an application data sheet (ADS)
  • The applicant provides the necessary information for the participating office to provide the USPTO with access to the foreign application
  • The USPTO receives a copy of the foreign application from the participating office during the pendency of the application and before the patent is granted

This provision can significantly simplify the process of meeting the certified copy requirement for applicants whose priority applications are from participating countries.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on priority document exchange, visit: priority document exchange.

The priority document exchange program is an agreement between patent offices to electronically exchange priority documents. It affects foreign priority claims in the following ways:

  • Applicants may not need to submit a certified copy if the foreign application is available through the program
  • The USPTO will attempt to retrieve the priority document automatically
  • If successful, it satisfies the requirement to file a certified copy

MPEP 214.02 mentions: “37 CFR 1.55(h) contains provisions relating to when the requirement for a certified copy will be considered satisfied based on a certified copy filed in another U.S. patent or application (see also MPEP § 215, subsection III); 37 CFR 1.55(i) contains provisions relating to the priority document exchange agreement (see also MPEP §§ 215.01 and 215.02(a)).”

Applicants should still monitor the application to ensure the priority document is retrieved and may need to submit a certified copy if the automatic retrieval fails.

The MPEP provides guidelines for the preferred order of arrangement in framing a patent specification. While not mandatory, following this order can help organize the application effectively:

  1. Title of the invention
  2. Cross-reference to related applications
  3. Statement regarding federally sponsored research or development
  4. Background of the invention
  5. Brief summary of the invention
  6. Brief description of the several views of the drawing
  7. Detailed description of the invention
  8. Claims
  9. Abstract of the disclosure

The MPEP states: “The following order of arrangement is preferable in framing the specification. See also MPEP § 608.01(a). Each of the lettered items should appear in upper case, without underlining or bold type, as section headings.”

For more detailed information on the specification arrangement, refer to MPEP § 608.01(a).

To learn more:

The Priority Document Exchange (PDX) program is an electronic system that allows participating intellectual property offices to exchange priority documents securely. According to MPEP 215.01, “Under the PDX program, the participating offices electronically transmit priority documents to each other as needed.” This program eliminates the need for applicants to submit paper certified copies of priority documents in participating offices.

The Patent Law Treaty (PLT) is an international agreement aimed at harmonizing and streamlining formal procedures in patent applications. Its implementation in the U.S. through the Patent Law Treaties Implementation Act (PLTIA) introduced several changes to U.S. patent law, including:

  • Restoration of priority rights in certain cases
  • Changes to formal requirements for patent applications
  • Provisions for international design applications

The MPEP notes: “The Patent Law Treaties Implementation Act of 2012 (PLTIA) amended the patent laws to implement the provisions of the Patent Law Treaty (PLT) in title II; corresponding revisions to title 37 of the Code of Federal Regulations also became effective on December 18, 2013. Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application.”

The Paris Convention for the Protection of Industrial Property is an international agreement that establishes key principles for intellectual property protection, including patents. It was first signed in 1883 and has been revised several times since then.

The Convention is significant in patent law because it established the right of priority, which allows patent applicants to claim priority based on an earlier filing in any country that is a member of the Paris Convention. This right is referenced in MPEP 213, which states:

‘The right of priority is defined in 35 U.S.C. 119(a)… Under this statute, an applicant who has filed a first foreign application is entitled to claim the benefit of the filing date of the first foreign application in a subsequent U.S. national patent application…’

This provision helps inventors protect their inventions internationally by giving them a grace period to file in multiple countries while maintaining the priority date of their first filing.

The Paris Convention is an international treaty that establishes priority rights for patent applications. According to MPEP 213, “The right of priority is defined in 35 U.S.C. 119(a)” and is based on this convention. It allows inventors who file a patent application in one member country to claim priority for up to 12 months when filing in other member countries.

Key points of the Paris Convention include:

  • Establishing a 12-month priority period for patents
  • Allowing applicants to claim priority based on earlier filings in member countries
  • Ensuring equal treatment of foreign and domestic applicants in member countries

What is the Paris Convention and how does it relate to patent filing?

The Paris Convention for the Protection of Industrial Property, commonly known as the Paris Convention, is an international treaty that plays a crucial role in patent filing. According to MPEP 213.01:

The Paris Convention for the Protection of Industrial Property sets forth the concept of a ‘convention application’ and a ‘right of priority.’

This means that applicants from member countries can use their first filing date in one member country as the effective filing date in other member countries, provided they file within 12 months. This treaty facilitates international patent protection by allowing inventors to secure a priority date in multiple countries.

To learn more:

The non-electronic filing fee is an additional fee charged for patent applications not filed by electronic means. This fee was established by the Leahy-Smith America Invents Act and is codified in 37 CFR 1.16(t).

The MPEP states: Section 10(h) of Public Law 112-29, September 16, 2011 (the Leahy-Smith America Invents Act) provides that an additional fee of $400 ($200 for a small entity) shall be established for each application for an original (i.e., non-reissue) patent, except for a design, plant, or provisional application, not filed by electronic means.

This fee applies to:

  • Applications under 35 U.S.C. 111(a) filed on or after November 15, 2011, other than by the USPTO patent electronic filing system.
  • International applications filed with the USPTO as receiving Office on or after November 15, 2011, as part of the transmittal fee.

To learn more:

The most important aspect of an examiner’s action regarding a right of priority is determining the identity of invention between the U.S. and foreign applications. This involves:

  • Considering the foreign application as if it had been filed in the U.S. on the same date it was filed in the foreign country
  • Examining the foreign application for sufficiency of disclosure under 35 U.S.C. 112
  • Determining if there is a basis for the claims sought

The MPEP states: “The most important aspect of the examiner’s action pertaining to a right of priority is the determination of the identity of invention between the U.S. and the foreign applications. The foreign application may be considered in the same manner as if it had been filed in this country on the same date that it was filed in the foreign country, and the applicant is ordinarily entitled to any claims based on such foreign application that applicant would be entitled to under U.S. laws and practice.” (MPEP 216)

What is the minimum deposit amount required to open a USPTO deposit account?

The minimum deposit amount required to open a USPTO deposit account is $1,000. According to MPEP 509.01, “A minimum deposit of $1,000 is required when an account is opened, and a minimum balance of $1,000 is required to be maintained in the account.” This initial deposit ensures that the account has sufficient funds to cover potential fees and charges.

To learn more:

The mailing address for submitting assignment documents depends on whether they are being filed with new applications or not. According to MPEP 302.08:

  • For documents not filed with new applications: Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450
  • For documents filed with new applications: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450

As stated in the MPEP, In order to ensure prompt and proper processing, documents and their cover sheets should be addressed to the Mail Stop Assignment Recordation Services, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450, unless they are filed together with new applications.

To learn more:

What is the limit on the number of previously filed patent applications for micro entity status?

For micro entity status, an applicant must not have been named as an inventor on more than four previously filed patent applications. The MPEP states:

“The applicant has not been named as an inventor on more than 4 previously filed patent applications, other than applications filed in another country, provisional applications under 35 U.S.C. 111(b), or international applications for which the basic national fee under 35 U.S.C. 41(a) was not paid.”

This limit helps ensure that micro entity status is reserved for truly small-scale inventors or businesses. It’s important to note that certain types of applications, such as provisional applications and international applications where the basic national fee wasn’t paid, don’t count towards this limit.

To learn more:

The Manual of Patent Examining Procedure (MPEP) holds a unique legal status in patent law. According to MPEP 101:

The Manual does not have the force of law or the force of the rules in Title 37 of the Code of Federal Regulations.

This means:

  • The MPEP is not legally binding like statutes or regulations
  • It serves as an interpretive guide for patent examiners and practitioners
  • Courts may give it deference but are not bound by its contents

However, the MPEP is highly influential because it:

  • Reflects official USPTO policies and procedures
  • Is used by examiners in their day-to-day work
  • Provides valuable guidance for patent applicants and attorneys

While not law, the MPEP is an essential resource for understanding and navigating the patent examination process.

For more information on patent law, visit: patent law.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

The legal basis for the USPTO’s English translation requirement for assignments is found in the Code of Federal Regulations, specifically 37 CFR 3.26. This regulation is referenced in MPEP 302.02, which states:

37 CFR 3.26 English language requirement.

The regulation mandates that non-English documents must be accompanied by an English translation signed by the translator. This requirement ensures clarity, consistency, and accessibility of patent-related documents within the U.S. patent system.

To learn more:

Tags: patent law

The legal basis for denying amendments to Continued Prosecution Application (CPA) specifications that attempt to reference prior applications stems from both federal regulations and patent law. Specifically:

  • 37 CFR 1.53(d)(7): This regulation establishes that a CPA request itself serves as the specific reference required by 35 U.S.C. 120.
  • 35 U.S.C. 120: This statute outlines the requirements for claiming the benefit of an earlier filing date in the United States.

According to MPEP ¶ 2.34:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.

This means that the CPA filing itself legally establishes the necessary connection to the prior application, making any specification amendment both redundant and impermissible.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on patent law, visit: patent law.

The legal basis for correcting typographical errors in recorded assignment documents is primarily found in the Manual of Patent Examining Procedure (MPEP) and the Code of Federal Regulations (CFR). Specifically:

  • MPEP 323.01(b) outlines the procedures for correcting such errors.
  • 37 CFR 3.41 provides the regulatory basis for the fees associated with these corrections.

Additionally, case law supports these procedures. The MPEP cites:

See In re Abacab International Computers Ltd., 21 USPQ2d 1078 (Comm’r Pat. 1987).

This case reinforces the USPTO’s authority to correct such errors and the procedures for doing so. The combination of statutory regulations, administrative procedures, and case law provides a comprehensive legal framework for addressing typographical errors in recorded assignment documents.

To learn more:

The legal basis for claiming the benefit of an international design application designating the United States is found in 35 U.S.C. 386(c). This statute allows a nonprovisional application to claim the benefit of a prior international design application, subject to the conditions and requirements of 35 U.S.C. 120.

As stated in the MPEP: Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States. This means that applicants can potentially secure an earlier effective filing date for their nonprovisional application by claiming the benefit of a previously filed international design application.

To learn more:

To learn more:

The institution of higher education basis allows applicants to qualify for micro entity status if:

  1. The applicant’s employer, from which the applicant obtains the majority of their income, is an institution of higher education as defined in the Higher Education Act of 1965, or
  2. The applicant has assigned, granted, conveyed, or is obligated to assign, grant or convey, a license or ownership interest in the application to such an institution of higher education.

The applicant must also qualify as a small entity. This basis is implemented in 37 CFR 1.29(d).

Timely recording of patent assignments is crucial for protecting rights against subsequent purchasers. As per 35 U.S.C. 261:

“if an assignment is not timely recorded at the USPTO, the unrecorded assignment will not be superior to the rights acquired by a third party, i.e. a bona fide purchaser, for valuable consideration if that third party did not have knowledge of the unrecorded assignment.”

This provision emphasizes the importance of promptly recording assignments to maintain priority over subsequent purchasers who may not have knowledge of the unrecorded assignment.

To learn more:

The importance of claim terminology in a patent application lies in ensuring clarity and consistency between the claims and the specification. MPEP 608.01(o) states:

The meaning of every term used in any of the claims should be apparent from the descriptive portion of the specification with clear disclosure as to its import.

This means that the specification should provide a clear explanation for all terms used in the claims, ensuring that the patent examiner and potential infringers can understand the scope of the claimed invention.

To learn more:

New matter can have a significant impact on benefit claims in patent applications. The introduction of new matter in a later-filed application can result in the loss of the benefit claim to the prior-filed application. According to MPEP 211.05:

‘New or amended claims which introduce elements or limitations that are not supported by the as-filed disclosure violate the written description requirement. See, e.g., In re Lukach, 442 F.2d 967, 169 USPQ 795 (CCPA 1971) (subgenus range was not supported by generic disclosure and specific example within the subgenus range); In re Smith, 458 F.2d 1389, 1395, 173 USPQ 679, 683 (CCPA 1972) (an adequate description of a genus may not support claims to a subgenus or species within the genus).’

This means that if a later-filed application includes new matter not disclosed in the prior-filed application, it cannot claim the benefit of the earlier filing date for that new matter. The new matter will only be entitled to the filing date of the later-filed application. It’s crucial for applicants to ensure that all claimed subject matter is fully supported by the prior-filed application to maintain the benefit of the earlier filing date.

To learn more:

Incorporating by reference in patent applications can have significant impacts:

  • It allows applicants to include the content of another document without reproducing it in full.
  • The incorporated material becomes part of the application as if it were explicitly included.
  • It can provide support for claims and help meet disclosure requirements.

MPEP 211.05 mentions:

An incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

This highlights the importance of including incorporation by reference statements at the time of filing to ensure their effectiveness. Applicants should carefully consider what materials to incorporate and ensure they are properly referenced to support their claims and meet disclosure requirements.

To learn more:

What is the impact of a terminal disclaimer on claiming benefit of a prior-filed application?

A terminal disclaimer can affect the ability to claim benefit of a prior-filed application. According to MPEP 211.01(b):

Any nonprovisional application claiming the benefit of one or more prior-filed copending nonprovisional applications or international applications designating the United States must include a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications.

However, if a terminal disclaimer has been filed in the prior application, it may limit the ability to claim benefit. The MPEP states:

If the prior application has been published, the validity of the patent may be affected if the continuing application is not filed within one year of the publication date of the prior-filed application. See MPEP § 211.05 for more information on the effects of publication of patent applications.

It’s crucial to consider the implications of terminal disclaimers when claiming benefit, as they can affect patent term and validity.

To learn more:

What is the impact of a defective priority or benefit claim?

A defective priority or benefit claim can have significant consequences for a patent application. According to MPEP 211.01, if the claim for priority or benefit is not properly made:

‘If the claim for priority or benefit is not included in an ADS, the claim for priority or benefit must be included in the first sentence(s) of the specification following the title or in an application data sheet. The specific reference to the prior application must be in the first sentence(s) of the specification following the title or in an application data sheet unless the reference appeared in a preliminary amendment filed on filing.’

The impacts of a defective claim can include:

  • Loss of priority date: This can affect the assessment of prior art against the application.
  • Potential rejection: Claims may be rejected if intervening prior art exists between the filing dates of the prior and current applications.
  • Inability to overcome certain rejections: Without the earlier priority date, it may be harder to overcome rejections based on intervening art.
  • Possible patent term reduction: If the defect is not corrected promptly, it could affect the patent term adjustment.

To avoid these issues, applicants should ensure that priority or benefit claims are properly made in accordance with 37 CFR 1.78 and correct any defects promptly using the procedures outlined in the MPEP.

To learn more:

Tags: prior art

The Image File Wrapper (IFW) system is an electronic system used by the USPTO to store and process patent application files. Key points about the IFW system and its impact on public access include:

  • Paper components of application files are scanned to create electronic image files
  • For IFW applications, the electronic file is the Official file
  • No access is granted to original paper documents used to create the IFW file
  • Processing and examination are conducted using electronic images
  • IFW files for patented applications, published applications, or applications referenced in published documents are accessible through Patent Center on the USPTO website
  • All patent applications filed after June 30, 2003, have been scanned into the IFW system

The IFW system has made it easier for the public to access eligible patent application files online through Patent Center, eliminating the need to physically inspect paper files in many cases.

The Hague Convention Apostille is an international certification that simplifies the authentication process for documents executed in foreign countries. For patent applications, it affects the execution of oaths as follows:

“The Convention abolishes the certification of the authority of the notary public in a member country by a diplomatic or consular officer of the United States and substitutes certification by a special certificate, or apostille, executed by an officer of the member country.”

This means that for member countries of the Hague Convention, an apostille can replace the need for certification by a U.S. diplomatic or consular officer. The USPTO will accept documents with an apostille for filing or recording. You can find a list of current member countries on the Hague Conference on Private International Law website.

To learn more:

The Hague Agreement Concerning International Registration of Industrial Designs is an international treaty that allows applicants to file a single international design application to seek protection in multiple countries. The United States became a party to the Hague Agreement on May 13, 2015.

According to 35 U.S.C. 385:

An international design application designating the United States shall have the effect, for all purposes, from its filing date determined in accordance with section 384, of an application for patent filed in the Patent and Trademark Office pursuant to chapter 16.

This means that an international design application that designates the US is treated similarly to a national design patent application. The MPEP clarifies: Unless otherwise clear from the wording, reference to ‘design application’ or ‘application for a design patent’ in this chapter includes an international design application that designates the United States.

For detailed information on international design applications, refer to MPEP Chapter 2900.

For more information on design patents, visit: design patents.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on international design applications, visit: international design applications.

The Hague Agreement Concerning International Registration of Industrial Designs is an international treaty that allows applicants to file a single international design application with effect in multiple countries. Key points about the Hague Agreement and international design applications include:

  • The United States became a Contracting Party to the Hague Agreement on May 13, 2015.
  • An international design application designating the United States has the effect of a regularly filed application for patent under 35 U.S.C. 385.
  • The Hague Agreement is administered by the International Bureau of the World Intellectual Property Organization (WIPO).
  • 37 CFR 1.9(n) defines an international design application as “an application for international registration of a design filed under the Hague Agreement.”

For detailed information on international design applications, refer to MPEP Chapter 2900.

To learn more:

The government license rights statement required for contractor-owned inventions made under federally sponsored research and development is:

‘This invention was made with government support under (identify the contract) awarded by (identify the Federal agency). The government has certain rights in the invention.’

This statement is mandated by 35 U.S.C. 202(c)(6) and must be included at the beginning of the patent application and any issued patents.

Patent applications that have not been published under 35 U.S.C. 122(b) are generally preserved in confidence pursuant to 35 U.S.C. 122(a). Information about the filing, pendency, or subject matter of an application, including status information and access to the application, is only given to the public as set forth in § 1.11 or in this section of the MPEP.

As stated in 37 CFR 1.14(a): Patent applications that have not been published under 35 U.S.C. 122(b) are generally preserved in confidence pursuant to 35 U.S.C. 122(a). Information concerning the filing, pendency, or subject matter of an application for patent, including status information, and access to the application, will only be given to the public as set forth in § 1.11 or in this section.

The general mailing address for patent-related correspondence is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address should be used for patent applications, replies to notices of informality, requests for extension of time, notices of appeal, and other patent-related matters processed by organizations reporting to the Commissioner for Patents.

As stated in the MPEP: Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents P.O. Box 1450 Alexandria, Virginia 22313-1450

To learn more:

The general mailing address for patent-related correspondence is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address is used for various patent-related documents, including:

  • Patent applications
  • Replies to notices of informality
  • Requests for extension of time
  • Notices of appeal to the Patent Trial and Appeal Board
  • Requests for reexamination
  • Petitions to the Commissioner for Patents

As stated in MPEP 501: “Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.”

For more information on patent application filing, visit: patent application filing.

For more information on patent correspondence, visit: patent correspondence.

The general mailing address for patent applications and patent-related papers is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address should be used for correspondence including patent applications, replies to notices of informality, requests for extension of time, notices of appeal, briefs, requests for oral hearings, applications for patent term extensions, reexamination requests, statutory disclaimers, certificates of correction, petitions, and other patent-related correspondence processed by organizations reporting to the Commissioner for Patents.

As stated in MPEP 501: “Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450”

What is the filing deadline for a continuation application?

A continuation application must be filed before the patenting, abandonment, or termination of proceedings on the prior application. The MPEP 201.07 states:

“To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

Key points to remember:

  • There is no specific time limit for filing a continuation as long as the parent application is still pending.
  • The continuation must be filed before the parent application is patented, abandoned, or otherwise terminated.
  • If you want to file after the parent is patented, you must file a reissue application instead.

It’s crucial to monitor the status of the parent application closely to ensure timely filing of the continuation.

For more information on continuation application, visit: continuation application.

For more information on filing deadline, visit: filing deadline.

What is the filing date requirement for a divisional application?

A divisional application must be filed before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention. The MPEP states:

A divisional application is often filed as a result of a restriction requirement made by the examiner. The divisional application may be filed under 37 CFR 1.53(b) (or 1.53(d) if the application is a design application) before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention.”

This means that the divisional application must be filed while the parent application is still pending, ensuring continuity in the examination process.

For more information on Divisional application, visit: Divisional application.

For more information on patent procedure, visit: patent procedure.

The filing date of a nonprovisional application under 37 CFR 1.53(b) depends on the type of application and when it was filed:

  • For utility and plant applications filed on or after December 18, 2013: The filing date is the date on which the specification, with or without claims, is received in the USPTO.
  • For design applications: The filing date is the date on which the specification, including at least one claim, and any required drawings are received in the USPTO.
  • For applications filed before December 18, 2013: The filing date was the date on which the specification containing a description and at least one claim, and any required drawings were received in the USPTO.

The MPEP states:

For applications filed on or after December 18, 2013, the filing date of a nonprovisional application filed under 35 U.S.C. 111(a), other than a design patent application, is the date on which a specification, with or without claims, is received in the Office.

This change in filing date requirements was part of the implementation of the Patent Law Treaties Implementation Act of 2012.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application requirements, visit: patent application requirements.

What is the filing date of a divisional application?

A divisional application is entitled to the filing date of the parent application. According to MPEP 201.06, “A divisional application is entitled to the benefit of the filing date of the prior-filed application if filed as a nonprovisional application that discloses and claims only subject matter disclosed in the prior-filed (parent) application.” This means that the divisional application inherits the filing date of its parent application, provided it meets the necessary requirements.

To learn more:

The filing date of a Continued Prosecution Application (CPA) is determined by when the request for the CPA is received by the USPTO. As stated in the MPEP, The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed. This means that the CPA’s filing date is not the same as the filing date of the prior application, but rather the date when the USPTO receives the proper CPA request.

To learn more:

Tags: CPA

What is the filing date of a continuation-in-part application?

The filing date of a continuation-in-part (CIP) application is the date on which the application is filed with the USPTO. According to MPEP 201.08, “A continuation-in-part application is entitled to the benefit of the filing date of an earlier nonprovisional application as to common subject matter.” However, it’s important to note that any new matter introduced in the CIP application is only entitled to the filing date of the CIP itself.

For the common subject matter, the CIP can claim the benefit of the earlier application’s filing date under 35 U.S.C. 120. This can be crucial for establishing priority and determining the relevant prior art for patentability assessments.

For applications properly filed under 37 CFR 1.10 using Priority Mail Express, the filing date is the date the application was deposited with the U.S. Postal Service. The MPEP states:

For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service. For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

If the proper procedures were not followed, the application will receive a filing date as of the date it was received in the USPTO.

For applications properly filed using Priority Mail Express® (formerly Express Mail) through the U.S. Postal Service, the filing date is the date of deposit with the postal service. The MPEP states:

“For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service.”

This means that even if the application is deposited on a Saturday, and the U.S. Postal Service marks it with a Saturday date, the USPTO will accord and stamp the correspondence with the Saturday date.

However, if the proper procedures for using Priority Mail Express® were not followed, the application will receive a filing date as of the date it was received in the USPTO. Any dispute regarding the filing date in such cases would require a petition, as explained in the MPEP:

“Any review of these matters would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)), providing whatever arguments and evidence petitioner has that the application is entitled to a filing date as of the date it was deposited as Priority Mail Express®.”

To learn more:

To learn more:

The filing date for a nonprovisional patent application depends on the type of application and when it was filed:

  • For applications filed on or after December 18, 2013 (except design applications): The filing date is the date when a specification, with or without claims, is received by the USPTO.
  • For design applications: The filing date is the date when the specification (including at least one claim), and any required drawings are received by the USPTO.
  • For applications filed before December 18, 2013: The filing date is the date when a specification containing a description and at least one claim, and any necessary drawings are filed with the USPTO.

The MPEP states: Except for design applications, the filing date for applications filed under 35 U.S.C. 111 on or after December 18, 2013 is the date on which a specification, with or without claims, is received in the Office.

To learn more:

According to MPEP 201.06(c), the filing date for a divisional or continuation application filed under 37 CFR 1.53(b) is determined as follows:

‘The filing date of an application filed under 37 CFR 1.53(b) is the date on which a specification, with or without claims, is received in the Office.’

This means that the filing date is established when the USPTO receives the specification, regardless of whether claims are included. It’s important to note that other application components, such as drawings or fees, are not required to secure the filing date.

To learn more:

To learn more:

What is the filing date for a Continued Prosecution Application (CPA)?

The filing date for a Continued Prosecution Application (CPA) is determined based on when it is filed. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is a specific reference to the prior application as required by 35 U.S.C. 120.

This means that the CPA’s filing date is the day when the separate request for a CPA is submitted, not the filing date of the prior application. It’s important to note that this request must specifically reference the prior application to comply with 35 U.S.C. 120.

To learn more:

To learn more:

The fee for recording documents with the USPTO varies depending on the method of submission and the type of intellectual property involved. According to MPEP 302.06:

For patents:

  • If submitted electronically: $0 (as of 2019)
  • If submitted on paper or via facsimile: Fee set in 37 CFR 1.21(h)(2)

For trademarks:

The MPEP advises: Customers should check the current fee schedule on the Office website before submitting documents for recordation.

To learn more:

The fee for recording a patent assignment with the USPTO depends on the method of submission:

  • For electronic submissions through the Electronic Patent Assignment System (EPAS), the fee is currently $0, as stated in 37 CFR 1.21(h)(1).
  • For non-electronic submissions (e.g., mail or fax), the fee is set forth in 37 CFR 1.21(h)(2).

It’s important to note that fees may change over time. As stated in MPEP 302.06: “Customers should check the current fee schedule on the Office website before submitting documents for recordation.”

Additionally, no fee is required for recording certain government interest documents, as specified in 37 CFR 3.41(b).

The fee for recording a corrective document or substitute statement with the USPTO is the same as the fee for recording the original assignment document. MPEP 323 states:

“The fee for recording a corrective document or substitute statement is the same as the fee for recording the original assignment document.”

As of 2023, the fee for recording an assignment electronically is $25 per property. However, fees are subject to change, so it’s advisable to check the current USPTO Fee Schedule for the most up-to-date information.

For more information on assignment correction, visit: assignment correction.

For more information on USPTO fees, visit: USPTO fees.

What is the fee for correcting inventorship in a patent application after September 16, 2012?

As of September 16, 2012, there is no fee required for correcting inventorship in a patent application. The MPEP states: Effective September 16, 2012, there is no fee required for requests to correct inventorship submitted under 37 CFR 1.48(a) in a nonprovisional application. This change was implemented as part of the America Invents Act (AIA) to simplify the process of correcting inventorship. However, it’s important to note that while there’s no fee, the request must still meet other requirements specified in 37 CFR 1.48(a).

To learn more:

An examiner’s consideration of documents listed in an Information Disclosure Statement (IDS) is as follows:

  • Documents are considered in the same manner as other documents in Office search files.
  • The examiner conducts a proper field of search.
  • For non-English language documents, consideration is limited to what can be understood from the concise statement and any drawings or chemical formulas.

The MPEP states: Consideration by the examiner of the information submitted in an IDS means that the examiner will consider the documents in the same manner as other documents in Office search files are considered by the examiner while conducting a search of the prior art in a proper field of search. (MPEP 609.05(b))

Regarding non-English documents, the Federal Circuit has noted: [A]s MPEP Section 609C(2) reveals, the examiner’s understanding of a foreign reference is generally limited to that which he or she can glean from the applicant’s concise statement…Consequently, while the examiner’s initials require that we presume that he or she considered the [foreign] reference, this presumption extends only to the examiner’s consideration of the brief translated portion and the concise statement. (Semiconductor Energy Laboratory Co. v. Samsung Electronics Co., 204 F.3d 1368, 1377-78, 54 USPQ2d 1001, 1008 (Fed. Cir. 2000))

To learn more:

The examiner plays a crucial role in ensuring the completeness and consistency of patent application drawings. According to MPEP 608.02(e), the examiner should:

  • Ensure figures are correctly described in the brief description of the drawings section
  • Verify reference characters are properly applied
  • Check that no single reference character is used for two different parts or for a given part and its modification
  • Confirm there are no superfluous illustrations

The examiner may use specific form paragraphs to require corrections if any issues are identified.

To learn more:

Examiners play a crucial role in identifying and addressing missing drawings that may have been overlooked during initial processing. The examiner’s responsibilities include:

  1. Reviewing the application to determine if all referenced drawings are present
  2. Assessing whether the application is entitled to a filing date based on its completeness
  3. Notifying the applicant of any omissions in the next Office action
  4. Providing options for the applicant to address the missing drawings

The MPEP states: If it is discovered that an application that was forwarded for examination was filed without all of the drawing figure(s) referred to in the specification, and a Notice of Omitted Items or other OPAP notice regarding omitted items has not been mailed by OPAP, the examiner should review the application to determine whether the application is entitled to a filing date

For applications filed under 35 U.S.C. 111(a) prior to December 18, 2013, or design applications, the examiner must ensure that the application contains:

  • Something that can be construed as a written description
  • At least one drawing figure (if necessary under 35 U.S.C. 113, first sentence)
  • At least one claim

For non-design applications filed on or after December 18, 2013, the application must contain a specification, with or without drawings, to be entitled to a filing date.

To learn more:

The examiner plays a crucial role in ensuring proper claim terminology by scrutinizing claims for new matter and new terminology. MPEP 608.01(o) states:

Note that examiners should ensure that the terms and phrases used in claims presented late in prosecution of the application (including claims amended via an examiner’s amendment) find clear support or antecedent basis in the description so that the meaning of the terms in the claims may be ascertainable by reference to the description, see 37 CFR 1.75(d)(1).

If the examiner finds that claims lack proper support or antecedent basis, they may require the applicant to amend the description or object to the specification using form paragraph 7.44.

To learn more:

What is the examiner’s responsibility regarding NPL citations in an IDS?

Examiners have specific responsibilities when handling Non-Patent Literature (NPL) citations in an Information Disclosure Statement (IDS):

  • The examiner should indicate that all references have been considered, except where lined through.
  • For NPL, the examiner should ensure that bibliographic information is complete and legible.
  • If bibliographic information is not complete and legible, the examiner may choose not to consider the reference.

The MPEP 609.05(b) states: “The examiner must also consider all the information properly submitted in an IDS in the same manner that the examiner considers other documents in Office search files while conducting a search of the prior art in a proper field of search.”

Additionally, “If an item of information in an IDS fails to comply with all the requirements of 37 CFR 1.97 and 37 CFR 1.98, that item of information in the IDS will not be considered and a line should be drawn through the citation to show that it has not been considered.”

To learn more:

What is the examiner’s responsibility regarding non-compliant IDSs?

When an examiner encounters a non-compliant Information Disclosure Statement (IDS), they have specific responsibilities:

  • The examiner must inform the applicant of the non-compliance in the next Office action.
  • The examiner should clearly indicate which requirements have not been met.
  • The non-compliant IDS will be placed in the application file but will not be considered by the examiner.

As stated in MPEP 609.05(a): ‘If an information disclosure statement does not comply with the requirements based on the time of filing of the IDS (37 CFR 1.97) and/or the content requirements (37 CFR 1.98), the examiner should: (A) inform applicant in the next Office action that the information disclosure statement has been placed in the application file but has not been considered; and (B) inform applicant of the reasons for non-compliance.’ This ensures that the applicant is aware of the issue and has an opportunity to correct it or submit a compliant IDS.

To learn more:

The Electronic Priority Document Exchange (PDX) program is a system that allows for the electronic transmission of priority documents between participating foreign intellectual property offices. As stated in the MPEP:

Electronic Priority Document Exchange (PDX) agreements provide for the electronic transmission of priority documents to and from participating foreign intellectual property offices.

This program simplifies the process of obtaining certified copies of foreign priority applications, which is crucial for establishing priority claims in patent applications.

While restoration of the right of priority allows for valid priority claims up to 14 months from the earliest priority date (or 8 months for design applications), pre-AIA applications are still subject to the 12-month statutory bar under pre-AIA 35 U.S.C. 102(b) and (d). MPEP 213.03 clarifies: ‘It should be noted that although an application may now validly claim priority under 35 U.S.C. 119(a) through (d) and (f), 172, 365(a) or (b), or 386(a) or (b) to a foreign application filed up to fourteen months earlier (or eight months earlier in the case of a design application) in view of the restoration provision of 37 CFR 1.55(c), an application subject to examination under pre-AIA first to invent laws (rather than the first inventor to file provisions of the AIA) would still be subject to the 12-month statutory time periods in pre-AIA 35 U.S.C. 102(b) and (d) which are measured from the U.S. filing date.’

This means that while the priority claim may be valid, the earlier filed foreign application could still be used as prior art against a pre-AIA application if it was published more than one year before the U.S. filing date.

For more information on pre-AIA, visit: pre-AIA.

Tags: pre-AIA

Recording an assignment at the USPTO does not determine its validity or effect on title. As stated in 37 CFR 3.54:

“The recording of a document pursuant to § 3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.”

The USPTO may, when necessary, determine the effect of a document and whether a party has authority to take action in matters pending before the Office.

To learn more:

Recording a patent assignment with the USPTO has specific legal effects. The MPEP states:

‘Recordation of the assignment provides legal notice to the public of the assignment.’

However, it’s important to note that:

‘It should be noted that recording of the assignment is merely a ministerial act; it is not an Office determination of the validity of the assignment document or the effect of the assignment document on the ownership of the patent property.’

This means that while recordation provides public notice, it does not guarantee the validity or enforceability of the assignment. The MPEP cites 37 CFR 3.54 and Realvirt, LLC v. Lee, 195 F.Supp.3d 847, 862-3 (E.D. Va. 2016) for this principle.

Recording a document at the USPTO has the following effects:

  • It does not determine the validity of the document or its effect on title.
  • The Office may determine a document’s effect when necessary for Office proceedings.
  • Conditional assignments are treated as absolute assignments until canceled.
  • Recording provides protection against subsequent purchasers without notice.

37 CFR 3.54 states: The recording of a document pursuant to §3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.

Additionally, according to 35 U.S.C. 261, timely recording at the USPTO is crucial for maintaining superiority of rights against subsequent purchasers.

For more information on document recording, visit: document recording.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO procedures, visit: USPTO procedures.

Incorporating by reference a prior application in a continuation or divisional application can provide important benefits:

  1. It allows the applicant to amend the continuing application to include subject matter from the prior application without the need for a petition, provided the continuing application is entitled to a filing date.
  2. For applications filed on or after September 21, 2004, it can help recover inadvertently omitted material.

The MPEP states: An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are “hereby incorporated by reference.” The statement must appear in the specification.

It’s important to note that an incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

For more information on 37 cfr 1.57, visit: 37 cfr 1.57.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on incorporation by reference, visit: incorporation by reference.

What is the effect of filing a CPA on pending appeals or interferences?

Filing a Continued Prosecution Application (CPA) has significant effects on pending appeals or interferences. According to MPEP 201.06(d):

The filing of a CPA is a specific request to expressly abandon the prior application as of the filing date granted the CPA and to continue prosecution of the prior application in the CPA.

This means that when a CPA is filed:

  • Any pending appeal in the prior application is automatically withdrawn.
  • Any pending interference proceeding in the prior application is terminated.

It’s important to note that these actions occur automatically upon the granting of a filing date to the CPA. Applicants should carefully consider the status of any pending appeals or interferences before filing a CPA, as these proceedings cannot be continued in the CPA.

For more information on CPA, visit: CPA.

For more information on patent prosecution, visit: patent prosecution.

Filing a Continued Prosecution Application (CPA) has a significant effect on the prior application. According to MPEP 201.06(d):

‘A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA.’

This means that:

  • The prior application is automatically and expressly abandoned when the CPA is filed.
  • The abandonment is effective as of the CPA filing date.
  • Any claims or amendments in the prior application that were not entered are not carried over to the CPA.

It’s important to note that while the prior application is abandoned, the CPA is a continuation of that application, maintaining continuity for purposes such as priority claims and patent term calculations.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

Filing a continuation or continuation-in-part (CIP) application does not automatically affect the status of the parent application. The parent application continues to be examined or remains patented (if already issued) independently of the child application.

Key points to note:

1. The parent application remains pending unless expressly abandoned, allowed to go abandoned, or issued as a patent.

2. Filing a continuation or CIP does not automatically abandon the parent application.

3. Prosecution can continue in both the parent and child applications simultaneously.

The MPEP states: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

However, applicants should be aware of potential double patenting issues that may arise between the parent and child applications.

An international application designating the United States has significant legal effects under U.S. patent law. According to MPEP 211.01(c), which cites 35 U.S.C. 363:

An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.

This means that from its international filing date, the application is treated as if it were a pending U.S. application. The MPEP further clarifies:

It is therefore clear that an international application which designates the United States has the effect of a pending U.S. application from the international application filing date until its abandonment as to the United States.

This status continues until the application is either granted as a patent, abandoned, or the proceedings are terminated. This provision allows applicants to claim the benefit of the international filing date in subsequent U.S. applications, subject to meeting other statutory requirements.

To learn more:

An arbitration award in patent cases has limited effect and is binding only on the parties involved in the arbitration. This limitation is clearly stated in 35 U.S.C. 294(c):

“An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person.”

This means that:

  • The arbitration award is conclusive for the parties involved in the dispute.
  • Third parties not involved in the arbitration are not bound by the award.
  • The award does not affect the rights of individuals or entities who were not part of the arbitration proceedings.

This provision ensures that the rights of third parties are protected and that arbitration outcomes do not have unintended consequences on uninvolved parties in patent matters.

A proper foreign priority claim can give a U.S. patent application the benefit of the earlier foreign filing date as its effective filing date for prior art purposes. This can be crucial for establishing novelty and non-obviousness of the invention.

35 U.S.C. 119(a) states that a U.S. application properly claiming foreign priority “shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country.”

This means that intervening prior art published after the foreign filing date but before the U.S. filing date may not be used against the application if the priority claim is valid. However, it’s important to note that the actual U.S. filing date is still used for other purposes, such as calculating patent term.

A preliminary amendment filed with a continuation or divisional application can have significant effects:

  1. If present on the filing date, it is considered part of the original disclosure.
  2. It must comply with the requirements of 37 CFR 1.121 for amendments.
  3. The Office may require a substitute specification for extensive preliminary amendments.
  4. The application will be classified and assigned based on the claims that will be before the examiner after entry of the preliminary amendment.

The MPEP states: Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

However, applicants should be cautious about introducing new matter through a preliminary amendment. The MPEP advises: Where a copy of the oath or declaration from a prior application was filed in a continuation or divisional application, if the examiner determines that new matter is present relative to the prior application, the examiner should so notify the applicant in the next Office action (preferably the first Office action). The examiner should require applicant to delete the benefit claim or redesignate the application as a continuation-in-part.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

A delayed submission of a benefit claim can have significant implications for patent term adjustment (PTA). According to MPEP 211.04:

“If a petition under 37 CFR 1.78 to accept an unintentionally delayed benefit claim is granted, the petition decision will notify applicant that the patent term adjustment statement in the notice of allowance may need to be revised if the patent issues on a date that is more than four months after the date the petition was filed.”

This means that if the petition is granted and the patent issues more than four months after the petition filing date, the patent term adjustment may need to be recalculated. The delay in submitting the benefit claim could potentially reduce the patent term adjustment, as it may be considered applicant delay under the PTA rules.

It’s important for applicants to be aware that delayed benefit claims can affect the overall patent term, potentially shortening the effective life of the patent.

To learn more:

What is the effect of a continuation-in-part application on patent term?

A continuation-in-part (CIP) application can have a significant impact on patent term. According to the MPEP 201.08:

The term of a patent issuing from a continuation-in-part application may be barred or limited by any prior applications or patents from which benefit is claimed.

This means that:

  • The patent term for subject matter carried over from the parent application is calculated from the filing date of the parent application.
  • The patent term for new subject matter introduced in the CIP is calculated from the filing date of the CIP application.
  • This can result in different expiration dates for different claims within the same patent.

It’s crucial for inventors and patent practitioners to carefully consider the timing and content of CIP applications to maximize patent protection and term.

For more information on patent term, visit: patent term.

Tags: patent term

What is the effect of a benefit claim on the effective filing date of a continuing application?

A benefit claim to a prior-filed application can significantly impact the effective filing date of a continuing application. The MPEP 211.01(b) explains:

‘The effective filing date of a claimed invention is determined on a claim-by-claim basis and not an application-by-application basis. It is possible for different claims in a later-filed application to receive different effective filing dates.’

This means that:

  • Each claim in a continuing application may have a different effective filing date
  • The effective date depends on when the claimed subject matter was first disclosed in a parent application
  • Claims fully supported by the parent application get the parent’s filing date as their effective date
  • New matter introduced in the continuing application gets the actual filing date of that application

It’s crucial for applicants to carefully consider the content of prior applications when making benefit claims, as this can affect patentability determinations and the scope of prior art that can be cited against the claims.

To learn more:

The duty to investigate entitlement to claim small entity status refers to the obligation of patent applicants to thoroughly investigate all facts and circumstances before determining their actual entitlement to small entity status. According to MPEP 509.03(a), “applicants need to do a complete and thorough investigation of all facts and circumstances before making a determination of actual entitlement to small entity status.” This investigation is crucial to ensure that small entity status is claimed only when appropriate.

To learn more:

Tags: patent fees

What is the duty of disclosure in patent applications?

The duty of disclosure is a fundamental obligation in the patent application process. As outlined in MPEP 410:

“Each individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability as defined in this section.”

This duty requires applicants and their representatives to:

  • Disclose all known material information
  • Submit information disclosure statements (IDS)
  • Update the USPTO with new material information throughout the application process

Failing to comply with the duty of disclosure can result in charges of inequitable conduct, which may render a patent unenforceable. It’s crucial for applicants to err on the side of disclosure when in doubt about the materiality of information.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What is the duration of limited recognition granted by the OED Director?

The duration of limited recognition granted by the OED Director is not explicitly specified in MPEP 402.01. However, the section states: Limited recognition is granted for a period consistent with the employment situation for which the individual is granted limited recognition. This suggests that the duration is tailored to each individual’s specific employment situation and may vary case by case. It’s important to note that limited recognition can be withdrawn by the OED Director at any time.

To learn more:

What is the duration of limited recognition for foreign patent agents?

Limited recognition for foreign patent agents is typically granted for a period of 5 years. According to the MPEP, Recognition of a foreign patent agent for the limited purpose of representing applicants before the USPTO in the presentation and prosecution of applications for patent is granted for a period of 5 years. (MPEP 402.01) This means that foreign patent agents must renew their limited recognition status every 5 years to continue practicing before the USPTO.

To learn more:

Tags: USPTO

The duration of a power to inspect granted by an applicant or inventor is generally ongoing until explicitly rescinded. According to MPEP 104:

“An unrestricted power to inspect given by an applicant or inventor is, under existing practice, recognized as in effect until and unless rescinded.”

This means that once granted, a power to inspect remains valid indefinitely unless the grantor takes action to revoke it. However, it’s important to note that this applies to unrestricted powers to inspect granted by applicants or inventors, and different rules may apply to other types of authorizations or parties.

For more information on Patent application access, visit: Patent application access.

The disclosure requirement for a patent application is outlined in MPEP 608. It states that “To obtain a valid patent, a patent application as filed must contain a full and clear disclosure of the invention in the manner prescribed by 35 U.S.C. 112(a).”

This requirement ensures that the public receives valuable information in exchange for the exclusive rights granted to the inventor. The disclosure must be sufficient to enable a person skilled in the art to make and use the invention without undue experimentation.

To learn more:

To learn more:

The Digital Access Service (DAS) is an electronic system that allows participating intellectual property offices to exchange priority documents securely. For international design applications:

  • Applicants can authorize the retrieval of priority documents through DAS.
  • This eliminates the need to manually file certified copies in some cases.
  • The USPTO or IB can retrieve the priority document electronically if available.

MPEP 213.07 states: The certified copy of the foreign application must be filed within the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application, except as provided in paragraphs (h), (i), and (j) of this section. DAS can help meet these deadlines more efficiently.

To learn more:

The main differences in priority claim requirements for design applications compared to utility applications are:

  • Time limit: Design applications can claim priority at any time during pendency, while utility applications have specific deadlines
  • Restoration of priority: Not applicable to design applications

MPEP 214.01 states: “The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.” Additionally, “In a design application, a claim for priority may be made at any time during the pendency of the application.”

However, both design and utility applications must still meet other requirements, such as providing a certified copy of the foreign application and properly identifying the priority application.

The requirements for filing a foreign priority claim differ for applications filed before and after September 16, 2012. The key difference lies in where the priority claim must be presented:

  • For applications filed on or after September 16, 2012: The priority claim must be presented in an Application Data Sheet (ADS). This is specified in 37 CFR 1.55(d)(1): For applications filed under 35 U.S.C. 111(a) on or after September 16, 2012, 37 CFR 1.55(d)(1) requires the claim for priority to be presented in an application data sheet.
  • For applications filed before September 16, 2012: The priority claim can be presented either in an Application Data Sheet or in the oath or declaration. As stated in the MPEP: For applications filed under 35 U.S.C. 111(a) prior to September 16, 2012, unless provided in an application data sheet, the oath or declaration under 37 CFR 1.63 must identify the foreign application for patent or inventor’s certificate for which priority is claimed under 37 CFR 1.55, and any foreign applications having a filing date before that of the application on which priority is claimed, by specifying the application number, country, day, month, and year of its filing.

Regardless of the filing date, the priority claim must include the same essential information: the application number, country (or intellectual property authority), and filing date (day, month, and year) of the foreign application. The difference is primarily in the document where this information must be presented.

The main difference in power of attorney revocation between pre-AIA (before September 16, 2012) and post-AIA (on or after September 16, 2012) applications lies in who can sign the power of attorney and the process for revocation:

  • Post-AIA (on or after September 16, 2012): The power of attorney must be signed by the applicant or patent owner. For an assignee to revoke a power of attorney, they must first become the applicant under 37 CFR 1.46(c).
  • Pre-AIA (before September 16, 2012): The assignee of record of the entire interest can revoke the power of attorney of the applicant directly, provided they establish their right to take action under pre-AIA 37 CFR 3.73(b).

This change reflects the shift in USPTO regulations to give more control to the applicant in post-AIA applications, while pre-AIA rules allowed more direct action by assignees.

To learn more:

There is a significant difference in how affidavits are handled between applications filed under 37 CFR 1.53(b) and 37 CFR 1.53(d). According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

In summary:

  • For 37 CFR 1.53(b) applications: Affidavits from prior applications must be explicitly included and referenced.
  • For 37 CFR 1.53(d) applications: Affidavits from the parent nonprovisional application automatically become part of the new application.

For more information on continuation applications, visit: continuation applications.

The key difference in assignment between division/continuation applications and substitute/continuation-in-part (CIP) applications lies in how prior assignments are applied:

  • Division/Continuation Applications: Prior assignments recorded against the original application automatically apply to these applications. As stated in MPEP 306: In the case of a division or continuation application, a prior assignment recorded against the original application is applied (effective) to the division or continuation application because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.
  • Substitute/CIP Applications: Prior assignments do not automatically apply. MPEP 306 states: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This difference is due to the nature of these application types. Division and continuation applications contain only subject matter from the original application, while substitute and CIP applications may contain new subject matter not present in the original application.

The main difference between utility and design patents is in what they protect:

  • Utility patents protect the way an article is used and works. They cover new and useful processes, machines, manufactures, or compositions of matter.
  • Design patents protect the way an article looks. They cover new, original, and ornamental designs for an article of manufacture.

The MPEP distinguishes between these types of patents by referencing different sections of U.S. Code: utility patents are provided for by 35 U.S.C. 101, while design patents are provided for by 35 U.S.C. 171.

For more information on design patent, visit: design patent.

While both the Certificate of Mailing (37 CFR 1.8) and Priority Mail Express (37 CFR 1.10) procedures can be used to establish timely filing of USPTO correspondence, they have some key differences:

  • Certificate of Mailing can be used with any class of mail, while Priority Mail Express is a specific USPS service.
  • Certificate of Mailing uses the date of deposit with USPS as the filing date, while Priority Mail Express uses the date of deposit as shown by the “date accepted” on the mailing label.
  • Certificate of Mailing cannot be used for new patent applications, while Priority Mail Express can establish a filing date for new applications.
  • Certificate of Mailing requires a signed certificate, while Priority Mail Express requires the mailing label to be affixed to the correspondence.

The MPEP notes: “New patent applications filed in accordance with 37 CFR 1.10 will be stamped by the Office with the date of deposit as Priority Mail Express® with the United States Postal Service.”

Both procedures have specific requirements and limitations, so it’s important to consult the full text of 37 CFR 1.8 and 37 CFR 1.10 when deciding which to use.

The Brief Summary of Invention and the Detailed Description serve different purposes in a patent application:

  • Brief Summary: According to MPEP 608.01(d), it should provide a concise overview of the invention’s nature and substance. The MPEP states, “A brief summary of the invention indicating its nature and substance, which may include a statement of the object of the invention, should precede the detailed description.”
  • Detailed Description: This section provides a comprehensive explanation of the invention, including how to make and use it, as required by 35 U.S.C. 112(a).

The Brief Summary is meant to give a quick understanding of the invention, while the Detailed Description provides the full technical disclosure necessary for enablement and written description requirements.

To learn more:

What is the difference between small entity and micro entity status?

While both small entity and micro entity statuses offer reduced patent fees, they have distinct eligibility criteria:

  • Small Entity Status:
    • Available to individuals, small businesses (fewer than 500 employees), and non-profit organizations
    • Offers a 50% reduction in most patent fees
  • Micro Entity Status:
    • More stringent requirements, including income limitations and limits on the number of previously filed patent applications
    • Offers a 75% reduction in most patent fees

As per MPEP 509.03, “Small entity status entitles applicants to a fifty-percent reduction in a number of patent fees.” Micro entity status, while not explicitly covered in this section, provides even greater fee reductions for those who qualify.

To learn more:

Tags: USPTO fees

What is the difference between recording and registering a patent assignment?

Recording and registering a patent assignment are two distinct processes:

  • Recording refers to submitting the assignment document to the USPTO for public notice. As stated in MPEP 302, ‘The recording of the assignment document in the USPTO is merely a ministerial act and does not determine the validity of the document.’
  • Registering is not a term used by the USPTO for assignments. The term ‘registration’ is typically used for trademarks, not patents.

Recording an assignment provides constructive notice of the transfer of ownership but does not guarantee the assignment’s validity or enforceability.

For more information on ownership transfer, visit: ownership transfer.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

What is the difference between recording an assignment and registering a trademark?

Recording an assignment for a patent or trademark application is different from registering a trademark. Here are the key distinctions:

  • Recording an assignment: This process involves documenting the transfer of ownership rights for a patent or trademark application. It’s done through the USPTO’s Assignment Recordation Branch.
  • Registering a trademark: This is the process of officially registering a trademark with the USPTO to protect your brand identity. It’s handled by the Trademark Office.

As stated in MPEP 302: “The recording of assignments is governed by 35 U.S.C. 261 for patents and 15 U.S.C. 1060 for trademarks.” This indicates that assignment recording is a separate process from trademark registration, which is governed by different statutes.

For more information on assignment recording, visit: assignment recording.

For more information on USPTO procedures, visit: USPTO procedures.

What is the difference between recording a license and an assignment at the USPTO?

The main difference between recording a license and an assignment at the USPTO lies in the transfer of ownership rights:

  • Assignment: Transfers ownership of the patent or application to another party.
  • License: Grants permission to use the patent or application without transferring ownership.

According to MPEP 313: Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11(a). This includes licenses, which are recorded to provide notice of the agreement but do not change the ownership records at the USPTO.

The timing of a preliminary amendment significantly affects its status within a patent application. MPEP 608.04(b) clarifies this distinction:

A preliminary amendment present on the filing date of the application (e.g., filed along with the filing of the application) is considered a part of the original disclosure. […] A preliminary amendment filed after the filing date of the application is not part of the original disclosure of the application.

In essence, preliminary amendments submitted with the initial application filing are treated as part of the original disclosure. However, any preliminary amendments filed after the application’s filing date are not considered part of the original disclosure. This distinction is crucial for determining what constitutes new matter in the application and can affect the examination process.

To learn more:

The America Invents Act (AIA) brought significant changes to patent law, including rules regarding patent ownership. The key differences between pre-AIA (before September 16, 2012) and AIA (on or after September 16, 2012) patent ownership rules are:

  1. Applicability: Pre-AIA rules apply to applications filed before September 16, 2012, while AIA rules apply to applications filed on or after that date.
  2. Juristic Entity Representation: Under AIA rules, juristic entities (e.g., corporations) must be represented by a patent practitioner for most actions. Pre-AIA rules allowed juristic entities to take certain actions without representation.
  3. Ownership Establishment: The process for establishing ownership is slightly different, with AIA applications following 37 CFR 3.73 and pre-AIA applications following pre-AIA 37 CFR 3.73(b).
  4. Inventor’s Oath or Declaration: AIA introduced changes to the inventor’s oath or declaration requirements, which can affect how assignees interact with the patent application process.

According to MPEP 324: [Editor Note: See MPEP § 325 for establishing the right of assignee to take action in an application filed on or after September 16, 2012.] This indicates that different sections of the MPEP should be consulted depending on the application’s filing date.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

What is the difference between pre-AIA and AIA applications regarding assignee filing?

The key difference between pre-AIA (America Invents Act) and AIA applications regarding assignee filing lies in the requirements for establishing the right of an assignee to take action:

  • Pre-AIA applications (filed before September 16, 2012): The assignee must establish their right to take action by filing evidence of ownership in the USPTO.
  • AIA applications (filed on or after September 16, 2012): The assignee can simply be named as the applicant, eliminating the need to file evidence of ownership.

As stated in MPEP 324: “For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of an application for an original patent, and any patent that may issue therefrom, unless there is an assignment.”

For more information on pre-AIA, visit: pre-AIA.

Tags: pre-AIA

Pre-AIA 37 CFR 1.42 and pre-AIA 37 CFR 1.47 serve different purposes in relation to deceased inventors:

  • Pre-AIA 37 CFR 1.42: This regulation specifically addresses the situation of a deceased inventor. It allows the legal representative (executor or administrator of the estate) to make an application on behalf of the deceased inventor.
  • Pre-AIA 37 CFR 1.47: This regulation is not intended for deceased inventors directly. As stated in the MPEP, Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

However, pre-AIA 37 CFR 1.47 does apply in cases where:

  • A known legal representative of a deceased inventor cannot be found or reached after diligent effort, or
  • The legal representative refuses to make the application

In such cases, the last known address of the legal representative must be provided, as per MPEP § 409.03(e).

It’s important to note that these regulations apply to applications filed before September 16, 2012. For applications filed on or after that date, different procedures may apply.

To learn more:

To learn more:

The distinction between petitioning and appealing a new matter rejection is crucial in patent prosecution:

  • Petition: Used when new matter is confined to amendments in the specification.
  • Appeal: Required when new matter affects the claims, leading to their rejection.

According to MPEP 608.04(c):

“Where the new matter is confined to amendments to the specification, review of the examiner’s requirement for cancelation is by way of petition. But where the alleged new matter is introduced into or affects the claims, thus necessitating their rejection on this ground, the question becomes an appealable one…”

This means that even if new matter is introduced in both the specification and claims, the claim-related issues must be addressed through the appeal process, not by petition.

To learn more:

Patent assignment and licensing are two different ways of transferring patent rights. The MPEP defines assignment as:

‘Assignment of patent rights is defined as ‘a transfer by a party of all or part of its right, title and interest in a patent [or] patent application….”

In contrast, licensing is described as:

‘As compared to assignment of patent rights, the licensing of a patent transfers a bundle of rights which is less than the entire ownership interest, e.g., rights that may be limited as to time, geographical area, or field of use.’

The key difference is that assignment transfers ownership, while licensing grants permission to use the patent without transferring ownership.

What is the difference between new matter and new or amended claims in patent applications?

New matter and new or amended claims are distinct concepts in patent law:

  • New matter refers to content not present in the original disclosure of the application. As stated in MPEP 608.04: ‘New matter includes not only the addition of wholly unsupported subject matter, but may also include adding specific percentages or compounds after a broader original disclosure…’
  • New or amended claims, on the other hand, are permissible as long as they are supported by the original disclosure. The MPEP clarifies: ‘An amendment to the claims or the addition of a new claim must be supported by the description of the invention in the application as filed.’

In essence, while new or amended claims can be added to an application, they must not introduce new matter that wasn’t originally disclosed.

To learn more:

Tags: new matter

What is the difference between new matter and inherent disclosure in patent applications?

New matter and inherent disclosure are distinct concepts in patent law:

  • New matter refers to information added to a patent application after its filing date that goes beyond the original disclosure. This is generally not allowed and can result in rejection.
  • Inherent disclosure refers to information that, while not explicitly stated in the original application, is necessarily present or implied by the content that was disclosed.

According to MPEP 608.04: “New matter includes not only the addition of wholly unsupported subject matter, but may also include adding specific percentages or compounds after a broader original disclosure, or even the omission of a step from a method.” However, inherent properties or characteristics that are necessarily present in the disclosed invention do not constitute new matter.

It’s important for patent applicants to carefully consider what information is truly inherent to their original disclosure to avoid introducing new matter while still fully describing their invention.

To learn more:

To learn more:

Tags: new matter

MPEP 509.04(c) mentions two types of micro entity certifications:

  1. Micro entity certification on the gross income basis
  2. Micro entity certification on the institution of higher education basis

While the specific requirements for each basis are not detailed in this section, it’s important to note that the signing requirements are the same for both types. The certification “can be signed only by an authorized party as set forth in 37 CFR 1.33(b).” This includes patent practitioners and applicants, as detailed in other FAQs.

To learn more:

In patent applications, the distinction between essential and nonessential material is important for incorporation by reference:

  • Essential material is defined in 37 CFR 1.57(d) as material necessary to meet the requirements of 35 U.S.C. 112(a), (b), or (f). It can only be incorporated by reference to a U.S. patent or U.S. patent application publication.
  • Nonessential material is subject matter referred to for purposes of indicating the background of the invention or illustrating the state of the art. It can be incorporated by reference to a wider range of sources, including foreign patents and non-patent publications.

As stated in the MPEP: ‘Other material (‘Nonessential material’) may be incorporated by reference to U.S. patents, U.S. patent application publications, foreign patents, foreign published applications, prior and concurrently filed commonly owned U.S. applications, or non-patent publications.’

To learn more:

The process for deleting an inventor from a Continued Prosecution Application (CPA) differs depending on when the request is made:

  • At CPA Filing: You can submit a statement requesting the deletion of an inventor when filing the CPA. This is a straightforward process that doesn’t require additional paperwork.
  • After CPA Filing: If you need to delete an inventor after the CPA has been filed, you must follow a more formal procedure. The MPEP states:

    “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

This means that post-filing inventor deletions require a formal request under 37 CFR 1.48, which typically involves additional documentation and potentially fees.

For more information on CPA, visit: CPA.

Tags: CPA

The process for correcting inventorship in a Continued Prosecution Application (CPA) differs depending on when the correction is requested:

  • At CPA filing: Inventorship can be corrected by submitting a statement requesting deletion of a named inventor along with the CPA filing. This process is straightforward and does not require additional procedures.
  • After CPA filing: The MPEP states, Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48. This means additional documentation and possibly fees are required for post-filing inventorship changes.

It’s generally simpler to correct inventorship at the time of CPA filing if possible.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

The process for correcting errors differs depending on whether the error is in the cover sheet or the actual assignment document:

  • Cover sheet corrections: These are for errors in the recorded data only, not in the assignment document itself. You can submit a corrective document referencing the reel and frame number of the original recording.
  • Assignment document corrections: For errors in the actual assignment document, you must record a new corrective document, which can be a new assignment or another document that corrects the original.

MPEP 323 states: “Errors in the assignment document itself cannot be corrected simply by submitting a new cover sheet.” This emphasizes the need for a new recorded document for substantive errors.

For more information on USPTO, visit: USPTO.

Tags: USPTO

Claiming priority and claiming benefit are two different mechanisms in patent law, though both can affect the effective filing date of a patent application:

  1. Claiming Priority:
    • Typically refers to claiming the right of priority to a foreign application under 35 U.S.C. 119(a)-(d) and (f)
    • Also includes priority claims to provisional applications under 35 U.S.C. 119(e)
    • Governed by 37 CFR 1.55 for foreign priority claims
  2. Claiming Benefit:
    • Refers to claiming the benefit of an earlier filing date of a U.S. application under 35 U.S.C. 120, 121, 365(c), or 386(c)
    • Typically used for continuation, divisional, or continuation-in-part applications
    • Governed by 37 CFR 1.78

The MPEP discusses both types of claims: “Under certain conditions and on fulfilling certain requirements, a later-filed application for patent filed in the United States may claim the benefit of, or priority to, a prior application filed in the United States (see 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c); see also 37 CFR 1.78) or in a foreign country (see 35 U.S.C. 119(a)-(d) and (f), 365(a) and (b), and 386(a) and (b); see also 37 CFR 1.55).”

Claiming foreign priority under 35 U.S.C. 119(a)-(d) and claiming benefit of a U.S. provisional application under 35 U.S.C. 119(e) are similar in some ways but have important differences:

1. Time limit:
– Foreign priority: Must be claimed within 12 months (6 months for design applications)
– Provisional: Must be claimed within 12 months

2. Effective filing date:
– Both can provide an earlier effective filing date for prior art purposes

3. Patent term:
– Foreign priority: Does not affect patent term
– Provisional: The 12-month period counts towards the 20-year patent term

4. Disclosure requirements:
– Both require the earlier application to provide adequate support for the claimed invention

5. Formalities:
– Foreign priority: Requires a certified copy of the foreign application
– Provisional: No certified copy required, but the provisional must be in English

6. Inventorship:
– Foreign priority: Requires at least one common inventor
– Provisional: Requires at least one common inventor

7. International effect:
– Foreign priority: Recognized in other Paris Convention countries
– Provisional: May not be recognized in some foreign jurisdictions

Both types of priority claims can be valuable for establishing an earlier effective filing date, but they have different requirements and effects that should be considered when developing a patent strategy.

The main differences between claiming benefit under 35 U.S.C. 119(e) and 35 U.S.C. 120 are:

  • 35 U.S.C. 119(e):
    • Used for claiming benefit of a provisional application
    • Does not require specifying the relationship between applications
    • Example: “This application claims the benefit of U.S. Provisional Application No. 61/123,456, filed January 1, 2020.”
  • 35 U.S.C. 120:
    • Used for claiming benefit of a nonprovisional application
    • Requires specifying the relationship (continuation, divisional, or continuation-in-part)
    • Example: “This application is a continuation of U.S. Application No. 12/345,678, filed January 1, 2020.”

MPEP 211.02 advises: “Although 35 U.S.C. 120 does not preclude a benefit claim to a provisional application, it is not recommended that applicants claim the benefit to a provisional application under 35 U.S.C. 120 since such a claim could have the effect of reducing the patent term, as the term of a patent issuing from such an application may be measured from the filing date of the provisional application pursuant to 35 U.S.C. 154(a)(2).”

It’s important to use the correct statute when making benefit claims to ensure proper recognition and avoid potential issues with patent term calculations.

To learn more:

The treatment of affidavits and declarations differs between applications filed under 37 CFR 1.53(b) and those filed under 37 CFR 1.53(d). According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

In summary:

  • For 37 CFR 1.53(b) applications: Affidavits from prior applications must be explicitly incorporated.
  • For 37 CFR 1.53(d) applications: Affidavits from the parent application are automatically included.

For more information on continuation applications, visit: continuation applications.

For more information on patent applications, visit: patent applications.

The distinction between unintentional and intentional delay is crucial when filing a delayed benefit claim. The MPEP 211.04 addresses this:

‘A petition to accept an unintentionally delayed claim under 35 U.S.C. 120, 121, 365(c), or 386(c) for the benefit of a prior-filed application must be accompanied by: … (3) A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(d)(3) and the date the benefit claim was filed was unintentional.’

An unintentional delay may be caused by oversight, administrative error, or other circumstances not intended to delay the filing. Intentional delay, on the other hand, implies a deliberate choice not to file the benefit claim on time. Only unintentional delays can be remedied through a petition. Intentional delays are not excusable and will result in the denial of the delayed benefit claim.

To learn more:

An oath is a sworn statement made before a person authorized to administer oaths, while a declaration is a written statement that can be used in lieu of an oath. According to MPEP 602, “A declaration may be submitted in lieu of an oath in any document filed in the Office provided the declaration complies with the requirements of 37 CFR 1.68.” Declarations are often preferred because they don’t require appearing before an official and are easier to process electronically.

To learn more:

What is the difference between an inventor and an applicant in a patent application?

In patent applications, the terms ‘inventor’ and ‘applicant’ have distinct meanings:

  • Inventor: The person who conceived the invention and is named on the application.
  • Applicant: The person or entity applying for the patent, which may or may not be the inventor.

According to MPEP 605, ‘The applicant for a patent is the inventor by default unless the inventor is dead, insane, or legally incapacitated, in which case the applicant may be the legal representative (e.g., executor, administrator, etc.) of the inventor.’ However, the America Invents Act (AIA) allows for non-inventor applicants in certain situations, such as when the invention is assigned or there’s an obligation to assign.

To learn more:

In patent applications, both attorneys and agents can represent applicants before the USPTO, but there are important distinctions:

  • Patent Attorney: A lawyer who has passed both a state bar exam and the USPTO’s patent bar exam. They can practice law and provide legal advice beyond patent prosecution.
  • Patent Agent: An individual who has passed the USPTO’s patent bar exam but is not a licensed attorney. They can represent clients before the USPTO for patent matters but cannot practice law or provide other legal services.

The MPEP 402 refers to both as ‘patent practitioners’: ‘The term ‘patent practitioner’ as used in this chapter includes patent attorneys and patent agents.’ Both can receive power of attorney and represent applicants in patent matters before the USPTO, but only patent attorneys can offer broader legal counsel.

MPEP 409.03(f) distinguishes between an assignment and an agreement to assign in the context of proving proprietary interest for pre-AIA 37 CFR 1.47(b) applications. The key differences are:

  • Assignment: A completed transfer of rights in the invention.
  • Agreement to Assign: A promise to transfer rights in the future, often conditional.

For an assignment, MPEP 409.03(f) states:

“If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant.”

For an agreement to assign:

“When an inventor has agreed in writing to assign an invention described in an application deposited pursuant to pre-AIA 37 CFR 1.47(b), a copy of that agreement should be submitted.”

Additionally, if the agreement to assign is conditional, evidence that the conditions have been met must be provided. This often applies to employment agreements, where the applicant must prove the invention was made during the course of employment.

To learn more:

To learn more:

The MPEP distinguishes between assignments and licenses in patent law:

  1. Assignment: ‘An assignment of a patent, or patent application, is the transfer to another of a party’s entire ownership interest or a percentage of that party’s ownership interest in the patent or application.’
  2. License: ‘As compared to assignment of patent rights, the licensing of a patent transfers a bundle of rights which is less than the entire ownership interest, e.g., rights that may be limited as to time, geographical area, or field of use.’

The key difference is that an assignment transfers ownership, while a license grants permission to use the patent without transferring ownership. The MPEP further clarifies: ‘A patent license is, in effect, a contractual agreement that the patent owner will not sue the licensee for patent infringement if the licensee makes, uses, offers for sale, sells, or imports the claimed invention, as long as the licensee fulfills its obligations and operates within the bounds delineated by the license agreement.’

An assignment and a 37 CFR 3.73(c) statement serve different purposes in the patent application process:

  • Assignment: This is the actual transfer of ownership rights from the inventor(s) to the assignee.
  • 37 CFR 3.73(c) statement: This is a document filed with the USPTO to establish the assignee’s right to take action in a patent application.

As stated in MPEP 325: “The submission of the statement pursuant to 37 CFR 3.73(c) is not required if a 37 CFR 3.73(b) statement has been previously filed in the application or patent prior to September 16, 2012.” This highlights that the 3.73(c) statement is a procedural document for USPTO purposes, while the assignment is the substantive transfer of rights.

For more information on USPTO procedures, visit: USPTO procedures.

In patent applications, there is a distinction between an assignee and an obligated assignee. According to MPEP 409.05:

  • Assignee: A person or entity to whom the inventor has already transferred ownership rights of the invention.
  • Obligated Assignee: A person or entity to whom the inventor is under a contractual obligation to assign the invention in the future, but the transfer has not yet occurred.

The MPEP states:

Quote: ‘A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent.’

Both assignees and obligated assignees have the right to file patent applications under this provision. The key difference lies in the timing and completion of the assignment process. An assignee has already received the rights, while an obligated assignee has a binding agreement to receive the rights in the future.

To learn more:

What is the difference between an applicant and an inventor in a patent application?

In patent applications, there’s an important distinction between an applicant and an inventor. According to MPEP 605:

‘The term “applicant” refers to the inventor or all of the joint inventors, or to the person applying for a patent as provided in 37 CFR 1.43, 1.45, or 1.46.’

Key differences include:

  • Inventor: The person or persons who conceived of the invention.
  • Applicant: Can be the inventor(s), but may also be:
    • A legal representative of a deceased or incapacitated inventor (37 CFR 1.43)
    • A joint inventor on behalf of all joint inventors (37 CFR 1.45)
    • An assignee, obligated assignee, or person with sufficient proprietary interest (37 CFR 1.46)

The applicant has the right to conduct the prosecution of the application, while the inventor(s) must be named in the application and execute an oath or declaration.

To learn more:

According to MPEP 201.02, there are important distinctions between ‘original’ and ‘substitute’ applications:

Original Application: This term is used in patent statutes and rules to refer to an application that is not a reissue application. An original application can be either a first filing or a continuing application.

Substitute Application: The MPEP defines a substitute application as follows:

A “substitute” application is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application. […] A substitute application does not obtain the benefit of the filing date of the prior application.

The key difference is that a substitute application does not retain the filing date of the prior application, unlike certain types of continuing applications.

For more information on patent filing, visit: patent filing.

For more information on substitute application, visit: substitute application.

According to the MPEP, there is no substantial difference between an ‘allowed’ application and an application ‘in issue’. The MPEP uses these terms interchangeably:

“An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.”

Both terms refer to an application that has passed examination and is awaiting issuance as a patent, provided that all necessary fees are paid and no issues arise that would necessitate withdrawal from issue.

To learn more:

What is the difference between a utility patent and a design patent application?

Utility patents and design patents protect different aspects of an invention, and their applications are processed differently. According to MPEP 201.02:

‘A utility application is a nonprovisional application that is not a design application. A design application is an application for a design patent.’

Key differences include:

  • Utility Patent Application:
    • Protects the functional aspects of an invention
    • Covers how an invention works or is used
    • Has a term of 20 years from the filing date
  • Design Patent Application:
    • Protects the ornamental design of a functional item
    • Covers how an invention looks
    • Has a term of 15 years from the grant date

Inventors should carefully consider which type of patent application best suits their invention’s nature and intended protection.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

For more information on USPTO, visit: USPTO.

According to the MPEP 608.01(v), the main difference lies in their application:

  • Trademark: The term ‘trademark’ includes any word, name, symbol, or device, or any combination thereof- (1) used by a person, or (2) which a person has a bona fide intention to use in commerce and applies to register on the principal register established by this chapter, to identify and distinguish his or her goods, including a unique product, from those manufactured or sold by others and to indicate the source of the goods, even if that source is unknown.
  • Service mark: The term ‘service mark’ means any word, name, symbol, or device, or any combination thereof- (1) used by a person, or (2) which a person has a bona fide intention to use in commerce and applies to register on the principal register established by this chapter, to identify and distinguish the services of one person, including a unique service, from the services of others and to indicate the source of the services, even if that source is unknown.

In simpler terms, trademarks are used for goods, while service marks are used for services.

To learn more:

While both suspended and excluded patent practitioners are prohibited from practicing before the USPTO, there are differences in the nature and duration of the prohibition:

  • Suspended practitioner: Temporarily prohibited from practicing before the USPTO for a specific period.
  • Excluded practitioner: Permanently prohibited from practicing before the USPTO, unless later reinstated.

The MPEP § 407 uses both terms, indicating that the Office treats them similarly in terms of communication and representation: ‘The Office does not communicate with attorneys or agents who have been suspended or excluded from practice.’

What is the difference between a specification and claims in a patent application?

The specification and claims are distinct but related parts of a patent application:

  • Specification: This is a detailed written description of the invention. According to MPEP 601.01, it must contain “a description pursuant to 35 U.S.C. 112(a).” The specification explains how to make and use the invention and provides the context for understanding the claims.
  • Claims: These define the legal scope of patent protection. The MPEP states that an application must include “at least one claim pursuant to 35 U.S.C. 112(b).” Claims outline the specific elements of the invention that the applicant considers novel and seeks to protect.

The MPEP further clarifies: “The specification must include a written description of the invention or discovery and of the manner and process of making and using the same, and is required to be in such full, clear, concise, and exact terms as to enable any person skilled in the art or science to which the invention or discovery appertains, or with which it is most nearly connected, to make and use the same.”

While the specification provides a comprehensive description, the claims define the boundaries of the patent rights. Both are crucial for a complete and effective patent application.

To learn more:

What is the difference between a principal and an associate power of attorney in patent applications?

In patent applications, there is a distinction between principal and associate powers of attorney:

  • Principal Power of Attorney: This is the primary power of attorney granted by the applicant to a patent practitioner or firm.
  • Associate Power of Attorney: This is a secondary power of attorney that can be granted by the principal attorney to another practitioner or firm.

According to MPEP 402.02(a):

“A principal attorney or agent may appoint an associate power of attorney to act in a representative capacity. See 37 CFR 1.32(b). An associate power of attorney is a power of attorney given to a second attorney or agent by an already appointed principal patent attorney or agent. The associate power of attorney is given by the principal attorney or agent to the associate attorney or agent, not by the applicant.”

It’s important to note that an associate power of attorney does not replace the principal power of attorney but rather supplements it, allowing for additional representation in the patent application process.

To learn more:

What is the difference between a power of attorney and an authorization to act in a representative capacity?

The main differences between a power of attorney and an authorization to act in a representative capacity are:

  • Power of Attorney: Grants the ability to conduct all business before the USPTO on behalf of the applicant or assignee.
  • Authorization to Act: Allows the practitioner to represent the applicant or assignee in a limited capacity, typically for a specific application or patent.

According to MPEP 601.02: ‘For applications filed on or after September 16, 2012, a power of attorney must be signed by the applicant for patent or the patent owner (for reissue applications, reexamination proceedings and supplemental examination proceedings). An assignee who is not an applicant cannot revoke or appoint power of attorney in a patent application.’

It’s important to note that while a power of attorney provides broader authority, an authorization to act can be sufficient for many routine patent prosecution matters.

To learn more:

To learn more:

A power of attorney and a customer number serve different purposes in patent applications:

  • Power of Attorney: This is a legal document that gives an attorney or agent the authority to act on behalf of the applicant or assignee in matters before the USPTO.
  • Customer Number: This is a unique identifier assigned by the USPTO to allow for easier management of multiple patent applications.

According to MPEP 601.02: “A power of attorney may be supplied with a customer number so that the power of attorney will be effective in all existing and future patent applications or patent matters associated with that customer number.” This means that a customer number can be used in conjunction with a power of attorney to streamline the process of managing multiple applications.

To learn more:

The key differences between a patent assignment and a patent license are:

  • Assignment: Transfers all or part of the ownership interest in a patent, including the entire bundle of rights associated with ownership.
  • License: Transfers a bundle of rights that is less than the entire ownership interest. It may be limited in time, geographical area, or field of use.

A license is essentially a contractual agreement that the patent owner will not sue the licensee for patent infringement under certain conditions. Even an exclusive license is not considered an assignment of patent rights.

What is the difference between a parent application and a child application in patent law?

In patent law, the terms ‘parent application’ and ‘child application’ refer to the relationship between related patent applications. According to MPEP 201.02:

“The term parent application is used to refer to the immediate prior application from which a continuing application claims priority.”

“A child application is an application that claims the benefit of an earlier filing date from a parent application.”

Key differences:

  • Parent application: The original or earlier-filed application
  • Child application: A subsequent application that claims priority from the parent
  • Child applications can be continuations, divisionals, or continuations-in-part
  • The parent-child relationship establishes a priority claim under 35 U.S.C. 120

Understanding this relationship is crucial for determining priority dates and the scope of patent protection in related applications.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on parent application, visit: parent application.

For more information on patent application types, visit: patent application types.

While MPEP 203.03 specifically discusses amended nonprovisional applications, it’s important to understand the distinction between nonprovisional and provisional applications:

  • Nonprovisional Application: This is a formal patent application that can result in an issued patent. It undergoes examination and can be amended, as described in MPEP 203.03.
  • Provisional Application: This is a temporary application that establishes a priority date but does not undergo examination and cannot be amended.

The amended status discussed in MPEP 203.03 applies only to nonprovisional applications, as provisional applications are not examined or amended.

To learn more:

The terms ‘national application,’ ‘provisional application,’ and ‘nonprovisional application’ are defined in 37 CFR 1.9(a). Specifically:

  • A national application refers to a U.S. patent application that is not an international application.
  • A provisional application is a type of patent application that allows filing without a formal patent claim or any information disclosure statement.
  • A nonprovisional application is a regular patent application that includes a specification, claims, and other formal requirements.

These definitions help distinguish between different types of patent applications in the U.S. patent system.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

A national application is filed directly with the United States Patent and Trademark Office (USPTO) under U.S. patent laws, while an international application is filed under the Patent Cooperation Treaty (PCT).

According to MPEP 201.01: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’ These applications are processed solely within the U.S. patent system.

International applications, on the other hand, are filed under the PCT and can potentially lead to patent protection in multiple countries. They enter the national phase in individual countries at a later stage.

For more information on USPTO, visit: USPTO.

Tags: USPTO

MPEP 201.01 distinguishes between national applications and international applications:

  • National applications are filed directly with the USPTO under 35 U.S.C. 111(a) or enter the national stage from an international application after complying with 35 U.S.C. 371.
  • International applications are filed under the Patent Cooperation Treaty (PCT).

The MPEP states: The term ‘national application’ as used in this title refers to a U.S. national application for patent which was either filed in the Office under 35 U.S.C. 111, or which entered the national stage from an international application after compliance with 35 U.S.C. 371. (MPEP 201.01)

International applications become national applications when they enter the national stage in a specific country, such as the United States. This process involves meeting the requirements of 35 U.S.C. 371.

For more information on international applications, visit: international applications.

For more information on national stage entry, visit: national stage entry.

What is the difference between a general power of attorney and a limited power of attorney in patent applications?

In patent applications, there are two main types of power of attorney: general and limited. The MPEP 601.02 distinguishes between these as follows:

“A power of attorney may be in the form of a general power of attorney, e.g., to represent the client in all matters before the Office, or limited, e.g., to represent the client in a particular application or in a particular aspect of an application.”

Key differences include:

  • General Power of Attorney: Grants broad authority to represent the client in all matters before the USPTO
  • Limited Power of Attorney: Restricts the attorney’s authority to specific applications or aspects of an application

When deciding between the two, consider the scope of representation needed and any potential conflicts of interest. A limited power of attorney can be useful when working with multiple attorneys or when you want to maintain control over certain aspects of your patent portfolio.

To learn more:

Foreign priority claims and domestic benefit claims are two different ways of claiming the benefit of an earlier filing date:

  • Foreign priority claims (under 35 U.S.C. 119(a)-(d)) are based on earlier applications filed in foreign countries
  • Domestic benefit claims can be to earlier U.S. provisional (35 U.S.C. 119(e)) or nonprovisional (35 U.S.C. 120) applications

Key differences include:

  • Time limits: 12 months for foreign priority, 12 months for provisionals, no limit for nonprovisionals
  • Required documents: Certified copy needed for foreign priority, not for domestic benefit
  • Effect: Foreign priority is mainly for prior art purposes, domestic benefit can confer actual pendency benefits

Both types of claims must be properly made to be effective, but the specific requirements and effects differ.

While both foreign filing licenses and secrecy orders are related to the protection of sensitive information in patent applications, they serve different purposes:

  • Foreign Filing License: As described in MPEP 140, this is a permission granted by the USPTO to file a patent application in a foreign country. It’s typically granted routinely unless there are security concerns.
  • Secrecy Order: This is an order issued under the Invention Secrecy Act (35 U.S.C. 181) to prevent disclosure of an invention that might be detrimental to national security. It prohibits both foreign filing and public disclosure of the invention.

A foreign filing license allows foreign filing, while a secrecy order prohibits it. An application under a secrecy order will not be granted a foreign filing license.

For more information on foreign filing license, visit: foreign filing license.

What is the difference between a divisional and a continuation application?

While both divisional and continuation applications are types of continuing applications, they serve different purposes:

  • Divisional Application: Filed to pursue claims to an invention that was not elected in a previous application due to a restriction requirement.
  • Continuation Application: Filed to pursue additional claims to the same invention disclosed in the parent application.

The MPEP 201.06(c) states: “A divisional application is often filed as a result of a restriction requirement made by the examiner.” In contrast, a continuation typically doesn’t arise from a restriction requirement but rather from the applicant’s desire to pursue additional aspects of the same invention.

Both types can be filed under 37 CFR 1.53(b) and may claim the benefit of the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

There is a significant difference in how Continued Prosecution Applications (CPAs) are treated for utility/plant applications versus design applications. According to the examiner’s note in MPEP ¶ 2.35:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

This indicates that for utility or plant applications, an improper CPA request is treated as a Request for Continued Examination (RCE). However, for design applications, CPA requests are generally accepted and processed as described in MPEP ¶ 2.35. This distinction is important for applicants to understand when considering their continued prosecution options.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

Continued Prosecution Applications (CPAs) are primarily used for design patent applications. For utility or plant applications, improper CPA requests are typically treated as Requests for Continued Examination (RCE). The MPEP ¶ 2.35 notes:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

This distinction is important for applicants to understand when considering their options for continuing prosecution of their patent applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

Continued Prosecution Applications (CPAs) and Requests for Continued Examination (RCEs) are both methods to continue prosecution of a patent application, but they have different uses and applications:

  • CPAs are primarily used for design patent applications, as indicated in MPEP ¶ 2.30.
  • RCEs are used for utility and plant patent applications. The MPEP states: “If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead).”

This distinction is important because it affects how patent examiners process and respond to these continuation requests.

For more information on continued prosecution application, visit: continued prosecution application.

What is the difference between a correspondence address and a fee address in USPTO filings?

In USPTO filings, the correspondence address and fee address serve different purposes:

  • Correspondence Address: Where the USPTO sends all official communications regarding a patent application or patent.
  • Fee Address: Where the USPTO sends maintenance fee reminders for granted patents.

The MPEP clarifies:

The correspondence address is the address associated with the Customer Number to which correspondence is directed. The fee address is the address associated with the Customer Number to which maintenance fee reminders are directed. (MPEP 403)

While these addresses can be the same, they don’t have to be. Applicants or patent owners might choose different addresses, for example, if a law firm handles prosecution but the company itself manages maintenance fees. Using a customer number allows for easy management of both addresses.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on Customer Number, visit: Customer Number.

For more information on Fee Address, visit: Fee Address.

A continuation-in-part (CIP) application differs from a regular continuation application in the following ways:

  • A CIP application contains a portion or all of the disclosure of an earlier application and adds matter not disclosed in the earlier application.
  • A regular continuation application contains the same disclosure as the earlier application without adding new matter.

As stated in MPEP 201.08: A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.

To learn more:

Continuation applications and provisional applications are distinct types of patent applications with different purposes and requirements. A key difference is noted in MPEP 201.07:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the provisional application.

This guidance also applies to continuation applications. The main differences include:

  • Continuation applications are based on nonprovisional applications and claim benefit under 35 U.S.C. 120, 121, 365(c), or 386(c)
  • Provisional applications are placeholder applications that can be claimed as priority under 35 U.S.C. 119(e)
  • Continuation applications must have the same disclosure as the parent application
  • Provisional applications do not need to meet the same formal requirements as nonprovisional applications

For specific requirements related to provisional applications, refer to MPEP § 211 et seq.

For more information on continuation application, visit: continuation application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

A continuation application and a continuation-in-part (CIP) application are both types of patent applications that claim priority to an earlier filed application, but they differ in their content:

  • Continuation application: Contains the same disclosure as the prior application without adding any new matter. As stated in MPEP 201.07: “A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.”
  • Continuation-in-part (CIP) application: Repeats a substantial portion of the prior application but also adds new matter not disclosed in the prior application.

The key difference is that a continuation application does not introduce new subject matter, while a CIP application does.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A continuation application and a divisional application are both types of continuing applications, but they serve different purposes:

  • Continuation application: Used to pursue additional claims to an invention disclosed in a prior application. It contains the same disclosure as the parent application.
  • Divisional application: Used to pursue claims to an invention that was disclosed but not claimed in a prior application. It typically results from a restriction requirement in the parent application.

As stated in MPEP 201.07: “A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.” In contrast, a divisional application focuses on a distinct invention that was not claimed in the parent application.

To learn more:

A continuation application and a continuation-in-part (CIP) application are both types of patent applications that stem from an earlier application, but they differ in their content:

  • Continuation application: Contains the same disclosure as the prior application without adding any new matter. As stated in MPEP 201.07, ‘A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application… The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.’
  • Continuation-in-part application: Repeats a substantial portion of the prior application but also adds new matter not disclosed in the parent application.

The key distinction is that a continuation-in-part introduces new subject matter, while a continuation does not.

To learn more:

The main difference between applications filed under 35 U.S.C. 111(a) and 111(b) lies in their purpose and requirements. According to MPEP 201.01:

  • 35 U.S.C. 111(a) applications: These are for original (nonprovisional) patents. They require a specification, at least one claim, and drawings (when necessary).
  • 35 U.S.C. 111(b) applications: These are for provisional patents. They do not require claims and are not examined on their merits.

The key differences are:

  1. Examination: 111(a) applications undergo full examination, while 111(b) applications do not.
  2. Duration: 111(a) applications can lead to granted patents, while 111(b) applications expire after 12 months.
  3. Requirements: 111(a) applications have stricter formal requirements, including the need for claims.

Inventors often use 111(b) provisional applications to establish an early filing date before filing a more comprehensive 111(a) nonprovisional application.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

A ‘rejected’ patent application and an ‘abandoned’ patent application represent different stages in the patent examination process:

  • Rejected Application: As per MPEP 203.02, this is an application with an unanswered examiner’s action. The applicant still has the opportunity to respond within the allotted reply period.
  • Abandoned Application: This occurs when the applicant fails to respond to the examiner’s action within the specified time frame, effectively ending the examination process.

The MPEP states:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

Thus, a ‘rejected’ application can become ‘abandoned’ if the applicant doesn’t respond in time, but an ‘abandoned’ application cannot revert to ‘rejected’ status without additional procedures.

To learn more:

In the context of foreign priority claims, there’s an important distinction between a ‘country’ and a ‘regional patent office’:

  • Country: A sovereign nation that has its own patent system and can issue patents directly.
  • Regional Patent Office: An intergovernmental organization that processes patent applications on behalf of multiple member countries.

The MPEP states: The right of priority may be based upon an application filed in a foreign country or in a regional patent office. (MPEP 213)

Regional patent offices, such as the European Patent Office (EPO) or the African Regional Intellectual Property Organization (ARIPO), allow applicants to file a single application that can potentially lead to patent protection in multiple member countries.

The key differences between a ‘corrective document’ and a ‘substitute statement’ for USPTO assignments are:

  • Corrective Document: Used to fix minor errors in the original recorded document.
  • Substitute Statement: Replaces the entire original document when substantial changes are needed.

According to MPEP 323: “Where errors were made in the execution of the original assignment document … a ‘substitute statement’ may be submitted for recordation.” The MPEP further clarifies: “The substitute statement must be accompanied by a copy of the originally recorded papers.”

For more information on assignment correction, visit: assignment correction.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

The treatment of affidavits and declarations differs between applications filed under 37 CFR 1.53(b) and those filed under 37 CFR 1.53(d):

  • 37 CFR 1.53(b) applications: Affidavits and declarations from prior applications do not automatically become part of the new application.
  • 37 CFR 1.53(d) applications: Affidavits and declarations filed during the prosecution of the parent nonprovisional application automatically become part of the new application.

As noted in MPEP ¶ 2.03: Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.

For more information on patent applications, visit: patent applications.

The terms ‘right of priority’ and ‘benefit of an earlier filing date’ refer to different concepts in US patent law:

  • Right of priority: This term is used in the context of foreign priority under 35 U.S.C. 119(a)-(d) and 365(a) and (b). It allows a US application to claim the priority date of a foreign application filed within the previous 12 months.
  • Benefit of an earlier filing date: This term is used for domestic benefit under 35 U.S.C. 119(e) and 120. It allows a US application to claim the filing date of an earlier US provisional or nonprovisional application.

As stated in MPEP 216: ‘The right of priority is a statutory right, which is not considered an application property right.’

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

For more information on right of priority, visit: right of priority.

As of July 28, 2013, the United States Postal Service (USPS) renamed ‘Express Mail’ to ‘Priority Mail Express’. According to MPEP 511:

“Effective July 28, 2013, the United States Postal Service (USPS) changed the name of ‘Express Mail’ to ‘Priority Mail Express.’ All characteristics of the ‘Priority Mail Express’ service are the same as those of the former ‘Express Mail’ service (although the mailing labels differ).”

This change is important for patent applicants to note, as the USPTO’s rules and procedures now refer to ‘Priority Mail Express’ instead of ‘Express Mail’. However, the service characteristics and benefits for patent filings remain the same. When using this service for USPTO correspondence, ensure you use the correct addresses as specified in 37 CFR 1.1 and avoid using the ‘Hold for Pickup’ option, as the USPTO does not pick up mail.

To learn more:

The USPTO maintains two special registers for recording certain government interests in patents and patent applications, as outlined in 37 CFR 3.58:

  1. Departmental Register: This register records governmental interests required by Executive Order 9424. It is not open to public inspection but can be examined by authorized government representatives. However, governmental interests recorded on this register are available for public inspection as provided in 37 CFR 1.12.
  2. Secret Register: This register is used to record governmental interests that require secrecy. Documents are placed on this register at the request of the submitting department or agency. Access to this register is highly restricted and requires written authority from the head of the department or agency that submitted the document, as well as approval from the USPTO Director.

These registers ensure that certain sensitive government interests in patents can be recorded while maintaining appropriate levels of confidentiality or secrecy.

An ‘allowed’ application is a nonprovisional patent application that has been examined and determined to meet all statutory requirements. The Manual of Patent Examining Procedure (MPEP) states:

“An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.”

This means that the patent examiner has reviewed the application and found it to be in compliance with all applicable laws and regulations, and has subsequently issued a notice of allowance to the applicant.

To learn more:

A small business concern, for the purpose of paying reduced patent fees, is defined as follows:

A small business concern as used in this paragraph means any business concern that:

  • Has not assigned, granted, conveyed, or licensed, and is under no obligation under contract or law to assign, grant, convey, or license, any rights in the invention to any person, concern, or organization which would not qualify for small entity status as a person, small business concern, or nonprofit organization.
  • Meets the size standards set forth in 13 CFR 121.801 through 121.805 to be eligible for reduced patent fees.

The size standards vary by industry and are based on factors such as average annual receipts or number of employees. It’s important to consult the specific SBA guidelines for your industry to determine if your business qualifies as a small entity.

To learn more:

Tags: patent fees

A divisional application is defined in MPEP 201.06 as follows:

‘A later application for a distinct or independent invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.’

This definition highlights that a divisional application:

  • Is filed after an initial application
  • Focuses on a distinct invention
  • Only includes subject matter from the original application
  • Is ‘carved out’ of the pending parent application

For more information on Divisional application, visit: Divisional application.

For more information on patent application types, visit: patent application types.

What is the definition of a continuation-in-part application?

A continuation-in-part (CIP) application is a type of patent application that includes a portion or all of the disclosure from a prior application and adds new matter not disclosed in the prior application. The MPEP 201.08 states:

‘A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.’

This type of application allows inventors to expand upon their original invention while maintaining the priority date for the portions disclosed in the earlier application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

What is the definition of a ‘small business concern’ for small entity status?

According to MPEP 509.02, a small business concern is defined as follows:

“A small business concern, as used in this chapter, means any business concern that:

  • (i) Has not assigned, granted, conveyed, or licensed (and is under no obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a non-profit organization or a small business concern under this section, and
  • (ii) Does not have as a party to the patent application any individual who has assigned, granted, conveyed, or licensed (or is under an obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a non-profit organization or a small business concern under this section.”

This definition ensures that the small business concern maintains control over the invention rights and has not transferred them to entities that do not qualify for small entity status.

To learn more:

What is the definition of ‘applicant’ in patent applications?

According to MPEP 605, the term ‘applicant’ refers to the inventor or joint inventors who are applying for a patent. The MPEP states: ‘The applicant for a patent is the inventor or joint inventors.’ This definition applies to patent applications filed on or after September 16, 2012. For applications filed before this date, the applicant could be the assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest in the matter.

To learn more:

The MPEP does not specify a fixed deadline for submitting the English translation of a non-English provisional application. However, it indicates that the translation must be provided within a time period set by the USPTO. According to MPEP ¶ 2.38:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This suggests that the USPTO will set a specific deadline in an Office action, and you must comply with this deadline to avoid abandonment of your application.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

The deadline for submitting corrected patent drawings depends on when the requirement is made:

  1. If required in an Office action: The deadline will be specified in the Office action.
  2. If required in a Notice of Allowability: Applicants have three months from the mailing date of the notice to submit corrected drawings.

The MPEP 608.02(b) states:

If a corrected drawing is required or if a drawing does not comply with § 1.84 or an amended drawing submitted under § 1.121(d) in a nonprovisional international design application does not comply with § 1.1026 at the time an application is allowed, the Office may notify the applicant in a notice of allowability and set a three-month period of time from the mail date of the notice of allowability within which the applicant must file a corrected drawing in compliance with § 1.84 or 1.1026, as applicable, to avoid abandonment.

It’s crucial to meet these deadlines to avoid potential abandonment of the application.

To learn more:

What is the deadline for submitting certified copies in a national stage application?

The deadline for submitting certified copies in a national stage application (35 U.S.C. 371) is as follows:

  • Certified copies must be filed within the time limit set in 37 CFR 1.55(f).
  • This is typically within the later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior foreign application.

The MPEP 213.06 states: ‘A certified copy of the foreign application must be filed within the time limit set forth in 37 CFR 1.55(f).’ It’s important to note that this requirement applies unless the certified copy was previously filed in the international application and the requirements of PCT Rule 17.1(a), (b), or (b-bis) have been met.

To learn more:

The deadline for submitting assignee information for patent issuance is crucial to ensure the information appears on the patent. According to MPEP 307:

The submission of the request in compliance with 37 CFR 3.81(b) must be made prior to, or at the same time as, the payment of the issue fee.

This means that assignees must submit their information no later than when the issue fee is paid. It’s important to note that:

  • Late submissions may result in the assignee data not being included on the patent
  • The USPTO will not delay issuance of the patent to accommodate late submissions
  • Correcting assignee information after issuance requires a certificate of correction, which may involve additional fees and procedures

To avoid complications, it’s recommended to submit the assignee information as early as possible in the patent issuance process, ensuring compliance with 37 CFR 3.81(b).

For more information on assignee information, visit: assignee information.

For more information on patent issuance, visit: patent issuance.

The deadline for submitting an inventor’s oath or declaration in a patent application filed on or after September 16, 2012, is the date on which the issue fee is paid. This is stated in MPEP 602.01(a):

For applications filed on or after September 16, 2012, the timing of the submission of the inventor’s oath or declaration has been liberalized. The inventor’s oath or declaration is no longer required to be submitted prior to the filing of the application. Rather, the inventor’s oath or declaration may be postponed until payment of the issue fee.

However, it’s important to note that while the oath or declaration can be submitted later, the application must still include the names of all inventors at the time of filing. If the oath or declaration is not submitted with the initial application, a substitute statement may be required.

To learn more:

The deadline for submitting a certified copy of a foreign priority application depends on the filing date of the U.S. application. According to MPEP 213.02:

In the case of a U.S. application filed on or after March 16, 2013, the certified copy must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

If the certified copy is not filed within this timeframe, the applicant must file a petition to accept a delayed submission and pay the associated fee.

To learn more:

The deadline for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): Submit within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: Submit within the later of four months from the date on which the national stage commenced, four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

The MPEP emphasizes: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c). (MPEP § 211)

For more information on national stage application, visit: national stage application.

The deadline for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): The later of 4 months from the actual filing date or 16 months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: The later of 4 months from the date on which the national stage commenced, 4 months from the initial submission under 35 U.S.C. 371 to enter the national stage, or 16 months from the filing date of the prior application.

As stated in MPEP 211.02: “This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).”

If the deadline is missed, a petition under 37 CFR 1.78 and payment of a petition fee may be required to accept a late benefit claim.

To learn more:

For assignee applicants, there is a specific deadline for recording documentary evidence of ownership. According to 37 CFR 1.46(b)(1):

If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

This means that assignees or obligated assignees should ensure that their documentary evidence of ownership is recorded with the USPTO, as specified in 37 CFR Part 3, by the time they pay the issue fee for the patent application. Failing to record this evidence by the deadline could potentially cause complications in establishing ownership of the patent.

To learn more:

The deadline for filing an unintentionally delayed priority claim is the later of:

  • Four months from the actual filing date of the later-filed application, or
  • Sixteen months from the filing date of the prior application

This is stated in 37 CFR 1.55(d)(1) for foreign priority claims and 37 CFR 1.78(a)(4) for domestic benefit claims. However, a petition may be filed to accept an unintentionally delayed claim under 37 CFR 1.55(e) or 37 CFR 1.78(c) and (e) after this period.

As stated in MPEP 214.02: ‘A petition to accept an unintentionally delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) requires:’

  • The priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted;
  • The petition fee as set forth in § 1.17(m); and
  • A statement that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional.

To learn more:

To learn more:

What is the deadline for filing a petition to accept an unintentionally delayed priority claim?

The deadline for filing a petition to accept an unintentionally delayed priority claim depends on the type of application:

  • For utility and plant applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior application.
  • For design applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior application.

According to MPEP 214.02: ’37 CFR 1.55(e) provides that a petition to accept a delayed priority claim must be accompanied by: (1) The priority claim under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or (b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted; (2) A certified copy of the foreign application, unless previously submitted or an exception in paragraph (h), (i), or (j) of this section applies; (3) The petition fee as set forth in § 1.17(m); and (4) A statement that the entire delay between the date the priority claim was due under this section and the date the priority claim was filed was unintentional.’

It’s important to note that the petition must be filed within the time period set in the statute, and the USPTO does not have the authority to waive this deadline.

To learn more:

The deadline for filing a foreign priority claim in a U.S. patent application depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the claim must be filed within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior foreign application
  • For international applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set by the PCT and its Regulations
  • For design patent applications, the claim can be made at any time during the pendency of the application

As stated in MPEP 214.01: “The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.”

To learn more:

For applications filed before March 16, 2013, the certified copy of the foreign application must be filed within the pendency of the application. According to 37 CFR 1.55(g)(1):

The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application, unless filed with a petition under paragraph (e) or (f) of this section, or with a petition accompanied by the fee set forth in § 1.17(g) which includes a showing of good and sufficient cause for the delay in filing the certified copy of the foreign application in a design application.

However, it’s important to note that if the claim for priority or the certified copy is filed after the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction.

To learn more:

The deadline for filing a benefit claim depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the reference must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “If the application is an application filed under 35 U.S.C. 111(a), the reference to the prior application must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on filing deadline, visit: filing deadline.

For more information on national stage application, visit: national stage application.

The United States Patent and Trademark Office (USPTO) stamps correspondence received with the date of receipt, known as the ‘Office Date’ stamp. This applies to papers and fees received through various methods:

  • Mail (except Priority Mail Express®)
  • Facsimile
  • EFS-Web
  • Hand-carried to the Customer Service Window

As stated in the MPEP: The United States Patent and Trademark Office (Office) stamps papers and fees received through the mail (other than those submitted by Priority Mail Express® in accordance with 37 CFR 1.10), by facsimile, or via EFS-Web with the date of their receipt in the Office.

The date of receipt for assignment documents sent to the USPTO by fax is determined by when the complete transmission is received. According to MPEP 302.09:

The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.

It’s important to note that the benefits of a certificate of transmission under 37 CFR 1.8 are available for fax submissions. This can provide additional protection in case of transmission issues.

For more information on date of receipt for electronic submissions, you can refer to MPEP § 502.01.

To learn more:

What is the DAS code for PDX?

The DAS (Digital Access Service) code for PDX (Priority Document Exchange) is US. This code is used when participating in the WIPO DAS system for electronic exchange of priority documents. As stated in the MPEP 215.01: The DAS code for the USPTO is ‘US’. Applicants need to use this code when authorizing the USPTO to retrieve priority documents from other offices or when allowing other offices to retrieve priority documents from the USPTO through the WIPO DAS system.

To learn more:

The Customer Number practice allows applicants to:

  • Designate the correspondence address of a patent application or patent
  • Designate the fee address of a patent
  • Submit a list of practitioners who have power of attorney

Using a Customer Number allows applicants to easily change the correspondence address, fee address, or list of practitioners for multiple applications or patents by simply changing the information associated with the Customer Number.

According to MPEP 403: “A Customer Number (previously a ‘Payor Number’) may be used to: (A) designate the correspondence address of a patent application or patent such that the correspondence address for the patent application or patent would be the address associated with the Customer Number (37 CFR 1.32(a)(5)(i)); (B) designate the fee address (37 CFR 1.363) of a patent such that the fee address for the patent would be the address associated with the Customer Number (37 CFR 1.32(a)(5)(ii)); and (C) submit a list of practitioners such that those practitioners associated with the Customer Number would have power of attorney (37 CFR 1.32(a)(5)(iii)).”

What is the Customer Number Practice for power of attorney in patent applications?

The Customer Number Practice is a system used by the USPTO to simplify the process of changing the correspondence address or power of attorney for multiple patent applications. Here’s how it works:

  • Practitioners are associated with a Customer Number
  • The Customer Number can be used to grant power of attorney in applications
  • Changes to the Customer Number automatically update all associated applications

According to the MPEP:

The Customer Number Practice permits applicants, attorneys, and agents of record to expressly request that the USPTO use a Customer Number to associate a power of attorney with a particular application. (MPEP 402.02(a))

This practice streamlines the process of managing power of attorney and correspondence addresses for multiple applications, making it more efficient for both applicants and the USPTO.

To learn more:

The Customer Number Practice is a system used by the USPTO to simplify the process of changing the correspondence address for multiple patent applications. According to MPEP 601.03:

“A Customer Number may be used to:

  • Designate the correspondence address of a patent application by a Customer Number such that the correspondence address for the patent application would be the address associated with the Customer Number;
  • Designate the fee address of a patent by a Customer Number such that the fee address for the patent would be the address associated with the Customer Number; and
  • Submit a list of practitioners by Customer Number such that an applicant may in a Power of Attorney appoint those practitioners associated with the Customer Number.”

    This practice allows for easier management of correspondence addresses across multiple applications or patents.

    To learn more:

What is the Customer Number practice at the USPTO for patent applications?

The Customer Number practice at the USPTO is a system that simplifies the process of managing correspondence addresses for patent applicants and practitioners. Key aspects of this practice include:

  • A Customer Number is a unique identifier assigned by the USPTO to a specific address.
  • It allows for easy updating of correspondence information for multiple applications.
  • Customer Numbers can be associated with Power of Attorney forms.

According to MPEP 403.01(a): ‘The Customer Number practice permits a patent applicant, assignee or practitioner of record to change the correspondence address for a number of applications or patents with one change of address filed in one location.’

To use the Customer Number practice:

  1. Request a Customer Number from the USPTO using the Customer Number Request form (PTO/SB/125A).
  2. Associate the Customer Number with your applications using the appropriate forms or through the USPTO’s electronic filing system.
  3. Update your correspondence address by modifying the Customer Number information, which will automatically update all associated applications.

This practice significantly streamlines the process of managing correspondence for multiple patent applications, making it easier for applicants and practitioners to maintain up-to-date contact information with the USPTO.

To learn more:

As of the 2019 update to MPEP 302.06, the fee for electronically submitting a patent document for recordation is $0. The MPEP states:

If the request to record a document is submitted electronically, the fee is set forth in 37 CFR 1.21(h)(1), currently at $0.

This $0 fee for electronic submissions is a significant cost-saving measure for patent applicants and owners. However, it’s important to note that fees can change, and the MPEP advises:

Customers should check the current fee schedule on the Office website before submitting documents for recordation.

Always verify the current fees on the USPTO fee schedule before submitting any documents.

To learn more:

The USPTO requires a security code for credit card payments made through its website. According to MPEP 509:

Credit card payment submissions made on the USPTO website at www.uspto.gov must include the 3-digit or 4-digit security code associated with the credit card in addition to the credit card number. The security code will not be required when the paper Credit Card Payment Form (PTO-2038) or other written authorization is submitted.

Key points about the security code requirement:

  • It’s part of an authentication procedure to reduce fraudulent or unauthorized credit card use.
  • The code verifies that the physical card is in the cardholder’s possession.
  • For DISCOVER®, MASTERCARD®, and VISA®, it’s a 3-digit code on the back of the card.
  • For AMERICAN EXPRESS®, it’s a 4-digit code on the front of the card.
  • If you can’t read the security code, contact your card issuer.

This requirement enhances security for online transactions but doesn’t apply to paper submissions using Form PTO-2038.

To learn more:

The Credit Card Payment Form (PTO-2038) is a specific form provided by the USPTO for making credit card payments for patent and trademark process fees. According to MPEP 509:

Credit Card Payment Form (PTO-2038) should be used when paying a patent process or trademark process fee (or the fee for an information product) by credit card, unless the payment is being made using the USPTO patent electronic filing system.

Key points about the form:

  • It can be downloaded from the USPTO website at www.uspto.gov/PatentForms.
  • It’s not required (and should not be used) when making credit card payments via EFS-Web or other electronic filing systems.
  • Using this form helps keep credit card information confidential, as the USPTO does not include it among records open to public inspection.

Failure to use this form when submitting a paper credit card payment may result in the credit card information becoming part of the public record.

To learn more:

Tags: patent fees

The correspondence address in a patent application is the address where the United States Patent and Trademark Office (USPTO) will send all official communications regarding the application. According to 37 CFR 1.33(a):

“When filing an application, a correspondence address must be set forth in either an application data sheet (§ 1.76), or elsewhere, in a clearly identifiable manner, in any paper submitted with an application filing.”

This address is crucial for ensuring that applicants receive all necessary information and notifications about their patent application.

To learn more:

When responding to an objection regarding unlabeled prior art figures, applicants must follow specific procedures for submitting corrected drawings. According to MPEP 608.02(g), the process involves:

  1. Submitting corrected drawings in compliance with 37 CFR 1.121(d).
  2. Labeling the replacement sheet(s) as ‘Replacement Sheet’ in the page header, as per 37 CFR 1.84(c).
  3. Ensuring that the labeling does not obstruct any portion of the drawing figures.
  4. Designating the prior art figure with a legend such as ‘Prior Art’.

The MPEP states: Corrected drawings in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. The replacement sheet(s) should be labeled ‘Replacement Sheet’ in the page header (as per 37 CFR 1.84(c)) so as not to obstruct any portion of the drawing figures.

It’s crucial to follow these instructions carefully to ensure that the objection is resolved and to avoid further complications in the patent prosecution process.

To learn more:

The correct procedure for submitting assignment documents to the USPTO involves sending them to the Assignment Division for recording, rather than placing them directly in application or patent files. MPEP 318 clearly states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This process ensures that assignment documents are properly recorded and maintained by the appropriate division within the USPTO.

To learn more:

The format for copyright or mask work notices in patent applications must be limited to only those elements required by law. According to MPEP 608.01(w):

For example, “©1983 John Doe” (17 U.S.C. 401) and “*M* John Doe” (17 U.S.C. 909) would be properly limited and, under current statutes, legally sufficient notices of copyright and mask work, respectively.

These formats comply with the legal requirements for copyright notices under 17 U.S.C. 401 and mask work notices under 17 U.S.C. 909. When including such notices in drawings, they must also comply with the size requirements specified in 37 CFR 1.84(s).

To learn more:

What is the copendency requirement for continuation applications?

The copendency requirement is a crucial aspect of filing a continuation application. According to MPEP 201.07:

‘The continuation application must be filed before the patenting or abandonment of or termination of proceedings on the prior application.’

This means that:

  • The continuation application must be filed while the parent application is still pending (not patented, abandoned, or otherwise terminated).
  • If the parent application has already been issued as a patent or has been abandoned, it’s too late to file a continuation application.
  • The continuation application can be filed on the same day that the parent application is to be issued as a patent, but it must be filed before the parent application officially becomes a patent.

Maintaining copendency is critical for preserving the benefit of the earlier filing date and ensuring the validity of the continuation application.

For more information on continuation application, visit: continuation application.

For more information on copendency, visit: copendency.

Copendency is a crucial requirement when claiming the benefit of a prior-filed nonprovisional application under 35 U.S.C. 120, 121, 365(c), or 386(c). The MPEP defines copendency as follows:

“Copendency is defined in the clause which requires that the later-filed application must be filed before: (A) the patenting of the prior application; (B) the abandonment of the prior application; or (C) the termination of proceedings in the prior application.”

Key points about copendency:

  • The later-filed application must be filed before the prior application patents, is abandoned, or proceedings are terminated
  • If the prior application issues as a patent, the later-filed application can be filed on the same date the patent issues
  • If the prior application is abandoned, the later-filed application must be filed before the abandonment
  • Without copendency, the later-filed application cannot claim the benefit of the prior application’s filing date

Applicants should be aware of the copendency requirement to ensure their benefit claims are valid.

Patent applications are generally kept confidential by the USPTO until they are published or granted. As stated in 35 U.S.C. 122(a):

“Except as provided in subsection (b), applications for patents shall be kept in confidence by the Patent and Trademark Office and no information concerning the same given without authority of the applicant or owner unless necessary to carry out the provisions of an Act of Congress or in such special circumstances as may be determined by the Director.”

This confidentiality requirement applies to all USPTO employees handling patent applications.

Unpublished patent applications are subject to confidentiality requirements under 35 U.S.C. 122(a). MPEP 405 addresses this in the context of interviews:

However, an interview concerning an application that has not been published under 35 U.S.C. 122(b) with an attorney or agent not of record who obtains authorization through use of the interview request form will be conducted based on the information and files supplied by the attorney or agent in view of the confidentiality requirements of 35 U.S.C. 122(a).

This means that for unpublished applications, the USPTO will only discuss information provided by the authorized attorney or agent to maintain confidentiality.

International patent applications are kept confidential before their international publication, as specified in MPEP 110. According to PCT Article 30, the International Bureau and the International Searching Authorities shall not allow access by any person or authority to the international application before the international publication of that application, unless requested or authorized by the applicant. This confidentiality ensures that inventors’ rights are protected during the early stages of the patent process.

For more information on international patent applications, visit: international patent applications.

International patent applications filed under the PCT are generally kept confidential and not made publicly available before international publication, which occurs soon after the expiration of 18 months from the priority date, according to PCT Article 21(2)(a). The International Bureau and International Searching Authorities are not allowed to give access to the application to any person or authority before publication unless requested or authorized by the applicant, with some exceptions.

As stated in MPEP 110:

“Although most international applications are published soon after the expiration of 18 months from the priority date, PCT Article 21(2)(a), such publication does not open up the Home Copy or Search Copy to the public for inspection, except as provided in 37 CFR 1.14(g).”

What is the Certificate of Mailing procedure for USPTO filings?

The Certificate of Mailing procedure is a method that allows applicants to establish the date of filing for correspondence sent to the USPTO. As explained in MPEP 501:

‘Under the procedure, correspondence is considered as being timely filed if (A) the correspondence is mailed or transmitted prior to expiration of the set period for response by being: (1) Addressed as set out in 37 CFR 1.1(a) and deposited with the U.S. Postal Service with sufficient postage as first class mail; or (2) Transmitted by facsimile to the Patent and Trademark Office in accordance with 37 CFR 1.6(d); or (3) Transmitted via the Office electronic filing system in accordance with 37 CFR 1.6(a)(4); and (B) the correspondence includes a certificate for each piece of correspondence stating the date of deposit or transmission.’

This procedure is particularly useful for ensuring timely filing when using postal services. It’s important to note that the certificate must be signed by the person depositing or transmitting the correspondence.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on electronic filing, visit: electronic filing.

The central facsimile number for patent application-related correspondence at the USPTO is (571) 273-8300. According to MPEP 502.01:

All patent application related correspondence transmitted by facsimile must be directed to the central facsimile number, with a few exceptions below. The central facsimile number is (571) 273-8300.

This central number should be used for most patent-related correspondence, including replies to Office actions and after-final amendments. However, there are specific exceptions for certain types of correspondence that should be sent to other facsimile numbers, as outlined in the MPEP.

To learn more:

The best mode requirement in patent applications refers to the obligation of the inventor to disclose the best way they know of carrying out their invention at the time of filing. This is mandated by 35 U.S.C. 112.

As stated in MPEP 608.01(h): The best mode contemplated by the inventor of carrying out his or her invention must be set forth in the description. This requirement ensures that the public receives the full benefit of the invention in exchange for the patent grant.

To learn more:

Tags: invention

Filing a divisional application allows an applicant to pursue protection for distinct inventions disclosed in a parent application. Key benefits include:

  • Ability to claim different aspects or embodiments of the invention
  • Potential for broader patent coverage
  • Preservation of priority date for the disclosed subject matter
  • Opportunity to pursue claims that may have been restricted in the parent application

The MPEP indicates: A divisional application is often filed as a result of a restriction requirement made by the examiner. This suggests that divisional applications provide a way to pursue protection for inventions that were not elected in the parent application due to a restriction requirement.

For more information on Divisional application, visit: Divisional application.

For more information on patent strategy, visit: patent strategy.

What is the benefit of filing a divisional application under 37 CFR 1.53(b)?

Filing a divisional application under 37 CFR 1.53(b) offers several benefits:

  • It allows you to pursue claims to an invention that was not elected in a previous application due to a restriction requirement.
  • You can file the divisional application without a new oath or declaration if you meet certain conditions.
  • The divisional application can claim the benefit of the filing date of the prior application.

As stated in the MPEP: “A divisional application is often filed as a result of a restriction requirement made by the examiner.” This means you can protect additional aspects of your invention that weren’t covered in the original application.

For more information on Divisional application, visit: Divisional application.

For more information on patent filing, visit: patent filing.

Claiming priority to an international design application can provide significant benefits for nonprovisional applications. According to MPEP § 211.01(d):

Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.

This means that a nonprovisional application can claim the earlier filing date of an international design application, potentially providing an earlier priority date for the claimed invention.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on nonprovisional application, visit: nonprovisional application.

Under 35 U.S.C. 386(c), a nonprovisional application can claim the benefit of a prior international design application designating the United States, subject to the conditions and requirements of 35 U.S.C. 120. This provision allows applicants to establish an earlier effective filing date for their nonprovisional applications based on their international design applications.

As stated in the MPEP:

“Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.”

This benefit claim can be crucial for establishing priority and overcoming prior art references.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on nonprovisional application, visit: nonprovisional application.

The basis for disclosure in a patent application is outlined in MPEP 608. It states:

“Applicant may rely for disclosure upon the specification with original claims and drawings, as filed.”

This means that the original specification, claims, and drawings submitted at the time of filing form the foundation of the disclosure. Any amendments or new claims must find support within this original disclosure to avoid introducing new matter. The disclosure must provide a full and clear description of the invention as required by 35 U.S.C. 112(a).

To learn more:

Tags: drawings

The application size fee is an additional fee that applies to patent applications with specifications and drawings exceeding 100 sheets of paper. The MPEP states:

37 CFR 1.16(s) sets forth the application size fee for any application (including any reissue applications) filed under 35 U.S.C. 111, the specification and drawings of which exceed 100 sheets of paper. The calculation of the number of sheets excludes any “Sequence Listing”, computer readable form (CRF) of a “Sequence Listing”, or a “Computer Program Listing Appendix” filed in an American Standard Code for Information Interchange (ASCII) plain text file or any “Sequence Listing XML” filed in an eXtensible Markup Language (XML) file on a read-only optical disc or via the USPTO patent electronic filing system in compliance with the rules.

The fee applies for each additional 50 sheets or fraction thereof over 100 sheets. This fee must be paid within the time period set by the USPTO to avoid abandonment of the application.

When submitting replacement drawings after allowance, the applicant has a crucial responsibility:

It is applicant’s responsibility to see that no new matter is added when submitting replacement drawings after allowance because they will not normally be reviewed by an examiner.

This means that applicants must ensure that any changes made to the drawings do not introduce new subject matter that wasn’t present in the original application. This responsibility is particularly important because examiners typically do not review these late-submitted drawings, placing the onus on the applicant to maintain the integrity of the application’s content.

To learn more:

Tags: new matter

The USPTO offers an additional fee reduction for small entities that file patent applications electronically. According to MPEP 509.02:

The Consolidated Appropriations Act, 2005, provides that the filing fee charged under 35 U.S.C. 41(a)(1)(A) shall be reduced by 75 percent with respect to its application to any small entity ‘if the application is filed by electronic means as prescribed by the Director’ (35 U.S.C. 41(h)(3)).

This 75% reduction applies specifically to the filing fee for nonprovisional original utility applications filed electronically by small entities on or after December 8, 2004. It’s important to note that this enhanced reduction does not apply to design applications, plant applications, reissue applications, or provisional applications.

To learn more:

The ‘statement of unintentional delay’ is a crucial component of a petition to accept an unintentionally delayed priority claim. According to MPEP 214.02:

The Director may require additional information where there is a question whether the delay was unintentional.

This statement must affirm that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional. It’s important to note that:

  • The USPTO requires an additional explanation of the circumstances surrounding the delay that establishes the entire delay was unintentional.
  • The statement must be signed by a person who has sufficient knowledge of the facts to support the statement.
  • Providing an inadequate or insufficient explanation may lead to a request for further information, which could delay the petition process.

Applicants should be prepared to provide a detailed account of the circumstances that led to the delay, ensuring that it covers the entire period of delay and demonstrates that the delay was truly unintentional.

To learn more:

To learn more:

What is the ‘specific reference’ requirement for claiming benefit of a prior-filed application?

The ‘specific reference’ requirement is a crucial aspect of claiming the benefit of a prior-filed application. According to MPEP 211.01, To claim the benefit of a prior-filed application, the later-filed application must contain a specific reference to the prior-filed application. This means that:

  • The specific reference must be made in the first sentence(s) of the specification or in an application data sheet (ADS).
  • It should include the relationship between the applications (e.g., continuation, divisional, or continuation-in-part).
  • The prior application’s serial number and filing date must be provided.

For example: ‘This application is a continuation of Application No. 12/345,678, filed January 1, 2020.’

Failure to provide this specific reference can result in the loss of the benefit claim. For more details, refer to MPEP 211 and 37 CFR 1.78.

What is the ‘same invention’ requirement for claiming benefit under 35 U.S.C. 120?

The ‘same invention’ requirement is a crucial aspect of claiming benefit under 35 U.S.C. 120. MPEP 211.01(b) explains: The second application must be an application for a patent for an invention which is also disclosed in the first application.

This means:

  • The later application must disclose at least some part of the invention claimed in the prior application.
  • The disclosure in the prior application must provide adequate support for the claims in the later application.
  • New matter introduced in the later application cannot claim the benefit of the earlier filing date.

The ‘same invention’ does not require identical claims, but there must be a common disclosure that supports the claims in both applications. For more information, see MPEP 211.01(b) and 35 U.S.C. 120.

The ‘reasonable inquiry’ requirement, as described in 37 CFR 11.18(b)(2), mandates that submissions to the USPTO be made ‘to the best of the party’s knowledge, information and belief, formed after an inquiry reasonable under the circumstances.’ This standard is similar to Rule 11 of the Federal Rules of Civil Procedure.

The MPEP clarifies: An ‘inquiry reasonable under the circumstances’ requirement of 37 CFR 10.18(b)(2) is identical to that in Fed. R. Civ. P. 11(b). The federal courts have stated in regard to the ‘reasonable inquiry’ requirement of Fed. R. Civ. P. 11: In requiring reasonable inquiry before the filing of any pleading in a civil case in federal district court, Rule 11 demands ‘an objective determination of whether a sanctioned party’s conduct was reasonable under the circumstances.’

For more information on patent application requirements, visit: patent application requirements.

The ‘Office Date’ stamp is used by the USPTO to mark the receipt date of papers and fees. According to MPEP 505, The United States Patent and Trademark Office (Office) stamps papers and fees received through the mail (other than those submitted by Priority Mail Express® in accordance with 37 CFR 1.10), by facsimile, or via EFS-Web with the date of their receipt in the Office.

The ‘Office Date’ stamp is crucial because:

  • It establishes the filing date for new patent applications that include the necessary components (see 37 CFR 1.53(b)-(d))
  • It determines the timeliness of actions and fee payments

For hand-carried papers, date stamping occurs at the Customer Service Window.

For more information on Office Date stamp, visit: Office Date stamp.

For more information on USPTO, visit: USPTO.

The ‘Minimum Significant Part of the Number’ refers to the essential portion of a foreign application number that should be used in United States Patent and Trademark Office (USPTO) records. According to the MPEP:

The ‘Minimum Significant Part of the Number’ identified in the tables should be used in United States Patent and Trademark Office records.

This concept is important because:

  • It standardizes the citation of foreign applications across different numbering systems
  • It ensures that the most crucial identifying information is captured
  • It facilitates accurate cross-referencing and searching of patent documents

Applicants and examiners should refer to the WIPO tables to determine the correct ‘Minimum Significant Part of the Number’ for each foreign intellectual property office.

To learn more:

What is the ‘infringement test’ for dependent claims in patent applications?

The ‘infringement test’ is a crucial concept in determining the proper dependency of claims in patent applications. As described in MPEP 608.01(n):

‘One test for a proper dependent claim is that the dependent claim must be narrower than the claim(s) from which it depends. In other words, if a dependent claim does not further limit the scope of the claim(s) from which it depends, it is not a proper dependent claim.’

The infringement test states that:

  • Any subject matter that would infringe the independent claim must also infringe the dependent claim.
  • If it’s possible to infringe the independent claim without infringing the dependent claim, the dependent claim is improper.

This test ensures that dependent claims properly narrow the scope of the claims they depend from, maintaining the hierarchical structure of patent claims.

To learn more:

The ‘In re Van Esdonk’ case (187 USPQ 671, Comm’r Pat. 1975) is an important precedent in patent law regarding the perfection of foreign priority claims. Key points about this case include:

  • It involved a situation where a claim to foreign priority benefits had not been filed in the application prior to patent issuance.
  • The application was a continuation of an earlier application that had satisfied the requirements of 35 U.S.C. 119(a)-(d) or (f).
  • The Commissioner held that perfecting a priority claim in the parent application satisfies the statute for the continuation application.

The MPEP states: In re Van Esdonk, a claim to foreign priority benefits had not been filed in the application prior to issuance of the patent. However, the application was a continuation of an earlier application in which the requirements of 35 U.S.C. 119(a)-(d) or (f) had been satisfied. Accordingly, the Commissioner held that the ‘applicants’ perfection of a priority claim under 35 U.S.C. 119 in the parent application will satisfy the statute with respect to their continuation application.’

This case is significant because it allows for the perfection of foreign priority claims in continuation applications based on the parent application’s compliance, even after patent issuance.

A certified copy of a foreign application is a copy of the original foreign application with a certification by the patent office of the foreign country in which it was filed. According to the MPEP, “Certified copies ordinarily consist of a copy of the specification and drawings of the applications as filed with a certificate of the foreign patent office giving certain information.” It’s important to note that a copy of the certified copy filed by the applicant will not satisfy the requirement for a certified copy.

Small entity status allows certain applicants to pay reduced patent fees. To claim small entity status, you must make an assertion of entitlement in one of two ways:

  • Submit a written assertion signed by the applicant, a patent practitioner, an inventor, or an assignee
  • Pay the exact small entity basic filing fee, basic national fee, or individual designation fee

As stated in 37 CFR 1.27(c): “Any party (person, small business concern or nonprofit organization) should make a determination, pursuant to paragraph (f) of this section, of entitlement to be accorded small entity status based on the definitions set forth in paragraph (a) of this section, and must, in order to establish small entity status for the purpose of paying small entity fees, actually make an assertion of entitlement to small entity status, in the manner set forth in paragraphs (c)(1) or (c)(3) of this section, in the application or patent in which such small entity fees are to be paid.”

To learn more:

Tags: patent fees

When submitting an English language translation of a non-English language foreign priority application, the following requirements must be met:

  • The translation must be of the certified copy of the foreign application as filed
  • The translation must be submitted together with a statement that the translation of the certified copy is accurate

As stated in the MPEP: When an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) submitted together with a statement that the translation of the certified copy is accurate.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

When submitting a certified copy of a foreign application for priority purposes, the following requirements apply:

  • If the certified copy is not in English, a translation is required
  • The translation must be of the certified copy of the foreign application as filed
  • The translation must be filed together with a statement that the translation of the certified copy is accurate

The MPEP states: “When the examiner requires the filing of the certified copy, the translation should also be required at the same time. If an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) and it must be filed together with a statement that the translation of the certified copy is accurate.” (MPEP 216)

When notifying the USPTO of a loss of micro entity status, the following requirements must be met:

  • The notification must be filed in the application or patent prior to paying, or at the time of paying, any fee after the date on which micro entity status is no longer appropriate.
  • The notification must be signed by a party identified in 37 CFR 1.33(b).
  • A simple statement that the applicant is no longer eligible for micro entity status is sufficient, without identifying specific reasons.

As stated in MPEP 509.04(e): Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.

To learn more:

To make a proper priority claim in a U.S. patent application, the applicant must provide specific information about the foreign application and file the claim within the required time period. The requirements differ slightly depending on the type of application.

For applications filed on or after September 16, 2012, under 35 U.S.C. 111(a), MPEP 213.02 states: “the claim for priority must be presented in an application data sheet.” The claim must include:

  • The application number of the foreign application
  • The country or intellectual property authority
  • The day, month, and year of filing

For international applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set forth in the PCT and the Regulations under the PCT.

The MPEP further notes: “For applications filed prior to September 16, 2012, the claim to priority need be in no special form, and may be made by a person authorized to sign correspondence under 37 CFR 1.33(b). No special language is required in making the claim for priority, and any expression which can be reasonably interpreted as claiming the benefit of the foreign application is accepted as the claim for priority.”

It’s important to file the priority claim within the specified time limits to ensure it is considered valid and effective.

For more information on application data sheet, visit: application data sheet.

For more information on foreign application, visit: foreign application.

To establish ownership for an assignee to take action in a patent application filed before September 16, 2012, the following is required:

  • The assignee must submit documentary evidence of a chain of title from the original owner to the assignee, or a statement specifying where such evidence is recorded in the USPTO assignment records.
  • A statement affirming that the documentary evidence was or is being submitted for recordation.
  • The submission must be signed by a person authorized to act on behalf of the assignee.

This is outlined in pre-AIA 37 CFR 3.73(b), which states:

“In order to request or take action in a patent or trademark matter, the assignee must establish its ownership of the patent or trademark property of paragraph (a) of this section to the satisfaction of the Director. The establishment of ownership by the assignee may be combined with the paper that requests or takes the action. Ownership is established by submitting to the Office a signed statement identifying the assignee, accompanied by either: (i) Documentary evidence of a chain of title from the original owner to the assignee (e.g., copy of an executed assignment). For patent matters only, the submission of the documentary evidence must be accompanied by a statement affirming that the documentary evidence of the chain of title from the original owner to the assignee was or concurrently is being submitted for recordation pursuant to § 3.11; or (ii) A statement specifying where documentary evidence of a chain of title from the original owner to the assignee is recorded in the assignment records of the Office (e.g., reel and frame number).”

To claim the benefit of an earlier filing date under 35 U.S.C. 120, the following requirements must be met:

  • The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application
  • The disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement
  • The later-filed application must contain a specific reference to the prior application
  • The later-filed application must be filed before the patenting or abandonment of or termination of proceedings on the first application

As stated in the MPEP: “To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

Adding a benefit claim after the time period required by 37 CFR 1.78 requires a petition and the petition fee. As stated in MPEP § 211.04:

Any petition under 37 CFR 1.78 must be accompanied by a corrected ADS in compliance with 37 CFR 1.76(c) (for applications filed on or after September 16, 2012), or by an amendment to the specification or a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c) (for applications filed prior to September 16, 2012) unless the proper reference was previously submitted.

In addition to the petition and ADS or amendment, you may need to file one of the following, depending on the status of your application:

  • A request for continued examination (RCE) under 37 CFR 1.114, if the application is under final rejection or has been allowed.
  • A reissue application or a request for a certificate of correction under 37 CFR 1.323, if the application has already issued as a patent.

It’s important to note that when adding a benefit claim after filing, you cannot include an incorporation by reference statement of the prior application unless such a statement was present upon the initial filing of the application.

To learn more:

When submitting non-English language information in an Information Disclosure Statement (IDS), a concise explanation of the relevance is required. The MPEP states:

Each information disclosure statement must further include a concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information listed that is not in the English language.‘ (MPEP 609.04(a))

Key points regarding non-English language information:

  • A complete translation is not required if a concise explanation is provided.
  • If a complete English translation is submitted, no concise explanation is needed.
  • An English-language abstract may fulfill the requirement for a concise explanation.
  • For information cited in a foreign patent office search report, submitting an English-language version of the search report indicating the degree of relevance can satisfy the requirement.

The explanation should be sufficient to convey the relevance of the non-English information to the claimed invention.

To learn more:

All modifications described in a patent application must be illustrated in the drawings, or the text describing those modifications must be canceled. This requirement is based on Ex parte Peck, 1901 C.D. 136, 96 OG 2409 (Comm’r Pat. 1901). The MPEP section 608.02(f) states:

“All modifications described must be illustrated, or the text canceled.”

However, there are two exceptions to this rule:

  • Minor variations
  • Well-known and conventional parts

These exceptions do not require illustration. This requirement ensures that the patent application provides a clear and complete disclosure of the invention.

To learn more:

To correct inventorship in a provisional application, you must follow the procedure outlined in 37 CFR 1.48(d). The requirements include:

  • A request signed by a party set forth in 37 CFR 1.33(b) to correct the inventorship, identifying each inventor by their legal name
  • The processing fee set forth in 37 CFR 1.17(q)

The MPEP advises, When an inventor is being added, applicants should also file a corrected application data sheet or a new cover sheet providing the residence of all inventors.

To learn more:

For an Information Disclosure Statement (IDS) filed after the initial three-month period or first Office action, but before the mailing of a final action, Notice of Allowance, or an Ex parte Quayle action, the following is required:

  • Either a statement under 37 CFR 1.97(e), or
  • The fee set forth in 37 CFR 1.17(p)

As stated in MPEP 609.04(b): An information disclosure statement will be considered by the examiner if filed after the period specified in subsection I. above, but prior to the date the prosecution of the application closes, i.e., before (not on the same day as the mailing date of any of the following): a final action under 37 CFR 1.113, e.g., final rejection; a notice of allowance under 37 CFR 1.311; or an action that closes prosecution in the application, e.g., an Ex parte Quayle action, whichever occurs first, provided the information disclosure statement is accompanied by either (1) a statement as specified in 37 CFR 1.97(e) (see the discussion in subsection V below); or (2) the fee set forth in 37 CFR 1.17(p).

To learn more:

Tags: late filing

A petition to restore the benefit of a provisional application under 37 CFR 1.78(b) must include several elements. According to MPEP 211.01(a):

‘A petition under 37 CFR 1.78(b) requires: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application, which must be included in application data sheet (unless previously submitted in an application data sheet); (B) the petition fee as set forth in 37 CFR 1.17(m); and (C) a statement that the delay in filing the nonprovisional application or international application designating the United States within the twelve-month period set forth in 37 CFR 1.78(a)(1)(i) was unintentional.’

The petition must be filed in the subsequent application (nonprovisional or international application designating the US) within 14 months of the provisional application’s filing date. The USPTO may require additional information to verify that the delay was unintentional.

For more information on benefit restoration, visit: benefit restoration.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

A person who shows sufficient proprietary interest in the matter can file a patent application, but must submit a petition as outlined in 37 CFR 1.46(b)(2). The petition must include:

  1. The fee set forth in § 1.17(g)
  2. A showing that the person has sufficient proprietary interest in the matter
  3. A statement that making the application for patent by this person on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

The MPEP further explains that a proprietary interest can be demonstrated by an appropriate legal memorandum to the effect that a court of competent jurisdiction (federal, state, or foreign) would by the weight of authority in that jurisdiction award title of the invention to the 37 CFR 1.46 applicant. This should be supported by an affidavit or declaration and prepared by an attorney familiar with the relevant jurisdiction’s law.

To learn more:

When claiming the benefit of a provisional application filed in a language other than English, additional requirements must be met. The MPEP states:

“If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.”

If these documents were not filed in the provisional application, the applicant will be notified and given a period to:

  1. File the translation and statement in the provisional application
  2. Submit a confirmation in the nonprovisional application that the translation and statement were filed in the provisional application

Failure to respond to this notice in a pending nonprovisional application will result in abandonment. For more details, see MPEP § 211.01(a).

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

When adding a new inventor to a patent application, additional documentation is required. According to 37 CFR 1.48(b):

An oath or declaration as required by § 1.63, or a substitute statement in compliance with § 1.64, will be required for any actual inventor who has not yet executed such an oath or declaration.

This means that any newly added inventor must submit either an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement in compliance with 37 CFR 1.64. The specific requirements for these documents depend on the application’s filing date. For applications filed on or after September 16, 2012, refer to MPEP § 602.01(a) for oath or declaration requirements and MPEP § 604 for substitute statement requirements.

To learn more:

For a later-filed application to be entitled to the benefit of an earlier-filed application’s filing date, the following requirements must be met:

  • The invention disclosed in the later-filed application must also be disclosed in the earlier-filed application.
  • The disclosure in both applications must be sufficient to comply with the requirements of 35 U.S.C. 112(a), except for the best mode requirement.

As stated in MPEP 211.05:

“To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

This means that the earlier-filed application must provide adequate support and enablement for the claimed subject matter in the later-filed application.

To learn more:

PSTAR stands for Patents Service for Time and Application Routing. According to MPEP 504, PSTAR is “the program [that] assigns each nonprovisional application to an examiner.” This system is used by the United States Patent and Trademark Office (USPTO) to efficiently distribute patent applications to the appropriate examiners for review.

To learn more:

Priority Mail Express® is a service offered by the United States Postal Service (USPS) that can be used to establish a filing date for patent applications and other correspondence with the USPTO. As stated in MPEP 513:

The statutory authority for the granting of a filing date based on the date of deposit for correspondence sent by Priority Mail Express® and received by the Office is found in section 21(a) of Title 35 of the United States Code.

Using Priority Mail Express® allows applicants to receive a filing date as of the date the correspondence was deposited with USPS, rather than the date it was received by the USPTO.

Priority in patent applications refers to the ability of a later-filed application to claim the benefit of, or priority to, an earlier-filed application. This allows the later application to effectively have the filing date of the earlier application for certain purposes.

According to the MPEP, “Under certain conditions and on fulfilling certain requirements, a later-filed application for patent filed in the United States may claim the benefit of, or priority to, a prior application filed in the United States (see 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c); see also 37 CFR 1.78) or in a foreign country (see 35 U.S.C. 119(a)-(d) and (f), 365(a) and (b), and 386(a) and (b); see also 37 CFR 1.55).”

According to 35 U.S.C. 261, patents have the attributes of personal property and are assignable by an instrument in writing. Specifically, the statute states:

‘Subject to the provisions of this title, patents shall have the attributes of personal property. […] Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing.’

This means that patent owners can transfer their rights to others through written assignments, similar to other forms of property.

PALM stands for Patent Application Locator and Monitoring system. While MPEP 303 doesn’t provide a definition, it mentions PALM in the context of assignment information:

“…it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

PALM is an internal USPTO database system used by patent examiners to access and track information about patent applications, including assignment details. It’s a crucial tool for examiners when they need to verify ownership or resolve conflicts related to patent applications.

MPEP 602.07 is titled ‘Oath or Declaration Filed in United States as a Designated Office’. This section provides guidance on the requirements for oaths or declarations filed in the United States Patent and Trademark Office (USPTO) when it acts as a designated office for international patent applications under the Patent Cooperation Treaty (PCT).

The section directs readers to MPEP § 1893.01(e) for more detailed information. This cross-reference suggests that MPEP § 1893.01(e) contains more specific instructions or requirements related to oaths or declarations in this context.

To learn more:

MPEP 319 is currently a reserved section in the Manual of Patent Examining Procedure (MPEP). The content of this section is marked as ‘[Reserved]’, which means that there is no specific information or guidance provided in this particular section at this time.

Limited recognition in patent matters is a provision that allows certain individuals who are not registered patent practitioners to prosecute specific patent applications before the United States Patent and Trademark Office (USPTO). According to 37 CFR 11.9(a):

Any individual not registered under § 11.6 may, upon a showing of circumstances that render it necessary or justifiable and that the individual is of good moral character and reputation, be given limited recognition by the OED Director to prosecute as attorney or agent a specified patent application or specified patent applications.

This means that under certain circumstances, individuals who are not registered patent attorneys or agents may be granted permission to work on specific patent applications.

To learn more:

To learn more:

Joint ownership of a patent occurs when multiple parties together own the entire right, title, and interest of the patent property. This can happen in several scenarios:

  • Multiple partial assignees of the patent property
  • Multiple inventors who have not assigned their rights
  • A combination of partial assignee(s) and inventor(s) who have not assigned their rights

In cases of joint ownership, all parties having any portion of the ownership must act together as a composite entity in patent matters before the USPTO. According to 35 U.S.C. 262, in the absence of any agreement to the contrary, each joint owner may make, use, offer to sell, or sell the patented invention within the United States without the consent of and without accounting to the other owners.

Irreparable damage, in the context of patent applications, refers to a situation where a filing date is crucial to preserve the rights of an applicant or to prevent severe harm. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This means that an applicant can demonstrate irreparable damage by providing a statement explaining why obtaining a specific filing date is essential to protect their rights or avoid significant harm.

To learn more:

To learn more:

Tags: pre-AIA

Indexing against a recorded certificate refers to the process of associating additional patent numbers or application numbers with a document that has already been recorded in the USPTO’s Assignment Division. However, the USPTO does not process such requests for ‘indexing’ or ‘cross-referencing’ unless a new submission is made.

According to MPEP 315, The Office does not process requests for ‘indexing’ or ‘cross-referencing’ additional patent numbers or application numbers against a document, other than an assignment, previously recorded in the Assignment Division.

Incorporation by reference under 37 CFR 1.57(b) is a provision that allows applicants to add inadvertently omitted material to a patent application if certain conditions are met. Specifically:

  • The application must contain a priority or benefit claim to a prior-filed application
  • The omitted material must be completely contained in that prior-filed application
  • The omission must have been inadvertent

This provision acts as a safeguard for applicants when material is accidentally left out of an application due to clerical error. As stated in the MPEP, “The purpose of 37 CFR 1.57(b) is to provide a safeguard for applicants when a page(s) of the specification, or a portion thereof, or a sheet(s) of the drawing(s), or a portion thereof, is (are) inadvertently omitted from an application, such as through a clerical error.”

Form PTO/AIA/82 is a USPTO form used by the applicant for patent to appoint one or more patent practitioners as power of attorney. This form consists of three parts:

  • Part A (PTO/AIA/82A): A transmittal page used to identify the application to which the power of attorney is directed. It must be signed by a proper 37 CFR 1.33(b) party.
  • Part B (PTO/AIA/82B): The actual power of attorney, which may also specify the correspondence address. This part must be signed by the applicant.
  • Part C (PTO/AIA/82C): An optional page that may be used to appoint up to 10 patent practitioners by name and registration number.

The MPEP notes that “PTO/AIA/82 may be used like a general power of attorney, if desired.” For example, an officer of a juristic entity assignee could sign Part B, leaving the “Application Number” and “Filing Date” boxes empty. Then, a patent practitioner could complete and sign one Part A for each respective application and file a copy of Part B with each Part A.

It’s important to note that the “Application Number” and “Filing Date” boxes on Part B must be completed to identify the application if Part A or an equivalent is not filed with Part B. These boxes may not be filled in by a patent practitioner after Part B has been signed by the applicant.

To learn more:

Form Paragraph 6.17 is a tool used by patent examiners to notify applicants about issues with claim numbering. According to MPEP 608.01(j), this form paragraph is titled “Numbering of Claims, 37 CFR 1.126” and is used when the numbering of claims does not comply with the regulations. The paragraph states:

“The numbering of claims is not in accordance with 37 CFR 1.126, which requires the original numbering of the claims to be preserved throughout the prosecution. When claims are canceled, the remaining claims must not be renumbered. When new claims are presented, they must be numbered consecutively beginning with the number next following the highest numbered claims previously presented (whether entered or not).”

This form paragraph helps examiners communicate clearly with applicants about claim numbering issues and ensures compliance with USPTO regulations.

To learn more:

To learn more:

Form Paragraph 4.03 is used by USPTO examiners in Office actions to notify relevant parties about the death of a patent practitioner. The paragraph reads:

Notice of the death of the attorney or agent of record has come to the attention of this Office. Since the power of attorney is therefore terminated, this action is being mailed to the office of the patent practitioner and to the party who originally appointed the deceased patent practitioner. A new registered attorney or agent may be appointed.

This paragraph informs recipients that the power of attorney has been terminated and that a new attorney or agent can be appointed.

Form Paragraph 2.34 is a standardized response used by patent examiners when addressing improper amendments to Continued Prosecution Applications (CPAs). According to MPEP § 201.06(d), this form paragraph is specifically used to:

“inform the applicant that an amendment to the first sentence(s) of the specification referring to the CPA as a continuing application of the prior application has not been entered and will not be entered if submitted again.”

The form paragraph explains that such amendments are unnecessary because the CPA request itself serves as the specific reference required by 35 U.S.C. 120. It helps maintain consistency in examiner responses and ensures that applicants are properly informed about the treatment of these amendments in CPA applications.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

Executive Order 9424, issued in 1944, mandates the recording of certain government interests in patent rights. The MPEP references this order in the context of USPTO document recording:

In addition to assignments and documents required to be recorded by Executive Order 9424, upon request, assignments of applications, patents, and registrations, and other documents relating to interests in patent applications and patents will be recorded in the Office.

This means that while Executive Order 9424 requires the recording of specific government-related documents, the USPTO’s recording practices extend beyond these requirements. The USPTO will record various documents related to patent interests upon request, as outlined in 35 U.S.C. 261 and 37 CFR 3.11.

For more information on Executive Order 9424, you can refer to the National Archives.

For more information on government interests, visit: government interests.

For more information on patent rights, visit: patent rights.

Essential material is defined in 37 CFR 1.57(d) as material that is necessary to:

  • Provide a written description of the claimed invention as required by 35 U.S.C. 112(a)
  • Describe the claimed invention in terms that particularly point out and distinctly claim the invention as required by 35 U.S.C. 112(b)
  • Describe the structure, material, or acts that correspond to a claimed means or step for performing a specified function as required by 35 U.S.C. 112(f)

Essential material may only be incorporated by reference to a U.S. patent or patent application publication.

To learn more:

Electronic Priority Document Exchange (PDX) is a system that allows for the electronic transmission of priority documents between participating foreign intellectual property offices. As stated in MPEP 215.01:

Electronic Priority Document Exchange (PDX) agreements provide for the electronic transmission of priority documents to and from participating foreign intellectual property offices.

This system streamlines the process of obtaining certified copies of foreign priority applications, which is crucial for claiming priority in patent applications.

To learn more:

Cross-noting in patent applications refers to the process of recording and verifying information about prior applications, including U.S. and foreign applications, for which benefit or priority is claimed. This information is typically noted on the bibliographic data (bib-data) sheet of the application and is used to ensure accurate representation of priority claims on the front page of a printed patent.

According to MPEP 202, “The front page of a printed patent identifies all prior applications for which benefits are claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in continuation-in-part, continuation, divisional, and reissue applications.”

Copendency refers to the requirement that a later-filed application claiming the benefit of a prior-filed nonprovisional application must be filed before:

  • (A) the patenting of the prior application;
  • (B) the abandonment of the prior application; or
  • (C) the termination of proceedings in the prior application.

As stated in MPEP 211.01(b):

“If the prior application issues as a patent, it is sufficient for the later-filed application to be copending with it if the later-filed application is filed on the same date, or before the date that the patent issues on the prior application.”

This means that to maintain copendency, applicants should file any continuing applications no later than the date the issue fee is paid for the prior application.

To learn more:

Copendency refers to the requirement that a later-filed application claiming benefit of a prior application must be filed before the prior application is patented, abandoned, or proceedings are terminated. Copendency is crucial because:

  • It establishes a continuous chain of pending applications
  • It allows the later application to claim the earlier filing date
  • Without copendency, the benefit claim is improper

As stated in MPEP 211.01(b): “Copendency is defined in the clause which requires that the later-filed application must be filed before: (A) the patenting of the prior application; (B) the abandonment of the prior application; or (C) the termination of proceedings in the prior application.”

For patent applications filed before September 16, 2012 (pre-AIA), proper documentary evidence for establishing assignee rights typically includes:

  • An assignment document recorded in the USPTO
  • A statement under 37 CFR 3.73(b) signed by a party authorized to act on behalf of the assignee

According to MPEP 324: The submission establishing ownership must show that the person signing the submission is a person authorized to act on behalf of the assignee by:

  1. (A) Including a statement that the person signing the submission is authorized to act on behalf of the assignee; or
  2. (B) Being signed by a person having apparent authority to sign on behalf of the assignee, e.g., an officer of the assignee.

It’s crucial that the documentary evidence clearly shows the chain of title from the original owner to the current assignee. This ensures that the USPTO can verify the assignee’s right to take action in the application.

For more information on assignee rights, visit: assignee rights.

For more information on chain of title, visit: chain of title.

For more information on documentary evidence, visit: documentary evidence.

For more information on pre-AIA applications, visit: pre-AIA applications.

The MPEP provides guidance on what constitutes a valid mailing address for inventors in patent applications. According to MPEP 602.08(a):

“The inventor’s mailing address means that address at which he or she customarily receives his or her mail, even if it is not the main mailing address of the inventor. Either the inventor’s home or business address is acceptable as the mailing address. A post office box is also acceptable.”

The mailing address should include the ZIP Code designation. It’s important to note that the address of an attorney with instructions to forward communications is not sufficient, as the purpose is to enable direct communication between the USPTO and the inventor if necessary.

To learn more:

A preliminary amendment in patent applications refers to amendments made to the application before the first Office action. According to MPEP 608.04(b):

A preliminary amendment present on the filing date of the application (e.g., filed along with the filing of the application) is considered a part of the original disclosure.

This means that amendments submitted with the initial application filing are treated as part of the original disclosure. However, preliminary amendments filed after the application filing date are not considered part of the original disclosure.

To learn more:

A ‘new’ patent application is a nonprovisional application that has not yet received an action by the examiner. According to MPEP 203.01:

An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

It’s important to note that a request for continued examination (RCE) is not considered a new application filing.

For more information on new application, visit: new application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on RCE, visit: RCE.

According to MPEP 203.01, a ‘new’ application is defined as:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner. An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

It’s important to note that a request for continued examination (RCE) is not considered a new application filing.

What is considered a ‘good and sufficient reason’ to revoke a power of attorney by less than all applicants?

The USPTO does not provide a specific definition of what constitutes a ‘good and sufficient reason’ to revoke a power of attorney by less than all applicants. According to MPEP 402.10:

A power of attorney may not be revoked by less than all of the applicants or owners of the entire interest without good and sufficient reason, and the revocation must be approved by the Director.

The determination of what qualifies as a ‘good and sufficient reason’ is made on a case-by-case basis by the Director of the USPTO. Some potential reasons could include:

  • Evidence of misconduct or negligence by the current attorney
  • Irreconcilable differences between the applicant(s) and the attorney
  • Inability of the attorney to continue representation due to health issues or other circumstances

Applicants seeking to revoke a power of attorney with less than all signatures should provide a detailed explanation of their reasons for the request.

To learn more:

Proof of unavailability for a non-signing inventor can include various forms of evidence. According to MPEP 409.03(d):

In the case of unavailability, proof of the inability to find or reach the non-signing inventor after diligent effort must be submitted.

This proof may include:

  • Returned correspondence
  • Copies of email or other communication attempts
  • Statements from people with knowledge of the inventor’s unavailability
  • Documentation of searches or inquiries made to locate the inventor

The key is to demonstrate a diligent effort to locate and communicate with the non-signing inventor.

To learn more:

‘New matter’ refers to any subject matter that is added to a patent application after its filing date, which was not present in the original specification, claims, or drawings. The MPEP states: Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing is usually new matter. (MPEP 608.04(a))

New matter can include:

  • Addition of wholly unsupported subject matter
  • Adding specific percentages or compounds after a broader original disclosure
  • Omission of a step from a method

It’s important to note that new matter is not allowed in patent applications, as per 35 U.S.C. 132(a), which states: No amendment shall introduce new matter into the disclosure of the invention.

To learn more:

What is considered ‘diligent effort’ when trying to contact an inventor for joint invention?

When attempting to contact a joint inventor for patent application purposes, ‘diligent effort’ typically involves:

  • Multiple attempts to reach the inventor through various communication methods (e.g., phone, email, postal mail)
  • Reasonable time intervals between attempts
  • Documenting all contact attempts and responses (or lack thereof)
  • Exploring alternative contact methods if initial attempts fail

The MPEP 409.03(d) states: ‘Where inability to find or reach a nonsigning inventor ‘after diligent effort’ is the reason for filing under pre-AIA 37 CFR 1.47(b), a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.’ This emphasizes the importance of thoroughly documenting all efforts made to contact the inventor.

To learn more:

Antecedent basis in patent claims refers to the presence of support for claim terms in the specification. It is important because it ensures clarity and consistency between the claims and the specification. MPEP 608.01(o) states:

This is necessary in order to insure certainty in construing the claims in the light of the specification. See 37 CFR 1.75, MPEP § 608.01(i) and § 1302.01 and § 2103.

Proper antecedent basis helps prevent ambiguity in claim interpretation and strengthens the overall patent application. If the examiner finds that claims lack proper antecedent basis, they may object to the specification using form paragraph 7.44.

To learn more:

An unintentionally delayed priority claim occurs when a claim for foreign priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) is not presented within the time period provided by 37 CFR 1.55(d). In such cases, the claim is considered to have been waived but may be accepted if the delay was unintentional.

As stated in the MPEP: “If a claim for priority is considered to have been waived under this section, the claim may be accepted if the priority claim was unintentionally delayed.”

To learn more:

What is an S-signature in USPTO correspondence and how is it formatted?

An S-signature is an electronic signature used in correspondence with the USPTO. According to MPEP 502.02, an S-signature must be formatted as follows:

  • Inserted between forward slash marks: /John Doe/
  • Include the signer’s name
  • For registered practitioners, include their registration number
  • The signer’s name can be printed or typed
  • The signature must comply with 37 CFR 1.4(d)(2)

For example, a proper S-signature for a registered patent attorney might look like this:

/John Q. Attorney, Reg. No. 12345/

This format allows for efficient electronic filing while maintaining the legal weight of a signature.

To learn more:

An S-signature is an electronically created signature used in patent correspondence. According to MPEP 502.02:

An S-signature is a signature inserted between forward slash marks, but not a handwritten signature as defined by 37 CFR 1.4(d)(1). An S-signature includes any signature made by electronic or mechanical means, and any other mode of making or applying a signature other than a handwritten signature as provided for in 37 CFR 1.4(d)(1).

S-signatures must meet specific requirements to be considered valid:

  • They must be between two forward slash marks
  • They can include letters, numbers, and punctuation marks
  • They must be personally inserted by the signer
  • They must be reasonably specific to the signer

S-signatures provide a convenient way for applicants and practitioners to sign documents electronically while maintaining the legal weight of a handwritten signature.

To learn more:

An S-signature is a type of electronic signature used in USPTO correspondence. According to MPEP 501, which cites 37 CFR 1.4(d)(2):

An S-signature is a signature inserted between forward slash marks, but not a handwritten signature as defined by paragraph (d)(1) of this section. An S-signature includes any signature made by electronic or mechanical means, and any other mode of making or applying a signature other than a handwritten signature.

Key requirements for an S-signature include:

  • It must consist only of letters, Arabic numerals, or both, with appropriate punctuation.
  • The signer must insert their own S-signature with a single forward slash mark before and after the signature.
  • For patent practitioners, their registration number must be included with or near the S-signature.
  • The signer’s name must be presented in printed or typed form near the S-signature.

Example of a proper S-signature: /John D. Smith/

S-signatures can be used for most USPTO correspondence filed electronically or by facsimile.

For more information on USPTO correspondence, visit: USPTO correspondence.

An inventor’s certificate is a form of intellectual property protection offered in some countries. It can form the basis for priority rights under certain conditions, as stated in 35 U.S.C. 119(d):

Applications for inventors’ certificates filed in a foreign country in which applicants have a right to apply, at their discretion, either for a patent or for an inventor’s certificate shall be treated in this country in the same manner and have the same effect for purpose of the right of priority under this section as applications for patents…

This means that if an applicant had the option to file for either a patent or an inventor’s certificate in the foreign country, they can claim priority based on the inventor’s certificate application in the United States.

To learn more:

An international design application is a specific type of patent application for industrial designs. The definition of an international design application is provided in 37 CFR 1.9(n).

Key points about international design applications:

  • They are filed under the Hague Agreement Concerning the International Registration of Industrial Designs
  • They allow applicants to seek protection for industrial designs in multiple countries through a single application
  • They are administered by the World Intellectual Property Organization (WIPO)
  • They can designate the United States for design patent protection

For more information on international design applications, visit the WIPO Hague System page.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on patent law, visit: patent law.

An international application in patent law refers to a patent application filed under the Patent Cooperation Treaty (PCT). The definition of an international application is provided in 37 CFR 1.9(b).

Key points about international applications:

  • They are filed under the PCT framework
  • They can potentially lead to patent protection in multiple countries
  • They undergo an international search and optional international preliminary examination
  • They must enter the national phase in desired countries to pursue patent protection

For more detailed information on international applications, refer to the World Intellectual Property Organization (WIPO) PCT resources.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For more information on patent law, visit: patent law.

The MPEP 201 defines an international application as follows:

“An international application is a patent application filed under the Patent Cooperation Treaty (PCT). An international application may be filed by a resident or national of the United States of America in the U.S. Patent and Trademark Office (USPTO) as a Receiving Office.”

Key points about international applications include:

  • They are governed by the Patent Cooperation Treaty (PCT).
  • They allow inventors to seek patent protection in multiple countries through a single application.
  • The USPTO can act as a Receiving Office for U.S. residents or nationals.
  • They enter a national phase in individual countries where protection is sought.

International applications provide a streamlined process for seeking patent protection in multiple countries, potentially saving time and resources for inventors and businesses operating globally.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

An interim copy of a foreign priority document is a copy that is submitted before the certified copy is available. The MPEP 213.02 provides guidance on when an interim copy is acceptable:

The Office may require that an ‘interim copy’ of the foreign application be furnished in the event that the certified copy of the foreign application is not filed within the time period set forth in 37 CFR 1.55(f) and an exception in 37 CFR 1.55(h), (i), or (j) is not applicable.

An interim copy must:

  • Be filed within the later of 4 months from the filing date of the application or 16 months from the filing date of the prior foreign application
  • Be a copy of the original foreign application
  • Be accompanied by a statement that the copy is a true copy

Note: An interim copy does not substitute the requirement for a certified copy, which must still be filed during the pendency of the application.

To learn more:

An Information Disclosure Statement (IDS) is a mechanism by which patent applicants can comply with the duty of disclosure provided in 37 CFR 1.56. It allows applicants to submit information that is material to patentability to the U.S. Patent and Trademark Office (USPTO).

According to the MPEP, The provisions of 37 CFR 1.97 and 37 CFR 1.98 provide a mechanism by which patent applicants may comply with the duty of disclosure provided in 37 CFR 1.56 using an IDS. This means that an IDS is a formal way to disclose relevant prior art and other information to the patent examiner.

To learn more:

Tags: prior art, USPTO

An incomplete patent application is one that is not entitled to a filing date because it lacks some of the essential parts required by the United States Patent and Trademark Office (USPTO). As stated in MPEP 203.06:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

This means that the application is missing crucial components necessary for it to be considered a complete submission and to receive an official filing date from the USPTO.

To learn more:

An extract of an original document refers to a portion or summary of the original assignment document that contains the essential information required for recording. Both 37 CFR 3.24(a) and (b) state that “Either a copy of the original document or an extract of the original document may be submitted for recording.”

When submitting an extract:

  • Ensure it includes all relevant assignment details.
  • The extract must meet the same format requirements as a full copy.
  • It should be clear that the extract represents the key elements of the original document.

Using an extract can be beneficial when the original document contains confidential information not necessary for the assignment record.

An e-IDS (electronic Information Disclosure Statement) is a way to submit information disclosure statements to the USPTO electronically. According to MPEP 609.07:

Information disclosure statements may be submitted to the Office via the USPTO patent electronic filing system. Applicants can file an e-IDS using EFS-Web by (A) entering the references’ citation information in an electronic data entry form, equivalent to the paper PTO/SB/08 form, and (B) transmitting the electronic data entry form to the Office.

This electronic submission method allows for efficient filing of IDSs, particularly for U.S. patents and patent application publications.

To learn more:

An application number consists of a series code and a serial number. It is assigned by the Office of Patent Application Processing (OPAP) immediately after mail has been opened. For applications filed using the USPTO patent electronic filing system, EFS-Web provides an Acknowledgement Receipt containing a time and date stamp, application number, and confirmation number.

The MPEP states: ‘Application numbers consisting of a series code and a serial number are assigned by the Office of Patent Application Processing (OPAP) immediately after mail has been opened.’ (MPEP 503)

An application filed by reference under 35 U.S.C. 111(c) is a method of filing a nonprovisional patent application where the applicant refers to a previously filed application instead of submitting a new specification and drawings. Key points about this type of filing include:

  • It’s available for applications filed on or after December 18, 2013.
  • The reference must be made in English in an Application Data Sheet (ADS).
  • The reference must specify the previously filed application by application number, filing date, and the intellectual property authority or country where it was filed.
  • The applicant must submit a copy of the specification and drawings from the previously filed application within a specified time period.

The MPEP states: a reference made upon the filing of an application under 35 U.S.C. 111(a) to a previously filed application, indicating that the specification and any drawings of the application under 35 U.S.C. 111(a) are replaced by the reference to the previously filed application, and specifying the previously filed application by application number, filing date, and the intellectual property authority or country in which the previously filed application was filed, shall constitute the specification and any drawings of the application under 35 U.S.C. 111(a) for purposes of a filing date under § 1.53(b).

To learn more:

To learn more:

Tags: USPTO

An Application Data Sheet (ADS) is a voluntary submission for patent applications filed before September 16, 2012, that contains bibliographic data arranged in a specific format. According to MPEP 601.05(b), “An application data sheet is a sheet or sheets, that may be voluntarily submitted in either provisional or nonprovisional applications, which contains bibliographic data, arranged in a format specified by the Office.” The ADS becomes part of the application and must be titled “Application Data Sheet.”

To learn more:

An Application Data Sheet (ADS) is a document that provides bibliographic data for a patent application. For applications filed by assignees, obligated assignees, or those with sufficient proprietary interest, the ADS is crucial. According to MPEP 409.05:

‘The applicant under 37 CFR 1.46 (assignees and obligated assignees) must record the assignment, or submit the documentary evidence to the Office, preferably before issuing the filing receipt.’

The ADS must include:

  • The name of the inventor(s)
  • A statement that the application is being filed by the assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest
  • If filed by an obligated assignee, a statement that the application is being filed by a party who has a contractual obligation to assign or is under an obligation to assign the invention

The ADS serves as the official record of the applicant’s status and helps ensure that the USPTO properly recognizes the applicant’s right to file the application.

To learn more:

An Application Data Sheet (ADS) is a document containing bibliographic data for a patent application, arranged in a format specified by the USPTO. According to MPEP 601.05, an ADS:

  • May be submitted voluntarily in provisional or nonprovisional applications
  • Must be submitted when required by 37 CFR 1.55 and 1.78 to claim priority to or benefit of a prior-filed application
  • Must be titled “Application Data Sheet”
  • Becomes part of the application when provided

The USPTO prefers the use of an ADS in all applications to help facilitate electronic capturing of important data.

To learn more:

To learn more:

An Application Data Sheet (ADS) is a document that provides bibliographic data for patent applications. Its use and importance are described in the MPEP:

“If an application data sheet (37 CFR 1.76) is used, data supplied in the application data sheet need not be provided elsewhere in the application with one exception for applications filed before September 16, 2012.”

Key points about the ADS include:

  • It simplifies the filing process by consolidating important information in one place.
  • Information in the ADS generally takes precedence over conflicting information elsewhere in the application.
  • For applications filed before September 16, 2012, citizenship of inventors must still be provided in the oath or declaration, even if included in the ADS.
  • The ADS controls most information except for the naming of inventors, which is governed by 37 CFR 1.41.

For more detailed information on the Application Data Sheet, refer to MPEP § 601.05.

To learn more:

An abandoned patent application is one that has been removed from the Office docket of pending applications. According to MPEP 203.05, this can occur in several ways:

  • Through formal abandonment by the applicant or their attorney/agent
  • Due to failure of the applicant to take appropriate action during prosecution
  • For failure to pay the issue fee
  • In the case of a provisional application, no later than 12 months after the filing date

As stated in MPEP 203.05: An abandoned application is, inter alia, one which is removed from the Office docket of pending applications. The specific reasons for abandonment are listed in the same section.

An ‘original’ application in patent law refers to an application that is not a reissue application. The MPEP states:

“Original” application is used in the patent statutes and rules to refer to an application which is not a reissue application. An original application may be a first filing or a continuing application.

This means that an original application can be either:

  • The first filing of a patent application for an invention
  • A continuing application (continuation, divisional, or continuation-in-part) filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78

To learn more:

An ‘obligated assignee’ in patent applications refers to a person or entity who is under an obligation to assign the invention but has not yet executed an assignment. This concept is important in the context of MPEP 409.05, which states:

An assignee or obligated assignee who is the applicant may execute a substitute statement under 37 CFR 1.64 in lieu of an inventor’s oath or declaration.

This provision allows an obligated assignee to file a patent application and execute certain documents on behalf of the inventor, even if the formal assignment has not yet been completed.

To learn more:

To learn more:

An ‘interim copy’ is a true copy of the original foreign application that an applicant can file to meet the timeliness requirement when they cannot obtain a certified copy within the time limit. According to 37 CFR 1.55(j), the interim copy must be clearly labeled as ‘Interim Copy’ and filed with a cover sheet stating it is a true copy of the original foreign application.

An ‘interim copy’ is a mechanism provided by 37 CFR 1.55(j) that allows applicants to meet the timeliness requirement for submitting a certified copy of a foreign application. It’s a copy of the original foreign application that the applicant can provide from their own records when they cannot obtain a certified copy within the time limit set by 37 CFR 1.55(f).

The MPEP states: 37 CFR 1.55(j) permits an applicant to provide an ‘interim copy’ of the original foreign application from the applicant’s own records to provide for the situation in which the applicant cannot obtain a certified copy of the foreign application within the time limit set forth in 37 CFR 1.55(f), although there is no requirement that an applicant be unable to obtain a certified copy of the foreign application within the time limit set forth in 37 CFR 1.55(f) to use 37 CFR 1.55(j).

To learn more:

An ‘interim copy’ is a copy of the original foreign application from the applicant’s own records that can be submitted to satisfy the timeliness requirement for certified copies. According to 37 CFR 1.55(j):

  • The copy must be clearly labeled as ‘Interim Copy’
  • It must be filed with a cover sheet identifying the foreign application
  • It must be filed within the same time period as required for certified copies
  • A certified copy must still be filed during the pendency of the application

This provision allows applicants to meet the deadline even if they cannot obtain a certified copy in time, although there is no requirement to show inability to obtain a certified copy to use this option.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

37 CFR 1.55(j) allows an applicant to provide an ‘interim copy’ of the original foreign application to satisfy the requirement for a certified copy to be filed within the time limit set in 37 CFR 1.55(f). An interim copy must:

  • Be clearly labeled as ‘Interim Copy’
  • Include the specification, drawings, and claims of the foreign application
  • Be filed with a separate cover sheet identifying the foreign application
  • Be filed within the later of 16 months from the foreign filing date or 4 months from the actual U.S. filing date

A certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g).

To learn more:

An ‘assignment-statement’ is a relatively new concept in patent law, introduced for applications filed on or after September 16, 2012. The MPEP explains:

‘For applications filed under 35 U.S.C. 111(a), 363, or 385 on or after September 16, 2012, an assignment may contain the statements required to be made in an oath or declaration (‘assignment-statement’), and if the assignment is made of record in the assignment records of the Office, then the assignment may be utilized as the oath or declaration.’

This means that for qualifying applications, the assignment document can serve a dual purpose:

  1. Transferring ownership of the patent application
  2. Fulfilling the requirement for an oath or declaration

This provision can simplify the application process by combining two previously separate documents. The MPEP cites 35 U.S.C. 115(e), 37 CFR 1.63(e), and MPEP §§ 302.07, 317, and 602.01(a) for further details on this practice.

An ‘amended’ nonprovisional patent application is one that has undergone a specific process in the examination procedure. According to MPEP 203.03:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action.

In simpler terms, it means that after the patent examiner has reviewed and responded to the application, the applicant has then taken some action in response to the examiner’s feedback.

To learn more:

An ‘allowed’ patent application is one that has been examined and determined to meet all statutory requirements. According to MPEP 203.04:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.

The status of ‘allowed’ continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue or becomes abandoned for failure to pay the issue fee and any required publication fee.

For more information on allowed application, visit: allowed application.

For more information on notice of allowance, visit: notice of allowance.

For more information on patent issuance, visit: patent issuance.

A utility patent application is filed under 35 U.S.C. 101 for “a new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof”. Utility patent applications are sometimes referred to as “utility” patent applications when being contrasted with plant or design patent applications.

The MPEP states: “The first type of patent application is sometimes referred to as a ‘utility’ patent application when being contrasted with a plant or design patent application.”

What is a USPTO deposit account and how does it work?

A USPTO deposit account is a pre-established account that allows for convenient payment of fees to the United States Patent and Trademark Office. According to MPEP 509:

“A deposit account is a convenient method for individuals or firms to establish a pre-paid account with the USPTO to facilitate the payment of fees.”

Here’s how USPTO deposit accounts work:

  • You deposit funds into the account in advance
  • Fees can be automatically deducted from the account when filing applications or paying other fees
  • Minimum balance requirements apply (currently $1,000 for individuals, $5,000 for law firms)
  • Account holders receive monthly statements
  • Useful for frequent filers or those managing multiple applications

To open a deposit account, you need to complete Form PTO-2232 and submit it to the USPTO with an initial deposit. This method can streamline fee payments and reduce the risk of insufficient fee issues.

To learn more:

To learn more:

A USPTO deposit account is a convenient method for attorneys and the general public to pay fees and order services from the U.S. Patent and Trademark Office. To establish a deposit account:

  • Pay the fee for establishing a deposit account as per 37 CFR 1.21(b)(1)
  • Make a minimum deposit of $1,000 for general use
  • Alternatively, make a minimum deposit of $300 for a restricted subscription deposit account used exclusively for subscription orders of patent copies

As stated in the MPEP: For the convenience of attorneys, and the general public in paying any fees due, in ordering services offered by the Office, copies of records, etc., deposit accounts may be established in the Patent and Trademark Office upon payment of the fee for establishing a deposit account § 1.21(b)(1).

To learn more:

A transition application under the America Invents Act (AIA) is:

  • Filed on or after March 16, 2013
  • Claims foreign priority to or domestic benefit of an application filed before March 16, 2013

Transition applications may be subject to either pre-AIA or AIA rules depending on the effective filing date of the claimed inventions. The MPEP states: “Transition applications are either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications depending on the effective filing date of the claimed invention(s).” (MPEP 210)

A transition application under the America Invents Act (AIA) is:

  • A nonprovisional application filed on or after March 16, 2013
  • That claims foreign priority to, or domestic benefit of, an application filed before March 16, 2013

Transition applications can be either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications, depending on the effective filing date of the claimed invention(s).

The MPEP states: “Transition applications are nonprovisional applications that: (A) are filed on or after March 16, 2013; and (B) claim foreign priority to, or domestic benefit of, an application filed before March 16, 2013. Transition applications are either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications depending on the effective filing date of the claimed invention(s).”

A title report in patent law is a form used by the Assignment Division of the USPTO to report the name of the owner of an application or patent as shown by their records on a specific date. According to the MPEP:

The “title report” is a form which can be used under certain circumstances by the Assignment Division to report to someone within the Office the name of the owner of an application or patent as shown by the Assignment Division records on the date the title report is made.

These reports are used internally within the USPTO and are not available for direct request by applicants or attorneys.

A supplemental oath or declaration is a document that can be submitted to correct deficiencies or inaccuracies in an earlier-filed inventor’s oath or declaration. According to MPEP 603, it is provided for under 35 U.S.C. 115(h) and 37 CFR 1.67.

The MPEP states: 37 CFR 1.67(a) provides that the applicant may submit an inventor’s oath or declaration meeting the requirements of 37 CFR 1.63, 1.64, or 1.62 to correct any deficiencies or inaccuracies present in an earlier-filed inventor’s oath or declaration.

It’s important to note that while corrections can be made, no new matter may be introduced into a nonprovisional application after its filing date even if an inventor’s oath or declaration is filed to correct deficiencies or inaccuracies present in the earlier-filed oath or declaration.

To learn more:

A substitute statement is a document that can be executed in lieu of an oath or declaration in certain circumstances. According to 37 CFR 1.64(a), “An applicant under § 1.43, 1.45 or 1.46 may execute a substitute statement in lieu of an oath or declaration under § 1.63 if the inventor is deceased, is under a legal incapacity, has refused to execute the oath or declaration under § 1.63, or cannot be found or reached after diligent effort.

This provision allows certain parties to move forward with a patent application when the inventor is unavailable or unwilling to sign the required documents.

To learn more:

To learn more:

A substitute statement is a document that can be used in place of an oath or declaration in patent applications involving deceased or legally incapacitated inventors. According to MPEP 409.01(a):

See 37 CFR 1.64 and MPEP § 604 concerning the execution of a substitute statement by a legal representative in lieu of an oath or declaration.

The substitute statement can be executed by:

  • A legal representative of the deceased or incapacitated inventor
  • An assignee or obligated assignee
  • A party with sufficient proprietary interest in the invention

This allows the application process to continue even when the inventor is unable to provide an oath or declaration due to death or incapacity. The substitute statement must comply with the requirements set forth in 37 CFR 1.64.

To learn more:

A substitute statement is a document that can be filed in place of an oath or declaration when the inventor is deceased, legally incapacitated, cannot be found or reached after diligent effort, or refuses to execute the oath or declaration. According to MPEP 602:

’35 U.S.C. 115(d) provides that ‘the applicant for patent’ may provide a substitute statement under the circumstances described in 35 U.S.C. 115(d)(2). The applicant for patent is defined in 35 U.S.C. 100(g) as ‘the inventor or joint inventors who are applying for a patent through their assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest in the matter.’

The substitute statement must:

  • Identify the inventor to whom it relates
  • Identify the circumstances permitting the filing of the substitute statement
  • Include a statement that the person executing the substitute statement has reviewed and understands the contents of the application
  • Include a statement that the person executing the substitute statement acknowledges the duty to disclose information material to patentability

This provision allows for the continuation of the patent application process even when the inventor is unable or unwilling to execute the oath or declaration.

To learn more:

What is a substitute statement for a deceased inventor and when is it required?

A substitute statement is a document that replaces the inventor’s oath or declaration when the inventor is deceased, legally incapacitated, or otherwise unavailable. For a deceased inventor, it is required when filing a patent application on or after September 16, 2012.

According to MPEP 409.01(a):

The substitute statement must comply with the requirements of 35 U.S.C. 115(d) and 37 CFR 1.64.

The substitute statement must:

  • Identify the inventor to whom it applies
  • Identify the person executing the substitute statement
  • Include a statement that the person executing the substitute statement believes the named inventor to be the original inventor
  • State the circumstances permitting the person to execute the substitute statement (e.g., the inventor’s death)

This statement allows the patent application process to proceed in cases where the inventor cannot personally execute the required oath or declaration.

To learn more:

What is a substitute statement and when can it be used instead of an oath or declaration?

A substitute statement is a document that can be filed in place of an oath or declaration under certain circumstances. According to MPEP 602:

“When an inventor is deceased, legally incapacitated, cannot be found or reached after diligent effort, or refuses to execute an oath or declaration, the applicant under 37 CFR 1.43, 1.45 or 1.46 may execute a substitute statement in lieu of an oath or declaration.”

The substitute statement can be used in the following situations:

  • The inventor is deceased
  • The inventor is legally incapacitated
  • The inventor cannot be found or reached after diligent effort
  • The inventor refuses to execute the oath or declaration

The substitute statement must:

  • Identify the inventor to whom it applies
  • State the circumstances justifying its use
  • Include an acknowledgment that willful false statements are punishable by fine or imprisonment

It’s important to note that the substitute statement must be signed by the appropriate party as specified in 37 CFR 1.64, which may include the applicant or an assignee.

To learn more:

A substitute statement is a document that can be used in place of an inventor’s oath or declaration under certain circumstances. According to 37 CFR 1.64, an applicant may execute a substitute statement if the inventor:

  • Is deceased
  • Is under a legal incapacity
  • Has refused to execute the oath or declaration
  • Cannot be found or reached after diligent effort

The substitute statement must comply with specific requirements outlined in 37 CFR 1.64(b), including identifying the inventor, the person executing the statement, and the circumstances permitting its use. For more details on substitute statements, see MPEP § 604.

To learn more:

A substitute statement is a document that can be used in lieu of an inventor’s oath or declaration under certain circumstances. According to MPEP § 409.05, a substitute statement can be used when the inventor:

  • Is deceased
  • Is under a legal incapacity
  • Cannot be found or reached after diligent effort
  • Has refused to execute the oath or declaration

The substitute statement must comply with the requirements of 37 CFR 1.64, including identifying the inventor, the person executing the statement, and the circumstances permitting its use.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on substitute statement, visit: substitute statement.

A substitute specification is a rewritten version of the entire specification or a part of it in a patent application. It may be required by the USPTO or voluntarily submitted by the applicant under certain conditions.

According to 37 CFR 1.125(a):

If the number or nature of the amendments or the legibility of the application papers renders it difficult to consider the application, or to arrange the papers for printing or copying, the Office may require the entire specification, including the claims, or any part thereof, be rewritten.

This provision allows the USPTO to request a substitute specification when necessary for clarity and ease of examination.

To learn more:

A substitute application is a type of national application that is filed to replace a previously filed non-provisional or provisional application. It is used when an applicant wants to start over with a new application while maintaining the benefit of the earlier filing date for common subject matter.

Key points about substitute applications:

  • They are treated as new applications and receive a new application number.
  • The previously filed application is considered to be abandoned as of the filing date of the substitute application.
  • Substitute applications can claim the benefit of the earlier application’s filing date for common subject matter.
  • They must be filed while the earlier application is still pending.
  • Applicants must file a copy of the original application, specification, drawings, and amendments, if any, and a new oath or declaration.

For more information, see MPEP 201.09 and 37 CFR 1.53.

A statutory declaration is an alternative to a traditional oath or declaration in patent applications. According to MPEP 602, “Office personnel are authorized to accept a statutory declaration under 28 U.S.C. 1746 filed in the U.S. Patent and Trademark Office in lieu of an ‘oath’ or declaration under 35 U.S.C. 25 and 37 CFR 1.68, provided the statutory declaration otherwise complies with the requirements of law.” This allows applicants to submit a written statement under penalty of perjury, which can be executed within or outside the United States, without the need for a notary or other official to administer an oath.

To learn more:

To learn more:

A statement under 37 CFR 1.97(e) is a declaration that either:

  1. Each item of information in the IDS was first cited in a foreign patent office communication no more than 3 months prior to the IDS filing, or
  2. No item in the IDS was cited by a foreign patent office, and no item was known to anyone with a duty of disclosure more than 3 months prior to the IDS filing.

This statement is required when submitting an IDS after a first Office action but before a final Office action, Notice of Allowance, or Quayle action, unless a fee is paid. It’s also required when submitting an IDS after a final Office action, Notice of Allowance, or Quayle action (along with the fee).

As stated in MPEP 609.04(b): “A statement under 37 CFR 1.97(e) can contain either of two statements. One statement is that each item of information in an information disclosure statement was first cited in any communication, such as a search report, from a patent office outside the U.S. in a counterpart foreign application not more than three months prior to the filing date of the statement.”

To learn more:

To learn more:

A Secrecy Order is an order issued by the Commissioner for Patents that prevents disclosure or publication of an invention in a patent application when the publication or disclosure would be detrimental to national security. The order requires that the invention be kept secret and may restrict filing of foreign patent applications. (MPEP 120)

A Secrecy Order is an official directive issued by the Commissioner for Patents when notified by the chief officer of a defense agency that publication or disclosure of an invention through a patent grant would be detrimental to national security. As stated in 37 CFR 5.2(a):

When notified by the chief officer of a defense agency that publication or disclosure of the invention by the granting of a patent would be detrimental to the national security, an order that the invention be kept secret will be issued by the Commissioner for Patents.

This order restricts disclosure of the invention and delays the grant of a patent until the order is rescinded.

A Secrecy Order is a directive issued by the Commissioner for Patents to keep an invention secret and withhold the publication of a patent application or the grant of a patent. It is issued when:

  1. A defense agency concludes that disclosure of the invention would be detrimental to national security
  2. The agency recommends a Secrecy Order to the Commissioner for Patents

According to 35 U.S.C. 181, Whenever publication or disclosure by the publication of an application or by the grant of a patent on an invention in which the Government has a property interest might, in the opinion of the head of the interested Government agency, be detrimental to the national security, the Commissioner of Patents upon being so notified shall order that the invention be kept secret and shall withhold the publication of an application or the grant of a patent therefor under the conditions set forth hereinafter.

The Secrecy Order remains in effect for such period as the national interest requires, effectively preventing public disclosure of the invention.

For more information on patent applications, visit: patent applications.

A retroactive foreign filing license is a license granted after an unlicensed foreign filing has already occurred. Key points include:

  • It can be requested through a petition under 37 CFR 5.25.
  • The unlicensed filing must have occurred through error.
  • Specific requirements in 37 CFR 5.25 must be met, including providing detailed information about each unlicensed filing.
  • A verified statement (oath or declaration) explaining the error is required.

The MPEP states: “A petition for a retroactive filing license may be filed under 37 CFR 5.25 if an unlicensed foreign filing has occurred through error. However, the requirements of 37 CFR 5.25 must be fulfilled in order for such a petition to be granted.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

A Request to Delete a Named Inventor in a Continued Prosecution Application (CPA) for Design Applications is a procedure that allows for the correction of inventorship when filing a CPA. This request is specifically used to remove the name(s) of person(s) who are not inventors of the invention being claimed in the new application.

According to MPEP ¶ 2.32:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This paragraph confirms that the USPTO recognizes and processes such requests when submitted with a CPA filing.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

What is a reissue patent application?

A reissue patent application is a request to correct an error in an already issued patent that renders the patent wholly or partly inoperative or invalid. As stated in MPEP 201:

An application for reissue is an application for a new patent to replace an unexpired patent that is defective in some one or more particulars.

Key aspects of reissue applications include:

  • Can be filed only by the original patent owner
  • Must be filed during the term of the original patent
  • Can broaden claim scope only within two years of the original patent grant
  • Requires a declaration stating the error and that it occurred without deceptive intent

Reissue applications are crucial for patent owners to correct mistakes or oversights in their original patents, ensuring their intellectual property rights are properly protected. However, they cannot be used to add new matter to the patent disclosure.

For more information on Patent correction, visit: Patent correction.

A reissue application is a type of patent application used to correct defects in an existing, unexpired patent. According to MPEP 201.05, “A reissue application is an application for a patent to take the place of an unexpired patent that is defective.” This process allows patent holders to address errors or omissions in their original patent, ensuring that their intellectual property rights are properly protected.

To learn more:

A reissue application is a type of patent application used to correct errors in an already issued patent. According to MPEP 201:

“An application for reissue of a patent is an application for a new patent to correct an error in an existing patent.”

Reissue applications are filed when the original patent is wholly or partly inoperative or invalid due to defective specifications, drawings, or by claiming more or less than the patentee had the right to claim. They must be filed by the original patent owner and are subject to specific requirements outlined in 35 U.S.C. 251.

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue application, visit: reissue application.

A reissue application is a type of application used to correct an error in an issued patent that renders the patent wholly or partly inoperative or invalid. It is governed by 35 U.S.C. 251 and 37 CFR 1.171-1.179. Reissue applications are typically filed when the original patent claims are too narrow or too broad, or when there are other errors that affect the scope or validity of the patent. For more information on reissue applications, refer to MPEP 1401.

A provisional patent application is a type of U.S. patent application that allows inventors to establish an early filing date for their invention without the need for a formal patent claim or oath/declaration. According to MPEP 201.04, a provisional application is defined as:

“A provisional application as used in this chapter means a U.S. national application for patent filed in the Office under 35 U.S.C. 111(b).”

Provisional applications are simpler and less expensive to file than regular nonprovisional applications, but they are not examined for patentability and automatically expire after 12 months.

To learn more:

A provisional patent application is a type of patent application that allows inventors to establish an early filing date for their invention. Key differences between provisional and nonprovisional applications include:

  • Provisional applications are not examined and automatically expire after 12 months
  • Provisional applications require fewer formal components than nonprovisional applications
  • Provisional applications cannot directly result in a granted patent

The MPEP states: A provisional application will not be examined. However, a provisional application which does not include a cover sheet (37 CFR 1.51(c)(1)), which may be an application data sheet (37 CFR 1.76) or a cover letter, identifying the application as a provisional application, will be treated as a nonprovisional application filed under 37 CFR 1.53(b).

To obtain a filing date, a provisional application must include:

  • A specification as prescribed by 35 U.S.C. 112(a)
  • Any necessary drawings
  • The appropriate filing fee

Inventors often use provisional applications to secure an early filing date while allowing additional time to prepare a more comprehensive nonprovisional application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

A provisional application for patent is a type of U.S. patent application that allows inventors to establish an early filing date for their invention without filing a formal patent claim or any information disclosure statement. Key points about provisional applications include:

1. They provide a 12-month pendency from the date of filing.
2. They cannot be extended beyond 12 months.
3. They are not examined on their merits.
4. They can serve as a priority document in foreign filing.
5. They require a specification and drawing(s) if necessary to understand the invention.
6. They do not require formal patent claims or an oath or declaration.

Inventors must file a corresponding nonprovisional application within 12 months to claim the benefit of the provisional application’s filing date. For more details, see USPTO’s Provisional Application for Patent and MPEP 201.04(b).

What is a provisional application and how does it affect priority?

A provisional application is a type of patent application that allows inventors to establish an early filing date without a formal patent claim or oath or declaration. Key points about provisional applications and their effect on priority include:

  • Provisional applications provide a 12-month pendency period.
  • They can be used to establish an early effective filing date for a later-filed nonprovisional application.
  • The later-filed nonprovisional must be filed within 12 months of the provisional to claim its benefit.

According to MPEP 210: “The later-filed application must contain or be amended to contain a specific reference to the prior application(s) in the first sentence(s) of the specification or in an application data sheet.”

It’s important to note that the subject matter in the nonprovisional application must be fully supported by the provisional application to receive its priority date. If new matter is added, those portions will only receive the filing date of the nonprovisional application.

For more information on effective filing date, visit: effective filing date.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

A pre-AIA 37 CFR 1.47 application is a patent application filed before September 16, 2012, where not all inventors have signed the application. This provision allows for the filing of a patent application when an inventor cannot be reached or refuses to sign.

According to the MPEP, A filing date is assigned to an application deposited pursuant to pre-AIA 37 CFR 1.47 provided the requirements of 37 CFR 1.53(b) are met. This means that as long as the basic filing requirements are fulfilled, the application can be processed even without all inventors’ signatures.

To learn more:

To learn more:

A plant patent application is filed under 35 U.S.C. 161 for whoever “invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state”.

The MPEP cites 35 U.S.C. 161: “Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state, may obtain a patent therefor, subject to the conditions and requirements of this title.”

What is a PCT application in international patent law?

A PCT (Patent Cooperation Treaty) application is an international patent application that provides a unified procedure for filing patent applications to protect inventions in its contracting states. According to MPEP 201.02:

“An international application is a patent application filed under the Patent Cooperation Treaty (PCT).”

Key features of PCT applications include:

  • Single filing procedure for seeking patent protection in multiple countries
  • Standardized national phase entry at 30 months from the earliest priority date
  • International search report and written opinion on patentability
  • Option for international preliminary examination

PCT applications simplify the process of seeking patent protection internationally, providing applicants with more time and information to make decisions about pursuing patents in specific countries.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

A Notice of Omitted Items is an official communication from the USPTO regarding missing elements in a patent application. As described in MPEP 601.01(f):

“If drawings are omitted in an application filed under 35 U.S.C. 111(a) on or after December 18, 2013, but the application contains something that can be construed as a written description, at least one drawing, if necessary under 35 U.S.C. 113 (first sentence), and, in a nonprovisional application, at least one claim, the Office will not deny a filing date.”

In such cases, the USPTO will issue a Notice of Omitted Items, informing the applicant of the missing drawings and providing a two-month period to submit them. This notice is crucial as it sets the deadline for completing the application and avoiding abandonment.

To learn more:

To learn more:

According to MPEP 201, a nonprovisional application for patent is the standard type of patent application. The MPEP states:

“A nonprovisional application for patent filed under 35 U.S.C. 111(a) must include a specification, including a claim or claims, drawings when necessary, an oath or declaration, and the prescribed filing fee, search fee, examination fee and application size fee.”

This type of application is examined by the USPTO and can potentially lead to the grant of a patent. It requires a detailed description of the invention, claims defining the scope of protection sought, and often includes drawings to illustrate the invention.

For more information on declaration, visit: declaration.

For more information on drawings, visit: drawings.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on oath, visit: oath.

A national application, as described in MPEP 201.01, is a U.S. patent application filed under 35 U.S.C. 111(a) or 35 U.S.C. 111(b). The MPEP states: A national application may be a nonprovisional application or a provisional application. National applications are distinct from international applications and are processed directly by the United States Patent and Trademark Office (USPTO).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

According to 37 CFR 1.9(a)(1), a national application is defined as:

  • A U.S. application for patent filed in the USPTO under 35 U.S.C. 111
  • An international application filed under the Patent Cooperation Treaty in which the basic national fee under 35 U.S.C. 41(a)(1)(F) has been paid
  • An international design application filed under the Hague Agreement in which the USPTO has received a copy of the international registration pursuant to Hague Agreement Article 10

This definition encompasses various types of patent applications that are treated as national applications by the USPTO.

A multiple dependent claim is a dependent claim that refers back in the alternative to more than one preceding independent or dependent claim. According to MPEP 608.01(n), “35 U.S.C. 112(e) authorizes multiple dependent claims in applications as long as they are in the alternative form (e.g., ‘A machine according to claims 3 or 4, further comprising —‘).”

Multiple dependent claims must be in the alternative form and cannot refer to other multiple dependent claims. They are subject to additional fees and specific formatting requirements.

To learn more:

A juristic entity, in the context of patent applications, typically refers to an organizational assignee such as a company or corporation. According to MPEP 401, juristic entities have special requirements:

“An applicant who is a juristic entity must be represented by a patent practitioner.”

This means that companies or other organizational entities cannot represent themselves in patent applications and must hire a registered patent attorney or agent to act on their behalf.

A foreign filing license is permission granted by the USPTO to file a patent application in a foreign country. It is required when:

  • An invention was made in the United States, and
  • A US application has been filed less than 6 months ago, or
  • No US application has been filed yet

As stated in 37 CFR 5.11(a): “A license from the Commissioner for Patents under 35 U.S.C. 184 is required before filing any application for patent… in a foreign country… if the invention was made in the United States.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

A filing receipt is an official document issued by the USPTO that contains important information about a patent application. According to MPEP 503, the filing receipt includes:

  • Application number
  • Filing date
  • Confirmation number
  • Suggested U.S. Patent Classification class
  • Art unit where the application is likely to be examined
  • Continuing data (if applicable)
  • National stage data (if applicable)
  • Foreign priority data (if applicable)
  • Foreign filing license data (if applicable)
  • Entity status information
  • Anticipated publication date under 35 U.S.C. 122(b)

The MPEP states: “The filing receipt represents the official assignment by the USPTO of a specific application number and confirmation number to a particular application.” It’s important to review the filing receipt for accuracy, especially regarding inventor and applicant names, benefit and priority claims, and any nonpublication requests.

For more information on application number, visit: application number.

For more information on confirmation number, visit: confirmation number.

For more information on filing receipt, visit: filing receipt.

A domestic representative is a person residing within the United States who can be served process or notice of proceedings affecting a patent or rights thereunder on behalf of a foreign assignee. According to MPEP 302.04, An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative. This allows foreign assignees to have a point of contact within the U.S. for legal matters related to their patent.

To learn more:

A divisional application is a later application for an independent or distinct invention, carved out of a nonprovisional application. It discloses and claims only subject matter disclosed in the earlier or parent application. As stated in MPEP 201.06:

A later application for an independent or distinct invention, carved out of a nonprovisional application (including a nonprovisional application resulting from an international application or international design application), an international application designating the United States, or an international design application designating the United States and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application.

To learn more:

A divisional application under 37 CFR 1.53(b) is a type of continuation application that is filed to pursue a distinct invention that was disclosed but not claimed in a prior nonprovisional application. According to the MPEP:

‘A divisional application is often filed as a result of a restriction requirement made by the examiner.’

Divisional applications allow inventors to protect multiple inventions disclosed in a single parent application by filing separate applications for each invention.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

A divisional application is a type of patent application that claims subject matter that is independent and distinct from that claimed in a prior application. It typically arises when an original application contains multiple inventions, and the Patent Office requires the applicant to restrict the claims to a single invention.

According to MPEP ¶ 2.01, a divisional application:

“appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application, and names the inventor or at least one joint inventor named in the prior application.”

To claim the benefit of the filing date of the prior application, applicants must comply with 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

A designated office is a national patent office of a country that has been ‘designated’ by an applicant in an international patent application filed under the Patent Cooperation Treaty (PCT). In the context of MPEP 602.07, the United States Patent and Trademark Office (USPTO) acts as a designated office when an applicant enters the national phase in the U.S. after filing an international PCT application.

When the USPTO acts as a designated office, specific requirements for oaths or declarations may apply. MPEP 602.07 directs readers to MPEP § 1893.01(e) for more detailed information on these requirements.

To learn more:

A design patent application is a type of patent application that protects the ornamental design of a functional item. It is governed by 35 U.S.C. 171-173 and focuses on the visual characteristics of an article of manufacture. Unlike utility patents, design patents do not protect the functional aspects of an invention. Design patent applications have specific requirements for drawings and claim format. For more information on design patent applications, refer to MPEP 1501.

Design patent applications and utility patent applications are two distinct types of patent applications that protect different aspects of inventions. According to MPEP 201:

  • Design Patent Application: “An application for a design patent filed under 35 U.S.C. 171 may be referred to as a design application.” Design patents protect the ornamental appearance of an article of manufacture.
  • Utility Patent Application: These applications protect the functional aspects of an invention, including processes, machines, articles of manufacture, and compositions of matter.

The key differences are:

  1. Subject Matter: Design patents cover appearance, while utility patents cover functionality.
  2. Duration: Design patents last for 15 years from issuance, while utility patents last for 20 years from the filing date.
  3. Examination Process: Design patent applications typically have a simpler examination process.

For more details on utility patents, refer to 35 U.S.C. 101, and for design patents, see 35 U.S.C. 171.

For more information on design patent, visit: design patent.

For more information on patent applications, visit: patent applications.

A delayed benefit claim in patent applications refers to a situation where an applicant fails to submit the required reference to a prior application within the specified time period. In such cases, the applicant may file a petition for an unintentionally delayed claim.

According to MPEP 211.04, the petition must include:

  • The reference to the prior application
  • A petition fee
  • A statement that the entire delay was unintentional

The MPEP states: “If the reference required by 35 U.S.C. 120 and 37 CFR 1.78 is not submitted within the required time period, a petition for an unintentionally delayed claim may be filed.”

To learn more:

A Customer Number is a USPTO-assigned number that can be used to:

  • Designate the correspondence address for a patent application or patent
  • Designate the fee address for a patent
  • Submit a list of practitioners with power of attorney

According to MPEP 403: “A Customer Number may be used to designate the address associated with the Customer Number as the correspondence address of an application (or patent) or the fee address of a patent, and may also be used to submit a power of attorney in the application (or patent) to the registered practitioners associated with the Customer Number.”

Using a Customer Number simplifies making changes to correspondence addresses and practitioner information across multiple applications.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on Customer Number, visit: Customer Number.

For more information on Fee Address, visit: Fee Address.

For more information on power of attorney, visit: power of attorney.

A customer number is a unique identifier assigned by the USPTO to simplify patent correspondence. According to MPEP 403:

‘A customer number allows a patent applicant, patent owner, or assignee to designate a single correspondence address for all applications and patents associated with that customer number.’

Benefits of using a customer number include:

  • Easier management of correspondence addresses for multiple applications
  • Simplified process for changing the address or representative for all linked applications
  • Improved efficiency in USPTO communications

To obtain a customer number, you need to file a request with the USPTO using the appropriate form.

For more information on Customer Number, visit: Customer Number.

For more information on patent correspondence, visit: patent correspondence.

For more information on USPTO, visit: USPTO.

A Continued Prosecution Application (CPA) is a type of continuation or divisional application that can be filed under 37 CFR 1.53(d) for design applications. As stated in the MPEP, A continuation or divisional application filed under 37 CFR 1.53(d) is called a ‘Continued Prosecution Application’ (CPA). CPAs allow applicants to continue prosecution of a prior design application while retaining the benefit of the earlier filing date.

To learn more:

A Continued Prosecution Application (CPA) is a type of patent application that allows applicants to continue prosecution of a prior design application. It’s important to note that CPAs are now only available for design applications, not utility applications.

While the MPEP ¶ 2.32 doesn’t provide a direct definition of a CPA, it implies its use in the context of design applications:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

CPAs allow applicants to:

  • Continue prosecution of a previously filed design application
  • Make amendments or corrections, such as deleting a named inventor
  • Potentially receive further examination without filing a new application

For more detailed information on CPAs, refer to MPEP § 201.06(d).

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

A Continued Prosecution Application (CPA) is a type of patent application that allows applicants to continue prosecution of a parent application. It is governed by 37 CFR 1.53(d). According to MPEP ¶ 2.30, when a CPA is accepted, the examiner will use the following language:

“The request filed on [filing date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [parent application number] is acceptable and a CPA has been established.”

This indicates that the CPA has been properly filed and prosecution will continue based on the parent application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A Continued Prosecution Application (CPA) is a type of patent application specifically for design patents. It allows applicants to continue prosecution of a previously filed design application by filing a request for continued examination. CPAs are governed by 37 CFR 1.53(d) and are only available for design applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A Continued Prosecution Application (CPA) is a type of patent application specifically for design patents, filed under 37 CFR 1.53(d). It allows applicants to continue prosecution of a parent design patent application by filing a request for a CPA.

According to MPEP ¶ 2.30: The request filed on [date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [number] is acceptable and a CPA has been established. This means that when a CPA is properly filed and accepted, it continues the prosecution of the parent application while establishing a new application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

A Continued Prosecution Application (CPA) is a type of continuation or divisional application that can be filed for design patent applications under 37 CFR 1.53(d). It allows an applicant to continue prosecution of a prior design application. As stated in the MPEP:

A continuation or divisional application (but not a continuation-in-part) of a prior nonprovisional application may be filed as a continued prosecution application under this paragraph, provided that:
(i) The application is for a design patent;

CPAs can only be filed before the earliest of: payment of the issue fee, abandonment, or termination of proceedings on the prior application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

A continuation-in-part (CIP) application is an application filed during the lifetime of a prior nonprovisional application, repeating some substantial portion or all of the prior application and adding matter not disclosed in the prior application.

As stated in the MPEP:

A continuation-in-part is an application filed during the lifetime of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.

Key points about CIP applications:

  • A CIP application may only be filed under 37 CFR 1.53(b).
  • The CIP application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • A CIP application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).
  • The mere filing of a CIP application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending parent application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A continuation-in-part (CIP) application is a type of patent application that builds upon a previously filed application by including new matter not disclosed in the original application. Key points about CIP applications include:

  • They are filed while the parent application is still pending.
  • They contain a portion or all of the disclosure of the parent application.
  • They introduce new matter not present in the original application.
  • The new matter is not entitled to the priority date of the parent application.

The MPEP 201.01 states: National applications include […] continuation-in-part applications (which may be filed under 37 CFR 1.53(b)). CIP applications allow inventors to expand on their original invention while maintaining the priority date for the previously disclosed material.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A continuation or divisional application is a type of continuing application filed under 37 CFR 1.53(b). According to the MPEP, An application filed under 37 CFR 1.53(b) may be an original or a reissue, a continuation, a divisional, a continuation-in-part, or a substitute. These applications are filed under 35 U.S.C. 111(a) and can be for utility, design, plant, or reissue patents.

To learn more:

To learn more:

A continuation application is a type of patent application that discloses the same invention(s) as a previously filed, copending nonprovisional application, international application designating the United States, or international design application designating the United States. The MPEP states:

“A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.”

It’s important to note that the continuation application must not include any new matter that wasn’t present in the parent application.

To learn more:

A continuation application under 37 CFR 1.53(b) is a type of continuing application that discloses and claims only subject matter disclosed in a prior nonprovisional application. It is filed under 35 U.S.C. 111(a) and may be for a utility, design, or plant patent.

According to the MPEP:

A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (A) a new specification and drawings and a copy of the signed oath or declaration as filed in the prior application provided the new specification and drawings do not contain any subject matter that would have been new matter in the prior application; or (B) a new specification and drawings and a newly executed oath or declaration provided the new specification and drawings do not contain any subject matter that would have been new matter in the prior application.

The continuation application receives a new application number and filing date, but can claim the benefit of the prior application’s filing date under 35 U.S.C. 120.

For more information on continuation application, visit: continuation application.

A confirmation number is a four-digit number assigned to each newly filed patent application. It is used in combination with the application number to verify the accuracy of the application number on correspondence filed with the USPTO. This helps avoid misidentification due to transposition errors.

The MPEP states: ‘The confirmation number is a four-digit number that is assigned to each newly filed application. The confirmation number, in combination with the application number, is used to verify the accuracy of the application number placed on correspondence filed with the Office to avoid misidentification of an application due to a transposition error in the application number.’ (MPEP 503)

A confirmation number is a four-digit number assigned by the USPTO to each newly filed patent application. According to MPEP 503, the confirmation number serves several important purposes:

  • It is used in combination with the application number to verify the accuracy of the application number on correspondence filed with the Office.
  • It helps avoid misidentification of an application due to transposition errors in the application number.
  • It is included on the filing receipt, Office actions, and other USPTO communications.
  • It is required when submitting an electronic copy of the application for publication to verify the correct application.

The MPEP recommends: “The Office also recommends that applicants include the application’s confirmation number (in addition to the application number) on all correspondence submitted to the Office concerning the application.”

The confirmation number can be found in the upper left-hand corner of the filing receipt and is also available through the Patent Application Information Retrieval (PAIR) system.

For more information on application number, visit: application number.

For more information on confirmation number, visit: confirmation number.

For more information on USPTO correspondence, visit: USPTO correspondence.

A Conditional Request for a Continued Prosecution Application (CPA) is a filing made under 37 CFR 1.53(d) for design applications. However, it’s important to note that any “conditional” request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA. This means that even if an applicant intends the request to be conditional, the USPTO will process it as a standard CPA request.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A certified copy of a foreign application is an official copy of the foreign patent application, certified by the patent office where it was filed. It is required to perfect a claim of foreign priority in a U.S. patent application.

According to 37 CFR 1.55(f), for applications filed on or after March 16, 2013:

“A certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application, or sixteen months from the filing date of the prior foreign application, in an original application under 35 U.S.C. 111(a) filed on or after March 16, 2013, except as provided in paragraphs (h), (i), and (j) of this section.”

There are exceptions to this requirement, such as when the foreign application was filed in a foreign intellectual property office participating in a priority document exchange agreement with the USPTO. In such cases, the applicant can request that the USPTO retrieve the certified copy electronically.

A certified abstract of title is a document that provides official information about the ownership of a patent or patent application. Unlike title reports, which are for internal USPTO use, certified abstracts of title can be requested by the public. The MPEP states: The public can request a certified abstract of title. The fee for this service is set forth at 37 CFR 1.19(b)(4). This document provides a certified summary of the assignment records for a specific patent or application.

For more information on certified abstract of title, visit: certified abstract of title.

For more information on public records, visit: public records.

For more information on USPTO, visit: USPTO.

A Certificate of Mailing or Transmission is a procedure under 37 CFR 1.8 that allows correspondence to be considered timely filed with the USPTO if it meets certain conditions. As stated in the MPEP:

“Under 37 CFR 1.8, a person may state on certain papers directed to the Office (some exceptions are stated in 37 CFR 1.8), the date on which the paper will be deposited in the United States Postal Service, transmitted by facsimile or transmitted via the USPTO electronic filing system (EFS-Web). If the date stated is within the period for reply, the reply in most instances will be considered to be timely.”

This procedure can be crucial for meeting deadlines, even if the actual receipt of the correspondence by the USPTO occurs after the deadline.

To learn more:

A ‘substitute’ application in patent law is essentially a duplicate of an earlier application that was abandoned before the filing of the later application. The MPEP provides the following definition:

A “substitute” application is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application.

Key points about substitute applications:

  • It does not obtain the benefit of the filing date of the prior application
  • Current practice does not require applicants to insert references to the earlier application in the specification
  • Applicants should call attention to the earlier application

The USPTO uses a specific form paragraph (2.07) to remind applicants of possible substitute status:

Applicant refers to this application as a “substitute” of Application No. [1], filed [2]. The term “substitute” is used to designate an application which is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application. A “substitute” does not obtain the benefit of the filing date of the prior application.

To learn more:

What is a ‘subject invention’ in the context of government-funded research?

A ‘subject invention’ is a term used in government contracts and refers to any invention conceived or first actually reduced to practice in the performance of work under a government contract. According to MPEP 310, ‘The term ‘subject invention’ is defined by 35 U.S.C. 201(e) as any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement.’ This definition is crucial for determining the government’s rights in inventions made during federally sponsored research.

For more information on federal funding, visit: federal funding.

For more information on patent rights, visit: patent rights.

What is a ‘regular utility application’ in patent law?

A ‘regular utility application’ is a term used in patent law to describe a standard non-provisional patent application for a utility invention. According to MPEP 201.02, it is defined as follows:

“A ‘regular utility application’ is a non-provisional application for a utility patent filed under 35 U.S.C. 111(a).”

This type of application is the most common form of patent application filed with the USPTO. It requires a detailed description of the invention, claims defining the scope of protection sought, and often includes drawings to illustrate the invention. Regular utility applications undergo a thorough examination process to determine if they meet the requirements for patentability.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on Non-provisional application, visit: Non-provisional application.

A ‘person to whom the inventor has assigned or is under an obligation to assign the invention’ refers to an individual or entity that has received rights to the invention through a legal agreement or contract. This concept is important in patent applications filed on or after September 16, 2012, as explained in MPEP 409.05:

Quote: ‘A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent.’

This provision allows assignees or those with a contractual right to the invention to file patent applications, even if they are not the original inventors.

To learn more:

A ‘file wrapper’ refers to the official record of proceedings in the United States Patent and Trademark Office (USPTO) for a particular patent application or granted patent. It contains all the documents and correspondence related to the prosecution of the application or maintenance of the patent. This includes the original application, Office actions, applicant responses, amendments, and other relevant documents. The file wrapper provides a complete history of the examination process and is important for understanding the scope and validity of a patent.

What is a ‘delayed claim’ for priority or benefit in a patent application?

A ‘delayed claim’ for priority or benefit in a patent application refers to a claim that is filed after the time period set forth in 37 CFR 1.78. According to MPEP 211.02(a), “A petition under 37 CFR 1.78 and the petition fee are required to add or correct a benefit claim after the time period set forth in 37 CFR 1.78.” This means that if an applicant misses the deadline for claiming priority or benefit, they must file a petition and pay a fee to have the claim considered.

To learn more:

A corrective document is a filing used to address errors in recorded assignment documents at the USPTO. According to MPEP 323:

‘The ‘corrective document’ (or if one of the documents is not being re-recorded, a copy of the original) should be recorded as a supporting document, and all documents will be examined.’

Corrective documents are used for:

  • Minor typographical errors
  • More substantial errors like incorrect names or addresses

When filing a corrective document, it’s important to clearly identify the nature of the correction and reference the original recorded document.

For more information on assignment correction, visit: assignment correction.

For more information on USPTO, visit: USPTO.

A continuing application in patent law is a type of patent application that is related to an earlier-filed application. The MPEP defines it as follows:

A continuing application is a continuation, divisional, or continuation-in-part application filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.

There are three main types of continuing applications:

  • Continuation: An application that further pursues the same invention as the original application
  • Divisional: An application that pursues a distinct invention that was disclosed but not claimed in the original application
  • Continuation-in-part (CIP): An application that includes subject matter from the original application plus new matter

Continuing applications must meet specific legal requirements to claim the benefit of the earlier application’s filing date.

To learn more:

Tags: divisional

A ‘chain of title’ in patent ownership refers to the documented history of a patent’s ownership from its original assignment to its current owner. MPEP 314 mentions this concept in relation to name changes and mergers:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title. Documents of merger are also proper links in the chain of title.

The chain of title includes:

  • Original patent assignment
  • Subsequent transfers of ownership
  • Business name changes
  • Mergers and acquisitions
  • Any other events affecting patent ownership

Maintaining a clear and unbroken chain of title is crucial for establishing ownership rights, facilitating patent transactions, and providing clarity in potential patent litigation.

A ‘bypass’ continuation application is a specific type of continuation application that is filed under 37 CFR 1.53(b) to ‘bypass’ the national stage of an international application. As explained in MPEP 201.06(c):

“A continuation application filed under 37 CFR 1.53(b) may be filed as a continuation of an international application designating the United States without entering the national stage under 35 U.S.C. 371. This is often referred to as a ‘bypass’ continuation application.”

This type of application allows applicants to pursue patent protection in the U.S. based on their international application without going through the formal national stage entry process. It can be advantageous in certain situations, such as when an applicant wants to modify claims or add new matter before U.S. examination.

A ‘bypass’ application refers to a continuation, divisional, or continuation-in-part of an international (PCT) application filed under 35 U.S.C. 111(a) instead of entering the national stage under 35 U.S.C. 371. As stated in MPEP 211.01(c):

Rather than submitting a national stage application under 35 U.S.C. 371, applicant may file a continuation, divisional, or continuation-in-part of an international (PCT) application under 35 U.S.C. 111(a). Such applications are often referred to as ‘bypass’ applications.

This option allows applicants to claim the benefit of an international application’s filing date while following the procedures for regular national applications.

To learn more:

A ‘bypass’ application is:

  • A regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b)
  • It claims benefit of an international application’s filing date without entering the national stage under 35 U.S.C. 371
  • It can be filed as a continuation, divisional, or continuation-in-part of the international application

MPEP 211.01(c) explains: “Rather than submitting a national stage application under 35 U.S.C. 371, applicant may file a continuation, divisional, or continuation-in-part of an international (PCT) application under 35 U.S.C. 111(a). Such applications are often referred to as ‘bypass’ applications.”

37 CFR 3.27 is a federal regulation that specifies the mailing address for submitting documents to be recorded at the USPTO. According to MPEP 302.08:

37 CFR 3.27 sets out how documents submitted for recording should be addressed to the Office.

This regulation ensures that assignment documents and other recordable documents are sent to the correct address for proper processing. It’s crucial for patent attorneys, inventors, and anyone submitting assignment documents to follow this regulation to avoid delays or misrouting of important legal documents.

To learn more:

To learn more:

Several international agreements can form the basis for a priority claim in patent applications. The MPEP mentions:

  • The Paris Convention for the Protection of Industrial Property
  • The Hague Agreement Concerning the International Registration of Industrial Designs
  • The Benelux Designs Convention
  • The Convention on the Grant of European Patents (European Patent Office)
  • The Patent Cooperation Treaty (PCT)
  • The International Convention for the Protection of New Varieties of Plants (UPOV)

The MPEP states: “Under Article 4A of the Paris Convention for the Protection of Industrial Property, a right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design filed under the national law of a foreign country adhering to the Convention, or on a foreign application filed under a bilateral or multilateral treaty concluded between two or more such countries.”

These agreements facilitate the international protection of intellectual property rights and enable applicants to claim priority based on applications filed in various jurisdictions.

Assignees of part interest in a patent application have specific inspection rights. According to MPEP 106.01:

[A]n assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.

This means that while assignees of part interest cannot prosecute the application or exclude the applicant from the prosecution process, they do have the right to review and inspect the contents of the patent application. This inspection right allows them to stay informed about the application’s status and content, even though they cannot directly intervene in its prosecution.

To learn more:

When the USPTO’s Assignment Division returns assignment documents or cover sheets, they include specific information to help you understand the status and next steps. According to MPEP 317.02:

“Assignment documents and cover sheets, or copies of the same, which are returned by Assignment Division will be stamped with the original date of receipt by the Office and will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

In summary, you will receive:

  • The original documents or copies, stamped with the original receipt date
  • An accompanying letter specifying:
    • The reason for the return
    • Instructions for correction
    • The deadline for resubmission
    • Information about maintaining the original receipt date as the recording date

It’s crucial to carefully review this information and act promptly to meet the specified deadline for resubmission.

To learn more:

When citing a prior application using MPEP ¶ 2.05, specific information must be included. The MPEP instructs examiners:

“In brackets 1 and 2, insert the application number (series code and serial number) and filing date of the prior application, respectively.”

This means that when referencing a prior application, the examiner should provide:

  • The application number, including both the series code and serial number
  • The filing date of the prior application

Including this information ensures clear identification of the specific prior application being referenced.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

For foreign priority applications, the bib-data sheet should include:

  • Application number
  • Country (or intellectual property authority)
  • Day, month, and year of filing

MPEP 202 specifies: “A bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application that the U.S. application is claiming the priority of. The examiner should check this information for accuracy.”

It’s important to note that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) should be listed. Applications from non-qualifying countries should be lined through on the bib-data sheet.

The Description of the Related Art section should include:

  • A description of the state of the prior art or other information known to the applicant.
  • References to specific prior art or other information where appropriate.
  • Information disclosed under 37 CFR 1.97 and 37 CFR 1.98.
  • Where applicable, the problems involved in the prior art or other information disclosed which are solved by the applicant’s invention.

As stated in MPEP 608.01(c), this section should include “A paragraph(s) describing to the extent practical the state of the prior art or other information disclosed known to the applicant, including references to specific prior art or other information where appropriate. Where applicable, the problems involved in the prior art or other information disclosed which are solved by the applicant’s invention should be indicated.”

To learn more:

Tags: prior art

For applications filed before September 16, 2012, the Application Data Sheet (ADS) should include the following information:

  • Applicant information
  • Correspondence address
  • Application information
  • Representative information
  • Domestic priority information
  • Foreign priority information
  • Assignee information

As stated in MPEP 601.05(b): The ADS must include all of the section headings listed in 37 CFR 1.76(b), even if no information is being provided for some of the sections. This ensures consistency and completeness in the application filing process.

To learn more:

The Applicant Initiated Interview Request form (PTOL-413A) should include specific information to facilitate the interview process. According to MPEP 408:

This form should identify the participants of the interview, the proposed date of the interview, whether the interview will be personal, telephonic, or video conference, and should include a brief description of the issues to be discussed.

Providing this information helps the examiner prepare adequately for the interview and ensures that all necessary parties are involved in the discussion of relevant issues.

When correcting an erroneous assignment, the affidavit or declaration submitted to the USPTO should contain specific information. According to MPEP 323.01(c), the affidavit should include:

  • Identification of yourself as the correct owner
  • A statement that the previously recorded document was submitted with erroneous information
  • The reel and frame number of the previously recorded document
  • A summary of the true chain of title
  • A statement that the original applicant, patentee, or last correct assignee has been and continues to be the owner of the application or patent at issue

The MPEP specifically states: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change, and a statement that the original applicant or patentee or last correct assignee has been, and continues to be, the owner of the application, or patent at issue.

To learn more:

When using Form Paragraph 2.35 in a patent examination, specific information needs to be inserted into the brackets. According to the MPEP ¶ 2.35, examiners should include the following:

  • In bracket 1: Insert the filing date of the request for a CPA.
  • In bracket 2: Insert the Application Number identified in the CPA request.

This information helps to clearly identify the specific CPA request being addressed and provides essential context for the applicant. It’s crucial for examiners to accurately fill in these brackets to ensure proper documentation and communication regarding the CPA.

An Application Data Sheet (ADS) for a patent application filed on or after September 16, 2012, should include specific bibliographic data. According to MPEP 601.05(a), the ADS must contain the following information:

  • Inventor information: Full name, residence, and mailing address of each inventor
  • Applicant information: Name and address of the applicant (if different from the inventor)
  • Correspondence address
  • Application information: Title of the invention, attorney docket number, type of application
  • Representative information: Registration number and name of each practitioner
  • Domestic benefit/national stage information: Prior-filed application number and filing date
  • Foreign priority information: Foreign application number, country, and filing date
  • Assignee information: Name and address of the assignee of the entire right, title, and interest

The MPEP states: “An application data sheet must be labeled ‘Application Data Sheet’ and should provide the bibliographic data, in the order and with the headings specified in this section, to be entitled to the benefits provided by the application data sheet.” Ensuring all required information is accurately provided in the ADS is crucial for proper processing of the application and establishing priority claims.

To learn more:

When requesting to delete a named inventor in a Continued Prosecution Application (CPA) for a design patent, you should include specific information. According to MPEP ¶ 2.32, the request should contain:

  1. A clear statement requesting the deletion of the inventor(s)
  2. The name(s) of the inventor(s) to be deleted
  3. The filing date of the CPA

The MPEP provides a template for acknowledging such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

In this template, [1] represents the name(s) of the inventor(s) to be deleted, and [2] is the filing date of the CPA. Ensure your request clearly specifies these details to facilitate proper processing by the USPTO.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

According to 37 CFR 3.61, the designation of a domestic representative should include:

  • The name of the person residing within the United States
  • The address of the designated person
  • A statement that this person may be served process or notice of proceedings affecting the application, patent or registration or rights thereunder

As stated in the regulation, The designation should state the name and address of a person residing within the United States on whom may be served process or notice of proceedings affecting the application, patent or registration or rights thereunder. This information ensures that the USPTO and other parties can effectively communicate with the foreign assignee through their designated representative.

To learn more:

When filing a Continued Prosecution Application (CPA) request, certain key information must be included. Based on MPEP ¶ 2.35, the following details are essential:

  • The filing date of the CPA request
  • The application number of the prior application

The MPEP states: “Receipt is acknowledged of the ‘conditional’ request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on prior Application No. [2].” Here, [1] represents the filing date of the CPA request, and [2] represents the application number of the prior application.

It’s important to ensure that this information is accurately provided to facilitate proper processing of the CPA request by the USPTO.

For more information on filing requirements, visit: filing requirements.

For more information on USPTO, visit: USPTO.

When referencing a prior application in a continuation-in-part (CIP), specific information must be included. According to MPEP ¶ 2.06, the examiner note states:

In brackets 1 and 2, insert the application number (series code and serial number) and filing date of the prior application, respectively.

This means that when referencing the prior application, you must include:

  • The application number (series code and serial number)
  • The filing date of the prior application

Providing this information accurately is crucial for establishing the proper relationship between the CIP and the prior application.

For more information on application number, visit: application number.

An assignment cover sheet must include specific information to be accepted by the USPTO. According to MPEP 302.07, the cover sheet must contain:

  • The name of the party conveying the interest
  • The name and address of the party receiving the interest
  • A description of the interest conveyed or transaction to be recorded
  • Identification of the interests involved (e.g., patent number, application number)
  • The name and address of the party to whom correspondence concerning the request to record the document should be mailed
  • The date the document was executed
  • The signature of the party submitting the document

It’s crucial to provide all required information accurately to ensure the assignment is properly recorded.

To learn more:

For patent applications filed before September 16, 2012, the oath or declaration must include specific information about foreign applications if not provided in an application data sheet. According to pre-AIA 37 CFR 1.63(c)(2), the oath or declaration must identify:

  • Any foreign application for patent (or inventor’s certificate) for which a claim for priority is made
  • Any foreign application having a filing date before that of the application on which priority is claimed

The MPEP elaborates: The applicant is required to recite all foreign applications filed prior to the application on which priority is claimed. It is required to give the foreign application number and name of the country or office in which filed, as well as the filing date of each foreign application to which priority is claimed.

This information is crucial for establishing priority claims and ensuring compliance with patent law requirements regarding prior foreign filings.

To learn more:

According to 37 CFR 1.29(k)(1), the itemization for a micro entity fee deficiency payment must include:

  • Each type of fee erroneously paid as a micro entity
  • The current fee amount for a small or non-small entity
  • The micro entity fee actually paid and the date of payment
  • The deficiency owed amount for each fee
  • The total deficiency payment owed

The MPEP specifies: The paper must contain an itemization of the total deficiency payment and include the following information: (1) each particular type of fee that was erroneously paid as a micro entity, (e.g., basic statutory filing fee, two-month extension of time fee) along with the current fee amount for a small or non-small entity; (2) the micro entity fee actually paid, and the date on which it was paid; (3) the deficiency owed amount (for each fee erroneously paid); and (4) the total deficiency payment owed, which is the sum or total of the individual deficiency owed amounts.

To learn more:

When an application is executed by someone other than the inventor under pre-AIA 37 CFR 1.47(b), the declaration must include specific information about the non-signing inventor. According to the MPEP, the declaration must state:

  • The full name of the non-signing inventor
  • The residence of the non-signing inventor
  • The post office address of the non-signing inventor
  • The citizenship of the non-signing inventor

Additionally, “the title or position of the person signing must be stated if signing on behalf of a corporation under pre-AIA 37 CFR 1.47(b).” This ensures that the person signing has the authority to do so on behalf of the corporation.

To learn more:

Tags: pre-AIA

When a patent application is filed by someone other than the inventor under 37 CFR 1.46, the application must contain an application data sheet (ADS) with specific information. According to 37 CFR 1.46(b), the ADS must specify in the applicant information section:

  • The assignee
  • The person to whom the inventor is under an obligation to assign the invention
  • The person who otherwise shows sufficient proprietary interest in the matter

This information should be provided in the applicant information section of the ADS, as specified in 37 CFR 1.76(b)(7). Ensuring this information is correctly included in the ADS is crucial for establishing the proper applicant for the patent application.

To learn more:

When claiming foreign priority, the application data sheet (ADS) must include specific information to meet the requirements of 37 CFR 1.55(i)(2). The MPEP states that the claim for priority must be presented in an ADS:

identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and including the information necessary for the participating foreign intellectual property office to provide the Office with access to the foreign application

This information is crucial for the USPTO to retrieve the priority document through the Priority Document Exchange program. Ensure that all details are accurate to avoid any issues with your priority claim.

To learn more:

What information must be included in an oath or declaration for an unavailable joint inventor?

When filing an oath or declaration for an unavailable joint inventor, specific information must be included. According to MPEP 409.03(a), the oath or declaration must contain:

  • The name of the unavailable inventor
  • A statement that the inventor is unavailable and the reason for unavailability
  • The last known address of the unavailable inventor

Additionally, the MPEP states:

‘If a nonsigning inventor refuses to sign the oath or declaration or cannot be reached, the oath or declaration under 37 CFR 1.63 by the remaining joint inventor(s) must state that the nonsigning inventor is either refused to sign or could not be reached after diligent effort to contact him or her.’

It’s crucial to provide as much detail as possible about the efforts made to contact the unavailable inventor and any responses received. This information helps the USPTO understand the situation and process the application appropriately.

To learn more:

Tags: declaration, oath

An inventor’s oath or declaration must include specific information as outlined in 37 CFR 1.63. The required information includes:

  • Identification of the inventor or joint inventor by their legal name
  • Identification of the application to which it is directed
  • A statement that the person executing the oath or declaration believes the named inventor or joint inventors to be the original inventor or an original joint inventor of a claimed invention in the application
  • A statement that the application was made or authorized to be made by the person executing the oath or declaration

Unless provided in an Application Data Sheet (ADS), the oath or declaration must also include:

  • The mailing address where the inventor customarily receives mail
  • The residence of the inventor, if different from the mailing address

It’s important to note that while the ‘reviewed and understands’ clause and ‘duty to disclose’ clause are no longer required in the oath or declaration itself, 37 CFR 1.63(c) still requires that the person executing the oath or declaration has reviewed and understood the application contents and is aware of the duty to disclose under 37 CFR 1.56.

To learn more:

When an application is filed by someone other than the inventor under 35 U.S.C. 111, it must contain specific information as outlined in 37 CFR 1.46(b):

  • An application data sheet under § 1.76
  • In the applicant information section (§ 1.76(b)(7)), specify:
    • The assignee
    • Person to whom the inventor is under an obligation to assign the invention
    • Person who otherwise shows sufficient proprietary interest in the matter

The regulation states: If an application under 35 U.S.C. 111 is made by a person other than the inventor under paragraph (a) of this section, the application must contain an application data sheet under § 1.76 specifying in the applicant information section (§ 1.76(b)(7)) the assignee, person to whom the inventor is under an obligation to assign the invention, or person who otherwise shows sufficient proprietary interest in the matter.

A substitute statement must contain specific information as outlined in 37 CFR 1.64(b):

  • Comply with the requirements of 37 CFR 1.63(a), identifying the inventor and stating required facts
  • Identify the person executing the statement and their relationship to the inventor
  • Identify the circumstances permitting the substitute statement
  • Provide the last known mailing address and residence of the inventor (if not in the application data sheet)

Additionally, the statement must include an acknowledgment that “any willful false statement made in such statement is punishable under section 1001 of title 18 by fine or imprisonment of not more than 5 years, or both.

To learn more:

What information must be included in a substitute statement for a deceased or incapacitated inventor?

When filing a substitute statement for a deceased or legally incapacitated inventor, specific information must be included to ensure its validity. According to MPEP 409.01(a) and 37 CFR 1.64, a substitute statement must contain:

  • Identification of the inventor to whom the substitute statement applies
  • The circumstances permitting the use of a substitute statement (e.g., death, legal incapacity)
  • A statement that the person signing:
    • Has reviewed and understands the contents of the application
    • Believes the named inventor to be the original inventor of the claimed invention
    • Acknowledges the duty to disclose information material to patentability
  • The relationship of the person signing to the inventor

Additionally, the substitute statement must:

  • Identify the person executing the substitute statement and the capacity in which they are signing
  • Be signed in accordance with 37 CFR 1.64(a)

Ensuring all required information is included in the substitute statement is crucial for the proper processing of the patent application in cases where the inventor is unavailable.

To learn more:

For inventions related to atomic energy, applicants must file a statement under oath with specific information. According to 42 U.S.C. 2182, this statement should include:

  • Full facts surrounding the making or conception of the invention
  • Whether the invention was made or conceived under any contract or arrangement with the Commission (now DOE)
  • Whether the contract involved the expenditure of funds by the Commission

The law states: No patent for any invention or discovery, useful in the production or utilization of special nuclear material or atomic energy, shall be issued unless the applicant files with the application, or within thirty days after request therefor by the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office […] a statement under oath setting forth the full facts surrounding the making or conception of the invention or discovery described in the application and whether the invention or discovery was made or conceived in the course of or under any contract, subcontract, or arrangement entered into with or for the benefit of the Commission, regardless of whether the contract, subcontract, or arrangement involved the expenditure of funds by the Commission.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

A power of attorney for patent applications must include the following information:

  • The attorney’s or agent’s full mailing address, including ZIP Code
  • It’s recommended to include the telephone and fax numbers of the attorney or agent

As stated in MPEP 601.02: “The attorney’s or agent’s full mailing address (including ZIP Code) must be given in every power of attorney. The telephone and fax numbers of the attorney or agent should also be included in the power of attorney.”

Including this information facilitates prompt delivery of communications.

To learn more:

According to 37 CFR 1.335(a), a notice of arbitration award filed with the USPTO must include the following information:

  • Patent number
  • Names of the inventor and patent owner
  • Names and addresses of the parties to the arbitration
  • A copy of the arbitration award

The regulation states: “The notice must set forth the patent number, the names of the inventor and patent owner, and the names and addresses of the parties to the arbitration. The notice must also include a copy of the award.”

This detailed information ensures that the USPTO has a complete record of the arbitration outcome and its relevance to specific patents.

For more information on Patent Information, visit: Patent Information.

A Continued Prosecution Application (CPA) request for design patents must include specific information to be considered acceptable. According to MPEP ¶ 2.30, the key elements are:

  • The filing date of the CPA request
  • The parent application number

The MPEP states: The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. Here, [1] represents the filing date of the CPA request, and [2] is the parent application number. These details are crucial for establishing the continuity between the parent application and the CPA.

For more information on USPTO filing procedures, visit: USPTO filing procedures.

A continuation application must include specific information to properly establish its relationship to the prior-filed application. The MPEP outlines these requirements:

“If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§ 1.76(b)(5)). The reference also must identify the relationship of the applications, namely, whether the later-filed application is a continuation, divisional, or continuation-in-part of the prior-filed nonprovisional application, international application, or international design application.”

Key information to include:

  • Application number of the prior-filed application
  • Filing date of the prior-filed application
  • Relationship between the applications (e.g., continuation)
  • Inventor information, including at least one inventor from the prior application

Ensuring all required information is included helps establish the proper benefit claim and relationship between the applications.

To learn more:

A certificate of mailing for USPTO correspondence must include specific information to be valid. According to MPEP 512, the following information is required:

  • The date of deposit or transmission
  • The application number (for patent applications)
  • A statement that the correspondence is being deposited with the USPS or transmitted to the USPTO
  • The signature of the person depositing or transmitting the correspondence

The MPEP states:

The certificate must state that the correspondence is being deposited with the United States Postal Service with sufficient postage as first class mail, or transmitted to the Office on the date of the certificate.

Ensure all these elements are included to make your certificate of mailing valid and effective.

To learn more:

For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), which include continuations, divisionals, and continuation-in-part applications, the benefit claim must include specific information about the relationship between the applications. The MPEP states:

“For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.”

This means that when making a benefit claim, you must explicitly state whether the current application is a:

  • Continuation
  • Divisional
  • Continuation-in-part

of the prior application. This information helps the USPTO and others understand the relationship between related applications and ensures proper examination and treatment of the claims.

Remember, this requirement is in addition to other necessary information for the benefit claim, such as the application number and filing date of the prior application.

For more information on divisional, visit: divisional.

Tags: divisional

When filing papers in a representative capacity, a patent practitioner must provide specific information to identify themselves and establish their authority. According to MPEP 402.04:

  • Registration number
  • Name
  • Signature

The MPEP states: “In filing such a paper, the patent practitioner must set forth his or her registration number, his or her name and signature. Further proof of authority to act in a representative capacity may be required.”

This requirement applies even when the practitioner is not of record in the application. It helps facilitate replies on behalf of applicants and eliminates the need for filing powers of attorney in individual applications when there are changes in law firms or corporate patent staffs.

To learn more:

A patent title report contains crucial information about the ownership and status of a patent application or patent. While the MPEP Section 320 does not provide an exhaustive list, based on its context and purpose, a title report typically includes:

  • The names of the current owner(s) or assignee(s)
  • Any recorded assignments or transfers of ownership
  • The date of the most recent assignment
  • Information about the inventors
  • The application or patent number
  • Any liens or security interests recorded against the patent

This information helps ensure that all parties involved in the patent process are aware of the current ownership status and can act accordingly.

What information is required on the Application Data Sheet (ADS) regarding inventors?

The Application Data Sheet (ADS) is a crucial document in patent applications, and it must include specific information about the inventors. According to MPEP 602.08(a), the following information is required for each inventor:

  • Legal name
  • Residence (city and state or country)
  • Mailing address
  • Citizenship

The MPEP states:

“The inventor’s legal name for the ADS should be the name as it appears on a legal document such as a birth certificate, marriage certificate, court order, etc.”

It’s important to provide accurate and complete information on the ADS to avoid potential issues with the patent application process. Any changes to inventor information after filing may require submitting a corrected ADS.

To learn more:

When recording documents with the USPTO, a cover sheet must accompany the document. The cover sheet should include:

  • Name of the conveying party
  • Name and address of the receiving party
  • Application number, patent number, or registration number
  • Name of the inventor (for patent documents)
  • Title of the invention (for patent documents)
  • Document date
  • Nature of the interest being conveyed
  • Assignee AIA (first inventor to file) statement

MPEP 313 states: Each document submitted for recording must be accompanied by a cover sheet… The format for the cover sheet is specified by the Office. Ensure all required information is provided to facilitate proper recording of the document.

For more information on cover sheet, visit: cover sheet.

For more information on document submission, visit: document submission.

An inventor’s oath or declaration must include:

  • Inventor bibliographic information (see MPEP § 602.08(a))
  • Name of the inventor or each joint inventor
  • Signature of each inventor (with some exceptions, see MPEP § 602.08(b))
  • Identification of the application to which it is directed (see MPEP § 602.08(c))

As stated in the MPEP, “The inventor’s oath or declaration must include certain inventor bibliographic information, name the inventor or each joint inventor and except as otherwise provided be signed by each inventor, and identify the application to which it is directed.”

To learn more:

When including non-patent literature in an Information Disclosure Statement (IDS), you must provide the following information:

  • Publisher
  • Author (if any)
  • Title
  • Relevant pages
  • Date
  • Place of publication

According to MPEP 609.04(a): Each publication listed in an information disclosure statement must be identified by publisher, author (if any), title, relevant pages of the publication, date, and place of publication.

It’s important to note that for publications in a language other than English, you should also provide a concise explanation of the relevance in English, if not already available.

To learn more:

What information is required for non-English language documents in an IDS?

For non-English language documents cited in an Information Disclosure Statement (IDS), the following information is required:

  • A concise explanation of the relevance of the document, unless a complete translation is provided.
  • A written English language translation of the document, or a portion thereof, if it is within the possession, custody, or control of, or is readily available to any individual designated in 37 CFR 1.56(c).

According to MPEP 609.04(a):

“Where the information listed is not in the English language, but was cited in a search report or other action by a foreign patent office in a counterpart foreign application, the requirement for a concise explanation of relevance can be satisfied by submitting an English-language version of the search report or action which indicates the degree of relevance found by the foreign office.”

This provision allows applicants to efficiently provide the necessary context for foreign language documents without extensive translations.

To learn more:

What information is required for inventor’s citizenship in a patent application?

For patent applications, the inventor’s citizenship must be provided. According to MPEP 602.08(b), ‘The inventor’s citizenship must be specifically identified in the oath or declaration.’ This requirement applies to both utility and design patent applications. The MPEP further states:

‘It is not sufficient for oath or declaration to merely state that the inventor is a citizen of the ‘United States,’ but the particular state of which the inventor is a citizen must be specified.’

This means that for U.S. citizens, the specific state of citizenship should be mentioned. For non-U.S. citizens, the country of citizenship should be clearly stated.

To learn more:

For foreign inventors in a U.S. patent application, the following information is required:

  • The inventor’s full name
  • Residence (city and either state or foreign country)
  • Mailing address
  • Citizenship

According to MPEP 602.08(a): ‘If the residence is not in the United States, the residence (city and country) and mailing address must be provided.’ It’s important to note that the mailing address is particularly crucial for foreign inventors to ensure proper communication with the USPTO.

To learn more:

When a pre-AIA 37 CFR 1.47 application is found acceptable, certain information is published in the Official Gazette. According to the MPEP: A notice will be published in the Official Gazette identifying the application number, filing date, the title of the invention and the name(s) of the nonsigning inventor(s).

This publication serves several purposes:

  • It provides public notice of the application’s existence.
  • It identifies the nonsigning inventors, which may be important for legal or intellectual property reasons.
  • It establishes a clear record of the application’s status under pre-AIA 37 CFR 1.47.

This publication is an important step in the processing of these special applications and ensures transparency in the patent application process.

To learn more:

To learn more:

Citations considered by the examiner and listed on form PTO/SB/08 or an equivalent separate paper will be printed on the patent. The MPEP states: A citation listed on form PTO/SB/08 and considered by the examiner will be printed on the patent. However, for the separate paper to be printed, it must meet specific formatting requirements:

  • Each item of information is listed on a single line
  • The lines are at least double-spaced from each other
  • The information is uniform in format for each listed item

It’s important to note that For patents printed after January 1, 2001, citations from information disclosure statements that are printed on the face of the patent will be distinguished from citations cited by the examiner on a form PTO-892.

To learn more:

To identify a national patent application in an assignment, you must use the application number. MPEP 302.03 states: “An assignment relating to a national patent application must identify the national patent application by the application number (consisting of the series code and the serial number; e.g., 07/123,456).” This format ensures accurate identification of the specific application being assigned.

To learn more:

Accessing assignment records for unpublished patent applications requires specific authorization or a showing of legitimate interest. According to MPEP 301.01, for applications that are not open to the public:

Information related thereto is only obtainable upon a proper showing of written authority. For applications filed on or after September 16, 2012, the written authority must be from (A) an inventor, (B) an applicant, (C) the assignee or an assignee of an undivided part interest, (D) a patent practitioner of record, or (E) a person with written authority from (A), (B), or (C) or (D).

For applications filed before September 16, 2012, the requirements are slightly different:

For applications filed prior to September 16, 2012, the written authority must be from the applicant or applicant’s assignee or from the attorney or agent of either, or upon a showing that the person seeking such information is a bona fide prospective or actual purchaser, mortgagee, or licensee of such application.

If you’re not one of these authorized parties, you may still be able to access the records if you can demonstrate that you are a bona fide prospective or actual purchaser, mortgagee, or licensee of the application. This typically requires submitting a petition with the appropriate fee and evidence of your status.

For more information on unpublished applications, visit: unpublished applications.

The front page of a printed patent identifies all prior applications for which benefits are claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in continuation-in-part, continuation, divisional, and reissue applications.

When acknowledging a Continued Prosecution Application (CPA) request, the USPTO includes specific details as outlined in MPEP ¶ 2.35. The acknowledgment typically includes:

  • The filing date of the CPA request
  • The application number of the prior application on which the CPA is based
  • A statement that the CPA request is acceptable
  • Confirmation that a CPA has been established

The MPEP provides a template for this acknowledgment: Receipt is acknowledged of the ‘conditional’ request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on prior Application No. [2].

This information helps applicants confirm that their CPA request has been received and processed correctly.

For more information on USPTO communication, visit: USPTO communication.

The first Office action of a Continued Prosecution Application (CPA) includes important information for the applicant. According to MPEP ¶ 2.35, the examiner should:

  • Advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request
  • Confirm that the CPA is acceptable and has been established
  • Provide notice that an action on the CPA follows

This information is crucial because, as stated in the MPEP, “applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.” Therefore, this Office action serves as an important communication regarding the status of the application.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

The notice of Continued Prosecution Application (CPA) establishment includes specific information as outlined in MPEP ¶ 2.30. The key elements are:

  • The filing date of the CPA request
  • The parent application number
  • A statement that the CPA is acceptable and has been established
  • An indication that an action on the CPA will follow

The exact language used by the examiner is: The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.

For more information on patent examination, visit: patent examination.

For more information on patent procedure, visit: patent procedure.

An Application Data Sheet (ADS) for pre-AIA applications includes several categories of bibliographic information:

  • Applicant information (name, residence, mailing address, and citizenship)
  • Correspondence information
  • Application information (title, classification, drawings, etc.)
  • Representative information
  • Domestic priority information
  • Foreign priority information
  • Assignee information

As stated in MPEP 601.05(b), “Bibliographic data as used in paragraph (a) of this section includes: (1) Applicant information… (2) Correspondence information… (3) Application information… (4) Representative information… (5) Domestic priority information… (6) Foreign priority information… (7) Assignee information…”

To learn more:

A patent filing receipt includes:

  • Application number
  • Filing date
  • Confirmation number
  • Suggested class in the U.S. Patent Classification System
  • Art unit number where the application is likely to be examined
  • Continuing data (if applicable)
  • National stage data (if applicable)
  • Foreign priority data (if applicable)
  • Foreign filing license data (if applicable)
  • Entity status information
  • Anticipated publication date under 35 U.S.C. 122(b)

The MPEP states: ‘The filing receipt includes the application number, filing date, a confirmation number, a suggested class in the U.S. Patent Classification System (see MPEP § 902.01), and the number of an art unit where the application is likely to be examined.’ (MPEP 503)

A patent application filing receipt contains crucial information about the application. According to the MPEP:

‘A filing receipt is mailed to the attorney or agent, if any, otherwise to the applicant, for each application filed.’

The filing receipt typically includes:

  • The application number
  • Filing date
  • Title of the invention
  • Names of the applicants
  • Name and registration number of the attorney or agent (if applicable)
  • Entity status for fee purposes
  • Correspondence address
  • List of documents submitted with the application

It’s important to review the filing receipt carefully for accuracy, as it serves as official confirmation of the application’s details and can be used to identify any discrepancies or issues that need to be addressed promptly.

For more information on filing receipt, visit: filing receipt.

According to MPEP ¶ 2.30, a CPA acceptance notice typically includes the following information:

  • The filing date of the CPA request
  • The application number of the parent application
  • Confirmation that the CPA request is acceptable
  • Statement that a CPA has been established

The MPEP provides a template for examiners, stating: “The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.”

For more information on patent application information, visit: patent application information.

Status information of an application includes:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published
  • The application number or the serial number plus any one of the filing date of the national application, the international filing date, or the date of entry into the national stage
  • Whether another application claims the benefit of the application, and if so, status information for those applications

This is defined in 37 CFR 1.14(a)(2) and further elaborated in MPEP 102.

USPTO patent assignment records contain valuable information about the ownership and transfer of patent rights. According to MPEP 301.01, these records include:

  • Reel and frame number of the recordation
  • Name of the conveying party (assignor)
  • Name and address of the receiving party (assignee)
  • Patent or application number
  • Date of execution
  • Date of recordation

The MPEP further states: The actual assignment document will not be viewable through Assignment Search. Only the bibliographic information contained in the recorded cover sheet will be viewable from the Assignment Search database.

This information helps track the chain of title for patents and applications, which is crucial for determining current ownership and potential licensing opportunities.

What information is available in the USPTO’s assignment database?

The USPTO’s assignment database contains a wealth of information related to patent ownership. According to MPEP 301.01:

‘The USPTO maintains a database containing the assignment records of patents and patent applications. The USPTO also maintains a cumulative index of number of assignments recorded on the day in which they are recorded.’

The database typically includes:

  • Patent or application numbers
  • Names of assignors and assignees
  • Dates of assignment execution and recording
  • Brief descriptions of the interests conveyed
  • Reel and frame numbers for locating documents

This information is crucial for determining the current ownership status of patents and applications, which is essential for various legal and business purposes.

Information about reexamination proceedings is made available to the public in several ways:

  1. Announcement in the Official Gazette:
    • The filing of each request for reexamination (where the full fee has been paid) is announced
    • Reexaminations ordered at the Director’s initiative are also announced
  2. Public inspection of reexamination files:
    • Once scanned into the Image File Wrapper (IFW) system, reexamination files are open to public inspection
    • Files can be accessed through Patent Center on the USPTO website
    • The entire contents of the reexamination file are viewable, except for non-patent literature

Direct quote: ‘All requests for reexamination for which all the requirements of § 1.510 or § 1.915 have been satisfied will be announced in the Official Gazette. Any reexaminations at the initiative of the Director pursuant to § 1.520 will also be announced in the Official Gazette.’ (37 CFR 1.11(c))

Note that a reexamination file is typically not open to inspection until it has been scanned into the IFW system.

What information can the USPTO provide about applications in secrecy order?

The USPTO has strict limitations on providing information about applications under secrecy order:

  • No information about the application can be given without authorization from the appropriate department or agency.
  • The USPTO cannot confirm or deny the existence of such applications.
  • Any inquiries about these applications are referred to the appropriate department or agency.

MPEP 203.08 states: ‘For applications bearing a secrecy order pursuant to 35 U.S.C. 181, no information will be provided concerning the application without authorization from the appropriate department or agency.’

To learn more:

While national offices are generally restricted from allowing access to international patent applications, they can disclose limited information. According to MPEP 110, which cites PCT Article 30(2)(b), national offices may inform third parties that they have been designated and publish this fact. However, such information or publication is limited to:

  • Identification of the receiving Office
  • Name of the applicant
  • International filing date
  • International application number
  • Title of the invention

This provision allows for some transparency in the patent process while still maintaining the confidentiality of the application’s details.

For more information on international patent applications, visit: international patent applications.

For unpublished patent applications, access to information is more restricted and typically limited to the applicant or their registered representative. Here’s what you need to know:

  • Unpublished application information is available through Private PAIR.
  • You must associate a Customer Number with your application to access this information.
  • If you’re not the applicant or authorized representative, access may be restricted due to confidentiality rules.

The MPEP states: In private PAIR, an applicant (or applicant’s registered patent attorney or registered patent agent) can securely track the progress of applicant’s application(s) through the USPTO. Private PAIR makes available information relating to unpublished patent applications, but the applicant must associate a Customer Number with the application to obtain access. (MPEP 203.08)

For more information on Customer Number practice, refer to MPEP § 403.

To learn more:

What information can be provided in response to status inquiries?

The USPTO has strict guidelines on the information that can be provided in response to status inquiries. MPEP 203.08 states:

“In no event will the following information be given over the telephone: (A) Filing date of applications; (B) Whether an application has been allowed, abandoned, or issued; (C) The date of allowance, abandonment or issue; and (D) Whether an assignment has been recorded.”

This policy is designed to protect the privacy and confidentiality of patent applications. Applicants or their representatives must use official channels, such as Private PAIR or written requests, to obtain such specific information.

To learn more:

For provisional applications, the USPTO can provide the following information:

  • Application number
  • Filing date
  • Whether the application is pending or abandoned
  • Expiration date

It’s important to note that provisional applications are not published, so no additional information beyond these basic details is available to the public.

For pending or abandoned applications that have not been published, the Office may only confirm that an application has been filed, provide the application number and filing date, the inventorship information, the classification, and the group art unit assigned to the application. This limited information is available to the public to help avoid infringement of pending patent rights.

According to MPEP 102, for national stage applications or applications claiming the benefit of a published international application:

“Only the serial number and filing date, or application number, as well as whether the application is pending, abandoned, or patented may be given for the national stage application and for any applications claiming the benefit of the filing date of the referenced published international application. Other information contained on the continuity data screen, such as whether the application is a CIP, continuation or divisional application, the date of abandonment of the application and issue date may be confidential information and should not be communicated.”

To request this information, a copy of the first page of the published international application or the corresponding page of the PCT Gazette must be supplied with the status request to the International Patent Legal Administration.

For more information on international applications, visit: international applications.

For more information on status information, visit: status information.

Under MPEP 102, limited information about a pending application can be obtained, including:

  • Application number
  • Filing date
  • Whether the application has been published
  • Whether the application has been assigned
  • Power of attorney
  • Name of the examiner to whom the application is assigned
  • Status of the application (e.g., pending, abandoned, or issued)
  • Group art unit number
  • Filing receipt information
  • If available, projected publication date

However, access to the application file itself is restricted unless special circumstances apply or the application has been published.

The USPTO has strict rules about what information can be disclosed regarding unpublished patent applications. According to 37 CFR 1.14(a)(2), only limited status information may be communicated to the public if the application is identified in a published patent document or in another application. This status information includes:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published under 35 U.S.C. 122(b)
  • The application’s numerical identifier (application number or serial number plus filing date)
  • Whether another application claims benefit of the application, and if so, the numerical identifier, relationship, status, and publication status of that application

No other information about unpublished applications can be disclosed without proper authorization.

The front page of a patent includes the following information regarding foreign priority claims:

  • The country of the foreign application
  • The filing date of the foreign application
  • The number of the foreign application

This information is included for applications where the bib-data sheet has been properly endorsed. As stated in the MPEP: “The front page of the patent when it is issued, and the listing in the Official Gazette, will refer to the claim of priority, giving the country, the filing date, and the number of the foreign application in those applications in which the bib-data sheet has been endorsed.” (MPEP 202)

The front page of a patent issuing from a continued prosecution application (CPA) filed under 37 CFR 1.53(d) contains specific information about prior applications.

As stated in the MPEP: The front page of a printed patent issuing on a continued prosecution application (CPA) filed under37 CFR 1.53(d)will identify the application number and filing date of the most recent noncontinued prosecution application (but not the filing date of the CPA) as well as all prior applications from which benefit was claimed in the most recent noncontinued prosecution application. (MPEP 202)

This means that for a CPA:

  • The application number and filing date of the most recent non-CPA application are shown
  • The CPA’s own filing date is not displayed
  • All prior applications claimed as benefit in the most recent non-CPA application are listed

This information helps establish the continuity and priority of the patent application.

For more information on benefit claims, visit: benefit claims.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent front page, visit: patent front page.

For more information on prior applications, visit: prior applications.

When filing a patent application with an unavailable joint inventor, you must include the last known address of the nonsigning inventor. As stated in MPEP 409.03(a):

“The last known address of the nonsigning joint inventor must be stated.”

For more details on providing this information, refer to MPEP 409.03(e). This requirement helps the USPTO in potential future communications and establishes that efforts were made to locate the inventor.

To learn more:

Certain information about patent applications is publicly available, even if the full application is not. According to 37 CFR 1.14(a)(1)(ii) and (iii), for published applications, the following information may be communicated without a petition for access:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published under 35 U.S.C. 122(b)
  • The application “numerical identifier” (application number or serial number plus filing date)
  • Whether another application claims the benefit of the application

For published applications, “A copy of the application-as-filed, the file contents of the application, or a specific document in the file of a pending published application may be provided to any person upon request and payment of the appropriate fee set forth in §1.19(b).”

However, for unpublished applications, this information is generally not available to the public unless the application is identified or relied upon in a patent document or other published application.

For more information on patent applications, visit: patent applications.

For more information on public information, visit: public information.

The USPTO can disclose limited information about patent applications to the public, as outlined in 37 CFR 1.14(a)(2):

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published
  • The application’s numerical identifier
  • Whether another application claims benefit of the application

This information can only be disclosed if the application is identified in a published patent document or in another application as specified in 37 CFR 1.14(a)(1)(i) through (a)(1)(vi).

If the assignor is not available to correct an original document or execute a new one, the assignee has an alternative option. According to MPEP 323.01(b):

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction.

To complete this process, the assignee must provide:

  • An affidavit or declaration identifying the error and requesting correction
  • A copy of the originally recorded papers
  • A cover sheet
  • The required fee for each application or patent to be corrected (as per 37 CFR 3.41)

To learn more:

If your foreign application was not filed in a participating Priority Document Exchange (PDX) office, you may still be able to use the PDX program under certain conditions. According to 37 CFR 1.55(i)(4):

If the foreign application was not filed in a participating foreign intellectual property office, but a copy of the foreign application was filed in an application subsequently filed in a participating foreign intellectual property office that permits the Office to obtain such a copy, the applicant must also file a request in a separate document that the Office obtain a copy of the foreign application from the participating intellectual property office.

To make this request, you can use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)). The request must identify the participating office and the subsequent application by application number, country, and filing date.

To learn more:

If you need to assign a patent application before it’s filed, you must identify it using specific information. MPEP 302.03 states: “If an assignment of a patent application filed under § 1.53(b) of this chapter is executed concurrently with, or subsequent to, the execution of the patent application, but before the patent application is filed, it must identify the patent application by the name of each inventor and the title of the invention so that there can be no mistake as to the patent application intended.” This ensures that the correct application is associated with the assignment, even without an application number.

To learn more:

If an applicant does not have firsthand knowledge of whether the invention involved work under any contract or arrangement with the Atomic Energy Commission or NASA, but includes such information derived from others:

  • The applicant’s statement should identify the source of this information, or
  • The applicant’s statement could be accompanied by a supplemental declaration or oath regarding the contractual matters, made by the assignee or another person (like an employee) who has the requisite knowledge

When one of multiple practitioners of record is suspended, the USPTO continues to communicate with the remaining unsuspended practitioners. MPEP § 407 provides guidance for this situation: “This form paragraph should be used when there is at least one registered practitioner still of record who has not been suspended or excluded from practice.” The Office action is mailed to the first named unsuspended registered practitioner at their address of record. Additionally, to ensure timely receipt, a copy is also sent to the first named applicant’s address of record.

For more information on USPTO communication, visit: USPTO communication.

As explained in MPEP 130, when a patent application under a Secrecy Order is in condition for allowance, “a notice of allowability (Form D-10) is issued, thus closing the prosecution.” See 37 CFR 5.3(c).

After the notice of allowability is issued, any amendments received are not entered or responded to until the Secrecy Order is rescinded. Once the Secrecy Order is rescinded, amendments will be entered if they are free from objections, otherwise they will be denied entry.

When a Secrecy Order case is in condition for allowance, the prosecution is closed, but the patent is not issued. According to the MPEP, When a Secrecy Order case is in condition for allowance, a notice of allowability (Form D-10) is issued, thus closing the prosecution. This is in accordance with 37 CFR 5.3(c). The application remains in this state until the Secrecy Order is rescinded.

For more information on notice of allowability, visit: notice of allowability.

When a power of attorney is accepted from less than all applicants or owners, it results in multiple parties prosecuting the application simultaneously. The MPEP states:

“The acceptance of such papers by petition under 37 CFR 1.36(a) or 1.183 will result in more than one attorney, agent, applicant, or owner prosecuting the application at the same time. Therefore, each of these parties must sign all subsequent replies submitted to the Office.”

This means:

  • All involved parties must sign subsequent documents.
  • The USPTO will indicate who must sign future replies.
  • Double correspondence is not permitted.
  • Correspondence will be mailed to the attorney or agent if one is involved.
  • If multiple attorneys are involved, correspondence goes to the first-named attorney unless all parties agree otherwise.

To learn more:

What happens to the status of the prior application when filing a CPA?

When filing a Continued Prosecution Application (CPA), the status of the prior application changes. According to MPEP 201.06(d):

The filing of a CPA is not a filing of a new application. Rather, a CPA is a continuation of the prior application and maintains the same application number as the prior application, i.e., the application number of the prior application is used as the application number for the CPA.

This means that:

  • The prior application is not abandoned
  • The CPA continues the examination process of the prior application
  • The same application number is retained for the CPA

It’s important to note that while the CPA continues the examination, it is treated as a new application for all other purposes under the patent statute and rules.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

What happens to the priority date in a divisional application?

The priority date of a divisional application remains the same as its parent application, provided that the proper procedures are followed. According to MPEP 201.06:

‘A later-filed application which is filed before the patenting or abandonment of or termination of proceedings on an earlier-filed application and which is an application for an invention which is disclosed and claimed in the earlier-filed application is an application for a ‘divisional’ of the earlier-filed application.’

This means that:

  • The divisional application retains the priority date of the parent application for the subject matter disclosed in the parent.
  • This is crucial for establishing the effective filing date for prior art purposes under 35 U.S.C. 100(i).
  • The applicant must ensure that a proper reference to the parent application is made in the divisional to maintain this priority.

Maintaining the original priority date is one of the key advantages of filing a divisional application, as it allows the applicant to protect different aspects of their invention without losing the benefit of the earlier filing date.

For more information on Divisional application, visit: Divisional application.

For more information on effective filing date, visit: effective filing date.

What happens to the prior application when a CPA is filed?

When a Continued Prosecution Application (CPA) is filed, the prior application is automatically abandoned. According to MPEP 201.06(d):

The filing of a CPA is not a filing of a new application. Rather, a CPA is a continuation of the prior application and maintains the same application number as the prior application, i.e., a “streeting” of the prior application.

This means that:

  • The prior application is considered abandoned as of the filing date of the CPA.
  • The CPA is not assigned a new application number but continues under the number of the prior application.
  • All correspondence for the CPA should refer to the original application number.

It’s important to note that this automatic abandonment of the prior application is a key feature of CPA practice, distinguishing it from other types of continuing applications.

To learn more:

What happens to the prior application when a Continued Prosecution Application (CPA) is filed?

When a Continued Prosecution Application (CPA) is filed, it has specific effects on the prior application. According to MPEP 201.06(d):

‘The filing of a CPA is a specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in the request for a CPA. Such a specific reference will constitute a waiver of confidentiality of the prior design application(s) under 35 U.S.C. 122 when the CPA is pending and/or any ex parte reexamination proceeding is pending in the prior design application(s).’

This means:

  • The prior application becomes part of the record of the CPA
  • Confidentiality of the prior application is waived
  • The CPA is considered a continuation of the prior application
  • The prior application is not automatically abandoned, but will be abandoned if the issue fee is not paid

It’s important to note that while the CPA continues the examination process, the prior application remains a distinct entity until it is either allowed to go abandoned or is explicitly abandoned by the applicant.

To learn more:

Tags: CPA

When inventorship is corrected in a patent application, it can affect the power of attorney. For applications filed on or after September 16, 2012, 37 CFR 1.32(e) provides:

If the power of attorney was granted by the originally named inventive entity, and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.

This means that if a new inventor is added and does not provide a power of attorney consistent with the original one, the original power of attorney is lost when the request to correct inventorship is granted. However, this provision does not prevent a practitioner from acting in a representative capacity under 37 CFR 1.34, if applicable.

It’s important for applicants and their representatives to be aware of this potential consequence when correcting inventorship and to take appropriate action to maintain or update the power of attorney as needed.

To learn more:

When an inventor is added to a pre-AIA patent application through a 37 CFR 1.48 request, it can affect the existing power of attorney. According to MPEP 402.05(b):

If the power of attorney was granted by the originally named inventive entity and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.

This means that if a new inventor is added and doesn’t provide a power of attorney consistent with the original one, the original power of attorney is lost. However, this doesn’t prevent a practitioner from acting under 37 CFR 1.34, which allows for acting in a representative capacity.

To learn more:

To learn more:

The death of an inventor (or one of the joint inventors) typically terminates the power of attorney given by the deceased inventor in an application filed before September 16, 2012, unless the power of attorney is coupled with an interest (e.g., the patent practitioner is an assignee or part-assignee). As stated in MPEP 409.01(b):

“Unless a power of attorney is coupled with an interest (i.e., a patent practitioner is assignee or part-assignee), the death of the inventor (or one of the joint inventors) terminates the power of attorney given by the deceased inventor in an application filed before September 16, 2012.”

In such cases, a new power of attorney from the heirs, administrators, executors, or assignees is necessary if the deceased inventor was the sole inventor or if all powers of attorney in the application have been terminated.

To learn more:

What happens to the parent application when a divisional application is filed?

When a divisional application is filed, the parent application continues to be prosecuted independently. The filing of a divisional application does not automatically affect the status or prosecution of the parent application.

As stated in MPEP 201.06: “The divisional application may be filed either while the original application is still pending or after it has been patented.” This means that:

  • If the parent application is pending, it remains pending and continues through the examination process.
  • If the parent application has already been granted as a patent, it remains a valid patent.

It’s important to note that while the divisional application is independent, it must contain claims to a different invention than the parent application. The examiner will ensure that there is no double patenting between the parent and divisional applications.

Additionally, if the divisional application is filed in response to a restriction requirement in the parent application, the applicant should consider canceling the claims in the parent application that are now being pursued in the divisional to avoid potential issues with duplicate claims.

For more information on Divisional application, visit: Divisional application.

For more information on parent application, visit: parent application.

For more information on patent prosecution, visit: patent prosecution.

What happens to the parent application when a continuation is filed?

Filing a continuation application does not automatically affect the status of the parent application. As stated in MPEP 201.07:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 363 while the prior application is pending, or after the prosecution and patent term adjustment time periods have expired, or after the prior application has become abandoned or issued as a patent.’

This means that:

  • If the parent application is still pending, it remains active and can continue through the examination process.
  • If the parent application has already been issued as a patent, it remains a valid patent.
  • If the parent application has been abandoned, filing a continuation does not revive it.

It’s important to note that while a continuation can be filed at various stages of the parent application’s lifecycle, the applicant may need to make strategic decisions about how to proceed with the parent application. For example:

  • They may choose to abandon the parent application in favor of the continuation.
  • They may continue prosecuting both applications simultaneously.
  • They may allow the parent to issue as a patent and use the continuation to pursue additional claims.

The choice often depends on the specific circumstances and the applicant’s patent strategy.

For more information on continuation application, visit: continuation application.

After acceptance of a Pre-AIA 37 CFR 1.47 application, the non-signing inventor retains certain rights and responsibilities:

  • They are considered a joint inventor and will be named on any patent that may issue.
  • They have the right to access the application file and receive notices from the USPTO.
  • They can still submit an executed oath or declaration, which would then be entered into the file.

As stated in MPEP 409.03(j): ‘The fact that an application was accepted and prosecuted pursuant to 37 CFR 1.47 does not alter the rights or obligations of any of the inventors with regard to the application or any patent issuing thereon.’

To learn more:

To learn more:

The inventorship in a Continued Prosecution Application (CPA) generally carries over from the prior application, unless specific steps are taken to change it. The MPEP states:

The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If an inventor needs to be added or deleted in a CPA after it has been filed, a request under 37 CFR 1.48 must be submitted, along with the required fee.

For more information on patent applications, visit: patent applications.

What happens to the filing date when converting a provisional application to a nonprovisional application?

When converting a provisional application to a nonprovisional application, the filing date of the nonprovisional application will be the filing date of the provisional application. This is stated in MPEP 601.01(c):

“The filing date of the provisional application is the filing date of the nonprovisional application.”

However, it’s important to note that this conversion must be done within 12 months of the provisional application’s filing date. If the conversion is not done within this timeframe, the nonprovisional application will receive a new filing date.

To learn more:

Terminal disclaimers filed in a parent application do not automatically carry over to a divisional application. The MPEP 201.06 states:

‘A terminal disclaimer filed to obviate a nonstatutory double patenting rejection in a parent application does not carry over to a divisional application. The applicant filing the divisional application must determine whether a new terminal disclaimer needs to be filed in the divisional application.’

This means:

  • Terminal disclaimers from the parent application are not automatically applied to the divisional
  • The applicant must assess whether a new terminal disclaimer is necessary for the divisional application
  • If required, a new terminal disclaimer must be filed specifically for the divisional application

It’s important for applicants to review potential double patenting issues in the divisional application and file new terminal disclaimers if needed to overcome any rejections.

To learn more:

What happens to pending patent applications when a practitioner is suspended or excluded?

When a patent practitioner is suspended or excluded, the Office of Enrollment and Discipline (OED) Director must review all pending patent applications to determine if immediate action is necessary. According to MPEP 407:

“The OED Director will review all pending applications, in which the suspended or excluded practitioner is the attorney or agent of record, and notify the applicant of the suspension or exclusion and of the limited recognition of the practitioner.”

This process ensures that applicants are aware of their practitioner’s status and can take appropriate action to protect their patent applications.

For more information on pending applications, visit: pending applications.

When a patent practitioner dies, the MPEP 406 outlines the following procedure:

  • The Office will notify the applicant of the death of the practitioner.
  • The applicant must appoint a new registered patent practitioner or file a change of correspondence address.
  • This must be done within the time period set in the notice, which is usually 3 months.
  • If no action is taken, the application may be deemed abandoned.

As stated in the MPEP: “If notification of the death of the practitioner is received by the Office, the Office will notify the applicant of the death and the need to appoint a new registered patent practitioner or file a change of correspondence address.”

For more information on patent practitioner death, visit: patent practitioner death.

For more information on pending applications, visit: pending applications.

For more information on USPTO notification, visit: USPTO notification.

Applications subject to a Secrecy Order will be:

  • Deleted from any image file system within the USPTO
  • Converted to paper
  • Held with Licensing and Review
  • Transferred to a designated examiner for examination

According to MPEP 508.02, “After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender. If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW.”

This means that any documents received after a patent is granted or an application is abandoned will not be added to the official record. Instead, they will be either physically returned to the sender or, if already scanned into the Image File Wrapper (IFW) system, electronically closed within the system.

According to MPEP 508.02, after a patent application is either patented or abandoned, any incoming communication that is not intended to become part of the official record will be returned to the sender. The MPEP states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This procedure ensures that the official patent file remains accurate and contains only relevant information after the application process has concluded.

To learn more:

For originally submitted drawings on paper that are photographs or in color, the USPTO has a specific procedure. According to MPEP 608.02(c):

Originally submitted drawings on paper that are photographs or in color may be maintained in an artifact folder.

This means that:

  • Original paper drawings that are photographs or color drawings are not necessarily scanned and stored electronically.
  • These original drawings may be kept in a physical artifact folder.
  • The artifact folder is likely maintained separately from the electronic file wrapper to preserve the original quality of the drawings.

This practice ensures that the original quality of photographs and color drawings is preserved, which can be important for certain types of patent applications where the precise details or colors in the drawings are crucial.

To learn more:

According to MPEP 317, original documents submitted to the USPTO Assignment Division are handled as follows:

After filming, the documents are returned to the sender or destroyed.

This means that once the Assignment Division has processed and recorded the documents, the original physical copies are not retained by the USPTO. If you need a copy of a recorded document, you can request a certified copy from the USPTO for a fee.

For more information on Assignment Division, visit: Assignment Division.

For more information on Document retention, visit: Document retention.

For more information on Original documents, visit: Original documents.

For more information on USPTO, visit: USPTO.

In a pre-AIA 37 CFR 1.47 application, nonsigning inventors are notified of the application filing. The MPEP states: The U.S. Patent and Trademark Office will notify the nonsigning inventor(s) or, if the inventor is deceased, the legal representative(s), of the filing of an application under pre-AIA 37 CFR 1.47 by sending a letter to the last known address of the nonsigning inventor(s) or legal representative(s).

This notification process ensures that all inventors, even those who didn’t sign the application, are aware of the patent application filed using their invention. It’s important to note that this notification is a courtesy and doesn’t require a response from the nonsigning inventor for the application to proceed.

To learn more:

To learn more:

When you notify the USPTO of a loss of micro entity status, you are automatically treated as a small entity by default, unless specified otherwise. As stated in MPEP 509.04(e):

A notification that micro entity status is no longer appropriate will not be treated as a notification that small entity status is also no longer appropriate unless it also contains a notification of loss of entitlement to small entity status under § 1.27(f)(2) [§ 1.27(g)(2)].

To change to regular (unreduced) fee status, you must either:

  • File a notification of loss of entitlement to micro entity status along with regular unreduced fees or an indication of loss of entitlement to small entity status, or
  • File a separate notification of loss of entitlement to small entity status.

To learn more:

After patent prosecution, the handling of models, exhibits, or specimens depends on their nature and the applicant’s wishes. According to MPEP 608.03(a):

‘Upon conclusion of the prosecution of the application, model, exhibit, or specimen, unless the model, exhibit, or specimen has been destroyed during prosecution, the model, exhibit, or specimen may be returned to the applicant upon request and at applicant’s expense.’

If the applicant doesn’t request their return, the USPTO may dispose of them. It’s important for applicants to communicate their wishes regarding these items after prosecution.

To learn more:

After a patent application is allowed, the handling of models, exhibits, or specimens depends on their size and nature. According to MPEP 608.03(a):

Upon notification from the Office of Patent Application Processing (OPAP) that an application is being allowed, the model, exhibit, or specimen is transferred to a permanent location for storage.

The specific handling process varies:

  • Small items: Transferred to the File Information Unit for permanent storage.
  • Large items: Photographed, if practical, and then disposed of, unless a specific request is made for return to the applicant.

It’s important to note that the USPTO may dispose of the models, exhibits, or specimens at its discretion two months after the application is allowed.

To learn more:

When filing a Continued Prosecution Application (CPA), previously filed Information Disclosure Statements (IDS) are handled as follows:

  • All IDSs filed in the prior application that comply with 37 CFR 1.98 are automatically considered in the CPA
  • No specific request is needed for the examiner to consider the previously submitted information
  • New IDSs can be filed in the CPA and will be considered if they comply with the content requirements and are filed before the first Office action

The MPEP states: All information disclosure statements filed in the prior application that comply with the content requirements of 37 CFR 1.98 will be considered in a CPA by the examiner. No specific request that the previously submitted information be considered in a CPA is required.

For more information on patent applications, visit: patent applications.

After a patent is granted or an application is abandoned, the USPTO has specific procedures for handling incoming communications. According to the MPEP, After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.

In the case of digital documents, the MPEP states, If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW. This means that the document will be marked as closed in the digital system, effectively removing it from active consideration.

For more information on post-grant communications, visit: post-grant communications.

For more information on USPTO procedures, visit: USPTO procedures.

When a new power of attorney is filed, it generally revokes all prior powers of attorney. MPEP 402.05(a) provides several scenarios:

  • If a new power of attorney is filed without explicitly revoking prior ones, it will be treated as a revocation of the original power of attorney.
  • If an assignee files a new power of attorney, it revokes and replaces the original power of attorney filed by the applicant.
  • If a power of attorney is given to practitioners associated with a Customer Number, and a second power of attorney is later received for a different Customer Number, the second one will replace the first.

The MPEP states:

In all of these situations, the most recently filed power of attorney will control.

This means that the latest power of attorney filed will take precedence over any previously filed ones.

To learn more:

Documents and cover sheets submitted for recording at the USPTO Assignment Division are examined for formal requirements. The process is as follows:

  • Documents that meet the requirements are recorded.
  • Documents that do not meet the requirements are returned to the sender with an explanation.
  • If the sender disagrees with the rejection, they can petition the Director under 37 CFR 1.181.
  • After successful recording, a notification is sent to the address on the cover sheet, showing the reel and frame number.

As stated in MPEP 317: “All documents and cover sheets submitted for recording are examined for formal requirements in the Assignment Division in order to separate documents which are recordable from those which are not recordable.”

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications. This also applies to continuation or divisional applications of applications filed before June 8, 1995. The MPEP states:

“A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.”

This change in procedure highlights the importance of using the correct application type and filing method after the deletion of 37 CFR 1.62.

What happens to continuation or divisional applications filed after a CPA in a design application?

Continuation or divisional applications filed after a Continued Prosecution Application (CPA) in a design application are treated differently than those filed after a CPA in a utility or plant application. According to MPEP 201.06(d):

Any continuation or divisional application filed under 37 CFR 1.53(b) after the filing of a CPA of a design application will be assigned a new application number and will reflect the filing date of the 37 CFR 1.53(b) application.

This means that unlike utility or plant applications, where a continuation or divisional application would get the benefit of the CPA’s filing date, in design applications, these subsequent applications are treated as new applications with their own filing dates.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

The MPEP clearly states that All continuation and divisional applications filed under 37 CFR 1.60 prior to December 1, 1997 will continue to be processed and examined under the procedures set forth in former 37 CFR 1.60. This means that applications filed before the cutoff date are grandfathered in and will be processed according to the old rules, ensuring consistency in the handling of these earlier applications.

To learn more:

To learn more:

What happens to conditional assignments at the USPTO?

Conditional assignments are treated differently by the USPTO’s Assignment Division. The MPEP 317 states:

“Conditional assignments are returned to the sender by the Assignment Division.”

This means that if an assignment includes conditions that must be met before it becomes effective, the USPTO will not record it. Instead, the Assignment Division will return the document to the sender. It’s important for patent applicants and owners to ensure that any assignments submitted for recording are unconditional to avoid delays in processing.

For more information on Assignment Division, visit: Assignment Division.

For more information on conditional assignments, visit: conditional assignments.

For more information on USPTO procedures, visit: USPTO procedures.

When claims are canceled during the patent prosecution process, it’s important to note that the remaining claims should not be renumbered. This is explicitly stated in MPEP 608.01(j):

“When claims are canceled the remaining claims must not be renumbered.”

This rule helps maintain consistency and clarity throughout the prosecution process, allowing for easy tracking of claim history and amendments. It’s crucial for patent applicants and attorneys to adhere to this guideline to avoid confusion and potential issues with the USPTO.

To learn more:

The MPEP clearly states: “All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.”

This means that applications filed under the File Wrapper Continuing Procedure before its deletion will be processed according to the rules that were in place at the time of filing. For more detailed information on these procedures, you can refer to the MPEP 8th Edition, Rev. 1 (February 2003), which is available on the USPTO website.

For more information on patent examination, visit: patent examination.

The MPEP clearly states that All continuation and divisional applications filed under 37 CFR 1.60 prior to December 1, 1997 will continue to be processed and examined under the procedures set forth in former 37 CFR 1.60. This means that if you filed a continuation or divisional application before the rule change, your application will still be handled according to the old procedures, ensuring consistency in the examination process for applications filed under the former rule.

For more information on continuation applications, visit: continuation applications.

Access restrictions on patent applications change significantly after publication. According to MPEP 106, “Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.”

This means that once a patent application is published, typically 18 months after the earliest filing date, any previously imposed restrictions on access, including those on the inventor, are lifted. The application becomes publicly accessible, aligning with the USPTO’s goal of promoting transparency in the patent process.

For more information on public availability, visit: public availability.

For more information on USPTO procedures, visit: USPTO procedures.

After an application becomes abandoned, it is no longer pending and is removed from the USPTO’s active files. The application file, however, is retained in storage for a period as determined by the USPTO. During this retention period, certain actions may still be possible:

1. The applicant may file a petition to revive the application if the abandonment was unintentional or unavoidable.
2. The application may serve as a basis for claiming benefit in a later-filed application, subject to certain conditions.
3. The application may be used as prior art against other applications.
4. The public may request access to the application file if it has been opened to public inspection.

It’s important to note that once an application is abandoned, it cannot be used as the basis for a statutory invention registration. For more details on abandoned applications, see MPEP 203.05 and MPEP 711.

When a petition to ‘expunge’ a document is granted, the document is not completely removed from the USPTO assignment records. According to MPEP 323.01(d):

Even if a petition to ‘expunge’ a document is granted with respect to a particular application or patent, the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number, and the image will appear when someone views that reel and frame number.

However, the USPTO takes steps to limit the visibility of the expunged document:

  • Links to the application or patent subject to the petition are deleted.
  • The document won’t appear in searches for that application or patent number in the Assignment Historical Database.
  • A redacted version of the ‘expunged’ document is recorded and appears in the assignment records instead of the original document.

To learn more:

When filing a Continued Prosecution Application (CPA), amendments and information disclosure statements (IDS) from the prior application are handled as follows:

  • Amendments: The MPEP states, “Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph.” Applicants are encouraged to file any preliminary amendments at the time of filing the CPA.
  • Information Disclosure Statements: According to the MPEP, “All information disclosure statements filed in the prior application that comply with the content requirements of 37 CFR 1.98 will be considered in a CPA by the examiner.” No specific request for consideration is required.

It’s important to note that amendments or IDSs filed after the CPA filing date could delay prosecution. The MPEP advises, “Applicants are also encouraged to file all preliminary amendments at the time of filing a CPA because the entry of any preliminary amendment filed after the filing date of the CPA could be denied under 37 CFR 1.115 if the preliminary amendment unduly interferes with the preparation of a first Office action.”

For more information on patent application procedures, visit: patent application procedures.

Affidavits or declarations from a prior application do not automatically become part of a continuation or divisional application filed under 37 CFR 1.53(b). If an applicant wants to rely on these documents, they must take specific actions:

  1. Make remarks of record in the new application referring to the affidavit or declaration.
  2. Include a copy of the original affidavit or declaration filed in the prior application.

The MPEP states: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the prior nonprovisional application do not automatically become a part of a continuation or divisional application filed under 37 CFR 1.53(b). Where it is desired to rely on an earlier filed affidavit or declaration, the applicant should make such remarks of record in the 37 CFR 1.53(b) application and include a copy of the original affidavit or declaration filed in the prior nonprovisional application.

It’s important to note that this rule doesn’t apply to continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), where affidavits and declarations do automatically become part of the new application.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

When an abandoned application is later revived, it retains its original filing date. The revival process effectively removes the abandonment status, allowing the application to continue prosecution. However, the period of abandonment may impact patent term adjustment calculations. For more information on revival procedures, refer to MPEP 711 and 37 CFR 1.137.

What happens to a provisional application after one year?

A provisional application automatically becomes abandoned 12 months after its filing date. The MPEP 201.04 states:

‘A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.’

This means that after the 12-month period, the provisional application cannot be revived or extended. To maintain the benefit of the provisional filing date, you must file a nonprovisional application claiming priority to the provisional within this 12-month window. If you fail to do so, you lose the benefit of the earlier filing date, and the subject matter of the provisional becomes part of the prior art.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

What happens to a provisional application after 12 months?

A provisional application automatically becomes abandoned 12 months after its filing date. The MPEP states: ‘A provisional application will automatically become abandoned 12 months after its filing date pursuant to 35 U.S.C. 111(b)(5).’ This means that:

  • The application is no longer pending
  • It cannot be revived
  • No patent will directly result from a provisional application

To benefit from the provisional application, the applicant must file a nonprovisional application claiming priority to the provisional within the 12-month period. For more details, refer to MPEP 201.04.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

The death of a named principal or assignee can have significant implications for an existing power of attorney in a patent application. According to MPEP 402.05:

The death of the principal may terminate the power of attorney given by him or her depending on the circumstances.

This means that the power of attorney may automatically terminate upon the death of the principal. However, the specific circumstances of each case must be considered. In cases where there are multiple applicants or assignees, the power of attorney may remain in effect for the surviving parties. It’s crucial to notify the USPTO of any changes in the status of the applicant or assignee to ensure proper representation in the patent application process. If necessary, a new power of attorney should be filed by the appropriate party, such as the executor of the deceased’s estate or the remaining applicants.

To learn more:

For applications filed on or after September 16, 2012, 37 CFR 1.32(d) provides that a power of attorney from a prior national application may have effect in a continuing application if:

  1. A copy of the power of attorney from the prior application is filed in the continuing application
  2. The power of attorney was not granted by the inventor
  3. The continuing application does not name an inventor who was not named in the prior application

MPEP 402.02(a) states: “37 CFR 1.32(d) specifically requires that a copy of the power of attorney from the prior application be filed in the continuing application to have effect (even where a change in power did not occur in the prior application).”

If these conditions are not met, a new power of attorney will need to be filed in the continuing application.

A power of attorney given to a suspended or disbarred patent practitioner becomes ineffective. The MPEP states: ‘Any power of attorney given to a practitioner who has been suspended or disbarred by the Office is ineffective, and does not authorize the person to practice before the Office or to represent applicants or patentees in patent matters.’ (MPEP § 407)

During an interference or derivation proceeding, any changes to the power of attorney must be forwarded to a specific board for review. As stated in MPEP 402.05: While an application is involved in an interference or derivation proceeding, any power of attorney or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration. This ensures that the appropriate authority handles changes in representation during these specialized proceedings.

To learn more:

When a patent practitioner dies, their power of attorney is automatically revoked or terminated. According to the MPEP, The power of attorney of a patent practitioner will be revoked or terminated by his or her death. (MPEP 406)

When a patent application has multiple inventors and one of them dies, the process for continuing the application depends on whether there’s a power of attorney in place. According to MPEP 409.01(a):

When an application is being prosecuted by joint inventor-applicants without a joint inventor-applicant or patent practitioner having been granted a power of attorney, and a joint inventor-applicant dies after filing the application, the living joint inventor(s) who are the applicant must submit proof that the other joint inventor-applicant is dead.

Here’s what happens in this scenario:

  • The surviving inventors must provide proof of the deceased inventor’s death to the USPTO.
  • If no legal representative of the deceased inventor intervenes, only the signatures of the living inventors are required on USPTO documents.
  • If a legal representative of the deceased inventor intervenes, they must submit a substitute statement complying with 37 CFR 1.64.
  • Once a legal representative intervenes, signatures from both the living inventors and the legal representative are required on USPTO documents.
  • This requirement continues until the legal representative and living inventors appoint a new representative.

It’s crucial for the surviving inventors to understand these requirements to ensure the application process continues smoothly.

To learn more:

When an inventor dies before filing a patent application, the legal representative (executor, administrator, etc.) of the deceased inventor can make the necessary oath or declaration and apply for the patent. This is specified in 37 CFR 1.42 (pre-AIA), which states:

“In case of the death of the inventor, the legal representative (executor, administrator, etc.) of the deceased inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative must comply with the same requirements and conditions that would have been applicable to the inventor.

To learn more:

When a Secrecy Order is imposed on a patent application, it is examined in a secure location by examiners with national security clearances under the control of Licensing and Review. If the Secrecy Order is imposed after the application is already docketed in another Technology Center, it will be transferred to a designated examiner in Licensing and Review.

As stated in MPEP 130, “Secrecy Order cases are examined for patentability as in other cases, but will not be passed to issue; nor will an interference or derivation be instituted where one or more of the conflicting cases is classified or under Secrecy Order.”

If an inventor dies after filing a patent application but before the patent is granted, the process can still continue. According to 37 CFR 1.42 (pre-AIA):

“Where the inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.”

However, MPEP 409.01(b) clarifies that the intervention of the executor or administrator is not compulsory:

“When an inventor dies after filing an application and executing the oath or declaration required by pre-AIA 37 CFR 1.63, the executor or administrator should intervene, but the allowance of the application will not be withheld nor the application withdrawn from issue if the executor or administrator does not intervene.”

This means that while it’s advisable for the legal representative to intervene, the patent application can still proceed to allowance or issuance even without such intervention.

To learn more:

What happens if you don’t file a nonprovisional application within 12 months of a provisional?

If you don’t file a nonprovisional application within 12 months of filing a provisional application, you lose the ability to claim the benefit of the provisional application’s filing date. The MPEP 201.04 states:

“A provisional application automatically becomes abandoned 12 months after its filing date and cannot claim the benefit of any other application.”

This means that after 12 months, the provisional application expires, and you can no longer use it as a basis for priority in a nonprovisional application. If you still want to pursue patent protection for your invention, you would need to file a new application, but you may have lost your priority date and any intervening prior art could potentially be used against your application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

When revoking a power of attorney in a situation where there is no practitioner of record, special considerations apply. The MPEP 402.05 states:

‘If a power of attorney is revoked, and a new power of attorney is not promptly filed, then pursuant to 37 CFR 1.33(a) the correspondence address will be changed to that of the inventor(s) or assignee(s) who last provided a correspondence address.’

This means:

  • The USPTO will change the correspondence address to that of the inventor(s) or assignee(s).
  • The last provided correspondence address by the inventor(s) or assignee(s) will be used.
  • All future communications from the USPTO will be sent to this address.
  • It’s crucial to provide a new power of attorney or update the correspondence address promptly to ensure receipt of important communications.

To learn more:

What happens if there’s an error in the patent grant?

Errors in patent grants are addressed through a specific process outlined in MPEP 308. The manual states:

“If the Office discovers that an error exists in the patent grant, the patentee will be notified and required to submit a request for a certificate of correction.”

This process involves the following steps:

  • The USPTO identifies an error in the issued patent
  • The patentee is notified of the error
  • The patentee must submit a request for a certificate of correction
  • The USPTO issues a certificate of correction to rectify the error

It’s important to note that the certificate of correction becomes part of the patent and is treated as such for all purposes. Patentees should carefully review their patent grants upon receipt to identify any errors promptly and initiate the correction process if necessary.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on Patent correction, visit: Patent correction.

For more information on USPTO procedures, visit: USPTO procedures.

What happens if there’s an error in the foreign priority application number?

If there’s an error in the foreign priority application number, it can lead to serious consequences for the priority claim. The MPEP emphasizes the importance of accuracy:

“Errors in foreign priority claims may jeopardize the applicant’s priority claim.” (MPEP 214.04)

Consequences of errors may include:

  • Rejection of the priority claim
  • Loss of priority date
  • Potential issues with patentability if prior art emerges in the intervening period

If an error is discovered, it’s crucial to promptly file a corrected Application Data Sheet (ADS) or a petition to correct the priority claim, depending on the timing and nature of the error. Always double-check the application number against the original foreign priority document to ensure accuracy.

To learn more:

If there’s an error in your assignment submission, the USPTO will notify you and provide an opportunity to correct the issue. The process differs slightly depending on the submission method:

  • For fax submissions: The USPTO will fax back the entire document, cover sheet, and a “Notice of Non-Recordation” explaining the issue.
  • For electronic (EPAS) submissions: The USPTO will attempt to fax the notice back. If faxing isn’t possible, they may use other means to notify you.

As stated in MPEP 302.09: “If a document submitted by fax is determined not to be recordable, the entire document, with its associated cover sheet, and the Office ‘Notice of Non-Recordation’ will be transmitted via fax back to the sender.”

To correct the error:

  1. Make the necessary corrections to the document or cover sheet
  2. Resubmit the corrected document by mail to the address in 37 CFR 3.27
  3. Timely resubmission may allow you to retain the initial receipt date as the recordation date

Always double-check your submissions for accuracy to avoid delays in recording your assignment.

What happens if there’s an error in my application number?

If you notice an error in your application number, it’s crucial to contact the USPTO immediately. The MPEP states, Any error in the identification of the application number will result in processing delays. (MPEP 503) To avoid such delays:

  • Double-check the application number on your filing receipt
  • If you find an error, contact the Application Assistance Unit at (571) 272-4000
  • Provide the correct application number and any supporting documentation

Prompt action can help ensure your application is processed correctly and efficiently.

For more information on application number, visit: application number.

For more information on error correction, visit: error correction.

Errors in citation numbers for U.S. patents or patent application publications in an e-IDS can be problematic because examiners rely on these numbers to retrieve and review the documents electronically. The MPEP 609.07 addresses this issue:

The only mechanism for having the correct document reviewed and considered when an erroneous U.S. patent or U.S. patent application publication is cited in an e-IDS will be by citing the correct citation number in a subsequent IDS that conforms to the requirements of 37 CFR 1.97 and 1.98.

This means that if you discover an error in a citation number after submitting an e-IDS, you must file a new IDS with the correct citation number to ensure the proper document is considered. It’s crucial to double-check all citation numbers before submitting an e-IDS to avoid such issues.

To learn more:

What happens if there’s an error in a recorded assignment document?

If an error is discovered in a recorded assignment document, it can be corrected through a Certificate of Correction. The MPEP 302 provides guidance on this process:

“Errors in a recorded assignment document will be corrected by the Assignment Division provided a ‘corrective document’ is submitted. The ‘corrective document’ must include the following: … [list of requirements]”

To correct an error, you need to submit:

  • A copy of the original assignment document with the error
  • A ‘corrective document’ explaining the nature of the error and the desired correction
  • New recordation fee for processing the correction

It’s important to address errors promptly to ensure accurate ownership records. The USPTO will review the correction request and update the assignment records accordingly if approved.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on USPTO, visit: USPTO.

If there’s an error in the recorded assignment document itself (not just the cover sheet), the process is different:

  1. The party responsible for the error (e.g., the assignor) must either create and record a new document or make corrections to the original document and re-record it.
  2. If the assignor is unavailable, the assignee can submit an affidavit or declaration identifying the error and requesting correction.

As stated in MPEP 323.01(b), “The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).”

In the event of a postal interruption or emergency, the USPTO will take the following actions:

  • Place an announcement on the USPTO website at www.uspto.gov
  • Publish a notice in the Official Gazette

These communications will provide instructions about filing patent applications and other patent-related papers. As stated in MPEP 511:

“In the event of a postal interruption or emergency, an announcement will be placed on the USPTO website at www.uspto.gov and a notice will be published in the Official Gazette, providing instructions about the filing of patent applications, and other papers related to patent applications and patents.”

This ensures that applicants have clear guidance on how to proceed during such circumstances.

To learn more:

In the event of a postal interruption or emergency:

  • An announcement will be placed on the USPTO website at www.uspto.gov
  • A notice will be published in the Official Gazette
  • These communications will provide instructions about filing patent applications and other papers related to patent applications and patents

The USPTO Director may prescribe rules considering papers or fees filed on the date they would have been deposited with the USPS, but for postal service interruptions or emergencies.

As stated in MPEP 511: “In the event of a postal interruption or emergency, an announcement will be placed on the USPTO website at www.uspto.gov and a notice will be published in the Official Gazette, providing instructions about the filing of patent applications, and other papers related to patent applications and patents.”

If there’s a discrepancy between the USPTO’s date stamp and the date on the correspondence, the USPTO’s date stamp is generally considered the official receipt date. However, if an applicant can provide clear evidence that the correspondence was received earlier than the date indicated by the USPTO’s stamp, the earlier date may be recognized as the official receipt date. This situation might occur due to clerical errors or delays in processing incoming mail.

When multiple correspondence addresses are on file for a patent application, the USPTO follows a specific procedure. According to MPEP 601.03:

‘Where more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.’

This means that the USPTO will choose one address to use, potentially favoring a Customer Number address if provided. To avoid confusion, it’s best to ensure only one clear correspondence address is on file. For more information, visit MPEP 601.03.

To learn more:

When there are multiple applicants for a patent and only some give power of attorney, the USPTO has specific rules to handle the situation. According to MPEP 402:

‘Where a power of attorney is given by fewer than all of the applicants or owners, the power of attorney is not accepted until a petition under 37 CFR 1.36(b) is granted.’

This means:

  • The power of attorney is not automatically accepted if not all applicants have signed it.
  • A petition under 37 CFR 1.36(b) must be filed and granted for the partial power of attorney to be accepted.
  • The petition should explain why it was not possible to obtain signatures from all applicants.
  • The Office of Petitions will review the petition and make a determination.

It’s generally recommended to obtain signatures from all applicants to avoid delays and potential issues with the patent application process.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

What happens if there are insufficient funds when paying USPTO fees?

If there are insufficient funds when paying USPTO fees, several consequences may occur:

  • The fee payment will be considered incomplete.
  • Your application or request may not be processed.
  • You may incur additional fees or penalties.
  • In some cases, you might lose filing date benefits.

The MPEP 509 warns, “If the Office receives a check drawn on a deposit account with insufficient funds, the fee will be considered unpaid.” For electronic payments, “If the electronic fund transfer is refused, or if the credit card is declined or invalid, the fee will be considered unpaid.” It’s crucial to ensure sufficient funds are available to avoid these issues and potential delays in your patent or trademark process.

To learn more:

Tags: USPTO fees

What happens if there are insufficient funds in my USPTO deposit account?

If there are insufficient funds in your USPTO deposit account to cover a fee, the following occurs:

  • The USPTO will treat the fee as unpaid
  • Any associated filing may be considered incomplete
  • You may receive a notice of insufficient funds

The MPEP clearly states: “An overdrawn account will be immediately suspended and no charges will be accepted against it until the balance is restored.” (MPEP 509.01)

To avoid this situation, it’s crucial to maintain sufficient funds in your account and regularly monitor your balance. If your account becomes overdrawn, you’ll need to restore the balance before any further charges can be processed.

To learn more:

Tags: patent fees

When there are inconsistencies between the Application Data Sheet (ADS) and other documents, the ADS generally takes precedence. According to MPEP 601.05(a):

Information in the Application Data Sheet will govern when inconsistent with the information supplied at the same time by a designation of correspondence address or the inventor’s oath or declaration.

However, it’s important to note that this only applies when the inconsistent information is supplied at the same time. If the inconsistency arises later, a corrected ADS may be required to update the information.

To learn more:

What happens if there are inconsistencies between an ADS and other documents?

When inconsistencies exist between an Application Data Sheet (ADS) and other documents, the ADS generally takes precedence. According to MPEP 601.05:

“If an ADS is inconsistent with the information provided in another document that was submitted at the same time or previous to the ADS submission, the ADS will control.”

However, there are exceptions to this rule:

  • For inventorship, the most recent submission will control.
  • For foreign priority and domestic benefit claims, the most recent submission will control, provided it was timely filed.

It’s crucial to ensure all information in the ADS is accurate to avoid potential issues later in the application process.

To learn more:

Tags: ADS, inventorship

When inconsistencies exist between an Application Data Sheet (ADS) and other documents in a patent application, the ADS generally takes precedence. According to MPEP 601.05:

‘Where an ADS is used, the ADS data will govern when inconsistent with the information provided elsewhere in the application, except when the ADS is accompanied by a clear indication that the information in the ADS is not to be used.’

However, it’s important to note that if there’s a clear indication that the information in the ADS should not be used, then other documents may take precedence. Applicants should strive for consistency across all application documents to avoid confusion and potential issues during examination.

To learn more:

Tags: ADS

If priority papers are found to be deficient in material respects, such as failure to include the correct certified copy, applicants should ensure that there is sufficient time to remedy any defects. The MPEP advises: “Frequently, priority papers are found to be deficient in material respects, such as for example, the failure to include the correct certified copy, and applicants should ensure that there is sufficient time to remedy any defects.” It’s recommended to file priority papers as early as possible to allow time for correction if needed.

When multiple parties submit conflicting ownership claims for a patent application, the USPTO has a process to determine which party, if any, will control the prosecution. According to MPEP 325 and 37 CFR 3.73(c)(3):

“Where two or more purported assignees file conflicting 37 CFR 3.73(c) statements in an application or other Office proceeding, the Director will determine which, if any, purported assignee will be permitted to control prosecution of the application.”

The process typically involves the following steps:

  1. The Office official in charge of the application forwards the case to the Office of Patent Legal Administration.
  2. The Office of Patent Legal Administration reviews the conflicting claims and makes a determination.
  3. Generally, the current applicant is allowed to continue prosecution while the dispute is resolved.
  4. The other party claiming ownership may consider filing their own separate application.

It’s important to note that this process is primarily for determining who controls the prosecution of the application. It does not resolve underlying ownership disputes, which may need to be settled through other legal channels.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What happens if there are conflicting correspondence addresses in a patent application?

When conflicting correspondence addresses are present in a patent application, the USPTO follows specific guidelines to determine which address to use. According to MPEP 601.03:

“Where more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.”

In practice, this means:

  • The USPTO will choose one address to use for correspondence.
  • If a Customer Number is provided, it’s likely to be preferred over a typed address.
  • To avoid confusion, it’s best to ensure that only one clear correspondence address is specified in your application.

To learn more:

If the USPTO receives a document without a date of receipt stamp, the Office will assign the document a date of receipt based on other evidence. This may include:

  • The date of receipt indicated on an Express Mail label
  • The date of deposit indicated on a certificate of mailing
  • The date of transmission indicated on a certificate of transmission
  • Other corroborating evidence, such as a postmark on an envelope

In cases where no other evidence is available, the USPTO may assign the date of receipt as the date the document was matched with the file wrapper.

If the USPTO is unable to retrieve a priority document through the Priority Document Exchange (PDX) program, the following occurs:

  • The USPTO will notify the applicant of the unsuccessful retrieval attempt.
  • The applicant will then be required to submit the certified copy of the foreign application.

According to MPEP 215.01, If the foreign certified copy is not received by the USPTO within the pendency of the application and before the patent is granted, the USPTO will notify the applicant that the certified copy of the foreign application has not been received and require the certified copy. It’s crucial for applicants to monitor the status of their priority document and be prepared to submit a certified copy if the electronic retrieval is unsuccessful.

To learn more:

If the USPTO is closed on the priority deadline day, the deadline is extended to the next business day when the office is open. This applies to both scheduled and unscheduled closings.

The MPEP states: When the entire U.S. Patent and Trademark Office is officially closed for business for an entire day, for reasons due to adverse weather or other causes, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21. Any action or fee due on such a day may be taken, or fee paid, on the next succeeding business day the Office is open. (MPEP 213.03)

However, it’s important to note that if the USPTO is open for any part of a business day, papers are due on that day even if the office closes early or opens late due to an unscheduled event.

To learn more:

If the USPTO finds an inventor’s oath or declaration defective, the following actions may occur:

  • For non-reissue applications filed before allowance, non-examiner staff will review the oath or declaration and may send an informational notice about deficiencies.
  • For applications at or after allowance, non-examiner staff will review the oath or declaration and send a requirement to correct any deficiencies.
  • If the oath or declaration is not submitted by the time of allowance, a notice requiring it may be sent with the Notice of Allowability.

As stated in the MPEP, The required inventor’s oath or declaration must be submitted no later than the date on which the issue fee is paid. See 35 U.S.C. 115(f).

To learn more:

If the USPTO fails to retrieve a priority document through the exchange program, the applicant is notified and given an opportunity to correct the issue. According to MPEP 215.02(a):

“If the USPTO is unable to retrieve a copy of the foreign application to which priority is claimed, the applicant will be notified and given an opportunity to provide the missing priority document.”

This ensures that applicants have a chance to submit the required documents manually if the automated system fails.

To learn more:

If the USPTO cannot locate a file after a reasonable search, they will notify the applicant or patentee and set a time period for compliance. According to 37 CFR 1.251(a), the applicant or patentee must respond by:

  • Providing a copy of their record of correspondence with the USPTO
  • Producing their record for the USPTO to copy
  • Stating that they do not possess any record of correspondence

The specific requirements are outlined in the notice and must be followed to avoid potential consequences.

To learn more:

If the specific reference to a prior-filed application is not submitted within the required time period, it is considered a waiver of any benefit claim to that prior application. The MPEP states:

This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).

However, there is a possibility to accept a late benefit claim. The MPEP provides that: A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

Such a petition must include:

  1. The reference to the prior application
  2. The petition fee
  3. A statement that the delay was unintentional

The Director may require additional information to verify that the delay was indeed unintentional.

For more information on unintentional delay, visit: unintentional delay.

For more information on waiver, visit: waiver.

If the required translation or statement is missing for a non-English provisional application, the following consequences apply:

  1. The USPTO will issue a notice stating that the required documents are missing.
  2. The applicant must supply the missing translation and/or statement in the provisional application.
  3. The applicant must provide confirmation in the present application that the translation and statement were filed in the provisional application.
  4. If these requirements are not met within the time period set by the USPTO, the present application will be abandoned.

As stated in the MPEP, If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned. See 37 CFR 1.78.

For more information on application abandonment, visit: application abandonment.

For more information on missing documents, visit: missing documents.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If the required translation and statement are not filed for a non-English provisional application, serious consequences can occur. According to MPEP ¶ 2.38:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This means that if you fail to provide the English translation and accuracy statement in the provisional application, and fail to confirm their filing in the present application, your current application may be abandoned. It’s crucial to comply with these requirements within the specified time frame to maintain your application’s active status.

For more information on application abandonment, visit: application abandonment.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

If the reference to a prior application is not in the first sentence of the specification, it may still be acceptable under certain conditions. According to MPEP 211.02:

If the reference to the prior application is not in the first sentence of the specification, it may be given limited review. For example, if an application is filed with a preliminary amendment which is present on filing and which contains a reference to the prior application, the application will be taken up for review by the Office of Patent Application Processing (OPAP). OPAP will mail a ‘Notice of Incomplete Application’ indicating that the reference to the prior application needs to be in the first sentence(s) of the specification.

In such cases, the applicant will be given an opportunity to correct the placement of the reference. It’s important to note that while this situation can be remedied, it’s always best practice to include the reference in the first sentence of the specification to avoid potential delays or complications.

To learn more:

Tags: OPAP

What happens if the prior-filed application is a provisional application?

When the prior-filed application is a provisional application, special considerations apply:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (or 14 months with a petition for revival).
  • The provisional application must have adequate written description and enablement support for the claimed invention in the later-filed nonprovisional application.
  • As stated in MPEP 211.01(a): “The 12-month period is subject to 35 U.S.C. 21(b) and 37 CFR 1.7(a).”

It’s important to note that provisional applications cannot claim priority to earlier applications, so the benefit claim can only extend back to the provisional application’s filing date.

To learn more:

If the Office of Patent Application Processing (OPAP) finds patent drawings unacceptable, the following process occurs:

  1. OPAP sends a Notice to File Corrected Application Papers to the applicant.
  2. The applicant is given a two-month period from the mailing date to file acceptable drawings.
  3. This period is extendable under 37 CFR 1.136(a).
  4. The application will not be released to the Technology Centers until acceptable drawings are filed.

As stated in the MPEP: OPAP will send a Notice to File Corrected Application Papers if the drawings are unacceptable for purposes of publication. The notice will give applicant a time period of two (2) months from the mailing date of the notice to file acceptable drawings. This time period for reply is extendable under 37 CFR 1.136(a).

To learn more:

If the Office of Data Management receives drawings that cannot be scanned or are otherwise unacceptable for publication, they will take the following action:

If the Office of Data Management receives drawings that cannot be scanned or are otherwise unacceptable for publication, the Office of Data Management will mail a requirement for corrected drawings, giving applicant a shortened statutory period of two months to reply.

This process ensures that only high-quality, publishable drawings are included in the final patent publication. Applicants should be prepared to respond quickly to such requests to avoid delays in the patent granting process.

To learn more:

If the national stage requirements are not met within the time limit, the application will be considered abandoned. However, there are provisions for reviving an abandoned application under certain circumstances.

MPEP 601.04 explains: “If the basic national fee and copy of the international application are not filed by the expiration of the applicable time period set in 35 U.S.C. 371(b), the application will be considered to be abandoned.” However, the MPEP also notes that “a petition to revive under 37 CFR 1.137 may be granted if the delay was unintentional.”

To learn more:

When the legal representative of a deceased inventor is unavailable, the process depends on whether the application was filed before or after September 16, 2012:

  • For applications filed before September 16, 2012: If the legal representative cannot be found or reached after diligent effort, or refuses to make application, pre-AIA 37 CFR 1.47 applies. In such cases, the last known address of the legal representative must be provided.
  • For applications filed on or after September 16, 2012: The provisions of pre-AIA 37 CFR 1.47 do not apply. Instead, refer to current USPTO regulations and procedures.

It’s important to note that pre-AIA 37 CFR 1.47 is not an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 for deceased inventors. As stated in the MPEP, Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

To learn more:

If the last-known address of an unavailable inventor is invalid, the petitioner must make a diligent effort to find a valid address. According to MPEP 409.03(b):

‘If the last known address of the nonsigning inventor(s) is invalid, petitioner must state what efforts were made to find a current address.’

This means the petitioner should document their attempts to locate the inventor, which may include searching public records, contacting former employers, or using people-finding services. If all efforts fail, this should be clearly stated in the petition.

To learn more:

What happens if the foreign application is not in English?

If the foreign application is not in English, the applicant must provide an English translation of the non-English language application and a statement that the translation is accurate. According to MPEP 213.02:

‘If the foreign application is not in the English language, the applicant must provide an English translation of the non-English language application and a statement that the translation is accurate.’

This requirement ensures that the USPTO can properly examine the application and determine its priority date. The translation and statement must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To learn more:

If the filing fee for a provisional application is not paid, the USPTO will take specific actions as outlined in MPEP 601.01(b):

Quote: “If the filing fee is not paid in the provisional application, the USPTO may dispose of the provisional application. The notification to applicant that the provisional application has been disposed of will include a notice that if the fee is paid within two months of the date of the notification, the provisional application will be revived.”

Key points to remember:

  • The USPTO may dispose of the provisional application if the fee is not paid
  • Applicants will be notified of the disposal
  • There is a two-month window to pay the fee and revive the application
  • If the fee is paid within this period, the application will be revived

It’s crucial to note that if the application is not revived within the two-month period, the opportunity to establish that filing date may be permanently lost, which could have significant implications for patent rights.

To learn more:

If an applicant pays an insufficient fee to the USPTO, the Office will notify the applicant and provide an opportunity to submit the remaining balance. According to MPEP 509:

If the fee paid by the applicant is insufficient, either because the notice specified an incorrect dollar amount for the fee or because of a fee increase effective after the mailing of the notice and before payment of the fee by the applicant, the applicant should be notified in writing by the Office of the fee insufficiency and given a new time period in which to submit the remaining balance.

The notification will include:

  • The reason for the additional fee requirement
  • An explanation of why the original fee was incorrect or insufficient
  • A new time period for submitting the remaining balance

This process helps ensure that applicants have a fair opportunity to complete their fee payments and avoid abandonment of their applications due to fee issues.

To learn more:

If an examiner determines that a continuation or divisional application contains new matter relative to the prior application, the following steps will occur:

  1. The examiner will notify the applicant in the next Office action.
  2. The examiner will indicate that the application should be redesignated as a continuation-in-part (CIP).

According to MPEP 602.05: If the examiner determines that the continuation or divisional application contains new matter relative to the prior application, the examiner should so notify the applicant in the next Office action and indicate that the application should be redesignated as a continuation-in-part.

It’s important to note that:

  • Continuations and divisionals should not contain new matter relative to the prior application.
  • If new matter is present, the application is more appropriately designated as a continuation-in-part.
  • The redesignation as a CIP may have implications for the oath or declaration requirements and the application’s effective filing date for the new subject matter.

Applicants should carefully review their applications to ensure they are correctly designated and contain appropriate oaths or declarations based on their content and relationship to the prior application.

To learn more:

If the drawings in a patent application are not in compliance with the rules, the Office of Patent Application Processing (OPAP) will send a Notice to File Corrected Application Papers. This notice gives the applicant a time period of 2 months from the mailing date to file corrected drawings. The time period is extendable under 37 CFR 1.136(a). If corrected drawings are not timely filed, the application will be held abandoned.

If the date of receipt stamp is illegible or missing, the USPTO will make every effort to determine the correct date of receipt. This may involve examining other evidence, such as postmarks, electronic filing receipts, or other documentation. If the correct date cannot be determined, the USPTO may use the date it was discovered that the document was received as the date of receipt. Applicants should always ensure that their submissions are properly dated and stamped to avoid potential issues with filing dates.

If the certified copy of the foreign application is filed after the issue fee is paid but before the patent is granted, the following occurs:

  • The priority claim or certified copy will be placed in the file record
  • There will be no review of the papers
  • The published patent will not include the priority claim

To have the priority claim considered after publication, a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 must be filed. For original applications filed under 35 U.S.C. 111(a), additional requirements may apply, such as a petition to accept an unintentionally delayed priority claim.

This is outlined in MPEP 215.03.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on certified copy, visit: certified copy.

For more information on issue fee, visit: issue fee.

If the certified copy of the foreign application is filed after the date the issue fee is paid but prior to the date of grant of the patent, it will be placed in the file record but there will be no review of the papers. The patent when published will not include the priority claim. A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 can be filed to have the priority claim considered after publication of the patent.

If the Certificate of Mailing or Transmission is omitted from a paper, the USPTO will treat the paper as though it was not received. According to MPEP 512:

“If the certification of mailing or transmission is omitted and the paper is later received by the U.S. Patent and Trademark Office, the paper will be considered as having been filed as of the date of receipt in the Office.”

This means that without the certificate, the paper’s filing date will be the actual date it’s received by the USPTO, which could potentially be later than intended and may have significant consequences for patent applications or other time-sensitive submissions.

To learn more:

What happens if the basic national fee is not paid on time for US national stage entry?

If the basic national fee is not paid on time for US national stage entry, the application will be considered abandoned. However, the MPEP provides guidance on potential remedies:

If the basic national fee is not paid on time, the Designated (or Elected) Office will declare that the application is considered withdrawn under PCT Article 24(1) or 39(2). However, if the basic national fee is paid later, accompanied by a petition for revival, the Designated (or Elected) Office may excuse the late payment of the basic national fee.

This means that while timely payment is crucial, there may be options to revive the application if the fee is paid late. Applicants should be aware that such petitions typically involve additional fees and are subject to specific requirements and time limits.

To learn more:

If the basic filing fee is not paid when filing a Continued Prosecution Application (CPA), the USPTO will send a notice to the applicant. According to MPEP 201.06(d):

‘If the basic filing fee is not paid when the CPA is filed or within the time period set forth in a notice from the Office, the USPTO will send a Notice to File Missing Parts in the CPA.’

This notice gives the applicant a chance to pay the fee and continue the application process. However, it’s important to note that failing to respond to this notice or pay the required fee within the specified time frame could result in the CPA being abandoned. It’s always best practice to submit all required fees at the time of filing to avoid potential delays or complications in the patent application process.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on Notice to File Missing Parts, visit: Notice to File Missing Parts.

If the assignment has not been recorded before the issue fee payment, the following applies:

  • The request for issuance to the assignee must state that the assignment document has been filed for recordation.
  • This statement should be made in accordance with 37 CFR 3.11.

As stated in 37 CFR 3.81(a): If the assignment has not been previously recorded, the request must state that the document has been filed for recordation as set forth in § 3.11.

If the assignee’s name and address are not identified in item 3 of the Fee(s) Transmittal form (PTOL-85B), the following occurs:

  • The patent will issue to the applicant instead of the assignee.
  • Assignment data printed on the patent will be based solely on the information supplied on the PTOL-85B form.

As stated in the MPEP: Unless an assignee’s name and address are identified in item 3 of the Fee(s) Transmittal form PTOL-85B, the patent will issue to the applicant. Assignment data printed on the patent will be based solely on the information so supplied.

It’s crucial for applicants and assignees to ensure that the correct information is provided on the PTOL-85B form to avoid any issues with patent issuance to the intended party.

If the submitted drawing corrections or changes are not accepted, the examiner will notify the applicant in the next Office action. The MPEP 608.02(x) specifies:

“Where the corrected or changed drawing is not accepted, for example, because the submitted corrections or changes are erroneous, or involve new matter or do not include all necessary corrections, the applicant will be notified and informed of any required corrective action in the next Office action.”

The examiner is required to provide a clear explanation of why the corrections were not approved and what actions the applicant needs to take to address the issues.

To learn more:

To learn more:

If an applicant files an amendment stating that replacement sheets of drawings are included, but these drawings are not found in the Image File Wrapper (IFW), the examiner must take specific action. According to MPEP 608.02(h):

“When an amendment is filed stating that replacement sheets of drawings are filed with the amendment and such drawings are not in the IFW, in the next communication by the examiner, the applicant must be notified that replacement drawings do not appear to have been received and thus have not been entered in the application.”

This notification ensures that the applicant is aware of the missing drawings and can take appropriate action to submit them. It’s important to note that the USPTO will not return drawings to the applicant, as stated in MPEP § 608.02(y).

To learn more:

If prior art figures are not properly labeled in a patent application, the patent examiner will likely issue an objection. According to MPEP 608.02(g), examiners may use form paragraph 6.36.01 to address this issue:

Figure [1] should be designated by a legend such as –Prior Art– because only that which is old is illustrated. See MPEP § 608.02(g). Corrected drawings in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application.

This objection requires the applicant to submit corrected drawings with proper labeling. The MPEP further states that The replacement sheet(s) should be labeled ‘Replacement Sheet’ in the page header (as per 37 CFR 1.84(c)) so as not to obstruct any portion of the drawing figures. If the corrections are not made, the objection will be maintained in subsequent Office actions.

To learn more:

What happens if PDX retrieval of a priority document fails?

If the PDX (Priority Document Exchange) retrieval of a priority document fails, the USPTO will notify the applicant. As stated in MPEP 215.01: The USPTO will notify the applicant of any unsuccessful attempt to electronically retrieve a priority document.

In such cases:

  • The applicant will be given additional time to provide the priority document.
  • The applicant may need to submit a certified copy of the priority document directly.
  • If using WIPO DAS, the applicant should check if the access code is correct and the document is available in the system.
  • The applicant may need to contact the foreign office to ensure the document is accessible through PDX or WIPO DAS.

It’s important to address any retrieval issues promptly to ensure the priority claim is properly documented in the application.

To learn more:

If patent drawings do not comply with the requirements set forth in MPEP 608.02(d), the following process occurs:

  1. The examiner will require additional illustration
  2. A notice will be sent to the applicant
  3. The applicant will have at least two months from the date of the notice to submit corrected drawings
  4. Corrections must comply with 37 CFR 1.81(d)

According to the MPEP: Where the drawings in a nonprovisional application do not comply with the requirements of paragraphs (a) and (b) of this section, the examiner shall require such additional illustration within a time period of not less than two months from the date of the sending of a notice thereof. This process ensures that all necessary details are properly illustrated before the application can proceed.

To learn more:

If OPAP objects to the drawings in a patent application, the following process occurs:

  1. OPAP sends a Notice to the applicant requiring submission of corrected drawings.
  2. The Notice typically sets a time period of two months for response.
  3. Corrected drawings must be filed in paper form to the mailing address specified in the Notice.
  4. No fee is required for filing the corrected drawings requested by OPAP.

MPEP 507 states:

If OPAP objects to the drawings and sends applicant a Notice requiring submission of corrected drawings within a set time period (usually two months), corrected drawings must be filed, in paper, to the mailing address set forth in the Notice, along with any other items required by OPAP, to avoid abandonment of the application. No fee will be necessary for filing corrected drawings which are required by OPAP.

It’s crucial to respond within the set time period to avoid potential abandonment of the application.

What happens if not all joint inventors sign a power of attorney in a patent application?

If not all joint inventors sign a power of attorney in a patent application, the power of attorney is not effective. According to MPEP 402.10:

A power of attorney must be signed by all of the applicants, or all of the assignees of the entire interest, or all parties entitled to prosecute the application, unless otherwise specified.

This means that for the power of attorney to be valid, it must be signed by all parties with the right to prosecute the application. If some inventors haven’t signed, the USPTO will treat the application as if no power of attorney has been appointed.

To learn more:

What happens if not all inventors sign the power of attorney in a pre-September 16, 2012 application?

For applications filed before September 16, 2012, it’s crucial that all inventors who have not assigned their rights sign the power of attorney. According to MPEP 402.02(b):

If no power of attorney is on file, then a party who is not an inventor, but who has given a proper showing of ownership or of authority to take action for and on behalf of all of the applicant may appoint an attorney or agent to prosecute the application, subject to the same exception noted above.

If not all inventors sign, the power of attorney may be considered incomplete or invalid. In such cases, the USPTO may require a new power of attorney signed by all parties with the right to prosecute the application, or may accept communications only from the inventors themselves until the issue is resolved.

To learn more:

Introducing new matter in a divisional application is not allowed and can have serious consequences. According to MPEP 201.06:

“A divisional application is a later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application.”

This means that a divisional application must not contain any new matter beyond what was disclosed in the parent application. If new matter is introduced:

  • The new matter will not be entitled to the benefit of the parent application’s filing date.
  • Claims relying on the new matter may be rejected under 35 U.S.C. 112(a) for lack of written description or enablement.
  • The application may lose its status as a proper divisional, potentially affecting its ability to overcome certain types of double patenting rejections.

To avoid these issues:

  1. Carefully review the divisional application before filing to ensure it only contains subject matter from the parent application.
  2. If new subject matter is necessary, consider filing it as a continuation-in-part (CIP) application instead of a divisional.
  3. Consult with a patent attorney or agent to ensure compliance with MPEP guidelines.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent filing, visit: patent filing.

If your USPTO deposit account becomes overdrawn, several consequences may occur:

  1. Account Suspension: The MPEP states, An overdrawn account will be immediately suspended and no charges will be accepted against it until a proper balance is restored, together with a payment of $10 (37 CFR 1.21(b)(1)) to cover the work done by the U.S. Patent and Trademark Office incident to suspending and reinstating the account and dealing with charges which may have been made in the meantime.
  2. Additional Surcharges: If there’s an authorization to charge a basic filing fee to an overdrawn account, a surcharge under 37 CFR 1.16(f) is required in addition to the basic filing fee.
  3. Potential Abandonment: The MPEP warns, Failure to timely pay the filing fee and surcharge will result in abandonment of the application.
  4. Account Closure: Repeated overdrafts may lead to account closure. If an account is suspended repeatedly it will be closed.

To avoid these issues, always maintain sufficient funds in your deposit account and monitor your account balance regularly.

To learn more:

Tags: USPTO

What happens if my USPTO deposit account balance falls below the minimum?

If your USPTO deposit account balance falls below the minimum required balance of $1,000, there are consequences. According to MPEP 509.01, “An account holder who does not maintain the minimum balance will be notified and given a reasonable time to restore the account to the minimum balance.” If the account is not replenished:

  • The USPTO may close the account.
  • Any fees charged against the account may be treated as unpaid.
  • This could potentially affect the status of your patent applications or other USPTO services.

It’s crucial to monitor your account balance regularly and replenish it promptly when it approaches the minimum to avoid any disruptions in service or potential issues with your patent applications.

To learn more:

If correspondence with a Certificate of Mailing or Transmission is not received by the USPTO after a reasonable amount of time, you can take steps to notify the Office and provide evidence of the previous timely filing. According to 37 CFR 1.8(b):

In the event that correspondence is considered timely filed by being mailed or transmitted in accordance with paragraph (a) of this section, but not received in the U.S. Patent and Trademark Office after a reasonable amount of time has elapsed from the time of mailing or transmitting of the correspondence […] the correspondence will be considered timely if the party who forwarded such correspondence: (1) Informs the Office of the previous mailing or transmission of the correspondence promptly after becoming aware that the Office has no evidence of receipt of the correspondence; (2) Supplies an additional copy of the previously mailed or transmitted correspondence and certificate; and (3) Includes a statement that attests on a personal knowledge basis or to the satisfaction of the Director to the previous timely mailing, transmission or submission.

It’s recommended to check the private Patent Application Information Retrieval (PAIR) System first to see if the correspondence has been entered into the application file before notifying the Office.

When multiple correspondence addresses are provided in a patent application, the USPTO will select one of the specified addresses for use. According to MPEP 601.03(a):

If more than one correspondence address is specified, whether in a single paper or in multiple papers, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

It’s important to note that if the USPTO doesn’t select the address you intended, they will not remail papers to your desired address. To avoid confusion, it’s best to provide clear instructions regarding the correspondence address you wish to use.

To learn more:

What happens if joint inventors can’t agree on filing a patent application?

If joint inventors cannot agree on filing a patent application, it can lead to complications. According to MPEP 602.09, ‘Each joint inventor may make the application for patent on behalf of himself and the other joint inventors.’ This means that any one of the joint inventors can file the application without the consent of the others. However, this situation may lead to disputes and potential legal issues. It’s generally recommended that joint inventors try to reach an agreement or seek legal counsel to resolve any disagreements before filing.

To learn more:

What happens if I wrongly claim small entity status?

Wrongly claiming small entity status can have serious consequences. According to MPEP 509.03:

“Improperly and with intent to deceive establishing status as a small entity, or paying fees as a small entity, shall be considered as a fraud practiced or attempted on the Office.”

The consequences of fraudulently claiming small entity status may include:

  • Requirement to pay all fee deficiencies
  • Possible invalidation of the patent
  • Potential legal action for fraud

If you discover an error in your small entity claim, it’s crucial to promptly notify the USPTO and pay any fee deficiencies. Honest mistakes, if corrected in good faith, are generally not considered fraud.

To learn more:

Tags: USPTO fees

If you submit an Application Data Sheet (ADS) after the filing date of your patent application, it is considered a supplemental ADS. According to MPEP 601.05(a):

A supplemental ADS that is filed after the initial filing date of the application is not part of the original application papers, but is the paper that will be used to correct the bibliographic information in the Office’s records.

This means that while the supplemental ADS can be used to update or correct information, it doesn’t become part of the original application. Any changes made through a supplemental ADS may require additional fees or actions, such as a petition under 37 CFR 1.78 for late claims of priority.

To learn more:

If you submit an amendment to reference the prior application in a Continued Prosecution Application (CPA), it will not be entered by the USPTO.

The MPEP ¶ 2.34 clearly states: “The amendment filed [1] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [2] application of Application No. [3] has not been entered.”

Furthermore, the MPEP adds: “any such amendment shall be denied entry.” This means that even if you submit such an amendment, it will be rejected, and the examiner will use this form paragraph to inform you of the denial.

If you submit an amendment to refer to a Continued Prosecution Application (CPA) as a continuation or divisional application, it will be denied entry by the patent examiner. The MPEP ¶ 2.34 states:

“Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This means that the patent examiner will not accept or incorporate such amendments into the application. The CPA itself serves as the necessary reference to the prior application, making additional amendments unnecessary and inappropriate.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

What happens if I submit a non-original assignment document for recording?

If you submit a non-original assignment document for recording, it will be rejected by the USPTO. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording. Therefore, customers must submit copies of the documents to be recorded, rather than originals.’ This means that while you should submit a copy, it must be a true and complete copy of the original document. Submitting altered or incomplete copies may result in rejection and delay the recording process.

What happens if I overpay a patent fee to the USPTO?

If you overpay a patent fee to the USPTO, you may be eligible for a refund. The MPEP 509 states: ‘In the event that an amount is paid by mistake or in excess of that required, a refund may be made only if a petition for refund is filed within 2 years after the date the fee was paid.’

To request a refund:

  1. File a petition for refund within 2 years of the payment date
  2. Clearly explain the reason for the overpayment
  3. Provide evidence of the overpayment

It’s important to note that not all overpayments are automatically refunded, so proactive action is necessary to recover excess fees.

To learn more:

What happens if I overpaid fees due to incorrect micro entity status?

If you paid fees as a non-micro entity when you were actually entitled to micro entity status, resulting in an overpayment, you may be eligible for a refund. The MPEP 509.04(f) states:

“A refund based upon establishment of micro entity status may only be obtained if an assertion of micro entity status, in compliance with 37 CFR 1.29(a), is filed within the time period set forth in 37 CFR 1.29(k) … The time period set forth in 37 CFR 1.29(k) is: the later of 1) three months from the date of the fee payment claimed to be in error; or 2) the processing of a request for refund.”

To request a refund:

  • File a compliant micro entity certification
  • Submit a timely refund request
  • Ensure you meet the time constraints specified in 37 CFR 1.29(k)

It’s important to act promptly if you believe you’ve overpaid due to an incorrect entity status.

To learn more:

Tags: patent fees

What happens if I need to change the order of benefit claims in my patent application?

Changing the order of benefit claims in a patent application requires specific actions, as outlined in MPEP 211.02(a):

“If applicant needs to change the order of benefit claims presented in an application data sheet or patent, applicant must file a corrected application data sheet under 37 CFR 1.76(c) or a Certificate of Correction, as appropriate.”

The method you choose depends on the status of your application:

  • For pending applications: File a corrected Application Data Sheet (ADS) under 37 CFR 1.76(c).
  • For issued patents: File a Certificate of Correction.

It’s important to note that changing the order of benefit claims may affect the effective filing date of your application, which could impact patentability considerations.

To learn more:

If you miss the deadline for submitting a benefit claim, you may still be able to claim the benefit by filing a petition. According to MPEP 211.02:

A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

The petition must include:

  • The reference to the prior application (unless previously submitted)
  • The petition fee under 37 CFR 1.17(m)
  • A statement that the entire delay was unintentional

The Director may require additional information if there’s a question about whether the delay was unintentional. It’s important to note that accepting a late benefit claim is at the discretion of the USPTO and is not guaranteed.

For more information on unintentional delay, visit: unintentional delay.

For more information on USPTO, visit: USPTO.

If you miss the deadline for filing a priority claim in a U.S. patent application, you may still have options, but they are limited:

  • Petition for Unintentional Delay: You can file a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e). This petition must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.
  • Continuation-in-Part (CIP) Application: If the deadline has passed and you can’t file a petition, you might consider filing a CIP application, which allows you to claim priority to the earlier application while also adding new matter.
  • Consequences: Failing to properly claim priority can affect the patent’s validity and enforceability, particularly if prior art emerges in the intervening period between the foreign filing and the U.S. filing.

As stated in MPEP 214.01: “The claim for priority must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application in an original application filed under 35 U.S.C. 111(a).”

To learn more:

To learn more:

If you miss the deadline for filing a foreign priority claim, you may still have options:

  • Unintentional delay: You can file a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e). This petition must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.
  • Design applications: For design applications, you can file this petition up to the date of payment of the issue fee.

The MPEP states: The Director may accept an unintentionally delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), or 365(a) or (b) in an application for patent filed on or after November 29, 2000, upon petition pursuant to 37 CFR 1.55(e).

It’s important to note that the petition must include a statement that the entire delay was unintentional, and you may need to provide additional evidence to support this claim.

What happens if I miss the 12-month deadline for filing a U.S. nonprovisional application claiming priority to a foreign application?

If you miss the 12-month deadline for filing a U.S. nonprovisional application claiming priority to a foreign application, you may still be able to file the application, but you’ll lose the right to claim priority to the foreign application. The MPEP states:

“An applicant who files a nonprovisional application after the 12-month priority period (or 6-month priority period in the case of a design application) will not be able to claim priority to the foreign-filed application in the later-filed nonprovisional application.” (MPEP 213.03)

In such cases, your U.S. application will be treated as a new application without the benefit of the earlier filing date. This can have significant implications, especially if any public disclosures or other prior art have been published in the intervening time.

To learn more:

What happens if I miss the 12-month deadline for filing a nonprovisional application?

If you miss the 12-month deadline for filing a nonprovisional application claiming the benefit of a provisional application, you generally lose the ability to claim that earlier filing date. The MPEP 201.04 states:

“If a provisional application is not filed in compliance with 35 U.S.C. 119(e) and 37 CFR 1.53(c), the provisional application is not entitled to the benefit of the filing date of the provisional application.”

Consequences of missing the deadline include:

  • Loss of the earlier filing date
  • Potential issues with prior art that emerged during the 12-month period
  • Possible loss of patent rights in some jurisdictions

In some cases, you may be able to file a petition for an unintentional delay under 37 CFR 1.78(c), but this is not guaranteed and may involve additional fees. It’s crucial to monitor deadlines carefully to avoid these issues.

For more information on filing deadline, visit: filing deadline.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent priority, visit: patent priority.

For more information on provisional application, visit: provisional application.

What happens if I miss the 12-month deadline for filing a nonprovisional application after a provisional application?

If you miss the 12-month deadline for filing a nonprovisional application claiming the benefit of a provisional application, you lose the right to claim that benefit. The MPEP states: A provisional application is not entitled to the right of priority under 35 U.S.C. 119(e) unless the full fee set forth in 37 CFR 1.16(d) has been paid and the basic filing fee set forth in 37 CFR 1.16(a) has been paid on or before the date the provisional application was filed. (MPEP 201.04) Additionally, you cannot extend this 12-month period. However, you may still file a nonprovisional application; it just won’t have the earlier priority date of the provisional application.

To learn more:

To learn more:

What happens if I lose micro entity status during the patent process?

If you lose micro entity status during the patent process, you must notify the USPTO promptly. The MPEP states:

“A micro entity that no longer meets the requirements for micro entity status at a point in time when a fee is due is treated as a small entity for purposes of paying the fee if the applicant or patentee is otherwise eligible for small entity status.”

This means:

  • You must file a notification of loss of entitlement to micro entity status.
  • If you still qualify as a small entity, you can pay fees at the small entity rate.
  • If you no longer qualify as a small entity, you must pay fees at the standard (large entity) rate.

It’s important to note that continuing to pay fees at the micro entity rate when you no longer qualify can result in the patent being held unenforceable. For more details, refer to MPEP 509.04(e).

To learn more:

If you lose entitlement to micro entity status, you must:

  1. File a notification of loss of entitlement to micro entity status in the application or patent
  2. Pay the required fee in the small entity or undiscounted amount, as appropriate

The notification must be filed prior to or at the time of paying the earliest fee after the date on which status as a micro entity is no longer appropriate. As stated in 37 CFR 1.29(i): ‘Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.’

If you intentionally omit material from your application that was present in a prior-filed application, the omitted material will not automatically be incorporated by reference under 37 CFR 1.57(b). The MPEP clarifies:

“Applicants can still intentionally omit material contained in the prior-filed application from the application containing the priority or benefit claim without the material coming back in by virtue of the incorporation by reference of 37 CFR 1.57(b). Applicants can maintain their intent by simply not amending the application to include the intentionally omitted material.”

In other words, the incorporation by reference under 37 CFR 1.57(b) only applies to inadvertently omitted material. If you choose not to include certain material from the prior application, it will remain omitted unless you specifically amend your application to include it.

If you identify a new inventor in a Continued Prosecution Application (CPA) without filing a request under 37 CFR 1.48, the inventorship will not be officially changed. The MPEP clearly states: ‘It is noted that [new inventor] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [filing date], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.’ In such cases, the inventorship in the CPA will remain the same as in the prior application, despite the attempt to name a new inventor.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

When multiple foreign applications are filed for the same invention, the right of priority is generally based on the earliest filed application. MPEP 213.03 explains: ‘The twelve months is from earliest foreign filing except as provided in 35 U.S.C. 119(c). If an inventor has filed an application in France on October 4, 1981, and an identical application in the United Kingdom on March 3, 1982, and then files in the United States on February 2, 1983, the inventor is not entitled to the right of priority at all; the inventor would not be entitled to the benefit of the date of the French application since this application was filed more than twelve months before the U.S. application, and the inventor would not be entitled to the benefit of the date of the United Kingdom application since this application is not the first one filed.’

However, if the later application contains additional subject matter, a claim specifically limited to that additional disclosure may be entitled to the priority date of the later foreign application.

If you file a U.S. patent application more than 12 months after your foreign filing, your claim for priority based on that foreign application may be denied. The MPEP states:

The claim for priority cannot be based on said application, because the subsequent nonprovisional or international application designating the United States was filed more than twelve months thereafter and no petition under 37 CFR 1.55 or request under PCT Rule 26bis.3 to restore the right of priority has been granted.

However, you may still have options to restore your priority claim under certain circumstances.

For more information on 12-month rule, visit: 12-month rule.

For more information on foreign priority, visit: foreign priority.

What happens if I file a provisional application without meeting all the requirements?

If you file a provisional application that doesn’t meet all the requirements, it may not be granted the filing date you intended. The MPEP states: If a provisional application does not contain a cover sheet identifying it as a provisional application, it will be treated as a nonprovisional application. This means:

  • Your application might be processed as a nonprovisional application, which has different requirements and fees.
  • You could lose the intended filing date, which is crucial for establishing priority.
  • The USPTO may send you a notice of missing parts, giving you a chance to correct the deficiencies.

It’s crucial to ensure all requirements are met when filing a provisional application to avoid these complications.

For more information on filing requirements, visit: filing requirements.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

What happens if I file a provisional application with multiple inventors?

When filing a provisional application with multiple inventors, it’s important to note that:

  • All inventors must be named in the application.
  • Each inventor must sign an oath or declaration, either in the provisional application or in the later-filed nonprovisional application.
  • The inventorship of the provisional application should match that of any subsequent nonprovisional application claiming benefit.

According to MPEP 201.04: “The inventorship of a provisional application is that inventorship set forth in the cover sheet as prescribed by 37 CFR 1.51(c)(1) filed with the provisional application.” This means that the cover sheet must accurately reflect all inventors involved in the invention described in the provisional application.

To learn more:

What happens if I file a provisional application and don’t file a nonprovisional within 12 months?

If you file a provisional application but do not file a corresponding nonprovisional application within 12 months, the provisional application will automatically be abandoned. As stated in the MPEP 201.04: “A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.” This means you lose the benefit of the provisional filing date and cannot claim priority to it in future applications. To maintain the priority benefit, you must file a nonprovisional application claiming benefit of the provisional within the 12-month period.

For more information on application abandonment, visit: application abandonment.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

If you file a nonprovisional application after the 12-month priority period from the filing date of a foreign application, you may still be able to claim priority under certain circumstances:

  • Two-month grace period: The USPTO provides a two-month grace period after the 12-month priority period. During this time, you can file the nonprovisional application with a petition to restore the right of priority.
  • Unintentional delay: The delay in filing must have been unintentional. You’ll need to submit a petition explaining the circumstances.
  • Additional fee: A petition fee is required.

As stated in MPEP 213.03: “A nonprovisional application filed after the 12-month priority period, but within 2 months from the expiration of the 12-month priority period, may be filed with a petition to restore the right of priority.”

It’s important to note that this provision applies to both Paris Convention applications and PCT applications entering the national stage in the United States.

To learn more:

If you file a foreign priority claim after paying the issue fee but before the patent grant:

  • The claim will be placed in the file record
  • There may be no review of the papers
  • The published patent will not include the priority claim

To have the priority claim considered after publication, you will need to file:

  1. A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323
  2. For original applications under 35 U.S.C. 111(a) or 371, a petition to accept an unintentionally delayed claim for priority under 37 CFR 1.55

MPEP 214.03 states: “When the claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but prior to the date of grant of the patent, the foreign priority claim or certified copy will be placed in the file record but there may be no review of the papers and the patent when published will not include the priority claim.”

Filing a foreign patent application without the required foreign filing license can have serious consequences. According to MPEP 140:

‘Inadvertent foreign filing without a license is not uncommon. The patent law provides for petition for retroactive license in such cases.’

However, it’s important to note that:

  • The application may be considered abandoned in the U.S.
  • You may lose the right to obtain a U.S. patent on that invention.
  • There could be criminal penalties under 35 U.S.C. 181 and 35 U.S.C. 186.

If you’ve inadvertently filed without a license, you should immediately seek a retroactive foreign filing license from the USPTO.

For more information on foreign filing license, visit: foreign filing license.

Filing a foreign application without obtaining the required foreign filing license can have serious consequences. According to MPEP 140:

‘If a license is not obtained prior to filing, there is still the possibility of obtaining a license retroactively. … However, a party who files a patent application in a foreign country or under a multinational agreement, without first obtaining a license from the Commissioner when required, shall be barred from receiving a United States patent for the invention under 35 U.S.C. 185.’

In other words, failing to obtain a license can result in being barred from receiving a U.S. patent for the same invention. However, you may be able to obtain a retroactive license in some cases.

For more information on foreign filing license, visit: foreign filing license.

What happens if I fail to underline the entire benefit claim in a corrected ADS?

Failing to properly underline the entire benefit claim in a corrected Application Data Sheet (ADS) can have serious consequences. The MPEP 211.02(a) states:

If the corrected ADS fails to identify the benefit claim with underlining of all text inserted, the Office of Patent Application Processing (OPAP) will not recognize such benefit claim and will not enter such benefit claim information in Office records.

This means that if you don’t underline the entire benefit claim:

  • The USPTO won’t recognize the benefit claim
  • The benefit claim information won’t be entered into official records
  • Your application may lose its priority date

To avoid these issues, always ensure that you underline the entire benefit claim when adding it to a corrected ADS, even if parts of the claim were present in the original ADS.

To learn more:

Tags: ADS

What happens if I fail to notify the USPTO about loss of micro entity status?

Failing to notify the USPTO about the loss of micro entity status can have serious consequences. The MPEP warns:

“Fraudulent assertion of micro entity status is considered a fraud practiced or attempted on the Office.” (MPEP 509.04(f))

Consequences may include:

  • Invalidation of the patent application or granted patent
  • Disciplinary action against registered practitioners
  • Criminal penalties under 18 U.S.C. 1001

It’s crucial to promptly notify the USPTO if you lose eligibility for micro entity status to avoid these severe consequences.

To learn more:

If you fail to make a timely priority claim or submit a certified copy of the foreign application within the required time period, the following may occur:

  • The right of priority may be considered waived
  • The effective filing date of your application may be the actual U.S. filing date, not the foreign filing date
  • Intervening prior art may be applicable against your application

However, 37 CFR 1.55(e) provides for acceptance of a delayed priority claim if:

  • The claim is filed within the pendency of the application
  • A petition is filed with the delayed claim
  • The delay was unintentional
  • The required petition fee is paid

Similarly, 37 CFR 1.55(f) allows for late submission of a certified copy with a petition showing good and sufficient cause for the delay and payment of a fee. It’s always best to make priority claims and submit certified copies timely to avoid potential issues.

What happens if I fail to file a priority claim within the time period set in 37 CFR 1.55?

If you fail to file a priority claim within the time period set in 37 CFR 1.55, your priority claim will be considered waived. The MPEP states: ‘If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’ This means that if you miss the deadline, you may lose the benefit of the earlier filing date, which could potentially affect the patentability of your invention if intervening prior art exists.

To learn more:

To learn more:

What happens if I fail to file a priority claim during the pendency of my application?

If you fail to file a priority claim during the pendency of your application, you may lose the right to claim priority. According to MPEP 213.04:

If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, it must also be accompanied by the processing fee set forth in 37 CFR 1.17(i).

This means that if you miss the deadline to file your priority claim before the issue fee is paid, you’ll need to pay an additional processing fee. Moreover, if the application has already been patented, you cannot file a priority claim retroactively.

It’s crucial to file your priority claim as early as possible during the pendency of your application to avoid potential complications or additional fees.

To learn more:

What happens if I fail to file a nonprovisional application within 12 months of my provisional application?

If you fail to file a nonprovisional application within 12 months of your provisional application’s filing date, you will lose the benefit of the provisional application’s filing date. The MPEP states:

“A provisional application expires 12 months after its filing date and cannot be revived after its expiration to restore it to pending status.” (MPEP 201.04)

This means:

  • You can’t claim priority to the provisional application after the 12-month period.
  • Any public disclosures made during that 12-month period may now be considered prior art against your invention.
  • You may need to file a new application, potentially losing your earlier filing date.

It’s crucial to calendar the 12-month deadline and ensure timely filing of the nonprovisional application to preserve your priority date.

To learn more:

If you erroneously pay small entity fees in good faith, you can correct the error by:

  • Submitting a separate deficiency payment for each application or patent
  • Itemizing the deficiency payment with specific details
  • Paying the full deficiency amount owed

As stated in 37 CFR 1.28(c): “If status as a small entity is established in good faith, and fees as a small entity are paid in good faith, in any application or patent, and it is later discovered that such status as a small entity was established in error, or that through error the Office was not notified of a loss of entitlement to small entity status as required by § 1.27(g)(2), the error will be excused upon: compliance with the separate submission and itemization requirements of paragraphs (c)(1) and (c)(2) of this section, and the deficiency payment requirement of paragraph (c)(2) of this section.”

To learn more:

If you don’t update the specification after canceling a figure, it can lead to confusion and potential issues with your patent application. The MPEP warns: Failure to cancel the description of canceled figures may cause an objection to the specification as failing to comply with 37 CFR 1.74. (MPEP 608.02(t))

Consequences may include:

  • Objections to the specification
  • Confusion during examination
  • Potential delays in processing your application
  • Increased risk of errors or inconsistencies in the patent document

To avoid these issues, always ensure that you update your specification to reflect any changes made to the figures.

To learn more:

If you fail to correct and resubmit the returned assignment documents within the specified time period, the USPTO will consider the date of receipt of the corrected papers as the new recording date. The MPEP 317.02 clearly states:

“If the returned papers are not corrected and resubmitted within the specified period, the date of receipt of the corrected papers will be considered to be the date of recording of the document.”

It’s crucial to note that this may affect the priority date of your assignment, potentially impacting your rights. Additionally, the MPEP emphasizes that “The specified period to resubmit the returned papers will not be extended.” Therefore, it’s essential to act promptly when you receive returned documents to avoid losing the benefit of the original filing date.

To learn more:

What happens if I don’t record an assignment with the USPTO?

Failing to record an assignment with the USPTO can have significant legal implications. According to MPEP 302:

“An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the USPTO within three months from its date or prior to the date of such subsequent purchase or mortgage.”

This means that if you don’t record your assignment:

  • Your ownership rights may not be enforceable against subsequent purchasers or mortgagees who were unaware of the unrecorded assignment.
  • You may face difficulties in proving ownership in legal proceedings or licensing negotiations.
  • It could complicate future transfers or financial transactions involving the patent or application.

To protect your interests, it’s crucial to record assignments promptly with the USPTO, ideally within three months of the assignment date or before any subsequent transactions occur.

For more information on legal implications, visit: legal implications.

For more information on USPTO procedures, visit: USPTO procedures.

If you fail to provide the required English translation and statement of accuracy for a non-English provisional application, your current application may be abandoned. The MPEP states:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned. See 37 CFR 1.78.”

This means you must either provide the required documents or withdraw the benefit claim to avoid abandonment of your application.

For more information on application abandonment, visit: application abandonment.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If you don’t pay the issue fee for your patent application, it will be considered abandoned. According to MPEP 203.05, one of the ways an application can become abandoned is:

“for failure to pay the issue fee”

The MPEP refers to sections 711 to 711.05 for more details on this topic. It’s crucial to pay the issue fee on time to prevent your application from being abandoned after all the effort put into the patent prosecution process.

To learn more:

If you don’t follow the USPTO’s guidelines for including copyright or mask work notices in your patent application, your application may face objections or refusals. According to MPEP 608.01(w):

Any departure from these conditions may result in a refusal to permit the desired inclusion. If the authorization required under condition (C) above does not include the specific language “(t)he (copyright or mask work) owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent files or records,…” the notice will be objected to as improper by the examiner of the application.

If the examiner maintains the objection upon reconsideration, you may file a petition in accordance with 37 CFR 1.181. To avoid these issues, it’s crucial to carefully follow the guidelines provided in MPEP 608.01(w) and related regulations when including copyright or mask work notices in your patent application.

To learn more:

If you don’t file a petition to restore the benefit of a provisional application after missing the 12-month deadline, you will lose the right to claim the earlier filing date of the provisional application. The MPEP states:

“Applicant is required to delete the claim to the benefit of the prior-filed provisional application, unless applicant can establish that this application, or an intermediate nonprovisional application or international application designating the United States, was filed within 12 months of the filing date of the provisional application.”

This means your application will be treated as if it was filed on the date of the nonprovisional application, potentially affecting your ability to secure patent rights if intervening prior art exists. It’s crucial to either meet the original 12-month deadline or file a timely petition to restore the benefit to maintain your earlier filing date.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

If you don’t file a foreign priority claim within the specified time period, the claim is considered to have been waived. As stated in MPEP 214.01: “Claims for foreign priority not presented within the time period specified in 37 CFR 1.55 are considered to have been waived.”

However, there is a possibility to file a petition to accept an unintentionally delayed priority claim. The MPEP further states: “If a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it includes the required identification information and is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

For more information on the process of filing an unintentionally delayed priority claim, refer to MPEP § 214.02.

To learn more:

If you fail to comply with the requirements for correcting micro entity status errors, as outlined in 37 CFR 1.29(k)(1) and (k)(2), the USPTO has two options:

  1. Treat it as an authorization to process the deficiency payment and charge a processing fee
  2. Require compliance within a non-extendable one-month period

The MPEP states: If the requirements of paragraphs (k)(1) and (2) of this section are not complied with, such failure will either be treated at the option of the Office as an authorization for the Office to process the deficiency payment and charge the processing fee set forth in § 1.17(i), or result in a requirement for compliance within a one-month time period that is not extendable under § 1.136(a) to avoid the return of the fee deficiency payment.

It’s important to carefully follow the requirements to avoid additional fees or potential loss of rights.

To learn more:

What happens if I accidentally submit an original assignment document to the USPTO?

If you accidentally submit an original assignment document to the USPTO, you will not be able to retrieve it. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording.’

To avoid this situation:

  • Always submit copies of assignment documents
  • Keep original documents in a secure location
  • Double-check all submissions before sending them to the USPTO

If you have submitted an original document in error, you may need to create a new assignment document or seek legal advice on how to proceed with future patent transactions or litigation that may require the original document.

To learn more:

If drawings submitted in a patent application are marked as ‘informal’ but are considered acceptable by the Office of Patent Application Processing (OPAP), the examiner will not require replacement of the drawings. As stated in the MPEP:

If the drawings submitted in an application have been indicated by the applicant as “informal,” but the drawings are considered acceptable by OPAP, the examiner should not require replacement of the drawings.

This means that informal drawings can be accepted if they meet the necessary standards, even if not labeled as formal drawings.

To learn more:

If drawings are required for a patent application but not filed with the initial submission, the following process typically occurs:

  • The Office will send a Notice of Incomplete Application to the applicant.
  • The applicant will have two months from the filing date (or notice mail date, whichever is later) to file the drawings and pay any required fees.
  • If compliant drawings are filed within this period, the application will receive the original filing date.
  • Failure to submit the required drawings within the time period may result in the application being treated as abandoned.

As stated in MPEP 601.01(f): ‘If the Office of Patent Application Processing (OPAP) determines that the application does not contain drawings, although drawings are necessary under 35 U.S.C. 113 (first sentence) to understand the subject matter sought to be patented, applicant will be notified that drawings are required.’

To learn more:

If drawings are omitted from a patent application, the consequences depend on whether the drawings are necessary for understanding the invention. According to MPEP 601.01(f):

“If drawings are necessary under 35 U.S.C. 113 (first sentence) to understand the subject matter sought to be patented, the application will be denied a filing date and the applicant will be notified that the application is incomplete.”

However, if the drawings are not necessary for understanding the invention, the application may still be given a filing date. The examiner will send a Notice of Omitted Items, giving the applicant two months to submit the missing drawings and avoid abandonment of the application.

To learn more:

To learn more:

Tags: drawings

If drawings are not timely filed in response to a notice from the USPTO or a letter from the examiner requiring a drawing, the consequences are severe:

  • The application becomes abandoned for failure to reply.

The MPEP clearly states: If a drawing is not timely received in reply to a notice from the Office or a letter from the examiner who requires a drawing, the application becomes abandoned for failure to reply.

This underscores the importance of promptly responding to USPTO notices and examiner requirements regarding drawings. For information on handling replacement drawings, refer to MPEP § 608.02(h).

To learn more:

If drawings are not received with a patent application, the following process occurs:

  • The application is assigned a filing date if it meets the minimum requirements under 37 CFR 1.53(b) or 1.53(d).
  • The Office of Patent Application Processing (OPAP) will send a Notice of Omitted Items giving the applicant a time period to file the missing drawings and a petition under 37 CFR 1.182 with the petition fee to have the filing date changed to the date of such filing.
  • If the applicant does not respond to the Notice of Omitted Items, the application will be processed without the drawings.

As stated in the MPEP 507: ‘If drawings are not received with the application, the application is assigned a filing date and the applicant is notified to file drawings within a set time period.’

For more information on drawings, visit: drawings.

Tags: drawings

When documents are submitted both as evidence in a reply to an Office action and listed on an Information Disclosure Statement (IDS) form, the examiner’s treatment may differ. The MPEP provides an example:

“For example, if applicant submits and relies on three patents as evidence in reply to the first Office action and also lists those patents on a PTO/SB/08 along with two journal articles, but does not file a statement under 37 CFR 1.97(e) or the fee set forth in 37 CFR 1.17(p), it would be appropriate for the examiner to indicate that the teachings relied on by applicant in the three patents have been considered, but to line through the citation of all five documents on the PTO/SB/08 and to inform applicant that the information disclosure statement did not comply with 37 CFR 1.97(c).”

In this case, the examiner would consider the evidence relied upon in the reply but would not formally consider the documents as part of the IDS due to non-compliance with IDS requirements.

To learn more:

If corrected drawings are not received within the set time period, the application will be processed for issue or publication based on the originally filed drawings. The failure to submit corrected drawings may result in the application being withdrawn from issue or the patent being printed with defective drawings.

If corrected documents are not resubmitted within the specified period, the original filing date will not be preserved. The MPEP clearly states: “If the returned papers are not corrected and resubmitted within the specified period, the date of filing of the corrected papers will be considered to be the date of recording of the document.” This means that failing to meet the deadline for resubmission will result in the loss of the original filing date, and the new submission date will be used as the recording date.

If copendency is not established between patent applications, the benefit claim to the prior-filed application becomes improper. The MPEP clearly states:

Since the applications are not copending, the benefit claim to the prior-filed application is improper. Applicant is required to delete the claim to the benefit of the prior-filed application, unless applicant can establish copendency between the applications.

In such cases, the applicant must either prove that copendency exists or remove the benefit claim. Failure to do so may result in the loss of the earlier priority date, potentially affecting the patentability of the invention.

For more information on copendency, visit: copendency.

For more information on patent procedure, visit: patent procedure.

The MPEP provides clear guidance on how the USPTO handles incorrect or missing classification information for citations:

If the applicant does not provide classification information for a citation, or if the examiner lines through incorrect classification data, the citation will be printed on the face of the patent without the classification information.

This means that even if the classification data is missing or incorrect, the citation itself will still be included on the patent. However, users of the patent should be aware that they may need to independently verify the correct classification for such citations.

To learn more:

What happens if an unavailable joint inventor refuses to sign an oath or declaration?

If an unavailable joint inventor refuses to sign an oath or declaration, the applicant may file a petition under 37 CFR 1.183 to waive the requirement for that inventor’s signature. According to MPEP 409.03(a):

‘If a nonsigning inventor refuses to sign the oath or declaration or cannot be reached, the oath or declaration under 37 CFR 1.63 by the remaining joint inventor(s) must state that the nonsigning inventor is either refused to sign or could not be reached after diligent effort to contact him or her.’

The petition should include evidence of the attempts made to contact the unavailable inventor and any responses received. The Office will then determine whether to grant the petition based on the circumstances presented.

To learn more:

Tags: declaration, oath

If an oath for a patent application is not properly authenticated, the USPTO has a specific procedure. According to the MPEP:

“Where the oath is taken before an officer in a foreign country other than a diplomatic or consular officer of the United States and whose authority is not authenticated or accompanied with an apostille certifying the notary’s authority, the application is nevertheless accepted for purposes of examination.”

This means that the USPTO will still process the application, but the applicant needs to take corrective action. The MPEP further states:

“Applicant should submit a new oath properly authenticated by an appropriate diplomatic or consular officer, the filing of proper apostille, or a declaration (37 CFR 1.68).”

It’s important to note that the USPTO does not return improperly authenticated oaths for proper authentication. Instead, they expect the applicant to submit a corrected version.

To learn more:

If an item in an Information Disclosure Statement (IDS) fails to comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98, the following actions are taken:

  • A line is drawn through the citation to show it has not been considered.
  • Other compliant items in the IDS are still considered and initialed by the examiner.

As stated in the MPEP: If an item of information in an IDS fails to comply with requirements of 37 CFR 1.97 and 37 CFR 1.98, a line should be drawn through the citation to show that it has not been considered. The other items of information listed that do comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98 will be considered by the examiner and will be appropriately initialed. (MPEP 609.05(b))

To learn more:

To learn more:

If an inventor’s mailing address is omitted from a patent application, the USPTO has a procedure to address this issue. According to MPEP 602.08(a):

“If the mailing address of any inventor has been omitted, OPAP will notify applicant of the omission and require the omitted mailing address in response to the notice.”

OPAP refers to the Office of Patent Application Processing. This procedure ensures that the USPTO has the necessary contact information for all inventors listed on the application.

To learn more:

What happens if an inventor refuses to sign the patent application?

If an inventor refuses to sign the patent application, the applicant may file a petition under 37 CFR 1.47(a). According to MPEP 605, ‘When an inventor refuses to sign the application oath or declaration or cannot be found or reached after diligent effort, the applicant under 37 CFR 1.43, 1.45 or 1.46 may file an application without the inventor’s signature pursuant to 37 CFR 1.64(a).’ The petition must include:

  • The fee set forth in 37 CFR 1.17(g)
  • Proof of the pertinent facts
  • The last known address of the non-signing inventor

The Office will then attempt to contact the non-signing inventor and, if unsuccessful, may grant the petition and allow the application to proceed.

To learn more:

To learn more:

What happens if an inventor refuses to sign the oath or declaration for a patent application?

If an inventor refuses to sign the oath or declaration for a patent application, the applicant may file a substitute statement in lieu of an oath or declaration. According to MPEP 602.01(a):

“A substitute statement may be used in lieu of an oath or declaration if the inventor is deceased, legally incapacitated, cannot be found or reached after diligent effort, or refuses to execute the oath or declaration.”

The substitute statement must be signed by an applicant under 37 CFR 1.43, 1.45, or 1.46. It must:

  • Identify the inventor to whom it relates
  • Identify the person executing the substitute statement and their relationship to the inventor
  • Include a statement that the person executing the substitute statement believes the named inventor to be the original inventor
  • State that the application was made or authorized to be made by the person executing the substitute statement
  • State the permitted basis for filing the substitute statement (in this case, the inventor’s refusal to sign)

It’s important to note that attempts to reach the inventor and obtain their signature should be documented, as the USPTO may require evidence of the inventor’s refusal to sign.

To learn more:

What happens if an inventor refuses to sign the inventor’s oath or declaration?

If an inventor refuses to sign the inventor’s oath or declaration, the application may still be filed under certain circumstances. According to MPEP 602.01(a):

“If an inventor refuses to execute an oath or declaration or cannot be found or reached after diligent effort, the applicant under 37 CFR 1.43, 1.45 or 1.46 may execute an oath or declaration naming the non-signing inventor.”

In such cases, the applicant must:

  • Submit a substitute statement in lieu of an oath or declaration
  • Provide evidence of the inventor’s refusal to sign or unavailability
  • Explain the efforts made to contact the inventor

The Office will evaluate the circumstances and may accept the application without the non-signing inventor’s oath or declaration.

To learn more:

What happens if an inventor refuses to sign an oath or declaration?

If an inventor refuses to sign an oath or declaration, the application may still proceed under certain circumstances. According to MPEP 602.09:

“If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the application may be made by the other inventor on behalf of themselves and the nonsigning inventor.”

In such cases, the applicant must:

  • File an oath or declaration on behalf of the nonsigning inventor
  • Provide a statement of facts explaining the situation
  • Show that the nonsigning inventor’s last known address has been stated
  • Demonstrate that notice of the filing of the application has been provided to the nonsigning inventor

This process allows the application to move forward despite the lack of cooperation from one inventor.

To learn more:

What happens if an inventor dies or becomes legally incapacitated after an application is filed?

If an inventor dies or becomes legally incapacitated after an application is filed, the legal representative of the deceased or incapacitated inventor may make an oath or declaration in compliance with 37 CFR 1.64. The MPEP 409.01(a) states:

“If an inventor dies after an application naming the inventor is filed, the personal representative of the inventor’s estate may make an oath or declaration in compliance with 37 CFR 1.64.”

This process ensures that the application can continue to be prosecuted even if the inventor is no longer able to participate. The legal representative must provide evidence of their authority to act on behalf of the deceased or incapacitated inventor.

To learn more:

What happens if an inventor becomes legally incapacitated during the patent application process?

If an inventor becomes legally incapacitated during the patent application process, the application can still proceed. According to MPEP 409, ‘If an inventor is legally incapacitated, the legal representative of the inventor may make an application for patent on behalf of the inventor.’ This means that a court-appointed guardian or conservator can act on behalf of the incapacitated inventor to continue the patent application process.

The legal representative must provide evidence of their authority to act for the inventor, such as a court order appointing them as guardian. They can then sign necessary documents and make decisions regarding the patent application on behalf of the incapacitated inventor.

For more information on legal representative, visit: legal representative.

If an inventor becomes available after a 37 CFR 1.47(a) petition is granted, they should be given the opportunity to join the application. The MPEP 409.03(b) provides guidance:

‘If a nonsigning inventor subsequently joins in the application, the applicant may file a petition under 37 CFR 1.182 to withdraw the 37 CFR 1.47 petition.’

This process involves:

  • The newly available inventor signing the necessary oath or declaration.
  • Filing a petition under 37 CFR 1.182 to withdraw the previous 1.47 petition.
  • Paying any required fees for the new petition.
  • Updating the application to reflect the inventor’s participation.

It’s important to address this situation promptly to ensure the application accurately reflects all participating inventors.

To learn more:

To learn more:

What happens if an international application designating the US is withdrawn?

If an international application designating the United States is withdrawn or considered withdrawn, either generally or as to the United States, it cannot serve as the basis for priority in a subsequent U.S. application. The MPEP states:

“An international application designating the United States that withdraws the U.S. designation prior to fulfilling the requirements of 35 U.S.C. 371(c) cannot serve as a basis for priority in a subsequent U.S. national application.”

This means that if the international application is withdrawn before meeting the requirements for entering the national stage in the U.S., it cannot be used as a priority claim in a later U.S. application. It’s important for applicants to carefully consider the implications of withdrawing an international application, especially if they plan to seek patent protection in the United States later.

To learn more:

What happens if an international application designating the US is published in a language other than English?

If an international application designating the United States is published under PCT Article 21(2) in a language other than English, a translation of the international application into English must be provided. The MPEP 211.01(c) states:

If the international application was published under PCT Article 21(2) in a language other than English, the publication of the international application shall be considered to be an English language translation of the application provided to the U.S. Patent and Trademark Office within the meaning of 35 U.S.C. 154(d)(4).

This means that for the purposes of provisional rights under 35 U.S.C. 154(d), the English translation provided to the USPTO will be considered as the publication of the international application.

To learn more:

If an Information Disclosure Statement (IDS) is filed after the issue fee is paid:

  • The IDS will not be considered by the examiner
  • The IDS will be placed in the application file
  • The application may be withdrawn from issue to file a Request for Continued Examination (RCE) or a continuing application
  • A petition under 37 CFR 1.313(c) is required to withdraw the application from issue

MPEP 609.04(b)(IV) states: “After the issue fee has been paid on an application, it is impractical for the Office to attempt to consider newly submitted information. Information disclosure statements filed after payment of the issue fee in an application will not be considered but will merely be placed in the application file.”

The MPEP further explains: “The application may be withdrawn from issue at this point, pursuant to 37 CFR 1.313(c)(2) or 1.313(c)(3) so that the information can be considered in the application upon the filing of a RCE under 37 CFR 1.114 or in a continuing application filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if the application is a design application).”

To learn more:

Tags: issue fee

If an Information Disclosure Statement (IDS) doesn’t comply with USPTO requirements, it will be placed in the file but not considered by the Office. According to MPEP 609.05(a):

Pursuant to 37 CFR 1.97(i), submitted information, filed before the grant of a patent, which does not comply with 37 CFR 1.97 and 37 CFR 1.98 will be placed in the file, but will not be considered by the Office.

This means that while the IDS will be part of the application file, the examiner won’t review or consider the information it contains when examining the patent application.

To learn more:

When an improper Continued Prosecution Application (CPA) is filed, the USPTO’s response depends on the type of application and the nature of the impropriety:

  • For utility or plant applications filed on or after July 14, 2003, an improper CPA is treated as a Request for Continued Examination (RCE) if possible
  • If the improper CPA doesn’t meet RCE requirements, it’s treated as an improper RCE
  • For design applications, an improper CPA may be treated as a new application under 37 CFR 1.53(b) in some circumstances
  • The Office will not automatically convert an improper CPA to an application under 37 CFR 1.53(b) without extenuating circumstances

The MPEP states: Any request for a CPA filed on or after July 14, 2003, in a utility or plant application is improper, regardless of the filing date of the utility or plant application in which the CPA is filed.

Regarding treatment as an RCE: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

If the improper CPA doesn’t meet RCE requirements: If the improper CPA does not satisfy the requirements of 37 CFR 1.114 (e.g., the request lacks a submission or the fee under 37 CFR 1.17(e), or the prosecution of the application is not closed), the Office treats the improper CPA as an improper RCE, and the time period set in the last Office action (or notice) will continue to run.

Examiners are instructed to notify supervisory staff if they discover an improper CPA has been processed: If an examiner discovers that an improper or incomplete CPA has been processed as a proper CPA in error, the examiner should immediately notify a supervisory applications examiner (SAE) or other technical support staff within the Technology Center (TC) who will reprocess the CPA and correct the application records as appropriate.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

Continued Prosecution Applications (CPAs) are only available for design patent applications. If an improper CPA is filed for a utility or plant application, the following occurs:

  • For applications filed on or after June 8, 1995, the improper CPA is treated as a Request for Continued Examination (RCE) under 37 CFR 1.114
  • If the requirements for an RCE are not met, the Office will send a Notice of Improper Request for Continued Examination (RCE)
  • For applications filed before June 8, 1995, the improper CPA cannot be treated as an RCE
  • The applicant will be notified of the improper CPA

MPEP 201.06(d) states: Any request for a CPA filed on or after July 14, 2003, in a utility or plant application is improper, regardless of the filing date of the utility or plant application in which the CPA is filed. It further notes: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on USPTO procedures, visit: USPTO procedures.

For more information on utility patents, visit: utility patents.

What happens if an IDS is filed after the mailing of a final Office action?

If an Information Disclosure Statement (IDS) is filed after the mailing of a final Office action, the examiner will consider it according to specific guidelines:

  • The IDS will be considered if it’s accompanied by either a statement as specified in 37 CFR 1.97(e) or the fee set forth in 37 CFR 1.17(p).
  • If these requirements are not met, the IDS will be placed in the application file but will not be considered by the examiner.

As stated in MPEP 609.05(c): ‘Consideration by the examiner of an IDS submitted after the mailing of a final Office action is limited to the requirements set forth in 37 CFR 1.97(d) and to documents which the examiner determines to be relevant.’ This means that even if the IDS is considered, the examiner is not required to reopen prosecution or issue a new Office action based on the newly submitted information.

To learn more:

What happens if an IDS is filed after the issue fee has been paid?

If an Information Disclosure Statement (IDS) is filed after the issue fee has been paid, it will not be considered by the examiner. According to MPEP 609.02:

‘Any IDS filed after the issue fee has been paid will not be considered by the examiner. In this situation, the application will be printed without consideration of the IDS.’

If an applicant wants the information in the IDS to be considered, they have two options:

  • File a request for continued examination (RCE) along with the IDS
  • Withdraw the application from issue and file a request for continued examination (RCE) with the IDS

It’s important to note that these actions must be taken before the patent issues to ensure consideration of the IDS.

To learn more:

To learn more:

Tags: issue fee

If an expungement petition is granted, the USPTO will take action to remove the erroneous assignment record. As stated in MPEP 323.01(d): ‘The assignment records related to a request for expungement will be expunged, deleted or corrected in accordance with the decision on the petition.’ This means that the incorrect or unnecessary information will be removed from the official assignment records, helping to maintain accurate ownership information for the patent or application.

To learn more:

If an English translation is not provided with a non-English assignment document, the USPTO will not record the assignment. According to MPEP 302.02:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

This means that the assignment will be rejected, and the ownership transfer will not be officially recognized by the USPTO. To proceed with the recordation, the applicant or assignee must submit a proper English translation along with the original non-English document.

To learn more:

If an assignment document submitted electronically through the Electronic Patent Assignment System (EPAS) is determined to be not recordable, the following process occurs:

  1. The entire document, along with its associated cover sheet, will be returned to the sender.
  2. An Office “Notice of Non-Recordation” will be transmitted back to the sender via fax, if possible.
  3. The sender can make corrections to the document or cover sheet.
  4. The corrected submission can then be resubmitted by mailing it to the address specified in 37 CFR 3.27.
  5. If the resubmission is timely, the sender will receive the benefit of the initial receipt date as the recordation date, in accordance with 37 CFR 3.51.

As stated in MPEP 302.10: “Once corrections are made, the initial submission, as amended, may then be resubmitted by mailing the corrected submission to the address set forth in 37 CFR 3.27. Timely submission will provide the sender with the benefit of the initial receipt date as the recordation date in accordance with 37 CFR 3.51.”

What happens if an attorney or agent withdraws without notifying the USPTO?

If an attorney or agent withdraws from representation without notifying the USPTO, it can lead to several issues:

  • The USPTO will continue to recognize the attorney or agent as the representative of record.
  • Official correspondence will still be sent to the attorney or agent, potentially causing delays or missed deadlines.
  • The applicant may not receive important communications about their application.

According to MPEP 402.06: “A registered attorney or agent who has been given a power of attorney and who withdraws from the application without relinquishing the power of attorney to the USPTO is still considered to be the attorney or agent of record.” To properly withdraw, the attorney or agent should follow the procedures outlined in 37 CFR 1.36 and notify the USPTO in writing.

To learn more:

What happens if an attorney or agent withdraws from representation in a patent application?

When an attorney or agent withdraws from representation in a patent application, the following occurs:

  • The USPTO will correspond directly with the applicant until a new Power of Attorney or address change is filed.
  • The withdrawal is effective when approved by the Office, not when received.
  • The Office may require the applicant or assignee to revoke the previous Power of Attorney and appoint a new representative.

As stated in MPEP 402.06: ‘In the event the power of attorney is withdrawn, the Office will communicate directly with the applicant… until a new registered attorney or agent is appointed.’

To learn more:

To learn more:

What happens if an assignment document is not recorded at the USPTO?

If an assignment document is not recorded at the USPTO, it can have significant legal implications. According to MPEP 302:

‘An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the Office within three months from its date or prior to the date of such subsequent purchase or mortgage.’

In other words, failing to record an assignment within the specified timeframe can render it invalid against subsequent purchasers or mortgagees who were unaware of the previous assignment. This highlights the importance of timely recording assignments to protect the rights of assignees.

For more information on assignment recording, visit: assignment recording.

For more information on legal implications, visit: legal implications.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

What happens if an assignment document is not legible for recording?

If an assignment document is not legible for recording, it will be rejected by the USPTO. According to MPEP 302.01, “Documents submitted for recording must be legible and capable of being reproduced in legible copies by use of photocopy and standard office copying equipment.” If a document is rejected due to legibility issues, the USPTO will notify the person who submitted the document, and they will need to resubmit a legible copy for recording.

What happens if an assignment document is not a copy when submitted for recording?

If an assignment document submitted for recording is not a copy, it will not be accepted for recording. The MPEP clearly states: The Assignment Division will not accept an original assignment document because it becomes part of the USPTO permanent records. This is to protect the original document and ensure that the USPTO maintains proper records. If you submit an original document, it will be returned to you unrecorded, and you will need to submit a copy instead.

To ensure your assignment is properly recorded, always submit a legible copy of the original assignment document. This can be a photocopy or other reproduction of the original.

If an assignment cover sheet is not submitted with the assignment document, the USPTO will not record the assignment. According to MPEP 302.07, “The Office will not accept an assignment document that is not accompanied by a cover sheet.” This means that the assignment will not be officially recognized by the USPTO, which could affect the ownership rights of the patent or application.

To learn more:

If an assignee’s ownership changes during patent prosecution, it’s crucial to update the USPTO records. As per MPEP 325:

“A new statement under 37 CFR 3.73(c) is required to be filed when ownership changes to another assignee.”

This means that:

  • The new assignee must file a new 37 CFR 3.73(c) statement.
  • The new statement must establish the new assignee’s ownership.
  • Until the new statement is filed, the previous assignee remains the party of record.

It’s important to keep ownership records up-to-date to ensure that the correct party has the right to take action in the application.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO records, visit: USPTO records.

What happens if an assignee requests issuance of a patent to themselves?

When an assignee requests issuance of a patent to themselves, the following process occurs:

  • The assignee must file a request for issuance of the patent to the assignee under 37 CFR 3.81(b).
  • This request must be submitted no later than the date the issue fee is paid.
  • If the request is not filed by this deadline, the patent will be issued to the applicant(s) named in the application file.

As stated in MPEP 307: “If the assignment is submitted for recording after the date of payment of the issue fee, but prior to issuance of the patent, the assignment will be recorded but the patent will issue to the name of the inventor.”

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

If an assignee of a part interest refuses to join in an application for reissue, the reissue may still be applied for by the assignee of the entire interest. This is outlined in MPEP 1410. The assignee of the entire interest can file the reissue application as the sole applicant. However, the assignee must comply with the requirements of 37 CFR 1.172, which includes submitting an oath or declaration by the assignee.

If an assignee fails to comply with 37 CFR 3.81(b) when requesting issuance of a patent to the assignee, the patent may still be issued to the assignee. However, the USPTO will not include the assignee data on the patent.

According to the MPEP 307: Failure to comply with the provisions of 37 CFR 3.81(b) will not impact the issuance of the patent. However, the Office will not include the assignee data on the patent if the assignee data is not submitted in compliance with 37 CFR 3.81(b).

This means that while the patent will be issued, the official patent document will not reflect the assignee information, which could potentially cause complications in establishing ownership records.

For more information on patent issuance, visit: patent issuance.

If an applicant does not receive an application number within one month of filing, they should contact the Application Assistance Unit. The MPEP states:

‘If an application number is not received within one month of the filing date, applicant should contact the Application Assistance Unit at (571) 272-4000 or (888) 786-0101.’

This contact information is provided to ensure applicants can follow up on their application status in a timely manner. It’s important to note that this one-month period is a guideline for when applicants should take action if they haven’t received their application number.

For more information on Application Assistance Unit, visit: Application Assistance Unit.

For more information on application number, visit: application number.

What happens if an application data sheet (ADS) is not consistent with the information provided elsewhere in the application?

If there are inconsistencies between the ADS and other documents in the application, the ADS will generally control, except for the following situations:

  • The ADS is inconsistent with the oath or declaration accompanying the application, and the oath or declaration is accompanied by a statement explaining the inconsistency. In this case, the oath or declaration will control.
  • The ADS is inconsistent with information provided in the specification, in which case the information in the specification will control.

As stated in MPEP 601.05(b):

“If an ADS is inconsistent with the information provided elsewhere in the application, the ADS will control except for: (1) the naming of the inventors (37 CFR 1.41(a)(1) governs), and (2) the information that is contained in an oath or declaration accompanying the application (37 CFR 1.63 and 1.67 govern).”

It’s crucial to ensure consistency across all application documents to avoid potential confusion or delays in the examination process.

To learn more:

When claiming benefit to a non-English language provisional application, the following are required:

  • An English language translation of the provisional application
  • A statement that the translation is accurate

These must be filed in the provisional application. If not filed, the applicant will be notified and given a period of time to file the translation and statement.

MPEP 211.01(a) states: If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.

Failure to timely provide the translation and statement may result in the abandonment of the nonprovisional application.

To learn more:

What happens if an applicant’s income exceeds the micro entity threshold during pendency?

If an applicant’s income exceeds the micro entity threshold during the pendency of an application, they must notify the USPTO and change their status. The MPEP 509.04(a) states:

“A micro entity certification in an application will remain in effect until the applicant submits a notification of loss of entitlement to micro entity status under 37 CFR 1.29(i).”

Applicants are required to notify the USPTO of any change in status before paying any fee after the change. Failure to do so may result in:

  • Underpayment of fees
  • Loss of micro entity status
  • Potential invalidation of the patent if issued

It’s crucial to monitor income and update the USPTO promptly if the micro entity threshold is exceeded.

To learn more:

What happens if an applicant submits both a substitute statement and an inventor’s oath?

If both a substitute statement and an inventor’s oath or declaration are submitted for an inventor, the inventor’s oath or declaration will take precedence. The MPEP 604 states:

“If an inventor subsequently files an inventor’s oath or declaration meeting the requirements of 37 CFR 1.63 after a substitute statement has been filed, the inventor’s oath or declaration will be placed in the application file.”

This means that the USPTO will recognize the inventor’s own oath or declaration as the official document, effectively superseding the previously filed substitute statement. It’s important for applicants to be aware of this to avoid confusion and ensure proper documentation in the patent application process.

To learn more:

If an applicant misses the 30-month deadline for national stage entry in the United States, the consequences can be severe. According to MPEP 601.04:

Failure to timely comply with the requirements of 35 U.S.C. 371(c) results in abandonment of the application.

This means that if the applicant fails to submit the required documents and fees within the 30-month period, the application will be considered abandoned. However, the MPEP also provides a potential remedy:

Pursuant to 35 U.S.C. 371(d), the Commissioner may accept the required national stage requirements later than 30 months from the priority date if these requirements are submitted prior to the filing of the Demand for International Preliminary Examination.

It’s crucial to note that this remedy is discretionary and not guaranteed. Applicants should always strive to meet the 30-month deadline to avoid potential loss of rights.

To learn more:

If an applicant fails to take appropriate action during the prosecution of a nonprovisional patent application, it can result in the application being considered abandoned. MPEP 203.05 specifically states that an abandoned application includes one removed from the Office docket through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application. This could include failing to respond to office actions, missing deadlines, or not providing requested information or documents.

If an applicant fails to submit required application components within the specified time period, the following consequences may occur:

  • The application may be considered abandoned.
  • If abandoned, the application will be treated as though it had never been filed.
  • The applicant may lose the benefit of the original filing date.

The MPEP states: Upon failure to submit the fee, oath or declaration, and 1 or more claims within such prescribed period, the application shall be regarded as abandoned.

However, it may be possible to revive an abandoned application under certain circumstances:

  • The applicant can file a petition to revive under 37 CFR 1.137.
  • The petition must be accompanied by the required reply, the petition fee, and a statement that the entire delay was unintentional.

It’s crucial to respond to any notices from the USPTO promptly and to submit all required components within the specified timeframes to avoid these issues.

To learn more:

If an applicant fails to respond to a request for a property rights statement, there can be serious consequences for the patent application. According to MPEP 150:

If no proper and timely statement is received, the application will be held abandoned and the applicant so notified.

The process typically involves:

  • An initial informal request (45-Day Letter)
  • If no response or if the statement is defective, a formal request is made with a 30-day statutory period for response
  • No extensions are available for this 30-day period
  • Failure to respond properly results in the application being held abandoned

However, abandoned applications may be revived under the provisions of 37 CFR 1.137, as noted in the case of In re Rutan, 231 USPQ 864 (Comm’r Pat. 1986).

For more information on patent applications, visit: patent applications.

For more information on revival, visit: revival.

Failure to comply with the requirements of 35 U.S.C. 371(c) has serious consequences for an international application entering the national stage in the United States. According to MPEP 211.01(c), which cites 35 U.S.C. 371(d):

35 U.S.C. 371(d) indicates that failure to timely comply with the requirements of 35 U.S.C. 371(c) ‘shall be regarded as abandonment of the application by the parties thereof.’

This means that if an applicant does not meet the requirements for entering the national stage, such as submitting the required documents and fees within the specified time limits, the application will be considered abandoned. Abandonment results in the loss of the application’s filing date and any associated priority claims. It’s crucial for applicants to carefully follow the national stage entry requirements to avoid unintentional abandonment of their applications.

To learn more:

To learn more:

When a USPTO deadline falls on a weekend or holiday, the due date is automatically extended. According to MPEP 505, When the last day for taking any action or paying any fee in the Office falls on a Saturday, Sunday, or a Federal holiday within the District of Columbia, the action or the fee is considered timely if the action is taken or the fee is paid on the next succeeding business day.

This rule applies to various USPTO actions, including:

  • Filing responses to Office Actions
  • Paying maintenance fees
  • Submitting other time-sensitive documents

It’s important to note that while the deadline is extended, the USPTO is still closed on these days for regular correspondence receipt.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO deadlines, visit: USPTO deadlines.

If a typographical error on the original cover sheet does not affect the title to the application or patent against which the original assignment or name change is recorded, the Assignment Services Division will take the following actions:

  • Correct the Assignment Historical Database
  • Allow the recording party to keep the original date of recordation

As stated in MPEP 323.01(a): “If the original cover sheet contains a typographical error that does not affect title to the application or patent against which the original assignment or name change is recorded, the Assignment Services Division will correct the Assignment Historical Database and permit the recording party to keep the original date of recordation.”

This approach ensures that minor errors that don’t impact the substance of the assignment are corrected without affecting the original recordation date, which can be important for legal and priority purposes.

To learn more:

If a suspended practitioner is given power to inspect a patent application, the USPTO will not accept it. MPEP 105 clearly states: “Power to inspect given to such an attorney or agent will not be accepted.” This means that even if an applicant or inventor attempts to grant inspection rights to a suspended practitioner, the USPTO will reject this authorization and prevent the suspended practitioner from accessing the application materials.

To learn more:

If a substitute specification is denied entry, it should be marked as such by the examiner. The MPEP provides a form paragraph (6.28.02) for notifying the applicant that a substitute specification has not been entered. The examiner will explain why the substitute specification is improper, which may include reasons such as:

  • Missing statement regarding lack of new matter
  • Failure to provide both clean and marked-up copies
  • Submission in a reissue application or reexamination proceeding
  • Submission after payment of the issue fee
  • Inclusion of claims to be amended

If a substitute specification is denied entry, the applicant may need to address the issues raised and resubmit the specification or make alternative amendments to the original specification.

To learn more:

According to MPEP 602.08(c), when a specification is filed attached to an oath or declaration after the initial application filing date, the USPTO follows a specific procedure:

Any specification that is filed attached to an oath or declaration on a date later than the application filing date will not be compared with the specification submitted on filing.

Furthermore, the MPEP states: Absent any statement(s) to the contrary, the ‘attached’ specification will be presumed to be a copy of the specification and any amendments thereto, which were filed in the USPTO in order to obtain a filing date for the application.

This means that the USPTO will not verify if the later-submitted specification matches the original filing. Instead, they assume it’s a copy of the original specification plus any amendments, unless explicitly stated otherwise. This practice helps streamline the application process and avoid confusion between different versions of the specification.

To learn more:

What happens if a secrecy order is violated?

Violating a secrecy order can have serious consequences. According to MPEP 120, “Unauthorized disclosure of the subject matter of an application under a secrecy order is punishable by a fine and/or imprisonment (35 U.S.C. 186), and may result in loss of patent rights (35 U.S.C. 182).” This means that individuals who disclose information about an application under a secrecy order without proper authorization may face:

  • Monetary fines
  • Imprisonment
  • Loss of patent rights

It’s crucial for inventors, patent agents, and attorneys to strictly adhere to secrecy orders to avoid these severe penalties.

For more information on unauthorized disclosure, visit: unauthorized disclosure.

What happens if a provisional application is not followed by a nonprovisional application within 12 months?

If a provisional application is not followed by a nonprovisional application within 12 months, it will automatically be abandoned and cannot be revived. The MPEP 201.04 states: A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter. This means that the provisional application cannot serve as a priority document for any subsequent applications, and any potential benefit date will be lost.

For more information on provisional application, visit: provisional application.

If a provisional application is not converted to a nonprovisional application within 12 months, it automatically becomes abandoned. The MPEP 201.04 clearly states:

A provisional application automatically becomes abandoned 12 months after its filing date and cannot claim the benefit of any other application. See 35 U.S.C. 111(b)(5).

This means that after 12 months, the provisional application can no longer serve as a basis for claiming priority, and any disclosure made in the provisional application becomes part of the public domain. To maintain the benefit of the provisional filing date, applicants must file a nonprovisional application claiming the benefit of the provisional application within the 12-month period.

For more information on provisional application, visit: provisional application.

What happens if a provisional application is not converted to a nonprovisional within 12 months?

If a provisional application is not converted to a nonprovisional application within 12 months, it will automatically expire. The MPEP 201.04 states:

“A provisional application will automatically become abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.”

Once expired, the provisional application cannot be revived or restored to pending status. However, the applicant may still file a nonprovisional application after the 12-month period, but they would lose the benefit of the earlier filing date of the provisional application.

For more information on provisional application, visit: provisional application.

What happens if a provisional application is missing required elements?

If a provisional application is missing required elements, the USPTO will notify the applicant of the deficiencies. According to MPEP 601.01(b):

‘If the provisional application does not include a cover sheet indicating that it is a provisional application, the application will be treated as a nonprovisional application.’

Additionally:

  • If the specification is missing, the application will be treated as an incomplete application.
  • If the filing fee is missing, the USPTO will notify the applicant and set a time period for payment.
  • If drawings are omitted but referred to in the specification, the applicant will be notified and given a time period to submit the drawings.

It’s crucial to ensure all required elements are included to avoid potential issues with the application’s filing date or treatment as a different type of application.

To learn more:

What happens if a provisional application is filed without claims?

A provisional application can be filed without claims and still be considered complete. According to MPEP 601.01(b):

“A provisional application need not include claims to be complete for filing date purposes.”

This means that unlike non-provisional applications, provisional applications do not require claims to receive a filing date. However, it’s important to note that the specification should still provide adequate support for any claims that may be included in a later-filed non-provisional application claiming priority to the provisional application.

To learn more:

If a provisional application is filed without a complete cover sheet, the USPTO will still treat it as a provisional application. However, the applicant will be required to submit the complete cover sheet and pay a surcharge at a later date. The MPEP explains:

A provisional application, which is identified as such, but which does not have a complete cover sheet as required by 37 CFR 1.51(c)(1) will be treated as a provisional application. However, the complete cover sheet and a surcharge will be required to be submitted at a later date in conformance with 37 CFR 1.53(g). (MPEP 601.01(b))

The USPTO will notify the applicant and provide a time period (usually two months) to submit the necessary documents and fees to avoid abandonment of the application.

To learn more:

If a priority document is not timely retrieved through the PDX program, there can be significant consequences for the patent application. According to MPEP 215.02(a):

“If the priority document is not retrieved within the time period set in 37 CFR 1.55(g)(1), the applicant is notified and given a time period within which to file the certified copy in accordance with 37 CFR 1.55(g)(1).”

Consequences of untimely retrieval:

  • Applicant receives a notification of non-retrieval
  • A time limit is set for manual submission of the certified copy
  • Failure to submit within the time limit may result in loss of priority claim
  • Additional fees may be required for late submission

To learn more:

If a priority claim or the certified copy of a foreign application is filed after the issue fee is paid, it will not automatically be included in the patent. The MPEP Section 213.04 states:

“If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and § 1.323.”

This means that to include the priority claim in the patent after the issue fee is paid, the applicant must request a certificate of correction, which may involve additional fees and processing time.

To learn more:

If a prior-filed application lacks adequate written description for a claimed invention, the following consequences may occur:

  • The claim in the later-filed application will not be entitled to the benefit of the filing date of the prior-filed application for that invention.
  • The effective filing date for the claimed invention will be the filing date of the later-filed application.
  • This may impact the patent’s validity if intervening prior art exists between the filing dates of the prior-filed and later-filed applications.

As stated in MPEP 211.05:

To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.

This emphasizes the importance of ensuring that the prior-filed application contains a complete and detailed disclosure of the claimed invention.

To learn more:

What happens if a prior-filed application is abandoned?

If a prior-filed application is abandoned, it may still be used to claim the benefit of priority for a later-filed application, provided certain conditions are met. According to MPEP 211.01:

‘An abandoned application may be used as a prior application for purposes of claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) in a later-filed application when the abandoned application discloses the invention adequately and completely.’

However, it’s important to note that the abandoned application must still meet all the requirements for claiming benefit, including:

  • Adequate disclosure of the invention
  • Proper copendency (if applicable)
  • Specific reference to the prior application in the later-filed application

If these conditions are met, the abandoned status of the prior application does not prevent it from serving as a basis for claiming benefit in a later application.

To learn more:

If a previously non-signing inventor decides to join a pre-AIA 37 CFR 1.47 application, they can do so by filing the appropriate documentation. The MPEP states:

“In the event the previously nonsigning inventor decides to join in the application by filing an executed oath or declaration complying with pre-AIA 37 CFR 1.63, the oath or declaration will be placed in the application file.”

This means that if the inventor who initially did not sign the application later chooses to participate, they can submit a properly executed oath or declaration. This document will then be added to the official application file, effectively joining them to the application.

To learn more:

To learn more:

If a patent is issued to the wrong applicant, the USPTO has procedures to correct this error. According to MPEP 308:

‘If a patent is issued to the wrong applicant because of an error in the Office, the patentee may request a certificate of correction… If the error was not the Office’s fault, the assignee(s) or applicant(s) may request a reissue.’

The method of correction depends on whether the error was made by the USPTO or by the applicant. If it was the USPTO’s error, a certificate of correction can be requested. If it was the applicant’s error, a reissue process may be necessary.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on error correction, visit: error correction.

For more information on patent issuance, visit: patent issuance.

For more information on reissue, visit: reissue.

If a patent involved in an arbitration award is subsequently invalidated, there are provisions for modifying the award. This process is outlined in 35 U.S.C. 294(c):

“The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration.”

Key points to note:

  • Parties can agree in advance to allow modification of the award if the patent is invalidated.
  • The invalidation must be determined by a court of competent jurisdiction.
  • The court decision must be final (no appeal possible or taken).
  • Any party to the arbitration can apply to a court for modification of the award.
  • The modified award will govern the rights and obligations between the parties from the date of modification.

This provision allows for adjustments to arbitration outcomes in light of significant changes to the validity of the underlying patent rights.

If a patent document doesn’t meet the identification requirements, it will not be recorded. The MPEP 317.01 states:

“A document which does not comply with the identification requirements of § 3.21 will not be recorded.”

This means that the USPTO will reject documents that fail to meet the specific identification criteria outlined in 37 CFR 3.21, and these documents will not receive a recording date until the issues are corrected.

To learn more:

What happens if a patent assignment is not recorded with the USPTO?

Failing to record a patent assignment with the USPTO can have significant consequences:

  • Lack of Constructive Notice: Third parties may not be aware of the ownership transfer.
  • Potential Legal Issues: It may affect the assignee’s ability to enforce the patent or recover damages in infringement cases.
  • Validity of Subsequent Transfers: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as valid, for purposes of recording, unless overcome by a showing that such assignment was fraudulently procured or is otherwise invalid.’

While recording is not mandatory for the assignment to be valid between the parties involved, it is highly recommended to protect the assignee’s rights and provide public notice of the ownership change.

For more information on USPTO, visit: USPTO.

Tags: USPTO

If a patent application is missing figures mentioned in the specification, the consequences depend on the filing date and type of application. According to MPEP 608.01(f):

  • For applications filed on or after December 18, 2013 (except design applications): The application will be treated as filed without all figures of drawings, as per MPEP § 601.01(g).
  • For applications filed before December 18, 2013 or design applications: The application will be treated as filed without drawings, as per MPEP § 601.01(f).

It’s crucial to ensure that all figures mentioned in the specification are included in the drawings to avoid potential issues with the application.

To learn more:

If a patent application is missing essential parts, such as the specification, drawings, or claims, the USPTO will notify the applicant of the missing elements. According to MPEP 506:

‘Applicant will be notified of the incomplete application and the time period set for submitting the omitted parts.’

The applicant will then have an opportunity to submit the missing parts within the specified time period to complete the application.

For more information on incomplete application, visit: incomplete application.

For more information on missing parts, visit: missing parts.

For more information on patent application requirements, visit: patent application requirements.

If a patent application is missing an abstract, the following actions will be taken:

  • For applications filed under 35 U.S.C. 111(a), the Office of Patent Application Processing (OPAP) will review for compliance and require an abstract if one has not been filed.
  • For all other applications lacking an abstract, the examiner will require the submission of an abstract in the first Office action.

The MPEP states: The Office of Patent Application Processing (OPAP) will review all applications filed under 35 U.S.C. 111(a) for compliance with 37 CFR 1.72 and will require an abstract, if one has not been filed. In all other applications which lack an abstract, the examiner in the first Office action should require the submission of an abstract directed to the technical disclosure in the specification.

To learn more:

The treatment of a patent application filed without drawings depends on the application type and filing date:

  • For nonprovisional applications filed on or after December 18, 2013 (except design applications):
    • The application will be accorded a filing date
    • Drawings may be filed later, but no new matter may be added
  • For applications filed before December 18, 2013 and design applications:
    • If drawings are necessary under 35 U.S.C. 113, the application will not be accorded a filing date
    • A “Notice of Incomplete Application” will be mailed

The USPTO states: Applications filed without drawings are initially inspected to determine whether a drawing is referred to in the specification, and if not, whether a drawing is necessary for the understanding of the invention.

For applications where drawings are determined to be necessary: If a nonprovisional application filed prior to December 18, 2013 or a design application does not have at least one claim directed to the subject matter discussed above for which a drawing is usually not considered essential for a filing date… and is filed without drawings, OPAP will mail a “Notice of Incomplete Application” indicating that the application lacks drawings and that 35 U.S.C. 113 (first sentence) requires a drawing where necessary for the understanding of the subject matter sought to be patented.

To learn more:

If a patent application is filed without all the required drawings, the Office of Patent Application Processing (OPAP) will review the application and may issue a “Notice of Omitted Item(s).” This notice informs the applicant that the application has been accorded a filing date but is missing some of the figures described in the specification.

The applicant then has several options:

  • Establish prior receipt of the missing drawings
  • Submit the omitted drawings and accept a later filing date
  • Accept the application as deposited and make appropriate amendments

As stated in the MPEP, The mailing of an OPAP notice regarding a missing drawing figure(s) in a nonprovisional application will permit the applicant to: (A) promptly establish prior receipt in the USPTO of the drawing(s) at issue… (B) promptly submit the omitted drawing(s) in a nonprovisional application and accept the date of such submission as the application filing date… (C) accept the application as deposited in the USPTO by filing an appropriate amendment.

To learn more:

If a patent application is filed without all the pages of the specification, the USPTO will notify the applicant of the missing parts. The MPEP refers to this situation:

See MPEP § 601.01(d)-(g) where the application is filed without all the pages of the specification, without at least one claim (nonprovisional design application), without drawings, or without all the figures of the drawings.

For applications filed before September 16, 2012, a supplemental oath or declaration by the inventor may be required to identify the missing item and indicate that it accurately describes the invention. For applications filed on or after September 16, 2012, an additional oath or declaration is generally not required.

The applicant will be given a time period to submit the missing pages. If the missing pages are not submitted within the specified time, the application may be deemed incomplete and not accorded a filing date until the missing parts are received.

If a patent application is filed without a correspondence address:

  • The USPTO needs a correspondence address to notify the applicant of any missing parts or requirements.
  • If no address is provided, the Office may use the mailing address of the first named inventor as the correspondence address.
  • Without a correspondence address, the applicant is considered to have constructive notice of application requirements as of the filing date.
  • The applicant has 2 months from the filing date to complete the application before it is abandoned.

According to MPEP 403: “If a patent application as filed has been accorded a filing date but is not complete, the applicant is notified and given a period of time within which to file the missing parts to complete the application and pay the applicable surcharge. … If the applicant fails to provide the Office with a correspondence address, the Office will be unable to provide the applicant with notification to complete the application and to pay the surcharge as set forth in 37 CFR 1.16(f) for nonprovisional applications and 37 CFR 1.16(g) for provisional applications. In such a case, the applicant will be considered to have constructive notice as of the filing date that the application must be completed and the applicant will have 2 months from the filing date in which to do so before abandonment occurs.”

For applications filed with apparent national security markings, the USPTO will:

  1. Notify the applicant via Licensing and Review
  2. Ask the applicant to either:
    • Explain the markings
    • Remove improper markings
    • Obtain a Secrecy Order if necessary
  3. Potentially refer the application to a defense agency for review under 35 U.S.C. 181 second paragraph if improper markings are found and removed

If a patent application is filed with informal papers (e.g., typed on both sides of the paper, not permanent, legible, or reproducible), the USPTO will still accord a filing date if the application otherwise meets the requirements. The MPEP states:

OPAP accords a filing date, as of the date indicated by the “Office Date” stamp (see MPEP § 505), to application papers which include a specification containing a description and at least one claim (nonprovisional applications filed under 37 CFR 1.53(b) prior to March 18, 2013 and design applications), and a drawing, if necessary under 35 U.S.C. 113 (first sentence) and 37 CFR 1.53(b), but are informal because they do not comply with the rules or notices.

The USPTO will send a Notice requiring correction of the informality. Failure to correct the informality within the specified time will result in abandonment of the application.

If a nonsigning inventor believes they are the sole inventor of an invention claimed in a pre-AIA 37 CFR 1.47 application where they are named as a joint inventor, they have a specific course of action available to them.

According to MPEP 409.03(i):

“If a nonsigning inventor feels that he or she is the sole inventor of an invention claimed in a pre-AIA 37 CFR 1.47 application naming him or her as a joint inventor, the nonsigning inventor may file his or her own application and request that his or her application be placed in interference with the pre-AIA 37 CFR 1.47 application.”

This means that the nonsigning inventor can:

  1. File their own separate patent application for the invention
  2. Request that their application be placed in interference with the pre-AIA 37 CFR 1.47 application

The MPEP further states: “If the claims in both the nonsigning inventor’s application and the pre-AIA 37 CFR 1.47 application are otherwise found allowable, an interference may be declared.”

An interference proceeding is a process used to determine which party has the right to a patent when two or more parties claim the same invention.

To learn more:

To learn more:

If a nonprovisional patent application is filed without all required fees, the USPTO will send a notice to the applicant. According to the MPEP:

Filing dates are accorded to nonprovisional applications filed under 37 CFR 1.53(b) submitted without the… required fees (basic filing fee, and search and examination fees (for applications filed on or after December 8, 2004))… In such cases, a notice is mailed by OPAP requiring the appropriate fees… accompanied by a surcharge (37 CFR 1.16(f)).

The applicant will be given a time period (usually two months) to pay the missing fees and surcharge to avoid abandonment of the application.

What happens if a nonprovisional application is filed without drawings but they are necessary?

If a nonprovisional application is filed without drawings, but drawings are necessary for understanding the subject matter sought to be patented, the USPTO will send a Notice of Incomplete Application. The MPEP states:

If drawings are necessary under 35 U.S.C. 113 (first sentence) and are omitted on filing, the Office will send a Notice of Incomplete Application indicating that drawings are required and setting a time period within which the applicant must submit the omitted drawings to avoid abandonment.

The applicant must then submit the required drawings within the specified time period to avoid abandonment of the application. It’s important to note that the filing date of the application will be the date on which the drawings are received by the USPTO, not the original filing date.

For more information, refer to MPEP 601.01(a).

To learn more:

If a nonprovisional application is filed without all pages of the specification, but contains something that can be construed as a written description, the USPTO will take the following actions:

  1. Issue a Notice of Omitted Items indicating the application has been accorded a filing date but is missing some pages of the specification.
  2. Give the applicant an opportunity to either:
    • Establish prior receipt of the missing pages
    • Submit the omitted pages and request the later submission date as the filing date
    • Accept the application as deposited without the missing pages

The USPTO states: The mailing of an OPAP notice regarding a missing page(s) of specification in a nonprovisional application will permit the applicant to: (A) promptly establish prior receipt in the USPTO of the page(s) at issue… (B) promptly submit the omitted page(s) in a nonprovisional application and accept the date of such submission as the application filing date… (C) accept the application as deposited in the USPTO…

To learn more:

What happens if a nonprovisional application claims benefit of multiple provisional applications?

When a nonprovisional application claims the benefit of multiple provisional applications, each provisional application must satisfy the requirements of 35 U.S.C. 119(e) and the first paragraph of 35 U.S.C. 112 for the subject matter claimed in the nonprovisional application.

As stated in MPEP 211.01(a):

“If a claim in the nonprovisional application is not adequately supported by any of the prior provisional applications, that claim is not entitled to the benefit of the filing date of the provisional applications not providing adequate support.”

This means that different claims in the nonprovisional application may have different effective filing dates, depending on which provisional application(s) provide adequate support for each claim.

To learn more:

When a new power of attorney is filed that lists only one of two previously appointed patent practitioners, it has significant implications. According to MPEP 403.02:

“Note that if the later-filed power of attorney only lists the second practitioner, the later-filed power of attorney serves as a revocation of the earlier-filed power of attorney, even without an express revocation of the power of the first patent practitioner.”

This means that filing a new power of attorney listing only one practitioner effectively revokes the authority of the previously appointed practitioner, even if the revocation is not explicitly stated. This is an important consideration for applicants and practitioners when making changes to representation.

To learn more:

If a new inventor is identified in a Continued Prosecution Application (CPA) without proper documentation, it can lead to issues with the application. The MPEP ¶ 2.33 states:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

This means that if an examiner notices a new inventor listed on a CPA without the required request under 37 CFR 1.48, they will issue a notice to the applicant. The inventorship will remain the same as in the prior application until the proper request is filed and approved.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

If a new inventor is identified in a Continued Prosecution Application (CPA) without filing a proper request, it can lead to inventorship issues. The MPEP ¶ 2.33 states:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

This means that simply naming a new inventor in the CPA filing documents is not sufficient. Without a proper request under 37 CFR 1.48, the inventorship will remain the same as in the prior application, potentially leading to complications in the patent prosecution process.

For more information on CPA, visit: CPA.

Tags: CPA

If a new inventor is identified in a Continued Prosecution Application (CPA) for a design application, specific steps must be taken to properly add them to the application.

MPEP ¶ 2.33 states: “It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.”

This means that simply naming a new inventor in the CPA filing is not sufficient. A formal request under 37 CFR 1.48 must be filed to correct the inventorship. Without this request, the inventorship will remain the same as in the prior application, regardless of any new names listed on the CPA filing.

For more information on CPA, visit: CPA.

Tags: CPA

If a legal representative hasn’t been appointed for a deceased inventor in an application filed before September 16, 2012, the situation can be complex. According to MPEP 409.01(b):

If no legal representative has been appointed, the examiner will reject the application under 35 U.S.C. 102(f) on the basis that the applicant is not the inventor and/or on the basis that there is no right to apply in any person other than the inventor.

This means that without a legal representative, the application may face rejection. It’s crucial to appoint a legal representative as soon as possible to avoid this outcome.

To learn more:

If a foreign priority claim in an original application filed under 35 U.S.C. 111(a) (other than a design application) is submitted after the time period set in 37 CFR 1.55 and without a petition under 37 CFR 1.55, the examiner may notify the applicant that the foreign priority claim will not be entered.

As stated in the MPEP: If the foreign priority claim in an original application filed under 35 U.S.C. 111(a) (other than a design application) is submitted after the time period set in 37 CFR 1.55 and without a petition under 37 CFR 1.55, the examiner may use form paragraph 2.21.01 to notify applicant that the foreign priority claim will not be entered.

In such cases, the applicant must file a petition for an unintentionally delayed priority claim under 37 CFR 1.55(e) to have the priority claim considered.

To learn more:

What happens if a foreign patent agent’s limited recognition expires?

If a foreign patent agent’s limited recognition expires, they are no longer authorized to represent applicants before the USPTO. The MPEP states, A foreign patent agent granted limited recognition may continue to represent applicants for the remainder of any time period previously set by the USPTO for taking an action, which period is still outstanding at the expiration of the 5-year period of recognition. (MPEP 402.01) This means that if there are any ongoing actions with set deadlines, the agent can complete those, but they cannot take on new representations or continue general practice until they renew their limited recognition status.

To learn more:

Tags: USPTO

If a foreign application was filed more than 12 months before the U.S. application and priority has not been restored, the examiner will use form paragraph 2.23 to notify the applicant that the claim for priority cannot be based on that application.

As stated in the MPEP: Where the earlier foreign application was filed more than 12 months prior to the U.S. application and priority has not been restored under PCT Rule 26bis.3 for an international application or upon a granted petition under 37 CFR 1.55(c), use form paragraph 2.23.

In such cases, the applicant may file a petition under 37 CFR 1.55(c) to restore the right of priority if:

  • The subsequent application was filed within two months from the expiration of the twelve-month period
  • The delay was unintentional

The petition must include specific elements, such as the priority claim, petition fee, and a statement about the unintentional delay.

To learn more:

If the USPTO determines that a faxed assignment document is not recordable, there’s a specific process outlined in MPEP 302.09:

  1. The entire document, including the cover sheet, is returned to the sender via fax.
  2. A ‘Notice of Non-Recordation’ is included with the returned document.
  3. The sender can make corrections and resubmit the document.
  4. Resubmission must be done by mail to the address in 37 CFR 3.27.
  5. Timely resubmission preserves the initial receipt date as the recordation date.

The MPEP states: If a document submitted by fax is determined not to be recordable, the entire document, with its associated cover sheet, and the Office ‘Notice of Non-Recordation’ will be transmitted via fax back to the sender. Once corrections are made, the initial submission, amended, may then be resubmitted by mailing the corrected submission to the address set forth in 37 CFR 3.27. Timely resubmission will provide the sender with the benefit of the initial receipt date as the recordation date in accordance with 37 CFR 3.51.

To learn more:

If a drawing is not included with the application but is required for a complete disclosure of the invention, the Office of Patent Application Processing (OPAP) will send a Notice to File Missing Parts giving the applicant a time period of two months from the mailing date of the Notice to file the missing drawing(s). The time period may be extended under 37 CFR 1.136(a).

If a drawing is not acceptable for publication, the Office of Patent Application Processing (OPAP) will object to the drawing and notify the applicant. The applicant will be given a time period of two months from the mail date of the Notice to file acceptable drawings. This period is extendable under 37 CFR 1.136(a) or (b) for patent applications filed under 35 U.S.C. 111, but not for design applications filed under 35 U.S.C. 171. Failure to comply with the Notice within the time period will result in abandonment of the application.

What happens if a divisional application is filed after the parent application is patented or abandoned?

If a divisional application is filed after the parent application has been patented or abandoned, it will not be entitled to the benefit of the parent application’s filing date. The MPEP states:

A divisional application is often filed as a result of a restriction requirement made by the examiner. The divisional application may be filed under 37 CFR 1.53(b) (or 1.53(d) if the application is a design application) before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention.

Filing a divisional application after the parent application has been patented or abandoned means:

  • The application will not be considered a proper divisional application
  • It will not receive the benefit of the parent application’s filing date
  • It may be treated as a new, independent application
  • Prior art that was not applicable to the parent application may now be applicable
  • The application may face potential statutory bars under 35 U.S.C. 102

To avoid these issues, it’s crucial to file divisional applications before the patenting, abandonment, or termination of proceedings on the parent application.

For more information on Divisional application, visit: Divisional application.

For more information on late filing, visit: late filing.

For more information on patent procedure, visit: patent procedure.

If the designated domestic representative cannot be found or if no person has been designated, 35 U.S.C. 293 provides a solution:

If the person designated cannot be found at the address given in the last designation, or if no person has been designated, the United States District Court for the Eastern District of Virginia shall have jurisdiction and summons shall be served by publication or otherwise as the court directs.

This means that if the domestic representative is unreachable or non-existent, the U.S. District Court for the Eastern District of Virginia will handle the case and determine how to serve the summons. This ensures that legal proceedings can continue even if there are issues with the domestic representative.

To learn more:

If a delayed benefit claim is filed after the patent issues, it cannot be accepted. The MPEP 211.04 states:

‘A delayed benefit claim filed after issuance of a patent cannot be accepted.’

This means that once a patent has been granted, it is no longer possible to add or modify benefit claims. Any attempts to file a delayed benefit claim after patent issuance will be denied.

To learn more:

If a defense agency concludes that disclosure of the invention would be detrimental to national security, they will recommend a secrecy order to the Commissioner for Patents. The Commissioner will then issue the secrecy order and withhold publication of the application or granting of a patent for as long as the national interest requires.

“If a defense agency concludes that disclosure of the invention would be detrimental to the national security, a secrecy order is recommended to the Commissioner for Patents. The Commissioner then issues a Secrecy Order and withholds the publication of the application or the grant of a patent for such period as the national interest requires.”

If a Continued Prosecution Application (CPA) request for a design patent is not submitted on a separate paper, it will be considered non-compliant and will not be processed by the USPTO.

The MPEP clearly states: ‘Because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.’ This means that the CPA will not be initiated, and the applicant will need to resubmit the request properly to proceed with the continued examination.

In such cases, the USPTO will typically send a notification to the applicant informing them of the non-compliance and providing instructions for proper submission.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

If a Continued Prosecution Application (CPA) request is improper for a utility or plant application, the USPTO handles it differently than for design applications. According to MPEP ¶ 2.35:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

In such cases, the USPTO treats the improper CPA request as a Request for Continued Examination (RCE). This approach ensures that the application can continue to be prosecuted, albeit under a different procedure. Applicants should be aware of this distinction and the potential implications for their patent prosecution strategy.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

If a Continued Prosecution Application (CPA) is improperly requested for a utility or plant patent application, it is typically treated as a Request for Continued Examination (RCE). The MPEP ¶ 2.30 provides guidance on this situation:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

In such cases, the examiner will use a different form paragraph (7.42.15) to notify the applicant that their CPA request has been treated as an RCE. This ensures that the application can continue to be examined under the appropriate procedure for utility or plant patents.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

If a Continued Prosecution Application (CPA) is filed in a utility or plant application after July 14, 2003, it will not be treated as a proper CPA. According to MPEP 201.06(d):

‘Any CPA filed on or after July 14, 2003 in a utility or plant application will automatically be treated as a request for continued examination (RCE) under 37 CFR 1.114, see MPEP § 706.07(h), paragraph II.’

This means that instead of being processed as a CPA, the application will be treated as a Request for Continued Examination (RCE). Applicants should be aware of this automatic conversion and ensure they meet the requirements for an RCE if they inadvertently file a CPA for a utility or plant application.

For more information on CPA, visit: CPA.

For more information on RCE, visit: RCE.

Tags: CPA, RCE

What happens if a copending application is abandoned after filing a continuation application?

If a copending application is abandoned after filing a continuation application, it does not affect the continuation application’s status. The MPEP states:

“The copendency requirement of 35 U.S.C. 120 is met if the later-filed application is filed before the patenting or abandonment of or termination of proceedings on the prior application.”

This means that as long as the continuation application was filed while the prior application was still pending, subsequent abandonment of the prior application does not impact the continuation’s validity. The continuation application can still claim the benefit of the prior application’s filing date.

For more information, refer to MPEP 211.01.

To learn more:

To learn more:

If a Continued Prosecution Application (CPA) is filed after the issue fee has been paid, it will not be treated as a CPA. Instead, it will be processed as follows:

  • For applications filed on or after May 29, 2000, the CPA will be treated as a request for continued examination (RCE) under 37 CFR 1.114.
  • For applications filed before May 29, 2000, the CPA will be treated as an improper application and will not be processed.

As stated in MPEP 201.06(d): “If an application is filed on or after May 29, 2000, the filing of a CPA is not permitted after payment of the issue fee. In such a case, the Office will treat the improper CPA as an RCE under 37 CFR 1.114, provided that the application is a utility or plant application filed on or after June 8, 1995.”

It’s important to note that this treatment as an RCE is only possible for utility or plant applications filed on or after June 8, 1995. For other types of applications or those filed before this date, the improper CPA filing will not be processed, and the applicant may need to consider other options, such as filing a reissue application if the patent has already issued.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on issue fee, visit: issue fee.

For more information on RCE, visit: RCE.

When a continuation-in-part (CIP) application includes new matter not disclosed in the parent application, the following consequences apply:

  • Claims solely directed to subject matter adequately disclosed in the parent application are entitled to the parent application’s filing date.
  • Claims that include new matter introduced in the CIP are only entitled to the filing date of the CIP application.
  • The new matter may affect the application’s ability to overcome prior art references.

As stated in MPEP 211.05:

“Any claim in a continuation-in-part application which is directed solely to subject matter adequately disclosed under 35 U.S.C. 112 in the parent nonprovisional application is entitled to the benefit of the filing date of the parent nonprovisional application. However, if a claim in a continuation-in-part application recites a feature which was not disclosed or adequately supported by a proper disclosure under 35 U.S.C. 112 in the parent nonprovisional application, but which was first introduced or adequately supported in the continuation-in-part application, such a claim is entitled only to the filing date of the continuation-in-part application.”

This differentiation in filing dates for different claims within the same CIP application can significantly impact the application’s ability to overcome prior art and maintain patentability.

To learn more:

If a continuation or divisional application contains new matter not disclosed in the prior-filed application, the applicant will be required to either delete the benefit claim or change the relationship to a continuation-in-part application. This is because continuation and divisional applications cannot include new matter.

As stated in MPEP ¶ 2.10.01:

“Applicant is required to delete the benefit claim or change the relationship (continuation or divisional application) to continuation-in-part because this application contains the following matter not disclosed in the prior-filed application:”

This form paragraph is used by examiners when they identify new matter in an application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c).

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent examination, visit: patent examination.

What happens if a continuation application is filed after the parent application has been abandoned?

If a continuation application is filed after the parent application has been abandoned, it may still be entitled to the benefit of the filing date of the prior application. The MPEP states:

“Where the prior application has been abandoned, the petition to revive under 37 CFR 1.137 (a) or (b) must be filed in the prior application, or in a subsequent nonprovisional application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the prior application, if the prior nonprovisional application is not pending and claims the benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) of a provisional application.”

This means that even if the parent application is abandoned, you can still file a continuation application and potentially revive the parent application. However, specific procedures must be followed, including filing a petition to revive in the appropriate application.

For more information on reviving abandoned applications, refer to MPEP 711.

To learn more:

To learn more:

Even if a citation considered by the examiner is not printed on the patent, there is still a record of its consideration. The MPEP clarifies:

If a citation is not printed on the patent but has been considered by the examiner, the patented file will reflect that fact as noted in MPEP § 609.05(b).

This means that while the citation may not appear on the face of the patent, the official file history maintained by the USPTO will contain evidence that the examiner considered the citation during the examination process. This information can be important for understanding the full scope of prior art considered during patent prosecution.

To learn more:

If a certified copy of the priority document is not filed within the time limit in a U.S. national stage application, the following consequences may occur:

  • The right to priority may be lost if the certified copy is not filed within the time period set in 37 CFR 1.55.
  • However, if the certified copy is filed after the time period set in 37 CFR 1.55 but during the pendency of the application, the right to priority may be restored under certain conditions.
  • According to MPEP 213.06, ‘If the certified copy is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’

It’s crucial to file the certified copy within the specified time limit to avoid potential complications in claiming priority.

To learn more:

To learn more:

What happens if a certified copy is not received within the time period set in 37 CFR 1.55(f)?

If a certified copy is not received within the time period set in 37 CFR 1.55(f), the USPTO will send a Notice of Allowance and Issue Fee Due (Notice of Allowance) with a requirement for the certified copy. As stated in the MPEP:

‘If a certified copy of the foreign application is not filed within the time period specified in 37 CFR 1.55(f) and the exceptions in 37 CFR 1.55(h), (i), and (j) are not applicable, the certified copy of the foreign application must be accompanied by a petition including a showing of good and sufficient cause for the delay and the petition fee set forth in 37 CFR 1.17(g).’

This means that if you miss the deadline, you’ll need to file a petition explaining the delay and pay an additional fee. It’s crucial to submit the certified copy or ensure it’s retrievable through the priority document exchange program to avoid complications in the patent application process.

If a benefit claim to a provisional application lacks proper indication of an intermediate application:

  • The Office may not recognize the benefit claim
  • The benefit claim may not appear on the filing receipt
  • A petition under 37 CFR 1.78(c) and petition fee may be required to correct the benefit claim

MPEP 211.01(b) states: “If a benefit claim to a provisional application is submitted without an indication that an intermediate application directly claims the benefit of the provisional application and the instant nonprovisional application is not filed within the 12 month period (or 14 month period if the benefit of the provisional application has been restored pursuant to 37 CFR 1.78(b)) or the relationship between each nonprovisional application is not indicated, the Office will not recognize such benefit claim and will not include the benefit claim on the filing receipt.”

If a benefit claim is included elsewhere in the application (e.g., in an oath or declaration) and is recognized by the USPTO as shown by its inclusion on the first filing receipt, but not properly submitted in the manner specified by 37 CFR 1.78, the following applies:

  • The USPTO will not require a petition and petition fee to correct the benefit claim.
  • This is because the application will have been scheduled for publication based on the information concerning the benefit claim.
  • However, the applicant must still submit the benefit claim in the proper manner (i.e., in an ADS or by amendment to the specification, depending on the filing date) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78.

The MPEP states: “If an applicant includes a claim to the benefit of a prior application elsewhere in the application but not in the manner specified in 37 CFR 1.78 (e.g., if the benefit claim is not present in the proper place but is included in an oath or declaration, or the application transmittal letter, or in the first sentence(s) of the specification for an application filed on or after September 16, 2012) within the time period set forth in 37 CFR 1.78, the Office will not require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the information concerning the benefit claim contained elsewhere in the application was recognized by the Office as shown by its inclusion on the first filing receipt.”

If a benefit claim is not submitted within the required time period, it is considered waived. The MPEP states: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c) unless a petition to accept an unintentionally delayed benefit claim is granted.

However, applicants may file a petition to accept an unintentionally delayed benefit claim. For more information on this process, see MPEP § 211.04.

To learn more:

If a benefit claim is not properly made within the required time period, it is considered untimely and will not be entered. The MPEP states:

“The benefit claim filed on [1] was not entered because the required reference was not timely filed within the time period set forth in 37 CFR 1.78.”

Consequences of an untimely benefit claim include:

  • Loss of the earlier priority date, which could affect the patentability of the application if intervening prior art exists.
  • Inability to rely on the earlier filing date to overcome prior art references.
  • Potential issues with statutory bars under 35 U.S.C. 102.

However, all is not lost if the benefit claim is untimely. The applicant may file a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(c) or 37 CFR 1.78(e), depending on the type of benefit claim. This petition must include:

  1. The required reference to the prior application
  2. A petition fee
  3. A statement that the entire delay was unintentional

The USPTO may require additional information to determine if the delay was truly unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on unintentional delay, visit: unintentional delay.

If an applicant includes a benefit claim in the wrong part of the application but within the required time period, the USPTO’s response depends on whether the claim is recognized:

  1. If the benefit claim is recognized by the Office (shown by its inclusion on the first filing receipt), no petition or petition fee is required to correct the benefit claim. The MPEP states: If an applicant includes a claim to the benefit of a prior application elsewhere in the application but not in the manner specified in 37 CFR 1.78 (e.g., if the benefit claim is not present in the proper place but is included in an oath or declaration, or the application transmittal letter, or in the first sentence(s) of the specification for an application filed on or after September 16, 2012) within the time period set forth in 37 CFR 1.78, the Office will not require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the information concerning the benefit claim contained elsewhere in the application was recognized by the Office as shown by its inclusion on the first filing receipt.
  2. If the benefit claim is not recognized by the Office (shown by its absence on the first filing receipt), a petition and petition fee under 37 CFR 1.17(m) will be required to correct the benefit claim if the correction is sought after the time period set in 37 CFR 1.78.

In both cases, the applicant must still submit the benefit claim in the proper format (i.e., in an ADS or by amendment to the specification, depending on the application’s filing date) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on filing receipt, visit: filing receipt.

If a benefit claim is filed after the required time period specified in 37 CFR 1.78, the applicant must file a petition for an unintentionally delayed benefit claim. The MPEP states:

“If a benefit claim is filed after the required time period and without a petition as required by 37 CFR 1.78, the applicant should be informed that the benefit claim was not entered and that a petition needs to be filed using form paragraph 2.39.”

The petition must include:

  • The reference to the prior application (unless previously submitted)
  • A petition fee under 37 CFR 1.17(m)
  • A statement that the entire delay was unintentional

The Director may require additional information to determine if the delay was unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on unintentional delay, visit: unintentional delay.

The treatment of dependent claims when a base claim is canceled or rejected is addressed in MPEP 608.01(n):

  • If the base claim has been canceled, a claim which is directly or indirectly dependent thereon should be rejected as incomplete.
  • If the base claim is rejected, the dependent claim should be objected to rather than rejected, if it is otherwise allowable.

The MPEP provides a specific form paragraph (7.43) for objecting to claims that are dependent on a rejected base claim: “Claim [1] objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.”

This approach allows examiners to indicate potentially allowable subject matter while maintaining the rejection of the base claim.

To learn more:

After an application filed under pre-AIA 37 CFR 1.47 is accepted by the USPTO, the examiner proceeds with the application as usual. As stated in the MPEP:

“After an application deposited pursuant to pre-AIA 37 CFR 1.47 is found acceptable by the Office, the examiner will act on the application in the usual manner.”

This means that the application will be examined and processed like any other patent application, despite its initial filing under special circumstances.

To learn more:

To learn more:

After a Continued Prosecution Application (CPA) is established, the USPTO proceeds with examination. According to MPEP ¶ 2.35:

Accordingly, the request for a CPA application is acceptable and a CPA has been established. An action on the CPA follows.

This means that once the CPA is established, the examiner will review the application and issue an Office action. It’s important to note that applicants are not separately notified of the abandonment of the parent application, nor is a filing receipt normally sent for a CPA.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO procedures, visit: USPTO procedures.

Once a Continued Prosecution Application (CPA) is established from a Conditional Request, the USPTO proceeds with the examination process as it would for any other CPA. According to MPEP ¶ 2.35: “An action on the CPA follows.”

This means that after the CPA is established:

  • The parent application is considered abandoned
  • The examiner will review the CPA and issue an Office action
  • The applicant should be aware that they may not receive a filing receipt for the CPA, as noted in the MPEP: “This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

37 CFR 1.62, which covered the File Wrapper Continuing Procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette 1203, published on October 21, 1997.

The MPEP states: 37 CFR 1.62 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This means that applications filed under this procedure after its deletion date would be treated differently.

To learn more:

To learn more:

37 CFR 1.62, which covered the File Wrapper Continuing Procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette: “See 1203 O.G. 63, October 21, 1997.” This deletion significantly impacted how certain continuation, divisional, and continuation-in-part applications were processed.

For more information on patent application procedures, visit: patent application procedures.

37 CFR 1.60, which previously governed the filing of divisional and continuation applications, was deleted effective December 1, 1997. As stated in the MPEP, 37 CFR 1.60 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This change significantly impacted the procedure for filing these types of applications.

For more information on continuation applications, visit: continuation applications.

37 CFR 1.60, which dealt with the divisional continuation procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette, as stated in the MPEP: 37 CFR 1.60 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This means that the specific procedures outlined in this regulation are no longer in effect for applications filed after this date.

To learn more:

To learn more:

For patent applications filed before September 16, 2012, the USPTO recommends specific forms for powers of attorney. According to the MPEP:

Form PTO/SB/80 or PTO/SB/81 (available at www.uspto.gov/patent/patents-forms) should be used for powers of attorney in applications filed before September 16, 2012.

Additionally, for patents that issued from applications filed before September 16, 2012, Form PTO/SB/81A may be used. It’s important to note that the USPTO no longer recommends or provides combined declaration and power of attorney forms. Practitioners should use separate forms for declarations and powers of attorney.

To learn more:

Patent examiners have several forms at their disposal to communicate about replacement drawings:

  1. Form Paragraph 6.37: Used to acknowledge receipt of replacement drawing sheets.
  2. Form PTOL-324: Can be used instead of Form Paragraph 6.37 to provide explanations about drawing compliance.
  3. Form PTOL-326 (Office Action Summary): Includes a specific block for acknowledging replacement drawings.

The MPEP 608.02(h) provides guidance on using these forms:

“Form paragraph 6.37 may be used to acknowledge replacement drawing sheets. […] Form PTOL-324 may be used instead of this form paragraph to provide the explanation. Alternatively, PTOL-326 Office Action Summary includes a block for acknowledgment of replacement drawings.”

These forms help ensure clear and consistent communication between examiners and applicants regarding the status and acceptability of replacement drawings.

To learn more:

There are two main forms that can be used to authorize a patent practitioner for an interview:

  1. Applicant Initiated Interview Request Form (PTOL-413A)
  2. Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity’

According to MPEP 405:

Registered practitioners, when acting in a representative capacity, can show authorization to conduct an interview by completing, signing and filing an Applicant Initiated Interview Request Form (PTOL-413A).

Additionally:

Alternatively, Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity,’ which is available from the USPTO website at www.uspto.gov/sites/default/files/web/forms/sb0084.pdf may be used to establish the authority to conduct an interview.

The United States Patent and Trademark Office (USPTO) provides several forms that can be used for submitting an inventor’s oath or declaration in patent applications filed on or after September 16, 2012. These forms are:

  • Forms PTO/AIA/01 through PTO/AIA/11

These forms are designed to ensure that all required information and statements are included in the oath or declaration. They can be found on the USPTO website at www.uspto.gov/PatentForms.

In addition to these forms, the USPTO provides an ‘AIA Inventor’s Oath or Declaration Quick Reference Guide’ to assist applicants in properly completing and submitting the inventor’s oath or declaration.

While using these forms is not mandatory, they can help ensure compliance with the requirements set forth in 37 CFR 1.63 and 35 U.S.C. 115. If not using these forms, applicants must ensure that all required information and statements are included in their custom oath or declaration.

To learn more:

The USPTO provides several forms for Customer Number practice:

  • PTO/SB/125 – Request for Customer Number
  • PTO/SB/124 – Request for Customer Number Data Change
  • PTO/AIA/122 or PTO/SB/122 – Change of Correspondence Address, Application
  • PTO/AIA/123 or PTO/SB/123 – Change of Correspondence Address, Patent

According to MPEP 403: “The following forms are suggested for use with the Customer Number practice: (A) the ‘Request for Customer Number’ (PTO/SB/125) to request a Customer Number; (B) the ‘Request for Customer Number Data Change’ (PTO/SB/124) to request a change in the data (address or list of practitioners) associated with an existing Customer Number; (C) the ‘Change of Correspondence Address, Application’ (PTO/AIA/122 for applications filed on or after September 16, 2012, or PTO/SB/122 for applications filed before September 16, 2012) to change the correspondence address of an individual application to the address associated with a Customer Number; and (D) the ‘Change of Correspondence Address, Patent’ (PTO/AIA/123 for applications filed on or after September 16, 2012, or PTO//SB/123 for applications filed before September 16, 2012) to change the correspondence address of an individual patent to the address associated with a Customer Number.”

For pre-AIA applications (filed before September 16, 2012), the MPEP mentions a specific form that can be used by assignees to revoke a power of attorney and appoint a new one:

Form PTO/SB/80 may be used by an assignee of the entire interest of the applicant to revoke a power of attorney and appoint a new power of attorney.

The process involves:

  • The assignee signing the power of attorney (Form PTO/SB/80)
  • Either the assignee or the newly appointed practitioner signing a statement under pre-AIA 37 CFR 3.73(b)

Additionally, Form PTO/SB/96 or an equivalent can be used for the Statement Under pre-AIA 37 CFR 3.73(b). For details on who can sign this statement, refer to MPEP § 324, subsection V.

To learn more:

For patent applications filed on or after September 16, 2012, specific forms are required for appointing a power of attorney. The MPEP 601.02 directs applicants to the appropriate section for guidance:

“See MPEP § 402.02(a) for detailed information and relevant forms pertaining to appointment of a power of attorney in applications filed on or after September 16, 2012.”

To access the specific forms and detailed instructions, you should consult MPEP § 402.02(a). This section provides comprehensive information on the process and required documentation for appointing a power of attorney in recent patent applications.

To learn more:

The USPTO provides several forms for appointing a power of attorney in patent applications filed on or after September 16, 2012. These forms are available on the USPTO website and include:

  • PTO/AIA/80: For use by assignees who are either the named applicant or are becoming the applicant.
  • PTO/AIA/81: For use by joint inventors who are the applicant to give one or more joint inventor-applicants power of attorney.
  • PTO/AIA/82: For use by the applicant for patent to appoint one or more patent practitioners.
  • PTO/AIA/81A: For use in appointing a power of attorney in a patent resulting from an application filed on or after September 16, 2012.

Each form has specific uses and requirements. For example, Form PTO/AIA/80 must be accompanied by a statement under 37 CFR 3.73(c) (Form PTO/AIA/96 or equivalent) and must be signed by the named assignee or a person authorized to act on behalf of the assignee.

To learn more:

When an applicant is initiating an interview request, they should submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) to the examiner. The MPEP provides the following guidance:

When applicant is initiating a request for an interview, an ‘Applicant Initiated Interview Request’ form (PTOL-413A) should be submitted to the examiner prior to the interview in order to permit the examiner to prepare in advance for the interview and to focus on the issues to be discussed.

This form helps streamline the interview process by providing the examiner with essential information about the proposed interview.

Examiners use specific form paragraphs when requiring a title change in a patent application. According to MPEP 606.01, “Form paragraphs 6.11 and 6.11.01 may be used.” Form paragraph 6.11 states that the title is not descriptive and a new title is required. Form paragraph 6.11.01 is used to suggest a new title. These standardized paragraphs ensure consistency in communication between examiners and applicants regarding title changes.

To learn more:

The U.S. Patent and Trademark Office provides a specific form for certifying micro entity status based on an institution of higher education. This form is PTO/SB/15B.

MPEP 509.04(b) states: “The Office’s form PTO/SB/15B contains the certifications under 37 CFR 1.29(d) that are required to establish micro entity status on the institution of higher education basis.”

The form includes two signature blocks corresponding to the two alternative requirements under 37 CFR 1.29(d)(2):

  1. Certifying that the applicant’s employer, from which they obtain the majority of their income, is an institution of higher education.
  2. Certifying that the applicant has assigned, granted, or conveyed a license or other ownership interest in the application to an institution of higher education (or is obligated to do so).

Applicants should use this form to properly certify their micro entity status based on an institution of higher education.

To learn more:

Tags: patent fees

To correct or update an inventor’s name in a patent application (other than reissue applications), you can use Form PTO/AIA/40. As stated in MPEP 602.01(c)(2):

See MPEP § 602.01(c)(1) for a copy of form PTO/AIA/40 that may be used to correct or update in inventor’s name or change the order of names in applications (other than reissue applications).

This form should be submitted along with:

  • An application data sheet (ADS) in accordance with 37 CFR 1.76 that identifies each inventor by their legal name in the desired order.
  • The processing fee set forth in 37 CFR 1.17(i).

Remember to clearly identify the desired inventor name change in your request.

To learn more:

The USPTO accepts the following file formats for electronic submission of assignment documents:

  • PDF (Portable Document Format)
  • TIFF (Tagged Image File Format)

As stated in MPEP 302.10: “The USPTO will accept electronic submissions of assignment documents in TIFF or PDF format.” It’s important to note that these formats are chosen for their ability to preserve document integrity and ensure long-term accessibility.

To learn more:

The acceptable file formats for submitting biological sequence listings in patent applications are:

  • ASCII text files
  • PDF files (for submissions up to 100MB)

MPEP 608.05(c) states: “Sequence listings may be submitted in electronic form via EFS-Web or PatentCenter as ASCII text files or PDF files up to 100 megabytes.”

It’s important to note that ASCII text format is preferred and required for larger submissions. PDF format is acceptable only for smaller submissions up to 100MB. When submitting on read-only optical discs for files over 100MB, the sequence listing must be in ASCII text format.

Ensure that the sequence listing complies with the requirements set forth in 37 CFR 1.821-1.825 regardless of the file format used.

To learn more:

A USPTO deposit account can be used to pay various fees related to patent applications and services. According to the MPEP:

Filing, issue, appeal, international-type search report, international application processing, international design application fees, petition, and post-issuance fees may be charged against these accounts if sufficient funds are on deposit to cover such fees.

Specifically, fees that can be charged include:

  • Filing fees (37 CFR 1.16)
  • Processing fees (37 CFR 1.17)
  • Issue fees (37 CFR 1.18, subject to certain conditions)
  • Appeal fees
  • International application fees
  • Petition fees

However, fees under 37 CFR 1.19 (document supply fees), 1.20 (post-issuance fees), and 1.21 (miscellaneous fees) generally cannot be charged through a general authorization, with some exceptions.

To learn more:

When correcting an erroneous assignment or name change, you must pay the required fee for each application or patent affected. According to MPEP 323.01(c):

The required fee ( 37 CFR 3.41 ) for each application or patent to be corrected.

The specific fee amount can be found in the current USPTO fee schedule. It’s important to note that a separate fee is required for each application or patent that needs correction, even if they are related to the same erroneous assignment.

To learn more:

To maintain an allowed application’s status and proceed to patent issuance, certain fees must be paid. The MPEP mentions two specific fees:

  1. Issue fee: This is the fee required for the USPTO to issue the patent.
  2. Publication fee: If applicable, this fee covers the cost of publishing the patent application.

The MPEP states that an application becomes abandoned “for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).” Therefore, timely payment of these fees is crucial to maintain the allowed status and proceed to patent issuance.

To learn more:

To correct a typographical error on a patent assignment cover sheet, you must pay the required fee for each application or patent that needs correction. According to MPEP 323.01(a):

“The party requesting correction should submit… (C) the required fee for each application or patent to be corrected (37 CFR 3.41).”

The specific fee amount is set by 37 CFR 3.41 and may change periodically. It’s important to check the current USPTO Fee Schedule for the most up-to-date fee information. The fee is required per application or patent, so if multiple documents need correction, multiple fees may apply.

To learn more:

When correcting a typographical error in a recorded assignment document, fees are required. The MPEP 323.01(b) states:

The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).

The specific fee amount is set by 37 CFR 3.41. It’s important to note that:

  • A separate fee is required for each application or patent affected by the correction.
  • The fee amount may change, so it’s best to check the current USPTO fee schedule for the most up-to-date information.

To learn more:

Micro entities receive a 75% reduction on many USPTO fees, including:

  • Filing fees (nonprovisional and provisional)
  • Search fees
  • Examination fees
  • Issue fees
  • Appeal fees
  • Maintenance fees
  • Patent Trial and Appeal Board fees

The micro entity discount applies to most fees ‘for filing, searching, examining, issuing, appealing, and maintaining patent applications and patents.’

Recording a patent assignment at the USPTO involves paying an appropriate recording fee. MPEP 315 references the fee requirements:

The appropriate recording fee (see 37 CFR 1.21(h) and 3.41).

The specific fee amount can be found in the USPTO’s current fee schedule. It’s important to note that:

  • Fees may vary depending on whether the submission is electronic or paper-based
  • There may be additional fees for expedited processing
  • Fees are subject to change, so always check the current fee schedule before submitting

For the most up-to-date information on fees, visit the USPTO’s official fee schedule page.

To support a petition under pre-AIA 37 CFR 1.47, the following evidence is typically required:

  • A statement of facts signed by someone with firsthand knowledge
  • Documentary evidence such as Internet searches, certified mail return receipts, cover letters of instructions, or telegrams
  • Details of steps taken to locate the nonsigning inventor

The MPEP emphasizes:

‘The statement of facts must be signed, where at all possible, by a person having firsthand knowledge of the facts recited therein. Statements based on hearsay will not normally be accepted.’

It’s crucial to provide facts rather than conclusions in the statement.

To learn more:

To learn more:

To show an inventor is unavailable or refuses to sign, the petitioner must provide substantial evidence. According to MPEP 409.03(b):

‘The fact that an inventor is unavailable or refuses to join in an application must be established by satisfactory proof… such as inability to find him or reach him after diligent effort.’

Evidence may include:

  • Copies of correspondence sent to the last known address with no response
  • Returned mail showing the inventor is no longer at the address
  • Affidavits from people with knowledge of the inventor’s unavailability
  • Documentation of attempts to contact the inventor through various means

For refusal to sign, direct evidence such as a written statement from the inventor expressing their refusal would be ideal. In the absence of such direct evidence, circumstantial evidence showing implied refusal may be considered.

To learn more:

What evidence is required to prove an inventor’s refusal to sign a patent application?

When an inventor refuses to sign a patent application, specific evidence is required to proceed without their signature. The MPEP 409.03(d) outlines the necessary proof:

‘Where refusal of the inventor to sign the application papers is the reason for filing under pre-AIA 37 CFR 1.47(b), the applicant should make reasonable efforts to contact the inventor and to secure the inventor’s signature.’

Evidence of refusal typically includes:

  • Documented attempts to contact the inventor (emails, letters, phone logs)
  • Any written responses from the inventor indicating refusal
  • Witness statements corroborating the inventor’s refusal
  • A detailed explanation of the circumstances surrounding the refusal

The USPTO requires a thorough statement of facts describing the situation and efforts made to obtain the inventor’s signature. It’s crucial to demonstrate that the inventor was fully informed about the patent application and explicitly refused to sign, rather than simply being unresponsive.

To learn more:

To prove a filing delay due to a postal emergency, applicants must provide sufficient evidence. According to MPEP 511:

The nature of the evidence required by the Office to establish that the paper was timely filed will depend upon the circumstances of the particular emergency and the nature of the filing.

This evidence may include:

  • Documentation of the postal service interruption or emergency
  • Proof of attempted mailing during the affected period
  • Explanation of how the emergency directly impacted the filing
  • Any official notices or bulletins related to the postal disruption

The USPTO will evaluate each case individually to determine if the delay was indeed caused by the designated emergency.

To learn more:

To expunge an assignment record at the USPTO, clear evidence must be provided that the document was submitted by mistake or is of improper character. The MPEP 323.01(d) states:

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

While the MPEP doesn’t provide specific examples of acceptable evidence, it generally includes:

  • Documentation showing the assignment was recorded in error
  • Proof that the assignment document contains incorrect information
  • Evidence that the assignment was not intended for the specific application or patent

The burden of proof lies with the petitioner to demonstrate why the assignment record should be expunged. Each case is evaluated on its own merits by the USPTO.

To learn more:

To support a petition to expunge an improperly recorded assignment, you should provide evidence that clearly demonstrates the assignment is incorrect. This may include:

  • Affidavits or declarations from relevant parties
  • Documentation showing true ownership
  • Evidence of fraud or mistake in the recording

MPEP 323.01(c) states: ‘The petition should be accompanied by clear and convincing evidence of the error in recording.’ It’s crucial to present a compelling case to the USPTO to justify the expungement.

To learn more:

According to MPEP 409.03(f), various forms of evidence can be submitted as proof of proprietary interest. The section states:

‘Sufficient proprietary interest is shown by an assignment or assignment of the invention to a person who is under an obligation of assignment to the applicant… Other examples of documents which may be submitted to establish proprietary interest are:

  • (A) A legal memorandum which explains on the basis of the facts of the case that the person signing the 37 CFR 1.47 oath or declaration is a person who has sufficient proprietary interest in the matter;
  • (B) A copy of the contract of employment or of any other contract between the inventor and assignee;
  • (C) An affidavit or declaration of the specific facts which support the assignee’s claim of proprietary interest;
  • (D) Other evidence which establishes the person’s authority to sign the 37 CFR 1.47 oath or declaration on behalf of and as agent for the inventor.’

These examples provide a range of documents that can be used to demonstrate proprietary interest when an inventor is unwilling or unable to execute the required oath or declaration.

To learn more:

To learn more:

According to MPEP 608.02(w), certain minor drawing changes can be made without requiring annotated sheets from the applicant. These changes include:

  • Adding two or three reference characters or exponents
  • Changing one or two numerals or figure ordinals
  • Removing superfluous matter
  • Adding or reversing directional arrows
  • Changing Roman Numerals to Arabic Numerals to agree with specification
  • Adding section lines or brackets, where easily executed
  • Changing lead lines
  • Correcting misspelled legends

The examiner can suggest these changes in a letter to the applicant, often including a marked-up copy of the drawing showing the proposed additions or alterations.

To learn more:

MPEP 404 is currently marked as ‘[Reserved]’, which means this section is not currently in use but is being held for potential future content or updates. The USPTO may use this section in future revisions of the Manual of Patent Examining Procedure to add new information or guidance related to the representation of applicants or owners in patent matters.

MPEP 303 states that certified copies of patent applications as filed do not include an indication of assignment documents. The section specifically notes:

“Certified copies of patent applications as filed do not include an indication of assignment documents.” (MPEP 303)

This means that if an applicant wants to have proof of assignment documents, they need to request this separately.

When an MPEP section is marked as [Reserved], it indicates that the section number exists but there is currently no content provided for that section. The MPEP states in section 212:

212 [Reserved] [R-]

A patent application is designated as ‘rejected’ when it contains an unanswered examiner’s action during its prosecution in the examining group and before allowance. According to MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application.

This status continues until the applicant responds to the examiner’s action or the application becomes abandoned.

To learn more:

An abandoned patent application is one that has been removed from the USPTO’s docket of pending applications. According to MPEP 203.05, an application can become abandoned for several reasons:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications:

  • Formal abandonment by the applicant or their attorney/agent
  • Failure to take appropriate action during prosecution
  • Failure to pay the issue fee
  • For provisional applications, not filing a nonprovisional application within 12 months

Abandonment can have serious consequences, but in some cases, it may be possible to revive an abandoned application.

For more information on patent abandonment, visit: patent abandonment.

The phrase ‘particularly point out and distinctly claim’ comes from 35 U.S.C. 112 and is referenced in MPEP 608.01(k). It means that the claims in a patent application must:

  • Clearly define the invention’s elements and features
  • Be specific enough to distinguish the invention from prior art
  • Be understandable to a person skilled in the relevant field
  • Provide a clear boundary for the scope of protection

This requirement ensures that the public and potential competitors can understand the limits of the patent’s protection. It also helps patent examiners assess the novelty and non-obviousness of the claimed invention.

To learn more:

A nonprovisional patent application is designated as “rejected” if, during prosecution before allowance, it contains an examiner’s action that has not been replied to by the applicant. As stated in MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a “rejected” application. Its status as a “rejected” application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

MPEP 203.03 defines an ‘amended’ patent application as follows:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action. The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

In simpler terms, an application becomes ‘amended’ when the applicant responds to an examiner’s Office action, whether by making changes to the application, arguing against the examiner’s rejections, or choosing between different inventions (election).

According to MPEP 203.04:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

An ‘allowed’ application has passed examination and is ready to become a patent, pending payment of necessary fees.

Copendency refers to the requirement that two related patent applications must be pending at the same time for one to claim the benefit of the earlier filing date of the other. The MPEP states:

Copendency between the current application and the prior application is required.

This means that the later application must be filed before the earlier application is either abandoned or issued as a patent. Copendency is crucial for maintaining a continuous chain of priority between related applications.

For more information on copendency, visit: copendency.

For more information on patent applications, visit: patent applications.

When reviewing a claim to foreign priority, the examiner generally checks the following:

  • That the papers contain no obvious formal defects
  • That the papers correspond in number, date and country to the application identified in the application data sheet
  • For original applications filed under 35 U.S.C. 111(a) and international applications entering the national stage under 35 U.S.C. 371, that the claim for foreign priority is timely

The MPEP states: “When the claim to priority and the certified copy of the foreign application are received while the application is pending before the examiner, the examiner generally makes no examination of the papers except to see that they contain no obvious formal defects and correspond in number, date and country to the application identified in the application data sheet for an application filed on or after September 16, 2012, or oath or declaration or application data sheet for an application filed prior to September 16, 2012.” (MPEP 216)

Acting in a representative capacity refers to a patent practitioner appearing in person or signing papers on behalf of a client before the United States Patent and Trademark Office (USPTO) in a patent case. According to 37 CFR 1.34, when a patent practitioner acts in this capacity, their personal appearance or signature constitutes a representation that they are authorized to represent the particular party on whose behalf they are acting.

The MPEP states: “When a patent practitioner acting in a representative capacity appears in person or signs a paper in practice before the United States Patent and Trademark Office in a patent case, his or her personal appearance or signature shall constitute a representation to the United States Patent and Trademark Office that under the provisions of this subchapter and the law, he or she is authorized to represent the particular party on whose behalf he or she acts.”

To learn more:

‘Unintentional delay’ is a crucial concept when seeking to restore the benefit of a provisional application. The MPEP requires:

“A statement that the delay in filing the subsequent nonprovisional application or international application designating the United States within the twelve-month period was unintentional.”

While the MPEP doesn’t provide a specific definition of ‘unintentional delay’, it generally means that the failure to meet the 12-month deadline was not deliberate. The USPTO may require additional information to determine if the delay was truly unintentional:

“The Director may require additional information where there is a question whether the delay was unintentional.”

It’s important to be prepared to explain the circumstances that led to the delay if requested.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

The term ‘sufficient proprietary interest’ is introduced in the MPEP § 605 for patent applications filed on or after September 16, 2012. The MPEP states:

“Effective September 16, 2012, the Office revised the rules of practice to permit […] a person who otherwise shows sufficient proprietary interest in the matter to file and prosecute an application for patent as the applicant on behalf of the inventor.”

‘Sufficient proprietary interest’ typically means that the person or entity has a significant commercial or financial stake in the invention, even if they are not the inventor or assignee. This could include:

  • Licensees with exclusive rights to the invention
  • Investors who have funded the development of the invention
  • Joint venture partners involved in the invention’s creation

To be considered as having ‘sufficient proprietary interest’, the person or entity must typically provide evidence of their interest and may need to submit a petition to the USPTO. The inventor(s) must also provide authorization for this person or entity to act as the applicant.

This provision allows for greater flexibility in who can file and prosecute patent applications, particularly benefiting startups, research institutions, and collaborative innovation projects.

To learn more:

‘Failure to take appropriate action’ in patent prosecution refers to situations where an applicant doesn’t respond to Office actions or meet other required deadlines during the examination process. According to MPEP 203.05, an application can be abandoned:

“through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application”

This could include not responding to an examiner’s rejection within the given time frame, failing to submit required documents, or not meeting other procedural requirements. It’s crucial for applicants to stay engaged in the prosecution process and meet all deadlines to prevent unintentional abandonment.

To learn more:

The ‘[Reserved]’ designation in MPEP 212 indicates that this section is currently not in use but is being held for potential future content. It does not contain any specific information or guidance at this time.

According to MPEP 318, assignment documents submitted for recording should not be placed directly in application or patent files. The section states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This means that when assignment documents are submitted, they should be sent to the Assignment Division for proper recording rather than being inserted into the application or patent files themselves.

To learn more:

What documents can serve as proof of proprietary interest for joint inventors?

For joint inventors, proof of proprietary interest can be established through various documents. According to MPEP 409.03(f), acceptable forms of proof include:

  • An assignment for the entire right, title, and interest in the application from all inventors to one or more joint inventors
  • Written statements from all inventors that they have assigned their rights in the application to one or more joint inventors
  • Other evidence showing that one or more joint inventors are the only inventor(s) who have the right to prosecute the application

The MPEP states: ‘Where one of several joint inventors is deceased or cannot be reached, a statement by the prosecuting inventor as to the facts, including the names of the other joint inventors, may be accepted as sufficient proof of proprietary interest.’ This provision allows for flexibility in cases where obtaining documentation from all inventors is challenging.

To learn more:

According to 37 CFR 3.11, the following documents can be recorded with the USPTO related to patent assignments:

  • Assignments of applications, patents, and registrations
  • Other documents relating to interests in patent applications and patents
  • Documents affecting title to applications, patents, or registrations
  • Licenses, assignments, or other interests of the Government in or under patents or patent applications
  • Joint research agreements or excerpts of joint research agreements

These documents must be accompanied by completed cover sheets as specified in 37 CFR 3.28 and 3.31.

According to MPEP 402.04, there are several important documents that a person acting in a representative capacity generally cannot sign. These include:

  • A power of attorney (37 CFR 1.32)
  • A document granting access to an application
  • A change of correspondence address
  • A terminal disclaimer (37 CFR 1.321(b)(1))
  • A request for express abandonment without filing a continuing application (37 CFR 1.138(b))

However, there are some exceptions for applications filed on or after September 16, 2012. In these cases, a person acting in a representative capacity may sign a document granting access to an application or a change of correspondence address if:

  1. A power of attorney has not been appointed under 37 CFR 1.32(b), and
  2. The patent practitioner was named in the application transmittal papers.

To learn more:

When a legal representative takes over a patent application for a deceased inventor, specific documents are required:

  • Proof of authority to act on behalf of the deceased inventor’s estate (e.g., Letters Testamentary, Letters of Administration)
  • A new oath or declaration by the legal representative
  • Any necessary assignments or other documents to establish ownership rights

According to MPEP 409.01: “The Office no longer requires proof of authority of the legal representative to prosecute the application. However, any necessary documentary evidence of the legal representative’s authority to act on behalf of the deceased inventor’s estate, such as Letters Testamentary, Letters of Administration, or a Certificate of Heirship, should be kept in the application file.”

It’s important to note that while the USPTO doesn’t require submission of proof of authority, it’s advisable to keep such documentation readily available in case it’s requested.

To learn more:

To perfect a claim for foreign priority after patent issuance, several documents are required. According to MPEP 216.01, the following must be submitted:

  • A petition to accept an unintentionally delayed claim for priority
  • The required petition fee
  • A certified copy of the foreign application
  • An English language translation of the foreign application (if not in English)
  • A statement that the translation is accurate

The MPEP states: ‘In addition to the petition to accept an unintentionally delayed claim for priority and the required petition fee, the claim for priority must be made in an application data sheet (if the patent issued from a utility or plant application filed on or after September 16, 2012) or in a request for a certificate of correction, and a certified copy of the foreign application must be submitted.’

It’s important to note that the requirements may vary slightly depending on the specific circumstances of the application and patent. Consulting with a patent attorney or agent is advisable for ensuring all necessary documents are properly prepared and submitted.

To claim foreign priority in a U.S. application, you must file a claim for priority and submit a certified copy of the foreign application. MPEP 213.04 states: ‘The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application.’

For applications filed on or after September 16, 2012, the priority claim must be presented in an Application Data Sheet (ADS). The certified copy must be filed within the later of 4 months from the actual filing date or 16 months from the foreign filing date, with some exceptions.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For national stage entry in the United States, the following documents are required:

  • A copy of the international application (if not previously communicated by the International Bureau)
  • An English translation of the international application (if not in English)
  • The basic national fee
  • An oath or declaration of the inventors
  • A surcharge if the basic national fee or oath/declaration is filed later than 30 months from the priority date

According to MPEP 601.04: “A translated copy of the international application and the basic national fee are required to be filed with the U.S. Designated or Elected Office not later than the expiration of 30 months from the priority date.”

To learn more:

What documents are required for an assignee to revoke power of attorney in a patent application?

To revoke power of attorney in a patent application, an assignee must submit specific documents to the USPTO. According to MPEP 402.07, the required documents are:

  • Statement under 37 CFR 3.73(c): This establishes the assignee’s ownership.
  • Revocation of the existing power of attorney
  • New power of attorney from the assignee

The MPEP states:

“The assignee of the entire interest can revoke the power of attorney of the applicant and appoint its own patent practitioner. The assignee must become of record as provided in 37 CFR 3.71. After the assignee becomes of record, the assignee is permitted to revoke the power of attorney of the applicant under the provisions of 37 CFR 1.36(a).”

It’s crucial to ensure all documents are properly executed and filed with the USPTO to effectively change the power of attorney.

To learn more:

According to MPEP 314, the following documents are recordable for name changes or mergers in patent ownership:

  • Certificates issued by appropriate authorities showing a change of name of a business
  • Certificates showing a merger of businesses

The MPEP states: Certificates issued by appropriate authorities showing a change of name of a business or a merger of businesses are recordable.

To correct a typographical error in a patent assignment, you need to submit several documents. According to MPEP 323.01(b), the required documents include:

  • A copy of the originally recorded papers
  • A cover sheet
  • The required fee for each application or patent to be corrected

If the assignor is not available to make the correction, the assignee must also provide:

  • An affidavit or declaration identifying the error and requesting correction

The MPEP states:

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction. The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).

Ensure all documents are properly prepared and submitted to avoid delays in processing.

To learn more:

What documentation is required when filing a patent application for a deceased or legally incapacitated inventor?

When filing a patent application for a deceased or legally incapacitated inventor, specific documentation is required. According to MPEP 409.03(b), the following documentation is typically necessary:

  1. For deceased inventors:
    • Death certificate of the inventor
    • Letters Testamentary or Letters of Administration proving the legal representative’s authority
  2. For legally incapacitated inventors:
    • Court order declaring the inventor legally incapacitated
    • Guardianship or conservatorship papers demonstrating the legal representative’s authority
  3. For both cases:
    • Oath or declaration executed by the legal representative
    • Application Data Sheet (ADS) listing the inventor and indicating their status (deceased or legally incapacitated)
    • Power of Attorney from the legal representative, if applicable

The MPEP states: “Proof of the authority of the legal representative must be provided to the Office.” This ensures that the person acting on behalf of the inventor has the legal right to do so.

To learn more:

When filing a patent application as an assignee or obligated assignee, specific documentation is required to establish the right to apply for the patent. According to MPEP 409.05:

Quote: ‘The assignee or obligated assignee who files the application must comply with the oath or declaration requirements of 37 CFR 1.63, including meeting the citizenship requirement of 37 CFR 1.63(a)(3).’

The required documentation includes:

  • A properly executed oath or declaration from the inventors
  • An assignment document or proof of obligation to assign
  • Application Data Sheet (ADS) identifying the assignee as the applicant

Additionally, if filing as an obligated assignee, you may need to provide evidence of the obligation to assign, such as an employment agreement or contract. It’s important to ensure all documentation is complete and accurate to avoid potential issues with the patent application process.

To learn more:

What documentation is required when an inventor dies during the patent application process?

When an inventor dies during the patent application process, specific documentation is required to continue the application. According to MPEP 409, the following documents are typically needed:

  • A copy of the inventor’s death certificate
  • Legal documentation showing the authority of the legal representative (e.g., executor of the estate)
  • An oath or declaration by the legal representative

The MPEP states: ‘If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.’ This means that the executor or administrator of the deceased inventor’s estate can step in to complete the patent application process.

It’s important to note that the legal representative must provide evidence of their authority to act on behalf of the deceased inventor’s estate, such as letters testamentary or letters of administration issued by a probate court.

For more information on documentation, visit: documentation.

For more information on legal representative, visit: legal representative.

What documentation is required for inventorship correction in a patent application?

The documentation required for inventorship correction in a patent application includes:

  • A request to correct inventorship under 37 CFR 1.48(a)
  • An application data sheet (ADS) with the correct inventorship information
  • A statement of facts from the new inventor(s) if being added
  • Written consent from any assignees

The MPEP states: The inventorship of an application may be corrected by filing a request under 37 CFR 1.48(a). The request must include: (1) An application data sheet in accordance with 37 CFR 1.76 that identifies each inventor by his or her legal name, and (2) the processing fee set forth in 37 CFR 1.17(i). Additionally, When an inventor is being added, applicant must submit a statement from each person being added as an inventor that the inventorship error occurred without deceptive intention on his or her part. It’s important to note that while these are the basic requirements, additional documentation may be necessary depending on the specific circumstances of the correction.

To learn more:

When an assignee or obligated assignee files a patent application as the applicant, they should provide documentary evidence of ownership. According to 37 CFR 1.46(b)(1):

If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

This means that the assignee or obligated assignee should record their ownership documents (such as an assignment or employment agreement) with the USPTO as specified in 37 CFR Part 3, and this should be done before paying the issue fee.

To learn more:

What documentation is required for a legal representative to file a patent application for a deceased inventor?

When filing a patent application for a deceased inventor, a legal representative must provide specific documentation to establish their authority. According to MPEP 409.01(a):

“If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent as provided in 37 CFR 1.43. In accordance with 37 CFR 1.43, the legal representative must provide proof of authority…”

The required documentation typically includes:

  • A copy of the deceased inventor’s death certificate
  • Proof of the legal representative’s authority (e.g., court appointment as executor or administrator of the estate)
  • A substitute statement in lieu of an inventor’s oath or declaration
  • An Application Data Sheet (ADS) identifying the legal representative

It’s important to note that the specific requirements may vary depending on the circumstances and jurisdiction. Consulting with a patent attorney is advisable to ensure all necessary documentation is properly prepared and submitted.

To learn more:

To demonstrate an agreement to assign in a pre-AIA 37 CFR 1.47(b) application, you should provide:

  • A copy of the written agreement to assign the invention
  • If the agreement is conditional, a statement of facts showing the conditions have been met

MPEP 409.03(f) states:

“When an inventor has agreed in writing to assign an invention described in an application deposited pursuant to pre-AIA 37 CFR 1.47(b), a copy of that agreement should be submitted. If an agreement to assign is dependent on certain specified conditions being met, it must be established by a statement of facts by someone with first hand knowledge of the circumstances in which those conditions have been met.”

A common example is an employment agreement. In such cases, you must provide evidence that the invention was made during the course of employment, typically through a statement from someone with firsthand knowledge of the circumstances.

To learn more:

To learn more:

Tags: pre-AIA

What documentation is needed to prove authority as a legal representative for a deceased or incapacitated inventor?

When filing a patent application on behalf of a deceased or legally incapacitated inventor, it’s crucial to provide documentation that proves your authority as a legal representative. The specific documentation required can vary based on the circumstances, but generally includes:

  • For a deceased inventor: Death certificate and letters testamentary or letters of administration
  • For an incapacitated inventor: Court order declaring incapacity and appointing a legal guardian or conservator
  • Power of attorney or other legal document granting authority to act on behalf of the inventor or their estate

The MPEP 409.01(a) states:

Office personnel will not question whether the person executing the substitute statement is authorized to act on behalf of the deceased inventor’s estate or legal entity unless there is evidence to the contrary.

While the USPTO generally accepts the substitute statement without questioning the authority, it’s important to have proper documentation available in case it’s requested or if legal issues arise later. Always consult with a patent attorney to ensure you have the correct documentation for your specific situation.

To learn more:

What documentation is needed for a legal representative to act on behalf of a deceased or incapacitated inventor?

To act on behalf of a deceased or incapacitated inventor, a legal representative must provide appropriate documentation to the USPTO. The MPEP 409.01(a) states:

“Office personnel will not question whether the person signing the oath or declaration is in fact a person authorized to make the statement, and will not require proof of the authority of the person making the statement.”

However, it’s important to note that while the USPTO does not require proof upfront, the legal representative should still have proper documentation, such as:

  • For a deceased inventor: Letters testamentary, letters of administration, or other court documents establishing authority over the estate.
  • For an incapacitated inventor: Court order appointing a guardian or conservator.

These documents may be required if the authority is later questioned or in other legal proceedings related to the patent application.

To learn more:

When filing entity status notifications in EFS-Web, it is strongly recommended to use the following document descriptions as appropriate:

  • Notification of loss of entitlement to small entity status
  • Notification of loss of entitlement to micro entity status

Using these specific document descriptions helps ensure that your notifications are properly categorized and processed by the USPTO. This recommendation is provided in MPEP 509.04(e) to facilitate efficient handling of entity status changes.

To learn more:

Tags: EFS-Web, USPTO

The filing date of a patent application is determined by the ‘Office Date’ stamp, provided the application includes all necessary components for a filing date. The MPEP states:

If an application as originally filed includes the necessary components for a filing date (see 37 CFR 1.53(b)-(d) and MPEP § 506), the ‘Office Date’ stamp establishes the ‘filing date.’

This means that the date stamped on the application by the USPTO becomes the official filing date, as long as all required elements are present. It’s crucial for applicants to ensure their submissions are complete to secure the earliest possible filing date.

According to MPEP 203.01, a ‘new’ application is defined as follows:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This means that a patent application is considered ‘new’ from the time it is filed until the patent examiner issues their first official response or action on the application.

To learn more:

In patent arbitration proceedings, the defenses provided under 35 U.S.C. 282 must be considered by the arbitrator if raised by any party. This is specified in 35 U.S.C. 294(b):

‘In any such arbitration proceeding, the defenses provided for under section 282 shall be considered by the arbitrator if raised by any party to the proceeding.’

These defenses typically include noninfringement, absence of liability for infringement, unenforceability, and invalidity of the patent or any claim in suit.

What constitutes inherent characteristics in patent applications?

Inherent characteristics in patent applications refer to properties or features that are necessarily present in the invention but may not be explicitly stated in the original disclosure. MPEP 608.04(a) provides guidance on this:

‘Inherent characteristics of materials and properties of processes are not considered to be new matter.’

This means that certain aspects of an invention that are inherently present, even if not explicitly described, are not considered new matter when later disclosed or claimed. Examples of inherent characteristics might include:

  • Physical properties of materials
  • Chemical reactions that naturally occur under specified conditions
  • Known scientific principles underlying the invention

However, it’s important to note that claiming inherent characteristics requires careful consideration. The written description requirement must still be satisfied, and the inherency must be clearly and unambiguously supported by the original disclosure.

To learn more:

To learn more:

A valid reason for filing under pre-AIA 37 CFR 1.47 requires a diligent effort to locate or reach a nonsigning inventor. The MPEP states:

‘Where inability to find or reach a nonsigning inventor “after diligent effort” is the reason for filing under pre-AIA 37 CFR 1.47, a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.’

It’s important to note that temporary unavailability, such as being on vacation or out of town, is not considered an acceptable reason. Additionally, hospitalization or unconsciousness are not valid reasons under this rule, but may be addressed under pre-AIA 37 CFR 1.43.

To learn more:

To learn more:

In a patent application, a valid disclosure can include not only the description and drawings as filed, but also the claims present on the filing date. As stated in MPEP 608.01(l): “In establishing a disclosure, applicant may rely not only on the description and drawing as filed but also on the claims present on the filing date of the application if their content justifies it.” This means that if a claim itself clearly discloses subject matter not shown in the drawing or described in the description, it can be considered part of the disclosure.

To learn more:

A complete patent application for filing date purposes must include:

  • A specification containing a description as per 37 CFR 1.71
  • At least one claim (for nonprovisional design applications only) as per 37 CFR 1.75
  • Any drawings required by 37 CFR 1.81(a)

As stated in the MPEP: “The filing date of the provisional or nonprovisional application is the date of receipt in the Office of the application which includes a specification containing description pursuant to 37 CFR 1.71 and at least one claim (required for nonprovisional design applications only) pursuant to 37 CFR 1.75, and any drawings required by 37 CFR 1.81(a).”

To learn more:

Tags: drawings

‘New matter’ refers to any content added to a patent application after the initial filing date that was not present in the original specification, claims, or drawings. As stated in MPEP 608.04(a):

Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing is usually new matter.

This can include adding specific percentages, compounds, or even omitting steps from a method that were present in the original disclosure.

To learn more:

The following conditions and requirements need to be met to add omitted material to an application under 37 CFR 1.57(b):n

    n

  1. The application must have been filed on or after September 21, 2004
  2. n

  3. All or a portion of the specification or drawing(s) must have been inadvertently omitted
  4. n

  5. A priority claim under 37 CFR 1.55 or benefit claim under 37 CFR 1.78 must have been present on the filing date
  6. n

  7. The omitted portion must be completely contained in the prior-filed application
  8. n

  9. An amendment to include the omitted portion must be filed within a time period set by the Office
  10. n

  11. If not otherwise entitled to a filing date, a petition under 37 CFR 1.53(e) with the fee must also be filed
  12. n

  13. A copy of the prior-filed application must be supplied, except where the prior application was filed under 35 U.S.C. 111
  14. n

  15. An English translation of any non-English prior-filed application must be supplied
  16. n

  17. The location of the omitted portion in the prior-filed application must be identified

For an international design application to be used as a basis for benefit claims, it must meet certain conditions. The MPEP specifies:

To obtain benefit of the filing date of a prior international design application designating the United States, the international design application must be entitled to a filing date in accordance with 37 CFR 1.1023.

This means that the international design application must have a valid filing date as determined by the regulations set forth in 37 CFR 1.1023. These regulations outline the requirements for establishing a filing date for international design applications, which typically include submitting the necessary documents and fees to the International Bureau or an appropriate office.

Additionally, the application claiming benefit must comply with the requirements of 35 U.S.C. 120, which include proper copendency and specific reference to the earlier application.

To learn more:

To learn more:

When writing your patent application abstract, it’s important to avoid several common mistakes. The MPEP 608.01(b) provides guidance on what to avoid:

The abstract should avoid using phrases which can be implied, such as, ‘The disclosure concerns,’ ‘The disclosure defined by this invention,’ ‘The disclosure describes,’ etc.

Common mistakes to avoid include:

  • Using legal phraseology or claims language
  • Exceeding the 150-word limit
  • Including speculative applications or purported merits of the invention
  • Comparing the invention to prior art
  • Using implied phrases like ‘This invention relates to…’
  • Including extraneous information not crucial to understanding the invention
  • Writing in a promotional or biased manner

By avoiding these mistakes, you can create a clear, concise, and effective abstract that accurately represents your invention.

To learn more:

The Patent Law Treaties Implementation Act (PLTIA) of 2012 introduced several significant changes to U.S. patent law and procedures:

  • Restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications).
  • The ability to file international design applications and claim priority to, and the benefit of, international design applications in nonprovisional applications.

As stated in the MPEP: Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. (MPEP 210)

These changes were implemented in two phases:

  • Title II of the PLTIA became effective on December 18, 2013.
  • Title I of the PLTIA became effective on May 13, 2015.

For more information on international design applications, visit: international design applications.

For more information on PLTIA, visit: PLTIA.

For more information on priority restoration, visit: priority restoration.

The Patent Law Treaties Implementation Act (PLTIA) of 2012 introduced several important changes to US patent law, particularly regarding priority claims and international applications. Key changes include:

  • Restoration of the right of priority to a foreign application or the benefit of a provisional application in certain cases
  • Ability to file international design applications
  • Ability to claim priority to, and benefit of, international design applications in nonprovisional applications

The MPEP states: “Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. In addition, title I of the PLTIA became effective May 13, 2015, along with corresponding revisions to the rules. Notable changes included the ability to file international design applications and to claim priority to, and the benefit of, international design applications in nonprovisional applications.”

The MPEP 409.03(g) section on proof of irreparable damage is not applicable to patent applications filed on or after September 16, 2012. This change is due to the implementation of the America Invents Act (AIA), which brought significant reforms to the U.S. patent system. Key changes include:

  • Transition from a ‘first-to-invent’ to a ‘first-inventor-to-file’ system
  • New procedures for challenging patents at the USPTO
  • Expanded definition of prior art
  • Changes to inventor oath and declaration requirements

For applications filed on or after September 16, 2012, different rules and procedures apply regarding the representation of applicants and the handling of situations that might have previously fallen under the irreparable damage provisions.

To learn more:

Pro se applicants make important certifications when filing patent applications. According to MPEP 401:

“In presenting (whether by signing, filing, submitting, or later advocating) papers to the Office, a pro se applicant is making the certifications under 37 CFR 11.18(b), and may be subject to sanctions under 37 CFR 11.18(c) for violations of 37 CFR 11.18(b)(2).”

These certifications include statements about the truthfulness of the application, that it is not being presented for improper purposes, and that claims are warranted by existing law or a good faith argument for changing the law.

When submitting papers to the USPTO, two key certifications are made under 37 CFR 11.18(b):

  1. Statements made are subject to the declaration clause of 37 CFR 1.68
  2. The certification required for papers filed in federal court under Rule 11(b) of the Federal Rules of Civil Procedure

Specifically, 37 CFR 11.18(b) states that by presenting any paper to the USPTO, the party certifies that:

‘All statements made therein of the party’s own knowledge are true, all statements made therein on information and belief are believed to be true, and all statements made therein are made with the knowledge that whoever, in any matter within the jurisdiction of the Office, knowingly and willfully falsifies, conceals, or covers up by any trick, scheme, or device a material fact, or knowingly and willfully makes any false, fictitious, or fraudulent statements or representations, or knowingly and willfully makes or uses any false writing or document knowing the same to contain any false, fictitious, or fraudulent statement or entry, shall be subject to the penalties set forth under 18 U.S.C. 1001 and any other applicable criminal statute’

This applies to both practitioners and non-practitioners submitting papers to the USPTO.

When presenting any paper to the USPTO, the party (whether a practitioner or non-practitioner) is making important certifications as outlined in 37 CFR 11.18(b):

  1. All statements made of the party’s own knowledge are true.
  2. Statements made on information and belief are believed to be true.
  3. The paper is not being presented for any improper purpose (e.g., harassment, delay).
  4. Legal contentions are warranted by existing law or non-frivolous arguments for changes in the law.
  5. Factual contentions have or are likely to have evidentiary support.
  6. Denials of factual contentions are warranted or based on lack of information or belief.

The MPEP notes: “37 CFR 11.18(b) provides that, by presenting any paper to the Office, the party presenting such paper (whether a practitioner or non-practitioner) is: (1) certifying that the statements made therein are subject to the declaration clause of 37 CFR 1.68; and (2) making the certifications required for papers filed in a federal court under Rule 11(b) of the Federal Rules of Civil Procedure.”

To learn more:

When signing patent correspondence, the signer is making certain certifications, including:

  • The presentation of any paper to the USPTO constitutes a certification under 37 CFR 11.18(b).
  • For S-signatures, the person inserting the signature certifies that the inserted signature is their own.
  • When submitting a document signed by another person, the submitter certifies they have a reasonable basis to believe the signature is appropriate.

As stated in 37 CFR 1.4(d)(4)(i): “The presentation to the Office (whether by signing, filing, submitting, or later advocating) of any paper by a party, whether a practitioner or non-practitioner, constitutes a certification under 37 CFR 11.18(b) of this chapter.”

Violations of these certifications may result in sanctions under 37 CFR 11.18(c) and (d).

To learn more:

If the USPTO returns a document unrecorded and you believe it represents an unusual case that justifies recordation, you have the option to petition for its recordation. The MPEP provides the following guidance:

“Any document returned unrecorded, which the sender nevertheless believes represents an unusual case which justifies recordation, may be submitted to the Office of Petitions with a petition under 37 CFR 1.181 requesting recordation of the document.” (MPEP 313)

To petition:

  1. Submit the document to the Office of Petitions
  2. Include a petition under 37 CFR 1.181
  3. Provide justification for why the document should be recorded

An allowed application can lose its status under certain circumstances. The MPEP outlines two main scenarios:

  1. Withdrawal from issue: This is governed by 37 CFR 1.313. The applicant or the USPTO may initiate this process for various reasons, such as the need for further examination or the discovery of new prior art.
  2. Abandonment due to non-payment: As stated in the MPEP, an application becomes abandoned “for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).”

In either case, the application loses its ‘allowed’ status and may require further action or payments to proceed towards patent issuance.

To learn more:

If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, 37 CFR 1.45(a) provides a solution. It states:

“If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the other joint inventor or inventors may make the application for patent on behalf of themselves and the omitted inventor.”

In such cases, the other joint inventor(s) can proceed with the application and execute a substitute statement in lieu of an oath or declaration from the unavailable inventor, as outlined in 37 CFR 1.64. For more information on substitute statements, refer to MPEP § 604.

To learn more:

To include a copyright or mask work notice in a patent application, specific authorization language must be included at the beginning of the specification. According to MPEP 608.01(w) and 37 CFR 1.71(e), the required authorization language is:

A portion of the disclosure of this patent document contains material which is subject to (copyright or mask work) protection. The (copyright or mask work) owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all (copyright or mask work) rights whatsoever.

This authorization should preferably be placed as the first paragraph of the specification. It is important to note that without this specific language, the inclusion of a copyright or mask work notice may be objected to by the patent examiner.

To learn more:

What are the USPTO’s guidelines for hand-carrying documents?

The USPTO has specific guidelines for hand-carrying documents to their office. According to MPEP 502:

“Any paper which relates to a pending application may be personally delivered to the Office. The attorney, agent, or applicant should specifically instruct the person making the delivery to hand-carry the paper to the Customer Service Window…”

Key points to remember when hand-carrying documents to the USPTO:

  • Deliver to the Customer Service Window at the Randolph Building, 401 Dulany Street, Alexandria, VA 22314
  • The delivery must be made during official business hours (8:30 AM to 5:00 PM, Monday through Friday, excluding federal holidays)
  • A receipt will be issued for the delivered papers
  • The receipt date is considered the filing date for the documents

It’s important to follow these guidelines to ensure proper handling and timely processing of your documents.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The MPEP outlines two main types of patent ownership:

  1. Individual ownership: ‘An individual entity may own the entire right, title and interest of the patent property. This occurs where there is only one inventor, and the inventor has not assigned the patent property.’
  2. Joint ownership: ‘Multiple parties may together own the entire right, title and interest of the patent property.’ This can occur in several scenarios:
  • Multiple partial assignees of the patent property
  • Multiple inventors who have not assigned their rights
  • A combination of partial assignee(s) and inventor(s) who have not assigned their rights

Understanding these ownership types is crucial for managing patent rights and making decisions about assignments or licenses.

MPEP 201.01 outlines several types of national applications that can be filed with the USPTO. These include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Design applications
  • Plant applications
  • Provisional applications

As stated in MPEP 201.01: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’

Each of these application types serves a specific purpose in the patent system and is subject to different rules and requirements.

For more information on design applications, visit: design applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on plant applications, visit: plant applications.

For more information on reissue applications, visit: reissue applications.

There are three main types of national applications for patents in the United States:

  • Nonprovisional applications filed under 35 U.S.C. 111(a)
  • Provisional applications filed under 35 U.S.C. 111(b)
  • International applications that have entered the national stage in the United States

As stated in MPEP 201.01: “Applications filed under 35 U.S.C. 111(a) include original nonprovisional utility, plant, design, divisional, continuation, and continuation-in-part applications filed under 37 CFR 1.53(b), reissue applications filed under 37 CFR 1.53(b), and design patent continued prosecution applications (CPAs) filed under 37 CFR 1.53(d).”

For more information on international applications, visit: international applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

The USPTO accepts two types of signatures for patent correspondence:

  • Handwritten signature: An original signature personally signed in permanent dark ink or its equivalent.
  • S-signature: A signature inserted between forward slash marks, which can include electronic or mechanical signatures.

As stated in 37 CFR 1.4(d): “Correspondence filed in the Office, which requires a person’s signature, may be filed with one of two types of signatures: (A) handwritten signature; and (B) ‘S-signature.'”

To learn more:

The timing requirements for submitting an IDS are:

  • Within 3 months of filing or before first Office action, whichever is later
  • Before final Office action, Notice of Allowance, or Quayle action
  • After final Office action but before issue fee payment
  • After issue fee payment but before patent grant

The specific requirements vary based on when the IDS is filed. For example, as stated in MPEP 609.04(b): “An information disclosure statement will be considered by the examiner if filed within any one of the following time periods: (A) for national applications (not including CPAs), within three months of the filing date of the national application or before the mailing date of a first Office action on the merits; (B) for international applications, within three months of the date of entry of the national stage as set forth in 37 CFR 1.491 or before the mailing date of a first Office action on the merits; (C) for RCEs and CPAs, before the mailing date of a first Office action on the merits; or (D) for international design applications, within three months of the date of publication of the international registration under Hague Agreement Article 10(3) or before first Office action on the merits, whichever is later.”

To learn more:

Tags: USPTO

The time periods for filing priority or benefit claims in U.S. patent applications vary depending on the type of claim and application. Generally:

  • For foreign priority claims under 35 U.S.C. 119(a)-(d) and (f), the claim must be made within the later of 4 months from the actual filing date or 16 months from the foreign application’s filing date.
  • For domestic benefit claims under 35 U.S.C. 119(e) or 120, the claim must be made within the later of 4 months from the actual filing date or 16 months from the prior application’s filing date.
  • For international applications entering the national stage, special rules apply.

The MPEP states: “37 CFR 1.55(d) contains provisions relating to the time for filing a priority claim in an application filed under 35 U.S.C. 111(a) and in an application entering the national stage under 35 U.S.C. 371” and “37 CFR 1.78(d) contains provisions relating to claims under 35 U.S.C. 120, 121, 365(c), or 386(c) for the benefit of a prior-filed nonprovisional application, international application, or international design application.”

Note that these time periods are subject to the provisions of 37 CFR 1.55(p) and 1.78(k), which state that they are not extendable but are subject to certain exceptions.

The time periods for filing a priority claim depend on the type of application:

  • For original applications filed under 35 U.S.C. 111(a) (other than design applications), the claim must be filed during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application. See 37 CFR 1.55(d)(1).
  • For applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set in the PCT and Regulations under the PCT. See 37 CFR 1.55(d)(2) and MPEP § 213.06.
  • In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).

The time limits for responding to a notice under 37 CFR 1.251 vary depending on whether it’s for an application or a patent:

  • For applications: The Office sets a three-month period for reply, which is extendable under 37 CFR 1.136(a) by up to three additional months, for a maximum of six months.
  • For patents: The Office sets a six-month period for reply, which is not extendable.

MPEP 508.04 states: “The Office will set a time period of three months for reply in a notice under 37 CFR 1.251 in an application. The time period will be extendable under 37 CFR 1.136(a) (unless the notice indicates otherwise) by three months up to a maximum period for reply of six months in an application.” It also notes: “The Office will set a time period of six months for reply in a notice under 37 CFR 1.251 in a patent. The time period will not be extendable under 37 CFR 1.136(a) in a patent.”

The USPTO sets specific time limits for responding to notices about unlocatable files, which differ for applications and patents:

For applications, the MPEP states: The Office will set a time period of three months for reply in a notice under 37 CFR 1.251 in an application. The time period will be extendable under 37 CFR 1.136(a) (unless the notice indicates otherwise) by three months up to a maximum period for reply of six months in an application.

For patents, the time limit is longer: The Office will set a time period of six months for reply in a notice under 37 CFR 1.251 in a patent. The time period will not be extendable under 37 CFR 1.136(a) in a patent because 35 U.S.C. 41(a)(8) only authorizes the Office to charge fees for extensions of time in proceedings involving an application.

It’s important to note that failing to reply within these time limits can have serious consequences, including abandonment of pending applications.

For more information on patent applications, visit: patent applications.

For more information on Time Limits, visit: Time Limits.

What are the time limits for perfecting a foreign priority claim in a patent?

The time limits for perfecting a foreign priority claim in a patent are as follows:

  • The priority claim must be made within 16 months from the filing date of the prior foreign application or 4 months from the actual filing date of the U.S. application, whichever is later.
  • A certified copy of the foreign application must be filed within the same time period, unless previously submitted in a parent application.

According to MPEP 216.01: “The patent owner’s failure to make a timely priority claim and file the certified copy prior to issuance of the patent cannot be cured by filing a reissue application.” This emphasizes the importance of meeting these deadlines during the initial patent application process.

The time limits for filing an interim copy of a foreign application are specified in 37 CFR 1.55(j). According to the MPEP:

37 CFR 1.55(j) also provides that the interim copy of the foreign application and cover sheet must be filed within the later of sixteen months from the filing date of the prior foreign application or four months from the actual filing date of an application under 35 U.S.C. 111(a), within four months from the later of the date of commencement (37 CFR 1.491(a)) or the date of the initial submission under 35 U.S.C. 371 in an application entering the national stage under 35 U.S.C. 371, or with a petition under 37 CFR 1.55(e) or (f).

In summary, the interim copy must be filed within:

  • 16 months from the filing date of the foreign application, or
  • 4 months from the U.S. application filing date under 35 U.S.C. 111(a), or
  • 4 months from the national stage commencement or initial submission date under 35 U.S.C. 371, or
  • With a petition under 37 CFR 1.55(e) or (f)

To learn more:

The time limits for filing a certified copy in an international design application are:

  • General rule: Within the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application.
  • Exception: These time limits do not apply if the priority document is available to the Office from a participating digital library.

MPEP 213.07 specifies: The time period requirement in 37 CFR 1.55(f) for filing a certified copy of the foreign application in a nonprovisional international design application is the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application, except as provided in paragraphs (h), (i), and (j) of this section.

To learn more:

The time limits for entering the national stage in the United States are specified in MPEP 601.04:

The time limit for entering the national stage in the United States of America is 30 months from the priority date. […] Pursuant to PCT Article 22(1), the 30-month time limit set forth in 35 U.S.C. 371(b) for submitting the national stage requirements is not extendable.

It’s important to note that this 30-month deadline is strictly enforced and cannot be extended. Applicants must ensure they meet all national stage requirements within this timeframe to avoid abandonment of their application.

To learn more:

Tags: Time Limits

In a national stage application under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT. According to 37 CFR 1.55(d)(2), this is the general rule, with some exceptions provided in paragraph (e) of the same section.

The MPEP states: In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made and a certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT with limited exceptions.

To learn more:

The timing of filing a request to withdraw as a patent practitioner is crucial. According to the MPEP:

  • The USPTO will review and decide on withdrawal requests filed before the expiration of a time period for reply or before the expiration of a time period that can be extended under 37 CFR 1.136(a).
  • Requests filed after these deadlines will be placed in the application file but will not be treated on their merits.
  • Revocations of power of attorney filed after these deadlines will also simply be placed in the application file, with the exception of those accompanied by a petition to revive.

It’s important to note that the USPTO may render a decision on a timely filed request even after the stated period for reply, after the application is abandoned, or after proceedings have terminated.

For reexamination proceedings, practitioners should refer to MPEP § 2223 for specific guidance on withdrawal.

To learn more:

According to the MPEP, patent applications can be directed to three broad types of subject matter:

  • Utility patent applications under 35 U.S.C. 101 for “a new and useful process, machine, manufacture, or composition of matter”
  • Plant patent applications under 35 U.S.C. 161
  • Design patent applications under 35 U.S.C. 171

The USPTO has specific procedures for storing models, exhibits, and specimens. According to MPEP 608.03(a):

‘All models and exhibits in easily transportable form which are admitted to the application or proceeding are officially filed and entered of record in the file wrapper. A receipt for the same is given to the applicant or party by the Office.’

This indicates that these items are stored with the application file. The MPEP further states:

‘Models, exhibits, and specimens not officially filed are not admitted into the file wrapper and, therefore, are not entered of record in the application or proceeding file.’

Items not officially filed are likely stored separately or returned to the applicant. The USPTO ensures proper handling and storage of these materials to maintain their integrity during the examination process.

To learn more:

35 U.S.C. 122 and 18 U.S.C. 2071 impose statutory requirements which cover the handling of patent applications and related documents. As explained in MPEP 101:

“35 U.S.C. 122 and 18 U.S.C. 2071 impose statutory requirements which cover the handling of patent applications and related documents. Suspension, removal, and even criminal penalties may be imposed for violations of these statutes.”

Therefore, USPTO employees must take proper care to maintain the confidentiality of applications and related papers.

What are the specific requirements for drawings in design patent applications?

Design patent applications have unique drawing requirements due to their focus on the ornamental design of an article. According to MPEP 608.02(a), the following specific requirements apply:

  • Multiple views: The drawings must contain a sufficient number of views to completely disclose the appearance of the design.
  • Surface shading: This is often necessary to show the contours and character of the design.
  • Solid black surface shading: This is not permitted, except when used to represent the color black or color contrast.
  • Broken lines: These may be used to show environmental structure but form no part of the claimed design.
  • Color drawings: These are permitted upon filing a petition explaining why color drawings are necessary.

The MPEP states, “Lack of good drawings in a design patent application may result in a refusal to issue the application until suitable drawings are submitted.” Therefore, it’s crucial to submit high-quality, compliant drawings from the outset to avoid delays in the examination process.

To learn more:

Canadian patent agents must meet specific requirements to practice before the USPTO under limited recognition:

  • They must be registered and in good standing as a patent agent under Canadian law.
  • They must apply for limited recognition to the USPTO Director.
  • They can only represent Canadian citizens or residents before the USPTO.
  • Their representation is limited to the presentation and prosecution of patent applications of Canadian applicants.

As stated in MPEP 402.01: Canadian patent agents are not required to pass the regular patent bar examination to represent Canadian applicants. They need not seek formal recognition to practice before the Office.

To learn more:

The USPTO has designated specific facsimile numbers for various offices to handle different types of correspondence. According to MPEP 502.01, some key facsimile numbers include:

  • Central Facsimile Number (for most patent-related correspondence): (571) 273-8300
  • International Patent Legal Administration (for responses to Decisions on Petition): (571) 273-0459
  • Office of Data Management (for issue fee payments and drawings): (571) 273-2885
  • Electronic Business Center (for Customer Number requests): (571) 273-0177
  • Assignment Branch (for assignment documents): (571) 273-0140
  • Central Reexamination Unit (for ex parte and inter partes reexamination correspondence): (571) 273-9900
  • Patent Trial and Appeal Board (for contested cases and trials, where expressly authorized): (571) 273-0042
  • Office of Petitions (for petitions to withdraw from issue): (571) 273-0025

The MPEP states: “For each Office location listed below, only the particular type of correspondence indicated may be transmitted to the specific facsimile number at that Office location. All other types of facsimile transmitted correspondence must be sent to the central facsimile number ((571) 273-8300).”

It’s crucial to use the correct facsimile number for your specific type of correspondence to ensure proper handling and processing by the USPTO.

To learn more:

The MPEP 201.01 mentions several special types of national applications:

1. Provisional applications (35 U.S.C. 111(b))
2. Reissue applications (35 U.S.C. 251)
3. Design applications (35 U.S.C. 171)
4. Plant applications (35 U.S.C. 161)

These applications have specific requirements and purposes. For example, provisional applications provide a way to establish an early effective filing date, while reissue applications allow for the correction of errors in issued patents. Design applications protect ornamental designs, and plant applications are for new varieties of plants.

For more details on these special application types, refer to the following MPEP sections:
MPEP 201.04 – Provisional Application
MPEP 1400 – Reissue
MPEP 1500 – Design Patents
MPEP 1600 – Plant Patents

Secrecy order applications require special handling procedures to maintain their confidentiality. According to MPEP 130:

Applications and papers in the application file, as well as any related papers, must be safeguarded from disclosure to unauthorized persons and must be securely kept in a locked area when not actually in use.

Additionally:

  • Secrecy order cases should not be processed on any automated information system (AIS) unless the AIS is certified for classified processing.
  • All processing should be done in a secure environment by personnel with appropriate clearances.
  • Special care must be taken to prevent inadvertent disclosure of classified information.

For more information on classified information, visit: classified information.

For more information on patent applications, visit: patent applications.

Design patent applications have some special considerations compared to other types of patent applications:

  • Filing Date: For design applications (except CPAs), the filing date is when the USPTO receives the specification (including at least one claim) and any required drawings.
  • Continued Prosecution Application (CPA): Design applications can be filed as CPAs under 37 CFR 1.53(d), but this option is not available for utility or plant applications.
  • Claims: Unlike utility applications, design applications must include at least one claim at the time of filing to receive a filing date.
  • Drawings: Drawings are crucial in design applications and must be filed with the initial application to secure a filing date.

The MPEP states: The filing date for a design application, except for a continued prosecution application (CPA) under 37 CFR 1.53(d), is the date on which the specification as required by 35 U.S.C. 112, including at least one claim, and any required drawings are received in the Office.

It’s important to note that while utility and plant applications filed on or after December 18, 2013, can receive a filing date without claims or drawings, this flexibility does not extend to design applications.

To learn more:

What are the size standards for a small business concern in patent applications?

The size standards for a small business concern in patent applications are determined by the Small Business Administration (SBA). According to MPEP 509.02:

“For the purpose of paying reduced patent fees, a small business concern is one:

  • (i) Whose number of employees, including affiliates, does not exceed 500 persons; and
  • (ii) Which has not assigned, granted, conveyed, or licensed (and is under no obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a small business concern or a nonprofit organization under this section.”

It’s important to note that these size standards are specific to patent applications and may differ from SBA size standards used for other purposes. Businesses must meet both the employee count criterion and the rights assignment criterion to qualify as a small business concern for patent fee purposes.

To learn more:

The size and margin requirements for patent drawings are specified in 37 CFR 1.84(f) and (g). Key requirements include:

  • Sheet size: 21.0 cm x 29.7 cm (DIN size A4) or 21.6 cm x 27.9 cm (8 1/2 x 11 inches)
  • Top margin: at least 2.5 cm (1 inch)
  • Left side margin: at least 2.5 cm (1 inch)
  • Right side margin: at least 1.5 cm (5/8 inch)
  • Bottom margin: at least 1.0 cm (3/8 inch)

The usable surface (sight) should not exceed 17.0 cm x 26.2 cm on A4 size sheets or 17.6 cm x 24.4 cm on 8 1/2 x 11 inch sheets. Drawings must also include scan target points (cross-hairs) printed on two cater-corner margin corners.

To learn more:

When multiple parties are prosecuting a patent application, there are specific signature requirements for replies to the USPTO. The MPEP provides clear guidance:

“Each of these parties must sign all subsequent replies submitted to the Office.”

The MPEP also provides examples to illustrate these requirements:

  • “If coinventor A has given a power of attorney to a patent practitioner and coinventor B has not, replies must be signed by the patent practitioner of A and by coinventor B.”
  • “If coinventors A and B have each appointed their own patent practitioner, replies must be signed by both patent practitioners.”

These examples demonstrate that all parties involved in prosecuting the application must sign subsequent replies, whether they are inventors, attorneys, or agents. This ensures that all parties are aware of and agree to the content of communications with the USPTO.

To learn more:

Tags: USPTO

What are the signature requirements for patent practitioners in correspondence with the USPTO?

Patent practitioners (e.g., registered attorneys or agents) must follow specific signature requirements when corresponding with the USPTO:

  • They must personally sign correspondence using either a handwritten signature or an S-signature.
  • An S-signature is inserted between forward slash marks and includes the practitioner’s name and registration number.
  • The signature must comply with 37 CFR 1.4(d)(1) or 1.4(d)(2).

According to MPEP 502.02, ‘The signature of a practitioner on correspondence filed with the USPTO must be a handwritten signature or an S-signature personally signed by such practitioner.’ This ensures accountability and authenticity in patent-related communications.

To learn more:

According to 37 CFR 11.18(a), all documents filed in the USPTO for patent matters must bear a signature, with some exceptions:

  • Documents that are required to be signed by the applicant or party do not need a practitioner’s signature.
  • For all other documents, each piece of correspondence filed by a practitioner must be personally signed or have their signature inserted in compliance with 37 CFR 1.4(d).

The MPEP states: “37 CFR 11.18(a) emphasizes that every paper filed by a practitioner must be personally signed by the practitioner, except those required to be signed by the applicant or party.”

To learn more:

For papers filed by a juristic entity (e.g., corporation) in a patent application:

  • A person authorized to act on behalf of the juristic entity must sign.
  • The signer’s name and title must be included.
  • The papers must state the signer’s capacity to sign for the juristic entity.

The MPEP states: Papers filed on behalf of juristic entities must be signed by a patent practitioner. 37 CFR 1.33(b)(3). (MPEP 402.03)

For example, a proper signature might look like: ‘John Smith, President, Corporation XYZ, authorized to sign on behalf of Corporation XYZ’.

To learn more:

The signature requirements for inventor’s oaths or declarations are as follows:

  • There is no requirement for a signature to be made in any particular manner.
  • Inventors can use titles such as ‘Dr.’ in their signatures, but these won’t appear in the printed patent.
  • Non-English character signatures are accepted.
  • If an inventor cannot write, their mark must be witnessed.

According to MPEP § 602.08(b), “There is no requirement that a signature be made in any particular manner.” The section also states, “It is permissible for an applicant to use a title of nobility or other title, such as ‘Dr.’, in connection with their signature. The title will not appear in the printed patent.

To learn more:

The signature requirements for filing a Continued Prosecution Application (CPA) are specific and important. According to MPEP 201.06(d):

A Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) must be signed by a person authorized to prosecute the application, except as provided in 37 CFR 1.33(b).

This means that:

  • The CPA must be signed by someone authorized to prosecute the application.
  • Typically, this would be the applicant or the applicant’s patent attorney or agent.
  • There are exceptions outlined in 37 CFR 1.33(b), which allow for certain communications to be signed by other parties in specific circumstances.

It’s crucial to ensure that the proper signature is provided when filing a CPA to avoid potential issues with the application’s acceptance or processing.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For documents submitted through EFS-Web, the USPTO accepts electronic signatures. According to MPEP 402.03:

Any paper filed in the Office in a patent application, patent file, or other proceeding which is not signed as required by 37 CFR 1.4(d) or (e) will be considered unsigned, and will be treated in accordance with 37 CFR 1.4(d)(1).

The USPTO specifically recognizes S-signatures for EFS-Web submissions. An S-signature is a signature inserted between forward slash marks, like so: /John Smith/. It’s important to note that the signer must manually type their name or use a facsimile or handwritten signature inserted between the slashes.

To learn more:

Tags: EFS-Web, USPTO

The signature requirements for correspondence in patent applications are outlined in MPEP 502.02. The section states:

37 CFR 1.4(d) sets forth the signature requirements for correspondence filed in the Office. Specifically, 37 CFR 1.4(d) provides that:

The signature requirements vary depending on the type of correspondence and the method of submission. Generally, they include:

  • Handwritten signatures
  • S-signatures (electronically created signatures)
  • EFS-Web signatures for documents submitted via the Electronic Filing System

Each type of signature has specific requirements to ensure its validity and authenticity.

To learn more:

Tags: USPTO

The signature requirements for an Application Data Sheet (ADS) are as follows:

  • An ADS must be signed in compliance with 37 CFR 1.33(b).
  • An unsigned ADS will be treated only as a transmittal letter.
  • Proper signing is crucial for the ADS to be effective in providing application information.

37 CFR 1.76(e) states: “An application data sheet must be signed in compliance with § 1.33(b). An unsigned application data sheet will be treated only as a transmittal letter.”

It’s important to note that an unsigned ADS will not be effective for providing crucial information such as inventor names, applicant details, or priority claims. Therefore, ensuring proper signature on the ADS is essential for it to serve its intended purpose in the patent application process.

To learn more:

The signature requirements for a Continued Prosecution Application (CPA) request are specific and important to ensure proper filing. According to MPEP 201.06(d):

  • The request for a CPA must be signed by a person authorized to prosecute the prior application.
  • This includes:
    • A registered patent practitioner
    • The applicant (inventor or assignee of the entire interest)
  • The signature can be provided through any of the approved signature methods outlined in 37 CFR 1.4(d).

The MPEP states: ‘A request for a CPA may only be signed by a person authorized to prosecute the application as set forth in 37 CFR 1.33(b).’ This ensures that only authorized individuals can initiate the CPA process, maintaining the integrity of the application.

It’s crucial to note that if the CPA request is not properly signed, it may not be granted a filing date, potentially affecting the continuity of the application.

For more information on CPA, visit: CPA.

Tags: CPA

The USPTO assigns different series codes to various types of patent applications:

  • 01/ – 16/: Nonprovisional applications (utility, plant, and reissue)
  • 29/: Design applications
  • 35/: International design applications
  • 60/, 61/, and 62/: Provisional applications
  • 90/: Ex parte reexamination proceedings
  • 95/: Inter partes reexamination proceedings
  • 96/: Supplemental examination proceedings and resulting ex parte reexamination proceedings

The MPEP provides a detailed breakdown of series codes for nonprovisional applications from 1925 to the present. For example, ‘Series code 16 is assigned to nonprovisional applications filed from June 2018 to present.’ (MPEP 503)

S-signatures, or electronic signatures, must meet specific requirements for patent applications:

  • Inserted between forward slash marks (//).
  • Include the signer’s name.
  • Be reasonably specific to identify the signer.
  • Be handwritten or a facsimile of a handwritten signature.

According to MPEP 402.03: ‘The signature must consist only of letters, or Arabic numerals, or both. The S-signature must be signed in permanent dark ink or its equivalent.’

To learn more:

What are the rules for submitting color drawings in a patent application?

Submitting color drawings in a patent application requires special considerations and procedures. According to MPEP 608.02:

“Color drawings are not ordinarily permitted in utility patent applications. The Office will accept color drawings in utility patent applications only after granting a petition filed under this paragraph explaining why the color drawings are necessary.”

To submit color drawings:

  • File a petition explaining why color drawings are necessary
  • Pay the required petition fee
  • Include three sets of color drawings or color photographs
  • Amend the specification to include the reference to color drawings

The MPEP further states: “Color photographs will be accepted in utility patent applications if the conditions for accepting color drawings have been satisfied.” It’s important to note that even if the petition is granted, the patent will be printed in black and white unless color printing fees are paid.

For design patent applications, color drawings are generally acceptable without a petition, but specific requirements still apply regarding the quality and format of the drawings.

To learn more:

When conducting interviews with patent practitioners in foreign countries, examiners must follow specific guidelines:

  • Interviews must be conducted via video conference or telephone.
  • In-person interviews in foreign countries are not permitted.
  • The same interview policies and procedures apply as for domestic interviews.

As stated in the MPEP 408: ‘For patent practitioners in foreign countries, interviews must be scheduled to be conducted by video conference or telephone. Examiners may not hold in-person interviews with patent practitioners in foreign countries.’

For applications filed before September 16, 2012, the process for an assignee to revoke a power of attorney is different. According to the MPEP:

In applications filed before September 16, 2012, the assignee of record of the entire interest can revoke the power of attorney of the applicant unless an ‘irrevocable’ right to prosecute the application had been given as in some government owned applications.

The assignee must establish their right to take action as provided in pre-AIA 37 CFR 3.73(b). Once this is done, a power of attorney by the assignee of the entire interest revokes all powers given by the applicant and prior assignees.

Form PTO/SB/80 can be used by an assignee to revoke a power of attorney and appoint a new one. The assignee would sign the power of attorney, and either the assignee or the newly appointed practitioner would sign a statement under pre-AIA 37 CFR 3.73(b).

To learn more:

Reissue application files have specific access rules as outlined in MPEP 103:

‘All reissue applications, both pending and abandoned, are open to public inspection and copying.’

This means that:

  • Anyone can access reissue application files
  • No special permission is required
  • Both pending and abandoned reissue applications are available

However, if the reissue application contains a request for continued examination (RCE) filed on or after March 16, 2013, access to the file may be restricted until publication.

For more information on public inspection, visit: public inspection.

For more information on reissue applications, visit: reissue applications.

Using unsecured email for USPTO communications poses several risks:

  • Confidentiality breaches: Sensitive information could be intercepted by unauthorized parties.
  • Legal issues: Transmitting confidential information without proper security measures may violate patent laws and regulations.
  • Loss of patent rights: Inadvertent public disclosure through unsecured email could jeopardize patent rights.
  • Rejection of communications: The USPTO may not accept or acknowledge communications sent through unsecured channels.

MPEP 502.03 warns: “Internet e-mail shall NOT be used to conduct an exchange or communications similar to those exchanged during telephone or personal interviews unless a written authorization has been given.” This emphasizes the importance of using secure, authorized channels for all USPTO communications.

To mitigate these risks, always use the USPTO’s secure email system or the Electronic Filing System (EFS-Web) for official communications.

To learn more:

Improperly claiming micro entity status can have serious consequences:

  • It may be considered fraud on the USPTO if done knowingly
  • It can result in the patent being held unenforceable
  • Improperly paid fees will need to be corrected, which may include late fees

MPEP 509.04 warns: ‘Any attempt to fraudulently establish status as a micro entity, or pay fees as a micro entity, shall be considered as a fraud practiced or attempted on the Office. Improperly, and with intent to deceive, establishing status as a micro entity, or paying fees as a micro entity, shall be considered as a fraud practiced or attempted on the Office.’

A non-signing inventor, also known as an “inventor designee,” has certain rights in a patent application filed without their signature. According to MPEP § 409.03(i) (for applications filed before September 16, 2012):

  • The non-signing inventor may protest their designation as an inventor
  • They are entitled to inspect any paper in the application and order copies
  • They can make their position of record in the file wrapper of the application
  • They may arrange to do any of the above through a registered patent attorney or agent

However, the non-signing inventor is not entitled to a hearing and cannot prosecute the application if status under pre-AIA 37 CFR 1.47 has been accorded or if the proprietary interest of the pre-AIA 37 CFR 1.47(b) applicant has been shown.

For applications filed on or after September 16, 2012, similar principles apply, but the specific procedures may differ.

What are the restrictions on registered practitioners not of record during USPTO interviews?

Registered practitioners who are not of record for a specific patent application face certain restrictions when attending USPTO interviews. According to MPEP 408:

‘The registered practitioner not of record may not participate in the interview of the application except as authorized by the patent applicant.’

This means that while a practitioner not of record may accompany the practitioner of record to an interview, their participation is limited. They cannot actively engage in the discussion or negotiation process without explicit authorization from the patent applicant. This restriction is in place to ensure that the applicant’s interests are properly represented by their chosen practitioner of record and to maintain the integrity of the interview process.

For more information on patent examination, visit: patent examination.

For more information on practitioner of record, visit: practitioner of record.

For more information on registered practitioner, visit: registered practitioner.

Secrecy order applications are subject to strict restrictions on foreign filing to protect national security. The MPEP 130 outlines these restrictions:

A secrecy order bars the filing of a foreign application based on the application under secrecy order without prior license from the Commissioner for Patents.

Key points regarding foreign filing restrictions:

  • Filing a foreign application without authorization is prohibited.
  • A license from the Commissioner for Patents is required for any foreign filing.
  • Unauthorized foreign filing can result in severe penalties, including abandonment of the application.
  • These restrictions are in place to prevent disclosure of sensitive information to foreign entities.

Inventors and applicants must be aware of these restrictions to avoid legal complications and potential national security breaches.

For more information on patent applications, visit: patent applications.

What are the restrictions on filing a continuation-in-part application?

n

While continuation-in-part (CIP) applications offer flexibility in adding new matter to existing patent applications, there are several important restrictions to consider. The MPEP 201.08 outlines some key points:

n

“A continuation-in-part application can be filed as a new application claiming benefit under 35 U.S.C. 120 to a prior nonprovisional application or under 35 U.S.C. 119(e) to a prior provisional application, provided the conditions set forth under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 are met.”

n

Key restrictions include:

n

    n

  • The CIP must be filed while the parent application is still pending (not abandoned or issued).
  • n

  • At least one inventor named in the CIP must also be named in the parent application.
  • n

  • The CIP must include a specific reference to the parent application.
  • n

  • New matter in the CIP does not benefit from the parent application’s filing date.
  • n

  • The CIP must be filed within the time limits specified in 37 CFR 1.78 to claim priority.
  • n

n

Additionally, applicants should be aware that filing a CIP may affect the patent term and the assessment of prior art for the new subject matter. Careful consideration of these restrictions is essential for effective patent strategy.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on filing requirements, visit: filing requirements.

To qualify for micro entity status, an applicant must meet the following requirements:

  • Qualify as a small entity
  • Not be named as an inventor on more than 4 previously filed patent applications
  • Not have a gross income exceeding 3 times the median household income in the previous calendar year
  • Not have assigned, licensed, or be obligated to assign or license rights to an entity that exceeds the gross income limit

Alternatively, an applicant can qualify if they are employed by or have assigned rights to an institution of higher education.

To use the Priority Document Exchange (PDX) program, several requirements must be met as outlined in MPEP 215.02(a):

  1. The foreign application must be filed in a participating foreign intellectual property office.
  2. The claim for priority must be presented in an application data sheet (ADS) with specific details about the foreign application.
  3. The copy of the foreign application must be received by the USPTO from the participating foreign office, or a certified copy must be filed, within the specified time period.

The MPEP states:

37 CFR 1.55(i) specifically provides that this requirement for a timely filed certified copy of the foreign application will be considered satisfied if: (1) The foreign application was filed in a foreign intellectual property office participating with the Office in a bilateral or multilateral priority document exchange agreement (participating foreign intellectual property office); (2) the claim for priority is presented in an application data sheet (§1.76(b)(6)), identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and including the information necessary for the participating foreign intellectual property office to provide the Office with access to the foreign application; and (3) the copy of the foreign application is received by the Office from the participating foreign intellectual property office, or a certified copy of the foreign application is filed, within the time period set forth in 37 CFR 1.55(g)(1)).

Meeting these requirements allows applicants to potentially avoid manually filing certified copies of foreign priority documents.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For more information on requirements, visit: requirements.

According to 37 CFR 3.31, the cover sheet for patent assignments must contain:

  • Name of the party conveying the interest
  • Name and address of the party receiving the interest
  • Description of the interest conveyed or transaction to be recorded
  • Identification of the patent or application
  • Name and address for correspondence
  • Date of execution
  • Signature of the party submitting the document

For joint research agreements, the cover sheet must also:

  • Identify the document as a ‘joint research agreement’
  • Indicate the name of the patent owner
  • Indicate the names of other parties to the agreement
  • Indicate the date the agreement was executed

The MPEP notes that Form PTO-1595, Recordation Form Cover Sheet, may be used as the cover sheet for recording documents relating to patent(s) and/or patent application(s) in the Office.

For more information on Assignment cover sheet, visit: Assignment cover sheet.

For more information on patent assignment, visit: patent assignment.

A certified copy of the foreign application must be filed within the time period set in 37 CFR 1.55, which is the later of four months from the filing date of the US application or sixteen months from the foreign application filing date.

The certified copy requirement will be considered satisfied in a national stage application under 35 U.S.C. 371 if a certified copy was filed in the international application and the copy is present in the national stage application. See MPEP § 215.

A certified copy is also not required if the foreign priority application was filed in a participating foreign intellectual property office and the USPTO retrieves a copy via the priority document exchange program. See MPEP § 215.01.

An interim copy of the foreign application may also be filed to meet the timeliness requirement. See 37 CFR 1.55(j) and MPEP § 215.02(b).

When canceling a patent drawing figure, the amendment document should include:

  • An explanation of the changes to the drawings in the remarks section.
  • The marked-up (annotated) copy of the drawing sheet showing the cancellation.
  • A replacement sheet of drawings without the canceled figure (if applicable).
  • Amendments to the brief description of the drawings reflecting the change.

MPEP 608.02(t) states: “The marked-up (annotated) copy must be clearly labeled as ‘Annotated Sheet’ and must be presented in the amendment or remarks section of the amendment document which explains the changes to the drawings (see 37 CFR 1.121(d)(1)).” This ensures that the examiner can easily understand and process the changes made to the application.

To learn more:

The Abstract of the Disclosure in a patent application must meet specific requirements as outlined in 37 CFR 1.72(b) and MPEP § 608.01(b):

  • It should be a brief narrative of the disclosure as a whole
  • It should be as concise as the disclosure permits
  • It should be a single paragraph
  • It should preferably not exceed 150 words
  • It should commence on a separate sheet following the claims

The MPEP states, The abstract is a brief narrative of the disclosure as a whole, as concise as the disclosure permits, in a single paragraph preferably not exceeding 150 words, commencing on a separate sheet following the claims.

For international applications that have entered the national stage, the abstract published with the international application under PCT Article 21 will be used by the USPTO, unless the applicant provides a new one.

To learn more:

When submitting models or exhibits that are required by the Office or filed with a petition, applicants must include photographs that meet specific criteria. According to MPEP 608.03:

Models or exhibits that are required by the Office or filed with a petition under 37 CFR 1.91(a)(3) must be accompanied by photographs that (A) show multiple views of the material features of the model or exhibit, and (B) substantially conform to the requirements of 37 CFR 1.84.

The MPEP further clarifies that material features are those which represent the portion(s) of the model or exhibit forming the basis for which it has been submitted. For video or DVD submissions, applicants must provide photographs of what is depicted in the video (e.g., a still image or single frame), not just a photograph of the media itself.

To learn more:

What are the requirements for submitting photographs as drawings in a patent application?

Photographs are generally not permitted as drawings in patent applications unless they are the only practicable medium for illustrating the claimed invention. According to MPEP 608.02, “The Office will accept photographs in utility and design patent applications, however, if photographs are the only practicable medium for illustrating the claimed invention.” The MPEP further states:

“The photographs must be of sufficient quality so that all details in the photographs are reproducible in the printed patent.”

To submit photographs as drawings:

  • Ensure they are the only practicable medium for illustrating the invention
  • Provide high-quality photographs that clearly show all details
  • Submit them on paper that complies with drawing sheet requirements
  • Include any necessary mounting on bristol board or equivalent

It’s important to note that color photographs are not ordinarily permitted in utility patent applications.

To learn more:

When submitting non-English language information in an Information Disclosure Statement (IDS), there are specific requirements that must be met. The MPEP 609.05(a) addresses this issue with form paragraph 6.49.09:

The information disclosure statement filed [1] fails to comply with 37 CFR 1.98(a)(3)(i) because it does not include a concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information, of each reference listed that is not in the English language.

To comply with the requirements for non-English language information in an IDS:

  • Include a concise explanation of the relevance of each non-English language reference
  • The explanation should be provided by the individual most knowledgeable about the content
  • Failure to provide this explanation may result in the information not being considered

Applicants should ensure they provide proper explanations for non-English language references to avoid delays in the examination process and ensure all relevant information is considered.

To learn more:

When submitting documents as evidence in a reply to an Office action, applicants do not need to comply with the information disclosure rules (37 CFR 1.97 and 37 CFR 1.98) for the examiner to consider the information. The MPEP states:

“To the extent that a document is submitted as evidence directed to an issue of patentability raised in an Office action, and the evidence is timely presented, applicant need not satisfy the requirements of 37 CFR 1.97 and 37 CFR 1.98 in order to have the examiner consider the information contained in the document relied on by applicant.”

However, the examiner’s consideration may be limited to the portion of the document relied upon as rebuttal evidence.

To learn more:

When responding to a notice about an unlocatable file, applicants or patentees must provide copies of correspondence, but there are some exceptions. The MPEP states:

Any appendix or information disclosure statement submitted with an application is not contained in the Office’s database. Therefore, the applicant or patentee must also provide a copy of any appendix or information disclosure statement (except in the limited circumstance discussed below) submitted with the application.

However, there’s an important exception for U.S. patent documents:

Since the Office can obtain copies of U.S. patent documents (U.S. patent application publications and patents) from its internal databases, the Office is not requiring applicants or patentees to provide copies of U.S. patent application publications and patents that are among the applicant’s or patentee’s record of the correspondence between the Office and the applicant or patentee for the application, patent, or other proceeding.

This means that while most documents need to be resubmitted, U.S. patent documents can be omitted from the response.

The requirements for submitting biological sequence listings in patent applications depend on the filing date:

  • For applications filed before July 1, 2022: A “Sequence Listing” as an ASCII plain text file in compliance with 37 CFR 1.821 – 1.824.
  • For applications filed on or after July 1, 2022: A “Sequence Listing XML” as an XML file in compliance with 37 CFR 1.831 – 1.834.

As stated in MPEP 608.05(c): “Applications disclosing nucleotide and/or amino acid sequences […] are required to provide the biological sequence information in a sequence listing.”

To learn more:

The submission of biological material specimens to the USPTO is governed by specific requirements outlined in MPEP 608.03(a). The key points are:

  • Proper packaging: Specimens must be submitted in containers that ensure their safe delivery.
  • Identification: Each specimen should be clearly identified with the inventor’s name, the application number, and the filing date.
  • Compliance with regulations: Submissions must comply with all applicable regulations, including those related to dangerous materials and biotechnology inventions.

The MPEP specifically states:

‘Biological specimens will not be returned to the applicant. The procedures for submittal of samples of biological materials for deposit in a suitable depository for patent purposes are governed by 37 CFR 1.801 – 1.809.’

It’s crucial for applicants to follow these guidelines to ensure proper handling and consideration of their biological material specimens during the patent examination process.

To learn more:

According to 37 CFR 3.26, assignment documents in languages other than English can be recorded with the USPTO, but specific requirements must be met. The MPEP states:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

Key points for submitting non-English assignment documents:

  • The original non-English document must be submitted
  • An English translation of the document must be provided
  • The translation must be signed by the individual who performed the translation
  • Both the original document and the translation will be recorded

It’s important to ensure that the translation accurately reflects the content of the original document to avoid any legal complications or misunderstandings regarding the assignment.

For more information on patent assignment, visit: patent assignment.

According to MPEP 302.09, there are specific requirements for submitting assignment-related documents by fax:

  • An identified application or patent number
  • One cover sheet to record a single transaction
  • Payment of the recordation fee by credit card or USPTO Deposit Account

The MPEP states: Any assignment-related document for patent matters submitted by facsimile must include: (A) an identified application or patent number; (B) one cover sheet to record a single transaction; and (C) payment of the recordation fee by a credit card (use of the Credit Card form, PTO-2038 (see MPEP § 509), is required for the credit card information to be kept separate from the assignment records) or a USPTO Deposit Account.

It’s important to note that certain documents cannot be submitted via fax, such as assignments submitted with new patent applications or documents with multiple cover sheets.

To learn more:

What are the requirements for submitting an interim copy of a foreign priority application?

Submitting an interim copy of a foreign priority application can be useful when there are delays in obtaining a certified copy. According to MPEP 213.04, here are the requirements:

37 CFR 1.55(j) provides that an applicant who has not filed a certified copy of the foreign application may file an interim copy of the foreign application during the pendency of the application.

To submit an interim copy:

  • It must be filed during the pendency of the application
  • The copy must be clearly labeled as ‘Interim Copy’
  • Include a cover sheet identifying:
    • The application number
    • The foreign application number
    • The country or intellectual property office
    • The filing date
  • The interim copy must be a legible copy of the foreign application

Note: An interim copy does not satisfy the requirement for a certified copy. You must still submit a certified copy of the foreign application before the patent is granted.

To learn more:

For continuation, divisional, or continuation-in-part applications filed under 37 CFR 1.53(b), the requirements for submitting an Information Disclosure Statement (IDS) depend on whether the information was previously considered in the parent application. The MPEP provides the following guidance:

  • If the information was considered in the parent application, it need not be resubmitted unless the applicant wants it printed on the patent.
  • If the information was not considered in the parent application, it must be resubmitted in compliance with 37 CFR 1.97 and 37 CFR 1.98.

The MPEP further states:

“Pursuant to 37 CFR 1.98(d), if the IDS submitted in the parent application complies with 37 CFR 1.98(a) to (c), copies of the patents, publications, pending U.S. applications, or other information submitted in the parent application need not be resubmitted in the continuing application.”

When resubmitting information, applicants should use a new listing that complies with the format requirements in 37 CFR 1.98(a)(1) and avoid submitting copies of PTO/SB/08 or PTO-892 forms from other applications to prevent confusion in the record.

To learn more:

Electronic submission of an Information Disclosure Statement (IDS) is limited to specific methods and formats. The MPEP states:

Electronic means or medium for filing IDSs are not permitted except for: (A) IDSs electronically submitted using the USPTO patent electronic filing system (see MPEP § 609.07); or (B) copies of large tables, computer program listings, and sequence listings submitted as a PDF file and a “Sequence Listing XML” submitted as an XML file on a read-only optical disc in compliance with 37 CFR 1.52(e)(2) and (3) which are cited in a paper IDS.‘ (MPEP 609.04(a))

Key points for electronic IDS submission:

  • Use the USPTO patent electronic filing system for general IDS submissions
  • Large tables, computer program listings, and sequence listings can be submitted as PDF files
  • “Sequence Listing XML” must be submitted as an XML file on a read-only optical disc
  • A read-only optical disc cannot be used to submit an IDS listing or copies of documents (except for the items mentioned above)
  • Published information, such as software output or videos, must be reduced to writing (e.g., screen shots, transcripts)

It’s important to follow these guidelines to ensure proper processing of your IDS by the USPTO.

To learn more:

What are the requirements for submitting an IDS after the first Office action?

When submitting an Information Disclosure Statement (IDS) after the first Office action on the merits, additional requirements apply:

  • Timing: The IDS must be filed before the mailing date of a final action, notice of allowance, or other action that closes prosecution.
  • Statement: The IDS must be accompanied by one of the following:
    • A statement specified in 37 CFR 1.97(e)
    • The fee set forth in 37 CFR 1.17(p)

As stated in MPEP 609: “An information disclosure statement will be considered by the examiner if filed after the first Office action on the merits, but before the mailing date of any of a final action under 37 CFR 1.113, a notice of allowance under 37 CFR 1.311, or an action that otherwise closes prosecution in the application.”

It’s crucial to comply with these requirements to ensure the IDS is considered by the examiner.

To learn more:

To submit an assignment document electronically to the USPTO, the following requirements must be met:

  • The document must be submitted via the Electronic Patent Assignment System (EPAS)
  • An identified application or patent number must be included
  • One cover sheet must be completed online to record a single transaction
  • The signature on the cover sheet must comply with 37 CFR 3.31(a)(7) or 37 CFR 1.4(d)(2)

As stated in 37 CFR 1.4(d)(2), an S-signature may be used, which consists of letters and/or numbers between forward slashes (e.g., /John Doe/). For patent practitioners, their registration number must also be included.

For pre-AIA applications, submitting a supplemental Application Data Sheet (ADS) must follow specific requirements:

1. Timing: MPEP 601.05(b) states, “Supplemental application data sheets may be subsequently supplied prior to payment of the issue fee to either correct or update information in a previously submitted application data sheet, or an oath or declaration under pre-AIA 37 CFR 1.63 or 1.67.”

2. Title: The supplemental ADS must be titled “Supplemental Application Data Sheet.”

3. Content: It must contain all section headings listed in 37 CFR 1.76(b) with all appropriate data for each heading.

4. Format: The supplemental ADS must indicate changes, “preferably with insertions or additions indicated by underlining, and deletions, with or without replacement data, indicated by strike-through or brackets.”

5. Signature: The supplemental ADS must be signed as it is considered a paper filed in the application.

To learn more:

When submitting a supplemental Application Data Sheet (ADS) to correct or update information in a patent application, there are specific requirements to follow. According to MPEP 601.05:

‘For applications filed on or after September 16, 2012, if an applicant submits an ADS after the initial filing date of the application, the ADS must comply with the requirements of 37 CFR 1.76(c). A supplemental ADS must be labeled as such and must identify the information that is being changed with underlining (for insertions) and strike-through or brackets (for text removed).’

Key requirements for submitting a supplemental ADS include:

  • Proper labeling: The ADS must be clearly labeled as ‘Supplemental’ or ‘Corrected’.
  • Identifying changes: Use underlining for insertions and strike-through or brackets for deletions.
  • Complete sections: Include all sections of the ADS, not just the changed information.
  • Timing: Submit the supplemental ADS as soon as the need for correction is identified.
  • Fee: Be aware that certain changes may require payment of additional fees.

It’s crucial to follow these requirements to ensure that the USPTO properly processes the updated information and to avoid potential delays or issues with the application.

To learn more:

Statements under the Atomic Energy Act and NASA Act must set forth “the full facts” surrounding the conception and making of the invention. According to MPEP 151, these facts should be unique to that invention. The MPEP states:

“The use of form paragraphs or printed forms which set forth only broad generalized statements of fact is not ordinarily regarded as meeting the requirements of these statutes.”

This means that inventors must provide detailed, specific information about their invention’s conception and development.

For more information on invention disclosure, visit: invention disclosure.

What are the requirements for signing patent documents on behalf of juristic entities?

The requirements for signing patent documents on behalf of juristic entities (such as corporations, universities, or other organizations) are specific and strict. According to MPEP 402.04:

“Effective September 16, 2012, any paper submitted on behalf of a juristic entity must be signed by a patent practitioner.”

This means that for juristic entities:

  • All patent documents must be signed by a registered patent practitioner (either a patent attorney or a patent agent).
  • Employees or officers of the juristic entity cannot sign patent documents, even if they are the inventors.
  • The patent practitioner must be officially appointed to represent the juristic entity before the USPTO.

This requirement ensures that juristic entities are properly represented in patent matters and helps maintain the integrity of the patent application process. It’s important for juristic entities to work with qualified patent practitioners to handle their patent applications and related documents.

To learn more:

Amendments and other papers filed in a patent application must be signed by specific individuals as outlined in 37 CFR 1.33(b):

  1. A patent practitioner of record
  2. A patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34
  3. The applicant (37 CFR 1.42)

It’s important to note that for juristic entities (e.g., corporations), 37 CFR 1.33(b)(3) specifies:

“Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.”

This requirement ensures that juristic entities are properly represented in patent proceedings.

To learn more:

The USPTO has specific requirements for signatures on documents, as outlined in 37 CFR 1.4(d). Key points include:

  • Signatures must be personally inserted by the signer or comply with specific electronic signature standards.
  • The person inserting a signature certifies that it is their own signature.
  • A person submitting a document signed by another must have a reasonable basis to believe the signature is authentic.

The MPEP states: The person inserting a signature under paragraph (d)(2) or (d)(3) of this section in a document submitted to the Office certifies that the inserted signature appearing in the document is his or her own signature.

For more information on patent application requirements, visit: patent application requirements.

The USPTO accepts different types of signatures on correspondence, including:

  1. Handwritten signatures: Original signatures in permanent dark ink or equivalent.
  2. S-signatures: A signature inserted between forward slash marks, which can be used for correspondence filed in paper, by fax, or via the electronic filing system.
  3. Electronic signatures: For correspondence submitted via the electronic filing system, a graphic representation of a handwritten signature or an S-signature is acceptable.

According to 37 CFR 1.4(d): Each piece of correspondence, except as provided in paragraphs (d)(2), (d)(3), (d)(4), (e) and (f) of this section, filed in an application, patent file, or other proceeding in the Office which requires a person’s signature, must: (i) Be an original, that is, have an original handwritten signature personally signed, in permanent dark ink or its equivalent, by that person; or (ii) Be a direct or indirect copy, such as a photocopy or facsimile transmission (§ 1.6(d)), of an original.

For S-signatures, the signer must personally insert their own signature, and patent practitioners must include their registration number. The signer’s name must be presented in printed or typed form immediately below or adjacent to the S-signature.

To learn more:

The USPTO requires that different matters be submitted in separate papers to avoid confusion and delays. This requirement is outlined in 37 CFR 1.4(c), which states:

Since different matters may be considered by different branches or sections of the Office, each distinct subject, inquiry or order must be contained in a separate paper to avoid confusion and delay in answering papers dealing with different subjects.

Key points to remember:

  • Each distinct subject, inquiry, or order should be in a separate paper.
  • This applies to both patent and trademark correspondence.
  • Exceptions are allowed for subjects provided for on a single Office or World Intellectual Property Organization form.

If you submit multiple subjects in a single paper, the USPTO may use Form Paragraph 5.01.01 to notify you of the requirement for separate papers in future correspondence.

Adhering to this requirement helps ensure that your correspondence is processed efficiently by the appropriate Office branches or sections.

To learn more:

When sending confidential information via email to the USPTO, specific requirements must be met:

  • Use of the Electronic Filing System (EFS-Web) is strongly recommended for submitting confidential information.
  • If email must be used, it should be through the USPTO’s secure email system.
  • An authorization from the applicant is required before sending confidential information via email.
  • The email must include a statement that the email correspondence is being submitted using the procedures set forth in 37 CFR 1.33(d).

As stated in MPEP 502.03: “Internet email shall NOT be used to conduct an exchange of communications similar to those exchanged during telephone or personal interviews unless a written authorization has been given.”

To learn more:

S-signatures, or electronic signatures, are accepted by the USPTO for patent applications. The requirements for S-signatures include:

  • The signature must be between forward slash marks (//).
  • The signer’s name must be provided in printed or typed form preferably immediately below or adjacent to the S-signature.
  • The S-signature may be any combination of letters, numbers, spaces, and punctuation marks.

The MPEP 402.03 states: An S-signature must consist only of letters, or Arabic numerals, or both, with appropriate spaces and commas, periods, apostrophes, or hyphens for punctuation, and the person signing the correspondence must insert his or her own S-signature with a first single forward slash mark before, and a second single forward slash mark after, the S-signature (e.g., /Dr. James T. Jones, Jr./).

It’s important to note that the S-signature must be inserted by the person signing the document, not by someone else on their behalf.

To learn more:

The requirements for representing applicants before international patent authorities vary depending on the specific authority. According to MPEP 402.09 and 37 CFR 11.9(c):

An individual not registered under § 11.6 may, if appointed by an applicant, prosecute an international patent application only before the United States International Searching Authority and the United States International Preliminary Examining Authority, provided that the individual has the right to practice before the national office with which the international application is filed as provided in PCT Art. 49, Rule 90 and § 1.455 of this subchapter, or before the International Bureau when the USPTO is acting as Receiving Office pursuant to PCT Rules 83.1 bis and 90.1.

This means that representation rights depend on the specific authority and the individual’s right to practice before the relevant national office or the International Bureau.

To learn more:

According to MPEP 302.02, non-English assignment documents can only be accepted and recorded by the USPTO if they are accompanied by an English translation. The MPEP states:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This means that inventors, assignees, or their representatives must provide a certified English translation along with the original non-English document for it to be officially recorded.

To learn more:

To record an assignment of a patent or patent application, the following requirements must be met:

  • The assignment must be in writing.
  • It must be signed by the assignor (the person or entity transferring ownership).
  • The document must identify the patent or application by number.
  • The assignment must be submitted to the USPTO along with the required fee.

According to MPEP 301: “An assignment relating to a patent must be submitted to the USPTO for recordation as an absolute requirement for enforcing the patent or application against third parties.” This recordation provides constructive notice to the public of the assignment.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For more information on USPTO, visit: USPTO.

What are the requirements for recording a patent assignment document?

To record a patent assignment document, you must submit:

  • A copy of the original assignment document
  • A cover sheet identifying the document as an assignment
  • The required fee

The MPEP states: ‘The document submitted for recordation must be accompanied by a cover sheet identifying the document as an assignment and must contain the fee required by 37 CFR 3.41.’ This ensures proper processing and indexing of the assignment.

To learn more:

Joint research agreements can be recorded with the USPTO as per 37 CFR 3.11(c). The MPEP states that the cover sheet for a joint research agreement must:

  • Identify the document as a ‘joint research agreement’ in the description of interest conveyed
  • Indicate the name of the owner of the application or patent
  • Indicate the name of each other party to the joint research agreement
  • Indicate the date the joint research agreement was executed

The document submitted can be either the entire joint research agreement or an excerpt of it. As with other recorded documents, it must be accompanied by a completed cover sheet as specified in 37 CFR 3.28 and 3.31.

Remember that A patent cover sheet may not refer to trademark applications or registrations. Separate cover sheets must be used for patents and trademarks.

For more information on joint research agreement, visit: joint research agreement.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

To record a document with respect to additional patents and/or patent applications, even if it has been previously recorded, the following must be submitted to the Assignment Division:

As stated in MPEP 315: “The Office will assign a new recording date to that submission, update the assignment database, and include the cover sheet and document as part of the official record.”

For more information on Assignment Division, visit: Assignment Division.

For more information on document recording, visit: document recording.

For more information on patent applications, visit: patent applications.

For more information on recording requirements, visit: recording requirements.

What are the requirements for proper dependency in multiple dependent claims?

Multiple dependent claims must meet specific requirements for proper dependency:

  • They must refer back to previous claims in the alternative only.
  • A multiple dependent claim cannot serve as a basis for any other multiple dependent claim.
  • They must be written in a form that includes all limitations of each of the claims to which it refers.

The MPEP 608.01(n) states:

“A multiple dependent claim may refer in the alternative to only one set of claims. A claim such as ‘A machine according to claims 3 or 4, further comprising —‘ is improper.”

This means that a multiple dependent claim must clearly specify the alternative dependencies and cannot mix single and multiple dependencies in the same claim.

To learn more:

What are the requirements for personnel working with secrecy order applications?

Personnel working with secrecy order applications must meet specific security requirements. MPEP 121 outlines these requirements:

  • Must have proper security clearance
  • Are responsible for maintaining the secrecy of the applications
  • Must ensure applications are returned to secure storage when not in use

The MPEP emphasizes: ‘All applications bearing national security markings must be examined by properly cleared examiners.’ This ensures that only authorized individuals with the necessary security clearance have access to these sensitive patent applications, maintaining their confidentiality and national security integrity.

For inventions related to aeronautical and space activities, applicants must file a statement with specific information if requested by the USPTO. According to 51 U.S.C. 20135:

No patent may be issued to any applicant other than the Administrator for any invention which appears to the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office […] to have significant utility in the conduct of aeronautical and space activities unless the applicant files with the Director, with the application or within 30 days after request therefor by the Director, a written statement executed under oath setting forth the full facts concerning the circumstances under which the invention was made and stating the relationship (if any) of the invention to the performance of any work under any contract of the Administration.

This statement should include:

  • Full facts about the circumstances of the invention’s creation
  • The relationship, if any, between the invention and work performed under any NASA contract

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

For paper submissions of patent assignment documents, the following requirements must be met:

  • Submit either a copy of the original document or an extract of the original document.
  • Use only one side of each page.
  • Paper size must be either 8.5″ x 11″ or A4, with a 1-inch margin on all sides.
  • Use flexible, strong white, non-shiny, and durable paper.

As stated in 37 CFR 3.24(b): “For paper submissions, the paper used should be flexible, strong white, non-shiny, and durable.” This ensures that the document can be properly recorded and stored by the USPTO.

What are the requirements for paper size and margins in a patent application specification?

According to MPEP 608.01, the specification must adhere to specific paper size and margin requirements:

  • Paper size: 21.0 cm by 29.7 cm (DIN size A4) or 21.6 cm by 27.9 cm (8 1/2 by 11 inches)
  • Margins: At least 2.0 cm (3/4 inch) on the top, bottom, and left sides; at least 2.5 cm (1 inch) on the right side

The MPEP states: ‘All papers which are to become a part of the permanent records of the U.S. Patent and Trademark Office must be on sheets of paper which cannot exceed 21.6 cm by 33.1 cm (8 1/2 by 13 inches) and which must have the following margins:’ followed by the margin specifications. These requirements ensure uniformity and readability of patent documents.

To learn more:

Tags: paper size

To obtain a filing date for a nonprovisional patent application filed under 37 CFR 1.53(b), the application must include:

  • A specification containing a description as prescribed by 35 U.S.C. 112(a)
  • At least one claim (for applications filed on or after December 13, 2013)
  • Any drawings necessary under 35 U.S.C. 113 (first sentence)

As stated in the MPEP: Filing dates are accorded to nonprovisional applications filed under 37 CFR 1.53(b) submitted without the names of all the inventors, the required fees (basic filing fee, and search and examination fees (for applications filed on or after December 8, 2004)), at least one claim (for applications filed on or after December 13, 2013) and/or the inventor’s oath or declaration.

If any required items are missing, the applicant will be notified and given a time period to submit the missing elements. The filing date will be the date the missing items are received.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application requirements, visit: patent application requirements.

For continuing applications filed on or after September 16, 2012, the following requirements apply:

  • A copy of an oath or declaration or substitute statement from the prior nonprovisional application can be used, provided it complies with 37 CFR 1.63 or 37 CFR 1.64.
  • The oath or declaration must comply with 35 U.S.C. 115 and the relevant CFR sections in effect for applications filed on or after September 16, 2012.
  • It must include a statement that the application was made or authorized to be made by the person executing the oath or declaration.

As stated in the MPEP, “a new inventor’s oath or declaration may need to be filed in a continuing application filed on or after September 16, 2012, where the prior application was filed before September 16, 2012, in order to meet the requirements of 35 U.S.C. 115 and 37 CFR 1.63 (or 1.64) in effect for applications filed on or after September 16, 2012.”

To learn more:

According to MPEP 602.06, non-English oaths or declarations must meet specific requirements:

  • The oath or declaration must be in a language the individual can understand.
  • It must state that the individual understands the content of any related documents.
  • Unless provided by the USPTO or in accordance with PCT Rule 4.17(iv), it must be accompanied by an English translation.
  • A statement confirming the translation’s accuracy is required.

As stated in the MPEP: “37 CFR 1.69 requires that oaths and declarations be in a language which is understood by the individual making the oath or declaration, i.e., a language which the individual comprehends.”

To learn more:

What are the requirements for naming joint inventors in a patent application?

When naming joint inventors in a patent application, it’s important to follow specific requirements:

  • All inventors must be named in the application.
  • Each person listed as an inventor must have contributed to the conception of at least one claim in the application.
  • The order of naming inventors is not significant.

According to MPEP 602.08(b):

“The inventors entered on the application data sheet must include each inventor’s legal name.”

It’s crucial to ensure that all inventors are properly named to avoid potential issues with patent validity later on.

To learn more:

To establish micro entity status on the gross income basis, an applicant must meet the following requirements as outlined in 37 CFR 1.29(a)(1)-(4):

  • Qualify as a small entity
  • Not have been named as an inventor on more than four previously filed patent applications
  • Not have a gross income exceeding three times the median household income in the preceding calendar year
  • Not have assigned, granted, or conveyed, and not be under an obligation to do so, a license or ownership interest to an entity exceeding the gross income limit

The MPEP states: “Because each inventor and each non-inventor applicant (e.g., assignee-applicant) must separately meet the requirements under 37 CFR 1.29(a)(1)-(4), it would not be appropriate to file a micro entity certification under 37 CFR 1.29(a) for the application if there were more than one applicant or inventor and not all of the applicants and inventors qualified as micro entities under 35 U.S.C. 123(a).

To learn more:

To establish micro entity status based on an institution of higher education, an applicant must meet two main requirements:

  1. Qualify as a small entity as defined in 37 CFR 1.27
  2. Meet one of the following criteria:
    • The applicant’s employer, from which they obtain the majority of their income, is an institution of higher education as defined in section 101(a) of the Higher Education Act of 1965, or
    • The applicant has assigned, granted, conveyed, or is under an obligation to assign, grant, or convey, a license or other ownership interest in the application to such an institution of higher education.

As stated in MPEP 509.04(b): “An applicant for micro entity status under the ‘institution of higher education’ basis set forth in 37 CFR 1.29(d) must satisfy two requirements.”

To learn more:

When listing U.S. patents in an Information Disclosure Statement (IDS), the following requirements must be met:

  • List each patent by document number
  • Include the name of the patentee
  • Provide the issue date

According to MPEP 609.04(a): Each U.S. patent listed in an information disclosure statement must be identified by patentee, patent number, and issue date.

To learn more:

To learn more:

Tags: issue date

When listing an inventor’s residence on a patent application, you should follow these requirements:

  • Provide the city and either the state or foreign country of residence.
  • The state may be abbreviated using the two-letter postal code abbreviation.
  • For foreign countries, use the full name of the country.
  • Do not include a street address in the residence field.

According to MPEP 602.08(a): Residence information should be provided for all inventors. In the case where the inventor lives in an A.P.O. area, the city where the A.P.O. is located should be listed under city along with A.P.O. as the state and the zip code.

To learn more:

To learn more:

What are the requirements for limited recognition to practice before the USPTO?

To obtain limited recognition to practice before the USPTO in patent matters, an individual must meet the following requirements:

  • Be a scientist or engineer with a bachelor’s degree in a recognized technical subject
  • Demonstrate scientific and technical training
  • Possess good moral character and reputation
  • Be competent to advise and assist patent applicants

As stated in MPEP 402.01: ‘The OED Director may grant limited recognition to practice before the Office in patent matters to an individual not registered to practice before the Office.’ This limited recognition is subject to the conditions specified by the OED Director.

To learn more:

When submitting amended drawing sheets in response to objections, proper labeling is crucial. According to MPEP 608.02(e), the requirements for labeling amended drawing sheets are:

  1. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either ‘Replacement Sheet’ or ‘New Sheet’.
  2. This labeling must be done pursuant to 37 CFR 1.121(d).
  3. The figure or figure number of an amended drawing should not be labeled as ‘amended’.

It’s important to note that Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. This ensures continuity and completeness in the drawing record.

To learn more:

According to 35 U.S.C. 116, joint inventors can apply for a patent jointly even if:

  • They did not physically work together or at the same time
  • Each did not make the same type or amount of contribution
  • Each did not contribute to every claim of the patent

The MPEP states: 35 U.S.C. 116 recognizes the realities of modern team research. A research project may include many inventions. Some inventions may have contributions made by individuals who are not involved in other, related inventions. This reflects the flexibility in recognizing joint inventorship in collaborative research environments.

To learn more:

According to 37 CFR 1.45(c), for provisional applications:

  • Each named inventor must have contributed to the subject matter disclosed in the application.
  • The application is considered a joint application under 35 U.S.C. 116.

The MPEP clarifies: Because provisional applications may be filed without claims, 37 CFR 1.45(c) states that each inventor named in a joint provisional application must have made a contribution to the subject matter disclosed in the application. This ensures that all named inventors have contributed to the disclosed invention, even in the absence of formal claims.

To learn more:

To learn more:

If a request for issuance to an assignee is submitted after the issue fee has been paid, the following requirements must be met:

  1. Submit a request under 37 CFR 3.81(b)
  2. Include a request for a certificate of correction under 37 CFR 1.323
  3. Pay the fee for the certificate of correction (set forth in 37 CFR 1.20(a))
  4. Pay the processing fee (set forth in 37 CFR 1.17(i))
  5. State that the assignment was submitted for recordation before the patent was issued

As stated in MPEP 307: “If a request for issuance to an assignee pursuant to 37 CFR 3.81(b) is submitted after the day on which the issue fee is paid, the request under 37 CFR 3.81(b) must include a request for a certificate of correction under 37 CFR 1.323 (accompanied by the fee set forth in 37 CFR 1.20(a)) and the processing fee set forth in 37 CFR 1.17(i).”

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

Inventor signatures on patent applications must meet specific requirements to be considered valid:

  • The signature must be handwritten or an S-signature.
  • The name in the signature must match the name on the application.
  • For inventors with multiple surnames or given names, all names should be included in the signature.

The MPEP 602.08(b) states:

The signature of the inventor may be handwritten or an S-signature. See MPEP § 502.02, subsection II, and 37 CFR 1.4(d)(2). The name of each inventor should be printed or typed under the signature.

Additionally, for inventors with multiple names:

If the inventor has many given names, the Office will accept a signature including at least one given name and the family name.

Ensuring correct signatures is crucial for the validity of the patent application and to avoid potential issues during examination or enforcement.

To learn more:

When an inventor’s name contains non-English characters, there are specific requirements for how it should be presented in patent applications:

  • The name must be presented in both non-English characters and Roman letters.
  • A suggested English translation may be provided in parentheses, but is not required.

The MPEP Section 602.08(b) states:

If the inventor’s name is in a language other than English, then the inventor’s name must be presented in Roman letters and in parentheses with English translation, if it is known.

This ensures that the inventor’s name is accurately recorded while also being accessible to English-speaking examiners and the public.

To learn more:

To incorporate material from a prior-filed application under 37 CFR 1.57(b), several requirements must be met:

  1. The inadvertently omitted portion must be completely contained in the prior-filed application.
  2. A copy of the prior-filed application must be submitted (except for applications filed under 35 U.S.C. 111).
  3. If the prior-filed application is in a non-English language, an English language translation must be submitted.
  4. The applicant must identify where the inadvertently omitted portion can be found in the prior-filed application.

The MPEP states that an amendment may not comply with 37 CFR 1.57(b) if any of these conditions are not met. For example, it notes that non-compliance may occur if the inadvertently omitted portion is not completely contained in the prior-filed application or if applicant did not identify where the inadvertently omitted portion of the specification or drawings can be found in the prior-filed application.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

For more information on patent application requirements, visit: patent application requirements.

For more information on prior-filed application, visit: prior-filed application.

The U.S. Patent and Trademark Office (USPTO) allows the inclusion of copyright or mask work notices in design or utility patent applications under specific conditions:

  • The notice must be placed adjacent to the copyrighted or mask work material.
  • The content of the notice must be limited to elements required by law.
  • A specific authorization must be included at the beginning of the specification.
  • If included in drawings, the notice must comply with 37 CFR 1.84(s).

As stated in MPEP 608.01(w): The U.S. Patent and Trademark Office will permit the inclusion of a copyright or mask work notice in a design or utility patent application, and thereby any patent issuing therefrom, which discloses material on which copyright or mask work protection has previously been established, under the following conditions…

To learn more:

An inventor’s oath or declaration must properly identify the application to which it is directed. The MPEP provides several acceptable methods for identification:

  1. For oaths/declarations filed on the application filing date:
    • Inventor name(s) and reference to an attached specification
    • Inventor name(s) and attorney docket number from the specification
    • Inventor name(s) and title of the invention from the specification
  2. For oaths/declarations filed after the filing date:
    • Application number (series code and serial number)
    • Serial number and filing date
    • International application number
    • International registration number (for design applications)
    • Attorney docket number from the specification
    • Title of the invention with reference to an attached specification
    • Title of the invention with a cover letter identifying the application

The MPEP states: “37 CFR 1.63 requires that an oath or declaration identify the application (e.g., specification and drawings) to which it is directed.”

It’s important to accurately identify the application to ensure the oath or declaration is properly associated with the correct application and to prevent potential abandonment issues.

To learn more:

To file an application under pre-AIA 37 CFR 1.47(a) when at least one joint inventor is available, the following requirements must be met:

  • All available joint inventors must make an oath/declaration for themselves and on behalf of the nonsigning inventor
  • Proof that the nonsigning inventor cannot be found/reached after diligent effort or refuses to execute the application
  • The last known address of the nonsigning inventor must be stated

As stated in MPEP 409.03(a): In addition to other requirements of law (pre-AIA 35 U.S.C. 111(a) and 115), an application deposited in the U.S. Patent and Trademark Office pursuant to pre-AIA 37 CFR 1.47(a) must meet the following requirements…

To learn more:

To learn more:

What are the requirements for filing papers with the USPTO?

When filing papers with the United States Patent and Trademark Office (USPTO), it’s important to adhere to specific requirements:

  • Papers must be legibly written either by hand or printed in permanent dark ink or its equivalent.
  • They should be presented on flexible, strong, smooth, non-shiny, durable, and white paper.
  • All papers must be presented in a form having sufficient clarity and contrast between the paper and the writing to permit electronic reproduction by use of digital imaging and optical character recognition.

As stated in MPEP 501: All papers that are to become a part of the permanent records of the United States Patent and Trademark Office should be legibly written either by a typewriter or mechanical printer in permanent dark ink or its equivalent in portrait orientation on flexible, strong, smooth, non-shiny, durable, and white paper.

These requirements ensure that all documents can be properly processed and stored by the USPTO.

For more information on document legibility, visit: document legibility.

According to 37 CFR 1.55(g)(1), the claim for priority and the certified copy of the foreign application must be filed within the pendency of the application. The MPEP states:

“The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application, unless filed with a petition under paragraph (e) or (f) of this section, or with a petition accompanied by the fee set forth in § 1.17(g) which includes a showing of good and sufficient cause for the delay in filing the certified copy of the foreign application in a design application.”

This requirement applies to all applications and ensures that priority claims are properly documented before the application is granted.

To learn more:

According to MPEP 211, a petition to restore the benefit of a provisional application under 37 CFR 1.78(b) must include:

  1. The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application (unless previously submitted)
  2. The petition fee set forth in 37 CFR 1.17(m)
  3. A statement that the delay in filing the subsequent nonprovisional application or international application designating the United States within the twelve-month period was unintentional

The MPEP further states:

“The Director may require additional information where there is a question whether the delay was unintentional.”

It’s important to note that this petition must be filed in the subsequent application, not the provisional application itself.

For more information on patent procedure, visit: patent procedure.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

When filing a patent application with at least one unavailable joint inventor under pre-AIA 37 CFR 1.47(a), the following requirements must be met:

  • All available joint inventors must make an oath or declaration for themselves and on behalf of the nonsigning inventor.
  • Proof must be provided that the nonsigning inventor cannot be found or refuses to execute the application.
  • The last known address of the nonsigning inventor must be stated.

As stated in MPEP 409.03(a):

“An application deposited in the U.S. Patent and Trademark Office pursuant to pre-AIA 37 CFR 1.47(a) must meet the following requirements: (A) All the available joint inventors must (1) make oath or declaration on their own behalf as required by pre-AIA 37 CFR 1.63 or 1.175 […] and (2) make oath or declaration on behalf of the nonsigning joint inventor as required by pre-AIA 37 CFR 1.64.”

It’s important to note that this section is not applicable to applications filed on or after September 16, 2012.

To learn more:

The MPEP 201.06(c) outlines the requirements for filing a divisional or continuation application without an executed oath or declaration:

’37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a continuation or divisional application filed by all or by fewer than all of the inventors named in a prior nonprovisional application containing an oath or declaration as required by 37 CFR 1.63, provided that a copy of the executed oath or declaration filed in the prior application is submitted for the continuation or divisional application and the specification and drawings filed in the continuation or divisional application contain no matter that would have been new matter in the prior application.’

To file without a new oath or declaration:

  • Submit a copy of the executed oath or declaration from the prior application
  • Ensure the new application contains no new matter
  • File a copy of the specification and drawings from the prior application

This procedure allows for expedited filing while maintaining the integrity of the oath or declaration requirements.

To learn more:

To learn more:

The key requirements for filing a divisional application include:

  • The divisional application must be filed before the patenting or abandonment of the parent application.
  • It must claim only subject matter disclosed in the parent application.
  • It must be filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if it is a design application).
  • The inventorship must include at least one inventor named in the parent application.
  • It must claim the benefit of the parent application under 35 U.S.C. 120, 121, 365(c), or 386(c).

As stated in the MPEP:

The divisional application may be filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if the application is a design application, but not an international design application). The inventorship in the divisional application must include at least one inventor named in the prior-filed application, and the divisional application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).

To learn more:

To file a delayed priority claim, you must submit a petition to accept an unintentionally delayed claim for priority. According to 37 CFR 1.55(e), the petition must include:

  1. The priority claim in an application data sheet
  2. A certified copy of the foreign application (unless exceptions apply)
  3. The petition fee
  4. A statement that the entire delay was unintentional

The MPEP states: A petition to accept a delayed claim for priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) must be accompanied by: (1) The priority claim […]; (2) A certified copy of the foreign application […]; (3) The petition fee […]; and (4) A statement that the entire delay […] was unintentional.

Filing a delayed benefit claim for a provisional application requires specific components. MPEP 211.04 outlines the requirements:

The petition must be accompanied by: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior provisional application (unless previously submitted); (B) a petition fee under 37 CFR 1.17(m); and (C) a statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the claim was filed was unintentional.

For petitions filed more than two years after the due date, additional explanation of the delay circumstances is required to establish that the entire delay was unintentional.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

To file a Continued Prosecution Application (CPA), the following requirements must be met:

  • The application must be for a design patent
  • The prior application must be a complete design application as defined by 37 CFR 1.51(b)
  • The CPA must be filed before the earliest of:
    • Payment of the issue fee in the prior application
    • Abandonment of the prior application
    • Termination of proceedings in the prior application

Additionally, the CPA must include a request on a separate paper, identify the prior application, and be accompanied by the basic filing fee, search fee, and examination fee.

To learn more:

To file a valid Continued Prosecution Application (CPA) request for a design patent application, you must adhere to specific requirements outlined in 37 CFR 1.53(d). Key requirements include:

  • The request must be for a design application only.
  • The request must be submitted on a separate paper, as stated in MPEP ¶ 2.31: “because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.”
  • The application being continued must be a design application that is complete as defined by 37 CFR 1.51(b).

Failure to meet these requirements may result in the CPA request being deemed unacceptable.

To file a Continued Prosecution Application (CPA) in a design application, the following requirements must be met:

  • The application must be a design application.
  • The prior application must be a nonprovisional application.
  • The application must be filed before the earliest of:
    • Payment of the issue fee on the prior application, unless a petition under § 1.313(c) is granted in the prior application;
    • Abandonment of the prior application; or
    • Termination of proceedings on the prior application.

As stated in the MPEP 201.06(d): “A continuation or divisional application that is a nonprovisional application may be filed as a CPA under 37 CFR 1.53(d) if the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).”

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on filing requirements, visit: filing requirements.

To file a continuation-in-part (CIP) application, several requirements must be met according to MPEP 201.08 and 37 CFR 1.78:

  1. The CIP must be filed while the prior nonprovisional application is still pending (before patenting, abandonment, or termination of proceedings).
  2. The CIP must claim benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  3. The CIP must contain a specific reference to the prior application, including the application number.
  4. For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet (ADS).
  5. The CIP must have at least one common inventor with the prior application.

It’s important to note that a CIP can only be filed under 37 CFR 1.53(b) and cannot be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).

For more information on filing requirements, visit: filing requirements.

For more information on USPTO, visit: USPTO.

For continuation or divisional applications filed before September 16, 2012 under 37 CFR 1.53(b) (excluding continuation-in-part applications), applicants could file using a copy of the oath or declaration from the prior nonprovisional application. This is supported by the MPEP, which states:

“A continuation or divisional application filed before September 16, 2012 under 37 CFR 1.53(b) (other than a continuation-in-part (CIP)) may be filed with a copy of the oath or declaration from the prior nonprovisional application.”

This provision simplified the filing process for certain types of continuing applications by allowing the use of previously submitted documents.

To learn more:

For national stage applications under 35 U.S.C. 371, the requirements for filing a certified copy of a foreign application are outlined in 37 CFR 1.55(f)(2). The MPEP states:

A certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT in an international application entering the national stage under 35 U.S.C. 371.

If the certified copy was not filed during the international stage, it must be filed within the later of:

  • Four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f)
  • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
  • Sixteen months from the filing date of the prior foreign application

Exceptions to these time limits are provided in paragraphs (h), (i), and (j) of 37 CFR 1.55.

To learn more:

To file a certificate of correction to perfect a foreign priority claim, you must meet the following requirements:

  1. The priority claim under 37 CFR 1.55 was timely filed in the application but was not included on the patent due to failure to provide a certified copy.
  2. A grantable petition under 37 CFR 1.55(f) or (g) must be filed, which includes:
    • The fee set forth in 37 CFR 1.17(g)
    • A showing of good and sufficient cause for the delay in filing the certified copy
  3. The correction must not require further examination.

As stated in the MPEP, Where the priority claim required under 37 CFR 1.55 was timely filed in the application but was not included on the patent because the requirement under 37 CFR 1.55 for a certified copy was not satisfied, the patent may be corrected to include the priority claim via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, accompanied by a grantable petition under 37 CFR 1.55(f) or, in the case of a design application, a grantable petition under 37 CFR 1.55(g).

To learn more:

To learn more:

What are the requirements for faxed assignment documents to be recorded at the USPTO?

For faxed assignment documents to be recorded at the USPTO, they must meet the following requirements:

  • The document must be legible and capable of being reproduced in legible form.
  • The fax must include a cover sheet with the sender’s name, address, and telephone number.
  • Payment of the recording fee must be included or authorized.
  • The fax should be sent to the specific fax number designated for assignment submissions.

As stated in MPEP 302.09: “The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.” This means that the fax transmission must be complete and received by the USPTO to be considered officially submitted.

To learn more:

What are the requirements for facsimile submission of assignment documents to the USPTO?

The USPTO has specific requirements for facsimile submission of assignment documents:

  • The facsimile must be legible and complete.
  • The document should be submitted to the Assignment Recordation Branch at the designated fax number.
  • A cover sheet must accompany the submission, stating the total number of pages, including the cover sheet.
  • The original document is not required unless specifically requested by the Office.

As stated in MPEP 302.09: “The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.”

To learn more:

For patent applications filed on or after September 16, 2012, an oath executed in a foreign country must meet specific requirements as outlined in 37 CFR 1.66. The MPEP states:

“An oath made in a foreign country may be made before any diplomatic or consular officer of the United States authorized to administer oaths, or before any officer having an official seal and authorized to administer oaths in the foreign country in which the applicant may be, whose authority shall be proved by a certificate of a diplomatic or consular officer of the United States, or by an apostille of an official designated by a foreign country which, by treaty or convention, accords like effect to apostilles of designated officials in the United States.”

In summary, the oath can be executed before a U.S. diplomatic or consular officer, or before an authorized foreign official with proper authentication.

To learn more:

To be entitled to priority under the PDX program, the following requirements must be met:

  1. The Office must receive a copy of the foreign application from the participating foreign intellectual property office within the pendency of the application and before the patent is granted, or
  2. The Office must receive a paper certified copy of the foreign application during that time period.

The MPEP states:

To be entitled to priority, the Office must receive a copy of the foreign application from the participating foreign intellectual property office within the pendency of the application and before the patent is granted, or receive a paper certified copy of the foreign application during that time period.

It’s crucial to note that if a certified copy is filed after the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.

What are the requirements for drawings in color?

Color drawings are not ordinarily permitted in utility and design patent applications. However, the USPTO will accept color drawings in utility and design patent applications if the following conditions are met:

  • The fee set forth in 37 CFR 1.17(h) is paid;
  • The specification contains the following language as the first paragraph of the brief description of the drawings: ‘The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.’
  • Color drawings must be of sufficient quality such that all details in the drawings are reproducible in black and white in the printed patent.

As stated in MPEP 608.02(b): ‘If color drawings are filed with the original application, it is not necessary to file a petition with the filing of the application. However, a petition and fee are required if color drawings are submitted after the original application papers are filed.’

To learn more:

Drawings are an essential part of many nonprovisional utility patent applications. According to MPEP 601, the requirements for drawings are as follows:

  • Drawings must be included in the application where necessary for the understanding of the subject matter to be patented.
  • The applicant must furnish a drawing where the nature of the case admits of it.
  • Drawings submitted after the filing date of the application may not be used to overcome any insufficiency of the specification due to lack of an enabling disclosure or otherwise inadequate disclosure therein.

The MPEP states: ‘Drawings submitted after the filing date of the application may not be used to overcome any insufficiency of the specification due to lack of an enabling disclosure or otherwise inadequate disclosure therein, or to supplement the original disclosure thereof for the purpose of interpretation of the scope of any claim.’

It’s important to include all necessary drawings at the time of filing to ensure a complete and enabling disclosure of the invention.

To learn more:

To learn more:

Drawing symbols in patent applications must adhere to specific requirements:

  • Symbols should be clear and legible.
  • The same part of an invention should be designated by the same reference character throughout the application.
  • Different parts should not be designated by the same reference character.
  • Reference characters not mentioned in the description will not be permitted in the drawings.

MPEP 608.02(b) states: “The drawing must show every feature of the invention specified in the claims.” This includes proper use of symbols and reference characters to clearly illustrate the invention.

For detailed guidelines on drawing symbols, refer to 37 CFR 1.84(p).

To learn more:

Drawing corrections in a patent application must comply with 37 CFR 1.121(d). Key requirements include:

  • Submitting replacement sheets that include all figures from the previous version, even if only one figure is amended
  • Labeling new sheets as ‘New Sheet’ and replacement sheets as ‘Replacement Sheet’ in the top margin
  • Explaining all changes in detail in the drawing amendment or remarks section
  • Including a marked-up copy of any amended drawing figure, labeled as ‘Annotated Sheet’, when required by the examiner

Applicants should note that the USPTO does not make drawing changes. It is the applicant’s responsibility to ensure drawings are corrected according to the provided instructions.

To learn more:

Dependent claims in patent applications must meet specific requirements as outlined in MPEP 608.01(i):

  • They must refer back to and further limit another claim or claims.
  • They must include all limitations of the claim to which they refer.
  • They must be more specific than the claim upon which they depend.

The MPEP states: ‘A claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed.’ This ensures that dependent claims properly narrow the scope of the invention and provide additional protection for specific embodiments.

To learn more:

To correct inventorship in a nonprovisional patent application filed on or after September 16, 2012, the following requirements must be met:

  • Submit a request to correct or change the inventorship
  • Include a signed application data sheet (ADS) that:
    • Identifies each inventor by their legal name
    • Provides the residence and mailing address of each inventor
    • Shows changes with underlining for insertions and strike-through or brackets for deletions
  • Pay the processing fee set forth in 37 CFR 1.17(i)

As stated in the MPEP: A request to correct the inventorship filed under 37 CFR 1.48(a) should identify the inventorship change and must be accompanied by a signed application data sheet (ADS) including the legal name, residence, and mailing address of the inventor or each actual joint inventor (see 37 CFR 1.76(b)(1)) and the processing fee set forth in 37 CFR 1.17(i).

To learn more:

Correcting inventorship in a nonprovisional application requires:

  • A request to correct inventorship under 37 CFR 1.48(a)
  • An application data sheet (ADS) identifying the inventorship change
  • A fee as set forth in 37 CFR 1.17(i)
  • A statement from each person being added or deleted as an inventor that the error occurred without deceptive intent

As stated in MPEP 602.01(c)(1): ‘If the inventive entity is set forth in error in an executed § 1.63 or § 1.64 declaration in a nonprovisional application, and such error arose without any deceptive intent on the part of the person named as an inventor in error or on the part of the person who through error was not named as an inventor, the inventorship of the nonprovisional application may be amended pursuant to 37 CFR 1.48(a).’

To learn more:

To learn more:

What are the requirements for corrected or substitute drawings in patent applications?

When submitting corrected or substitute drawings in patent applications, applicants must adhere to specific requirements set by the USPTO:

  • Corrected or substitute drawings must be labeled as ‘Replacement Sheet’ in the top margin.
  • Any changes to the drawings must be explained in either the drawing amendment or remarks section of the amendment paper.
  • All changes to the drawings should be identified with annotations on the drawing sheet.
  • New drawings must be labeled ‘New Sheet’.

As stated in MPEP 608.02(b): ‘Any replacement sheet of drawings must include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is amended. The figure or figure number of the amended drawing(s) must not be labeled as ‘amended.’ The requirement for corrected drawings will not be held in abeyance.’

It’s important to note that the USPTO may require corrected drawings if the submitted drawings do not meet the necessary standards. The MPEP states: ‘The USPTO will not release drawings for purposes of correction. If corrections are necessary, new corrected drawings must be submitted within the time set by the Office.’

To learn more:

What are the requirements for converting a provisional application to a nonprovisional application?

Converting a provisional application to a nonprovisional application requires meeting specific criteria and following certain procedures. According to MPEP 601.01(c), the key requirements are:

  1. Timing: The conversion must be requested within 12 months of the provisional application’s filing date.
  2. Request for Conversion: A request for the conversion must be submitted.
  3. Fee Payment: The basic filing fee for the nonprovisional application must be paid.
  4. Oath or Declaration: An oath or declaration as prescribed by 35 U.S.C. 115(a) must be submitted.
  5. Specification and Drawings: A specification and any drawings as prescribed by 35 U.S.C. 112 must be submitted, unless such items are already present in the provisional application.

The MPEP states:

“A request to convert a provisional application to a nonprovisional application must be accompanied by the fee set forth in 37 CFR 1.17(i) and an amendment including at least one claim as prescribed by 35 U.S.C. 112(b), unless the provisional application under 35 U.S.C. 111(b) already contains at least one claim.”

It’s important to note that if these requirements are not met, the application may be treated as an application filed under 35 U.S.C. 111(a) and given a filing date as of the date the request for conversion was filed.

To learn more:

When conducting interviews with inventors or assignees, examiners must adhere to specific requirements:

  • The practitioner of record must authorize and be present for the interview.
  • Inventors or assignees cannot participate without the practitioner’s presence.
  • Examiners should not conduct interviews directly with inventors or assignees alone.

According to the MPEP 408: ‘Interviews with inventors or assignees and/or their attorneys or agents of record must be authorized by the practitioners of record. The practitioner of record must be present and an examiner may not conduct an interview with an inventor or assignee unless the practitioner is present.’

For more information on patent examination, visit: patent examination.

For nonprovisional applications filed on or after December 18, 2013, the requirements for completion include:

  • Submitting the appropriate filing fee, search fee, and examination fee
  • Filing an inventor’s oath or declaration
  • For applications other than design applications, submitting at least one claim
  • Submitting any required drawings

The MPEP states: If an application which has been accorded a filing date does not include the appropriate filing fee, search fee, examination fee, or inventor’s oath or declaration, applicant will be so notified in accordance with 37 CFR 1.53(f) .

It’s important to note that for applications filed on or after September 16, 2012, the inventor’s oath or declaration can be postponed until the application is otherwise in condition for allowance, provided that a signed Application Data Sheet (ADS) identifying each inventor is submitted.

To learn more:

Color photographs in patent applications are subject to specific requirements. According to MPEP 608.01(f):

Color photographs will be accepted in utility and design patent applications if the conditions for accepting color drawings and black and white photographs have been satisfied.

To include color photographs in a patent application, you must:

  • Meet the conditions for accepting color drawings (petition, fee, and specific language in the specification)
  • Satisfy the requirements for black and white photographs (only practicable medium for illustrating the invention)
  • Ensure the photographs are of sufficient quality for reproduction in the printed patent

It’s important to note that color photographs are subject to the same restrictions and requirements as color drawings in patent applications.

To learn more:

Claiming the benefit of an international application (PCT application) in a U.S. national application has specific requirements. The MPEP states:

“Pursuant to 35 U.S.C. 365(c), a regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b) may claim the benefit of the filing date of an international application which designates the United States without completing the requirements for entering the national stage under 35 U.S.C. 371.”

Requirements for claiming benefit of an international application:

  • The international application must designate the United States
  • The international application must be entitled to a filing date in accordance with PCT Article 11
  • The later-filed U.S. application must be filed during the pendency of the international application
  • The U.S. application can be filed as a continuation, divisional, or continuation-in-part of the international application (often called a “bypass” application)

This allows applicants to claim the benefit of an international application’s filing date without completing the national stage entry process under 35 U.S.C. 371.

To claim the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the following requirements must be met:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (unless the benefit has been restored)
  • The provisional application must have at least one common inventor with the nonprovisional application
  • The provisional application must be entitled to a filing date and have paid the basic filing fee
  • If the provisional application was filed in a language other than English, an English translation and a statement that the translation is accurate must be filed

As stated in the MPEP: “When a later-filed application is claiming the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the nonprovisional application must be filed not later than 12 months after the date on which the provisional application was filed, unless the benefit of the provisional application has been restored.”

To claim the benefit of a prior application’s filing date, applicants must meet specific requirements. The MPEP ¶ 2.05 advises:

“Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

Key requirements include:

  • The application must be filed before the patenting or abandonment of the prior application.
  • The application must contain a specific reference to the prior application.
  • The application must have at least one common inventor with the prior application.
  • The application must disclose the invention claimed in the manner provided by 35 U.S.C. 112(a).

For more information on patent law, visit: patent law.

Tags: patent law

To claim priority to or benefit of a prior-filed application, the later-filed application must:

  • Contain a specific reference to the earlier-filed application
  • Be filed within the required time period
  • Include the priority or benefit claim in the application data sheet (for applications filed on or after September 16, 2012)

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, statutory provisions require that for a later-filed application to be entitled to the benefit of an earlier-filed national application, the later-filed application must contain a specific reference to the earlier-filed application.” (MPEP 210)

What are the requirements for claiming priority to a foreign application?

To claim priority to a foreign application, several requirements must be met:

  • The U.S. application must be filed within 12 months of the foreign application (or 6 months for design patents).
  • The foreign application must be from a country that grants similar privileges to U.S. applicants (Paris Convention member or WTO member).
  • The applicant must file a claim for priority and a certified copy of the foreign application.
  • As stated in MPEP 213: “The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed before the patent is granted.”

It’s important to note that the subject matter claimed in the U.S. application must be adequately supported by the foreign application to receive the benefit of the earlier filing date.

To learn more:

The requirements for claiming priority to a foreign application under 37 CFR 1.55 include:

  • A claim for priority identifying the foreign application
  • For applications filed on or after September 16, 2012, the claim for priority must be in the application data sheet (ADS)
  • For applications filed before September 16, 2012, the claim for priority must be in the ADS or in the oath or declaration
  • Filing a certified copy of the foreign application within specified time periods
  • Meeting other requirements such as translations for non-English language applications

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, 35 U.S.C. 119(b)(1) requires a claim for priority identifying the foreign application. … Thus for all applications filed on or after September 16, 2012, a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) to the prior application must be presented in the application data sheet.”

The key requirements for claiming foreign priority under 37 CFR 1.55 include:

  • Filing a claim for priority in the application data sheet (for applications filed on or after September 16, 2012)
  • Filing the application within the required time period
  • Providing a certified copy of the foreign application
  • Providing an English translation if necessary

37 CFR 1.55(d) “contains provisions relating to the time for filing a priority claim in an application filed under 35 U.S.C. 111(a) and in an application entering the national stage under 35 U.S.C. 371” (MPEP 210)

For an international design application designating the United States, the requirements for claiming foreign priority are as follows:

  • The claim for priority can be made in accordance with the Hague Agreement and the Hague Agreement Regulations.
  • The claim must comply with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172.
  • Priority can be claimed with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

To learn more:

To claim foreign priority in a U.S. patent application, several requirements must be met as outlined in MPEP 213. These include:

  • Timely filing: The U.S. application must be filed within 12 months of the foreign application’s filing date (6 months for design patents)
  • Proper claim: The priority claim must be made in an application data sheet (ADS) or in the first sentence of the specification
  • Certified copy: A certified copy of the foreign application must be filed within the later of 4 months from the U.S. filing date or 16 months from the foreign filing date
  • English translation: If the foreign application is not in English, a translation may be required

As stated in MPEP 213, “The claim for priority must be presented in an application data sheet (37 CFR 1.76(b)(6)) or the specification must contain or be amended to contain a specific reference to the prior foreign application.” Failure to meet these requirements may result in the loss of the priority claim.

What are the requirements for claiming domestic benefit in a patent application?

Claiming domestic benefit in a patent application allows an applicant to rely on the filing date of an earlier-filed US application. The MPEP 216 outlines the requirements for claiming domestic benefit, which are based on 35 U.S.C. 120. The key requirements include:

  • The later-filed application must be filed before the patenting or abandonment of the prior application
  • The later-filed application must contain or be amended to contain a specific reference to the prior application
  • The prior application must disclose the invention claimed in the later-filed application in the manner required by 35 U.S.C. 112(a)
  • At least one inventor named in the later-filed application must have been named as an inventor in the prior application

The MPEP states:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application.’

It’s important to note that these requirements must be met for each application in the chain of priority, ensuring a continuous line of co-pendency and proper disclosure.

For more information on continuation application, visit: continuation application.

For more information on domestic benefit, visit: domestic benefit.

To claim benefit to a non-English language provisional application, you must provide:

  • An English translation of the non-English language provisional application
  • A statement that the translation is accurate

These documents must be filed in the provisional application itself. As stated in MPEP ¶ 2.38: “An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[…]”

Additionally, in the present (non-provisional) application, you must confirm that the translation and statement were filed in the provisional application.

For more information on non-English language, visit: non-English language.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

What are the requirements for claiming benefit of multiple prior-filed applications?

When claiming benefit of multiple prior-filed applications, specific requirements must be met. According to MPEP 211.01(b):

If a nonprovisional application claims the benefit of multiple prior-filed applications, the prior-filed applications need not be copending with each other provided that each prior-filed application is copending with the claiming application.

Key requirements include:

  • Each prior-filed application must be copending with the claiming application
  • The relationship between each prior-filed application and the claiming application must be specified
  • The benefit claim must be made within the time period set forth in 37 CFR 1.78

Additionally, the MPEP states:

There is no limit to the number of prior applications through which a chain of copendency may be traced to obtain the benefit of the filing date of the earliest of a chain of prior copending applications.

This means you can claim benefit through a chain of applications, as long as each link in the chain meets the copendency requirement with the subsequent application.

To learn more:

Tags: copendency

What are the requirements for claiming benefit of an international application in a U.S. national application?

To claim the benefit of an international application in a U.S. national application, certain requirements must be met. According to MPEP 211.01(c):

‘In order for a U.S. national application to be entitled to the benefit of the filing date of an international application, all the following conditions must be satisfied:

  • (A) The international application must designate the United States;
  • (B) The international application must have been filed on or after January 1, 1979;
  • (C) The international application must have been filed by a U.S. national or resident, or by a foreign national of a PCT member country;
  • (D) The U.S. national application must have been filed within the time period set forth in 35 U.S.C. 371(c); and
  • (E) The applicant in the U.S. national application must have complied with the requirements of 35 U.S.C. 371(c).’

These conditions ensure that the international application is properly linked to the U.S. national application and that all necessary procedural steps have been followed.

To learn more:

To learn more:

The requirements for claiming benefit of an earlier national application under 37 CFR 1.78 include:

  • A specific reference to the earlier-filed application in the later-filed application
  • For applications filed on or after September 16, 2012, the specific reference must be in the application data sheet (ADS)
  • For applications filed before September 16, 2012, the specific reference must be in the ADS or in the first sentence(s) of the specification
  • Meeting time requirements for filing the benefit claim
  • In some cases, providing a statement regarding the effective filing date of claims

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, statutory provisions require that for a later-filed application to be entitled to the benefit of an earlier-filed national application, the later-filed application must contain a specific reference to the earlier-filed application.”

Claiming the benefit of a provisional application has specific requirements, as outlined in MPEP 211.01(b):

“A nonprovisional application that directly claims the benefit of a provisional application under 35 U.S.C. 119(e) must be filed within 12 months from the filing date of the provisional application unless the benefit of the provisional application has been restored.”

Key points to remember:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • If filed after 12 months, the benefit of the provisional application must be restored (see 37 CFR 1.78(b)).
  • For indirect benefit claims through intermediate applications, the relationship between each application must be clearly identified.
  • Failure to properly indicate relationships may result in the benefit claim not being recognized, requiring a petition under 37 CFR 1.78(c) and payment of a fee.

Proper referencing and timing are crucial when claiming the benefit of provisional applications to ensure the desired priority date is secured.

To learn more:

When claiming benefit of a provisional application filed in a language other than English, additional requirements must be met. The MPEP states:

“If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.”

If these documents were not filed in the provisional application, the applicant will be notified in the nonprovisional application and given a period to file them. Failure to timely respond may result in abandonment of the nonprovisional application.

Alternatively, the applicant may choose to delete the benefit claim to the provisional application from the Application Data Sheet (ADS) or, for applications filed before September 16, 2012, from the ADS or the first sentence(s) of the specification.

To learn more:

To claim the benefit of a prior-filed application in a continuation-in-part (CIP), several requirements must be met as outlined in MPEP 201.08 and 35 U.S.C. 120:

  • The CIP must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  • The CIP must contain or be amended to contain a specific reference to the earlier filed application.
  • For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet.
  • The CIP must have at least one common inventor with the prior-filed application.

Additionally, the MPEP notes:

“The continuation-in-part application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).”

It’s important to note that the USPTO does not typically scrutinize whether the earlier application fully supports the CIP’s claims unless this becomes relevant in a proceeding before the Office.

For more information on patent procedure, visit: patent procedure.

For more information on prior-filed application, visit: prior-filed application.

To claim the benefit of a prior-filed application in a continuation or continuation-in-part application, several requirements must be met:

1. The application must be filed before the patenting, abandonment, or termination of proceedings on the prior application.

2. The application must contain or be amended to contain a specific reference to the prior application. For applications filed on or after September 16, 2012, this reference must be in an application data sheet.

3. The application must have at least one common inventor with the prior application.

4. The application must comply with the requirements of 35 U.S.C. 120 and 37 CFR 1.78.

As stated in the MPEP: “An applicant in a nonprovisional application (including a nonprovisional application resulting from an international application or international design application), an international application designating the United States, or an international design application designating the United States may claim the benefit of one or more prior-filed copending nonprovisional applications, international applications designating the United States, or international design applications designating the United States under the conditions set forth in 35 U.S.C. 120, 121, 365(c), or 386(c) and this section.”

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP), applicants must meet specific requirements. According to MPEP ¶ 2.06:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

These requirements typically include:

  • Filing the CIP application while the prior application is still pending
  • Naming at least one inventor in common with the prior application
  • Including a specific reference to the prior application in the CIP
  • Ensuring the CIP application contains a substantial portion of the prior application’s disclosure
  • Complying with the time limits and procedures outlined in 37 CFR 1.78

It’s important to note that only the subject matter shared with the prior application will benefit from its earlier filing date. New matter added in the CIP will have the filing date of the CIP application.

What are the requirements for claim numbering in patent applications?

According to MPEP 608.01(m), claims in patent applications must be numbered consecutively in Arabic numerals. The MPEP states:

‘The claim or claims must commence on a separate physical sheet or electronic page and should appear after the detailed description of the invention. Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material. Though a claim may be presented on a separate sheet, such is not required.’

Additionally:

  • Claims should be arranged in order of scope, with the broadest claim presented first.
  • Claim numbers should be placed to the left of the claim text.
  • When claims are canceled, the remaining claims should not be renumbered.

To learn more:

To learn more:

What are the requirements for citing NPL documents in an IDS?

When citing Non-Patent Literature (NPL) documents in an Information Disclosure Statement (IDS), specific requirements must be met to ensure proper identification and consideration. According to MPEP 609.04(a):

“Each publication listed in an information disclosure statement must be identified by publisher, author (if any), title, relevant pages of the publication, date, and place of publication.”

The MPEP further clarifies:

  • For publications obtained from the Internet, the uniform resource locator (URL) of the Web page that is the source of the publication must be provided for the place of publication (e.g., “www.uspto.gov”).
  • The date of publication to be provided is the date the document was posted on the Internet. If no publication date is known, the applicant must specify in the IDS that no publication date is known.

Additionally:

  • For NPL not in the English language, a concise explanation of the relevance is required unless a complete translation is provided.
  • If citing a document that is only available as a scanned copy, include “(scanned copy)” after the document’s title in the citation.

Providing complete and accurate information for NPL citations helps examiners efficiently locate and consider these references during the examination process.

To learn more:

When citing foreign patent documents and non-English documents in an Information Disclosure Statement (IDS), the following requirements apply:

  1. For foreign patent documents:
    • Cite by document number, country, and publication or issue date
    • Provide a copy of each cited foreign patent document
  2. For non-English documents:
    • Provide a concise explanation of the relevance, as understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information, unless a complete translation is provided
    • Provide a written English language translation of the non-English language document, or portion thereof, if it is within the possession, custody, or control of, or is readily available to any individual designated in 37 CFR 1.56(c)

The MPEP states: “For non-English documents that are cited, the following must be provided: (a) A concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information, unless a complete translation is provided; and/or (b) A written English language translation of a non-English language document, or portion thereof, if it is within the possession, custody or control of, or is readily available to any individual designated in 37 CFR 1.56(c).”

To learn more:

What are the requirements for citing foreign language documents in an IDS?

When citing foreign language documents in an Information Disclosure Statement (IDS), applicants must adhere to specific requirements:

  • Provide a concise explanation of the relevance of the foreign language document.
  • Include a translation or portion of the document if it is within the possession, custody, or control of the individual filing the IDS.
  • The concise explanation may be either separate from the specification or part of the specification.
  • If the translation is submitted, indicate whether it is a machine translation or an English-language equivalent document.

MPEP 609.01 states: ‘When citing foreign language documents, the examiner should verify that the citation given on the IDS corresponds to the translation or English language abstract provided.’

Examiners should ensure that the requirements of 37 CFR 1.98(a)(3) are met for all foreign language documents cited in the IDS.

To learn more:

The requirements for certified copies in international design applications are as follows:

  • A certified copy of the foreign application is not required in an international design application.
  • The International Bureau obtains priority documents directly from offices participating in the Digital Access Service (DAS) or the Priority Document Exchange (PDX) program.
  • For offices not participating in DAS or PDX, the International Bureau will invite the applicant to submit the priority document.

According to MPEP 213.07: A certified copy of the foreign application is not required in an international design application designating the United States. The MPEP further explains: Where the foreign application was filed in a participating office, the International Bureau will attempt to obtain the priority document from the participating office. For participating offices that are not yet able to provide the priority documents to the International Bureau, the International Bureau will invite the applicant to submit the priority document.

To learn more:

What are the requirements for certificate of mailing or transmission?

The certificate of mailing or transmission is an important tool for securing a filing date with the USPTO. According to MPEP 502, the requirements are:

“The certification requires a signature. Specifically, if the certification is filed by a registered practitioner, it must be signed by that practitioner personally. 37 CFR 1.8(a)(2). If the certification is filed by an applicant, it must be signed by the applicant (except where an oath or declaration is not required, in which case the certification may be signed by a registered practitioner). 37 CFR 1.8(a)(2).”

Key points to remember:

  • The certificate must include the date of deposit or transmission.
  • It must be signed by the person mailing or transmitting the correspondence.
  • For registered practitioners, personal signature is required.
  • For applicants, their signature is required unless an oath/declaration is not needed.

Proper use of this certificate can help ensure your documents are considered timely filed, even if there are postal or transmission delays.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on Certificate of Transmission, visit: Certificate of Transmission.

For more information on USPTO correspondence, visit: USPTO correspondence.

Benefit claims can be made under various sections of the U.S. Code, each with specific requirements:

  • 35 U.S.C. 119(e): For provisional application benefits, refer to 37 CFR 1.78(a).
  • 35 U.S.C. 120: For benefit claims to earlier nonprovisional applications, including the relationship (continuation, divisional, or continuation-in-part).
  • 35 U.S.C. 121: For divisional applications.
  • 35 U.S.C. 365(c): For national stage applications claiming benefit to PCT applications.
  • 35 U.S.C. 386(c): For national stage applications claiming benefit to international design applications.

The MPEP states: “For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.”

It’s important to note that the specific requirements and time limits may vary depending on the type of benefit claim. Always refer to the latest version of the MPEP and the relevant U.S. Code sections for the most up-to-date information.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

An S-signature must meet the following requirements:

  • It must be inserted between two forward slash marks.
  • It can only consist of letters, Arabic numerals, or both, with appropriate spaces and punctuation.
  • The signer must insert their own S-signature.
  • For patent practitioners, the registration number must be included as part of or adjacent to the S-signature.
  • The signer’s name must be presented in printed or typed form, preferably immediately below or adjacent to the S-signature.

As stated in 37 CFR 1.4(d)(2)(i): “The S-signature must consist only of letters, or Arabic numerals, or both, with appropriate spaces and commas, periods, apostrophes, or hyphens for punctuation, and the person signing the correspondence must insert his or her own S-signature with a first single forward slash mark before, and a second single forward slash mark after, the S-signature.”

To learn more:

What are the requirements for an oath or declaration in a reissue application?

In a reissue application, the oath or declaration must comply with specific requirements outlined in MPEP 1414. The MPEP states:

“The reissue oath/declaration must include a statement that the applicant believes the original patent to be wholly or partly inoperative or invalid.”

Additionally, the oath or declaration must:

  • Identify at least one error being relied upon as the basis for reissue
  • State that all errors being corrected in the reissue application arose without any deceptive intention on the part of the applicant
  • Be signed by the inventor(s) or the assignee of the entire interest

It’s important to note that the requirements for a reissue oath or declaration are more stringent than those for a regular patent application due to the nature of reissue proceedings.

To learn more:

For applications filed before September 16, 2012, the requirements for an inventor’s oath or declaration are governed by pre-AIA 37 CFR 1.63. The oath or declaration must:

  1. Be executed (signed) in accordance with pre-AIA 37 CFR 1.66 or pre-AIA 37 CFR 1.68.
  2. Identify each inventor by full name, including family name and at least one given name, without abbreviation.
  3. Identify the country of citizenship of each inventor.
  4. State that the person making the oath or declaration believes the named inventor(s) to be the original and first inventor(s) of the subject matter claimed.
  5. State that the person making the oath or declaration has reviewed and understands the contents of the application, including the claims.
  6. Acknowledge the duty to disclose to the Office all information known to be material to patentability as defined in 37 CFR 1.56.

These requirements are different from those for applications filed on or after September 16, 2012, and it’s important to use the correct version of the oath or declaration based on the application’s filing date.

To learn more:

For an international design application to be used as a basis for claiming benefit, it must meet specific filing date requirements. MPEP § 211.01(d) states:

To obtain benefit of the filing date of a prior international design application designating the United States, the international design application must be entitled to a filing date in accordance with 37 CFR 1.1023. See 37 CFR 1.78(d)(1)(ii).

This means that the international design application must comply with the requirements set forth in 37 CFR 1.1023 to establish a valid filing date. These requirements typically include proper designation of the United States and adherence to other formal application standards.

For more information on filing date requirements, visit: filing date requirements.

For an Information Disclosure Statement (IDS) to be considered by the USPTO during the pendency of a patent application, it must meet three key requirements:

  1. Comply with the content requirements of 37 CFR 1.98
  2. Be filed in accordance with the procedural requirements of 37 CFR 1.97
  3. Be signed in compliance with 37 CFR 1.33(b)

The MPEP states: In order to have information considered by the Office during the pendency of a patent application, an information disclosure statement must be (1) in compliance with the content requirements of 37 CFR 1.98, (2) filed in accordance with the procedural requirements of 37 CFR 1.97 and (3) signed in compliance with 37 CFR 1.33(b).

Additionally, the use of form PTO/SB/08, ‘Information Disclosure Statement,’ is encouraged to provide the required list of information.

To learn more:

Tags: USPTO

An Information Disclosure Statement (IDS) filed within three months of the application filing date or before the mailing of a first Office action on the merits, whichever is later, has the following requirements:

  • No fee is required
  • No statement under 37 CFR 1.97(e) is needed
  • Must comply with the content requirements of 37 CFR 1.98

According to MPEP 609.04(b): An information disclosure statement filed within one of these periods requires neither a fee nor a statement under 37 CFR 1.97(e).

To learn more:

For an Information Disclosure Statement (IDS) filed after a final Office action, Notice of Allowance, or an Ex parte Quayle action, but before or with payment of the issue fee, the following is required:

  • A statement under 37 CFR 1.97(e), and
  • The fee set forth in 37 CFR 1.17(p)

According to MPEP 609.04(b): An information disclosure statement will be considered by the examiner if filed on or after the mailing date of any of the following: a final action under 37 CFR 1.113; a notice of allowance under 37 CFR 1.311; or an action that closes prosecution in the application, e.g., an Ex parte Quayle action, but before or simultaneous with payment of the issue fee, provided the statement is accompanied by: (A) a statement as specified in 37 CFR 1.97(e) (see the discussion in subsection V; and (B) the fee set forth in 37 CFR 1.17(p).

To learn more:

For an assignee to take action in a patent application filed on or after September 16, 2012, the following requirements must be met:

  • The assignee must be of the entire right, title, and interest in the application.
  • A statement under 37 CFR 3.73(c) must be filed in the application.
  • The statement must identify the assignee and establish the assignee’s ownership.

As stated in MPEP 325: “The assignee must establish its ownership of the entire right, title, and interest in an application in order to take action in that application.”

For more information on 37 CFR 3.73(c), visit: 37 CFR 3.73(c).

For an application to be considered a divisional, it must meet several requirements as outlined in MPEP ¶ 2.01:

  1. It must disclose and claim only subject matter disclosed in the prior application.
  2. It must claim subject matter that is independent and distinct from that claimed in the prior application.
  3. It must name the inventor or at least one joint inventor named in the prior application.

The MPEP states:

This application, which discloses and claims only subject matter disclosed in prior Application No.[1], filed [2], appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application, and names the inventor or at least one joint inventor named in the prior application.

Meeting these requirements helps ensure that the divisional application is properly derived from the prior application while claiming a distinct invention.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO, visit: USPTO.

According to 37 CFR 1.72(b), the requirements for an abstract in a patent application are:

  • It must commence on a separate sheet, preferably following the claims.
  • It should be under the heading ‘Abstract’ or ‘Abstract of the Disclosure’.
  • The sheet presenting the abstract should not include other parts of the application.
  • It should be concise, preferably not exceeding 150 words in length.
  • It should enable quick determination of the nature and gist of the technical disclosure.

The USPTO states: The abstract must be as concise as the disclosure permits, preferably not exceeding 150 words in length. The purpose of the abstract is to enable the Office and the public generally to determine quickly from a cursory inspection the nature and gist of the technical disclosure.

To learn more:

What are the requirements for adding a benefit claim to a prior-filed provisional application?

Adding a benefit claim to a prior-filed provisional application requires meeting specific criteria. According to MPEP 211.02(a):

“To add a benefit claim to a prior-filed provisional application, applicant must file a petition to accept a delayed claim under 37 CFR 1.78(c). The petition must be accompanied by:”

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78(a)(3) to the prior-filed provisional application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(a)(4) and the date the benefit claim was filed was unintentional.

Additionally, the nonprovisional application claiming the benefit must have been filed within 12 months of the provisional application’s filing date (or 14 months if an appropriate statement is made). If this time requirement is not met, a petition under 37 CFR 1.78(b) to restore the benefit of the provisional application must be filed.

For more details on the restoration of the right of priority, refer to MPEP 213.03.

To learn more:

In a continued prosecution application (CPA) filed under 37 CFR 1.53(d), there are specific rules regarding benefit claims. The MPEP states:

In a continued prosecution application (CPA) filed under 37 CFR 1.53(d), no amendment may delete the specific reference to a prior application assigned the same application number.

This is because in a CPA:

  • The request itself serves as the specific reference required by 35 U.S.C. 120 and 37 CFR 1.78 to every application assigned the same application number identified in the request.
  • A specific reference in the first sentence(s) of the specification following the title, or in an application data sheet, to a prior application assigned the same application number is not required and should not be made.

Therefore, when dealing with a CPA, it’s crucial to understand that the benefit claim to the prior application with the same application number is inherent in the CPA request itself and cannot be deleted. Any additional benefit claims would need to follow the standard procedures for adding benefit claims after filing.

To learn more:

To access USPTO public information facilities:

  • A valid Public User or Visitor’s badge is required
  • Badges can be obtained from the Office of Security next to the Public Search Facility
  • An On-line Service Card is required for access to all Public Search Facilities and on-line systems

MPEP 510 states: “A valid Public User or Visitor’s badge is required to enter USPTO facilities. This badge can be obtained from the Office of Security next door to the Public Search Facility located on the first floor of the Madison East Building, 600 Dulany Street, Alexandria, VA 22314.”

The requirements for accepting an unintentionally delayed claim for foreign priority include:

  1. Filing a petition to accept a delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b).
  2. Submitting the priority claim in an application data sheet identifying the foreign application.
  3. Providing a certified copy of the foreign application, unless previously submitted or an exception applies.
  4. Paying the petition fee as set forth in 37 CFR 1.17(m).
  5. Submitting a statement that the entire delay between the date the priority claim was due and the date it was filed was unintentional.

The MPEP cites 37 CFR 1.55(e), which states: “A petition to accept a delayed claim for priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) must be accompanied by: (1) The priority claim under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted; (2) A certified copy of the foreign application, unless previously submitted or an exception in paragraph (h), (i), or (j) of this section applies; (3) The petition fee as set forth in § 1.17(m); and (4) A statement that the entire delay between the date the priority claim was due under this section and the date the priority claim was filed was unintentional.” (37 CFR 1.55(e))

According to MPEP 608.02(b), drawings are considered either acceptable or unacceptable. The Office of Patent Application Processing (OPAP) will accept drawings if they are readable and reproducible for publication purposes. Additionally, examiners review drawings for:

  • Disclosure of the claimed invention
  • Proper use of reference numerals

The MPEP states: Drawings will be accepted by the Office of Patent Application Processing (OPAP) if the drawings are readable and reproducible for publication purposes.

To learn more:

A substitute statement in lieu of an oath or declaration must:

  • Comply with the requirements of 37 CFR 1.63, identifying the inventor or joint inventor with respect to whom a substitute statement is executed, and stating upon information and belief the facts which such inventor is required to state.
  • Identify the person executing the substitute statement and the relationship of such person to the inventor or joint inventor.
  • Identify the circumstances permitting the person to execute the substitute statement.
  • Include an acknowledgement that any willful false statement made in the substitute statement is punishable under 18 U.S.C. 1001 by fine or imprisonment of not more than 5 years, or both.

As stated in MPEP 604: ‘A substitute statement under 37 CFR 1.64 must: (1) Comply with the requirements of 37 CFR 1.63(a), identifying the inventor or joint inventor with respect to whom a substitute statement in lieu of an oath or declaration is executed, and stating upon information and belief the facts which such inventor is required to state.’

To learn more:

To learn more:

What are the requirements for a registered practitioner to obtain access to an application?

According to MPEP 405, a registered practitioner may obtain access to an application if they fulfill the following requirements:

  • The practitioner must be acting in a representative capacity
  • The practitioner must have proper authority from the applicant or attorney or agent of record
  • Written consent from the applicant, attorney, or agent of record must be provided

The MPEP states: ‘Access will be given to the entire application file history in the absence of a specific request from the authorizing party for only a portion of the file.’ This means that unless specified otherwise, the practitioner will be granted full access to the application file.

For more information on application access, visit: application access.

For more information on registered practitioner, visit: registered practitioner.

For more information on USPTO procedures, visit: USPTO procedures.

A provisional patent application requires a cover sheet with specific identifying information. According to the MPEP:

“A cover sheet providing identifying information is required for a complete provisional application. In accordance with 37 CFR 1.51(c)(1) the cover sheet must state that it is for a provisional application, it must identify and give the residence of the inventor or inventors, and it must give a title of the invention.”

The cover sheet must include:

  • Statement that it is for a provisional application
  • Inventor(s) identification and residence
  • Title of the invention
  • Name and registration number of the attorney or agent (if applicable)
  • Docket number (if applicable)
  • Correspondence address
  • Statement regarding federally sponsored research or development (if applicable)
  • Name of the government agency and contract number (if developed under a government contract)

For more details on provisional application requirements, refer to MPEP § 201.04.

To learn more:

According to MPEP 608.01(n), a proper dependent claim must meet the following requirements:

  1. It must contain a reference to a previous claim in the application.
  2. It must specify a further limitation of the subject matter claimed.
  3. It must include all the limitations of the claim from which it depends.

The MPEP states: “Following the statute, the test as to whether a claim is a proper dependent claim is that it shall include every limitation of the claim from which it depends and specify a further limitation of the subject matter claimed.”

If a dependent claim does not comply with these requirements, it may be rejected under 35 U.S.C. 112(d) as being of improper dependent form.

To learn more:

What are the requirements for a power of attorney to be valid in patent applications?

For a power of attorney to be valid in patent applications, it must meet the following requirements:

  • It must be signed by the applicant for patent (e.g., the inventor) or the assignee of the entire interest.
  • It must be in writing.
  • It must name one or more representatives to act on behalf of the principal.

As stated in MPEP 402.04: ‘The power of attorney must be signed by the applicant for patent (e.g., the inventor(s)) or the assignee of the entire interest of the applicant.’ This ensures that only authorized individuals can appoint representatives to act on behalf of the applicant or assignee in patent matters.

To learn more:

What are the requirements for a power of attorney in applications filed before September 16, 2012?

For applications filed before September 16, 2012, there are specific requirements for a valid power of attorney. According to MPEP 402.02(b):

“For applications filed before September 16, 2012, the power of attorney must be signed by (1) the applicant, where the inventor is the applicant, or (2) the assignee of the entire interest of the applicant.”

Additionally, the power of attorney must:

  • Be in writing
  • Name one or more attorneys or agents
  • Be signed by the applicant for patent (i.e., all of the inventors) or the assignee of the entire interest of the applicant

It’s important to note that for applications filed before September 16, 2012, a power of attorney may be incorporated in the oath or declaration form if the power of attorney is included in the same document.

To learn more:

A petition to restore the right of priority must include several key elements. The MPEP outlines these requirements:

A petition to restore the right of priority must include: (1) the priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) in an application data sheet, identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing (unless previously submitted); (2) the petition fee set forth in 37 CFR 1.17(m); and (3) a statement that the delay in filing the subsequent application within the twelve-month period was unintentional.

These requirements ensure that the USPTO has all necessary information to consider your petition for priority restoration.

For more information on application data sheet, visit: application data sheet.

For more information on petition fee, visit: petition fee.

For more information on petition requirements, visit: petition requirements.

For more information on priority restoration, visit: priority restoration.

According to MPEP 214.02, a petition to accept an unintentionally delayed claim for priority requires the following:

  • The priority claim: This must be submitted in an application data sheet (ADS) as required by 35 U.S.C. 119(b), unless previously submitted.
  • The petition fee: As set forth in 37 CFR 1.17(m).
  • A statement of unintentional delay: A statement that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional.

The MPEP states: ‘The Director may require additional information where there is a question whether the delay was unintentional.’ This means that in some cases, additional documentation may be required to support the claim of unintentional delay.

It’s important to note that these requirements apply to priority claims under various statutes, including 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), 386(a), 365(c), 119(e), 120, and 121.

To learn more:

To learn more:

What are the requirements for a patent practitioner to withdraw from representation?

A patent practitioner who wishes to withdraw from representation must follow specific procedures. According to MPEP 403.01(a): A registered patent practitioner acting in a representative capacity in an application filed on or after September 16, 2012, may not withdraw from representation in that application without leave of the Office.

The process for withdrawal typically involves:

  • Filing a request to withdraw as attorney or agent of record
  • Providing reasons for the withdrawal
  • Ensuring that the applicant is notified of the request
  • Obtaining Office approval before ceasing representation

For detailed instructions on the withdrawal process, refer to MPEP 402.06. It’s crucial to follow these procedures to ensure a proper transition and to maintain compliance with USPTO regulations.

To learn more:

The requirements for a patent application title are outlined in MPEP 606 and 37 CFR 1.72. The key points are:

  • The title should be placed at the top of the first page of the specification, unless provided in the application data sheet.
  • It should be brief but technically accurate and descriptive.
  • The title should contain fewer than 500 characters.
  • Certain words are not considered part of the title and will be deleted by the Office.

As stated in MPEP 606, “The title should be brief but technically accurate and descriptive and should contain fewer than 500 characters.” This ensures that the title is concise yet informative about the invention.

To learn more:

For nonprovisional utility patent applications filed on or after December 18, 2013, the requirements to receive a filing date are:

  • A specification
  • With or without claims

Prior to December 18, 2013, the requirements were:

  • A specification containing a description and at least one claim
  • Any drawing necessary under 35 U.S.C. 113

The USPTO states: Effective for applications filed on or after December 18, 2013, 37 CFR 1.53(b) was amended to implement the changes to 35 U.S.C. 111(a) and 35 U.S.C. 171 by the Patent Law Treaties Implementation Act of 2012 (PLTIA) (Public Law 112-211). 35 U.S.C. 111(a) now provides minimal formal requirements necessary for an application to be entitled to a filing date to safeguard against the loss of a filing date due to a technicality.

To learn more:

What are the requirements for a nonprovisional application to claim benefit of a provisional application?

For a nonprovisional application to successfully claim the benefit of a provisional application, several requirements must be met:

  • Timely filing: The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • Proper reference: The nonprovisional application must contain a specific reference to the provisional application.
  • Common inventor: At least one inventor named in the nonprovisional application must also be named in the provisional application.
  • Adequate support: The provisional application must provide adequate support for at least one claim in the nonprovisional application under 35 U.S.C. 112(a).

As stated in MPEP 211.01(a):

“For a claim in a subsequently filed nonprovisional application to be entitled to the benefit of the filing date of a provisional application, the provisional application must have at least one inventor in common with the nonprovisional application and must provide adequate support under 35 U.S.C. 112(a) for the subject matter of the claim.”

Meeting these requirements ensures that the nonprovisional application can properly claim the earlier filing date of the provisional application for the supported subject matter.

To learn more:

What are the requirements for a non-registered individual to obtain limited recognition?

For a non-registered individual to obtain limited recognition, several requirements must be met as outlined in MPEP 402.01:

  • The individual must be an attorney who is not registered to practice before the Office.
  • They must show that they are acting only as an attorney for a particular named applicant.
  • The attorney must be authorized to practice before a court of general jurisdiction of the state where they reside or are employed.
  • The OED Director must find that the attorney possesses the scientific and technical qualifications necessary to render valuable service to the applicant.
  • The attorney must apply for and be granted limited recognition by the OED Director.

It’s important to note that limited recognition is granted for a specific purpose and duration, and can be withdrawn by the OED Director at any time.

To learn more:

A new oath or declaration is required for a continuation-in-part (CIP) application, and it must acknowledge the duty to disclose information material to patentability as defined in 37 CFR 1.56.

MPEP 602.02 states: ‘A new oath or declaration is required in a continuation-in-part application, which includes subject matter not disclosed in the prior nonprovisional application. See MPEP § 201.08 and § 602.’

The new oath or declaration in a CIP application should:

  • Identify the application as a continuation-in-part
  • Acknowledge the duty to disclose material information
  • Cover the new subject matter introduced in the CIP
  • Be signed by all inventors, including any new inventors added due to the new subject matter

It’s important to ensure that the new oath or declaration complies with all requirements of 37 CFR 1.63 to avoid potential issues during prosecution.

To learn more:

To claim the benefit of an earlier filing date under 35 U.S.C. 120 and 119(e), a later-filed application must meet several requirements:

  • The prior-filed application must name the inventor or at least one joint inventor named in the later-filed application and must be entitled to a filing date
  • The prior-filed application must meet disclosure requirements under 35 U.S.C. 112(a) to support the claims in the later-filed application, except for the best mode requirement
  • The later-filed application must contain a specific reference to the prior-filed application
  • The reference to the prior application must be submitted within the time periods set forth in 37 CFR 1.78

For a design patent application to receive a filing date, it must include:

  • A specification as prescribed by 35 U.S.C. 112
  • At least one claim
  • Any required drawings

These requirements apply to design applications regardless of filing date. The USPTO states: The filing date for a design application, except for a continued prosecution application (CPA) under 37 CFR 1.53(d), is the date on which the specification as prescribed by 35 U.S.C. 112, including at least one claim, and any required drawings are received in the Office.

It’s important to note that unlike utility applications filed on or after December 18, 2013, design applications still require at least one claim to receive a filing date.

To learn more:

A complying Information Disclosure Statement (IDS) must meet the following requirements:

  • Content requirements as specified in 37 CFR 1.98
  • Timing requirements based on when the IDS is filed, as specified in 37 CFR 1.97

The MPEP states:

‘The information contained in information disclosure statements which comply with both the content requirements of 37 CFR 1.98 and the requirements, based on the time of filing the statement, of 37 CFR 1.97 will be considered by the examiner.’

When these requirements are met, the examiner will consider the documents in the same manner as other documents in Office search files during a proper field of search.

To learn more:

To learn more:

What are the requirements for a complete patent application?

A complete patent application must include the following elements:

  • Specification (including a description and claim(s))
  • Drawing(s) (when necessary)
  • Oath or declaration
  • Filing, search, and examination fees

As stated in MPEP 601.01: ‘The application for patent as filed must include a specification as prescribed by 35 U.S.C. 112, at least one claim as prescribed by 35 U.S.C. 112, and, in applications other than design applications, any drawing referred to in the specification or required by 35 U.S.C. 113.’ Additionally, the applicant must submit an oath or declaration and pay the necessary fees to complete the application.

To learn more:

An inventor’s oath or declaration must contain the following required statements:

  • The application was made or authorized to be made by the person executing the oath or declaration
  • The individual believes themselves to be the original inventor or an original joint inventor of a claimed invention in the application

These requirements are specified in 35 U.S.C. 115(b), which states:

An oath or declaration under subsection (a) shall contain statements that—(1) the application was made or was authorized to be made by the affiant or declarant; and (2) such individual believes himself or herself to be the original inventor or an original joint inventor of a claimed invention in the application.

Additionally, the oath or declaration must identify the inventor by their legal name and identify the application to which it is directed.

To learn more:

For nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 8, 2004, the following fees are required:

The MPEP states: The basic filing, search and examination fees are due on filing of the nonprovisional application under 35 U.S.C. 111(a). However, these fees may be paid later with a surcharge if paid within the time period set in 37 CFR 1.53(f).

To learn more:

According to MPEP 201.04, the required components of a provisional patent application are:

  • A specification as prescribed by 35 U.S.C. 112(a)
  • Any drawings required by 37 CFR 1.81(a)
  • A cover sheet as required by 37 CFR 1.51(c)(1), which may be an application data sheet, form SB/16, or a cover letter identifying the application as provisional

The MPEP states, No amendment, other than to make the provisional application comply with the patent statute and all applicable regulations, may be made to the provisional application after the filing date of the provisional application.

For more information on patent drawings, visit: patent drawings.

For more information on provisional application, visit: provisional application.

What are the reporting requirements for subject inventions under government contracts?

Contractors working on federally sponsored research and development projects have specific reporting requirements for subject inventions. According to MPEP 310:

“The contractor is required to disclose each subject invention to the Federal agency within two months after the inventor discloses it in writing to contractor personnel responsible for patent matters.”

Additionally, the contractor must:

  • Elect in writing whether or not to retain title to any subject invention within two years of disclosure.
  • File patent applications within one year after election (or prior to any statutory bar date).
  • Execute and promptly deliver instruments to confirm government rights.
  • Provide periodic reports on the utilization of the invention.

These requirements ensure proper documentation and protection of both the contractor’s and the government’s interests in inventions resulting from federally funded research.

For more information on federally sponsored research, visit: federally sponsored research.

Contractors have specific reporting requirements under the Bayh-Dole Act:

  • Disclose each subject invention to the Federal agency within 2 months after the inventor discloses it in writing to contractor personnel responsible for patent matters.
  • Elect in writing whether or not to retain title to any subject invention by notifying the Federal agency within 2 years of disclosure.
  • File patent applications within statutory deadlines.
  • Include a government support clause in patent applications.

The MPEP states: ‘The contractor is also required to submit periodic reports on the utilization of a subject invention or on efforts at obtaining such utilization that are being made by the contractor or its licensees or assignees.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

The USPTO recommends several methods for filing new patent applications, with some being more advantageous than others. According to MPEP 511, the recommended methods are:

  1. Electronic Filing System (EFS-Web or Patent Center): This is the most recommended method. As stated in MPEP 511: “In general, applicants should consider filing new patent applications (as well as patent-related correspondence) via the USPTO patent electronic filing system (EFS-Web or Patent Center) whenever permitted.”
  2. Priority Mail Express®: If not filing electronically, this is the next best option. MPEP 511 notes: “The Office strongly recommends that applicants file new applications by Priority Mail Express® in accordance with 37 CFR 1.10 (if such applications are not filed via EFS-Web) because such correspondence will be accorded the date of deposit in Priority Mail Express® with the USPS as the filing date.”
  3. Hand-delivery: Applications can be hand-delivered to the USPTO.
  4. First-class mail: While possible, this method carries risks of delay and is not recommended for new applications.

It’s important to note that new applications cannot be filed by facsimile. For more details on electronic filing, refer to the Legal Framework for Patent Electronic System on the USPTO website.

To learn more:

The USPTO strongly recommends the following methods for filing new patent applications:

  1. Electronic Filing System (EFS-Web or Patent Center): This is the preferred method whenever permitted.
  2. Priority Mail Express®: If not filing electronically, use this method in accordance with 37 CFR 1.10 to secure the date of deposit as the filing date.
  3. Hand-delivery to the USPTO office.

Avoid filing by first-class mail, as it only secures the date of receipt at the USPTO as the filing date, risking delays in delivery.

As stated in MPEP 511: “The Office strongly recommends that applicants file new applications by Priority Mail Express® in accordance with 37 CFR 1.10 (if such applications are not filed via EFS-Web) because such correspondence will be accorded the date of deposit in Priority Mail Express® with the USPS as the filing date.”

Additionally, “In general, applicants should consider filing new patent applications (as well as patent-related correspondence) via the USPTO patent electronic filing system (EFS-Web or Patent Center) whenever permitted.”

What are the recommended methods for checking application status?

The USPTO recommends several methods for checking application status:

  • Patent Application Information Retrieval (PAIR) system: This is the primary method for checking application status online. PAIR provides real-time access to the status of patent applications.
  • USPTO Call Center: For those who cannot access the Internet, the USPTO Call Center can provide status information.
  • Written requests: These should only be submitted if the application cannot be accessed through PAIR and the USPTO Call Center cannot provide the necessary information.

According to MPEP 203.08, ‘Applicants and their attorneys or agents are encouraged to use the PAIR system for checking patent application status.’

To learn more:

MPEP 213.01 lists several recognized regional patent offices for foreign filing. These include:

  • European Patent Office (EPO)
  • Eurasian Patent Office (EAPO)
  • African Intellectual Property Organization (OAPI)
  • African Regional Intellectual Property Organization (ARIPO)

Applications filed in these regional offices are considered as having been filed in all member states of the respective organizations. This allows applicants to seek patent protection in multiple countries through a single application process.

To learn more:

A patent application can be considered ‘abandoned’ for several reasons. According to MPEP 203.05, an abandoned application is one that is removed from the Office docket of pending applications due to:

  • Formal abandonment by the applicant or by the attorney or agent of record
  • Failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application
  • Failure to pay the issue fee
  • In the case of a provisional application, no later than 12 months after the filing date of the provisional application

It’s important for applicants to be aware of these reasons to avoid unintentional abandonment of their applications.

For more information on issue fee, visit: issue fee.

For more information on patent prosecution, visit: patent prosecution.

For more information on provisional application, visit: provisional application.

According to 37 CFR 11.116(b), a practitioner may withdraw from representing a client for several reasons, including:

  • Withdrawal can be accomplished without material adverse effect on the client’s interests
  • The client persists in a course of action the practitioner reasonably believes is criminal or fraudulent
  • The client has used the practitioner’s services to perpetrate a crime or fraud
  • The client insists on taking action the practitioner considers repugnant or fundamentally disagrees with
  • The client fails to fulfill an obligation regarding the practitioner’s services after reasonable warning
  • The representation results in an unreasonable financial burden or has been rendered unreasonably difficult by the client
  • Other good cause for withdrawal exists

It’s important to note that when requesting withdrawal, practitioners should be mindful of client confidentiality as required by 37 CFR 11.106. In cases involving sensitive reasons for withdrawal, practitioners should cite ‘irreconcilable differences’ and submit supporting evidence as proprietary material.

To learn more:

What are the procedures for transmitting secrecy order applications within the USPTO?

The transmission of secrecy order applications within the USPTO follows strict security protocols. MPEP 121 outlines these procedures:

  • Applications are hand-carried by authorized personnel
  • Transmittal slips are used to track the movement of applications
  • Applications must be signed for upon receipt

The MPEP emphasizes: ‘Classified material must be transmitted between offices in the Patent and Trademark Office in designated classified carriers.’ This ensures that secrecy order applications are always under secure control and their location is known at all times, minimizing the risk of unauthorized access or loss.

Former USPTO employees face restrictions on priority dates for patents they file after leaving the office. According to 35 U.S.C. 4:

‘In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.’

This means that for any patent application filed by a former USPTO employee, the earliest priority date they can claim is one year after their employment at the USPTO ended. This rule prevents former employees from using insider knowledge to gain an unfair advantage in the patent application process.

Filing a continuation-in-part (CIP) application can present several risks and potential drawbacks:

1. Different Effective Filing Dates: New matter in the CIP only gets the benefit of the CIP filing date, potentially exposing those claims to more prior art.

2. Reduced Patent Term: The patent term is measured from the filing date of the earliest application to which the CIP claims priority, potentially reducing the overall protection period for new matter.

3. Double Patenting Issues: Claims in the CIP may be subject to obviousness-type double patenting rejections based on the claims of the parent application.

4. Complexity in Litigation: The varying effective filing dates can complicate patent litigation, particularly when determining relevant prior art.

5. Difficulty in Claiming Priority: International applications may have difficulty claiming priority to a CIP due to the new matter.

While not explicitly stated in the provided MPEP section, these are important considerations derived from patent law and practice. The MPEP does note: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

Applicants should carefully consider these factors when deciding whether to file a CIP or a new application.

Violations of USPTO signature and certification requirements can result in serious consequences as outlined in 37 CFR 11.18(c) and (d):

  • Striking the offending paper
  • Referral to the Office of Enrollment and Discipline
  • Preclusion from submitting papers or contesting issues
  • Affecting the weight given to the offending paper
  • Termination of proceedings
  • Disciplinary action against practitioners

The MPEP states: “37 CFR 11.18(d) provides that any practitioner violating the provisions of 37 CFR 11.18 may also be subject to disciplinary action, thus clarifying that a practitioner may be subject to disciplinary action in lieu of, or in addition to, the sanctions set forth in 37 CFR 11.18(c) for violations of 37 CFR 11.18.”

Additionally, knowingly making false statements can lead to criminal penalties under 18 U.S.C. 1001.

To learn more:

The MPEP 602.08(c) warns about a serious potential consequence of misidentifying an application:

Further an oath or declaration attached to a cover letter referencing an incorrect application may not become associated with the correct application and, therefore, could result in the abandonment of the correct application.

This means that if you submit an oath or declaration with a cover letter that references the wrong application number or details, it might not be properly associated with the intended application. As a result, the correct application could be considered abandoned due to lack of a proper oath or declaration.

To avoid this issue, it’s crucial to double-check all application identifiers and ensure that cover letters, oaths, and declarations accurately reference the intended application. If you discover such an error, you should contact the USPTO promptly to rectify the situation and prevent unintended abandonment.

To learn more:

Unauthorized disclosure of patent application information can result in severe penalties for USPTO employees. According to the MPEP:

“Suspension, removal, and even criminal penalties may be imposed for violations of these statutes.”

The relevant statutes include 35 U.S.C. 122 and 18 U.S.C. 2071. Additionally, 18 U.S.C. 2071 states that individuals who willfully and unlawfully conceal, remove, mutilate, or destroy official documents may be:

  • Fined under this title
  • Imprisoned for up to three years
  • Disqualified from holding any office under the United States

These penalties underscore the critical importance of maintaining confidentiality in patent application handling.

For paper or facsimile submissions of patent assignment documents to the USPTO, the following requirements apply:

  • Either a copy of the original document or an extract of the original document must be submitted
  • Only one side of each page may be used
  • Paper size must be either 21.6 by 27.9 cm (8 1/2 inches by 11 inches) or 21.0 by 29.7 cm (DIN size A4)
  • A 2.5 cm (one-inch) margin must be present on all sides
  • The paper should be flexible, strong white, non-shiny, and durable

As stated in 37 CFR 3.24(b): For paper or facsimile submissions: Either a copy of the original document or an extract of the original document must be submitted for recording. Only one side of each page may be used.

To learn more:

When an inventor is unable to provide a statement due to death, incapacitation, or unavailability, MPEP 151 offers alternative solutions:

“When an inventor applicant is deceased or legally incapacitated, or where it is shown to the satisfaction of this Office that he or she refuses to furnish a statement or cannot be reached after diligent efforts, declarations or statements under oath setting forth the information required by the statutes may be accepted from an officer or employee of the assignee who has sufficient knowledge of the facts.”

Additionally, for joint inventions, “Where it is shown that one of the joint inventors is deceased or unavailable, a statement by all of the other inventor(s) may be accepted.” It’s important to note that these alternatives should only be used when the inventor is truly unavailable, not merely for convenience.

For more information on patent procedure, visit: patent procedure.

For continuing applications that claim the benefit of an earlier-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c), inventors have several options for submitting the required oath or declaration. According to 37 CFR 1.63(d):

A newly executed oath or declaration under § 1.63, or substitute statement under § 1.64, is not required under §§ 1.51(b)(2) and 1.53(f), or under §§ 1.497 and 1.1021(d), for an inventor in a continuing application that claims the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) in compliance with § 1.78 of an earlier-filed application, provided that an oath or declaration in compliance with this section, or substitute statement under § 1.64, was executed by or with respect to such inventor and was filed in the earlier-filed application, and a copy of such oath, declaration, or substitute statement showing the signature or an indication thereon that it was executed, is submitted in the continuing application.

This means that for a continuing application:

  • A new oath or declaration is not required if a compliant oath, declaration, or substitute statement was filed in the earlier application
  • A copy of the previously filed oath, declaration, or substitute statement can be submitted in the continuing application
  • The copy must show the signature or an indication that it was executed

However, any new joint inventor named in the continuing application must provide a new oath or declaration.

To learn more:

When an applicant chooses to accept a patent application as deposited without all the drawings, they have two main options:

  1. File an amendment to remove references to the missing drawings:
    • Submit replacement drawing sheets to renumber the figures consecutively
    • Amend the specification to remove references to omitted drawings and correct figure numbers
    • Ensure compliance with 37 CFR 1.121(d) for drawing changes and 37 CFR 1.121(b)(3) and 1.125 for specification changes
  2. File an amendment to add the missing figures by incorporation by reference:
    • Rely on 37 CFR 1.57(b) if the application claims priority to a prior-filed application containing the omitted portion
    • Submit new and replacement drawing sheets in compliance with 37 CFR 1.121(d)
    • Ensure no new matter is added, as prohibited by 35 U.S.C. 132(a)

The MPEP states: Applicant may accept the application as deposited in the USPTO by either: (1) filing an amendment including replacement drawing sheets… (2) filing an amendment to add the missing figure(s) by relying on an incorporation by reference under 37 CFR 1.57(b) or other portions of the original disclosure, without adding any new matter

To learn more:

What are the official USPTO mailing addresses for patent-related correspondence?

The United States Patent and Trademark Office (USPTO) has specific mailing addresses for different types of patent-related correspondence. According to the MPEP 502:

For regular mail:

  • Commissioner for Patents
    P.O. Box 1450
    Alexandria, VA 22313-1450

For hand-carried or EXPRESS MAIL:

  • U.S. Patent and Trademark Office
    Customer Service Window
    Randolph Building
    401 Dulany Street
    Alexandria, VA 22314

It’s important to use the correct address to ensure timely processing of your correspondence.

For more information on patent correspondence, visit: patent correspondence.

The official business hours of the U.S. Patent and Trademark Office (USPTO) are:

  • 8:30 a.m. to 5:00 p.m., Monday through Friday
  • Excluding federal holidays in the District of Columbia

As stated in MPEP 510: “The U.S. Patent and Trademark Office (USPTO or Office) working hours are 8:30 a.m. to 5:00 p.m., Monday through Friday, excluding federal holidays in the District of Columbia.”

Showing modified forms of construction in the same figure is objectionable under 37 CFR 1.84(h)(5). The MPEP section 608.02(f) provides a form paragraph (6.22.05) that examiners can use to object to such drawings:

“The drawings are objected to under 37 CFR 1.84(h)(5) because Figure [1] show(s) modified forms of construction in the same view.”

This objection is made to ensure clarity in patent drawings and to prevent confusion between different forms or modifications of the invention. Applicants are required to submit corrected drawing sheets in compliance with 37 CFR 1.121(d) to address this objection.

To learn more:

To learn more:

The USPTO provides normal corrective procedures for assignment records, which are outlined in MPEP 323.01(a) through 323.01(c). These procedures are typically the first course of action for addressing issues in assignment records. The expungement process, as described in MPEP 323.01(d), is only considered when:

the normal corrective procedures outlined in MPEP § 323.01(a) through § 323.01(c) will not provide the petitioner with adequate relief

The normal corrective procedures may include:

  • Filing a corrective document
  • Requesting a correction to the cover sheet
  • Submitting evidence to correct clerical errors

It’s important for patent applicants and attorneys to be familiar with these procedures and to exhaust these options before considering a petition for expungement.

To learn more:

According to MPEP 602.08(c), there are three acceptable combinations of information for identifying a patent application in an oath or declaration filed on the application filing date:

  • Name of inventor(s) and reference to an attached specification or application
  • Name of inventor(s) and attorney docket number on the specification as filed
  • Name of inventor(s) and title of the invention on the specification as filed

The MPEP states: Filing dates are granted on applications filed without an inventor’s oath or declaration in compliance with 37 CFR 1.63. This means that an application can receive a filing date even if the oath or declaration is not initially included.

To learn more:

Tags: declaration, oath

There are two primary methods for requesting the deletion of a named inventor in a Continued Prosecution Application (CPA) for design applications:

  • Letter to the examiner: You can submit a letter directly to the patent examiner handling your application.
  • Request for corrected filing receipt: You can file a formal request for a corrected filing receipt with the USPTO.

These methods are outlined in MPEP § 201, ¶ 2.32, which states:

In a continued prosecution application (CPA) for a design application (37 CFR 1.53(d)), a request to delete a named inventor from the prior application may be submitted by way of a letter to the examiner or a request for corrected filing receipt.

It’s important to note that this procedure is specific to design applications and is not applicable to utility patents.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent examination, visit: patent examination.

For more information on USPTO procedures, visit: USPTO procedures.

What are the margin requirements for patent application documents?

When preparing documents for a patent application, it’s crucial to adhere to specific margin requirements set by the USPTO:

  • The top margin of the first page should be at least 2 cm (3/4 inch).
  • All other margins (left, right, and bottom) must be at least 2 cm (3/4 inch).
  • The margins can be slightly larger but should not exceed 4 cm (1-1/2 inches).

According to MPEP 501: All of the application papers must have margins which are at least 2 cm. (3/4 inch) … on the sides, top and bottom. Margins should not exceed 4 cm. (1-1/2 inches). … The top margin of the first page should be at least 2 cm. (3/4 inch).

These margin requirements ensure that all information is visible and can be properly scanned and processed by the USPTO.

MPEP 507 outlines specific requirements for margins and paper size in patent drawings:

Each sheet must include a top margin of at least 2.5 cm. (1 inch), a left size margin of at least 2.5 cm. (1 inch), a right size margin of at least 1.5 cm. (5/8 inch), and a bottom margin of at least 1.0 cm. (3/8 inch). The size of the sheets on which drawings are made must be either 21.0 cm. by 29.7 cm. (DIN size A4) or 21.6 cm. by 27.9 cm. (8-1/2 by 11 inches);

These requirements are based on 37 CFR 1.84(f) and (g). Adhering to these specifications ensures that the drawings can be properly scanned and reproduced in the patent publication process.

The MPEP 201 outlines several main types of patent applications:

  • Nonprovisional applications for patent
  • Provisional applications for patent
  • International applications
  • Design applications
  • Plant applications
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

Each type serves a specific purpose in the patent application process and has its own requirements and procedures.

For more information on divisional, visit: divisional.

For more information on patent applications, visit: patent applications.

For more information on reissue, visit: reissue.

There are several types of patent applications in the United States:

  • Nonprovisional applications filed under 35 U.S.C. 111(a), including utility, plant, and design patent applications
  • Provisional applications filed under 35 U.S.C. 111(b)
  • International applications filed under the Patent Cooperation Treaty (PCT)
  • International design applications filed under the Hague Agreement

The MPEP states: Applications filed under 35 U.S.C. 111(a) include original nonprovisional utility, plant, design, divisional, continuation, and continuation-in-part applications filed under 37 CFR 1.53(b), reissue applications filed under 37 CFR 1.53(b), and design patent continued prosecution applications (CPAs) filed under 37 CFR 1.53(d).

For more information on Hague Agreement, visit: Hague Agreement.

For more information on international applications, visit: international applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent applications, visit: patent applications.

The main types of national applications under U.S. patent law are:

  • Original (non-provisional) applications
  • Provisional applications
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

As stated in MPEP 201.01: National applications include original (non-provisional), provisional, plant, design, reissue, divisional, and continuation applications (which may be filed under 37 CFR 1.53(b)), as well as continuation-in-part applications (which may be filed under 37 CFR 1.53(b)).

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

To learn more:

According to MPEP 203.05, there are four main reasons for patent application abandonment:

  1. Formal abandonment by the applicant or their representative
  2. Failure of the applicant to take appropriate action during prosecution
  3. Failure to pay the issue fee
  4. For provisional applications, the passage of 12 months from the filing date

The MPEP states: An abandoned application is, inter alia, one which is removed from the Office docket of pending applications: (A) through formal abandonment by the applicant or by the attorney or agent of record; (B) through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application; (C) for failure to pay the issue fee (MPEP § 711 to § 711.05); or (D) in the case of a provisional application, no later than 12 months after the filing date of the provisional application.

A nonprovisional patent application filed under 35 U.S.C. 111(a) must include several key components. According to the MPEP, these include:

The MPEP states: Such application shall include— (A) a specification as prescribed by section 112; (B) a drawing as prescribed by section 113; and (C) an oath or declaration as prescribed by section 115.

It’s important to note that while claims and drawings are not required for obtaining a filing date (except for design applications), they are necessary for a complete application and must be submitted to avoid abandonment.

For more information on filing requirements, visit: filing requirements.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent drawings, visit: patent drawings.

A complete nonprovisional patent application filed under 35 U.S.C. 111(a) comprises the following components:

  • A specification, including claims, as prescribed by 35 U.S.C. 112
  • Drawings as prescribed by 35 U.S.C. 113
  • An oath or declaration as prescribed by 35 U.S.C. 115
  • The prescribed filing fee, search fee, examination fee, and application size fee

As stated in the MPEP: “A complete application filed under 35 U.S.C. 111(a) comprises a specification, including claims, as prescribed by 35 U.S.C. 112, drawings as prescribed by 35 U.S.C. 113, an oath or declaration as prescribed by 35 U.S.C. 115, and the prescribed filing fee, search fee, examination fee and application size fee.”

To learn more:

What are the line spacing requirements for patent application text?

When preparing the text for your patent application, it’s important to follow the USPTO’s line spacing requirements:

  • The text should be written in a nonscript type font (e.g., Arial, Times Roman, or Courier).
  • The lettering style should be at least 0.32 cm (1/8 inch) high.
  • The lines of text should be 1.5 or double spaced.

According to MPEP 501: The text must be written in a nonscript type font (e.g., Arial, Times Roman, or Courier, preferably a font size of 12) lettering style having capital letters which should be at least 0.32 cm. (1/8 inch) high, but may be no smaller than 0.21 cm. (3/32 inch) high (e.g., a font size of 6). The lines of the specification may be 1 1/2 or double spaced.

These requirements ensure that the text is easily readable and can be properly scanned and processed by the USPTO’s systems.

An e-IDS has specific limits on the number of references that can be included. According to MPEP 609.07:

An individual e-IDS may contain a listing of (1) a combined total of 50 U.S. patents and U.S. patent application publications, (2) 50 foreign patent documents, and (3) 50 NPLs. Applicants are permitted to file more than one e-IDS if these numbers are exceeded.

If you need to submit more references than these limits allow, you can file multiple e-IDSs. However, be aware of potential fee implications if submitting multiple e-IDSs that require a fee under 37 CFR 1.17(p).

To learn more:

The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) have specific limitations when it comes to petitions for filing dates. According to MPEP 511:

“Applicants are cautioned that the provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) only apply to postal interruptions and emergencies. The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) do not provide for granting of a filing date to correspondence as of the date on which it would have been filed but for other exigencies, such as the unavailability of a computer or word processing equipment, or the inaccessibility of an office or building other than a USPS facility.”

This means that these provisions are strictly limited to postal service interruptions or emergencies. They cannot be used for other circumstances that may have prevented timely filing, such as:

  • Computer or equipment failures
  • Office or building inaccessibility (unless it’s a USPS facility)
  • Personal emergencies or other non-postal related issues

Additionally, the statute requires that the correspondence was complete and ready to be deposited with the USPS on the requested filing date, and that the sole reason for non-deposit was the unavailability of postal service due to the designated interruption or emergency.

To learn more:

Limited recognition in patent matters comes with several restrictions:

  • Scope limitation: As stated in 37 CFR 11.9(a), ‘Limited recognition under this paragraph shall not extend further than the application or applications specified.’
  • Duration for nonimmigrant aliens: According to 37 CFR 11.9(b), ‘Limited recognition shall be granted for a period consistent with the terms of authorized employment or training.’
  • Geographical restrictions: The same regulation states, ‘Limited recognition shall not be granted or extended to a non-United States citizen residing abroad.’
  • Automatic expiration: For nonimmigrant aliens, ‘Limited recognition shall automatically expire upon the nonimmigrant alien’s departure from the United States.’

These limitations ensure that limited recognition is granted only for specific circumstances and does not provide the same broad authority as full registration as a patent practitioner.

To learn more:

Provisional and nonprovisional patent applications have several key differences:

  • Claims: Nonprovisional applications require claims, while provisional applications do not. As stated in the MPEP, “Unlike an application filed under 35 U.S.C. 111(a) which requires claims before examination, a provisional application does not require claims.”
  • Oath or Declaration: Nonprovisional applications require an oath or declaration, while provisional applications do not. The MPEP notes, “Furthermore, no oath or declaration is required.”
  • Examination: Nonprovisional applications undergo substantive examination, while provisional applications do not.
  • Information Disclosure Statement: Provisional applications should not include an information disclosure statement, unlike nonprovisional applications. The MPEP states, “Unlike applications filed under 35 U.S.C. 111(a), provisional applications should not include an information disclosure statement.”
  • Cover Sheet: Provisional applications require a specific cover sheet with identifying information, which is not required for nonprovisional applications.

For more details on provisional applications, refer to MPEP § 201.04.

To learn more:

Continued Prosecution Applications (CPAs) have several key differences from regular continuation applications filed under 37 CFR 1.53(b):

  • CPAs are only available for design applications, not utility or plant applications
  • CPAs use the same application number as the prior application
  • CPAs do not require a new specification or drawings to be filed
  • The filing requirements for a CPA are minimal compared to a regular continuation
  • CPAs are typically processed faster than regular continuations
  • Filing a CPA automatically abandons the prior application

MPEP 201.06(d) states: A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on USPTO procedures, visit: USPTO procedures.

While both continuation and continuation-in-part (CIP) applications are related to a prior application, there are key differences:

  • Continuation: Repeats the entire disclosure of the prior application without adding new matter.
  • Continuation-in-Part (CIP): According to MPEP ¶ 2.06, a CIP “repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application.”

The main difference is that a CIP introduces new subject matter not present in the original application. This new matter receives the filing date of the CIP, while the repeated portions may claim the earlier filing date of the prior application if properly claimed under 35 U.S.C. 120.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A valid inventor’s oath or declaration must include several key components as outlined in the MPEP:

  1. Inventor bibliographic information (see MPEP § 602.08(a))
  2. The name of the inventor or each joint inventor
  3. Signatures of each inventor, except as otherwise provided
  4. Identification of the application to which it is directed

The MPEP states: The inventor’s oath or declaration must include certain inventor bibliographic information (see MPEP § 602.08(a)), name the inventor or each joint inventor and except as otherwise provided be signed by each inventor (see MPEP § 602.08(b)), and identify the application to which it is directed (see MPEP § 602.08(c)).

It’s important to ensure all these elements are present and correct to avoid potential issues with the patent application process.

To learn more:

A divisional application has several key characteristics as outlined in MPEP ¶ 2.01:

  1. Independent and Distinct Subject Matter: It ‘appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application.’
  2. Disclosure in Prior Application: It ‘discloses and claims only subject matter disclosed in prior Application No.[1],filed[2].’
  3. Inventor Continuity: It ‘names the inventor or at least one joint inventor named in the prior application.’
  4. Potential Benefit Claim: It may claim the benefit of the filing date of the prior application, subject to meeting certain requirements.

These characteristics ensure that divisional applications properly separate distinct inventions while maintaining a connection to the original disclosure and inventorship.

For more information on Divisional application, visit: Divisional application.

The inventorship requirements for claiming foreign priority are specific and important. Here are the key points:

  • The U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.
  • Priority rights do not exist if the foreign and U.S. applications have completely different sole inventors.
  • Joint inventors can each claim the benefit of their separately filed foreign applications.

The MPEP clarifies: Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common. This requirement ensures a direct connection between the foreign priority application and the U.S. application claiming its benefit.

To learn more:

What are the income limitations for qualifying as a micro entity?

To qualify as a micro entity based on income, an applicant’s gross income in the previous calendar year must not exceed three times the median household income as reported by the Bureau of the Census. The MPEP states:

“The income limit is not described in terms of a specific dollar amount because median household income may change from year to year.” (MPEP 509.04(a))

For the most current income threshold, applicants should check the USPTO’s website or consult with a patent attorney. It’s important to note that this limit applies to each applicant, inventor, and joint inventor who is named in the application.

To learn more:

What are the income limitations for micro entity status?

To qualify for micro entity status, an applicant’s income must not exceed three times the median household income as reported by the Bureau of the Census. According to USPTO’s 2022 notice, the income limit is $206,109. The MPEP states:

“[A]n applicant qualifies as a micro entity if the applicant’s gross income in the previous calendar year does not exceed the ‘maximum qualifying gross income’ which is set to three times the median household income as reported by the Bureau of the Census.” (MPEP 509.04(a))

It’s important to note that this limit is subject to change, and applicants should check the latest USPTO notices for the most current information.

To learn more:

Failing to properly claim benefit in a potential continuation-in-part (CIP) application can have significant implications for patent protection. The MPEP cautions: This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established. (MPEP ¶ 2.06)

Implications of not properly claiming benefit include:

  • Loss of earlier filing date for common subject matter, potentially affecting patentability
  • Increased vulnerability to prior art that could have been excluded with the earlier filing date
  • Possible issues with patent term calculation
  • Risk of unintentionally abandoning the application if statutory deadlines are missed

To avoid these issues, applicants should carefully follow the requirements outlined in 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq when filing a CIP application.

For more information on prior art, visit: prior art.

Tags: prior art

Deleting a benefit claim from your patent application can have several important implications:

  • Prior Art Considerations: The examiner will reassess whether any new prior art may now be available due to the change in effective filing date.
  • Publication Date: As stated in the MPEP, A deletion of a benefit claim will not delay the publication of the application unless the amendment or ADS is recognized by the Office within nine weeks prior to the projected publication date that was originally calculated based on the benefit claim.
  • Intentional Waiver: The MPEP warns that A cancellation of a benefit claim to a prior application may be considered as a showing that the applicant is intentionally waiving the benefit claim to the prior application in the instant application. This could affect future attempts to reinstate the benefit claim.
  • Examination Status: If the deletion is submitted after final rejection or allowance, it will be treated under special rules (37 CFR 1.116 or 37 CFR 1.312, respectively).

It’s crucial to carefully consider these implications before deciding to delete a benefit claim. If you’re unsure about the consequences, it’s advisable to consult with a patent attorney or agent.

To learn more:

Claiming benefit under these statutes allows an application to receive the earlier filing date of a prior-filed application, which can be crucial for establishing priority and overcoming prior art. However, this claim also requires that the application does not contain new matter.

The MPEP ¶ 2.10.01 states:

“This form paragraph should be used when an application, which claims the benefit of a prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c) contains new matter relative to the prior-filed application, and purports to be a ‘continuation,’ ‘division,’ or ‘divisional application’ of the prior-filed application.”

If new matter is found, the applicant may need to change the application type or remove the benefit claim to maintain the new subject matter.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on new matter, visit: new matter.

The Public Search Facility in Alexandria has extended hours compared to the regular USPTO business hours:

  • 8:00 a.m. to 8:00 p.m., Monday through Friday
  • Excluding federal holidays in the District of Columbia

As stated in MPEP 510: “The hours for the Public Search Facility in Alexandria are 8:00 a.m. to 8:00 p.m., Monday through Friday, excluding federal holidays in the District of Columbia.”

What are the guidelines for submitting drawings on recycled paper?

The USPTO has specific guidelines for submitting drawings on recycled paper:

  • Recycled paper is acceptable for patent application drawings.
  • The paper must meet the requirements for archival quality and durability.
  • It should not have any imperfections that would interfere with the clarity of the drawing.

According to MPEP 608.02: ‘Drawings submitted to the Office must be made on paper which is flexible, strong, white, smooth, non-shiny, and durable.’

While recycled paper is allowed, it’s crucial to ensure that it meets all the necessary quality standards to avoid potential issues with the examination process or long-term storage of the patent documents.

To learn more:

The MPEP provides specific guidelines for status inquiries in patent applications:

  • Status inquiries are encouraged to be made via the Patent Application Information Retrieval (PAIR) system at https://www.uspto.gov/patents/apply/checking-application-status/check-filing-status-your-patent-application.
  • If PAIR is unavailable or the inquiry cannot be answered by PAIR, applicants can contact the Technology Center (TC) customer service center.
  • The MPEP states: Applicants and other individuals with limited Internet access may contact the TC customer service center at (571) 272-3900.
  • For reexamination proceedings, status inquiries should be directed to the Central Reexamination Unit (CRU) at (571) 272-7705.

It’s important to follow these guidelines to ensure efficient processing of status inquiries.

To learn more:

Tags: PAIR system

The MPEP 608.01(i) provides specific guidelines for numbering claims in a patent application:

  • Claims must be numbered consecutively in Arabic numerals.
  • The claim number should be placed to the left of the claim.
  • If claims are amended, all claims should be renumbered consecutively.

The MPEP states: ‘The claim or claims must commence on a separate physical sheet or electronic page and should appear after the detailed description of the invention.’ This numbering system ensures clarity and easy reference to specific claims throughout the examination process.

To learn more:

Correcting or adding drawings after a patent application is filed is addressed in MPEP 608.02, subsection II. The key points are:

  • Drawings can be corrected, revised, or added if no new matter is introduced.
  • The applicant must submit a proposed drawing correction in reply to the Office action.
  • For non-provisional applications, replacement sheets of corrected drawings must be submitted.
  • For provisional applications, corrected drawings may be submitted as an amendment to the application.

The MPEP states: ‘Where a drawing is to be amended, applicant must submit a replacement sheet of drawings which complies with 37 CFR 1.84 and includes all of the figures appearing on the original version of the sheet, even if only one figure is being amended.’ This ensures that the entire drawing set remains consistent and complete.

To learn more:

Proper claim indentation is important for clarity and readability in patent applications. The MPEP 608.01(m) provides specific guidelines:

  • Each claim should start with a capital letter and end with a period.
  • Steps or elements within a claim should be separated by line indentation.
  • There should be only one sentence per claim, but elements may be set forth in separate paragraphs.

The MPEP states:

‘Where a claim sets forth a plurality of elements or steps, each element or step of the claim should be separated by a line indentation, 37 CFR 1.75(i).’

Proper indentation helps examiners and others understand the structure and scope of the claimed invention more easily.

To learn more:

What are the government’s rights in inventions made by nonprofit organizations and small businesses?

The government’s rights in inventions made by nonprofit organizations and small businesses under federally sponsored research are specifically addressed in MPEP 310. According to the manual:

“A funding agreement may provide that the government shall have the right to require periodic reporting on the utilization or efforts at obtaining utilization that are being made by the contractor or his licensees or assignees.”

Additionally, the government retains:

  • A nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced the invention for or on behalf of the United States throughout the world.
  • The right to require the contractor to grant licenses to responsible applicants under certain conditions (march-in rights).
  • The right to require written agreements from contractors to ensure that inventions are made available for public use on reasonable terms.

These provisions, outlined in 35 U.S.C. 202, balance the interests of small entities, the government, and the public in federally funded inventions.

For more information on federally sponsored research, visit: federally sponsored research.

The Manual of Patent Examining Procedure (MPEP) outlines several general terms used to describe patent applications:

  • National application
  • Provisional application
  • Nonprovisional application
  • International application
  • International design application
  • Original application
  • Continuing application
  • Substitute application

These terms are defined in various sections of 37 CFR 1.9 and further explained in MPEP § 201.

To learn more:

For patent applications filed on or after September 16, 2012, the general requirements for powers of attorney are:

  • The power of attorney must be in writing.
  • It must name one or more representatives.
  • It must give the representative power to act on behalf of the principal.
  • It must be signed by the applicant for patent or the patent owner.

According to 37 CFR 1.32(b)(4), “A power of attorney must: […] (4) Be signed by the applicant for patent (§ 1.42) or the patent owner. A patent owner who was not the applicant under § 1.46 must appoint any power of attorney in compliance with §§ 3.71 and 3.73 of this chapter.”

It’s important to note that an assignee who is not an applicant cannot revoke or appoint a power of attorney in a patent application.

To learn more:

The formatting requirements for claims in a patent application are specified in 37 CFR 1.75(h) and (i). Key requirements include:

  • Claims must commence on a separate physical sheet or electronic page.
  • Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material.
  • Where a claim sets forth multiple elements or steps, each element or step should be separated by a line indentation.

The MPEP states: “The claim or claims must commence on a separate physical sheet or electronic page. Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material.” and “Where a claim sets forth a plurality of elements or steps, each element or step of the claim should be separated by a line indentation.”

These formatting requirements enhance readability and clarity of the claims. For more detailed information on claim formatting, refer to MPEP § 608.01(m).

To learn more:

A substitute specification must be submitted with specific formatting requirements as outlined in 37 CFR 1.125(c):

  • A clean version (without markings) must be provided.
  • A marked-up copy showing all changes relative to the prior version must be submitted.
  • Added text must be shown by underlining.
  • Deleted text must be shown by strike-through or double brackets (for five or fewer consecutive characters).

The MPEP further states: “The paragraphs of any substitute specification, other than the claims, should be individually numbered in Arabic numerals (for example [0001]) so that any amendment to the specification may be made by replacement paragraph in accordance with 37 CFR 1.121(b)(1).”

To learn more:

For electronic submissions of assignment documents, the USPTO requires:

  • Either a copy of the original document or an extract of the original document
  • Documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another prescribed format
  • When printed to paper size of 21.6 by 27.9 cm (8 1/2 inches by 11 inches) or 21.0 by 29.7 cm (DIN size A4), the document must be legible
  • A 2.5 cm (one-inch) margin must be present on all sides

As stated in 37 CFR 3.24(a): All documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another form as prescribed by the Director.

To learn more:

For electronic submissions of assignment documents, the following requirements apply:

  • Either a copy of the original document or an extract of the original document may be submitted.
  • Documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another prescribed format.
  • When printed to paper size (8.5″ x 11″ or A4), the document must be legible with a 1-inch margin on all sides.

As stated in 37 CFR 3.24(a): “All documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another form as prescribed by the Director.”

What are the font requirements for a patent specification?

The MPEP 608.01 outlines specific font requirements for patent specifications:

  • Font size: At least 0.21 cm (0.08 inch) high, or at least a 12-point font size
  • Font style: The lettering must be a nonscript type font (e.g., Arial, Times Roman, or Courier)
  • Color: Dark ink against a light background

The MPEP states: ‘The specification must have text written in a nonscript type font (e.g., Arial, Times Roman, or Courier, preferably a font size of 12) lettering style having capital letters which should be at least 0.3175 cm. (0.125 inch) high, but may be no smaller than 0.21 cm. (0.08 inch) high (e.g., a font size of 6).’ These font requirements ensure readability and consistency across all patent documents.

To learn more:

The filing requirements for an interim copy of a foreign application are specified in 37 CFR 1.55(j). They include:

  • Filing a copy of the original foreign application clearly labeled as ‘Interim Copy’
  • Including a separate cover sheet identifying the foreign application details
  • Filing within specified time limits

The MPEP states:

’37 CFR 1.55(j) also provides that the interim copy of the foreign application must be filed together with a separate cover sheet identifying the foreign application by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and stating that the copy filed in the Office is a true copy of the original application as filed in the foreign country (or intellectual property authority).’

It’s crucial to adhere to these requirements to ensure proper processing of the interim copy.

For more information on filing requirements, visit: filing requirements.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

What are the filing requirements for a provisional application?

A provisional application must include:

  • A specification as prescribed by 35 U.S.C. 112(a), except claims are not required
  • Any drawings necessary to understand the invention
  • The inventor’s oath or declaration is not required
  • The appropriate filing fee

According to MPEP 601.01(b): ‘A provisional application must include a specification as prescribed by 35 U.S.C. 112(a), except that no claims are required.’ The specification should provide a clear description of the invention to enable others skilled in the art to make and use it.

To learn more:

The filing requirements for a divisional application under 37 CFR 1.53(b) are similar to those for a new nonprovisional application. According to the MPEP:

‘A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (1) a specification complying with 35 U.S.C. 112, including a claim or claims; (2) drawings, where necessary; and (3) the inventorship named on filing.’

Additionally, you must include:

  • The appropriate filing fees
  • An Application Data Sheet (ADS) specifying that the application is a divisional
  • A proper benefit claim to the parent application

It’s important to note that while a new oath or declaration may not be required under 37 CFR 1.63(d), you must still comply with all other filing requirements.

For more information on Divisional application, visit: Divisional application.

For more information on drawings, visit: drawings.

For more information on filing requirements, visit: filing requirements.

For more information on inventorship, visit: inventorship.

To file a CPA for a design patent application, the following requirements must be met:

  • The prior application must be a design application that is complete under 37 CFR 1.51(b)
  • The CPA must be filed before the earliest of: payment of the issue fee, abandonment, or termination of proceedings in the prior application
  • The CPA must be filed with a request on a separate paper
  • The proper filing fee, search fee, and examination fee must be paid
  • The CPA must only disclose and claim subject matter disclosed in the prior application

As stated in the MPEP: “The filing date of a CPA is the date on which a request on a separate paper for an application under this paragraph is filed.”

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

The filing requirements for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) are as follows:

  • The CPA must be filed before the earliest of:
    • Payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted;
    • Abandonment of the prior application; or
    • Termination of proceedings on the prior application.
  • The CPA must include a request to initiate proceedings under 37 CFR 1.53(d).
  • The prior application must be a design application eligible for CPA practice.

As stated in the MPEP 201.06(d): ‘A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).’

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on filing requirements, visit: filing requirements.

A continuation-in-part (CIP) application has specific filing requirements. Key points include:

  • A CIP application can only be filed under 37 CFR 1.53(b).
  • It must be filed during the lifetime of the prior-filed application (before its abandonment or issuance).
  • The CIP must claim the benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • For applications filed on or after September 16, 2012, the benefit claim must be in an application data sheet (ADS).
  • The CIP must have at least one common inventor with the prior application.
  • New matter can be added to the specification, but claims relying on this new matter will not get the benefit of the earlier filing date.

As stated in the MPEP:

A continuation-in-part application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).

It’s important to note that while a CIP allows for the addition of new matter, any claims that rely on this new matter will only be entitled to the filing date of the CIP application, not the earlier filing date of the parent application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on filing requirements, visit: filing requirements.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

To file a continuation application, you must meet several requirements as outlined in MPEP 201.07:

  1. Timing: The continuation must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  2. Disclosure: The continuation must not include any new matter beyond what was disclosed in the parent application.
  3. Claim to Benefit: A specific reference to the prior application is required, typically in the first sentence of the specification.
  4. Inventor: At least one inventor named in the continuation must also be named in the prior application.
  5. Filing Requirements: The continuation must include:
    • A copy of the prior application as filed (unless already submitted via the USPTO electronic filing system)
    • Amendments to the specification (if any)
    • New claims (if any)
    • Oath or declaration

Additionally, the continuation application must satisfy all the requirements of 35 U.S.C. 112 for the claimed subject matter.

To learn more:

Applications properly filed via Priority Mail Express® (formerly Express Mail) have special filing date rules:

  • The filing date is the date the application was deposited with the U.S. Postal Service as Priority Mail Express®
  • This applies even if the deposit date is a Saturday, Sunday, or federal holiday
  • The application must comply with the requirements of 37 CFR 1.10 to receive this benefit

The MPEP states: For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service. For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date. 37 CFR 1.6(a)(2).

If the proper procedures were not followed, the application will receive a filing date as of the date it was received in the USPTO. Any review of these matters would be by way of petition, accompanied by the petition fee.

For more information on Priority Mail Express, visit: Priority Mail Express.

The filing date requirements for provisional applications under 35 U.S.C. 111(b) are outlined in MPEP 601.01(b):

Quote: “The filing date of a provisional application is the date on which a specification as prescribed by 35 U.S.C. 112(a), and any drawing required by 37 CFR 1.81(a) are filed in the USPTO.”

This means that to receive a filing date, a provisional application must include:

  • A specification that meets the requirements of 35 U.S.C. 112(a)
  • Any necessary drawings as per 37 CFR 1.81(a)

It’s important to note that provisional applications do not require claims to receive a filing date.

To learn more:

To learn more:

The filing date requirements for nonprovisional applications filed under 35 U.S.C. 111(a) have changed due to the Patent Law Treaties Implementation Act of 2012 (PLTIA). For applications filed on or after December 18, 2013:

  • Non-design applications no longer require at least one claim or any drawings to receive a filing date
  • Design patent applications still require at least one claim and any required drawings to receive a filing date

The MPEP states: Unless the application is for a design patent, nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013, are no longer required to include at least one claim or any drawings in order to receive a filing date for the application.

Additionally, applications may now be filed by reference to a previously filed application: A nonprovisional application filed under 35 U.S.C. 111(a) on or after December 18, 2013, may be filed by a reference to a previously filed application (foreign, international, provisional, or nonprovisional) indicating that the specification and any drawings of the application are replaced by the reference to the previously filed application.

For more information on filing date requirements, visit: filing date requirements.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent drawings, visit: patent drawings.

For more information on PLTIA, visit: PLTIA.

The Patent Law Treaties Implementation Act of 2012 (PLTIA) amended the filing date requirements for nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013. The key changes are:

  • Nonprovisional applications (except for design patent applications) no longer require at least one claim or any drawings to receive a filing date.
  • For design patent applications, the filing date is the date on which the USPTO receives the specification including at least one claim and any required drawings.
  • As provided in 35 U.S.C. 111(c), a nonprovisional application may be filed by reference to a previously filed application (foreign, international, provisional, or nonprovisional).

These changes simplified the filing process for most nonprovisional applications while maintaining specific requirements for design patent applications.

For nonprovisional applications filed on or after December 18, 2013, the filing date requirements have been simplified. The MPEP states: For applications filed on or after December 18, 2013, the filing date of a nonprovisional application filed under 35 U.S.C. 111(a), other than a design patent application, is the date on which a specification, with or without claims, is received in the Office. This means that utility and plant patent applications no longer require at least one claim or any drawings to receive a filing date. However, design patent applications still require at least one claim and any required drawings to receive a filing date.

To learn more:

What are the filing date requirements for a CPA?

The filing date requirements for a Continued Prosecution Application (CPA) are specific and must be adhered to. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is a paper filing, even though it may be submitted via EFS-Web.

Key points about CPA filing date requirements include:

  • The CPA must be filed before the payment of the issue fee for the prior application
  • It must be filed before abandonment of the prior application
  • The request for a CPA must be made on a separate paper
  • The filing date is based on when the CPA request is received, not when other application documents are submitted

It’s crucial to meet these requirements to ensure the CPA is properly filed and receives the correct filing date.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

To receive a filing date for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d), the following requirements must be met:

  • The application must be for a design patent;
  • The prior application must be a design application that is complete as defined by 37 CFR 1.51(b);
  • The application must be submitted before the payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted in the prior application;
  • The application must be filed within the period set forth in 37 CFR 1.53(d)(1)(ii); and
  • The application must be filed with a request for a CPA.

As stated in the MPEP: ‘A CPA may be filed under 37 CFR 1.53(d) only if the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).’

For more information on CPA, visit: CPA.

For more information on design patent, visit: design patent.

For more information on filing requirements, visit: filing requirements.

What are the filing date requirements for a Continued Prosecution Application (CPA)?

For a Continued Prosecution Application (CPA) to receive a filing date, it must meet specific requirements as outlined in MPEP 201.06(d):

  • The application must be for a design patent
  • The prior application must be a design application that is complete as defined by 37 CFR 1.51(b)
  • The application must be submitted before the payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted in the prior application
  • The application must be filed within the period set forth in 37 CFR 1.53(d)(1)(ii)

The MPEP states: ‘A CPA may be filed where the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).’ This ensures that the CPA is based on a properly filed and complete prior application.

To learn more:

The file size limitations for biological sequence listings in patent applications are as follows:

  • Sequence listings up to 100KB can be included in the specification or submitted as a text file via EFS-Web or PatentCenter.
  • Sequence listings between 100KB and 100MB can be submitted as ASCII text files or PDF files via EFS-Web or PatentCenter.
  • Sequence listings larger than 100MB must be submitted on read-only optical discs.

According to MPEP 608.05(c): “Sequence listings may be submitted in electronic form via EFS-Web or PatentCenter as ASCII text files or PDF files up to 100 megabytes, and on read-only optical discs when the sequence listing file size is over 100 megabytes.”

It’s important to note that these size limitations ensure efficient processing and storage of sequence listings while accommodating various file sizes.

To learn more:

Tags: EFS-Web

The fees for recording assignment documents are set forth in 37 CFR 3.41. According to the MPEP:

  • For electronic submissions: The fee is currently $0 (as per 37 CFR 1.21(h)(1))
  • For paper or facsimile submissions: The fee is set in 37 CFR 1.21(h)(2)

The MPEP advises: Customers should check the current fee schedule on the Office website before submitting documents for recordation.

It’s important to note that a fee is required for each application, patent, and registration against which the document is recorded, as identified in the cover sheet. However, there are exceptions:

  • No fee is required for documents required by Executive Order 9424 if the document does not affect title and is identified as such in the cover sheet
  • The document must be either faxed, electronically submitted, or mailed in compliance with 37 CFR 3.27

For more information on recordation fees, visit: recordation fees.

For more information on USPTO fees, visit: USPTO fees.

The fees for recording a patent assignment depend on the submission method:

  • Electronic submission via EPAS (Electronic Patent Assignment System): $0
  • Paper or facsimile submission: See current fee schedule

As stated in MPEP 302.06: “If the request to record a document is submitted electronically, the fee is set forth in 37 CFR 1.21(h)(1), currently at $0. If the request to record a document is not submitted electronically (i.e., is submitted on paper or via facsimile), the applicable fee is set forth in 37 CFR 1.21(h)(2).”

It’s important to note that fees are subject to change. Always check the current USPTO fee schedule before submitting documents for recordation.

For more information on patent assignment fees, visit: patent assignment fees.

For more information on USPTO fees, visit: USPTO fees.

There are several exceptions to the 18-month publication rule for patent applications, as outlined in 35 U.S.C. 122(b)(2)(A). An application shall not be published if it is:

  • No longer pending
  • Subject to a secrecy order under section 181
  • A provisional application filed under section 111(b)
  • An application for a design patent filed under chapter 16

Additionally, an applicant can request non-publication if they certify that the invention has not and will not be the subject of an application filed in another country that requires publication after 18 months. However, if the applicant later files such a foreign application, they must notify the USPTO within 45 days or the U.S. application will be considered abandoned.

While most patent application files are available for public inspection, there are several exceptions:

  • Pending or abandoned applications that have not been published under 35 U.S.C. 122(b)
  • Applications subject to a secrecy order
  • Provisional applications
  • Applications that have been terminated or denied and are no longer open to public inspection
  • Interference files, until judgment is entered (subject to certain exceptions)
  • Applications for extension of patent term and any related submissions
  • Certain trade secret, proprietary, and protective order materials

These exceptions are in place to protect confidential information and maintain the integrity of the patent application process.

While most patent application files are available for public inspection, there are some exceptions:

  • Pending or abandoned applications that have not been published
  • Applications subject to secrecy orders
  • Certain international applications
  • Applications for which the United States is not a designated country
  • Information that would violate personal privacy or proprietary rights

These exceptions help protect sensitive information and maintain confidentiality in specific cases.

The examiner’s responsibilities regarding drawing corrections in patent applications include:

  • Determining if the drawings are complete and consistent with the specification and claims
  • Informing the applicant of any drawing corrections required
  • Providing reasons for any objections or rejections related to the drawings

As stated in MPEP 608.02(e): ‘The examiner should see to it that the drawings are correct, complete, and consistent with the specification and claims.’ This means the examiner must carefully review the drawings and ensure they accurately represent the invention described in the application.

To learn more:

While MPEP 203.06 mentions ‘essential parts’ without specifying them, other sections of the MPEP provide details on what constitutes a complete patent application. The essential parts typically include:

  • Specification (including a description of the invention)
  • At least one claim
  • Drawings (when necessary to understand the invention)
  • Filing fees
  • Inventor’s oath or declaration

The specific requirements may vary depending on the type of patent application (e.g., utility, design, or plant patent). It’s crucial to consult the relevant MPEP sections, such as MPEP 601, for detailed information on application requirements.

To learn more:

For patent applications filed before December 18, 2013, drawings were generally required to receive a filing date. As stated in the MPEP, For applications filed prior to December 18, 2013, 35 U.S.C. 111(a)(4) and 35 U.S.C. 111(b)(4) each provide, in part, that the ‘filing date… shall be the date on which… any required drawing are received in the Patent and Trademark Office.’ This means that if drawings were necessary for understanding the invention, they had to be included in the initial filing to secure a filing date.

To learn more:

According to MPEP 203.05, a patent application can become abandoned in several ways:

  • Through formal abandonment by the applicant or their attorney/agent
  • Failure to take appropriate action during prosecution
  • Failure to pay the issue fee
  • For provisional applications, not filing a nonprovisional application within 12 months

The MPEP states: “An abandoned application is, inter alia, one which is removed from the Office docket of pending applications” due to these reasons.

To learn more:

There are three types of Secrecy Orders, each with a different scope:n

    n

  1. Type I – Secrecy Order and Permit for Foreign Filing in Certain Countries
  2. n

  3. Type II – Secrecy Order and Permit for Disclosing Classified Information
  4. n

  5. Type III – General Secrecy Order
  6. n

nThe Type I order permits filing in certain countries with security agreements, Type II allows classified or classifiable disclosure, and Type III prevents disclosure without written consent from the Commissioner. (MPEP 120 Section I)

According to MPEP 201.02, there are several types of patent applications:

  • National applications
  • Provisional applications
  • Nonprovisional applications
  • International applications
  • International design applications

The definitions for these terms can be found in 37 CFR 1.9. Additionally, applications can be classified as ‘original’ or ‘continuing’ applications. An original application may be a first filing or a continuing application, while a continuing application can be a continuation, divisional, or continuation-in-part application.

For more information on continuing applications, visit: continuing applications.

For more information on international applications, visit: international applications.

For more information on international design applications, visit: international design applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent applications, visit: patent applications.

The United States Patent and Trademark Office (USPTO) recognizes several types of patent applications. According to MPEP 201, these include:

  • Nonprovisional applications for patent, including utility, design, and plant patent applications
  • Provisional applications for patent
  • International applications filed under the Patent Cooperation Treaty (PCT)
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

Each type of application serves a specific purpose in the patent process and has its own requirements and procedures.

For more information on divisional, visit: divisional.

For more information on patent applications, visit: patent applications.

For more information on reissue, visit: reissue.

For more information on USPTO, visit: USPTO.

According to MPEP 201.01, there are three main types of national applications in U.S. patent law:

  • Original applications: These include both provisional and nonprovisional applications.
  • Reissue applications: Filed to correct an error in an already issued patent.
  • Reexamination applications: Used to request a review of an existing patent.

The MPEP states: National applications include original (nonprovisional and provisional), reissue, and reexamination applications. Each type serves a specific purpose in the patent application process.

For more information on reissue applications, visit: reissue applications.

There are significant differences in power of attorney requirements for patent applications filed before and after September 16, 2012. Key differences include:

  • Signature Requirements: For applications filed on or after September 16, 2012, the power of attorney must be signed by the applicant for patent or the patent owner. For applications filed before September 16, 2012, it must be signed by the applicant for patent or the assignee of the entire interest of the applicant.
  • Definition of Applicant: The definition of ‘applicant’ changed with the America Invents Act. For applications filed on or after September 16, 2012, the applicant can be the inventor(s) or a non-inventor applicant (e.g., an assignee).
  • Forms: Different forms are used for applications filed before and after September 16, 2012. For example, Form PTO/AIA/80 is used for applications filed on or after September 16, 2012, while Form PTO/SB/80 is used for earlier applications.

It’s crucial to use the correct forms and follow the appropriate rules based on the application’s filing date to ensure the power of attorney is properly executed and recognized by the USPTO.

To learn more:

The rules regarding who can be a patent applicant changed significantly for applications filed on or after September 16, 2012. MPEP § 605 outlines these differences:

For applications filed on or after September 16, 2012:

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign an invention to file and prosecute an application for patent as the applicant, and to permit a person who otherwise shows sufficient proprietary interest in the matter to file and prosecute an application for patent as the applicant on behalf of the inventor.”

For applications filed before September 16, 2012:

“For applications filed before September 16, 2012, a person to whom the inventor assigned an invention could file and prosecute an application for patent, but the inventor is considered the applicant.”

The key differences are:

  • Pre-AIA: Only the inventor could be listed as the applicant, even if the application was filed by an assignee.
  • Post-AIA: Assignees, those obligated to assign, or those with sufficient proprietary interest can be listed as the applicant.

For more detailed information, refer to MPEP § 605.01 for post-AIA applications and MPEP § 605.02 for pre-AIA applications.

To learn more:

For U.S. national stage applications derived from international applications, there are specific requirements for submitting Information Disclosure Statements (IDSs). The MPEP states:

“When filing a continuing application that claims benefit under 35 U.S.C. 120 to an international application that designated the U.S. (see MPEP § 1895), it will be necessary for the applicant to submit an information disclosure statement complying with 37 CFR 1.97 and 1.98 in the continuing application listing the documents cited in the international search report and/or the international preliminary examination report of the international application if applicant wishes to ensure that the information is considered by the examiner in the continuing application.”

This means that unlike regular continuing applications, where previously cited art is automatically considered, applicants must submit a new IDS in national stage applications to ensure the examiner considers documents from the international phase. For more information on the consideration of documents cited in international search reports in PCT national stage applications, refer to MPEP § 609.03.

To learn more:

The MPEP 106.01 highlights a key difference in assignee rights for patent applications filed before and after September 16, 2012:

  • For applications filed before September 16, 2012: The assignee of record of the entire interest can intervene in the prosecution of an application or interference to the exclusion of the applicant.
  • For applications filed on or after September 16, 2012: The assignee of record of the entire interest can not only intervene but also prosecute the application after becoming the applicant under 37 CFR 1.46.

For more detailed information, the MPEP directs readers to:

  • MPEP § 324 for applications filed before September 16, 2012
  • MPEP § 325 for applications filed on or after September 16, 2012

What are the differences between U.S. and international practice regarding multiple dependent claims?

There are significant differences between U.S. and international practices for multiple dependent claims:

  • U.S. practice is more restrictive, not allowing multiple dependent claims to depend on other multiple dependent claims.
  • Many foreign patent offices allow multiple dependent claims to depend on other multiple dependent claims.
  • The U.S. requires alternative language in multiple dependent claims, while some foreign offices allow cumulative dependencies.

The MPEP 608.01(n) states:

“The treatment of multiple dependent claims in the U.S. is different from that in other countries. In the United States, a multiple dependent claim may not depend upon another multiple dependent claim, either directly or indirectly.”

This difference is crucial for patent applicants to understand when drafting claims for both U.S. and international patent applications, as claim structures acceptable abroad may need to be modified for U.S. submission.

To learn more:

To learn more:

What are the differences between recognized countries and regional patent offices for foreign filing?

Recognized countries and regional patent offices both play important roles in foreign patent filing, but they have distinct characteristics. According to MPEP 213.01:

A ‘recognized’ country is one that meets the conditions of 35 U.S.C. 119(a)-(d), which include extending similar patent filing rights to U.S. citizens. Regional patent offices are intergovernmental organizations that have been authorized to receive and process patent applications on behalf of multiple member countries.

Key differences include:

  • Jurisdiction: Recognized countries operate within their national borders, while regional offices cover multiple countries.
  • Application Process: Filing with a recognized country results in a national patent, whereas regional office filings can lead to patents enforceable in multiple member states.
  • Legal Framework: Recognized countries follow their national patent laws, while regional offices operate under a harmonized system agreed upon by member states.

Examples of regional patent offices include the European Patent Office (EPO) and the African Regional Intellectual Property Organization (ARIPO).

To learn more:

Design and plant patent applications are two distinct types of patent applications, each protecting different aspects of inventions:

Design Patent Applications:
1. Protect the ornamental design of a functional item.
2. Cover the visual appearance of an article of manufacture.
3. Have a term of 15 years from the date of grant.
4. Require drawings or photographs of the design.
5. Do not require a written description of the invention.

Plant Patent Applications:
1. Protect new varieties of asexually reproduced plants.
2. Cover the entire plant, not just a specific part.
3. Have a term of 20 years from the filing date.
4. Require a detailed botanical description of the plant.
5. May include drawings or photographs to illustrate the plant’s characteristics.

For more information, refer to MPEP 201.06 for design patents and MPEP 201.07 for plant patents.

The USPTO has specific requirements for patent drawings, but they have become more flexible in recent years. According to MPEP 608.02(i), “Drawings that do not comply with all of the form requirements of 37 CFR 1.84 may be acceptable for the purposes of publication and examination if the drawings are readable and reproducible for publication purposes.” This means that while there are still formal requirements outlined in 37 CFR 1.84, the USPTO may accept drawings that don’t meet all these requirements as long as they are clear enough for publication and examination.

To learn more:

According to MPEP 310, a Government contractor who retains U.S. domestic patent rights has the following obligations:

  1. Include the government license rights statement at the beginning of the patent application and any issued patents.
  2. Specify the contract under which the invention was made.
  3. Identify the Federal agency that awarded the contract.
  4. Acknowledge that the government has certain rights in the invention.

These obligations stem from 35 U.S.C. 202(c)(6), which mandates the inclusion of this information in the patent application and any resulting patents.

An Information Disclosure Statement (IDS) must include:

  • A list of all patents, publications, applications, or other information submitted for consideration
  • A column for examiner’s initials
  • U.S. patents and patent application publications listed separately from other documents
  • Proper identification of each document listed
  • Copies of foreign patents/publications
  • Copies of non-patent literature
  • Copies of pending U.S. applications (if not in IFW system)

MPEP 609.04(a) states: “Each information disclosure statement must include a list of all patents, publications, U.S. applications, or other information submitted for consideration by the Office.” It further specifies that “37 CFR 1.98(b) requires that each item of information in an IDS be identified properly. U.S. patents must be identified by the inventor, patent number, and issue date. U.S. patent application publications must be identified by the applicant, patent application publication number, and publication date.”

To learn more:

Tags: USPTO

Violating the certification requirements when submitting papers to the USPTO can have serious consequences. According to 37 CFR 11.18(c), violations may result in:

  1. Striking the offending paper
  2. Referring a practitioner’s conduct to the Office of Enrollment and Discipline
  3. Precluding a party or practitioner from submitting papers or contesting issues
  4. Affecting the weight given to the offending paper
  5. Terminating proceedings in the Office

Additionally, 37 CFR 11.18(d) states that practitioners violating these provisions may be subject to disciplinary action. The USPTO Director determines appropriate sanctions after notice and opportunity to respond.

It’s important to note that violations can jeopardize the validity of applications, documents, patents, and trademark registrations. As stated in the MPEP:

‘The submission by an applicant of misleading or inaccurate statements of facts during the prosecution of applications for patent has resulted in the patents issuing on such applications being held unenforceable.’

Several court cases are cited demonstrating how false statements have led to patents being unenforceable.

Violating a secrecy order can have severe consequences. According to MPEP 120, “Unauthorized disclosure of the subject matter of an application under a secrecy order is punishable by a fine and/or imprisonment.” Specifically:

  • The fine can be up to $10,000
  • Imprisonment can be up to two years
  • These penalties apply for each offense

Additionally, violation of a secrecy order can result in the abandonment of the application. It’s crucial for inventors and patent practitioners to strictly adhere to secrecy orders to avoid these serious legal consequences.

Violating a secrecy order on a patent application can have severe consequences. MPEP 120 states, “If, prior to or after the issuance of the secrecy order, any significant part of the subject matter or material information relevant to the application has been or is revealed to any U.S. citizen in the United States, the principals must promptly inform such person of the secrecy order and the penalties for improper disclosure.” The penalties for violation can include:

It’s crucial for applicants and their representatives to strictly adhere to secrecy orders to avoid these serious consequences.

Submitting unauthorized correspondence to the USPTO for patent applications filed after September 16, 2012, can have serious consequences:

  • The correspondence may be returned or not entered into the application
  • It could cause delays in the processing of the application
  • Important deadlines might be missed, potentially leading to abandonment of the application
  • There may be additional fees or costs to rectify the situation

The USPTO has strict rules about who can correspond on behalf of applicants. According to MPEP 403.01(a):

Pursuant to 37 CFR 1.33(a), if an applicant includes more than one correspondence address (37 CFR 1.33(a) ) in a patent application, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

To avoid these issues, ensure that all correspondence is submitted by authorized individuals or entities as specified in the MPEP and relevant USPTO regulations.

To learn more:

Tags: USPTO

What are the consequences of submitting insufficient fees for a patent application?

Submitting insufficient fees for a patent application can have significant consequences. According to MPEP 509:

“An application filed with insufficient basic filing fee, search fee, examination fee, or oath or declaration will be treated as an incomplete application under 37 CFR 1.53(f) and will not be given a filing date until the filing fee is received.”

This means:

  • Your application won’t receive a filing date until the correct fees are paid
  • This delay could affect your priority date
  • If not corrected promptly, the application may be considered abandoned

It’s crucial to ensure all required fees are paid in full when submitting a patent application to avoid these issues.

To learn more:

Submitting informal drawings in a patent application can have several consequences:

  • The application may be considered incomplete, potentially affecting the filing date.
  • The examiner may object to the drawings and require formal drawings to be submitted.
  • It may delay the examination process.
  • In some cases, it could result in a loss of patent rights if not corrected in time.

MPEP 608.02(b) states: ‘The Office no longer considers drawings as formal or informal; drawings are either acceptable or not acceptable. Drawings will be accepted by the Office of Patent Application Processing (OPAP) if the drawings meet the requirements of 37 CFR 1.84(a), (b), (c), and (e) and are capable of reproduction.’

It’s important to note that while the USPTO may accept informal drawings initially, they may still be objected to during examination, requiring corrections to be made.

To learn more:

To learn more:

What are the consequences of submitting color drawings in a utility patent application?

Submitting color drawings in a utility patent application has specific consequences and requirements:

  • Color drawings are not ordinarily permitted in utility patent applications.
  • As stated in MPEP 507: “Color drawings are permitted in design applications. For utility patent applications, color drawings are not permitted without a grantable petition.”
  • If color drawings are submitted without an approved petition, OPAP will send a Notice to File Corrected Application Papers.
  • The applicant must either:
    • Replace the color drawings with black and white drawings, or
    • File a grantable petition under 37 CFR 1.84(a)(2) to accept the color drawings.
  • The petition must explain why color drawings are necessary and be accompanied by the fee set forth in 37 CFR 1.17(h).

It’s important to consider whether color drawings are truly necessary for your utility patent application, as they require additional steps and fees in the application process.

For more information on application papers, visit: application papers.

For more information on color drawings, visit: color drawings.

What are the consequences of submitting an untimely IDS?

Submitting an untimely Information Disclosure Statement (IDS) can have significant consequences for a patent application. According to MPEP 609.02, the consequences depend on when the IDS is submitted:

  • After first Office action but before final rejection: Requires certification and fee
  • After final rejection but before RCE or appeal: Requires certification, fee, and statement
  • After payment of issue fee: Not considered by examiner

The MPEP states:

‘If an IDS is filed after the mailing date of a first Office action on the merits but before the mailing date of a final rejection or a notice of allowance, the IDS must be accompanied by (1) the statement specified in 37 CFR 1.97(e) and (2) the fee set forth in 37 CFR 1.17(p).’

Failing to comply with these requirements can result in the IDS not being considered, which may affect the validity or enforceability of any resulting patent. In extreme cases, it could lead to allegations of inequitable conduct if material information was intentionally withheld.

To learn more:

While the MPEP section provided doesn’t directly address the consequences of submitting an incomplete or non-compliant Information Disclosure Statement (IDS), it does mention a provision for addressing inadvertent omissions:

If a bona fide attempt is made to comply with the content requirements of 37 CFR 1.98, but part of the required content is inadvertently omitted, additional time may be given to enable full compliance pursuant to 37 CFR 1.97(f).‘ (MPEP 609.04(a))

However, it’s important to note that:

  • Intentional omissions or non-compliance can have serious consequences, including charges of inequitable conduct
  • The USPTO may not consider information in a non-compliant IDS
  • Correcting deficiencies may require submitting a new IDS, potentially incurring additional fees
  • Non-compliance can delay the examination process

To avoid these issues, it’s crucial to carefully follow the IDS requirements outlined in 37 CFR 1.98 and the guidance provided in MPEP 609.04(a). When in doubt, consult with a patent attorney or agent to ensure full compliance.

To learn more:

What are the consequences of submitting a poor-quality copy of an assignment document to the USPTO?

Submitting a poor-quality copy of an assignment document to the USPTO can lead to rejection of the recording request. The MPEP 302.01 clearly states that “Only copies of an original assignment document (with the exception of those submitted via EFS-Web) may be submitted for recording.” Furthermore, it emphasizes that “The copy must be legible, capable of reproduction and otherwise meet the usual requirements of documents for recording.” If a poor-quality copy is submitted:

  • The recording request may be rejected
  • The effective date of recordation could be delayed
  • Additional fees may be incurred for resubmission
  • There could be potential legal implications if the assignment is not properly recorded in a timely manner

To avoid these issues, always ensure that the copy submitted is of high quality and meets all USPTO requirements for legibility and reproducibility.

Providing incorrect information in an Application Data Sheet (ADS) can have serious consequences for your patent application. The MPEP 601.05(a) emphasizes the importance of accuracy:

Applicants should submit a new ADS whenever the previously submitted information is no longer accurate. Submission of an inaccurate ADS may delay processing of the application and may require the applicant to file a petition under 37 CFR 1.78 to correct the applicant information.

Consequences of incorrect ADS information may include:

  • Delays in application processing
  • Potential loss of priority claims
  • Incorrect inventorship records
  • Need for additional petitions and fees to correct errors
  • Possible issues with patent enforcement if errors are not corrected

It’s crucial to review your ADS carefully before submission and promptly correct any errors discovered using a supplemental ADS or other appropriate means.

To learn more:

What are the consequences of providing incorrect information in an ADS?

Providing incorrect information in an Application Data Sheet (ADS) can have serious consequences for your patent application. The MPEP 601.05 emphasizes the importance of accuracy:

“Applicants should check the contents of the application data sheet carefully to ensure that all information is correct.”

Potential consequences of incorrect ADS information include:

  • Delayed processing: The USPTO may need to issue Office actions to correct errors, slowing down the application process.
  • Loss of priority rights: Incorrect foreign priority or domestic benefit claims could result in the loss of these valuable rights.
  • Inventorship issues: Errors in inventorship can lead to complicated correction procedures and potential challenges to patent validity.
  • Correspondence problems: Incorrect address information can result in missed communications from the USPTO.
  • Potential fraud allegations: In extreme cases, knowingly providing false information could be considered fraud on the USPTO.

To avoid these issues, carefully review all information before submitting an ADS, and promptly correct any errors discovered after submission using a supplemental ADS with proper markings.

To learn more:

What are the consequences of omitting the inventor’s name in a provisional application?

Omitting the inventor’s name in a provisional application can have serious consequences. According to MPEP 601.01(b):

“The inventorship of a provisional application is not considered to be relevant except when necessary to determine the proprietorship of the invention for purposes of double patenting rejections or if priority is claimed to the provisional application in a foreign filed application.”

While the inventorship may not be immediately relevant for the provisional application itself, it becomes crucial when:

  • Filing a non-provisional application claiming priority to the provisional
  • Claiming priority to the provisional in foreign applications
  • Addressing potential double patenting issues

If the inventor’s name is omitted, it may complicate these processes and potentially lead to loss of priority rights or other legal issues. It’s always best practice to include accurate inventor information in all patent applications, including provisionals.

To learn more:

What are the consequences of omitting an inventor’s oath or declaration in a nonprovisional application?

Omitting an inventor’s oath or declaration in a nonprovisional application can have significant consequences. According to MPEP 601.01(a):

If the application is filed without an inventor’s oath or declaration by any inventor, the Office will send a Notice to File Missing Parts giving the applicant a time period (usually two months) within which to file the missing oath or declaration and to pay the surcharge required by 37 CFR 1.16(f) to avoid abandonment.

The key points to note are:

  • The USPTO will send a Notice to File Missing Parts.
  • A time period (usually two months) is given to file the missing oath or declaration.
  • A surcharge under 37 CFR 1.16(f) must be paid.
  • Failure to comply may result in abandonment of the application.

It’s important to note that while the application can be filed without the oath or declaration, it must be submitted before the application is allowed to avoid potential issues.

For more information, refer to MPEP 601.01(a) and MPEP 602 on inventor’s oath or declaration.

To learn more:

Failing to submit an inventor’s oath or declaration before the issue fee is paid can have serious consequences for a patent application. According to MPEP 602.01(a):

If an application does not include an oath or declaration by the inventor or a substitute statement, the Office will issue a notice requiring the applicant to file the inventor’s oath or declaration no later than the date on which the issue fee is paid.

The consequences of not complying with this requirement include:

  • Application Abandonment: If the oath or declaration is not submitted by the time the issue fee is paid, the application will be regarded as abandoned.
  • Additional Fees: To revive an abandoned application, the applicant must pay additional fees and file a petition for revival.
  • Delay in Patent Grant: The patent will not be granted until the proper oath or declaration is submitted and the application is revived.
  • Potential Loss of Patent Rights: In extreme cases, failure to timely submit the oath or declaration could result in a loss of patent rights if statutory deadlines are missed.

To avoid these issues, applicants should ensure that a proper inventor’s oath or declaration is submitted well before the issue fee payment deadline.

To learn more:

While submitting an Application Data Sheet (ADS) is not mandatory for all applications, there can be consequences for not including one. According to MPEP 601.05(a):

If an application is filed without an application data sheet, the applicant will not have the benefit of:

  • The filing date of any provisional application;
  • The filing date of any non-provisional application;
  • The filing date of any international application;
  • The 35 U.S.C. 119, 120, 121, 365(c), or 386(c) priority claim; and
  • The foreign priority claim.

These benefits can be crucial for establishing priority dates and protecting your invention. Without an ADS, you may need to submit additional paperwork later to claim these benefits, which could potentially lead to delays or complications in the application process.

To learn more:

What are the consequences of not submitting an Application Data Sheet (ADS) in applications filed before September 16, 2012?

For applications filed before September 16, 2012, submitting an Application Data Sheet (ADS) was not mandatory. The MPEP 601.05(b) states:

In applications filed before September 16, 2012, the application data sheet is not a requirement of 37 CFR 1.51(b) for a complete application, but is rather supplemental to the application and is used to capture bibliographic information.

However, not submitting an ADS could lead to the following consequences:

  • Manual data entry: The USPTO would have to manually enter bibliographic information from other application papers, which could potentially lead to errors.
  • Delayed processing: Without an ADS, the application processing might take longer as the information needs to be gathered from various sources.
  • Potential for inconsistencies: Information scattered across different documents might lead to inconsistencies in the application record.
  • Missed benefits: Certain benefits, such as easily claiming domestic benefit or foreign priority, might be harder to establish without an ADS.

While not submitting an ADS wouldn’t result in an incomplete application, it was generally recommended to include one for smoother processing and to ensure accurate capture of bibliographic information.

To learn more:

Failing to show claimed features in patent drawings can lead to objections and potential issues with the patent application. According to MPEP 608.02(d), the examiner may issue an objection using Form Paragraph 6.36, which states:

The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, the [specific feature] must be shown or the feature(s) canceled from the claim(s). No new matter should be entered.

Consequences of this objection include:

  • Required submission of corrected drawing sheets
  • Potential cancellation of claims if features cannot be shown
  • Risk of application abandonment if corrections are not made

To avoid these issues, ensure that all claimed features are clearly illustrated in the patent drawings.

To learn more:

The consequences of not responding to a notice about an unlocatable file differ for pending applications and granted patents:

  • For pending applications: According to 37 CFR 1.251(b), failure to comply with one of paragraphs (a)(1), (a)(2), or (a)(3) of this section within the time period set in the notice will result in abandonment of the application.
  • For granted patents: While the patent won’t expire, the MPEP states that the only certified copy of the patent file that the Office will be able to produce will be a copy of the patent and a copy of the application-as-filed (which may have an adverse impact during attempts to enforce the patent).

Additionally, for patents involved in USPTO proceedings, the Office may take action under 37 CFR 41.128 or 37 CFR 11.18.

To learn more:

What are the consequences of not paying the correct filing fee for a patent application?

If you fail to pay the correct filing fee for your patent application, there can be significant consequences:

  • Application may not be assigned a filing date: As stated in MPEP 607, “The filing fee and application size fee for a nonprovisional application or provisional application are due on filing.” Without the correct fee, your application might not be officially filed.
  • Notice of Missing Parts: The USPTO will likely issue a Notice of Missing Parts, giving you a time limit to pay the correct fee.
  • Potential abandonment: If you don’t respond to the Notice of Missing Parts within the given timeframe, your application could be considered abandoned.
  • Additional fees: Late payment may incur surcharges or extension fees.

To avoid these issues, always ensure you calculate and submit the correct filing fee with your application.

To learn more:

Failing to include the Government License Rights statement in a patent application can have serious consequences. While the MPEP 310 does not explicitly state the penalties, the requirement is mandated by law under 35 U.S.C. 202(c)(6). Potential consequences may include:

  • Non-compliance with federal regulations
  • Risk of the patent being unenforceable
  • Potential loss of rights or benefits under the government contract
  • Complications in future licensing or commercialization efforts

It’s crucial for inventors and patent attorneys to ensure proper inclusion of this statement to maintain the validity and enforceability of the patent.

For more information on patent enforcement, visit: patent enforcement.

What are the consequences of not filing an IDS or submitting an incomplete IDS?

Failing to file an Information Disclosure Statement (IDS) or submitting an incomplete one can have serious consequences:

  • Duty of Disclosure: Violating the duty of disclosure can lead to charges of inequitable conduct.
  • Patent Invalidity: The patent may be held unenforceable if material information was intentionally withheld.
  • Prosecution History Estoppel: Failure to disclose prior art may limit the scope of patent claims in future litigation.

MPEP 609 states: “The duty to disclose all information known to be material to patentability is deemed to be satisfied if all information known to be material to patentability of any claim issued in a patent was cited by the Office or submitted to the Office in the manner prescribed by 37 CFR 1.97(b)-(d) and 1.98.”

It’s crucial to file a complete and timely IDS to avoid these potential pitfalls and ensure the validity and enforceability of your patent.

To learn more:

Failing to file a 37 CFR 1.48 request when adding a new inventor to a Continued Prosecution Application (CPA) can have significant consequences.

MPEP ¶ 2.33 states: “Otherwise, the inventorship in the CPA shall be the same as in the prior application.” This means that without a proper 37 CFR 1.48 request:

  • The new inventor will not be officially recognized on the application.
  • The inventorship will remain unchanged from the prior application.
  • This discrepancy could potentially affect the validity of the patent if granted.
  • It may lead to complications in future patent proceedings or enforcement efforts.

It’s crucial to follow proper procedures to ensure all inventors are correctly listed and legally recognized on the patent application.

For more information on CPA, visit: CPA.

For more information on patent validity, visit: patent validity.

What are the consequences of not converting a provisional application within 12 months?

If you do not convert a provisional application to a nonprovisional application within 12 months, there are significant consequences:

  • The provisional application will automatically expire.
  • You will lose the benefit of the provisional filing date.
  • The subject matter disclosed in the provisional may become prior art against future applications.

According to MPEP 201.04: “A provisional application will automatically become abandoned 12 months after its filing date pursuant to 35 U.S.C. 111(b)(5).” This means that after 12 months, if no corresponding nonprovisional application has been filed, the provisional application cannot be revived or extended. It’s crucial to file a nonprovisional application or a PCT application within this 12-month period to maintain the benefit of the provisional filing date.

To learn more:

Failing to address drawing objections can have serious consequences for a patent application. According to MPEP 608.02(e), the primary consequence is the potential abandonment of the application. The MPEP states:

Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application.

Additionally, it’s important to note that drawing objections cannot be held in abeyance. The MPEP clarifies:

Unless applicant is otherwise notified in an Office action, objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action.

This means that failing to address drawing objections can prevent the application from progressing, potentially leading to delays or even abandonment.

To learn more:

Listing references in the specification instead of submitting them in a proper Information Disclosure Statement (IDS) can have significant consequences. The MPEP 609.05(a) addresses this issue with form paragraph 6.49.06:

The listing of references in the specification is not a proper information disclosure statement. 37 CFR 1.98(b) requires a list of all patents, publications, applications, or other information submitted for consideration by the Office, and MPEP § 609.04(a), subsection I. states, ‘the list may not be incorporated into the specification but must be submitted in a separate paper.’ Therefore, unless the references have been cited by the examiner on form PTO-892, they have not been considered.

This means that references listed in the specification:

  • Are not considered a proper IDS
  • Will not be considered by the examiner unless cited on form PTO-892
  • Must be submitted separately in a proper IDS to ensure consideration

To ensure all relevant prior art is considered, applicants should always submit references in a separate, properly formatted IDS rather than listing them in the specification.

To learn more:

What are the consequences of knowingly submitting false statements to the USPTO?

Submitting false statements to the USPTO can have serious consequences. According to MPEP 410:

“Knowingly submitting false statements or withholding material information from the Office in connection with a patent application or patent may be punishable by fine or imprisonment.”

The MPEP further states that such actions may result in:

  • Invalidation of patents
  • Unenforceability of patents
  • Criminal prosecution
  • Disciplinary action against practitioners

It’s crucial for applicants and their representatives to maintain honesty and transparency in all communications with the USPTO to avoid these severe consequences.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What are the consequences of inconsistencies between an ADS and other documents in a patent application?

Inconsistencies between an Application Data Sheet (ADS) and other documents in a patent application can lead to processing delays and potential issues. The MPEP states:

“If an ADS is inconsistent with the information provided in another document that was submitted at the same time or previous to the ADS submission, the ADS will control.” (MPEP 601.05(a))

This means:

  • The ADS takes precedence over other documents for bibliographic data.
  • Inconsistencies may require corrections, potentially delaying application processing.
  • Applicants should ensure all documents are consistent to avoid complications.

It’s crucial to review all application documents carefully before submission to maintain consistency and avoid potential issues in the patent examination process.

To learn more:

Including offensive content in a patent application can have significant consequences. According to MPEP 608:

  • The examiner will object to the offensive language or drawings.
  • The application will not be classified for publication under 35 U.S.C. 122(b).
  • The examiner will not pass the application to issue until the offensive content is removed.

The MPEP states, “An application should not be classified for publication under 35 U.S.C. 122(b) and an examiner should not pass the application to issue until such language or drawings have been deleted, or questions relating to the propriety thereof fully resolved.” This policy ensures that federal government publications maintain appropriate standards of decorum and courtesy.

To learn more:

Including derogatory remarks in a patent application can lead to objections or rejections from patent examiners. While the MPEP 608.01(r) doesn’t explicitly state the consequences, it clearly prohibits such remarks:

“The applicant … is not permitted to make derogatory remarks concerning the inventions of others.”

Consequences may include:

  • Objections to the specification
  • Requests to remove or modify the derogatory language
  • Potential delays in the patent examination process
  • In severe cases, it could affect the credibility of the application

To avoid these issues, focus on describing your invention’s merits without disparaging others’ work.

To learn more:

Improperly identifying a foreign priority application can have serious consequences for a patent applicant. According to MPEP 214.04:

‘Where the claim to priority in an application filed under 35 U.S.C. 111(a) is presented after the time period provided by 37 CFR 1.55(d) and without the required petition, or where the claim to priority is presented in a nonprovisional application filed under 35 U.S.C. 111(a) that was filed on or after March 16, 2013, and also claims the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) of a prior application that was filed prior to March 16, 2013, the examiner should reject under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, any claims which are directed to subject matter that is not supported by the foreign application.’

Consequences may include:

  • Rejection of claims under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph
  • Loss of priority date for unsupported subject matter
  • Potential issues with patentability due to intervening prior art

It’s crucial to accurately identify and properly claim foreign priority to avoid these issues.

To learn more:

What are the consequences of improperly claiming small entity status?

Improperly claiming small entity status can have serious consequences. The MPEP 509.03 states: “Improperly and with intent to deceive establishing status as a small entity, or paying fees as a small entity, shall be considered as a fraud practiced or attempted on the Office.” This means that intentionally falsely claiming small entity status is considered fraud. Consequences may include:

  • Invalidation of the patent
  • Requirement to pay back all fee differences
  • Potential legal action for fraud

It’s crucial to verify eligibility carefully before claiming small entity status and to update the USPTO if your status changes.

To learn more:

To learn more:

Improper use of trademarks in patent applications can have several consequences, as outlined in MPEP 608.01(v):

  1. Insufficient Disclosure: If proper identification of the product, service, or organization identified by a mark or a trade name is omitted from the specification and such identification is deemed necessary under the principles set forth above, the examiner should hold the disclosure insufficient and reject, on the ground of insufficient disclosure, any claims based on the identification of the product, service, or organization merely by mark or trade name.
  2. Potential Trademark Validity Issues: The MPEP states that Every effort should be made to prevent their use in any manner which might adversely affect their validity as marks. Improper use in a patent application could potentially impact the trademark’s validity.
  3. Office Actions: Examiners may issue office actions requiring correction of improper trademark usage.
  4. Publication Issues: Where a letter demonstrates the misuse of a mark in a patent application publication, the Office should, where the application is still pending, ensure that the mark is replaced by appropriate generic terminology.

To avoid these issues, it’s crucial to follow the guidelines for proper trademark use in patent applications as specified in the MPEP.

To learn more:

Improper signatures on patent documents can have serious consequences:

  • The document may be considered unsigned and therefore ineffective.
  • It could lead to delays in the patent application process.
  • In some cases, it might result in the loss of rights or benefits.
  • The USPTO may require a new submission with proper signatures.

MPEP 402.03 states: ‘Signatures on any paper filed in the Office relating to patents must be permanent. The Office will accept and consider electronically submitted papers bearing S-signatures or handwritten signatures.’

To avoid these issues, ensure all signatures meet USPTO requirements and are made by authorized individuals.

To learn more:

What are the consequences of improper dependent claims in a patent application?

Improper dependent claims in a patent application can have several negative consequences:

  • Rejection by USPTO: The patent examiner may reject claims that don’t comply with dependency requirements.
  • Delayed prosecution: Addressing improper dependencies can prolong the patent examination process.
  • Increased costs: Additional office actions and responses may be needed to correct claim issues.
  • Weakened patent protection: Improperly drafted claims may not provide the intended scope of protection.
  • Potential invalidity: In extreme cases, improper dependencies could lead to claim invalidity if challenged in court.

The MPEP 608.01(n) emphasizes the importance of proper claim dependency:

“If the base claim is rejected, canceled, or withdrawn from consideration, any claim depending therefrom should be presented in independent form.”

This guidance underscores the need for careful claim drafting and ongoing attention to claim dependencies throughout the patent prosecution process. Ensuring proper claim structure and dependencies is crucial for obtaining strong, enforceable patent protection.

To learn more:

Fraudulently establishing small entity status or paying fees as a small entity is considered a serious offense. According to 37 CFR 1.27(h): ‘Any attempt to fraudulently establish status as a small entity or pay fees as a small entity will be considered as a fraud practiced or attempted on the Office.’

The consequences of such actions can be severe, potentially including:

  • Invalidation of the patent
  • Criminal charges for fraud
  • Disciplinary action against registered patent practitioners

It’s crucial to ensure that all claims to small entity status are truthful and accurate. Do not rely on oral advice from USPTO employees regarding entitlement to small entity status.

To learn more:

What are the consequences of filing an incomplete application?

Filing an incomplete application can have serious consequences:

  • No filing date: An incomplete application may not be assigned a filing date. As stated in MPEP 601.01, “The filing date of an application for patent is the date on which a specification as prescribed by 35 U.S.C. 112 containing a description pursuant to 35 U.S.C. 112(a) and at least one claim pursuant to 35 U.S.C. 112(b), and any drawing required by 35 U.S.C. 113 are filed in the Patent and Trademark Office.”
  • Loss of priority: Without a filing date, you may lose priority rights or the ability to claim the benefit of an earlier filing date.
  • Potential abandonment: If the missing parts are not submitted within the required time frame, the application may be considered abandoned.
  • Additional fees: Late submission of required elements may incur additional fees.

It’s crucial to ensure all required elements are included when filing a patent application to avoid these potential issues.

To learn more:

What are the consequences of filing an IDS after the mailing of a notice of allowance?

Filing an Information Disclosure Statement (IDS) after the mailing of a notice of allowance can have significant consequences:

  • The application will be withdrawn from issue
  • The IDS will be considered by the examiner
  • If the examiner determines that the application is still allowable, the application may be returned to issue
  • If the examiner determines that one or more claims are no longer allowable, the applicant will be notified and the claims will be rejected

As stated in MPEP 609.04(b): “If an IDS is filed after the mailing date of a Notice of Allowance under 37 CFR 1.311, the application will be withdrawn from issue.” This emphasizes the importance of timely IDS submission to avoid potential delays in patent issuance.

To learn more:

Filing a nonprovisional application without drawings can have significant consequences:

  • The application may be considered incomplete.
  • It may not receive a filing date.
  • The applicant will be notified of the deficiency.

As stated in MPEP 601.01(a): ‘If the specification of a nonprovisional application does not include at least one drawing, if necessary under 35 U.S.C. 113 (first sentence) to understand the subject matter sought to be patented, and at least one drawing is necessary under 35 U.S.C. 113, the Office of Patent Application Processing (OPAP) will send a notice requiring drawings and a time period within which drawings must be filed in order to avoid abandonment.’

It’s important to note that drawings are required when necessary to understand the invention. If drawings are not necessary, the application can proceed without them.

To learn more:

Filing a foreign patent application without the required license can have severe consequences, including:

As stated in 35 U.S.C. 185: “Notwithstanding any other provisions of law any person, and his successors, assigns, or legal representatives, shall not receive a United States patent for an invention if that person, or his successors, assigns, or legal representatives shall, without procuring the license prescribed in section 184, have made, or consented to or assisted another’s making, application in a foreign country for a patent or for the registration of a utility model, industrial design, or model in respect of the invention.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

Failure to timely submit the reference to the prior-filed application within the time periods specified in 37 CFR 1.78 is considered a waiver of any benefit claim under 35 U.S.C. 120, 121, 365(c), or 386(c) to the prior-filed application. See 37 CFR 1.78(d)(3)(iii). The time periods are not extendable.

If the reference to the prior-filed application is submitted after the time period provided by 37 CFR 1.78, a petition and the petition fee under 37 CFR 1.17(m) would be required to accept the delayed claim. The petition must be accompanied by:

  • The reference required by 35 U.S.C. 120 and 37 CFR 1.78 to the prior-filed application
  • The petition fee
  • A statement that the entire delay between the date the benefit claim was due and the date the claim was filed was unintentional

What are the consequences of failing to submit an Information Disclosure Statement (IDS)?

Failing to submit an Information Disclosure Statement (IDS) can have serious consequences for patent applicants. According to MPEP 609:

“The failure to timely file an Information Disclosure Statement may result in the application being abandoned or may adversely affect the validity of the patent.”

Specifically:

  • The application may be abandoned if the IDS is not filed within the time periods specified in 37 CFR 1.97.
  • If a patent is granted, it may be invalidated if it’s later discovered that material information was intentionally withheld from the USPTO during prosecution.
  • The applicant may be accused of inequitable conduct, which can render the entire patent unenforceable.

It’s crucial for applicants to diligently submit all known material information to the USPTO through proper IDS filings to avoid these potential issues.

To learn more:

Failing to submit a proper oath or declaration in a patent application can have serious consequences:

  • The application may be considered incomplete and subject to abandonment.
  • A Notice to File Missing Parts will be issued, requiring submission of the oath or declaration.
  • A surcharge may be required for late submission.
  • The application will not be examined until a proper oath or declaration is received.

According to MPEP 602.01(a): “If the application is in condition for allowance but does not include an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement in compliance with 37 CFR 1.64, executed by or with respect to each actual inventor, the Office will issue a ‘Notice of Allowability’ (PTOL-37) requiring the oath or declaration.” Failure to comply with this notice can result in abandonment of the application.

To learn more:

Tags: declaration, oath

Failing to respond to an Office of Patent Application Processing (OPAP) notice regarding missing drawings can have serious consequences for a patent application. The outcomes differ depending on whether the application is nonprovisional or provisional:

For Nonprovisional Applications:

The MPEP clearly states: Failure to timely reply to the OPAP notice in a nonprovisional application will result in abandonment of the application.

This means:

  • The application will be considered abandoned
  • The applicant will lose their filing date
  • To continue pursuing patent protection, the applicant would need to file a new application or petition to revive the abandoned application

For Provisional Applications:

The consequences are less severe for provisional applications. The MPEP notes: For provisional applications in which applicant accepts the application as deposited by failing to timely file a petition in response to an OPAP notice regarding omitted items, if the provisional application is complete under 37 CFR 1.51(c), it will be held in the Office’s Image File Wrapper (IFW) system and automatically abandoned at the end of its pendency period.

This means:

  • The provisional application remains on file for its 12-month pendency period
  • It can still serve as a priority document for a later-filed nonprovisional application
  • However, the missing drawings will not be part of the application’s disclosure

It’s crucial for applicants to carefully review and respond to any OPAP notices to avoid potential loss of rights or limited disclosure in their patent applications.

To learn more:

The consequences of failing to respond to a 37 CFR 1.251 notice differ for pending applications and granted patents:

  • For pending applications: Failure to reply within the set time period will result in abandonment of the application. MPEP 508.04 cites 37 CFR 1.251(b): “With regard to a pending application, failure to comply with one of paragraphs (a)(1), (a)(2), or (a)(3) of this section within the time period set in the notice will result in abandonment of the application.”
  • For granted patents: While the patent won’t expire, there may be limitations on the certified copy of the patent file that the Office can produce. MPEP 508.04 states: “While abandonment (or expiration) of a patent is not an issue if a patentee fails to timely comply with a notice under 37 CFR 1.251, in such a situation the only certified copy of the patent file that the Office will be able to produce will be a copy of the patent and a copy of the application-as-filed (which may have an adverse impact during attempts to enforce the patent).”

Additionally, for patents involved in proceedings before the Office, action may be taken under 37 CFR 41.128 or 37 CFR 11.18.

What are the consequences of failing to record a patent assignment with the USPTO?

Failing to record a patent assignment with the USPTO can have several important consequences:

  • Lack of legal notice: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as notice to the world of the ownership of the patent.’ Without recording, third parties may not have legal notice of the assignment.
  • Potential validity issues: In some cases, failure to record an assignment could affect the validity of subsequent actions taken by the assignee.
  • Difficulties in enforcement: Unrecorded assignments may complicate patent enforcement efforts, as the assignee’s standing to sue could be challenged.
  • Problems in future transactions: Lack of a clear chain of title can cause issues in future sales, licenses, or other transactions involving the patent.

While recording is not mandatory, it is highly recommended to protect the assignee’s rights and ensure a clear chain of title for the patent.

For more information on legal notice, visit: legal notice.

For more information on patent assignment, visit: patent assignment.

Failing to meet the disclosure requirements when claiming benefit of an earlier application can have several consequences:

  • Loss of earlier filing date for affected claims
  • Potential invalidity of the patent if issued
  • Exposure to prior art that would have been otherwise excluded
  • Possible rejection under 35 U.S.C. 102 or 103

The MPEP 211.05 provides an example of such consequences:

“In New Railhead, the patented drill bit was the subject of a commercial offer for sale. A provisional application was filed after the sale offer, but well within the one year grace period of 35 U.S.C. 102(b). A nonprovisional application, which issued as Patent No. 5,899,283, was filed within one year of the filing of the provisional application but more than one year after the sale offer. If the ‘283 patent was not afforded the benefit date of the provisional application, the patent would be invalid under 35 U.S.C. 102(b) since it was filed more than one year after the commercial offer for sale.”

This example illustrates how failing to meet disclosure requirements can lead to patent invalidity due to intervening prior art. It’s crucial for applicants to ensure that earlier-filed applications provide adequate support for later-claimed inventions to maintain the desired priority date and avoid potential rejections or invalidations.

To learn more:

Failing to comply with the inventor’s oath or declaration requirements can have serious consequences for a patent application or an issued patent. However, the America Invents Act (AIA) introduced some provisions to mitigate these consequences. According to 35 U.S.C. 115(h)(3):

A patent shall not be invalid or unenforceable based upon the failure to comply with a requirement under this section if the failure is remedied as provided under paragraph (1).

This means that:

  • A patent will not be automatically invalidated or rendered unenforceable due to defects in the oath or declaration
  • The applicant or patentee has the opportunity to remedy any deficiencies in the oath or declaration

However, it’s important to note that while this provision provides some protection, it’s still crucial to comply with the oath or declaration requirements to avoid potential issues or delays in the patent prosecution process. Failure to provide a proper oath or declaration can result in:

  • Delays in the examination process
  • Increased costs due to the need for corrections or additional filings
  • Potential challenges to the validity of the patent in litigation

Therefore, applicants should make every effort to ensure that the inventor’s oath or declaration is properly executed and contains all required information and statements as specified in 37 CFR 1.63 and 35 U.S.C. 115.

To learn more:

What are the consequences of bounced checks or insufficient funds for USPTO fee payments?

Submitting a check that bounces or having insufficient funds for USPTO fee payments can have serious consequences. The MPEP 509 states: ‘If any fee is paid by a check which is uncollectible or is returned unpaid, or if any payment is made in an amount less than the required amount, the fee payment shall be regarded as incomplete and the processing of the application or other filing shall be held in abeyance until the full fee payment is made.’

Consequences may include:

  • Suspension of application processing
  • Potential loss of filing date
  • Additional fees or penalties
  • Possible disciplinary action for repeated occurrences

To avoid these issues, ensure sufficient funds are available and consider using more reliable payment methods like electronic funds transfer or credit cards.

To learn more:

Tags: USPTO fees

An ineffective incorporation by reference in a patent application can have several consequences:

  1. The incorporated material may not be considered part of the application disclosure.
  2. This could result in rejections under 35 U.S.C. 112 for lack of written description or enablement.
  3. The application may lose the benefit of an earlier filing date if the incorporation was meant to provide essential subject matter.
  4. Corrections may be required, which could delay prosecution.

According to 37 CFR 1.57(h): ‘An incorporation of material by reference that does not comply with paragraphs (c), (d), or (e) of this section is not effective to incorporate such material unless corrected within any time period set by the Office, but in no case later than the close of prosecution as defined by § 1.114(b), or abandonment of the application, whichever occurs earlier.’

It’s crucial to ensure that all incorporations by reference are properly executed to avoid these potential issues.

To learn more:

To learn more:

What are the consequences of an improper title in a patent application?

An improper title in a patent application can lead to several consequences:

  • Rejection or objection: The USPTO may reject or object to the application if the title doesn’t meet the requirements outlined in MPEP 606.
  • Delayed processing: An improper title may cause delays in processing the application as it may need to be corrected.
  • Misclassification: An inaccurate or vague title might result in the application being misclassified, potentially affecting the examination process.
  • Difficulty in prior art searches: A poor title can make it harder for examiners to conduct effective prior art searches, potentially impacting the examination quality.

As stated in MPEP 606, The title of the invention should be placed at the top of the first page of the specification unless it is provided in an application data sheet. The title should be brief but technically accurate and descriptive and should contain fewer than 500 characters. Adhering to these guidelines helps avoid potential issues and ensures smooth processing of the application.

To learn more:

Improper signatures on patent correspondence can have serious consequences. While the MPEP 502.02 doesn’t explicitly list all consequences, it emphasizes the importance of proper signatures:

Correspondence filed in the Office by applicants and other parties must be signed by the applicants or other party, or by a registered patent attorney or agent of record in the patent application or patent.

The potential consequences of an improper signature include:

  • Rejection or return of the correspondence
  • Delays in processing the application or request
  • Potential loss of rights or missed deadlines
  • Requirement for ratification or confirmation of the signature
  • In severe cases, charges of fraud or inequitable conduct

To avoid these issues, it’s crucial to ensure all signatures comply with USPTO requirements as outlined in 37 CFR 1.4 and MPEP 502.02. When in doubt, consult with a registered patent attorney or agent to verify proper signature practices.

To learn more:

What are the consequences of adding new matter to a patent application?

Adding new matter to a patent application can have serious consequences:

  • Rejection or objection: The USPTO will issue a rejection or objection to the new matter. As stated in MPEP 608.04, ‘If new matter is added to the claims, the examiner should reject the claims under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph – written description requirement.’
  • Loss of priority date: New matter may result in a later effective filing date for the affected claims.
  • Inability to claim benefit: As per the MPEP, ‘New matter includes not only the addition of wholly unsupported subject matter, but may also include adding specific percentages or compounds after a broader original disclosure, or even the omission of a step from a method.’
  • Need for continuation-in-part: To properly include the new matter, a continuation-in-part application may be necessary.

It’s crucial to ensure all subject matter is fully supported by the original disclosure to avoid these issues.

To learn more:

To learn more:

Tags: new matter

When a typographical error on the original cover sheet affects the title to the application or patent against which the assignment or name change is recorded, the consequences are more significant:

  • The recording party will not be entitled to keep the original date of recordation
  • The Assignment Services Division will correct its automated records
  • The date of recordation will be changed to the date the corrected cover sheet was received in the Office

As stated in MPEP 323.01(a): “If the original cover sheet contains a typographical error that affects title to the application or patent against which the assignment or name change is recorded, the recording party will not be entitled to keep the original date of recordation. Rather, the Assignment Services Division will correct its automated records and change the date of recordation to the date the corrected cover sheet was received in the Office.”

This approach ensures that errors affecting the substance of the assignment or title are properly addressed, even if it means adjusting the recordation date. It’s crucial for patent owners and assignees to be aware of this policy to avoid potential issues with priority dates or legal standing.

To learn more:

For unpublished patent applications, confidentiality is a critical concern. The MPEP states:

An interview concerning an application that has not been published under 35 U.S.C. 122(b) with an attorney or agent not of record who obtains authorization through use of the interview request form will be conducted based on the information and files supplied by the attorney or agent in view of the confidentiality requirements of 35 U.S.C. 122(a).

This means that for unpublished applications, the USPTO will only discuss information provided by the attorney or agent to maintain confidentiality. The examiner cannot disclose any information from the application file that hasn’t been supplied by the practitioner.

For more information on unpublished applications, visit: unpublished applications.

There are several key conditions that must be met to use incorporation by reference under 37 CFR 1.57(b):

  1. The application must have been filed on or after September 21, 2004
  2. Material must have been inadvertently omitted from the application
  3. A priority or benefit claim to a prior-filed application must have been present on the filing date
  4. The omitted material must be completely contained in the prior-filed application
  5. An amendment to add the omitted material must be filed within the time period set by the USPTO
  6. Other requirements like supplying copies of prior applications may apply

As stated in the MPEP: “The following conditions and requirements need to be met for an applicant to add omitted material to an application pursuant to 37 CFR 1.57(b):” followed by a list of specific conditions labeled (A) through (I).

The right of priority under 35 U.S.C. 386(a) or (b) for international design applications is subject to specific conditions:

  • It applies only to nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing from them.
  • For nonprovisional applications, priority can be claimed with respect to a prior international design application that designates at least one country other than the United States.
  • For international design applications designating the United States, priority can be claimed with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: The right of priority under 35 U.S.C. 386(a) or (b) with respect to an international design application is applicable only to nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

To learn more:

To learn more:

A later-filed application for patent in the United States may claim the benefit of, or priority to, a prior application under certain conditions. These conditions are outlined in various U.S. statutes and regulations:

The specific requirements and time frames may vary based on the filing date of the later-filed nonprovisional application and the type of priority or benefit claim being made.

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

For more information on prior-filed application, visit: prior-filed application.

When filing a Continued Prosecution Application (CPA), there are specific conditions under which the prior application may be automatically abandoned. According to MPEP 201.06(d):

A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA. See 37 CFR 1.53(d)(2)(v).

However, it’s important to note that:

  • The prior application is only expressly abandoned if the CPA is properly filed.
  • If the CPA is improper (e.g., filed in a utility application), the express abandonment of the prior application will not be effective.
  • The abandonment of the prior application is automatic upon the filing date of the properly filed CPA.

This automatic abandonment provision ensures a clear transition from the prior application to the CPA, which is particularly relevant for design applications where CPAs are permitted.

For more information on CPA, visit: CPA.

Tags: CPA

The abandonment of an international application in the United States is governed by specific legal provisions. According to MPEP 211.01(c), which cites 35 U.S.C. 371(d):

35 U.S.C. 371(d) indicates that failure to timely comply with the requirements of 35 U.S.C. 371(c) ‘shall be regarded as abandonment of the application by the parties thereof.’

This means that an international application designating the United States will be considered abandoned if the applicant fails to meet the requirements for entering the national stage under 35 U.S.C. 371(c) within the specified time limits. These requirements typically include submitting necessary documents, paying required fees, and providing an English translation of the application if it was not originally filed in English.

For more information on national stage entry, visit: national stage entry.

For a national application to claim the benefit of a prior international application designating the United States, certain conditions must be met. MPEP 211.01(c) outlines these conditions, referencing 35 U.S.C. 365(c) and 35 U.S.C. 120:

The first sentence of 35 U.S.C. 365(c) specifically provides that ‘[i]n accordance with the conditions and requirements of section 120,… a national application shall be entitled to the benefit of the filing date of a prior international application designating the United States.’

The key conditions include:

  • The international application must designate the United States
  • The national application must be filed before the patenting, abandonment, or termination of proceedings on the international application
  • The national application must contain a specific reference to the international application
  • The international application must comply with the requirements of 35 U.S.C. 371(c)

Additionally, the MPEP states:

The condition of 35 U.S.C. 120 relating to the time of filing requires the later application to be ‘filed before the patenting or abandonment of or termination of proceedings on the first application….’

Meeting these conditions allows applicants to claim the earlier filing date of the international application, which can be crucial for establishing priority and overcoming prior art references.

To learn more:

To learn more:

OPAP may object to patent drawings for several reasons, including:

  1. Line quality issues
  2. Missing lead lines
  3. Excessive or non-English text
  4. Incorrect margins or paper size
  5. Improper figure labeling
  6. Illegible photographs
  7. Unauthorized color drawings or photographs

For example, regarding line quality, MPEP 507 states:

OPAP may object to and require corrected drawings within a set time period, if the drawings: (A) have a line quality that is too light to be reproduced (weight of all lines and letters must be heavy enough to permit adequate reproduction) or text that is illegible (reference characters, sheet numbers, and view numbers must be plain and legible). See 37 CFR 1.84(l) and (p)(1);

The MPEP outlines several reasons why an amendment might not comply with 37 CFR 1.57(b). These include:

  • The application was filed before September 21, 2004 (the effective date of the provisions)
  • The claim for priority/benefit of the prior-filed application was not present on the filing date
  • The omitted portion is not completely contained in the prior-filed application
  • A copy of the prior-filed application was not submitted (except for applications filed under 35 U.S.C. 111)
  • An English language translation of a non-English prior-filed application was not submitted
  • The applicant did not identify where the omitted portion can be found in the prior-filed application

If any of these conditions are not met, the examiner will state that the amendment to add inadvertently omitted material pursuant to 37 CFR 1.57(b) filed [date] is not in compliance with 37 CFR 1.57(b) because [specific reason].

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

MPEP 203.05 outlines several circumstances under which a patent application can become abandoned:

  1. Through formal abandonment by the applicant or by the attorney or agent of record;
  2. Through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application;
  3. For failure to pay the issue fee (see MPEP § 711 to § 711.05); or
  4. In the case of a provisional application, no later than 12 months after the filing date of the provisional application (see MPEP § 711.03(c) and 35 U.S.C. 111(b)(5)).

An abandoned application is removed from the Office docket of pending applications. It’s important to note that abandonment can occur unintentionally, such as missing a deadline, or intentionally, such as when an applicant decides not to pursue the application further.

The Patent Law Treaties Implementation Act (PLTIA) made several changes to priority and benefit claims, including:

  • Restoration of the right of priority to a foreign application or benefit of a provisional application within two months of the deadline
  • Ability to file international design applications
  • Claiming priority to and benefit of international design applications

The MPEP notes: “Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application.” (MPEP 210)

The USPTO has specific certification requirements for signatures in correspondence. According to MPEP 501, which cites 37 CFR 1.4(d)(4):

The person inserting a signature under paragraph (d)(2) or (d)(3) of this section in a document submitted to the Office certifies that the inserted signature appearing in the document is his or her own signature. A person submitting a document signed by another under paragraph (d)(2) or (d)(3) of this section is obligated to have a reasonable basis to believe that the person whose signature is present on the document was actually inserted by that person, and should retain evidence of authenticity of the signature.

Key points about signature certifications:

  • The person inserting an S-signature certifies it as their own.
  • When submitting a document signed by another, you must have a reasonable belief that the signature is authentic.
  • Evidence of signature authenticity should be retained.
  • Violations of certification rules may result in sanctions.

These requirements apply to both handwritten and S-signatures. They ensure the integrity and authenticity of documents submitted to the USPTO.

For more information on USPTO correspondence, visit: USPTO correspondence.

The Electronic Patent Assignment System (EPAS) offers several benefits for submitting assignment documents to the USPTO. While not explicitly stated in MPEP 302.10, the following advantages can be inferred:

  • Convenience: Users can submit documents directly from their computer, eliminating the need for physical mailing.
  • Efficiency: Electronic submission can be faster than traditional paper-based methods.
  • Direct Integration: As stated in the MPEP, EPAS allows submission “directly into the automated Patent and Trademark Assignment System,” potentially reducing processing times.
  • Flexibility: Various types of documents related to title can be submitted through the system.
  • Multiple Payment Options: Users can pay fees using credit card, electronic fund transfer, or deposit account.

These benefits make EPAS an attractive option for those needing to submit assignment documents to the USPTO.

To learn more:

What are the benefits of using EPAS for assignment submissions?

The Electronic Patent Assignment System (EPAS) offers several advantages for submitting assignment documents:

  • 24/7 availability for submissions
  • Immediate confirmation of receipt
  • Faster processing times compared to paper submissions
  • Reduced risk of errors through guided data entry
  • Ability to save and resume incomplete submissions

The MPEP 302.10 states, ‘Assignment documents can be electronically submitted via the Electronic Patent Assignment System (EPAS) by registered ePAS users.’ This system streamlines the assignment process and improves efficiency for both applicants and the USPTO.

To learn more:

Filing a CPA for a design patent application offers several benefits:

  • Minimal filing requirements compared to a regular continuation application
  • No new filing receipt is normally issued
  • Faster processing time, as it uses the same application number and file wrapper
  • For examination priority, CPAs are treated as “amended” applications rather than “new” applications, potentially resulting in faster examination
  • The prior application is automatically abandoned, simplifying the process

As stated in the MPEP: “A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).”

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

Filing a continuation application offers several benefits to patent applicants:

  1. Pursuing additional claims: As stated in MPEP 201.07, “The disclosure presented in the continuation must be the same as that of the original application; i.e., the continuation should not include anything which would constitute new matter if inserted in the original application.” This allows applicants to pursue different or broader claims based on the same disclosure.
  2. Extending prosecution: A continuation application provides more time to negotiate with the USPTO, potentially leading to stronger patent protection.
  3. Maintaining pendency: It keeps the application pending, which can be strategically important in fast-evolving technologies or competitive markets.
  4. Addressing new prior art: If new prior art emerges during the prosecution of the parent application, a continuation allows for claim adjustments to overcome this art.
  5. Commercial considerations: As products evolve or market conditions change, continuation applications allow for tailoring claims to cover new aspects of the invention or competitor products.

By utilizing continuation applications strategically, inventors and businesses can build a stronger patent portfolio and maintain flexibility in their intellectual property protection strategy.

For more information on patent strategy, visit: patent strategy.

Electronically submitting assignment documents to the USPTO offers several benefits:

  • Faster Processing: Electronic submissions are typically processed more quickly than paper submissions.
  • Immediate Confirmation: You receive immediate confirmation of your submission.
  • Cost-Effective: No mailing costs or delays associated with physical delivery.
  • 24/7 Availability: You can submit documents at any time, not limited to office hours.
  • Reduced Risk of Loss: Electronic submissions minimize the risk of documents being lost in transit.
  • Environmentally Friendly: Reduces paper usage and associated environmental impacts.

The MPEP 302.10 states: “Assignment documents can be submitted to the Office electronically via the Office’s Electronic Patent Assignment System (EPAS).” This system is designed to streamline the submission process and provide these benefits to patent applicants and owners.

To learn more:

Filing a provisional patent application offers several benefits but also has limitations:

Benefits:

  • Establishes an early filing date quickly and inexpensively
  • Allows use of ‘Patent Pending’ for up to 12 months
  • Provides time to assess commercial potential before filing a nonprovisional application
  • Does not require claims or an oath/declaration

Limitations:

  • Limited 12-month pendency
  • Cannot directly mature into a patent
  • Not examined for patentability
  • Cannot claim priority to any earlier applications

The MPEP notes: A provisional application is not entitled to the right of priority of any other application under 35 U.S.C. 119 or 365(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121 or 365(c) or § 1.78 of any other application.

Additionally, No claim for priority under 35 U.S.C. 119(e) or § 1.78(a)(4) may be made in a design application based on a provisional application. This limits the use of provisional applications in certain contexts.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

Filing a continuation-in-part (CIP) application has several benefits and potential drawbacks:

Benefits:

  • Allows addition of new subject matter to an existing invention
  • Maintains the priority date of the original application for common subject matter
  • Provides an opportunity to strengthen the patent application with new data or improvements
  • Allows for changes in inventorship to reflect new contributions

Drawbacks:

  • New subject matter only gets the filing date of the CIP, potentially exposing it to more prior art
  • Can complicate the patent term calculation
  • May result in multiple patents with overlapping subject matter, requiring terminal disclaimers
  • Increases overall costs due to additional filing and prosecution fees

The MPEP notes: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

Inventors and patent attorneys should carefully consider these factors when deciding whether to file a CIP or a new application.

For more information on new subject matter, visit: new subject matter.

For more information on patent strategy, visit: patent strategy.

To obtain a filing date for a nonprovisional utility patent application filed on or after 12/18/2013, the application must include:

  • A specification with or without claims (35 U.S.C. 111(a)(2)(A))
  • Drawings, if necessary for an understanding of the invention (35 U.S.C. 111(a)(2)(B)), but see 37 CFR 1.81(a) for applications filed before 12/18/2013 requiring drawings where they are necessary for the understanding of the invention
  • The inventor’s oath or declaration, which may be filed later if an application data sheet (ADS) is submitted identifying the inventor(s) (35 U.S.C. 111(a)(2)(C) and 115)
  • The applicable filing fees (basic filing fee, search fee, examination fee, any required excess claims fees) (35 U.S.C. 41 and 37 CFR 1.16)

An application missing any of the above items will be treated as incomplete and no filing date will be granted until the missing item(s) are submitted.

What are the basic requirements for entering the national stage in the US?

To enter the national stage in the United States, applicants must fulfill several basic requirements. According to the MPEP:

  • File a copy of the international application (unless previously communicated by the International Bureau or waived)
  • Submit an English language translation of the international application (if not in English)
  • Pay the basic national fee
  • Submit an oath or declaration of the inventor(s)

The MPEP states: For national stage applications having an international filing date on or after September 16, 2012, the requirement for the inventor’s oath or declaration or substitute statement has been eliminated as a requirement for completing national stage entry. The inventor’s oath or declaration is not required until the application is otherwise in condition for allowance.

It’s important to note that while the inventor’s oath or declaration is not required for initial national stage entry, it must be submitted before the application can be allowed.

To learn more:

The basic filing requirements for a nonprovisional patent application under 35 U.S.C. 111(a) are:

  • A specification (with or without claims)
  • Any required drawings
  • The appropriate filing fee, search fee, and examination fee
  • An oath or declaration

The MPEP states: The procedure for filing a nonprovisional application under 35 U.S.C. 111(a) is set forth in 37 CFR 1.53(b) and 37 CFR 1.53(d). For applications filed on or after December 18, 2013, the filing date is generally the date when the specification is received by the USPTO, with or without claims.

To learn more:

To learn more:

According to MPEP 301, patents have the attributes of personal property. The MPEP states:

’35 U.S.C. 261 Ownership; assignment. Subject to the provisions of this title, patents shall have the attributes of personal property.’

This means that patents can be bought, sold, licensed, or transferred like other forms of property. However, it’s important to note that owning a patent doesn’t necessarily grant the right to practice the invention, as other legal considerations may apply.

For more information on patent rights, visit: patent rights.

For more information on personal property, visit: personal property.

The assignment rules for substitute and continuation-in-part applications differ from those for division and continuation applications. As per the MPEP, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This means that for substitute or continuation-in-part applications, a new assignment must be recorded if they are to be issued to an assignee. However, there’s an exception: unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

For more detailed information, refer to MPEP § 307 and MPEP § 308.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on patent assignment, visit: patent assignment.

For more information on substitute application, visit: substitute application.

The USPTO provides several methods for checking application status:

  • Patent Application Information Retrieval (PAIR) system: This is the primary method for checking application status online.
  • Automated voice response system: Available at 703-308-4357 for limited status information.
  • USPTO Contact Center: Available for general information at 800-786-9199.

As stated in MPEP 203.08: “Inquiries as to the status of applications, by persons entitled to the information, should be answered promptly. It is forbidden, however, to give information concerning the date of filing applications, the names of the inventors, or the prosecution of the application to persons not entitled to receive information.”

To learn more:

Tags: USPTO

After a patent is granted, the applicant has specific responsibilities regarding models, exhibits, or specimens:

  • The applicant is responsible for retaining the actual model, exhibit, or specimen for the enforceable life of the patent.
  • This responsibility does not apply if:
    • The model or exhibit substantially conforms to the requirements of 37 CFR 1.52 or 1.84.
    • The model or exhibit has been described by photographs that substantially conform to 37 CFR 1.84.
    • The model, exhibit, or specimen is perishable.

As stated in 37 CFR 1.94(b), Applicant is responsible for retaining the actual model, exhibit, or specimen for the enforceable life of any patent resulting from the application. This ensures that the item is available if needed for future reference or legal proceedings.

To learn more:

Tags: patent grant

Filing a provisional patent application offers several advantages, as outlined in the MPEP:

  1. Establishing Priority: It allows applicants to quickly and inexpensively file provisional applications and establish a priority date for their invention.
  2. Paris Convention Priority: It starts the Paris Convention priority year, allowing foreign filings within 12 months while maintaining the U.S. filing date.
  3. Simplified Filing: As stated in the MPEP, No claim is required in a provisional application and No oath or declaration is required in a provisional application.
  4. Patent Term: The MPEP notes, The domestic priority period will not count in the measurement of the 20-year patent term. This puts domestic applicants… on equal footing with foreign applicants with respect to the patent term.
  5. Time for Development: It provides a 12-month period to further develop the invention before filing a nonprovisional application.

These advantages make provisional applications a useful tool for inventors to secure an early filing date while allowing time for further development and market assessment.

For more information on patent strategy, visit: patent strategy.

For more information on patent term, visit: patent term.

For more information on provisional application, visit: provisional application.

Filing a Continued Prosecution Application (CPA) for design patents has several advantages over filing a regular continuation application under 37 CFR 1.53(b):

  • Minimal filing requirements – only a request on a separate paper and the filing fee are needed
  • No new oath or declaration is required
  • Faster processing – the CPA uses the file and contents of the prior application
  • Potentially faster examination – CPAs are often treated as “amended” applications for examination priority
  • No need for a new specification or drawings

The MPEP notes: “A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).”

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

Electronically submitting assignment documents offers several advantages:

  • Faster recordation: Electronic submissions are processed more quickly than paper submissions.
  • Reduced risk of loss: Electronic documents are less likely to be misplaced or lost in transit.
  • Immediate confirmation: You receive instant confirmation of your submission.
  • 24/7 accessibility: You can submit documents at any time, not just during business hours.

The MPEP 302.10 states: “Assignment documents filed electronically are recorded faster and are less likely to become lost or misplaced.” This underscores the efficiency and reliability of electronic submissions.

To learn more:

The USPTO accepts two primary methods for submitting biological sequence listings in patent applications:

  1. USPTO patent electronic filing system: This is the preferred method for submitting sequence listings.
  2. Read-only optical disc: An alternative method if electronic filing is not possible.

These submission methods apply to both pre-July 1, 2022, and post-July 1, 2022 applications. As stated in MPEP 608.05(c): “[…] submission must be submitted via the USPTO patent electronic filing system or on read-only optical disc.”

It’s important to note that the file format requirements differ based on the application filing date, but the submission methods remain the same.

To learn more:

What are the accepted payment methods for patent fees?

The USPTO accepts various payment methods for patent fees:

  • Credit or debit card
  • Electronic funds transfer (EFT)
  • Deposit account
  • Check or money order

As stated in MPEP 509: ‘Fees may be paid by U.S. credit card, electronic funds transfer (EFT), deposit account, check or money order.’ Electronic payment methods are preferred for their efficiency and speed.

To learn more:

The USPTO accepts various methods of payment for patent and trademark process fees. According to MPEP 509, the primary methods include:

  • Credit cards (AMERICAN EXPRESS®, DISCOVER®, MASTER CARD®, and VISA®)
  • Deposit accounts
  • Electronic funds transfer (EFT)
  • Other forms of payment accepted by the Office

It’s important to note that credit card payments are subject to a transaction maximum. As stated in the MPEP: Effective June 1, 2015, the credit card transaction maximum is $24,999.99 as specified in section 7045 of the ‘Treasury Financial Manual.’ This limit does not apply to other payment methods.

To learn more:

Tags: USPTO fees

The USPTO accepts several methods for submitting documents for recordation. According to MPEP 302.06:

  • Electronic submission
  • Paper submission
  • Facsimile (fax) submission

The MPEP states: See MPEP §§ 302.08 – 302.10 for additional information regarding the acceptable ways to submit documents for recordation.

It’s important to note that the method of submission can affect the recording fee. Electronic submissions currently have a $0 fee, while paper and fax submissions may incur a fee as set forth in 37 CFR 1.21(h)(2).

To learn more:

What are the acceptable methods for filing papers with the USPTO?

The USPTO accepts several methods for filing papers:

  • Hand-delivery to the USPTO office in Alexandria, Virginia
  • First-class mail through the United States Postal Service (USPS)
  • Express Mail service of the USPS
  • Electronic filing through the USPTO’s Electronic Filing System (EFS-Web)

As stated in MPEP 501: ‘Papers may be filed using first class mail through the United States Postal Service.’ The MPEP also notes that ‘Correspondence may be hand-carried to the Office.’ For electronic filing, it’s important to note that ‘EFS-Web can be used to file new applications, enter the national stage under 35 U.S.C. 371, and submit most follow-on documents in patent applications.’

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on Express Mail, visit: Express Mail.

For more information on first-class mail, visit: first-class mail.

For more information on hand-delivery, visit: hand-delivery.

According to 37 CFR 1.84(a), there are two acceptable categories for presenting drawings in utility and design patent applications:

  1. Black ink drawings: Black and white drawings are normally required. India ink or its equivalent must be used to secure solid black lines.
  2. Color drawings/photographs: Color drawings are permitted in design applications without a petition. For utility applications, color drawings or photographs require a granted petition explaining why color is necessary.

Additionally, grayscale drawings and black and white photographs may be acceptable in certain circumstances, such as when they are the only practicable medium for illustrating the claimed invention.

To learn more:

Reissue applications are used to correct errors in already issued patents. According to MPEP 201:

‘An application for reissue is made by the patentee when the patent is, through error without any deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent.’

Key points about reissue applications:

  • They are filed under 35 U.S.C. 251.
  • They can be used to broaden or narrow the scope of patent claims.
  • There are time limitations for broadening reissues (within two years from the grant of the original patent).

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue application, visit: reissue application.

MPEP 201.01 briefly mentions reissue applications as one of the types of national applications. Specifically, it states:

‘National applications include original applications and reissue applications (filed under 35 U.S.C. 251).’

Reissue applications are a specialized type of patent application used to correct errors in an already issued patent. They are governed by 35 U.S.C. 251, which allows a patentee to apply for a reissue of their patent if it is deemed to be wholly or partly inoperative or invalid due to certain types of errors.

For more detailed information on reissue applications, refer to MPEP 1400 – Correction of Patents.

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue applications, visit: reissue applications.

Provisional applications are a type of patent application that allows inventors to establish an early filing date without the formal requirements of a non-provisional application. According to MPEP 201:

‘A provisional application is a U.S. national application for patent filed in the USPTO under 35 U.S.C. 111(b).’

Key differences between provisional and non-provisional applications:

  • Provisional applications have a simplified filing process and lower fees.
  • They do not require formal patent claims or an oath or declaration.
  • Provisional applications are not examined and automatically expire after 12 months.
  • To obtain patent protection, a non-provisional application claiming benefit of the provisional must be filed within 12 months.

Non-provisional applications, on the other hand, are formal patent applications that are examined by the USPTO and can result in an issued patent if approved.

For more information on Non-provisional application, visit: Non-provisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

March-in rights are a provision of the Bayh-Dole Act that allow the government to intervene in certain circumstances:

  • The government can require the contractor or exclusive licensee to grant a license to a responsible applicant.
  • If the contractor or licensee refuses, the government can grant the license itself.
  • These rights are exercised only in specific situations, such as when the contractor is not taking effective steps to achieve practical application of the invention.

The MPEP explains: ‘March-in rights allow the government to grant licenses to other parties… where the contractor has failed to take effective steps to achieve practical application of the invention.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

For more information on patent licensing, visit: patent licensing.

International applications under the Patent Cooperation Treaty (PCT) are a type of patent application that provides a unified procedure for filing patent applications in its contracting states. According to MPEP 201:

‘An international application is a national application for patent which is filed under the Patent Cooperation Treaty (PCT).’

Key aspects of PCT applications:

  • Allow seeking patent protection in multiple countries simultaneously
  • Provide a streamlined filing process for international patent protection
  • Include an international search and optional international preliminary examination
  • Must enter the national phase in desired countries within specified timeframes
  • Do not result in an ‘international patent’ but facilitate national/regional patent grants

PCT applications are particularly useful for inventors seeking broad international patent protection.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

Excess claims fees are additional fees charged for patent applications that contain more than a certain number of claims. According to the MPEP:

  • 37 CFR 1.16(h) sets the fee for each independent claim in excess of three.
  • 37 CFR 1.16(i) sets the fee for each claim (independent or dependent) in excess of twenty.

The MPEP states: The excess claims fees specified in 37 CFR 1.16(h) and (i) apply to any excess claims fee paid, regardless of the filing date of the application and regardless of the date on which the claim necessitating the excess claims fee payment was added to the application.

These fees also apply to reissue applications, but the claims in the original patent are not counted when determining excess claims fees for a reissue application. For applications filed without claims, excess claims fees are due when the excess claims are presented in the application.

To learn more:

According to MPEP 608.01(r), derogatory remarks in a patent specification are:

“statements disparaging the products or processes of any particular person other than the applicant, or statements as to the merits or validity of applications or patents of another person.”

This means you should avoid criticizing specific inventions, products, or patents of others in your patent application. Instead, focus on describing your invention’s advancements without disparaging existing technologies.

To learn more:

Tags: prior art

MPEP 303 mentions conflicting claims as a situation where assignment information becomes crucial:

“When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims…” (MPEP 303)

Conflicting claims occur when two or more patent applications claim the same or overlapping subject matter. This is significant because:

  • It may indicate potential ownership disputes
  • It can affect the novelty or non-obviousness of the claimed inventions
  • It might require the USPTO to initiate an interference or derivation proceeding

In such cases, examiners need to verify assignment information to determine the proper course of action.

While the MPEP 608.02(x) doesn’t provide an exhaustive list, it does mention several common reasons why drawing corrections might be rejected:

  • Erroneous corrections: The submitted changes contain errors or inaccuracies.
  • New matter: The corrections introduce new subject matter not supported by the original disclosure.
  • Incomplete corrections: The submission doesn’t include all necessary corrections identified by the examiner.

The MPEP states:

“Where the corrected or changed drawing is not accepted, for example, because the submitted corrections or changes are erroneous, or involve new matter or do not include all necessary corrections, the applicant will be notified and informed of any required corrective action in the next Office action.”

Applicants should carefully review their drawing corrections to ensure they address all issues raised by the examiner and don’t introduce new problems.

To learn more:

To learn more:

Common objections to patent drawings, as outlined in MPEP 608.02(e), include:

  • Failure to show essential structural details (Form Paragraph 6.22.01)
  • Different reference numbers referring to the same part (Form Paragraph 6.22.02)
  • The same reference number used for different parts (Form Paragraph 6.22.03)
  • Reference signs mentioned in the description but not in the drawings (Form Paragraph 6.22.06)
  • Reference characters in the drawings not mentioned in the description (Form Paragraph 6.22.07)

These objections are based on non-compliance with various sections of 37 CFR 1.84, which governs standards for drawings in patent applications.

To learn more:

Annotated sheets in patent drawings are marked-up copies of drawings that show proposed changes to the original drawings. According to MPEP 608.02(v), “When changes are to be made in the drawing itself, other than mere changes in reference characters, designations of figures, or inking over lines pale and rough, a marked-up copy of the drawing should be filed with a replacement drawing.” These annotated sheets are used to clearly indicate the modifications being made to the original drawings.

To learn more:

What are ‘march-in rights’ in government-funded inventions?

‘March-in rights’ are a significant aspect of government rights in federally funded inventions. As described in MPEP 310, these rights allow the government to require the contractor, assignee, or exclusive licensee of a subject invention to grant a license to a responsible applicant under certain circumstances. The MPEP states:

‘March-in rights permit the Government, in specified circumstances, to require the contractor or successors in title to the patent to grant a nonexclusive, partially exclusive, or exclusive license to a responsible applicant or applicants.’

These circumstances include:

  • Failure to take effective steps to achieve practical application of the invention
  • Health and safety needs not being reasonably satisfied
  • Public use requirements specified by Federal regulations not being met

March-in rights serve as a safeguard to ensure that federally funded inventions benefit the public.

For more information on patent licensing, visit: patent licensing.

In cases where an inventor does not execute the oath or declaration, such as when a substitute statement is filed, the USPTO requires specific address information. According to MPEP 602.08(a):

“In situations where an inventor does not execute the oath or declaration and the inventor is not deceased or legally incapacitated, such as in an application filed on or after September 16, 2012 in which a substitute statement under 37 CFR 1.64 is filed, the inventor’s most recent home address must be given to enable the Office to communicate directly with the inventor as necessary.”

This requirement ensures that the USPTO can maintain direct communication with the inventor if needed, even when they are not directly involved in executing the application documents.

To learn more:

For delayed priority claims filed more than two years after the due date, additional explanation is required. The MPEP states:

“A person filing a petition to accept a delayed priority claim more than two years after the date the foreign priority claim was due is required to provide additional explanation of the circumstances surrounding the delay that establishes that the entire delay was unintentional. This requirement is in addition to the requirement to provide a statement that the entire delay was unintentional in 37 CFR 1.55(e).”

This additional explanation helps the USPTO determine if the delay was truly unintentional, as required for acceptance of the delayed claim. Applicants should be prepared to provide a detailed account of the circumstances leading to the delay.

To learn more:

When correcting inventorship after an Office action on the merits has been given or mailed in the application, there are additional requirements:

  • Pay the fee set forth in 37 CFR 1.17(d) in addition to the processing fee
  • This additional fee is not required if inventors are being deleted due to claim cancellation

The MPEP states: 37 CFR 1.48(c) provides that the fee set forth in 37 CFR 1.17(d) (in addition to the processing fee) is required when requests under 37 CFR 1.48 are filed after the Office action on the merits has been given or mailed in the application. However, the fee will not be required when inventors are deleted if the request to correct or change inventorship is accompanied by a statement that the request to correct or change the inventorship is due solely to the cancelation of claims in the application.

To learn more:

After receiving a MPEP ¶ 2.05 notification, an applicant should take the following actions:

  1. Review the notification carefully: Understand the examiner’s assessment that the application may constitute a continuation or division.
  2. Verify the information: Confirm that the prior application number and filing date mentioned in the notification are correct.
  3. Assess the application’s status: Determine if the application should indeed be treated as a continuation, division, or both.
  4. File appropriate documents: If the application is intended to be a continuation or division, ensure that all necessary documents, such as a reference to the prior application under 35 U.S.C. 120, 121, or 365(c), are properly filed.
  5. Respond to the examiner: Provide any necessary clarifications or corrections regarding the application’s status.

The MPEP ¶ 2.05 notification states: “Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.” (MPEP ¶ 2.05)

It’s crucial to follow these steps promptly to ensure proper processing of the application and to secure any potential benefits of the earlier filing date.

For more information on applicant actions, visit: applicant actions.

For more information on continuation application, visit: continuation application.

When a patent practitioner dies, the law firm should take the following actions:

  • Promptly notify the USPTO’s Office of Enrollment and Discipline (OED) of the practitioner’s death.
  • Inform clients with pending applications about the situation and the need to appoint a new representative.
  • Assist clients in filing new powers of attorney or authorizations of agent for pending applications.
  • Provide the USPTO with updated correspondence addresses for affected applications.

The MPEP 406 states: ‘When it is known that the attorney or agent of record in an application is deceased, the Office should be promptly notified.’ This notification helps ensure a smooth transition and continued proper handling of patent applications.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO notification, visit: USPTO notification.

According to 37 CFR 5.1(d), an applicant must take one of three actions to prevent abandonment of a national security classified patent application without a Secrecy Order. The MPEP states: Pursuant to 37 CFR 5.1(d), if no Secrecy Order has issued in a national security classified patent application, the Office will set a time period within which the applicant must take one of the following three actions in order to prevent abandonment of the application: (A) obtain a Secrecy Order; (B) declassify the application; or (C) submit evidence of a good faith effort to obtain a Secrecy Order pursuant to 37 CFR 5.2(a). These actions ensure proper handling of potentially sensitive information.

For more information on patent abandonment, visit: patent abandonment.

If an examiner comes across a patent application that contains national security markings but does not have a Secrecy Order imposed, MPEP 130 instructs that “the examiner should require the applicant to seek imposition of a Secrecy Order or authority to cancel the markings.” This should be done preferably with the first office action and before final disposition of the application.

37 CFR 5.1(d) states that if no Secrecy Order has issued, the USPTO will set a time period for the applicant to take one of three actions to prevent abandonment:

  1. Obtain a Secrecy Order
  2. Declassify the application
  3. Submit evidence of a good faith effort to obtain a Secrecy Order under 37 CFR 5.2(a)

Additionally, per 37 CFR 5.1(e), “a national security classified patent application will not be allowed until the application is declassified and any Secrecy Order pursuant to 37 CFR 5.2(a) has been rescinded.”

An assignee of a pre-AIA patent application (filed before September 16, 2012) can take various actions once they have established ownership. According to MPEP 324, these actions include:

  • Signing a reply to an Office action
  • Requesting a continued prosecution application (CPA)
  • Signing a terminal disclaimer
  • Submitting a Fee(s) Transmittal form
  • Requesting status of an application
  • Appointing a registered patent practitioner to prosecute the application
  • Granting power to inspect an application
  • Consenting to the filing of a reissue application
  • Consenting to the correction of inventorship

The MPEP states: The owner or assignee (other than a juristic entity) of a patent property based on an application filed before September 16, 2012, can take action in a patent application or patent proceeding in numerous instances. However, it’s important to note that as of September 16, 2012, juristic entities must be represented by a patent practitioner for most actions.

For more information on assignee rights, visit: assignee rights.

For more information on patent prosecution, visit: patent prosecution.

For more information on pre-AIA applications, visit: pre-AIA applications.

When a patent application is ‘rejected’, the applicant has several options:

  1. Respond to the examiner’s action within the allotted reply period
  2. Request an interview with the examiner to discuss the rejection
  3. File an amendment to address the examiner’s concerns
  4. Present arguments challenging the rejection
  5. Allow the application to become abandoned if they choose not to pursue it further

According to MPEP 203.02:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

The most crucial action is to respond within the specified timeframe to prevent the application from becoming abandoned.

To learn more:

According to MPEP 203.03, an applicant has several options when responding to an examiner’s action:

The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

These options can be broken down as follows:

  • Election: Choosing between different inventions or species identified by the examiner.
  • Traverse: Arguing against the examiner’s rejections or objections.
  • Amendment: Modifying the application to address the examiner’s concerns or to clarify the invention.

To learn more:

What actions can a suspended or excluded practitioner take during the 30-day limited recognition period?

During the 30-day limited recognition period, suspended or excluded practitioners are allowed to perform specific actions to protect their clients’ interests. According to MPEP 407:

“During the 30-day period of limited recognition, the suspended or excluded practitioner may conclude work on behalf of a client on any matters that were pending before the Office on the date of entry of the order of suspension or exclusion.”

Specifically, the practitioner may:

  • Receive and forward correspondence related to pending matters
  • Make appropriate filings to protect the client’s rights
  • Conclude or withdraw from representation in pending proceedings
  • Perform limited actions necessary to transfer the client’s case to another registered practitioner

It’s important to note that this limited recognition does not allow the practitioner to take on new clients or file new patent applications during this period.

What actions can a practitioner take to preserve an applicant’s rights without a power of attorney?

A practitioner can take certain actions to preserve an applicant’s rights without a formal power of attorney, but these are generally limited to urgent situations. The MPEP 402.04 provides some examples:

  • Filing a patent application to prevent statutory bar
  • Filing a response to an Office action with a nearing deadline
  • Filing a notice of appeal when the period for appeal is about to expire

The MPEP states: ‘Such actions, if taken by a registered patent practitioner, will be accepted by the Office if submitted in a timely manner.’ However, it’s important to note that these actions are typically allowed only in emergencies to prevent the loss of patent rights. The practitioner should follow up with proper documentation of authority as soon as possible after taking such actions.

To learn more:

According to MPEP 325, a patent owner or assignee who has become the applicant can take various actions in a patent application. These include:

  • Signing a reply to an Office action (37 CFR 1.33(b)(3))
  • Requesting a continued prosecution application (CPA) under 37 CFR 1.53(d)
  • Filing a disclaimer under 37 CFR 1.321
  • Submitting a Fee(s) Transmittal (PTOL-85B)
  • Requesting the status of an application
  • Filing an application under 37 CFR 1.46
  • Appointing a registered patent practitioner to prosecute the application
  • Granting a power to inspect the application
  • Consenting to the filing of a reissue application
  • Consenting to the correction of inventorship

The MPEP notes: “As the applicant, the owner or assignee that is not a juristic entity can sign a reply to an Office action (37 CFR 1.33(b)(3)), a request for a continued prosecution application under 37 CFR 1.53(d) (MPEP § 201.06(d)), a disclaimer under 37 CFR 1.321 (MPEP § 1490), Fee(s) Transmittal (PTOL-85B) (MPEP § 1306), or a request for status of an application (MPEP § 102).”

It’s important to note that for juristic entities (e.g., corporations), many actions must be signed by a patent practitioner after September 16, 2012.

For more information on continued prosecution application, visit: continued prosecution application.

If a benefit claim is improper due to lack of copendency, the MPEP ¶ 2.11 outlines the required action:

Applicant is required to delete the claim to the benefit of the prior-filed application, unless applicant can establish copendency between the applications.

This means the applicant has two options:

  1. Delete the benefit claim to the prior-filed application, or
  2. Provide evidence to establish that copendency actually exists between the applications.

If the applicant cannot prove copendency, they must remove the benefit claim to avoid potential issues with the application’s validity or examination process.

For more information on copendency, visit: copendency.

For more information on patent procedure, visit: patent procedure.

When the required documents for a non-English provisional application are missing, the USPTO takes specific actions to notify the applicant. According to MPEP ¶ 2.38:

“Use this form paragraph to notify applicant that an English translation of the non-English language provisional application and/or a statement that the translation is accurate is required.”

The USPTO will issue an Office action informing the applicant of the missing documents and setting a time period for their submission. The applicant must then provide the missing translation and/or accuracy statement in the provisional application and confirm their filing in the present application. Failure to do so within the specified time period may result in the abandonment of the present application.

For more information on missing documents, visit: missing documents.

For more information on patent procedure, visit: patent procedure.

A national security classified patent application cannot be allowed until specific conditions are met. The MPEP clearly states: Pursuant to 37 CFR 5.1(e), a national security classified patent application will not be allowed until the application is declassified and any Secrecy Order pursuant to 37 CFR 5.2(a) has been rescinded. This means that both declassification of the application and rescission of any Secrecy Order are necessary prerequisites for allowance.

For more information on declassification, visit: declassification.

When a patent is granted on an application filed by someone other than the inventor, it is issued to the real party in interest. This is stipulated in both 35 U.S.C. 118 and 37 CFR 1.46(e):

35 U.S.C. 118 states: If the Director grants a patent on an application filed under this section by a person other than the inventor, the patent shall be granted to the real party in interest and upon such notice to the inventor as the Director considers to be sufficient.

37 CFR 1.46(e) further clarifies: If a patent is granted on an application filed under this section by a person other than the inventor, the patent shall be granted to the real party in interest. Otherwise, the patent may be issued to the assignee or jointly to the inventor and the assignee as provided in § 3.81.

Patent attorneys and examiners generally do not need to be concerned about ‘[Reserved]’ sections like MPEP 212. These sections contain no substantive information and do not affect current patent examination procedures. However, it’s good practice to stay informed about MPEP updates in case reserved sections are filled with new content in the future.

While providing the last known address where the nonsigning inventor customarily receives mail is the primary requirement, the MPEP suggests that additional addresses may be beneficial:

‘Inasmuch as a nonsigning inventor is notified that an application pursuant to pre-AIA 37 CFR 1.47 has been filed on his or her behalf, other addresses at which the nonsigning inventor may be reached should also be given.’

This recommendation aims to increase the chances of successfully notifying the nonsigning inventor about the application. If you’re aware of multiple addresses where the inventor might be reached, it’s advisable to include them all.

To learn more:

To learn more:

While the abstract itself should not include drawings, it can refer to them. The MPEP 608.01(b) provides guidance on including references to drawings and chemical formulas:

Where applicable, the abstract should include the following: (1) if a machine or apparatus, its organization and operation; (2) if an article, its method of making; (3) if a chemical compound, its identity and use; (4) if a mixture, its ingredients; (5) if a process, the steps.

When referencing drawings:

  • Use reference characters (in parentheses) when referring to parts shown in the drawings
  • Do not include actual drawings in the abstract itself

For chemical formulas, you can include them if they best summarize the invention, but ensure they fit within the 150-word limit and single-paragraph format.

To learn more:

Tags: drawings

Yes, each separate oath or declaration by an inventor should be complete in itself. The MPEP clearly states: “Each separate oath or declaration by an inventor should be complete in itself.” This guideline ensures that each inventor’s oath or declaration can stand alone and provide all necessary information without relying on other documents. This is particularly important for applications filed on or after September 16, 2012, where joint inventors may execute separate oaths or declarations.

To learn more:

All relevant information from MPEP 609.04 – Content and Timing Requirements for an Information Disclosure Statement has been thoroughly covered in the previously generated FAQs. No additional meaningful questions can be formulated without significant repetition or overlap with existing content.

To learn more:

To learn more:

All relevant information from MPEP 323.01(b) – Typographical Errors in Recorded Assignment Document has been covered in previous FAQs. No additional meaningful questions can be generated without repetition.

To learn more:

To learn more:

All relevant information from MPEP 502.05 – Correspondence Transmitted by EFS-Web has been thoroughly covered in the previously generated FAQs. No additional meaningful questions can be created without substantial repetition of existing content.

To learn more:

To learn more:

All relevant information from MPEP ¶ 2.33 New Inventor Identified in CPA (for Design Applications) has been covered in the previous FAQs. No additional meaningful questions can be generated without redundancy.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

All relevant information from MPEP 323.01 – Correction of Error in Recorded Cover Sheet has been covered in previous FAQs. No further meaningful questions can be generated without redundancy.

To learn more:

To learn more:

To learn more:

No, there is currently no content in MPEP 212. The section is marked as ‘[Reserved]’, which means it is empty and being held for potential future use.

Yes, the USPTO provides an official form for requesting correction of inventorship or inventor name. The MPEP states:

The Office has a form PTO/AIA/40 to request correction in a patent application (other than a reissue application) relating to inventorship, an inventor name, or order of names.

This form, PTO/AIA/40, can be used for various corrections related to inventorship and inventor names. It’s available on the USPTO website at www.uspto.gov/PatentForms. Using this official form can help ensure that you provide all necessary information for your request and may streamline the process of correcting inventorship or inventor names in your patent application.

To learn more:

Tags: USPTO Forms

Yes, the United States Patent and Trademark Office (USPTO) provides an official form for requesting correction of inventorship in a patent application (other than a reissue application). The details are as follows:

  • Form number: PTO/AIA/40
  • Purpose: To request correction relating to inventorship, an inventor name, or order of names
  • Availability: The form can be found on the USPTO website at www.uspto.gov/PatentForms

The MPEP states: The Office has a form PTO/AIA/40 to request correction in a patent application (other than a reissue application) relating to inventorship, an inventor name, or order of names. The form is reproduced below and is also available on www.uspto.gov/PatentForms.

To learn more:

Yes, there is an exception for certain applications filed before November 25, 2005. According to the Examiner Note in MPEP ¶ 2.38:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This means that for non-provisional applications filed before November 25, 2005, it was acceptable to file the English translation and accuracy statement in the non-provisional application itself, rather than in the provisional application. For applications filed after this date, the current rules requiring filing in the provisional application apply.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

Yes, there is an additional fee for correcting inventorship after an Office action has been issued or mailed. According to 37 CFR 1.48(c):

Any request to correct or change the inventorship under paragraph (a) of this section filed after the Office action on the merits has been given or mailed in the application must also be accompanied by the fee set forth in § 1.17(d), unless the request is accompanied by a statement that the request to correct or change the inventorship is due solely to the cancelation of claims in the application.

This means that in addition to the processing fee required for all inventorship correction requests, an extra fee is required if the request is filed after an Office action, unless the change is due to claim cancellation.

To learn more:

Yes, there is a time limit for submitting priority documents in a U.S. patent application. The MPEP 215.02(a) states:

“[T]he time period set forth in 37 CFR 1.55(f) for filing a certified copy of the foreign application is satisfied if the USPTO retrieves a copy of the priority document within the pendency of the application and before the patent is granted.”

This means that the priority document must be available to the USPTO before the patent is granted. However, it’s important to note that the specific time limit can vary depending on the type of application and other factors outlined in 37 CFR 1.55(f).

To learn more:

Tags: time limit

Yes, there is a time limit for filing a petition to restore the benefit of a provisional application. According to MPEP 211:

“Applicant may wish to file a petition to restore the benefit of the provisional application under 37 CFR 1.78 in the subsequent nonprovisional application or international application designating the United States if the subsequent application was filed within two months from the expiration of the twelve-month period and the delay was unintentional.”

This means you have a two-month grace period after the expiration of the initial 12-month period to file the petition. It’s crucial to act quickly if you miss the original deadline and wish to restore the benefit of your provisional application.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

Yes, there is a deadline for filing the English translation and accuracy statement for a non-English provisional application. While MPEP ¶ 2.38 doesn’t specify an exact timeframe, it indicates that the USPTO will set a time period in an Office action:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This means that when the USPTO notices that the required documents are missing, they will issue an Office action with a specific deadline. It’s crucial to comply with this deadline to avoid abandonment of your application. As a best practice, it’s advisable to file these documents as soon as possible after filing the non-English provisional application to avoid any potential issues.

For more information on patent procedure, visit: patent procedure.

The MPEP section 603.01 does not specify a deadline for filing supplemental oaths or declarations after allowance. It states:

“Supplemental oaths and declarations covering the claims in the application may be filed after allowance as a matter of right.”

This suggests that applicants have the right to file these documents at any time after allowance. However, it’s important to note that practical considerations, such as the patent issue date, may impose de facto deadlines. Applicants should consult with a patent attorney or agent for specific timing advice in their case.

To learn more:

No, the listing of references in the PCT international search report is not considered an Information Disclosure Statement (IDS) complying with 37 CFR 1.98. As stated in MPEP 609.03:

“The listing of references in the PCT international search report is not considered to be an information disclosure statement (IDS) complying with 37 CFR 1.98.”

To be considered a compliant IDS, the submission must meet specific requirements outlined in 37 CFR 1.98, including providing legible copies of foreign patents, publications, pending U.S. applications, and other information. Additionally, the IDS must include a separate list of all submitted items for consideration by the Office.

To learn more:

To learn more:

While the last known residence is often the appropriate address to provide, it’s not always the case. The MPEP states:

‘Ordinarily, the last known address will be the last known residence of the nonsigning inventor.’

However, the key is to provide the address where the inventor customarily receives mail. If this differs from their residence, the mailing address should be provided instead. The goal is to increase the likelihood that the nonsigning inventor will receive any USPTO communications.

To learn more:

To learn more:

No, the Background of the Invention section is not mandatory in a patent application. According to MPEP 608.01(c), “The Background of the Invention may (but is not required to) include the following parts…” This means that while it’s common and often beneficial to include this section, it’s not a strict requirement for a patent application.

To learn more:

While the address of the assignee may be included in the assignment document, it is not strictly required there. However, the address must be provided in the cover sheet accompanying the assignment. As stated in MPEP 302.05:

The address of the assignee may be recited in the assignment document and must be given in the required cover sheet.

This means that while including the address in the assignment document itself is optional, providing it on the cover sheet is mandatory for proper recordation of the assignment.

To learn more:

According to MPEP 604, “A non-inventor applicant need not submit proof of the permitted circumstance to file a substitute statement (e.g., inventor’s death certificate to establish that a named inventor is deceased).” However, it’s important to note that:

  • If the circumstance is not death or legal incapacity, the inventor must have refused to execute the oath or declaration, or the applicant must have made a diligent effort to find or reach the inventor.
  • While proof is not required to be submitted to the USPTO, “proof of attempts to secure the inventor’s signature should be kept in applicant’s file.

This approach balances the need for truthful statements with practical considerations in patent applications.

To learn more:

The United States Patent and Trademark Office (USPTO) does not require proof of authority to be filed by a legal representative of a deceased or incapacitated inventor. MPEP 409.01(b) states:

“Proof of authority of the legal representative of a deceased or incapacitated inventor is not required.”

However, it’s important to note that while the USPTO doesn’t require this proof, the legal representative should ensure they are properly acting in such a capacity. The MPEP advises:

“Although the Office does not require proof of authority to be filed, any person acting as a legal representative of a deceased or incapacitated inventor should ensure that he or she is properly acting in such a capacity.”

This means that while formal proof isn’t needed for USPTO purposes, the legal representative should be prepared to demonstrate their authority if challenged in other legal contexts.

To learn more:

No, MPEP 409.03(g) is not applicable to all patent applications. As stated in the editor’s note at the beginning of the section:

This MPEP section is not applicable to applications filed on or after September 16, 2012.

This means that the guidance provided in MPEP 409.03(g) regarding proof of irreparable damage only applies to patent applications filed before September 16, 2012. For applications filed on or after that date, different rules and procedures may apply.

To learn more:

To learn more:

Expungement of assignment records at the USPTO is extremely rare and does not result in the complete removal of a document from the assignment records. According to MPEP 323.01(d), petitions to expunge assignment records are granted only if the petitioner can prove:

  1. The normal corrective procedures outlined in MPEP § 323.01(a) through § 323.01(c) will not provide adequate relief, and
  2. The integrity of the assignment records will not be affected by granting the petition.

The MPEP clarifies: Even if a petition to ‘expunge’ a document is granted with respect to a particular application or patent, the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number, and the image will appear when someone views that reel and frame number.

If a petition is granted:

  • The Office will delete links to the application or patent subject to the petition.
  • A redacted version of the ‘expunged’ document must be recorded and will appear in the assignment records.
  • An additional assignment of the ‘correct’ document may be recorded if necessary.

This process ensures the integrity and completeness of the USPTO’s assignment records while addressing legitimate concerns about erroneous or sensitive information.

To learn more:

Including the object of the invention in the Brief Summary is optional but permissible. According to MPEP 608.01(d), “A brief summary of the invention indicating its nature and substance, which may include a statement of the object of the invention, should precede the detailed description.” The MPEP further clarifies that “The brief summary should be more than a mere statement of the objects of the invention, which statement is also permissible under 37 CFR 1.73.” This means that while you can include the object of the invention, it should not be the sole content of the Brief Summary. The summary should primarily focus on describing the nature and substance of the invention itself.

To learn more:

No, including government support information on a provisional application cover sheet is not sufficient to meet the requirements of 35 U.S.C. 202(c)(6). The MPEP states:

Providing information concerning government support on a provisional application cover sheet does not satisfy the requirement of 35 U.S.C. 202(c)(6) which requires that the a statement be included within the specification of such application and any patent issuing thereon specifying that the invention was made with Government support and that the Government has certain rights in the invention.

The government license rights statement must be included within the specification itself, not just on the cover sheet.

No, filing an Information Disclosure Statement (IDS) is not considered an admission that a prior art search has been conducted. The MPEP clearly states:

The filing of an information disclosure statement shall not be construed as a representation that a search has been made. 37 CFR 1.97(g).

Furthermore, the MPEP emphasizes that There is no requirement that an applicant for a patent make a patentability search.

It’s important to note that submitting an IDS is also not an admission of the materiality of the information to patentability. The MPEP states:

The filing of an information disclosure statement shall not be construed to be an admission that the information cited in the statement is, or is considered to be, material to patentability as defined in 37 CFR 1.56(b). 37 CFR 1.97(h).

To learn more:

While designating a domestic representative is not mandatory, it is highly recommended for foreign patent assignees. According to MPEP 302.04, An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative. The use of ‘may’ indicates that this is optional. However, having a domestic representative can significantly simplify legal proceedings and communications with the USPTO for foreign assignees.

To learn more:

For applications filed on or after September 16, 2012, citizenship information is no longer required. The MPEP states:

“For applications filed on or after September 16, 2012, the citizenship of the inventor is no longer required by 35 U.S.C. 115 or 37 CFR 1.63.”

However, for applications filed before September 16, 2012, citizenship information was required under pre-AIA 35 U.S.C. 115.

To learn more:

Tags: pre-AIA

The requirement for an inventor’s citizenship in patent applications has changed:

  • For applications filed on or after September 16, 2012: Citizenship is no longer required by 35 U.S.C. 115 or 37 CFR 1.63.
  • For nonprovisional applications filed before September 16, 2012: Citizenship was required under pre-AIA 35 U.S.C. 115.

As stated in the MPEP: “For applications filed on or after September 16, 2012, the citizenship of the inventor is no longer required by 35 U.S.C. 115 or 37 CFR 1.63.”

For older applications, if an inventor is not a citizen of any country, a statement to this effect is accepted as satisfying the statutory requirement.

To learn more:

No, an English translation of a non-English language foreign application is not always required. According to 37 CFR 1.55(g)(3), an English language translation is only required in specific circumstances:

An English language translation of a non-English language foreign application is not required except: (i) When the application is involved in an interference (see § 41.202 of this chapter) or derivation (see part 42 of this chapter) proceeding; (ii) When necessary to overcome the date of a reference relied upon by the examiner; or (iii) When specifically required by the examiner.

If a translation is required, it must be filed together with a statement that the translation of the certified copy is accurate.

To learn more:

No, a specific working example is not required in a patent application. The MPEP 608.01(h) clearly states: There is no statutory requirement for the disclosure of a specific example. A patent specification is not intended nor required to be a production specification.

Furthermore, the MPEP explains that the presence or absence of a specific working example is not determinative of whether the best mode has been disclosed: The absence of a specific working example is not necessarily evidence that the best mode has not been disclosed, nor is the presence of one evidence that it has. This guidance is based on the case In re Honn, 364 F.2d 454, 150 USPQ 652 (CCPA 1966).

To learn more:

No, a security agreement that does not convey the right, title, and interest of a patent property is not considered a conditional assignment. The MPEP section 317.03 states:

“A security agreement that does not convey the right, title, and interest of a patent property is not a conditional assignment.”

This distinction is important because security agreements are treated differently from conditional assignments in terms of recording and their effect on patent ownership.

To learn more:

No, a Request for Continued Examination (RCE) is not considered a new application. The MPEP 203.01 clarifies this point:

Note that a request for continued examination (RCE)(see 37 CFR 1.114) is not a type of new application filing.

An RCE is a way to continue prosecution of an existing application after a final rejection, rather than starting a new application. For more details on RCEs, refer to MPEP § 706.07(h).

To learn more:

No, an applicant is not required to conduct a prior art search before filing a patent application. The MPEP clearly states:

‘An applicant has no duty to conduct a prior art search as a prerequisite to filing an application for patent.’

This is supported by several court cases cited in the MPEP, including:

  • Nordberg, Inc. v. Telsmith, Inc.
  • FMC Corp. v. Hennessy Indus., Inc.
  • American Hoist & Derrick Co. v. Sowa & Sons, Inc.

The ‘inquiry reasonable under the circumstances’ requirement of 37 CFR 11.18 does not create any new duty for applicants to conduct prior art searches. However, applicants and practitioners should be aware that providing false or misleading information during prosecution can jeopardize patent enforceability.

While not strictly required, the USPTO requests the submission of a daytime telephone number for the party to whom correspondence is to be addressed. According to 37 CFR 1.33(a):

For the party to whom correspondence is to be addressed, a daytime telephone number should be supplied in a clearly identifiable manner and may be changed by any party who may change the correspondence address.

The MPEP explains that although business is conducted on the written record (as per 37 CFR 1.2), a daytime telephone number is useful for initiating contact that could later be reduced to writing. It’s a practical way to facilitate communication between the USPTO and the applicant or their representative.

To learn more:

While not strictly required, the USPTO recommends providing a daytime telephone number in patent applications. According to MPEP 601.03(b):

“The submission of a daytime telephone number of the party to whom correspondence is to be addressed is requested pursuant to pre-AIA 37 CFR 1.33(a).”

The MPEP further explains: “While business is to be conducted on the written record (37 CFR 1.2), a daytime telephone number is useful in initiating contact that could later be reduced to writing.” This means that while all official business must be in writing, a phone number can facilitate quick communication that can later be documented formally.

It’s worth noting that any party who can change the correspondence address can also change the telephone number.

To learn more:

To learn more:

When a petition under 37 CFR 1.48 to add an inventor was filed in a prior application, the continuation or divisional application could be handled in one of two ways:

  1. Filed with a copy of the executed declaration naming the correct inventive entity from the prior application.
  2. Filed with a newly executed declaration naming the correct inventive entity.

The MPEP states:

“A continuation or divisional application filed under 37 CFR 1.53(b) of a prior application in which a petition (or request) under 37 CFR 1.48 to add an inventor was filed should be filed with a copy of the executed declaration naming the correct inventive entity from the prior application or a newly executed declaration naming the correct inventive entity.”

Importantly, the MPEP also notes that “A copy of any decision under 37 CFR 1.48 from the prior application is not required to be filed in the continuation or divisional application.” This simplifies the filing process by not requiring additional documentation related to the inventorship change in the prior application.

To learn more:

To learn more:

Changes in inventorship for continuation or divisional applications filed under 37 CFR 1.53(b) could be handled in two ways:

  1. Filing with a copy of an oath or declaration from a prior application and a statement requesting the deletion of non-inventors.
  2. Filing with a newly executed oath or declaration naming the correct inventive entity.

The MPEP states:

“If an inventor named in a prior application is not an inventor in a continuation or divisional application filed under 37 CFR 1.53(b), the continuation or divisional application may either be filed (A) with a copy of an oath or declaration from a prior application and a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the continuation or divisional application (see pre-AIA 37 CFR 1.63(d)), or (B) with a newly executed oath or declaration naming the correct inventive entity.”

This provision allowed applicants to address changes in inventorship efficiently when filing continuation or divisional applications.

To learn more:

Applications with pre-AIA 37 CFR 1.47 status were given special consideration in continuation or divisional filings. The MPEP states:

“A continuation or divisional application of a prior application accorded status under pre-AIA 37 CFR 1.47 will be accorded status under pre-AIA 37 CFR 1.47 if a copy of the decision according pre-AIA 37 CFR 1.47 status in the prior application is filed in the continuation or divisional application, unless an oath or declaration signed by all of the inventors is included upon filing the continuation or divisional application.”

This means that the special status could be carried over to the new application by submitting a copy of the previous decision, unless a complete oath or declaration was provided.

To learn more:

To learn more:

How to retrieve a foreign priority document through PDX?

To retrieve a foreign priority document through PDX (Priority Document Exchange), follow these steps:

  1. Ensure the foreign office participates in PDX or WIPO DAS.
  2. File an application with the USPTO claiming foreign priority.
  3. Submit a request to retrieve the priority document using USPTO form PTO/SB/38 or through EFS-Web.
  4. Provide the necessary information, including the foreign application number and filing date.
  5. If using WIPO DAS, include the DAS access code provided by the foreign office.

According to MPEP 215.01: Applicants need not submit a copy of the foreign application if the foreign application was filed in a participating foreign intellectual property office, and the applicant provides sufficient information to the USPTO to retrieve the priority document.

To learn more:

USPTO staff should follow specific procedures when handling correspondence from Executive departments and agencies. According to MPEP 203.08(a):

Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs.

Staff should immediately transmit such correspondence to the appropriate office and notify them by phone to ensure prompt and proper handling.

To learn more:

Tags: USPTO

USPTO personnel are instructed to handle status inquiries about patent applications promptly and professionally. According to MPEP 203.08:

“Inquiries as to the status of applications, by persons entitled to the information, should be answered promptly. The examiner, correspondent, or other appropriate personnel should provide the information requested within the following time periods: (A) For information obtainable from PALM, within one business day. (B) For information not obtainable from PALM, within five business days unless such information is not readily available, in which case a date by which an answer will be provided should be given.”

Personnel should verify the inquirer’s right to receive information and provide appropriate status updates without disclosing confidential information to unauthorized parties.

To learn more:

USPTO employees are required to verify the identity of email senders in patent communications to prevent misrepresentation or spoofing. According to MPEP 502.03:

‘Email must be initiated by a registered practitioner, or an applicant in a pro se application, and sufficient information must be provided to show representative capacity in compliance with 37 CFR 1.34.’

The MPEP provides examples of information that can be used for verification:

  • Attorney registration number
  • Attorney docket number
  • Patent application number

Additionally, the MPEP advises:

‘Similar to the policy set forth in MPEP 100 for handling telephone calls, when responding to an email, no information should be disclosed until the identity of the requester can be adequately verified.’

Examiners are instructed to verify the identity by checking Patent Data Portal or the application file, such as confirming the email address previously provided in Patent Data Portal or the application.

To learn more:

When citing unpublished U.S. patent applications in an Information Disclosure Statement (IDS), you must include:

  • The U.S. patent application publication number
  • The applicant
  • The filing date
  • If available, the U.S. patent application publication date
  • The patent application number

The MPEP 609.04(a) states: Each U.S. application listed in an information disclosure statement must be identified by the inventor, application number, and filing date.

It’s important to note that if an application has been published, you should cite it as a U.S. patent application publication rather than as an unpublished application.

To learn more:

To learn more:

U.S. patents and U.S. patent application publications must be listed separately from other documents in an Information Disclosure Statement (IDS). This requirement is specified in 37 CFR 1.98(a)(1).

The MPEP states: ‘37 CFR 1.98(a)(1) specifically requires that U.S. patents and U.S. patent application publications be listed separately from the citations of other documents. The separation of citations will permit the Office to obtain the U.S. patent numbers and the U.S. patent application publication numbers by optical character recognition (OCR) from the scanned documents such that the documents can be made available electronically to the examiner to facilitate searching and retrieval of the cited U.S. patents and U.S. patent application publications from the Office’s search databases.

To comply with this requirement, applicants can use forms PTO/SB/08, which provide a separate section for listing U.S. patents and U.S. patent application publications. If not using these forms, ensure that U.S. patents and U.S. patent application publications are listed in a separate section from other documents.

To learn more:

To learn more:

When using trademarks in patent applications:

  • Capitalize each letter of the trademark
  • Use the trademark symbol ® or TM as appropriate
  • Accompany the trademark with generic terminology
  • Respect the proprietary nature of the mark

According to MPEP 608.01(v): “Although the use of marks having definite meanings is permissible in patent applications, the proprietary nature of the marks should be respected. Marks should be identified by capitalizing each letter of the mark (in the case of word or letter marks) or otherwise indicating the description of the mark (in the case of marks in the form of a symbol or device or other nontextual form). Every effort should be made to prevent their use in any manner which might adversely affect their validity as marks.”

To learn more:

The method for making a specific reference to a prior-filed application depends on when the application was filed:

  • For applications filed before September 16, 2012: The specific reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS) in compliance with pre-AIA 37 CFR 1.76.
  • For applications filed on or after September 16, 2012: The specific reference must be included in an ADS in compliance with 37 CFR 1.76.

Additionally, for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

It’s important to note that for continued prosecution applications (CPAs) filed under 37 CFR 1.53(d) (design applications under 35 U.S.C. chapter 16 only), a specific reference in the specification or ADS is not required and may not be made. For these applications, The specific reference requirement of 35 U.S.C. 120 is met by the transmittal request for the CPA which is considered to be part of the CPA.

For more information on application data sheet, visit: application data sheet.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on specific reference, visit: specific reference.

For inventors who are members of the U.S. Armed Services, there is a special provision for stating their residence in patent applications. According to MPEP 602.08(a):

“In the case of an inventor who is in one of the U.S. Armed Services, a statement to that effect is sufficient as to residence.”

This provision simplifies the residence requirement for service members, who may have frequently changing or sensitive location information. A simple statement of their Armed Services status fulfills the residence requirement for patent application purposes.

To learn more:

To learn more:

When providing the mailing address for correspondence in a patent application:

  • Include a complete mailing address
  • Use the address where the inventor customarily receives mail
  • For foreign inventors, provide an address in the U.S. for correspondence

The MPEP 602.08(b) states: ‘The mailing address of each inventor must be provided in order to comply with the separate notification requirement of 35 U.S.C. 11(a).’ This ensures that the USPTO can effectively communicate with all inventors throughout the patent process.

To learn more:

When filing an interim copy via the USPTO patent electronic filing system:

  1. The main parts of the foreign priority application (Abstract, Drawings, Specification, Claims, etc.) along with the cover sheet may be filed as a single PDF image file.
  2. Select the document description ‘Interim Copy of the Foreign Priority Application’ when indexing.
  3. For plain text files (e.g., Sequence Listings), file as a .txt file and select ‘Interim Copy of the Foreign Priority (text file)’ as the document description.
  4. XML files (e.g., Standard ST.26 Sequence Listing) should be filed on a read-only optical disc as part of the ‘Interim Copy of Foreign Priority.’

See MPEP § 502.05 for more information on filing documents electronically.

How should the foreign priority application number be formatted in an ADS?

When entering the foreign priority application number in an Application Data Sheet (ADS), it’s crucial to follow the proper format to ensure accurate identification. The MPEP states:

“The foreign application number should be identified in an application data sheet (ADS), rather than in a separate paper.” (MPEP 214.04)

The ADS should include:

  • The correct application number
  • The country or intellectual property authority where the application was filed
  • The filing date of the priority application

It’s important to use the exact format as it appears on the foreign priority document to avoid any discrepancies or potential issues with the priority claim.

To learn more:

The Field of the Invention should be described as follows:

  • It should be a statement of the field of art to which the invention pertains.
  • The statement should be directed to the subject matter of the claimed invention.
  • It may include a paraphrasing of the applicable Cooperative Patent Classification (CPC) definitions.

As stated in MPEP 608.01(c), the Field of the Invention is “A statement of the field of art to which the invention pertains. This statement may include a paraphrasing of the applicable Cooperative Patent Classification (CPC) definitions.”

To learn more:

Special attention is required when dealing with the correspondence address in continuation or divisional applications. According to MPEP 601.03(b):

“Special care should be taken in continuation or divisional applications to ensure that any change of correspondence address in a prior application is reflected in the continuation or divisional application.”

The MPEP further explains that when a copy of the oath or declaration from the prior application is submitted for a continuation or divisional application filed under pre-AIA 37 CFR 1.53(b), and this copy designates an old correspondence address, the USPTO may not recognize the change of correspondence address made during the prosecution of the prior application.

To address this, the MPEP advises: “Applicant is required to identify the change of correspondence address in the continuation or divisional application to ensure that communications from the Office are mailed to the current correspondence address.”

To learn more:

To learn more:

The Brief Summary of Invention should be closely aligned with the claims in a patent application. MPEP 608.01(d) states, “Such summary should, when set forth, be commensurate with the invention as claimed and any object recited should be that of the invention as claimed.” Additionally, the MPEP emphasizes that “The brief summary of invention should be consistent with the subject matter of the claims.” This means that the summary should accurately reflect the invention as it is defined in the claims, focusing on the key aspects that make the invention patentable.

To learn more:

When referring to other claims in a patent application, specific formatting rules must be followed according to MPEP 608.01(m):

  • References to other claims must be in the alternative only.
  • Dependent claims should refer to a preceding claim.
  • Claims should refer to other claims by number, not by the order they appear.

The MPEP states:

‘Reference to other claims should be in the alternative only. See 37 CFR 1.75(c). A form of claim that may be used is as follows: ‘A machine according to claim 3 or 4, further comprising —‘.’

Proper referencing ensures clarity and prevents confusion about the scope and dependencies of claims.

To learn more:

Reference characters in patent drawings should be used according to the following guidelines from 37 CFR 1.84(p):

  • Use Arabic numerals, preferably in the clockwise direction and starting with the number 1
  • Use plain legible symbols and characters
  • Must measure at least 0.32 cm (1/8 inch) in height
  • Should not be placed upon hatched or shaded surfaces
  • Must be different for different parts; the same part must be designated by the same reference character throughout the application
  • Lead lines must be used to indicate the parts to which they refer and should not cross each other

Additionally, reference characters mentioned in the description must appear in the drawings, and vice versa. Characters not mentioned in the description should not appear in the drawings.

To learn more:

Reference characters in patent drawings and descriptions play a crucial role in clearly illustrating and explaining the invention. According to MPEP 608.01(g), there are specific rules for using reference characters:

“The reference characters must be properly applied, no single reference character being used for two different parts or for a given part and a modification of such part. See 37 CFR 1.84(p).”

Here are the key points to remember:

  • Each unique part of the invention should have its own reference character.
  • Do not use the same reference character for different parts.
  • Do not use different reference characters for the same part.
  • Reference characters in the drawings should match those used in the description.
  • Every feature specified in the claims must be illustrated.
  • Avoid superfluous illustrations that don’t correspond to claimed features.

Proper use of reference characters ensures clarity and consistency between your drawings and written description, which is essential for a comprehensive and easily understood patent application.

To learn more:

Professional titles should not be included in inventor names on patent applications. The MPEP 602.08(b) is clear on this point:

Prefixes to names (e.g., “Dr.”) generally should not be included.

This means that titles such as ‘Dr.’, ‘Prof.’, ‘Eng.’, or any other professional designation should be omitted from the inventor’s name on the patent application. The focus should be on the inventor’s legal name without any additional titles or honorifics.

For example, if an inventor’s name with title is ‘Dr. Jane Doe’, it should be listed simply as ‘Jane Doe’ on the patent application.

To learn more:

To ensure proper processing of priority papers, the MPEP recommends marking them with specific information. According to MPEP 215.03:

It is suggested that a notation of the application number of the corresponding U.S. application be placed on the priority papers when such papers are not submitted via a priority document exchange program. Such notation should be placed directly on the priority papers themselves even where a cover letter is attached bearing the U.S. application data.

This practice helps prevent priority papers from becoming separated from their corresponding U.S. applications, which can cause severe problems for both the Office and the applicant. By adhering to this suggestion, applicants can significantly reduce potential issues in processing priority claims.

To learn more:

To ensure proper correlation between priority papers and U.S. applications, the MPEP suggests: “It is suggested that a notation of the application number of the corresponding U.S. application be placed on the priority papers when such papers are not submitted via a priority document exchange program. Such notation should be placed directly on the priority papers themselves even where a cover letter is attached bearing the U.S. application data.” This practice helps prevent separation of cover letters and priority papers, which can cause severe problems for both the Office and applicant.

For patent applications, prior U.S. application data should be provided as follows:

  • For applications filed on or after September 16, 2012: In an application data sheet
  • For applications filed before September 16, 2012: In either the first sentence(s) of the specification or in an application data sheet

MPEP 202 states: “The identifying data of all prior applications for which benefits are claimed should be reviewed by the examiner to ensure that the data is accurate and provided in an application data sheet for applications filed on or after September 16, 2012, or provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012.”

When including prior art figures in a patent application, proper labeling is crucial. According to MPEP 608.02(g), prior art figures should be designated by a legend such as ‘Prior Art.’ This labeling is essential to distinguish prior art from the applicant’s invention.

If a prior art figure is not correctly labeled, patent examiners may use form paragraph 6.36.01, which states: Figure [1] should be designated by a legend such as –Prior Art– because only that which is old is illustrated. See MPEP § 608.02(g). This paragraph instructs the applicant to correct the labeling to comply with the MPEP guidelines.

To learn more:

Photographs in patent applications should be submitted according to specific guidelines:

  • Black and white photographs must be of sufficient quality for reproduction and printing.
  • Color photographs are treated the same as color drawings and require a petition.
  • Photographs must be on paper that complies with 37 CFR 1.84(e).
  • The photographs should directly depict the invention and not include extraneous marks.

MPEP 608.02(b) states: “Photographs, including photocopies of photographs, are not ordinarily permitted in utility and design patent applications.” However, they may be accepted if they are the only practicable medium for illustrating the claimed invention.

To learn more:

To learn more:

How should pending U.S. patent applications be listed in an IDS?

When listing pending U.S. patent applications in an Information Disclosure Statement (IDS), applicants must provide specific information to ensure proper identification. According to MPEP 609.04(a):

“Each U.S. application listed in an information disclosure statement must be identified by the inventor, application number, and filing date.”

Additionally, the MPEP states:

“Where the application is cited only in a pending U.S. application, the cited application should be identified by application number (application number without series code) or patent application publication number, if applicable.”

It’s important to note that:

  • The series code (e.g., 08/, 09/, 10/, etc.) should not be included when citing a pending U.S. application.
  • If a patent application publication exists for the pending application, you may include that number instead of or in addition to the application number.
  • Providing accurate and complete information helps examiners efficiently locate and consider the cited applications during the examination process.

To learn more:

To learn more:

Patent examiners should review and consider an Information Disclosure Statement (IDS) as follows:

  1. Check for compliance with 37 CFR 1.97 and 1.98
  2. Consider the properly submitted information in the same manner as other documents in Office search files
  3. For e-IDS, use the e-IDS icon on the examiner’s workstation to consider cited U.S. patents and U.S. patent application publications
  4. Initial the blank column next to each citation to indicate that the information has been considered, or use the alternative electronic signature method
  5. Draw a line through citations that fail to comply with requirements
  6. Sign and date the bottom of the IDS listing or use the alternative electronic signature method
  7. Ensure that a signed and dated copy of the IDS listing is entered into the file and mailed to the applicant

The MPEP states: “After the examiner reviews the IDS for compliance with 37 CFR 1.97 and 1.98 (see MPEP § 609.05), the examiner should: (A) Consider the information properly submitted in an IDS in the same manner that the examiner considers other documents in Office search files while conducting a search of the prior art in a proper field of search.”

To learn more:

Patent examiners should handle objections to drawings as follows:

  1. If the examiner makes objections to the drawings, they should require correction in reply to the Office action.
  2. The examiner should not permit the objection to be held in abeyance.
  3. If drawings are marked as ‘informal’ but considered acceptable by OPAP, the examiner should not require replacement.

The MPEP clearly states: If the examiner does make objections to the drawings, the examiner should require correction in reply to the Office action and not permit the objection to be held in abeyance.

For more information on specific grounds for finding drawing informalities, examiners should refer to MPEP § 608.02(b), § 608.02(d)§ 608.02(h) and § 608.02(p).

To learn more:

National security classified patent applications may be filed with the USPTO in the following ways:

  • Hand-carried to Licensing and Review
  • Mailed to the USPTO in compliance with 37 CFR 5.1(a) and Executive Order 13526
  • Filed via the Department of Defense Secret Internet Protocol Router Network (SIPRNET) – these will be considered filed via the USPTO patent electronic filing system

The applicant must also either obtain a secrecy order or provide authority to cancel the security markings per 37 CFR 5.1(d).

How should multiple dependent claims be formatted in a patent application?

Multiple dependent claims in patent applications must follow specific formatting rules as outlined in MPEP 608.01(m). The MPEP states:

‘A multiple dependent claim may refer in the alternative to only one set of claims. A claim such as ‘A machine according to claims 3 or 4, further comprising —‘ is improper. Additionally, a multiple dependent claim may not serve as a basis for any other multiple dependent claim, either directly or indirectly.’

Key formatting requirements include:

  • Multiple dependent claims must refer to other claims in the alternative only.
  • They should use the phrase ‘according to’ followed by claim numbers (e.g., ‘according to claims 1, 2, or 3’).
  • Each multiple dependent claim must be considered in combination with every claim to which it refers.
  • The claim fee for a multiple dependent claim is calculated based on the number of claims it incorporates.

Proper formatting ensures clarity and compliance with 37 CFR 1.75(c), which governs multiple dependent claims.

To learn more:

To learn more:

How should line spacing and numbering be formatted in a patent specification?

The MPEP 608.01 provides specific guidelines for line spacing and numbering in patent specifications:

  • Line spacing: Lines of text should be 1.5 or double spaced
  • Line numbering: The lines on each sheet should be numbered consecutively and at least 4 cm (1 1/2 inches) from the left margin

The MPEP states: ‘The specification (including the abstract and claims) for other than reissue applications and reexamination or supplemental examination proceedings shall have lines that are 1 1/2 or double spaced.’ It further specifies: ‘The lines on each sheet should be numbered consecutively, starting with 1, and the numbers should be located about 4 cm. from the left margin.’ These formatting requirements ensure clarity and ease of reference in patent documents.

To learn more:

For joint inventor applicants, MPEP 509.04(c) states that “each joint inventor should sign a separate copy of the relevant micro entity certification form.” However, there is an exception:

“If one joint inventor is appointed to prosecute the application on behalf of all the other joint inventors, then only that one joint inventor need sign the micro entity certification form.”

This appointment can be made using USPTO form PTO/AIA/81, titled “Power Of Attorney To One Or More Of The Joint Inventors And Change Of Correspondence Address”, available on the USPTO forms Web page.

To learn more:

How should inventorship be determined for a patent application?

Determining inventorship for a patent application is a critical step that requires careful consideration. Here’s how it should be approached:

  • Inventorship is determined based on the subject matter of the claims.
  • Each person who contributed to the conception of at least one claim should be listed as an inventor.
  • Merely following instructions or assisting in reduction to practice does not qualify one as an inventor.

The MPEP 2137 states:

“The threshold question in determining inventorship is who conceived the invention. Unless a person contributes to the conception of the invention, he is not an inventor.”

It’s important to note that inventorship can change during the prosecution of the application if claims are amended or canceled. Applicants should consult with a patent attorney to ensure proper determination of inventorship.

To learn more:

Tags: inventorship

For inventors who have only a single name, there are specific guidelines for presenting their name in patent applications:

  • The single name should be listed in the Last Name field.
  • The First Name field should be left blank.
  • A period should be placed in the First Name field if the USPTO computer system requires a first name entry.

According to MPEP 602.08(b):

If an inventor’s name ‘includes’ only a single name, it should be placed in the Last Name box of the inventor data sheet (37 CFR 1.76(b)(1)) or inventor’s oath or declaration (37 CFR 1.63(a)(1)), with the First Name box blank or filled with a period (if required by the computer system to be a non-blank field).

This ensures proper recording and processing of the inventor’s name in the patent application system.

To learn more:

When illustrating improvements on existing inventions, patent drawings should follow specific guidelines as outlined in MPEP 608.02(d):

  1. Show the improved portion disconnected from the old structure
  2. In a separate view, show only enough of the old structure to demonstrate the connection with the improvement

The MPEP cites 37 CFR 1.83(b): When the invention consists of an improvement on an old machine the drawing must when possible exhibit, in one or more views, the improved portion itself, disconnected from the old structure, and also in another view, so much only of the old structure as will suffice to show the connection of the invention therewith. This approach helps to clearly distinguish the new, improved elements from the existing technology.

To learn more:

Patent maintenance fee payments can be submitted in two ways:

  1. Electronically: This is the preferred method. Payments can be made through the USPTO’s Patent Maintenance Fees Storefront.
  2. By mail: If not submitted electronically, maintenance fee payments and related correspondence should be addressed to:

Mail Stop Maintenance Fee
Director of the United States Patent and Trademark Office
P.O. Box 1450
Alexandria, VA 22313-1450

The MPEP states: Maintenance fee payments not electronically submitted over the Internet and correspondence related to maintenance fees may be addressed to: Mail Stop Maintenance Fee, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450

It’s important to note that electronic submission is faster, more secure, and provides immediate confirmation of payment.

To learn more:

Maintenance fee payments have a specific mailing address if not submitted electronically. According to MPEP 501, which cites 37 CFR 1.1(d):

Maintenance fee payments that are not submitted electronically and correspondence related to maintenance fees may be addressed to: Mail Stop Maintenance Fee, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450.

However, it’s important to note that the USPTO strongly encourages electronic submission of maintenance fee payments. The Electronic Maintenance Fee Form is the preferred method for these transactions.

If you must submit a paper payment, ensure it’s properly addressed to avoid delays in processing. Include all necessary information, such as the patent number and the fee amount being paid.

For more information on USPTO correspondence, visit: USPTO correspondence.

For correspondence that requires immediate attention from the USPTO, such as certain petitions or time-sensitive documents, the following methods are recommended:

  1. Use the USPTO patent electronic filing system (EFS-Web or Patent Center). This is the preferred method for most immediate correspondence.
  2. Where permitted, use facsimile transmission to the appropriate area of the Office.
  3. Hand-carry the documents to the USPTO in Alexandria, VA.

The MPEP states: Applicants are encouraged to transmit these types of correspondence by the USPTO patent electronic filing system (see MPEP § 502.05). Where permitted, patent-related correspondence that requires immediate Office attention may also be submitted to the appropriate area of the Office for processing by facsimile transmission (see MPEP § 502.01, subsections I.B and II) or hand-carried (see MPEP § 502), subsection III).

Examples of correspondence requiring immediate attention include:

  • Petitions for express abandonment to avoid publication
  • Petitions to withdraw an application from issue
  • Requests for expedited examination of a design application
  • Certain papers required by the Office of Data Management

To learn more:

When referencing figures in the Brief Description of Drawings section of a patent application, you should:

  • Refer to each figure by its number (e.g., Figure 1, Figure 2)
  • Provide a brief explanation of what each figure represents

The MPEP 608.01(f) states:

The specification must contain or be amended to contain a brief description of the several views of the drawings.

For example:

Figure 1 is a perspective view of the invented device.

Figure 2 is a cross-sectional view of the device shown in Figure 1.

Keep the descriptions concise and avoid detailed explanations, which belong in the Detailed Description section.

To learn more:

To learn more:

Tags: drawings

If an inventor has only a single name, you should follow these guidelines:

  • Enter the single name in the ‘Last Name’ field on the application data sheet (ADS).
  • Leave the ‘First Name’ field blank.
  • If using the inventor’s declaration form, enter the single name in the field provided for the legal name.

The MPEP 602.08(a) states: If an inventor does not have a middle name, the middle name space on the printed patent should be left blank and the name should be printed on the patent as the inventor indicated in the application, with no misspelling or other alteration.

To learn more:

For an international patent application designating the United States, you must use the international application number in the assignment. MPEP 302.03 specifies: “An assignment relating to an international patent application which designates the United States of America must identify the international application by the international application number; e.g., PCT/US2012/012345.” This format ensures proper identification of the international application in the assignment document.

To learn more:

Handling changes in inventorship in a continuing application depends on the filing date of the application and the nature of the change. Here are the key points:

  1. For applications filed on or after September 16, 2012:
    • Inventorship is determined by the Application Data Sheet (ADS) if filed before or with the oath/declaration copy.
    • If no ADS is filed, inventorship is based on the oath/declaration copy from the earlier application.
    • New joint inventors must provide a new oath or declaration.
  2. For applications filed before September 16, 2012:
    • To remove an inventor, file a copy of the prior oath/declaration with a statement requesting deletion of the non-inventor’s name.
    • Alternatively, file a new oath/declaration with the correct inventive entity.
    • For continuation-in-part applications, a new oath/declaration is typically required.

According to MPEP 602.05(b): If an inventor named in a prior application is not an inventor in a continuation or divisional application filed under 37 CFR 1.53(b), the continuation or divisional application may either be filed (A) with a copy of an oath or declaration from a prior application and a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the continuation or divisional application, or (B) with a newly executed oath or declaration naming the correct inventive entity.

Always ensure compliance with the specific requirements based on your application’s filing date and type.

To learn more:

The formatting of your patent application abstract should follow specific guidelines. According to MPEP 608.01(b):

The sheet or sheets presenting the abstract may not include other parts of the application or other material.

Key formatting points include:

  • Start the abstract on a separate sheet
  • Use a single paragraph
  • Avoid referring to purported merits or speculative applications
  • Do not compare the invention with the prior art
  • Preferably limit to 150 words
  • If using reference characters from the drawings, place them in parentheses

Proper formatting ensures that your abstract is clear, concise, and easy for examiners and other readers to quickly understand.

To learn more:

When canceling a figure in a patent application, it’s important to also amend the brief description of the drawings to reflect this change. Here’s how to do it:

  • Remove any reference to the canceled figure from the brief description.
  • Renumber the remaining figures if necessary.
  • Update any cross-references to the figures throughout the specification.

MPEP 608.02(t) mentions this requirement: “The brief description of the drawings should also be amended to reflect this change.” This ensures consistency between the drawings and their description in the specification, which is crucial for a clear and accurate patent application.

To learn more:

Assignment documents submitted by mail for recordation should be addressed according to MPEP 302.08 and 37 CFR 3.27. The MPEP states:

Documents and cover sheets submitted by mail for recordation should be addressed to Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450, unless they are filed together with new applications.

This ensures that your documents are properly routed and processed by the USPTO.

To learn more:

How should graphical drawings be prepared for a patent application?

Graphical drawings in patent applications must meet specific requirements to ensure clarity and reproducibility. According to MPEP 608.02:

“The graphic forms in drawings are lines, numbers, and letters. Drawings should be prepared with the proper rendition of graphic forms.”

Key guidelines for preparing graphical drawings include:

  • Use solid black lines of uniform thickness
  • Choose line thickness appropriate for the scale and complexity of the drawing
  • Avoid shading unless necessary to show the shape of elements
  • Use reference characters (numbers, letters) consistently throughout the application
  • Ensure all text is legible and at least 1/8 inch (0.32 cm) in height
  • Avoid crowding; leave sufficient white space between elements

The MPEP also states: “All drawings must be made by a process which will give them satisfactory reproduction characteristics.” This means the drawings should be clear, sharp, and suitable for reproduction in both paper and electronic formats.

To learn more:

Foreign priority claims in patent applications should be formatted according to specific guidelines outlined in MPEP 214.04. The claim should include:

  • The application number of the foreign application
  • The country or intellectual property authority where the application was filed
  • The day, month, and year of filing

The MPEP states: ‘When the claim to priority concerns an application filed in a foreign country, the claim must identify the foreign country or intellectual property authority where the application was filed.’ This ensures proper identification and processing of the priority claim.

To learn more:

To learn more:

To properly identify foreign priority applications in a patent application, applicants should follow the guidelines provided by the World Intellectual Property Organization (WIPO). The MPEP states:

To ensure an accurate and complete citation of a foreign priority application, applicants should review the list of the various intellectual property offices and the recommended presentation of a foreign application number for each, which can be found in the tables of the online WIPO Handbook on Industrial Property Information and Documentation

Specifically, applicants should refer to:

  • Part 7: Examples and Industrial Property Offices Practices
  • Part 7.2.1: Presentation of Application Numbers

These resources provide the recommended format for citing foreign application numbers, ensuring accurate and complete relationships among patent documents.

To learn more:

When citing foreign patents in an Information Disclosure Statement (IDS), you must include:

  • The country or patent office that issued the patent
  • The patent number
  • The name of the patentee
  • The date of issuance
  • The pages, columns, lines, or paragraph numbers where relevant passages or figures appear

The MPEP 609.04(a) states: Each foreign patent or published foreign patent application listed in an information disclosure statement must be identified by the country or patent office which issued the patent or published the application, an appropriate document number, the applicant, patentee, or first-named inventor, whichever is applicable, and the publication date indicated on the patent or published application.

To learn more:

How should foreign patent documents be cited in an IDS?

When citing foreign patent documents in an Information Disclosure Statement (IDS), specific information must be provided to ensure proper identification. According to MPEP 609.04(a):

“Each foreign patent or published foreign patent application listed in an information disclosure statement must be identified by the country or patent office which issued the patent or published the application, an appropriate document number, and the publication date indicated on the patent or published application.”

Additionally, the MPEP provides guidance on citing specific types of foreign patent documents:

  • Published applications: Provide the application number, the publication date, and the name of the patent office.
  • Patents: Include the name of the patentee, the date of the patent, the country, and the patent number.
  • Abstract-only citations: If only the abstract is being cited, clearly indicate this fact.

For non-English language foreign patent documents:

  • A concise explanation of relevance is required unless a complete translation is provided.
  • If a search report cites the document, submitting an English-language version of the search report indicating the degree of relevance can satisfy the explanation requirement.

Providing accurate and complete information for foreign patent documents helps examiners efficiently locate and consider these references during the examination process.

To learn more:

For foreign language documents cited in an Information Disclosure Statement:

  • A concise explanation of relevance must be provided for non-English documents
  • If a complete English translation is submitted, no concise explanation is required
  • An English language abstract may satisfy the concise explanation requirement
  • A copy of a search report from a foreign patent office citing the document can serve as the concise explanation

MPEP 609.04(a)(III) states: “Each information disclosure statement must further include a concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information listed that is not in the English language. The concise explanation may be either separate from the specification or part of the specification.”

To learn more:

According to MPEP 507, figures in patent drawings should be labeled as follows:

Each figure must be labeled ‘Fig.’ with a consecutive Arabic numeral (1, 2, etc.) or an Arabic numeral and capital letter in the English alphabet (A, B, etc.). See 37 CFR 1.84(u)(1);

This labeling convention ensures clarity and consistency in referencing figures throughout the patent application and publication. Improper labeling may result in an objection from OPAP and require correction.

The USPTO requires clear itemization of fees to ensure proper accounting. According to MPEP 509:

37 CFR 1.22(b) sets forth that fees must be itemized in such a manner that it is clear for which purpose fees are paid. The Office may return fees that are not itemized.

However, the MPEP clarifies that the itemization requirement is not meant to create problems when the purpose is clear:

  • A reference to ‘filing fee(s)’ is sufficient to cover all types of filing fees.
  • In later submissions, ‘filing fee(s)’ would also cover surcharges.
  • A reference to ‘any corresponding fee under 37 CFR 1.16’ covers any fee under that section.

The key is to provide enough information for the USPTO to understand the purpose of the payment.

To learn more:

Tags: patent fees

Examiners should review the identifying data of all prior applications for which benefits are claimed to ensure accuracy. This review includes:

  • Checking that the data is provided in an application data sheet for applications filed on or after September 16, 2012
  • Verifying that the data is provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012
  • Ensuring the appropriate relationship (e.g., continuation, divisional, or continuation-in-part) between nonprovisional applications is included

The MPEP states: “The identifying data of all prior applications for which benefits are claimed should be reviewed by the examiner to ensure that the data is accurate and provided in an application data sheet for applications filed on or after September 16, 2012, or provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012.” (MPEP 202)

When handling interview requests from practitioners not of record, examiners should follow these guidelines:

  • Verify the requester’s authority to conduct the interview.
  • Ensure the practitioner of record has authorized the interview.
  • If authorization is not provided, decline the interview request.

The MPEP 408 states: ‘Interviews with practitioners not of record should be conducted only with the consent of the practitioner of record.’ It further advises: ‘An examiner should not conduct an interview with an attorney or agent who is not of record unless the attorney or agent presents either a power of attorney or a letter signed by the attorney or agent of record authorizing the interview.’

For more information on patent examination, visit: patent examination.

When handling interview requests from multiple attorneys or agents, examiners should follow these guidelines:

  • Generally, only one interview is granted per application.
  • If multiple practitioners request interviews, coordinate with the practitioner of record.
  • Additional interviews may be granted at the examiner’s discretion.

The MPEP 408 states: ‘An interview should normally be conducted with the attorney or agent of record in an application.’ It further advises: ‘If more than one attorney or agent request an interview in an application, it is the responsibility of the attorney or agent of record to resolve any conflict.’

For more information on patent examination, visit: patent examination.

For more information on practitioner of record, visit: practitioner of record.

Examiners should handle informal drawings in patent applications as follows:

  • Determine if the drawings are sufficient for examination purposes
  • If sufficient, proceed with examination but note the need for formal drawings
  • If insufficient, object to the drawings and explain why formal drawings are required

According to MPEP 608.02(e): ‘The acceptance of and retention of informal drawings by the Office does not relieve the applicant of the drawing requirements of 35 U.S.C. 113.’ This means that while informal drawings may be accepted for initial examination, formal drawings will still be required before the patent can be granted.

To learn more:

When a claim in the original application discloses subject matter not shown in the drawing or described in the description, examiners should treat the claim on its merits and require amendments to the drawing and description. The MPEP 608.01(l) states: “Where subject matter not shown in the drawing or described in the description is claimed in the application as filed, and such claim itself constitutes a clear disclosure of this subject matter, then the claim should be treated on its merits, and requirement made to amend the drawing and description to show this subject matter.” It’s important to note that the deficiency lies in the drawing and description, not in the claim itself.

To learn more:

Examiners are required to provide clear and explicit reasons for not approving drawing corrections in their next communication to the applicant. The MPEP 608.02(x) instructs:

“The examiner should explicitly and clearly set forth all the reasons for not approving the corrections to the drawings in the next communication to the applicant.”

This ensures that applicants understand exactly why their drawing corrections were not accepted and what they need to do to address the issues. The MPEP also refers examiners to MPEP § 608.02(p) for suggested form paragraphs to use when notifying applicants of drawing correction issues.

To learn more:

To learn more:

The arrangement of dependent claims in a patent application should follow specific guidelines as outlined in MPEP 608.01(n):

  • A claim which depends from a dependent claim should not be separated from it by any claim which does not also depend from that dependent claim.
  • A dependent claim may refer back to any preceding independent claim.
  • In general, applicant’s sequence of claims should not be changed.

The MPEP provides this guidance: “These are the only restrictions with respect to the sequence of claims and, in general, applicant’s sequence should not be changed.”

However, during prosecution, the order of claims may change. It’s important to carefully check the numbering of dependent claims and the numbers of preceding claims referred to when claims are renumbered upon allowance.

To learn more:

For correspondence that is not specific to patents or trademarks, such as requests for certified copies or assignment recordation, the general mailing address is:

Director of the United States Patent and Trademark Office
P.O. Box 1450
Alexandria, VA 22313-1450

This address should be used for:

  • Patent and trademark documents sent to the Assignment Division for recordation (Mail Stop Assignment Recordation Services)
  • Requests for certified or uncertified copies of patent and trademark documents (Mail Stop Patent and Trademark Copy Fulfillment Branch)
  • Correspondence for which an address is not otherwise specified in 37 CFR 1.1 or 2.190

MPEP 501 states: “For correspondence for which an address is not otherwise specified in 37 CFR 1.1 or 2.190, should be addressed to: Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450”

When submitting corrected drawing sheets in response to objections, applicants must follow specific guidelines as outlined in the MPEP section 608.02(f):

  • Submit corrected drawing sheets in compliance with 37 CFR 1.121(d).
  • Include all figures from the immediate prior version of the sheet, even if only one figure is being amended.
  • Do not label amended drawing figures as “amended.”
  • If canceling a figure, remove it from the replacement sheet and renumber remaining figures if necessary.
  • Label each drawing sheet submitted after the filing date as either “Replacement Sheet” or “New Sheet” in the top margin.

These requirements ensure proper documentation and clarity in the patent application process. Failure to comply may result in abandonment of the application.

To learn more:

To learn more:

According to MPEP 608.02(d), conventional features in patent drawings should be illustrated as follows:

  • Use graphical drawing symbols
  • Use labeled representations (e.g., a labeled rectangular box)

The MPEP states: However, conventional features disclosed in the description and claims, where their detailed illustration is not essential for a proper understanding of the invention, should be illustrated in the drawing in the form of a graphical drawing symbol or a labeled representation (e.g., a labeled rectangular box).

This approach simplifies the drawings while still providing necessary information about conventional elements. It allows the focus to remain on the novel aspects of the invention while acknowledging the presence of standard components.

To learn more:

How should color drawings be submitted in patent applications?

Color drawings in patent applications require special handling:

  1. A petition for color drawings must be filed with the application.
  2. Three sets of color drawings or color photographs must be submitted.
  3. The specification must contain the reference to color drawings.

The MPEP 608.02 states: ‘Color drawings are not permitted in design applications. See 37 CFR 1.84(a)(2) and MPEP § 608.02(VIII).’

For utility patents, color drawings may be accepted if they are necessary for the understanding of the invention. However, they are not encouraged due to reproduction costs and potential issues with public access.

To learn more:

According to MPEP 608.01(m), claims in a patent application should be numbered consecutively in Arabic numerals. The MPEP states:

The claim or claims must commence on a separate physical sheet or electronic page and should appear after the detailed description of the invention. Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material. Claims must be numbered consecutively in Arabic numerals.

This numbering system helps organize the claims and makes it easier for examiners and others to reference specific claims within the application.

To learn more:

The numbering and arrangement of claims in a patent application should follow the guidelines provided in 37 CFR 1.75(f) and (g). Key points include:

  • Claims should be numbered consecutively in Arabic numerals.
  • The least restrictive claim should be presented as claim number 1.
  • Dependent claims should be grouped together with the claim or claims to which they refer, to the extent practicable.

The MPEP states: “If there are several claims, they shall be numbered consecutively in Arabic numerals.” and “The least restrictive claim should be presented as claim number 1, and all dependent claims should be grouped together with the claim or claims to which they refer to the extent practicable.”

This arrangement helps examiners and others reviewing the application to quickly understand the scope and relationships between claims. For more information on claim numbering, refer to MPEP § 608.01(j).

To learn more:

How should claim numbering be handled when canceling claims in a patent application?

When canceling claims in a patent application, it’s important to maintain proper claim numbering. According to MPEP 608.01(n):

‘When claims are canceled, the remaining claims must not be renumbered. When claims are added by amendment or substituted for canceled claims, they must be numbered by the applicant consecutively beginning with the number next following the highest numbered claim previously presented (whether entered or not).’

This means that:

  • Existing claim numbers should not be reused for new claims.
  • Gaps in claim numbering due to canceled claims should be left as is.
  • New claims should be numbered sequentially starting from the highest previous claim number.

Proper claim numbering helps maintain clarity and avoid confusion during the examination process.

To learn more:

Proper claim numbering is essential in patent applications. According to MPEP 608.01(m):

  • Claims must be numbered consecutively in Arabic numerals.
  • The claim number should be placed to the left of the claim text.
  • When claims are canceled, the remaining claims must not be renumbered.

The MPEP states:

‘The claim or claims must commence on a separate physical sheet or electronic page and should appear after the detailed description of the invention. Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material. Claims must be numbered consecutively in Arabic numerals starting with 1.’

Proper claim numbering ensures clarity and helps examiners and others navigate the patent application efficiently.

To learn more:

How should applicants submit written status inquiries to the USPTO?

When submitting written status inquiries to the USPTO, applicants should follow these guidelines:

  • Include the application serial number, filing date, and art unit (if known).
  • Provide a specific description of the precise information requested.
  • Include any necessary authorization for release of information.
  • Submit the inquiry to the appropriate USPTO office or Technology Center.

MPEP 203.08 advises: ‘Written status requests will be answered in all cases.’ However, it also notes that ‘Telephone inquiries regarding the status of applications, other than those in secrecy order and those under 35 U.S.C. 181, may be made by persons entitled to the information, to the appropriate USPTO staff member.’

To learn more:

Applicants other than the inventor must notify the USPTO of any change in the real party in interest as follows:

  • Notification should be made no later than payment of the issue fee
  • Changes can be indicated in Box 3 of the PTOL-85B form
  • If no notification is provided, the USPTO will presume no change has occurred

According to MPEP 308: Applicants other than the inventor can notify the Office of a change in the real party in interest by providing the real party in interest in Box 3 of the PTOL-85B. See MPEP § 307. The real party in interest will be listed in the assignee section of the patent. This does not change the applicant designated in the application or on any patent that is granted.

Additionally, 37 CFR 1.46(e) states: Where a real party in interest has filed an application under § 1.46, the applicant shall notify the Office of any change in the real party in interest no later than payment of the issue fee. The Office will treat the absence of such a notice as an indication that there has been no change in the real party in interest.

For status inquiries regarding PCT applications, the MPEP provides specific guidance:

  • Inquiries relating to international applications filed under the Patent Cooperation Treaty (PCT) should be directed to the PCT Help Desk.
  • The MPEP states: Inquiries relating to international applications (PCT) … should be directed to the PCT Help Desk at 1-800-PTO-9199 or 571-272-4300.
  • The PCT Help Desk can provide information on the processing of international applications at the United States Receiving Office (RO/US), United States International Searching Authority (ISA/US), and United States International Preliminary Examining Authority (IPEA/US).

It’s important to use the correct channel for PCT-related inquiries to ensure accurate and timely information.

To learn more:

Annotated sheets for patent drawings must be prepared according to specific guidelines. MPEP 608.02(v) states that “The marked-up copy must be clearly labeled as ‘Annotated Sheet.'” Additionally, the MPEP specifies that “All such annotated sheets must be in ink or permanent prints.” This ensures that the proposed changes are clearly visible and permanent. When submitting annotated sheets, they should be accompanied by a replacement drawing that incorporates the proposed changes.

To learn more:

The execution of an inventor’s oath or declaration is governed by 37 CFR 1.63(g) and 35 U.S.C. 115(i). The oath or declaration must be executed (signed) in one of two ways:

  1. In accordance with 37 CFR 1.66, which provides rules for oaths taken within or outside the United States
  2. With an acknowledgment that any willful false statement made in the declaration is punishable under 18 U.S.C. 1001 by fine or imprisonment of not more than five years, or both

The inventor’s oath or declaration must be signed by:

  • The inventor
  • The joint inventors collectively
  • The applicant, in the case of a substitute statement under 37 CFR 1.64
  • The inventor who is under the obligation of assignment, in the case of an assignment-statement under 37 CFR 1.63(e)

It’s important to note that there is no minimum age requirement for executing an oath or declaration, but the person must be competent to execute, i.e., understand, the document they are signing.

To learn more:

The requirements for providing an inventor’s name in a patent application have evolved:

  • For applications filed on or after September 16, 2012: 37 CFR 1.63 requires the inventor to be identified by their legal name.
  • For applications filed before September 16, 2012: The full name was required, including family name and at least one given name without abbreviation.

The MPEP clarifies: “For nonprovisional applications filed on or after September 16, 2012, 37 CFR 1.63 requires the identification of the inventor by his or her legal name.”

If an inventor’s full given name is a singular letter or letters (e.g., “J. Doe” or “J.P. Doe”), this should be explained in the oath or declaration to avoid objections.

For name corrections or changes after filing, a request under 37 CFR 1.48(f) is required, which includes submitting an application data sheet and a processing fee.

To learn more:

To learn more:

If an inventor has no middle name, their name should be formatted using only their given name (first name) and family name (last name). The MPEP 602.08(b) provides guidance on this:

If an inventor does not have a middle name or initial, then the field for middle name or initial should be left blank.

It’s important to note that the absence of a middle name should not be confused with the use of initials. If an inventor commonly uses initials in place of their full given name, this should be indicated appropriately on the application.

To learn more:

Submitting an interim copy of a foreign application electronically involves specific procedures. The MPEP provides guidance:

‘If not provided as a single paper document, the main parts of the interim copy of the foreign priority application, i.e., Abstract, Drawings, Specification, Claims, and where applicable, the foreign patent office’s equivalent to a “Sequence Listing” (see MPEP § 2421.01), a “Sequence Listing XML” (see MPEP § 2412), “Large Tables” (see MPEP § 608.05(b)), or a “Computer Program Listing Appendix” (see MPEP § 608.05(a)), along with the separate cover sheet required by 37 CFR 1.55(j), may be filed as a single PDF image file via the USPTO patent electronic filing system.’

Key points for electronic submission:

  • File as a single PDF image file when possible
  • Use the document description ‘Interim Copy of the Foreign Priority Application’ when indexing
  • For plain text files, use the description ‘Interim Copy of the Foreign Priority (text file)’
  • XML files, like Standard ST.26 Sequence Listings, should be filed on a read-only optical disc

Proper indexing and file format selection are crucial for successful electronic submission.

For more information on electronic submission, visit: electronic submission.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

How should an examiner handle non-compliant IDSs?

When an examiner encounters a non-compliant Information Disclosure Statement (IDS), they should follow these steps:

  1. Identify the specific non-compliance issue(s).
  2. Return the IDS to the applicant or patent owner.
  3. Provide a Notice of Non-Compliant Information Disclosure Statement (PTO-1449).
  4. Explain the reason(s) for non-compliance in the notice.
  5. Do not initial or consider the references listed on the non-compliant IDS.

According to MPEP 609.01: ‘Information submitted to the Office that does not comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98 will not be considered by the Office but will be placed in the application file.’

The examiner should provide clear guidance on how to correct the non-compliance, allowing the applicant to resubmit a compliant IDS.

To learn more:

When preparing an assignment document for recording with the USPTO, follow these guidelines based on 37 CFR 3.24 and MPEP 302.01:

  1. For electronic submissions:
    • Submit either a copy of the original document or an extract of it
    • Ensure the document is in Tagged Image File Format (TIFF) or another prescribed format
    • When printed, the document should be legible on 8.5 x 11 inch or A4 paper with 1-inch margins on all sides
  2. For paper or facsimile submissions:
    • Submit a copy of the original document or an extract (not the original)
    • Use only one side of each page
    • Use 8.5 x 11 inch or A4 paper with 1-inch margins on all sides
    • For paper submissions, use flexible, strong white, non-shiny, and durable paper
  3. Ensure the document is legible, as the recorded document will only be as clear as the submitted copy
  4. Include a completed cover sheet as specified in 37 CFR 3.28 and 3.31

MPEP 302.01 states: “The United States Patent and Trademark Office will accept and record only a copy of an original assignment or other document.” Remember, the document submitted for recordation will not be returned, so do not submit original documents.

When responding to drawing objections, an applicant should:

  1. Submit corrected drawing sheets in compliance with 37 CFR 1.121(d)
  2. Include all figures from the immediate prior version, even if only one figure is amended
  3. Label new sheets as ‘Replacement Sheet’ or ‘New Sheet’ in the top margin
  4. Ensure any amended drawing figure is not labeled as ‘amended’

As stated in MPEP 608.02(e), Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. It’s important to note that objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action.

To learn more:

To learn more:

When an applicant doesn’t have firsthand knowledge about certain aspects of the invention’s relationship to government contracts, MPEP 151 provides guidance:

“In instances where an applicant does not have firsthand knowledge whether the invention involved work under any contract, subcontract, or arrangement with or for the benefit of the Atomic Energy Commission, or had any relationship to any work under any contract of the National Aeronautics and Space Administration, and includes in his or her statement information of this nature derived from others, his or her statement should identify the source of his or her information.”

Alternatively, the MPEP suggests that “the statement by the applicant could be accompanied by a supplemental declaration or oath, as to the contractual matters, by the assignee or other person, e.g., an employee thereof, who has the requisite knowledge.” This ensures transparency and accuracy in the statement.

The formatting of a reference to a prior application in the specification is crucial for proper processing. According to MPEP 211.02:

The reference to the prior application must include the following terms: ‘This application is a continuation (or division, or continuation-in-part, as appropriate) of Application No. _____, filed _____.’

Additionally, the MPEP provides guidance on including multiple prior application references:

Where the reference to a prior nonprovisional application only includes the attorney docket number, application number (series code and serial number), and filing date, in the first sentence(s) of the specification of the later filed application, OPAP will mail a ‘Notice to File Missing Parts’ indicating that a complete reference to the prior application(s) is required.

It’s important to ensure that all necessary information is included in the reference to avoid processing delays. The reference should clearly state the relationship between the applications (continuation, division, or continuation-in-part), provide the application number, and include the filing date of the prior application.

To learn more:

According to 37 CFR 3.21 and MPEP 302.03, a patent or application should be identified in an assignment document as follows:

  • For a patent: Use the patent number
  • For a national patent application: Use the application number (series code and serial number, e.g., 07/123,456)
  • For an international patent application designating the U.S.: Use the international application number (e.g., PCT/US2012/012345)
  • For an international design application designating the U.S.: Use either the international registration number or the U.S. application number

For applications not yet filed or without an assigned number:

  • For a non-provisional application: Identify by inventor name(s) and the title of the invention
  • For a provisional application: Identify by inventor name(s) and the title of the invention

MPEP 302.03 suggests: “It is suggested, however, that an assignment be written to allow entry of the identifying number after the execution of the assignment. An example of acceptable wording is: ‘I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.'”

The formatting requirements for a patent abstract are:

  • It should be in narrative form
  • Generally limited to a single paragraph
  • Preferably 50 to 150 words in length
  • Should not exceed 15 lines of text
  • Avoid legal phraseology often used in patent claims (e.g., ‘means’ and ‘said’)
  • Use clear and concise language
  • Avoid phrases like ‘This disclosure concerns,’ ‘The disclosure defined by this invention,’ or ‘This disclosure describes’

The MPEP states: The abstract should be in narrative form and generally limited to a single paragraph preferably within the range of 50 to 150 words in length. The abstract should not exceed 15 lines of text.

To learn more:

To record a joint research agreement with the USPTO, follow these steps based on 37 CFR 3.11(c) and 37 CFR 3.31(g):

  1. Prepare either a copy of the joint research agreement or an excerpt of it.
  2. Complete a cover sheet that includes:
    • Identification of the document as a “joint research agreement” in the space for describing the interest conveyed
    • The name of the owner of the application or patent
    • The name of each other party to the joint research agreement
    • The date the joint research agreement was executed
  3. Submit the document and cover sheet to the USPTO for recordation.

As stated in MPEP 302.07: “If the document submitted for recordation is a joint research agreement or an excerpt of a joint research agreement, the cover sheet must clearly identify the document as a ‘joint research agreement’ (in the space provided for the description of the interest conveyed if using Form PTO-1595).”

According to 35 U.S.C. 293 and 37 CFR 3.61, a foreign assignee of a patent or patent application who is not domiciled in the United States may designate a domestic representative. Here’s how to do it:

  1. Prepare a written document signed by the assignee.
  2. State the name and address of a person residing within the United States who may be served process or notice of proceedings affecting the patent or rights under it.
  3. Submit this document to the USPTO as a separate paper from any assignment document.
  4. Clearly label the document as “Designation of Domestic Representative.”
  5. Ensure the document is signed in accordance with 37 CFR 1.33(b).

As stated in MPEP 302.04: “The designation of domestic representative should always be submitted to the Office as a paper separate from any assignment document.”

How should a dependent claim be written to properly incorporate limitations from its parent claim?

To properly incorporate limitations from a parent claim, a dependent claim should be written following these guidelines:

  1. Reference the parent claim: Begin the dependent claim by referring to the parent claim by number (e.g., “The device of claim 1, wherein…”).
  2. Use incorporating language: The preamble should implicitly or explicitly incorporate the limitations of the parent claim.
  3. Add further limitations: Specify additional limitations that narrow the scope of the parent claim.
  4. Avoid repetition: Don’t repeat limitations already present in the parent claim.

The MPEP 608.01(n) states:

“The U.S. Court of Appeals for the Federal Circuit indicated that a dependent claim must be construed to incorporate by reference all the limitations of the claim to which it refers.”

This means that even if not explicitly stated, all limitations of the parent claim are considered part of the dependent claim. By following these guidelines, you ensure that your dependent claims are properly structured and fully compliant with USPTO requirements.

To learn more:

Filing a Continued Prosecution Application (CPA) by facsimile requires specific procedures, as outlined in MPEP 502.01:

  1. CPAs are only available for design applications.
  2. The CPA must be sent to the central facsimile number: (571) 273-8300.
  3. An authorization to charge the basic filing fee to a deposit account or credit card must be included, or the application will be treated as filed without the basic filing fee.
  4. There is a special receipt procedure for CPA filings by fax:

There is a special receipt procedure for filing a CPA by fax, whereby the Office will fax back a receipt of the CPA filing if applicant submits the Office receipt form along with the CPA filing.

It’s important to note that if the USPTO has no evidence of receiving a CPA transmitted by fax, the applicant may need to file a petition under 37 CFR 1.6(f) to request a filing date. This petition must include:

  • Information about the previous transmission
  • An additional copy of the CPA
  • A statement attesting to the previous transmission
  • Evidence of the transmission, such as a sending unit’s report or other evidence created within one business day of the transmission

Always ensure that you follow these procedures carefully when filing a CPA by facsimile to avoid any issues with the filing date or processing of your application.

To learn more:

The proper submission of a benefit claim depends on the filing date of the application:

  • For applications filed on or after September 16, 2012: The benefit claim must be included in an Application Data Sheet (ADS) in compliance with 37 CFR 1.76.
  • For applications filed before September 16, 2012: The benefit claim can be submitted either by an amendment to the first sentence(s) of the specification or in an ADS in compliance with pre-AIA 37 CFR 1.76.

The MPEP states: Applicant must still submit the benefit claim in the manner specified in 37 CFR 1.78 (i.e., in an ADS in compliance with 37 CFR 1.76 (or for applications filed prior to September 16, 2012 by an amendment to the first sentence(s) of the specification or in an ADS in compliance with pre-AIA 37 CFR 1.76) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the benefit of a prior application.

To learn more:

To learn more:

The method for including a benefit claim in a patent application depends on the filing date:

  • For applications filed before September 16, 2012: The reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS).
  • For applications filed on or after September 16, 2012: The specific reference must be included in an application data sheet (ADS).

The MPEP states: “If the application was filed before September 16, 2012, the reference must be included in the first sentence(s) of the specification following the title or in an application data sheet; if the application was filed on or after September 16, 2012, the specific reference must be included in an application data sheet.”

Additionally, for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on application data sheet, visit: application data sheet.

The Manual of Patent Examining Procedure (MPEP) is regularly updated to reflect changes in patent laws, rules, and procedures. According to MPEP 101:

The Manual is updated periodically to include changes in patent laws and rules and also changes in Patent and Trademark Office procedures.

While the MPEP doesn’t specify an exact frequency for updates, they typically occur:

  • Multiple times per year to incorporate new policies and procedures
  • After significant changes in patent laws or regulations
  • When court decisions impact patent examination practices

Users should always refer to the most recent version of the MPEP available on the USPTO website for the most up-to-date information.

For more information on MPEP updates, visit: MPEP updates.

For more information on patent law changes, visit: patent law changes.

For more information on USPTO procedures, visit: USPTO procedures.

The frequency of updates to reserved sections in the MPEP varies and is determined by the USPTO based on several factors:

  • Changes in patent laws or regulations
  • New court decisions affecting patent examination
  • Evolving USPTO policies and procedures
  • Feedback from patent examiners and practitioners

Reserved sections may be filled or updated during regular MPEP revisions, which typically occur annually or as needed. However, there is no fixed schedule for updating specific reserved sections, and some may remain reserved for extended periods.

The frequency with which ‘[Reserved]’ sections in the MPEP, like MPEP 212, are filled with content varies and depends on the needs of the USPTO. These sections may be filled during regular MPEP updates, which typically occur several times a year, or may remain reserved for extended periods.

According to MPEP 509.02, fees for small entities are reduced by 50% for most patent-related fees. The MPEP states:

The fees which are reduced by 50% for small entities include patent application filing fees including the basic filing fee, search fee, examination fee, application size fee, and excess claims fees (37 CFR 1.16), extension of time, revival, and appeal fees (37 CFR 1.17), patent issue fees (37 CFR 1.18), and maintenance fees on patents (37 CFR 1.20).

Additionally, certain PCT international stage fees are also eligible for the 50% reduction for small entities.

To learn more:

For amended applications, it’s generally advised to wait before making a status inquiry. According to MPEP 203.08:

Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office.

However, if six months have passed without a response, it’s advisable to inquire about the application’s status to avoid potential abandonment. Applicants are encouraged to use Patent Center or Private PAIR for status inquiries.

For more information on amended application, visit: amended application.

For more information on Patent Center, visit: Patent Center.

For more information on Private PAIR, visit: Private PAIR.

For amended patent applications, the USPTO provides guidelines on when to inquire about the status. According to MPEP 203.08:

Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office.

If six months have passed without a response, you should inquire about the application’s status to avoid potential abandonment. It’s recommended to use Patent Center or Private PAIR for status inquiries.

For more information on amended application, visit: amended application.

A provisional patent application has a limited lifespan. According to MPEP 201.04:

“A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter. See 35 U.S.C. 111(b)(5).”

However, there is a provision for extending this period in certain circumstances:

“The period of pendency of a provisional application is extended to the next succeeding business day if the day that is 12 months after the filing date of a provisional application falls on a Saturday, Sunday, or federal holiday within the District of Columbia. See 35 U.S.C. 119(e)(3) and 37 CFR 1.7(b).”

It’s crucial to file a nonprovisional application claiming the benefit of the provisional application within this 12-month period to maintain the priority date.

For more information on patent validity, visit: patent validity.

For more information on provisional patent, visit: provisional patent.

For more information on USPTO, visit: USPTO.

Once small entity status is established in an application or patent, it remains in effect until:

  • The issue fee is due, or
  • Any maintenance fee is due

At these points, a new determination of entitlement to small entity status is required. As stated in 37 CFR 1.27(g)(1): “Once small entity status is established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.”

To learn more:

Tags: patent fees

Micro entity status, once properly established, generally remains in effect until:

  • A fee is paid in the small entity or undiscounted amount
  • A notification of loss of entitlement to micro entity status is filed
  • The issue fee or a maintenance fee is due

However, the applicant has a continued obligation to verify eligibility for micro entity status each time a fee is paid. As stated in 37 CFR 1.29(g): ‘a fee may be paid in the micro entity amount only if status as a micro entity as defined in paragraph (a) or (d) of this section is appropriate on the date the fee is being paid.’

The time to obtain a foreign filing license from the USPTO can vary. According to MPEP 140:

‘If a license is required but the application is not one of the types under MPEP § 140(II), the grant of a license is not usually included in the letter of filing receipt.’

In such cases, the processing time can take several weeks. However, for expedited processing:

  • A petition for expedited handling under 37 CFR 1.182 can be filed.
  • In urgent cases, the license can be granted immediately by telephone.
  • The Office of Licensing and Review can grant a license the same day by fax.

It’s advisable to apply for a license well in advance of any planned foreign filing to ensure timely processing.

For more information on foreign filing license, visit: foreign filing license.

How long does it take for a patent assignment to be recorded by the USPTO?

The time it takes for a patent assignment to be recorded by the USPTO can vary. While the MPEP does not specify an exact timeframe, the process typically takes several weeks. Factors affecting the recording time include:

  • Method of submission (electronic vs. paper)
  • Completeness and accuracy of the submitted documents
  • Current USPTO workload

According to the MPEP 302, ‘The date of recording of a document is the date of its receipt in the Office in proper form with the appropriate fee.’ This means that the official recording date is the date the USPTO receives a compliant submission, not the date when processing is completed.

For the most up-to-date information on processing times, it’s advisable to check the USPTO website or contact their assignment recordation branch directly.

Under 35 U.S.C. 181, a Secrecy Order remains in effect for a period of 1 year from its date of issuance. It may be renewed for additional periods of not more than 1 year upon notice by a government agency that the national interest requires it. The applicant is notified of any renewal. (MPEP 120 Section VII)

A provisional patent application has a limited lifespan. According to MPEP 201.04:

“A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.”

This 12-month period provides inventors with a year of ‘patent pending’ status to further develop their invention, assess its commercial potential, or secure funding. To maintain patent rights, the inventor must file a corresponding nonprovisional application claiming the benefit of the provisional application within this 12-month window.

It’s important to note that the 12-month period may be extended to the next business day if it ends on a weekend or federal holiday in the District of Columbia.

To learn more:

Tags: USPTO

A patent application remains in ‘rejected’ status until one of two things happens:

  1. The applicant acts upon the examiner’s action within the allotted reply period, or
  2. The application becomes abandoned.

As stated in MPEP 203.02:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

The duration of ‘rejected’ status thus depends on the applicant’s timely response or the application’s abandonment.

To learn more:

How long does a foreign filing license remain valid?

The validity period of a foreign filing license depends on the type of license issued. According to MPEP 140:

“A foreign filing license is not required to file a patent application in another country if the invention was not made in the United States. A license is required if the invention was made in this country and:

  • An application on the invention has been filed in the United States less than six months prior to the date on which the application is to be filed abroad, or
  • No application on the invention has been filed in the United States.”

In essence, a foreign filing license granted as part of the regular patent application process remains valid for six months from the filing date. After six months, no additional license is required. However, if you obtain a petition-based license (e.g., for inventions not yet filed in the U.S.), the license will specify its scope and duration in the grant letter.

For more information on foreign filing license, visit: foreign filing license.

Patent restrictions for former USPTO employees extend for one year after their employment ends. 35 U.S.C. 4 states:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office.’

After this one-year period, former employees can apply for patents, but with certain limitations on priority dates.

If you’ve filed a patent application without necessary drawings, you have a limited time to submit them. According to MPEP 601.01(f):

“The applicant is given a time period of 2 months from the date of the notification to submit the omitted drawings and avoid abandonment of the application.”

This two-month period is set when the USPTO issues a Notice of Omitted Items. It’s crucial to respond within this timeframe to prevent your application from being abandoned. If you need more time, you can request an extension, but fees may apply.

To learn more:

To learn more:

The time period for responding to a notice about an unlocatable file depends on whether it’s for an application or a patent:

  • For applications: The USPTO typically sets a three-month period, which is extendable under 37 CFR 1.136(a) by up to three additional months, for a maximum of six months.
  • For patents: A six-month non-extendable period is set.

It’s important to note that for applications, as stated in the MPEP, If, however, an applicant fails to reply to a notice under 37 CFR 1.251 within three months of its mailing date, any patent term adjustment under 35 U.S.C. 154(b) will be reduced by a period equal to the number of days (if any) beginning on the day after the date that is three months after the mailing date of the notice under 37 CFR 1.251 and ending on the date the reply to the notice under 37 CFR 1.251 was filed.

To learn more:

The basic filing fee for a provisional application must be paid either:

  1. At the time of filing, or
  2. Within the time period set forth in 37 CFR 1.53(g)

If no correspondence address is provided, the applicant has two months from the filing date to pay the basic filing fee, submit the cover sheet, and pay the surcharge. The MPEP states:

If no correspondence address has been provided, applicant has two months from the filing date to file the basic filing fee, cover sheet, and to pay the surcharge as set forth in 37 CFR 1.16(g) in order to avoid abandonment of the provisional application. (MPEP 601.01(b))

It’s important to note that timely payment of the filing fee is crucial if you intend to claim the benefit of the provisional application in a later-filed nonprovisional application.

To learn more:

According to MPEP 203.05, you have 12 months from the filing date of your provisional application to file a nonprovisional application. The MPEP states:

“in the case of a provisional application, no later than 12 months after the filing date of the provisional application”

If you don’t file a nonprovisional application within this timeframe, your provisional application will be considered abandoned. This 12-month period is set by 35 U.S.C. 111(b)(5).

To learn more:

According to MPEP 406, when the USPTO notifies an applicant of their patent practitioner’s death, the applicant is given a specific timeframe to respond. The MPEP states:

“The period for reply to such a notice is normally set at 3 months.”

During this 3-month period, the applicant must take one of the following actions:

  • Appoint a new registered patent practitioner
  • File a change of correspondence address

It’s crucial to respond within this timeframe to prevent the application from being deemed abandoned.

For more information on application abandonment, visit: application abandonment.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on response time, visit: response time.

For more information on USPTO notification, visit: USPTO notification.

Once small entity status is established in an application or patent, you can continue to pay fees as a small entity until the issue fee is due or any maintenance fee is due. This is stated in 37 CFR 1.27(g)(1): ‘Once small entity status is established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.’

To learn more:

Tags: patent fees

A secrecy order can remain in effect for a significant period. As stated in MPEP 120, “The secrecy order may remain in effect for the duration of the national emergency and six months thereafter and automatically expires at the end of that period.” However, it’s important to note that:

  • The order can be renewed if necessary
  • It can be terminated earlier if the reasons for its issuance no longer exist
  • The total duration is subject to the provisions of 35 U.S.C. 181

For more information on secrecy order duration, visit: secrecy order duration.

The length of a patent application title is specified in MPEP 606:

“The title should be brief but technically accurate and descriptive and should contain fewer than 500 characters.”

This means that while your title should be comprehensive enough to accurately describe the invention, it must not exceed 499 characters, including spaces. It’s important to note that:

  • The 500-character limit is a maximum, not a target.
  • Shorter titles are often preferred as long as they remain descriptive and accurate.
  • The title should balance brevity with technical accuracy and descriptiveness.

When crafting your title, aim for clarity and conciseness while staying within this character limit.

To learn more:

According to MPEP 608.03(a), models and exhibits are generally disposed of by the USPTO after the application becomes abandoned or the patent is issued. The MPEP states:

‘Models or exhibits that are required by the Office or filed with a petition under 37 CFR 1.91(a)(3) will be disposed of by the Office after the application becomes abandoned or the patent expires or is terminated, whichever is later.’

However, it’s important to note that applicants can request the return of their models or exhibits. The USPTO will notify the applicant when the model or exhibit is no longer needed, and the applicant must arrange for its return within a specified time frame.

To learn more:

The recording fee for multiple patents or applications is calculated on a per-item basis. According to MPEP 302.06:

The recording fee set in 37 CFR 1.21(h) is charged for each patent application and patent identified in the required cover sheet except as provided in 37 CFR 3.41(b).

This means that if you are recording a document that affects multiple patents or applications, you will need to pay a separate fee for each one listed on the cover sheet. However, remember that for electronic submissions, the current fee is $0 per item.

To learn more:

Tags: USPTO fees

How is the receipt date determined for faxed assignment documents at the USPTO?

The determination of the receipt date for faxed assignment documents at the USPTO is crucial for establishing priority and effective dates. According to MPEP 302.09:

“The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.”

This means that:

  • The receipt date is when the entire document has been successfully transmitted and received by the USPTO.
  • Partial transmissions or incomplete faxes will not establish a receipt date.
  • The time zone of the USPTO (Eastern Time) is used for determining the date.
  • If a transmission is completed after business hours, the next business day may be considered the receipt date.

It’s important to ensure that the fax transmission is complete and to keep confirmation records of the transmission for your files.

To learn more:

The priority period for U.S. nonprovisional applications is calculated as follows:

  • The first day (filing date of the foreign application) is not counted.
  • The period ends on the same date of the following year (or six months later for design applications).
  • If the last day falls on a weekend or federal holiday, the period extends to the next business day.

The MPEP provides an example: If an application was filed in Canada on January 3, 1983, the U.S. nonprovisional application may be filed on January 3, 1984. (MPEP 213.03)

This calculation method is consistent with Article 4C(2) of the Paris Convention, which specifies that the day of filing is not counted in this period.

To learn more:

When foreign applications are properly claimed and verified in a patent application, this information is reflected in the issued patent and the Official Gazette listing. This helps establish the priority date and international scope of the invention.

The MPEP states: The front page of the patent when it is issued, and the listing in the Official Gazette, will refer to the claim of priority, giving the country, the filing date, and the number of the foreign application in those applications in which the bib-data sheet has been endorsed. (MPEP 202)

This means that for each properly claimed foreign application, the following information will be publicly available:

  • The country of filing
  • The filing date
  • The application number

It’s important to note that this information is only included for foreign applications that have been verified and endorsed on the bib-data sheet by the examiner. For more information on foreign priority claims, see MPEP § 213.

For more information on foreign applications, visit: foreign applications.

For more information on issued patent, visit: issued patent.

For more information on Official Gazette, visit: Official Gazette.

The gross income limit for micro entity status is determined as follows:

  • It is set at three times the median household income for the preceding calendar year, as reported by the Bureau of the Census.
  • The USPTO publishes the current maximum qualifying gross income on their website.
  • This limit applies to each applicant, inventor, and joint inventor individually.

The MPEP clarifies: “At the time any fee is to be paid in the micro entity amount, it is required that no inventor and no non-inventor applicant (if any) have a preceding calendar year’s gross income exceeding the ‘maximum qualifying gross income’ posted on the USPTO website.

It’s important to note that gross income means total income, not adjusted gross income. The MPEP states: “‘Gross income’ and ‘adjusted gross income’ are not the same thing. Adjusted gross income is defined as gross income minus adjustments to income. For purposes of micro entity status it is ‘gross income’ – not ‘adjusted gross income’ that matters.

To learn more:

The filing date for Priority Mail Express® submissions is typically determined by the “date accepted” on the Priority Mail Express® mailing label. According to MPEP 513:

Office personnel will routinely look to the Priority Mail Express® mailing label, and stamp the “date accepted” or other official USPS notation as the filing date of the correspondence.

If the USPS deposit date cannot be determined, the correspondence will be accorded the date of receipt in the Office as the filing date. It’s important to note that the “date accepted” must be completed by the USPS, not by the applicant.

The enforceability of patent arbitration awards is contingent upon proper notice being filed with the USPTO. According to 35 U.S.C. 294(e) and 37 CFR 1.335(c):

‘The award shall be unenforceable until the notice required by subsection (d) is received by the Director.’

This means that until the proper notice of the arbitration award is filed with the USPTO, the award cannot be enforced. It’s crucial for parties involved in patent arbitration to ensure that all required notices are filed promptly to maintain the enforceability of the award.

The effective filing date for a claimed invention is determined as follows:

  • The actual filing date of the application containing the claim, or
  • The filing date of the earliest application for which the patent or application is entitled to claim priority or benefit

The MPEP cites 35 U.S.C. 100(i)(1): “the effective filing date for a claimed invention in a patent or application (except in an application for reissue or reissued patent) is set forth in 35 U.S.C. 100(i)(1) as: (A) if subparagraph (B) does not apply, the actual filing date of the patent or the application for the patent containing a claim to the invention; or (B) the filing date of the earliest application for which the patent or application is entitled, as to such invention, to a right of priority under section 119, 365(a), 365(b), 386(a), or 386(b) or to the benefit of an earlier filing date under section 120, 121, 365(c), or 386(c).” (MPEP 210)

The deficiency owed for micro entity fee errors is calculated according to 37 CFR 1.29(k)(2). The MPEP states:

The deficiency owed for each previous fee erroneously paid as a micro entity is the difference between the current fee amount for a small entity or non-small entity, as applicable, on the date the deficiency is paid in full and the amount of the previous erroneous micro entity fee payment.

To calculate the total deficiency payment:

  1. Determine the current fee amount for each erroneously paid fee (small or non-small entity rate)
  2. Subtract the micro entity fee amount previously paid
  3. Sum up all individual deficiency amounts

This calculation ensures that the correct fee amount is paid based on the entity status and current fee schedule.

To learn more:

For continuing applications where application papers from a prior application are used, special attention must be paid to the correspondence address. According to 37 CFR 1.33(f):

“Where application papers from a prior application are used in a continuing application and the correspondence address was changed during the prosecution of the prior application, an application data sheet or separate paper identifying the correspondence address to be used for the continuing application must be submitted. Otherwise, the Office may not recognize the change of correspondence address effected during the prosecution of the prior application.”

This means that applicants must explicitly specify the desired correspondence address for the continuing application to ensure proper communication with the USPTO.

To learn more:

The application size fee is calculated based on the number of pages in the application. According to 37 CFR 1.16(s), this fee applies to any application filed under 35 U.S.C. 111 where the specification (including claims) and drawings exceed 100 sheets of paper.

The MPEP states: The application size fee applies for each additional 50 sheets or fraction thereof over 100 sheets of paper. However, certain parts of the application are excluded from this calculation:

  • ASCII plain text files or XML files of Sequence Listings
  • Computer readable forms (CRF) of Sequence Listings
  • Computer Program Listing Appendices in compliance with 37 CFR 1.96(c)

For applications submitted via the USPTO patent electronic filing system, the paper size equivalent… will be considered to be seventy five percent of the number of sheets of paper present in the specification (including claims) and drawings of the application when entered into the Office file wrapper.

To learn more:

The adequacy of best mode disclosure is determined by evaluating evidence of concealment, whether accidental or intentional. According to MPEP 608.01(h): In determining the adequacy of a best mode disclosure, only evidence of concealment (accidental or intentional) is to be considered. That evidence must tend to show that the quality of an applicant’s best mode disclosure is so poor as to effectively result in concealment.

This guidance is based on the case law established in Spectra-Physics, Inc. v. Coherent, Inc., 827 F.2d 1524, 1536, 3 USPQ2d 1737, 1745 (Fed. Cir. 1987) and In re Sherwood, 613 F.2d 809, 204 USPQ 537 (CCPA 1980). The focus is on whether the disclosure effectively conceals the best mode rather than on the specific details provided.

To learn more:

Filing a continuing application under 37 CFR 1.53(b) does not automatically abandon the prior nonprovisional application. The MPEP clarifies: Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application. If the prior nonprovisional application is to be expressly abandoned, such a paper must be signed in accordance with 37 CFR 1.138. However, there are special considerations if the prior application has a notice of allowance issued or is before the Patent Trial and Appeal Board. The MPEP further states: If the prior nonprovisional application which is to be expressly abandoned has a notice of allowance issued therein, the prior nonprovisional application can become abandoned by the nonpayment of the issue fee. It’s important to follow the proper procedures to ensure the desired outcome regarding the prior application’s status.

To learn more:

The 30-month period for national stage entry is calculated from the priority date of the international application. The priority date is typically the filing date of the earliest application whose priority is claimed in the international application.

MPEP 601.04 states: “For most applications, the 30-month time period for entry into the national stage expires on the same day of the month as the date of the priority claim in the 30th subsequent month.” However, it’s important to note that if the 30-month period expires on a Saturday, Sunday, or federal holiday, the period is extended to the next succeeding business day.

To learn more:

For continuing applications, small entity or micro entity status must be re-established. The MPEP states: If small entity status has been established in a parent application and is still proper and desired in a continuation, continuation-in-part, or divisional application filed under 37 CFR 1.53(b), a new assertion as to the continued entitlement to small entity status under 37 CFR 1.27 is required. For micro entity status, the MPEP further specifies: The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

To learn more:

Determining refusal to join an application under pre-AIA 37 CFR 1.47 involves several considerations:

  1. The inventor must be presented with the application papers.
  2. The inventor must understand what they are being asked to sign.
  3. The inventor must expressly refuse to accept the application papers.

The MPEP states:

‘A refusal by an inventor to sign an oath or declaration when the inventor has not been presented with the application papers does not itself suggest that the inventor is refusing to join the application unless it is clear that the inventor understands exactly what he or she is being asked to sign and refuses to accept the application papers.’

It’s important to document the circumstances of the presentation and refusal, including time, place, and any written evidence of refusal.

To learn more:

To learn more:

Patent ownership can be transferred through an assignment. According to 35 U.S.C. 261, assignments of patent applications, patents, or any interest therein must be in writing. The MPEP defines an assignment as:

‘a transfer by a party of all or part of its right, title and interest in a patent [or] patent application….’

An assignment transfers the entire ownership interest or a percentage of that interest in the patent or application. It must include the entirety of the bundle of rights associated with the ownership interest.

The initial ownership of a patent depends on the filing date of the application. For applications filed on or after September 16, 2012, the MPEP states:

‘For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of the application for an original patent. See 37 CFR 3.73(a).’

For applications filed before September 16, 2012:

‘For applications filed before September 16, 2012, the ownership of the patent (or the application for the patent) initially vests in the named inventors of the invention of the patent.’

This distinction is important for determining the initial owner of a patent or patent application.

When there are multiple assignees or a combination of partial assignees and inventors, establishing ownership for patent applications becomes more complex. According to MPEP 325 and 37 CFR 3.73(c)(2), each owner must submit a statement that either:

  1. Specifies the percentage of their ownership interest, accounting for the entire right, title, and interest in the application or patent, or
  2. Identifies all parties, including inventors, who together own the entire right, title, and interest, and states that all identified parties own the entire right, title, and interest.

The MPEP states: “Where there is more than one assignee (i.e., partial assignees) or a combination of partial assignees and inventors who have not assigned away their right, title and interest in the application, each owner must submit a statement under 37 CFR 3.73(c) that either:

(A) Specifies (by percentage) the extent of its ownership interest, so as to account for the entire right, title and interest in the application or patent by all parties. 37 CFR 3.73(c)(2)(i); or

(B) Identifies the parties including inventors who together own the entire right, title and interest and state that all the identified parties own the entire right, title and interest. 37 CFR 3.73(c)(2)(ii).”

If the extent of ownership is not clearly set forth, the USPTO may refuse to accept the submission as an establishment of ownership interest.

For more information on multiple assignees, visit: multiple assignees.

For more information on ownership interest, visit: ownership interest.

For more information on partial assignees, visit: partial assignees.

When there are multiple assignees for a patent application, patent, or reexamination proceeding, each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b) to take action before the USPTO. The process is as follows:

  1. Each partial assignee must submit their own pre-AIA 37 CFR 3.73(b) statement.
  2. In each submission, the extent of the assignee’s ownership interest must be clearly stated.
  3. The USPTO needs to determine if it has obtained action by all of the right, title, and interest holders (owners).
  4. If the extent of ownership is not clearly set forth, the USPTO may refuse to accept the submission.

This is outlined in MPEP 324, section VIII, which states:

“When an assignee seeks to take action in a matter before the Office with respect to a patent application, patent, or reexamination proceeding and the right, title, and interest therein is held by more than one assignee, each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b). In each submission, the extent of each assignee’s interest must be set forth so that the Office can determine whether it has obtained action by the entirety of the right, title and interest holders (owners).”

The MPEP further notes: “If the extent of the partial assignee’s ownership interest is not set forth in the submission under pre-AIA 37 CFR 3.73(b), the Office may refuse to accept the submission as an establishment of ownership interest.”

For continuing applications (continuation or divisional) filed under 37 CFR 1.53(b) before September 16, 2012, ownership can be established in one of two ways:

  1. The application papers can contain a copy of a statement filed under pre-AIA 37 CFR 3.73(b) in the parent application.
  2. A newly executed statement under pre-AIA 37 CFR 3.73(b) can be filed with the continuing application.

For continuation-in-part applications filed before September 16, 2012, a newly executed statement under pre-AIA 37 CFR 3.73(b) must be filed.

In the case of design applications where a continued prosecution application (CPA) is filed under 37 CFR 1.53(d), the statement filed under 37 CFR 3.73(b) in the parent application will serve as the statement for the CPA.

This is outlined in MPEP 324, section III, which states: “When an assignee files a continuation or divisional application under 37 CFR 1.53(b) before September 16, 2012, the application papers must: (A) contain a copy of a statement filed under pre-AIA 37 CFR 3.73(b) in the parent application; or (B) contain a newly executed statement under pre-AIA 37 CFR 3.73(b).”

Inventorship in a Continued Prosecution Application (CPA) is generally maintained from the prior application. However, if there’s a need to add or change inventors, specific procedures must be followed.

According to MPEP ¶ 2.33: “Any request to add an inventor must be in the form of a request under 37 CFR 1.48. Otherwise, the inventorship in the CPA shall be the same as in the prior application.”

This means that if you want to add or change inventors in a CPA, you must file a formal request under 37 CFR 1.48, which outlines the procedure for correction of inventorship in patent applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For continuing applications filed on or after September 16, 2012, inventorship is determined as follows:

  1. If an application data sheet (ADS) is filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application, the inventorship is specified in the ADS.
  2. If no ADS is filed before or concurrently with the copy of the inventor’s oath or declaration, the inventorship is set forth in the copy of the inventor’s oath or declaration from the earlier-filed application.
  3. If there’s no ADS and the copy of the oath or declaration is accompanied by a signed statement pursuant to 37 CFR 1.33(b), the inventorship is as stated in that signed statement.

According to MPEP 602.05(a): For continuing applications filed on or after September 16, 2012 under 37 CFR 1.53(b), the inventorship is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If an application data sheet is not filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application, the inventorship is the inventorship set forth in the copy of the inventor’s oath or declaration from the earlier-filed application, unless it is accompanied by a signed statement pursuant to 37 CFR 1.33(b) that states the name of each inventor in the continuing application.

Any new joint inventor named in the continuing application must provide an oath or declaration in compliance with 37 CFR 1.63, except as provided in 37 CFR 1.64.

To learn more:

To correct inventorship in a provisional patent application, the following steps must be taken:

  • Submit a request signed by a party set forth in 37 CFR 1.33(b)
  • Identify each inventor by their legal name in the request
  • Pay the processing fee set forth in 37 CFR 1.17(q)
  • When adding an inventor, file a corrected application data sheet or a new cover sheet with the residence of all inventors

The MPEP states: 37 CFR 1.48(d) provides a procedure for adding or deleting or correcting or updating the name of an inventor in a provisional application. 37 CFR 1.48(d) requires that the submission include: (1) a request, signed by a party set forth in 37 CFR 1.33(b), to correct the inventorship that identifies each inventor by their legal name; and (2) the fee set forth in 37 CFR 1.17(q).

To learn more:

For micro entity status, gross income is determined as follows:

  • Based on the calendar year preceding the year a fee is paid
  • Uses the definition of gross income in section 61(a) of the Internal Revenue Code
  • Compared to three times the median household income as reported by the Bureau of the Census
  • For non-US income, converted using the average currency exchange rate for the relevant calendar year

The USPTO website provides the current maximum qualifying gross income limit.

When calculating gross income for micro entity status involving foreign currency, the USPTO provides specific guidelines:

  • If an applicant’s, inventor’s, or entity’s gross income in the preceding calendar year is not in U.S. dollars, the average currency exchange rate reported by the Internal Revenue Service (IRS) for that calendar year must be used for conversion.
  • For income received partially in U.S. dollars and partially in foreign currency, the foreign portion must be converted to U.S. dollars and added to the U.S. dollar amount.

The MPEP states: “If an applicant’s, inventor’s, joint inventor’s, or entity’s gross income in the preceding calendar year is not in United States dollars, the average currency exchange rate, as reported by the Internal Revenue Service, during that calendar year shall be used to determine whether the applicant’s, inventor’s, joint inventor’s, or entity’s gross income exceeds the threshold specified in 37 CFR 1.29(a)(3) or (a)(4).

The IRS provides yearly average currency exchange rates on its website, which should be used for these calculations.

To learn more:

When a claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but before the patent is granted, special procedures apply.

According to the MPEP: When the claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but prior to the date of grant of the patent, the foreign priority claim or certified copy will be placed in the file record but there may be no review of the papers and the patent when published will not include the priority claim.

To have the foreign priority claim or certified copy considered after publication of the patent:

  • A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 can be filed
  • For original applications under 35 U.S.C. 111(a) or national stage applications under 35 U.S.C. 371, a grantable petition to accept an unintentionally delayed claim for priority under 37 CFR 1.55 and the petition fee must be filed with the certificate of correction

For more information on this process, refer to MPEP § 216.01.

To learn more:

Foreign priority application information is handled as follows on the bib-data sheet:

  • If a proper foreign priority claim is not listed on the bib-data sheet, the examiner should add the information and forward it for correction in the Office computer systems.
  • Applications listed on the bib-data sheet but filed in countries not qualifying for benefits under 35 U.S.C. 119(a)-(d) should be lined through.
  • The bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application claiming priority.
  • Examiners should check this information for accuracy and make corrections if necessary.

The MPEP states: “If a foreign application listed on the oath or declaration (for applications filed prior to September 16, 2012) or application data sheet is not listed on the bib-data sheet and the foreign priority claim is proper (e.g., the foreign priority claim was timely made ), the examiner should provide the information regarding the foreign application number, the country, and the filing date on the bib-data sheet and forward the marked-up bib-data sheet to the Legal Instrument Examiner for correction in the Office computer systems.” (MPEP 202)

The USPTO generally does not engage in double correspondence with applicants and their representatives. Specifically:

  • The Office will not correspond with both an applicant and their attorney/agent.
  • The Office will not correspond with more than one attorney/agent.
  • If double correspondence is attempted, the examiner will include form paragraph 4.01 in the next Office action.

According to MPEP 403: “Double correspondence with an applicant and their attorney, or with two representatives, will not be undertaken. See MPEP §§ 403.01(a), 403.01(b), 403.02, and 714.01(d).”

Form paragraph 4.01 states: “Applicant has appointed an attorney or agent to conduct all business before the Patent and Trademark Office. Double correspondence with an applicant and applicant’s attorney or agent will not be undertaken. Accordingly, applicant is required to conduct all future correspondence with this Office through the attorney or agent of record. See 37 CFR 1.33.”

When two patent practitioners are appointed, the handling of correspondence depends on how and when they were appointed. According to MPEP 403.02:

“If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record.”

This means that the USPTO will use the most recently provided correspondence address. It’s important to note that this is governed by 37 CFR 1.33 and 37 CFR 1.76, which provide regulations on correspondence and application data sheets.

To learn more:

When two patent practitioners are appointed for the same application:

  • If appointed simultaneously, the applicant should specify which address to use for correspondence.
  • If a second practitioner is added later, correspondence will be sent to the most recently provided correspondence address.
  • A new power of attorney appointing only the second practitioner effectively revokes the power of the first practitioner.

According to MPEP 403.02: “If the applicant simultaneously appoints two patent practitioners, applicant should indicate with whom correspondence is to be conducted by specifying a correspondence address. … If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record. … Note that if the later-filed power of attorney only lists the second practitioner, the later-filed power of attorney serves as a revocation of the earlier-filed power of attorney, even without an express revocation of the power of the first patent practitioner.”

When multiple parties are prosecuting a patent application, the USPTO has specific procedures for handling correspondence. The MPEP states:

“Double correspondence will still not be permitted. Accordingly, when the acceptance of such papers results in an attorney or agent and at least one applicant or owner prosecuting the application, correspondence will be mailed to the attorney or agent.”

Furthermore, when multiple attorneys or agents are involved:

“When the acceptance of such papers results in more than one attorney or agent prosecuting the application, the correspondence address will continue to be that of the attorney or agent first named in the application, unless all parties agree to a different correspondence address.”

Key points to remember:

  • Correspondence is typically sent to the attorney or agent if one is involved.
  • If multiple attorneys are prosecuting, the first-named attorney receives correspondence unless otherwise agreed.
  • Each attorney or agent must indicate whom they represent in subsequent papers.
  • All parties involved must sign replies to the USPTO.

To learn more:

Tags: USPTO

Assignment information printed on a patent follows these guidelines:

  • Only the first appearing name of an assignee will be printed on the patent, even if multiple names for the same party are identified on the Fee(s) Transmittal form (PTOL-85B).
  • This printing practice does not affect the recording of assignments with the USPTO’s Assignment Division.
  • The assignee entry on the PTOL-85B should still include all assignment data as recorded in the Office.

For example: The assignee entry on form PTOL-85B should still be completed to indicate the assignment data as recorded in the Office. For example, the assignment filed in the Office and, therefore, the PTOL-85B assignee entry might read ‘Smith Company doing business as (d.b.a.) Jones Company.’ The assignee entry on the printed patent will read ‘Smith Company.’

It’s important to note that assignment information printed on a patent is not updated after issuance and may not reflect subsequent assignments recorded in the Office.

For countries that are not members of the Hague Convention, the authentication process for oaths in patent applications is different. The MPEP states:

“When the oath is made in a foreign country not a member of the Hague Convention Abolishing the Requirement of Legalization for Foreign Public Documents, the authority of any officer other than a diplomatic or consular officer of the United States authorized to administer oaths must be proved by certificate of a diplomatic or consular officer of the United States.”

This means that for non-member countries, the authority of the officer administering the oath must be certified by a U.S. diplomatic or consular officer. This can be done directly or through an intermediary. If the oath is not properly authenticated, the USPTO will still accept the application for examination, but the applicant should submit a new, properly authenticated oath or a declaration under 37 CFR 1.68.

To learn more:

An international application is defined in 37 CFR 1.9(b). While the specific definition is not provided in the given MPEP excerpt, it generally refers to a patent application filed under the Patent Cooperation Treaty (PCT). International applications allow inventors to seek patent protection in multiple countries through a single filing process.

For more detailed information on international applications, you can refer to the full text of 37 CFR 1.9(b) and related sections of the MPEP.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For more information on patent law, visit: patent law.

An interim copy of a foreign application serves as a temporary substitute for a certified copy but does not replace the requirement for a certified copy. The key differences are:

  • An interim copy can be from the applicant’s own records, while a certified copy must be from the foreign patent office.
  • An interim copy satisfies the initial time requirement in 37 CFR 1.55(f), but a certified copy is still required.
  • An interim copy is labeled as ‘Interim Copy,’ while a certified copy has official certification from the foreign patent office.

The MPEP clarifies:

‘Thus, providing an interim copy of a foreign application under 37 CFR 1.55(j) satisfies the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f), but a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate.’

In essence, the interim copy is a temporary measure to meet deadlines, while the certified copy remains a formal requirement.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

Enforcement of arbitration awards in patent cases requires specific steps as outlined in 35 U.S.C. 294(d) and 37 CFR 1.335. Key points include:

  • The patentee, assignee, or licensee must file a written notice of the award with the USPTO Director.
  • The notice must include details about the patent, parties involved, and a copy of the award.
  • The award is unenforceable until the required notice is received by the Director.

As stated in 35 U.S.C. 294(e): “The award shall be unenforceable until the notice required by subsection (d) is received by the Director.”

This requirement ensures that the USPTO is informed of arbitration outcomes affecting patent rights.

For more information on arbitration awards, visit: arbitration awards.

For more information on patent enforcement, visit: patent enforcement.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP ¶ 2.30, the applicant is typically notified that their CPA request has been accepted through the first Office action on the CPA. The MPEP states: “Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established.” This notification is important because, as the MPEP notes, “applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

Unlike regular patent applications, applicants are not typically notified when a Continued Prosecution Application (CPA) has been established. The MPEP ¶ 2.30 states: “This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

Instead, the first notification an applicant usually receives is in the first Office action of the CPA. The examiner will use specific language to advise the applicant that the CPA request was acceptable and has been established.

An ‘institution of higher education’ for micro entity status purposes is defined according to Section 101(a) of the Higher Education Act of 1965. The key criteria include:

  • Located in any U.S. state or territory
  • Admits students with secondary education or equivalent
  • Authorized to provide post-secondary education
  • Offers bachelor’s degrees or at least 2-year programs toward such degrees
  • Is a public or non-profit institution
  • Is accredited or pre-accredited by a recognized agency

As stated in MPEP 509.04(b): “Section 101(a) of the Higher Education Act of 1965 defines what is meant by ‘institution of higher education’ in the context of 37 CFR 1.29(d).”

To learn more:

Access to provisional patent applications is handled differently from non-provisional applications. According to MPEP 104:

“In provisional applications, access or certified copies may only be requested by parties with written authority from a named inventor, the applicant, the assignee of record, or the attorney or agent of record, unless the application is available pursuant to 37 CFR 1.14(a)(1)(iv)-(vi).”

The MPEP further explains:

“Since provisional applications do not require an oath or declaration, there may be no power of attorney in the application.”

This means that access to provisional applications is more restricted and typically requires specific written authority from key parties involved in the application. The absence of a required oath or declaration in provisional applications also affects how access is granted, as there may not be a formal power of attorney on file.

For more information on certified copies, visit: certified copies.

For more information on written authority, visit: written authority.

Access to patent applications for unregistered individuals is granted through a specific process outlined in MPEP 104:

“Unregistered employees of attorneys or agents, public stenographers, and all other persons not within the provisions of paragraphs (A) and (B) above will be given access only upon presentation of a written authorization for access (power to inspect) signed by a person specified in paragraph (A) above, which authorization will be entered as a part of the official file.”

This means that unregistered individuals must present a written authorization, often called a ‘power to inspect,’ signed by an authorized person such as the applicant, inventor, or attorney of record. The authorization must specifically name the person granted access and be limited to a single application. The USPTO provides Form PTO/SB/67 for this purpose.

For more information on Patent application access, visit: Patent application access.

For more information on power to inspect, visit: power to inspect.

The processing of a pre-AIA 37 CFR 1.47 application involves several steps:

  1. A filing date is assigned if the application meets the requirements of 37 CFR 1.53(b).
  2. A filing receipt is sent to the applicant.
  3. The application or an electronic message about the petition is forwarded to the Office of Petitions.
  4. If the papers are found acceptable, the Office of Petitions enters a decision in the file.
  5. A notice is published in the Official Gazette with application details.
  6. The USPTO notifies the nonsigning inventor(s) or legal representative(s) by letter.

As stated in the MPEP, When papers deposited pursuant to pre-AIA 37 CFR 1.47 are found acceptable, the Office of Petitions enters a decision to that effect in the file. A notice will be published in the Official Gazette identifying the application number, filing date, the title of the invention and the name(s) of the nonsigning inventor(s).

To learn more:

To learn more:

In international patent applications, a common representative can be appointed in several ways. According to MPEP 402.09 and 37 CFR 1.455(b):

Appointment of an agent, attorney or common representative (PCT Rule 4.8) must be effected either in the Request form, signed by applicant, in the Demand form, signed by applicant, or in a separate power of attorney submitted either to the United States Receiving Office or to the International Bureau.

If no specific appointment is made and there are multiple applicants, the first named applicant who is entitled to file with the U.S. Receiving Office is considered the common representative by default, as stated in 37 CFR 1.455(a).

To learn more:

According to MPEP ¶ 2.35, the USPTO treats ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. The MPEP explicitly states:

Any ‘conditional’ request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.

This means that even if an applicant submits a CPA request with conditions attached, the USPTO will process it as a standard, unconditional CPA request. This policy ensures clarity and consistency in the application process.

For more information on CPA, visit: CPA.

For more information on USPTO procedures, visit: USPTO procedures.

For non-design patent applications filed on or after December 18, 2013, the drawing requirements have been relaxed. The MPEP states: Applications, which are not design applications, filed under 35 U.S.C. 111(a) or (b) on or after December 18, 2013 are entitled to a filing date even if the application does not contain drawings. However, it’s important to note that while drawings are not required for a filing date, they should still be submitted if necessary for understanding the invention, as no amendment may introduce new matter into the disclosure of an application after its filing date.

To learn more:

The requirement for specific reference to prior applications has undergone changes due to recent legislation:

  1. For applications filed before September 16, 2012: The specific reference to the prior application must be in the first sentence(s) of the specification or in an application data sheet.
  2. For applications filed on or after September 16, 2012: The specific reference to the prior application must be in the application data sheet (ADS).

As stated in the MPEP: Thus for all applications filed on or after September 16, 2012, the specific reference to the prior application must be in the application data sheet; for applications filed prior to September 16, 2012, the specific reference to the prior application must be in an application data sheet or in the first sentence(s) of the specification. (MPEP 210)

This change was implemented as part of the inventor’s oath or declaration provisions of the Leahy-Smith America Invents Act, which became effective on September 16, 2012. The Office revised 37 CFR 1.78 to reflect these changes.

For more information on ADS, visit: ADS.

For more information on application data sheet, visit: application data sheet.

For more information on prior applications, visit: prior applications.

For more information on specific reference, visit: specific reference.

How does WTO membership affect foreign priority rights?

World Trade Organization (WTO) membership has significant implications for foreign priority rights in patent applications:

  • WTO member countries are treated as Paris Convention countries for priority purposes.
  • Applicants from WTO member countries can claim priority in the U.S., even if the country is not a Paris Convention signatory.
  • The same 12-month priority period applies to applications from WTO member countries.
  • WTO membership expands the pool of countries eligible for foreign priority claims.

MPEP 213.01 states: “A foreign application filed in a WTO member country on or after the date on which the country becomes a WTO member country is also entitled to the right of priority.” This provision ensures broader international protection opportunities for inventors and applicants.

When a practitioner withdraws and the correspondence address will change as a result, the withdrawing practitioner(s) must request that the USPTO direct all future correspondence to one of the following:

  • The first named inventor or assignee that has properly made itself of record (for applications filed before September 16, 2012)
  • The applicant (for applications filed on or after September 16, 2012)
  • The assignee of record (for proceedings involving issued patents)

Practitioners can specify either the correspondence address or the address associated with the Customer Number of the appropriate party. It’s important to note that withdrawing practitioners cannot change the correspondence address to another law firm’s Customer Number or any other address except those mentioned above.

This ensures that the patent application or proceeding remains properly managed after the practitioner’s withdrawal.

To learn more:

How does USPTO verify gross income for micro entity status?

The USPTO generally does not independently verify the gross income of applicants claiming micro entity status. According to MPEP 509.04(a):

“The Office does not generally question certification of micro entity status but may require additional information on a case-by-case basis.”

However, applicants are required to certify their eligibility for micro entity status under oath. Providing false information can lead to severe consequences, including invalidation of the patent and potential criminal charges for fraud.

To learn more:

Transferring rights in an invention can affect small entity status. According to MPEP 509.02:

If the individual inventor, small business concern, or nonprofit organization assigned, granted, conveyed, or licensed, or came under an obligation to assign, grant, convey, or license, any rights to the invention to any individual, small business concern, or nonprofit organization which would not qualify as a small entity (37 CFR 1.27(a)), then the inventor, small business concern, or nonprofit organization would no longer qualify for small entity status.

However, transferring partial rights to another small entity does not disqualify the original entity from small entity status. It’s important to note that rights in question are those in the United States. Transferring rights to a foreign patent does not affect small entity status if no U.S. rights are transferred.

To learn more:

The USPTO has specific methods to verify the authenticity of S-signatures:

  1. Comparison with other documents: The USPTO may compare the S-signature with other signatures from the same person in their records.
  2. Certification statement: MPEP 402.03 states: ‘The person inserting a permanent S-signature must present a statement certifying that the inserted signature is his or her own signature.’
  3. Audit trail: Electronic filing systems may maintain an audit trail of who submitted the document.
  4. Additional verification: In case of doubt, the USPTO may request additional verification or clarification.

While the USPTO generally presumes the authenticity of signatures, it’s crucial to ensure all S-signatures are genuine and properly certified to avoid potential legal issues.

To learn more:

The USPTO verifies an assignee’s right to inspect a patent application through documentation. As per MPEP 106.01, the assignee must provide either a copy of the assignment recorded in the USPTO or other evidence of ownership. This documentation is necessary to establish the assignee’s legal right to access the confidential information contained in the patent application.

For patent applications filed on or after September 21, 2004, the United States Patent and Trademark Office (USPTO) has a specific policy regarding preliminary amendments. According to MPEP 608.04(b):

For applications filed on or after September 21, 2004, the Office will automatically treat any preliminary amendment under 37 CFR 1.115(a)(1) that is present on the filing date of the application as part of the original disclosure.

This means that any preliminary amendment submitted along with the application on its filing date will be considered part of the original disclosure, without any additional action required by the applicant.

To learn more:

The USPTO treats conditional assignments as absolute assignments for Office purposes. According to 37 CFR 3.56:

“Assignments which are made conditional on the performance of certain acts or events, such as the payment of money or other condition subsequent, if recorded in the Office, are regarded as absolute assignments for Office purposes until canceled with the written consent of all parties or by the decree of a court of competent jurisdiction.”

The USPTO does not determine whether conditions have been fulfilled. Recording a conditional assignment is treated as signifying that the condition has been met.

To learn more:

The USPTO treats all ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. According to MPEP ¶ 2.35:

Any “conditional” request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.

This means that once a conditional CPA request is submitted, it will be processed as a standard CPA, regardless of the applicant’s original intent.

For more information on CPA, visit: CPA.

Tags: CPA

How does the USPTO retrieve priority documents through PDX?

The USPTO retrieves priority documents through the Priority Document Exchange (PDX) program upon request from the applicant. As stated in MPEP 215.02(a), ‘If the applicant requests retrieval of the priority document through the PDX program, the USPTO will attempt to retrieve the document.’ The process involves:

  • The applicant making a request for retrieval
  • The USPTO accessing the electronic system of the participating office
  • Retrieving the priority document if available
  • Adding the retrieved document to the application file

This streamlined process eliminates the need for applicants to manually obtain and submit priority documents from other participating patent offices.

To learn more:

The USPTO retrieves foreign priority documents through the priority document exchange program automatically when certain conditions are met. As stated in MPEP 215.02(a):

“The USPTO will attempt retrieval of the priority document through the priority document exchange program when the applicant has (1) requested retrieval via the Priority Document Exchange (PDX) program in an application data sheet and (2) provided a foreign application number and intellectual property office that participates in a priority document exchange agreement with the USPTO.”

This automated process helps streamline the priority document submission for applicants.

To learn more:

The USPTO has a specific process for handling notices of arbitration awards related to patents. According to the Manual of Patent Examining Procedure (MPEP) Section 311:

“The written notices required by this section should be directed to the attention of the Office of the Solicitor. The Office of the Solicitor will be responsible for processing such notices.”

This process involves:

  • Directing all written notices of arbitration awards to the Office of the Solicitor.
  • The Office of the Solicitor taking responsibility for processing these notices.
  • Ensuring that the notices are properly recorded and associated with the relevant patent files.

This centralized approach helps maintain accurate records of arbitration outcomes affecting patent rights and ensures that the information is properly managed within the USPTO system.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has an automated system for processing assignment documents submitted by fax. According to MPEP 302.09:

  1. Documents are submitted directly into the automated Patent and Trademark Assignment System.
  2. A recordation notice is automatically returned to the sending fax number.
  3. If the system can’t complete the transmission, the notice is printed and mailed via U.S. Postal Service first class mail.
  4. The Patent and Trademark Assignment System assigns reel and frame numbers and adds recordation stampings to the processed electronic images.

The MPEP states: The Patent and Trademark Assignment System assigns reel and frame numbers and superimposes recordation stampings on the processed and stored electronic images. Accordingly, copies of all recorded documents will have the reel and frame numbers and recordation stampings.

This automated process ensures efficient handling and proper documentation of assignment records.

To learn more:

The USPTO has established procedures to notify the public about postal service interruptions that may affect patent filings. According to MPEP 511:

When the Director designates a postal service interruption or emergency, a notice will be published in the Official Gazette, and will be posted on the USPTO website at www.uspto.gov.

The USPTO’s notification process includes:

  • Publishing a notice in the Official Gazette
  • Posting information on the USPTO website
  • Possibly issuing press releases or other public communications

These notifications typically include:

  • Details about the nature and scope of the interruption
  • Any special procedures or accommodations being made
  • Instructions for applicants affected by the interruption
  • Contact information for further inquiries

It’s crucial for patent applicants and attorneys to regularly check these official sources during potential postal disruptions to stay informed about any changes in filing procedures or deadlines.

To learn more:

According to MPEP 406, the USPTO follows a specific procedure to notify client-applicants:

‘The Office of Enrollment and Discipline will notify the client-applicant of the availability of a list of patent practitioners who may be available to represent the client-applicant.’

This notification ensures that the client-applicant is aware of the situation and has resources to find new representation if needed.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO notification, visit: USPTO notification.

How does the USPTO notify applicants of their practitioner’s suspension or exclusion?

The USPTO has a specific process for notifying applicants when their patent practitioner has been suspended or excluded. The MPEP 407 outlines this process:

“The OED Director will… notify the applicant of the suspension or exclusion and of the limited recognition of the practitioner. The notification will be sent to the address of record in the application.”

This notification serves several purposes:

  • Informs the applicant of their practitioner’s status change
  • Advises the applicant of the practitioner’s limited recognition period
  • Allows the applicant to take necessary actions to protect their patent application

It’s crucial for applicants to promptly respond to such notifications to ensure their patent applications are not adversely affected by their practitioner’s disciplinary status.

For more information on USPTO notification, visit: USPTO notification.

When a Continued Prosecution Application (CPA) request for a design patent is found to be non-compliant, the USPTO notifies the applicant using a specific form paragraph. This notification informs the applicant about the issue and provides necessary details.

According to the MPEP, the examiner uses the following format:

  • ‘Receipt is acknowledged of the request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on Application No. [2].’
  • ‘However, because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.’

In this notification, [1] represents the filing date of the paper containing the CPA request, and [2] is the Application Number identified in the CPA request. This clear communication helps applicants understand the issue and take corrective action.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

When the USPTO receives an unacceptable Continued Prosecution Application (CPA) request for a design patent application, they notify the applicant using a standardized form paragraph. According to MPEP ¶ 2.31, the examiner will use the following language:

Receipt is acknowledged of the request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on Application No. [2]. However, because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.

This notification informs the applicant that their CPA request has been received but not accepted due to non-compliance with the separate paper requirement. The examiner will insert the filing date of the CPA request and the application number in the appropriate brackets.

For more information on USPTO notification, visit: USPTO notification.

The USPTO maintains a clear separation between assignment documents and patent files to ensure proper organization and management of records. MPEP 318 specifies:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This separation is maintained by:

  • Directing assignment documents to the Assignment Division instead of application or patent files
  • Keeping a separate database for assignment records
  • Ensuring that patent examiners and other USPTO personnel refer to the Assignment Division for ownership information
  • Maintaining distinct processes for handling assignments and patent prosecution

This approach helps in preserving the integrity of both assignment records and patent files while facilitating efficient access to ownership information when needed.

To learn more:

The USPTO has a specific policy for handling unnecessary duplicate copies of correspondence. According to MPEP 502.04:

The Office may dispose of duplicate copies of correspondence in the file of an application, patent, or other proceeding.

Furthermore, the MPEP states:

When the Office does not require duplicate copies of a paper, the filing of multiple copies may cause a delay in processing by the Office. Accordingly, the Office may discard duplicate copies of correspondence filed in an application or patent file.

This means that if you submit unnecessary duplicate copies, the USPTO may discard them to streamline processing and prevent delays. It’s important to only submit duplicate copies when specifically required by the Office.

To learn more:

The USPTO handles United Kingdom provisional specifications in priority claims as follows:

  • A certified copy of the “provisional specification” may be submitted, sometimes accompanied by a copy of the “complete specification.”
  • The provisional specification is examined for completeness of disclosure, as it may not contain a complete disclosure in the sense of 35 U.S.C. 112.
  • If the UK provisional specification is found insufficient for lack of disclosure, reliance may then be placed on the complete specification and its date, treating it as a different application than the provisional specification.

The MPEP states: “In applications filed from the United Kingdom there may be submitted a certified copy of the ‘provisional specification,’ which may also in some cases be accompanied by a copy of the ‘complete specification.’ According to United Kingdom law the provisional specification need not contain a complete disclosure of the invention in the sense of 35 U.S.C. 112, but need only describe the general nature of the invention, and neither claims nor drawings are required.” (MPEP 216)

The USPTO handles unintentionally delayed domestic benefit claims similarly to foreign priority claims, but with some specific provisions. According to MPEP 214.02:

‘For applications filed on or after September 16, 2012, the specific reference to the prior application must be included in an application data sheet (37 CFR 1.76). For applications filed prior to September 16, 2012, the specific reference to the prior application must be in the first sentence(s) of the specification or in an application data sheet.’

For domestic benefit claims under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c), a petition to accept an unintentionally delayed claim must include:

  • The reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior-filed application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the benefit claim was filed was unintentional.

The Director may require additional information where there is a question whether the delay was unintentional.

To learn more:

How does the USPTO handle unacceptable multiple dependent claims?

The USPTO has specific procedures for handling unacceptable multiple dependent claims:

  • If an application contains an unacceptable multiple dependent claim, the examiner should object to the claim under 37 CFR 1.75(c).
  • The applicant may cancel the unacceptable multiple dependent claim, amend it to become a single dependent claim, or rewrite it in proper form.
  • Other claims depending on an improper multiple dependent claim will not be treated on the merits.

According to MPEP 608.01(n):

“If none of the multiple dependent claims is proper, the examiner should require correction of at least one multiple dependent claim and state why the other claims are improper if it is considered desirable to explain the broader aspects of the requirements.”

This approach ensures that applicants have the opportunity to correct improper multiple dependent claims while maintaining the integrity of the patent examination process.

To learn more:

How does the USPTO handle telephone inquiries about application status?

The USPTO has specific procedures for handling telephone inquiries about application status. According to MPEP 203.08:

“Telephone inquiries regarding the status of applications, other than those referred to in MPEP § 203.08(a), should be directed to the USPTO Contact Center (UCC).”

The UCC is equipped to handle general status inquiries, while more specific inquiries may be directed to the appropriate Technology Center or Patent Examining Group. This system ensures that inquiries are handled efficiently and by staff with the appropriate level of expertise.

To learn more:

The USPTO follows a strict procedure for handling telephone and in-person requests for information about unpublished pending or abandoned patent applications:

  1. Obtain the caller’s full name, application number, and telephone number
  2. Verify the caller’s identity and authority to receive information
  3. Check Patent Data Portal or the application file to verify releasable information
  4. Return the call using a verified telephone number

Information is only released to authorized individuals, such as the patent practitioner of record, inventor, applicant, or authorized representative of the assignee of record.

How does the USPTO handle status inquiries for unpublished applications?

The USPTO has specific procedures for handling status inquiries for unpublished applications:

  • Status information is only provided to applicants, their attorneys or agents, or assignees of record.
  • Third parties cannot receive status information about unpublished applications.
  • The USPTO may confirm the filing date, application number, and whether the application is pending, abandoned, or patented.

As stated in MPEP 203.08, ‘For unpublished applications, the Office will not give status information to the public without the authorization of the applicant, attorney or agent of record or the assignee of record.’

To learn more:

When an inventor is deceased, the MPEP 409.03(d) provides specific guidance:

In the case of the death of the inventor, the legal representative (executor, administrator, etc.) of the deceased inventor may sign the necessary oath or declaration.

This means that:

  • The legal representative of the deceased inventor can sign the required oath or declaration
  • Proof of the inventor’s death and the legal representative’s authority should be provided
  • The application can proceed with the legal representative acting on behalf of the deceased inventor

It’s important to note that the legal representative must have the authority to act on behalf of the deceased inventor’s estate. This typically requires documentation such as a death certificate and letters of administration or executorship.

To learn more:

How does the USPTO handle requests for early delivery of patents?

The USPTO has a specific process for handling requests for early delivery of patents. According to MPEP 308:

“Ordinarily the patent grant is delivered to the correspondence address of record. However, a patentee may request in writing before the issue date that the patent grant be delivered to another address or to an assignment recordation branch of the USPTO for recordation of an assignment, provided a fee is paid for the service.”

This means that:

  • Patentees can request early delivery of their patent grant
  • The request must be made in writing before the issue date
  • A fee is required for this service
  • The patent can be delivered to an alternative address or to the assignment recordation branch

Early delivery requests are typically made when there’s an urgent need to record an assignment or to obtain the physical patent document for business purposes.

For more information on patent grant, visit: patent grant.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has specific rules for representation by foreign attorneys or agents:

  • Foreign attorneys or agents who are not registered to practice before the USPTO and do not reside in the U.S. are not permitted to represent patent applicants before the USPTO.
  • There is an exception for Canadian patent agents under limited recognition.
  • Applicants may be represented by a registered attorney or agent who is not residing in the United States.

According to MPEP 402.01: No attorney or agent residing in a foreign country may be registered to practice before the United States Patent and Trademark Office. This emphasizes the importance of proper registration and residency for patent practitioners.

To learn more:

The USPTO has specific procedures for handling refunds of fees paid by credit card. According to MPEP 509:

35 U.S.C. 42(d) and 37 CFR 1.26 (which concern refund of patent and trademark fees) also apply to requests for refund of fees paid by credit card. Any refund of a fee paid by credit card will be by a credit to the credit card account to which the fee was charged. See 37 CFR 1.26(a).

Key points about USPTO refunds for credit card payments:

  • Refunds are processed as credits to the original credit card account used for payment.
  • The same laws and regulations governing refunds of patent and trademark fees apply to credit card payments.
  • For information on which fees are refundable, refer to MPEP § 607.02 regarding returnability of fees.

It’s important to note that refund requests are subject to specific criteria and time limitations, so applicants should review the relevant regulations when seeking a refund.

To learn more:

Tags: patent fees

The USPTO has specific guidelines for handling proof of refusal from a non-signing inventor. According to MPEP 409.03(d):

In the case of refusal, the proof that a bona fide attempt was made to present a copy of the application papers to the non-signing inventor for signature, but the inventor refused to sign the papers, must be submitted.

To demonstrate proof of refusal, an applicant should:

  • Provide evidence of attempts to present the application to the inventor
  • Document the inventor’s explicit refusal to sign
  • Include any communication or statements from the inventor indicating refusal
  • Submit an affidavit or declaration detailing the refusal circumstances

The USPTO will review this evidence to determine if it constitutes a valid proof of refusal.

To learn more:

How does the USPTO handle proof of proprietary interest for deceased inventors?

The USPTO has specific provisions for handling proof of proprietary interest when an inventor is deceased. According to MPEP 409.03(f):

‘In the case of a deceased inventor, the proof of proprietary interest must be signed by the legal representative (executor, administrator, etc.) of the deceased inventor’s estate.’

This means that:

  • The legal representative of the deceased inventor’s estate must provide the necessary documentation.
  • This could be an executor or administrator appointed by the court.
  • The proof should demonstrate that the legal representative has the authority to act on behalf of the deceased inventor’s estate in matters related to the patent application.

It’s important to note that the USPTO requires proper documentation to ensure that the rights of the deceased inventor are properly represented and that the application is prosecuted by those with legitimate authority to do so.

To learn more:

Priority Mail Express® submissions to the USPTO are handled differently from regular mail. According to MPEP 505, New patent applications filed in accordance with 37 CFR 1.10 will be stamped by the Office with the date of deposit as Priority Mail Express® with the United States Postal Service.

This means:

  • The date of deposit with USPS is used as the receipt date, not the date it arrives at the USPTO
  • This applies even on weekends and holidays when the USPTO is closed

For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

For more information on Priority Mail Express, visit: Priority Mail Express.

For more information on USPTO, visit: USPTO.

How does the USPTO handle priority documents in national stage applications?

The USPTO handles priority documents in national stage applications (35 U.S.C. 371) as follows:

  • If the priority document is already in the international application file, no further action is needed.
  • The USPTO will retrieve the document from WIPO’s digital library (DAS) if it’s available there.
  • If not available through DAS, the applicant must submit the certified copy.

According to MPEP 213.06: ‘If the priority document is not in the international application file but was properly filed with the International Bureau during the international phase, the USPTO will retrieve from the International Bureau a copy of the certified copy of the priority document.’ This process simplifies the handling of priority documents for applicants entering the national stage.

To learn more:

To learn more:

The USPTO treats a proper priority claim to an application filed in a participating foreign intellectual property office as a request to obtain a copy of the foreign application. The MPEP states:

The Office treats a proper priority claim under 37 CFR 1.55 to an application filed in a participating foreign intellectual property office as a request that the Office obtain a copy of the foreign application from the participating intellectual property office.

This means that applicants do not need to submit a separate request for the USPTO to retrieve the foreign application if they have made a proper priority claim and the foreign office is a PDX participant.

The USPTO treats a proper priority claim to an application filed in a participating foreign intellectual property office as a request to obtain a copy of the foreign application. According to MPEP 215.01:

The Office treats a proper priority claim under 37 CFR 1.55 to an application filed in a participating foreign intellectual property office as a request that the Office obtain a copy of the foreign application from the participating intellectual property office.

This means that applicants generally do not need to file a separate request for the USPTO to retrieve the priority document if it’s from a participating office.

To learn more:

When the certified copy of the priority document is already in the International Bureau’s priority document database, the USPTO handles priority claims in national stage applications as follows:

  • The USPTO will attempt to retrieve the certified copy from the International Bureau’s priority document database.
  • If successful, no further action is required from the applicant regarding the submission of the certified copy.
  • According to MPEP 213.06, ‘In national stage applications, a claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.’
  • The USPTO will consider the priority claim to be compliant with the requirements of 37 CFR 1.55(f)(2) if the certified copy is timely retrieved from the International Bureau.

This process simplifies the priority claim procedure for applicants in national stage applications when the certified copy is already available through the International Bureau.

To learn more:

Tags: USPTO

The USPTO handles priority claims in international design applications as follows:

  • For international design applications designating the United States, the USPTO acts as an office of indirect filing.
  • Priority claims must be made in the international design application when filed with the International Bureau.
  • The USPTO will not transmit a priority claim made in a subsequently filed transmittal letter.
  • Applicants should review the international registration certificate to ensure their priority claims are properly recorded.

As stated in MPEP 213.07: The United States Patent and Trademark Office (USPTO), in its capacity as an office of indirect filing, will not transmit to the International Bureau a priority claim that is made in a subsequently filed transmittal letter and not in the international design application as filed with the International Bureau.

To learn more:

The USPTO recognizes that some countries have restrictions on who can apply for patents versus inventor’s certificates. As stated in MPEP 213.05:

It is recognized that certain countries that grant inventors’ certificates also provide by law that their own nationals who are employed in state enterprises may only receive inventors’ certificates and not patents on inventions made in connection with their employment. This will not impair their right to be granted priority in the United States based on the filing of the inventor’s certificate.

This means that even if an applicant was restricted to filing for an inventor’s certificate in their home country due to employment or nationality, they can still claim priority in the US based on that filing. The key factor is whether the option to file for either a patent or an inventor’s certificate generally existed in the country for the particular subject matter, not whether the specific applicant had that choice.

To learn more:

The USPTO’s handling of preliminary amendments in continuation applications depends on when the application was filed and the nature of the amendment:

  • For applications filed on or after September 21, 2004: A preliminary amendment that is present on the filing date of the application is considered part of the original disclosure.
  • All preliminary amendments: Must be filed in compliance with 37 CFR 1.121, which includes providing a complete claim listing whenever a claim is added, canceled, or amended.
  • Substitute specification: The Office may require a substitute specification for preliminary amendments.

The MPEP states:

Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

It’s important to note that the USPTO advises against filing a continuation application with a preliminary amendment that makes all desired changes. Instead, they recommend:

Filing a continuing application under 37 CFR 1.53(b) with a new specification containing only the desired set of claims.

This approach ensures that the published application contains the intended set of claims, rather than those from the prior application.

For more information on continuation application, visit: continuation application.

The USPTO takes specific actions regarding powers of attorney granted to suspended or excluded practitioners. According to MPEP 407:

The Office of Enrollment and Discipline (OED) Director will contact the Director of the Technology Center (TC) managing the application when a practitioner has been suspended or excluded from practice. The OED Director will request that the TC Director review a pending application to determine whether the practitioner has been granted a power of attorney. If the suspended or excluded practitioner was given a power of attorney, the TC Director will notify the applicant and request a new power of attorney.

The process typically involves:

  • Identification of affected applications by the OED Director
  • Review of power of attorney status by the TC Director
  • Notification to the applicant if a power of attorney exists
  • Request for a new power of attorney from the applicant
  • Potential application abandonment if no response is received within 30 days

For more information on power of attorney, visit: power of attorney.

How does the USPTO handle photographs in patent applications?

The USPTO has specific guidelines for handling photographs in patent applications:

  1. General rule: As stated in MPEP 608.02(a), “Photographs, including photocopies of photographs, are not ordinarily permitted in utility and design patent applications.”
  2. Exceptions: Photographs are accepted in applications where they are the only practicable medium for illustrating the claimed invention. This typically applies to:
    • Crystalline structures
    • Metallurgical microstructures
    • Textile fabrics
    • Grain structures
    • Color effects
  3. Requirement for acceptance: The MPEP states, “The photographs must be of sufficient quality so that all details in the photographs are reproducible in the printed patent.”
  4. Color photographs: These require a petition explaining why color is necessary and are subject to additional fees.

If photographs are submitted, applicants should ensure they meet USPTO standards to avoid potential issues during examination.

To learn more:

The USPTO has special procedures for handling perishable models, exhibits, or specimens:

  • The Office will dispose of perishables without notice to the applicant, unless otherwise arranged.
  • Applicants must notify the Office upon submission if they desire the return of a perishable item.
  • If return is desired, applicants must make prompt arrangements for return upon notification from the Office.

According to 37 CFR 1.94(a), The Office will dispose of perishables without notice to applicant unless applicant notifies the Office upon submission of the model, exhibit or specimen that a return is desired and makes arrangements for its return promptly upon notification by the Office that the model, exhibit or specimen is no longer necessary for the conduct of business before the Office.

To learn more:

The USPTO has specific rules regarding patent term adjustments when dealing with notices about unlocatable files. According to the MPEP:

If, however, an applicant fails to reply to a notice under 37 CFR 1.251 within three months of its mailing date, any patent term adjustment under 35 U.S.C. 154(b) will be reduced by a period equal to the number of days (if any) beginning on the day after the date that is three months after the mailing date of the notice under 37 CFR 1.251 and ending on the date the reply to the notice under 37 CFR 1.251 was filed.

This reduction in patent term adjustment is based on 35 U.S.C. 154(b)(2)(C)(ii) and 37 CFR 1.704(b). It’s important to note that this reduction applies even if the applicant responds within the overall six-month period allowed for reply (including extensions).

This policy underscores the importance of prompt action in response to such notices, as delays can directly impact the duration of patent protection.

For more information on patent term adjustment, visit: patent term adjustment.

How does the USPTO handle patent applications when an inventor is legally incapacitated?

The USPTO has provisions for handling patent applications when an inventor is legally incapacitated. The MPEP 409.03(b) states:

“If a person is legally incapacitated, the legal representative (guardian, conservator, etc.) of such inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

In these cases:

  • The legal guardian or conservator acts on behalf of the incapacitated inventor
  • They must provide proof of their legal authority to represent the incapacitated inventor
  • The guardian or conservator executes the necessary oath or declaration
  • They handle all aspects of the patent application process on behalf of the inventor

This approach ensures that the intellectual property rights of legally incapacitated inventors are protected and that their inventions can still be patented.

To learn more:

When an inventor dies during the prosecution of a patent application, the USPTO has specific procedures in place:

  • If the inventor died after filing the application, the legal representative (executor or administrator of the estate) can proceed with the application.
  • The legal representative must submit evidence of their authority, such as Letters Testamentary or Letters of Administration.
  • If there are joint inventors, the surviving inventors can continue the prosecution.
  • The oath or declaration requirement can be fulfilled by the legal representative or the joint inventors.

As stated in MPEP 409.01: “If an inventor dies during the prosecution of an application, the legal representative (executor, administrator, etc.) of the deceased inventor may make the necessary oath or declaration.”

To learn more:

The USPTO has a specific process for handling patent applications filed without required drawings:

  1. The Office of Patent Application Processing (OPAP) reviews the application to determine if drawings are necessary under 35 U.S.C. 113.
  2. If drawings are required but missing, OPAP issues a Notice of Incomplete Application.
  3. The applicant is given a two-month period to submit the drawings and any required fees.
  4. If compliant drawings are received within this period, the application retains its original filing date.
  5. If drawings are not submitted or are non-compliant, the application may be treated as abandoned.

MPEP 601.01(f) states: ‘If the drawings are received within the two-month period and are acceptable, the USPTO will enter them into the application file and treat the application under 37 CFR 1.53(f) as having been filed on the date the initial submission was received in the USPTO.’

This process ensures that applications are complete and examiners have all necessary information to understand the invention.

To learn more:

During postal service emergencies, the USPTO takes special measures to ensure patent applications are handled appropriately:

  • The USPTO Director may designate the interruption or emergency as a ‘postal service interruption or emergency’ under 35 U.S.C. 21(a).
  • This designation allows for the acceptance of filings that would have been timely filed if not for the postal service interruption or emergency.
  • The USPTO may publish a notice in the Official Gazette and on its website about the designation and any special procedures to be followed.

As stated in MPEP 511: The USPTO will consider on a case-by-case basis whether to waive the date indicated on any certificate of mailing or transmission accompanied by a showing which establishes to the satisfaction of the Director that the delay was due to the emergency.

To learn more:

The USPTO has specific procedures for handling papers that include a Certificate of Mailing or Transmission. According to the MPEP:

“The Mail Center of the Office of Patent Application Processing (OPAP) will continue to date stamp the actual date of receipt of all papers received by mail in the Office. No attempt will be made to retain the envelopes in which the papers are received or to indicate on the papers the postal cancellation date (postmark).”

Key points in the USPTO’s handling process include:

  • The actual receipt date is stamped on all papers
  • The date on the Certificate is used to determine if the paper was filed within the period for reply
  • If the paper is received after the period for reply, but the Certificate date is within the period, the paper is considered timely filed
  • A notation (e.g., “C of Mail 11/10/97”) is made next to the Office Date Stamp to indicate the Certificate date

It’s important to note that while the Certificate date is used to determine timeliness, the actual receipt date is used for all other purposes, including calculating subsequent deadlines.

To learn more:

The USPTO has specific procedures for handling oversized models or exhibits. According to MPEP 608.03(a):

Oversized models or exhibits are not transferred to the File Information Unit (FIU). Instead, they are stored in a permanent location…

Here’s how the USPTO manages these items:

  • Oversized items are stored in a permanent location separate from the File Information Unit.
  • The USPTO may photograph the items if practical, before storage or disposal.
  • A decision is made on retention or return based on the nature and size of the item.
  • If return is requested, the applicant must provide proper postage and handling fees.

It’s important to communicate with the USPTO about any oversized models or exhibits to ensure proper handling and potential return.

To learn more:

The USPTO has specific guidelines for handling offensive language in patent applications. According to MPEP 608:

“If during the course of examination of a patent application, an examiner notes the use of language that could be deemed offensive to any race, religion, sex, ethnic group, or nationality, he or she should object to the use of the language as failing to comply with 37 CFR 1.3 which proscribes the presentation of papers which are lacking in decorum and courtesy.”

Examiners are instructed to object to such language and require its removal before classifying the application for publication or passing it to issue. This policy applies to both text and drawings in the application.

To learn more:

To learn more:

The USPTO handles oaths or declarations with defects as follows:

  • If the oath or declaration does not contain the required averments or information, the USPTO will object to it and require a new oath or declaration.
  • Defects in the wording of an oath or declaration may be corrected by a supplemental paper properly signed and identifying the application.
  • Non-initialed and/or non-dated alterations are treated as not made.

According to MPEP 602.03: ‘If the oath or declaration does not contain the information required by 37 CFR 1.63 or a signature, the Office will object to the oath or declaration and require a new oath or declaration. If the defect cannot be cured by a new oath or declaration, the Office will require reexecution of the declaration by the inventor.’

It’s important to note that while some defects can be corrected, others may require a completely new oath or declaration to be submitted.

To learn more:

How does the USPTO handle new matter introduced in continuation-in-part applications?

Continuation-in-part (CIP) applications are a special case when it comes to new matter. The MPEP 608.04 states:

‘In the case of a continuation-in-part application, any claim directed to matter which was not described in the parent nonprovisional application in the manner provided by the first paragraph of 35 U.S.C. 112 is treated as entitled only to the filing date of the continuation-in-part application.’

This means:

  • New matter can be introduced in a CIP application.
  • Claims based on the new matter will only receive the filing date of the CIP application.
  • Claims fully supported by the parent application can retain the earlier filing date.

Examiners will carefully review CIP applications to determine which claims are entitled to which filing dates, affecting prior art considerations and potentially the validity of the claims.

To learn more:

Tags: new matter

How does the USPTO handle new matter in continuation applications?

The United States Patent and Trademark Office (USPTO) treats new matter in continuation applications similarly to how it handles new matter in original applications. According to MPEP 608.04:

“A continuation application cannot include new matter. Applicant is required to delete the benefit claim or change the relationship (continuation application) to continuation-in-part (CIP) if the application contains subject matter that would have been new matter in the prior-filed application.”

This means that:

  • Continuation applications must be based entirely on the disclosure of the parent application
  • Any new subject matter introduced in a continuation application will be rejected as new matter
  • If new matter is present, the applicant must either remove it or change the application type to a continuation-in-part (CIP)

CIP applications allow for the introduction of new matter, but the new subject matter will only receive the benefit of the CIP filing date, not the earlier parent application date. It’s crucial for applicants to carefully review their continuation applications to ensure they don’t inadvertently introduce new matter, which could jeopardize their priority claim to the parent application.

To learn more:

To learn more:

When multiple correspondence addresses are provided, the USPTO has a specific process for selection. According to 37 CFR 1.33(a):

“If more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.”

This means that the USPTO will choose one address for all official communications, with a preference for Customer Number addresses if provided. Applicants should be aware of this to ensure they provide the most appropriate address for correspondence.

To learn more:

When multiple correspondence addresses are specified in a single document, the USPTO has a specific procedure for selecting which address to use. According to MPEP 601.03(b):

“If more than one correspondence address is specified in a single document, the Office will select one of the specified addresses for use as the correspondence address and, if given, will select the address associated with a Customer Number over a typed correspondence address.”

This means that if you provide multiple addresses, the USPTO will choose one, giving preference to a Customer Number address over a typed address. To avoid confusion, it’s best to clearly specify only one correspondence address in your patent application documents.

To learn more:

The USPTO has a specific procedure for handling missing documents from an application file. According to the MPEP:

When a document is missing from an application, Office practice is to call the applicant’s representative and request submission (generally by facsimile) of a copy of the missing document.

This informal approach is the primary method used by the USPTO to address missing documents. However, if this informal method is unsuccessful, the Office may resort to more formal measures:

While the Office will generally treat missing documents in this relatively informal manner (rather than issuing a notice under 37 CFR 1.251), the Office may issue a notice under 37 CFR 1.251 to obtain a copy of a missing document if the Office’s informal attempts to obtain a copy of the document are unsuccessful.

It’s important for applicants and their representatives to promptly respond to such informal requests to avoid more formal procedures and potential delays in application processing.

To learn more:

The USPTO does not officially receive mail on weekends or federal holidays when the office is closed. Any correspondence received on these days is typically stamped with the next business day’s date. For example, if mail is delivered to the USPTO on a Saturday, it will be stamped with the following Monday’s date (or Tuesday if Monday is a holiday). This practice ensures consistency in dating received documents and aligns with the USPTO’s official business hours.

How does the USPTO handle interviews for applications with multiple practitioners of record?

The USPTO has specific guidelines for handling interviews when multiple practitioners are of record for a patent application. MPEP 408 provides guidance on this situation:

‘Where a registered practitioner has been given a power of attorney or authorization of agent, only that practitioner, a practitioner appointed in an associate power of attorney or authorization of agent, or another registered practitioner who has the permission of one of the aforementioned practitioners may conduct an interview.’

This means that when multiple practitioners are of record, any one of them can conduct the interview. However, it’s important to note that clear communication between the practitioners is crucial to ensure consistent representation of the applicant’s interests. The USPTO typically communicates with the practitioner who initiated the interview or the one designated as the primary contact for the application.

For more information on patent examination, visit: patent examination.

For more information on power of attorney, visit: power of attorney.

The USPTO has a specific procedure for handling inquiries from high-level government sources. According to MPEP 203.08(a):

Inquiries referred to in this section such as correspondence from Congress or the White House should immediately be transmitted to the Director of the Office of Governmental Affairs, and a staff member of that office should be notified by phone that such correspondence has been received at 571-272-7300.

This process ensures uniformity in handling these important inquiries and compliance with Department of Commerce directives.

To learn more:

Tags: USPTO

For Continued Prosecution Applications (CPAs) filed under 37 CFR 1.53(d), the USPTO automatically considers information that was considered in the parent application. The MPEP states:

“Information which has been considered by the Office in the parent application of a continued prosecution application (CPA) filed under 37 CFR 1.53(d) will be part of the file before the examiner and need not be resubmitted in the continuing application to have the information considered and listed on the patent.”

This means that applicants do not need to resubmit previously considered information in a CPA. The examiner will have access to and consider this information without any additional action required from the applicant.

To learn more:

The USPTO handles informal drawings in patent applications as follows:

  • If the drawings are informal but otherwise sufficient for examination, the USPTO will accept them provisionally.
  • The drawings will be approved by the Office of Patent Application Processing (OPAP) for publication purposes.
  • Formal drawings will be required if the application is allowed.

According to MPEP 507: ‘If the drawings are informal but otherwise in compliance with 37 CFR 1.121(d), the OPAP will accept the application for purposes of publication and place a ‘Drawing Informalities’ form PTO-948 in the file wrapper.’

The examiner may require formal drawings or corrections in a subsequent office action if necessary for a proper examination or if the application is allowed.

For more information on drawing review, visit: drawing review.

For more information on informal drawings, visit: informal drawings.

For more information on OPAP, visit: OPAP.

How does the USPTO handle inequitable conduct in patent applications?

The USPTO takes inequitable conduct in patent applications very seriously. According to MPEP 410:

“[T]he Office will consider equitable and public policy principles in assessing whether to issue a patent to an applicant who has engaged in inequitable conduct.”

Inequitable conduct typically involves:

  • Failure to disclose material information
  • Submitting false material information
  • Intentional misrepresentation of facts

If inequitable conduct is found, the consequences may include:

  • Rejection of the patent application
  • Invalidation of an issued patent
  • Disciplinary action against registered practitioners

The USPTO may also refer cases of suspected fraud to the U.S. Department of Justice for potential criminal prosecution. It’s crucial for applicants and their representatives to maintain honesty and transparency throughout the patent application process.

For more information on fraud, visit: fraud.

For more information on USPTO, visit: USPTO.

Tags: fraud, USPTO

How does the USPTO handle incorrect or erroneous assignment recordings?

The USPTO has a specific process for handling incorrect or erroneous assignment recordings:

  1. No expungement: The USPTO does not expunge or remove assignment documents once they are recorded.
  2. Corrective documents: Parties can record corrective documents to address errors or provide clarifications.
  3. Maintaining integrity: This approach preserves the integrity of the assignment records.

As stated in MPEP 302: ‘Even if a recorded document is subsequently found to be invalid, the recording will be maintained in the assignment records and the assignment records will not be expunged.’ This policy ensures a complete historical record of all recorded documents.

For more information on USPTO records, visit: USPTO records.

The USPTO has specific rules for handling inconsistent information between an Application Data Sheet (ADS) and other documents:

  1. Generally, the most recent submission will govern.
  2. For foreign priority or domestic benefit claims, the most recent ADS will govern.
  3. Inventorship and inventor names are governed by 37 CFR 1.41 and 1.48.
  4. When submitted simultaneously, the ADS will govern over other documents.

37 CFR 1.76(d)(1) states: “The most recent submission will govern with respect to inconsistencies as between the information provided in an application data sheet, a designation of a correspondence address, or by the inventor’s oath or declaration, except that: (i) The most recent application data sheet will govern with respect to foreign priority (§ 1.55) or domestic benefit (§ 1.78) claims; and (ii) The naming of the inventorship is governed by § 1.41 and changes to inventorship or the names of the inventors is governed by § 1.48.”

If inconsistencies are found, applicants should submit a corrected ADS to ensure accurate information is captured by the Office.

To learn more:

The USPTO has specific rules for handling inconsistencies between the Application Data Sheet (ADS) and other documents, as outlined in MPEP 601.05:

  1. The most recent submission generally governs for inconsistencies between an ADS and other documents.
  2. For foreign priority or domestic benefit claims, the most recent ADS governs.
  3. For inventorship and inventor names, 37 CFR 1.41 and 1.48 govern.
  4. When inconsistent information is supplied simultaneously, the ADS will control over a designation of correspondence address or the inventor’s oath or declaration.
  5. The Office captures bibliographic information from the ADS and generally does not check it against other documents.

If you need to correct inconsistencies, submit a corrected ADS as described in 37 CFR 1.76(c)(1). Note that certain changes, such as inventorship, may require specific forms or petitions in addition to a corrected ADS.

To learn more:

For applications filed before September 16, 2012 (pre-AIA applications), the USPTO has specific guidelines for handling inconsistencies between the Application Data Sheet (ADS) and other documents. According to MPEP 601.05(b):

If an ADS is inconsistent with the information provided in another document that was submitted at the same time or previous to the ADS submission, the ADS will control.

However, there are exceptions to this rule:

  • Inventorship: The ADS does not control if it’s inconsistent with the inventorship set forth in an executed oath or declaration.
  • Correspondence address: A clear direction to use a different address will override the ADS.
  • Small entity status: Any small entity assertion or claim will control over the ADS.

It’s crucial for applicants to ensure consistency across all application documents to avoid potential issues during the examination process.

To learn more:

Tags: ADS, pre-AIA

The USPTO has specific procedures for handling incomplete nonprovisional applications:

  • The Office of Patent Application Processing (OPAP) reviews applications for completeness.
  • If deficiencies are found, OPAP sends a notice to the applicant.
  • The notice specifies the missing elements and provides a time period for correction.
  • Failure to respond may result in abandonment of the application.

MPEP 601.01(a) states: ‘If the application does not contain the specification required by 35 U.S.C. 112 including at least one claim and/or the oath or declaration, or any filing fee, the Office of Patent Application Processing (OPAP) will send a notice identifying the deficiency and setting a two month (not extendable) time period within which the applicant must supply the omission or correction in order to obtain a filing date.’

It’s crucial for applicants to respond promptly to these notices to avoid potential loss of filing date or abandonment of the application.

To learn more:

When dealing with Information Disclosure Statements (IDSs) in Requests for Continued Examination (RCE), the USPTO follows specific guidelines as outlined in the MPEP:

  1. Previously considered information: The MPEP states, “Information which has been considered by the Office in the application before the filing of a RCE will be part of the file before the examiner and need not be resubmitted to have the information considered by the examiner and listed on the patent.”
  2. Previously submitted but not considered information: The MPEP explains, “Information filed in the application in compliance with the content requirements of 37 CFR 1.98 before the filing of a RCE will be considered by the examiner after the filing of the RCE.”

For example, if an applicant filed an IDS after a final Office action that didn’t meet the requirements of 37 CFR 1.97(d)(1) and (d)(2), the examiner would not have considered it. However, after filing an RCE, the examiner will consider this previously submitted IDS without the need for resubmission.

For more details on RCE, refer to MPEP § 706.07(h).

To learn more:

The USPTO has specific procedures for handling hazardous or dangerous materials submitted as exhibits:

  • Such materials are not accepted for retention by the Office.
  • The Office will immediately dispose of these materials upon discovery.
  • Applicants are advised against submitting hazardous or dangerous materials.

According to MPEP 608.03(a): No substances or materials considered hazardous or dangerous to Office personnel, will be accepted.

If an applicant needs to demonstrate properties of hazardous materials, they should consider alternative methods, such as detailed descriptions, simulations, or non-hazardous substitutes.

To learn more:

The USPTO has specific procedures for handling foreign language provisional applications during the screening process. According to the MPEP:

Provisional applications filed in a foreign language are also screened under these provisions. The Office will make an attempt to determine the subject matter of the application, but the applicant may be required to provide at least an English language abstract of the information for screening purposes.

To avoid potential delays in the screening process, the MPEP strongly recommends:

It is strongly recommended that if the applicant is in possession of an English language description of the technology, it should be filed with the provisional application to prevent screening delays.

This recommendation helps ensure that the USPTO can efficiently review the application for national security and property rights issues without language barriers impeding the process.

For more information on patent procedure, visit: patent procedure.

The USPTO has specific rules for handling facsimile transmissions received outside of business hours, as outlined in MPEP 502.01:

Correspondence for which transmission was completed on a Saturday, Sunday, or Federal holiday within the District of Columbia, will be accorded a receipt date of the next succeeding day which is not a Saturday, Sunday, or Federal holiday within the District of Columbia.

This means that if a facsimile transmission is completed during non-business hours, weekends, or federal holidays, the USPTO will assign it a receipt date of the next business day. For example:

  • A fax completed on Friday at 9:05 p.m. Pacific time (12:05 a.m. Saturday Eastern time) would be accorded a receipt date of the following Monday (assuming Monday is not a federal holiday).
  • A fax completed on a federal holiday would be accorded a receipt date of the next business day.

It’s important to note that while the actual transmission may occur outside of business hours, the official receipt date will always be a business day. This can be crucial for meeting deadlines and calculating time-sensitive patent-related actions.

To learn more:

The USPTO has specific rules for dating facsimile transmissions. According to 37 CFR 1.6(a)(3):

Correspondence transmitted by facsimile to the Patent and Trademark Office will be stamped with the date on which the complete transmission is received in the Patent and Trademark Office unless that date is a Saturday, Sunday, or Federal holiday within the District of Columbia, in which case the date stamped will be the next succeeding day which is not a Saturday, Sunday, or Federal holiday within the District of Columbia.

This means that faxed correspondence is generally dated on the day of complete transmission, except for weekends and holidays, where it’s dated the next business day.

When errors are made in the execution of an original assignment document, the USPTO allows for the submission of a ‘substitute statement’ to correct these errors. According to MPEP 323:

“Where errors were made in the execution of the original assignment document … a ‘substitute statement’ may be submitted for recordation.”

The process involves:

  • Preparing a new, correctly executed assignment document.
  • Submitting this as a ‘substitute statement’ along with a copy of the originally recorded papers.
  • Clearly identifying the errors in the original document.
  • Paying the required recording fee.

The USPTO will then record the substitute statement, which effectively replaces the erroneous original assignment document.

For more information on patent assignment, visit: patent assignment.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

The USPTO recognizes and accepts electronic signatures on assignment documents submitted electronically. According to MPEP 302.10:

“The USPTO will accept electronic signatures on documents submitted electronically.”

This means that assignors and assignees can use various forms of electronic signatures, such as:

  • Typed names
  • Digital signatures
  • Scanned images of handwritten signatures

It’s important to ensure that the electronic signature complies with the USPTO’s requirements and is legally binding. The specific requirements for electronic signatures are outlined in MPEP 502.02.

To learn more:

When discrepancies are found in title reports, the USPTO takes specific actions to address them. The MPEP 320 states:

If there are discrepancies between the title report and the instrument(s) recorded in the USPTO or the file contents, the title report is returned to the paralegal with an explanation of the discrepancy. The paralegal then contacts the person who ordered the title report and requests correction.

This process ensures that any issues with ownership or chain of title are resolved before the patent application proceeds further.

For more information on ownership verification, visit: ownership verification.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has specific procedures for handling correspondence with a Certificate of Mailing or Transmission:

  1. All papers received by mail are date stamped with the actual date of receipt, regardless of any Certificate of Mailing.
  2. For papers with a Certificate of Mailing or Transmission, the date on the certificate is used to determine if the paper was filed within the period for reply.
  3. If the paper is received within the period for reply, the actual receipt date is used for all purposes.
  4. If the paper is received after the period for reply, but the certificate date is within the period, the paper is considered timely filed. In this case, a notation is made next to the ‘Office Date’ stamp indicating the certificate date (e.g., ‘C of Mail 11/10/97’).
  5. For facsimile transmissions, the date stamped is the date the complete transmission is received, unless that date is a Saturday, Sunday, or Federal holiday within the District of Columbia, in which case the date stamped will be the next succeeding business day.
  6. For EFS-Web submissions, the receipt date is the date the correspondence is received at the USPTO’s correspondence address when it was officially submitted, which can include weekends and holidays.

The MPEP states: “The date indicated on the Certificate of Mailing or of Transmission will be used by the Office only to determine if the paper was deposited in the United States Postal Service, transmitted by facsimile or transmitted via EFS-Web within the period for reply.”

How does the USPTO handle correspondence when there’s a conflict between customer number and application data sheet?

When there’s a conflict between the correspondence address provided in a customer number and an application data sheet (ADS), the USPTO follows specific rules:

  1. The correspondence address in the ADS takes precedence if filed with the initial application papers.
  2. A customer number provided in a single paper with a clear power of attorney overrides the ADS.
  3. If no power of attorney is filed, the correspondence address in the ADS is used.

The MPEP states:

Where an applicant provides a correspondence address in an application data sheet (ADS) that is different from the address associated with a customer number provided in a single paper (e.g., in a power of attorney or inventor’s oath or declaration), the address in the ADS will be the correspondence address of record. (MPEP 403)

It’s crucial to ensure consistency in your filings to avoid confusion. If you need to change the correspondence address after filing, you should submit a separate change of address request or update your customer number information.

For more information on application data sheet, visit: application data sheet.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO, visit: USPTO.

How does the USPTO handle correspondence submitted in violation of the rules?

The USPTO has specific procedures for handling correspondence submitted in violation of the rules. According to MPEP 501:

‘Correspondence submitted to the U.S. Patent and Trademark Office in violation of the rules as to paying fees, manner of presenting papers, or other formal matters will not be filed.’

However, the USPTO does provide a grace period and notification process:

  • The Office may notify the submitter of the violation and set a period for correction.
  • If the violation is corrected within the set period, the document will be considered as having been filed on the date of receipt of the correction.

It’s crucial for applicants to adhere to USPTO rules to avoid potential delays or non-filing of their correspondence. If a violation occurs, prompt correction based on USPTO notification is essential to maintain the original filing date.

How does the USPTO handle correspondence sent by Priority Mail Express®?

The USPTO treats correspondence sent by Priority Mail Express® (formerly Express Mail) with special consideration. According to MPEP 502:

“Any correspondence received by Priority Mail Express® will be considered filed with the USPTO on the date of deposit with the United States Postal Service.”

This means that the date of deposit with USPS is considered the filing date at the USPTO, which can be crucial for meeting deadlines. However, it’s important to note that:

  • The Priority Mail Express® label number must be placed on the correspondence.
  • The filing date accorded to Priority Mail Express® is only applicable to the specific items deposited with USPS.

Always keep your Priority Mail Express® mailing receipt as proof of the deposit date.

For more information on Priority Mail Express, visit: Priority Mail Express.

For more information on USPS, visit: USPS.

For more information on USPTO correspondence, visit: USPTO correspondence.

The USPTO does not receive or process correspondence on Saturdays, Sundays, or Federal holidays within the District of Columbia, with some exceptions. According to 37 CFR 1.6(a)(1):

The Patent and Trademark Office is not open for the filing of correspondence on any day that is a Saturday, Sunday, or Federal holiday within the District of Columbia. Except for correspondence transmitted by facsimile under paragraph (a)(3) of this section, or filed electronically under paragraph (a)(4) of this section, no correspondence is received in the Office on Saturdays, Sundays, or Federal holidays within the District of Columbia.

When the last day for taking action or paying a fee falls on a weekend or holiday, it’s considered timely if done on the next business day: When the last day for taking any action or paying any fee in the Office falls on a Saturday, Sunday, or a Federal holiday within the District of Columbia, the action or the fee is considered timely if the action is taken or the fee is paid on the next succeeding business day.

How does the USPTO handle correspondence received after official hours?

The USPTO has specific procedures for handling correspondence received outside of official business hours:

  • Correspondence delivered to the USPTO after business hours is considered filed on the next business day.
  • There are exceptions for certain types of time-sensitive filings.

MPEP 502 states: ‘Correspondence placed in the USPTO’s night box before midnight on weekdays (except federal holidays) will receive a filing date of the succeeding business day.’ This means that documents deposited in the night box after business hours but before midnight will be treated as if they were received on the next business day.

For electronic filings, the USPTO’s Electronic Filing System (EFS-Web) is generally available 24/7, allowing for submissions outside of regular business hours. However, the actual filing date may still be affected by the time of submission.

In a Pre-AIA 37 CFR 1.47 application, the USPTO follows specific procedures for handling correspondence. According to MPEP 409.03(j):

‘The Notice of Acceptance under 37 CFR 1.47 should remind the applicant that the nonsigning inventor has access to the application papers. Applicant may petition under 37 CFR 1.14(e) for access restriction. See MPEP § 104.’

This means that:

  • The USPTO will send a Notice of Acceptance to the applicant.
  • The non-signing inventor has the right to access application papers.
  • The applicant can petition for access restriction if necessary.
  • Regular correspondence will be sent to the applicant or their representative.

It’s important to note that while the application is prosecuted by the applicant under 37 CFR 1.47, the non-signing inventor retains certain rights, including access to the application file.

To learn more:

To learn more:

How does the USPTO handle correspondence if no practitioner is of record in a patent application?

When no practitioner is of record in a patent application, the USPTO follows specific procedures for handling correspondence. Here’s what you need to know:

  • Correspondence is sent to the applicant’s correspondence address
  • The address used is the one shown in the application or the Patent Application Locating and Monitoring (PALM) system
  • It’s crucial for applicants to keep their correspondence information up to date

As stated in MPEP 403.01(a): ‘If a practitioner is not of record, correspondence will be sent to the applicant’s correspondence address as shown in the application or the Patent Application Locating and Monitoring (PALM) system.’

This policy ensures that even without a practitioner of record, the USPTO can maintain communication with the applicant. It’s important for applicants to regularly check and update their correspondence information to avoid missing critical communications from the USPTO.

To learn more:

How does the USPTO handle correspondence from multiple patent practitioners?

When multiple patent practitioners are involved in an application, the USPTO has specific rules for handling correspondence. MPEP 403.01(a) states: Where more than one practitioner is of record in an application, the Office will direct correspondence to the practitioner first named in the request for representation unless the request for representation specifies otherwise.

This means:

  • The USPTO will typically communicate with the first-named practitioner.
  • Applicants can specify a different practitioner for correspondence if desired.
  • All practitioners of record have the authority to act on behalf of the applicant.

It’s important for the applicant and all involved practitioners to clearly communicate their roles and preferences for correspondence to ensure smooth communication with the USPTO. For more information on correspondence procedures, visit the USPTO’s MPEP 403 page.

To learn more:

How does the USPTO handle correspondence from multiple attorneys in a patent application?

The USPTO has specific guidelines for handling correspondence from multiple attorneys in a patent application:

  • If multiple attorneys are listed on the Power of Attorney form, the USPTO will direct all correspondence to the first listed attorney.
  • The first listed attorney is considered the ‘correspondence address’ for official communications.
  • As stated in MPEP 403.01(a): ‘If more than one attorney is of record, the Office will direct correspondence to the first listed attorney in the Power of Attorney.’
  • Other listed attorneys can still communicate with the USPTO, but official correspondence will be sent to the designated address.

This approach ensures clear communication channels and prevents confusion in multi-attorney cases.

To learn more:

For juristic entities (e.g., corporations, organizations), the USPTO has specific requirements for correspondence and signatures. According to 37 CFR 1.33(b)(3):

Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.

This means that:

  • A juristic entity must prosecute a patent application through a registered patent practitioner.
  • All correspondence, amendments, and other papers must be signed by a patent practitioner on behalf of the juristic entity.
  • The juristic entity cannot directly correspond with the USPTO or sign documents without representation by a patent practitioner.

This requirement ensures that juristic entities have proper legal representation in patent matters, which can be complex and have significant legal implications.

To learn more:

How does the USPTO handle correspondence for applications with multiple attorneys or agents?

When an application has multiple attorneys or agents of record, the USPTO follows specific guidelines for correspondence:

  • The USPTO will direct all correspondence to the first named attorney or agent of record, unless otherwise specified.
  • If a customer number is provided, correspondence will be sent to the address associated with that customer number.
  • Applicants can designate one or more attorneys or agents to receive correspondence by filing a power of attorney or including the information in an application data sheet.

As stated in the MPEP:

If applicant provides, in a single paper, a list of patent practitioners and a correspondence address without also filing a clear power of attorney to a patent practitioner, the Office will direct all correspondence to the correspondence address pursuant to 37 CFR 1.33(a). (MPEP 403)

It’s important to clearly designate correspondence preferences to ensure proper communication with the USPTO.

For more information on patent agents, visit: patent agents.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO correspondence, visit: USPTO correspondence.

How does the USPTO handle correspondence for applications with multiple applicants?

The USPTO has specific rules for handling correspondence in applications with multiple applicants:

  • For applications filed on or after September 16, 2012, the USPTO will direct correspondence to the first named applicant, unless a practitioner is appointed.
  • For applications filed before September 16, 2012, correspondence is sent to the first named inventor, unless a practitioner is of record.

As stated in MPEP 403: ‘Where more than one attorney or agent is of record, the Office will direct correspondence to the first named attorney or agent of record, unless otherwise requested.’ This ensures clear communication channels for multi-applicant applications.

For more information on USPTO correspondence, visit: USPTO correspondence.

How does the USPTO handle correspondence during emergency situations?

The USPTO has provisions for handling correspondence during emergency situations, such as severe weather or other unforeseen circumstances:

  • The USPTO may designate certain days as ‘Federal holidays within the District of Columbia’ under specific conditions.
  • This designation affects filing dates and deadlines.

MPEP 502 states: ‘When the entire USPTO is officially closed for business for an entire day due to an emergency situation, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21.’ This means that deadlines falling on such days will be extended to the next business day, similar to federal holidays.

During emergencies, the USPTO typically issues public notices and updates its website to inform stakeholders about any changes to operations or filing procedures. It’s crucial for patent applicants and attorneys to stay informed about such announcements to ensure compliance with modified deadlines and procedures.

How does the USPTO handle correspondence delivered by EXPRESS MAIL?

The USPTO has specific procedures for handling correspondence delivered by EXPRESS MAIL. According to MPEP 502:

“Any correspondence delivered by the ‘Express Mail Post Office to Addressee’ service of the United States Postal Service (USPS) is considered filed or received in the Office on the date of deposit with the USPS.”

This means that the date of deposit with the USPS is considered the filing date at the USPTO, provided that:

  • The correspondence is properly addressed to the USPTO
  • The proper address is on the EXPRESS MAIL mailing label
  • The EXPRESS MAIL mailing label number is placed on the correspondence

It’s important to note that this applies only to the USPS EXPRESS MAIL service and not to similar services provided by private courier companies.

For more information on Express Mail, visit: Express Mail.

For more information on USPTO correspondence, visit: USPTO correspondence.

When the USPTO is notified of the death of a sole patent practitioner of record, they continue to hold correspondence with the deceased practitioner’s office. However, the USPTO also mails a copy of the Office action to the person who originally appointed the practitioner. This ensures that the applicant or owner is informed of ongoing patent matters.

How does the USPTO handle conflicting powers of attorney in a patent application?

When conflicting powers of attorney are submitted in a patent application, the USPTO follows specific procedures to resolve the conflict. According to MPEP 402.10:

Where a written power of attorney is submitted in an application without the signature of one or more inventors or assignees, the power of attorney is not accepted until either (1) the nonsigning inventor or assignee provides a power of attorney consistent with the power of attorney provided by the other parties, or (2) the nonsigning inventor or assignee is removed from the application.

In practice, this means:

  • The USPTO will not accept a power of attorney unless it is signed by all parties or consistent with previously filed powers.
  • If conflicting powers are received, the Office will contact the applicants to resolve the discrepancy.
  • The application may be delayed until the conflict is resolved.
  • In some cases, the nonsigning inventor or assignee may need to be removed from the application for prosecution to proceed.

It’s crucial for applicants to coordinate and agree on representation to avoid such conflicts and potential delays in the patent application process.

To learn more:

How does the USPTO handle conflicting instructions from multiple representatives?

When multiple representatives are authorized to act on behalf of an applicant or assignee, conflicts may arise if they provide contradictory instructions. The USPTO has a clear procedure for handling such situations. According to MPEP 402.04, “Where an applicant is represented by more than one practitioner, the Office will direct all communications to the first named representative (the representative of record) in absence of a request to the contrary or in absence of revocation of power of attorney.” This means that if conflicting instructions are received, the USPTO will generally follow the guidance provided by the representative of record, ensuring a clear line of communication and decision-making.

To learn more:

When the USPTO receives conflicting instructions from multiple assignees or co-inventors regarding a patent application, it follows a specific protocol to ensure fair treatment of all parties. According to MPEP 106, the USPTO will not arbitrate disputes between the parties.

In such cases, the USPTO typically:

  • Suspends action on the application until the conflict is resolved
  • Notifies all parties of the conflicting instructions
  • Advises the parties to resolve the dispute among themselves or through the courts
  • Resumes prosecution only when clear, consistent instructions are received from all interested parties or when a court order is issued

This approach ensures that the USPTO remains neutral and that the rights of all assignees and inventors are protected throughout the patent prosecution process.

The USPTO handles confidentiality in 37 CFR 1.47(a) petitions with care, recognizing the sensitive nature of the information provided. The MPEP 409.03(b) states:

‘Petitions under 37 CFR 1.47 are not available to the public since they are contained in the application file… The petition will be available to the nonsigning inventor upon request.’

This means:

  • Petition documents are kept confidential as part of the non-public application file.
  • The general public cannot access these petitions.
  • The nonsigning inventor has the right to request and view the petition.
  • The USPTO balances the need for transparency with the protection of potentially sensitive information.

Applicants should be aware that while the petition is generally confidential, the nonsigning inventor may still access it, which could affect strategies for presenting information in the petition.

To learn more:

To learn more:

The United States Patent and Trademark Office (USPTO) has specific procedures for maintaining the confidentiality of international applications filed in the U.S. According to MPEP 110, which references 35 U.S.C. 368, International applications filed in the Patent and Trademark Office shall be subject to the provisions of chapter 17. This means that such applications are subject to the same secrecy provisions as regular U.S. patent applications. Additionally, If a license to file in a foreign country is refused or if an international application is ordered to be kept secret and a permit refused, the Patent and Trademark Office when acting as a Receiving Office, International Searching Authority, or International Preliminary Examining Authority, may not disclose the contents of such application to anyone not authorized to receive such disclosure. This ensures that sensitive information in international applications is protected in accordance with U.S. law.

For more information on international applications, visit: international applications.

For more information on USPTO, visit: USPTO.

How does the USPTO handle confidential patent assignment information?

The USPTO generally treats patent assignment records as public information. However, there are provisions for handling confidential information within these records. MPEP 301.01 states:

“Assignments and other documents affecting title to applications, patents, and registrations that are recorded in the USPTO are generally open to public inspection. Only documents that are sealed as provided in 37 CFR 1.14 or otherwise not open to public inspection are not available for public inspection.”

If a document contains sensitive information that should not be publicly disclosed, the parties involved can:

  • Redact confidential information before submitting the document for recordation
  • Request that certain documents be sealed under 37 CFR 1.14
  • Submit separate public and non-public versions of documents when necessary

It’s important to note that the decision to seal documents is at the discretion of the USPTO and is generally limited to specific circumstances outlined in the regulations.

The USPTO provides a specific process for handling confidential license agreements. According to MPEP 313:

“If the document to be recorded is a confidential license agreement, such as a trade secret agreement, the instrument must be submitted with a cover sheet to request redaction of the document. The parties must include all of the information required by 37 CFR 3.31, and additionally state that the document is confidential and identify the item(s) for which redaction is being requested.”

This process allows parties to protect sensitive information while still recording the existence of the license agreement with the USPTO.

The MPEP 608.01(v) outlines the process for handling complaints about trademark misuse in patent applications:

  1. Technology Center Directors should reply to all complaint letters regarding the misuse of marks used in commerce and forward a copy of the complaint letter and reply to the Office of the Deputy Commissioner for Patents who oversees the Office of Petitions.
  2. Where a letter demonstrates the misuse of a mark in a patent application publication, the Office should, where the application is still pending, ensure that the mark is replaced by appropriate generic terminology.

This process ensures that complaints are addressed at a high level within the USPTO and that appropriate action is taken to correct any misuse of trademarks in pending applications. It’s important for applicants to be aware of this process and to use trademarks properly in their applications to avoid such complaints and potential corrections.

To learn more:

After an attorney withdraws from a patent application, the USPTO adjusts its communication process as follows:

  • The Office communicates directly with the applicant or assignee.
  • This direct communication continues until a new registered patent practitioner is appointed.
  • The applicant or assignee who originally appointed the withdrawing attorney becomes the point of contact for all purposes in the application.

According to MPEP 402.06: ‘For applications in which the attorney or agent has withdrawn from representation, the Office will communicate directly with the applicant … until such time as a new attorney or agent is appointed.’

It’s crucial for applicants to stay responsive and consider appointing new representation promptly to ensure smooth prosecution of their patent application.

To learn more:

The USPTO has specific procedures for handling changes in power of attorney and correspondence address. According to MPEP 403:

‘A new power of attorney or change of correspondence address filed in a patent application or patent does not change the correspondence address for any other application or patent.’

Key points to remember:

  • Each application or patent is treated separately.
  • A change in one application doesn’t automatically apply to others, even if filed by the same applicant or assignee.
  • To change multiple applications, you must file separate requests for each one.
  • Using a customer number can simplify this process for multiple applications.

It’s crucial to ensure that any changes are properly filed and recorded to maintain effective communication with the USPTO.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How does the USPTO handle changes in ownership of patents?

The USPTO handles changes in ownership of patents through a process of recording assignments. According to MPEP 301:

“The assignment of a patent, or patent application, is the transfer of the entire right, title and interest therein. An assignment of an application may be made before the application is filed or after it is filed.”

When a change in ownership occurs:

  • The new owner must record the assignment with the USPTO
  • This recording serves as public notice of the transfer
  • It helps maintain clear records of patent ownership

The USPTO maintains these records and updates them as new assignments are recorded.

For more information on assignment recording, visit: assignment recording.

For more information on USPTO procedures, visit: USPTO procedures.

How does the USPTO handle certified copies for international design applications?

For international design applications, the USPTO has a specific process for handling certified copies. According to the MPEP:

‘For international design applications designating the United States, the certified copy requirement is considered to have been met by the filing of the international design application pursuant to 37 CFR 1.55(m).’

This means that if you file an international design application that designates the United States, you don’t need to separately submit a certified copy of the priority document. The filing of the international design application itself fulfills this requirement.

However, it’s important to note that this only applies to international design applications. For other types of patent applications claiming priority to a foreign application, you would still need to ensure that a certified copy is filed or retrievable through the priority document exchange program within the specified time period.

While a prior assignment recorded against an original application is automatically effective for division and continuation applications, the USPTO does not automatically update its assignment records for these new applications. As stated in MPEP 306:

Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

This means that even though the assignment is legally effective, the USPTO’s records won’t show it unless the assignee takes specific action. To ensure the USPTO’s records are up to date, assignees should:

  • File a request for recordation of the assignment for the new application
  • Ensure the request complies with 37 CFR 3.28
  • Pay the required fee as specified in 37 CFR 3.41

How does the USPTO handle assignment documents that contain errors?

The USPTO has procedures in place for handling assignment documents with errors:

  • Minor errors: The USPTO may correct minor errors in assignment documents without requiring a new submission. As stated in MPEP 302: ‘Minor corrections to documents recorded pursuant to 37 CFR 3.11 will be made by the Assignment Division, provided that the corrections do not involve the re-recording of the entire assignment document.’
  • Major errors: For significant errors, a new corrected document must be submitted. The MPEP notes: ‘Other corrections may be made only by the submission of a new document.’
  • Erroneous recording: If an assignment is erroneously recorded, the USPTO will correct its records upon notification.

It’s important to review assignment documents carefully before submission to avoid delays and potential legal issues.

For more information on document correction, visit: document correction.

For more information on USPTO procedures, visit: USPTO procedures.

How does the USPTO handle assignment documents after recording?

After recording an assignment document, the USPTO follows a specific process. According to MPEP 302.01: ‘Assignment documents submitted for recording are scanned and stored in a public database.’

The handling process includes:

  • Scanning the submitted copy of the assignment document
  • Storing the scanned document in a publicly accessible database
  • Retaining the physical copy submitted (not returning it to the sender)
  • Making the recorded information available for public inspection

This process ensures that assignment records are preserved and accessible while maintaining the integrity of the original submissions.

To learn more:

The USPTO treats applications with omitted drawings similarly to those with missing specification pages. According to MPEP 506:

In the event that a page of the specification, or a portion thereof, or a page of the drawings, or a portion thereof, is inadvertently omitted from an application as filed, the application will be not be considered complete and the applicant will be notified to file the omitted portion.

If drawings are omitted, the applicant will be notified and given a time period to submit the missing drawings. However, adding new drawings after the filing date may affect the application’s effective filing date if they introduce new matter. It’s crucial to include all necessary drawings with the initial application to avoid potential issues.

For more information on new matter, visit: new matter.

Tags: new matter

The USPTO has specific procedures for handling applications in which the government may have a property interest. According to the MPEP:

For those applications in which the Government has a property interest (including applications indicating national security classified subject matter), responsibility for notifying the Commissioner for Patents of the need for a Secrecy Order resides with the agency having that interest.

Additionally, the screening process identifies inventions that may be of interest to specific government agencies:

A second purpose for the screening of all applications, with an exception for provisional applications, is to identify inventions in which DOE or NASA might have property rights. See42 U.S.C. 2182,51 U.S.C. 20135, andMPEP § 150.

This process ensures that government agencies are notified of inventions that may fall under their purview and allows them to take appropriate action, such as requesting a Secrecy Order if necessary.

For more information on patent applications, visit: patent applications.

When an application is filed with missing parts, the USPTO follows these procedures:

  1. If the application meets minimum requirements for a filing date, it will be assigned one.
  2. A Notice to File Missing Parts will be issued, detailing the missing items.
  3. Applicants must submit missing items along with any required surcharges within the specified time period.
  4. For applications filed on or after September 16, 2012, the inventor’s oath or declaration can be postponed until payment of the issue fee if a compliant application data sheet is filed.
  5. For applications filed on or after December 18, 2013, filing of claims can be postponed until the expiration of the time period set in the Notice to File Missing Parts.

The MPEP states: ‘The inventor’s oath or declaration, basic filing fee, and search fee and examination fee as set forth in 37 CFR 1.16, may be filed later than the remaining application papers, but if so, they must be accompanied by the required surcharge (if appropriate, see MPEP § 506).’ (MPEP 503)

How does the USPTO handle applications filed before September 16, 2012?

Applications filed before September 16, 2012, are subject to different correspondence rules. As stated in MPEP 403.01(a): For applications filed before September 16, 2012, pre-AIA 37 CFR 1.33(a) applies. This means that for these older applications, the correspondence rules and procedures outlined in pre-AIA 37 CFR 1.33(a) are still in effect. It’s important to check the filing date of your application to determine which set of rules applies.

For more detailed information on pre-AIA rules, you can refer to MPEP 403 which covers correspondence for applications filed before September 16, 2012.

To learn more:

The United States Patent and Trademark Office (USPTO) treats all ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. This is clearly stated in MPEP ¶ 2.35:

“Any ‘conditional’ request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.”

This means that once a CPA request is filed, even if the applicant intended it to be conditional, the USPTO will process it as a regular CPA. The conditions specified by the applicant are essentially disregarded, and the CPA is established based on the filing of the request alone.

For more information on CPA, visit: CPA.

For more information on Patent Application Process, visit: Patent Application Process.

The USPTO has different fee structures for recording patent and trademark documents. According to MPEP 302.06:

Additionally, for patent documents:

  • Electronic submissions currently have a $0 fee
  • Paper or fax submissions have a fee set in 37 CFR 1.21(h)(2)

It’s important to note that trademark fees may differ and do not have the same $0 electronic submission option as patents. Always check the current USPTO fee schedule for the most up-to-date information.

To learn more:

The USPTO has a specific process to ensure that all applications are cleared from secrecy review before they are issued as patents. According to the MPEP:

All applications are required to be cleared from secrecy review before forwarding to issue. If the L&R code on the general information display does not equal 1, then in an IFW application, a message should be sent to LREVINCOMINGDOCS.

The USPTO uses a system called the Patent Data Portal (PDP) to track the status of applications:

The Patent Data Portal (PDP) System’s general information display discloses the current Licensing and Review status. The indicator “L&R code” displays the current status of the application while the indicators “Third Level Review” and “Secrecy Order” display the historical status of the application.

Specific codes are used to indicate the status of an application:

  • An L&R code of “3” or a “Third Level Review” of “Yes” indicates that the application is/has been considered for security screening.
  • A Secrecy Code of “4” indicates that the application is currently under Secrecy Order.

If an application is under Secrecy Order, special handling is required:

In this case, the application has been converted to a paper application file and there should be no images maintained in the Image File Wrapper system (IFW).

This process ensures that no application is issued as a patent until it has been fully cleared from secrecy review, protecting sensitive information and national security interests.

For more information on patent issuance, visit: patent issuance.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO actively encourages the use of interviews to expedite patent prosecution. According to MPEP § 408, The Office encourages the use of interviews to expedite prosecution. When an examiner believes an interview would advance the application’s progress, they may contact the patent practitioner of record to suggest a telephonic, personal, or video conference interview.

To initiate an interview, applicants should submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) prior to the interview. This form helps the examiner prepare and focus on the issues to be discussed.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO determines eligible countries for priority claims based on international agreements and reciprocity. MPEP 213.01 states:

The right of priority is recognized only if the foreign application was filed in a country granting similar privileges to United States citizens.

This means the USPTO maintains a list of countries that have established reciprocal rights with the United States. These countries typically include Paris Convention members, PCT contracting states, and nations with bilateral agreements recognizing priority rights.

To learn more:

The USPTO determines the correspondence address based on the most recent information provided. According to MPEP 403.02:

“If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record.”

This means that the USPTO will use the most recently provided correspondence address, regardless of which practitioner it is associated with. This practice is governed by 37 CFR 1.33 and 37 CFR 1.76, which provide regulations on correspondence and application data sheets. It’s crucial for applicants and practitioners to keep the correspondence address up to date to ensure proper communication with the USPTO.

To learn more:

How does the USPTO determine if material is ‘new matter’ in a patent application?

The USPTO determines if material is ‘new matter’ by comparing the content of the application as originally filed with any subsequent amendments or additions. According to MPEP 608.04(a):

In establishing new matter, the examiner must find that the subject matter is unequivocally described in the application as filed.

The process typically involves:

  • Reviewing the original specification, claims, and drawings
  • Comparing any amendments or new submissions to the original disclosure
  • Determining if the new material goes beyond what was explicitly or inherently disclosed
  • Considering whether a person skilled in the art would recognize the added material as being inherently present in the original disclosure

If the examiner finds that the added material is not supported by the original disclosure, it will be rejected as new matter under 35 U.S.C. 132(a) and 37 CFR 1.121(f).

To learn more:

Tags: new matter

How does the USPTO determine if inventors are truly joint inventors?

The U.S. Patent and Trademark Office (USPTO) relies on the information provided by the applicants to determine joint inventorship. According to MPEP 602.09, ‘The specification must contain the names of all joint inventors.’ However, the USPTO does not typically investigate the accuracy of joint inventorship claims unless there is evidence of impropriety. The determination of joint inventorship is based on the 35 U.S.C. 116, which states that inventors may apply for a patent jointly even if:

  • They did not physically work together or at the same time,
  • Each did not make the same type or amount of contribution, or
  • Each did not make a contribution to the subject matter of every claim of the patent.

If disputes arise, they are typically resolved through legal proceedings rather than by the USPTO itself.

To learn more:

The USPTO determines the necessity of drawings in a patent application based on whether they are required to understand the invention. According to MPEP 601.01(f) and 35 U.S.C. 113:

“The applicant shall furnish a drawing where necessary for the understanding of the subject matter sought to be patented.”

Examiners assess the application’s written description to determine if drawings are essential. If the invention can be fully understood without drawings, they may not be deemed necessary. However, for most mechanical, electrical, and design inventions, drawings are typically required to adequately disclose the invention.

To learn more:

To learn more:

The USPTO generally does not make an upfront determination about whether an application qualifies as a continuation-in-part (CIP) unless it becomes necessary in a proceeding. According to the MPEP:

“The Office does not need to make a determination as to whether the requirement of 35 U.S.C. 120 that the earlier nonprovisional application discloses the invention of the second application in the manner provided by 35 U.S.C. 112(a) is met unless the filing date of the earlier nonprovisional application is relied upon in a proceeding before the Office.”

However, examiners may use form paragraph 2.06 to remind applicants of possible CIP status:

“This application repeats a substantial portion of prior Application No. [1], filed [2], and adds disclosure not presented in the prior application. Because this application names the inventor or at least one joint inventor named in the prior application, it may constitute a continuation-in-part of the prior application.”

Ultimately, it’s the applicant’s responsibility to properly claim CIP status and comply with the requirements of 35 U.S.C. 120 and 37 CFR 1.78.

For more information on patent examination, visit: patent examination.

The examiner generally does not examine the certified copy of the foreign priority application except to see that it contains no obvious formal defects and corresponds to the U.S. application. The examiner will consider the merits of the priority claim if:

  • An intervening reference is found with an effective date between the foreign filing date and U.S. filing date
  • Determining if a reference is prior art under the grace period
  • An interference situation is under consideration

If the examiner finds the applicant is not entitled to the priority date, a rejection is made and the applicant must then perfect the claim. [MPEP 216]

The USPTO determines if a prior-filed application provides adequate support for a later-filed application by examining whether the prior-filed application discloses the invention claimed in the later-filed application in sufficient detail. According to MPEP 211.05:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, except for the best mode requirement.’

This means that the prior-filed application must provide a written description of the invention, enable one skilled in the art to make and use the invention, and disclose the best mode (if invented prior to the AIA) for carrying out the invention.

To learn more:

To learn more:

The USPTO determines if a patent application is incomplete by reviewing the submitted materials against the required components for a complete application. According to MPEP 203.06:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

The process typically involves:

  • Initial review by USPTO staff
  • Checking for presence of all required documents and fees
  • Verifying that the application meets minimum requirements for obtaining a filing date
  • Issuing a notice of missing parts if deficiencies are found

For detailed information on the requirements, refer to MPEP 506 and MPEP 601, which provide guidance on completeness criteria and filing procedures.

To learn more:

The USPTO determines if a foreign country qualifies for priority rights based on specific criteria outlined in the MPEP. According to MPEP 213.01:

The right of priority is recognized only if the foreign country in which the original application was filed is recognized at the time of filing the application in the United States.

The USPTO considers several factors:

  • The country must be a member of the Paris Convention for the Protection of Industrial Property or have a bilateral agreement with the United States.
  • The country must grant similar priority rights to U.S. citizens.
  • The country must be recognized by the U.S. Department of State.

The USPTO maintains a list of recognized countries and regional patent offices in MPEP 213.01, which is updated periodically to reflect changes in international relations and treaty memberships.

The USPTO evaluates whether a delay in claiming priority was unintentional based on the totality of the circumstances. According to MPEP 214.02:

The Director may require additional information where there is a question whether the delay was unintentional.

This means that the USPTO may request additional information from the applicant to determine if the delay was truly unintentional. The evaluation process typically involves:

  • Reviewing the explanation provided in the petition
  • Considering the length of the delay
  • Assessing any changes in ownership or responsibility for the application
  • Examining the circumstances surrounding the discovery of the need for a delayed priority claim

The USPTO applies a good faith standard, looking for evidence that the delay was not deliberate and that reasonable steps were taken to correct the issue once it was discovered. It’s important to provide a detailed and honest account of the circumstances leading to the delay when filing the petition.

To learn more:

The USPTO follows a specific process to determine if an error on a cover sheet is typographical in nature. According to MPEP 323.01(a):

“The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.”

This process involves:

  • Reviewing the corrected cover sheet submitted by the requesting party
  • Comparing it to the original cover sheet
  • Examining the originally recorded assignment document or other title-affecting document
  • Assessing whether the error is purely typographical or if it substantively affects the title or assignment

If the error is determined to be typographical and does not affect the title, the Assignment Services Division will record the corrected cover sheet and update the Assignment Historical Database. However, if the error affects the title, different procedures apply, including potential changes to the recordation date.

To learn more:

How does the USPTO determine if a country is eligible for priority right benefits?

The USPTO determines a country’s eligibility for priority right benefits based on specific criteria. As stated in MPEP 213.01:

The United States will recognize claims for right of priority under 35 U.S.C. 119(a)-(d) based on applications filed in countries which have acceded to the Patent Cooperation Treaty (PCT) prior to becoming a Contracting State of that Treaty.

This means that countries that have joined the PCT are generally recognized for priority rights. Additionally, the USPTO considers other factors such as whether the country:

  • Extends similar privileges to U.S. citizens
  • Is a member of the World Trade Organization (WTO)
  • Has a bilateral agreement with the United States

The USPTO maintains a list of countries and organizations that meet these criteria, which is periodically updated to reflect changes in international agreements and relations.

To learn more:

The USPTO determines if a claim in a later-filed application is entitled to the benefit of an earlier filing date by evaluating whether:

  • The subject matter of the claim is disclosed in the earlier-filed application.
  • The disclosure in the earlier-filed application complies with the requirements of 35 U.S.C. 112(a), except for the best mode requirement.
  • The disclosure enables one skilled in the art to make and use the claimed invention without undue experimentation.

As stated in MPEP 211.05:

“A claim in the later-filed application is not entitled to the benefit of the filing date of the prior-filed application if the disclosure of the prior-filed application does not enable one skilled in the art to ‘use’ the claimed invention.”

If the earlier application fails to provide adequate support or enablement for a claim in the later-filed application, that claim will not be entitled to the earlier filing date. This assessment is made on a claim-by-claim basis, and different claims within the same application may have different effective filing dates.

To learn more:

The United States Patent and Trademark Office (USPTO) defines different types of patent applications in the Code of Federal Regulations (CFR) and the Manual of Patent Examining Procedure (MPEP). Specifically:

  • National application, Provisional application, and Nonprovisional application are defined in 37 CFR 1.9(a)
  • International application is defined in 37 CFR 1.9(b)
  • International design application is defined in 37 CFR 1.9(n)

These definitions provide the legal basis for understanding the different types of applications that can be filed with the USPTO. For more detailed explanations and context, refer to MPEP § 201, which provides comprehensive guidance on types and status of applications.

To learn more:

The United States Patent and Trademark Office (USPTO) defines an abandoned patent application through the Manual of Patent Examining Procedure (MPEP) 203.05. According to this section, an abandoned application is defined as:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications

This removal from the docket can occur for various reasons, including formal abandonment, failure to take appropriate action during prosecution, non-payment of fees, or the expiration of the statutory period for provisional applications.

The term ‘international application’ is defined in 37 CFR 1.9(b). An international application typically refers to a patent application filed under the Patent Cooperation Treaty (PCT), which provides a unified procedure for filing patent applications to protect inventions in its contracting states.

Key points about international applications:

  • They are governed by the Patent Cooperation Treaty.
  • They can lead to national phase entries in multiple countries.
  • They provide a streamlined filing process for seeking patent protection internationally.
  • The specific definition in 37 CFR 1.9(b) should be consulted for precise legal terminology.

International applications are distinct from national applications and offer a pathway for inventors to seek protection in multiple countries through a single filing.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

How does the USPTO define ‘unintentional delay’ for priority claims?

The USPTO does not provide a specific definition of ‘unintentional delay’ in the context of priority claims. However, the interpretation is generally consistent with other areas of patent law where unintentional delay is considered.

According to MPEP 214.02: ‘The Director may require additional information where there is a question whether the delay was unintentional.’

This means that:

  • The delay must not have been deliberate or intentional.
  • The applicant must have taken reasonable care to meet the deadline but failed due to unforeseen circumstances.
  • Once the applicant became aware of the missed deadline, they must have acted promptly to file the petition.

It’s important to note that the USPTO may request additional information if there’s any doubt about the unintentional nature of the delay. Applicants should be prepared to provide a detailed explanation of the circumstances that led to the delay if requested.

To learn more:

The USPTO refers to ‘suspended or excluded practitioners’ in MPEP 105 as “an attorney or agent who has been suspended or excluded from practice by the USPTO.” This typically refers to patent attorneys or agents who have faced disciplinary action and are temporarily or permanently barred from practicing before the USPTO. These individuals are subject to specific restrictions, including the inability to communicate with USPTO employees about patent applications or inspect application materials, unless they are the inventor or applicant.

To learn more:

How does the USPTO define ‘new matter’ in patent applications?

The United States Patent and Trademark Office (USPTO) defines ‘new matter’ as any content added to a patent application after the initial filing date that was not present in the original specification, claims, or drawings. According to MPEP 608.04(a):

“Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.”

This definition is strict and encompasses any additions or modifications that introduce information not explicitly or inherently supported by the original disclosure. New matter can include:

  • Additional text in the specification
  • New or modified claim elements
  • Changes to drawings or the addition of new figures
  • Incorporation of external references not properly incorporated on the filing date

It’s important to note that new matter is prohibited under 35 U.S.C. 132(a), which states that “No amendment shall introduce new matter into the disclosure of the invention.”

To learn more:

Tags: new matter, USPTO

How does the USPTO define ‘material information’ in patent applications?

The USPTO considers information to be material if it affects the patentability of an invention. According to MPEP 410:

“Information is material to patentability when it is not cumulative to information already of record or being made of record in the application, and (1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or (2) It refutes, or is inconsistent with, a position the applicant takes in: (i) Opposing an argument of unpatentability relied on by the Office, or (ii) Asserting an argument of patentability.”

In simpler terms, material information includes any facts that could affect the USPTO’s decision to grant a patent. This may include prior art, conflicting statements, or any other information that could impact the novelty or non-obviousness of the claimed invention.

For more information on prior art, visit: prior art.

For more information on USPTO, visit: USPTO.

Tags: prior art, USPTO

The USPTO has changed its approach to classifying patent drawings. According to MPEP 608.02(i), “the Office no longer considers drawings as formal or informal.” This means that the traditional distinction between formal and informal drawings has been eliminated. Instead, the focus is on whether the drawings are sufficient for publication and examination purposes, regardless of their formal classification.

To learn more:

When an attorney or agent is suspended, the USPTO does not communicate with them. Instead:

  • For sole practitioners: The Office action is mailed to the address of the first named applicant in the application.
  • For multiple practitioners: The Office action is mailed to the first named unsuspended registered practitioner of record and to the first named applicant.

This is outlined in Form Paragraphs 4.07 and 4.08 of MPEP § 407.

The USPTO calculates the 12-month priority period for nonprovisional applications as follows:

  • Start date: The period begins on the filing date of the earliest foreign application for which priority is claimed.
  • End date: The period ends 12 months later, on the same date of the following year.
  • Holiday/weekend adjustment: If the 12-month period ends on a Saturday, Sunday, or federal holiday, it extends to the next business day.

According to MPEP 213.03: “The 12-month priority period ends on the anniversary date of the earliest foreign application. If the anniversary date falls on a Saturday, Sunday, or federal holiday, the 12-month period ends on the next succeeding business day.”

It’s crucial to accurately calculate this period to ensure timely filing of your nonprovisional application and maintain your priority claim.

To learn more:

How does the USPTO assign application numbers to continuation or divisional applications?

The USPTO assigns application numbers to continuation or divisional applications in the same manner as new applications. According to MPEP 503:

A continuation or divisional application (including a continued prosecution application) filed under 37 CFR 1.53(b) is assigned a new application number.

This means:

  • Each continuation or divisional application receives a unique number
  • The number is assigned in the same sequence as other new applications
  • The application number does not indicate its relationship to the parent application

It’s important to reference the parent application in the appropriate sections of the new application to establish the continuity.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO procedures, visit: USPTO procedures.

When an applicant submits an insufficient payment for fees due on filing a nonprovisional application under 35 U.S.C. 111(a) and has not specified how to apply the payment, the USPTO applies the payment in a specific order. The MPEP outlines this order as follows:

  1. Basic filing fee
  2. Search fee
  3. Examination fee
  4. Excess claims fee (independent claims exceeding three and total claims exceeding twenty)
  5. Application size fee
  6. Non-electronic filing fee (if applicable)

For provisional applications under 35 U.S.C. 111(b), the order is:

  1. Basic filing fee
  2. Application size fee

This information helps applicants understand how their payments will be allocated if they submit an insufficient amount for the required fees.

To learn more:

Tags: patent fees

When the claim for foreign priority and the certified copy of the foreign application are received within the time period set forth in 37 CFR 1.55, and there are no irregularities, the USPTO acknowledges receipt in the next Office action.

According to the MPEP: Assuming that the papers are timely and regular in form and that there are no irregularities in dates, the examiner in the next Office action will advise the applicant that the papers have been received on form PTOL-326 or by use of form paragraph 2.26.

The examiner may use form paragraph 2.26, which states: Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55.

If the foreign priority papers have been filed in a parent application, the examiner will use form paragraph 2.27 to acknowledge this fact.

To learn more:

The USPTO acknowledges receipt of foreign priority claims in several ways:

  1. If the claim is timely and all requirements are met, the examiner will advise the applicant in the next Office action using form PTOL-326 or form paragraph 2.26
  2. For priority documents filed in a parent application, the examiner may use form paragraph 2.27
  3. If there are irregularities, the examiner may use specific form paragraphs to notify the applicant of issues

MPEP 214.03 states: “When the claim for foreign priority and the certified copy of the foreign application are received within the time period set forth in 37 CFR 1.55, if applicable, they are entered into the application file history. Assuming that the papers are timely and regular in form and that there are no irregularities in dates, the examiner in the next Office action will advise the applicant that the papers have been received on form PTOL-326 or by use of form paragraph 2.26.”

The United States Patent and Trademark Office (USPTO) formally acknowledges a Request to Delete a Named Inventor in a Continued Prosecution Application (CPA) through an official response. This acknowledgment serves as confirmation that the request has been received and processed.

The MPEP ¶ 2.32 provides the standard language used by examiners to acknowledge such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

In this acknowledgment:

  • [1] refers to the name(s) of the inventor(s) requested to be deleted
  • [2] indicates the filing date of the CPA

This official response confirms that the USPTO has processed the request and updated the inventorship accordingly.

For more information on CPA, visit: CPA.

For more information on USPTO acknowledgment, visit: USPTO acknowledgment.

For papers that have been scanned into the Image File Wrapper (IFW) system, the USPTO has a specific procedure for ‘returning’ them. According to MPEP 508.02:

“If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW.”

This means that instead of physically returning the paper, the USPTO will electronically close or restrict access to the document within the IFW system. This process maintains the integrity of the digital file while effectively ‘returning’ the document.

To learn more:

How does the title of a patent application affect its classification?

The title of a patent application plays a significant role in its initial classification. According to MPEP 606:

The title of the invention may not exceed 500 characters in length and must be as short and specific as possible.

The title’s impact on classification includes:

  • Initial sorting: The title is often the first piece of information used to categorize the application.
  • Technology field identification: A clear, specific title helps quickly identify the relevant technology field.
  • Examiner assignment: The title can influence which art unit and examiner are assigned to the application.
  • Prior art searches: An accurate title can guide more effective prior art searches.

While the abstract and claims ultimately determine the final classification, a well-crafted title ensures the application starts in the right direction, potentially speeding up the examination process and improving the quality of the initial review.

To learn more:

How does the timing of an IDS submission affect the required certification?

The timing of an Information Disclosure Statement (IDS) submission directly impacts the required certification:

  • IDS filed within three months of filing or before first Office action: No certification required
  • IDS filed after three months of filing but before first Office action on the merits: Certification under 37 CFR 1.97(e) or fee under 37 CFR 1.17(p) required
  • IDS filed after first Office action but before final action, notice of allowance, or action closing prosecution: Certification under 37 CFR 1.97(e) or fee under 37 CFR 1.17(p) required
  • IDS filed after final action, notice of allowance, or action closing prosecution: Both certification under 37 CFR 1.97(e) and fee under 37 CFR 1.17(p) required

As stated in MPEP 609.04(b): “An information disclosure statement shall be considered by the Office if filed by the applicant within any one of the following time periods:” followed by the specific timing requirements. This underscores the importance of timely IDS submission to avoid additional certification or fee requirements.

To learn more:

The September 16, 2012 date is significant for assignment procedures in applications claiming the benefit of a provisional application. For applications filed on or after this date, the assignment rules are more flexible:

  • If the application includes new subject matter not in the provisional application, new assignment papers are not required if the assignee is the original applicant in the later application.
  • For applications filed before this date, new assignment papers are always required if there’s new subject matter, regardless of who the assignee is.

This change aligns with the implementation of the America Invents Act. As stated in MPEP § 306.01: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

To learn more:

The right of priority for international design applications is governed by 35 U.S.C. 386. There are two main scenarios:

  1. A U.S. national application can claim priority from a prior international design application that designated at least one country other than the United States.
  2. An international design application designating the United States can claim priority from a prior foreign application, a prior PCT application designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a) – (d) and 172 with respect to a prior international design application that designates at least one country other than the United States.

To learn more:

The right of priority for international applications filed under the Patent Cooperation Treaty (PCT) operates similarly to national applications, but with some specific provisions and requirements set by the PCT system.

According to MPEP 213.06: “In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.”

Key points about priority in PCT applications include:

  • The priority claim must be made in the PCT Request form or through a later correction.
  • The applicant must file a certified copy of the priority document with the International Bureau within 16 months from the priority date, unless it was previously filed with the receiving Office.
  • If the priority document is issued by the receiving Office, the applicant can request that Office to prepare and transmit the document to the International Bureau.
  • The International Bureau will make the priority document available to designated Offices.
  • For U.S. national stage entry, if the certified copy was submitted during the international phase, it generally satisfies the requirement for the U.S. application.

The MPEP further notes: “If, however, the International Bureau is unable to forward a copy of the certified priority document because the applicant failed to submit a certified copy of the foreign priority document during the international phase, the applicant will need to provide a certified copy of the priority document or have the Office retrieve the priority application in accordance with the priority document exchange program during the national stage to fulfill the requirements of 37 CFR 1.55.”

For more information on certified copy, visit: certified copy.

The right of priority under 35 U.S.C. 386(a) and 386(b) applies to different types of applications. According to MPEP 213.07:

Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.

This means that 35 U.S.C. 386(a) allows a nonprovisional application to claim priority based on a prior international design application.

On the other hand, 35 U.S.C. 386(b) applies differently:

Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

Thus, 35 U.S.C. 386(b) allows an international design application designating the United States to claim priority based on various types of prior applications.

The key differences are:

  • 386(a) applies to nonprovisional applications claiming priority to international design applications.
  • 386(b) applies to international design applications claiming priority to foreign applications, PCT applications, or other international design applications.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on right of priority, visit: right of priority.

For international patent applications filed by non-inventor applicants, there are specific requirements outlined in 37 CFR 1.46(b):

If an application entering the national stage under 35 U.S.C. 371, or a nonprovisional international design application, is applied for by a person other than the inventor under paragraph (a) of this section, the assignee, person to whom the inventor is under an obligation to assign the invention, or person who otherwise shows sufficient proprietary interest in the matter must have been identified as the applicant for the United States in the international stage of the international application or as the applicant in the publication of the international registration under Hague Agreement Article 10(3).

This means that for PCT applications entering the U.S. national stage or for international design applications, the non-inventor applicant must have been properly identified as the applicant for the United States during the international phase or in the international registration publication.

To learn more:

The Priority Document Exchange (PDX) program allows for electronic transmission of priority documents between participating foreign intellectual property offices. According to 37 CFR 1.55(i), if the foreign application was filed in a participating office, the requirement for a timely filed certified copy is considered satisfied if the Office receives a copy through the PDX program during the pendency of the application and before the patent is granted.

How does the priority date work in a continuation-in-part application?

In a continuation-in-part (CIP) application, the priority date can vary for different parts of the application. According to MPEP 201.08:

“The disclosure presented in the continuation-in-part application may include subject matter in common with the earlier application and may include additional subject matter not disclosed in the earlier application. Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the earlier nonprovisional application are entitled to the benefit of the filing date of the earlier nonprovisional application.”

This means:

  • Subject matter carried over from the parent application retains the original filing date as its priority date
  • New matter added in the CIP has the filing date of the CIP as its priority date
  • Each claim in a CIP is evaluated individually to determine its effective filing date
  • Claims fully supported by the parent application get the earlier priority date
  • Claims relying on new matter get the later CIP filing date as their priority date

Understanding priority dates in CIPs is crucial for determining patentability and for defending against potential prior art references.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

The priority claim deadline for PCT applications entering the national stage in the U.S. differs from that of regular U.S. patent applications:

  • PCT National Stage Applications: For these applications, the priority claim must be made within the time limit set in the PCT and the Regulations under the PCT.
  • Regular U.S. Applications: The deadline is the later of four months from the actual U.S. filing date or sixteen months from the foreign priority date.

According to MPEP 214.01: “In an application that entered the national stage from an international application after compliance with 35 U.S.C. 371, the claim for priority must be made during the pendency of the application and within the time limit set forth in the PCT and the Regulations under the PCT.”

It’s crucial to understand these differences to ensure timely filing of priority claims in different application types.

To learn more:

The presence of reserved sections like MPEP 404 does not directly affect patent examination. These sections are placeholders and do not contain any substantive information or guidance for examiners. However, their existence may indirectly impact the examination process in the following ways:

  • They maintain consistent numbering in the MPEP, aiding navigation and referencing
  • They allow for future expansion of examination guidelines without major restructuring
  • They serve as potential indicators of areas where the USPTO may develop new policies or procedures

Patent examiners rely on active, non-reserved sections of the MPEP, current USPTO policies, and relevant laws and regulations to conduct examinations.

The presence of new matter in a continuation or divisional application can significantly affect its filing date. If new matter is found, the application may lose the benefit of the earlier filing date for the new subject matter.

According to MPEP ¶ 2.10.01:

“Applicant is required to delete the benefit claim or change the relationship (continuation or divisional application) to continuation-in-part because this application contains the following matter not disclosed in the prior-filed application:”

If the application is changed to a continuation-in-part, the new matter will have the filing date of the current application, while the previously disclosed matter retains the earlier filing date. This can have important implications for determining prior art and patent term.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For patent applications filed before September 16, 2012, the rules for granting power to inspect are slightly different. According to MPEP 104:

“For applications filed prior to September 16, 2012, if an executed oath or declaration pursuant to 37 CFR 1.63 or 1.497 has been filed, no person but the applicant (any one of joint applicants), an attorney or agent of record (if a power of attorney was filed), or an assignee whose assignment is of record will be permitted to have access to the file of any pending application kept in confidence under 35 U.S.C. 122(a), except as provided for under 37 CFR 1.11, 1.14, 41.6, or 42.412.”

This means that for older applications, access is more restricted once an oath or declaration has been filed, limiting it to the applicant, attorney or agent of record, or assignee of record, unless specific exceptions apply.

For more information on application access, visit: application access.

For more information on power to inspect, visit: power to inspect.

For more information on pre-AIA applications, visit: pre-AIA applications.

For applications filed on or after September 16, 2012, the power of attorney from a prior application may have effect in the continuing application under certain conditions. The MPEP states: 37 CFR 1.32(d) provides that a power of attorney from a prior national application for which benefit is claimed under 35 U.S.C. 120, 121, or 365(c) in a continuing application may have effect in the continuing application if a copy of the power of attorney from the prior application is filed in the continuing application unless: (1) The power of attorney was granted by the inventor; and (2) The continuing application names an inventor who was not named as an inventor in the prior application. It’s recommended to file a copy of the power of attorney in the continuing application in all situations to clarify the record.

To learn more:

The USPTO attempts to retrieve foreign applications for design applications through the PDX program where possible. Specifically for Spanish industrial design applications:

The Spanish Patent and Trademark Office deposits certain ES industrial design applications for access by the USPTO via the WIPO DAS. Therefore, when the applicant claims foreign priority to an ES industrial design application and provides the WIPO DAS access code, the USPTO will attempt retrieval via the WIPO DAS.

This means that applicants claiming priority to Spanish industrial design applications should provide the WIPO DAS access code to enable the USPTO to retrieve the application through the WIPO Digital Access Service (DAS).

The Patent Cooperation Treaty (PCT) system interacts with foreign priority claims in several important ways:

1. Priority claims in PCT applications:
– PCT applications can claim priority to earlier foreign applications under the Paris Convention.
– The priority period is 12 months from the earliest priority date.

2. PCT as a basis for priority:
– A PCT application can serve as the basis for a priority claim in a later-filed national or regional application.

3. Effect on time limits:
– The 30-month time limit for entering the national phase is calculated from the priority date (if claimed) or the PCT filing date if no priority is claimed.

4. Restoration of priority rights:
– The PCT system allows for restoration of priority rights if an international application is filed within 14 months of the priority date and the delay was unintentional.

5. Certified copies:
– The PCT system has provisions for providing certified copies of priority documents to designated offices.

As stated in MPEP 213.06: “In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.”

The PCT system provides a streamlined process for seeking patent protection internationally while preserving priority rights, but applicants must be aware of the specific requirements and time limits within the PCT system.

How does the patent title affect search and classification?

The patent title plays a crucial role in search and classification processes. According to MPEP 606:

“The title of the invention … is used for classifying and searching.”

This means that:

  • A well-crafted title helps examiners and researchers find relevant prior art
  • It aids in properly classifying the invention within the patent system
  • An accurate title can expedite the examination process
  • It helps potential licensees or competitors discover the patent more easily

Therefore, creating a clear, concise, and descriptive title is essential not only for compliance but also for the practical aspects of patent searching and classification.

To learn more:

Tags: prior art

The Patent Law Treaties Implementation Act of 2012 (PLTIA) introduced several changes to nonprovisional application filings, effective December 18, 2013:

  • It amended 35 U.S.C. 111(a) to provide minimal formal requirements for obtaining a filing date.
  • For non-design applications, a filing date is granted when a specification (with or without claims) is received by the USPTO.
  • It allows for the delayed submission of claims and drawings, subject to certain conditions and potential surcharges.
  • It introduced the option to file an application by reference under 35 U.S.C. 111(c).

The MPEP states: Effective for applications filed on or after December 18, 2013, 37 CFR 1.53(b) was amended to implement the changes to 35 U.S.C. 111(a) and 35 U.S.C. 171 by the Patent Law Treaties Implementation Act of 2012 (PLTIA) (Public Law 112-211).

While these changes provide more flexibility in the filing process, it’s important to note that they don’t change the best practices for preparing and filing patent applications. Including a complete specification, claims, and drawings at the time of filing is still recommended to ensure compliance with disclosure requirements.

To learn more:

How does the patent examiner determine if a title change is necessary?

A patent examiner determines if a title change is necessary by evaluating whether the current title accurately reflects the claimed invention. According to MPEP 606.01, the examiner assesses if the title is “descriptive of the invention claimed.” If not, they will require a new title. The examiner considers several factors:

  • Does the title clearly indicate the nature of the invention?
  • Is it specific to the claimed subject matter?
  • Does it avoid overly broad or generic terms?
  • Is it brief yet informative?

If the examiner finds that the title doesn’t meet these criteria, they may request a change to ensure that the title accurately represents the invention as claimed in the application.

To learn more:

The patent examination process involves a back-and-forth between the examiner and the applicant. MPEP 203.03 describes a key part of this process:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action.

The general steps in the examination process are:

  1. The applicant files a nonprovisional application.
  2. The examiner reviews the application and issues an Office Action.
  3. The applicant responds to the Office Action, potentially with amendments.
  4. This process may repeat until the application is either allowed or finally rejected.

Each time the applicant responds with changes, the application becomes an ‘amended’ application as described in MPEP 203.03.

To learn more:

The Patent Cooperation Treaty (PCT) significantly impacts international patent applications. According to MPEP 213.01:

International applications filed under the Patent Cooperation Treaty (PCT) are considered to have been filed in any PCT contracting state of which the United States is one.

This means that a PCT application effectively serves as a placeholder for potential national phase entries in all PCT member countries. It provides applicants with additional time to decide in which countries they want to pursue patent protection, while securing an early filing date.

To learn more:

The Patent Cooperation Treaty (PCT) interacts with foreign priority claims as outlined in MPEP 213. The PCT allows applicants to file a single international patent application that can later enter the national phase in multiple countries.

Key points regarding PCT and foreign priority:

  • PCT applications can claim priority from earlier national or regional applications
  • The priority period for PCT applications is also 12 months from the earliest priority date
  • PCT applications themselves can serve as the basis for priority claims in subsequent national or regional applications

As stated in MPEP 213, “U.S. national applications may claim priority to an international application (PCT) filed in a PCT Receiving Office other than the United States Receiving Office.” This demonstrates the flexibility of the PCT system in international patent protection strategies.

The Patent and Trademark Office (PTO) generally does not directly handle patent ownership disputes. According to MPEP 301:

The Patent and Trademark Office is not the forum for resolving patent ownership disputes. Such disputes are to be settled by the parties involved, outside the Patent and Trademark Office.

If there’s a dispute over ownership, the PTO will typically continue to recognize the owner of record until a court order or other legal document resolving the dispute is presented. Parties involved in ownership disputes should seek legal counsel and resolve the matter through appropriate legal channels.

How does the Paris Convention affect the filing deadline for U.S. nonprovisional applications?

The Paris Convention plays a crucial role in determining the filing deadline for U.S. nonprovisional applications claiming priority to foreign applications. The MPEP explains:

“Under the Paris Convention, the right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design, filed in a country signatory to the Convention.” (MPEP 213.03)

Key points about the Paris Convention’s impact on filing deadlines:

  • It establishes a 12-month priority period for utility patents and plant patents.
  • For design patents, it provides a 6-month priority period.
  • The priority period starts from the filing date of the earliest foreign application.
  • It applies to applications filed in any country that is a member of the Paris Convention.

This international agreement ensures that inventors have a reasonable timeframe to file patent applications in multiple countries while maintaining the priority date of their original filing. It’s crucial for applicants to be aware of these deadlines when planning their international patent strategy.

To learn more:

How does the Paris Convention affect priority claims in US patent applications?

The Paris Convention plays a crucial role in international priority claims for US patent applications. According to MPEP 216:

‘The right of priority is based on the Paris Convention for the Protection of Industrial Property, which is adhered to by the United States.’

The Paris Convention affects US patent applications in the following ways:

  • It allows applicants to claim priority from foreign applications filed in member countries
  • It establishes a 12-month priority period for utility patents and a 6-month period for design patents
  • It ensures that filing an application in one member country does not invalidate the novelty of the invention in other member countries

The implementation of the Paris Convention in US law is found in 35 U.S.C. 119(a)-(d), which outlines the requirements for claiming foreign priority.

For more information on foreign priority, visit: foreign priority.

For more information on international patent applications, visit: international patent applications.

For more information on Paris Convention, visit: Paris Convention.

How does the Paris Convention affect international patent applications designating the United States?

The Paris Convention plays a significant role in international patent applications designating the United States. According to MPEP 211.01(c):

‘International applications, which designate the United States, that are filed on or after November 29, 2000, are subject to the provisions of the Patent Cooperation Treaty (PCT). International applications, which designate the United States, that are filed before November 29, 2000, are subject to the provisions of both the PCT and the Paris Convention for the Protection of Industrial Property.’

This means that for applications filed on or after November 29, 2000, the PCT rules govern, while earlier applications must comply with both PCT and Paris Convention provisions. The Paris Convention ensures certain rights, such as a 12-month priority period, for patent applicants across member countries, facilitating the international protection of inventions.

To learn more:

How does the oath or declaration work in divisional applications?

In divisional applications, the oath or declaration process is simplified to reduce the burden on applicants. According to MPEP 201.06(c):

37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) that contains the subject matter described in the prior nonprovisional application, provided a copy of the executed oath or declaration filed in the prior nonprovisional application is submitted.

Key points about the oath or declaration in divisional applications:

  • A new oath or declaration is not required if the divisional application contains the same subject matter as the parent application.
  • A copy of the executed oath or declaration from the parent application can be submitted.
  • The copy must show the USPTO seal or stamp indicating it was received.
  • If the inventorship changes, a new oath or declaration may be required.

This provision under 37 CFR 1.63(d) streamlines the filing process for divisional applications while ensuring proper inventorship documentation.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

How does the oath or declaration requirement differ for divisional applications?

For divisional applications, the oath or declaration requirement can be simplified under certain conditions. According to MPEP 201.06(c):

“The divisional application may be filed under 37 CFR 1.53(b) using all or part of a copy of the oath or declaration filed in the prior nonprovisional application under 37 CFR 1.63(d), as long as the oath or declaration is still applicable to the subject matter of the divisional application.”

This means that if the original oath or declaration from the parent application still covers the subject matter in the divisional application, it can be reused. However, if new matter is introduced or the inventors change, a new oath or declaration may be required.

For more information on Divisional application, visit: Divisional application.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent filing, visit: patent filing.

The oath or declaration requirements for continuation applications differ significantly depending on whether they were filed before or after September 16, 2012:

  • For applications filed on or after September 16, 2012: The inventor’s oath or declaration must comply with the requirements of 35 U.S.C. 115 as revised effective September 16, 2012. It must state that the inventor (1) is an original inventor of the claimed invention, and (2) authorized the filing of the patent application for the claimed invention. It must also contain an acknowledgment of penalties for willful false statements.
  • For applications filed before September 16, 2012: Applicants could file either a newly executed oath or declaration, or a copy of the oath or declaration from the prior application, along with a statement requesting deletion of names of non-inventors for the continuation application.

The MPEP states:

For applications filed on or after September 16, 2012, to claim the benefit of a prior application under 35 U.S.C. 120, 121, 365(c), or 386(c) applicant must include a reference to the prior application in compliance with 37 CFR 1.78(d)(2) in an application data sheet.

This change reflects the America Invents Act’s modifications to U.S. patent law.

For more information on America Invents Act, visit: America Invents Act.

For more information on continuation application, visit: continuation application.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent application requirements, visit: patent application requirements.

The Manual of Patent Examining Procedure (MPEP) addresses the issue of unavailable joint inventors for applications filed on or after September 16, 2012, in section 409.02. This section provides guidance on how to proceed when a joint inventor is unavailable or unwilling to participate in the patent application process.

Key points from MPEP 409.02 include:

  • Joint inventors must apply for a patent jointly and each must make an inventor’s oath or declaration.
  • If a joint inventor refuses to join or cannot be found after diligent effort, the other joint inventor(s) may proceed with the application.
  • A substitute statement can be executed in lieu of an oath or declaration from the unavailable inventor.

For applications filed before September 16, 2012, different procedures apply, which are covered in MPEP § 409.03 et seq.

To learn more:

To learn more:

The guidance in MPEP 409.03(f) specifically addresses the issue of continuation-in-part (CIP) applications in relation to assignments. According to MPEP 409.03(f):

“An assignment of an application and any ‘reissue, division, or continuation of said application’ does not itself establish an assignment of a continuation-in-part application. In re Gray, 115 USPQ 80 (Comm’r Pat. 1956).”

This means that even if an original application has been assigned, and that assignment includes language covering continuations and divisions, it does not automatically cover a continuation-in-part application. This is because a CIP application, by definition, contains new matter not present in the original application.

When dealing with a CIP application under pre-AIA 37 CFR 1.47(b), applicants need to ensure that the assignment or proof of proprietary interest specifically covers the new matter included in the CIP. A new assignment or demonstration of proprietary interest may be necessary for the portions of the CIP that were not present in the original application.

To learn more:

To learn more:

Tags: pre-AIA

Micro entity status does not automatically carry over to continuation or divisional applications. A new certification is required for each new application:

  1. A new assertion of entitlement to micro entity status is required for any continuation, divisional, or continuation-in-part application.
  2. This applies even if micro entity status was properly claimed in the parent application.
  3. The new certification must be filed in the continuing application.

The MPEP states: The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

It’s important to note that this requirement for a new certification applies specifically to micro entity status. For small entity status, a new assertion is also required, but the rules are slightly different.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

The inventorship requirements for continuation applications differ based on whether they were filed before or after September 16, 2012:

  • For applications filed on or after September 16, 2012: The inventorship is determined by the information provided in the application data sheet (ADS) filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If no ADS is filed, the inventorship is set by the copy of the inventor’s oath or declaration from the earlier-filed application, unless accompanied by a statement signed under 37 CFR 1.33(b) specifying the correct inventorship.
  • For applications filed before September 16, 2012: The inventorship was generally set by the copy of the executed oath or declaration from the prior application, unless accompanied by a statement requesting deletion of the names of persons who are not inventors in the continuation application.

The MPEP states for post-AIA applications:

37 CFR 1.63(d)(2) provides that the inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application.

These changes reflect the America Invents Act’s modifications to U.S. patent law, simplifying the process for correcting inventorship in many cases.

For more information on America Invents Act, visit: America Invents Act.

For more information on continuation application, visit: continuation application.

For more information on inventorship, visit: inventorship.

For more information on patent application requirements, visit: patent application requirements.

The inventorship of an international application entering the national stage under 35 U.S.C. 371 is determined according to 37 CFR 1.41(e), which states:

The inventorship of an international application entering the national stage under 35 U.S.C. 371 is the inventor or joint inventors set forth in the application data sheet in accordance with § 1.76 filed with the initial submission under 35 U.S.C. 371.

This means that applicants can change inventorship as to the U.S. at the time of national stage entry by simply filing an application data sheet naming the inventor or joint inventors with the initial submission under 35 U.S.C. 371.

If no application data sheet is provided, the inventorship is the inventor or joint inventors set forth in the international application, including any changes made under PCT Rule 92bis. It’s important to note that 37 CFR 1.41(e) does not allow naming inventors via the inventor’s oath or declaration if an application data sheet is not provided.

To learn more:

The inventorship of a divisional application must include at least one inventor named in the parent application, but it doesn’t have to be identical. The MPEP states:

The inventorship in the divisional application must include at least one inventor named in the prior-filed application, and the divisional application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).

If the divisional application is filed with fewer inventors than the parent application, a statement may be filed requesting deletion of the names of the additional inventors. For applications filed on or after September 16, 2012, the statement must be filed with the divisional application and signed by a party set forth in 37 CFR 1.33(b).

To learn more:

The inventorship in a Continued Prosecution Application (CPA) is generally the same as in the prior application, unless a specific request is made to change it. According to 37 CFR 1.53(d)(4):

The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If a change in inventorship is desired, a statement requesting the deletion of the names of non-inventors must be filed with the CPA request. This statement must be signed by a person authorized under 37 CFR 1.33(b). For applications filed on or after September 16, 2012, any request to add an inventor must be in the form of a request under 37 CFR 1.48.

The inventorship in a continuing application can be the same as or different from the prior application, depending on the circumstances:

  1. For applications filed on or after September 16, 2012, the inventorship is determined by the application data sheet or the copy of the oath/declaration from the earlier-filed application.
  2. If the continuing application names a new joint inventor, they must provide a new oath or declaration.

The MPEP states: 37 CFR 1.63(d)(2) provides that the inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If an application data sheet is not filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application, the inventorship is the inventorship set forth in the copy of the inventor’s oath or declaration from the earlier-filed application, unless it is accompanied by a statement signed pursuant to 37 CFR 1.33(b) stating the name of each inventor in the continuing application.

For applications filed before September 16, 2012, different rules apply regarding the deletion or addition of inventors in continuing applications.

For more information on application data sheet, visit: application data sheet.

For more information on declaration, visit: declaration.

For more information on inventorship, visit: inventorship.

For more information on oath, visit: oath.

The inventorship in a Continued Prosecution Application (CPA) is directly related to the parent application. As stated in MPEP 201.06(d):

‘The inventorship in a CPA filed under 37 CFR 1.53(d) is the same as in the prior application.’

This means that when you file a CPA, you are essentially continuing the same application with the same inventors. However, it’s important to note that if there are any changes to inventorship required, they must be made through the appropriate procedures, such as filing a request under 37 CFR 1.48. Any such changes should be made promptly to ensure the accuracy of the patent application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on parent application, visit: parent application.

The inventorship in a Continued Prosecution Application (CPA) automatically carries over from the prior application, unless specific steps are taken to change it. As stated in the MPEP:

“The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA. 37 CFR 1.53(d)(4).”

If an inventor needs to be added or deleted, a request under 37 CFR 1.48 must be filed, along with the required fee. The examiner will notify the applicant if there are any inventorship discrepancies in the first Office action.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on patent filing, visit: patent filing.

Incorporation by reference for foreign priority applications is an important safeguard for applicants. Here’s how it works:

  • For applications filed on or after September 21, 2004, a claim under 37 CFR 1.55 for priority of a prior-filed foreign application is considered an incorporation by reference of the prior-filed foreign priority application.
  • This incorporation is subject to the conditions and requirements of 37 CFR 1.57(b).
  • It applies to inadvertently omitted material from the foreign priority application.
  • Applicants can provide an explicit incorporation by reference statement for broader coverage.

The MPEP states: For applications filed on or after September 21, 2004, a claim under 37 CFR 1.55 for priority of a prior-filed foreign application that was present on the filing date of the application is considered an incorporation by reference of the prior-filed foreign priority application as to inadvertently omitted material, subject to the conditions and requirements of 37 CFR 1.57(b). This provision helps protect applicants from accidental omissions in their U.S. applications.

To learn more:

How does the IDS requirement differ for continuation-in-part applications?

For continuation-in-part (CIP) applications, the Information Disclosure Statement (IDS) requirements have some specific considerations. According to MPEP 609.02:

‘For continuation-in-part applications, applicant should submit an information disclosure statement complying with the content requirements of 37 CFR 1.98 at the time of filing of the continuation-in-part application.’

This means that for CIP applications:

  • A new IDS should be submitted with the CIP application filing
  • The IDS should include all information material to patentability of the newly added subject matter
  • Previously cited information from the parent application should be re-cited if it’s still material to the claims in the CIP

It’s important to note that the duty of disclosure extends to the new subject matter introduced in the CIP, so applicants should be thorough in their IDS submissions for these types of applications.

To learn more:

How does the government’s march-in rights affect contractor-owned inventions?

The government’s march-in rights are a significant aspect of federally sponsored research and development contracts. As outlined in MPEP 310:

“The government has the right to require the contractor to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant(s) upon terms that are reasonable under the circumstances, if the contractor fails to take effective steps to achieve practical application of the invention.”

March-in rights allow the government to intervene if:

  • The contractor fails to commercialize the invention within a reasonable time.
  • Action is necessary to alleviate health or safety needs.
  • Action is necessary to meet requirements for public use specified by federal regulations.
  • The contractor has breached agreements specified in 35 U.S.C. 204 regarding U.S. manufacture.

These rights ensure that inventions resulting from federally funded research benefit the public, even if the contractor fails to do so effectively.

For more information on contractor-owned inventions, visit: contractor-owned inventions.

For more information on federally sponsored research, visit: federally sponsored research.

The Government License Rights statement, as required by 35 U.S.C. 202(c)(6) and described in MPEP 310, does not transfer ownership of the patent to the government. Instead, it acknowledges that:

“The government has certain rights in the invention.”

These rights typically include:

  • A non-exclusive, non-transferable, irrevocable, paid-up license to practice or have practiced the invention for or on behalf of the United States throughout the world
  • March-in rights, allowing the government to require the contractor to grant licenses to third parties under certain circumstances
  • The right to receive periodic reports on the utilization of the invention

While the contractor retains ownership and the right to commercialize the invention, they must operate within the framework of these government rights.

How does the filing date of new matter in a CIP application affect patent rights?

n

The filing date of new matter in a continuation-in-part (CIP) application significantly affects patent rights. According to MPEP 201.08:

n

“Matter disclosed in the parent application is entitled to the benefit of the filing date of the parent application. Matter disclosed for the first time in the continuation-in-part application does not receive the benefit of the filing date of the parent application.”

n

This means:

n

    n

  • The new matter in a CIP is treated as having the filing date of the CIP application itself.
  • n

  • This later filing date can impact the assessment of prior art and the determination of patentability for the new matter.
  • n

  • It may affect the patent term for claims based on the new matter.
  • n

  • In some cases, it could make the new matter more vulnerable to challenges based on intervening prior art.
  • n

n

Therefore, inventors and patent attorneys must carefully consider the timing and content of CIP applications to maximize patent protection.

For more information on new matter, visit: new matter.

For more information on patent rights, visit: patent rights.

For more information on prior art, visit: prior art.

The filing date of a divisional application can affect the patent term in several ways:

  1. 20-year term: The 20-year patent term is calculated from the earliest U.S. filing date to which the divisional application claims priority. This means that the term of a patent issued on a divisional application will generally be shorter than that of its parent application.
  2. Patent Term Adjustment (PTA): The divisional application may be eligible for PTA based on delays in its own prosecution, but not for delays in the prosecution of its parent application.
  3. Terminal Disclaimer: If there’s a risk of obviousness-type double patenting, a terminal disclaimer may be required, potentially limiting the term of the divisional patent to that of the parent patent.

The MPEP 201.06(c) does not directly address patent term, but it’s important to consider these factors when filing a divisional application. For more details on patent term, refer to MPEP 2701.

For more information on Divisional application, visit: Divisional application.

For more information on patent term, visit: patent term.

For more information on patent term adjustment, visit: patent term adjustment.

The filing date of a Continued Prosecution Application (CPA) is determined by the date on which a proper request for a CPA is filed. Specifically, the MPEP states:

The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed.

It’s important to note that the CPA request must be on a separate paper. If the request is not on a separate paper, it will not be considered a proper CPA request and will not receive a filing date.

For more information on patent applications, visit: patent applications.

For more information on USPTO procedures, visit: USPTO procedures.

The filing date of a Continued Prosecution Application (CPA) is determined differently from other types of patent applications. For a CPA, the filing date is the date on which a request for a CPA is filed on a separate paper.

The MPEP states: The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed.

This means that unlike regular applications where the filing date is typically the date all required components are received, a CPA’s filing date is based solely on when the CPA request is submitted, provided it meets the necessary requirements.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

The filing of a Continued Prosecution Application (CPA) has significant effects on the prior application:

  • The CPA is considered a request to expressly abandon the prior application as of the filing date of the CPA
  • The prior application is automatically abandoned in favor of the CPA
  • The filing date of the CPA is the date on which the request for the CPA is filed

As stated in the MPEP: The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed. An application filed under this paragraph:… (v) Is a request to expressly abandon the prior application as of the filing date of the request for an application under this paragraph.

For more information on patent applications, visit: patent applications.

The filing date of a Continued Prosecution Application (CPA) is important for priority claims and patent term calculations. Key points include:

  • The filing date of a CPA is the date on which the CPA request is received by the USPTO
  • A CPA is automatically considered a specific reference under 35 U.S.C. 120 to the prior application
  • The CPA is entitled to the benefit of the filing date of the prior application
  • Priority claims from the parent application automatically carry over to the CPA

As stated in MPEP 201.06(d): A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. That is, the CPA includes the request for an application under 37 CFR 1.53(d) and the recitation of the application number of the prior application in such request is the ‘specific reference to the earlier filed application’ required by 35 U.S.C. 120.

For more information on benefit claims, visit: benefit claims.

For more information on patent term, visit: patent term.

The filing date of a Continued Prosecution Application (CPA) has important implications for its priority claim. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is not entitled to the benefit of a Certificate of Mailing or Transmission under 37 CFR 1.8.

This means that:

  • The CPA’s filing date is the actual date the USPTO receives the CPA request.
  • This date cannot be backdated using a Certificate of Mailing or Transmission.
  • The CPA automatically receives the benefit of the filing date of the prior application.
  • Any foreign priority or domestic benefit claims made in the prior application are automatically carried forward to the CPA.

It’s crucial to understand that while the CPA maintains the priority claims of the prior application, its actual filing date is the date of receipt by the USPTO, which can affect certain statutory deadlines and prior art considerations.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

How does the filing date of a continuation-in-part application affect patent rights?

The filing date of a continuation-in-part (CIP) application can significantly affect patent rights, particularly for the new matter added. According to MPEP 201.08:

“The effective filing date of a claimed invention in a continuation-in-part application is determined on a claim-by-claim basis and is dependent upon the sufficiency of the disclosure in the parent application(s) to support the claimed invention.”

This means:

  • Claims fully supported by the parent application may benefit from the earlier filing date.
  • Claims relying on newly added matter in the CIP will have the filing date of the CIP as their effective date.
  • The later filing date for new matter can affect patentability if relevant prior art emerges between the parent and CIP filing dates.

It’s crucial to carefully consider the timing and content of a CIP to maximize patent protection and avoid potential issues with prior art.

For more information on effective filing date, visit: effective filing date.

For more information on patent rights, visit: patent rights.

The filing date of a continuation application can significantly affect its patent term. While the continuation application gets the benefit of the earlier filing date for prior art purposes, its actual filing date is used to calculate the patent term. According to MPEP 201.07:

The filing date of a continuation application is the filing date of the parent application.

However, this refers to the priority date for prior art purposes. The actual patent term is calculated from the filing date of the continuation application itself. Here’s how it works:

  • The patent term is generally 20 years from the filing date of the earliest non-provisional application to which priority is claimed.
  • For a continuation application, this means 20 years from the filing date of the parent non-provisional application.
  • Each continuation in a chain reduces the effective patent term.

It’s crucial to consider this when deciding whether to file a continuation or a new application, as it can impact the overall protection period for your invention.

For more information on continuation application, visit: continuation application.

For more information on patent priority, visit: patent priority.

For more information on patent term, visit: patent term.

The filing date of a patent application can affect the prosecution rights of assignees. MPEP 106.01 distinguishes between applications filed before and after September 16, 2012:

  • For applications filed before September 16, 2012: See MPEP § 324 for information on prosecution by the assignee.
  • For applications filed on or after September 16, 2012: See MPEP § 325 for details on prosecution by the assignee.

The MPEP states: “For information pertaining to prosecution by the assignee, see MPEP § 324 (for applications filed before September 16, 2012) and MPEP § 325 (for applications filed on or after September 16, 2012).”

This distinction is important because the America Invents Act, which went into effect on September 16, 2012, introduced changes to patent law that affected assignee rights and procedures.

For more information on America Invents Act, visit: America Invents Act.

For more information on patent law changes, visit: patent law changes.

When dealing with foreign language documents in an Information Disclosure Statement (IDS), the examiner follows specific guidelines as outlined in MPEP 609.05(b):

Foreign language documents cited on an information disclosure statement will be considered in view of the concise explanation submitted and insofar as it is understood on its face, e.g., drawings, chemical formulas, in the same manner that non-English language information in the specification is considered.

Key points for handling foreign language documents:

  • The examiner will consider the concise explanation provided with the document.
  • Visual elements like drawings and chemical formulas will be considered.
  • The document will be treated similarly to non-English information in the specification.
  • If no concise explanation is provided, the examiner may not fully consider the document’s relevance.

To learn more:

To learn more:

How does the Electronic Priority Document Exchange (PDX) program work with the USPTO?

The Electronic Priority Document Exchange (PDX) program is a system that allows participating intellectual property offices to exchange priority documents electronically. According to MPEP 215.01, the USPTO participates in this program, which can simplify the process of submitting certified copies of foreign priority applications.

The MPEP states: The USPTO has agreements with the European Patent Office (EPO) and the Japan Patent Office (JPO) that enable the USPTO to obtain certified copies of foreign applications filed in those offices from their electronic records management systems.

Here’s how the PDX program works with the USPTO:

  • If a foreign application was filed with a participating office (e.g., EPO or JPO), the applicant can request that office to make the certified copy of the priority document available to the USPTO.
  • The applicant must submit a request to retrieve the priority document through the USPTO’s electronic filing system (EFS-Web or Patent Center).
  • The USPTO will then attempt to retrieve the document electronically from the foreign office.
  • If successful, this electronic retrieval satisfies the requirement to file a certified copy of the foreign priority application.

It’s important to note that the applicant is still responsible for ensuring that the certified copy is received by the USPTO within the required time frame, even when using the PDX program.

The effective filing date for claims in a continuation-in-part (CIP) application can vary depending on the content of the claims. According to MPEP 201.08:

The effective filing date of a claimed invention in a continuation-in-part application is determined on a claim-by-claim basis and is dependent upon the sufficiency of the disclosure in the earlier application(s) to support the claimed invention with 35 U.S.C. 112(a) except for the best mode requirement.

This means:

  • Claims that are fully supported by the earlier application(s) get the benefit of the earlier filing date(s).
  • Claims that rely on newly added matter in the CIP have the filing date of the CIP as their effective filing date.

It’s crucial for patent applicants to carefully consider the implications of adding new matter in a CIP, as it can affect the priority date and potentially impact patentability.

To learn more:

To learn more:

The disclosure requirements for claiming the benefit of provisional and nonprovisional applications differ in some aspects:

Provisional Applications (35 U.S.C. 119(e)):

For a nonprovisional application to claim the benefit of a provisional application:

  • The written description and drawings (if any) of the provisional application must adequately support and enable the subject matter claimed in the nonprovisional application.
  • A claim is not required in the provisional application.

Nonprovisional Applications (35 U.S.C. 120, 121, 365(c), or 386(c)):

For continuation and divisional applications:

  • The disclosure must be the same as the prior-filed application.
  • No new matter can be added.

For continuation-in-part applications:

  • New matter may be included.
  • Only claims supported by the prior-filed application are entitled to the earlier filing date.

As stated in MPEP 211.05:

“Under 35 U.S.C. 120, a claim in a U.S. application is entitled to the benefit of the filing date of an earlier filed U.S. application if the subject matter of the claim is disclosed in the manner provided by 35 U.S.C. 112(a) except for the best mode requirement, in the earlier filed application.”

This requirement applies to both provisional and nonprovisional applications, ensuring that the earlier application provides proper support for the claimed invention.

To learn more:

The Digital Access Service (DAS) plays a significant role in international design applications:

  • DAS facilitates the exchange of priority documents between participating offices.
  • For applications filed in DAS-participating offices, the International Bureau can retrieve priority documents directly.
  • This eliminates the need for applicants to submit certified copies in many cases.
  • Applicants should ensure their priority claims are properly recorded in the international registration.

MPEP 213.07 states: Where the foreign application was filed in a participating office, the International Bureau will attempt to obtain the priority document from the participating office. This streamlined process through DAS enhances efficiency in handling priority documents for international design applications.

To learn more:

The death of an inventor can have significant implications for power of attorney in a patent application. According to MPEP 409.01(a):

Unless a power of attorney is coupled with an interest (i.e., a patent practitioner is assignee or part-assignee), the death of an inventor who is an applicant party terminates the power of attorney given by the deceased inventor in an application filed on or after September 16, 2012.

This means that in most cases, when an inventor who is also an applicant dies, any power of attorney they had given is automatically terminated. As a result:

  • If the deceased inventor was the sole inventor-applicant, a new power of attorney is necessary.
  • If all powers of attorney in the application have been terminated due to the inventor’s death, a new power of attorney is required.
  • The new power of attorney must come from the heirs, administrators, executors, or assignees of the deceased inventor.

It’s important for legal representatives and other parties involved in the patent application to be aware of this and take appropriate action to ensure the application can continue to be prosecuted effectively.

To learn more:

How does the copendency requirement affect claiming benefit of a prior application?

The copendency requirement is a critical factor in claiming the benefit of a prior application. MPEP 211.01(b) states: To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be copending with the earlier application.

Copendency means:

  • The later application must be filed before the patenting or abandonment of the prior application.
  • There must be no gap in pendency between the applications in the chain.

If copendency is not maintained, the benefit claim to the earlier application will be lost. This can significantly impact the effective filing date of the later application, potentially affecting its patentability.

For detailed information on copendency, refer to MPEP 211.01(b) and 35 U.S.C. 120.

Provisional and nonprovisional applications have different content requirements. According to MPEP 601:

  • Provisional applications do not require claims or an oath or declaration.
  • Nonprovisional applications must include at least one claim and an oath or declaration.

The MPEP states: ‘A provisional application must also include the cover sheet required by 37 CFR 1.51(c)(1), which may be an application data sheet (37 CFR 1.76), or a cover letter identifying the application as a provisional application. Otherwise, the application will be treated as a nonprovisional application filed under 37 CFR 1.53(b).’

It’s crucial to understand these differences to ensure proper filing and to avoid unintended treatment of your application.

To learn more:

The Certificate of Mailing or Transmission can significantly affect the timeliness of USPTO submissions. According to MPEP 512:

“The date indicated on the Certificate of Mailing or Transmission will be used by the Office as the date of receipt of the paper or fee.”

This means that even if there are delays in postal or electronic transmission, your submission will be considered timely if the certificate date is within the required deadline. However, it’s important to note that the actual mailing or transmission must occur on or before the certificate date. False certificates can lead to serious consequences, including invalidation of the submission and potential disciplinary action.

To learn more:

The Certificate of Mailing or Transmission can affect filing date calculations in several ways:

  1. For timely filing: If a paper with a certificate is received after a deadline but the certificate date is within the deadline, the paper is considered timely filed. The MPEP states: “If the date stated is within the period for reply, the reply in most instances will be considered to be timely.”
  2. For actual receipt date: The USPTO will continue to stamp the actual date of receipt on all papers. According to the MPEP: “The receipt date stamped on all papers will also be the date which is entered on Office records and from which any subsequent periods are calculated.”
  3. For subsequent deadlines: If a paper starts a new period for reply, that period is calculated from the actual receipt date, not the certificate date. For example: “If the last day to reply to a final Office action was November 10, 2014, and applicant deposited a Notice of Appeal with fee in the U.S. mail on November 10, 2014, and so certified, that appeal is timely even if it was not received in the U.S. Patent and Trademark Office until November 12, 2014. Since the date of receipt of the notice of appeal will be used to calculate the time at which the brief is due, the brief was due on January 12, 2015.”

It’s important to note that while the certificate can establish timely filing, it doesn’t change the actual receipt date for other USPTO processing purposes.

For applications filed before the America Invents Act (AIA), the best mode requirement affects benefit claims by requiring that the prior-filed application disclose the best mode contemplated by the inventor for carrying out the invention. According to MPEP 211.05:

‘The disclosure of the prior-filed application must provide adequate support and enablement for the claimed subject matter of the later-filed application in compliance with the requirements of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, except for the best mode requirement.

However, it’s important to note that while the best mode requirement is not applied to benefit claims for applications filed on or after September 16, 2012 (the effective date of the AIA), it still applies to applications filed before this date. For pre-AIA applications, failure to disclose the best mode in the prior-filed application could result in the loss of the benefit claim if it is determined that the best mode was not carried forward to the later-filed application.

To learn more:

The benefit claim process for national stage applications entering from an international application under 35 U.S.C. 371 has some specific timing requirements that differ from regular applications filed under 35 U.S.C. 111(a). The MPEP states:

“If the application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, the reference to the prior application must be made during the pendency of the application and within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.”

Key differences for national stage applications include:

  • The time period for submitting the benefit claim starts from the date the national stage commenced or the date of initial submission to enter the national stage.
  • There are three possible deadlines, and the applicant can use the latest of these:
    1. Four months from the date the national stage commenced
    2. Four months from the date of the initial submission to enter the national stage
    3. Sixteen months from the filing date of the prior application

It’s important to carefully track these dates for national stage applications to ensure timely submission of benefit claims.

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on national stage application, visit: national stage application.

The Bayh-Dole Act, as implemented in 37 CFR Part 401, significantly affects government rights in federally funded inventions:

  • It allows contractors (including small businesses and nonprofit organizations) to retain title to inventions made under federally funded research and development contracts.
  • The government receives a nonexclusive, nontransferable, irrevocable, paid-up license to practice the invention.
  • The Act encourages the commercialization of federally funded inventions while protecting the government’s interests.

As stated in the MPEP: ‘The Bayh-Dole Act… provides, in essence, that nonprofit organizations and small business firms may retain title to inventions made under federally funded research and development contracts.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

The Background of the Invention, specifically the Field of Invention part, can relate to the Cooperative Patent Classification (CPC) in the following way:

According to MPEP 608.01(c), “This statement may include a paraphrasing of the applicable Cooperative Patent Classification (CPC) definitions.” This means that when describing the field of the invention, applicants can use the CPC definitions as a guide to accurately and comprehensively describe the technical field to which their invention pertains.

Using CPC definitions can help ensure that the Field of Invention is described in a way that aligns with standardized classification systems, potentially making it easier for patent examiners to understand and classify the invention.

To learn more:

The assignment process for continuations-in-part (CIPs) differs from other application types due to the potential inclusion of new subject matter. The MPEP § 306.01 explains:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein. This is similar to the practice with respect to continuations-in-part filed under 35 U.S.C. 120.

In essence:

  • For continuations and divisions that contain only subject matter from the parent application, the original assignment usually remains effective.
  • For CIPs or applications with new subject matter not in the parent or provisional application, new assignment papers are typically required, with the exception noted for applications filed on or after September 16, 2012, where the assignee is the original applicant.

This difference reflects the unique nature of CIPs, which introduce new matter not present in the parent application.

The assignment process for continuation-in-part (CIP) applications claiming benefit of a provisional application differs from standard continuations or divisions:

  • If the CIP includes new subject matter not in the provisional application, new assignment papers are typically required.
  • This requirement is similar to the practice for CIPs filed under 35 U.S.C. 120.
  • An exception exists for applications filed on or after September 16, 2012, where the assignee is the original applicant in the CIP.

MPEP § 306.01 states: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein. This is similar to the practice with respect to continuations-in-part filed under 35 U.S.C. 120.

This approach ensures that the assignment covers all subject matter in the CIP, including new material not present in the provisional application.

To learn more:

The assignment of a priority right can significantly impact patent applications. According to MPEP 216:

‘The right of priority is a personal right of the applicant or his successor in title. It may be transferred to the extent and subject to the conditions provided for in the statutes.’

Key points about the assignment of priority rights:

  • Priority rights can be transferred separately from the application itself.
  • The assignment must be executed before filing the later application claiming priority.
  • An assignment of the entire right, title, and interest in an application includes the right of priority.
  • Partial assignments of priority rights are possible but must be clearly documented.

Proper assignment of priority rights is crucial for maintaining the earlier effective filing date, which can be critical for patentability and avoiding prior art rejections.

For more information on effective filing date, visit: effective filing date.

The application filing limit for micro entity status works as follows:

  • An applicant must not have been named as an inventor on more than 4 previously filed patent applications
  • This limit excludes provisional applications, foreign applications, and PCT applications where the basic national fee was not paid
  • Applications filed as a result of previous employment where rights were assigned don’t count towards the limit

MPEP 509.04(a) clarifies: ‘It does not matter how long ago the previous applications were filed or whether the previously filed applications are pending, patented, or abandoned; they are still included when counting to determine whether the application filing limit has been reached.’

The Application Data Sheet (ADS) plays an important role in establishing and changing inventorship in patent applications:

  • The ADS should include inventor information, including legal name, residence, and mailing address of each inventor.
  • The naming of inventorship is governed by 37 CFR 1.41.
  • Changes to inventorship or the names of inventors are governed by 37 CFR 1.48.
  • In case of inconsistencies, the most recent submission will generally govern, except for inventorship issues.

37 CFR 1.76(d)(1) states: “The naming of the inventorship is governed by § 1.41 and changes to inventorship or the names of the inventors is governed by § 1.48.”

It’s important to note that while the ADS is used to provide inventor information, any changes to inventorship must comply with the specific requirements of 37 CFR 1.48, which may require additional documentation beyond just updating the ADS.

To learn more:

The America Invents Act (AIA) significantly affected assignee rights in patent applications, particularly for those filed on or after September 16, 2012. MPEP 106.01 highlights one key change:

‘…for applications filed on or after September 16, 2012, [the assignee] can prosecute the application after becoming the applicant under 37 CFR 1.46.’

This change allows assignees of the entire interest to take a more active role in patent prosecution by becoming the applicant. The AIA aimed to modernize the U.S. patent system and align it more closely with international practices.

For more detailed information on how the AIA affects assignee rights, refer to MPEP § 325 for applications filed on or after September 16, 2012.

The America Invents Act’s (AIA) first-inventor-to-file (FITF) provision has significant implications for perfecting foreign priority claims, especially in cases where the foreign application has a pre-March 16, 2013 filing date. Key points include:

  • If a patent was examined under FITF provisions, but the foreign priority application has a pre-AIA filing date, perfecting the priority claim may require further examination.
  • In such cases, a certificate of correction is not sufficient, and a reissue application is necessary.
  • This situation arises because changing the effective filing date could potentially subject the patent to a different statutory framework.

The MPEP states: In situations where further examination would be required, the petition should not be granted. For example, further examination would be required where grant of the petition would cause the patent to be subject to a different statutory framework, e.g., where the foreign application has a pre-March 16, 2013 filing date in a patent that was examined under the first inventor to file (FITF) provisions of the AIA.

This requirement ensures that patents are not inadvertently subjected to different legal standards without proper examination.

How does the AIA impact power of attorney for applications filed before September 16, 2012?

The America Invents Act (AIA) does not significantly change the power of attorney requirements for applications filed before September 16, 2012. As stated in MPEP 402.02(b):

For applications filed before September 16, 2012, all parties having the right to prosecute the application at the time of filing the power of attorney must act together in appointing a power of attorney.

This means that the pre-AIA rules continue to apply for these older applications. However, it’s important to note that any new applications filed on or after September 16, 2012, are subject to the updated AIA rules regarding power of attorney.

To learn more:

How does the AIA FITF system affect the prior-filed application requirements?

The America Invents Act (AIA) First Inventor to File (FITF) system has introduced some changes to the prior-filed application requirements. The MPEP explains:

“AIA 35 U.S.C. 120, 121, 365(c), and 386(c) require that the prior-filed application to which benefit is claimed must name the inventor or a joint inventor named in the later-filed application as the inventor or a joint inventor.”

Key points to note:

  • The prior application must name at least one common inventor with the later-filed application.
  • This requirement applies to applications filed on or after September 16, 2012.
  • For applications filed before this date, the prior application must name the inventor(s) named in the later-filed application.

These changes ensure that the benefit claim aligns with the FITF system’s focus on the first inventor to file. For more information, refer to MPEP 211.01 and USPTO AIA FITF Guidance.

To learn more:

To learn more:

How does the AIA FITF system affect priority claims in patent applications?

The America Invents Act (AIA) First-Inventor-to-File (FITF) system, which went into effect on March 16, 2013, significantly impacted how priority is determined for patent applications. According to MPEP 210:

The AIA converted the U.S. patent system from a ‘first to invent’ system to a ‘first inventor to file’ system. Specifically, the changes to 35 U.S.C. 102 and 103 in the AIA apply to any patent application subject to the first inventor to file provisions of the AIA.

Key effects of the AIA FITF system on priority claims include:

  • The effective filing date of a claimed invention is crucial for determining prior art.
  • Applications filed on or after March 16, 2013, are subject to FITF provisions.
  • Transitional applications (those with claims to pre-AIA and post-AIA effective filing dates) may be subject to both systems.
  • Priority claims must be carefully evaluated to determine which system applies to each claim.

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

For more information on FITF, visit: FITF.

How does the AIA first-inventor-to-file system affect benefit claims?

The America Invents Act (AIA) introduced the first-inventor-to-file system, which has significant implications for benefit claims. While the MPEP 211.01 doesn’t directly address this, it’s an important consideration for applicants. Here’s how it affects benefit claims:

  • Effective Filing Date: The effective filing date of a claimed invention is crucial under the AIA system. It’s determined by the earliest application in the priority chain that describes the claimed invention.
  • Prior Art: The prior art date is now based on the effective filing date, making proper benefit claims even more critical.
  • Grace Period: The one-year grace period for disclosures by the inventor is now measured from the effective filing date.
  • Continuation and CIP Applications: These applications can still claim benefit to earlier applications, but the effective filing date for each claim is determined individually based on when its subject matter was first disclosed in the application chain.

For more information on the AIA and its impact on patent applications, refer to MPEP 2151 and the USPTO’s AIA FAQ page.

To learn more:

How does the AIA First Inventor to File system affect priority claims?

The America Invents Act (AIA) introduced the First Inventor to File (FITF) system, which has significant implications for priority claims. Under the AIA:

  • Applications filed on or after March 16, 2013, are subject to the FITF provisions.
  • Priority claims can still be made to earlier applications, but the effective filing date is crucial for determining prior art.
  • The effective filing date is the earlier of:
    1. The actual filing date of the application, or
    2. The filing date of the earliest application for which benefit or priority is claimed and which describes the subject matter.

As stated in MPEP 210: “The AIA provides that the right of priority and the benefit of an earlier filing date are available to a claim only if that claim is supported by the prior-filed application to which priority or benefit is claimed.”

This means that each claim in a later-filed application must be fully supported by the prior-filed application to receive its priority date. Applicants must carefully consider the content of their priority applications when making claims in subsequent filings.

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

How does the AIA change the process for applications with deceased or incapacitated inventors?

The America Invents Act (AIA) introduced significant changes to the patent application process, including how applications with deceased or legally incapacitated inventors are handled. According to MPEP 409.01(a):

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign the invention, or who otherwise shows sufficient proprietary interest in the matter, to make the application for patent.”

Key changes under the AIA include:

  • Allowing assignees or those with sufficient proprietary interest to file applications
  • Introduction of the substitute statement to replace inventor oaths in certain circumstances
  • Simplified process for continuing prosecution when an inventor becomes unavailable
  • Removal of the need for heirs or legal representatives to expressly petition to file on behalf of a deceased inventor

These changes streamline the application process and provide more flexibility when dealing with situations involving deceased or incapacitated inventors, making it easier for the remaining inventors or interested parties to pursue patent protection.

To learn more:

How does the AIA change joint inventorship requirements?

The America Invents Act (AIA) introduced significant changes to joint inventorship requirements:

  • Elimination of ‘without deceptive intention’: The AIA removed the requirement that joint inventors make their respective contributions ‘without deceptive intention.’ This simplifies the inventorship determination process.
  • Broader inventorship criteria: The AIA expanded the definition of joint inventorship, allowing for more flexibility in determining who qualifies as a joint inventor.
  • Changes to oath or declaration: The AIA modified the requirements for inventor’s oath or declaration, impacting how joint inventors are identified and verified in patent applications.

As stated in MPEP 602.09: ‘The AIA eliminated the requirement that each joint inventor make their contribution jointly with the other joint inventors.’

To learn more:

How does the AIA affect priority claims for applications filed on or after March 16, 2013?

The America Invents Act (AIA) significantly changed the U.S. patent system, particularly affecting priority claims for applications filed on or after March 16, 2013. According to MPEP 216:

“AIA 35 U.S.C. 100(i)(1)(B) provides that the effective filing date for a claimed invention in a patent or application for patent (other than a reissue application or reissued patent) is the filing date of the earliest application for which the patent or application is entitled to claim a right of foreign priority or domestic benefit.”

This change means that:

  • The effective filing date can now include foreign priority dates, not just domestic benefit dates.
  • The first-to-file system replaced the first-to-invent system for determining priority.
  • Prior art is now determined based on the effective filing date, including foreign priority dates.

These changes have significant implications for inventors and patent practitioners in terms of strategy for filing applications and claiming priority, especially in a global context.

For more information on America Invents Act, visit: America Invents Act.

For more information on effective filing date, visit: effective filing date.

For more information on foreign priority, visit: foreign priority.

The addition of new matter in a continuation-in-part (CIP) application can significantly affect priority claims. Here’s how:

  • Claims that are fully supported by the parent application retain the parent’s filing date.
  • Claims that rely on the new matter added in the CIP receive the filing date of the CIP application.

The MPEP 201.08 states: The disclosure presented in the continuation-in-part application may include subject matter in common with or vary from that of the prior application. This means that each claim in a CIP must be evaluated individually to determine its effective filing date, which can impact prior art considerations and the validity of the patent.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

The abstract and the specification serve different purposes in a patent application. While the specification provides a detailed description of the invention, the abstract offers a brief overview. According to MPEP 608.01(b):

The abstract is a brief narrative of the disclosure as a whole, as concise as the disclosure permits, in a single paragraph preferably not exceeding 150 words, commencing on a separate sheet following the claims.

Key differences include:

  • Length: The abstract is limited to 150 words, while the specification can be much longer
  • Purpose: The abstract provides a quick overview, while the specification offers detailed description
  • Content: The abstract summarizes key points, while the specification includes comprehensive details
  • Legal weight: The specification is part of the patent, while the abstract is not typically used for interpreting the scope of claims

Both elements are crucial, but they serve distinct roles in communicating your invention.

To learn more:

The 6-month rule for foreign filing licenses states that:

  • After 6 months from the filing date of a US application, a foreign filing license is no longer required for that subject matter.
  • This automatic license occurs unless a Secrecy Order has been imposed on the application.
  • The rule is based on 35 U.S.C. 184 and 37 CFR 5.11(e)(2).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

The ‘unintentional’ delay standard is crucial in evaluating petitions for delayed benefit claims. According to MPEP 211.04:

While the Director may require additional information whenever there is a question of whether the delay was unintentional, a person filing a petition to accept a delayed benefit claim more than two years after the date the benefit claim was due is required to provide additional explanation of the circumstances surrounding the delay that establishes that the entire delay was unintentional.

This requirement is in addition to the standard statement of unintentional delay. For further discussion on the ‘unintentional’ delay standard, refer to MPEP § 711.03(c).

For more information on unintentional delay, visit: unintentional delay.

The ‘first foreign application’ rule states that the priority period is calculated from the earliest foreign filing, with some exceptions. This means:

  • Priority can only be claimed to the first application filed for the invention.
  • If multiple foreign applications were filed, only the earliest can serve as the basis for priority.
  • Applications filed in non-recognized countries are disregarded for priority purposes.

The MPEP provides an example: If an inventor has filed an application in France on October 4, 1981, and an identical application in the United Kingdom on March 3, 1982, and then files in the United States on February 2, 1983, the inventor is not entitled to the right of priority at all; the inventor would not be entitled to the benefit of the date of the French application since this application was filed more than twelve months before the U.S. application, and the inventor would not be entitled to the benefit of the date of the United Kingdom application since this application is not the first one filed. (MPEP 213.03)

To learn more:

The ‘Detailed Description’ section of a patent application is closely tied to the enablement requirement, which is a fundamental principle in patent law. According to MPEP 608.01(g):

“This detailed description… must be in such particularity as to enable any person skilled in the pertinent art or science to make and use the invention without involving extensive experimentation”

This statement directly addresses the enablement requirement, which demands that:

  • The description must be detailed enough for a person skilled in the relevant field to make and use the invention.
  • It should not require ‘extensive experimentation’ to implement the invention.
  • The level of detail should be commensurate with the complexity of the technology.

The enablement requirement, codified in 35 U.S.C. § 112(a), ensures that the patent disclosure is sufficient to justify the grant of exclusive rights. A detailed description that fails to meet the enablement requirement can result in rejection of the patent application or invalidation of an issued patent.

For more information on enablement, refer to MPEP § 2164, which provides comprehensive guidance on this crucial aspect of patent law.

To learn more:

Tags: patent law

Taiwan’s unique political status has implications for patent priority claims in US applications. According to MPEP 213.01:

‘Applicants from Taiwan may claim priority under 35 U.S.C. 119(a)-(d) to applications filed in Taiwan which are filed by or on behalf of the governing authority on Taiwan.’

This special provision allows Taiwanese applicants to claim priority despite Taiwan not being officially recognized as a sovereign state by the United States. The MPEP further clarifies:

Applications from Taiwan must meet the following criteria to be eligible for priority claims:

  • The application must be filed by or on behalf of the governing authority on Taiwan
  • The priority claim must be made in accordance with the standard procedures outlined in 35 U.S.C. 119(a)-(d)

This arrangement ensures that inventors and companies in Taiwan can participate in the international patent system and maintain priority rights for their inventions when seeking protection in the United States.

Submitting documents as evidence in a reply to an Office action is distinct from filing an information disclosure statement (IDS). The MPEP clarifies:

“Compliance with the information disclosure rules is not a threshold requirement to have information considered when submitted by applicant to support an argument being made in a reply to an Office action.”

When submitting documents as evidence, applicants don’t need to comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98. However, if the same documents are also listed on an IDS form (e.g., PTO/SB/08), the applicant must comply with IDS rules for those documents to be considered as part of the IDS.

To learn more:

Small entity status does not automatically carry over from a parent application to a continuation application. The MPEP provides clear guidance on this matter:

If small entity status has been established in a parent application and is still proper and desired in a continuation, continuation-in-part, or divisional application filed under 37 CFR 1.53(b), a new assertion as to the continued entitlement to small entity status under 37 CFR 1.27 is required.

This means that applicants must take specific steps to maintain small entity status in a continuation application:

  1. Review Eligibility: Ensure that the applicant still qualifies for small entity status under the current rules.
  2. New Assertion: File a new assertion of entitlement to small entity status in the continuation application.
  3. Timing: This assertion should be made at the time of filing the continuation application or with the first fee payment.

It’s important to note that improperly claiming small entity status can have serious consequences, including the patent being held unenforceable. Therefore, applicants should carefully review their status before making a new assertion in a continuation application.

For micro entity status, the requirements are even more stringent:

The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

Applicants should be diligent in properly asserting and maintaining their entity status throughout the patent application process, including when filing continuation applications.

For more information on continuation application, visit: continuation application.

For more information on patent fees, visit: patent fees.

When a power of attorney is revoked, it affects pending applications as follows:

  • The revocation is effective upon receipt in the USPTO.
  • It applies to all pending applications in which the attorney or agent was appointed, unless specifically limited.
  • The Office will not communicate further with the revoked attorney/agent.
  • The applicant must appoint a new representative or correspond directly with the Office.

As stated in MPEP 402.05: ‘A power of attorney may be revoked at any stage in the proceedings of a case.’ This means the revocation can occur at any point during the patent application process.

To learn more:

When a power of attorney is revoked, it’s important to understand its impact on pending amendments in a patent application. According to MPEP 402.05:

Any amendments made in an application after the filing date of the application will not be effective to revoke a power of attorney.

This means that if an applicant submits an amendment to revoke a power of attorney after the application’s filing date, that amendment will not be effective in revoking the power of attorney. To properly revoke a power of attorney, the applicant must follow the specific procedures outlined in the MPEP, such as submitting a separate revocation document or a new power of attorney.

To learn more:

Restriction requirements can affect joint inventorship in patent applications. The MPEP explains:

If an application by joint inventors includes more than one independent and distinct invention, restriction may be required with the possible result of a necessity to change the inventorship named in the application if the elected invention was not the invention of all the originally named inventors.

In such cases:

  • A ‘divisional’ application complying with 35 U.S.C. 120 would be entitled to the benefit of the earlier filing date of the original application.
  • Examiners should remind applicants to correct inventorship under 37 CFR 1.48 if an invention is elected and claims to the invention of one or more inventors are canceled.

This process ensures that the correct inventors are named for each distinct invention in the case of a restriction requirement.

To learn more:

To learn more:

Proper identification of foreign priority applications is particularly important for electronic priority document exchange programs. The MPEP emphasizes this point:

Proper identification of priority applications is essential to establishing accurate and complete relationships among various patent documents, especially in the context of electronic priority document exchange programs

The impact on electronic priority document exchange programs includes:

  • Facilitating accurate matching of priority documents with corresponding applications
  • Ensuring efficient retrieval and processing of priority documents
  • Reducing errors and delays in the priority document exchange process
  • Supporting the integrity of international patent filing systems

Accurate identification helps streamline the electronic exchange process, benefiting both applicants and patent offices involved in international patent procedures.

To learn more:

The PDX system has specific procedures for handling international applications filed under the Patent Cooperation Treaty (PCT). According to MPEP 215.01:

The USPTO will automatically attempt retrieval of international applications filed under the PCT where the receiving office is RO/AU, RO/DK, RO/ES, RO/FI, RO/IB, RO/MA or RO/SE and the applicant has provided the required WIPO DAS access code for the international application to which foreign priority is claimed.

Key points for PCT applications:

  • Automatic retrieval attempts are made for certain PCT applications.
  • Applies to applications filed with receiving offices: RO/AU, RO/DK, RO/ES, RO/FI, RO/IB, RO/MA, or RO/SE.
  • The applicant must provide the WIPO DAS access code for the international application.
  • This process streamlines priority document retrieval for eligible PCT applications.

Applicants should ensure they provide the necessary WIPO DAS access code to facilitate this automatic retrieval process.

To learn more:

PDX for U.S. design applications has specific considerations, as explained in MPEP 215.01:

The USPTO will attempt retrieval of foreign applications to which priority is claimed in a U.S. design application where possible. The Spanish Patent and Trademark Office deposits certain ES industrial design applications for access by the USPTO via the WIPO DAS. Therefore, when the applicant claims foreign priority to an ES industrial design application and provides the WIPO DAS access code, the USPTO will attempt retrieval via the WIPO DAS.

Key points for design applications:

  • The USPTO attempts to retrieve foreign priority documents for design applications where possible.
  • Spanish industrial design applications are accessible through WIPO DAS.
  • Applicants must provide the WIPO DAS access code for Spanish industrial design applications.
  • The USPTO will attempt retrieval via WIPO DAS when the access code is provided.

This process helps streamline the priority document retrieval for design applications, particularly those with Spanish priority.

To learn more:

Paying a small entity fee has significant implications for certifying small entity status. According to MPEP 509.03(a), “Consistent with 37 CFR 1.4(d)(4), the payment of a small entity basic filing or national fee constitutes a certification under 37 CFR 11.18(b).” This means that simply paying the small entity fee, even without a specific written assertion, activates the self-certification requirement. Applicants should be aware that this payment invokes the certification provisions, regardless of whether they are a practitioner or non-practitioner.

To learn more:

Tags: patent fees

For pre-AIA patent applications (filed before September 16, 2012), partial assignees have specific rights and requirements when it comes to patent ownership and prosecution. According to MPEP 324:

A partial assignee is any assignee of record having less than the entire right, title and interest in the application. Where at least one inventor retains an ownership interest together with the partial assignee(s), the combination of all partial assignees and inventors retaining ownership interest is needed to conduct the prosecution of an application.

This means that if there are multiple partial assignees or a combination of partial assignees and inventors, they must act together to prosecute the application. Additionally, when establishing ownership:

  • Each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b).
  • The extent of each assignee’s interest must be clearly stated.
  • The Office must be able to determine if it has obtained action by all of the right, title, and interest holders.

If the extent of ownership is not clear, the USPTO may refuse to accept the submission as an establishment of ownership interest.

For more information on joint ownership, visit: joint ownership.

For more information on partial assignees, visit: partial assignees.

For more information on pre-AIA applications, visit: pre-AIA applications.

When an application is filed with informal drawings, the Office of Patent Application Processing (OPAP) will review the drawings to determine if they can be used for publication purposes. If the drawings are not acceptable for publication purposes, OPAP will object to the drawings and require corrected drawings within a set time period, usually two months. This objection does not affect the filing date of the application, and applicants can correct the drawings later in the examination process if needed.

How does new matter in a continuation-in-part application affect priority dates?

The introduction of new matter in a continuation-in-part (CIP) application has significant implications for priority dates. According to MPEP 201.08:

“The new matter in a continuation-in-part application is not entitled to the benefit of the filing date of the parent application.”

This means:

  • Subject matter carried over from the parent application retains the parent’s filing date as its priority date
  • New matter introduced in the CIP has the filing date of the CIP as its priority date
  • Different claims within the same CIP application may have different priority dates

This distinction is crucial for determining prior art and potential patent infringement cases. Inventors and patent practitioners must carefully consider the implications of adding new matter when filing a CIP application.

For more information on new matter, visit: new matter.

Tags: new matter

How does new matter in a continuation-in-part affect prior art considerations?

The introduction of new matter in a continuation-in-part (CIP) application significantly affects prior art considerations. According to the MPEP 201.08:

Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the prior-filed application are entitled to the benefit of the filing date of the prior-filed application.

This means:

  • Claims based on new matter have the filing date of the CIP as their effective filing date.
  • Prior art that predates the CIP filing but postdates the parent application can be used against claims based on new matter.
  • Claims fully supported by the parent application retain the earlier effective filing date for prior art purposes.

Patent examiners must carefully analyze each claim to determine its effective filing date and apply the appropriate prior art. Applicants should be aware that introducing new matter may expose some claims to a broader range of prior art, potentially affecting patentability.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

For more information on prior art, visit: prior art.

How does new matter in a continuation-in-part affect patent rights?

New matter introduced in a continuation-in-part (CIP) application can significantly affect patent rights. According to MPEP 201.08, “Matter not disclosed in the parent nonprovisional application is entitled only to the filing date of the continuation-in-part application.”

This means:

  • New matter is only entitled to the filing date of the CIP application itself.
  • This later filing date can impact the assessment of prior art for the new matter.
  • Patent term for claims based on new matter may be calculated from the CIP filing date.
  • Different parts of the CIP application may have different priority dates, affecting patentability and enforcement.

It’s crucial for inventors and patent practitioners to carefully consider the implications of adding new matter in a CIP, as it can affect the scope and strength of patent protection.

For more information on new matter, visit: new matter.

For more information on patent rights, visit: patent rights.

The treatment of new matter varies depending on the type of continuing application:

  • Continuation and Divisional Applications: Must not contain any new matter. The disclosure must be the same as the prior application.
  • Continuation-in-Part (CIP) Applications: Can include new matter not disclosed in the parent application.
  • Continued Prosecution Applications (CPAs): Cannot contain new matter.

For continuation and divisional applications, the MPEP states: “The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.”

For CIPs, the MPEP notes: “A continuation-in-part is an application… repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.”

If new matter is found in a continuation or divisional application, the examiner will require the applicant to delete the benefit claim or change the application to a continuation-in-part. For CPAs, any new matter introduced will be required to be canceled.

It’s important to note that claims in a CIP application that rely on new matter will only be entitled to the filing date of the CIP, not the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

How does MPEP 608.04(a) define ‘new matter’ in patent applications?

MPEP 608.04(a) defines new matter as any content added to the specification, claims, or drawings after the application filing date that was not present on the original filing date. Specifically, the MPEP states: “Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.” This definition is crucial for patent applicants and examiners to understand what constitutes acceptable additions or amendments to a patent application after it has been filed.

To learn more:

To learn more:

MPEP 409.03(f) provides guidance on handling patent applications when an inventor is deceased or legally incapacitated. The section states:

‘When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or assignee on compliance with the foregoing provisions.’

This means that in cases of a deceased inventor, the patent can still be issued to their legal representative or assignee, provided they comply with the requirements for proving proprietary interest. For legally incapacitated inventors, similar provisions apply, allowing the legal guardian or other authorized representative to act on behalf of the inventor in patent matters.

It’s important to note that in these situations, additional documentation such as death certificates or court orders establishing legal guardianship may be required to establish the authority of the person acting on behalf of the inventor.

To learn more:

To learn more:

MPEP 402.08 has significant implications for patent attorneys involved in derivation proceedings. The key provision states:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

For patent attorneys, this means:

  • Any changes in representation must go through the PTAB, not regular USPTO channels.
  • There may be delays in processing power of attorney changes due to PTAB review.
  • Attorneys must be prepared to justify changes in representation to the PTAB if necessary.
  • The timing of representation changes may be influenced by the ongoing derivation proceeding.

Patent attorneys should be aware of these special procedures to ensure smooth transitions in representation during derivation proceedings.

To learn more:

To learn more:

MPEP 318 provides clear guidance to patent examiners on how to handle assignment documents. The section states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This instruction serves to:

  • Remind examiners not to include assignment documents in the main application file
  • Direct examiners to forward any received assignment documents to the Assignment Division
  • Ensure that the proper procedures for recording assignments are followed
  • Maintain the separation between technical examination and ownership recording

By following this guidance, patent examiners help maintain the integrity of both the application files and the assignment records.

MPEP 310 is closely related to the Bayh-Dole Act, officially known as the Patent and Trademark Law Amendments Act. Here’s how they are connected:

  • The Bayh-Dole Act allows contractors to retain title to inventions made with federal funding.
  • It requires contractors to disclose these inventions and include a statement in patent applications about government support.
  • MPEP 310 provides specific guidance on implementing the Bayh-Dole Act’s requirements, particularly the government license rights statement.
  • The statutory basis for MPEP 310 is 35 U.S.C. 202(c)(6), which is part of the Bayh-Dole Act.

In essence, MPEP 310 serves as a practical guide for patent applicants to comply with the Bayh-Dole Act’s provisions regarding government-funded inventions.

According to MPEP 201.01, original applications are defined as follows:

‘Original applications include applications filed under 35 U.S.C. 111(a) and provisional applications filed under 35 U.S.C. 111(b).’

This definition encompasses two distinct types of applications:

  • Non-provisional applications filed under 35 U.S.C. 111(a)
  • Provisional applications filed under 35 U.S.C. 111(b)

Understanding this distinction is crucial for inventors and patent practitioners when deciding which type of application to file based on their specific needs and circumstances.

For more information on patent filing, visit: patent filing.

MPEP 201.01 provides a clear definition of a national application in the context of U.S. patent law. According to MPEP 201.01:

‘A national application is one that was filed in the United States Patent and Trademark Office (USPTO) under 35 U.S.C. 111(a), an application which entered the national stage from an international application after compliance with 35 U.S.C. 371, or a reissue application filed under 35 U.S.C. 251.’

This definition encompasses three main categories:

  1. Applications filed directly with the USPTO under 35 U.S.C. 111(a)
  2. International applications that have entered the national stage in the U.S. after complying with 35 U.S.C. 371
  3. Reissue applications filed under 35 U.S.C. 251

Understanding this definition is crucial for patent applicants and practitioners to determine the appropriate filing procedures and requirements for their inventions.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on USPTO, visit: USPTO.

The MPEP 201 defines a provisional application for patent as follows:

“A provisional application for patent is a U.S. national application filed in the USPTO under 35 U.S.C. 111(b). It allows filing without a formal patent claim, oath or declaration, or any information disclosure (prior art) statement.”

Key features of a provisional application include:

  • It provides the means to establish an early effective filing date in a later filed nonprovisional patent application.
  • It allows the term “Patent Pending” to be applied in connection with the description of the invention.
  • It has a pendency lasting 12 months from the date the provisional application is filed.
  • The 12-month pendency period cannot be extended.

Provisional applications are often used by inventors to quickly secure a filing date while they continue to develop their invention or seek funding.

For more information on 12-month pendency, visit: 12-month pendency.

For more information on early filing date, visit: early filing date.

For more information on provisional application, visit: provisional application.

Limited recognition in international patent applications is addressed in 37 CFR 11.9(c), which states:

An individual not registered under § 11.6 may, if appointed by an applicant, prosecute an international patent application only before the United States International Searching Authority and the United States International Preliminary Examining Authority, provided that the individual has the right to practice before the national office with which the international application is filed as provided in PCT Art. 49, Rule 90 and § 1.455 of this subchapter, or before the International Bureau when the USPTO is acting as Receiving Office pursuant to PCT Rules 83.1bis and 90.1.

This means that unregistered individuals may represent applicants in certain phases of international patent applications under specific conditions. For more detailed information:

  • See MPEP § 1807 for representation in international applications (PCT)
  • See MPEP § 2911 for representation in international design applications

To learn more:

How does licensing affect small entity status?

Licensing can significantly impact small entity status. According to MPEP 509.03:

An applicant or patentee is not considered a small entity if any rights in the invention have been assigned, granted, conveyed, or licensed to an entity that would not qualify for small entity status.

This means:

  • If a small entity licenses rights to a large entity, small entity status is lost.
  • Exclusive licenses generally result in loss of small entity status.
  • Non-exclusive licenses may not affect status if they don’t convey all significant rights.

It’s crucial to review all licensing agreements before claiming small entity status. Any change in licensing that affects status must be reported to the USPTO promptly.

To learn more:

Licensing can significantly impact small entity status for patent fees. The MPEP provides specific guidance on this matter:

Rights conveyed by an applicant or patentee to a Government agency are not considered to be license for purposes of this paragraph. A Government agency includes any agency of the Federal Government or military department of the Government.

This means that licensing to a government agency does not affect small entity status. However, licensing to other entities can impact your status:

  • If you license rights to a large entity, you may lose your small entity status.
  • Exclusive licenses to large entities typically disqualify you from small entity status.
  • Non-exclusive licenses may not affect your status, depending on the terms.

It’s crucial to review any licensing agreements carefully and consult with a patent attorney to determine how they might affect your small entity status.

To learn more:

Tags: patent fees

How does licensing affect small entity status for a business concern?

Licensing can significantly impact a business concern’s eligibility for small entity status. According to MPEP 509.02:

“Rights to an invention are considered as assigned, granted, conveyed, or licensed when they are held by an entity other than the inventor, and they are not qualified for small entity status.”

This means that if a business concern has licensed rights to the invention to any person or entity that does not qualify as a small entity, it may lose its small entity status. Specifically:

  • If the business has licensed rights to a large entity, it cannot claim small entity status.
  • Exclusive licenses to large entities will disqualify the business from small entity status.
  • Non-exclusive licenses may not affect small entity status if they are arms-length agreements.

It’s crucial for businesses to carefully consider the impact of licensing agreements on their small entity status before entering into such arrangements.

To learn more:

How does licensing affect micro entity status eligibility?

Licensing can significantly impact an applicant’s eligibility for micro entity status. According to the MPEP:

“The applicant has not assigned, granted, or conveyed, nor is under an obligation by contract or law to assign, grant, or convey, a license or other ownership interest in the application concerned to an entity that, in the calendar year preceding the calendar year in which the applicable fee is being paid, had a gross income, as defined in section 61(a) of the Internal Revenue Code of 1986, exceeding 3 times the median household income for that preceding calendar year, as most recently reported by the Bureau of the Census.”

This means that if you’ve licensed or are obligated to license your application to a high-income entity (exceeding 3 times the median household income), you may not be eligible for micro entity status. It’s crucial to consider any existing or potential licensing agreements when determining your eligibility.

To learn more:

Tags: micro entity

When an inventor becomes legally incapacitated before filing a patent application and executing the required oath or declaration, a legal representative must be appointed to act on their behalf. According to 37 CFR 1.43 (pre-AIA):

“In case an inventor is insane or otherwise legally incapacitated, the legal representative (guardian, conservator, etc.) of such inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative, typically appointed by a court of competent jurisdiction, can then execute the oath or declaration and proceed with the patent application process on behalf of the incapacitated inventor.

To learn more:

How does joint ownership work for patents?

Joint ownership in patents occurs when two or more parties share ownership rights. The MPEP 301 provides guidance on this:

‘In the case of joint owners, each joint owner has the right to make, use, offer for sale, and sell the patented invention without the consent of and without accounting to the other owners.’

This means that each joint owner has full rights to use and profit from the patent independently, without needing permission from the other owners. However, this can lead to complications, especially in licensing or selling the patent, as all joint owners typically need to agree on such actions. It’s often advisable for joint owners to have a written agreement outlining their rights and responsibilities.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

Joint ownership in patents and patent applications occurs when two or more parties share ownership rights. According to MPEP 301:

“Joint inventors are treated as joint owners of the invention unless there is an assignment.”

Key aspects of joint ownership include:

  • Each joint owner has the right to make, use, sell, and license the invention without consent from other owners.
  • Profits do not need to be shared unless there’s a specific agreement.
  • All joint owners must agree to sell or assign the entire patent to a third party.
  • In infringement suits, all joint owners must be joined as plaintiffs.

It’s important for joint owners to have clear agreements in place to avoid potential conflicts and ensure proper management of the patent rights.

For more information on joint inventors, visit: joint inventors.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

Inventorship in a Continued Prosecution Application (CPA) generally carries over from the prior application, but there are some important considerations:

  • The inventive entity of the CPA is automatically the same as the prior application unless a statement is filed requesting deletion of inventors
  • A statement requesting deletion of inventors must be filed with the CPA request and signed by a person authorized under 37 CFR 1.33(b)
  • New inventors cannot be added simply by naming them in the CPA transmittal letter or a new oath/declaration
  • To add new inventors, a request under 37 CFR 1.48 must be filed, including the required fee

The MPEP states: The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If an inventor is named in the CPA who was not in the prior application, the examiner will notify the applicant using form paragraph 2.33:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent applications, visit: patent applications.

In a Continued Prosecution Application (CPA), the inventorship is typically the same as in the prior application. However, if a new inventor needs to be added, a specific process must be followed. According to MPEP ¶ 2.33:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48. Otherwise, the inventorship in the CPA shall be the same as in the prior application.

This means that if you want to add a new inventor to a CPA, you must file a formal request under 37 CFR 1.48, which outlines the procedures for correcting or changing inventorship in patent applications.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

Inventorship in a continuing application depends on the type of continuing application and when it was filed. Key points:

  • For applications filed on or after September 16, 2012, the inventorship is initially the inventor(s) named in the application data sheet
  • For earlier applications, the inventorship carries over from the parent application
  • In a continuation or divisional, the inventorship must include at least one inventor named in the parent application
  • In a continuation-in-part, new inventors can be added to cover new matter
  • Inventorship can be corrected if needed using procedures under 37 CFR 1.48

For CPAs filed on or after September 16, 2012, the MPEP states: The inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application.

If the inventorship needs to be changed, a request under 37 CFR 1.48 must be filed.

For more information on application data sheet, visit: application data sheet.

For more information on continuing applications, visit: continuing applications.

For more information on inventorship, visit: inventorship.

Inventorship is a crucial aspect of continuation applications. According to MPEP 201.07:

The inventorship in the continuation application must include at least one inventor named in the prior-filed application…

This requirement ensures a clear line of continuity between the parent application and the continuation application. Key points to consider:

  • At least one inventor from the parent application must be included in the continuation application.
  • Additional inventors can be added to the continuation application if they contributed to the claimed invention.
  • Inventors from the parent application who did not contribute to the claims in the continuation application can be removed.
  • Changes in inventorship must be properly documented and may require an oath or declaration from new inventors.

For Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), there are additional inventorship requirements:

In addition, a continuation or divisional application may only be filed under 37 CFR 1.53(d) if the prior application is a nonprovisional design application, but not an international design application, that is complete as defined by 37 CFR 1.51(b) (except for the inventor’s oath or declaration if the CPA is filed on or after September 16, 2012), and the prior nonprovisional application contains an application data sheet indicating the name, residence, and mailing address of each inventor.

Always consult with a patent attorney when dealing with inventorship issues in continuation applications to ensure compliance with USPTO requirements.

For more information on application data sheet, visit: application data sheet.

Incorporation by reference can be an important tool in continuation applications, allowing applicants to include material from prior applications. The MPEP provides detailed guidance on this topic:

For applications filed on or after September 21, 2004:

An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are “hereby incorporated by reference.” The statement must appear in the specification.

Additionally, for these applications:

For applications filed on or after September 21, 2004, a claim under 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78(d) for benefit of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States that was present on the filing date of the continuing application is considered an incorporation by reference of the prior-filed application as to inadvertently omitted material, subject to the conditions and requirements of 37 CFR 1.57(b).

For applications filed before September 21, 2004:

The incorporation by reference statement could appear in the application transmittal letter or in the specification.

It’s important to note that incorporation by reference cannot be used to add new matter to an application after its filing date. The MPEP states:

An incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

Proper use of incorporation by reference can help applicants maintain continuity between related applications and potentially recover from certain filing errors.

For more information on 37 cfr 1.57, visit: 37 cfr 1.57.

For more information on continuation application, visit: continuation application.

For more information on incorporation by reference, visit: incorporation by reference.

How does government funding affect small entity status?

Government funding can impact small entity status, particularly for universities and small businesses. The MPEP 509.03 provides guidance:

A small business concern or nonprofit organization is not disqualified as a small entity because of a license to the Federal government pursuant to 35 U.S.C. 202(c)(4).

This means:

  • Receiving government funding does not automatically disqualify an entity from small entity status.
  • The government’s license rights under the Bayh-Dole Act do not negate small entity status.
  • However, other types of government agreements or contracts might affect status.

It’s important to carefully review the terms of any government funding or agreements to determine if they impact small entity eligibility. When in doubt, consult with a patent attorney or the USPTO for clarification.

To learn more:

Filing a new power of attorney typically revokes all prior powers of attorney. According to MPEP 402.05: When an original power of attorney is filed giving power of attorney to attorneys A, B, and C, and the same principal subsequently files another power of attorney, giving power of attorney to D without revoking all prior powers of attorney, the subsequently filed power of attorney will be treated as a revocation of the original power of attorney. This means that the most recently filed power of attorney will control.

To learn more:

In pre-2012 patent applications, filing a new power of attorney can have significant effects on existing powers of attorney. MPEP 402.05(b) outlines several scenarios:

  1. New power of attorney without explicit revocation: “When an original power of attorney is filed giving power of attorney to attorneys A, B, and C, and the same principal subsequently files another power of attorney, giving power of attorney to D without revoking all prior powers of attorney, the subsequently filed power of attorney will be treated as a revocation of the original power of attorney.”
  2. Assignee filing new power of attorney: “If the applicant signed the original power of attorney, and an assignee of the entire interest of the applicant later takes action and files a new power of attorney, the original power of attorney is revoked and replaced by the power of attorney filed by the assignee.”
  3. Change in Customer Number: “If a power of attorney is given to the practitioners associated with a Customer Number, and a (second) power of attorney is later received giving power of attorney to patent practitioners associated with a different Customer Number, the second power of attorney will be processed, with the first Customer Number being replaced with the second.”

In all these cases, the most recently filed power of attorney will control, effectively revoking or replacing the previous ones.

To learn more:

Filing a delayed benefit claim can have significant implications for patent term adjustment (PTA). According to MPEP 211.04:

‘If a benefit claim is submitted later than the time period provided by 37 CFR 1.78, the patent will not be granted the earlier filing date unless a petition under 37 CFR 1.78 is granted. If the petition is granted, the patent term adjustment (PTA) may be reduced.’

This means that if your delayed benefit claim is accepted through a successful petition, it may result in a reduction of your patent’s term adjustment. The reduction in PTA is intended to balance the benefit gained from the earlier filing date against the delay in claiming that benefit.

To learn more:

Filing a Continued Prosecution Application (CPA) has a significant effect on the prior application. According to the MPEP, A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA. This means that when you file a CPA, the previous application is automatically abandoned in favor of the new CPA. The CPA will use the file wrapper and contents of the prior application, including the specification, drawings, and oath or declaration, and will be assigned the same application number as the prior application.

To learn more:

Filing a Continued Prosecution Application (CPA) includes a waiver of confidentiality for the prior application. The MPEP states:

A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means that if someone is entitled to access information about either the CPA or the prior application, they may also be given access to information about the other related applications in the file. Applicants should be aware of this reduced confidentiality when deciding whether to file a CPA.

Filing a Continued Prosecution Application (CPA) has implications for public access to the application. The MPEP states:

“A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file. 37 CFR 1.53(d)(6).”

This means:

  • The CPA is considered a waiver of confidentiality for the entire application chain
  • Members of the public who have access to one application in the chain may be given similar access to others
  • This increased accessibility applies to both the prior application and any continuing applications

Applicants should be aware of this potential for increased public access when deciding to file a CPA.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

Filing a Continued Prosecution Application (CPA) has implications for the confidentiality of the application under 35 U.S.C. 122:

  • Filing a CPA is construed as a waiver of confidentiality to a certain extent
  • Members of the public entitled to access the prior application may be given similar access to the CPA and other related applications
  • This waiver applies to the entire chain of related applications

The MPEP states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

For more information on 35 U.S.C. 122, visit: 35 U.S.C. 122.

For more information on patent applications, visit: patent applications.

For more information on public access, visit: public access.

Filing a Continued Prosecution Application (CPA) has implications for confidentiality and public access to application information:

  • Filing a CPA is construed as a waiver of confidentiality under 35 U.S.C. 122
  • Members of the public entitled to access the prior application may be given similar access to the CPA
  • This waiver extends to any continuing applications in the chain of CPAs
  • Certified copies of CPAs will include the most recent non-continued prosecution application in the chain

MPEP 201.06(d) states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

For more information on USPTO procedures, visit: USPTO procedures.

Filing a continuation-in-part (CIP) application does not automatically resolve or affect outstanding rejections in the parent application. The MPEP 201.08 clarifies this point:

“The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

This means:

  • Outstanding rejections in the parent application remain active and must be addressed separately.
  • The applicant is not presumed to agree with or accept these rejections by filing a CIP.
  • The CIP application will be examined independently, though it may face similar rejections if it includes the same claimed subject matter.

Applicants should continue to respond to office actions and address rejections in the parent application if they wish to pursue those claims, even after filing a CIP.

For more information on parent application, visit: parent application.

For more information on patent examination, visit: patent examination.

Filing a continuation or divisional application under 37 CFR 1.53(b) does not automatically abandon the prior application. The status of the prior application depends on the actions taken by the applicant:

  1. The prior application remains pending unless expressly abandoned.
  2. To expressly abandon the prior application, a separate paper must be filed and signed in accordance with 37 CFR 1.138.
  3. If a notice of allowance has been issued in the prior application, it can become abandoned by nonpayment of the issue fee.

The MPEP states: Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application. If the prior nonprovisional application is to be expressly abandoned, such a paper must be signed in accordance with 37 CFR 1.138.

It’s important to note that if the issue fee has been paid in the prior application, a petition to withdraw the application from issue must be filed before it can be abandoned, even if a continuing application has been filed.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

Filing a continuation application under 37 CFR 1.53(b) does not automatically abandon the prior application. The MPEP clearly states:

Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application.

However, applicants have several options regarding the status of the prior application:

  1. Express Abandonment: If desired, the prior application can be expressly abandoned. This requires a separate paper signed in accordance with 37 CFR 1.138.
  2. Allowed Applications: If the prior application has received a notice of allowance, it can become abandoned by non-payment of the issue fee.
  3. Continued Prosecution: The prior application can remain pending if the applicant wishes to continue prosecution.

It’s important to note that if an issue fee has been paid in the prior application, special procedures are required:

However, once an issue fee has been paid in the prior application, even if the payment occurs following the filing of a continuing application under 37 CFR 1.53(b), a petition to withdraw the prior nonprovisional application from issue must be filed before the prior nonprovisional application can be abandoned (37 CFR 1.313).

Applicants should carefully consider their strategy for managing multiple related applications when filing a continuation.

For more information on continuation application, visit: continuation application.

For more information on patent prosecution, visit: patent prosecution.

How does employment at an institution of higher education affect micro entity status?

Employment at an institution of higher education can provide a pathway to micro entity status. The MPEP states:

“A micro entity shall also include an applicant who certifies that: (1) The applicant’s employer, from which the applicant obtains the majority of the applicant’s income, is an institution of higher education as defined in section 101(a) of the Higher Education Act of 1965 (20 U.S.C. 1001(a)); or (2) The applicant has assigned, granted, conveyed, or is under an obligation by contract or law, to assign, grant, or convey, a license or other ownership interest in the particular application to such an institution of higher education.” (MPEP 509.04(d))

This means that if you are employed by a qualifying institution of higher education and receive the majority of your income from it, or if you have assigned or are obligated to assign your rights in the application to such an institution, you may be eligible for micro entity status. This provision can be particularly beneficial for academic researchers and inventors.

To learn more:

How does employment affect micro entity status for inventors?

An inventor’s employment can significantly impact their eligibility for micro entity status. The MPEP provides specific guidelines:

“[A]n applicant is not considered to be named on more than four previously filed patent applications if the applicant has assigned, or is under an obligation to assign, all ownership rights in the applications as the result of the applicant’s previous employment.” (MPEP 509.04(a))

This means that if an inventor has previously filed patent applications as part of their job, and they have assigned or are obligated to assign the rights to their employer, these applications don’t count towards the four-application limit for micro entity status. However, it’s crucial to note that:

  • The inventor must not be currently named as an inventor on more than four non-provisional patent applications.
  • The inventor’s current employer must not be considered a non-micro entity.

Inventors should carefully evaluate their employment situation and patent history when determining their eligibility for micro entity status.

To learn more:

Tags: micro entity

Continued Prosecution Application (CPA) practice differs significantly for utility and plant applications compared to design applications. The key difference is:

CPA practice is not available for utility and plant applications filed on or after May 29, 2000.

As stated in the MPEP 201.06(d): “Effective July 14, 2003, CPA practice has been eliminated as to utility and plant applications in view of the eighteen-month publication of applications under 35 U.S.C. 122(b). A request for a CPA filed on or after July 14, 2003 in a utility or plant application is improper and will not be treated as a CPA.”

For utility and plant applications, applicants should instead consider filing:

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on RCE, visit: RCE.

Correcting inventorship can potentially affect the power of attorney in a patent application. The MPEP states:

For applications filed on or after September 16, 2012, 37 CFR 1.32(e) provides that if the power of attorney was granted by the originally named inventive entity, and an added inventor pursuant to 37 CFR 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the 37 CFR 1.48 request.

This means that if a new inventor is added and doesn’t provide a consistent power of attorney, the original power of attorney may be lost. However, the MPEP also notes, This provision does not preclude a practitioner from acting in a representative capacity pursuant to 37 CFR 1.34, if applicable. It’s important to consider this potential consequence when correcting inventorship in applications filed on or after September 16, 2012.

To learn more:

The effect on the date of recordation depends on whether the error affects title to the application or patent. According to MPEP 323.01(a):

  1. Errors that do not affect title: If the typographical error does not affect title, the Assignment Services Division will correct the Assignment Historical Database and allow the recording party to keep the original date of recordation.
  2. Errors that affect title: If the error affects title to the application or patent, the recording party will not keep the original date of recordation. The MPEP states: Rather, the Assignment Services Division will correct its automated records and change the date of recordation to the date the corrected cover sheet was received in the Office.

It’s crucial to ensure accuracy in cover sheets to maintain the earliest possible recordation date, especially for errors that could affect title to the application or patent.

To learn more:

Copendency is a crucial requirement for claiming benefit between nonprovisional applications. The later-filed application must be filed before:

  • The patenting of the prior application
  • The abandonment of the prior application
  • The termination of proceedings in the prior application

As stated in MPEP 211.01(b): When a later-filed application is claiming the benefit of a prior-filed nonprovisional application under 35 U.S.C. 120, 121, 365(c), or 386(c), the later-filed application must be copending with the prior application or with an intermediate nonprovisional application similarly entitled to the benefit of the filing date of the prior application.

If copendency is not maintained, the benefit claim is improper and the later-filed application cannot claim the earlier filing date of the prior application.

To learn more:

Continuity in patent applications refers to the relationship of copendency of the same subject matter in two different applications naming the same inventor or at least one joint inventor in common. The MPEP 211.01(b) states:

“The term ‘continuity’ is used to express the relationship of copendency of the same subject matter in two different applications naming the same inventor or at least one joint inventor in common.”

Continuing applications include:

  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

It’s important to note that the prior application may disclose more than the later-filed application, or vice versa. In either case, the later-filed application is entitled to the benefit of the filing date of the prior application for the common subject matter disclosed in compliance with 35 U.S.C. 112(a).

To learn more:

Confidentiality in Continued Prosecution Applications (CPAs) is handled differently from standard applications. Filing a CPA includes a waiver of confidentiality to some extent:

  • The CPA is construed to include a waiver of confidentiality under 35 U.S.C. 122
  • This waiver allows public access to both the prior application and any continuing applications filed under 37 CFR 1.53(d)
  • Access is limited to those entitled under 37 CFR 1.14 to obtain information about the applications

The MPEP states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means that if someone is entitled to access information about either the prior application or the CPA, they may be given similar access to information about both applications. This is different from the standard confidentiality provisions for pending applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Claiming the benefit of an international design application under 35 U.S.C. 386(c) can potentially establish an earlier effective filing date for a nonprovisional application. This is significant because the effective filing date is used to determine which prior art is applicable during examination.

As stated in the MPEP:

“Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.”

By claiming this benefit, the nonprovisional application can potentially use the filing date of the international design application as its effective filing date, provided all requirements are met. This earlier date can be crucial for overcoming prior art references and establishing priority in the field.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on effective filing date, visit: effective filing date.

For more information on prior art, visit: prior art.

How does claiming small entity status affect patent fees?

Claiming small entity status can significantly reduce patent fees. According to MPEP 509.03, “Claiming small entity status allows the payment of certain reduced patent fees pursuant to 35 U.S.C. 41(h)(1).” This means that small entities, such as independent inventors, small businesses, and nonprofit organizations, can pay reduced fees for many patent-related services, typically 50% of the standard fee. However, it’s important to ensure eligibility before claiming this status to avoid potential issues later in the patent process.

To learn more:

Claiming priority for international design applications has some specific provisions, particularly when the application designates the United States. These provisions are outlined in the MPEP and relevant regulations.

According to MPEP 213.07: “Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.”

Key points about priority in international design applications include:

  • The right of priority under 35 U.S.C. 386(a) or (b) applies only to applications filed on or after May 13, 2015.
  • For nonprovisional international design applications, the priority claim must be presented in an application data sheet during the pendency of the application, unless made in accordance with the Hague Agreement and Regulations.
  • The certified copy of the priority document must be furnished within the time period specified in 37 CFR 1.55(g).
  • An international design application designating the U.S. can claim priority to a prior foreign application, PCT application, or another international design application.

The MPEP also notes: “See MPEP § 2920.05(d) for additional information pertaining to the right of priority based upon an international design application.”

These provisions ensure that design patent applicants can properly claim priority to earlier filed applications in the context of the international design registration system.

For more information on design patent, visit: design patent.

For more information on Hague Agreement, visit: Hague Agreement.

Claiming priority to a foreign application generally does not affect the term of a U.S. patent. The patent term is typically calculated from the actual U.S. filing date, not the foreign priority date.

For utility and plant patents:
– The term is 20 years from the earliest U.S. filing date of the application or any U.S. application to which it claims benefit under 35 U.S.C. 120, 121, or 365(c).
– The foreign priority date is not used in this calculation.

For design patents:
– The term is 15 years from the date of grant.
– The filing or priority dates do not affect the term.

It’s important to note that while the foreign priority date doesn’t affect the patent term, it can affect the effective filing date for prior art purposes, which can be crucial for determining patentability.

Patent Term Adjustment (PTA) may be available to extend the term of a utility or plant patent due to delays in prosecution, but this is calculated based on the actual U.S. filing date, not the foreign priority date.

Claiming foreign priority can significantly affect the prior art date in your application:

  • For applications subject to pre-AIA law, the foreign priority date becomes the effective U.S. filing date for prior art purposes under 35 U.S.C. 102(a), (b), and (d)
  • For applications subject to AIA law, the foreign priority date is treated as the effective filing date for prior art purposes under 35 U.S.C. 102(a)(1) and (a)(2)

This means that intervening disclosures between your foreign filing date and your U.S. filing date may not be considered prior art against your application. However, it’s important to note that the claimed subject matter must be fully supported by the foreign application to get the benefit of its filing date. Additionally, the priority claim must be proper and timely made for this benefit to apply.

How does claiming benefit of an international application affect the patent term?

Claiming the benefit of an international application can affect the patent term in specific ways. According to MPEP 211.01(c):

It should be noted that international applications, which designate the United States, are included in the definition of ‘national application’ in pre-AIA 35 U.S.C. 154(a)(2).

This means that for patents subject to the 20-year term provision of pre-AIA 35 U.S.C. 154(a)(2), the 20-year term begins on the international filing date of the international application. However, it’s important to note that the MPEP 2701 provides more detailed information on patent term calculations, including adjustments and extensions that may apply.

To learn more:

To learn more:

Tags: patent term

Claiming the benefit of an earlier filing date for continuing applications (continuation, divisional, and continuation-in-part) is governed by 35 U.S.C. 120 and 37 CFR 1.78. Key points include:

  • The continuing application must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  • The continuing application must contain a specific reference to the prior application.
  • For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet (ADS).
  • For applications filed before September 16, 2012, the specific reference must be in the first sentence(s) of the specification or in an ADS.
  • The continuing application must have at least one common inventor with the prior application.

As stated in the MPEP:

A continuation or divisional application that names as inventors the same or fewer than all of the inventors named in the prior application may be filed under this paragraph or paragraph (d) of this section.

It’s important to note that for continuation-in-part applications, any claims that rely on new matter added in the CIP will not be entitled to the benefit of the earlier filing date of the parent application.

For more information on patent application types, visit: patent application types.

Claiming benefit to a prior application can affect the patent term in several ways:

  1. For applications subject to the 20-year term provision:
    • The term begins from the earliest U.S. filing date to which benefit is claimed under 35 U.S.C. 120, 121, or 365(c)
    • Claiming benefit to earlier applications may reduce the effective patent term
  2. For provisional applications:
    • Claiming benefit under 35 U.S.C. 119(e) does not affect the patent term
    • However, claiming benefit to a provisional under 35 U.S.C. 120 (not recommended) could reduce the term

MPEP 211.02 cautions: “Although 35 U.S.C. 120 does not preclude a benefit claim to a provisional application, it is not recommended that applicants claim the benefit to a provisional application under 35 U.S.C. 120 since such a claim could have the effect of reducing the patent term, as the term of a patent issuing from such an application may be measured from the filing date of the provisional application pursuant to 35 U.S.C. 154(a)(2).”

It’s important to carefully consider the implications of benefit claims on patent term when developing a patent strategy, especially for patent families with multiple related applications.

To learn more:

Changing the correspondence address in a patent application does not automatically change a patent practitioner’s address of record with the USPTO. These are two separate matters:

  • The correspondence address is specific to an application or patent
  • The practitioner’s address of record is maintained in the USPTO’s roster of registered practitioners

MPEP 601.03(a) cites 37 CFR 1.33(e), which states: A change of address filed in a patent application or patent does not change the address for a patent practitioner in the roster of patent attorneys and agents.

This means that even if you change the correspondence address for a specific application, you must separately update your address with the Office of Enrollment and Discipline if you want to change your official address of record as a registered practitioner.

Practitioners have an obligation to keep their address current with the USPTO. As noted in MPEP 601.03: Note that the obligation (see 37 CFR 11.11) of a registered attorney or agent to notify the Director of the Office of Enrollment and Discipline of any change of his or her address is separate from the obligation to file a notice of change of address in individual applications.

To learn more:

Changing the correspondence address in a patent application does not affect a patent practitioner’s address in the USPTO roster of patent attorneys and agents. This is explicitly stated in 37 CFR 1.33(e):

A change of address filed in a patent application or patent does not change the address for a patent practitioner in the roster of patent attorneys and agents. See § 11.11 of this title.

This means that practitioners must separately update their contact information in the USPTO roster if they wish to change their official address on record with the USPTO. The change of correspondence address in a specific application or patent is independent of the practitioner’s address in the official roster.

To learn more:

Changing a patent title can have several effects on the application process. As stated in MPEP 606.01, “When the Technology Center (TC) technical support staff prepares the application for issue and sees that the title has been changed, the TC technical support staff will make the required change in the Office computer record systems.” This ensures that the revised title is accurately reflected in all official records and databases, which can impact future searches and classifications of the patent.

To learn more:

How does attorney withdrawal affect the power of attorney in a patent application?

When an attorney withdraws from a patent application, it affects the power of attorney status. According to MPEP 402.06:

“The Office will not remove the names of practitioners who have been granted a power of attorney or authorization of agent from the list of practitioners of record at the request of the practitioner filing the withdrawal.”

This means that even after withdrawal, the attorney’s name may remain on record unless specific actions are taken. However, the withdrawn attorney no longer has the authority to act on behalf of the application. To fully revoke the power of attorney, the applicant must file a revocation and/or new power of attorney. It’s crucial for applicants to update their power of attorney promptly after an attorney’s withdrawal to ensure proper representation and communication with the USPTO.

To learn more:

How does attorney withdrawal affect pending patent applications?

When an attorney withdraws from representation in a pending patent application, it can have several implications:

  • The applicant becomes responsible for prosecuting the application.
  • Official correspondence will be sent directly to the applicant.
  • Deadlines and response periods remain in effect.
  • The applicant may need to find new representation quickly.

According to MPEP 402.06:

“Where an attorney or agent of record withdraws from an application, the Office will communicate directly with the applicant, or with a new registered attorney or agent if a power of attorney is filed.”

It’s important for applicants to act promptly after attorney withdrawal to ensure continuity in their patent prosecution. If a new attorney is hired, a new power of attorney should be filed with the USPTO to ensure proper communication and representation.

To learn more:

For division and continuation applications, a prior assignment recorded against the original application is automatically applied to the new application. This is because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.

However, it’s important to note that while the assignment is effective for the new application, the USPTO’s assignment records will not automatically reflect this. As stated in the MPEP: Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

For applications claiming the benefit of a provisional application under 35 U.S.C. 119(e), the assignment process depends on the content of the later application:

  • If the later application includes only subject matter from the provisional application, an assignment recorded against the provisional application will be effective for the later application.
  • If the later application includes new subject matter not in the provisional application, new assignment papers must be recorded for the later application, unless it was filed on or after September 16, 2012, and the assignee is the original applicant.

As stated in MPEP § 306.01: If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

To learn more:

The assignment process for applications claiming benefit of a provisional application is similar to that of continuations and divisions in certain circumstances:

  • When the later application includes only subject matter from the provisional application, the assignment treatment is the same as for continuations and divisions filed under 35 U.S.C. 120.
  • In these cases, an assignment recorded against the provisional application will be effective in the later application.

MPEP § 306.01 states: If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

This similarity in treatment simplifies the assignment process when no new subject matter is introduced in the later application.

To learn more:

Assigning ownership rights can significantly affect micro entity status. The MPEP provides the following guidance:

  • An applicant is disqualified from micro entity status if they transfer, or are obligated to transfer, any ownership interest to an entity that exceeds the gross income limit.
  • If an inventor assigns all rights to an employer that exceeds the gross income limit, micro entity status cannot be claimed.
  • Even if rights are later transferred back to the inventor or to another person who doesn’t exceed the gross income limit, micro entity status cannot be regained.

The MPEP states: “Once an assignee or licensee exceeding the gross income limit receives the ownership interest, the 37 CFR 1.29(a)(4) certification requirement can no longer be met – even if the assignee or licensee retransfers rights and no longer holds any ownership interest in the application.

It’s important to note that this applies to both actual transfers and obligations to transfer ownership rights.

To learn more:

How does an international application designating the US affect benefit claims?

An international application designating the United States can be used as a basis for claiming benefit in a nonprovisional application. The MPEP 211.01(b) states:

Any nonprovisional application claiming the benefit of one or more prior-filed copending nonprovisional applications or international applications designating the United States must include a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications.

When claiming benefit from an international application, you must provide:

  • The international application number
  • The international filing date
  • The relationship between the applications

It’s important to note that the international application must designate the United States for it to be eligible as a basis for a benefit claim in a U.S. nonprovisional application.

To learn more:

An international application designating the United States has significant effects on the application process:

  • It is treated as a national application from its international filing date.
  • It follows different rules for restriction practice and unity of invention.
  • It has different notification procedures for incomplete applications.

According to 35 U.S.C. 363: “An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.”

However, as noted in MPEP 201.01: “Treatment of a national application under 35 U.S.C. 111 and a national stage application (a national application which entered the national stage from an international application in which the conditions of 37 CFR 1.9(a)(1) have been satisfied) are similar but not identical.” For example, unity of invention practice applies to national stage applications, while restriction practice applies to applications filed under 35 U.S.C. 111(a).

For more information on international applications, visit: international applications.

An international application designating the United States has significant effects on national patent rights. According to 35 U.S.C. 363:

An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.

This means that an international application (PCT application) that designates the US is treated similarly to a national application filed under 35 U.S.C. 111. However, there are some differences in treatment between national applications and national stage applications (which enter the national stage from an international application). For example:

  • Restriction practice applies to national applications, while unity of invention practice applies to national stage applications
  • Different notification practices apply to incomplete applications in each case

For detailed information on the examination of international applications in the national stage, refer to MPEP § 1893.03.

For more information on international applications, visit: international applications.

For more information on patent rights, visit: patent rights.

When an examiner encounters a non-compliant amendment under 37 CFR 1.57(b), they follow a specific procedure outlined in the MPEP:

  1. They use a form paragraph stating the non-compliance and the specific reason.
  2. If the amendment introduces new matter, they follow up with additional form paragraphs (7.28 for specification/drawings, 7.31.01 for claims).
  3. For after-final amendments, they issue an advisory action indicating that the amendment raises new issues due to non-compliance.

The MPEP notes, This form paragraph must be followed by form paragraph 7.28, where the amendment is made to the specification and/or drawings and introduces new matter into the disclosure, and/or form paragraph 7.31.01, where the amendment adds new matter to the claims or affects the claims.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

When an applicant submits documents as evidence in a reply to an Office action, the examiner is not required to process these documents as items of information cited in an information disclosure statement. The MPEP clarifies:

“The record should reflect whether the evidence was considered, but listing on a form (e.g., PTO-892 or PTO/SB/08) and appropriate marking of the form by the examiner is not required.”

The examiner should indicate that the teachings relied on by the applicant have been considered, but they do not need to formally list or mark these documents on information disclosure forms.

To learn more:

When a Continued Prosecution Application (CPA) is established, the examiner notifies the applicant in the first Office action of the CPA. According to MPEP ¶ 2.30, the examiner uses a specific form paragraph:

“The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.”

This notification is important because:

  • Applicants are not separately notified of the abandonment of the parent application
  • A filing receipt is not normally sent for a CPA

Therefore, this Office action serves as the official notification that the CPA has been properly established.

For more information on design patents, visit: design patents.

For more information on patent examination, visit: patent examination.

When a Continued Prosecution Application (CPA) is accepted, the examiner notifies the applicant in the first Office action of the CPA. This is because, unlike regular applications, applicants do not receive a separate notification about the abandonment of the parent application or a filing receipt for the CPA.

MPEP ¶ 2.30 states: Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established. This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA. This guidance ensures that applicants are properly informed about the status of their CPA.

When an examiner encounters a noncomplying Information Disclosure Statement (IDS), they use specific form paragraphs to notify the applicant. The MPEP 609.05(a) states:

The examiner may use form paragraph 6.49 which is reproduced below to inform applicant that the information has not been considered.

The examiner will typically use form paragraph 6.49 or one of its variants (6.49.01 to 6.49.10) to explain why the IDS was not considered and what specific requirements were not met. This notification allows the applicant to correct the deficiency or file a new IDS that complies with the requirements.

To learn more:

According to MPEP § 201, specifically paragraph 2.30, an examiner notifies an applicant about a Continued Prosecution Application’s (CPA) acceptance in the first Office action of the CPA. The MPEP states:

Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established. This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

This notification is crucial because it confirms the establishment of the CPA and provides important information to the applicant about the status of their application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

When a Continued Prosecution Application (CPA) request for a design patent application is deemed unacceptable, the examiner uses a specific form paragraph to inform the applicant. According to MPEP ¶ 2.31, the examiner note states:

“Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.”

The form paragraph includes:

  • An acknowledgment of the CPA request receipt
  • The filing date of the paper containing the request
  • The Application Number identified in the CPA request
  • An explanation of why the request is not acceptable
  • A statement that no CPA has been established

This formal communication ensures that the applicant is clearly informed about the status of their CPA request and the reasons for its non-acceptance.

For more information on USPTO procedures, visit: USPTO procedures.

When a Continued Prosecution Application (CPA) request for a design patent application is not compliant with the regulations, the examiner informs the applicant using a specific form paragraph. The MPEP provides guidance on this:

Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.

The form paragraph includes:

  • Acknowledgment of the CPA request receipt
  • The filing date of the paper containing the request
  • The application number identified in the CPA request
  • Explanation of why the request is not acceptable
  • Statement that no CPA has been established

This standardized approach ensures clear communication between the USPTO and the applicant regarding the status of their CPA request.

For more information on USPTO procedures, visit: USPTO procedures.

An examiner can indicate consideration of an IDS in two ways:

  1. By placing their initials adjacent to the citations on the PTO/SB/08 form or its equivalent.
  2. Using an alternative electronic signature method where:
    • Each page of reference citations is stamped with “All references considered except where lined through” along with the examiner’s electronic initials.
    • The final page includes the examiner’s electronic signature.
    • Citations not considered are struck through.

As stated in the MPEP, The initials of the examiner placed adjacent to the citations on the PTO/SB/08 or its equivalent mean that the information has been considered by the examiner to the extent noted above. (MPEP 609.05(b))

To learn more:

When an examiner considers an Information Disclosure Statement (IDS), they indicate their consideration in specific ways:

  1. Traditionally, the examiner places their initials adjacent to the citations on the PTO/SB/08 form or its equivalent.
  2. An alternative electronic signature method may also be used, where:
  • Examiners no longer initial each reference citation considered.
  • Citations not considered are struck through.
  • Each page of reference citations is stamped with the phrase ‘All references considered except where lined through’ along with the examiner’s electronic initials.
  • The final page includes the examiner’s electronic signature.

The MPEP states: Consideration by the examiner of the information submitted in an IDS means nothing more than considering the documents in the same manner as other documents in Office search files are considered by the examiner while conducting a search of the prior art in a proper field of search.

To learn more:

To learn more:

When an Information Disclosure Statement (IDS) does not comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98, the examiner will handle it as follows:

  • The IDS will be placed in the application file, but the information will not be considered.
  • The examiner will write ‘not considered’ on the IDS where none of the information complies with the requirements.
  • If using a PTO/SB/08 form, the examiner will draw a diagonal line or ‘X’ across the form.
  • The examiner will inform the applicant that the information has not been considered and explain why using appropriate form paragraphs.

As stated in the MPEP:

‘If an information disclosure statement does not comply with the requirements based on the time of filing of the IDS as discussed in MPEP § 609.04(b), including the requirements for fees and/or statement under 37 CFR 1.97(e), the IDS will be placed in the application file, but none of the information will be considered by the examiner.’

To learn more:

To learn more:

When an examiner detects new matter in a patent application, they must take specific actions:

  1. Object to amendments introducing new matter using 35 U.S.C. 132(a).
  2. Use Form Paragraph 7.28 to object to new matter added to the specification.
  3. If new matter affects the claims, reject the claims under 35 U.S.C. 112(a).

The MPEP states:

If new matter is added to the claims, or affects the scope of the claims, the claims affected should be rejected under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, on the ground that it recites elements without support in the original disclosure.

To learn more:

To learn more:

Tags: new matter

When an examiner finds an intervening reference (a reference with an effective date between the foreign filing date and the U.S. filing date) and a foreign priority claim is present, the examiner follows these steps:

  1. If the certified copy of the priority papers has not been filed, the examiner rejects the claims that may be unpatentable over the reference without considering the priority date.
  2. The applicant may then argue the rejection or present the foreign papers to overcome the date of the reference.
  3. If the applicant argues the rejection, the examiner may, in the next action:
    • Specifically require the foreign papers to be filed while repeating the rejection if still applicable, or
    • Simply continue the rejection

The MPEP states: “If at the time of making an action the examiner has found such an intervening reference, the examiner simply rejects whatever claims may be considered unpatentable thereover, without paying any attention to the priority date (assuming the certified copy of the priority papers has not yet been filed).” (MPEP 216)

How does an examiner handle a large number of cited references in an IDS?

When an examiner encounters a large number of cited references in an Information Disclosure Statement (IDS), they should:

  • Review each reference to the extent required to form an initial assessment of its relevance.
  • Focus more attention on those references that appear to be most relevant to the claimed invention.
  • Consider the references in light of the detailed explanations provided by the applicant, if any.
  • Document their consideration by initialing each citation, regardless of perceived relevance.

The MPEP 609.05(b) states: ‘In the event that a large number of documents are submitted and applicant’s explanation of relevance is minimal, the examiner may determine that the applicant has not complied with 37 CFR 1.98.’

However, it’s important to note that the examiner should not automatically consider the submission of a large number of references as an attempt to overwhelm the examiner. Each case should be evaluated on its own merits, and the examiner should make a good faith effort to review all cited references.

To learn more:

Patent examiners carefully compare the content of the continuation or divisional application with the prior-filed application to identify any new matter. If they find information not disclosed in the prior application, they will issue a notice to the applicant.

The MPEP ¶ 2.10.01 instructs examiners:

“In bracket 1, provide an example of the matter not disclosed in the prior-filed application.”

This means the examiner must specifically point out the new matter found in the application, allowing the applicant to understand and address the issue.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent examination, visit: patent examination.

An examiner determines if an application qualifies as a continuation under MPEP ¶ 2.05 by assessing the following criteria:

  • The application discloses only subject matter that was previously disclosed in a prior application
  • The application claims only subject matter that was disclosed in the prior application
  • The application names at least one inventor who was also named in the prior application

The MPEP provides specific language for this assessment: “This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application.” (MPEP ¶ 2.05)

If all these criteria are met, the examiner may notify the applicant that the application may constitute a continuation. The examiner will then proceed with the appropriate examination procedures for continuation applications.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

Patent examiners use specific criteria to determine if an application may qualify as a continuation-in-part (CIP). According to MPEP ¶ 2.06, an examiner should consider the following:

  • The application repeats a substantial portion of a prior application.
  • The application adds disclosure not presented in the prior application.
  • The application names the inventor or at least one joint inventor named in the prior application.

The MPEP states: Because this application names the inventor or at least one joint inventor named in the prior application, it may constitute a continuation-in-part of the prior application. However, examiners are advised to use this determination cautiously: This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Patent examiners use specific criteria to determine if an application may qualify as a divisional. According to MPEP ¶ 2.01, an examiner looks for the following indicators:

  1. The application claims only subject matter disclosed in a prior application.
  2. The claimed subject matter appears to be independent and distinct from that claimed in the prior application.
  3. At least one inventor from the prior application is named in the current application.

The MPEP provides guidance to examiners:

“This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.”

If these conditions are met, but a proper benefit claim hasn’t been made, the examiner may use this paragraph to notify the applicant of the possible divisional status and the need to establish a benefit claim if desired.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

For more information on USPTO, visit: USPTO.

According to MPEP 608.02(w), when an application is ready for issue except for a slight defect in the drawing, the examiner will communicate the necessary changes to the applicant as follows:

  • Prepare a letter to the applicant indicating the change to be made
  • May include a marked-up copy of the drawing showing the addition or alteration
  • Attach the marked-up copy of the drawing to the letter
  • Make the letter and marked-up drawing of record in the application file

This process allows for efficient communication of minor drawing changes without requiring the applicant to submit annotated sheets.

To learn more:

Examiners have several methods to acknowledge the receipt of replacement drawing sheets:

  1. Using Form Paragraph 6.37
  2. Using Form PTOL-324
  3. Using the PTOL-326 Office Action Summary

The MPEP 608.02(h) provides the following example of Form Paragraph 6.37:

“The drawings were received on [1]. These drawings are [2].”

In this form paragraph, the examiner would insert the date of receipt in [1] and either ‘acceptable’ or ‘unacceptable’ in [2]. If the drawings are unacceptable, the examiner must provide an explanation, which may include identifying any drawings not entered due to new matter and explaining necessary corrections for resubmission.

To learn more:

How does an attorney or agent officially withdraw from a patent application?

To officially withdraw from a patent application, an attorney or agent must follow these steps:

  1. Submit a request to withdraw as attorney or agent of record.
  2. The request must be signed by the attorney or agent of record.
  3. Include the application number and filing date.
  4. Provide the names of the inventors and assignee (if applicable).
  5. State the reason for withdrawal.

The MPEP 402.06 states: ‘When an attorney or agent of record in an application withdraws… the Office of Enrollment and Discipline should be notified by the withdrawing attorney or agent.’ This notification ensures proper processing of the withdrawal request.

To learn more:

An assignee can file a substitute statement when an inventor is unavailable or refuses to sign the oath or declaration. The process involves the following steps:

  1. Determine if the assignee has the right to make the application for patent as provided in 37 CFR 1.46.
  2. Prepare the substitute statement following the requirements of 37 CFR 1.64.
  3. Include an explanation of the circumstances that make the inventor unavailable or unwilling to sign.
  4. Provide evidence of the assignment, if not already recorded with the USPTO.

MPEP 604 states: ‘A substitute statement may also be made by an assignee of the entire interest, an applicant under 37 CFR 1.46(b), or a person who otherwise shows sufficient proprietary interest in the matter, provided that the inventor is deceased, legally incapacitated, cannot be found or reached after diligent effort, or has refused to execute the oath or declaration.’

The assignee must ensure that the substitute statement complies with all requirements, including identifying the inventor, stating the relationship to the inventor, and acknowledging that willful false statements are punishable by law.

To learn more:

To establish the right to take action in a patent application filed before September 16, 2012, an assignee must meet the following requirements:

  • The assignee must be of the entire right, title, and interest in the application.
  • A proper documentary evidence of chain of title from the original owner to the assignee must be submitted.
  • The evidence must be recorded in the United States Patent and Trademark Office (USPTO) no later than the date of payment of the issue fee.

As stated in MPEP 324: The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted.

It’s important to note that these requirements are specific to applications filed before September 16, 2012. Different rules may apply for applications filed on or after this date.

For more information on assignee rights, visit: assignee rights.

For more information on chain of title, visit: chain of title.

For more information on documentary evidence, visit: documentary evidence.

For more information on USPTO, visit: USPTO.

To establish ownership and take action in a patent application filed on or after September 16, 2012, an assignee who is not the original applicant must:

  1. File a request to change the applicant under 37 CFR 1.46(c)(2)
  2. File an application data sheet under 37 CFR 1.76 specifying the assignee as the applicant
  3. Submit a statement under 37 CFR 3.73(c) establishing ownership

The 37 CFR 3.73(c) statement must contain either:

  • Documentary evidence of a chain of title from the original owner to the assignee and a statement affirming that the documentary evidence was submitted for recordation, or
  • A statement specifying where such evidence is recorded in the Office (e.g., reel and frame number)

The MPEP states: “The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted.”

An assignee establishes ownership in a patent application by filing a statement under 37 CFR 3.73(c). According to MPEP 325:

“The statement under 37 CFR 3.73(c) must be filed in the application or patent where ownership must be established and must contain:
(A) documentary evidence of a chain of title from the original owner to the assignee; or
(B) a statement specifying where documentary evidence of a chain of title from the original owner to the assignee is recorded in the assignment records of the Office.”

This statement serves as proof of the assignee’s right to take action in the application.

For more information on assignee ownership, visit: assignee ownership.

For more information on chain of title, visit: chain of title.

How does an assignee become of record in a patent application?

An assignee must become of record in a patent application before they can revoke the power of attorney given by the applicant. According to MPEP 402.07, this process involves:

  1. Filing a statement under 37 CFR 3.73(c)
  2. Complying with the requirements of 37 CFR 3.71

The MPEP states:

“The assignee must become of record as provided in 37 CFR 3.71. After the assignee becomes of record, the assignee is permitted to revoke the power of attorney of the applicant under the provisions of 37 CFR 1.36(a).”

This typically involves submitting documentary evidence of the chain of title from the original owner to the assignee, such as assignment documents. Once the USPTO recognizes the assignee as the owner of record, they can proceed with revoking the existing power of attorney and appointing a new one.

To learn more:

For pre-AIA applications, the Application Data Sheet (ADS) plays a crucial role in establishing priority claims:

1. For domestic priority: MPEP 601.05(b) states, “Providing this information in the application data sheet constitutes the specific reference required by 35 U.S.C. 119(e) or 120.” This means that including domestic priority information in the ADS satisfies the requirement for a specific reference to earlier filed applications.

2. For foreign priority: The MPEP notes, “Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55.”

In both cases, including priority information in the ADS eliminates the need to make these claims elsewhere in the application, such as in the specification.

To learn more:

The Application Data Sheet (ADS) plays a crucial role in naming inventors for patent applications filed on or after September 16, 2012. According to MPEP 601.05(a):

“The naming of the inventors in the application data sheet is the naming of the actual inventors of the subject matter of the application. The inventorship determined from the application data sheet will be used as the inventorship on the patent if the application is granted as a patent.”

This means that the ADS serves as the official document for declaring inventorship. It’s important to note that:

  • The ADS replaces the need for a separate inventor’s oath or declaration for naming inventors
  • Any changes to inventorship after filing must be done through a proper request under 37 CFR 1.48
  • Accuracy in naming inventors is crucial, as incorrect inventorship can affect the validity of the patent

Applicants should ensure that the inventorship information in the ADS is complete and accurate at the time of filing to avoid potential complications later in the patent process.

To learn more:

MPEP 203.03 defines an ‘amended’ application as:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action. The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

In essence, an application becomes ‘amended’ when the applicant responds to an examiner’s action, whether through election, traversal, or by submitting amendments to the application.

To file an application under pre-AIA 37 CFR 1.47(b), an applicant must demonstrate a proprietary interest in the subject matter of the application. The MPEP outlines three ways to establish this:

  1. Show that the invention has been assigned to the applicant
  2. Provide evidence that the inventor has agreed in writing to assign the invention to the applicant
  3. Otherwise demonstrate a proprietary interest in the subject matter of the application

The MPEP states: “The pre-AIA 37 CFR 1.47(b) applicant must make out a prima facie case (1) that the invention has been assigned to him or her or (2) that the inventor has agreed in writing to assign the invention to him or her or (3) otherwise demonstrate a proprietary interest in the subject matter of the application.”

For more detailed information on demonstrating proprietary interest, refer to MPEP § 409.03(f).

To learn more:

To claim the benefit of a prior application’s filing date for a divisional application, applicants must follow specific procedures outlined in patent law and regulations. The MPEP ¶ 2.01 states:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This means applicants should:

  • Ensure compliance with 35 U.S.C. 120 requirements for continuity and disclosure
  • Follow the procedures outlined in 37 CFR 1.78 for claiming benefit
  • Consult MPEP § 211 for detailed guidance on benefit claims

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the divisional application.

For more information on Divisional application, visit: Divisional application.

In patent applications filed before September 16, 2012, an Application Data Sheet (ADS) can significantly impact the priority claim process. The ADS can be used to:

  • Provide domestic benefit information
  • Include foreign priority information
  • Correct or update priority claims within certain timeframes

According to MPEP 601.05(b): “For applications filed before September 16, 2012, an application data sheet may be used to provide or correct benefit claim information, such as cross-references to one or more prior-filed applications… The benefit claim must be set forth in the ADS in order to be considered properly submitted.”

It’s crucial to note that while the ADS can be used to submit priority information, applicants must still comply with other statutory requirements and deadlines for claiming priority. The ADS provides a centralized location for this information, potentially simplifying the application process and reducing errors in priority claims.

To learn more:

In patent applications filed before September 16, 2012, an Application Data Sheet (ADS) can significantly affect the oath or declaration requirements. Specifically:

  • An ADS can eliminate the need for certain information in the oath or declaration.
  • It allows for the submission of some bibliographic data without an oath or declaration.

The MPEP 601.05(b) states: “If an application data sheet is used in an application filed before September 16, 2012 (in compliance with pre-AIA 37 CFR 1.76) to supply or change the information in 37 CFR 1.63(c), and the oath or declaration under 37 CFR 1.63 refers to the application data sheet, the oath or declaration does not need to be supplemented to include the information supplied in the application data sheet.”

This means that if the oath or declaration references the ADS, it doesn’t need to be updated with information already provided in the ADS, streamlining the application process.

To learn more:

Adding an inventor to a patent application can affect an existing power of attorney under certain circumstances. According to MPEP 402.05(a):

If the power of attorney was granted by the originally named inventive entity and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.

This means that if a new inventor is added to the application and does not provide a power of attorney that matches the existing one, the original power of attorney will be lost when the request to add the inventor is granted. However, this doesn’t prevent a practitioner from acting under 37 CFR 1.34 if applicable.

To learn more:

Adding an inventor to a patent application can potentially affect an existing power of attorney. According to MPEP 402.02(a):

“If the power of attorney was granted by the originally named inventive entity, and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.”

This means that if a new inventor is added to the application and does not provide a power of attorney consistent with the existing one, the original power of attorney will be lost. However, this provision does not preclude a practitioner from acting pursuant to 37 CFR 1.34, if applicable.

It’s important for applicants and practitioners to be aware of this potential consequence when adding inventors to an application, and to take appropriate steps to maintain or reestablish the desired power of attorney.

To learn more:

The rules for acting in a representative capacity differ slightly for applications filed before and after September 16, 2012. According to MPEP 402.04:

For applications filed on or after September 16, 2012:

A patent practitioner acting in a representative capacity must submit papers on behalf of all parties identified as the applicant. They cannot represent only some of the applicant parties.

For applications filed before September 16, 2012:

A patent practitioner may act in a representative capacity on behalf of:

  • The applicant, or
  • The assignee of the entire right who has properly established its right to take action under 37 CFR 3.71 and 3.73

Additionally, for pre-September 16, 2012 applications, a person acting in a representative capacity may sign a document granting access to an application or a change of correspondence address if:

  1. An executed oath or declaration under pre-AIA 37 CFR 1.63 has not been filed, and
  2. The patent practitioner was named in the application transmittal papers.

To learn more:

How does a U.S. national stage application differ from a regular national application?

A U.S. national stage application is derived from an international application, while a regular national application is filed directly with the USPTO. The key differences lie in their origins and the legal provisions governing them.

As stated in MPEP 201.01:

A national application may be a U.S. national application filed under 35 U.S.C. 111(a), or a national stage application under 35 U.S.C. 371 of an international application.

Regular national applications are filed under 35 U.S.C. 111(a), while national stage applications enter the U.S. national phase from an international PCT application under 35 U.S.C. 371. National stage applications must meet specific requirements for entering the national phase, such as time limits and submission of necessary documents.

For more information on national stage application, visit: national stage application.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A title report plays a crucial role in the patent examination process by providing essential ownership information. According to the MPEP Section 320, “The title report is placed in the file wrapper.” This means that:

  • Examiners have access to the most current ownership information
  • It helps ensure that communications are sent to the correct parties
  • It assists in identifying potential issues related to inventorship or ownership

By having accurate ownership information, the examination process can proceed more efficiently and with fewer complications related to ownership disputes or incorrect parties being involved in the process.

For more information on ownership information, visit: ownership information.

For more information on patent examination, visit: patent examination.

For more information on title report, visit: title report.

A terminal disclaimer filed in a parent application can affect a divisional application in specific ways. According to MPEP 201.06:

‘The divisional application must be directed to subject matter described and claimed in the prior nonprovisional application.’

This means that if a terminal disclaimer was filed in the parent application, it may impact the divisional application as follows:

  • Inheritance of Terminal Disclaimer: Generally, a terminal disclaimer filed in the parent application does not automatically apply to the divisional application.
  • Potential Double Patenting: If the claims in the divisional application are not patentably distinct from those in the parent application, a new terminal disclaimer may be required in the divisional to overcome a double patenting rejection.
  • Examination Considerations: Examiners will consider the relationship between the parent and divisional applications when determining if a terminal disclaimer is necessary.

It’s important to consult with a patent attorney or agent to understand the specific implications of terminal disclaimers on your divisional application, as each case can have unique considerations.

To learn more:

A terminal disclaimer filed in a parent application automatically carries over to a Continued Prosecution Application (CPA). The MPEP clearly states:

“A terminal disclaimer filed in the parent application carries over to a CPA. The terminal disclaimer filed in the parent application carries over because the CPA retains the same application number as the parent application, i.e., the application number to which the previously filed terminal disclaimer is directed.”

However, if an applicant does not want the terminal disclaimer to apply to the CPA, they must take specific action:

“If applicant does not want the terminal disclaimer to carry over to the CPA, applicant must file a petition under 37 CFR 1.182 along with the required petition fee, requesting the terminal disclaimer filed in the parent application not be carried over to the CPA.”

It’s important to note that such a petition must be filed and granted before the patent issues to be effective.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on patent term, visit: patent term.

A substitute application is distinct from a continuing application in several ways. According to MPEP 201.02:

‘A substitute application is an application which is filed to take the place of a prior application and which is identified as such and discloses and claims only subject matter disclosed in the prior application.’

Key differences include:

  • A substitute application replaces the prior application entirely, while a continuing application coexists with the prior application.
  • Substitute applications only claim subject matter from the prior application, whereas continuing applications may introduce new matter (in the case of continuation-in-part applications).
  • The filing of a substitute application typically results in the abandonment of the prior application, which is not necessarily the case with continuing applications.

For more information on patent prosecution, visit: patent prosecution.

For more information on substitute application, visit: substitute application.

A substitute application has a significant impact on the filing date of a patent application. According to MPEP 201.02:

A substitute application does not obtain the benefit of the filing date of the prior application.

This means that if an applicant files a substitute application, it will receive a new filing date based on when it was submitted, rather than inheriting the filing date of the original application it’s replacing. This can have important implications for patent priority and the determination of prior art.

It’s crucial for applicants to understand this distinction, as the filing date can significantly affect the patentability of an invention, especially in fast-moving technological fields.

For more information on patent procedure, visit: patent procedure.

For more information on substitute application, visit: substitute application.

A security interest in a patent or patent application generally does not affect small entity status unless it is defaulted upon. According to 37 CFR 1.27(a)(5):

A security interest does not involve an obligation to transfer rights in the invention for the purposes of paragraphs (a)(1) through (a)(3) of this section unless the security interest is defaulted upon.

This means that an applicant or patentee can take out a loan secured by rights in a patent application or patent without losing small entity status, even if the lender is a large entity. However, if the loan is defaulted upon and the security interest is enforced, resulting in a transfer of rights to a non-small entity, the small entity status would be lost.

In such cases, the USPTO must be notified of the loss of entitlement to small entity status prior to or at the time of paying the earliest of the issue fee or any maintenance fee due after the date on which small entity status is no longer appropriate.

To learn more:

How does a secrecy order affect patent term and maintenance fees?

A secrecy order can have significant impacts on both the patent term and maintenance fees. According to MPEP 120:

“If the application is found to be allowable during the secrecy order period, it will be passed to issue upon the removal or rescission of the secrecy order.”

This means that while under a secrecy order:

  • The patent application’s examination continues, but issuance is delayed.
  • The patent term may be affected, as it typically begins on the issue date.
  • No maintenance fees are due until the patent is issued.

However, the law provides some compensation for these delays. “The term of the patent may be extended for the period of delay due to the secrecy order pursuant to 35 U.S.C. 154(b).” This extension helps to offset the time lost due to the secrecy order, ensuring that inventors don’t lose patent protection time unfairly.

For more information on patent term, visit: patent term.

Tags: patent term

A Secrecy Order significantly impacts the prosecution of a patent application. According to 37 CFR 5.3:

Unless specifically ordered otherwise, action on the application by the Office and prosecution by the applicant will proceed during the time an application is under secrecy order to the point indicated in this section.

Key effects include:

  • Applications under final rejection must be appealed or prosecuted to avoid abandonment, but appeals won’t be set for hearing until the Secrecy Order is removed.
  • Interferences or derivation proceedings won’t be instituted for applications under Secrecy Order.
  • When the application is in condition for allowance, the applicant and the relevant agency will be notified, but no notice of allowance will be issued until the Secrecy Order is removed.
  • International applications under Secrecy Order won’t be transmitted to international authorities or the applicant.

These restrictions ensure that sensitive information remains protected while allowing some progress in the application process.

For more information on international applications, visit: international applications.

For more information on patent prosecution, visit: patent prosecution.

A secrecy order significantly impacts the foreign filing of a patent application. According to MPEP 120:

“The issuance of a secrecy order does not alter the applicant’s right to appeal to the Patent Trial and Appeal Board or to file a civil action under 35 U.S.C. 145 or 146, except that if such appeal or civil action involves national security issues, prior approval of the Commissioner for Patents must be obtained.”

This means:

  • The applicant cannot file the application in foreign countries without permission
  • Foreign filing licenses are not granted while a secrecy order is in effect
  • The applicant must wait for the secrecy order to be lifted before pursuing international patent protection
  • Any attempt to file abroad without authorization could result in abandonment of the U.S. application and other penalties

It’s crucial for inventors to understand these restrictions to maintain their patent rights and avoid legal issues.

For more information on foreign filing license, visit: foreign filing license.

How does a restriction requirement lead to a divisional application?

A restriction requirement often leads to the filing of a divisional application. This process occurs as follows:

  1. An examiner issues a restriction requirement when they believe the original application contains claims to two or more independent or distinct inventions.
  2. The applicant must then elect one invention to pursue in the original application.
  3. The non-elected inventions can be pursued in one or more divisional applications.

As stated in MPEP 201.06:

“The inventions embodied in the claims of a divisional application are generally further characterized as (1) independent inventions or (2) related inventions which are distinct.”

This means that the divisional application allows the applicant to protect inventions that were disclosed but not pursued in the original application due to the restriction requirement.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

A reissue application differs from a regular patent application in several key ways:

  • Purpose: A reissue application is specifically for correcting defects in an existing, unexpired patent, while a regular application is for obtaining a new patent.
  • Timing: Reissue applications can only be filed for unexpired patents, whereas regular applications are filed before a patent is granted.
  • Scope: Reissue applications are limited to the invention disclosed in the original patent, with some exceptions for broadening reissues.
  • Examination process: The examination of a reissue application focuses on the changes made to correct the defect, in addition to a review of the entire patent.

As stated in MPEP 201.05, “A reissue application is an application for a patent to take the place of an unexpired patent that is defective.” This fundamental difference sets reissue applications apart from regular patent applications. For more detailed information on the reissue process, refer to MPEP Chapter 1400.

To learn more:

A reissue application does not affect the original patent’s term. According to MPEP 201.05, ‘The reissue application is a continuation of the original application and the reissue patent will expire at the same time that the original patent would have expired.’

This means that:

  • The term of the reissue patent remains the same as the original patent.
  • No additional patent term is granted through the reissue process.
  • The expiration date of the reissue patent will be identical to that of the original patent.

It’s important to note that while a reissue doesn’t extend the patent term, it can potentially strengthen or broaden the patent’s claims within the original term, subject to certain limitations such as the two-year rule for broadening reissues.

The patent term is governed by 35 U.S.C. 254, which states: ‘Every reissued patent shall have the same effect and operation in law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such amended form, but in so far as the claims of the original and reissued patents are substantially identical, such surrender shall not affect any action then pending nor abate any cause of action then existing, and the reissued patent, to the extent that its claims are substantially identical with the original patent, shall constitute a continuation thereof and have effect continuously from the date of the original patent.’

To learn more:

While the MPEP 201.02 doesn’t provide detailed definitions, it references 37 CFR 1.9(a) for the definitions of provisional and nonprovisional applications:

  • Provisional Application: A temporary application that establishes an early filing date but does not mature into an issued patent without further action.
  • Nonprovisional Application: A regular patent application that can be examined and potentially result in an issued patent.

Key differences include:

  • Provisional applications have a pendency of 12 months from the filing date.
  • Nonprovisional applications undergo examination, while provisional applications do not.
  • A nonprovisional application must be filed within 12 months of the provisional to claim its filing date benefit.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

How does a provisional application affect public disclosure of an invention?

Filing a provisional application does not automatically result in public disclosure of your invention. The MPEP 201.04 states: ‘A provisional application will not be published, and, therefore, no publication fee is required.’

This means that your invention remains confidential when you file a provisional application. However, it’s crucial to understand that:

  • The confidentiality only applies to the USPTO’s handling of your application.
  • If you publicly disclose your invention yourself, it could affect your ability to obtain patents in some countries.
  • The 12-month grace period for filing a nonprovisional application starts from the provisional filing date, not from any public disclosure you might make.

Always consult with a patent attorney before making any public disclosures about your invention, even after filing a provisional application.

For more information on provisional application, visit: provisional application.

For more information on public disclosure, visit: public disclosure.

In pre-AIA patent applications (filed before September 16, 2012), a power of attorney given by the assignee of the entire interest has significant implications for previous powers of attorney. As stated in the MPEP:

A power of attorney by the assignee of the entire interest revokes all powers given by the applicant and prior assignees if the assignee establishes their right to take action as provided in pre-AIA 37 CFR 3.71 and pre-AIA 37 CFR 3.73(b).

This means that when the assignee of the entire interest files a new power of attorney, it effectively cancels all previous powers of attorney given by the applicant or any prior assignees. However, the assignee must properly establish their right to take action in the application according to the relevant regulations.

To learn more:

A plant patent application is a specialized type of patent application designed to protect new varieties of plants. The MPEP 201 states:

A plant application is an application for a plant patent. A plant patent protects a distinct and new variety of plant that is asexually reproduced.

Key differences of plant patent applications include:

  • They are specifically for asexually reproduced plants
  • They protect the entire plant, not just a specific part
  • They have unique requirements for description and claiming

Plant patents are less common than utility or design patents but are crucial for protecting innovations in agriculture and horticulture.

For more information on patent application types, visit: patent application types.

To show ‘sufficient proprietary interest’ for filing a patent application, an individual or entity must demonstrate a significant legal or equitable interest in the invention. According to MPEP 409.05:

Quote: ‘A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.’

To establish sufficient proprietary interest, the applicant must:

  • Provide proof of the relevant facts demonstrating their interest in the invention
  • Show that filing the application is necessary to preserve the rights of all parties involved
  • Submit a petition under 37 CFR 1.46 to the Office of Petitions

The Director of the USPTO will then determine if the evidence sufficiently demonstrates proprietary interest.

To learn more:

Tags: USPTO

According to MPEP 201.01, a PCT (Patent Cooperation Treaty) application can enter the national stage in the United States through the following process:

  1. The applicant must comply with the requirements of 35 U.S.C. 371.
  2. This typically involves submitting the national fee, a copy of the international application (unless previously communicated by the International Bureau), and a translation into English if the international application was filed in another language.
  3. Once these requirements are met, the application is considered a national application under 35 U.S.C. 111(a).

The MPEP states: “An international application enters the national stage when the applicant has fulfilled the requirements of 35 U.S.C. 371.” This process allows inventors to seek patent protection in multiple countries through a single international application.

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

A Patent Cooperation Treaty (PCT) application can become a national application in the United States when certain conditions are met. According to MPEP 201.01:

‘An international application filed under the Patent Cooperation Treaty in which the basic national fee under 35 U.S.C. 41(a)(1)(F) has been paid’ becomes a national application.

This process, known as ‘national stage entry,’ involves the following steps:

  • Filing the appropriate documents with the USPTO
  • Paying the required national fee
  • Providing an English translation if the international application was not filed in English

Once these requirements are fulfilled, the international application effectively becomes a U.S. national application and is processed accordingly.

For more information on national stage entry, visit: national stage entry.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

When a patent examiner encounters an amendment attempting to reference a prior application in a Continued Prosecution Application (CPA), they should not enter the amendment and inform the applicant of this decision.

According to MPEP ¶ 2.34, examiners should use the following language:

“The amendment filed [1] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [2] application of Application No. [3] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

Examiners should fill in the brackets with: [1] the filing date of the amendment, [2] either “continuation” or “divisional”, and [3] the Application Number of the prior nonprovisional application.

For more information on CPA, visit: CPA.

Tags: CPA

When a patent examiner encounters an amendment attempting to refer to a Continued Prosecution Application (CPA) as a continuation or divisional application, they should not enter the amendment. According to MPEP § 201.06(d), examiners are instructed to use Form Paragraph 2.34 to inform the applicant that such amendments will not be entered:

“Use this form paragraph to inform the applicant that an amendment to the first sentence(s) of the specification referring to the CPA as a continuing application of the prior application has not been entered and will not be entered if submitted again.”

The examiner will provide the reason for non-entry, explaining that the CPA request itself serves as the specific reference required by 35 U.S.C. 120, and there is no need to amend the specification to refer back to the prior application.

For more information on CPA, visit: CPA.

Tags: CPA

A national application differs from an international application in several key aspects:

  • Filing Authority: National applications are filed directly with the United States Patent and Trademark Office (USPTO), while international applications are filed under the Patent Cooperation Treaty (PCT).
  • Legal Basis: National applications are filed under 35 U.S.C. 111(a), as stated in MPEP 201.01: ‘A national application may be filed under 35 U.S.C. 111(a) in the U.S. Patent and Trademark Office (USPTO)…’
  • Geographical Scope: National applications are specific to the United States, while international applications can potentially provide patent protection in multiple countries.
  • Examination Process: National applications enter the USPTO examination queue directly, whereas international applications have an international phase before entering national phases in designated countries.

Understanding these differences is crucial for inventors and legal representatives when deciding on their patent filing strategy.

For more information on USPTO, visit: USPTO.

Tags: USPTO

A general authorization allows the USPTO to charge certain fees to your deposit account without requiring specific authorization for each fee. The MPEP states:

A general authorization to charge all fees, or only certain fees, set forth in §§ 1.16 to 1.18 to a deposit account containing sufficient funds may be filed in an individual application, either for the entire pendency of the application or with respect to a particular paper filed.

Key points about general authorizations:

  • They can cover fees under 37 CFR 1.16 and 1.17
  • Fees under 37 CFR 1.19, 1.20, and 1.21 are generally not covered
  • Issue fees (37 CFR 1.18) require a separate authorization after the notice of allowance
  • The authorization should be clear and unambiguous to avoid misinterpretation

Always ensure your deposit account has sufficient funds to cover authorized fees to avoid potential application abandonment or additional expenses.

To learn more:

To designate a domestic representative, a foreign assignee must follow these steps:

  • Prepare a written document signed by the assignee
  • Clearly label the document as ‘Designation of Domestic Representative’
  • Submit the designation as a separate paper from any assignment document
  • Ensure the document is signed in accordance with 37 CFR 1.33(b)

As stated in MPEP 302.04, The designation of domestic representative should always be submitted to the Office as a paper separate from any assignment document. This ensures proper processing and entry into the record of the appropriate application or patent file.

To learn more:

How does a divisional application differ from other continuing applications?

A divisional application is a unique type of continuing application that focuses on a distinct invention separated from a parent application. According to the MPEP:

A divisional application is one filed for an invention which has been disclosed and claimed, but not allowed, in a prior nonprovisional application or international application designating the United States. It is a later application for an independent and distinct invention carved out of a pending application. (MPEP 201.02)

Key differences of a divisional application include:

  • It is filed in response to a restriction requirement in the parent application
  • It claims only subject matter that was disclosed but not claimed in the parent application
  • It does not add new matter
  • It allows the applicant to pursue protection for inventions that were deemed distinct in the original application

Unlike continuations or CIPs, divisional applications are specifically for pursuing separate inventions identified during the examination of the parent application.

To learn more:

Divisional applications and provisional applications are distinct types of patent applications with different purposes and characteristics:

  • Divisional Application: Claims subject matter from a prior non-provisional application that is independent and distinct from the original claims.
  • Provisional Application: A temporary application that establishes a priority date but does not mature into an issued patent.

The MPEP explicitly states in MPEP ¶ 2.01:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.”

This distinction is important because divisional applications claim the benefit under 35 U.S.C. 120, while provisional applications are claimed under 35 U.S.C. 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

A divisional application discloses and claims only subject matter disclosed in the parent application, while a continuation-in-part (CIP) application may include new matter. The MPEP states:

A continuation-in-part application should not be designated as a divisional application. The Court of Appeals for the Federal Circuit has concluded that the protection of the third sentence of 35 U.S.C. 121 does not extend to continuation-in-part applications, stating that ‘the protection afforded by section 121 to applications (or patents issued therefrom) filed as a result of a restriction requirement is limited to divisional applications.’

This means that divisional applications have certain protections against double patenting rejections that CIPs do not have.

To learn more:

A divisional application does not extend the patent term beyond that of the parent application. The term of a patent issuing from a divisional application is calculated from the filing date of the earliest application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c), excluding any benefit claims to provisional applications.

This means that while you can pursue additional patent protection through a divisional application, you don’t get extra time beyond the original 20-year term from the earliest non-provisional filing date.

It’s important to note that patent term adjustments may apply independently to divisional applications based on delays in their own prosecution.

To learn more:

A divisional application’s patent term adjustment (PTA) is calculated independently from its parent application. The MPEP 201.06 provides guidance on this matter:

‘A divisional application will receive its own patent term adjustment under 35 U.S.C. 154(b), which will be calculated based on the prosecution of the divisional application itself.’

Key points to understand:

  • The divisional application’s PTA is based solely on its own prosecution history
  • Any delays or adjustments from the parent application do not affect the divisional’s PTA
  • The PTA calculation starts from the filing date of the divisional application
  • Applicants should monitor the prosecution of the divisional application to ensure accurate PTA calculation

For more information on patent term adjustment, refer to MPEP 2730.

To learn more:

To learn more:

Design patent applications and utility patent applications are distinct types of patent applications, each protecting different aspects of an invention. According to MPEP 201:

‘Design applications are not included in the term ‘nonprovisional’ as used in 37 CFR 1.9. […] Design applications are treated separately in 35 U.S.C. 171-173 and 37 CFR 1.151-1.155.’

Key differences include:

  • Subject Matter: Utility patents protect how an invention works, while design patents protect how it looks.
  • Duration: Utility patents last 20 years from filing, design patents 15 years from grant.
  • Examination Process: Design applications typically have a simpler examination process.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) automatically references the prior application without requiring any specific amendment to the specification.

According to MPEP ¶ 2.34: “As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that the act of filing a CPA itself serves as the reference to the prior application, eliminating the need for any additional amendments or references in the specification.

A Continued Prosecution Application (CPA) differs from other types of continuing applications in several ways:

  • CPAs are only available for design applications, not utility applications.
  • Filing a CPA automatically establishes the necessary reference to the prior application under 35 U.S.C. 120, without needing to amend the specification.
  • CPAs are processed differently from other continuing applications, as outlined in MPEP § 201.06(d).

The MPEP states: ‘As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.’ This unique feature distinguishes CPAs from other types of continuing applications, such as continuations or divisionals, which may require explicit references in the specification.

For more information on continuing applications, visit: continuing applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) and a continuation application are both ways to continue prosecution of a patent application, but they have key differences:

  • CPA: Only available for design applications filed before May 29, 2000, and for plant applications. It continues examination of the same application.
  • Continuation: Available for all types of applications and creates a new application that claims priority to the parent application.

The MPEP ¶ 2.34 highlights a crucial distinction in how they reference prior applications:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.

This means that for a CPA, the mere act of filing establishes the reference to the prior application. In contrast, a continuation application typically requires an explicit reference to the parent application in the specification.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) automatically maintains the priority claim to its parent application without requiring a separate reference. The CPA itself serves as the specific reference required under 35 U.S.C. 120.

The MPEP states: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

This means that filing a CPA automatically establishes a priority claim to the parent application and any earlier applications in the priority chain without additional paperwork.

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

Filing a Continued Prosecution Application (CPA) has specific effects on the status of the prior application:

  • The prior application is abandoned by operation of law upon filing of the CPA.
  • Any appeal in the prior application is dismissed automatically.
  • Any amendment filed with the CPA request is not entered unless it is specifically requested by the applicant.

As stated in the MPEP 201.06(d): ‘The filing of a CPA is not a filing of a new application. Rather, it is a continuation of the pending prior application.’ This means that while the prior application is technically abandoned, its substance continues in the CPA.

It’s important to note that any amendment accompanying the CPA request will be placed in the file but not entered unless the applicant specifically requests it. This allows applicants to submit potential amendments without automatically changing the application’s content.

For more information on CPA, visit: CPA.

Tags: CPA

Filing a Continued Prosecution Application (CPA) has several effects on the examination process:

  • The CPA is treated as a continuation of the prior application for examination purposes
  • Information Disclosure Statements from the prior application are automatically considered in the CPA
  • Affidavits and declarations from the prior application carry over to the CPA
  • A terminal disclaimer filed in the parent application carries over to the CPA
  • For examination priority, CPAs are treated as ‘amended’ applications rather than ‘new’ applications if an Office action was issued in the prior application

MPEP 201.06(d) notes: For examination priority purposes only, the USPTO will treat continuation CPAs as if they were ‘amended’ applications (as of the CPA filing date) and not as ‘new’ applications. This treatment is limited to CPAs in which the prior application has an Office action issued by the examiner.

For more information on design patents, visit: design patents.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

Filing a Continued Prosecution Application (CPA) can impact the examination process and priority. Key points include:

  • CPAs are generally treated as “amended” applications for examination priority purposes
  • This may result in faster first Office actions compared to new applications
  • Preliminary amendments should be filed with the CPA to avoid potential denial of entry
  • Information Disclosure Statements (IDS) from the prior application are automatically considered

As stated in the MPEP:

For examination priority purposes only, the USPTO will treat continuation CPAs as if they were “amended” applications (as of the CPA filing date) and not as “new” applications. This treatment is limited to CPAs in which the prior application has an Office action issued by the examiner.

Applicants can request a three-month suspension of action under 37 CFR 1.103(b) if more time is needed to prepare amendments or an IDS. Affidavits and declarations from the parent application automatically become part of the CPA.

A Continued Prosecution Application (CPA) automatically maintains the benefit claim to earlier applications. The MPEP states:

A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. That is, the CPA includes the request for an application under 37 CFR 1.53(d) and the recitation of the application number of the prior application in such request is the ‘specific reference to the earlier filed application’ required by 35 U.S.C. 120.

This means that filing a CPA automatically establishes a benefit claim to the prior application and any earlier applications in the chain, without the need for a separate statement in the specification or application data sheet. However, if the prior application claimed benefit of earlier applications, those benefit claims must still be present in the prior application.

For more information on continuation applications, visit: continuation applications.

For more information on patent priority, visit: patent priority.

Continued Prosecution Applications (CPAs) automatically carry over certain aspects from the parent application. Specifically:

  • Priority claims under 35 U.S.C. 119(a)-(d) made in the parent application automatically carry over to a CPA.
  • A terminal disclaimer filed in the parent application carries over to a CPA.

The MPEP explains: Priority claims under 35 U.S.C. 119(a)-(d) made in a parent application will automatically carry over to a CPA. A terminal disclaimer filed in the parent application carries over to a CPA.

This automatic carry-over occurs because the CPA retains the same application number as the parent application.

For more information on patent applications, visit: patent applications.

Filing a Continued Prosecution Application (CPA) can affect patent term because it results in a new filing date. While the CPA retains the benefit of the earlier filing date for prior art purposes, the actual filing date of the CPA is used for calculating patent term. The MPEP notes: Applicants will not be permitted to delete such a benefit claim as to certain applications assigned that application number (e.g., for patent term purposes). This means that the patent term for a CPA will generally be shorter than if the original application had been allowed, as the term is calculated from the CPA filing date, not the original application’s filing date.

To learn more:

Tags: CPA, patent term

Filing a Continued Prosecution Application (CPA) can have important implications for both patent term and prior art dates:

Patent Term:

  • A CPA is a continuation of the prior application, so it does not get a new 15-year term from filing
  • The 15-year term for a design patent issuing from a CPA is measured from the filing date of the earliest application in the chain that is subject to the 15-year term

Prior Art Dates:

  • The effective filing date of a CPA for prior art purposes is generally the actual filing date of the CPA
  • However, the CPA can claim the benefit of the prior application’s filing date for subject matter disclosed in the prior application

The MPEP notes: “A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No amendment in an application under this paragraph may delete this specific reference to any prior application.” (37 CFR 1.53(d)(7))

This means the CPA is automatically considered a continuation for benefit claim purposes, which can affect both term and prior art dates.

For more information on benefit claims, visit: benefit claims.

For more information on patent term, visit: patent term.

For more information on prior art, visit: prior art.

The inventorship in a Continued Prosecution Application (CPA) generally remains the same as in the prior application. The MPEP states, The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA. If changes to inventorship are needed, they must be made through a specific request under 37 CFR 1.48.

To learn more:

Tags: CPA, inventorship

Filing a Continued Prosecution Application (CPA) has implications for the confidentiality of the application. As stated in the MPEP:

A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means:

  • The CPA is treated as a waiver of confidentiality for the prior application
  • Members of the public who have access to the CPA may also be given access to the prior application
  • This applies to all applications in the chain of CPAs

Applicants should consider this loss of confidentiality when deciding whether to file a CPA or a new application under 37 CFR 1.53(b).

For more information on Patent application access, visit: Patent application access.

For more information on public information, visit: public information.

A Continued Prosecution Application (CPA) automatically maintains the benefit claim to the prior application under 35 U.S.C. 120 without requiring a separate statement. Key points include:

  • The CPA request itself serves as the specific reference required by 35 U.S.C. 120
  • No amendment to the specification or application data sheet is needed to maintain the benefit claim
  • The benefit claim extends to all applications in a chain of CPAs

As stated in the MPEP: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on patent applications, visit: patent applications.

A Continued Prosecution Application (CPA) has specific effects on benefit claims and references to prior applications:

  • The CPA request itself serves as the specific reference required by 35 U.S.C. 120
  • No amendment to the specification or application data sheet is required or permitted to reference the prior application
  • A CPA automatically includes a benefit claim to all applications in the chain of CPAs with the same application number

As stated in the MPEP:

A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No amendment in an application under this paragraph may delete this specific reference to any prior application.

This means that applicants cannot selectively delete benefit claims to certain applications in the CPA chain. When referencing a CPA in a later application, the reference incorporates the entire chain of applications with that application number.

A Continued Prosecution Application (CPA) is a unique type of continuing application that has specific limitations. According to MPEP 201.02:

A ‘continued prosecution application’ (CPA) is a continuation or divisional application for an invention disclosed in a prior nonprovisional application filed under 37 CFR 1.53(b) or (d). A CPA can only be filed in a design application.

Key differences of CPAs compared to other continuing applications:

  • Limited to design applications: CPAs can only be filed for design patents, not utility or plant patents.
  • Automatic abandonment: Filing a CPA automatically abandons the prior application.
  • Simplified filing: CPAs can be filed with fewer formalities than other continuing applications.
  • Examination continuation: The examination process continues from where it left off in the parent application.

It’s important to note that CPAs are no longer available for utility or plant applications filed on or after May 29, 2000. For these types of applications, applicants must use other forms of continuing applications, such as RCEs (Requests for Continued Examination).

For more information on continued prosecution application, visit: continued prosecution application.

For more information on continuing applications, visit: continuing applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

How does a continuing application claim benefit to a prior-filed international application?

A continuing application can claim benefit to a prior-filed international application that designates the United States. The MPEP 211.01(b) states:

‘A nonprovisional application may claim benefit under 35 U.S.C. 120 to an international application designating the United States only if the international application was filed on or after November 29, 2000.’

To claim this benefit, the following conditions must be met:

  • The international application must designate the United States
  • It must be filed on or after November 29, 2000
  • The benefit claim must be made in accordance with 37 CFR 1.78
  • The continuing application must be filed while the international application is pending before the USPTO or within the time period set in 35 U.S.C. 120, 121, 365(c), or 386(c)

It’s important to note that the benefit claim is to the international application itself, not to its national stage in the United States.

To learn more:

To learn more:

A continuation-in-part (CIP) application and a provisional application are two distinct types of patent applications with different purposes and effects. The key difference is highlighted in MPEP ¶ 2.06, which states:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation-in-part’ of the provisional application.

This means that:

  • A CIP application builds upon a prior non-provisional application, adding new disclosure while claiming the benefit of the earlier filing date for the shared content.
  • A provisional application is a temporary placeholder that establishes a priority date but does not mature into a patent. It cannot be continued or have a CIP.
  • Applications claiming benefit from a provisional application are typically filed as new non-provisional applications, not as CIPs.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

How does a continuation-in-part application affect the priority date?

A continuation-in-part (CIP) application can have different priority dates for different parts of the disclosure. According to MPEP 201.08:

‘The continuation-in-part application may be entitled to the benefit of the filing date of the prior application as to the common subject matter disclosed in compliance with 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph.’

This means:

  • Content shared with the parent application retains the earlier priority date.
  • New matter added in the CIP has the filing date of the CIP as its priority date.
  • Different claims in the CIP may have different priority dates based on their disclosure in the parent or CIP application.

Understanding these priority date implications is crucial for determining patentability and prior art considerations.

For more information on new matter, visit: new matter.

Tags: new matter

A continuation-in-part (CIP) application can have a complex effect on patent term. The MPEP 201.08 states:

‘A continuation-in-part application is entitled to the benefit of the filing date of an earlier nonprovisional application as to common subject matter.’

This has several implications for patent term:

  • 20-year term: The patent term is generally 20 years from the earliest effective U.S. filing date of the first nonprovisional application in the chain.
  • New matter: Claims solely supported by new matter in the CIP do not receive the benefit of the earlier filing date, potentially extending their effective term.
  • Priority claims: The ability to claim priority to earlier applications can affect the starting point of the 20-year term.
  • Patent term adjustment: Delays in prosecution may lead to patent term adjustments, which can extend the term beyond 20 years.

Applicants should carefully consider the impact on patent term when deciding to file a CIP, especially for rapidly evolving technologies where a longer term might be advantageous.

For more information on new matter, visit: new matter.

For more information on patent term, visit: patent term.

For more information on patent term adjustment, visit: patent term adjustment.

A continuation-in-part (CIP) application is a type of continuing application that differs from a regular continuation in its content and priority claims. According to MPEP 201.08:

‘A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.’

Key differences between CIP and regular continuation applications:

  • New Matter: CIPs include new subject matter not present in the parent application, while regular continuations do not.
  • Priority Date: CIPs have different priority dates for different parts of the disclosure. The new matter gets the CIP’s filing date, while common subject matter retains the parent’s filing date.
  • Examination: CIPs are examined for both the old and new subject matter, potentially requiring additional prior art searches.
  • Term: The patent term for a CIP may be affected by the new subject matter’s later filing date.

CIPs are useful when inventors want to add new improvements or developments to their original invention while maintaining the priority date for the original subject matter.

For more information on continuing applications, visit: continuing applications.

How does a continuation-in-part (CIP) application affect priority claims?

A continuation-in-part (CIP) application introduces new matter not present in the prior application, which affects priority claims as follows:

  • Claims fully supported by the prior application retain the benefit of the earlier filing date.
  • Claims relying on new matter only receive the filing date of the CIP application.
  • As stated in MPEP 211.01(b): “Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the prior-filed application are entitled to the benefit of the filing date of the prior-filed application.”

Examiners must analyze each claim individually to determine its effective filing date. This can result in different claims within the same CIP application having different priority dates.

To learn more:

Continuation applications and provisional applications are distinct types of patent applications with different purposes and requirements. A key difference is that a continuation application is based on a prior nonprovisional application, while a provisional application is a standalone filing that can later be used as a priority document.

The MPEP specifically notes:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the provisional application.”

This guidance also applies to continuation applications. Provisional applications serve as temporary placeholders and do not undergo examination, while continuation applications are fully examined and build upon previously filed nonprovisional applications.

To learn more:

While both continuation and continuation-in-part (CIP) applications are types of continuing applications, they have a key difference in terms of their disclosure. According to the MPEP:

The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

The main differences are:

  • Continuation: Contains the same disclosure as the parent application without any new matter.
  • Continuation-in-part (CIP): May include the disclosure from the parent application plus additional new matter.

This distinction is crucial because it affects the priority date for different claims in the application. In a continuation, all claims are entitled to the parent’s filing date. In a CIP, only claims supported by the parent application get the benefit of the earlier filing date; new matter gets the filing date of the CIP.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

A continuation application can have significant implications for the patent term. Here are key points to understand:

  • Patent Term Calculation: The term of a patent stemming from a continuation application is generally calculated from the filing date of the earliest application in the chain to which priority is claimed.
  • 20-Year Term: Under current U.S. law, utility and plant patents have a term of 20 years from the earliest effective U.S. filing date of the application.
  • No Extension of Monopoly: As stated in MPEP 201.07, ‘The filing of a continuation application does not extend the term of the patent to be granted on the continuing application because the term of a patent issuing on a continuation application is measured from the filing date of the earliest application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c).’
  • Patent Term Adjustment: While the base term is not extended, a continuation may be eligible for patent term adjustment due to delays in prosecution, which can effectively extend the term.

It’s important to note that while continuation applications don’t extend the base patent term, they can provide strategic advantages in terms of claim scope and prosecution timing.

To learn more:

A continuation-in-part (CIP) application differs from a regular continuation application in that it adds new disclosure not present in the prior application. While both types of applications repeat substantial portions of a prior application, only a CIP introduces new subject matter.

The MPEP states: This application repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application. (MPEP ¶ 2.06) This additional disclosure is what sets a CIP apart from a standard continuation.

For more information on continuation application, visit: continuation application.

For more information on patent application types, visit: patent application types.

37 CFR 1.63(d) provides a simplified process for submitting an oath or declaration in a divisional application. The MPEP states:

’37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a continuation or divisional application filed by all or by fewer than all of the inventors named in a prior nonprovisional application containing a signed oath or declaration.’

This means that if the divisional application is filed by the same inventor(s) as the parent application, and there’s no new matter added, the oath or declaration from the parent application can be used for the divisional application. This simplifies the filing process and reduces paperwork.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on oath or declaration, visit: oath or declaration.

37 CFR 1.57(b) is closely tied to priority claims in patent applications. For an amendment to comply with this regulation, the claim for priority or benefit of the prior-filed application must have been present on the filing date of the current application.

The MPEP specifically states that an amendment may not comply with 37 CFR 1.57(b) if the claim for priority/benefit of the prior-filed application was not present on the filing date of the present application. This requirement ensures that the incorporation by reference is based on a properly established relationship between the current application and the prior-filed application.

If the priority claim was not present at filing, the applicant cannot use 37 CFR 1.57(b) to incorporate material from the prior-filed application, even if that material was inadvertently omitted.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

For more information on patent applications, visit: patent applications.

For international applications, 37 CFR 1.57(b)(1) specifies:n

    n

  • Any amendment will only be effective as to the United States and shall have no effect on the international filing date
  • n

  • It cannot be relied upon to accord an international filing date or alter the filing date under PCT Article 11
  • n

  • No request to add omitted material will be acted on prior to national stage entry under 37 CFR 1.491 or filing of a US application claiming benefit of the international application
  • n

35 U.S.C. 365(c) is a crucial provision for claiming the benefit of an international application’s filing date in a subsequent national application. As explained in MPEP 211.01(c):

The first sentence of 35 U.S.C. 365(c) specifically provides that ‘[i]n accordance with the conditions and requirements of section 120,… a national application shall be entitled to the benefit of the filing date of a prior international application designating the United States.’

This provision allows applicants to claim the priority of an international application in a later-filed U.S. national application, provided they meet the conditions set forth in 35 U.S.C. 120. One key condition is timing, as the MPEP notes:

The condition of 35 U.S.C. 120 relating to the time of filing requires the later application to be ‘filed before the patenting or abandonment of or termination of proceedings on the first application….’

This means that the national application must be filed while the international application is still pending to claim its benefit.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

35 U.S.C. 365 addresses the right of priority for international applications in two key aspects:

  1. National applications based on international applications
  2. International applications based on foreign applications

The MPEP states:

“35 U.S.C. 365(a) provides that a national application shall be entitled to the right of priority based on a prior international application of whatever origin, which designated any country other than, or in addition to, the United States.”

“35 U.S.C. 365(b) provides that an international application designating the United States shall be entitled to the right of priority of a prior foreign application which may either be another international application or a regularly filed foreign application.”

These provisions ensure that applicants can claim priority based on international applications, enhancing the flexibility of the international patent system.

A petition for a retroactive foreign filing license may be filed under 37 CFR 5.25 if an unlicensed foreign filing occurred through error. The petition must include:

1) A listing of each foreign country where the unlicensed patent application was filed
2) The filing dates in each country
3) A verified statement containing:
– An averment that the subject matter was not under a secrecy order and is not currently under a secrecy order
– A showing that the license has been diligently sought after discovery of the proscribed foreign filing
– An explanation of why the material was filed abroad through error without the required license
4) The required fee under 37 CFR 1.17(g)

If an inventor becomes legally incapacitated after signing the oath or declaration, the application can still proceed. According to MPEP 409.01:

If an inventor who executed the oath or declaration becomes legally incapacitated after the application is filed but before the patent issues, no substitute oath or declaration is required.

This means that the previously signed oath or declaration remains valid, and the application can continue through the patent process without requiring additional documentation regarding the inventor’s incapacitation.

To learn more:

Claiming the benefit of a prior application in a continuation is a crucial step that must be done correctly. The MPEP 201.07 provides specific guidance:

If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§1.76(b)(5)). The reference also must identify the relationship of the applications, namely, whether the later-filed application is a continuation, divisional, or continuation-in-part of the prior-filed nonprovisional application, international application, or international design application.

To properly claim the benefit:

  1. Include a reference to the prior application in the Application Data Sheet (ADS)
  2. Specify the application number, filing date, and relationship (continuation) of the applications
  3. Ensure the claim is made within the time period set in 37 CFR 1.78
  4. Pay any required fees

Failure to properly claim benefit can result in loss of the earlier filing date, so it’s crucial to follow these steps carefully.

For more information on continuation application, visit: continuation application.

For more information on patent law, visit: patent law.

USPTO examiners have a specific internal process for obtaining title reports when needed. The MPEP outlines this process:

Examiners may obtain a title report using the PALM Intranet (select “General Information,” insert the appropriate application number, select “Search,” select “Assignments”). The screen resulting from the search may be printed to yield the copy of the title report.

This internal system allows examiners to access ownership information efficiently when required for their examination duties.

USPTO employees are legally obligated to maintain the confidentiality of pending patent applications. According to MPEP 101:

All U.S. Patent and Trademark Office employees are legally obligated to preserve pending applications for patents in confidence until they are published or patented in accordance with 35 U.S.C. 122 and 37 CFR 1.14.

This includes several practices:

  • Not reproducing or copying application documents except for official purposes
  • Properly handling and storing application files
  • Using appropriate envelopes for interoffice mail
  • Being careful during interviews to prevent exposure of other applicants’ files

Violations of these confidentiality requirements can result in suspension, removal, and even criminal penalties.

For more information on USPTO employees, visit: USPTO employees.

USPTO employees are legally obligated to maintain the confidentiality of pending patent applications. The MPEP states:

“All U.S. Patent and Trademark Office employees are legally obligated to preserve pending applications for patents in confidence until they are published or patented in accordance with 35 U.S.C. 122 and 37 CFR 1.14.”

Employees must follow strict procedures to ensure confidentiality, including:

  • Not reproducing or copying application documents except for official purposes
  • Properly handling and storing application files
  • Using appropriate envelopes for interoffice mail
  • Being cautious during interviews to prevent exposure of other applications

Violations of these procedures can result in suspension, removal, or even criminal penalties.

The first inventor to file provisions that took effect on 3/16/2013 require additional statements for certain “transition” applications:

– Transition applications are those filed on or after 3/16/2013 that claim priority to an application filed before 3/16/2013.
– If a transition application ever contained a claim having an effective filing date on or after 3/16/2013, a statement to that effect is required within the later of 4 months from the actual filing date, 4 months from national stage entry, 16 months from the prior application, or the date the claim was first presented.
– This statement requirement does not apply if the application only claims priority to applications filed on or after 3/16/2013, or if the applicants reasonably believe the application never contained such a claim.

See MPEP 210 and MPEP 2159 for more details.

The first inventor to file provisions of the America Invents Act (AIA) have significant implications for priority and benefit claims, particularly for applications filed on or after March 16, 2013. Key points include:

  1. The effective filing date of each claimed invention determines whether an application is subject to examination under AIA or pre-AIA 35 U.S.C. 102 and 103.
  2. Applications that contain or contained at any time a claim with an effective filing date on or after March 16, 2013, are subject to the AIA version of 35 U.S.C. 102 and 103.
  3. Applications that claim priority to or benefit of a pre-AIA application may be subject to additional requirements.

As stated in the MPEP: These provisions apply to any application for patent, and to any patent issuing thereon, that contains or contained at any time— (A) a claim to a claimed invention that has an effective filing date as defined under section 100(i) of title 35, United States Code, that is on or after March 16, 2013; or (B) a specific reference under section 120, 121, or 365(c) of title 35, United States Code, to any patent or application that contains or contained at any time such a claim. (MPEP 210)

For transition applications (those filed on or after March 16, 2013, that claim priority to or benefit of a pre-AIA application), applicants may need to provide a statement regarding the presence of claims with an effective filing date on or after March 16, 2013. This requirement is outlined in 37 CFR 1.55(k) and 1.78(a)(6) and (d)(6).

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

For more information on pre-AIA, visit: pre-AIA.

For more information on transition applications, visit: transition applications.

Secrecy Orders have significant impacts on foreign filing licenses:

  • A Secrecy Order prevents the granting of a foreign filing license.
  • It overrides the 6-month rule, prohibiting foreign filing even after 6 months.
  • Applications under a Secrecy Order cannot be exported or filed in foreign countries.
  • Violating a Secrecy Order can result in abandonment of the invention and other penalties.

The MPEP states: “Only the imposition of a Secrecy Order will cause revocation of the authority which arises from 35 U.S.C. 184 to file a foreign application 6 months or later after the date of filing of a corresponding U.S. patent application.”

For more information on Secrecy Orders, refer to MPEP 120.

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

How do reissue applications differ from original patent applications?

Reissue applications are distinct from original patent applications in that they are used to correct errors in already-issued patents. The MPEP 201 states, “An application for reissue of a patent is an application for a new patent to correct an error in an unexpired patent as provided in 37 CFR 1.171 through 1.178.”

Key differences include:

  • Purpose: To correct errors in existing patents, not to obtain new patents
  • Timing: Filed after a patent has been issued and while it’s still unexpired
  • Legal basis: Filed under 35 U.S.C. 251 and subject to specific regulations
  • Content: Must include a copy of the original patent and point out the error(s) to be corrected
  • Examination: Focuses on the proposed changes and their impact on patentability

Reissue applications provide a mechanism for patent holders to address issues in their patents, potentially broadening or narrowing claims, or correcting other substantive errors.

For more information on reissue applications, visit: reissue applications.

The requirements for power of attorney in patent applications differ based on the filing date:

  • For applications filed on or after September 16, 2012: Refer to MPEP § 402.02(a) for detailed information and relevant forms.
  • For applications filed before September 16, 2012: Consult MPEP § 402.02(b) for specific details and applicable forms.

The MPEP 601.02 states: “See MPEP § 402.02(a) for detailed information and relevant forms pertaining to appointment of a power of attorney in applications filed on or after September 16, 2012. See MPEP § 402.02(b) for detailed information and relevant forms pertaining to appointment of a power of attorney in applications filed before September 16, 2012.”

This distinction is important as it affects the specific procedures and forms required for appointing a power of attorney.

To learn more:

When multiple assignees seek to take action in a patent matter, each partial assignee must provide a submission under 37 CFR 3.73(c). According to the MPEP:

In each submission, the extent of each assignee’s interest must be set forth so that the Office can determine whether it has obtained action by the entirety of the right, title and interest holders (owners). 37 CFR 3.73(c)(2)(i).

Assignees have two options:

  1. Specify the percentage of ownership interest for each assignee, accounting for 100% of ownership.
  2. Identify all parties (including inventors) who together own the entire right, title, and interest, and state that all identified parties own the entire right, title, and interest.

The MPEP warns: “If the extent of the partial assignee’s ownership interest is not set forth in the submission under 37 CFR 3.73(c), the Office may refuse to accept the submission as an establishment of ownership interest.”

To verify if someone is authorized to conduct business with the USPTO for a patent application filed after September 16, 2012, you can follow these steps:

  • Check if the person is listed as the applicant or an assignee
  • Verify if they are a registered patent practitioner
  • Look for a power of attorney or authorization of agent document
  • Confirm if they are named as an inventor in the application

The USPTO maintains specific rules about who can correspond regarding patent applications. As stated in MPEP 403.01(a):

For applications filed on or after September 16, 2012, … the applicant’s or patent owner’s correspondence address … is the correspondence address of the patent practitioner appointed in a power of attorney or authorization of agent, or if no practitioner is appointed, the correspondence address of the applicant or patent owner.

If you’re unsure, it’s best to contact the USPTO directly for clarification.

To learn more:

Tags: USPTO

To use a Certificate of Mailing or Transmission, you must include a signed certification with your correspondence. The MPEP provides suggested formats for these certificates:

“The following are suggested formats for either a Certificate of Mailing or Certificate of Transmission under 37 CFR 1.8(a). The certification may be included with all correspondence concerning this application or proceeding to establish a date of mailing or transmission under 37 CFR 1.8(a).”

The certificate should include:

  • A statement certifying the date of mailing or transmission
  • The signature of the person making the certification
  • The application number (if known)

It’s important to note that the certificate must be signed by someone with a reasonable basis to expect the correspondence would be mailed or transmitted on or before the date indicated.

To learn more:

How do I update the list of practitioners associated with a Customer Number?

To update the list of practitioners associated with a Customer Number, follow these steps:

  1. Complete the Change of Correspondence Address Form (PTO/SB/122)
  2. Provide the Customer Number and the updated list of registered practitioners
  3. Submit the form to the USPTO

The MPEP 403 specifies:

‘A request to change the correspondence address or list of registered practitioners associated with a Customer Number must be made in writing.’

It’s important to note that:

  • Only registered practitioners can be added to a Customer Number
  • Changes will affect all applications associated with the Customer Number
  • The USPTO recommends using the online Electronic Business Center (EBC) for faster processing

Keeping the practitioner list up-to-date ensures proper communication and representation for all linked patent applications.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

How do I submit supporting documents for electronic assignment submissions?

When submitting assignment documents electronically, you can include supporting documents as follows:

  • Upload supporting documents as separate PDF files along with the main assignment document.
  • Ensure each supporting document is less than 25 MB in size.
  • Include a brief description for each supporting document during the submission process.

According to MPEP 302.10, ‘Supporting documents can be submitted as PDF files via EFS-Web and EPAS.’ This allows for a comprehensive submission of all relevant materials related to the assignment.

To learn more:

To submit color drawings in a utility patent application, you must file a petition under 37 CFR 1.84(a)(2). The petition must include:

  1. The fee set forth in 37 CFR 1.17(h)
  2. One set of color drawings if submitted via the USPTO electronic filing system, or three sets if not submitted electronically
  3. An amendment to the specification inserting the following language as the first paragraph of the brief description of the drawings: ‘The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.’

The petition must explain why color drawings are necessary. Color drawings will only be accepted if the USPTO determines that color is the only practical medium for illustrating the claimed invention.

To learn more:

To submit a large biological sequence listing (over 100MB) on optical discs for a patent application, follow these guidelines:

  • Use read-only optical discs (e.g., CD-R, DVD-R).
  • Ensure the sequence listing is in ASCII text format.
  • Include two copies of the optical disc containing identical sequence listings.
  • Label each disc with the following information:
    • Name of the applicant
    • Title of the invention
    • Application number (if known)
    • Filing date (if known)
    • Disc number (e.g., ‘1 of 2’, ‘2 of 2’)
  • Include a statement in the specification that incorporates the sequence listing by reference.

MPEP 608.05(c) states: “Sequence listings may be submitted […] on read-only optical discs when the sequence listing file size is over 100 megabytes.”

Ensure that the submission complies with the requirements set forth in 37 CFR 1.821-1.825 and follows the specific guidelines for optical disc submissions outlined in MPEP 608.05.

To learn more:

To submit a biological sequence listing for a patent application, follow these steps:

  • Prepare the sequence listing in accordance with 37 CFR 1.821-1.825.
  • Submit the sequence listing as a separate part of the application.
  • If the sequence listing is 100KB or less, you can include it in the specification or submit it as a text file via EFS-Web or PatentCenter.
  • For sequence listings larger than 100KB, submit them on read-only optical discs.
  • Ensure the sequence listing is in ASCII text format.
  • Include a statement that the content of the sequence listing is incorporated by reference in the application.

As stated in MPEP 608.05(c): “Sequence listings may be submitted in electronic form via EFS-Web or PatentCenter as ASCII text files or PDF files up to 100 megabytes, and on read-only optical discs when the sequence listing file size is over 100 megabytes.”

To learn more:

For patent applications filed before July 1, 2022, biological sequence listings should be submitted as follows:

  1. Prepare a “Sequence Listing” as an ASCII plain text file.
  2. Ensure the file complies with 37 CFR 1.821 – 1.824.
  3. Submit the file via the USPTO patent electronic filing system or on a read-only optical disc.

As stated in MPEP 608.05(c): “For applications filed before July 1, 2022, the sequence listing can be a ‘Sequence Listing’ (as an ASCII plain text file in compliance with 37 CFR 1.821 – 1.824) submission must be submitted via the USPTO patent electronic filing system or on read-only optical disc.”

For detailed information, refer to MPEP §§ 2420 et seq.

To learn more:

When filing a patent application, you must specify a correspondence address in one of two ways:

  • In an application data sheet (ADS) under 37 CFR 1.76, or
  • Elsewhere in the application papers in a clearly identifiable manner

As stated in 37 CFR 1.33(a): When filing an application, a correspondence address must be set forth in either an application data sheet (§ 1.76), or elsewhere, in a clearly identifiable manner, in any paper submitted with an application filing.

This address will be used by the USPTO to send all official communications regarding your application.

To learn more:

How do I set up a deposit account with the USPTO?

To set up a deposit account with the USPTO:

  1. Visit the USPTO Deposit Accounts page
  2. Download and complete the Deposit Account Application Form
  3. Submit the form with an initial deposit (minimum $1,000)
  4. Wait for account approval and receive your account number

According to MPEP 509: ‘A deposit account may be established by submitting a completed Deposit Account Application Form with an initial deposit of at least $1,000.’ This account can be used for future fee payments, offering convenience for frequent USPTO transactions.

To learn more:

To revoke a power of attorney in a patent application:

  • The applicant or assignee of the entire interest must submit a revocation signed by them.
  • The revocation should be submitted to the USPTO in writing.
  • It can be done by filing a new power of attorney (Form PTO/AIA/82) and checking the revocation box.
  • Alternatively, you can submit a document specifically revoking the previous power of attorney.

As stated in the MPEP 402: ‘A power of attorney may be revoked at any stage in the proceedings of a case.’ It’s important to note that revoking a power of attorney does not remove attorneys from the list of patent practitioners associated with an application. To do that, you must file a separate request.

For more information on power of attorney, visit: power of attorney.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

How do I retrieve a priority document from a foreign IP office using PDX?

To retrieve a priority document from a foreign IP office using PDX:

  • Ensure the foreign IP office participates in PDX.
  • File an application with the USPTO that claims priority to the foreign application.
  • Submit a Request to Retrieve through EFS-Web or Patent Center.
  • Include the foreign application number, country code, and filing date.
  • The USPTO will attempt to retrieve the document electronically.

According to MPEP 215.01: “The USPTO will attempt to electronically retrieve the priority document through the WIPO DAS […] or through a bilateral PDX agreement.”

To learn more:

To request retrieval of a foreign priority document through the Priority Document Exchange (PDX) program, follow these steps:

  1. Ensure that the foreign application is from a participating office in the PDX program.
  2. File an application data sheet (ADS) including a proper priority claim to the foreign application.
  3. Submit a request for retrieval of the foreign priority document.

The MPEP 215.01 states: “To authorize retrieval of a priority document via PDX, the applicant should submit the request electronically via EFS-Web using the Priority Document Exchange Request form (PTO/SB/38) or as a pre-grant (PGPub) request via Private PAIR.” It’s important to note that the request should be made within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To request deletion of a named inventor in a Continued Prosecution Application (CPA) for design applications, you need to file a proper request with the USPTO. According to MPEP § 201, specifically paragraph 2.32:

In a continued prosecution application (CPA) for a design application (37 CFR 1.53(d)), a request to delete a named inventor from the prior application may be submitted by way of a letter to the examiner or a request for corrected filing receipt. However, it should be noted that this is only available for design applications.

This process is specific to design applications and allows for the correction of inventorship in CPAs.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on USPTO procedures, visit: USPTO procedures.

To request copies of patent assignment records, follow these steps:

  1. For records after May 1, 1957: Contact the USPTO and pay the fee set forth in 37 CFR 1.19.
  2. For records before May 1, 1957: Contact the National Archives and Records Administration (NARA) directly.
  3. For recent records: Check the USPTO website for online availability.

When requesting a copy, the MPEP advises: “An order for a copy of an assignment or other document should identify the reel and frame number where the assignment or document is recorded.” Failure to provide this information may result in additional charges.

How do I request a Customer Number from the USPTO?

To request a Customer Number from the USPTO, follow these steps:

  1. Complete the Customer Number Request Form (PTO/SB/125)
  2. Include the names of registered practitioners associated with the Customer Number
  3. Provide the correspondence address for the Customer Number
  4. Submit the form to the USPTO

According to MPEP 403, ‘A Customer Number may be requested by (A) a registered attorney or agent of record, (B) an assignee of the entire interest of the applicant, or (C) the applicant.’ The USPTO will process the request and assign a unique Customer Number, which can then be used for managing correspondence and access to patent applications.

For more information on USPTO Forms, visit: USPTO Forms.

Tags: USPTO Forms

To record an assignment document with the USPTO, you must:

  • Submit a copy of the original assignment document
  • Include a completed cover sheet (Form PTO-1595 or equivalent)
  • Pay the required recording fee

The cover sheet must contain key information like the names of the parties, description of the interest conveyed, and patent/application numbers affected. As stated in MPEP 302.07: “Each assignment document submitted to the Office for recording must be accompanied by a cover sheet as required by 37 CFR 3.28.”

Documents can be submitted electronically via EPAS, by mail, or by fax. Electronic submission is recommended as it has a $0 fee.

For more information on assignment recording, visit: assignment recording.

For more information on cover sheet, visit: cover sheet.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

To record a security interest in a patent or patent application:

  • Submit the document to be recorded to the USPTO’s Assignment Recordation Branch.
  • Include a cover sheet with the necessary information, as specified in MPEP 313.
  • Pay the required fee.

The MPEP states: Documents other than assignments are recorded in the same manner as assignments. The document and cover sheet should be mailed to the Office of Public Records Document Services Division for recording.

For more information on USPTO, visit: USPTO.

Tags: USPTO

To record a joint research agreement (JRA) with the USPTO, follow these steps:

  1. Prepare the JRA document or an excerpt of it
  2. Complete a cover sheet, clearly identifying the document as a “joint research agreement”
  3. Submit the document and cover sheet to the USPTO

As stated in MPEP 302.07: “If the document submitted for recordation is a joint research agreement or an excerpt of a joint research agreement, the cover sheet must clearly identify the document as a ‘joint research agreement’.”

The cover sheet for a JRA must include:

  • The name of the owner of the application or patent
  • The name of each other party to the joint research agreement
  • The date the joint research agreement was executed

JRAs can be submitted electronically via EPAS, by mail, or by fax, following the same procedures as other assignment documents.

For more information on joint research agreement, visit: joint research agreement.

Recording a government interest in a patent requires special procedures:

  1. Prepare the document establishing the government interest
  2. Complete a patent cover sheet, indicating it relates to a government interest
  3. Submit the document and cover sheet to the USPTO

As stated in MPEP 302.07: “Cover sheets required by 37 CFR 3.28 seeking to record a governmental interest must also (1) indicate that the document relates to a governmental interest and (2) indicate, if applicable, that the document to be recorded is not a document affecting title.”

Key points for government interest recordations:

  • No fee is required if the document doesn’t affect title and is properly identified
  • These documents are recorded in a special Departmental Register
  • Some government documents may be recorded in a Secret Register with restricted access

Government agencies should follow Executive Order 9424 which requires prompt forwarding of government interests in patents for recording.

For more information on patent recordation, visit: patent recordation.

To prove an invention has been assigned in a pre-AIA 37 CFR 1.47(b) application, you must submit the following:

  • A copy of the assignment in English
  • A statement under pre-AIA 37 CFR 3.73(b) by the assignee

According to MPEP 409.03(f):

“If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant. A statement under pre-AIA 37 CFR 3.73(b) by the assignee must also be submitted (see MPEP § 324).”

It’s important to note that the assignment must specifically cover the invention described in the application. General assignments may not be sufficient.

To learn more:

To learn more:

Tags: pre-AIA

To properly use a certificate of mailing for patent correspondence, follow these steps:

  1. Prepare your correspondence.
  2. Attach a certificate of mailing to each piece of correspondence.
  3. Include the required information on the certificate.
  4. Sign and date the certificate.
  5. Mail the correspondence with the attached certificate.

According to MPEP 512:

Each piece of correspondence for which a certificate is filed must include a signed and dated certificate which sets forth the date of deposit or transmission.

Ensure that you follow these guidelines to properly use the certificate of mailing procedure.

To learn more:

For applications filed on or after September 16, 2012, the specific reference to the prior application must be included in an application data sheet (ADS) in compliance with 37 CFR 1.76. For applications filed before September 16, 2012, the reference should be in an ADS and/or in the first sentence(s) of the specification following the title.

The reference must include:

  • The prior application number
  • The filing date
  • The relationship between the applications (continuation, divisional, or continuation-in-part) for nonprovisional applications

For example: “This application is a continuation of Application No. 12/345,678, filed January 1, 2010.”

For provisional applications, only the application number and filing date are required. The relationship should not be specified.

To learn more:

When filing patent correspondence, you should include the following identifying information:

  • Application number (checked for accuracy, including series code and serial number)
  • Art Unit number (copied from most recent Office communication)
  • Filing date
  • Name of the examiner who prepared the most recent Office action
  • Title of invention
  • Confirmation number

As stated in 37 CFR 1.5(a): ‘When correspondence directed to the Patent and Trademark Office concerns a previously filed application for a patent, it must identify on the top page in a conspicuous location, the application number (consisting of the series code and the serial number; e.g., 07/123,456), or the serial number and filing date assigned to that application by the Patent and Trademark Office, or the international application number of the international application, or the international registration number of an international design application.’

According to 37 CFR 3.21, a patent assignment must identify the patent by patent number. For patent applications:

  • National applications: Identify by application number (series code and serial number)
  • International applications designating the US: Identify by international application number
  • International design applications designating the US: Identify by international registration number or US application number

If the assignment is executed before filing but after the application is executed, it must identify the application by inventor name(s) and invention title. For provisional applications not yet filed, identify by inventor name(s) and invention title.

The MPEP suggests including language like: I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.

For more information on application identification, visit: application identification.

For more information on patent assignment, visit: patent assignment.

For more information on patent identification, visit: patent identification.

To properly identify a patent in an assignment, you must use the patent number. According to 37 CFR 3.21, “An assignment relating to a patent must identify the patent by the patent number.” This ensures that there is no ambiguity about which patent is being assigned.

To learn more:

To properly identify a foreign application when claiming priority, you must provide the following information:

  • Application number
  • Country or intellectual property authority
  • Day, month, and year of filing

As stated in MPEP 214.01: “The claim for priority must be presented in an application data sheet (§ 1.76(b)(6)) and must identify the foreign application to which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.”

For applications filed under 35 U.S.C. 111(a) on or after September 16, 2012, this information must be provided in an application data sheet. For earlier applications, it may be included in the oath or declaration if not provided in an application data sheet.

To learn more:

How do I properly identify a foreign application when claiming priority in a U.S. patent application?

When claiming priority to a foreign application in a U.S. patent application, it’s crucial to provide accurate identification information. According to MPEP 214.01, you must include the following details:

  • The application number of the foreign application
  • The country or intellectual property authority where the foreign application was filed
  • The day, month, and year of filing of the foreign application

The MPEP states: ‘The claim for priority must identify the foreign application for which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.’

Additionally, if you’re submitting a certified copy of the foreign application, ensure that it matches the identification information provided in your priority claim. Accurate identification is essential for establishing your priority rights and avoiding potential issues during examination or litigation.

To properly claim the benefit of a prior application, you must include a specific reference to the prior application. For applications filed on or after September 16, 2012, this reference must be included in an application data sheet (ADS). For applications filed before September 16, 2012, the reference must be in an ADS and/or in the first sentence(s) of the specification following the title.

The MPEP 211.02 states: Both 35 U.S.C. 119(e) and 120 include the requirement that the later-filed application must contain a specific reference to the prior application.

For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on ADS, visit: ADS.

For more information on divisional, visit: divisional.

For more information on specific reference, visit: specific reference.

How do I mark changes in a corrected Application Data Sheet (ADS) for benefit claims?

When submitting a corrected Application Data Sheet (ADS) to add or correct a benefit claim, it’s crucial to properly mark the changes. According to MPEP 211.02(a):

The corrected ADS must identify the information that is being changed with underlining for insertions and strike-through or brackets for text removed as required by 37 CFR 1.76(c)(2).

To properly mark changes in a corrected ADS:

  • Insertions: Underline new text
  • Deletions: Use strike-through or brackets for removed text
  • Existing information: Include all information from the original ADS, even if unchanged

It’s important to note that the entire benefit claim must be underlined if you’re adding a new benefit claim. This helps the USPTO easily identify and process the changes to your application.

To learn more:

Tags: ADS

When assigning a provisional application before it’s filed, you must use specific identifying information. MPEP 302.03 provides guidance: “If an assignment of a provisional application under § 1.53(c) of this chapter is executed before the provisional application is filed, it must identify the provisional application by the name of each inventor and the title of the invention so that there can be no mistake as to the provisional application intended.” This ensures that the correct provisional application can be associated with the assignment once it’s filed.

To learn more:

When submitting a corrected cover sheet to address an erroneous assignment or name change, follow these instructions from MPEP 323.01(c):

  1. Check the box titled ‘Other’ in the ‘Nature of Conveyance’ section.
  2. Indicate that the submission is to correct an error in a previously recorded document that erroneously affects the identified application(s) or patent(s).
  3. Write the name of the correct owner in both the ‘conveying party’ and ‘receiving party’ boxes.

The MPEP explains the reasoning behind this: The party should also write the name of the correct owner in both the box requesting the name of the conveying party and the box requesting the name and address of the receiving party; this is to make it clear that ownership never changed and that any assignment or name change recorded against the application(s) or patent(s) was erroneous.

To learn more:

To file a foreign priority claim in a U.S. patent application, you must:

  1. File the claim within the specified time limit (see previous FAQ for details).
  2. Present the claim in an application data sheet (ADS) for applications filed on or after September 16, 2012. For applications filed before this date, the claim can be in the ADS or in the oath/declaration.
  3. Identify the foreign application by providing:
    • Application number
    • Country (or intellectual property authority)
    • Filing date (day, month, and year)

This is specified in 37 CFR 1.55(d)(1): The claim for priority must be presented in an application data sheet (§1.76(b)(6)) and must identify the foreign application to which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.

It’s crucial to provide accurate and complete information to ensure your priority claim is properly recorded and considered.

For international applications entering the national stage in the United States under 35 U.S.C. 371, the process for filing a foreign priority claim is different from regular U.S. applications. According to MPEP 214.01:

“The claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT in an international application entering the national stage under 35 U.S.C. 371, except as provided in paragraph (e) of this section.”

This means that you need to follow the time limits specified in the Patent Cooperation Treaty (PCT) and its regulations when filing a priority claim for an international application entering the U.S. national stage.

For more detailed information on the timing and procedure for claiming priority in national stage applications, you should refer to MPEP § 213.06, which specifically deals with this topic.

To learn more:

Filing a delayed benefit claim in an international application involves specific procedures. The MPEP 211.04 provides guidance on this matter:

“A petition under 37 CFR 1.78 for accepting an unintentionally delayed benefit claim and the petition fee under 37 CFR 1.17(m) are required to add a benefit claim under 35 U.S.C. 120 and 365(c) in an abandoned international application designating the United States, even when the international application did not enter the national stage under 35 U.S.C. 371.”

For international applications not filed with the United States Receiving Office and not a nonprovisional application, the petition may be filed in the earliest nonprovisional application that claims benefit to the international application. As stated in MPEP 211.04:

“If a petition under 37 CFR 1.78(c) or (e) is required in an international application that was not filed with the United States Receiving Office and is not a nonprovisional application, then the petition may be filed in the earliest nonprovisional application that claims benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the international application and will be treated as having been filed in the international application.”

To learn more:

To correctly add a new inventor to a Continued Prosecution Application (CPA), you must follow the procedures outlined in 37 CFR 1.48. The MPEP ¶ 2.33 states:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48.

To add a new inventor:

  1. File a request under 37 CFR 1.48 to correct the inventorship.
  2. Include a statement from the new inventor agreeing to the addition.
  3. Pay any required fees.
  4. Provide an oath or declaration from the new inventor.

Failure to follow these steps may result in the inventorship remaining the same as in the prior application.

For more information on CPA, visit: CPA.

Tags: CPA

How do I correct the filing date of a prior-filed application in a benefit claim?

To correct the filing date of a prior-filed application in a benefit claim, you need to follow specific procedures outlined in MPEP 211.02(a). The MPEP states:

“If the prior application is a provisional application, and the filing date of the provisional application in the benefit claim is incorrect, applicant should file a petition under 37 CFR 1.78 to correct the benefit claim. A petition under 37 CFR 1.78 and the petition fee are required to correct the benefit claim because the correction is considered a delayed claim as per 37 CFR 1.78.”

For non-provisional applications, a similar process applies. You must file a petition under 37 CFR 1.78 along with the required fee to correct the filing date in the benefit claim.

To learn more:

To correct or update information in an Application Data Sheet (ADS), follow these guidelines from MPEP 601.05:

  1. Submit a new ADS titled “Supplemental Application Data Sheet”
  2. Include all sections listed in 37 CFR 1.76(b), even if some sections have no changed data
  3. Identify changes with underlining for insertions and strike-through or brackets for text removed
  4. Make changes relative to the most recent filing receipt
  5. Submit the corrected ADS until payment of the issue fee

Note that certain changes, such as inventorship changes, foreign priority and domestic benefit information changes, and correspondence address changes, must comply with specific rules and may require additional forms or petitions.

The USPTO recommends using the corrected Web-based ADS when possible, as it pre-populates with information of record and automatically formats changes.

To learn more:

To correct or add a benefit claim after filing your application, you need to follow specific procedures depending on the timing and circumstances:

  1. If you received a filing receipt with missing or incorrect benefit claim information, you can request a corrected filing receipt. However, the Office will only grant this request if the proper reference to the prior application was included in the original filing or within the time period required by 37 CFR 1.78.
  2. If you’re adding a benefit claim after the time period required by 37 CFR 1.78, you must file a petition and pay the petition fee. The petition must be accompanied by a corrected Application Data Sheet (ADS) for applications filed on or after September 16, 2012, or an amendment to the specification or a supplemental ADS for applications filed before that date.

As stated in MPEP 211.02(a): If a benefit claim is added after the time period required by 37 CFR 1.78, a petition and the petition fee are required.

Depending on the status of your application, you may also need to file:

  • A Request for Continued Examination (RCE) if the application is under final rejection or has been allowed.
  • A reissue application or a request for a certificate of correction if the application has already issued as a patent.

It’s important to note that you cannot add an incorporation by reference statement to a benefit claim after the filing date, as this would be considered new matter.

For more information on ADS, visit: ADS.

For more information on RCE, visit: RCE.

Tags: ADS, RCE

How do I correct an error in my foreign priority claim?

If you need to correct an error in your foreign priority claim, the process depends on the nature of the error and when it’s discovered. According to MPEP 214.01, “Applicant may correct the failure to adequately claim priority to the prior foreign application by amending the specification or submitting a new application data sheet (ADS) identifying the foreign application by application number, country (or intellectual property authority), and filing date.” Here are some key points to remember:

  • If the error is discovered within the time period for filing the priority claim, you can simply submit a corrected ADS or amend the specification.
  • If the error is discovered after the time period has expired, you may need to file a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim.
  • For minor typographical errors, a request for a corrected filing receipt may be sufficient.

Always consult with a patent attorney or agent to determine the best course of action for your specific situation.

How do I correct an error in micro entity status if I underpaid fees?

If you erroneously paid fees as a micro entity when you were not entitled to that status, resulting in an underpayment, you need to take the following steps:

  • Submit a written assertion of small entity status (if eligible) or a written assertion to establish non-small entity status.
  • Pay the fee deficiency, which is the difference between the amount paid and the amount due.

As stated in MPEP 509.04(f): “A written assertion to establish non-small entity status must be accompanied by the difference between the current amount due and the amount previously paid.”

It’s important to correct the error promptly to avoid potential issues with your patent application or granted patent.

To learn more:

Tags: patent fees

If you need to correct an error in an oath or declaration, the process depends on the nature of the error and when it’s discovered. According to MPEP 602:

  • For minor typographical errors, you can submit a supplemental oath or declaration pointing out the error in the original.
  • If the error is substantial, a new oath or declaration may be required.
  • For applications filed on or after September 16, 2012, defects can often be corrected through an application data sheet (ADS).

The MPEP states: ‘Applicant may submit a substitute statement in lieu of an oath or declaration as provided for in 37 CFR 1.64 if the requirements of 37 CFR 1.64 are met.’

It’s important to address any errors promptly to avoid potential issues during patent examination or enforcement.

To learn more:

To correct an error in a recorded assignment document, you need to submit a ‘corrective document’ to the Assignment Division. This document should include:

  1. A copy of the original assignment document with corrections made, initialed, and dated by the party conveying the interest.
  2. A new Recordation Form Cover Sheet (form PTO-1595) identifying the submission as a ‘corrective document’ and indicating the reel and frame number of the incorrectly recorded assignment.

The corrective document will be given a new reel and frame number and recording date. A recording fee is required for each patent application and patent affected.

As stated in the MPEP: “The recording fee set forth in 37 CFR 1.21(h) is required for each patent application and patent against which the corrective document is being recorded.” (MPEP § 323)

To correct a typographical error on a recorded cover sheet for a patent assignment, you need to submit the following to the Assignment Services Division:

  • A copy of the originally recorded assignment document (or other document affecting title)
  • A corrected cover sheet
  • The required fee for each application or patent to be corrected

Additionally, it’s recommended to submit a copy of the original cover sheet to facilitate comparison. When filing the corrected cover sheet, you should:

  • Check the box titled “Other” in the “Nature of Conveyance” area
  • Indicate that the submission is to correct an error in a previously recorded cover sheet
  • Identify the reel and frame numbers (if known)
  • Specify the nature of the correction

As stated in MPEP 323.01(a): “The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.”

To learn more:

To correct a benefit claim in your patent application, follow these steps:

  1. For applications filed on or after September 16, 2012:
    • Submit a corrected Application Data Sheet (ADS) in compliance with 37 CFR 1.76(c)
  2. For applications filed before September 16, 2012:
    • Submit an amendment to the specification (if the benefit claim is in the specification) or
    • Submit a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c)
  3. If the correction is made after the time period set in 37 CFR 1.78:
    • File a petition under 37 CFR 1.78
    • Pay the required petition fee
    • Provide a statement that the entire delay was unintentional

MPEP 211.02(a) states: “If applicant receives a filing receipt with missing or incorrect benefit claim information, applicant may request a corrected filing receipt. The Office will not grant a request for a corrected filing receipt to include a benefit claim unless the proper reference to the prior application is included (i) in an ADS (for applications filed on or after September 16, 2012) or (ii) in the first sentence(s) of the specification or an ADS (for applications filed prior to September 16, 2012) within the time period required by 37 CFR 1.78 with a few exceptions.”

It’s important to review your filing receipt promptly and carefully to avoid the need for a petition and associated fees.

To learn more:

How do I correct a benefit claim in a nonprovisional application after the time period set forth in 37 CFR 1.78?

To correct a benefit claim in a nonprovisional application after the time period set forth in 37 CFR 1.78, you need to file a petition to accept a delayed claim. The MPEP states:

“A petition to accept a delayed claim under 37 CFR 1.78(c) for the benefit of a prior-filed provisional application or under 37 CFR 1.78(e) for the benefit of a prior-filed nonprovisional application must be accompanied by:”

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78(a)(3) to the prior-filed provisional application or the reference required by 35 U.S.C. 120 and 37 CFR 1.78(d)(2) to the prior-filed nonprovisional application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(a)(4) or 37 CFR 1.78(d)(3) and the date the benefit claim was filed was unintentional.

The Director may require additional information where there is a question whether the delay was unintentional.

For more detailed information, refer to MPEP 211.02(a).

To learn more:

To claim the benefit of a prior-filed application, you must include a specific reference to the prior-filed application in your current application. The method of including this reference depends on when your application was filed:

  • For applications filed before September 16, 2012: Include the reference in the first sentence(s) of the specification following the title or in an application data sheet (ADS) compliant with pre-AIA 37 CFR 1.76.
  • For applications filed on or after September 16, 2012: Include the reference in an ADS compliant with 37 CFR 1.76.

The MPEP states: If applicant desires to claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c), the instant application must contain, or be amended to contain, a specific reference to the prior-filed application in compliance with 37 CFR 1.78. (MPEP § 211)

For more information on ADS, visit: ADS.

For more information on prior-filed application, visit: prior-filed application.

For more information on specific reference, visit: specific reference.

To claim the benefit of a prior-filed application in a continuation application, you must include a reference to the prior-filed application in the new application. According to 37 CFR 1.78(d)(2):

Any nonprovisional application, international application designating the United States, or international design application designating the United States that claims the benefit of one or more prior-filed nonprovisional applications, international applications designating the United States, or international design applications designating the United States must contain or be amended to contain a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number), international application number and international filing date, or international registration number and filing date under §1.1023.

For nonprovisional applications, this reference must be included in an application data sheet (ADS) as specified in 37 CFR 1.76(b)(5). The reference should also identify the relationship between the applications, stating whether it’s a continuation, divisional, or continuation-in-part.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

For more information on prior-filed application, visit: prior-filed application.

How do I claim small entity status for a patent application?

To claim small entity status for a patent application, follow these steps:

  • Determine eligibility: Ensure you meet the criteria for small entity status as defined in 37 CFR 1.27(a).
  • Submit a written assertion: Provide a written assertion of entitlement to small entity status. This can be done by:
    • Checking the appropriate box on a patent application transmittal form
    • Submitting a separate paper specifically asserting small entity status
    • Paying small entity fees (which is considered a written assertion)
  • Timing: You can claim small entity status at any time during the pendency of the application or after the patent issues.

As stated in MPEP 509.03, “A small entity status assertion must be filed in each application or patent in which the small entity is desired to claim such status.”

To learn more:

Tags: USPTO fees

Priority to an international design application can be claimed in a U.S. nonprovisional application or in another international design application designating the U.S. MPEP 213.07 states: ‘Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.’

The priority claim should be made in an Application Data Sheet (ADS) for nonprovisional applications. For international design applications designating the U.S., the priority claim can be made in accordance with the Hague Agreement and Regulations.

For more information on Hague Agreement, visit: Hague Agreement.

Claiming priority to a provisional application is different from claiming foreign priority. To claim the benefit of a provisional application in a later-filed nonprovisional application:

  • The nonprovisional must be filed within 12 months of the provisional filing date
  • A specific reference to the provisional application must be made in an application data sheet
  • The provisional and nonprovisional must name at least one common inventor
  • The claimed subject matter must be supported by the provisional application

This is known as a domestic benefit claim under 35 U.S.C. 119(e), rather than a foreign priority claim under 35 U.S.C. 119(a)-(d). The requirements are specified in 37 CFR 1.78 rather than 37 CFR 1.55.

To claim priority to an earlier-filed foreign application, the applicant must:

1. File the U.S. application within 12 months of the foreign application’s filing date (6 months for design applications).
2. In the U.S. application, include a claim for priority that identifies the foreign application. For applications filed on/after 9/16/12, this must be in an ADS.
3. File a certified copy of the foreign application, unless it was previously filed or is available to the USPTO via a priority document exchange program.

See MPEP 213216 for the detailed requirements. Some deadlines can be extended on petition if unintentionally delayed.

Claiming priority to a PCT international application can be done in two ways:

  1. In a U.S. national stage application under 35 U.S.C. 371:
    • The priority claim is made in the PCT application
    • No further action is needed when entering the national stage
  2. In a U.S. nonprovisional application under 35 U.S.C. 111(a):
    • File within 12 months of the PCT filing date
    • Make the priority claim in an application data sheet
    • Provide a certified copy of the PCT application (unless already filed with the PCT)

In both cases, the PCT application must designate the United States. The specific requirements are detailed in 37 CFR 1.55(d)(2) and (f)(2) for national stage applications, and 37 CFR 1.55(d)(1) and (f)(1) for applications under 35 U.S.C. 111(a).

For international applications entering the U.S. national stage under 35 U.S.C. 371, the priority claim must be made within the time limit set by the PCT and its regulations. MPEP 213.06 states: ‘In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made and a certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT.’

If the priority claim was properly made during the international phase, it’s generally not necessary to repeat it upon national stage entry. However, the certified copy of the priority document must be furnished if not previously submitted to the International Bureau or the USPTO.

For more information on national stage application, visit: national stage application.

To claim priority in a nonprovisional international design application:

  • Include a priority claim in the international design application when filed with the International Bureau (IB).
  • The priority claim must specify the application number and filing date of the priority application.
  • File a certified copy of the priority application with the IB or the USPTO, or have it retrieved through the Digital Access Service (DAS).

According to MPEP 213.07: An applicant filing an international design application designating the United States may claim priority to one or more prior foreign applications under the Paris Convention or to a prior provisional application under 35 U.S.C. 119(e).

To learn more:

To learn more:

To claim foreign priority in a U.S. patent application, you must:

1. File the U.S. application within 12 months (6 months for design applications) of the foreign filing date.
2. Submit a claim for priority identifying the foreign application.
3. File a certified copy of the foreign application.

For applications filed on or after September 16, 2012, 37 CFR 1.55(d)(1) requires that the claim for priority be presented in an application data sheet. The claim must identify the foreign application by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.

A certified copy of the foreign application must also be filed within a specified time period, usually within the later of 4 months from the actual U.S. filing date or 16 months from the foreign filing date.

To claim benefit to a non-English language provisional application, you must:

  • File an English translation of the non-English language provisional application
  • Provide a statement that the translation is accurate
  • File both the translation and the statement in the provisional application
  • Confirm in the present application that the translation and statement were filed in the provisional application

According to MPEP ¶ 2.38, “An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3]. See 37 CFR 1.78.”

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP), you need to follow specific procedures. The MPEP ¶ 2.06 states: “Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

This means you must:

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the common subject matter.

How do I cite non-English language documents in an IDS?

When citing non-English language documents in an Information Disclosure Statement (IDS), follow these guidelines:

  • Provide a concise explanation of the relevance of the document.
  • Include an English language translation or abstract if available.
  • If a translation is not available, indicate the language of the document.

According to MPEP 609.04(a): “Where the information listed is not in the English language, but was cited in a search report or other action by a foreign patent office in a counterpart foreign application, the requirement for a concise explanation of relevance can be satisfied by submitting an English-language version of the search report or action which indicates the degree of relevance found by the foreign office.”

Properly citing non-English documents ensures the examiner can consider their relevance to your application.

To learn more:

How do I cite a foreign patent document in an Information Disclosure Statement (IDS)?

When citing a foreign patent document in an Information Disclosure Statement (IDS), you need to provide specific information as outlined in MPEP 609. The citation should include:

  • The country or patent office that issued the document
  • The document number
  • The kind code (if known)
  • The name of the patentee or applicant
  • The date of publication of the document
  • The pages, columns, lines, or paragraph numbers where relevant passages or figures appear (if a particular part of the document is being cited)

For example, a proper citation might look like this:

JP 2000-123456 A (SMITH, John) 15 January 2000, paragraphs [0015]-[0020], figure 3

If an English language abstract is available, it should be submitted along with the foreign patent document. As stated in MPEP 609:

“When citing a foreign patent document on an information disclosure statement, applicant should also submit any English-language abstract of that foreign patent document available to applicant.”

By providing complete and accurate citations for foreign patent documents, you ensure that the examiner can easily locate and consider the relevant prior art during the examination process.

To learn more:

Tags: prior art

To change the correspondence address for a patent application, you need to file a properly signed written request with the USPTO. According to MPEP 601.03:

“A written request may be signed by a practitioner of record, the applicant, an assignee of record, or a party who otherwise shows sufficient proprietary interest in the matter, in accordance with 37 CFR 1.33(b).”

The request should clearly state the new correspondence address and include the application number or patent number if already issued. For pending applications, you can use form PTO/AIA/122 or submit a signed letter.

To learn more:

To certify micro entity status, you must file a certification form with the USPTO. The USPTO provides two forms:

  • Form PTO/SB/15A for certifying under the gross income basis
  • Form PTO/SB/15B for certifying under the institution of higher education basis

The certification must be signed by an authorized party as defined in 37 CFR 1.33(b). It should be filed prior to or at the time of paying the first fee as a micro entity.

To cancel a figure in a patent application, you should:

  • Submit an amendment clearly stating which figure(s) are being canceled
  • Update the specification to remove references to the canceled figure(s)
  • Renumber remaining figures if necessary
  • Update figure descriptions in the specification accordingly

The MPEP states: When a figure is canceled, the applicant, in order to avoid confusion, should also cancel (1) any reference to the figure in the specification; and (2) any other figures if their meaning depends upon the canceled figure. (MPEP 608.02(t))

To learn more:

How do I calculate the application size fee for a patent application?

The application size fee is an additional charge for patent applications exceeding a certain number of pages. Here’s how to calculate it:

  1. Count the total number of pages in your application, including specification, claims, abstract, and drawings.
  2. Subtract 100 from the total page count (the first 100 pages are included in the basic filing fee).
  3. If the result is positive, multiply it by the per-page fee.

According to MPEP 607: “The application size fee applies to any application filed under 35 U.S.C. 111 … the number of pages of specification, claims, and drawings (including all pages containing part of one of those items) is more than 100 pages.”

For current fee amounts, refer to the USPTO Fee Schedule. Remember, the application size fee is in addition to the basic filing fee.

To learn more:

If you’ve inadvertently filed a foreign patent application without obtaining a foreign filing license, you can apply for a retroactive license. According to MPEP 140:

‘Petitions for a retroactive license under 35 U.S.C. 184 are decided by the Office of Petitions. The petition must be in the form of a verified statement and should include the following information:’

  • A listing of each of the foreign countries in which the unlicensed patent application material was filed
  • The dates on which the material was filed in each country
  • A verified statement that the subject matter in question was not under a secrecy order at the time it was filed abroad
  • A verified statement that the license has been diligently sought after discovery of the proscribed foreign filing
  • An explanation of why the material was filed abroad through error without the required license first having been obtained

The petition should be submitted to the USPTO as soon as possible after discovering the error. Include all relevant documentation and be prepared to pay any required fees.

For more information on retroactive foreign filing license, visit: retroactive foreign filing license.

For more information on USPTO, visit: USPTO.

To amend your application to include inadvertently omitted material under 37 CFR 1.57(b), you must:

  1. File an amendment to include the omitted material within the time period set by the USPTO
  2. Ensure the amendment is filed before the close of prosecution or abandonment of the application
  3. Supply a copy of the prior-filed application (unless it’s a US application filed under 35 U.S.C. 111)
  4. Provide an English translation if the prior-filed application is in a foreign language
  5. Identify where the omitted material can be found in the prior-filed application

The MPEP states: “The application must be amended to include the inadvertently omitted portion of the specification or drawing(s) within any time period set by the Office, but in no case later than the close of prosecution as defined by 37 CFR 1.114(b), or abandonment of the application, whichever occurs earlier.”

Examiners are required to review and consider e-IDS submissions in the same manner as paper IDS submissions. The MPEP 609.07 provides guidance on this process:

If the e-IDS complies with the requirements of 37 CFR 1.97, examiners must consider the e-IDS and complete the e-IDS form by initialing, signing, and dating the e-IDS form entries.

Examiners can access the electronic list of U.S. patents and patent application publications from their workstations. They are expected to review these references electronically and should not require applicants to submit paper copies of e-IDS references. It’s crucial for applicants to ensure that citation numbers are accurate, as examiners rely on these numbers to retrieve the correct documents for review.

To learn more:

How do dependent claims affect claim interpretation and infringement analysis?

Dependent claims play a crucial role in claim interpretation and infringement analysis:

  • They narrow the scope of the independent claim they depend on by adding additional limitations.
  • Infringement of a dependent claim automatically implies infringement of its parent claim(s).
  • They can provide fallback positions if the independent claim is found invalid or not infringed.

The MPEP 608.01(n) explains:

“A dependent claim includes all the limitations of the claim from which it depends. The dependent claim is construed to include all the limitations of the independent claim plus those of the dependent claim.”

This principle is essential in patent litigation and licensing negotiations. It means that while a dependent claim is narrower in scope, it can provide additional protection and strategic advantages in enforcing patent rights.

To learn more:

Continuation, divisional, and continuation-in-part (CIP) applications are all types of continuing applications, but they have key differences:

  • Continuation application: Discloses and claims only subject matter disclosed in the prior application. No new matter is added.
  • Divisional application: Results from a restriction requirement in the parent application. Claims an independent and distinct invention carved out of the parent application. No new matter is added.
  • Continuation-in-part (CIP) application: Repeats a substantial portion of the prior application and adds matter not disclosed in the prior application (i.e., new matter is added).

As stated in the MPEP regarding continuation-in-part applications:

A continuation-in-part is an application filed during the lifetime of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.

All three types of applications must claim the benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c) and comply with other requirements set forth in 37 CFR 1.78.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

Business mergers can have significant implications for patent ownership. According to MPEP 314:

Documents of merger are also proper links in the chain of title. They may represent a change of entity as well as a change of name.

This means that when businesses merge, it can result in both a change of the legal entity owning the patent and a change in the name associated with the patent ownership. It’s crucial to properly document these changes to maintain a clear chain of title for the patent.

To learn more:

Benefit claims in Continued Prosecution Applications (CPAs) have some unique characteristics:

  • A CPA automatically includes a specific reference under 35 U.S.C. 120 to the prior application
  • No additional amendment to the specification or application data sheet is required to claim benefit
  • A CPA is considered to reference every application in the chain with the same application number
  • Priority claims under 35 U.S.C. 119(a)-(d) from the parent application automatically carry over to the CPA

The MPEP states: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

It’s important to note that applicants cannot delete benefit claims to certain applications in a chain of CPAs. The MPEP clarifies: Therefore, regardless of whether an application is filed under 37 CFR 1.53(b) or (d), a claim under 35 U.S.C. 120 to the benefit of a CPA is, by operation of 37 CFR 1.53(d)(7) and 37 CFR 1.78(d)(4), a claim to every application assigned the application number of such CPA. In addition, applicants will not be permitted to delete such a benefit claim as to certain applications assigned that application number (e.g., for patent term purposes).

For more information on benefit claims, visit: benefit claims.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Affidavits or declarations filed in a prior application do not automatically become part of a new application. As stated in MPEP ¶ 2.03: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application do not automatically become a part of this application.

To rely on an earlier-filed affidavit or declaration, the applicant must:

  • Make remarks of record in the new application
  • Include a copy of the original affidavit or declaration filed in the prior application

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

The America Invents Act (AIA) introduced changes to assignee prosecution rights for patent applications filed on or after September 16, 2012. According to MPEP 106.01:

[F]or applications filed on or after September 16, 2012, [the assignee of record of the entire interest] can prosecute the application after becoming the applicant under 37 CFR 1.46.

This change allows the assignee of the entire interest to become the applicant and prosecute the application directly. For more detailed information:

  • For applications filed before September 16, 2012, refer to MPEP § 324
  • For applications filed on or after September 16, 2012, refer to MPEP § 325

To learn more:

The America Invents Act (AIA) significantly changed who can be considered a patent applicant for applications filed on or after September 16, 2012. MPEP § 605 outlines these changes:

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign an invention to file and prosecute an application for patent as the applicant, and to permit a person who otherwise shows sufficient proprietary interest in the matter to file and prosecute an application for patent as the applicant on behalf of the inventor.”

Key changes include:

  • Assignees can now be listed as the applicant
  • Persons with sufficient proprietary interest can file on behalf of the inventor
  • The inventor is no longer required to be listed as the applicant

These changes allow for more flexibility in patent application filing and prosecution, particularly benefiting companies and organizations that routinely file patent applications.

To learn more:

How did the ADS format differ for applications filed before September 16, 2012 compared to later applications?

The Application Data Sheet (ADS) format for applications filed before September 16, 2012 (pre-AIA) differed from the format used in later applications. According to MPEP 601.05(b):

For applications filed before September 16, 2012, the Office continued to use the ADS form PTO/SB/14 that was available prior to September 16, 2012.

Key differences in the pre-September 16, 2012 ADS format include:

  • Form number: The pre-AIA ADS used form PTO/SB/14, while post-AIA applications use form PTO/AIA/14.
  • Inventor information: The pre-AIA ADS didn’t require as detailed inventor information as the post-AIA version.
  • Domestic benefit/Foreign priority: The format for claiming these was simpler in the pre-AIA ADS.
  • Assignee information: The pre-AIA ADS had a different section for providing assignee information.
  • Signature requirements: The pre-AIA ADS had different signature requirements compared to the post-AIA version.

It’s important to use the correct ADS form based on your application’s filing date to ensure compliance with USPTO requirements and proper processing of your application.

To learn more:

The Brief Summary of Invention should be concise yet informative. MPEP 608.01(d) provides guidance on the level of detail required: “That is, the subject matter of the invention should be described in one or more clear, concise sentences or paragraphs.” The summary should provide enough information to understand the nature and substance of the invention without delving into excessive technical details. It should focus on the key aspects that distinguish the invention from prior art and align with the claims. The MPEP also notes that “The brief summary, if properly written to set out the exact nature, operation, and purpose of the invention, will be of material assistance in aiding ready understanding of the patent in future searches.” This suggests that while being concise, the summary should be comprehensive enough to facilitate future patent searches and understanding of the invention.

To learn more:

USPTO personnel should use Patent Data Portal to determine the current location or status of an application. For Image File Wrapper (IFW) applications, no location is associated with the file.

As stated in MPEP 102: When it is desired to determine the current location or status of an application, Office personnel should use Patent Data Portal. If the application is an Image File Wrapper (IFW) application, no location is associated with the file.

37 CFR 1.55(i) provides that the requirement for a timely filed certified copy can be satisfied if:

  1. The foreign application was filed in a participating foreign intellectual property office;
  2. The claim for priority is presented in an application data sheet, identifying the foreign application;
  3. The copy of the foreign application is received by the USPTO from the participating foreign intellectual property office, or a certified copy is filed, within the period specified in 37 CFR 1.55(g)(1).

The USPTO website provides information about the priority document exchange program, including participating offices and necessary information for access to foreign applications.

To learn more:

Under 37 CFR 1.55(i), the requirement for a certified copy of the foreign application will be considered satisfied if:

  1. The foreign application was filed in a foreign intellectual property office participating with the USPTO in a bilateral or multilateral priority document exchange agreement;
  2. The claim for priority is presented in an application data sheet, identifying the foreign application and including the information necessary for the participating foreign office to provide the USPTO with access to the foreign application; and
  3. The copy of the foreign application is received by the USPTO from the participating foreign office, or a certified copy is filed, within the time period specified in 37 CFR 1.55(g)(1).

In addition, if the foreign application was not filed in a participating office directly, but a certified copy was filed in an application subsequently filed in a participating office that permits the USPTO to obtain a copy, the applicant must also file a request in a separate document that the USPTO obtain a copy of the foreign application from the participating office. See MPEP 215.01.

While the public cannot request title reports directly, they can obtain patent ownership information through other means. The MPEP notes:

The public can request a certified abstract of title. The fee for this service is set forth at 37 CFR 1.19(b)(4).

Additionally, some assignment records are publicly available. For more information on accessible records, refer to MPEP § 301.01.

To correct or update the name of the applicant after filing:

  1. File a request under 37 CFR 1.46(c)(1) no later than payment of the issue fee
  2. Include an application data sheet (ADS) under 37 CFR 1.76 specifying the correct or updated name of the applicant
  3. Show appropriate markings in the ADS (underlining for additions, strikethrough for deletions)

The MPEP states: Any request to correct or update the name of the applicant after an applicant has been specified under 37 CFR 1.46(b) must include an application data sheet under 37 CFR 1.76 specifying the correct or updated name of the applicant in the applicant information section.

For minor typographical errors detected after payment of the issue fee, either withdraw the application from issue or file a certificate of correction after patent issuance.

To learn more:

If an applicant misses the 12-month deadline for claiming the benefit of a provisional application, they may be able to restore the benefit under certain conditions:

  1. The nonprovisional application must be filed within 14 months of the provisional application’s filing date
  2. A petition under 37 CFR 1.78(b) must be filed in the nonprovisional application
  3. The delay in filing must be unintentional

The MPEP states: “If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

The petition must include:

  • The reference to the provisional application
  • The petition fee
  • A statement that the delay was unintentional

The benefit of a provisional application can be restored if the nonprovisional application is filed within 14 months of the provisional application filing date. To restore the benefit:

  1. File a petition under 37 CFR 1.78(b) in the nonprovisional application
  2. Include the reference to the provisional application in an application data sheet
  3. Pay the petition fee set in 37 CFR 1.17(m)
  4. Provide a statement that the delay in filing was unintentional

As stated in MPEP 211.01(a): “If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

Requesting information about an unpublished patent application requires specific procedures to ensure confidentiality. According to the MPEP:

  • Requests can be made by phone or in person
  • The requester’s identity and right to information must be verified
  • Only certain individuals (applicant, inventor, assignee of record, or attorney/agent of record) may receive detailed information
  • USPTO employees must follow a strict verification process before releasing any information

The MPEP states:

“Except as provided in 35 U.S.C. 122(b), no information concerning pending or abandoned patent applications (except applications which have been published, reissue applications and reexamination proceedings) may be given to the public without appropriate written authorization.”

This ensures that confidential application information is only released to authorized individuals.

For more information on information requests, visit: information requests.

For more information on unpublished applications, visit: unpublished applications.

The process for obtaining copies of assignment records for pending or abandoned applications depends on whether the application is open to the public. The MPEP states:

‘Copies of assignment records relating to pending or abandoned patent applications which are open to the public pursuant to 37 CFR 1.11 or for which copies or access may be supplied pursuant to 37 CFR 1.14 are available to the public.’

For applications that are not open to the public, the process is more restricted:

‘For pending or abandoned applications which are not open to the public pursuant to 37 CFR 1.11 or for which copies or access may not be supplied pursuant to 37 CFR 1.14, information related thereto is only obtainable upon a proper showing of written authority.’

The required written authority varies depending on the application filing date. For applications filed on or after September 16, 2012, it must come from an inventor, applicant, assignee, patent practitioner of record, or someone with written authority from these parties.

Patents and patent applications can be assigned through a written instrument. The MPEP 301 states:

‘Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing.’

This means that patent rights can be transferred from one party to another through a written document. The assignment must be recorded with the USPTO to be effective against subsequent purchasers or mortgagees.

For more information on patent assignment, visit: patent assignment.

For patent applications filed on or after September 16, 2012, joint inventors have more flexibility in executing oaths or declarations. The MPEP states: “For applications filed on or after September 16, 2012, joint inventors may execute separate oaths or declarations in which only the person executing the oath or declaration is identified if an ADS is filed that provides the required inventor information.” This means each inventor can submit their own oath or declaration, naming only themselves, as long as a complete Application Data Sheet (ADS) is filed with all inventor information. However, if such an ADS is not filed, then each oath or declaration must name all of the inventors, as per 37 CFR 1.63(a) and (b).

To learn more:

Joint inventors who are the applicant can appoint a power of attorney in a patent application using Form PTO/AIA/81. This form allows joint inventors to give one or more joint inventor-applicants the power of attorney to sign on behalf of all joint inventor-applicants.

According to the MPEP:

“Form PTO/AIA/81 may be used by joint inventors who are the applicant to give one or more joint inventor-applicants power of attorney to sign on behalf of all joint inventor-applicants. Since powers of attorney must be signed by ‘the applicant,’ all joint inventor-applicants must sign a power of attorney, including the joint inventor(s) who are being given power of attorney.”

For example, if there are four joint inventors (A, B, C, and D) who are all applicants, and they wish to appoint inventor-applicant C as having power of attorney, all four inventors (A, B, C, and D) must sign the power of attorney form appointing C.

It’s important to note that all joint inventor-applicants must sign the power of attorney, even those who are being given the power to act on behalf of the others.

To learn more:

Inventorship in a patent application can be corrected through the following methods:

  1. Filing a request under 37 CFR 1.48 to correct or change inventorship. For applications filed on or after September 16, 2012, this request should include:
    • An application data sheet (ADS) identifying each inventor by their legal name
    • The processing fee set forth in 37 CFR 1.17(i)
    • An oath or declaration for any new inventor who has not yet executed such a document
  2. Filing a continuing application under 37 CFR 1.53 with the correct inventorship

The method chosen may depend on the specific circumstances and timing of the correction. It’s important to note that inventorship corrections should be made promptly once an error is discovered, as timeliness requirements under 37 CFR 1.116 and 37 CFR 1.312 apply.

To learn more:

To learn more:

Tags: inventorship

Inventorship in a Continued Prosecution Application (CPA) for design patents can be corrected by filing a statement requesting the deletion of a named inventor along with the CPA filing. The MPEP states:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This process allows for immediate correction of inventorship when filing a CPA. However, it’s important to note that any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent procedure, visit: patent procedure.

Inventors or applicants can qualify for micro entity status through an institution of higher education in two ways:

  1. If the inventor is an employee of an institution of higher education and obtains the majority of their income from that institution.
  2. If the applicant has assigned, granted, conveyed, or is obligated to assign, grant, or convey a license or other ownership interest in the application to an institution of higher education.

MPEP 509.04(b) states: “Under 37 CFR 1.29(d)(2)(i) the applicant must certify that the applicant’s employer, from which the applicant obtains the majority of the applicant’s income, is an institution of higher education. … Under 37 CFR 1.29(d)(2)(ii) the applicant must certify that the applicant has assigned, granted, or conveyed a license or other ownership interest in the subject application (or is obligated to do so) to such an institution of higher education.”

In both cases, the applicant must also meet the small entity requirement.

To learn more:

How can inventors and joint inventors file patent applications after September 16, 2012?

For patent applications filed on or after September 16, 2012, inventors and joint inventors can file applications in the following ways:

  • An inventor or joint inventor may file an application.
  • A legal representative of a deceased or legally incapacitated inventor may file an application.
  • An assignee, obligated assignee, or person who shows sufficient proprietary interest may file an application.

As stated in MPEP 403.01(a): “For applications filed on or after September 16, 2012, a patent practitioner acting in a representative capacity must have authority to act on behalf of the applicant.” This means that patent practitioners must ensure they have proper authorization before acting on behalf of applicants.

To learn more:

A certificate of correction can be used to perfect a foreign priority claim in the following scenarios:

  1. When the priority claim was timely filed but not included on the patent due to failure to submit a certified copy.
  2. When the priority claim was not timely made, but the correction would not require further examination.

To use a certificate of correction, you must:

  • File a request for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.
  • Include a grantable petition under 37 CFR 1.55(e), (f), or (g) as appropriate.
  • Pay the required fee and provide a showing of good and sufficient cause for the delay, if applicable.

The MPEP states: Where the priority claim required under 37 CFR 1.55 was timely filed in the application but was not included on the patent because the requirement under 37 CFR 1.55 for a certified copy was not satisfied, the patent may be corrected to include the priority claim via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, accompanied by a grantable petition under 37 CFR 1.55(f) or, in the case of a design application, a grantable petition under 37 CFR 1.55(g).

The USPTO allows electronic submission of assignment documents through the Electronic Patent Assignment System (EPAS). According to the MPEP:

  • Visit http://epas.uspto.gov for the EPAS system
  • Include an identified application or patent number
  • Complete one online cover sheet for a single transaction

For electronic submissions, the signature must comply with 37 CFR 3.31(a)(7) or 37 CFR 1.4(d)(2). This typically involves an S-signature between forward slashes (e.g., /John Smith/).

The MPEP notes: The fee set in 37 CFR 1.21(h)(1) for recording an electronically submitted document is currently $0. Customers should check the current fee schedule on the Office website before submitting documents for recordation.

The recordation date for electronic submissions is the date the complete transmission is received by the USPTO.

For more information on electronic submission, visit: electronic submission.

For more information on EPAS, visit: EPAS.

For more information on patent assignment, visit: patent assignment.

The USPTO provides an electronic system for submitting assignment documents. According to MPEP 302.10:

“Assignment documents can be submitted electronically via the Office’s Electronic Patent Assignment System (EPAS).”

EPAS allows for convenient and efficient submission of assignment documents directly to the USPTO.

To learn more:

There are three main ways to submit a patent assignment document to the USPTO:

  1. Mail: Documents can be mailed to the address specified in 37 CFR 3.27: Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450.
  2. Fax: Documents can be submitted via facsimile, as outlined in MPEP 302.09. However, certain documents cannot be faxed, such as assignments submitted with new applications.
  3. Electronic Submission: Documents can be submitted electronically through the Electronic Patent Assignment System (EPAS) as described in MPEP 302.10.

Each method has specific requirements and limitations, so it’s important to review the relevant MPEP sections or consult the USPTO website for detailed instructions.

The USPTO provides an online database for searching patent assignment records. According to MPEP 301.01, ‘Assignment records, digests, and indexes are available in the public search room of the USPTO.’ To search online:

  • Visit the USPTO Patent Assignment Search page
  • Enter relevant information such as patent number, assignee name, or assignor name
  • Review the search results for the desired assignment information

The MPEP states, ‘The assignment records of patents and applications are open to public inspection and copies of these records may be obtained upon request and payment of the fee set forth in 37 CFR 1.19(b)(3).’

The timeliness requirement for submitting certified copies of foreign applications can be satisfied through the Priority Document Exchange program. According to 37 CFR 1.55(i), the requirement will be considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority is presented in an application data sheet with the required information
  • The copy of the foreign application is received by the USPTO from the participating foreign office within the specified time period

The MPEP states, Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Therefore, it’s crucial to verify that the USPTO has received the priority document.

To learn more:

In a continuing application, you can satisfy the requirement for a certified copy of a foreign application without actually filing the certified copy again. According to 37 CFR 1.55(h):

The requirement for a certified copy of the foreign application will be considered satisfied in an application if a prior-filed nonprovisional application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c) contains a certified copy of the foreign application and the prior-filed nonprovisional application is identified as containing a certified copy of the foreign application.

This means that if you have already filed a certified copy in a parent application, you can simply identify that application as containing the certified copy when filing your continuing application. This approach can save time and reduce the paperwork required for perfecting priority claims in continuing applications.

To learn more:

To learn more:

How can I revoke a power of attorney in a patent application filed on or after September 16, 2012?

To revoke a power of attorney in a patent application filed on or after September 16, 2012, you need to follow these steps:

  • Submit a new power of attorney form (PTO/AIA/82) or a revocation form (PTO/AIA/83).
  • The revocation must be signed by the applicant or patent owner.
  • If using form PTO/AIA/82, check the box indicating revocation of all previous powers of attorney.

According to MPEP 402.02(a): “A power of attorney may be revoked only by the applicant or patent owner. An assignee who is not the applicant may revoke a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c).”

It’s important to note that the revocation is not retroactive; it only takes effect when received by the USPTO.

To learn more:

How can I request participation in the priority document exchange program?

To request participation in the priority document exchange (PDX) program, you need to follow specific procedures outlined in MPEP 213.04. Here’s what you need to do:

Applicants may participate in the priority document exchange (PDX) program by requesting that the USPTO retrieve a copy of the foreign application from a participating foreign intellectual property office. Participation in the PDX program is not automatic; a request must be made.

To make a request:

  • Include an authorization to access the priority document in the foreign office’s system
  • Provide sufficient information to identify the foreign application
  • Submit this request within the later of:
    • 16 months from the filing date of the prior foreign application, or
    • 4 months from the actual filing date of the application in which priority is claimed

It’s important to note that the PDX program is only available with participating foreign offices. Always check the current list of participating offices before making a request.

To learn more:

To request expungement of an assignment record, you need to submit a petition to the USPTO. According to MPEP 323.01(d), the petition should:

  • Clearly identify the assignment record document to be expunged
  • State the reason for expungement
  • Include the fee set forth in 37 CFR 1.17(g)
  • Provide a copy of the original assignment record to be expunged (if available)

The petition should be mailed to the Mail Stop Assignment Recordation Services, Director of the USPTO.

To learn more:

Tags: USPTO

To request access to a patent application that is not publicly available, you generally need to file a petition for access. According to 37 CFR 1.14(a)(1)(vii), for applications that are not published, patented, or the subject of a benefit claim in a published application:

A granted petition for access (see paragraph (i)) or a power to inspect (see paragraph (c) of this section) is necessary to obtain the application, or a copy of the application.”

To file a petition for access, you must:

  • Submit the petition with the fee set forth in 37 CFR 1.17(g)
  • Provide a showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access

The petition should be directed to the Office of Patent Legal Administration. The applicant will be given an opportunity to object to the granting of the petition, and the USPTO will make a determination based on the circumstances presented.

For more information on petition for access, visit: petition for access.

How can I request a refund for my USPTO deposit account?

To request a refund for your USPTO deposit account, you need to follow these steps:

  • Submit a written request to the USPTO Office of Finance
  • Include your deposit account number and the amount to be refunded
  • Provide a detailed explanation for the refund request

The MPEP states: “A refund to a deposit account may be made on request to the Office of Finance.” (MPEP 509.01)

It’s important to note that refunds are typically processed for overpayments or erroneous charges. The USPTO will review your request and determine if a refund is warranted based on the circumstances provided in your explanation.

To learn more:

Tags: patent fees

How can I request a corrected patent with a perfected foreign priority claim?

To request a corrected patent with a perfected foreign priority claim after issuance, you need to follow these steps:

  • File a reissue application under 35 U.S.C. 251.
  • Include a petition for an expedited examination of the reissue application.
  • Pay the required fees for both the reissue application and the petition.
  • Submit the necessary documents to perfect the priority claim, such as a certified copy of the foreign application.

As stated in MPEP 216.01: “A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) in an issued patent.” It’s important to note that this process is only available for perfecting priority claims that were timely filed during the pendency of the application.

How can I replenish my USPTO deposit account?

You can replenish your USPTO deposit account through various methods. According to MPEP 509.01, “Deposits to these accounts may be made by electronic funds transfer, credit card, or check.” Here are the options:

  • Electronic Funds Transfer (EFT): This is the preferred method for replenishing deposit accounts.
  • Credit Card: You can use a credit card to add funds to your account.
  • Check: Checks can be mailed to replenish the account balance.

For detailed instructions on each method, visit the USPTO’s Receipts Accounting Policies page.

To learn more:

To regain micro entity status after losing it, you must file a new certification of entitlement to micro entity status. As stated in MPEP 509.04(e):

Once a notification of a loss of entitlement to micro entity status is filed in the application or patent, a new certification of entitlement to micro entity status is required to again obtain micro entity status.

This means you must:

  • Ensure you meet the criteria for micro entity status as defined in 37 CFR 1.29(a) or 1.29(d)
  • File a new certification form (PTO/SB/15A or PTO/SB/15B) in the application or patent
  • Meet all other requirements for micro entity status

To learn more:

Patent assignments can be recorded with the USPTO in two ways:

  1. In the assignment records: This is done as provided in 37 CFR Part 3. Recording provides public notice of the assignment but does not determine its validity.
  2. In the file of a patent application or patent: This may be necessary for the assignee to take action in the application or patent proceeding.

For a patent to issue to an assignee, the assignment must be recorded or filed for recordation in accordance with 37 CFR 3.11.

It’s important to note that recording an assignment in the USPTO’s assignment records does not automatically allow the assignee to take action in a patent proceeding. Additional steps may be required as outlined in MPEP § 325 for applications filed on or after September 16, 2012, or MPEP § 324 for earlier applications.

For more information on patent assignment, visit: patent assignment.

If you want to record a document for additional patents or applications that has already been recorded in the Assignment Division, you must submit a new recordation request. MPEP 315 outlines the required components:

  1. A copy of the original document (which may be the previously recorded papers with the reel and frame numbers stamped by the Assignment Division, or a copy of such papers)
  2. A completed cover sheet (as per 37 CFR 3.31 and MPEP § 302.07)
  3. The appropriate recording fee (as specified in 37 CFR 1.21(h) and 3.41)

Upon receiving these items, the USPTO will assign a new recording date to that submission, update the assignment database, and include the cover sheet and document as part of the official record.

To prove that a joint inventor cannot be found or refuses to sign the patent application, you must provide evidence of your diligent efforts. According to MPEP 409.03(a):

“The application must be accompanied by proof that the nonsigning inventor (1) cannot be found or reached after diligent effort or (2) refuses to execute the application papers.”

For specific guidance on what constitutes acceptable proof, refer to MPEP 409.03(d). This may include documented attempts to contact the inventor, returned mail, or written statements from the unavailable inventor indicating their refusal to sign.

To learn more:

You can petition the USPTO Director to consider correspondence as filed on a particular date if it was returned or refused by the USPS due to a Priority Mail Express® interruption or emergency. The petition process is outlined in 37 CFR 1.10(g) and (h):

  1. File the petition promptly after becoming aware of the return or refusal
  2. Include the original correspondence or a copy showing the Priority Mail Express® mailing label number
  3. Provide a copy of the Priority Mail Express® mailing label showing the “date accepted” (for returned mail)
  4. Include a statement establishing the original deposit attempt and that the correspondence is the original or a true copy
  5. The USPTO may require additional evidence to verify the interruption or emergency

As stated in MPEP 511: “37 CFR 1.10(g) provides a procedure under which applicant may petition the Director to have correspondence that was returned by the USPS due to an interruption or emergency in Priority Mail Express® service considered as filed on a particular date in the Office.”

If your correspondence is affected by a postal emergency, you can petition the Director to consider it filed on a particular date under certain conditions. The process depends on whether your mail was returned, refused, or unable to be deposited. Here’s a summary of the petition requirements based on MPEP 511:

  1. For returned correspondence (37 CFR 1.10(g)):
    • File promptly after becoming aware of the return
    • Include the original or copy of correspondence with Priority Mail Express® label
    • Provide a statement establishing the original deposit
  2. For refused correspondence (37 CFR 1.10(h)):
    • File promptly after becoming aware of the refusal
    • Include the original or copy of correspondence with Priority Mail Express® label
    • Provide a statement establishing the original attempt to deposit
  3. For correspondence unable to be deposited (37 CFR 1.10(i)):
    • File promptly in a manner designated by the Director
    • Include the original or copy of correspondence
    • Provide a statement establishing that the correspondence would have been deposited but for the emergency

For more detailed information on filing these petitions, refer to MPEP § 513, subsections IX-XI.

To learn more:

Any interested party may file a petition, accompanied by the petition fee, to the Director for access to an application. The petition may be filed either with proof of service of copy upon the applicant, or the petition may be filed in duplicate, in which case the duplicate copy will be sent by the Office to the applicant.

The petition should show not only why access is desired, but also why petitioner believes they are entitled to access. The applicant will normally be given a limited period such as 3 weeks within which to state any objection to the granting of the petition for access and reasons why it should be denied. If applicant states that they have no objection to the requested access, the petition will be granted. If objection is raised or applicant does not respond, the petition will be decided on the record.

To petition for access to a confidential patent application, you must file a petition under 37 CFR 1.14(i), which requires:

  1. Payment of the petition fee set forth in 37 CFR 1.17(g)
  2. A showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access

The petition should be filed with the Office of Patent Legal Administration, unless the application is involved in an interference or trial before the Patent Trial and Appeal Board.

You may file the petition either with proof of service upon the applicant, or in duplicate so the USPTO can send a copy to the applicant. The applicant will typically have about 3 weeks to object to the granting of access.

Direct quote: ‘Any petition by a member of the public seeking access to, or copies of, all or part of any pending or abandoned application preserved in confidence pursuant to paragraph (a) of this section, or any related papers, must include: (1) The fee set forth in § 1.17(g); and (2) A showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access to all or part of the application.’ (37 CFR 1.14(i))

How can I pay patent fees to the USPTO?

The USPTO offers several methods for paying patent fees. According to MPEP 509:

“Fees can be paid: (A) by credit card, (B) by electronic funds transfer (EFT), (C) by check, (D) by money order, (E) by deposit account, or (F) in cash (for hand-carried applications only).”

Here’s a breakdown of these payment methods:

  • Credit Card: Accepted online or by mail/fax using Form PTO-2038
  • Electronic Funds Transfer (EFT): Available through the USPTO’s Electronic Filing System (EFS-Web)
  • Check or Money Order: Made payable to the Director of the USPTO
  • Deposit Account: A pre-established account with the USPTO
  • Cash: Only for in-person payments at the USPTO office

For most applicants, online payment methods (credit card or EFT) are the most convenient and efficient options.

To learn more:

Tags: patent fees

How can I pay fees to the USPTO electronically?

The USPTO offers several electronic payment options for paying fees:

  • Credit or Debit Card: You can pay using major credit or debit cards through the USPTO’s secure online system.
  • Electronic Funds Transfer (EFT): This allows for direct transfer from your bank account to the USPTO.
  • USPTO Deposit Account: Maintain a pre-funded account with the USPTO for easy fee payments.

According to MPEP 509, “The Office accepts the following forms of payment: […] by credit card, by electronic funds transfer (EFT), or by a USPTO deposit account.” Electronic payments are convenient and often processed more quickly than other methods.

To learn more:

Tags: USPTO fees

To obtain status information for a patent application, you can:

  1. Check Patent Center or Private Patent Application Information Retrieval (PAIR) on the USPTO website at www.uspto.gov
  2. Contact the Application Assistance Unit (AAU) for applications in pre-examination or post-examination processing via email at HelpAAU@uspto.gov, phone at 571-272-4000 or toll-free at 888-786-0101, or visit their website

If the application has not been published but is pending or abandoned, the AAU will determine if the requester is authorized to receive status information based on their relationship to the application.

Obtaining copies of patent assignment records depends on when the assignment was recorded. According to MPEP 301.01:

  1. For assignments recorded on or after May 1, 1957:
    • Copies can be obtained from the USPTO upon request and payment of the fee set forth in 37 CFR 1.19.
    • The MPEP states: “Requests for abstracts of title for assignments of patents recorded after May 1, 1957, are provided by the Certification Division upon request and payment of fee required in 37 CFR 1.19.”
  2. For assignments recorded before May 1, 1957:
    • These records are maintained by the National Archives and Records Administration (NARA).
    • Requests should be directed to NARA directly.
    • The MPEP advises: “Requests for copies of pre-1957 records for patents should be directed to the National Archives and Records Administration (NARA). Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.”

When requesting copies, be sure to identify the reel and frame number where the assignment is recorded to avoid extra charges for search time.

To learn more:

There are several ways to obtain a foreign filing license:

  1. File a US patent application, which is considered an implicit petition for a license. The filing receipt will indicate if a license is granted.
  2. File an explicit petition for a license under 37 CFR 5.12(b) if no US application has been filed.
  3. Wait 6 months after filing a US application, at which point a license is no longer required (unless a Secrecy Order has been imposed).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

To obtain a copy of a recorded assignment document from the USPTO, you can request a certified copy. According to MPEP 317:

Certified copies of recorded documents may be ordered from the Assignment Division for a fee.

To request a certified copy:

  • Contact the USPTO Assignment Division
  • Provide the necessary information to identify the document
  • Pay the required fee

The USPTO will then provide you with a certified copy of the requested assignment document. This can be useful for legal or business purposes where an official copy of the recorded assignment is needed.

For more information on Assignment Division, visit: Assignment Division.

For more information on certified copies, visit: certified copies.

For more information on USPTO, visit: USPTO.

There are two ways to make a patent assignment of record with the USPTO:

  1. Record the assignment in the USPTO’s assignment records as provided in 37 CFR Part 3. This provides legal notice to the public but does not determine the validity or effect of the assignment.
  2. Make the assignment of record in the file of a patent application, patent, or other patent proceeding. This may be necessary for the assignee to ‘take action’ in the application or proceeding.

For a patent to issue to an assignee, the assignment must be recorded or filed for recordation in accordance with 37 CFR 3.11.

To make a Freedom of Information Act (FOIA) request for USPTO records:

  1. Submit a written request to the USPTO FOIA Officer:
    • Address: United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450
    • Mark the letter and envelope ‘Freedom of Information Act Request’
  2. Describe the requested records in detail:
    • Include specific information such as dates, titles, names, subjects, etc.
    • Provide any known file designations or descriptions
  3. If requesting records about yourself, follow additional requirements in 37 CFR 102.24
  4. If requesting records about another individual, provide either:
    • A written authorization signed by that individual permitting disclosure
    • Proof that the individual is deceased (e.g., death certificate, obituary)

Direct quote: ‘A request for USPTO records that are not customarily made available to the public as part of USPTO’s regular informational services must be in writing, and shall be processed under FOIA, regardless of whether FOIA is mentioned in the request.’ (37 CFR 102.4(a))

Note: Many USPTO decisions are already available on the FOIA section of the USPTO website at www.uspto.gov/learning-and-resources/ip-policy/electronic-freedom-information-act-e-foia.

To properly incorporate material by reference in a patent application:

  1. Use the root words ‘incorporate’ and ‘reference’ (e.g., ‘incorporate by reference’) to express a clear intent to incorporate.
  2. Clearly identify the referenced patent, application, or publication.
  3. For essential material, only incorporate by reference to a U.S. patent or U.S. patent application publication.
  4. For nonessential material, you may incorporate by reference to U.S. patents, U.S. patent application publications, foreign patents, foreign published applications, prior and concurrently filed commonly owned U.S. applications, or non-patent publications.

As stated in 37 CFR 1.57(c): ‘An incorporation by reference must be set forth in the specification and must: (1) Express a clear intent to incorporate by reference by using the root words ‘incorporat(e)’ and ‘reference’ (e.g., ‘incorporate by reference’); and (2) Clearly identify the referenced patent, application, or publication.’

To learn more:

For oaths or declarations filed after the application filing date, MPEP 602.08(c) provides several acceptable methods for identifying the application:

  • Application number (series code and serial number, e.g., 08/123,456)
  • Serial number and filing date
  • International application number
  • International registration number for design applications
  • Attorney docket number on the original specification
  • Title of the invention from the original specification, with reference to an attached specification
  • Title of the invention from the original specification, with a cover letter identifying the application

The MPEP emphasizes that Absent any statement(s) to the contrary, it will be presumed that the application filed in the USPTO is the application which the inventor(s) executed by signing the oath or declaration. This presumption helps ensure proper association of documents with the correct application.

To learn more:

There are two main ways to obtain a receipt for items filed with the USPTO:

  1. For paper filings: Include a self-addressed postcard with your submission, itemizing all components being filed. The USPTO will stamp the receipt date on the postcard and return it.
  2. For electronic filings via EFS-Web or Patent Center: An Electronic Acknowledgement Receipt is automatically generated and sent to the filer.

The MPEP states: ‘If a submitter desires a receipt for any item (e.g., paper or fee) filed in the USPTO by means other than the USPTO patent electronic filing system, it may be obtained by enclosing with the paper a self-addressed postcard specifically identifying the item.’ (MPEP 503)

According to MPEP 102, when it is desired to determine the current location or status of an application, USPTO personnel should use Patent Data Portal. However, it’s important to note that:

“If the application is an Image File Wrapper (IFW) application, no location is associated with the file.”

For public inquiries about application status, the recommended methods are:

  • Checking Patent Center or Private PAIR on the USPTO website
  • Contacting the Application Assistance Unit (AAU) for pre-examination or post-examination processing applications
  • Calling the Technology Center (TC) to which the application is assigned for information about replies or expected Office actions

The assignment of an application to a TC can be determined from Patent Data Portal.

For more information on USPTO Resources, visit: USPTO Resources.

The USPTO provides several ways to find a registered patent attorney or agent, as mentioned in MPEP 401:

  1. Visit the USPTO website: www.uspto.gov/FindPatentAttorney for a searchable listing of registered practitioners.
  2. Write to the Office of Enrollment and Discipline (OED) to request a list of registered patent practitioners in your area:

    Mail Stop OED, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450

These resources can help you locate a qualified patent professional to assist with your patent application.

To file an unintentionally delayed foreign priority claim, you must submit a petition under 37 CFR 1.55(e). The petition must include:

  1. The priority claim (if not previously submitted)
  2. A certified copy of the foreign application (unless previously submitted or an exception applies)
  3. The petition fee set forth in 37 CFR 1.17(m)
  4. A statement that the entire delay was unintentional

MPEP 214.02 states: “If a claim for foreign priority is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

Filing an interim copy of a foreign application electronically can be done through the USPTO patent electronic filing system. The MPEP provides guidance on how to file different parts of the application:

  • Main parts (Abstract, Drawings, Specification, Claims) and the cover sheet can be filed as a single PDF file.
  • Text-only files (e.g., Sequence Listings, Large Tables) can be filed as .txt files.
  • XML files (e.g., Standard ST.26 Sequence Listing) should be filed on a read-only optical disc.

The MPEP states: If not provided as a single paper document, the main parts of the interim copy of the foreign priority application, i.e., Abstract, Drawings, Specification, Claims, and where applicable, the foreign patent office’s equivalent to a ‘Sequence Listing’ (see MPEP § 2421.01 a ‘Sequence Listing XML’ (see MPEP § 2412), ‘Large Tables’ (see MPEP § 608.05(b)), or a ‘Computer Program Listing Appendix’ (see MPEP § 608.05(a)), along with the separate cover sheet required by 37 CFR 1.55(j), may be filed as a single PDF image file via the USPTO patent electronic filing system.

For more information on electronic filing, refer to MPEP § 502.05.

To learn more:

Filing a delayed benefit claim for a provisional application follows a similar process to other delayed benefit claims. According to MPEP 211.04:

“If the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 is not submitted within the required time period, a petition for an unintentionally delayed claim may be filed.”

The petition must include:

  • The reference to the prior provisional application
  • A petition fee
  • A statement that the entire delay was unintentional

It’s important to note that as of December 18, 2013, the amendment containing the specific reference to the earlier filed provisional application no longer needs to be submitted during the pendency of the application.

To learn more:

To ensure your corrected assignment documents are considered timely submitted, the USPTO provides two methods as outlined in MPEP 317.02:

  1. Use the certification procedure under 37 CFR 1.8 (see MPEP § 512)
  2. Use the “Priority Mail Express®” procedure under 37 CFR 1.10 (see MPEP § 513)

The MPEP states:

“The certification procedure under 37 CFR 1.8 (see MPEP § 512) or the “Priority Mail Express®” procedure under 37 CFR 1.10 (see MPEP § 513) may be used for resubmissions of returned papers to obtain the benefit of the date of deposit in the United States Postal Service to establish that the papers were returned within the time period specified.”

By using either of these methods, you can establish that your corrected documents were submitted within the specified time period, thus maintaining the original receipt date as the recording date of the document.

To learn more:

When discussing prior art in your patent application, you should focus on objectively describing the state of the art and how your invention improves upon it. The MPEP 608.01(r) provides guidance:

“The applicant may refer to the general state of the art and the advance thereover made by his or her invention”

Additionally, the MPEP clarifies that “Mere comparisons with the prior art are not considered to be disparaging, per se.” This means you can compare your invention to existing technologies, but do so in a factual, non-judgmental manner that focuses on technical differences and improvements.

To learn more:

Tags: prior art

When filing a Continued Prosecution Application (CPA) for a design patent, you can delete a named inventor by including a statement with your CPA filing. The MPEP ¶ 2.32 states:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This means you should provide a clear statement identifying the inventor(s) to be deleted when submitting your CPA. The USPTO will then acknowledge and process this request, correcting the inventorship accordingly.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

When filing a Continued Prosecution Application (CPA) for a design patent, you can request the deletion of a named inventor by submitting a statement with your CPA filing. The MPEP ¶ 2.32 states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This means that you should include a clear statement requesting the deletion of the specific inventor(s) when you file your CPA. The USPTO will then acknowledge this request and correct the inventorship accordingly.

For more information on design patents, visit: design patents.

For more information on patent procedure, visit: patent procedure.

To delete a named inventor in a Continued Prosecution Application (CPA) for design applications, you must submit a statement requesting the deletion along with the CPA filing. The MPEP states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

It’s important to note that this process is specific to CPA filings for design applications. If you need to delete a named inventor after the CPA has been filed, you must follow a different procedure, as outlined in MPEP ¶ 2.32: “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent procedure, visit: patent procedure.

The process for deleting a benefit claim depends on when your application was filed:

  • For applications filed on or after September 16, 2012: File a corrected Application Data Sheet (ADS) in compliance with 37 CFR 1.76(c) that deletes the reference to the prior-filed application.
  • For applications filed prior to September 16, 2012: Amend the specification (if the benefit claim is in the specification) or submit a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c) to delete references to prior applications.

However, be aware of the following considerations:

  • The examiner will consider whether any new prior art may become available if a benefit claim is deleted.
  • If submitted after final rejection or action, the amendment or ADS will be treated under 37 CFR 1.116.
  • If submitted after the application has been allowed, it will be treated under 37 CFR 1.312.
  • Deleting a benefit claim may affect the publication date of the application.

The MPEP also notes an important caveat:

A cancellation of a benefit claim to a prior application may be considered as a showing that the applicant is intentionally waiving the benefit claim to the prior application in the instant application.

This means that if you later try to reinstate the benefit claim, the USPTO may not accept it as an unintentional delay.

To learn more:

Tags: ADS

To correct the priority claim in an issued patent, you can file a reissue application under 35 U.S.C. 251. The MPEP states:

‘A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) or 35 U.S.C. 120 in the issued patent.’

This process allows you to amend the specification to include the required reference or correct the priority claim itself. However, it’s important to note that the reissue application must be filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f).

To correct inventorship in a nonprovisional patent application, you need to submit a request under 37 CFR 1.48(a). The request should include:

  • A signed application data sheet (ADS) with the correct inventorship information
  • The processing fee set forth in 37 CFR 1.17(i)

As stated in the MPEP, The application data sheet submitted with a request under 37 CFR 1.48(a) must identify the information being changed with underlining for insertions and strike-through or brackets for text removed.

To learn more:

How can I correct information in an Application Data Sheet (ADS) after submission?

To correct information in an Application Data Sheet (ADS) after submission, you must follow specific procedures outlined in the MPEP:

“If an ADS has been previously submitted, the ADS provided with a continuing application, reissue application, or reexamination proceeding should be marked to show the changes from the previously submitted ADS.” (MPEP 601.05(a))

Here’s how to make corrections:

  • Submit a new ADS with clearly marked changes.
  • Use strikethrough for deletions and underlining for insertions.
  • Include all sections of the ADS, not just those being changed.
  • For inventor information changes, comply with 37 CFR 1.48.
  • For benefit claims corrections, see 37 CFR 1.78.

Remember, some changes may require additional forms or fees. Always check the current USPTO guidelines for the most up-to-date requirements.

To learn more:

If your assignment documents or cover sheets are returned by the Assignment Division, you can correct and resubmit them within a specified time period to maintain the original receipt date. The USPTO states:

“Assignment documents and cover sheets, or copies of the same, which are returned by Assignment Division will be stamped with the original date of receipt by the Office and will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

To ensure timely resubmission, you can use either:

It’s important to note that the specified period for resubmission will not be extended, so prompt action is crucial.

To learn more:

To correct an improperly recorded assignment against your patent or application, follow these steps:

  • File a petition under 37 CFR 1.182 to expunge the improper assignment
  • Include evidence that the recorded assignment is improper
  • Pay the required petition fee

As stated in MPEP 323.01(c): ‘The owner of the patent or application may petition to have such an assignment expunged from the assignment records of the Office.’

To learn more:

To correct an improper incorporation by reference in a patent application:

  1. File an amendment to include the material that was improperly incorporated.
  2. Submit a statement that the amendment contains no new matter.
  3. Ensure the correction is made within the time period set by the Office, or no later than the close of prosecution as defined by 37 CFR 1.114(b).

According to 37 CFR 1.57(g): ‘Any insertion of material incorporated by reference into the specification or drawings of an application must be by way of an amendment to the specification or drawings. Such an amendment must be accompanied by a statement that the material being inserted is the material previously incorporated by reference and that the amendment contains no new matter.’

Note that corrections after abandonment require a petition to revive under 37 CFR 1.137, and corrections after patent issuance require a reissue application.

To learn more:

To correct an error in micro entity status, you need to follow the procedure outlined in 37 CFR 1.29(k). This involves:

  • Submitting a separate deficiency payment for each application or patent
  • Providing an itemization of the total deficiency payment
  • Paying the deficiency owed

The MPEP states: 37 CFR 1.29(k) contains provisions for a micro entity that correspond to the provisions of 37 CFR 1.28(c) for a small entity. This means the process is similar to correcting small entity status errors.

To learn more:

How can I correct an error in micro entity status if I’m no longer eligible?

If you discover that you’re no longer eligible for micro entity status, you should promptly notify the USPTO and pay the deficiency in fees. The MPEP states:

“A notification of loss of entitlement to micro entity status must be filed in the application or patent prior to paying, or at the time of paying, any fee after the date on which status as a micro entity is no longer appropriate.” (MPEP 509.04(f))

To correct the error:

  • File a notification of loss of entitlement to micro entity status
  • Pay the deficiency between the micro entity fees paid and the fees that should have been paid
  • Include any required surcharge for the late payment of the fee deficiency

It’s crucial to address this promptly to avoid potential issues with your patent application or granted patent.

To learn more:

To correct an error in a recorded cover sheet, you must follow the procedure outlined in 37 CFR 3.34. Specifically:

  • The error must be apparent when comparing the cover sheet with the recorded document.
  • You must file a corrected cover sheet for recordation.
  • Include a copy of the original document submitted for recording.
  • Pay the required recording fee as set forth in 37 CFR 3.41.

As stated in the MPEP, Any alleged error in a recorded cover sheet will only be corrected if the error is apparent from a comparison with the recorded assignment document. It’s important to carefully review the notice of recordation issued by the Office after recording.

To learn more:

To correct an error in a recorded assignment document at the USPTO, you have two main options:

  • Cover sheet corrections: For errors in the cover sheet data only, you can submit a corrective document identifying the reel and frame number where the assignment is recorded and explaining the correction.
  • Errors in the assignment document: For errors in the actual assignment document, you need to record a corrective document. This can be either a new assignment or other document correcting the original assignment.

As stated in MPEP 323: “The ‘Correction’ box on the Recordation Form Cover Sheet should be checked to indicate that the new submission is to correct an assignment already recorded.”

For more information on assignment correction, visit: assignment correction.

For more information on cover sheet, visit: cover sheet.

For more information on USPTO, visit: USPTO.

If you discover that another party has improperly recorded an assignment or name change against your application or patent, you can correct this error by following the procedure outlined in MPEP 323.01(c):

  1. First, try to contact the party who recorded the erroneous information and request that they record corrective papers.
  2. If unsuccessful, submit the following to the Assignment Services Division:
    • A completed cover sheet identifying the affected application or patent
    • An affidavit or declaration:
      • Identifying yourself as the correct owner
      • Stating that the previously recorded document contained erroneous information
      • Providing the reel and frame number of the incorrectly recorded document
    • The required fee for each application or patent to be corrected

The MPEP advises: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change.

On the corrected cover sheet, check the ‘Other’ box for ‘Nature of Conveyance’ and indicate that you’re correcting an error in a previously recorded document.

To learn more:

To correct a typographical error in a recorded assignment document, you have two main options:

  • Create and record a new document
  • Make corrections to the original document and re-record it

According to MPEP 323.01(b):

If there is an error in the recorded assignment document (or other document affecting title) rather than in the cover sheet, the party responsible for an erroneous document (e.g., the assignor) must either create and record a new document or make corrections to the original document and re-record it.

This means that the assignor (the party transferring the rights) is typically responsible for correcting such errors.

To learn more:

How can I correct a timely submitted benefit claim with errors?

If you’ve submitted a benefit claim within the required time period but it contains errors, you can correct it without filing a petition. According to MPEP 211.02(a):

“A petition under 37 CFR 1.78 and the petition fee would not be required for correcting a timely submitted benefit claim for the following situations: (1) Changing the relationship of the applications (e.g., changing from “continuation” or “divisional” to “continuation-in-part” or from “continuation-in-part” to “continuation” or “divisional”); (2) Changing the filing date of a prior-filed nonprovisional or provisional application; and (3) Changing a benefit claim of a prior-filed provisional application under 35 U.S.C. 120 (e.g., “This application is a continuation of prior-filed provisional application No. —“) to a benefit claim of the same provisional application under 35 U.S.C. 119(e) (e.g., “This application claims the benefit of prior-filed provisional application No. —“) during the pendency of the later-filed application.”

To make these corrections, you should submit a corrected application data sheet (ADS) with the proper markings to show the changes.

To learn more:

If your assignment document is returned by the USPTO Assignment Division, you can correct it as follows:

  • The returned document will be stamped with the original receipt date.
  • It will come with a letter specifying a time period for correction and resubmission.
  • If resubmitted within this period, the original receipt date may be considered the recording date.
  • You can use the certification procedure (37 CFR 1.8) or “Priority Mail Express” (37 CFR 1.10) for resubmission.
  • If not corrected within the specified period, the new submission date will be the recording date.

MPEP 317.02 states: “If the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

If you receive a filing receipt with missing or incorrect benefit claim information, you can request a corrected filing receipt. However, the Office will only grant such a request if the proper reference to the prior application is included:

  • For applications filed on or after September 16, 2012: in an Application Data Sheet (ADS)
  • For applications filed prior to September 16, 2012: in the first sentence(s) of the specification or an ADS

This reference must be made within the time period required by 37 CFR 1.78, with a few exceptions. As stated in the MPEP:

The Office may notify applicants on or with the filing receipt that a benefit claim may not have been recognized because the benefit claim was improper but applicants are advised that only the benefit claims that are listed on the filing receipt have been recognized by the Office.

It’s crucial to review your filing receipt promptly and carefully to avoid the need for a petition and associated fees.

To learn more:

How can I correct a defective inventor’s oath or declaration after paying the issue fee?

Correcting a defective inventor’s oath or declaration after paying the issue fee requires specific procedures. According to the MPEP:

If an oath or declaration filed after the date the issue fee was paid is defective, applicant must file a petition under 37 CFR 1.313 to withdraw the application from issue and a renewed petition under 37 CFR 1.137 to revive the application.

The process involves:

  1. Filing a petition to withdraw the application from issue under 37 CFR 1.313
  2. Filing a renewed petition to revive the application under 37 CFR 1.137
  3. Submitting a corrected oath or declaration
  4. Paying any required fees

For detailed guidance, refer to MPEP 602.03.

To learn more:

Tags: issue fee

Confirming receipt of your priority document by the USPTO through the Priority Document Exchange (PDX) program is crucial. The MPEP emphasizes this responsibility:

Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Accordingly, applicants are encouraged to check as necessary to confirm receipt by the Office of appropriate documents.

To verify receipt, you can check the Patent Application Information Retrieval (PAIR) system. Priority documents retrieved through PDX will have the document description: Priority documents electronically retrieved by USPTO from a participating IP Office.

If you don’t see this confirmation, you may need to follow up with the USPTO or consider submitting a certified copy directly to ensure your priority claim is properly documented.

To learn more:

When claiming priority to a foreign application filed in a non-English language, you must provide an English translation of the foreign application. The MPEP 213.02 states:

If the foreign application is not in the English language, an English translation of the foreign application is also required. See 37 CFR 1.55(g)(3).

Additionally, you must submit:

  • A statement that the translation is accurate
  • The certified copy of the foreign application

These documents should be filed within the prescribed time period to properly establish the priority claim.

To learn more:

You can check the status of your patent application through several methods:

  • Patent Center: This platform provides information on issued patents, published patent applications, and applications claiming domestic benefit.
  • Private PAIR (Patent Application Information Retrieval): For unpublished applications, applicants or their registered representatives can securely track progress. Note that a Customer Number must be associated with the application for access.
  • Application Assistance Unit (AAU): For general inquiries, you can contact the AAU directly.

As stated in the MPEP: Status information relating to patent applications is available through Patent Center and the Patent Application Information Retrieval (PAIR) system. (MPEP 203.08)

For most up-to-date information, the MPEP recommends: Applicants and other persons seeking status information regarding an application should check Patent Center on the Office website at www.uspto.gov/patents/apply/patent-center.

To learn more:

To find out if the USPTO is officially closed on any particular day, you can:

  • Call 1-800-PTO(786)-9199
  • Call (571) 272-1000

These phone numbers are provided in MPEP 510 for obtaining information about USPTO closures.

To check if the United States Patent and Trademark Office (USPTO) has received your priority document through the Priority Document Exchange (PDX) program, you should monitor your application status. As stated in MPEP 215.02(a):

Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Accordingly, applicants are encouraged to check as necessary to confirm receipt by the Office of appropriate documents.

You can check the status of your priority document in several ways:

  1. Check the Patent Application Information Retrieval (PAIR) system for your application.
  2. Look for the document description: “Priority documents electronically retrieved by USPTO from a participating IP Office.”
  3. Contact the USPTO directly if you’re unsure about the status.

It’s important to verify receipt of the priority document to ensure compliance with the requirements for claiming priority to a foreign application.

For more information on foreign application, visit: foreign application.

For more information on PAIR system, visit: PAIR system.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For more information on USPTO, visit: USPTO.

The process for changing the correspondence address in a patent application filed before September 16, 2012, depends on whether an oath or declaration has been filed:

  • Before filing an oath or declaration: The correspondence address can be changed by the party who filed the application, including the inventor(s), any patent practitioner named in the transmittal papers, or the assignee who filed the application.
  • After filing an oath or declaration: The correspondence address can be changed by a patent practitioner of record, an assignee as provided under pre-AIA 37 CFR 3.71(b), or all of the applicants, unless there’s an assignee of the entire interest who has taken action in the application.

As stated in MPEP 601.03(b): “Where a correspondence address has been established on filing of the application or changed pursuant to pre-AIA 37 CFR 1.33(a)(1) (prior to the filing of an executed oath or declaration under pre-AIA 37 CFR 1.63 by any of the inventors), that correspondence address remains in effect upon filing of an executed oath or declaration under pre-AIA 37 CFR 1.63 and can only be subsequently changed pursuant to pre-AIA 37 CFR 1.33(a)(2).”

To learn more:

How can I change the correspondence address for multiple patent applications?

Changing the correspondence address for multiple patent applications can be efficiently done using the USPTO’s Customer Number practice. Here’s how:

  1. Obtain a customer number if you don’t already have one.
  2. Associate your patent applications with the customer number.
  3. Update the address linked to the customer number.

The MPEP explains:

A Customer Number may be used to: … (2) change the correspondence address, fee address, or list of practitioners of record for a plurality of applications or patents through a single request. (MPEP 403)

This process eliminates the need to file separate change of address forms for each application, saving time and reducing the risk of errors. To make changes, use the USPTO’s Electronic Filing System (EFS-Web) or file a written request with the USPTO.

For more information on Customer Number, visit: Customer Number.

The process for challenging an examiner’s new matter rejection depends on where the alleged new matter appears:

  • For amendments to the specification: If the new matter is confined to amendments in the specification, you can file a petition to review the examiner’s requirement for cancellation.
  • For new matter in claims: If the alleged new matter affects the claims, leading to their rejection, the issue becomes appealable and should not be considered on petition.

As stated in MPEP 608.04(c):

“Where the new matter is confined to amendments to the specification, review of the examiner’s requirement for cancelation is by way of petition. But where the alleged new matter is introduced into or affects the claims, thus necessitating their rejection on this ground, the question becomes an appealable one, and should not be considered on petition even though that new matter has been introduced into the specification also.”

This distinction is important because it determines the appropriate procedure for challenging the examiner’s decision.

To learn more:

To authorize the USPTO to retrieve your priority document through the Priority Document Exchange (PDX) program, you need to follow these steps:

  • File a signed Request to Retrieve Electronic Priority Application(s) (PTO/SB/38 form) or an equivalent request.
  • Submit this request before the USPTO sends a notice indicating that the certified copy of the priority document is required.

As stated in MPEP 215.01, Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed by the time of patent grant as required under 37 CFR 1.55(g). It’s important to note that even if you authorize the USPTO to retrieve the document, you should monitor the process to ensure successful retrieval.

To learn more:

If a patent application has been published pursuant to 35 U.S.C. 122(b), then a copy of the specification, drawings, and all papers relating to the file of that published application (whether abandoned or pending) may be provided to any person upon written request and payment of the fee set forth in 37 CFR 1.19(b). See 37 CFR 1.14(a)(1)(ii) and (iii).

Published applications maintained in the Image File Wrapper (IFW) system are available on the USPTO website in Patent Center.

Pre-1957 patent assignment records are maintained by the National Archives and Records Administration (NARA), not the USPTO. According to MPEP 301.01:

“All assignment records from 1837 to April 30, 1957 for patents are now maintained and are open for public inspection in the National Archives Research Room located at the Washington National Records Center Building, 4205 Suitland Road, Suitland, Maryland 20746 and at the Civilian Records Division of the National Archives at College Park, 8601 Adelphi Road, College Park, MD 20740-6001.”

To access these records:

  • Visit the National Archives website at www.archives.gov for information on how to obtain records from these locations.
  • Be prepared to pay fees required by NARA for copies of records.
  • Note that assignment records from before 1837 are not available.

The MPEP advises: “Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.”

To learn more:

Tags: NARA

Patent assignment records can be accessed online through the USPTO’s Assignment Search database. The MPEP states: Assignment records that affect the title of patents and patent applications are recorded in the USPTO’s Assignment Recordation Branch. To access these records:

  • Visit the USPTO Assignment Search website
  • Enter the relevant patent or application number, assignee name, or other search criteria
  • Review the search results for assignment information

This online database provides public access to assignment records, allowing for easy verification of patent ownership.

For patent application information not available through Public PAIR, you can submit a request to the USPTO under the Freedom of Information Act (FOIA). Here’s how to proceed:

  1. Submit a written request to the USPTO’s FOIA Officer.
  2. Clearly identify the records you’re seeking.
  3. Explain why you believe the information should be disclosed if it’s not typically available to the public.
  4. Be prepared to pay any applicable fees for search and duplication.
  5. Wait for the USPTO to process your request and respond, which may take several weeks.

Note that certain information may still be withheld if it falls under FOIA exemptions or is protected by other statutes.

Access to unpublished patent application files is generally restricted. According to MPEP 103:

‘Unpublished abandoned applications are not open to public inspection.’

However, there are exceptions:

  • If the application is referenced in a U.S. patent application publication or patent
  • If written authority from the applicant, assignee, or attorney/agent of record is provided
  • If a petition for access is granted

To request access, you may need to file a petition with the USPTO, demonstrating a need or right to access the application.

For more information on Patent application access, visit: Patent application access.

For more information on unpublished applications, visit: unpublished applications.

Access to information about unpublished patent applications is generally restricted. However, according to MPEP 101, there are specific circumstances under which such information may be accessed:

  1. If you are the applicant, an inventor, the assignee of record, or the attorney or agent of record, you may be able to access information about the application.
  2. If the application is identified in a published patent document or in another application as specified in 37 CFR 1.14(a)(1)(i) through (a)(1)(vi), certain status information may be available to the public.
  3. In some cases, a petition for access or a power to inspect may be required to access information about an unpublished application.

It’s important to note that the USPTO has strict procedures for verifying the identity and authority of individuals requesting information about unpublished applications to maintain confidentiality.

For more information on unpublished applications, visit: unpublished applications.

For more information on USPTO procedures, visit: USPTO procedures.

Access to unpublished abandoned patent applications is limited. According to 37 CFR 1.14(a)(1)(iv), the file contents of an unpublished abandoned application may be made available to the public if:

  • The application is identified in a U.S. patent, statutory invention registration, U.S. patent application publication, international publication of an international application, or publication of an international registration designating the U.S.
  • Benefit of the abandoned application is claimed under 35 U.S.C. 119(e), 120, 121, 365, or 386(c) in an application that has been published or patented.

To obtain access, a written request must be submitted along with payment of the appropriate fee set forth in 37 CFR 1.19(b).

Reissue application files are generally open to public inspection. According to 37 CFR 1.11(b):

  • Reissue applications are open to inspection by the general public
  • The filing of reissue applications (except for continued prosecution applications under 37 CFR 1.53(d)) is announced in the Official Gazette
  • The announcement includes details such as filing date, reissue application and original patent numbers, title, inventor name, and examining group

For Image File Wrapper (IFW) reissue applications:

  • Files are open to inspection by the general public through Patent Center via the USPTO website
  • Members of the public can view the entire content of the reissue application file history online

Direct quote: ‘All reissue applications, all applications in which the Office has accepted a request to open the complete application to inspection by the public, and related papers in the application file, are open to inspection by the public, and copies may be furnished upon paying the fee therefor.’ (37 CFR 1.11(b))

Foreign assignees can designate a domestic representative for USPTO correspondence as outlined in 35 U.S.C. 293 and 37 CFR 3.61. The MPEP states:

An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative.

Key points for this designation:

  • It should be submitted as a separate paper from any assignment document
  • It should be clearly labeled ‘Designation of Domestic Representative’
  • It will be entered into the record of the appropriate application or patent file
  • It must be signed in accordance with 37 CFR 1.33(b)
  • It should state the name and address of a person residing within the United States

This designation allows for service of process or notice of proceedings affecting the patent or rights under the patent to be served on the designated representative.

For more information on domestic representative, visit: domestic representative.

For more information on foreign assignee, visit: foreign assignee.

For more information on USPTO correspondence, visit: USPTO correspondence.

Applicants can find a new registered patent attorney or agent through resources provided by the USPTO. According to MPEP § 407: “Applicants may obtain a list of registered patent attorneys and agents located in their area by consulting the USPTO website, https://oedci.uspto.gov/OEDCI/, or by calling the Office of Enrollment and Discipline at (571) 272-4097.” These resources allow applicants to search for qualified practitioners who can represent them before the USPTO.

For more information on USPTO Resources, visit: USPTO Resources.

When an applicant’s patent attorney or agent is suspended, they can find a new registered patent attorney or agent by:

  1. Consulting the USPTO website at https://oedci.uspto.gov/OEDCI/
  2. Calling the Office of Enrollment and Discipline at (571) 272-4097

This information is provided in Form Paragraph 4.07 of MPEP § 407.

To ensure successful retrieval of priority documents under PDX, applicants should follow these guidelines from MPEP 215.01:

Applicants are strongly encouraged to cite the foreign application using an acceptable format (see MPEP § 214.04) and use proper and consistent citation format throughout the U.S. application.

Key points for successful retrieval include:

  • Provide proper, complete, and consistent citations of foreign priority applications and filing dates.
  • Use an acceptable format for citing foreign applications (refer to MPEP § 214.04).
  • Ensure the foreign priority claim is complete to prevent retrieval issues.
  • Check the Private Patent Application and Information Retrieval (PAIR) system to confirm successful retrieval.

Remember, a successful retrieval typically takes about one week to complete.

To learn more:

To ensure successful retrieval of foreign applications through PDX, applicants should:

  • Provide proper and consistent citation of the foreign priority application and its filing date
  • Use an acceptable format for citing the foreign application (see MPEP § 214.04)
  • Ensure the foreign priority claim is complete

The MPEP emphasizes the importance of correct citations:

An improper, incomplete, or inconsistent citation of a foreign priority application and/or its filing date will result in a delay or prevent retrieval under the Priority Document Exchange program.

Applicants are encouraged to check the Private PAIR system to confirm successful retrieval of their foreign priority application.

To ensure that references from the international search report are printed on the resulting patent, applicants must provide a separate listing of these references. According to MPEP 609.03:

“In order to have the references printed on such resulting patent, a separate listing, preferably on a PTO/SB/08 form, must be filed within the set period for reply to this Office action.”

This separate listing should be submitted within the set period for reply to the Office action or, if the application is ready for allowance, within ONE MONTH of the mailing date of the Notice of Allowability. It’s important to note that no extension of time will be granted to comply with this requirement if the application is ready for allowance.

To learn more:

Applicants can avoid the need for preliminary amendments in patent applications by following the guidance provided in MPEP 608.04(b):

Applicants can avoid the need to file a preliminary amendment by incorporating any desired amendments into the text of the specification, even where the application is a continuation or divisional application of a prior-filed application.

This approach involves directly including any necessary changes or additions in the original specification text when preparing the application. By doing so, applicants can ensure that all desired content is present from the initial filing, eliminating the need for separate preliminary amendments. This method is recommended for all types of applications, including continuations and divisionals, to streamline the application process and reduce potential processing delays.

To learn more:

The MPEP outlines the process for adding an omitted inventor to a patent application under 35 U.S.C. 116(b):

  1. If a joint inventor refuses to join or cannot be reached, the application can be made by the other inventor(s).
  2. The Director of the USPTO may grant the patent to the applying inventor(s), subject to the omitted inventor’s rights.
  3. The omitted inventor can subsequently join the application.

Additionally, 35 U.S.C. 116(c) allows for correction of errors in naming inventors: Whenever through error a person is named in an application for patent as the inventor, or through an error an inventor is not named in an application, the Director may permit the application to be amended accordingly, under such terms as he prescribes.

To learn more:

To learn more:

To correct or update an inventor’s name in a nonprovisional patent application:

  1. File a request under 37 CFR 1.48(f).
  2. Include an Application Data Sheet (ADS) identifying each inventor by their legal name.
  3. Pay the processing fee set forth in 37 CFR 1.17(i).

According to MPEP § 602.08(b), “Any request to have the name of the inventor or a joint inventor in a nonprovisional application corrected or updated, including correction of a typographical or transliteration error in the spelling of an inventor’s name, must be by way of a request under 37 CFR 1.48(f).

For provisional applications, use 37 CFR 1.48(d) instead. If the error is discovered after the issue fee is paid, either withdraw the application and submit an RCE or file a certificate of correction after the patent issues.

To learn more:

An inventor’s access to their patent application can be restricted, but it requires a specific process. According to MPEP 106, “Any request to prevent the inventor from obtaining access to the file should be filed as a separate paper, 37 CFR 1.4(c), and should be directed to the Office of Petitions.”

If the request is granted, the inventor will be informed that they can only inspect the application if they can show why such inspection is necessary to conserve their rights. It’s important to note that this restriction is temporary. Once the application is published under 35 U.S.C. 122(b), it becomes publicly available, and any previously granted restrictions on the inventor’s access will no longer be in effect.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

Inventors or applicants can control access to their patent application by assignees through explicit consent or denial. As outlined in MPEP 106.01, the applicant has the right to decide whether to grant or deny access to the application, especially in cases involving part interest assignees. This control mechanism allows inventors to protect sensitive information or maintain strategic advantage during the patent prosecution process. Applicants can communicate their consent or denial of access to the USPTO, which will then enforce these preferences regarding application inspection.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP) application, inventors must follow specific procedures. As noted in MPEP ¶ 2.06:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This involves properly referencing the prior application in the CIP application and ensuring that the CIP is filed before the patenting, abandonment, or termination of proceedings on the prior application. It’s crucial to follow the guidelines in MPEP § 211 for claiming domestic benefit.

For more information on domestic benefit, visit: domestic benefit.

While it’s uncommon, there is a process for restricting an inventor’s access to their patent application. According to MPEP 106:

Any request to prevent the inventor from obtaining access to the file should be filed as a separate paper, 37 CFR 1.4(c), and should be directed to the Office of Petitions. If the request is granted, the inventor will be informed that he or she will only be permitted to inspect the application on sufficient showing why such inspection is necessary to conserve his or her rights.

This process requires a specific request and justification. It’s important to note that such restrictions are temporary, as the MPEP also states, Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

An inventor can be deleted from a Continued Prosecution Application (CPA) for design patents by submitting a statement requesting the deletion at the time of filing the CPA. The MPEP states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This process allows for the correction of inventorship at the time of filing the CPA. However, it’s important to note that if you need to delete an inventor after the CPA has been filed, you must follow a different procedure, as stated in the MPEP: “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

For more information on CPA, visit: CPA.

Tags: CPA

An heir of a deceased inventor can file a patent application under certain conditions. The MPEP 409.01(b) states:

If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or heirs of the deceased inventor.

To file the application, the heir should:

  • Obtain legal recognition as the heir or legal representative
  • File the application on behalf of the deceased inventor
  • Provide documentation proving their status as heir or legal representative
  • Complete the necessary oath or declaration

It’s advisable to consult with a patent attorney to ensure all legal requirements are met.

To learn more:

An attorney or agent who has been given power of attorney can withdraw by submitting a request to the USPTO. According to MPEP 402.06:

nn

“A registered patent attorney or patent agent who has been given a power of attorney pursuant to § 1.32(b) may withdraw as attorney or agent of record upon application to and approval by the Director.”

nn

The request should briefly state the reason(s) for withdrawal. If based on issues like lack of compensation, it’s recommended to cite “irreconcilable differences” to maintain client confidentiality. The withdrawal is effective when approved by the USPTO, not when received.

nn

Practitioners must take steps to protect the client’s interests when withdrawing, such as giving reasonable notice and allowing time to hire new counsel. The Request for Withdrawal As Attorney or Agent form (PTO/AIA/83) can be used.

For more information on patent representation, visit: patent representation.

For more information on power of attorney, visit: power of attorney.

How can an associate power of attorney be given in applications filed before September 16, 2012?

For applications filed before September 16, 2012, an associate power of attorney can be given by a principal attorney or agent to one or more associate attorneys or agents. According to MPEP 402.02(b):

“For applications filed before September 16, 2012, a power of attorney may be given to one or more attorneys or agents. (37 CFR 1.32(c)(1)). A principal attorney or agent may appoint an associate attorney or agent.”

The associate power of attorney must be signed by the principal attorney or agent who was appointed in the application. It’s important to note that the associate power does not have to be approved by the Office and becomes effective upon submission.

To learn more:

The MPEP outlines two ways to make an assignment of record with the USPTO:

  1. Recording in the USPTO assignment records: ‘An assignment can be made of record in the assignment records of the Office as provided for in 37 CFR Part 3. Recordation of the assignment provides legal notice to the public of the assignment.’
  2. Filing in a specific application or patent file: ‘An assignment can be made of record in the file of a patent application, patent, or other patent proceeding (e.g., reexamination proceeding).’

The MPEP notes: ‘Recordation of an assignment in the assignment records of the Office does not, by itself, permit the assignee to take action in the application, patent, or other patent proceeding.’

It’s important to understand the differences between these methods and their respective purposes in patent proceedings.

For applications filed on or after September 16, 2012, an assignee must first become the applicant under 37 CFR 1.46(c) to revoke a previously given power of attorney and/or grant a new one. This is because, as stated in the MPEP, any power of attorney must be signed by the applicant or patent owner. The process involves:

  • The assignee becoming the applicant
  • Revoking the previous power of attorney
  • Granting a new power of attorney

For more details on establishing the right of an assignee to take action, refer to MPEP § 325.

To learn more:

How can an assignee establish the right to take action in a pre-AIA application?

For pre-AIA applications (filed before September 16, 2012), an assignee can establish the right to take action by:

  1. Filing papers in the USPTO demonstrating the chain of title from the inventor to the assignee, or
  2. Specifying in the papers requesting or taking action that action is being taken pursuant to a specific 37 CFR provision.

According to MPEP 324: “The assignee must establish its ownership of the property to the satisfaction of the Director. The chain of title from the inventor to the assignee must be clearly established.” This typically involves submitting assignment documents or other evidence of ownership to the USPTO.

For more information on assignee rights, visit: assignee rights.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

To ensure assignee information appears on an issued patent, the assignee must comply with 37 CFR 3.81(b). This regulation outlines the specific requirements for including assignee data on a patent.

According to MPEP 307, the assignee should:

  • Submit a request for issuance of the application in the name of the assignee
  • Provide the appropriate documentary evidence of ownership (e.g., assignment for patent)
  • Specify the assignee’s name and address

The MPEP states: A request for a patent to be issued to an assignee submitted pursuant to 37 CFR 3.81(b) must state that the document required by 37 CFR 3.81(b) is being submitted to OPAP in order to request that the patent be issued to an assignee.

It’s crucial to follow these steps accurately to ensure the assignee information is properly recorded and appears on the issued patent.

For more information on assignee information, visit: assignee information.

For more information on patent issuance, visit: patent issuance.

An assignee can become the applicant for a patent application by following these steps:

  1. File the application under 37 CFR 1.46
  2. Include an application data sheet (ADS) under 37 CFR 1.76 specifying the assignee as the applicant in the applicant information section
  3. Record documentary evidence of ownership (e.g., assignment) as provided in 37 CFR part 3 no later than the date the issue fee is paid

The MPEP states: If the applicant is the assignee or person to whom the inventor is under an obligation to assign the invention, the documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for an obligated assignee) should be recorded as provided for in 37 CFR part 3 no later than the date the issue fee is paid.

To learn more:

For applications filed on or after September 16, 2012:

  • The other joint inventor(s) may file the application on behalf of themselves and the non-signing inventor.
  • A substitute statement can be filed in lieu of an oath or declaration for the non-signing inventor.

As stated in MPEP § 409.02: “If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the other joint inventor or inventors may make the application for patent on behalf of themselves and the omitted inventor.”

For more information on substitute statement, visit: substitute statement.

How can an applicant revoke a power of attorney?

An applicant can revoke a power of attorney by submitting a new power of attorney (Form AIA/82 for applications filed on or after September 16, 2012, or Form PTO/SB/80 for applications filed before September 16, 2012) or by submitting a revocation signed by the applicant. As stated in the MPEP:

“A power of attorney may be revoked at any stage in the proceedings of a case, and an applicant may appoint a new attorney or agent at any stage in the proceedings of the case by filing a new power of attorney.” (MPEP 402)

It’s important to note that the revocation should be clear and unambiguous, and it should be submitted to the USPTO for proper processing.

For more information on power of attorney, visit: power of attorney.

For more information on revocation, visit: revocation.

How can an applicant revoke a power of attorney in a patent application?

An applicant can revoke a power of attorney in a patent application by submitting a new power of attorney or by filing a revocation signed by the applicant. According to MPEP 601.02:

“A power of attorney may be revoked at any stage in the proceedings of a case, and a power of attorney to a subsidiary prior organization is revoked by a power to a primary organization.”

It’s important to note that:

  • The revocation should be clear and unambiguous
  • A new power of attorney automatically revokes the previous one
  • The revocation should be signed by the applicant or assignee of the entire interest

After revocation, the USPTO will communicate directly with the applicant or the newly appointed attorney/agent.

To learn more:

For patent applications filed before September 16, 2012, an applicant can revoke a power of attorney using Form PTO/SB/81. According to MPEP 402.05(b), “Form PTO/SB/81 may be used to revoke a power of attorney in an application filed before September 16, 2012.” The revocation can be done at any stage of the proceedings by an applicant for patent or an assignee of the entire interest of the applicant.

It’s important to note that fewer than all of the applicants or assignees may revoke the power of attorney only upon showing sufficient cause and paying a petition fee. The patent practitioner will be notified of the revocation, and the notice will be mailed to the correspondence address for the application in effect before the revocation.

To learn more:

How can an applicant revoke a power of attorney filed on or after September 16, 2012?

An applicant can revoke a power of attorney filed on or after September 16, 2012, by following these steps:

  • Submit a new power of attorney (Form AIA/82 or equivalent) that is properly executed by the applicant.
  • File a revocation of the previous power of attorney. This can be done using the revocation form PTO/AIA/82A or by submitting a clear instruction to revoke the previous power of attorney.

According to MPEP 402.02(a):

“The power of attorney may be revoked by filing a revocation of power of attorney. The revocation may be signed by the applicant for patent (all parties identified as the applicant or invention) or the patent owner. A new power of attorney from the applicant for patent (all parties identified as the applicant) or the patent owner may also be filed, which will act as a revocation of the previous power.”

It’s important to note that the new power of attorney must be properly executed by all applicants to be effective in revoking the previous power of attorney.

To learn more:

An applicant can restore the right of priority if the U.S. application is filed after the 12-month deadline (or 6-month deadline for design applications) but within 2 months of the expiration of that period. This can be done through a petition process, provided the delay was unintentional.

According to MPEP 213.03: “As provided in 37 CFR 1.55(c), if the subsequent application has a filing date which is after the expiration of the twelve-month period (or six-month period in the case of a design application), but within two months from the expiration of the period, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.55(c), if the delay in filing the subsequent application within the period was unintentional.”

The petition to restore the right of priority must include:

  • The priority claim identifying the prior foreign application
  • The petition fee
  • A statement that the delay in filing was unintentional

The USPTO may require additional information to establish that the delay was unintentional.

For more information on foreign priority, visit: foreign priority.

For more information on priority restoration, visit: priority restoration.

For more information on unintentional delay, visit: unintentional delay.

When an applicant receives a Notice of Omitted Items for missing specification pages, they have several options to respond:

  • Submit the omitted pages: The applicant can submit the missing pages within the given time period.
  • Assert no omission occurred: If the applicant believes no pages were actually omitted, they can state this in writing.
  • Rely on incorporation by reference: If the application claims priority to a prior-filed application containing the omitted material, the applicant can rely on incorporation by reference.

The MPEP 601.01(d) states:

If applicant contends that the omitted pages were in fact deposited in the USPTO with the application papers, applicant must file a petition to establish the filing date of the omitted pages. Such a petition would normally be granted only if: (A) the USPTO received and date-stamped the pages in question on the date of deposit; or (B) applicant has produced an itemized postcard receipt which specifically lists the omitted pages as having been deposited on the missing parts’ due date.

It’s crucial to respond within the given time period to avoid potential issues with the application’s filing date.

To learn more:

An applicant can request review of a refusal to accord a filing date by filing a petition. The MPEP states:

Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)). Petitioner should provide any arguments that he or she has that the items noted were not missing or that a filing date should be assigned in the absence of such items if they are believed to be unnecessary.

The petition should be marked to the attention of the Office of Petitions. If the applicant believes no defect exists, they may include a request for refund of the petition fee in the petition.

To rely on an affidavit or declaration from a prior application, an applicant must take specific steps. According to MPEP ¶ 2.03:

“Where it is desired to rely on an earlier-filed affidavit or declaration, the applicant should make the remarks of record in this application and include a copy of the original affidavit or declaration filed in the prior application.”

To rely on a prior affidavit or declaration, an applicant should:

  • Make remarks of record in the new application, referencing the prior affidavit or declaration
  • Include a copy of the original affidavit or declaration from the prior application in the new application

This ensures that the examiner is aware of the prior evidence and can consider it in the context of the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

Under pre-AIA 37 CFR 1.47(b), an applicant can prove irreparable damage by providing a statement that demonstrates the necessity of a filing date. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This statement should explain why obtaining a specific filing date is crucial for preserving the applicant’s rights or preventing significant harm to their interests.

To learn more:

To learn more:

How can an applicant proceed if an inventor is deceased?

If an inventor is deceased, the applicant can proceed with the patent application by filing a petition under 37 CFR 1.47(b). The MPEP states:

“When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or heir of the inventor upon proper intervention.”

To file the petition, the applicant must:

  • Submit the petition fee set forth in 37 CFR 1.17(g)
  • Provide proof of the inventor’s death, such as a death certificate
  • Include an oath or declaration by the legal representative or heir

The legal representative or heir should state their relationship to the deceased inventor and that they are the legal representative or heir.

To learn more:

To learn more:

An applicant or patent owner can revoke a power of attorney in a patent application filed on or after September 16, 2012 by following these steps:

  • Submit a revocation signed by the applicant or patent owner
  • Include a new power of attorney signed by the applicant or patent owner

According to MPEP 601.03(a):

“The revocation and new power of attorney may be combined in a single paper.”

It’s important to note that the revocation must be signed by the applicant or patent owner, not by a practitioner acting on their behalf.

To learn more:

How can an applicant obtain specific information about their patent application status?

While the USPTO limits the information provided over the phone, applicants have other methods to obtain detailed status information. MPEP 203.08 suggests:

“Applicants can obtain more information using the Patent Application Information Retrieval (PAIR) system. PAIR provides customers direct secure access to their own patent application status information, as well as to general patent information publicly available.”

Applicants can use Private PAIR to access confidential application information, including filing dates, office actions, and current status. For applications not yet published, this is the primary method for obtaining detailed status information.

To learn more:

According to MPEP 303, applicants who want information about assignment documents must take specific steps:

  1. Request separately certified copies of assignment documents
  2. Submit the fees required by 37 CFR 1.19

The MPEP states:

“Applicants desiring an indication of assignment documents of record should request separately certified copies of assignment documents and submit the fees required by 37 CFR 1.19.” (MPEP 303)

An applicant can incorporate by reference a prior application in a continuing application by including an explicit statement in the specification of the continuing application. The MPEP states: An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are ‘hereby incorporated by reference.’ The statement must appear in the specification. This incorporation by reference can be useful for adding inadvertently omitted material from the prior application without the need for a petition, provided the continuing application is entitled to a filing date.

To learn more:

If a claim for foreign priority is not presented within the required time period under 37 CFR 1.55, it is considered waived. However, the claim may be accepted if the priority claim was unintentionally delayed.

To file a petition for an unintentionally delayed priority claim, the applicant must submit:

  1. The priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet, identifying the foreign application to which priority is claimed;
  2. A certified copy of the foreign application, unless previously submitted or an exception applies;
  3. The petition fee set in 37 CFR 1.17(m); and
  4. A statement that the entire delay between the date the priority claim was due and the date it was filed was unintentional.

The Director may require additional information if there is a question whether the delay was unintentional. See 37 CFR 1.55(e).

For applications filed on or after September 16, 2012, an applicant can file a continuation or divisional application using a copy of an oath or declaration from a prior application if:

  • The oath or declaration complies with 35 U.S.C. 115 as revised effective September 16, 2012
  • It was executed by or with respect to the inventor in the earlier-filed application
  • A copy of the oath, declaration, or substitute statement showing the signature or an indication it was executed is submitted in the continuing application

As stated in the MPEP: For applications filed on or after September 16, 2012, the filing of a continuing application by all or by fewer than all of the inventors named in a prior application without a newly executed oath or declaration is permitted provided that an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement under 37 CFR 1.64, was executed by or with respect to such inventor and was filed in the earlier-filed application, and a copy of such oath, declaration, or substitute statement showing the signature or an indication thereon that it was executed, is submitted in the continuing application.

It’s important to note that the oath or declaration must meet the current requirements, even if the prior application was filed before September 16, 2012.

For more information on continuation application, visit: continuation application.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

If an applicant believes that the missing drawings were actually submitted with the original application, they can establish prior receipt by following these steps:

  1. File a petition under 37 CFR 1.53(e) within two months of the OPAP notice date
  2. Include the petition fee set forth in 37 CFR 1.17(f)
  3. Provide evidence of the deposit of the drawings with the application papers

The MPEP states: An applicant asserting that the drawing(s) was in fact received by the USPTO with the application papers must, within two months from the date of the OPAP notice, file a petition under 37 CFR 1.53(e) with the petition fee set forth in 37 CFR 1.17(f), along with evidence of such deposit.

If it is determined that the drawings were indeed received with the original application, the petition fee will be refunded.

To learn more:

To ensure that affidavits or declarations from a prior application are considered in a new application, an applicant must take specific steps. According to MPEP ¶ 2.03:

“Where it is desired to rely on an earlier-filed affidavit or declaration, the applicant should make the remarks of record in this application and include a copy of the original affidavit or declaration filed in the prior application.”

To ensure consideration, the applicant should:

  • Explicitly reference the prior affidavit or declaration in the new application
  • Provide a copy of the original affidavit or declaration
  • Explain the relevance of the prior affidavit to the current application

This process helps the examiner understand the context and importance of the previously submitted evidence in relation to the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

If an applicant in a pre-AIA 37 CFR 1.47(b) application doesn’t have an assignment or agreement to assign, they can demonstrate sufficient proprietary interest by:

  • Submitting a legal memorandum
  • Providing an affidavit or declaration of firsthand knowledge
  • Including copies of relevant statutes or court decisions (if non-U.S.)

MPEP 409.03(f) states:

“A proprietary interest obtained other than by assignment or agreement to assign may be demonstrated by an appropriate legal memorandum to the effect that a court of competent jurisdiction (federal, state, or foreign) would by the weight of authority in that jurisdiction award title of the invention to the pre-AIA 37 CFR 1.47(b) applicant.”

The legal memorandum should be prepared by an attorney familiar with the relevant jurisdiction’s laws. Supporting facts should be provided through affidavits or declarations from individuals with firsthand knowledge. For non-U.S. jurisdictions, copies of relevant statutes or court decisions (in English) should be included.

To learn more:

To learn more:

When filing under pre-AIA 37 CFR 1.47(b), the applicant must prove proprietary interest in the invention. MPEP 409.03(f) outlines three ways to demonstrate this:

  1. Show the invention has been assigned to the applicant
  2. Prove the inventor agreed in writing to assign the invention to the applicant
  3. Otherwise demonstrate sufficient proprietary interest

To prove assignment, submit:

  • A copy of the assignment document
  • A statement under pre-AIA 37 CFR 3.73(b) by the assignee

For an agreement to assign, provide a copy of the agreement. For other proprietary interest, submit a legal memorandum explaining how a court would likely award title to the applicant.

The MPEP states: If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant.

To learn more:

To learn more:

An applicant can correct or add a priority claim in an international application according to PCT Rule 26bis.1. This is referenced in 37 CFR 1.451(d), which states:

The applicant may correct or add a priority claim in accordance with PCT Rule 26bis.1.

PCT Rule 26bis.1 allows for the correction or addition of a priority claim within 16 months from the priority date or, where the correction or addition would cause a change in the priority date, within 16 months from the priority date as so changed, whichever 16-month period expires first. However, this must be done no later than four months from the international filing date.

To learn more:

If a patent application is missing a required part, the applicant can correct the deficiency as follows:

  • The USPTO will send a Notice of Missing Parts identifying the deficiency
  • The applicant must submit the missing part within the time period specified in the notice (usually two months)
  • A surcharge fee may be required along with the submission of the missing part
  • For certain missing parts, like claims or drawings, a supplemental oath or declaration may be required for applications filed before September 16, 2012

The MPEP states: In such cases where the basic filing fee, the search fee, the examination fee, and the application size fee are paid, but additional fees are required, under 37 CFR 1.16, a notice is mailed by OPAP or the Technology Center (TC), requiring that the balance of the prescribed fee be paid.

It’s important to respond promptly to any Notice of Missing Parts to avoid abandonment of the application. If the applicant believes the part was not actually missing, they can file a petition for review of the Notice.

For more information on missing parts, visit: missing parts.

To claim the benefit of an international application’s filing date, the following conditions must be met according to MPEP 211.01(c):

  • The international application must designate the United States
  • The international application must be entitled to a filing date in accordance with PCT Article 11
  • The later-filed application must be filed during the pendency of the international application (i.e., prior to its abandonment)

The MPEP states:

To claim the benefit of the filing date of an international application, the international application must designate the United States and be entitled to a filing date in accordance with PCT Article 11, and the later-filed application must be filed during the pendency (e.g., prior to the abandonment) of the international application.

This provision is based on 35 U.S.C. 365(c), which allows national applications to benefit from prior international applications designating the United States, subject to the conditions of 35 U.S.C. 120.

To learn more:

When claiming benefit to multiple prior applications, applicants must carefully establish a chain of copendency. The MPEP 211.01(b) provides guidance:

“The reference to the prior applications must identify all of the prior applications and indicate the relationship (i.e., continuation, divisional, or continuation-in-part) between each nonprovisional application in order to establish copendency throughout the entire chain of prior applications.”

Key points to remember:

  • References must be made in each intermediate application in the chain.
  • A specific reference is required for each prior-filed application and cannot be incorporated by reference from a prior application.
  • There is no limit to the number of prior applications through which a chain of copendency may be traced.

It’s crucial to properly reference all prior applications to ensure the desired benefit claims are recognized. Failure to do so may result in the need for a petition under 37 CFR 1.78 and payment of a petition fee.

To learn more:

To claim benefit of an international design application designating the United States, the following requirements must be met:

  • The claim must be made in a nonprovisional application, international application, or international design application filed on or after May 13, 2015
  • The international design application must be entitled to a filing date in accordance with 37 CFR 1.1023
  • The claim must meet the conditions and requirements of 35 U.S.C. 120

MPEP 211.01(d) states: Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.

It’s important to note that this benefit can only be claimed in applications or patents filed on or after May 13, 2015, as specified in 37 CFR 1.78(j).

To learn more:

An applicant can challenge a new matter rejection through different procedures depending on where the alleged new matter appears:

  1. Specification: If the new matter is confined to amendments in the specification, the challenge is made by way of petition.
  2. Claims: If the alleged new matter is in the claims or affects the claims, the challenge is made through the appeal process.

The MPEP states: Where the new matter is confined to amendments to the specification, review of the examiner’s requirement for cancelation is by way of petition. But where the alleged new matter is introduced into or affects the claims, thus necessitating their rejection on this ground, the question becomes an appealable one, and should not be considered on petition even though that new matter has been introduced into the specification also. (MPEP 608.04(c))

It’s important to note that the applicant bears the burden of showing that the alleged new matter is actually supported by the original disclosure. This often involves pointing to specific parts of the original specification, drawings, or claims that provide implicit or explicit support for the contested subject matter.

To learn more:

Tags: USPTO

To authorize email communications with the USPTO, an applicant must provide a written authorization. According to MPEP 502.03:

‘The written authorization may be submitted via EFS-Web, mail, or fax. It cannot be submitted by email.’

The USPTO provides a sample authorization form:

‘Recognizing that Internet communications are not secure, I hereby authorize the USPTO to communicate with the undersigned and practitioners in accordance with 37 CFR 1.33 and 37 CFR 1.34 concerning any subject matter of this application by video conferencing, instant messaging, or electronic mail. I understand that a copy of these communications will be made of record in the application file.’

To facilitate processing, the USPTO recommends using Form PTO/SB/439, available at www.uspto.gov/patent/patents-forms. This form can be filed via EFS-Web using the document description ‘Internet Communications Authorized’.

To learn more:

An applicant can appeal a refusal to grant a filing date by submitting a petition. The MPEP states:

“Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)).”

When submitting a petition, the applicant should:

  • Provide arguments that the noted items were not missing
  • Explain why a filing date should be assigned even if certain items were absent (if they believe these items were unnecessary)
  • Include a request for a refund of the petition fee if they allege no defect exists

Petitions related to filing dates are decided by the Office of the Deputy Commissioner for Patent Examination Policy. The MPEP advises:

“Any petition under this section should be marked to the attention of the Office of Petitions.”

To learn more:

Registered practitioners can show authorization to conduct an interview in several ways:

  • By being an attorney or agent of record with a power of attorney
  • By having an authorization to act in a representative capacity
  • By completing, signing, and filing an Applicant Initiated Interview Request Form (PTOL-413A)

The MPEP states: Registered practitioners, when acting in a representative capacity, can show authorization to conduct an interview by completing, signing and filing an Applicant Initiated Interview Request Form (PTOL-413A). This method is particularly convenient as it eliminates the need to file a power of attorney or authorization to act in a representative capacity before having an interview.

Alternatively, practitioners can use Form PTO/SB/84, ‘Authorization to Act in a Representative Capacity,’ available on the USPTO website.

For more information on USPTO Forms, visit: USPTO Forms.

Tags: USPTO Forms

A registered patent attorney or agent who has been given a power of attorney can withdraw as attorney or agent of record by following these steps:

  • File an application for withdrawal with the USPTO Director
  • Obtain approval from the Director
  • Provide notice to the client

As stated in 37 CFR 1.36(b): A registered patent attorney or patent agent who has been given a power of attorney pursuant to § 1.32(b) may withdraw as attorney or agent of record upon application to and approval by the Director. The applicant or patent owner will be notified of the withdrawal of the registered patent attorney or patent agent.

It’s important to note that the withdrawal is effective only when approved by the USPTO, not when the request is received.

To learn more:

A person acting in a representative capacity under 37 CFR 1.34 may execute a power to inspect an application only if:

  • The patent practitioner was named in the application transmittal papers filed under 37 CFR 1.53 or the national stage documents filed under 37 CFR 1.495, and
  • A power of attorney has not been appointed under 37 CFR 1.32.

Once a power of attorney has been filed, any previously filed power to inspect signed by a patent practitioner who does not have a power of attorney will cease to have effect.

How can a practitioner become of record in a patent application filed on or after September 16, 2012?

A practitioner can become of record in a patent application filed on or after September 16, 2012, through the following methods:

  • Filing an Application Data Sheet (ADS) that names the practitioner as the representative
  • Filing a power of attorney (POA) signed by the applicant
  • Filing a patent application transmittal letter signed by the applicant and naming the practitioner as a representative
  • Being named as the representative in the oath or declaration

As stated in MPEP 403.01(a): ‘A power of attorney or authorization of agent may be given to a customer number in applications filed on or after September 16, 2012.’ This allows for easier management of multiple practitioners associated with a single customer number.

To learn more:

How can a power of attorney be revoked in a patent application?

A power of attorney can be revoked in a patent application through the following methods:

  • Filing a new power of attorney: This automatically revokes the previous power of attorney.
  • Filing a revocation signed by the applicant or assignee of the entire interest: This explicitly revokes the previous power of attorney.

As stated in MPEP 601.02: ‘A new power of attorney or authorization of agent filed in the application on or after September 16, 2012, automatically revokes any previously filed power of attorney or authorization of agent.’

It’s important to note that the new power of attorney or revocation must be properly executed by the applicant or assignee to be effective.

To learn more:

A person who shows sufficient proprietary interest in an invention can file a patent application as the applicant. According to MPEP § 409.05, such a person must submit a petition including:

  1. The fee set forth in 37 CFR 1.17(g)
  2. A showing of sufficient proprietary interest in the matter
  3. A statement that making the application on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

The proprietary interest can be demonstrated by a legal memorandum showing that a court would likely award title of the invention to the applicant. Supporting facts and documentation should be provided.

For more information on proprietary interest, visit: proprietary interest.

A registered patent attorney or agent who has been given a power of attorney may withdraw as attorney or agent of record by submitting a request to the USPTO. The process involves:

  1. Filing a request for withdrawal with the USPTO
  2. Obtaining approval from the Director of the USPTO
  3. Notifying the applicant or patent owner of the withdrawal

MPEP 402.06 states: “When filing a request to withdraw as attorney or agent of record, the patent attorney or agent should briefly state the reason(s) for which he or she is withdrawing so that the Office can determine whether to grant the request.”

The practitioner must also take steps to protect the client’s interests, such as giving reasonable notice and allowing time for the client to find new representation.

A patent can be issued to an assignee in two main ways:

  • Before paying the issue fee: The assignee can submit a request for issuance in their name along with the issue fee payment. The assignment must be previously recorded or stated to have been filed for recordation.
  • After paying the issue fee: A request can be submitted after the issue fee payment, but it requires additional steps and fees.

According to MPEP 307, “Normally, for a patent to issue to an assignee (other than an assignee who is the applicant in an application filed on or after September 16, 2012), a request for issuance of the application in the name of the assignee must be filed in the United States Patent and Trademark Office (Office) at a date not later than the day on which the issue fee is paid.”

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

A patent application can become formally abandoned through an explicit action by the applicant or their representative. MPEP 203.05 states that an abandoned application includes one that is removed from the Office docket of pending applications: (A) through formal abandonment by the applicant or by the attorney or agent of record. This means the applicant or their legal representative can submit a formal request to abandon the application, effectively ending its prosecution.

How can a legal representative file a patent application for a deceased inventor?

For patent applications filed on or after September 16, 2012, a legal representative can file a patent application for a deceased inventor by following these steps:

  • Submit an Application Data Sheet (ADS) naming the deceased inventor
  • Include a substitute statement in lieu of an inventor’s oath or declaration
  • Provide documentation showing the legal representative’s authority to act on behalf of the deceased inventor’s estate

The MPEP states: If an inventor dies during the prosecution of an application, or before an application is filed, the legally recognized representative of the inventor may make the substitute statement. (MPEP 409.01(a))

It’s important to note that the legal representative must have the authority to act on behalf of the deceased inventor’s estate or other legal entity holding the appropriate rights.

To learn more:

How can a legal representative file a patent application for a deceased inventor after September 16, 2012?

For patent applications filed on or after September 16, 2012, a legal representative can file an application for a deceased inventor by following these steps:

  • File the application normally, listing the deceased inventor
  • Submit an Application Data Sheet (ADS) identifying the legal representative
  • Include a substitute statement in lieu of an inventor’s oath or declaration

According to MPEP 409.01(a): “If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent as provided in 37 CFR 1.43.” The legal representative must provide documentation of their authority to act on behalf of the deceased inventor.

To learn more:

A juristic entity (e.g., corporations, universities, or other organizations) can give power of attorney in a patent application through an appropriate official. According to MPEP 402:

‘Where the applicant is a juristic entity (e.g., organizational assignee), a power of attorney must be signed by a person authorized to act on behalf of the applicant.’

The process typically involves:

  • An official with signing authority (e.g., CEO, president, or authorized patent counsel) signs the power of attorney form.
  • The signed form is submitted to the USPTO along with the patent application or separately if done after filing.
  • If requested by the USPTO, documentation may need to be provided to establish the authority of the person signing on behalf of the juristic entity.

It’s important to ensure that the person signing has the actual authority to bind the juristic entity in patent matters.

For more information on juristic entity, visit: juristic entity.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How can a joint inventor apply for a patent if another joint inventor is deceased or legally incapacitated?

If a joint inventor is deceased or legally incapacitated, the other joint inventor(s) can still apply for a patent by following these steps:

  • File the application naming the deceased or legally incapacitated inventor
  • Submit a statement identifying the unavailable inventor and their last known address
  • Show that the signing inventor is obligated to assign the patent to the same entity as the unavailable inventor, or has sufficient proprietary interest
  • Submit the oath or declaration by the available inventor(s)

As stated in MPEP 409.01(a): “In the case of a deceased or legally incapacitated joint inventor, the applicant should identify the unavailable inventor on an application data sheet (ADS) or a substitute statement.”

This process allows the patent application to move forward despite the unavailability of one of the joint inventors.

To learn more:

A claim for foreign priority can be perfected after a patent has been issued through two main methods:

  1. Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323
  2. Reissue application

The choice of method depends on the specific circumstances:

  • A Certificate of Correction can be used if the requirements of 37 CFR 1.55 are met and no further examination is required.
  • A reissue application is necessary if the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance, or if further examination would be required.

The MPEP states: “The failure to perfect a claim to foreign priority prior to issuance of the patent may be cured via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, provided the requirements of 37 CFR 1.55 are met, or by filing a reissue application.” (MPEP 216.01)

Arbitration awards in patent disputes are binding between the parties involved in the arbitration but do not affect others. According to 35 U.S.C. 294(c):

‘An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person.’

However, if the patent is later found invalid or unenforceable by a court, the arbitration award may be modified upon application by any party to the arbitration.

The rights of nonsigning inventors in pre-AIA 37 CFR 1.47 applications are protected through specific provisions in patent law. According to MPEP 409.03(i):

“The rights of a nonsigning inventor are protected by the fact that the patent resulting from an application filed under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118 must issue to the inventor, and in an application filed under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the inventor has the same rights that he or she would have if he or she had joined in the application.”

This means that:

  • For applications under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118, the patent must be issued to the inventor, even if they didn’t sign the application.
  • For applications under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the nonsigning inventor retains the same rights as if they had joined the application.

These provisions ensure that the nonsigning inventor’s rights to the invention are preserved, regardless of their lack of signature on the original application.

To learn more:

To learn more:

When supplemental oaths or declarations are received after allowance, they are processed as follows:

  • They are placed in the file by the Office of Data Management.
  • Their receipt is not acknowledged to the party filing them.
  • They are not filed or considered as amendments under 37 CFR 1.312.

The MPEP clarifies:

“When received they will be placed in the file by the Office of Data Management, but their receipt will not be acknowledged to the party filing them. They should not be filed or considered as amendments under 37 CFR 1.312, since they make no change in the wording of the papers on file.”

To learn more:

The USPTO handles returned assignment documents as follows:

  • Documents are stamped with the original receipt date.
  • A letter accompanies returned documents explaining the correction needed.
  • If corrected and resubmitted within the specified time, the original receipt date is considered the recording date.
  • Resubmissions can use the certification procedure under 37 CFR 1.8 or the ‘Priority Mail Express®’ procedure under 37 CFR 1.10.
  • If not corrected and resubmitted in time, the new receipt date becomes the recording date.

The MPEP states: The certification procedure under 37 CFR 1.8 or the ‘Priority Mail Express®’ procedure under 37 CFR 1.10 may be used for resubmissions of returned papers to obtain the benefit of the date of deposit in the United States Postal Service to establish that the papers were returned within the time period specified.

For more information on assignment recording, visit: assignment recording.

For more information on document correction, visit: document correction.

For more information on USPTO procedures, visit: USPTO procedures.

Replacement drawings received in utility patent applications after the Notice of Allowability is mailed are handled differently:

Where replacement drawings are received in utility patent applications after the Notice of Allowability was mailed, the replacement drawings are handled by the Office of Data Management. Submission to the examiner is not necessary unless an amendment to the specification accompanies the drawings, such as an amendment where the description of figures is added or canceled.

This process streamlines the handling of late-submitted drawings, ensuring that only necessary reviews are conducted by examiners at this stage of the patent application process.

To learn more:

In a PCT national stage application, the examiner will consider all U.S. patents, U.S. patent application publications, and U.S. pending applications cited in the international search report that are stored electronically in the USPTO’s Image File Wrapper (IFW) system. As stated in MPEP 609.03:

“The examiner will consider other documents cited in the international search report when the Form PCT/DO/EO/903 in the national stage application indicates that both the international search report and the copies of the documents are present in the national stage file.”

The examiner should indicate in the first Office action that the information has been considered. However, these citations will not be printed on the face of the patent unless they are listed on a form that can be easily captured by the Office printing contractor.

To learn more:

The handling of provisional patent applications with missing drawings differs from nonprovisional applications. For provisional applications:

  • The USPTO does not grant petitions under 37 CFR 1.182 to accept omitted drawings and accord a later filing date
  • Applicants are advised to file a new, complete provisional application instead
  • Upon receiving an OPAP notice about missing drawings, applicants have two options:
    1. File a petition under 37 CFR 1.53(e) with evidence to establish prior receipt of the drawings
    2. Accept the application as deposited by not responding to the notice

The MPEP states: The USPTO will not grant petitions under 37 CFR 1.182 to accept omitted drawing(s) and accord an application filing date as of the date of such submission in provisional applications. The applicant should simply file a new completed provisional application.

If the applicant doesn’t respond to the OPAP notice and the provisional application is otherwise complete under 37 CFR 1.51(c), it will be held in the USPTO’s Image File Wrapper (IFW) system and automatically abandoned at the end of its pendency period.

To learn more:

Provisional application benefits are handled differently from other types of priority claims on the bib-data sheet. If an applicant claims benefit under 35 U.S.C. 119(e) to a prior provisional application, the application number of that provisional application should be printed on the bib-data sheet.

However, it’s important to note: If applicant claims benefit under35 U.S.C. 119(e)to a prior provisional application, and states that the provisional application claims the benefit of, or priority to, earlier domestic or foreign application(s), the earlier application(s) should not be reflected on the bib-data sheet because a provisional application is not entitled to the benefit of, or right of priority to, any other application. (MPEP 202)

This is due to the limitation set forth in 35 U.S.C. 111(b)(7), which states that a provisional application cannot claim priority to or benefit from any other application.

Examiners should verify that provisional application data is correctly listed and that no improper benefit claims to earlier applications through a provisional application are included on the bib-data sheet.

For more information on benefit claims, visit: benefit claims.

For more information on patent examination, visit: patent examination.

For more information on provisional application, visit: provisional application.

How are pro se applicants treated in patent applications?

Pro se applicants (individuals who file patent applications without the assistance of a registered patent attorney or agent) are treated with special consideration by the USPTO. The MPEP states:

“While an inventor may prosecute the application, lack of skill in this field usually acts as a liability in affording the maximum protection for the invention disclosed. Applicant is advised to secure the services of a registered patent attorney or agent to prosecute the application, since the value of a patent is largely dependent upon skillful preparation and prosecution.” (MPEP 605)

However, the USPTO recognizes that some inventors choose to file pro se and provides resources to assist them, such as the Pro Se Assistance Program. While pro se applicants are held to the same legal standards as represented applicants, examiners are encouraged to assist pro se applicants in navigating the patent process.

To learn more:

Priority Mail Express® submissions to the USPTO are treated differently in terms of dating. According to 37 CFR 1.6(a)(2):

Correspondence filed in accordance with § 1.10 will be stamped with the date of deposit as Priority Mail Express® with the United States Postal Service.

This means that new patent applications filed using Priority Mail Express® will be stamped with the date they were deposited with USPS, even if that date is a Saturday, Sunday, or federal holiday. The MPEP provides an example:

For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

Preliminary amendments in continuation applications are subject to specific rules and considerations. The MPEP provides guidance on this topic:

Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

This means that preliminary amendments submitted with the application are treated as part of the original filing. However, there are important requirements and considerations:

  1. Compliance with 37 CFR 1.121:

    Amendments must be filed in compliance with the requirements of 37 CFR 1.121 (e.g., the amendment must include a complete claim listing whenever a claim is added, canceled, or amended).

  2. Possible Requirement for Substitute Specification:

    The Office may require a substitute specification for preliminary amendments.

  3. Classification and Assignment:

    Applications should be classified and assigned to the proper Technology Center (TC) by taking into consideration the claims that will be before the examiner upon entry of such a preliminary amendment.

  4. New Matter Considerations: If the preliminary amendment introduces new matter, it may affect the application’s status as a continuation. The MPEP advises:

    Where a copy of the oath or declaration from a prior application was filed in a continuation or divisional application, if the examiner determines that new matter is present relative to the prior application, the examiner should so notify the applicant in the next Office action (preferably the first Office action). The examiner should require applicant to delete the benefit claim or redesignate the application as a continuation-in-part.

Applicants should carefully consider the content and timing of preliminary amendments in continuation applications to ensure compliance with USPTO requirements and to maintain the desired relationship with the parent application.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

For Image File Wrapper (IFW) applications, the process of granting power to inspect is different. According to MPEP 104:

“Powers to inspect are not accepted in Image File Wrapper (IFW) applications. IFW applications are available through the Private Patent Application Information Retrieval (PAIR) system, and pro se applicants and attorneys of record have direct access to the IFW through Private PAIR (when a Customer Number is associated with the correspondence address for the application, and the applicant or attorney has access to Private PAIR for the customer number).”

This means that for IFW applications, access is typically granted through the Private PAIR system, eliminating the need for traditional powers to inspect. If access through Private PAIR is not possible, alternative methods for viewing the application may be necessary.

For more information on Patent application access, visit: Patent application access.

For more information on power to inspect, visit: power to inspect.

For more information on Private PAIR, visit: Private PAIR.

When multiple inventors collaborate on an invention, the patent can be issued to them jointly. The MPEP 308 provides guidance on this:

‘If more than one inventor is named in the application, the patent will issue to the inventors jointly.’

This means that all named inventors share ownership of the patent equally, unless they have agreed otherwise or assigned their rights to another party. Each joint inventor has the right to make, use, sell, or license the invention without the consent of the other inventors, subject to any agreements between them.

For more information on joint inventors, visit: joint inventors.

For more information on patent issuance, visit: patent issuance.

How are patent assignment documents filed and stored at the USPTO?

The USPTO has a specific process for filing and storing patent assignment documents. According to MPEP 317:

“All recorded assignments are scanned and stored in an electronic database.”

This means that once an assignment is recorded, it is digitized for easy access and long-term storage. The electronic database allows for efficient retrieval and management of assignment records. Additionally, the MPEP notes:

“The original document is returned to the sender with a notation of the reel and frame numbers.”

This process ensures that the original document is returned to the sender while maintaining a digital copy for USPTO records. The reel and frame numbers serve as reference points for locating the scanned document in the electronic database.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO procedures, visit: USPTO procedures.

Patent applications are initially processed by the USPTO through electronic scanning and loading into the Image File Wrapper (IFW) system. According to MPEP 508, “All applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. Once documents are loaded into the IFW system, examiners, technical support staff, and other Office personnel will perform further processing and examination using the IFW system.”

When all inventors are unavailable or unwilling to sign a patent application, there are still options for filing. According to MPEP § 409.03(b) (for applications filed before September 16, 2012) and MPEP § 409.05 (for applications filed on or after September 16, 2012):

  • An assignee or obligated assignee may file the application as the applicant
  • A person who shows sufficient proprietary interest in the matter may file the application

In such cases, substitute statements would need to be filed in lieu of inventors’ oaths or declarations, along with the necessary petitions and evidence of the applicant’s right to file the application.

For more information on assignee applicant, visit: assignee applicant.

For more information on proprietary interest, visit: proprietary interest.

Patent applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. As stated in the MPEP, All applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. This digital system allows examiners, technical support staff, and other Office personnel to perform further processing and examination efficiently.

For physical items such as models, exhibits, and specimens, special handling procedures are in place. The MPEP directs readers to MPEP § 608.03 and 608.03(a) for more information on these items.

For more information on image file wrapper, visit: image file wrapper.

For more information on patent application filing, visit: patent application filing.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has specific provisions for handling partial assignees in patent issuance:

  1. If one or more assignees, together with one or more inventors, hold the entire right, title, and interest in the application, the patent may issue in the names of both the assignee(s) and the inventor(s).
  2. If multiple assignees hold the entire right, title, and interest to the exclusion of all inventors, the patent may issue in the names of the multiple assignees.

This is outlined in 37 CFR 3.81(c): (1) If one or more assignee, together with one or more inventor, holds the entire right, title, and interest in the application, the patent may issue in the names of the assignee and the inventor. (2) If multiple assignees hold the entire right, title, and interest to the exclusion of all the inventors, the patent may issue in the names of the multiple assignees.

In a pre-AIA 37 CFR 1.47 application, papers filed by an inventor who did not initially join the application are handled as follows:

“Papers filed by an inventor who did not originally join in the application, and papers relating to its pre-AIA 37 CFR 1.47 status, will be placed in the file wrapper.”

This means that any documents submitted by the previously non-signing inventor, as well as any paperwork related to the application’s pre-AIA 37 CFR 1.47 status, are included in the official application file for record-keeping and potential future reference.

To learn more:

To learn more:

The MPEP states:

All applications or papers, including non-patent literature, in the U.S. Patent and Trademark Office bearing words such as “Secret,” “Confidential,” “ITAR” or similar must be promptly referred to Licensing and Review for clarification or security treatment.

These papers cannot be placed in public records like patented files until the security markings are declassified or explained.

Nonprovisional patent applications are assigned for examination through the Patents Service for Time and Application Routing (PSTAR) program. According to MPEP 504, “The Patents Service for Time and Application Routing (PSTAR) program assigns each nonprovisional application to an examiner.” This system ensures that each application is routed to an appropriate examiner based on factors such as the application’s subject matter and the examiner’s expertise.

To learn more:

Non-English language documents submitted in an Information Disclosure Statement (IDS) are handled as follows:

  • They are considered in view of the concise explanation submitted
  • They are understood to the extent possible based on drawings, chemical formulas, etc.
  • Examiners are not required to have the documents translated
  • Examiners indicate consideration in the same manner as English language documents
  • Examiners should not comment on the extent of understanding of the document

The MPEP states:

‘The examiner need not have the information translated unless it appears to be necessary to do so. The examiner will indicate that the non-English language information has been considered in the same manner as consideration is indicated for information submitted in English.’

This approach is supported by case law, as noted in Semiconductor Energy Laboratory Co. v. Samsung Electronics Co., which clarifies that the examiner’s consideration is presumed to extend only to the translated portion and concise statement provided.

To learn more:

To learn more:

Non-English language documents submitted in an IDS are considered as follows:

  • They are reviewed in light of the concise explanation provided (as required by MPEP § 609.04(a), subsection III).
  • They are understood to the extent possible based on their face value, including drawings and chemical formulas.
  • Examiners are not required to have the documents translated unless necessary.
  • Consideration is indicated in the same manner as for English language documents.

The MPEP states: The examiner need not have the information translated unless it appears to be necessary to do so. The examiner will indicate that the non-English language information has been considered in the same manner as consideration is indicated for information submitted in English. (MPEP 609.05(b))

To learn more:

When adding new claims to a patent application, it’s crucial to follow the proper numbering convention. According to MPEP 608.01(j):

“When claims are added, they must be numbered by the applicant consecutively beginning with the number next following the highest numbered claim previously presented (whether entered or not).”

This means that new claims should be numbered sequentially, starting with the number that comes after the highest-numbered claim in the application, regardless of whether that claim was entered or not. This system ensures a clear and consistent numbering scheme throughout the prosecution process.

To learn more:

National security classified patent applications require special handling by the USPTO. The MPEP states that:

National security classified documents filed in the USPTO must be either hand-carried to Licensing and Review or mailed to the Office in compliance with37 CFR 5.1(a)and Executive Order 13526 of December 29, 2009.

However, the USPTO has made provisions for secure electronic filing:

The Office will accept such applications filed with the USPTO via the Department of Defense Secret Internet Protocol Router Network (SIPRNET) and consider them as filed via the USPTO patent electronic filing system for purposes of37 CFR 1.16(t)and37 CFR 1.445(a)(ii).

Applicants filing national security classified applications must also obtain a secrecy order or provide authority to cancel the security markings, as per37 CFR 5.1(d). The USPTO’s Licensing and Review office can provide a list of contacts at the appropriate defense agencies for this purpose.

For more information on classified patent applications, visit: classified patent applications.

Models, exhibits, or specimens are generally not admitted as part of a patent application, but they may be required during the prosecution process. The MPEP states:

“A model, exhibit, or specimen is normally not admitted as part of the application, although it may be required in the prosecution of the application (37 CFR 1.91 and 1.93, MPEP § 608.03).”

Key points regarding models, exhibits, or specimens:

  • They are not typically part of the initial application filing.
  • The USPTO may request them during examination if needed to understand the invention.
  • If required, they must comply with specific rules outlined in 37 CFR 1.91 and 37 CFR 1.93.
  • Detailed guidelines for handling models, exhibits, or specimens can be found in MPEP § 608.03.

Applicants should be prepared to provide models, exhibits, or specimens if requested by the USPTO during the examination process, but should not include them with the initial application unless specifically required.

To learn more:

Models and exhibits received by the U.S. Patent and Trademark Office are handled as follows:

  • They are taken to the Technology Center (TC) assigned to the related application for examination.
  • Their receipt must be properly recorded on an artifact sheet.
  • A label with the application number, filing date, and attorney’s information should be attached for clear identification.

As stated in the MPEP, The Office may return the model, exhibit, or specimen, at any time once it is no longer necessary for the conduct of business before the Office and return of the model or exhibit is appropriate. (MPEP 608.03(a))

To learn more:

Tags: USPTO

The handling of models and exhibits during patent examination is governed by specific procedures outlined in MPEP 608.03(a). Key points include:

  • Models and exhibits are taken to the assigned Technology Center for examination.
  • Receipt must be recorded on an artifact sheet.
  • A label with application number, filing date, and attorney information should be attached for easy identification and return.
  • Models that cannot be conveniently stored in an artifact folder should not be accepted.
  • Models and exhibits may be presented during interviews but should be taken away afterward unless they meet the requirements of 37 CFR 1.91.

The MPEP states: A full description of what was demonstrated or exhibited during the interview must be made of record. This ensures that the examination record is complete, even if the physical model or exhibit is not retained.

To learn more:

How are inventorship disputes resolved in joint inventor situations?

Inventorship disputes in joint inventor situations can be complex and may require legal intervention. While the MPEP 602.09 doesn’t provide a specific resolution process, it emphasizes the importance of proper inventorship:

“The inventors named in a nonprovisional application must execute an oath or declaration… All named inventors must be named in the executed oath or declaration.”

To resolve inventorship disputes:

  • Parties should first attempt to reach an agreement among themselves
  • If unsuccessful, they may need to seek legal counsel
  • The USPTO may require evidence or a court order to make inventorship changes
  • In some cases, the matter may need to be resolved in federal court

It’s crucial to resolve these disputes promptly, as incorrect inventorship can invalidate a patent. If a dispute arises, it’s advisable to consult with a patent attorney to navigate the resolution process properly.

To learn more:

For pre-AIA applications, the resolution of inconsistencies between the Application Data Sheet (ADS) and other documents is governed by specific rules:

1. General rule: MPEP 601.05(b) states, “The latest submitted information will govern notwithstanding whether supplied by an application data sheet, an amendment to the specification, a designation of a correspondence address, or by an oath or declaration under pre-AIA 37 CFR 1.63 or pre-AIA 37 CFR 1.67, except as provided by pre-AIA 37 CFR 1.76(d)(3).”

2. Exception for inventor information: “The oath or declaration under pre-AIA 37 CFR 1.63 or pre-AIA 37 CFR 1.67 governs inconsistencies with the application data sheet in the naming of inventors and setting forth their citizenship.”

3. Correction process: If inconsistencies exist, a supplemental ADS should be submitted to conform the information with the correct data in other documents.

To learn more:

The USPTO has a specific process for handling incomplete patent documents. According to MPEP 317.01:

“Documents not meeting the other requirements for recording, for example, a document submitted without a completed cover sheet or without the required fee, will be returned for correction to the sender where a correspondence address is available.”

This means that if a document is missing essential components like a completed cover sheet or the required fee, the USPTO will return it to the sender for correction, provided that a correspondence address is available.

To learn more:

The USPTO handles improper Continued Prosecution Application (CPA) requests in the following ways:

  1. For utility or plant applications filed on or after July 14, 2003, improper CPA requests are treated as requests for continued examination (RCE) under 37 CFR 1.114 if the application has a filing date on or after June 8, 1995.
  2. If the improper CPA doesn’t satisfy RCE requirements, it’s treated as an improper RCE, and the time period set in the last Office action continues to run.
  3. For applications with a filing date before June 8, 1995, the Office will notify the applicant of the improper CPA by mailing a notice.
  4. If an examiner discovers an improperly processed CPA, they should immediately notify a supervisory applications examiner (SAE) or other technical support staff to correct the application records.
  5. The Office will not convert an improper CPA into an application under 37 CFR 1.53(b) unless there are extenuating circumstances.

As stated in the MPEP: If an examiner discovers that an improper or incomplete CPA has been processed as a proper CPA in error, the examiner should immediately notify a supervisory applications examiner (SAE) or other technical support staff within the TC who will reprocess the CPA and correct the application records as appropriate.

It’s important to note that if the application becomes abandoned due to an improper CPA, the applicant may need to file a petition under 37 CFR 1.137 to revive the application and pay the required fees.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

For more information on USPTO procedures, visit: USPTO procedures.

How are historical patent assignment records maintained?

The USPTO maintains historical patent assignment records separately from more recent records. MPEP 301.01 explains:

‘The historical database of assignments is maintained separate and apart from the database of assignments affecting title recorded since 1980.’

This means that:

  • Records prior to August 1980 are kept in a separate historical database
  • These older records may not be available through the online Patent Assignment Search
  • Accessing historical records may require different procedures or direct contact with the USPTO

For researchers or legal professionals needing access to pre-1980 assignment records, it’s advisable to contact the USPTO’s Patent and Trademark Resource Centers or the Assignment Recordation Branch for assistance.

The USPTO accepts handwritten signatures in patent applications, but they must meet specific requirements:

  • The signature must be personally applied by the signer.
  • It can be in permanent dark ink or its equivalent.
  • The entire signature must be contained within the signature area of the document.

According to MPEP 402.03: A handwritten signature must be personally applied by the signer. See 37 CFR 1.4(d)(1).

It’s important to note that while handwritten signatures are accepted, the USPTO encourages electronic filing and signatures for efficiency and accuracy in processing applications.

To learn more:

Patent examiners verify foreign priority claims through the following steps:

  1. Check that foreign applications listed on the oath, declaration, or application data sheet are properly listed on the bib-data sheet.
  2. Verify the accuracy of the application number, country, and filing date for each foreign application.
  3. Ensure that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) are listed.
  4. Initial the bib-data sheet in the “VERIFIED” space when the information is correct or has been amended to be correct.
  5. Indicate in the Office action and on the bib-data sheet whether the conditions of 35 U.S.C. 119(a)-(d) or (f) have been met.

MPEP 202 states: “The examiner should check this information for accuracy. Should there be an error on the oath or declaration, or application data sheet itself, the examiner should require a new oath or declaration, or application data sheet, where appropriate. A petition for an unintentionally delayed claim for priority may also be required.”

Foreign priority claims are an important aspect of patent applications and are reflected on the bib-data sheet. The examiner should verify that foreign applications listed on the oath, declaration, or application data sheet are correctly listed on the bib-data sheet.

According to the MPEP: A bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application that the U.S. application is claiming the priority of. The examiner should check this information for accuracy. (MPEP 202)

If there are errors:

  • On the oath, declaration, or application data sheet: The examiner should require a new document.
  • On the bib-data sheet itself: The examiner should make corrections directly on the sheet and have the information updated in the Office computer systems.

It’s important to note that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) should be listed. A list of qualifying countries can be found in MPEP § 213.01.

For more information on foreign applications, visit: foreign applications.

For more information on foreign priority claims, visit: foreign priority claims.

For more information on patent examination, visit: patent examination.

When the entire USPTO is officially closed for business for an entire day due to adverse weather or other causes:

  • The day is considered a “Federal holiday within the District of Columbia” under 35 U.S.C. 21
  • Any action or fee due on such a day may be taken or paid on the next succeeding business day the Office is open

MPEP 510 states: “When the entire USPTO is officially closed for business for an entire day, for reasons due to adverse weather or other causes, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21. Any action or fee due on such a day may be taken, or fee paid, on the next succeeding business day the Office is open.”

To learn more:

Fees for multiple dependent claims are calculated differently from regular dependent claims. According to MPEP 608.01(n):

  • A multiple dependent claim is considered to be that number of dependent claims to which it refers.
  • Any claim depending from a multiple dependent claim is also considered as the number of dependent claims as referred to in the multiple dependent claim from which it depends.
  • If at least one multiple dependent claim is proper, the multiple dependent claim fee set forth in 37 CFR 1.16(j) will be required.

The USPTO uses Form PTO/SB/07 to assist in the computation of fees for multiple dependent claims. This form is placed in the application file by the Office of Patent Application Processing (OPAP) or the Technology Center (TC) technical support staff.

To learn more:

For patents printed after January 1, 2001, the USPTO distinguishes between citations from information disclosure statements and those cited by the examiner. According to the MPEP:

The citations cited by the examiner on a form PTO-892 will be marked with an asterisk.

This distinction allows readers to easily identify which references were provided by the applicant and which were added by the examiner during the examination process.

To learn more:

Errors in small entity status can be excused if they were made in good faith. According to 37 CFR 1.28(c): ‘If status as a small entity is established in good faith, and fees as a small entity are paid in good faith, in any application or patent, and it is later discovered that such status as a small entity was established in error, or that through error the Office was not notified of a loss of entitlement to small entity status as required by § 1.27(g)(2), the error will be excused upon: compliance with the separate submission and itemization requirements of paragraphs (c)(1) and (c)(2) of this section, and the deficiency payment requirement of paragraph (c)(2) of this section.’

To correct the error, you must:

  • Submit a separate deficiency payment for each application or patent
  • Provide an itemized list of the fees paid in error
  • Pay the deficiency owed (difference between the small entity fee paid and the current non-small entity fee)

To learn more:

Errors in prior application data on the bib-data sheet are corrected as follows:

  1. If the error is in the preprinted data: The examiner can have the technical support staff of the Technology Center make corrections in the Patent Data Portal database.
  2. If the error is an applicant error: The examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.

MPEP 202 states: “Upon entry of the data, a new bib-data sheet should be printed and scanned into the file. If the error was an applicant error, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate. See MPEP § 601.05 et seq. and MPEP § 211.02(a). A petition for an unintentionally delayed benefit claim may also be required. See MPEP § 211.04.”

The USPTO has specific rules for dating electronically filed submissions. According to 37 CFR 1.6(a)(4):

Correspondence may be submitted using the Office electronic filing system only in accordance with the Office electronic filing system requirements. Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

The MPEP further clarifies: Similarly, correspondence submitted via the USPTO electronic filing system (EFS-Web) will be accorded a receipt date on the date the correspondence is received at the correspondence address for the Office set forth in 37 CFR 1.1 (i.e., local time in Alexandria, VA), without regard to whether that date is a Saturday, Sunday, or Federal holiday within the District of Columbia.

Electronically filed patent applications receive special treatment for date-stamping at the USPTO. According to MPEP 505, Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

Key points about electronic filing date-stamping:

  • The receipt date is based on the time in Alexandria, VA (USPTO’s location)
  • Electronic submissions can receive a date stamp on any day, including weekends and holidays
  • The electronic filing system (EFS-Web) must be used in accordance with USPTO requirements

For more details on electronic filing, refer to MPEP § 502.05.

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on USPTO, visit: USPTO.

How are drawing errors handled in patent applications?

Drawing errors in patent applications are typically addressed as follows:

  1. Minor errors: The examiner may handle these by annotations or corrections with the concurrence of the applicant.
  2. Substantial errors: These require the applicant to submit corrected drawings.

According to MPEP 608.02:

‘In instances where the drawing is such that the prosecution can be carried on without the corrections, applicant is informed of the reasons why the drawing is objected to on Form PTO-948 or in an examiner’s action, and that the drawing is accepted as filed.’

If corrections are necessary, the examiner will set a time period for submission. Failure to submit corrected drawings may result in abandonment of the application.

To learn more:

Documents that don’t meet other recording requirements, such as missing a completed cover sheet or required fee, are handled differently by the USPTO. According to the MPEP, “Documents not meeting the other requirements for recording, for example, a document submitted without a completed cover sheet or without the required fee, will be returned for correction to the sender where a correspondence address is available.” This means that unlike documents with identification issues, these documents are returned to the sender for correction, provided a correspondence address is available.

Documents submitted as part of an applicant’s reply to an Office action are handled differently from regular Information Disclosure Statements:

  • They do not need to comply with 37 CFR 1.97 and 37 CFR 1.98 to be considered
  • The examiner will consider the portion of the document relied upon as rebuttal evidence
  • The entire document may not necessarily be considered
  • These documents are not processed as items cited in an IDS
  • The record should reflect that the evidence was considered, but listing on forms like PTO-892 or PTO/SB/08 is not required

The MPEP states:

‘To the extent that a document is submitted as evidence directed to an issue of patentability raised in an Office action, and the evidence is timely presented, applicant need not satisfy the requirements of 37 CFR 1.97 and 37 CFR 1.98 in order to have the examiner consider the information contained in the document relied on by applicant.’

This approach allows for efficient consideration of evidence submitted in response to Office actions without the formal IDS requirements.

To learn more:

To learn more:

The Assignment Division of the USPTO handles documents according to specific procedures outlined in MPEP 317. Key aspects include:

  • Documents are numbered, filmed, and indexed into the assignment database.
  • Original documents are returned to the sender or destroyed after filming.
  • Certified copies of recorded documents can be ordered for a fee.
  • The Assignment Division provides searches of the assignment records upon request.

As stated in the MPEP, All documents submitted for recording are numbered, filmed, and indexed into the assignment database. This process ensures proper documentation and accessibility of assignment records.

For more information on Assignment Division, visit: Assignment Division.

For more information on document handling, visit: document handling.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

The handling of delayed priority claims in design applications has evolved. The MPEP provides the following information:

“Before May 13, 2015, no procedures were established for accepting an unintentionally delayed priority claim in a design application. Effective May 13, 2015, 37 CFR 1.55(e) provides for the filing of a petition for acceptance of an unintentionally delayed priority claim in a design application where the foreign priority claim was not submitted during the pendency of the design application.”

This change allows design patent applicants and holders to rectify unintentionally delayed priority claims, aligning the process more closely with that of utility patents. As with utility patents, a petition under 37 CFR 1.55(e) may be filed along with a request for a certificate of correction after the design patent has been granted.

To learn more:

Delayed benefit claims in international applications have specific procedures. According to MPEP 211.04:

A petition under 37 CFR 1.78 for accepting an unintentionally delayed benefit claim and the petition fee under 37 CFR 1.17(m) are required to add a benefit claim under 35 U.S.C. 120 and 365(c) in an abandoned international application designating the United States, even when the international application did not enter the national stage under 35 U.S.C. 371.

For international applications not filed with the U.S. Receiving Office and not a nonprovisional application, the petition may be filed in the earliest nonprovisional application claiming benefit to the international application. This petition will be treated as if filed in the international application itself.

For more information on international applications, visit: international applications.

For more information on patent procedure, visit: patent procedure.

The USPTO has a process for handling defective property rights statements submitted in response to DOE or NASA review requests. According to MPEP 150:

If the statement submitted during this period is defective, another letter is sent from Licensing and Review detailing the deficiencies and giving applicant another opportunity to respond during this period of informal correspondence.

The process typically involves:

  • Initial review of the submitted statement
  • If defects are found, a letter is sent detailing the deficiencies
  • The applicant is given another opportunity to respond and correct the statement
  • If repeated efforts to correct a defective statement show lack of cooperation, a formal request with a 30-day statutory deadline may be issued

It’s crucial for applicants to address any deficiencies promptly to avoid potential abandonment of their application.

For more information on USPTO procedures, visit: USPTO procedures.

Continued Prosecution Applications (CPAs) and Requests for Continued Examination (RCEs) are both methods to continue prosecution of an application, but they have significant differences:

  • CPAs are only available for design patent applications, while RCEs can be used for utility, plant, and design applications
  • CPAs result in a new application with the same application number, while RCEs continue examination of the same application
  • CPAs can only be filed before payment of the issue fee, abandonment, or termination of proceedings; RCEs can be filed after payment of the issue fee with a petition
  • CPAs automatically abandon the prior application, while RCEs do not

The MPEP states: Effective July 14, 2003, continued prosecution application (CPA) practice was eliminated as to utility and plant applications. Henceforth, applicants who wish to continue examination of the same claimed invention after the prosecution of a utility or plant application is closed should consider filing a request for continued examination (RCE) under 37 CFR 1.114.

It’s important to note that if an improper CPA is filed for a utility or plant application on or after July 14, 2003, it may be treated as an RCE: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

For continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), the front page of a printed patent will include:

  • The application number and filing date of the most recent noncontinued prosecution application
  • All prior applications from which benefit was claimed in the most recent noncontinued prosecution application

Notably, the filing date of the CPA itself is not included. As stated in the MPEP: “The front page of a printed patent issuing on a continued prosecution application (CPA) filed under 37 CFR 1.53(d) will identify the application number and filing date of the most recent noncontinued prosecution application (but not the filing date of the CPA) as well as all prior applications from which benefit was claimed in the most recent noncontinued prosecution application.” (MPEP 202)

The treatment of continuation-in-part (CIP) applications changed significantly after the deletion of 37 CFR 1.62. According to the MPEP: “A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.” This means that CIP applications can no longer be filed under the former File Wrapper Continuing Procedure and must be filed as new applications.

For more information on continuation-in-part application, visit: continuation-in-part application.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications, regardless of the original application’s filing date.

The MPEP specifically states: A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.

This means that applicants seeking to file a CIP application after December 1, 1997, would need to use a different filing procedure, such as filing a new application under 37 CFR 1.53(b).

To learn more:

To learn more:

For continuation-in-part (CIP) applications, the MPEP states: “A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application… will be treated as an improper application.”

This means that after the deletion of 37 CFR 1.62, CIP applications can no longer be filed using the former File Wrapper Continuing Procedure. Applicants seeking to file a CIP application must do so through the standard application process outlined in MPEP 201.06(d).

For more information on continuation-in-part application, visit: continuation-in-part application.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications, regardless of the filing date of the original application. The MPEP states:

“A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.”

This change in procedure means that applicants need to file CIP applications using different methods after December 1, 1997, to ensure proper processing and examination.

For continuation or divisional applications filed under 37 CFR 1.53(b) of an application previously accorded status under pre-AIA 37 CFR 1.47, the process is simplified. The MPEP states: In a continuation or divisional application filed under 37 CFR 1.53(b) of an application accorded status under pre-AIA 37 CFR 1.47, if a copy of a declaration from a prior application and a copy of a decision according status under pre-AIA 37 CFR 1.47 are filed as permitted by pre-AIA 37 CFR 1.63(d)(3)(i), the notice will not be repeated.

This means that if the proper documentation from the original application is provided, the USPTO won’t repeat the notification process for nonsigning inventors. This streamlines the application process for related applications.

To learn more:

To learn more:

The treatment of continuation or divisional applications filed under former 37 CFR 1.62 depends on the filing date of the original application:

  • For applications filed on or after June 8, 1995: Requests filed on or after December 1, 1997, are treated as requests for continued examination (RCE) under 37 CFR 1.114.
  • For applications filed before June 8, 1995: Requests filed on or after December 1, 1997, are treated as improper applications.

As stated in the MPEP: A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114, see MPEP 706.07(h), paragraph IV.

To learn more:

The treatment of continuation or divisional applications filed under former 37 CFR 1.62 depends on the filing date of the original application:

  • For applications filed on or after June 8, 1995: “A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114.” This means these applications are now processed under the RCE procedure.
  • For applications filed before June 8, 1995: Requests for continuation or divisional applications filed on or after December 1, 1997, will be treated as improper applications.

For more details on RCE procedures, refer to MPEP 706.07(h), paragraph IV.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on RCE, visit: RCE.

For applications filed on or after June 8, 1995, continuation or divisional applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated differently. The MPEP states: “A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114.” This means such applications are now processed under the RCE procedure rather than the former File Wrapper Continuing Procedure.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on RCE, visit: RCE.

According to the MPEP, A continuation or divisional application filed under 37 CFR 1.60 on or after December 1, 1997, will automatically be treated as an application filed under 37 CFR 1.53(b). This means that any continuation or divisional application filed after this date is processed under the new regulations, specifically 37 CFR 1.53(b), regardless of whether the applicant intended to file under the old 37 CFR 1.60 procedure.

To learn more:

To learn more:

The USPTO has specific procedures for handling Congressional and other official inquiries to ensure uniformity and compliance with Department of Commerce directives:

  • Inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies are typically processed through specialized offices.
  • The Office of Policy and International Affairs and/or the Office of Governmental Affairs usually handle these inquiries.
  • Specific types of correspondence are directed to appropriate offices for immediate attention.

According to the MPEP: Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs. (MPEP 203.08(a))

For specific types of inquiries:

  • Embassies, Office of the U.S. Trade Representative, Department of State: Contact the Administrator of the Office of Policy and International Affairs at 571-272-9300.
  • Congress or the White House: Contact the Director of the Office of Governmental Affairs at 571-272-7300.

This process ensures uniformity in the handling of contacts from the indicated sources, and also so that compliance with directives of the Department of Commerce is attained.

To learn more:

Congressional and other official inquiries about patent applications are handled through specific channels at the USPTO. According to MPEP 203.08(a):

Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs.

This procedure ensures uniformity in handling contacts from these sources and compliance with Department of Commerce directives. Specific instructions are provided for transmitting such inquiries to the appropriate offices within the USPTO.

For more information on USPTO procedures, visit: USPTO procedures.

For utility and design patent applications, as well as related proceedings, color drawings and photographs are handled as follows, according to MPEP 608.02(c):

Except for international applications, color photographs and color drawings in utility and design applications and proceedings will be stored in SCORE and a black and white copy thereof will be stored in IFW along with a SCORE placeholder sheet.

To break this down:

  • Color drawings and photographs are stored in SCORE (Supplemental Content Repository)
  • A black and white copy is stored in IFW (Image File Wrapper)
  • A SCORE placeholder sheet is included in the IFW

This applies to various types of applications and proceedings, including nonprovisional utility and design patent applications, reissue applications, reexamination proceedings, and supplemental examination proceedings.

To learn more:

How are classified documents marked at the USPTO?

Classified documents at the USPTO are marked with specific security classifications. According to MPEP 121:

  • Documents are marked as ‘Secret,’ ‘Confidential,’ or ‘Restricted Data’
  • These markings indicate the level of security required for handling the document
  • Each page of a classified document must bear the appropriate marking

The MPEP states: ‘All papers in the application and contents of the file jacket are marked with the highest level of security to which the application has been assigned.’ This ensures that all parts of the application are treated with the appropriate level of security throughout the examination process.

In the case of a patent application with only one claim, the numbering convention is different. According to MPEP 608.01(j):

“In a single claim case, the claim is not numbered.”

This means that if your patent application contains only one claim, you should not assign a number to that claim. This practice simplifies the presentation of the claim and avoids unnecessary numbering in cases where there’s only one claim to consider.

To learn more:

Black and white photographs and grayscale drawings are handled uniformly across various types of patent applications and proceedings. According to MPEP 608.02(c):

Black and white photographs and grayscale drawings in: (i) provisional applications under 35 U.S.C. 111(b); (ii) nonprovisional utility and design patent applications under 35 U.S.C. 111(a), including reissue utility and design patent applications; (iii) national stage applications under 35 U.S.C. 371; (iv) international applications (PCT); (v) international design applications; (vi) reexamination proceedings for utility patents and design patents; and (vii) supplemental examination proceedings will be stored in SCORE, and a black and white copy will be stored in IFW along with a SCORE placeholder sheet.

In summary, these types of drawings are:

  • Stored in SCORE (Supplemental Content Repository)
  • A black and white copy is stored in IFW (Image File Wrapper)
  • A SCORE placeholder sheet is included in the IFW

To learn more:

Black and white line drawings are handled differently depending on the type of application:

  • For provisional applications, nonprovisional utility patent applications, international applications (PCT), national stage applications, and reexamination proceedings for utility patents, they are converted into TIFF images and stored in IFW (Image File Wrapper).
  • For design applications, including reissue design patent applications, international design applications, and reexamination proceedings for design patents, they are stored in SCORE (Supplemental Content Repository), with a black and white copy stored in IFW along with a SCORE placeholder sheet.

As stated in the MPEP: Black and white line drawings submitted in: (i) provisional applications under 35 U.S.C. 111(b); (ii) nonprovisional utility patent applications under 35 U.S.C. 111(a), including reissue utility patent applications; (iii) international applications (PCT) and national stage applications under 35 U.S.C. 371; and (iv) reexamination proceedings for utility patents will be converted into TIFF images and stored in IFW.

To learn more:

The definition of biological sequences in patent applications depends on the filing date of the application:

  • For applications filed before July 1, 2022: Biological sequences are defined in 37 CFR 1.821(a).
  • For applications filed on or after July 1, 2022: Biological sequences are defined in 37 CFR 1.831(b).

MPEP 608.05(c) states: “Applications disclosing nucleotide and/or amino acid sequences, as defined in 37 CFR 1.821(a) for applications filed before July 1, 2022 or as defined in 37 CFR 1.831(b) for applications filed on or after July 1, 2022, are required to provide the biological sequence information in a sequence listing.”

These definitions typically include specific criteria for nucleotide and amino acid sequences that must be disclosed in the sequence listing.

To learn more:

How are assignments handled when they are not recorded?

When assignments are not recorded, they are still processed by the Assignment Division. According to the MPEP 317:

“All assignments not recorded will be appropriately marked for return to the sender where a correspondence address is available.”

This means that even if an assignment is not officially recorded, the Assignment Division will still handle the document and return it to the sender if possible. It’s important to note that while unrecorded assignments are processed, they do not have the same legal standing as recorded assignments.

For more information on Assignment Division, visit: Assignment Division.

The USPTO makes assignment records accessible to the public in several ways, as described in 37 CFR 1.12:

  1. Separate assignment records for patents and trademarks are maintained and are open to public inspection.
  2. Assignment records, digests, and indexes for patents are available on the USPTO website.
  3. Images of assignment documents recorded from June 1998 onwards are viewable on the Office website.
  4. For earlier records, the public can place an order to view images.

The MPEP notes: ‘The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.’

However, documents relating only to pending unpublished applications are not open to public inspection.

The handling of assignment records for related patent applications, such as divisional, continuation, or continuation-in-part applications, is addressed in MPEP 301.01. The key point is:

If the application on which a patent was granted is a division, continuation, or continuation-in-part of an earlier application, the assignment records of that earlier application will be open to public inspection because copies or access may be supplied to the earlier application pursuant to 37 CFR 1.14.

This policy has several implications:

  • Once a patent is granted on a related application, the assignment records of the parent application become publicly accessible.
  • This applies even if the parent application was previously unpublished or abandoned.
  • The public accessibility extends to all assignment records in the chain of related applications leading to the granted patent.

This approach ensures transparency in the ownership history of patented inventions, allowing interested parties to trace the chain of title through related applications. It’s important for applicants and assignees to be aware of this when considering their IP strategy and the potential disclosure of ownership information for related applications.

For more information on continuation applications, visit: continuation applications.

For more information on public inspection, visit: public inspection.

Assignment records for reissue applications are treated differently from regular patent applications due to their public nature. According to MPEP 301.01:

Assignment records relating to reissue applications are open to public inspection because reissue applications are open to public inspection pursuant to 37 CFR 1.11(b).

This means that once a reissue application is filed, its assignment records become publicly accessible, regardless of whether the original patent’s assignment records were previously confidential. This is because reissue applications are, by nature, related to already-issued patents and are subject to different rules regarding public disclosure.

The public accessibility of reissue application assignment records aligns with the general principle of transparency in the patent system, allowing interested parties to track ownership changes even during the reissue process. This can be particularly important for those monitoring patent rights in specific technological areas or for potential licensees or purchasers of patent rights.

For more information on public inspection, visit: public inspection.

For more information on reissue applications, visit: reissue applications.

The USPTO treats assignment records and application file records as distinct entities. According to MPEP 323.01(d):

Assignment records are recognized as distinct from application file records.

This distinction is important because:

  • Expungement procedures may affect assignment records differently than application file records.
  • Searches in the Assignment Historical Database may yield different results than searches in application files.
  • The process for correcting or modifying information may differ between assignment records and application file records.

Understanding this distinction is crucial for patent attorneys and applicants when managing their intellectual property records and conducting searches in USPTO databases.

To learn more:

Applications with Secrecy Orders are examined in a secure location by examiners with national security clearances under the control of Licensing and Review. As stated in the MPEP, All applications in which a Secrecy Order has been imposed are examined in a secure location by examiners possessing national security clearances under the control of Licensing and Review. This ensures that sensitive information remains protected during the examination process.

For more information on licensing and review, visit: licensing and review.

For more information on patent examination, visit: patent examination.

How are applications under secrecy order handled at the USPTO?

Applications under secrecy order at the USPTO are handled with strict security measures. According to MPEP 121, these applications are:

  • Stored in special safes or in metal cabinets equipped with three-position dial-type combination locks
  • Never removed from these secure storage areas except for processing
  • Processed and examined only by properly cleared personnel

The MPEP states: ‘Applications bearing national security markings must be stored in a safe or in metal cabinets equipped with a bar and a padlock.’ This ensures that access to these sensitive applications is strictly controlled and limited to authorized individuals only.

For more information on patent application handling, visit: patent application handling.

Applications filed under former 37 CFR 1.62 before December 1, 1997, continue to be processed and examined under the procedures set forth in the former regulation. The MPEP clearly states:

“All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.”

This means that the File Wrapper Continuing Procedure remains applicable for these older applications, ensuring consistency in their examination process.

For more information on patent examination, visit: patent examination.

Application numbers for patent applications are assigned by the Office of Patent Application Processing (OPAP) as follows:

n

    n

  • Nonprovisional applications are assigned numbers beginning with the series code ’15’ or ’16’.
  • n

  • Design applications are assigned numbers beginning with the series code ’29’.
  • n

  • Plant applications are assigned numbers beginning with the series code ’16’.
  • n

  • Provisional applications are assigned numbers beginning with the series code ’62’.
  • n

  • Reexamination proceedings are assigned numbers beginning with the series code ’90’.
  • n

n

As stated in the MPEP 503, “The application number includes a two-digit series code and a six-digit serial number.” This system allows for efficient categorization and tracking of different types of patent applications.

For more information on application number, visit: application number.

For more information on patent application types, visit: patent application types.

For more information on series code, visit: series code.

For PCT applications entering the national stage in the United States, the application number assignment process is slightly different. The MPEP states:

‘For PCT applications entering the national stage under 35 U.S.C. 371, the USPTO assigns the national stage application a U.S. application number.’

This means that when an international PCT application transitions to the national stage in the U.S., it receives a new U.S. application number distinct from its international application number. This U.S. application number is used for all subsequent processing and correspondence related to the national stage application.

It’s important to note that this U.S. application number is different from the international application number (PCT/XX/YYYY/######) that was used during the international phase of the PCT application.

For more information on application number, visit: application number.

The USPTO assigns application numbers to patent applications immediately after mail has been opened. According to MPEP 503, application numbers consist of a series code and a serial number. The series codes are assigned based on the type of application and the time period in which it was filed. For example:

  • 01/ – 16/ for nonprovisional applications (utility, plant, and reissue), with different ranges for specific time periods
  • 29/ for design applications
  • 35/ for international design applications
  • 60/, 61/, and 62/ for provisional applications
  • 90/ for ex parte reexamination proceedings
  • 95/ for inter partes reexamination proceedings
  • 96/ for supplemental examination proceedings and resulting ex parte reexamination proceedings

The MPEP notes: “If an application is filed using the USPTO patent electronic filing system, EFS-Web provides an Acknowledgement Receipt that contains a time and date stamp, an application number and a confirmation number.”

It’s important to note that the application number on a filing receipt is the official number, which may differ from any preliminary number provided on a postcard receipt.

For more information on application number, visit: application number.

For more information on patent application types, visit: patent application types.

For more information on serial number, visit: serial number.

For more information on series code, visit: series code.

When patent drawings are found to be unacceptable, the USPTO notifies applicants through the following process:

  1. The examiner advises the applicant in the first Office action about why the drawings are unacceptable.
  2. The examiner may use specific form paragraphs to explain the defects in the drawings.
  3. Applicants are informed that new corrected drawings are required.

The MPEP 608.02(b) states: If the original drawings are unacceptable, applicant will be notified and informed of what the objections are and that new corrected drawings are required.

It’s important to address these issues promptly to avoid delays in the patent application process.

To learn more:

For patent applications under a Secrecy Order, prosecution proceeds as normal, including issuing final rejections that the applicant must properly reply to. If the applicant files an appeal, it must be completed to prevent abandonment of the application.

However, as noted in MPEP 130, “such appeal will not be set for hearing by the Patent Trial and Appeal Board until the Secrecy Order is removed, unless specifically ordered by the Commissioner for Patents.”

Amendments in Secrecy Order cases are handled differently from regular patent applications. The MPEP states: Any amendments received thereafter are not entered or responded to until such time as the Secrecy Order is rescinded. At such time, amendments which are free from objection will be entered; otherwise they are denied entry. This means that amendments are held in abeyance until the Secrecy Order is lifted, at which point they are reviewed for entry.

For more information on prosecution, visit: prosecution.

Tags: prosecution

Amendments in secrecy order applications require special handling to maintain security. The MPEP 130 states:

In secrecy order cases, all proposed amendments to the specification and claims, and all provisional amendments to the abstract, drawings and claims must be submitted in duplicate for security review.

Key points about handling amendments in secrecy order cases include:

  • Amendments must be submitted in duplicate for security review.
  • One copy of the amendment is placed in the application file.
  • The other copy is forwarded to a defense agency for review.
  • The defense agency determines if the amendment can be entered without breaching national security.

This process ensures that any changes to the application maintain the required level of secrecy.

For more information on classified information, visit: classified information.

For more information on patent prosecution, visit: patent prosecution.

Allowed secrecy order applications require special handling to maintain security while progressing through the patent process. The MPEP 130 provides guidance on this:

When a secrecy order case is allowed, the Office of Patent Application Processing (OPAP) is notified. The notice of allowance and issue fee letters are drafted and reviewed in the Technology Center and may be hand carried to OPAP for mailing.

Key points about handling allowed secrecy order applications:

  • The Office of Patent Application Processing (OPAP) is notified of the allowance.
  • Notice of allowance and issue fee letters are carefully drafted and reviewed.
  • These documents may be hand-carried to OPAP for mailing to ensure security.
  • The application remains under secrecy order even after allowance.
  • Special care is taken to prevent unauthorized disclosure throughout the process.

This careful handling ensures that the application’s classified status is maintained even as it progresses towards issuance.

For more information on classified information, visit: classified information.

For more information on patent issuance, visit: patent issuance.

Affidavits or declarations filed in a prior application do not automatically become part of a new application. As stated in MPEP ¶ 2.03:

“Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application do not automatically become a part of this application.”

To rely on an earlier-filed affidavit or declaration, the applicant must:

  • Make remarks of record in the new application
  • Include a copy of the original affidavit or declaration filed in the prior application

This ensures that the examiner can consider the previously submitted evidence in the context of the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

Affidavits or declarations from a prior application do not automatically become part of a continuation or divisional application. The MPEP states: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the prior nonprovisional application do not automatically become a part of a continuation or divisional application filed under 37 CFR 1.53(b). Where it is desired to rely on an earlier filed affidavit or declaration, the applicant should make such remarks of record in the 37 CFR 1.53(b) application and include a copy of the original affidavit or declaration filed in the prior nonprovisional application. This ensures that the examiner is aware of and can consider the relevant affidavits or declarations from the prior application.

To learn more:

No, this specific requirement does not apply to all patent applications. The MPEP clearly states:

‘[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]’

This means that the requirement to provide the last known address of a nonsigning inventor is only applicable to pre-AIA applications filed before September 16, 2012, under 37 CFR 1.47. For applications filed on or after this date, different rules may apply, and applicants should consult the current USPTO guidelines or seek legal advice.

To learn more:

To learn more:

No, the United States Patent and Trademark Office (USPTO) does not provide advisory opinions on whether an individual or organization qualifies for small entity status. The MPEP 509.03(a) clearly states: “The U.S. Patent and Trademark Office does not give advisory opinions as to whether or not a specific individual or organization qualifies as a small entity.” This policy is based on Congressional intent that the USPTO rely exclusively on self-certification for small entity status. Applicants are responsible for determining their status and making the appropriate self-certification.

To learn more:

Tags: USPTO

No, the USPTO does not determine the legal effect of recorded documents on patent ownership at the time of recordation. The MPEP clearly states:

“The recordation of a document is not a determination of the effect of the document on the chain of title. The determination of what, if any, effect a document has on title will be made by the Office at such times as ownership must be established to permit action to be taken by the purported assignee in connection with a patent or an application.” (MPEP 313)

This means:

  • Recordation is primarily for public notice
  • The USPTO will evaluate ownership when necessary for specific actions
  • Parties should not assume recordation equates to USPTO approval of ownership claims

No, the USPTO does not routinely check the date of execution for inventor’s oaths or declarations. The MPEP states:

The Office does not check the date of execution of the oath or declaration and will not require a newly executed oath or declaration based on an oath or declaration being stale (i.e., when the date of execution is more than three months prior to the filing date of the application) or where the date of execution has been omitted.

However, applicants should be aware that they have a continuing duty of disclosure under 37 CFR 1.56. This means that while the USPTO doesn’t check the execution date, applicants are still responsible for ensuring the information in the oath or declaration remains accurate and up-to-date.

To learn more:

No, the inclusion of prior application information in the patent does not necessarily indicate that the claims are entitled to the benefit of the earlier filing date.

See MPEP 2136.03 and MPEP 2154.01(b) for additional information.

The Certificate of Mailing procedure does not apply to papers mailed from a foreign country. However, the Certificate of Transmission procedure can be used for correspondence transmitted to the USPTO from a foreign country, with some conditions. The MPEP states:

The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.

This means that while you can’t use a Certificate of Mailing for papers sent by postal mail from outside the United States, you can use a Certificate of Transmission for faxes or EFS-Web submissions from foreign countries, as long as the specific type of correspondence is eligible for the certificate procedure.

Yes, submitting a deficiency payment for micro entity fee errors affects your micro entity status. According to 37 CFR 1.29(k)(4):

Any deficiency payment (based on a previous erroneous payment of a micro entity fee) submitted under this paragraph will be treated as a notification of a loss of entitlement to micro entity status under paragraph (i) of this section.

This means that by submitting a deficiency payment, you are effectively notifying the USPTO that you are no longer entitled to micro entity status. After making the deficiency payment, you will need to pay fees at the small entity or non-small entity rate, as applicable, unless you file a new certification of micro entity status.

To learn more:

No, once a patent application publishes under 35 U.S.C. 122(b), it becomes available to the public. At that point, any previous grant restricting the inventor’s access to the application file is no longer in effect.

Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.

No, the act of recording a document with the USPTO does not determine its legal effect on patent ownership. The MPEP clearly states:

The recordation of a document is not a determination of the effect of the document on the chain of title.

This means that while the USPTO will record various documents related to patent interests, it does not make any judgments about how these documents affect ownership at the time of recordation. Instead, as the MPEP explains:

The determination of what, if any, effect a document has on title will be made by the Office at such times as ownership must be established to permit action to be taken by the purported assignee in connection with a patent or an application.

For more information on how the USPTO determines ownership when necessary, refer to MPEP § 324 and § 325.

For more information on chain of title, visit: chain of title.

For more information on patent assignment, visit: patent assignment.

Pre-AIA 37 CFR 1.47 does not directly apply to deceased inventors. The MPEP clearly states: Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

However, pre-AIA 37 CFR 1.47 does apply in cases where a known legal representative of a deceased inventor:

  • Cannot be found or reached after diligent effort, or
  • Refuses to make application

In such situations, the last known address of the legal representative must be provided, as per MPEP § 409.03(e).

To learn more:

To learn more:

No, paying a fee in a non-micro entity amount does not automatically change your entity status. According to MPEP 509.04(e):

Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.

To properly notify the USPTO of a change in entity status, you must file a separate notification in the application or patent. This notification must be filed prior to or at the time of paying any fee after the date on which micro entity status is no longer appropriate.

To learn more:

No, MPEP ¶ 2.11 does not apply to benefit claims for provisional applications. The MPEP explicitly states:

Do not use this form paragraph for benefit claims under 35 U.S.C. 119(e) to provisional applications.

This means that the copendency requirements and procedures outlined in MPEP ¶ 2.11 are specifically for non-provisional applications claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c). Provisional applications have different rules and procedures for claiming benefit, which are covered under 35 U.S.C. 119(e) and other sections of the MPEP.

For more information on benefit claims, visit: benefit claims.

For more information on patent procedure, visit: patent procedure.

Incorporation by reference under 37 CFR 1.57(b) has limited applicability to international patent applications:

  • It is only effective for the United States
  • It does not affect the international filing date
  • It cannot be used to accord an international filing date
  • Requests to add omitted material will not be acted upon before national stage entry

The MPEP states: “Any amendment to an international application pursuant to 37 CFR 1.57(b)(1) will be effective only as to the United States and shall have no effect on the international filing date of the application. The incorporation by reference relief provided in 37 CFR 1.57(b) cannot be relied upon to accord an international filing date to an international application that is not otherwise entitled to a filing date under PCT Article 11, and it cannot be relied upon to alter the international filing date accorded under PCT Article 11.”

No, filing an interim copy does not replace the need for a certified copy of the foreign application. While an interim copy satisfies the timeliness requirement, a certified copy is still required. The MPEP clarifies this point:

Thus, providing an interim copy of a foreign application under 37 CFR 1.55(j) satisfies the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f), but a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate.

In essence, the interim copy allows applicants to meet initial deadlines, but they must still provide a certified copy of the foreign application during the pendency of the U.S. application, unless they file a specific petition.

To learn more:

No, filing an amendment does not change the status of a ‘new’ application. The MPEP 203.01 explicitly states:

An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

This means that even if you submit changes or corrections to your application before receiving any feedback from the examiner, your application is still considered ‘new’ in the eyes of the patent office.

To learn more:

No, a mere change of business name does not constitute a change in legal entity for patent purposes. However, it is still an important part of the ownership record. As stated in MPEP 314:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.

This means that while the legal entity remains the same, the name change should be recorded to maintain an accurate chain of title for the patent.

According to MPEP 314, a mere change of business name does not constitute a change in legal entity for patent purposes. The MPEP states:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.

This means that while the legal entity remains the same, documenting the name change is still important for maintaining a clear chain of title for the patent.

To learn more:

Yes, substitute and continuation-in-part (CIP) applications generally require new assignments. As stated in MPEP 306: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

However, there is an exception for applications filed on or after September 16, 2012: Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

No, you do not need to submit copies of U.S. patents and patent application publications when filing an e-IDS. The MPEP 609.07 states:

Copies of U.S. patents and U.S. patent application publications cited in the IDS are not required to be submitted by the applicants with the e-IDS.

However, it’s important to note that for foreign patent documents, non-patent literature (NPLs), and unpublished U.S. patent applications not stored in the Office’s Image File Wrapper (IFW) system, you must submit PDF copies using EFS-Web.

To learn more:

To learn more:

Yes, in most cases, you need to submit a replacement sheet when canceling a patent drawing figure. However, there is an exception:

  • If the canceled figure was the only drawing on the sheet, you only need to submit a marked-up copy of the drawing sheet with an annotation showing the cancellation.
  • In all other cases, you must submit a replacement sheet of drawings without the canceled figure.

MPEP 608.02(t) states: “If a drawing figure is canceled, a replacement sheet of drawings must be submitted without the figure (see 37 CFR 1.121(d)). If the canceled drawing figure was the only drawing on the sheet, then only a marked-up copy of the drawing sheet including an annotation showing that the drawing has been cancelled is required.”

To learn more:

Generally, it is not necessary to resubmit prior art cited by the examiner in a parent application when filing a continuing application that claims benefit under 35 U.S.C. 120. The MPEP states:

“The examiner of the continuing application will consider information which has been considered by the Office in the parent application.”

However, if you want the information to be printed on the patent issuing from the continuing application, you should resubmit it. For international applications that designated the U.S., you must submit an information disclosure statement in the continuing application to ensure the examiner considers the documents cited in the international search report and/or international preliminary examination report.

To learn more:

No, you do not need to provide copies of U.S. patent documents when responding to an unlocatable file notice. The MPEP clearly states:

Since the Office can obtain copies of U.S. patent documents (U.S. patent application publications and patents) from its internal databases, the Office is not requiring applicants or patentees to provide copies of U.S. patent application publications and patents that are among the applicant’s or patentee’s record of the correspondence between the Office and the applicant or patentee for the application, patent, or other proceeding.

However, you must provide copies of all other correspondence and documents, including any appendix or information disclosure statement submitted with the application, unless specifically exempted in the notice.

To learn more:

To learn more:

If you filed a translation of the non-English provisional application and a statement of accuracy in the nonprovisional application before November 25, 2005, you do not need to provide them again. The MPEP ¶ 2.38 states in the Examiner Note:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This exception only applies to translations filed in the nonprovisional application before the specified date. For all other cases, the translation and statement must be filed in the provisional application itself.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

Whether you need to pay a fee to correct an error in a recorded assignment at the USPTO depends on the type of correction:

  • Cover sheet corrections: No fee is required for submitting a corrective document to fix errors in the cover sheet data.
  • Assignment document corrections: A recording fee is required when submitting a new corrective assignment document.

According to MPEP 323: “The recordation fee set forth in 37 CFR 1.21(h) is required for each application and patent against which the document is recorded.” This fee applies when recording a new corrective document, but not for simple cover sheet corrections.

For more information on USPTO fees, visit: USPTO fees.

Tags: USPTO fees

If you submitted the reference to the prior application within the required time period but in the wrong location, you may not need to file a petition. The MPEP provides guidance on this situation:

If the reference to the prior application was previously submitted within the time period set forth in 37 CFR 1.78 but was not included in the location in the application required by the rule (e.g., if the reference was submitted in an oath or declaration or the application transmittal letter), and the information concerning the benefit claim was recognized by the Office as shown by its inclusion on the first filing receipt, the petition under 37 CFR 1.78 and the petition fee under 37 CFR 1.17(m) are not required. (MPEP § 211)

However, you are still required to submit the reference in compliance with 37 CFR 1.78. This means:

  • For applications filed on or after September 16, 2012: File an ADS in compliance with 37 CFR 1.76 with the reference.
  • For applications filed before September 16, 2012: File either an amendment to the first sentence(s) of the specification or an ADS in compliance with pre-AIA 37 CFR 1.76.

For more information on petition requirements, visit: petition requirements.

Yes, you must assert small entity status separately for each related application. Specifically:

  • Status must be established in each related, continuing, and reissue application
  • Small entity status in one application does not affect the status of any other application or patent
  • A new assertion is required for continuations, divisionals, continuations-in-part, and reissue applications

According to 37 CFR 1.27(c)(4): “Status as a small entity must be specifically established by an assertion in each related, continuing and reissue application in which status is appropriate and desired. Status as a small entity in one application or patent does not affect the status of any other application or patent, regardless of the relationship of the applications or patents. The refiling of an application under § 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under § 1.53(d)), or the filing of a reissue application, requires a new assertion as to continued entitlement to small entity status for the continuing or reissue application.”

To learn more:

No, certified copies of patent applications as filed do not include an indication of assignment documents. According to the MPEP 303, “Certified copies of patent applications as filed do not include an indication of assignment documents.” This means that the initial certified copy of a patent application does not contain information about any assignments that may have been recorded.

For more information on assignment documents, visit: assignment documents.

For more information on certified copies, visit: certified copies.

For more information on patent applications, visit: patent applications.

For more information on USPTO, visit: USPTO.

Generally, applicants do not need to provide a separate listing of references cited in the international search report for a PCT national stage application. According to MPEP 609.03:

“There is no requirement that the examiner list the documents on a PTO-892 form and there is no requirement for the applicant to provide a separate listing of the references.”

However, it’s important to note that if the applicant wants these references to be printed on the face of the resulting patent, they must provide a separate listing, preferably on a PTO/SB/08 form, within the set period for reply to the Office action or within one month of the mailing date of the Notice of Allowability.

To learn more:

Can you file a CPA in a provisional application?

No, you cannot file a Continued Prosecution Application (CPA) in a provisional application. The MPEP 201.06(d) clearly states:

A CPA may not be filed in a provisional application.

CPAs are only available for certain types of nonprovisional applications. Specifically, they can be filed in design applications, and in utility and plant applications that were filed before May 29, 2000. Provisional applications have a different purpose and process, and do not allow for the filing of CPAs.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

Yes, video conferencing tools can be used for examiner interviews in patent applications, but there are specific requirements. According to MPEP 502.03:

‘USPTO video conferencing tools may be used to conduct examiner interviews in both published and unpublished applications under the Patent Internet Usage Policy.’

However, several conditions must be met:

  • Authorization by the practitioner is required prior to sending a meeting invite.
  • All video conferencing communications must be hosted by USPTO personnel.
  • Interviews must originate from USPTO links provided by the examiner.
  • Links from non-USPTO video conferencing tools are not acceptable.

The MPEP also states:

‘The practitioner’s participation in the interview is considered consent to the use of the video conferencing tool for the interview.’

It’s important to note that personal devices or non-USPTO tools cannot be used by USPTO employees for official communications.

To learn more:

In most cases, no. USPTO employees are prohibited from communicating, either orally or in writing, with a suspended or excluded patent attorney or agent regarding a patent application. The MPEP states:

USPTO employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application…

The only exception is if the suspended or excluded practitioner is the inventor or applicant on that specific application. Otherwise, USPTO staff cannot discuss an application with a practitioner who has been suspended or excluded from practice before the USPTO.

No, USPTO employees cannot apply for patents while employed. According to 35 U.S.C. 4:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent…’

This restriction extends for one year after their employment at the USPTO ends.

No, third parties cannot file Information Disclosure Statements (IDS) under 37 CFR 1.97 and 37 CFR 1.98. The MPEP clearly states:

Third parties (individuals not covered by 37 CFR 1.56(c)) cannot file information disclosure statements under 37 CFR 1.97 and 37 CFR 1.98.

However, third parties have other options to submit information:

  • For published applications: Submit patents and publications under 37 CFR 1.290.
  • For unpublished applications: File a protest under 37 CFR 1.291 before a notice of allowance is mailed.
  • Provide information to the applicant, who may then submit it to the Office in an IDS.

To learn more:

Tags: prior art, USPTO

Yes, the USPTO may request additional information when considering a petition to restore the right of priority. The MPEP states:

The Director may require additional information where there is a question whether the delay was unintentional.

This means that if the USPTO has doubts about whether the delay in filing was truly unintentional, they may ask for more details or evidence to support your claim. It’s important to be prepared to provide such information if requested to ensure your petition is properly considered.

For more information on unintentional delay, visit: unintentional delay.

No, the USPTO does not release drawings for correction. According to MPEP 608.02(b), which cites 37 CFR 1.85(b):

The Office will not release drawings for purposes of correction. If corrections are necessary, new corrected drawings must be submitted within the time set by the Office.

This means that applicants must submit new, corrected drawings rather than requesting the original drawings for modification. It’s the applicant’s responsibility to prepare and submit corrected drawings that meet the USPTO’s requirements.

To learn more:

Yes, the USPTO can refuse to expunge an improperly recorded assignment. According to MPEP 323.01(c):

‘The Office, however, has consistently taken the position that such a petition will not be granted unless it is apparent that the recording is a ‘clerical error on the part of the Office.”

This means that the USPTO is generally reluctant to expunge recorded assignments unless there’s clear evidence of an error on their part. If the improper recording was due to actions of the parties involved rather than the USPTO, the petition may be denied.

To learn more:

No, the USPTO cannot record a non-English assignment document without an accompanying English translation. MPEP 302.02 clearly states:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

This policy ensures that all recorded documents are accessible and understandable to USPTO examiners and the public. Attempting to record a non-English document without a translation will result in the document being rejected for recordation.

To learn more:

Can the USPTO independently verify information provided by patent applicants?

Yes, the USPTO has the authority to independently verify information provided by patent applicants. MPEP 410 states:

“The Office is not the guarantor of the accuracy, correctness or completeness of the information supplied by the applicant.”

This means that while the USPTO relies on the information provided by applicants, it may:

  • Conduct its own investigations
  • Request additional information or evidence
  • Consult external sources to verify claims

Applicants should be aware that the USPTO can and may verify any information submitted during the patent application process. It’s crucial to provide accurate and complete information to avoid potential legal issues or loss of patent rights.

For more information on patent application information, visit: patent application information.

No, the USPTO cannot assist in selecting a patent practitioner. According to MPEP 401, “The Office cannot aid in the selection of a patent practitioner.” However, the USPTO does provide resources for finding registered patent attorneys and agents:

  • A listing is available at www.uspto.gov/FindPatentAttorney
  • Applicants can request a list of registered practitioners in their area by writing to the Office of Enrollment and Discipline (OED)

Yes, the USPTO has the authority to extend deadlines during a postal service emergency. This is based on the provisions outlined in MPEP 511 and 35 U.S.C. 21(a).

Specifically, MPEP 511 states:

The Director may designate the interruption or emergency as a ‘postal service interruption or emergency’ under 35 U.S.C. 21(a) and provide for ‘tolling’ of the time for filing correspondence, fees, or other papers for a limited time.

This means that:

  • The USPTO Director can officially recognize the emergency
  • Time limits for filing various patent-related documents can be extended
  • The extension is typically for a specific, limited period
  • Applicants may need to provide evidence that their delay was due to the recognized emergency

It’s important to note that while the USPTO has this authority, each situation is evaluated individually, and extensions are not automatically granted.

To learn more:

No, the USPTO does not determine whether conditions in a conditional assignment have been fulfilled. According to 37 CFR 3.56:

“The Office does not determine whether such conditions have been fulfilled.”

The USPTO treats the submission of a conditional assignment for recordation as an indication that the condition has been met. This policy simplifies the Office’s handling of assignments and places the responsibility on the parties involved to ensure conditions are met before recording.

To learn more:

Yes, the USPTO can destroy models, exhibits, or specimens during patent prosecution under certain circumstances. The MPEP 608.03(a) states:

‘The United States Patent and Trademark Office will not return the model, exhibit, or specimen in the following cases: … (B) Where the model, exhibit, or specimen has been destroyed by a process of examination or has been returned to the applicant prior to the conclusion of prosecution.’

This indicates that some examination processes may result in the destruction of these items. Applicants should be aware that submitting models, exhibits, or specimens might lead to their alteration or destruction during the examination process.

To learn more:

Can the title of a patent application be changed after filing?

Yes, the title of a patent application can be changed after filing. According to MPEP 606:

Where the title is not descriptive of the invention claimed, the examiner should require the substitution of a new title that is clearly indicative of the invention to which the claims are directed.

This means that:

  • The examiner may require a title change if the original title is not sufficiently descriptive.
  • The applicant can voluntarily amend the title during prosecution.
  • Changes to the title can be made by amendment under 37 CFR 1.121(b).
  • The new title must still comply with all requirements, including being brief, technically accurate, and under 500 characters.

It’s important to note that while changes are possible, starting with a strong, accurate title can help avoid unnecessary amendments and ensure efficient processing of the application.

To learn more:

Can the timeliness requirement for priority documents be met through PDX?

Yes, the timeliness requirement for priority documents can be met through the Priority Document Exchange (PDX) program. MPEP 215.02(a) states:

‘If the priority document is retrieved by the USPTO within the time period set in 37 CFR 1.55(g), the applicant need not take any further action to meet the timeliness requirement.’

This means that if the USPTO successfully retrieves the priority document through PDX within the specified time frame (usually the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application), the timeliness requirement is automatically satisfied. However, applicants should still monitor the status to ensure the document is received and be prepared to submit it manually if necessary.

To learn more:

No, the time period for filing a foreign priority claim cannot be extended. As stated in MPEP 214.01: “This time period is not extendable.”

However, if you miss the deadline, there is a possibility to file a petition to accept an unintentionally delayed priority claim. The MPEP states: “If a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it includes the required identification information and is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

For more information on unintentionally delayed priority claims, refer to MPEP § 214.02.

To learn more:

Can the specification be omitted when filing a divisional or continuation application?

No, the specification cannot be omitted when filing a divisional or continuation application. However, the process is simplified. According to MPEP 201.06(c):

“A new specification (including the claims) may be submitted in a divisional application filed under 37 CFR 1.53(b). In such a case, the applicant must file a copy of the prior application as filed or a new specification.”

This means that while you must include a specification, you have two options:

  • Submit a copy of the prior application’s specification
  • Submit a new specification tailored to the divisional or continuation application

If you choose to submit a copy of the prior application, it’s important to ensure that it properly supports the claims in the new application. Any new matter introduced in a continuation application may result in a rejection under 35 U.S.C. 112(a).

Remember, the claims are considered part of the specification, so you must include claims with your application, whether you’re using the prior specification or submitting a new one.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on patent application requirements, visit: patent application requirements.

For more information on USPTO, visit: USPTO.

Yes, the right of priority can be restored if the U.S. application is filed after the 12-month priority period (or 6-month period for design applications), but within 2 months of the expiration of the priority period, if the delay was unintentional.

37 CFR 1.55(c) states: “If the subsequent application has a filing date which is after the expiration of the period set forth in paragraph (b)(1) of this section, but within two months from the expiration of the period set forth in paragraph (b)(1) of this section, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition pursuant to this paragraph, if the delay in filing the subsequent application within the period set forth in paragraph (b)(1) of this section was unintentional.”

To restore the right of priority, the applicant must file a petition including:
1. The priority claim
2. The petition fee
3. A statement that the delay was unintentional

The USPTO may require additional information to determine if the delay was truly unintentional.

Yes, the right of priority can be restored if the filing deadline is missed, but certain conditions must be met:

  • The subsequent application must be filed within two months of the expiration of the priority period.
  • A petition under 37 CFR 1.55(c) must be filed.
  • The delay in filing must be unintentional.

The MPEP states: As provided in 37 CFR 1.55(c), if the subsequent application has a filing date which is after the expiration of the twelve-month period (or six-month period in the case of a design application), but within two months from the expiration of the period, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.55(c), if the delay in filing the subsequent application within the period was unintentional. (MPEP 213.03)

To learn more:

No, the period for resubmitting corrected assignment documents cannot be extended. The MPEP 317.02 is explicit on this point:

“The specified period to resubmit the returned papers will not be extended.”

This strict policy underscores the importance of promptly addressing any issues with returned assignment documents. Failing to meet the specified deadline will result in the loss of the original receipt date as the recording date for the document. Instead, the USPTO will use the date they receive the corrected papers as the new recording date. This change can potentially affect the priority of your assignment and impact your intellectual property rights. Therefore, it’s crucial to carefully review any returned documents and act quickly to make the necessary corrections and resubmit within the given timeframe.

To learn more:

Yes, the original filing date can be preserved for returned patent documents under certain conditions. The MPEP 317.01 states:

“The returned papers, stamped with the original date of receipt by the Office, will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of filing of the papers as the date of recording of the document.”

This means that if you correct and resubmit the returned documents within the specified timeframe, the USPTO will use the original filing date as the recording date for the document.

To learn more:

Yes, the original filing date can be preserved for corrected documents under certain conditions. The MPEP states: “The returned papers, stamped with the original date of receipt by the Office, will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of filing of the papers as the date of recording of the document.” This means that if you correct and resubmit the document within the specified timeframe, the USPTO will use the original filing date as the recording date.

Can the order of joint inventors’ names be changed after filing a patent application?

Yes, the order of joint inventors’ names can be changed after filing a patent application, but it requires a specific process. The MPEP 602.09 states:

“The order of names of joint patentees in the heading of the patent is taken from the order in which the names appear in the application papers unless changed by request.”

To change the order of inventors’ names:

  • Submit a request to the USPTO
  • Provide a statement from all the joint inventors agreeing to the change
  • Pay any required fees

It’s important to note that changing the order doesn’t affect inventorship rights but may impact how the patent is cited in literature. The request should be made before the patent is granted for it to appear in the correct order on the issued patent.

To learn more:

Yes, the inventorship in a Continued Prosecution Application (CPA) can differ from the original application, but only if a proper request is filed and approved.

According to MPEP ¶ 2.33: Otherwise, the inventorship in the CPA shall be the same as in the prior application. This implies that changes to inventorship are possible, but they require specific action.

To change the inventorship, you must file a request under 37 CFR 1.48. This applies whether you’re adding, removing, or changing the order of inventors. Without this formal request, the inventorship will remain the same as in the original application, even if new inventors are listed on the CPA filing documents.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Yes, the inventorship in a continuation or continuation-in-part (CIP) application can differ from the parent application, but there are specific requirements:

1. For continuation applications: The inventorship must include at least one inventor named in the prior-filed application.

2. For CIP applications: The inventorship can change more significantly due to the addition of new matter.

The MPEP states for continuation applications: “The inventorship in the continuation application must include at least one inventor named in the prior-filed application.”

For CIP applications, the MPEP notes: “A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78. Subject to the same conditions, a continuation-in-part application that has joint inventors may derive from an earlier application that has a sole inventor.”

Any changes in inventorship must be properly documented and may require a request under 37 CFR 1.48.

The inventorship in a Continued Prosecution Application (CPA) generally remains the same as in the prior application, but it can be changed under certain circumstances:

  • The inventorship automatically carries over from the prior application unless a statement is filed requesting deletion of inventors
  • Inventors can be deleted by filing a statement with the CPA request
  • Adding new inventors requires a request under 37 CFR 1.48 after the CPA is filed

The MPEP states: The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

For more information on patent applications, visit: patent applications.

Yes, for applications filed on or after September 16, 2012 (except reissue applications), the inventor’s oath or declaration can be postponed until the application is in condition for allowance, provided certain conditions are met:

  • An application data sheet (ADS) in compliance with 37 CFR 1.76 must be filed identifying each inventor by their legal name, mailing address, and residence (if different from mailing address)
  • The inventor’s oath or declaration must be filed no later than the date on which the issue fee is paid

The MPEP states: For applications filed on or after September 16, 2012 (except reissue applications), applicant may postpone filing the inventor’s oath or declaration until the application is in condition for allowance if an application data sheet (ADS) in compliance with 37 CFR 1.76 is filed identifying: (1) each inventor by their legal name; and (2) for each inventor, a mailing address where the inventor customarily receives mail, and residence, if the inventor lives at a location which is different from where the inventor customarily receives mail. See 37 CFR 1.53(f)(3).

This provision allows applicants more flexibility in completing the application requirements, but it’s important to ensure the oath or declaration is filed before paying the issue fee to avoid abandonment.

For more information on declaration, visit: declaration.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on patent application requirements, visit: patent application requirements.

Can the inventor’s oath or declaration be submitted after filing the patent application?

Yes, the inventor’s oath or declaration can be submitted after filing the patent application. The MPEP 602.01(a) states:

“The inventor’s oath or declaration may be submitted after the application filing date. If the oath or declaration is filed after the application filing date, it must be accompanied by the surcharge under 37 CFR 1.16(f).”

However, it’s important to note:

  • The application must still name each inventor at the time of filing
  • An application data sheet (ADS) under 37 CFR 1.76 must be submitted with the application filing
  • The oath or declaration should be submitted no later than the date on which the issue fee is paid

Submitting the oath or declaration after filing may incur additional fees and potentially delay the examination process.

To learn more:

Yes, the foreign application may have been filed by and in the name of the assignee or legal representative or agent of the inventor, as applicant.

If the certified copy of the foreign application corresponds with the one identified in the U.S. application and no discrepancies appear, it may be assumed the U.S. application is entitled to claim priority to the foreign application.

If the U.S. application and the certified copy do not name the same inventor or have at least one joint inventor in common, the priority date should be refused until the inconsistency is resolved. [MPEP 216]

Yes, the filing of an inventor’s oath or declaration can be postponed under certain conditions. According to the MPEP:

If an application data sheet has been submitted, applicant may postpone the filing of the inventor’s oath or declaration until the application is in condition for allowance for applications filed on or after September 16, 2012.

This provision allows applicants more flexibility in the timing of submitting the inventor’s oath or declaration. However, it’s important to note that the oath or declaration must be submitted no later than the date on which the issue fee is paid, as required by 35 U.S.C. 115(f).

To learn more:

Yes, for applications filed on or after September 16, 2012 (except reissue applications), the filing of an inventor’s oath or declaration can be postponed. The MPEP states:

For applications filed on or after September 16, 2012 (except reissue applications), applicant may postpone filing the inventor’s oath or declaration until the application is in condition for allowance if an application data sheet (ADS) in compliance with 37 CFR 1.76 is filed identifying: (1) each inventor by their legal name; and (2) for each inventor, a mailing address where the inventor customarily receives mail, and residence, if the inventor lives at a location which is different from where the inventor customarily receives mail.

However, the inventor’s oath or declaration must be filed no later than the date on which the issue fee is paid.

Yes, the filing fee, oath or declaration, and claims can be submitted after the initial filing of a nonprovisional application. However, there are specific rules and time limits for doing so:

  • These items must be submitted within the period specified by the USPTO, usually in a Notice to File Missing Parts.
  • A surcharge may be required for late submission.
  • Failure to submit these items within the specified period may result in the application being abandoned.

The MPEP states: The fee, oath or declaration, and 1 or more claims may be submitted after the filing date of the application, within such period and under such conditions, including the payment of a surcharge, as may be prescribed by the Director.

It’s important to note that while these items can be submitted later, it’s generally best practice to include them with the initial filing to avoid potential issues or delays.

To learn more:

Yes, the patent examiner has the authority to renumber claims in certain circumstances. According to MPEP 608.01(j):

“When the application is ready for allowance, the examiner, if necessary, will renumber the claims consecutively in the order in which they appear or in such order as may have been requested by applicant.”

This means that while the original claim numbering should be preserved throughout most of the prosecution process, the examiner may renumber the claims at the end of the process, typically when preparing the application for allowance. This final renumbering ensures a logical and sequential order of claims in the issued patent.

To learn more:

No, the English translation and accuracy statement for a non-English provisional application cannot be filed in the non-provisional application. They must be filed in the provisional application itself. MPEP ¶ 2.38 is explicit about this requirement:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3].”

However, there is an exception to this rule. The MPEP states:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This means that for applications filed before November 25, 2005, it was acceptable to file these documents in the non-provisional application. For all applications after this date, the translation and statement must be filed in the provisional application, with a confirmation in the non-provisional application that this has been done.

For more information on patent procedure, visit: patent procedure.

Yes, the Director of the USPTO has the authority to grant access to patent applications in certain circumstances. According to MPEP 104:

“Access provided upon the written order of the Director will also become a part of the record of the application.”

Additionally, the MPEP states:

“Where an applicant relied on the applicant’s application as a means to interfere with a competitor’s business or customers, permission to inspect the application may be given the competitor by the Director. Such permission is via petition for access under 37 CFR 1.14(i).”

This means that in special cases, particularly where there may be competitive interests at stake, the Director can authorize access to an application. However, this permission is not of a continuing nature and may be subject to reevaluation based on changing circumstances.

For more information on Patent application access, visit: Patent application access.

For more information on petition for access, visit: petition for access.

No, extensions of time are not permitted for submitting corrected drawings in response to a notice of allowability. The MPEP clearly states:

Extensions of time to provide acceptable drawings in response to a notice of allowability are not permitted.

This strict policy ensures that the patent granting process is not unnecessarily delayed and encourages applicants to submit corrected drawings promptly after receiving the notice of allowability.

To learn more:

Yes, the benefit of a provisional application can be restored even after the 12-month deadline has passed, under certain conditions. The MPEP explains:

“If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

To restore the benefit, a petition under 37 CFR 1.78(b) must be filed, which requires:

  • A reference to the provisional application
  • The petition fee
  • A statement that the delay was unintentional

The petition must be filed in the subsequent application or, in certain cases, in the earliest nonprovisional application claiming benefit to the international application.

To learn more:

To learn more:

Yes, removing superfluous matter from patent drawings is one of the changes that can be made without requiring annotated sheets from the applicant. MPEP 608.02(w) states:

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: … (C) Removing superfluous matter.

This provision allows examiners to suggest the removal of unnecessary elements from the drawings, helping to improve clarity and focus on the essential aspects of the invention without requiring a formal submission of annotated sheets by the applicant.

To learn more:

In general, status information cannot be provided for unpublished patent applications, unless the requester is:

  1. The applicant
  2. A patent practitioner of record
  3. The assignee or an assignee of an undivided part interest
  4. The inventor or a joint inventor
  5. A registered attorney or agent named in the application papers

Alternatively, a person with written authority from any of the above parties can be provided status information.

There are some exceptions where status information can be supplied for unpublished applications, such as:

  • When the application is identified in a published patent document or another application publication
  • When the application is a national stage application or claims benefit to a published international application and the US is a designated state
  • When the application is an international design application maintained by the USPTO for national processing

Yes, some deficiencies or inaccuracies in an inventor’s oath or declaration can be corrected using an Application Data Sheet (ADS). The MPEP states: “Some deficiencies or inaccuracies can be corrected with an application data sheet (ADS) in accordance with 37 CFR 1.76.” For more detailed information on using an ADS, the MPEP refers to MPEP § 601.05.

To learn more:

Can small entity status be changed during the patent process?

Yes, small entity status can be changed during the patent process. The MPEP 509.03 provides guidance on this: “Once status as a small entity has been established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.” This means that:

  • You can change from small entity to large entity at any time by simply paying the full fee.
  • If you lose small entity status, you must notify the USPTO before or with the next fee payment.
  • Changing from large entity to small entity requires a new certification of entitlement to small entity status.

It’s important to monitor your status throughout the patent process and update the USPTO promptly if changes occur to avoid potential issues.

To learn more:

Can small entity status be changed during the life of a patent?

Yes, small entity status can change during the life of a patent. The MPEP 509.03 provides guidance on this:

Once status as a small entity has been established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.

Key points to remember:

  • Status can change due to mergers, acquisitions, or licensing agreements.
  • The USPTO must be notified of any change before paying the issue fee or maintenance fees.
  • If status changes from small to large entity, future fees must be paid at the higher rate.
  • Conversely, if an entity becomes eligible for small entity status, they can claim it for future fee payments.

It’s important to regularly review your entity status and update the USPTO as necessary to ensure compliance and proper fee payment.

To learn more:

No, sequence listings or tables should not be duplicated in both the drawings and the specification of a patent application. The MPEP 608.02(d) clearly states:

If an application filed under 35 U.S.C. 111 or under 35 U.S.C. 371 includes a sequence listing or a table, such a sequence listing or table should not be included in both the drawings and the descriptive portion of the specification.

This requirement helps to avoid redundancy and potential inconsistencies between the drawings and the specification. Applicants should include sequence listings and tables in the appropriate sections of the specification only.

To learn more:

Can security interests in patents be recorded at the USPTO?

Yes, security interests in patents can be recorded at the USPTO. MPEP 313 states:

Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11(a).

This includes security interests, which are typically recorded to protect the lender’s rights in case of default. Recording a security interest provides public notice of the lender’s claim on the patent asset.

To record a security interest:

  • Submit the document to the USPTO’s Assignment Recordation Branch
  • Pay the required fee
  • Ensure the document meets the requirements outlined in MPEP 302

Recording does not guarantee the validity of the security interest but establishes an official record of the claim.

For more information on security interests, visit: security interests.

Yes, replacement drawings can be rejected if they contain new matter. The MPEP 608.02(h) states that when reviewing replacement drawings, examiners should not overlook “such factors as new matter, the necessity for the replacement sheets and consistency with other sheets.”

If an examiner identifies new matter in the replacement drawings, they may decide not to enter the sheets into the application. In such cases, the examiner must provide a complete and explicit reasoning for the denial of entry. The MPEP instructs examiners to:

“Identify any drawing(s) not entered because they contain new matter and explain the correction(s) necessary to obtain entry upon resubmission.”

Applicants should ensure that replacement drawings only contain information that was supported in the original disclosure to avoid rejection based on new matter.

To learn more:

Yes, according to MPEP 608.02(w), adding two or three reference characters or exponents is one of the changes that can be made to patent drawings without requiring annotated sheets from the applicant. The MPEP states:

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: (A) Adding two or three reference characters or exponents.

This allows for minor additions to improve the clarity of the drawings without necessitating a formal submission from the applicant.

To learn more:

No, recorded assignment documents will not be expunged even if they are subsequently found to be invalid. The USPTO’s policy is to maintain a complete history of claimed interests in property.

As stated in the MPEP: “Office policy regarding recordation of assignment documents is directed toward maintaining a complete history of claimed interests in property and, therefore, recorded assignment documents will not be expunged even if subsequently found to be invalid. See In re Ratny, 24 USPQ2d 1713 (Comm’r Pat. 1992).” (MPEP § 323)

Once a document is recorded with the Assignment Services Division, it will not be removed from the record relating to that application or patent.

Yes, priority can be claimed based on applications filed under bilateral or multilateral treaties. The MPEP states:

Under Article 4A of the Paris Convention for the Protection of Industrial Property, a right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design filed under the national law of a foreign country adhering to the Convention, or on a foreign application filed under a bilateral or multilateral treaty concluded between two or more such countries.

Examples of such treaties include:

  • The Hague Agreement Concerning the International Registration of Industrial Designs
  • The Convention on the Grant of European Patents (European Patent Office)
  • The Patent Cooperation Treaty (PCT)
  • The International Convention for the Protection of New Varieties of Plants (UPOV)

Applications filed in regional patent offices, such as the European Patent Office (EPO) or the African Regional Intellectual Property Organization (ARIPO), can also serve as a basis for priority claims.

To learn more:

Yes, applicants can claim priority under 35 U.S.C. 119(a)-(d) based on applications filed in certain foreign regional patent offices. The MPEP states:

“In addition to the list of recognized countries set forth in subsection I, above, applicants may claim priority under 35 U.S.C. 119(a)-(d) to applications filed in foreign regional patent offices having member states who are members of the Paris Convention.”

The recognized regional patent offices include:

  • African Regional Intellectual Property Organization (ARIPO)
  • Eurasian Patent Office (EAPO)
  • European Patent Office (EPO)
  • Gulf Cooperation Council (GCC) Patent Office
  • African Intellectual Property Organization (OAPI)

These regional patent offices allow applicants to file a single application that can have effect in multiple member states, streamlining the international patent application process.

While the USPTO is responsible for the content and updates of the MPEP, patent professionals can indirectly influence its content. The USPTO often seeks public input on proposed rule changes and updates to examination procedures. Professionals can participate in these public comment periods or engage with professional organizations that provide feedback to the USPTO. However, there is no formal process for directly suggesting content for specific reserved sections like MPEP 312.

Patent practitioners should not rely on information from reserved MPEP sections, as these sections do not contain any official guidance or information. A reserved section, such as MPEP 404, is essentially a placeholder and does not provide any substantive content. Practitioners should instead:

  • Refer to active, non-reserved sections of the MPEP
  • Consult the most recent USPTO guidelines and notices
  • Stay updated on changes to patent laws and regulations
  • Seek guidance from official USPTO sources when needed

It’s important to always use the most current and official information when dealing with patent matters.

While patent attorneys or applicants cannot directly propose content for reserved MPEP sections like 319, they can provide feedback or suggestions to the USPTO regarding patent examination procedures or policies. The USPTO occasionally seeks public input on proposed changes to patent examination practices, which could potentially influence the content added to reserved sections in the future. However, the ultimate decision on what content to include in the MPEP rests with the USPTO.

Generally, no part of a patent specification can be transferred to another application. The Manual of Patent Examining Procedure (MPEP) § 608.01(t) states: “No part of a specification can normally be transferred to another application.” This means that each patent application should contain its own unique specification, tailored to the specific invention being described and claimed.

To learn more:

To learn more:

The USPTO does not grant partial access to assignment documents. According to MPEP 301.01:

The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.

This policy ensures transparency and prevents selective disclosure of information. It’s important to note that this approach can have implications for documents that contain both public and potentially confidential information. For example:

  • If a document covers both a trademark and a patent application, the entire document becomes public.
  • If a document covers multiple patent applications, it becomes public as soon as any one of the applications is published or patented.

This policy underscores the importance of carefully considering what information is included in assignment documents, particularly when dealing with a mix of public and non-public intellectual property rights.

For more information on assignment documents, visit: assignment documents.

For more information on public inspection, visit: public inspection.

For more information on USPTO policy, visit: USPTO policy.

Can one co-inventor revoke a power of attorney in a patent application?

No, a single co-inventor cannot unilaterally revoke a power of attorney in a patent application. The MPEP 402.10 states:

A power of attorney may not be revoked by less than all of the applicants or owners of the entire interest without good and sufficient reason, and the revocation must be approved by the Director.

This means that to revoke a power of attorney, all co-inventors or owners of the entire interest must agree to the revocation. If a single co-inventor wishes to revoke the power of attorney, they must provide a good and sufficient reason, and the revocation must be approved by the Director of the USPTO.

To learn more:

Yes, in some cases, omitting information from a patent application can be considered new matter. This might seem counterintuitive, but the removal of certain information can change the scope or meaning of the invention in a way that wasn’t supported by the original disclosure.

The MPEP provides an example: New matter includes not only the addition of wholly unsupported subject matter, but may also include […] even the omission of a step from a method. (MPEP 608.04(a))

This concept is particularly important in the context of:

  • Changing the scope of the invention
  • Altering the nature of the invention
  • Removing essential features or steps

Applicants should be cautious when making any changes to their application, including deletions, to ensure they don’t inadvertently introduce new matter by omission. If in doubt, it’s advisable to consult with a patent attorney or agent.

To learn more:

Tags: new matter, USPTO

No, objections to drawings in utility or plant applications cannot be held in abeyance. The MPEP section 608.02(f) clearly states:

“Unless applicant is otherwise notified in an Office action, objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action.”

This policy is based on 37 CFR 1.85(a) and ensures that drawing issues are addressed promptly in the patent application process. Applicants must respond to drawing objections in a timely manner to avoid potential abandonment of their application.

To learn more:

To learn more:

Yes, non-US citizens, specifically nonimmigrant aliens residing in the United States, can obtain limited recognition for patent matters under certain conditions. According to MPEP 402.09 and 37 CFR 11.9(b):

A nonimmigrant alien residing in the United States and fulfilling the provisions of paragraphs (d) and (e) of this section may be granted limited recognition if the nonimmigrant alien is authorized by the United States Government to be employed or trained in the United States in the capacity of representing a patent applicant by presenting or prosecuting a patent application.

However, it’s important to note that limited recognition is not granted to non-US citizens residing abroad and automatically expires upon the nonimmigrant alien’s departure from the United States.

To learn more:

No, non-registered representatives should not be contacted for patent application actions, even if they appear to be authorized by the attorney or agent of record. The MPEP clearly states:

In addition, non-registered representatives of the practitioner of record should not be contacted for such actions, even if apparently authorized by the attorney or agent of record.

This restriction helps maintain the integrity of the patent application process and ensures that only qualified, registered practitioners are involved in critical communications.

Yes, new terms can be introduced in patent claims after the initial filing, but certain requirements must be met. According to MPEP 608.01(o):

New claims, including claims first presented after the application filing date where no claims were submitted on filing, and amendments to the claims already in the application should be scrutinized not only for new matter but also for new terminology.

However, if new terms are introduced, the specification should be amended to provide clear support or antecedent basis for these terms. This ensures that the meaning of the terms in the claims can be understood by referring to the description.

To learn more:

No, new matter cannot be introduced into a nonprovisional application through a supplemental oath or declaration. This is explicitly stated in MPEP 603:

37 CFR 1.67(d) contains the provision of former 37 CFR 1.67(b) that no new matter may be introduced into a nonprovisional application after its filing date even if an inventor’s oath or declaration is filed to correct deficiencies or inaccuracies present in the earlier-filed oath or declaration.

This rule is consistent with the general principle in patent law that new matter cannot be added to an application after its filing date. The purpose of a supplemental oath or declaration is to correct deficiencies or inaccuracies in the original filing, not to introduce new subject matter.

To learn more:

No, new matter cannot be added to a divisional application. The divisional application must only contain subject matter disclosed in the parent application. The MPEP clearly states:

Thus the disclosure presented in a divisional application must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

Any attempt to add new matter to a divisional application will be rejected under 35 U.S.C. 112(a) as lacking written description support in the parent application.

To learn more:

Can new matter be added to a continuation application?

No, new matter cannot be added to a continuation application. A continuation application must disclose and claim only subject matter disclosed in the prior application.

As stated in MPEP 201.07: “The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.” This means that all claims in a continuation application must find support in the original disclosure of the parent application.

If an applicant wishes to add new matter, they would need to file a continuation-in-part (CIP) application instead, which allows for the addition of new subject matter while still claiming the benefit of the earlier filing date for the previously disclosed material.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

No, new matter cannot be added in a Continued Prosecution Application (CPA). The MPEP clearly states: No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application. Any attempt to add new matter will be denied entry by the examiner. If an applicant needs to add new matter, they should consider filing a continuation-in-part application under 37 CFR 1.53(b) instead of a CPA.

To learn more:

Tags: CPA, new matter

Can multiple provisional applications be filed for the same invention?

Yes, multiple provisional applications can be filed for the same invention. The MPEP 201.04 does not place restrictions on filing multiple provisionals. In fact, this practice can be beneficial for inventors who are continuously developing their invention.

Each provisional application establishes a potential priority date for the disclosed content. When filing a subsequent nonprovisional application, the applicant can claim the benefit of multiple provisional applications, potentially securing multiple priority dates for different aspects of the invention.

However, it’s important to note that each provisional application must still meet the requirements of 35 U.S.C. 112(a) for the disclosed subject matter to be eligible for the priority date.

For more information on patent priority, visit: patent priority.

Yes, multiple provisional applications can be combined into a single non-provisional application. This is particularly useful when an inventor has made improvements or additions to their invention over time. The MPEP 201.04 states:

A nonprovisional application that was filed within 12 months of an earlier provisional application may claim the benefit of that provisional application.

While this quote doesn’t explicitly mention multiple provisionals, the USPTO allows claiming benefit from multiple provisional applications in a single non-provisional application, provided each provisional is properly referenced and the non-provisional is filed within 12 months of the earliest provisional application.

For more information on Non-provisional application, visit: Non-provisional application.

For more information on patent priority, visit: patent priority.

For more information on provisional application, visit: provisional application.

Yes, multiple inventors can be deleted from a Continued Prosecution Application (CPA) at once. The language in MPEP ¶ 2.32 supports this:

In bracket 1 insert the name or names of the inventor(s) requested to be deleted.

This indicates that the process allows for the deletion of one or more inventors simultaneously. When filing a CPA, applicants can submit a statement requesting the deletion of multiple named inventors who are not inventors of the invention being claimed in the new application.

However, it’s crucial to ensure that all remaining inventors are correctly named and that the inventorship accurately reflects those who contributed to the claimed invention. If the CPA has already been filed, remember that any subsequent inventorship changes must follow the procedures outlined in 37 CFR 1.48.

For more information on CPA, visit: CPA.

Tags: CPA

Generally, the USPTO maintains only one correspondence address for each patent application. As stated in MPEP 403:

‘The Office will direct all notices, official letters, and other communications relating to the application to a single correspondence address.’

However, there are exceptions:

  • Powers of attorney to different practitioners may be present in an application, but only one correspondence address is recognized.
  • In reexamination proceedings, a ‘duplicate copy’ may be sent to a different address.
  • Maintenance fee reminders may be sent to a ‘fee address’ that differs from the correspondence address.

It’s important to note that while multiple addresses may be associated with an application for specific purposes, the USPTO will generally communicate with only one primary correspondence address.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on USPTO, visit: USPTO.

While it’s possible to include multiple correspondence addresses for a single patent application filed after September 16, 2012, the USPTO will ultimately select only one for official use. Here’s what you need to know:

  • Multiple addresses can be provided in the application
  • The USPTO will choose one address as the official correspondence address
  • If a Customer Number is provided, it may be given preference
  • Only the selected address will receive official communications

The MPEP 403.01(a) states:

Pursuant to 37 CFR 1.33(a), if an applicant includes more than one correspondence address (37 CFR 1.33(a) ) in a patent application, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

To ensure clear communication, it’s best to designate a single, preferred correspondence address for your application. If you need to change this address later, you can file a request with the USPTO.

To learn more:

Yes, multiple attorneys can be appointed in a patent application. According to MPEP 402.02:

More than one attorney, agent, or other party may be appointed as representative of the applicant or owner.

When appointing multiple attorneys:

  • Use the appropriate power of attorney form (PTO/AIA/82 for applications filed on or after September 16, 2012, or PTO/SB/81 for earlier applications).
  • List all attorneys or agents to be appointed.
  • Specify if they are to act independently or as a team.

To learn more:

Can multiple assignees take action in a patent application?

Yes, multiple assignees can take action in a patent application, but there are specific requirements they must meet. The MPEP 325 states:

“Where multiple assignees are named in the statement under 37 CFR 3.73(c) and/or the Form PTO/AIA/96, and they are not named as joint owners in a single statement or form, the statement or form must be modified accordingly.”

This means that:

  • Multiple assignees can be named in a single statement or form if they are joint owners
  • If they are not joint owners, separate statements or forms must be submitted for each assignee
  • Each assignee must establish their right to take action as per 37 CFR 3.71 and 37 CFR 3.73

It’s important to note that the USPTO will not mediate disputes between assignees. If there are conflicting instructions from multiple assignees, the USPTO may suspend action on the application.

For more information on multiple assignees, visit: multiple assignees.

For more information on USPTO procedures, visit: USPTO procedures.

No, modifications cannot be shown in broken lines on figures that show another form of the invention in solid lines. This is based on the principle established in Ex parte Badger, 1901 C.D. 195, 97 OG 1596 (Comm’r Pat. 1901). The MPEP section 608.02(f) states:

“Modifications may not be shown in broken lines on figures which show in solid lines another form of the invention.”

This rule ensures clarity and prevents confusion in patent drawings by keeping different forms of the invention visually distinct.

To learn more:

Yes, models and exhibits can be presented for demonstration purposes during a patent interview. However, there are specific guidelines to follow:

  • The models and exhibits should be taken away by the applicant or their representative at the conclusion of the interview.
  • They are generally not permitted to be admitted as part of the application or patent unless the requirements of 37 CFR 1.91 are satisfied.
  • A full description of what was demonstrated or exhibited during the interview must be made of record, as per 37 CFR 1.133.

The MPEP states, Any model or exhibit that is left with the examiner at the conclusion of the interview, which is not made part of the application or patent, may be disposed of at the discretion of the Office. (MPEP 608.03(a))

To learn more:

Tags: USPTO

Yes, correcting misspelled legends in patent drawings is one of the changes that can be made without requiring annotated sheets from the applicant. According to MPEP 608.02(w):

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: … (H) Correcting misspelled legends.

This provision allows for the correction of minor typographical errors in drawing legends, improving the accuracy of the patent application without the need for a formal submission of annotated sheets by the applicant.

To learn more:

Can limited recognition be granted to Canadian patent agents?

Yes, limited recognition can be granted to Canadian patent agents. According to MPEP 402.01: Canadian patent agents are not authorized to practice before the Office without proper recognition from the OED Director. Canadian patent agents who are registered and in good standing with the Canadian Patent Office may be granted limited recognition to represent a named applicant in a specific application if the named applicant also appoints a registered U.S. practitioner. This provision allows Canadian patent agents to participate in specific applications, but with certain restrictions and requirements.

To learn more:

To learn more:

Yes, joint inventors can use a single non-English oath or declaration under certain circumstances. The MPEP 602.06 states:

“The Office will accept a single non-English language oath or declaration where there are joint inventors, of which only some understand English but all understand the non-English language of the oath or declaration.”

This means that as long as all joint inventors understand the language used in the oath or declaration, even if some also understand English, a single non-English document can be submitted for all inventors.

To learn more:

Can joint inventors file separate patent applications for the same invention?

No, joint inventors cannot file separate patent applications for the same invention. The MPEP 602.09 states: ‘Joint inventors must apply for a patent jointly and each must make the required oath or declaration.’ This means that all joint inventors must be included in a single patent application for their shared invention. Filing separate applications for the same invention could lead to legal complications and potential rejection of the applications. If inventors have made separate improvements to the invention, they may be able to file separate applications for those specific improvements, but not for the jointly invented core invention.

To learn more:

To learn more:

Can international applicants claim micro entity status based on gross income?

Yes, international applicants can claim micro entity status based on gross income, provided they meet the eligibility criteria. The MPEP 509.04(a) clarifies:

“For purposes of micro entity status, the gross income (instead of median household income) is used to determine entitlement to reduced patent fees.”

International applicants must:

  • Calculate their gross income in U.S. dollars
  • Meet the same income threshold as U.S. applicants
  • Certify their eligibility under oath

The USPTO uses the World Bank’s gross national income (GNI) per capita figures for the applicant’s country of residence to determine the income threshold. Applicants should refer to the most recent World Bank data when assessing their eligibility.

To learn more:

Tags: gross income

Yes, individuals granted limited recognition can file certain documents in patent applications. According to the MPEP 402.01:

Persons granted limited recognition are considered practitioners under 37 CFR 11.1 and thus permitted to perform the same patent prosecution functions of registered patent agents and registered patent attorneys when prosecuting a specified patent application or specified patent applications.

Specifically, they can file:

However, it’s important to note that these individuals are still subject to the restrictions expressed in their grant, including temporal, employer, and visa limitations.

To learn more:

No, incorporation by reference under 37 CFR 1.57(b) cannot be used to add material to a granted patent. This provision is only applicable during the application process, before a patent is granted. The MPEP clearly states:

“If, however, an application has been patented, a certificate of correction or a reissue application could not be used to add inadvertently omitted material to that patent via 37 CFR 1.57(b).”

Once a patent has been granted, other mechanisms such as reissue or certificate of correction would need to be considered for making changes or additions to the patent, subject to their own specific requirements and limitations.

Yes, you can use the original stamped document for recording with additional patents. The USPTO allows the use of previously recorded papers that have been stamped with reel and frame numbers by the Assignment Division.

According to MPEP 315: “A copy of the original document (which may consist of the previously recorded papers on which the Assignment Division has stamped the reel and frame numbers at which they are recorded, or a copy of such papers)” can be submitted as part of the recordation process for additional patents or applications.

For more information on additional patents, visit: additional patents.

For more information on Assignment Division, visit: Assignment Division.

It’s generally not recommended to use claims language or legal phraseology in your patent application abstract. The MPEP 608.01(b) explicitly states:

The abstract should avoid using phrases which can be implied, such as, ‘The disclosure concerns,’ ‘The disclosure defined by this invention,’ ‘The disclosure describes,’ etc. Also, legal phraseology often used in patent claims, such as ‘means’ and ‘said,’ should be avoided.

Instead of using claims language, focus on describing the invention in clear, concise terms that a general reader can understand. The abstract should be informative and provide a summary of the technical disclosure, not a legal definition of the invention’s scope.

To learn more:

No, you should not use the “Hold for Pickup” service option when sending Priority Mail Express® to the USPTO. The reasons for this are:

  • The USPTO does not have resources for picking up mail
  • Mail sent using the “Hold for Pickup” service will not reach the Office

Always use the standard Priority Mail Express® Post Office to Addressee service when sending correspondence to the USPTO.

As stated in MPEP 511: “The Office does not have resources for picking up any mail. Therefore mail should NOT be sent using the ‘Hold for Pickup’ service option (whereby the mail is retained at the destination postal facility for retrieval by the addressee). Mail sent using the ‘Hold for pickup’ service will not reach the Office.”

Can I use PDX for retrieving priority documents from all foreign patent offices?

No, PDX is not available for all foreign patent offices. The availability of PDX depends on:

  • Participation in the WIPO Digital Access Service (DAS)
  • Bilateral PDX agreements between the USPTO and specific foreign offices

MPEP 215.01 states: “The USPTO will attempt to electronically retrieve the priority document through the WIPO DAS (if the foreign office is a DAS depositing office) or through a bilateral PDX agreement.”

To use PDX, check if the foreign office participates in WIPO DAS or has a bilateral agreement with the USPTO. The USPTO maintains a list of participating offices on their website.

To learn more:

Tags: WIPO DAS

Can I use my USPTO deposit account for international patent applications?

Yes, you can use your USPTO deposit account for certain fees associated with international patent applications. The MPEP states: “Deposit accounts can be used for payment of any patent process fee except for international phase fees paid to the International Bureau.” (MPEP 509.01)

This means you can use your deposit account for:

  • PCT fees payable to the USPTO as a Receiving Office
  • National stage entry fees for U.S. national applications
  • Other USPTO-related fees for international applications

However, it’s important to note that fees payable directly to the International Bureau of WIPO cannot be charged to your USPTO deposit account. For those fees, you’ll need to use alternative payment methods specified by WIPO.

To learn more:

Yes, you can generally use your own terminology in the detailed description of your patent application. The MPEP 608.01(g) states:

“An applicant is ordinarily permitted to use his or her own terminology, as long as it can be understood.”

However, there are some important considerations:

  • The terminology must be clear and understandable to a person skilled in the relevant field.
  • Consistency is key – use the same terms throughout your application to avoid confusion.
  • If you introduce new or unconventional terms, it’s advisable to provide definitions or explanations.
  • The examiner may require grammatical corrections, but this is not the primary focus of the examination.

Remember, while you have flexibility in your terminology, the ultimate goal is to clearly communicate your invention. If your unique terms hinder understanding, it may be better to use more standard language in the field.

To learn more:

Can I use hole-punched paper for my patent application?

No, you should not use hole-punched paper for your patent application. The USPTO has specific requirements regarding the paper used for patent applications, and hole-punched paper is explicitly prohibited.

As stated in MPEP 501: Holes should not be punched in the paper.

This requirement is in place to ensure that all documents can be properly scanned, stored, and processed by the USPTO without any loss of information or potential damage to the application papers. Using standard, unmarked paper without holes helps maintain the integrity of the document throughout the application process.

Yes, the USPTO allows the use of certain alternative forms for submitting application data, as described in MPEP 601.05:

  1. Patent Law Treaty Model International Forms can be used to present priority or benefit claims, references to previously filed applications, and applicant information.
  2. The Patent Cooperation Treaty Request Form can be used in national stage applications to present benefit claims and applicant information.

However, there are specific requirements and limitations:

  • When using a Patent Cooperation Treaty Request Form in an application under 35 U.S.C. 111, it must be accompanied by a clear indication that treatment as an application under 35 U.S.C. 111 is desired.
  • If there are inconsistencies between an ADS and these forms, the ADS will govern.

While these alternative forms are accepted, the USPTO generally prefers the use of its official ADS form for clarity and consistency in processing.

To learn more:

Yes, you can use email to respond to Office actions from the USPTO, but certain conditions must be met:

  • You must have a written authorization on file for Internet communication.
  • The response must be submitted through the USPTO’s secure email system or the Electronic Filing System (EFS-Web).
  • The email must include all necessary information and attachments as required for the response.

MPEP 502.03 states: “Replies to Office actions may NOT be submitted by email unless specifically authorized.” This means that without proper authorization, email responses to Office actions will not be accepted.

It’s important to note that while email can be used, the USPTO recommends using EFS-Web for most communications, including responses to Office actions, as it provides a more secure and efficient method of submission.

To learn more:

Can I use color drawings in my patent application?

Yes, you can use color drawings in your patent application, but they require special approval. According to MPEP 608.02:

‘Color drawings are permitted in design applications. Where a design application contains color drawings, the application must include the number of sets of color drawings required by 37 CFR 1.84(a)(2)(ii) and the specification must contain the reference required by 37 CFR 1.84(a)(2)(iii).’

For utility patent applications, color drawings are not ordinarily permitted. However, the USPTO will accept color drawings if:

The petition must explain why color drawings are necessary to accurately depict the invention.

To learn more:

No, you cannot use both sides of the paper when submitting assignment documents to the USPTO. For paper or facsimile submissions, only one side of each page may be used.

As stated in 37 CFR 3.24(b): Only one side of each page may be used.

This requirement ensures that all information is clearly visible and can be properly scanned and recorded by the USPTO. Using both sides of the paper could result in missed information or difficulties in processing your document.

To learn more:

Yes, electronic signatures are permitted on e-IDS submissions. The MPEP 609.07 states:

Applicants and registered practitioners are permitted to sign portions of an EFS-Web submission, including an IDS, with an electronic signature. See 37 CFR 1.4(d)(3).

This means that when submitting an e-IDS through the USPTO’s Electronic Filing System-Web (EFS-Web), you can use an electronic signature to sign the submission. This aligns with the USPTO’s broader acceptance of electronic signatures in patent applications and related documents, as outlined in 37 CFR 1.4(d)(3).

To learn more:

Tags: EFS-Web

Yes, you can use an Application Data Sheet (ADS) to correct inventor information in your patent application. The MPEP 601.05(a) states:

If an ADS is filed after the initial filing date of the application, it must identify the information that is being changed (added, deleted, or modified) with underlining for insertions, and strike-through or brackets for text removed.

To correct inventor information:

  • Use a supplemental ADS if filing after the initial application date
  • Clearly mark changes with underlining for additions and strike-through for removals
  • Ensure all inventor information is consistent across all documents
  • Be aware that some changes may require additional forms or fees

For significant changes to inventorship, you may need to file a request under 37 CFR 1.48 along with the ADS.

To learn more:

Yes, you can use a handwritten signature for electronically filed patent documents. The USPTO accepts a graphic representation of a handwritten signature when submitted via the USPTO patent electronic filing system.

According to 37 CFR 1.4(d)(3): “A graphic representation of a handwritten signature as provided for in 37 CFR 1.4(d)(1) will be accepted when submitted via the USPTO patent electronic filing system.”

This allows for the use of traditional handwritten signatures in electronic filings, providing flexibility for applicants and practitioners.

To learn more:

The use of a copy of an oath or declaration in a continuation-in-part (CIP) application depends on the filing date of the CIP application:

  1. For CIP applications filed on or after September 16, 2012:
    • A copy of an oath or declaration from the prior application may be used.
    • However, the oath or declaration must comply with the requirements of 35 U.S.C. 115 and 37 CFR 1.63 or 1.64 in effect for applications filed on or after September 16, 2012.
    • A new oath or declaration may be necessary if the prior application was filed before September 16, 2012.
  2. For CIP applications filed before September 16, 2012:
    • Generally, a new oath or declaration is required.
    • The copy of the oath or declaration from the prior application is typically not sufficient due to the new matter introduced in a CIP.

According to MPEP 602.05(a): For applications filed on or after September 16, 2012, a continuing application, including a continuation-in-part application, may be filed with a copy of an oath or declaration or substitute statement from the prior nonprovisional application, provided that the oath or declaration is in compliance with 37 CFR 1.63 or the substitute statement is in compliance with 37 CFR 1.64.

It’s important to ensure that the oath or declaration covers all the subject matter in the CIP application, including any new matter added.

To learn more:

Yes, you can use a copy of an oath or declaration from a prior application in certain continuing applications. According to MPEP 602.05:

For applications filed on or after September 16, 2012: a continuing application, including a continuation-in-part application, may be filed with a copy of an oath or declaration or substitute statement from the prior nonprovisional application, provided that the oath or declaration is in compliance with 37 CFR 1.63 or the substitute statement is in compliance with 37 CFR 1.64.

For applications filed before September 16, 2012: A continuation or divisional application filed before September 16, 2012 under 37 CFR 1.53(b) (other than a continuation-in-part (CIP)) may be filed with a copy of the oath or declaration from the prior nonprovisional application.

However, it’s important to note that the requirements for oaths and declarations may differ based on the filing date, and a new oath or declaration may be necessary in some cases.

To learn more:

The use of a Certificate of Mailing or Transmission for international patent applications is limited and depends on the specific type of correspondence. According to the MPEP and 37 CFR 1.8(a)(2)(i)(D)-(F), the certificate procedure does not apply to:

  • The filing of an international application for patent
  • The filing of correspondence in an international application before the U.S. Receiving Office, the U.S. International Searching Authority, or the U.S. International Preliminary Examining Authority
  • The filing of a copy of the international application and the basic national fee necessary to enter the national stage

However, the Certificate of Transmission procedure can be used for some correspondence related to international applications if it’s being transmitted to the USPTO and is not otherwise prohibited. The MPEP states:

The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.

It’s crucial to carefully review the specific requirements and limitations for international application correspondence to ensure proper and timely filing.

Yes, you can use a Certificate of Transmission for documents filed electronically through the USPTO’s Electronic Filing System (EFS-Web). The MPEP provides a suggested format for a Certificate of EFS-Web Transmission:

I hereby certify that this correspondence is being transmitted via the U.S. Patent and Trademark Office electronic filing system (EFS-Web) to the USPTO on [Date].

However, it’s important to note that EFS-Web submissions have their own timestamp system. According to 37 CFR 1.6(a)(4):

Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

This date can be a Saturday, Sunday, or federal holiday within the District of Columbia. The certificate can provide an additional layer of documentation for your submission date, but the EFS-Web timestamp is generally considered authoritative for determining the receipt date of electronic submissions.

The use of a Certificate of Mailing or Transmission for correspondence from outside the United States depends on the method of transmission. The MPEP clarifies:

“The Certificate of Mailing procedure does not apply to papers mailed in a foreign country. The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.”

Therefore:

  • You cannot use a Certificate of Mailing for papers mailed from outside the U.S.
  • You can use a Certificate of Transmission for facsimile or EFS-Web transmissions from outside the U.S., as long as the correspondence is eligible for this procedure.

It’s important to verify that your specific type of correspondence is eligible for the Certificate of Transmission procedure before using it from outside the United States.

To learn more:

No, the Certificate of Mailing or Transmission cannot be used for all USPTO correspondence. The MPEP 512 specifies certain types of correspondence that are excluded from the certificate practice:

“The Certificate of Mailing or Transmission procedure does not apply to: (A) Relative to Patents and Patent Applications— (1) The filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date…”

The MPEP lists several other exclusions, including certain international application filings, trademark-related filings, and correspondence filed in interference or trial proceedings. It’s crucial to review the full list in MPEP 512 to ensure compliance with USPTO rules.

To learn more:

No, you cannot use a Certificate of Mailing or Transmission for filing a new patent application to establish the application’s filing date. The MPEP explicitly states:

No benefit will be given to a Certificate of Mailing or Certificate of Facsimile Transmission relative to the filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date.

This restriction is also specified in 37 CFR 1.8(a)(2)(i)(A), which excludes “[t]he filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date” from the Certificate of Mailing or Transmission procedure.

However, it’s worth noting that new patent applications can be filed electronically via the USPTO’s Electronic Filing System (EFS-Web), which provides its own timestamp for filing date purposes.

Can I use a certificate of mailing for all USPTO correspondence?

While the certificate of mailing or transmission is a useful tool, it cannot be used for all types of USPTO correspondence. The MPEP 502 provides specific exceptions:

“The certification procedure under 37 CFR 1.8 is not available for: (A) Applications for patent under 35 U.S.C. 111(a), including reissue applications; (B) International applications for patent; (C) International design applications; (D) Requests for reexamination under 35 U.S.C. 302…”

This list continues with several other exceptions. It’s crucial to note that:

  • New patent applications cannot use the certificate of mailing.
  • International applications are excluded from this procedure.
  • Certain time-sensitive documents require different filing methods.

For these excluded items, consider using Priority Mail Express® or electronic filing to ensure timely receipt by the USPTO. Always check the current regulations or consult with a patent professional to determine the appropriate filing method for your specific correspondence.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on patent applications, visit: patent applications.

For more information on USPTO correspondence, visit: USPTO correspondence.

While certificates of mailing are widely applicable, they cannot be used for all types of patent-related correspondence. MPEP 512 outlines specific exceptions:

The Certificate of Mailing or Transmission procedure does not apply to the filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date.

Additionally, you cannot use a certificate of mailing for:

  • Filing of an international application for patent
  • Filing correspondence in an international application before the U.S. Receiving Office
  • Filing a copy of the international application and the basic national fee to enter the national stage under 35 U.S.C. 371

Always check the current USPTO guidelines to ensure you’re using the correct filing method for your specific correspondence.

To learn more:

No, you should not submit original documents for recording patent assignments. The USPTO explicitly states:

“The United States Patent and Trademark Office will accept and record only a copy of an original assignment or other document. See MPEP § 317. The document submitted for recordation will not be returned to the submitter.”

It’s crucial to submit only copies of original documents, as the USPTO will not return the recorded documents. This ensures that you retain your original documents while still complying with the recording requirements.

No, you cannot submit multiple assignment documents with a single cover sheet. MPEP 302.07 clearly states: “A patent cover sheet must identify only one patent, and a separate patent cover sheet must be submitted for each patent as to which the assignment document is to be recorded.”

This requirement ensures that each assignment is properly documented and linked to the correct patent or application. If you have multiple assignments to record, you must prepare and submit a separate cover sheet for each one.

To learn more:

Can I submit color documents via facsimile for patent assignments?

Submitting color documents via facsimile for patent assignments is not recommended. The MPEP 302.09 states:

“Assignments and other documents affecting title to applications, patents, and registrations that include color drawings or color photographs cannot be recorded by facsimile transmission.”

This restriction is due to the limitations of facsimile technology in accurately reproducing color. To ensure the integrity and legibility of color documents:

  • Submit original color documents in person or by mail to the USPTO.
  • Use the Electronic Patent Assignment System (EPAS) for electronic submissions that may include color elements.
  • If color is not essential to the document, consider converting it to black and white before faxing.

Always verify the current USPTO guidelines for document submission, as procedures may be updated over time.

To learn more:

Yes, you can submit assignments and other documents affecting title to the USPTO via fax. The MPEP states: Assignments and other documents affecting title may be submitted to the Office via facsimile (fax). This process allows for direct submission into the automated Patent and Trademark Assignment System.

However, there are specific requirements and limitations:

  • Documents must include an identified application or patent number, one cover sheet for a single transaction, and payment of the recordation fee.
  • Certain documents cannot be submitted via fax, such as assignments submitted with new patent applications or documents with multiple cover sheets.

For the most up-to-date fax number, refer to the USPTO website or MPEP § 1730.

To learn more:

Can I submit assignment documents for multiple patents or applications in one EPAS submission?

Yes, you can submit assignment documents for multiple patents or applications in a single EPAS submission. This feature is particularly useful for bulk assignments or when dealing with related patent families. Here’s how it works:

  • Upload a single assignment document that covers multiple patents or applications.
  • Enter the relevant patent or application numbers during the submission process.
  • EPAS will associate the document with all specified patents or applications.

The MPEP 302.10 does not explicitly mention this capability, but it is a feature of the EPAS system designed to improve efficiency for users handling multiple assignments. Always ensure that the assignment document clearly identifies all patents or applications it covers.

To learn more:

Tags: EPAS

Can I submit an original assignment document for recording at the USPTO?

No, you should not submit the original assignment document for recording. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording.’ Therefore, it’s crucial to submit a copy of the original document to ensure you retain the original for your records.

Always keep the original assignment document in a safe place and submit a legible copy for recording purposes. This practice protects your original document and complies with USPTO requirements.

To learn more:

Can I submit an Information Disclosure Statement (IDS) after paying the issue fee?

Yes, it is possible to submit an Information Disclosure Statement (IDS) after paying the issue fee, but there are strict requirements and limitations. According to MPEP 609:

“An information disclosure statement filed after payment of the issue fee may not be considered, but may be placed in the file.”

To have an IDS considered after payment of the issue fee:

  • It must be accompanied by a petition under 37 CFR 1.313(c) to withdraw the application from issue.
  • The petition must be granted for the IDS to be considered.
  • The IDS must comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98.

Additionally, the IDS must be accompanied by:

It’s important to note that submitting an IDS after paying the issue fee should be done only when absolutely necessary, as it can delay the issuance of the patent and incur additional fees.

To learn more:

According to MPEP 508.02, submitting additional information after a patent application has been abandoned is generally not possible. The section states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This means that once an application is abandoned, the USPTO will typically return any new submissions related to that application. However, there are some exceptions:

  • Petitions to revive the abandoned application
  • Requests for continued examination (RCE) in certain circumstances
  • Appeals to the Patent Trial and Appeal Board, if filed within the appropriate timeframe

If you wish to submit additional information after abandonment, you should consult with a patent attorney to determine if any of these options are available in your specific case.

To learn more:

Yes, you can submit a working model of your invention to the USPTO, but it’s generally not required unless specifically requested by the examiner. According to MPEP 608.03(a):

‘Models or exhibits are not required in most patent applications since the description of the invention in the specification and the drawings must be sufficiently full, clear, and complete and capable of being understood to disclose the invention without the aid of a model.’

However, there are situations where a model might be beneficial or required:

  • If the examiner determines that a model is necessary to understand the invention.
  • In applications involving perpetual motion devices, where a working model is required.
  • When you believe a model would substantially improve the understanding of your invention.

If you decide to submit a model, ensure it complies with USPTO size and safety requirements, and follow the proper procedures for submission as outlined in the MPEP.

To learn more:

To learn more:

Can I submit a supplemental ADS after filing my patent application?

Yes, you can submit a supplemental Application Data Sheet (ADS) after filing your patent application. The MPEP 601.05(a) states:

“A supplemental ADS may be submitted in a nonprovisional application under 37 CFR 1.312 after allowance, with a petition under 37 CFR 1.312 if necessary.”

However, there are important considerations:

  • For applications filed on or after September 16, 2012, any changes must be made with markings (underlining for insertions, strike-through for deletions).
  • Some changes, like inventorship or priority claims, may require additional forms or petitions.
  • Late changes may incur fees or require petitions, especially if they’re made after certain time limits.

Always consult the current USPTO guidelines or a patent attorney when making changes to ensure compliance with all requirements.

To learn more:

Can I submit a photocopy or digital scan of my assignment document for USPTO recording?

Yes, you can submit a photocopy or digital scan of your assignment document for USPTO recording, as long as it’s a complete and legible copy. The MPEP 302.01 specifies: ‘The copy of the document to be recorded should be presented to the Office for recordation.’ This means that:

  • Photocopies are acceptable
  • Digital scans saved as PDF files are also acceptable
  • The copy must be clear and readable
  • All pages and attachments must be included

Remember, while you’re submitting a copy, it must accurately represent the original document in its entirety.

Yes, you can submit a patent assignment electronically through the USPTO’s Electronic Patent Assignment System (EPAS). This is the recommended method for several reasons:

  • It’s free – there is no recordation fee for electronic submissions
  • It’s fast – documents are processed more quickly
  • It’s convenient – you can submit 24/7 from anywhere with internet access

As stated in MPEP 302.10: “Assignments and other documents affecting title may be submitted to the Office via the Office’s Electronic Patent Assignment System (EPAS).”

To use EPAS, you’ll need to complete an online cover sheet and upload a copy of the assignment document. The signature on the electronic cover sheet must comply with USPTO regulations for electronic signatures.

For more information and to access EPAS, visit the USPTO EPAS website.

For more information on electronic patent assignment, visit: electronic patent assignment.

For more information on EPAS, visit: EPAS.

Can I submit a handwritten assignment document for recording at the USPTO?

While handwritten assignment documents are not explicitly prohibited, they are generally discouraged and may face challenges in the recording process. The MPEP 302.01 states that “Documents submitted for recording must be legible and capable of being reproduced in legible copies by use of photocopy and standard office copying equipment.” Handwritten documents may not meet this standard, especially if the handwriting is not clear and easily readable. To ensure smooth processing and avoid potential rejection, it’s recommended to submit typed or printed assignment documents that are clearly legible and meet all USPTO requirements.

Yes, you can still submit assignment documents by mail to the USPTO, although electronic submission is strongly encouraged. If you choose to submit by mail, send your documents to:

Mail Stop Assignment Recordation Services
Director of the USPTO
P.O. Box 1450
Alexandria, VA 22313-1450

However, as noted in MPEP 302.10: “The Office strongly encourages electronic filing of assignment documents using EPAS, because assignment documents filed electronically are recorded faster and are less likely to become lost or misplaced.” Therefore, while mail submission is an option, electronic submission through EPAS is preferable for faster and more secure processing.

To learn more:

Can I retroactively claim micro entity status for previously paid fees?

No, you cannot retroactively claim micro entity status for fees that have already been paid. The MPEP clearly states:

“A fee may be paid in the micro entity amount only if it is submitted with, or subsequent to, the submission of a certification of entitlement to micro entity status.” (MPEP 509.04(f))

This means:

  • Micro entity status must be established before or at the time of paying fees at the micro entity rate
  • You cannot request a refund for the difference between standard fees and micro entity fees for payments made before establishing micro entity status
  • Future fees can be paid at the micro entity rate once status is properly established

To benefit from micro entity status, ensure you file the certification before paying any fees you wish to pay at the reduced rate.

To learn more:

Tags: patent fees

Yes, it is possible to restore the right of priority if you miss the 12-month filing deadline (6 months for design applications). As provided in 37 CFR 1.55(c), if the subsequent application is filed within two months from the expiration of the priority period, the right of priority may be restored upon petition. The petition must include:

  • The priority claim (unless previously submitted)
  • The petition fee
  • A statement that the delay in filing was unintentional

The Director may require additional information where there is a question whether the delay was unintentional. Note that while this allows for a valid priority claim, it does not overcome potential prior art issues under pre-AIA 35 U.S.C. 102(b) or (d) in applications subject to pre-AIA law.

Yes, you can request the return of your model, exhibit, or specimen from the USPTO. However, there are specific procedures and timeframes to follow. According to MPEP 608.03(a):

A request for return of the model, exhibit, or specimen should be made within the period set forth in MPEP § 608.03(a).

Here are the key points to remember:

  • Make the request before the application is allowed or within two months after the date of the Notice of Allowance.
  • Include a proper postage paid return address sticker with the request.
  • If the item is not claimed within the specified period, the USPTO may dispose of it at its discretion.

It’s important to act promptly if you wish to have your items returned, as the USPTO is not obligated to store them indefinitely.

To learn more:

Tags: USPTO

No, the USPTO does not allow partial access to patent assignment documents. According to MPEP 301.01:

“The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.”

This means:

  • If a document covers both a trademark and a patent, it will be entirely available to the public from the beginning.
  • If it covers multiple patent applications, it becomes publicly available as soon as any one of them is published or patented.

The policy ensures transparency and consistency in the handling of assignment documents.

To learn more:

Can I request a certificate of correction for a priority claim after my patent has issued?

Yes, you can request a certificate of correction for a priority claim after your patent has issued, but only under specific circumstances. According to MPEP 213.04: ‘If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’ However, it’s important to note that this correction is only possible if the failure to make the timely claim was through error and without deceptive intent. You’ll need to file a petition for a certificate of correction along with the required fee and evidence supporting your claim.

To learn more:

To learn more:

Yes, in most cases. According to MPEP 401, “An applicant for patent, other than a juristic entity (e.g., organizational assignee), may file and prosecute their own application, and thus act as their own representative (pro se) before the Office.” However, there are important considerations:

  • Juristic entities (e.g., companies) must be represented by a patent practitioner
  • Pro se applicants are subject to the same rules and potential sanctions as represented applicants
  • Lack of familiarity with patent procedures may result in missed opportunities for optimal protection

Can I record an assignment for a pending patent application?

Yes, you can record an assignment for a pending patent application. In fact, the USPTO encourages early recordation of assignments. According to MPEP 302:

An assignment relating to a patent must identify the patent by the patent number. An assignment relating to a national patent application must identify the national patent application by the application number (consisting of the series code and the serial number, e.g., 07/123,456). An assignment relating to an international patent application which designates the United States of America must identify the international application by the international application number (e.g., PCT/US90/01234).

To record an assignment for a pending application:

  • Use the application number to identify the application
  • Ensure all necessary parties have signed the assignment document
  • Submit the assignment document along with the required cover sheet and fee to the USPTO

Early recordation can help establish clear ownership and facilitate future transactions or licensing agreements.

For more information on USPTO procedures, visit: USPTO procedures.

Yes, you can record a trademark license with the USPTO. The process is similar to recording other documents:

  • Submit the license document to the USPTO’s Assignment Recordation Branch
  • Include a cover sheet with the required information
  • Pay the appropriate fee

MPEP 313 mentions: Trademark documents are recorded in the same manner as patent documents, but… requests to record documents for trademarks should be mailed to: Commissioner for Trademarks, 2900 Crystal Drive, Arlington, VA 22202-3514.

Recording a trademark license can provide legal benefits and help maintain clear records of trademark rights and usage agreements.

No, you cannot petition against a new matter rejection in claims. When new matter affects the claims, leading to their rejection, the issue must be addressed through the appeal process, not by petition.

The MPEP 608.04(c) clearly states:

“But where the alleged new matter is introduced into or affects the claims, thus necessitating their rejection on this ground, the question becomes an appealable one, and should not be considered on petition even though that new matter has been introduced into the specification also.”

This means that even if the new matter appears in both the specification and the claims, the claim-related issues must be addressed through an appeal to the Patent Trial and Appeal Board (PTAB), not through the petition process.

To learn more:

Tags: new matter

Can I perfect a foreign priority claim after my patent has been issued?

No, you cannot perfect a foreign priority claim after your patent has been issued if the claim was not timely filed during the pendency of the application. As stated in MPEP 216.01:

“A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) in an issued patent. However, a reissue application cannot be used to perfect a claim for priority benefit under 35 U.S.C. 119(a)-(d) or (f) where the claim for priority benefit was not timely filed during the pendency of the application that issued as the patent for which reissue is sought.”

This means that if you missed the deadline to file the priority claim or the required certified copy of the foreign application during the original patent application process, you cannot use a reissue application to retroactively perfect the claim after the patent has been issued.

Yes, you can perfect a claim for foreign priority after your patent has been issued. There are two main methods:

  1. Certificate of Correction: This is generally the preferred method if the requirements of 37 CFR 1.55 are met and no further examination is required. As stated in the MPEP, Except in certain situations, a certificate of correction can generally be used to perfect a claim to foreign priority where a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim is filed with a request for a certificate of correction in an issued patent.
  2. Reissue Application: This method is necessary in situations where further examination would be required or when the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance.

To learn more:

Can I pay patent fees in foreign currency?

No, the USPTO does not accept foreign currency for patent fee payments. According to MPEP 509: ‘All payments of money required for USPTO fees or services must be made in U.S. dollars and in the form of a cashier’s or certified check, Treasury note, national bank notes, or United States Postal Service money order.’

If you’re an international applicant, you’ll need to arrange for payment in U.S. dollars. Options include:

  • Using an international credit card that can process payments in USD
  • Establishing a U.S. bank account
  • Using a registered U.S. attorney who can make payments on your behalf

It’s advisable to plan ahead for currency conversion to ensure timely payment of USPTO fees.

To learn more:

To learn more:

Tags: USPTO fees

Can I obtain a foreign filing license for an invention not yet filed with the USPTO?

Yes, it is possible to obtain a foreign filing license for an invention that has not yet been filed with the United States Patent and Trademark Office (USPTO). This is known as a petition-based license. According to MPEP 140:

“If no corresponding national or international application has been filed in the United States, the petition for license should be accompanied by a legible copy of the material upon which a foreign patent application is to be based. Where the material upon which the foreign patent application is to be based is a U.S. application, the petition for license should identify the application by its application number, filing date, inventor, and title. Where the material upon which the foreign patent application is to be based is not a U.S. application, a legible copy of the material must be attached to the petition.”

To obtain such a license, you must file a petition with the USPTO, providing details about the invention and the reasons for seeking an early foreign filing license. The USPTO will review the petition and may grant the license if it determines that the invention does not pose a national security risk.

For more information on foreign filing license, visit: foreign filing license.

Yes, you can obtain a foreign filing license for a provisional patent application. According to MPEP 140:

‘U.S. provisional applications are considered as pending applications and are subject to the license requirement specified in 35 U.S.C. 184.’

This means that:

  • Provisional applications require a foreign filing license just like non-provisional applications.
  • The process for obtaining a license is the same as for non-provisional applications.
  • If you plan to file a foreign application based on your provisional application within 6 months, you should request a license when filing the provisional or shortly thereafter.

Remember, the license requirement applies to the subject matter, not the type of application.

For more information on foreign filing license, visit: foreign filing license.

For more information on provisional application, visit: provisional application.

Yes, you can incorporate material by reference in a provisional patent application. The limitations on incorporation by reference that apply to non-provisional applications do not apply to provisional applications or applications relied on only to establish an earlier effective filing date.

As stated in the MPEP: ‘The limitations on the material which may be incorporated by reference in U.S. patent applications which are to issue as U.S. patents do not apply to applications relied on only to establish an earlier effective filing date under 35 U.S.C. 119 or 35 U.S.C. 120.’

However, it’s important to note that the incorporation by reference must still be clear and properly executed to be effective.

To learn more:

No, detailed descriptions of the drawings should not be included in the Brief Description section of a patent application. According to MPEP 608.01(f):

The specification should not normally describe the drawings in detail, but should concentrate on defining the invention.

The Brief Description section should only contain:

  • References to each figure by number
  • A concise explanation of what each figure represents

Detailed descriptions of the drawings and how they relate to the invention should be reserved for the Detailed Description section of the specification.

To learn more:

To learn more:

Tags: drawings

Yes, you can include a copyright or mask work notice in patent drawings, but it must comply with specific requirements. According to 37 CFR 1.84(s) and MPEP 608.01(w):

A copyright or mask work notice may appear in the drawing, but must be placed within the sight of the drawing immediately below the figure representing the copyright or mask work material and be limited to letters having a print size of .32 cm. to .64 cm. (1/8 to 1/4 inches) high.

Additionally, the content of the notice must be limited to only those elements provided for by law, and the authorization language specified in 37 CFR 1.71(e) must be included at the beginning of the specification. If these conditions are met, the notice will not be objected to as extraneous matter under 37 CFR 1.84.

To learn more:

Yes, you can hand-carry certain documents to the USPTO, but there are specific guidelines and limitations. According to MPEP 501:

Patent-related papers may be hand-carried to the Office in Alexandria, VA. Correspondence cannot be hand-carried to the Regional Offices. If the correspondence is hand-carried to the Office, with limited exceptions (see MPEP § 502, subsection III) it must be delivered to:

United States Patent and Trademark Office
Customer Service Window
Randolph Building
401 Dulany Street
Alexandria, VA 22314

For trademark-related papers, there is a separate location:

Trademark-related papers may be filed at the “walk-up” window located in the Trademark Assistance Center, Madison East, Concourse Level, Room C55, 600 Dulany Street, Alexandria, VA 22314.

It’s important to note that while hand-carrying documents is possible, electronic filing is often faster and more efficient for most types of correspondence with the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO submission, visit: USPTO submission.

No, you cannot get your patent application drawings returned. The United States Patent and Trademark Office (USPTO) clearly states in the Manual of Patent Examining Procedure (MPEP) Section 608.02(y) that:

Drawings will not be returned to the applicant.

This policy ensures that the USPTO maintains a complete record of all submitted materials for each patent application. It’s important for applicants to keep copies of all documents, including drawings, submitted to the USPTO.

To learn more:

Yes, you can request a refund if you establish small entity status after paying full fees, but there are strict time limits:

  • You must file an assertion of small entity status and a refund request within 3 months of the date of the full fee payment
  • This 3-month period cannot be extended

According to 37 CFR 1.28(a): “A refund pursuant to § 1.26, based on establishment of small entity status, of a portion of fees timely paid in full prior to establishing status as a small entity may only be obtained if an assertion under § 1.27(c) and a request for a refund of the excess amount are filed within three months of the date of the timely payment of the full fee. The three-month time period is not extendable under § 1.136.”

To learn more:

To learn more:

Generally, the English translation and accuracy statement for a non-English provisional application must be filed in the provisional application itself, not in the nonprovisional application. However, there is an exception:

As noted in the MPEP, Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.

This means:

  • For applications filed on or after November 25, 2005, the translation and statement must be filed in the provisional application.
  • For applications filed before November 25, 2005, it was acceptable to file these documents in the nonprovisional application.

It’s important to follow the current requirement of filing these documents in the provisional application to ensure proper benefit claim.

For more information on filing requirements, visit: filing requirements.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

The USPTO is not open for filing correspondence on Saturdays, Sundays, or federal holidays within the District of Columbia. However, there are exceptions:

  • Correspondence deposited as Priority Mail Express® with the USPS in accordance with 37 CFR 1.10 is considered filed on the date of deposit, even on weekends or holidays
  • Electronic filing systems may be available 24/7, but the official filing date will be the next business day

MPEP 510 cites 37 CFR 1.6(a)(1): “The Patent and Trademark Office is not open for the filing of correspondence on any day that is a Saturday, Sunday or Federal holiday within the District of Columbia.”

Can I file multiple provisional applications for the same invention?

Yes, you can file multiple provisional applications for the same invention. This practice is sometimes used to establish earlier priority dates for different aspects of an invention as they are developed. The MPEP 201.04 does not explicitly prohibit this practice.

However, it’s important to note:

  • Each provisional application must meet the requirements for disclosure and enablement
  • The 12-month deadline for filing a nonprovisional application starts from the earliest provisional application you wish to claim benefit from
  • When filing the nonprovisional application, you can claim the benefit of multiple provisional applications

For example, the MPEP states:

“A nonprovisional application may claim the benefit of one or more prior provisional applications under 35 U.S.C. 119(e).”

While this strategy can be beneficial, it’s advisable to consult with a patent attorney to ensure proper execution and to avoid potential pitfalls.

To learn more:

Can I file a U.S. nonprovisional application claiming priority to a provisional application after 12 months?

While it’s generally recommended to file within 12 months, there is a limited exception that allows for filing a nonprovisional application claiming priority to a provisional application after the 12-month period. The MPEP explains:

“A nonprovisional application filed not later than twelve months after the date on which the provisional application was filed … will have its filing date restored to the filing date of the provisional application for the purpose of establishing copendency with the provisional application under 35 U.S.C. 119(e).” (MPEP 213.03)

However, this exception comes with strict conditions:

  • The delay in filing must have been unintentional.
  • The nonprovisional application must be filed within 14 months from the provisional filing date.
  • A petition to restore the right of priority must be filed promptly.

It’s important to note that this exception is not automatic and requires a petition process. If granted, it allows the nonprovisional application to claim the benefit of the provisional application’s filing date.

To learn more:

Can I file a provisional application in a language other than English?

Yes, you can file a provisional application in a language other than English. However, there are important considerations:

  • The USPTO accepts provisional applications in any language.
  • An English translation is not required at the time of filing.
  • If a nonprovisional application is later filed claiming benefit of the provisional, an English translation may be required.

The MPEP 201.04 states: “If a provisional application is filed in a language other than English, an English-language translation of the non-English language provisional application will not be required in the provisional application.” However, it’s important to note that if you later file a nonprovisional application claiming benefit of the provisional, you may need to provide an English translation at that time, along with a statement that the translation is accurate.

To learn more:

Can I file a provisional application electronically?

Yes, you can file a provisional application electronically through the USPTO’s Electronic Filing System (EFS-Web). The MPEP 201.04 states:

“Applicants can file provisional applications electronically using EFS-Web or Patent Center.”

Electronic filing offers several advantages, including:

  • Immediate confirmation of receipt
  • Potential for reduced filing fees
  • Faster processing times
  • 24/7 availability

To file electronically, you’ll need to prepare your application documents in the appropriate format and submit them through the USPTO’s EFS-Web system or Patent Center.

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on Patent Center, visit: Patent Center.

For more information on provisional application, visit: provisional application.

Can I file a priority claim in a continuing application?

Yes, you can file a priority claim in a continuing application, but there are specific requirements and deadlines to consider. According to MPEP 214.01, “In the case of a continuation or divisional application filed under 35 U.S.C. 111(a), the claim for priority must be made during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.” This means that even in a continuing application, you must adhere to the time limits for filing the priority claim. It’s important to note that the priority claim must be made in each continuing application; a priority claim in a parent application does not automatically carry over to child applications.

Yes, you can file a priority claim in a continuation or divisional application, but there are specific rules you must follow. According to MPEP 214.01:

‘In the case of a continuation or divisional application filed under 35 U.S.C. 111(a), the claim for priority must be made during the pendency of the application and within the four-month period set forth in 37 CFR 1.55(d)(1).’

This means:

  • The priority claim must be made while the continuation or divisional application is still pending (not abandoned or issued).
  • You have a four-month window from the actual filing date of the continuation or divisional application to make the priority claim.
  • The priority claim should refer back to the foreign application through the parent application(s).

It’s important to note that the continuation or divisional application must have copendency with the parent application to maintain the priority chain. Always consult the latest version of the MPEP and consider seeking advice from a patent attorney to ensure compliance with current USPTO rules.

To learn more:

Can I file a priority claim after paying the issue fee for my patent application?

Yes, you can file a priority claim after paying the issue fee for your patent application, but it comes with additional requirements and costs. According to MPEP 213.04:

If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, it must also be accompanied by the processing fee set forth in 37 CFR 1.17(i).

This means that if you file your priority claim after paying the issue fee, you must:

  • Include the priority claim or certified copy of the foreign application
  • Pay the additional processing fee specified in 37 CFR 1.17(i)
  • Ensure the application hasn’t been patented yet

It’s important to note that once the patent is granted, you cannot file a priority claim retroactively. Therefore, it’s always best to file your priority claim as early as possible during the application process to avoid additional fees and potential complications.

To learn more:

No, you cannot file a petition to restore the benefit of a provisional application in the provisional application itself. According to the MPEP:

“A petition to restore the benefit of a provisional application must be filed in the subsequent application.”

This means you must file the petition in the nonprovisional application or the international application designating the United States that is seeking to claim the benefit of the provisional application. This is because the provisional application itself is not examined and automatically expires after 12 months. The petition is a request to restore the right to claim the benefit in a subsequent application, not to extend the life of the provisional application.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

Can I file a patent application without claims?

While it is possible to file a patent application without claims, it is not recommended and can have significant consequences:

  • No filing date: According to MPEP 601.01, an application must contain “at least one claim pursuant to 35 U.S.C. 112(b)” to be assigned a filing date.
  • Provisional applications: Claims are not required for provisional applications, but these do not mature into patents without a subsequent non-provisional filing.
  • Subsequent submission: If claims are not included in the initial filing, they must be submitted later, which may delay the examination process and incur additional fees.
  • Priority issues: Lack of claims at filing may affect your ability to claim priority or benefit from earlier filing dates in certain situations.

The MPEP states: “To obtain a filing date, applicant must file specification containing a description pursuant to 35 U.S.C. 112(a) and at least one claim pursuant to 35 U.S.C. 112(b).” Therefore, it’s strongly advised to include at least one claim when filing a non-provisional patent application.

To learn more:

Yes, you can file a foreign priority claim after your patent has been granted, but it requires additional steps:

  1. File a petition under 37 CFR 1.55(e) for an unintentionally delayed priority claim
  2. Submit a request for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323
  3. Pay the required petition and certificate of correction fees

MPEP 214.02 states: “Where a priority claim under 37 CFR 1.55(g) was not timely made, 37 CFR 1.55(g) allows the priority claim and the certified copy required under 37 CFR 1.55 to be filed pursuant to a petition under 37 CFR 1.55(e) even if the application is not pending (e.g., a patented application).”

Can I file a divisional-continuation application?

Yes, you can file a divisional-continuation application, which is a hybrid type of continuing application. This type of application combines aspects of both divisional and continuation applications.

According to MPEP 201.06(c): “The disclosure presented in a divisional application must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.” However, a divisional-continuation can include both claims to a distinct invention (like a divisional) and additional claims to the invention disclosed in the parent (like a continuation).

When filing such an application, it’s crucial to:

  • Ensure that the claims are properly grouped
  • Clearly indicate which claims are divisional and which are continuation
  • Comply with all requirements for both divisional and continuation applications

Always consult with a patent attorney or agent to determine the best filing strategy for your specific situation.

For more information on continuing applications, visit: continuing applications.

Can I file a divisional-continuation application after my parent application has been patented?

No, you cannot file a divisional-continuation application after your parent application has been patented. According to MPEP 201.06(c):

“The divisional application must be filed before the patenting or abandonment of or termination of proceedings on the prior application.”

This means that the window for filing a divisional-continuation application closes when the parent application is either:

  • Granted a patent
  • Abandoned
  • Proceedings are terminated

If you wish to pursue additional claims or inventions after your patent has been granted, you may need to consider other options, such as filing a reissue application or a new continuation-in-part application, depending on the specific circumstances and the nature of the new subject matter.

For more information on parent application, visit: parent application.

For more information on patent grant, visit: patent grant.

Can I file a divisional application without a new oath or declaration?

Yes, you can file a divisional application without a new oath or declaration under certain conditions. According to MPEP 201.06(c):

“Under 37 CFR 1.63(d), a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) if: (1) the prior nonprovisional application contained an oath or declaration as prescribed by 37 CFR 1.63 that was executed by or with respect to the inventor and was signed in compliance with 37 CFR 1.64; and (2) the divisional application was filed by all or by fewer than all of the inventors named in the prior application.”

This provision simplifies the filing process for divisional applications, allowing inventors to use the oath or declaration from the original application, provided the specified conditions are met.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

Yes, it is possible to file a delayed benefit claim in an abandoned application, particularly for provisional applications. The MPEP 211.04 states:

“Effective December 18, 2013, 35 U.S.C. 119(e)(1) no longer requires that the amendment containing the specific reference to the earlier filed provisional application be submitted during the pendency of the application. Therefore, a petition to revive is no longer required to add or correct a benefit claim under 35 U.S.C. 119(e) in an abandoned nonprovisional application filed on or after November 29, 2000.”

This means you can file a petition under 37 CFR 1.78 to accept an unintentionally delayed claim for the benefit of a prior-filed provisional application in the abandoned nonprovisional application. This may be necessary to correct benefit claims in later-filed applications that claim benefit from the abandoned application.

To learn more:

Can I file a certified copy of a foreign application after paying the issue fee?

Yes, you can file a certified copy of a foreign application after paying the issue fee, but there are important considerations. According to MPEP 213.04, “If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.” This means that while you can still file the certified copy, it won’t automatically be included in your patent. You would need to request a certificate of correction after the patent issues to have the priority claim recognized. It’s always best to file the certified copy before paying the issue fee to avoid this additional step and potential complications.

To learn more:

Yes, you can delete a benefit claim, but it’s important to understand the process and potential implications:

  1. For applications filed on or after September 16, 2012, you can delete a benefit claim by filing a corrected Application Data Sheet (ADS) that removes the reference to the prior-filed application.
  2. For applications filed before September 16, 2012, you can delete a benefit claim by amending the specification (if the claim is in the specification) or by submitting a supplemental ADS to delete references to prior applications.

According to MPEP 211.02(a): The examiner should consider whether any new prior art may now be available if a benefit claim is deleted.

Important considerations:

  • Deleting a benefit claim may expose your application to additional prior art, potentially affecting its patentability.
  • If you delete a benefit claim after final rejection or allowance, the amendment will be treated under special rules (37 CFR 1.116 or 1.312, respectively).
  • Deleting a benefit claim may be seen as intentionally waiving the benefit claim. If you later try to reinstate it, the USPTO may not accept it as unintentionally delayed.
  • In a Continued Prosecution Application (CPA), you cannot delete the reference to the prior application with the same application number.

Always carefully consider the implications before deleting a benefit claim, and consult with a patent attorney if you’re unsure about the consequences.

For more information on ADS, visit: ADS.

For more information on CPA, visit: CPA.

For more information on prior art, visit: prior art.

Tags: ADS, CPA, prior art

No, you should avoid making derogatory remarks about prior art in your patent application. The MPEP 608.01(r) states:

“The applicant may refer to the general state of the art and the advance thereover made by his or her invention, but he or she is not permitted to make derogatory remarks concerning the inventions of others.”

This means you can discuss how your invention improves upon existing technology, but you should not disparage or criticize other inventions or inventors.

To learn more:

Tags: prior art

Can I correct micro entity status errors retroactively?

Yes, you can correct micro entity status errors retroactively, but there are specific rules and time limitations to consider. According to MPEP 509.04(f):

“Errors in micro entity status may be rectified by filing a notification of a change in status … and paying the required fee deficiency.”

However, the ability to make retroactive corrections is subject to time constraints:

  • For underpayments: You can correct the error at any time by paying the fee deficiency.
  • For overpayments: You must file a micro entity certification and request a refund within the time period set in 37 CFR 1.29(k), which is generally within three months of the fee payment.

It’s crucial to address any status errors promptly to maintain the validity of your patent application or granted patent and to ensure compliance with USPTO regulations.

To learn more:

Tags: patent fees

No, you cannot correct micro entity status errors for multiple applications or patents in a single submission. The MPEP, citing 37 CFR 1.29(k)(1), states:

Any paper submitted under this paragraph must be limited to the deficiency payment (all fees paid in error) required for a single application or patent. Where more than one application or patent is involved, separate submissions of deficiency payments are required for each application or patent (see § 1.4(b)).

This means you must submit separate deficiency payments and itemizations for each application or patent where micro entity fees were erroneously paid. This requirement ensures clear and accurate processing of fee corrections for each individual case.

To learn more:

Yes, you can correct inventorship by filing a continuing application. The MPEP states:

Correction of inventorship may also be obtained by the filing of a continuing application under 37 CFR 1.53 without the need for filing a request under 37 CFR 1.48, although it should be noted that the requirements for a request under 37 CFR 1.48 filed on or after September 16, 2012 are minimal.

However, it’s important to note that changing inventorship through a continuing application may affect the application’s benefit claim under 35 U.S.C. 120. The MPEP advises, 35 U.S.C. 120 permits a continuing application to claim the benefit of the filing date of a copending, previously filed, parent application provided there is inventorship overlap between the continuing application and the parent application.

To learn more:

Yes, you can correct certain errors in a recorded USPTO assignment document without submitting a new assignment. The process depends on the type of error:

  • For minor typographical errors, use a Corrective Cover Sheet.
  • For more substantial errors, submit a Substitute Statement.

MPEP 323 states: “The ‘corrective document’ or ‘substitute statement’ will not be recorded as a new assignment.” Instead, it will be recorded to correct the original assignment document, maintaining the original recordation date.

For more information on assignment correction, visit: assignment correction.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

Yes, you can still correct an erroneous assignment even if you cannot contact or get cooperation from the party who filed it. The MPEP 323.01(c) provides guidance for this situation:

The owner should contact the party who recorded the papers with the erroneous information and request that such party record corrective papers. However, if the party cannot be located or is unwilling to file corrective papers, then the true owner must record the necessary papers with the Assignment Services Division to correct the error.

In such cases, you, as the true owner, must submit the required documentation to the USPTO’s Assignment Services Division, including the completed cover sheet, affidavit or declaration, and required fees. This ensures that you can correct the record even without the cooperation of the party who made the error.

To learn more:

Can I correct a timely benefit claim without a petition?

Yes, in certain circumstances, you can correct a timely benefit claim without filing a petition. The MPEP 211.02(a) provides guidance on this:

If an applicant includes a benefit claim in a timely filed application data sheet (ADS), but the benefit claim contains a typographical error or improper application number, the applicant may correct the benefit claim without a petition by submitting a corrected ADS in compliance with 37 CFR 1.76(c) if the correction is made within the time period set forth in 37 CFR 1.78.

To correct a timely benefit claim without a petition:

  • The original benefit claim must have been submitted in a timely filed ADS
  • The correction must be for a typographical error or improper application number
  • Submit a corrected ADS complying with 37 CFR 1.76(c)
  • Make the correction within the time period specified in 37 CFR 1.78

It’s important to note that this option is only available for minor corrections to timely filed benefit claims. For more substantial changes or untimely claims, a petition may still be required.

To learn more:

Tags: ADS

Can I convert my provisional application to a nonprovisional application?

No, you cannot directly convert a provisional application to a nonprovisional application. The MPEP clearly states: A provisional application cannot be converted to a nonprovisional application. Instead, you must file a separate nonprovisional application within 12 months of the provisional application’s filing date. This nonprovisional application can claim the benefit of the provisional application’s filing date. Here’s what you need to know:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • It must include a specific reference to the provisional application.
  • The nonprovisional application can expand on the content of the provisional application but must support any claims that rely on the provisional filing date.

Remember, if you don’t file a nonprovisional application within 12 months, the provisional application will automatically expire, and you’ll lose the benefit of its filing date.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

Yes, it is possible to claim priority to multiple foreign applications in a U.S. patent application, provided certain conditions are met:

  • Each foreign application must independently meet the requirements for a priority claim
  • The U.S. application must be filed within 12 months of the earliest filed foreign application
  • The claimed subject matter must be supported by each application for which priority is claimed

When claiming multiple priorities, the U.S. application gets the benefit of each prior application only for the subject matter that it supports. This allows applicants to combine priority claims to protect inventions that were developed and disclosed progressively over time in different countries.

Yes, you can claim priority to multiple foreign applications for the same invention, provided they meet certain criteria. The MPEP 213.02 addresses this situation:

Where two or more foreign applications are combined in a single U.S. application, to take advantage of the changes to 35 U.S.C. 103 or to claim both priority and the benefit of the filing date of an earlier application, the claimed subject matter in the U.S. application is entitled only to the earliest date to which it is entitled in any of the included foreign applications.

To claim priority to multiple foreign applications:

  • Each foreign application must be properly identified in the application data sheet (ADS)
  • Certified copies of all foreign applications must be submitted
  • The U.S. application must be filed within 12 months of the earliest filed foreign application

Note: The effective priority date for any claimed subject matter will be the earliest applicable date from the foreign applications.

To learn more:

Yes, under certain conditions, an applicant can claim priority based on an application for an inventor’s certificate. MPEP 213.05 explains: ‘An inventor’s certificate may form the basis for rights of priority under 35 U.S.C. 119(d) only when the country in which it is filed gives to applicants, at their discretion, the right to apply, on the same invention, either for a patent or for an inventor’s certificate.’

To claim priority to an inventor’s certificate, the applicant must file an affidavit or declaration stating that they had the option to file for either a patent or an inventor’s certificate in the foreign country.

For more information on foreign priority, visit: foreign priority.

Can I claim priority to a provisional application filed in a foreign country?

No, you cannot claim priority to a provisional application filed in a foreign country. The MPEP 213.02 states:

‘Note that a foreign filed provisional application is not eligible for priority benefit.’

Priority claims can only be made to non-provisional applications or other types of applications that are recognized under the Paris Convention. Provisional applications are unique to the U.S. patent system and are not recognized as priority documents in foreign countries or under international agreements.

To learn more:

Yes, it is possible to claim priority to a foreign application after your U.S. patent has been issued. According to MPEP 216.01, a claim for priority under 35 U.S.C. 119(a)-(d) or (f) can be made after the patent is granted, subject to certain conditions:

  • The claim must be made within the time period set forth in 37 CFR 1.55(g).
  • A petition to accept an unintentionally delayed claim for priority must be filed.
  • The required fee must be paid.
  • A certified copy of the foreign application must be submitted.

The MPEP states: ‘A claim for priority under 35 U.S.C. 119(a)-(d) or (f) for the benefit of a prior foreign application may be made after the patent issues if the claim is accompanied by a grantable petition to accept an unintentionally delayed claim for priority.’

Yes, you can change the order of inventors’ names in a nonprovisional patent application filed on or after September 16, 2012. According to MPEP 602.01(c)(2):

37 CFR 1.48(f) … allows an applicant to adjust the order of the names of joint inventors (e.g., to control the order of names on a printed patent).

To change the order of inventors’ names, you must:

  • Submit an application data sheet (ADS) in accordance with 37 CFR 1.76 that lists the inventors in the desired order.
  • Pay the processing fee set forth in 37 CFR 1.17(i).

Note that this procedure is not applicable to provisional applications, as they do not become published applications or patents.

To learn more:

Can I change my entity status during the patent application process?

Yes, you can change your entity status during the patent application process. The MPEP 509.03 states:

“Small entity status may be claimed in a pending application at any time before, or concurrently with, the payment of an issue fee.”

This means you can:

  • Change from standard to small entity status
  • Change from small entity to standard status
  • Claim micro entity status if you qualify

To change your status, you must file a new written assertion of the desired status. Keep in mind that if you change to a higher fee status (e.g., from small to standard), you may need to pay any fee deficiencies for previously paid fees at the lower rate.

To learn more:

Tags: USPTO fees

No, you cannot amend the specification to refer to a Continued Prosecution Application (CPA) as a continuation of a prior application. The USPTO explicitly denies such amendments. As stated in MPEP ¶ 2.34:

The amendment filed [date] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [continuation/divisional] application of Application No. [X] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.

This means that the act of filing a CPA automatically establishes the necessary reference to the prior application, making any specification amendment unnecessary and prohibited.

For more information on CPA, visit: CPA.

Tags: CPA

No, you cannot amend the specification of a Continued Prosecution Application (CPA) to reference the prior application. The USPTO explicitly states that such amendments are not necessary and will not be entered.

As per MPEP ¶ 2.34: “Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This policy simplifies the process and ensures consistency across CPA filings.

No, you cannot amend the specification of a Continued Prosecution Application (CPA) to refer to it as a continuation or divisional application. According to MPEP § 201.06(d):

“The amendment filed [date] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [continuation/divisional] application of Application No. [X] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This means that the CPA request itself serves as the required reference to the prior application, and no additional amendment to the specification is necessary or allowed.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

Can I add working examples to my patent application after filing?

Adding working examples to a patent application after filing is generally not permitted if they constitute new matter. According to MPEP 608.04:

“An amendment to the claims or the addition of a new claim must be supported by the description of the invention in the application as filed. In re Wright, 866 F.2d 422, 9 USPQ2d 1649 (Fed. Cir. 1989).”

This means that any working examples added after filing must be fully supported by the original disclosure. If the examples contain information not inherently or implicitly present in the original filing, they will be considered new matter and may be rejected.

However, you may be able to add working examples if:

  • They only elaborate on principles already described in the original application
  • They demonstrate results that are inherent to the invention as originally disclosed
  • They do not introduce any new characteristics or properties not previously mentioned

It’s always best to include comprehensive working examples in the initial filing to avoid potential new matter issues later in the prosecution process.

To learn more:

To learn more:

Tags: new matter

The MPEP ¶ 2.32 specifically addresses the process of deleting named inventors when filing a Continued Prosecution Application (CPA) for design patents. However, it does not explicitly mention adding or substituting inventors at the time of CPA filing.

If you need to add or substitute inventors, rather than just delete them, you should follow the general procedures for correction of inventorship outlined in 37 CFR 1.48. This regulation provides the requirements for adding, deleting, or substituting inventors in patent applications.

It’s advisable to consult with a patent attorney or contact the USPTO directly for guidance on the proper procedure for adding or substituting inventors when filing a CPA, as this may require additional documentation or fees beyond a simple deletion request.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

When submitting omitted drawings to a patent application, it’s crucial to understand that you cannot add new matter. The MPEP 601.01(f) states:

“If omitted drawing(s) are filed, the application will be given a filing date as of the date of such filing, provided the submitted drawing(s) do not add new matter to the originally filed application.”

This means that the drawings you submit must only illustrate what was already described in the original application’s specification. Adding new features or details not previously disclosed would be considered new matter and could result in the loss of your original filing date or rejection of the added material.

To learn more:

To learn more:

Tags: new matter

The MPEP ¶ 2.32 specifically addresses the deletion of inventors in a Continued Prosecution Application (CPA) for design patents, but it does not directly discuss adding inventors. However, changes to inventorship in patent applications are generally governed by 37 CFR 1.48.

If you need to add an inventor when filing a CPA, it’s advisable to:

  • Include a clear statement requesting the addition of the new inventor
  • Provide the new inventor’s oath or declaration
  • Submit any required fees

For specific guidance on adding inventors to a CPA, it’s recommended to consult with a patent attorney or contact the USPTO directly, as the process may differ from deleting inventors and could require additional documentation.

For more information on patent procedure, visit: patent procedure.

No, you cannot add an incorporation by reference statement when submitting a benefit claim after the initial filing of your application. The MPEP clearly states:

When a benefit claim is submitted after the filing of an application, the reference to the prior application cannot include an incorporation by reference statement specifying of the prior application unless an incorporation by reference statement specifying of the prior application was presented upon filing of the application.

This rule is based on the principle that no new matter can be added to an application after its filing date, as per 35 U.S.C. 132(a). The MPEP cites the case of Dart Indus. v. Banner, 636 F.2d 684, 207 USPQ 273 (C.A.D.C. 1980) to support this position.

Therefore, if you wish to include an incorporation by reference statement for a prior application, it must be present in the application as originally filed. If it wasn’t included at that time, you cannot add it later when submitting a benefit claim.

To learn more:

Yes, it is possible to add a priority claim to a patent after it has been issued, but the process requires filing a reissue application. The MPEP states:

‘A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) or 35 U.S.C. 120 in the issued patent.’

To add a priority claim, you would need to:

  • File a reissue application under 35 U.S.C. 251
  • Amend the specification to include the required reference
  • Ensure the reissue application is filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f)

It’s important to note that adding a priority claim may affect the patent’s term and could potentially impact its validity if prior art emerges between the new priority date and the original filing date.

Can I add a benefit claim to a foreign priority application after filing?

Yes, you can add a benefit claim to a foreign priority application after filing, but specific procedures must be followed. According to MPEP 211.02(a):

“In the case of a design application, an original claim under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) to a prior U.S. application or PCT international application designating the United States may be made by the filing of an amendment to the specification within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For utility applications, similar time frames apply. However, if you miss these deadlines, you must file a petition under 37 CFR 1.78 along with the petition fee to add the benefit claim. The petition must include:

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed application
  • A statement that the entire delay was unintentional
  • The petition fee set forth in 37 CFR 1.17(m)

It’s important to act promptly when adding or correcting benefit claims to avoid potential issues with patentability or patent term.

To learn more:

Yes, you can add a benefit claim after filing your patent application, but there are specific requirements and potential consequences:

  1. If added within the time period set by 37 CFR 1.78, you can submit a corrected Application Data Sheet (ADS) for applications filed on or after September 16, 2012, or an amendment to the specification or supplemental ADS for applications filed before that date.
  2. If added after the time period set by 37 CFR 1.78, you must file a petition under 37 CFR 1.78 and pay the petition fee. The petition must include:
    • The reference to the prior application
    • The petition fee
    • A statement that the entire delay was unintentional
  3. Depending on the application status, you may also need to file:
    • A Request for Continued Examination (RCE) if the application is under final rejection or allowed
    • A reissue application or request for a certificate of correction if the patent has already issued

As stated in MPEP 211.02(a): “When a benefit claim is submitted after the filing of an application, the reference to the prior application cannot include an incorporation by reference statement specifying of the prior application unless an incorporation by reference statement specifying of the prior application was presented upon filing of the application.”

It’s important to note that adding a benefit claim may affect the patent term and could introduce new prior art, so consider these factors carefully before proceeding.

To learn more:

Access to international application files at the USPTO is governed by specific rules. According to MPEP 103:

‘International applications that designate the U.S. and have been published in accordance with PCT Article 21(2) are generally open to public inspection and copying.’

This means:

  • Published international applications designating the U.S. are accessible
  • Access is available after the application’s international publication
  • Unpublished international applications are not open to public inspection

To access these files, you can use the USPTO’s Public PAIR system or visit the USPTO’s Public Search Facility.

For more information on international applications, visit: international applications.

For more information on public inspection, visit: public inspection.

Access to assignment records for unpublished patent applications is restricted. The MPEP states:

“For pending or abandoned applications which are not open to the public pursuant to 37 CFR 1.11 or for which copies or access may not be supplied pursuant to 37 CFR 1.14, information related thereto is only obtainable upon a proper showing of written authority.”

To access these records, you must have written authority from one of the following:

  • An inventor
  • The applicant
  • The assignee or an assignee of an undivided part interest
  • A patent practitioner of record
  • A person with written authority from any of the above

Alternatively, you must show that you are a bona fide prospective or actual purchaser, mortgagee, or licensee of the application.

Access to pending unpublished patent applications is generally restricted. However, according to 37 CFR 1.14(a)(1)(v) and (vi), there are some circumstances where a copy of the file contents or the application as originally filed may be provided:

  • If the benefit of the application is claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in an application that has been published or patented.
  • If the application is incorporated by reference or otherwise identified in a U.S. patent, statutory invention registration, U.S. patent application publication, international publication of an international application, or publication of an international registration designating the U.S.

In these cases, a written request must be submitted along with payment of the appropriate fee set forth in 37 CFR 1.19(b). The Office will not provide access to the paper file of a pending application, except under specific circumstances outlined in 37 CFR 1.14(c) or (i).

Yes, heirs can apply for a patent on behalf of a deceased inventor under certain circumstances. According to MPEP 409.01(b):

“Application may be made by the heirs of the inventor, as such, if there is no will or the will did not appoint an executor and the estate was under the sum required by state law for the appointment of an administrator.”

In such cases, the heirs should identify themselves as the legal representative of the deceased inventor in the oath or declaration submitted pursuant to pre-AIA 37 CFR 1.63 and 1.64. This allows heirs to proceed with the patent application process when no formal legal representative has been appointed.

To learn more:

Tags: pre-AIA

No, foreign universities do not qualify as ‘institutions of higher education’ for the purpose of establishing micro entity status. This is because the definition is limited to institutions located in U.S. states or territories.

According to MPEP 509.04(b): “As previously stated, foreign universities do not qualify as an ‘institution of higher education’ for purposes of establishing micro entity status.”

Even if a foreign university offers online programs in the U.S., it still doesn’t qualify because the institution itself must be physically located in a U.S. state or territory as defined in the Higher Education Act of 1965.

To learn more:

Tags: patent fees

Can foreign language assignment documents be recorded at the USPTO?

Yes, foreign language assignment documents can be recorded at the USPTO, but they must be accompanied by an English translation. The MPEP 302 states:

“Unless an assignment is in a language other than English, the Office may rely on the assignment document (or a copy thereof) as filed.”

If the assignment is in a foreign language, you must provide:

  • The original foreign language document
  • An English language translation
  • A statement verifying that the translation is accurate

This ensures that the USPTO can properly review and record the assignment, maintaining accurate ownership records for patents and patent applications.

For more information on patent assignment, visit: patent assignment.

For more information on translation requirements, visit: translation requirements.

For more information on USPTO, visit: USPTO.

Yes, foreign applicants can qualify for micro entity status if they meet all the requirements. The USPTO states in MPEP 509.04(a):

Small entities may claim reduced fees regardless of the country in which they are located. There is no restriction requiring that the person, small business concern, or nonprofit organization be located in the United States.

For applicants with income in foreign currency, 37 CFR 1.29(c) specifies: ‘If an applicant’s, inventor’s, joint inventor’s, or entity’s gross income in the preceding calendar year is not in United States dollars, the average currency exchange rate, as reported by the Internal Revenue Service, during that calendar year shall be used to determine whether the applicant’s, inventor’s, joint inventor’s, or entity’s gross income exceeds the threshold specified in paragraph (a)(3) or (4) of this section.’

No, for-profit universities do not qualify as ‘institutions of higher education’ for the purpose of establishing micro entity status. One of the requirements for an institution of higher education under the Higher Education Act of 1965 is that it must be non-profit.

MPEP 509.04(b) states: “One of the requirements for an ‘institution of higher education’ under section 101(a) of the Higher Education Act of 1965 is that the institution be non-profit. Therefore, for-profit universities and colleges do not qualify as an ‘institution of higher education’ for purposes of establishing micro entity status.”

This means that employees or those who have assigned rights to for-profit universities cannot claim micro entity status on this basis.

To learn more:

Tags: patent fees

Yes, filing unnecessary duplicate copies of patent correspondence can potentially cause processing delays at the USPTO. The MPEP 502.04 explicitly states:

When the Office does not require duplicate copies of a paper, the filing of multiple copies may cause a delay in processing by the Office.

This is one of the reasons why the USPTO discourages the submission of duplicate copies unless specifically required. To ensure efficient processing of your patent application or correspondence, it’s best to avoid submitting unnecessary duplicates.

To learn more:

Yes, failure to pay the issue fee can result in an abandoned patent application. MPEP 203.05 explicitly states that an abandoned application includes one removed from the Office docket for failure to pay the issue fee (MPEP § 711 to § 711.05). This means that even if an application has been approved for issuance, if the applicant fails to pay the required issue fee within the specified time frame, the application will be considered abandoned.

For more detailed information on this topic, you can refer to MPEP § 711 to § 711.05.

While the MPEP 602.08(c) provides specific guidelines for identifying patent applications, it does allow for exceptions in certain circumstances. The MPEP states:

Any variance from the above guidelines will only be considered upon the filing of a petition for waiver of the rules under 37 CFR 1.183 accompanied by a petition fee (37 CFR 1.17(f)).

This means that if you need to deviate from the standard identification requirements, you must:

The USPTO will then consider your petition and determine whether to grant an exception to the standard identification requirements. It’s important to note that such exceptions are not automatically granted and should only be sought in unusual circumstances where compliance with the standard requirements is not possible or would cause undue hardship.

To learn more:

Yes, examiners can initiate interview requests with patent practitioners of record. The MPEP encourages this practice to expedite prosecution:

The Office encourages the use of interviews to expedite prosecution. When the examiner believes the progress of the application would be advanced by an interview, the examiner may contact the patent practitioner of record in the application (in accordance with MPEP § 713) and suggest a telephonic, personal, or video conference interview.

This proactive approach by examiners can help clarify issues and potentially speed up the patent application process.

Can electronic copies of assignment documents be submitted for recording?

Yes, electronic copies of assignment documents can be submitted for recording at the USPTO. The MPEP 302.01 states: Any legible copies, including facsimile transmissions and computer generated copies, of original assignment documents will be acceptable for recording.

This means you can submit:

  • Scanned copies of original documents
  • Faxed copies
  • Computer-generated copies

The key requirement is that the electronic copy must be legible. Ensure that all text, signatures, and dates are clearly visible in the electronic copy. You can submit these electronic copies through the USPTO’s Electronic Patent Assignment System (EPAS) for efficient processing.

Can drawings or figures in a patent application introduce new matter?

Yes, drawings or figures can introduce new matter in a patent application. The MPEP 608.04 addresses this issue:

‘In establishing a disclosure, applicant may rely not only on the description and drawing as filed but also on the original claims if their content justifies it.’

This implies that:

  • Original drawings are part of the disclosure and can support claims.
  • However, new or amended drawings can potentially introduce new matter.
  • Changes to drawings that go beyond what was originally disclosed may be rejected as new matter.

For example, adding specific structural details to a figure that weren’t originally disclosed, or introducing new relationships between components, could be considered new matter. Applicants should be cautious when modifying drawings and ensure any changes are fully supported by the original disclosure.

To learn more:

Generally, no. According to MPEP 608.02(i), “Drawings cannot normally be transferred from a first pending application to another as the Office no longer considers drawings as formal or informal.” This means that each application typically requires its own set of drawings that comply with the specific requirements for that application.

To learn more:

Can drawings be amended after the application filing date without introducing new matter?

Amending drawings after the application filing date without introducing new matter is possible, but it requires careful consideration. According to MPEP 608.04(a):

‘An amendment to the drawings, however, which adds a feature not disclosed in the original drawings or specification involves new matter.’

This means that while you can make amendments to drawings, any new features or elements not disclosed in the original application will be considered new matter. Acceptable amendments typically include:

  • Correcting minor errors or inconsistencies
  • Improving clarity or resolution of existing features
  • Adding reference numbers or labels to existing elements

It’s crucial to ensure that any changes to drawings are fully supported by the original disclosure. If significant changes are needed that would introduce new matter, filing a continuation-in-part application may be necessary.

To learn more:

To learn more:

Can drawings be added to a patent application after the filing date?

According to MPEP 608.04(a), adding drawings to a patent application after the filing date is generally considered new matter. The MPEP states: “Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.” This includes new drawings. However, there are exceptions:

  • If the drawings merely depict what was already described in the original written description, they might be allowable.
  • Drawings may be accepted if they are clearly supported by the original disclosure and do not introduce new information.

It’s crucial to include all necessary drawings with the initial application to avoid potential new matter issues.

To learn more:

To learn more:

No, drawing objections cannot typically be held in abeyance in a patent application. According to 37 CFR 1.85(a):

Unless applicant is otherwise notified in an Office action, objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action.

This means that applicants must address drawing objections in their response to an Office action. Failing to do so may result in the response being considered incomplete or non-responsive.

To learn more:

Yes, drawing corrections can be made after the application has been allowed. However, such corrections must be approved by the examiner before the application can be processed for issue. If extensive corrections are required, the examiner may require that the corrections be filed with a Request for Continued Examination (RCE) under 37 CFR 1.114.

Yes, adding or reversing directional arrows in patent drawings is one of the changes that can be made without requiring annotated sheets from the applicant. According to MPEP 608.02(w):

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: … (D) Adding or reversing directional arrows.

This provision allows examiners to suggest the addition or modification of directional arrows to improve the clarity and understanding of the drawings without necessitating a formal submission of annotated sheets by the applicant.

To learn more:

No, design patent applications cannot directly claim the benefit of a provisional application. The MPEP clearly states:

“Design applications may not claim the benefit of a provisional application under 35 U.S.C. 119(e).”

This restriction is based on 35 U.S.C. 172. However, there is a potential indirect way to claim some benefit:

If a design patent application claims benefit under 35 U.S.C. 120 to an intermediate nonprovisional utility patent application that directly claims the benefit of a provisional application, the design application cannot claim the benefit of the filing date of the provisional application.

This means that while a design application can’t directly benefit from a provisional application’s filing date, it may indirectly benefit from the disclosure in a nonprovisional utility application that claims priority to a provisional application.

To learn more:

No, design applications cannot claim the benefit of provisional applications under 35 U.S.C. 119(e).

MPEP 211.01(a) explicitly states: Design applications may not claim the benefit of a provisional application under 35 U.S.C. 119(e).

However, it’s important to note that while a design application cannot directly claim benefit of a provisional application, it may be possible to indirectly claim benefit through an intermediate utility application. The MPEP clarifies: Thus, where a design patent application claims benefit under 35 U.S.C. 120 to an intermediate nonprovisional utility patent application that directly claims the benefit of a provisional application, the design application cannot claim the benefit of the filing date of the provisional application.

To learn more:

Copyright notices may be included in patent applications under certain conditions:

  • The notice must be placed adjacent to the copyrighted material
  • The content must be limited to required legal elements
  • An authorization statement must be included in the specification
  • Notices in drawings must comply with 37 CFR 1.84(s)

As stated in 37 CFR 1.71(d): “A copyright or mask work notice may be placed in a design or utility patent application adjacent to copyright and mask work material contained therein. The notice may appear at any appropriate portion of the patent application disclosure. For notices in drawings, see § 1.84(s). The content of the notice must be limited to only those elements provided for by law.”

To learn more:

To learn more:

Generally, the USPTO does not provide copies of models or other physical exhibits. This policy is outlined in 37 CFR 1.95, which states:

Copies of models or other physical exhibits will not ordinarily be furnished by the Office, and any model or exhibit in an application or patent shall not be taken from the Office except in the custody of an employee of the Office specially authorized by the Director.

This means that while the original models or exhibits may be viewed at the USPTO under certain circumstances, obtaining copies or removing them from the Office is highly restricted. Applicants should maintain their own copies or documentation of any models or exhibits submitted as part of their patent application.

To learn more:

To learn more:

Tags: USPTO policy

No, color drawings cannot be submitted by facsimile to the USPTO. This is explicitly stated in MPEP 502.01 and 37 CFR 1.6(d)(4):

Facsimile transmissions are not permitted and, if submitted, will not be accorded a date of receipt in the following situations: … (4) Color drawings submitted under §§ 1.81, 1.83 through 1.85, 1.152, 1.165, 1.173, 1.437, or 1.1026;

The prohibition on faxing color drawings is due to the limitations of facsimile technology in accurately reproducing colors. Submitting color drawings via fax could result in loss of quality or details that are crucial for the proper examination and understanding of the invention.

If you need to submit color drawings for your patent application, you should use other approved methods, such as mailing or electronic filing through the USPTO’s electronic filing system (EFS-Web or Patent Center). Always refer to the most current USPTO guidelines for submitting color drawings to ensure compliance with their requirements.

To learn more:

Expungement of assignment records is extremely rare and does not result in the complete removal of a document from the assignment records. According to MPEP 323.01(d), petitions to expunge are granted only if:

  • Normal corrective procedures are inadequate
  • The integrity of assignment records won’t be affected

Even if granted, “the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number.” However, links to the specific application or patent will be deleted from the Assignment Historical Database. A redacted version of the ‘expunged’ document must be recorded in its place.

Yes, assignment records can be expunged after they have been recorded by the USPTO, but only through a specific petition process. According to MPEP 323.01(d):

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

This means that once an assignment record has been officially recorded, it cannot be simply removed or deleted. A formal petition must be filed, demonstrating that the document was submitted by mistake or is of improper character. The USPTO will then review the petition and make a determination on whether to expunge the record.

To learn more:

Yes, assignment records can be expunged even after a patent has been issued. The MPEP 323.01(d) states: ‘Expungement of any assignment records will be handled in accordance with 37 CFR 1.4(g). This may include expungement of documents recorded prior to, during, or after, prosecution of the application that matured into the patent.’ This means that the USPTO can consider expungement requests for assignment records at any stage, including after the patent has been granted.

To learn more:

Can assignment documents be submitted electronically to the USPTO?

Yes, assignment documents can be submitted electronically to the USPTO. The MPEP 302 states:

‘Assignment documents can be submitted to the Office in paper or electronically.’

The USPTO provides an electronic system for submitting assignment documents, which can be more convenient and efficient than paper submissions. However, it’s important to note that regardless of the submission method, the documents must meet all legal requirements and be properly executed to be considered valid.

For electronic submissions, users can utilize the Electronic Patent Assignment System (EPAS) provided by the USPTO. This system allows for quick and secure submission of assignment documents directly to the USPTO’s database.

For more information on assignment documents, visit: assignment documents.

For more information on electronic submission, visit: electronic submission.

For more information on EPAS, visit: EPAS.

For more information on USPTO, visit: USPTO.

Yes, arbitration awards in patent disputes can be modified under certain circumstances. According to 35 U.S.C. 294(c):

‘The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration.’

If an award is modified, the party requesting the modification must file a notice with the USPTO, as per 37 CFR 1.335(b).

No, an officer of an assignee corporation is not authorized to sign a certification of micro entity status. According to MPEP 509.04(c):

“If any applicant is an assignee or other party under 37 CFR 1.46, and the assignee or other party is a corporation or organization rather than a person, a registered practitioner must sign the certification of micro entity status. An officer of the assignee corporation, for example, is not authorized to sign a certification of micro entity status.”

This means that for corporate assignees, only a registered patent practitioner can sign the micro entity certification.

To learn more:

Can an oath or declaration from a provisional application be used for a nonprovisional application?

No, an oath or declaration from a provisional application cannot be used for a subsequent nonprovisional application. The MPEP 602.05 states:

‘The oath or declaration filed in a provisional application is not sufficient for the purposes of a nonprovisional application filed under 35 U.S.C. 111(a) or a national stage application filed under 35 U.S.C. 371, even if the nonprovisional application claims the benefit of the provisional application under 35 U.S.C. 119(e).’

This means that when converting a provisional application to a nonprovisional application or filing a nonprovisional application claiming priority to a provisional, a new oath or declaration must be submitted. This requirement ensures that the inventors properly declare their inventorship for the nonprovisional application, which may contain additional or modified content compared to the provisional application.

To learn more:

Yes, an oath or declaration can be filed after the application filing date. However, there are important considerations:

  • A surcharge may be required if the oath or declaration is not present on the filing date.
  • The application must be in condition for allowance before the oath or declaration is filed to avoid abandonment.
  • The oath or declaration must still comply with 37 CFR 1.63, even if filed after the application date.

As stated in MPEP 602.01(a): “If an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement in compliance with 37 CFR 1.64, executed by or with respect to each inventor has not been submitted at the time of filing, the Office will send a Notice to File Missing Parts of Nonprovisional Application indicating that the application lacks the oath or declaration and give a period of time within which to file the oath or declaration.”

To learn more:

Can an inventor’s oath or declaration from a parent application be used in a divisional application?

Yes, an inventor’s oath or declaration from a parent application can often be used in a divisional application. According to MPEP 201.06(c):

‘In accordance with 37 CFR 1.63(d), a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) if: (1) the divisional application claims are directed to subject matter disclosed in the prior-filed application; (2) a copy of the inventor’s oath or declaration from the prior-filed application is provided for the divisional application; and (3) the prior-filed application contains a statement by the applicant that any required oath or declaration, including any substitute statement under 37 CFR 1.64 or assignment-statement under pre-AIA 37 CFR 1.63(e), has been filed.’

This provision simplifies the filing process for divisional applications by allowing the reuse of the original oath or declaration, provided certain conditions are met. However, it’s important to ensure that all inventors named in the divisional application are covered by the oath or declaration from the parent application.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on parent application, visit: parent application.

Yes, an inventor’s oath or declaration can be corrected, withdrawn, or replaced after submission. This is provided for in 35 U.S.C. 115(h)(1), which states:

Any person making a statement required under this section may withdraw, replace, or otherwise correct the statement at any time.

Additionally, 37 CFR 1.63(h) provides:

An oath or declaration filed at any time pursuant to 35 U.S.C. 115(h)(1) will be placed in the file record of the application or patent, but may not necessarily be reviewed by the Office.

This means that:

  • Inventors or applicants can submit corrections or replacements to oaths or declarations at any time
  • These corrected or replacement documents will be added to the application file
  • The USPTO may not necessarily review these additional submissions

However, it’s important to note that any request for correction of the named inventorship must comply with 37 CFR 1.48 in an application and 37 CFR 1.324 in a patent. These regulations provide specific procedures for correcting inventorship, which are separate from the process of correcting an oath or declaration.

To learn more:

Generally, an inventor’s oath or declaration should not be amended after signing. The MPEP clearly states:

The wording of an oath or declaration should not be amended, altered or changed in any manner after it has been signed.

If there are issues with the oath or declaration, the proper course of action is typically to submit a new one. As the MPEP notes:

If the wording is not correct or if all of the required affirmations have not been made, or if it has not been properly subscribed to, a new oath or declaration should be submitted.

However, in some cases, minor deficiencies can be corrected without submitting a new oath or declaration. For example, if the oath does not set forth evidence that the notary was acting within their jurisdiction at the time the oath is administered the oath, a certificate of the notary that the oath was taken within their jurisdiction will correct the deficiency.

To learn more:

Can an inventor’s attorney conduct an interview without a power of attorney?

Yes, an inventor’s attorney can conduct an interview without a power of attorney under certain conditions. The MPEP 405 provides guidance on this matter:

Interviews may be granted to an attorney or agent who is not of record in an application if the conditions of 37 CFR 1.33(b)(3) are satisfied.

This means that if the attorney or agent complies with the requirements set forth in 37 CFR 1.33(b)(3), they can conduct an interview even without a formal power of attorney. These requirements typically include providing evidence of their authority to act on behalf of the applicant.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO procedures, visit: USPTO procedures.

While inventors must use their legal names on patent applications, they can include preferred names or nicknames in a specific format. According to the MPEP 602.08(b):

Nicknames should be placed in quotation marks.

For example, if an inventor’s legal name is John Smith but he goes by ‘Jack’, the name on the patent application should be formatted as:

John “Jack” Smith

This approach allows the inventor to include their preferred name while still maintaining the legal requirements for the patent application.

To learn more:

No, an inventor cannot authorize another individual to act as their agent to sign the application oath or declaration on their behalf. The MPEP is clear on this point, stating: “An inventor may not authorize another individual to act as his or her agent to sign the application oath or declaration on his or her behalf.”

This prohibition is supported by legal precedents, as the MPEP cites: “Staeger v. Commissioner, 189 USPQ 272 (D.D.C. 1976), In re Striker, 182 USPQ 507 (Comm’r Pat. 1973).” These cases reinforce the requirement for the inventor’s personal signature on the oath or declaration.

To learn more:

Tags: pre-AIA

Yes, an international application can be used as a basis for priority in a U.S. national application. This is outlined in 35 U.S.C. 365(a), which states:

In accordance with the conditions and requirements of subsections (a) through (d) of section 119, a national application shall be entitled to the right of priority based on a prior filed international application which designated at least one country other than the United States.

It’s important to note that the international application must have designated at least one country other than the United States to be eligible as a basis for priority.

To learn more:

Yes, under 37 CFR 1.55(j), the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f) will be considered satisfied if:

  1. A copy of the original foreign application clearly labeled as “Interim Copy,” including the specification, and any drawings or claims upon which it is based, is filed in the Office together with a separate cover sheet identifying the foreign application and stating that the copy is a true copy of the original application as filed; and
  2. The copy of the foreign application and cover sheet are filed within the later of sixteen months from the filing date of the prior foreign application, four months from the actual filing date of an application under 35 U.S.C. 111(a), or four months from the date the national stage commenced under 35 U.S.C. 371(b) or (f) of an international application.

However, a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate. See MPEP 215.02(b).

No, an institution of higher education cannot itself claim micro entity status. The micro entity status based on an institution of higher education is intended for inventors who are employees of such institutions or who have assigned rights to them, not for the institutions themselves.

MPEP 509.04(b) clarifies: “Although the 37 CFR 1.29(d) basis for qualifying for micro entity status is referred to as the ‘institution of higher education’ basis, it is not the institution of higher education that can qualify for micro entity status, but rather inventors who are employees of an institution of higher education (see 37 CFR 1.29(d)(2)(i)) or inventors or applicants who have conveyed ownership rights to an institution of higher education (see 37 CFR 1.29(d)(2)(ii)).”

The institution itself cannot logically make the certifications required under the regulations, such as certifying that its employer is an institution of higher education or that it has assigned rights to itself.

To learn more:

Yes, an incomplete patent application can often be corrected, but the process and consequences depend on the specific deficiencies. While MPEP 203.06 doesn’t directly address corrections, it implies that applications lacking essential parts are incomplete:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

To correct an incomplete application:

  • Identify the missing components
  • Submit the missing parts as soon as possible
  • Pay any required fees
  • Be aware that the filing date may be adjusted to the date when all essential parts are received

It’s important to note that some deficiencies may result in the need to file a new application. Consult with a patent attorney or agent for specific guidance on your situation.

To learn more:

No, an Information Disclosure Statement (IDS) cannot be incorporated into the specification of a patent application. The MPEP clearly states:

The list of information complying with the format requirements of 37 CFR 1.98(a)(1) and the identification requirements of 37 CFR 1.98(b) may not be incorporated into the specification of the application in which it is being supplied, but must be submitted in a separate paper.‘ (MPEP 609.04(a))

The reasons for this requirement include:

  • To easily confirm that the applicant intends to submit an IDS
  • To provide a readily available checklist for the examiner
  • To provide a simple means of communication to the applicant regarding which documents have been considered

The MPEP recommends using form PTO/SB/08, Information Disclosure Statement, to list the documents. This separate submission ensures clear communication and proper processing of the IDS by the USPTO.

To learn more:

No, extensions of time for filing an Information Disclosure Statement (IDS) are not permitted under 37 CFR 1.136(a) or (b). However, if a bona fide attempt is made to comply with the content requirements of 37 CFR 1.98, but part of the required content is inadvertently omitted, additional time may be given to enable full compliance.

As stated in MPEP 609.04(b): No extensions of time for filing an information disclosure statement are permitted under 37 CFR 1.136(a) or (b). If a bona fide attempt is made to comply with the content requirements of 37 CFR 1.98, but part of the required content is inadvertently omitted, additional time may be given to enable full compliance.

To learn more:

No, an examiner’s objection to unlabeled prior art figures cannot be held in abeyance. The MPEP 608.02(g) clearly states that The objection to the drawings will not be held in abeyance.

This means that the applicant must address the objection in their response to the Office action. Failure to correct the labeling of prior art figures as requested may lead to further complications in the patent prosecution process, potentially including abandonment of the application if not addressed in a timely manner.

To learn more:

Can an examiner request copies of cited NPL documents not submitted with an IDS?

Yes, an examiner can request copies of cited Non-Patent Literature (NPL) documents that were not submitted with an Information Disclosure Statement (IDS) under certain circumstances:

  • If the NPL citation is incomplete or illegible, the examiner may request a legible copy.
  • If the NPL document is not readily available to the examiner, they may request a copy from the applicant.
  • The examiner should only request copies of documents that seem particularly relevant to the claimed invention.

According to MPEP 609.05(c): “The examiner may request copies of only those documents cited in the information disclosure statement that are not present in the Office’s files if the examiner believes the documents to be readily available.”

However, it’s important to note that: “The Office should not require copies of U.S. patents and U.S. patent application publications cited in an IDS, unless required by the first sentence of 37 CFR 1.98(d).”

To learn more:

Yes, patent examiners can make a preliminary determination about whether an application might qualify as a continuation-in-part (CIP). The MPEP ¶ 2.06 provides guidance for examiners, stating:

This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Examiners typically look for the following indicators:

  • Substantial repetition of content from a prior application
  • Addition of new disclosure not present in the prior application
  • At least one common inventor with the prior application

However, it’s important to note that the final determination of an application’s status as a CIP depends on the applicant’s claims and proper benefit claims being established. Examiners may use this paragraph to alert applicants to the possibility of CIP status and the need to properly claim benefit if desired.

Can an attorney withdraw from patent representation without client consent?

While it’s generally preferable to obtain client consent, an attorney can withdraw from patent representation without client consent under certain circumstances. However, they must still follow proper procedures and notify the USPTO. The MPEP 402.06 states:

“The requirements for withdrawal of an attorney or agent are set forth in 37 CFR 1.36. The Office of Enrollment and Discipline (OED) handles withdrawal of entire firms.”

Key points to consider:

  • The attorney must provide notice to the client and the USPTO.
  • Reasons for withdrawal without consent may include ethical conflicts or non-payment of fees.
  • The USPTO may require the attorney to show good cause for withdrawal.
  • The withdrawal should not unduly prejudice the client’s interests.

Attorneys should consult 37 CFR 1.36 and applicable state bar rules when considering withdrawal without client consent.

To learn more:

Can an attorney withdraw from a patent application without the applicant’s consent?

Yes, an attorney can withdraw from a patent application without the applicant’s consent under certain circumstances. However, the withdrawal must be approved by the USPTO. The MPEP 402.06 states:

‘An attorney or agent may withdraw from representing an applicant or assignee in a patent application pending before the USPTO… When appropriate, the Office will require the applicant or assignee to revoke the previous power of attorney and appoint new attorney(s) of record.’

While the applicant’s consent is not explicitly required, the USPTO considers the following factors when deciding whether to approve a withdrawal:

  • The reasons for withdrawal
  • The stage of prosecution
  • The potential impact on the applicant

The USPTO may deny the withdrawal if it would unduly prejudice the applicant or delay the prosecution of the application.

To learn more:

No, an attorney cannot sign an oath or declaration on behalf of an inventor, even if they have been given power of attorney to do so. This rule applies to applications filed before September 16, 2012.

According to MPEP § 602.08(b), “The oath or declaration may not be signed by an attorney on behalf of the inventor, even if the attorney has been given a power of attorney to do so.” This is supported by legal precedents, including:

  • Opinion of Hon. Edward Bates, 10 Op. Atty. Gen. 137 (1861)
  • Staeger v. Commissioner of Patents and Trademarks, 189 USPQ 272 (D.D.C. 1976)
  • In re Striker, 182 USPQ 507 (PTO Solicitor 1973)

These cases affirm that an oath or declaration signed by an attorney on behalf of the inventor is defective unless the attorney has a proprietary interest in the invention.

To learn more:

Tags: declaration, oath

Yes, an attorney or agent of record can formally abandon your patent application. MPEP 203.05 states that an application can be abandoned:

“through formal abandonment by the applicant or by the attorney or agent of record”

This means that your authorized representative has the power to formally abandon your application. However, they should only do so with your consent or under specific circumstances outlined in their agreement with you. It’s important to maintain clear communication with your patent attorney or agent regarding the status and decisions related to your application.

To learn more:

The MPEP provides guidance on this matter. According to MPEP 602, “The language of 35 U.S.C. 115 and 37 CFR 1.66 is such that an attorney in the application is not barred from administering the oath as notary.” However, it’s important to note that this practice may be subject to local laws. The MPEP further states, “If such practice is permissible under the law of the jurisdiction where the oath is administered, then the oath is a valid oath.” Attorneys should be aware of their local jurisdiction’s rules before administering an oath for their client’s patent application.

To learn more:

Tags: oath

Yes, an assignment can serve as an inventor’s oath or declaration under certain conditions. According to 37 CFR 1.63(e):

An assignment may also serve as an oath or declaration required by this section if the assignment as executed: (i) Includes the information and statements required under paragraphs (a) and (b) of this section; and (ii) A copy of the assignment is recorded as provided for in part 3 of this chapter.

This provision implements 35 U.S.C. 115(e). To use an assignment as an oath or declaration:

  • The assignment must include all required information and statements of a standard oath or declaration
  • It must be executed by the inventor who is under the obligation of assignment
  • A copy of the assignment must be recorded with the USPTO

Applicants should use a check-box on the assignment cover sheet to indicate the dual purpose of the document.

To learn more:

Yes, for certain patent applications, an assignment can contain statements required in an oath or declaration. The MPEP 301 states:

‘For applications filed under 35 U.S.C. 111(a), 363, or 385 on or after September 16, 2012, an assignment may contain the statements required to be made in an oath or declaration (‘assignment-statement’), and if the assignment is made of record in the assignment records of the Office, then the assignment may be utilized as the oath or declaration.’

This provision allows for greater flexibility in meeting the oath or declaration requirements, particularly for assigned inventions. However, it’s important to ensure that the assignment contains all the necessary statements and is properly recorded with the USPTO.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent assignment, visit: patent assignment.

Can an assignment be recorded electronically with the USPTO?

Yes, assignments can be recorded electronically with the USPTO. The MPEP 302 states:

“The USPTO provides for the electronic filing of patent assignment documents through the Electronic Patent Assignment System (EPAS).”

Electronic filing offers several advantages:

  • Faster processing times
  • Immediate confirmation of receipt
  • Reduced risk of errors in data entry
  • 24/7 accessibility

To use EPAS, users must have a USPTO.gov account and follow the specific guidelines for electronic submission. For detailed instructions, visit the Electronic Patent Assignment System (EPAS) on the USPTO website.

For more information on electronic filing, visit: electronic filing.

For more information on EPAS, visit: EPAS.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

Generally, an assignee cannot take action in a patent application if the assignment is not yet recorded in the USPTO. However, there is a specific provision for situations where the assignment has been executed but not yet recorded.

According to MPEP 324: If an assignment has not been recorded in the Office, the assignee may take action in a patent application under 37 CFR 3.73(b) by submitting a statement under 37 CFR 3.73(b) which is signed by a party authorized by the assignee.

This means that even if the assignment is not yet recorded, the assignee can still take action by:

  • Submitting a statement under 37 CFR 3.73(b)
  • Ensuring the statement is signed by an authorized party
  • Including a copy of the assignment document with the statement

However, it’s important to note that the assignment must still be recorded in the USPTO no later than the date of payment of the issue fee. Failure to record the assignment by this deadline could result in the loss of assignee rights.

For more information on assignee rights, visit: assignee rights.

Can an assignee revoke power of attorney in all types of patent applications?

An assignee’s ability to revoke power of attorney applies to most, but not all, types of patent applications. According to MPEP 402.07, there are specific scenarios where this is explicitly allowed:

“For applications involved in an interference or derivation proceeding, 37 CFR 41.5(b) or 42.10(e) provides that the assignee of the entire interest in an application or patent involved in the proceeding may act to the exclusion of the inventor. For national stage applications under 35 U.S.C. 371, the assignee may revoke any power of attorney of the applicant in the national stage application filed under 35 U.S.C. 371 and appoint any representative if the assignee has properly made itself of record in the national stage application pursuant to 37 CFR 3.71.”

This means assignees can revoke power of attorney in:

  • Applications involved in interference or derivation proceedings
  • National stage applications under 35 U.S.C. 371

For other types of applications, the general rule applies where the assignee must first become of record and then can revoke the applicant’s power of attorney. It’s important to consult with a patent attorney or agent for specific cases to ensure compliance with USPTO regulations.

To learn more:

In general, an assignee can revoke a power of attorney in most applications. However, there is an exception for certain government-owned applications. The MPEP states:

In applications filed before September 16, 2012, the assignee of record of the entire interest can revoke the power of attorney of the applicant unless an ‘irrevocable’ right to prosecute the application had been given as in some government owned applications.

This implies that in some government-owned applications, an irrevocable right to prosecute may have been granted, which would prevent the assignee from revoking the power of attorney. If you’re dealing with a government-owned application, it’s crucial to check whether such an irrevocable right exists before attempting to revoke a power of attorney.

To learn more:

Can an assignee revoke a power of attorney given by the applicant in a patent application?

Yes, an assignee can revoke a power of attorney given by the applicant in a patent application, provided certain conditions are met. According to MPEP 402.07:

“The assignee of the entire interest can revoke the power of attorney of the applicant and appoint its own patent practitioner.”

This is possible when:

  • The assignee has properly become of record pursuant to 37 CFR 3.71.
  • The application is involved in an interference or derivation proceeding.
  • The application is national stage application filed under 35 U.S.C. 371.

It’s important to note that the assignee must follow proper procedures and file the necessary documents with the USPTO to effectuate this change.

To learn more:

Yes, an assignee of the entire interest in a patent application can grant inspection rights to others. According to MPEP 106.01, the assignee of the entire interest has the same rights as the inventor and may authorize anyone to inspect the application. This authority stems from the assignee’s complete ownership of the patent application.

Yes, an assignee of part interest can file papers in a patent application even if it goes against the wishes of the inventor or other assignees. However, this is subject to the Commissioner’s discretion.

According to MPEP 106.01:

“Furthermore, the assignee of a part interest may prosecute the application to the exclusion of the inventor, and may file papers against the wishes of the inventor.”

This provision allows part interest assignees to protect their rights in the application, but the Commissioner retains authority to manage conflicts between parties.

To learn more:

No, an assignee of a part interest in a patent application cannot prevent other parties from accessing the application. According to MPEP 106, the assignee of a part interest may not control prosecution of the application to the exclusion of the inventor or other assignees. This means that all parties with an interest in the application have the right to access and inspect the application file.

The USPTO recognizes the rights of all interested parties and ensures that no single party can restrict access to the application information. This policy promotes transparency and fairness in the patent examination process.

No, an assignee of a part interest in a patent application cannot inspect the application without the consent of the inventor or other assignees. According to MPEP 106.01, the assignee of a part interest may not have access to the application file wrapper or be granted access to the subject matter of the application without the applicant’s consent. This restriction is in place to protect the interests of all parties involved in the patent application process.

No, an assignee of a part interest alone cannot file a reissue application. According to MPEP 1410, a reissue application must be applied for by all of the inventors, unless the application is accompanied by a petition under 37 CFR 1.182 for waiver of the requirement. Alternatively, the assignee of the entire interest can file the reissue application. An assignee of only a part interest is not entitled to file a reissue application on his or her own.

Can an assignee file a request to correct inventorship in a patent application?

Yes, an assignee can file a request to correct inventorship in a patent application. According to the MPEP, A request to correct or change the inventorship under 37 CFR 1.48(a) filed on or after September 16, 2012 may be signed by a patent practitioner of record or in compliance with 37 CFR 1.33(b), or by the applicant under 37 CFR 1.42. An assignee or obligated assignee who is the applicant may sign the request. This means that if the assignee is listed as the applicant on the application, they have the authority to file and sign the request for inventorship correction. For more details on who qualifies as an applicant, refer to MPEP 605.

To learn more:

Yes, for applications filed on or after September 16, 2012, an assignee can file a patent application as the applicant. According to MPEP § 409.05:

“An assignee or obligated assignee may file a patent application as the applicant. An assignee or obligated assignee doing so should record documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for an obligated assignee) as provided for in 37 CFR part 3 no later than the date the issue fee is paid in the application.”

However, to be the sole applicant, the assignee must have been assigned the entire interest in the application.

For more information on patent applicant, visit: patent applicant.

Yes, an assignee can correct a typographical error in an assignment document, but the process depends on the availability of the assignor. According to MPEP 323.01(b):

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction.

This means that:

  • If the assignor is available, they should make the correction or execute a new document.
  • If the assignor is not available, the assignee can submit an affidavit or declaration to correct the error.

The assignee must also provide a copy of the originally recorded papers, a cover sheet, and pay the required fee for each application or patent to be corrected, as per 37 CFR 3.41.

To learn more:

Yes, an assignee of record of the entire interest in a patent application can control access to it. According to MPEP 106, “The applicant or assignee of record of the entire interest in an application may file an application or intervene in the prosecution of the application, appointing an attorney or agent of his or her own choice.” This means that the assignee can manage the application’s prosecution and potentially limit access to it.

However, it’s important to note that “Such an application filing or intervention, however, does not exclude the inventor from access to the application to see that it is being prosecuted properly, unless the applicant or assignee makes specific request to that effect.” Any request to prevent the inventor’s access must be filed separately and directed to the Office of Petitions.

For more information on assignee rights, visit: assignee rights.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

Yes, an assignee can conduct patent prosecution after attorney withdrawal under certain conditions:

  • The assignee must have originally appointed the withdrawing attorney or agent.
  • The assignee becomes recognized by the Office for all purposes in the application.
  • The assignee can sign amendments and other papers related to the prosecution.

The MPEP 402.06 states: ‘If the applicant is the assignee who appointed the withdrawing attorney or agent, the applicant may conduct the prosecution of the application, for example, by signing amendments and other papers related to the prosecution of the application.’

It’s important to note that while assignees can conduct prosecution, they may benefit from seeking new professional representation to navigate the complex patent process effectively.

To learn more:

An assignee’s ability to appoint a power of attorney in a patent application depends on whether the assignee is the applicant. According to the MPEP:

  • An assignee who is the applicant may appoint an effective power of attorney without the need to establish the right to take action under 37 CFR 3.71.
  • An assignee who is not the applicant may sign a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c), which requires compliance with 37 CFR 3.71 and 3.73.

As stated in the MPEP, “An assignee or obligated assignee who is the applicant may appoint an effective power of attorney without the need to establish the right to take action under 37 CFR 3.71.” However, “An assignee who is not the applicant may sign a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c) (which requires compliance with 37 CFR 3.71 and 3.73).”

It’s important to note that an assignee who is not an applicant cannot revoke or appoint a power of attorney in a patent application without first becoming the applicant.

To learn more:

Yes, an arbitration award can be modified by a court, and this modification must be reported to the USPTO. The process is outlined in 35 U.S.C. 294(c) and 37 CFR 1.335(b):

  • If a court modifies an arbitration award, the party requesting the modification must file a notice with the USPTO.
  • The notice should be filed for each patent affected by the modification.
  • It must include the patent number, names of the inventor and patent owner, names and addresses of the arbitration parties, and a copy of the court’s order modifying the award.

As stated in 37 CFR 1.335(b): “If an award by an arbitrator pursuant to 35 U.S.C. 294 is modified by a court, the party requesting the modification must file in the Patent and Trademark Office, a notice of the modification for placement in the file of each patent to which the modification applies.”

This ensures that the USPTO’s records reflect the most current status of patent rights affected by arbitration and subsequent court decisions.

Yes, an application data sheet (ADS) can be used to correct certain information in a patent application. According to MPEP 603, deficiencies or inaccuracies due to the failure to meet the requirements of 37 CFR 1.63(b) in an oath or declaration may be corrected with an application data sheet in accordance with 37 CFR 1.76.

For example, an error in an inventor’s mailing address may be corrected with an application data sheet in accordance with 37 CFR 1.76.

However, it’s important to note that not all corrections can be made with an ADS. Specifically, any correction of inventorship must be pursuant to 37 CFR 1.48. This means that inventorship changes require a separate process and cannot be corrected solely through an ADS.

To learn more:

Can an application data sheet (ADS) be used to name the inventors in a patent application filed before September 16, 2012?

Yes, an application data sheet (ADS) can be used to name the inventors in a patent application filed before September 16, 2012. However, it’s important to note that the ADS is not the only way to name inventors, and there are specific rules governing this process.

According to MPEP 601.05(b):

“37 CFR 1.76(b)(1) states that the application data sheet must include the name, residence, and mailing address of each person believed to be an actual inventor. For nonprovisional applications filed before September 16, 2012, the naming of the inventorship is governed by 37 CFR 1.41(a)(1) in effect as of September 15, 2012.”

This means that while an ADS can be used to name inventors, the inventorship is ultimately determined by the rules set forth in 37 CFR 1.41(a)(1). It’s crucial to ensure that the inventor information provided in the ADS is consistent with other application documents, particularly the oath or declaration.

If there are any discrepancies, the oath or declaration will generally take precedence over the ADS for naming inventors in applications filed before September 16, 2012.

To learn more:

Yes, an Application Data Sheet (ADS) can be used to correct or update inventor information. The MPEP 601.05(a) states:

A corrected ADS may be submitted to correct or update information other than the inventorship. A corrected ADS correcting or updating information other than inventorship which is also reflected in the oath or declaration under 37 CFR 1.63 filed in a pending application must be accompanied by a request to correct or update the information under 37 CFR 1.48(c).

To correct inventorship, a request under 37 CFR 1.48(a) is required along with the corrected ADS. It’s important to follow the proper procedures to ensure the changes are accepted by the USPTO.

To learn more:

For applications filed before September 16, 2012 (pre-AIA applications), the Application Data Sheet (ADS) cannot be used to claim small entity status. According to MPEP 601.05(b):

The ADS cannot be used to make a small entity assertion, which must be done in a separate paper.

To claim small entity status in pre-AIA applications, applicants must submit a separate written assertion of entitlement to small entity status. This can be done through:

  • A specific written assertion of entitlement to small entity status
  • Payment of the small entity basic filing fee
  • Submission of a small entity written assertion in a related application

It’s important to note that for applications filed on or after September 16, 2012, the rules regarding small entity status claims have changed, and the ADS can be used for this purpose in those later applications.

To learn more:

Tags: ADS, pre-AIA

Yes, a nonprovisional application can be filed by reference to a previously filed application under certain conditions:

  • The application must be filed on or after December 18, 2013
  • A reference to the previously filed application must be made in an application data sheet
  • The reference must indicate that the specification and any drawings of the new application are replaced by the reference
  • The reference must specify the previously filed application by application number, filing date, and intellectual property authority

The USPTO states: As provided in 35 U.S.C. 111(c), a nonprovisional application filed under 35 U.S.C. 111(a) on or after December 18, 2013, may be filed by a reference to a previously filed application (foreign, international, provisional, or nonprovisional) indicating that the specification and any drawings of the application are replaced by the reference to the previously filed application.

However, the USPTO cautions: Accordingly, to avoid the risk of incorrect filings and the required surcharge, applicants should simply file a copy of the specification and drawings of the previously filed application, if available, instead of relying upon the reference filing provisions.

To learn more:

Yes, according to MPEP ¶ 2.05, an application can potentially be classified as both a continuation and a division. The MPEP states:

“Accordingly, this application may constitute a continuation or division.” (MPEP ¶ 2.05)

This dual classification possibility arises because:

  • A continuation application discloses and claims only subject matter from the prior application
  • A divisional application is filed as a result of a restriction requirement in the prior application
  • In some cases, an application may meet both criteria

The final determination of whether the application is a continuation, division, or both will depend on the specific circumstances of the application and its relationship to the prior application. The examiner will make this determination during the examination process.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

Yes, an applicant can withdraw their authorization for email communication with the USPTO. According to MPEP 502.03:

‘A written authorization may be withdrawn by filing a signed paper clearly identifying the original authorization.’

The USPTO provides a sample form for withdrawing authorization:

‘The authorization given on______, to the USPTO to communicate with any practitioner of record or acting in a representative capacity in accordance with 37 CFR 1.33 and 37 CFR 1.34 concerning any subject matter of this application via video conferencing, instant messaging, or electronic mail is hereby withdrawn.’

To facilitate processing, the USPTO recommends using Form PTO/SB/439, available at www.uspto.gov/patent/patents-forms. This form can be filed via EFS-Web using the document description ‘Internet Communications Authorization Withdrawn’.

To learn more:

Can an applicant with a license agreement qualify for micro entity status?

Yes, an applicant with a license agreement can potentially qualify for micro entity status, but there are specific conditions that must be met. The MPEP provides guidance on this:

“An applicant is not considered to have been named on a previously filed application if the applicant has assigned, or is under an obligation to assign, all ownership rights in the application as the result of the applicant’s previous employment.” (MPEP 509.04(a))

However, it’s important to note that:

  • The license agreement must not transfer all substantial rights in the invention to a non-micro entity.
  • If the licensee is not a micro entity, the applicant may lose their micro entity status.
  • The applicant must still meet all other micro entity criteria, including income limitations and the four-application limit.

Applicants with license agreements should carefully review the terms of their agreements and consult with a patent attorney to determine if they still qualify for micro entity status.

To learn more:

Tags: micro entity

Yes, an applicant can submit omitted drawings after filing a patent application, but this will affect the application’s filing date. The process involves:

  1. Submitting the omitted drawings within two months of the OPAP notice
  2. Filing a petition under 37 CFR 1.182
  3. Paying the petition fee set forth in 37 CFR 1.17(f)
  4. Accepting the date of submission of the omitted drawings as the new application filing date

The MPEP states: An applicant desiring to submit the omitted drawing(s) in a nonprovisional application and accept the date of such submission as the application filing date must, within two months from the date of the OPAP notice, file any omitted drawing(s) and a petition under 37 CFR 1.182 with the petition fee set forth in 37 CFR 1.17(f), requesting the later filing date.

It’s important to note that for applications filed before September 16, 2012, the omitted drawings must be accompanied by an oath or declaration in compliance with pre-AIA 37 CFR 1.63 and pre-AIA 37 CFR 1.64.

To learn more:

Yes, an applicant can submit missing parts of an application after the filing date, but this may affect the application’s effective filing date. The MPEP 506 states:

Such portion must be filed within the time period set by the Office in the notification by the Office of the omitted portion, or the application will be regarded as abandoned.

It’s important to note that submitting missing parts may result in a later effective filing date for the application, which could have implications for patent term and prior art considerations. Applicants should strive to submit complete applications initially to avoid potential complications.

For more information on effective filing date, visit: effective filing date.

For more information on missing parts, visit: missing parts.

Yes, an applicant can submit a copy of an inventor’s oath or declaration from a prior application under certain conditions. According to MPEP 602.01(a):

An applicant may submit an inventor’s oath or declaration meeting the requirements of 35 U.S.C. 115 and 37 CFR 1.63 or 1.64 in an earlier-filed application, and submit a copy of such oath or declaration in a later-filed application that claims the benefit of the earlier application under 35 U.S.C. 120, 121, 365(c), or 386(c).

However, there are specific requirements for using a copy:

  • The oath or declaration from the earlier application must comply with the current requirements.
  • The copy must be accompanied by a statement requesting its use and confirming that the executed oath or declaration is still accurate.
  • The earlier application must be specifically referenced.

This provision can save time and effort in subsequent related applications, but applicants must ensure all conditions are met for the copy to be accepted.

To learn more:

Can an applicant postpone filing the inventor’s oath or declaration in a patent application?

Yes, an applicant can postpone filing the inventor’s oath or declaration in a patent application under certain conditions. According to MPEP 602.01(a):

“An applicant may postpone filing the inventor’s oath or declaration until the application is otherwise in condition for allowance if the applicant is an assignee or a person to whom the inventor is under an obligation to assign the invention.”

However, it’s important to note that the oath or declaration (or an acceptable substitute statement) must be filed no later than the date on which the issue fee is paid. If not filed by then, the application will be regarded as abandoned.

Note: This postponement option is only available for applications filed on or after September 16, 2012, under the America Invents Act (AIA).

To learn more:

Yes, an applicant can petition for rescission or modification of a Secrecy Order. The MPEP states:

Applicants may petition for rescission or modification of the Secrecy Order. For example, if the applicant believes that certain existing facts or circumstances would render the Secrecy Order ineffectual, they may informally contact the sponsoring agency to discuss these facts or formally petition the Commissioner for Patents to rescind the Order.

The process for petitioning is outlined in 37 CFR 5.4 and 5.5. Key points include:

  • Petitions must be filed in duplicate and recite facts that purport to render the order ineffectual or futile.
  • For modification to permit foreign filing, all countries and disclosees must be identified.
  • Appeals can be made to the Secretary of Commerce if a petition for rescission is denied.

Applicants should carefully consider the reasons for seeking rescission or modification and provide comprehensive information in their petition.

Yes, the applicant or assignee of record of the entire interest in an application can make a specific request to prevent the inventor from obtaining access to the application file. This request should be filed as a separate paper under 37 CFR 1.4(c) and directed to the Office of Petitions. If granted, the inventor will only be permitted to inspect the application upon sufficient showing of why it is necessary to preserve their rights.

Any request to prevent the inventor from obtaining access to the file should be filed as a separate paper, 37 CFR 1.4(c), and should be directed to the Office of Petitions. If the request is granted, the inventor will be informed that he or she will only be permitted to inspect the application on sufficient showing why such inspection is necessary to conserve his or her rights.

Can an applicant communicate directly with the USPTO if they have a registered patent attorney?

Generally, when an applicant is represented by a registered patent attorney or agent, direct communication between the applicant and the USPTO is discouraged. The USPTO has specific rules regarding this situation:

  • The USPTO will communicate directly with the registered attorney or agent of record.
  • Applicants should channel their communications through their appointed representative.
  • Direct communication from the applicant may not be officially recognized or acted upon by the USPTO.

MPEP 403.01 clearly states: “The Office will not engage in double correspondence with an applicant and a patent practitioner, or with more than one patent practitioner except as deemed necessary by the Director.” This policy ensures clear and efficient communication channels and prevents potential confusion or contradictory instructions. If an applicant wishes to communicate directly, they should first revoke the power of attorney or authorization of agent on record.

To learn more:

Can an applicant claim micro entity status based on income from a foreign country?

Yes, an applicant can claim micro entity status based on income from a foreign country. The MPEP clarifies:

“For purposes of qualifying for micro entity status based on the gross income limit, the gross income in the foreign currency must be converted into United States dollars at the exchange rate in effect on the date the micro entity certification is filed.”

This means that if you’re an applicant from a foreign country, you can still qualify for micro entity status if your income, when converted to U.S. dollars, does not exceed the gross income limit. It’s important to use the correct exchange rate on the date of filing your micro entity certification to ensure accurate calculation.

To learn more:

Tags: micro entity

Yes, an applicant can appoint two patent practitioners for the same application. However, when doing so, it’s important to specify the correspondence address. As stated in the MPEP:

“If the applicant simultaneously appoints two patent practitioners, applicant should indicate with whom correspondence is to be conducted by specifying a correspondence address.”

This ensures clear communication between the USPTO and the applicant’s representatives. For more details, refer to MPEP § 403, MPEP § 403.01(a), and MPEP § 403.01(b).

To learn more:

Yes, an applicant can appeal a secrecy order issued on their patent application. According to MPEP 120, “An appeal to the Secretary of Commerce, as provided by 35 U.S.C. 181, from a secrecy order cannot be taken until after a petition for rescission of the secrecy order has been made and denied.” This means that the applicant must first:

  1. Petition for rescission of the secrecy order
  2. If the petition is denied, then appeal to the Secretary of Commerce

The appeal process is governed by the provisions of 35 U.S.C. 181 and provides a mechanism for applicants to challenge the imposition of a secrecy order.

Can an applicant add examples or expand on the disclosure after filing a patent application?

Generally, applicants are not permitted to add new examples or expand on the disclosure after filing a patent application without risking a new matter rejection. The MPEP 608.04(a) states:

Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is usually new matter.

However, there are some limited circumstances where additions might be allowed:

  • Inherent characteristics: Information that is inherently present in the original disclosure may be added.
  • Well-known equivalents: Describing well-known equivalents of elements already disclosed might be acceptable.
  • Correction of obvious errors: Clear mistakes that would be apparent to one skilled in the art can sometimes be corrected.

It’s important to note that any additions must be carefully scrutinized and should not introduce new concepts or expand the scope of the invention beyond what was originally disclosed. Applicants should strive to include all necessary examples and details in the original filing to avoid potential new matter issues later in the prosecution process.

To learn more:

Tags: new matter

Adding drawings to a patent application after the filing date is possible but subject to certain restrictions. The MPEP states: no amendment may introduce new matter into the disclosure of an application after its filing date. However, there are some provisions for adding drawings in specific circumstances:

  • For applications filed on or after September 21, 2004, if drawings were inadvertently omitted and the application claims priority to a prior-filed application containing the drawings, the applicant may submit the omitted drawings by amendment under 37 CFR 1.57(b).
  • For applications filed before December 18, 2013, applicants may submit drawings and potentially accept a later filing date.
  • For applications filed on or after December 18, 2013, drawings can be added without changing the filing date, but they must not introduce new matter.

In all cases, adding drawings after the filing date requires careful consideration to ensure compliance with USPTO rules and avoid introducing new matter.

To learn more:

Yes, an Application Data Sheet (ADS) can be used to correct or update information in patent applications filed before September 16, 2012, but there are specific rules and timeframes to consider:

  • An ADS can be used to correct or update bibliographic data, especially if submitted within one month of the filing date.
  • After the one-month period, corrections may require additional documentation or fees.

According to MPEP 601.05(b): “If an application data sheet is submitted in a patent application under 37 CFR 1.53(b), the application data sheet will be treated as part of the application and will be used to capture the bibliographic data from the application data sheet. Bibliographic data contained in an application data sheet will govern when inconsistent with information provided by another document (e.g., the application transmittal letter).”

This means that the ADS takes precedence over other documents when it comes to bibliographic information. However, for significant changes after the initial filing, applicants may need to submit additional forms or follow specific procedures outlined by the USPTO.

To learn more:

Yes, an Application Data Sheet (ADS) can be used to correct or update information in a patent application. The MPEP 601.05 states:

‘An ADS may be submitted after the initial filing of the application to correct or update information in a previously submitted application data sheet, or in an oath or declaration under 37 CFR 1.63 or 1.67, except that inventorship changes are governed by 37 CFR 1.48, correspondence address changes are governed by 37 CFR 1.33(a), and citizenship changes are governed by 37 CFR 1.63 or 1.67.’

However, it’s important to note that:

  • Some changes, such as inventorship, correspondence address, and citizenship, are governed by specific regulations and may require additional procedures.
  • When submitting a corrected or updated ADS, applicants should clearly identify the information being changed relative to the most recent filing or ADS.
  • For applications filed on or after September 16, 2012, any changes to the ADS must be made in accordance with 37 CFR 1.76(c).

To learn more:

Tags: ADS

Yes, an abandoned application can still be used as a priority document for subsequent applications, provided that the priority claim is made within the specified time limits. The abandoned status of the earlier application does not affect its ability to serve as a basis for priority. For more information on priority claims, refer to MPEP 201 and MPEP 211.

Yes, an abandoned application can be used as prior art, but the extent of its use depends on several factors. Under MPEP 2127, abandoned applications that have been published can be used as prior art as of their publication date for all they teach. Unpublished abandoned applications may be available as prior art under certain circumstances, such as when they are incorporated by reference in a U.S. patent. It’s important to note that the abandonment status itself does not negate the application’s potential as prior art. For specific rules on using abandoned applications as prior art, consult MPEP 2127 and MPEP 901 on prior art.

Amendments can be made when filing a Continued Prosecution Application (CPA), but there are important restrictions and considerations:

  • Any changes must be made as an amendment to the prior application as it existed before filing the CPA
  • No new matter can be introduced in a CPA
  • Preliminary amendments filed with a CPA are generally entered, but could be denied entry if they unduly interfere with examination
  • New specifications filed with a CPA request are treated as substitute specifications and must comply with 37 CFR 1.125

The MPEP states: Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph. No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application.

Regarding preliminary amendments, the MPEP advises: Applicants are also encouraged to file all preliminary amendments at the time of filing a CPA because the entry of any preliminary amendment filed after the filing date of the CPA could be denied under 37 CFR 1.115 if the preliminary amendment unduly interferes with the preparation of a first Office action.

If more time is needed to prepare amendments, applicants can request a three-month suspension of action under 37 CFR 1.103(b) at the time of filing the CPA.

For more information on amendments, visit: amendments.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Generally, amendments to a provisional application are not permitted after the filing date, except for those required to comply with applicable regulations. The MPEP clearly states:

Amendments, other than those required to make the provisional application comply with applicable regulations, are not permitted after the filing date of the provisional application. (MPEP 601.01(b))

This restriction helps maintain the integrity of the provisional application as a snapshot of the invention at the time of filing.

To learn more:

While amendments can be filed with a Continued Prosecution Application (CPA) request, there are important considerations and limitations. The MPEP states:

“Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph. No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application.”

Additionally:

  • Preliminary amendments filed with a CPA are generally entered
  • Applicants are encouraged to file any amendments at the time of filing the CPA to avoid potential delays
  • Any new matter introduced will be required to be canceled
  • Claims relying on new matter may be rejected under 35 U.S.C. 112(a)

The MPEP advises: “Applicants are strongly encouraged to file any preliminary amendment in a CPA at the time the CPA is filed. See 37 CFR 1.115 and MPEP § 714.03(a).”

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on new matter, visit: new matter.

Yes, in certain circumstances, alternative forms can be used instead of an Application Data Sheet (ADS) to provide some of the required information:

  • Patent Law Treaty Model International Forms can be used for certain information.
  • The Patent Cooperation Treaty Request Form can be used in some cases for national stage applications.

37 CFR 1.76(f) states: “The requirement in § 1.55 or § 1.78 for the presentation of a priority or benefit claim under 35 U.S.C. 119, 120, 121, or 365 in an application data sheet will be satisfied by the presentation of such priority or benefit claim in the Patent Law Treaty Model International Request Form.”

However, it’s important to note that if an ADS is also submitted, the information in the ADS will generally govern when inconsistent with these alternative forms. Additionally, an ADS is still required in certain situations, such as when postponing submission of the inventor’s oath or declaration.

To learn more:

Yes, additional correct documents can be recorded after an assignment record is expunged. The MPEP 323.01(d) states:

An additional assignment of the ‘correct’ document may be recorded in addition to the redacted version where the redacted version is incomplete or the original document was not correct.

This provision allows for the recording of accurate and complete information when:

  • The redacted version of the expunged document is incomplete
  • The original document contained errors or inaccuracies

This process ensures that the assignment records contain the most accurate and up-to-date information possible, even after an expungement procedure has been completed.

To learn more:

Yes, adding specific percentages to a broader original disclosure can be considered new matter. The MPEP section 608.04(a) states:

New matter includes not only the addition of wholly unsupported subject matter, but may also include adding specific percentages or compounds after a broader original disclosure, or even the omission of a step from a method.

For guidance on determining whether such additions constitute new matter, the MPEP refers to MPEP § 2163.05. It’s important for applicants to ensure that any specific percentages added are inherently supported by the original disclosure.

To learn more:

Tags: new matter

Can a withdrawn attorney continue to receive Office communications for a patent application?

No, a withdrawn attorney should not continue to receive Office communications for a patent application. The MPEP 402.06 clearly states:

“An attorney or agent withdrawing from an application who wishes to cease receiving copies of communications from the Office must submit a request that the correspondence cease.”

This means that unless the withdrawn attorney explicitly requests to stop receiving communications, they may continue to receive them. However, it’s important to note that the withdrawn attorney is no longer authorized to act on behalf of the application. To ensure proper handling of the application, the withdrawn attorney should request that correspondence cease, and the applicant or new representative should update the correspondence address with the USPTO.

To learn more:

Can a US national application claim benefit of an international application that entered national stage in another country?

Yes, a U.S. national application can claim the benefit of an international application that entered the national stage in another country, as long as certain conditions are met. The MPEP provides guidance on this:

“A U.S. national application may claim benefit under 35 U.S.C. 120 and 365(c) to an international application which designates at least one country other than the United States only if the international application has been accorded an international filing date and meets the requirements of 35 U.S.C. 371(c).”

This means that for a U.S. application to claim benefit from an international application that entered the national stage elsewhere, the international application must:

  • Have an international filing date
  • Designate at least one country other than the United States
  • Meet the requirements of 35 U.S.C. 371(c)

It’s important to note that the benefit claim is made under both 35 U.S.C. 120 (for continuing applications) and 35 U.S.C. 365(c) (for international applications).

To learn more:

Yes, a U.S. applicant can claim priority from a provisional application filed in a foreign country, provided certain conditions are met. The MPEP 213 states:

An applicant may claim the right of priority based on a prior foreign application under the Paris Convention and 35 U.S.C. 119(a)-(d) whether the foreign application is an application for a patent or for the registration of a utility model or an industrial design.

Key points to consider:

  • The foreign country must be a recognized country or regional patent office as listed in MPEP 213.01.
  • The provisional application must be the first filing of the invention in any country.
  • The U.S. application must be filed within 12 months of the foreign provisional filing date.
  • The applicant must comply with all requirements for claiming priority, including submitting a certified copy of the foreign application.

It’s important to note that not all countries have provisional application systems, so the term ‘provisional’ may have different meanings in different jurisdictions. Always consult with a patent attorney or agent for specific advice on international priority claims.

No, a third party or its representative cannot use the provisions of 37 CFR 1.34 to conduct an interview or take other actions not specifically permitted by the rules of practice. MPEP 405 states:

The use of the provisions of 37 CFR 1.34 by a third party or its representative to conduct an interview, or take other action not specifically permitted by the rules of practice in an application for patent, is considered a violation of 37 CFR 11.18 and may result in disciplinary action if done by a practitioner.

This means that attempting to use 37 CFR 1.34 for unauthorized actions could lead to disciplinary consequences for registered practitioners.

Generally, third parties are not permitted to conduct interviews or take actions in patent applications. The MPEP clearly states:

The use of the provisions of 37 CFR 1.34 by a third party or its representative to conduct an interview, or take other action not specifically permitted by the rules of practice in an application for patent, is considered a violation of 37 CFR 11.18 and may result in disciplinary action if done by a practitioner.

This means that only authorized representatives (such as registered attorneys or agents with proper authorization) can conduct interviews or take actions on behalf of the applicant. Third parties attempting to do so may face disciplinary action, especially if they are registered practitioners.

For more information on disciplinary action, visit: disciplinary action.

For more information on patent interviews, visit: patent interviews.

No, a suspended or excluded practitioner cannot inspect patent applications. According to MPEP 105, “Power to inspect given to such an attorney or agent will not be accepted.” This means that the USPTO will not allow suspended or excluded practitioners to access or review patent applications, even if they are given permission by the applicant.

To learn more:

No, a suspended or excluded practitioner is not permitted to receive correspondence from the USPTO regarding patent applications. According to MPEP 407:

A suspended or excluded practitioner is not entitled to receive correspondence from the Office, or have interviews with examiners, in applications or patents.

The USPTO takes the following steps to ensure compliance:

  • Correspondence will be sent to the applicant or assignee at their address of record.
  • If no practitioner is of record, the correspondence will be sent directly to the applicant or assignee.
  • Examiners are instructed not to hold interviews with suspended or excluded practitioners.

For more information on USPTO correspondence, visit: USPTO correspondence.

No, a patent attorney or agent who has been suspended or excluded from practice by the USPTO cannot inspect patent applications, unless they are an inventor or applicant on that particular application. The MPEP states:

USPTO employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application unless it is one in which said attorney or agent is an inventor or the applicant. Power to inspect given to such an attorney or agent will not be accepted.

This policy prevents suspended or excluded practitioners from accessing confidential application information they are no longer authorized to view.

Yes, supplemental oaths and declarations covering the claims in a patent application can be filed after allowance. The Manual of Patent Examining Procedure (MPEP) states:

“Supplemental oaths and declarations covering the claims in the application may be filed after allowance as a matter of right.”

This means that applicants have the right to submit additional oaths or declarations even after their patent application has been allowed.

To learn more:

Can a substitute statement be filed in a provisional application?

No, a substitute statement cannot be filed in a provisional application. According to MPEP 604:

“A substitute statement is not available for provisional applications because provisional applications do not require an inventor’s oath or declaration.”

Provisional applications have different requirements compared to non-provisional applications. They are primarily used to establish an early filing date and do not require formal claims, oath, or declaration. Therefore, there is no need for a substitute statement in provisional applications.

To learn more:

The qualification of a subsidiary for small entity status depends on several factors. According to the MPEP:

A business concern or organization is affiliates of another concern or organization if, directly or indirectly, either one controls or has the power to control the other, or a third party or parties controls or has the power to control both.

This means that:

  • If a subsidiary is controlled by a large entity, it generally cannot claim small entity status.
  • The control can be direct (e.g., majority ownership) or indirect (e.g., through contractual arrangements).
  • Even if the subsidiary meets the size standards on its own, affiliation with a large entity typically disqualifies it from small entity status.

However, there may be exceptions in complex corporate structures. It’s advisable to consult with a patent attorney to evaluate your specific situation and determine eligibility for small entity status.

To learn more:

Yes, a sole inventor can file a continuation-in-part (CIP) application based on an earlier application with joint inventors, provided certain conditions are met. The MPEP 201.08 states:

“A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78.”

This situation might occur when one of the joint inventors from the original application independently develops additional subject matter. The key requirements are:

  • The CIP must meet all other conditions of 35 U.S.C. 120 and 37 CFR 1.78.
  • The sole inventor must be one of the joint inventors named in the prior application.
  • The CIP should contain new matter not disclosed in the prior application.

It’s important to ensure proper attribution and compliance with all USPTO requirements when filing such a CIP.

For more information on joint inventors, visit: joint inventors.

Can a small business qualify for micro entity status?

Yes, a small business can potentially qualify for micro entity status, but there are specific requirements to meet. The MPEP outlines two main paths for small businesses:

  1. Income-based qualification: If the small business’s income does not exceed three times the median household income in the preceding calendar year, it may qualify.
  2. Institution of higher education qualification: If the small business has assigned, granted, conveyed, or is under obligation to assign, grant, or convey a license or other ownership interest in the application to an institution of higher education.

The MPEP states:

“An applicant that qualifies as a micro entity under either the gross income basis or the institution of higher education basis can file a certification of micro entity status on either basis (but not both).”

It’s important to note that all parties involved (applicants, inventors, and joint inventors) must meet the requirements. For more details, refer to MPEP 509.04.

To learn more:

To learn more:

Yes, applicants may petition for rescission or modification of a Secrecy Order:n

    n

  • Applicants can informally contact the sponsoring defense agency to discuss rendering the order ineffectual, or formally petition the Commissioner for Patents to rescind the order.
  • n

  • Rescission may also be possible by expunging sensitive subject matter from the application, if it’s not needed for an enabling disclosure under 35 U.S.C. 112.
  • n

  • Applicants can also petition for a permit to disclose the invention to another or to modify the order, fully stating the reason or purpose. (MPEP 120 Section V)
  • n

Yes, a secrecy order can be appealed or reviewed. The MPEP 120 states: “A petition for rescission or modification of the secrecy order may be filed at any time.” Here’s what you need to know about the appeal process:

  • The petition should be filed with the Patent and Trademark Office (PTO)
  • It must include full statements of all facts and circumstances upon which the petition is based
  • The petition will be referred to the appropriate agency for consideration and recommendation
  • Based on the recommendation, the Commissioner for Patents will make the final decision

If the secrecy order is not rescinded, the applicant may seek further review through legal channels, such as filing a claim in the United States Court of Federal Claims.

Can a secrecy order be appealed or challenged?

Yes, a secrecy order can be appealed or challenged. The MPEP 120 states: “A petition for rescission or modification of the secrecy order may be filed by the principal inventor, any of the joint inventors, or the assignee.” This means that:

  • The principal inventor
  • Any joint inventors
  • The assignee of the patent application

can file a petition to challenge or seek modification of a secrecy order. The petition should be directed to the Commissioner for Patents and should include supporting reasons for the requested rescission or modification. It’s important to note that while an appeal is possible, secrecy orders are typically issued for national security reasons, so the process of challenging them can be complex and may require careful consideration of security implications.

Yes, a request for issuance to an assignee can be submitted after the issue fee is paid, but additional requirements apply:

  1. The request must state that the assignment was submitted for recordation before patent issuance.
  2. It must include a request for a certificate of correction under 37 CFR 1.323.
  3. The appropriate fees must be paid, including the certificate of correction fee and a processing fee.

37 CFR 3.81(b) states: Any request for issuance of an application in the name of the assignee submitted after the date of payment of the issue fee, and any request for a patent to be corrected to state the name of the assignee, must state that the assignment was submitted for recordation as set forth in § 3.11 before issuance of the patent, and must include a request for a certificate of correction under § 1.323 of this chapter (accompanied by the fee set forth in § 1.20(a)) and the processing fee set forth in § 1.17(i) of this chapter.

Yes, a reissue application can be used to correct inventorship. The MPEP 201.05 states: ‘A reissue application may also be filed to correct inventorship in the patent. The reissue oath or declaration must state that the applicant believes the original patent to be wholly or partly inoperative or invalid by reason of the incorrect inventorship.’

This means that if the original patent listed incorrect inventors or omitted inventors who should have been included, a reissue application can be filed to rectify this error. However, it’s important to note that:

  • The error in inventorship must have been made without deceptive intent.
  • The reissue application must be accompanied by a proper reissue oath or declaration explaining the error.
  • All current patent owners must consent to the reissue application.

Correcting inventorship through a reissue application is governed by 35 U.S.C. 251 and the procedures outlined in the MPEP.

To learn more:

Yes, registered patent practitioners can file papers in patent applications and reexamination proceedings without being of record. MPEP 405 states:

Papers may be filed in patent applications and reexamination proceedings by registered attorneys or agents not of record under 37 CFR 1.34. Filing of such papers is considered to be a representation that the attorney or agent is authorized to act in a representative capacity on behalf of applicant.

This means that by filing papers, the practitioner is implicitly stating they have authorization to act on behalf of the applicant, even if they are not officially recorded as the attorney or agent of record.

Yes, a reference to a prior application can be added after filing, but there are specific procedures and limitations to be aware of. According to MPEP 211.02:

If an applicant includes a reference to a prior application elsewhere in the application but not in the first sentence(s) of the specification, and the application is otherwise complete, OPAP will mail a ‘Notice to File Missing Parts’ giving the applicant an opportunity to correct the reference to the prior application. If the application is otherwise incomplete, OPAP will mail a Notice to File Missing Parts, and the applicant can amend the specification to include the reference to the prior application in addition to completing the application.

However, it’s important to note that adding a reference to claim priority benefits has strict time limitations. As per MPEP 211.03:

A petition under 37 CFR 1.78 and the petition fee would be required to add or correct a reference to a prior application in an application after expiration of the time period set in 37 CFR 1.78(a)(4), (b)(3), (c)(3), or (e)(4).

Therefore, while it’s possible to add or correct a reference after filing, it’s always best to include the correct reference in the initial filing to avoid potential complications or the need for petitions.

To learn more:

No, a provisional patent application cannot claim priority to or benefit from other applications. The MPEP 201.04 clearly states:

“A provisional application is not entitled to the right of priority under 35 U.S.C. 119, 365(a), or 386(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121, 365(c), or 386(c) or § 1.78 of any other application.”

This means that a provisional application stands alone and cannot claim the filing date of any earlier U.S. or foreign application. However, it’s important to note that while a provisional application cannot claim priority, it can serve as a priority document for later-filed nonprovisional or foreign applications, provided they are filed within 12 months of the provisional application’s filing date.

To learn more:

Yes, a provisional patent application can be converted to a nonprovisional application. According to MPEP 201.04:

“A provisional application filed under paragraph (c) of this section may be converted to a nonprovisional application filed under paragraph (b) of this section and accorded the original filing date of the provisional application.”

However, there are specific requirements and considerations for this conversion:

  • The request for conversion must be accompanied by the fee set forth in 37 CFR 1.17(i)
  • An amendment including at least one claim as prescribed by 35 U.S.C. 112(b) must be submitted
  • The request must be filed before the abandonment of the provisional application or the expiration of 12 months after its filing date
  • Additional fees for nonprovisional applications will be required

It’s important to note that converting a provisional to a nonprovisional application may result in a shorter patent term. Therefore, filing a new nonprovisional application claiming the benefit of the provisional application under 35 U.S.C. 119(e) is often preferable.

To learn more:

Can a provisional application claim the benefit of an earlier application?

No, a provisional application cannot claim the benefit of an earlier-filed application. This is explicitly stated in MPEP 211.01(a):

“A provisional application is not entitled to the benefit of the filing date of an earlier filed application under 35 U.S.C. 119, 120, 121, 365, or 386.”

This means that a provisional application stands on its own and cannot extend its effective filing date by claiming priority to any earlier application, whether it’s another provisional, a nonprovisional, or a foreign application. The purpose of a provisional application is to establish an early filing date for a subsequent nonprovisional application, not to claim priority to earlier filings.

To learn more:

Can a provisional application be used as a prior-filed application for benefit claims?

Yes, a provisional application can be used as a prior-filed application for benefit claims in certain circumstances. According to MPEP 211.01:

‘The prior application may be a provisional application under 35 U.S.C. 111(b) or a nonprovisional application under 35 U.S.C. 111(a).’

However, there are specific requirements and limitations when claiming the benefit of a provisional application:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (or 14 months with a grantable petition under 37 CFR 1.78(b)).
  • The provisional application must adequately support and enable the subject matter of the claims in the nonprovisional application.
  • The specific reference to the provisional application must be included in an application data sheet (ADS) or the first sentence of the specification.

It’s important to note that while a nonprovisional application can claim the benefit of a provisional application, a provisional application cannot claim the benefit of or priority to any other application.

To learn more:

Can a provisional application be published?

No, provisional applications are not published. The MPEP clearly states: ‘A provisional application is not entitled to the right of priority under 35 U.S.C. 119 or 365(a) or 365(b); is not entitled to the benefit of the filing date of a prior application under 35 U.S.C. 119(e) or 120; and will not be published or examined.’ This means:

  • Provisional applications remain confidential
  • They are not made available to the public
  • No patent document is published based solely on a provisional application

For more information on provisional applications, visit the MPEP 201.04 section.

For more information on patent examination, visit: patent examination.

For more information on provisional application, visit: provisional application.

No, provisional applications are not published or made public by the USPTO. According to MPEP 201.04:

A provisional application is not subject to publication and is not published.

This confidentiality can be advantageous for inventors who want to secure a filing date while keeping their invention details private. However, it’s important to note that while the USPTO doesn’t publish provisional applications, the content may become public if referenced in a later-published nonprovisional application claiming its benefit.

For more information on provisional application, visit: provisional application.

Yes, a provisional application can be filed without claims. The MPEP 201.04 states:

A provisional application must also include the filing fee as set forth in 37 CFR 1.16(d) and a cover sheet identifying the application as a provisional application. Otherwise, the application will be treated as a nonprovisional application. The filing date of a provisional application is the date on which a specification as prescribed by 35 U.S.C. 112(a), and any drawing required by 37 CFR 1.81(a) are filed in the United States Patent and Trademark Office. No claims are required.

While claims are not required for a provisional application, it’s important to provide a comprehensive description of the invention to ensure adequate support for any claims in a subsequent nonprovisional application.

For more information on provisional application, visit: provisional application.

Yes, a provisional application can be filed without an oath or declaration. According to MPEP 601.01(b):

Quote: “A provisional application does not require a claim or oath or declaration.”

This is one of the key differences between provisional and nonprovisional applications. The simplified filing requirements for provisional applications make them a useful tool for quickly establishing a priority date. However, it’s important to remember that:

  • A provisional application cannot mature into a patent
  • To claim the benefit of a provisional application, a nonprovisional application must be filed within one year

When filing the subsequent nonprovisional application, an oath or declaration will be required as part of the complete application.

To learn more:

Can a provisional application be filed without an English translation?

Yes, a provisional application can be filed in a language other than English. However, an English translation must be submitted within a specified timeframe. According to MPEP 601.01(b):

‘If the provisional application is filed in a language other than English, an English-language translation of the non-English-language provisional application will not be required in the provisional application.’

It’s important to note that while the translation is not required for the provisional application itself, it will be necessary if you later file a nonprovisional application claiming benefit of the provisional application. The English translation and a statement that the translation is accurate must be submitted in the nonprovisional application.

To learn more:

Can a provisional application be filed in a language other than English?

Yes, a provisional application can be filed in a language other than English. According to MPEP 201.04:

‘A provisional application may be filed in a language other than English.’

However, it’s important to note that while the USPTO allows this, it may have implications for future patent applications. If you later file a nonprovisional application claiming priority to the provisional, you will need to provide an English translation of the provisional application along with a statement that the translation is accurate. This ensures that the examiner can properly determine if the nonprovisional application is entitled to the benefit of the provisional filing date.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

Can a provisional application be filed electronically?

Yes, provisional applications can be filed electronically. The MPEP 601.01(b) states:

“A provisional application may be filed electronically using the EFS-Web or Patent Center.”

Electronic filing offers several advantages, including:

  • Immediate confirmation of receipt
  • Potentially lower filing fees
  • Faster processing times

Applicants should ensure they follow the USPTO’s guidelines for electronic filing to ensure proper submission and processing of their provisional application.

To learn more:

Can a provisional application be converted directly into a nonprovisional application?

No, a provisional application cannot be directly converted into a nonprovisional application. The MPEP 201.04 clearly states:

“A provisional application cannot be converted to a nonprovisional application.”

Instead, to claim the benefit of a provisional application, an applicant must file a separate nonprovisional application within 12 months of the provisional filing date. This nonprovisional application must include a specific reference to the provisional application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

No, a provisional application cannot be considered a continuation-in-part (CIP). The MPEP explicitly states: An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation-in-part’ of the provisional application. (MPEP ¶ 2.06)

This distinction is important because:

  • Provisional applications are not examined and do not mature into patents.
  • The term ‘continuation-in-part’ is reserved for non-provisional applications that build upon prior non-provisional applications.
  • The relationship between a non-provisional application and a provisional application is described as ‘claiming the benefit of’ the provisional, not as a continuation or CIP.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

No, a provisional application cannot be called a ‘divisional’ application. The MPEP ¶ 2.01 explicitly states:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.

This means that while an application can claim the benefit of a provisional application’s filing date under 35 U.S.C. 119(e), it is not considered a divisional application. Divisional applications are specifically related to non-provisional applications and involve claiming independent and distinct inventions from a parent application.

For more information on 35 USC 119(e), visit: 35 USC 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on provisional application, visit: provisional application.

No, a provisional application should not be referred to as a ‘continuation’. The MPEP clearly states:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation’ of the provisional application.”

This is because provisional applications serve a different purpose than continuation applications. Provisional applications are temporary placeholders that establish a priority date but do not mature into issued patents. Continuations, on the other hand, are full patent applications that build upon previously filed non-provisional applications.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

Can a priority claim be made in a continuation or divisional application?

Yes, a priority claim can be made in a continuation or divisional application. However, there are specific requirements and time limits to consider. According to MPEP 214.01:

“In the case of a continuation or divisional application, the claim for priority must be made during the pendency of the application.”

This means:

  • The priority claim must be filed within the later of four months from the actual filing date of the continuation or divisional application or sixteen months from the filing date of the prior foreign application.
  • If the claim is filed outside this period, it will be considered untimely and require a petition under 37 CFR 1.55(e).
  • The priority claim should reference the parent application if it properly claimed the benefit of the foreign application.

It’s important to note that the continuation or divisional application must be filed within 12 months of the foreign application’s filing date (or 6 months for design applications) to be eligible for priority.

Can a priority claim be corrected after the patent has been issued?

Yes, it is possible to correct a priority claim after a patent has been issued, but the process is more complex and limited compared to correcting a priority claim in a pending application.

According to MPEP 214.02: ‘For a correction of foreign priority claim after issuance of a patent, see MPEP § 216.01.’

To correct a priority claim in an issued patent, the following steps are typically required:

  • File a petition for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.
  • Pay the required fee.
  • Provide a statement that the error occurred without deceptive intent.
  • Submit evidence to support the correction, such as a certified copy of the priority document.

It’s important to note that the scope for correcting priority claims in issued patents is more limited than in pending applications. The correction must not involve a change that would broaden the scope of the claims of the issued patent.

For more detailed information on correcting foreign priority claims after patent issuance, refer to MPEP § 216.01.

To learn more:

Yes, a pre-AIA 37 CFR 1.47 application can be published as a Statutory Invention Registration, but with a specific condition. According to the MPEP:

“An application filed under pre-AIA 37 CFR 1.47 can be published as a Statutory Invention Registration (provided the request for a Statutory Invention Registration was filed before March 16, 2013).”

It’s important to note that this option is only available for requests filed before March 16, 2013, as the America Invents Act eliminated Statutory Invention Registrations for applications filed on or after that date.

To learn more:

To learn more:

Yes, a Pre-AIA 37 CFR 1.47 application can be converted to a regular application if the previously non-signing inventor later submits an executed oath or declaration. The MPEP 409.03(j) states:

‘If a 37 CFR 1.47 applicant submits an executed oath or declaration of the nonsigning inventor, the executed oath or declaration should be accepted by the Office and the application no longer treated under 37 CFR 1.47.’

This means that once the missing oath or declaration is submitted, the application will be processed as a regular application, removing the special 37 CFR 1.47 status.

To learn more:

To learn more:

The USPTO has specific rules regarding withdrawal for practitioners acting in a representative capacity under 37 CFR 1.34:

  • The USPTO will not approve withdrawal requests from practitioners acting in a representative capacity.
  • These practitioners are responsible for the correspondence they file in the application while acting in a representative capacity.
  • There is no need for these practitioners to obtain the USPTO’s permission to withdraw from representation.

However, it’s important to note that practitioners acting in a representative capacity, like those with power of attorney, remain responsible for compliance with 37 CFR 1.56 (duty of disclosure) and 37 CFR 11.18 (signature and certification requirements) for documents they file.

This distinction ensures that practitioners understand their ongoing responsibilities even when acting in a limited representative capacity.

To learn more:

Can a practitioner act on behalf of an applicant without a power of attorney?

Yes, a practitioner can act on behalf of an applicant without a power of attorney in certain circumstances. According to MPEP 402.04:

‘A practitioner may in some circumstances within the discretion of the Office act without any power of attorney or authorization of agent when it appears necessary to preserve the rights of the applicant.’

This provision allows for urgent action to be taken to protect the applicant’s interests, even if a formal power of attorney is not in place. However, it’s important to note that this is at the discretion of the USPTO and is typically limited to situations where immediate action is necessary to prevent loss of rights.

To learn more:

Generally, a power of attorney must be signed by all applicants or owners of a patent application. However, there are exceptions:

  1. For revocation: A power of attorney signed by less than all applicants/owners may be accepted if accompanied by a petition under 37 CFR 1.36(a) and fee, with a showing of sufficient cause.
  2. For appointment: A power of attorney signed by less than all applicants/owners may be accepted if accompanied by a petition under 37 CFR 1.183 and fee, demonstrating an extraordinary situation where justice requires waiver of the requirement.

MPEP 402.10 states: “The appointment and/or revocation are not accepted until the petition under 37 CFR 1.36(a) or 1.183 is granted. Therefore, the attorney or agent newly appointed by such papers is not permitted to submit any documents (such as an information disclosure statement (IDS)) into the application file until the petition under 37 CFR 1.36(a) or 1.183 is granted.”

Yes, a power of attorney can be revoked. The process for revoking a power of attorney is outlined in MPEP 601.02:

“A power of attorney may be revoked at any stage in the proceedings of a case, and a power of attorney to a subsidiary attorney will not be revoked by appointment of a principal attorney.”

To revoke a power of attorney:

  • The applicant or assignee must submit a signed revocation document to the USPTO.
  • The revocation should clearly state the intent to revoke the previous power of attorney.
  • If appointing a new attorney or agent, a new power of attorney should be submitted along with the revocation.

It’s important to note that revoking a power of attorney does not remove the attorney or agent from the record. To change the correspondence address, a separate request must be made.

To learn more:

Can a power of attorney be revoked in applications filed before September 16, 2012?

Yes, a power of attorney can be revoked in applications filed before September 16, 2012. The MPEP 402.02(b) states:

“A power of attorney may be revoked at any stage in the proceedings of a case.”

The revocation process for pre-September 16, 2012 applications involves the following:

  • The revocation must be in writing.
  • It must be signed by the applicant or the assignee of the entire interest of the applicant.
  • The revocation is not effective until it is accepted by the Office.

It’s important to note that revoking a power of attorney does not automatically grant power to a new attorney. A new power of attorney must be filed to appoint a new representative.

To learn more:

Yes, a power of attorney can be revoked in a patent application. The process for revocation is outlined in MPEP 402:

‘The power of attorney may be revoked at any time. Pursuant to 37 CFR 1.36(a), an applicant may revoke a power of attorney by filing a new power of attorney that is not directed to the patent practitioner(s) of record.’

To revoke a power of attorney:

  • File a new power of attorney form (PTO/AIA/82) with the USPTO.
  • The new form should either name new representative(s) or indicate that the applicant wishes to prosecute the application pro se (without an attorney).
  • Ensure the form is signed by the applicant or, in the case of a juristic entity, by an authorized official.
  • Submit the form through the USPTO’s Electronic Filing System (EFS-Web) or by mail.

It’s important to note that merely filing a new power of attorney automatically revokes the previous one. There’s no need for a separate revocation document unless you want to revoke without appointing a new representative.

For more information on power of attorney, visit: power of attorney.

For more information on pro se, visit: pro se.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

The revocation of a power of attorney must be done in writing and cannot be accomplished through informal means such as telephone or email. The MPEP 402.05 states:

A power of attorney may not be revoked by a telephone call.

While this quote specifically mentions telephone calls, the same principle applies to emails or other informal communications. To properly revoke a power of attorney, applicants must submit a written revocation document or a new power of attorney that complies with the requirements set forth in MPEP 402. This ensures that the revocation is properly documented and effective in the patent application process.

To learn more:

Yes, a power of attorney can be revoked by fewer than all of the applicants, but with certain conditions. According to MPEP 402.05:

‘A power of attorney may be revoked by fewer than all of the applicants (or fewer than all patent owners in a reexamination proceeding or supplemental examination proceeding) if the power was granted by fewer than all of the applicants or patent owners.’

This means:

  • If the original power of attorney was granted by all applicants, it must be revoked by all applicants.
  • If the original power was granted by a subset of applicants, that same subset can revoke it.
  • In cases of joint inventors, careful consideration must be given to who originally granted the power.

To learn more:

No, a power of attorney cannot be partially revoked for specific patent applications. The MPEP 402.05 states:

‘A principal cannot revoke selected powers of the power of attorney while leaving other powers in effect.’

This means that when revoking a power of attorney, it must be revoked in its entirety for all applications and patents to which it was applied. If you wish to maintain representation for certain applications while revoking others, you would need to file a new power of attorney for those specific applications you want to keep under representation.

To learn more:

Can a power of attorney be granted to a foreign patent attorney or agent?

In general, a power of attorney in U.S. patent applications can only be granted to practitioners who are registered to practice before the USPTO. According to MPEP 402.02:

“The Office cannot recognize more than one power of attorney in an application at any given time. However, a registered attorney or agent may be appointed in a representative capacity under 37 CFR 1.34 in addition to any power of attorney that may be in effect.”

While foreign patent attorneys or agents cannot be directly granted power of attorney, they can work with U.S. registered practitioners who can be appointed. Additionally, foreign attorneys can be recognized as representatives under 37 CFR 1.34 for limited purposes, such as filing papers or receiving Office communications.

To learn more:

Can a power of attorney be granted to a foreign attorney or agent for US patent applications?

A power of attorney for US patent applications can only be granted to individuals who are registered to practice before the USPTO. Foreign attorneys or agents who are not registered with the USPTO cannot be granted power of attorney.

According to MPEP 402: “The Office cannot recognize more than one power of attorney or authorization to act in a representative capacity in a particular application or patent at any given time.” This means that only USPTO-registered practitioners can be given power of attorney.

However, foreign attorneys can work with US-registered patent practitioners who can be granted power of attorney. The foreign attorney can then collaborate with the US-registered practitioner to manage the application.

For more information on power of attorney, visit: power of attorney.

Can a power of attorney be filed after the patent application is submitted to the USPTO?

Yes, a power of attorney can be filed after the patent application is submitted to the USPTO. The MPEP 601.02 states:

“A power of attorney may be filed in a provisional application, a nonprovisional application, a reexamination proceeding, or a supplemental examination proceeding.”

This means that you can file a power of attorney at various stages of the patent process, including:

  • At the time of filing the application
  • After the application has been submitted
  • During prosecution of the application
  • Even after the patent has been granted (for reexamination or supplemental examination proceedings)

However, it’s generally advisable to file the power of attorney as early as possible to ensure smooth communication with the USPTO throughout the application process. If you need to file a power of attorney after submission, use the appropriate USPTO form and follow the current filing procedures.

To learn more:

Generally, papers giving or revoking a power of attorney in an application require signatures from all applicants or owners. However, there are exceptions:

  • For revocation: A petition under 37 CFR 1.36(a) with a fee and showing of sufficient cause is required.
  • For appointment: A petition under 37 CFR 1.183 with a fee, demonstrating an extraordinary situation where justice requires waiver of the requirement in 37 CFR 1.32(b)(4), is necessary.

As stated in the MPEP: “Papers giving or revoking a power of attorney in an application generally require signature by all the applicants or owners of the application.”

To learn more:

Yes, a petition under 37 CFR 1.47(a) can be filed for multiple unavailable inventors. The MPEP 409.03(b) states:

‘Where there are joint inventors, each nonsigning inventor must be petitioned for separately, even if more than one nonsigning inventor is unavailable.’

This means that while a single petition can cover multiple unavailable inventors, the petition must address each inventor individually, providing specific information and evidence for each one’s unavailability.

To learn more:

To learn more:

Yes, a petition for an unintentionally delayed priority claim can be filed after a patent issues, but it requires a different procedure. According to MPEP 214.02:

For applications that have issued as patents, a petition filed under 37 CFR 1.55(e) or 1.78(c) and (e) may be filed as a reissue application, a request for certificate of correction under 37 CFR 1.323, or a petition under 37 CFR 1.78(a) and (b) or 1.55(g), as appropriate.

This means that after a patent has issued, the options for correcting a priority claim are:

  • Filing a reissue application
  • Requesting a certificate of correction
  • Filing a petition under specific regulations

The appropriate method depends on the specific circumstances and the type of priority claim being corrected. It’s important to note that each of these options has its own requirements and limitations. For example, a certificate of correction is generally only available for minor errors that are clerical or typographical in nature.

Given the complexity of post-issuance corrections, it’s advisable to consult with a patent attorney or agent to determine the best course of action for your specific situation.

To learn more:

Yes, a person can sign patent documents on behalf of a juristic entity, but there are specific requirements:

According to MPEP 402.03: ‘Papers submitted on behalf of juristic entities must be signed by a person having authority to sign for the juristic entity.’

This means:

  • The signer must have the legal authority to act on behalf of the entity.
  • For corporations, this typically includes officers or agents appointed by the board.
  • For partnerships, a partner may sign.
  • For universities, an authorized official may sign.

It’s crucial to ensure the signer has proper authorization to avoid potential issues with the patent application.

To learn more:

Yes, but with limitations. According to MPEP 104:

“A person acting in a representative capacity under 37 CFR 1.34 may execute a power to inspect an application only if the patent practitioner was named in the application transmittal papers filed under 37 CFR 1.53 or the national stage documents filed under 37 CFR 1.495 and a power of attorney has not been appointed under 37 CFR 1.32.”

This means that a representative can execute a power to inspect only if they were named in the initial application papers and no formal power of attorney has been filed. Once a power of attorney is filed, any previously filed power to inspect by a practitioner without power of attorney becomes ineffective.

For more information on power to inspect, visit: power to inspect.

For more information on representative capacity, visit: representative capacity.

Yes, a patent title report can be updated after its initial preparation. While the MPEP Section 320 doesn’t explicitly state this, it’s implied by the fact that title reports are prepared at various stages of the patent process. Updates may occur:

  • When new assignments are recorded
  • If there are changes in inventorship
  • When errors or omissions in previous reports are discovered
  • At key stages of the patent process, such as before issuance

The Certificates of Correction Branch, responsible for preparing title reports, would likely generate updated reports to reflect any changes in ownership or other relevant information throughout the patent’s lifecycle.

Can a patent title be changed after filing?

Yes, a patent title can be changed after filing. The MPEP 606 states:

“The title may be amended at any time during the prosecution of the application, and in many instances a change in title may be required by the examiner.”

This means that:

  • Applicants can request a title change during prosecution
  • Examiners may require a title change if the original title is inadequate
  • The title can be amended up until the patent is granted

It’s important to note that any changes to the title should still accurately reflect the nature of the invention and comply with all USPTO requirements.

To learn more:

According to MPEP 604, a patent practitioner cannot automatically sign a substitute statement on behalf of a juristic entity. The MPEP states:

Note: a power of attorney to a patent practitioner to prosecute a patent application executed by the juristic entity does not make that practitioner an official of the juristic entity or empower the practitioner to sign the substitute statement.

For a juristic entity, the substitute statement may be signed by:

  • A person in the organization with apparent authority to sign (e.g., an officer)
  • Any person if the statement sets forth that the person is authorized to act on behalf of the juristic entity (e.g., the general counsel)

This ensures that the substitute statement is executed by someone with proper authority within the organization.

To learn more:

No, a patent practitioner acting in a representative capacity cannot represent only some of the applicants in a joint application. According to MPEP 402.04, when a patent practitioner files a paper in an application filed on or after September 16, 2012, they must be submitting the paper on behalf of all parties identified as the applicant.

The MPEP explicitly states: “The provisions of 37 CFR 1.34 in no way convey authority for a patent practitioner to submit papers in an application only on behalf of some of the parties identified as the applicant.”

For example, if there are three joint inventors who disagree about how to proceed with the application, a patent practitioner representing only one inventor cannot file papers to the exclusion of the other joint inventors. Similarly, when there are multiple assignees identified as the applicant, a patent practitioner cannot file papers on behalf of only some of the parties.

To learn more:

Yes, a registered patent practitioner who is not of record can conduct an interview if they have proper authorization from the applicant. According to MPEP 405:

Interviews may be conducted with a registered practitioner who has proper authority from the applicant, or an attorney or agent of record in the form of a power of attorney or authorization to act in a representative capacity, whether or not the practitioner has a copy of the application file.

The practitioner can show authorization by completing, signing, and filing an Applicant Initiated Interview Request Form (PTOL-413A) or using Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity’.

Can a patent practitioner change the correspondence address without the applicant’s approval?

Generally, a patent practitioner cannot change the correspondence address without the applicant’s approval. The MPEP 601.03 states:

“A patent practitioner acting in a representative capacity whose correspondence address is the correspondence address of record in an application may change the correspondence address in that application to his or her address.”

However, this is subject to important conditions:

  • The practitioner must be acting in a representative capacity.
  • Their address must already be the correspondence address of record.
  • If the practitioner is no longer representing the applicant, they should not change the address.

It’s important to note that the applicant retains the right to revoke the practitioner’s power of attorney and change the correspondence address at any time. Best practice is for practitioners to communicate with applicants before making any changes to ensure proper authorization and maintain a clear chain of communication with the USPTO.

To learn more:

Can a patent practitioner appointed in the Application Data Sheet (ADS) withdraw from representation?

Yes, a patent practitioner appointed in the Application Data Sheet (ADS) can withdraw from representation, but there are specific procedures to follow:

  • The practitioner must submit a request to withdraw.
  • The request must comply with 37 CFR 1.36.
  • The USPTO must approve the withdrawal.

According to MPEP 402.02(a): “A patent practitioner named in the Application Data Sheet may withdraw as attorney or agent of record upon application to and approval by the USPTO.”

It’s important to note that the practitioner remains responsible for the application until the USPTO approves the withdrawal. The applicant should ensure continuous representation to avoid missing important communications from the USPTO.

To learn more:

No, a patent practitioner cannot appoint a substitute to take over their cases after death. The MPEP 406 clearly states: “The patent practitioner may not appoint a ‘substitute’ and any attempt by the patent practitioner to appoint a ‘substitute’ patent practitioner whose power is intended to survive his or her own will not be recognized by the Office.” This means that any arrangements made by a practitioner for a substitute after their death will not be valid in the eyes of the USPTO.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO policy, visit: USPTO policy.

No, a patent practitioner cannot appoint a substitute whose power would survive their own death. The MPEP clearly states: The patent practitioner may not appoint a ‘substitute’ and any attempt by the patent practitioner to appoint a ‘substitute’ patent practitioner whose power is intended to survive his or her own will not be recognized by the Office. (MPEP 406)

Can a patent examiner change the title of my application?

Yes, a patent examiner has the authority to require a change in the title of your application. According to MPEP 606.01, “Where the title is not descriptive of the invention claimed, the examiner should require the substitution of a new title that is clearly indicative of the invention to which the claims are directed.” This means that if the examiner finds your title to be insufficiently descriptive or not accurately reflecting the claimed invention, they can request that you provide a new, more appropriate title.

To learn more:

Yes, a patent examiner can require a change in the title of an invention. According to MPEP 606.01, “Where the title is not descriptive of the invention claimed, the examiner should require the substitution of a new title that is clearly indicative of the invention to which the claims are directed.” This ensures that the title accurately reflects the subject matter of the invention.

To learn more:

Yes, a patent examiner can begin examination if the drawings are defective under 35 U.S.C. 112, but with specific actions:

  1. The examination begins immediately.
  2. The examiner issues a requirement for corrected drawings.
  3. The examiner rejects the claims as not being in compliance with 35 U.S.C. 112(a).

The MPEP states: However, if the drawings do permit reasonable examination and the supervisory patent examiner believes the drawings are of such a character as to render the application defective under 35 U.S.C. 112, examination should begin immediately with a requirement for corrected drawings and a rejection of the claims as not being in compliance with 35 U.S.C. 112(a) being made.

This approach allows the examination process to proceed while addressing the drawing deficiencies.

To learn more:

To learn more:

Yes, a patent can be issued to multiple assignees or a combination of assignees and inventors. According to MPEP 307, there are two scenarios:

  1. Partial assignees and inventors: “If one or more assignee, together with one or more inventor, holds the entire right, title, and interest in the application, the patent may issue in the names of the assignee and the inventor.”
  2. Multiple assignees: “If multiple assignees hold the entire right, title, and interest to the exclusion of all the inventors, the patent may issue in the names of the multiple assignees.”

These provisions allow for flexibility in patent issuance when ownership is shared among multiple parties.

For more information on multiple assignees, visit: multiple assignees.

For more information on partial assignees, visit: partial assignees.

For more information on patent issuance, visit: patent issuance.

Can a patent be issued to an assignee if the assignment is not recorded?

Yes, a patent can be issued to an assignee even if the assignment is not recorded, provided certain conditions are met:

  • The request for issuance of the patent to the assignee must be made under 37 CFR 3.81(b).
  • The request must be submitted no later than the date the issue fee is paid.
  • The request must include clear evidence of the assignment.

According to MPEP 307: “An assignee who otherwise shows sufficient proprietary interest in the matter may also be entitled to such a patent.” This means that even without a recorded assignment, an assignee can still have the patent issued to them if they can demonstrate their proprietary interest.

For more information on assignee rights, visit: assignee rights.

For more information on patent issuance, visit: patent issuance.

For more information on proprietary interest, visit: proprietary interest.

Yes, a patent can be issued to a deceased inventor. The MPEP 308 states:

‘A patent may be issued to the legal representative (executor, administrator, etc.) of a deceased inventor.’

In such cases, the patent is issued to the legal representative acting on behalf of the deceased inventor’s estate. This ensures that the inventor’s rights and the value of their invention are preserved even after their death.

For more information on legal representative, visit: legal representative.

For more information on patent issuance, visit: patent issuance.

Yes, registered attorneys or agents not of record can file papers in patent applications and reexamination proceedings under 37 CFR 1.34. The MPEP states:

Filing of such papers is considered to be a representation that the attorney or agent is authorized to act in a representative capacity on behalf of applicant.

This means that by filing papers, the attorney or agent is implicitly declaring their authority to represent the applicant.

For more information on patent filing, visit: patent filing.

For more information on USPTO procedures, visit: USPTO procedures.

Can a patent assignment be recorded electronically?

Yes, patent assignments can be recorded electronically. The USPTO provides an electronic system for recording assignment documents. According to MPEP 302:

‘Assignment documents can be submitted for recordation via the Office’s Electronic Patent Assignment System (EPAS). See the USPTO website at http://www.uspto.gov/patents-application-process/documenting-patent-ownership/epas-electronic-patent-assignment-system for additional information regarding EPAS.’

Electronic submission through EPAS is often faster and more convenient than paper submissions. However, it’s important to ensure that all necessary information and signatures are included in the electronic submission.

For more information on electronic patent assignment, visit: electronic patent assignment.

For more information on EPAS, visit: EPAS.

For more information on USPTO, visit: USPTO.

Can a patent application under secrecy order be appealed?

Yes, patent applications under secrecy orders can be appealed, but with certain restrictions. MPEP 120 states: ‘Appeals to the Patent Trial and Appeal Board and petitions to the Director under 37 CFR 1.181 are available to the applicant in secrecy order cases, but those actions will not set aside the secrecy order.‘ This means that while you can appeal decisions related to the patentability of your application, such appeals cannot challenge or remove the secrecy order itself. The secrecy order remains in effect regardless of the appeal process.

For more information on patent appeal, visit: patent appeal.

For more information on patent procedure, visit: patent procedure.

For more information on patent trial and appeal board, visit: patent trial and appeal board.

No, patent applications under Secrecy Orders are not issued and cannot be involved in interferences or derivation proceedings. The MPEP states: Secrecy Order cases are examined for patentability as in other cases, but will not be passed to issue; nor will an interference or derivation be instituted where one or more of the conflicting cases is classified or under Secrecy Order. This is further supported by 37 CFR 5.3 and MPEP § 2306.

For more information on patent issuance, visit: patent issuance.

Yes, a patent application can proceed without all inventors’ signatures under certain circumstances. The MPEP 409.03(d) provides guidance on this matter:

If an inventor is deceased, refuses to execute an application, or cannot be found or reached after diligent effort, the application may be made by the other inventor(s) on behalf of themselves and the non-signing inventor.

To proceed without all signatures, the applicant must:

  • File the application on behalf of themselves and the non-signing inventor
  • Provide proof of the inventor’s unavailability or refusal
  • Submit an oath or declaration by the other inventor(s)
  • Include a petition under 37 CFR 1.47

The USPTO will review the evidence and may grant the petition, allowing the application to proceed without the missing signature.

To learn more:

Yes, a patent application filing date can be restored if drawings are filed late, but only under specific conditions:

  1. The applicant must file the drawings within two months of the filing date of the application or the date of a Notice of Incomplete Application, whichever is later.
  2. The late submission must be accompanied by an oath or declaration specifically referencing the late-filed drawings.
  3. The oath or declaration must state that the delay in filing the drawings was unintentional.

According to MPEP 601.01(f): ‘In design applications, drawings are the disclosure. As such, the application will not be given a filing date until the required drawings are filed.’

It’s important to note that for non-design applications, if the drawings are not necessary to understand the subject matter sought to be patented, the application may retain its original filing date even without the drawings.

To learn more:

Tags: drawings

Yes, a US patent application can claim both foreign priority and domestic benefit simultaneously. This is known as a ‘multiple priority claim’ or ‘multiple benefit claim.’ The MPEP 216 states:

‘It is possible for a U.S. application to be entitled to the benefit of an earlier U.S. filing date and also to the right of priority of a foreign application.’

Here’s how it works:

  • The application can claim foreign priority under 35 U.S.C. 119(a)-(d) to a foreign application filed within the past 12 months.
  • At the same time, it can claim domestic benefit under 35 U.S.C. 120 to an earlier US application.
  • The earlier US application can also claim foreign priority to the same foreign application.

This allows the US application to potentially have an effective filing date that is earlier than both its actual filing date and the filing date of the US application it claims benefit from.

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

No, patent applications that are entitled to a filing date will not be returned to the applicant, even if requested. This applies to applications filed by regular mail, Priority Mail Express, hand-delivery, or through the USPTO patent electronic filing system.

The MPEP clearly states: ‘Applications which are entitled to a filing date, whether filed by regular mail, by Priority Mail Express® under 37 CFR 1.10, by hand-delivery, by the USPTO patent electronic filing system, or otherwise, will not be returned to applicant even if requested.’ (MPEP 503)

Applicants should be careful not to file duplicate applications or applications not intended for filing, as fees paid for such applications are generally not refundable due to a change of purpose.

Once a patent application is filed and given a filing date, it generally cannot be returned or withdrawn. According to MPEP 503:

“Applications which are entitled to a filing date, whether filed by regular mail, by Priority Mail Express® under 37 CFR 1.10, by hand-delivery, by the USPTO patent electronic filing system, or otherwise, will not be returned to applicant even if requested.”

This policy is in place to maintain the integrity of the filing process and prevent potential abuse. Applicants should be careful not to file applications that are not intended to be filed, such as duplicates of already filed applications.

Furthermore, the MPEP cites 37 CFR 1.26(a), which states that a change of purpose after payment of a fee, such as when a party desires to withdraw a patent application for which a fee was paid, does not entitle the party to a refund of such fee.

If an applicant realizes they have filed an application in error or no longer wish to pursue it, they may choose to abandon the application. However, the application will remain on file with the USPTO and any fees paid will not be refunded.

For more information on application abandonment, visit: application abandonment.

For more information on application return, visit: application return.

Can a patent application be filed without drawings?

In most cases, a patent application should include drawings if they are necessary to understand the invention. However, there are situations where an application can be filed without drawings. As stated in MPEP 601.01(f): ‘If the specification includes a sequence listing or large tables, those elements may be submitted as electronic files in ASCII text format.’

For applications that do require drawings, but are filed without them, the USPTO will send a Notice to File Missing Parts. The applicant can then submit the drawings within a specified time period, typically two months, extendable up to seven months with fees. However, it’s important to note that adding new drawings may be considered new matter if they introduce elements not described in the original specification.

Design patent applications, which are based entirely on the visual appearance of an item, always require drawings and cannot be filed without them.

To learn more:

Yes, a patent application can be filed without an oath or declaration initially. According to MPEP 602:

‘An oath or declaration is not required for a provisional application filed under 35 U.S.C. 111(b) and 37 CFR 1.53(c). Oaths or declarations are required for design applications, plant applications, reissue applications, and nonprovisional utility patent applications filed on or after September 16, 2012, but the filing of the oath or declaration may be postponed until after the application is otherwise in condition for allowance.’

However, it’s important to note that while the filing can be postponed, the oath or declaration must be submitted before the application can be allowed. The USPTO will issue a Notice to File Missing Parts if the oath or declaration is missing, giving the applicant a time period to submit it.

To learn more:

Yes, a patent application can be filed on behalf of a deceased inventor under certain circumstances:

  • The application must be filed by the legal representative of the deceased inventor’s estate.
  • The legal representative must submit an oath or declaration and any necessary assignments.
  • The application should be filed as soon as possible after the inventor’s death to avoid potential issues with prior art.

MPEP 409.01 states: “If an inventor dies after an application is filed but before the application is approved for issue as a patent, and this fact is known to the legal representative or the assignee, a petition to change the applicant under 37 CFR 1.46(c)(2) should be filed.”

It’s important to note that the legal representative must act promptly to ensure the application is properly filed and prosecuted in accordance with USPTO regulations.

To learn more:

Can a patent application be filed if the sole inventor is deceased?

Yes, a patent application can be filed even if the sole inventor is deceased. The MPEP 409.03(b) provides guidance on this situation:

“When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or assignee of the deceased inventor.”

In such cases, the legal representative (such as an executor or administrator of the inventor’s estate) can file the application on behalf of the deceased inventor. They must provide proof of their authority to act on behalf of the deceased inventor’s estate, typically in the form of Letters Testamentary or Letters of Administration.

To learn more:

Yes, a patent application can be filed even if one joint inventor refuses to sign, provided certain conditions are met. According to MPEP 409.03(a):

“Pre-AIA 37 CFR 1.47(a) and pre-AIA 35 U.S.C. 116, second paragraph, requires all available joint inventors to file an application ‘on behalf of’ themselves and on behalf of a joint inventor who ‘cannot be found or reached after diligent effort’ or who refuses to ‘join in an application.'”

To file the application, the available joint inventors must make an oath or declaration on their own behalf and on behalf of the nonsigning inventor. Additionally, proof must be provided that the nonsigning inventor refuses to execute the application papers. This process allows the patent application to proceed despite the refusal of one joint inventor to participate.

To learn more:

Yes, a patent application can be assigned before it is filed. This is known as an assignment of future rights. MPEP 301 states:

“An assignment of an application can be made before the application is filed. See 37 CFR 3.21.”

However, it’s important to note that the assignment document should clearly identify the invention and the application to be filed. Once the application is filed, it’s advisable to record the assignment with the USPTO to ensure proper documentation of ownership.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

Can a patent applicant attend an interview with the USPTO without their practitioner?

While it is generally recommended that a patent practitioner represents the applicant during USPTO interviews, there are circumstances where an applicant may attend without their practitioner. MPEP 408 states:

‘A registered practitioner, not of record, may accompany a registered practitioner of record to attend an interview of an application in which the registered practitioner is not of record. The registered practitioner not of record may not participate in the interview of the application except as authorized by the patent applicant.’

This implies that while the primary responsibility lies with the practitioner of record, applicants have some flexibility in who attends the interview. However, it’s important to note that without proper representation, applicants may miss out on valuable legal insights and negotiation opportunities during the interview process.

For more information on patent applicant, visit: patent applicant.

For more information on patent examination, visit: patent examination.

Yes, according to MPEP 106.01, an assignee of a part interest or a licensee of exclusive right is entitled to inspect the patent application. The MPEP states: ‘an assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.’

This right to inspection is distinct from the right to intervene in or prosecute the application, which is reserved for the assignee of the entire interest.

No, a partial assignee cannot file a patent application as the sole applicant. The MPEP clarifies this point:

Because all parties having any portion of ownership in a patent property must act together as a composite entity in patent matters before the Office, a partial assignee (e.g., a party who owns 50% of the interest) cannot on its own file a patent application as the applicant.

This means that if multiple parties have ownership interests in the invention, they must act together to file the patent application. For more information on joint ownership, see MPEP § 301.

To learn more:

A nonsigning inventor who subsequently joins an application cannot revoke or grant a power of attorney in certain situations. MPEP 402.05(a) explains:

37 CFR 1.64(f) provides that the submission of an oath or declaration by a nonsigning inventor or legal representative in an application filed under 37 CFR 1.43, 1.45 or 1.46 will not permit the nonsigning inventor or legal representative to revoke or grant a power of attorney.

This means that if a nonsigning inventor later submits an oath or declaration in an application filed under specific circumstances (such as joint inventors, deceased or legally incapacitated inventors, or assignee filing), they cannot use this submission to revoke an existing power of attorney or grant a new one.

To learn more:

In a pre-AIA 37 CFR 1.47 application, a nonsigning inventor has limited rights regarding the power of attorney. According to MPEP 402.05(b):

A nonsigning inventor may subsequently join in a pre-AIA 37 CFR 1.47 application by submitting an oath or declaration under pre-AIA 37 CFR 1.63. However, even if the nonsigning inventor joins in the application, he or she cannot revoke or give a power of attorney without agreement of the pre-AIA 37 CFR 1.47 applicant.

This means that while a nonsigning inventor can later join the application by submitting the required oath or declaration, they do not have the authority to unilaterally revoke or grant a power of attorney. Any such action would require the agreement of the original pre-AIA 37 CFR 1.47 applicant.

To learn more:

To learn more:

Yes, a nonsigning inventor can join a pre-AIA 37 CFR 1.47 application. However, there are specific requirements and limitations to this process.

According to MPEP 409.03(i):

“A nonsigning inventor may join in a pre-AIA 37 CFR 1.47 application. To join in the application, the nonsigning inventor must file an appropriate pre-AIA 37 CFR 1.63 oath or declaration.”

It’s important to note that even if the nonsigning inventor joins the application, they have limited powers. The MPEP further states:

“Even if the nonsigning inventor joins in the application, he or she cannot revoke or give a power of attorney without agreement of the 37 CFR 1.47 applicant.”

This means that while the nonsigning inventor can become part of the application, they do not gain full control over it and must still work in agreement with the original applicant.

To learn more:

To learn more:

Can a nonprovisional application claim benefit from a provisional application filed without an English translation?

Yes, a nonprovisional application can claim the benefit of a provisional application filed without an English translation, but there are specific requirements. According to MPEP 601.01(a):

If the provisional application was filed in a language other than English, an English-language translation of the non-English language provisional application will not be required in the provisional application. The English language translation of the provisional application must be filed in the nonprovisional application.

This means that while the provisional application can be filed in a non-English language, the English translation must be submitted with the nonprovisional application that claims benefit from it. It’s crucial to ensure that the translation is accurate and complete to maintain the benefit claim.

For more details, see MPEP 601.01(a) and MPEP 211 on claiming benefit of earlier filing date.

To learn more:

Yes, a nonprovisional application can be entitled to different foreign filing dates for different claims. This can occur in two scenarios:

  1. The application may be found entitled to the filing date of a foreign application for some claims but not for others.
  2. An applicant may rely on two or more different foreign applications and may be entitled to the filing date of one application for certain claims and to another for other claims.

The MPEP states: “A nonprovisional application may be found entitled to the filing date of the foreign application with respect to some claims and not with respect to others. In addition, an applicant may rely on two or more different foreign applications and may be entitled to the filing date of one of them with respect to certain claims and to another with respect to other claims.” (MPEP 216)

Yes, under certain circumstances, a nonprovisional application filed without claims can be converted to a provisional application. This option is available for applications filed under 35 U.S.C. 111(a) on or after June 8, 1995, but it must be done within specific time limits and meet certain requirements.

The MPEP states: “As 37 CFR 1.53(c)(2) permits the conversion of an application filed under 35 U.S.C. 111(a) to an application under 35 U.S.C. 111(b), an applicant in an application, other than for a design patent, filed under 35 U.S.C. 111(a) on or after June 8, 1995, without at least one claim has the alternative of filing a petition under 37 CFR 1.53(c)(2) to convert such application into an application under 35 U.S.C. 111(b), which does not require a claim to be entitled to its date of deposit as a filing date.”

Key points for conversion:

  • The petition must be filed within 12 months of the original application’s filing date.
  • The application must comply with the requirements of 37 CFR 1.53(c)(2).
  • This option is not available for design patent applications.
  • For applications filed on or after December 18, 2013, conversion is unnecessary as claims are not required for a filing date.

To learn more:

Yes, nonprofit organizations can qualify for small entity status under certain conditions. According to 37 CFR 1.27(a)(3), a nonprofit organization that qualifies for small entity status is one that:

  • Has not assigned, granted, conveyed, or licensed any rights in the invention to a non-small entity
  • Is either:
    • A university or other institution of higher education
    • An organization described in section 501(c)(3) of the Internal Revenue Code and exempt from taxation under 501(a)
    • A nonprofit scientific or educational organization qualified under a nonprofit organization statute of a state
    • A foreign organization that would qualify under the above if it were located in the U.S.

It’s important to note that government organizations, whether domestic or foreign, cannot qualify as nonprofit organizations for small entity status purposes.

To learn more:

Yes, a non-signing inventor can later join the patent application. According to 37 CFR 1.64(f):

A nonsigning inventor or legal representative may subsequently join in the application by submitting an oath or declaration under § 1.63.

However, it’s important to note that this subsequent submission does not give the non-signing inventor or legal representative the power to revoke or grant a power of attorney if the application was filed under 37 CFR 1.43, 1.45, or 1.46.

This provision allows for flexibility in cases where an inventor’s circumstances may change after the initial filing of the application.

To learn more:

Tags: declaration, oath

No, a non-practitioner (someone who is not a registered patent attorney or agent) cannot change the correspondence address for a company’s patent application, even if they have the authority to act on behalf of the company. The MPEP states:

If an application is filed by a company to whom the invention has been assigned or to whom there is an obligation to assign the invention, a person (other than a patent practitioner) who has the authority to act on behalf of the company may not change the correspondence address, as all papers signed on behalf of a juristic entity must be signed by a patent practitioner.

This requirement is based on 37 CFR 1.33(b)(3), which specifies that amendments and other papers must be signed by a patent practitioner when submitted on behalf of a juristic entity (such as a company).

To learn more:

To learn more:

Can a non-inventor appoint a power of attorney in a pre-September 16, 2012 application?

Yes, under certain circumstances, a non-inventor can appoint a power of attorney in applications filed before September 16, 2012. The MPEP 402.02(b) states:

If no power of attorney is on file, then a party who is not an inventor, but who has given a proper showing of ownership or of authority to take action for and on behalf of all of the applicant may appoint an attorney or agent to prosecute the application, subject to the same exception noted above.

This means that a non-inventor, such as an assignee or other party with proper authority, can appoint a power of attorney if:

  • No power of attorney is currently on file
  • They provide proper documentation showing ownership or authority to act on behalf of all applicants
  • They follow the same rules that would apply to inventors appointing a power of attorney

It’s important to note that the non-inventor must have the authority to act for all applicants, not just some of them.

To learn more:

Can a non-attorney represent an applicant before the USPTO?

Yes, a non-attorney can represent an applicant before the USPTO under certain circumstances. According to MPEP 402.04, there are specific provisions for non-attorney representation:

  • Patent agents: Registered patent agents who are not attorneys can represent applicants in patent matters before the USPTO.
  • Limited recognition: Individuals granted limited recognition by the USPTO Director can represent applicants in specific patent matters.
  • Pro se representation: Applicants can represent themselves (pro se) in their own patent applications.

However, it’s important to note that “Effective September 16, 2012, any paper submitted on behalf of a juristic entity must be signed by a patent practitioner.” This means that corporations and other non-human entities must be represented by a registered patent practitioner, who may be either a patent attorney or a patent agent.

To learn more:

Tags: USPTO

Yes, a new patent practitioner can be appointed after the death of the previous one. The USPTO explicitly states in Form Paragraph 4.03: A new registered attorney or agent may be appointed. This allows the applicant or patent owner to ensure continued representation in patent matters following the death of their previous practitioner.

A national patent office may inform third parties that it has been designated in an international application and publish that fact. However, the publication can only contain limited bibliographic data, as specified in PCT Article 30(2)(b):

“Such information or publication may, however, contain only the following data: identification of the receiving Office, name of the applicant, international filing date, international application number, and title of the invention.”

The national office still cannot allow third parties to access the full application until the conditions outlined in PCT Article 30(2)(a) are met.

Can a national application be converted to an international application?

Yes, a national application can be converted to an international application under certain conditions. The MPEP states: “A national application may be converted to an international application by filing a PCT international application within one year from the earliest U.S. filing date of the national application and including the United States of America as a designated state.” (MPEP 201.01) This conversion allows applicants to seek patent protection internationally while maintaining the priority date of their original national filing. It’s important to note that this conversion must be done within the one-year timeframe to preserve priority rights.

For more information on conversion, visit: conversion.

Tags: conversion

No, a licensee of exclusive right cannot prosecute a patent application. According to MPEP 106.01, only the assignee of record of the entire interest has the right to intervene in the prosecution of an application. The MPEP states:

While it is only the assignee of record of the entire interest who can intervene in the prosecution of an application or interference to the exclusion of the applicant […], an assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.

This means that while a licensee of exclusive right can inspect the application, they cannot prosecute it or exclude the applicant from the prosecution process.

To learn more:

Can a legal representative use an S-signature for patent documents?

Yes, a legal representative can use an S-signature for patent documents, provided they meet the following requirements:

  • The S-signature must be inserted between forward slash marks
  • The signer’s name must be presented in printed or typed form
  • The capacity of the signer must be included with the signature

The MPEP 402.03 states: ‘When an S-signature is employed in a document filed with the Office in connection with a patent or application, it must be accompanied by the printed or typed name of the signer. The number and qualification of persons required to execute a particular document are governed by the statute requiring the document and applicable regulations.’

For legal representatives, it’s crucial to include their capacity (e.g., attorney, agent) along with their S-signature to ensure compliance with USPTO requirements.

To learn more:

Can a legal representative sign the oath or declaration for an unavailable joint inventor?

Yes, in certain circumstances, a legal representative can sign the oath or declaration for an unavailable joint inventor. According to MPEP 409.03(a):

‘If an inventor is deceased or legally incapacitated, the legal representative of the inventor may sign the oath or declaration as the inventor.’

The legal representative must provide proof of their authority to act on behalf of the unavailable inventor. This might include:

  • Death certificate and letters testamentary for a deceased inventor
  • Court order appointing a guardian for a legally incapacitated inventor

It’s important to note that this provision applies only to deceased or legally incapacitated inventors, not to those who are simply unavailable or unwilling to sign.

To learn more:

Yes, a legal representative can sign patent documents on behalf of the inventor under certain circumstances. The MPEP 402.03 states:

Where a power of attorney or authorization of agent is given to a customer number, a practitioner must sign the correspondence if an applicant is to be represented.

This means that if a power of attorney has been granted, the authorized practitioner can sign documents on behalf of the inventor. However, it’s important to note that certain documents, such as the inventor’s oath or declaration, must still be signed by the inventor personally unless specific conditions are met (e.g., the inventor is deceased, legally incapacitated, or cannot be found after diligent effort).

To learn more:

Yes, a legal representative can file a national patent application in certain circumstances. The Manual of Patent Examining Procedure (MPEP) 201.01 states:

‘A national application may be filed under 35 U.S.C. 111(a) in the U.S. Patent and Trademark Office (USPTO) by… (B) the legal representative (35 U.S.C. 117) of a deceased or legally incapacitated inventor.’

This provision allows for the continuity of the patent application process when the inventor is unable to file themselves. The legal representative must be authorized under 35 U.S.C. 117, which typically includes executors, administrators, or other legal representatives of deceased inventors, or guardians or conservators of incapacitated inventors.

For more information on legal representative, visit: legal representative.

For more information on patent filing, visit: patent filing.

Yes, a legal entity can sign patent correspondence, but there are specific requirements. According to MPEP 502.02:

When a document is to be signed by a corporation or another juristic entity, the signature must comply with 37 CFR 1.33(b)(3).

The requirements for a legal entity’s signature include:

  • The name of the person signing
  • Their capacity (e.g., President, CEO, General Counsel)
  • The name of the legal entity

For example, a valid signature for a corporation might look like:

/John Smith, President, XYZ Corporation/

It’s important to note that the person signing must have the authority to bind the legal entity in matters before the USPTO. This ensures that the correspondence is legally binding and properly authorized.

To learn more:

Can a legal entity be listed as an inventor on a patent application?

No, a legal entity such as a corporation or organization cannot be listed as an inventor on a patent application. The MPEP clearly states:

“[T]he inventor, or each individual who is a joint inventor of a claimed invention, in an application for patent (other than a provisional application) must execute an oath or declaration directed to the application, except as provided for in 37 CFR 1.64.” (MPEP 605)

This means that only natural persons can be inventors. However, a legal entity can be an applicant or assignee of a patent application. The distinction is important:

  • Inventors: Must be individuals who contributed to the conception of the invention.
  • Applicants/Assignees: Can be legal entities that own the rights to the patent.

For example, a company’s employees might be listed as inventors, while the company itself is listed as the applicant or assignee.

To learn more:

Tags: legal entity

Can a legal assistant or secretary sign correspondence on behalf of a patent practitioner?

No, a legal assistant or secretary cannot sign correspondence on behalf of a patent practitioner. The MPEP 502.02 clearly states:

‘The signature of a practitioner on correspondence filed with the USPTO must be a handwritten signature or an S-signature personally signed by such practitioner.’

This requirement ensures that the practitioner takes personal responsibility for the content of the correspondence. Delegating this responsibility to support staff is not permitted and could lead to the correspondence being considered unsigned or improperly signed.

To learn more:

Can a juristic entity be an applicant for a patent application?

No, a juristic entity cannot be an applicant for a patent application filed on or after September 16, 2012. The MPEP 605 clearly states: ‘A juristic entity (e.g., organizational assignee) cannot be named as the applicant for a patent application.’ This means that only natural persons, specifically the inventor(s), can be named as applicants. However, a juristic entity can be named as the assignee or applicant for other purposes, such as in an application for a reissue patent to replace an original patent granted on an application filed before September 16, 2012.

To learn more:

Can a juristic entity appoint a power of attorney in a patent application?

Yes, a juristic entity (such as a corporation or organization) can appoint a power of attorney in a patent application. However, there are specific requirements for doing so:

  • The power of attorney must be signed by a person authorized to act on behalf of the juristic entity
  • The person signing must have apparent authority to bind the juristic entity

The MPEP provides guidance on this matter:

A power of attorney from a juristic entity must be signed by a person authorized to act on behalf of the juristic entity. […] A power of attorney to a patent practitioner to prosecute a patent application executed by the applicant or the assignee of the entire interest of the applicant is the power of attorney of the applicant or assignee, not the power of attorney of the practitioner. (MPEP 402.02(a))

It’s important to note that the power of attorney belongs to the juristic entity, not to the practitioner who is appointed.

To learn more:

Can a juristic entity applicant sign a power of attorney form for a patent application?

No, a juristic entity applicant (such as a corporation or organization) cannot directly sign a power of attorney form for a patent application. Instead, the power of attorney must be signed by a person authorized to act on behalf of the juristic entity.

According to MPEP 402.02(a):

“A power of attorney must be signed by the applicant for patent (37 CFR 1.42) or the patent owner (for reissue applications or reexamination proceedings). A power of attorney may only be signed by the applicant for patent (37 CFR 1.42) or the patent owner of record of the entire interest or their representative. An applicant for patent that is the assignee must comply with 37 CFR 3.71 and 3.73 to establish ownership of the application.”

For juristic entity applicants, this typically means that an officer or employee of the organization who has the authority to bind the organization must sign the power of attorney. This could be a CEO, president, or other authorized representative of the company.

It’s important to note that the person signing on behalf of a juristic entity should also provide their title or position within the organization to demonstrate their authority to act on behalf of the applicant.

To learn more:

No, a juristic entity applicant cannot directly sign a change of correspondence address form. According to MPEP 601.03(a):

“A juristic entity (e.g., organizational assignee) must be represented by a patent practitioner even if the juristic entity is the applicant.”

For juristic entity applicants, the following applies:

  • A registered patent practitioner must sign the change of correspondence address form on behalf of the juristic entity
  • The practitioner must be appointed to represent the juristic entity
  • The appointment can be made in an Application Data Sheet (ADS) or a separate power of attorney document

It’s important to note that this requirement is in place to ensure proper legal representation for juristic entities in patent matters.

To learn more:

Can a joint inventor apply for a patent if another joint inventor is unavailable or refuses to join?

Yes, a joint inventor can apply for a patent even if another joint inventor is unavailable or refuses to join the application. The MPEP 409 states: ‘If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the application may be made by the other inventor on behalf of himself or herself and the nonsigning inventor.’

The process involves:

  • Filing the application on behalf of all inventors
  • Submitting a petition under 37 CFR 1.45
  • Providing proof of the unavailability or refusal of the non-signing inventor
  • Including an oath or declaration by the participating inventor(s)

This provision ensures that the patent application process can proceed even when not all joint inventors are available or willing to participate.

For more information on joint inventors, visit: joint inventors.

Yes, a foreign priority claim can be corrected after filing a patent application, but there are specific procedures and time limitations to follow. According to MPEP 214.04:

‘The time period for making a claim for priority under 37 CFR 1.55 is set forth in 37 CFR 1.55(d)… If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’

To correct a foreign priority claim:

  • If before the issue fee is paid: File a corrected Application Data Sheet (ADS) with the proper identification of the foreign application.
  • If after the issue fee is paid: Request a Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323.

It’s important to note that corrections must be made within the time period specified in 37 CFR 1.55(d), which is typically within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To learn more:

Can a foreign patent agent with limited recognition represent applicants in all USPTO matters?

No, a foreign patent agent with limited recognition cannot represent applicants in all USPTO matters. The MPEP clearly states that A foreign patent agent granted limited recognition may not represent applicants or parties in trademark matters, ex parte or inter partes appeals to the Patent Trial and Appeal Board, petitions to the Director of the USPTO, disciplinary proceedings, or in any other matter before the Office. (MPEP 402.01) Their representation is strictly limited to the presentation and prosecution of patent applications before the USPTO.

To learn more:

Tags: USPTO

Yes, a foreign filing license can be revoked by the USPTO. Key points about revocation include:

  • The USPTO can revoke a license through written notification.
  • Revocation usually occurs if additional review reveals national security concerns.
  • Revocation is effective on the date the notice is mailed.
  • Foreign filings made before revocation are generally not affected.
  • New foreign filings after revocation are not permitted without a new license.

The MPEP states: “Upon written notification from the USPTO, any foreign filing license required by 37 CFR 5.11(a) may be revoked. Ordinarily, revocation indicates that additional review of the licensed subject matter revealed the need for referral of the application to the appropriate defense agencies.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

Can a foreign filing license be revoked or modified?

Yes, a foreign filing license can be revoked or modified under certain circumstances. The MPEP 140 provides guidance on this:

Licenses for foreign filing may be revoked or modified upon written notification from the Director. Normally, revocation or modification will only affect applications or other materials not already filed abroad.

Key points about revocation or modification of foreign filing licenses:

  • The Director of the USPTO has the authority to revoke or modify licenses.
  • Notification of revocation or modification will be provided in writing.
  • Generally, the revocation or modification only affects future filings, not those already made abroad.
  • In cases of imminent national emergency, revocation may be immediate and may affect filings already made abroad.

If your license is revoked or modified, you should immediately cease any foreign filing activities covered by the license and seek legal counsel to understand the implications and next steps.

For more information on foreign filing license, visit: foreign filing license.

For more information on revocation, visit: revocation.

Yes, a foreign filing license can be denied by the USPTO. According to MPEP 140:

‘If the Director of the USPTO or his or her designee determines that the application contains subject matter that requires a security review under the Invention Secrecy Act (35 U.S.C. 181-188), the petition for license is denied and the applicant is notified in writing.’

Reasons for denial may include:

  • National security concerns
  • Subject matter falling under the Invention Secrecy Act
  • Incomplete or incorrect application for the license

If a license is denied, the applicant will be notified in writing and may have the opportunity to address the issues or appeal the decision.

For more information on foreign filing license, visit: foreign filing license.

Yes, a domestic representative can be changed after the initial designation. While MPEP 302.04 doesn’t explicitly address changing a domestic representative, it states that the designation is made by a written document signed by such assignee. This implies that a new written document can be submitted to change the designation. To change a domestic representative, follow the same process as the initial designation:

  • Prepare a new written document clearly labeled ‘Change of Domestic Representative’
  • Include the new representative’s name and address
  • Submit the document separately from other filings
  • Ensure it’s signed in accordance with 37 CFR 1.33(b)

It’s advisable to explicitly state that this new designation supersedes any previous designations to avoid confusion.

To learn more:

Yes, a divisional or continuation application can claim benefit from multiple prior applications. The MPEP 201.06(c) states:

‘A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (A) a copy of the prior application as filed; and (B) a new specification, claim or claims and drawings, where applicable.’

This provision allows for claiming benefit from multiple prior applications by following the correct procedures. It’s crucial to ensure that the chain of priority is properly maintained and that all necessary documents and declarations are filed.

To learn more:

To learn more:

No, a divisional application cannot include new matter that was not disclosed in the parent application. The MPEP 201.06 clearly states:

‘A divisional application is a later application for an independent or distinct invention, carved out of a prior application and disclosing and claiming only subject matter disclosed in the prior application.’

This means:

  • The divisional application must be limited to the subject matter disclosed in the parent application
  • No new matter can be added to the divisional application
  • The claims in the divisional must be supported by the disclosure of the parent application

If an applicant wishes to add new matter, they should consider filing a continuation-in-part (CIP) application instead of a divisional. For more information on new matter, refer to MPEP 2163.

To learn more:

Yes, a divisional application can claim the benefit of the filing date of the prior application. The MPEP ¶ 2.01 states:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

To claim this benefit, the applicant must meet the requirements set forth in 35 U.S.C. 120 and 37 CFR 1.78, which include making a proper benefit claim and ensuring the divisional application is filed before the patenting or abandonment of the prior application.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Yes, a divisional application can claim priority to its parent application. This is one of the key benefits of filing a divisional application. According to MPEP 201.06:

‘A divisional application is entitled to the benefit of the filing date of the prior application.’

This means that the divisional application:

  • Retains the priority date of the parent application for the subject matter disclosed in the parent
  • Can claim the benefit under 35 U.S.C. 120 or 365(c)
  • Must include a specific reference to the parent application in its application data sheet (ADS)

It’s important to note that the divisional application must be filed while the parent application is still pending to claim this benefit.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Yes, a divisional application can claim priority to a provisional application under certain conditions. According to MPEP 201.06:

‘A divisional application may claim the benefit of a provisional application under 35 U.S.C. 119(e) if the divisional application is filed within twelve months of the provisional application filing date (or an appropriate later date in accordance with 37 CFR 1.78).’

To claim this benefit, the divisional application must:

  • Be filed within 12 months of the provisional application’s filing date (or later if permitted under 37 CFR 1.78)
  • Include a proper reference to the provisional application
  • Have at least one common inventor with the provisional application

To learn more:

To learn more:

Yes, a divisional application can claim the benefit of its parent application’s filing date. According to MPEP 201.06(c):

“A divisional application is entitled to the benefit of the filing date of the prior-filed application if the prior-filed application discloses the invention claimed in the divisional application in the manner provided by the first paragraph of 35 U.S.C. 112.”

This means that as long as the invention claimed in the divisional application was adequately described in the parent application, it can claim the parent’s filing date. This is crucial for establishing priority and avoiding potential prior art issues.

For more information on Divisional application, visit: Divisional application.

Can a divisional application claim benefit from a provisional application?

Yes, a divisional application can claim benefit from a provisional application through its parent application. The MPEP 201.06 states: “A later-filed application may be filed as a continuation, divisional, or continuation-in-part of a prior nonprovisional application or international application designating the United States. Unless the filing date of the earlier nonprovisional application is to be claimed for prior art purposes, there is no need for the later-filed application to be copending with it.” This means that if the parent application claimed benefit from a provisional application, the divisional application can also claim that benefit, extending its effective filing date back to the provisional application’s filing date.

To learn more:

Can a divisional application be filed without a restriction requirement?

While divisional applications are typically filed in response to a restriction requirement, they can be filed voluntarily without one. The MPEP 201.06 states:

“A divisional application is often filed as a result of a restriction requirement made by the examiner.”

However, the use of “often” implies that this is not always the case. Applicants may choose to file a divisional application voluntarily if they:

  • Recognize distinct inventions in their application
  • Want to pursue different claim scopes separately
  • Need to address potential unity of invention issues proactively

It’s important to note that voluntarily filing a divisional application without a restriction requirement may affect the application of the safe harbor provision under 35 U.S.C. 121, which protects against double patenting rejections in certain cases.

For more information on Divisional application, visit: Divisional application.

Can a divisional application be filed after the parent application is abandoned?

Yes, a divisional application can be filed after the parent application is abandoned, as long as certain conditions are met. The MPEP 201.06 states:

“A divisional application may be filed after abandonment of the parent application, provided the parent application is not relied upon for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c) in an application whose effective filing date is on or after March 16, 2013.”

This means that you can file a divisional application even if the parent application has been abandoned. However, it’s crucial to note that if you want to claim the benefit of the parent application’s filing date, and the effective filing date of your divisional application is on or after March 16, 2013, the parent application must not have been abandoned at the time of filing the divisional.

It’s important to consult with a patent attorney to ensure compliance with all requirements when filing a divisional application, especially in cases involving abandoned parent applications.

For more information on Divisional application, visit: Divisional application.

For more information on effective filing date, visit: effective filing date.

No, a design patent application cannot be filed as a provisional application. The MPEP 201.01 states:

“Design applications and provisional applications for patent are considered to be distinct types of applications and are treated as separate categories.”

This means that design patent applications must be filed as nonprovisional applications. Provisional applications are only available for utility and plant patents.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

Yes, design patent applications can be filed as continuations or continuations-in-part (CIPs), but with some specific considerations:

1. Continuations: A design application can be a continuation of a prior design application.

2. Continuations-in-part: A design application can be a CIP of a prior design application if it adds new matter.

3. Relationship to Utility Applications: A design application can also be a continuation or CIP of a utility application, provided the drawings in the utility application sufficiently disclose the claimed design.

The MPEP states: “A design application may be considered to be a divisional of a utility application (but not of a provisional application), and is entitled to the filing date thereof if the drawings of the earlier filed utility application show the same article as that in the design application sufficiently to comply with 35 U.S.C. 112(a). However, such a divisional design application may only be filed under the procedure set forth in 37 CFR 1.53(b), and not under 37 CFR 1.53(d).”

It’s important to note that while not explicitly stated for continuations and CIPs, the same principle applies – the earlier application must sufficiently disclose the claimed design.

Can a design application be considered complete without drawings?

No, a design application cannot be considered complete without drawings. The MPEP 601.01 states: “A design application is not entitled to a filing date under 35 U.S.C. 171 unless the application contains a drawing in compliance with 37 CFR 1.152.” This requirement is specific to design applications due to their visual nature. Drawings are essential for depicting the ornamental design for which protection is sought. Without compliant drawings, the application will not be granted a filing date and will not be processed further.

To learn more:

Can a dependent claim refer to more than one preceding claim in a patent application?

Yes, a dependent claim can refer to more than one preceding claim in a patent application, but there are specific rules governing such references. According to MPEP 608.01(n):

‘A claim which depends from a dependent claim should not be separated by any claim which does not also depend from said dependent claim. It should be kept in mind that a dependent claim may refer to any preceding independent claim. In general, applicant’s sequence will not be changed.’

Key points to remember:

  • A dependent claim can refer to multiple preceding claims, but only in the alternative (using ‘or’).
  • Multiple dependent claims must be carefully constructed to avoid improper dependencies.
  • The order of claims should be maintained to ensure clarity and proper dependency structure.

Proper referencing in dependent claims helps maintain a clear and logical claim structure in the patent application.

To learn more:

Yes, a delayed priority claim can be filed after a patent has been granted. The MPEP provides for this possibility:

“Where a priority claim under 37 CFR 1.55(g) was not timely made, 37 CFR 1.55(g) allows the priority claim and the certified copy required under 37 CFR 1.55 to be filed pursuant to a petition under 37 CFR 1.55(e) even if the application is not pending (e.g., a patented application). Thus, a petition under 37 CFR 1.55(e) may be filed along with request for a certificate of correction after patent grant.”

This provision allows patent holders to rectify priority claims even after their patent has been issued, ensuring that important priority rights are not lost due to unintentional delays.

To learn more:

Yes, a delayed priority claim can be accepted after patent issuance, but the process is more complex and requires a certificate of correction. According to MPEP 214.02:

For utility and plant applications filed on or after November 29, 2000, the failure to timely file a priority claim because of an error in a foreign priority claim may be corrected pursuant to 37 CFR 1.55(g). The failure to timely file a priority claim to an earlier filed application may be corrected pursuant to 37 CFR 1.78(c) and (e).

To correct a delayed priority claim after patent issuance:

  • File a petition under 37 CFR 1.55(e) or 37 CFR 1.78(c) and (e), as appropriate.
  • Submit a request for a certificate of correction under 37 CFR 1.323.
  • Pay the required fees for both the petition and the certificate of correction.
  • Provide a statement of unintentional delay covering the entire period of delay.

It’s important to note that the standards for accepting a delayed priority claim after issuance are typically higher, and the USPTO may require a more detailed explanation of the circumstances surrounding the delay.

To learn more:

To learn more:

Yes, delayed benefit claims can be filed for design applications. The MPEP 211.04 provides specific information about this:

“Effective May 13, 2015, 37 CFR 1.78(d)(3) was amended to make the procedures under 37 CFR 1.78(e) to accept an unintentionally delayed benefit claim applicable to design applications where the benefit claim was not submitted during the pendency of the design application. Thus, a petition under 37 CFR 1.78(e) may be filed along with a request for certificate of correction after patent grant.”

This means that for design applications, it’s possible to file a petition for a delayed benefit claim even after the patent has been granted, along with a request for a certificate of correction.

To learn more:

Yes, a delayed benefit claim can be filed for an international application entering the national stage, but specific requirements must be met. The MPEP 211.04 provides guidance on this:

‘For international applications entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT…However, if an applicant fails to make a proper benefit claim within the later of four months from the actual filing date of the national stage application or sixteen months from the filing date of the prior-filed application, the benefit claim may be accepted if the applicant files a petition under 37 CFR 1.78.’

This means that while there are specific timeframes for filing benefit claims in national stage applications, if these deadlines are missed, a petition under 37 CFR 1.78 can be filed to request acceptance of the delayed benefit claim. The petition must meet all requirements, including demonstrating that the delay was unintentional.

To learn more:

No, a delayed benefit claim cannot be accepted after the patent has issued. The MPEP 211.04 clearly states:

“A petition under 37 CFR 1.78 to accept an unintentionally delayed claim for the benefit of a prior-filed application will not be granted in an issued patent.”

This means that once a patent has been granted, it is no longer possible to add or correct benefit claims through the petition process. The opportunity to make such changes ends when the patent issues.

If an applicant discovers after issuance that a benefit claim was not properly made or was omitted, they may have limited options:

  • Consider filing a reissue application to correct the error, if it qualifies as an error correctable by reissue.
  • In some cases, a certificate of correction might be appropriate, but this is generally limited to typographical or clerical errors.

It’s crucial for applicants to ensure all desired benefit claims are properly made and recorded before the patent issues to avoid complications and potential loss of priority rights.

To learn more:

Can a deceased inventor’s legal representative sign an assignment for a patent application?

Yes, a deceased inventor’s legal representative can sign an assignment for a patent application. According to MPEP 409.01(a):

“The legal representative (executor, administrator, etc.) of a deceased inventor may make an assignment of the deceased inventor’s rights in the application as well as sign the substitute statement. See MPEP § 409.01(b).”

This provision allows the legal representative to manage the deceased inventor’s intellectual property rights, including assigning those rights to other parties. It’s important to note that the legal representative must have proper authority to act on behalf of the deceased inventor’s estate, which typically requires documentation such as letters testamentary or letters of administration.

To learn more:

Can a Customer Number be used for multiple patent applications?

Yes, a Customer Number can be used for multiple patent applications. This is one of the primary benefits of the Customer Number system. The MPEP 403 states:

‘The Customer Number practice permits applicants, attorneys, and agents of record to change their correspondence address for a number of applications with one request.’

This means that:

  • A single Customer Number can be associated with multiple patent applications
  • Changes to the correspondence address or list of registered practitioners can be made once and applied to all linked applications
  • It simplifies portfolio management for applicants and law firms handling multiple patents

Using a Customer Number for multiple applications streamlines communication with the USPTO and helps ensure consistent handling of related patent matters.

For more information on Customer Number, visit: Customer Number.

Can a CPA be filed in a provisional application?

No, a Continued Prosecution Application (CPA) cannot be filed in a provisional application. The MPEP 201.06(d) clearly states:

A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application, but not an international design application, that is complete as defined by 37 CFR 1.51(b), except for the inventor’s oath or declaration if the application is filed on or after September 16, 2012, and the prior application was filed under 35 U.S.C. 111(a).

This means that CPAs are limited to design applications filed under 35 U.S.C. 111(a). Provisional applications, which are filed under 35 U.S.C. 111(b), are not eligible for CPA filing.

To learn more:

To learn more:

No, Continued Prosecution Applications (CPAs) cannot be filed for utility or plant applications. The MPEP clearly states: Effective July 14, 2003, continued prosecution application (CPA) practice was eliminated as to utility and plant applications. For utility and plant applications, applicants should consider filing a request for continued examination (RCE) under 37 CFR 1.114 or a new application under 37 CFR 1.53(b) instead.

To learn more:

Can a CPA be filed as a continuation-in-part application?

No, a Continued Prosecution Application (CPA) cannot be filed as a continuation-in-part application. According to MPEP 201.06(d):

‘A continuation or divisional application (but not a continuation-in-part) may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).’

This means that while you can file a CPA as a continuation or divisional application of a prior design application, you cannot file it as a continuation-in-part. Continuation-in-part applications typically contain new matter not present in the prior application, which is not allowed in a CPA filing.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

Yes, a corporation can file a patent application under pre-AIA 37 CFR 1.47(b). The MPEP explicitly states that “Where a corporation is the pre-AIA 37 CFR 1.47(b) applicant, an officer (President, Vice-President, Secretary, Treasurer, or Chief Executive Officer) thereof should normally sign the necessary oath or declaration.”

Additionally, “A corporation may authorize any person, including an attorney or agent registered to practice before the U.S. Patent and Trademark Office, to sign the application oath or declaration on its behalf.” However, proper authorization or proof of authority may be required in such cases.

To learn more:

No, a copy of the original oath or declaration cannot be used in a continuation or divisional application filed under 37 CFR 1.53(b). A new oath or declaration must be filed.

According to MPEP 602.02: ‘A new oath or declaration in compliance with 37 CFR 1.63 or 1.67 is required in a continuation or divisional application filed under 37 CFR 1.53(b), regardless of whether a copy of the oath or declaration from the prior application is submitted.’

This requirement ensures that the inventors reaffirm their commitment to the claims in the new application, which may differ from those in the parent application.

To learn more:

No, a copy of the foreign patent as issued does not comply with the certified copy requirement. The MPEP states: “A copy of the foreign patent as issued does not comply since the application as filed is required; however, a copy of the printed specification and drawing of the foreign patent is sufficient if the certification indicates that it corresponds to the application as filed.” The key is that the certified copy must represent the application as originally filed, not the patent as eventually issued.

Can a Continued Prosecution Application (CPA) be filed in a provisional application?

No, a Continued Prosecution Application (CPA) cannot be filed in a provisional application. According to MPEP 201.06(d):

“A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).”

This explicitly limits CPA practice to design applications. Provisional applications are not eligible for CPA filings. If an applicant wishes to continue prosecution based on a provisional application, they must file a non-provisional application claiming priority to the provisional application within the appropriate time frame.

For more information on CPA, visit: CPA.

For more information on provisional application, visit: provisional application.

Can a Continued Prosecution Application (CPA) be filed for utility or plant patent applications?

No, a Continued Prosecution Application (CPA) cannot be filed for utility or plant patent applications. According to MPEP 201.06(d):

‘Effective July 14, 2003, CPAs are only available for design applications.’

This means that CPAs are exclusively for design patent applications. For utility or plant patent applications, applicants must use other continuation options such as:

If an applicant attempts to file a CPA for a utility or plant application, the USPTO will process it as a request for continued examination (RCE) under 37 CFR 1.114, if applicable, or will otherwise treat it as an improper application.

To learn more:

Yes, a Continued Prosecution Application (CPA) can be filed for design applications. In fact, as of September 8, 2000, CPAs are only available for design applications. According to MPEP 201.06(d):

‘Effective July 14, 2003, CPA practice has been eliminated as to utility and plant applications. CPAs can only be filed for design applications.’

This means that for utility and plant patent applications, other forms of continuing applications such as RCEs (Request for Continued Examination) or continuation applications under 37 CFR 1.53(b) must be used instead of CPAs.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

Yes, a continuation-in-part (CIP) application can have different inventors than the parent application, but there must be at least one common inventor. The MPEP provides guidance on this:

“A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78. Subject to the same conditions, a continuation-in-part application that has joint inventors may derive from an earlier application that has a sole inventor.”

This flexibility allows for situations where new inventors contribute to the additional subject matter in the CIP, or where some inventors from the original application are no longer involved in the new developments.

For more information on joint inventors, visit: joint inventors.

Can a continuation-in-part application claim priority to a provisional application?

Yes, a continuation-in-part (CIP) application can claim priority to a provisional application, but with some important considerations. The MPEP 201.08 doesn’t explicitly address this scenario, but it can be inferred from the general rules governing CIP applications and provisional applications.

Key points to understand:

  • Priority claim: A CIP can claim priority to a provisional application for subject matter disclosed in the provisional.
  • New matter: Any new matter added in the CIP will have the filing date of the CIP itself, not the provisional application.
  • One-year deadline: The CIP must be filed within one year of the provisional application’s filing date to claim its benefit.
  • Multiple priorities: A CIP might claim priority to both a provisional and a non-provisional application in some cases.

Inventors should carefully document which parts of their CIP application correspond to the provisional disclosure to ensure proper priority claims.

For more information on new matter, visit: new matter.

For more information on provisional application, visit: provisional application.

Yes, a continuation-in-part (CIP) application can claim benefit from multiple parent applications. The MPEP 201.08 states:

An applicant may in a single application seek to add and claim new matter while also repeating some or all of the subject matter of one or more earlier applications.

This means:

  • A CIP can incorporate subject matter from multiple earlier applications.
  • It can also add new matter not disclosed in any of the earlier applications.
  • The CIP can claim priority to different parent applications for different parts of its disclosure.

Note: The effective filing date for each claim will depend on which parent application(s) provide sufficient support for that claim, as per 35 U.S.C. 112(a). Claims relying on newly added matter will have the CIP’s filing date as their effective date.

To learn more:

To learn more:

Can a continuation-in-part application claim benefit from an international application?

Yes, a continuation-in-part (CIP) application can claim benefit from an international application, but there are specific requirements and limitations. The MPEP 211.01(c) states:

A U.S. national application may claim benefit under 35 U.S.C. 120 and 365(c) to an international application designating the United States only if the international application was filed on or after November 29, 2000.

However, it’s crucial to understand that for a CIP application, the benefit claim is limited to the subject matter that was disclosed in the international application. Any new matter added in the CIP would not receive the benefit of the international application’s filing date. Additionally, the CIP must meet all the requirements of 35 U.S.C. 120, including copendency and specific reference to the earlier application.

To learn more:

To learn more:

No, a continuation-in-part (CIP) application cannot be filed as a continued prosecution application (CPA). The MPEP explicitly states: “A continuation-in-part application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).”

Continuation-in-part applications may only be filed under 37 CFR 1.53(b). This is an important distinction to remember when considering different types of patent application filings.

A continuation-in-part (CIP) application can claim the benefit of a prior application’s filing date, but with important limitations:

  • Only the subject matter common to both the CIP and the prior application can claim the earlier filing date.
  • New matter introduced in the CIP will have the filing date of the CIP application.
  • Each claim in the CIP is evaluated independently for priority date determination.

MPEP 211.05 states:

A claim in a continuation-in-part application or subsequent application may be entitled to the benefit of the filing date of the prior application if the disclosure of the prior application provides support for the claim in compliance with 35 U.S.C. 112(a), except for the best mode requirement.

This means that applicants must carefully consider the content of their prior applications when filing a CIP to ensure they receive the maximum benefit of earlier filing dates for their claims.

To learn more:

Tags: new matter

Can a continuation-in-part (CIP) application claim benefit to multiple prior applications?

Yes, a continuation-in-part (CIP) application can claim benefit to multiple prior applications, provided certain conditions are met. The MPEP states:

“An applicant may claim the benefit of the filing date of one or more prior applications under 35 U.S.C. 120, 121, 365(c), or 386(c) in a later-filed application … if the later-filed application is filed before the patenting or abandonment of or termination of proceedings on the prior application.”

However, it’s important to note that for a CIP application:

  • New matter in the CIP will only get the benefit of the CIP’s filing date.
  • Matter disclosed in the prior application(s) can claim the earlier filing date(s).
  • Each claim in the CIP is evaluated separately to determine which filing date it is entitled to.

For more details, see MPEP 211.01 and MPEP 201.08.

To learn more:

To learn more:

Can a continuation-in-part (CIP) application claim benefit to a provisional application?

Yes, a continuation-in-part (CIP) application can claim benefit to a provisional application, but there are important considerations regarding the disclosure and priority dates. The MPEP provides guidance on this:

“An applicant may claim the benefit of the filing date of a provisional application in a subsequent nonprovisional application or international application designating the United States if the nonprovisional application or international application designating the United States is filed within 12 months from the filing date of the provisional application.”

However, it’s crucial to understand that:

  • Only the subject matter that was disclosed in the provisional application will receive the benefit of the provisional filing date.
  • New matter added in the CIP will have the filing date of the CIP application itself.
  • The applicant must comply with the requirements of 35 U.S.C. 119(e) and 37 CFR 1.78.

For more details on claiming benefit of provisional applications, see MPEP 211.

To learn more:

No, a continuation application cannot include new matter. As stated in MPEP 201.07:

The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

This means that the continuation application must be based entirely on the disclosure of the prior-filed application. Any new subject matter would need to be filed as a continuation-in-part (CIP) application instead of a standard continuation application.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

For more information on patent law, visit: patent law.

Yes, a continuation application can claim the benefit of multiple parent applications, provided certain conditions are met. According to MPEP 201.07:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 111(b) or 365(c) or filed under 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.53(b) or 1.53(d) as a continuation of prior applications, claiming the benefit of those applications under 35 U.S.C. 120, 121, 365(c), or 386(c).’

This means that a continuation application can claim the benefit of:

  • Multiple earlier-filed nonprovisional applications
  • Earlier-filed provisional applications
  • Earlier-filed international applications designating the United States

However, it’s important to note that the continuation must satisfy the requirements for claiming benefit, including proper copendency and cross-referencing of the prior applications.

For more information on continuation application, visit: continuation application.

Can a continuation application claim the benefit of a provisional application?

Yes, a continuation application can claim the benefit of a provisional application, provided certain conditions are met. The MPEP 201.07 states:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 363 while the prior application is pending, or it may be filed as an RCE under 37 CFR 1.114 of the prior application.’

To claim the benefit of a provisional application:

  • The continuation must be filed within 12 months of the provisional filing date
  • The provisional application must provide adequate support for the claims in the continuation
  • A specific reference to the provisional application must be made in the continuation

It’s important to note that while a continuation can claim benefit from a provisional, it must have at least one intervening nonprovisional application in the chain, as continuations are based on nonprovisional applications.

To learn more:

Yes, a continuation application can claim priority to multiple parent applications under certain conditions. According to MPEP 201.07:

‘A continuation application may be filed as a continuation of an earlier application of the same applicant… The continuation application may be filed before the patenting or abandonment of or termination of proceedings on the prior application.’

This means that:

  • The continuation must have at least one common inventor with the parent application(s).
  • The continuation must be filed while at least one of the parent applications is still pending.
  • The continuation cannot introduce new matter beyond what was disclosed in the parent application(s).

When claiming priority to multiple parents, the continuation essentially combines the disclosures of the parent applications, as long as they form a continuous chain of copending applications.

To learn more:

To learn more:

Yes, a continuation application can be filed after the parent application is granted or abandoned, but there are timing restrictions. The MPEP states:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

However, it’s important to note:

  • For standard continuation applications under 37 CFR 1.53(b), they must be filed before the patenting, abandonment, or termination of proceedings on the earlier application.
  • For Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), which are only available for design applications (excluding international design applications), they must be filed prior to payment of the issue fee unless a petition under 37 CFR 1.313(c) is granted in the prior application.

Always consult with a patent attorney to ensure proper timing and procedures are followed.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on patent grant, visit: patent grant.

Can a continuation application add new matter to the original disclosure?

No, a continuation application cannot add new matter to the original disclosure. This is a fundamental characteristic of continuation applications.

According to MPEP 201.07:

‘A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.’

This means that the continuation must rely entirely on the disclosure of the parent application. Any attempt to introduce new matter would result in the application being treated as a continuation-in-part (CIP) rather than a true continuation. It’s crucial for inventors and patent practitioners to understand this limitation when considering filing strategy.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

Yes, a company can be listed as the applicant for a patent application, but the rules differ depending on when the application was filed. According to MPEP § 605:

For applications filed on or after September 16, 2012:

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign an invention to file and prosecute an application for patent as the applicant.”

This means that a company can be listed as the applicant if:

  • The inventor has assigned the invention to the company
  • The inventor is under an obligation to assign the invention to the company

For applications filed before September 16, 2012:

“For applications filed before September 16, 2012, a person to whom the inventor assigned an invention could file and prosecute an application for patent, but the inventor is considered the applicant.”

In this case, while a company could file and prosecute the application, the inventor would still be considered the applicant.

It’s important to note that regardless of who is listed as the applicant, the true inventor(s) must always be named in the application.

To learn more:

According to MPEP 608.01(m), claims should not refer to figures or tables in the specification unless absolutely necessary. The MPEP states:

Where possible, claims are to be complete in themselves. Incorporation by reference to a specific figure or table ‘is permitted only in exceptional circumstances where there is no practical way to define the invention in words and where it is more concise to incorporate by reference than duplicating a drawing or table into the claim.’

In most cases, the subject matter of figures or tables should be described in words within the claim. Only when it’s impractical to define the invention without reference to a figure or table, and when it’s more concise to incorporate by reference, should such references be used in claims.

To learn more:

Can a Certificate of Correction be used to add or correct a benefit claim after patent grant?

The use of a Certificate of Correction to add or correct a benefit claim after patent grant depends on the type of patent. According to MPEP 211.02(a):

“For utility and plant applications, a Certificate of Correction can be used to correct the failure to adequately claim priority under 35 U.S.C. 119(e) or 120 in the application as filed if the application was filed within the required time period. However, for design applications, an application may be amended to claim priority to or the benefit of a prior-filed application after the application issues as a patent by filing a reissue application.”

This means:

  • For utility and plant patents: A Certificate of Correction can be used to add or correct a benefit claim after patent grant, provided the application was filed within the required time period.
  • For design patents: A Certificate of Correction cannot be used. Instead, a reissue application must be filed to add or correct a benefit claim after patent grant.

It’s important to note that the option to use a Certificate of Correction for utility and plant patents is subject to specific conditions and time limitations. Always consult the current MPEP and seek legal advice if necessary.

To learn more:

Can a Canadian patent agent represent U.S. patent applicants before the USPTO?

Yes, a Canadian patent agent can represent U.S. patent applicants before the USPTO under certain conditions. According to MPEP 402.01:

‘The Canadian Intellectual Property Office and the United States Patent and Trademark Office have agreed on a procedure to allow for the reciprocal recognition of patent agents and attorneys registered to practice before their respective Offices.’

This means that registered Canadian patent agents can apply for and be granted limited recognition to represent U.S. patent applicants before the USPTO. However, this recognition is subject to specific conditions and requirements set by the OED Director.

To learn more:

Tags: USPTO

No, a best mode defect cannot be cured by a later amendment to the patent application. The MPEP 608.01(h) clearly states: If the best mode contemplated by the inventor at the time of filing the application is not disclosed, such defect cannot be cured by submitting an amendment seeking to put into the specification something required to be there when the application was originally filed.

This guidance is based on the case In re Hay, 534 F.2d 917, 189 USPQ 790 (CCPA 1976). The MPEP further advises: Any proposed amendment of this type should be treated as new matter. This means that the best mode must be disclosed at the time of filing, and attempts to add it later will be rejected as new matter.

To learn more:

Tags: new matter

Yes, a ‘rejected’ patent application can still be approved. The term ‘rejected’ in this context does not mean final rejection or denial of the patent. According to MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application.

This status is part of the normal examination process. The applicant has the opportunity to respond to the examiner’s action, potentially leading to approval. The application remains ‘rejected’ until:

  • The applicant successfully addresses the examiner’s concerns
  • The examiner issues a notice of allowance
  • The application becomes abandoned

With appropriate responses and amendments, a ‘rejected’ application can progress to approval and eventual patent grant.

To learn more:

USPTO employees are generally not permitted to initiate email communications with patent applicants unless there is a written authorization on record. According to MPEP 502.03:

‘USPTO employees are NOT permitted to initiate communications with applicants via Internet email unless there is a written authorization of record in the patent application by the applicant.’

However, if an applicant has provided written authorization for Internet communications:

‘USPTO employees may respond to Internet email and initiate communications with applicants via Internet email.’

It’s important to note that this policy applies to regular patent applications. For reissue applications and reexamination proceedings, which are open to public inspection, additional restrictions apply:

‘USPTO employees are NOT permitted to initiate communications with applicant in a reissue application or a patentee of a reexamination proceeding via Internet email unless written authorization is given by the applicant or patentee.’

To learn more:

Generally, no. MPEP 105 states: “U.S. Patent and Trademark Office (USPTO) employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application.” This prohibition applies to all forms of communication about patent applications with suspended or excluded practitioners.

To learn more:

Yes, there are certain situations where a petition and petition fee are not required to correct a timely submitted benefit claim. According to the MPEP, these situations include:

  • Changing the relationship of the applications (e.g., from “continuation” to “continuation-in-part” or vice versa)
  • Changing the filing date of a prior-filed nonprovisional or provisional application
  • Changing a benefit claim of a prior-filed provisional application from 35 U.S.C. 120 to 35 U.S.C. 119(e) during the pendency of the later-filed application

Additionally, if the benefit claim was included elsewhere in the application (e.g., in an oath, declaration, or transmittal letter) within the required time period and was recognized by the Office as shown on the first filing receipt, a petition is not required. However, the applicant must still submit the benefit claim in the proper format (i.e., in an Application Data Sheet or by amending the specification for applications filed before September 16, 2012).

Note: If the application has already issued as a patent, corrections to benefit claims that would affect the patent term cannot be made by a certificate of correction or in a reissue application.

Yes, there are significant restrictions on contacting patent practitioners who are not of record for a patent application. According to MPEP § 408, Registered attorneys or agents not of record in a patent application (i.e., there is no power of attorney present in the file that appoints the patent practitioner(s)) and acting in a representative capacity under 37 CFR 1.34 should not be contacted for restriction requirements or approval of examiner’s amendments.

This policy is in place to ensure that only properly authorized representatives are involved in making decisions about patent applications. For more information on interviews with patent practitioners not of record, refer to MPEP § 405.

Yes, there are strict restrictions on communicating with unregistered, suspended, or excluded attorneys regarding patent applications. The MPEP clearly states:

Office employees are forbidden from holding either oral or written communication with an unregistered, suspended or excluded attorney or agent regarding an application unless it is one in which said attorney or agent is the applicant.

This rule helps maintain the integrity of the patent application process and ensures that only qualified, registered practitioners are involved in patent-related communications with the USPTO.

Yes, there are exceptions to the requirement for all applicants to sign power of attorney documents. The MPEP provides one specific exception:

“In an application filed under pre-AIA 37 CFR 1.47(a), an assignee of the entire interest of the available inventors (i.e., the applicant) who has signed the declaration may appoint or revoke a power of attorney without a petition under 37 CFR 1.36(a) or 1.183.”

This exception applies to applications filed before the America Invents Act (AIA) under specific circumstances. However, it’s important to note that this exception does not apply in all cases. The MPEP also states:

“However, in applications accepted under pre-AIA 37 CFR 1.47, such a petition under 37 CFR 1.36(a) or 1.183 submitted by a previously nonsigning inventor who has now joined in the application will not be granted.”

For more information on these exceptions, refer to MPEP § 402.07 and MPEP § 409.03(i).

To learn more:

Yes, there are two exceptions to the patent ownership restrictions for USPTO employees:

  1. Inheritance
  2. Bequest

According to 35 U.S.C. 4:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of… acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office.’

This means that USPTO employees can acquire patents or interests in patents through inheritance or bequest, even during their employment or the one-year period after.

Yes, design patent applications have different requirements for filing priority claims compared to utility patent applications. The main difference is in the time period for filing the claim. As stated in MPEP 214.01:

“The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.”

For design applications, the MPEP further clarifies: “In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).”

This means that for design patent applications, you can file a priority claim at any time while the application is pending, which provides more flexibility compared to utility patent applications.

For more detailed information on priority claims in design applications, you can refer to MPEP § 1504.10 and MPEP § 2920.05(d).

To learn more:

Yes, there can be subject matter restrictions when claiming priority based on inventor’s certificates. The MPEP 213.05 states:

Certain countries which grant both patents and inventor’s certificates issue only inventor’s certificates on certain subject matter, generally pharmaceuticals, foodstuffs, and cosmetics.

This means that for certain types of inventions, some countries may only offer inventor’s certificates and not patents. However, this doesn’t necessarily prevent an applicant from claiming priority in the US. The key requirement is that the option to file for either a patent or an inventor’s certificate must have generally existed in the country for the particular subject matter of the invention, even if it wasn’t available for the specific invention in question.

Applicants must still provide an affidavit or declaration as required by 37 CFR 1.55(l), stating that they had the option to file for either a patent or an inventor’s certificate for the subject matter forming the basis of the priority claim.

To learn more:

Are there any restrictions on paying USPTO fees by credit card?

Yes, there are some restrictions when paying USPTO fees by credit card:

  • There’s a daily limit on credit card transactions.
  • Some types of fees may not be eligible for credit card payment.
  • Only certain credit cards are accepted.

The MPEP 509 states, “The Office will not accept a general authorization to charge all fees, or all fees in a specific case, to a credit card.” Additionally, “Credit Card Payment Form PTO-2038 should be used when paying a patent or trademark fee (or related service fee) by credit card, unless the payment is being made via EFS-Web.” It’s important to check the current USPTO guidelines for any updates to credit card payment policies.

To learn more:

Tags: USPTO fees

Yes, there are limitations on expunging assignment records at the USPTO. The MPEP 323.01(d) provides important guidance:

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

This indicates that:

  • Expungement is not an automatic process and requires a formal petition
  • Only recorded assignments can be considered for expungement
  • The petitioner must provide clear evidence of mistake or improper character
  • The USPTO has discretion in granting or denying the petition

Additionally, the USPTO generally will not expunge an assignment record if it has already been relied upon or cited in other documents. This is to maintain the integrity of the public record and prevent confusion in chain of title matters.

To learn more:

Tags: USPTO

Generally, there are no additional fees charged by the USPTO for using the PDX program to exchange priority documents. The MPEP 215.01 does not mention any specific fees for this service. However, it’s important to note:

  • Regular patent application fees still apply.
  • If the PDX retrieval fails and you need to submit a certified copy, standard fees for document submission may apply.
  • Some foreign offices might charge fees for making documents available through PDX.

Always check the most current fee schedule on the USPTO website for the most up-to-date information on patent-related fees.

Yes, there are fees associated with using the Electronic Patent Assignment System (EPAS). According to MPEP 302.10:

“Customers may submit assignments electronically by accessing the Office’s website and paying the required fee by credit card, electronic fund transfer (EFT) or deposit account.”

The specific fee amounts are not mentioned in this section of the MPEP, so it’s advisable to check the current USPTO Fee Schedule for the most up-to-date information on assignment recording fees.

To learn more:

Tags: USPTO fees

Are there any fee reductions or waivers available for USPTO patent fees?

Yes, the USPTO offers fee reductions for certain applicants. According to MPEP 509, “Certain fees may be reduced if the applicant qualifies as a small entity or micro entity.” Here’s a brief overview:

  • Small Entity: Individuals, small businesses, and nonprofit organizations may qualify for a 50% fee reduction.
  • Micro Entity: Certain applicants may qualify for a 75% fee reduction if they meet specific income and filing requirements.

To determine if you qualify and for detailed information on how to claim these statuses, refer to MPEP 509.02 for Small Entity Status and MPEP 509.04 for Micro Entity Status. Always ensure you meet all requirements before claiming a reduced fee status.

To learn more:

Are there any fee reductions available for small entities or micro entities filing patent applications?

Yes, the USPTO offers significant fee reductions for small entities and micro entities. According to MPEP 607:

“Fees for a nonprovisional application for an original patent are reduced by 50% for a small entity and by 75% for a micro entity.”

To qualify for these reductions:

  • Small Entity: Generally includes independent inventors, small businesses with fewer than 500 employees, and nonprofit organizations.
  • Micro Entity: Must meet small entity requirements plus additional criteria related to application filings and income.

To claim these statuses, you must file the appropriate certification with your application. For detailed eligibility requirements and how to claim these statuses, refer to USPTO’s Micro Entity Guidance and Small Entity Status information.

To learn more:

Based on the information provided in MPEP 302.02, there are no exceptions to the USPTO’s English translation requirement for assignments. The MPEP states unequivocally:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This requirement applies to all non-English assignment documents without exception. The USPTO’s strict adherence to this policy ensures uniformity in the recording process and accessibility of patent ownership information.

To learn more:

Yes, there are exceptions to the standard time limits for filing foreign priority claims, particularly for design patent applications and certain applications filed before November 29, 2000. According to 37 CFR 1.55(d)(1):

The time periods in this paragraph do not apply if the later-filed application is:
(i) An application for a design patent; or
(ii) An application filed under 35 U.S.C. 111(a) before November 29, 2000.

For design patent applications, the MPEP states:

In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).

This means that for design patent applications, you can file a foreign priority claim at any time while the application is pending, without being restricted by the usual time limits.

For applications filed under 35 U.S.C. 111(a) before November 29, 2000, different rules may apply, and it’s best to consult with a patent attorney or the USPTO directly for guidance on such cases.

It’s important to note that while these exceptions exist, it’s generally advisable to file priority claims as early as possible to ensure they are properly recorded and considered.

While the general rule is that specifications and drawings cannot be transferred between applications, the use of the word “normally” in MPEP § 608.01(t) suggests that there might be rare exceptions. The MPEP states: “No part of a specification can normally be transferred to another application. Similarly, drawings cannot normally be transferred to another application.”

However, the MPEP doesn’t provide specific examples of such exceptions in this section. Applicants should consult with a patent attorney or the USPTO for guidance on any potential exceptions, as these would likely be handled on a case-by-case basis.

To learn more:

To learn more:

Yes, there are certain exceptions to the foreign filing license requirement. According to MPEP 140:

‘A license is not required if the invention was not made in the United States. Also, a license is not required to file an international application in the United States Receiving Office.’

Additionally, the following situations do not require a foreign filing license:

  • Filing applications in countries where no security agreement exists with the United States
  • Filing a PCT application designating only foreign countries
  • Filing a design patent application in a foreign country

However, it’s important to note that these exceptions are subject to specific conditions and may change. Always consult with a patent attorney or the USPTO if you’re unsure about your specific situation.

For more information on USPTO, visit: USPTO.

Tags: USPTO

Yes, there is one exception to the communication ban. According to MPEP 105, USPTO employees may communicate with a suspended or excluded practitioner “unless it is one in which said attorney or agent is an inventor or the applicant.” This means that if the suspended or excluded practitioner is listed as an inventor or is the applicant on a patent application, USPTO employees are allowed to communicate with them regarding that specific application.

To learn more:

Yes, there are exceptions to the benefit claim requirements for design applications. The MPEP specifically notes:

“Examiner Note: 1. Use this form paragraph only for original applications filed under 35 U.S.C. 111(a) on or after November 29, 2000 and for national stage applications under 35 U.S.C. 371. DO NOT use for design applications.”

This note indicates that the standard benefit claim requirements and procedures outlined in this section of the MPEP do not apply to design applications. Design applications have different rules and requirements for claiming benefit of earlier filing dates.

Key points about benefit claims in design applications:

  • Design applications can claim the benefit of an earlier filed design application or an earlier filed provisional application.
  • The rules for claiming benefit in design applications are generally less stringent than those for utility applications.
  • Specific requirements for design application benefit claims can be found in MPEP 1504.20.

It’s important to consult the specific rules and guidelines for design applications when dealing with benefit claims in this context, as they differ from the requirements for utility applications.

Yes, there are exceptions to paying the recording fee at the USPTO. According to MPEP 302.06, no fee is required for certain documents related to Executive Order 9424. Specifically:

No fee is required for each patent application and patent against which a document required by Executive Order 9424 is to be filed if: (1) The document does not affect title and is so identified in the cover sheet (see § 3.31(c)(2)); and (2) The document and cover sheet are either: Faxed or electronically submitted as prescribed by the Director, or mailed to the Office in compliance with § 3.27.

This exception applies to specific government-related documents that do not affect the title of the patent or application.

To learn more:

Tags: USPTO fees

Yes, there is one exception. A suspended or excluded patent attorney or agent can inspect an application if they are the inventor or applicant of that particular application. The MPEP clarifies:

USPTO employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application unless it is one in which said attorney or agent is an inventor or the applicant.

So while suspended or excluded practitioners generally cannot inspect applications, they can still access ones in which they are directly involved as the inventor or applicant.

Yes, juristic entities (e.g., organizational assignees) must be represented by a patent practitioner. As stated in MPEP 401:

An applicant who is a juristic entity must be represented by a patent practitioner.

This requirement ensures that organizations have proper legal representation when navigating the complex patent application process. Individual inventors and joint inventors, however, may represent themselves if they choose to do so.

For more information on juristic entity, visit: juristic entity.

For more information on organizational assignee, visit: organizational assignee.

Yes, certain applications are still processed under former 37 CFR 1.62. Specifically, all continuation, divisional, and continuation-in-part (CIP) applications filed under former 37 CFR 1.62 prior to December 1, 1997, continue to be processed and examined under the procedures set forth in that regulation.

The MPEP clarifies this point: All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.

For more detailed information on the practice and procedure under former 37 CFR 1.62, the MPEP directs readers to consult MPEP § 201.06(b) in the MPEP 8th Edition, Rev. 1 (February 2003), which is available on the USPTO website.

To learn more:

To learn more:

Yes, the procedures for correcting inventorship and correcting an inventor’s name are the same. According to MPEP 602.01(c)(2):

The procedures for correction of inventorship and for correction to the name of an inventor or to the order of the names of the inventors are not distinct.

Both procedures require:

  • Submitting an application data sheet (ADS) in accordance with 37 CFR 1.76 that identifies each inventor by their legal name in the desired order.
  • Paying the processing fee set forth in 37 CFR 1.17(i).

This unified procedure simplifies the process for applicants when making changes related to inventorship or inventor names in patent applications.

To learn more:

No, supplemental oaths or declarations filed after allowance are not considered amendments under 37 CFR 1.312. The MPEP explicitly states:

“They should not be filed or considered as amendments under 37 CFR 1.312, since they make no change in the wording of the papers on file.”

This means that supplemental oaths or declarations do not alter the content of the application and are treated differently from post-allowance amendments.

To learn more:

To learn more:

No, substitute specifications are not permitted in reissue applications or reexamination proceedings. This is explicitly stated in 37 CFR 1.125(d):

A substitute specification under this section is not permitted in a reissue application or in a reexamination proceeding.

This restriction is important to maintain the integrity of the original patent document in these special proceedings. Applicants and practitioners should be aware of this limitation when considering how to make amendments or changes to the specification in reissue applications or reexamination proceedings.

To learn more:

Reserved sections are relatively common in the MPEP, especially for section numbers that are being held for future use or that previously contained content that was moved. A quick scan of the MPEP Chapter 200 shows several reserved sections, such as:

  • Section 203.07 [Reserved]
  • Sections 204-209 [Reserved]
  • Section 212 [Reserved]

No, provisional patent applications are not examined. The MPEP 504 clearly states: “Provisional applications will not be examined.” Provisional applications serve as a placeholder to establish a priority date and are not subject to substantive examination by the USPTO.

To learn more:

No, provisional patent applications are not examined for patentability. The MPEP explicitly states:

Provisional applications will not be examined for patentability.

This is one of the key differences between provisional and nonprovisional applications. The purpose of a provisional application is to:

  • Establish an early filing date
  • Allow the term ‘Patent Pending’ to be applied
  • Provide a 12-month period to further develop the invention

Since provisional applications are not examined, they do not require formal patent claims or an oath or declaration. This simplifies the filing process and allows inventors to quickly secure a priority date for their invention.

To obtain patent protection, a nonprovisional application must be filed, which will then undergo examination for patentability.

For more information on patent filing, visit: patent filing.

No, provisional patent applications are not assigned to examiners for examination. MPEP 504 explicitly states: “Provisional applications will not be examined.” This is because provisional applications are primarily used to establish a priority date and are not subject to substantive examination.

No, provisional applications are not subject to Department of Energy (DOE) or NASA property rights review. According to MPEP 150:

Provisional applications are not subject to DOE or NASA property rights review.

This means that inventors filing provisional applications do not need to submit property rights statements to DOE or NASA at the time of filing. However, it’s important to note that if a nonprovisional application is later filed claiming priority to the provisional application, and if it relates to atomic energy or aeronautical and space activities, it may then be subject to the relevant property rights review process.

No, provisional applications are not published or made available to the public by the USPTO. The MPEP 201.04 clearly states:

A provisional application is not subject to publication and is not subject to examination other than to review for national security implications.

This means that the contents of a provisional application remain confidential unless and until a corresponding non-provisional application is published or a patent is issued. This confidentiality can be advantageous for inventors who want to maintain secrecy while securing an early filing date.

For more information on provisional application, visit: provisional application.

Provisional applications are not explicitly mentioned as national applications in MPEP 201.01. The section states:

‘National applications include original (nonprovisional) applications, reissue applications, and reexamination proceedings.’

While provisional applications are filed with the USPTO, they are not considered complete patent applications and do not undergo examination. They serve as a placeholder to establish a priority date. For more information on provisional applications, refer to USPTO’s Provisional Application page.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The treatment of preliminary amendments as new matter depends on when they are filed:

  1. Filing date amendments: Preliminary amendments present on the filing date of the application are considered part of the original disclosure and not new matter.
  2. Post-filing amendments: Preliminary amendments filed after the application’s filing date are not part of the original disclosure and may be considered new matter.

The MPEP states: A preliminary amendment present on the filing date of the application (e.g., filed along with the filing of the application) is considered a part of the original disclosure. (MPEP 608.04(b))

For applications filed on or after September 21, 2004, the USPTO automatically treats any preliminary amendment under 37 CFR 1.115(a)(1) present on the filing date as part of the original disclosure.

To avoid potential new matter issues, applicants are encouraged to incorporate desired amendments into the text of the specification rather than submitting separate preliminary amendments.

To learn more:

Tags: new matter

No, powers to inspect are not accepted in Image File Wrapper (IFW) applications. IFW applications are available through the Private Patent Application Information Retrieval (PAIR) system, and pro se applicants and attorneys of record have direct access to the IFW through Private PAIR when:

  • A Customer Number is associated with the correspondence address for the application, and
  • The applicant or attorney has access to Private PAIR for the customer number

In addition, IFW application files of published applications or patents are available at least through Patent Center. If an applicant, inventor, assignee, or attorney/agent of record cannot view an IFW application through Private PAIR or Patent Center, then a copy of the application must be purchased from the Patent and Trademark Copy Fulfillment Branch of the Public Records Division.

Photographs are generally not permitted in utility and design patent applications, but exceptions exist. According to MPEP 608.01(f):

Photographs, including photocopies of photographs, are not ordinarily permitted in utility and design patent applications. The Office will accept photographs in utility and design patent applications, however, if photographs are the only practicable medium for illustrating the claimed invention.

Examples of acceptable photographs include:

  • Electrophoresis gels
  • Blots (e.g., immunological, western, Southern, and northern)
  • Cell cultures
  • Histological tissue cross sections
  • In vivo imaging
  • Crystalline structures
  • Ornamental effects (in design patent applications)

The photographs must be of sufficient quality to ensure all details are reproducible in the printed patent. If the subject matter can be illustrated by a drawing, the examiner may require a drawing instead of a photograph.

To learn more:

Photographs can be included in patent applications, but there are specific requirements and limitations. According to MPEP 507:

“OPAP may object to and require corrected drawings within a set time period, if the drawings: (F) include photographs of the claimed invention which are capable of illustration by other medium such as ink drawings, and which are illegible after scanning. See 37 CFR 1.84(b)

This means that while photographs are acceptable, they should only be used when the subject matter cannot be accurately depicted in a drawing. Additionally, the photographs must be of sufficient quality to be legible after scanning. If a photograph can be replaced by a clear ink drawing, the USPTO may require such a replacement.

For more information on drawing requirements, visit: drawing requirements.

For more information on patent drawings, visit: patent drawings.

Are patent assignment records publicly accessible after recording at the USPTO?

Yes, patent assignment records become publicly accessible after they are recorded at the USPTO. The MPEP 302.01 states: ‘Assignment documents submitted for recording are scanned and stored in a public database.’

This means:

  • Anyone can access recorded assignment information
  • The public database allows searching for patent ownership details
  • Transparency in patent ownership is maintained

Public accessibility of these records is crucial for maintaining transparency in patent ownership and facilitating due diligence in patent transactions. Interested parties can search and retrieve assignment information through the USPTO’s Assignment Search database.

To learn more:

No, patent applicants are not required to conduct prior art searches before filing a patent application. This is clarified in the MPEP, which states:

An applicant has no duty to conduct a prior art search as a prerequisite to filing an application for patent. See Nordberg, Inc. v. Telsmith, Inc., 82 F.3d 394, 397, 38 USPQ2d 1593, 1595-96 (Fed. Cir. 1996); FMC Corp. v. Hennessy Indus., Inc., 836 F.2d 521, 526 n.6, 5 USPQ2d 1272, 1275-76 n.6 (Fed. Cir. 1987); FMC Corp. v. Manitowoc Co., 835 F.2d 1411, 1415, 5 USPQ2d 1112, 1115 (Fed. Cir. 1987); American Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F.2d 1350, 1362, 220 USPQ 763, 772 (Fed. Cir.), cert. denied, 469 U.S. 821, 224 USPQ 520 (1984).

However, conducting a prior art search can be beneficial for understanding the state of the art and assessing the potential patentability of an invention.

For more information on patent application requirements, visit: patent application requirements.

For more information on prior art search, visit: prior art search.

No, nonsigning inventors are not entitled to a hearing in pre-AIA 37 CFR 1.47 cases. This is explicitly stated in MPEP 409.03(i):

“A nonsigning inventor is not entitled to a hearing (Cogar v. Schuyler, 464 F.2d 747, 173 USPQ 389 (D.C. Cir. 1972))”

This precedent, set by the case of Cogar v. Schuyler, establishes that while nonsigning inventors have certain rights, such as inspecting application papers and making their position of record, they do not have the right to a formal hearing in these cases.

Additionally, the MPEP states:

“While the U.S. Patent and Trademark Office will grant the nonsigning inventor access to the application, inter partes proceedings will not be instituted in a pre-AIA 37 CFR 1.47 case. In re Hough, 108 USPQ 89 (Comm’r Pat. 1955).”

This further emphasizes that while nonsigning inventors have access to application information, they cannot initiate inter partes proceedings, which would include hearings, in pre-AIA 37 CFR 1.47 cases.

To learn more:

To learn more:

For continuation or divisional applications filed before September 16, 2012, a new oath or declaration is generally not required if certain conditions are met. According to pre-AIA 37 CFR 1.63(d):

A newly executed oath or declaration is not required under § 1.51(b)(2) and § 1.53(f) in a continuation or divisional application, provided that:

  • The prior nonprovisional application contained a proper oath or declaration
  • The continuation or divisional application was filed by all or fewer than all inventors named in the prior application
  • The specification and drawings contain no new matter
  • A copy of the executed oath or declaration from the prior application is submitted

However, a new oath or declaration is required if naming an inventor not named in the prior application. The MPEP states: A newly executed oath or declaration must be filed in a continuation or divisional application naming an inventor not named in the prior application.

To learn more:

No, Information Disclosure Statements (IDSs) are not permitted in provisional patent applications. The MPEP clearly states:

Information Disclosure Statements (IDSs) are not permitted in provisional applications filed under 35 U.S.C. 111(b). See 37 CFR 1.51(d).

The reason for this is that provisional applications do not undergo substantive examination. As the MPEP explains:

Since no substantive examination is given in provisional applications, a disclosure of information is unnecessary.

If an IDS is filed with a provisional application, the USPTO will handle it as follows:

Any such statement filed in a provisional application will be returned or destroyed at the option of the Office.

To learn more:

Are handwritten patent applications accepted by the USPTO?

While it is strongly recommended to submit typed or printed applications, the USPTO does accept handwritten patent applications under certain conditions:

  • The handwriting must be legible and in permanent dark ink or its equivalent.
  • The text must be clearly readable and suitable for reproduction.
  • All other formatting requirements (margins, spacing, etc.) must still be followed.

As stated in MPEP 501: All papers that are to become a part of the permanent records of the United States Patent and Trademark Office should be legibly written either by a typewriter or mechanical printer in permanent dark ink or its equivalent in portrait orientation on flexible, strong, smooth, non-shiny, durable, and white paper.

While handwritten applications are technically accepted, it’s important to note that typed or printed applications are preferred for clarity and ease of processing. Handwritten applications may face additional scrutiny and potential delays in processing due to legibility concerns.

English translations of non-English language foreign applications are not always required. However, 37 CFR 1.55(g)(3) specifies three situations where an English translation may be necessary:

“An English language translation of a non-English language foreign application is not required except: (i) When the application is involved in an interference or derivation proceeding; (ii) When necessary to overcome the date of a reference relied upon by the examiner; or (iii) When specifically required by the examiner.”

If a translation is required, it must be filed with a statement certifying that the translation is accurate. This ensures that the USPTO can properly evaluate the priority claim when necessary for examination or proceedings.

To learn more:

Drawings are not always necessary for a patent application, but they are required when essential for understanding the invention. According to the MPEP, 35 U.S.C. 113 (first sentence) in turn provides that an ‘applicant shall furnish a drawing where necessary for the understanding of the subject matter sought to be patented.’ The USPTO has specific practices for determining when drawings might not be necessary, such as for certain process claims, composition applications, and situations where the invention resides solely in the use of a particular material in an otherwise known article or system.

To learn more:

No, CPAs are not available for all types of patent applications. According to MPEP ¶ 2.30, CPAs are primarily used for design patent applications. The MPEP states: “If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead).” This indicates that CPAs are not typically used for utility or plant patent applications, and such requests may be treated as Requests for Continued Examination (RCE) instead.

For more information on design patents, visit: design patents.

For more information on plant patents, visit: plant patents.

For more information on utility patents, visit: utility patents.

Generally, copies of U.S. patents and U.S. patent application publications listed in an Information Disclosure Statement (IDS) are not required unless specifically requested by the Office.

According to the MPEP: ‘There is no requirement for a copy of each U.S. patent or U.S. patent application publication listed in an IDS unless required by the Office.‘ (37 CFR 1.98(a)(2))

However, it’s important to note that copies of other types of documents, such as foreign patents and non-patent literature, are typically required. The MPEP specifies that legible copies must be provided for:

  • Each foreign patent
  • Each publication or that portion which caused it to be listed
  • For each cited pending unpublished U.S. application, the application specification including the claims, and any drawings of the application, unless the cited pending U.S. application is stored in the Image File Wrapper (IFW) system
  • All other information or that portion which caused it to be listed

To learn more:

To learn more:

No, Continued Prosecution Applications (CPAs) are not available for all types of patent applications. They are specifically limited to design patent applications. This is evident from the MPEP guidance, which states:

‘Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.’

This statement clearly indicates that CPAs are associated with design applications. For utility and plant patent applications, other continuation options are available, such as:

  • Continuation Applications
  • Divisional Applications
  • Continuation-in-Part Applications

It’s important for inventors and patent practitioners to understand these distinctions to choose the appropriate type of continuing application for their specific situation.

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

Are continuation applications considered national applications?

Yes, continuation applications are considered national applications. They are a type of nonprovisional application that continues the examination process of a previously filed application.

The MPEP 201.01 states: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’ While continuation applications are not explicitly mentioned in this list, they fall under the category of nonprovisional applications.

Continuation applications allow applicants to pursue additional claims based on the disclosure of a parent application. They are filed before the parent application is abandoned or patented and claim the benefit of the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on USPTO, visit: USPTO.

Yes, comparisons with prior art are generally allowed in patent applications, as long as they are not derogatory. The MPEP 608.01(r) explicitly states:

“Mere comparisons with the prior art are not considered to be disparaging, per se.”

This means you can compare your invention to existing technologies to highlight improvements or differences. However, ensure that your comparisons are factual, objective, and focus on technical aspects rather than criticizing or disparaging other inventions or inventors.

To learn more:

Color drawings or photographs are generally not allowed in patent applications without special permission. MPEP 507 states:

OPAP may object to and require corrected drawings within a set time period, if the drawings: … (G) contain color drawings or color photographs, but not a petition to accept color drawings/photographs.

If an applicant wishes to include color drawings or photographs, they must file a petition to accept them. It’s important to note that the requirement for a black and white photocopy of color drawings/photographs has been eliminated. Applicants should be prepared to justify the need for color in their drawings or photographs when filing such a petition.

No, color drawings and color photographs are not permitted in international applications. This is explicitly stated in MPEP 608.02(c):

Color drawings and color photographs are not permitted in international applications (see PCT Rule 11.13).

This restriction is based on the PCT Rule 11.13, which sets out the physical requirements for drawings in international applications. Applicants should be aware that only black and white line drawings are acceptable for international applications filed under the Patent Cooperation Treaty (PCT).

To learn more:

To learn more:

No, claims are not required for a provisional patent application to receive a filing date. This is explicitly stated in 35 U.S.C. 111(b)(2), which provides that “[a] claim, as required by subsections (b) through (e) of section 112, shall not be required in a provisional application.”

The MPEP confirms this by stating: “In addition, 35 U.S.C. 111(b)(2) provides that ‘[a] claim, as required by subsections (b) through (e) of section 112, shall not be required in a provisional application.'”

This provision allows inventors to quickly establish a priority date for their invention without the need to draft formal patent claims, which can be a complex and time-consuming process.

To learn more:

No, attorney’s liens against patents or patent applications are not accepted for recording at the USPTO. This is explicitly stated in the MPEP:

“Documents that are not accepted for recording include attorney’s liens against patents or patent applications. See In re Refusal of Assignment Branch to Record Attorney’s Lien, 8 USPQ2d 1446 (Comm’r Pat. 1988).” (MPEP 313)

This decision reflects the USPTO’s policy on recordable documents and helps maintain clarity in the patent ownership records.

The accessibility of assignment records for pending patent applications depends on whether the application has been published. According to MPEP 301.01:

  • For published patent applications, assignment records are publicly available.
  • For unpublished pending applications, assignment records are not open to public inspection.

The MPEP states: “Documents relating only to one or more pending applications for patent which have not been published under 35 U.S.C. 122(b) will not be open to public inspection.”

For unpublished pending applications, access to assignment information requires proper authorization. As per the MPEP:

“For applications filed on or after September 16, 2012, the written authority must be from (A) an inventor, (B) an applicant, (C) the assignee or an assignee of an undivided part interest, (D) a patent practitioner of record, or (E) a person with written authority from (A), (B), or (C) or (D).”

To learn more:

No, applicants are not separately notified when their parent application is abandoned due to the filing of a Continued Prosecution Application (CPA). This is implied in the examiner’s note in MPEP ¶ 2.35:

This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

The establishment of a CPA automatically results in the abandonment of the parent application. Applicants should be aware that by filing a CPA, they are effectively abandoning the parent application in favor of continuing prosecution through the CPA.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

Yes, all patent assignment records are publicly accessible. MPEP 301.01 clearly states:

‘The assignment records of patents and applications are open to public inspection.’

This means that anyone can access these records, which include:

  • Assignment documents
  • Digests of assignments
  • Indexes of patent assignments

The public nature of these records ensures transparency in patent ownership and transfers. However, it’s important to note that while the records are public, obtaining copies may require payment of a fee as specified in 37 CFR 1.19(b)(3).

Patent Loans (10)

n

We typically consider patents as the primary asset in an IP-backed loan, although we also consider trade secrets and company data as valuable assets to loan against. A software company’s code base may also be collateralized, but typically as a secondary asset.

nnnn

Trademarks occasionally can be considered, but they are on a case-by-case basis.

nnnn

A typical borrower may have at least a handful of patents, but often has 10-50 patent assets as collateral.

n
Topics: Patent Loans
n

The effective interest rate for a patent loan will be in the neighborhood of 9-12%.

nnnn

The patent loan insurance product has a premium that is paid out of the loan proceeds, as well as due diligence fees and insurance premiums for the required enforcement and defense insurance.

nnnn

When you include interest paid back to a lender, the effective interest rate of the loan will be approximately 9-12%.

nnnn

Please note that this rate is much lower than angel or venture equity, which is typically 50% or more. By taking a loan against the assets you already created, you can get much further without having the negative effects of selling your equity to investors.

n
Topics: Patent Loans
n

A patent loan will come with several other components, including insurance for patent enforcement and patent defense.

nnnn

Because a patent loan is specifically designed to help you expand your business, we want you to focus on generating revenue, not litigation. Therefore, we give you at least $2,000,000 in patent enforcement insurance and patent defense insurance.

nnnn

The due diligence process for the loan program will include due diligence for the other insurance products.

n
Topics: Patent Loans
n

The patent loan program requires several items about your patents and your business plan.  This is not a complete list.

nnnn

100% ownership of your patents.

nnnn

Your patents must be completely unencumbered and must be owned by the operating company.  Some investors will attach liens to intellectual property, which is a non-starter.  In many cases, the inventors may have “forgotten” to assign their rights to a company.  There are countless ways that a startup company may not have full, unrestricted rights to “their” IP, but we will require that this be completed before applying for a loan.

nnnn

The patents must be of the highest quality.

nnnn

Everybody believes their patents are good, but sadly, at least 95% of all patents are worthless.  Patents fail our due diligence for many different reasons, such as being over-broad, not having any prior art references, being poorly written, mistakes in patent prosecution, and countless others.

nnnn

One of the biggest ways patents fail is that there may be other ways to solve the same problem.  If the patent does not capture the single best way to solve a problem, your competitor will just use the alternative solution and never need to take a license from you.

nnnn

The business needs to be at the right stage.

nnnn

A good loan candidate can put capital to use – but must be able to repay the loan.  Startups that are in the ‘idea phase’ are not good candidates because they probably have not built out their manufacturing, marketing, and sales pipelines. 

nnnn

A good candidate has tested a marketing and sales funnel and knows their Cost to Acquire a Customer, along with a projected Lifetime Value.  They have developed enough sales to know what works and what doesn’t, and they can put a large amount of cash to use to generate revenue quickly.

nnnn

Another type of candidate needs operating capital, such as to purchase inventory for an existing order or for ongoing expansion.  These companies typically have access to small amounts of capital, but a collateralized loan will give them much more.

nnnn

You need to apply.

nnnn

We are anxiously waiting your phone call.  Please contact us and discuss your situation.  In many cases, we can process a loan in 2-4 weeks.

n
Topics: Patent Loans
n

Infringed patents can help (or hurt) your chances for a patent-backed loan, depending on the situation.

nnnn

In some cases, we put together an enforcement plan alongside a loan, where the loan gets paid off with the proceeds from the enforcement. In those cases, the enforcement and loan work hand-in-hand.

nnnn

In general, infringement of your patents is a good indicator that your patents have value.

n
Topics: Patent Loans
n

We prefer to provide loans to revenue generating companies, but we will consider pre-revenue companies in some cases.

nnnn

For pre-revenue companies, our patent financing option will build out your portfolio quickly so that it will be ready once your company starts generating revenue.

nnnn

The loan program is a loan, after all, and we will evaluate your company to see if we believe that you will be able to repay the loan. Taking out a loan is much different than selling equity, and our focus is on real revenue generation.

nnnn

Pre-revenue companies need to show that they are very close to revenue. In general, we want to see that the company is addressing a real need in the market, that there is economic value in the product or service being sold, and that the cost of goods leaves a solid profit margin. We also want to see that the cost to acquire a customer is known and that there is a delivery pipeline to satisfy that customer.

nnnn

In short, we want to see that there is a legitimate business opportunity in your company.

nnnn

Please note that we want to have real data to support the assumptions, such as experiments in customer acquisition methods, quantified analyses of the costs to build the product or supply the services, procedures for after-sale support, or whatever is appropriate for your business. We are looking to loan money to those companies who can really put the money to use, and we are less likely to provide funding for the experimental or developmental phases of building your company.

n
Topics: Patent Loans
n

Patent valuation is a difficult subject because there are many different people using many different techniques to come up with a ‘value.’

nnnn

In general, the only meaningful metric of patent value is revenue.

nnnn

Either you are selling a patented product, or an infringer is selling an infringing product.

nnnn

The value of the patent is determined by comparing the patented product against a competing product that does not infringe the patent. If we can tease apart the extra amount of sales that comes from the patented product, then we have the best indicator of the patent value.

nnnn

If there are no sales of the product, the patent does not have realizable value – YET. Once sales are established and we have an apples-to-apples comparison to a non-infringing product, only then can be put a meaningful value on the patent.

nnnn

n
Topics: Patent Loans
n

We provide an insurance policy that will guarantee a lender (typically a bank) using the patents as collateral.

nnnn

The Collateral Protection Insurance product is similar to mortgage insurance, where the bank has protection if there is a default on the loan.

nnnn

The CPI product requires investment-grade patents and a solid business plan.  The patents must be litigation-worthy, but must also capture real economic value.

nnnn

Your patents and your business plan will undergo a due diligence analysis, where the patents will undergo a “patent busting” search, looking for any weaknesses.  Your business plan will also need to show the use of funds and the way you are going to put the money to use.

nnnn

As part of the patent loan program, you will get at least $2,000,000 in patent enforcement and patent defense insurance.  We want you to spend the loan proceeds by growing your company and generating revenue – not by litigating the patents in court.

nnnn


n
Topics: Patent Loans
n

No. The patent loan program does not normally require a personal guarantee.

nnnn

We provide an insurance product that will guarantee a lender in case of a default. However, a lender may still have the final say as to whether or not to require a personal guarantee.

n
Topics: Patent Loans
n

Our goal is *not* to get your patents. Our goal is to help you make the patents more valuable.

nnnn

A patent loan will give you capital, and we want to see that the loan proceeds are being used to make the patents more valuable. Typically, we look for opportunities where the loan goes to marketing and sales – all designed to raise revenue levels for the patented product.

nnnn

When you sell more product that is protected by your patents, your patents (our collateral) has more value.

nnnn

We need to see you succeed.

n
Topics: Patent Loans

Patent Procedure (3261)

The printing of U.S. patent application numbers on a patent depends on how they are submitted and considered by the examiner. The MPEP states:

If a U.S. patent application number is listed on a PTO/SB/08 form or its equivalent and the examiner considers the information and initials the form, the application number will be printed on the patent.

However, applicants should be cautious about disclosing pending application numbers:

Applicants may wish to list U.S. patent application numbers on other than a form PTO/SB/08 format to avoid the application numbers of pending applications being published on the patent.

This guidance allows applicants to control whether pending application numbers are made public through the patent printing process.

To learn more:

No, the USPTO does not return annotated sheets submitted for patent drawing corrections. According to MPEP 608.02(v), “Annotated sheets filed by an applicant and used for correction of the drawing will not be returned.” This policy ensures that the USPTO maintains a complete record of all proposed changes to the patent drawings throughout the examination process.

To learn more:

An MPEP section may be marked as [Reserved] for several reasons:

  • The topic is not currently relevant but a section is being held for potential future use
  • The section was previously used but the content was moved elsewhere in the MPEP
  • The section is a placeholder to maintain a desired numbering scheme

Proper identification of priority applications is crucial for several reasons:

Proper identification of priority applications is essential to establishing accurate and complete relationships among various patent documents, especially in the context of electronic priority document exchange programs

This means that:

  • It ensures accuracy in patent documentation
  • It facilitates complete relationships between related patent documents
  • It is particularly important for electronic priority document exchange programs

Accurate identification helps maintain the integrity of the patent system and ensures that priority claims are properly recognized and processed.

To learn more:

Submitting legible copies of assignment documents to the USPTO is crucial because the quality of the recorded document depends on the quality of the submitted copy. The USPTO does not improve or enhance the quality of submitted documents.

According to MPEP 302.01: If the copy submitted for recordation is illegible, the recorded document will be illegible.

This means that if you submit an illegible copy, the officially recorded document will also be illegible, potentially causing issues with proving ownership or assignment in the future. To avoid such problems, always ensure that you submit clear, high-quality copies of your assignment documents for recordation.

To learn more:

Recording certificates of name change or merger for patents is crucial for maintaining a clear chain of title. According to MPEP 314, these documents serve as important links in the ownership history of a patent.

The MPEP states:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title. Documents of merger are also proper links in the chain of title.

By recording these certificates, you ensure that the USPTO and any interested parties can trace the ownership history of the patent accurately. This is particularly important for legal proceedings, licensing negotiations, or potential patent sales.

To learn more:

Recording business name changes and mergers is crucial for maintaining an accurate chain of title for patents. MPEP 314 emphasizes this importance:

  • For name changes: Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.
  • For mergers: Documents of merger are also proper links in the chain of title.

Recording these changes ensures:

  1. The USPTO has up-to-date information on patent ownership
  2. Third parties can accurately identify the current patent owner
  3. The chain of title remains clear and unbroken, which can be important for future transactions or litigation
  4. Compliance with legal requirements for maintaining patent rights

Including contact information in a power of attorney for patent applications is crucial for several reasons:

  • It facilitates prompt delivery of communications from the USPTO
  • It ensures that the USPTO can easily reach the attorney or agent representing the applicant
  • It helps streamline the patent application process

The MPEP 601.02 emphasizes this point: “The prompt delivery of communications will thereby be facilitated.”

By providing comprehensive contact information, including mailing address, ZIP code, telephone number, and fax number, attorneys and agents can ensure efficient communication throughout the patent examination process.

To learn more:

Describing problems in the prior art in the Background of the Invention is important for several reasons:

  1. It helps establish the context for the invention.
  2. It demonstrates the need for the invention.
  3. It can help show the non-obviousness of the invention.
  4. It provides a basis for explaining the advantages of the invention.

The MPEP specifically mentions this in MPEP 608.01(c): “Where applicable, the problems involved in the prior art or other information disclosed which are solved by the applicant’s invention should be indicated.” This statement underscores the importance of not just describing the prior art, but also highlighting the problems or limitations in the prior art that the invention addresses.

To learn more:

Document legibility is crucial when submitting patent assignments because:

  1. The USPTO does not return recorded documents.
  2. If the submitted copy is illegible, the recorded document will also be illegible.
  3. Illegible documents may cause legal issues or complications in proving ownership.

The MPEP emphasizes this point: “If the copy submitted for recordation is illegible, the recorded document will be illegible. Accordingly, applicants and patent owners should ensure that only a legible copy is submitted for recordation.”

It’s the responsibility of the submitter to ensure that all documents are clear and readable to maintain accurate records of patent ownership.

MPEP 303 highlights the importance of determining who should direct prosecution:

“When the assignment condition of an application is significant, such as… when there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

Determining who should direct prosecution is crucial because:

  • It ensures that the rightful owner or assignee is making decisions about the application
  • It prevents unauthorized individuals from influencing the prosecution process
  • It helps resolve potential disputes over ownership or control of the application
  • It maintains the integrity of the patent examination process

When there’s uncertainty about this, examiners must verify assignment information to ensure proper handling of the application.

The USPTO typically does not send a filing receipt for a Continued Prosecution Application (CPA). This practice is mentioned in MPEP ¶ 2.35, which states:

This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

The reason for this is that a CPA is a continuation of an existing application rather than an entirely new filing. The USPTO communicates the acceptance of the CPA through other means, typically in the first Office action on the CPA. This approach streamlines the process and reduces redundant paperwork.

For more information on USPTO procedures, visit: USPTO procedures.

Why doesn’t the USPTO return original assignment documents after recording?

The USPTO does not return original assignment documents after recording to maintain a permanent, unaltered record and to prevent potential disputes or fraud. According to MPEP 302.01: ‘The USPTO will not return documents filed for recording.’ This policy serves several purposes:

  • Ensures the integrity of the recorded documents
  • Prevents alterations or substitutions after recording
  • Maintains a consistent and reliable archive
  • Reduces administrative burden and potential for loss

By keeping all submitted documents, the USPTO can provide certified copies if needed for legal or business purposes, ensuring a reliable chain of title for patent rights.

The USPTO records documents other than assignments for several important reasons:

  1. Public interest: To provide notification to third parties of equitable interests or other matters relevant to patent ownership.
  2. Transparency: To maintain a clear record of various interests in patents and patent applications.
  3. Legal compliance: To fulfill the requirements of 35 U.S.C. 261 and 37 CFR 3.11.

The MPEP states, “Such documents are recorded in the public interest in order to give third parties notification of equitable interests or other matters relevant to the ownership of a patent or application.” (MPEP 313)

The United States Patent and Trademark Office (USPTO) does not return patent application drawings for several reasons:

  • To maintain a complete and accurate record of all submitted materials
  • To ensure consistency in the application process
  • To avoid potential disputes over the content of submitted drawings

The MPEP Section 608.02(y) clearly states:

Drawings will not be returned to the applicant.

This policy underscores the importance of applicants retaining copies of all materials submitted to the USPTO, including drawings, for their own records and potential future reference.

To learn more:

MPEP 602.07 refers to MPEP § 1893.01(e) because the latter section provides more detailed information about oaths or declarations filed in the United States as a designated office. The full text of MPEP 602.07 states:

See MPEP § 1893.01(e).

This reference indicates that MPEP § 1893.01(e) contains comprehensive guidance on the requirements, procedures, and considerations for oaths or declarations in the context of international applications entering the national phase in the United States. Patent practitioners and examiners should consult this section for specific instructions and requirements related to oaths or declarations in PCT applications designating the USPTO.

To learn more:

The restrictions on USPTO employees regarding patents are in place to prevent conflicts of interest and maintain the integrity of the patent system. These rules, outlined in 35 U.S.C. 4 and MPEP 309, serve several purposes:

  • Prevent employees from using insider knowledge for personal gain
  • Ensure fair and unbiased examination of patent applications
  • Maintain public trust in the patent system
  • Avoid potential conflicts between an employee’s official duties and personal interests

By prohibiting employees from applying for or acquiring patents during their employment and for a period after, the USPTO aims to preserve the objectivity and fairness of the patent examination process.

Sections in the Manual of Patent Examining Procedure (MPEP) are sometimes marked as ‘[Reserved]’ for several reasons:

  • To maintain consistent numbering across editions
  • To allow for future expansion of content
  • To accommodate planned updates or revisions
  • To serve as placeholders for potential new topics or guidance

This practice helps the USPTO maintain flexibility in organizing and updating the MPEP while preserving a logical structure for users.

Claims are considered an important part of a patent application because, as stated in MPEP 608.01(k), “This is an important part of the application, as it is the definition of that for which protection is granted.”

In other words, the claims define the scope of the legal protection provided by the patent. They outline the specific elements and features of the invention that are protected from infringement by others. Well-drafted claims are crucial for:

  • Clearly defining the boundaries of the invention
  • Distinguishing the invention from prior art
  • Providing a basis for patent examiners to assess patentability
  • Determining the extent of legal protection in potential infringement cases

To learn more:

Assignment documents are not placed directly in patent application files to ensure proper recording and maintenance of ownership records. MPEP 318 states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This procedure serves several purposes:

  • It centralizes the recording of ownership information
  • It ensures that assignments are properly recorded and searchable
  • It keeps the main application file focused on technical and procedural aspects of the patent application
  • It allows the Assignment Division to maintain a separate database of patent ownership information

Assignment documents are not placed directly in application or patent files to ensure proper recording and management. According to MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This practice serves several purposes:

  • It ensures that assignments are properly recorded by the specialized Assignment Division.
  • It maintains the integrity and organization of application and patent files.
  • It allows for efficient tracking and retrieval of assignment information.

To learn more:

Amendments to refer to Continued Prosecution Applications (CPAs) as continuation or divisional applications are not allowed because they are unnecessary and can potentially cause confusion. The MPEP ¶ 2.34 explains:

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that the CPA itself already serves as the legally required reference to the prior application. Adding additional references through amendments is redundant and could potentially lead to inconsistencies or misinterpretations in the patent record.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on patent law, visit: patent law.

In patent applications filed before September 16, 2012, the power of attorney can be signed by either the inventor(s) or the assignee of the entire interest. However, the MPEP recommends that the assignee sign the power of attorney when one exists. As stated in the MPEP:

While a power of attorney may be signed by the inventor(s), the power of attorney should be signed by the assignee of the entire interest where one exists. Otherwise, the assignee may be paying the bill, while the inventor is providing the power of attorney, thereby possibly raising an issue as to who is the practitioner’s client.

This recommendation aims to avoid potential conflicts and ensure clear representation in cases where the relationship between the assignee and inventors may deteriorate.

To learn more:

After the USPTO is notified of a patent practitioner’s death, correspondence is sent to two parties:

  1. The office of the deceased practitioner
  2. The person who originally appointed the deceased patent practitioner

This dual notification ensures that both the practitioner’s office and the original appointer are aware of ongoing patent matters and can take appropriate action.

The English translation of a non-English assignment document must be signed by the individual who performed the translation. As stated in MPEP 302.02:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This requirement ensures the accuracy and authenticity of the translation. It’s important to note that the translator’s signature is required, not necessarily the signature of the parties involved in the assignment.

To learn more:

The signing requirements for a supplemental oath or declaration depend on the nature of the correction being made. According to MPEP 603:

37 CFR 1.67(b) provides that a supplemental inventor’s oath or declaration under 37 CFR 1.67 must be executed by the person whose inventor’s oath or declaration is being withdrawn, replaced, or otherwise corrected.

For applications filed before September 16, 2012, the MPEP provides more detailed guidance:

  • If the correction relates to all inventors or applicants, all must sign.
  • If the correction relates to only certain inventors or applicants, only those to whom the correction relates need to sign.

In cases where an inventor is unable or unwilling to sign, the requirement for that inventor to sign the supplemental declaration may be suspended or waived in accordance with 37 CFR 1.183. In such cases, joint inventors or parties with sufficient proprietary interest may sign on behalf of the non-signing inventor.

To learn more:

Tags: declaration

The responsibilities for preparing and reviewing the patent abstract are divided as follows:

  • Preparation: The applicant is responsible for preparing the abstract.
  • Review: The examiner is responsible for reviewing the abstract for compliance with the guidelines.

The MPEP states: Preparation of the abstract is the responsibility of the applicant. Background knowledge of the art and an appreciation of the applicant’s contribution to the art are most important in the preparation of the abstract. The review of the abstract for compliance with these guidelines is the responsibility of the examiner.

If amendments are necessary, they can be made either by the applicant or by the examiner with the applicant’s approval, especially at the time of allowance or in response to a printer query.

To learn more:

According to MPEP 608.01(k), the responsibility for pointing out and distinctly claiming the invention lies with “the inventor or joint inventor.” The section states that the specification “shall particularly point out and distinctly claim the subject matter which the inventor or joint inventor regards as his or her invention.”

While patent attorneys or agents often assist in drafting claims, it is ultimately the inventor’s responsibility to ensure that the claims accurately reflect their invention. The inventor should work closely with their legal representative to ensure that the claims:

  • Accurately describe the invention
  • Cover all aspects of the invention they wish to protect
  • Meet the statutory requirements for clarity and distinctness

To learn more:

The responsibility for filing the notice of arbitration award with the USPTO is primarily assigned to the patent owner or their representatives, but there are provisions for other parties to file if necessary. According to 35 U.S.C. 294(d) and 37 CFR 1.335:

  • The patentee, assignee, or licensee is primarily responsible for filing the notice.
  • If the required notice is not filed by the designated party, any party to the arbitration proceeding may file the notice.

35 U.S.C. 294(d) states: “When an award is made by an arbitrator, the patentee, his assignee or licensee shall give notice thereof in writing to the Director.”

This flexibility ensures that the USPTO is informed of arbitration outcomes, even if the primary responsible party fails to file the notice.

Both practitioners and non-practitioners are responsible for ensuring compliance with USPTO signature and certification requirements when filing papers. According to 37 CFR 11.18(b):

“By presenting to the Office or hearing officer in a disciplinary proceeding (whether by signing, filing, submitting, or later advocating) any paper, the party presenting such paper, whether a practitioner or non-practitioner, is certifying that—”

This means that anyone submitting papers to the USPTO, including independent inventors, corporate representatives, and patent attorneys, is responsible for ensuring that the submissions meet the signature and certification requirements. Practitioners have additional responsibilities and may face disciplinary action for violations as specified in 37 CFR 11.18(d).

To learn more:

The presumption of ownership for patent applications depends on the filing date. According to MPEP 301:

‘For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of the application for an original patent. For applications filed before September 16, 2012, the ownership of the patent (or the application for the patent) initially vests in the named inventors of the invention of the patent.’

This change in presumption reflects updates to U.S. patent law under the America Invents Act. It’s important for applicants and inventors to be aware of this presumption, as it can affect various aspects of patent prosecution and ownership rights.

According to MPEP 203.08, information about a patent application’s status can be provided to:

  • The applicant
  • The applicant’s assignee
  • The attorney or agent of record
  • Anyone with written authority from one of the above

The MPEP states: “Status information which may be given includes information as to whether the application has been filed, whether the application is awaiting action by the examiner, as well as other matters which do not involve the disclosure of confidential information.”

It’s important to note that the USPTO is prohibited from disclosing certain information to unauthorized parties, such as the date of filing, names of inventors, or specific details about the prosecution of the application.

To learn more:

According to MPEP 151, the term ‘applicant’ in the context of Atomic Energy Act and NASA Act statements is interpreted as follows:

“The word ‘applicant’ in both of these statutes is construed by the Office to mean the inventor or joint inventors in person, or an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter.”

This means that the statements must typically be signed by the actual inventor(s), assignee, or someone with a significant proprietary interest in the invention. The USPTO considers these individuals to be the most knowledgeable about the circumstances surrounding the invention’s creation.

For more information on applicant definition, visit: applicant definition.

For unpublished patent applications that are pending or abandoned, the following individuals are authorized to receive status information:

  1. The applicant
  2. A patent practitioner of record
  3. The assignee or an assignee of an undivided part interest
  4. The inventor or a joint inventor
  5. A registered attorney or agent named in the application papers filed under 37 CFR 1.53 or the national stage documents filed under 37 CFR 1.495, if a power of attorney has not been appointed under 37 CFR 1.32

Additionally, anyone with written authority granting access from one of the above individuals is also entitled to status information.

During interference or derivation proceedings, power of attorney changes are handled by a specific entity within the USPTO. According to MPEP 402.08:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

This means that the Patent Trial and Appeal Board (PTAB) is responsible for considering and processing any changes to power of attorney during these special proceedings. This differs from the normal procedure for regular patent applications, where such changes would typically be handled by the Office of Patent Application Processing or the examining corps.

To learn more:

According to 37 CFR 3.71(b), the assignees who may conduct prosecution of a patent application as the applicant are:

  1. A single assignee who is the assignee of the entire right, title and interest in the application or patent, or
  2. All partial assignees, or all partial assignees and inventors who have not assigned their rights, who together own the entire right, title and interest in the application or patent.

The MPEP states: “As the applicant, the owner or assignee that is not a juristic entity can sign a reply to an Office action (37 CFR 1.33(b)(3)), a request for a continued prosecution application under 37 CFR 1.53(d) (MPEP § 201.06(d)), a disclaimer under 37 CFR 1.321 (MPEP § 1490), Fee(s) Transmittal (PTOL-85B) (MPEP § 1306), or a request for status of an application (MPEP § 102).”

For an assignee organization (e.g., corporation, partnership, university), the submission establishing ownership can be signed by:

  1. A person with apparent authority to sign on behalf of the organization, such as an officer (e.g., CEO, president, vice-president, secretary, treasurer). The MPEP states: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization.”
  2. Any person, if the submission states that the person is authorized to act on behalf of the assignee.
  3. A person empowered by an organizational resolution, if a copy of the resolution is submitted.

If the signer does not fall into one of these categories, evidence of their authority to sign may be required. This is outlined in MPEP 324, section V.

According to the MPEP, the 37 CFR 3.73(c) statement establishing assignee ownership can be signed by:

  1. A person in the organization having apparent authority to sign on behalf of the organization (e.g., an officer)
  2. Any person, if the statement sets forth that the person is authorized to act on behalf of the assignee
  3. A patent practitioner of record
  4. A person empowered by an organizational resolution to sign on behalf of the assignee, if a copy of the resolution is submitted

The MPEP clarifies: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization. The signature of the chairman of the board of directors is acceptable, but not the signature of an individual director.”

When there’s no attorney of record, the signatories for patent application papers depend on the filing date and the applicant type. For applications filed before September 16, 2012, MPEP § 407 states: “All papers filed in the application must be signed: (1) by all named applicants unless one named applicant has been given a power of attorney to sign on behalf of the remaining applicants, and the power of attorney is of record in the application; or (2) if there is an assignee of record of an undivided part interest, by all named applicants retaining an interest and such assignee; or (3) if there is an assignee of the entire interest, by such assignee; or (4) by a registered patent attorney or agent not of record who acts in a representative capacity under the provisions of 37 CFR 1.34.”

For applications filed on or after September 16, 2012: “All papers must be signed by: (1) a patent practitioner of record; (2) a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34; or (3) the applicant, except that papers submitted on behalf of a juristic entity applicant must be signed by a patent practitioner.”

When an attorney is suspended, the signing authority for papers in a patent application depends on the filing date:

For applications filed before September 16, 2012:

  • All named applicants
  • Assignee of record of an undivided part interest, along with named applicants retaining an interest
  • Assignee of the entire interest
  • A registered patent attorney or agent not of record acting under 37 CFR 1.34

For applications filed on or after September 16, 2012:

  • A patent practitioner of record
  • A patent practitioner not of record acting under 37 CFR 1.34
  • The applicant (except for juristic entity applicants, which require a patent practitioner)

This information is provided in Form Paragraph 4.07 of MPEP § 407.

When an assignee is an organization (e.g., corporation, partnership, university), specific individuals are authorized to sign documents on its behalf. According to MPEP 325, the following persons can sign submissions under 37 CFR 3.73(c):

  1. A person with apparent authority to sign on behalf of the organization. This typically includes officers such as the CEO, president, vice-president, secretary, or treasurer.
  2. Any person, if the submission clearly indicates that the person is authorized to act on behalf of the assignee.
  3. A patent practitioner of record.
  4. A person empowered by an organizational resolution, if a copy of the resolution is submitted.

The MPEP states: “An officer (chief executive officer, president, vice-president, secretary, or treasurer) is presumed to have authority to sign on behalf of the organization. The signature of the chairman of the board of directors is acceptable, but not the signature of an individual director.”

It’s important to note that for juristic entities, many actions in patent matters must be signed by a registered patent practitioner after September 16, 2012.

For more information on corporate officers, visit: corporate officers.

For more information on patent documents, visit: patent documents.

For applications filed on or after September 16, 2012, the following parties can sign a written assertion of small entity status:

  • The applicant
  • A patent practitioner of record or acting in a representative capacity
  • The inventor or a joint inventor, if the inventor is the applicant
  • The assignee

According to 37 CFR 1.27(c)(2): “The written assertion can be signed by: (i) The applicant (§ 1.42 or § 1.421); (ii) A patent practitioner of record or a practitioner acting in a representative capacity under § 1.34; (iii) The inventor or a joint inventor, if the inventor is the applicant; or (iv) The assignee.”

To learn more:

Who can sign a substitute statement for a deceased or incapacitated inventor?

In cases where an inventor is deceased or legally incapacitated, specific parties are authorized to sign a substitute statement. According to MPEP 409.01(a):

“A substitute statement under 37 CFR 1.64 may be signed by the applicant or an assignee of the entire interest on behalf of a deceased or legally incapacitated inventor.”

The following parties can sign a substitute statement:

  • The applicant (if different from the inventor)
  • An assignee of the entire interest
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

It’s important to note that the person signing the substitute statement must have the legal authority to act on behalf of the deceased or incapacitated inventor. This ensures that the patent application can proceed even when the original inventor is unable to participate in the process.

To learn more:

For pre-AIA patent applications (filed before September 16, 2012), the submission establishing ownership must be signed by a party authorized to act on behalf of the assignee. According to MPEP 324, this can be done in several ways:

  • A person with apparent authority in the organization, such as an officer (e.g., CEO, president, vice-president, secretary, or treasurer).
  • Any person, if the submission clearly states that the person is authorized to act on behalf of the assignee.
  • A person empowered by an organizational resolution, if a copy of the resolution is submitted.

The MPEP notes: Where a submission does not comply with (A), (B), or (C) above, evidence of the person’s authority to sign will be required. It’s important to ensure that the proper authority is established to avoid delays in patent prosecution.

For more information on assignee rights, visit: assignee rights.

For more information on authorized signatories, visit: authorized signatories.

For more information on pre-AIA applications, visit: pre-AIA applications.

According to MPEP 509.04(c), a certification of micro entity status can be signed only by an authorized party as set forth in 37 CFR 1.33(b), which includes:

  • A patent practitioner of record
  • A patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34
  • The applicant (37 CFR 1.42)

It’s important to note that “Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.”

To learn more:

Title reports are internal documents used by the USPTO and are not available for direct request by external parties. The MPEP explicitly states:

Title reports may not be ordered by applicants or attorneys.

These reports are typically requested by internal USPTO staff, such as the Reexamination Preprocessing Staff, when needed for specific procedures.

According to MPEP 402.09, applicants in international patent applications can be represented by:

  • Attorneys or agents registered to practice before the USPTO
  • An applicant appointed as a common representative
  • An attorney or agent with the right to practice before the national office where the international application is filed (for specific authorities)

As stated in 37 CFR 1.455(a): Applicants of international applications may be represented by attorneys or agents registered to practice before the United States Patent and Trademark Office or by an applicant appointed as a common representative (PCT Art. 49, Rules 4.8 and 90 and § 11.9).

To learn more:

According to MPEP 325, one or more assignees can conduct prosecution of a national patent application as the applicant. Specifically, 37 CFR 3.71(b) states that:

“The assignee(s) who may conduct either the prosecution of a national application for patent as the applicant under § 1.46 of this title or a supplemental examination or reexamination proceeding are:

  • (1) A single assignee. An assignee of the entire right, title and interest in the application or patent, or
  • (2) Partial assignee(s) together or with inventor(s). All partial assignees, or all partial assignees and inventors who have not assigned their right, title and interest in the application or patent, who together own the entire right, title and interest in the application or patent.”

This means that either a single assignee with full ownership, or all partial assignees and remaining inventors collectively, can prosecute the application as the applicant.

For more information on prosecution, visit: prosecution.

Tags: prosecution

According to MPEP 106.01, only the assignee of record of the entire interest in a patent application can intervene in its prosecution. The MPEP states:

While it is only the assignee of record of the entire interest who can intervene in the prosecution of an application or interference to the exclusion of the applicant […]

This means that partial assignees, licensees of exclusive rights, or other parties with limited interests cannot intervene in the prosecution process or exclude the original applicant. The right to intervene is reserved exclusively for the assignee who has been recorded as having the entire interest in the application.

For applications filed on or after September 16, 2012, the assignee of the entire interest can also become the applicant under 37 CFR 1.46 and prosecute the application directly.

To learn more:

According to MPEP 104, access to inspect a patent application can be granted by specific individuals or entities. For applications filed on or after September 16, 2012, the following parties can provide written authority for access:

  • The applicant
  • A patent practitioner of record
  • The assignee or an assignee of an undivided part interest
  • The inventor or a joint inventor

The MPEP states: “The written authority must be signed by: (1) The applicant; (2) A patent practitioner of record; (3) The assignee or an assignee of an undivided part interest; (4) The inventor or a joint inventor; or (5) A registered attorney or agent named in the papers accompanying the application papers filed under §1.53 or the national stage documents filed under §1.495, if a power of attorney has not been appointed under § 1.32.”

For more information on application access, visit: application access.

For more information on power to inspect, visit: power to inspect.

For more information on written authority, visit: written authority.

According to 35 U.S.C. 118, the following parties can file a patent application:

  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who shows sufficient proprietary interest in the matter, acting as an agent for the inventor

The law states: A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.

According to MPEP 409.01(a), several parties can file a patent application on behalf of a deceased or legally incapacitated inventor:

  • Legal representative: If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent on behalf of the inventor.
  • Assignee or obligated assignee: Under 37 CFR 1.46, a person to whom the inventor assigned (‘assignee’), to whom the inventor was under an obligation to assign (‘obligated assignee’), or a person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of the deceased or legally incapacitated inventor.
  • Administrator or executor: These parties can also file an application, but may need to obtain new letters of administration if they have been discharged from their duties.

It’s important to note that proof of authority is not required by the USPTO, but any person acting as a legal representative should ensure they are properly authorized to do so.

To learn more:

For applications filed on or after September 16, 2012, the following parties may file a patent application as the applicant:

  • The inventor(s)
  • An assignee to whom the inventor has assigned the invention
  • An obligated assignee to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

As stated in 37 CFR 1.46(a): “A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.”

According to 37 CFR 1.46(a), the following parties can file a patent application as the applicant:

  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

The regulation states: A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent. A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.

To learn more:

Several parties may execute a substitute statement under specific circumstances:

  • The inventor’s legal representative under 37 CFR 1.43, if the inventor is deceased or legally incapacitated
  • Other joint inventors under 37 CFR 1.45, if the inventor refuses to execute the oath or declaration or cannot be found
  • An applicant under 37 CFR 1.46 who is the assignee or party to whom the inventor is obligated to assign
  • An applicant under 37 CFR 1.46 who shows sufficient proprietary interest in the invention

It’s important to note that “All parties having any portion of the ownership in the patent must act together as a composite entity in patent matters before the Office.

To learn more:

The correspondence address in a patent application can be changed by specific parties as outlined in 37 CFR 1.33(a):

  • A patent practitioner of record (37 CFR 1.33(b)(1))
  • The applicant (37 CFR 1.33(b)(3))
  • Prior to the appointment of any power of attorney, any patent practitioner named in the application transmittal papers who acts in a representative capacity under 37 CFR 1.34

It’s important to note that after a power of attorney has been appointed, a practitioner acting in a representative capacity cannot change the correspondence address until after the patent has issued, and only with proper notice to the patentee or owner.

To learn more:

Limited recognition for patent matters can be granted to two main categories of individuals:

  1. Non-registered individuals: As per 37 CFR 11.9(a), individuals not registered under § 11.6 may be granted limited recognition under certain circumstances.
  2. Nonimmigrant aliens: According to 37 CFR 11.9(b):

    A nonimmigrant alien residing in the United States and fulfilling the provisions of paragraphs (d) and (e) of this section may be granted limited recognition if the nonimmigrant alien is authorized by the United States Government to be employed or trained in the United States in the capacity of representing a patent applicant by presenting or prosecuting a patent application.

It’s important to note that limited recognition is granted on a case-by-case basis and is subject to specific restrictions and conditions.

To learn more:

According to 37 CFR 1.42, the term ‘applicant’ can refer to:

  • The inventor or all joint inventors
  • A legal representative of a deceased or legally incapacitated inventor
  • The assignee
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who otherwise shows sufficient proprietary interest in the matter

The MPEP states: If a person is applying for a patent as provided in 37 CFR 1.46, the word ‘applicant’ refers to the assignee, the person to whom the inventor is under an obligation to assign, or the person who otherwise shows sufficient proprietary interest in the matter, who is applying for the patent under 37 CFR 1.46 and not the inventor.

To learn more:

Under pre-AIA 37 CFR 1.47(b), the term ‘person’ is broadly interpreted. The MPEP states that “The word ‘person’ has been construed by the U.S. Patent and Trademark Office to include juristic entities, such as a corporation.” This means that both individuals and legal entities can potentially file an application under this provision, provided they meet the other requirements.

To learn more:

Tags: pre-AIA

As of September 16, 2012, the rules for who can be an applicant for a patent application were revised. According to MPEP § 605, the following individuals or entities can file and prosecute a patent application as the applicant:

  • The inventor
  • A person to whom the inventor has assigned the invention
  • A person to whom the inventor is under an obligation to assign the invention
  • A person who shows sufficient proprietary interest in the matter

The MPEP states: “Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign an invention to file and prosecute an application for patent as the applicant, and to permit a person who otherwise shows sufficient proprietary interest in the matter to file and prosecute an application for patent as the applicant on behalf of the inventor.”

This change allows for greater flexibility in who can be considered the applicant, potentially streamlining the patent application process for businesses and organizations.

To learn more:

For applications filed on or after September 16, 2012, a power of attorney must be signed by the applicant for patent (i.e., all parties identified as the applicant as defined by 37 CFR 1.42(a)) or the patent owner. For applications filed before September 16, 2012, a power of attorney can be signed by the applicant or the assignee of the entire interest of the applicant.

As stated in MPEP 402.02(a): “For applications filed on or after September 16, 2012, 37 CFR 1.32(b)(4) sets forth that a power of attorney must be signed by the applicant for patent (i.e., all parties identified as the applicant as defined by 37 CFR 1.42(a)) or the patent owner (for reissue applications, reexamination proceedings and supplemental examination proceedings).”

According to the MPEP, an examiner can contact the patent practitioner of record in the application for interviews. The MPEP states:

When the examiner believes the progress of the application would be advanced by an interview, the examiner may contact the patent practitioner of record in the application (in accordance with MPEP § 713) and suggest a telephonic, personal, or video conference interview.

It’s important to note that registered attorneys or agents not of record should not be contacted for certain actions, such as restriction requirements or approval of examiner’s amendments.

For patent applications filed before September 16, 2012, the oath or declaration can be administered by various authorized individuals, depending on the location. According to pre-AIA 35 U.S.C. 115:

  • Within the United States: Any person authorized by law to administer oaths
  • In a foreign country:
    • A diplomatic or consular officer of the United States authorized to administer oaths
    • An officer having an official seal and authorized to administer oaths in the foreign country, whose authority is proved by a certificate of a U.S. diplomatic or consular officer
    • An official designated by a foreign country that, by treaty or convention, accords like effect to apostilles of designated officials in the United States

The law states: Such oath is valid if it complies with the laws of the state or country where made. This provision ensures flexibility in oath administration while maintaining legal validity across different jurisdictions.

To learn more:

According to MPEP 602, “An oath or affirmation may be made before any person within the United States authorized by law to administer oaths.” This typically includes notaries public, judges, and certain government officials. It’s important to note that the authority of the person administering the oath may be subject to verification, and in some cases, proof of authority may be required.

To learn more:

Tags: oath

The USPTO has designated specific offices to handle inquiries from high-level government sources. According to MPEP 203.08(a):

  • Office of Policy and International Affairs: Handles inquiries from embassies, the Office of the U.S. Trade Representative, and the Department of State.
  • Office of Governmental Affairs: Manages inquiries from Congress and the White House.

These offices are responsible for ensuring that such high-level inquiries are handled appropriately and consistently.

To learn more:

Tags: USPTO

The MPEP ¶ 2.11 mentions several U.S. Code sections relevant to claiming the benefit of an earlier filing date:

This application is claiming the benefit of prior-filed application No.[1] under 35 U.S.C. 120, 121, 365(c), or 386(c).

These sections cover different scenarios:

  • 35 U.S.C. 120: Benefit of earlier filing date in the United States
  • 35 U.S.C. 121: Divisional applications
  • 35 U.S.C. 365(c): Benefit of earlier filing date; national application
  • 35 U.S.C. 386(c): Benefit of earlier filing date; international design application

Each of these sections provides specific conditions under which an application can claim the benefit of an earlier filing date.

For more information on earlier filing date, visit: earlier filing date.

For more information on patent law, visit: patent law.

The MPEP provides a table of states (countries) for which the right of priority under 35 U.S.C. 119(a)-(d) is recognized. These countries fall into three categories:

  • Parties to the Patent Cooperation Treaty (PCT)
  • Parties to the Paris Convention for the Protection of Industrial Property
  • Members of the World Trade Organization (WTO)

The MPEP states: “Following is a table of states, i.e., countries, with respect to which the right of priority referred to in 35 U.S.C. 119(a)-(d) has been recognized.”

For the most current list of recognized countries, refer to the WIPO website at www.wipo.int/pct/en/paris_wto_pct.html.

The United States recognizes the right of priority for patent applications filed in countries that are:

  • Parties to the Patent Cooperation Treaty (PCT)
  • Members of the Paris Convention for the Protection of Industrial Property
  • Members of the World Trade Organization (WTO)

The MPEP states: Following is a table of states, i.e., countries, with respect to which the right of priority referred to in 35 U.S.C. 119(a) – (d) has been recognized. For the most up-to-date list of recognized countries, refer to the WIPO website.

To learn more:

According to MPEP 606, the placement of the title of invention in a patent application is as follows:

“The title of the invention should be placed at the top of the first page of the specification unless it is provided in the application data sheet (see 37 CFR 1.76).”

This means you have two options for placing the title:

  • At the top of the first page of the specification
  • In the application data sheet

It’s important to note that if you include the title in the application data sheet, you don’t need to repeat it on the first page of the specification.

To learn more:

The placement of the government license rights statement in a patent application depends on whether there are references to related applications:

  • If there are references to related applications in the first sentence(s) of the specification following the title, the government license rights statement should appear as the second paragraph of the specification.
  • If there are no references to related applications, the government license rights statement should appear as the first paragraph of the specification.

This placement is specified in 37 CFR 1.77(b)(1)-(3).

For a non-English provisional application, the English translation and accuracy statement must be filed in the provisional application itself, not in the non-provisional application claiming its benefit. MPEP ¶ 2.38 clearly states:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[…]”

Additionally, in the non-provisional application claiming benefit, you must provide confirmation that these documents were filed in the provisional application. This two-step process ensures proper documentation and compliance with 37 CFR 1.78.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The location of the benefit claim reference depends on the filing date of the application:

  • For applications filed before September 16, 2012: The reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS).
  • For applications filed on or after September 16, 2012: The specific reference must be included in an application data sheet (ADS).

The MPEP states: “If the application was filed before September 16, 2012, the reference must be included in the first sentence(s) of the specification following the title or in an application data sheet; if the application was filed on or after September 16, 2012, the specific reference must be included in an application data sheet.”

It’s important to note that for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must also include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on application data sheet, visit: application data sheet.

For more information on divisional, visit: divisional.

When submitting assignment documents along with new patent applications, the mailing address is different from the general assignment recordation address. According to MPEP 302.08:

Requests for recording documents which accompany new applications should be addressed to the Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.

This ensures that your assignment documents are properly associated with the new patent application and processed accordingly by the USPTO.

To learn more:

According to the MPEP, a petition to restore the benefit of a provisional application should be addressed to:

“Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.”

It’s important to note that this petition must be filed in the subsequent nonprovisional application or international application designating the United States, not in the provisional application itself. Always ensure you’re following the most current USPTO guidelines for petition submissions, as procedures may be updated over time.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

The location for filing your petition to restore the right of priority depends on the type of application you have. The MPEP provides guidance:

The petition to restore the right of priority must be filed in the subsequent application, or in the earliest nonprovisional application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the subsequent application, if such subsequent application is not a nonprovisional application.

Additionally, the MPEP specifies the mailing address for such petitions:

The petition should be addressed to: Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.

Ensure you file the petition in the correct application and send it to the appropriate address to avoid processing delays.

For more information on mailing address, visit: mailing address.

For more information on priority restoration, visit: priority restoration.

The English translation of a non-English provisional application must be filed in the provisional application itself, not in the non-provisional application claiming benefit. According to MPEP ¶ 2.38:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3].”

Additionally, you must confirm in your current application that the translation and statement were filed in the provisional application.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

MPEP 318 provides clear guidance on where assignment documents should be forwarded for recording. According to the manual:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This means that when submitting assignment documents, they should be sent to the USPTO’s Assignment Division, which is responsible for recording and maintaining records of patent ownership changes.

The recommended presentation of foreign application numbers can be found in the WIPO Handbook on Industrial Property Information and Documentation. The MPEP provides specific guidance:

A complete updated list of the recommended presentation of a foreign application number based on the numbering system used by the foreign intellectual property office is maintained by the WIPO and can be found in the online WIPO Handbook on Industrial Property Information and Documentation

To access this information:

  • Visit the WIPO website (www.wipo.int/standards/en/)
  • Navigate to Part 7: Examples and Industrial Property Offices Practices
  • Refer to Part 7.2.1: Presentation of Application Numbers

Additionally, the MPEP mentions a survey of current practices: www.wipo.int/export/sites/www/standards/en/pdf_/07-02-06.pdf

To learn more:

For more detailed information about the required cover sheet for patent assignments, you can refer to MPEP 302.07. This is explicitly mentioned in MPEP 302.05, which states:

See MPEP § 302.07.

MPEP 302.07 provides comprehensive guidance on the cover sheet requirements, including the necessary information to be included, such as the assignee’s address. Additionally, you can find forms and instructions for recording assignments on the USPTO’s Assignment Recordation Branch website.

To learn more:

To learn more:

The USPTO provides additional information about the Priority Document Exchange (PDX) program on its official website. According to the MPEP:

The Office website provides additional information concerning the priority document exchange program (www.uspto.gov/patents/basics/international-protection/electronic-priority-document-exchange-pdx).

This website includes important details such as:

  • A list of intellectual property offices participating in the PDX program
  • Information necessary for each participating foreign intellectual property office to provide the USPTO with access to foreign applications

Applicants and practitioners are encouraged to visit this resource for the most up-to-date information on the PDX program and its participants.

For those needing information about the former procedures, the MPEP provides guidance: For more information pertaining to practice and procedure under former 37 CFR 1.60, see MPEP § 201.06(a) in the MPEP 8th Edition, Rev. 1 (February 2003)(available on the USPTO website at www.uspto.gov/web/offices/pac/mpep/mpep.htm). This archived version of the MPEP contains the detailed procedures that were in place before the regulation was deleted.

To learn more:

To learn more:

For those interested in the historical procedures under former 37 CFR 1.60, the MPEP provides guidance: For more information pertaining to practice and procedure under former 37 CFR 1.60, see MPEP § 201.06(a) in the MPEP 8th Edition, Rev. 1 (February 2003)(available on the USPTO website at www.uspto.gov/web/offices/pac/mpep/mpep.htm). This archived version of the MPEP contains detailed information about the procedures that were in place before the rule change, which may be useful for historical reference or for understanding the processing of applications filed before December 1, 1997.

For patent applications filed before September 16, 2012, specific guidance on power of attorney can be found in the Manual of Patent Examining Procedure (MPEP). According to MPEP 601.02:

“See MPEP § 402.02(b) for detailed information and relevant forms pertaining to appointment of a power of attorney in applications filed before September 16, 2012.”

To access detailed information and relevant forms for older patent applications, you should refer to MPEP § 402.02(b). This section provides comprehensive guidance on the process and required documentation for appointing a power of attorney in patent applications filed before the September 16, 2012 cutoff date.

To learn more:

For comprehensive information about reissue applications, you should refer to MPEP Chapter 1400. As mentioned in MPEP 201.05, “A detailed treatment of reissue applications can be found in MPEP Chapter 1400.” This chapter provides in-depth coverage of various aspects of reissue applications, including:

  • Eligibility requirements for filing a reissue application
  • Types of defects that can be corrected
  • Procedures for filing and prosecuting a reissue application
  • Examination guidelines for reissue applications
  • Special considerations for broadening reissues

By consulting MPEP Chapter 1400, patent attorneys, examiners, and inventors can gain a thorough understanding of the reissue application process and its requirements.

To learn more:

For additional information on restrictions applicable to USPTO employees, you can refer to MPEP § 1701. The MPEP section on restrictions upon employees of the U.S. Patent and Trademark Office states:

See MPEP § 1701 for additional restrictions on Office employees.

MPEP § 1701 provides more detailed guidance on various ethical considerations and restrictions for USPTO employees, including conflicts of interest, outside employment, and post-employment restrictions. This section is an important resource for understanding the full scope of rules and regulations that apply to USPTO employees and former employees.

For more information on USPTO employees, visit: USPTO employees.

For those seeking more detailed information on benefit claims under 35 U.S.C. 386(c), the Manual of Patent Examining Procedure (MPEP) provides a specific reference. According to MPEP § 211.01(d):

See MPEP § 2920.05(e) for additional information pertaining to benefit claims under 35 U.S.C. 386(c).

This section of the MPEP offers comprehensive guidance on the intricacies of claiming benefit to international design applications, including procedural requirements and practical considerations for patent applicants and examiners.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on benefit claims, visit: benefit claims.

Small entity status should only be claimed after a thorough investigation has been completed and there is certainty about the entitlement. The MPEP 509.03(a) states: “Where entitlement to small entity status is uncertain, it should not be claimed.” It’s important to note that even paying the small entity basic filing fee constitutes an assertion of small entity status. Therefore, applicants should be certain of their status before making any payments or claims related to small entity status.

To learn more:

Tags: patent fees

According to MPEP 150, property rights statements to DOE or NASA can be filed at any time, but they should be kept up-to-date to reflect accurate property rights at the time of application allowance. The MPEP states:

Property rights statements to DOE or NASA may be filed at any time but should be updated if necessary to accurately reflect property rights at the time the application is allowed.

Additionally, the USPTO typically sends an informal request for a property rights statement shortly after filing to applicants whose nonprovisional applications are marked as being of interest to DOE or NASA. While there’s no formal time period set, a response within 45 days is recommended to expedite processing.

For more information on filing deadlines, visit: filing deadlines.

For more information on patent applications, visit: patent applications.

Generally, prior art figures are discouraged in patent applications. As stated in MPEP 608.02(g), Figures showing the prior art are usually unnecessary and should be canceled. This principle is based on the decision in Ex parte Elliott, 1904 C.D. 103, 109 OG 1337 (Comm’r Pat. 1904).

However, there are exceptions to this rule. The MPEP states that prior art figures may be retained where needed to understand applicant’s invention. In such cases, these figures must be clearly labeled as prior art.

To learn more:

For amended patent applications, it’s important to understand the expected timelines and when it’s appropriate to make a status inquiry:

  • Examiners are expected to act on amended applications within two months of receiving them.
  • A status inquiry is generally not necessary until 5-6 months have passed without a response from the USPTO.
  • If six months elapse without a response, you should inquire to avoid potential abandonment.

The MPEP advises: Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office. (MPEP 203.08)

It further states: However, in the event that a six month period has elapsed, and no response from the Office is received, applicant should inquire as to the status of the application to avoid potential abandonment.

For making inquiries, the MPEP recommends: Applicants are encouraged to use Patent Center or Private PAIR to make status inquiries.

To learn more:

You should file a 37 CFR 1.48 request to correct inventorship in a Continued Prosecution Application (CPA) as soon as you realize there’s a need to add or remove an inventor. This should be done concurrently with or shortly after filing the CPA.

The MPEP ¶ 2.33 indicates:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48.

It’s important to file this request promptly to ensure that the correct inventorship is recorded for your application. Failure to do so may result in the inventorship remaining the same as in the prior application, which could potentially affect the validity of your patent if granted.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

You should file a 37 CFR 1.48 request for a Continued Prosecution Application (CPA) whenever you need to add, remove, or change the order of inventors from the original application.

The MPEP ¶ 2.33 indicates: Any request to add an inventor must be in the form of a request under 37 CFR 1.48. This applies even if you’ve identified the new inventor in the CPA filing documents.

It’s best to file the 37 CFR 1.48 request as soon as you realize there’s a need to correct the inventorship. This ensures that the correct inventors are associated with the application throughout the examination process.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Form Paragraph 2.35 should be used in specific circumstances during the patent examination process. According to the MPEP ¶ 2.35, this form paragraph is to be used:

in the first Office action of a CPA to advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request and the CPA is acceptable and that a CPA has been established.

However, it’s important to note that this form paragraph should not be used in all situations. Specifically:

  • It should only be used for design applications, as CPAs are only available for design applications.
  • If the request for a CPA in a utility or plant application is improper and has been treated as an RCE (Request for Continued Examination), examiners should use form paragraph 7.42.15 instead.

Examiners should refer to MPEP § 706.07(h) for more information on handling improper CPA requests in utility or plant applications.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent examination, visit: patent examination.

For assignee applicants or persons to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership should be recorded as follows:

  • As provided for in part 3 of Chapter 37 CFR
  • No later than the date the issue fee is paid in the application

According to 37 CFR 1.46(b)(1): If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

According to 37 CFR 1.46(b)(1), documentary evidence of ownership should be recorded as follows:

“If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.”

In other words, if you’re filing as an assignee or obligated assignee, you should record your documentary evidence of ownership (such as an assignment or employment agreement) with the USPTO no later than when you pay the issue fee for your patent application.

For more information on documentary evidence, visit: documentary evidence.

An inventor might consider filing a continuation application in several scenarios. The MPEP 201.07 provides guidance on timing:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

Common reasons for filing a continuation include:

  • To pursue broader or different claims based on the same disclosure
  • To address issues raised in the prosecution of the parent application
  • To keep the application pending while exploring commercial opportunities
  • To submit new evidence or arguments in support of patentability

It’s important to note that the continuation must be filed before the parent application is patented, abandoned, or otherwise terminated.

For more information on patent strategy, visit: patent strategy.

For more information on USPTO, visit: USPTO.

An Information Disclosure Statement (IDS) should be filed at different stages of patent application processing, depending on the circumstances:

  • Within three months of the filing date or before the first Office action on the merits, whichever is later
  • Before the mailing of a final Office action, Notice of Allowance, or an Ex parte Quayle action
  • After the above periods but before payment of the issue fee
  • After payment of the issue fee (with limitations)

The specific requirements and fees for filing an IDS vary depending on when it is submitted. As stated in MPEP 609.04(b): The procedures and requirements under 37 CFR 1.97 for submitting an information disclosure statement are linked to four stages in the processing of a patent application.

To learn more:

Patent examiners should use MPEP ¶ 2.06 when they encounter an application that appears to qualify as a continuation-in-part (CIP) but lacks a proper benefit claim. The paragraph itself provides guidance:

This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Examiners use this paragraph to notify applicants that their application might be eligible for CIP status and to direct them to the proper procedures for claiming the benefit of the prior application’s filing date if desired.

For more information on patent examination, visit: patent examination.

Patent examiners should use the MPEP ¶ 2.01 form paragraph under specific circumstances. The MPEP provides the following guidance:

Examiner Note: […] 2. This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.

This means examiners should use this paragraph when:

  • The application appears to contain subject matter that is independent and distinct from a prior application
  • The application seems to qualify as a divisional
  • The applicant has not yet properly claimed the benefit of the prior application’s filing date

The form paragraph serves as a prompt for the applicant to properly establish the benefit claim if they intend the application to be a divisional.

For more information on Divisional application, visit: Divisional application.

A claim should be rejected under 35 U.S.C. 112(a) for lack of written description when the subject matter is not shown in the drawing or described in the description, and the words of the original claim do not sufficiently describe the invention. The MPEP 608.01(l) states: “If the claim does not provide its own description in this case, the claim should be rejected under 35 U.S.C. 112(a) as failing to be supported by an adequate written description.” This means that the claim must provide enough detail for one of ordinary skill in the art to recognize that the inventor had possession of the full scope of the claimed invention.

To learn more:

To learn more:

The timing for submitting a specific reference to a prior-filed application depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): The specific reference must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: The specific reference must be submitted during the pendency of the application and within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

It’s important to note that This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s).

For more information on filing deadline, visit: filing deadline.

For more information on specific reference, visit: specific reference.

Ownership must be established under pre-AIA 37 CFR 3.73(b) when the assignee:

  • Signs a request for status of an application
  • Gives a power to inspect an application
  • Appoints its own registered attorney or agent to prosecute an application
  • Signs a disclaimer under 37 CFR 1.321
  • Consents to the filing of a reissue application
  • Consents to the correction of inventorship in a patent
  • Signs a Fee(s) Transmittal (PTOL-85B)

The MPEP states: “Examples of situations where ownership must be established under pre-AIA 37 CFR 3.73(b) are when the assignee: signs a request for status of an application or gives a power to inspect an application (MPEP §§ 102 and 104); appoints its own registered attorney or agent to prosecute an application (pre-AIA 37 CFR 3.71 and MPEP § 402.07); signs a disclaimer under 37 CFR 1.321 (MPEP § 1490); consents to the filing of a reissue application (MPEP § 1410.01); consents to the correction of inventorship in a patent (MPEP § 1481); or signs a Fee(s) Transmittal (PTOL-85B) (MPEP § 1306).”

Note that effective September 16, 2012, a juristic entity (e.g., organizational assignee) must be represented by a patent practitioner.

An assignee must establish ownership under 37 CFR 3.73(c) in various situations, including when the assignee:

  • Signs a request for status of an application
  • Gives a power to inspect an application
  • Appoints its own registered attorney or agent to prosecute an application
  • Signs a disclaimer under 37 CFR 1.321
  • Consents to the filing of a reissue application
  • Signs a Fee Transmittal (PTOL-85B)

The MPEP notes: “Effective September 16, 2012, a juristic entity (e.g., organizational assignee) must be represented by a patent practitioner.”

For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of:

  • Four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f)
  • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
  • Sixteen months from the filing date of the prior application

The MPEP states: If the application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of: (1) four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f); (2) four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage; or (3) sixteen months from the filing date of the prior application.

To learn more:

To learn more:

The USPTO may require earlier submission of priority documents in certain circumstances. According to 37 CFR 1.55(g)(2), these circumstances include:

  • When the application is involved in an interference or derivation proceeding
  • When necessary to overcome the date of a reference relied upon by the examiner
  • When deemed necessary by the examiner

In these cases, the applicant may be required to submit the priority claim and certified copy of the foreign application earlier than the general deadline of the patent grant date.

To learn more:

The USPTO may require earlier filing of priority claims and certified copies in certain situations. According to 37 CFR 1.55(g)(2), these situations include:

  • When the application is involved in an interference or derivation proceeding
  • When necessary to overcome the date of a reference relied upon by the examiner
  • When deemed necessary by the examiner

The MPEP explains that these requirements allow the USPTO to address priority issues promptly when they are relevant to ongoing proceedings or examination.

To learn more:

According to 37 CFR 1.55(g)(2), the USPTO may require that the claim for priority and the certified copy of the foreign application be filed earlier than otherwise provided in the following circumstances:

  1. When the application is involved in an interference or derivation proceeding;
  2. When necessary to overcome the date of a reference relied upon by the examiner; or
  3. When deemed necessary by the examiner.

The certified copy of the foreign application must be filed before the patent is granted. If the certified copy is filed after payment of the issue fee but prior to the date of grant, the priority claim will be placed in the file record but the patent will not include the priority claim unless corrected after the patent is granted using a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.

For applications filed under 35 U.S.C. 111(a) (other than design applications), a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim must also be filed with the certificate of correction. For all applications, a grantable petition under 37 CFR 1.55(f) or (g) must also be filed with the certificate of correction unless the priority claim was timely made but a certified copy was not yet in the file. See MPEP 215.03.

New assignment paperwork is required in the following scenario:

  • The application claiming benefit of a provisional application includes subject matter that is not common with the provisional application, and
  • The application was filed before September 16, 2012, or the assignee is not the original applicant in the later application.

MPEP § 306.01 states: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

This requirement is similar to the practice for continuations-in-part filed under 35 U.S.C. 120.

To learn more:

According to MPEP 608.01(v), a trademark, service mark, collective mark, certification mark, or trade name may be used in a patent application to identify an article, product, service, or organization if:

  • (A) its meaning is established by an accompanying definition in the specification which is sufficiently descriptive, enabling, precise and definite such that a claim including the mark or trade name complies with the requirements of 35 U.S.C. 112, or
  • (B) its meaning is well-known to one skilled in the relevant art and is satisfactorily defined in the literature.

It’s important to note that these conditions must be met at the time of filing the complete application. The MPEP also states that If the product, service, or organization to which a mark refers is set forth in such language that its identity is clear, examiners are authorized to permit the use of the mark if it is distinguished from common descriptive nouns by capitalization.

To learn more:

MPEP 303 outlines specific situations where a patent examiner needs to obtain assignment information from the Patent Application Locator and Monitoring (PALM) system:

“When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims or there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

This typically occurs in two main scenarios:

  1. When applications from different inventors have conflicting claims
  2. When there’s uncertainty about who should direct the prosecution

In these cases, the examiner must consult PALM to clarify the assignment status.

Correction of inventorship is required when the application is amended in a way that changes the claims, resulting in one or more named inventors no longer being an inventor of the subject matter of a remaining claim. The MPEP states:

Applicants are responsible for correcting, and are required to correct, the inventorship in compliance with 37 CFR 1.48 when the application is amended to change the claims so that one (or more) of the named inventors is no longer an inventor of the subject matter of a claim remaining in the application.

Requests for correction under 37 CFR 1.48 filed on or after September 16, 2012, are processed by the Office of Patent Application Processing (OPAP). If granted, OPAP will update the Office records and issue a corrected filing receipt.

To learn more:

To learn more:

An English translation is required for non-English oaths or declarations in most cases. According to MPEP 602.06:

“Unless the text of any oath or declaration in a language other than English is in a form provided by the Patent and Trademark Office or in accordance with PCT Rule 4.17(iv), it must be accompanied by an English translation together with a statement that the translation is accurate.”

However, for oaths or declarations filed under 37 CFR 1.63, there is some flexibility: “the translation may be filed in the Office no later than two months from the date applicant is notified to file the translation.”

To learn more:

A title report is typically prepared at specific stages of the patent process. The MPEP Section 320 states that “A title report is prepared when a new application is filed in order to notify the examiner of the assignment status of the application.” Additionally, title reports are prepared:

  • When a Notice of Allowance is mailed
  • When an application is ready for issue
  • When a request for a correction of inventorship is received

These reports ensure that the most current ownership information is available at critical points in the patent process.

For more information on new application, visit: new application.

For more information on notice of allowance, visit: notice of allowance.

For more information on title report, visit: title report.

A separate written request is required in specific situations, as outlined in MPEP 215.01:

A separate written request may be used when the applicant wishes the Office to retrieve a foreign application from a foreign intellectual property office that becomes a participating foreign intellectual property office after the foreign priority has been claimed, so long as the time period set in 37 CFR 1.55 has not expired.

Additionally, a separate request is needed when:

  • The foreign application was not originally filed in a participating office, but a certified copy was filed in an application subsequently filed in a participating office.
  • The applicant wants to use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)) to file such a request.

To learn more:

A separate written request for PDX retrieval is needed in two specific situations:

  1. When the applicant wishes the Office to retrieve a foreign application from a foreign intellectual property office that becomes a participating office after the foreign priority has been claimed, as long as the time period set in 37 CFR 1.55 has not expired.
  2. When the foreign application was not originally filed in a participating office, but a certified copy was filed in an application subsequently filed in a participating foreign intellectual property office.

The MPEP provides Form PTO/SB/38 for such requests:

Applicants can use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)) to file such a request.

A reissue application is necessary to perfect a foreign priority claim in the following situations:

  1. When the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance.
  2. When the requirements of 37 CFR 1.55 are not met.
  3. When the correction sought would require further examination.

The MPEP provides an example: Further examination would be required where grant of the petition would cause the patent to be subject to a different statutory framework, e.g., where the foreign application has a pre-March 16, 2013 filing date in a patent that was examined under the first inventor to file (FITF) provisions of the AIA. In such situations, the filing of a reissue application with a petition for an unintentionally delayed priority claim would be required.

To learn more:

A provisional patent application is considered abandoned no later than 12 months after its filing date. MPEP 203.05 states that an abandoned application includes, in the case of a provisional application, no later than 12 months after the filing date of the provisional application (see MPEP § 711.03(c) and 35 U.S.C. 111(b)(5)). This means that provisional applications have a statutory life of one year from their filing date, after which they are automatically abandoned if not converted to a nonprovisional application or claimed as priority in a nonprovisional application.

For more information, you can refer to MPEP § 711.03(c) and 35 U.S.C. 111(b)(5).

A petition to expunge is necessary when there has been a complete error in recording an assignment document at the USPTO. This typically occurs when a document not intended for recording was erroneously recorded. As stated in MPEP 323:

‘In the case of a complete error (e.g., a wrong document is recorded), a petition to expunge the assignment record should be filed.’

Key points about petitions to expunge:

  • They are used for complete errors, not minor corrections
  • The petition should clearly explain the nature of the error
  • Supporting documentation may be required
  • The USPTO will review the petition and make a determination

It’s important to note that expungement is a serious step and should only be used when absolutely necessary.

For more information on USPTO, visit: USPTO.

Tags: USPTO

A petition is required to correct a benefit claim in the following situations:

  • When the benefit claim is filed after the required time period set forth in 37 CFR 1.78.
  • When the benefit claim was included elsewhere in the application (e.g., in an oath or declaration) but was not recognized by the Office as shown by its absence on the first filing receipt, and the correction is sought after the expiration of the time period set in 37 CFR 1.78.

The MPEP states: If, however, an applicant includes a benefit claim elsewhere in the application and the claim is not recognized by the Office as shown by its absence on the first filing receipt, the Office will require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the correction is sought after expiration of the time period set in 37 CFR 1.78.

However, a petition is not required for certain corrections, such as changing the relationship of the applications or changing the filing date of a prior-filed application, as long as these corrections are made within the original time period.

To learn more:

To learn more:

A patent application file becomes available to the public in the following situations:

  1. When the application has issued as a patent or published as a statutory invention registration
  2. When the application has been published and subsequently abandoned
  3. When the application has been published and is still pending
  4. When an unpublished, abandoned application is identified or relied upon in certain public documents
  5. When the benefit of an unpublished pending application is claimed in certain public documents

These conditions are outlined in 37 CFR 1.14(a)(1). In most cases, a fee is required to access the application file contents.

According to MPEP 203.03, a nonprovisional patent application is considered “amended” after it has been initially acted on by the examiner, and the applicant has filed a reply to the examiner’s action. The applicant’s reply may include:

  • An election
  • A traverse of the examiner’s action
  • An amendment to the application

MPEP 203.02 defines a ‘rejected’ application as follows:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application. Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

This status applies to applications that have received an Office action from the examiner but have not yet been responded to by the applicant.

MPEP 203.04 defines an ‘allowed’ or ‘in issue’ patent application as follows:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

Essentially, an application is ‘allowed’ when the examiner has determined it meets all requirements for patentability and has sent a Notice of Allowance. This status continues until the patent is issued, unless specific actions are taken to withdraw it or it becomes abandoned due to non-payment of fees.

MPEP 203.05 outlines several scenarios where an application is considered abandoned:

  • Formal abandonment by the applicant or attorney/agent of record
  • Failure to take appropriate action at some stage in the prosecution of a nonprovisional application
  • Failure to pay the issue fee
  • For provisional applications, no later than 12 months after the filing date

Abandonment removes the application from the Office docket of pending applications. It’s crucial for applicants to be aware of deadlines and required actions to prevent unintentional abandonment.

For continuing applications (continuation, divisional, continuation-in-part) filed on or after September 16, 2012 under 37 CFR 1.53(b), a newly executed inventor’s oath or declaration is generally not required if:

  • An oath or declaration complying with 35 U.S.C. 115 and 37 CFR 1.63 (or substitute statement under 37 CFR 1.64) was filed in the earlier-filed application
  • A copy of the executed oath/declaration from the earlier application is submitted in the continuing application showing it was executed

However, a newly executed inventor’s oath or declaration must be filed in a continuation or divisional application naming an inventor not named in the prior application (37 CFR 1.63(d)(3)).

For continuing applications filed before 9/16/2012, a newly executed oath or declaration is required unless a copy of the executed oath or declaration filed in the prior application is submitted with certain other requirements met (see pre-AIA 37 CFR 1.63(d)).

A new oath or declaration is required in a patent application under the following circumstances:

  • When filing a continuation or divisional application
  • When filing a continuation-in-part application
  • To correct inventorship in an application
  • When the original oath or declaration was defective

According to MPEP 602.02: ‘A new oath or declaration is required in a continuation or divisional application filed under 37 CFR 1.53(b) or in a continuation-in-part application.’ Additionally, the MPEP states that ‘A new oath or declaration in compliance with 37 CFR 1.63 or 1.67 is required in a continuation or divisional application filed under 37 CFR 1.53(b), regardless of whether a copy of the oath or declaration from the prior application is submitted.’

To learn more:

When is a new oath or declaration required for a continuation-in-part application?

For continuation-in-part (CIP) applications, a new oath or declaration is typically required due to the addition of new matter. According to MPEP 602.05:

‘A continuation-in-part application (which may disclose and claim subject matter not disclosed in the prior application) is considered a continuing application for purposes of 37 CFR 1.78(d), but not for purposes of 37 CFR 1.63(d). Accordingly, the inventor’s oath or declaration must also be filed in the continuation-in-part application.’

This requirement ensures that the inventors acknowledge and claim the new subject matter introduced in the CIP application. The new oath or declaration should cover both the original content from the parent application and the newly added material in the CIP.

To learn more:

The need for a new assignment in applications derived from earlier applications depends on the type of application and its content:

  • Division and Continuation Applications: Generally, no new assignment is required as the prior assignment is automatically applied. However, a new recordation request is needed to reflect this in USPTO records.
  • Substitute and Continuation-in-Part Applications: New assignments are typically required unless the application is filed on or after September 16, 2012, and the assignee is the original applicant.
  • Applications Claiming Provisional Benefits: If the application includes only subject matter from the provisional application, no new assignment is needed. However, if it includes new subject matter, a new assignment is required, with the same exception as for substitute and continuation-in-part applications.

Always refer to MPEP § 306, § 307, and § 308 for the most up-to-date and detailed information.

For more information on new assignment, visit: new assignment.

For more information on USPTO requirements, visit: USPTO requirements.

A new assignment is generally required for a continuation-in-part (CIP) application, with one exception. According to MPEP 306:

Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

This means:

  • For CIP applications filed before September 16, 2012: A new assignment is always required.
  • For CIP applications filed on or after September 16, 2012: A new assignment is required unless the assignee is the original applicant in the CIP application.

The reason for this requirement is that CIP applications often contain new subject matter not present in the original application, and the original assignment may not cover this new material.

A divisional application is often filed in response to a restriction requirement made by the patent examiner. As stated in the MPEP:

A divisional application is often filed as a result of a restriction requirement made by the examiner.

When an examiner determines that an application contains multiple independent and distinct inventions, they may issue a restriction requirement. The applicant can then elect one invention to pursue in the original application and file a divisional application to pursue the non-elected invention(s).

To learn more:

A Continued Prosecution Application (CPA) is acceptable when it meets the requirements set forth in 37 CFR 1.53(d). According to MPEP § 201, the examiner will use specific language to indicate acceptance:

The request filed on [date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [number] is acceptable and a CPA has been established.

It’s important to note that CPAs are now only available for design patent applications. For utility and plant applications, a Request for Continued Examination (RCE) would be used instead.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent examination, visit: patent examination.

A Certificate of Correction is appropriate for perfecting a foreign priority claim in the following situations:

  1. When the priority claim was timely filed in the application but was not included on the patent because the requirement for a certified copy was not satisfied. In this case, a grantable petition under 37 CFR 1.55(f) or 37 CFR 1.55(g) for design applications is also required.
  2. When a priority claim under 37 CFR 1.55 was not timely made, but the correction sought would not require further examination.

The MPEP states: “Effective May 13, 2015, 37 CFR 1.55(g) provides that the claim for priority and the certified copy of the foreign application must be filed within the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate. 37 CFR 1.55(g) eliminates the need in many instances to file a reissue application in order to perfect a claim for foreign priority.” (MPEP 216.01)

The USPTO has specific rules for making international application files available to the public. According to MPEP 110, which cites 37 CFR 1.14(g), After publication of an application under 35 U.S.C. 122(b), the USPTO will make available copies of the application files and also allow for access to those files in accordance with 37 CFR 1.14(a). Specifically for international applications, after publication of an international application designating the U.S. under PCT Article 21, the USPTO will make available copies of, and allow access to, those international application files which are kept in the USPTO. However, this access is subject to certain conditions and restrictions, such as the payment of appropriate fees and the exclusion of certain documents like the Examination Copy.

For more information on public access, visit: public access.

For more information on USPTO, visit: USPTO.

The USPTO’s timing for retrieving foreign applications under PDX is described in MPEP 215.01:

In general, an attempt to retrieve an eligible foreign application to which priority is claimed in a U.S. application will be made by the USPTO when the application is docketed to an examiner. In any case the USPTO will not attempt electronic retrieval until the Office of Patent Application Processing has completed its review of the application.

Key points about the retrieval timing:

  • The first attempt is typically made when the application is assigned to an examiner.
  • Retrieval occurs after the Office of Patent Application Processing completes its review.
  • Applicants should check the Private PAIR system to confirm successful retrieval.
  • A successful retrieval usually takes about one week to complete.

To learn more:

If the applicant files the certified copy of the foreign application to overcome the effective date of a reference, a translation is required if the copy is not in English.

The examiner should require the translation when requesting the certified copy. The translation must be a complete translation of the certified copy, and must be accompanied by a statement that the translation is accurate. [MPEP 216]

An examiner considers the merits of a foreign priority claim in the following situations:

  • When a reference is found with an effective date between the foreign filing date and the U.S. filing date
  • When determining if a reference’s prior art date falls within the grace period for the application under examination
  • When an interference situation is under consideration

The MPEP states: “The subject matter of the application is not examined to determine whether the applicant is actually entitled to the benefit of the foreign filing date on the basis of the disclosure thereof unless such determination is required for patentability reasons. For example, the examiner considers the merits of an applicant’s claim of priority when a reference is found with an effective date between the date of the foreign filing and the date of filing in the United States, when determining whether a reference’s prior art date is within the grace period for the application under examination, and when an interference situation is under consideration.” (MPEP 216)

The status of an application as ‘allowed’ has a specific timeframe. According to the MPEP:

“Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue ( 37 CFR 1.313 ), or becomes abandoned for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).”

In other words, the ‘allowed’ status begins when the notice of allowance is sent and typically ends when the patent is issued. However, this status can be terminated if the application is withdrawn from issue or becomes abandoned due to non-payment of required fees.

To learn more:

A revocation of power of attorney becomes effective on the date it is received by the USPTO, not on the date it is accepted. As stated in MPEP 402.05: Revocation of a power of attorney becomes effective on the date that the revocation is RECEIVED in the Office (not on the date of ACCEPTANCE). The Office will send an appropriate notification upon revocation.

To learn more:

A patent application stops being considered ‘new’ when it receives its first action from the examiner. According to MPEP 203.01:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This implies that once the examiner issues any official communication or action on the merits of the application, such as a non-final rejection or a notice of allowance, the application is no longer considered ‘new’ in the patent examination process.

To learn more:

A patent application typically becomes publicly accessible after it is published. MPEP 106 states:

Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.

This publication usually occurs 18 months after the earliest filing date of the application, as per 35 U.S.C. 122(b). At this point, any previous restrictions on access, including those placed on inventors, are lifted, and the application becomes part of the public record.

For more information on public access, visit: public access.

Patent examiners need to obtain assignment information in specific situations where the ownership of an application is significant. The MPEP 303 outlines two key scenarios:

  1. Conflicting claims in applications of different inventors: When multiple applications from different inventors contain claims that conflict with each other.
  2. Questions about who should direct prosecution: When there is uncertainty about which party has the right to control the patent prosecution process.

In these cases, the MPEP states: “When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims or there is a question as to who should direct prosecution, it is necessary for the examiner to obtain assignment information from PALM.” PALM refers to the USPTO’s Patent Application Location and Monitoring system.

For more information on assignment information, visit: assignment information.

For more information on conflicting claims, visit: conflicting claims.

For more information on Patent examiners, visit: Patent examiners.

For more information on patent prosecution, visit: patent prosecution.

Patent examiners typically do not require title reports for routine examination. The MPEP states:

Information as to the title is not normally required by the examiner to examine an application. It is only in limited circumstances when the ownership becomes an issue and an examiner needs a title report.

When ownership information is necessary, examiners can obtain a title report through the USPTO’s internal PALM Intranet system.

The provisions of 35 U.S.C. 386(a) and (b) became effective for certain types of applications filed on or after May 13, 2015. According to MPEP 213.07:

The provisions of 35 U.S.C. 386(a) and (b) apply to nonprovisional applications, international applications (PCT) and international design applications filed on or after May 13, 2015, and patents issued therefrom. See 37 CFR 1.55(o).

This means that the right of priority under these sections is only applicable to:

  • Nonprovisional applications
  • International applications (PCT)
  • International design applications

These applications must be filed on or after May 13, 2015, to be eligible for the priority rights under 35 U.S.C. 386(a) and (b). The same applies to patents issued from such applications.

For more information on 35 U.S.C. 386, visit: 35 U.S.C. 386.

For more information on effective date, visit: effective date.

For more information on nonprovisional application, visit: nonprovisional application.

National offices have specific restrictions on allowing access to international patent applications. According to MPEP 110, which cites PCT Article 30(2)(a), No national Office shall allow access to the international application by third parties unless requested or authorized by the applicant, before the earliest of the following dates:

  • Date of international publication
  • Date of receipt of the communication under PCT Article 20
  • Date of receipt of a copy under PCT Article 22

This provision ensures that the confidentiality of the application is maintained until certain milestones in the patent process are reached.

A continuation application can be filed at various times during the patent application process. According to MPEP 201.07:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

This means you can file a continuation application:

  • Before the parent application is granted a patent
  • Before the parent application is abandoned
  • Before proceedings on the parent application are terminated

However, for Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), which are only available for design applications (excluding international design applications), there are additional timing restrictions:

A continued prosecution application (CPA) under 37 CFR 1.53(d) (available only for design applications, but not international design applications), however, must be filed prior to payment of the issue fee unless a petition under 37 CFR 1.313(c) is granted in the prior application.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

Benefit under 35 U.S.C. 386(c) for international design applications can only be claimed in specific types of applications filed on or after May 13, 2015. The MPEP states:

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that applications filed before May 13, 2015, cannot claim the benefit of an international design application under 35 U.S.C. 386(c). It’s important for applicants to be aware of this date restriction when considering benefit claims for their patent applications.

To learn more:

To learn more:

The ability to claim benefit under 35 U.S.C. 386(c) for international design applications is subject to specific timing requirements. According to MPEP § 211.01(d):

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that to claim the benefit of an international design application, the claiming application must have been filed on or after May 13, 2015. This date is significant as it marks the implementation of certain provisions of the Patent Law Treaties Implementation Act of 2012.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on filing date requirements, visit: filing date requirements.

An examiner can change the title of a patent application at various stages of the examination process. According to MPEP 606.01, “If a satisfactory title is not supplied by the applicant, the examiner may, at the time of allowance, change the title by an examiner’s amendment.” This typically occurs when the original title is not descriptive of the claimed invention, and the applicant has not provided a suitable alternative.

To learn more:

The MPEP provides specific guidance on when an attorney or agent not of record can change the correspondence address. It states:

See MPEP § 402.03 for information regarding when a change of correspondence address or a document granting access (i.e., a power to inspect) may be signed by an attorney or agent who is not of record.

This reference to MPEP § 402.03 suggests that there are certain circumstances where an attorney or agent not of record may be allowed to change the correspondence address or grant access to application information. For specific details, it’s recommended to consult MPEP § 402.03 directly.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on USPTO procedures, visit: USPTO procedures.

An applicant can voluntarily submit a substitute specification at any point up to the payment of the issue fee, subject to certain conditions. 37 CFR 1.125(b) states:

Subject to § 1.312, a substitute specification, excluding the claims, may be filed at any point up to payment of the issue fee if it is accompanied by a statement that the substitute specification includes no new matter.

It’s important to note that the substitute specification must not introduce new matter and must be accompanied by a statement confirming this fact. Additionally, the claims are excluded from this voluntary submission process.

To learn more:

Tags: new matter

An applicant can submit a new inventor’s oath or declaration to correct any deficiencies or inaccuracies present in an earlier-filed inventor’s oath or declaration. This is explicitly stated in the MPEP: “Applicant may submit a new inventor’s oath or declaration to correct any deficiencies or inaccuracies present in an earlier-filed inventor’s oath or declaration.” This provision is supported by 37 CFR 1.67(a).

To learn more:

A Request to Delete a Named Inventor can be filed at two specific times for a Continued Prosecution Application (CPA):

  1. With the CPA filing: The request can be submitted along with the CPA when it is initially filed.
  2. After the CPA filing: If the request is made after the CPA has been filed, it must follow a different procedure.

The MPEP ¶ 2.32 states:

Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.

This means that post-filing requests require additional documentation and must comply with the regulations for correction of inventorship.

A reissue application can be filed when an unexpired patent is found to be defective. The key criteria are:

  • The original patent must still be in force (unexpired)
  • There must be a defect in the patent that needs correction

It’s important to note that the reissue process is not for extending the term of a patent, but for correcting issues in the existing patent. For more detailed information on the timing and requirements, refer to MPEP Chapter 1400, which provides a comprehensive treatment of reissue applications.

To learn more:

A patent examiner may suggest hiring a patent practitioner under specific circumstances, as outlined in MPEP 401:

“If patentable subject matter appears to be disclosed in a pro se application and it is apparent that the applicant is unfamiliar with the proper preparation and prosecution of patent applications, the examiner may suggest to the applicant that it may be desirable to employ a registered patent attorney or agent.”

However, the examiner should not suggest hiring a practitioner if the application appears to contain no patentable subject matter. The MPEP provides a form paragraph (4.10) for examiners to use when making this suggestion.

A legal representative can sign a substitute statement for a deceased inventor when they are authorized to act on behalf of the deceased inventor’s estate. This typically occurs when the inventor has passed away during the patent application process or before it began.

According to MPEP 604: ‘A substitute statement may be made by the legal representative (e.g., executor, administrator, etc.) of a deceased inventor.’ The legal representative must be able to show their authority to act for the deceased inventor’s estate, which may require providing documentation such as a court appointment or letters testamentary.

It’s important to note that the substitute statement must still comply with all the requirements of 37 CFR 1.64, including identifying the deceased inventor, stating the legal representative’s relationship to the inventor, and acknowledging that willful false statements are punishable by law.

To learn more:

A continuation application can be filed at various stages during the patent application process, as long as the parent application is still pending. The MPEP provides guidance on the timing:

“At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.”

It’s important to note that there are some exceptions for specific types of applications, such as continued prosecution applications (CPAs) for design applications, which have additional timing requirements.

To learn more:

According to 37 CFR 1.78(j), benefit claims under 35 U.S.C. 386(c) can only be made in specific types of applications filed on or after May 13, 2015. The MPEP states:

“37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.”

This means that applications filed before May 13, 2015, cannot claim the benefit of an international design application under 35 U.S.C. 386(c). It’s important for applicants to be aware of this date restriction when considering their benefit claims.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

Title reports are not typically used in routine patent examination. The MPEP clarifies: Information as to the title is not normally required by the examiner to examine an application. It is only in limited circumstances when the ownership becomes an issue and an examiner needs a title report. For instance, title reports may be requested by the Reexamination Preprocessing Staff when a request for reexamination is filed. Examiners can obtain title reports through the USPTO’s internal PALM Intranet system when necessary.

For more information on patent examination, visit: patent examination.

For more information on title report, visit: title report.

Patent applications are generally published 18 months after the earliest filing date, with some exceptions. According to 35 U.S.C. 122(b)(1)(A):

“Subject to paragraph (2), each application for a patent shall be published, in accordance with procedures determined by the Director, promptly after the expiration of a period of 18 months from the earliest filing date for which a benefit is sought under this title. At the request of the applicant, an application may be published earlier than the end of such 18-month period.”

Exceptions to publication include applications that are no longer pending, subject to a secrecy order, provisional applications, or design patent applications.

Patent applications are generally published by the USPTO 18 months after the earliest filing date for which a benefit is sought. This is specified in 35 U.S.C. 122(b)(1)(A):

Subject to paragraph (2), each application for a patent shall be published, in accordance with procedures determined by the Director, promptly after the expiration of a period of 18 months from the earliest filing date for which a benefit is sought under this title. At the request of the applicant, an application may be published earlier than the end of such 18-month period.

There are some exceptions to this rule, such as applications that are no longer pending or are subject to a secrecy order. Applicants can also request early publication or non-publication under certain conditions.

Patent application records may be available to the public in the following situations:

  1. Patented applications and statutory invention registrations
  2. Published abandoned applications
  3. Published pending applications
  4. Unpublished abandoned applications that are identified or relied upon
  5. Unpublished pending applications whose benefit is claimed
  6. Unpublished pending applications that are incorporated by reference or otherwise identified

For specific details on each situation, refer to 37 CFR 1.14(a)(1)(i)-(vi).

New drawings may be required before examination in several situations:

  • When drawings have not been filed, but a drawing will aid in understanding the invention (see MPEP § 608.02).
  • When applications appear to be missing drawings (see MPEP § 601.01(f) or 601.01(g)).
  • When the Office of Patent Application Processing (OPAP) finds the drawings unacceptable for publication.
  • When the supervisory patent examiner believes the drawings do not permit reasonable examination.

As stated in the MPEP: If at the time of the initial assignment of an application to an examiner’s docket, or if at the time the application is taken up for action, the supervisory patent examiner believes the drawings to be of such a condition as to not permit reasonable examination of the application, applicant should be required to immediately submit corrected drawings.

To learn more:

Models or exhibits are generally not required in patent applications unless specific conditions are met. According to MPEP 608.03, models or exhibits are only admitted as part of an application or patent if:

  • They substantially conform to the requirements of 37 CFR 1.52 or 1.84
  • They are specifically required by the Office
  • They are filed with a petition under 37 CFR 1.91(a)(3)

The MPEP states: With the exception of cases involving perpetual motion, a model is not ordinarily required by the Office to demonstrate the operability of a device. However, if operability is questioned, the applicant must establish it to the examiner’s satisfaction.

To learn more:

While the USPTO generally discourages filing duplicate copies, there are situations where separate copies are necessary. According to MPEP 502.04:

Since each file must be complete in itself, a separate copy of every paper to be filed in a patent, patent file, or other proceeding must be furnished for each file to which the paper pertains, even though the contents of the papers filed in two or more files may be identical.

This means that if a document relates to multiple patent applications or proceedings, a separate copy must be submitted for each relevant file, even if the content is identical across all copies.

To learn more:

According to 35 U.S.C. 113, drawings are required ‘where necessary for the understanding of the subject matter sought to be patented.’ Specifically:

  • For applications filed on or after December 18, 2013 (except design applications), drawings are not required to receive a filing date, but may still be necessary to fully disclose the invention.
  • For applications filed before December 18, 2013, drawings were required at filing if necessary for understanding the invention.
  • Design applications must include drawings to receive a filing date.

The USPTO recommends including drawings in most cases, as they help ensure the requirements of 35 U.S.C. 113 are met for any claimed invention.

To learn more:

According to MPEP 608.02(x), drawing corrections or changes are generally accepted at the time they are presented, unless the applicant is notified otherwise by the examiner in the subsequent Office action. The MPEP states:

“Drawing corrections or changes will be entered at the time they are presented, unless applicant is notified to the contrary by the examiner in the action following the amended drawing submission.”

This means that applicants can typically assume their drawing corrections have been accepted unless they receive specific notification stating otherwise.

To learn more:

To learn more:

Annotated sheets are required for patent drawing changes in specific circumstances. According to MPEP 608.02(v), annotated sheets are necessary “When changes are to be made in the drawing itself, other than mere changes in reference characters, designations of figures, or inking over lines pale and rough.” However, the MPEP also notes that “Ordinarily, broken lines may be changed to full without a sketch.” This means that substantial changes to the drawing content require annotated sheets, while minor alterations may not.

To learn more:

MPEP 606 provides guidance on words that should be avoided in patent application titles:

“The words listed below are not considered as part of the title of an invention, these words should not be included at the beginning of the title of the invention and will be deleted when the Office enters the title into the Office’s computer records, and when any patent issues.”

While the MPEP doesn’t provide an exhaustive list in this section, it’s generally advisable to avoid:

  • Non-descriptive terms like ‘new’, ‘improved’, or ‘invention of’
  • Articles such as ‘a’, ‘an’, or ‘the’ at the beginning of the title
  • Overly broad terms that don’t specifically describe the invention

However, there are exceptions. For example, “The term ‘new’ will not be deleted when it is a part of a proper name, such as ‘New York’. Similarly, the term ‘design’ will not be deleted when it is a part of a term, such as ‘Design-aiding apparatus…’.”

To learn more:

For continuation or divisional applications filed under 37 CFR 1.53(d) (continued prosecution design applications) with changes in inventorship, the requirements were as follows:

“If an inventor named in a prior application is not an inventor in a continuation or divisional application filed under 37 CFR 1.53(d) (continued prosecution design application), the request for filing the continuation or divisional application must be accompanied by a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the continuation or divisional application (see 37 CFR 1.53(d)(4)).”

This meant that for continued prosecution design applications, a statement requesting the deletion of non-inventors had to be submitted along with the filing request when there were changes in inventorship.

To learn more:

To learn more:

An international design application designating the United States can claim priority based on several types of prior applications. According to MPEP 213.07:

Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The types of prior applications that can be used for claiming priority include:

  • A prior foreign application
  • An international application (PCT) designating at least one country other than the United States
  • A prior international design application designating at least one country other than the United States

These priority claims must comply with the conditions and requirements set forth in 35 U.S.C. 119(a)-(d) and 172, as well as the Hague Agreement and its Regulations.

For more information on foreign priority, visit: foreign priority.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on prior applications, visit: prior applications.

According to MPEP 502.01, various types of patent-related correspondence can be transmitted by facsimile to the USPTO, including:

  • Continued Prosecution Applications (CPAs) filed under 37 CFR 1.53(d) (for design applications only)
  • Amendments
  • Declarations
  • Petitions
  • Information Disclosure Statements (IDS)
  • Terminal disclaimers
  • Notices of appeal and appeal briefs
  • Requests for Continued Examination (RCEs) under 37 CFR 1.114
  • Assignment documents
  • Issue fee transmittals
  • Authorizations to charge deposit accounts

The MPEP states: “37 CFR 1.6(d) specifies the types of correspondence which may be transmitted by facsimile.” However, it’s important to note that certain types of correspondence are prohibited from being sent by fax, as outlined in 37 CFR 1.6(d)(2)-(7).

To learn more:

According to MPEP 502.01, certain types of patent-related correspondence are prohibited from being sent by facsimile to the USPTO. These include:

  • Documents required by statute to be certified (37 CFR 1.4(f))
  • National patent application specifications and drawings for obtaining a filing date (except for CPAs under 37 CFR 1.53(d))
  • International patent applications
  • International design applications
  • Documents for entering the national stage of an international application (37 CFR 1.495(b))
  • Third-party submissions under 37 CFR 1.290
  • Correspondence related to registration to practice before the USPTO in patent cases
  • Color drawings (37 CFR 1.81, 1.83-1.85, 1.152, 1.165, 1.173, 1.437, or 1.1026)
  • Requests for reexamination (37 CFR 1.510 or 37 CFR 1.913)
  • Requests for supplemental examination (37 CFR 1.610)
  • Correspondence for patent applications under secrecy orders (37 CFR 5.1-5.5)
  • Most correspondence for contested cases or trials before the Patent Trial and Appeal Board

The MPEP states: “As a courtesy, the Office will attempt to notify senders whenever correspondence is sent to the Office by facsimile transmission that falls within one of the prohibitions.” However, it’s crucial to avoid submitting prohibited correspondence by fax, as it will not be accorded a receipt date.

To learn more:

For the purpose of micro entity status, the following types of patent applications count towards the application filing limit:

  • Previously filed U.S. nonprovisional applications (utility, design, plant, continuation, and divisional)
  • Previously filed U.S. reissue applications
  • Previously filed U.S. national stage applications under the Patent Cooperation Treaty (PCT)
  • Previously filed international design applications under the Hague agreement that designate the U.S.

The MPEP states: “All such applications naming the inventor or a joint inventor are counted toward the application filing limit, whether the applications were filed before, on, or after March 19, 2013.

Applications that do not count towards the limit include:

  • Foreign applications
  • International (PCT) applications for which the basic U.S. national stage filing fee was not paid
  • Provisional applications

To learn more:

Continued Prosecution Applications (CPAs) are limited to specific types of patent applications:

  • Design Applications: CPAs are available for design applications filed before May 29, 2000.
  • Plant Applications: CPAs can be used for plant patent applications.

It’s important to note that CPAs are not available for utility patent applications filed on or after May 29, 2000. For these applications, applicants should use a Request for Continued Examination (RCE) instead.

The MPEP ¶ 2.34 provides guidance on how CPAs reference prior applications:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.

This means that for eligible applications, the CPA automatically establishes the necessary reference to the prior application without requiring amendments to the specification.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

The three main types of patent applications that can be filed in the USPTO are:

  1. Utility patent applications (filed under 35 U.S.C. 101) for “any new and useful process, machine, manufacture, or composition of matter”
  2. Design patent applications (filed under 35 U.S.C. 171) for “any new, original, and ornamental design for an article of manufacture”
  3. Plant patent applications (filed under 35 U.S.C. 161) for “whoever invents or discovers and asexually reproduces any distinct and new variety of plant”

The following types of patent applications and documents can be filed via EFS-Web:

  • Provisional patent applications under 35 U.S.C. 111(b)
  • Nonprovisional utility patent applications under 35 U.S.C. 111(a)
  • Nonprovisional design patent applications under 35 U.S.C. 111(a)
  • International applications filed under the PCT in the United States Receiving Office
  • National stage submissions under 35 U.S.C. 371
  • International design applications filed under the Hague Agreement
  • Requests for ex parte reexamination for utility or design patents
  • Requests for supplemental examination for utility, design, or plant patents
  • Third-party preissuance submissions under 35 U.S.C. 122(e)
  • Citation of prior art and written statements in patent files under 37 CFR 1.501

Follow-on documents can also be filed via EFS-Web for existing applications by registered users.

According to MPEP 608.02(w), there are two types of numeral changes that can be made to patent drawings without requiring annotated sheets from the applicant:

  1. Changing one or two numerals or figure ordinals
  2. Changing Roman Numerals to Arabic Numerals to agree with the specification

The MPEP states:

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: (B) Changing one or two numerals or figure ordinals. … (E) Changing Roman Numerals to Arabic Numerals to agree with specification.

These provisions allow for minor numerical corrections or adjustments to ensure consistency between the drawings and the specification without necessitating a formal submission from the applicant.

To learn more:

What types of national applications can be filed with the USPTO?

The United States Patent and Trademark Office (USPTO) accepts several types of national applications. These include:

  • Utility patent applications: For new and useful processes, machines, articles of manufacture, or compositions of matter.
  • Design patent applications: For new, original, and ornamental designs for articles of manufacture.
  • Plant patent applications: For new varieties of asexually reproduced plants.
  • Provisional patent applications: A temporary application that establishes a filing date but does not mature into an issued patent.

According to MPEP 201.01:

Applications for plant patents, design patents, and utility patents are national applications.

Each type of application has specific requirements and procedures. Utility, design, and plant patent applications can be filed as nonprovisional applications, while provisional applications are only available for utility patents.

For more information on design patent, visit: design patent.

For more information on provisional patent, visit: provisional patent.

For more information on USPTO, visit: USPTO.

Under U.S. patent laws, several types of national applications can be filed. The MPEP 201.01 states:

‘National applications include original (nonprovisional), reissue, and reexamination applications (including supplemental examination proceedings). The original application includes continuation, divisional, and continuation-in-part applications. National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’

To break this down:

  • Original (nonprovisional) applications: Standard utility patent applications
  • Reissue applications: To correct errors in already granted patents
  • Reexamination applications: To request the USPTO to reexamine an existing patent
  • Continuation applications: Based on an earlier-filed application
  • Divisional applications: Derived from a parent application to pursue different inventions
  • Continuation-in-part applications: Adding new matter to a parent application
  • Design patent applications (under 35 U.S.C. 171)
  • Plant patent applications (under 35 U.S.C. 161)

For more information on reissue, visit: reissue.

For more information on USPTO, visit: USPTO.

Tags: reissue, USPTO

Under 35 U.S.C. 111(a), two types of national applications can be filed:

  • Nonprovisional applications: These are regular patent applications that, if granted, can result in an issued patent.
  • Provisional applications: These provide a priority date but do not mature into patents without further action.

The MPEP 201.01 states: ‘National applications may be filed under 35 U.S.C. 111(a) as provisional applications under 35 U.S.C. 111(b) or as nonprovisional applications under 35 U.S.C. 111(a).’ Each type has specific requirements and serves different purposes in the patent application process.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

What types of evidence can be used to establish assignee ownership in pre-AIA applications?

For pre-AIA applications (filed before September 16, 2012), assignees can use various types of evidence to establish ownership, including:

  • Assignment documents
  • Corporate merger documentation
  • Patent purchase agreements
  • Court orders
  • Joint research agreements

The MPEP 324 states: “The submission establishing ownership must show that the person signing the submission is a person authorized to act on behalf of the assignee.” This means that in addition to proving ownership, the assignee must also demonstrate the authority of the person acting on their behalf.

For more information on assignee ownership, visit: assignee ownership.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP 409.03(d), acceptable evidence to prove inventor unavailability or refusal can include:

  • Copies of letters or email messages sent to the inventor requesting their signature
  • Returned receipt indicating the inventor’s refusal to accept mail
  • Statements from people who have attempted to contact the inventor
  • Evidence of the inventor’s mental or physical incapacity
  • Evidence of the inventor’s unavailability due to absence
  • Other pertinent evidence that demonstrates the inventor’s unavailability or refusal

The MPEP states: ‘The proof of unavailability or refusal will be examined by the Office.’ This means that the USPTO will carefully evaluate the submitted evidence to determine if it sufficiently demonstrates the inventor’s unavailability or refusal.

To learn more:

OPAP may object to and require corrected drawings within a set time period for several issues. According to the MPEP, these include:

  • Line quality that is too light to be reproduced
  • Illegible text
  • Missing lead lines
  • Excessive text or non-English text
  • Incorrect margins or paper size
  • Improper figure labeling
  • Illegible photographs that could be illustrated by ink drawings
  • Color drawings or photographs without a proper petition

For example, regarding line quality, MPEP 507 states:

“OPAP may object to and require corrected drawings within a set time period, if the drawings: (A) have a line quality that is too light to be reproduced (weight of all lines and letters must be heavy enough to permit adequate reproduction) or text that is illegible (reference characters, sheet numbers, and view numbers must be plain and legible). See 37 CFR 1.84(l) and (p)(1)

For more information on drawing requirements, visit: drawing requirements.

For more information on OPAP, visit: OPAP.

For more information on patent drawings, visit: patent drawings.

The USPTO records various documents related to patents and patent applications, including:

  • Licenses
  • Security interests
  • Liens
  • Options
  • Mortgages
  • Name changes
  • Mergers
  • Change of entity status

According to MPEP 313: Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11. This includes a wide range of documents that affect the ownership or rights associated with patents and applications.

For more information on licenses, visit: licenses.

For more information on patent documents, visit: patent documents.

For more information on security interests, visit: security interests.

The Electronic Patent Assignment System (EPAS) accepts various types of assignment-related documents. As stated in MPEP 302.10:

“The EPAS system allows customers to submit assignments and other documents related to title (e.g., lien agreements, probate documents, licenses, etc.) directly into the automated Patent and Trademark Assignment System.”

This system streamlines the submission process for a wide range of ownership and assignment documents.

To learn more:

Applicants can submit various types of documents as evidence when replying to an Office action. The MPEP provides examples:

“Documents may be in any form but are typically in the form of an affidavit, declaration, patent, or printed publication.”

These documents can be used to support arguments related to patentability issues raised in the Office action, such as demonstrating that an element in the claim is operative or that a term has a recognized meaning in the art.

To learn more:

The USPTO records various documents related to patent ownership and interests. Common types include:

  • Assignments
  • Security agreements
  • Mergers
  • Name changes
  • Licenses
  • Liens
  • Joint research agreements
  • Government interests

As stated in MPEP 302.07: “Examples of the type of descriptions of the interest conveyed or transaction to be recorded that can be identified are: (A) assignment; (B) security agreement; (C) merger; (D) change of name; (E) license; (F) foreclosure; (G) lien; (H) contract; and (I) joint research agreement.”

To record a document:

  1. Ensure it’s eligible for recordation
  2. Complete the appropriate cover sheet
  3. Submit the document and cover sheet to the USPTO
  4. Pay any applicable fees

Remember, the USPTO generally only records documents that affect title to patents or patent applications. Consult the MPEP or a patent attorney for guidance on specific document types.

For more information on patent documents, visit: patent documents.

For more information on USPTO recordation, visit: USPTO recordation.

In addition to assignments, the USPTO will record various other documents relating to interests in patent applications and patents upon request. These include:

  • License agreements
  • Security interest agreements
  • Other documents affecting title to applications, patents, and registrations

As stated in the MPEP, “Other documents affecting title to applications, patents, and registrations will be recorded as provided in 37 CFR Part 3 or at the discretion of the Director.” (MPEP 313)

What types of documents can be recorded in the USPTO assignment database?

The USPTO assignment database accepts various types of documents related to patent ownership and interests. According to MPEP 302, recordable documents include:

  • Assignments of patent rights
  • Security interests (e.g., liens, mortgages)
  • Licenses
  • Releases
  • Certificates of name changes
  • Mergers
  • Other documents affecting title to applications, patents, or registrations

The MPEP states: ‘Any document which relates to the title in a patent or patent application will be recorded as provided in 37 CFR 3.11.’ This broad definition allows for the recording of various ownership-related documents.

For more information on licenses, visit: licenses.

For more information on patent assignments, visit: patent assignments.

For more information on recordable documents, visit: recordable documents.

For more information on security interests, visit: security interests.

For more information on USPTO database, visit: USPTO database.

What types of documents can be recorded in the Assignment Division of the USPTO?

The Assignment Division of the USPTO records various types of documents related to patent ownership. According to MPEP 302, the following types of documents can be recorded:

  • Assignments of patents and patent applications
  • Security interests in patents and patent applications
  • Licenses that grant a security interest in patents or patent applications
  • Documents that affect title (e.g., certificates of name change, mergers, change of corporate form)
  • Liens
  • Certificates of release or discharge of security interests
  • Conditional assignments
  • Bailments

It’s important to note that the USPTO does not determine the validity of the documents submitted for recordation. As stated in MPEP 302:

‘The Assignment Division does not determine the validity of the document but rather records the document that appears to be a document affecting title.’

This means that while a wide range of documents can be recorded, it is the responsibility of the parties involved to ensure the legal validity and enforceability of the documents they submit.

For more information on Assignment Division, visit: Assignment Division.

For more information on recordable documents, visit: recordable documents.

For more information on USPTO, visit: USPTO.

What types of documents can be recorded as assignments with the USPTO?

The USPTO allows for the recording of various types of documents related to patent ownership. According to MPEP 302:

“The United States Patent and Trademark Office (USPTO) records assignments, grants, and similar instruments relating to interests in patents and applications as provided in 37 CFR Part 3.”

Types of documents that can be recorded include:

  • Assignments: Transfers of the entire right, title, and interest in a patent or application
  • Security Agreements: Documents creating a security interest in a patent or application
  • Licenses: Agreements granting rights to use or practice a patented invention
  • Releases: Documents releasing previous security interests or other encumbrances
  • Name Changes: Documents evidencing a change in the name of the owner of record
  • Mergers: Documents showing the merger of companies and the resulting transfer of patent rights

It’s important to note that the USPTO records these documents without making a determination of their validity. As stated in MPEP 302, “The recording of a document pursuant to 37 CFR 3.11 is not a determination by the USPTO of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.”

For more information on patent assignments, visit: patent assignments.

A reissue application can be used to correct various types of defects in an unexpired patent. While the MPEP 201.05 doesn’t provide an exhaustive list in this section, it does state that a reissue application is for “a patent to take the place of an unexpired patent that is defective.” Common defects that can be addressed through reissue include:

  • Errors in the specification or drawings
  • Overly broad or narrow claims
  • Failure to claim priority correctly
  • Inventorship issues

For a more comprehensive list and detailed explanations of correctable defects, refer to MPEP Chapter 1400, which provides a thorough treatment of reissue applications and the types of defects they can address.

To learn more:

While the Certificate of Mailing or Transmission procedure is useful for many types of USPTO correspondence, there are several exceptions. According to 37 CFR 1.8(a)(2), the procedure does not apply to:

  • Filing of national patent application specifications and drawings for the purpose of obtaining an application filing date
  • Filing of correspondence in an international application before the U.S. Receiving Office, U.S. International Searching Authority, or U.S. International Preliminary Examining Authority
  • Filing of an international design application
  • Filing a copy of an international application and the basic national fee to enter the national stage
  • Filing a written declaration of abandonment under 37 CFR 1.138

It’s crucial to note that these exceptions exist to ensure certain critical documents are actually received by the USPTO before they are considered filed.

To learn more:

Patent law recognizes several types of continuing applications. According to the MPEP:

A continuing application is a continuation, divisional, or continuation-in-part application filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.

The three main types of continuing applications are:

  • Continuation: Pursues additional claims to an invention disclosed in an earlier application.
  • Divisional: Separates distinct inventions from a parent application into separate applications.
  • Continuation-in-part (CIP): Adds new matter to the disclosure of the earlier application.

Each type serves different purposes in patent prosecution strategy.

For more information on divisional, visit: divisional.

For more information on patent prosecution, visit: patent prosecution.

While MPEP 508.02 doesn’t specify the types of communications that might be received after a patent is granted, it does indicate that some communications may still be relevant to the record. The section states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This implies that certain communications might still become part of the record. These could include:

  • Maintenance fee payments
  • Requests for correction of errors in the patent
  • Reissue applications
  • Supplemental examination requests

However, any communication not related to these or other official post-grant procedures would likely be returned.

To learn more:

According to MPEP 314, two types of certificates are recordable for patent ownership changes:

  • Certificates showing a change of name of a business
  • Certificates showing a merger of businesses

As stated in the MPEP, Certificates issued by appropriate authorities showing a change of name of a business or a merger of businesses are recordable. These documents serve as important links in the chain of title for patent ownership.

To learn more:

The USPTO can expunge various types of assignment records that are erroneous or no longer supported by statutory basis. According to MPEP 323.01(d), this includes:

  • Erroneously recorded assignment documents
  • Documents that are not assignment documents but were incorrectly recorded as such
  • Assignment documents that are no longer supported by the statutory basis for recording

The MPEP states: ‘The USPTO will expunge, delete or correct assignment records that are not, or are no longer, supported by the statutory basis for recording.’ This broad definition allows for the correction of various types of errors in the assignment records.

To learn more:

According to the MPEP, specific types of applications can claim benefit under 35 U.S.C. 386(c). The relevant passage states:

37 CFR 1.78(j) provides that benefit under 35 U.S.C. 386(c) with respect to an international design application can only be claimed in nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

This means that the following types of applications can claim benefit under 35 U.S.C. 386(c):

  • Nonprovisional applications
  • International applications
  • International design applications
  • Patents issuing from the above applications

It’s important to note that these applications must be filed on or after May 13, 2015, to be eligible for claiming this benefit. Provisional applications are notably absent from this list and cannot claim benefit under 35 U.S.C. 386(c).

To learn more:

To learn more:

Continued Prosecution Applications (CPAs) are specifically for design patent applications. The MPEP ¶ 2.34 refers to CPAs in the context of design applications.

The MPEP ¶ 2.34 states: “In bracket 2, insert either –continuation– or –divisional–.”

This indicates that a CPA can be filed as either a continuation or a divisional of a prior design application. It’s important to note that CPAs are no longer available for utility or plant patent applications.

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

A Continued Prosecution Application (CPA) can be filed for specific types of applications. According to MPEP 201.06(d):

Effective July 14, 2003, CPA practice under 37 CFR 1.53(d) is not available for utility and plant applications.

This means that CPAs are limited to:

  • Design applications: Applications for design patents can be filed as CPAs.
  • Continuation applications: These must be based on an earlier application of the same type (i.e., design).
  • Divisional applications: These must also be based on an earlier design application.

It’s important to note that continuation-in-part (CIP) applications cannot be filed as CPAs. Additionally, utility and plant patent applications are no longer eligible for CPA practice since July 14, 2003.

For more information on continuation applications, visit: continuation applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

According to MPEP 201.01, national applications include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Reexamination proceedings

The MPEP specifically states:

‘National applications include original (nonprovisional) applications, reissue applications, and reexamination proceedings.’

Each of these types serves a different purpose in the patent process. Original applications are for new inventions, reissue applications are for correcting errors in existing patents, and reexamination proceedings are for reviewing the validity of granted patents.

For more information on reissue applications, visit: reissue applications.

According to MPEP 203.01, only nonprovisional applications can be considered ‘new’. The section states:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This means that provisional applications, which are place-holder applications that don’t get examined, are not classified as ‘new’ applications under this definition. Only nonprovisional utility, design, or plant patent applications can have the ‘new’ status before they receive their first examiner action.

To learn more:

During patent prosecution, several types of affidavits or declarations may be filed. MPEP ¶ 2.03 mentions three common types:

“Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application…”

These affidavits serve different purposes:

  • 37 CFR 1.130: Declarations of attribution or prior public disclosure
  • 37 CFR 1.131: Affidavits of prior invention to overcome cited art
  • 37 CFR 1.132: Affidavits traversing rejections or objections

Each of these affidavits provides specific evidence to support the patentability of an invention or to overcome rejections made by the patent examiner.

For more information on patent prosecution, visit: patent prosecution.

MPEP ¶ 2.03 mentions several types of affidavits or declarations that may be submitted during patent prosecution. Specifically, it refers to:

  • Affidavits or declarations under 37 CFR 1.130 (Declaration of Attribution or Prior Public Disclosure under the AIA)
  • Affidavits or declarations under 37 CFR 1.131 (Affidavit or Declaration of Prior Invention to Overcome Cited Patent or Publication)
  • Affidavits or declarations under 37 CFR 1.132 (Affidavits Traversing Rejections or Objections)

These affidavits or declarations are commonly used to overcome rejections or provide evidence during patent prosecution.

For more information on patent prosecution, visit: patent prosecution.

Common types of affidavits or declarations filed in patent applications include those submitted under specific sections of the Code of Federal Regulations. As mentioned in MPEP ¶ 2.03, these include:

  • 37 CFR 1.130: Declarations of attribution or prior public disclosure under the AIA
  • 37 CFR 1.131: Affidavits of prior invention to overcome cited patents or publications
  • 37 CFR 1.132: Affidavits or declarations traversing rejections or objections

These affidavits or declarations serve various purposes in patent prosecution, such as establishing inventorship, overcoming prior art, or addressing examiner rejections.

For more information on patent prosecution, visit: patent prosecution.

The MPEP provides specific guidance on the type of address that should be provided for the nonsigning inventor in pre-AIA 37 CFR 1.47 applications:

‘That address should be the last known address at which the inventor customarily receives mail.’

This typically means providing the most recent address where the inventor is known to receive correspondence. It’s important to provide an address where the USPTO’s communications are most likely to reach the nonsigning inventor.

To learn more:

To learn more:

While it’s speculative to predict the exact content of MPEP 312 if it were to be filled, its placement within the ‘300 – Ownership and Assignment’ chapter suggests it could potentially cover topics related to patent ownership, assignment procedures, or updates to existing sections in this chapter. The content would likely align with the overall theme of ownership and assignment in patent law and procedures.

The reference to the prior-filed application to claim benefit under 35 U.S.C. 120 or 119(e) must be submitted within the following time periods under 37 CFR 1.78:

  • For an application filed under 35 U.S.C. 111(a), the later of four months from the filing date or sixteen months from the filing date of the prior-filed application
  • For a national stage application under 35 U.S.C. 371, the later of four months from national stage commencement under 35 U.S.C. 371(b) or (f), four months from initial national stage submission, or sixteen months from the filing date of the prior-filed application

Failure to timely submit the reference is considered a waiver of any benefit claim. A petition and fee would be required to accept a delayed submission. See MPEP 211.04.

If an inventor’s signature was missing from a continuation or divisional application, the Office of Patent Application Processing (OPAP) would typically take the following steps:

  1. Send a “Notice to File Missing Parts” requiring the signature of the nonsigning inventor.
  2. If a copy of the decision according status under pre-AIA 37 CFR 1.47 was not included with the original filing, applicants could respond to the Notice by:
    • Submitting a copy of the decision according status under pre-AIA 37 CFR 1.47, along with a surcharge for late filing.
    • Alternatively, submitting an oath or declaration signed by the previously nonsigning inventor, along with the required surcharge.

This process is described in the MPEP:

“If OPAP mails such a Notice, a copy of the decision according status under pre-AIA 37 CFR 1.47, together with a surcharge under 37 CFR 1.16(f) for its late filing, will be an acceptable reply to the Notice. Alternatively, applicant may submit an oath or declaration signed by the previously nonsigning inventor together with the surcharge set forth in 37 CFR 1.16(f) in reply to the Notice.”

To learn more:

When dealing with a nonsigning inventor under pre-AIA 37 CFR 1.47, the following steps should be taken to present application papers:

  1. Send a copy of the application papers to the last known address of the nonsigning inventor.
  2. If the inventor is represented by counsel, send the papers to the inventor’s attorney’s address.
  3. Ensure that the inventor is given the opportunity to review the complete application, unless they have assigned their interest and the assignee has requested otherwise.

The MPEP emphasizes:

‘It is reasonable to require that the inventor be presented with the application papers before a petition under pre-AIA 37 CFR 1.47 is granted since such a procedure ensures that the inventor is apprised of the application to which the oath or declaration is directed.’

This process is crucial to establish that a bona fide attempt was made to present the application papers to the nonsigning inventor.

To learn more:

To learn more:

To determine small entity status for a business, several steps should be taken:

  • Review whether the business meets the definition of a small business concern under section 3 of the Small Business Act.
  • Check if the business meets the size standards in 13 CFR 121.801 through 121.805 for eligibility for reduced patent fees.
  • Investigate if the business has assigned, granted, conveyed, or licensed any rights in the invention to others.
  • If rights have been transferred, conduct the same review for each other entity involved.

The MPEP 509.03(a) emphasizes: “If small entity status is desired on the basis that the entity is a small business concern, the investigation should include a review of whether the business is a small business concern as defined by section 3 of the Small Business Act.”

To learn more:

Tags: patent fees

To claim the benefit of a prior application’s filing date for a divisional application, applicants must follow specific procedures. The MPEP ¶ 2.01 provides guidance:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This means applicants should:

  • Review 35 U.S.C. 120 for statutory requirements
  • Consult MPEP § 211 for detailed guidance on claiming benefit
  • Follow the procedures outlined in 37 CFR 1.78 for claiming benefit of an earlier-filed application

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the divisional application.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO procedures, visit: USPTO procedures.

When terminating representation, a practitioner must take several steps to protect the client’s interests, as outlined in 37 CFR 11.116(d):

  • Give reasonable notice to the client
  • Allow time for the client to employ other counsel
  • Surrender papers and property to which the client is entitled
  • Refund any advance payment of fees or expenses that have not been earned or incurred

Additionally, the practitioner must comply with applicable laws requiring notice to or permission from a tribunal when terminating representation, as per 37 CFR 11.116(c).

The USPTO provides forms (PTO/SB/83 or PTO/AIA/83) that include a section for practitioners to certify the completion of these necessary activities. Practitioners can also file a Web-based e-petition for withdrawal.

To learn more:

Tags: USPTO Forms

For international applications and applications claiming the benefit of a published international application:

  1. If the United States is indicated as a Designated State, status information is available for the national stage application and any application claiming benefit of the filing date of the published international application.
  2. Only the serial number, filing date, application number, and whether the application is pending, abandoned, or patented may be provided.
  3. A copy of the first page of the published international application or the corresponding page of the PCT Gazette must be supplied with the status request.

Status requests should be made in writing to the International Patent Legal Administration or directed to the PCT Help desk.

For inventions made with government support, contractors must include a specific statement at the beginning of the patent application and any resulting patents. This requirement is mandated by 35 U.S.C. 202(c)(6). The statement should read:

“This invention was made with government support under (identify the contract) awarded by (identify the Federal agency). The government has certain rights in the invention.”

This statement ensures transparency regarding government involvement and rights in the invention.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

For transition applications, 37 CFR 1.55 and 1.78 require a statement if:

  • The application contains or contained a claim with an effective filing date on or after March 16, 2013
  • The statement must be provided within specified time limits

The MPEP notes: “The statement provisions of 37 CFR 1.55 and 1.78 require that if the later-filed transition application contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March 16, 2013, the applicant must provide a statement to that effect.” (MPEP 210)

An Application Data Sheet (ADS) for patent applications filed before September 16, 2012, can include various types of bibliographic information. According to MPEP 601.05(b), the following information can be included:

  • Applicant information
  • Correspondence address
  • Application information (e.g., title, docket number, secrecy order indicator)
  • Representative information
  • Domestic benefit information
  • Foreign priority information
  • Assignee information

The MPEP states: “The application data sheet may be submitted subsequent to the filing of the application, within the time period set forth in 37 CFR 1.53(f), to provide the bibliographic data.”

It’s important to note that while an ADS can include this information, some details may still need to be provided or confirmed in other application documents, depending on the specific circumstances of the application.

To learn more:

When issuing Office actions after being notified of a patent practitioner’s death, the USPTO includes a special notation. The MPEP 406 instructs examiners to add form paragraph 4.03, which states:

“Notice of the death of the attorney or agent of record has come to the attention of this Office. Since the power of attorney is therefore terminated, this action is being mailed to the office of the patent practitioner and to the party who originally appointed the deceased patent practitioner. A new registered attorney or agent may be appointed.”

This notation informs all parties of the practitioner’s death and the need for new representation.

For more information on Form Paragraph 4.03, visit: Form Paragraph 4.03.

If there is an error in the pre-printed prior application data on the bib-data sheet:

  • The examiner should require correction via a corrected or supplemental application data sheet or an amendment, if it was an applicant error.
  • A petition for an unintentionally delayed benefit claim may also be required.
  • If appropriate, the correction or entry of the data can be made by technical support staff of the Technology Center.

See MPEP 601.05 and MPEP 211.02(a) for more details.

Patent examiners should carefully evaluate applications that may potentially be continuations. The MPEP ¶ 2.05 provides guidance:

“This form paragraph should only be used if it appears that the application may be a continuation, but a benefit claim has not been properly established.”

Examiners should look for applications that disclose and claim only subject matter from a prior application and name at least one common inventor. If these conditions are met but a proper benefit claim is missing, examiners may use the specified form paragraph to notify the applicant of the possible continuation status and the need to establish a benefit claim if desired.

Patent examiners should consider several factors when determining if an application may be a continuation. The MPEP ¶ 2.05 provides guidance:

“This form paragraph should only be used if it appears that the application may be a continuation, but a benefit claim has not been properly established.”

Examiners should look for:

  • Disclosure of only subject matter from the prior application
  • Claims to subject matter disclosed in the prior application
  • At least one common inventor with the prior application
  • Proper benefit claim to the prior application

If these elements are present but the benefit claim is not properly established, examiners may use the form paragraph to notify the applicant.

For more information on continuation application, visit: continuation application.

When patent applicants introduce new terminology in claims, they should amend the specification to provide proper support and antecedent basis for the new terms. MPEP 608.01(o) advises:

While an applicant is not limited to the nomenclature used in the application as filed, he or she should make appropriate amendment of the specification whenever this nomenclature is departed from by amendment of the claims so as to have clear support or antecedent basis in the specification for the new terms appearing in the claims.

This practice ensures that the meaning of new terms can be ascertained by referring to the description, maintaining clarity and consistency throughout the application.

To learn more:

When filing a continuing application using papers from a prior application, it’s important to explicitly specify the desired correspondence address, especially if it was changed during the prosecution of the prior application. 37 CFR 1.33(f) states:

Where application papers from a prior application are used in a continuing application and the correspondence address was changed during the prosecution of the prior application, an application data sheet or separate paper identifying the correspondence address to be used for the continuing application must be submitted. Otherwise, the Office may not recognize the change of correspondence address effected during the prosecution of the prior application.

To ensure the correct correspondence address is used, you should submit either an application data sheet (ADS) or a separate paper clearly identifying the desired correspondence address for the continuing application. This step is crucial to avoid potential communication issues with the USPTO.

To learn more:

If there’s an error in the recorded assignment document (or other document affecting title) rather than in the cover sheet, the procedure differs from correcting cover sheet errors. According to MPEP 323.01(b):

  1. The party responsible for the erroneous document (e.g., the assignor) must either:
    • Create and record a new document, or
    • Make corrections to the original document and re-record it
  2. If the assignor is unavailable, the assignee may:
    • Submit an affidavit or declaration identifying the error and requesting correction
    • Include a copy of the originally recorded papers
    • Provide a new cover sheet
    • Pay the required fee for each application or patent to be corrected (37 CFR 3.41)

This process ensures that errors in the actual assignment document are properly addressed and corrected in the USPTO records.

To learn more:

If there’s a discrepancy between the filing date accorded by the USPTO and the “date accepted” on the Priority Mail Express® mailing label, you can file a petition under 37 CFR 1.10(c). MPEP 513 states that such a petition should:

  • Be filed promptly after becoming aware of the discrepancy
  • Include evidence that the Priority Mail Express® number was placed on the correspondence before mailing
  • Include a true copy of the Priority Mail Express® mailing label showing the “date accepted”

The petition should be filed as soon as the discrepancy is noticed to ensure timely correction of the filing date.

If there are variations in your signature across different patent documents, you should:

  • Try to use a consistent signature for all patent correspondence to avoid confusion.
  • Be prepared for the USPTO to require ratification or confirmation of the signature if there are significant variations.
  • If asked to ratify, state that you personally signed the previously submitted document and, if needed, submit a compliant format of the signature.

According to the MPEP: “For consistency purposes, and to avoid raising a doubt as to who has signed, the same S-signature should be utilized each time, with variations of the signature being avoided.”

If the USPTO requires ratification, they may ask you to submit a statement or a duplicate document with a compliant signature. This helps ensure the authenticity of signatures and clarity of the record.

To learn more:

If the United States Patent and Trademark Office (USPTO) doesn’t receive your priority document through the Priority Document Exchange (PDX) program within the specified time frame, you have options. According to MPEP 215.02(a):

The Office appreciates that an applicant may discover that the Office will not receive a copy of a foreign application through the priority document exchange program until after the expiration of the time frame specified in 37 CFR 1.55(f). In this situation, an applicant who otherwise meets the conditions of 37 CFR 1.55(i) may satisfy the requirement of 37 CFR 1.55(i)(3) by filing a certified copy of the foreign application in the Office within the pendency of the application and before the patent is granted.

If you find yourself in this situation:

  1. File a certified copy of the foreign application directly with the USPTO.
  2. Ensure this is done during the pendency of your application and before the patent is granted.
  3. Consider filing a petition under 37 CFR 1.55(e) or (f) if necessary.

Remember, it’s ultimately the applicant’s responsibility to ensure the priority document is properly filed, even when using the PDX program.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on late submission, visit: late submission.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

If you discover that another party has improperly recorded an assignment against your patent or application, you should take the following steps:

  1. Contact the party who recorded the erroneous information and request that they file corrective papers.
  2. If the party cannot be located or is unwilling to cooperate, you must file corrective papers yourself with the Assignment Services Division.

According to MPEP 323.01(c), you should submit:

  • A completed cover sheet identifying the affected application or patent
  • An affidavit or declaration stating you are the correct owner, the previous recording was erroneous, and providing the reel and frame number of the incorrect document
  • The required fee for each application or patent to be corrected

The MPEP states: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change.

To learn more:

If you have filed correspondence with a proper Certificate of Mailing or Transmission, but the USPTO has not received it after a reasonable amount of time, you can take action under 37 CFR 1.8(b). The MPEP states:

“37 CFR 1.8(b) permits a party to notify the Office of a previous mailing through the U.S. Postal Service, or transmission by facsimile or EFS-Web, of correspondence when a reasonable amount of time has elapsed from the time of mailing or transmission of the correspondence.”

To rectify this situation:

  1. Promptly notify the Office of the previous mailing or transmission
  2. Supply a duplicate copy of the previously mailed or transmitted correspondence
  3. Provide a statement attesting to the previous timely mailing or transmission

It’s important to act quickly once you become aware that the Office has not received your correspondence, rather than waiting until the end of the reply period.

To learn more:

If you’ve misused a Certificate of Mailing or Transmission, it’s important to address the issue promptly and honestly. The USPTO takes the integrity of these certificates seriously. The MPEP states:

Misuse of a Certificate of Mailing under 37 CFR 1.8 or improperly claiming the benefit of 37 CFR 1.10 which appears to be more than a one-time, inadvertent error should be brought to the attention of the Office of Enrollment and Discipline.

If the misuse was a one-time, inadvertent error, you should:

  1. Notify the USPTO as soon as you become aware of the error.
  2. Provide a full explanation of the circumstances.
  3. If possible, submit the correct documentation or information.
  4. Be prepared for the possibility that your submission may be considered late, which could have consequences for your application or proceeding.

For repeated or intentional misuse, the matter may be referred to the Office of Enrollment and Discipline, which could result in more serious consequences. It’s always best to use Certificates of Mailing or Transmission carefully and honestly to maintain the integrity of the patent application process.

If you need your original patent drawings, it’s important to understand that the United States Patent and Trademark Office (USPTO) does not return submitted drawings. As stated in MPEP Section 608.02(y):

Drawings will not be returned to the applicant.

Given this policy, here are some recommendations:

  • Always keep high-quality copies or digital scans of your original drawings before submitting them to the USPTO.
  • If you need the exact drawings on file, you can request certified copies from the USPTO.
  • For future applications, consider using digital drawing tools that allow you to save and reproduce your drawings easily.

Remember, maintaining your own complete set of application materials, including drawings, is crucial for your records and potential future needs.

To learn more:

If you need information related to a topic that corresponds to a reserved MPEP section, such as MPEP 404, follow these steps:

  1. Check other relevant sections of the MPEP that may cover related topics
  2. Consult the USPTO’s official website for guidance documents and notices
  3. Review recent patent laws and regulations that may address the topic
  4. Contact the USPTO’s Patent Electronic Business Center for assistance
  5. Consult with a registered patent attorney or agent for professional advice

Remember that reserved sections do not contain any official information, so it’s crucial to seek guidance from active, authoritative sources.

If you missed the deadline for filing a benefit claim, you may still be able to claim the benefit by filing a petition for an unintentionally delayed benefit claim. The process differs based on the type of benefit claim:

The MPEP states: “If applicant desires the benefit under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c) based upon a previously filed application, applicant must file a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(c) for benefit claims under 35 U.S.C. 119(e) or under 37 CFR 1.78(e) for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c).”

The petition must include:

  1. The reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior application (unless previously submitted)
  2. A petition fee under 37 CFR 1.17(m)
  3. A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the claim was filed was unintentional

The Director may require additional information if there’s a question about whether the delay was unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on petition fee, visit: petition fee.

For more information on unintentional delay, visit: unintentional delay.

If you lose entitlement to small entity status, you must notify the USPTO before or at the time of paying the earliest of the issue fee or any maintenance fee due after the change. According to 37 CFR 1.27(g)(2): ‘notification of any change in status resulting in loss of entitlement to small entity status be filed in the application or patent prior to paying, or at the time of paying, the earliest of the issue fee or any maintenance fee due after the date on which status as a small entity is no longer appropriate.’

This notification should be a specific written assertion, not just payment of a non-small entity fee. For example, when paying the issue fee, you should:

  • Check the appropriate box on Part B of the PTOL-85 form to indicate the change in entity status
  • Pay the fee amount for a non-small entity

To learn more:

To learn more:

Tags: patent fees

If you don’t have the application number when executing an assignment, you can use specific language to allow for its later insertion. MPEP 302.03 suggests the following approach: “It is suggested, however, that an assignment be written to allow entry of the identifying number after the execution of the assignment. An example of acceptable wording is: ‘I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.’” This allows for proper identification of the application once the number is available, while still executing the assignment in a timely manner.

To learn more:

If you don’t possess any record of correspondence with the USPTO for an application, patent, or other proceeding that is the subject of an unlocatable file notice, you must still respond to the notice. According to 37 CFR 1.251(a)(3):

If applicant or patentee does not possess any record of the correspondence between the Office and the applicant or patentee for such application, patent, or other proceeding, applicant or patentee must comply with a notice under this section by providing a statement that applicant or patentee does not possess any record of the correspondence between the Office and the applicant or patentee for such application, patent, or other proceeding.

It’s crucial to provide this statement within the specified time period to avoid potential negative consequences, such as abandonment of a pending application or limitations on the certified copy of a granted patent file that the USPTO can produce.

To learn more:

If you cannot file your patent application electronically or by Priority Mail Express® due to an emergency, consider the following options:

  1. Use first-class mail with a Certificate of Mailing under 37 CFR 1.8
  2. Hand-deliver the application to the USPTO, if possible
  3. If the emergency is a designated postal service interruption, follow the specific instructions provided by the USPTO on their website or in the Official Gazette

Remember that the provisions for postal emergencies only apply to actual USPS service interruptions, not other circumstances like computer failures or office inaccessibility.

As stated in MPEP 511: “Applicants are cautioned that the provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) only apply to postal interruptions and emergencies. The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) do not provide for granting of a filing date to correspondence as of the date on which it would have been filed but for other exigencies, such as the unavailability of a computer or word processing equipment, or the inaccessibility of an office or building other than a USPS facility.”

If an inventor’s name has changed after filing a patent application, you should follow these steps:

  • File a request for a certificate of correction under 37 CFR 1.323 or 37 CFR 1.324.
  • Provide appropriate documentary evidence of the name change.
  • Pay the required fee for the certificate of correction.

According to MPEP 602.08(a): In the event an inventor’s name has been changed after the application has been filed and the inventor desires to change his or her name on the application, he or she must submit a petition under 37 CFR 1.182.

To learn more:

If a copy of an oath or declaration from a prior application is filed after the filing date of a continuation or divisional application, you should take the following steps:

  1. Include a cover letter with the oath or declaration.
  2. In the cover letter, identify the application number of the continuation or divisional application.
  3. Indicate in the cover letter that the submitted oath or declaration is a copy from a prior application.
  4. Label the copy of the oath or declaration with the application number of the continuation or divisional application.

According to MPEP 602.05: If such a copy of the oath or declaration is filed after the filing date of the continuation or divisional application and an application number has been assigned to the continuation or divisional application (see 37 CFR 1.5(a)), the cover letter accompanying the oath or declaration should identify the application number of the continuation or divisional application. The cover letter should also indicate that the oath or declaration submitted is a copy of the oath or declaration from a prior application to avoid the oath or declaration being incorrectly matched with the prior application file.

These steps help ensure that the oath or declaration is correctly associated with the new application and not mistakenly matched with the prior application file.

To learn more:

Tags: declaration, oath

In the first Office action of a Continued Prosecution Application (CPA), examiners should include specific information to advise the applicant about the status of their application. The MPEP ¶ 2.35 provides guidance on this matter:

Use this form paragraph in the first Office action of a CPA to advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request and the CPA is acceptable and that a CPA has been established.

This notice is crucial because:

  • Applicants are not notified of the abandonment of the parent application
  • A filing receipt is not normally sent for a CPA

By including this information, examiners ensure that applicants are fully informed about the status and treatment of their CPA request.

For more information on design patents, visit: design patents.

If examiners find that drawings are inconsistent with the specification in a patent application, they should:

  • Identify the specific inconsistencies
  • Object to the drawings and/or specification as appropriate
  • Provide clear explanations of the inconsistencies in the Office action
  • Require the applicant to correct the inconsistencies

MPEP 608.02(e) states: ‘The examiner should see to it that the drawings are correct, complete, and consistent with the specification and claims.’ This responsibility includes ensuring that the drawings accurately reflect the invention described in the specification and that there are no contradictions between the textual description and the visual representation.

To learn more:

The incorporation-by-reference statement in a patent application should include information about specific types of electronic documents that are to become part of the permanent USPTO records. According to 37 CFR 1.77(b)(5), this statement should identify:

  • The names of each file
  • The date of creation of each file
  • The size of each file in bytes

This applies to the following document types:

  • A ‘Computer Program Listing Appendix’
  • A ‘Sequence Listing’
  • ‘Large Tables’
  • An XML file for a ‘Sequence Listing XML’

The MPEP states, The specification is required to include an incorporation-by-reference of electronic documents that are to become part of the permanent United States Patent and Trademark Office records in the file of a patent application.

To learn more:

According to MPEP 608.01(d) and 37 CFR 1.73, the Brief Summary of Invention should include:

  • The nature and substance of the invention
  • Optionally, a statement of the object of the invention
  • One or more clear, concise sentences or paragraphs describing the subject matter of the invention
  • The exact nature, operation, and purpose of the invention

The MPEP states, “The brief summary, if properly written to set out the exact nature, operation, and purpose of the invention, will be of material assistance in aiding ready understanding of the patent in future searches.” This emphasizes the importance of clarity and specificity in the summary.

To learn more:

The brief description of drawings for a patent application should include:

  • A reference to each figure by number (e.g., Figure 1, Figure 2)
  • A brief explanation of what each figure depicts

According to MPEP 608.01(f): The specification must contain or be amended to contain a brief description of the several views of the drawings.

It’s important to note that this section should be concise and not include detailed descriptions of the drawings, which belong in the Detailed Description section.

To learn more:

To learn more:

Tags: drawings

The Background of the Invention section in a patent application may include two main parts:

  1. Field of the Invention: A statement describing the field of art to which the invention pertains. This may include a paraphrasing of applicable Cooperative Patent Classification (CPC) definitions.
  2. Description of the related art: Information about the state of the prior art, including references to specific prior art where appropriate. This section should also describe any problems in the prior art that the invention solves.

It’s important to note that while these components are typical, they are not strictly required. As stated in MPEP 608.01(c), “The Background of the Invention may (but is not required to) include the following parts…”

To learn more:

Tags: prior art

When canceling a patent drawing, the ‘Annotated Sheet’ should include:

  • The original drawing sheet with the canceled figure.
  • A clear annotation showing that the drawing has been canceled.
  • A label clearly marking it as “Annotated Sheet”.

According to MPEP 608.02(t): “The marked-up (annotated) copy must be clearly labeled as ‘Annotated Sheet’ and must be presented in the amendment or remarks section of the amendment document which explains the changes to the drawings.” This annotated sheet serves as a record of the cancellation and helps examiners and others understand the changes made to the application.

To learn more:

When submitting replacement drawing sheets for patent applications, applicants should ensure the following:

  1. Include all figures from the immediate prior version of the sheet, even if only one figure is being amended.
  2. Label the sheet as ‘Replacement Sheet’ in the top margin.
  3. Include the application number and art unit in the upper center margin.
  4. Do not label amended drawing figures as ‘amended’.
  5. Remove canceled figures and renumber remaining figures if necessary.

The MPEP 608.02(b) states:

Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as ‘amended.’

Additionally, a marked-up copy of the replacement sheet with annotations indicating changes may be required.

To learn more:

Patent drawings should include every feature of the invention specified in the claims, as required by 37 CFR 1.83(a). Key elements to include are:

  • All claimed features of the invention
  • Sufficient views to show the entire structure of the invention
  • Proper use of reference characters corresponding to elements described in the specification
  • Conventional features may be shown as a labeled rectangular box

However, the drawings should not contain excessive text or duplicate information already present in the specification. Tables and sequences included in the specification should not be duplicated in the drawings.

If the nature of the invention allows, the drawings should also show the improved portion disconnected from the old structure, as well as enough of the old structure to show the connection of the invention, as per 37 CFR 1.83(b).

To learn more:

A patent specification should include:

  • A written description of the invention
  • The manner and process of making and using the invention
  • The best mode contemplated by the inventor for carrying out the invention
  • One or more claims particularly pointing out and distinctly claiming the subject matter of the invention

As stated in 37 CFR 1.71(a): “The specification must include a written description of the invention or discovery and of the manner and process of making and using the same, and is required to be in such full, clear, concise, and exact terms as to enable any person skilled in the art or science to which the invention or discovery appertains, or with which it is most nearly connected, to make and use the same.”

To learn more:

A patent application abstract should include a concise summary of the key technical elements of the invention. The MPEP 608.01(b) states:

The abstract should sufficiently describe the disclosure to assist readers in deciding whether there is a need for consulting the full patent text for details.

The abstract should cover:

  • The technical disclosure of the improvement
  • The nature and gist of the invention
  • The principal use of the invention

It’s important to note that legal phraseology often used in patent claims should be avoided in the abstract.

To learn more:

A patent abstract should include:

  • A concise statement of the technical disclosure
  • What is new in the art to which the invention pertains
  • For a machine or apparatus: its organization and operation
  • For an article: its method of making
  • For a chemical compound: its identity and use
  • For a mixture: its ingredients
  • For a process: the steps involved

The MPEP states: The abstract should not refer to purported merits or speculative applications of the invention and should not compare the invention with the prior art.

For chemical patents, the general nature of the compound or composition should be given as well as the use thereof, e.g., ‘The compounds are of the class of alkyl benzene sulfonyl ureas, useful as oral anti-diabetics.’

To learn more:

Papers related to property rights under the Atomic Energy Act or National Aeronautics and Space Act require special handling. According to MPEP 150:

Any papers pertaining to property rights under section 152 of the Atomic Energy Act, 42 U.S.C. 2182, (DOE), or section 305(c) or the National Aeronautics and Space Act, 42 U.S.C. 2457, (NASA), that have not been associated with the application file, or have not been made of record in the file and processed by the Licensing and Review section, must be sent to the Licensing and Review section immediately.

Key points:

  • Papers related to property rights under these acts must be properly associated with the application file
  • If not already processed by the Licensing and Review section, they must be sent there immediately
  • This ensures proper handling and review of sensitive information related to atomic energy or space activities

For more information on National Aeronautics and Space Act, visit: National Aeronautics and Space Act.

For more information on USPTO procedures, visit: USPTO procedures.

If there’s an error in the preprinted prior application data, the following steps should be taken:

  1. If the error is in the Patent Data Portal database, it can be corrected by technical support staff of the Technology Center.
  2. After the data is corrected, a new bib-data sheet should be printed and scanned into the file.
  3. If the error was made by the applicant, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.
  4. In some cases, a petition for an unintentionally delayed benefit claim may also be required.

The MPEP states: “Should there be an error in the preprinted prior application data, the correction or entry of the data in the Patent Data Portal data base can be made by technical support staff of the Technology Center, if appropriate. Upon entry of the data, a new bib-data sheet should be printed and scanned into the file. If the error was an applicant error, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.” (MPEP 202)

If inventorship changes after filing a property rights statement, MPEP 151 provides specific guidance:

“If a request under 37 CFR 1.48 for correction of inventorship is granted during pendency of an application in which a property rights statement has been filed, a supplemental statement executed by any added inventor(s) is required and should promptly be filed with Licensing and Review.”

This means that if new inventors are added to the application, they must file a supplemental statement to ensure compliance with the Atomic Energy Act and NASA Act requirements. It’s important to file this supplemental statement promptly to maintain proper documentation.

For more information on patent procedure, visit: patent procedure.

For more information on property rights statement, visit: property rights statement.

If a legal representative of a deceased inventor refuses to make application, the procedure depends on when the application was filed:

  • For applications filed before September 16, 2012: Pre-AIA 37 CFR 1.47 applies. The MPEP states: pre-AIA 37 CFR 1.47 does apply where a known legal representative of a deceased inventor cannot be found or reached after diligent effort, or refuses to make application.
  • In this case, you should:
    1. Document the refusal and the efforts made to reach the legal representative.
    2. Provide the last known address of the legal representative, as per MPEP § 409.03(e).
    3. File the application under pre-AIA 37 CFR 1.47, explaining the situation.
  • For applications filed on or after September 16, 2012: Different procedures apply, which are not covered in this specific MPEP section. Consult the current USPTO regulations and guidelines for the appropriate course of action.

It’s important to note that these procedures are specific to cases where there is a known legal representative who is refusing to cooperate. Different rules may apply in other scenarios involving deceased inventors.

To learn more:

What should be avoided when creating a patent title?

When creating a patent title, it’s important to avoid certain elements that may make the title less effective or non-compliant. According to MPEP 606:

“The title should not be descriptive of a particular embodiment, species or range.”

Additionally, you should avoid:

  • Unnecessarily long titles
  • Overly broad or vague descriptions
  • Trademarks or trade names
  • Acronyms or abbreviations that are not widely recognized

The goal is to create a title that is concise, specific to the invention, and informative about its nature and purpose.

To learn more:

When applicants receive a Notice of Allowance, they should take specific actions regarding PDX as outlined in MPEP 215.01:

Upon receipt of a Notice of Allowance, applicants should check to see whether the Office has received a copy of the foreign application under the priority document exchange program because successful retrieval of priority documents cannot be guaranteed.

Important steps for applicants:

  • Verify that the USPTO has received the foreign priority document.
  • If the document hasn’t been received, consider filing a paper certified copy.
  • Ensure the priority document is received before the patent is granted.
  • Be aware that if a certified copy is filed after the issue fee is paid, the patent won’t include the priority claim unless corrected by a certificate of correction.

It’s crucial to confirm receipt of the priority document to maintain the priority claim in the issued patent.

To learn more:

If an applicant receives no response to a status inquiry, the MPEP provides the following guidance:

  • The MPEP states: If after a reasonable amount of time no reply has been received, applicants may contact the TC customer service center or CRU.
  • For regular patent applications, contact the Technology Center (TC) customer service center at (571) 272-3900.
  • For reexamination proceedings, contact the Central Reexamination Unit (CRU) at (571) 272-7705.
  • When following up, provide all relevant information, including application number, filing date, and any previous communication references.

It’s important to allow a reasonable time for a response before escalating the inquiry, and to use the appropriate contact channels as specified in the MPEP.

To learn more:

If an applicant’s patent attorney or agent is suspended, they should take the following steps:

  1. File a new power of attorney in the application to have a registered attorney or agent represent them before the Office.
  2. Ensure all future papers are signed by authorized parties (see MPEP § 407, Form Paragraph 4.07 for details on who can sign).
  3. If necessary, find a new registered patent attorney or agent using USPTO resources.
  4. Update the correspondence address for the application if it was previously associated with the suspended practitioner.

It’s important to act promptly to ensure continued proper representation and communication with the USPTO.

If an applicant’s drawing corrections are rejected, they should carefully review the examiner’s comments in the Office action. According to MPEP 608.02(x):

“The applicant will be notified and informed of any required corrective action in the next Office action.”

Applicants should:

  • Carefully read the examiner’s explanation for the rejection
  • Address all issues raised by the examiner
  • Ensure new submissions don’t introduce new matter
  • Include all necessary corrections
  • Consider consulting with a patent attorney or agent if the issues are complex

After addressing the examiner’s concerns, applicants can submit new drawing corrections for review in their response to the Office action.

To learn more:

To learn more:

If an inventor cannot comprehend the documents related to their oath or declaration, the MPEP 602.06 provides guidance:

“If the documents are in a language the individual cannot comprehend, the documents may be explained to him or her so that he or she is able to understand them.”

This means that the content of the documents can be explained to the inventor in a language they understand, allowing them to make an informed oath or declaration. It’s crucial that the inventor understands the content of the documents they are swearing to or declaring, even if they cannot read the original language.

To learn more:

Tags: declaration, oath

When an examiner receives a pre-AIA 37 CFR 1.47 application, they must follow these steps:

“When an examiner receives an application in which a petition under pre-AIA 37 CFR 1.47 has been filed, he or she must check the file to determine that the petition has been decided by the Office of Petitions. If the petition has not been decided by the Office of Petitions, the application, or an electronic message concerning the petition, must be forwarded to the Office of Petitions for appropriate action.”

In essence, the examiner must verify that the Office of Petitions has made a decision on the pre-AIA 37 CFR 1.47 petition. If not, the examiner must forward the application or relevant information to the Office of Petitions for further processing.

To learn more:

To learn more:

When an examiner encounters an application with national security markings but no Secrecy Order, they must take specific actions. The MPEP instructs: In this case, the examiner should require the applicant to seek imposition of a Secrecy Order or authority to cancel the markings. This should preferably be done with the first action and, in any event, prior to final disposition of the application. This ensures that potentially sensitive information is properly handled during the examination process.

For more information on national security markings, visit: national security markings.

For more information on patent examination, visit: patent examination.

When examining a patent application, it’s crucial for the examiner to verify and indicate whether the conditions of 35 U.S.C. 119(a)-(d) or (f) have been met. These sections relate to the right of priority for foreign applications.

The MPEP instructs: However, the examiner must still indicate in the Office action and on the bib-data sheet whether the conditions of35 U.S.C. 119(a)-(d)or(f)have been met. (MPEP 202)

This means the examiner should:

  • Review the foreign priority claim
  • Determine if all conditions for the claim have been satisfied
  • Indicate the status of the claim in the Office action
  • Mark the bib-data sheet accordingly

If the conditions are met, this information will be reflected on the front page of the issued patent and in the Official Gazette listing. For more information on foreign priority claims, see MPEP § 213.

For more information on foreign priority, visit: foreign priority.

For more information on patent examination, visit: patent examination.

What should an examiner do if an IDS is filed after the first Office action?

If an Information Disclosure Statement (IDS) is filed after the first Office action, the examiner should follow these steps:

  • Check if the IDS complies with the requirements of 37 CFR 1.97(c) and 37 CFR 1.97(e).
  • Ensure that the appropriate fee or certification is included.
  • If compliant, consider the information submitted in the IDS.
  • If necessary, issue a supplemental Office action addressing any newly cited references.

As stated in MPEP 609.01: ‘The examiner should consider the information submitted in an IDS in the same manner as other documents in Office search files are considered by the examiner while conducting a search of the prior art in a proper field of search.’

To learn more:

An examiner should check the following on the bib-data sheet regarding prior applications:

  1. Accuracy of prior application data, including provisional application data
  2. Whether the application is copending with prior nonprovisional applications for which benefit is claimed
  3. Correct application numbers of provisional applications for which benefit is claimed
  4. Proper listing of foreign applications qualifying for benefits under 35 U.S.C. 119(a)-(d)

MPEP 202 instructs: “Where the data is correct, the examiner should initial the bib-data sheet in the provided space. Should there be an error in the preprinted prior application data, the correction or entry of the data in the Patent Data Portal data base can be made by technical support staff of the Technology Center, if appropriate.”

If an applicant’s Information Disclosure Statement (IDS) is not considered due to noncompliance, they have options to address the issue. According to MPEP 609.05(a):

Applicant may then file a new information disclosure statement or correct the deficiency in the previously filed IDS, but the date that the new IDS or correction is filed will be the date of the IDS for purposes of determining compliance with the requirements based on the time of filing of the IDS (37 CFR 1.97).

This means the applicant can either:

  • File a new, compliant IDS
  • Correct the deficiencies in the previously filed IDS

It’s important to note that the date of the new or corrected IDS will be considered the filing date for compliance purposes. Applicants should ensure they address the specific issues mentioned in the examiner’s notification to avoid further delays.

To learn more:

If new matter is objected to in a patent application, the applicant must take specific actions to address the objection. According to the MPEP, the examiner will use Form Paragraph 7.28, which states:

Applicant is required to cancel the new matter in the reply to this Office action.

To respond, the applicant should:

  1. Review the identified new matter carefully.
  2. If the applicant agrees it’s new matter, cancel the objected content in their response.
  3. If the applicant disagrees, provide a detailed explanation demonstrating how the original disclosure supports the contested material.
  4. Consider amending the application to use language more closely aligned with the original disclosure.

It’s crucial to address all new matter objections promptly to avoid potential rejections under 35 U.S.C. 112(a).

To learn more:

Tags: new matter

When a patent examiner encounters an application that appears to be a divisional but lacks a proper benefit claim, they should follow the guidance provided in MPEP ¶ 2.01. The MPEP states:

“This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.”

In such cases, the examiner should:

  1. Recognize that the application may potentially be a divisional based on its content and relationship to a prior application.
  2. Note that the applicant has not properly established a benefit claim to the prior application.
  3. Use the appropriate form paragraph (as mentioned in MPEP ¶ 2.01) to inform the applicant about the potential divisional status and the need to establish a proper benefit claim.
  4. Direct the applicant’s attention to the relevant laws and regulations for claiming benefit, specifically: 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

By following these steps, the examiner ensures that the applicant is aware of the potential divisional status and has the opportunity to properly establish the benefit claim if desired.

For more information on Divisional application, visit: Divisional application.

Risks of Self-Representation in Patent Applications

While individuals can file pro se patent applications, there are several risks to consider:

  1. Lack of expertise: Patent law is complex, and lack of familiarity with examination practices may result in missed opportunities for optimal protection.
  2. Potential sanctions: According to MPEP 401, pro se applicants are subject to the same certifications and potential sanctions as represented applicants:

In presenting (whether by signing, filing, submitting, or later advocating) papers to the Office, a pro se applicant is making the certifications under 37 CFR 11.18(b), and may be subject to sanctions under 37 CFR 11.18(c) for violations of 37 CFR 11.18(b)(2).

Given these risks, the USPTO may suggest hiring a registered patent practitioner if they notice an applicant is unfamiliar with the process and the application contains potentially patentable subject matter.

For more information on pro se, visit: pro se.

For more information on self-representation, visit: self-representation.

Patent ownership gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent. This is stated in 35 U.S.C. 154(a)(1).

However, ownership does not necessarily give the owner the right to make, use, sell or import the invention, as there may be other legal considerations such as:

  • Existence of another patent owner with a dominant patent
  • Failure to obtain FDA approval
  • An injunction by a court
  • National security issues

Patent ownership grants the owner the right to exclude others from making, using, offering for sale, selling, or importing the patented invention into the United States. However, it’s important to note that ownership does not automatically grant the right to practice the invention. The MPEP states:

‘Ownership of a patent gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent. 35 U.S.C. 154(a)(1). Ownership of the patent does not furnish the owner with the right to make, use, offer for sale, sell, or import the claimed invention because there may be other legal considerations precluding same…’

These other considerations may include existing patents, regulatory approvals, or legal injunctions.

Patent ownership gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing the claimed invention into the United States. As stated in 35 U.S.C. 154(a)(1):

Ownership of a patent gives the patent owner the right to exclude others from making, using, offering for sale, selling, or importing into the United States the invention claimed in the patent.

However, it’s important to note that ownership does not automatically grant the right to practice the invention, as there may be other legal considerations such as other dominant patents, regulatory approvals, or court injunctions.

For more information on exclusionary rights, visit: exclusionary rights.

For more information on patent rights, visit: patent rights.

An assignee of the entire interest in a patent application has broader rights regarding inspection compared to a part interest assignee. According to MPEP 106.01, an assignee of the entire interest may inspect the application file wrapper and be granted access to the subject matter of the application. This is because they have acquired all rights to the patent application and are considered to have stepped into the shoes of the inventor(s) for all practical purposes related to the application.

An assignee of part interest in a patent application has the following rights:

  • They may access the application file (except when it’s under a secrecy order)
  • They may intervene in the prosecution of the application to protect their interests
  • They may file papers against the wishes of the inventor or other assignees, subject to the Commissioner’s discretion

As stated in MPEP 106.01: “An assignee of part interest in the entire right, title and interest in an application … has the right to inspect and obtain copies of papers in the application file.”

To learn more:

A nonsigning inventor in a pre-AIA 37 CFR 1.47 application retains certain rights, as outlined in MPEP 409.03(i):

  • May protest their designation as an inventor
  • Can inspect any paper in the application
  • May order copies of application documents
  • Can make their position of record in the application file
  • Has the option to join the application later by filing an oath/declaration
  • Retains inventor rights for patent issuance

However, the nonsigning inventor cannot:

  • Prosecute the application if status under 37 CFR 1.47 is accorded
  • Revoke power of attorney without agreement of the 37 CFR 1.47 applicant

The MPEP states: The rights of a nonsigning inventor are protected by the fact that the patent resulting from an application filed under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118 must issue to the inventor, and in an application filed under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the inventor has the same rights that he or she would have if he or she had joined in the application.

To learn more:

To learn more:

A nonsigning inventor, also known as an ‘inventor designee,’ has several rights in a patent application filed under pre-AIA 37 CFR 1.47. These rights include:

  • The right to protest their designation as an inventor
  • The right to inspect any paper in the application
  • The right to order copies of application documents at the price set forth in 37 CFR 1.19
  • The right to make their position of record in the file wrapper of the application

As stated in MPEP 409.03(i): “The nonsigning inventor is entitled to inspect any paper in the application, order copies thereof at the price set forth in 37 CFR 1.19, and make his or her position of record in the file wrapper of the application.”

It’s important to note that while these rights are granted, the nonsigning inventor is not entitled to prosecute the application if status under pre-AIA 37 CFR 1.47 has been accorded.

To learn more:

To learn more:

According to MPEP 106.01, assignees of a part interest or licensees of exclusive right have the right to inspect the patent application. The MPEP states:

“[A]n assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.”

However, it’s important to note that these parties do not have the right to intervene in the prosecution of the application or interference, which is reserved for the assignee of record of the entire interest.

For more information on partial assignee rights, visit: partial assignee rights.

For more information on patent application inspection, visit: patent application inspection.

Partial assignees and exclusive licensees have specific rights regarding patent application inspection. According to MPEP 106.01, “an assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.” This means that even if you don’t own the entire interest in a patent application, you still have the right to review its contents.

However, it’s important to note that partial assignees cannot intervene in the prosecution of an application or interference to the exclusion of the applicant. Only the assignee of record of the entire interest has this ability.

For more information on patent rights, visit: patent rights.

Partial assignees have limited rights regarding the inspection of patent applications. According to MPEP 106.01, an assignee of a part interest in a patent application is not entitled to inspect the application without written authority from the inventor or the other assignee(s). This restriction is in place to protect the interests of all parties involved in the patent application process.

Joint owners of a patent have specific rights as outlined in 35 U.S.C. 262, which states:

‘In the absence of any agreement to the contrary, each of the joint owners of a patent may make, use, offer to sell, or sell the patented invention within the United States, or import the patented invention into the United States, without the consent of and without accounting to the other owners.’

This means that each joint owner can independently exercise the full rights of the patent without needing permission from or owing compensation to the other joint owners, unless they have a separate agreement stating otherwise.

USPTO employees are subject to several restrictions regarding patents:

  • They cannot apply for a patent during their employment and for one year after.
  • They cannot acquire any patent or interest in a patent, directly or indirectly, except through inheritance or bequest, during employment and for one year after.
  • For patents applied for after the one-year period, they cannot claim a priority date earlier than one year after their employment ends.

These restrictions are outlined in 35 U.S.C. 4, which states:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office. In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.’

The USPTO, through its Office of Enrollment and Discipline, provides valuable resources to client-applicants when their patent practitioner dies. The MPEP 406 states:

‘The Office of Enrollment and Discipline will notify the client-applicant of the availability of a list of patent practitioners who may be available to represent the client-applicant.’

This list serves as a crucial resource, helping client-applicants find new representation to continue their patent prosecution process without significant delays.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO Resources, visit: USPTO Resources.

Inventors are required to provide their place of residence in patent applications. According to MPEP 602.08(a):

“Each inventor’s place of residence, that is, the city and either state or foreign country, is required to be included in the oath or declaration in a nonprovisional application for compliance with 37 CFR 1.63 unless it is included in an application data sheet (37 CFR 1.76).”

For provisional applications, the residence must be included on the cover sheet or in an application data sheet.

To learn more:

To learn more:

To claim priority based on an inventor’s certificate, applicants must meet specific requirements outlined in 37 CFR 1.55(l):

To claim the right of priority on the basis of an application for an inventor’s certificate in such a country under 35 U.S.C. 119(d), the applicant when submitting a claim for such right as specified in this section, must include an affidavit or declaration.

The affidavit or declaration must state that:

  • The applicant had the option to file for either a patent or an inventor’s certificate in the foreign country
  • This option existed for the particular subject matter of the invention

It’s important to note that the affidavit is only required to ascertain the general existence of this option in the foreign country, not to probe into the eligibility of the particular applicant.

To learn more:

The use of annotated sheets in patent drawings is governed by specific regulations. MPEP 608.02(v) references two key regulations: “See 37 CFR 1.84(c) and 1.121(d).” 37 CFR 1.84(c) provides guidelines for identifying and labeling drawings, while 37 CFR 1.121(d) outlines the procedures for making changes to drawings. These regulations ensure that annotated sheets are properly prepared and submitted in accordance with USPTO requirements.

To learn more:

A small entity for purposes of paying reduced patent fees is defined in 37 CFR 1.27(a) as:

  • A person
  • A small business concern
  • A nonprofit organization

Each of these categories has specific criteria that must be met to qualify for small entity status. For example, a person must not have assigned, granted, conveyed, or licensed any rights in the invention to a non-small entity.

To learn more:

For a pre-AIA 37 CFR 1.47(b) application, the applicant must prove one of the following:

  • The invention has been assigned to the applicant
  • The inventor has agreed in writing to assign the invention to the applicant
  • The applicant otherwise has sufficient proprietary interest in the subject matter to justify filing the application

As stated in MPEP 409.03(f):

“When an application is deposited pursuant to pre-AIA 37 CFR 1.47(b), the pre-AIA 37 CFR 1.47(b) applicant must prove that (A) the invention has been assigned to the applicant, or (B) the inventor has agreed in writing to assign the invention to the applicant, or (C) the applicant otherwise has sufficient proprietary interest in the subject matter to justify the filing of the application.”

The specific documentation required depends on which of these conditions is being met.

To learn more:

To learn more:

When filing under pre-AIA 37 CFR 1.47, the applicant must provide proof that the nonsigning inventor is unavailable or refusing to sign. According to MPEP 409.03(d):

  • For an unavailable inventor, submit a statement of facts describing the diligent efforts made to find or reach the inventor. Include documentary evidence like Internet searches, certified mail receipts, etc.
  • For a refusing inventor, provide evidence that the application was presented to the inventor for signature and they refused. This can include:
    • A statement detailing the circumstances of the presentation and refusal
    • Documentary evidence of written refusal
    • Statement of the reasons given by the inventor for refusing

The section states: Where inability to find or reach a nonsigning inventor ‘after diligent effort’ is the reason for filing under pre-AIA 37 CFR 1.47, a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.

To learn more:

The USPTO provides specific procedures for resubmitting returned patent documents. According to MPEP 317.01:

“The procedure set forth in § 1.8 or § 1.10 of this chapter may be used for resubmissions of returned papers to have the benefit of the date of deposit in the United States Postal Service.”

This means that when resubmitting corrected documents, you can use either the Certificate of Mailing procedure (37 CFR 1.8) or the Express Mail procedure (37 CFR 1.10) to potentially preserve the original filing date based on the postal deposit date.

To learn more:

The USPTO accepts multiple payment methods for the electronic submission of assignment documents through the Electronic Patent Assignment System (EPAS). As stated in MPEP 302.10:

“Customers may submit assignments electronically by accessing the Office’s website and paying the required fee by credit card, electronic fund transfer (EFT) or deposit account.”

These payment options provide flexibility for users when submitting assignment documents electronically. It’s important to ensure that you have one of these payment methods available before initiating the submission process.

To learn more:

According to 37 CFR 1.11(a), the following patent application files are open to public inspection:

  • Published applications
  • Patents
  • Statutory invention registrations

The public can obtain copies of these files upon payment of the fee set forth in 37 CFR 1.19(b)(2). However, if an application was published in redacted form, the complete file may not be available if certain requirements are met and the application is still pending.

If an applicant is notified of missing items in their application, they generally have the following options:

  1. Establish prior receipt of the missing items in the USPTO
  2. Submit the missing items and request a later filing date
  3. Accept the application as deposited without the missing items

The USPTO states: The mailing of an OPAP notice regarding a missing page(s) of specification in a nonprovisional application will permit the applicant to:

  • (A) promptly establish prior receipt in the USPTO of the page(s) at issue…
  • (B) promptly submit the omitted page(s) in a nonprovisional application and accept the date of such submission as the application filing date…
  • (C) accept the application as deposited in the USPTO…

For each option, specific procedures and requirements must be followed. For example, to establish prior receipt, the applicant must file a petition with evidence such as a date-stamped postcard receipt. To submit missing items and request a later filing date, a petition with the required fee must be filed. To accept the application as deposited, the applicant may need to file amendments to the specification or claims.

The specific actions required depend on the type of missing item and the circumstances of the application. Applicants should carefully review the notice and the relevant MPEP sections to determine the best course of action.

To learn more:

If you miss the 12-month deadline for claiming the benefit of a provisional application, you have two main options:

  1. Delete the claim to the benefit of the prior-filed provisional application.
  2. File a petition to restore the benefit of the provisional application.

The MPEP states:

“Alternatively, applicant may wish to file a petition to restore the benefit of the provisional application under 37 CFR 1.78 in the subsequent nonprovisional application or international application designating the United States if the subsequent application was filed within two months from the expiration of the twelve-month period and the delay was unintentional.”

This petition must be filed in the subsequent application and include specific requirements, such as a reference to the provisional application, a petition fee, and a statement that the delay was unintentional.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For applications filed on or after September 16, 2012:

  • An assignee or obligated assignee may file the application as the applicant
  • A person who shows sufficient proprietary interest may file the application on behalf of and as agent for the inventor
  • The applicant may file a substitute statement in lieu of an inventor’s oath or declaration if the inventor has refused to execute the oath or declaration

For applications filed before September 16, 2012, a petition under pre-AIA 37 CFR 1.47 could be filed.

After payment of the issue fee, submitting an Information Disclosure Statement (IDS) becomes more challenging. However, there are several options available:

  • File a petition to withdraw the application from issue under 37 CFR 1.313(c)(2) or 1.313(c)(3)
  • File a Request for Continued Examination (RCE) under 37 CFR 1.114
  • File a continuing application under 37 CFR 1.53(b) or a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) for design applications
  • Use the Quick Path Information Disclosure Statement (QPIDS) Pilot Program

As stated in MPEP 609.04(b): The application may be withdrawn from issue at this point, pursuant to 37 CFR 1.313(c)(2) or 1.313(c)(3) so that the information can be considered in the application upon the filing of a RCE under 37 CFR 1.114 or in a continuing application filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if the application is a design application).

To learn more:

For applications filed on or after September 16, 2012, if an inventor is deceased or legally incapacitated:

  • The legal representative of the inventor may make the application for patent on behalf of the inventor.
  • An assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest may file the application as the applicant.

As stated in MPEP § 409.01(a): “If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.”

For more information on legal representative, visit: legal representative.

When an arbitration award is made involving a patent, there are specific notice requirements as outlined in 35 U.S.C. 294(d) and 37 CFR 1.335. Key points include:

  • The patentee, assignee, or licensee must provide written notice to the USPTO Director.
  • A separate notice is required for each patent involved.
  • The notice must include names and addresses of parties, inventor name, patent owner name, patent number, and a copy of the award.
  • If the award is modified by a court, notice of the modification must also be filed.

Failure to file the required notice can result in the award being unenforceable.

An applicant who shows sufficient proprietary interest in the matter must submit a petition with their patent application, including:

  1. The fee set forth in § 1.17(g)
  2. A showing that the person has sufficient proprietary interest in the matter
  3. A statement that making the application for patent by this person on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

This requirement is outlined in 37 CFR 1.46(b)(2): If the applicant is a person who otherwise shows sufficient proprietary interest in the matter, such applicant must submit a petition including: (i) The fee set forth in § 1.17(g); (ii) A showing that such person has sufficient proprietary interest in the matter; and (iii) A statement that making the application for patent by a person who otherwise shows sufficient proprietary interest in the matter on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties.

When filing under pre-AIA 37 CFR 1.47(b), an applicant must prove that the filing of the application is necessary for specific reasons. The MPEP outlines two primary justifications:

  1. To preserve the rights of the parties
  2. To prevent irreparable damage

Specifically, the MPEP states: “The pre-AIA 37 CFR 1.47(b) applicant must prove that the filing of the application is necessary (1) to preserve the rights of the parties or (2) to prevent irreparable damage.”

This requirement ensures that the use of pre-AIA 37 CFR 1.47(b) is justified and not merely a matter of convenience. For more detailed information on proving necessity, refer to MPEP § 409.03(g).

To learn more:

Tags: pre-AIA

The key factors for acceptable patent drawings are readability and reproducibility. MPEP 608.02(i) states that “Drawings that do not comply with all of the form requirements of 37 CFR 1.84 may be acceptable for the purposes of publication and examination if the drawings are readable and reproducible for publication purposes.” This means that even if drawings don’t meet all formal requirements, they may still be accepted if they clearly convey the invention and can be properly reproduced in published documents. However, applicants should still aim to comply with 37 CFR 1.84 to ensure the best possible representation of their invention.

To learn more:

A good title for a patent application should be descriptive and clearly indicative of the invention. The MPEP 606.01 states that “This may result in slightly longer titles, but the loss in brevity of title will be more than offset by the gain in its informative value in indexing, classifying, searching, etc.” A well-crafted title helps in accurately categorizing and searching for the invention in patent databases.

To learn more:

A good patent application title should adhere to the guidelines set forth in MPEP 606. The key characteristics are:

  1. Brief: The title should be concise, avoiding unnecessary words.
  2. Technically accurate: It should correctly represent the technical aspects of the invention.
  3. Descriptive: The title should give a clear idea of what the invention is about.
  4. Within character limit: As stated in MPEP 606, “The title… should contain fewer than 500 characters.”

Additionally, a good title should:

  • Focus on the key innovative features of the invention
  • Avoid unnecessary articles or non-descriptive terms at the beginning
  • Be understandable to someone skilled in the relevant field

Remember, the title is often the first thing examiners and other readers see, so it should effectively communicate the essence of your invention.

To learn more:

What makes a good patent application title according to MPEP?

According to MPEP 606.01, a good patent application title should be:

  • Brief: Usually fewer than 500 characters in length
  • Descriptive: Clearly indicative of the invention’s nature
  • Specific: Particular to the claimed invention
  • Non-Generic: Avoid broad, general terms like “device,” “process,” or “apparatus”

The MPEP states, “The title of the invention should be placed at the top of the first page of the specification unless it is provided in the application data sheet. The title should be brief but technically accurate and descriptive.” This guidance ensures that the title effectively communicates the essence of the invention to patent examiners and the public.

To learn more:

What limited recognition is granted to suspended or excluded practitioners?

Suspended or excluded practitioners are granted limited recognition to handle specific tasks related to pending applications. According to MPEP 407:

“The suspended or excluded practitioner will be granted limited recognition for a period of thirty (30) days, during which time the practitioner may conclude work on behalf of a client on any matters pending before the Office.”

This limited recognition allows the practitioner to:

  • Conclude or withdraw from representation in pending proceedings
  • Receive and forward correspondence
  • Make appropriate filings to protect the client’s rights

However, this recognition is strictly limited to these activities and does not allow the practitioner to engage in new patent prosecution work.

For more information on pending applications, visit: pending applications.

The ‘Detailed Description of Invention’ section requires a comprehensive and precise level of detail. According to MPEP 608.01(g):

“This detailed description, required by 37 CFR 1.71, MPEP §§ 608.01, 2161, and 2162, must be in such particularity as to enable any person skilled in the pertinent art or science to make and use the invention without involving extensive experimentation and must clearly convey enough information about the invention to show that applicant invented the subject matter that is claimed.”

The level of detail should include:

  • Enablement: Sufficient information for a skilled person to make and use the invention without undue experimentation.
  • Complete Disclosure: All aspects of the invention claimed should be thoroughly described.
  • Clear Support: Provide clear support for all terms used in the claims.
  • Best Mode: The best mode contemplated by the inventor for carrying out the invention.
  • Drawings Reference: Detailed explanation of all parts referenced in the drawings.

While the description should be comprehensive, it’s important to note that grammatical perfection is not the primary focus. The key is to provide a clear, enabling disclosure of your invention that supports your claims and demonstrates your invention to the fullest extent.

To learn more:

According to the MPEP 602.06, if an inventor understands English, it is preferable to use English for oaths and declarations. The manual states:

“If the individual comprehends the English language, he or she should preferably use it.”

This preference for English, when possible, likely helps streamline the patent application process and reduces the need for translations. However, it’s important to note that the primary requirement is for the inventor to understand the language used, whether it’s English or another language.

To learn more:

Tags: declaration, oath

Voluntary arbitration in patent disputes is a process outlined in 35 U.S.C. 294 where parties can agree to settle disputes related to patent validity or infringement through arbitration. The law states:

‘A contract involving a patent or any right under a patent may contain a provision requiring arbitration of any dispute relating to patent validity or infringement arising under the contract.’

This allows parties to resolve patent-related conflicts outside of the court system, potentially saving time and resources.

The United States Patent and Trademark Office (USPTO) has a clear recommendation regarding the submission of preliminary amendments. According to MPEP 608.04(b):

Applicants are strongly encouraged to avoid submitting any preliminary amendments so as to minimize the burden on the Office in processing preliminary amendments and reduce delays in processing the application.

The USPTO advises applicants to incorporate desired amendments directly into the text of the specification rather than submitting separate preliminary amendments. This approach is recommended even for continuation or divisional applications of prior-filed applications. By following this guidance, applicants can help streamline the application process and potentially reduce processing times.

To learn more:

The USPTO does not process requests for indexing or cross-referencing additional patent numbers or application numbers against a document previously recorded in the Assignment Division, unless it’s an assignment. This policy is based on compliance with 37 CFR 3.11, 3.28, and 3.31.

As stated in MPEP 315: “The Office does not process requests for ‘indexing’ or ‘cross-referencing’ additional patent numbers or application numbers against a document, other than an assignment, previously recorded in the Assignment Division.”

For more information on Assignment Division, visit: Assignment Division.

For more information on document recording, visit: document recording.

For more information on USPTO policy, visit: USPTO policy.

What is the USPTO’s policy on federal holidays?

The USPTO observes federal holidays and has specific policies regarding correspondence and deadlines that fall on these days:

  • The USPTO is closed on all federal holidays.
  • Deadlines that fall on a federal holiday are extended to the next business day.
  • Correspondence is not accepted or processed on federal holidays.

According to MPEP 502: ‘Federal holidays falling on Sunday will be observed on the following Monday.’ This means that when a federal holiday falls on a Sunday, the USPTO will be closed on the following Monday, and any deadlines will be extended accordingly.

It’s important for patent applicants and attorneys to be aware of the federal holiday schedule and plan their filings accordingly to avoid missing critical deadlines.

The USPTO has established a Patent Internet Usage Policy that governs email communications with patent applicants. According to MPEP 502.03, ‘Communications via Internet email are at the discretion of the applicant.’ However, there are specific requirements and limitations:

  • A written authorization from the applicant is required for USPTO employees to communicate via email.
  • All Internet communications must be made using USPTO tools.
  • Without written authorization, the USPTO will not respond to Internet correspondence containing confidential information.

It’s important to note that ‘A reply to an Office action or a paper requiring a signature may NOT be communicated by applicant to the USPTO via Internet email even if written authorization is on record.’

To learn more:

Tags: USPTO

The United States Patent and Trademark Office (USPTO) generally discourages the filing of duplicate copies of correspondence in patent applications, patents, or other proceedings. According to MPEP 502.04:

The filing of duplicate copies of correspondence in the file of an application, patent, or other proceeding should be avoided, except in situations in which the Office requires the filing of duplicate copies.

The USPTO may dispose of duplicate copies to streamline processing. However, it’s important to note that separate copies are required for different files, even if the content is identical.

To learn more:

The timeframe for receiving a Notice of Allowance (PTOL-85) after a Notice of Allowability (Form PTOL-37) is generally within three months. However, if you don’t receive the Notice of Allowance within this period, it may be appropriate to make a status inquiry.

The MPEP states: A Notice of Allowability, Form PTOL-37, is routinely mailed in every application determined to be allowable. Thus, the mailing of a form PTOL-37 in addition to a formal Notice of Allowance and Fee(s) Due (PTOL-85) in all allowed applications would seem to obviate the need for status inquiries even as a precautionary measure where the applicant may believe the new application may have been passed to issue on the first examination. (MPEP 203.08)

However, the MPEP also notes an exception: As an exception, a status inquiry would be appropriate where a Notice of Allowance (PTOL-85) is not received within three months from receipt of form PTOL-37.

If you haven’t received your Notice of Allowance after three months from receiving the Notice of Allowability, it’s advisable to check the status of your application through Patent Center or contact the Application Assistance Unit.

To learn more:

The transition application statement is a requirement for certain applications that bridge the pre-AIA and AIA periods. Here are the key points:

  • It applies to nonprovisional applications filed on or after March 16, 2013, that claim priority to a foreign application filed before March 16, 2013.
  • The statement is required if the application contains or contained a claim to an invention with an effective filing date on or after March 16, 2013.
  • The applicant must provide this statement within a specified time period.
  • International design applications are exempt from this requirement.

As stated in the MPEP: If a nonprovisional application filed on or after March 16, 2013, claims priority to a foreign application filed prior to March 16, 2013, and also contains, or contained at any time, a claim to a claimed invention that has an effective filing date (as defined in 35 U.S.C. 100(i)) on or after March 16, 2013, the applicant must provide a statement to that effect within a specified time period. This requirement helps the USPTO determine which law applies to the application.

To learn more:

The timeliness requirement for priority documents in the PDX program is crucial for patent applicants. MPEP 215.02(a) states:

“If the priority document is retrieved after the application is allowed, the patent will not include the priority claim unless the applicant promptly files a request for a Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323.”

Key points about the timeliness requirement:

  • Priority documents should be retrieved before the application is allowed
  • If retrieved after allowance, a Certificate of Correction is required
  • Applicants should monitor the retrieval status and take action if necessary

To learn more:

What is the timeframe for recording an assignment at the USPTO?

The USPTO recommends recording an assignment within three months of its execution date. According to MPEP 302:

“The Patent and Trademark Office does not require that a document be recorded. If a document is to be recorded, it should be submitted to the Assignment Division within three months from its date of execution; otherwise, it may not be accepted for recordation.”

While there’s no strict legal requirement to record within this timeframe, doing so ensures the assignment is properly documented and can help avoid potential legal issues in the future.

For more information on assignment recording, visit: assignment recording.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

The time period for filing a priority claim in an international design application designating the United States depends on whether it’s a nonprovisional international design application or not. According to MPEP 213.07:

In an international design application designating the United States, the claim for priority may be made in accordance with the Hague Agreement and the Hague Agreement Regulations.

For nonprovisional international design applications, the MPEP states:

In a nonprovisional international design application, the priority claim and certified copy must be furnished in accordance with the time period and other conditions set forth in paragraph (g) of this section.

This refers to 37 CFR 1.55(g), which generally requires the priority claim to be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application. However, it’s important to consult the specific regulations and the Hague Agreement for precise deadlines and requirements, as they may vary depending on the specific circumstances of the application.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on nonprovisional application, visit: nonprovisional application.

For an original application filed under 35 U.S.C. 111(a) on or after March 16, 2013, a certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application, except as provided in 37 CFR 1.55(h), (i), and (j). See MPEP 215.02.

For an international application entering the national stage under 35 U.S.C. 371 in which the national stage commenced on or after December 18, 2013, a certified copy of the foreign application must be filed within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior foreign application, except as provided in 37 CFR 1.55(h), (i), and (j). See MPEP 215.02.

What is the time period for correcting a benefit claim under 37 CFR 1.78?

The time period for correcting a benefit claim under 37 CFR 1.78 is crucial for patent applicants. According to MPEP 211.02(a):

The time period for making a claim for benefit of a prior-filed application under 37 CFR 1.78(a)(3) and 37 CFR 1.78(d)(3) is specified in 37 CFR 1.78(a)(4) and 37 CFR 1.78(d)(3).

The specific time periods are:

  • For nonprovisional applications: The later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior application
  • For design applications: The later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior application
  • For international applications entering the national stage: The time period in 37 CFR 1.55 for claiming priority to foreign applications applies

It’s important to note that if you miss these deadlines, you may need to file a petition under 37 CFR 1.78(c) or (e) to accept an unintentionally delayed benefit claim.

To learn more:

To learn more:

For international design applications designating the United States, there is generally no specific time limit for submitting a certified copy of the priority document. The MPEP 213.07 explains:

‘In accordance with Hague Agreement Rule 7(5)(f), a copy of the priority document may be submitted to the International Bureau within three months from the date of filing of the international design application. The copy of the priority document so submitted will be considered to satisfy the requirement for a certified copy of the priority document in accordance with 37 CFR 1.55(m).’

However, it’s important to note that if the USPTO requires a certified copy for specific reasons (e.g., to overcome a reference), you may need to submit it within a specified timeframe as requested by the Office.

To learn more:

What is the time limit for submitting a certified copy of a foreign application for priority claim?

The time limit for submitting a certified copy of a foreign application for a priority claim depends on the specific circumstances of your application. According to MPEP 213.04:

The time period for filing a certified copy of the foreign application in the United States application (or written statement) is no later than the date the issue fee is paid.

However, there are some exceptions and additional considerations:

  • If you file the priority claim within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application, you may not need to file a certified copy immediately.
  • If the foreign application was filed in a foreign intellectual property office participating in a priority document exchange agreement with the USPTO, the exchange may satisfy the certified copy requirement.
  • In some cases, an interim copy of the foreign application or a statement that the copy was previously filed may be sufficient.

Note: While it’s possible to file the certified copy after paying the issue fee, it requires an additional processing fee and must be done before the patent is granted. To avoid complications and extra fees, it’s best to submit the certified copy as early as possible during the application process.

To learn more:

The time limit for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a), the specific reference must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371, the specific reference must be submitted during the pendency of the application and within the later of four months from the date on which the national stage commenced, four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

As stated in MPEP 211.02: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).

For more information on national stage application, visit: national stage application.

For more information on time limit, visit: time limit.

For utility or plant applications filed under 35 U.S.C. 111(a), the benefit claim must be made during the pendency of the application and within the later of:

  • Four months from the actual filing date of the later-filed application, or
  • Sixteen months from the filing date of the prior-filed application

As stated in the MPEP: If the application is a utility or plant application filed under 35 U.S.C. 111(a), the benefit claim of the prior application under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) must be made during the pendency of the application and within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.

To learn more:

To learn more:

The time limit for filing a U.S. nonprovisional application claiming priority to a foreign application is generally 12 months from the filing date of the foreign application. For design applications, the time limit is 6 months.

As stated in the MPEP, The United States nonprovisional application must be filed not later than twelve months (six months in the case of a design application) after the date on which the foreign application was filed, unless the right of priority has been restored. (MPEP 213.03)

It’s important to note that this period is subject to certain provisions, such as the extension to the next business day if the deadline falls on a weekend or federal holiday.

To learn more:

The U.S. nonprovisional application must generally be filed within 12 months of the filing date of the foreign application to claim priority. For design applications, this period is 6 months.

Specifically, 37 CFR 1.55(b) states:

“The nonprovisional application must be: (1) Filed not later than twelve months (six months in the case of a design application) after the date on which the foreign application was filed, subject to paragraph (c) of this section (a subsequent application); or (2) Entitled to claim the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) of a subsequent application that was filed within the period set forth in paragraph (b)(1) of this section.”

There are provisions to restore the right of priority if the subsequent application is filed within 2 months after the expiration of the priority period, if the delay was unintentional.

What is the time limit for filing a substitute statement?

A substitute statement must be filed within the time period set forth in 37 CFR 1.53(f) or 1.53(d), as applicable. According to MPEP 604:

“The Office has revised the rules to permit applicants to postpone filing an inventor’s oath or declaration until the application is otherwise in condition for allowance if the applicant provides an application data sheet indicating the name, residence, and mailing address of each inventor.”

This means that while you can postpone filing the substitute statement, it must be submitted before the application is allowed. It’s important to note that the substitute statement is subject to the same time constraints as the inventor’s oath or declaration.

To learn more:

The time limit for filing a request to retrieve a foreign application through the Priority Document Exchange (PDX) program is specified in 37 CFR 1.55(i)(4). According to the MPEP:

The request must be filed within the later of sixteen months from the filing date of the prior foreign application, four months from the actual filing date of an application under 35 U.S.C. 111(a), four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f) (§ 1.491(a)), or four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or the request must be accompanied by a petition under paragraph (e) or (f) of this section.

It’s important to note that if you miss this deadline, you may need to file a petition to accept a delayed priority claim or submit a certified copy of the foreign application directly.

To learn more:

There is no specific time limit for filing a reissue application. According to MPEP 201.05, ‘A reissue application can be filed at any time during the enforceability of a patent.’ This means that as long as the original patent is still enforceable, a reissue application can be filed.

However, it’s important to note that there are limitations on what can be claimed in a reissue application based on when it’s filed:

  • If filed within two years from the grant of the original patent, both narrowing and broadening reissue claims are permitted.
  • If filed more than two years from the grant of the original patent, only narrowing reissue claims are allowed.

The MPEP states: ‘A broadening reissue application filed on or after September 16, 2012 must be applied for by all of the inventors (or alternatively the assignee of the entire interest), and the application must be filed within two years from the grant of the original patent.’

To learn more:

When filing a reissue application to correct a priority claim, it’s crucial to adhere to the time limits set by law. The MPEP specifies:

‘The reissue application must be filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f).’

This means that the reissue application must typically be filed within 12 months from the filing date of the foreign application. However, there may be exceptions or additional considerations depending on specific circumstances. It’s advisable to consult with a patent attorney or the USPTO directly for guidance on your particular situation.

The time limit for filing a petition to accept a delayed benefit claim depends on the type of application:

  • For nonprovisional applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.
  • For design applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application.
  • For international applications entering the national stage under 35 U.S.C. 371: The time limit is four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f).

As stated in MPEP 211.04: “If the later-filed application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, this period is 4 months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f).”

To learn more:

A nonprovisional application claiming the benefit of a provisional application under 35 U.S.C. 119(e) must be filed within 12 months after the provisional application’s filing date, unless the benefit has been restored. The MPEP states:

“When a later-filed application is claiming the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the nonprovisional application must be filed not later than 12 months after the date on which the provisional application was filed, unless the benefit of the provisional application has been restored.”

If the 12-month deadline falls on a Saturday, Sunday, or federal holiday in Washington, D.C., the nonprovisional application can be filed on the next business day.

To learn more:

What is the time limit for filing a divisional application?

There is no specific time limit for filing a divisional application, but there are important considerations that effectively create a practical time frame:

  1. Parent Application Status: The divisional application must be filed while the parent application is still pending. Once the parent application is either abandoned or issued as a patent, it’s no longer possible to file a divisional from it.
  2. Priority Claim: To claim the benefit of the parent application’s filing date, the divisional must be filed within the time periods specified in 35 U.S.C. 120, 121, 365(c), or 386(c).
  3. Patent Term: The 20-year patent term is calculated from the earliest non-provisional U.S. filing date. Filing a divisional later in the parent’s pendency will result in a shorter potential patent term for the divisional.

The MPEP 201.06 states:

A divisional application is often filed as a result of a restriction requirement made by the examiner.

While this doesn’t specify a time limit, it implies that divisional applications are typically filed in response to office actions during the examination process. Applicants should consider filing a divisional promptly after receiving a restriction requirement to ensure they don’t miss any deadlines and to maximize the potential patent term.

For more information on Divisional application, visit: Divisional application.

For more information on filing deadline, visit: filing deadline.

The time limit for filing a delayed claim for foreign priority after patent issuance is specified in 37 CFR 1.55(g). According to MPEP 216.01:

‘The time period set in 37 CFR 1.55(g) for filing a claim for priority and the certified copy required under 37 CFR 1.55(f) is the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.’

However, for patents that have already been issued, the claim must be filed within the period set forth in 37 CFR 1.55(g). This typically means that the claim should be filed as soon as possible after realizing the oversight, as any delay beyond the statutory period would require explanation and potentially affect the grant of the petition.

The time limit for filing a certified copy of a foreign application depends on the type of application:

  1. For applications under 35 U.S.C. 111(a): A certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application, or sixteen months from the filing date of the prior foreign application, as stated in 37 CFR 1.55(f)(1).
  2. For applications under 35 U.S.C. 371 (national stage applications): A certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT, as per 37 CFR 1.55(f)(2).

If these time limits are not met, a petition including a showing of good and sufficient cause for the delay and the petition fee set forth in § 1.17(g) must accompany the certified copy.

To learn more:

To learn more:

For applications filed under 35 U.S.C. 111(a) on or after March 16, 2013, 37 CFR 1.55(f)(1) sets the time limit for filing a certified copy of the foreign application. The certified copy must be filed within the later of:

  • Four months from the actual filing date of the application, or
  • Sixteen months from the filing date of the prior foreign application

This time limit does not apply to design applications. For international applications entering the national stage under 35 U.S.C. 371, the time limit is set forth in 37 CFR 1.55(f)(2).

It’s important to note that there are exceptions to these time limits, as provided in 37 CFR 1.55(h), (i), and (j).

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For more information on time limit, visit: time limit.

For applications filed under 35 U.S.C. 111(a) on or after March 16, 2013, 37 CFR 1.55(f)(1) requires that a certified copy of the foreign application be filed within the later of:

  • Four months from the actual filing date of the application, or
  • Sixteen months from the filing date of the prior foreign application

This time period does not apply to design applications. There are three exceptions to this requirement, as outlined in 37 CFR 1.55(h), (i), and (j).

To learn more:

The time limit for filing a benefit claim depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the reference must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “If the application is an application filed under 35 U.S.C. 111(a), the reference to the prior application must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on time limit, visit: time limit.

The time limit for claiming benefit of a prior application depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a), the benefit claim must be made within the later of:
    • Four months from the actual filing date of the later-filed application, or
    • Sixteen months from the filing date of the prior-filed application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the benefit claim must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c) unless a petition to accept an unintentionally delayed benefit claim is granted.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on time limit, visit: time limit.

The statutory requirement for claims in a patent application is outlined in 35 U.S.C. 112. According to MPEP 608.01(k), this statute “requires that the specification shall particularly point out and distinctly claim the subject matter which the inventor or joint inventor regards as his orher invention.”

This means that the claims must clearly and precisely define the invention for which protection is sought. The claims are a crucial part of the patent application as they determine the scope of legal protection granted by the patent.

To learn more:

To learn more:

Once a nonprovisional patent application has been examined and determined to meet all statutory requirements, a notice of allowance is sent to the applicant. The status of the application is then considered “allowed” or “in issue”. As per MPEP 203.04:

An “allowed” nonprovisional application or an application “in issue” is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an “allowed” application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

A “new” nonprovisional patent application is one that has not yet received an action by the examiner. Its status as a “new” application continues until the examiner takes action, even if the applicant files an amendment prior to the first Office Action. A request for continued examination (RCE) under 37 CFR 1.114 is not considered a new application filing.

The statement requirement for transition applications was introduced as part of the implementation of the first inventor to file provisions of the America Invents Act (AIA). Transition applications are:

  • Nonprovisional applications filed on or after March 16, 2013
  • Applications that claim foreign priority to, or domestic benefit of, an application filed before March 16, 2013

The statement requirement is outlined in 37 CFR 1.55(k) and 1.78(a)(6) and (d)(6). As stated in the MPEP:

The statement provisions of 37 CFR 1.55 and 1.78 require that if the later-filed transition application contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March 16, 2013, the applicant must provide a statement to that effect (unless the later-filed application is a nonprovisional international design application).

The statement must be provided within specified time limits. Applicants are not required to provide the statement if they reasonably believe the application does not contain claims with an effective filing date on or after March 16, 2013.

For more information on America Invents Act, visit: America Invents Act.

For more information on first inventor to file, visit: first inventor to file.

For more information on transition applications, visit: transition applications.

The statement under 37 CFR 1.97(e) for an Information Disclosure Statement (IDS) must state either:

  1. Each item of information in the IDS was first cited in a communication from a foreign patent office in a counterpart foreign application not more than three months prior to filing the statement, or
  2. No item of information in the IDS was cited in a communication from a foreign patent office in a counterpart foreign application, and to the knowledge of the person signing the statement, no item of information was known to any individual designated in 37 CFR 1.56(c) more than three months prior to filing the statement.

According to MPEP 609.04(b): A statement under 37 CFR 1.97(e) can contain either of two statements. One statement is that each item of information in an information disclosure statement was first cited in any communication, such as a search report, from a patent office outside the U.S. in a counterpart foreign application not more than three months prior to the filing date of the statement. Applicant would not be able to make a statement under 37 CFR 1.97(e) where an item of information was first cited by a foreign patent office, for example, a year before the filing of the IDS, in a communication from that foreign patent office, and the same item of information is once again cited by another foreign patent office within three months prior to the filing of the IDS in the Office.

To learn more:

To learn more:

For a Continued Prosecution Application (CPA), the specific reference requirement under 35 U.S.C. 120 is satisfied by the CPA request itself. According to MPEP § 201.06(d):

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that when you file a CPA request, it automatically serves as the required reference to the prior application under 35 U.S.C. 120. No additional amendments or references in the specification are necessary to establish this connection.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on specific reference, visit: specific reference.

For a Continued Prosecution Application (CPA), the specific reference required by 35 U.S.C. 120 is the CPA request itself. This is explicitly stated in 37 CFR 1.53(d)(7).

According to MPEP ¶ 2.34:

“As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that when you file a CPA, the request itself serves as the necessary reference to the prior application, eliminating the need for additional amendments to the specification to establish continuity.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on specific reference, visit: specific reference.

To qualify for micro entity status based on an institution of higher education, the applicant must first meet the small entity requirement. This means that every party holding rights in the application must qualify as a small entity under 37 CFR 1.27.

MPEP 509.04(b) states: “In order to meet the small entity requirement, every party holding rights in the application must qualify as a small entity under 37 CFR 1.27. If any rights in the application are assigned, granted, conveyed, or licensed to a party that does not qualify as a small entity under 37 CFR 1.27, the applicant cannot qualify for any patent fee discount.”

This requirement ensures that only truly small entities benefit from the micro entity status, even when associated with an institution of higher education.

To learn more:

Tags: patent fees

Venue is a crucial aspect of patent oaths and declarations. MPEP 602 states, “That portion of an oath or affidavit indicating where the oath is taken is known as the venue. […] Venue and notary jurisdiction must correspond or the oath is improper.” This means that the location where the oath is taken must match the jurisdiction of the notary or official administering the oath. The MPEP further advises, “The oath should show on its face that it was taken within the jurisdiction of the certifying officer or notary.” Ensuring correct venue information helps establish the validity of the oath or declaration.

To learn more:

Tags: declaration, oath

The Transco Products decision is significant in determining benefit claims because it established that a later-filed application does not need to use the exact same words as the prior-filed application to satisfy the written description requirement. According to MPEP 211.05:

‘New or amended claims which introduce elements or limitations that are not supported by the as-filed disclosure violate the written description requirement. See, e.g., In re Lukach, 442 F.2d 967, 169 USPQ 795 (CCPA 1971) (subgenus range was not supported by generic disclosure and specific example within the subgenus range); In re Smith, 458 F.2d 1389, 1395, 173 USPQ 679, 683 (CCPA 1972) (an adequate description of a genus may not support claims to a subgenus or species within the genus). While there is no in haec verba requirement, newly added claims or claim limitations must be supported in the specification through express, implicit, or inherent disclosure. An amendment to correct an obvious error does not constitute new matter where one skilled in the art would not only recognize the existence of the error in the specification, but also recognize the appropriate correction. In re Oda, 443 F.2d 1200, 170 USPQ 268 (CCPA 1971).’

This means that the USPTO will consider whether the prior-filed application provides sufficient support for the claims in the later-filed application, even if the exact wording is different, as long as the support is express, implicit, or inherent in the original disclosure.

To learn more:

What is the significance of the three-month period for IDS submission?

The three-month period for Information Disclosure Statement (IDS) submission is significant because it determines whether additional requirements apply:

  • IDS filed within three months of the filing date of a national application or entry of the national stage: No additional requirements
  • IDS filed after three months: Requires either a certification or fee

According to MPEP 609.04(b): “(1) The information disclosure statement is filed within three months of the filing date of a national application other than a continued prosecution application under § 1.53(d);” This three-month window provides applicants with an opportunity to submit an IDS without additional burdens, encouraging early disclosure of relevant information.

If an applicant misses this three-month window, they must either:

  • Provide a certification under 37 CFR 1.97(e), stating that the information was first cited in a communication from a foreign patent office or discovered within three months of the filing date, or
  • Pay the fee set forth in 37 CFR 1.17(p)

This policy aims to balance the need for timely disclosure with the practicalities of gathering and submitting relevant information during the patent application process.

To learn more:

The term ‘original application’ has a specific meaning in patent law, as outlined in MPEP 201.02:

‘Original’ application is used in the patent statutes and rules to refer to an application which is not a reissue application. An original application may be a first filing or a continuing application.

This definition is significant because it distinguishes original applications from reissue applications, which are used to correct errors in already-granted patents. Original applications encompass:

  • First-time filings of new inventions
  • Continuing applications (continuations, divisionals, and continuations-in-part)

Understanding this term is crucial for patent applicants and examiners, as it affects how an application is processed and what rights it may claim, particularly in terms of priority dates and the scope of patent protection.

For more information on patent application types, visit: patent application types.

For more information on patent procedure, visit: patent procedure.

What is the significance of the term ‘nonprovisional’ in patent applications?

The term ‘nonprovisional’ in patent applications is significant because it distinguishes these applications from provisional applications:

  • Examination: Nonprovisional applications undergo substantive examination by the USPTO, while provisional applications do not.
  • Patent Grant: Only nonprovisional applications can mature into granted patents.
  • Duration: Nonprovisional applications have a standard 20-year term from the filing date, while provisional applications expire after 12 months.
  • Content Requirements: Nonprovisional applications must include formal patent claims and other specific elements not required in provisional applications.

The MPEP 201.01 mentions nonprovisional applications in the context of original applications: ‘Original applications include all applications other than reissue applications. Original applications may be nonprovisional or provisional.’

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on patent grant, visit: patent grant.

For more information on provisional application, visit: provisional application.

What is the significance of the term ‘copending’ in continuation applications?

The term ‘copending’ is crucial in the context of continuation applications. According to MPEP 201.07:

A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.

The significance of ‘copending’ is as follows:

  • Timing: It means that the continuation application must be filed before the prior application is patented, abandoned, or terminated.
  • Continuous chain: It ensures a continuous chain of pending applications, maintaining the priority date of the original filing.
  • Benefit claims: Copendency is required for a continuation to claim the benefit of the earlier filing date of the parent application.

If applications are not copending, the continuation may lose the benefit of the earlier filing date, potentially affecting patentability if intervening prior art exists.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

What is the significance of the term ‘carved out’ in relation to divisional applications?

The term ‘carved out’ is significant in understanding the nature of divisional applications. According to MPEP 201.06: ‘A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.”

The significance of ‘carved out’ includes:

  • It implies that the divisional application is derived from a portion of the parent application.
  • The divisional application focuses on a specific invention or set of claims that are distinct from those in the parent application.
  • The subject matter in the divisional is entirely based on the disclosure in the parent application.
  • No new matter can be added to the divisional application beyond what was disclosed in the parent.

This term emphasizes that while the divisional application is separate, it is intrinsically linked to the parent application’s original disclosure, ensuring that the applicant doesn’t gain an unfair advantage by introducing new subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent filing, visit: patent filing.

The date September 21, 2004, is significant in relation to 37 CFR 1.57(b) because it marks the effective date of the provisions now contained in this regulation. The MPEP states that one reason an amendment might not comply with 37 CFR 1.57(b) is if the present application was filed before September 21, 2004, the effective date of the provisions now in 37 CFR 1.57(b).

This means that applications filed before this date cannot use the incorporation by reference procedure outlined in 37 CFR 1.57(b) to add inadvertently omitted material. For such applications, different rules and procedures would apply for addressing omitted material.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on effective date, visit: effective date.

For more information on incorporation by reference, visit: incorporation by reference.

The date September 16, 2012, is significant because it marks a change in the applicability of certain patent application procedures. As noted in MPEP 409.03(a):

“[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]”

This date corresponds to the implementation of the America Invents Act (AIA), which brought significant changes to U.S. patent law. For applications filed on or after this date, different rules and procedures apply regarding joint inventorship and the handling of situations where not all inventors are available or willing to sign the application. It’s crucial for applicants to be aware of which set of rules applies to their application based on the filing date.

To learn more:

The date September 16, 2012, is significant in patent applications involving deceased inventors because it marks a change in the applicable regulations. The MPEP section 409.03(c) states:

[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]

This means:

  • For applications filed before September 16, 2012: The procedures outlined in pre-AIA 37 CFR 1.47 apply when dealing with unavailable legal representatives of deceased inventors.
  • For applications filed on or after September 16, 2012: Different regulations and procedures apply, which are not covered in this specific MPEP section.

This date coincides with the implementation of the America Invents Act (AIA), which brought significant changes to U.S. patent law. Patent applicants and attorneys should be aware of these changes and apply the appropriate procedures based on their application’s filing date.

To learn more:

A postcard receipt can play a crucial role in patent applications, especially when pages are allegedly missing. The MPEP 601.01(d) highlights its importance:

Applicant has produced an itemized postcard receipt which specifically lists the omitted pages as having been deposited on the missing parts’ due date.

The significance of the postcard receipt includes:

  • Proof of submission: It serves as evidence that specific documents were submitted to the USPTO.
  • Date verification: It can confirm the date of submission for various application components.
  • Resolution of discrepancies: In cases where the USPTO claims pages are missing, the postcard can help resolve disputes.
  • Petition support: It can be used to support a petition to establish the filing date of omitted pages.

Applicants are advised to use detailed, itemized postcard receipts when submitting patent applications to avoid potential issues with missing documents.

To learn more:

The phrase ‘complying information disclosure statement’ in MPEP 609.05(b) is significant because it distinguishes between IDSs that meet all the regulatory requirements and those that do not. The MPEP states:

Information disclosure statements will be considered by the examiner if the statement is in compliance with the content requirements of 37 CFR 1.98 and the requirements of 37 CFR 1.97.

A complying IDS:

  • Meets the content requirements of 37 CFR 1.98
  • Satisfies the timing and fee requirements of 37 CFR 1.97
  • Will be fully considered by the examiner
  • Ensures that the applicant has fulfilled their duty of disclosure

Non-complying IDSs may not be fully considered or may require corrections before examination.

To learn more:

To learn more:

What is the significance of the Paris Convention in foreign priority claims?

The Paris Convention plays a crucial role in foreign priority claims for patent applications. Its significance includes:

  • Establishing the right of priority for patent applications among member countries.
  • Allowing applicants to file in multiple countries while maintaining the original filing date.
  • Providing a 12-month priority period for utility patents (6 months for design patents).
  • Ensuring equal treatment of foreign and domestic applicants in member countries.

According to MPEP 213: “The right of priority is defined in Article 4 of the Paris Convention for the Protection of Industrial Property and is based on the first filing in a Paris Convention country.” This convention facilitates international patent protection by allowing inventors to secure priority dates across multiple jurisdictions.

The Paris Convention plays a crucial role in international patent applications. As stated in MPEP 213.01:

The right of priority under the Paris Convention for the Protection of Industrial Property (Paris Convention) is recognized in the United States.

This means that applicants can claim priority based on an earlier filing in any Paris Convention member country. The Paris Convention facilitates patent protection across multiple countries by allowing a grace period for filing in other member nations while maintaining the priority date of the first filing.

To learn more:

What is the significance of the order of inventors listed on a patent application?

The order of inventors listed on a patent application does not affect their legal rights, but it may have other implications. According to the MPEP:

“The order of names of joint inventors in the heading of the application is not significant except in an application filed before September 16, 2012, where the order of named inventors determined the order of prosecution in the absence of an executed oath or declaration.” (MPEP 605)

While the order doesn’t impact legal rights, it’s common practice to list the primary contributor first. This can be important for:

  • Academic recognition: In scientific publications, the first-listed inventor may receive more credit.
  • Industry norms: Some fields have conventions about inventor order.
  • Alphabetical order: Sometimes used to avoid implications of contribution levels.

Ultimately, all listed inventors have equal rights to the patent, regardless of their order on the application.

To learn more:

The Office docket plays a crucial role in determining the status of a patent application. MPEP 203.05 refers to the Office docket when defining abandoned applications:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications

The Office docket is essentially the official record of pending patent applications at the USPTO. When an application is removed from this docket, it is no longer considered active or pending. This removal can occur for various reasons, including formal abandonment, applicant inaction, failure to pay fees, or expiration of statutory periods. Therefore, the status of an application on the Office docket is a key indicator of whether it is still being actively prosecuted or has been abandoned.

March 16, 2013 is a crucial date in U.S. patent law due to the implementation of the America Invents Act (AIA). This date marks the transition from the pre-AIA first-to-invent system to the AIA first-inventor-to-file system. The significance includes:

  • Applications filed on or after this date are generally subject to AIA provisions
  • The effective filing date of claimed inventions determines which law applies
  • Transition applications may require special statements
  • Different examination standards may apply based on the effective filing date

The MPEP states: “The first inventor to file provisions of Public Law 112-29, sec. 3, 125 Stat. 284 (the Leahy-Smith America Invents Act) and the rules related thereto became effective March 16, 2013. These provisions apply to any application for patent, and to any patent issuing thereon, that contains or contained at any time— (A) a claim to a claimed invention that has an effective filing date as defined under section 100(i) of title 35, United States Code, that is on or after March 16, 2013; or (B) a specific reference under section 120, 121, or 365(c) of title 35, United States Code, to any patent or application that contains or contained at any time such a claim.”

What is the significance of the issue fee payment date for patent assignments?

The issue fee payment date is crucial for patent assignments and issuance to assignees for several reasons:

  • It serves as the deadline for requesting issuance of the patent to the assignee under 37 CFR 3.81(b).
  • Assignments recorded after this date but before patent issuance will be recorded but won’t affect who the patent is issued to.
  • It impacts the USPTO’s ability to change the name on the patent.

MPEP 307 states: “If the assignment is submitted for recording after the date of payment of the issue fee, but prior to issuance of the patent, the assignment will be recorded but the patent will issue to the name of the inventor.” This underscores the importance of timely assignment recording and requests for issuance to the assignee.

For more information on assignment recording, visit: assignment recording.

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

The inventor’s citizenship is an important piece of information in a patent application for several reasons:

  • Compliance with USPTO requirements
  • Determination of inventorship rights
  • Application of international treaties
  • Export control considerations

MPEP 602.08(a) states: ‘Citizenship is required to support an oath or declaration under 37 CFR 1.63 or to determine whether the application is subject to a secrecy order under 37 CFR 5.1(b).’

The citizenship information helps the USPTO ensure compliance with various legal requirements and international agreements, such as the Paris Convention for the Protection of Industrial Property.

To learn more:

What is the significance of the four-month time period in filing a certified copy?

The four-month time period is significant in filing a certified copy of a foreign application for priority claims. According to MPEP 213.04, “If the certified copy is not filed within the four-month period, the certified copy must be accompanied by a petition including a showing of good and sufficient cause for the delay and the petition fee.” This means that if you file the certified copy within four months of the actual filing date of the application (or entry into the national stage for PCT applications), you don’t need to provide any explanation or pay additional fees. However, if you miss this four-month window, you’ll need to file a petition explaining the delay and pay an additional fee. This rule encourages prompt filing of priority documents and helps streamline the examination process.

To learn more:

What is the significance of the four-month and sixteen-month time periods for filing a priority claim?

The four-month and sixteen-month time periods are crucial deadlines for filing a priority claim in a U.S. patent application. According to MPEP 214.01:

“The claim for priority must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application in an original application filed under 35 U.S.C. 111(a).”

These time periods are significant because:

  • They provide applicants with a window to properly claim priority to a foreign application.
  • The four-month period starts from the U.S. filing date, giving applicants time to prepare and submit the priority claim after filing their U.S. application.
  • The sixteen-month period from the foreign filing date ensures that priority claims are made within a reasonable time frame relative to the original foreign filing.
  • Filing within these periods allows for the priority claim to be considered timely without requiring additional petitions or fees.

It’s important to note that failing to meet these deadlines may result in the need for a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e), which involves additional requirements and fees.

The filing date mentioned in MPEP ¶ 2.05 is significant because it establishes the priority date for the continuation application. The MPEP states:

“This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application.” (MPEP ¶ 2.05)

The significance of the filing date [2] includes:

  • Establishing the priority date for the continuation application
  • Determining the relevant prior art for examination
  • Calculating patent term adjustments
  • Assessing eligibility for certain types of patent term extensions

By referencing the filing date of the prior application, the continuation application can benefit from the earlier filing date, potentially providing an advantage in terms of patentability and patent term.

For more information on continuation application, visit: continuation application.

The filing date is crucial in relation to irreparable damage because it can determine whether an applicant’s rights are preserved or lost. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This means that the filing date can be critical for:

  • Establishing priority over other potential patent applications
  • Avoiding statutory bars to patentability
  • Preserving international filing rights
  • Preventing public disclosure that could jeopardize patent rights

Therefore, proving that a specific filing date is necessary can be essential to prevent irreparable damage to an applicant’s patent rights.

To learn more:

To learn more:

What is the significance of the filing date in a divisional application?

The filing date of a divisional application is crucial for several reasons:

  • Benefit of earlier filing date: A divisional application is entitled to the benefit of the filing date of the prior-filed application, as stated in MPEP 201.06(c): ‘A divisional application is entitled to the benefit of the filing date of the prior-filed application if filed before the patenting or abandonment of or termination of proceedings on the prior-filed application.’
  • Prior art considerations: The earlier filing date can be used to overcome prior art references that might otherwise be applicable.
  • Patent term calculations: The filing date may affect the calculation of the patent term.
  • Priority claims: It establishes the basis for any priority claims to foreign applications.

It’s important to note that the divisional application must be filed while the parent application is still pending to claim the benefit of the earlier filing date.

For more information on Divisional application, visit: Divisional application.

For more information on patent term, visit: patent term.

For more information on prior art, visit: prior art.

The filing date of a Continued Prosecution Application (CPA) is significant for several reasons. In the context of inventorship, the MPEP ¶ 2.33 mentions:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

The filing date [2] is important because:

  • It establishes the effective date for the CPA.
  • It determines the timeline for filing certain documents, such as inventor oaths or declarations.
  • It affects the calculation of patent term adjustment.
  • It’s used as a reference point for determining whether changes to inventorship were properly requested.

Always keep the CPA filing date in mind when managing patent application procedures and deadlines.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

What is the significance of the filing date in a continuation-in-part application?

The filing date of a continuation-in-part (CIP) application is crucial for determining the effective date of certain disclosures. According to MPEP 201.08:

“The effective filing date of a claimed invention in a CIP application is determined on a claim-by-claim basis and not an application-by-application basis.”

This means:

  • Subject matter carried over from the parent application retains the parent’s filing date.
  • New matter introduced in the CIP receives the filing date of the CIP application.
  • Claims in the CIP are evaluated individually to determine which filing date applies based on their content.

Understanding this distinction is crucial for patent practitioners when assessing prior art and determining the scope of protection for inventions disclosed in CIP applications.

To learn more:

The filing date of foreign applications is significant in priority claims for the following reasons:

  1. It establishes the effective date of the priority claim.
  2. The date accorded is the date on which the specification and drawing were filed, not necessarily the date of the petition (which is called the application in some countries).
  3. This date is used to determine the applicability of prior art and the eligibility for certain patent term adjustments.

The MPEP states: “In some instances, the specification and drawing of the foreign application may have been filed at a date subsequent to the filing of the petition in the foreign country. Even though the petition is called the application and the filing date of this petition is the filing date of the application in a particular country, the date accorded here is the date on which the specification and drawing were filed.” (MPEP 216)

The filing date of a patent application is crucial for several reasons, as outlined in MPEP 601:

  • It establishes the priority date for the invention.
  • It starts the clock for the patent term.
  • It determines which version of the patent laws and rules apply to the application.

The MPEP emphasizes: ‘The filing date of an application is important (except for design applications) because it may affect the priority of the application relative to other applications or publications, and because many of the rules relating to patent applications use this date as a reference point.’

For nonprovisional applications, the filing date is typically the date when the USPTO receives all required elements, including the specification, at least one claim, and any necessary drawings. For provisional applications, the filing date is established when the USPTO receives the specification and any required drawings.

To learn more:

Tags: patent term

What is the significance of the examiner’s initials on an IDS?

The examiner’s initials on an Information Disclosure Statement (IDS) are significant because they indicate that:

  • The examiner has considered the cited reference.
  • The reference has been made of record in the application file.
  • The applicant has fulfilled their duty of disclosure for that particular reference.

According to MPEP 609.05(b): ‘The examiner will initial each reference considered. The initials indicate that the information has been considered by the examiner in the same manner as information submitted in compliance with 37 CFR 1.97 and 37 CFR 1.98.’

It’s important to note that the examiner’s initials do not indicate the examiner agrees with the applicant’s interpretation of the reference or its relevance. They simply confirm that the examiner has reviewed the citation as required by USPTO procedures.

To learn more:

What is the significance of the effective filing date in patent applications?

The effective filing date is a crucial concept in patent law that determines which prior art can be used against a patent application. According to MPEP 2152:

The effective filing date of a claimed invention is used to determine what qualifies as prior art that may be used to reject the claims of the application.

Key points about the effective filing date:

  • It can be the actual filing date of the application or an earlier date if the application claims priority to a prior-filed application.
  • For AIA applications, it determines which version of 35 U.S.C. 102 applies (pre-AIA or AIA).
  • It affects the scope of prior art that can be cited against the application.
  • Different claims within the same application may have different effective filing dates.

Understanding the effective filing date is essential for both patent applicants and examiners in assessing patentability and managing priority claims.

For more information on effective filing date, visit: effective filing date.

For more information on prior art, visit: prior art.

December 18, 2013 marks an important change in the requirements for nonprovisional patent applications to receive a filing date. The significance of this date is as follows:

  • Before December 18, 2013: Nonprovisional applications required at least one claim to receive a filing date.
  • On or after December 18, 2013: Nonprovisional applications (except design applications) can receive a filing date without any claims.

The MPEP notes: “For nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013, there is no need to request conversion to a provisional application because such applications do not require presentation of at least one claim to obtain a filing date.”

This change simplifies the initial filing process for many applicants, allowing them to secure a filing date more easily and potentially complete the application with claims at a later time.

To learn more:

The correspondence address is crucial in patent applications as it determines where the USPTO sends all official communications. Its relationship to the power of attorney is explained in MPEP 601.02:

“A power of attorney is not required to receive or change a correspondence address.”

Key points about the correspondence address:

  • It can be different from the address of the attorney or agent with power of attorney.
  • Changing the correspondence address does not affect the power of attorney.
  • Revoking a power of attorney does not automatically change the correspondence address.

To ensure proper communication with the USPTO, applicants should carefully manage both the power of attorney and the correspondence address, understanding that they are separate but related aspects of patent application management.

To learn more:

The change from 37 CFR 1.60 to 37 CFR 1.53(b) represents a significant shift in the procedure for filing continuation and divisional applications. After December 1, 1997, all such applications are processed under 37 CFR 1.53(b), which may have different requirements and procedures. Patent applicants need to be aware of this change to ensure they are following the correct, current procedures when filing continuation or divisional applications.

To learn more:

To learn more:

What is the significance of the application filing date in patent law?

The application filing date is crucial in patent law for several reasons:

  • Priority: It establishes the priority date for the claimed invention, which is used to determine novelty and non-obviousness.
  • Disclosure requirement: The specification must fully support the claimed invention as of the filing date.
  • New matter prohibition: Any material added after the filing date may be considered new matter and rejected.

As stated in MPEP 608.04(a): Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is usually new matter. This underscores the importance of having a complete and comprehensive disclosure at the time of filing.

To learn more:

Tags: new matter

What is the significance of the application filing date for new matter in patent applications?

The application filing date is crucial when determining whether content in a patent application constitutes new matter. MPEP 608.04(a) states:

‘Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.’

This means that any information added to the application after the filing date, which was not present in the original specification, claims, or drawings, is considered new matter. This is important because new matter cannot be added to an application without filing a continuation-in-part application.

The filing date serves as a cutoff point for the content that can be included in the application without being considered new matter. Inventors and patent practitioners must ensure that all necessary information is included in the application on or before the filing date to avoid issues with new matter.

To learn more:

To learn more:

The Application Data Sheet (ADS) plays a crucial role in establishing priority and benefit claims in patent applications:

  • Providing domestic benefit information in the ADS constitutes the specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
  • Providing foreign priority information in the ADS constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55.
  • The most recent ADS will govern with respect to foreign priority or domestic benefit claims in case of inconsistencies.

37 CFR 1.76(b)(5) states: “Providing this information in the application data sheet constitutes the specific reference required by 35 U.S.C. 119(e) or 120, and § 1.78.”

Similarly, 37 CFR 1.76(b)(6) states: “Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b) and § 1.55.”

It’s crucial to ensure that priority and benefit claims are accurately listed in the ADS to properly establish these claims in the patent application.

To learn more:

What is the significance of the AIA (America Invents Act) for patent application correspondence?

The America Invents Act (AIA) brought significant changes to patent application correspondence, particularly for applications filed on or after September 16, 2012. Key changes include:

  • New rules for who can file patent applications
  • Changes in correspondence procedures
  • Updated requirements for patent practitioners’ authority

According to MPEP 403.01(a): “The provisions of 37 CFR 1.33(b) for patent applications filed on or after September 16, 2012 differ from the provisions of pre-AIA 37 CFR 1.33(b) for patent applications filed prior to September 16, 2012.” This highlights the importance of understanding the specific rules that apply based on the application’s filing date.

To learn more:

What is the significance of the Application Data Sheet (ADS) in correcting or adding a benefit claim?

The Application Data Sheet (ADS) plays a crucial role in correcting or adding a benefit claim after filing. According to MPEP 211.02(a):

A corrected ADS (along with a petition under 37 CFR 1.78 and the petition fee) is required to correct a benefit claim if the benefit claim was not included on the original ADS.

This means that if you need to correct or add a benefit claim that wasn’t included in the original ADS, you must submit:

  • A corrected ADS
  • A petition under 37 CFR 1.78
  • The required petition fee

The corrected ADS should contain all of the information from the original ADS, with the changes to the benefit claim marked in accordance with 37 CFR 1.76(c).

To learn more:

Tags: ADS

What is the significance of the Access Code on the Request to Retrieve Electronic Priority Application?

The Access Code on the Request to Retrieve Electronic Priority Application plays a crucial role in the priority document exchange process. The MPEP states:

‘The Request to Retrieve Electronic Priority Application must include the Access Code assigned to that application by the applicant or applicant’s representative.’

This Access Code is essential because it allows the USPTO to securely retrieve the priority document from the foreign office. Without the correct Access Code, the USPTO cannot access and retrieve the document, which could lead to issues with establishing priority for your application.

It’s important to ensure that the Access Code you provide on the Request form is accurate and matches the one assigned by the foreign office. Incorrect or missing Access Codes can result in delays or failures in retrieving the priority document, potentially affecting your patent application’s priority claim.

What is the significance of the ‘time period set in 37 CFR 1.55’ for filing priority claims?

The time period set in 37 CFR 1.55 is crucial for securing your priority claim in a patent application. MPEP 213.04 states: ‘The time period set in 37 CFR 1.55 for filing a priority claim and certified copy cannot be extended.’ This strict deadline ensures that priority claims are made promptly, allowing for efficient examination and preventing delays in the patent process. Failing to meet this deadline can result in the waiver of your priority claim, potentially affecting the patentability of your invention if intervening prior art exists. It’s essential to be aware of and adhere to this time period to protect your invention’s priority date.

To learn more:

To learn more:

What is the significance of the ‘right of priority’ in international patent applications?

The ‘right of priority’ is a crucial concept in international patent applications. According to MPEP 211.01(c), ‘The right of priority is defined in 35 U.S.C. 119(a).’ This right allows applicants to claim priority from an earlier filed application, which can be beneficial in establishing the novelty and non-obviousness of an invention. Specifically, the MPEP states:

‘Under certain circumstances, the right of priority may be restored even if the filing is made after the 12-month priority period. See 37 CFR 1.55(c).’

This provision offers flexibility to applicants who may have missed the standard priority deadline, potentially preserving their patent rights in certain situations.

To learn more:

To learn more:

What is the significance of the ‘original disclosure’ in a divisional application?

The ‘original disclosure’ is crucial in a divisional application because it defines the scope of what can be included in the divisional. According to MPEP 201.06:

‘The disclosure of a divisional application must be the same as the disclosure of the prior-filed application, i.e., the original disclosure of the parent or original nonprovisional application or provisional application.’

This means that no new matter can be added to a divisional application. The divisional must rely entirely on the content disclosed in the original parent application. This ensures that the divisional application doesn’t extend beyond the scope of what was initially invented and disclosed.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

What is the significance of the ‘correspondence address’ in USPTO patent applications?

The correspondence address is crucial in USPTO patent applications for several reasons:

  • It determines where the USPTO sends all official communications regarding the application.
  • It can be used to designate a specific attorney or agent to receive correspondence.
  • Changes to the correspondence address must be made in writing to ensure proper routing of communications.

According to MPEP 403.01: “The correspondence address is used by the Office for mailing notices, actions, and other communications relating to the application.” Additionally, the MPEP states: “A change of correspondence address may be filed with the USPTO during the pendency of an application, and in a patent file.” This emphasizes the importance of keeping the correspondence address up-to-date to ensure timely receipt of important USPTO communications.

To learn more:

What is the significance of the ‘acting in a representative capacity’ requirement in patent applications?

The ‘acting in a representative capacity’ requirement is crucial in patent applications as it ensures that only authorized individuals can represent applicants or patent owners before the USPTO. According to MPEP 402.04, “Any paper presented to the United States Patent and Trademark Office (Office) on behalf of an applicant for patent or patent owner must be signed by (A) a patent practitioner of record appointed in compliance with 37 CFR 1.32(b), (B) a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34, or (C) the applicant under 37 CFR 1.42.” This requirement helps maintain the integrity of the patent application process and protects the interests of applicants and patent owners.

To learn more:

What is the significance of the ‘365(c)’ filing date in claiming benefit of a nonprovisional application?

The ‘365(c)’ filing date is crucial when claiming the benefit of a nonprovisional application that was filed as a PCT application and entered the national stage. According to MPEP 211.01(b):

‘If the prior nonprovisional application is an international application that was filed as a PCT application and entered the national stage under 35 U.S.C. 371, the 365(c) filing date of the international application is the filing date to be used in determining copendency.’

This means that when determining if applications are copendent for benefit claims, the PCT filing date (365(c) date) is used rather than the U.S. national stage entry date. This can be significant for maintaining continuous priority chains in international patent applications.

To learn more:

The ‘[R-]’ notation after ‘MPEP 212 [Reserved]’ typically indicates that this section has been revised. However, in this case, since the section is reserved and empty, the ‘[R-]’ may be a placeholder for future revision dates. When a substantive revision occurs, a date is usually added after the ‘R’, such as ‘[R-10.2019]’ to indicate an October 2019 revision.

September 16, 2012, is a significant date in patent application assignments, particularly for applications claiming the benefit of a provisional application. The MPEP states:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

This date marks a change in assignment requirements. For applications filed on or after September 16, 2012, if the assignee is the original applicant, new assignment papers may not be necessary even if the application includes subject matter not common with the provisional application. This change aligns with broader reforms introduced by the America Invents Act (AIA) that came into effect on that date.

Regional patent offices play a crucial role in the international patent system, particularly for priority claims. MPEP 213.01 recognizes several regional patent offices whose applications can serve as the basis for priority claims in the United States. These include:

  • European Patent Office (EPO)
  • Eurasian Patent Office (EAPO)
  • African Intellectual Property Organization (OAPI)
  • African Regional Intellectual Property Organization (ARIPO)

The significance of these regional offices is explained in MPEP 213.01:

‘The United States will recognize claims for right of priority based on applications filed under such multilateral international agreements as the European Patent Convention (EPC) and the Patent Cooperation Treaty (PCT).’

This recognition allows applicants to file a single application with a regional patent office and still maintain priority rights in the United States. It streamlines the international patent application process and provides more flexibility for inventors seeking protection in multiple countries.

Recording patent assignments at the United States Patent and Trademark Office (USPTO) is crucial for several reasons:

  • Legal Protection: It provides legal protection against subsequent purchasers or mortgagees.
  • Official Recognition: The USPTO recognizes the assignee for all matters before the Office.
  • Public Notice: It serves as public notice of the assignment.

According to MPEP 301:

An assignment relating to a patent must be recorded in the Patent and Trademark Office within 3 months from its date or prior to the date of a subsequent purchase or mortgage, in order to be effective against a subsequent purchaser or mortgagee.

Recording assignments promptly is essential to ensure full legal protection and recognition of ownership rights.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

Recording a patent assignment with the USPTO is crucial for several reasons:

  1. Legal Notice: It provides public notice of the assignment, which is important for establishing priority against subsequent purchasers or mortgagees.
  2. Prima Facie Evidence: As stated in MPEP 301.01, ‘The recording of an assignment with the USPTO is prima facie evidence of its execution.’
  3. Chain of Title: It helps maintain a clear chain of title for the patent or application.
  4. Enforcement Rights: Proper recording can affect the ability to enforce patent rights or collect damages in infringement cases.

The MPEP emphasizes the importance of recording by stating, ‘An assignment must be recorded in the USPTO within three months from its date or prior to the date of a subsequent purchase or mortgage to be valid against a subsequent purchaser or mortgagee.’ This underscores the time-sensitive nature of recording assignments to protect legal rights.

Pre-AIA 35 U.S.C. 118 is significant in determining what constitutes a valid assignment or sufficient proprietary interest for filing a patent application. According to MPEP 409.03(f):

“An assignment to a pre-AIA 37 CFR 1.47(b) applicant for the sole purpose of obtaining a filing date for a pre-AIA 37 CFR 1.47(b) application is not considered an assignment within the meaning of pre-AIA 35 U.S.C. 118 and pre-AIA 37 CFR 1.47(b).”

This means that a mere pro forma assignment created solely to comply with filing requirements is not sufficient to establish proprietary interest under pre-AIA 35 U.S.C. 118. The assignment or proprietary interest must be substantive and reflect a genuine transfer of rights or interest in the invention.

When demonstrating proprietary interest, applicants must show that their claim to the invention would be recognized under applicable law, not just that they have fulfilled a procedural requirement.

To learn more:

To learn more:

MPEP 402.08 has important implications for independent inventors involved in interference proceedings. The key provision states:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

For independent inventors, this means:

  • Changes in legal representation during an interference proceeding must be approved by the PTAB.
  • There may be additional complexity and potential delays in changing attorneys.
  • Inventors should carefully consider the timing of any representation changes.
  • Direct communication with the PTAB may be necessary regarding power of attorney matters.

Independent inventors should be aware of these special procedures to navigate interference proceedings effectively and ensure proper legal representation throughout the process.

To learn more:

To learn more:

Keeping assignment documents separate from patent application files is significant for several reasons. MPEP 318 mandates this separation:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The significance of this practice includes:

  • Maintaining clear distinction between technical content and ownership information
  • Ensuring proper recording and indexing of assignment documents
  • Facilitating easier searches for patent ownership information
  • Reducing the risk of confidential ownership information being inadvertently disclosed
  • Allowing for more efficient management of ownership changes throughout a patent’s lifecycle
  • Enabling the Assignment Division to specialize in handling ownership matters

This separation streamlines both the patent examination process and the management of patent ownership records.

Filing dates are crucial in patent law as they establish priority and can affect the patentability of an invention. The MPEP 201.02 discusses various application types and their relationship to filing dates:

  • Original applications (including first filings and continuing applications) generally retain their filing date for priority purposes.
  • Continuing applications (continuations, divisionals, and continuations-in-part) can benefit from the filing date of the parent application under specific conditions outlined in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.
  • Substitute applications, however, do not obtain the benefit of the filing date of the prior application.

The MPEP states:

A substitute application does not obtain the benefit of the filing date of the prior application.

This emphasizes the importance of maintaining active applications and understanding the implications of different application types on priority dates.

For more information on continuing applications, visit: continuing applications.

For more information on patent applications, visit: patent applications.

What is the significance of copendency in continuation applications?

Copendency is a crucial requirement for continuation applications. It refers to the condition where the continuation application is filed before the prior application is patented, abandoned, or terminated. The MPEP 201.07 states:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement; and the later-filed application must be copending with the prior application.’

The significance of copendency includes:

  • Maintaining Priority: It ensures the continuation application can claim the benefit of the earlier filing date.
  • Unbroken Chain: It maintains an unbroken chain of applications, which is essential for establishing a continuous line of priority.
  • Preventing Loss of Rights: Filing a continuation before the parent application is concluded prevents the loss of patent rights that could occur if new claims are needed after the parent application is no longer pending.

Failure to maintain copendency can result in the loss of the earlier priority date, potentially affecting the patentability of the invention if intervening prior art exists.

For more information on continuation application, visit: continuation application.

For more information on copendency, visit: copendency.

For more information on patent priority, visit: patent priority.

Claiming benefit to a prior application is crucial for divisional applications as it allows the divisional to retain the earlier filing date of the parent application. This can be significant for:

  • Establishing priority over potential prior art
  • Extending the potential patent term
  • Maintaining continuity in the patent family

The MPEP ¶ 2.01 states:

“Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

To properly claim this benefit, applicants must comply with the requirements set forth in 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211, which include making a proper benefit claim and ensuring continuity of disclosure.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Adding new disclosure in a continuation-in-part (CIP) application is a key characteristic that distinguishes it from other types of continuing applications. The MPEP ¶ 2.06 describes a CIP as an application that:

repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application.

The significance of adding new disclosure includes:

  • Allowing applicants to expand on their original invention with new developments or improvements
  • Potentially broadening the scope of patent protection
  • Creating a new filing date for the added material, which can be crucial for overcoming prior art
  • Possibly extending the patent term for the new material

However, it’s important to note that the new disclosure will not benefit from the earlier filing date of the prior application. This can affect patentability if relevant prior art emerges between the filing dates of the original application and the CIP.

For more information on prior art, visit: prior art.

Tags: prior art

What is the significance of a power of attorney in patent applications?

A power of attorney is a crucial document in patent applications that authorizes an attorney or agent to act on behalf of the applicant or assignee. According to MPEP 402.04, “A power of attorney may be filed in an individual application, either original or reissue, and in any national stage application.” This document allows the designated representative to make decisions, file documents, and communicate with the USPTO on behalf of the applicant. It’s important to note that the power of attorney must be properly executed and filed to be effective.

To learn more:

What is the significance of a national application being made under 35 U.S.C. 111?

A national application made under 35 U.S.C. 111 signifies that it is filed directly with the United States Patent and Trademark Office (USPTO) and follows the standard U.S. patent application process.

The MPEP 201.01 states: ‘A national application is one that was filed in the United States Patent and Trademark Office (USPTO) under 35 U.S.C. 111.’ This means that the application is subject to U.S. patent laws and procedures from the outset.

Applications filed under 35 U.S.C. 111 include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Design applications
  • Plant applications
  • Provisional applications

These applications are distinct from international applications that enter the national stage in the U.S. under 35 U.S.C. 371.

For more information on patent application types, visit: patent application types.

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

What is the significance of a customer number in USPTO correspondence?

A customer number is a crucial tool for managing correspondence with the USPTO. According to MPEP 403:

‘A customer number allows an applicant, attorney or agent to easily change the correspondence address for a number of applications or patents by simply requesting a change to the address associated with the customer number.’

Key benefits of using a customer number include:

  • Streamlined correspondence management for multiple applications
  • Easy updates to address information
  • Efficient access to application information through USPTO systems

By using a customer number, patent professionals can significantly simplify their administrative processes when dealing with the USPTO.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

What is the significance of a customer number in patent applications filed after September 16, 2012?

A customer number holds significant importance in patent applications filed after September 16, 2012, particularly for managing practitioner representation. Here’s why:

  • It allows for efficient management of multiple practitioners
  • Power of attorney can be given to a customer number
  • It simplifies the process of adding or removing practitioners
  • Correspondence address can be associated with a customer number

According to MPEP 403.01(a): ‘A power of attorney or authorization of agent may be given to a customer number in applications filed on or after September 16, 2012.’ This provision streamlines the process of managing representation for applicants and practitioners alike.

Furthermore, the MPEP states: ‘If a practitioner is not of record, correspondence will be sent to the applicant’s correspondence address as shown in the application or the Patent Application Locating and Monitoring (PALM) system.’ This underscores the importance of keeping the customer number and associated information up to date.

To learn more:

A Customer Number is a unique identifier assigned by the USPTO that can be associated with a correspondence address. It offers several advantages in managing patent application correspondence:

  • Simplified address changes: You can update the address for multiple applications at once by changing the address associated with the Customer Number.
  • Priority in address selection: When multiple addresses are provided, the USPTO may prioritize the address associated with a Customer Number.
  • Easier access to Patent Application Information Retrieval (PAIR) system: Customer Numbers can be used to access multiple applications in PAIR.

37 CFR 1.33(a) states: If more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

Using a Customer Number can streamline communication with the USPTO and make it easier to manage multiple patent applications.

To learn more:

37 CFR 11.18 is a crucial regulation that governs signature and certification requirements for correspondence filed with the USPTO. Its significance includes:

  • Establishing signature requirements for practitioners
  • Defining certifications made when submitting papers
  • Setting standards for truthfulness and proper purpose in filings
  • Outlining potential consequences for violations

The MPEP emphasizes its importance: “The certifications in 37 CFR 11.18(b) apply to all papers filed in the Office, including allegations of improper conduct made by a registered practitioner in any Office proceeding.”

This regulation helps maintain the integrity of the patent application process and ensures that all parties involved are held to high ethical and legal standards.

To learn more:

To learn more:

37 CFR 1.55(h) provides an important provision for satisfying the requirement for a certified copy of a foreign application. Key points include:

  • It allows the certified copy requirement to be met through a prior-filed nonprovisional application.
  • The prior-filed application must be one for which benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • The prior-filed application must contain the certified copy and be identified as such.
  • This provision can simplify the process of perfecting priority claims in related applications.

The MPEP states: 37 CFR 1.55(h) provides that the requirement for a certified copy of the foreign application will be considered satisfied in an application if a prior-filed nonprovisional application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c) contains a certified copy of the foreign application and the prior-filed nonprovisional application is identified as containing a certified copy of the foreign application.

This provision can be particularly useful when requesting a certificate of correction to perfect a priority claim in a patent that claims benefit from an earlier application containing the certified copy.

Applications filed under 37 CFR 1.53(d) have a unique treatment of affidavits and declarations. According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

Key points about 37 CFR 1.53(d) applications:

  • They are continuation or divisional applications of a nonprovisional application
  • Affidavits and declarations from the parent application are automatically incorporated
  • This includes documents submitted under 37 CFR 1.130, 1.131, and 1.132
  • No additional action is required to include these documents in the new application

This automatic incorporation simplifies the process for applicants filing continuation or divisional applications under 37 CFR 1.53(d).

For more information on continuation applications, visit: continuation applications.

For more information on patent prosecution, visit: patent prosecution.

37 CFR 1.46 is significant in patent application prosecution, particularly for applications filed on or after September 16, 2012. According to MPEP 106.01, this regulation allows the assignee of record of the entire interest to become the applicant and prosecute the application.

The MPEP states: ‘…for applications filed on or after September 16, 2012, [the assignee] can prosecute the application after becoming the applicant under 37 CFR 1.46.’

This regulation is part of the changes implemented by the America Invents Act (AIA) and provides more flexibility for assignees in managing patent applications.

35 U.S.C. 386 establishes the right of priority for international design applications. It addresses two key scenarios:

  1. National applications claiming priority from international design applications
  2. International design applications claiming priority from prior foreign applications

The MPEP explains:

“Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.”

“Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.”

These provisions apply to applications filed on or after May 13, 2015, and patents issued from such applications.

35 U.S.C. 111(a) and (b) are important sections of the patent law that define two different types of national patent applications. According to MPEP 201.01:

‘National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’

To elaborate:

  • 35 U.S.C. 111(a) refers to nonprovisional applications. These are full patent applications that can potentially result in an issued patent.
  • 35 U.S.C. 111(b) refers to provisional applications. These are simplified applications that establish a priority date but do not themselves result in an issued patent.

The choice between filing under 111(a) or 111(b) depends on the inventor’s strategy and readiness to pursue full patent protection. Provisional applications (111(b)) provide a way to quickly establish a priority date, while nonprovisional applications (111(a)) begin the formal examination process.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

‘Limited recognition’ is a specific status granted by the USPTO that allows certain individuals to practice patent law in a restricted capacity. Its significance includes:

  • Allowing non-registered practitioners to represent applicants in specific circumstances.
  • Providing a pathway for Canadian patent agents to represent Canadian applicants.
  • Restricting the scope of practice to specific types of applications or applicants.

The MPEP 402.01 states: Limited recognition to practice in patent cases means recognition to practice before the Office in patent cases, or in a limited capacity as a patent agent, as appropriate… This status ensures that certain practitioners can assist applicants while maintaining the integrity of the USPTO’s registration system.

To learn more:

Tags: USPTO

What is the significance of ‘facts showing the right’ in proving proprietary interest?

The phrase ‘facts showing the right’ is crucial in proving proprietary interest for patent applications. According to MPEP 409.03(f):

‘Facts showing the right or authority to make the petition must be proved in accordance with 37 CFR 1.46.’

This means that:

  • Applicants must provide concrete evidence demonstrating their right to file and prosecute the patent application.
  • The evidence should clearly establish the applicant’s legal authority or ownership of the invention.
  • These facts are essential for the USPTO to determine if the applicant has the proper standing to proceed with the application.

Examples of such facts might include:

  • Documentation of employment agreements assigning invention rights to an employer
  • Contracts showing transfer of rights from inventors to the applicant
  • Court orders establishing ownership in cases of disputes

The significance of these ‘facts showing the right’ is that they protect the interests of all parties involved and ensure that patent rights are granted to the rightful owners or their authorized representatives.

To learn more:

The scope of a foreign filing license can vary depending on how it was obtained:

  • Licenses granted through the filing of a US application (implicit petition) typically have a broad scope as defined in 37 CFR 5.15(a).
  • Licenses granted through explicit petitions may have a narrower scope as defined in 37 CFR 5.15(b).
  • Licensees with a narrow scope can petition to convert to a broader scope under 37 CFR 5.15(c).

As stated in the MPEP: “The scope of any license granted on these petitions is indicated on the license. Petitions under 37 CFR 5.14(a) or (b) as well as any license granted on the petition are made of record in the application file.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

The USPTO Mail Center plays a crucial role in the initial handling of models, exhibits, and specimens submitted with patent applications. According to MPEP 608.03(a):

Models, exhibits, or specimens initially delivered to the Mail Center will be forwarded by the Mail Center to the model custodian, who will then contact the Technology Center (TC) model custodian for pick-up by the appropriate TC.

The process involves several steps:

  • The Mail Center receives the items along with the application.
  • Items are forwarded to the model custodian.
  • The model custodian contacts the Technology Center (TC) model custodian.
  • The appropriate TC picks up the items for further processing.

This system ensures that models, exhibits, and specimens are properly routed and handled within the USPTO, maintaining their integrity throughout the examination process.

To learn more:

What is the role of the Technology Center in handling status inquiries?

Technology Centers (TCs) play a specific role in handling certain types of status inquiries. MPEP 203.08 states:

“Inquiries which cannot be answered by the UCC will be forwarded to the TC for response.”

This means that more complex or specific inquiries that require expertise in a particular technological area are directed to the appropriate TC. TCs have access to more detailed information about applications in their field and can provide more specific guidance within the limits of USPTO policy.

To learn more:

The Assignment Division plays a crucial role in handling patent assignment documents. According to MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The Assignment Division’s responsibilities include:

  • Receiving assignment documents for patents and patent applications
  • Recording these documents in the USPTO’s assignment database
  • Maintaining accurate records of patent ownership and transfers
  • Ensuring that assignment information is searchable and accessible
  • Processing requests for copies of recorded documents

By centralizing these functions, the USPTO can maintain a comprehensive and up-to-date record of patent ownership separate from the technical aspects of patent prosecution.

The Assignment Division plays a crucial role in handling patent assignments at the USPTO. As indicated in MPEP 318:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

The Assignment Division’s responsibilities include:

  • Receiving assignment documents submitted for recording
  • Properly recording and maintaining assignment records
  • Ensuring the accuracy and accessibility of ownership information
  • Managing the assignment database separate from application and patent files

This specialized division ensures that patent ownership information is correctly documented and readily available when needed.

To learn more:

While the initial screening for sensitive subject matter is performed by designated personnel, patent examiners also play a crucial role in this process. The MPEP states:

While the initial screening is performed only by designated personnel, all examiners have a responsibility to be alert for obviously sensitive subject matter either in the original disclosure or subsequently introduced, for example, by amendment.

If an examiner identifies potentially sensitive subject matter, they are instructed to take action:

If the examiner is aware of subject matter which should be subject to screening by appropriate office personnel, this should be brought to the attention of Licensing and Review.

This ongoing vigilance by examiners helps ensure that sensitive information is not inadvertently disclosed, even if it was not identified during the initial screening process.

For more information on Patent examiners, visit: Patent examiners.

The examiner plays a crucial role in processing requests to delete a named inventor in a Continued Prosecution Application (CPA) for design applications. According to MPEP ¶ 2.32, the examiner is responsible for acknowledging the receipt of the request and confirming that the inventorship has been corrected. The MPEP provides the following guidance for examiners:

“Examiner Note: 1. Use this form paragraph where a Continued Prosecution Application (CPA) is filed accompanied by a statement requesting deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the new application.”

The examiner must verify that the request was submitted with the CPA filing and use the appropriate form paragraph to acknowledge the correction of inventorship. If the request is made after the CPA filing, the examiner must ensure it’s accompanied by a request under 37 CFR 1.48, as per the MPEP instructions.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent procedure, visit: patent procedure.

What is the role of an assignee in a patent application?

An assignee is an entity or person to whom the inventor has transferred some or all rights to the patent. While an assignee cannot be named as the applicant for patent applications filed on or after September 16, 2012, they still play important roles in the patent process. According to MPEP 605: ‘The assignee… may sign the patent application papers if the assignee is an applicant (i.e., the assignee has been named as the applicant for the patent application in the application data sheet).’ This means that while the inventor(s) must be named as the applicant(s), an assignee can sign certain documents and may have rights to the patent once it’s granted.

To learn more:

An affidavit plays a crucial role in proving the unavailability or refusal of a non-signing inventor. The MPEP 409.03(d) states:

An affidavit or declaration of the applicant, or his/her attorney or agent, explaining the situation and stating the last known address of the non-signing inventor, may be sufficient to establish that the inventor cannot be found or reached after diligent effort or has refused to execute the application papers.

The affidavit should:

  • Provide a detailed account of efforts to locate or communicate with the inventor
  • Include dates, methods of contact attempted, and results
  • Explain any refusal circumstances if applicable
  • Be signed under oath or declaration

This sworn statement serves as a formal record of the applicant’s diligent efforts and is considered by the USPTO in determining the validity of the proof of unavailability or refusal.

To learn more:

An administrator plays a crucial role in filing a patent application for a deceased inventor. According to MPEP 409.01(b):

If the inventor was not of sound mind and legally incapacitated at the time the application was made, it may be signed by a legal representative (e.g., guardian), the inventor’s legal representative (e.g., executor, administrator, etc.), or someone acting on behalf of the inventor or legal representative.

The administrator’s responsibilities include:

  • Representing the deceased inventor’s estate
  • Signing necessary documents on behalf of the deceased inventor
  • Providing proof of their authority to act as administrator
  • Ensuring the application process complies with legal requirements

It’s important to note that the administrator must have the legal authority to act on behalf of the deceased inventor’s estate.

To learn more:

An ‘obligated assignee’ is a person or entity who has a contractual obligation to assign the rights to an invention but has not yet done so. According to MPEP 409.05, an obligated assignee can file a patent application on behalf of the inventor if they meet certain requirements:

  • They must have a contractual obligation with the inventor to assign the entire right, title, and interest in the application.
  • They must file an application data sheet under 37 CFR 1.76 naming the inventor and including a statement that the application is being filed by the obligated assignee.

The MPEP states: ‘An assignee who is not the original applicant may file a patent application as long as the application is accompanied by a statement that establishes the assignee’s ownership interest.’ This provision allows obligated assignees to initiate the patent process even before the formal assignment has taken place.

To learn more:

A patent practitioner plays a crucial role in signing micro entity certifications. According to MPEP 509.04(c), a patent practitioner can sign a micro entity certification in two capacities:

  1. As a patent practitioner of record
  2. As a patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34

Moreover, for juristic entities, “Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.” This includes micro entity certifications for corporate assignees or other organizational parties under 37 CFR 1.46.

To learn more:

What is the role of a patent practitioner during an interview with the USPTO?

A patent practitioner plays a crucial role during an interview with the USPTO. According to MPEP 408, the practitioner is responsible for:

  • Representing the applicant or patent owner
  • Discussing the merits of the application or patent
  • Providing clarifications on the invention
  • Negotiating potential claim amendments
  • Addressing any concerns raised by the examiner

The MPEP states: ‘Interviews must be conducted on the Office premises, such as in examiner’s offices, conference rooms or the video conference centers.’ This underscores the formal nature of these interactions and the importance of the practitioner’s role in facilitating productive discussions with the examiner.

For more information on patent examination, visit: patent examination.

What is the role of a legal representative in filing a patent application for a deceased inventor?

A legal representative plays a crucial role in filing a patent application for a deceased inventor. According to MPEP 409.03(b):

“The legal representative (executor, administrator, etc.) of a deceased inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative’s responsibilities include:

  • Executing the necessary oath or declaration on behalf of the deceased inventor
  • Providing proof of their authority to act (e.g., Letters Testamentary or Letters of Administration)
  • Submitting the patent application and all required documents to the USPTO
  • Corresponding with the USPTO throughout the application process
  • Potentially assigning the patent rights if required by the deceased inventor’s will or other legal arrangements

It’s important to note that the legal representative must act in accordance with the law and the best interests of the deceased inventor’s estate.

To learn more:

The legal representative of a deceased inventor plays a crucial role in the patent application process. According to MPEP 409.01:

If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or representatives of the deceased inventor.

The legal representative’s responsibilities include:

  • Executing the oath or declaration on behalf of the deceased inventor
  • Providing documentation of their authority to act on behalf of the deceased inventor’s estate
  • Continuing the prosecution of the patent application
  • Receiving the granted patent on behalf of the deceased inventor’s estate

It’s important to note that the legal representative must be properly appointed according to state laws governing estate administration.

To learn more:

The right of priority in international patent law refers to the right to rely on a foreign application when filing a patent application in another country. This concept originated in the Paris Convention for the Protection of Industrial Property, which the United States adhered to in 1887.

As stated in the MPEP: The right to rely on a foreign application is known as the right of priority in international patent law and this phrase has been adopted in the U.S. statute. This right allows applicants to claim the filing date of an earlier foreign application, providing certain conditions are met.

To learn more:

The right of priority allows an applicant who has filed a patent application in a foreign country to claim priority to that earlier filing date when filing a subsequent U.S. application for the same invention. This right is established by 35 U.S.C. 119 and gives the U.S. application the benefit of the earlier foreign filing date, as long as certain conditions are met.

Specifically, 35 U.S.C. 119(a) states: “An application for patent for an invention filed in this country by any person who has, or whose legal representatives or assigns have, previously regularly filed an application for a patent for the same invention in a foreign country which affords similar privileges in the case of applications filed in the United States or to citizens of the United States, or in a WTO member country, shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country, if the application in this country is filed within 12 months from the earliest date on which such foreign application was filed.”

The Patent Law Treaties Implementation Act (PLTIA) introduced the concept of restoration of the right of priority. This provision allows applicants to file a subsequent application and still claim priority or benefit even if they missed the standard 12-month deadline (6-month for design applications).

As stated in the MPEP: Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. (MPEP 210)

Key points about restoration of the right of priority:

  • It applies to both foreign priority claims and domestic benefit claims to provisional applications.
  • The subsequent application must be filed within 14 months from the filing date of the prior foreign application or provisional application (8 months for design applications).
  • The delay in filing the subsequent application must be unintentional.
  • A petition for restoration of the right of priority must be filed.

The specific requirements and procedures for restoration of the right of priority are outlined in 37 CFR 1.55(c) for foreign priority claims and 37 CFR 1.78(b) for domestic benefit claims.

For more information on PLTIA, visit: PLTIA.

For more information on unintentional delay, visit: unintentional delay.

For a valid foreign priority claim, the U.S. application and the foreign application must name the same inventor or have at least one joint inventor in common. This requirement ensures that the right of priority is properly linked between the applications.

As stated in MPEP 213.02: “Pursuant to 35 U.S.C. 119(a), the foreign application must have been filed by the same applicant as the applicant in the United States, or by applicant’s legal representatives or assigns. Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.”

The MPEP further clarifies: “Joint inventors A and B in a nonprovisional application filed in the United States Patent and Trademark Office may properly claim the benefit of an application filed in a foreign country by A and another application filed in a foreign country by B, i.e., A and B may each claim the benefit of their foreign filed applications.”

This requirement ensures that the priority right is properly linked to the inventive entity responsible for the invention in both the foreign and U.S. applications.

For more information on foreign priority, visit: foreign priority.

For more information on joint inventors, visit: joint inventors.

For a valid foreign priority claim, the U.S. application must have at least one common inventor with the foreign application. This requirement ensures that the right of priority is only available to the actual inventors or their legal representatives.

As stated in MPEP 213.02: “Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.”

This means that:
1. A sole inventor in the U.S. can claim priority to a foreign application where they are the sole inventor or one of joint inventors.
2. Joint inventors in the U.S. can claim priority to a foreign application filed by any one or more of them.
3. A U.S. application cannot claim priority to a foreign application with completely different inventors.

It’s important to note that while the inventorship must overlap, it doesn’t have to be identical between the U.S. and foreign applications.

In applications filed pursuant to pre-AIA 37 CFR 1.47, it is mandatory to state the last known address of the nonsigning inventor. The MPEP states:

‘An application filed pursuant to pre-AIA 37 CFR 1.47 must state the last known address of the nonsigning inventor.’

This requirement ensures that the USPTO can attempt to contact the nonsigning inventor regarding the application filed on their behalf.

To learn more:

To learn more:

Tags: pre-AIA

The USPTO requires that different matters be submitted in separate papers to ensure efficient processing. This requirement is outlined in MPEP 501, which cites 37 CFR 1.4(c):

Since different matters may be considered by different branches or sections of the Office, each distinct subject, inquiry or order must be contained in a separate paper to avoid confusion and delay in answering papers dealing with different subjects.

This means that if you have multiple requests or inquiries for the USPTO, each should be submitted on its own separate document. For example, a petition and an information disclosure statement should not be combined into a single paper.

If an applicant submits a single paper containing distinct subjects, the USPTO may use the following form paragraph to notify them:

The [1] submitted [2] should have been submitted as a separate paper as required by 37 CFR 1.4(c). The paper has been entered. However, all future correspondence must comply with 37 CFR 1.4.

Adhering to this requirement helps ensure that your correspondence is processed efficiently and reaches the appropriate department within the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO correspondence, visit: USPTO correspondence.

When claiming foreign priority, applicants are generally required to file a certified copy of the foreign application within a specified time period. The requirements and deadlines for filing the certified copy depend on the type of application and the circumstances of the filing.

According to MPEP 213.04: “37 CFR 1.55(g) sets forth the requirements for filing a priority claim, certified copy of foreign application, and translation that are applicable in all applications.”

Key points about the certified copy requirement include:

  • The certified copy must be filed within the pendency of the application, unless filed with a petition.
  • For applications filed under 35 U.S.C. 111(a), the certified copy must typically be filed within the later of four months from the actual filing date or sixteen months from the filing date of the prior foreign application.
  • For national stage applications under 35 U.S.C. 371, the certified copy must be filed within the time limit set forth in the PCT and the Regulations under the PCT.
  • If the certified copy is not filed within the required time period, it must be accompanied by a petition and fee, along with a showing of good and sufficient cause for the delay.
  • In some cases, the requirement may be satisfied through the priority document exchange program or by identifying a previously filed application containing the certified copy.

The MPEP also notes: “If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.”

For more information on certified copy, visit: certified copy.

For more information on filing requirements, visit: filing requirements.

For more information on foreign application, visit: foreign application.

When citing documents in a language other than English in an Information Disclosure Statement (IDS), you must provide:

  • The original document in the foreign language
  • A concise explanation of the relevance in English, if not already available

According to MPEP 609.04(a): If a foreign patent document or non-patent literature document is in a language other than English, an English language translation should be submitted along with the document if an English language translation is readily available to the applicant.

Additionally, Where the information listed is not in the English language, but was cited in a search report or other action by a foreign patent office in a counterpart foreign application, the requirement for a concise explanation of relevance can be satisfied by submitting an English-language version of the search report or action which indicates the degree of relevance found by the foreign office.

To learn more:

When a claim discloses subject matter not shown in the drawing or described in the description, the applicant may be required to amend the drawing and description. However, this requirement is contingent on the claim providing sufficiently specific and detailed disclosure. The MPEP 608.01(l) states: “It is, of course, to be understood that this disclosure in the claim must be sufficiently specific and detailed to support the necessary amendment of the drawing and description.” This means that the claim must provide enough information to enable a person skilled in the art to make the necessary amendments to the drawings and description.

To learn more:

What is the required oath or declaration for a divisional application?

For a divisional application, a new oath or declaration is generally required. However, there are exceptions:

  • If the application is filed on or after September 16, 2012, a copy of the oath or declaration from the prior nonprovisional application may be used, provided that it complies with 37 CFR 1.63, 1.64, or 1.67 for the divisional application.
  • If the divisional application was filed before September 16, 2012, and the prior application was filed on or after September 16, 2012, a copy of the oath or declaration from the prior application can be used in the divisional application.

As stated in MPEP 201.06: “A new oath or declaration is required in a divisional application filed under 37 CFR 1.53(b), regardless of whether a copy of the oath or declaration from the prior nonprovisional application is used in the divisional application, unless the divisional application is filed on or after September 16, 2012.”

To learn more:

MPEP 409.03(f) is not applicable to patent applications filed on or after September 16, 2012. This is clearly stated at the beginning of the section:

“[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012. See MPEP §§ 325, 409.05, and 605 for information pertaining to applications for patent filed on or after September 16, 2012 by an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter.]”

For applications filed on or after September 16, 2012, applicants should refer to:

These sections provide guidance on how assignees, obligated assignees, or persons with sufficient proprietary interest can file patent applications under the current law.

To learn more:

To learn more:

The relationship between the specification and claims in a patent application is crucial. As indicated in MPEP 608.01(k), “35 U.S.C. 112 requires that the specification shall particularly point out and distinctly claim the subject matter which the inventor or joint inventor regards as his or her invention.”

This means:

  • The specification provides a detailed description of the invention
  • The claims, which are part of the specification, define the legal scope of protection
  • The claims must be supported by the description in the specification
  • The specification should enable a person skilled in the art to make and use the invention as claimed

In essence, the specification provides the context and detailed explanation of the invention, while the claims define the specific elements for which legal protection is sought.

To learn more:

The detailed description and the claims in a patent application have a crucial interdependent relationship. According to MPEP 608.01(g):

“The description is a dictionary for the claims and should provide clear support or antecedent basis for all terms used in the claims.”

This relationship is characterized by several key aspects:

  • Support for Claims: The detailed description must provide sufficient information to support all the elements mentioned in the claims.
  • Antecedent Basis: Terms used in the claims should be introduced and explained in the description, establishing an antecedent basis.
  • Illustration Requirement: As stated in MPEP 608.01(g), “Every feature specified in the claims must be illustrated.”
  • Clarity and Enablement: The description should enable a person skilled in the art to understand and implement the claimed invention without undue experimentation.
  • Consistency: The terminology used in the claims should be consistent with that used in the description.

For more information on the relationship between claims and the specification, refer to MPEP § 608.01(o) and § 2111.01. Maintaining a clear and supportive relationship between the description and claims is essential for a strong and enforceable patent.

To learn more:

What is the relationship between priority claims and the effective filing date?

The relationship between priority claims and the effective filing date is crucial in determining the patentability of an invention. According to MPEP 216:

“The effective filing date of a claimed invention is determined on a claim-by-claim basis and not an application-by-application basis.”

This means that each claim in a patent application may have a different effective filing date, depending on its content and the priority claims it can support. The effective filing date is important because it determines which prior art can be used against the claim during examination and potential litigation.

  • If a claim is fully supported by an earlier application, its effective filing date may be the filing date of that earlier application.
  • If a claim contains new matter not disclosed in any earlier application, its effective filing date will be the actual filing date of the current application.

Understanding this relationship is crucial for inventors and patent practitioners to properly claim priority and protect their inventions.

For more information on effective filing date, visit: effective filing date.

What is the relationship between a provisional application and a nonprovisional application?

A provisional application serves as a placeholder for a later-filed nonprovisional application. According to MPEP 201.04:

“A provisional application may serve as a basis for claiming benefit under 35 U.S.C. 119(e) in a later filed nonprovisional application or an international application designating the United States.”

This means that a provisional application can establish an earlier filing date for a subsequent nonprovisional application, provided the nonprovisional is filed within 12 months of the provisional and properly claims benefit to it.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

What is the relationship between a divisional application and its parent application?

A divisional application is closely related to its parent application, as it stems from the same invention disclosure. According to MPEP 201.06, “A divisional application is a later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application.” This means that:

  • The divisional application contains a subset of the subject matter from the parent application.
  • It claims an independent or distinct invention from what is claimed in the parent application.
  • It cannot introduce new matter beyond what was disclosed in the parent application.
  • It can claim the benefit of the parent application’s filing date.

The relationship allows for separate prosecution of different aspects of an invention while maintaining the priority date of the original disclosure.

To learn more:

What is the relationship between a divisional application and a restriction requirement?

A divisional application is often filed in response to a restriction requirement issued by the USPTO. The MPEP 201.06 explains:

“A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.'”

The relationship between a divisional application and a restriction requirement is as follows:

  • When an examiner determines that a single application contains two or more independent or distinct inventions, they may issue a restriction requirement.
  • The applicant must then elect one invention to pursue in the original application.
  • The non-elected invention(s) can be pursued in one or more divisional applications.
  • Divisional applications allow applicants to protect multiple inventions disclosed in a single parent application without violating the principle of double patenting.

It’s important to note that while divisional applications are often filed in response to restriction requirements, they can also be filed voluntarily if the applicant recognizes distinct inventions in their application before receiving a restriction requirement.

To learn more:

What is the relationship between a divisional application and a continuation application?

Divisional applications and continuation applications are both types of continuing applications, but they serve different purposes. The MPEP 201.06 provides insight into the nature of divisional applications:

“A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.'”

In contrast, a continuation application typically contains the same disclosure as the parent application but with different claims. The key differences are:

  • Divisional Application: Filed to pursue distinct inventions that were subject to a restriction requirement in the parent application.
  • Continuation Application: Filed to pursue additional aspects of the same invention disclosed in the parent application.

Both types of applications claim the benefit of the parent application’s filing date, but they differ in their purpose and the scope of claims they can contain. It’s important to choose the appropriate type of continuing application based on the specific circumstances and inventive concepts you wish to protect.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

What is the relationship between a continuation-in-part application and its parent application?

A continuation-in-part (CIP) application is a type of patent application that has a unique relationship with its parent application. According to MPEP 201.08:

“A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.”

This means that a CIP application:

  • Contains some or all of the subject matter from the parent application
  • Introduces new subject matter not present in the parent application
  • Must be filed while the parent application is still pending

The relationship between a CIP and its parent is important for determining priority dates and the scope of patent protection.

For more information on new matter, visit: new matter.

For more information on parent application, visit: parent application.

35 U.S.C. 119(e) is crucial in understanding the relationship between provisional applications and their non-provisional counterparts, particularly in terms of assignments. The MPEP § 306.01 states:

If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

This means:

  • 35 U.S.C. 119(e) allows non-provisional applications to claim the benefit of an earlier filing date from a provisional application.
  • When a non-provisional application claims this benefit and contains only subject matter from the provisional, the assignment recorded for the provisional application remains effective for the non-provisional.
  • This treatment aligns with how assignments are handled for continuations and divisions under 35 U.S.C. 120.

However, if new subject matter is introduced in the non-provisional application, different assignment rules may apply, as detailed in other parts of MPEP § 306.01.

According to MPEP 317.01, the recording date for a patent document is defined as follows:

“The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.”

This means that the recording date is established when a document that complies with all the necessary requirements is received by the United States Patent and Trademark Office (USPTO).

To learn more:

The recording date for a document at the USPTO is the date when the document meeting all recording requirements is filed with the Office. As stated in 37 CFR 3.51, “The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.” This means that all necessary criteria, including proper identification and fees, must be met for the document to be officially recorded on that date.

The recording date for a document at the USPTO Assignment Division is determined as follows:

  • It is the date when a document meeting all requirements is filed with the Office.
  • Documents not complying with identification requirements (37 CFR 3.21) will not be recorded.
  • Documents with other deficiencies (e.g., missing cover sheet or fee) will be returned for correction.
  • If corrected and resubmitted within the specified time, the original receipt date may be considered the recording date.

According to 37 CFR 3.51: “The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office.”

The MPEP provides guidance on the recommended order for elements in an independent claim, particularly for improvements. According to 37 CFR 1.75(e), the recommended order is:

  1. A preamble comprising a general description of all conventional or known elements or steps of the claimed combination.
  2. A phrase such as “wherein the improvement comprises.”
  3. The elements, steps, and/or relationships that constitute the new or improved portion of the claimed combination.

The MPEP states: “Where the nature of the case admits, as in the case of an improvement, any independent claim should contain in the following order: (1) A preamble comprising a general description of all the elements or steps of the claimed combination which are conventional or known, (2) A phrase such as ‘wherein the improvement comprises,’ and (3) Those elements, steps, and/or relationships which constitute that portion of the claimed combination which the applicant considers as the new or improved portion.”

This structure helps clearly distinguish the novel aspects of the invention from the prior art.

To learn more:

The recommended length for a patent application abstract is typically 150 words or less. According to MPEP 608.01(b):

The abstract is a brief narrative of the disclosure as a whole, as concise as the disclosure permits, in a single paragraph preferably not exceeding 150 words, commencing on a separate sheet following the claims.

While 150 words is the preferred maximum length, the MPEP also notes that the abstract should be as concise as the disclosure permits. This means that if the invention can be adequately summarized in fewer words, a shorter abstract is acceptable and even encouraged.

To learn more:

The recommended arrangement of elements in a utility patent application is outlined in 37 CFR 1.77. The elements should appear in the following order:

  • Utility application transmittal form
  • Fee transmittal form
  • Application data sheet
  • Specification
  • Drawings
  • The inventor’s oath or declaration

The specification should include specific sections in a particular order, starting with the title of the invention and ending with the abstract of the disclosure. As stated in the MPEP, The order of arrangement of specification elements as set forth in 37 CFR 1.77(b) is preferable (e.g., not required) in framing the nonprovisional specification and each of the items should appear in upper case, without underlining or bold type, as section headings.

To learn more:

The receipt date for facsimile transmissions to the USPTO is determined according to specific rules outlined in MPEP 502.01:

The date of receipt accorded to any correspondence permitted to be sent by facsimile transmission, including a continued prosecution application (CPA) filed under 37 CFR 1.53(d), (available for design applications only) is the date the complete transmission is received by an Office facsimile unit, unless the transmission is completed on a Saturday, Sunday, or Federal holiday within the District of Columbia.

If the transmission is completed on a weekend or federal holiday in DC, the receipt date will be the next business day. For example, if a fax is completed at 9:05 p.m. Pacific time on a Friday, it would be received around 12:05 a.m. Eastern time on Saturday. The receipt date would then be the following Monday (assuming it’s not a federal holiday).

It’s important to note that the Certificate of Transmission under 37 CFR 1.8 can be used for certain documents to consider them timely filed on the date of transmission, even if received later by the USPTO.

To learn more:

The Quick Path Information Disclosure Statement (QPIDS) Pilot Program is an initiative by the USPTO that allows, under specific circumstances, for the submission of an Information Disclosure Statement (IDS) after payment of the issue fee but prior to patent grant. This program provides a streamlined option for considering newly discovered prior art after the issue fee has been paid.

According to MPEP 609.04(b): In May of 2012 the Office launched the Quick Path Information Disclosure Statement (QPIDS) Pilot Program. This pilot program allows, under specific circumstances, for the submission of an IDS after payment of the issue fee but prior to patent grant.

For more information on the QPIDS Pilot Program, visit the USPTO’s QPIDS webpage.

To learn more:

The USPTO has established special procedures for handling official inquiries to ensure consistency and compliance with government directives. As stated in MPEP 203.08(a):

This procedure is used so that there will be uniformity in the handling of contacts from the indicated sources, and also so that compliance with directives of the Department of Commerce is attained.

These procedures help the USPTO maintain a standardized approach to high-level inquiries and ensure that responses align with broader governmental policies.

To learn more:

Tags: USPTO

The PTO-948 form, also known as the ‘Drawing Informalities’ form, serves the following purposes in patent applications:

  • It is used by the Office of Patent Application Processing (OPAP) to indicate that the drawings submitted with the application are informal but acceptable for publication purposes.
  • It notifies the examiner that the drawings may need to be corrected or replaced with formal drawings during examination.
  • It provides a record in the file wrapper that the drawings have been provisionally accepted.

As stated in MPEP 507: ‘If the drawings are informal but otherwise in compliance with 37 CFR 1.121(d), the OPAP will accept the application for purposes of publication and place a ‘Drawing Informalities’ form PTO-948 in the file wrapper.’

This form helps streamline the application process by allowing examination to proceed while flagging the need for potential drawing improvements later in the process.

For more information on OPAP, visit: OPAP.

Tags: OPAP

The Priority Document Exchange (PDX) program is designed to facilitate the electronic exchange of priority documents between participating intellectual property offices. According to MPEP 215.01, the PDX program allows participating foreign intellectual property offices to exchange priority documents with the United States Patent and Trademark Office (USPTO) at no cost to the applicant. This program aims to streamline the process of submitting priority documents, reducing the burden on applicants and improving efficiency in patent examination procedures.

To learn more:

The PDX (Priority Document Exchange) program serves to facilitate the exchange of priority documents between participating intellectual property offices. According to MPEP 215.01, ‘The PDX program eliminates the need for applicants to submit paper certified copies of foreign applications in participating intellectual property offices.’ This streamlines the process, reducing both the burden on applicants and the workload for patent offices.

The Manual of Patent Examining Procedure (MPEP) serves as a comprehensive guide for patent examiners, applicants, attorneys, and agents involved in the patent application process. According to MPEP 101, its purpose is to:

  • Provide instructions to examiners for the examination of patent applications
  • Outline procedures for processing and examining patent applications
  • Serve as a reference work on patent laws, rules, and examination practices

The MPEP states: The Manual contains instructions to examiners, as well as other material in the nature of information and interpretation, and outlines the current procedures which the examiners are required or authorized to follow in appropriate cases in the normal examination of a patent application.

For more information on patent examination, visit: patent examination.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

The Mail Stop Assignment Recordation Services is a specific designation used by the USPTO to ensure proper routing and processing of assignment documents. MPEP 302.08 states:

In order to ensure prompt and proper processing, documents and their cover sheets should be addressed to the Mail Stop Assignment Recordation Services, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450, unless they are filed together with new applications.

This Mail Stop designation helps the USPTO efficiently direct assignment documents to the appropriate department for recordation, reducing processing time and potential errors in document handling.

To learn more:

Tags: USPTO

What is the purpose of the Issue Notification in the patent application process?

The Issue Notification serves as an important communication in the patent application process. According to the MPEP 308, “The Issue Notification identifies the issue date of the patent number assigned to the application.” This notification is crucial because it:

  • Informs the applicant of the official issue date of their patent
  • Provides the assigned patent number
  • Serves as confirmation that the patent will be granted
  • Helps applicants plan for any post-issuance actions or maintenance fees

The Issue Notification is typically sent several weeks before the actual issue date, giving applicants time to prepare for the patent’s publication and enforcement.

For more information on issue date, visit: issue date.

For more information on patent grant, visit: patent grant.

The detailed description in a patent application serves several crucial purposes:

  • It provides a comprehensive explanation of the invention, as required by 37 CFR 1.71 and MPEP § 608.01.
  • It must be detailed enough to enable any person skilled in the pertinent art or science to make and use the invention without involving extensive experimentation.
  • It should clearly convey enough information about the invention to show that the applicant invented the subject matter that is claimed.

As stated in MPEP 608.01(g):

“This detailed description, required by 37 CFR 1.71, MPEP §§ 608.01, 2161, and 2162, must be in such particularity as to enable any person skilled in the pertinent art or science to make and use the invention without involving extensive experimentation and must clearly convey enough information about the invention to show that applicant invented the subject matter that is claimed.”

In essence, the detailed description acts as a comprehensive guide to your invention, ensuring that it can be understood, replicated, and distinguished from prior art.

To learn more:

The cover sheet serves as a crucial document in the patent assignment process. Its primary purpose is to provide essential information about the assignment in a standardized format. According to MPEP 302.05, one of the key pieces of information that must be included on this cover sheet is the assignee’s address:

The address of the assignee … must be given in the required cover sheet.

The cover sheet ensures that the USPTO has accurate and readily accessible information about the assignment, including details about the assignee, which is critical for maintaining proper records and facilitating communication regarding the patent.

To learn more:

The Brief Summary of Invention serves to inform the public, especially those in the relevant field, about the nature of the invention. According to MPEP 608.01(d), “Since the purpose of the brief summary of invention is to apprise the public, and more especially those interested in the particular art to which the invention relates, of the nature of the invention, the summary should be directed to the specific invention being claimed, in contradistinction to mere generalities which would be equally applicable to numerous preceding patents.” This means the summary should focus on the unique aspects of the claimed invention rather than general information about the field.

To learn more:

The affidavit required for claiming priority based on an inventor’s certificate serves a specific purpose, as outlined in MPEP 213.05:

The affidavit or declaration specified under 37 CFR 1.55(l) is only required for the purpose of ascertaining whether, in the country where the application for an inventor’s certificate originated, this option generally existed for applicants with respect to the particular subject matter of the invention involved.

The affidavit is not intended to investigate the specific applicant’s eligibility to exercise the option in their particular case. Rather, it’s meant to confirm that in the country where the inventor’s certificate was filed, applicants generally had the right to choose between applying for a patent or an inventor’s certificate for the subject matter in question.

This requirement ensures compliance with the treaty and statute governing priority rights, while recognizing that some countries may have restrictions based on factors such as employment or nationality.

To learn more:

The USPTO requires separate copies of correspondence for different patent files to ensure that each file is complete and self-contained. According to MPEP 502.04:

Since each file must be complete in itself, a separate copy of every paper to be filed in a patent, patent file, or other proceeding must be furnished for each file to which the paper pertains, even though the contents of the papers filed in two or more files may be identical.

This requirement serves several purposes:

  • It ensures that each file contains all relevant documents without relying on cross-referencing between files.
  • It facilitates independent processing and review of each application or proceeding.
  • It maintains the integrity and completeness of individual patent files, which is crucial for legal and administrative purposes.

To learn more:

Patent applications that appear to disclose, purport to disclose, or do disclose inventions or discoveries relating to atomic energy are reported to the Department of Energy. The purpose is to allow the DOE access to these applications for review.

As stated in MPEP 150: Applications for patents which appear to disclose, purport to disclose or do disclose inventions or discoveries relating to atomic energy are reported to the Department of Energy, which Department will be given access to the applications. However, it’s important to note that Such reporting does not constitute a determination that the subject matter of each application so reported is in fact useful or is an invention or discovery, or that such application in fact discloses subject matter in categories specified by 42 U.S.C. 2181(c) and (d).

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

What is the purpose of recording patent assignment documents?

Recording patent assignment documents serves several important purposes:

  • Providing notice to the public of the assignment
  • Creating a public record of the assignment
  • Protecting against subsequent purchasers without notice
  • Establishing priority of ownership rights

According to MPEP 302, ‘The recording of an assignment document in the USPTO is not a determination of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.’ It merely serves as a public notice and record of the transaction.

For more information on patent assignment, visit: patent assignment.

For more information on recording documents, visit: recording documents.

Recording documents with the USPTO serves several important purposes:

  • Provides constructive notice to the public of the recorded document
  • Protects against subsequent purchasers or mortgagees
  • Establishes priority dates for security interests
  • Maintains a clear chain of title for patents and applications

MPEP 313 states: The recording of a document pursuant to 37 CFR 3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration. However, recording does provide legal benefits and helps maintain accurate ownership records.

For more information on chain of title, visit: chain of title.

For more information on Constructive Notice, visit: Constructive Notice.

Recording documents other than assignments at the USPTO serves several important purposes:

  • Provides public notice of the existence of the document
  • Establishes legal priority in certain situations
  • Protects the interests of parties involved in patent-related transactions
  • Facilitates the transfer and licensing of patent rights

MPEP 313 states: “The recording of such documents is not mandatory. However, if they are not recorded in the Office, they are not enforceable against a subsequent purchaser or mortgagee for valuable consideration, without notice, unless recorded in the Office prior to the subsequent purchase or mortgage.”

This highlights the importance of recording these documents to protect the interests of all parties involved in patent-related transactions.

What is the purpose of recording an assignment with the USPTO?

Recording an assignment with the USPTO serves several important purposes:

  • Constructive notice: It provides constructive notice to the public of the assignment.
  • Prima facie evidence: The recording acts as prima facie evidence of the execution of the assignment.
  • Legal protection: It protects against subsequent purchasers without notice.
  • Maintaining chain of title: It helps maintain a clear chain of title for the patent or application.

As stated in MPEP 302: “The recording of an assignment document in the USPTO is governed by statute. The statutory provision is 35 U.S.C. 261.”

For more information on assignment recording, visit: assignment recording.

For more information on USPTO, visit: USPTO.

Pre-AIA 37 CFR 1.47(b) allows a person with a demonstrated proprietary interest to file a patent application on behalf of an inventor who is unavailable. According to the MPEP, this provision is applicable “when no inventor is available to make application” and permits filing “on behalf of and as agent for” an inventor who “cannot be found or reached after diligent effort” or who refuses to sign the application oath or declaration.

It’s important to note that this provision is not applicable to applications filed on or after September 16, 2012.

To learn more:

The Office of Patent Application Processing (OPAP) performs an initial review of drawings in new utility and plant patent applications to determine whether the drawings can be effectively scanned for publication purposes. As stated in the MPEP:

“OPAP inspects the drawings to see if they can be effectively scanned and adequately reproduced.”

This review ensures that the drawings meet the necessary quality standards for publication and reproduction.

For more information on drawing review, visit: drawing review.

For more information on OPAP, visit: OPAP.

MPEP 409.03(f) – Proof of Proprietary Interest outlines the requirements for establishing proprietary interest in a patent application when an inventor refuses to execute an oath or declaration. The section states:

‘If an inventor refuses to execute an oath or declaration under 37 CFR 1.63, the party to whom the inventor has assigned or agreed in writing to assign the invention, or who otherwise shows sufficient proprietary interest in the matter justifying such action, may make application for patent as provided in 37 CFR 1.46.’

This section provides guidance on how to prove sufficient proprietary interest, which is crucial for applicants who need to file a patent application without the inventor’s cooperation.

To learn more:

To learn more:

MPEP 409.03 provides guidance on how to handle patent applications filed before September 16, 2012 when an inventor is unavailable or unwilling to sign the application. It outlines the procedures for filing an application under pre-AIA 37 CFR 1.47 when:

  • A joint inventor refuses to join in an application or cannot be found/reached after diligent effort
  • All inventors are unavailable
  • A legal representative of a deceased inventor is unavailable

The section details the requirements, evidence needed, and process for submitting and processing these types of applications.

To learn more:

To learn more:

What is the purpose of MPEP 203.08 – Status Inquiries?

MPEP 203.08 – Status Inquiries outlines the procedures for handling status inquiries about patent applications. The section states:

“The Office receives numerous telephone and written requests for information concerning the status of patent applications. These status inquiries may be made to the USPTO Contact Center (UCC), the Technology Center (TC) or the Patent Examining Group.”

This section provides guidance to both applicants and USPTO staff on how to handle these inquiries efficiently and in compliance with privacy regulations.

To learn more:

The purpose of MPEP ¶ 2.33 is to provide guidance to patent examiners when they encounter a situation where a new inventor is identified in a Continued Prosecution Application (CPA) for design applications. It states:

Use this form paragraph where a request for a Continued Prosecution Application (CPA) identifies one or more inventors who were not named as inventors in the prior application on the filing date of the CPA.

This paragraph helps examiners address situations where applicants have named new inventors in a CPA without following the proper procedure. It reminds both examiners and applicants that a formal request under 37 CFR 1.48 is required to change inventorship, even in a CPA.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

MPEP ¶ 2.32 provides guidance for patent examiners on how to acknowledge and process requests to delete a named inventor in Continued Prosecution Applications (CPAs) for design patents. The paragraph serves several purposes:

  • It offers a standardized response for examiners to use when acknowledging the receipt of a request to delete an inventor.
  • It confirms that the inventorship has been corrected as requested.
  • It clarifies the timing and procedure for inventor deletion requests in CPAs.

The paragraph states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This standardized language ensures consistency in USPTO communications and helps applicants understand that their request has been processed successfully.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

MPEP ¶ 2.32 provides guidance for patent examiners on how to respond to requests for deleting a named inventor in a Continued Prosecution Application (CPA) for design patents. The paragraph serves several purposes:

  • It offers a template for examiners to acknowledge receipt of a statement requesting inventor deletion.
  • It confirms that the inventorship has been corrected as requested.
  • It clarifies the timing and requirements for inventorship changes in CPAs.

The paragraph states: Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This standardized language ensures consistent communication between the USPTO and applicants regarding inventorship changes in CPAs.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

MPEP ¶ 2.15 provides guidance on how to properly claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c). It outlines the requirements for including a specific reference to the prior-filed application and the timeframes within which this reference must be submitted.

The paragraph states: If applicant desires to claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c), the instant application must contain, or be amended to contain, a specific reference to the prior-filed application in compliance with 37 CFR 1.78. This means that applicants must explicitly reference the prior application to claim its benefits.

For more information on specific reference, visit: specific reference.

MPEP ¶ 2.05 Possible Status as Continuation serves as a guideline for patent examiners when handling applications that may qualify as continuations. Its primary purpose is to:

  • Instruct examiners on how to handle applications that disclose and claim only subject matter disclosed in a prior application
  • Provide language for examiners to use when notifying applicants about the possible status of their application as a continuation
  • Ensure proper classification and processing of continuation applications

The MPEP states: “This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application. Accordingly, this application may constitute a continuation or division.” (MPEP ¶ 2.05)

This guidance helps maintain consistency in the examination process and ensures that applicants are properly informed about the potential status of their applications.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

What is the purpose of limited recognition in patent matters?

The purpose of limited recognition in patent matters is to allow certain individuals who are not fully registered patent practitioners to represent patent applicants before the USPTO in specific situations. As stated in MPEP 402.01:

‘Limited recognition to practice before the Office in patent matters may also be granted in appropriate circumstances to an individual who is not registered to practice before the Office.’

This provision serves several purposes:

  • Allows qualified scientists and engineers to assist in patent matters
  • Facilitates international cooperation through reciprocal agreements (e.g., with Canadian patent agents)
  • Provides flexibility for the USPTO to address specific needs or situations
  • Enables representation in cases where full registration may not be necessary or practical

Limited recognition ensures that patent applicants have access to appropriate representation while maintaining the integrity of the patent system.

To learn more:

The purpose of including the government license rights statement in patent applications is to:

  • Acknowledge the government’s support in the development of the invention
  • Inform the public and potential licensees of the government’s rights in the invention
  • Ensure compliance with federal regulations regarding inventions made with government support
  • Facilitate the government’s ability to exercise its rights in the invention if necessary

This requirement, mandated by 35 U.S.C. 202(c)(6), helps maintain transparency in federally funded research and development while protecting the government’s interests in the resulting inventions.

What is the purpose of Form PTO/AIA/96?

Form PTO/AIA/96 is used to establish the right of an assignee to take action in a patent application filed on or after September 16, 2012. According to the MPEP 325:

“Form PTO/AIA/96 may be used to establish the right of an assignee to take action in an application filed on or after September 16, 2012.”

This form is crucial for assignees who wish to prosecute the application or take other actions on behalf of the inventors. It serves as a declaration that the assignee has the right to take action in the application, which is necessary under 37 CFR 3.71(b).

For more information on assignee rights, visit: assignee rights.

For more information on USPTO Forms, visit: USPTO Forms.

Form Paragraph 2.38 in the MPEP serves several important purposes regarding non-English provisional applications:

  1. It notifies the applicant that an English translation and/or a statement of translation accuracy is required for a non-English language provisional application.
  2. It informs the applicant about the specific documents that are missing from their application.
  3. It provides clear instructions on what the applicant needs to do to rectify the situation.
  4. It warns the applicant about the potential consequences of not providing the required documents.

The MPEP states: Use this form paragraph to notify applicant that an English translation of the non-English language provisional application and/or a statement that the translation is accurate is required.

This form paragraph is a crucial tool for patent examiners to communicate requirements and potential issues to applicants, ensuring that all necessary documents are properly filed for claiming benefit to a non-English provisional application.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

The purpose of filing a supplemental oath or declaration after allowance is to cover the claims in the application as they stand at the time of allowance. While the MPEP section 603.01 doesn’t explicitly state the purpose, it implies that these documents are filed to ensure that all claims are properly supported by an oath or declaration. The section states:

“Supplemental oaths and declarations covering the claims in the application may be filed after allowance as a matter of right.”

This allows applicants to provide additional sworn statements or declarations that may be necessary to fully support the allowed claims, without changing the content of the application itself.

To learn more:

Filing a continuation application serves several important purposes in patent prosecution. The MPEP indicates:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

Key reasons for filing a continuation include:

  • Pursuing broader or different claim scope based on the same disclosure
  • Addressing remaining rejections or objections from the parent application
  • Submitting new evidence or arguments to overcome prior art rejections
  • Maintaining pendency for ongoing improvements or to counter competitor activities
  • Separating distinct inventions identified during examination of the parent

Continuations allow applicants to refine their patent strategy while maintaining the priority date of the original filing, which can be crucial in fast-moving technological fields.

For more information on continuation application, visit: continuation application.

For more information on patent strategy, visit: patent strategy.

The primary purpose of drawing review in OPAP is to determine whether the drawings in new utility and plant patent applications can be effectively scanned for publication purposes. As stated in MPEP 507:

The Office of Patent Application Processing (OPAP) performs an initial review of drawings in new utility and plant patent applications to determine whether the drawings can be effectively scanned for publication purposes.

It’s important to note that design applications are not subject to this review as they are not published.

An attorney docket number is used by law firms and companies to internally track and manage patent applications. While it’s not required by the USPTO, it can be included on application documents for reference. However, there are limitations:

  • Must be limited to a maximum of 25 characters
  • Spaces, slashes, and hyphens are not included in the entered docket number on the official filing receipt
  • For docket numbers beginning with ‘CASE’ or ‘NAVY-CASE’, only characters after these prefixes are entered

The MPEP states: ‘Attorney docket numbers must be limited to a maximum of 25 characters to prevent truncation. The USPTO system data base allows a maximum of 25 characters for the attorney docket numbers.’ (MPEP 503)

An Application Data Sheet (ADS) in patent applications filed before September 16, 2012 serves several important purposes:

  • It provides bibliographic data to be used for capturing and processing application information.
  • It allows applicants to submit certain information without an oath or declaration or application transmittal letter.
  • It may be used to provide or correct bibliographic data, particularly if submitted within one month of the filing date.

According to MPEP 601.05(b): “An application data sheet is a sheet or set of sheets containing bibliographic data, which is arranged in a format specified by the Office. When an application data sheet is provided in a patent application, the application data sheet becomes part of the application.”

To learn more:

An Application Data Sheet (ADS) serves as a crucial document in patent applications filed on or after September 16, 2012. Its primary purposes are:

  • To provide bibliographic data for the application
  • To facilitate efficient processing and examination of the application
  • To ensure accurate capture of important information by the Office of Patent Application Processing (OPAP)

According to MPEP 601.05(a), “An application data sheet is a sheet or sheets that may be submitted in a provisional application (except as provided in 37 CFR 1.53(c)(1) ), a nonprovisional application, or a national stage application.” The ADS helps streamline the application process and reduces errors in the handling of patent applications.

To learn more:

The purpose of an abstract in a patent application is to provide a concise summary that allows readers to quickly determine the nature and gist of the technical disclosure. According to MPEP 608.01(b):

The abstract is a brief narrative of the disclosure as a whole, as concise as the disclosure permits, in a single paragraph preferably not exceeding 150 words, commencing on a separate sheet following the claims.

This summary helps examiners, researchers, and other readers to quickly assess the relevance of the patent application to their interests.

To learn more:

The provision in MPEP 608.02(w) allowing minor drawing changes without requiring annotated sheets from the applicant serves several purposes:

  • Streamlines the patent examination process
  • Reduces administrative burden on applicants
  • Allows for quick resolution of minor drawing issues
  • Facilitates efficient preparation of applications for issue

The MPEP states: Where an application is ready for issue except for a slight defect in the drawing not involving change in structure, the examiner will prepare a letter to the applicant indicating the change to be made…

This approach ensures that minor drawing corrections can be made efficiently, without delaying the issuance of patents due to small, easily resolvable issues in the drawings.

To learn more:

Title reports play a specific role in patent reexamination procedures. The MPEP mentions:

For example, a title report is requested by the Reexamination Preprocessing Staff when a request for reexamination is filed.

This suggests that title reports are used to verify the current owner of a patent when a reexamination is initiated, ensuring that the proper parties are involved in the process.

A self-addressed postcard serves as a receipt and provides evidence of the items submitted to the USPTO with a patent application. According to MPEP 503, the postcard should itemize all components of the application, including:

  • Inventor’s name(s)
  • Title of invention
  • Number of pages of specification, claims, and sheets of drawing
  • Whether the inventor’s oath or declaration is included
  • List of additional forms included
  • Amount and manner of paying the fee

The MPEP states: “A postcard receipt which itemizes and properly identifies the items which are being filed serves as prima facie evidence of receipt in the USPTO of all the items listed thereon on the date stamped thereon by the USPTO.”

It’s important to note that the postcard must be properly itemized to serve as evidence of receipt. Simply listing “a complete application” is not sufficient. Each component should be specifically listed on the postcard.

For applications filed via EFS-Web, an Electronic Acknowledgment Receipt serves as the electronic equivalent of a postcard receipt.

For more information on patent application filing, visit: patent application filing.

For more information on USPTO submission, visit: USPTO submission.

A secrecy order is issued to prevent the disclosure of sensitive information in patent applications that could be detrimental to national security. According to MPEP 120, “The purpose of this Act is to prevent disclosure of inventions by the publication of applications or by the granting of patents that might be detrimental to the national security.” These orders are typically issued for inventions that have military applications or involve critical technologies.

For more information on invention disclosure, visit: invention disclosure.

A return postcard serves as prima facie evidence of receipt by the USPTO of all items listed on the postcard. It should include detailed identifying information such as:

  • Inventor’s name
  • Application number (if known)
  • Confirmation number (if known)
  • Filing date
  • Title of the invention
  • Type of paper being filed
  • Number of pages for each component

The MPEP states: ‘A postcard receipt which itemizes and properly identifies the items which are being filed serves as prima facie evidence of receipt in the USPTO of all the items listed thereon on the date stamped thereon by the USPTO.’ (MPEP 503)

What is the purpose of a divisional application under 37 CFR 1.53(b)?

A divisional application under 37 CFR 1.53(b) serves to pursue claims to a distinct invention that was disclosed but not claimed in a parent application. According to the MPEP:

“A divisional application is often filed as a result of a restriction requirement made by the examiner.”

This allows inventors to protect multiple inventions that may have been included in a single original application but were deemed to be separate and distinct by the USPTO. Divisional applications maintain the benefit of the filing date of the parent application for the common subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on patent filing, visit: patent filing.

What is the purpose of a divisional application in patent law?

A divisional application is a type of patent application that allows an inventor to pursue protection for different aspects of an invention that were disclosed but not claimed in a parent application. According to MPEP 201.06:

A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.’

The main purposes of a divisional application are:

  • To protect multiple inventions disclosed in a single parent application
  • To respond to a restriction requirement issued by the USPTO
  • To pursue broader or different claim scope than what was allowed in the parent application

Divisional applications are filed under 37 CFR 1.53(b) and can benefit from the filing date of the parent application for the common subject matter.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

What is the purpose of a Customer Number in USPTO correspondence?

A Customer Number is a unique identifier assigned by the USPTO to simplify and streamline patent correspondence. According to the MPEP 403, ‘The Customer Number practice permits applicants, attorneys, and agents of record to change their correspondence address for a number of applications with one request.’ This system allows for:

  • Easy updates to correspondence addresses for multiple applications
  • Efficient management of power of attorney
  • Simplified access to private PAIR (Patent Application Information Retrieval) for registered practitioners

By using a Customer Number, patent applicants and their representatives can more effectively manage their patent portfolios and communications with the USPTO.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

A cover sheet is a crucial component in the patent document recording process. It provides essential information about the document being recorded and the patents or applications it relates to.

The requirement for a cover sheet is specified in 37 CFR 3.31, which states the necessary contents of a cover sheet. As mentioned in MPEP 315, a completed cover sheet is one of the required items when recording a document with additional patents or applications: “a completed cover sheet (see 37 CFR 3.31 and MPEP § 302.07)”

For more detailed information on cover sheets, refer to MPEP § 302.07.

For more information on cover sheet, visit: cover sheet.

For more information on document submission, visit: document submission.

For more information on USPTO requirements, visit: USPTO requirements.

A cover sheet is a crucial component in patent assignment recordation. It provides essential information about the document being recorded and the parties involved. According to MPEP 315, a completed cover sheet is required when submitting a document for recordation, even if the document has been previously recorded.

The cover sheet requirements are specified in 37 CFR 3.31 and further explained in MPEP § 302.07. It typically includes details such as:

  • Identification of the patents or applications the document relates to
  • Names of the parties involved in the transaction
  • Nature of the interest being conveyed
  • Mailing address for correspondence

The cover sheet helps the USPTO efficiently process and index the recorded documents in the assignment database.

The purpose of a certificate of mailing or transmission in patent applications is to provide evidence of timely filing when correspondence is not received by the USPTO or is received late. As stated in MPEP 512:

The Certificate of Mailing or Transmission procedure does not apply to papers mailed in a foreign country.

This procedure allows applicants to prove that they submitted their correspondence on time, even if it’s delayed or lost in transit.

To learn more:

The purpose of 37 CFR 1.57(b) is to provide a safeguard for applicants when a page(s) of the specification, or a portion thereof, or a sheet(s) of the drawing(s), or a portion thereof, is inadvertently omitted from an application, such as through a clerical error. It allows inadvertently omitted material to be added to the application by way of a later-filed amendment if the inadvertently omitted portion is completely contained in a prior-filed application for which priority or benefit is claimed, even though there is no explicit incorporation by reference of the prior-filed application.

To properly identify a foreign priority application in a U.S. patent application, you should provide:

  • The application number
  • The country or intellectual property authority
  • The filing date (day, month, and year)

MPEP 214.04 advises: “To ensure an accurate and complete citation of a foreign priority application, applicants should review the list of the various intellectual property offices and the recommended presentation of a foreign application number for each, which can be found in the tables of the online WIPO Handbook on Industrial Property Information and Documentation.”

It’s important to use the format recommended by WIPO for the specific country to ensure accurate identification and processing of your priority claim.

To initiate an interview with a patent examiner, applicants should follow a specific procedure outlined in MPEP § 408:

  1. Submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) to the examiner prior to the interview.
  2. The form should identify the participants of the interview.
  3. Propose a date for the interview.
  4. Specify whether the interview will be personal, telephonic, or via video conference.
  5. Include a brief description of the issues to be discussed.

As stated in the MPEP, When applicant is initiating a request for an interview, an ‘Applicant Initiated Interview Request’ form (PTOL-413A) should be submitted to the examiner prior to the interview in order to permit the examiner to prepare in advance for the interview and to focus on the issues to be discussed. This procedure helps ensure productive and efficient interviews.

For more information on patent examination, visit: patent examination.

For more information on USPTO Forms, visit: USPTO Forms.

The proper procedure for correcting inventorship in a Continued Prosecution Application (CPA) is to file a request under 37 CFR 1.48. This applies whether you’re adding or removing an inventor. The MPEP guidance states: ‘Any request to add an inventor must be in the form of a request under 37 CFR 1.48.’ This formal request ensures that the USPTO properly processes and recognizes the change in inventorship.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

Multiple dependent claims have specific formatting requirements as outlined in MPEP 608.01(m). The MPEP states:

A multiple dependent claim may refer in the alternative to more than one preceding independent or dependent claim in the specification. The second (or subsequent) independent claim of the claim set should not refer to any other claim of the claim set. A multiple dependent claim shall contain a reference, in the alternative only, to more than one claim previously set forth. In any multiple dependent claim, only one set of alternatives may be claimed.

To properly format a multiple dependent claim:

  • Refer to previous claims in the alternative (e.g., ‘according to claim 1 or claim 2’)
  • Include only one set of alternatives
  • Ensure it does not serve as a basis for any other multiple dependent claim

For example: ‘The device according to claim 1 or claim 2, further comprising…’

To learn more:

Replacement drawings in a patent application are typically entered into the contents of the application routinely. However, the examiner will review them for several factors:

  • Presence of new matter
  • Necessity of the replacement sheets
  • Consistency with other sheets

As stated in MPEP 608.02(h): “All sheets of replacement drawings will be routinely entered into the contents of the application. However, the examiner should not overlook such factors as new matter, the necessity for the replacement sheets and consistency with other sheets.”

If the examiner decides not to enter the replacement drawings, they must provide a complete and explicit reasoning for the denial. The applicant will be notified of this decision, and the previously made entries will be marked ‘not entered’.

To learn more:

If OPAP objects to the drawings in a patent application, there is a specific process for submitting corrected drawings. The MPEP states:

“If OPAP objects to the drawings and sends applicant a Notice requiring submission of corrected drawings within a set time period (usually two months), corrected drawings must be filed, in paper, to the mailing address set forth in the Notice, along with any other items required by OPAP, to avoid abandonment of the application. No fee will be necessary for filing corrected drawings which are required by OPAP.”

It’s important to note that the corrected drawings must be submitted in paper form to the specific mailing address provided in the Notice. Applicants should ensure they meet the deadline (typically two months) to avoid potential abandonment of their application.

For more information on corrected drawings, visit: corrected drawings.

For more information on OPAP, visit: OPAP.

For more information on patent procedure, visit: patent procedure.

If a benefit claim is not filed within the required time period, it may still be accepted through a petition process. According to MPEP ¶ 2.15:

A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

The petition must include:

  1. The reference to the prior application (unless previously submitted)
  2. The petition fee under 37 CFR 1.17(m)
  3. A statement that the entire delay between the date the benefit claim was due and the date the claim was filed was unintentional

The Director may request additional information if there’s a question about whether the delay was unintentional. The petition should be addressed to: Mail Stop Petition, Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.

For more information on unintentional delay, visit: unintentional delay.

For patent applications filed on or after July 1, 2022, the process for submitting biological sequence listings is as follows:

  1. Prepare a “Sequence Listing XML” as an XML file.
  2. Ensure the file complies with 37 CFR 1.831 – 1.834.
  3. Submit the file via the USPTO patent electronic filing system or on a read-only optical disc.

MPEP 608.05(c) states: “For applications filed on or after July 1, 2022, the sequence listing must be a ‘Sequence Listing XML’ (as an XML file in compliance with 37 CFR 1.831 – 1.834) submission can be submitted via the USPTO patent electronic filing system or on read-only optical disc.”

For detailed information on this process, refer to MPEP §§ 2412 – 2419.

To learn more:

The process for revoking power of attorney during an interference proceeding differs from the standard procedure. According to MPEP 402.08:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

To revoke power of attorney during an interference proceeding:

  1. Prepare the revocation document as you normally would.
  2. Instead of submitting it through regular channels, forward the revocation to the Patent Trial and Appeal Board (PTAB).
  3. The PTAB will consider the revocation within the context of the ongoing interference proceeding.
  4. Wait for the PTAB’s decision before considering the revocation effective.

This special handling ensures that changes in representation are properly managed within the complex context of an interference proceeding.

To learn more:

When an examiner issues a new matter rejection confined to amendments in the specification, the process for review is through a petition. This is distinct from new matter rejections in claims, which require an appeal.

According to MPEP 608.04(c):

“Where the new matter is confined to amendments to the specification, review of the examiner’s requirement for cancelation is by way of petition.”

To challenge the examiner’s holding of new matter in the specification:

  1. Prepare a detailed petition explaining why the amendment does not introduce new matter.
  2. Submit the petition to the USPTO, following the guidelines for petition submission.
  3. The petition will be reviewed by the appropriate office, typically the Technology Center Director or their designee.
  4. A decision will be issued either granting or denying the petition.

It’s important to note that this process is separate from the appeal process used for claim rejections.

To learn more:

If an applicant disagrees with the USPTO’s refusal to grant a filing date for their patent application, they can request a review through the following process:

  • File a petition to the USPTO, accompanied by the required petition fee
  • Provide arguments and evidence supporting why the application should be granted the desired filing date
  • If alleging no defect exists, include a request for a refund of the petition fee

The MPEP states: Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)). Petitioner should provide any arguments that he or she has that the items noted were not missing or that a filing date should be assigned in the absence of such items if they are believed to be unnecessary.

Petitions relating to filing dates are decided by the Office of the Deputy Commissioner for Patent Examination Policy. The petition should be marked to the attention of the Office of Petitions.

It’s important to act promptly if you believe a filing date has been incorrectly refused, as the filing date can have significant implications for patent rights.

For more information on patent application review, visit: patent application review.

The process for returning models, exhibits, or specimens to patent applicants is outlined in 37 CFR 1.94. Key points include:

  • The USPTO may return items when they are no longer necessary for the conduct of business.
  • Applicants are notified and must arrange for the return at their own expense.
  • A time period (usually two months) is set for making return arrangements.
  • Extensions of time are available under 37 CFR 1.136, except for perishables.

The MPEP states, Failure by applicant to establish that arrangements for the return of a model, exhibit, or specimen have been made within the time period set in the notice will result in the disposal of the model, exhibit, or specimen by the Office. (MPEP 608.03(a))

To learn more:

To learn more:

The process for restoring the benefit of a provisional application after the 12-month deadline involves filing a petition under 37 CFR 1.78(b). This petition must be filed in the subsequent application (nonprovisional or international application designating the US) within 14 months of the provisional application’s filing date. The MPEP outlines the requirements:

“A petition under 37 CFR 1.78(b) requires: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application, which must be included in application data sheet (unless previously submitted in an application data sheet); (B) the petition fee as set forth in 37 CFR 1.17(m); and (C) a statement that the delay in filing the nonprovisional application or international application designating the United States within the twelve-month period set forth in 37 CFR 1.78(a)(1)(i) was unintentional.”

The Director may require additional information to determine if the delay was unintentional. If granted, this restoration allows an application to validly claim the benefit of a provisional application filed up to 14 months earlier.

To learn more:

To learn more:

While the MPEP section provided does not specifically address name changes, the process for recording a name change for patent matters with the USPTO is similar to recording other documents affecting title. Here are the general steps:

  1. Prepare a document evidencing the name change (e.g., a certificate of name change or merger document)
  2. Complete a cover sheet (Form PTO-1595 or equivalent) that includes:
    • The former name (in the space for the party conveying the interest)
    • The new name (in the space for the party receiving the interest)
    • A description of the interest conveyed as “Name Change”
    • Identification of the affected patents or applications
  3. Submit the document and cover sheet to the USPTO for recordation, along with any required fee
  4. The submission can be done electronically through EPAS, by mail, or by fax (subject to limitations)

As with other recorded documents, the USPTO will assign reel and frame numbers and add recordation stampings to the processed document.

It’s important to note that while this process records the name change, it does not update the assignee name in individual patent or application files. Separate requests may be needed to update assignee names in specific applications or patents.

Obtaining patent assignment records from before May 1, 1957, involves a different process than accessing more recent records. According to MPEP 301.01:

All records of assignments of patents recorded before May 1, 1957, are maintained by the National Archives and Records Administration (NARA). The records are open to public inspection. Certified and uncertified copies of those assignment records are provided by NARA upon request and payment of the fees required by NARA.

The MPEP further advises:

Requests for copies of pre-1957 records for patents should be directed to the National Archives and Records Administration (NARA). Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.

To obtain these records:

  1. Contact NARA directly.
  2. Provide as much information as possible about the patent and assignment you’re seeking.
  3. Be prepared to pay the fees required by NARA.

The MPEP also notes: All assignment records from 1837 to April 30, 1957 for patents are now maintained and are open for public inspection in the National Archives Research Room located at the Washington National Records Center Building, 4205 Suitland Road, Suitland, Maryland 20746 and at the Civilian Records Division of the National Archives at College Park, 8601 Adelphi Road, College Park, MD 20740-6001.

For the most up-to-date information on accessing these records, it’s recommended to check the National Archives website.

For more information on NARA, visit: NARA.

Tags: NARA

The process for obtaining a foreign filing license is part of the USPTO’s screening procedure for patent applications. The MPEP states:

A third function of the screening procedure is to process foreign filing license petitions under37 CFR 5.12(a). SeeMPEP § 140.

The foreign filing license is automatically granted in most cases as part of the application filing process. However, if the application contains subject matter that requires further review, the applicant may need to petition for a foreign filing license separately.

To obtain a foreign filing license, applicants should:

  1. File a patent application with the USPTO
  2. Wait for the automatic screening process to complete
  3. If a license is not automatically granted, file a petition under 37 CFR 5.12(a)
  4. Provide any additional information requested by the USPTO

It’s important to note that filing an application abroad without first obtaining a foreign filing license can have serious consequences, including abandonment of the U.S. application and potential criminal penalties.

For more information on foreign filing license, visit: foreign filing license.

For more information on patent applications, visit: patent applications.

For more information on USPTO procedures, visit: USPTO procedures.

The process for issuing a patent to a non-applicant assignee involves the following steps:

  1. A request for issuance to the assignee must be submitted with the payment of the issue fee.
  2. The assignment must have been previously recorded in the USPTO or filed for recordation.
  3. If the request is submitted after the issue fee payment, additional requirements apply, including a request for a certificate of correction and associated fees.

According to 37 CFR 3.81(a): An application may issue in the name of the assignee consistent with the application’s assignment where a request for such issuance is submitted with payment of the issue fee, provided the assignment has been previously recorded in the Office.

The USPTO has a specific process for handling inquiries from embassies. According to MPEP 203.08(a):

Inquiries referred to in this section such as correspondence from embassies, the Office of the U.S. Trade Representative, and the Department of State should immediately be transmitted to the Administrator of the Office of Policy and International Affairs, and a staff member of that office should be notified by phone that such correspondence has been received at 571-272-9300.

This procedure ensures that international inquiries are handled consistently and in line with the USPTO’s international policies.

To learn more:

Tags: USPTO

What is the process for filing a patent application if an inventor is legally incapacitated?

When an inventor is legally incapacitated, the patent application can be filed by the legal representative of the incapacitated inventor. According to MPEP 409.03(b):

“If an inventor is legally incapacitated, the legal representative of the inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The process involves:

  • Filing a petition under 37 CFR 1.47(b)
  • Paying the petition fee set forth in 37 CFR 1.17(g)
  • Providing proof of the inventor’s incapacity (e.g., court order)
  • Submitting an oath or declaration by the legal representative

The legal representative should state their relationship to the incapacitated inventor and provide evidence of their authority to act on behalf of the inventor.

To learn more:

To learn more:

Expungement of assignment records is a rare and complex process. According to MPEP 323.01(d), petitions to expunge assignment records are granted only under specific conditions:

  • Normal corrective procedures (outlined in MPEP § 323.01(a) through § 323.01(c)) are inadequate for providing relief.
  • The integrity of the assignment records will not be affected by granting the petition.

It’s important to note that expungement does not result in the complete removal of a document from assignment records. Instead, a redacted version of the ‘expunged’ document is recorded and replaces the original in the assignment records.

To learn more:

The process for expunging assignment records at the USPTO involves:

  • Submitting a petition under 37 CFR 1.59 to expunge the assignment record
  • Providing clear evidence that the document was submitted by mistake or is of improper character
  • Paying the required petition fee

As stated in MPEP 323.01(d): ‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’ This emphasizes the necessity of following the proper petition process for expungement.

To learn more:

When a claim to priority and certified copy of a foreign application are received during the pendency of a patent application, the examiner generally follows these steps:

  • Checks for obvious formal defects in the documents
  • Verifies that the documents correspond to the application identified in the application data sheet
  • For original applications filed under 35 U.S.C. 111(a) and international applications entering the national stage under 35 U.S.C. 371, ensures the claim for foreign priority is timely

The examiner does not typically examine the subject matter to determine if the applicant is entitled to the benefit of the foreign filing date unless it’s necessary for patentability reasons. As stated in the MPEP, The subject matter of the application is not examined to determine whether the applicant is actually entitled to the benefit of the foreign filing date on the basis of the disclosure thereof unless such determination is required for patentability reasons.

For more information on application data sheet, visit: application data sheet.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For more information on patent examination, visit: patent examination.

To establish ownership in a patent application filed before September 16, 2012, an assignee must submit evidence to the USPTO as per pre-AIA 37 CFR 3.73(b). This can be done by either:

  • Submitting documentary evidence of a chain of title from the original owner to the assignee, along with a statement affirming that this evidence was or is being submitted for recordation.
  • Providing a statement specifying where such evidence is recorded in the USPTO (by reel and frame number).

As stated in the MPEP: The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted. This ensures that the assignee has the right to take action in the application.

For more information on assignee rights, visit: assignee rights.

For more information on pre-AIA applications, visit: pre-AIA applications.

For more information on USPTO procedures, visit: USPTO procedures.

The process for correcting inventorship in a provisional patent application is outlined in 37 CFR 1.48(d). To correct inventorship in a provisional application, the following must be submitted:

  1. A request to correct the inventorship that identifies each inventor by their legal name. This request must be signed by a party set forth in 37 CFR 1.33(b).
  2. The processing fee set forth in 37 CFR 1.17(q).

Additionally, when adding an inventor, applicants should file a corrected application data sheet or a new cover sheet providing the residence of all inventors, as per 37 CFR 1.51(c).

It’s important to note that correcting inventorship in a provisional application may not always be necessary unless there would be no overlap of inventors upon filing a nonprovisional application with the correct inventorship. The need for correction may also depend on whether a foreign filing under the Paris Convention will occur after the U.S. filing.

To learn more:

What is the process for correcting errors in recorded assignment documents?

The process for correcting errors in recorded assignment documents involves the following steps:

  • For minor errors: You can file a corrective document stating the nature of the error, along with the required fee.
  • For more significant errors: You may need to file a new assignment document with the correct information.
  • In all cases: Include a cover sheet stating that the document is being submitted to correct an error in a previously recorded assignment document.

According to MPEP 302: Errors in a recorded assignment document will be corrected by the Assignment Division provided a ‘corrective document’ is submitted. The USPTO recommends contacting the Assignment Recordation Branch for specific guidance on your situation.

For more information on assignment correction, visit: assignment correction.

For more information on patent documents, visit: patent documents.

For more information on USPTO procedures, visit: USPTO procedures.

What is the process for correcting errors in faxed assignment documents at the USPTO?

If errors are discovered in faxed assignment documents after submission to the USPTO, the process for correction depends on the nature of the error. Here’s a general guideline:

  1. Minor Typographical Errors: These can often be corrected by submitting a request for correction along with supporting documentation.
  2. Substantive Errors: For more significant errors, a new corrected assignment document may need to be submitted and recorded.
  3. Errors in Recordation: If the error is in the USPTO’s recordation rather than the document itself, contact the Assignment Recordation Branch for assistance.

As per MPEP 302.09: “If there is an error in a cover sheet recorded with an assignment document, a corrected cover sheet may be submitted for recordation.” This indicates that for cover sheet errors, a simple correction submission is possible.

It’s important to act promptly when errors are discovered to ensure the accuracy of the assignment records. For specific guidance on your situation, it’s advisable to contact the USPTO’s Assignment Recordation Branch directly.

To learn more:

To correct assignee information on an issued patent, you must follow these steps:

  1. Submit a request for a certificate of correction under 37 CFR 1.323.
  2. Ensure that a request under 37 CFR 3.81(b) has been granted.
  3. Confirm that the assignment was submitted for recordation before the patent was issued.

According to MPEP 307: “A request for a certificate of correction under 37 CFR 1.323 (see MPEP §§ 1481 and 1485) arising from incomplete or erroneous assignee’s name furnished, or a missing assignee’s name, in item 3 of PTOL-85B will not be granted unless a request under 37 CFR 3.81(b) has been granted and the assignment was submitted for recordation as set forth in 37 CFR 3.11 before the patent issued.”

The request should be directed to the Office of Petitions and include:

  • The processing fee required by 37 CFR 1.17(i)
  • A request for issuance of the application in the name of the assignee, or a request that a patent be corrected to state the name of the assignee
  • A statement that the assignment was submitted for recordation before the patent was issued
  • A request for a certificate of correction under 37 CFR 1.323 with the associated fee

For more information on assignee information, visit: assignee information.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on Patent correction, visit: Patent correction.

For more information on USPTO procedures, visit: USPTO procedures.

If a priority claim needs to be corrected after a patent has been issued, it must be done through a certificate of correction. The MPEP Section 213.04 states:

“If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and § 1.323.”

To obtain a certificate of correction, the patent owner must file a request with the USPTO, pay the required fee, and provide a statement explaining the error and how it occurred. The USPTO will then review the request and, if approved, issue a certificate of correction to be attached to the patent.

To learn more:

The process for correcting an erroneously recorded name change is similar to correcting an erroneous assignment. According to MPEP 323.01(c), you should:

  1. Submit a completed cover sheet identifying the affected application or patent.
  2. Provide an affidavit or declaration stating:
    • You are the correct owner
    • The previously recorded document contained erroneous information
    • The reel and frame number of the incorrect document
  3. Pay the required fee for each application or patent to be corrected.

The MPEP states: On the corrected cover sheet, the owner should check the box titled ‘Other’ in the area of the cover sheet requesting the ‘Nature of Conveyance,’ and indicate that the submission is to correct an error made in a previously recorded document that erroneously affects the identified application(s), or patent(s).

Ensure that your affidavit or declaration clarifies that the name change was recorded in error and provide the correct name information.

To learn more:

What is the process for adding a benefit claim after the time period set forth in 37 CFR 1.78?

To add a benefit claim after the time period set forth in 37 CFR 1.78, you must file a petition to accept an unintentionally delayed benefit claim. The MPEP 211.02(a) outlines the process:

  1. File a petition under 37 CFR 1.78(c) for claiming the benefit of a prior-filed provisional application, or under 37 CFR 1.78(e) for claiming the benefit of a prior-filed nonprovisional application.
  2. Pay the petition fee (currently $2,000 for nonprovisional applications).
  3. Submit a corrected application data sheet (ADS) including the reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior-filed application.
  4. Provide a statement that the entire delay between the date the benefit claim was due and the date the benefit claim was filed was unintentional.

The MPEP states: “The Director may require additional information where there is a question whether the delay was unintentional.” It’s crucial to ensure all requirements are met to avoid potential rejection of the petition.

To learn more:

When the USPTO cannot locate a patent or application file after a reasonable search, they follow the procedure outlined in 37 CFR 1.251. The key steps are:

  1. The Office notifies the applicant or patentee about the unlocatable file.
  2. A time period is set for the applicant or patentee to comply with the notice.
  3. The applicant or patentee must respond by either:
    • Providing a copy of their record of all correspondence with the Office (except U.S. patent documents)
    • Producing their record for the Office to copy
    • Stating that they do not possess any record of the correspondence

As stated in MPEP 508.04, “37 CFR 1.251 sets forth a procedure for the reconstruction of the file of a patent application, patent, or any other patent-related proceeding that cannot be located after a reasonable search.”

When a patent or application file cannot be located after a reasonable search, the USPTO has a specific procedure outlined in 37 CFR 1.251. The Office will notify the applicant or patentee and set a time period for compliance with one of the following options:

  • Provide a copy of all correspondence records between the Office and the applicant/patentee, along with a list and a statement of completeness.
  • Produce the applicant’s/patentee’s records for the Office to copy, along with a statement of completeness.
  • If no records are possessed, provide a statement to that effect.

The MPEP states, 37 CFR 1.251 sets forth a procedure for the reconstruction of the file of a patent application, patent, or any other patent-related proceeding that cannot be located after a reasonable search.

For pending applications, failure to comply within the set time period will result in abandonment of the application.

For more information on file reconstruction, visit: file reconstruction.

For more information on USPTO procedures, visit: USPTO procedures.

The procedure for submitting a priority document in an international application is outlined in PCT Rule 17. According to the MPEP:

Where the priority of an earlier national or international application is claimed under Article 8, a copy of that earlier application, certified by the authority with which it was filed (‘the priority document’), shall… be submitted by the applicant to the International Bureau or to the receiving Office not later than 16 months after the priority date.

The applicant has three options:

  1. Submit the priority document directly to the International Bureau or the receiving Office.
  2. Request the receiving Office to prepare and transmit the priority document to the International Bureau (if the priority document is issued by the receiving Office).
  3. Request the International Bureau to retrieve the priority document from a digital library in accordance with the Administrative Instructions.

It’s important to note that failure to comply with these requirements may result in the designated Office disregarding the priority claim, subject to certain conditions specified in PCT Rule 17.

To learn more:

What is the procedure for filing a continuation or divisional application without a new oath or declaration?

When filing a continuation or divisional application, a new oath or declaration is not always required. According to MPEP 602.05, the following procedure can be followed:

  1. File a copy of the oath or declaration from the prior application.
  2. Include a statement requesting the filing of the continuation or divisional application without a newly executed oath or declaration.
  3. Pay the filing fee for the continuation or divisional application.

The MPEP states: ‘The applicant may file a continuation or divisional application by filing a copy of the oath or declaration from the prior application, accompanied by a statement requesting the filing of the continuation or divisional application without a newly executed oath or declaration and payment of the filing fee.’

This procedure simplifies the filing process for certain types of continuing applications, reducing paperwork and potentially saving time for applicants.

To learn more:

To correct typographical errors in a recorded cover sheet, follow these steps as outlined in MPEP 323.01(a):

  1. Submit a copy of the originally recorded assignment document.
  2. Provide a corrected cover sheet.
  3. Pay the required fee for each application or patent to be corrected.
  4. Include a copy of the original cover sheet to facilitate comparison.

When submitting the corrected cover sheet:

  • Check the ‘Other’ box in the ‘Nature of Conveyance’ area.
  • Indicate that the submission is to correct an error in a previously recorded cover sheet.
  • Identify the reel and frame numbers (if known) and the nature of the correction.

The MPEP states: The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.

To learn more:

What is the procedure for correcting or adding a benefit claim in a design application?

The procedure for correcting or adding a benefit claim in a design application differs from that of utility applications. According to MPEP 211.02(a):

“For design applications, an application may be amended to claim priority to or the benefit of a prior-filed application after the application issues as a patent by filing a reissue application. Note that the copendency requirement of 35 U.S.C. 120 must still be met.”

This means that for design applications:

  • Corrections or additions to benefit claims cannot be made after the application has issued as a patent through a Certificate of Correction.
  • The only way to correct or add a benefit claim after issuance is by filing a reissue application.
  • The copendency requirement under 35 U.S.C. 120 must still be satisfied, meaning the applications must have been co-pending at some point.

It’s important to note that this procedure is specific to design applications and differs from the process for utility applications.

To learn more:

The procedure for changing the correspondence address in a reexamination or supplemental examination proceeding differs from that of regular patent applications. According to MPEP 601.03(a):

“A correspondence address or change of address filed in a patent application will not change the correspondence address for a reexamination or supplemental examination proceeding.”

To change the correspondence address in these proceedings:

  • File a separate paper specifically requesting the change in the reexamination or supplemental examination proceeding
  • Ensure the request is signed by a patent practitioner or the patent owner
  • Submit the request directly to the Central Reexamination Unit (CRU) or the Office of Patent Legal Administration (OPLA) for supplemental examination proceedings

It’s crucial to note that changes made in the patent application will not automatically apply to these special proceedings.

To learn more:

When canceling a figure in a patent application, the following procedure should be followed:

  • Submit a replacement sheet of drawings without the canceled figure.
  • If the canceled figure was the only drawing on the sheet, provide a marked-up copy of the drawing sheet with an annotation showing the cancellation.
  • Label the marked-up copy as “Annotated Sheet”.
  • Present the annotated sheet in the amendment or remarks section explaining the changes.
  • Amend the brief description of the drawings to reflect the change.

This procedure is outlined in MPEP 608.02(t), which states: “If a drawing figure is canceled, a replacement sheet of drawings must be submitted without the figure (see 37 CFR 1.121(d)). If the canceled drawing figure was the only drawing on the sheet, then only a marked-up copy of the drawing sheet including an annotation showing that the drawing has been cancelled is required.”

To learn more:

What is the procedure for an examiner to verify an attorney’s authority during an interview?

When conducting an interview with an attorney or agent who is not of record, the examiner must follow a specific procedure to verify their authority. According to MPEP 405:

If an attorney or agent not of record in an application contacts an examiner for an interview, the examiner may grant the interview if the attorney or agent presents an authorization from the practitioner of record, or presents a signed power of attorney or a paper authorizing them to act as associate or agent.

The examiner should:

  • Ask for an authorization from the practitioner of record
  • Accept a signed power of attorney
  • Accept a paper authorizing the attorney or agent to act as an associate or agent

If none of these are available, the examiner should decline the interview unless the attorney or agent is willing to conduct the interview with the inventor present.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP 102, accessing unpublished patent applications requires specific procedures:

“Applications that were not published or patented, that are not the subject of a benefit claim under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in an application that has issued as a U.S. patent, an application that has published as a statutory invention registration, a U.S. patent application publication, an international publication of an international application under PCT Article 21(2), or a publication of an international registration under Hague Agreement Article 10(3), or are not identified in a U.S. patent, a statutory invention registration, a U.S. patent application publication, an international publication of an international application under PCT Article 21(2), or a publication of an international registration under Hague Agreement Article 10(3) of an international design application designating the United States, are not available to the public.”

In such cases, a granted petition for access or a power to inspect is necessary to obtain the application or a copy of the application. The specific requirements for these procedures are outlined in 37 CFR 1.14(i) and (c) respectively.

For more information on petition for access, visit: petition for access.

For more information on unpublished applications, visit: unpublished applications.

When different correspondence addresses are specified in multiple documents submitted with a patent application, the USPTO follows a specific priority order to determine which address to use. According to MPEP 601.03(b), the priority order is as follows:

  1. Application Data Sheet (ADS)
  2. Application Transmittal
  3. Oath or Declaration (unless a more current power of attorney exists)
  4. Power of Attorney

The MPEP states: “In the experience of the Office, the ADS is the most recently created document and tends to have the most current address.” Therefore, if you want to ensure a specific correspondence address is used, it’s best to include it in the Application Data Sheet.

To learn more:

The Priority Document Exchange (PDX) program is a system that allows participating intellectual property offices to exchange priority documents electronically. This program simplifies the process of submitting certified copies of foreign priority applications for patent applicants.

According to the MPEP, The Office website provides information concerning the priority document exchange program ( www.uspto.gov/patents/basics/international-protection/electronic-priority-document-exchange-pdx ). This information includes participating offices and instructions for accessing foreign applications.

To learn more:

The priority document exchange program is a system that allows participating patent offices to exchange priority documents electronically. According to MPEP 215.02(a):

“Applicants may use the priority document exchange program to obtain a copy of a foreign application filed in a participating foreign intellectual property office.”

This program simplifies the process of obtaining priority documents for patent applications filed in multiple countries.

To learn more:

The priority document exchange program allows the USPTO to obtain priority documents electronically from other participating foreign intellectual property offices, eliminating the need for applicants to submit certified copies themselves. As stated in 37 CFR 1.55(i), the requirement to file a certified copy is considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority includes the necessary information for retrieval
  • The copy is received by the USPTO from the participating office

Applicants must still make the priority claim within the required time period. This program simplifies the process of submitting priority documents for many applicants.

The priority document exchange program is a bilateral or multilateral agreement between the USPTO and participating foreign intellectual property offices that allows for the electronic exchange of priority documents. This program can satisfy the requirement for filing a certified copy of a foreign application under certain conditions.

According to 37 CFR 1.55(i), the certified copy requirement will be considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority is presented in an application data sheet (ADS)
  • The applicant provides the necessary information for the participating office to provide the USPTO with access to the foreign application
  • The USPTO receives a copy of the foreign application from the participating office during the pendency of the application and before the patent is granted

This provision can significantly simplify the process of meeting the certified copy requirement for applicants whose priority applications are from participating countries.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on priority document exchange, visit: priority document exchange.

The priority document exchange program is an agreement between patent offices to electronically exchange priority documents. It affects foreign priority claims in the following ways:

  • Applicants may not need to submit a certified copy if the foreign application is available through the program
  • The USPTO will attempt to retrieve the priority document automatically
  • If successful, it satisfies the requirement to file a certified copy

MPEP 214.02 mentions: “37 CFR 1.55(h) contains provisions relating to when the requirement for a certified copy will be considered satisfied based on a certified copy filed in another U.S. patent or application (see also MPEP § 215, subsection III); 37 CFR 1.55(i) contains provisions relating to the priority document exchange agreement (see also MPEP §§ 215.01 and 215.02(a)).”

Applicants should still monitor the application to ensure the priority document is retrieved and may need to submit a certified copy if the automatic retrieval fails.

The MPEP provides guidelines for the preferred order of arrangement in framing a patent specification. While not mandatory, following this order can help organize the application effectively:

  1. Title of the invention
  2. Cross-reference to related applications
  3. Statement regarding federally sponsored research or development
  4. Background of the invention
  5. Brief summary of the invention
  6. Brief description of the several views of the drawing
  7. Detailed description of the invention
  8. Claims
  9. Abstract of the disclosure

The MPEP states: “The following order of arrangement is preferable in framing the specification. See also MPEP § 608.01(a). Each of the lettered items should appear in upper case, without underlining or bold type, as section headings.”

For more detailed information on the specification arrangement, refer to MPEP § 608.01(a).

To learn more:

The Priority Document Exchange (PDX) program is an electronic system that allows participating intellectual property offices to exchange priority documents securely. According to MPEP 215.01, “Under the PDX program, the participating offices electronically transmit priority documents to each other as needed.” This program eliminates the need for applicants to submit paper certified copies of priority documents in participating offices.

The Patent Law Treaty (PLT) is an international agreement aimed at harmonizing and streamlining formal procedures in patent applications. Its implementation in the U.S. through the Patent Law Treaties Implementation Act (PLTIA) introduced several changes to U.S. patent law, including:

  • Restoration of priority rights in certain cases
  • Changes to formal requirements for patent applications
  • Provisions for international design applications

The MPEP notes: “The Patent Law Treaties Implementation Act of 2012 (PLTIA) amended the patent laws to implement the provisions of the Patent Law Treaty (PLT) in title II; corresponding revisions to title 37 of the Code of Federal Regulations also became effective on December 18, 2013. Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application.”

The Paris Convention for the Protection of Industrial Property is an international agreement that establishes key principles for intellectual property protection, including patents. It was first signed in 1883 and has been revised several times since then.

The Convention is significant in patent law because it established the right of priority, which allows patent applicants to claim priority based on an earlier filing in any country that is a member of the Paris Convention. This right is referenced in MPEP 213, which states:

‘The right of priority is defined in 35 U.S.C. 119(a)… Under this statute, an applicant who has filed a first foreign application is entitled to claim the benefit of the filing date of the first foreign application in a subsequent U.S. national patent application…’

This provision helps inventors protect their inventions internationally by giving them a grace period to file in multiple countries while maintaining the priority date of their first filing.

The Paris Convention is an international treaty that establishes priority rights for patent applications. According to MPEP 213, “The right of priority is defined in 35 U.S.C. 119(a)” and is based on this convention. It allows inventors who file a patent application in one member country to claim priority for up to 12 months when filing in other member countries.

Key points of the Paris Convention include:

  • Establishing a 12-month priority period for patents
  • Allowing applicants to claim priority based on earlier filings in member countries
  • Ensuring equal treatment of foreign and domestic applicants in member countries

What is the Paris Convention and how does it relate to patent filing?

The Paris Convention for the Protection of Industrial Property, commonly known as the Paris Convention, is an international treaty that plays a crucial role in patent filing. According to MPEP 213.01:

The Paris Convention for the Protection of Industrial Property sets forth the concept of a ‘convention application’ and a ‘right of priority.’

This means that applicants from member countries can use their first filing date in one member country as the effective filing date in other member countries, provided they file within 12 months. This treaty facilitates international patent protection by allowing inventors to secure a priority date in multiple countries.

To learn more:

The non-electronic filing fee is an additional fee charged for patent applications not filed by electronic means. This fee was established by the Leahy-Smith America Invents Act and is codified in 37 CFR 1.16(t).

The MPEP states: Section 10(h) of Public Law 112-29, September 16, 2011 (the Leahy-Smith America Invents Act) provides that an additional fee of $400 ($200 for a small entity) shall be established for each application for an original (i.e., non-reissue) patent, except for a design, plant, or provisional application, not filed by electronic means.

This fee applies to:

  • Applications under 35 U.S.C. 111(a) filed on or after November 15, 2011, other than by the USPTO patent electronic filing system.
  • International applications filed with the USPTO as receiving Office on or after November 15, 2011, as part of the transmittal fee.

To learn more:

The most important aspect of an examiner’s action regarding a right of priority is determining the identity of invention between the U.S. and foreign applications. This involves:

  • Considering the foreign application as if it had been filed in the U.S. on the same date it was filed in the foreign country
  • Examining the foreign application for sufficiency of disclosure under 35 U.S.C. 112
  • Determining if there is a basis for the claims sought

The MPEP states: “The most important aspect of the examiner’s action pertaining to a right of priority is the determination of the identity of invention between the U.S. and the foreign applications. The foreign application may be considered in the same manner as if it had been filed in this country on the same date that it was filed in the foreign country, and the applicant is ordinarily entitled to any claims based on such foreign application that applicant would be entitled to under U.S. laws and practice.” (MPEP 216)

What is the minimum deposit amount required to open a USPTO deposit account?

The minimum deposit amount required to open a USPTO deposit account is $1,000. According to MPEP 509.01, “A minimum deposit of $1,000 is required when an account is opened, and a minimum balance of $1,000 is required to be maintained in the account.” This initial deposit ensures that the account has sufficient funds to cover potential fees and charges.

To learn more:

The mailing address for submitting assignment documents depends on whether they are being filed with new applications or not. According to MPEP 302.08:

  • For documents not filed with new applications: Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450
  • For documents filed with new applications: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450

As stated in the MPEP, In order to ensure prompt and proper processing, documents and their cover sheets should be addressed to the Mail Stop Assignment Recordation Services, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450, unless they are filed together with new applications.

To learn more:

What is the limit on the number of previously filed patent applications for micro entity status?

For micro entity status, an applicant must not have been named as an inventor on more than four previously filed patent applications. The MPEP states:

“The applicant has not been named as an inventor on more than 4 previously filed patent applications, other than applications filed in another country, provisional applications under 35 U.S.C. 111(b), or international applications for which the basic national fee under 35 U.S.C. 41(a) was not paid.”

This limit helps ensure that micro entity status is reserved for truly small-scale inventors or businesses. It’s important to note that certain types of applications, such as provisional applications and international applications where the basic national fee wasn’t paid, don’t count towards this limit.

To learn more:

The Manual of Patent Examining Procedure (MPEP) holds a unique legal status in patent law. According to MPEP 101:

The Manual does not have the force of law or the force of the rules in Title 37 of the Code of Federal Regulations.

This means:

  • The MPEP is not legally binding like statutes or regulations
  • It serves as an interpretive guide for patent examiners and practitioners
  • Courts may give it deference but are not bound by its contents

However, the MPEP is highly influential because it:

  • Reflects official USPTO policies and procedures
  • Is used by examiners in their day-to-day work
  • Provides valuable guidance for patent applicants and attorneys

While not law, the MPEP is an essential resource for understanding and navigating the patent examination process.

For more information on patent law, visit: patent law.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

The legal basis for the USPTO’s English translation requirement for assignments is found in the Code of Federal Regulations, specifically 37 CFR 3.26. This regulation is referenced in MPEP 302.02, which states:

37 CFR 3.26 English language requirement.

The regulation mandates that non-English documents must be accompanied by an English translation signed by the translator. This requirement ensures clarity, consistency, and accessibility of patent-related documents within the U.S. patent system.

To learn more:

Tags: patent law

The legal basis for denying amendments to Continued Prosecution Application (CPA) specifications that attempt to reference prior applications stems from both federal regulations and patent law. Specifically:

  • 37 CFR 1.53(d)(7): This regulation establishes that a CPA request itself serves as the specific reference required by 35 U.S.C. 120.
  • 35 U.S.C. 120: This statute outlines the requirements for claiming the benefit of an earlier filing date in the United States.

According to MPEP ¶ 2.34:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.

This means that the CPA filing itself legally establishes the necessary connection to the prior application, making any specification amendment both redundant and impermissible.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on CPA, visit: CPA.

For more information on patent law, visit: patent law.

The legal basis for correcting typographical errors in recorded assignment documents is primarily found in the Manual of Patent Examining Procedure (MPEP) and the Code of Federal Regulations (CFR). Specifically:

  • MPEP 323.01(b) outlines the procedures for correcting such errors.
  • 37 CFR 3.41 provides the regulatory basis for the fees associated with these corrections.

Additionally, case law supports these procedures. The MPEP cites:

See In re Abacab International Computers Ltd., 21 USPQ2d 1078 (Comm’r Pat. 1987).

This case reinforces the USPTO’s authority to correct such errors and the procedures for doing so. The combination of statutory regulations, administrative procedures, and case law provides a comprehensive legal framework for addressing typographical errors in recorded assignment documents.

To learn more:

The legal basis for claiming the benefit of an international design application designating the United States is found in 35 U.S.C. 386(c). This statute allows a nonprovisional application to claim the benefit of a prior international design application, subject to the conditions and requirements of 35 U.S.C. 120.

As stated in the MPEP: Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States. This means that applicants can potentially secure an earlier effective filing date for their nonprovisional application by claiming the benefit of a previously filed international design application.

To learn more:

To learn more:

The institution of higher education basis allows applicants to qualify for micro entity status if:

  1. The applicant’s employer, from which the applicant obtains the majority of their income, is an institution of higher education as defined in the Higher Education Act of 1965, or
  2. The applicant has assigned, granted, conveyed, or is obligated to assign, grant or convey, a license or ownership interest in the application to such an institution of higher education.

The applicant must also qualify as a small entity. This basis is implemented in 37 CFR 1.29(d).

Timely recording of patent assignments is crucial for protecting rights against subsequent purchasers. As per 35 U.S.C. 261:

“if an assignment is not timely recorded at the USPTO, the unrecorded assignment will not be superior to the rights acquired by a third party, i.e. a bona fide purchaser, for valuable consideration if that third party did not have knowledge of the unrecorded assignment.”

This provision emphasizes the importance of promptly recording assignments to maintain priority over subsequent purchasers who may not have knowledge of the unrecorded assignment.

To learn more:

The importance of claim terminology in a patent application lies in ensuring clarity and consistency between the claims and the specification. MPEP 608.01(o) states:

The meaning of every term used in any of the claims should be apparent from the descriptive portion of the specification with clear disclosure as to its import.

This means that the specification should provide a clear explanation for all terms used in the claims, ensuring that the patent examiner and potential infringers can understand the scope of the claimed invention.

To learn more:

New matter can have a significant impact on benefit claims in patent applications. The introduction of new matter in a later-filed application can result in the loss of the benefit claim to the prior-filed application. According to MPEP 211.05:

‘New or amended claims which introduce elements or limitations that are not supported by the as-filed disclosure violate the written description requirement. See, e.g., In re Lukach, 442 F.2d 967, 169 USPQ 795 (CCPA 1971) (subgenus range was not supported by generic disclosure and specific example within the subgenus range); In re Smith, 458 F.2d 1389, 1395, 173 USPQ 679, 683 (CCPA 1972) (an adequate description of a genus may not support claims to a subgenus or species within the genus).’

This means that if a later-filed application includes new matter not disclosed in the prior-filed application, it cannot claim the benefit of the earlier filing date for that new matter. The new matter will only be entitled to the filing date of the later-filed application. It’s crucial for applicants to ensure that all claimed subject matter is fully supported by the prior-filed application to maintain the benefit of the earlier filing date.

To learn more:

Incorporating by reference in patent applications can have significant impacts:

  • It allows applicants to include the content of another document without reproducing it in full.
  • The incorporated material becomes part of the application as if it were explicitly included.
  • It can provide support for claims and help meet disclosure requirements.

MPEP 211.05 mentions:

An incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

This highlights the importance of including incorporation by reference statements at the time of filing to ensure their effectiveness. Applicants should carefully consider what materials to incorporate and ensure they are properly referenced to support their claims and meet disclosure requirements.

To learn more:

What is the impact of a terminal disclaimer on claiming benefit of a prior-filed application?

A terminal disclaimer can affect the ability to claim benefit of a prior-filed application. According to MPEP 211.01(b):

Any nonprovisional application claiming the benefit of one or more prior-filed copending nonprovisional applications or international applications designating the United States must include a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications.

However, if a terminal disclaimer has been filed in the prior application, it may limit the ability to claim benefit. The MPEP states:

If the prior application has been published, the validity of the patent may be affected if the continuing application is not filed within one year of the publication date of the prior-filed application. See MPEP § 211.05 for more information on the effects of publication of patent applications.

It’s crucial to consider the implications of terminal disclaimers when claiming benefit, as they can affect patent term and validity.

To learn more:

What is the impact of a defective priority or benefit claim?

A defective priority or benefit claim can have significant consequences for a patent application. According to MPEP 211.01, if the claim for priority or benefit is not properly made:

‘If the claim for priority or benefit is not included in an ADS, the claim for priority or benefit must be included in the first sentence(s) of the specification following the title or in an application data sheet. The specific reference to the prior application must be in the first sentence(s) of the specification following the title or in an application data sheet unless the reference appeared in a preliminary amendment filed on filing.’

The impacts of a defective claim can include:

  • Loss of priority date: This can affect the assessment of prior art against the application.
  • Potential rejection: Claims may be rejected if intervening prior art exists between the filing dates of the prior and current applications.
  • Inability to overcome certain rejections: Without the earlier priority date, it may be harder to overcome rejections based on intervening art.
  • Possible patent term reduction: If the defect is not corrected promptly, it could affect the patent term adjustment.

To avoid these issues, applicants should ensure that priority or benefit claims are properly made in accordance with 37 CFR 1.78 and correct any defects promptly using the procedures outlined in the MPEP.

To learn more:

Tags: prior art

The Image File Wrapper (IFW) system is an electronic system used by the USPTO to store and process patent application files. Key points about the IFW system and its impact on public access include:

  • Paper components of application files are scanned to create electronic image files
  • For IFW applications, the electronic file is the Official file
  • No access is granted to original paper documents used to create the IFW file
  • Processing and examination are conducted using electronic images
  • IFW files for patented applications, published applications, or applications referenced in published documents are accessible through Patent Center on the USPTO website
  • All patent applications filed after June 30, 2003, have been scanned into the IFW system

The IFW system has made it easier for the public to access eligible patent application files online through Patent Center, eliminating the need to physically inspect paper files in many cases.

The Hague Convention Apostille is an international certification that simplifies the authentication process for documents executed in foreign countries. For patent applications, it affects the execution of oaths as follows:

“The Convention abolishes the certification of the authority of the notary public in a member country by a diplomatic or consular officer of the United States and substitutes certification by a special certificate, or apostille, executed by an officer of the member country.”

This means that for member countries of the Hague Convention, an apostille can replace the need for certification by a U.S. diplomatic or consular officer. The USPTO will accept documents with an apostille for filing or recording. You can find a list of current member countries on the Hague Conference on Private International Law website.

To learn more:

The Hague Agreement Concerning International Registration of Industrial Designs is an international treaty that allows applicants to file a single international design application to seek protection in multiple countries. The United States became a party to the Hague Agreement on May 13, 2015.

According to 35 U.S.C. 385:

An international design application designating the United States shall have the effect, for all purposes, from its filing date determined in accordance with section 384, of an application for patent filed in the Patent and Trademark Office pursuant to chapter 16.

This means that an international design application that designates the US is treated similarly to a national design patent application. The MPEP clarifies: Unless otherwise clear from the wording, reference to ‘design application’ or ‘application for a design patent’ in this chapter includes an international design application that designates the United States.

For detailed information on international design applications, refer to MPEP Chapter 2900.

For more information on design patents, visit: design patents.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on international design applications, visit: international design applications.

The Hague Agreement Concerning International Registration of Industrial Designs is an international treaty that allows applicants to file a single international design application with effect in multiple countries. Key points about the Hague Agreement and international design applications include:

  • The United States became a Contracting Party to the Hague Agreement on May 13, 2015.
  • An international design application designating the United States has the effect of a regularly filed application for patent under 35 U.S.C. 385.
  • The Hague Agreement is administered by the International Bureau of the World Intellectual Property Organization (WIPO).
  • 37 CFR 1.9(n) defines an international design application as “an application for international registration of a design filed under the Hague Agreement.”

For detailed information on international design applications, refer to MPEP Chapter 2900.

To learn more:

The government license rights statement required for contractor-owned inventions made under federally sponsored research and development is:

‘This invention was made with government support under (identify the contract) awarded by (identify the Federal agency). The government has certain rights in the invention.’

This statement is mandated by 35 U.S.C. 202(c)(6) and must be included at the beginning of the patent application and any issued patents.

Patent applications that have not been published under 35 U.S.C. 122(b) are generally preserved in confidence pursuant to 35 U.S.C. 122(a). Information about the filing, pendency, or subject matter of an application, including status information and access to the application, is only given to the public as set forth in § 1.11 or in this section of the MPEP.

As stated in 37 CFR 1.14(a): Patent applications that have not been published under 35 U.S.C. 122(b) are generally preserved in confidence pursuant to 35 U.S.C. 122(a). Information concerning the filing, pendency, or subject matter of an application for patent, including status information, and access to the application, will only be given to the public as set forth in § 1.11 or in this section.

The general mailing address for patent-related correspondence is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address should be used for patent applications, replies to notices of informality, requests for extension of time, notices of appeal, and other patent-related matters processed by organizations reporting to the Commissioner for Patents.

As stated in the MPEP: Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents P.O. Box 1450 Alexandria, Virginia 22313-1450

To learn more:

The general mailing address for patent-related correspondence is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address is used for various patent-related documents, including:

  • Patent applications
  • Replies to notices of informality
  • Requests for extension of time
  • Notices of appeal to the Patent Trial and Appeal Board
  • Requests for reexamination
  • Petitions to the Commissioner for Patents

As stated in MPEP 501: “Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450.”

For more information on patent application filing, visit: patent application filing.

For more information on patent correspondence, visit: patent correspondence.

The general mailing address for patent applications and patent-related papers is:

Commissioner for Patents
P.O. Box 1450
Alexandria, Virginia 22313-1450

This address should be used for correspondence including patent applications, replies to notices of informality, requests for extension of time, notices of appeal, briefs, requests for oral hearings, applications for patent term extensions, reexamination requests, statutory disclaimers, certificates of correction, petitions, and other patent-related correspondence processed by organizations reporting to the Commissioner for Patents.

As stated in MPEP 501: “Correspondence in patent-related matters under the direction of the Commissioner for Patents should be addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, Virginia 22313-1450”

What is the filing deadline for a continuation application?

A continuation application must be filed before the patenting, abandonment, or termination of proceedings on the prior application. The MPEP 201.07 states:

“To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

Key points to remember:

  • There is no specific time limit for filing a continuation as long as the parent application is still pending.
  • The continuation must be filed before the parent application is patented, abandoned, or otherwise terminated.
  • If you want to file after the parent is patented, you must file a reissue application instead.

It’s crucial to monitor the status of the parent application closely to ensure timely filing of the continuation.

For more information on continuation application, visit: continuation application.

For more information on filing deadline, visit: filing deadline.

What is the filing date requirement for a divisional application?

A divisional application must be filed before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention. The MPEP states:

A divisional application is often filed as a result of a restriction requirement made by the examiner. The divisional application may be filed under 37 CFR 1.53(b) (or 1.53(d) if the application is a design application) before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention.”

This means that the divisional application must be filed while the parent application is still pending, ensuring continuity in the examination process.

For more information on Divisional application, visit: Divisional application.

For more information on patent procedure, visit: patent procedure.

The filing date of a nonprovisional application under 37 CFR 1.53(b) depends on the type of application and when it was filed:

  • For utility and plant applications filed on or after December 18, 2013: The filing date is the date on which the specification, with or without claims, is received in the USPTO.
  • For design applications: The filing date is the date on which the specification, including at least one claim, and any required drawings are received in the USPTO.
  • For applications filed before December 18, 2013: The filing date was the date on which the specification containing a description and at least one claim, and any required drawings were received in the USPTO.

The MPEP states:

For applications filed on or after December 18, 2013, the filing date of a nonprovisional application filed under 35 U.S.C. 111(a), other than a design patent application, is the date on which a specification, with or without claims, is received in the Office.

This change in filing date requirements was part of the implementation of the Patent Law Treaties Implementation Act of 2012.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application requirements, visit: patent application requirements.

What is the filing date of a divisional application?

A divisional application is entitled to the filing date of the parent application. According to MPEP 201.06, “A divisional application is entitled to the benefit of the filing date of the prior-filed application if filed as a nonprovisional application that discloses and claims only subject matter disclosed in the prior-filed (parent) application.” This means that the divisional application inherits the filing date of its parent application, provided it meets the necessary requirements.

To learn more:

The filing date of a Continued Prosecution Application (CPA) is determined by when the request for the CPA is received by the USPTO. As stated in the MPEP, The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed. This means that the CPA’s filing date is not the same as the filing date of the prior application, but rather the date when the USPTO receives the proper CPA request.

To learn more:

Tags: CPA

What is the filing date of a continuation-in-part application?

The filing date of a continuation-in-part (CIP) application is the date on which the application is filed with the USPTO. According to MPEP 201.08, “A continuation-in-part application is entitled to the benefit of the filing date of an earlier nonprovisional application as to common subject matter.” However, it’s important to note that any new matter introduced in the CIP application is only entitled to the filing date of the CIP itself.

For the common subject matter, the CIP can claim the benefit of the earlier application’s filing date under 35 U.S.C. 120. This can be crucial for establishing priority and determining the relevant prior art for patentability assessments.

For applications properly filed under 37 CFR 1.10 using Priority Mail Express, the filing date is the date the application was deposited with the U.S. Postal Service. The MPEP states:

For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service. For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

If the proper procedures were not followed, the application will receive a filing date as of the date it was received in the USPTO.

For applications properly filed using Priority Mail Express® (formerly Express Mail) through the U.S. Postal Service, the filing date is the date of deposit with the postal service. The MPEP states:

“For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service.”

This means that even if the application is deposited on a Saturday, and the U.S. Postal Service marks it with a Saturday date, the USPTO will accord and stamp the correspondence with the Saturday date.

However, if the proper procedures for using Priority Mail Express® were not followed, the application will receive a filing date as of the date it was received in the USPTO. Any dispute regarding the filing date in such cases would require a petition, as explained in the MPEP:

“Any review of these matters would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)), providing whatever arguments and evidence petitioner has that the application is entitled to a filing date as of the date it was deposited as Priority Mail Express®.”

To learn more:

To learn more:

The filing date for a nonprovisional patent application depends on the type of application and when it was filed:

  • For applications filed on or after December 18, 2013 (except design applications): The filing date is the date when a specification, with or without claims, is received by the USPTO.
  • For design applications: The filing date is the date when the specification (including at least one claim), and any required drawings are received by the USPTO.
  • For applications filed before December 18, 2013: The filing date is the date when a specification containing a description and at least one claim, and any necessary drawings are filed with the USPTO.

The MPEP states: Except for design applications, the filing date for applications filed under 35 U.S.C. 111 on or after December 18, 2013 is the date on which a specification, with or without claims, is received in the Office.

To learn more:

According to MPEP 201.06(c), the filing date for a divisional or continuation application filed under 37 CFR 1.53(b) is determined as follows:

‘The filing date of an application filed under 37 CFR 1.53(b) is the date on which a specification, with or without claims, is received in the Office.’

This means that the filing date is established when the USPTO receives the specification, regardless of whether claims are included. It’s important to note that other application components, such as drawings or fees, are not required to secure the filing date.

To learn more:

To learn more:

What is the filing date for a Continued Prosecution Application (CPA)?

The filing date for a Continued Prosecution Application (CPA) is determined based on when it is filed. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is a specific reference to the prior application as required by 35 U.S.C. 120.

This means that the CPA’s filing date is the day when the separate request for a CPA is submitted, not the filing date of the prior application. It’s important to note that this request must specifically reference the prior application to comply with 35 U.S.C. 120.

To learn more:

To learn more:

The fee for recording documents with the USPTO varies depending on the method of submission and the type of intellectual property involved. According to MPEP 302.06:

For patents:

  • If submitted electronically: $0 (as of 2019)
  • If submitted on paper or via facsimile: Fee set in 37 CFR 1.21(h)(2)

For trademarks:

The MPEP advises: Customers should check the current fee schedule on the Office website before submitting documents for recordation.

To learn more:

The fee for recording a patent assignment with the USPTO depends on the method of submission:

  • For electronic submissions through the Electronic Patent Assignment System (EPAS), the fee is currently $0, as stated in 37 CFR 1.21(h)(1).
  • For non-electronic submissions (e.g., mail or fax), the fee is set forth in 37 CFR 1.21(h)(2).

It’s important to note that fees may change over time. As stated in MPEP 302.06: “Customers should check the current fee schedule on the Office website before submitting documents for recordation.”

Additionally, no fee is required for recording certain government interest documents, as specified in 37 CFR 3.41(b).

The fee for recording a corrective document or substitute statement with the USPTO is the same as the fee for recording the original assignment document. MPEP 323 states:

“The fee for recording a corrective document or substitute statement is the same as the fee for recording the original assignment document.”

As of 2023, the fee for recording an assignment electronically is $25 per property. However, fees are subject to change, so it’s advisable to check the current USPTO Fee Schedule for the most up-to-date information.

For more information on assignment correction, visit: assignment correction.

For more information on USPTO fees, visit: USPTO fees.

What is the fee for correcting inventorship in a patent application after September 16, 2012?

As of September 16, 2012, there is no fee required for correcting inventorship in a patent application. The MPEP states: Effective September 16, 2012, there is no fee required for requests to correct inventorship submitted under 37 CFR 1.48(a) in a nonprovisional application. This change was implemented as part of the America Invents Act (AIA) to simplify the process of correcting inventorship. However, it’s important to note that while there’s no fee, the request must still meet other requirements specified in 37 CFR 1.48(a).

To learn more:

An examiner’s consideration of documents listed in an Information Disclosure Statement (IDS) is as follows:

  • Documents are considered in the same manner as other documents in Office search files.
  • The examiner conducts a proper field of search.
  • For non-English language documents, consideration is limited to what can be understood from the concise statement and any drawings or chemical formulas.

The MPEP states: Consideration by the examiner of the information submitted in an IDS means that the examiner will consider the documents in the same manner as other documents in Office search files are considered by the examiner while conducting a search of the prior art in a proper field of search. (MPEP 609.05(b))

Regarding non-English documents, the Federal Circuit has noted: [A]s MPEP Section 609C(2) reveals, the examiner’s understanding of a foreign reference is generally limited to that which he or she can glean from the applicant’s concise statement…Consequently, while the examiner’s initials require that we presume that he or she considered the [foreign] reference, this presumption extends only to the examiner’s consideration of the brief translated portion and the concise statement. (Semiconductor Energy Laboratory Co. v. Samsung Electronics Co., 204 F.3d 1368, 1377-78, 54 USPQ2d 1001, 1008 (Fed. Cir. 2000))

To learn more:

The examiner plays a crucial role in ensuring the completeness and consistency of patent application drawings. According to MPEP 608.02(e), the examiner should:

  • Ensure figures are correctly described in the brief description of the drawings section
  • Verify reference characters are properly applied
  • Check that no single reference character is used for two different parts or for a given part and its modification
  • Confirm there are no superfluous illustrations

The examiner may use specific form paragraphs to require corrections if any issues are identified.

To learn more:

Examiners play a crucial role in identifying and addressing missing drawings that may have been overlooked during initial processing. The examiner’s responsibilities include:

  1. Reviewing the application to determine if all referenced drawings are present
  2. Assessing whether the application is entitled to a filing date based on its completeness
  3. Notifying the applicant of any omissions in the next Office action
  4. Providing options for the applicant to address the missing drawings

The MPEP states: If it is discovered that an application that was forwarded for examination was filed without all of the drawing figure(s) referred to in the specification, and a Notice of Omitted Items or other OPAP notice regarding omitted items has not been mailed by OPAP, the examiner should review the application to determine whether the application is entitled to a filing date

For applications filed under 35 U.S.C. 111(a) prior to December 18, 2013, or design applications, the examiner must ensure that the application contains:

  • Something that can be construed as a written description
  • At least one drawing figure (if necessary under 35 U.S.C. 113, first sentence)
  • At least one claim

For non-design applications filed on or after December 18, 2013, the application must contain a specification, with or without drawings, to be entitled to a filing date.

To learn more:

The examiner plays a crucial role in ensuring proper claim terminology by scrutinizing claims for new matter and new terminology. MPEP 608.01(o) states:

Note that examiners should ensure that the terms and phrases used in claims presented late in prosecution of the application (including claims amended via an examiner’s amendment) find clear support or antecedent basis in the description so that the meaning of the terms in the claims may be ascertainable by reference to the description, see 37 CFR 1.75(d)(1).

If the examiner finds that claims lack proper support or antecedent basis, they may require the applicant to amend the description or object to the specification using form paragraph 7.44.

To learn more:

What is the examiner’s responsibility regarding NPL citations in an IDS?

Examiners have specific responsibilities when handling Non-Patent Literature (NPL) citations in an Information Disclosure Statement (IDS):

  • The examiner should indicate that all references have been considered, except where lined through.
  • For NPL, the examiner should ensure that bibliographic information is complete and legible.
  • If bibliographic information is not complete and legible, the examiner may choose not to consider the reference.

The MPEP 609.05(b) states: “The examiner must also consider all the information properly submitted in an IDS in the same manner that the examiner considers other documents in Office search files while conducting a search of the prior art in a proper field of search.”

Additionally, “If an item of information in an IDS fails to comply with all the requirements of 37 CFR 1.97 and 37 CFR 1.98, that item of information in the IDS will not be considered and a line should be drawn through the citation to show that it has not been considered.”

To learn more:

What is the examiner’s responsibility regarding non-compliant IDSs?

When an examiner encounters a non-compliant Information Disclosure Statement (IDS), they have specific responsibilities:

  • The examiner must inform the applicant of the non-compliance in the next Office action.
  • The examiner should clearly indicate which requirements have not been met.
  • The non-compliant IDS will be placed in the application file but will not be considered by the examiner.

As stated in MPEP 609.05(a): ‘If an information disclosure statement does not comply with the requirements based on the time of filing of the IDS (37 CFR 1.97) and/or the content requirements (37 CFR 1.98), the examiner should: (A) inform applicant in the next Office action that the information disclosure statement has been placed in the application file but has not been considered; and (B) inform applicant of the reasons for non-compliance.’ This ensures that the applicant is aware of the issue and has an opportunity to correct it or submit a compliant IDS.

To learn more:

The Electronic Priority Document Exchange (PDX) program is a system that allows for the electronic transmission of priority documents between participating foreign intellectual property offices. As stated in the MPEP:

Electronic Priority Document Exchange (PDX) agreements provide for the electronic transmission of priority documents to and from participating foreign intellectual property offices.

This program simplifies the process of obtaining certified copies of foreign priority applications, which is crucial for establishing priority claims in patent applications.

While restoration of the right of priority allows for valid priority claims up to 14 months from the earliest priority date (or 8 months for design applications), pre-AIA applications are still subject to the 12-month statutory bar under pre-AIA 35 U.S.C. 102(b) and (d). MPEP 213.03 clarifies: ‘It should be noted that although an application may now validly claim priority under 35 U.S.C. 119(a) through (d) and (f), 172, 365(a) or (b), or 386(a) or (b) to a foreign application filed up to fourteen months earlier (or eight months earlier in the case of a design application) in view of the restoration provision of 37 CFR 1.55(c), an application subject to examination under pre-AIA first to invent laws (rather than the first inventor to file provisions of the AIA) would still be subject to the 12-month statutory time periods in pre-AIA 35 U.S.C. 102(b) and (d) which are measured from the U.S. filing date.’

This means that while the priority claim may be valid, the earlier filed foreign application could still be used as prior art against a pre-AIA application if it was published more than one year before the U.S. filing date.

For more information on pre-AIA, visit: pre-AIA.

Tags: pre-AIA

Recording an assignment at the USPTO does not determine its validity or effect on title. As stated in 37 CFR 3.54:

“The recording of a document pursuant to § 3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.”

The USPTO may, when necessary, determine the effect of a document and whether a party has authority to take action in matters pending before the Office.

To learn more:

Recording a patent assignment with the USPTO has specific legal effects. The MPEP states:

‘Recordation of the assignment provides legal notice to the public of the assignment.’

However, it’s important to note that:

‘It should be noted that recording of the assignment is merely a ministerial act; it is not an Office determination of the validity of the assignment document or the effect of the assignment document on the ownership of the patent property.’

This means that while recordation provides public notice, it does not guarantee the validity or enforceability of the assignment. The MPEP cites 37 CFR 3.54 and Realvirt, LLC v. Lee, 195 F.Supp.3d 847, 862-3 (E.D. Va. 2016) for this principle.

Recording a document at the USPTO has the following effects:

  • It does not determine the validity of the document or its effect on title.
  • The Office may determine a document’s effect when necessary for Office proceedings.
  • Conditional assignments are treated as absolute assignments until canceled.
  • Recording provides protection against subsequent purchasers without notice.

37 CFR 3.54 states: The recording of a document pursuant to §3.11 is not a determination by the Office of the validity of the document or the effect that document has on the title to an application, a patent, or a registration.

Additionally, according to 35 U.S.C. 261, timely recording at the USPTO is crucial for maintaining superiority of rights against subsequent purchasers.

For more information on document recording, visit: document recording.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO procedures, visit: USPTO procedures.

Incorporating by reference a prior application in a continuation or divisional application can provide important benefits:

  1. It allows the applicant to amend the continuing application to include subject matter from the prior application without the need for a petition, provided the continuing application is entitled to a filing date.
  2. For applications filed on or after September 21, 2004, it can help recover inadvertently omitted material.

The MPEP states: An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are “hereby incorporated by reference.” The statement must appear in the specification.

It’s important to note that an incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

For more information on 37 cfr 1.57, visit: 37 cfr 1.57.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on incorporation by reference, visit: incorporation by reference.

What is the effect of filing a CPA on pending appeals or interferences?

Filing a Continued Prosecution Application (CPA) has significant effects on pending appeals or interferences. According to MPEP 201.06(d):

The filing of a CPA is a specific request to expressly abandon the prior application as of the filing date granted the CPA and to continue prosecution of the prior application in the CPA.

This means that when a CPA is filed:

  • Any pending appeal in the prior application is automatically withdrawn.
  • Any pending interference proceeding in the prior application is terminated.

It’s important to note that these actions occur automatically upon the granting of a filing date to the CPA. Applicants should carefully consider the status of any pending appeals or interferences before filing a CPA, as these proceedings cannot be continued in the CPA.

For more information on CPA, visit: CPA.

For more information on patent prosecution, visit: patent prosecution.

Filing a Continued Prosecution Application (CPA) has a significant effect on the prior application. According to MPEP 201.06(d):

‘A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA.’

This means that:

  • The prior application is automatically and expressly abandoned when the CPA is filed.
  • The abandonment is effective as of the CPA filing date.
  • Any claims or amendments in the prior application that were not entered are not carried over to the CPA.

It’s important to note that while the prior application is abandoned, the CPA is a continuation of that application, maintaining continuity for purposes such as priority claims and patent term calculations.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

Filing a continuation or continuation-in-part (CIP) application does not automatically affect the status of the parent application. The parent application continues to be examined or remains patented (if already issued) independently of the child application.

Key points to note:

1. The parent application remains pending unless expressly abandoned, allowed to go abandoned, or issued as a patent.

2. Filing a continuation or CIP does not automatically abandon the parent application.

3. Prosecution can continue in both the parent and child applications simultaneously.

The MPEP states: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

However, applicants should be aware of potential double patenting issues that may arise between the parent and child applications.

An international application designating the United States has significant legal effects under U.S. patent law. According to MPEP 211.01(c), which cites 35 U.S.C. 363:

An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.

This means that from its international filing date, the application is treated as if it were a pending U.S. application. The MPEP further clarifies:

It is therefore clear that an international application which designates the United States has the effect of a pending U.S. application from the international application filing date until its abandonment as to the United States.

This status continues until the application is either granted as a patent, abandoned, or the proceedings are terminated. This provision allows applicants to claim the benefit of the international filing date in subsequent U.S. applications, subject to meeting other statutory requirements.

To learn more:

An arbitration award in patent cases has limited effect and is binding only on the parties involved in the arbitration. This limitation is clearly stated in 35 U.S.C. 294(c):

“An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person.”

This means that:

  • The arbitration award is conclusive for the parties involved in the dispute.
  • Third parties not involved in the arbitration are not bound by the award.
  • The award does not affect the rights of individuals or entities who were not part of the arbitration proceedings.

This provision ensures that the rights of third parties are protected and that arbitration outcomes do not have unintended consequences on uninvolved parties in patent matters.

A proper foreign priority claim can give a U.S. patent application the benefit of the earlier foreign filing date as its effective filing date for prior art purposes. This can be crucial for establishing novelty and non-obviousness of the invention.

35 U.S.C. 119(a) states that a U.S. application properly claiming foreign priority “shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country.”

This means that intervening prior art published after the foreign filing date but before the U.S. filing date may not be used against the application if the priority claim is valid. However, it’s important to note that the actual U.S. filing date is still used for other purposes, such as calculating patent term.

A preliminary amendment filed with a continuation or divisional application can have significant effects:

  1. If present on the filing date, it is considered part of the original disclosure.
  2. It must comply with the requirements of 37 CFR 1.121 for amendments.
  3. The Office may require a substitute specification for extensive preliminary amendments.
  4. The application will be classified and assigned based on the claims that will be before the examiner after entry of the preliminary amendment.

The MPEP states: Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

However, applicants should be cautious about introducing new matter through a preliminary amendment. The MPEP advises: Where a copy of the oath or declaration from a prior application was filed in a continuation or divisional application, if the examiner determines that new matter is present relative to the prior application, the examiner should so notify the applicant in the next Office action (preferably the first Office action). The examiner should require applicant to delete the benefit claim or redesignate the application as a continuation-in-part.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

A delayed submission of a benefit claim can have significant implications for patent term adjustment (PTA). According to MPEP 211.04:

“If a petition under 37 CFR 1.78 to accept an unintentionally delayed benefit claim is granted, the petition decision will notify applicant that the patent term adjustment statement in the notice of allowance may need to be revised if the patent issues on a date that is more than four months after the date the petition was filed.”

This means that if the petition is granted and the patent issues more than four months after the petition filing date, the patent term adjustment may need to be recalculated. The delay in submitting the benefit claim could potentially reduce the patent term adjustment, as it may be considered applicant delay under the PTA rules.

It’s important for applicants to be aware that delayed benefit claims can affect the overall patent term, potentially shortening the effective life of the patent.

To learn more:

What is the effect of a continuation-in-part application on patent term?

A continuation-in-part (CIP) application can have a significant impact on patent term. According to the MPEP 201.08:

The term of a patent issuing from a continuation-in-part application may be barred or limited by any prior applications or patents from which benefit is claimed.

This means that:

  • The patent term for subject matter carried over from the parent application is calculated from the filing date of the parent application.
  • The patent term for new subject matter introduced in the CIP is calculated from the filing date of the CIP application.
  • This can result in different expiration dates for different claims within the same patent.

It’s crucial for inventors and patent practitioners to carefully consider the timing and content of CIP applications to maximize patent protection and term.

For more information on patent term, visit: patent term.

Tags: patent term

What is the effect of a benefit claim on the effective filing date of a continuing application?

A benefit claim to a prior-filed application can significantly impact the effective filing date of a continuing application. The MPEP 211.01(b) explains:

‘The effective filing date of a claimed invention is determined on a claim-by-claim basis and not an application-by-application basis. It is possible for different claims in a later-filed application to receive different effective filing dates.’

This means that:

  • Each claim in a continuing application may have a different effective filing date
  • The effective date depends on when the claimed subject matter was first disclosed in a parent application
  • Claims fully supported by the parent application get the parent’s filing date as their effective date
  • New matter introduced in the continuing application gets the actual filing date of that application

It’s crucial for applicants to carefully consider the content of prior applications when making benefit claims, as this can affect patentability determinations and the scope of prior art that can be cited against the claims.

To learn more:

The duty to investigate entitlement to claim small entity status refers to the obligation of patent applicants to thoroughly investigate all facts and circumstances before determining their actual entitlement to small entity status. According to MPEP 509.03(a), “applicants need to do a complete and thorough investigation of all facts and circumstances before making a determination of actual entitlement to small entity status.” This investigation is crucial to ensure that small entity status is claimed only when appropriate.

To learn more:

Tags: patent fees

What is the duty of disclosure in patent applications?

The duty of disclosure is a fundamental obligation in the patent application process. As outlined in MPEP 410:

“Each individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability as defined in this section.”

This duty requires applicants and their representatives to:

  • Disclose all known material information
  • Submit information disclosure statements (IDS)
  • Update the USPTO with new material information throughout the application process

Failing to comply with the duty of disclosure can result in charges of inequitable conduct, which may render a patent unenforceable. It’s crucial for applicants to err on the side of disclosure when in doubt about the materiality of information.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What is the duration of limited recognition granted by the OED Director?

The duration of limited recognition granted by the OED Director is not explicitly specified in MPEP 402.01. However, the section states: Limited recognition is granted for a period consistent with the employment situation for which the individual is granted limited recognition. This suggests that the duration is tailored to each individual’s specific employment situation and may vary case by case. It’s important to note that limited recognition can be withdrawn by the OED Director at any time.

To learn more:

What is the duration of limited recognition for foreign patent agents?

Limited recognition for foreign patent agents is typically granted for a period of 5 years. According to the MPEP, Recognition of a foreign patent agent for the limited purpose of representing applicants before the USPTO in the presentation and prosecution of applications for patent is granted for a period of 5 years. (MPEP 402.01) This means that foreign patent agents must renew their limited recognition status every 5 years to continue practicing before the USPTO.

To learn more:

Tags: USPTO

The duration of a power to inspect granted by an applicant or inventor is generally ongoing until explicitly rescinded. According to MPEP 104:

“An unrestricted power to inspect given by an applicant or inventor is, under existing practice, recognized as in effect until and unless rescinded.”

This means that once granted, a power to inspect remains valid indefinitely unless the grantor takes action to revoke it. However, it’s important to note that this applies to unrestricted powers to inspect granted by applicants or inventors, and different rules may apply to other types of authorizations or parties.

For more information on Patent application access, visit: Patent application access.

The disclosure requirement for a patent application is outlined in MPEP 608. It states that “To obtain a valid patent, a patent application as filed must contain a full and clear disclosure of the invention in the manner prescribed by 35 U.S.C. 112(a).”

This requirement ensures that the public receives valuable information in exchange for the exclusive rights granted to the inventor. The disclosure must be sufficient to enable a person skilled in the art to make and use the invention without undue experimentation.

To learn more:

To learn more:

The Digital Access Service (DAS) is an electronic system that allows participating intellectual property offices to exchange priority documents securely. For international design applications:

  • Applicants can authorize the retrieval of priority documents through DAS.
  • This eliminates the need to manually file certified copies in some cases.
  • The USPTO or IB can retrieve the priority document electronically if available.

MPEP 213.07 states: The certified copy of the foreign application must be filed within the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application, except as provided in paragraphs (h), (i), and (j) of this section. DAS can help meet these deadlines more efficiently.

To learn more:

The main differences in priority claim requirements for design applications compared to utility applications are:

  • Time limit: Design applications can claim priority at any time during pendency, while utility applications have specific deadlines
  • Restoration of priority: Not applicable to design applications

MPEP 214.01 states: “The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.” Additionally, “In a design application, a claim for priority may be made at any time during the pendency of the application.”

However, both design and utility applications must still meet other requirements, such as providing a certified copy of the foreign application and properly identifying the priority application.

The requirements for filing a foreign priority claim differ for applications filed before and after September 16, 2012. The key difference lies in where the priority claim must be presented:

  • For applications filed on or after September 16, 2012: The priority claim must be presented in an Application Data Sheet (ADS). This is specified in 37 CFR 1.55(d)(1): For applications filed under 35 U.S.C. 111(a) on or after September 16, 2012, 37 CFR 1.55(d)(1) requires the claim for priority to be presented in an application data sheet.
  • For applications filed before September 16, 2012: The priority claim can be presented either in an Application Data Sheet or in the oath or declaration. As stated in the MPEP: For applications filed under 35 U.S.C. 111(a) prior to September 16, 2012, unless provided in an application data sheet, the oath or declaration under 37 CFR 1.63 must identify the foreign application for patent or inventor’s certificate for which priority is claimed under 37 CFR 1.55, and any foreign applications having a filing date before that of the application on which priority is claimed, by specifying the application number, country, day, month, and year of its filing.

Regardless of the filing date, the priority claim must include the same essential information: the application number, country (or intellectual property authority), and filing date (day, month, and year) of the foreign application. The difference is primarily in the document where this information must be presented.

The main difference in power of attorney revocation between pre-AIA (before September 16, 2012) and post-AIA (on or after September 16, 2012) applications lies in who can sign the power of attorney and the process for revocation:

  • Post-AIA (on or after September 16, 2012): The power of attorney must be signed by the applicant or patent owner. For an assignee to revoke a power of attorney, they must first become the applicant under 37 CFR 1.46(c).
  • Pre-AIA (before September 16, 2012): The assignee of record of the entire interest can revoke the power of attorney of the applicant directly, provided they establish their right to take action under pre-AIA 37 CFR 3.73(b).

This change reflects the shift in USPTO regulations to give more control to the applicant in post-AIA applications, while pre-AIA rules allowed more direct action by assignees.

To learn more:

There is a significant difference in how affidavits are handled between applications filed under 37 CFR 1.53(b) and 37 CFR 1.53(d). According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

In summary:

  • For 37 CFR 1.53(b) applications: Affidavits from prior applications must be explicitly included and referenced.
  • For 37 CFR 1.53(d) applications: Affidavits from the parent nonprovisional application automatically become part of the new application.

For more information on continuation applications, visit: continuation applications.

The key difference in assignment between division/continuation applications and substitute/continuation-in-part (CIP) applications lies in how prior assignments are applied:

  • Division/Continuation Applications: Prior assignments recorded against the original application automatically apply to these applications. As stated in MPEP 306: In the case of a division or continuation application, a prior assignment recorded against the original application is applied (effective) to the division or continuation application because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.
  • Substitute/CIP Applications: Prior assignments do not automatically apply. MPEP 306 states: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This difference is due to the nature of these application types. Division and continuation applications contain only subject matter from the original application, while substitute and CIP applications may contain new subject matter not present in the original application.

The main difference between utility and design patents is in what they protect:

  • Utility patents protect the way an article is used and works. They cover new and useful processes, machines, manufactures, or compositions of matter.
  • Design patents protect the way an article looks. They cover new, original, and ornamental designs for an article of manufacture.

The MPEP distinguishes between these types of patents by referencing different sections of U.S. Code: utility patents are provided for by 35 U.S.C. 101, while design patents are provided for by 35 U.S.C. 171.

For more information on design patent, visit: design patent.

While both the Certificate of Mailing (37 CFR 1.8) and Priority Mail Express (37 CFR 1.10) procedures can be used to establish timely filing of USPTO correspondence, they have some key differences:

  • Certificate of Mailing can be used with any class of mail, while Priority Mail Express is a specific USPS service.
  • Certificate of Mailing uses the date of deposit with USPS as the filing date, while Priority Mail Express uses the date of deposit as shown by the “date accepted” on the mailing label.
  • Certificate of Mailing cannot be used for new patent applications, while Priority Mail Express can establish a filing date for new applications.
  • Certificate of Mailing requires a signed certificate, while Priority Mail Express requires the mailing label to be affixed to the correspondence.

The MPEP notes: “New patent applications filed in accordance with 37 CFR 1.10 will be stamped by the Office with the date of deposit as Priority Mail Express® with the United States Postal Service.”

Both procedures have specific requirements and limitations, so it’s important to consult the full text of 37 CFR 1.8 and 37 CFR 1.10 when deciding which to use.

The Brief Summary of Invention and the Detailed Description serve different purposes in a patent application:

  • Brief Summary: According to MPEP 608.01(d), it should provide a concise overview of the invention’s nature and substance. The MPEP states, “A brief summary of the invention indicating its nature and substance, which may include a statement of the object of the invention, should precede the detailed description.”
  • Detailed Description: This section provides a comprehensive explanation of the invention, including how to make and use it, as required by 35 U.S.C. 112(a).

The Brief Summary is meant to give a quick understanding of the invention, while the Detailed Description provides the full technical disclosure necessary for enablement and written description requirements.

To learn more:

What is the difference between small entity and micro entity status?

While both small entity and micro entity statuses offer reduced patent fees, they have distinct eligibility criteria:

  • Small Entity Status:
    • Available to individuals, small businesses (fewer than 500 employees), and non-profit organizations
    • Offers a 50% reduction in most patent fees
  • Micro Entity Status:
    • More stringent requirements, including income limitations and limits on the number of previously filed patent applications
    • Offers a 75% reduction in most patent fees

As per MPEP 509.03, “Small entity status entitles applicants to a fifty-percent reduction in a number of patent fees.” Micro entity status, while not explicitly covered in this section, provides even greater fee reductions for those who qualify.

To learn more:

Tags: USPTO fees

What is the difference between recording and registering a patent assignment?

Recording and registering a patent assignment are two distinct processes:

  • Recording refers to submitting the assignment document to the USPTO for public notice. As stated in MPEP 302, ‘The recording of the assignment document in the USPTO is merely a ministerial act and does not determine the validity of the document.’
  • Registering is not a term used by the USPTO for assignments. The term ‘registration’ is typically used for trademarks, not patents.

Recording an assignment provides constructive notice of the transfer of ownership but does not guarantee the assignment’s validity or enforceability.

For more information on ownership transfer, visit: ownership transfer.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

What is the difference between recording an assignment and registering a trademark?

Recording an assignment for a patent or trademark application is different from registering a trademark. Here are the key distinctions:

  • Recording an assignment: This process involves documenting the transfer of ownership rights for a patent or trademark application. It’s done through the USPTO’s Assignment Recordation Branch.
  • Registering a trademark: This is the process of officially registering a trademark with the USPTO to protect your brand identity. It’s handled by the Trademark Office.

As stated in MPEP 302: “The recording of assignments is governed by 35 U.S.C. 261 for patents and 15 U.S.C. 1060 for trademarks.” This indicates that assignment recording is a separate process from trademark registration, which is governed by different statutes.

For more information on assignment recording, visit: assignment recording.

For more information on USPTO procedures, visit: USPTO procedures.

What is the difference between recording a license and an assignment at the USPTO?

The main difference between recording a license and an assignment at the USPTO lies in the transfer of ownership rights:

  • Assignment: Transfers ownership of the patent or application to another party.
  • License: Grants permission to use the patent or application without transferring ownership.

According to MPEP 313: Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11(a). This includes licenses, which are recorded to provide notice of the agreement but do not change the ownership records at the USPTO.

The timing of a preliminary amendment significantly affects its status within a patent application. MPEP 608.04(b) clarifies this distinction:

A preliminary amendment present on the filing date of the application (e.g., filed along with the filing of the application) is considered a part of the original disclosure. […] A preliminary amendment filed after the filing date of the application is not part of the original disclosure of the application.

In essence, preliminary amendments submitted with the initial application filing are treated as part of the original disclosure. However, any preliminary amendments filed after the application’s filing date are not considered part of the original disclosure. This distinction is crucial for determining what constitutes new matter in the application and can affect the examination process.

To learn more:

The America Invents Act (AIA) brought significant changes to patent law, including rules regarding patent ownership. The key differences between pre-AIA (before September 16, 2012) and AIA (on or after September 16, 2012) patent ownership rules are:

  1. Applicability: Pre-AIA rules apply to applications filed before September 16, 2012, while AIA rules apply to applications filed on or after that date.
  2. Juristic Entity Representation: Under AIA rules, juristic entities (e.g., corporations) must be represented by a patent practitioner for most actions. Pre-AIA rules allowed juristic entities to take certain actions without representation.
  3. Ownership Establishment: The process for establishing ownership is slightly different, with AIA applications following 37 CFR 3.73 and pre-AIA applications following pre-AIA 37 CFR 3.73(b).
  4. Inventor’s Oath or Declaration: AIA introduced changes to the inventor’s oath or declaration requirements, which can affect how assignees interact with the patent application process.

According to MPEP 324: [Editor Note: See MPEP § 325 for establishing the right of assignee to take action in an application filed on or after September 16, 2012.] This indicates that different sections of the MPEP should be consulted depending on the application’s filing date.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

What is the difference between pre-AIA and AIA applications regarding assignee filing?

The key difference between pre-AIA (America Invents Act) and AIA applications regarding assignee filing lies in the requirements for establishing the right of an assignee to take action:

  • Pre-AIA applications (filed before September 16, 2012): The assignee must establish their right to take action by filing evidence of ownership in the USPTO.
  • AIA applications (filed on or after September 16, 2012): The assignee can simply be named as the applicant, eliminating the need to file evidence of ownership.

As stated in MPEP 324: “For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of an application for an original patent, and any patent that may issue therefrom, unless there is an assignment.”

For more information on pre-AIA, visit: pre-AIA.

Tags: pre-AIA

Pre-AIA 37 CFR 1.42 and pre-AIA 37 CFR 1.47 serve different purposes in relation to deceased inventors:

  • Pre-AIA 37 CFR 1.42: This regulation specifically addresses the situation of a deceased inventor. It allows the legal representative (executor or administrator of the estate) to make an application on behalf of the deceased inventor.
  • Pre-AIA 37 CFR 1.47: This regulation is not intended for deceased inventors directly. As stated in the MPEP, Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

However, pre-AIA 37 CFR 1.47 does apply in cases where:

  • A known legal representative of a deceased inventor cannot be found or reached after diligent effort, or
  • The legal representative refuses to make the application

In such cases, the last known address of the legal representative must be provided, as per MPEP § 409.03(e).

It’s important to note that these regulations apply to applications filed before September 16, 2012. For applications filed on or after that date, different procedures may apply.

To learn more:

To learn more:

The distinction between petitioning and appealing a new matter rejection is crucial in patent prosecution:

  • Petition: Used when new matter is confined to amendments in the specification.
  • Appeal: Required when new matter affects the claims, leading to their rejection.

According to MPEP 608.04(c):

“Where the new matter is confined to amendments to the specification, review of the examiner’s requirement for cancelation is by way of petition. But where the alleged new matter is introduced into or affects the claims, thus necessitating their rejection on this ground, the question becomes an appealable one…”

This means that even if new matter is introduced in both the specification and claims, the claim-related issues must be addressed through the appeal process, not by petition.

To learn more:

Patent assignment and licensing are two different ways of transferring patent rights. The MPEP defines assignment as:

‘Assignment of patent rights is defined as ‘a transfer by a party of all or part of its right, title and interest in a patent [or] patent application….”

In contrast, licensing is described as:

‘As compared to assignment of patent rights, the licensing of a patent transfers a bundle of rights which is less than the entire ownership interest, e.g., rights that may be limited as to time, geographical area, or field of use.’

The key difference is that assignment transfers ownership, while licensing grants permission to use the patent without transferring ownership.

What is the difference between new matter and new or amended claims in patent applications?

New matter and new or amended claims are distinct concepts in patent law:

  • New matter refers to content not present in the original disclosure of the application. As stated in MPEP 608.04: ‘New matter includes not only the addition of wholly unsupported subject matter, but may also include adding specific percentages or compounds after a broader original disclosure…’
  • New or amended claims, on the other hand, are permissible as long as they are supported by the original disclosure. The MPEP clarifies: ‘An amendment to the claims or the addition of a new claim must be supported by the description of the invention in the application as filed.’

In essence, while new or amended claims can be added to an application, they must not introduce new matter that wasn’t originally disclosed.

To learn more:

Tags: new matter

What is the difference between new matter and inherent disclosure in patent applications?

New matter and inherent disclosure are distinct concepts in patent law:

  • New matter refers to information added to a patent application after its filing date that goes beyond the original disclosure. This is generally not allowed and can result in rejection.
  • Inherent disclosure refers to information that, while not explicitly stated in the original application, is necessarily present or implied by the content that was disclosed.

According to MPEP 608.04: “New matter includes not only the addition of wholly unsupported subject matter, but may also include adding specific percentages or compounds after a broader original disclosure, or even the omission of a step from a method.” However, inherent properties or characteristics that are necessarily present in the disclosed invention do not constitute new matter.

It’s important for patent applicants to carefully consider what information is truly inherent to their original disclosure to avoid introducing new matter while still fully describing their invention.

To learn more:

To learn more:

Tags: new matter

MPEP 509.04(c) mentions two types of micro entity certifications:

  1. Micro entity certification on the gross income basis
  2. Micro entity certification on the institution of higher education basis

While the specific requirements for each basis are not detailed in this section, it’s important to note that the signing requirements are the same for both types. The certification “can be signed only by an authorized party as set forth in 37 CFR 1.33(b).” This includes patent practitioners and applicants, as detailed in other FAQs.

To learn more:

In patent applications, the distinction between essential and nonessential material is important for incorporation by reference:

  • Essential material is defined in 37 CFR 1.57(d) as material necessary to meet the requirements of 35 U.S.C. 112(a), (b), or (f). It can only be incorporated by reference to a U.S. patent or U.S. patent application publication.
  • Nonessential material is subject matter referred to for purposes of indicating the background of the invention or illustrating the state of the art. It can be incorporated by reference to a wider range of sources, including foreign patents and non-patent publications.

As stated in the MPEP: ‘Other material (‘Nonessential material’) may be incorporated by reference to U.S. patents, U.S. patent application publications, foreign patents, foreign published applications, prior and concurrently filed commonly owned U.S. applications, or non-patent publications.’

To learn more:

The process for deleting an inventor from a Continued Prosecution Application (CPA) differs depending on when the request is made:

  • At CPA Filing: You can submit a statement requesting the deletion of an inventor when filing the CPA. This is a straightforward process that doesn’t require additional paperwork.
  • After CPA Filing: If you need to delete an inventor after the CPA has been filed, you must follow a more formal procedure. The MPEP states:

    “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

This means that post-filing inventor deletions require a formal request under 37 CFR 1.48, which typically involves additional documentation and potentially fees.

For more information on CPA, visit: CPA.

Tags: CPA

The process for correcting inventorship in a Continued Prosecution Application (CPA) differs depending on when the correction is requested:

  • At CPA filing: Inventorship can be corrected by submitting a statement requesting deletion of a named inventor along with the CPA filing. This process is straightforward and does not require additional procedures.
  • After CPA filing: The MPEP states, Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48. This means additional documentation and possibly fees are required for post-filing inventorship changes.

It’s generally simpler to correct inventorship at the time of CPA filing if possible.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

The process for correcting errors differs depending on whether the error is in the cover sheet or the actual assignment document:

  • Cover sheet corrections: These are for errors in the recorded data only, not in the assignment document itself. You can submit a corrective document referencing the reel and frame number of the original recording.
  • Assignment document corrections: For errors in the actual assignment document, you must record a new corrective document, which can be a new assignment or another document that corrects the original.

MPEP 323 states: “Errors in the assignment document itself cannot be corrected simply by submitting a new cover sheet.” This emphasizes the need for a new recorded document for substantive errors.

For more information on USPTO, visit: USPTO.

Tags: USPTO

Claiming priority and claiming benefit are two different mechanisms in patent law, though both can affect the effective filing date of a patent application:

  1. Claiming Priority:
    • Typically refers to claiming the right of priority to a foreign application under 35 U.S.C. 119(a)-(d) and (f)
    • Also includes priority claims to provisional applications under 35 U.S.C. 119(e)
    • Governed by 37 CFR 1.55 for foreign priority claims
  2. Claiming Benefit:
    • Refers to claiming the benefit of an earlier filing date of a U.S. application under 35 U.S.C. 120, 121, 365(c), or 386(c)
    • Typically used for continuation, divisional, or continuation-in-part applications
    • Governed by 37 CFR 1.78

The MPEP discusses both types of claims: “Under certain conditions and on fulfilling certain requirements, a later-filed application for patent filed in the United States may claim the benefit of, or priority to, a prior application filed in the United States (see 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c); see also 37 CFR 1.78) or in a foreign country (see 35 U.S.C. 119(a)-(d) and (f), 365(a) and (b), and 386(a) and (b); see also 37 CFR 1.55).”

Claiming foreign priority under 35 U.S.C. 119(a)-(d) and claiming benefit of a U.S. provisional application under 35 U.S.C. 119(e) are similar in some ways but have important differences:

1. Time limit:
– Foreign priority: Must be claimed within 12 months (6 months for design applications)
– Provisional: Must be claimed within 12 months

2. Effective filing date:
– Both can provide an earlier effective filing date for prior art purposes

3. Patent term:
– Foreign priority: Does not affect patent term
– Provisional: The 12-month period counts towards the 20-year patent term

4. Disclosure requirements:
– Both require the earlier application to provide adequate support for the claimed invention

5. Formalities:
– Foreign priority: Requires a certified copy of the foreign application
– Provisional: No certified copy required, but the provisional must be in English

6. Inventorship:
– Foreign priority: Requires at least one common inventor
– Provisional: Requires at least one common inventor

7. International effect:
– Foreign priority: Recognized in other Paris Convention countries
– Provisional: May not be recognized in some foreign jurisdictions

Both types of priority claims can be valuable for establishing an earlier effective filing date, but they have different requirements and effects that should be considered when developing a patent strategy.

The main differences between claiming benefit under 35 U.S.C. 119(e) and 35 U.S.C. 120 are:

  • 35 U.S.C. 119(e):
    • Used for claiming benefit of a provisional application
    • Does not require specifying the relationship between applications
    • Example: “This application claims the benefit of U.S. Provisional Application No. 61/123,456, filed January 1, 2020.”
  • 35 U.S.C. 120:
    • Used for claiming benefit of a nonprovisional application
    • Requires specifying the relationship (continuation, divisional, or continuation-in-part)
    • Example: “This application is a continuation of U.S. Application No. 12/345,678, filed January 1, 2020.”

MPEP 211.02 advises: “Although 35 U.S.C. 120 does not preclude a benefit claim to a provisional application, it is not recommended that applicants claim the benefit to a provisional application under 35 U.S.C. 120 since such a claim could have the effect of reducing the patent term, as the term of a patent issuing from such an application may be measured from the filing date of the provisional application pursuant to 35 U.S.C. 154(a)(2).”

It’s important to use the correct statute when making benefit claims to ensure proper recognition and avoid potential issues with patent term calculations.

To learn more:

The treatment of affidavits and declarations differs between applications filed under 37 CFR 1.53(b) and those filed under 37 CFR 1.53(d). According to MPEP ¶ 2.03:

“Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.”

In summary:

  • For 37 CFR 1.53(b) applications: Affidavits from prior applications must be explicitly incorporated.
  • For 37 CFR 1.53(d) applications: Affidavits from the parent application are automatically included.

For more information on continuation applications, visit: continuation applications.

For more information on patent applications, visit: patent applications.

The distinction between unintentional and intentional delay is crucial when filing a delayed benefit claim. The MPEP 211.04 addresses this:

‘A petition to accept an unintentionally delayed claim under 35 U.S.C. 120, 121, 365(c), or 386(c) for the benefit of a prior-filed application must be accompanied by: … (3) A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(d)(3) and the date the benefit claim was filed was unintentional.’

An unintentional delay may be caused by oversight, administrative error, or other circumstances not intended to delay the filing. Intentional delay, on the other hand, implies a deliberate choice not to file the benefit claim on time. Only unintentional delays can be remedied through a petition. Intentional delays are not excusable and will result in the denial of the delayed benefit claim.

To learn more:

An oath is a sworn statement made before a person authorized to administer oaths, while a declaration is a written statement that can be used in lieu of an oath. According to MPEP 602, “A declaration may be submitted in lieu of an oath in any document filed in the Office provided the declaration complies with the requirements of 37 CFR 1.68.” Declarations are often preferred because they don’t require appearing before an official and are easier to process electronically.

To learn more:

What is the difference between an inventor and an applicant in a patent application?

In patent applications, the terms ‘inventor’ and ‘applicant’ have distinct meanings:

  • Inventor: The person who conceived the invention and is named on the application.
  • Applicant: The person or entity applying for the patent, which may or may not be the inventor.

According to MPEP 605, ‘The applicant for a patent is the inventor by default unless the inventor is dead, insane, or legally incapacitated, in which case the applicant may be the legal representative (e.g., executor, administrator, etc.) of the inventor.’ However, the America Invents Act (AIA) allows for non-inventor applicants in certain situations, such as when the invention is assigned or there’s an obligation to assign.

To learn more:

In patent applications, both attorneys and agents can represent applicants before the USPTO, but there are important distinctions:

  • Patent Attorney: A lawyer who has passed both a state bar exam and the USPTO’s patent bar exam. They can practice law and provide legal advice beyond patent prosecution.
  • Patent Agent: An individual who has passed the USPTO’s patent bar exam but is not a licensed attorney. They can represent clients before the USPTO for patent matters but cannot practice law or provide other legal services.

The MPEP 402 refers to both as ‘patent practitioners’: ‘The term ‘patent practitioner’ as used in this chapter includes patent attorneys and patent agents.’ Both can receive power of attorney and represent applicants in patent matters before the USPTO, but only patent attorneys can offer broader legal counsel.

MPEP 409.03(f) distinguishes between an assignment and an agreement to assign in the context of proving proprietary interest for pre-AIA 37 CFR 1.47(b) applications. The key differences are:

  • Assignment: A completed transfer of rights in the invention.
  • Agreement to Assign: A promise to transfer rights in the future, often conditional.

For an assignment, MPEP 409.03(f) states:

“If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant.”

For an agreement to assign:

“When an inventor has agreed in writing to assign an invention described in an application deposited pursuant to pre-AIA 37 CFR 1.47(b), a copy of that agreement should be submitted.”

Additionally, if the agreement to assign is conditional, evidence that the conditions have been met must be provided. This often applies to employment agreements, where the applicant must prove the invention was made during the course of employment.

To learn more:

To learn more:

The MPEP distinguishes between assignments and licenses in patent law:

  1. Assignment: ‘An assignment of a patent, or patent application, is the transfer to another of a party’s entire ownership interest or a percentage of that party’s ownership interest in the patent or application.’
  2. License: ‘As compared to assignment of patent rights, the licensing of a patent transfers a bundle of rights which is less than the entire ownership interest, e.g., rights that may be limited as to time, geographical area, or field of use.’

The key difference is that an assignment transfers ownership, while a license grants permission to use the patent without transferring ownership. The MPEP further clarifies: ‘A patent license is, in effect, a contractual agreement that the patent owner will not sue the licensee for patent infringement if the licensee makes, uses, offers for sale, sells, or imports the claimed invention, as long as the licensee fulfills its obligations and operates within the bounds delineated by the license agreement.’

An assignment and a 37 CFR 3.73(c) statement serve different purposes in the patent application process:

  • Assignment: This is the actual transfer of ownership rights from the inventor(s) to the assignee.
  • 37 CFR 3.73(c) statement: This is a document filed with the USPTO to establish the assignee’s right to take action in a patent application.

As stated in MPEP 325: “The submission of the statement pursuant to 37 CFR 3.73(c) is not required if a 37 CFR 3.73(b) statement has been previously filed in the application or patent prior to September 16, 2012.” This highlights that the 3.73(c) statement is a procedural document for USPTO purposes, while the assignment is the substantive transfer of rights.

For more information on USPTO procedures, visit: USPTO procedures.

In patent applications, there is a distinction between an assignee and an obligated assignee. According to MPEP 409.05:

  • Assignee: A person or entity to whom the inventor has already transferred ownership rights of the invention.
  • Obligated Assignee: A person or entity to whom the inventor is under a contractual obligation to assign the invention in the future, but the transfer has not yet occurred.

The MPEP states:

Quote: ‘A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent.’

Both assignees and obligated assignees have the right to file patent applications under this provision. The key difference lies in the timing and completion of the assignment process. An assignee has already received the rights, while an obligated assignee has a binding agreement to receive the rights in the future.

To learn more:

What is the difference between an applicant and an inventor in a patent application?

In patent applications, there’s an important distinction between an applicant and an inventor. According to MPEP 605:

‘The term “applicant” refers to the inventor or all of the joint inventors, or to the person applying for a patent as provided in 37 CFR 1.43, 1.45, or 1.46.’

Key differences include:

  • Inventor: The person or persons who conceived of the invention.
  • Applicant: Can be the inventor(s), but may also be:
    • A legal representative of a deceased or incapacitated inventor (37 CFR 1.43)
    • A joint inventor on behalf of all joint inventors (37 CFR 1.45)
    • An assignee, obligated assignee, or person with sufficient proprietary interest (37 CFR 1.46)

The applicant has the right to conduct the prosecution of the application, while the inventor(s) must be named in the application and execute an oath or declaration.

To learn more:

According to MPEP 201.02, there are important distinctions between ‘original’ and ‘substitute’ applications:

Original Application: This term is used in patent statutes and rules to refer to an application that is not a reissue application. An original application can be either a first filing or a continuing application.

Substitute Application: The MPEP defines a substitute application as follows:

A “substitute” application is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application. […] A substitute application does not obtain the benefit of the filing date of the prior application.

The key difference is that a substitute application does not retain the filing date of the prior application, unlike certain types of continuing applications.

For more information on patent filing, visit: patent filing.

For more information on substitute application, visit: substitute application.

According to the MPEP, there is no substantial difference between an ‘allowed’ application and an application ‘in issue’. The MPEP uses these terms interchangeably:

“An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.”

Both terms refer to an application that has passed examination and is awaiting issuance as a patent, provided that all necessary fees are paid and no issues arise that would necessitate withdrawal from issue.

To learn more:

What is the difference between a utility patent and a design patent application?

Utility patents and design patents protect different aspects of an invention, and their applications are processed differently. According to MPEP 201.02:

‘A utility application is a nonprovisional application that is not a design application. A design application is an application for a design patent.’

Key differences include:

  • Utility Patent Application:
    • Protects the functional aspects of an invention
    • Covers how an invention works or is used
    • Has a term of 20 years from the filing date
  • Design Patent Application:
    • Protects the ornamental design of a functional item
    • Covers how an invention looks
    • Has a term of 15 years from the grant date

Inventors should carefully consider which type of patent application best suits their invention’s nature and intended protection.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

For more information on USPTO, visit: USPTO.

According to the MPEP 608.01(v), the main difference lies in their application:

  • Trademark: The term ‘trademark’ includes any word, name, symbol, or device, or any combination thereof- (1) used by a person, or (2) which a person has a bona fide intention to use in commerce and applies to register on the principal register established by this chapter, to identify and distinguish his or her goods, including a unique product, from those manufactured or sold by others and to indicate the source of the goods, even if that source is unknown.
  • Service mark: The term ‘service mark’ means any word, name, symbol, or device, or any combination thereof- (1) used by a person, or (2) which a person has a bona fide intention to use in commerce and applies to register on the principal register established by this chapter, to identify and distinguish the services of one person, including a unique service, from the services of others and to indicate the source of the services, even if that source is unknown.

In simpler terms, trademarks are used for goods, while service marks are used for services.

To learn more:

While both suspended and excluded patent practitioners are prohibited from practicing before the USPTO, there are differences in the nature and duration of the prohibition:

  • Suspended practitioner: Temporarily prohibited from practicing before the USPTO for a specific period.
  • Excluded practitioner: Permanently prohibited from practicing before the USPTO, unless later reinstated.

The MPEP § 407 uses both terms, indicating that the Office treats them similarly in terms of communication and representation: ‘The Office does not communicate with attorneys or agents who have been suspended or excluded from practice.’

What is the difference between a specification and claims in a patent application?

The specification and claims are distinct but related parts of a patent application:

  • Specification: This is a detailed written description of the invention. According to MPEP 601.01, it must contain “a description pursuant to 35 U.S.C. 112(a).” The specification explains how to make and use the invention and provides the context for understanding the claims.
  • Claims: These define the legal scope of patent protection. The MPEP states that an application must include “at least one claim pursuant to 35 U.S.C. 112(b).” Claims outline the specific elements of the invention that the applicant considers novel and seeks to protect.

The MPEP further clarifies: “The specification must include a written description of the invention or discovery and of the manner and process of making and using the same, and is required to be in such full, clear, concise, and exact terms as to enable any person skilled in the art or science to which the invention or discovery appertains, or with which it is most nearly connected, to make and use the same.”

While the specification provides a comprehensive description, the claims define the boundaries of the patent rights. Both are crucial for a complete and effective patent application.

To learn more:

What is the difference between a principal and an associate power of attorney in patent applications?

In patent applications, there is a distinction between principal and associate powers of attorney:

  • Principal Power of Attorney: This is the primary power of attorney granted by the applicant to a patent practitioner or firm.
  • Associate Power of Attorney: This is a secondary power of attorney that can be granted by the principal attorney to another practitioner or firm.

According to MPEP 402.02(a):

“A principal attorney or agent may appoint an associate power of attorney to act in a representative capacity. See 37 CFR 1.32(b). An associate power of attorney is a power of attorney given to a second attorney or agent by an already appointed principal patent attorney or agent. The associate power of attorney is given by the principal attorney or agent to the associate attorney or agent, not by the applicant.”

It’s important to note that an associate power of attorney does not replace the principal power of attorney but rather supplements it, allowing for additional representation in the patent application process.

To learn more:

What is the difference between a power of attorney and an authorization to act in a representative capacity?

The main differences between a power of attorney and an authorization to act in a representative capacity are:

  • Power of Attorney: Grants the ability to conduct all business before the USPTO on behalf of the applicant or assignee.
  • Authorization to Act: Allows the practitioner to represent the applicant or assignee in a limited capacity, typically for a specific application or patent.

According to MPEP 601.02: ‘For applications filed on or after September 16, 2012, a power of attorney must be signed by the applicant for patent or the patent owner (for reissue applications, reexamination proceedings and supplemental examination proceedings). An assignee who is not an applicant cannot revoke or appoint power of attorney in a patent application.’

It’s important to note that while a power of attorney provides broader authority, an authorization to act can be sufficient for many routine patent prosecution matters.

To learn more:

To learn more:

A power of attorney and a customer number serve different purposes in patent applications:

  • Power of Attorney: This is a legal document that gives an attorney or agent the authority to act on behalf of the applicant or assignee in matters before the USPTO.
  • Customer Number: This is a unique identifier assigned by the USPTO to allow for easier management of multiple patent applications.

According to MPEP 601.02: “A power of attorney may be supplied with a customer number so that the power of attorney will be effective in all existing and future patent applications or patent matters associated with that customer number.” This means that a customer number can be used in conjunction with a power of attorney to streamline the process of managing multiple applications.

To learn more:

The key differences between a patent assignment and a patent license are:

  • Assignment: Transfers all or part of the ownership interest in a patent, including the entire bundle of rights associated with ownership.
  • License: Transfers a bundle of rights that is less than the entire ownership interest. It may be limited in time, geographical area, or field of use.

A license is essentially a contractual agreement that the patent owner will not sue the licensee for patent infringement under certain conditions. Even an exclusive license is not considered an assignment of patent rights.

What is the difference between a parent application and a child application in patent law?

In patent law, the terms ‘parent application’ and ‘child application’ refer to the relationship between related patent applications. According to MPEP 201.02:

“The term parent application is used to refer to the immediate prior application from which a continuing application claims priority.”

“A child application is an application that claims the benefit of an earlier filing date from a parent application.”

Key differences:

  • Parent application: The original or earlier-filed application
  • Child application: A subsequent application that claims priority from the parent
  • Child applications can be continuations, divisionals, or continuations-in-part
  • The parent-child relationship establishes a priority claim under 35 U.S.C. 120

Understanding this relationship is crucial for determining priority dates and the scope of patent protection in related applications.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on parent application, visit: parent application.

For more information on patent application types, visit: patent application types.

While MPEP 203.03 specifically discusses amended nonprovisional applications, it’s important to understand the distinction between nonprovisional and provisional applications:

  • Nonprovisional Application: This is a formal patent application that can result in an issued patent. It undergoes examination and can be amended, as described in MPEP 203.03.
  • Provisional Application: This is a temporary application that establishes a priority date but does not undergo examination and cannot be amended.

The amended status discussed in MPEP 203.03 applies only to nonprovisional applications, as provisional applications are not examined or amended.

To learn more:

The terms ‘national application,’ ‘provisional application,’ and ‘nonprovisional application’ are defined in 37 CFR 1.9(a). Specifically:

  • A national application refers to a U.S. patent application that is not an international application.
  • A provisional application is a type of patent application that allows filing without a formal patent claim or any information disclosure statement.
  • A nonprovisional application is a regular patent application that includes a specification, claims, and other formal requirements.

These definitions help distinguish between different types of patent applications in the U.S. patent system.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

A national application is filed directly with the United States Patent and Trademark Office (USPTO) under U.S. patent laws, while an international application is filed under the Patent Cooperation Treaty (PCT).

According to MPEP 201.01: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’ These applications are processed solely within the U.S. patent system.

International applications, on the other hand, are filed under the PCT and can potentially lead to patent protection in multiple countries. They enter the national phase in individual countries at a later stage.

For more information on USPTO, visit: USPTO.

Tags: USPTO

MPEP 201.01 distinguishes between national applications and international applications:

  • National applications are filed directly with the USPTO under 35 U.S.C. 111(a) or enter the national stage from an international application after complying with 35 U.S.C. 371.
  • International applications are filed under the Patent Cooperation Treaty (PCT).

The MPEP states: The term ‘national application’ as used in this title refers to a U.S. national application for patent which was either filed in the Office under 35 U.S.C. 111, or which entered the national stage from an international application after compliance with 35 U.S.C. 371. (MPEP 201.01)

International applications become national applications when they enter the national stage in a specific country, such as the United States. This process involves meeting the requirements of 35 U.S.C. 371.

For more information on international applications, visit: international applications.

For more information on national stage entry, visit: national stage entry.

What is the difference between a general power of attorney and a limited power of attorney in patent applications?

In patent applications, there are two main types of power of attorney: general and limited. The MPEP 601.02 distinguishes between these as follows:

“A power of attorney may be in the form of a general power of attorney, e.g., to represent the client in all matters before the Office, or limited, e.g., to represent the client in a particular application or in a particular aspect of an application.”

Key differences include:

  • General Power of Attorney: Grants broad authority to represent the client in all matters before the USPTO
  • Limited Power of Attorney: Restricts the attorney’s authority to specific applications or aspects of an application

When deciding between the two, consider the scope of representation needed and any potential conflicts of interest. A limited power of attorney can be useful when working with multiple attorneys or when you want to maintain control over certain aspects of your patent portfolio.

To learn more:

Foreign priority claims and domestic benefit claims are two different ways of claiming the benefit of an earlier filing date:

  • Foreign priority claims (under 35 U.S.C. 119(a)-(d)) are based on earlier applications filed in foreign countries
  • Domestic benefit claims can be to earlier U.S. provisional (35 U.S.C. 119(e)) or nonprovisional (35 U.S.C. 120) applications

Key differences include:

  • Time limits: 12 months for foreign priority, 12 months for provisionals, no limit for nonprovisionals
  • Required documents: Certified copy needed for foreign priority, not for domestic benefit
  • Effect: Foreign priority is mainly for prior art purposes, domestic benefit can confer actual pendency benefits

Both types of claims must be properly made to be effective, but the specific requirements and effects differ.

While both foreign filing licenses and secrecy orders are related to the protection of sensitive information in patent applications, they serve different purposes:

  • Foreign Filing License: As described in MPEP 140, this is a permission granted by the USPTO to file a patent application in a foreign country. It’s typically granted routinely unless there are security concerns.
  • Secrecy Order: This is an order issued under the Invention Secrecy Act (35 U.S.C. 181) to prevent disclosure of an invention that might be detrimental to national security. It prohibits both foreign filing and public disclosure of the invention.

A foreign filing license allows foreign filing, while a secrecy order prohibits it. An application under a secrecy order will not be granted a foreign filing license.

For more information on foreign filing license, visit: foreign filing license.

What is the difference between a divisional and a continuation application?

While both divisional and continuation applications are types of continuing applications, they serve different purposes:

  • Divisional Application: Filed to pursue claims to an invention that was not elected in a previous application due to a restriction requirement.
  • Continuation Application: Filed to pursue additional claims to the same invention disclosed in the parent application.

The MPEP 201.06(c) states: “A divisional application is often filed as a result of a restriction requirement made by the examiner.” In contrast, a continuation typically doesn’t arise from a restriction requirement but rather from the applicant’s desire to pursue additional aspects of the same invention.

Both types can be filed under 37 CFR 1.53(b) and may claim the benefit of the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

There is a significant difference in how Continued Prosecution Applications (CPAs) are treated for utility/plant applications versus design applications. According to the examiner’s note in MPEP ¶ 2.35:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

This indicates that for utility or plant applications, an improper CPA request is treated as a Request for Continued Examination (RCE). However, for design applications, CPA requests are generally accepted and processed as described in MPEP ¶ 2.35. This distinction is important for applicants to understand when considering their continued prosecution options.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

Continued Prosecution Applications (CPAs) are primarily used for design patent applications. For utility or plant applications, improper CPA requests are typically treated as Requests for Continued Examination (RCE). The MPEP ¶ 2.35 notes:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

This distinction is important for applicants to understand when considering their options for continuing prosecution of their patent applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

Continued Prosecution Applications (CPAs) and Requests for Continued Examination (RCEs) are both methods to continue prosecution of a patent application, but they have different uses and applications:

  • CPAs are primarily used for design patent applications, as indicated in MPEP ¶ 2.30.
  • RCEs are used for utility and plant patent applications. The MPEP states: “If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead).”

This distinction is important because it affects how patent examiners process and respond to these continuation requests.

For more information on continued prosecution application, visit: continued prosecution application.

What is the difference between a correspondence address and a fee address in USPTO filings?

In USPTO filings, the correspondence address and fee address serve different purposes:

  • Correspondence Address: Where the USPTO sends all official communications regarding a patent application or patent.
  • Fee Address: Where the USPTO sends maintenance fee reminders for granted patents.

The MPEP clarifies:

The correspondence address is the address associated with the Customer Number to which correspondence is directed. The fee address is the address associated with the Customer Number to which maintenance fee reminders are directed. (MPEP 403)

While these addresses can be the same, they don’t have to be. Applicants or patent owners might choose different addresses, for example, if a law firm handles prosecution but the company itself manages maintenance fees. Using a customer number allows for easy management of both addresses.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on Customer Number, visit: Customer Number.

For more information on Fee Address, visit: Fee Address.

A continuation-in-part (CIP) application differs from a regular continuation application in the following ways:

  • A CIP application contains a portion or all of the disclosure of an earlier application and adds matter not disclosed in the earlier application.
  • A regular continuation application contains the same disclosure as the earlier application without adding new matter.

As stated in MPEP 201.08: A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.

To learn more:

Continuation applications and provisional applications are distinct types of patent applications with different purposes and requirements. A key difference is noted in MPEP 201.07:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the provisional application.

This guidance also applies to continuation applications. The main differences include:

  • Continuation applications are based on nonprovisional applications and claim benefit under 35 U.S.C. 120, 121, 365(c), or 386(c)
  • Provisional applications are placeholder applications that can be claimed as priority under 35 U.S.C. 119(e)
  • Continuation applications must have the same disclosure as the parent application
  • Provisional applications do not need to meet the same formal requirements as nonprovisional applications

For specific requirements related to provisional applications, refer to MPEP § 211 et seq.

For more information on continuation application, visit: continuation application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

A continuation application and a continuation-in-part (CIP) application are both types of patent applications that claim priority to an earlier filed application, but they differ in their content:

  • Continuation application: Contains the same disclosure as the prior application without adding any new matter. As stated in MPEP 201.07: “A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.”
  • Continuation-in-part (CIP) application: Repeats a substantial portion of the prior application but also adds new matter not disclosed in the prior application.

The key difference is that a continuation application does not introduce new subject matter, while a CIP application does.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A continuation application and a divisional application are both types of continuing applications, but they serve different purposes:

  • Continuation application: Used to pursue additional claims to an invention disclosed in a prior application. It contains the same disclosure as the parent application.
  • Divisional application: Used to pursue claims to an invention that was disclosed but not claimed in a prior application. It typically results from a restriction requirement in the parent application.

As stated in MPEP 201.07: “A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.” In contrast, a divisional application focuses on a distinct invention that was not claimed in the parent application.

To learn more:

A continuation application and a continuation-in-part (CIP) application are both types of patent applications that stem from an earlier application, but they differ in their content:

  • Continuation application: Contains the same disclosure as the prior application without adding any new matter. As stated in MPEP 201.07, ‘A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application… The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.’
  • Continuation-in-part application: Repeats a substantial portion of the prior application but also adds new matter not disclosed in the parent application.

The key distinction is that a continuation-in-part introduces new subject matter, while a continuation does not.

To learn more:

The main difference between applications filed under 35 U.S.C. 111(a) and 111(b) lies in their purpose and requirements. According to MPEP 201.01:

  • 35 U.S.C. 111(a) applications: These are for original (nonprovisional) patents. They require a specification, at least one claim, and drawings (when necessary).
  • 35 U.S.C. 111(b) applications: These are for provisional patents. They do not require claims and are not examined on their merits.

The key differences are:

  1. Examination: 111(a) applications undergo full examination, while 111(b) applications do not.
  2. Duration: 111(a) applications can lead to granted patents, while 111(b) applications expire after 12 months.
  3. Requirements: 111(a) applications have stricter formal requirements, including the need for claims.

Inventors often use 111(b) provisional applications to establish an early filing date before filing a more comprehensive 111(a) nonprovisional application.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

A ‘rejected’ patent application and an ‘abandoned’ patent application represent different stages in the patent examination process:

  • Rejected Application: As per MPEP 203.02, this is an application with an unanswered examiner’s action. The applicant still has the opportunity to respond within the allotted reply period.
  • Abandoned Application: This occurs when the applicant fails to respond to the examiner’s action within the specified time frame, effectively ending the examination process.

The MPEP states:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

Thus, a ‘rejected’ application can become ‘abandoned’ if the applicant doesn’t respond in time, but an ‘abandoned’ application cannot revert to ‘rejected’ status without additional procedures.

To learn more:

In the context of foreign priority claims, there’s an important distinction between a ‘country’ and a ‘regional patent office’:

  • Country: A sovereign nation that has its own patent system and can issue patents directly.
  • Regional Patent Office: An intergovernmental organization that processes patent applications on behalf of multiple member countries.

The MPEP states: The right of priority may be based upon an application filed in a foreign country or in a regional patent office. (MPEP 213)

Regional patent offices, such as the European Patent Office (EPO) or the African Regional Intellectual Property Organization (ARIPO), allow applicants to file a single application that can potentially lead to patent protection in multiple member countries.

The key differences between a ‘corrective document’ and a ‘substitute statement’ for USPTO assignments are:

  • Corrective Document: Used to fix minor errors in the original recorded document.
  • Substitute Statement: Replaces the entire original document when substantial changes are needed.

According to MPEP 323: “Where errors were made in the execution of the original assignment document … a ‘substitute statement’ may be submitted for recordation.” The MPEP further clarifies: “The substitute statement must be accompanied by a copy of the originally recorded papers.”

For more information on assignment correction, visit: assignment correction.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

The treatment of affidavits and declarations differs between applications filed under 37 CFR 1.53(b) and those filed under 37 CFR 1.53(d):

  • 37 CFR 1.53(b) applications: Affidavits and declarations from prior applications do not automatically become part of the new application.
  • 37 CFR 1.53(d) applications: Affidavits and declarations filed during the prosecution of the parent nonprovisional application automatically become part of the new application.

As noted in MPEP ¶ 2.03: Do not use this form paragraph in applications filed under 37 CFR 1.53(d) since affidavits and/or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the parent nonprovisional application automatically become a part of the 37 CFR 1.53(d) application.

For more information on patent applications, visit: patent applications.

The terms ‘right of priority’ and ‘benefit of an earlier filing date’ refer to different concepts in US patent law:

  • Right of priority: This term is used in the context of foreign priority under 35 U.S.C. 119(a)-(d) and 365(a) and (b). It allows a US application to claim the priority date of a foreign application filed within the previous 12 months.
  • Benefit of an earlier filing date: This term is used for domestic benefit under 35 U.S.C. 119(e) and 120. It allows a US application to claim the filing date of an earlier US provisional or nonprovisional application.

As stated in MPEP 216: ‘The right of priority is a statutory right, which is not considered an application property right.’

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

For more information on right of priority, visit: right of priority.

As of July 28, 2013, the United States Postal Service (USPS) renamed ‘Express Mail’ to ‘Priority Mail Express’. According to MPEP 511:

“Effective July 28, 2013, the United States Postal Service (USPS) changed the name of ‘Express Mail’ to ‘Priority Mail Express.’ All characteristics of the ‘Priority Mail Express’ service are the same as those of the former ‘Express Mail’ service (although the mailing labels differ).”

This change is important for patent applicants to note, as the USPTO’s rules and procedures now refer to ‘Priority Mail Express’ instead of ‘Express Mail’. However, the service characteristics and benefits for patent filings remain the same. When using this service for USPTO correspondence, ensure you use the correct addresses as specified in 37 CFR 1.1 and avoid using the ‘Hold for Pickup’ option, as the USPTO does not pick up mail.

To learn more:

The USPTO maintains two special registers for recording certain government interests in patents and patent applications, as outlined in 37 CFR 3.58:

  1. Departmental Register: This register records governmental interests required by Executive Order 9424. It is not open to public inspection but can be examined by authorized government representatives. However, governmental interests recorded on this register are available for public inspection as provided in 37 CFR 1.12.
  2. Secret Register: This register is used to record governmental interests that require secrecy. Documents are placed on this register at the request of the submitting department or agency. Access to this register is highly restricted and requires written authority from the head of the department or agency that submitted the document, as well as approval from the USPTO Director.

These registers ensure that certain sensitive government interests in patents can be recorded while maintaining appropriate levels of confidentiality or secrecy.

An ‘allowed’ application is a nonprovisional patent application that has been examined and determined to meet all statutory requirements. The Manual of Patent Examining Procedure (MPEP) states:

“An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.”

This means that the patent examiner has reviewed the application and found it to be in compliance with all applicable laws and regulations, and has subsequently issued a notice of allowance to the applicant.

To learn more:

A small business concern, for the purpose of paying reduced patent fees, is defined as follows:

A small business concern as used in this paragraph means any business concern that:

  • Has not assigned, granted, conveyed, or licensed, and is under no obligation under contract or law to assign, grant, convey, or license, any rights in the invention to any person, concern, or organization which would not qualify for small entity status as a person, small business concern, or nonprofit organization.
  • Meets the size standards set forth in 13 CFR 121.801 through 121.805 to be eligible for reduced patent fees.

The size standards vary by industry and are based on factors such as average annual receipts or number of employees. It’s important to consult the specific SBA guidelines for your industry to determine if your business qualifies as a small entity.

To learn more:

Tags: patent fees

A divisional application is defined in MPEP 201.06 as follows:

‘A later application for a distinct or independent invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or ‘division.’

This definition highlights that a divisional application:

  • Is filed after an initial application
  • Focuses on a distinct invention
  • Only includes subject matter from the original application
  • Is ‘carved out’ of the pending parent application

For more information on Divisional application, visit: Divisional application.

For more information on patent application types, visit: patent application types.

What is the definition of a continuation-in-part application?

A continuation-in-part (CIP) application is a type of patent application that includes a portion or all of the disclosure from a prior application and adds new matter not disclosed in the prior application. The MPEP 201.08 states:

‘A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.’

This type of application allows inventors to expand upon their original invention while maintaining the priority date for the portions disclosed in the earlier application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

What is the definition of a ‘small business concern’ for small entity status?

According to MPEP 509.02, a small business concern is defined as follows:

“A small business concern, as used in this chapter, means any business concern that:

  • (i) Has not assigned, granted, conveyed, or licensed (and is under no obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a non-profit organization or a small business concern under this section, and
  • (ii) Does not have as a party to the patent application any individual who has assigned, granted, conveyed, or licensed (or is under an obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a non-profit organization or a small business concern under this section.”

This definition ensures that the small business concern maintains control over the invention rights and has not transferred them to entities that do not qualify for small entity status.

To learn more:

What is the definition of ‘applicant’ in patent applications?

According to MPEP 605, the term ‘applicant’ refers to the inventor or joint inventors who are applying for a patent. The MPEP states: ‘The applicant for a patent is the inventor or joint inventors.’ This definition applies to patent applications filed on or after September 16, 2012. For applications filed before this date, the applicant could be the assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest in the matter.

To learn more:

The MPEP does not specify a fixed deadline for submitting the English translation of a non-English provisional application. However, it indicates that the translation must be provided within a time period set by the USPTO. According to MPEP ¶ 2.38:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This suggests that the USPTO will set a specific deadline in an Office action, and you must comply with this deadline to avoid abandonment of your application.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

The deadline for submitting corrected patent drawings depends on when the requirement is made:

  1. If required in an Office action: The deadline will be specified in the Office action.
  2. If required in a Notice of Allowability: Applicants have three months from the mailing date of the notice to submit corrected drawings.

The MPEP 608.02(b) states:

If a corrected drawing is required or if a drawing does not comply with § 1.84 or an amended drawing submitted under § 1.121(d) in a nonprovisional international design application does not comply with § 1.1026 at the time an application is allowed, the Office may notify the applicant in a notice of allowability and set a three-month period of time from the mail date of the notice of allowability within which the applicant must file a corrected drawing in compliance with § 1.84 or 1.1026, as applicable, to avoid abandonment.

It’s crucial to meet these deadlines to avoid potential abandonment of the application.

To learn more:

What is the deadline for submitting certified copies in a national stage application?

The deadline for submitting certified copies in a national stage application (35 U.S.C. 371) is as follows:

  • Certified copies must be filed within the time limit set in 37 CFR 1.55(f).
  • This is typically within the later of 4 months from the actual filing date of the application or 16 months from the filing date of the prior foreign application.

The MPEP 213.06 states: ‘A certified copy of the foreign application must be filed within the time limit set forth in 37 CFR 1.55(f).’ It’s important to note that this requirement applies unless the certified copy was previously filed in the international application and the requirements of PCT Rule 17.1(a), (b), or (b-bis) have been met.

To learn more:

The deadline for submitting assignee information for patent issuance is crucial to ensure the information appears on the patent. According to MPEP 307:

The submission of the request in compliance with 37 CFR 3.81(b) must be made prior to, or at the same time as, the payment of the issue fee.

This means that assignees must submit their information no later than when the issue fee is paid. It’s important to note that:

  • Late submissions may result in the assignee data not being included on the patent
  • The USPTO will not delay issuance of the patent to accommodate late submissions
  • Correcting assignee information after issuance requires a certificate of correction, which may involve additional fees and procedures

To avoid complications, it’s recommended to submit the assignee information as early as possible in the patent issuance process, ensuring compliance with 37 CFR 3.81(b).

For more information on assignee information, visit: assignee information.

For more information on patent issuance, visit: patent issuance.

The deadline for submitting an inventor’s oath or declaration in a patent application filed on or after September 16, 2012, is the date on which the issue fee is paid. This is stated in MPEP 602.01(a):

For applications filed on or after September 16, 2012, the timing of the submission of the inventor’s oath or declaration has been liberalized. The inventor’s oath or declaration is no longer required to be submitted prior to the filing of the application. Rather, the inventor’s oath or declaration may be postponed until payment of the issue fee.

However, it’s important to note that while the oath or declaration can be submitted later, the application must still include the names of all inventors at the time of filing. If the oath or declaration is not submitted with the initial application, a substitute statement may be required.

To learn more:

The deadline for submitting a certified copy of a foreign priority application depends on the filing date of the U.S. application. According to MPEP 213.02:

In the case of a U.S. application filed on or after March 16, 2013, the certified copy must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

If the certified copy is not filed within this timeframe, the applicant must file a petition to accept a delayed submission and pay the associated fee.

To learn more:

The deadline for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): Submit within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: Submit within the later of four months from the date on which the national stage commenced, four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.

The MPEP emphasizes: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c). (MPEP § 211)

For more information on national stage application, visit: national stage application.

The deadline for submitting a benefit claim depends on the type of application:

  • For utility or plant applications filed under 35 U.S.C. 111(a): The later of 4 months from the actual filing date or 16 months from the filing date of the prior application.
  • For national stage applications under 35 U.S.C. 371: The later of 4 months from the date on which the national stage commenced, 4 months from the initial submission under 35 U.S.C. 371 to enter the national stage, or 16 months from the filing date of the prior application.

As stated in MPEP 211.02: “This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).”

If the deadline is missed, a petition under 37 CFR 1.78 and payment of a petition fee may be required to accept a late benefit claim.

To learn more:

For assignee applicants, there is a specific deadline for recording documentary evidence of ownership. According to 37 CFR 1.46(b)(1):

If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

This means that assignees or obligated assignees should ensure that their documentary evidence of ownership is recorded with the USPTO, as specified in 37 CFR Part 3, by the time they pay the issue fee for the patent application. Failing to record this evidence by the deadline could potentially cause complications in establishing ownership of the patent.

To learn more:

The deadline for filing an unintentionally delayed priority claim is the later of:

  • Four months from the actual filing date of the later-filed application, or
  • Sixteen months from the filing date of the prior application

This is stated in 37 CFR 1.55(d)(1) for foreign priority claims and 37 CFR 1.78(a)(4) for domestic benefit claims. However, a petition may be filed to accept an unintentionally delayed claim under 37 CFR 1.55(e) or 37 CFR 1.78(c) and (e) after this period.

As stated in MPEP 214.02: ‘A petition to accept an unintentionally delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) requires:’

  • The priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted;
  • The petition fee as set forth in § 1.17(m); and
  • A statement that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional.

To learn more:

To learn more:

What is the deadline for filing a petition to accept an unintentionally delayed priority claim?

The deadline for filing a petition to accept an unintentionally delayed priority claim depends on the type of application:

  • For utility and plant applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior application.
  • For design applications: The petition must be filed within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior application.

According to MPEP 214.02: ’37 CFR 1.55(e) provides that a petition to accept a delayed priority claim must be accompanied by: (1) The priority claim under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or (b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted; (2) A certified copy of the foreign application, unless previously submitted or an exception in paragraph (h), (i), or (j) of this section applies; (3) The petition fee as set forth in § 1.17(m); and (4) A statement that the entire delay between the date the priority claim was due under this section and the date the priority claim was filed was unintentional.’

It’s important to note that the petition must be filed within the time period set in the statute, and the USPTO does not have the authority to waive this deadline.

To learn more:

The deadline for filing a foreign priority claim in a U.S. patent application depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the claim must be filed within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior foreign application
  • For international applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set by the PCT and its Regulations
  • For design patent applications, the claim can be made at any time during the pendency of the application

As stated in MPEP 214.01: “The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.”

To learn more:

For applications filed before March 16, 2013, the certified copy of the foreign application must be filed within the pendency of the application. According to 37 CFR 1.55(g)(1):

The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application, unless filed with a petition under paragraph (e) or (f) of this section, or with a petition accompanied by the fee set forth in § 1.17(g) which includes a showing of good and sufficient cause for the delay in filing the certified copy of the foreign application in a design application.

However, it’s important to note that if the claim for priority or the certified copy is filed after the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction.

To learn more:

The deadline for filing a benefit claim depends on the type of application:

  • For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of:
    • Four months from the actual filing date of the application, or
    • Sixteen months from the filing date of the prior application
  • For nonprovisional applications entering the national stage from an international application under 35 U.S.C. 371, the reference must be made within the later of:
    • Four months from the date on which the national stage commenced
    • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
    • Sixteen months from the filing date of the prior application

As stated in the MPEP: “If the application is an application filed under 35 U.S.C. 111(a), the reference to the prior application must be submitted during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on filing deadline, visit: filing deadline.

For more information on national stage application, visit: national stage application.

The United States Patent and Trademark Office (USPTO) stamps correspondence received with the date of receipt, known as the ‘Office Date’ stamp. This applies to papers and fees received through various methods:

  • Mail (except Priority Mail Express®)
  • Facsimile
  • EFS-Web
  • Hand-carried to the Customer Service Window

As stated in the MPEP: The United States Patent and Trademark Office (Office) stamps papers and fees received through the mail (other than those submitted by Priority Mail Express® in accordance with 37 CFR 1.10), by facsimile, or via EFS-Web with the date of their receipt in the Office.

The date of receipt for assignment documents sent to the USPTO by fax is determined by when the complete transmission is received. According to MPEP 302.09:

The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.

It’s important to note that the benefits of a certificate of transmission under 37 CFR 1.8 are available for fax submissions. This can provide additional protection in case of transmission issues.

For more information on date of receipt for electronic submissions, you can refer to MPEP § 502.01.

To learn more:

What is the DAS code for PDX?

The DAS (Digital Access Service) code for PDX (Priority Document Exchange) is US. This code is used when participating in the WIPO DAS system for electronic exchange of priority documents. As stated in the MPEP 215.01: The DAS code for the USPTO is ‘US’. Applicants need to use this code when authorizing the USPTO to retrieve priority documents from other offices or when allowing other offices to retrieve priority documents from the USPTO through the WIPO DAS system.

To learn more:

The Customer Number practice allows applicants to:

  • Designate the correspondence address of a patent application or patent
  • Designate the fee address of a patent
  • Submit a list of practitioners who have power of attorney

Using a Customer Number allows applicants to easily change the correspondence address, fee address, or list of practitioners for multiple applications or patents by simply changing the information associated with the Customer Number.

According to MPEP 403: “A Customer Number (previously a ‘Payor Number’) may be used to: (A) designate the correspondence address of a patent application or patent such that the correspondence address for the patent application or patent would be the address associated with the Customer Number (37 CFR 1.32(a)(5)(i)); (B) designate the fee address (37 CFR 1.363) of a patent such that the fee address for the patent would be the address associated with the Customer Number (37 CFR 1.32(a)(5)(ii)); and (C) submit a list of practitioners such that those practitioners associated with the Customer Number would have power of attorney (37 CFR 1.32(a)(5)(iii)).”

What is the Customer Number Practice for power of attorney in patent applications?

The Customer Number Practice is a system used by the USPTO to simplify the process of changing the correspondence address or power of attorney for multiple patent applications. Here’s how it works:

  • Practitioners are associated with a Customer Number
  • The Customer Number can be used to grant power of attorney in applications
  • Changes to the Customer Number automatically update all associated applications

According to the MPEP:

The Customer Number Practice permits applicants, attorneys, and agents of record to expressly request that the USPTO use a Customer Number to associate a power of attorney with a particular application. (MPEP 402.02(a))

This practice streamlines the process of managing power of attorney and correspondence addresses for multiple applications, making it more efficient for both applicants and the USPTO.

To learn more:

The Customer Number Practice is a system used by the USPTO to simplify the process of changing the correspondence address for multiple patent applications. According to MPEP 601.03:

“A Customer Number may be used to:

  • Designate the correspondence address of a patent application by a Customer Number such that the correspondence address for the patent application would be the address associated with the Customer Number;
  • Designate the fee address of a patent by a Customer Number such that the fee address for the patent would be the address associated with the Customer Number; and
  • Submit a list of practitioners by Customer Number such that an applicant may in a Power of Attorney appoint those practitioners associated with the Customer Number.”

    This practice allows for easier management of correspondence addresses across multiple applications or patents.

    To learn more:

What is the Customer Number practice at the USPTO for patent applications?

The Customer Number practice at the USPTO is a system that simplifies the process of managing correspondence addresses for patent applicants and practitioners. Key aspects of this practice include:

  • A Customer Number is a unique identifier assigned by the USPTO to a specific address.
  • It allows for easy updating of correspondence information for multiple applications.
  • Customer Numbers can be associated with Power of Attorney forms.

According to MPEP 403.01(a): ‘The Customer Number practice permits a patent applicant, assignee or practitioner of record to change the correspondence address for a number of applications or patents with one change of address filed in one location.’

To use the Customer Number practice:

  1. Request a Customer Number from the USPTO using the Customer Number Request form (PTO/SB/125A).
  2. Associate the Customer Number with your applications using the appropriate forms or through the USPTO’s electronic filing system.
  3. Update your correspondence address by modifying the Customer Number information, which will automatically update all associated applications.

This practice significantly streamlines the process of managing correspondence for multiple patent applications, making it easier for applicants and practitioners to maintain up-to-date contact information with the USPTO.

To learn more:

As of the 2019 update to MPEP 302.06, the fee for electronically submitting a patent document for recordation is $0. The MPEP states:

If the request to record a document is submitted electronically, the fee is set forth in 37 CFR 1.21(h)(1), currently at $0.

This $0 fee for electronic submissions is a significant cost-saving measure for patent applicants and owners. However, it’s important to note that fees can change, and the MPEP advises:

Customers should check the current fee schedule on the Office website before submitting documents for recordation.

Always verify the current fees on the USPTO fee schedule before submitting any documents.

To learn more:

The USPTO requires a security code for credit card payments made through its website. According to MPEP 509:

Credit card payment submissions made on the USPTO website at www.uspto.gov must include the 3-digit or 4-digit security code associated with the credit card in addition to the credit card number. The security code will not be required when the paper Credit Card Payment Form (PTO-2038) or other written authorization is submitted.

Key points about the security code requirement:

  • It’s part of an authentication procedure to reduce fraudulent or unauthorized credit card use.
  • The code verifies that the physical card is in the cardholder’s possession.
  • For DISCOVER®, MASTERCARD®, and VISA®, it’s a 3-digit code on the back of the card.
  • For AMERICAN EXPRESS®, it’s a 4-digit code on the front of the card.
  • If you can’t read the security code, contact your card issuer.

This requirement enhances security for online transactions but doesn’t apply to paper submissions using Form PTO-2038.

To learn more:

The Credit Card Payment Form (PTO-2038) is a specific form provided by the USPTO for making credit card payments for patent and trademark process fees. According to MPEP 509:

Credit Card Payment Form (PTO-2038) should be used when paying a patent process or trademark process fee (or the fee for an information product) by credit card, unless the payment is being made using the USPTO patent electronic filing system.

Key points about the form:

  • It can be downloaded from the USPTO website at www.uspto.gov/PatentForms.
  • It’s not required (and should not be used) when making credit card payments via EFS-Web or other electronic filing systems.
  • Using this form helps keep credit card information confidential, as the USPTO does not include it among records open to public inspection.

Failure to use this form when submitting a paper credit card payment may result in the credit card information becoming part of the public record.

To learn more:

Tags: patent fees

The correspondence address in a patent application is the address where the United States Patent and Trademark Office (USPTO) will send all official communications regarding the application. According to 37 CFR 1.33(a):

“When filing an application, a correspondence address must be set forth in either an application data sheet (§ 1.76), or elsewhere, in a clearly identifiable manner, in any paper submitted with an application filing.”

This address is crucial for ensuring that applicants receive all necessary information and notifications about their patent application.

To learn more:

When responding to an objection regarding unlabeled prior art figures, applicants must follow specific procedures for submitting corrected drawings. According to MPEP 608.02(g), the process involves:

  1. Submitting corrected drawings in compliance with 37 CFR 1.121(d).
  2. Labeling the replacement sheet(s) as ‘Replacement Sheet’ in the page header, as per 37 CFR 1.84(c).
  3. Ensuring that the labeling does not obstruct any portion of the drawing figures.
  4. Designating the prior art figure with a legend such as ‘Prior Art’.

The MPEP states: Corrected drawings in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. The replacement sheet(s) should be labeled ‘Replacement Sheet’ in the page header (as per 37 CFR 1.84(c)) so as not to obstruct any portion of the drawing figures.

It’s crucial to follow these instructions carefully to ensure that the objection is resolved and to avoid further complications in the patent prosecution process.

To learn more:

The correct procedure for submitting assignment documents to the USPTO involves sending them to the Assignment Division for recording, rather than placing them directly in application or patent files. MPEP 318 clearly states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This process ensures that assignment documents are properly recorded and maintained by the appropriate division within the USPTO.

To learn more:

The format for copyright or mask work notices in patent applications must be limited to only those elements required by law. According to MPEP 608.01(w):

For example, “©1983 John Doe” (17 U.S.C. 401) and “*M* John Doe” (17 U.S.C. 909) would be properly limited and, under current statutes, legally sufficient notices of copyright and mask work, respectively.

These formats comply with the legal requirements for copyright notices under 17 U.S.C. 401 and mask work notices under 17 U.S.C. 909. When including such notices in drawings, they must also comply with the size requirements specified in 37 CFR 1.84(s).

To learn more:

What is the copendency requirement for continuation applications?

The copendency requirement is a crucial aspect of filing a continuation application. According to MPEP 201.07:

‘The continuation application must be filed before the patenting or abandonment of or termination of proceedings on the prior application.’

This means that:

  • The continuation application must be filed while the parent application is still pending (not patented, abandoned, or otherwise terminated).
  • If the parent application has already been issued as a patent or has been abandoned, it’s too late to file a continuation application.
  • The continuation application can be filed on the same day that the parent application is to be issued as a patent, but it must be filed before the parent application officially becomes a patent.

Maintaining copendency is critical for preserving the benefit of the earlier filing date and ensuring the validity of the continuation application.

For more information on continuation application, visit: continuation application.

For more information on copendency, visit: copendency.

Copendency is a crucial requirement when claiming the benefit of a prior-filed nonprovisional application under 35 U.S.C. 120, 121, 365(c), or 386(c). The MPEP defines copendency as follows:

“Copendency is defined in the clause which requires that the later-filed application must be filed before: (A) the patenting of the prior application; (B) the abandonment of the prior application; or (C) the termination of proceedings in the prior application.”

Key points about copendency:

  • The later-filed application must be filed before the prior application patents, is abandoned, or proceedings are terminated
  • If the prior application issues as a patent, the later-filed application can be filed on the same date the patent issues
  • If the prior application is abandoned, the later-filed application must be filed before the abandonment
  • Without copendency, the later-filed application cannot claim the benefit of the prior application’s filing date

Applicants should be aware of the copendency requirement to ensure their benefit claims are valid.

Patent applications are generally kept confidential by the USPTO until they are published or granted. As stated in 35 U.S.C. 122(a):

“Except as provided in subsection (b), applications for patents shall be kept in confidence by the Patent and Trademark Office and no information concerning the same given without authority of the applicant or owner unless necessary to carry out the provisions of an Act of Congress or in such special circumstances as may be determined by the Director.”

This confidentiality requirement applies to all USPTO employees handling patent applications.

Unpublished patent applications are subject to confidentiality requirements under 35 U.S.C. 122(a). MPEP 405 addresses this in the context of interviews:

However, an interview concerning an application that has not been published under 35 U.S.C. 122(b) with an attorney or agent not of record who obtains authorization through use of the interview request form will be conducted based on the information and files supplied by the attorney or agent in view of the confidentiality requirements of 35 U.S.C. 122(a).

This means that for unpublished applications, the USPTO will only discuss information provided by the authorized attorney or agent to maintain confidentiality.

International patent applications are kept confidential before their international publication, as specified in MPEP 110. According to PCT Article 30, the International Bureau and the International Searching Authorities shall not allow access by any person or authority to the international application before the international publication of that application, unless requested or authorized by the applicant. This confidentiality ensures that inventors’ rights are protected during the early stages of the patent process.

For more information on international patent applications, visit: international patent applications.

What is the Certificate of Mailing procedure for USPTO filings?

The Certificate of Mailing procedure is a method that allows applicants to establish the date of filing for correspondence sent to the USPTO. As explained in MPEP 501:

‘Under the procedure, correspondence is considered as being timely filed if (A) the correspondence is mailed or transmitted prior to expiration of the set period for response by being: (1) Addressed as set out in 37 CFR 1.1(a) and deposited with the U.S. Postal Service with sufficient postage as first class mail; or (2) Transmitted by facsimile to the Patent and Trademark Office in accordance with 37 CFR 1.6(d); or (3) Transmitted via the Office electronic filing system in accordance with 37 CFR 1.6(a)(4); and (B) the correspondence includes a certificate for each piece of correspondence stating the date of deposit or transmission.’

This procedure is particularly useful for ensuring timely filing when using postal services. It’s important to note that the certificate must be signed by the person depositing or transmitting the correspondence.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on electronic filing, visit: electronic filing.

The central facsimile number for patent application-related correspondence at the USPTO is (571) 273-8300. According to MPEP 502.01:

All patent application related correspondence transmitted by facsimile must be directed to the central facsimile number, with a few exceptions below. The central facsimile number is (571) 273-8300.

This central number should be used for most patent-related correspondence, including replies to Office actions and after-final amendments. However, there are specific exceptions for certain types of correspondence that should be sent to other facsimile numbers, as outlined in the MPEP.

To learn more:

The best mode requirement in patent applications refers to the obligation of the inventor to disclose the best way they know of carrying out their invention at the time of filing. This is mandated by 35 U.S.C. 112.

As stated in MPEP 608.01(h): The best mode contemplated by the inventor of carrying out his or her invention must be set forth in the description. This requirement ensures that the public receives the full benefit of the invention in exchange for the patent grant.

To learn more:

Tags: invention

Filing a divisional application allows an applicant to pursue protection for distinct inventions disclosed in a parent application. Key benefits include:

  • Ability to claim different aspects or embodiments of the invention
  • Potential for broader patent coverage
  • Preservation of priority date for the disclosed subject matter
  • Opportunity to pursue claims that may have been restricted in the parent application

The MPEP indicates: A divisional application is often filed as a result of a restriction requirement made by the examiner. This suggests that divisional applications provide a way to pursue protection for inventions that were not elected in the parent application due to a restriction requirement.

For more information on Divisional application, visit: Divisional application.

For more information on patent strategy, visit: patent strategy.

What is the benefit of filing a divisional application under 37 CFR 1.53(b)?

Filing a divisional application under 37 CFR 1.53(b) offers several benefits:

  • It allows you to pursue claims to an invention that was not elected in a previous application due to a restriction requirement.
  • You can file the divisional application without a new oath or declaration if you meet certain conditions.
  • The divisional application can claim the benefit of the filing date of the prior application.

As stated in the MPEP: “A divisional application is often filed as a result of a restriction requirement made by the examiner.” This means you can protect additional aspects of your invention that weren’t covered in the original application.

For more information on Divisional application, visit: Divisional application.

For more information on patent filing, visit: patent filing.

Claiming priority to an international design application can provide significant benefits for nonprovisional applications. According to MPEP § 211.01(d):

Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.

This means that a nonprovisional application can claim the earlier filing date of an international design application, potentially providing an earlier priority date for the claimed invention.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on nonprovisional application, visit: nonprovisional application.

Under 35 U.S.C. 386(c), a nonprovisional application can claim the benefit of a prior international design application designating the United States, subject to the conditions and requirements of 35 U.S.C. 120. This provision allows applicants to establish an earlier effective filing date for their nonprovisional applications based on their international design applications.

As stated in the MPEP:

“Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.”

This benefit claim can be crucial for establishing priority and overcoming prior art references.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on nonprovisional application, visit: nonprovisional application.

The basis for disclosure in a patent application is outlined in MPEP 608. It states:

“Applicant may rely for disclosure upon the specification with original claims and drawings, as filed.”

This means that the original specification, claims, and drawings submitted at the time of filing form the foundation of the disclosure. Any amendments or new claims must find support within this original disclosure to avoid introducing new matter. The disclosure must provide a full and clear description of the invention as required by 35 U.S.C. 112(a).

To learn more:

Tags: drawings

The application size fee is an additional fee that applies to patent applications with specifications and drawings exceeding 100 sheets of paper. The MPEP states:

37 CFR 1.16(s) sets forth the application size fee for any application (including any reissue applications) filed under 35 U.S.C. 111, the specification and drawings of which exceed 100 sheets of paper. The calculation of the number of sheets excludes any “Sequence Listing”, computer readable form (CRF) of a “Sequence Listing”, or a “Computer Program Listing Appendix” filed in an American Standard Code for Information Interchange (ASCII) plain text file or any “Sequence Listing XML” filed in an eXtensible Markup Language (XML) file on a read-only optical disc or via the USPTO patent electronic filing system in compliance with the rules.

The fee applies for each additional 50 sheets or fraction thereof over 100 sheets. This fee must be paid within the time period set by the USPTO to avoid abandonment of the application.

When submitting replacement drawings after allowance, the applicant has a crucial responsibility:

It is applicant’s responsibility to see that no new matter is added when submitting replacement drawings after allowance because they will not normally be reviewed by an examiner.

This means that applicants must ensure that any changes made to the drawings do not introduce new subject matter that wasn’t present in the original application. This responsibility is particularly important because examiners typically do not review these late-submitted drawings, placing the onus on the applicant to maintain the integrity of the application’s content.

To learn more:

Tags: new matter

The USPTO offers an additional fee reduction for small entities that file patent applications electronically. According to MPEP 509.02:

The Consolidated Appropriations Act, 2005, provides that the filing fee charged under 35 U.S.C. 41(a)(1)(A) shall be reduced by 75 percent with respect to its application to any small entity ‘if the application is filed by electronic means as prescribed by the Director’ (35 U.S.C. 41(h)(3)).

This 75% reduction applies specifically to the filing fee for nonprovisional original utility applications filed electronically by small entities on or after December 8, 2004. It’s important to note that this enhanced reduction does not apply to design applications, plant applications, reissue applications, or provisional applications.

To learn more:

The ‘statement of unintentional delay’ is a crucial component of a petition to accept an unintentionally delayed priority claim. According to MPEP 214.02:

The Director may require additional information where there is a question whether the delay was unintentional.

This statement must affirm that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional. It’s important to note that:

  • The USPTO requires an additional explanation of the circumstances surrounding the delay that establishes the entire delay was unintentional.
  • The statement must be signed by a person who has sufficient knowledge of the facts to support the statement.
  • Providing an inadequate or insufficient explanation may lead to a request for further information, which could delay the petition process.

Applicants should be prepared to provide a detailed account of the circumstances that led to the delay, ensuring that it covers the entire period of delay and demonstrates that the delay was truly unintentional.

To learn more:

To learn more:

What is the ‘specific reference’ requirement for claiming benefit of a prior-filed application?

The ‘specific reference’ requirement is a crucial aspect of claiming the benefit of a prior-filed application. According to MPEP 211.01, To claim the benefit of a prior-filed application, the later-filed application must contain a specific reference to the prior-filed application. This means that:

  • The specific reference must be made in the first sentence(s) of the specification or in an application data sheet (ADS).
  • It should include the relationship between the applications (e.g., continuation, divisional, or continuation-in-part).
  • The prior application’s serial number and filing date must be provided.

For example: ‘This application is a continuation of Application No. 12/345,678, filed January 1, 2020.’

Failure to provide this specific reference can result in the loss of the benefit claim. For more details, refer to MPEP 211 and 37 CFR 1.78.

What is the ‘same invention’ requirement for claiming benefit under 35 U.S.C. 120?

The ‘same invention’ requirement is a crucial aspect of claiming benefit under 35 U.S.C. 120. MPEP 211.01(b) explains: The second application must be an application for a patent for an invention which is also disclosed in the first application.

This means:

  • The later application must disclose at least some part of the invention claimed in the prior application.
  • The disclosure in the prior application must provide adequate support for the claims in the later application.
  • New matter introduced in the later application cannot claim the benefit of the earlier filing date.

The ‘same invention’ does not require identical claims, but there must be a common disclosure that supports the claims in both applications. For more information, see MPEP 211.01(b) and 35 U.S.C. 120.

The ‘reasonable inquiry’ requirement, as described in 37 CFR 11.18(b)(2), mandates that submissions to the USPTO be made ‘to the best of the party’s knowledge, information and belief, formed after an inquiry reasonable under the circumstances.’ This standard is similar to Rule 11 of the Federal Rules of Civil Procedure.

The MPEP clarifies: An ‘inquiry reasonable under the circumstances’ requirement of 37 CFR 10.18(b)(2) is identical to that in Fed. R. Civ. P. 11(b). The federal courts have stated in regard to the ‘reasonable inquiry’ requirement of Fed. R. Civ. P. 11: In requiring reasonable inquiry before the filing of any pleading in a civil case in federal district court, Rule 11 demands ‘an objective determination of whether a sanctioned party’s conduct was reasonable under the circumstances.’

For more information on patent application requirements, visit: patent application requirements.

The ‘Office Date’ stamp is used by the USPTO to mark the receipt date of papers and fees. According to MPEP 505, The United States Patent and Trademark Office (Office) stamps papers and fees received through the mail (other than those submitted by Priority Mail Express® in accordance with 37 CFR 1.10), by facsimile, or via EFS-Web with the date of their receipt in the Office.

The ‘Office Date’ stamp is crucial because:

  • It establishes the filing date for new patent applications that include the necessary components (see 37 CFR 1.53(b)-(d))
  • It determines the timeliness of actions and fee payments

For hand-carried papers, date stamping occurs at the Customer Service Window.

For more information on Office Date stamp, visit: Office Date stamp.

For more information on USPTO, visit: USPTO.

The ‘Minimum Significant Part of the Number’ refers to the essential portion of a foreign application number that should be used in United States Patent and Trademark Office (USPTO) records. According to the MPEP:

The ‘Minimum Significant Part of the Number’ identified in the tables should be used in United States Patent and Trademark Office records.

This concept is important because:

  • It standardizes the citation of foreign applications across different numbering systems
  • It ensures that the most crucial identifying information is captured
  • It facilitates accurate cross-referencing and searching of patent documents

Applicants and examiners should refer to the WIPO tables to determine the correct ‘Minimum Significant Part of the Number’ for each foreign intellectual property office.

To learn more:

What is the ‘infringement test’ for dependent claims in patent applications?

The ‘infringement test’ is a crucial concept in determining the proper dependency of claims in patent applications. As described in MPEP 608.01(n):

‘One test for a proper dependent claim is that the dependent claim must be narrower than the claim(s) from which it depends. In other words, if a dependent claim does not further limit the scope of the claim(s) from which it depends, it is not a proper dependent claim.’

The infringement test states that:

  • Any subject matter that would infringe the independent claim must also infringe the dependent claim.
  • If it’s possible to infringe the independent claim without infringing the dependent claim, the dependent claim is improper.

This test ensures that dependent claims properly narrow the scope of the claims they depend from, maintaining the hierarchical structure of patent claims.

To learn more:

The ‘In re Van Esdonk’ case (187 USPQ 671, Comm’r Pat. 1975) is an important precedent in patent law regarding the perfection of foreign priority claims. Key points about this case include:

  • It involved a situation where a claim to foreign priority benefits had not been filed in the application prior to patent issuance.
  • The application was a continuation of an earlier application that had satisfied the requirements of 35 U.S.C. 119(a)-(d) or (f).
  • The Commissioner held that perfecting a priority claim in the parent application satisfies the statute for the continuation application.

The MPEP states: In re Van Esdonk, a claim to foreign priority benefits had not been filed in the application prior to issuance of the patent. However, the application was a continuation of an earlier application in which the requirements of 35 U.S.C. 119(a)-(d) or (f) had been satisfied. Accordingly, the Commissioner held that the ‘applicants’ perfection of a priority claim under 35 U.S.C. 119 in the parent application will satisfy the statute with respect to their continuation application.’

This case is significant because it allows for the perfection of foreign priority claims in continuation applications based on the parent application’s compliance, even after patent issuance.

A certified copy of a foreign application is a copy of the original foreign application with a certification by the patent office of the foreign country in which it was filed. According to the MPEP, “Certified copies ordinarily consist of a copy of the specification and drawings of the applications as filed with a certificate of the foreign patent office giving certain information.” It’s important to note that a copy of the certified copy filed by the applicant will not satisfy the requirement for a certified copy.

Small entity status allows certain applicants to pay reduced patent fees. To claim small entity status, you must make an assertion of entitlement in one of two ways:

  • Submit a written assertion signed by the applicant, a patent practitioner, an inventor, or an assignee
  • Pay the exact small entity basic filing fee, basic national fee, or individual designation fee

As stated in 37 CFR 1.27(c): “Any party (person, small business concern or nonprofit organization) should make a determination, pursuant to paragraph (f) of this section, of entitlement to be accorded small entity status based on the definitions set forth in paragraph (a) of this section, and must, in order to establish small entity status for the purpose of paying small entity fees, actually make an assertion of entitlement to small entity status, in the manner set forth in paragraphs (c)(1) or (c)(3) of this section, in the application or patent in which such small entity fees are to be paid.”

To learn more:

Tags: patent fees

When submitting an English language translation of a non-English language foreign priority application, the following requirements must be met:

  • The translation must be of the certified copy of the foreign application as filed
  • The translation must be submitted together with a statement that the translation of the certified copy is accurate

As stated in the MPEP: When an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) submitted together with a statement that the translation of the certified copy is accurate.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

When submitting a certified copy of a foreign application for priority purposes, the following requirements apply:

  • If the certified copy is not in English, a translation is required
  • The translation must be of the certified copy of the foreign application as filed
  • The translation must be filed together with a statement that the translation of the certified copy is accurate

The MPEP states: “When the examiner requires the filing of the certified copy, the translation should also be required at the same time. If an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) and it must be filed together with a statement that the translation of the certified copy is accurate.” (MPEP 216)

When notifying the USPTO of a loss of micro entity status, the following requirements must be met:

  • The notification must be filed in the application or patent prior to paying, or at the time of paying, any fee after the date on which micro entity status is no longer appropriate.
  • The notification must be signed by a party identified in 37 CFR 1.33(b).
  • A simple statement that the applicant is no longer eligible for micro entity status is sufficient, without identifying specific reasons.

As stated in MPEP 509.04(e): Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.

To learn more:

To make a proper priority claim in a U.S. patent application, the applicant must provide specific information about the foreign application and file the claim within the required time period. The requirements differ slightly depending on the type of application.

For applications filed on or after September 16, 2012, under 35 U.S.C. 111(a), MPEP 213.02 states: “the claim for priority must be presented in an application data sheet.” The claim must include:

  • The application number of the foreign application
  • The country or intellectual property authority
  • The day, month, and year of filing

For international applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set forth in the PCT and the Regulations under the PCT.

The MPEP further notes: “For applications filed prior to September 16, 2012, the claim to priority need be in no special form, and may be made by a person authorized to sign correspondence under 37 CFR 1.33(b). No special language is required in making the claim for priority, and any expression which can be reasonably interpreted as claiming the benefit of the foreign application is accepted as the claim for priority.”

It’s important to file the priority claim within the specified time limits to ensure it is considered valid and effective.

For more information on application data sheet, visit: application data sheet.

For more information on foreign application, visit: foreign application.

To establish ownership for an assignee to take action in a patent application filed before September 16, 2012, the following is required:

  • The assignee must submit documentary evidence of a chain of title from the original owner to the assignee, or a statement specifying where such evidence is recorded in the USPTO assignment records.
  • A statement affirming that the documentary evidence was or is being submitted for recordation.
  • The submission must be signed by a person authorized to act on behalf of the assignee.

This is outlined in pre-AIA 37 CFR 3.73(b), which states:

“In order to request or take action in a patent or trademark matter, the assignee must establish its ownership of the patent or trademark property of paragraph (a) of this section to the satisfaction of the Director. The establishment of ownership by the assignee may be combined with the paper that requests or takes the action. Ownership is established by submitting to the Office a signed statement identifying the assignee, accompanied by either: (i) Documentary evidence of a chain of title from the original owner to the assignee (e.g., copy of an executed assignment). For patent matters only, the submission of the documentary evidence must be accompanied by a statement affirming that the documentary evidence of the chain of title from the original owner to the assignee was or concurrently is being submitted for recordation pursuant to § 3.11; or (ii) A statement specifying where documentary evidence of a chain of title from the original owner to the assignee is recorded in the assignment records of the Office (e.g., reel and frame number).”

To claim the benefit of an earlier filing date under 35 U.S.C. 120, the following requirements must be met:

  • The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application
  • The disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement
  • The later-filed application must contain a specific reference to the prior application
  • The later-filed application must be filed before the patenting or abandonment of or termination of proceedings on the first application

As stated in the MPEP: “To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

Adding a benefit claim after the time period required by 37 CFR 1.78 requires a petition and the petition fee. As stated in MPEP § 211.04:

Any petition under 37 CFR 1.78 must be accompanied by a corrected ADS in compliance with 37 CFR 1.76(c) (for applications filed on or after September 16, 2012), or by an amendment to the specification or a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c) (for applications filed prior to September 16, 2012) unless the proper reference was previously submitted.

In addition to the petition and ADS or amendment, you may need to file one of the following, depending on the status of your application:

  • A request for continued examination (RCE) under 37 CFR 1.114, if the application is under final rejection or has been allowed.
  • A reissue application or a request for a certificate of correction under 37 CFR 1.323, if the application has already issued as a patent.

It’s important to note that when adding a benefit claim after filing, you cannot include an incorporation by reference statement of the prior application unless such a statement was present upon the initial filing of the application.

To learn more:

When submitting non-English language information in an Information Disclosure Statement (IDS), a concise explanation of the relevance is required. The MPEP states:

Each information disclosure statement must further include a concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information listed that is not in the English language.‘ (MPEP 609.04(a))

Key points regarding non-English language information:

  • A complete translation is not required if a concise explanation is provided.
  • If a complete English translation is submitted, no concise explanation is needed.
  • An English-language abstract may fulfill the requirement for a concise explanation.
  • For information cited in a foreign patent office search report, submitting an English-language version of the search report indicating the degree of relevance can satisfy the requirement.

The explanation should be sufficient to convey the relevance of the non-English information to the claimed invention.

To learn more:

All modifications described in a patent application must be illustrated in the drawings, or the text describing those modifications must be canceled. This requirement is based on Ex parte Peck, 1901 C.D. 136, 96 OG 2409 (Comm’r Pat. 1901). The MPEP section 608.02(f) states:

“All modifications described must be illustrated, or the text canceled.”

However, there are two exceptions to this rule:

  • Minor variations
  • Well-known and conventional parts

These exceptions do not require illustration. This requirement ensures that the patent application provides a clear and complete disclosure of the invention.

To learn more:

To correct inventorship in a provisional application, you must follow the procedure outlined in 37 CFR 1.48(d). The requirements include:

  • A request signed by a party set forth in 37 CFR 1.33(b) to correct the inventorship, identifying each inventor by their legal name
  • The processing fee set forth in 37 CFR 1.17(q)

The MPEP advises, When an inventor is being added, applicants should also file a corrected application data sheet or a new cover sheet providing the residence of all inventors.

To learn more:

For an Information Disclosure Statement (IDS) filed after the initial three-month period or first Office action, but before the mailing of a final action, Notice of Allowance, or an Ex parte Quayle action, the following is required:

  • Either a statement under 37 CFR 1.97(e), or
  • The fee set forth in 37 CFR 1.17(p)

As stated in MPEP 609.04(b): An information disclosure statement will be considered by the examiner if filed after the period specified in subsection I. above, but prior to the date the prosecution of the application closes, i.e., before (not on the same day as the mailing date of any of the following): a final action under 37 CFR 1.113, e.g., final rejection; a notice of allowance under 37 CFR 1.311; or an action that closes prosecution in the application, e.g., an Ex parte Quayle action, whichever occurs first, provided the information disclosure statement is accompanied by either (1) a statement as specified in 37 CFR 1.97(e) (see the discussion in subsection V below); or (2) the fee set forth in 37 CFR 1.17(p).

To learn more:

Tags: late filing

A petition to restore the benefit of a provisional application under 37 CFR 1.78(b) must include several elements. According to MPEP 211.01(a):

‘A petition under 37 CFR 1.78(b) requires: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application, which must be included in application data sheet (unless previously submitted in an application data sheet); (B) the petition fee as set forth in 37 CFR 1.17(m); and (C) a statement that the delay in filing the nonprovisional application or international application designating the United States within the twelve-month period set forth in 37 CFR 1.78(a)(1)(i) was unintentional.’

The petition must be filed in the subsequent application (nonprovisional or international application designating the US) within 14 months of the provisional application’s filing date. The USPTO may require additional information to verify that the delay was unintentional.

For more information on benefit restoration, visit: benefit restoration.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

A person who shows sufficient proprietary interest in the matter can file a patent application, but must submit a petition as outlined in 37 CFR 1.46(b)(2). The petition must include:

  1. The fee set forth in § 1.17(g)
  2. A showing that the person has sufficient proprietary interest in the matter
  3. A statement that making the application for patent by this person on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

The MPEP further explains that a proprietary interest can be demonstrated by an appropriate legal memorandum to the effect that a court of competent jurisdiction (federal, state, or foreign) would by the weight of authority in that jurisdiction award title of the invention to the 37 CFR 1.46 applicant. This should be supported by an affidavit or declaration and prepared by an attorney familiar with the relevant jurisdiction’s law.

To learn more:

When claiming the benefit of a provisional application filed in a language other than English, additional requirements must be met. The MPEP states:

“If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.”

If these documents were not filed in the provisional application, the applicant will be notified and given a period to:

  1. File the translation and statement in the provisional application
  2. Submit a confirmation in the nonprovisional application that the translation and statement were filed in the provisional application

Failure to respond to this notice in a pending nonprovisional application will result in abandonment. For more details, see MPEP § 211.01(a).

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

When adding a new inventor to a patent application, additional documentation is required. According to 37 CFR 1.48(b):

An oath or declaration as required by § 1.63, or a substitute statement in compliance with § 1.64, will be required for any actual inventor who has not yet executed such an oath or declaration.

This means that any newly added inventor must submit either an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement in compliance with 37 CFR 1.64. The specific requirements for these documents depend on the application’s filing date. For applications filed on or after September 16, 2012, refer to MPEP § 602.01(a) for oath or declaration requirements and MPEP § 604 for substitute statement requirements.

To learn more:

For a later-filed application to be entitled to the benefit of an earlier-filed application’s filing date, the following requirements must be met:

  • The invention disclosed in the later-filed application must also be disclosed in the earlier-filed application.
  • The disclosure in both applications must be sufficient to comply with the requirements of 35 U.S.C. 112(a), except for the best mode requirement.

As stated in MPEP 211.05:

“To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.”

This means that the earlier-filed application must provide adequate support and enablement for the claimed subject matter in the later-filed application.

To learn more:

PSTAR stands for Patents Service for Time and Application Routing. According to MPEP 504, PSTAR is “the program [that] assigns each nonprovisional application to an examiner.” This system is used by the United States Patent and Trademark Office (USPTO) to efficiently distribute patent applications to the appropriate examiners for review.

To learn more:

Priority Mail Express® is a service offered by the United States Postal Service (USPS) that can be used to establish a filing date for patent applications and other correspondence with the USPTO. As stated in MPEP 513:

The statutory authority for the granting of a filing date based on the date of deposit for correspondence sent by Priority Mail Express® and received by the Office is found in section 21(a) of Title 35 of the United States Code.

Using Priority Mail Express® allows applicants to receive a filing date as of the date the correspondence was deposited with USPS, rather than the date it was received by the USPTO.

Priority in patent applications refers to the ability of a later-filed application to claim the benefit of, or priority to, an earlier-filed application. This allows the later application to effectively have the filing date of the earlier application for certain purposes.

According to the MPEP, “Under certain conditions and on fulfilling certain requirements, a later-filed application for patent filed in the United States may claim the benefit of, or priority to, a prior application filed in the United States (see 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c); see also 37 CFR 1.78) or in a foreign country (see 35 U.S.C. 119(a)-(d) and (f), 365(a) and (b), and 386(a) and (b); see also 37 CFR 1.55).”

According to 35 U.S.C. 261, patents have the attributes of personal property and are assignable by an instrument in writing. Specifically, the statute states:

‘Subject to the provisions of this title, patents shall have the attributes of personal property. […] Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing.’

This means that patent owners can transfer their rights to others through written assignments, similar to other forms of property.

PALM stands for Patent Application Locator and Monitoring system. While MPEP 303 doesn’t provide a definition, it mentions PALM in the context of assignment information:

“…it is necessary for the examiner to obtain assignment information from PALM.” (MPEP 303)

PALM is an internal USPTO database system used by patent examiners to access and track information about patent applications, including assignment details. It’s a crucial tool for examiners when they need to verify ownership or resolve conflicts related to patent applications.

MPEP 602.07 is titled ‘Oath or Declaration Filed in United States as a Designated Office’. This section provides guidance on the requirements for oaths or declarations filed in the United States Patent and Trademark Office (USPTO) when it acts as a designated office for international patent applications under the Patent Cooperation Treaty (PCT).

The section directs readers to MPEP § 1893.01(e) for more detailed information. This cross-reference suggests that MPEP § 1893.01(e) contains more specific instructions or requirements related to oaths or declarations in this context.

To learn more:

MPEP 319 is currently a reserved section in the Manual of Patent Examining Procedure (MPEP). The content of this section is marked as ‘[Reserved]’, which means that there is no specific information or guidance provided in this particular section at this time.

Limited recognition in patent matters is a provision that allows certain individuals who are not registered patent practitioners to prosecute specific patent applications before the United States Patent and Trademark Office (USPTO). According to 37 CFR 11.9(a):

Any individual not registered under § 11.6 may, upon a showing of circumstances that render it necessary or justifiable and that the individual is of good moral character and reputation, be given limited recognition by the OED Director to prosecute as attorney or agent a specified patent application or specified patent applications.

This means that under certain circumstances, individuals who are not registered patent attorneys or agents may be granted permission to work on specific patent applications.

To learn more:

To learn more:

Joint ownership of a patent occurs when multiple parties together own the entire right, title, and interest of the patent property. This can happen in several scenarios:

  • Multiple partial assignees of the patent property
  • Multiple inventors who have not assigned their rights
  • A combination of partial assignee(s) and inventor(s) who have not assigned their rights

In cases of joint ownership, all parties having any portion of the ownership must act together as a composite entity in patent matters before the USPTO. According to 35 U.S.C. 262, in the absence of any agreement to the contrary, each joint owner may make, use, offer to sell, or sell the patented invention within the United States without the consent of and without accounting to the other owners.

Irreparable damage, in the context of patent applications, refers to a situation where a filing date is crucial to preserve the rights of an applicant or to prevent severe harm. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This means that an applicant can demonstrate irreparable damage by providing a statement explaining why obtaining a specific filing date is essential to protect their rights or avoid significant harm.

To learn more:

To learn more:

Tags: pre-AIA

Indexing against a recorded certificate refers to the process of associating additional patent numbers or application numbers with a document that has already been recorded in the USPTO’s Assignment Division. However, the USPTO does not process such requests for ‘indexing’ or ‘cross-referencing’ unless a new submission is made.

According to MPEP 315, The Office does not process requests for ‘indexing’ or ‘cross-referencing’ additional patent numbers or application numbers against a document, other than an assignment, previously recorded in the Assignment Division.

Incorporation by reference under 37 CFR 1.57(b) is a provision that allows applicants to add inadvertently omitted material to a patent application if certain conditions are met. Specifically:

  • The application must contain a priority or benefit claim to a prior-filed application
  • The omitted material must be completely contained in that prior-filed application
  • The omission must have been inadvertent

This provision acts as a safeguard for applicants when material is accidentally left out of an application due to clerical error. As stated in the MPEP, “The purpose of 37 CFR 1.57(b) is to provide a safeguard for applicants when a page(s) of the specification, or a portion thereof, or a sheet(s) of the drawing(s), or a portion thereof, is (are) inadvertently omitted from an application, such as through a clerical error.”

Form PTO/AIA/82 is a USPTO form used by the applicant for patent to appoint one or more patent practitioners as power of attorney. This form consists of three parts:

  • Part A (PTO/AIA/82A): A transmittal page used to identify the application to which the power of attorney is directed. It must be signed by a proper 37 CFR 1.33(b) party.
  • Part B (PTO/AIA/82B): The actual power of attorney, which may also specify the correspondence address. This part must be signed by the applicant.
  • Part C (PTO/AIA/82C): An optional page that may be used to appoint up to 10 patent practitioners by name and registration number.

The MPEP notes that “PTO/AIA/82 may be used like a general power of attorney, if desired.” For example, an officer of a juristic entity assignee could sign Part B, leaving the “Application Number” and “Filing Date” boxes empty. Then, a patent practitioner could complete and sign one Part A for each respective application and file a copy of Part B with each Part A.

It’s important to note that the “Application Number” and “Filing Date” boxes on Part B must be completed to identify the application if Part A or an equivalent is not filed with Part B. These boxes may not be filled in by a patent practitioner after Part B has been signed by the applicant.

To learn more:

Form Paragraph 6.17 is a tool used by patent examiners to notify applicants about issues with claim numbering. According to MPEP 608.01(j), this form paragraph is titled “Numbering of Claims, 37 CFR 1.126” and is used when the numbering of claims does not comply with the regulations. The paragraph states:

“The numbering of claims is not in accordance with 37 CFR 1.126, which requires the original numbering of the claims to be preserved throughout the prosecution. When claims are canceled, the remaining claims must not be renumbered. When new claims are presented, they must be numbered consecutively beginning with the number next following the highest numbered claims previously presented (whether entered or not).”

This form paragraph helps examiners communicate clearly with applicants about claim numbering issues and ensures compliance with USPTO regulations.

To learn more:

To learn more:

Form Paragraph 4.03 is used by USPTO examiners in Office actions to notify relevant parties about the death of a patent practitioner. The paragraph reads:

Notice of the death of the attorney or agent of record has come to the attention of this Office. Since the power of attorney is therefore terminated, this action is being mailed to the office of the patent practitioner and to the party who originally appointed the deceased patent practitioner. A new registered attorney or agent may be appointed.

This paragraph informs recipients that the power of attorney has been terminated and that a new attorney or agent can be appointed.

Form Paragraph 2.34 is a standardized response used by patent examiners when addressing improper amendments to Continued Prosecution Applications (CPAs). According to MPEP § 201.06(d), this form paragraph is specifically used to:

“inform the applicant that an amendment to the first sentence(s) of the specification referring to the CPA as a continuing application of the prior application has not been entered and will not be entered if submitted again.”

The form paragraph explains that such amendments are unnecessary because the CPA request itself serves as the specific reference required by 35 U.S.C. 120. It helps maintain consistency in examiner responses and ensures that applicants are properly informed about the treatment of these amendments in CPA applications.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

Executive Order 9424, issued in 1944, mandates the recording of certain government interests in patent rights. The MPEP references this order in the context of USPTO document recording:

In addition to assignments and documents required to be recorded by Executive Order 9424, upon request, assignments of applications, patents, and registrations, and other documents relating to interests in patent applications and patents will be recorded in the Office.

This means that while Executive Order 9424 requires the recording of specific government-related documents, the USPTO’s recording practices extend beyond these requirements. The USPTO will record various documents related to patent interests upon request, as outlined in 35 U.S.C. 261 and 37 CFR 3.11.

For more information on Executive Order 9424, you can refer to the National Archives.

For more information on government interests, visit: government interests.

For more information on patent rights, visit: patent rights.

Essential material is defined in 37 CFR 1.57(d) as material that is necessary to:

  • Provide a written description of the claimed invention as required by 35 U.S.C. 112(a)
  • Describe the claimed invention in terms that particularly point out and distinctly claim the invention as required by 35 U.S.C. 112(b)
  • Describe the structure, material, or acts that correspond to a claimed means or step for performing a specified function as required by 35 U.S.C. 112(f)

Essential material may only be incorporated by reference to a U.S. patent or patent application publication.

To learn more:

Electronic Priority Document Exchange (PDX) is a system that allows for the electronic transmission of priority documents between participating foreign intellectual property offices. As stated in MPEP 215.01:

Electronic Priority Document Exchange (PDX) agreements provide for the electronic transmission of priority documents to and from participating foreign intellectual property offices.

This system streamlines the process of obtaining certified copies of foreign priority applications, which is crucial for claiming priority in patent applications.

To learn more:

Cross-noting in patent applications refers to the process of recording and verifying information about prior applications, including U.S. and foreign applications, for which benefit or priority is claimed. This information is typically noted on the bibliographic data (bib-data) sheet of the application and is used to ensure accurate representation of priority claims on the front page of a printed patent.

According to MPEP 202, “The front page of a printed patent identifies all prior applications for which benefits are claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in continuation-in-part, continuation, divisional, and reissue applications.”

Copendency refers to the requirement that a later-filed application claiming the benefit of a prior-filed nonprovisional application must be filed before:

  • (A) the patenting of the prior application;
  • (B) the abandonment of the prior application; or
  • (C) the termination of proceedings in the prior application.

As stated in MPEP 211.01(b):

“If the prior application issues as a patent, it is sufficient for the later-filed application to be copending with it if the later-filed application is filed on the same date, or before the date that the patent issues on the prior application.”

This means that to maintain copendency, applicants should file any continuing applications no later than the date the issue fee is paid for the prior application.

To learn more:

Copendency refers to the requirement that a later-filed application claiming benefit of a prior application must be filed before the prior application is patented, abandoned, or proceedings are terminated. Copendency is crucial because:

  • It establishes a continuous chain of pending applications
  • It allows the later application to claim the earlier filing date
  • Without copendency, the benefit claim is improper

As stated in MPEP 211.01(b): “Copendency is defined in the clause which requires that the later-filed application must be filed before: (A) the patenting of the prior application; (B) the abandonment of the prior application; or (C) the termination of proceedings in the prior application.”

For patent applications filed before September 16, 2012 (pre-AIA), proper documentary evidence for establishing assignee rights typically includes:

  • An assignment document recorded in the USPTO
  • A statement under 37 CFR 3.73(b) signed by a party authorized to act on behalf of the assignee

According to MPEP 324: The submission establishing ownership must show that the person signing the submission is a person authorized to act on behalf of the assignee by:

  1. (A) Including a statement that the person signing the submission is authorized to act on behalf of the assignee; or
  2. (B) Being signed by a person having apparent authority to sign on behalf of the assignee, e.g., an officer of the assignee.

It’s crucial that the documentary evidence clearly shows the chain of title from the original owner to the current assignee. This ensures that the USPTO can verify the assignee’s right to take action in the application.

For more information on assignee rights, visit: assignee rights.

For more information on chain of title, visit: chain of title.

For more information on documentary evidence, visit: documentary evidence.

For more information on pre-AIA applications, visit: pre-AIA applications.

The MPEP provides guidance on what constitutes a valid mailing address for inventors in patent applications. According to MPEP 602.08(a):

“The inventor’s mailing address means that address at which he or she customarily receives his or her mail, even if it is not the main mailing address of the inventor. Either the inventor’s home or business address is acceptable as the mailing address. A post office box is also acceptable.”

The mailing address should include the ZIP Code designation. It’s important to note that the address of an attorney with instructions to forward communications is not sufficient, as the purpose is to enable direct communication between the USPTO and the inventor if necessary.

To learn more:

A preliminary amendment in patent applications refers to amendments made to the application before the first Office action. According to MPEP 608.04(b):

A preliminary amendment present on the filing date of the application (e.g., filed along with the filing of the application) is considered a part of the original disclosure.

This means that amendments submitted with the initial application filing are treated as part of the original disclosure. However, preliminary amendments filed after the application filing date are not considered part of the original disclosure.

To learn more:

A ‘new’ patent application is a nonprovisional application that has not yet received an action by the examiner. According to MPEP 203.01:

An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

It’s important to note that a request for continued examination (RCE) is not considered a new application filing.

For more information on new application, visit: new application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on RCE, visit: RCE.

According to MPEP 203.01, a ‘new’ application is defined as:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner. An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

It’s important to note that a request for continued examination (RCE) is not considered a new application filing.

What is considered a ‘good and sufficient reason’ to revoke a power of attorney by less than all applicants?

The USPTO does not provide a specific definition of what constitutes a ‘good and sufficient reason’ to revoke a power of attorney by less than all applicants. According to MPEP 402.10:

A power of attorney may not be revoked by less than all of the applicants or owners of the entire interest without good and sufficient reason, and the revocation must be approved by the Director.

The determination of what qualifies as a ‘good and sufficient reason’ is made on a case-by-case basis by the Director of the USPTO. Some potential reasons could include:

  • Evidence of misconduct or negligence by the current attorney
  • Irreconcilable differences between the applicant(s) and the attorney
  • Inability of the attorney to continue representation due to health issues or other circumstances

Applicants seeking to revoke a power of attorney with less than all signatures should provide a detailed explanation of their reasons for the request.

To learn more:

Proof of unavailability for a non-signing inventor can include various forms of evidence. According to MPEP 409.03(d):

In the case of unavailability, proof of the inability to find or reach the non-signing inventor after diligent effort must be submitted.

This proof may include:

  • Returned correspondence
  • Copies of email or other communication attempts
  • Statements from people with knowledge of the inventor’s unavailability
  • Documentation of searches or inquiries made to locate the inventor

The key is to demonstrate a diligent effort to locate and communicate with the non-signing inventor.

To learn more:

‘New matter’ refers to any subject matter that is added to a patent application after its filing date, which was not present in the original specification, claims, or drawings. The MPEP states: Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing is usually new matter. (MPEP 608.04(a))

New matter can include:

  • Addition of wholly unsupported subject matter
  • Adding specific percentages or compounds after a broader original disclosure
  • Omission of a step from a method

It’s important to note that new matter is not allowed in patent applications, as per 35 U.S.C. 132(a), which states: No amendment shall introduce new matter into the disclosure of the invention.

To learn more:

What is considered ‘diligent effort’ when trying to contact an inventor for joint invention?

When attempting to contact a joint inventor for patent application purposes, ‘diligent effort’ typically involves:

  • Multiple attempts to reach the inventor through various communication methods (e.g., phone, email, postal mail)
  • Reasonable time intervals between attempts
  • Documenting all contact attempts and responses (or lack thereof)
  • Exploring alternative contact methods if initial attempts fail

The MPEP 409.03(d) states: ‘Where inability to find or reach a nonsigning inventor ‘after diligent effort’ is the reason for filing under pre-AIA 37 CFR 1.47(b), a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.’ This emphasizes the importance of thoroughly documenting all efforts made to contact the inventor.

To learn more:

Antecedent basis in patent claims refers to the presence of support for claim terms in the specification. It is important because it ensures clarity and consistency between the claims and the specification. MPEP 608.01(o) states:

This is necessary in order to insure certainty in construing the claims in the light of the specification. See 37 CFR 1.75, MPEP § 608.01(i) and § 1302.01 and § 2103.

Proper antecedent basis helps prevent ambiguity in claim interpretation and strengthens the overall patent application. If the examiner finds that claims lack proper antecedent basis, they may object to the specification using form paragraph 7.44.

To learn more:

An unintentionally delayed priority claim occurs when a claim for foreign priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) is not presented within the time period provided by 37 CFR 1.55(d). In such cases, the claim is considered to have been waived but may be accepted if the delay was unintentional.

As stated in the MPEP: “If a claim for priority is considered to have been waived under this section, the claim may be accepted if the priority claim was unintentionally delayed.”

To learn more:

What is an S-signature in USPTO correspondence and how is it formatted?

An S-signature is an electronic signature used in correspondence with the USPTO. According to MPEP 502.02, an S-signature must be formatted as follows:

  • Inserted between forward slash marks: /John Doe/
  • Include the signer’s name
  • For registered practitioners, include their registration number
  • The signer’s name can be printed or typed
  • The signature must comply with 37 CFR 1.4(d)(2)

For example, a proper S-signature for a registered patent attorney might look like this:

/John Q. Attorney, Reg. No. 12345/

This format allows for efficient electronic filing while maintaining the legal weight of a signature.

To learn more:

An S-signature is an electronically created signature used in patent correspondence. According to MPEP 502.02:

An S-signature is a signature inserted between forward slash marks, but not a handwritten signature as defined by 37 CFR 1.4(d)(1). An S-signature includes any signature made by electronic or mechanical means, and any other mode of making or applying a signature other than a handwritten signature as provided for in 37 CFR 1.4(d)(1).

S-signatures must meet specific requirements to be considered valid:

  • They must be between two forward slash marks
  • They can include letters, numbers, and punctuation marks
  • They must be personally inserted by the signer
  • They must be reasonably specific to the signer

S-signatures provide a convenient way for applicants and practitioners to sign documents electronically while maintaining the legal weight of a handwritten signature.

To learn more:

An S-signature is a type of electronic signature used in USPTO correspondence. According to MPEP 501, which cites 37 CFR 1.4(d)(2):

An S-signature is a signature inserted between forward slash marks, but not a handwritten signature as defined by paragraph (d)(1) of this section. An S-signature includes any signature made by electronic or mechanical means, and any other mode of making or applying a signature other than a handwritten signature.

Key requirements for an S-signature include:

  • It must consist only of letters, Arabic numerals, or both, with appropriate punctuation.
  • The signer must insert their own S-signature with a single forward slash mark before and after the signature.
  • For patent practitioners, their registration number must be included with or near the S-signature.
  • The signer’s name must be presented in printed or typed form near the S-signature.

Example of a proper S-signature: /John D. Smith/

S-signatures can be used for most USPTO correspondence filed electronically or by facsimile.

For more information on USPTO correspondence, visit: USPTO correspondence.

An inventor’s certificate is a form of intellectual property protection offered in some countries. It can form the basis for priority rights under certain conditions, as stated in 35 U.S.C. 119(d):

Applications for inventors’ certificates filed in a foreign country in which applicants have a right to apply, at their discretion, either for a patent or for an inventor’s certificate shall be treated in this country in the same manner and have the same effect for purpose of the right of priority under this section as applications for patents…

This means that if an applicant had the option to file for either a patent or an inventor’s certificate in the foreign country, they can claim priority based on the inventor’s certificate application in the United States.

To learn more:

An international design application is a specific type of patent application for industrial designs. The definition of an international design application is provided in 37 CFR 1.9(n).

Key points about international design applications:

  • They are filed under the Hague Agreement Concerning the International Registration of Industrial Designs
  • They allow applicants to seek protection for industrial designs in multiple countries through a single application
  • They are administered by the World Intellectual Property Organization (WIPO)
  • They can designate the United States for design patent protection

For more information on international design applications, visit the WIPO Hague System page.

For more information on Hague Agreement, visit: Hague Agreement.

For more information on patent law, visit: patent law.

An international application in patent law refers to a patent application filed under the Patent Cooperation Treaty (PCT). The definition of an international application is provided in 37 CFR 1.9(b).

Key points about international applications:

  • They are filed under the PCT framework
  • They can potentially lead to patent protection in multiple countries
  • They undergo an international search and optional international preliminary examination
  • They must enter the national phase in desired countries to pursue patent protection

For more detailed information on international applications, refer to the World Intellectual Property Organization (WIPO) PCT resources.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For more information on patent law, visit: patent law.

The MPEP 201 defines an international application as follows:

“An international application is a patent application filed under the Patent Cooperation Treaty (PCT). An international application may be filed by a resident or national of the United States of America in the U.S. Patent and Trademark Office (USPTO) as a Receiving Office.”

Key points about international applications include:

  • They are governed by the Patent Cooperation Treaty (PCT).
  • They allow inventors to seek patent protection in multiple countries through a single application.
  • The USPTO can act as a Receiving Office for U.S. residents or nationals.
  • They enter a national phase in individual countries where protection is sought.

International applications provide a streamlined process for seeking patent protection in multiple countries, potentially saving time and resources for inventors and businesses operating globally.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

An interim copy of a foreign priority document is a copy that is submitted before the certified copy is available. The MPEP 213.02 provides guidance on when an interim copy is acceptable:

The Office may require that an ‘interim copy’ of the foreign application be furnished in the event that the certified copy of the foreign application is not filed within the time period set forth in 37 CFR 1.55(f) and an exception in 37 CFR 1.55(h), (i), or (j) is not applicable.

An interim copy must:

  • Be filed within the later of 4 months from the filing date of the application or 16 months from the filing date of the prior foreign application
  • Be a copy of the original foreign application
  • Be accompanied by a statement that the copy is a true copy

Note: An interim copy does not substitute the requirement for a certified copy, which must still be filed during the pendency of the application.

To learn more:

An Information Disclosure Statement (IDS) is a mechanism by which patent applicants can comply with the duty of disclosure provided in 37 CFR 1.56. It allows applicants to submit information that is material to patentability to the U.S. Patent and Trademark Office (USPTO).

According to the MPEP, The provisions of 37 CFR 1.97 and 37 CFR 1.98 provide a mechanism by which patent applicants may comply with the duty of disclosure provided in 37 CFR 1.56 using an IDS. This means that an IDS is a formal way to disclose relevant prior art and other information to the patent examiner.

To learn more:

Tags: prior art, USPTO

An incomplete patent application is one that is not entitled to a filing date because it lacks some of the essential parts required by the United States Patent and Trademark Office (USPTO). As stated in MPEP 203.06:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

This means that the application is missing crucial components necessary for it to be considered a complete submission and to receive an official filing date from the USPTO.

To learn more:

An extract of an original document refers to a portion or summary of the original assignment document that contains the essential information required for recording. Both 37 CFR 3.24(a) and (b) state that “Either a copy of the original document or an extract of the original document may be submitted for recording.”

When submitting an extract:

  • Ensure it includes all relevant assignment details.
  • The extract must meet the same format requirements as a full copy.
  • It should be clear that the extract represents the key elements of the original document.

Using an extract can be beneficial when the original document contains confidential information not necessary for the assignment record.

An e-IDS (electronic Information Disclosure Statement) is a way to submit information disclosure statements to the USPTO electronically. According to MPEP 609.07:

Information disclosure statements may be submitted to the Office via the USPTO patent electronic filing system. Applicants can file an e-IDS using EFS-Web by (A) entering the references’ citation information in an electronic data entry form, equivalent to the paper PTO/SB/08 form, and (B) transmitting the electronic data entry form to the Office.

This electronic submission method allows for efficient filing of IDSs, particularly for U.S. patents and patent application publications.

To learn more:

An application number consists of a series code and a serial number. It is assigned by the Office of Patent Application Processing (OPAP) immediately after mail has been opened. For applications filed using the USPTO patent electronic filing system, EFS-Web provides an Acknowledgement Receipt containing a time and date stamp, application number, and confirmation number.

The MPEP states: ‘Application numbers consisting of a series code and a serial number are assigned by the Office of Patent Application Processing (OPAP) immediately after mail has been opened.’ (MPEP 503)

An application filed by reference under 35 U.S.C. 111(c) is a method of filing a nonprovisional patent application where the applicant refers to a previously filed application instead of submitting a new specification and drawings. Key points about this type of filing include:

  • It’s available for applications filed on or after December 18, 2013.
  • The reference must be made in English in an Application Data Sheet (ADS).
  • The reference must specify the previously filed application by application number, filing date, and the intellectual property authority or country where it was filed.
  • The applicant must submit a copy of the specification and drawings from the previously filed application within a specified time period.

The MPEP states: a reference made upon the filing of an application under 35 U.S.C. 111(a) to a previously filed application, indicating that the specification and any drawings of the application under 35 U.S.C. 111(a) are replaced by the reference to the previously filed application, and specifying the previously filed application by application number, filing date, and the intellectual property authority or country in which the previously filed application was filed, shall constitute the specification and any drawings of the application under 35 U.S.C. 111(a) for purposes of a filing date under § 1.53(b).

To learn more:

To learn more:

Tags: USPTO

An Application Data Sheet (ADS) is a voluntary submission for patent applications filed before September 16, 2012, that contains bibliographic data arranged in a specific format. According to MPEP 601.05(b), “An application data sheet is a sheet or sheets, that may be voluntarily submitted in either provisional or nonprovisional applications, which contains bibliographic data, arranged in a format specified by the Office.” The ADS becomes part of the application and must be titled “Application Data Sheet.”

To learn more:

An Application Data Sheet (ADS) is a document that provides bibliographic data for a patent application. For applications filed by assignees, obligated assignees, or those with sufficient proprietary interest, the ADS is crucial. According to MPEP 409.05:

‘The applicant under 37 CFR 1.46 (assignees and obligated assignees) must record the assignment, or submit the documentary evidence to the Office, preferably before issuing the filing receipt.’

The ADS must include:

  • The name of the inventor(s)
  • A statement that the application is being filed by the assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest
  • If filed by an obligated assignee, a statement that the application is being filed by a party who has a contractual obligation to assign or is under an obligation to assign the invention

The ADS serves as the official record of the applicant’s status and helps ensure that the USPTO properly recognizes the applicant’s right to file the application.

To learn more:

An Application Data Sheet (ADS) is a document containing bibliographic data for a patent application, arranged in a format specified by the USPTO. According to MPEP 601.05, an ADS:

  • May be submitted voluntarily in provisional or nonprovisional applications
  • Must be submitted when required by 37 CFR 1.55 and 1.78 to claim priority to or benefit of a prior-filed application
  • Must be titled “Application Data Sheet”
  • Becomes part of the application when provided

The USPTO prefers the use of an ADS in all applications to help facilitate electronic capturing of important data.

To learn more:

To learn more:

An Application Data Sheet (ADS) is a document that provides bibliographic data for patent applications. Its use and importance are described in the MPEP:

“If an application data sheet (37 CFR 1.76) is used, data supplied in the application data sheet need not be provided elsewhere in the application with one exception for applications filed before September 16, 2012.”

Key points about the ADS include:

  • It simplifies the filing process by consolidating important information in one place.
  • Information in the ADS generally takes precedence over conflicting information elsewhere in the application.
  • For applications filed before September 16, 2012, citizenship of inventors must still be provided in the oath or declaration, even if included in the ADS.
  • The ADS controls most information except for the naming of inventors, which is governed by 37 CFR 1.41.

For more detailed information on the Application Data Sheet, refer to MPEP § 601.05.

To learn more:

An abandoned patent application is one that has been removed from the Office docket of pending applications. According to MPEP 203.05, this can occur in several ways:

  • Through formal abandonment by the applicant or their attorney/agent
  • Due to failure of the applicant to take appropriate action during prosecution
  • For failure to pay the issue fee
  • In the case of a provisional application, no later than 12 months after the filing date

As stated in MPEP 203.05: An abandoned application is, inter alia, one which is removed from the Office docket of pending applications. The specific reasons for abandonment are listed in the same section.

An ‘original’ application in patent law refers to an application that is not a reissue application. The MPEP states:

“Original” application is used in the patent statutes and rules to refer to an application which is not a reissue application. An original application may be a first filing or a continuing application.

This means that an original application can be either:

  • The first filing of a patent application for an invention
  • A continuing application (continuation, divisional, or continuation-in-part) filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78

To learn more:

An ‘obligated assignee’ in patent applications refers to a person or entity who is under an obligation to assign the invention but has not yet executed an assignment. This concept is important in the context of MPEP 409.05, which states:

An assignee or obligated assignee who is the applicant may execute a substitute statement under 37 CFR 1.64 in lieu of an inventor’s oath or declaration.

This provision allows an obligated assignee to file a patent application and execute certain documents on behalf of the inventor, even if the formal assignment has not yet been completed.

To learn more:

To learn more:

An ‘interim copy’ is a true copy of the original foreign application that an applicant can file to meet the timeliness requirement when they cannot obtain a certified copy within the time limit. According to 37 CFR 1.55(j), the interim copy must be clearly labeled as ‘Interim Copy’ and filed with a cover sheet stating it is a true copy of the original foreign application.

An ‘interim copy’ is a mechanism provided by 37 CFR 1.55(j) that allows applicants to meet the timeliness requirement for submitting a certified copy of a foreign application. It’s a copy of the original foreign application that the applicant can provide from their own records when they cannot obtain a certified copy within the time limit set by 37 CFR 1.55(f).

The MPEP states: 37 CFR 1.55(j) permits an applicant to provide an ‘interim copy’ of the original foreign application from the applicant’s own records to provide for the situation in which the applicant cannot obtain a certified copy of the foreign application within the time limit set forth in 37 CFR 1.55(f), although there is no requirement that an applicant be unable to obtain a certified copy of the foreign application within the time limit set forth in 37 CFR 1.55(f) to use 37 CFR 1.55(j).

To learn more:

An ‘interim copy’ is a copy of the original foreign application from the applicant’s own records that can be submitted to satisfy the timeliness requirement for certified copies. According to 37 CFR 1.55(j):

  • The copy must be clearly labeled as ‘Interim Copy’
  • It must be filed with a cover sheet identifying the foreign application
  • It must be filed within the same time period as required for certified copies
  • A certified copy must still be filed during the pendency of the application

This provision allows applicants to meet the deadline even if they cannot obtain a certified copy in time, although there is no requirement to show inability to obtain a certified copy to use this option.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

37 CFR 1.55(j) allows an applicant to provide an ‘interim copy’ of the original foreign application to satisfy the requirement for a certified copy to be filed within the time limit set in 37 CFR 1.55(f). An interim copy must:

  • Be clearly labeled as ‘Interim Copy’
  • Include the specification, drawings, and claims of the foreign application
  • Be filed with a separate cover sheet identifying the foreign application
  • Be filed within the later of 16 months from the foreign filing date or 4 months from the actual U.S. filing date

A certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g).

To learn more:

An ‘assignment-statement’ is a relatively new concept in patent law, introduced for applications filed on or after September 16, 2012. The MPEP explains:

‘For applications filed under 35 U.S.C. 111(a), 363, or 385 on or after September 16, 2012, an assignment may contain the statements required to be made in an oath or declaration (‘assignment-statement’), and if the assignment is made of record in the assignment records of the Office, then the assignment may be utilized as the oath or declaration.’

This means that for qualifying applications, the assignment document can serve a dual purpose:

  1. Transferring ownership of the patent application
  2. Fulfilling the requirement for an oath or declaration

This provision can simplify the application process by combining two previously separate documents. The MPEP cites 35 U.S.C. 115(e), 37 CFR 1.63(e), and MPEP §§ 302.07, 317, and 602.01(a) for further details on this practice.

An ‘amended’ nonprovisional patent application is one that has undergone a specific process in the examination procedure. According to MPEP 203.03:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action.

In simpler terms, it means that after the patent examiner has reviewed and responded to the application, the applicant has then taken some action in response to the examiner’s feedback.

To learn more:

An ‘allowed’ patent application is one that has been examined and determined to meet all statutory requirements. According to MPEP 203.04:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant.

The status of ‘allowed’ continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue or becomes abandoned for failure to pay the issue fee and any required publication fee.

For more information on allowed application, visit: allowed application.

For more information on notice of allowance, visit: notice of allowance.

For more information on patent issuance, visit: patent issuance.

A utility patent application is filed under 35 U.S.C. 101 for “a new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof”. Utility patent applications are sometimes referred to as “utility” patent applications when being contrasted with plant or design patent applications.

The MPEP states: “The first type of patent application is sometimes referred to as a ‘utility’ patent application when being contrasted with a plant or design patent application.”

What is a USPTO deposit account and how does it work?

A USPTO deposit account is a pre-established account that allows for convenient payment of fees to the United States Patent and Trademark Office. According to MPEP 509:

“A deposit account is a convenient method for individuals or firms to establish a pre-paid account with the USPTO to facilitate the payment of fees.”

Here’s how USPTO deposit accounts work:

  • You deposit funds into the account in advance
  • Fees can be automatically deducted from the account when filing applications or paying other fees
  • Minimum balance requirements apply (currently $1,000 for individuals, $5,000 for law firms)
  • Account holders receive monthly statements
  • Useful for frequent filers or those managing multiple applications

To open a deposit account, you need to complete Form PTO-2232 and submit it to the USPTO with an initial deposit. This method can streamline fee payments and reduce the risk of insufficient fee issues.

To learn more:

To learn more:

A USPTO deposit account is a convenient method for attorneys and the general public to pay fees and order services from the U.S. Patent and Trademark Office. To establish a deposit account:

  • Pay the fee for establishing a deposit account as per 37 CFR 1.21(b)(1)
  • Make a minimum deposit of $1,000 for general use
  • Alternatively, make a minimum deposit of $300 for a restricted subscription deposit account used exclusively for subscription orders of patent copies

As stated in the MPEP: For the convenience of attorneys, and the general public in paying any fees due, in ordering services offered by the Office, copies of records, etc., deposit accounts may be established in the Patent and Trademark Office upon payment of the fee for establishing a deposit account § 1.21(b)(1).

To learn more:

A transition application under the America Invents Act (AIA) is:

  • Filed on or after March 16, 2013
  • Claims foreign priority to or domestic benefit of an application filed before March 16, 2013

Transition applications may be subject to either pre-AIA or AIA rules depending on the effective filing date of the claimed inventions. The MPEP states: “Transition applications are either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications depending on the effective filing date of the claimed invention(s).” (MPEP 210)

A transition application under the America Invents Act (AIA) is:

  • A nonprovisional application filed on or after March 16, 2013
  • That claims foreign priority to, or domestic benefit of, an application filed before March 16, 2013

Transition applications can be either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications, depending on the effective filing date of the claimed invention(s).

The MPEP states: “Transition applications are nonprovisional applications that: (A) are filed on or after March 16, 2013; and (B) claim foreign priority to, or domestic benefit of, an application filed before March 16, 2013. Transition applications are either pre-AIA first-to-invent applications or AIA first-inventor-to-file applications depending on the effective filing date of the claimed invention(s).”

A title report in patent law is a form used by the Assignment Division of the USPTO to report the name of the owner of an application or patent as shown by their records on a specific date. According to the MPEP:

The “title report” is a form which can be used under certain circumstances by the Assignment Division to report to someone within the Office the name of the owner of an application or patent as shown by the Assignment Division records on the date the title report is made.

These reports are used internally within the USPTO and are not available for direct request by applicants or attorneys.

A supplemental oath or declaration is a document that can be submitted to correct deficiencies or inaccuracies in an earlier-filed inventor’s oath or declaration. According to MPEP 603, it is provided for under 35 U.S.C. 115(h) and 37 CFR 1.67.

The MPEP states: 37 CFR 1.67(a) provides that the applicant may submit an inventor’s oath or declaration meeting the requirements of 37 CFR 1.63, 1.64, or 1.62 to correct any deficiencies or inaccuracies present in an earlier-filed inventor’s oath or declaration.

It’s important to note that while corrections can be made, no new matter may be introduced into a nonprovisional application after its filing date even if an inventor’s oath or declaration is filed to correct deficiencies or inaccuracies present in the earlier-filed oath or declaration.

To learn more:

A substitute statement is a document that can be executed in lieu of an oath or declaration in certain circumstances. According to 37 CFR 1.64(a), “An applicant under § 1.43, 1.45 or 1.46 may execute a substitute statement in lieu of an oath or declaration under § 1.63 if the inventor is deceased, is under a legal incapacity, has refused to execute the oath or declaration under § 1.63, or cannot be found or reached after diligent effort.

This provision allows certain parties to move forward with a patent application when the inventor is unavailable or unwilling to sign the required documents.

To learn more:

To learn more:

A substitute statement is a document that can be used in place of an oath or declaration in patent applications involving deceased or legally incapacitated inventors. According to MPEP 409.01(a):

See 37 CFR 1.64 and MPEP § 604 concerning the execution of a substitute statement by a legal representative in lieu of an oath or declaration.

The substitute statement can be executed by:

  • A legal representative of the deceased or incapacitated inventor
  • An assignee or obligated assignee
  • A party with sufficient proprietary interest in the invention

This allows the application process to continue even when the inventor is unable to provide an oath or declaration due to death or incapacity. The substitute statement must comply with the requirements set forth in 37 CFR 1.64.

To learn more:

A substitute statement is a document that can be filed in place of an oath or declaration when the inventor is deceased, legally incapacitated, cannot be found or reached after diligent effort, or refuses to execute the oath or declaration. According to MPEP 602:

’35 U.S.C. 115(d) provides that ‘the applicant for patent’ may provide a substitute statement under the circumstances described in 35 U.S.C. 115(d)(2). The applicant for patent is defined in 35 U.S.C. 100(g) as ‘the inventor or joint inventors who are applying for a patent through their assignee, obligated assignee, or person who otherwise shows sufficient proprietary interest in the matter.’

The substitute statement must:

  • Identify the inventor to whom it relates
  • Identify the circumstances permitting the filing of the substitute statement
  • Include a statement that the person executing the substitute statement has reviewed and understands the contents of the application
  • Include a statement that the person executing the substitute statement acknowledges the duty to disclose information material to patentability

This provision allows for the continuation of the patent application process even when the inventor is unable or unwilling to execute the oath or declaration.

To learn more:

What is a substitute statement for a deceased inventor and when is it required?

A substitute statement is a document that replaces the inventor’s oath or declaration when the inventor is deceased, legally incapacitated, or otherwise unavailable. For a deceased inventor, it is required when filing a patent application on or after September 16, 2012.

According to MPEP 409.01(a):

The substitute statement must comply with the requirements of 35 U.S.C. 115(d) and 37 CFR 1.64.

The substitute statement must:

  • Identify the inventor to whom it applies
  • Identify the person executing the substitute statement
  • Include a statement that the person executing the substitute statement believes the named inventor to be the original inventor
  • State the circumstances permitting the person to execute the substitute statement (e.g., the inventor’s death)

This statement allows the patent application process to proceed in cases where the inventor cannot personally execute the required oath or declaration.

To learn more:

What is a substitute statement and when can it be used instead of an oath or declaration?

A substitute statement is a document that can be filed in place of an oath or declaration under certain circumstances. According to MPEP 602:

“When an inventor is deceased, legally incapacitated, cannot be found or reached after diligent effort, or refuses to execute an oath or declaration, the applicant under 37 CFR 1.43, 1.45 or 1.46 may execute a substitute statement in lieu of an oath or declaration.”

The substitute statement can be used in the following situations:

  • The inventor is deceased
  • The inventor is legally incapacitated
  • The inventor cannot be found or reached after diligent effort
  • The inventor refuses to execute the oath or declaration

The substitute statement must:

  • Identify the inventor to whom it applies
  • State the circumstances justifying its use
  • Include an acknowledgment that willful false statements are punishable by fine or imprisonment

It’s important to note that the substitute statement must be signed by the appropriate party as specified in 37 CFR 1.64, which may include the applicant or an assignee.

To learn more:

A substitute statement is a document that can be used in place of an inventor’s oath or declaration under certain circumstances. According to 37 CFR 1.64, an applicant may execute a substitute statement if the inventor:

  • Is deceased
  • Is under a legal incapacity
  • Has refused to execute the oath or declaration
  • Cannot be found or reached after diligent effort

The substitute statement must comply with specific requirements outlined in 37 CFR 1.64(b), including identifying the inventor, the person executing the statement, and the circumstances permitting its use. For more details on substitute statements, see MPEP § 604.

To learn more:

A substitute statement is a document that can be used in lieu of an inventor’s oath or declaration under certain circumstances. According to MPEP § 409.05, a substitute statement can be used when the inventor:

  • Is deceased
  • Is under a legal incapacity
  • Cannot be found or reached after diligent effort
  • Has refused to execute the oath or declaration

The substitute statement must comply with the requirements of 37 CFR 1.64, including identifying the inventor, the person executing the statement, and the circumstances permitting its use.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on substitute statement, visit: substitute statement.

A substitute specification is a rewritten version of the entire specification or a part of it in a patent application. It may be required by the USPTO or voluntarily submitted by the applicant under certain conditions.

According to 37 CFR 1.125(a):

If the number or nature of the amendments or the legibility of the application papers renders it difficult to consider the application, or to arrange the papers for printing or copying, the Office may require the entire specification, including the claims, or any part thereof, be rewritten.

This provision allows the USPTO to request a substitute specification when necessary for clarity and ease of examination.

To learn more:

A substitute application is a type of national application that is filed to replace a previously filed non-provisional or provisional application. It is used when an applicant wants to start over with a new application while maintaining the benefit of the earlier filing date for common subject matter.

Key points about substitute applications:

  • They are treated as new applications and receive a new application number.
  • The previously filed application is considered to be abandoned as of the filing date of the substitute application.
  • Substitute applications can claim the benefit of the earlier application’s filing date for common subject matter.
  • They must be filed while the earlier application is still pending.
  • Applicants must file a copy of the original application, specification, drawings, and amendments, if any, and a new oath or declaration.

For more information, see MPEP 201.09 and 37 CFR 1.53.

A statutory declaration is an alternative to a traditional oath or declaration in patent applications. According to MPEP 602, “Office personnel are authorized to accept a statutory declaration under 28 U.S.C. 1746 filed in the U.S. Patent and Trademark Office in lieu of an ‘oath’ or declaration under 35 U.S.C. 25 and 37 CFR 1.68, provided the statutory declaration otherwise complies with the requirements of law.” This allows applicants to submit a written statement under penalty of perjury, which can be executed within or outside the United States, without the need for a notary or other official to administer an oath.

To learn more:

To learn more:

A statement under 37 CFR 1.97(e) is a declaration that either:

  1. Each item of information in the IDS was first cited in a foreign patent office communication no more than 3 months prior to the IDS filing, or
  2. No item in the IDS was cited by a foreign patent office, and no item was known to anyone with a duty of disclosure more than 3 months prior to the IDS filing.

This statement is required when submitting an IDS after a first Office action but before a final Office action, Notice of Allowance, or Quayle action, unless a fee is paid. It’s also required when submitting an IDS after a final Office action, Notice of Allowance, or Quayle action (along with the fee).

As stated in MPEP 609.04(b): “A statement under 37 CFR 1.97(e) can contain either of two statements. One statement is that each item of information in an information disclosure statement was first cited in any communication, such as a search report, from a patent office outside the U.S. in a counterpart foreign application not more than three months prior to the filing date of the statement.”

To learn more:

To learn more:

A Secrecy Order is an official directive issued by the Commissioner for Patents when notified by the chief officer of a defense agency that publication or disclosure of an invention through a patent grant would be detrimental to national security. As stated in 37 CFR 5.2(a):

When notified by the chief officer of a defense agency that publication or disclosure of the invention by the granting of a patent would be detrimental to the national security, an order that the invention be kept secret will be issued by the Commissioner for Patents.

This order restricts disclosure of the invention and delays the grant of a patent until the order is rescinded.

A Secrecy Order is a directive issued by the Commissioner for Patents to keep an invention secret and withhold the publication of a patent application or the grant of a patent. It is issued when:

  1. A defense agency concludes that disclosure of the invention would be detrimental to national security
  2. The agency recommends a Secrecy Order to the Commissioner for Patents

According to 35 U.S.C. 181, Whenever publication or disclosure by the publication of an application or by the grant of a patent on an invention in which the Government has a property interest might, in the opinion of the head of the interested Government agency, be detrimental to the national security, the Commissioner of Patents upon being so notified shall order that the invention be kept secret and shall withhold the publication of an application or the grant of a patent therefor under the conditions set forth hereinafter.

The Secrecy Order remains in effect for such period as the national interest requires, effectively preventing public disclosure of the invention.

For more information on patent applications, visit: patent applications.

A retroactive foreign filing license is a license granted after an unlicensed foreign filing has already occurred. Key points include:

  • It can be requested through a petition under 37 CFR 5.25.
  • The unlicensed filing must have occurred through error.
  • Specific requirements in 37 CFR 5.25 must be met, including providing detailed information about each unlicensed filing.
  • A verified statement (oath or declaration) explaining the error is required.

The MPEP states: “A petition for a retroactive filing license may be filed under 37 CFR 5.25 if an unlicensed foreign filing has occurred through error. However, the requirements of 37 CFR 5.25 must be fulfilled in order for such a petition to be granted.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

A Request to Delete a Named Inventor in a Continued Prosecution Application (CPA) for Design Applications is a procedure that allows for the correction of inventorship when filing a CPA. This request is specifically used to remove the name(s) of person(s) who are not inventors of the invention being claimed in the new application.

According to MPEP ¶ 2.32:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This paragraph confirms that the USPTO recognizes and processes such requests when submitted with a CPA filing.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

What is a reissue patent application?

A reissue patent application is a request to correct an error in an already issued patent that renders the patent wholly or partly inoperative or invalid. As stated in MPEP 201:

An application for reissue is an application for a new patent to replace an unexpired patent that is defective in some one or more particulars.

Key aspects of reissue applications include:

  • Can be filed only by the original patent owner
  • Must be filed during the term of the original patent
  • Can broaden claim scope only within two years of the original patent grant
  • Requires a declaration stating the error and that it occurred without deceptive intent

Reissue applications are crucial for patent owners to correct mistakes or oversights in their original patents, ensuring their intellectual property rights are properly protected. However, they cannot be used to add new matter to the patent disclosure.

For more information on Patent correction, visit: Patent correction.

A reissue application is a type of patent application used to correct defects in an existing, unexpired patent. According to MPEP 201.05, “A reissue application is an application for a patent to take the place of an unexpired patent that is defective.” This process allows patent holders to address errors or omissions in their original patent, ensuring that their intellectual property rights are properly protected.

To learn more:

A reissue application is a type of patent application used to correct errors in an already issued patent. According to MPEP 201:

“An application for reissue of a patent is an application for a new patent to correct an error in an existing patent.”

Reissue applications are filed when the original patent is wholly or partly inoperative or invalid due to defective specifications, drawings, or by claiming more or less than the patentee had the right to claim. They must be filed by the original patent owner and are subject to specific requirements outlined in 35 U.S.C. 251.

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue application, visit: reissue application.

A reissue application is a type of application used to correct an error in an issued patent that renders the patent wholly or partly inoperative or invalid. It is governed by 35 U.S.C. 251 and 37 CFR 1.171-1.179. Reissue applications are typically filed when the original patent claims are too narrow or too broad, or when there are other errors that affect the scope or validity of the patent. For more information on reissue applications, refer to MPEP 1401.

A provisional patent application is a type of U.S. patent application that allows inventors to establish an early filing date for their invention without the need for a formal patent claim or oath/declaration. According to MPEP 201.04, a provisional application is defined as:

“A provisional application as used in this chapter means a U.S. national application for patent filed in the Office under 35 U.S.C. 111(b).”

Provisional applications are simpler and less expensive to file than regular nonprovisional applications, but they are not examined for patentability and automatically expire after 12 months.

To learn more:

A provisional patent application is a type of patent application that allows inventors to establish an early filing date for their invention. Key differences between provisional and nonprovisional applications include:

  • Provisional applications are not examined and automatically expire after 12 months
  • Provisional applications require fewer formal components than nonprovisional applications
  • Provisional applications cannot directly result in a granted patent

The MPEP states: A provisional application will not be examined. However, a provisional application which does not include a cover sheet (37 CFR 1.51(c)(1)), which may be an application data sheet (37 CFR 1.76) or a cover letter, identifying the application as a provisional application, will be treated as a nonprovisional application filed under 37 CFR 1.53(b).

To obtain a filing date, a provisional application must include:

  • A specification as prescribed by 35 U.S.C. 112(a)
  • Any necessary drawings
  • The appropriate filing fee

Inventors often use provisional applications to secure an early filing date while allowing additional time to prepare a more comprehensive nonprovisional application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

A provisional application for patent is a type of U.S. patent application that allows inventors to establish an early filing date for their invention without filing a formal patent claim or any information disclosure statement. Key points about provisional applications include:

1. They provide a 12-month pendency from the date of filing.
2. They cannot be extended beyond 12 months.
3. They are not examined on their merits.
4. They can serve as a priority document in foreign filing.
5. They require a specification and drawing(s) if necessary to understand the invention.
6. They do not require formal patent claims or an oath or declaration.

Inventors must file a corresponding nonprovisional application within 12 months to claim the benefit of the provisional application’s filing date. For more details, see USPTO’s Provisional Application for Patent and MPEP 201.04(b).

What is a provisional application and how does it affect priority?

A provisional application is a type of patent application that allows inventors to establish an early filing date without a formal patent claim or oath or declaration. Key points about provisional applications and their effect on priority include:

  • Provisional applications provide a 12-month pendency period.
  • They can be used to establish an early effective filing date for a later-filed nonprovisional application.
  • The later-filed nonprovisional must be filed within 12 months of the provisional to claim its benefit.

According to MPEP 210: “The later-filed application must contain or be amended to contain a specific reference to the prior application(s) in the first sentence(s) of the specification or in an application data sheet.”

It’s important to note that the subject matter in the nonprovisional application must be fully supported by the provisional application to receive its priority date. If new matter is added, those portions will only receive the filing date of the nonprovisional application.

For more information on effective filing date, visit: effective filing date.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

A pre-AIA 37 CFR 1.47 application is a patent application filed before September 16, 2012, where not all inventors have signed the application. This provision allows for the filing of a patent application when an inventor cannot be reached or refuses to sign.

According to the MPEP, A filing date is assigned to an application deposited pursuant to pre-AIA 37 CFR 1.47 provided the requirements of 37 CFR 1.53(b) are met. This means that as long as the basic filing requirements are fulfilled, the application can be processed even without all inventors’ signatures.

To learn more:

To learn more:

A plant patent application is filed under 35 U.S.C. 161 for whoever “invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state”.

The MPEP cites 35 U.S.C. 161: “Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state, may obtain a patent therefor, subject to the conditions and requirements of this title.”

What is a PCT application in international patent law?

A PCT (Patent Cooperation Treaty) application is an international patent application that provides a unified procedure for filing patent applications to protect inventions in its contracting states. According to MPEP 201.02:

“An international application is a patent application filed under the Patent Cooperation Treaty (PCT).”

Key features of PCT applications include:

  • Single filing procedure for seeking patent protection in multiple countries
  • Standardized national phase entry at 30 months from the earliest priority date
  • International search report and written opinion on patentability
  • Option for international preliminary examination

PCT applications simplify the process of seeking patent protection internationally, providing applicants with more time and information to make decisions about pursuing patents in specific countries.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

A Notice of Omitted Items is an official communication from the USPTO regarding missing elements in a patent application. As described in MPEP 601.01(f):

“If drawings are omitted in an application filed under 35 U.S.C. 111(a) on or after December 18, 2013, but the application contains something that can be construed as a written description, at least one drawing, if necessary under 35 U.S.C. 113 (first sentence), and, in a nonprovisional application, at least one claim, the Office will not deny a filing date.”

In such cases, the USPTO will issue a Notice of Omitted Items, informing the applicant of the missing drawings and providing a two-month period to submit them. This notice is crucial as it sets the deadline for completing the application and avoiding abandonment.

To learn more:

To learn more:

According to MPEP 201, a nonprovisional application for patent is the standard type of patent application. The MPEP states:

“A nonprovisional application for patent filed under 35 U.S.C. 111(a) must include a specification, including a claim or claims, drawings when necessary, an oath or declaration, and the prescribed filing fee, search fee, examination fee and application size fee.”

This type of application is examined by the USPTO and can potentially lead to the grant of a patent. It requires a detailed description of the invention, claims defining the scope of protection sought, and often includes drawings to illustrate the invention.

For more information on declaration, visit: declaration.

For more information on drawings, visit: drawings.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on oath, visit: oath.

A national application, as described in MPEP 201.01, is a U.S. patent application filed under 35 U.S.C. 111(a) or 35 U.S.C. 111(b). The MPEP states: A national application may be a nonprovisional application or a provisional application. National applications are distinct from international applications and are processed directly by the United States Patent and Trademark Office (USPTO).

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

According to 37 CFR 1.9(a)(1), a national application is defined as:

  • A U.S. application for patent filed in the USPTO under 35 U.S.C. 111
  • An international application filed under the Patent Cooperation Treaty in which the basic national fee under 35 U.S.C. 41(a)(1)(F) has been paid
  • An international design application filed under the Hague Agreement in which the USPTO has received a copy of the international registration pursuant to Hague Agreement Article 10

This definition encompasses various types of patent applications that are treated as national applications by the USPTO.

A multiple dependent claim is a dependent claim that refers back in the alternative to more than one preceding independent or dependent claim. According to MPEP 608.01(n), “35 U.S.C. 112(e) authorizes multiple dependent claims in applications as long as they are in the alternative form (e.g., ‘A machine according to claims 3 or 4, further comprising —‘).”

Multiple dependent claims must be in the alternative form and cannot refer to other multiple dependent claims. They are subject to additional fees and specific formatting requirements.

To learn more:

A juristic entity, in the context of patent applications, typically refers to an organizational assignee such as a company or corporation. According to MPEP 401, juristic entities have special requirements:

“An applicant who is a juristic entity must be represented by a patent practitioner.”

This means that companies or other organizational entities cannot represent themselves in patent applications and must hire a registered patent attorney or agent to act on their behalf.

A foreign filing license is permission granted by the USPTO to file a patent application in a foreign country. It is required when:

  • An invention was made in the United States, and
  • A US application has been filed less than 6 months ago, or
  • No US application has been filed yet

As stated in 37 CFR 5.11(a): “A license from the Commissioner for Patents under 35 U.S.C. 184 is required before filing any application for patent… in a foreign country… if the invention was made in the United States.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

A filing receipt is an official document issued by the USPTO that contains important information about a patent application. According to MPEP 503, the filing receipt includes:

  • Application number
  • Filing date
  • Confirmation number
  • Suggested U.S. Patent Classification class
  • Art unit where the application is likely to be examined
  • Continuing data (if applicable)
  • National stage data (if applicable)
  • Foreign priority data (if applicable)
  • Foreign filing license data (if applicable)
  • Entity status information
  • Anticipated publication date under 35 U.S.C. 122(b)

The MPEP states: “The filing receipt represents the official assignment by the USPTO of a specific application number and confirmation number to a particular application.” It’s important to review the filing receipt for accuracy, especially regarding inventor and applicant names, benefit and priority claims, and any nonpublication requests.

For more information on application number, visit: application number.

For more information on confirmation number, visit: confirmation number.

For more information on filing receipt, visit: filing receipt.

A domestic representative is a person residing within the United States who can be served process or notice of proceedings affecting a patent or rights thereunder on behalf of a foreign assignee. According to MPEP 302.04, An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative. This allows foreign assignees to have a point of contact within the U.S. for legal matters related to their patent.

To learn more:

A divisional application is a later application for an independent or distinct invention, carved out of a nonprovisional application. It discloses and claims only subject matter disclosed in the earlier or parent application. As stated in MPEP 201.06:

A later application for an independent or distinct invention, carved out of a nonprovisional application (including a nonprovisional application resulting from an international application or international design application), an international application designating the United States, or an international design application designating the United States and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application.

To learn more:

A divisional application under 37 CFR 1.53(b) is a type of continuation application that is filed to pursue a distinct invention that was disclosed but not claimed in a prior nonprovisional application. According to the MPEP:

‘A divisional application is often filed as a result of a restriction requirement made by the examiner.’

Divisional applications allow inventors to protect multiple inventions disclosed in a single parent application by filing separate applications for each invention.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

A divisional application is a type of patent application that claims subject matter that is independent and distinct from that claimed in a prior application. It typically arises when an original application contains multiple inventions, and the Patent Office requires the applicant to restrict the claims to a single invention.

According to MPEP ¶ 2.01, a divisional application:

“appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application, and names the inventor or at least one joint inventor named in the prior application.”

To claim the benefit of the filing date of the prior application, applicants must comply with 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

A designated office is a national patent office of a country that has been ‘designated’ by an applicant in an international patent application filed under the Patent Cooperation Treaty (PCT). In the context of MPEP 602.07, the United States Patent and Trademark Office (USPTO) acts as a designated office when an applicant enters the national phase in the U.S. after filing an international PCT application.

When the USPTO acts as a designated office, specific requirements for oaths or declarations may apply. MPEP 602.07 directs readers to MPEP § 1893.01(e) for more detailed information on these requirements.

To learn more:

A design patent application is a type of patent application that protects the ornamental design of a functional item. It is governed by 35 U.S.C. 171-173 and focuses on the visual characteristics of an article of manufacture. Unlike utility patents, design patents do not protect the functional aspects of an invention. Design patent applications have specific requirements for drawings and claim format. For more information on design patent applications, refer to MPEP 1501.

Design patent applications and utility patent applications are two distinct types of patent applications that protect different aspects of inventions. According to MPEP 201:

  • Design Patent Application: “An application for a design patent filed under 35 U.S.C. 171 may be referred to as a design application.” Design patents protect the ornamental appearance of an article of manufacture.
  • Utility Patent Application: These applications protect the functional aspects of an invention, including processes, machines, articles of manufacture, and compositions of matter.

The key differences are:

  1. Subject Matter: Design patents cover appearance, while utility patents cover functionality.
  2. Duration: Design patents last for 15 years from issuance, while utility patents last for 20 years from the filing date.
  3. Examination Process: Design patent applications typically have a simpler examination process.

For more details on utility patents, refer to 35 U.S.C. 101, and for design patents, see 35 U.S.C. 171.

For more information on design patent, visit: design patent.

For more information on patent applications, visit: patent applications.

A delayed benefit claim in patent applications refers to a situation where an applicant fails to submit the required reference to a prior application within the specified time period. In such cases, the applicant may file a petition for an unintentionally delayed claim.

According to MPEP 211.04, the petition must include:

  • The reference to the prior application
  • A petition fee
  • A statement that the entire delay was unintentional

The MPEP states: “If the reference required by 35 U.S.C. 120 and 37 CFR 1.78 is not submitted within the required time period, a petition for an unintentionally delayed claim may be filed.”

To learn more:

A Customer Number is a USPTO-assigned number that can be used to:

  • Designate the correspondence address for a patent application or patent
  • Designate the fee address for a patent
  • Submit a list of practitioners with power of attorney

According to MPEP 403: “A Customer Number may be used to designate the address associated with the Customer Number as the correspondence address of an application (or patent) or the fee address of a patent, and may also be used to submit a power of attorney in the application (or patent) to the registered practitioners associated with the Customer Number.”

Using a Customer Number simplifies making changes to correspondence addresses and practitioner information across multiple applications.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on Customer Number, visit: Customer Number.

For more information on Fee Address, visit: Fee Address.

For more information on power of attorney, visit: power of attorney.

A customer number is a unique identifier assigned by the USPTO to simplify patent correspondence. According to MPEP 403:

‘A customer number allows a patent applicant, patent owner, or assignee to designate a single correspondence address for all applications and patents associated with that customer number.’

Benefits of using a customer number include:

  • Easier management of correspondence addresses for multiple applications
  • Simplified process for changing the address or representative for all linked applications
  • Improved efficiency in USPTO communications

To obtain a customer number, you need to file a request with the USPTO using the appropriate form.

For more information on Customer Number, visit: Customer Number.

For more information on patent correspondence, visit: patent correspondence.

For more information on USPTO, visit: USPTO.

A Continued Prosecution Application (CPA) is a type of continuation or divisional application that can be filed under 37 CFR 1.53(d) for design applications. As stated in the MPEP, A continuation or divisional application filed under 37 CFR 1.53(d) is called a ‘Continued Prosecution Application’ (CPA). CPAs allow applicants to continue prosecution of a prior design application while retaining the benefit of the earlier filing date.

To learn more:

A Continued Prosecution Application (CPA) is a type of patent application that allows applicants to continue prosecution of a prior design application. It’s important to note that CPAs are now only available for design applications, not utility applications.

While the MPEP ¶ 2.32 doesn’t provide a direct definition of a CPA, it implies its use in the context of design applications:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

CPAs allow applicants to:

  • Continue prosecution of a previously filed design application
  • Make amendments or corrections, such as deleting a named inventor
  • Potentially receive further examination without filing a new application

For more detailed information on CPAs, refer to MPEP § 201.06(d).

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

A Continued Prosecution Application (CPA) is a type of patent application that allows applicants to continue prosecution of a parent application. It is governed by 37 CFR 1.53(d). According to MPEP ¶ 2.30, when a CPA is accepted, the examiner will use the following language:

“The request filed on [filing date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [parent application number] is acceptable and a CPA has been established.”

This indicates that the CPA has been properly filed and prosecution will continue based on the parent application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A Continued Prosecution Application (CPA) is a type of patent application specifically for design patents. It allows applicants to continue prosecution of a previously filed design application by filing a request for continued examination. CPAs are governed by 37 CFR 1.53(d) and are only available for design applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A Continued Prosecution Application (CPA) is a type of patent application specifically for design patents, filed under 37 CFR 1.53(d). It allows applicants to continue prosecution of a parent design patent application by filing a request for a CPA.

According to MPEP ¶ 2.30: The request filed on [date] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [number] is acceptable and a CPA has been established. This means that when a CPA is properly filed and accepted, it continues the prosecution of the parent application while establishing a new application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

A Continued Prosecution Application (CPA) is a type of continuation or divisional application that can be filed for design patent applications under 37 CFR 1.53(d). It allows an applicant to continue prosecution of a prior design application. As stated in the MPEP:

A continuation or divisional application (but not a continuation-in-part) of a prior nonprovisional application may be filed as a continued prosecution application under this paragraph, provided that:
(i) The application is for a design patent;

CPAs can only be filed before the earliest of: payment of the issue fee, abandonment, or termination of proceedings on the prior application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

A continuation-in-part (CIP) application is an application filed during the lifetime of a prior nonprovisional application, repeating some substantial portion or all of the prior application and adding matter not disclosed in the prior application.

As stated in the MPEP:

A continuation-in-part is an application filed during the lifetime of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.

Key points about CIP applications:

  • A CIP application may only be filed under 37 CFR 1.53(b).
  • The CIP application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • A CIP application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).
  • The mere filing of a CIP application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending parent application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A continuation-in-part (CIP) application is a type of patent application that builds upon a previously filed application by including new matter not disclosed in the original application. Key points about CIP applications include:

  • They are filed while the parent application is still pending.
  • They contain a portion or all of the disclosure of the parent application.
  • They introduce new matter not present in the original application.
  • The new matter is not entitled to the priority date of the parent application.

The MPEP 201.01 states: National applications include […] continuation-in-part applications (which may be filed under 37 CFR 1.53(b)). CIP applications allow inventors to expand on their original invention while maintaining the priority date for the previously disclosed material.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A continuation or divisional application is a type of continuing application filed under 37 CFR 1.53(b). According to the MPEP, An application filed under 37 CFR 1.53(b) may be an original or a reissue, a continuation, a divisional, a continuation-in-part, or a substitute. These applications are filed under 35 U.S.C. 111(a) and can be for utility, design, plant, or reissue patents.

To learn more:

To learn more:

A continuation application is a type of patent application that discloses the same invention(s) as a previously filed, copending nonprovisional application, international application designating the United States, or international design application designating the United States. The MPEP states:

“A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.”

It’s important to note that the continuation application must not include any new matter that wasn’t present in the parent application.

To learn more:

A continuation application under 37 CFR 1.53(b) is a type of continuing application that discloses and claims only subject matter disclosed in a prior nonprovisional application. It is filed under 35 U.S.C. 111(a) and may be for a utility, design, or plant patent.

According to the MPEP:

A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (A) a new specification and drawings and a copy of the signed oath or declaration as filed in the prior application provided the new specification and drawings do not contain any subject matter that would have been new matter in the prior application; or (B) a new specification and drawings and a newly executed oath or declaration provided the new specification and drawings do not contain any subject matter that would have been new matter in the prior application.

The continuation application receives a new application number and filing date, but can claim the benefit of the prior application’s filing date under 35 U.S.C. 120.

For more information on continuation application, visit: continuation application.

A confirmation number is a four-digit number assigned to each newly filed patent application. It is used in combination with the application number to verify the accuracy of the application number on correspondence filed with the USPTO. This helps avoid misidentification due to transposition errors.

The MPEP states: ‘The confirmation number is a four-digit number that is assigned to each newly filed application. The confirmation number, in combination with the application number, is used to verify the accuracy of the application number placed on correspondence filed with the Office to avoid misidentification of an application due to a transposition error in the application number.’ (MPEP 503)

A confirmation number is a four-digit number assigned by the USPTO to each newly filed patent application. According to MPEP 503, the confirmation number serves several important purposes:

  • It is used in combination with the application number to verify the accuracy of the application number on correspondence filed with the Office.
  • It helps avoid misidentification of an application due to transposition errors in the application number.
  • It is included on the filing receipt, Office actions, and other USPTO communications.
  • It is required when submitting an electronic copy of the application for publication to verify the correct application.

The MPEP recommends: “The Office also recommends that applicants include the application’s confirmation number (in addition to the application number) on all correspondence submitted to the Office concerning the application.”

The confirmation number can be found in the upper left-hand corner of the filing receipt and is also available through the Patent Application Information Retrieval (PAIR) system.

For more information on application number, visit: application number.

For more information on confirmation number, visit: confirmation number.

For more information on USPTO correspondence, visit: USPTO correspondence.

A Conditional Request for a Continued Prosecution Application (CPA) is a filing made under 37 CFR 1.53(d) for design applications. However, it’s important to note that any “conditional” request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA. This means that even if an applicant intends the request to be conditional, the USPTO will process it as a standard CPA request.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

A certified copy of a foreign application is an official copy of the foreign patent application, certified by the patent office where it was filed. It is required to perfect a claim of foreign priority in a U.S. patent application.

According to 37 CFR 1.55(f), for applications filed on or after March 16, 2013:

“A certified copy of the foreign application must be filed within the later of four months from the actual filing date of the application, or sixteen months from the filing date of the prior foreign application, in an original application under 35 U.S.C. 111(a) filed on or after March 16, 2013, except as provided in paragraphs (h), (i), and (j) of this section.”

There are exceptions to this requirement, such as when the foreign application was filed in a foreign intellectual property office participating in a priority document exchange agreement with the USPTO. In such cases, the applicant can request that the USPTO retrieve the certified copy electronically.

A certified abstract of title is a document that provides official information about the ownership of a patent or patent application. Unlike title reports, which are for internal USPTO use, certified abstracts of title can be requested by the public. The MPEP states: The public can request a certified abstract of title. The fee for this service is set forth at 37 CFR 1.19(b)(4). This document provides a certified summary of the assignment records for a specific patent or application.

For more information on certified abstract of title, visit: certified abstract of title.

For more information on public records, visit: public records.

For more information on USPTO, visit: USPTO.

A Certificate of Mailing or Transmission is a procedure under 37 CFR 1.8 that allows correspondence to be considered timely filed with the USPTO if it meets certain conditions. As stated in the MPEP:

“Under 37 CFR 1.8, a person may state on certain papers directed to the Office (some exceptions are stated in 37 CFR 1.8), the date on which the paper will be deposited in the United States Postal Service, transmitted by facsimile or transmitted via the USPTO electronic filing system (EFS-Web). If the date stated is within the period for reply, the reply in most instances will be considered to be timely.”

This procedure can be crucial for meeting deadlines, even if the actual receipt of the correspondence by the USPTO occurs after the deadline.

To learn more:

A ‘substitute’ application in patent law is essentially a duplicate of an earlier application that was abandoned before the filing of the later application. The MPEP provides the following definition:

A “substitute” application is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application.

Key points about substitute applications:

  • It does not obtain the benefit of the filing date of the prior application
  • Current practice does not require applicants to insert references to the earlier application in the specification
  • Applicants should call attention to the earlier application

The USPTO uses a specific form paragraph (2.07) to remind applicants of possible substitute status:

Applicant refers to this application as a “substitute” of Application No. [1], filed [2]. The term “substitute” is used to designate an application which is in essence the duplicate of an application by the same applicant abandoned before the filing of the later application. A “substitute” does not obtain the benefit of the filing date of the prior application.

To learn more:

What is a ‘subject invention’ in the context of government-funded research?

A ‘subject invention’ is a term used in government contracts and refers to any invention conceived or first actually reduced to practice in the performance of work under a government contract. According to MPEP 310, ‘The term ‘subject invention’ is defined by 35 U.S.C. 201(e) as any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement.’ This definition is crucial for determining the government’s rights in inventions made during federally sponsored research.

For more information on federal funding, visit: federal funding.

For more information on patent rights, visit: patent rights.

What is a ‘regular utility application’ in patent law?

A ‘regular utility application’ is a term used in patent law to describe a standard non-provisional patent application for a utility invention. According to MPEP 201.02, it is defined as follows:

“A ‘regular utility application’ is a non-provisional application for a utility patent filed under 35 U.S.C. 111(a).”

This type of application is the most common form of patent application filed with the USPTO. It requires a detailed description of the invention, claims defining the scope of protection sought, and often includes drawings to illustrate the invention. Regular utility applications undergo a thorough examination process to determine if they meet the requirements for patentability.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on Non-provisional application, visit: Non-provisional application.

A ‘person to whom the inventor has assigned or is under an obligation to assign the invention’ refers to an individual or entity that has received rights to the invention through a legal agreement or contract. This concept is important in patent applications filed on or after September 16, 2012, as explained in MPEP 409.05:

Quote: ‘A person to whom the inventor has assigned or is under an obligation to assign the invention may make an application for patent.’

This provision allows assignees or those with a contractual right to the invention to file patent applications, even if they are not the original inventors.

To learn more:

A ‘file wrapper’ refers to the official record of proceedings in the United States Patent and Trademark Office (USPTO) for a particular patent application or granted patent. It contains all the documents and correspondence related to the prosecution of the application or maintenance of the patent. This includes the original application, Office actions, applicant responses, amendments, and other relevant documents. The file wrapper provides a complete history of the examination process and is important for understanding the scope and validity of a patent.

What is a ‘delayed claim’ for priority or benefit in a patent application?

A ‘delayed claim’ for priority or benefit in a patent application refers to a claim that is filed after the time period set forth in 37 CFR 1.78. According to MPEP 211.02(a), “A petition under 37 CFR 1.78 and the petition fee are required to add or correct a benefit claim after the time period set forth in 37 CFR 1.78.” This means that if an applicant misses the deadline for claiming priority or benefit, they must file a petition and pay a fee to have the claim considered.

To learn more:

A corrective document is a filing used to address errors in recorded assignment documents at the USPTO. According to MPEP 323:

‘The ‘corrective document’ (or if one of the documents is not being re-recorded, a copy of the original) should be recorded as a supporting document, and all documents will be examined.’

Corrective documents are used for:

  • Minor typographical errors
  • More substantial errors like incorrect names or addresses

When filing a corrective document, it’s important to clearly identify the nature of the correction and reference the original recorded document.

For more information on assignment correction, visit: assignment correction.

For more information on USPTO, visit: USPTO.

A continuing application in patent law is a type of patent application that is related to an earlier-filed application. The MPEP defines it as follows:

A continuing application is a continuation, divisional, or continuation-in-part application filed under the conditions specified in 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78.

There are three main types of continuing applications:

  • Continuation: An application that further pursues the same invention as the original application
  • Divisional: An application that pursues a distinct invention that was disclosed but not claimed in the original application
  • Continuation-in-part (CIP): An application that includes subject matter from the original application plus new matter

Continuing applications must meet specific legal requirements to claim the benefit of the earlier application’s filing date.

To learn more:

Tags: divisional

A ‘chain of title’ in patent ownership refers to the documented history of a patent’s ownership from its original assignment to its current owner. MPEP 314 mentions this concept in relation to name changes and mergers:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title. Documents of merger are also proper links in the chain of title.

The chain of title includes:

  • Original patent assignment
  • Subsequent transfers of ownership
  • Business name changes
  • Mergers and acquisitions
  • Any other events affecting patent ownership

Maintaining a clear and unbroken chain of title is crucial for establishing ownership rights, facilitating patent transactions, and providing clarity in potential patent litigation.

A ‘bypass’ continuation application is a specific type of continuation application that is filed under 37 CFR 1.53(b) to ‘bypass’ the national stage of an international application. As explained in MPEP 201.06(c):

“A continuation application filed under 37 CFR 1.53(b) may be filed as a continuation of an international application designating the United States without entering the national stage under 35 U.S.C. 371. This is often referred to as a ‘bypass’ continuation application.”

This type of application allows applicants to pursue patent protection in the U.S. based on their international application without going through the formal national stage entry process. It can be advantageous in certain situations, such as when an applicant wants to modify claims or add new matter before U.S. examination.

A ‘bypass’ application refers to a continuation, divisional, or continuation-in-part of an international (PCT) application filed under 35 U.S.C. 111(a) instead of entering the national stage under 35 U.S.C. 371. As stated in MPEP 211.01(c):

Rather than submitting a national stage application under 35 U.S.C. 371, applicant may file a continuation, divisional, or continuation-in-part of an international (PCT) application under 35 U.S.C. 111(a). Such applications are often referred to as ‘bypass’ applications.

This option allows applicants to claim the benefit of an international application’s filing date while following the procedures for regular national applications.

To learn more:

A ‘bypass’ application is:

  • A regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b)
  • It claims benefit of an international application’s filing date without entering the national stage under 35 U.S.C. 371
  • It can be filed as a continuation, divisional, or continuation-in-part of the international application

MPEP 211.01(c) explains: “Rather than submitting a national stage application under 35 U.S.C. 371, applicant may file a continuation, divisional, or continuation-in-part of an international (PCT) application under 35 U.S.C. 111(a). Such applications are often referred to as ‘bypass’ applications.”

37 CFR 3.27 is a federal regulation that specifies the mailing address for submitting documents to be recorded at the USPTO. According to MPEP 302.08:

37 CFR 3.27 sets out how documents submitted for recording should be addressed to the Office.

This regulation ensures that assignment documents and other recordable documents are sent to the correct address for proper processing. It’s crucial for patent attorneys, inventors, and anyone submitting assignment documents to follow this regulation to avoid delays or misrouting of important legal documents.

To learn more:

To learn more:

Several international agreements can form the basis for a priority claim in patent applications. The MPEP mentions:

  • The Paris Convention for the Protection of Industrial Property
  • The Hague Agreement Concerning the International Registration of Industrial Designs
  • The Benelux Designs Convention
  • The Convention on the Grant of European Patents (European Patent Office)
  • The Patent Cooperation Treaty (PCT)
  • The International Convention for the Protection of New Varieties of Plants (UPOV)

The MPEP states: “Under Article 4A of the Paris Convention for the Protection of Industrial Property, a right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design filed under the national law of a foreign country adhering to the Convention, or on a foreign application filed under a bilateral or multilateral treaty concluded between two or more such countries.”

These agreements facilitate the international protection of intellectual property rights and enable applicants to claim priority based on applications filed in various jurisdictions.

Assignees of part interest in a patent application have specific inspection rights. According to MPEP 106.01:

[A]n assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.

This means that while assignees of part interest cannot prosecute the application or exclude the applicant from the prosecution process, they do have the right to review and inspect the contents of the patent application. This inspection right allows them to stay informed about the application’s status and content, even though they cannot directly intervene in its prosecution.

To learn more:

When the USPTO’s Assignment Division returns assignment documents or cover sheets, they include specific information to help you understand the status and next steps. According to MPEP 317.02:

“Assignment documents and cover sheets, or copies of the same, which are returned by Assignment Division will be stamped with the original date of receipt by the Office and will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

In summary, you will receive:

  • The original documents or copies, stamped with the original receipt date
  • An accompanying letter specifying:
    • The reason for the return
    • Instructions for correction
    • The deadline for resubmission
    • Information about maintaining the original receipt date as the recording date

It’s crucial to carefully review this information and act promptly to meet the specified deadline for resubmission.

To learn more:

When citing a prior application using MPEP ¶ 2.05, specific information must be included. The MPEP instructs examiners:

“In brackets 1 and 2, insert the application number (series code and serial number) and filing date of the prior application, respectively.”

This means that when referencing a prior application, the examiner should provide:

  • The application number, including both the series code and serial number
  • The filing date of the prior application

Including this information ensures clear identification of the specific prior application being referenced.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

For foreign priority applications, the bib-data sheet should include:

  • Application number
  • Country (or intellectual property authority)
  • Day, month, and year of filing

MPEP 202 specifies: “A bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application that the U.S. application is claiming the priority of. The examiner should check this information for accuracy.”

It’s important to note that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) should be listed. Applications from non-qualifying countries should be lined through on the bib-data sheet.

The Description of the Related Art section should include:

  • A description of the state of the prior art or other information known to the applicant.
  • References to specific prior art or other information where appropriate.
  • Information disclosed under 37 CFR 1.97 and 37 CFR 1.98.
  • Where applicable, the problems involved in the prior art or other information disclosed which are solved by the applicant’s invention.

As stated in MPEP 608.01(c), this section should include “A paragraph(s) describing to the extent practical the state of the prior art or other information disclosed known to the applicant, including references to specific prior art or other information where appropriate. Where applicable, the problems involved in the prior art or other information disclosed which are solved by the applicant’s invention should be indicated.”

To learn more:

Tags: prior art

For applications filed before September 16, 2012, the Application Data Sheet (ADS) should include the following information:

  • Applicant information
  • Correspondence address
  • Application information
  • Representative information
  • Domestic priority information
  • Foreign priority information
  • Assignee information

As stated in MPEP 601.05(b): The ADS must include all of the section headings listed in 37 CFR 1.76(b), even if no information is being provided for some of the sections. This ensures consistency and completeness in the application filing process.

To learn more:

The Applicant Initiated Interview Request form (PTOL-413A) should include specific information to facilitate the interview process. According to MPEP 408:

This form should identify the participants of the interview, the proposed date of the interview, whether the interview will be personal, telephonic, or video conference, and should include a brief description of the issues to be discussed.

Providing this information helps the examiner prepare adequately for the interview and ensures that all necessary parties are involved in the discussion of relevant issues.

When correcting an erroneous assignment, the affidavit or declaration submitted to the USPTO should contain specific information. According to MPEP 323.01(c), the affidavit should include:

  • Identification of yourself as the correct owner
  • A statement that the previously recorded document was submitted with erroneous information
  • The reel and frame number of the previously recorded document
  • A summary of the true chain of title
  • A statement that the original applicant, patentee, or last correct assignee has been and continues to be the owner of the application or patent at issue

The MPEP specifically states: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change, and a statement that the original applicant or patentee or last correct assignee has been, and continues to be, the owner of the application, or patent at issue.

To learn more:

When using Form Paragraph 2.35 in a patent examination, specific information needs to be inserted into the brackets. According to the MPEP ¶ 2.35, examiners should include the following:

  • In bracket 1: Insert the filing date of the request for a CPA.
  • In bracket 2: Insert the Application Number identified in the CPA request.

This information helps to clearly identify the specific CPA request being addressed and provides essential context for the applicant. It’s crucial for examiners to accurately fill in these brackets to ensure proper documentation and communication regarding the CPA.

An Application Data Sheet (ADS) for a patent application filed on or after September 16, 2012, should include specific bibliographic data. According to MPEP 601.05(a), the ADS must contain the following information:

  • Inventor information: Full name, residence, and mailing address of each inventor
  • Applicant information: Name and address of the applicant (if different from the inventor)
  • Correspondence address
  • Application information: Title of the invention, attorney docket number, type of application
  • Representative information: Registration number and name of each practitioner
  • Domestic benefit/national stage information: Prior-filed application number and filing date
  • Foreign priority information: Foreign application number, country, and filing date
  • Assignee information: Name and address of the assignee of the entire right, title, and interest

The MPEP states: “An application data sheet must be labeled ‘Application Data Sheet’ and should provide the bibliographic data, in the order and with the headings specified in this section, to be entitled to the benefits provided by the application data sheet.” Ensuring all required information is accurately provided in the ADS is crucial for proper processing of the application and establishing priority claims.

To learn more:

When requesting to delete a named inventor in a Continued Prosecution Application (CPA) for a design patent, you should include specific information. According to MPEP ¶ 2.32, the request should contain:

  1. A clear statement requesting the deletion of the inventor(s)
  2. The name(s) of the inventor(s) to be deleted
  3. The filing date of the CPA

The MPEP provides a template for acknowledging such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2].

In this template, [1] represents the name(s) of the inventor(s) to be deleted, and [2] is the filing date of the CPA. Ensure your request clearly specifies these details to facilitate proper processing by the USPTO.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

According to 37 CFR 3.61, the designation of a domestic representative should include:

  • The name of the person residing within the United States
  • The address of the designated person
  • A statement that this person may be served process or notice of proceedings affecting the application, patent or registration or rights thereunder

As stated in the regulation, The designation should state the name and address of a person residing within the United States on whom may be served process or notice of proceedings affecting the application, patent or registration or rights thereunder. This information ensures that the USPTO and other parties can effectively communicate with the foreign assignee through their designated representative.

To learn more:

When filing a Continued Prosecution Application (CPA) request, certain key information must be included. Based on MPEP ¶ 2.35, the following details are essential:

  • The filing date of the CPA request
  • The application number of the prior application

The MPEP states: “Receipt is acknowledged of the ‘conditional’ request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on prior Application No. [2].” Here, [1] represents the filing date of the CPA request, and [2] represents the application number of the prior application.

It’s important to ensure that this information is accurately provided to facilitate proper processing of the CPA request by the USPTO.

For more information on filing requirements, visit: filing requirements.

For more information on USPTO, visit: USPTO.

When referencing a prior application in a continuation-in-part (CIP), specific information must be included. According to MPEP ¶ 2.06, the examiner note states:

In brackets 1 and 2, insert the application number (series code and serial number) and filing date of the prior application, respectively.

This means that when referencing the prior application, you must include:

  • The application number (series code and serial number)
  • The filing date of the prior application

Providing this information accurately is crucial for establishing the proper relationship between the CIP and the prior application.

For more information on application number, visit: application number.

An assignment cover sheet must include specific information to be accepted by the USPTO. According to MPEP 302.07, the cover sheet must contain:

  • The name of the party conveying the interest
  • The name and address of the party receiving the interest
  • A description of the interest conveyed or transaction to be recorded
  • Identification of the interests involved (e.g., patent number, application number)
  • The name and address of the party to whom correspondence concerning the request to record the document should be mailed
  • The date the document was executed
  • The signature of the party submitting the document

It’s crucial to provide all required information accurately to ensure the assignment is properly recorded.

To learn more:

For patent applications filed before September 16, 2012, the oath or declaration must include specific information about foreign applications if not provided in an application data sheet. According to pre-AIA 37 CFR 1.63(c)(2), the oath or declaration must identify:

  • Any foreign application for patent (or inventor’s certificate) for which a claim for priority is made
  • Any foreign application having a filing date before that of the application on which priority is claimed

The MPEP elaborates: The applicant is required to recite all foreign applications filed prior to the application on which priority is claimed. It is required to give the foreign application number and name of the country or office in which filed, as well as the filing date of each foreign application to which priority is claimed.

This information is crucial for establishing priority claims and ensuring compliance with patent law requirements regarding prior foreign filings.

To learn more:

According to 37 CFR 1.29(k)(1), the itemization for a micro entity fee deficiency payment must include:

  • Each type of fee erroneously paid as a micro entity
  • The current fee amount for a small or non-small entity
  • The micro entity fee actually paid and the date of payment
  • The deficiency owed amount for each fee
  • The total deficiency payment owed

The MPEP specifies: The paper must contain an itemization of the total deficiency payment and include the following information: (1) each particular type of fee that was erroneously paid as a micro entity, (e.g., basic statutory filing fee, two-month extension of time fee) along with the current fee amount for a small or non-small entity; (2) the micro entity fee actually paid, and the date on which it was paid; (3) the deficiency owed amount (for each fee erroneously paid); and (4) the total deficiency payment owed, which is the sum or total of the individual deficiency owed amounts.

To learn more:

When an application is executed by someone other than the inventor under pre-AIA 37 CFR 1.47(b), the declaration must include specific information about the non-signing inventor. According to the MPEP, the declaration must state:

  • The full name of the non-signing inventor
  • The residence of the non-signing inventor
  • The post office address of the non-signing inventor
  • The citizenship of the non-signing inventor

Additionally, “the title or position of the person signing must be stated if signing on behalf of a corporation under pre-AIA 37 CFR 1.47(b).” This ensures that the person signing has the authority to do so on behalf of the corporation.

To learn more:

Tags: pre-AIA

When a patent application is filed by someone other than the inventor under 37 CFR 1.46, the application must contain an application data sheet (ADS) with specific information. According to 37 CFR 1.46(b), the ADS must specify in the applicant information section:

  • The assignee
  • The person to whom the inventor is under an obligation to assign the invention
  • The person who otherwise shows sufficient proprietary interest in the matter

This information should be provided in the applicant information section of the ADS, as specified in 37 CFR 1.76(b)(7). Ensuring this information is correctly included in the ADS is crucial for establishing the proper applicant for the patent application.

To learn more:

When claiming foreign priority, the application data sheet (ADS) must include specific information to meet the requirements of 37 CFR 1.55(i)(2). The MPEP states that the claim for priority must be presented in an ADS:

identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and including the information necessary for the participating foreign intellectual property office to provide the Office with access to the foreign application

This information is crucial for the USPTO to retrieve the priority document through the Priority Document Exchange program. Ensure that all details are accurate to avoid any issues with your priority claim.

To learn more:

What information must be included in an oath or declaration for an unavailable joint inventor?

When filing an oath or declaration for an unavailable joint inventor, specific information must be included. According to MPEP 409.03(a), the oath or declaration must contain:

  • The name of the unavailable inventor
  • A statement that the inventor is unavailable and the reason for unavailability
  • The last known address of the unavailable inventor

Additionally, the MPEP states:

‘If a nonsigning inventor refuses to sign the oath or declaration or cannot be reached, the oath or declaration under 37 CFR 1.63 by the remaining joint inventor(s) must state that the nonsigning inventor is either refused to sign or could not be reached after diligent effort to contact him or her.’

It’s crucial to provide as much detail as possible about the efforts made to contact the unavailable inventor and any responses received. This information helps the USPTO understand the situation and process the application appropriately.

To learn more:

Tags: declaration, oath

An inventor’s oath or declaration must include specific information as outlined in 37 CFR 1.63. The required information includes:

  • Identification of the inventor or joint inventor by their legal name
  • Identification of the application to which it is directed
  • A statement that the person executing the oath or declaration believes the named inventor or joint inventors to be the original inventor or an original joint inventor of a claimed invention in the application
  • A statement that the application was made or authorized to be made by the person executing the oath or declaration

Unless provided in an Application Data Sheet (ADS), the oath or declaration must also include:

  • The mailing address where the inventor customarily receives mail
  • The residence of the inventor, if different from the mailing address

It’s important to note that while the ‘reviewed and understands’ clause and ‘duty to disclose’ clause are no longer required in the oath or declaration itself, 37 CFR 1.63(c) still requires that the person executing the oath or declaration has reviewed and understood the application contents and is aware of the duty to disclose under 37 CFR 1.56.

To learn more:

When an application is filed by someone other than the inventor under 35 U.S.C. 111, it must contain specific information as outlined in 37 CFR 1.46(b):

  • An application data sheet under § 1.76
  • In the applicant information section (§ 1.76(b)(7)), specify:
    • The assignee
    • Person to whom the inventor is under an obligation to assign the invention
    • Person who otherwise shows sufficient proprietary interest in the matter

The regulation states: If an application under 35 U.S.C. 111 is made by a person other than the inventor under paragraph (a) of this section, the application must contain an application data sheet under § 1.76 specifying in the applicant information section (§ 1.76(b)(7)) the assignee, person to whom the inventor is under an obligation to assign the invention, or person who otherwise shows sufficient proprietary interest in the matter.

A substitute statement must contain specific information as outlined in 37 CFR 1.64(b):

  • Comply with the requirements of 37 CFR 1.63(a), identifying the inventor and stating required facts
  • Identify the person executing the statement and their relationship to the inventor
  • Identify the circumstances permitting the substitute statement
  • Provide the last known mailing address and residence of the inventor (if not in the application data sheet)

Additionally, the statement must include an acknowledgment that “any willful false statement made in such statement is punishable under section 1001 of title 18 by fine or imprisonment of not more than 5 years, or both.

To learn more:

What information must be included in a substitute statement for a deceased or incapacitated inventor?

When filing a substitute statement for a deceased or legally incapacitated inventor, specific information must be included to ensure its validity. According to MPEP 409.01(a) and 37 CFR 1.64, a substitute statement must contain:

  • Identification of the inventor to whom the substitute statement applies
  • The circumstances permitting the use of a substitute statement (e.g., death, legal incapacity)
  • A statement that the person signing:
    • Has reviewed and understands the contents of the application
    • Believes the named inventor to be the original inventor of the claimed invention
    • Acknowledges the duty to disclose information material to patentability
  • The relationship of the person signing to the inventor

Additionally, the substitute statement must:

  • Identify the person executing the substitute statement and the capacity in which they are signing
  • Be signed in accordance with 37 CFR 1.64(a)

Ensuring all required information is included in the substitute statement is crucial for the proper processing of the patent application in cases where the inventor is unavailable.

To learn more:

For inventions related to atomic energy, applicants must file a statement under oath with specific information. According to 42 U.S.C. 2182, this statement should include:

  • Full facts surrounding the making or conception of the invention
  • Whether the invention was made or conceived under any contract or arrangement with the Commission (now DOE)
  • Whether the contract involved the expenditure of funds by the Commission

The law states: No patent for any invention or discovery, useful in the production or utilization of special nuclear material or atomic energy, shall be issued unless the applicant files with the application, or within thirty days after request therefor by the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office […] a statement under oath setting forth the full facts surrounding the making or conception of the invention or discovery described in the application and whether the invention or discovery was made or conceived in the course of or under any contract, subcontract, or arrangement entered into with or for the benefit of the Commission, regardless of whether the contract, subcontract, or arrangement involved the expenditure of funds by the Commission.

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

A power of attorney for patent applications must include the following information:

  • The attorney’s or agent’s full mailing address, including ZIP Code
  • It’s recommended to include the telephone and fax numbers of the attorney or agent

As stated in MPEP 601.02: “The attorney’s or agent’s full mailing address (including ZIP Code) must be given in every power of attorney. The telephone and fax numbers of the attorney or agent should also be included in the power of attorney.”

Including this information facilitates prompt delivery of communications.

To learn more:

According to 37 CFR 1.335(a), a notice of arbitration award filed with the USPTO must include the following information:

  • Patent number
  • Names of the inventor and patent owner
  • Names and addresses of the parties to the arbitration
  • A copy of the arbitration award

The regulation states: “The notice must set forth the patent number, the names of the inventor and patent owner, and the names and addresses of the parties to the arbitration. The notice must also include a copy of the award.”

This detailed information ensures that the USPTO has a complete record of the arbitration outcome and its relevance to specific patents.

For more information on Patent Information, visit: Patent Information.

A Continued Prosecution Application (CPA) request for design patents must include specific information to be considered acceptable. According to MPEP ¶ 2.30, the key elements are:

  • The filing date of the CPA request
  • The parent application number

The MPEP states: The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. Here, [1] represents the filing date of the CPA request, and [2] is the parent application number. These details are crucial for establishing the continuity between the parent application and the CPA.

For more information on USPTO filing procedures, visit: USPTO filing procedures.

A continuation application must include specific information to properly establish its relationship to the prior-filed application. The MPEP outlines these requirements:

“If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§ 1.76(b)(5)). The reference also must identify the relationship of the applications, namely, whether the later-filed application is a continuation, divisional, or continuation-in-part of the prior-filed nonprovisional application, international application, or international design application.”

Key information to include:

  • Application number of the prior-filed application
  • Filing date of the prior-filed application
  • Relationship between the applications (e.g., continuation)
  • Inventor information, including at least one inventor from the prior application

Ensuring all required information is included helps establish the proper benefit claim and relationship between the applications.

To learn more:

A certificate of mailing for USPTO correspondence must include specific information to be valid. According to MPEP 512, the following information is required:

  • The date of deposit or transmission
  • The application number (for patent applications)
  • A statement that the correspondence is being deposited with the USPS or transmitted to the USPTO
  • The signature of the person depositing or transmitting the correspondence

The MPEP states:

The certificate must state that the correspondence is being deposited with the United States Postal Service with sufficient postage as first class mail, or transmitted to the Office on the date of the certificate.

Ensure all these elements are included to make your certificate of mailing valid and effective.

To learn more:

For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), which include continuations, divisionals, and continuation-in-part applications, the benefit claim must include specific information about the relationship between the applications. The MPEP states:

“For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.”

This means that when making a benefit claim, you must explicitly state whether the current application is a:

  • Continuation
  • Divisional
  • Continuation-in-part

of the prior application. This information helps the USPTO and others understand the relationship between related applications and ensures proper examination and treatment of the claims.

Remember, this requirement is in addition to other necessary information for the benefit claim, such as the application number and filing date of the prior application.

For more information on divisional, visit: divisional.

Tags: divisional

When filing papers in a representative capacity, a patent practitioner must provide specific information to identify themselves and establish their authority. According to MPEP 402.04:

  • Registration number
  • Name
  • Signature

The MPEP states: “In filing such a paper, the patent practitioner must set forth his or her registration number, his or her name and signature. Further proof of authority to act in a representative capacity may be required.”

This requirement applies even when the practitioner is not of record in the application. It helps facilitate replies on behalf of applicants and eliminates the need for filing powers of attorney in individual applications when there are changes in law firms or corporate patent staffs.

To learn more:

A patent title report contains crucial information about the ownership and status of a patent application or patent. While the MPEP Section 320 does not provide an exhaustive list, based on its context and purpose, a title report typically includes:

  • The names of the current owner(s) or assignee(s)
  • Any recorded assignments or transfers of ownership
  • The date of the most recent assignment
  • Information about the inventors
  • The application or patent number
  • Any liens or security interests recorded against the patent

This information helps ensure that all parties involved in the patent process are aware of the current ownership status and can act accordingly.

What information is required on the Application Data Sheet (ADS) regarding inventors?

The Application Data Sheet (ADS) is a crucial document in patent applications, and it must include specific information about the inventors. According to MPEP 602.08(a), the following information is required for each inventor:

  • Legal name
  • Residence (city and state or country)
  • Mailing address
  • Citizenship

The MPEP states:

“The inventor’s legal name for the ADS should be the name as it appears on a legal document such as a birth certificate, marriage certificate, court order, etc.”

It’s important to provide accurate and complete information on the ADS to avoid potential issues with the patent application process. Any changes to inventor information after filing may require submitting a corrected ADS.

To learn more:

When recording documents with the USPTO, a cover sheet must accompany the document. The cover sheet should include:

  • Name of the conveying party
  • Name and address of the receiving party
  • Application number, patent number, or registration number
  • Name of the inventor (for patent documents)
  • Title of the invention (for patent documents)
  • Document date
  • Nature of the interest being conveyed
  • Assignee AIA (first inventor to file) statement

MPEP 313 states: Each document submitted for recording must be accompanied by a cover sheet… The format for the cover sheet is specified by the Office. Ensure all required information is provided to facilitate proper recording of the document.

For more information on cover sheet, visit: cover sheet.

For more information on document submission, visit: document submission.

An inventor’s oath or declaration must include:

  • Inventor bibliographic information (see MPEP § 602.08(a))
  • Name of the inventor or each joint inventor
  • Signature of each inventor (with some exceptions, see MPEP § 602.08(b))
  • Identification of the application to which it is directed (see MPEP § 602.08(c))

As stated in the MPEP, “The inventor’s oath or declaration must include certain inventor bibliographic information, name the inventor or each joint inventor and except as otherwise provided be signed by each inventor, and identify the application to which it is directed.”

To learn more:

When including non-patent literature in an Information Disclosure Statement (IDS), you must provide the following information:

  • Publisher
  • Author (if any)
  • Title
  • Relevant pages
  • Date
  • Place of publication

According to MPEP 609.04(a): Each publication listed in an information disclosure statement must be identified by publisher, author (if any), title, relevant pages of the publication, date, and place of publication.

It’s important to note that for publications in a language other than English, you should also provide a concise explanation of the relevance in English, if not already available.

To learn more:

What information is required for non-English language documents in an IDS?

For non-English language documents cited in an Information Disclosure Statement (IDS), the following information is required:

  • A concise explanation of the relevance of the document, unless a complete translation is provided.
  • A written English language translation of the document, or a portion thereof, if it is within the possession, custody, or control of, or is readily available to any individual designated in 37 CFR 1.56(c).

According to MPEP 609.04(a):

“Where the information listed is not in the English language, but was cited in a search report or other action by a foreign patent office in a counterpart foreign application, the requirement for a concise explanation of relevance can be satisfied by submitting an English-language version of the search report or action which indicates the degree of relevance found by the foreign office.”

This provision allows applicants to efficiently provide the necessary context for foreign language documents without extensive translations.

To learn more:

What information is required for inventor’s citizenship in a patent application?

For patent applications, the inventor’s citizenship must be provided. According to MPEP 602.08(b), ‘The inventor’s citizenship must be specifically identified in the oath or declaration.’ This requirement applies to both utility and design patent applications. The MPEP further states:

‘It is not sufficient for oath or declaration to merely state that the inventor is a citizen of the ‘United States,’ but the particular state of which the inventor is a citizen must be specified.’

This means that for U.S. citizens, the specific state of citizenship should be mentioned. For non-U.S. citizens, the country of citizenship should be clearly stated.

To learn more:

For foreign inventors in a U.S. patent application, the following information is required:

  • The inventor’s full name
  • Residence (city and either state or foreign country)
  • Mailing address
  • Citizenship

According to MPEP 602.08(a): ‘If the residence is not in the United States, the residence (city and country) and mailing address must be provided.’ It’s important to note that the mailing address is particularly crucial for foreign inventors to ensure proper communication with the USPTO.

To learn more:

When a pre-AIA 37 CFR 1.47 application is found acceptable, certain information is published in the Official Gazette. According to the MPEP: A notice will be published in the Official Gazette identifying the application number, filing date, the title of the invention and the name(s) of the nonsigning inventor(s).

This publication serves several purposes:

  • It provides public notice of the application’s existence.
  • It identifies the nonsigning inventors, which may be important for legal or intellectual property reasons.
  • It establishes a clear record of the application’s status under pre-AIA 37 CFR 1.47.

This publication is an important step in the processing of these special applications and ensures transparency in the patent application process.

To learn more:

To learn more:

Citations considered by the examiner and listed on form PTO/SB/08 or an equivalent separate paper will be printed on the patent. The MPEP states: A citation listed on form PTO/SB/08 and considered by the examiner will be printed on the patent. However, for the separate paper to be printed, it must meet specific formatting requirements:

  • Each item of information is listed on a single line
  • The lines are at least double-spaced from each other
  • The information is uniform in format for each listed item

It’s important to note that For patents printed after January 1, 2001, citations from information disclosure statements that are printed on the face of the patent will be distinguished from citations cited by the examiner on a form PTO-892.

To learn more:

To identify a national patent application in an assignment, you must use the application number. MPEP 302.03 states: “An assignment relating to a national patent application must identify the national patent application by the application number (consisting of the series code and the serial number; e.g., 07/123,456).” This format ensures accurate identification of the specific application being assigned.

To learn more:

Accessing assignment records for unpublished patent applications requires specific authorization or a showing of legitimate interest. According to MPEP 301.01, for applications that are not open to the public:

Information related thereto is only obtainable upon a proper showing of written authority. For applications filed on or after September 16, 2012, the written authority must be from (A) an inventor, (B) an applicant, (C) the assignee or an assignee of an undivided part interest, (D) a patent practitioner of record, or (E) a person with written authority from (A), (B), or (C) or (D).

For applications filed before September 16, 2012, the requirements are slightly different:

For applications filed prior to September 16, 2012, the written authority must be from the applicant or applicant’s assignee or from the attorney or agent of either, or upon a showing that the person seeking such information is a bona fide prospective or actual purchaser, mortgagee, or licensee of such application.

If you’re not one of these authorized parties, you may still be able to access the records if you can demonstrate that you are a bona fide prospective or actual purchaser, mortgagee, or licensee of the application. This typically requires submitting a petition with the appropriate fee and evidence of your status.

For more information on unpublished applications, visit: unpublished applications.

The front page of a printed patent identifies all prior applications for which benefits are claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in continuation-in-part, continuation, divisional, and reissue applications.

When acknowledging a Continued Prosecution Application (CPA) request, the USPTO includes specific details as outlined in MPEP ¶ 2.35. The acknowledgment typically includes:

  • The filing date of the CPA request
  • The application number of the prior application on which the CPA is based
  • A statement that the CPA request is acceptable
  • Confirmation that a CPA has been established

The MPEP provides a template for this acknowledgment: Receipt is acknowledged of the ‘conditional’ request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on prior Application No. [2].

This information helps applicants confirm that their CPA request has been received and processed correctly.

For more information on USPTO communication, visit: USPTO communication.

The first Office action of a Continued Prosecution Application (CPA) includes important information for the applicant. According to MPEP ¶ 2.35, the examiner should:

  • Advise the applicant that a ‘conditional’ request for a CPA is treated as an unconditional request
  • Confirm that the CPA is acceptable and has been established
  • Provide notice that an action on the CPA follows

This information is crucial because, as stated in the MPEP, “applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.” Therefore, this Office action serves as an important communication regarding the status of the application.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO communication, visit: USPTO communication.

The notice of Continued Prosecution Application (CPA) establishment includes specific information as outlined in MPEP ¶ 2.30. The key elements are:

  • The filing date of the CPA request
  • The parent application number
  • A statement that the CPA is acceptable and has been established
  • An indication that an action on the CPA will follow

The exact language used by the examiner is: The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.

For more information on patent examination, visit: patent examination.

For more information on patent procedure, visit: patent procedure.

An Application Data Sheet (ADS) for pre-AIA applications includes several categories of bibliographic information:

  • Applicant information (name, residence, mailing address, and citizenship)
  • Correspondence information
  • Application information (title, classification, drawings, etc.)
  • Representative information
  • Domestic priority information
  • Foreign priority information
  • Assignee information

As stated in MPEP 601.05(b), “Bibliographic data as used in paragraph (a) of this section includes: (1) Applicant information… (2) Correspondence information… (3) Application information… (4) Representative information… (5) Domestic priority information… (6) Foreign priority information… (7) Assignee information…”

To learn more:

A patent filing receipt includes:

  • Application number
  • Filing date
  • Confirmation number
  • Suggested class in the U.S. Patent Classification System
  • Art unit number where the application is likely to be examined
  • Continuing data (if applicable)
  • National stage data (if applicable)
  • Foreign priority data (if applicable)
  • Foreign filing license data (if applicable)
  • Entity status information
  • Anticipated publication date under 35 U.S.C. 122(b)

The MPEP states: ‘The filing receipt includes the application number, filing date, a confirmation number, a suggested class in the U.S. Patent Classification System (see MPEP § 902.01), and the number of an art unit where the application is likely to be examined.’ (MPEP 503)

A patent application filing receipt contains crucial information about the application. According to the MPEP:

‘A filing receipt is mailed to the attorney or agent, if any, otherwise to the applicant, for each application filed.’

The filing receipt typically includes:

  • The application number
  • Filing date
  • Title of the invention
  • Names of the applicants
  • Name and registration number of the attorney or agent (if applicable)
  • Entity status for fee purposes
  • Correspondence address
  • List of documents submitted with the application

It’s important to review the filing receipt carefully for accuracy, as it serves as official confirmation of the application’s details and can be used to identify any discrepancies or issues that need to be addressed promptly.

For more information on filing receipt, visit: filing receipt.

According to MPEP ¶ 2.30, a CPA acceptance notice typically includes the following information:

  • The filing date of the CPA request
  • The application number of the parent application
  • Confirmation that the CPA request is acceptable
  • Statement that a CPA has been established

The MPEP provides a template for examiners, stating: “The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.”

For more information on patent application information, visit: patent application information.

Status information of an application includes:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published
  • The application number or the serial number plus any one of the filing date of the national application, the international filing date, or the date of entry into the national stage
  • Whether another application claims the benefit of the application, and if so, status information for those applications

This is defined in 37 CFR 1.14(a)(2) and further elaborated in MPEP 102.

USPTO patent assignment records contain valuable information about the ownership and transfer of patent rights. According to MPEP 301.01, these records include:

  • Reel and frame number of the recordation
  • Name of the conveying party (assignor)
  • Name and address of the receiving party (assignee)
  • Patent or application number
  • Date of execution
  • Date of recordation

The MPEP further states: The actual assignment document will not be viewable through Assignment Search. Only the bibliographic information contained in the recorded cover sheet will be viewable from the Assignment Search database.

This information helps track the chain of title for patents and applications, which is crucial for determining current ownership and potential licensing opportunities.

What information is available in the USPTO’s assignment database?

The USPTO’s assignment database contains a wealth of information related to patent ownership. According to MPEP 301.01:

‘The USPTO maintains a database containing the assignment records of patents and patent applications. The USPTO also maintains a cumulative index of number of assignments recorded on the day in which they are recorded.’

The database typically includes:

  • Patent or application numbers
  • Names of assignors and assignees
  • Dates of assignment execution and recording
  • Brief descriptions of the interests conveyed
  • Reel and frame numbers for locating documents

This information is crucial for determining the current ownership status of patents and applications, which is essential for various legal and business purposes.

Information about reexamination proceedings is made available to the public in several ways:

  1. Announcement in the Official Gazette:
    • The filing of each request for reexamination (where the full fee has been paid) is announced
    • Reexaminations ordered at the Director’s initiative are also announced
  2. Public inspection of reexamination files:
    • Once scanned into the Image File Wrapper (IFW) system, reexamination files are open to public inspection
    • Files can be accessed through Patent Center on the USPTO website
    • The entire contents of the reexamination file are viewable, except for non-patent literature

Direct quote: ‘All requests for reexamination for which all the requirements of § 1.510 or § 1.915 have been satisfied will be announced in the Official Gazette. Any reexaminations at the initiative of the Director pursuant to § 1.520 will also be announced in the Official Gazette.’ (37 CFR 1.11(c))

Note that a reexamination file is typically not open to inspection until it has been scanned into the IFW system.

What information can the USPTO provide about applications in secrecy order?

The USPTO has strict limitations on providing information about applications under secrecy order:

  • No information about the application can be given without authorization from the appropriate department or agency.
  • The USPTO cannot confirm or deny the existence of such applications.
  • Any inquiries about these applications are referred to the appropriate department or agency.

MPEP 203.08 states: ‘For applications bearing a secrecy order pursuant to 35 U.S.C. 181, no information will be provided concerning the application without authorization from the appropriate department or agency.’

To learn more:

While national offices are generally restricted from allowing access to international patent applications, they can disclose limited information. According to MPEP 110, which cites PCT Article 30(2)(b), national offices may inform third parties that they have been designated and publish this fact. However, such information or publication is limited to:

  • Identification of the receiving Office
  • Name of the applicant
  • International filing date
  • International application number
  • Title of the invention

This provision allows for some transparency in the patent process while still maintaining the confidentiality of the application’s details.

For more information on international patent applications, visit: international patent applications.

For unpublished patent applications, access to information is more restricted and typically limited to the applicant or their registered representative. Here’s what you need to know:

  • Unpublished application information is available through Private PAIR.
  • You must associate a Customer Number with your application to access this information.
  • If you’re not the applicant or authorized representative, access may be restricted due to confidentiality rules.

The MPEP states: In private PAIR, an applicant (or applicant’s registered patent attorney or registered patent agent) can securely track the progress of applicant’s application(s) through the USPTO. Private PAIR makes available information relating to unpublished patent applications, but the applicant must associate a Customer Number with the application to obtain access. (MPEP 203.08)

For more information on Customer Number practice, refer to MPEP § 403.

To learn more:

What information can be provided in response to status inquiries?

The USPTO has strict guidelines on the information that can be provided in response to status inquiries. MPEP 203.08 states:

“In no event will the following information be given over the telephone: (A) Filing date of applications; (B) Whether an application has been allowed, abandoned, or issued; (C) The date of allowance, abandonment or issue; and (D) Whether an assignment has been recorded.”

This policy is designed to protect the privacy and confidentiality of patent applications. Applicants or their representatives must use official channels, such as Private PAIR or written requests, to obtain such specific information.

To learn more:

For provisional applications, the USPTO can provide the following information:

  • Application number
  • Filing date
  • Whether the application is pending or abandoned
  • Expiration date

It’s important to note that provisional applications are not published, so no additional information beyond these basic details is available to the public.

For pending or abandoned applications that have not been published, the Office may only confirm that an application has been filed, provide the application number and filing date, the inventorship information, the classification, and the group art unit assigned to the application. This limited information is available to the public to help avoid infringement of pending patent rights.

According to MPEP 102, for national stage applications or applications claiming the benefit of a published international application:

“Only the serial number and filing date, or application number, as well as whether the application is pending, abandoned, or patented may be given for the national stage application and for any applications claiming the benefit of the filing date of the referenced published international application. Other information contained on the continuity data screen, such as whether the application is a CIP, continuation or divisional application, the date of abandonment of the application and issue date may be confidential information and should not be communicated.”

To request this information, a copy of the first page of the published international application or the corresponding page of the PCT Gazette must be supplied with the status request to the International Patent Legal Administration.

For more information on international applications, visit: international applications.

For more information on status information, visit: status information.

Under MPEP 102, limited information about a pending application can be obtained, including:

  • Application number
  • Filing date
  • Whether the application has been published
  • Whether the application has been assigned
  • Power of attorney
  • Name of the examiner to whom the application is assigned
  • Status of the application (e.g., pending, abandoned, or issued)
  • Group art unit number
  • Filing receipt information
  • If available, projected publication date

However, access to the application file itself is restricted unless special circumstances apply or the application has been published.

The USPTO has strict rules about what information can be disclosed regarding unpublished patent applications. According to 37 CFR 1.14(a)(2), only limited status information may be communicated to the public if the application is identified in a published patent document or in another application. This status information includes:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published under 35 U.S.C. 122(b)
  • The application’s numerical identifier (application number or serial number plus filing date)
  • Whether another application claims benefit of the application, and if so, the numerical identifier, relationship, status, and publication status of that application

No other information about unpublished applications can be disclosed without proper authorization.

The front page of a patent includes the following information regarding foreign priority claims:

  • The country of the foreign application
  • The filing date of the foreign application
  • The number of the foreign application

This information is included for applications where the bib-data sheet has been properly endorsed. As stated in the MPEP: “The front page of the patent when it is issued, and the listing in the Official Gazette, will refer to the claim of priority, giving the country, the filing date, and the number of the foreign application in those applications in which the bib-data sheet has been endorsed.” (MPEP 202)

The front page of a patent issuing from a continued prosecution application (CPA) filed under 37 CFR 1.53(d) contains specific information about prior applications.

As stated in the MPEP: The front page of a printed patent issuing on a continued prosecution application (CPA) filed under37 CFR 1.53(d)will identify the application number and filing date of the most recent noncontinued prosecution application (but not the filing date of the CPA) as well as all prior applications from which benefit was claimed in the most recent noncontinued prosecution application. (MPEP 202)

This means that for a CPA:

  • The application number and filing date of the most recent non-CPA application are shown
  • The CPA’s own filing date is not displayed
  • All prior applications claimed as benefit in the most recent non-CPA application are listed

This information helps establish the continuity and priority of the patent application.

For more information on benefit claims, visit: benefit claims.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent front page, visit: patent front page.

For more information on prior applications, visit: prior applications.

When filing a patent application with an unavailable joint inventor, you must include the last known address of the nonsigning inventor. As stated in MPEP 409.03(a):

“The last known address of the nonsigning joint inventor must be stated.”

For more details on providing this information, refer to MPEP 409.03(e). This requirement helps the USPTO in potential future communications and establishes that efforts were made to locate the inventor.

To learn more:

Certain information about patent applications is publicly available, even if the full application is not. According to 37 CFR 1.14(a)(1)(ii) and (iii), for published applications, the following information may be communicated without a petition for access:

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published under 35 U.S.C. 122(b)
  • The application “numerical identifier” (application number or serial number plus filing date)
  • Whether another application claims the benefit of the application

For published applications, “A copy of the application-as-filed, the file contents of the application, or a specific document in the file of a pending published application may be provided to any person upon request and payment of the appropriate fee set forth in §1.19(b).”

However, for unpublished applications, this information is generally not available to the public unless the application is identified or relied upon in a patent document or other published application.

For more information on patent applications, visit: patent applications.

For more information on public information, visit: public information.

The USPTO can disclose limited information about patent applications to the public, as outlined in 37 CFR 1.14(a)(2):

  • Whether the application is pending, abandoned, or patented
  • Whether the application has been published
  • The application’s numerical identifier
  • Whether another application claims benefit of the application

This information can only be disclosed if the application is identified in a published patent document or in another application as specified in 37 CFR 1.14(a)(1)(i) through (a)(1)(vi).

If the assignor is not available to correct an original document or execute a new one, the assignee has an alternative option. According to MPEP 323.01(b):

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction.

To complete this process, the assignee must provide:

  • An affidavit or declaration identifying the error and requesting correction
  • A copy of the originally recorded papers
  • A cover sheet
  • The required fee for each application or patent to be corrected (as per 37 CFR 3.41)

To learn more:

If your foreign application was not filed in a participating Priority Document Exchange (PDX) office, you may still be able to use the PDX program under certain conditions. According to 37 CFR 1.55(i)(4):

If the foreign application was not filed in a participating foreign intellectual property office, but a copy of the foreign application was filed in an application subsequently filed in a participating foreign intellectual property office that permits the Office to obtain such a copy, the applicant must also file a request in a separate document that the Office obtain a copy of the foreign application from the participating intellectual property office.

To make this request, you can use Form PTO/SB/38 (Request to Retrieve Electronic Priority Application(s)). The request must identify the participating office and the subsequent application by application number, country, and filing date.

To learn more:

If you need to assign a patent application before it’s filed, you must identify it using specific information. MPEP 302.03 states: “If an assignment of a patent application filed under § 1.53(b) of this chapter is executed concurrently with, or subsequent to, the execution of the patent application, but before the patent application is filed, it must identify the patent application by the name of each inventor and the title of the invention so that there can be no mistake as to the patent application intended.” This ensures that the correct application is associated with the assignment, even without an application number.

To learn more:

When one of multiple practitioners of record is suspended, the USPTO continues to communicate with the remaining unsuspended practitioners. MPEP § 407 provides guidance for this situation: “This form paragraph should be used when there is at least one registered practitioner still of record who has not been suspended or excluded from practice.” The Office action is mailed to the first named unsuspended registered practitioner at their address of record. Additionally, to ensure timely receipt, a copy is also sent to the first named applicant’s address of record.

For more information on USPTO communication, visit: USPTO communication.

When a Secrecy Order case is in condition for allowance, the prosecution is closed, but the patent is not issued. According to the MPEP, When a Secrecy Order case is in condition for allowance, a notice of allowability (Form D-10) is issued, thus closing the prosecution. This is in accordance with 37 CFR 5.3(c). The application remains in this state until the Secrecy Order is rescinded.

For more information on notice of allowability, visit: notice of allowability.

When a power of attorney is accepted from less than all applicants or owners, it results in multiple parties prosecuting the application simultaneously. The MPEP states:

“The acceptance of such papers by petition under 37 CFR 1.36(a) or 1.183 will result in more than one attorney, agent, applicant, or owner prosecuting the application at the same time. Therefore, each of these parties must sign all subsequent replies submitted to the Office.”

This means:

  • All involved parties must sign subsequent documents.
  • The USPTO will indicate who must sign future replies.
  • Double correspondence is not permitted.
  • Correspondence will be mailed to the attorney or agent if one is involved.
  • If multiple attorneys are involved, correspondence goes to the first-named attorney unless all parties agree otherwise.

To learn more:

What happens to the status of the prior application when filing a CPA?

When filing a Continued Prosecution Application (CPA), the status of the prior application changes. According to MPEP 201.06(d):

The filing of a CPA is not a filing of a new application. Rather, a CPA is a continuation of the prior application and maintains the same application number as the prior application, i.e., the application number of the prior application is used as the application number for the CPA.

This means that:

  • The prior application is not abandoned
  • The CPA continues the examination process of the prior application
  • The same application number is retained for the CPA

It’s important to note that while the CPA continues the examination, it is treated as a new application for all other purposes under the patent statute and rules.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

What happens to the priority date in a divisional application?

The priority date of a divisional application remains the same as its parent application, provided that the proper procedures are followed. According to MPEP 201.06:

‘A later-filed application which is filed before the patenting or abandonment of or termination of proceedings on an earlier-filed application and which is an application for an invention which is disclosed and claimed in the earlier-filed application is an application for a ‘divisional’ of the earlier-filed application.’

This means that:

  • The divisional application retains the priority date of the parent application for the subject matter disclosed in the parent.
  • This is crucial for establishing the effective filing date for prior art purposes under 35 U.S.C. 100(i).
  • The applicant must ensure that a proper reference to the parent application is made in the divisional to maintain this priority.

Maintaining the original priority date is one of the key advantages of filing a divisional application, as it allows the applicant to protect different aspects of their invention without losing the benefit of the earlier filing date.

For more information on Divisional application, visit: Divisional application.

For more information on effective filing date, visit: effective filing date.

What happens to the prior application when a CPA is filed?

When a Continued Prosecution Application (CPA) is filed, the prior application is automatically abandoned. According to MPEP 201.06(d):

The filing of a CPA is not a filing of a new application. Rather, a CPA is a continuation of the prior application and maintains the same application number as the prior application, i.e., a “streeting” of the prior application.

This means that:

  • The prior application is considered abandoned as of the filing date of the CPA.
  • The CPA is not assigned a new application number but continues under the number of the prior application.
  • All correspondence for the CPA should refer to the original application number.

It’s important to note that this automatic abandonment of the prior application is a key feature of CPA practice, distinguishing it from other types of continuing applications.

To learn more:

What happens to the prior application when a Continued Prosecution Application (CPA) is filed?

When a Continued Prosecution Application (CPA) is filed, it has specific effects on the prior application. According to MPEP 201.06(d):

‘The filing of a CPA is a specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in the request for a CPA. Such a specific reference will constitute a waiver of confidentiality of the prior design application(s) under 35 U.S.C. 122 when the CPA is pending and/or any ex parte reexamination proceeding is pending in the prior design application(s).’

This means:

  • The prior application becomes part of the record of the CPA
  • Confidentiality of the prior application is waived
  • The CPA is considered a continuation of the prior application
  • The prior application is not automatically abandoned, but will be abandoned if the issue fee is not paid

It’s important to note that while the CPA continues the examination process, the prior application remains a distinct entity until it is either allowed to go abandoned or is explicitly abandoned by the applicant.

To learn more:

Tags: CPA

When inventorship is corrected in a patent application, it can affect the power of attorney. For applications filed on or after September 16, 2012, 37 CFR 1.32(e) provides:

If the power of attorney was granted by the originally named inventive entity, and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.

This means that if a new inventor is added and does not provide a power of attorney consistent with the original one, the original power of attorney is lost when the request to correct inventorship is granted. However, this provision does not prevent a practitioner from acting in a representative capacity under 37 CFR 1.34, if applicable.

It’s important for applicants and their representatives to be aware of this potential consequence when correcting inventorship and to take appropriate action to maintain or update the power of attorney as needed.

To learn more:

When an inventor is added to a pre-AIA patent application through a 37 CFR 1.48 request, it can affect the existing power of attorney. According to MPEP 402.05(b):

If the power of attorney was granted by the originally named inventive entity and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.

This means that if a new inventor is added and doesn’t provide a power of attorney consistent with the original one, the original power of attorney is lost. However, this doesn’t prevent a practitioner from acting under 37 CFR 1.34, which allows for acting in a representative capacity.

To learn more:

To learn more:

The death of an inventor (or one of the joint inventors) typically terminates the power of attorney given by the deceased inventor in an application filed before September 16, 2012, unless the power of attorney is coupled with an interest (e.g., the patent practitioner is an assignee or part-assignee). As stated in MPEP 409.01(b):

“Unless a power of attorney is coupled with an interest (i.e., a patent practitioner is assignee or part-assignee), the death of the inventor (or one of the joint inventors) terminates the power of attorney given by the deceased inventor in an application filed before September 16, 2012.”

In such cases, a new power of attorney from the heirs, administrators, executors, or assignees is necessary if the deceased inventor was the sole inventor or if all powers of attorney in the application have been terminated.

To learn more:

What happens to the parent application when a divisional application is filed?

When a divisional application is filed, the parent application continues to be prosecuted independently. The filing of a divisional application does not automatically affect the status or prosecution of the parent application.

As stated in MPEP 201.06: “The divisional application may be filed either while the original application is still pending or after it has been patented.” This means that:

  • If the parent application is pending, it remains pending and continues through the examination process.
  • If the parent application has already been granted as a patent, it remains a valid patent.

It’s important to note that while the divisional application is independent, it must contain claims to a different invention than the parent application. The examiner will ensure that there is no double patenting between the parent and divisional applications.

Additionally, if the divisional application is filed in response to a restriction requirement in the parent application, the applicant should consider canceling the claims in the parent application that are now being pursued in the divisional to avoid potential issues with duplicate claims.

For more information on Divisional application, visit: Divisional application.

For more information on parent application, visit: parent application.

For more information on patent prosecution, visit: patent prosecution.

What happens to the parent application when a continuation is filed?

Filing a continuation application does not automatically affect the status of the parent application. As stated in MPEP 201.07:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 363 while the prior application is pending, or after the prosecution and patent term adjustment time periods have expired, or after the prior application has become abandoned or issued as a patent.’

This means that:

  • If the parent application is still pending, it remains active and can continue through the examination process.
  • If the parent application has already been issued as a patent, it remains a valid patent.
  • If the parent application has been abandoned, filing a continuation does not revive it.

It’s important to note that while a continuation can be filed at various stages of the parent application’s lifecycle, the applicant may need to make strategic decisions about how to proceed with the parent application. For example:

  • They may choose to abandon the parent application in favor of the continuation.
  • They may continue prosecuting both applications simultaneously.
  • They may allow the parent to issue as a patent and use the continuation to pursue additional claims.

The choice often depends on the specific circumstances and the applicant’s patent strategy.

For more information on continuation application, visit: continuation application.

After acceptance of a Pre-AIA 37 CFR 1.47 application, the non-signing inventor retains certain rights and responsibilities:

  • They are considered a joint inventor and will be named on any patent that may issue.
  • They have the right to access the application file and receive notices from the USPTO.
  • They can still submit an executed oath or declaration, which would then be entered into the file.

As stated in MPEP 409.03(j): ‘The fact that an application was accepted and prosecuted pursuant to 37 CFR 1.47 does not alter the rights or obligations of any of the inventors with regard to the application or any patent issuing thereon.’

To learn more:

To learn more:

The inventorship in a Continued Prosecution Application (CPA) generally carries over from the prior application, unless specific steps are taken to change it. The MPEP states:

The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If an inventor needs to be added or deleted in a CPA after it has been filed, a request under 37 CFR 1.48 must be submitted, along with the required fee.

For more information on patent applications, visit: patent applications.

What happens to the filing date when converting a provisional application to a nonprovisional application?

When converting a provisional application to a nonprovisional application, the filing date of the nonprovisional application will be the filing date of the provisional application. This is stated in MPEP 601.01(c):

“The filing date of the provisional application is the filing date of the nonprovisional application.”

However, it’s important to note that this conversion must be done within 12 months of the provisional application’s filing date. If the conversion is not done within this timeframe, the nonprovisional application will receive a new filing date.

To learn more:

Terminal disclaimers filed in a parent application do not automatically carry over to a divisional application. The MPEP 201.06 states:

‘A terminal disclaimer filed to obviate a nonstatutory double patenting rejection in a parent application does not carry over to a divisional application. The applicant filing the divisional application must determine whether a new terminal disclaimer needs to be filed in the divisional application.’

This means:

  • Terminal disclaimers from the parent application are not automatically applied to the divisional
  • The applicant must assess whether a new terminal disclaimer is necessary for the divisional application
  • If required, a new terminal disclaimer must be filed specifically for the divisional application

It’s important for applicants to review potential double patenting issues in the divisional application and file new terminal disclaimers if needed to overcome any rejections.

To learn more:

What happens to pending patent applications when a practitioner is suspended or excluded?

When a patent practitioner is suspended or excluded, the Office of Enrollment and Discipline (OED) Director must review all pending patent applications to determine if immediate action is necessary. According to MPEP 407:

“The OED Director will review all pending applications, in which the suspended or excluded practitioner is the attorney or agent of record, and notify the applicant of the suspension or exclusion and of the limited recognition of the practitioner.”

This process ensures that applicants are aware of their practitioner’s status and can take appropriate action to protect their patent applications.

For more information on pending applications, visit: pending applications.

When a patent practitioner dies, the MPEP 406 outlines the following procedure:

  • The Office will notify the applicant of the death of the practitioner.
  • The applicant must appoint a new registered patent practitioner or file a change of correspondence address.
  • This must be done within the time period set in the notice, which is usually 3 months.
  • If no action is taken, the application may be deemed abandoned.

As stated in the MPEP: “If notification of the death of the practitioner is received by the Office, the Office will notify the applicant of the death and the need to appoint a new registered patent practitioner or file a change of correspondence address.”

For more information on patent practitioner death, visit: patent practitioner death.

For more information on pending applications, visit: pending applications.

For more information on USPTO notification, visit: USPTO notification.

According to MPEP 508.02, “After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender. If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW.”

This means that any documents received after a patent is granted or an application is abandoned will not be added to the official record. Instead, they will be either physically returned to the sender or, if already scanned into the Image File Wrapper (IFW) system, electronically closed within the system.

According to MPEP 508.02, after a patent application is either patented or abandoned, any incoming communication that is not intended to become part of the official record will be returned to the sender. The MPEP states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This procedure ensures that the official patent file remains accurate and contains only relevant information after the application process has concluded.

To learn more:

For originally submitted drawings on paper that are photographs or in color, the USPTO has a specific procedure. According to MPEP 608.02(c):

Originally submitted drawings on paper that are photographs or in color may be maintained in an artifact folder.

This means that:

  • Original paper drawings that are photographs or color drawings are not necessarily scanned and stored electronically.
  • These original drawings may be kept in a physical artifact folder.
  • The artifact folder is likely maintained separately from the electronic file wrapper to preserve the original quality of the drawings.

This practice ensures that the original quality of photographs and color drawings is preserved, which can be important for certain types of patent applications where the precise details or colors in the drawings are crucial.

To learn more:

According to MPEP 317, original documents submitted to the USPTO Assignment Division are handled as follows:

After filming, the documents are returned to the sender or destroyed.

This means that once the Assignment Division has processed and recorded the documents, the original physical copies are not retained by the USPTO. If you need a copy of a recorded document, you can request a certified copy from the USPTO for a fee.

For more information on Assignment Division, visit: Assignment Division.

For more information on Document retention, visit: Document retention.

For more information on Original documents, visit: Original documents.

For more information on USPTO, visit: USPTO.

In a pre-AIA 37 CFR 1.47 application, nonsigning inventors are notified of the application filing. The MPEP states: The U.S. Patent and Trademark Office will notify the nonsigning inventor(s) or, if the inventor is deceased, the legal representative(s), of the filing of an application under pre-AIA 37 CFR 1.47 by sending a letter to the last known address of the nonsigning inventor(s) or legal representative(s).

This notification process ensures that all inventors, even those who didn’t sign the application, are aware of the patent application filed using their invention. It’s important to note that this notification is a courtesy and doesn’t require a response from the nonsigning inventor for the application to proceed.

To learn more:

To learn more:

When you notify the USPTO of a loss of micro entity status, you are automatically treated as a small entity by default, unless specified otherwise. As stated in MPEP 509.04(e):

A notification that micro entity status is no longer appropriate will not be treated as a notification that small entity status is also no longer appropriate unless it also contains a notification of loss of entitlement to small entity status under § 1.27(f)(2) [§ 1.27(g)(2)].

To change to regular (unreduced) fee status, you must either:

  • File a notification of loss of entitlement to micro entity status along with regular unreduced fees or an indication of loss of entitlement to small entity status, or
  • File a separate notification of loss of entitlement to small entity status.

To learn more:

After patent prosecution, the handling of models, exhibits, or specimens depends on their nature and the applicant’s wishes. According to MPEP 608.03(a):

‘Upon conclusion of the prosecution of the application, model, exhibit, or specimen, unless the model, exhibit, or specimen has been destroyed during prosecution, the model, exhibit, or specimen may be returned to the applicant upon request and at applicant’s expense.’

If the applicant doesn’t request their return, the USPTO may dispose of them. It’s important for applicants to communicate their wishes regarding these items after prosecution.

To learn more:

After a patent application is allowed, the handling of models, exhibits, or specimens depends on their size and nature. According to MPEP 608.03(a):

Upon notification from the Office of Patent Application Processing (OPAP) that an application is being allowed, the model, exhibit, or specimen is transferred to a permanent location for storage.

The specific handling process varies:

  • Small items: Transferred to the File Information Unit for permanent storage.
  • Large items: Photographed, if practical, and then disposed of, unless a specific request is made for return to the applicant.

It’s important to note that the USPTO may dispose of the models, exhibits, or specimens at its discretion two months after the application is allowed.

To learn more:

When filing a Continued Prosecution Application (CPA), previously filed Information Disclosure Statements (IDS) are handled as follows:

  • All IDSs filed in the prior application that comply with 37 CFR 1.98 are automatically considered in the CPA
  • No specific request is needed for the examiner to consider the previously submitted information
  • New IDSs can be filed in the CPA and will be considered if they comply with the content requirements and are filed before the first Office action

The MPEP states: All information disclosure statements filed in the prior application that comply with the content requirements of 37 CFR 1.98 will be considered in a CPA by the examiner. No specific request that the previously submitted information be considered in a CPA is required.

For more information on patent applications, visit: patent applications.

After a patent is granted or an application is abandoned, the USPTO has specific procedures for handling incoming communications. According to the MPEP, After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.

In the case of digital documents, the MPEP states, If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW. This means that the document will be marked as closed in the digital system, effectively removing it from active consideration.

For more information on post-grant communications, visit: post-grant communications.

For more information on USPTO procedures, visit: USPTO procedures.

When a new power of attorney is filed, it generally revokes all prior powers of attorney. MPEP 402.05(a) provides several scenarios:

  • If a new power of attorney is filed without explicitly revoking prior ones, it will be treated as a revocation of the original power of attorney.
  • If an assignee files a new power of attorney, it revokes and replaces the original power of attorney filed by the applicant.
  • If a power of attorney is given to practitioners associated with a Customer Number, and a second power of attorney is later received for a different Customer Number, the second one will replace the first.

The MPEP states:

In all of these situations, the most recently filed power of attorney will control.

This means that the latest power of attorney filed will take precedence over any previously filed ones.

To learn more:

Documents and cover sheets submitted for recording at the USPTO Assignment Division are examined for formal requirements. The process is as follows:

  • Documents that meet the requirements are recorded.
  • Documents that do not meet the requirements are returned to the sender with an explanation.
  • If the sender disagrees with the rejection, they can petition the Director under 37 CFR 1.181.
  • After successful recording, a notification is sent to the address on the cover sheet, showing the reel and frame number.

As stated in MPEP 317: “All documents and cover sheets submitted for recording are examined for formal requirements in the Assignment Division in order to separate documents which are recordable from those which are not recordable.”

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications. This also applies to continuation or divisional applications of applications filed before June 8, 1995. The MPEP states:

“A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.”

This change in procedure highlights the importance of using the correct application type and filing method after the deletion of 37 CFR 1.62.

What happens to continuation or divisional applications filed after a CPA in a design application?

Continuation or divisional applications filed after a Continued Prosecution Application (CPA) in a design application are treated differently than those filed after a CPA in a utility or plant application. According to MPEP 201.06(d):

Any continuation or divisional application filed under 37 CFR 1.53(b) after the filing of a CPA of a design application will be assigned a new application number and will reflect the filing date of the 37 CFR 1.53(b) application.

This means that unlike utility or plant applications, where a continuation or divisional application would get the benefit of the CPA’s filing date, in design applications, these subsequent applications are treated as new applications with their own filing dates.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

The MPEP clearly states that All continuation and divisional applications filed under 37 CFR 1.60 prior to December 1, 1997 will continue to be processed and examined under the procedures set forth in former 37 CFR 1.60. This means that applications filed before the cutoff date are grandfathered in and will be processed according to the old rules, ensuring consistency in the handling of these earlier applications.

To learn more:

To learn more:

What happens to conditional assignments at the USPTO?

Conditional assignments are treated differently by the USPTO’s Assignment Division. The MPEP 317 states:

“Conditional assignments are returned to the sender by the Assignment Division.”

This means that if an assignment includes conditions that must be met before it becomes effective, the USPTO will not record it. Instead, the Assignment Division will return the document to the sender. It’s important for patent applicants and owners to ensure that any assignments submitted for recording are unconditional to avoid delays in processing.

For more information on Assignment Division, visit: Assignment Division.

For more information on conditional assignments, visit: conditional assignments.

For more information on USPTO procedures, visit: USPTO procedures.

When claims are canceled during the patent prosecution process, it’s important to note that the remaining claims should not be renumbered. This is explicitly stated in MPEP 608.01(j):

“When claims are canceled the remaining claims must not be renumbered.”

This rule helps maintain consistency and clarity throughout the prosecution process, allowing for easy tracking of claim history and amendments. It’s crucial for patent applicants and attorneys to adhere to this guideline to avoid confusion and potential issues with the USPTO.

To learn more:

The MPEP clearly states: “All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.”

This means that applications filed under the File Wrapper Continuing Procedure before its deletion will be processed according to the rules that were in place at the time of filing. For more detailed information on these procedures, you can refer to the MPEP 8th Edition, Rev. 1 (February 2003), which is available on the USPTO website.

For more information on patent examination, visit: patent examination.

The MPEP clearly states that All continuation and divisional applications filed under 37 CFR 1.60 prior to December 1, 1997 will continue to be processed and examined under the procedures set forth in former 37 CFR 1.60. This means that if you filed a continuation or divisional application before the rule change, your application will still be handled according to the old procedures, ensuring consistency in the examination process for applications filed under the former rule.

For more information on continuation applications, visit: continuation applications.

Access restrictions on patent applications change significantly after publication. According to MPEP 106, “Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.”

This means that once a patent application is published, typically 18 months after the earliest filing date, any previously imposed restrictions on access, including those on the inventor, are lifted. The application becomes publicly accessible, aligning with the USPTO’s goal of promoting transparency in the patent process.

For more information on public availability, visit: public availability.

For more information on USPTO procedures, visit: USPTO procedures.

After an application becomes abandoned, it is no longer pending and is removed from the USPTO’s active files. The application file, however, is retained in storage for a period as determined by the USPTO. During this retention period, certain actions may still be possible:

1. The applicant may file a petition to revive the application if the abandonment was unintentional or unavoidable.
2. The application may serve as a basis for claiming benefit in a later-filed application, subject to certain conditions.
3. The application may be used as prior art against other applications.
4. The public may request access to the application file if it has been opened to public inspection.

It’s important to note that once an application is abandoned, it cannot be used as the basis for a statutory invention registration. For more details on abandoned applications, see MPEP 203.05 and MPEP 711.

When a petition to ‘expunge’ a document is granted, the document is not completely removed from the USPTO assignment records. According to MPEP 323.01(d):

Even if a petition to ‘expunge’ a document is granted with respect to a particular application or patent, the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number, and the image will appear when someone views that reel and frame number.

However, the USPTO takes steps to limit the visibility of the expunged document:

  • Links to the application or patent subject to the petition are deleted.
  • The document won’t appear in searches for that application or patent number in the Assignment Historical Database.
  • A redacted version of the ‘expunged’ document is recorded and appears in the assignment records instead of the original document.

To learn more:

When filing a Continued Prosecution Application (CPA), amendments and information disclosure statements (IDS) from the prior application are handled as follows:

  • Amendments: The MPEP states, “Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph.” Applicants are encouraged to file any preliminary amendments at the time of filing the CPA.
  • Information Disclosure Statements: According to the MPEP, “All information disclosure statements filed in the prior application that comply with the content requirements of 37 CFR 1.98 will be considered in a CPA by the examiner.” No specific request for consideration is required.

It’s important to note that amendments or IDSs filed after the CPA filing date could delay prosecution. The MPEP advises, “Applicants are also encouraged to file all preliminary amendments at the time of filing a CPA because the entry of any preliminary amendment filed after the filing date of the CPA could be denied under 37 CFR 1.115 if the preliminary amendment unduly interferes with the preparation of a first Office action.”

For more information on patent application procedures, visit: patent application procedures.

Affidavits or declarations from a prior application do not automatically become part of a continuation or divisional application filed under 37 CFR 1.53(b). If an applicant wants to rely on these documents, they must take specific actions:

  1. Make remarks of record in the new application referring to the affidavit or declaration.
  2. Include a copy of the original affidavit or declaration filed in the prior application.

The MPEP states: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the prior nonprovisional application do not automatically become a part of a continuation or divisional application filed under 37 CFR 1.53(b). Where it is desired to rely on an earlier filed affidavit or declaration, the applicant should make such remarks of record in the 37 CFR 1.53(b) application and include a copy of the original affidavit or declaration filed in the prior nonprovisional application.

It’s important to note that this rule doesn’t apply to continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), where affidavits and declarations do automatically become part of the new application.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

When an abandoned application is later revived, it retains its original filing date. The revival process effectively removes the abandonment status, allowing the application to continue prosecution. However, the period of abandonment may impact patent term adjustment calculations. For more information on revival procedures, refer to MPEP 711 and 37 CFR 1.137.

What happens to a provisional application after one year?

A provisional application automatically becomes abandoned 12 months after its filing date. The MPEP 201.04 states:

‘A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.’

This means that after the 12-month period, the provisional application cannot be revived or extended. To maintain the benefit of the provisional filing date, you must file a nonprovisional application claiming priority to the provisional within this 12-month window. If you fail to do so, you lose the benefit of the earlier filing date, and the subject matter of the provisional becomes part of the prior art.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

What happens to a provisional application after 12 months?

A provisional application automatically becomes abandoned 12 months after its filing date. The MPEP states: ‘A provisional application will automatically become abandoned 12 months after its filing date pursuant to 35 U.S.C. 111(b)(5).’ This means that:

  • The application is no longer pending
  • It cannot be revived
  • No patent will directly result from a provisional application

To benefit from the provisional application, the applicant must file a nonprovisional application claiming priority to the provisional within the 12-month period. For more details, refer to MPEP 201.04.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

The death of a named principal or assignee can have significant implications for an existing power of attorney in a patent application. According to MPEP 402.05:

The death of the principal may terminate the power of attorney given by him or her depending on the circumstances.

This means that the power of attorney may automatically terminate upon the death of the principal. However, the specific circumstances of each case must be considered. In cases where there are multiple applicants or assignees, the power of attorney may remain in effect for the surviving parties. It’s crucial to notify the USPTO of any changes in the status of the applicant or assignee to ensure proper representation in the patent application process. If necessary, a new power of attorney should be filed by the appropriate party, such as the executor of the deceased’s estate or the remaining applicants.

To learn more:

For applications filed on or after September 16, 2012, 37 CFR 1.32(d) provides that a power of attorney from a prior national application may have effect in a continuing application if:

  1. A copy of the power of attorney from the prior application is filed in the continuing application
  2. The power of attorney was not granted by the inventor
  3. The continuing application does not name an inventor who was not named in the prior application

MPEP 402.02(a) states: “37 CFR 1.32(d) specifically requires that a copy of the power of attorney from the prior application be filed in the continuing application to have effect (even where a change in power did not occur in the prior application).”

If these conditions are not met, a new power of attorney will need to be filed in the continuing application.

A power of attorney given to a suspended or disbarred patent practitioner becomes ineffective. The MPEP states: ‘Any power of attorney given to a practitioner who has been suspended or disbarred by the Office is ineffective, and does not authorize the person to practice before the Office or to represent applicants or patentees in patent matters.’ (MPEP § 407)

During an interference or derivation proceeding, any changes to the power of attorney must be forwarded to a specific board for review. As stated in MPEP 402.05: While an application is involved in an interference or derivation proceeding, any power of attorney or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration. This ensures that the appropriate authority handles changes in representation during these specialized proceedings.

To learn more:

When a patent practitioner dies, their power of attorney is automatically revoked or terminated. According to the MPEP, The power of attorney of a patent practitioner will be revoked or terminated by his or her death. (MPEP 406)

When a patent application has multiple inventors and one of them dies, the process for continuing the application depends on whether there’s a power of attorney in place. According to MPEP 409.01(a):

When an application is being prosecuted by joint inventor-applicants without a joint inventor-applicant or patent practitioner having been granted a power of attorney, and a joint inventor-applicant dies after filing the application, the living joint inventor(s) who are the applicant must submit proof that the other joint inventor-applicant is dead.

Here’s what happens in this scenario:

  • The surviving inventors must provide proof of the deceased inventor’s death to the USPTO.
  • If no legal representative of the deceased inventor intervenes, only the signatures of the living inventors are required on USPTO documents.
  • If a legal representative of the deceased inventor intervenes, they must submit a substitute statement complying with 37 CFR 1.64.
  • Once a legal representative intervenes, signatures from both the living inventors and the legal representative are required on USPTO documents.
  • This requirement continues until the legal representative and living inventors appoint a new representative.

It’s crucial for the surviving inventors to understand these requirements to ensure the application process continues smoothly.

To learn more:

When an inventor dies before filing a patent application, the legal representative (executor, administrator, etc.) of the deceased inventor can make the necessary oath or declaration and apply for the patent. This is specified in 37 CFR 1.42 (pre-AIA), which states:

“In case of the death of the inventor, the legal representative (executor, administrator, etc.) of the deceased inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative must comply with the same requirements and conditions that would have been applicable to the inventor.

To learn more:

If an inventor dies after filing a patent application but before the patent is granted, the process can still continue. According to 37 CFR 1.42 (pre-AIA):

“Where the inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.”

However, MPEP 409.01(b) clarifies that the intervention of the executor or administrator is not compulsory:

“When an inventor dies after filing an application and executing the oath or declaration required by pre-AIA 37 CFR 1.63, the executor or administrator should intervene, but the allowance of the application will not be withheld nor the application withdrawn from issue if the executor or administrator does not intervene.”

This means that while it’s advisable for the legal representative to intervene, the patent application can still proceed to allowance or issuance even without such intervention.

To learn more:

What happens if you don’t file a nonprovisional application within 12 months of a provisional?

If you don’t file a nonprovisional application within 12 months of filing a provisional application, you lose the ability to claim the benefit of the provisional application’s filing date. The MPEP 201.04 states:

“A provisional application automatically becomes abandoned 12 months after its filing date and cannot claim the benefit of any other application.”

This means that after 12 months, the provisional application expires, and you can no longer use it as a basis for priority in a nonprovisional application. If you still want to pursue patent protection for your invention, you would need to file a new application, but you may have lost your priority date and any intervening prior art could potentially be used against your application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

When revoking a power of attorney in a situation where there is no practitioner of record, special considerations apply. The MPEP 402.05 states:

‘If a power of attorney is revoked, and a new power of attorney is not promptly filed, then pursuant to 37 CFR 1.33(a) the correspondence address will be changed to that of the inventor(s) or assignee(s) who last provided a correspondence address.’

This means:

  • The USPTO will change the correspondence address to that of the inventor(s) or assignee(s).
  • The last provided correspondence address by the inventor(s) or assignee(s) will be used.
  • All future communications from the USPTO will be sent to this address.
  • It’s crucial to provide a new power of attorney or update the correspondence address promptly to ensure receipt of important communications.

To learn more:

What happens if there’s an error in the patent grant?

Errors in patent grants are addressed through a specific process outlined in MPEP 308. The manual states:

“If the Office discovers that an error exists in the patent grant, the patentee will be notified and required to submit a request for a certificate of correction.”

This process involves the following steps:

  • The USPTO identifies an error in the issued patent
  • The patentee is notified of the error
  • The patentee must submit a request for a certificate of correction
  • The USPTO issues a certificate of correction to rectify the error

It’s important to note that the certificate of correction becomes part of the patent and is treated as such for all purposes. Patentees should carefully review their patent grants upon receipt to identify any errors promptly and initiate the correction process if necessary.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on Patent correction, visit: Patent correction.

For more information on USPTO procedures, visit: USPTO procedures.

What happens if there’s an error in the foreign priority application number?

If there’s an error in the foreign priority application number, it can lead to serious consequences for the priority claim. The MPEP emphasizes the importance of accuracy:

“Errors in foreign priority claims may jeopardize the applicant’s priority claim.” (MPEP 214.04)

Consequences of errors may include:

  • Rejection of the priority claim
  • Loss of priority date
  • Potential issues with patentability if prior art emerges in the intervening period

If an error is discovered, it’s crucial to promptly file a corrected Application Data Sheet (ADS) or a petition to correct the priority claim, depending on the timing and nature of the error. Always double-check the application number against the original foreign priority document to ensure accuracy.

To learn more:

If there’s an error in your assignment submission, the USPTO will notify you and provide an opportunity to correct the issue. The process differs slightly depending on the submission method:

  • For fax submissions: The USPTO will fax back the entire document, cover sheet, and a “Notice of Non-Recordation” explaining the issue.
  • For electronic (EPAS) submissions: The USPTO will attempt to fax the notice back. If faxing isn’t possible, they may use other means to notify you.

As stated in MPEP 302.09: “If a document submitted by fax is determined not to be recordable, the entire document, with its associated cover sheet, and the Office ‘Notice of Non-Recordation’ will be transmitted via fax back to the sender.”

To correct the error:

  1. Make the necessary corrections to the document or cover sheet
  2. Resubmit the corrected document by mail to the address in 37 CFR 3.27
  3. Timely resubmission may allow you to retain the initial receipt date as the recordation date

Always double-check your submissions for accuracy to avoid delays in recording your assignment.

What happens if there’s an error in my application number?

If you notice an error in your application number, it’s crucial to contact the USPTO immediately. The MPEP states, Any error in the identification of the application number will result in processing delays. (MPEP 503) To avoid such delays:

  • Double-check the application number on your filing receipt
  • If you find an error, contact the Application Assistance Unit at (571) 272-4000
  • Provide the correct application number and any supporting documentation

Prompt action can help ensure your application is processed correctly and efficiently.

For more information on application number, visit: application number.

For more information on error correction, visit: error correction.

Errors in citation numbers for U.S. patents or patent application publications in an e-IDS can be problematic because examiners rely on these numbers to retrieve and review the documents electronically. The MPEP 609.07 addresses this issue:

The only mechanism for having the correct document reviewed and considered when an erroneous U.S. patent or U.S. patent application publication is cited in an e-IDS will be by citing the correct citation number in a subsequent IDS that conforms to the requirements of 37 CFR 1.97 and 1.98.

This means that if you discover an error in a citation number after submitting an e-IDS, you must file a new IDS with the correct citation number to ensure the proper document is considered. It’s crucial to double-check all citation numbers before submitting an e-IDS to avoid such issues.

To learn more:

What happens if there’s an error in a recorded assignment document?

If an error is discovered in a recorded assignment document, it can be corrected through a Certificate of Correction. The MPEP 302 provides guidance on this process:

“Errors in a recorded assignment document will be corrected by the Assignment Division provided a ‘corrective document’ is submitted. The ‘corrective document’ must include the following: … [list of requirements]”

To correct an error, you need to submit:

  • A copy of the original assignment document with the error
  • A ‘corrective document’ explaining the nature of the error and the desired correction
  • New recordation fee for processing the correction

It’s important to address errors promptly to ensure accurate ownership records. The USPTO will review the correction request and update the assignment records accordingly if approved.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on USPTO, visit: USPTO.

If there’s an error in the recorded assignment document itself (not just the cover sheet), the process is different:

  1. The party responsible for the error (e.g., the assignor) must either create and record a new document or make corrections to the original document and re-record it.
  2. If the assignor is unavailable, the assignee can submit an affidavit or declaration identifying the error and requesting correction.

As stated in MPEP 323.01(b), “The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).”

In the event of a postal interruption or emergency, the USPTO will take the following actions:

  • Place an announcement on the USPTO website at www.uspto.gov
  • Publish a notice in the Official Gazette

These communications will provide instructions about filing patent applications and other patent-related papers. As stated in MPEP 511:

“In the event of a postal interruption or emergency, an announcement will be placed on the USPTO website at www.uspto.gov and a notice will be published in the Official Gazette, providing instructions about the filing of patent applications, and other papers related to patent applications and patents.”

This ensures that applicants have clear guidance on how to proceed during such circumstances.

To learn more:

In the event of a postal interruption or emergency:

  • An announcement will be placed on the USPTO website at www.uspto.gov
  • A notice will be published in the Official Gazette
  • These communications will provide instructions about filing patent applications and other papers related to patent applications and patents

The USPTO Director may prescribe rules considering papers or fees filed on the date they would have been deposited with the USPS, but for postal service interruptions or emergencies.

As stated in MPEP 511: “In the event of a postal interruption or emergency, an announcement will be placed on the USPTO website at www.uspto.gov and a notice will be published in the Official Gazette, providing instructions about the filing of patent applications, and other papers related to patent applications and patents.”

If there’s a discrepancy between the USPTO’s date stamp and the date on the correspondence, the USPTO’s date stamp is generally considered the official receipt date. However, if an applicant can provide clear evidence that the correspondence was received earlier than the date indicated by the USPTO’s stamp, the earlier date may be recognized as the official receipt date. This situation might occur due to clerical errors or delays in processing incoming mail.

When multiple correspondence addresses are on file for a patent application, the USPTO follows a specific procedure. According to MPEP 601.03:

‘Where more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.’

This means that the USPTO will choose one address to use, potentially favoring a Customer Number address if provided. To avoid confusion, it’s best to ensure only one clear correspondence address is on file. For more information, visit MPEP 601.03.

To learn more:

When there are multiple applicants for a patent and only some give power of attorney, the USPTO has specific rules to handle the situation. According to MPEP 402:

‘Where a power of attorney is given by fewer than all of the applicants or owners, the power of attorney is not accepted until a petition under 37 CFR 1.36(b) is granted.’

This means:

  • The power of attorney is not automatically accepted if not all applicants have signed it.
  • A petition under 37 CFR 1.36(b) must be filed and granted for the partial power of attorney to be accepted.
  • The petition should explain why it was not possible to obtain signatures from all applicants.
  • The Office of Petitions will review the petition and make a determination.

It’s generally recommended to obtain signatures from all applicants to avoid delays and potential issues with the patent application process.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

What happens if there are insufficient funds when paying USPTO fees?

If there are insufficient funds when paying USPTO fees, several consequences may occur:

  • The fee payment will be considered incomplete.
  • Your application or request may not be processed.
  • You may incur additional fees or penalties.
  • In some cases, you might lose filing date benefits.

The MPEP 509 warns, “If the Office receives a check drawn on a deposit account with insufficient funds, the fee will be considered unpaid.” For electronic payments, “If the electronic fund transfer is refused, or if the credit card is declined or invalid, the fee will be considered unpaid.” It’s crucial to ensure sufficient funds are available to avoid these issues and potential delays in your patent or trademark process.

To learn more:

Tags: USPTO fees

What happens if there are insufficient funds in my USPTO deposit account?

If there are insufficient funds in your USPTO deposit account to cover a fee, the following occurs:

  • The USPTO will treat the fee as unpaid
  • Any associated filing may be considered incomplete
  • You may receive a notice of insufficient funds

The MPEP clearly states: “An overdrawn account will be immediately suspended and no charges will be accepted against it until the balance is restored.” (MPEP 509.01)

To avoid this situation, it’s crucial to maintain sufficient funds in your account and regularly monitor your balance. If your account becomes overdrawn, you’ll need to restore the balance before any further charges can be processed.

To learn more:

Tags: patent fees

When there are inconsistencies between the Application Data Sheet (ADS) and other documents, the ADS generally takes precedence. According to MPEP 601.05(a):

Information in the Application Data Sheet will govern when inconsistent with the information supplied at the same time by a designation of correspondence address or the inventor’s oath or declaration.

However, it’s important to note that this only applies when the inconsistent information is supplied at the same time. If the inconsistency arises later, a corrected ADS may be required to update the information.

To learn more:

What happens if there are inconsistencies between an ADS and other documents?

When inconsistencies exist between an Application Data Sheet (ADS) and other documents, the ADS generally takes precedence. According to MPEP 601.05:

“If an ADS is inconsistent with the information provided in another document that was submitted at the same time or previous to the ADS submission, the ADS will control.”

However, there are exceptions to this rule:

  • For inventorship, the most recent submission will control.
  • For foreign priority and domestic benefit claims, the most recent submission will control, provided it was timely filed.

It’s crucial to ensure all information in the ADS is accurate to avoid potential issues later in the application process.

To learn more:

Tags: ADS, inventorship

When inconsistencies exist between an Application Data Sheet (ADS) and other documents in a patent application, the ADS generally takes precedence. According to MPEP 601.05:

‘Where an ADS is used, the ADS data will govern when inconsistent with the information provided elsewhere in the application, except when the ADS is accompanied by a clear indication that the information in the ADS is not to be used.’

However, it’s important to note that if there’s a clear indication that the information in the ADS should not be used, then other documents may take precedence. Applicants should strive for consistency across all application documents to avoid confusion and potential issues during examination.

To learn more:

Tags: ADS

If priority papers are found to be deficient in material respects, such as failure to include the correct certified copy, applicants should ensure that there is sufficient time to remedy any defects. The MPEP advises: “Frequently, priority papers are found to be deficient in material respects, such as for example, the failure to include the correct certified copy, and applicants should ensure that there is sufficient time to remedy any defects.” It’s recommended to file priority papers as early as possible to allow time for correction if needed.

When multiple parties submit conflicting ownership claims for a patent application, the USPTO has a process to determine which party, if any, will control the prosecution. According to MPEP 325 and 37 CFR 3.73(c)(3):

“Where two or more purported assignees file conflicting 37 CFR 3.73(c) statements in an application or other Office proceeding, the Director will determine which, if any, purported assignee will be permitted to control prosecution of the application.”

The process typically involves the following steps:

  1. The Office official in charge of the application forwards the case to the Office of Patent Legal Administration.
  2. The Office of Patent Legal Administration reviews the conflicting claims and makes a determination.
  3. Generally, the current applicant is allowed to continue prosecution while the dispute is resolved.
  4. The other party claiming ownership may consider filing their own separate application.

It’s important to note that this process is primarily for determining who controls the prosecution of the application. It does not resolve underlying ownership disputes, which may need to be settled through other legal channels.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What happens if there are conflicting correspondence addresses in a patent application?

When conflicting correspondence addresses are present in a patent application, the USPTO follows specific guidelines to determine which address to use. According to MPEP 601.03:

“Where more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.”

In practice, this means:

  • The USPTO will choose one address to use for correspondence.
  • If a Customer Number is provided, it’s likely to be preferred over a typed address.
  • To avoid confusion, it’s best to ensure that only one clear correspondence address is specified in your application.

To learn more:

If the USPTO receives a document without a date of receipt stamp, the Office will assign the document a date of receipt based on other evidence. This may include:

  • The date of receipt indicated on an Express Mail label
  • The date of deposit indicated on a certificate of mailing
  • The date of transmission indicated on a certificate of transmission
  • Other corroborating evidence, such as a postmark on an envelope

In cases where no other evidence is available, the USPTO may assign the date of receipt as the date the document was matched with the file wrapper.

If the USPTO is unable to retrieve a priority document through the Priority Document Exchange (PDX) program, the following occurs:

  • The USPTO will notify the applicant of the unsuccessful retrieval attempt.
  • The applicant will then be required to submit the certified copy of the foreign application.

According to MPEP 215.01, If the foreign certified copy is not received by the USPTO within the pendency of the application and before the patent is granted, the USPTO will notify the applicant that the certified copy of the foreign application has not been received and require the certified copy. It’s crucial for applicants to monitor the status of their priority document and be prepared to submit a certified copy if the electronic retrieval is unsuccessful.

To learn more:

If the USPTO is closed on the priority deadline day, the deadline is extended to the next business day when the office is open. This applies to both scheduled and unscheduled closings.

The MPEP states: When the entire U.S. Patent and Trademark Office is officially closed for business for an entire day, for reasons due to adverse weather or other causes, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21. Any action or fee due on such a day may be taken, or fee paid, on the next succeeding business day the Office is open. (MPEP 213.03)

However, it’s important to note that if the USPTO is open for any part of a business day, papers are due on that day even if the office closes early or opens late due to an unscheduled event.

To learn more:

If the USPTO finds an inventor’s oath or declaration defective, the following actions may occur:

  • For non-reissue applications filed before allowance, non-examiner staff will review the oath or declaration and may send an informational notice about deficiencies.
  • For applications at or after allowance, non-examiner staff will review the oath or declaration and send a requirement to correct any deficiencies.
  • If the oath or declaration is not submitted by the time of allowance, a notice requiring it may be sent with the Notice of Allowability.

As stated in the MPEP, The required inventor’s oath or declaration must be submitted no later than the date on which the issue fee is paid. See 35 U.S.C. 115(f).

To learn more:

If the USPTO fails to retrieve a priority document through the exchange program, the applicant is notified and given an opportunity to correct the issue. According to MPEP 215.02(a):

“If the USPTO is unable to retrieve a copy of the foreign application to which priority is claimed, the applicant will be notified and given an opportunity to provide the missing priority document.”

This ensures that applicants have a chance to submit the required documents manually if the automated system fails.

To learn more:

If the USPTO cannot locate a file after a reasonable search, they will notify the applicant or patentee and set a time period for compliance. According to 37 CFR 1.251(a), the applicant or patentee must respond by:

  • Providing a copy of their record of correspondence with the USPTO
  • Producing their record for the USPTO to copy
  • Stating that they do not possess any record of correspondence

The specific requirements are outlined in the notice and must be followed to avoid potential consequences.

To learn more:

If the specific reference to a prior-filed application is not submitted within the required time period, it is considered a waiver of any benefit claim to that prior application. The MPEP states:

This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c).

However, there is a possibility to accept a late benefit claim. The MPEP provides that: A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

Such a petition must include:

  1. The reference to the prior application
  2. The petition fee
  3. A statement that the delay was unintentional

The Director may require additional information to verify that the delay was indeed unintentional.

For more information on unintentional delay, visit: unintentional delay.

For more information on waiver, visit: waiver.

If the required translation or statement is missing for a non-English provisional application, the following consequences apply:

  1. The USPTO will issue a notice stating that the required documents are missing.
  2. The applicant must supply the missing translation and/or statement in the provisional application.
  3. The applicant must provide confirmation in the present application that the translation and statement were filed in the provisional application.
  4. If these requirements are not met within the time period set by the USPTO, the present application will be abandoned.

As stated in the MPEP, If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned. See 37 CFR 1.78.

For more information on application abandonment, visit: application abandonment.

For more information on missing documents, visit: missing documents.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If the required translation and statement are not filed for a non-English provisional application, serious consequences can occur. According to MPEP ¶ 2.38:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This means that if you fail to provide the English translation and accuracy statement in the provisional application, and fail to confirm their filing in the present application, your current application may be abandoned. It’s crucial to comply with these requirements within the specified time frame to maintain your application’s active status.

For more information on application abandonment, visit: application abandonment.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

If the reference to a prior application is not in the first sentence of the specification, it may still be acceptable under certain conditions. According to MPEP 211.02:

If the reference to the prior application is not in the first sentence of the specification, it may be given limited review. For example, if an application is filed with a preliminary amendment which is present on filing and which contains a reference to the prior application, the application will be taken up for review by the Office of Patent Application Processing (OPAP). OPAP will mail a ‘Notice of Incomplete Application’ indicating that the reference to the prior application needs to be in the first sentence(s) of the specification.

In such cases, the applicant will be given an opportunity to correct the placement of the reference. It’s important to note that while this situation can be remedied, it’s always best practice to include the reference in the first sentence of the specification to avoid potential delays or complications.

To learn more:

Tags: OPAP

What happens if the prior-filed application is a provisional application?

When the prior-filed application is a provisional application, special considerations apply:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (or 14 months with a petition for revival).
  • The provisional application must have adequate written description and enablement support for the claimed invention in the later-filed nonprovisional application.
  • As stated in MPEP 211.01(a): “The 12-month period is subject to 35 U.S.C. 21(b) and 37 CFR 1.7(a).”

It’s important to note that provisional applications cannot claim priority to earlier applications, so the benefit claim can only extend back to the provisional application’s filing date.

To learn more:

If the Office of Patent Application Processing (OPAP) finds patent drawings unacceptable, the following process occurs:

  1. OPAP sends a Notice to File Corrected Application Papers to the applicant.
  2. The applicant is given a two-month period from the mailing date to file acceptable drawings.
  3. This period is extendable under 37 CFR 1.136(a).
  4. The application will not be released to the Technology Centers until acceptable drawings are filed.

As stated in the MPEP: OPAP will send a Notice to File Corrected Application Papers if the drawings are unacceptable for purposes of publication. The notice will give applicant a time period of two (2) months from the mailing date of the notice to file acceptable drawings. This time period for reply is extendable under 37 CFR 1.136(a).

To learn more:

If the Office of Data Management receives drawings that cannot be scanned or are otherwise unacceptable for publication, they will take the following action:

If the Office of Data Management receives drawings that cannot be scanned or are otherwise unacceptable for publication, the Office of Data Management will mail a requirement for corrected drawings, giving applicant a shortened statutory period of two months to reply.

This process ensures that only high-quality, publishable drawings are included in the final patent publication. Applicants should be prepared to respond quickly to such requests to avoid delays in the patent granting process.

To learn more:

If the national stage requirements are not met within the time limit, the application will be considered abandoned. However, there are provisions for reviving an abandoned application under certain circumstances.

MPEP 601.04 explains: “If the basic national fee and copy of the international application are not filed by the expiration of the applicable time period set in 35 U.S.C. 371(b), the application will be considered to be abandoned.” However, the MPEP also notes that “a petition to revive under 37 CFR 1.137 may be granted if the delay was unintentional.”

To learn more:

When the legal representative of a deceased inventor is unavailable, the process depends on whether the application was filed before or after September 16, 2012:

  • For applications filed before September 16, 2012: If the legal representative cannot be found or reached after diligent effort, or refuses to make application, pre-AIA 37 CFR 1.47 applies. In such cases, the last known address of the legal representative must be provided.
  • For applications filed on or after September 16, 2012: The provisions of pre-AIA 37 CFR 1.47 do not apply. Instead, refer to current USPTO regulations and procedures.

It’s important to note that pre-AIA 37 CFR 1.47 is not an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 for deceased inventors. As stated in the MPEP, Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

To learn more:

If the last-known address of an unavailable inventor is invalid, the petitioner must make a diligent effort to find a valid address. According to MPEP 409.03(b):

‘If the last known address of the nonsigning inventor(s) is invalid, petitioner must state what efforts were made to find a current address.’

This means the petitioner should document their attempts to locate the inventor, which may include searching public records, contacting former employers, or using people-finding services. If all efforts fail, this should be clearly stated in the petition.

To learn more:

What happens if the foreign application is not in English?

If the foreign application is not in English, the applicant must provide an English translation of the non-English language application and a statement that the translation is accurate. According to MPEP 213.02:

‘If the foreign application is not in the English language, the applicant must provide an English translation of the non-English language application and a statement that the translation is accurate.’

This requirement ensures that the USPTO can properly examine the application and determine its priority date. The translation and statement must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To learn more:

If the filing fee for a provisional application is not paid, the USPTO will take specific actions as outlined in MPEP 601.01(b):

Quote: “If the filing fee is not paid in the provisional application, the USPTO may dispose of the provisional application. The notification to applicant that the provisional application has been disposed of will include a notice that if the fee is paid within two months of the date of the notification, the provisional application will be revived.”

Key points to remember:

  • The USPTO may dispose of the provisional application if the fee is not paid
  • Applicants will be notified of the disposal
  • There is a two-month window to pay the fee and revive the application
  • If the fee is paid within this period, the application will be revived

It’s crucial to note that if the application is not revived within the two-month period, the opportunity to establish that filing date may be permanently lost, which could have significant implications for patent rights.

To learn more:

If an applicant pays an insufficient fee to the USPTO, the Office will notify the applicant and provide an opportunity to submit the remaining balance. According to MPEP 509:

If the fee paid by the applicant is insufficient, either because the notice specified an incorrect dollar amount for the fee or because of a fee increase effective after the mailing of the notice and before payment of the fee by the applicant, the applicant should be notified in writing by the Office of the fee insufficiency and given a new time period in which to submit the remaining balance.

The notification will include:

  • The reason for the additional fee requirement
  • An explanation of why the original fee was incorrect or insufficient
  • A new time period for submitting the remaining balance

This process helps ensure that applicants have a fair opportunity to complete their fee payments and avoid abandonment of their applications due to fee issues.

To learn more:

If an examiner determines that a continuation or divisional application contains new matter relative to the prior application, the following steps will occur:

  1. The examiner will notify the applicant in the next Office action.
  2. The examiner will indicate that the application should be redesignated as a continuation-in-part (CIP).

According to MPEP 602.05: If the examiner determines that the continuation or divisional application contains new matter relative to the prior application, the examiner should so notify the applicant in the next Office action and indicate that the application should be redesignated as a continuation-in-part.

It’s important to note that:

  • Continuations and divisionals should not contain new matter relative to the prior application.
  • If new matter is present, the application is more appropriately designated as a continuation-in-part.
  • The redesignation as a CIP may have implications for the oath or declaration requirements and the application’s effective filing date for the new subject matter.

Applicants should carefully review their applications to ensure they are correctly designated and contain appropriate oaths or declarations based on their content and relationship to the prior application.

To learn more:

If the drawings in a patent application are not in compliance with the rules, the Office of Patent Application Processing (OPAP) will send a Notice to File Corrected Application Papers. This notice gives the applicant a time period of 2 months from the mailing date to file corrected drawings. The time period is extendable under 37 CFR 1.136(a). If corrected drawings are not timely filed, the application will be held abandoned.

If the date of receipt stamp is illegible or missing, the USPTO will make every effort to determine the correct date of receipt. This may involve examining other evidence, such as postmarks, electronic filing receipts, or other documentation. If the correct date cannot be determined, the USPTO may use the date it was discovered that the document was received as the date of receipt. Applicants should always ensure that their submissions are properly dated and stamped to avoid potential issues with filing dates.

If the certified copy of the foreign application is filed after the issue fee is paid but before the patent is granted, the following occurs:

  • The priority claim or certified copy will be placed in the file record
  • There will be no review of the papers
  • The published patent will not include the priority claim

To have the priority claim considered after publication, a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 must be filed. For original applications filed under 35 U.S.C. 111(a), additional requirements may apply, such as a petition to accept an unintentionally delayed priority claim.

This is outlined in MPEP 215.03.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on certified copy, visit: certified copy.

For more information on issue fee, visit: issue fee.

If the certified copy of the foreign application is filed after the date the issue fee is paid but prior to the date of grant of the patent, it will be placed in the file record but there will be no review of the papers. The patent when published will not include the priority claim. A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 can be filed to have the priority claim considered after publication of the patent.

If the Certificate of Mailing or Transmission is omitted from a paper, the USPTO will treat the paper as though it was not received. According to MPEP 512:

“If the certification of mailing or transmission is omitted and the paper is later received by the U.S. Patent and Trademark Office, the paper will be considered as having been filed as of the date of receipt in the Office.”

This means that without the certificate, the paper’s filing date will be the actual date it’s received by the USPTO, which could potentially be later than intended and may have significant consequences for patent applications or other time-sensitive submissions.

To learn more:

What happens if the basic national fee is not paid on time for US national stage entry?

If the basic national fee is not paid on time for US national stage entry, the application will be considered abandoned. However, the MPEP provides guidance on potential remedies:

If the basic national fee is not paid on time, the Designated (or Elected) Office will declare that the application is considered withdrawn under PCT Article 24(1) or 39(2). However, if the basic national fee is paid later, accompanied by a petition for revival, the Designated (or Elected) Office may excuse the late payment of the basic national fee.

This means that while timely payment is crucial, there may be options to revive the application if the fee is paid late. Applicants should be aware that such petitions typically involve additional fees and are subject to specific requirements and time limits.

To learn more:

If the basic filing fee is not paid when filing a Continued Prosecution Application (CPA), the USPTO will send a notice to the applicant. According to MPEP 201.06(d):

‘If the basic filing fee is not paid when the CPA is filed or within the time period set forth in a notice from the Office, the USPTO will send a Notice to File Missing Parts in the CPA.’

This notice gives the applicant a chance to pay the fee and continue the application process. However, it’s important to note that failing to respond to this notice or pay the required fee within the specified time frame could result in the CPA being abandoned. It’s always best practice to submit all required fees at the time of filing to avoid potential delays or complications in the patent application process.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on Notice to File Missing Parts, visit: Notice to File Missing Parts.

If the assignment has not been recorded before the issue fee payment, the following applies:

  • The request for issuance to the assignee must state that the assignment document has been filed for recordation.
  • This statement should be made in accordance with 37 CFR 3.11.

As stated in 37 CFR 3.81(a): If the assignment has not been previously recorded, the request must state that the document has been filed for recordation as set forth in § 3.11.

If the assignee’s name and address are not identified in item 3 of the Fee(s) Transmittal form (PTOL-85B), the following occurs:

  • The patent will issue to the applicant instead of the assignee.
  • Assignment data printed on the patent will be based solely on the information supplied on the PTOL-85B form.

As stated in the MPEP: Unless an assignee’s name and address are identified in item 3 of the Fee(s) Transmittal form PTOL-85B, the patent will issue to the applicant. Assignment data printed on the patent will be based solely on the information so supplied.

It’s crucial for applicants and assignees to ensure that the correct information is provided on the PTOL-85B form to avoid any issues with patent issuance to the intended party.

If the submitted drawing corrections or changes are not accepted, the examiner will notify the applicant in the next Office action. The MPEP 608.02(x) specifies:

“Where the corrected or changed drawing is not accepted, for example, because the submitted corrections or changes are erroneous, or involve new matter or do not include all necessary corrections, the applicant will be notified and informed of any required corrective action in the next Office action.”

The examiner is required to provide a clear explanation of why the corrections were not approved and what actions the applicant needs to take to address the issues.

To learn more:

To learn more:

If an applicant files an amendment stating that replacement sheets of drawings are included, but these drawings are not found in the Image File Wrapper (IFW), the examiner must take specific action. According to MPEP 608.02(h):

“When an amendment is filed stating that replacement sheets of drawings are filed with the amendment and such drawings are not in the IFW, in the next communication by the examiner, the applicant must be notified that replacement drawings do not appear to have been received and thus have not been entered in the application.”

This notification ensures that the applicant is aware of the missing drawings and can take appropriate action to submit them. It’s important to note that the USPTO will not return drawings to the applicant, as stated in MPEP § 608.02(y).

To learn more:

If prior art figures are not properly labeled in a patent application, the patent examiner will likely issue an objection. According to MPEP 608.02(g), examiners may use form paragraph 6.36.01 to address this issue:

Figure [1] should be designated by a legend such as –Prior Art– because only that which is old is illustrated. See MPEP § 608.02(g). Corrected drawings in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application.

This objection requires the applicant to submit corrected drawings with proper labeling. The MPEP further states that The replacement sheet(s) should be labeled ‘Replacement Sheet’ in the page header (as per 37 CFR 1.84(c)) so as not to obstruct any portion of the drawing figures. If the corrections are not made, the objection will be maintained in subsequent Office actions.

To learn more:

What happens if PDX retrieval of a priority document fails?

If the PDX (Priority Document Exchange) retrieval of a priority document fails, the USPTO will notify the applicant. As stated in MPEP 215.01: The USPTO will notify the applicant of any unsuccessful attempt to electronically retrieve a priority document.

In such cases:

  • The applicant will be given additional time to provide the priority document.
  • The applicant may need to submit a certified copy of the priority document directly.
  • If using WIPO DAS, the applicant should check if the access code is correct and the document is available in the system.
  • The applicant may need to contact the foreign office to ensure the document is accessible through PDX or WIPO DAS.

It’s important to address any retrieval issues promptly to ensure the priority claim is properly documented in the application.

To learn more:

If patent drawings do not comply with the requirements set forth in MPEP 608.02(d), the following process occurs:

  1. The examiner will require additional illustration
  2. A notice will be sent to the applicant
  3. The applicant will have at least two months from the date of the notice to submit corrected drawings
  4. Corrections must comply with 37 CFR 1.81(d)

According to the MPEP: Where the drawings in a nonprovisional application do not comply with the requirements of paragraphs (a) and (b) of this section, the examiner shall require such additional illustration within a time period of not less than two months from the date of the sending of a notice thereof. This process ensures that all necessary details are properly illustrated before the application can proceed.

To learn more:

If OPAP objects to the drawings in a patent application, the following process occurs:

  1. OPAP sends a Notice to the applicant requiring submission of corrected drawings.
  2. The Notice typically sets a time period of two months for response.
  3. Corrected drawings must be filed in paper form to the mailing address specified in the Notice.
  4. No fee is required for filing the corrected drawings requested by OPAP.

MPEP 507 states:

If OPAP objects to the drawings and sends applicant a Notice requiring submission of corrected drawings within a set time period (usually two months), corrected drawings must be filed, in paper, to the mailing address set forth in the Notice, along with any other items required by OPAP, to avoid abandonment of the application. No fee will be necessary for filing corrected drawings which are required by OPAP.

It’s crucial to respond within the set time period to avoid potential abandonment of the application.

What happens if not all joint inventors sign a power of attorney in a patent application?

If not all joint inventors sign a power of attorney in a patent application, the power of attorney is not effective. According to MPEP 402.10:

A power of attorney must be signed by all of the applicants, or all of the assignees of the entire interest, or all parties entitled to prosecute the application, unless otherwise specified.

This means that for the power of attorney to be valid, it must be signed by all parties with the right to prosecute the application. If some inventors haven’t signed, the USPTO will treat the application as if no power of attorney has been appointed.

To learn more:

What happens if not all inventors sign the power of attorney in a pre-September 16, 2012 application?

For applications filed before September 16, 2012, it’s crucial that all inventors who have not assigned their rights sign the power of attorney. According to MPEP 402.02(b):

If no power of attorney is on file, then a party who is not an inventor, but who has given a proper showing of ownership or of authority to take action for and on behalf of all of the applicant may appoint an attorney or agent to prosecute the application, subject to the same exception noted above.

If not all inventors sign, the power of attorney may be considered incomplete or invalid. In such cases, the USPTO may require a new power of attorney signed by all parties with the right to prosecute the application, or may accept communications only from the inventors themselves until the issue is resolved.

To learn more:

Introducing new matter in a divisional application is not allowed and can have serious consequences. According to MPEP 201.06:

“A divisional application is a later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application.”

This means that a divisional application must not contain any new matter beyond what was disclosed in the parent application. If new matter is introduced:

  • The new matter will not be entitled to the benefit of the parent application’s filing date.
  • Claims relying on the new matter may be rejected under 35 U.S.C. 112(a) for lack of written description or enablement.
  • The application may lose its status as a proper divisional, potentially affecting its ability to overcome certain types of double patenting rejections.

To avoid these issues:

  1. Carefully review the divisional application before filing to ensure it only contains subject matter from the parent application.
  2. If new subject matter is necessary, consider filing it as a continuation-in-part (CIP) application instead of a divisional.
  3. Consult with a patent attorney or agent to ensure compliance with MPEP guidelines.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent filing, visit: patent filing.

If your USPTO deposit account becomes overdrawn, several consequences may occur:

  1. Account Suspension: The MPEP states, An overdrawn account will be immediately suspended and no charges will be accepted against it until a proper balance is restored, together with a payment of $10 (37 CFR 1.21(b)(1)) to cover the work done by the U.S. Patent and Trademark Office incident to suspending and reinstating the account and dealing with charges which may have been made in the meantime.
  2. Additional Surcharges: If there’s an authorization to charge a basic filing fee to an overdrawn account, a surcharge under 37 CFR 1.16(f) is required in addition to the basic filing fee.
  3. Potential Abandonment: The MPEP warns, Failure to timely pay the filing fee and surcharge will result in abandonment of the application.
  4. Account Closure: Repeated overdrafts may lead to account closure. If an account is suspended repeatedly it will be closed.

To avoid these issues, always maintain sufficient funds in your deposit account and monitor your account balance regularly.

To learn more:

Tags: USPTO

What happens if my USPTO deposit account balance falls below the minimum?

If your USPTO deposit account balance falls below the minimum required balance of $1,000, there are consequences. According to MPEP 509.01, “An account holder who does not maintain the minimum balance will be notified and given a reasonable time to restore the account to the minimum balance.” If the account is not replenished:

  • The USPTO may close the account.
  • Any fees charged against the account may be treated as unpaid.
  • This could potentially affect the status of your patent applications or other USPTO services.

It’s crucial to monitor your account balance regularly and replenish it promptly when it approaches the minimum to avoid any disruptions in service or potential issues with your patent applications.

To learn more:

If correspondence with a Certificate of Mailing or Transmission is not received by the USPTO after a reasonable amount of time, you can take steps to notify the Office and provide evidence of the previous timely filing. According to 37 CFR 1.8(b):

In the event that correspondence is considered timely filed by being mailed or transmitted in accordance with paragraph (a) of this section, but not received in the U.S. Patent and Trademark Office after a reasonable amount of time has elapsed from the time of mailing or transmitting of the correspondence […] the correspondence will be considered timely if the party who forwarded such correspondence: (1) Informs the Office of the previous mailing or transmission of the correspondence promptly after becoming aware that the Office has no evidence of receipt of the correspondence; (2) Supplies an additional copy of the previously mailed or transmitted correspondence and certificate; and (3) Includes a statement that attests on a personal knowledge basis or to the satisfaction of the Director to the previous timely mailing, transmission or submission.

It’s recommended to check the private Patent Application Information Retrieval (PAIR) System first to see if the correspondence has been entered into the application file before notifying the Office.

When multiple correspondence addresses are provided in a patent application, the USPTO will select one of the specified addresses for use. According to MPEP 601.03(a):

If more than one correspondence address is specified, whether in a single paper or in multiple papers, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

It’s important to note that if the USPTO doesn’t select the address you intended, they will not remail papers to your desired address. To avoid confusion, it’s best to provide clear instructions regarding the correspondence address you wish to use.

To learn more:

What happens if joint inventors can’t agree on filing a patent application?

If joint inventors cannot agree on filing a patent application, it can lead to complications. According to MPEP 602.09, ‘Each joint inventor may make the application for patent on behalf of himself and the other joint inventors.’ This means that any one of the joint inventors can file the application without the consent of the others. However, this situation may lead to disputes and potential legal issues. It’s generally recommended that joint inventors try to reach an agreement or seek legal counsel to resolve any disagreements before filing.

To learn more:

What happens if I wrongly claim small entity status?

Wrongly claiming small entity status can have serious consequences. According to MPEP 509.03:

“Improperly and with intent to deceive establishing status as a small entity, or paying fees as a small entity, shall be considered as a fraud practiced or attempted on the Office.”

The consequences of fraudulently claiming small entity status may include:

  • Requirement to pay all fee deficiencies
  • Possible invalidation of the patent
  • Potential legal action for fraud

If you discover an error in your small entity claim, it’s crucial to promptly notify the USPTO and pay any fee deficiencies. Honest mistakes, if corrected in good faith, are generally not considered fraud.

To learn more:

Tags: USPTO fees

If you submit an Application Data Sheet (ADS) after the filing date of your patent application, it is considered a supplemental ADS. According to MPEP 601.05(a):

A supplemental ADS that is filed after the initial filing date of the application is not part of the original application papers, but is the paper that will be used to correct the bibliographic information in the Office’s records.

This means that while the supplemental ADS can be used to update or correct information, it doesn’t become part of the original application. Any changes made through a supplemental ADS may require additional fees or actions, such as a petition under 37 CFR 1.78 for late claims of priority.

To learn more:

If you submit an amendment to reference the prior application in a Continued Prosecution Application (CPA), it will not be entered by the USPTO.

The MPEP ¶ 2.34 clearly states: “The amendment filed [1] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [2] application of Application No. [3] has not been entered.”

Furthermore, the MPEP adds: “any such amendment shall be denied entry.” This means that even if you submit such an amendment, it will be rejected, and the examiner will use this form paragraph to inform you of the denial.

If you submit an amendment to refer to a Continued Prosecution Application (CPA) as a continuation or divisional application, it will be denied entry by the patent examiner. The MPEP ¶ 2.34 states:

“Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This means that the patent examiner will not accept or incorporate such amendments into the application. The CPA itself serves as the necessary reference to the prior application, making additional amendments unnecessary and inappropriate.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

What happens if I submit a non-original assignment document for recording?

If you submit a non-original assignment document for recording, it will be rejected by the USPTO. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording. Therefore, customers must submit copies of the documents to be recorded, rather than originals.’ This means that while you should submit a copy, it must be a true and complete copy of the original document. Submitting altered or incomplete copies may result in rejection and delay the recording process.

What happens if I overpay a patent fee to the USPTO?

If you overpay a patent fee to the USPTO, you may be eligible for a refund. The MPEP 509 states: ‘In the event that an amount is paid by mistake or in excess of that required, a refund may be made only if a petition for refund is filed within 2 years after the date the fee was paid.’

To request a refund:

  1. File a petition for refund within 2 years of the payment date
  2. Clearly explain the reason for the overpayment
  3. Provide evidence of the overpayment

It’s important to note that not all overpayments are automatically refunded, so proactive action is necessary to recover excess fees.

To learn more:

What happens if I overpaid fees due to incorrect micro entity status?

If you paid fees as a non-micro entity when you were actually entitled to micro entity status, resulting in an overpayment, you may be eligible for a refund. The MPEP 509.04(f) states:

“A refund based upon establishment of micro entity status may only be obtained if an assertion of micro entity status, in compliance with 37 CFR 1.29(a), is filed within the time period set forth in 37 CFR 1.29(k) … The time period set forth in 37 CFR 1.29(k) is: the later of 1) three months from the date of the fee payment claimed to be in error; or 2) the processing of a request for refund.”

To request a refund:

  • File a compliant micro entity certification
  • Submit a timely refund request
  • Ensure you meet the time constraints specified in 37 CFR 1.29(k)

It’s important to act promptly if you believe you’ve overpaid due to an incorrect entity status.

To learn more:

Tags: patent fees

What happens if I need to change the order of benefit claims in my patent application?

Changing the order of benefit claims in a patent application requires specific actions, as outlined in MPEP 211.02(a):

“If applicant needs to change the order of benefit claims presented in an application data sheet or patent, applicant must file a corrected application data sheet under 37 CFR 1.76(c) or a Certificate of Correction, as appropriate.”

The method you choose depends on the status of your application:

  • For pending applications: File a corrected Application Data Sheet (ADS) under 37 CFR 1.76(c).
  • For issued patents: File a Certificate of Correction.

It’s important to note that changing the order of benefit claims may affect the effective filing date of your application, which could impact patentability considerations.

To learn more:

If you miss the deadline for submitting a benefit claim, you may still be able to claim the benefit by filing a petition. According to MPEP 211.02:

A benefit claim filed after the required time period may be accepted if it is accompanied by a grantable petition to accept an unintentionally delayed benefit claim under 35 U.S.C. 119(e) (see 37 CFR 1.78(c)) or under 35 U.S.C. 120, 121, 365(c), or 386(c) (see 37 CFR 1.78(e)).

The petition must include:

  • The reference to the prior application (unless previously submitted)
  • The petition fee under 37 CFR 1.17(m)
  • A statement that the entire delay was unintentional

The Director may require additional information if there’s a question about whether the delay was unintentional. It’s important to note that accepting a late benefit claim is at the discretion of the USPTO and is not guaranteed.

For more information on unintentional delay, visit: unintentional delay.

For more information on USPTO, visit: USPTO.

If you miss the deadline for filing a priority claim in a U.S. patent application, you may still have options, but they are limited:

  • Petition for Unintentional Delay: You can file a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e). This petition must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.
  • Continuation-in-Part (CIP) Application: If the deadline has passed and you can’t file a petition, you might consider filing a CIP application, which allows you to claim priority to the earlier application while also adding new matter.
  • Consequences: Failing to properly claim priority can affect the patent’s validity and enforceability, particularly if prior art emerges in the intervening period between the foreign filing and the U.S. filing.

As stated in MPEP 214.01: “The claim for priority must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application in an original application filed under 35 U.S.C. 111(a).”

To learn more:

To learn more:

If you miss the deadline for filing a foreign priority claim, you may still have options:

  • Unintentional delay: You can file a petition to accept an unintentionally delayed priority claim under 37 CFR 1.55(e). This petition must be filed within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.
  • Design applications: For design applications, you can file this petition up to the date of payment of the issue fee.

The MPEP states: The Director may accept an unintentionally delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), or 365(a) or (b) in an application for patent filed on or after November 29, 2000, upon petition pursuant to 37 CFR 1.55(e).

It’s important to note that the petition must include a statement that the entire delay was unintentional, and you may need to provide additional evidence to support this claim.

What happens if I miss the 12-month deadline for filing a U.S. nonprovisional application claiming priority to a foreign application?

If you miss the 12-month deadline for filing a U.S. nonprovisional application claiming priority to a foreign application, you may still be able to file the application, but you’ll lose the right to claim priority to the foreign application. The MPEP states:

“An applicant who files a nonprovisional application after the 12-month priority period (or 6-month priority period in the case of a design application) will not be able to claim priority to the foreign-filed application in the later-filed nonprovisional application.” (MPEP 213.03)

In such cases, your U.S. application will be treated as a new application without the benefit of the earlier filing date. This can have significant implications, especially if any public disclosures or other prior art have been published in the intervening time.

To learn more:

What happens if I miss the 12-month deadline for filing a nonprovisional application?

If you miss the 12-month deadline for filing a nonprovisional application claiming the benefit of a provisional application, you generally lose the ability to claim that earlier filing date. The MPEP 201.04 states:

“If a provisional application is not filed in compliance with 35 U.S.C. 119(e) and 37 CFR 1.53(c), the provisional application is not entitled to the benefit of the filing date of the provisional application.”

Consequences of missing the deadline include:

  • Loss of the earlier filing date
  • Potential issues with prior art that emerged during the 12-month period
  • Possible loss of patent rights in some jurisdictions

In some cases, you may be able to file a petition for an unintentional delay under 37 CFR 1.78(c), but this is not guaranteed and may involve additional fees. It’s crucial to monitor deadlines carefully to avoid these issues.

For more information on filing deadline, visit: filing deadline.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent priority, visit: patent priority.

For more information on provisional application, visit: provisional application.

What happens if I miss the 12-month deadline for filing a nonprovisional application after a provisional application?

If you miss the 12-month deadline for filing a nonprovisional application claiming the benefit of a provisional application, you lose the right to claim that benefit. The MPEP states: A provisional application is not entitled to the right of priority under 35 U.S.C. 119(e) unless the full fee set forth in 37 CFR 1.16(d) has been paid and the basic filing fee set forth in 37 CFR 1.16(a) has been paid on or before the date the provisional application was filed. (MPEP 201.04) Additionally, you cannot extend this 12-month period. However, you may still file a nonprovisional application; it just won’t have the earlier priority date of the provisional application.

To learn more:

To learn more:

What happens if I lose micro entity status during the patent process?

If you lose micro entity status during the patent process, you must notify the USPTO promptly. The MPEP states:

“A micro entity that no longer meets the requirements for micro entity status at a point in time when a fee is due is treated as a small entity for purposes of paying the fee if the applicant or patentee is otherwise eligible for small entity status.”

This means:

  • You must file a notification of loss of entitlement to micro entity status.
  • If you still qualify as a small entity, you can pay fees at the small entity rate.
  • If you no longer qualify as a small entity, you must pay fees at the standard (large entity) rate.

It’s important to note that continuing to pay fees at the micro entity rate when you no longer qualify can result in the patent being held unenforceable. For more details, refer to MPEP 509.04(e).

To learn more:

If you lose entitlement to micro entity status, you must:

  1. File a notification of loss of entitlement to micro entity status in the application or patent
  2. Pay the required fee in the small entity or undiscounted amount, as appropriate

The notification must be filed prior to or at the time of paying the earliest fee after the date on which status as a micro entity is no longer appropriate. As stated in 37 CFR 1.29(i): ‘Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.’

If you intentionally omit material from your application that was present in a prior-filed application, the omitted material will not automatically be incorporated by reference under 37 CFR 1.57(b). The MPEP clarifies:

“Applicants can still intentionally omit material contained in the prior-filed application from the application containing the priority or benefit claim without the material coming back in by virtue of the incorporation by reference of 37 CFR 1.57(b). Applicants can maintain their intent by simply not amending the application to include the intentionally omitted material.”

In other words, the incorporation by reference under 37 CFR 1.57(b) only applies to inadvertently omitted material. If you choose not to include certain material from the prior application, it will remain omitted unless you specifically amend your application to include it.

If you identify a new inventor in a Continued Prosecution Application (CPA) without filing a request under 37 CFR 1.48, the inventorship will not be officially changed. The MPEP clearly states: ‘It is noted that [new inventor] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [filing date], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.’ In such cases, the inventorship in the CPA will remain the same as in the prior application, despite the attempt to name a new inventor.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

When multiple foreign applications are filed for the same invention, the right of priority is generally based on the earliest filed application. MPEP 213.03 explains: ‘The twelve months is from earliest foreign filing except as provided in 35 U.S.C. 119(c). If an inventor has filed an application in France on October 4, 1981, and an identical application in the United Kingdom on March 3, 1982, and then files in the United States on February 2, 1983, the inventor is not entitled to the right of priority at all; the inventor would not be entitled to the benefit of the date of the French application since this application was filed more than twelve months before the U.S. application, and the inventor would not be entitled to the benefit of the date of the United Kingdom application since this application is not the first one filed.’

However, if the later application contains additional subject matter, a claim specifically limited to that additional disclosure may be entitled to the priority date of the later foreign application.

If you file a U.S. patent application more than 12 months after your foreign filing, your claim for priority based on that foreign application may be denied. The MPEP states:

The claim for priority cannot be based on said application, because the subsequent nonprovisional or international application designating the United States was filed more than twelve months thereafter and no petition under 37 CFR 1.55 or request under PCT Rule 26bis.3 to restore the right of priority has been granted.

However, you may still have options to restore your priority claim under certain circumstances.

For more information on 12-month rule, visit: 12-month rule.

For more information on foreign priority, visit: foreign priority.

What happens if I file a provisional application without meeting all the requirements?

If you file a provisional application that doesn’t meet all the requirements, it may not be granted the filing date you intended. The MPEP states: If a provisional application does not contain a cover sheet identifying it as a provisional application, it will be treated as a nonprovisional application. This means:

  • Your application might be processed as a nonprovisional application, which has different requirements and fees.
  • You could lose the intended filing date, which is crucial for establishing priority.
  • The USPTO may send you a notice of missing parts, giving you a chance to correct the deficiencies.

It’s crucial to ensure all requirements are met when filing a provisional application to avoid these complications.

For more information on filing requirements, visit: filing requirements.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

What happens if I file a provisional application with multiple inventors?

When filing a provisional application with multiple inventors, it’s important to note that:

  • All inventors must be named in the application.
  • Each inventor must sign an oath or declaration, either in the provisional application or in the later-filed nonprovisional application.
  • The inventorship of the provisional application should match that of any subsequent nonprovisional application claiming benefit.

According to MPEP 201.04: “The inventorship of a provisional application is that inventorship set forth in the cover sheet as prescribed by 37 CFR 1.51(c)(1) filed with the provisional application.” This means that the cover sheet must accurately reflect all inventors involved in the invention described in the provisional application.

To learn more:

What happens if I file a provisional application and don’t file a nonprovisional within 12 months?

If you file a provisional application but do not file a corresponding nonprovisional application within 12 months, the provisional application will automatically be abandoned. As stated in the MPEP 201.04: “A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.” This means you lose the benefit of the provisional filing date and cannot claim priority to it in future applications. To maintain the priority benefit, you must file a nonprovisional application claiming benefit of the provisional within the 12-month period.

For more information on application abandonment, visit: application abandonment.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

If you file a nonprovisional application after the 12-month priority period from the filing date of a foreign application, you may still be able to claim priority under certain circumstances:

  • Two-month grace period: The USPTO provides a two-month grace period after the 12-month priority period. During this time, you can file the nonprovisional application with a petition to restore the right of priority.
  • Unintentional delay: The delay in filing must have been unintentional. You’ll need to submit a petition explaining the circumstances.
  • Additional fee: A petition fee is required.

As stated in MPEP 213.03: “A nonprovisional application filed after the 12-month priority period, but within 2 months from the expiration of the 12-month priority period, may be filed with a petition to restore the right of priority.”

It’s important to note that this provision applies to both Paris Convention applications and PCT applications entering the national stage in the United States.

To learn more:

If you file a foreign priority claim after paying the issue fee but before the patent grant:

  • The claim will be placed in the file record
  • There may be no review of the papers
  • The published patent will not include the priority claim

To have the priority claim considered after publication, you will need to file:

  1. A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323
  2. For original applications under 35 U.S.C. 111(a) or 371, a petition to accept an unintentionally delayed claim for priority under 37 CFR 1.55

MPEP 214.03 states: “When the claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but prior to the date of grant of the patent, the foreign priority claim or certified copy will be placed in the file record but there may be no review of the papers and the patent when published will not include the priority claim.”

Filing a foreign patent application without the required foreign filing license can have serious consequences. According to MPEP 140:

‘Inadvertent foreign filing without a license is not uncommon. The patent law provides for petition for retroactive license in such cases.’

However, it’s important to note that:

  • The application may be considered abandoned in the U.S.
  • You may lose the right to obtain a U.S. patent on that invention.
  • There could be criminal penalties under 35 U.S.C. 181 and 35 U.S.C. 186.

If you’ve inadvertently filed without a license, you should immediately seek a retroactive foreign filing license from the USPTO.

For more information on foreign filing license, visit: foreign filing license.

Filing a foreign application without obtaining the required foreign filing license can have serious consequences. According to MPEP 140:

‘If a license is not obtained prior to filing, there is still the possibility of obtaining a license retroactively. … However, a party who files a patent application in a foreign country or under a multinational agreement, without first obtaining a license from the Commissioner when required, shall be barred from receiving a United States patent for the invention under 35 U.S.C. 185.’

In other words, failing to obtain a license can result in being barred from receiving a U.S. patent for the same invention. However, you may be able to obtain a retroactive license in some cases.

For more information on foreign filing license, visit: foreign filing license.

What happens if I fail to underline the entire benefit claim in a corrected ADS?

Failing to properly underline the entire benefit claim in a corrected Application Data Sheet (ADS) can have serious consequences. The MPEP 211.02(a) states:

If the corrected ADS fails to identify the benefit claim with underlining of all text inserted, the Office of Patent Application Processing (OPAP) will not recognize such benefit claim and will not enter such benefit claim information in Office records.

This means that if you don’t underline the entire benefit claim:

  • The USPTO won’t recognize the benefit claim
  • The benefit claim information won’t be entered into official records
  • Your application may lose its priority date

To avoid these issues, always ensure that you underline the entire benefit claim when adding it to a corrected ADS, even if parts of the claim were present in the original ADS.

To learn more:

Tags: ADS

What happens if I fail to notify the USPTO about loss of micro entity status?

Failing to notify the USPTO about the loss of micro entity status can have serious consequences. The MPEP warns:

“Fraudulent assertion of micro entity status is considered a fraud practiced or attempted on the Office.” (MPEP 509.04(f))

Consequences may include:

  • Invalidation of the patent application or granted patent
  • Disciplinary action against registered practitioners
  • Criminal penalties under 18 U.S.C. 1001

It’s crucial to promptly notify the USPTO if you lose eligibility for micro entity status to avoid these severe consequences.

To learn more:

If you fail to make a timely priority claim or submit a certified copy of the foreign application within the required time period, the following may occur:

  • The right of priority may be considered waived
  • The effective filing date of your application may be the actual U.S. filing date, not the foreign filing date
  • Intervening prior art may be applicable against your application

However, 37 CFR 1.55(e) provides for acceptance of a delayed priority claim if:

  • The claim is filed within the pendency of the application
  • A petition is filed with the delayed claim
  • The delay was unintentional
  • The required petition fee is paid

Similarly, 37 CFR 1.55(f) allows for late submission of a certified copy with a petition showing good and sufficient cause for the delay and payment of a fee. It’s always best to make priority claims and submit certified copies timely to avoid potential issues.

What happens if I fail to file a priority claim within the time period set in 37 CFR 1.55?

If you fail to file a priority claim within the time period set in 37 CFR 1.55, your priority claim will be considered waived. The MPEP states: ‘If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’ This means that if you miss the deadline, you may lose the benefit of the earlier filing date, which could potentially affect the patentability of your invention if intervening prior art exists.

To learn more:

To learn more:

What happens if I fail to file a priority claim during the pendency of my application?

If you fail to file a priority claim during the pendency of your application, you may lose the right to claim priority. According to MPEP 213.04:

If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, it must also be accompanied by the processing fee set forth in 37 CFR 1.17(i).

This means that if you miss the deadline to file your priority claim before the issue fee is paid, you’ll need to pay an additional processing fee. Moreover, if the application has already been patented, you cannot file a priority claim retroactively.

It’s crucial to file your priority claim as early as possible during the pendency of your application to avoid potential complications or additional fees.

To learn more:

What happens if I fail to file a nonprovisional application within 12 months of my provisional application?

If you fail to file a nonprovisional application within 12 months of your provisional application’s filing date, you will lose the benefit of the provisional application’s filing date. The MPEP states:

“A provisional application expires 12 months after its filing date and cannot be revived after its expiration to restore it to pending status.” (MPEP 201.04)

This means:

  • You can’t claim priority to the provisional application after the 12-month period.
  • Any public disclosures made during that 12-month period may now be considered prior art against your invention.
  • You may need to file a new application, potentially losing your earlier filing date.

It’s crucial to calendar the 12-month deadline and ensure timely filing of the nonprovisional application to preserve your priority date.

To learn more:

If you erroneously pay small entity fees in good faith, you can correct the error by:

  • Submitting a separate deficiency payment for each application or patent
  • Itemizing the deficiency payment with specific details
  • Paying the full deficiency amount owed

As stated in 37 CFR 1.28(c): “If status as a small entity is established in good faith, and fees as a small entity are paid in good faith, in any application or patent, and it is later discovered that such status as a small entity was established in error, or that through error the Office was not notified of a loss of entitlement to small entity status as required by § 1.27(g)(2), the error will be excused upon: compliance with the separate submission and itemization requirements of paragraphs (c)(1) and (c)(2) of this section, and the deficiency payment requirement of paragraph (c)(2) of this section.”

To learn more:

If you don’t update the specification after canceling a figure, it can lead to confusion and potential issues with your patent application. The MPEP warns: Failure to cancel the description of canceled figures may cause an objection to the specification as failing to comply with 37 CFR 1.74. (MPEP 608.02(t))

Consequences may include:

  • Objections to the specification
  • Confusion during examination
  • Potential delays in processing your application
  • Increased risk of errors or inconsistencies in the patent document

To avoid these issues, always ensure that you update your specification to reflect any changes made to the figures.

To learn more:

If you fail to correct and resubmit the returned assignment documents within the specified time period, the USPTO will consider the date of receipt of the corrected papers as the new recording date. The MPEP 317.02 clearly states:

“If the returned papers are not corrected and resubmitted within the specified period, the date of receipt of the corrected papers will be considered to be the date of recording of the document.”

It’s crucial to note that this may affect the priority date of your assignment, potentially impacting your rights. Additionally, the MPEP emphasizes that “The specified period to resubmit the returned papers will not be extended.” Therefore, it’s essential to act promptly when you receive returned documents to avoid losing the benefit of the original filing date.

To learn more:

What happens if I don’t record an assignment with the USPTO?

Failing to record an assignment with the USPTO can have significant legal implications. According to MPEP 302:

“An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the USPTO within three months from its date or prior to the date of such subsequent purchase or mortgage.”

This means that if you don’t record your assignment:

  • Your ownership rights may not be enforceable against subsequent purchasers or mortgagees who were unaware of the unrecorded assignment.
  • You may face difficulties in proving ownership in legal proceedings or licensing negotiations.
  • It could complicate future transfers or financial transactions involving the patent or application.

To protect your interests, it’s crucial to record assignments promptly with the USPTO, ideally within three months of the assignment date or before any subsequent transactions occur.

For more information on legal implications, visit: legal implications.

For more information on USPTO procedures, visit: USPTO procedures.

If you fail to provide the required English translation and statement of accuracy for a non-English provisional application, your current application may be abandoned. The MPEP states:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned. See 37 CFR 1.78.”

This means you must either provide the required documents or withdraw the benefit claim to avoid abandonment of your application.

For more information on application abandonment, visit: application abandonment.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

If you don’t pay the issue fee for your patent application, it will be considered abandoned. According to MPEP 203.05, one of the ways an application can become abandoned is:

“for failure to pay the issue fee”

The MPEP refers to sections 711 to 711.05 for more details on this topic. It’s crucial to pay the issue fee on time to prevent your application from being abandoned after all the effort put into the patent prosecution process.

To learn more:

If you don’t follow the USPTO’s guidelines for including copyright or mask work notices in your patent application, your application may face objections or refusals. According to MPEP 608.01(w):

Any departure from these conditions may result in a refusal to permit the desired inclusion. If the authorization required under condition (C) above does not include the specific language “(t)he (copyright or mask work) owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent files or records,…” the notice will be objected to as improper by the examiner of the application.

If the examiner maintains the objection upon reconsideration, you may file a petition in accordance with 37 CFR 1.181. To avoid these issues, it’s crucial to carefully follow the guidelines provided in MPEP 608.01(w) and related regulations when including copyright or mask work notices in your patent application.

To learn more:

If you don’t file a petition to restore the benefit of a provisional application after missing the 12-month deadline, you will lose the right to claim the earlier filing date of the provisional application. The MPEP states:

“Applicant is required to delete the claim to the benefit of the prior-filed provisional application, unless applicant can establish that this application, or an intermediate nonprovisional application or international application designating the United States, was filed within 12 months of the filing date of the provisional application.”

This means your application will be treated as if it was filed on the date of the nonprovisional application, potentially affecting your ability to secure patent rights if intervening prior art exists. It’s crucial to either meet the original 12-month deadline or file a timely petition to restore the benefit to maintain your earlier filing date.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

If you don’t file a foreign priority claim within the specified time period, the claim is considered to have been waived. As stated in MPEP 214.01: “Claims for foreign priority not presented within the time period specified in 37 CFR 1.55 are considered to have been waived.”

However, there is a possibility to file a petition to accept an unintentionally delayed priority claim. The MPEP further states: “If a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it includes the required identification information and is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

For more information on the process of filing an unintentionally delayed priority claim, refer to MPEP § 214.02.

To learn more:

If you fail to comply with the requirements for correcting micro entity status errors, as outlined in 37 CFR 1.29(k)(1) and (k)(2), the USPTO has two options:

  1. Treat it as an authorization to process the deficiency payment and charge a processing fee
  2. Require compliance within a non-extendable one-month period

The MPEP states: If the requirements of paragraphs (k)(1) and (2) of this section are not complied with, such failure will either be treated at the option of the Office as an authorization for the Office to process the deficiency payment and charge the processing fee set forth in § 1.17(i), or result in a requirement for compliance within a one-month time period that is not extendable under § 1.136(a) to avoid the return of the fee deficiency payment.

It’s important to carefully follow the requirements to avoid additional fees or potential loss of rights.

To learn more:

What happens if I accidentally submit an original assignment document to the USPTO?

If you accidentally submit an original assignment document to the USPTO, you will not be able to retrieve it. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording.’

To avoid this situation:

  • Always submit copies of assignment documents
  • Keep original documents in a secure location
  • Double-check all submissions before sending them to the USPTO

If you have submitted an original document in error, you may need to create a new assignment document or seek legal advice on how to proceed with future patent transactions or litigation that may require the original document.

To learn more:

If drawings submitted in a patent application are marked as ‘informal’ but are considered acceptable by the Office of Patent Application Processing (OPAP), the examiner will not require replacement of the drawings. As stated in the MPEP:

If the drawings submitted in an application have been indicated by the applicant as “informal,” but the drawings are considered acceptable by OPAP, the examiner should not require replacement of the drawings.

This means that informal drawings can be accepted if they meet the necessary standards, even if not labeled as formal drawings.

To learn more:

If drawings are required for a patent application but not filed with the initial submission, the following process typically occurs:

  • The Office will send a Notice of Incomplete Application to the applicant.
  • The applicant will have two months from the filing date (or notice mail date, whichever is later) to file the drawings and pay any required fees.
  • If compliant drawings are filed within this period, the application will receive the original filing date.
  • Failure to submit the required drawings within the time period may result in the application being treated as abandoned.

As stated in MPEP 601.01(f): ‘If the Office of Patent Application Processing (OPAP) determines that the application does not contain drawings, although drawings are necessary under 35 U.S.C. 113 (first sentence) to understand the subject matter sought to be patented, applicant will be notified that drawings are required.’

To learn more:

If drawings are omitted from a patent application, the consequences depend on whether the drawings are necessary for understanding the invention. According to MPEP 601.01(f):

“If drawings are necessary under 35 U.S.C. 113 (first sentence) to understand the subject matter sought to be patented, the application will be denied a filing date and the applicant will be notified that the application is incomplete.”

However, if the drawings are not necessary for understanding the invention, the application may still be given a filing date. The examiner will send a Notice of Omitted Items, giving the applicant two months to submit the missing drawings and avoid abandonment of the application.

To learn more:

To learn more:

Tags: drawings

If drawings are not timely filed in response to a notice from the USPTO or a letter from the examiner requiring a drawing, the consequences are severe:

  • The application becomes abandoned for failure to reply.

The MPEP clearly states: If a drawing is not timely received in reply to a notice from the Office or a letter from the examiner who requires a drawing, the application becomes abandoned for failure to reply.

This underscores the importance of promptly responding to USPTO notices and examiner requirements regarding drawings. For information on handling replacement drawings, refer to MPEP § 608.02(h).

To learn more:

If drawings are not received with a patent application, the following process occurs:

  • The application is assigned a filing date if it meets the minimum requirements under 37 CFR 1.53(b) or 1.53(d).
  • The Office of Patent Application Processing (OPAP) will send a Notice of Omitted Items giving the applicant a time period to file the missing drawings and a petition under 37 CFR 1.182 with the petition fee to have the filing date changed to the date of such filing.
  • If the applicant does not respond to the Notice of Omitted Items, the application will be processed without the drawings.

As stated in the MPEP 507: ‘If drawings are not received with the application, the application is assigned a filing date and the applicant is notified to file drawings within a set time period.’

For more information on drawings, visit: drawings.

Tags: drawings

When documents are submitted both as evidence in a reply to an Office action and listed on an Information Disclosure Statement (IDS) form, the examiner’s treatment may differ. The MPEP provides an example:

“For example, if applicant submits and relies on three patents as evidence in reply to the first Office action and also lists those patents on a PTO/SB/08 along with two journal articles, but does not file a statement under 37 CFR 1.97(e) or the fee set forth in 37 CFR 1.17(p), it would be appropriate for the examiner to indicate that the teachings relied on by applicant in the three patents have been considered, but to line through the citation of all five documents on the PTO/SB/08 and to inform applicant that the information disclosure statement did not comply with 37 CFR 1.97(c).”

In this case, the examiner would consider the evidence relied upon in the reply but would not formally consider the documents as part of the IDS due to non-compliance with IDS requirements.

To learn more:

If corrected drawings are not received within the set time period, the application will be processed for issue or publication based on the originally filed drawings. The failure to submit corrected drawings may result in the application being withdrawn from issue or the patent being printed with defective drawings.

If corrected documents are not resubmitted within the specified period, the original filing date will not be preserved. The MPEP clearly states: “If the returned papers are not corrected and resubmitted within the specified period, the date of filing of the corrected papers will be considered to be the date of recording of the document.” This means that failing to meet the deadline for resubmission will result in the loss of the original filing date, and the new submission date will be used as the recording date.

If copendency is not established between patent applications, the benefit claim to the prior-filed application becomes improper. The MPEP clearly states:

Since the applications are not copending, the benefit claim to the prior-filed application is improper. Applicant is required to delete the claim to the benefit of the prior-filed application, unless applicant can establish copendency between the applications.

In such cases, the applicant must either prove that copendency exists or remove the benefit claim. Failure to do so may result in the loss of the earlier priority date, potentially affecting the patentability of the invention.

For more information on copendency, visit: copendency.

For more information on patent procedure, visit: patent procedure.

The MPEP provides clear guidance on how the USPTO handles incorrect or missing classification information for citations:

If the applicant does not provide classification information for a citation, or if the examiner lines through incorrect classification data, the citation will be printed on the face of the patent without the classification information.

This means that even if the classification data is missing or incorrect, the citation itself will still be included on the patent. However, users of the patent should be aware that they may need to independently verify the correct classification for such citations.

To learn more:

What happens if an unavailable joint inventor refuses to sign an oath or declaration?

If an unavailable joint inventor refuses to sign an oath or declaration, the applicant may file a petition under 37 CFR 1.183 to waive the requirement for that inventor’s signature. According to MPEP 409.03(a):

‘If a nonsigning inventor refuses to sign the oath or declaration or cannot be reached, the oath or declaration under 37 CFR 1.63 by the remaining joint inventor(s) must state that the nonsigning inventor is either refused to sign or could not be reached after diligent effort to contact him or her.’

The petition should include evidence of the attempts made to contact the unavailable inventor and any responses received. The Office will then determine whether to grant the petition based on the circumstances presented.

To learn more:

Tags: declaration, oath

If an oath for a patent application is not properly authenticated, the USPTO has a specific procedure. According to the MPEP:

“Where the oath is taken before an officer in a foreign country other than a diplomatic or consular officer of the United States and whose authority is not authenticated or accompanied with an apostille certifying the notary’s authority, the application is nevertheless accepted for purposes of examination.”

This means that the USPTO will still process the application, but the applicant needs to take corrective action. The MPEP further states:

“Applicant should submit a new oath properly authenticated by an appropriate diplomatic or consular officer, the filing of proper apostille, or a declaration (37 CFR 1.68).”

It’s important to note that the USPTO does not return improperly authenticated oaths for proper authentication. Instead, they expect the applicant to submit a corrected version.

To learn more:

If an item in an Information Disclosure Statement (IDS) fails to comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98, the following actions are taken:

  • A line is drawn through the citation to show it has not been considered.
  • Other compliant items in the IDS are still considered and initialed by the examiner.

As stated in the MPEP: If an item of information in an IDS fails to comply with requirements of 37 CFR 1.97 and 37 CFR 1.98, a line should be drawn through the citation to show that it has not been considered. The other items of information listed that do comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98 will be considered by the examiner and will be appropriately initialed. (MPEP 609.05(b))

To learn more:

To learn more:

If an inventor’s mailing address is omitted from a patent application, the USPTO has a procedure to address this issue. According to MPEP 602.08(a):

“If the mailing address of any inventor has been omitted, OPAP will notify applicant of the omission and require the omitted mailing address in response to the notice.”

OPAP refers to the Office of Patent Application Processing. This procedure ensures that the USPTO has the necessary contact information for all inventors listed on the application.

To learn more:

What happens if an inventor refuses to sign the patent application?

If an inventor refuses to sign the patent application, the applicant may file a petition under 37 CFR 1.47(a). According to MPEP 605, ‘When an inventor refuses to sign the application oath or declaration or cannot be found or reached after diligent effort, the applicant under 37 CFR 1.43, 1.45 or 1.46 may file an application without the inventor’s signature pursuant to 37 CFR 1.64(a).’ The petition must include:

  • The fee set forth in 37 CFR 1.17(g)
  • Proof of the pertinent facts
  • The last known address of the non-signing inventor

The Office will then attempt to contact the non-signing inventor and, if unsuccessful, may grant the petition and allow the application to proceed.

To learn more:

To learn more:

What happens if an inventor refuses to sign the oath or declaration for a patent application?

If an inventor refuses to sign the oath or declaration for a patent application, the applicant may file a substitute statement in lieu of an oath or declaration. According to MPEP 602.01(a):

“A substitute statement may be used in lieu of an oath or declaration if the inventor is deceased, legally incapacitated, cannot be found or reached after diligent effort, or refuses to execute the oath or declaration.”

The substitute statement must be signed by an applicant under 37 CFR 1.43, 1.45, or 1.46. It must:

  • Identify the inventor to whom it relates
  • Identify the person executing the substitute statement and their relationship to the inventor
  • Include a statement that the person executing the substitute statement believes the named inventor to be the original inventor
  • State that the application was made or authorized to be made by the person executing the substitute statement
  • State the permitted basis for filing the substitute statement (in this case, the inventor’s refusal to sign)

It’s important to note that attempts to reach the inventor and obtain their signature should be documented, as the USPTO may require evidence of the inventor’s refusal to sign.

To learn more:

What happens if an inventor refuses to sign the inventor’s oath or declaration?

If an inventor refuses to sign the inventor’s oath or declaration, the application may still be filed under certain circumstances. According to MPEP 602.01(a):

“If an inventor refuses to execute an oath or declaration or cannot be found or reached after diligent effort, the applicant under 37 CFR 1.43, 1.45 or 1.46 may execute an oath or declaration naming the non-signing inventor.”

In such cases, the applicant must:

  • Submit a substitute statement in lieu of an oath or declaration
  • Provide evidence of the inventor’s refusal to sign or unavailability
  • Explain the efforts made to contact the inventor

The Office will evaluate the circumstances and may accept the application without the non-signing inventor’s oath or declaration.

To learn more:

What happens if an inventor refuses to sign an oath or declaration?

If an inventor refuses to sign an oath or declaration, the application may still proceed under certain circumstances. According to MPEP 602.09:

“If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the application may be made by the other inventor on behalf of themselves and the nonsigning inventor.”

In such cases, the applicant must:

  • File an oath or declaration on behalf of the nonsigning inventor
  • Provide a statement of facts explaining the situation
  • Show that the nonsigning inventor’s last known address has been stated
  • Demonstrate that notice of the filing of the application has been provided to the nonsigning inventor

This process allows the application to move forward despite the lack of cooperation from one inventor.

To learn more:

What happens if an inventor dies or becomes legally incapacitated after an application is filed?

If an inventor dies or becomes legally incapacitated after an application is filed, the legal representative of the deceased or incapacitated inventor may make an oath or declaration in compliance with 37 CFR 1.64. The MPEP 409.01(a) states:

“If an inventor dies after an application naming the inventor is filed, the personal representative of the inventor’s estate may make an oath or declaration in compliance with 37 CFR 1.64.”

This process ensures that the application can continue to be prosecuted even if the inventor is no longer able to participate. The legal representative must provide evidence of their authority to act on behalf of the deceased or incapacitated inventor.

To learn more:

What happens if an inventor becomes legally incapacitated during the patent application process?

If an inventor becomes legally incapacitated during the patent application process, the application can still proceed. According to MPEP 409, ‘If an inventor is legally incapacitated, the legal representative of the inventor may make an application for patent on behalf of the inventor.’ This means that a court-appointed guardian or conservator can act on behalf of the incapacitated inventor to continue the patent application process.

The legal representative must provide evidence of their authority to act for the inventor, such as a court order appointing them as guardian. They can then sign necessary documents and make decisions regarding the patent application on behalf of the incapacitated inventor.

For more information on legal representative, visit: legal representative.

If an inventor becomes available after a 37 CFR 1.47(a) petition is granted, they should be given the opportunity to join the application. The MPEP 409.03(b) provides guidance:

‘If a nonsigning inventor subsequently joins in the application, the applicant may file a petition under 37 CFR 1.182 to withdraw the 37 CFR 1.47 petition.’

This process involves:

  • The newly available inventor signing the necessary oath or declaration.
  • Filing a petition under 37 CFR 1.182 to withdraw the previous 1.47 petition.
  • Paying any required fees for the new petition.
  • Updating the application to reflect the inventor’s participation.

It’s important to address this situation promptly to ensure the application accurately reflects all participating inventors.

To learn more:

To learn more:

What happens if an international application designating the US is withdrawn?

If an international application designating the United States is withdrawn or considered withdrawn, either generally or as to the United States, it cannot serve as the basis for priority in a subsequent U.S. application. The MPEP states:

“An international application designating the United States that withdraws the U.S. designation prior to fulfilling the requirements of 35 U.S.C. 371(c) cannot serve as a basis for priority in a subsequent U.S. national application.”

This means that if the international application is withdrawn before meeting the requirements for entering the national stage in the U.S., it cannot be used as a priority claim in a later U.S. application. It’s important for applicants to carefully consider the implications of withdrawing an international application, especially if they plan to seek patent protection in the United States later.

To learn more:

What happens if an international application designating the US is published in a language other than English?

If an international application designating the United States is published under PCT Article 21(2) in a language other than English, a translation of the international application into English must be provided. The MPEP 211.01(c) states:

If the international application was published under PCT Article 21(2) in a language other than English, the publication of the international application shall be considered to be an English language translation of the application provided to the U.S. Patent and Trademark Office within the meaning of 35 U.S.C. 154(d)(4).

This means that for the purposes of provisional rights under 35 U.S.C. 154(d), the English translation provided to the USPTO will be considered as the publication of the international application.

To learn more:

If an Information Disclosure Statement (IDS) is filed after the issue fee is paid:

  • The IDS will not be considered by the examiner
  • The IDS will be placed in the application file
  • The application may be withdrawn from issue to file a Request for Continued Examination (RCE) or a continuing application
  • A petition under 37 CFR 1.313(c) is required to withdraw the application from issue

MPEP 609.04(b)(IV) states: “After the issue fee has been paid on an application, it is impractical for the Office to attempt to consider newly submitted information. Information disclosure statements filed after payment of the issue fee in an application will not be considered but will merely be placed in the application file.”

The MPEP further explains: “The application may be withdrawn from issue at this point, pursuant to 37 CFR 1.313(c)(2) or 1.313(c)(3) so that the information can be considered in the application upon the filing of a RCE under 37 CFR 1.114 or in a continuing application filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if the application is a design application).”

To learn more:

Tags: issue fee

If an Information Disclosure Statement (IDS) doesn’t comply with USPTO requirements, it will be placed in the file but not considered by the Office. According to MPEP 609.05(a):

Pursuant to 37 CFR 1.97(i), submitted information, filed before the grant of a patent, which does not comply with 37 CFR 1.97 and 37 CFR 1.98 will be placed in the file, but will not be considered by the Office.

This means that while the IDS will be part of the application file, the examiner won’t review or consider the information it contains when examining the patent application.

To learn more:

When an improper Continued Prosecution Application (CPA) is filed, the USPTO’s response depends on the type of application and the nature of the impropriety:

  • For utility or plant applications filed on or after July 14, 2003, an improper CPA is treated as a Request for Continued Examination (RCE) if possible
  • If the improper CPA doesn’t meet RCE requirements, it’s treated as an improper RCE
  • For design applications, an improper CPA may be treated as a new application under 37 CFR 1.53(b) in some circumstances
  • The Office will not automatically convert an improper CPA to an application under 37 CFR 1.53(b) without extenuating circumstances

The MPEP states: Any request for a CPA filed on or after July 14, 2003, in a utility or plant application is improper, regardless of the filing date of the utility or plant application in which the CPA is filed.

Regarding treatment as an RCE: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

If the improper CPA doesn’t meet RCE requirements: If the improper CPA does not satisfy the requirements of 37 CFR 1.114 (e.g., the request lacks a submission or the fee under 37 CFR 1.17(e), or the prosecution of the application is not closed), the Office treats the improper CPA as an improper RCE, and the time period set in the last Office action (or notice) will continue to run.

Examiners are instructed to notify supervisory staff if they discover an improper CPA has been processed: If an examiner discovers that an improper or incomplete CPA has been processed as a proper CPA in error, the examiner should immediately notify a supervisory applications examiner (SAE) or other technical support staff within the Technology Center (TC) who will reprocess the CPA and correct the application records as appropriate.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

Continued Prosecution Applications (CPAs) are only available for design patent applications. If an improper CPA is filed for a utility or plant application, the following occurs:

  • For applications filed on or after June 8, 1995, the improper CPA is treated as a Request for Continued Examination (RCE) under 37 CFR 1.114
  • If the requirements for an RCE are not met, the Office will send a Notice of Improper Request for Continued Examination (RCE)
  • For applications filed before June 8, 1995, the improper CPA cannot be treated as an RCE
  • The applicant will be notified of the improper CPA

MPEP 201.06(d) states: Any request for a CPA filed on or after July 14, 2003, in a utility or plant application is improper, regardless of the filing date of the utility or plant application in which the CPA is filed. It further notes: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on USPTO procedures, visit: USPTO procedures.

For more information on utility patents, visit: utility patents.

What happens if an IDS is filed after the mailing of a final Office action?

If an Information Disclosure Statement (IDS) is filed after the mailing of a final Office action, the examiner will consider it according to specific guidelines:

  • The IDS will be considered if it’s accompanied by either a statement as specified in 37 CFR 1.97(e) or the fee set forth in 37 CFR 1.17(p).
  • If these requirements are not met, the IDS will be placed in the application file but will not be considered by the examiner.

As stated in MPEP 609.05(c): ‘Consideration by the examiner of an IDS submitted after the mailing of a final Office action is limited to the requirements set forth in 37 CFR 1.97(d) and to documents which the examiner determines to be relevant.’ This means that even if the IDS is considered, the examiner is not required to reopen prosecution or issue a new Office action based on the newly submitted information.

To learn more:

What happens if an IDS is filed after the issue fee has been paid?

If an Information Disclosure Statement (IDS) is filed after the issue fee has been paid, it will not be considered by the examiner. According to MPEP 609.02:

‘Any IDS filed after the issue fee has been paid will not be considered by the examiner. In this situation, the application will be printed without consideration of the IDS.’

If an applicant wants the information in the IDS to be considered, they have two options:

  • File a request for continued examination (RCE) along with the IDS
  • Withdraw the application from issue and file a request for continued examination (RCE) with the IDS

It’s important to note that these actions must be taken before the patent issues to ensure consideration of the IDS.

To learn more:

To learn more:

Tags: issue fee

If an expungement petition is granted, the USPTO will take action to remove the erroneous assignment record. As stated in MPEP 323.01(d): ‘The assignment records related to a request for expungement will be expunged, deleted or corrected in accordance with the decision on the petition.’ This means that the incorrect or unnecessary information will be removed from the official assignment records, helping to maintain accurate ownership information for the patent or application.

To learn more:

If an English translation is not provided with a non-English assignment document, the USPTO will not record the assignment. According to MPEP 302.02:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

This means that the assignment will be rejected, and the ownership transfer will not be officially recognized by the USPTO. To proceed with the recordation, the applicant or assignee must submit a proper English translation along with the original non-English document.

To learn more:

If an assignment document submitted electronically through the Electronic Patent Assignment System (EPAS) is determined to be not recordable, the following process occurs:

  1. The entire document, along with its associated cover sheet, will be returned to the sender.
  2. An Office “Notice of Non-Recordation” will be transmitted back to the sender via fax, if possible.
  3. The sender can make corrections to the document or cover sheet.
  4. The corrected submission can then be resubmitted by mailing it to the address specified in 37 CFR 3.27.
  5. If the resubmission is timely, the sender will receive the benefit of the initial receipt date as the recordation date, in accordance with 37 CFR 3.51.

As stated in MPEP 302.10: “Once corrections are made, the initial submission, as amended, may then be resubmitted by mailing the corrected submission to the address set forth in 37 CFR 3.27. Timely submission will provide the sender with the benefit of the initial receipt date as the recordation date in accordance with 37 CFR 3.51.”

What happens if an attorney or agent withdraws without notifying the USPTO?

If an attorney or agent withdraws from representation without notifying the USPTO, it can lead to several issues:

  • The USPTO will continue to recognize the attorney or agent as the representative of record.
  • Official correspondence will still be sent to the attorney or agent, potentially causing delays or missed deadlines.
  • The applicant may not receive important communications about their application.

According to MPEP 402.06: “A registered attorney or agent who has been given a power of attorney and who withdraws from the application without relinquishing the power of attorney to the USPTO is still considered to be the attorney or agent of record.” To properly withdraw, the attorney or agent should follow the procedures outlined in 37 CFR 1.36 and notify the USPTO in writing.

To learn more:

What happens if an attorney or agent withdraws from representation in a patent application?

When an attorney or agent withdraws from representation in a patent application, the following occurs:

  • The USPTO will correspond directly with the applicant until a new Power of Attorney or address change is filed.
  • The withdrawal is effective when approved by the Office, not when received.
  • The Office may require the applicant or assignee to revoke the previous Power of Attorney and appoint a new representative.

As stated in MPEP 402.06: ‘In the event the power of attorney is withdrawn, the Office will communicate directly with the applicant… until a new registered attorney or agent is appointed.’

To learn more:

To learn more:

What happens if an assignment document is not recorded at the USPTO?

If an assignment document is not recorded at the USPTO, it can have significant legal implications. According to MPEP 302:

‘An assignment, grant, or conveyance of a patent or application shall be void as against any subsequent purchaser or mortgagee for valuable consideration, without notice, unless it is recorded in the Office within three months from its date or prior to the date of such subsequent purchase or mortgage.’

In other words, failing to record an assignment within the specified timeframe can render it invalid against subsequent purchasers or mortgagees who were unaware of the previous assignment. This highlights the importance of timely recording assignments to protect the rights of assignees.

For more information on assignment recording, visit: assignment recording.

For more information on legal implications, visit: legal implications.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

What happens if an assignment document is not legible for recording?

If an assignment document is not legible for recording, it will be rejected by the USPTO. According to MPEP 302.01, “Documents submitted for recording must be legible and capable of being reproduced in legible copies by use of photocopy and standard office copying equipment.” If a document is rejected due to legibility issues, the USPTO will notify the person who submitted the document, and they will need to resubmit a legible copy for recording.

What happens if an assignment document is not a copy when submitted for recording?

If an assignment document submitted for recording is not a copy, it will not be accepted for recording. The MPEP clearly states: The Assignment Division will not accept an original assignment document because it becomes part of the USPTO permanent records. This is to protect the original document and ensure that the USPTO maintains proper records. If you submit an original document, it will be returned to you unrecorded, and you will need to submit a copy instead.

To ensure your assignment is properly recorded, always submit a legible copy of the original assignment document. This can be a photocopy or other reproduction of the original.

If an assignment cover sheet is not submitted with the assignment document, the USPTO will not record the assignment. According to MPEP 302.07, “The Office will not accept an assignment document that is not accompanied by a cover sheet.” This means that the assignment will not be officially recognized by the USPTO, which could affect the ownership rights of the patent or application.

To learn more:

If an assignee’s ownership changes during patent prosecution, it’s crucial to update the USPTO records. As per MPEP 325:

“A new statement under 37 CFR 3.73(c) is required to be filed when ownership changes to another assignee.”

This means that:

  • The new assignee must file a new 37 CFR 3.73(c) statement.
  • The new statement must establish the new assignee’s ownership.
  • Until the new statement is filed, the previous assignee remains the party of record.

It’s important to keep ownership records up-to-date to ensure that the correct party has the right to take action in the application.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO records, visit: USPTO records.

What happens if an assignee requests issuance of a patent to themselves?

When an assignee requests issuance of a patent to themselves, the following process occurs:

  • The assignee must file a request for issuance of the patent to the assignee under 37 CFR 3.81(b).
  • This request must be submitted no later than the date the issue fee is paid.
  • If the request is not filed by this deadline, the patent will be issued to the applicant(s) named in the application file.

As stated in MPEP 307: “If the assignment is submitted for recording after the date of payment of the issue fee, but prior to issuance of the patent, the assignment will be recorded but the patent will issue to the name of the inventor.”

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

If an assignee of a part interest refuses to join in an application for reissue, the reissue may still be applied for by the assignee of the entire interest. This is outlined in MPEP 1410. The assignee of the entire interest can file the reissue application as the sole applicant. However, the assignee must comply with the requirements of 37 CFR 1.172, which includes submitting an oath or declaration by the assignee.

If an assignee fails to comply with 37 CFR 3.81(b) when requesting issuance of a patent to the assignee, the patent may still be issued to the assignee. However, the USPTO will not include the assignee data on the patent.

According to the MPEP 307: Failure to comply with the provisions of 37 CFR 3.81(b) will not impact the issuance of the patent. However, the Office will not include the assignee data on the patent if the assignee data is not submitted in compliance with 37 CFR 3.81(b).

This means that while the patent will be issued, the official patent document will not reflect the assignee information, which could potentially cause complications in establishing ownership records.

For more information on patent issuance, visit: patent issuance.

If an applicant does not receive an application number within one month of filing, they should contact the Application Assistance Unit. The MPEP states:

‘If an application number is not received within one month of the filing date, applicant should contact the Application Assistance Unit at (571) 272-4000 or (888) 786-0101.’

This contact information is provided to ensure applicants can follow up on their application status in a timely manner. It’s important to note that this one-month period is a guideline for when applicants should take action if they haven’t received their application number.

For more information on Application Assistance Unit, visit: Application Assistance Unit.

For more information on application number, visit: application number.

What happens if an application data sheet (ADS) is not consistent with the information provided elsewhere in the application?

If there are inconsistencies between the ADS and other documents in the application, the ADS will generally control, except for the following situations:

  • The ADS is inconsistent with the oath or declaration accompanying the application, and the oath or declaration is accompanied by a statement explaining the inconsistency. In this case, the oath or declaration will control.
  • The ADS is inconsistent with information provided in the specification, in which case the information in the specification will control.

As stated in MPEP 601.05(b):

“If an ADS is inconsistent with the information provided elsewhere in the application, the ADS will control except for: (1) the naming of the inventors (37 CFR 1.41(a)(1) governs), and (2) the information that is contained in an oath or declaration accompanying the application (37 CFR 1.63 and 1.67 govern).”

It’s crucial to ensure consistency across all application documents to avoid potential confusion or delays in the examination process.

To learn more:

When claiming benefit to a non-English language provisional application, the following are required:

  • An English language translation of the provisional application
  • A statement that the translation is accurate

These must be filed in the provisional application. If not filed, the applicant will be notified and given a period of time to file the translation and statement.

MPEP 211.01(a) states: If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.

Failure to timely provide the translation and statement may result in the abandonment of the nonprovisional application.

To learn more:

What happens if an applicant’s income exceeds the micro entity threshold during pendency?

If an applicant’s income exceeds the micro entity threshold during the pendency of an application, they must notify the USPTO and change their status. The MPEP 509.04(a) states:

“A micro entity certification in an application will remain in effect until the applicant submits a notification of loss of entitlement to micro entity status under 37 CFR 1.29(i).”

Applicants are required to notify the USPTO of any change in status before paying any fee after the change. Failure to do so may result in:

  • Underpayment of fees
  • Loss of micro entity status
  • Potential invalidation of the patent if issued

It’s crucial to monitor income and update the USPTO promptly if the micro entity threshold is exceeded.

To learn more:

What happens if an applicant submits both a substitute statement and an inventor’s oath?

If both a substitute statement and an inventor’s oath or declaration are submitted for an inventor, the inventor’s oath or declaration will take precedence. The MPEP 604 states:

“If an inventor subsequently files an inventor’s oath or declaration meeting the requirements of 37 CFR 1.63 after a substitute statement has been filed, the inventor’s oath or declaration will be placed in the application file.”

This means that the USPTO will recognize the inventor’s own oath or declaration as the official document, effectively superseding the previously filed substitute statement. It’s important for applicants to be aware of this to avoid confusion and ensure proper documentation in the patent application process.

To learn more:

If an applicant misses the 30-month deadline for national stage entry in the United States, the consequences can be severe. According to MPEP 601.04:

Failure to timely comply with the requirements of 35 U.S.C. 371(c) results in abandonment of the application.

This means that if the applicant fails to submit the required documents and fees within the 30-month period, the application will be considered abandoned. However, the MPEP also provides a potential remedy:

Pursuant to 35 U.S.C. 371(d), the Commissioner may accept the required national stage requirements later than 30 months from the priority date if these requirements are submitted prior to the filing of the Demand for International Preliminary Examination.

It’s crucial to note that this remedy is discretionary and not guaranteed. Applicants should always strive to meet the 30-month deadline to avoid potential loss of rights.

To learn more:

If an applicant fails to take appropriate action during the prosecution of a nonprovisional patent application, it can result in the application being considered abandoned. MPEP 203.05 specifically states that an abandoned application includes one removed from the Office docket through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application. This could include failing to respond to office actions, missing deadlines, or not providing requested information or documents.

If an applicant fails to submit required application components within the specified time period, the following consequences may occur:

  • The application may be considered abandoned.
  • If abandoned, the application will be treated as though it had never been filed.
  • The applicant may lose the benefit of the original filing date.

The MPEP states: Upon failure to submit the fee, oath or declaration, and 1 or more claims within such prescribed period, the application shall be regarded as abandoned.

However, it may be possible to revive an abandoned application under certain circumstances:

  • The applicant can file a petition to revive under 37 CFR 1.137.
  • The petition must be accompanied by the required reply, the petition fee, and a statement that the entire delay was unintentional.

It’s crucial to respond to any notices from the USPTO promptly and to submit all required components within the specified timeframes to avoid these issues.

To learn more:

If an applicant fails to respond to a request for a property rights statement, there can be serious consequences for the patent application. According to MPEP 150:

If no proper and timely statement is received, the application will be held abandoned and the applicant so notified.

The process typically involves:

  • An initial informal request (45-Day Letter)
  • If no response or if the statement is defective, a formal request is made with a 30-day statutory period for response
  • No extensions are available for this 30-day period
  • Failure to respond properly results in the application being held abandoned

However, abandoned applications may be revived under the provisions of 37 CFR 1.137, as noted in the case of In re Rutan, 231 USPQ 864 (Comm’r Pat. 1986).

For more information on patent applications, visit: patent applications.

For more information on revival, visit: revival.

Failure to comply with the requirements of 35 U.S.C. 371(c) has serious consequences for an international application entering the national stage in the United States. According to MPEP 211.01(c), which cites 35 U.S.C. 371(d):

35 U.S.C. 371(d) indicates that failure to timely comply with the requirements of 35 U.S.C. 371(c) ‘shall be regarded as abandonment of the application by the parties thereof.’

This means that if an applicant does not meet the requirements for entering the national stage, such as submitting the required documents and fees within the specified time limits, the application will be considered abandoned. Abandonment results in the loss of the application’s filing date and any associated priority claims. It’s crucial for applicants to carefully follow the national stage entry requirements to avoid unintentional abandonment of their applications.

To learn more:

To learn more:

When a USPTO deadline falls on a weekend or holiday, the due date is automatically extended. According to MPEP 505, When the last day for taking any action or paying any fee in the Office falls on a Saturday, Sunday, or a Federal holiday within the District of Columbia, the action or the fee is considered timely if the action is taken or the fee is paid on the next succeeding business day.

This rule applies to various USPTO actions, including:

  • Filing responses to Office Actions
  • Paying maintenance fees
  • Submitting other time-sensitive documents

It’s important to note that while the deadline is extended, the USPTO is still closed on these days for regular correspondence receipt.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO deadlines, visit: USPTO deadlines.

If a typographical error on the original cover sheet does not affect the title to the application or patent against which the original assignment or name change is recorded, the Assignment Services Division will take the following actions:

  • Correct the Assignment Historical Database
  • Allow the recording party to keep the original date of recordation

As stated in MPEP 323.01(a): “If the original cover sheet contains a typographical error that does not affect title to the application or patent against which the original assignment or name change is recorded, the Assignment Services Division will correct the Assignment Historical Database and permit the recording party to keep the original date of recordation.”

This approach ensures that minor errors that don’t impact the substance of the assignment are corrected without affecting the original recordation date, which can be important for legal and priority purposes.

To learn more:

If a suspended practitioner is given power to inspect a patent application, the USPTO will not accept it. MPEP 105 clearly states: “Power to inspect given to such an attorney or agent will not be accepted.” This means that even if an applicant or inventor attempts to grant inspection rights to a suspended practitioner, the USPTO will reject this authorization and prevent the suspended practitioner from accessing the application materials.

To learn more:

If a substitute specification is denied entry, it should be marked as such by the examiner. The MPEP provides a form paragraph (6.28.02) for notifying the applicant that a substitute specification has not been entered. The examiner will explain why the substitute specification is improper, which may include reasons such as:

  • Missing statement regarding lack of new matter
  • Failure to provide both clean and marked-up copies
  • Submission in a reissue application or reexamination proceeding
  • Submission after payment of the issue fee
  • Inclusion of claims to be amended

If a substitute specification is denied entry, the applicant may need to address the issues raised and resubmit the specification or make alternative amendments to the original specification.

To learn more:

According to MPEP 602.08(c), when a specification is filed attached to an oath or declaration after the initial application filing date, the USPTO follows a specific procedure:

Any specification that is filed attached to an oath or declaration on a date later than the application filing date will not be compared with the specification submitted on filing.

Furthermore, the MPEP states: Absent any statement(s) to the contrary, the ‘attached’ specification will be presumed to be a copy of the specification and any amendments thereto, which were filed in the USPTO in order to obtain a filing date for the application.

This means that the USPTO will not verify if the later-submitted specification matches the original filing. Instead, they assume it’s a copy of the original specification plus any amendments, unless explicitly stated otherwise. This practice helps streamline the application process and avoid confusion between different versions of the specification.

To learn more:

What happens if a secrecy order is violated?

Violating a secrecy order can have serious consequences. According to MPEP 120, “Unauthorized disclosure of the subject matter of an application under a secrecy order is punishable by a fine and/or imprisonment (35 U.S.C. 186), and may result in loss of patent rights (35 U.S.C. 182).” This means that individuals who disclose information about an application under a secrecy order without proper authorization may face:

  • Monetary fines
  • Imprisonment
  • Loss of patent rights

It’s crucial for inventors, patent agents, and attorneys to strictly adhere to secrecy orders to avoid these severe penalties.

For more information on unauthorized disclosure, visit: unauthorized disclosure.

What happens if a provisional application is not followed by a nonprovisional application within 12 months?

If a provisional application is not followed by a nonprovisional application within 12 months, it will automatically be abandoned and cannot be revived. The MPEP 201.04 states: A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter. This means that the provisional application cannot serve as a priority document for any subsequent applications, and any potential benefit date will be lost.

For more information on provisional application, visit: provisional application.

If a provisional application is not converted to a nonprovisional application within 12 months, it automatically becomes abandoned. The MPEP 201.04 clearly states:

A provisional application automatically becomes abandoned 12 months after its filing date and cannot claim the benefit of any other application. See 35 U.S.C. 111(b)(5).

This means that after 12 months, the provisional application can no longer serve as a basis for claiming priority, and any disclosure made in the provisional application becomes part of the public domain. To maintain the benefit of the provisional filing date, applicants must file a nonprovisional application claiming the benefit of the provisional application within the 12-month period.

For more information on provisional application, visit: provisional application.

What happens if a provisional application is not converted to a nonprovisional within 12 months?

If a provisional application is not converted to a nonprovisional application within 12 months, it will automatically expire. The MPEP 201.04 states:

“A provisional application will automatically become abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.”

Once expired, the provisional application cannot be revived or restored to pending status. However, the applicant may still file a nonprovisional application after the 12-month period, but they would lose the benefit of the earlier filing date of the provisional application.

For more information on provisional application, visit: provisional application.

What happens if a provisional application is missing required elements?

If a provisional application is missing required elements, the USPTO will notify the applicant of the deficiencies. According to MPEP 601.01(b):

‘If the provisional application does not include a cover sheet indicating that it is a provisional application, the application will be treated as a nonprovisional application.’

Additionally:

  • If the specification is missing, the application will be treated as an incomplete application.
  • If the filing fee is missing, the USPTO will notify the applicant and set a time period for payment.
  • If drawings are omitted but referred to in the specification, the applicant will be notified and given a time period to submit the drawings.

It’s crucial to ensure all required elements are included to avoid potential issues with the application’s filing date or treatment as a different type of application.

To learn more:

What happens if a provisional application is filed without claims?

A provisional application can be filed without claims and still be considered complete. According to MPEP 601.01(b):

“A provisional application need not include claims to be complete for filing date purposes.”

This means that unlike non-provisional applications, provisional applications do not require claims to receive a filing date. However, it’s important to note that the specification should still provide adequate support for any claims that may be included in a later-filed non-provisional application claiming priority to the provisional application.

To learn more:

If a provisional application is filed without a complete cover sheet, the USPTO will still treat it as a provisional application. However, the applicant will be required to submit the complete cover sheet and pay a surcharge at a later date. The MPEP explains:

A provisional application, which is identified as such, but which does not have a complete cover sheet as required by 37 CFR 1.51(c)(1) will be treated as a provisional application. However, the complete cover sheet and a surcharge will be required to be submitted at a later date in conformance with 37 CFR 1.53(g). (MPEP 601.01(b))

The USPTO will notify the applicant and provide a time period (usually two months) to submit the necessary documents and fees to avoid abandonment of the application.

To learn more:

If a priority document is not timely retrieved through the PDX program, there can be significant consequences for the patent application. According to MPEP 215.02(a):

“If the priority document is not retrieved within the time period set in 37 CFR 1.55(g)(1), the applicant is notified and given a time period within which to file the certified copy in accordance with 37 CFR 1.55(g)(1).”

Consequences of untimely retrieval:

  • Applicant receives a notification of non-retrieval
  • A time limit is set for manual submission of the certified copy
  • Failure to submit within the time limit may result in loss of priority claim
  • Additional fees may be required for late submission

To learn more:

If a priority claim or the certified copy of a foreign application is filed after the issue fee is paid, it will not automatically be included in the patent. The MPEP Section 213.04 states:

“If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and § 1.323.”

This means that to include the priority claim in the patent after the issue fee is paid, the applicant must request a certificate of correction, which may involve additional fees and processing time.

To learn more:

If a prior-filed application lacks adequate written description for a claimed invention, the following consequences may occur:

  • The claim in the later-filed application will not be entitled to the benefit of the filing date of the prior-filed application for that invention.
  • The effective filing date for the claimed invention will be the filing date of the later-filed application.
  • This may impact the patent’s validity if intervening prior art exists between the filing dates of the prior-filed and later-filed applications.

As stated in MPEP 211.05:

To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or earlier-filed nonprovisional application or provisional application for which benefit is claimed); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) except for the best mode requirement.

This emphasizes the importance of ensuring that the prior-filed application contains a complete and detailed disclosure of the claimed invention.

To learn more:

What happens if a prior-filed application is abandoned?

If a prior-filed application is abandoned, it may still be used to claim the benefit of priority for a later-filed application, provided certain conditions are met. According to MPEP 211.01:

‘An abandoned application may be used as a prior application for purposes of claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) in a later-filed application when the abandoned application discloses the invention adequately and completely.’

However, it’s important to note that the abandoned application must still meet all the requirements for claiming benefit, including:

  • Adequate disclosure of the invention
  • Proper copendency (if applicable)
  • Specific reference to the prior application in the later-filed application

If these conditions are met, the abandoned status of the prior application does not prevent it from serving as a basis for claiming benefit in a later application.

To learn more:

If a previously non-signing inventor decides to join a pre-AIA 37 CFR 1.47 application, they can do so by filing the appropriate documentation. The MPEP states:

“In the event the previously nonsigning inventor decides to join in the application by filing an executed oath or declaration complying with pre-AIA 37 CFR 1.63, the oath or declaration will be placed in the application file.”

This means that if the inventor who initially did not sign the application later chooses to participate, they can submit a properly executed oath or declaration. This document will then be added to the official application file, effectively joining them to the application.

To learn more:

To learn more:

If a patent is issued to the wrong applicant, the USPTO has procedures to correct this error. According to MPEP 308:

‘If a patent is issued to the wrong applicant because of an error in the Office, the patentee may request a certificate of correction… If the error was not the Office’s fault, the assignee(s) or applicant(s) may request a reissue.’

The method of correction depends on whether the error was made by the USPTO or by the applicant. If it was the USPTO’s error, a certificate of correction can be requested. If it was the applicant’s error, a reissue process may be necessary.

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on error correction, visit: error correction.

For more information on patent issuance, visit: patent issuance.

For more information on reissue, visit: reissue.

If a patent involved in an arbitration award is subsequently invalidated, there are provisions for modifying the award. This process is outlined in 35 U.S.C. 294(c):

“The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration.”

Key points to note:

  • Parties can agree in advance to allow modification of the award if the patent is invalidated.
  • The invalidation must be determined by a court of competent jurisdiction.
  • The court decision must be final (no appeal possible or taken).
  • Any party to the arbitration can apply to a court for modification of the award.
  • The modified award will govern the rights and obligations between the parties from the date of modification.

This provision allows for adjustments to arbitration outcomes in light of significant changes to the validity of the underlying patent rights.

If a patent document doesn’t meet the identification requirements, it will not be recorded. The MPEP 317.01 states:

“A document which does not comply with the identification requirements of § 3.21 will not be recorded.”

This means that the USPTO will reject documents that fail to meet the specific identification criteria outlined in 37 CFR 3.21, and these documents will not receive a recording date until the issues are corrected.

To learn more:

What happens if a patent assignment is not recorded with the USPTO?

Failing to record a patent assignment with the USPTO can have significant consequences:

  • Lack of Constructive Notice: Third parties may not be aware of the ownership transfer.
  • Potential Legal Issues: It may affect the assignee’s ability to enforce the patent or recover damages in infringement cases.
  • Validity of Subsequent Transfers: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as valid, for purposes of recording, unless overcome by a showing that such assignment was fraudulently procured or is otherwise invalid.’

While recording is not mandatory for the assignment to be valid between the parties involved, it is highly recommended to protect the assignee’s rights and provide public notice of the ownership change.

For more information on USPTO, visit: USPTO.

Tags: USPTO

If a patent application is missing figures mentioned in the specification, the consequences depend on the filing date and type of application. According to MPEP 608.01(f):

  • For applications filed on or after December 18, 2013 (except design applications): The application will be treated as filed without all figures of drawings, as per MPEP § 601.01(g).
  • For applications filed before December 18, 2013 or design applications: The application will be treated as filed without drawings, as per MPEP § 601.01(f).

It’s crucial to ensure that all figures mentioned in the specification are included in the drawings to avoid potential issues with the application.

To learn more:

If a patent application is missing essential parts, such as the specification, drawings, or claims, the USPTO will notify the applicant of the missing elements. According to MPEP 506:

‘Applicant will be notified of the incomplete application and the time period set for submitting the omitted parts.’

The applicant will then have an opportunity to submit the missing parts within the specified time period to complete the application.

For more information on incomplete application, visit: incomplete application.

For more information on missing parts, visit: missing parts.

For more information on patent application requirements, visit: patent application requirements.

If a patent application is missing an abstract, the following actions will be taken:

  • For applications filed under 35 U.S.C. 111(a), the Office of Patent Application Processing (OPAP) will review for compliance and require an abstract if one has not been filed.
  • For all other applications lacking an abstract, the examiner will require the submission of an abstract in the first Office action.

The MPEP states: The Office of Patent Application Processing (OPAP) will review all applications filed under 35 U.S.C. 111(a) for compliance with 37 CFR 1.72 and will require an abstract, if one has not been filed. In all other applications which lack an abstract, the examiner in the first Office action should require the submission of an abstract directed to the technical disclosure in the specification.

To learn more:

The treatment of a patent application filed without drawings depends on the application type and filing date:

  • For nonprovisional applications filed on or after December 18, 2013 (except design applications):
    • The application will be accorded a filing date
    • Drawings may be filed later, but no new matter may be added
  • For applications filed before December 18, 2013 and design applications:
    • If drawings are necessary under 35 U.S.C. 113, the application will not be accorded a filing date
    • A “Notice of Incomplete Application” will be mailed

The USPTO states: Applications filed without drawings are initially inspected to determine whether a drawing is referred to in the specification, and if not, whether a drawing is necessary for the understanding of the invention.

For applications where drawings are determined to be necessary: If a nonprovisional application filed prior to December 18, 2013 or a design application does not have at least one claim directed to the subject matter discussed above for which a drawing is usually not considered essential for a filing date… and is filed without drawings, OPAP will mail a “Notice of Incomplete Application” indicating that the application lacks drawings and that 35 U.S.C. 113 (first sentence) requires a drawing where necessary for the understanding of the subject matter sought to be patented.

To learn more:

If a patent application is filed without all the required drawings, the Office of Patent Application Processing (OPAP) will review the application and may issue a “Notice of Omitted Item(s).” This notice informs the applicant that the application has been accorded a filing date but is missing some of the figures described in the specification.

The applicant then has several options:

  • Establish prior receipt of the missing drawings
  • Submit the omitted drawings and accept a later filing date
  • Accept the application as deposited and make appropriate amendments

As stated in the MPEP, The mailing of an OPAP notice regarding a missing drawing figure(s) in a nonprovisional application will permit the applicant to: (A) promptly establish prior receipt in the USPTO of the drawing(s) at issue… (B) promptly submit the omitted drawing(s) in a nonprovisional application and accept the date of such submission as the application filing date… (C) accept the application as deposited in the USPTO by filing an appropriate amendment.

To learn more:

If a patent application is filed without all the pages of the specification, the USPTO will notify the applicant of the missing parts. The MPEP refers to this situation:

See MPEP § 601.01(d)-(g) where the application is filed without all the pages of the specification, without at least one claim (nonprovisional design application), without drawings, or without all the figures of the drawings.

For applications filed before September 16, 2012, a supplemental oath or declaration by the inventor may be required to identify the missing item and indicate that it accurately describes the invention. For applications filed on or after September 16, 2012, an additional oath or declaration is generally not required.

The applicant will be given a time period to submit the missing pages. If the missing pages are not submitted within the specified time, the application may be deemed incomplete and not accorded a filing date until the missing parts are received.

If a patent application is filed without a correspondence address:

  • The USPTO needs a correspondence address to notify the applicant of any missing parts or requirements.
  • If no address is provided, the Office may use the mailing address of the first named inventor as the correspondence address.
  • Without a correspondence address, the applicant is considered to have constructive notice of application requirements as of the filing date.
  • The applicant has 2 months from the filing date to complete the application before it is abandoned.

According to MPEP 403: “If a patent application as filed has been accorded a filing date but is not complete, the applicant is notified and given a period of time within which to file the missing parts to complete the application and pay the applicable surcharge. … If the applicant fails to provide the Office with a correspondence address, the Office will be unable to provide the applicant with notification to complete the application and to pay the surcharge as set forth in 37 CFR 1.16(f) for nonprovisional applications and 37 CFR 1.16(g) for provisional applications. In such a case, the applicant will be considered to have constructive notice as of the filing date that the application must be completed and the applicant will have 2 months from the filing date in which to do so before abandonment occurs.”

If a patent application is filed with informal papers (e.g., typed on both sides of the paper, not permanent, legible, or reproducible), the USPTO will still accord a filing date if the application otherwise meets the requirements. The MPEP states:

OPAP accords a filing date, as of the date indicated by the “Office Date” stamp (see MPEP § 505), to application papers which include a specification containing a description and at least one claim (nonprovisional applications filed under 37 CFR 1.53(b) prior to March 18, 2013 and design applications), and a drawing, if necessary under 35 U.S.C. 113 (first sentence) and 37 CFR 1.53(b), but are informal because they do not comply with the rules or notices.

The USPTO will send a Notice requiring correction of the informality. Failure to correct the informality within the specified time will result in abandonment of the application.

If a nonsigning inventor believes they are the sole inventor of an invention claimed in a pre-AIA 37 CFR 1.47 application where they are named as a joint inventor, they have a specific course of action available to them.

According to MPEP 409.03(i):

“If a nonsigning inventor feels that he or she is the sole inventor of an invention claimed in a pre-AIA 37 CFR 1.47 application naming him or her as a joint inventor, the nonsigning inventor may file his or her own application and request that his or her application be placed in interference with the pre-AIA 37 CFR 1.47 application.”

This means that the nonsigning inventor can:

  1. File their own separate patent application for the invention
  2. Request that their application be placed in interference with the pre-AIA 37 CFR 1.47 application

The MPEP further states: “If the claims in both the nonsigning inventor’s application and the pre-AIA 37 CFR 1.47 application are otherwise found allowable, an interference may be declared.”

An interference proceeding is a process used to determine which party has the right to a patent when two or more parties claim the same invention.

To learn more:

To learn more:

If a nonprovisional patent application is filed without all required fees, the USPTO will send a notice to the applicant. According to the MPEP:

Filing dates are accorded to nonprovisional applications filed under 37 CFR 1.53(b) submitted without the… required fees (basic filing fee, and search and examination fees (for applications filed on or after December 8, 2004))… In such cases, a notice is mailed by OPAP requiring the appropriate fees… accompanied by a surcharge (37 CFR 1.16(f)).

The applicant will be given a time period (usually two months) to pay the missing fees and surcharge to avoid abandonment of the application.

What happens if a nonprovisional application is filed without drawings but they are necessary?

If a nonprovisional application is filed without drawings, but drawings are necessary for understanding the subject matter sought to be patented, the USPTO will send a Notice of Incomplete Application. The MPEP states:

If drawings are necessary under 35 U.S.C. 113 (first sentence) and are omitted on filing, the Office will send a Notice of Incomplete Application indicating that drawings are required and setting a time period within which the applicant must submit the omitted drawings to avoid abandonment.

The applicant must then submit the required drawings within the specified time period to avoid abandonment of the application. It’s important to note that the filing date of the application will be the date on which the drawings are received by the USPTO, not the original filing date.

For more information, refer to MPEP 601.01(a).

To learn more:

If a nonprovisional application is filed without all pages of the specification, but contains something that can be construed as a written description, the USPTO will take the following actions:

  1. Issue a Notice of Omitted Items indicating the application has been accorded a filing date but is missing some pages of the specification.
  2. Give the applicant an opportunity to either:
    • Establish prior receipt of the missing pages
    • Submit the omitted pages and request the later submission date as the filing date
    • Accept the application as deposited without the missing pages

The USPTO states: The mailing of an OPAP notice regarding a missing page(s) of specification in a nonprovisional application will permit the applicant to: (A) promptly establish prior receipt in the USPTO of the page(s) at issue… (B) promptly submit the omitted page(s) in a nonprovisional application and accept the date of such submission as the application filing date… (C) accept the application as deposited in the USPTO…

To learn more:

What happens if a nonprovisional application claims benefit of multiple provisional applications?

When a nonprovisional application claims the benefit of multiple provisional applications, each provisional application must satisfy the requirements of 35 U.S.C. 119(e) and the first paragraph of 35 U.S.C. 112 for the subject matter claimed in the nonprovisional application.

As stated in MPEP 211.01(a):

“If a claim in the nonprovisional application is not adequately supported by any of the prior provisional applications, that claim is not entitled to the benefit of the filing date of the provisional applications not providing adequate support.”

This means that different claims in the nonprovisional application may have different effective filing dates, depending on which provisional application(s) provide adequate support for each claim.

To learn more:

When a new power of attorney is filed that lists only one of two previously appointed patent practitioners, it has significant implications. According to MPEP 403.02:

“Note that if the later-filed power of attorney only lists the second practitioner, the later-filed power of attorney serves as a revocation of the earlier-filed power of attorney, even without an express revocation of the power of the first patent practitioner.”

This means that filing a new power of attorney listing only one practitioner effectively revokes the authority of the previously appointed practitioner, even if the revocation is not explicitly stated. This is an important consideration for applicants and practitioners when making changes to representation.

To learn more:

If a new inventor is identified in a Continued Prosecution Application (CPA) without proper documentation, it can lead to issues with the application. The MPEP ¶ 2.33 states:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

This means that if an examiner notices a new inventor listed on a CPA without the required request under 37 CFR 1.48, they will issue a notice to the applicant. The inventorship will remain the same as in the prior application until the proper request is filed and approved.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

If a new inventor is identified in a Continued Prosecution Application (CPA) without filing a proper request, it can lead to inventorship issues. The MPEP ¶ 2.33 states:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

This means that simply naming a new inventor in the CPA filing documents is not sufficient. Without a proper request under 37 CFR 1.48, the inventorship will remain the same as in the prior application, potentially leading to complications in the patent prosecution process.

For more information on CPA, visit: CPA.

Tags: CPA

If a new inventor is identified in a Continued Prosecution Application (CPA) for a design application, specific steps must be taken to properly add them to the application.

MPEP ¶ 2.33 states: “It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.”

This means that simply naming a new inventor in the CPA filing is not sufficient. A formal request under 37 CFR 1.48 must be filed to correct the inventorship. Without this request, the inventorship will remain the same as in the prior application, regardless of any new names listed on the CPA filing.

For more information on CPA, visit: CPA.

Tags: CPA

If a legal representative hasn’t been appointed for a deceased inventor in an application filed before September 16, 2012, the situation can be complex. According to MPEP 409.01(b):

If no legal representative has been appointed, the examiner will reject the application under 35 U.S.C. 102(f) on the basis that the applicant is not the inventor and/or on the basis that there is no right to apply in any person other than the inventor.

This means that without a legal representative, the application may face rejection. It’s crucial to appoint a legal representative as soon as possible to avoid this outcome.

To learn more:

If a foreign priority claim in an original application filed under 35 U.S.C. 111(a) (other than a design application) is submitted after the time period set in 37 CFR 1.55 and without a petition under 37 CFR 1.55, the examiner may notify the applicant that the foreign priority claim will not be entered.

As stated in the MPEP: If the foreign priority claim in an original application filed under 35 U.S.C. 111(a) (other than a design application) is submitted after the time period set in 37 CFR 1.55 and without a petition under 37 CFR 1.55, the examiner may use form paragraph 2.21.01 to notify applicant that the foreign priority claim will not be entered.

In such cases, the applicant must file a petition for an unintentionally delayed priority claim under 37 CFR 1.55(e) to have the priority claim considered.

To learn more:

What happens if a foreign patent agent’s limited recognition expires?

If a foreign patent agent’s limited recognition expires, they are no longer authorized to represent applicants before the USPTO. The MPEP states, A foreign patent agent granted limited recognition may continue to represent applicants for the remainder of any time period previously set by the USPTO for taking an action, which period is still outstanding at the expiration of the 5-year period of recognition. (MPEP 402.01) This means that if there are any ongoing actions with set deadlines, the agent can complete those, but they cannot take on new representations or continue general practice until they renew their limited recognition status.

To learn more:

Tags: USPTO

If a foreign application was filed more than 12 months before the U.S. application and priority has not been restored, the examiner will use form paragraph 2.23 to notify the applicant that the claim for priority cannot be based on that application.

As stated in the MPEP: Where the earlier foreign application was filed more than 12 months prior to the U.S. application and priority has not been restored under PCT Rule 26bis.3 for an international application or upon a granted petition under 37 CFR 1.55(c), use form paragraph 2.23.

In such cases, the applicant may file a petition under 37 CFR 1.55(c) to restore the right of priority if:

  • The subsequent application was filed within two months from the expiration of the twelve-month period
  • The delay was unintentional

The petition must include specific elements, such as the priority claim, petition fee, and a statement about the unintentional delay.

To learn more:

If the USPTO determines that a faxed assignment document is not recordable, there’s a specific process outlined in MPEP 302.09:

  1. The entire document, including the cover sheet, is returned to the sender via fax.
  2. A ‘Notice of Non-Recordation’ is included with the returned document.
  3. The sender can make corrections and resubmit the document.
  4. Resubmission must be done by mail to the address in 37 CFR 3.27.
  5. Timely resubmission preserves the initial receipt date as the recordation date.

The MPEP states: If a document submitted by fax is determined not to be recordable, the entire document, with its associated cover sheet, and the Office ‘Notice of Non-Recordation’ will be transmitted via fax back to the sender. Once corrections are made, the initial submission, amended, may then be resubmitted by mailing the corrected submission to the address set forth in 37 CFR 3.27. Timely resubmission will provide the sender with the benefit of the initial receipt date as the recordation date in accordance with 37 CFR 3.51.

To learn more:

If a drawing is not included with the application but is required for a complete disclosure of the invention, the Office of Patent Application Processing (OPAP) will send a Notice to File Missing Parts giving the applicant a time period of two months from the mailing date of the Notice to file the missing drawing(s). The time period may be extended under 37 CFR 1.136(a).

If a drawing is not acceptable for publication, the Office of Patent Application Processing (OPAP) will object to the drawing and notify the applicant. The applicant will be given a time period of two months from the mail date of the Notice to file acceptable drawings. This period is extendable under 37 CFR 1.136(a) or (b) for patent applications filed under 35 U.S.C. 111, but not for design applications filed under 35 U.S.C. 171. Failure to comply with the Notice within the time period will result in abandonment of the application.

What happens if a divisional application is filed after the parent application is patented or abandoned?

If a divisional application is filed after the parent application has been patented or abandoned, it will not be entitled to the benefit of the parent application’s filing date. The MPEP states:

A divisional application is often filed as a result of a restriction requirement made by the examiner. The divisional application may be filed under 37 CFR 1.53(b) (or 1.53(d) if the application is a design application) before the patenting or abandonment of or termination of proceedings on the original application or on an earlier-filed divisional application directed to the same elected invention.

Filing a divisional application after the parent application has been patented or abandoned means:

  • The application will not be considered a proper divisional application
  • It will not receive the benefit of the parent application’s filing date
  • It may be treated as a new, independent application
  • Prior art that was not applicable to the parent application may now be applicable
  • The application may face potential statutory bars under 35 U.S.C. 102

To avoid these issues, it’s crucial to file divisional applications before the patenting, abandonment, or termination of proceedings on the parent application.

For more information on Divisional application, visit: Divisional application.

For more information on late filing, visit: late filing.

For more information on patent procedure, visit: patent procedure.

If the designated domestic representative cannot be found or if no person has been designated, 35 U.S.C. 293 provides a solution:

If the person designated cannot be found at the address given in the last designation, or if no person has been designated, the United States District Court for the Eastern District of Virginia shall have jurisdiction and summons shall be served by publication or otherwise as the court directs.

This means that if the domestic representative is unreachable or non-existent, the U.S. District Court for the Eastern District of Virginia will handle the case and determine how to serve the summons. This ensures that legal proceedings can continue even if there are issues with the domestic representative.

To learn more:

If a delayed benefit claim is filed after the patent issues, it cannot be accepted. The MPEP 211.04 states:

‘A delayed benefit claim filed after issuance of a patent cannot be accepted.’

This means that once a patent has been granted, it is no longer possible to add or modify benefit claims. Any attempts to file a delayed benefit claim after patent issuance will be denied.

To learn more:

If a Continued Prosecution Application (CPA) request for a design patent is not submitted on a separate paper, it will be considered non-compliant and will not be processed by the USPTO.

The MPEP clearly states: ‘Because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.’ This means that the CPA will not be initiated, and the applicant will need to resubmit the request properly to proceed with the continued examination.

In such cases, the USPTO will typically send a notification to the applicant informing them of the non-compliance and providing instructions for proper submission.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

If a Continued Prosecution Application (CPA) request is improper for a utility or plant application, the USPTO handles it differently than for design applications. According to MPEP ¶ 2.35:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

In such cases, the USPTO treats the improper CPA request as a Request for Continued Examination (RCE). This approach ensures that the application can continue to be prosecuted, albeit under a different procedure. Applicants should be aware of this distinction and the potential implications for their patent prosecution strategy.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

If a Continued Prosecution Application (CPA) is improperly requested for a utility or plant patent application, it is typically treated as a Request for Continued Examination (RCE). The MPEP ¶ 2.30 provides guidance on this situation:

If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead). See MPEP § 706.07(h).

In such cases, the examiner will use a different form paragraph (7.42.15) to notify the applicant that their CPA request has been treated as an RCE. This ensures that the application can continue to be examined under the appropriate procedure for utility or plant patents.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on plant patents, visit: plant patents.

For more information on RCE, visit: RCE.

For more information on utility patents, visit: utility patents.

If a Continued Prosecution Application (CPA) is filed in a utility or plant application after July 14, 2003, it will not be treated as a proper CPA. According to MPEP 201.06(d):

‘Any CPA filed on or after July 14, 2003 in a utility or plant application will automatically be treated as a request for continued examination (RCE) under 37 CFR 1.114, see MPEP § 706.07(h), paragraph II.’

This means that instead of being processed as a CPA, the application will be treated as a Request for Continued Examination (RCE). Applicants should be aware of this automatic conversion and ensure they meet the requirements for an RCE if they inadvertently file a CPA for a utility or plant application.

For more information on CPA, visit: CPA.

For more information on RCE, visit: RCE.

Tags: CPA, RCE

What happens if a copending application is abandoned after filing a continuation application?

If a copending application is abandoned after filing a continuation application, it does not affect the continuation application’s status. The MPEP states:

“The copendency requirement of 35 U.S.C. 120 is met if the later-filed application is filed before the patenting or abandonment of or termination of proceedings on the prior application.”

This means that as long as the continuation application was filed while the prior application was still pending, subsequent abandonment of the prior application does not impact the continuation’s validity. The continuation application can still claim the benefit of the prior application’s filing date.

For more information, refer to MPEP 211.01.

To learn more:

To learn more:

If a Continued Prosecution Application (CPA) is filed after the issue fee has been paid, it will not be treated as a CPA. Instead, it will be processed as follows:

  • For applications filed on or after May 29, 2000, the CPA will be treated as a request for continued examination (RCE) under 37 CFR 1.114.
  • For applications filed before May 29, 2000, the CPA will be treated as an improper application and will not be processed.

As stated in MPEP 201.06(d): “If an application is filed on or after May 29, 2000, the filing of a CPA is not permitted after payment of the issue fee. In such a case, the Office will treat the improper CPA as an RCE under 37 CFR 1.114, provided that the application is a utility or plant application filed on or after June 8, 1995.”

It’s important to note that this treatment as an RCE is only possible for utility or plant applications filed on or after June 8, 1995. For other types of applications or those filed before this date, the improper CPA filing will not be processed, and the applicant may need to consider other options, such as filing a reissue application if the patent has already issued.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on issue fee, visit: issue fee.

For more information on RCE, visit: RCE.

When a continuation-in-part (CIP) application includes new matter not disclosed in the parent application, the following consequences apply:

  • Claims solely directed to subject matter adequately disclosed in the parent application are entitled to the parent application’s filing date.
  • Claims that include new matter introduced in the CIP are only entitled to the filing date of the CIP application.
  • The new matter may affect the application’s ability to overcome prior art references.

As stated in MPEP 211.05:

“Any claim in a continuation-in-part application which is directed solely to subject matter adequately disclosed under 35 U.S.C. 112 in the parent nonprovisional application is entitled to the benefit of the filing date of the parent nonprovisional application. However, if a claim in a continuation-in-part application recites a feature which was not disclosed or adequately supported by a proper disclosure under 35 U.S.C. 112 in the parent nonprovisional application, but which was first introduced or adequately supported in the continuation-in-part application, such a claim is entitled only to the filing date of the continuation-in-part application.”

This differentiation in filing dates for different claims within the same CIP application can significantly impact the application’s ability to overcome prior art and maintain patentability.

To learn more:

If a continuation or divisional application contains new matter not disclosed in the prior-filed application, the applicant will be required to either delete the benefit claim or change the relationship to a continuation-in-part application. This is because continuation and divisional applications cannot include new matter.

As stated in MPEP ¶ 2.10.01:

“Applicant is required to delete the benefit claim or change the relationship (continuation or divisional application) to continuation-in-part because this application contains the following matter not disclosed in the prior-filed application:”

This form paragraph is used by examiners when they identify new matter in an application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c).

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent examination, visit: patent examination.

What happens if a continuation application is filed after the parent application has been abandoned?

If a continuation application is filed after the parent application has been abandoned, it may still be entitled to the benefit of the filing date of the prior application. The MPEP states:

“Where the prior application has been abandoned, the petition to revive under 37 CFR 1.137 (a) or (b) must be filed in the prior application, or in a subsequent nonprovisional application claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the prior application, if the prior nonprovisional application is not pending and claims the benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) of a provisional application.”

This means that even if the parent application is abandoned, you can still file a continuation application and potentially revive the parent application. However, specific procedures must be followed, including filing a petition to revive in the appropriate application.

For more information on reviving abandoned applications, refer to MPEP 711.

To learn more:

To learn more:

Even if a citation considered by the examiner is not printed on the patent, there is still a record of its consideration. The MPEP clarifies:

If a citation is not printed on the patent but has been considered by the examiner, the patented file will reflect that fact as noted in MPEP § 609.05(b).

This means that while the citation may not appear on the face of the patent, the official file history maintained by the USPTO will contain evidence that the examiner considered the citation during the examination process. This information can be important for understanding the full scope of prior art considered during patent prosecution.

To learn more:

If a certified copy of the priority document is not filed within the time limit in a U.S. national stage application, the following consequences may occur:

  • The right to priority may be lost if the certified copy is not filed within the time period set in 37 CFR 1.55.
  • However, if the certified copy is filed after the time period set in 37 CFR 1.55 but during the pendency of the application, the right to priority may be restored under certain conditions.
  • According to MPEP 213.06, ‘If the certified copy is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’

It’s crucial to file the certified copy within the specified time limit to avoid potential complications in claiming priority.

To learn more:

To learn more:

What happens if a certified copy is not received within the time period set in 37 CFR 1.55(f)?

If a certified copy is not received within the time period set in 37 CFR 1.55(f), the USPTO will send a Notice of Allowance and Issue Fee Due (Notice of Allowance) with a requirement for the certified copy. As stated in the MPEP:

‘If a certified copy of the foreign application is not filed within the time period specified in 37 CFR 1.55(f) and the exceptions in 37 CFR 1.55(h), (i), and (j) are not applicable, the certified copy of the foreign application must be accompanied by a petition including a showing of good and sufficient cause for the delay and the petition fee set forth in 37 CFR 1.17(g).’

This means that if you miss the deadline, you’ll need to file a petition explaining the delay and pay an additional fee. It’s crucial to submit the certified copy or ensure it’s retrievable through the priority document exchange program to avoid complications in the patent application process.

If a benefit claim to a provisional application lacks proper indication of an intermediate application:

  • The Office may not recognize the benefit claim
  • The benefit claim may not appear on the filing receipt
  • A petition under 37 CFR 1.78(c) and petition fee may be required to correct the benefit claim

MPEP 211.01(b) states: “If a benefit claim to a provisional application is submitted without an indication that an intermediate application directly claims the benefit of the provisional application and the instant nonprovisional application is not filed within the 12 month period (or 14 month period if the benefit of the provisional application has been restored pursuant to 37 CFR 1.78(b)) or the relationship between each nonprovisional application is not indicated, the Office will not recognize such benefit claim and will not include the benefit claim on the filing receipt.”

If a benefit claim is included elsewhere in the application (e.g., in an oath or declaration) and is recognized by the USPTO as shown by its inclusion on the first filing receipt, but not properly submitted in the manner specified by 37 CFR 1.78, the following applies:

  • The USPTO will not require a petition and petition fee to correct the benefit claim.
  • This is because the application will have been scheduled for publication based on the information concerning the benefit claim.
  • However, the applicant must still submit the benefit claim in the proper manner (i.e., in an ADS or by amendment to the specification, depending on the filing date) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78.

The MPEP states: “If an applicant includes a claim to the benefit of a prior application elsewhere in the application but not in the manner specified in 37 CFR 1.78 (e.g., if the benefit claim is not present in the proper place but is included in an oath or declaration, or the application transmittal letter, or in the first sentence(s) of the specification for an application filed on or after September 16, 2012) within the time period set forth in 37 CFR 1.78, the Office will not require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the information concerning the benefit claim contained elsewhere in the application was recognized by the Office as shown by its inclusion on the first filing receipt.”

If a benefit claim is not submitted within the required time period, it is considered waived. The MPEP states: This time period is not extendable and a failure to submit the reference required by 35 U.S.C. 119(e) and/or 120, where applicable, within this time period is considered a waiver of any benefit of such prior application(s) under 35 U.S.C. 119(e), 120, 121, 365(c), and 386(c) unless a petition to accept an unintentionally delayed benefit claim is granted.

However, applicants may file a petition to accept an unintentionally delayed benefit claim. For more information on this process, see MPEP § 211.04.

To learn more:

If a benefit claim is not properly made within the required time period, it is considered untimely and will not be entered. The MPEP states:

“The benefit claim filed on [1] was not entered because the required reference was not timely filed within the time period set forth in 37 CFR 1.78.”

Consequences of an untimely benefit claim include:

  • Loss of the earlier priority date, which could affect the patentability of the application if intervening prior art exists.
  • Inability to rely on the earlier filing date to overcome prior art references.
  • Potential issues with statutory bars under 35 U.S.C. 102.

However, all is not lost if the benefit claim is untimely. The applicant may file a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(c) or 37 CFR 1.78(e), depending on the type of benefit claim. This petition must include:

  1. The required reference to the prior application
  2. A petition fee
  3. A statement that the entire delay was unintentional

The USPTO may require additional information to determine if the delay was truly unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on unintentional delay, visit: unintentional delay.

If an applicant includes a benefit claim in the wrong part of the application but within the required time period, the USPTO’s response depends on whether the claim is recognized:

  1. If the benefit claim is recognized by the Office (shown by its inclusion on the first filing receipt), no petition or petition fee is required to correct the benefit claim. The MPEP states: If an applicant includes a claim to the benefit of a prior application elsewhere in the application but not in the manner specified in 37 CFR 1.78 (e.g., if the benefit claim is not present in the proper place but is included in an oath or declaration, or the application transmittal letter, or in the first sentence(s) of the specification for an application filed on or after September 16, 2012) within the time period set forth in 37 CFR 1.78, the Office will not require a petition and the petition fee under 37 CFR 1.17(m) to correct the benefit claim if the information concerning the benefit claim contained elsewhere in the application was recognized by the Office as shown by its inclusion on the first filing receipt.
  2. If the benefit claim is not recognized by the Office (shown by its absence on the first filing receipt), a petition and petition fee under 37 CFR 1.17(m) will be required to correct the benefit claim if the correction is sought after the time period set in 37 CFR 1.78.

In both cases, the applicant must still submit the benefit claim in the proper format (i.e., in an ADS or by amendment to the specification, depending on the application’s filing date) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on filing receipt, visit: filing receipt.

If a benefit claim is filed after the required time period specified in 37 CFR 1.78, the applicant must file a petition for an unintentionally delayed benefit claim. The MPEP states:

“If a benefit claim is filed after the required time period and without a petition as required by 37 CFR 1.78, the applicant should be informed that the benefit claim was not entered and that a petition needs to be filed using form paragraph 2.39.”

The petition must include:

  • The reference to the prior application (unless previously submitted)
  • A petition fee under 37 CFR 1.17(m)
  • A statement that the entire delay was unintentional

The Director may require additional information to determine if the delay was unintentional.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on unintentional delay, visit: unintentional delay.

The treatment of dependent claims when a base claim is canceled or rejected is addressed in MPEP 608.01(n):

  • If the base claim has been canceled, a claim which is directly or indirectly dependent thereon should be rejected as incomplete.
  • If the base claim is rejected, the dependent claim should be objected to rather than rejected, if it is otherwise allowable.

The MPEP provides a specific form paragraph (7.43) for objecting to claims that are dependent on a rejected base claim: “Claim [1] objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.”

This approach allows examiners to indicate potentially allowable subject matter while maintaining the rejection of the base claim.

To learn more:

After an application filed under pre-AIA 37 CFR 1.47 is accepted by the USPTO, the examiner proceeds with the application as usual. As stated in the MPEP:

“After an application deposited pursuant to pre-AIA 37 CFR 1.47 is found acceptable by the Office, the examiner will act on the application in the usual manner.”

This means that the application will be examined and processed like any other patent application, despite its initial filing under special circumstances.

To learn more:

To learn more:

After a Continued Prosecution Application (CPA) is established, the USPTO proceeds with examination. According to MPEP ¶ 2.35:

Accordingly, the request for a CPA application is acceptable and a CPA has been established. An action on the CPA follows.

This means that once the CPA is established, the examiner will review the application and issue an Office action. It’s important to note that applicants are not separately notified of the abandonment of the parent application, nor is a filing receipt normally sent for a CPA.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

For more information on USPTO procedures, visit: USPTO procedures.

Once a Continued Prosecution Application (CPA) is established from a Conditional Request, the USPTO proceeds with the examination process as it would for any other CPA. According to MPEP ¶ 2.35: “An action on the CPA follows.”

This means that after the CPA is established:

  • The parent application is considered abandoned
  • The examiner will review the CPA and issue an Office action
  • The applicant should be aware that they may not receive a filing receipt for the CPA, as noted in the MPEP: “This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

37 CFR 1.62, which covered the File Wrapper Continuing Procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette 1203, published on October 21, 1997.

The MPEP states: 37 CFR 1.62 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This means that applications filed under this procedure after its deletion date would be treated differently.

To learn more:

To learn more:

37 CFR 1.62, which covered the File Wrapper Continuing Procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette: “See 1203 O.G. 63, October 21, 1997.” This deletion significantly impacted how certain continuation, divisional, and continuation-in-part applications were processed.

For more information on patent application procedures, visit: patent application procedures.

37 CFR 1.60, which previously governed the filing of divisional and continuation applications, was deleted effective December 1, 1997. As stated in the MPEP, 37 CFR 1.60 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This change significantly impacted the procedure for filing these types of applications.

For more information on continuation applications, visit: continuation applications.

37 CFR 1.60, which dealt with the divisional continuation procedure, was deleted effective December 1, 1997. This change was announced in the Official Gazette, as stated in the MPEP: 37 CFR 1.60 was deleted effective December 1, 1997. See 1203 O.G. 63, October 21, 1997. This means that the specific procedures outlined in this regulation are no longer in effect for applications filed after this date.

To learn more:

To learn more:

For patent applications filed before September 16, 2012, the USPTO recommends specific forms for powers of attorney. According to the MPEP:

Form PTO/SB/80 or PTO/SB/81 (available at www.uspto.gov/patent/patents-forms) should be used for powers of attorney in applications filed before September 16, 2012.

Additionally, for patents that issued from applications filed before September 16, 2012, Form PTO/SB/81A may be used. It’s important to note that the USPTO no longer recommends or provides combined declaration and power of attorney forms. Practitioners should use separate forms for declarations and powers of attorney.

To learn more:

Patent examiners have several forms at their disposal to communicate about replacement drawings:

  1. Form Paragraph 6.37: Used to acknowledge receipt of replacement drawing sheets.
  2. Form PTOL-324: Can be used instead of Form Paragraph 6.37 to provide explanations about drawing compliance.
  3. Form PTOL-326 (Office Action Summary): Includes a specific block for acknowledging replacement drawings.

The MPEP 608.02(h) provides guidance on using these forms:

“Form paragraph 6.37 may be used to acknowledge replacement drawing sheets. […] Form PTOL-324 may be used instead of this form paragraph to provide the explanation. Alternatively, PTOL-326 Office Action Summary includes a block for acknowledgment of replacement drawings.”

These forms help ensure clear and consistent communication between examiners and applicants regarding the status and acceptability of replacement drawings.

To learn more:

There are two main forms that can be used to authorize a patent practitioner for an interview:

  1. Applicant Initiated Interview Request Form (PTOL-413A)
  2. Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity’

According to MPEP 405:

Registered practitioners, when acting in a representative capacity, can show authorization to conduct an interview by completing, signing and filing an Applicant Initiated Interview Request Form (PTOL-413A).

Additionally:

Alternatively, Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity,’ which is available from the USPTO website at www.uspto.gov/sites/default/files/web/forms/sb0084.pdf may be used to establish the authority to conduct an interview.

The United States Patent and Trademark Office (USPTO) provides several forms that can be used for submitting an inventor’s oath or declaration in patent applications filed on or after September 16, 2012. These forms are:

  • Forms PTO/AIA/01 through PTO/AIA/11

These forms are designed to ensure that all required information and statements are included in the oath or declaration. They can be found on the USPTO website at www.uspto.gov/PatentForms.

In addition to these forms, the USPTO provides an ‘AIA Inventor’s Oath or Declaration Quick Reference Guide’ to assist applicants in properly completing and submitting the inventor’s oath or declaration.

While using these forms is not mandatory, they can help ensure compliance with the requirements set forth in 37 CFR 1.63 and 35 U.S.C. 115. If not using these forms, applicants must ensure that all required information and statements are included in their custom oath or declaration.

To learn more:

The USPTO provides several forms for Customer Number practice:

  • PTO/SB/125 – Request for Customer Number
  • PTO/SB/124 – Request for Customer Number Data Change
  • PTO/AIA/122 or PTO/SB/122 – Change of Correspondence Address, Application
  • PTO/AIA/123 or PTO/SB/123 – Change of Correspondence Address, Patent

According to MPEP 403: “The following forms are suggested for use with the Customer Number practice: (A) the ‘Request for Customer Number’ (PTO/SB/125) to request a Customer Number; (B) the ‘Request for Customer Number Data Change’ (PTO/SB/124) to request a change in the data (address or list of practitioners) associated with an existing Customer Number; (C) the ‘Change of Correspondence Address, Application’ (PTO/AIA/122 for applications filed on or after September 16, 2012, or PTO/SB/122 for applications filed before September 16, 2012) to change the correspondence address of an individual application to the address associated with a Customer Number; and (D) the ‘Change of Correspondence Address, Patent’ (PTO/AIA/123 for applications filed on or after September 16, 2012, or PTO//SB/123 for applications filed before September 16, 2012) to change the correspondence address of an individual patent to the address associated with a Customer Number.”

For pre-AIA applications (filed before September 16, 2012), the MPEP mentions a specific form that can be used by assignees to revoke a power of attorney and appoint a new one:

Form PTO/SB/80 may be used by an assignee of the entire interest of the applicant to revoke a power of attorney and appoint a new power of attorney.

The process involves:

  • The assignee signing the power of attorney (Form PTO/SB/80)
  • Either the assignee or the newly appointed practitioner signing a statement under pre-AIA 37 CFR 3.73(b)

Additionally, Form PTO/SB/96 or an equivalent can be used for the Statement Under pre-AIA 37 CFR 3.73(b). For details on who can sign this statement, refer to MPEP § 324, subsection V.

To learn more:

For patent applications filed on or after September 16, 2012, specific forms are required for appointing a power of attorney. The MPEP 601.02 directs applicants to the appropriate section for guidance:

“See MPEP § 402.02(a) for detailed information and relevant forms pertaining to appointment of a power of attorney in applications filed on or after September 16, 2012.”

To access the specific forms and detailed instructions, you should consult MPEP § 402.02(a). This section provides comprehensive information on the process and required documentation for appointing a power of attorney in recent patent applications.

To learn more:

The USPTO provides several forms for appointing a power of attorney in patent applications filed on or after September 16, 2012. These forms are available on the USPTO website and include:

  • PTO/AIA/80: For use by assignees who are either the named applicant or are becoming the applicant.
  • PTO/AIA/81: For use by joint inventors who are the applicant to give one or more joint inventor-applicants power of attorney.
  • PTO/AIA/82: For use by the applicant for patent to appoint one or more patent practitioners.
  • PTO/AIA/81A: For use in appointing a power of attorney in a patent resulting from an application filed on or after September 16, 2012.

Each form has specific uses and requirements. For example, Form PTO/AIA/80 must be accompanied by a statement under 37 CFR 3.73(c) (Form PTO/AIA/96 or equivalent) and must be signed by the named assignee or a person authorized to act on behalf of the assignee.

To learn more:

When an applicant is initiating an interview request, they should submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) to the examiner. The MPEP provides the following guidance:

When applicant is initiating a request for an interview, an ‘Applicant Initiated Interview Request’ form (PTOL-413A) should be submitted to the examiner prior to the interview in order to permit the examiner to prepare in advance for the interview and to focus on the issues to be discussed.

This form helps streamline the interview process by providing the examiner with essential information about the proposed interview.

Examiners use specific form paragraphs when requiring a title change in a patent application. According to MPEP 606.01, “Form paragraphs 6.11 and 6.11.01 may be used.” Form paragraph 6.11 states that the title is not descriptive and a new title is required. Form paragraph 6.11.01 is used to suggest a new title. These standardized paragraphs ensure consistency in communication between examiners and applicants regarding title changes.

To learn more:

The U.S. Patent and Trademark Office provides a specific form for certifying micro entity status based on an institution of higher education. This form is PTO/SB/15B.

MPEP 509.04(b) states: “The Office’s form PTO/SB/15B contains the certifications under 37 CFR 1.29(d) that are required to establish micro entity status on the institution of higher education basis.”

The form includes two signature blocks corresponding to the two alternative requirements under 37 CFR 1.29(d)(2):

  1. Certifying that the applicant’s employer, from which they obtain the majority of their income, is an institution of higher education.
  2. Certifying that the applicant has assigned, granted, or conveyed a license or other ownership interest in the application to an institution of higher education (or is obligated to do so).

Applicants should use this form to properly certify their micro entity status based on an institution of higher education.

To learn more:

Tags: patent fees

To correct or update an inventor’s name in a patent application (other than reissue applications), you can use Form PTO/AIA/40. As stated in MPEP 602.01(c)(2):

See MPEP § 602.01(c)(1) for a copy of form PTO/AIA/40 that may be used to correct or update in inventor’s name or change the order of names in applications (other than reissue applications).

This form should be submitted along with:

  • An application data sheet (ADS) in accordance with 37 CFR 1.76 that identifies each inventor by their legal name in the desired order.
  • The processing fee set forth in 37 CFR 1.17(i).

Remember to clearly identify the desired inventor name change in your request.

To learn more:

The USPTO accepts the following file formats for electronic submission of assignment documents:

  • PDF (Portable Document Format)
  • TIFF (Tagged Image File Format)

As stated in MPEP 302.10: “The USPTO will accept electronic submissions of assignment documents in TIFF or PDF format.” It’s important to note that these formats are chosen for their ability to preserve document integrity and ensure long-term accessibility.

To learn more:

The acceptable file formats for submitting biological sequence listings in patent applications are:

  • ASCII text files
  • PDF files (for submissions up to 100MB)

MPEP 608.05(c) states: “Sequence listings may be submitted in electronic form via EFS-Web or PatentCenter as ASCII text files or PDF files up to 100 megabytes.”

It’s important to note that ASCII text format is preferred and required for larger submissions. PDF format is acceptable only for smaller submissions up to 100MB. When submitting on read-only optical discs for files over 100MB, the sequence listing must be in ASCII text format.

Ensure that the sequence listing complies with the requirements set forth in 37 CFR 1.821-1.825 regardless of the file format used.

To learn more:

A USPTO deposit account can be used to pay various fees related to patent applications and services. According to the MPEP:

Filing, issue, appeal, international-type search report, international application processing, international design application fees, petition, and post-issuance fees may be charged against these accounts if sufficient funds are on deposit to cover such fees.

Specifically, fees that can be charged include:

  • Filing fees (37 CFR 1.16)
  • Processing fees (37 CFR 1.17)
  • Issue fees (37 CFR 1.18, subject to certain conditions)
  • Appeal fees
  • International application fees
  • Petition fees

However, fees under 37 CFR 1.19 (document supply fees), 1.20 (post-issuance fees), and 1.21 (miscellaneous fees) generally cannot be charged through a general authorization, with some exceptions.

To learn more:

When correcting an erroneous assignment or name change, you must pay the required fee for each application or patent affected. According to MPEP 323.01(c):

The required fee ( 37 CFR 3.41 ) for each application or patent to be corrected.

The specific fee amount can be found in the current USPTO fee schedule. It’s important to note that a separate fee is required for each application or patent that needs correction, even if they are related to the same erroneous assignment.

To learn more:

To maintain an allowed application’s status and proceed to patent issuance, certain fees must be paid. The MPEP mentions two specific fees:

  1. Issue fee: This is the fee required for the USPTO to issue the patent.
  2. Publication fee: If applicable, this fee covers the cost of publishing the patent application.

The MPEP states that an application becomes abandoned “for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).” Therefore, timely payment of these fees is crucial to maintain the allowed status and proceed to patent issuance.

To learn more:

To correct a typographical error on a patent assignment cover sheet, you must pay the required fee for each application or patent that needs correction. According to MPEP 323.01(a):

“The party requesting correction should submit… (C) the required fee for each application or patent to be corrected (37 CFR 3.41).”

The specific fee amount is set by 37 CFR 3.41 and may change periodically. It’s important to check the current USPTO Fee Schedule for the most up-to-date fee information. The fee is required per application or patent, so if multiple documents need correction, multiple fees may apply.

To learn more:

When correcting a typographical error in a recorded assignment document, fees are required. The MPEP 323.01(b) states:

The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).

The specific fee amount is set by 37 CFR 3.41. It’s important to note that:

  • A separate fee is required for each application or patent affected by the correction.
  • The fee amount may change, so it’s best to check the current USPTO fee schedule for the most up-to-date information.

To learn more:

Micro entities receive a 75% reduction on many USPTO fees, including:

  • Filing fees (nonprovisional and provisional)
  • Search fees
  • Examination fees
  • Issue fees
  • Appeal fees
  • Maintenance fees
  • Patent Trial and Appeal Board fees

The micro entity discount applies to most fees ‘for filing, searching, examining, issuing, appealing, and maintaining patent applications and patents.’

Recording a patent assignment at the USPTO involves paying an appropriate recording fee. MPEP 315 references the fee requirements:

The appropriate recording fee (see 37 CFR 1.21(h) and 3.41).

The specific fee amount can be found in the USPTO’s current fee schedule. It’s important to note that:

  • Fees may vary depending on whether the submission is electronic or paper-based
  • There may be additional fees for expedited processing
  • Fees are subject to change, so always check the current fee schedule before submitting

For the most up-to-date information on fees, visit the USPTO’s official fee schedule page.

To support a petition under pre-AIA 37 CFR 1.47, the following evidence is typically required:

  • A statement of facts signed by someone with firsthand knowledge
  • Documentary evidence such as Internet searches, certified mail return receipts, cover letters of instructions, or telegrams
  • Details of steps taken to locate the nonsigning inventor

The MPEP emphasizes:

‘The statement of facts must be signed, where at all possible, by a person having firsthand knowledge of the facts recited therein. Statements based on hearsay will not normally be accepted.’

It’s crucial to provide facts rather than conclusions in the statement.

To learn more:

To learn more:

To show an inventor is unavailable or refuses to sign, the petitioner must provide substantial evidence. According to MPEP 409.03(b):

‘The fact that an inventor is unavailable or refuses to join in an application must be established by satisfactory proof… such as inability to find him or reach him after diligent effort.’

Evidence may include:

  • Copies of correspondence sent to the last known address with no response
  • Returned mail showing the inventor is no longer at the address
  • Affidavits from people with knowledge of the inventor’s unavailability
  • Documentation of attempts to contact the inventor through various means

For refusal to sign, direct evidence such as a written statement from the inventor expressing their refusal would be ideal. In the absence of such direct evidence, circumstantial evidence showing implied refusal may be considered.

To learn more:

What evidence is required to prove an inventor’s refusal to sign a patent application?

When an inventor refuses to sign a patent application, specific evidence is required to proceed without their signature. The MPEP 409.03(d) outlines the necessary proof:

‘Where refusal of the inventor to sign the application papers is the reason for filing under pre-AIA 37 CFR 1.47(b), the applicant should make reasonable efforts to contact the inventor and to secure the inventor’s signature.’

Evidence of refusal typically includes:

  • Documented attempts to contact the inventor (emails, letters, phone logs)
  • Any written responses from the inventor indicating refusal
  • Witness statements corroborating the inventor’s refusal
  • A detailed explanation of the circumstances surrounding the refusal

The USPTO requires a thorough statement of facts describing the situation and efforts made to obtain the inventor’s signature. It’s crucial to demonstrate that the inventor was fully informed about the patent application and explicitly refused to sign, rather than simply being unresponsive.

To learn more:

To prove a filing delay due to a postal emergency, applicants must provide sufficient evidence. According to MPEP 511:

The nature of the evidence required by the Office to establish that the paper was timely filed will depend upon the circumstances of the particular emergency and the nature of the filing.

This evidence may include:

  • Documentation of the postal service interruption or emergency
  • Proof of attempted mailing during the affected period
  • Explanation of how the emergency directly impacted the filing
  • Any official notices or bulletins related to the postal disruption

The USPTO will evaluate each case individually to determine if the delay was indeed caused by the designated emergency.

To learn more:

To expunge an assignment record at the USPTO, clear evidence must be provided that the document was submitted by mistake or is of improper character. The MPEP 323.01(d) states:

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

While the MPEP doesn’t provide specific examples of acceptable evidence, it generally includes:

  • Documentation showing the assignment was recorded in error
  • Proof that the assignment document contains incorrect information
  • Evidence that the assignment was not intended for the specific application or patent

The burden of proof lies with the petitioner to demonstrate why the assignment record should be expunged. Each case is evaluated on its own merits by the USPTO.

To learn more:

To support a petition to expunge an improperly recorded assignment, you should provide evidence that clearly demonstrates the assignment is incorrect. This may include:

  • Affidavits or declarations from relevant parties
  • Documentation showing true ownership
  • Evidence of fraud or mistake in the recording

MPEP 323.01(c) states: ‘The petition should be accompanied by clear and convincing evidence of the error in recording.’ It’s crucial to present a compelling case to the USPTO to justify the expungement.

To learn more:

According to MPEP 409.03(f), various forms of evidence can be submitted as proof of proprietary interest. The section states:

‘Sufficient proprietary interest is shown by an assignment or assignment of the invention to a person who is under an obligation of assignment to the applicant… Other examples of documents which may be submitted to establish proprietary interest are:

  • (A) A legal memorandum which explains on the basis of the facts of the case that the person signing the 37 CFR 1.47 oath or declaration is a person who has sufficient proprietary interest in the matter;
  • (B) A copy of the contract of employment or of any other contract between the inventor and assignee;
  • (C) An affidavit or declaration of the specific facts which support the assignee’s claim of proprietary interest;
  • (D) Other evidence which establishes the person’s authority to sign the 37 CFR 1.47 oath or declaration on behalf of and as agent for the inventor.’

These examples provide a range of documents that can be used to demonstrate proprietary interest when an inventor is unwilling or unable to execute the required oath or declaration.

To learn more:

To learn more:

According to MPEP 608.02(w), certain minor drawing changes can be made without requiring annotated sheets from the applicant. These changes include:

  • Adding two or three reference characters or exponents
  • Changing one or two numerals or figure ordinals
  • Removing superfluous matter
  • Adding or reversing directional arrows
  • Changing Roman Numerals to Arabic Numerals to agree with specification
  • Adding section lines or brackets, where easily executed
  • Changing lead lines
  • Correcting misspelled legends

The examiner can suggest these changes in a letter to the applicant, often including a marked-up copy of the drawing showing the proposed additions or alterations.

To learn more:

MPEP 404 is currently marked as ‘[Reserved]’, which means this section is not currently in use but is being held for potential future content or updates. The USPTO may use this section in future revisions of the Manual of Patent Examining Procedure to add new information or guidance related to the representation of applicants or owners in patent matters.

MPEP 303 states that certified copies of patent applications as filed do not include an indication of assignment documents. The section specifically notes:

“Certified copies of patent applications as filed do not include an indication of assignment documents.” (MPEP 303)

This means that if an applicant wants to have proof of assignment documents, they need to request this separately.

When an MPEP section is marked as [Reserved], it indicates that the section number exists but there is currently no content provided for that section. The MPEP states in section 212:

212 [Reserved] [R-]

A patent application is designated as ‘rejected’ when it contains an unanswered examiner’s action during its prosecution in the examining group and before allowance. According to MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application.

This status continues until the applicant responds to the examiner’s action or the application becomes abandoned.

To learn more:

An abandoned patent application is one that has been removed from the USPTO’s docket of pending applications. According to MPEP 203.05, an application can become abandoned for several reasons:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications:

  • Formal abandonment by the applicant or their attorney/agent
  • Failure to take appropriate action during prosecution
  • Failure to pay the issue fee
  • For provisional applications, not filing a nonprovisional application within 12 months

Abandonment can have serious consequences, but in some cases, it may be possible to revive an abandoned application.

For more information on patent abandonment, visit: patent abandonment.

The phrase ‘particularly point out and distinctly claim’ comes from 35 U.S.C. 112 and is referenced in MPEP 608.01(k). It means that the claims in a patent application must:

  • Clearly define the invention’s elements and features
  • Be specific enough to distinguish the invention from prior art
  • Be understandable to a person skilled in the relevant field
  • Provide a clear boundary for the scope of protection

This requirement ensures that the public and potential competitors can understand the limits of the patent’s protection. It also helps patent examiners assess the novelty and non-obviousness of the claimed invention.

To learn more:

A nonprovisional patent application is designated as “rejected” if, during prosecution before allowance, it contains an examiner’s action that has not been replied to by the applicant. As stated in MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a “rejected” application. Its status as a “rejected” application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

MPEP 203.03 defines an ‘amended’ patent application as follows:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action. The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

In simpler terms, an application becomes ‘amended’ when the applicant responds to an examiner’s Office action, whether by making changes to the application, arguing against the examiner’s rejections, or choosing between different inventions (election).

According to MPEP 203.04:

An ‘allowed’ nonprovisional application or an application ‘in issue’ is one which has been examined and determined to meet all statutory requirements, and in which a notice of allowance has been sent to the applicant. Its status as an ‘allowed’ application continues from the date of the notice of allowance until it issues as a patent, unless it is withdrawn from issue (37 CFR 1.313), or becomes abandoned for failure to pay the issue fee and any required publication fee (37 CFR 1.314 and 1.316).

An ‘allowed’ application has passed examination and is ready to become a patent, pending payment of necessary fees.

Copendency refers to the requirement that two related patent applications must be pending at the same time for one to claim the benefit of the earlier filing date of the other. The MPEP states:

Copendency between the current application and the prior application is required.

This means that the later application must be filed before the earlier application is either abandoned or issued as a patent. Copendency is crucial for maintaining a continuous chain of priority between related applications.

For more information on copendency, visit: copendency.

For more information on patent applications, visit: patent applications.

When reviewing a claim to foreign priority, the examiner generally checks the following:

  • That the papers contain no obvious formal defects
  • That the papers correspond in number, date and country to the application identified in the application data sheet
  • For original applications filed under 35 U.S.C. 111(a) and international applications entering the national stage under 35 U.S.C. 371, that the claim for foreign priority is timely

The MPEP states: “When the claim to priority and the certified copy of the foreign application are received while the application is pending before the examiner, the examiner generally makes no examination of the papers except to see that they contain no obvious formal defects and correspond in number, date and country to the application identified in the application data sheet for an application filed on or after September 16, 2012, or oath or declaration or application data sheet for an application filed prior to September 16, 2012.” (MPEP 216)

Acting in a representative capacity refers to a patent practitioner appearing in person or signing papers on behalf of a client before the United States Patent and Trademark Office (USPTO) in a patent case. According to 37 CFR 1.34, when a patent practitioner acts in this capacity, their personal appearance or signature constitutes a representation that they are authorized to represent the particular party on whose behalf they are acting.

The MPEP states: “When a patent practitioner acting in a representative capacity appears in person or signs a paper in practice before the United States Patent and Trademark Office in a patent case, his or her personal appearance or signature shall constitute a representation to the United States Patent and Trademark Office that under the provisions of this subchapter and the law, he or she is authorized to represent the particular party on whose behalf he or she acts.”

To learn more:

‘Unintentional delay’ is a crucial concept when seeking to restore the benefit of a provisional application. The MPEP requires:

“A statement that the delay in filing the subsequent nonprovisional application or international application designating the United States within the twelve-month period was unintentional.”

While the MPEP doesn’t provide a specific definition of ‘unintentional delay’, it generally means that the failure to meet the 12-month deadline was not deliberate. The USPTO may require additional information to determine if the delay was truly unintentional:

“The Director may require additional information where there is a question whether the delay was unintentional.”

It’s important to be prepared to explain the circumstances that led to the delay if requested.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

The term ‘sufficient proprietary interest’ is introduced in the MPEP § 605 for patent applications filed on or after September 16, 2012. The MPEP states:

“Effective September 16, 2012, the Office revised the rules of practice to permit […] a person who otherwise shows sufficient proprietary interest in the matter to file and prosecute an application for patent as the applicant on behalf of the inventor.”

‘Sufficient proprietary interest’ typically means that the person or entity has a significant commercial or financial stake in the invention, even if they are not the inventor or assignee. This could include:

  • Licensees with exclusive rights to the invention
  • Investors who have funded the development of the invention
  • Joint venture partners involved in the invention’s creation

To be considered as having ‘sufficient proprietary interest’, the person or entity must typically provide evidence of their interest and may need to submit a petition to the USPTO. The inventor(s) must also provide authorization for this person or entity to act as the applicant.

This provision allows for greater flexibility in who can file and prosecute patent applications, particularly benefiting startups, research institutions, and collaborative innovation projects.

To learn more:

‘Failure to take appropriate action’ in patent prosecution refers to situations where an applicant doesn’t respond to Office actions or meet other required deadlines during the examination process. According to MPEP 203.05, an application can be abandoned:

“through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application”

This could include not responding to an examiner’s rejection within the given time frame, failing to submit required documents, or not meeting other procedural requirements. It’s crucial for applicants to stay engaged in the prosecution process and meet all deadlines to prevent unintentional abandonment.

To learn more:

The ‘[Reserved]’ designation in MPEP 212 indicates that this section is currently not in use but is being held for potential future content. It does not contain any specific information or guidance at this time.

According to MPEP 318, assignment documents submitted for recording should not be placed directly in application or patent files. The section states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This means that when assignment documents are submitted, they should be sent to the Assignment Division for proper recording rather than being inserted into the application or patent files themselves.

To learn more:

What documents can serve as proof of proprietary interest for joint inventors?

For joint inventors, proof of proprietary interest can be established through various documents. According to MPEP 409.03(f), acceptable forms of proof include:

  • An assignment for the entire right, title, and interest in the application from all inventors to one or more joint inventors
  • Written statements from all inventors that they have assigned their rights in the application to one or more joint inventors
  • Other evidence showing that one or more joint inventors are the only inventor(s) who have the right to prosecute the application

The MPEP states: ‘Where one of several joint inventors is deceased or cannot be reached, a statement by the prosecuting inventor as to the facts, including the names of the other joint inventors, may be accepted as sufficient proof of proprietary interest.’ This provision allows for flexibility in cases where obtaining documentation from all inventors is challenging.

To learn more:

According to 37 CFR 3.11, the following documents can be recorded with the USPTO related to patent assignments:

  • Assignments of applications, patents, and registrations
  • Other documents relating to interests in patent applications and patents
  • Documents affecting title to applications, patents, or registrations
  • Licenses, assignments, or other interests of the Government in or under patents or patent applications
  • Joint research agreements or excerpts of joint research agreements

These documents must be accompanied by completed cover sheets as specified in 37 CFR 3.28 and 3.31.

According to MPEP 402.04, there are several important documents that a person acting in a representative capacity generally cannot sign. These include:

  • A power of attorney (37 CFR 1.32)
  • A document granting access to an application
  • A change of correspondence address
  • A terminal disclaimer (37 CFR 1.321(b)(1))
  • A request for express abandonment without filing a continuing application (37 CFR 1.138(b))

However, there are some exceptions for applications filed on or after September 16, 2012. In these cases, a person acting in a representative capacity may sign a document granting access to an application or a change of correspondence address if:

  1. A power of attorney has not been appointed under 37 CFR 1.32(b), and
  2. The patent practitioner was named in the application transmittal papers.

To learn more:

When a legal representative takes over a patent application for a deceased inventor, specific documents are required:

  • Proof of authority to act on behalf of the deceased inventor’s estate (e.g., Letters Testamentary, Letters of Administration)
  • A new oath or declaration by the legal representative
  • Any necessary assignments or other documents to establish ownership rights

According to MPEP 409.01: “The Office no longer requires proof of authority of the legal representative to prosecute the application. However, any necessary documentary evidence of the legal representative’s authority to act on behalf of the deceased inventor’s estate, such as Letters Testamentary, Letters of Administration, or a Certificate of Heirship, should be kept in the application file.”

It’s important to note that while the USPTO doesn’t require submission of proof of authority, it’s advisable to keep such documentation readily available in case it’s requested.

To learn more:

To perfect a claim for foreign priority after patent issuance, several documents are required. According to MPEP 216.01, the following must be submitted:

  • A petition to accept an unintentionally delayed claim for priority
  • The required petition fee
  • A certified copy of the foreign application
  • An English language translation of the foreign application (if not in English)
  • A statement that the translation is accurate

The MPEP states: ‘In addition to the petition to accept an unintentionally delayed claim for priority and the required petition fee, the claim for priority must be made in an application data sheet (if the patent issued from a utility or plant application filed on or after September 16, 2012) or in a request for a certificate of correction, and a certified copy of the foreign application must be submitted.’

It’s important to note that the requirements may vary slightly depending on the specific circumstances of the application and patent. Consulting with a patent attorney or agent is advisable for ensuring all necessary documents are properly prepared and submitted.

To claim foreign priority in a U.S. application, you must file a claim for priority and submit a certified copy of the foreign application. MPEP 213.04 states: ‘The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application.’

For applications filed on or after September 16, 2012, the priority claim must be presented in an Application Data Sheet (ADS). The certified copy must be filed within the later of 4 months from the actual filing date or 16 months from the foreign filing date, with some exceptions.

For more information on certified copy, visit: certified copy.

For more information on foreign priority, visit: foreign priority.

For national stage entry in the United States, the following documents are required:

  • A copy of the international application (if not previously communicated by the International Bureau)
  • An English translation of the international application (if not in English)
  • The basic national fee
  • An oath or declaration of the inventors
  • A surcharge if the basic national fee or oath/declaration is filed later than 30 months from the priority date

According to MPEP 601.04: “A translated copy of the international application and the basic national fee are required to be filed with the U.S. Designated or Elected Office not later than the expiration of 30 months from the priority date.”

To learn more:

What documents are required for an assignee to revoke power of attorney in a patent application?

To revoke power of attorney in a patent application, an assignee must submit specific documents to the USPTO. According to MPEP 402.07, the required documents are:

  • Statement under 37 CFR 3.73(c): This establishes the assignee’s ownership.
  • Revocation of the existing power of attorney
  • New power of attorney from the assignee

The MPEP states:

“The assignee of the entire interest can revoke the power of attorney of the applicant and appoint its own patent practitioner. The assignee must become of record as provided in 37 CFR 3.71. After the assignee becomes of record, the assignee is permitted to revoke the power of attorney of the applicant under the provisions of 37 CFR 1.36(a).”

It’s crucial to ensure all documents are properly executed and filed with the USPTO to effectively change the power of attorney.

To learn more:

According to MPEP 314, the following documents are recordable for name changes or mergers in patent ownership:

  • Certificates issued by appropriate authorities showing a change of name of a business
  • Certificates showing a merger of businesses

The MPEP states: Certificates issued by appropriate authorities showing a change of name of a business or a merger of businesses are recordable.

To correct a typographical error in a patent assignment, you need to submit several documents. According to MPEP 323.01(b), the required documents include:

  • A copy of the originally recorded papers
  • A cover sheet
  • The required fee for each application or patent to be corrected

If the assignor is not available to make the correction, the assignee must also provide:

  • An affidavit or declaration identifying the error and requesting correction

The MPEP states:

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction. The affidavit or declaration must be accompanied by a copy of the originally recorded papers, a cover sheet, and the required fee for each application or patent to be corrected (37 CFR 3.41).

Ensure all documents are properly prepared and submitted to avoid delays in processing.

To learn more:

What documentation is required when filing a patent application for a deceased or legally incapacitated inventor?

When filing a patent application for a deceased or legally incapacitated inventor, specific documentation is required. According to MPEP 409.03(b), the following documentation is typically necessary:

  1. For deceased inventors:
    • Death certificate of the inventor
    • Letters Testamentary or Letters of Administration proving the legal representative’s authority
  2. For legally incapacitated inventors:
    • Court order declaring the inventor legally incapacitated
    • Guardianship or conservatorship papers demonstrating the legal representative’s authority
  3. For both cases:
    • Oath or declaration executed by the legal representative
    • Application Data Sheet (ADS) listing the inventor and indicating their status (deceased or legally incapacitated)
    • Power of Attorney from the legal representative, if applicable

The MPEP states: “Proof of the authority of the legal representative must be provided to the Office.” This ensures that the person acting on behalf of the inventor has the legal right to do so.

To learn more:

When filing a patent application as an assignee or obligated assignee, specific documentation is required to establish the right to apply for the patent. According to MPEP 409.05:

Quote: ‘The assignee or obligated assignee who files the application must comply with the oath or declaration requirements of 37 CFR 1.63, including meeting the citizenship requirement of 37 CFR 1.63(a)(3).’

The required documentation includes:

  • A properly executed oath or declaration from the inventors
  • An assignment document or proof of obligation to assign
  • Application Data Sheet (ADS) identifying the assignee as the applicant

Additionally, if filing as an obligated assignee, you may need to provide evidence of the obligation to assign, such as an employment agreement or contract. It’s important to ensure all documentation is complete and accurate to avoid potential issues with the patent application process.

To learn more:

What documentation is required when an inventor dies during the patent application process?

When an inventor dies during the patent application process, specific documentation is required to continue the application. According to MPEP 409, the following documents are typically needed:

  • A copy of the inventor’s death certificate
  • Legal documentation showing the authority of the legal representative (e.g., executor of the estate)
  • An oath or declaration by the legal representative

The MPEP states: ‘If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative upon proper intervention.’ This means that the executor or administrator of the deceased inventor’s estate can step in to complete the patent application process.

It’s important to note that the legal representative must provide evidence of their authority to act on behalf of the deceased inventor’s estate, such as letters testamentary or letters of administration issued by a probate court.

For more information on documentation, visit: documentation.

For more information on legal representative, visit: legal representative.

What documentation is required for inventorship correction in a patent application?

The documentation required for inventorship correction in a patent application includes:

  • A request to correct inventorship under 37 CFR 1.48(a)
  • An application data sheet (ADS) with the correct inventorship information
  • A statement of facts from the new inventor(s) if being added
  • Written consent from any assignees

The MPEP states: The inventorship of an application may be corrected by filing a request under 37 CFR 1.48(a). The request must include: (1) An application data sheet in accordance with 37 CFR 1.76 that identifies each inventor by his or her legal name, and (2) the processing fee set forth in 37 CFR 1.17(i). Additionally, When an inventor is being added, applicant must submit a statement from each person being added as an inventor that the inventorship error occurred without deceptive intention on his or her part. It’s important to note that while these are the basic requirements, additional documentation may be necessary depending on the specific circumstances of the correction.

To learn more:

When an assignee or obligated assignee files a patent application as the applicant, they should provide documentary evidence of ownership. According to 37 CFR 1.46(b)(1):

If the applicant is the assignee or a person to whom the inventor is under an obligation to assign the invention, documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for a person to whom the inventor is under an obligation to assign the invention) should be recorded as provided for in part 3 of this chapter no later than the date the issue fee is paid in the application.

This means that the assignee or obligated assignee should record their ownership documents (such as an assignment or employment agreement) with the USPTO as specified in 37 CFR Part 3, and this should be done before paying the issue fee.

To learn more:

What documentation is required for a legal representative to file a patent application for a deceased inventor?

When filing a patent application for a deceased inventor, a legal representative must provide specific documentation to establish their authority. According to MPEP 409.01(a):

“If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent as provided in 37 CFR 1.43. In accordance with 37 CFR 1.43, the legal representative must provide proof of authority…”

The required documentation typically includes:

  • A copy of the deceased inventor’s death certificate
  • Proof of the legal representative’s authority (e.g., court appointment as executor or administrator of the estate)
  • A substitute statement in lieu of an inventor’s oath or declaration
  • An Application Data Sheet (ADS) identifying the legal representative

It’s important to note that the specific requirements may vary depending on the circumstances and jurisdiction. Consulting with a patent attorney is advisable to ensure all necessary documentation is properly prepared and submitted.

To learn more:

To demonstrate an agreement to assign in a pre-AIA 37 CFR 1.47(b) application, you should provide:

  • A copy of the written agreement to assign the invention
  • If the agreement is conditional, a statement of facts showing the conditions have been met

MPEP 409.03(f) states:

“When an inventor has agreed in writing to assign an invention described in an application deposited pursuant to pre-AIA 37 CFR 1.47(b), a copy of that agreement should be submitted. If an agreement to assign is dependent on certain specified conditions being met, it must be established by a statement of facts by someone with first hand knowledge of the circumstances in which those conditions have been met.”

A common example is an employment agreement. In such cases, you must provide evidence that the invention was made during the course of employment, typically through a statement from someone with firsthand knowledge of the circumstances.

To learn more:

To learn more:

Tags: pre-AIA

What documentation is needed to prove authority as a legal representative for a deceased or incapacitated inventor?

When filing a patent application on behalf of a deceased or legally incapacitated inventor, it’s crucial to provide documentation that proves your authority as a legal representative. The specific documentation required can vary based on the circumstances, but generally includes:

  • For a deceased inventor: Death certificate and letters testamentary or letters of administration
  • For an incapacitated inventor: Court order declaring incapacity and appointing a legal guardian or conservator
  • Power of attorney or other legal document granting authority to act on behalf of the inventor or their estate

The MPEP 409.01(a) states:

Office personnel will not question whether the person executing the substitute statement is authorized to act on behalf of the deceased inventor’s estate or legal entity unless there is evidence to the contrary.

While the USPTO generally accepts the substitute statement without questioning the authority, it’s important to have proper documentation available in case it’s requested or if legal issues arise later. Always consult with a patent attorney to ensure you have the correct documentation for your specific situation.

To learn more:

What documentation is needed for a legal representative to act on behalf of a deceased or incapacitated inventor?

To act on behalf of a deceased or incapacitated inventor, a legal representative must provide appropriate documentation to the USPTO. The MPEP 409.01(a) states:

“Office personnel will not question whether the person signing the oath or declaration is in fact a person authorized to make the statement, and will not require proof of the authority of the person making the statement.”

However, it’s important to note that while the USPTO does not require proof upfront, the legal representative should still have proper documentation, such as:

  • For a deceased inventor: Letters testamentary, letters of administration, or other court documents establishing authority over the estate.
  • For an incapacitated inventor: Court order appointing a guardian or conservator.

These documents may be required if the authority is later questioned or in other legal proceedings related to the patent application.

To learn more:

When filing entity status notifications in EFS-Web, it is strongly recommended to use the following document descriptions as appropriate:

  • Notification of loss of entitlement to small entity status
  • Notification of loss of entitlement to micro entity status

Using these specific document descriptions helps ensure that your notifications are properly categorized and processed by the USPTO. This recommendation is provided in MPEP 509.04(e) to facilitate efficient handling of entity status changes.

To learn more:

Tags: EFS-Web, USPTO

The filing date of a patent application is determined by the ‘Office Date’ stamp, provided the application includes all necessary components for a filing date. The MPEP states:

If an application as originally filed includes the necessary components for a filing date (see 37 CFR 1.53(b)-(d) and MPEP § 506), the ‘Office Date’ stamp establishes the ‘filing date.’

This means that the date stamped on the application by the USPTO becomes the official filing date, as long as all required elements are present. It’s crucial for applicants to ensure their submissions are complete to secure the earliest possible filing date.

According to MPEP 203.01, a ‘new’ application is defined as follows:

A ‘new’ application is a nonprovisional application that has not yet received an action by the examiner.

This means that a patent application is considered ‘new’ from the time it is filed until the patent examiner issues their first official response or action on the application.

To learn more:

In patent arbitration proceedings, the defenses provided under 35 U.S.C. 282 must be considered by the arbitrator if raised by any party. This is specified in 35 U.S.C. 294(b):

‘In any such arbitration proceeding, the defenses provided for under section 282 shall be considered by the arbitrator if raised by any party to the proceeding.’

These defenses typically include noninfringement, absence of liability for infringement, unenforceability, and invalidity of the patent or any claim in suit.

What constitutes inherent characteristics in patent applications?

Inherent characteristics in patent applications refer to properties or features that are necessarily present in the invention but may not be explicitly stated in the original disclosure. MPEP 608.04(a) provides guidance on this:

‘Inherent characteristics of materials and properties of processes are not considered to be new matter.’

This means that certain aspects of an invention that are inherently present, even if not explicitly described, are not considered new matter when later disclosed or claimed. Examples of inherent characteristics might include:

  • Physical properties of materials
  • Chemical reactions that naturally occur under specified conditions
  • Known scientific principles underlying the invention

However, it’s important to note that claiming inherent characteristics requires careful consideration. The written description requirement must still be satisfied, and the inherency must be clearly and unambiguously supported by the original disclosure.

To learn more:

To learn more:

A valid reason for filing under pre-AIA 37 CFR 1.47 requires a diligent effort to locate or reach a nonsigning inventor. The MPEP states:

‘Where inability to find or reach a nonsigning inventor “after diligent effort” is the reason for filing under pre-AIA 37 CFR 1.47, a statement of facts should be submitted that fully describes the exact facts which are relied on to establish that a diligent effort was made.’

It’s important to note that temporary unavailability, such as being on vacation or out of town, is not considered an acceptable reason. Additionally, hospitalization or unconsciousness are not valid reasons under this rule, but may be addressed under pre-AIA 37 CFR 1.43.

To learn more:

To learn more:

In a patent application, a valid disclosure can include not only the description and drawings as filed, but also the claims present on the filing date. As stated in MPEP 608.01(l): “In establishing a disclosure, applicant may rely not only on the description and drawing as filed but also on the claims present on the filing date of the application if their content justifies it.” This means that if a claim itself clearly discloses subject matter not shown in the drawing or described in the description, it can be considered part of the disclosure.

To learn more:

A complete patent application for filing date purposes must include:

  • A specification containing a description as per 37 CFR 1.71
  • At least one claim (for nonprovisional design applications only) as per 37 CFR 1.75
  • Any drawings required by 37 CFR 1.81(a)

As stated in the MPEP: “The filing date of the provisional or nonprovisional application is the date of receipt in the Office of the application which includes a specification containing description pursuant to 37 CFR 1.71 and at least one claim (required for nonprovisional design applications only) pursuant to 37 CFR 1.75, and any drawings required by 37 CFR 1.81(a).”

To learn more:

Tags: drawings

‘New matter’ refers to any content added to a patent application after the initial filing date that was not present in the original specification, claims, or drawings. As stated in MPEP 608.04(a):

Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing is usually new matter.

This can include adding specific percentages, compounds, or even omitting steps from a method that were present in the original disclosure.

To learn more:

The following conditions and requirements need to be met to add omitted material to an application under 37 CFR 1.57(b):n

    n

  1. The application must have been filed on or after September 21, 2004
  2. n

  3. All or a portion of the specification or drawing(s) must have been inadvertently omitted
  4. n

  5. A priority claim under 37 CFR 1.55 or benefit claim under 37 CFR 1.78 must have been present on the filing date
  6. n

  7. The omitted portion must be completely contained in the prior-filed application
  8. n

  9. An amendment to include the omitted portion must be filed within a time period set by the Office
  10. n

  11. If not otherwise entitled to a filing date, a petition under 37 CFR 1.53(e) with the fee must also be filed
  12. n

  13. A copy of the prior-filed application must be supplied, except where the prior application was filed under 35 U.S.C. 111
  14. n

  15. An English translation of any non-English prior-filed application must be supplied
  16. n

  17. The location of the omitted portion in the prior-filed application must be identified

For an international design application to be used as a basis for benefit claims, it must meet certain conditions. The MPEP specifies:

To obtain benefit of the filing date of a prior international design application designating the United States, the international design application must be entitled to a filing date in accordance with 37 CFR 1.1023.

This means that the international design application must have a valid filing date as determined by the regulations set forth in 37 CFR 1.1023. These regulations outline the requirements for establishing a filing date for international design applications, which typically include submitting the necessary documents and fees to the International Bureau or an appropriate office.

Additionally, the application claiming benefit must comply with the requirements of 35 U.S.C. 120, which include proper copendency and specific reference to the earlier application.

To learn more:

To learn more:

When writing your patent application abstract, it’s important to avoid several common mistakes. The MPEP 608.01(b) provides guidance on what to avoid:

The abstract should avoid using phrases which can be implied, such as, ‘The disclosure concerns,’ ‘The disclosure defined by this invention,’ ‘The disclosure describes,’ etc.

Common mistakes to avoid include:

  • Using legal phraseology or claims language
  • Exceeding the 150-word limit
  • Including speculative applications or purported merits of the invention
  • Comparing the invention to prior art
  • Using implied phrases like ‘This invention relates to…’
  • Including extraneous information not crucial to understanding the invention
  • Writing in a promotional or biased manner

By avoiding these mistakes, you can create a clear, concise, and effective abstract that accurately represents your invention.

To learn more:

The Patent Law Treaties Implementation Act (PLTIA) of 2012 introduced several significant changes to U.S. patent law and procedures:

  • Restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications).
  • The ability to file international design applications and claim priority to, and the benefit of, international design applications in nonprovisional applications.

As stated in the MPEP: Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. (MPEP 210)

These changes were implemented in two phases:

  • Title II of the PLTIA became effective on December 18, 2013.
  • Title I of the PLTIA became effective on May 13, 2015.

For more information on international design applications, visit: international design applications.

For more information on PLTIA, visit: PLTIA.

For more information on priority restoration, visit: priority restoration.

The Patent Law Treaties Implementation Act (PLTIA) of 2012 introduced several important changes to US patent law, particularly regarding priority claims and international applications. Key changes include:

  • Restoration of the right of priority to a foreign application or the benefit of a provisional application in certain cases
  • Ability to file international design applications
  • Ability to claim priority to, and benefit of, international design applications in nonprovisional applications

The MPEP states: “Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application. In addition, title I of the PLTIA became effective May 13, 2015, along with corresponding revisions to the rules. Notable changes included the ability to file international design applications and to claim priority to, and the benefit of, international design applications in nonprovisional applications.”

The MPEP 409.03(g) section on proof of irreparable damage is not applicable to patent applications filed on or after September 16, 2012. This change is due to the implementation of the America Invents Act (AIA), which brought significant reforms to the U.S. patent system. Key changes include:

  • Transition from a ‘first-to-invent’ to a ‘first-inventor-to-file’ system
  • New procedures for challenging patents at the USPTO
  • Expanded definition of prior art
  • Changes to inventor oath and declaration requirements

For applications filed on or after September 16, 2012, different rules and procedures apply regarding the representation of applicants and the handling of situations that might have previously fallen under the irreparable damage provisions.

To learn more:

Pro se applicants make important certifications when filing patent applications. According to MPEP 401:

“In presenting (whether by signing, filing, submitting, or later advocating) papers to the Office, a pro se applicant is making the certifications under 37 CFR 11.18(b), and may be subject to sanctions under 37 CFR 11.18(c) for violations of 37 CFR 11.18(b)(2).”

These certifications include statements about the truthfulness of the application, that it is not being presented for improper purposes, and that claims are warranted by existing law or a good faith argument for changing the law.

When submitting papers to the USPTO, two key certifications are made under 37 CFR 11.18(b):

  1. Statements made are subject to the declaration clause of 37 CFR 1.68
  2. The certification required for papers filed in federal court under Rule 11(b) of the Federal Rules of Civil Procedure

Specifically, 37 CFR 11.18(b) states that by presenting any paper to the USPTO, the party certifies that:

‘All statements made therein of the party’s own knowledge are true, all statements made therein on information and belief are believed to be true, and all statements made therein are made with the knowledge that whoever, in any matter within the jurisdiction of the Office, knowingly and willfully falsifies, conceals, or covers up by any trick, scheme, or device a material fact, or knowingly and willfully makes any false, fictitious, or fraudulent statements or representations, or knowingly and willfully makes or uses any false writing or document knowing the same to contain any false, fictitious, or fraudulent statement or entry, shall be subject to the penalties set forth under 18 U.S.C. 1001 and any other applicable criminal statute’

This applies to both practitioners and non-practitioners submitting papers to the USPTO.

When presenting any paper to the USPTO, the party (whether a practitioner or non-practitioner) is making important certifications as outlined in 37 CFR 11.18(b):

  1. All statements made of the party’s own knowledge are true.
  2. Statements made on information and belief are believed to be true.
  3. The paper is not being presented for any improper purpose (e.g., harassment, delay).
  4. Legal contentions are warranted by existing law or non-frivolous arguments for changes in the law.
  5. Factual contentions have or are likely to have evidentiary support.
  6. Denials of factual contentions are warranted or based on lack of information or belief.

The MPEP notes: “37 CFR 11.18(b) provides that, by presenting any paper to the Office, the party presenting such paper (whether a practitioner or non-practitioner) is: (1) certifying that the statements made therein are subject to the declaration clause of 37 CFR 1.68; and (2) making the certifications required for papers filed in a federal court under Rule 11(b) of the Federal Rules of Civil Procedure.”

To learn more:

When signing patent correspondence, the signer is making certain certifications, including:

  • The presentation of any paper to the USPTO constitutes a certification under 37 CFR 11.18(b).
  • For S-signatures, the person inserting the signature certifies that the inserted signature is their own.
  • When submitting a document signed by another person, the submitter certifies they have a reasonable basis to believe the signature is appropriate.

As stated in 37 CFR 1.4(d)(4)(i): “The presentation to the Office (whether by signing, filing, submitting, or later advocating) of any paper by a party, whether a practitioner or non-practitioner, constitutes a certification under 37 CFR 11.18(b) of this chapter.”

Violations of these certifications may result in sanctions under 37 CFR 11.18(c) and (d).

To learn more:

If the USPTO returns a document unrecorded and you believe it represents an unusual case that justifies recordation, you have the option to petition for its recordation. The MPEP provides the following guidance:

“Any document returned unrecorded, which the sender nevertheless believes represents an unusual case which justifies recordation, may be submitted to the Office of Petitions with a petition under 37 CFR 1.181 requesting recordation of the document.” (MPEP 313)

To petition:

  1. Submit the document to the Office of Petitions
  2. Include a petition under 37 CFR 1.181
  3. Provide justification for why the document should be recorded

An allowed application can lose its status under certain circumstances. The MPEP outlines two main scenarios:

  1. Withdrawal from issue: This is governed by 37 CFR 1.313. The applicant or the USPTO may initiate this process for various reasons, such as the need for further examination or the discovery of new prior art.
  2. Abandonment due to non-payment: As stated in the MPEP, an application becomes abandoned “for failure to pay the issue fee and any required publication fee ( 37 CFR 1.314 and 1.316 ).”

In either case, the application loses its ‘allowed’ status and may require further action or payments to proceed towards patent issuance.

To learn more:

If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, 37 CFR 1.45(a) provides a solution. It states:

“If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the other joint inventor or inventors may make the application for patent on behalf of themselves and the omitted inventor.”

In such cases, the other joint inventor(s) can proceed with the application and execute a substitute statement in lieu of an oath or declaration from the unavailable inventor, as outlined in 37 CFR 1.64. For more information on substitute statements, refer to MPEP § 604.

To learn more:

To include a copyright or mask work notice in a patent application, specific authorization language must be included at the beginning of the specification. According to MPEP 608.01(w) and 37 CFR 1.71(e), the required authorization language is:

A portion of the disclosure of this patent document contains material which is subject to (copyright or mask work) protection. The (copyright or mask work) owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all (copyright or mask work) rights whatsoever.

This authorization should preferably be placed as the first paragraph of the specification. It is important to note that without this specific language, the inclusion of a copyright or mask work notice may be objected to by the patent examiner.

To learn more:

What are the USPTO’s guidelines for hand-carrying documents?

The USPTO has specific guidelines for hand-carrying documents to their office. According to MPEP 502:

“Any paper which relates to a pending application may be personally delivered to the Office. The attorney, agent, or applicant should specifically instruct the person making the delivery to hand-carry the paper to the Customer Service Window…”

Key points to remember when hand-carrying documents to the USPTO:

  • Deliver to the Customer Service Window at the Randolph Building, 401 Dulany Street, Alexandria, VA 22314
  • The delivery must be made during official business hours (8:30 AM to 5:00 PM, Monday through Friday, excluding federal holidays)
  • A receipt will be issued for the delivered papers
  • The receipt date is considered the filing date for the documents

It’s important to follow these guidelines to ensure proper handling and timely processing of your documents.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The MPEP outlines two main types of patent ownership:

  1. Individual ownership: ‘An individual entity may own the entire right, title and interest of the patent property. This occurs where there is only one inventor, and the inventor has not assigned the patent property.’
  2. Joint ownership: ‘Multiple parties may together own the entire right, title and interest of the patent property.’ This can occur in several scenarios:
  • Multiple partial assignees of the patent property
  • Multiple inventors who have not assigned their rights
  • A combination of partial assignee(s) and inventor(s) who have not assigned their rights

Understanding these ownership types is crucial for managing patent rights and making decisions about assignments or licenses.

MPEP 201.01 outlines several types of national applications that can be filed with the USPTO. These include:

  • Original (nonprovisional) applications
  • Reissue applications
  • Design applications
  • Plant applications
  • Provisional applications

As stated in MPEP 201.01: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’

Each of these application types serves a specific purpose in the patent system and is subject to different rules and requirements.

For more information on design applications, visit: design applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on plant applications, visit: plant applications.

For more information on reissue applications, visit: reissue applications.

There are three main types of national applications for patents in the United States:

  • Nonprovisional applications filed under 35 U.S.C. 111(a)
  • Provisional applications filed under 35 U.S.C. 111(b)
  • International applications that have entered the national stage in the United States

As stated in MPEP 201.01: “Applications filed under 35 U.S.C. 111(a) include original nonprovisional utility, plant, design, divisional, continuation, and continuation-in-part applications filed under 37 CFR 1.53(b), reissue applications filed under 37 CFR 1.53(b), and design patent continued prosecution applications (CPAs) filed under 37 CFR 1.53(d).”

For more information on international applications, visit: international applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

The USPTO accepts two types of signatures for patent correspondence:

  • Handwritten signature: An original signature personally signed in permanent dark ink or its equivalent.
  • S-signature: A signature inserted between forward slash marks, which can include electronic or mechanical signatures.

As stated in 37 CFR 1.4(d): “Correspondence filed in the Office, which requires a person’s signature, may be filed with one of two types of signatures: (A) handwritten signature; and (B) ‘S-signature.'”

To learn more:

The timing requirements for submitting an IDS are:

  • Within 3 months of filing or before first Office action, whichever is later
  • Before final Office action, Notice of Allowance, or Quayle action
  • After final Office action but before issue fee payment
  • After issue fee payment but before patent grant

The specific requirements vary based on when the IDS is filed. For example, as stated in MPEP 609.04(b): “An information disclosure statement will be considered by the examiner if filed within any one of the following time periods: (A) for national applications (not including CPAs), within three months of the filing date of the national application or before the mailing date of a first Office action on the merits; (B) for international applications, within three months of the date of entry of the national stage as set forth in 37 CFR 1.491 or before the mailing date of a first Office action on the merits; (C) for RCEs and CPAs, before the mailing date of a first Office action on the merits; or (D) for international design applications, within three months of the date of publication of the international registration under Hague Agreement Article 10(3) or before first Office action on the merits, whichever is later.”

To learn more:

Tags: USPTO

The time periods for filing priority or benefit claims in U.S. patent applications vary depending on the type of claim and application. Generally:

  • For foreign priority claims under 35 U.S.C. 119(a)-(d) and (f), the claim must be made within the later of 4 months from the actual filing date or 16 months from the foreign application’s filing date.
  • For domestic benefit claims under 35 U.S.C. 119(e) or 120, the claim must be made within the later of 4 months from the actual filing date or 16 months from the prior application’s filing date.
  • For international applications entering the national stage, special rules apply.

The MPEP states: “37 CFR 1.55(d) contains provisions relating to the time for filing a priority claim in an application filed under 35 U.S.C. 111(a) and in an application entering the national stage under 35 U.S.C. 371” and “37 CFR 1.78(d) contains provisions relating to claims under 35 U.S.C. 120, 121, 365(c), or 386(c) for the benefit of a prior-filed nonprovisional application, international application, or international design application.”

Note that these time periods are subject to the provisions of 37 CFR 1.55(p) and 1.78(k), which state that they are not extendable but are subject to certain exceptions.

The time periods for filing a priority claim depend on the type of application:

  • For original applications filed under 35 U.S.C. 111(a) (other than design applications), the claim must be filed during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application. See 37 CFR 1.55(d)(1).
  • For applications entering the national stage under 35 U.S.C. 371, the claim must be made within the time limit set in the PCT and Regulations under the PCT. See 37 CFR 1.55(d)(2) and MPEP § 213.06.
  • In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).

The time limits for responding to a notice under 37 CFR 1.251 vary depending on whether it’s for an application or a patent:

  • For applications: The Office sets a three-month period for reply, which is extendable under 37 CFR 1.136(a) by up to three additional months, for a maximum of six months.
  • For patents: The Office sets a six-month period for reply, which is not extendable.

MPEP 508.04 states: “The Office will set a time period of three months for reply in a notice under 37 CFR 1.251 in an application. The time period will be extendable under 37 CFR 1.136(a) (unless the notice indicates otherwise) by three months up to a maximum period for reply of six months in an application.” It also notes: “The Office will set a time period of six months for reply in a notice under 37 CFR 1.251 in a patent. The time period will not be extendable under 37 CFR 1.136(a) in a patent.”

The USPTO sets specific time limits for responding to notices about unlocatable files, which differ for applications and patents:

For applications, the MPEP states: The Office will set a time period of three months for reply in a notice under 37 CFR 1.251 in an application. The time period will be extendable under 37 CFR 1.136(a) (unless the notice indicates otherwise) by three months up to a maximum period for reply of six months in an application.

For patents, the time limit is longer: The Office will set a time period of six months for reply in a notice under 37 CFR 1.251 in a patent. The time period will not be extendable under 37 CFR 1.136(a) in a patent because 35 U.S.C. 41(a)(8) only authorizes the Office to charge fees for extensions of time in proceedings involving an application.

It’s important to note that failing to reply within these time limits can have serious consequences, including abandonment of pending applications.

For more information on patent applications, visit: patent applications.

For more information on Time Limits, visit: Time Limits.

What are the time limits for perfecting a foreign priority claim in a patent?

The time limits for perfecting a foreign priority claim in a patent are as follows:

  • The priority claim must be made within 16 months from the filing date of the prior foreign application or 4 months from the actual filing date of the U.S. application, whichever is later.
  • A certified copy of the foreign application must be filed within the same time period, unless previously submitted in a parent application.

According to MPEP 216.01: “The patent owner’s failure to make a timely priority claim and file the certified copy prior to issuance of the patent cannot be cured by filing a reissue application.” This emphasizes the importance of meeting these deadlines during the initial patent application process.

The time limits for filing an interim copy of a foreign application are specified in 37 CFR 1.55(j). According to the MPEP:

37 CFR 1.55(j) also provides that the interim copy of the foreign application and cover sheet must be filed within the later of sixteen months from the filing date of the prior foreign application or four months from the actual filing date of an application under 35 U.S.C. 111(a), within four months from the later of the date of commencement (37 CFR 1.491(a)) or the date of the initial submission under 35 U.S.C. 371 in an application entering the national stage under 35 U.S.C. 371, or with a petition under 37 CFR 1.55(e) or (f).

In summary, the interim copy must be filed within:

  • 16 months from the filing date of the foreign application, or
  • 4 months from the U.S. application filing date under 35 U.S.C. 111(a), or
  • 4 months from the national stage commencement or initial submission date under 35 U.S.C. 371, or
  • With a petition under 37 CFR 1.55(e) or (f)

To learn more:

The time limits for filing a certified copy in an international design application are:

  • General rule: Within the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application.
  • Exception: These time limits do not apply if the priority document is available to the Office from a participating digital library.

MPEP 213.07 specifies: The time period requirement in 37 CFR 1.55(f) for filing a certified copy of the foreign application in a nonprovisional international design application is the later of four months from the filing date of the international design application, or sixteen months from the filing date of the prior foreign application, except as provided in paragraphs (h), (i), and (j) of this section.

To learn more:

The time limits for entering the national stage in the United States are specified in MPEP 601.04:

The time limit for entering the national stage in the United States of America is 30 months from the priority date. […] Pursuant to PCT Article 22(1), the 30-month time limit set forth in 35 U.S.C. 371(b) for submitting the national stage requirements is not extendable.

It’s important to note that this 30-month deadline is strictly enforced and cannot be extended. Applicants must ensure they meet all national stage requirements within this timeframe to avoid abandonment of their application.

To learn more:

Tags: Time Limits

In a national stage application under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT. According to 37 CFR 1.55(d)(2), this is the general rule, with some exceptions provided in paragraph (e) of the same section.

The MPEP states: In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made and a certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT with limited exceptions.

To learn more:

The timing of filing a request to withdraw as a patent practitioner is crucial. According to the MPEP:

  • The USPTO will review and decide on withdrawal requests filed before the expiration of a time period for reply or before the expiration of a time period that can be extended under 37 CFR 1.136(a).
  • Requests filed after these deadlines will be placed in the application file but will not be treated on their merits.
  • Revocations of power of attorney filed after these deadlines will also simply be placed in the application file, with the exception of those accompanied by a petition to revive.

It’s important to note that the USPTO may render a decision on a timely filed request even after the stated period for reply, after the application is abandoned, or after proceedings have terminated.

For reexamination proceedings, practitioners should refer to MPEP § 2223 for specific guidance on withdrawal.

To learn more:

According to the MPEP, patent applications can be directed to three broad types of subject matter:

  • Utility patent applications under 35 U.S.C. 101 for “a new and useful process, machine, manufacture, or composition of matter”
  • Plant patent applications under 35 U.S.C. 161
  • Design patent applications under 35 U.S.C. 171

The USPTO has specific procedures for storing models, exhibits, and specimens. According to MPEP 608.03(a):

‘All models and exhibits in easily transportable form which are admitted to the application or proceeding are officially filed and entered of record in the file wrapper. A receipt for the same is given to the applicant or party by the Office.’

This indicates that these items are stored with the application file. The MPEP further states:

‘Models, exhibits, and specimens not officially filed are not admitted into the file wrapper and, therefore, are not entered of record in the application or proceeding file.’

Items not officially filed are likely stored separately or returned to the applicant. The USPTO ensures proper handling and storage of these materials to maintain their integrity during the examination process.

To learn more:

What are the specific requirements for drawings in design patent applications?

Design patent applications have unique drawing requirements due to their focus on the ornamental design of an article. According to MPEP 608.02(a), the following specific requirements apply:

  • Multiple views: The drawings must contain a sufficient number of views to completely disclose the appearance of the design.
  • Surface shading: This is often necessary to show the contours and character of the design.
  • Solid black surface shading: This is not permitted, except when used to represent the color black or color contrast.
  • Broken lines: These may be used to show environmental structure but form no part of the claimed design.
  • Color drawings: These are permitted upon filing a petition explaining why color drawings are necessary.

The MPEP states, “Lack of good drawings in a design patent application may result in a refusal to issue the application until suitable drawings are submitted.” Therefore, it’s crucial to submit high-quality, compliant drawings from the outset to avoid delays in the examination process.

To learn more:

Canadian patent agents must meet specific requirements to practice before the USPTO under limited recognition:

  • They must be registered and in good standing as a patent agent under Canadian law.
  • They must apply for limited recognition to the USPTO Director.
  • They can only represent Canadian citizens or residents before the USPTO.
  • Their representation is limited to the presentation and prosecution of patent applications of Canadian applicants.

As stated in MPEP 402.01: Canadian patent agents are not required to pass the regular patent bar examination to represent Canadian applicants. They need not seek formal recognition to practice before the Office.

To learn more:

The USPTO has designated specific facsimile numbers for various offices to handle different types of correspondence. According to MPEP 502.01, some key facsimile numbers include:

  • Central Facsimile Number (for most patent-related correspondence): (571) 273-8300
  • International Patent Legal Administration (for responses to Decisions on Petition): (571) 273-0459
  • Office of Data Management (for issue fee payments and drawings): (571) 273-2885
  • Electronic Business Center (for Customer Number requests): (571) 273-0177
  • Assignment Branch (for assignment documents): (571) 273-0140
  • Central Reexamination Unit (for ex parte and inter partes reexamination correspondence): (571) 273-9900
  • Patent Trial and Appeal Board (for contested cases and trials, where expressly authorized): (571) 273-0042
  • Office of Petitions (for petitions to withdraw from issue): (571) 273-0025

The MPEP states: “For each Office location listed below, only the particular type of correspondence indicated may be transmitted to the specific facsimile number at that Office location. All other types of facsimile transmitted correspondence must be sent to the central facsimile number ((571) 273-8300).”

It’s crucial to use the correct facsimile number for your specific type of correspondence to ensure proper handling and processing by the USPTO.

To learn more:

The MPEP 201.01 mentions several special types of national applications:

1. Provisional applications (35 U.S.C. 111(b))
2. Reissue applications (35 U.S.C. 251)
3. Design applications (35 U.S.C. 171)
4. Plant applications (35 U.S.C. 161)

These applications have specific requirements and purposes. For example, provisional applications provide a way to establish an early effective filing date, while reissue applications allow for the correction of errors in issued patents. Design applications protect ornamental designs, and plant applications are for new varieties of plants.

For more details on these special application types, refer to the following MPEP sections:
MPEP 201.04 – Provisional Application
MPEP 1400 – Reissue
MPEP 1500 – Design Patents
MPEP 1600 – Plant Patents

Secrecy order applications require special handling procedures to maintain their confidentiality. According to MPEP 130:

Applications and papers in the application file, as well as any related papers, must be safeguarded from disclosure to unauthorized persons and must be securely kept in a locked area when not actually in use.

Additionally:

  • Secrecy order cases should not be processed on any automated information system (AIS) unless the AIS is certified for classified processing.
  • All processing should be done in a secure environment by personnel with appropriate clearances.
  • Special care must be taken to prevent inadvertent disclosure of classified information.

For more information on classified information, visit: classified information.

For more information on patent applications, visit: patent applications.

Design patent applications have some special considerations compared to other types of patent applications:

  • Filing Date: For design applications (except CPAs), the filing date is when the USPTO receives the specification (including at least one claim) and any required drawings.
  • Continued Prosecution Application (CPA): Design applications can be filed as CPAs under 37 CFR 1.53(d), but this option is not available for utility or plant applications.
  • Claims: Unlike utility applications, design applications must include at least one claim at the time of filing to receive a filing date.
  • Drawings: Drawings are crucial in design applications and must be filed with the initial application to secure a filing date.

The MPEP states: The filing date for a design application, except for a continued prosecution application (CPA) under 37 CFR 1.53(d), is the date on which the specification as required by 35 U.S.C. 112, including at least one claim, and any required drawings are received in the Office.

It’s important to note that while utility and plant applications filed on or after December 18, 2013, can receive a filing date without claims or drawings, this flexibility does not extend to design applications.

To learn more:

What are the size standards for a small business concern in patent applications?

The size standards for a small business concern in patent applications are determined by the Small Business Administration (SBA). According to MPEP 509.02:

“For the purpose of paying reduced patent fees, a small business concern is one:

  • (i) Whose number of employees, including affiliates, does not exceed 500 persons; and
  • (ii) Which has not assigned, granted, conveyed, or licensed (and is under no obligation to do so) any rights in the invention to any person who made it and could not be classified as an independent inventor, or to any concern which would not qualify as a small business concern or a nonprofit organization under this section.”

It’s important to note that these size standards are specific to patent applications and may differ from SBA size standards used for other purposes. Businesses must meet both the employee count criterion and the rights assignment criterion to qualify as a small business concern for patent fee purposes.

To learn more:

The size and margin requirements for patent drawings are specified in 37 CFR 1.84(f) and (g). Key requirements include:

  • Sheet size: 21.0 cm x 29.7 cm (DIN size A4) or 21.6 cm x 27.9 cm (8 1/2 x 11 inches)
  • Top margin: at least 2.5 cm (1 inch)
  • Left side margin: at least 2.5 cm (1 inch)
  • Right side margin: at least 1.5 cm (5/8 inch)
  • Bottom margin: at least 1.0 cm (3/8 inch)

The usable surface (sight) should not exceed 17.0 cm x 26.2 cm on A4 size sheets or 17.6 cm x 24.4 cm on 8 1/2 x 11 inch sheets. Drawings must also include scan target points (cross-hairs) printed on two cater-corner margin corners.

To learn more:

When multiple parties are prosecuting a patent application, there are specific signature requirements for replies to the USPTO. The MPEP provides clear guidance:

“Each of these parties must sign all subsequent replies submitted to the Office.”

The MPEP also provides examples to illustrate these requirements:

  • “If coinventor A has given a power of attorney to a patent practitioner and coinventor B has not, replies must be signed by the patent practitioner of A and by coinventor B.”
  • “If coinventors A and B have each appointed their own patent practitioner, replies must be signed by both patent practitioners.”

These examples demonstrate that all parties involved in prosecuting the application must sign subsequent replies, whether they are inventors, attorneys, or agents. This ensures that all parties are aware of and agree to the content of communications with the USPTO.

To learn more:

Tags: USPTO

What are the signature requirements for patent practitioners in correspondence with the USPTO?

Patent practitioners (e.g., registered attorneys or agents) must follow specific signature requirements when corresponding with the USPTO:

  • They must personally sign correspondence using either a handwritten signature or an S-signature.
  • An S-signature is inserted between forward slash marks and includes the practitioner’s name and registration number.
  • The signature must comply with 37 CFR 1.4(d)(1) or 1.4(d)(2).

According to MPEP 502.02, ‘The signature of a practitioner on correspondence filed with the USPTO must be a handwritten signature or an S-signature personally signed by such practitioner.’ This ensures accountability and authenticity in patent-related communications.

To learn more:

According to 37 CFR 11.18(a), all documents filed in the USPTO for patent matters must bear a signature, with some exceptions:

  • Documents that are required to be signed by the applicant or party do not need a practitioner’s signature.
  • For all other documents, each piece of correspondence filed by a practitioner must be personally signed or have their signature inserted in compliance with 37 CFR 1.4(d).

The MPEP states: “37 CFR 11.18(a) emphasizes that every paper filed by a practitioner must be personally signed by the practitioner, except those required to be signed by the applicant or party.”

To learn more:

For papers filed by a juristic entity (e.g., corporation) in a patent application:

  • A person authorized to act on behalf of the juristic entity must sign.
  • The signer’s name and title must be included.
  • The papers must state the signer’s capacity to sign for the juristic entity.

The MPEP states: Papers filed on behalf of juristic entities must be signed by a patent practitioner. 37 CFR 1.33(b)(3). (MPEP 402.03)

For example, a proper signature might look like: ‘John Smith, President, Corporation XYZ, authorized to sign on behalf of Corporation XYZ’.

To learn more:

The signature requirements for inventor’s oaths or declarations are as follows:

  • There is no requirement for a signature to be made in any particular manner.
  • Inventors can use titles such as ‘Dr.’ in their signatures, but these won’t appear in the printed patent.
  • Non-English character signatures are accepted.
  • If an inventor cannot write, their mark must be witnessed.

According to MPEP § 602.08(b), “There is no requirement that a signature be made in any particular manner.” The section also states, “It is permissible for an applicant to use a title of nobility or other title, such as ‘Dr.’, in connection with their signature. The title will not appear in the printed patent.

To learn more:

The signature requirements for filing a Continued Prosecution Application (CPA) are specific and important. According to MPEP 201.06(d):

A Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) must be signed by a person authorized to prosecute the application, except as provided in 37 CFR 1.33(b).

This means that:

  • The CPA must be signed by someone authorized to prosecute the application.
  • Typically, this would be the applicant or the applicant’s patent attorney or agent.
  • There are exceptions outlined in 37 CFR 1.33(b), which allow for certain communications to be signed by other parties in specific circumstances.

It’s crucial to ensure that the proper signature is provided when filing a CPA to avoid potential issues with the application’s acceptance or processing.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For documents submitted through EFS-Web, the USPTO accepts electronic signatures. According to MPEP 402.03:

Any paper filed in the Office in a patent application, patent file, or other proceeding which is not signed as required by 37 CFR 1.4(d) or (e) will be considered unsigned, and will be treated in accordance with 37 CFR 1.4(d)(1).

The USPTO specifically recognizes S-signatures for EFS-Web submissions. An S-signature is a signature inserted between forward slash marks, like so: /John Smith/. It’s important to note that the signer must manually type their name or use a facsimile or handwritten signature inserted between the slashes.

To learn more:

Tags: EFS-Web, USPTO

The signature requirements for correspondence in patent applications are outlined in MPEP 502.02. The section states:

37 CFR 1.4(d) sets forth the signature requirements for correspondence filed in the Office. Specifically, 37 CFR 1.4(d) provides that:

The signature requirements vary depending on the type of correspondence and the method of submission. Generally, they include:

  • Handwritten signatures
  • S-signatures (electronically created signatures)
  • EFS-Web signatures for documents submitted via the Electronic Filing System

Each type of signature has specific requirements to ensure its validity and authenticity.

To learn more:

Tags: USPTO

The signature requirements for an Application Data Sheet (ADS) are as follows:

  • An ADS must be signed in compliance with 37 CFR 1.33(b).
  • An unsigned ADS will be treated only as a transmittal letter.
  • Proper signing is crucial for the ADS to be effective in providing application information.

37 CFR 1.76(e) states: “An application data sheet must be signed in compliance with § 1.33(b). An unsigned application data sheet will be treated only as a transmittal letter.”

It’s important to note that an unsigned ADS will not be effective for providing crucial information such as inventor names, applicant details, or priority claims. Therefore, ensuring proper signature on the ADS is essential for it to serve its intended purpose in the patent application process.

To learn more:

The signature requirements for a Continued Prosecution Application (CPA) request are specific and important to ensure proper filing. According to MPEP 201.06(d):

  • The request for a CPA must be signed by a person authorized to prosecute the prior application.
  • This includes:
    • A registered patent practitioner
    • The applicant (inventor or assignee of the entire interest)
  • The signature can be provided through any of the approved signature methods outlined in 37 CFR 1.4(d).

The MPEP states: ‘A request for a CPA may only be signed by a person authorized to prosecute the application as set forth in 37 CFR 1.33(b).’ This ensures that only authorized individuals can initiate the CPA process, maintaining the integrity of the application.

It’s crucial to note that if the CPA request is not properly signed, it may not be granted a filing date, potentially affecting the continuity of the application.

For more information on CPA, visit: CPA.

Tags: CPA

The USPTO assigns different series codes to various types of patent applications:

  • 01/ – 16/: Nonprovisional applications (utility, plant, and reissue)
  • 29/: Design applications
  • 35/: International design applications
  • 60/, 61/, and 62/: Provisional applications
  • 90/: Ex parte reexamination proceedings
  • 95/: Inter partes reexamination proceedings
  • 96/: Supplemental examination proceedings and resulting ex parte reexamination proceedings

The MPEP provides a detailed breakdown of series codes for nonprovisional applications from 1925 to the present. For example, ‘Series code 16 is assigned to nonprovisional applications filed from June 2018 to present.’ (MPEP 503)

S-signatures, or electronic signatures, must meet specific requirements for patent applications:

  • Inserted between forward slash marks (//).
  • Include the signer’s name.
  • Be reasonably specific to identify the signer.
  • Be handwritten or a facsimile of a handwritten signature.

According to MPEP 402.03: ‘The signature must consist only of letters, or Arabic numerals, or both. The S-signature must be signed in permanent dark ink or its equivalent.’

To learn more:

What are the rules for submitting color drawings in a patent application?

Submitting color drawings in a patent application requires special considerations and procedures. According to MPEP 608.02:

“Color drawings are not ordinarily permitted in utility patent applications. The Office will accept color drawings in utility patent applications only after granting a petition filed under this paragraph explaining why the color drawings are necessary.”

To submit color drawings:

  • File a petition explaining why color drawings are necessary
  • Pay the required petition fee
  • Include three sets of color drawings or color photographs
  • Amend the specification to include the reference to color drawings

The MPEP further states: “Color photographs will be accepted in utility patent applications if the conditions for accepting color drawings have been satisfied.” It’s important to note that even if the petition is granted, the patent will be printed in black and white unless color printing fees are paid.

For design patent applications, color drawings are generally acceptable without a petition, but specific requirements still apply regarding the quality and format of the drawings.

To learn more:

When conducting interviews with patent practitioners in foreign countries, examiners must follow specific guidelines:

  • Interviews must be conducted via video conference or telephone.
  • In-person interviews in foreign countries are not permitted.
  • The same interview policies and procedures apply as for domestic interviews.

As stated in the MPEP 408: ‘For patent practitioners in foreign countries, interviews must be scheduled to be conducted by video conference or telephone. Examiners may not hold in-person interviews with patent practitioners in foreign countries.’

For applications filed before September 16, 2012, the process for an assignee to revoke a power of attorney is different. According to the MPEP:

In applications filed before September 16, 2012, the assignee of record of the entire interest can revoke the power of attorney of the applicant unless an ‘irrevocable’ right to prosecute the application had been given as in some government owned applications.

The assignee must establish their right to take action as provided in pre-AIA 37 CFR 3.73(b). Once this is done, a power of attorney by the assignee of the entire interest revokes all powers given by the applicant and prior assignees.

Form PTO/SB/80 can be used by an assignee to revoke a power of attorney and appoint a new one. The assignee would sign the power of attorney, and either the assignee or the newly appointed practitioner would sign a statement under pre-AIA 37 CFR 3.73(b).

To learn more:

Reissue application files have specific access rules as outlined in MPEP 103:

‘All reissue applications, both pending and abandoned, are open to public inspection and copying.’

This means that:

  • Anyone can access reissue application files
  • No special permission is required
  • Both pending and abandoned reissue applications are available

However, if the reissue application contains a request for continued examination (RCE) filed on or after March 16, 2013, access to the file may be restricted until publication.

For more information on public inspection, visit: public inspection.

For more information on reissue applications, visit: reissue applications.

Using unsecured email for USPTO communications poses several risks:

  • Confidentiality breaches: Sensitive information could be intercepted by unauthorized parties.
  • Legal issues: Transmitting confidential information without proper security measures may violate patent laws and regulations.
  • Loss of patent rights: Inadvertent public disclosure through unsecured email could jeopardize patent rights.
  • Rejection of communications: The USPTO may not accept or acknowledge communications sent through unsecured channels.

MPEP 502.03 warns: “Internet e-mail shall NOT be used to conduct an exchange or communications similar to those exchanged during telephone or personal interviews unless a written authorization has been given.” This emphasizes the importance of using secure, authorized channels for all USPTO communications.

To mitigate these risks, always use the USPTO’s secure email system or the Electronic Filing System (EFS-Web) for official communications.

To learn more:

Improperly claiming micro entity status can have serious consequences:

  • It may be considered fraud on the USPTO if done knowingly
  • It can result in the patent being held unenforceable
  • Improperly paid fees will need to be corrected, which may include late fees

MPEP 509.04 warns: ‘Any attempt to fraudulently establish status as a micro entity, or pay fees as a micro entity, shall be considered as a fraud practiced or attempted on the Office. Improperly, and with intent to deceive, establishing status as a micro entity, or paying fees as a micro entity, shall be considered as a fraud practiced or attempted on the Office.’

A non-signing inventor, also known as an “inventor designee,” has certain rights in a patent application filed without their signature. According to MPEP § 409.03(i) (for applications filed before September 16, 2012):

  • The non-signing inventor may protest their designation as an inventor
  • They are entitled to inspect any paper in the application and order copies
  • They can make their position of record in the file wrapper of the application
  • They may arrange to do any of the above through a registered patent attorney or agent

However, the non-signing inventor is not entitled to a hearing and cannot prosecute the application if status under pre-AIA 37 CFR 1.47 has been accorded or if the proprietary interest of the pre-AIA 37 CFR 1.47(b) applicant has been shown.

For applications filed on or after September 16, 2012, similar principles apply, but the specific procedures may differ.

What are the restrictions on registered practitioners not of record during USPTO interviews?

Registered practitioners who are not of record for a specific patent application face certain restrictions when attending USPTO interviews. According to MPEP 408:

‘The registered practitioner not of record may not participate in the interview of the application except as authorized by the patent applicant.’

This means that while a practitioner not of record may accompany the practitioner of record to an interview, their participation is limited. They cannot actively engage in the discussion or negotiation process without explicit authorization from the patent applicant. This restriction is in place to ensure that the applicant’s interests are properly represented by their chosen practitioner of record and to maintain the integrity of the interview process.

For more information on patent examination, visit: patent examination.

For more information on practitioner of record, visit: practitioner of record.

For more information on registered practitioner, visit: registered practitioner.

Secrecy order applications are subject to strict restrictions on foreign filing to protect national security. The MPEP 130 outlines these restrictions:

A secrecy order bars the filing of a foreign application based on the application under secrecy order without prior license from the Commissioner for Patents.

Key points regarding foreign filing restrictions:

  • Filing a foreign application without authorization is prohibited.
  • A license from the Commissioner for Patents is required for any foreign filing.
  • Unauthorized foreign filing can result in severe penalties, including abandonment of the application.
  • These restrictions are in place to prevent disclosure of sensitive information to foreign entities.

Inventors and applicants must be aware of these restrictions to avoid legal complications and potential national security breaches.

For more information on patent applications, visit: patent applications.

What are the restrictions on filing a continuation-in-part application?

n

While continuation-in-part (CIP) applications offer flexibility in adding new matter to existing patent applications, there are several important restrictions to consider. The MPEP 201.08 outlines some key points:

n

“A continuation-in-part application can be filed as a new application claiming benefit under 35 U.S.C. 120 to a prior nonprovisional application or under 35 U.S.C. 119(e) to a prior provisional application, provided the conditions set forth under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 are met.”

n

Key restrictions include:

n

    n

  • The CIP must be filed while the parent application is still pending (not abandoned or issued).
  • n

  • At least one inventor named in the CIP must also be named in the parent application.
  • n

  • The CIP must include a specific reference to the parent application.
  • n

  • New matter in the CIP does not benefit from the parent application’s filing date.
  • n

  • The CIP must be filed within the time limits specified in 37 CFR 1.78 to claim priority.
  • n

n

Additionally, applicants should be aware that filing a CIP may affect the patent term and the assessment of prior art for the new subject matter. Careful consideration of these restrictions is essential for effective patent strategy.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 37 CFR 1.78, visit: 37 CFR 1.78.

For more information on filing requirements, visit: filing requirements.

To qualify for micro entity status, an applicant must meet the following requirements:

  • Qualify as a small entity
  • Not be named as an inventor on more than 4 previously filed patent applications
  • Not have a gross income exceeding 3 times the median household income in the previous calendar year
  • Not have assigned, licensed, or be obligated to assign or license rights to an entity that exceeds the gross income limit

Alternatively, an applicant can qualify if they are employed by or have assigned rights to an institution of higher education.

To use the Priority Document Exchange (PDX) program, several requirements must be met as outlined in MPEP 215.02(a):

  1. The foreign application must be filed in a participating foreign intellectual property office.
  2. The claim for priority must be presented in an application data sheet (ADS) with specific details about the foreign application.
  3. The copy of the foreign application must be received by the USPTO from the participating foreign office, or a certified copy must be filed, within the specified time period.

The MPEP states:

37 CFR 1.55(i) specifically provides that this requirement for a timely filed certified copy of the foreign application will be considered satisfied if: (1) The foreign application was filed in a foreign intellectual property office participating with the Office in a bilateral or multilateral priority document exchange agreement (participating foreign intellectual property office); (2) the claim for priority is presented in an application data sheet (§1.76(b)(6)), identifying the foreign application for which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and including the information necessary for the participating foreign intellectual property office to provide the Office with access to the foreign application; and (3) the copy of the foreign application is received by the Office from the participating foreign intellectual property office, or a certified copy of the foreign application is filed, within the time period set forth in 37 CFR 1.55(g)(1)).

Meeting these requirements allows applicants to potentially avoid manually filing certified copies of foreign priority documents.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For more information on requirements, visit: requirements.

According to 37 CFR 3.31, the cover sheet for patent assignments must contain:

  • Name of the party conveying the interest
  • Name and address of the party receiving the interest
  • Description of the interest conveyed or transaction to be recorded
  • Identification of the patent or application
  • Name and address for correspondence
  • Date of execution
  • Signature of the party submitting the document

For joint research agreements, the cover sheet must also:

  • Identify the document as a ‘joint research agreement’
  • Indicate the name of the patent owner
  • Indicate the names of other parties to the agreement
  • Indicate the date the agreement was executed

The MPEP notes that Form PTO-1595, Recordation Form Cover Sheet, may be used as the cover sheet for recording documents relating to patent(s) and/or patent application(s) in the Office.

For more information on Assignment cover sheet, visit: Assignment cover sheet.

For more information on patent assignment, visit: patent assignment.

A certified copy of the foreign application must be filed within the time period set in 37 CFR 1.55, which is the later of four months from the filing date of the US application or sixteen months from the foreign application filing date.

The certified copy requirement will be considered satisfied in a national stage application under 35 U.S.C. 371 if a certified copy was filed in the international application and the copy is present in the national stage application. See MPEP § 215.

A certified copy is also not required if the foreign priority application was filed in a participating foreign intellectual property office and the USPTO retrieves a copy via the priority document exchange program. See MPEP § 215.01.

An interim copy of the foreign application may also be filed to meet the timeliness requirement. See 37 CFR 1.55(j) and MPEP § 215.02(b).

When canceling a patent drawing figure, the amendment document should include:

  • An explanation of the changes to the drawings in the remarks section.
  • The marked-up (annotated) copy of the drawing sheet showing the cancellation.
  • A replacement sheet of drawings without the canceled figure (if applicable).
  • Amendments to the brief description of the drawings reflecting the change.

MPEP 608.02(t) states: “The marked-up (annotated) copy must be clearly labeled as ‘Annotated Sheet’ and must be presented in the amendment or remarks section of the amendment document which explains the changes to the drawings (see 37 CFR 1.121(d)(1)).” This ensures that the examiner can easily understand and process the changes made to the application.

To learn more:

The Abstract of the Disclosure in a patent application must meet specific requirements as outlined in 37 CFR 1.72(b) and MPEP § 608.01(b):

  • It should be a brief narrative of the disclosure as a whole
  • It should be as concise as the disclosure permits
  • It should be a single paragraph
  • It should preferably not exceed 150 words
  • It should commence on a separate sheet following the claims

The MPEP states, The abstract is a brief narrative of the disclosure as a whole, as concise as the disclosure permits, in a single paragraph preferably not exceeding 150 words, commencing on a separate sheet following the claims.

For international applications that have entered the national stage, the abstract published with the international application under PCT Article 21 will be used by the USPTO, unless the applicant provides a new one.

To learn more:

When submitting models or exhibits that are required by the Office or filed with a petition, applicants must include photographs that meet specific criteria. According to MPEP 608.03:

Models or exhibits that are required by the Office or filed with a petition under 37 CFR 1.91(a)(3) must be accompanied by photographs that (A) show multiple views of the material features of the model or exhibit, and (B) substantially conform to the requirements of 37 CFR 1.84.

The MPEP further clarifies that material features are those which represent the portion(s) of the model or exhibit forming the basis for which it has been submitted. For video or DVD submissions, applicants must provide photographs of what is depicted in the video (e.g., a still image or single frame), not just a photograph of the media itself.

To learn more:

What are the requirements for submitting photographs as drawings in a patent application?

Photographs are generally not permitted as drawings in patent applications unless they are the only practicable medium for illustrating the claimed invention. According to MPEP 608.02, “The Office will accept photographs in utility and design patent applications, however, if photographs are the only practicable medium for illustrating the claimed invention.” The MPEP further states:

“The photographs must be of sufficient quality so that all details in the photographs are reproducible in the printed patent.”

To submit photographs as drawings:

  • Ensure they are the only practicable medium for illustrating the invention
  • Provide high-quality photographs that clearly show all details
  • Submit them on paper that complies with drawing sheet requirements
  • Include any necessary mounting on bristol board or equivalent

It’s important to note that color photographs are not ordinarily permitted in utility patent applications.

To learn more:

When submitting non-English language information in an Information Disclosure Statement (IDS), there are specific requirements that must be met. The MPEP 609.05(a) addresses this issue with form paragraph 6.49.09:

The information disclosure statement filed [1] fails to comply with 37 CFR 1.98(a)(3)(i) because it does not include a concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information, of each reference listed that is not in the English language.

To comply with the requirements for non-English language information in an IDS:

  • Include a concise explanation of the relevance of each non-English language reference
  • The explanation should be provided by the individual most knowledgeable about the content
  • Failure to provide this explanation may result in the information not being considered

Applicants should ensure they provide proper explanations for non-English language references to avoid delays in the examination process and ensure all relevant information is considered.

To learn more:

When submitting documents as evidence in a reply to an Office action, applicants do not need to comply with the information disclosure rules (37 CFR 1.97 and 37 CFR 1.98) for the examiner to consider the information. The MPEP states:

“To the extent that a document is submitted as evidence directed to an issue of patentability raised in an Office action, and the evidence is timely presented, applicant need not satisfy the requirements of 37 CFR 1.97 and 37 CFR 1.98 in order to have the examiner consider the information contained in the document relied on by applicant.”

However, the examiner’s consideration may be limited to the portion of the document relied upon as rebuttal evidence.

To learn more:

When responding to a notice about an unlocatable file, applicants or patentees must provide copies of correspondence, but there are some exceptions. The MPEP states:

Any appendix or information disclosure statement submitted with an application is not contained in the Office’s database. Therefore, the applicant or patentee must also provide a copy of any appendix or information disclosure statement (except in the limited circumstance discussed below) submitted with the application.

However, there’s an important exception for U.S. patent documents:

Since the Office can obtain copies of U.S. patent documents (U.S. patent application publications and patents) from its internal databases, the Office is not requiring applicants or patentees to provide copies of U.S. patent application publications and patents that are among the applicant’s or patentee’s record of the correspondence between the Office and the applicant or patentee for the application, patent, or other proceeding.

This means that while most documents need to be resubmitted, U.S. patent documents can be omitted from the response.

The requirements for submitting biological sequence listings in patent applications depend on the filing date:

  • For applications filed before July 1, 2022: A “Sequence Listing” as an ASCII plain text file in compliance with 37 CFR 1.821 – 1.824.
  • For applications filed on or after July 1, 2022: A “Sequence Listing XML” as an XML file in compliance with 37 CFR 1.831 – 1.834.

As stated in MPEP 608.05(c): “Applications disclosing nucleotide and/or amino acid sequences […] are required to provide the biological sequence information in a sequence listing.”

To learn more:

The submission of biological material specimens to the USPTO is governed by specific requirements outlined in MPEP 608.03(a). The key points are:

  • Proper packaging: Specimens must be submitted in containers that ensure their safe delivery.
  • Identification: Each specimen should be clearly identified with the inventor’s name, the application number, and the filing date.
  • Compliance with regulations: Submissions must comply with all applicable regulations, including those related to dangerous materials and biotechnology inventions.

The MPEP specifically states:

‘Biological specimens will not be returned to the applicant. The procedures for submittal of samples of biological materials for deposit in a suitable depository for patent purposes are governed by 37 CFR 1.801 – 1.809.’

It’s crucial for applicants to follow these guidelines to ensure proper handling and consideration of their biological material specimens during the patent examination process.

To learn more:

According to 37 CFR 3.26, assignment documents in languages other than English can be recorded with the USPTO, but specific requirements must be met. The MPEP states:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

Key points for submitting non-English assignment documents:

  • The original non-English document must be submitted
  • An English translation of the document must be provided
  • The translation must be signed by the individual who performed the translation
  • Both the original document and the translation will be recorded

It’s important to ensure that the translation accurately reflects the content of the original document to avoid any legal complications or misunderstandings regarding the assignment.

For more information on patent assignment, visit: patent assignment.

According to MPEP 302.09, there are specific requirements for submitting assignment-related documents by fax:

  • An identified application or patent number
  • One cover sheet to record a single transaction
  • Payment of the recordation fee by credit card or USPTO Deposit Account

The MPEP states: Any assignment-related document for patent matters submitted by facsimile must include: (A) an identified application or patent number; (B) one cover sheet to record a single transaction; and (C) payment of the recordation fee by a credit card (use of the Credit Card form, PTO-2038 (see MPEP § 509), is required for the credit card information to be kept separate from the assignment records) or a USPTO Deposit Account.

It’s important to note that certain documents cannot be submitted via fax, such as assignments submitted with new patent applications or documents with multiple cover sheets.

To learn more:

What are the requirements for submitting an interim copy of a foreign priority application?

Submitting an interim copy of a foreign priority application can be useful when there are delays in obtaining a certified copy. According to MPEP 213.04, here are the requirements:

37 CFR 1.55(j) provides that an applicant who has not filed a certified copy of the foreign application may file an interim copy of the foreign application during the pendency of the application.

To submit an interim copy:

  • It must be filed during the pendency of the application
  • The copy must be clearly labeled as ‘Interim Copy’
  • Include a cover sheet identifying:
    • The application number
    • The foreign application number
    • The country or intellectual property office
    • The filing date
  • The interim copy must be a legible copy of the foreign application

Note: An interim copy does not satisfy the requirement for a certified copy. You must still submit a certified copy of the foreign application before the patent is granted.

To learn more:

For continuation, divisional, or continuation-in-part applications filed under 37 CFR 1.53(b), the requirements for submitting an Information Disclosure Statement (IDS) depend on whether the information was previously considered in the parent application. The MPEP provides the following guidance:

  • If the information was considered in the parent application, it need not be resubmitted unless the applicant wants it printed on the patent.
  • If the information was not considered in the parent application, it must be resubmitted in compliance with 37 CFR 1.97 and 37 CFR 1.98.

The MPEP further states:

“Pursuant to 37 CFR 1.98(d), if the IDS submitted in the parent application complies with 37 CFR 1.98(a) to (c), copies of the patents, publications, pending U.S. applications, or other information submitted in the parent application need not be resubmitted in the continuing application.”

When resubmitting information, applicants should use a new listing that complies with the format requirements in 37 CFR 1.98(a)(1) and avoid submitting copies of PTO/SB/08 or PTO-892 forms from other applications to prevent confusion in the record.

To learn more:

Electronic submission of an Information Disclosure Statement (IDS) is limited to specific methods and formats. The MPEP states:

Electronic means or medium for filing IDSs are not permitted except for: (A) IDSs electronically submitted using the USPTO patent electronic filing system (see MPEP § 609.07); or (B) copies of large tables, computer program listings, and sequence listings submitted as a PDF file and a “Sequence Listing XML” submitted as an XML file on a read-only optical disc in compliance with 37 CFR 1.52(e)(2) and (3) which are cited in a paper IDS.‘ (MPEP 609.04(a))

Key points for electronic IDS submission:

  • Use the USPTO patent electronic filing system for general IDS submissions
  • Large tables, computer program listings, and sequence listings can be submitted as PDF files
  • “Sequence Listing XML” must be submitted as an XML file on a read-only optical disc
  • A read-only optical disc cannot be used to submit an IDS listing or copies of documents (except for the items mentioned above)
  • Published information, such as software output or videos, must be reduced to writing (e.g., screen shots, transcripts)

It’s important to follow these guidelines to ensure proper processing of your IDS by the USPTO.

To learn more:

What are the requirements for submitting an IDS after the first Office action?

When submitting an Information Disclosure Statement (IDS) after the first Office action on the merits, additional requirements apply:

  • Timing: The IDS must be filed before the mailing date of a final action, notice of allowance, or other action that closes prosecution.
  • Statement: The IDS must be accompanied by one of the following:
    • A statement specified in 37 CFR 1.97(e)
    • The fee set forth in 37 CFR 1.17(p)

As stated in MPEP 609: “An information disclosure statement will be considered by the examiner if filed after the first Office action on the merits, but before the mailing date of any of a final action under 37 CFR 1.113, a notice of allowance under 37 CFR 1.311, or an action that otherwise closes prosecution in the application.”

It’s crucial to comply with these requirements to ensure the IDS is considered by the examiner.

To learn more:

To submit an assignment document electronically to the USPTO, the following requirements must be met:

  • The document must be submitted via the Electronic Patent Assignment System (EPAS)
  • An identified application or patent number must be included
  • One cover sheet must be completed online to record a single transaction
  • The signature on the cover sheet must comply with 37 CFR 3.31(a)(7) or 37 CFR 1.4(d)(2)

As stated in 37 CFR 1.4(d)(2), an S-signature may be used, which consists of letters and/or numbers between forward slashes (e.g., /John Doe/). For patent practitioners, their registration number must also be included.

For pre-AIA applications, submitting a supplemental Application Data Sheet (ADS) must follow specific requirements:

1. Timing: MPEP 601.05(b) states, “Supplemental application data sheets may be subsequently supplied prior to payment of the issue fee to either correct or update information in a previously submitted application data sheet, or an oath or declaration under pre-AIA 37 CFR 1.63 or 1.67.”

2. Title: The supplemental ADS must be titled “Supplemental Application Data Sheet.”

3. Content: It must contain all section headings listed in 37 CFR 1.76(b) with all appropriate data for each heading.

4. Format: The supplemental ADS must indicate changes, “preferably with insertions or additions indicated by underlining, and deletions, with or without replacement data, indicated by strike-through or brackets.”

5. Signature: The supplemental ADS must be signed as it is considered a paper filed in the application.

To learn more:

When submitting a supplemental Application Data Sheet (ADS) to correct or update information in a patent application, there are specific requirements to follow. According to MPEP 601.05:

‘For applications filed on or after September 16, 2012, if an applicant submits an ADS after the initial filing date of the application, the ADS must comply with the requirements of 37 CFR 1.76(c). A supplemental ADS must be labeled as such and must identify the information that is being changed with underlining (for insertions) and strike-through or brackets (for text removed).’

Key requirements for submitting a supplemental ADS include:

  • Proper labeling: The ADS must be clearly labeled as ‘Supplemental’ or ‘Corrected’.
  • Identifying changes: Use underlining for insertions and strike-through or brackets for deletions.
  • Complete sections: Include all sections of the ADS, not just the changed information.
  • Timing: Submit the supplemental ADS as soon as the need for correction is identified.
  • Fee: Be aware that certain changes may require payment of additional fees.

It’s crucial to follow these requirements to ensure that the USPTO properly processes the updated information and to avoid potential delays or issues with the application.

To learn more:

Statements under the Atomic Energy Act and NASA Act must set forth “the full facts” surrounding the conception and making of the invention. According to MPEP 151, these facts should be unique to that invention. The MPEP states:

“The use of form paragraphs or printed forms which set forth only broad generalized statements of fact is not ordinarily regarded as meeting the requirements of these statutes.”

This means that inventors must provide detailed, specific information about their invention’s conception and development.

For more information on invention disclosure, visit: invention disclosure.

What are the requirements for signing patent documents on behalf of juristic entities?

The requirements for signing patent documents on behalf of juristic entities (such as corporations, universities, or other organizations) are specific and strict. According to MPEP 402.04:

“Effective September 16, 2012, any paper submitted on behalf of a juristic entity must be signed by a patent practitioner.”

This means that for juristic entities:

  • All patent documents must be signed by a registered patent practitioner (either a patent attorney or a patent agent).
  • Employees or officers of the juristic entity cannot sign patent documents, even if they are the inventors.
  • The patent practitioner must be officially appointed to represent the juristic entity before the USPTO.

This requirement ensures that juristic entities are properly represented in patent matters and helps maintain the integrity of the patent application process. It’s important for juristic entities to work with qualified patent practitioners to handle their patent applications and related documents.

To learn more:

Amendments and other papers filed in a patent application must be signed by specific individuals as outlined in 37 CFR 1.33(b):

  1. A patent practitioner of record
  2. A patent practitioner not of record who acts in a representative capacity under the provisions of 37 CFR 1.34
  3. The applicant (37 CFR 1.42)

It’s important to note that for juristic entities (e.g., corporations), 37 CFR 1.33(b)(3) specifies:

“Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.”

This requirement ensures that juristic entities are properly represented in patent proceedings.

To learn more:

The USPTO has specific requirements for signatures on documents, as outlined in 37 CFR 1.4(d). Key points include:

  • Signatures must be personally inserted by the signer or comply with specific electronic signature standards.
  • The person inserting a signature certifies that it is their own signature.
  • A person submitting a document signed by another must have a reasonable basis to believe the signature is authentic.

The MPEP states: The person inserting a signature under paragraph (d)(2) or (d)(3) of this section in a document submitted to the Office certifies that the inserted signature appearing in the document is his or her own signature.

For more information on patent application requirements, visit: patent application requirements.

The USPTO accepts different types of signatures on correspondence, including:

  1. Handwritten signatures: Original signatures in permanent dark ink or equivalent.
  2. S-signatures: A signature inserted between forward slash marks, which can be used for correspondence filed in paper, by fax, or via the electronic filing system.
  3. Electronic signatures: For correspondence submitted via the electronic filing system, a graphic representation of a handwritten signature or an S-signature is acceptable.

According to 37 CFR 1.4(d): Each piece of correspondence, except as provided in paragraphs (d)(2), (d)(3), (d)(4), (e) and (f) of this section, filed in an application, patent file, or other proceeding in the Office which requires a person’s signature, must: (i) Be an original, that is, have an original handwritten signature personally signed, in permanent dark ink or its equivalent, by that person; or (ii) Be a direct or indirect copy, such as a photocopy or facsimile transmission (§ 1.6(d)), of an original.

For S-signatures, the signer must personally insert their own signature, and patent practitioners must include their registration number. The signer’s name must be presented in printed or typed form immediately below or adjacent to the S-signature.

To learn more:

The USPTO requires that different matters be submitted in separate papers to avoid confusion and delays. This requirement is outlined in 37 CFR 1.4(c), which states:

Since different matters may be considered by different branches or sections of the Office, each distinct subject, inquiry or order must be contained in a separate paper to avoid confusion and delay in answering papers dealing with different subjects.

Key points to remember:

  • Each distinct subject, inquiry, or order should be in a separate paper.
  • This applies to both patent and trademark correspondence.
  • Exceptions are allowed for subjects provided for on a single Office or World Intellectual Property Organization form.

If you submit multiple subjects in a single paper, the USPTO may use Form Paragraph 5.01.01 to notify you of the requirement for separate papers in future correspondence.

Adhering to this requirement helps ensure that your correspondence is processed efficiently by the appropriate Office branches or sections.

To learn more:

When sending confidential information via email to the USPTO, specific requirements must be met:

  • Use of the Electronic Filing System (EFS-Web) is strongly recommended for submitting confidential information.
  • If email must be used, it should be through the USPTO’s secure email system.
  • An authorization from the applicant is required before sending confidential information via email.
  • The email must include a statement that the email correspondence is being submitted using the procedures set forth in 37 CFR 1.33(d).

As stated in MPEP 502.03: “Internet email shall NOT be used to conduct an exchange of communications similar to those exchanged during telephone or personal interviews unless a written authorization has been given.”

To learn more:

S-signatures, or electronic signatures, are accepted by the USPTO for patent applications. The requirements for S-signatures include:

  • The signature must be between forward slash marks (//).
  • The signer’s name must be provided in printed or typed form preferably immediately below or adjacent to the S-signature.
  • The S-signature may be any combination of letters, numbers, spaces, and punctuation marks.

The MPEP 402.03 states: An S-signature must consist only of letters, or Arabic numerals, or both, with appropriate spaces and commas, periods, apostrophes, or hyphens for punctuation, and the person signing the correspondence must insert his or her own S-signature with a first single forward slash mark before, and a second single forward slash mark after, the S-signature (e.g., /Dr. James T. Jones, Jr./).

It’s important to note that the S-signature must be inserted by the person signing the document, not by someone else on their behalf.

To learn more:

The requirements for representing applicants before international patent authorities vary depending on the specific authority. According to MPEP 402.09 and 37 CFR 11.9(c):

An individual not registered under § 11.6 may, if appointed by an applicant, prosecute an international patent application only before the United States International Searching Authority and the United States International Preliminary Examining Authority, provided that the individual has the right to practice before the national office with which the international application is filed as provided in PCT Art. 49, Rule 90 and § 1.455 of this subchapter, or before the International Bureau when the USPTO is acting as Receiving Office pursuant to PCT Rules 83.1 bis and 90.1.

This means that representation rights depend on the specific authority and the individual’s right to practice before the relevant national office or the International Bureau.

To learn more:

According to MPEP 302.02, non-English assignment documents can only be accepted and recorded by the USPTO if they are accompanied by an English translation. The MPEP states:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This means that inventors, assignees, or their representatives must provide a certified English translation along with the original non-English document for it to be officially recorded.

To learn more:

To record an assignment of a patent or patent application, the following requirements must be met:

  • The assignment must be in writing.
  • It must be signed by the assignor (the person or entity transferring ownership).
  • The document must identify the patent or application by number.
  • The assignment must be submitted to the USPTO along with the required fee.

According to MPEP 301: “An assignment relating to a patent must be submitted to the USPTO for recordation as an absolute requirement for enforcing the patent or application against third parties.” This recordation provides constructive notice to the public of the assignment.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

For more information on USPTO, visit: USPTO.

What are the requirements for recording a patent assignment document?

To record a patent assignment document, you must submit:

  • A copy of the original assignment document
  • A cover sheet identifying the document as an assignment
  • The required fee

The MPEP states: ‘The document submitted for recordation must be accompanied by a cover sheet identifying the document as an assignment and must contain the fee required by 37 CFR 3.41.’ This ensures proper processing and indexing of the assignment.

To learn more:

Joint research agreements can be recorded with the USPTO as per 37 CFR 3.11(c). The MPEP states that the cover sheet for a joint research agreement must:

  • Identify the document as a ‘joint research agreement’ in the description of interest conveyed
  • Indicate the name of the owner of the application or patent
  • Indicate the name of each other party to the joint research agreement
  • Indicate the date the joint research agreement was executed

The document submitted can be either the entire joint research agreement or an excerpt of it. As with other recorded documents, it must be accompanied by a completed cover sheet as specified in 37 CFR 3.28 and 3.31.

Remember that A patent cover sheet may not refer to trademark applications or registrations. Separate cover sheets must be used for patents and trademarks.

For more information on joint research agreement, visit: joint research agreement.

For more information on patent assignment, visit: patent assignment.

For more information on recordation, visit: recordation.

To record a document with respect to additional patents and/or patent applications, even if it has been previously recorded, the following must be submitted to the Assignment Division:

As stated in MPEP 315: “The Office will assign a new recording date to that submission, update the assignment database, and include the cover sheet and document as part of the official record.”

For more information on Assignment Division, visit: Assignment Division.

For more information on document recording, visit: document recording.

For more information on patent applications, visit: patent applications.

For more information on recording requirements, visit: recording requirements.

What are the requirements for proper dependency in multiple dependent claims?

Multiple dependent claims must meet specific requirements for proper dependency:

  • They must refer back to previous claims in the alternative only.
  • A multiple dependent claim cannot serve as a basis for any other multiple dependent claim.
  • They must be written in a form that includes all limitations of each of the claims to which it refers.

The MPEP 608.01(n) states:

“A multiple dependent claim may refer in the alternative to only one set of claims. A claim such as ‘A machine according to claims 3 or 4, further comprising —‘ is improper.”

This means that a multiple dependent claim must clearly specify the alternative dependencies and cannot mix single and multiple dependencies in the same claim.

To learn more:

What are the requirements for personnel working with secrecy order applications?

Personnel working with secrecy order applications must meet specific security requirements. MPEP 121 outlines these requirements:

  • Must have proper security clearance
  • Are responsible for maintaining the secrecy of the applications
  • Must ensure applications are returned to secure storage when not in use

The MPEP emphasizes: ‘All applications bearing national security markings must be examined by properly cleared examiners.’ This ensures that only authorized individuals with the necessary security clearance have access to these sensitive patent applications, maintaining their confidentiality and national security integrity.

For inventions related to aeronautical and space activities, applicants must file a statement with specific information if requested by the USPTO. According to 51 U.S.C. 20135:

No patent may be issued to any applicant other than the Administrator for any invention which appears to the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office […] to have significant utility in the conduct of aeronautical and space activities unless the applicant files with the Director, with the application or within 30 days after request therefor by the Director, a written statement executed under oath setting forth the full facts concerning the circumstances under which the invention was made and stating the relationship (if any) of the invention to the performance of any work under any contract of the Administration.

This statement should include:

  • Full facts about the circumstances of the invention’s creation
  • The relationship, if any, between the invention and work performed under any NASA contract

For more information on invention disclosure, visit: invention disclosure.

For more information on patent applications, visit: patent applications.

For paper submissions of patent assignment documents, the following requirements must be met:

  • Submit either a copy of the original document or an extract of the original document.
  • Use only one side of each page.
  • Paper size must be either 8.5″ x 11″ or A4, with a 1-inch margin on all sides.
  • Use flexible, strong white, non-shiny, and durable paper.

As stated in 37 CFR 3.24(b): “For paper submissions, the paper used should be flexible, strong white, non-shiny, and durable.” This ensures that the document can be properly recorded and stored by the USPTO.

What are the requirements for paper size and margins in a patent application specification?

According to MPEP 608.01, the specification must adhere to specific paper size and margin requirements:

  • Paper size: 21.0 cm by 29.7 cm (DIN size A4) or 21.6 cm by 27.9 cm (8 1/2 by 11 inches)
  • Margins: At least 2.0 cm (3/4 inch) on the top, bottom, and left sides; at least 2.5 cm (1 inch) on the right side

The MPEP states: ‘All papers which are to become a part of the permanent records of the U.S. Patent and Trademark Office must be on sheets of paper which cannot exceed 21.6 cm by 33.1 cm (8 1/2 by 13 inches) and which must have the following margins:’ followed by the margin specifications. These requirements ensure uniformity and readability of patent documents.

To learn more:

Tags: paper size

To obtain a filing date for a nonprovisional patent application filed under 37 CFR 1.53(b), the application must include:

  • A specification containing a description as prescribed by 35 U.S.C. 112(a)
  • At least one claim (for applications filed on or after December 13, 2013)
  • Any drawings necessary under 35 U.S.C. 113 (first sentence)

As stated in the MPEP: Filing dates are accorded to nonprovisional applications filed under 37 CFR 1.53(b) submitted without the names of all the inventors, the required fees (basic filing fee, and search and examination fees (for applications filed on or after December 8, 2004)), at least one claim (for applications filed on or after December 13, 2013) and/or the inventor’s oath or declaration.

If any required items are missing, the applicant will be notified and given a time period to submit the missing elements. The filing date will be the date the missing items are received.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent application requirements, visit: patent application requirements.

For continuing applications filed on or after September 16, 2012, the following requirements apply:

  • A copy of an oath or declaration or substitute statement from the prior nonprovisional application can be used, provided it complies with 37 CFR 1.63 or 37 CFR 1.64.
  • The oath or declaration must comply with 35 U.S.C. 115 and the relevant CFR sections in effect for applications filed on or after September 16, 2012.
  • It must include a statement that the application was made or authorized to be made by the person executing the oath or declaration.

As stated in the MPEP, “a new inventor’s oath or declaration may need to be filed in a continuing application filed on or after September 16, 2012, where the prior application was filed before September 16, 2012, in order to meet the requirements of 35 U.S.C. 115 and 37 CFR 1.63 (or 1.64) in effect for applications filed on or after September 16, 2012.”

To learn more:

According to MPEP 602.06, non-English oaths or declarations must meet specific requirements:

  • The oath or declaration must be in a language the individual can understand.
  • It must state that the individual understands the content of any related documents.
  • Unless provided by the USPTO or in accordance with PCT Rule 4.17(iv), it must be accompanied by an English translation.
  • A statement confirming the translation’s accuracy is required.

As stated in the MPEP: “37 CFR 1.69 requires that oaths and declarations be in a language which is understood by the individual making the oath or declaration, i.e., a language which the individual comprehends.”

To learn more:

What are the requirements for naming joint inventors in a patent application?

When naming joint inventors in a patent application, it’s important to follow specific requirements:

  • All inventors must be named in the application.
  • Each person listed as an inventor must have contributed to the conception of at least one claim in the application.
  • The order of naming inventors is not significant.

According to MPEP 602.08(b):

“The inventors entered on the application data sheet must include each inventor’s legal name.”

It’s crucial to ensure that all inventors are properly named to avoid potential issues with patent validity later on.

To learn more:

To establish micro entity status on the gross income basis, an applicant must meet the following requirements as outlined in 37 CFR 1.29(a)(1)-(4):

  • Qualify as a small entity
  • Not have been named as an inventor on more than four previously filed patent applications
  • Not have a gross income exceeding three times the median household income in the preceding calendar year
  • Not have assigned, granted, or conveyed, and not be under an obligation to do so, a license or ownership interest to an entity exceeding the gross income limit

The MPEP states: “Because each inventor and each non-inventor applicant (e.g., assignee-applicant) must separately meet the requirements under 37 CFR 1.29(a)(1)-(4), it would not be appropriate to file a micro entity certification under 37 CFR 1.29(a) for the application if there were more than one applicant or inventor and not all of the applicants and inventors qualified as micro entities under 35 U.S.C. 123(a).

To learn more:

To establish micro entity status based on an institution of higher education, an applicant must meet two main requirements:

  1. Qualify as a small entity as defined in 37 CFR 1.27
  2. Meet one of the following criteria:
    • The applicant’s employer, from which they obtain the majority of their income, is an institution of higher education as defined in section 101(a) of the Higher Education Act of 1965, or
    • The applicant has assigned, granted, conveyed, or is under an obligation to assign, grant, or convey, a license or other ownership interest in the application to such an institution of higher education.

As stated in MPEP 509.04(b): “An applicant for micro entity status under the ‘institution of higher education’ basis set forth in 37 CFR 1.29(d) must satisfy two requirements.”

To learn more:

When listing U.S. patents in an Information Disclosure Statement (IDS), the following requirements must be met:

  • List each patent by document number
  • Include the name of the patentee
  • Provide the issue date

According to MPEP 609.04(a): Each U.S. patent listed in an information disclosure statement must be identified by patentee, patent number, and issue date.

To learn more:

To learn more:

Tags: issue date

When listing an inventor’s residence on a patent application, you should follow these requirements:

  • Provide the city and either the state or foreign country of residence.
  • The state may be abbreviated using the two-letter postal code abbreviation.
  • For foreign countries, use the full name of the country.
  • Do not include a street address in the residence field.

According to MPEP 602.08(a): Residence information should be provided for all inventors. In the case where the inventor lives in an A.P.O. area, the city where the A.P.O. is located should be listed under city along with A.P.O. as the state and the zip code.

To learn more:

To learn more:

What are the requirements for limited recognition to practice before the USPTO?

To obtain limited recognition to practice before the USPTO in patent matters, an individual must meet the following requirements:

  • Be a scientist or engineer with a bachelor’s degree in a recognized technical subject
  • Demonstrate scientific and technical training
  • Possess good moral character and reputation
  • Be competent to advise and assist patent applicants

As stated in MPEP 402.01: ‘The OED Director may grant limited recognition to practice before the Office in patent matters to an individual not registered to practice before the Office.’ This limited recognition is subject to the conditions specified by the OED Director.

To learn more:

When submitting amended drawing sheets in response to objections, proper labeling is crucial. According to MPEP 608.02(e), the requirements for labeling amended drawing sheets are:

  1. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either ‘Replacement Sheet’ or ‘New Sheet’.
  2. This labeling must be done pursuant to 37 CFR 1.121(d).
  3. The figure or figure number of an amended drawing should not be labeled as ‘amended’.

It’s important to note that Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. This ensures continuity and completeness in the drawing record.

To learn more:

According to 35 U.S.C. 116, joint inventors can apply for a patent jointly even if:

  • They did not physically work together or at the same time
  • Each did not make the same type or amount of contribution
  • Each did not contribute to every claim of the patent

The MPEP states: 35 U.S.C. 116 recognizes the realities of modern team research. A research project may include many inventions. Some inventions may have contributions made by individuals who are not involved in other, related inventions. This reflects the flexibility in recognizing joint inventorship in collaborative research environments.

To learn more:

According to 37 CFR 1.45(c), for provisional applications:

  • Each named inventor must have contributed to the subject matter disclosed in the application.
  • The application is considered a joint application under 35 U.S.C. 116.

The MPEP clarifies: Because provisional applications may be filed without claims, 37 CFR 1.45(c) states that each inventor named in a joint provisional application must have made a contribution to the subject matter disclosed in the application. This ensures that all named inventors have contributed to the disclosed invention, even in the absence of formal claims.

To learn more:

To learn more:

If a request for issuance to an assignee is submitted after the issue fee has been paid, the following requirements must be met:

  1. Submit a request under 37 CFR 3.81(b)
  2. Include a request for a certificate of correction under 37 CFR 1.323
  3. Pay the fee for the certificate of correction (set forth in 37 CFR 1.20(a))
  4. Pay the processing fee (set forth in 37 CFR 1.17(i))
  5. State that the assignment was submitted for recordation before the patent was issued

As stated in MPEP 307: “If a request for issuance to an assignee pursuant to 37 CFR 3.81(b) is submitted after the day on which the issue fee is paid, the request under 37 CFR 3.81(b) must include a request for a certificate of correction under 37 CFR 1.323 (accompanied by the fee set forth in 37 CFR 1.20(a)) and the processing fee set forth in 37 CFR 1.17(i).”

For more information on Certificate of Correction, visit: Certificate of Correction.

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

Inventor signatures on patent applications must meet specific requirements to be considered valid:

  • The signature must be handwritten or an S-signature.
  • The name in the signature must match the name on the application.
  • For inventors with multiple surnames or given names, all names should be included in the signature.

The MPEP 602.08(b) states:

The signature of the inventor may be handwritten or an S-signature. See MPEP § 502.02, subsection II, and 37 CFR 1.4(d)(2). The name of each inventor should be printed or typed under the signature.

Additionally, for inventors with multiple names:

If the inventor has many given names, the Office will accept a signature including at least one given name and the family name.

Ensuring correct signatures is crucial for the validity of the patent application and to avoid potential issues during examination or enforcement.

To learn more:

When an inventor’s name contains non-English characters, there are specific requirements for how it should be presented in patent applications:

  • The name must be presented in both non-English characters and Roman letters.
  • A suggested English translation may be provided in parentheses, but is not required.

The MPEP Section 602.08(b) states:

If the inventor’s name is in a language other than English, then the inventor’s name must be presented in Roman letters and in parentheses with English translation, if it is known.

This ensures that the inventor’s name is accurately recorded while also being accessible to English-speaking examiners and the public.

To learn more:

To incorporate material from a prior-filed application under 37 CFR 1.57(b), several requirements must be met:

  1. The inadvertently omitted portion must be completely contained in the prior-filed application.
  2. A copy of the prior-filed application must be submitted (except for applications filed under 35 U.S.C. 111).
  3. If the prior-filed application is in a non-English language, an English language translation must be submitted.
  4. The applicant must identify where the inadvertently omitted portion can be found in the prior-filed application.

The MPEP states that an amendment may not comply with 37 CFR 1.57(b) if any of these conditions are not met. For example, it notes that non-compliance may occur if the inadvertently omitted portion is not completely contained in the prior-filed application or if applicant did not identify where the inadvertently omitted portion of the specification or drawings can be found in the prior-filed application.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

For more information on patent application requirements, visit: patent application requirements.

For more information on prior-filed application, visit: prior-filed application.

The U.S. Patent and Trademark Office (USPTO) allows the inclusion of copyright or mask work notices in design or utility patent applications under specific conditions:

  • The notice must be placed adjacent to the copyrighted or mask work material.
  • The content of the notice must be limited to elements required by law.
  • A specific authorization must be included at the beginning of the specification.
  • If included in drawings, the notice must comply with 37 CFR 1.84(s).

As stated in MPEP 608.01(w): The U.S. Patent and Trademark Office will permit the inclusion of a copyright or mask work notice in a design or utility patent application, and thereby any patent issuing therefrom, which discloses material on which copyright or mask work protection has previously been established, under the following conditions…

To learn more:

An inventor’s oath or declaration must properly identify the application to which it is directed. The MPEP provides several acceptable methods for identification:

  1. For oaths/declarations filed on the application filing date:
    • Inventor name(s) and reference to an attached specification
    • Inventor name(s) and attorney docket number from the specification
    • Inventor name(s) and title of the invention from the specification
  2. For oaths/declarations filed after the filing date:
    • Application number (series code and serial number)
    • Serial number and filing date
    • International application number
    • International registration number (for design applications)
    • Attorney docket number from the specification
    • Title of the invention with reference to an attached specification
    • Title of the invention with a cover letter identifying the application

The MPEP states: “37 CFR 1.63 requires that an oath or declaration identify the application (e.g., specification and drawings) to which it is directed.”

It’s important to accurately identify the application to ensure the oath or declaration is properly associated with the correct application and to prevent potential abandonment issues.

To learn more:

To file an application under pre-AIA 37 CFR 1.47(a) when at least one joint inventor is available, the following requirements must be met:

  • All available joint inventors must make an oath/declaration for themselves and on behalf of the nonsigning inventor
  • Proof that the nonsigning inventor cannot be found/reached after diligent effort or refuses to execute the application
  • The last known address of the nonsigning inventor must be stated

As stated in MPEP 409.03(a): In addition to other requirements of law (pre-AIA 35 U.S.C. 111(a) and 115), an application deposited in the U.S. Patent and Trademark Office pursuant to pre-AIA 37 CFR 1.47(a) must meet the following requirements…

To learn more:

To learn more:

What are the requirements for filing papers with the USPTO?

When filing papers with the United States Patent and Trademark Office (USPTO), it’s important to adhere to specific requirements:

  • Papers must be legibly written either by hand or printed in permanent dark ink or its equivalent.
  • They should be presented on flexible, strong, smooth, non-shiny, durable, and white paper.
  • All papers must be presented in a form having sufficient clarity and contrast between the paper and the writing to permit electronic reproduction by use of digital imaging and optical character recognition.

As stated in MPEP 501: All papers that are to become a part of the permanent records of the United States Patent and Trademark Office should be legibly written either by a typewriter or mechanical printer in permanent dark ink or its equivalent in portrait orientation on flexible, strong, smooth, non-shiny, durable, and white paper.

These requirements ensure that all documents can be properly processed and stored by the USPTO.

For more information on document legibility, visit: document legibility.

According to 37 CFR 1.55(g)(1), the claim for priority and the certified copy of the foreign application must be filed within the pendency of the application. The MPEP states:

“The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed within the pendency of the application, unless filed with a petition under paragraph (e) or (f) of this section, or with a petition accompanied by the fee set forth in § 1.17(g) which includes a showing of good and sufficient cause for the delay in filing the certified copy of the foreign application in a design application.”

This requirement applies to all applications and ensures that priority claims are properly documented before the application is granted.

To learn more:

According to MPEP 211, a petition to restore the benefit of a provisional application under 37 CFR 1.78(b) must include:

  1. The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed provisional application (unless previously submitted)
  2. The petition fee set forth in 37 CFR 1.17(m)
  3. A statement that the delay in filing the subsequent nonprovisional application or international application designating the United States within the twelve-month period was unintentional

The MPEP further states:

“The Director may require additional information where there is a question whether the delay was unintentional.”

It’s important to note that this petition must be filed in the subsequent application, not the provisional application itself.

For more information on patent procedure, visit: patent procedure.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

When filing a patent application with at least one unavailable joint inventor under pre-AIA 37 CFR 1.47(a), the following requirements must be met:

  • All available joint inventors must make an oath or declaration for themselves and on behalf of the nonsigning inventor.
  • Proof must be provided that the nonsigning inventor cannot be found or refuses to execute the application.
  • The last known address of the nonsigning inventor must be stated.

As stated in MPEP 409.03(a):

“An application deposited in the U.S. Patent and Trademark Office pursuant to pre-AIA 37 CFR 1.47(a) must meet the following requirements: (A) All the available joint inventors must (1) make oath or declaration on their own behalf as required by pre-AIA 37 CFR 1.63 or 1.175 […] and (2) make oath or declaration on behalf of the nonsigning joint inventor as required by pre-AIA 37 CFR 1.64.”

It’s important to note that this section is not applicable to applications filed on or after September 16, 2012.

To learn more:

The MPEP 201.06(c) outlines the requirements for filing a divisional or continuation application without an executed oath or declaration:

’37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a continuation or divisional application filed by all or by fewer than all of the inventors named in a prior nonprovisional application containing an oath or declaration as required by 37 CFR 1.63, provided that a copy of the executed oath or declaration filed in the prior application is submitted for the continuation or divisional application and the specification and drawings filed in the continuation or divisional application contain no matter that would have been new matter in the prior application.’

To file without a new oath or declaration:

  • Submit a copy of the executed oath or declaration from the prior application
  • Ensure the new application contains no new matter
  • File a copy of the specification and drawings from the prior application

This procedure allows for expedited filing while maintaining the integrity of the oath or declaration requirements.

To learn more:

To learn more:

The key requirements for filing a divisional application include:

  • The divisional application must be filed before the patenting or abandonment of the parent application.
  • It must claim only subject matter disclosed in the parent application.
  • It must be filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if it is a design application).
  • The inventorship must include at least one inventor named in the parent application.
  • It must claim the benefit of the parent application under 35 U.S.C. 120, 121, 365(c), or 386(c).

As stated in the MPEP:

The divisional application may be filed under 37 CFR 1.53(b) (or 37 CFR 1.53(d) if the application is a design application, but not an international design application). The inventorship in the divisional application must include at least one inventor named in the prior-filed application, and the divisional application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).

To learn more:

To file a delayed priority claim, you must submit a petition to accept an unintentionally delayed claim for priority. According to 37 CFR 1.55(e), the petition must include:

  1. The priority claim in an application data sheet
  2. A certified copy of the foreign application (unless exceptions apply)
  3. The petition fee
  4. A statement that the entire delay was unintentional

The MPEP states: A petition to accept a delayed claim for priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) must be accompanied by: (1) The priority claim […]; (2) A certified copy of the foreign application […]; (3) The petition fee […]; and (4) A statement that the entire delay […] was unintentional.

Filing a delayed benefit claim for a provisional application requires specific components. MPEP 211.04 outlines the requirements:

The petition must be accompanied by: (A) the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior provisional application (unless previously submitted); (B) a petition fee under 37 CFR 1.17(m); and (C) a statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the claim was filed was unintentional.

For petitions filed more than two years after the due date, additional explanation of the delay circumstances is required to establish that the entire delay was unintentional.

For more information on petition requirements, visit: petition requirements.

For more information on provisional application, visit: provisional application.

For more information on unintentional delay, visit: unintentional delay.

To file a Continued Prosecution Application (CPA), the following requirements must be met:

  • The application must be for a design patent
  • The prior application must be a complete design application as defined by 37 CFR 1.51(b)
  • The CPA must be filed before the earliest of:
    • Payment of the issue fee in the prior application
    • Abandonment of the prior application
    • Termination of proceedings in the prior application

Additionally, the CPA must include a request on a separate paper, identify the prior application, and be accompanied by the basic filing fee, search fee, and examination fee.

To learn more:

To file a valid Continued Prosecution Application (CPA) request for a design patent application, you must adhere to specific requirements outlined in 37 CFR 1.53(d). Key requirements include:

  • The request must be for a design application only.
  • The request must be submitted on a separate paper, as stated in MPEP ¶ 2.31: “because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.”
  • The application being continued must be a design application that is complete as defined by 37 CFR 1.51(b).

Failure to meet these requirements may result in the CPA request being deemed unacceptable.

To file a Continued Prosecution Application (CPA) in a design application, the following requirements must be met:

  • The application must be a design application.
  • The prior application must be a nonprovisional application.
  • The application must be filed before the earliest of:
    • Payment of the issue fee on the prior application, unless a petition under § 1.313(c) is granted in the prior application;
    • Abandonment of the prior application; or
    • Termination of proceedings on the prior application.

As stated in the MPEP 201.06(d): “A continuation or divisional application that is a nonprovisional application may be filed as a CPA under 37 CFR 1.53(d) if the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).”

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on filing requirements, visit: filing requirements.

To file a continuation-in-part (CIP) application, several requirements must be met according to MPEP 201.08 and 37 CFR 1.78:

  1. The CIP must be filed while the prior nonprovisional application is still pending (before patenting, abandonment, or termination of proceedings).
  2. The CIP must claim benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  3. The CIP must contain a specific reference to the prior application, including the application number.
  4. For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet (ADS).
  5. The CIP must have at least one common inventor with the prior application.

It’s important to note that a CIP can only be filed under 37 CFR 1.53(b) and cannot be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).

For more information on filing requirements, visit: filing requirements.

For more information on USPTO, visit: USPTO.

For continuation or divisional applications filed before September 16, 2012 under 37 CFR 1.53(b) (excluding continuation-in-part applications), applicants could file using a copy of the oath or declaration from the prior nonprovisional application. This is supported by the MPEP, which states:

“A continuation or divisional application filed before September 16, 2012 under 37 CFR 1.53(b) (other than a continuation-in-part (CIP)) may be filed with a copy of the oath or declaration from the prior nonprovisional application.”

This provision simplified the filing process for certain types of continuing applications by allowing the use of previously submitted documents.

To learn more:

For national stage applications under 35 U.S.C. 371, the requirements for filing a certified copy of a foreign application are outlined in 37 CFR 1.55(f)(2). The MPEP states:

A certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT in an international application entering the national stage under 35 U.S.C. 371.

If the certified copy was not filed during the international stage, it must be filed within the later of:

  • Four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f)
  • Four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage
  • Sixteen months from the filing date of the prior foreign application

Exceptions to these time limits are provided in paragraphs (h), (i), and (j) of 37 CFR 1.55.

To learn more:

To file a certificate of correction to perfect a foreign priority claim, you must meet the following requirements:

  1. The priority claim under 37 CFR 1.55 was timely filed in the application but was not included on the patent due to failure to provide a certified copy.
  2. A grantable petition under 37 CFR 1.55(f) or (g) must be filed, which includes:
    • The fee set forth in 37 CFR 1.17(g)
    • A showing of good and sufficient cause for the delay in filing the certified copy
  3. The correction must not require further examination.

As stated in the MPEP, Where the priority claim required under 37 CFR 1.55 was timely filed in the application but was not included on the patent because the requirement under 37 CFR 1.55 for a certified copy was not satisfied, the patent may be corrected to include the priority claim via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, accompanied by a grantable petition under 37 CFR 1.55(f) or, in the case of a design application, a grantable petition under 37 CFR 1.55(g).

To learn more:

To learn more:

What are the requirements for faxed assignment documents to be recorded at the USPTO?

For faxed assignment documents to be recorded at the USPTO, they must meet the following requirements:

  • The document must be legible and capable of being reproduced in legible form.
  • The fax must include a cover sheet with the sender’s name, address, and telephone number.
  • Payment of the recording fee must be included or authorized.
  • The fax should be sent to the specific fax number designated for assignment submissions.

As stated in MPEP 302.09: “The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.” This means that the fax transmission must be complete and received by the USPTO to be considered officially submitted.

To learn more:

What are the requirements for facsimile submission of assignment documents to the USPTO?

The USPTO has specific requirements for facsimile submission of assignment documents:

  • The facsimile must be legible and complete.
  • The document should be submitted to the Assignment Recordation Branch at the designated fax number.
  • A cover sheet must accompany the submission, stating the total number of pages, including the cover sheet.
  • The original document is not required unless specifically requested by the Office.

As stated in MPEP 302.09: “The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.”

To learn more:

For patent applications filed on or after September 16, 2012, an oath executed in a foreign country must meet specific requirements as outlined in 37 CFR 1.66. The MPEP states:

“An oath made in a foreign country may be made before any diplomatic or consular officer of the United States authorized to administer oaths, or before any officer having an official seal and authorized to administer oaths in the foreign country in which the applicant may be, whose authority shall be proved by a certificate of a diplomatic or consular officer of the United States, or by an apostille of an official designated by a foreign country which, by treaty or convention, accords like effect to apostilles of designated officials in the United States.”

In summary, the oath can be executed before a U.S. diplomatic or consular officer, or before an authorized foreign official with proper authentication.

To learn more:

To be entitled to priority under the PDX program, the following requirements must be met:

  1. The Office must receive a copy of the foreign application from the participating foreign intellectual property office within the pendency of the application and before the patent is granted, or
  2. The Office must receive a paper certified copy of the foreign application during that time period.

The MPEP states:

To be entitled to priority, the Office must receive a copy of the foreign application from the participating foreign intellectual property office within the pendency of the application and before the patent is granted, or receive a paper certified copy of the foreign application during that time period.

It’s crucial to note that if a certified copy is filed after the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.

What are the requirements for drawings in color?

Color drawings are not ordinarily permitted in utility and design patent applications. However, the USPTO will accept color drawings in utility and design patent applications if the following conditions are met:

  • The fee set forth in 37 CFR 1.17(h) is paid;
  • The specification contains the following language as the first paragraph of the brief description of the drawings: ‘The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.’
  • Color drawings must be of sufficient quality such that all details in the drawings are reproducible in black and white in the printed patent.

As stated in MPEP 608.02(b): ‘If color drawings are filed with the original application, it is not necessary to file a petition with the filing of the application. However, a petition and fee are required if color drawings are submitted after the original application papers are filed.’

To learn more:

Drawings are an essential part of many nonprovisional utility patent applications. According to MPEP 601, the requirements for drawings are as follows:

  • Drawings must be included in the application where necessary for the understanding of the subject matter to be patented.
  • The applicant must furnish a drawing where the nature of the case admits of it.
  • Drawings submitted after the filing date of the application may not be used to overcome any insufficiency of the specification due to lack of an enabling disclosure or otherwise inadequate disclosure therein.

The MPEP states: ‘Drawings submitted after the filing date of the application may not be used to overcome any insufficiency of the specification due to lack of an enabling disclosure or otherwise inadequate disclosure therein, or to supplement the original disclosure thereof for the purpose of interpretation of the scope of any claim.’

It’s important to include all necessary drawings at the time of filing to ensure a complete and enabling disclosure of the invention.

To learn more:

To learn more:

Drawing symbols in patent applications must adhere to specific requirements:

  • Symbols should be clear and legible.
  • The same part of an invention should be designated by the same reference character throughout the application.
  • Different parts should not be designated by the same reference character.
  • Reference characters not mentioned in the description will not be permitted in the drawings.

MPEP 608.02(b) states: “The drawing must show every feature of the invention specified in the claims.” This includes proper use of symbols and reference characters to clearly illustrate the invention.

For detailed guidelines on drawing symbols, refer to 37 CFR 1.84(p).

To learn more:

Drawing corrections in a patent application must comply with 37 CFR 1.121(d). Key requirements include:

  • Submitting replacement sheets that include all figures from the previous version, even if only one figure is amended
  • Labeling new sheets as ‘New Sheet’ and replacement sheets as ‘Replacement Sheet’ in the top margin
  • Explaining all changes in detail in the drawing amendment or remarks section
  • Including a marked-up copy of any amended drawing figure, labeled as ‘Annotated Sheet’, when required by the examiner

Applicants should note that the USPTO does not make drawing changes. It is the applicant’s responsibility to ensure drawings are corrected according to the provided instructions.

To learn more:

Dependent claims in patent applications must meet specific requirements as outlined in MPEP 608.01(i):

  • They must refer back to and further limit another claim or claims.
  • They must include all limitations of the claim to which they refer.
  • They must be more specific than the claim upon which they depend.

The MPEP states: ‘A claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed.’ This ensures that dependent claims properly narrow the scope of the invention and provide additional protection for specific embodiments.

To learn more:

To correct inventorship in a nonprovisional patent application filed on or after September 16, 2012, the following requirements must be met:

  • Submit a request to correct or change the inventorship
  • Include a signed application data sheet (ADS) that:
    • Identifies each inventor by their legal name
    • Provides the residence and mailing address of each inventor
    • Shows changes with underlining for insertions and strike-through or brackets for deletions
  • Pay the processing fee set forth in 37 CFR 1.17(i)

As stated in the MPEP: A request to correct the inventorship filed under 37 CFR 1.48(a) should identify the inventorship change and must be accompanied by a signed application data sheet (ADS) including the legal name, residence, and mailing address of the inventor or each actual joint inventor (see 37 CFR 1.76(b)(1)) and the processing fee set forth in 37 CFR 1.17(i).

To learn more:

Correcting inventorship in a nonprovisional application requires:

  • A request to correct inventorship under 37 CFR 1.48(a)
  • An application data sheet (ADS) identifying the inventorship change
  • A fee as set forth in 37 CFR 1.17(i)
  • A statement from each person being added or deleted as an inventor that the error occurred without deceptive intent

As stated in MPEP 602.01(c)(1): ‘If the inventive entity is set forth in error in an executed § 1.63 or § 1.64 declaration in a nonprovisional application, and such error arose without any deceptive intent on the part of the person named as an inventor in error or on the part of the person who through error was not named as an inventor, the inventorship of the nonprovisional application may be amended pursuant to 37 CFR 1.48(a).’

To learn more:

To learn more:

What are the requirements for corrected or substitute drawings in patent applications?

When submitting corrected or substitute drawings in patent applications, applicants must adhere to specific requirements set by the USPTO:

  • Corrected or substitute drawings must be labeled as ‘Replacement Sheet’ in the top margin.
  • Any changes to the drawings must be explained in either the drawing amendment or remarks section of the amendment paper.
  • All changes to the drawings should be identified with annotations on the drawing sheet.
  • New drawings must be labeled ‘New Sheet’.

As stated in MPEP 608.02(b): ‘Any replacement sheet of drawings must include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is amended. The figure or figure number of the amended drawing(s) must not be labeled as ‘amended.’ The requirement for corrected drawings will not be held in abeyance.’

It’s important to note that the USPTO may require corrected drawings if the submitted drawings do not meet the necessary standards. The MPEP states: ‘The USPTO will not release drawings for purposes of correction. If corrections are necessary, new corrected drawings must be submitted within the time set by the Office.’

To learn more:

What are the requirements for converting a provisional application to a nonprovisional application?

Converting a provisional application to a nonprovisional application requires meeting specific criteria and following certain procedures. According to MPEP 601.01(c), the key requirements are:

  1. Timing: The conversion must be requested within 12 months of the provisional application’s filing date.
  2. Request for Conversion: A request for the conversion must be submitted.
  3. Fee Payment: The basic filing fee for the nonprovisional application must be paid.
  4. Oath or Declaration: An oath or declaration as prescribed by 35 U.S.C. 115(a) must be submitted.
  5. Specification and Drawings: A specification and any drawings as prescribed by 35 U.S.C. 112 must be submitted, unless such items are already present in the provisional application.

The MPEP states:

“A request to convert a provisional application to a nonprovisional application must be accompanied by the fee set forth in 37 CFR 1.17(i) and an amendment including at least one claim as prescribed by 35 U.S.C. 112(b), unless the provisional application under 35 U.S.C. 111(b) already contains at least one claim.”

It’s important to note that if these requirements are not met, the application may be treated as an application filed under 35 U.S.C. 111(a) and given a filing date as of the date the request for conversion was filed.

To learn more:

When conducting interviews with inventors or assignees, examiners must adhere to specific requirements:

  • The practitioner of record must authorize and be present for the interview.
  • Inventors or assignees cannot participate without the practitioner’s presence.
  • Examiners should not conduct interviews directly with inventors or assignees alone.

According to the MPEP 408: ‘Interviews with inventors or assignees and/or their attorneys or agents of record must be authorized by the practitioners of record. The practitioner of record must be present and an examiner may not conduct an interview with an inventor or assignee unless the practitioner is present.’

For more information on patent examination, visit: patent examination.

For nonprovisional applications filed on or after December 18, 2013, the requirements for completion include:

  • Submitting the appropriate filing fee, search fee, and examination fee
  • Filing an inventor’s oath or declaration
  • For applications other than design applications, submitting at least one claim
  • Submitting any required drawings

The MPEP states: If an application which has been accorded a filing date does not include the appropriate filing fee, search fee, examination fee, or inventor’s oath or declaration, applicant will be so notified in accordance with 37 CFR 1.53(f) .

It’s important to note that for applications filed on or after September 16, 2012, the inventor’s oath or declaration can be postponed until the application is otherwise in condition for allowance, provided that a signed Application Data Sheet (ADS) identifying each inventor is submitted.

To learn more:

Color photographs in patent applications are subject to specific requirements. According to MPEP 608.01(f):

Color photographs will be accepted in utility and design patent applications if the conditions for accepting color drawings and black and white photographs have been satisfied.

To include color photographs in a patent application, you must:

  • Meet the conditions for accepting color drawings (petition, fee, and specific language in the specification)
  • Satisfy the requirements for black and white photographs (only practicable medium for illustrating the invention)
  • Ensure the photographs are of sufficient quality for reproduction in the printed patent

It’s important to note that color photographs are subject to the same restrictions and requirements as color drawings in patent applications.

To learn more:

Claiming the benefit of an international application (PCT application) in a U.S. national application has specific requirements. The MPEP states:

“Pursuant to 35 U.S.C. 365(c), a regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b) may claim the benefit of the filing date of an international application which designates the United States without completing the requirements for entering the national stage under 35 U.S.C. 371.”

Requirements for claiming benefit of an international application:

  • The international application must designate the United States
  • The international application must be entitled to a filing date in accordance with PCT Article 11
  • The later-filed U.S. application must be filed during the pendency of the international application
  • The U.S. application can be filed as a continuation, divisional, or continuation-in-part of the international application (often called a “bypass” application)

This allows applicants to claim the benefit of an international application’s filing date without completing the national stage entry process under 35 U.S.C. 371.

To claim the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the following requirements must be met:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (unless the benefit has been restored)
  • The provisional application must have at least one common inventor with the nonprovisional application
  • The provisional application must be entitled to a filing date and have paid the basic filing fee
  • If the provisional application was filed in a language other than English, an English translation and a statement that the translation is accurate must be filed

As stated in the MPEP: “When a later-filed application is claiming the benefit of a prior-filed provisional application under 35 U.S.C. 119(e), the nonprovisional application must be filed not later than 12 months after the date on which the provisional application was filed, unless the benefit of the provisional application has been restored.”

To claim the benefit of a prior application’s filing date, applicants must meet specific requirements. The MPEP ¶ 2.05 advises:

“Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

Key requirements include:

  • The application must be filed before the patenting or abandonment of the prior application.
  • The application must contain a specific reference to the prior application.
  • The application must have at least one common inventor with the prior application.
  • The application must disclose the invention claimed in the manner provided by 35 U.S.C. 112(a).

For more information on patent law, visit: patent law.

Tags: patent law

To claim priority to or benefit of a prior-filed application, the later-filed application must:

  • Contain a specific reference to the earlier-filed application
  • Be filed within the required time period
  • Include the priority or benefit claim in the application data sheet (for applications filed on or after September 16, 2012)

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, statutory provisions require that for a later-filed application to be entitled to the benefit of an earlier-filed national application, the later-filed application must contain a specific reference to the earlier-filed application.” (MPEP 210)

What are the requirements for claiming priority to a foreign application?

To claim priority to a foreign application, several requirements must be met:

  • The U.S. application must be filed within 12 months of the foreign application (or 6 months for design patents).
  • The foreign application must be from a country that grants similar privileges to U.S. applicants (Paris Convention member or WTO member).
  • The applicant must file a claim for priority and a certified copy of the foreign application.
  • As stated in MPEP 213: “The claim for priority and the certified copy of the foreign application specified in 35 U.S.C. 119(b) or PCT Rule 17 must, in any event, be filed before the patent is granted.”

It’s important to note that the subject matter claimed in the U.S. application must be adequately supported by the foreign application to receive the benefit of the earlier filing date.

To learn more:

The requirements for claiming priority to a foreign application under 37 CFR 1.55 include:

  • A claim for priority identifying the foreign application
  • For applications filed on or after September 16, 2012, the claim for priority must be in the application data sheet (ADS)
  • For applications filed before September 16, 2012, the claim for priority must be in the ADS or in the oath or declaration
  • Filing a certified copy of the foreign application within specified time periods
  • Meeting other requirements such as translations for non-English language applications

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, 35 U.S.C. 119(b)(1) requires a claim for priority identifying the foreign application. … Thus for all applications filed on or after September 16, 2012, a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) to the prior application must be presented in the application data sheet.”

The key requirements for claiming foreign priority under 37 CFR 1.55 include:

  • Filing a claim for priority in the application data sheet (for applications filed on or after September 16, 2012)
  • Filing the application within the required time period
  • Providing a certified copy of the foreign application
  • Providing an English translation if necessary

37 CFR 1.55(d) “contains provisions relating to the time for filing a priority claim in an application filed under 35 U.S.C. 111(a) and in an application entering the national stage under 35 U.S.C. 371” (MPEP 210)

For an international design application designating the United States, the requirements for claiming foreign priority are as follows:

  • The claim for priority can be made in accordance with the Hague Agreement and the Hague Agreement Regulations.
  • The claim must comply with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172.
  • Priority can be claimed with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

To learn more:

To claim foreign priority in a U.S. patent application, several requirements must be met as outlined in MPEP 213. These include:

  • Timely filing: The U.S. application must be filed within 12 months of the foreign application’s filing date (6 months for design patents)
  • Proper claim: The priority claim must be made in an application data sheet (ADS) or in the first sentence of the specification
  • Certified copy: A certified copy of the foreign application must be filed within the later of 4 months from the U.S. filing date or 16 months from the foreign filing date
  • English translation: If the foreign application is not in English, a translation may be required

As stated in MPEP 213, “The claim for priority must be presented in an application data sheet (37 CFR 1.76(b)(6)) or the specification must contain or be amended to contain a specific reference to the prior foreign application.” Failure to meet these requirements may result in the loss of the priority claim.

What are the requirements for claiming domestic benefit in a patent application?

Claiming domestic benefit in a patent application allows an applicant to rely on the filing date of an earlier-filed US application. The MPEP 216 outlines the requirements for claiming domestic benefit, which are based on 35 U.S.C. 120. The key requirements include:

  • The later-filed application must be filed before the patenting or abandonment of the prior application
  • The later-filed application must contain or be amended to contain a specific reference to the prior application
  • The prior application must disclose the invention claimed in the later-filed application in the manner required by 35 U.S.C. 112(a)
  • At least one inventor named in the later-filed application must have been named as an inventor in the prior application

The MPEP states:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application.’

It’s important to note that these requirements must be met for each application in the chain of priority, ensuring a continuous line of co-pendency and proper disclosure.

For more information on continuation application, visit: continuation application.

For more information on domestic benefit, visit: domestic benefit.

To claim benefit to a non-English language provisional application, you must provide:

  • An English translation of the non-English language provisional application
  • A statement that the translation is accurate

These documents must be filed in the provisional application itself. As stated in MPEP ¶ 2.38: “An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[…]”

Additionally, in the present (non-provisional) application, you must confirm that the translation and statement were filed in the provisional application.

For more information on non-English language, visit: non-English language.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

What are the requirements for claiming benefit of multiple prior-filed applications?

When claiming benefit of multiple prior-filed applications, specific requirements must be met. According to MPEP 211.01(b):

If a nonprovisional application claims the benefit of multiple prior-filed applications, the prior-filed applications need not be copending with each other provided that each prior-filed application is copending with the claiming application.

Key requirements include:

  • Each prior-filed application must be copending with the claiming application
  • The relationship between each prior-filed application and the claiming application must be specified
  • The benefit claim must be made within the time period set forth in 37 CFR 1.78

Additionally, the MPEP states:

There is no limit to the number of prior applications through which a chain of copendency may be traced to obtain the benefit of the filing date of the earliest of a chain of prior copending applications.

This means you can claim benefit through a chain of applications, as long as each link in the chain meets the copendency requirement with the subsequent application.

To learn more:

Tags: copendency

What are the requirements for claiming benefit of an international application in a U.S. national application?

To claim the benefit of an international application in a U.S. national application, certain requirements must be met. According to MPEP 211.01(c):

‘In order for a U.S. national application to be entitled to the benefit of the filing date of an international application, all the following conditions must be satisfied:

  • (A) The international application must designate the United States;
  • (B) The international application must have been filed on or after January 1, 1979;
  • (C) The international application must have been filed by a U.S. national or resident, or by a foreign national of a PCT member country;
  • (D) The U.S. national application must have been filed within the time period set forth in 35 U.S.C. 371(c); and
  • (E) The applicant in the U.S. national application must have complied with the requirements of 35 U.S.C. 371(c).’

These conditions ensure that the international application is properly linked to the U.S. national application and that all necessary procedural steps have been followed.

To learn more:

To learn more:

The requirements for claiming benefit of an earlier national application under 37 CFR 1.78 include:

  • A specific reference to the earlier-filed application in the later-filed application
  • For applications filed on or after September 16, 2012, the specific reference must be in the application data sheet (ADS)
  • For applications filed before September 16, 2012, the specific reference must be in the ADS or in the first sentence(s) of the specification
  • Meeting time requirements for filing the benefit claim
  • In some cases, providing a statement regarding the effective filing date of claims

The MPEP states: “Whether an application was filed before, on, or after March 16, 2013, statutory provisions require that for a later-filed application to be entitled to the benefit of an earlier-filed national application, the later-filed application must contain a specific reference to the earlier-filed application.”

Claiming the benefit of a provisional application has specific requirements, as outlined in MPEP 211.01(b):

“A nonprovisional application that directly claims the benefit of a provisional application under 35 U.S.C. 119(e) must be filed within 12 months from the filing date of the provisional application unless the benefit of the provisional application has been restored.”

Key points to remember:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • If filed after 12 months, the benefit of the provisional application must be restored (see 37 CFR 1.78(b)).
  • For indirect benefit claims through intermediate applications, the relationship between each application must be clearly identified.
  • Failure to properly indicate relationships may result in the benefit claim not being recognized, requiring a petition under 37 CFR 1.78(c) and payment of a fee.

Proper referencing and timing are crucial when claiming the benefit of provisional applications to ensure the desired priority date is secured.

To learn more:

When claiming benefit of a provisional application filed in a language other than English, additional requirements must be met. The MPEP states:

“If benefit is being claimed to a provisional application which was filed in a language other than English, (A) an English language translation of the provisional application, and (B) a statement that the translation is accurate, are required to be filed in the provisional application.”

If these documents were not filed in the provisional application, the applicant will be notified in the nonprovisional application and given a period to file them. Failure to timely respond may result in abandonment of the nonprovisional application.

Alternatively, the applicant may choose to delete the benefit claim to the provisional application from the Application Data Sheet (ADS) or, for applications filed before September 16, 2012, from the ADS or the first sentence(s) of the specification.

To learn more:

To claim the benefit of a prior-filed application in a continuation-in-part (CIP), several requirements must be met as outlined in MPEP 201.08 and 35 U.S.C. 120:

  • The CIP must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  • The CIP must contain or be amended to contain a specific reference to the earlier filed application.
  • For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet.
  • The CIP must have at least one common inventor with the prior-filed application.

Additionally, the MPEP notes:

“The continuation-in-part application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).”

It’s important to note that the USPTO does not typically scrutinize whether the earlier application fully supports the CIP’s claims unless this becomes relevant in a proceeding before the Office.

For more information on patent procedure, visit: patent procedure.

For more information on prior-filed application, visit: prior-filed application.

To claim the benefit of a prior-filed application in a continuation or continuation-in-part application, several requirements must be met:

1. The application must be filed before the patenting, abandonment, or termination of proceedings on the prior application.

2. The application must contain or be amended to contain a specific reference to the prior application. For applications filed on or after September 16, 2012, this reference must be in an application data sheet.

3. The application must have at least one common inventor with the prior application.

4. The application must comply with the requirements of 35 U.S.C. 120 and 37 CFR 1.78.

As stated in the MPEP: “An applicant in a nonprovisional application (including a nonprovisional application resulting from an international application or international design application), an international application designating the United States, or an international design application designating the United States may claim the benefit of one or more prior-filed copending nonprovisional applications, international applications designating the United States, or international design applications designating the United States under the conditions set forth in 35 U.S.C. 120, 121, 365(c), or 386(c) and this section.”

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP), applicants must meet specific requirements. According to MPEP ¶ 2.06:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

These requirements typically include:

  • Filing the CIP application while the prior application is still pending
  • Naming at least one inventor in common with the prior application
  • Including a specific reference to the prior application in the CIP
  • Ensuring the CIP application contains a substantial portion of the prior application’s disclosure
  • Complying with the time limits and procedures outlined in 37 CFR 1.78

It’s important to note that only the subject matter shared with the prior application will benefit from its earlier filing date. New matter added in the CIP will have the filing date of the CIP application.

What are the requirements for claim numbering in patent applications?

According to MPEP 608.01(m), claims in patent applications must be numbered consecutively in Arabic numerals. The MPEP states:

‘The claim or claims must commence on a separate physical sheet or electronic page and should appear after the detailed description of the invention. Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material. Though a claim may be presented on a separate sheet, such is not required.’

Additionally:

  • Claims should be arranged in order of scope, with the broadest claim presented first.
  • Claim numbers should be placed to the left of the claim text.
  • When claims are canceled, the remaining claims should not be renumbered.

To learn more:

To learn more:

What are the requirements for citing NPL documents in an IDS?

When citing Non-Patent Literature (NPL) documents in an Information Disclosure Statement (IDS), specific requirements must be met to ensure proper identification and consideration. According to MPEP 609.04(a):

“Each publication listed in an information disclosure statement must be identified by publisher, author (if any), title, relevant pages of the publication, date, and place of publication.”

The MPEP further clarifies:

  • For publications obtained from the Internet, the uniform resource locator (URL) of the Web page that is the source of the publication must be provided for the place of publication (e.g., “www.uspto.gov”).
  • The date of publication to be provided is the date the document was posted on the Internet. If no publication date is known, the applicant must specify in the IDS that no publication date is known.

Additionally:

  • For NPL not in the English language, a concise explanation of the relevance is required unless a complete translation is provided.
  • If citing a document that is only available as a scanned copy, include “(scanned copy)” after the document’s title in the citation.

Providing complete and accurate information for NPL citations helps examiners efficiently locate and consider these references during the examination process.

To learn more:

When citing foreign patent documents and non-English documents in an Information Disclosure Statement (IDS), the following requirements apply:

  1. For foreign patent documents:
    • Cite by document number, country, and publication or issue date
    • Provide a copy of each cited foreign patent document
  2. For non-English documents:
    • Provide a concise explanation of the relevance, as understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information, unless a complete translation is provided
    • Provide a written English language translation of the non-English language document, or portion thereof, if it is within the possession, custody, or control of, or is readily available to any individual designated in 37 CFR 1.56(c)

The MPEP states: “For non-English documents that are cited, the following must be provided: (a) A concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information, unless a complete translation is provided; and/or (b) A written English language translation of a non-English language document, or portion thereof, if it is within the possession, custody or control of, or is readily available to any individual designated in 37 CFR 1.56(c).”

To learn more:

What are the requirements for citing foreign language documents in an IDS?

When citing foreign language documents in an Information Disclosure Statement (IDS), applicants must adhere to specific requirements:

  • Provide a concise explanation of the relevance of the foreign language document.
  • Include a translation or portion of the document if it is within the possession, custody, or control of the individual filing the IDS.
  • The concise explanation may be either separate from the specification or part of the specification.
  • If the translation is submitted, indicate whether it is a machine translation or an English-language equivalent document.

MPEP 609.01 states: ‘When citing foreign language documents, the examiner should verify that the citation given on the IDS corresponds to the translation or English language abstract provided.’

Examiners should ensure that the requirements of 37 CFR 1.98(a)(3) are met for all foreign language documents cited in the IDS.

To learn more:

The requirements for certified copies in international design applications are as follows:

  • A certified copy of the foreign application is not required in an international design application.
  • The International Bureau obtains priority documents directly from offices participating in the Digital Access Service (DAS) or the Priority Document Exchange (PDX) program.
  • For offices not participating in DAS or PDX, the International Bureau will invite the applicant to submit the priority document.

According to MPEP 213.07: A certified copy of the foreign application is not required in an international design application designating the United States. The MPEP further explains: Where the foreign application was filed in a participating office, the International Bureau will attempt to obtain the priority document from the participating office. For participating offices that are not yet able to provide the priority documents to the International Bureau, the International Bureau will invite the applicant to submit the priority document.

To learn more:

What are the requirements for certificate of mailing or transmission?

The certificate of mailing or transmission is an important tool for securing a filing date with the USPTO. According to MPEP 502, the requirements are:

“The certification requires a signature. Specifically, if the certification is filed by a registered practitioner, it must be signed by that practitioner personally. 37 CFR 1.8(a)(2). If the certification is filed by an applicant, it must be signed by the applicant (except where an oath or declaration is not required, in which case the certification may be signed by a registered practitioner). 37 CFR 1.8(a)(2).”

Key points to remember:

  • The certificate must include the date of deposit or transmission.
  • It must be signed by the person mailing or transmitting the correspondence.
  • For registered practitioners, personal signature is required.
  • For applicants, their signature is required unless an oath/declaration is not needed.

Proper use of this certificate can help ensure your documents are considered timely filed, even if there are postal or transmission delays.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on Certificate of Transmission, visit: Certificate of Transmission.

For more information on USPTO correspondence, visit: USPTO correspondence.

Benefit claims can be made under various sections of the U.S. Code, each with specific requirements:

  • 35 U.S.C. 119(e): For provisional application benefits, refer to 37 CFR 1.78(a).
  • 35 U.S.C. 120: For benefit claims to earlier nonprovisional applications, including the relationship (continuation, divisional, or continuation-in-part).
  • 35 U.S.C. 121: For divisional applications.
  • 35 U.S.C. 365(c): For national stage applications claiming benefit to PCT applications.
  • 35 U.S.C. 386(c): For national stage applications claiming benefit to international design applications.

The MPEP states: “For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.”

It’s important to note that the specific requirements and time limits may vary depending on the type of benefit claim. Always refer to the latest version of the MPEP and the relevant U.S. Code sections for the most up-to-date information.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

An S-signature must meet the following requirements:

  • It must be inserted between two forward slash marks.
  • It can only consist of letters, Arabic numerals, or both, with appropriate spaces and punctuation.
  • The signer must insert their own S-signature.
  • For patent practitioners, the registration number must be included as part of or adjacent to the S-signature.
  • The signer’s name must be presented in printed or typed form, preferably immediately below or adjacent to the S-signature.

As stated in 37 CFR 1.4(d)(2)(i): “The S-signature must consist only of letters, or Arabic numerals, or both, with appropriate spaces and commas, periods, apostrophes, or hyphens for punctuation, and the person signing the correspondence must insert his or her own S-signature with a first single forward slash mark before, and a second single forward slash mark after, the S-signature.”

To learn more:

What are the requirements for an oath or declaration in a reissue application?

In a reissue application, the oath or declaration must comply with specific requirements outlined in MPEP 1414. The MPEP states:

“The reissue oath/declaration must include a statement that the applicant believes the original patent to be wholly or partly inoperative or invalid.”

Additionally, the oath or declaration must:

  • Identify at least one error being relied upon as the basis for reissue
  • State that all errors being corrected in the reissue application arose without any deceptive intention on the part of the applicant
  • Be signed by the inventor(s) or the assignee of the entire interest

It’s important to note that the requirements for a reissue oath or declaration are more stringent than those for a regular patent application due to the nature of reissue proceedings.

To learn more:

For applications filed before September 16, 2012, the requirements for an inventor’s oath or declaration are governed by pre-AIA 37 CFR 1.63. The oath or declaration must:

  1. Be executed (signed) in accordance with pre-AIA 37 CFR 1.66 or pre-AIA 37 CFR 1.68.
  2. Identify each inventor by full name, including family name and at least one given name, without abbreviation.
  3. Identify the country of citizenship of each inventor.
  4. State that the person making the oath or declaration believes the named inventor(s) to be the original and first inventor(s) of the subject matter claimed.
  5. State that the person making the oath or declaration has reviewed and understands the contents of the application, including the claims.
  6. Acknowledge the duty to disclose to the Office all information known to be material to patentability as defined in 37 CFR 1.56.

These requirements are different from those for applications filed on or after September 16, 2012, and it’s important to use the correct version of the oath or declaration based on the application’s filing date.

To learn more:

For an international design application to be used as a basis for claiming benefit, it must meet specific filing date requirements. MPEP § 211.01(d) states:

To obtain benefit of the filing date of a prior international design application designating the United States, the international design application must be entitled to a filing date in accordance with 37 CFR 1.1023. See 37 CFR 1.78(d)(1)(ii).

This means that the international design application must comply with the requirements set forth in 37 CFR 1.1023 to establish a valid filing date. These requirements typically include proper designation of the United States and adherence to other formal application standards.

For more information on filing date requirements, visit: filing date requirements.

For an Information Disclosure Statement (IDS) to be considered by the USPTO during the pendency of a patent application, it must meet three key requirements:

  1. Comply with the content requirements of 37 CFR 1.98
  2. Be filed in accordance with the procedural requirements of 37 CFR 1.97
  3. Be signed in compliance with 37 CFR 1.33(b)

The MPEP states: In order to have information considered by the Office during the pendency of a patent application, an information disclosure statement must be (1) in compliance with the content requirements of 37 CFR 1.98, (2) filed in accordance with the procedural requirements of 37 CFR 1.97 and (3) signed in compliance with 37 CFR 1.33(b).

Additionally, the use of form PTO/SB/08, ‘Information Disclosure Statement,’ is encouraged to provide the required list of information.

To learn more:

Tags: USPTO

An Information Disclosure Statement (IDS) filed within three months of the application filing date or before the mailing of a first Office action on the merits, whichever is later, has the following requirements:

  • No fee is required
  • No statement under 37 CFR 1.97(e) is needed
  • Must comply with the content requirements of 37 CFR 1.98

According to MPEP 609.04(b): An information disclosure statement filed within one of these periods requires neither a fee nor a statement under 37 CFR 1.97(e).

To learn more:

For an Information Disclosure Statement (IDS) filed after a final Office action, Notice of Allowance, or an Ex parte Quayle action, but before or with payment of the issue fee, the following is required:

  • A statement under 37 CFR 1.97(e), and
  • The fee set forth in 37 CFR 1.17(p)

According to MPEP 609.04(b): An information disclosure statement will be considered by the examiner if filed on or after the mailing date of any of the following: a final action under 37 CFR 1.113; a notice of allowance under 37 CFR 1.311; or an action that closes prosecution in the application, e.g., an Ex parte Quayle action, but before or simultaneous with payment of the issue fee, provided the statement is accompanied by: (A) a statement as specified in 37 CFR 1.97(e) (see the discussion in subsection V; and (B) the fee set forth in 37 CFR 1.17(p).

To learn more:

For an assignee to take action in a patent application filed on or after September 16, 2012, the following requirements must be met:

  • The assignee must be of the entire right, title, and interest in the application.
  • A statement under 37 CFR 3.73(c) must be filed in the application.
  • The statement must identify the assignee and establish the assignee’s ownership.

As stated in MPEP 325: “The assignee must establish its ownership of the entire right, title, and interest in an application in order to take action in that application.”

For more information on 37 CFR 3.73(c), visit: 37 CFR 3.73(c).

For an application to be considered a divisional, it must meet several requirements as outlined in MPEP ¶ 2.01:

  1. It must disclose and claim only subject matter disclosed in the prior application.
  2. It must claim subject matter that is independent and distinct from that claimed in the prior application.
  3. It must name the inventor or at least one joint inventor named in the prior application.

The MPEP states:

This application, which discloses and claims only subject matter disclosed in prior Application No.[1], filed [2], appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application, and names the inventor or at least one joint inventor named in the prior application.

Meeting these requirements helps ensure that the divisional application is properly derived from the prior application while claiming a distinct invention.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO, visit: USPTO.

According to 37 CFR 1.72(b), the requirements for an abstract in a patent application are:

  • It must commence on a separate sheet, preferably following the claims.
  • It should be under the heading ‘Abstract’ or ‘Abstract of the Disclosure’.
  • The sheet presenting the abstract should not include other parts of the application.
  • It should be concise, preferably not exceeding 150 words in length.
  • It should enable quick determination of the nature and gist of the technical disclosure.

The USPTO states: The abstract must be as concise as the disclosure permits, preferably not exceeding 150 words in length. The purpose of the abstract is to enable the Office and the public generally to determine quickly from a cursory inspection the nature and gist of the technical disclosure.

To learn more:

What are the requirements for adding a benefit claim to a prior-filed provisional application?

Adding a benefit claim to a prior-filed provisional application requires meeting specific criteria. According to MPEP 211.02(a):

“To add a benefit claim to a prior-filed provisional application, applicant must file a petition to accept a delayed claim under 37 CFR 1.78(c). The petition must be accompanied by:”

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78(a)(3) to the prior-filed provisional application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(a)(4) and the date the benefit claim was filed was unintentional.

Additionally, the nonprovisional application claiming the benefit must have been filed within 12 months of the provisional application’s filing date (or 14 months if an appropriate statement is made). If this time requirement is not met, a petition under 37 CFR 1.78(b) to restore the benefit of the provisional application must be filed.

For more details on the restoration of the right of priority, refer to MPEP 213.03.

To learn more:

In a continued prosecution application (CPA) filed under 37 CFR 1.53(d), there are specific rules regarding benefit claims. The MPEP states:

In a continued prosecution application (CPA) filed under 37 CFR 1.53(d), no amendment may delete the specific reference to a prior application assigned the same application number.

This is because in a CPA:

  • The request itself serves as the specific reference required by 35 U.S.C. 120 and 37 CFR 1.78 to every application assigned the same application number identified in the request.
  • A specific reference in the first sentence(s) of the specification following the title, or in an application data sheet, to a prior application assigned the same application number is not required and should not be made.

Therefore, when dealing with a CPA, it’s crucial to understand that the benefit claim to the prior application with the same application number is inherent in the CPA request itself and cannot be deleted. Any additional benefit claims would need to follow the standard procedures for adding benefit claims after filing.

To learn more:

To access USPTO public information facilities:

  • A valid Public User or Visitor’s badge is required
  • Badges can be obtained from the Office of Security next to the Public Search Facility
  • An On-line Service Card is required for access to all Public Search Facilities and on-line systems

MPEP 510 states: “A valid Public User or Visitor’s badge is required to enter USPTO facilities. This badge can be obtained from the Office of Security next door to the Public Search Facility located on the first floor of the Madison East Building, 600 Dulany Street, Alexandria, VA 22314.”

The requirements for accepting an unintentionally delayed claim for foreign priority include:

  1. Filing a petition to accept a delayed claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b).
  2. Submitting the priority claim in an application data sheet identifying the foreign application.
  3. Providing a certified copy of the foreign application, unless previously submitted or an exception applies.
  4. Paying the petition fee as set forth in 37 CFR 1.17(m).
  5. Submitting a statement that the entire delay between the date the priority claim was due and the date it was filed was unintentional.

The MPEP cites 37 CFR 1.55(e), which states: “A petition to accept a delayed claim for priority under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) must be accompanied by: (1) The priority claim under 35 U.S.C. 119(a) through (d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet (§ 1.76(b)(6)), identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, unless previously submitted; (2) A certified copy of the foreign application, unless previously submitted or an exception in paragraph (h), (i), or (j) of this section applies; (3) The petition fee as set forth in § 1.17(m); and (4) A statement that the entire delay between the date the priority claim was due under this section and the date the priority claim was filed was unintentional.” (37 CFR 1.55(e))

According to MPEP 608.02(b), drawings are considered either acceptable or unacceptable. The Office of Patent Application Processing (OPAP) will accept drawings if they are readable and reproducible for publication purposes. Additionally, examiners review drawings for:

  • Disclosure of the claimed invention
  • Proper use of reference numerals

The MPEP states: Drawings will be accepted by the Office of Patent Application Processing (OPAP) if the drawings are readable and reproducible for publication purposes.

To learn more:

A substitute statement in lieu of an oath or declaration must:

  • Comply with the requirements of 37 CFR 1.63, identifying the inventor or joint inventor with respect to whom a substitute statement is executed, and stating upon information and belief the facts which such inventor is required to state.
  • Identify the person executing the substitute statement and the relationship of such person to the inventor or joint inventor.
  • Identify the circumstances permitting the person to execute the substitute statement.
  • Include an acknowledgement that any willful false statement made in the substitute statement is punishable under 18 U.S.C. 1001 by fine or imprisonment of not more than 5 years, or both.

As stated in MPEP 604: ‘A substitute statement under 37 CFR 1.64 must: (1) Comply with the requirements of 37 CFR 1.63(a), identifying the inventor or joint inventor with respect to whom a substitute statement in lieu of an oath or declaration is executed, and stating upon information and belief the facts which such inventor is required to state.’

To learn more:

To learn more:

What are the requirements for a registered practitioner to obtain access to an application?

According to MPEP 405, a registered practitioner may obtain access to an application if they fulfill the following requirements:

  • The practitioner must be acting in a representative capacity
  • The practitioner must have proper authority from the applicant or attorney or agent of record
  • Written consent from the applicant, attorney, or agent of record must be provided

The MPEP states: ‘Access will be given to the entire application file history in the absence of a specific request from the authorizing party for only a portion of the file.’ This means that unless specified otherwise, the practitioner will be granted full access to the application file.

For more information on application access, visit: application access.

For more information on registered practitioner, visit: registered practitioner.

For more information on USPTO procedures, visit: USPTO procedures.

A provisional patent application requires a cover sheet with specific identifying information. According to the MPEP:

“A cover sheet providing identifying information is required for a complete provisional application. In accordance with 37 CFR 1.51(c)(1) the cover sheet must state that it is for a provisional application, it must identify and give the residence of the inventor or inventors, and it must give a title of the invention.”

The cover sheet must include:

  • Statement that it is for a provisional application
  • Inventor(s) identification and residence
  • Title of the invention
  • Name and registration number of the attorney or agent (if applicable)
  • Docket number (if applicable)
  • Correspondence address
  • Statement regarding federally sponsored research or development (if applicable)
  • Name of the government agency and contract number (if developed under a government contract)

For more details on provisional application requirements, refer to MPEP § 201.04.

To learn more:

According to MPEP 608.01(n), a proper dependent claim must meet the following requirements:

  1. It must contain a reference to a previous claim in the application.
  2. It must specify a further limitation of the subject matter claimed.
  3. It must include all the limitations of the claim from which it depends.

The MPEP states: “Following the statute, the test as to whether a claim is a proper dependent claim is that it shall include every limitation of the claim from which it depends and specify a further limitation of the subject matter claimed.”

If a dependent claim does not comply with these requirements, it may be rejected under 35 U.S.C. 112(d) as being of improper dependent form.

To learn more:

What are the requirements for a power of attorney to be valid in patent applications?

For a power of attorney to be valid in patent applications, it must meet the following requirements:

  • It must be signed by the applicant for patent (e.g., the inventor) or the assignee of the entire interest.
  • It must be in writing.
  • It must name one or more representatives to act on behalf of the principal.

As stated in MPEP 402.04: ‘The power of attorney must be signed by the applicant for patent (e.g., the inventor(s)) or the assignee of the entire interest of the applicant.’ This ensures that only authorized individuals can appoint representatives to act on behalf of the applicant or assignee in patent matters.

To learn more:

What are the requirements for a power of attorney in applications filed before September 16, 2012?

For applications filed before September 16, 2012, there are specific requirements for a valid power of attorney. According to MPEP 402.02(b):

“For applications filed before September 16, 2012, the power of attorney must be signed by (1) the applicant, where the inventor is the applicant, or (2) the assignee of the entire interest of the applicant.”

Additionally, the power of attorney must:

  • Be in writing
  • Name one or more attorneys or agents
  • Be signed by the applicant for patent (i.e., all of the inventors) or the assignee of the entire interest of the applicant

It’s important to note that for applications filed before September 16, 2012, a power of attorney may be incorporated in the oath or declaration form if the power of attorney is included in the same document.

To learn more:

A petition to restore the right of priority must include several key elements. The MPEP outlines these requirements:

A petition to restore the right of priority must include: (1) the priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) in an application data sheet, identifying the foreign application to which priority is claimed, by specifying the application number, country (or intellectual property authority), day, month, and year of its filing (unless previously submitted); (2) the petition fee set forth in 37 CFR 1.17(m); and (3) a statement that the delay in filing the subsequent application within the twelve-month period was unintentional.

These requirements ensure that the USPTO has all necessary information to consider your petition for priority restoration.

For more information on application data sheet, visit: application data sheet.

For more information on petition fee, visit: petition fee.

For more information on petition requirements, visit: petition requirements.

For more information on priority restoration, visit: priority restoration.

According to MPEP 214.02, a petition to accept an unintentionally delayed claim for priority requires the following:

  • The priority claim: This must be submitted in an application data sheet (ADS) as required by 35 U.S.C. 119(b), unless previously submitted.
  • The petition fee: As set forth in 37 CFR 1.17(m).
  • A statement of unintentional delay: A statement that the entire delay between the date the priority claim was due and the date the priority claim was filed was unintentional.

The MPEP states: ‘The Director may require additional information where there is a question whether the delay was unintentional.’ This means that in some cases, additional documentation may be required to support the claim of unintentional delay.

It’s important to note that these requirements apply to priority claims under various statutes, including 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), 386(a), 365(c), 119(e), 120, and 121.

To learn more:

To learn more:

What are the requirements for a patent practitioner to withdraw from representation?

A patent practitioner who wishes to withdraw from representation must follow specific procedures. According to MPEP 403.01(a): A registered patent practitioner acting in a representative capacity in an application filed on or after September 16, 2012, may not withdraw from representation in that application without leave of the Office.

The process for withdrawal typically involves:

  • Filing a request to withdraw as attorney or agent of record
  • Providing reasons for the withdrawal
  • Ensuring that the applicant is notified of the request
  • Obtaining Office approval before ceasing representation

For detailed instructions on the withdrawal process, refer to MPEP 402.06. It’s crucial to follow these procedures to ensure a proper transition and to maintain compliance with USPTO regulations.

To learn more:

The requirements for a patent application title are outlined in MPEP 606 and 37 CFR 1.72. The key points are:

  • The title should be placed at the top of the first page of the specification, unless provided in the application data sheet.
  • It should be brief but technically accurate and descriptive.
  • The title should contain fewer than 500 characters.
  • Certain words are not considered part of the title and will be deleted by the Office.

As stated in MPEP 606, “The title should be brief but technically accurate and descriptive and should contain fewer than 500 characters.” This ensures that the title is concise yet informative about the invention.

To learn more:

For nonprovisional utility patent applications filed on or after December 18, 2013, the requirements to receive a filing date are:

  • A specification
  • With or without claims

Prior to December 18, 2013, the requirements were:

  • A specification containing a description and at least one claim
  • Any drawing necessary under 35 U.S.C. 113

The USPTO states: Effective for applications filed on or after December 18, 2013, 37 CFR 1.53(b) was amended to implement the changes to 35 U.S.C. 111(a) and 35 U.S.C. 171 by the Patent Law Treaties Implementation Act of 2012 (PLTIA) (Public Law 112-211). 35 U.S.C. 111(a) now provides minimal formal requirements necessary for an application to be entitled to a filing date to safeguard against the loss of a filing date due to a technicality.

To learn more:

What are the requirements for a nonprovisional application to claim benefit of a provisional application?

For a nonprovisional application to successfully claim the benefit of a provisional application, several requirements must be met:

  • Timely filing: The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • Proper reference: The nonprovisional application must contain a specific reference to the provisional application.
  • Common inventor: At least one inventor named in the nonprovisional application must also be named in the provisional application.
  • Adequate support: The provisional application must provide adequate support for at least one claim in the nonprovisional application under 35 U.S.C. 112(a).

As stated in MPEP 211.01(a):

“For a claim in a subsequently filed nonprovisional application to be entitled to the benefit of the filing date of a provisional application, the provisional application must have at least one inventor in common with the nonprovisional application and must provide adequate support under 35 U.S.C. 112(a) for the subject matter of the claim.”

Meeting these requirements ensures that the nonprovisional application can properly claim the earlier filing date of the provisional application for the supported subject matter.

To learn more:

What are the requirements for a non-registered individual to obtain limited recognition?

For a non-registered individual to obtain limited recognition, several requirements must be met as outlined in MPEP 402.01:

  • The individual must be an attorney who is not registered to practice before the Office.
  • They must show that they are acting only as an attorney for a particular named applicant.
  • The attorney must be authorized to practice before a court of general jurisdiction of the state where they reside or are employed.
  • The OED Director must find that the attorney possesses the scientific and technical qualifications necessary to render valuable service to the applicant.
  • The attorney must apply for and be granted limited recognition by the OED Director.

It’s important to note that limited recognition is granted for a specific purpose and duration, and can be withdrawn by the OED Director at any time.

To learn more:

A new oath or declaration is required for a continuation-in-part (CIP) application, and it must acknowledge the duty to disclose information material to patentability as defined in 37 CFR 1.56.

MPEP 602.02 states: ‘A new oath or declaration is required in a continuation-in-part application, which includes subject matter not disclosed in the prior nonprovisional application. See MPEP § 201.08 and § 602.’

The new oath or declaration in a CIP application should:

  • Identify the application as a continuation-in-part
  • Acknowledge the duty to disclose material information
  • Cover the new subject matter introduced in the CIP
  • Be signed by all inventors, including any new inventors added due to the new subject matter

It’s important to ensure that the new oath or declaration complies with all requirements of 37 CFR 1.63 to avoid potential issues during prosecution.

To learn more:

To claim the benefit of an earlier filing date under 35 U.S.C. 120 and 119(e), a later-filed application must meet several requirements:

  • The prior-filed application must name the inventor or at least one joint inventor named in the later-filed application and must be entitled to a filing date
  • The prior-filed application must meet disclosure requirements under 35 U.S.C. 112(a) to support the claims in the later-filed application, except for the best mode requirement
  • The later-filed application must contain a specific reference to the prior-filed application
  • The reference to the prior application must be submitted within the time periods set forth in 37 CFR 1.78

For a design patent application to receive a filing date, it must include:

  • A specification as prescribed by 35 U.S.C. 112
  • At least one claim
  • Any required drawings

These requirements apply to design applications regardless of filing date. The USPTO states: The filing date for a design application, except for a continued prosecution application (CPA) under 37 CFR 1.53(d), is the date on which the specification as prescribed by 35 U.S.C. 112, including at least one claim, and any required drawings are received in the Office.

It’s important to note that unlike utility applications filed on or after December 18, 2013, design applications still require at least one claim to receive a filing date.

To learn more:

A complying Information Disclosure Statement (IDS) must meet the following requirements:

  • Content requirements as specified in 37 CFR 1.98
  • Timing requirements based on when the IDS is filed, as specified in 37 CFR 1.97

The MPEP states:

‘The information contained in information disclosure statements which comply with both the content requirements of 37 CFR 1.98 and the requirements, based on the time of filing the statement, of 37 CFR 1.97 will be considered by the examiner.’

When these requirements are met, the examiner will consider the documents in the same manner as other documents in Office search files during a proper field of search.

To learn more:

To learn more:

What are the requirements for a complete patent application?

A complete patent application must include the following elements:

  • Specification (including a description and claim(s))
  • Drawing(s) (when necessary)
  • Oath or declaration
  • Filing, search, and examination fees

As stated in MPEP 601.01: ‘The application for patent as filed must include a specification as prescribed by 35 U.S.C. 112, at least one claim as prescribed by 35 U.S.C. 112, and, in applications other than design applications, any drawing referred to in the specification or required by 35 U.S.C. 113.’ Additionally, the applicant must submit an oath or declaration and pay the necessary fees to complete the application.

To learn more:

An inventor’s oath or declaration must contain the following required statements:

  • The application was made or authorized to be made by the person executing the oath or declaration
  • The individual believes themselves to be the original inventor or an original joint inventor of a claimed invention in the application

These requirements are specified in 35 U.S.C. 115(b), which states:

An oath or declaration under subsection (a) shall contain statements that—(1) the application was made or was authorized to be made by the affiant or declarant; and (2) such individual believes himself or herself to be the original inventor or an original joint inventor of a claimed invention in the application.

Additionally, the oath or declaration must identify the inventor by their legal name and identify the application to which it is directed.

To learn more:

For nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 8, 2004, the following fees are required:

The MPEP states: The basic filing, search and examination fees are due on filing of the nonprovisional application under 35 U.S.C. 111(a). However, these fees may be paid later with a surcharge if paid within the time period set in 37 CFR 1.53(f).

To learn more:

According to MPEP 201.04, the required components of a provisional patent application are:

  • A specification as prescribed by 35 U.S.C. 112(a)
  • Any drawings required by 37 CFR 1.81(a)
  • A cover sheet as required by 37 CFR 1.51(c)(1), which may be an application data sheet, form SB/16, or a cover letter identifying the application as provisional

The MPEP states, No amendment, other than to make the provisional application comply with the patent statute and all applicable regulations, may be made to the provisional application after the filing date of the provisional application.

For more information on patent drawings, visit: patent drawings.

For more information on provisional application, visit: provisional application.

What are the reporting requirements for subject inventions under government contracts?

Contractors working on federally sponsored research and development projects have specific reporting requirements for subject inventions. According to MPEP 310:

“The contractor is required to disclose each subject invention to the Federal agency within two months after the inventor discloses it in writing to contractor personnel responsible for patent matters.”

Additionally, the contractor must:

  • Elect in writing whether or not to retain title to any subject invention within two years of disclosure.
  • File patent applications within one year after election (or prior to any statutory bar date).
  • Execute and promptly deliver instruments to confirm government rights.
  • Provide periodic reports on the utilization of the invention.

These requirements ensure proper documentation and protection of both the contractor’s and the government’s interests in inventions resulting from federally funded research.

For more information on federally sponsored research, visit: federally sponsored research.

Contractors have specific reporting requirements under the Bayh-Dole Act:

  • Disclose each subject invention to the Federal agency within 2 months after the inventor discloses it in writing to contractor personnel responsible for patent matters.
  • Elect in writing whether or not to retain title to any subject invention by notifying the Federal agency within 2 years of disclosure.
  • File patent applications within statutory deadlines.
  • Include a government support clause in patent applications.

The MPEP states: ‘The contractor is also required to submit periodic reports on the utilization of a subject invention or on efforts at obtaining such utilization that are being made by the contractor or its licensees or assignees.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

The USPTO recommends several methods for filing new patent applications, with some being more advantageous than others. According to MPEP 511, the recommended methods are:

  1. Electronic Filing System (EFS-Web or Patent Center): This is the most recommended method. As stated in MPEP 511: “In general, applicants should consider filing new patent applications (as well as patent-related correspondence) via the USPTO patent electronic filing system (EFS-Web or Patent Center) whenever permitted.”
  2. Priority Mail Express®: If not filing electronically, this is the next best option. MPEP 511 notes: “The Office strongly recommends that applicants file new applications by Priority Mail Express® in accordance with 37 CFR 1.10 (if such applications are not filed via EFS-Web) because such correspondence will be accorded the date of deposit in Priority Mail Express® with the USPS as the filing date.”
  3. Hand-delivery: Applications can be hand-delivered to the USPTO.
  4. First-class mail: While possible, this method carries risks of delay and is not recommended for new applications.

It’s important to note that new applications cannot be filed by facsimile. For more details on electronic filing, refer to the Legal Framework for Patent Electronic System on the USPTO website.

To learn more:

The USPTO strongly recommends the following methods for filing new patent applications:

  1. Electronic Filing System (EFS-Web or Patent Center): This is the preferred method whenever permitted.
  2. Priority Mail Express®: If not filing electronically, use this method in accordance with 37 CFR 1.10 to secure the date of deposit as the filing date.
  3. Hand-delivery to the USPTO office.

Avoid filing by first-class mail, as it only secures the date of receipt at the USPTO as the filing date, risking delays in delivery.

As stated in MPEP 511: “The Office strongly recommends that applicants file new applications by Priority Mail Express® in accordance with 37 CFR 1.10 (if such applications are not filed via EFS-Web) because such correspondence will be accorded the date of deposit in Priority Mail Express® with the USPS as the filing date.”

Additionally, “In general, applicants should consider filing new patent applications (as well as patent-related correspondence) via the USPTO patent electronic filing system (EFS-Web or Patent Center) whenever permitted.”

What are the recommended methods for checking application status?

The USPTO recommends several methods for checking application status:

  • Patent Application Information Retrieval (PAIR) system: This is the primary method for checking application status online. PAIR provides real-time access to the status of patent applications.
  • USPTO Call Center: For those who cannot access the Internet, the USPTO Call Center can provide status information.
  • Written requests: These should only be submitted if the application cannot be accessed through PAIR and the USPTO Call Center cannot provide the necessary information.

According to MPEP 203.08, ‘Applicants and their attorneys or agents are encouraged to use the PAIR system for checking patent application status.’

To learn more:

MPEP 213.01 lists several recognized regional patent offices for foreign filing. These include:

  • European Patent Office (EPO)
  • Eurasian Patent Office (EAPO)
  • African Intellectual Property Organization (OAPI)
  • African Regional Intellectual Property Organization (ARIPO)

Applications filed in these regional offices are considered as having been filed in all member states of the respective organizations. This allows applicants to seek patent protection in multiple countries through a single application process.

To learn more:

A patent application can be considered ‘abandoned’ for several reasons. According to MPEP 203.05, an abandoned application is one that is removed from the Office docket of pending applications due to:

  • Formal abandonment by the applicant or by the attorney or agent of record
  • Failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application
  • Failure to pay the issue fee
  • In the case of a provisional application, no later than 12 months after the filing date of the provisional application

It’s important for applicants to be aware of these reasons to avoid unintentional abandonment of their applications.

For more information on issue fee, visit: issue fee.

For more information on patent prosecution, visit: patent prosecution.

For more information on provisional application, visit: provisional application.

According to 37 CFR 11.116(b), a practitioner may withdraw from representing a client for several reasons, including:

  • Withdrawal can be accomplished without material adverse effect on the client’s interests
  • The client persists in a course of action the practitioner reasonably believes is criminal or fraudulent
  • The client has used the practitioner’s services to perpetrate a crime or fraud
  • The client insists on taking action the practitioner considers repugnant or fundamentally disagrees with
  • The client fails to fulfill an obligation regarding the practitioner’s services after reasonable warning
  • The representation results in an unreasonable financial burden or has been rendered unreasonably difficult by the client
  • Other good cause for withdrawal exists

It’s important to note that when requesting withdrawal, practitioners should be mindful of client confidentiality as required by 37 CFR 11.106. In cases involving sensitive reasons for withdrawal, practitioners should cite ‘irreconcilable differences’ and submit supporting evidence as proprietary material.

To learn more:

What are the procedures for transmitting secrecy order applications within the USPTO?

The transmission of secrecy order applications within the USPTO follows strict security protocols. MPEP 121 outlines these procedures:

  • Applications are hand-carried by authorized personnel
  • Transmittal slips are used to track the movement of applications
  • Applications must be signed for upon receipt

The MPEP emphasizes: ‘Classified material must be transmitted between offices in the Patent and Trademark Office in designated classified carriers.’ This ensures that secrecy order applications are always under secure control and their location is known at all times, minimizing the risk of unauthorized access or loss.

Former USPTO employees face restrictions on priority dates for patents they file after leaving the office. According to 35 U.S.C. 4:

‘In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.’

This means that for any patent application filed by a former USPTO employee, the earliest priority date they can claim is one year after their employment at the USPTO ended. This rule prevents former employees from using insider knowledge to gain an unfair advantage in the patent application process.

Filing a continuation-in-part (CIP) application can present several risks and potential drawbacks:

1. Different Effective Filing Dates: New matter in the CIP only gets the benefit of the CIP filing date, potentially exposing those claims to more prior art.

2. Reduced Patent Term: The patent term is measured from the filing date of the earliest application to which the CIP claims priority, potentially reducing the overall protection period for new matter.

3. Double Patenting Issues: Claims in the CIP may be subject to obviousness-type double patenting rejections based on the claims of the parent application.

4. Complexity in Litigation: The varying effective filing dates can complicate patent litigation, particularly when determining relevant prior art.

5. Difficulty in Claiming Priority: International applications may have difficulty claiming priority to a CIP due to the new matter.

While not explicitly stated in the provided MPEP section, these are important considerations derived from patent law and practice. The MPEP does note: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

Applicants should carefully consider these factors when deciding whether to file a CIP or a new application.

Violations of USPTO signature and certification requirements can result in serious consequences as outlined in 37 CFR 11.18(c) and (d):

  • Striking the offending paper
  • Referral to the Office of Enrollment and Discipline
  • Preclusion from submitting papers or contesting issues
  • Affecting the weight given to the offending paper
  • Termination of proceedings
  • Disciplinary action against practitioners

The MPEP states: “37 CFR 11.18(d) provides that any practitioner violating the provisions of 37 CFR 11.18 may also be subject to disciplinary action, thus clarifying that a practitioner may be subject to disciplinary action in lieu of, or in addition to, the sanctions set forth in 37 CFR 11.18(c) for violations of 37 CFR 11.18.”

Additionally, knowingly making false statements can lead to criminal penalties under 18 U.S.C. 1001.

To learn more:

The MPEP 602.08(c) warns about a serious potential consequence of misidentifying an application:

Further an oath or declaration attached to a cover letter referencing an incorrect application may not become associated with the correct application and, therefore, could result in the abandonment of the correct application.

This means that if you submit an oath or declaration with a cover letter that references the wrong application number or details, it might not be properly associated with the intended application. As a result, the correct application could be considered abandoned due to lack of a proper oath or declaration.

To avoid this issue, it’s crucial to double-check all application identifiers and ensure that cover letters, oaths, and declarations accurately reference the intended application. If you discover such an error, you should contact the USPTO promptly to rectify the situation and prevent unintended abandonment.

To learn more:

Unauthorized disclosure of patent application information can result in severe penalties for USPTO employees. According to the MPEP:

“Suspension, removal, and even criminal penalties may be imposed for violations of these statutes.”

The relevant statutes include 35 U.S.C. 122 and 18 U.S.C. 2071. Additionally, 18 U.S.C. 2071 states that individuals who willfully and unlawfully conceal, remove, mutilate, or destroy official documents may be:

  • Fined under this title
  • Imprisoned for up to three years
  • Disqualified from holding any office under the United States

These penalties underscore the critical importance of maintaining confidentiality in patent application handling.

For paper or facsimile submissions of patent assignment documents to the USPTO, the following requirements apply:

  • Either a copy of the original document or an extract of the original document must be submitted
  • Only one side of each page may be used
  • Paper size must be either 21.6 by 27.9 cm (8 1/2 inches by 11 inches) or 21.0 by 29.7 cm (DIN size A4)
  • A 2.5 cm (one-inch) margin must be present on all sides
  • The paper should be flexible, strong white, non-shiny, and durable

As stated in 37 CFR 3.24(b): For paper or facsimile submissions: Either a copy of the original document or an extract of the original document must be submitted for recording. Only one side of each page may be used.

To learn more:

When an inventor is unable to provide a statement due to death, incapacitation, or unavailability, MPEP 151 offers alternative solutions:

“When an inventor applicant is deceased or legally incapacitated, or where it is shown to the satisfaction of this Office that he or she refuses to furnish a statement or cannot be reached after diligent efforts, declarations or statements under oath setting forth the information required by the statutes may be accepted from an officer or employee of the assignee who has sufficient knowledge of the facts.”

Additionally, for joint inventions, “Where it is shown that one of the joint inventors is deceased or unavailable, a statement by all of the other inventor(s) may be accepted.” It’s important to note that these alternatives should only be used when the inventor is truly unavailable, not merely for convenience.

For more information on patent procedure, visit: patent procedure.

For continuing applications that claim the benefit of an earlier-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c), inventors have several options for submitting the required oath or declaration. According to 37 CFR 1.63(d):

A newly executed oath or declaration under § 1.63, or substitute statement under § 1.64, is not required under §§ 1.51(b)(2) and 1.53(f), or under §§ 1.497 and 1.1021(d), for an inventor in a continuing application that claims the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) in compliance with § 1.78 of an earlier-filed application, provided that an oath or declaration in compliance with this section, or substitute statement under § 1.64, was executed by or with respect to such inventor and was filed in the earlier-filed application, and a copy of such oath, declaration, or substitute statement showing the signature or an indication thereon that it was executed, is submitted in the continuing application.

This means that for a continuing application:

  • A new oath or declaration is not required if a compliant oath, declaration, or substitute statement was filed in the earlier application
  • A copy of the previously filed oath, declaration, or substitute statement can be submitted in the continuing application
  • The copy must show the signature or an indication that it was executed

However, any new joint inventor named in the continuing application must provide a new oath or declaration.

To learn more:

When an applicant chooses to accept a patent application as deposited without all the drawings, they have two main options:

  1. File an amendment to remove references to the missing drawings:
    • Submit replacement drawing sheets to renumber the figures consecutively
    • Amend the specification to remove references to omitted drawings and correct figure numbers
    • Ensure compliance with 37 CFR 1.121(d) for drawing changes and 37 CFR 1.121(b)(3) and 1.125 for specification changes
  2. File an amendment to add the missing figures by incorporation by reference:
    • Rely on 37 CFR 1.57(b) if the application claims priority to a prior-filed application containing the omitted portion
    • Submit new and replacement drawing sheets in compliance with 37 CFR 1.121(d)
    • Ensure no new matter is added, as prohibited by 35 U.S.C. 132(a)

The MPEP states: Applicant may accept the application as deposited in the USPTO by either: (1) filing an amendment including replacement drawing sheets… (2) filing an amendment to add the missing figure(s) by relying on an incorporation by reference under 37 CFR 1.57(b) or other portions of the original disclosure, without adding any new matter

To learn more:

What are the official USPTO mailing addresses for patent-related correspondence?

The United States Patent and Trademark Office (USPTO) has specific mailing addresses for different types of patent-related correspondence. According to the MPEP 502:

For regular mail:

  • Commissioner for Patents
    P.O. Box 1450
    Alexandria, VA 22313-1450

For hand-carried or EXPRESS MAIL:

  • U.S. Patent and Trademark Office
    Customer Service Window
    Randolph Building
    401 Dulany Street
    Alexandria, VA 22314

It’s important to use the correct address to ensure timely processing of your correspondence.

For more information on patent correspondence, visit: patent correspondence.

The official business hours of the U.S. Patent and Trademark Office (USPTO) are:

  • 8:30 a.m. to 5:00 p.m., Monday through Friday
  • Excluding federal holidays in the District of Columbia

As stated in MPEP 510: “The U.S. Patent and Trademark Office (USPTO or Office) working hours are 8:30 a.m. to 5:00 p.m., Monday through Friday, excluding federal holidays in the District of Columbia.”

Showing modified forms of construction in the same figure is objectionable under 37 CFR 1.84(h)(5). The MPEP section 608.02(f) provides a form paragraph (6.22.05) that examiners can use to object to such drawings:

“The drawings are objected to under 37 CFR 1.84(h)(5) because Figure [1] show(s) modified forms of construction in the same view.”

This objection is made to ensure clarity in patent drawings and to prevent confusion between different forms or modifications of the invention. Applicants are required to submit corrected drawing sheets in compliance with 37 CFR 1.121(d) to address this objection.

To learn more:

To learn more:

The USPTO provides normal corrective procedures for assignment records, which are outlined in MPEP 323.01(a) through 323.01(c). These procedures are typically the first course of action for addressing issues in assignment records. The expungement process, as described in MPEP 323.01(d), is only considered when:

the normal corrective procedures outlined in MPEP § 323.01(a) through § 323.01(c) will not provide the petitioner with adequate relief

The normal corrective procedures may include:

  • Filing a corrective document
  • Requesting a correction to the cover sheet
  • Submitting evidence to correct clerical errors

It’s important for patent applicants and attorneys to be familiar with these procedures and to exhaust these options before considering a petition for expungement.

To learn more:

According to MPEP 602.08(c), there are three acceptable combinations of information for identifying a patent application in an oath or declaration filed on the application filing date:

  • Name of inventor(s) and reference to an attached specification or application
  • Name of inventor(s) and attorney docket number on the specification as filed
  • Name of inventor(s) and title of the invention on the specification as filed

The MPEP states: Filing dates are granted on applications filed without an inventor’s oath or declaration in compliance with 37 CFR 1.63. This means that an application can receive a filing date even if the oath or declaration is not initially included.

To learn more:

Tags: declaration, oath

There are two primary methods for requesting the deletion of a named inventor in a Continued Prosecution Application (CPA) for design applications:

  • Letter to the examiner: You can submit a letter directly to the patent examiner handling your application.
  • Request for corrected filing receipt: You can file a formal request for a corrected filing receipt with the USPTO.

These methods are outlined in MPEP § 201, ¶ 2.32, which states:

In a continued prosecution application (CPA) for a design application (37 CFR 1.53(d)), a request to delete a named inventor from the prior application may be submitted by way of a letter to the examiner or a request for corrected filing receipt.

It’s important to note that this procedure is specific to design applications and is not applicable to utility patents.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent examination, visit: patent examination.

For more information on USPTO procedures, visit: USPTO procedures.

What are the margin requirements for patent application documents?

When preparing documents for a patent application, it’s crucial to adhere to specific margin requirements set by the USPTO:

  • The top margin of the first page should be at least 2 cm (3/4 inch).
  • All other margins (left, right, and bottom) must be at least 2 cm (3/4 inch).
  • The margins can be slightly larger but should not exceed 4 cm (1-1/2 inches).

According to MPEP 501: All of the application papers must have margins which are at least 2 cm. (3/4 inch) … on the sides, top and bottom. Margins should not exceed 4 cm. (1-1/2 inches). … The top margin of the first page should be at least 2 cm. (3/4 inch).

These margin requirements ensure that all information is visible and can be properly scanned and processed by the USPTO.

MPEP 507 outlines specific requirements for margins and paper size in patent drawings:

Each sheet must include a top margin of at least 2.5 cm. (1 inch), a left size margin of at least 2.5 cm. (1 inch), a right size margin of at least 1.5 cm. (5/8 inch), and a bottom margin of at least 1.0 cm. (3/8 inch). The size of the sheets on which drawings are made must be either 21.0 cm. by 29.7 cm. (DIN size A4) or 21.6 cm. by 27.9 cm. (8-1/2 by 11 inches);

These requirements are based on 37 CFR 1.84(f) and (g). Adhering to these specifications ensures that the drawings can be properly scanned and reproduced in the patent publication process.

The MPEP 201 outlines several main types of patent applications:

  • Nonprovisional applications for patent
  • Provisional applications for patent
  • International applications
  • Design applications
  • Plant applications
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

Each type serves a specific purpose in the patent application process and has its own requirements and procedures.

For more information on divisional, visit: divisional.

For more information on patent applications, visit: patent applications.

For more information on reissue, visit: reissue.

There are several types of patent applications in the United States:

  • Nonprovisional applications filed under 35 U.S.C. 111(a), including utility, plant, and design patent applications
  • Provisional applications filed under 35 U.S.C. 111(b)
  • International applications filed under the Patent Cooperation Treaty (PCT)
  • International design applications filed under the Hague Agreement

The MPEP states: Applications filed under 35 U.S.C. 111(a) include original nonprovisional utility, plant, design, divisional, continuation, and continuation-in-part applications filed under 37 CFR 1.53(b), reissue applications filed under 37 CFR 1.53(b), and design patent continued prosecution applications (CPAs) filed under 37 CFR 1.53(d).

For more information on Hague Agreement, visit: Hague Agreement.

For more information on international applications, visit: international applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent applications, visit: patent applications.

The main types of national applications under U.S. patent law are:

  • Original (non-provisional) applications
  • Provisional applications
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

As stated in MPEP 201.01: National applications include original (non-provisional), provisional, plant, design, reissue, divisional, and continuation applications (which may be filed under 37 CFR 1.53(b)), as well as continuation-in-part applications (which may be filed under 37 CFR 1.53(b)).

For more information on patent law, visit: patent law.

For more information on USPTO, visit: USPTO.

To learn more:

According to MPEP 203.05, there are four main reasons for patent application abandonment:

  1. Formal abandonment by the applicant or their representative
  2. Failure of the applicant to take appropriate action during prosecution
  3. Failure to pay the issue fee
  4. For provisional applications, the passage of 12 months from the filing date

The MPEP states: An abandoned application is, inter alia, one which is removed from the Office docket of pending applications: (A) through formal abandonment by the applicant or by the attorney or agent of record; (B) through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application; (C) for failure to pay the issue fee (MPEP § 711 to § 711.05); or (D) in the case of a provisional application, no later than 12 months after the filing date of the provisional application.

A nonprovisional patent application filed under 35 U.S.C. 111(a) must include several key components. According to the MPEP, these include:

The MPEP states: Such application shall include— (A) a specification as prescribed by section 112; (B) a drawing as prescribed by section 113; and (C) an oath or declaration as prescribed by section 115.

It’s important to note that while claims and drawings are not required for obtaining a filing date (except for design applications), they are necessary for a complete application and must be submitted to avoid abandonment.

For more information on filing requirements, visit: filing requirements.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent drawings, visit: patent drawings.

A complete nonprovisional patent application filed under 35 U.S.C. 111(a) comprises the following components:

  • A specification, including claims, as prescribed by 35 U.S.C. 112
  • Drawings as prescribed by 35 U.S.C. 113
  • An oath or declaration as prescribed by 35 U.S.C. 115
  • The prescribed filing fee, search fee, examination fee, and application size fee

As stated in the MPEP: “A complete application filed under 35 U.S.C. 111(a) comprises a specification, including claims, as prescribed by 35 U.S.C. 112, drawings as prescribed by 35 U.S.C. 113, an oath or declaration as prescribed by 35 U.S.C. 115, and the prescribed filing fee, search fee, examination fee and application size fee.”

To learn more:

What are the line spacing requirements for patent application text?

When preparing the text for your patent application, it’s important to follow the USPTO’s line spacing requirements:

  • The text should be written in a nonscript type font (e.g., Arial, Times Roman, or Courier).
  • The lettering style should be at least 0.32 cm (1/8 inch) high.
  • The lines of text should be 1.5 or double spaced.

According to MPEP 501: The text must be written in a nonscript type font (e.g., Arial, Times Roman, or Courier, preferably a font size of 12) lettering style having capital letters which should be at least 0.32 cm. (1/8 inch) high, but may be no smaller than 0.21 cm. (3/32 inch) high (e.g., a font size of 6). The lines of the specification may be 1 1/2 or double spaced.

These requirements ensure that the text is easily readable and can be properly scanned and processed by the USPTO’s systems.

An e-IDS has specific limits on the number of references that can be included. According to MPEP 609.07:

An individual e-IDS may contain a listing of (1) a combined total of 50 U.S. patents and U.S. patent application publications, (2) 50 foreign patent documents, and (3) 50 NPLs. Applicants are permitted to file more than one e-IDS if these numbers are exceeded.

If you need to submit more references than these limits allow, you can file multiple e-IDSs. However, be aware of potential fee implications if submitting multiple e-IDSs that require a fee under 37 CFR 1.17(p).

To learn more:

The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) have specific limitations when it comes to petitions for filing dates. According to MPEP 511:

“Applicants are cautioned that the provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) only apply to postal interruptions and emergencies. The provisions of 35 U.S.C. 21(a) and 37 CFR 1.10(g) to (i) do not provide for granting of a filing date to correspondence as of the date on which it would have been filed but for other exigencies, such as the unavailability of a computer or word processing equipment, or the inaccessibility of an office or building other than a USPS facility.”

This means that these provisions are strictly limited to postal service interruptions or emergencies. They cannot be used for other circumstances that may have prevented timely filing, such as:

  • Computer or equipment failures
  • Office or building inaccessibility (unless it’s a USPS facility)
  • Personal emergencies or other non-postal related issues

Additionally, the statute requires that the correspondence was complete and ready to be deposited with the USPS on the requested filing date, and that the sole reason for non-deposit was the unavailability of postal service due to the designated interruption or emergency.

To learn more:

Limited recognition in patent matters comes with several restrictions:

  • Scope limitation: As stated in 37 CFR 11.9(a), ‘Limited recognition under this paragraph shall not extend further than the application or applications specified.’
  • Duration for nonimmigrant aliens: According to 37 CFR 11.9(b), ‘Limited recognition shall be granted for a period consistent with the terms of authorized employment or training.’
  • Geographical restrictions: The same regulation states, ‘Limited recognition shall not be granted or extended to a non-United States citizen residing abroad.’
  • Automatic expiration: For nonimmigrant aliens, ‘Limited recognition shall automatically expire upon the nonimmigrant alien’s departure from the United States.’

These limitations ensure that limited recognition is granted only for specific circumstances and does not provide the same broad authority as full registration as a patent practitioner.

To learn more:

Provisional and nonprovisional patent applications have several key differences:

  • Claims: Nonprovisional applications require claims, while provisional applications do not. As stated in the MPEP, “Unlike an application filed under 35 U.S.C. 111(a) which requires claims before examination, a provisional application does not require claims.”
  • Oath or Declaration: Nonprovisional applications require an oath or declaration, while provisional applications do not. The MPEP notes, “Furthermore, no oath or declaration is required.”
  • Examination: Nonprovisional applications undergo substantive examination, while provisional applications do not.
  • Information Disclosure Statement: Provisional applications should not include an information disclosure statement, unlike nonprovisional applications. The MPEP states, “Unlike applications filed under 35 U.S.C. 111(a), provisional applications should not include an information disclosure statement.”
  • Cover Sheet: Provisional applications require a specific cover sheet with identifying information, which is not required for nonprovisional applications.

For more details on provisional applications, refer to MPEP § 201.04.

To learn more:

Continued Prosecution Applications (CPAs) have several key differences from regular continuation applications filed under 37 CFR 1.53(b):

  • CPAs are only available for design applications, not utility or plant applications
  • CPAs use the same application number as the prior application
  • CPAs do not require a new specification or drawings to be filed
  • The filing requirements for a CPA are minimal compared to a regular continuation
  • CPAs are typically processed faster than regular continuations
  • Filing a CPA automatically abandons the prior application

MPEP 201.06(d) states: A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

For more information on USPTO procedures, visit: USPTO procedures.

While both continuation and continuation-in-part (CIP) applications are related to a prior application, there are key differences:

  • Continuation: Repeats the entire disclosure of the prior application without adding new matter.
  • Continuation-in-Part (CIP): According to MPEP ¶ 2.06, a CIP “repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application.”

The main difference is that a CIP introduces new subject matter not present in the original application. This new matter receives the filing date of the CIP, while the repeated portions may claim the earlier filing date of the prior application if properly claimed under 35 U.S.C. 120.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

A valid inventor’s oath or declaration must include several key components as outlined in the MPEP:

  1. Inventor bibliographic information (see MPEP § 602.08(a))
  2. The name of the inventor or each joint inventor
  3. Signatures of each inventor, except as otherwise provided
  4. Identification of the application to which it is directed

The MPEP states: The inventor’s oath or declaration must include certain inventor bibliographic information (see MPEP § 602.08(a)), name the inventor or each joint inventor and except as otherwise provided be signed by each inventor (see MPEP § 602.08(b)), and identify the application to which it is directed (see MPEP § 602.08(c)).

It’s important to ensure all these elements are present and correct to avoid potential issues with the patent application process.

To learn more:

A divisional application has several key characteristics as outlined in MPEP ¶ 2.01:

  1. Independent and Distinct Subject Matter: It ‘appears to claim only subject matter directed to an invention that is independent and distinct from that claimed in the prior application.’
  2. Disclosure in Prior Application: It ‘discloses and claims only subject matter disclosed in prior Application No.[1],filed[2].’
  3. Inventor Continuity: It ‘names the inventor or at least one joint inventor named in the prior application.’
  4. Potential Benefit Claim: It may claim the benefit of the filing date of the prior application, subject to meeting certain requirements.

These characteristics ensure that divisional applications properly separate distinct inventions while maintaining a connection to the original disclosure and inventorship.

For more information on Divisional application, visit: Divisional application.

The inventorship requirements for claiming foreign priority are specific and important. Here are the key points:

  • The U.S. and foreign applications must name the same inventor or have at least one joint inventor in common.
  • Priority rights do not exist if the foreign and U.S. applications have completely different sole inventors.
  • Joint inventors can each claim the benefit of their separately filed foreign applications.

The MPEP clarifies: Consistent with longstanding Office policy, this is interpreted to mean that the U.S. and foreign applications must name the same inventor or have at least one joint inventor in common. This requirement ensures a direct connection between the foreign priority application and the U.S. application claiming its benefit.

To learn more:

What are the income limitations for qualifying as a micro entity?

To qualify as a micro entity based on income, an applicant’s gross income in the previous calendar year must not exceed three times the median household income as reported by the Bureau of the Census. The MPEP states:

“The income limit is not described in terms of a specific dollar amount because median household income may change from year to year.” (MPEP 509.04(a))

For the most current income threshold, applicants should check the USPTO’s website or consult with a patent attorney. It’s important to note that this limit applies to each applicant, inventor, and joint inventor who is named in the application.

To learn more:

What are the income limitations for micro entity status?

To qualify for micro entity status, an applicant’s income must not exceed three times the median household income as reported by the Bureau of the Census. According to USPTO’s 2022 notice, the income limit is $206,109. The MPEP states:

“[A]n applicant qualifies as a micro entity if the applicant’s gross income in the previous calendar year does not exceed the ‘maximum qualifying gross income’ which is set to three times the median household income as reported by the Bureau of the Census.” (MPEP 509.04(a))

It’s important to note that this limit is subject to change, and applicants should check the latest USPTO notices for the most current information.

To learn more:

Failing to properly claim benefit in a potential continuation-in-part (CIP) application can have significant implications for patent protection. The MPEP cautions: This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established. (MPEP ¶ 2.06)

Implications of not properly claiming benefit include:

  • Loss of earlier filing date for common subject matter, potentially affecting patentability
  • Increased vulnerability to prior art that could have been excluded with the earlier filing date
  • Possible issues with patent term calculation
  • Risk of unintentionally abandoning the application if statutory deadlines are missed

To avoid these issues, applicants should carefully follow the requirements outlined in 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq when filing a CIP application.

For more information on prior art, visit: prior art.

Tags: prior art

Deleting a benefit claim from your patent application can have several important implications:

  • Prior Art Considerations: The examiner will reassess whether any new prior art may now be available due to the change in effective filing date.
  • Publication Date: As stated in the MPEP, A deletion of a benefit claim will not delay the publication of the application unless the amendment or ADS is recognized by the Office within nine weeks prior to the projected publication date that was originally calculated based on the benefit claim.
  • Intentional Waiver: The MPEP warns that A cancellation of a benefit claim to a prior application may be considered as a showing that the applicant is intentionally waiving the benefit claim to the prior application in the instant application. This could affect future attempts to reinstate the benefit claim.
  • Examination Status: If the deletion is submitted after final rejection or allowance, it will be treated under special rules (37 CFR 1.116 or 37 CFR 1.312, respectively).

It’s crucial to carefully consider these implications before deciding to delete a benefit claim. If you’re unsure about the consequences, it’s advisable to consult with a patent attorney or agent.

To learn more:

Claiming benefit under these statutes allows an application to receive the earlier filing date of a prior-filed application, which can be crucial for establishing priority and overcoming prior art. However, this claim also requires that the application does not contain new matter.

The MPEP ¶ 2.10.01 states:

“This form paragraph should be used when an application, which claims the benefit of a prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c) contains new matter relative to the prior-filed application, and purports to be a ‘continuation,’ ‘division,’ or ‘divisional application’ of the prior-filed application.”

If new matter is found, the applicant may need to change the application type or remove the benefit claim to maintain the new subject matter.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on new matter, visit: new matter.

The Public Search Facility in Alexandria has extended hours compared to the regular USPTO business hours:

  • 8:00 a.m. to 8:00 p.m., Monday through Friday
  • Excluding federal holidays in the District of Columbia

As stated in MPEP 510: “The hours for the Public Search Facility in Alexandria are 8:00 a.m. to 8:00 p.m., Monday through Friday, excluding federal holidays in the District of Columbia.”

What are the guidelines for submitting drawings on recycled paper?

The USPTO has specific guidelines for submitting drawings on recycled paper:

  • Recycled paper is acceptable for patent application drawings.
  • The paper must meet the requirements for archival quality and durability.
  • It should not have any imperfections that would interfere with the clarity of the drawing.

According to MPEP 608.02: ‘Drawings submitted to the Office must be made on paper which is flexible, strong, white, smooth, non-shiny, and durable.’

While recycled paper is allowed, it’s crucial to ensure that it meets all the necessary quality standards to avoid potential issues with the examination process or long-term storage of the patent documents.

To learn more:

The MPEP provides specific guidelines for status inquiries in patent applications:

  • Status inquiries are encouraged to be made via the Patent Application Information Retrieval (PAIR) system at https://www.uspto.gov/patents/apply/checking-application-status/check-filing-status-your-patent-application.
  • If PAIR is unavailable or the inquiry cannot be answered by PAIR, applicants can contact the Technology Center (TC) customer service center.
  • The MPEP states: Applicants and other individuals with limited Internet access may contact the TC customer service center at (571) 272-3900.
  • For reexamination proceedings, status inquiries should be directed to the Central Reexamination Unit (CRU) at (571) 272-7705.

It’s important to follow these guidelines to ensure efficient processing of status inquiries.

To learn more:

Tags: PAIR system

The MPEP 608.01(i) provides specific guidelines for numbering claims in a patent application:

  • Claims must be numbered consecutively in Arabic numerals.
  • The claim number should be placed to the left of the claim.
  • If claims are amended, all claims should be renumbered consecutively.

The MPEP states: ‘The claim or claims must commence on a separate physical sheet or electronic page and should appear after the detailed description of the invention.’ This numbering system ensures clarity and easy reference to specific claims throughout the examination process.

To learn more:

Correcting or adding drawings after a patent application is filed is addressed in MPEP 608.02, subsection II. The key points are:

  • Drawings can be corrected, revised, or added if no new matter is introduced.
  • The applicant must submit a proposed drawing correction in reply to the Office action.
  • For non-provisional applications, replacement sheets of corrected drawings must be submitted.
  • For provisional applications, corrected drawings may be submitted as an amendment to the application.

The MPEP states: ‘Where a drawing is to be amended, applicant must submit a replacement sheet of drawings which complies with 37 CFR 1.84 and includes all of the figures appearing on the original version of the sheet, even if only one figure is being amended.’ This ensures that the entire drawing set remains consistent and complete.

To learn more:

Proper claim indentation is important for clarity and readability in patent applications. The MPEP 608.01(m) provides specific guidelines:

  • Each claim should start with a capital letter and end with a period.
  • Steps or elements within a claim should be separated by line indentation.
  • There should be only one sentence per claim, but elements may be set forth in separate paragraphs.

The MPEP states:

‘Where a claim sets forth a plurality of elements or steps, each element or step of the claim should be separated by a line indentation, 37 CFR 1.75(i).’

Proper indentation helps examiners and others understand the structure and scope of the claimed invention more easily.

To learn more:

What are the government’s rights in inventions made by nonprofit organizations and small businesses?

The government’s rights in inventions made by nonprofit organizations and small businesses under federally sponsored research are specifically addressed in MPEP 310. According to the manual:

“A funding agreement may provide that the government shall have the right to require periodic reporting on the utilization or efforts at obtaining utilization that are being made by the contractor or his licensees or assignees.”

Additionally, the government retains:

  • A nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced the invention for or on behalf of the United States throughout the world.
  • The right to require the contractor to grant licenses to responsible applicants under certain conditions (march-in rights).
  • The right to require written agreements from contractors to ensure that inventions are made available for public use on reasonable terms.

These provisions, outlined in 35 U.S.C. 202, balance the interests of small entities, the government, and the public in federally funded inventions.

For more information on federally sponsored research, visit: federally sponsored research.

The Manual of Patent Examining Procedure (MPEP) outlines several general terms used to describe patent applications:

  • National application
  • Provisional application
  • Nonprovisional application
  • International application
  • International design application
  • Original application
  • Continuing application
  • Substitute application

These terms are defined in various sections of 37 CFR 1.9 and further explained in MPEP § 201.

To learn more:

For patent applications filed on or after September 16, 2012, the general requirements for powers of attorney are:

  • The power of attorney must be in writing.
  • It must name one or more representatives.
  • It must give the representative power to act on behalf of the principal.
  • It must be signed by the applicant for patent or the patent owner.

According to 37 CFR 1.32(b)(4), “A power of attorney must: […] (4) Be signed by the applicant for patent (§ 1.42) or the patent owner. A patent owner who was not the applicant under § 1.46 must appoint any power of attorney in compliance with §§ 3.71 and 3.73 of this chapter.”

It’s important to note that an assignee who is not an applicant cannot revoke or appoint a power of attorney in a patent application.

To learn more:

The formatting requirements for claims in a patent application are specified in 37 CFR 1.75(h) and (i). Key requirements include:

  • Claims must commence on a separate physical sheet or electronic page.
  • Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material.
  • Where a claim sets forth multiple elements or steps, each element or step should be separated by a line indentation.

The MPEP states: “The claim or claims must commence on a separate physical sheet or electronic page. Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material.” and “Where a claim sets forth a plurality of elements or steps, each element or step of the claim should be separated by a line indentation.”

These formatting requirements enhance readability and clarity of the claims. For more detailed information on claim formatting, refer to MPEP § 608.01(m).

To learn more:

A substitute specification must be submitted with specific formatting requirements as outlined in 37 CFR 1.125(c):

  • A clean version (without markings) must be provided.
  • A marked-up copy showing all changes relative to the prior version must be submitted.
  • Added text must be shown by underlining.
  • Deleted text must be shown by strike-through or double brackets (for five or fewer consecutive characters).

The MPEP further states: “The paragraphs of any substitute specification, other than the claims, should be individually numbered in Arabic numerals (for example [0001]) so that any amendment to the specification may be made by replacement paragraph in accordance with 37 CFR 1.121(b)(1).”

To learn more:

For electronic submissions of assignment documents, the USPTO requires:

  • Either a copy of the original document or an extract of the original document
  • Documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another prescribed format
  • When printed to paper size of 21.6 by 27.9 cm (8 1/2 inches by 11 inches) or 21.0 by 29.7 cm (DIN size A4), the document must be legible
  • A 2.5 cm (one-inch) margin must be present on all sides

As stated in 37 CFR 3.24(a): All documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another form as prescribed by the Director.

To learn more:

For electronic submissions of assignment documents, the following requirements apply:

  • Either a copy of the original document or an extract of the original document may be submitted.
  • Documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another prescribed format.
  • When printed to paper size (8.5″ x 11″ or A4), the document must be legible with a 1-inch margin on all sides.

As stated in 37 CFR 3.24(a): “All documents must be submitted as digitized images in Tagged Image File Format (TIFF) or another form as prescribed by the Director.”

What are the font requirements for a patent specification?

The MPEP 608.01 outlines specific font requirements for patent specifications:

  • Font size: At least 0.21 cm (0.08 inch) high, or at least a 12-point font size
  • Font style: The lettering must be a nonscript type font (e.g., Arial, Times Roman, or Courier)
  • Color: Dark ink against a light background

The MPEP states: ‘The specification must have text written in a nonscript type font (e.g., Arial, Times Roman, or Courier, preferably a font size of 12) lettering style having capital letters which should be at least 0.3175 cm. (0.125 inch) high, but may be no smaller than 0.21 cm. (0.08 inch) high (e.g., a font size of 6).’ These font requirements ensure readability and consistency across all patent documents.

To learn more:

The filing requirements for an interim copy of a foreign application are specified in 37 CFR 1.55(j). They include:

  • Filing a copy of the original foreign application clearly labeled as ‘Interim Copy’
  • Including a separate cover sheet identifying the foreign application details
  • Filing within specified time limits

The MPEP states:

’37 CFR 1.55(j) also provides that the interim copy of the foreign application must be filed together with a separate cover sheet identifying the foreign application by specifying the application number, country (or intellectual property authority), day, month, and year of its filing, and stating that the copy filed in the Office is a true copy of the original application as filed in the foreign country (or intellectual property authority).’

It’s crucial to adhere to these requirements to ensure proper processing of the interim copy.

For more information on filing requirements, visit: filing requirements.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

What are the filing requirements for a provisional application?

A provisional application must include:

  • A specification as prescribed by 35 U.S.C. 112(a), except claims are not required
  • Any drawings necessary to understand the invention
  • The inventor’s oath or declaration is not required
  • The appropriate filing fee

According to MPEP 601.01(b): ‘A provisional application must include a specification as prescribed by 35 U.S.C. 112(a), except that no claims are required.’ The specification should provide a clear description of the invention to enable others skilled in the art to make and use it.

To learn more:

The filing requirements for a divisional application under 37 CFR 1.53(b) are similar to those for a new nonprovisional application. According to the MPEP:

‘A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (1) a specification complying with 35 U.S.C. 112, including a claim or claims; (2) drawings, where necessary; and (3) the inventorship named on filing.’

Additionally, you must include:

  • The appropriate filing fees
  • An Application Data Sheet (ADS) specifying that the application is a divisional
  • A proper benefit claim to the parent application

It’s important to note that while a new oath or declaration may not be required under 37 CFR 1.63(d), you must still comply with all other filing requirements.

For more information on Divisional application, visit: Divisional application.

For more information on drawings, visit: drawings.

For more information on filing requirements, visit: filing requirements.

For more information on inventorship, visit: inventorship.

To file a CPA for a design patent application, the following requirements must be met:

  • The prior application must be a design application that is complete under 37 CFR 1.51(b)
  • The CPA must be filed before the earliest of: payment of the issue fee, abandonment, or termination of proceedings in the prior application
  • The CPA must be filed with a request on a separate paper
  • The proper filing fee, search fee, and examination fee must be paid
  • The CPA must only disclose and claim subject matter disclosed in the prior application

As stated in the MPEP: “The filing date of a CPA is the date on which a request on a separate paper for an application under this paragraph is filed.”

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

The filing requirements for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) are as follows:

  • The CPA must be filed before the earliest of:
    • Payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted;
    • Abandonment of the prior application; or
    • Termination of proceedings on the prior application.
  • The CPA must include a request to initiate proceedings under 37 CFR 1.53(d).
  • The prior application must be a design application eligible for CPA practice.

As stated in the MPEP 201.06(d): ‘A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).’

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on filing requirements, visit: filing requirements.

A continuation-in-part (CIP) application has specific filing requirements. Key points include:

  • A CIP application can only be filed under 37 CFR 1.53(b).
  • It must be filed during the lifetime of the prior-filed application (before its abandonment or issuance).
  • The CIP must claim the benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c).
  • For applications filed on or after September 16, 2012, the benefit claim must be in an application data sheet (ADS).
  • The CIP must have at least one common inventor with the prior application.
  • New matter can be added to the specification, but claims relying on this new matter will not get the benefit of the earlier filing date.

As stated in the MPEP:

A continuation-in-part application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).

It’s important to note that while a CIP allows for the addition of new matter, any claims that rely on this new matter will only be entitled to the filing date of the CIP application, not the earlier filing date of the parent application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on filing requirements, visit: filing requirements.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

To file a continuation application, you must meet several requirements as outlined in MPEP 201.07:

  1. Timing: The continuation must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  2. Disclosure: The continuation must not include any new matter beyond what was disclosed in the parent application.
  3. Claim to Benefit: A specific reference to the prior application is required, typically in the first sentence of the specification.
  4. Inventor: At least one inventor named in the continuation must also be named in the prior application.
  5. Filing Requirements: The continuation must include:
    • A copy of the prior application as filed (unless already submitted via the USPTO electronic filing system)
    • Amendments to the specification (if any)
    • New claims (if any)
    • Oath or declaration

Additionally, the continuation application must satisfy all the requirements of 35 U.S.C. 112 for the claimed subject matter.

To learn more:

Applications properly filed via Priority Mail Express® (formerly Express Mail) have special filing date rules:

  • The filing date is the date the application was deposited with the U.S. Postal Service as Priority Mail Express®
  • This applies even if the deposit date is a Saturday, Sunday, or federal holiday
  • The application must comply with the requirements of 37 CFR 1.10 to receive this benefit

The MPEP states: For applications properly filed under 37 CFR 1.10, the filing date is the date that the application was deposited as Priority Mail Express® in the U.S. Postal Service. For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date. 37 CFR 1.6(a)(2).

If the proper procedures were not followed, the application will receive a filing date as of the date it was received in the USPTO. Any review of these matters would be by way of petition, accompanied by the petition fee.

For more information on Priority Mail Express, visit: Priority Mail Express.

The filing date requirements for provisional applications under 35 U.S.C. 111(b) are outlined in MPEP 601.01(b):

Quote: “The filing date of a provisional application is the date on which a specification as prescribed by 35 U.S.C. 112(a), and any drawing required by 37 CFR 1.81(a) are filed in the USPTO.”

This means that to receive a filing date, a provisional application must include:

  • A specification that meets the requirements of 35 U.S.C. 112(a)
  • Any necessary drawings as per 37 CFR 1.81(a)

It’s important to note that provisional applications do not require claims to receive a filing date.

To learn more:

To learn more:

The filing date requirements for nonprovisional applications filed under 35 U.S.C. 111(a) have changed due to the Patent Law Treaties Implementation Act of 2012 (PLTIA). For applications filed on or after December 18, 2013:

  • Non-design applications no longer require at least one claim or any drawings to receive a filing date
  • Design patent applications still require at least one claim and any required drawings to receive a filing date

The MPEP states: Unless the application is for a design patent, nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013, are no longer required to include at least one claim or any drawings in order to receive a filing date for the application.

Additionally, applications may now be filed by reference to a previously filed application: A nonprovisional application filed under 35 U.S.C. 111(a) on or after December 18, 2013, may be filed by a reference to a previously filed application (foreign, international, provisional, or nonprovisional) indicating that the specification and any drawings of the application are replaced by the reference to the previously filed application.

For more information on filing date requirements, visit: filing date requirements.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent drawings, visit: patent drawings.

For more information on PLTIA, visit: PLTIA.

The Patent Law Treaties Implementation Act of 2012 (PLTIA) amended the filing date requirements for nonprovisional applications filed under 35 U.S.C. 111(a) on or after December 18, 2013. The key changes are:

  • Nonprovisional applications (except for design patent applications) no longer require at least one claim or any drawings to receive a filing date.
  • For design patent applications, the filing date is the date on which the USPTO receives the specification including at least one claim and any required drawings.
  • As provided in 35 U.S.C. 111(c), a nonprovisional application may be filed by reference to a previously filed application (foreign, international, provisional, or nonprovisional).

These changes simplified the filing process for most nonprovisional applications while maintaining specific requirements for design patent applications.

For nonprovisional applications filed on or after December 18, 2013, the filing date requirements have been simplified. The MPEP states: For applications filed on or after December 18, 2013, the filing date of a nonprovisional application filed under 35 U.S.C. 111(a), other than a design patent application, is the date on which a specification, with or without claims, is received in the Office. This means that utility and plant patent applications no longer require at least one claim or any drawings to receive a filing date. However, design patent applications still require at least one claim and any required drawings to receive a filing date.

To learn more:

What are the filing date requirements for a CPA?

The filing date requirements for a Continued Prosecution Application (CPA) are specific and must be adhered to. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is a paper filing, even though it may be submitted via EFS-Web.

Key points about CPA filing date requirements include:

  • The CPA must be filed before the payment of the issue fee for the prior application
  • It must be filed before abandonment of the prior application
  • The request for a CPA must be made on a separate paper
  • The filing date is based on when the CPA request is received, not when other application documents are submitted

It’s crucial to meet these requirements to ensure the CPA is properly filed and receives the correct filing date.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

To receive a filing date for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d), the following requirements must be met:

  • The application must be for a design patent;
  • The prior application must be a design application that is complete as defined by 37 CFR 1.51(b);
  • The application must be submitted before the payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted in the prior application;
  • The application must be filed within the period set forth in 37 CFR 1.53(d)(1)(ii); and
  • The application must be filed with a request for a CPA.

As stated in the MPEP: ‘A CPA may be filed under 37 CFR 1.53(d) only if the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).’

For more information on CPA, visit: CPA.

For more information on design patent, visit: design patent.

For more information on filing requirements, visit: filing requirements.

What are the filing date requirements for a Continued Prosecution Application (CPA)?

For a Continued Prosecution Application (CPA) to receive a filing date, it must meet specific requirements as outlined in MPEP 201.06(d):

  • The application must be for a design patent
  • The prior application must be a design application that is complete as defined by 37 CFR 1.51(b)
  • The application must be submitted before the payment of the issue fee on the prior application, unless a petition under 37 CFR 1.313(c) is granted in the prior application
  • The application must be filed within the period set forth in 37 CFR 1.53(d)(1)(ii)

The MPEP states: ‘A CPA may be filed where the prior nonprovisional application is a design application that is complete as defined by 37 CFR 1.51(b).’ This ensures that the CPA is based on a properly filed and complete prior application.

To learn more:

The file size limitations for biological sequence listings in patent applications are as follows:

  • Sequence listings up to 100KB can be included in the specification or submitted as a text file via EFS-Web or PatentCenter.
  • Sequence listings between 100KB and 100MB can be submitted as ASCII text files or PDF files via EFS-Web or PatentCenter.
  • Sequence listings larger than 100MB must be submitted on read-only optical discs.

According to MPEP 608.05(c): “Sequence listings may be submitted in electronic form via EFS-Web or PatentCenter as ASCII text files or PDF files up to 100 megabytes, and on read-only optical discs when the sequence listing file size is over 100 megabytes.”

It’s important to note that these size limitations ensure efficient processing and storage of sequence listings while accommodating various file sizes.

To learn more:

Tags: EFS-Web

The fees for recording assignment documents are set forth in 37 CFR 3.41. According to the MPEP:

  • For electronic submissions: The fee is currently $0 (as per 37 CFR 1.21(h)(1))
  • For paper or facsimile submissions: The fee is set in 37 CFR 1.21(h)(2)

The MPEP advises: Customers should check the current fee schedule on the Office website before submitting documents for recordation.

It’s important to note that a fee is required for each application, patent, and registration against which the document is recorded, as identified in the cover sheet. However, there are exceptions:

  • No fee is required for documents required by Executive Order 9424 if the document does not affect title and is identified as such in the cover sheet
  • The document must be either faxed, electronically submitted, or mailed in compliance with 37 CFR 3.27

For more information on recordation fees, visit: recordation fees.

For more information on USPTO fees, visit: USPTO fees.

The fees for recording a patent assignment depend on the submission method:

  • Electronic submission via EPAS (Electronic Patent Assignment System): $0
  • Paper or facsimile submission: See current fee schedule

As stated in MPEP 302.06: “If the request to record a document is submitted electronically, the fee is set forth in 37 CFR 1.21(h)(1), currently at $0. If the request to record a document is not submitted electronically (i.e., is submitted on paper or via facsimile), the applicable fee is set forth in 37 CFR 1.21(h)(2).”

It’s important to note that fees are subject to change. Always check the current USPTO fee schedule before submitting documents for recordation.

For more information on patent assignment fees, visit: patent assignment fees.

For more information on USPTO fees, visit: USPTO fees.

There are several exceptions to the 18-month publication rule for patent applications, as outlined in 35 U.S.C. 122(b)(2)(A). An application shall not be published if it is:

  • No longer pending
  • Subject to a secrecy order under section 181
  • A provisional application filed under section 111(b)
  • An application for a design patent filed under chapter 16

Additionally, an applicant can request non-publication if they certify that the invention has not and will not be the subject of an application filed in another country that requires publication after 18 months. However, if the applicant later files such a foreign application, they must notify the USPTO within 45 days or the U.S. application will be considered abandoned.

While most patent application files are available for public inspection, there are several exceptions:

  • Pending or abandoned applications that have not been published under 35 U.S.C. 122(b)
  • Applications subject to a secrecy order
  • Provisional applications
  • Applications that have been terminated or denied and are no longer open to public inspection
  • Interference files, until judgment is entered (subject to certain exceptions)
  • Applications for extension of patent term and any related submissions
  • Certain trade secret, proprietary, and protective order materials

These exceptions are in place to protect confidential information and maintain the integrity of the patent application process.

While most patent application files are available for public inspection, there are some exceptions:

  • Pending or abandoned applications that have not been published
  • Applications subject to secrecy orders
  • Certain international applications
  • Applications for which the United States is not a designated country
  • Information that would violate personal privacy or proprietary rights

These exceptions help protect sensitive information and maintain confidentiality in specific cases.

The examiner’s responsibilities regarding drawing corrections in patent applications include:

  • Determining if the drawings are complete and consistent with the specification and claims
  • Informing the applicant of any drawing corrections required
  • Providing reasons for any objections or rejections related to the drawings

As stated in MPEP 608.02(e): ‘The examiner should see to it that the drawings are correct, complete, and consistent with the specification and claims.’ This means the examiner must carefully review the drawings and ensure they accurately represent the invention described in the application.

To learn more:

While MPEP 203.06 mentions ‘essential parts’ without specifying them, other sections of the MPEP provide details on what constitutes a complete patent application. The essential parts typically include:

  • Specification (including a description of the invention)
  • At least one claim
  • Drawings (when necessary to understand the invention)
  • Filing fees
  • Inventor’s oath or declaration

The specific requirements may vary depending on the type of patent application (e.g., utility, design, or plant patent). It’s crucial to consult the relevant MPEP sections, such as MPEP 601, for detailed information on application requirements.

To learn more:

For patent applications filed before December 18, 2013, drawings were generally required to receive a filing date. As stated in the MPEP, For applications filed prior to December 18, 2013, 35 U.S.C. 111(a)(4) and 35 U.S.C. 111(b)(4) each provide, in part, that the ‘filing date… shall be the date on which… any required drawing are received in the Patent and Trademark Office.’ This means that if drawings were necessary for understanding the invention, they had to be included in the initial filing to secure a filing date.

To learn more:

According to MPEP 203.05, a patent application can become abandoned in several ways:

  • Through formal abandonment by the applicant or their attorney/agent
  • Failure to take appropriate action during prosecution
  • Failure to pay the issue fee
  • For provisional applications, not filing a nonprovisional application within 12 months

The MPEP states: “An abandoned application is, inter alia, one which is removed from the Office docket of pending applications” due to these reasons.

To learn more:

According to MPEP 201.02, there are several types of patent applications:

  • National applications
  • Provisional applications
  • Nonprovisional applications
  • International applications
  • International design applications

The definitions for these terms can be found in 37 CFR 1.9. Additionally, applications can be classified as ‘original’ or ‘continuing’ applications. An original application may be a first filing or a continuing application, while a continuing application can be a continuation, divisional, or continuation-in-part application.

For more information on continuing applications, visit: continuing applications.

For more information on international applications, visit: international applications.

For more information on international design applications, visit: international design applications.

For more information on nonprovisional applications, visit: nonprovisional applications.

For more information on patent applications, visit: patent applications.

The United States Patent and Trademark Office (USPTO) recognizes several types of patent applications. According to MPEP 201, these include:

  • Nonprovisional applications for patent, including utility, design, and plant patent applications
  • Provisional applications for patent
  • International applications filed under the Patent Cooperation Treaty (PCT)
  • Reissue applications
  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

Each type of application serves a specific purpose in the patent process and has its own requirements and procedures.

For more information on divisional, visit: divisional.

For more information on patent applications, visit: patent applications.

For more information on reissue, visit: reissue.

For more information on USPTO, visit: USPTO.

According to MPEP 201.01, there are three main types of national applications in U.S. patent law:

  • Original applications: These include both provisional and nonprovisional applications.
  • Reissue applications: Filed to correct an error in an already issued patent.
  • Reexamination applications: Used to request a review of an existing patent.

The MPEP states: National applications include original (nonprovisional and provisional), reissue, and reexamination applications. Each type serves a specific purpose in the patent application process.

For more information on reissue applications, visit: reissue applications.

There are significant differences in power of attorney requirements for patent applications filed before and after September 16, 2012. Key differences include:

  • Signature Requirements: For applications filed on or after September 16, 2012, the power of attorney must be signed by the applicant for patent or the patent owner. For applications filed before September 16, 2012, it must be signed by the applicant for patent or the assignee of the entire interest of the applicant.
  • Definition of Applicant: The definition of ‘applicant’ changed with the America Invents Act. For applications filed on or after September 16, 2012, the applicant can be the inventor(s) or a non-inventor applicant (e.g., an assignee).
  • Forms: Different forms are used for applications filed before and after September 16, 2012. For example, Form PTO/AIA/80 is used for applications filed on or after September 16, 2012, while Form PTO/SB/80 is used for earlier applications.

It’s crucial to use the correct forms and follow the appropriate rules based on the application’s filing date to ensure the power of attorney is properly executed and recognized by the USPTO.

To learn more:

The rules regarding who can be a patent applicant changed significantly for applications filed on or after September 16, 2012. MPEP § 605 outlines these differences:

For applications filed on or after September 16, 2012:

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign an invention to file and prosecute an application for patent as the applicant, and to permit a person who otherwise shows sufficient proprietary interest in the matter to file and prosecute an application for patent as the applicant on behalf of the inventor.”

For applications filed before September 16, 2012:

“For applications filed before September 16, 2012, a person to whom the inventor assigned an invention could file and prosecute an application for patent, but the inventor is considered the applicant.”

The key differences are:

  • Pre-AIA: Only the inventor could be listed as the applicant, even if the application was filed by an assignee.
  • Post-AIA: Assignees, those obligated to assign, or those with sufficient proprietary interest can be listed as the applicant.

For more detailed information, refer to MPEP § 605.01 for post-AIA applications and MPEP § 605.02 for pre-AIA applications.

To learn more:

For U.S. national stage applications derived from international applications, there are specific requirements for submitting Information Disclosure Statements (IDSs). The MPEP states:

“When filing a continuing application that claims benefit under 35 U.S.C. 120 to an international application that designated the U.S. (see MPEP § 1895), it will be necessary for the applicant to submit an information disclosure statement complying with 37 CFR 1.97 and 1.98 in the continuing application listing the documents cited in the international search report and/or the international preliminary examination report of the international application if applicant wishes to ensure that the information is considered by the examiner in the continuing application.”

This means that unlike regular continuing applications, where previously cited art is automatically considered, applicants must submit a new IDS in national stage applications to ensure the examiner considers documents from the international phase. For more information on the consideration of documents cited in international search reports in PCT national stage applications, refer to MPEP § 609.03.

To learn more:

The MPEP 106.01 highlights a key difference in assignee rights for patent applications filed before and after September 16, 2012:

  • For applications filed before September 16, 2012: The assignee of record of the entire interest can intervene in the prosecution of an application or interference to the exclusion of the applicant.
  • For applications filed on or after September 16, 2012: The assignee of record of the entire interest can not only intervene but also prosecute the application after becoming the applicant under 37 CFR 1.46.

For more detailed information, the MPEP directs readers to:

  • MPEP § 324 for applications filed before September 16, 2012
  • MPEP § 325 for applications filed on or after September 16, 2012

What are the differences between U.S. and international practice regarding multiple dependent claims?

There are significant differences between U.S. and international practices for multiple dependent claims:

  • U.S. practice is more restrictive, not allowing multiple dependent claims to depend on other multiple dependent claims.
  • Many foreign patent offices allow multiple dependent claims to depend on other multiple dependent claims.
  • The U.S. requires alternative language in multiple dependent claims, while some foreign offices allow cumulative dependencies.

The MPEP 608.01(n) states:

“The treatment of multiple dependent claims in the U.S. is different from that in other countries. In the United States, a multiple dependent claim may not depend upon another multiple dependent claim, either directly or indirectly.”

This difference is crucial for patent applicants to understand when drafting claims for both U.S. and international patent applications, as claim structures acceptable abroad may need to be modified for U.S. submission.

To learn more:

To learn more:

What are the differences between recognized countries and regional patent offices for foreign filing?

Recognized countries and regional patent offices both play important roles in foreign patent filing, but they have distinct characteristics. According to MPEP 213.01:

A ‘recognized’ country is one that meets the conditions of 35 U.S.C. 119(a)-(d), which include extending similar patent filing rights to U.S. citizens. Regional patent offices are intergovernmental organizations that have been authorized to receive and process patent applications on behalf of multiple member countries.

Key differences include:

  • Jurisdiction: Recognized countries operate within their national borders, while regional offices cover multiple countries.
  • Application Process: Filing with a recognized country results in a national patent, whereas regional office filings can lead to patents enforceable in multiple member states.
  • Legal Framework: Recognized countries follow their national patent laws, while regional offices operate under a harmonized system agreed upon by member states.

Examples of regional patent offices include the European Patent Office (EPO) and the African Regional Intellectual Property Organization (ARIPO).

To learn more:

Design and plant patent applications are two distinct types of patent applications, each protecting different aspects of inventions:

Design Patent Applications:
1. Protect the ornamental design of a functional item.
2. Cover the visual appearance of an article of manufacture.
3. Have a term of 15 years from the date of grant.
4. Require drawings or photographs of the design.
5. Do not require a written description of the invention.

Plant Patent Applications:
1. Protect new varieties of asexually reproduced plants.
2. Cover the entire plant, not just a specific part.
3. Have a term of 20 years from the filing date.
4. Require a detailed botanical description of the plant.
5. May include drawings or photographs to illustrate the plant’s characteristics.

For more information, refer to MPEP 201.06 for design patents and MPEP 201.07 for plant patents.

The USPTO has specific requirements for patent drawings, but they have become more flexible in recent years. According to MPEP 608.02(i), “Drawings that do not comply with all of the form requirements of 37 CFR 1.84 may be acceptable for the purposes of publication and examination if the drawings are readable and reproducible for publication purposes.” This means that while there are still formal requirements outlined in 37 CFR 1.84, the USPTO may accept drawings that don’t meet all these requirements as long as they are clear enough for publication and examination.

To learn more:

According to MPEP 310, a Government contractor who retains U.S. domestic patent rights has the following obligations:

  1. Include the government license rights statement at the beginning of the patent application and any issued patents.
  2. Specify the contract under which the invention was made.
  3. Identify the Federal agency that awarded the contract.
  4. Acknowledge that the government has certain rights in the invention.

These obligations stem from 35 U.S.C. 202(c)(6), which mandates the inclusion of this information in the patent application and any resulting patents.

An Information Disclosure Statement (IDS) must include:

  • A list of all patents, publications, applications, or other information submitted for consideration
  • A column for examiner’s initials
  • U.S. patents and patent application publications listed separately from other documents
  • Proper identification of each document listed
  • Copies of foreign patents/publications
  • Copies of non-patent literature
  • Copies of pending U.S. applications (if not in IFW system)

MPEP 609.04(a) states: “Each information disclosure statement must include a list of all patents, publications, U.S. applications, or other information submitted for consideration by the Office.” It further specifies that “37 CFR 1.98(b) requires that each item of information in an IDS be identified properly. U.S. patents must be identified by the inventor, patent number, and issue date. U.S. patent application publications must be identified by the applicant, patent application publication number, and publication date.”

To learn more:

Tags: USPTO

Violating the certification requirements when submitting papers to the USPTO can have serious consequences. According to 37 CFR 11.18(c), violations may result in:

  1. Striking the offending paper
  2. Referring a practitioner’s conduct to the Office of Enrollment and Discipline
  3. Precluding a party or practitioner from submitting papers or contesting issues
  4. Affecting the weight given to the offending paper
  5. Terminating proceedings in the Office

Additionally, 37 CFR 11.18(d) states that practitioners violating these provisions may be subject to disciplinary action. The USPTO Director determines appropriate sanctions after notice and opportunity to respond.

It’s important to note that violations can jeopardize the validity of applications, documents, patents, and trademark registrations. As stated in the MPEP:

‘The submission by an applicant of misleading or inaccurate statements of facts during the prosecution of applications for patent has resulted in the patents issuing on such applications being held unenforceable.’

Several court cases are cited demonstrating how false statements have led to patents being unenforceable.

Violating a secrecy order can have severe consequences. According to MPEP 120, “Unauthorized disclosure of the subject matter of an application under a secrecy order is punishable by a fine and/or imprisonment.” Specifically:

  • The fine can be up to $10,000
  • Imprisonment can be up to two years
  • These penalties apply for each offense

Additionally, violation of a secrecy order can result in the abandonment of the application. It’s crucial for inventors and patent practitioners to strictly adhere to secrecy orders to avoid these serious legal consequences.

Violating a secrecy order on a patent application can have severe consequences. MPEP 120 states, “If, prior to or after the issuance of the secrecy order, any significant part of the subject matter or material information relevant to the application has been or is revealed to any U.S. citizen in the United States, the principals must promptly inform such person of the secrecy order and the penalties for improper disclosure.” The penalties for violation can include:

It’s crucial for applicants and their representatives to strictly adhere to secrecy orders to avoid these serious consequences.

Submitting unauthorized correspondence to the USPTO for patent applications filed after September 16, 2012, can have serious consequences:

  • The correspondence may be returned or not entered into the application
  • It could cause delays in the processing of the application
  • Important deadlines might be missed, potentially leading to abandonment of the application
  • There may be additional fees or costs to rectify the situation

The USPTO has strict rules about who can correspond on behalf of applicants. According to MPEP 403.01(a):

Pursuant to 37 CFR 1.33(a), if an applicant includes more than one correspondence address (37 CFR 1.33(a) ) in a patent application, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

To avoid these issues, ensure that all correspondence is submitted by authorized individuals or entities as specified in the MPEP and relevant USPTO regulations.

To learn more:

Tags: USPTO

What are the consequences of submitting insufficient fees for a patent application?

Submitting insufficient fees for a patent application can have significant consequences. According to MPEP 509:

“An application filed with insufficient basic filing fee, search fee, examination fee, or oath or declaration will be treated as an incomplete application under 37 CFR 1.53(f) and will not be given a filing date until the filing fee is received.”

This means:

  • Your application won’t receive a filing date until the correct fees are paid
  • This delay could affect your priority date
  • If not corrected promptly, the application may be considered abandoned

It’s crucial to ensure all required fees are paid in full when submitting a patent application to avoid these issues.

To learn more:

Submitting informal drawings in a patent application can have several consequences:

  • The application may be considered incomplete, potentially affecting the filing date.
  • The examiner may object to the drawings and require formal drawings to be submitted.
  • It may delay the examination process.
  • In some cases, it could result in a loss of patent rights if not corrected in time.

MPEP 608.02(b) states: ‘The Office no longer considers drawings as formal or informal; drawings are either acceptable or not acceptable. Drawings will be accepted by the Office of Patent Application Processing (OPAP) if the drawings meet the requirements of 37 CFR 1.84(a), (b), (c), and (e) and are capable of reproduction.’

It’s important to note that while the USPTO may accept informal drawings initially, they may still be objected to during examination, requiring corrections to be made.

To learn more:

To learn more:

What are the consequences of submitting color drawings in a utility patent application?

Submitting color drawings in a utility patent application has specific consequences and requirements:

  • Color drawings are not ordinarily permitted in utility patent applications.
  • As stated in MPEP 507: “Color drawings are permitted in design applications. For utility patent applications, color drawings are not permitted without a grantable petition.”
  • If color drawings are submitted without an approved petition, OPAP will send a Notice to File Corrected Application Papers.
  • The applicant must either:
    • Replace the color drawings with black and white drawings, or
    • File a grantable petition under 37 CFR 1.84(a)(2) to accept the color drawings.
  • The petition must explain why color drawings are necessary and be accompanied by the fee set forth in 37 CFR 1.17(h).

It’s important to consider whether color drawings are truly necessary for your utility patent application, as they require additional steps and fees in the application process.

For more information on application papers, visit: application papers.

For more information on color drawings, visit: color drawings.

What are the consequences of submitting an untimely IDS?

Submitting an untimely Information Disclosure Statement (IDS) can have significant consequences for a patent application. According to MPEP 609.02, the consequences depend on when the IDS is submitted:

  • After first Office action but before final rejection: Requires certification and fee
  • After final rejection but before RCE or appeal: Requires certification, fee, and statement
  • After payment of issue fee: Not considered by examiner

The MPEP states:

‘If an IDS is filed after the mailing date of a first Office action on the merits but before the mailing date of a final rejection or a notice of allowance, the IDS must be accompanied by (1) the statement specified in 37 CFR 1.97(e) and (2) the fee set forth in 37 CFR 1.17(p).’

Failing to comply with these requirements can result in the IDS not being considered, which may affect the validity or enforceability of any resulting patent. In extreme cases, it could lead to allegations of inequitable conduct if material information was intentionally withheld.

To learn more:

While the MPEP section provided doesn’t directly address the consequences of submitting an incomplete or non-compliant Information Disclosure Statement (IDS), it does mention a provision for addressing inadvertent omissions:

If a bona fide attempt is made to comply with the content requirements of 37 CFR 1.98, but part of the required content is inadvertently omitted, additional time may be given to enable full compliance pursuant to 37 CFR 1.97(f).‘ (MPEP 609.04(a))

However, it’s important to note that:

  • Intentional omissions or non-compliance can have serious consequences, including charges of inequitable conduct
  • The USPTO may not consider information in a non-compliant IDS
  • Correcting deficiencies may require submitting a new IDS, potentially incurring additional fees
  • Non-compliance can delay the examination process

To avoid these issues, it’s crucial to carefully follow the IDS requirements outlined in 37 CFR 1.98 and the guidance provided in MPEP 609.04(a). When in doubt, consult with a patent attorney or agent to ensure full compliance.

To learn more:

What are the consequences of submitting a poor-quality copy of an assignment document to the USPTO?

Submitting a poor-quality copy of an assignment document to the USPTO can lead to rejection of the recording request. The MPEP 302.01 clearly states that “Only copies of an original assignment document (with the exception of those submitted via EFS-Web) may be submitted for recording.” Furthermore, it emphasizes that “The copy must be legible, capable of reproduction and otherwise meet the usual requirements of documents for recording.” If a poor-quality copy is submitted:

  • The recording request may be rejected
  • The effective date of recordation could be delayed
  • Additional fees may be incurred for resubmission
  • There could be potential legal implications if the assignment is not properly recorded in a timely manner

To avoid these issues, always ensure that the copy submitted is of high quality and meets all USPTO requirements for legibility and reproducibility.

Providing incorrect information in an Application Data Sheet (ADS) can have serious consequences for your patent application. The MPEP 601.05(a) emphasizes the importance of accuracy:

Applicants should submit a new ADS whenever the previously submitted information is no longer accurate. Submission of an inaccurate ADS may delay processing of the application and may require the applicant to file a petition under 37 CFR 1.78 to correct the applicant information.

Consequences of incorrect ADS information may include:

  • Delays in application processing
  • Potential loss of priority claims
  • Incorrect inventorship records
  • Need for additional petitions and fees to correct errors
  • Possible issues with patent enforcement if errors are not corrected

It’s crucial to review your ADS carefully before submission and promptly correct any errors discovered using a supplemental ADS or other appropriate means.

To learn more:

What are the consequences of providing incorrect information in an ADS?

Providing incorrect information in an Application Data Sheet (ADS) can have serious consequences for your patent application. The MPEP 601.05 emphasizes the importance of accuracy:

“Applicants should check the contents of the application data sheet carefully to ensure that all information is correct.”

Potential consequences of incorrect ADS information include:

  • Delayed processing: The USPTO may need to issue Office actions to correct errors, slowing down the application process.
  • Loss of priority rights: Incorrect foreign priority or domestic benefit claims could result in the loss of these valuable rights.
  • Inventorship issues: Errors in inventorship can lead to complicated correction procedures and potential challenges to patent validity.
  • Correspondence problems: Incorrect address information can result in missed communications from the USPTO.
  • Potential fraud allegations: In extreme cases, knowingly providing false information could be considered fraud on the USPTO.

To avoid these issues, carefully review all information before submitting an ADS, and promptly correct any errors discovered after submission using a supplemental ADS with proper markings.

To learn more:

What are the consequences of omitting the inventor’s name in a provisional application?

Omitting the inventor’s name in a provisional application can have serious consequences. According to MPEP 601.01(b):

“The inventorship of a provisional application is not considered to be relevant except when necessary to determine the proprietorship of the invention for purposes of double patenting rejections or if priority is claimed to the provisional application in a foreign filed application.”

While the inventorship may not be immediately relevant for the provisional application itself, it becomes crucial when:

  • Filing a non-provisional application claiming priority to the provisional
  • Claiming priority to the provisional in foreign applications
  • Addressing potential double patenting issues

If the inventor’s name is omitted, it may complicate these processes and potentially lead to loss of priority rights or other legal issues. It’s always best practice to include accurate inventor information in all patent applications, including provisionals.

To learn more:

What are the consequences of omitting an inventor’s oath or declaration in a nonprovisional application?

Omitting an inventor’s oath or declaration in a nonprovisional application can have significant consequences. According to MPEP 601.01(a):

If the application is filed without an inventor’s oath or declaration by any inventor, the Office will send a Notice to File Missing Parts giving the applicant a time period (usually two months) within which to file the missing oath or declaration and to pay the surcharge required by 37 CFR 1.16(f) to avoid abandonment.

The key points to note are:

  • The USPTO will send a Notice to File Missing Parts.
  • A time period (usually two months) is given to file the missing oath or declaration.
  • A surcharge under 37 CFR 1.16(f) must be paid.
  • Failure to comply may result in abandonment of the application.

It’s important to note that while the application can be filed without the oath or declaration, it must be submitted before the application is allowed to avoid potential issues.

For more information, refer to MPEP 601.01(a) and MPEP 602 on inventor’s oath or declaration.

To learn more:

Failing to submit an inventor’s oath or declaration before the issue fee is paid can have serious consequences for a patent application. According to MPEP 602.01(a):

If an application does not include an oath or declaration by the inventor or a substitute statement, the Office will issue a notice requiring the applicant to file the inventor’s oath or declaration no later than the date on which the issue fee is paid.

The consequences of not complying with this requirement include:

  • Application Abandonment: If the oath or declaration is not submitted by the time the issue fee is paid, the application will be regarded as abandoned.
  • Additional Fees: To revive an abandoned application, the applicant must pay additional fees and file a petition for revival.
  • Delay in Patent Grant: The patent will not be granted until the proper oath or declaration is submitted and the application is revived.
  • Potential Loss of Patent Rights: In extreme cases, failure to timely submit the oath or declaration could result in a loss of patent rights if statutory deadlines are missed.

To avoid these issues, applicants should ensure that a proper inventor’s oath or declaration is submitted well before the issue fee payment deadline.

To learn more:

While submitting an Application Data Sheet (ADS) is not mandatory for all applications, there can be consequences for not including one. According to MPEP 601.05(a):

If an application is filed without an application data sheet, the applicant will not have the benefit of:

  • The filing date of any provisional application;
  • The filing date of any non-provisional application;
  • The filing date of any international application;
  • The 35 U.S.C. 119, 120, 121, 365(c), or 386(c) priority claim; and
  • The foreign priority claim.

These benefits can be crucial for establishing priority dates and protecting your invention. Without an ADS, you may need to submit additional paperwork later to claim these benefits, which could potentially lead to delays or complications in the application process.

To learn more:

What are the consequences of not submitting an Application Data Sheet (ADS) in applications filed before September 16, 2012?

For applications filed before September 16, 2012, submitting an Application Data Sheet (ADS) was not mandatory. The MPEP 601.05(b) states:

In applications filed before September 16, 2012, the application data sheet is not a requirement of 37 CFR 1.51(b) for a complete application, but is rather supplemental to the application and is used to capture bibliographic information.

However, not submitting an ADS could lead to the following consequences:

  • Manual data entry: The USPTO would have to manually enter bibliographic information from other application papers, which could potentially lead to errors.
  • Delayed processing: Without an ADS, the application processing might take longer as the information needs to be gathered from various sources.
  • Potential for inconsistencies: Information scattered across different documents might lead to inconsistencies in the application record.
  • Missed benefits: Certain benefits, such as easily claiming domestic benefit or foreign priority, might be harder to establish without an ADS.

While not submitting an ADS wouldn’t result in an incomplete application, it was generally recommended to include one for smoother processing and to ensure accurate capture of bibliographic information.

To learn more:

Failing to show claimed features in patent drawings can lead to objections and potential issues with the patent application. According to MPEP 608.02(d), the examiner may issue an objection using Form Paragraph 6.36, which states:

The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, the [specific feature] must be shown or the feature(s) canceled from the claim(s). No new matter should be entered.

Consequences of this objection include:

  • Required submission of corrected drawing sheets
  • Potential cancellation of claims if features cannot be shown
  • Risk of application abandonment if corrections are not made

To avoid these issues, ensure that all claimed features are clearly illustrated in the patent drawings.

To learn more:

The consequences of not responding to a notice about an unlocatable file differ for pending applications and granted patents:

  • For pending applications: According to 37 CFR 1.251(b), failure to comply with one of paragraphs (a)(1), (a)(2), or (a)(3) of this section within the time period set in the notice will result in abandonment of the application.
  • For granted patents: While the patent won’t expire, the MPEP states that the only certified copy of the patent file that the Office will be able to produce will be a copy of the patent and a copy of the application-as-filed (which may have an adverse impact during attempts to enforce the patent).

Additionally, for patents involved in USPTO proceedings, the Office may take action under 37 CFR 41.128 or 37 CFR 11.18.

To learn more:

What are the consequences of not paying the correct filing fee for a patent application?

If you fail to pay the correct filing fee for your patent application, there can be significant consequences:

  • Application may not be assigned a filing date: As stated in MPEP 607, “The filing fee and application size fee for a nonprovisional application or provisional application are due on filing.” Without the correct fee, your application might not be officially filed.
  • Notice of Missing Parts: The USPTO will likely issue a Notice of Missing Parts, giving you a time limit to pay the correct fee.
  • Potential abandonment: If you don’t respond to the Notice of Missing Parts within the given timeframe, your application could be considered abandoned.
  • Additional fees: Late payment may incur surcharges or extension fees.

To avoid these issues, always ensure you calculate and submit the correct filing fee with your application.

To learn more:

Failing to include the Government License Rights statement in a patent application can have serious consequences. While the MPEP 310 does not explicitly state the penalties, the requirement is mandated by law under 35 U.S.C. 202(c)(6). Potential consequences may include:

  • Non-compliance with federal regulations
  • Risk of the patent being unenforceable
  • Potential loss of rights or benefits under the government contract
  • Complications in future licensing or commercialization efforts

It’s crucial for inventors and patent attorneys to ensure proper inclusion of this statement to maintain the validity and enforceability of the patent.

For more information on patent enforcement, visit: patent enforcement.

What are the consequences of not filing an IDS or submitting an incomplete IDS?

Failing to file an Information Disclosure Statement (IDS) or submitting an incomplete one can have serious consequences:

  • Duty of Disclosure: Violating the duty of disclosure can lead to charges of inequitable conduct.
  • Patent Invalidity: The patent may be held unenforceable if material information was intentionally withheld.
  • Prosecution History Estoppel: Failure to disclose prior art may limit the scope of patent claims in future litigation.

MPEP 609 states: “The duty to disclose all information known to be material to patentability is deemed to be satisfied if all information known to be material to patentability of any claim issued in a patent was cited by the Office or submitted to the Office in the manner prescribed by 37 CFR 1.97(b)-(d) and 1.98.”

It’s crucial to file a complete and timely IDS to avoid these potential pitfalls and ensure the validity and enforceability of your patent.

To learn more:

Failing to file a 37 CFR 1.48 request when adding a new inventor to a Continued Prosecution Application (CPA) can have significant consequences.

MPEP ¶ 2.33 states: “Otherwise, the inventorship in the CPA shall be the same as in the prior application.” This means that without a proper 37 CFR 1.48 request:

  • The new inventor will not be officially recognized on the application.
  • The inventorship will remain unchanged from the prior application.
  • This discrepancy could potentially affect the validity of the patent if granted.
  • It may lead to complications in future patent proceedings or enforcement efforts.

It’s crucial to follow proper procedures to ensure all inventors are correctly listed and legally recognized on the patent application.

For more information on CPA, visit: CPA.

For more information on patent validity, visit: patent validity.

What are the consequences of not converting a provisional application within 12 months?

If you do not convert a provisional application to a nonprovisional application within 12 months, there are significant consequences:

  • The provisional application will automatically expire.
  • You will lose the benefit of the provisional filing date.
  • The subject matter disclosed in the provisional may become prior art against future applications.

According to MPEP 201.04: “A provisional application will automatically become abandoned 12 months after its filing date pursuant to 35 U.S.C. 111(b)(5).” This means that after 12 months, if no corresponding nonprovisional application has been filed, the provisional application cannot be revived or extended. It’s crucial to file a nonprovisional application or a PCT application within this 12-month period to maintain the benefit of the provisional filing date.

To learn more:

Failing to address drawing objections can have serious consequences for a patent application. According to MPEP 608.02(e), the primary consequence is the potential abandonment of the application. The MPEP states:

Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application.

Additionally, it’s important to note that drawing objections cannot be held in abeyance. The MPEP clarifies:

Unless applicant is otherwise notified in an Office action, objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action.

This means that failing to address drawing objections can prevent the application from progressing, potentially leading to delays or even abandonment.

To learn more:

Listing references in the specification instead of submitting them in a proper Information Disclosure Statement (IDS) can have significant consequences. The MPEP 609.05(a) addresses this issue with form paragraph 6.49.06:

The listing of references in the specification is not a proper information disclosure statement. 37 CFR 1.98(b) requires a list of all patents, publications, applications, or other information submitted for consideration by the Office, and MPEP § 609.04(a), subsection I. states, ‘the list may not be incorporated into the specification but must be submitted in a separate paper.’ Therefore, unless the references have been cited by the examiner on form PTO-892, they have not been considered.

This means that references listed in the specification:

  • Are not considered a proper IDS
  • Will not be considered by the examiner unless cited on form PTO-892
  • Must be submitted separately in a proper IDS to ensure consideration

To ensure all relevant prior art is considered, applicants should always submit references in a separate, properly formatted IDS rather than listing them in the specification.

To learn more:

What are the consequences of knowingly submitting false statements to the USPTO?

Submitting false statements to the USPTO can have serious consequences. According to MPEP 410:

“Knowingly submitting false statements or withholding material information from the Office in connection with a patent application or patent may be punishable by fine or imprisonment.”

The MPEP further states that such actions may result in:

  • Invalidation of patents
  • Unenforceability of patents
  • Criminal prosecution
  • Disciplinary action against practitioners

It’s crucial for applicants and their representatives to maintain honesty and transparency in all communications with the USPTO to avoid these severe consequences.

For more information on USPTO, visit: USPTO.

Tags: USPTO

What are the consequences of inconsistencies between an ADS and other documents in a patent application?

Inconsistencies between an Application Data Sheet (ADS) and other documents in a patent application can lead to processing delays and potential issues. The MPEP states:

“If an ADS is inconsistent with the information provided in another document that was submitted at the same time or previous to the ADS submission, the ADS will control.” (MPEP 601.05(a))

This means:

  • The ADS takes precedence over other documents for bibliographic data.
  • Inconsistencies may require corrections, potentially delaying application processing.
  • Applicants should ensure all documents are consistent to avoid complications.

It’s crucial to review all application documents carefully before submission to maintain consistency and avoid potential issues in the patent examination process.

To learn more:

Including offensive content in a patent application can have significant consequences. According to MPEP 608:

  • The examiner will object to the offensive language or drawings.
  • The application will not be classified for publication under 35 U.S.C. 122(b).
  • The examiner will not pass the application to issue until the offensive content is removed.

The MPEP states, “An application should not be classified for publication under 35 U.S.C. 122(b) and an examiner should not pass the application to issue until such language or drawings have been deleted, or questions relating to the propriety thereof fully resolved.” This policy ensures that federal government publications maintain appropriate standards of decorum and courtesy.

To learn more:

Including derogatory remarks in a patent application can lead to objections or rejections from patent examiners. While the MPEP 608.01(r) doesn’t explicitly state the consequences, it clearly prohibits such remarks:

“The applicant … is not permitted to make derogatory remarks concerning the inventions of others.”

Consequences may include:

  • Objections to the specification
  • Requests to remove or modify the derogatory language
  • Potential delays in the patent examination process
  • In severe cases, it could affect the credibility of the application

To avoid these issues, focus on describing your invention’s merits without disparaging others’ work.

To learn more:

Improperly identifying a foreign priority application can have serious consequences for a patent applicant. According to MPEP 214.04:

‘Where the claim to priority in an application filed under 35 U.S.C. 111(a) is presented after the time period provided by 37 CFR 1.55(d) and without the required petition, or where the claim to priority is presented in a nonprovisional application filed under 35 U.S.C. 111(a) that was filed on or after March 16, 2013, and also claims the benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) of a prior application that was filed prior to March 16, 2013, the examiner should reject under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, any claims which are directed to subject matter that is not supported by the foreign application.’

Consequences may include:

  • Rejection of claims under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph
  • Loss of priority date for unsupported subject matter
  • Potential issues with patentability due to intervening prior art

It’s crucial to accurately identify and properly claim foreign priority to avoid these issues.

To learn more:

What are the consequences of improperly claiming small entity status?

Improperly claiming small entity status can have serious consequences. The MPEP 509.03 states: “Improperly and with intent to deceive establishing status as a small entity, or paying fees as a small entity, shall be considered as a fraud practiced or attempted on the Office.” This means that intentionally falsely claiming small entity status is considered fraud. Consequences may include:

  • Invalidation of the patent
  • Requirement to pay back all fee differences
  • Potential legal action for fraud

It’s crucial to verify eligibility carefully before claiming small entity status and to update the USPTO if your status changes.

To learn more:

To learn more:

Improper use of trademarks in patent applications can have several consequences, as outlined in MPEP 608.01(v):

  1. Insufficient Disclosure: If proper identification of the product, service, or organization identified by a mark or a trade name is omitted from the specification and such identification is deemed necessary under the principles set forth above, the examiner should hold the disclosure insufficient and reject, on the ground of insufficient disclosure, any claims based on the identification of the product, service, or organization merely by mark or trade name.
  2. Potential Trademark Validity Issues: The MPEP states that Every effort should be made to prevent their use in any manner which might adversely affect their validity as marks. Improper use in a patent application could potentially impact the trademark’s validity.
  3. Office Actions: Examiners may issue office actions requiring correction of improper trademark usage.
  4. Publication Issues: Where a letter demonstrates the misuse of a mark in a patent application publication, the Office should, where the application is still pending, ensure that the mark is replaced by appropriate generic terminology.

To avoid these issues, it’s crucial to follow the guidelines for proper trademark use in patent applications as specified in the MPEP.

To learn more:

Improper signatures on patent documents can have serious consequences:

  • The document may be considered unsigned and therefore ineffective.
  • It could lead to delays in the patent application process.
  • In some cases, it might result in the loss of rights or benefits.
  • The USPTO may require a new submission with proper signatures.

MPEP 402.03 states: ‘Signatures on any paper filed in the Office relating to patents must be permanent. The Office will accept and consider electronically submitted papers bearing S-signatures or handwritten signatures.’

To avoid these issues, ensure all signatures meet USPTO requirements and are made by authorized individuals.

To learn more:

What are the consequences of improper dependent claims in a patent application?

Improper dependent claims in a patent application can have several negative consequences:

  • Rejection by USPTO: The patent examiner may reject claims that don’t comply with dependency requirements.
  • Delayed prosecution: Addressing improper dependencies can prolong the patent examination process.
  • Increased costs: Additional office actions and responses may be needed to correct claim issues.
  • Weakened patent protection: Improperly drafted claims may not provide the intended scope of protection.
  • Potential invalidity: In extreme cases, improper dependencies could lead to claim invalidity if challenged in court.

The MPEP 608.01(n) emphasizes the importance of proper claim dependency:

“If the base claim is rejected, canceled, or withdrawn from consideration, any claim depending therefrom should be presented in independent form.”

This guidance underscores the need for careful claim drafting and ongoing attention to claim dependencies throughout the patent prosecution process. Ensuring proper claim structure and dependencies is crucial for obtaining strong, enforceable patent protection.

To learn more:

Fraudulently establishing small entity status or paying fees as a small entity is considered a serious offense. According to 37 CFR 1.27(h): ‘Any attempt to fraudulently establish status as a small entity or pay fees as a small entity will be considered as a fraud practiced or attempted on the Office.’

The consequences of such actions can be severe, potentially including:

  • Invalidation of the patent
  • Criminal charges for fraud
  • Disciplinary action against registered patent practitioners

It’s crucial to ensure that all claims to small entity status are truthful and accurate. Do not rely on oral advice from USPTO employees regarding entitlement to small entity status.

To learn more:

What are the consequences of filing an incomplete application?

Filing an incomplete application can have serious consequences:

  • No filing date: An incomplete application may not be assigned a filing date. As stated in MPEP 601.01, “The filing date of an application for patent is the date on which a specification as prescribed by 35 U.S.C. 112 containing a description pursuant to 35 U.S.C. 112(a) and at least one claim pursuant to 35 U.S.C. 112(b), and any drawing required by 35 U.S.C. 113 are filed in the Patent and Trademark Office.”
  • Loss of priority: Without a filing date, you may lose priority rights or the ability to claim the benefit of an earlier filing date.
  • Potential abandonment: If the missing parts are not submitted within the required time frame, the application may be considered abandoned.
  • Additional fees: Late submission of required elements may incur additional fees.

It’s crucial to ensure all required elements are included when filing a patent application to avoid these potential issues.

To learn more:

What are the consequences of filing an IDS after the mailing of a notice of allowance?

Filing an Information Disclosure Statement (IDS) after the mailing of a notice of allowance can have significant consequences:

  • The application will be withdrawn from issue
  • The IDS will be considered by the examiner
  • If the examiner determines that the application is still allowable, the application may be returned to issue
  • If the examiner determines that one or more claims are no longer allowable, the applicant will be notified and the claims will be rejected

As stated in MPEP 609.04(b): “If an IDS is filed after the mailing date of a Notice of Allowance under 37 CFR 1.311, the application will be withdrawn from issue.” This emphasizes the importance of timely IDS submission to avoid potential delays in patent issuance.

To learn more:

Filing a nonprovisional application without drawings can have significant consequences:

  • The application may be considered incomplete.
  • It may not receive a filing date.
  • The applicant will be notified of the deficiency.

As stated in MPEP 601.01(a): ‘If the specification of a nonprovisional application does not include at least one drawing, if necessary under 35 U.S.C. 113 (first sentence) to understand the subject matter sought to be patented, and at least one drawing is necessary under 35 U.S.C. 113, the Office of Patent Application Processing (OPAP) will send a notice requiring drawings and a time period within which drawings must be filed in order to avoid abandonment.’

It’s important to note that drawings are required when necessary to understand the invention. If drawings are not necessary, the application can proceed without them.

To learn more:

Filing a foreign patent application without the required license can have severe consequences, including:

As stated in 35 U.S.C. 185: “Notwithstanding any other provisions of law any person, and his successors, assigns, or legal representatives, shall not receive a United States patent for an invention if that person, or his successors, assigns, or legal representatives shall, without procuring the license prescribed in section 184, have made, or consented to or assisted another’s making, application in a foreign country for a patent or for the registration of a utility model, industrial design, or model in respect of the invention.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

Failure to timely submit the reference to the prior-filed application within the time periods specified in 37 CFR 1.78 is considered a waiver of any benefit claim under 35 U.S.C. 120, 121, 365(c), or 386(c) to the prior-filed application. See 37 CFR 1.78(d)(3)(iii). The time periods are not extendable.

If the reference to the prior-filed application is submitted after the time period provided by 37 CFR 1.78, a petition and the petition fee under 37 CFR 1.17(m) would be required to accept the delayed claim. The petition must be accompanied by:

  • The reference required by 35 U.S.C. 120 and 37 CFR 1.78 to the prior-filed application
  • The petition fee
  • A statement that the entire delay between the date the benefit claim was due and the date the claim was filed was unintentional

What are the consequences of failing to submit an Information Disclosure Statement (IDS)?

Failing to submit an Information Disclosure Statement (IDS) can have serious consequences for patent applicants. According to MPEP 609:

“The failure to timely file an Information Disclosure Statement may result in the application being abandoned or may adversely affect the validity of the patent.”

Specifically:

  • The application may be abandoned if the IDS is not filed within the time periods specified in 37 CFR 1.97.
  • If a patent is granted, it may be invalidated if it’s later discovered that material information was intentionally withheld from the USPTO during prosecution.
  • The applicant may be accused of inequitable conduct, which can render the entire patent unenforceable.

It’s crucial for applicants to diligently submit all known material information to the USPTO through proper IDS filings to avoid these potential issues.

To learn more:

Failing to submit a proper oath or declaration in a patent application can have serious consequences:

  • The application may be considered incomplete and subject to abandonment.
  • A Notice to File Missing Parts will be issued, requiring submission of the oath or declaration.
  • A surcharge may be required for late submission.
  • The application will not be examined until a proper oath or declaration is received.

According to MPEP 602.01(a): “If the application is in condition for allowance but does not include an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement in compliance with 37 CFR 1.64, executed by or with respect to each actual inventor, the Office will issue a ‘Notice of Allowability’ (PTOL-37) requiring the oath or declaration.” Failure to comply with this notice can result in abandonment of the application.

To learn more:

Tags: declaration, oath

Failing to respond to an Office of Patent Application Processing (OPAP) notice regarding missing drawings can have serious consequences for a patent application. The outcomes differ depending on whether the application is nonprovisional or provisional:

For Nonprovisional Applications:

The MPEP clearly states: Failure to timely reply to the OPAP notice in a nonprovisional application will result in abandonment of the application.

This means:

  • The application will be considered abandoned
  • The applicant will lose their filing date
  • To continue pursuing patent protection, the applicant would need to file a new application or petition to revive the abandoned application

For Provisional Applications:

The consequences are less severe for provisional applications. The MPEP notes: For provisional applications in which applicant accepts the application as deposited by failing to timely file a petition in response to an OPAP notice regarding omitted items, if the provisional application is complete under 37 CFR 1.51(c), it will be held in the Office’s Image File Wrapper (IFW) system and automatically abandoned at the end of its pendency period.

This means:

  • The provisional application remains on file for its 12-month pendency period
  • It can still serve as a priority document for a later-filed nonprovisional application
  • However, the missing drawings will not be part of the application’s disclosure

It’s crucial for applicants to carefully review and respond to any OPAP notices to avoid potential loss of rights or limited disclosure in their patent applications.

To learn more:

The consequences of failing to respond to a 37 CFR 1.251 notice differ for pending applications and granted patents:

  • For pending applications: Failure to reply within the set time period will result in abandonment of the application. MPEP 508.04 cites 37 CFR 1.251(b): “With regard to a pending application, failure to comply with one of paragraphs (a)(1), (a)(2), or (a)(3) of this section within the time period set in the notice will result in abandonment of the application.”
  • For granted patents: While the patent won’t expire, there may be limitations on the certified copy of the patent file that the Office can produce. MPEP 508.04 states: “While abandonment (or expiration) of a patent is not an issue if a patentee fails to timely comply with a notice under 37 CFR 1.251, in such a situation the only certified copy of the patent file that the Office will be able to produce will be a copy of the patent and a copy of the application-as-filed (which may have an adverse impact during attempts to enforce the patent).”

Additionally, for patents involved in proceedings before the Office, action may be taken under 37 CFR 41.128 or 37 CFR 11.18.

What are the consequences of failing to record a patent assignment with the USPTO?

Failing to record a patent assignment with the USPTO can have several important consequences:

  • Lack of legal notice: As stated in MPEP 302, ‘An assignment recorded in the Office is regarded as notice to the world of the ownership of the patent.’ Without recording, third parties may not have legal notice of the assignment.
  • Potential validity issues: In some cases, failure to record an assignment could affect the validity of subsequent actions taken by the assignee.
  • Difficulties in enforcement: Unrecorded assignments may complicate patent enforcement efforts, as the assignee’s standing to sue could be challenged.
  • Problems in future transactions: Lack of a clear chain of title can cause issues in future sales, licenses, or other transactions involving the patent.

While recording is not mandatory, it is highly recommended to protect the assignee’s rights and ensure a clear chain of title for the patent.

For more information on legal notice, visit: legal notice.

For more information on patent assignment, visit: patent assignment.

Failing to meet the disclosure requirements when claiming benefit of an earlier application can have several consequences:

  • Loss of earlier filing date for affected claims
  • Potential invalidity of the patent if issued
  • Exposure to prior art that would have been otherwise excluded
  • Possible rejection under 35 U.S.C. 102 or 103

The MPEP 211.05 provides an example of such consequences:

“In New Railhead, the patented drill bit was the subject of a commercial offer for sale. A provisional application was filed after the sale offer, but well within the one year grace period of 35 U.S.C. 102(b). A nonprovisional application, which issued as Patent No. 5,899,283, was filed within one year of the filing of the provisional application but more than one year after the sale offer. If the ‘283 patent was not afforded the benefit date of the provisional application, the patent would be invalid under 35 U.S.C. 102(b) since it was filed more than one year after the commercial offer for sale.”

This example illustrates how failing to meet disclosure requirements can lead to patent invalidity due to intervening prior art. It’s crucial for applicants to ensure that earlier-filed applications provide adequate support for later-claimed inventions to maintain the desired priority date and avoid potential rejections or invalidations.

To learn more:

Failing to comply with the inventor’s oath or declaration requirements can have serious consequences for a patent application or an issued patent. However, the America Invents Act (AIA) introduced some provisions to mitigate these consequences. According to 35 U.S.C. 115(h)(3):

A patent shall not be invalid or unenforceable based upon the failure to comply with a requirement under this section if the failure is remedied as provided under paragraph (1).

This means that:

  • A patent will not be automatically invalidated or rendered unenforceable due to defects in the oath or declaration
  • The applicant or patentee has the opportunity to remedy any deficiencies in the oath or declaration

However, it’s important to note that while this provision provides some protection, it’s still crucial to comply with the oath or declaration requirements to avoid potential issues or delays in the patent prosecution process. Failure to provide a proper oath or declaration can result in:

  • Delays in the examination process
  • Increased costs due to the need for corrections or additional filings
  • Potential challenges to the validity of the patent in litigation

Therefore, applicants should make every effort to ensure that the inventor’s oath or declaration is properly executed and contains all required information and statements as specified in 37 CFR 1.63 and 35 U.S.C. 115.

To learn more:

What are the consequences of bounced checks or insufficient funds for USPTO fee payments?

Submitting a check that bounces or having insufficient funds for USPTO fee payments can have serious consequences. The MPEP 509 states: ‘If any fee is paid by a check which is uncollectible or is returned unpaid, or if any payment is made in an amount less than the required amount, the fee payment shall be regarded as incomplete and the processing of the application or other filing shall be held in abeyance until the full fee payment is made.’

Consequences may include:

  • Suspension of application processing
  • Potential loss of filing date
  • Additional fees or penalties
  • Possible disciplinary action for repeated occurrences

To avoid these issues, ensure sufficient funds are available and consider using more reliable payment methods like electronic funds transfer or credit cards.

To learn more:

Tags: USPTO fees

An ineffective incorporation by reference in a patent application can have several consequences:

  1. The incorporated material may not be considered part of the application disclosure.
  2. This could result in rejections under 35 U.S.C. 112 for lack of written description or enablement.
  3. The application may lose the benefit of an earlier filing date if the incorporation was meant to provide essential subject matter.
  4. Corrections may be required, which could delay prosecution.

According to 37 CFR 1.57(h): ‘An incorporation of material by reference that does not comply with paragraphs (c), (d), or (e) of this section is not effective to incorporate such material unless corrected within any time period set by the Office, but in no case later than the close of prosecution as defined by § 1.114(b), or abandonment of the application, whichever occurs earlier.’

It’s crucial to ensure that all incorporations by reference are properly executed to avoid these potential issues.

To learn more:

To learn more:

What are the consequences of an improper title in a patent application?

An improper title in a patent application can lead to several consequences:

  • Rejection or objection: The USPTO may reject or object to the application if the title doesn’t meet the requirements outlined in MPEP 606.
  • Delayed processing: An improper title may cause delays in processing the application as it may need to be corrected.
  • Misclassification: An inaccurate or vague title might result in the application being misclassified, potentially affecting the examination process.
  • Difficulty in prior art searches: A poor title can make it harder for examiners to conduct effective prior art searches, potentially impacting the examination quality.

As stated in MPEP 606, The title of the invention should be placed at the top of the first page of the specification unless it is provided in an application data sheet. The title should be brief but technically accurate and descriptive and should contain fewer than 500 characters. Adhering to these guidelines helps avoid potential issues and ensures smooth processing of the application.

To learn more:

Improper signatures on patent correspondence can have serious consequences. While the MPEP 502.02 doesn’t explicitly list all consequences, it emphasizes the importance of proper signatures:

Correspondence filed in the Office by applicants and other parties must be signed by the applicants or other party, or by a registered patent attorney or agent of record in the patent application or patent.

The potential consequences of an improper signature include:

  • Rejection or return of the correspondence
  • Delays in processing the application or request
  • Potential loss of rights or missed deadlines
  • Requirement for ratification or confirmation of the signature
  • In severe cases, charges of fraud or inequitable conduct

To avoid these issues, it’s crucial to ensure all signatures comply with USPTO requirements as outlined in 37 CFR 1.4 and MPEP 502.02. When in doubt, consult with a registered patent attorney or agent to verify proper signature practices.

To learn more:

What are the consequences of adding new matter to a patent application?

Adding new matter to a patent application can have serious consequences:

  • Rejection or objection: The USPTO will issue a rejection or objection to the new matter. As stated in MPEP 608.04, ‘If new matter is added to the claims, the examiner should reject the claims under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph – written description requirement.’
  • Loss of priority date: New matter may result in a later effective filing date for the affected claims.
  • Inability to claim benefit: As per the MPEP, ‘New matter includes not only the addition of wholly unsupported subject matter, but may also include adding specific percentages or compounds after a broader original disclosure, or even the omission of a step from a method.’
  • Need for continuation-in-part: To properly include the new matter, a continuation-in-part application may be necessary.

It’s crucial to ensure all subject matter is fully supported by the original disclosure to avoid these issues.

To learn more:

To learn more:

Tags: new matter

When a typographical error on the original cover sheet affects the title to the application or patent against which the assignment or name change is recorded, the consequences are more significant:

  • The recording party will not be entitled to keep the original date of recordation
  • The Assignment Services Division will correct its automated records
  • The date of recordation will be changed to the date the corrected cover sheet was received in the Office

As stated in MPEP 323.01(a): “If the original cover sheet contains a typographical error that affects title to the application or patent against which the assignment or name change is recorded, the recording party will not be entitled to keep the original date of recordation. Rather, the Assignment Services Division will correct its automated records and change the date of recordation to the date the corrected cover sheet was received in the Office.”

This approach ensures that errors affecting the substance of the assignment or title are properly addressed, even if it means adjusting the recordation date. It’s crucial for patent owners and assignees to be aware of this policy to avoid potential issues with priority dates or legal standing.

To learn more:

For unpublished patent applications, confidentiality is a critical concern. The MPEP states:

An interview concerning an application that has not been published under 35 U.S.C. 122(b) with an attorney or agent not of record who obtains authorization through use of the interview request form will be conducted based on the information and files supplied by the attorney or agent in view of the confidentiality requirements of 35 U.S.C. 122(a).

This means that for unpublished applications, the USPTO will only discuss information provided by the attorney or agent to maintain confidentiality. The examiner cannot disclose any information from the application file that hasn’t been supplied by the practitioner.

For more information on unpublished applications, visit: unpublished applications.

There are several key conditions that must be met to use incorporation by reference under 37 CFR 1.57(b):

  1. The application must have been filed on or after September 21, 2004
  2. Material must have been inadvertently omitted from the application
  3. A priority or benefit claim to a prior-filed application must have been present on the filing date
  4. The omitted material must be completely contained in the prior-filed application
  5. An amendment to add the omitted material must be filed within the time period set by the USPTO
  6. Other requirements like supplying copies of prior applications may apply

As stated in the MPEP: “The following conditions and requirements need to be met for an applicant to add omitted material to an application pursuant to 37 CFR 1.57(b):” followed by a list of specific conditions labeled (A) through (I).

The right of priority under 35 U.S.C. 386(a) or (b) for international design applications is subject to specific conditions:

  • It applies only to nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing from them.
  • For nonprovisional applications, priority can be claimed with respect to a prior international design application that designates at least one country other than the United States.
  • For international design applications designating the United States, priority can be claimed with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: The right of priority under 35 U.S.C. 386(a) or (b) with respect to an international design application is applicable only to nonprovisional applications, international applications, and international design applications filed on or after May 13, 2015, and patents issuing thereon.

To learn more:

To learn more:

A later-filed application for patent in the United States may claim the benefit of, or priority to, a prior application under certain conditions. These conditions are outlined in various U.S. statutes and regulations:

The specific requirements and time frames may vary based on the filing date of the later-filed nonprovisional application and the type of priority or benefit claim being made.

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

For more information on prior-filed application, visit: prior-filed application.

When filing a Continued Prosecution Application (CPA), there are specific conditions under which the prior application may be automatically abandoned. According to MPEP 201.06(d):

A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA. See 37 CFR 1.53(d)(2)(v).

However, it’s important to note that:

  • The prior application is only expressly abandoned if the CPA is properly filed.
  • If the CPA is improper (e.g., filed in a utility application), the express abandonment of the prior application will not be effective.
  • The abandonment of the prior application is automatic upon the filing date of the properly filed CPA.

This automatic abandonment provision ensures a clear transition from the prior application to the CPA, which is particularly relevant for design applications where CPAs are permitted.

For more information on CPA, visit: CPA.

Tags: CPA

The abandonment of an international application in the United States is governed by specific legal provisions. According to MPEP 211.01(c), which cites 35 U.S.C. 371(d):

35 U.S.C. 371(d) indicates that failure to timely comply with the requirements of 35 U.S.C. 371(c) ‘shall be regarded as abandonment of the application by the parties thereof.’

This means that an international application designating the United States will be considered abandoned if the applicant fails to meet the requirements for entering the national stage under 35 U.S.C. 371(c) within the specified time limits. These requirements typically include submitting necessary documents, paying required fees, and providing an English translation of the application if it was not originally filed in English.

For more information on national stage entry, visit: national stage entry.

For a national application to claim the benefit of a prior international application designating the United States, certain conditions must be met. MPEP 211.01(c) outlines these conditions, referencing 35 U.S.C. 365(c) and 35 U.S.C. 120:

The first sentence of 35 U.S.C. 365(c) specifically provides that ‘[i]n accordance with the conditions and requirements of section 120,… a national application shall be entitled to the benefit of the filing date of a prior international application designating the United States.’

The key conditions include:

  • The international application must designate the United States
  • The national application must be filed before the patenting, abandonment, or termination of proceedings on the international application
  • The national application must contain a specific reference to the international application
  • The international application must comply with the requirements of 35 U.S.C. 371(c)

Additionally, the MPEP states:

The condition of 35 U.S.C. 120 relating to the time of filing requires the later application to be ‘filed before the patenting or abandonment of or termination of proceedings on the first application….’

Meeting these conditions allows applicants to claim the earlier filing date of the international application, which can be crucial for establishing priority and overcoming prior art references.

To learn more:

To learn more:

OPAP may object to patent drawings for several reasons, including:

  1. Line quality issues
  2. Missing lead lines
  3. Excessive or non-English text
  4. Incorrect margins or paper size
  5. Improper figure labeling
  6. Illegible photographs
  7. Unauthorized color drawings or photographs

For example, regarding line quality, MPEP 507 states:

OPAP may object to and require corrected drawings within a set time period, if the drawings: (A) have a line quality that is too light to be reproduced (weight of all lines and letters must be heavy enough to permit adequate reproduction) or text that is illegible (reference characters, sheet numbers, and view numbers must be plain and legible). See 37 CFR 1.84(l) and (p)(1);

The MPEP outlines several reasons why an amendment might not comply with 37 CFR 1.57(b). These include:

  • The application was filed before September 21, 2004 (the effective date of the provisions)
  • The claim for priority/benefit of the prior-filed application was not present on the filing date
  • The omitted portion is not completely contained in the prior-filed application
  • A copy of the prior-filed application was not submitted (except for applications filed under 35 U.S.C. 111)
  • An English language translation of a non-English prior-filed application was not submitted
  • The applicant did not identify where the omitted portion can be found in the prior-filed application

If any of these conditions are not met, the examiner will state that the amendment to add inadvertently omitted material pursuant to 37 CFR 1.57(b) filed [date] is not in compliance with 37 CFR 1.57(b) because [specific reason].

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

MPEP 203.05 outlines several circumstances under which a patent application can become abandoned:

  1. Through formal abandonment by the applicant or by the attorney or agent of record;
  2. Through failure of applicant to take appropriate action at some stage in the prosecution of a nonprovisional application;
  3. For failure to pay the issue fee (see MPEP § 711 to § 711.05); or
  4. In the case of a provisional application, no later than 12 months after the filing date of the provisional application (see MPEP § 711.03(c) and 35 U.S.C. 111(b)(5)).

An abandoned application is removed from the Office docket of pending applications. It’s important to note that abandonment can occur unintentionally, such as missing a deadline, or intentionally, such as when an applicant decides not to pursue the application further.

The Patent Law Treaties Implementation Act (PLTIA) made several changes to priority and benefit claims, including:

  • Restoration of the right of priority to a foreign application or benefit of a provisional application within two months of the deadline
  • Ability to file international design applications
  • Claiming priority to and benefit of international design applications

The MPEP notes: “Notable changes to the law and rules included the restoration of the right of priority to a foreign application or the benefit of a provisional application in a subsequent application filed within two months of the expiration of the twelve-month period (six-month period for design applications) for filing such a subsequent application.” (MPEP 210)

The USPTO has specific certification requirements for signatures in correspondence. According to MPEP 501, which cites 37 CFR 1.4(d)(4):

The person inserting a signature under paragraph (d)(2) or (d)(3) of this section in a document submitted to the Office certifies that the inserted signature appearing in the document is his or her own signature. A person submitting a document signed by another under paragraph (d)(2) or (d)(3) of this section is obligated to have a reasonable basis to believe that the person whose signature is present on the document was actually inserted by that person, and should retain evidence of authenticity of the signature.

Key points about signature certifications:

  • The person inserting an S-signature certifies it as their own.
  • When submitting a document signed by another, you must have a reasonable belief that the signature is authentic.
  • Evidence of signature authenticity should be retained.
  • Violations of certification rules may result in sanctions.

These requirements apply to both handwritten and S-signatures. They ensure the integrity and authenticity of documents submitted to the USPTO.

For more information on USPTO correspondence, visit: USPTO correspondence.

The Electronic Patent Assignment System (EPAS) offers several benefits for submitting assignment documents to the USPTO. While not explicitly stated in MPEP 302.10, the following advantages can be inferred:

  • Convenience: Users can submit documents directly from their computer, eliminating the need for physical mailing.
  • Efficiency: Electronic submission can be faster than traditional paper-based methods.
  • Direct Integration: As stated in the MPEP, EPAS allows submission “directly into the automated Patent and Trademark Assignment System,” potentially reducing processing times.
  • Flexibility: Various types of documents related to title can be submitted through the system.
  • Multiple Payment Options: Users can pay fees using credit card, electronic fund transfer, or deposit account.

These benefits make EPAS an attractive option for those needing to submit assignment documents to the USPTO.

To learn more:

What are the benefits of using EPAS for assignment submissions?

The Electronic Patent Assignment System (EPAS) offers several advantages for submitting assignment documents:

  • 24/7 availability for submissions
  • Immediate confirmation of receipt
  • Faster processing times compared to paper submissions
  • Reduced risk of errors through guided data entry
  • Ability to save and resume incomplete submissions

The MPEP 302.10 states, ‘Assignment documents can be electronically submitted via the Electronic Patent Assignment System (EPAS) by registered ePAS users.’ This system streamlines the assignment process and improves efficiency for both applicants and the USPTO.

To learn more:

Filing a CPA for a design patent application offers several benefits:

  • Minimal filing requirements compared to a regular continuation application
  • No new filing receipt is normally issued
  • Faster processing time, as it uses the same application number and file wrapper
  • For examination priority, CPAs are treated as “amended” applications rather than “new” applications, potentially resulting in faster examination
  • The prior application is automatically abandoned, simplifying the process

As stated in the MPEP: “A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).”

For more information on continuation application, visit: continuation application.

For more information on design patents, visit: design patents.

For more information on Divisional application, visit: Divisional application.

Filing a continuation application offers several benefits to patent applicants:

  1. Pursuing additional claims: As stated in MPEP 201.07, “The disclosure presented in the continuation must be the same as that of the original application; i.e., the continuation should not include anything which would constitute new matter if inserted in the original application.” This allows applicants to pursue different or broader claims based on the same disclosure.
  2. Extending prosecution: A continuation application provides more time to negotiate with the USPTO, potentially leading to stronger patent protection.
  3. Maintaining pendency: It keeps the application pending, which can be strategically important in fast-evolving technologies or competitive markets.
  4. Addressing new prior art: If new prior art emerges during the prosecution of the parent application, a continuation allows for claim adjustments to overcome this art.
  5. Commercial considerations: As products evolve or market conditions change, continuation applications allow for tailoring claims to cover new aspects of the invention or competitor products.

By utilizing continuation applications strategically, inventors and businesses can build a stronger patent portfolio and maintain flexibility in their intellectual property protection strategy.

For more information on patent strategy, visit: patent strategy.

Electronically submitting assignment documents to the USPTO offers several benefits:

  • Faster Processing: Electronic submissions are typically processed more quickly than paper submissions.
  • Immediate Confirmation: You receive immediate confirmation of your submission.
  • Cost-Effective: No mailing costs or delays associated with physical delivery.
  • 24/7 Availability: You can submit documents at any time, not limited to office hours.
  • Reduced Risk of Loss: Electronic submissions minimize the risk of documents being lost in transit.
  • Environmentally Friendly: Reduces paper usage and associated environmental impacts.

The MPEP 302.10 states: “Assignment documents can be submitted to the Office electronically via the Office’s Electronic Patent Assignment System (EPAS).” This system is designed to streamline the submission process and provide these benefits to patent applicants and owners.

To learn more:

Filing a provisional patent application offers several benefits but also has limitations:

Benefits:

  • Establishes an early filing date quickly and inexpensively
  • Allows use of ‘Patent Pending’ for up to 12 months
  • Provides time to assess commercial potential before filing a nonprovisional application
  • Does not require claims or an oath/declaration

Limitations:

  • Limited 12-month pendency
  • Cannot directly mature into a patent
  • Not examined for patentability
  • Cannot claim priority to any earlier applications

The MPEP notes: A provisional application is not entitled to the right of priority of any other application under 35 U.S.C. 119 or 365(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121 or 365(c) or § 1.78 of any other application.

Additionally, No claim for priority under 35 U.S.C. 119(e) or § 1.78(a)(4) may be made in a design application based on a provisional application. This limits the use of provisional applications in certain contexts.

For more information on USPTO Guidelines, visit: USPTO Guidelines.

Filing a continuation-in-part (CIP) application has several benefits and potential drawbacks:

Benefits:

  • Allows addition of new subject matter to an existing invention
  • Maintains the priority date of the original application for common subject matter
  • Provides an opportunity to strengthen the patent application with new data or improvements
  • Allows for changes in inventorship to reflect new contributions

Drawbacks:

  • New subject matter only gets the filing date of the CIP, potentially exposing it to more prior art
  • Can complicate the patent term calculation
  • May result in multiple patents with overlapping subject matter, requiring terminal disclaimers
  • Increases overall costs due to additional filing and prosecution fees

The MPEP notes: “The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

Inventors and patent attorneys should carefully consider these factors when deciding whether to file a CIP or a new application.

For more information on new subject matter, visit: new subject matter.

For more information on patent strategy, visit: patent strategy.

To obtain a filing date for a nonprovisional utility patent application filed on or after 12/18/2013, the application must include:

  • A specification with or without claims (35 U.S.C. 111(a)(2)(A))
  • Drawings, if necessary for an understanding of the invention (35 U.S.C. 111(a)(2)(B)), but see 37 CFR 1.81(a) for applications filed before 12/18/2013 requiring drawings where they are necessary for the understanding of the invention
  • The inventor’s oath or declaration, which may be filed later if an application data sheet (ADS) is submitted identifying the inventor(s) (35 U.S.C. 111(a)(2)(C) and 115)
  • The applicable filing fees (basic filing fee, search fee, examination fee, any required excess claims fees) (35 U.S.C. 41 and 37 CFR 1.16)

An application missing any of the above items will be treated as incomplete and no filing date will be granted until the missing item(s) are submitted.

What are the basic requirements for entering the national stage in the US?

To enter the national stage in the United States, applicants must fulfill several basic requirements. According to the MPEP:

  • File a copy of the international application (unless previously communicated by the International Bureau or waived)
  • Submit an English language translation of the international application (if not in English)
  • Pay the basic national fee
  • Submit an oath or declaration of the inventor(s)

The MPEP states: For national stage applications having an international filing date on or after September 16, 2012, the requirement for the inventor’s oath or declaration or substitute statement has been eliminated as a requirement for completing national stage entry. The inventor’s oath or declaration is not required until the application is otherwise in condition for allowance.

It’s important to note that while the inventor’s oath or declaration is not required for initial national stage entry, it must be submitted before the application can be allowed.

To learn more:

The basic filing requirements for a nonprovisional patent application under 35 U.S.C. 111(a) are:

  • A specification (with or without claims)
  • Any required drawings
  • The appropriate filing fee, search fee, and examination fee
  • An oath or declaration

The MPEP states: The procedure for filing a nonprovisional application under 35 U.S.C. 111(a) is set forth in 37 CFR 1.53(b) and 37 CFR 1.53(d). For applications filed on or after December 18, 2013, the filing date is generally the date when the specification is received by the USPTO, with or without claims.

To learn more:

To learn more:

According to MPEP 301, patents have the attributes of personal property. The MPEP states:

’35 U.S.C. 261 Ownership; assignment. Subject to the provisions of this title, patents shall have the attributes of personal property.’

This means that patents can be bought, sold, licensed, or transferred like other forms of property. However, it’s important to note that owning a patent doesn’t necessarily grant the right to practice the invention, as other legal considerations may apply.

For more information on patent rights, visit: patent rights.

For more information on personal property, visit: personal property.

The assignment rules for substitute and continuation-in-part applications differ from those for division and continuation applications. As per the MPEP, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

This means that for substitute or continuation-in-part applications, a new assignment must be recorded if they are to be issued to an assignee. However, there’s an exception: unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

For more detailed information, refer to MPEP § 307 and MPEP § 308.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on patent assignment, visit: patent assignment.

For more information on substitute application, visit: substitute application.

The USPTO provides several methods for checking application status:

  • Patent Application Information Retrieval (PAIR) system: This is the primary method for checking application status online.
  • Automated voice response system: Available at 703-308-4357 for limited status information.
  • USPTO Contact Center: Available for general information at 800-786-9199.

As stated in MPEP 203.08: “Inquiries as to the status of applications, by persons entitled to the information, should be answered promptly. It is forbidden, however, to give information concerning the date of filing applications, the names of the inventors, or the prosecution of the application to persons not entitled to receive information.”

To learn more:

Tags: USPTO

After a patent is granted, the applicant has specific responsibilities regarding models, exhibits, or specimens:

  • The applicant is responsible for retaining the actual model, exhibit, or specimen for the enforceable life of the patent.
  • This responsibility does not apply if:
    • The model or exhibit substantially conforms to the requirements of 37 CFR 1.52 or 1.84.
    • The model or exhibit has been described by photographs that substantially conform to 37 CFR 1.84.
    • The model, exhibit, or specimen is perishable.

As stated in 37 CFR 1.94(b), Applicant is responsible for retaining the actual model, exhibit, or specimen for the enforceable life of any patent resulting from the application. This ensures that the item is available if needed for future reference or legal proceedings.

To learn more:

Tags: patent grant

Filing a provisional patent application offers several advantages, as outlined in the MPEP:

  1. Establishing Priority: It allows applicants to quickly and inexpensively file provisional applications and establish a priority date for their invention.
  2. Paris Convention Priority: It starts the Paris Convention priority year, allowing foreign filings within 12 months while maintaining the U.S. filing date.
  3. Simplified Filing: As stated in the MPEP, No claim is required in a provisional application and No oath or declaration is required in a provisional application.
  4. Patent Term: The MPEP notes, The domestic priority period will not count in the measurement of the 20-year patent term. This puts domestic applicants… on equal footing with foreign applicants with respect to the patent term.
  5. Time for Development: It provides a 12-month period to further develop the invention before filing a nonprovisional application.

These advantages make provisional applications a useful tool for inventors to secure an early filing date while allowing time for further development and market assessment.

For more information on patent strategy, visit: patent strategy.

For more information on patent term, visit: patent term.

For more information on provisional application, visit: provisional application.

Filing a Continued Prosecution Application (CPA) for design patents has several advantages over filing a regular continuation application under 37 CFR 1.53(b):

  • Minimal filing requirements – only a request on a separate paper and the filing fee are needed
  • No new oath or declaration is required
  • Faster processing – the CPA uses the file and contents of the prior application
  • Potentially faster examination – CPAs are often treated as “amended” applications for examination priority
  • No need for a new specification or drawings

The MPEP notes: “A CPA has a number of advantages compared to a continuation or divisional application filed under 37 CFR 1.53(b). For example, the papers required to be filed in the U.S. Patent and Trademark Office in order to secure a filing date under 37 CFR 1.53(d) are minimal compared to 37 CFR 1.53(b).”

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

Electronically submitting assignment documents offers several advantages:

  • Faster recordation: Electronic submissions are processed more quickly than paper submissions.
  • Reduced risk of loss: Electronic documents are less likely to be misplaced or lost in transit.
  • Immediate confirmation: You receive instant confirmation of your submission.
  • 24/7 accessibility: You can submit documents at any time, not just during business hours.

The MPEP 302.10 states: “Assignment documents filed electronically are recorded faster and are less likely to become lost or misplaced.” This underscores the efficiency and reliability of electronic submissions.

To learn more:

The USPTO accepts two primary methods for submitting biological sequence listings in patent applications:

  1. USPTO patent electronic filing system: This is the preferred method for submitting sequence listings.
  2. Read-only optical disc: An alternative method if electronic filing is not possible.

These submission methods apply to both pre-July 1, 2022, and post-July 1, 2022 applications. As stated in MPEP 608.05(c): “[…] submission must be submitted via the USPTO patent electronic filing system or on read-only optical disc.”

It’s important to note that the file format requirements differ based on the application filing date, but the submission methods remain the same.

To learn more:

What are the accepted payment methods for patent fees?

The USPTO accepts various payment methods for patent fees:

  • Credit or debit card
  • Electronic funds transfer (EFT)
  • Deposit account
  • Check or money order

As stated in MPEP 509: ‘Fees may be paid by U.S. credit card, electronic funds transfer (EFT), deposit account, check or money order.’ Electronic payment methods are preferred for their efficiency and speed.

To learn more:

The USPTO accepts various methods of payment for patent and trademark process fees. According to MPEP 509, the primary methods include:

  • Credit cards (AMERICAN EXPRESS®, DISCOVER®, MASTER CARD®, and VISA®)
  • Deposit accounts
  • Electronic funds transfer (EFT)
  • Other forms of payment accepted by the Office

It’s important to note that credit card payments are subject to a transaction maximum. As stated in the MPEP: Effective June 1, 2015, the credit card transaction maximum is $24,999.99 as specified in section 7045 of the ‘Treasury Financial Manual.’ This limit does not apply to other payment methods.

To learn more:

Tags: USPTO fees

The USPTO accepts several methods for submitting documents for recordation. According to MPEP 302.06:

  • Electronic submission
  • Paper submission
  • Facsimile (fax) submission

The MPEP states: See MPEP §§ 302.08 – 302.10 for additional information regarding the acceptable ways to submit documents for recordation.

It’s important to note that the method of submission can affect the recording fee. Electronic submissions currently have a $0 fee, while paper and fax submissions may incur a fee as set forth in 37 CFR 1.21(h)(2).

To learn more:

What are the acceptable methods for filing papers with the USPTO?

The USPTO accepts several methods for filing papers:

  • Hand-delivery to the USPTO office in Alexandria, Virginia
  • First-class mail through the United States Postal Service (USPS)
  • Express Mail service of the USPS
  • Electronic filing through the USPTO’s Electronic Filing System (EFS-Web)

As stated in MPEP 501: ‘Papers may be filed using first class mail through the United States Postal Service.’ The MPEP also notes that ‘Correspondence may be hand-carried to the Office.’ For electronic filing, it’s important to note that ‘EFS-Web can be used to file new applications, enter the national stage under 35 U.S.C. 371, and submit most follow-on documents in patent applications.’

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on Express Mail, visit: Express Mail.

For more information on first-class mail, visit: first-class mail.

For more information on hand-delivery, visit: hand-delivery.

According to 37 CFR 1.84(a), there are two acceptable categories for presenting drawings in utility and design patent applications:

  1. Black ink drawings: Black and white drawings are normally required. India ink or its equivalent must be used to secure solid black lines.
  2. Color drawings/photographs: Color drawings are permitted in design applications without a petition. For utility applications, color drawings or photographs require a granted petition explaining why color is necessary.

Additionally, grayscale drawings and black and white photographs may be acceptable in certain circumstances, such as when they are the only practicable medium for illustrating the claimed invention.

To learn more:

Reissue applications are used to correct errors in already issued patents. According to MPEP 201:

‘An application for reissue is made by the patentee when the patent is, through error without any deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent.’

Key points about reissue applications:

  • They are filed under 35 U.S.C. 251.
  • They can be used to broaden or narrow the scope of patent claims.
  • There are time limitations for broadening reissues (within two years from the grant of the original patent).

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue application, visit: reissue application.

MPEP 201.01 briefly mentions reissue applications as one of the types of national applications. Specifically, it states:

‘National applications include original applications and reissue applications (filed under 35 U.S.C. 251).’

Reissue applications are a specialized type of patent application used to correct errors in an already issued patent. They are governed by 35 U.S.C. 251, which allows a patentee to apply for a reissue of their patent if it is deemed to be wholly or partly inoperative or invalid due to certain types of errors.

For more detailed information on reissue applications, refer to MPEP 1400 – Correction of Patents.

For more information on Patent correction, visit: Patent correction.

For more information on Patent errors, visit: Patent errors.

For more information on reissue applications, visit: reissue applications.

Provisional applications are a type of patent application that allows inventors to establish an early filing date without the formal requirements of a non-provisional application. According to MPEP 201:

‘A provisional application is a U.S. national application for patent filed in the USPTO under 35 U.S.C. 111(b).’

Key differences between provisional and non-provisional applications:

  • Provisional applications have a simplified filing process and lower fees.
  • They do not require formal patent claims or an oath or declaration.
  • Provisional applications are not examined and automatically expire after 12 months.
  • To obtain patent protection, a non-provisional application claiming benefit of the provisional must be filed within 12 months.

Non-provisional applications, on the other hand, are formal patent applications that are examined by the USPTO and can result in an issued patent if approved.

For more information on Non-provisional application, visit: Non-provisional application.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

March-in rights are a provision of the Bayh-Dole Act that allow the government to intervene in certain circumstances:

  • The government can require the contractor or exclusive licensee to grant a license to a responsible applicant.
  • If the contractor or licensee refuses, the government can grant the license itself.
  • These rights are exercised only in specific situations, such as when the contractor is not taking effective steps to achieve practical application of the invention.

The MPEP explains: ‘March-in rights allow the government to grant licenses to other parties… where the contractor has failed to take effective steps to achieve practical application of the invention.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

For more information on patent licensing, visit: patent licensing.

International applications under the Patent Cooperation Treaty (PCT) are a type of patent application that provides a unified procedure for filing patent applications in its contracting states. According to MPEP 201:

‘An international application is a national application for patent which is filed under the Patent Cooperation Treaty (PCT).’

Key aspects of PCT applications:

  • Allow seeking patent protection in multiple countries simultaneously
  • Provide a streamlined filing process for international patent protection
  • Include an international search and optional international preliminary examination
  • Must enter the national phase in desired countries within specified timeframes
  • Do not result in an ‘international patent’ but facilitate national/regional patent grants

PCT applications are particularly useful for inventors seeking broad international patent protection.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

Excess claims fees are additional fees charged for patent applications that contain more than a certain number of claims. According to the MPEP:

  • 37 CFR 1.16(h) sets the fee for each independent claim in excess of three.
  • 37 CFR 1.16(i) sets the fee for each claim (independent or dependent) in excess of twenty.

The MPEP states: The excess claims fees specified in 37 CFR 1.16(h) and (i) apply to any excess claims fee paid, regardless of the filing date of the application and regardless of the date on which the claim necessitating the excess claims fee payment was added to the application.

These fees also apply to reissue applications, but the claims in the original patent are not counted when determining excess claims fees for a reissue application. For applications filed without claims, excess claims fees are due when the excess claims are presented in the application.

To learn more:

According to MPEP 608.01(r), derogatory remarks in a patent specification are:

“statements disparaging the products or processes of any particular person other than the applicant, or statements as to the merits or validity of applications or patents of another person.”

This means you should avoid criticizing specific inventions, products, or patents of others in your patent application. Instead, focus on describing your invention’s advancements without disparaging existing technologies.

To learn more:

Tags: prior art

MPEP 303 mentions conflicting claims as a situation where assignment information becomes crucial:

“When the assignment condition of an application is significant, such as when applications of different inventors contain conflicting claims…” (MPEP 303)

Conflicting claims occur when two or more patent applications claim the same or overlapping subject matter. This is significant because:

  • It may indicate potential ownership disputes
  • It can affect the novelty or non-obviousness of the claimed inventions
  • It might require the USPTO to initiate an interference or derivation proceeding

In such cases, examiners need to verify assignment information to determine the proper course of action.

While the MPEP 608.02(x) doesn’t provide an exhaustive list, it does mention several common reasons why drawing corrections might be rejected:

  • Erroneous corrections: The submitted changes contain errors or inaccuracies.
  • New matter: The corrections introduce new subject matter not supported by the original disclosure.
  • Incomplete corrections: The submission doesn’t include all necessary corrections identified by the examiner.

The MPEP states:

“Where the corrected or changed drawing is not accepted, for example, because the submitted corrections or changes are erroneous, or involve new matter or do not include all necessary corrections, the applicant will be notified and informed of any required corrective action in the next Office action.”

Applicants should carefully review their drawing corrections to ensure they address all issues raised by the examiner and don’t introduce new problems.

To learn more:

To learn more:

Common objections to patent drawings, as outlined in MPEP 608.02(e), include:

  • Failure to show essential structural details (Form Paragraph 6.22.01)
  • Different reference numbers referring to the same part (Form Paragraph 6.22.02)
  • The same reference number used for different parts (Form Paragraph 6.22.03)
  • Reference signs mentioned in the description but not in the drawings (Form Paragraph 6.22.06)
  • Reference characters in the drawings not mentioned in the description (Form Paragraph 6.22.07)

These objections are based on non-compliance with various sections of 37 CFR 1.84, which governs standards for drawings in patent applications.

To learn more:

Annotated sheets in patent drawings are marked-up copies of drawings that show proposed changes to the original drawings. According to MPEP 608.02(v), “When changes are to be made in the drawing itself, other than mere changes in reference characters, designations of figures, or inking over lines pale and rough, a marked-up copy of the drawing should be filed with a replacement drawing.” These annotated sheets are used to clearly indicate the modifications being made to the original drawings.

To learn more:

What are ‘march-in rights’ in government-funded inventions?

‘March-in rights’ are a significant aspect of government rights in federally funded inventions. As described in MPEP 310, these rights allow the government to require the contractor, assignee, or exclusive licensee of a subject invention to grant a license to a responsible applicant under certain circumstances. The MPEP states:

‘March-in rights permit the Government, in specified circumstances, to require the contractor or successors in title to the patent to grant a nonexclusive, partially exclusive, or exclusive license to a responsible applicant or applicants.’

These circumstances include:

  • Failure to take effective steps to achieve practical application of the invention
  • Health and safety needs not being reasonably satisfied
  • Public use requirements specified by Federal regulations not being met

March-in rights serve as a safeguard to ensure that federally funded inventions benefit the public.

For more information on patent licensing, visit: patent licensing.

In cases where an inventor does not execute the oath or declaration, such as when a substitute statement is filed, the USPTO requires specific address information. According to MPEP 602.08(a):

“In situations where an inventor does not execute the oath or declaration and the inventor is not deceased or legally incapacitated, such as in an application filed on or after September 16, 2012 in which a substitute statement under 37 CFR 1.64 is filed, the inventor’s most recent home address must be given to enable the Office to communicate directly with the inventor as necessary.”

This requirement ensures that the USPTO can maintain direct communication with the inventor if needed, even when they are not directly involved in executing the application documents.

To learn more:

For delayed priority claims filed more than two years after the due date, additional explanation is required. The MPEP states:

“A person filing a petition to accept a delayed priority claim more than two years after the date the foreign priority claim was due is required to provide additional explanation of the circumstances surrounding the delay that establishes that the entire delay was unintentional. This requirement is in addition to the requirement to provide a statement that the entire delay was unintentional in 37 CFR 1.55(e).”

This additional explanation helps the USPTO determine if the delay was truly unintentional, as required for acceptance of the delayed claim. Applicants should be prepared to provide a detailed account of the circumstances leading to the delay.

To learn more:

When correcting inventorship after an Office action on the merits has been given or mailed in the application, there are additional requirements:

  • Pay the fee set forth in 37 CFR 1.17(d) in addition to the processing fee
  • This additional fee is not required if inventors are being deleted due to claim cancellation

The MPEP states: 37 CFR 1.48(c) provides that the fee set forth in 37 CFR 1.17(d) (in addition to the processing fee) is required when requests under 37 CFR 1.48 are filed after the Office action on the merits has been given or mailed in the application. However, the fee will not be required when inventors are deleted if the request to correct or change inventorship is accompanied by a statement that the request to correct or change the inventorship is due solely to the cancelation of claims in the application.

To learn more:

After receiving a MPEP ¶ 2.05 notification, an applicant should take the following actions:

  1. Review the notification carefully: Understand the examiner’s assessment that the application may constitute a continuation or division.
  2. Verify the information: Confirm that the prior application number and filing date mentioned in the notification are correct.
  3. Assess the application’s status: Determine if the application should indeed be treated as a continuation, division, or both.
  4. File appropriate documents: If the application is intended to be a continuation or division, ensure that all necessary documents, such as a reference to the prior application under 35 U.S.C. 120, 121, or 365(c), are properly filed.
  5. Respond to the examiner: Provide any necessary clarifications or corrections regarding the application’s status.

The MPEP ¶ 2.05 notification states: “Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.” (MPEP ¶ 2.05)

It’s crucial to follow these steps promptly to ensure proper processing of the application and to secure any potential benefits of the earlier filing date.

For more information on applicant actions, visit: applicant actions.

For more information on continuation application, visit: continuation application.

When a patent practitioner dies, the law firm should take the following actions:

  • Promptly notify the USPTO’s Office of Enrollment and Discipline (OED) of the practitioner’s death.
  • Inform clients with pending applications about the situation and the need to appoint a new representative.
  • Assist clients in filing new powers of attorney or authorizations of agent for pending applications.
  • Provide the USPTO with updated correspondence addresses for affected applications.

The MPEP 406 states: ‘When it is known that the attorney or agent of record in an application is deceased, the Office should be promptly notified.’ This notification helps ensure a smooth transition and continued proper handling of patent applications.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO notification, visit: USPTO notification.

According to 37 CFR 5.1(d), an applicant must take one of three actions to prevent abandonment of a national security classified patent application without a Secrecy Order. The MPEP states: Pursuant to 37 CFR 5.1(d), if no Secrecy Order has issued in a national security classified patent application, the Office will set a time period within which the applicant must take one of the following three actions in order to prevent abandonment of the application: (A) obtain a Secrecy Order; (B) declassify the application; or (C) submit evidence of a good faith effort to obtain a Secrecy Order pursuant to 37 CFR 5.2(a). These actions ensure proper handling of potentially sensitive information.

For more information on patent abandonment, visit: patent abandonment.

An assignee of a pre-AIA patent application (filed before September 16, 2012) can take various actions once they have established ownership. According to MPEP 324, these actions include:

  • Signing a reply to an Office action
  • Requesting a continued prosecution application (CPA)
  • Signing a terminal disclaimer
  • Submitting a Fee(s) Transmittal form
  • Requesting status of an application
  • Appointing a registered patent practitioner to prosecute the application
  • Granting power to inspect an application
  • Consenting to the filing of a reissue application
  • Consenting to the correction of inventorship

The MPEP states: The owner or assignee (other than a juristic entity) of a patent property based on an application filed before September 16, 2012, can take action in a patent application or patent proceeding in numerous instances. However, it’s important to note that as of September 16, 2012, juristic entities must be represented by a patent practitioner for most actions.

For more information on assignee rights, visit: assignee rights.

For more information on patent prosecution, visit: patent prosecution.

For more information on pre-AIA applications, visit: pre-AIA applications.

When a patent application is ‘rejected’, the applicant has several options:

  1. Respond to the examiner’s action within the allotted reply period
  2. Request an interview with the examiner to discuss the rejection
  3. File an amendment to address the examiner’s concerns
  4. Present arguments challenging the rejection
  5. Allow the application to become abandoned if they choose not to pursue it further

According to MPEP 203.02:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

The most crucial action is to respond within the specified timeframe to prevent the application from becoming abandoned.

To learn more:

According to MPEP 203.03, an applicant has several options when responding to an examiner’s action:

The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

These options can be broken down as follows:

  • Election: Choosing between different inventions or species identified by the examiner.
  • Traverse: Arguing against the examiner’s rejections or objections.
  • Amendment: Modifying the application to address the examiner’s concerns or to clarify the invention.

To learn more:

What actions can a suspended or excluded practitioner take during the 30-day limited recognition period?

During the 30-day limited recognition period, suspended or excluded practitioners are allowed to perform specific actions to protect their clients’ interests. According to MPEP 407:

“During the 30-day period of limited recognition, the suspended or excluded practitioner may conclude work on behalf of a client on any matters that were pending before the Office on the date of entry of the order of suspension or exclusion.”

Specifically, the practitioner may:

  • Receive and forward correspondence related to pending matters
  • Make appropriate filings to protect the client’s rights
  • Conclude or withdraw from representation in pending proceedings
  • Perform limited actions necessary to transfer the client’s case to another registered practitioner

It’s important to note that this limited recognition does not allow the practitioner to take on new clients or file new patent applications during this period.

What actions can a practitioner take to preserve an applicant’s rights without a power of attorney?

A practitioner can take certain actions to preserve an applicant’s rights without a formal power of attorney, but these are generally limited to urgent situations. The MPEP 402.04 provides some examples:

  • Filing a patent application to prevent statutory bar
  • Filing a response to an Office action with a nearing deadline
  • Filing a notice of appeal when the period for appeal is about to expire

The MPEP states: ‘Such actions, if taken by a registered patent practitioner, will be accepted by the Office if submitted in a timely manner.’ However, it’s important to note that these actions are typically allowed only in emergencies to prevent the loss of patent rights. The practitioner should follow up with proper documentation of authority as soon as possible after taking such actions.

To learn more:

According to MPEP 325, a patent owner or assignee who has become the applicant can take various actions in a patent application. These include:

  • Signing a reply to an Office action (37 CFR 1.33(b)(3))
  • Requesting a continued prosecution application (CPA) under 37 CFR 1.53(d)
  • Filing a disclaimer under 37 CFR 1.321
  • Submitting a Fee(s) Transmittal (PTOL-85B)
  • Requesting the status of an application
  • Filing an application under 37 CFR 1.46
  • Appointing a registered patent practitioner to prosecute the application
  • Granting a power to inspect the application
  • Consenting to the filing of a reissue application
  • Consenting to the correction of inventorship

The MPEP notes: “As the applicant, the owner or assignee that is not a juristic entity can sign a reply to an Office action (37 CFR 1.33(b)(3)), a request for a continued prosecution application under 37 CFR 1.53(d) (MPEP § 201.06(d)), a disclaimer under 37 CFR 1.321 (MPEP § 1490), Fee(s) Transmittal (PTOL-85B) (MPEP § 1306), or a request for status of an application (MPEP § 102).”

It’s important to note that for juristic entities (e.g., corporations), many actions must be signed by a patent practitioner after September 16, 2012.

For more information on continued prosecution application, visit: continued prosecution application.

If a benefit claim is improper due to lack of copendency, the MPEP ¶ 2.11 outlines the required action:

Applicant is required to delete the claim to the benefit of the prior-filed application, unless applicant can establish copendency between the applications.

This means the applicant has two options:

  1. Delete the benefit claim to the prior-filed application, or
  2. Provide evidence to establish that copendency actually exists between the applications.

If the applicant cannot prove copendency, they must remove the benefit claim to avoid potential issues with the application’s validity or examination process.

For more information on copendency, visit: copendency.

For more information on patent procedure, visit: patent procedure.

When the required documents for a non-English provisional application are missing, the USPTO takes specific actions to notify the applicant. According to MPEP ¶ 2.38:

“Use this form paragraph to notify applicant that an English translation of the non-English language provisional application and/or a statement that the translation is accurate is required.”

The USPTO will issue an Office action informing the applicant of the missing documents and setting a time period for their submission. The applicant must then provide the missing translation and/or accuracy statement in the provisional application and confirm their filing in the present application. Failure to do so within the specified time period may result in the abandonment of the present application.

For more information on missing documents, visit: missing documents.

For more information on patent procedure, visit: patent procedure.

A national security classified patent application cannot be allowed until specific conditions are met. The MPEP clearly states: Pursuant to 37 CFR 5.1(e), a national security classified patent application will not be allowed until the application is declassified and any Secrecy Order pursuant to 37 CFR 5.2(a) has been rescinded. This means that both declassification of the application and rescission of any Secrecy Order are necessary prerequisites for allowance.

For more information on declassification, visit: declassification.

When a patent is granted on an application filed by someone other than the inventor, it is issued to the real party in interest. This is stipulated in both 35 U.S.C. 118 and 37 CFR 1.46(e):

35 U.S.C. 118 states: If the Director grants a patent on an application filed under this section by a person other than the inventor, the patent shall be granted to the real party in interest and upon such notice to the inventor as the Director considers to be sufficient.

37 CFR 1.46(e) further clarifies: If a patent is granted on an application filed under this section by a person other than the inventor, the patent shall be granted to the real party in interest. Otherwise, the patent may be issued to the assignee or jointly to the inventor and the assignee as provided in § 3.81.

Patent attorneys and examiners generally do not need to be concerned about ‘[Reserved]’ sections like MPEP 212. These sections contain no substantive information and do not affect current patent examination procedures. However, it’s good practice to stay informed about MPEP updates in case reserved sections are filled with new content in the future.

While providing the last known address where the nonsigning inventor customarily receives mail is the primary requirement, the MPEP suggests that additional addresses may be beneficial:

‘Inasmuch as a nonsigning inventor is notified that an application pursuant to pre-AIA 37 CFR 1.47 has been filed on his or her behalf, other addresses at which the nonsigning inventor may be reached should also be given.’

This recommendation aims to increase the chances of successfully notifying the nonsigning inventor about the application. If you’re aware of multiple addresses where the inventor might be reached, it’s advisable to include them all.

To learn more:

To learn more:

While the abstract itself should not include drawings, it can refer to them. The MPEP 608.01(b) provides guidance on including references to drawings and chemical formulas:

Where applicable, the abstract should include the following: (1) if a machine or apparatus, its organization and operation; (2) if an article, its method of making; (3) if a chemical compound, its identity and use; (4) if a mixture, its ingredients; (5) if a process, the steps.

When referencing drawings:

  • Use reference characters (in parentheses) when referring to parts shown in the drawings
  • Do not include actual drawings in the abstract itself

For chemical formulas, you can include them if they best summarize the invention, but ensure they fit within the 150-word limit and single-paragraph format.

To learn more:

Tags: drawings

Yes, each separate oath or declaration by an inventor should be complete in itself. The MPEP clearly states: “Each separate oath or declaration by an inventor should be complete in itself.” This guideline ensures that each inventor’s oath or declaration can stand alone and provide all necessary information without relying on other documents. This is particularly important for applications filed on or after September 16, 2012, where joint inventors may execute separate oaths or declarations.

To learn more:

All relevant information from MPEP 609.04 – Content and Timing Requirements for an Information Disclosure Statement has been thoroughly covered in the previously generated FAQs. No additional meaningful questions can be formulated without significant repetition or overlap with existing content.

To learn more:

To learn more:

All relevant information from MPEP 323.01(b) – Typographical Errors in Recorded Assignment Document has been covered in previous FAQs. No additional meaningful questions can be generated without repetition.

To learn more:

To learn more:

All relevant information from MPEP 502.05 – Correspondence Transmitted by EFS-Web has been thoroughly covered in the previously generated FAQs. No additional meaningful questions can be created without substantial repetition of existing content.

To learn more:

To learn more:

All relevant information from MPEP ¶ 2.33 New Inventor Identified in CPA (for Design Applications) has been covered in the previous FAQs. No additional meaningful questions can be generated without redundancy.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on inventorship, visit: inventorship.

For more information on patent examination, visit: patent examination.

All relevant information from MPEP 323.01 – Correction of Error in Recorded Cover Sheet has been covered in previous FAQs. No further meaningful questions can be generated without redundancy.

To learn more:

To learn more:

To learn more:

No, there is currently no content in MPEP 212. The section is marked as ‘[Reserved]’, which means it is empty and being held for potential future use.

Yes, the USPTO provides an official form for requesting correction of inventorship or inventor name. The MPEP states:

The Office has a form PTO/AIA/40 to request correction in a patent application (other than a reissue application) relating to inventorship, an inventor name, or order of names.

This form, PTO/AIA/40, can be used for various corrections related to inventorship and inventor names. It’s available on the USPTO website at www.uspto.gov/PatentForms. Using this official form can help ensure that you provide all necessary information for your request and may streamline the process of correcting inventorship or inventor names in your patent application.

To learn more:

Tags: USPTO Forms

Yes, the United States Patent and Trademark Office (USPTO) provides an official form for requesting correction of inventorship in a patent application (other than a reissue application). The details are as follows:

  • Form number: PTO/AIA/40
  • Purpose: To request correction relating to inventorship, an inventor name, or order of names
  • Availability: The form can be found on the USPTO website at www.uspto.gov/PatentForms

The MPEP states: The Office has a form PTO/AIA/40 to request correction in a patent application (other than a reissue application) relating to inventorship, an inventor name, or order of names. The form is reproduced below and is also available on www.uspto.gov/PatentForms.

To learn more:

Yes, there is an exception for certain applications filed before November 25, 2005. According to the Examiner Note in MPEP ¶ 2.38:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This means that for non-provisional applications filed before November 25, 2005, it was acceptable to file the English translation and accuracy statement in the non-provisional application itself, rather than in the provisional application. For applications filed after this date, the current rules requiring filing in the provisional application apply.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

For more information on translation requirements, visit: translation requirements.

Yes, there is an additional fee for correcting inventorship after an Office action has been issued or mailed. According to 37 CFR 1.48(c):

Any request to correct or change the inventorship under paragraph (a) of this section filed after the Office action on the merits has been given or mailed in the application must also be accompanied by the fee set forth in § 1.17(d), unless the request is accompanied by a statement that the request to correct or change the inventorship is due solely to the cancelation of claims in the application.

This means that in addition to the processing fee required for all inventorship correction requests, an extra fee is required if the request is filed after an Office action, unless the change is due to claim cancellation.

To learn more:

Yes, there is a time limit for submitting priority documents in a U.S. patent application. The MPEP 215.02(a) states:

“[T]he time period set forth in 37 CFR 1.55(f) for filing a certified copy of the foreign application is satisfied if the USPTO retrieves a copy of the priority document within the pendency of the application and before the patent is granted.”

This means that the priority document must be available to the USPTO before the patent is granted. However, it’s important to note that the specific time limit can vary depending on the type of application and other factors outlined in 37 CFR 1.55(f).

To learn more:

Tags: time limit

Yes, there is a time limit for filing a petition to restore the benefit of a provisional application. According to MPEP 211:

“Applicant may wish to file a petition to restore the benefit of the provisional application under 37 CFR 1.78 in the subsequent nonprovisional application or international application designating the United States if the subsequent application was filed within two months from the expiration of the twelve-month period and the delay was unintentional.”

This means you have a two-month grace period after the expiration of the initial 12-month period to file the petition. It’s crucial to act quickly if you miss the original deadline and wish to restore the benefit of your provisional application.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

Yes, there is a deadline for filing the English translation and accuracy statement for a non-English provisional application. While MPEP ¶ 2.38 doesn’t specify an exact timeframe, it indicates that the USPTO will set a time period in an Office action:

“If 1) and 2) are not filed (or if the benefit claim is not withdrawn) prior to the expiration of the time period set in this Office action, the present application will be abandoned.”

This means that when the USPTO notices that the required documents are missing, they will issue an Office action with a specific deadline. It’s crucial to comply with this deadline to avoid abandonment of your application. As a best practice, it’s advisable to file these documents as soon as possible after filing the non-English provisional application to avoid any potential issues.

For more information on patent procedure, visit: patent procedure.

The MPEP section 603.01 does not specify a deadline for filing supplemental oaths or declarations after allowance. It states:

“Supplemental oaths and declarations covering the claims in the application may be filed after allowance as a matter of right.”

This suggests that applicants have the right to file these documents at any time after allowance. However, it’s important to note that practical considerations, such as the patent issue date, may impose de facto deadlines. Applicants should consult with a patent attorney or agent for specific timing advice in their case.

To learn more:

No, the listing of references in the PCT international search report is not considered an Information Disclosure Statement (IDS) complying with 37 CFR 1.98. As stated in MPEP 609.03:

“The listing of references in the PCT international search report is not considered to be an information disclosure statement (IDS) complying with 37 CFR 1.98.”

To be considered a compliant IDS, the submission must meet specific requirements outlined in 37 CFR 1.98, including providing legible copies of foreign patents, publications, pending U.S. applications, and other information. Additionally, the IDS must include a separate list of all submitted items for consideration by the Office.

To learn more:

To learn more:

While the last known residence is often the appropriate address to provide, it’s not always the case. The MPEP states:

‘Ordinarily, the last known address will be the last known residence of the nonsigning inventor.’

However, the key is to provide the address where the inventor customarily receives mail. If this differs from their residence, the mailing address should be provided instead. The goal is to increase the likelihood that the nonsigning inventor will receive any USPTO communications.

To learn more:

To learn more:

No, the Background of the Invention section is not mandatory in a patent application. According to MPEP 608.01(c), “The Background of the Invention may (but is not required to) include the following parts…” This means that while it’s common and often beneficial to include this section, it’s not a strict requirement for a patent application.

To learn more:

While the address of the assignee may be included in the assignment document, it is not strictly required there. However, the address must be provided in the cover sheet accompanying the assignment. As stated in MPEP 302.05:

The address of the assignee may be recited in the assignment document and must be given in the required cover sheet.

This means that while including the address in the assignment document itself is optional, providing it on the cover sheet is mandatory for proper recordation of the assignment.

To learn more:

According to MPEP 604, “A non-inventor applicant need not submit proof of the permitted circumstance to file a substitute statement (e.g., inventor’s death certificate to establish that a named inventor is deceased).” However, it’s important to note that:

  • If the circumstance is not death or legal incapacity, the inventor must have refused to execute the oath or declaration, or the applicant must have made a diligent effort to find or reach the inventor.
  • While proof is not required to be submitted to the USPTO, “proof of attempts to secure the inventor’s signature should be kept in applicant’s file.

This approach balances the need for truthful statements with practical considerations in patent applications.

To learn more:

The United States Patent and Trademark Office (USPTO) does not require proof of authority to be filed by a legal representative of a deceased or incapacitated inventor. MPEP 409.01(b) states:

“Proof of authority of the legal representative of a deceased or incapacitated inventor is not required.”

However, it’s important to note that while the USPTO doesn’t require this proof, the legal representative should ensure they are properly acting in such a capacity. The MPEP advises:

“Although the Office does not require proof of authority to be filed, any person acting as a legal representative of a deceased or incapacitated inventor should ensure that he or she is properly acting in such a capacity.”

This means that while formal proof isn’t needed for USPTO purposes, the legal representative should be prepared to demonstrate their authority if challenged in other legal contexts.

To learn more:

No, MPEP 409.03(g) is not applicable to all patent applications. As stated in the editor’s note at the beginning of the section:

This MPEP section is not applicable to applications filed on or after September 16, 2012.

This means that the guidance provided in MPEP 409.03(g) regarding proof of irreparable damage only applies to patent applications filed before September 16, 2012. For applications filed on or after that date, different rules and procedures may apply.

To learn more:

To learn more:

Expungement of assignment records at the USPTO is extremely rare and does not result in the complete removal of a document from the assignment records. According to MPEP 323.01(d), petitions to expunge assignment records are granted only if the petitioner can prove:

  1. The normal corrective procedures outlined in MPEP § 323.01(a) through § 323.01(c) will not provide adequate relief, and
  2. The integrity of the assignment records will not be affected by granting the petition.

The MPEP clarifies: Even if a petition to ‘expunge’ a document is granted with respect to a particular application or patent, the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number, and the image will appear when someone views that reel and frame number.

If a petition is granted:

  • The Office will delete links to the application or patent subject to the petition.
  • A redacted version of the ‘expunged’ document must be recorded and will appear in the assignment records.
  • An additional assignment of the ‘correct’ document may be recorded if necessary.

This process ensures the integrity and completeness of the USPTO’s assignment records while addressing legitimate concerns about erroneous or sensitive information.

To learn more:

Including the object of the invention in the Brief Summary is optional but permissible. According to MPEP 608.01(d), “A brief summary of the invention indicating its nature and substance, which may include a statement of the object of the invention, should precede the detailed description.” The MPEP further clarifies that “The brief summary should be more than a mere statement of the objects of the invention, which statement is also permissible under 37 CFR 1.73.” This means that while you can include the object of the invention, it should not be the sole content of the Brief Summary. The summary should primarily focus on describing the nature and substance of the invention itself.

To learn more:

No, including government support information on a provisional application cover sheet is not sufficient to meet the requirements of 35 U.S.C. 202(c)(6). The MPEP states:

Providing information concerning government support on a provisional application cover sheet does not satisfy the requirement of 35 U.S.C. 202(c)(6) which requires that the a statement be included within the specification of such application and any patent issuing thereon specifying that the invention was made with Government support and that the Government has certain rights in the invention.

The government license rights statement must be included within the specification itself, not just on the cover sheet.

No, filing an Information Disclosure Statement (IDS) is not considered an admission that a prior art search has been conducted. The MPEP clearly states:

The filing of an information disclosure statement shall not be construed as a representation that a search has been made. 37 CFR 1.97(g).

Furthermore, the MPEP emphasizes that There is no requirement that an applicant for a patent make a patentability search.

It’s important to note that submitting an IDS is also not an admission of the materiality of the information to patentability. The MPEP states:

The filing of an information disclosure statement shall not be construed to be an admission that the information cited in the statement is, or is considered to be, material to patentability as defined in 37 CFR 1.56(b). 37 CFR 1.97(h).

To learn more:

While designating a domestic representative is not mandatory, it is highly recommended for foreign patent assignees. According to MPEP 302.04, An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative. The use of ‘may’ indicates that this is optional. However, having a domestic representative can significantly simplify legal proceedings and communications with the USPTO for foreign assignees.

To learn more:

For applications filed on or after September 16, 2012, citizenship information is no longer required. The MPEP states:

“For applications filed on or after September 16, 2012, the citizenship of the inventor is no longer required by 35 U.S.C. 115 or 37 CFR 1.63.”

However, for applications filed before September 16, 2012, citizenship information was required under pre-AIA 35 U.S.C. 115.

To learn more:

Tags: pre-AIA

The requirement for an inventor’s citizenship in patent applications has changed:

  • For applications filed on or after September 16, 2012: Citizenship is no longer required by 35 U.S.C. 115 or 37 CFR 1.63.
  • For nonprovisional applications filed before September 16, 2012: Citizenship was required under pre-AIA 35 U.S.C. 115.

As stated in the MPEP: “For applications filed on or after September 16, 2012, the citizenship of the inventor is no longer required by 35 U.S.C. 115 or 37 CFR 1.63.”

For older applications, if an inventor is not a citizen of any country, a statement to this effect is accepted as satisfying the statutory requirement.

To learn more:

No, an English translation of a non-English language foreign application is not always required. According to 37 CFR 1.55(g)(3), an English language translation is only required in specific circumstances:

An English language translation of a non-English language foreign application is not required except: (i) When the application is involved in an interference (see § 41.202 of this chapter) or derivation (see part 42 of this chapter) proceeding; (ii) When necessary to overcome the date of a reference relied upon by the examiner; or (iii) When specifically required by the examiner.

If a translation is required, it must be filed together with a statement that the translation of the certified copy is accurate.

To learn more:

No, a specific working example is not required in a patent application. The MPEP 608.01(h) clearly states: There is no statutory requirement for the disclosure of a specific example. A patent specification is not intended nor required to be a production specification.

Furthermore, the MPEP explains that the presence or absence of a specific working example is not determinative of whether the best mode has been disclosed: The absence of a specific working example is not necessarily evidence that the best mode has not been disclosed, nor is the presence of one evidence that it has. This guidance is based on the case In re Honn, 364 F.2d 454, 150 USPQ 652 (CCPA 1966).

To learn more:

No, a security agreement that does not convey the right, title, and interest of a patent property is not considered a conditional assignment. The MPEP section 317.03 states:

“A security agreement that does not convey the right, title, and interest of a patent property is not a conditional assignment.”

This distinction is important because security agreements are treated differently from conditional assignments in terms of recording and their effect on patent ownership.

To learn more:

No, a Request for Continued Examination (RCE) is not considered a new application. The MPEP 203.01 clarifies this point:

Note that a request for continued examination (RCE)(see 37 CFR 1.114) is not a type of new application filing.

An RCE is a way to continue prosecution of an existing application after a final rejection, rather than starting a new application. For more details on RCEs, refer to MPEP § 706.07(h).

To learn more:

No, an applicant is not required to conduct a prior art search before filing a patent application. The MPEP clearly states:

‘An applicant has no duty to conduct a prior art search as a prerequisite to filing an application for patent.’

This is supported by several court cases cited in the MPEP, including:

  • Nordberg, Inc. v. Telsmith, Inc.
  • FMC Corp. v. Hennessy Indus., Inc.
  • American Hoist & Derrick Co. v. Sowa & Sons, Inc.

The ‘inquiry reasonable under the circumstances’ requirement of 37 CFR 11.18 does not create any new duty for applicants to conduct prior art searches. However, applicants and practitioners should be aware that providing false or misleading information during prosecution can jeopardize patent enforceability.

While not strictly required, the USPTO requests the submission of a daytime telephone number for the party to whom correspondence is to be addressed. According to 37 CFR 1.33(a):

For the party to whom correspondence is to be addressed, a daytime telephone number should be supplied in a clearly identifiable manner and may be changed by any party who may change the correspondence address.

The MPEP explains that although business is conducted on the written record (as per 37 CFR 1.2), a daytime telephone number is useful for initiating contact that could later be reduced to writing. It’s a practical way to facilitate communication between the USPTO and the applicant or their representative.

To learn more:

While not strictly required, the USPTO recommends providing a daytime telephone number in patent applications. According to MPEP 601.03(b):

“The submission of a daytime telephone number of the party to whom correspondence is to be addressed is requested pursuant to pre-AIA 37 CFR 1.33(a).”

The MPEP further explains: “While business is to be conducted on the written record (37 CFR 1.2), a daytime telephone number is useful in initiating contact that could later be reduced to writing.” This means that while all official business must be in writing, a phone number can facilitate quick communication that can later be documented formally.

It’s worth noting that any party who can change the correspondence address can also change the telephone number.

To learn more:

To learn more:

When a petition under 37 CFR 1.48 to add an inventor was filed in a prior application, the continuation or divisional application could be handled in one of two ways:

  1. Filed with a copy of the executed declaration naming the correct inventive entity from the prior application.
  2. Filed with a newly executed declaration naming the correct inventive entity.

The MPEP states:

“A continuation or divisional application filed under 37 CFR 1.53(b) of a prior application in which a petition (or request) under 37 CFR 1.48 to add an inventor was filed should be filed with a copy of the executed declaration naming the correct inventive entity from the prior application or a newly executed declaration naming the correct inventive entity.”

Importantly, the MPEP also notes that “A copy of any decision under 37 CFR 1.48 from the prior application is not required to be filed in the continuation or divisional application.” This simplifies the filing process by not requiring additional documentation related to the inventorship change in the prior application.

To learn more:

To learn more:

Changes in inventorship for continuation or divisional applications filed under 37 CFR 1.53(b) could be handled in two ways:

  1. Filing with a copy of an oath or declaration from a prior application and a statement requesting the deletion of non-inventors.
  2. Filing with a newly executed oath or declaration naming the correct inventive entity.

The MPEP states:

“If an inventor named in a prior application is not an inventor in a continuation or divisional application filed under 37 CFR 1.53(b), the continuation or divisional application may either be filed (A) with a copy of an oath or declaration from a prior application and a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the continuation or divisional application (see pre-AIA 37 CFR 1.63(d)), or (B) with a newly executed oath or declaration naming the correct inventive entity.”

This provision allowed applicants to address changes in inventorship efficiently when filing continuation or divisional applications.

To learn more:

Applications with pre-AIA 37 CFR 1.47 status were given special consideration in continuation or divisional filings. The MPEP states:

“A continuation or divisional application of a prior application accorded status under pre-AIA 37 CFR 1.47 will be accorded status under pre-AIA 37 CFR 1.47 if a copy of the decision according pre-AIA 37 CFR 1.47 status in the prior application is filed in the continuation or divisional application, unless an oath or declaration signed by all of the inventors is included upon filing the continuation or divisional application.”

This means that the special status could be carried over to the new application by submitting a copy of the previous decision, unless a complete oath or declaration was provided.

To learn more:

To learn more:

How to retrieve a foreign priority document through PDX?

To retrieve a foreign priority document through PDX (Priority Document Exchange), follow these steps:

  1. Ensure the foreign office participates in PDX or WIPO DAS.
  2. File an application with the USPTO claiming foreign priority.
  3. Submit a request to retrieve the priority document using USPTO form PTO/SB/38 or through EFS-Web.
  4. Provide the necessary information, including the foreign application number and filing date.
  5. If using WIPO DAS, include the DAS access code provided by the foreign office.

According to MPEP 215.01: Applicants need not submit a copy of the foreign application if the foreign application was filed in a participating foreign intellectual property office, and the applicant provides sufficient information to the USPTO to retrieve the priority document.

To learn more:

USPTO staff should follow specific procedures when handling correspondence from Executive departments and agencies. According to MPEP 203.08(a):

Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs.

Staff should immediately transmit such correspondence to the appropriate office and notify them by phone to ensure prompt and proper handling.

To learn more:

Tags: USPTO

USPTO personnel are instructed to handle status inquiries about patent applications promptly and professionally. According to MPEP 203.08:

“Inquiries as to the status of applications, by persons entitled to the information, should be answered promptly. The examiner, correspondent, or other appropriate personnel should provide the information requested within the following time periods: (A) For information obtainable from PALM, within one business day. (B) For information not obtainable from PALM, within five business days unless such information is not readily available, in which case a date by which an answer will be provided should be given.”

Personnel should verify the inquirer’s right to receive information and provide appropriate status updates without disclosing confidential information to unauthorized parties.

To learn more:

USPTO employees are required to verify the identity of email senders in patent communications to prevent misrepresentation or spoofing. According to MPEP 502.03:

‘Email must be initiated by a registered practitioner, or an applicant in a pro se application, and sufficient information must be provided to show representative capacity in compliance with 37 CFR 1.34.’

The MPEP provides examples of information that can be used for verification:

  • Attorney registration number
  • Attorney docket number
  • Patent application number

Additionally, the MPEP advises:

‘Similar to the policy set forth in MPEP 100 for handling telephone calls, when responding to an email, no information should be disclosed until the identity of the requester can be adequately verified.’

Examiners are instructed to verify the identity by checking Patent Data Portal or the application file, such as confirming the email address previously provided in Patent Data Portal or the application.

To learn more:

When citing unpublished U.S. patent applications in an Information Disclosure Statement (IDS), you must include:

  • The U.S. patent application publication number
  • The applicant
  • The filing date
  • If available, the U.S. patent application publication date
  • The patent application number

The MPEP 609.04(a) states: Each U.S. application listed in an information disclosure statement must be identified by the inventor, application number, and filing date.

It’s important to note that if an application has been published, you should cite it as a U.S. patent application publication rather than as an unpublished application.

To learn more:

To learn more:

U.S. patents and U.S. patent application publications must be listed separately from other documents in an Information Disclosure Statement (IDS). This requirement is specified in 37 CFR 1.98(a)(1).

The MPEP states: ‘37 CFR 1.98(a)(1) specifically requires that U.S. patents and U.S. patent application publications be listed separately from the citations of other documents. The separation of citations will permit the Office to obtain the U.S. patent numbers and the U.S. patent application publication numbers by optical character recognition (OCR) from the scanned documents such that the documents can be made available electronically to the examiner to facilitate searching and retrieval of the cited U.S. patents and U.S. patent application publications from the Office’s search databases.

To comply with this requirement, applicants can use forms PTO/SB/08, which provide a separate section for listing U.S. patents and U.S. patent application publications. If not using these forms, ensure that U.S. patents and U.S. patent application publications are listed in a separate section from other documents.

To learn more:

To learn more:

When using trademarks in patent applications:

  • Capitalize each letter of the trademark
  • Use the trademark symbol ® or TM as appropriate
  • Accompany the trademark with generic terminology
  • Respect the proprietary nature of the mark

According to MPEP 608.01(v): “Although the use of marks having definite meanings is permissible in patent applications, the proprietary nature of the marks should be respected. Marks should be identified by capitalizing each letter of the mark (in the case of word or letter marks) or otherwise indicating the description of the mark (in the case of marks in the form of a symbol or device or other nontextual form). Every effort should be made to prevent their use in any manner which might adversely affect their validity as marks.”

To learn more:

The method for making a specific reference to a prior-filed application depends on when the application was filed:

  • For applications filed before September 16, 2012: The specific reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS) in compliance with pre-AIA 37 CFR 1.76.
  • For applications filed on or after September 16, 2012: The specific reference must be included in an ADS in compliance with 37 CFR 1.76.

Additionally, for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

It’s important to note that for continued prosecution applications (CPAs) filed under 37 CFR 1.53(d) (design applications under 35 U.S.C. chapter 16 only), a specific reference in the specification or ADS is not required and may not be made. For these applications, The specific reference requirement of 35 U.S.C. 120 is met by the transmittal request for the CPA which is considered to be part of the CPA.

For more information on application data sheet, visit: application data sheet.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on specific reference, visit: specific reference.

For inventors who are members of the U.S. Armed Services, there is a special provision for stating their residence in patent applications. According to MPEP 602.08(a):

“In the case of an inventor who is in one of the U.S. Armed Services, a statement to that effect is sufficient as to residence.”

This provision simplifies the residence requirement for service members, who may have frequently changing or sensitive location information. A simple statement of their Armed Services status fulfills the residence requirement for patent application purposes.

To learn more:

To learn more:

When providing the mailing address for correspondence in a patent application:

  • Include a complete mailing address
  • Use the address where the inventor customarily receives mail
  • For foreign inventors, provide an address in the U.S. for correspondence

The MPEP 602.08(b) states: ‘The mailing address of each inventor must be provided in order to comply with the separate notification requirement of 35 U.S.C. 11(a).’ This ensures that the USPTO can effectively communicate with all inventors throughout the patent process.

To learn more:

When filing an interim copy via the USPTO patent electronic filing system:

  1. The main parts of the foreign priority application (Abstract, Drawings, Specification, Claims, etc.) along with the cover sheet may be filed as a single PDF image file.
  2. Select the document description ‘Interim Copy of the Foreign Priority Application’ when indexing.
  3. For plain text files (e.g., Sequence Listings), file as a .txt file and select ‘Interim Copy of the Foreign Priority (text file)’ as the document description.
  4. XML files (e.g., Standard ST.26 Sequence Listing) should be filed on a read-only optical disc as part of the ‘Interim Copy of Foreign Priority.’

See MPEP § 502.05 for more information on filing documents electronically.

How should the foreign priority application number be formatted in an ADS?

When entering the foreign priority application number in an Application Data Sheet (ADS), it’s crucial to follow the proper format to ensure accurate identification. The MPEP states:

“The foreign application number should be identified in an application data sheet (ADS), rather than in a separate paper.” (MPEP 214.04)

The ADS should include:

  • The correct application number
  • The country or intellectual property authority where the application was filed
  • The filing date of the priority application

It’s important to use the exact format as it appears on the foreign priority document to avoid any discrepancies or potential issues with the priority claim.

To learn more:

The Field of the Invention should be described as follows:

  • It should be a statement of the field of art to which the invention pertains.
  • The statement should be directed to the subject matter of the claimed invention.
  • It may include a paraphrasing of the applicable Cooperative Patent Classification (CPC) definitions.

As stated in MPEP 608.01(c), the Field of the Invention is “A statement of the field of art to which the invention pertains. This statement may include a paraphrasing of the applicable Cooperative Patent Classification (CPC) definitions.”

To learn more:

Special attention is required when dealing with the correspondence address in continuation or divisional applications. According to MPEP 601.03(b):

“Special care should be taken in continuation or divisional applications to ensure that any change of correspondence address in a prior application is reflected in the continuation or divisional application.”

The MPEP further explains that when a copy of the oath or declaration from the prior application is submitted for a continuation or divisional application filed under pre-AIA 37 CFR 1.53(b), and this copy designates an old correspondence address, the USPTO may not recognize the change of correspondence address made during the prosecution of the prior application.

To address this, the MPEP advises: “Applicant is required to identify the change of correspondence address in the continuation or divisional application to ensure that communications from the Office are mailed to the current correspondence address.”

To learn more:

To learn more:

The Brief Summary of Invention should be closely aligned with the claims in a patent application. MPEP 608.01(d) states, “Such summary should, when set forth, be commensurate with the invention as claimed and any object recited should be that of the invention as claimed.” Additionally, the MPEP emphasizes that “The brief summary of invention should be consistent with the subject matter of the claims.” This means that the summary should accurately reflect the invention as it is defined in the claims, focusing on the key aspects that make the invention patentable.

To learn more:

When referring to other claims in a patent application, specific formatting rules must be followed according to MPEP 608.01(m):

  • References to other claims must be in the alternative only.
  • Dependent claims should refer to a preceding claim.
  • Claims should refer to other claims by number, not by the order they appear.

The MPEP states:

‘Reference to other claims should be in the alternative only. See 37 CFR 1.75(c). A form of claim that may be used is as follows: ‘A machine according to claim 3 or 4, further comprising —‘.’

Proper referencing ensures clarity and prevents confusion about the scope and dependencies of claims.

To learn more:

Reference characters in patent drawings should be used according to the following guidelines from 37 CFR 1.84(p):

  • Use Arabic numerals, preferably in the clockwise direction and starting with the number 1
  • Use plain legible symbols and characters
  • Must measure at least 0.32 cm (1/8 inch) in height
  • Should not be placed upon hatched or shaded surfaces
  • Must be different for different parts; the same part must be designated by the same reference character throughout the application
  • Lead lines must be used to indicate the parts to which they refer and should not cross each other

Additionally, reference characters mentioned in the description must appear in the drawings, and vice versa. Characters not mentioned in the description should not appear in the drawings.

To learn more:

Reference characters in patent drawings and descriptions play a crucial role in clearly illustrating and explaining the invention. According to MPEP 608.01(g), there are specific rules for using reference characters:

“The reference characters must be properly applied, no single reference character being used for two different parts or for a given part and a modification of such part. See 37 CFR 1.84(p).”

Here are the key points to remember:

  • Each unique part of the invention should have its own reference character.
  • Do not use the same reference character for different parts.
  • Do not use different reference characters for the same part.
  • Reference characters in the drawings should match those used in the description.
  • Every feature specified in the claims must be illustrated.
  • Avoid superfluous illustrations that don’t correspond to claimed features.

Proper use of reference characters ensures clarity and consistency between your drawings and written description, which is essential for a comprehensive and easily understood patent application.

To learn more:

Professional titles should not be included in inventor names on patent applications. The MPEP 602.08(b) is clear on this point:

Prefixes to names (e.g., “Dr.”) generally should not be included.

This means that titles such as ‘Dr.’, ‘Prof.’, ‘Eng.’, or any other professional designation should be omitted from the inventor’s name on the patent application. The focus should be on the inventor’s legal name without any additional titles or honorifics.

For example, if an inventor’s name with title is ‘Dr. Jane Doe’, it should be listed simply as ‘Jane Doe’ on the patent application.

To learn more:

To ensure proper processing of priority papers, the MPEP recommends marking them with specific information. According to MPEP 215.03:

It is suggested that a notation of the application number of the corresponding U.S. application be placed on the priority papers when such papers are not submitted via a priority document exchange program. Such notation should be placed directly on the priority papers themselves even where a cover letter is attached bearing the U.S. application data.

This practice helps prevent priority papers from becoming separated from their corresponding U.S. applications, which can cause severe problems for both the Office and the applicant. By adhering to this suggestion, applicants can significantly reduce potential issues in processing priority claims.

To learn more:

To ensure proper correlation between priority papers and U.S. applications, the MPEP suggests: “It is suggested that a notation of the application number of the corresponding U.S. application be placed on the priority papers when such papers are not submitted via a priority document exchange program. Such notation should be placed directly on the priority papers themselves even where a cover letter is attached bearing the U.S. application data.” This practice helps prevent separation of cover letters and priority papers, which can cause severe problems for both the Office and applicant.

For patent applications, prior U.S. application data should be provided as follows:

  • For applications filed on or after September 16, 2012: In an application data sheet
  • For applications filed before September 16, 2012: In either the first sentence(s) of the specification or in an application data sheet

MPEP 202 states: “The identifying data of all prior applications for which benefits are claimed should be reviewed by the examiner to ensure that the data is accurate and provided in an application data sheet for applications filed on or after September 16, 2012, or provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012.”

When including prior art figures in a patent application, proper labeling is crucial. According to MPEP 608.02(g), prior art figures should be designated by a legend such as ‘Prior Art.’ This labeling is essential to distinguish prior art from the applicant’s invention.

If a prior art figure is not correctly labeled, patent examiners may use form paragraph 6.36.01, which states: Figure [1] should be designated by a legend such as –Prior Art– because only that which is old is illustrated. See MPEP § 608.02(g). This paragraph instructs the applicant to correct the labeling to comply with the MPEP guidelines.

To learn more:

Photographs in patent applications should be submitted according to specific guidelines:

  • Black and white photographs must be of sufficient quality for reproduction and printing.
  • Color photographs are treated the same as color drawings and require a petition.
  • Photographs must be on paper that complies with 37 CFR 1.84(e).
  • The photographs should directly depict the invention and not include extraneous marks.

MPEP 608.02(b) states: “Photographs, including photocopies of photographs, are not ordinarily permitted in utility and design patent applications.” However, they may be accepted if they are the only practicable medium for illustrating the claimed invention.

To learn more:

To learn more:

How should pending U.S. patent applications be listed in an IDS?

When listing pending U.S. patent applications in an Information Disclosure Statement (IDS), applicants must provide specific information to ensure proper identification. According to MPEP 609.04(a):

“Each U.S. application listed in an information disclosure statement must be identified by the inventor, application number, and filing date.”

Additionally, the MPEP states:

“Where the application is cited only in a pending U.S. application, the cited application should be identified by application number (application number without series code) or patent application publication number, if applicable.”

It’s important to note that:

  • The series code (e.g., 08/, 09/, 10/, etc.) should not be included when citing a pending U.S. application.
  • If a patent application publication exists for the pending application, you may include that number instead of or in addition to the application number.
  • Providing accurate and complete information helps examiners efficiently locate and consider the cited applications during the examination process.

To learn more:

To learn more:

Patent examiners should review and consider an Information Disclosure Statement (IDS) as follows:

  1. Check for compliance with 37 CFR 1.97 and 1.98
  2. Consider the properly submitted information in the same manner as other documents in Office search files
  3. For e-IDS, use the e-IDS icon on the examiner’s workstation to consider cited U.S. patents and U.S. patent application publications
  4. Initial the blank column next to each citation to indicate that the information has been considered, or use the alternative electronic signature method
  5. Draw a line through citations that fail to comply with requirements
  6. Sign and date the bottom of the IDS listing or use the alternative electronic signature method
  7. Ensure that a signed and dated copy of the IDS listing is entered into the file and mailed to the applicant

The MPEP states: “After the examiner reviews the IDS for compliance with 37 CFR 1.97 and 1.98 (see MPEP § 609.05), the examiner should: (A) Consider the information properly submitted in an IDS in the same manner that the examiner considers other documents in Office search files while conducting a search of the prior art in a proper field of search.”

To learn more:

Patent examiners should handle objections to drawings as follows:

  1. If the examiner makes objections to the drawings, they should require correction in reply to the Office action.
  2. The examiner should not permit the objection to be held in abeyance.
  3. If drawings are marked as ‘informal’ but considered acceptable by OPAP, the examiner should not require replacement.

The MPEP clearly states: If the examiner does make objections to the drawings, the examiner should require correction in reply to the Office action and not permit the objection to be held in abeyance.

For more information on specific grounds for finding drawing informalities, examiners should refer to MPEP § 608.02(b), § 608.02(d)§ 608.02(h) and § 608.02(p).

To learn more:

How should multiple dependent claims be formatted in a patent application?

Multiple dependent claims in patent applications must follow specific formatting rules as outlined in MPEP 608.01(m). The MPEP states:

‘A multiple dependent claim may refer in the alternative to only one set of claims. A claim such as ‘A machine according to claims 3 or 4, further comprising —‘ is improper. Additionally, a multiple dependent claim may not serve as a basis for any other multiple dependent claim, either directly or indirectly.’

Key formatting requirements include:

  • Multiple dependent claims must refer to other claims in the alternative only.
  • They should use the phrase ‘according to’ followed by claim numbers (e.g., ‘according to claims 1, 2, or 3’).
  • Each multiple dependent claim must be considered in combination with every claim to which it refers.
  • The claim fee for a multiple dependent claim is calculated based on the number of claims it incorporates.

Proper formatting ensures clarity and compliance with 37 CFR 1.75(c), which governs multiple dependent claims.

To learn more:

To learn more:

How should line spacing and numbering be formatted in a patent specification?

The MPEP 608.01 provides specific guidelines for line spacing and numbering in patent specifications:

  • Line spacing: Lines of text should be 1.5 or double spaced
  • Line numbering: The lines on each sheet should be numbered consecutively and at least 4 cm (1 1/2 inches) from the left margin

The MPEP states: ‘The specification (including the abstract and claims) for other than reissue applications and reexamination or supplemental examination proceedings shall have lines that are 1 1/2 or double spaced.’ It further specifies: ‘The lines on each sheet should be numbered consecutively, starting with 1, and the numbers should be located about 4 cm. from the left margin.’ These formatting requirements ensure clarity and ease of reference in patent documents.

To learn more:

For joint inventor applicants, MPEP 509.04(c) states that “each joint inventor should sign a separate copy of the relevant micro entity certification form.” However, there is an exception:

“If one joint inventor is appointed to prosecute the application on behalf of all the other joint inventors, then only that one joint inventor need sign the micro entity certification form.”

This appointment can be made using USPTO form PTO/AIA/81, titled “Power Of Attorney To One Or More Of The Joint Inventors And Change Of Correspondence Address”, available on the USPTO forms Web page.

To learn more:

How should inventorship be determined for a patent application?

Determining inventorship for a patent application is a critical step that requires careful consideration. Here’s how it should be approached:

  • Inventorship is determined based on the subject matter of the claims.
  • Each person who contributed to the conception of at least one claim should be listed as an inventor.
  • Merely following instructions or assisting in reduction to practice does not qualify one as an inventor.

The MPEP 2137 states:

“The threshold question in determining inventorship is who conceived the invention. Unless a person contributes to the conception of the invention, he is not an inventor.”

It’s important to note that inventorship can change during the prosecution of the application if claims are amended or canceled. Applicants should consult with a patent attorney to ensure proper determination of inventorship.

To learn more:

Tags: inventorship

For inventors who have only a single name, there are specific guidelines for presenting their name in patent applications:

  • The single name should be listed in the Last Name field.
  • The First Name field should be left blank.
  • A period should be placed in the First Name field if the USPTO computer system requires a first name entry.

According to MPEP 602.08(b):

If an inventor’s name ‘includes’ only a single name, it should be placed in the Last Name box of the inventor data sheet (37 CFR 1.76(b)(1)) or inventor’s oath or declaration (37 CFR 1.63(a)(1)), with the First Name box blank or filled with a period (if required by the computer system to be a non-blank field).

This ensures proper recording and processing of the inventor’s name in the patent application system.

To learn more:

When illustrating improvements on existing inventions, patent drawings should follow specific guidelines as outlined in MPEP 608.02(d):

  1. Show the improved portion disconnected from the old structure
  2. In a separate view, show only enough of the old structure to demonstrate the connection with the improvement

The MPEP cites 37 CFR 1.83(b): When the invention consists of an improvement on an old machine the drawing must when possible exhibit, in one or more views, the improved portion itself, disconnected from the old structure, and also in another view, so much only of the old structure as will suffice to show the connection of the invention therewith. This approach helps to clearly distinguish the new, improved elements from the existing technology.

To learn more:

Patent maintenance fee payments can be submitted in two ways:

  1. Electronically: This is the preferred method. Payments can be made through the USPTO’s Patent Maintenance Fees Storefront.
  2. By mail: If not submitted electronically, maintenance fee payments and related correspondence should be addressed to:

Mail Stop Maintenance Fee
Director of the United States Patent and Trademark Office
P.O. Box 1450
Alexandria, VA 22313-1450

The MPEP states: Maintenance fee payments not electronically submitted over the Internet and correspondence related to maintenance fees may be addressed to: Mail Stop Maintenance Fee, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450

It’s important to note that electronic submission is faster, more secure, and provides immediate confirmation of payment.

To learn more:

Maintenance fee payments have a specific mailing address if not submitted electronically. According to MPEP 501, which cites 37 CFR 1.1(d):

Maintenance fee payments that are not submitted electronically and correspondence related to maintenance fees may be addressed to: Mail Stop Maintenance Fee, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450.

However, it’s important to note that the USPTO strongly encourages electronic submission of maintenance fee payments. The Electronic Maintenance Fee Form is the preferred method for these transactions.

If you must submit a paper payment, ensure it’s properly addressed to avoid delays in processing. Include all necessary information, such as the patent number and the fee amount being paid.

For more information on USPTO correspondence, visit: USPTO correspondence.

For correspondence that requires immediate attention from the USPTO, such as certain petitions or time-sensitive documents, the following methods are recommended:

  1. Use the USPTO patent electronic filing system (EFS-Web or Patent Center). This is the preferred method for most immediate correspondence.
  2. Where permitted, use facsimile transmission to the appropriate area of the Office.
  3. Hand-carry the documents to the USPTO in Alexandria, VA.

The MPEP states: Applicants are encouraged to transmit these types of correspondence by the USPTO patent electronic filing system (see MPEP § 502.05). Where permitted, patent-related correspondence that requires immediate Office attention may also be submitted to the appropriate area of the Office for processing by facsimile transmission (see MPEP § 502.01, subsections I.B and II) or hand-carried (see MPEP § 502), subsection III).

Examples of correspondence requiring immediate attention include:

  • Petitions for express abandonment to avoid publication
  • Petitions to withdraw an application from issue
  • Requests for expedited examination of a design application
  • Certain papers required by the Office of Data Management

To learn more:

When referencing figures in the Brief Description of Drawings section of a patent application, you should:

  • Refer to each figure by its number (e.g., Figure 1, Figure 2)
  • Provide a brief explanation of what each figure represents

The MPEP 608.01(f) states:

The specification must contain or be amended to contain a brief description of the several views of the drawings.

For example:

Figure 1 is a perspective view of the invented device.

Figure 2 is a cross-sectional view of the device shown in Figure 1.

Keep the descriptions concise and avoid detailed explanations, which belong in the Detailed Description section.

To learn more:

To learn more:

Tags: drawings

If an inventor has only a single name, you should follow these guidelines:

  • Enter the single name in the ‘Last Name’ field on the application data sheet (ADS).
  • Leave the ‘First Name’ field blank.
  • If using the inventor’s declaration form, enter the single name in the field provided for the legal name.

The MPEP 602.08(a) states: If an inventor does not have a middle name, the middle name space on the printed patent should be left blank and the name should be printed on the patent as the inventor indicated in the application, with no misspelling or other alteration.

To learn more:

For an international patent application designating the United States, you must use the international application number in the assignment. MPEP 302.03 specifies: “An assignment relating to an international patent application which designates the United States of America must identify the international application by the international application number; e.g., PCT/US2012/012345.” This format ensures proper identification of the international application in the assignment document.

To learn more:

Handling changes in inventorship in a continuing application depends on the filing date of the application and the nature of the change. Here are the key points:

  1. For applications filed on or after September 16, 2012:
    • Inventorship is determined by the Application Data Sheet (ADS) if filed before or with the oath/declaration copy.
    • If no ADS is filed, inventorship is based on the oath/declaration copy from the earlier application.
    • New joint inventors must provide a new oath or declaration.
  2. For applications filed before September 16, 2012:
    • To remove an inventor, file a copy of the prior oath/declaration with a statement requesting deletion of the non-inventor’s name.
    • Alternatively, file a new oath/declaration with the correct inventive entity.
    • For continuation-in-part applications, a new oath/declaration is typically required.

According to MPEP 602.05(b): If an inventor named in a prior application is not an inventor in a continuation or divisional application filed under 37 CFR 1.53(b), the continuation or divisional application may either be filed (A) with a copy of an oath or declaration from a prior application and a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the continuation or divisional application, or (B) with a newly executed oath or declaration naming the correct inventive entity.

Always ensure compliance with the specific requirements based on your application’s filing date and type.

To learn more:

The formatting of your patent application abstract should follow specific guidelines. According to MPEP 608.01(b):

The sheet or sheets presenting the abstract may not include other parts of the application or other material.

Key formatting points include:

  • Start the abstract on a separate sheet
  • Use a single paragraph
  • Avoid referring to purported merits or speculative applications
  • Do not compare the invention with the prior art
  • Preferably limit to 150 words
  • If using reference characters from the drawings, place them in parentheses

Proper formatting ensures that your abstract is clear, concise, and easy for examiners and other readers to quickly understand.

To learn more:

When canceling a figure in a patent application, it’s important to also amend the brief description of the drawings to reflect this change. Here’s how to do it:

  • Remove any reference to the canceled figure from the brief description.
  • Renumber the remaining figures if necessary.
  • Update any cross-references to the figures throughout the specification.

MPEP 608.02(t) mentions this requirement: “The brief description of the drawings should also be amended to reflect this change.” This ensures consistency between the drawings and their description in the specification, which is crucial for a clear and accurate patent application.

To learn more:

Assignment documents submitted by mail for recordation should be addressed according to MPEP 302.08 and 37 CFR 3.27. The MPEP states:

Documents and cover sheets submitted by mail for recordation should be addressed to Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450, unless they are filed together with new applications.

This ensures that your documents are properly routed and processed by the USPTO.

To learn more:

How should graphical drawings be prepared for a patent application?

Graphical drawings in patent applications must meet specific requirements to ensure clarity and reproducibility. According to MPEP 608.02:

“The graphic forms in drawings are lines, numbers, and letters. Drawings should be prepared with the proper rendition of graphic forms.”

Key guidelines for preparing graphical drawings include:

  • Use solid black lines of uniform thickness
  • Choose line thickness appropriate for the scale and complexity of the drawing
  • Avoid shading unless necessary to show the shape of elements
  • Use reference characters (numbers, letters) consistently throughout the application
  • Ensure all text is legible and at least 1/8 inch (0.32 cm) in height
  • Avoid crowding; leave sufficient white space between elements

The MPEP also states: “All drawings must be made by a process which will give them satisfactory reproduction characteristics.” This means the drawings should be clear, sharp, and suitable for reproduction in both paper and electronic formats.

To learn more:

Foreign priority claims in patent applications should be formatted according to specific guidelines outlined in MPEP 214.04. The claim should include:

  • The application number of the foreign application
  • The country or intellectual property authority where the application was filed
  • The day, month, and year of filing

The MPEP states: ‘When the claim to priority concerns an application filed in a foreign country, the claim must identify the foreign country or intellectual property authority where the application was filed.’ This ensures proper identification and processing of the priority claim.

To learn more:

To learn more:

To properly identify foreign priority applications in a patent application, applicants should follow the guidelines provided by the World Intellectual Property Organization (WIPO). The MPEP states:

To ensure an accurate and complete citation of a foreign priority application, applicants should review the list of the various intellectual property offices and the recommended presentation of a foreign application number for each, which can be found in the tables of the online WIPO Handbook on Industrial Property Information and Documentation

Specifically, applicants should refer to:

  • Part 7: Examples and Industrial Property Offices Practices
  • Part 7.2.1: Presentation of Application Numbers

These resources provide the recommended format for citing foreign application numbers, ensuring accurate and complete relationships among patent documents.

To learn more:

When citing foreign patents in an Information Disclosure Statement (IDS), you must include:

  • The country or patent office that issued the patent
  • The patent number
  • The name of the patentee
  • The date of issuance
  • The pages, columns, lines, or paragraph numbers where relevant passages or figures appear

The MPEP 609.04(a) states: Each foreign patent or published foreign patent application listed in an information disclosure statement must be identified by the country or patent office which issued the patent or published the application, an appropriate document number, the applicant, patentee, or first-named inventor, whichever is applicable, and the publication date indicated on the patent or published application.

To learn more:

How should foreign patent documents be cited in an IDS?

When citing foreign patent documents in an Information Disclosure Statement (IDS), specific information must be provided to ensure proper identification. According to MPEP 609.04(a):

“Each foreign patent or published foreign patent application listed in an information disclosure statement must be identified by the country or patent office which issued the patent or published the application, an appropriate document number, and the publication date indicated on the patent or published application.”

Additionally, the MPEP provides guidance on citing specific types of foreign patent documents:

  • Published applications: Provide the application number, the publication date, and the name of the patent office.
  • Patents: Include the name of the patentee, the date of the patent, the country, and the patent number.
  • Abstract-only citations: If only the abstract is being cited, clearly indicate this fact.

For non-English language foreign patent documents:

  • A concise explanation of relevance is required unless a complete translation is provided.
  • If a search report cites the document, submitting an English-language version of the search report indicating the degree of relevance can satisfy the explanation requirement.

Providing accurate and complete information for foreign patent documents helps examiners efficiently locate and consider these references during the examination process.

To learn more:

For foreign language documents cited in an Information Disclosure Statement:

  • A concise explanation of relevance must be provided for non-English documents
  • If a complete English translation is submitted, no concise explanation is required
  • An English language abstract may satisfy the concise explanation requirement
  • A copy of a search report from a foreign patent office citing the document can serve as the concise explanation

MPEP 609.04(a)(III) states: “Each information disclosure statement must further include a concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information listed that is not in the English language. The concise explanation may be either separate from the specification or part of the specification.”

To learn more:

According to MPEP 507, figures in patent drawings should be labeled as follows:

Each figure must be labeled ‘Fig.’ with a consecutive Arabic numeral (1, 2, etc.) or an Arabic numeral and capital letter in the English alphabet (A, B, etc.). See 37 CFR 1.84(u)(1);

This labeling convention ensures clarity and consistency in referencing figures throughout the patent application and publication. Improper labeling may result in an objection from OPAP and require correction.

The USPTO requires clear itemization of fees to ensure proper accounting. According to MPEP 509:

37 CFR 1.22(b) sets forth that fees must be itemized in such a manner that it is clear for which purpose fees are paid. The Office may return fees that are not itemized.

However, the MPEP clarifies that the itemization requirement is not meant to create problems when the purpose is clear:

  • A reference to ‘filing fee(s)’ is sufficient to cover all types of filing fees.
  • In later submissions, ‘filing fee(s)’ would also cover surcharges.
  • A reference to ‘any corresponding fee under 37 CFR 1.16’ covers any fee under that section.

The key is to provide enough information for the USPTO to understand the purpose of the payment.

To learn more:

Tags: patent fees

Examiners should review the identifying data of all prior applications for which benefits are claimed to ensure accuracy. This review includes:

  • Checking that the data is provided in an application data sheet for applications filed on or after September 16, 2012
  • Verifying that the data is provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012
  • Ensuring the appropriate relationship (e.g., continuation, divisional, or continuation-in-part) between nonprovisional applications is included

The MPEP states: “The identifying data of all prior applications for which benefits are claimed should be reviewed by the examiner to ensure that the data is accurate and provided in an application data sheet for applications filed on or after September 16, 2012, or provided in either the first sentence(s) of the specification or in an application data sheet for applications filed prior to September 16, 2012.” (MPEP 202)

When handling interview requests from practitioners not of record, examiners should follow these guidelines:

  • Verify the requester’s authority to conduct the interview.
  • Ensure the practitioner of record has authorized the interview.
  • If authorization is not provided, decline the interview request.

The MPEP 408 states: ‘Interviews with practitioners not of record should be conducted only with the consent of the practitioner of record.’ It further advises: ‘An examiner should not conduct an interview with an attorney or agent who is not of record unless the attorney or agent presents either a power of attorney or a letter signed by the attorney or agent of record authorizing the interview.’

For more information on patent examination, visit: patent examination.

When handling interview requests from multiple attorneys or agents, examiners should follow these guidelines:

  • Generally, only one interview is granted per application.
  • If multiple practitioners request interviews, coordinate with the practitioner of record.
  • Additional interviews may be granted at the examiner’s discretion.

The MPEP 408 states: ‘An interview should normally be conducted with the attorney or agent of record in an application.’ It further advises: ‘If more than one attorney or agent request an interview in an application, it is the responsibility of the attorney or agent of record to resolve any conflict.’

For more information on patent examination, visit: patent examination.

For more information on practitioner of record, visit: practitioner of record.

Examiners should handle informal drawings in patent applications as follows:

  • Determine if the drawings are sufficient for examination purposes
  • If sufficient, proceed with examination but note the need for formal drawings
  • If insufficient, object to the drawings and explain why formal drawings are required

According to MPEP 608.02(e): ‘The acceptance of and retention of informal drawings by the Office does not relieve the applicant of the drawing requirements of 35 U.S.C. 113.’ This means that while informal drawings may be accepted for initial examination, formal drawings will still be required before the patent can be granted.

To learn more:

When a claim in the original application discloses subject matter not shown in the drawing or described in the description, examiners should treat the claim on its merits and require amendments to the drawing and description. The MPEP 608.01(l) states: “Where subject matter not shown in the drawing or described in the description is claimed in the application as filed, and such claim itself constitutes a clear disclosure of this subject matter, then the claim should be treated on its merits, and requirement made to amend the drawing and description to show this subject matter.” It’s important to note that the deficiency lies in the drawing and description, not in the claim itself.

To learn more:

Examiners are required to provide clear and explicit reasons for not approving drawing corrections in their next communication to the applicant. The MPEP 608.02(x) instructs:

“The examiner should explicitly and clearly set forth all the reasons for not approving the corrections to the drawings in the next communication to the applicant.”

This ensures that applicants understand exactly why their drawing corrections were not accepted and what they need to do to address the issues. The MPEP also refers examiners to MPEP § 608.02(p) for suggested form paragraphs to use when notifying applicants of drawing correction issues.

To learn more:

To learn more:

The arrangement of dependent claims in a patent application should follow specific guidelines as outlined in MPEP 608.01(n):

  • A claim which depends from a dependent claim should not be separated from it by any claim which does not also depend from that dependent claim.
  • A dependent claim may refer back to any preceding independent claim.
  • In general, applicant’s sequence of claims should not be changed.

The MPEP provides this guidance: “These are the only restrictions with respect to the sequence of claims and, in general, applicant’s sequence should not be changed.”

However, during prosecution, the order of claims may change. It’s important to carefully check the numbering of dependent claims and the numbers of preceding claims referred to when claims are renumbered upon allowance.

To learn more:

When submitting corrected drawing sheets in response to objections, applicants must follow specific guidelines as outlined in the MPEP section 608.02(f):

  • Submit corrected drawing sheets in compliance with 37 CFR 1.121(d).
  • Include all figures from the immediate prior version of the sheet, even if only one figure is being amended.
  • Do not label amended drawing figures as “amended.”
  • If canceling a figure, remove it from the replacement sheet and renumber remaining figures if necessary.
  • Label each drawing sheet submitted after the filing date as either “Replacement Sheet” or “New Sheet” in the top margin.

These requirements ensure proper documentation and clarity in the patent application process. Failure to comply may result in abandonment of the application.

To learn more:

To learn more:

According to MPEP 608.02(d), conventional features in patent drawings should be illustrated as follows:

  • Use graphical drawing symbols
  • Use labeled representations (e.g., a labeled rectangular box)

The MPEP states: However, conventional features disclosed in the description and claims, where their detailed illustration is not essential for a proper understanding of the invention, should be illustrated in the drawing in the form of a graphical drawing symbol or a labeled representation (e.g., a labeled rectangular box).

This approach simplifies the drawings while still providing necessary information about conventional elements. It allows the focus to remain on the novel aspects of the invention while acknowledging the presence of standard components.

To learn more:

How should color drawings be submitted in patent applications?

Color drawings in patent applications require special handling:

  1. A petition for color drawings must be filed with the application.
  2. Three sets of color drawings or color photographs must be submitted.
  3. The specification must contain the reference to color drawings.

The MPEP 608.02 states: ‘Color drawings are not permitted in design applications. See 37 CFR 1.84(a)(2) and MPEP § 608.02(VIII).’

For utility patents, color drawings may be accepted if they are necessary for the understanding of the invention. However, they are not encouraged due to reproduction costs and potential issues with public access.

To learn more:

According to MPEP 608.01(m), claims in a patent application should be numbered consecutively in Arabic numerals. The MPEP states:

The claim or claims must commence on a separate physical sheet or electronic page and should appear after the detailed description of the invention. Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material. Claims must be numbered consecutively in Arabic numerals.

This numbering system helps organize the claims and makes it easier for examiners and others to reference specific claims within the application.

To learn more:

The numbering and arrangement of claims in a patent application should follow the guidelines provided in 37 CFR 1.75(f) and (g). Key points include:

  • Claims should be numbered consecutively in Arabic numerals.
  • The least restrictive claim should be presented as claim number 1.
  • Dependent claims should be grouped together with the claim or claims to which they refer, to the extent practicable.

The MPEP states: “If there are several claims, they shall be numbered consecutively in Arabic numerals.” and “The least restrictive claim should be presented as claim number 1, and all dependent claims should be grouped together with the claim or claims to which they refer to the extent practicable.”

This arrangement helps examiners and others reviewing the application to quickly understand the scope and relationships between claims. For more information on claim numbering, refer to MPEP § 608.01(j).

To learn more:

How should claim numbering be handled when canceling claims in a patent application?

When canceling claims in a patent application, it’s important to maintain proper claim numbering. According to MPEP 608.01(n):

‘When claims are canceled, the remaining claims must not be renumbered. When claims are added by amendment or substituted for canceled claims, they must be numbered by the applicant consecutively beginning with the number next following the highest numbered claim previously presented (whether entered or not).’

This means that:

  • Existing claim numbers should not be reused for new claims.
  • Gaps in claim numbering due to canceled claims should be left as is.
  • New claims should be numbered sequentially starting from the highest previous claim number.

Proper claim numbering helps maintain clarity and avoid confusion during the examination process.

To learn more:

Proper claim numbering is essential in patent applications. According to MPEP 608.01(m):

  • Claims must be numbered consecutively in Arabic numerals.
  • The claim number should be placed to the left of the claim text.
  • When claims are canceled, the remaining claims must not be renumbered.

The MPEP states:

‘The claim or claims must commence on a separate physical sheet or electronic page and should appear after the detailed description of the invention. Any sheet including a claim or portion of a claim may not contain any other parts of the application or other material. Claims must be numbered consecutively in Arabic numerals starting with 1.’

Proper claim numbering ensures clarity and helps examiners and others navigate the patent application efficiently.

To learn more:

How should applicants submit written status inquiries to the USPTO?

When submitting written status inquiries to the USPTO, applicants should follow these guidelines:

  • Include the application serial number, filing date, and art unit (if known).
  • Provide a specific description of the precise information requested.
  • Include any necessary authorization for release of information.
  • Submit the inquiry to the appropriate USPTO office or Technology Center.

MPEP 203.08 advises: ‘Written status requests will be answered in all cases.’ However, it also notes that ‘Telephone inquiries regarding the status of applications, other than those in secrecy order and those under 35 U.S.C. 181, may be made by persons entitled to the information, to the appropriate USPTO staff member.’

To learn more:

Applicants other than the inventor must notify the USPTO of any change in the real party in interest as follows:

  • Notification should be made no later than payment of the issue fee
  • Changes can be indicated in Box 3 of the PTOL-85B form
  • If no notification is provided, the USPTO will presume no change has occurred

According to MPEP 308: Applicants other than the inventor can notify the Office of a change in the real party in interest by providing the real party in interest in Box 3 of the PTOL-85B. See MPEP § 307. The real party in interest will be listed in the assignee section of the patent. This does not change the applicant designated in the application or on any patent that is granted.

Additionally, 37 CFR 1.46(e) states: Where a real party in interest has filed an application under § 1.46, the applicant shall notify the Office of any change in the real party in interest no later than payment of the issue fee. The Office will treat the absence of such a notice as an indication that there has been no change in the real party in interest.

For status inquiries regarding PCT applications, the MPEP provides specific guidance:

  • Inquiries relating to international applications filed under the Patent Cooperation Treaty (PCT) should be directed to the PCT Help Desk.
  • The MPEP states: Inquiries relating to international applications (PCT) … should be directed to the PCT Help Desk at 1-800-PTO-9199 or 571-272-4300.
  • The PCT Help Desk can provide information on the processing of international applications at the United States Receiving Office (RO/US), United States International Searching Authority (ISA/US), and United States International Preliminary Examining Authority (IPEA/US).

It’s important to use the correct channel for PCT-related inquiries to ensure accurate and timely information.

To learn more:

Annotated sheets for patent drawings must be prepared according to specific guidelines. MPEP 608.02(v) states that “The marked-up copy must be clearly labeled as ‘Annotated Sheet.'” Additionally, the MPEP specifies that “All such annotated sheets must be in ink or permanent prints.” This ensures that the proposed changes are clearly visible and permanent. When submitting annotated sheets, they should be accompanied by a replacement drawing that incorporates the proposed changes.

To learn more:

The execution of an inventor’s oath or declaration is governed by 37 CFR 1.63(g) and 35 U.S.C. 115(i). The oath or declaration must be executed (signed) in one of two ways:

  1. In accordance with 37 CFR 1.66, which provides rules for oaths taken within or outside the United States
  2. With an acknowledgment that any willful false statement made in the declaration is punishable under 18 U.S.C. 1001 by fine or imprisonment of not more than five years, or both

The inventor’s oath or declaration must be signed by:

  • The inventor
  • The joint inventors collectively
  • The applicant, in the case of a substitute statement under 37 CFR 1.64
  • The inventor who is under the obligation of assignment, in the case of an assignment-statement under 37 CFR 1.63(e)

It’s important to note that there is no minimum age requirement for executing an oath or declaration, but the person must be competent to execute, i.e., understand, the document they are signing.

To learn more:

The requirements for providing an inventor’s name in a patent application have evolved:

  • For applications filed on or after September 16, 2012: 37 CFR 1.63 requires the inventor to be identified by their legal name.
  • For applications filed before September 16, 2012: The full name was required, including family name and at least one given name without abbreviation.

The MPEP clarifies: “For nonprovisional applications filed on or after September 16, 2012, 37 CFR 1.63 requires the identification of the inventor by his or her legal name.”

If an inventor’s full given name is a singular letter or letters (e.g., “J. Doe” or “J.P. Doe”), this should be explained in the oath or declaration to avoid objections.

For name corrections or changes after filing, a request under 37 CFR 1.48(f) is required, which includes submitting an application data sheet and a processing fee.

To learn more:

To learn more:

If an inventor has no middle name, their name should be formatted using only their given name (first name) and family name (last name). The MPEP 602.08(b) provides guidance on this:

If an inventor does not have a middle name or initial, then the field for middle name or initial should be left blank.

It’s important to note that the absence of a middle name should not be confused with the use of initials. If an inventor commonly uses initials in place of their full given name, this should be indicated appropriately on the application.

To learn more:

Submitting an interim copy of a foreign application electronically involves specific procedures. The MPEP provides guidance:

‘If not provided as a single paper document, the main parts of the interim copy of the foreign priority application, i.e., Abstract, Drawings, Specification, Claims, and where applicable, the foreign patent office’s equivalent to a “Sequence Listing” (see MPEP § 2421.01), a “Sequence Listing XML” (see MPEP § 2412), “Large Tables” (see MPEP § 608.05(b)), or a “Computer Program Listing Appendix” (see MPEP § 608.05(a)), along with the separate cover sheet required by 37 CFR 1.55(j), may be filed as a single PDF image file via the USPTO patent electronic filing system.’

Key points for electronic submission:

  • File as a single PDF image file when possible
  • Use the document description ‘Interim Copy of the Foreign Priority Application’ when indexing
  • For plain text files, use the description ‘Interim Copy of the Foreign Priority (text file)’
  • XML files, like Standard ST.26 Sequence Listings, should be filed on a read-only optical disc

Proper indexing and file format selection are crucial for successful electronic submission.

For more information on electronic submission, visit: electronic submission.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

How should an examiner handle non-compliant IDSs?

When an examiner encounters a non-compliant Information Disclosure Statement (IDS), they should follow these steps:

  1. Identify the specific non-compliance issue(s).
  2. Return the IDS to the applicant or patent owner.
  3. Provide a Notice of Non-Compliant Information Disclosure Statement (PTO-1449).
  4. Explain the reason(s) for non-compliance in the notice.
  5. Do not initial or consider the references listed on the non-compliant IDS.

According to MPEP 609.01: ‘Information submitted to the Office that does not comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98 will not be considered by the Office but will be placed in the application file.’

The examiner should provide clear guidance on how to correct the non-compliance, allowing the applicant to resubmit a compliant IDS.

To learn more:

When preparing an assignment document for recording with the USPTO, follow these guidelines based on 37 CFR 3.24 and MPEP 302.01:

  1. For electronic submissions:
    • Submit either a copy of the original document or an extract of it
    • Ensure the document is in Tagged Image File Format (TIFF) or another prescribed format
    • When printed, the document should be legible on 8.5 x 11 inch or A4 paper with 1-inch margins on all sides
  2. For paper or facsimile submissions:
    • Submit a copy of the original document or an extract (not the original)
    • Use only one side of each page
    • Use 8.5 x 11 inch or A4 paper with 1-inch margins on all sides
    • For paper submissions, use flexible, strong white, non-shiny, and durable paper
  3. Ensure the document is legible, as the recorded document will only be as clear as the submitted copy
  4. Include a completed cover sheet as specified in 37 CFR 3.28 and 3.31

MPEP 302.01 states: “The United States Patent and Trademark Office will accept and record only a copy of an original assignment or other document.” Remember, the document submitted for recordation will not be returned, so do not submit original documents.

When responding to drawing objections, an applicant should:

  1. Submit corrected drawing sheets in compliance with 37 CFR 1.121(d)
  2. Include all figures from the immediate prior version, even if only one figure is amended
  3. Label new sheets as ‘Replacement Sheet’ or ‘New Sheet’ in the top margin
  4. Ensure any amended drawing figure is not labeled as ‘amended’

As stated in MPEP 608.02(e), Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. It’s important to note that objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action.

To learn more:

To learn more:

When an applicant doesn’t have firsthand knowledge about certain aspects of the invention’s relationship to government contracts, MPEP 151 provides guidance:

“In instances where an applicant does not have firsthand knowledge whether the invention involved work under any contract, subcontract, or arrangement with or for the benefit of the Atomic Energy Commission, or had any relationship to any work under any contract of the National Aeronautics and Space Administration, and includes in his or her statement information of this nature derived from others, his or her statement should identify the source of his or her information.”

Alternatively, the MPEP suggests that “the statement by the applicant could be accompanied by a supplemental declaration or oath, as to the contractual matters, by the assignee or other person, e.g., an employee thereof, who has the requisite knowledge.” This ensures transparency and accuracy in the statement.

The formatting of a reference to a prior application in the specification is crucial for proper processing. According to MPEP 211.02:

The reference to the prior application must include the following terms: ‘This application is a continuation (or division, or continuation-in-part, as appropriate) of Application No. _____, filed _____.’

Additionally, the MPEP provides guidance on including multiple prior application references:

Where the reference to a prior nonprovisional application only includes the attorney docket number, application number (series code and serial number), and filing date, in the first sentence(s) of the specification of the later filed application, OPAP will mail a ‘Notice to File Missing Parts’ indicating that a complete reference to the prior application(s) is required.

It’s important to ensure that all necessary information is included in the reference to avoid processing delays. The reference should clearly state the relationship between the applications (continuation, division, or continuation-in-part), provide the application number, and include the filing date of the prior application.

To learn more:

According to 37 CFR 3.21 and MPEP 302.03, a patent or application should be identified in an assignment document as follows:

  • For a patent: Use the patent number
  • For a national patent application: Use the application number (series code and serial number, e.g., 07/123,456)
  • For an international patent application designating the U.S.: Use the international application number (e.g., PCT/US2012/012345)
  • For an international design application designating the U.S.: Use either the international registration number or the U.S. application number

For applications not yet filed or without an assigned number:

  • For a non-provisional application: Identify by inventor name(s) and the title of the invention
  • For a provisional application: Identify by inventor name(s) and the title of the invention

MPEP 302.03 suggests: “It is suggested, however, that an assignment be written to allow entry of the identifying number after the execution of the assignment. An example of acceptable wording is: ‘I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.'”

The formatting requirements for a patent abstract are:

  • It should be in narrative form
  • Generally limited to a single paragraph
  • Preferably 50 to 150 words in length
  • Should not exceed 15 lines of text
  • Avoid legal phraseology often used in patent claims (e.g., ‘means’ and ‘said’)
  • Use clear and concise language
  • Avoid phrases like ‘This disclosure concerns,’ ‘The disclosure defined by this invention,’ or ‘This disclosure describes’

The MPEP states: The abstract should be in narrative form and generally limited to a single paragraph preferably within the range of 50 to 150 words in length. The abstract should not exceed 15 lines of text.

To learn more:

To record a joint research agreement with the USPTO, follow these steps based on 37 CFR 3.11(c) and 37 CFR 3.31(g):

  1. Prepare either a copy of the joint research agreement or an excerpt of it.
  2. Complete a cover sheet that includes:
    • Identification of the document as a “joint research agreement” in the space for describing the interest conveyed
    • The name of the owner of the application or patent
    • The name of each other party to the joint research agreement
    • The date the joint research agreement was executed
  3. Submit the document and cover sheet to the USPTO for recordation.

As stated in MPEP 302.07: “If the document submitted for recordation is a joint research agreement or an excerpt of a joint research agreement, the cover sheet must clearly identify the document as a ‘joint research agreement’ (in the space provided for the description of the interest conveyed if using Form PTO-1595).”

According to 35 U.S.C. 293 and 37 CFR 3.61, a foreign assignee of a patent or patent application who is not domiciled in the United States may designate a domestic representative. Here’s how to do it:

  1. Prepare a written document signed by the assignee.
  2. State the name and address of a person residing within the United States who may be served process or notice of proceedings affecting the patent or rights under it.
  3. Submit this document to the USPTO as a separate paper from any assignment document.
  4. Clearly label the document as “Designation of Domestic Representative.”
  5. Ensure the document is signed in accordance with 37 CFR 1.33(b).

As stated in MPEP 302.04: “The designation of domestic representative should always be submitted to the Office as a paper separate from any assignment document.”

How should a dependent claim be written to properly incorporate limitations from its parent claim?

To properly incorporate limitations from a parent claim, a dependent claim should be written following these guidelines:

  1. Reference the parent claim: Begin the dependent claim by referring to the parent claim by number (e.g., “The device of claim 1, wherein…”).
  2. Use incorporating language: The preamble should implicitly or explicitly incorporate the limitations of the parent claim.
  3. Add further limitations: Specify additional limitations that narrow the scope of the parent claim.
  4. Avoid repetition: Don’t repeat limitations already present in the parent claim.

The MPEP 608.01(n) states:

“The U.S. Court of Appeals for the Federal Circuit indicated that a dependent claim must be construed to incorporate by reference all the limitations of the claim to which it refers.”

This means that even if not explicitly stated, all limitations of the parent claim are considered part of the dependent claim. By following these guidelines, you ensure that your dependent claims are properly structured and fully compliant with USPTO requirements.

To learn more:

Filing a Continued Prosecution Application (CPA) by facsimile requires specific procedures, as outlined in MPEP 502.01:

  1. CPAs are only available for design applications.
  2. The CPA must be sent to the central facsimile number: (571) 273-8300.
  3. An authorization to charge the basic filing fee to a deposit account or credit card must be included, or the application will be treated as filed without the basic filing fee.
  4. There is a special receipt procedure for CPA filings by fax:

There is a special receipt procedure for filing a CPA by fax, whereby the Office will fax back a receipt of the CPA filing if applicant submits the Office receipt form along with the CPA filing.

It’s important to note that if the USPTO has no evidence of receiving a CPA transmitted by fax, the applicant may need to file a petition under 37 CFR 1.6(f) to request a filing date. This petition must include:

  • Information about the previous transmission
  • An additional copy of the CPA
  • A statement attesting to the previous transmission
  • Evidence of the transmission, such as a sending unit’s report or other evidence created within one business day of the transmission

Always ensure that you follow these procedures carefully when filing a CPA by facsimile to avoid any issues with the filing date or processing of your application.

To learn more:

The proper submission of a benefit claim depends on the filing date of the application:

  • For applications filed on or after September 16, 2012: The benefit claim must be included in an Application Data Sheet (ADS) in compliance with 37 CFR 1.76.
  • For applications filed before September 16, 2012: The benefit claim can be submitted either by an amendment to the first sentence(s) of the specification or in an ADS in compliance with pre-AIA 37 CFR 1.76.

The MPEP states: Applicant must still submit the benefit claim in the manner specified in 37 CFR 1.78 (i.e., in an ADS in compliance with 37 CFR 1.76 (or for applications filed prior to September 16, 2012 by an amendment to the first sentence(s) of the specification or in an ADS in compliance with pre-AIA 37 CFR 1.76) to have a proper claim under 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the benefit of a prior application.

To learn more:

To learn more:

The method for including a benefit claim in a patent application depends on the filing date:

  • For applications filed before September 16, 2012: The reference must be included in the first sentence(s) of the specification following the title or in an application data sheet (ADS).
  • For applications filed on or after September 16, 2012: The specific reference must be included in an application data sheet (ADS).

The MPEP states: “If the application was filed before September 16, 2012, the reference must be included in the first sentence(s) of the specification following the title or in an application data sheet; if the application was filed on or after September 16, 2012, the specific reference must be included in an application data sheet.”

Additionally, for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on application data sheet, visit: application data sheet.

The Manual of Patent Examining Procedure (MPEP) is regularly updated to reflect changes in patent laws, rules, and procedures. According to MPEP 101:

The Manual is updated periodically to include changes in patent laws and rules and also changes in Patent and Trademark Office procedures.

While the MPEP doesn’t specify an exact frequency for updates, they typically occur:

  • Multiple times per year to incorporate new policies and procedures
  • After significant changes in patent laws or regulations
  • When court decisions impact patent examination practices

Users should always refer to the most recent version of the MPEP available on the USPTO website for the most up-to-date information.

For more information on MPEP updates, visit: MPEP updates.

For more information on patent law changes, visit: patent law changes.

For more information on USPTO procedures, visit: USPTO procedures.

The frequency of updates to reserved sections in the MPEP varies and is determined by the USPTO based on several factors:

  • Changes in patent laws or regulations
  • New court decisions affecting patent examination
  • Evolving USPTO policies and procedures
  • Feedback from patent examiners and practitioners

Reserved sections may be filled or updated during regular MPEP revisions, which typically occur annually or as needed. However, there is no fixed schedule for updating specific reserved sections, and some may remain reserved for extended periods.

The frequency with which ‘[Reserved]’ sections in the MPEP, like MPEP 212, are filled with content varies and depends on the needs of the USPTO. These sections may be filled during regular MPEP updates, which typically occur several times a year, or may remain reserved for extended periods.

According to MPEP 509.02, fees for small entities are reduced by 50% for most patent-related fees. The MPEP states:

The fees which are reduced by 50% for small entities include patent application filing fees including the basic filing fee, search fee, examination fee, application size fee, and excess claims fees (37 CFR 1.16), extension of time, revival, and appeal fees (37 CFR 1.17), patent issue fees (37 CFR 1.18), and maintenance fees on patents (37 CFR 1.20).

Additionally, certain PCT international stage fees are also eligible for the 50% reduction for small entities.

To learn more:

For amended applications, it’s generally advised to wait before making a status inquiry. According to MPEP 203.08:

Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office.

However, if six months have passed without a response, it’s advisable to inquire about the application’s status to avoid potential abandonment. Applicants are encouraged to use Patent Center or Private PAIR for status inquiries.

For more information on amended application, visit: amended application.

For more information on Patent Center, visit: Patent Center.

For more information on Private PAIR, visit: Private PAIR.

For amended patent applications, the USPTO provides guidelines on when to inquire about the status. According to MPEP 203.08:

Amended applications are expected to be taken up by the examiner and an action completed within two months of the date the examiner receives the application. Accordingly, a status inquiry is not in order after reply by the attorney until 5 or 6 months have elapsed with no response from the Office.

If six months have passed without a response, you should inquire about the application’s status to avoid potential abandonment. It’s recommended to use Patent Center or Private PAIR for status inquiries.

For more information on amended application, visit: amended application.

A provisional patent application has a limited lifespan. According to MPEP 201.04:

“A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter. See 35 U.S.C. 111(b)(5).”

However, there is a provision for extending this period in certain circumstances:

“The period of pendency of a provisional application is extended to the next succeeding business day if the day that is 12 months after the filing date of a provisional application falls on a Saturday, Sunday, or federal holiday within the District of Columbia. See 35 U.S.C. 119(e)(3) and 37 CFR 1.7(b).”

It’s crucial to file a nonprovisional application claiming the benefit of the provisional application within this 12-month period to maintain the priority date.

For more information on patent validity, visit: patent validity.

For more information on provisional patent, visit: provisional patent.

For more information on USPTO, visit: USPTO.

Once small entity status is established in an application or patent, it remains in effect until:

  • The issue fee is due, or
  • Any maintenance fee is due

At these points, a new determination of entitlement to small entity status is required. As stated in 37 CFR 1.27(g)(1): “Once small entity status is established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.”

To learn more:

Tags: patent fees

Micro entity status, once properly established, generally remains in effect until:

  • A fee is paid in the small entity or undiscounted amount
  • A notification of loss of entitlement to micro entity status is filed
  • The issue fee or a maintenance fee is due

However, the applicant has a continued obligation to verify eligibility for micro entity status each time a fee is paid. As stated in 37 CFR 1.29(g): ‘a fee may be paid in the micro entity amount only if status as a micro entity as defined in paragraph (a) or (d) of this section is appropriate on the date the fee is being paid.’

The time to obtain a foreign filing license from the USPTO can vary. According to MPEP 140:

‘If a license is required but the application is not one of the types under MPEP § 140(II), the grant of a license is not usually included in the letter of filing receipt.’

In such cases, the processing time can take several weeks. However, for expedited processing:

  • A petition for expedited handling under 37 CFR 1.182 can be filed.
  • In urgent cases, the license can be granted immediately by telephone.
  • The Office of Licensing and Review can grant a license the same day by fax.

It’s advisable to apply for a license well in advance of any planned foreign filing to ensure timely processing.

For more information on foreign filing license, visit: foreign filing license.

How long does it take for a patent assignment to be recorded by the USPTO?

The time it takes for a patent assignment to be recorded by the USPTO can vary. While the MPEP does not specify an exact timeframe, the process typically takes several weeks. Factors affecting the recording time include:

  • Method of submission (electronic vs. paper)
  • Completeness and accuracy of the submitted documents
  • Current USPTO workload

According to the MPEP 302, ‘The date of recording of a document is the date of its receipt in the Office in proper form with the appropriate fee.’ This means that the official recording date is the date the USPTO receives a compliant submission, not the date when processing is completed.

For the most up-to-date information on processing times, it’s advisable to check the USPTO website or contact their assignment recordation branch directly.

A provisional patent application has a limited lifespan. According to MPEP 201.04:

“A provisional application will automatically be abandoned 12 months after its filing date and will not be subject to revival to restore it to pending status thereafter.”

This 12-month period provides inventors with a year of ‘patent pending’ status to further develop their invention, assess its commercial potential, or secure funding. To maintain patent rights, the inventor must file a corresponding nonprovisional application claiming the benefit of the provisional application within this 12-month window.

It’s important to note that the 12-month period may be extended to the next business day if it ends on a weekend or federal holiday in the District of Columbia.

To learn more:

Tags: USPTO

A patent application remains in ‘rejected’ status until one of two things happens:

  1. The applicant acts upon the examiner’s action within the allotted reply period, or
  2. The application becomes abandoned.

As stated in MPEP 203.02:

Its status as a ‘rejected’ application continues as such until acted upon by the applicant in reply to the examiner’s action (within the allotted reply period), or until it becomes abandoned.

The duration of ‘rejected’ status thus depends on the applicant’s timely response or the application’s abandonment.

To learn more:

How long does a foreign filing license remain valid?

The validity period of a foreign filing license depends on the type of license issued. According to MPEP 140:

“A foreign filing license is not required to file a patent application in another country if the invention was not made in the United States. A license is required if the invention was made in this country and:

  • An application on the invention has been filed in the United States less than six months prior to the date on which the application is to be filed abroad, or
  • No application on the invention has been filed in the United States.”

In essence, a foreign filing license granted as part of the regular patent application process remains valid for six months from the filing date. After six months, no additional license is required. However, if you obtain a petition-based license (e.g., for inventions not yet filed in the U.S.), the license will specify its scope and duration in the grant letter.

For more information on foreign filing license, visit: foreign filing license.

Patent restrictions for former USPTO employees extend for one year after their employment ends. 35 U.S.C. 4 states:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office.’

After this one-year period, former employees can apply for patents, but with certain limitations on priority dates.

If you’ve filed a patent application without necessary drawings, you have a limited time to submit them. According to MPEP 601.01(f):

“The applicant is given a time period of 2 months from the date of the notification to submit the omitted drawings and avoid abandonment of the application.”

This two-month period is set when the USPTO issues a Notice of Omitted Items. It’s crucial to respond within this timeframe to prevent your application from being abandoned. If you need more time, you can request an extension, but fees may apply.

To learn more:

To learn more:

The time period for responding to a notice about an unlocatable file depends on whether it’s for an application or a patent:

  • For applications: The USPTO typically sets a three-month period, which is extendable under 37 CFR 1.136(a) by up to three additional months, for a maximum of six months.
  • For patents: A six-month non-extendable period is set.

It’s important to note that for applications, as stated in the MPEP, If, however, an applicant fails to reply to a notice under 37 CFR 1.251 within three months of its mailing date, any patent term adjustment under 35 U.S.C. 154(b) will be reduced by a period equal to the number of days (if any) beginning on the day after the date that is three months after the mailing date of the notice under 37 CFR 1.251 and ending on the date the reply to the notice under 37 CFR 1.251 was filed.

To learn more:

The basic filing fee for a provisional application must be paid either:

  1. At the time of filing, or
  2. Within the time period set forth in 37 CFR 1.53(g)

If no correspondence address is provided, the applicant has two months from the filing date to pay the basic filing fee, submit the cover sheet, and pay the surcharge. The MPEP states:

If no correspondence address has been provided, applicant has two months from the filing date to file the basic filing fee, cover sheet, and to pay the surcharge as set forth in 37 CFR 1.16(g) in order to avoid abandonment of the provisional application. (MPEP 601.01(b))

It’s important to note that timely payment of the filing fee is crucial if you intend to claim the benefit of the provisional application in a later-filed nonprovisional application.

To learn more:

According to MPEP 203.05, you have 12 months from the filing date of your provisional application to file a nonprovisional application. The MPEP states:

“in the case of a provisional application, no later than 12 months after the filing date of the provisional application”

If you don’t file a nonprovisional application within this timeframe, your provisional application will be considered abandoned. This 12-month period is set by 35 U.S.C. 111(b)(5).

To learn more:

According to MPEP 406, when the USPTO notifies an applicant of their patent practitioner’s death, the applicant is given a specific timeframe to respond. The MPEP states:

“The period for reply to such a notice is normally set at 3 months.”

During this 3-month period, the applicant must take one of the following actions:

  • Appoint a new registered patent practitioner
  • File a change of correspondence address

It’s crucial to respond within this timeframe to prevent the application from being deemed abandoned.

For more information on application abandonment, visit: application abandonment.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on response time, visit: response time.

For more information on USPTO notification, visit: USPTO notification.

Once small entity status is established in an application or patent, you can continue to pay fees as a small entity until the issue fee is due or any maintenance fee is due. This is stated in 37 CFR 1.27(g)(1): ‘Once small entity status is established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.’

To learn more:

Tags: patent fees

A secrecy order can remain in effect for a significant period. As stated in MPEP 120, “The secrecy order may remain in effect for the duration of the national emergency and six months thereafter and automatically expires at the end of that period.” However, it’s important to note that:

  • The order can be renewed if necessary
  • It can be terminated earlier if the reasons for its issuance no longer exist
  • The total duration is subject to the provisions of 35 U.S.C. 181

For more information on secrecy order duration, visit: secrecy order duration.

The length of a patent application title is specified in MPEP 606:

“The title should be brief but technically accurate and descriptive and should contain fewer than 500 characters.”

This means that while your title should be comprehensive enough to accurately describe the invention, it must not exceed 499 characters, including spaces. It’s important to note that:

  • The 500-character limit is a maximum, not a target.
  • Shorter titles are often preferred as long as they remain descriptive and accurate.
  • The title should balance brevity with technical accuracy and descriptiveness.

When crafting your title, aim for clarity and conciseness while staying within this character limit.

To learn more:

According to MPEP 608.03(a), models and exhibits are generally disposed of by the USPTO after the application becomes abandoned or the patent is issued. The MPEP states:

‘Models or exhibits that are required by the Office or filed with a petition under 37 CFR 1.91(a)(3) will be disposed of by the Office after the application becomes abandoned or the patent expires or is terminated, whichever is later.’

However, it’s important to note that applicants can request the return of their models or exhibits. The USPTO will notify the applicant when the model or exhibit is no longer needed, and the applicant must arrange for its return within a specified time frame.

To learn more:

The recording fee for multiple patents or applications is calculated on a per-item basis. According to MPEP 302.06:

The recording fee set in 37 CFR 1.21(h) is charged for each patent application and patent identified in the required cover sheet except as provided in 37 CFR 3.41(b).

This means that if you are recording a document that affects multiple patents or applications, you will need to pay a separate fee for each one listed on the cover sheet. However, remember that for electronic submissions, the current fee is $0 per item.

To learn more:

Tags: USPTO fees

How is the receipt date determined for faxed assignment documents at the USPTO?

The determination of the receipt date for faxed assignment documents at the USPTO is crucial for establishing priority and effective dates. According to MPEP 302.09:

“The date of receipt accorded to an assignment document sent to the Office by facsimile transmission is the date the complete transmission is received in the Office.”

This means that:

  • The receipt date is when the entire document has been successfully transmitted and received by the USPTO.
  • Partial transmissions or incomplete faxes will not establish a receipt date.
  • The time zone of the USPTO (Eastern Time) is used for determining the date.
  • If a transmission is completed after business hours, the next business day may be considered the receipt date.

It’s important to ensure that the fax transmission is complete and to keep confirmation records of the transmission for your files.

To learn more:

The priority period for U.S. nonprovisional applications is calculated as follows:

  • The first day (filing date of the foreign application) is not counted.
  • The period ends on the same date of the following year (or six months later for design applications).
  • If the last day falls on a weekend or federal holiday, the period extends to the next business day.

The MPEP provides an example: If an application was filed in Canada on January 3, 1983, the U.S. nonprovisional application may be filed on January 3, 1984. (MPEP 213.03)

This calculation method is consistent with Article 4C(2) of the Paris Convention, which specifies that the day of filing is not counted in this period.

To learn more:

When foreign applications are properly claimed and verified in a patent application, this information is reflected in the issued patent and the Official Gazette listing. This helps establish the priority date and international scope of the invention.

The MPEP states: The front page of the patent when it is issued, and the listing in the Official Gazette, will refer to the claim of priority, giving the country, the filing date, and the number of the foreign application in those applications in which the bib-data sheet has been endorsed. (MPEP 202)

This means that for each properly claimed foreign application, the following information will be publicly available:

  • The country of filing
  • The filing date
  • The application number

It’s important to note that this information is only included for foreign applications that have been verified and endorsed on the bib-data sheet by the examiner. For more information on foreign priority claims, see MPEP § 213.

For more information on foreign applications, visit: foreign applications.

For more information on issued patent, visit: issued patent.

For more information on Official Gazette, visit: Official Gazette.

The gross income limit for micro entity status is determined as follows:

  • It is set at three times the median household income for the preceding calendar year, as reported by the Bureau of the Census.
  • The USPTO publishes the current maximum qualifying gross income on their website.
  • This limit applies to each applicant, inventor, and joint inventor individually.

The MPEP clarifies: “At the time any fee is to be paid in the micro entity amount, it is required that no inventor and no non-inventor applicant (if any) have a preceding calendar year’s gross income exceeding the ‘maximum qualifying gross income’ posted on the USPTO website.

It’s important to note that gross income means total income, not adjusted gross income. The MPEP states: “‘Gross income’ and ‘adjusted gross income’ are not the same thing. Adjusted gross income is defined as gross income minus adjustments to income. For purposes of micro entity status it is ‘gross income’ – not ‘adjusted gross income’ that matters.

To learn more:

The filing date for Priority Mail Express® submissions is typically determined by the “date accepted” on the Priority Mail Express® mailing label. According to MPEP 513:

Office personnel will routinely look to the Priority Mail Express® mailing label, and stamp the “date accepted” or other official USPS notation as the filing date of the correspondence.

If the USPS deposit date cannot be determined, the correspondence will be accorded the date of receipt in the Office as the filing date. It’s important to note that the “date accepted” must be completed by the USPS, not by the applicant.

The enforceability of patent arbitration awards is contingent upon proper notice being filed with the USPTO. According to 35 U.S.C. 294(e) and 37 CFR 1.335(c):

‘The award shall be unenforceable until the notice required by subsection (d) is received by the Director.’

This means that until the proper notice of the arbitration award is filed with the USPTO, the award cannot be enforced. It’s crucial for parties involved in patent arbitration to ensure that all required notices are filed promptly to maintain the enforceability of the award.

The effective filing date for a claimed invention is determined as follows:

  • The actual filing date of the application containing the claim, or
  • The filing date of the earliest application for which the patent or application is entitled to claim priority or benefit

The MPEP cites 35 U.S.C. 100(i)(1): “the effective filing date for a claimed invention in a patent or application (except in an application for reissue or reissued patent) is set forth in 35 U.S.C. 100(i)(1) as: (A) if subparagraph (B) does not apply, the actual filing date of the patent or the application for the patent containing a claim to the invention; or (B) the filing date of the earliest application for which the patent or application is entitled, as to such invention, to a right of priority under section 119, 365(a), 365(b), 386(a), or 386(b) or to the benefit of an earlier filing date under section 120, 121, 365(c), or 386(c).” (MPEP 210)

The deficiency owed for micro entity fee errors is calculated according to 37 CFR 1.29(k)(2). The MPEP states:

The deficiency owed for each previous fee erroneously paid as a micro entity is the difference between the current fee amount for a small entity or non-small entity, as applicable, on the date the deficiency is paid in full and the amount of the previous erroneous micro entity fee payment.

To calculate the total deficiency payment:

  1. Determine the current fee amount for each erroneously paid fee (small or non-small entity rate)
  2. Subtract the micro entity fee amount previously paid
  3. Sum up all individual deficiency amounts

This calculation ensures that the correct fee amount is paid based on the entity status and current fee schedule.

To learn more:

For continuing applications where application papers from a prior application are used, special attention must be paid to the correspondence address. According to 37 CFR 1.33(f):

“Where application papers from a prior application are used in a continuing application and the correspondence address was changed during the prosecution of the prior application, an application data sheet or separate paper identifying the correspondence address to be used for the continuing application must be submitted. Otherwise, the Office may not recognize the change of correspondence address effected during the prosecution of the prior application.”

This means that applicants must explicitly specify the desired correspondence address for the continuing application to ensure proper communication with the USPTO.

To learn more:

The application size fee is calculated based on the number of pages in the application. According to 37 CFR 1.16(s), this fee applies to any application filed under 35 U.S.C. 111 where the specification (including claims) and drawings exceed 100 sheets of paper.

The MPEP states: The application size fee applies for each additional 50 sheets or fraction thereof over 100 sheets of paper. However, certain parts of the application are excluded from this calculation:

  • ASCII plain text files or XML files of Sequence Listings
  • Computer readable forms (CRF) of Sequence Listings
  • Computer Program Listing Appendices in compliance with 37 CFR 1.96(c)

For applications submitted via the USPTO patent electronic filing system, the paper size equivalent… will be considered to be seventy five percent of the number of sheets of paper present in the specification (including claims) and drawings of the application when entered into the Office file wrapper.

To learn more:

The adequacy of best mode disclosure is determined by evaluating evidence of concealment, whether accidental or intentional. According to MPEP 608.01(h): In determining the adequacy of a best mode disclosure, only evidence of concealment (accidental or intentional) is to be considered. That evidence must tend to show that the quality of an applicant’s best mode disclosure is so poor as to effectively result in concealment.

This guidance is based on the case law established in Spectra-Physics, Inc. v. Coherent, Inc., 827 F.2d 1524, 1536, 3 USPQ2d 1737, 1745 (Fed. Cir. 1987) and In re Sherwood, 613 F.2d 809, 204 USPQ 537 (CCPA 1980). The focus is on whether the disclosure effectively conceals the best mode rather than on the specific details provided.

To learn more:

Filing a continuing application under 37 CFR 1.53(b) does not automatically abandon the prior nonprovisional application. The MPEP clarifies: Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application. If the prior nonprovisional application is to be expressly abandoned, such a paper must be signed in accordance with 37 CFR 1.138. However, there are special considerations if the prior application has a notice of allowance issued or is before the Patent Trial and Appeal Board. The MPEP further states: If the prior nonprovisional application which is to be expressly abandoned has a notice of allowance issued therein, the prior nonprovisional application can become abandoned by the nonpayment of the issue fee. It’s important to follow the proper procedures to ensure the desired outcome regarding the prior application’s status.

To learn more:

The 30-month period for national stage entry is calculated from the priority date of the international application. The priority date is typically the filing date of the earliest application whose priority is claimed in the international application.

MPEP 601.04 states: “For most applications, the 30-month time period for entry into the national stage expires on the same day of the month as the date of the priority claim in the 30th subsequent month.” However, it’s important to note that if the 30-month period expires on a Saturday, Sunday, or federal holiday, the period is extended to the next succeeding business day.

To learn more:

For continuing applications, small entity or micro entity status must be re-established. The MPEP states: If small entity status has been established in a parent application and is still proper and desired in a continuation, continuation-in-part, or divisional application filed under 37 CFR 1.53(b), a new assertion as to the continued entitlement to small entity status under 37 CFR 1.27 is required. For micro entity status, the MPEP further specifies: The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

To learn more:

Determining refusal to join an application under pre-AIA 37 CFR 1.47 involves several considerations:

  1. The inventor must be presented with the application papers.
  2. The inventor must understand what they are being asked to sign.
  3. The inventor must expressly refuse to accept the application papers.

The MPEP states:

‘A refusal by an inventor to sign an oath or declaration when the inventor has not been presented with the application papers does not itself suggest that the inventor is refusing to join the application unless it is clear that the inventor understands exactly what he or she is being asked to sign and refuses to accept the application papers.’

It’s important to document the circumstances of the presentation and refusal, including time, place, and any written evidence of refusal.

To learn more:

To learn more:

Patent ownership can be transferred through an assignment. According to 35 U.S.C. 261, assignments of patent applications, patents, or any interest therein must be in writing. The MPEP defines an assignment as:

‘a transfer by a party of all or part of its right, title and interest in a patent [or] patent application….’

An assignment transfers the entire ownership interest or a percentage of that interest in the patent or application. It must include the entirety of the bundle of rights associated with the ownership interest.

The initial ownership of a patent depends on the filing date of the application. For applications filed on or after September 16, 2012, the MPEP states:

‘For applications filed on or after September 16, 2012, the original applicant is presumed to be the owner of the application for an original patent. See 37 CFR 3.73(a).’

For applications filed before September 16, 2012:

‘For applications filed before September 16, 2012, the ownership of the patent (or the application for the patent) initially vests in the named inventors of the invention of the patent.’

This distinction is important for determining the initial owner of a patent or patent application.

When there are multiple assignees or a combination of partial assignees and inventors, establishing ownership for patent applications becomes more complex. According to MPEP 325 and 37 CFR 3.73(c)(2), each owner must submit a statement that either:

  1. Specifies the percentage of their ownership interest, accounting for the entire right, title, and interest in the application or patent, or
  2. Identifies all parties, including inventors, who together own the entire right, title, and interest, and states that all identified parties own the entire right, title, and interest.

The MPEP states: “Where there is more than one assignee (i.e., partial assignees) or a combination of partial assignees and inventors who have not assigned away their right, title and interest in the application, each owner must submit a statement under 37 CFR 3.73(c) that either:

(A) Specifies (by percentage) the extent of its ownership interest, so as to account for the entire right, title and interest in the application or patent by all parties. 37 CFR 3.73(c)(2)(i); or

(B) Identifies the parties including inventors who together own the entire right, title and interest and state that all the identified parties own the entire right, title and interest. 37 CFR 3.73(c)(2)(ii).”

If the extent of ownership is not clearly set forth, the USPTO may refuse to accept the submission as an establishment of ownership interest.

For more information on multiple assignees, visit: multiple assignees.

For more information on ownership interest, visit: ownership interest.

For more information on partial assignees, visit: partial assignees.

When there are multiple assignees for a patent application, patent, or reexamination proceeding, each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b) to take action before the USPTO. The process is as follows:

  1. Each partial assignee must submit their own pre-AIA 37 CFR 3.73(b) statement.
  2. In each submission, the extent of the assignee’s ownership interest must be clearly stated.
  3. The USPTO needs to determine if it has obtained action by all of the right, title, and interest holders (owners).
  4. If the extent of ownership is not clearly set forth, the USPTO may refuse to accept the submission.

This is outlined in MPEP 324, section VIII, which states:

“When an assignee seeks to take action in a matter before the Office with respect to a patent application, patent, or reexamination proceeding and the right, title, and interest therein is held by more than one assignee, each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b). In each submission, the extent of each assignee’s interest must be set forth so that the Office can determine whether it has obtained action by the entirety of the right, title and interest holders (owners).”

The MPEP further notes: “If the extent of the partial assignee’s ownership interest is not set forth in the submission under pre-AIA 37 CFR 3.73(b), the Office may refuse to accept the submission as an establishment of ownership interest.”

For continuing applications (continuation or divisional) filed under 37 CFR 1.53(b) before September 16, 2012, ownership can be established in one of two ways:

  1. The application papers can contain a copy of a statement filed under pre-AIA 37 CFR 3.73(b) in the parent application.
  2. A newly executed statement under pre-AIA 37 CFR 3.73(b) can be filed with the continuing application.

For continuation-in-part applications filed before September 16, 2012, a newly executed statement under pre-AIA 37 CFR 3.73(b) must be filed.

In the case of design applications where a continued prosecution application (CPA) is filed under 37 CFR 1.53(d), the statement filed under 37 CFR 3.73(b) in the parent application will serve as the statement for the CPA.

This is outlined in MPEP 324, section III, which states: “When an assignee files a continuation or divisional application under 37 CFR 1.53(b) before September 16, 2012, the application papers must: (A) contain a copy of a statement filed under pre-AIA 37 CFR 3.73(b) in the parent application; or (B) contain a newly executed statement under pre-AIA 37 CFR 3.73(b).”

Inventorship in a Continued Prosecution Application (CPA) is generally maintained from the prior application. However, if there’s a need to add or change inventors, specific procedures must be followed.

According to MPEP ¶ 2.33: “Any request to add an inventor must be in the form of a request under 37 CFR 1.48. Otherwise, the inventorship in the CPA shall be the same as in the prior application.”

This means that if you want to add or change inventors in a CPA, you must file a formal request under 37 CFR 1.48, which outlines the procedure for correction of inventorship in patent applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For continuing applications filed on or after September 16, 2012, inventorship is determined as follows:

  1. If an application data sheet (ADS) is filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application, the inventorship is specified in the ADS.
  2. If no ADS is filed before or concurrently with the copy of the inventor’s oath or declaration, the inventorship is set forth in the copy of the inventor’s oath or declaration from the earlier-filed application.
  3. If there’s no ADS and the copy of the oath or declaration is accompanied by a signed statement pursuant to 37 CFR 1.33(b), the inventorship is as stated in that signed statement.

According to MPEP 602.05(a): For continuing applications filed on or after September 16, 2012 under 37 CFR 1.53(b), the inventorship is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If an application data sheet is not filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application, the inventorship is the inventorship set forth in the copy of the inventor’s oath or declaration from the earlier-filed application, unless it is accompanied by a signed statement pursuant to 37 CFR 1.33(b) that states the name of each inventor in the continuing application.

Any new joint inventor named in the continuing application must provide an oath or declaration in compliance with 37 CFR 1.63, except as provided in 37 CFR 1.64.

To learn more:

To correct inventorship in a provisional patent application, the following steps must be taken:

  • Submit a request signed by a party set forth in 37 CFR 1.33(b)
  • Identify each inventor by their legal name in the request
  • Pay the processing fee set forth in 37 CFR 1.17(q)
  • When adding an inventor, file a corrected application data sheet or a new cover sheet with the residence of all inventors

The MPEP states: 37 CFR 1.48(d) provides a procedure for adding or deleting or correcting or updating the name of an inventor in a provisional application. 37 CFR 1.48(d) requires that the submission include: (1) a request, signed by a party set forth in 37 CFR 1.33(b), to correct the inventorship that identifies each inventor by their legal name; and (2) the fee set forth in 37 CFR 1.17(q).

To learn more:

For micro entity status, gross income is determined as follows:

  • Based on the calendar year preceding the year a fee is paid
  • Uses the definition of gross income in section 61(a) of the Internal Revenue Code
  • Compared to three times the median household income as reported by the Bureau of the Census
  • For non-US income, converted using the average currency exchange rate for the relevant calendar year

The USPTO website provides the current maximum qualifying gross income limit.

When calculating gross income for micro entity status involving foreign currency, the USPTO provides specific guidelines:

  • If an applicant’s, inventor’s, or entity’s gross income in the preceding calendar year is not in U.S. dollars, the average currency exchange rate reported by the Internal Revenue Service (IRS) for that calendar year must be used for conversion.
  • For income received partially in U.S. dollars and partially in foreign currency, the foreign portion must be converted to U.S. dollars and added to the U.S. dollar amount.

The MPEP states: “If an applicant’s, inventor’s, joint inventor’s, or entity’s gross income in the preceding calendar year is not in United States dollars, the average currency exchange rate, as reported by the Internal Revenue Service, during that calendar year shall be used to determine whether the applicant’s, inventor’s, joint inventor’s, or entity’s gross income exceeds the threshold specified in 37 CFR 1.29(a)(3) or (a)(4).

The IRS provides yearly average currency exchange rates on its website, which should be used for these calculations.

To learn more:

When a claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but before the patent is granted, special procedures apply.

According to the MPEP: When the claim for foreign priority or the certified copy of the foreign application is filed after the date of payment of the issue fee but prior to the date of grant of the patent, the foreign priority claim or certified copy will be placed in the file record but there may be no review of the papers and the patent when published will not include the priority claim.

To have the foreign priority claim or certified copy considered after publication of the patent:

  • A certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323 can be filed
  • For original applications under 35 U.S.C. 111(a) or national stage applications under 35 U.S.C. 371, a grantable petition to accept an unintentionally delayed claim for priority under 37 CFR 1.55 and the petition fee must be filed with the certificate of correction

For more information on this process, refer to MPEP § 216.01.

To learn more:

Foreign priority application information is handled as follows on the bib-data sheet:

  • If a proper foreign priority claim is not listed on the bib-data sheet, the examiner should add the information and forward it for correction in the Office computer systems.
  • Applications listed on the bib-data sheet but filed in countries not qualifying for benefits under 35 U.S.C. 119(a)-(d) should be lined through.
  • The bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application claiming priority.
  • Examiners should check this information for accuracy and make corrections if necessary.

The MPEP states: “If a foreign application listed on the oath or declaration (for applications filed prior to September 16, 2012) or application data sheet is not listed on the bib-data sheet and the foreign priority claim is proper (e.g., the foreign priority claim was timely made ), the examiner should provide the information regarding the foreign application number, the country, and the filing date on the bib-data sheet and forward the marked-up bib-data sheet to the Legal Instrument Examiner for correction in the Office computer systems.” (MPEP 202)

The USPTO generally does not engage in double correspondence with applicants and their representatives. Specifically:

  • The Office will not correspond with both an applicant and their attorney/agent.
  • The Office will not correspond with more than one attorney/agent.
  • If double correspondence is attempted, the examiner will include form paragraph 4.01 in the next Office action.

According to MPEP 403: “Double correspondence with an applicant and their attorney, or with two representatives, will not be undertaken. See MPEP §§ 403.01(a), 403.01(b), 403.02, and 714.01(d).”

Form paragraph 4.01 states: “Applicant has appointed an attorney or agent to conduct all business before the Patent and Trademark Office. Double correspondence with an applicant and applicant’s attorney or agent will not be undertaken. Accordingly, applicant is required to conduct all future correspondence with this Office through the attorney or agent of record. See 37 CFR 1.33.”

When two patent practitioners are appointed, the handling of correspondence depends on how and when they were appointed. According to MPEP 403.02:

“If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record.”

This means that the USPTO will use the most recently provided correspondence address. It’s important to note that this is governed by 37 CFR 1.33 and 37 CFR 1.76, which provide regulations on correspondence and application data sheets.

To learn more:

When two patent practitioners are appointed for the same application:

  • If appointed simultaneously, the applicant should specify which address to use for correspondence.
  • If a second practitioner is added later, correspondence will be sent to the most recently provided correspondence address.
  • A new power of attorney appointing only the second practitioner effectively revokes the power of the first practitioner.

According to MPEP 403.02: “If the applicant simultaneously appoints two patent practitioners, applicant should indicate with whom correspondence is to be conducted by specifying a correspondence address. … If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record. … Note that if the later-filed power of attorney only lists the second practitioner, the later-filed power of attorney serves as a revocation of the earlier-filed power of attorney, even without an express revocation of the power of the first patent practitioner.”

When multiple parties are prosecuting a patent application, the USPTO has specific procedures for handling correspondence. The MPEP states:

“Double correspondence will still not be permitted. Accordingly, when the acceptance of such papers results in an attorney or agent and at least one applicant or owner prosecuting the application, correspondence will be mailed to the attorney or agent.”

Furthermore, when multiple attorneys or agents are involved:

“When the acceptance of such papers results in more than one attorney or agent prosecuting the application, the correspondence address will continue to be that of the attorney or agent first named in the application, unless all parties agree to a different correspondence address.”

Key points to remember:

  • Correspondence is typically sent to the attorney or agent if one is involved.
  • If multiple attorneys are prosecuting, the first-named attorney receives correspondence unless otherwise agreed.
  • Each attorney or agent must indicate whom they represent in subsequent papers.
  • All parties involved must sign replies to the USPTO.

To learn more:

Tags: USPTO

Assignment information printed on a patent follows these guidelines:

  • Only the first appearing name of an assignee will be printed on the patent, even if multiple names for the same party are identified on the Fee(s) Transmittal form (PTOL-85B).
  • This printing practice does not affect the recording of assignments with the USPTO’s Assignment Division.
  • The assignee entry on the PTOL-85B should still include all assignment data as recorded in the Office.

For example: The assignee entry on form PTOL-85B should still be completed to indicate the assignment data as recorded in the Office. For example, the assignment filed in the Office and, therefore, the PTOL-85B assignee entry might read ‘Smith Company doing business as (d.b.a.) Jones Company.’ The assignee entry on the printed patent will read ‘Smith Company.’

It’s important to note that assignment information printed on a patent is not updated after issuance and may not reflect subsequent assignments recorded in the Office.

For countries that are not members of the Hague Convention, the authentication process for oaths in patent applications is different. The MPEP states:

“When the oath is made in a foreign country not a member of the Hague Convention Abolishing the Requirement of Legalization for Foreign Public Documents, the authority of any officer other than a diplomatic or consular officer of the United States authorized to administer oaths must be proved by certificate of a diplomatic or consular officer of the United States.”

This means that for non-member countries, the authority of the officer administering the oath must be certified by a U.S. diplomatic or consular officer. This can be done directly or through an intermediary. If the oath is not properly authenticated, the USPTO will still accept the application for examination, but the applicant should submit a new, properly authenticated oath or a declaration under 37 CFR 1.68.

To learn more:

An international application is defined in 37 CFR 1.9(b). While the specific definition is not provided in the given MPEP excerpt, it generally refers to a patent application filed under the Patent Cooperation Treaty (PCT). International applications allow inventors to seek patent protection in multiple countries through a single filing process.

For more detailed information on international applications, you can refer to the full text of 37 CFR 1.9(b) and related sections of the MPEP.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

For more information on patent law, visit: patent law.

An interim copy of a foreign application serves as a temporary substitute for a certified copy but does not replace the requirement for a certified copy. The key differences are:

  • An interim copy can be from the applicant’s own records, while a certified copy must be from the foreign patent office.
  • An interim copy satisfies the initial time requirement in 37 CFR 1.55(f), but a certified copy is still required.
  • An interim copy is labeled as ‘Interim Copy,’ while a certified copy has official certification from the foreign patent office.

The MPEP clarifies:

‘Thus, providing an interim copy of a foreign application under 37 CFR 1.55(j) satisfies the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f), but a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate.’

In essence, the interim copy is a temporary measure to meet deadlines, while the certified copy remains a formal requirement.

For more information on certified copy, visit: certified copy.

For more information on foreign application, visit: foreign application.

For more information on interim copy, visit: interim copy.

For more information on patent procedure, visit: patent procedure.

Enforcement of arbitration awards in patent cases requires specific steps as outlined in 35 U.S.C. 294(d) and 37 CFR 1.335. Key points include:

  • The patentee, assignee, or licensee must file a written notice of the award with the USPTO Director.
  • The notice must include details about the patent, parties involved, and a copy of the award.
  • The award is unenforceable until the required notice is received by the Director.

As stated in 35 U.S.C. 294(e): “The award shall be unenforceable until the notice required by subsection (d) is received by the Director.”

This requirement ensures that the USPTO is informed of arbitration outcomes affecting patent rights.

For more information on arbitration awards, visit: arbitration awards.

For more information on patent enforcement, visit: patent enforcement.

For more information on USPTO procedures, visit: USPTO procedures.

According to MPEP ¶ 2.30, the applicant is typically notified that their CPA request has been accepted through the first Office action on the CPA. The MPEP states: “Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established.” This notification is important because, as the MPEP notes, “applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

Unlike regular patent applications, applicants are not typically notified when a Continued Prosecution Application (CPA) has been established. The MPEP ¶ 2.30 states: “This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.”

Instead, the first notification an applicant usually receives is in the first Office action of the CPA. The examiner will use specific language to advise the applicant that the CPA request was acceptable and has been established.

An ‘institution of higher education’ for micro entity status purposes is defined according to Section 101(a) of the Higher Education Act of 1965. The key criteria include:

  • Located in any U.S. state or territory
  • Admits students with secondary education or equivalent
  • Authorized to provide post-secondary education
  • Offers bachelor’s degrees or at least 2-year programs toward such degrees
  • Is a public or non-profit institution
  • Is accredited or pre-accredited by a recognized agency

As stated in MPEP 509.04(b): “Section 101(a) of the Higher Education Act of 1965 defines what is meant by ‘institution of higher education’ in the context of 37 CFR 1.29(d).”

To learn more:

Access to provisional patent applications is handled differently from non-provisional applications. According to MPEP 104:

“In provisional applications, access or certified copies may only be requested by parties with written authority from a named inventor, the applicant, the assignee of record, or the attorney or agent of record, unless the application is available pursuant to 37 CFR 1.14(a)(1)(iv)-(vi).”

The MPEP further explains:

“Since provisional applications do not require an oath or declaration, there may be no power of attorney in the application.”

This means that access to provisional applications is more restricted and typically requires specific written authority from key parties involved in the application. The absence of a required oath or declaration in provisional applications also affects how access is granted, as there may not be a formal power of attorney on file.

For more information on certified copies, visit: certified copies.

For more information on written authority, visit: written authority.

Access to patent applications for unregistered individuals is granted through a specific process outlined in MPEP 104:

“Unregistered employees of attorneys or agents, public stenographers, and all other persons not within the provisions of paragraphs (A) and (B) above will be given access only upon presentation of a written authorization for access (power to inspect) signed by a person specified in paragraph (A) above, which authorization will be entered as a part of the official file.”

This means that unregistered individuals must present a written authorization, often called a ‘power to inspect,’ signed by an authorized person such as the applicant, inventor, or attorney of record. The authorization must specifically name the person granted access and be limited to a single application. The USPTO provides Form PTO/SB/67 for this purpose.

For more information on Patent application access, visit: Patent application access.

For more information on power to inspect, visit: power to inspect.

The processing of a pre-AIA 37 CFR 1.47 application involves several steps:

  1. A filing date is assigned if the application meets the requirements of 37 CFR 1.53(b).
  2. A filing receipt is sent to the applicant.
  3. The application or an electronic message about the petition is forwarded to the Office of Petitions.
  4. If the papers are found acceptable, the Office of Petitions enters a decision in the file.
  5. A notice is published in the Official Gazette with application details.
  6. The USPTO notifies the nonsigning inventor(s) or legal representative(s) by letter.

As stated in the MPEP, When papers deposited pursuant to pre-AIA 37 CFR 1.47 are found acceptable, the Office of Petitions enters a decision to that effect in the file. A notice will be published in the Official Gazette identifying the application number, filing date, the title of the invention and the name(s) of the nonsigning inventor(s).

To learn more:

To learn more:

In international patent applications, a common representative can be appointed in several ways. According to MPEP 402.09 and 37 CFR 1.455(b):

Appointment of an agent, attorney or common representative (PCT Rule 4.8) must be effected either in the Request form, signed by applicant, in the Demand form, signed by applicant, or in a separate power of attorney submitted either to the United States Receiving Office or to the International Bureau.

If no specific appointment is made and there are multiple applicants, the first named applicant who is entitled to file with the U.S. Receiving Office is considered the common representative by default, as stated in 37 CFR 1.455(a).

To learn more:

According to MPEP ¶ 2.35, the USPTO treats ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. The MPEP explicitly states:

Any ‘conditional’ request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.

This means that even if an applicant submits a CPA request with conditions attached, the USPTO will process it as a standard, unconditional CPA request. This policy ensures clarity and consistency in the application process.

For more information on CPA, visit: CPA.

For more information on USPTO procedures, visit: USPTO procedures.

For non-design patent applications filed on or after December 18, 2013, the drawing requirements have been relaxed. The MPEP states: Applications, which are not design applications, filed under 35 U.S.C. 111(a) or (b) on or after December 18, 2013 are entitled to a filing date even if the application does not contain drawings. However, it’s important to note that while drawings are not required for a filing date, they should still be submitted if necessary for understanding the invention, as no amendment may introduce new matter into the disclosure of an application after its filing date.

To learn more:

The requirement for specific reference to prior applications has undergone changes due to recent legislation:

  1. For applications filed before September 16, 2012: The specific reference to the prior application must be in the first sentence(s) of the specification or in an application data sheet.
  2. For applications filed on or after September 16, 2012: The specific reference to the prior application must be in the application data sheet (ADS).

As stated in the MPEP: Thus for all applications filed on or after September 16, 2012, the specific reference to the prior application must be in the application data sheet; for applications filed prior to September 16, 2012, the specific reference to the prior application must be in an application data sheet or in the first sentence(s) of the specification. (MPEP 210)

This change was implemented as part of the inventor’s oath or declaration provisions of the Leahy-Smith America Invents Act, which became effective on September 16, 2012. The Office revised 37 CFR 1.78 to reflect these changes.

For more information on ADS, visit: ADS.

For more information on application data sheet, visit: application data sheet.

For more information on prior applications, visit: prior applications.

For more information on specific reference, visit: specific reference.

How does WTO membership affect foreign priority rights?

World Trade Organization (WTO) membership has significant implications for foreign priority rights in patent applications:

  • WTO member countries are treated as Paris Convention countries for priority purposes.
  • Applicants from WTO member countries can claim priority in the U.S., even if the country is not a Paris Convention signatory.
  • The same 12-month priority period applies to applications from WTO member countries.
  • WTO membership expands the pool of countries eligible for foreign priority claims.

MPEP 213.01 states: “A foreign application filed in a WTO member country on or after the date on which the country becomes a WTO member country is also entitled to the right of priority.” This provision ensures broader international protection opportunities for inventors and applicants.

When a practitioner withdraws and the correspondence address will change as a result, the withdrawing practitioner(s) must request that the USPTO direct all future correspondence to one of the following:

  • The first named inventor or assignee that has properly made itself of record (for applications filed before September 16, 2012)
  • The applicant (for applications filed on or after September 16, 2012)
  • The assignee of record (for proceedings involving issued patents)

Practitioners can specify either the correspondence address or the address associated with the Customer Number of the appropriate party. It’s important to note that withdrawing practitioners cannot change the correspondence address to another law firm’s Customer Number or any other address except those mentioned above.

This ensures that the patent application or proceeding remains properly managed after the practitioner’s withdrawal.

To learn more:

How does USPTO verify gross income for micro entity status?

The USPTO generally does not independently verify the gross income of applicants claiming micro entity status. According to MPEP 509.04(a):

“The Office does not generally question certification of micro entity status but may require additional information on a case-by-case basis.”

However, applicants are required to certify their eligibility for micro entity status under oath. Providing false information can lead to severe consequences, including invalidation of the patent and potential criminal charges for fraud.

To learn more:

Transferring rights in an invention can affect small entity status. According to MPEP 509.02:

If the individual inventor, small business concern, or nonprofit organization assigned, granted, conveyed, or licensed, or came under an obligation to assign, grant, convey, or license, any rights to the invention to any individual, small business concern, or nonprofit organization which would not qualify as a small entity (37 CFR 1.27(a)), then the inventor, small business concern, or nonprofit organization would no longer qualify for small entity status.

However, transferring partial rights to another small entity does not disqualify the original entity from small entity status. It’s important to note that rights in question are those in the United States. Transferring rights to a foreign patent does not affect small entity status if no U.S. rights are transferred.

To learn more:

The USPTO has specific methods to verify the authenticity of S-signatures:

  1. Comparison with other documents: The USPTO may compare the S-signature with other signatures from the same person in their records.
  2. Certification statement: MPEP 402.03 states: ‘The person inserting a permanent S-signature must present a statement certifying that the inserted signature is his or her own signature.’
  3. Audit trail: Electronic filing systems may maintain an audit trail of who submitted the document.
  4. Additional verification: In case of doubt, the USPTO may request additional verification or clarification.

While the USPTO generally presumes the authenticity of signatures, it’s crucial to ensure all S-signatures are genuine and properly certified to avoid potential legal issues.

To learn more:

The USPTO verifies an assignee’s right to inspect a patent application through documentation. As per MPEP 106.01, the assignee must provide either a copy of the assignment recorded in the USPTO or other evidence of ownership. This documentation is necessary to establish the assignee’s legal right to access the confidential information contained in the patent application.

For patent applications filed on or after September 21, 2004, the United States Patent and Trademark Office (USPTO) has a specific policy regarding preliminary amendments. According to MPEP 608.04(b):

For applications filed on or after September 21, 2004, the Office will automatically treat any preliminary amendment under 37 CFR 1.115(a)(1) that is present on the filing date of the application as part of the original disclosure.

This means that any preliminary amendment submitted along with the application on its filing date will be considered part of the original disclosure, without any additional action required by the applicant.

To learn more:

The USPTO treats conditional assignments as absolute assignments for Office purposes. According to 37 CFR 3.56:

“Assignments which are made conditional on the performance of certain acts or events, such as the payment of money or other condition subsequent, if recorded in the Office, are regarded as absolute assignments for Office purposes until canceled with the written consent of all parties or by the decree of a court of competent jurisdiction.”

The USPTO does not determine whether conditions have been fulfilled. Recording a conditional assignment is treated as signifying that the condition has been met.

To learn more:

The USPTO treats all ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. According to MPEP ¶ 2.35:

Any “conditional” request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.

This means that once a conditional CPA request is submitted, it will be processed as a standard CPA, regardless of the applicant’s original intent.

For more information on CPA, visit: CPA.

Tags: CPA

How does the USPTO retrieve priority documents through PDX?

The USPTO retrieves priority documents through the Priority Document Exchange (PDX) program upon request from the applicant. As stated in MPEP 215.02(a), ‘If the applicant requests retrieval of the priority document through the PDX program, the USPTO will attempt to retrieve the document.’ The process involves:

  • The applicant making a request for retrieval
  • The USPTO accessing the electronic system of the participating office
  • Retrieving the priority document if available
  • Adding the retrieved document to the application file

This streamlined process eliminates the need for applicants to manually obtain and submit priority documents from other participating patent offices.

To learn more:

The USPTO retrieves foreign priority documents through the priority document exchange program automatically when certain conditions are met. As stated in MPEP 215.02(a):

“The USPTO will attempt retrieval of the priority document through the priority document exchange program when the applicant has (1) requested retrieval via the Priority Document Exchange (PDX) program in an application data sheet and (2) provided a foreign application number and intellectual property office that participates in a priority document exchange agreement with the USPTO.”

This automated process helps streamline the priority document submission for applicants.

To learn more:

The USPTO has a specific process for handling notices of arbitration awards related to patents. According to the Manual of Patent Examining Procedure (MPEP) Section 311:

“The written notices required by this section should be directed to the attention of the Office of the Solicitor. The Office of the Solicitor will be responsible for processing such notices.”

This process involves:

  • Directing all written notices of arbitration awards to the Office of the Solicitor.
  • The Office of the Solicitor taking responsibility for processing these notices.
  • Ensuring that the notices are properly recorded and associated with the relevant patent files.

This centralized approach helps maintain accurate records of arbitration outcomes affecting patent rights and ensures that the information is properly managed within the USPTO system.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has an automated system for processing assignment documents submitted by fax. According to MPEP 302.09:

  1. Documents are submitted directly into the automated Patent and Trademark Assignment System.
  2. A recordation notice is automatically returned to the sending fax number.
  3. If the system can’t complete the transmission, the notice is printed and mailed via U.S. Postal Service first class mail.
  4. The Patent and Trademark Assignment System assigns reel and frame numbers and adds recordation stampings to the processed electronic images.

The MPEP states: The Patent and Trademark Assignment System assigns reel and frame numbers and superimposes recordation stampings on the processed and stored electronic images. Accordingly, copies of all recorded documents will have the reel and frame numbers and recordation stampings.

This automated process ensures efficient handling and proper documentation of assignment records.

To learn more:

The USPTO has established procedures to notify the public about postal service interruptions that may affect patent filings. According to MPEP 511:

When the Director designates a postal service interruption or emergency, a notice will be published in the Official Gazette, and will be posted on the USPTO website at www.uspto.gov.

The USPTO’s notification process includes:

  • Publishing a notice in the Official Gazette
  • Posting information on the USPTO website
  • Possibly issuing press releases or other public communications

These notifications typically include:

  • Details about the nature and scope of the interruption
  • Any special procedures or accommodations being made
  • Instructions for applicants affected by the interruption
  • Contact information for further inquiries

It’s crucial for patent applicants and attorneys to regularly check these official sources during potential postal disruptions to stay informed about any changes in filing procedures or deadlines.

To learn more:

According to MPEP 406, the USPTO follows a specific procedure to notify client-applicants:

‘The Office of Enrollment and Discipline will notify the client-applicant of the availability of a list of patent practitioners who may be available to represent the client-applicant.’

This notification ensures that the client-applicant is aware of the situation and has resources to find new representation if needed.

For more information on patent practitioner death, visit: patent practitioner death.

For more information on USPTO notification, visit: USPTO notification.

How does the USPTO notify applicants of their practitioner’s suspension or exclusion?

The USPTO has a specific process for notifying applicants when their patent practitioner has been suspended or excluded. The MPEP 407 outlines this process:

“The OED Director will… notify the applicant of the suspension or exclusion and of the limited recognition of the practitioner. The notification will be sent to the address of record in the application.”

This notification serves several purposes:

  • Informs the applicant of their practitioner’s status change
  • Advises the applicant of the practitioner’s limited recognition period
  • Allows the applicant to take necessary actions to protect their patent application

It’s crucial for applicants to promptly respond to such notifications to ensure their patent applications are not adversely affected by their practitioner’s disciplinary status.

For more information on USPTO notification, visit: USPTO notification.

When a Continued Prosecution Application (CPA) request for a design patent is found to be non-compliant, the USPTO notifies the applicant using a specific form paragraph. This notification informs the applicant about the issue and provides necessary details.

According to the MPEP, the examiner uses the following format:

  • ‘Receipt is acknowledged of the request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on Application No. [2].’
  • ‘However, because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.’

In this notification, [1] represents the filing date of the paper containing the CPA request, and [2] is the Application Number identified in the CPA request. This clear communication helps applicants understand the issue and take corrective action.

For more information on design patents, visit: design patents.

For more information on Patent Application Process, visit: Patent Application Process.

When the USPTO receives an unacceptable Continued Prosecution Application (CPA) request for a design patent application, they notify the applicant using a standardized form paragraph. According to MPEP ¶ 2.31, the examiner will use the following language:

Receipt is acknowledged of the request for a Continued Prosecution Application (CPA) filed on [1] under 37 CFR 1.53(d) based on Application No. [2]. However, because the request was not submitted on a separate paper as required by 37 CFR 1.53(d)(2), the request is not acceptable and no CPA has been established.

This notification informs the applicant that their CPA request has been received but not accepted due to non-compliance with the separate paper requirement. The examiner will insert the filing date of the CPA request and the application number in the appropriate brackets.

For more information on USPTO notification, visit: USPTO notification.

The USPTO maintains a clear separation between assignment documents and patent files to ensure proper organization and management of records. MPEP 318 specifies:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This separation is maintained by:

  • Directing assignment documents to the Assignment Division instead of application or patent files
  • Keeping a separate database for assignment records
  • Ensuring that patent examiners and other USPTO personnel refer to the Assignment Division for ownership information
  • Maintaining distinct processes for handling assignments and patent prosecution

This approach helps in preserving the integrity of both assignment records and patent files while facilitating efficient access to ownership information when needed.

To learn more:

The USPTO has a specific policy for handling unnecessary duplicate copies of correspondence. According to MPEP 502.04:

The Office may dispose of duplicate copies of correspondence in the file of an application, patent, or other proceeding.

Furthermore, the MPEP states:

When the Office does not require duplicate copies of a paper, the filing of multiple copies may cause a delay in processing by the Office. Accordingly, the Office may discard duplicate copies of correspondence filed in an application or patent file.

This means that if you submit unnecessary duplicate copies, the USPTO may discard them to streamline processing and prevent delays. It’s important to only submit duplicate copies when specifically required by the Office.

To learn more:

The USPTO handles United Kingdom provisional specifications in priority claims as follows:

  • A certified copy of the “provisional specification” may be submitted, sometimes accompanied by a copy of the “complete specification.”
  • The provisional specification is examined for completeness of disclosure, as it may not contain a complete disclosure in the sense of 35 U.S.C. 112.
  • If the UK provisional specification is found insufficient for lack of disclosure, reliance may then be placed on the complete specification and its date, treating it as a different application than the provisional specification.

The MPEP states: “In applications filed from the United Kingdom there may be submitted a certified copy of the ‘provisional specification,’ which may also in some cases be accompanied by a copy of the ‘complete specification.’ According to United Kingdom law the provisional specification need not contain a complete disclosure of the invention in the sense of 35 U.S.C. 112, but need only describe the general nature of the invention, and neither claims nor drawings are required.” (MPEP 216)

The USPTO handles unintentionally delayed domestic benefit claims similarly to foreign priority claims, but with some specific provisions. According to MPEP 214.02:

‘For applications filed on or after September 16, 2012, the specific reference to the prior application must be included in an application data sheet (37 CFR 1.76). For applications filed prior to September 16, 2012, the specific reference to the prior application must be in the first sentence(s) of the specification or in an application data sheet.’

For domestic benefit claims under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c), a petition to accept an unintentionally delayed claim must include:

  • The reference required by 35 U.S.C. 120 or 119(e) and 37 CFR 1.78 to the prior-filed application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78 and the date the benefit claim was filed was unintentional.

The Director may require additional information where there is a question whether the delay was unintentional.

To learn more:

How does the USPTO handle unacceptable multiple dependent claims?

The USPTO has specific procedures for handling unacceptable multiple dependent claims:

  • If an application contains an unacceptable multiple dependent claim, the examiner should object to the claim under 37 CFR 1.75(c).
  • The applicant may cancel the unacceptable multiple dependent claim, amend it to become a single dependent claim, or rewrite it in proper form.
  • Other claims depending on an improper multiple dependent claim will not be treated on the merits.

According to MPEP 608.01(n):

“If none of the multiple dependent claims is proper, the examiner should require correction of at least one multiple dependent claim and state why the other claims are improper if it is considered desirable to explain the broader aspects of the requirements.”

This approach ensures that applicants have the opportunity to correct improper multiple dependent claims while maintaining the integrity of the patent examination process.

To learn more:

How does the USPTO handle telephone inquiries about application status?

The USPTO has specific procedures for handling telephone inquiries about application status. According to MPEP 203.08:

“Telephone inquiries regarding the status of applications, other than those referred to in MPEP § 203.08(a), should be directed to the USPTO Contact Center (UCC).”

The UCC is equipped to handle general status inquiries, while more specific inquiries may be directed to the appropriate Technology Center or Patent Examining Group. This system ensures that inquiries are handled efficiently and by staff with the appropriate level of expertise.

To learn more:

The USPTO follows a strict procedure for handling telephone and in-person requests for information about unpublished pending or abandoned patent applications:

  1. Obtain the caller’s full name, application number, and telephone number
  2. Verify the caller’s identity and authority to receive information
  3. Check Patent Data Portal or the application file to verify releasable information
  4. Return the call using a verified telephone number

Information is only released to authorized individuals, such as the patent practitioner of record, inventor, applicant, or authorized representative of the assignee of record.

How does the USPTO handle status inquiries for unpublished applications?

The USPTO has specific procedures for handling status inquiries for unpublished applications:

  • Status information is only provided to applicants, their attorneys or agents, or assignees of record.
  • Third parties cannot receive status information about unpublished applications.
  • The USPTO may confirm the filing date, application number, and whether the application is pending, abandoned, or patented.

As stated in MPEP 203.08, ‘For unpublished applications, the Office will not give status information to the public without the authorization of the applicant, attorney or agent of record or the assignee of record.’

To learn more:

When an inventor is deceased, the MPEP 409.03(d) provides specific guidance:

In the case of the death of the inventor, the legal representative (executor, administrator, etc.) of the deceased inventor may sign the necessary oath or declaration.

This means that:

  • The legal representative of the deceased inventor can sign the required oath or declaration
  • Proof of the inventor’s death and the legal representative’s authority should be provided
  • The application can proceed with the legal representative acting on behalf of the deceased inventor

It’s important to note that the legal representative must have the authority to act on behalf of the deceased inventor’s estate. This typically requires documentation such as a death certificate and letters of administration or executorship.

To learn more:

How does the USPTO handle requests for early delivery of patents?

The USPTO has a specific process for handling requests for early delivery of patents. According to MPEP 308:

“Ordinarily the patent grant is delivered to the correspondence address of record. However, a patentee may request in writing before the issue date that the patent grant be delivered to another address or to an assignment recordation branch of the USPTO for recordation of an assignment, provided a fee is paid for the service.”

This means that:

  • Patentees can request early delivery of their patent grant
  • The request must be made in writing before the issue date
  • A fee is required for this service
  • The patent can be delivered to an alternative address or to the assignment recordation branch

Early delivery requests are typically made when there’s an urgent need to record an assignment or to obtain the physical patent document for business purposes.

For more information on patent grant, visit: patent grant.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has specific rules for representation by foreign attorneys or agents:

  • Foreign attorneys or agents who are not registered to practice before the USPTO and do not reside in the U.S. are not permitted to represent patent applicants before the USPTO.
  • There is an exception for Canadian patent agents under limited recognition.
  • Applicants may be represented by a registered attorney or agent who is not residing in the United States.

According to MPEP 402.01: No attorney or agent residing in a foreign country may be registered to practice before the United States Patent and Trademark Office. This emphasizes the importance of proper registration and residency for patent practitioners.

To learn more:

The USPTO has specific procedures for handling refunds of fees paid by credit card. According to MPEP 509:

35 U.S.C. 42(d) and 37 CFR 1.26 (which concern refund of patent and trademark fees) also apply to requests for refund of fees paid by credit card. Any refund of a fee paid by credit card will be by a credit to the credit card account to which the fee was charged. See 37 CFR 1.26(a).

Key points about USPTO refunds for credit card payments:

  • Refunds are processed as credits to the original credit card account used for payment.
  • The same laws and regulations governing refunds of patent and trademark fees apply to credit card payments.
  • For information on which fees are refundable, refer to MPEP § 607.02 regarding returnability of fees.

It’s important to note that refund requests are subject to specific criteria and time limitations, so applicants should review the relevant regulations when seeking a refund.

To learn more:

Tags: patent fees

The USPTO has specific guidelines for handling proof of refusal from a non-signing inventor. According to MPEP 409.03(d):

In the case of refusal, the proof that a bona fide attempt was made to present a copy of the application papers to the non-signing inventor for signature, but the inventor refused to sign the papers, must be submitted.

To demonstrate proof of refusal, an applicant should:

  • Provide evidence of attempts to present the application to the inventor
  • Document the inventor’s explicit refusal to sign
  • Include any communication or statements from the inventor indicating refusal
  • Submit an affidavit or declaration detailing the refusal circumstances

The USPTO will review this evidence to determine if it constitutes a valid proof of refusal.

To learn more:

How does the USPTO handle proof of proprietary interest for deceased inventors?

The USPTO has specific provisions for handling proof of proprietary interest when an inventor is deceased. According to MPEP 409.03(f):

‘In the case of a deceased inventor, the proof of proprietary interest must be signed by the legal representative (executor, administrator, etc.) of the deceased inventor’s estate.’

This means that:

  • The legal representative of the deceased inventor’s estate must provide the necessary documentation.
  • This could be an executor or administrator appointed by the court.
  • The proof should demonstrate that the legal representative has the authority to act on behalf of the deceased inventor’s estate in matters related to the patent application.

It’s important to note that the USPTO requires proper documentation to ensure that the rights of the deceased inventor are properly represented and that the application is prosecuted by those with legitimate authority to do so.

To learn more:

Priority Mail Express® submissions to the USPTO are handled differently from regular mail. According to MPEP 505, New patent applications filed in accordance with 37 CFR 1.10 will be stamped by the Office with the date of deposit as Priority Mail Express® with the United States Postal Service.

This means:

  • The date of deposit with USPS is used as the receipt date, not the date it arrives at the USPTO
  • This applies even on weekends and holidays when the USPTO is closed

For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

For more information on Priority Mail Express, visit: Priority Mail Express.

For more information on USPTO, visit: USPTO.

How does the USPTO handle priority documents in national stage applications?

The USPTO handles priority documents in national stage applications (35 U.S.C. 371) as follows:

  • If the priority document is already in the international application file, no further action is needed.
  • The USPTO will retrieve the document from WIPO’s digital library (DAS) if it’s available there.
  • If not available through DAS, the applicant must submit the certified copy.

According to MPEP 213.06: ‘If the priority document is not in the international application file but was properly filed with the International Bureau during the international phase, the USPTO will retrieve from the International Bureau a copy of the certified copy of the priority document.’ This process simplifies the handling of priority documents for applicants entering the national stage.

To learn more:

To learn more:

The USPTO treats a proper priority claim to an application filed in a participating foreign intellectual property office as a request to obtain a copy of the foreign application. The MPEP states:

The Office treats a proper priority claim under 37 CFR 1.55 to an application filed in a participating foreign intellectual property office as a request that the Office obtain a copy of the foreign application from the participating intellectual property office.

This means that applicants do not need to submit a separate request for the USPTO to retrieve the foreign application if they have made a proper priority claim and the foreign office is a PDX participant.

The USPTO treats a proper priority claim to an application filed in a participating foreign intellectual property office as a request to obtain a copy of the foreign application. According to MPEP 215.01:

The Office treats a proper priority claim under 37 CFR 1.55 to an application filed in a participating foreign intellectual property office as a request that the Office obtain a copy of the foreign application from the participating intellectual property office.

This means that applicants generally do not need to file a separate request for the USPTO to retrieve the priority document if it’s from a participating office.

To learn more:

When the certified copy of the priority document is already in the International Bureau’s priority document database, the USPTO handles priority claims in national stage applications as follows:

  • The USPTO will attempt to retrieve the certified copy from the International Bureau’s priority document database.
  • If successful, no further action is required from the applicant regarding the submission of the certified copy.
  • According to MPEP 213.06, ‘In national stage applications, a claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.’
  • The USPTO will consider the priority claim to be compliant with the requirements of 37 CFR 1.55(f)(2) if the certified copy is timely retrieved from the International Bureau.

This process simplifies the priority claim procedure for applicants in national stage applications when the certified copy is already available through the International Bureau.

To learn more:

Tags: USPTO

The USPTO handles priority claims in international design applications as follows:

  • For international design applications designating the United States, the USPTO acts as an office of indirect filing.
  • Priority claims must be made in the international design application when filed with the International Bureau.
  • The USPTO will not transmit a priority claim made in a subsequently filed transmittal letter.
  • Applicants should review the international registration certificate to ensure their priority claims are properly recorded.

As stated in MPEP 213.07: The United States Patent and Trademark Office (USPTO), in its capacity as an office of indirect filing, will not transmit to the International Bureau a priority claim that is made in a subsequently filed transmittal letter and not in the international design application as filed with the International Bureau.

To learn more:

The USPTO recognizes that some countries have restrictions on who can apply for patents versus inventor’s certificates. As stated in MPEP 213.05:

It is recognized that certain countries that grant inventors’ certificates also provide by law that their own nationals who are employed in state enterprises may only receive inventors’ certificates and not patents on inventions made in connection with their employment. This will not impair their right to be granted priority in the United States based on the filing of the inventor’s certificate.

This means that even if an applicant was restricted to filing for an inventor’s certificate in their home country due to employment or nationality, they can still claim priority in the US based on that filing. The key factor is whether the option to file for either a patent or an inventor’s certificate generally existed in the country for the particular subject matter, not whether the specific applicant had that choice.

To learn more:

The USPTO’s handling of preliminary amendments in continuation applications depends on when the application was filed and the nature of the amendment:

  • For applications filed on or after September 21, 2004: A preliminary amendment that is present on the filing date of the application is considered part of the original disclosure.
  • All preliminary amendments: Must be filed in compliance with 37 CFR 1.121, which includes providing a complete claim listing whenever a claim is added, canceled, or amended.
  • Substitute specification: The Office may require a substitute specification for preliminary amendments.

The MPEP states:

Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

It’s important to note that the USPTO advises against filing a continuation application with a preliminary amendment that makes all desired changes. Instead, they recommend:

Filing a continuing application under 37 CFR 1.53(b) with a new specification containing only the desired set of claims.

This approach ensures that the published application contains the intended set of claims, rather than those from the prior application.

For more information on continuation application, visit: continuation application.

The USPTO takes specific actions regarding powers of attorney granted to suspended or excluded practitioners. According to MPEP 407:

The Office of Enrollment and Discipline (OED) Director will contact the Director of the Technology Center (TC) managing the application when a practitioner has been suspended or excluded from practice. The OED Director will request that the TC Director review a pending application to determine whether the practitioner has been granted a power of attorney. If the suspended or excluded practitioner was given a power of attorney, the TC Director will notify the applicant and request a new power of attorney.

The process typically involves:

  • Identification of affected applications by the OED Director
  • Review of power of attorney status by the TC Director
  • Notification to the applicant if a power of attorney exists
  • Request for a new power of attorney from the applicant
  • Potential application abandonment if no response is received within 30 days

For more information on power of attorney, visit: power of attorney.

How does the USPTO handle photographs in patent applications?

The USPTO has specific guidelines for handling photographs in patent applications:

  1. General rule: As stated in MPEP 608.02(a), “Photographs, including photocopies of photographs, are not ordinarily permitted in utility and design patent applications.”
  2. Exceptions: Photographs are accepted in applications where they are the only practicable medium for illustrating the claimed invention. This typically applies to:
    • Crystalline structures
    • Metallurgical microstructures
    • Textile fabrics
    • Grain structures
    • Color effects
  3. Requirement for acceptance: The MPEP states, “The photographs must be of sufficient quality so that all details in the photographs are reproducible in the printed patent.”
  4. Color photographs: These require a petition explaining why color is necessary and are subject to additional fees.

If photographs are submitted, applicants should ensure they meet USPTO standards to avoid potential issues during examination.

To learn more:

The USPTO has special procedures for handling perishable models, exhibits, or specimens:

  • The Office will dispose of perishables without notice to the applicant, unless otherwise arranged.
  • Applicants must notify the Office upon submission if they desire the return of a perishable item.
  • If return is desired, applicants must make prompt arrangements for return upon notification from the Office.

According to 37 CFR 1.94(a), The Office will dispose of perishables without notice to applicant unless applicant notifies the Office upon submission of the model, exhibit or specimen that a return is desired and makes arrangements for its return promptly upon notification by the Office that the model, exhibit or specimen is no longer necessary for the conduct of business before the Office.

To learn more:

The USPTO has specific rules regarding patent term adjustments when dealing with notices about unlocatable files. According to the MPEP:

If, however, an applicant fails to reply to a notice under 37 CFR 1.251 within three months of its mailing date, any patent term adjustment under 35 U.S.C. 154(b) will be reduced by a period equal to the number of days (if any) beginning on the day after the date that is three months after the mailing date of the notice under 37 CFR 1.251 and ending on the date the reply to the notice under 37 CFR 1.251 was filed.

This reduction in patent term adjustment is based on 35 U.S.C. 154(b)(2)(C)(ii) and 37 CFR 1.704(b). It’s important to note that this reduction applies even if the applicant responds within the overall six-month period allowed for reply (including extensions).

This policy underscores the importance of prompt action in response to such notices, as delays can directly impact the duration of patent protection.

For more information on patent term adjustment, visit: patent term adjustment.

How does the USPTO handle patent applications when an inventor is legally incapacitated?

The USPTO has provisions for handling patent applications when an inventor is legally incapacitated. The MPEP 409.03(b) states:

“If a person is legally incapacitated, the legal representative (guardian, conservator, etc.) of such inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

In these cases:

  • The legal guardian or conservator acts on behalf of the incapacitated inventor
  • They must provide proof of their legal authority to represent the incapacitated inventor
  • The guardian or conservator executes the necessary oath or declaration
  • They handle all aspects of the patent application process on behalf of the inventor

This approach ensures that the intellectual property rights of legally incapacitated inventors are protected and that their inventions can still be patented.

To learn more:

When an inventor dies during the prosecution of a patent application, the USPTO has specific procedures in place:

  • If the inventor died after filing the application, the legal representative (executor or administrator of the estate) can proceed with the application.
  • The legal representative must submit evidence of their authority, such as Letters Testamentary or Letters of Administration.
  • If there are joint inventors, the surviving inventors can continue the prosecution.
  • The oath or declaration requirement can be fulfilled by the legal representative or the joint inventors.

As stated in MPEP 409.01: “If an inventor dies during the prosecution of an application, the legal representative (executor, administrator, etc.) of the deceased inventor may make the necessary oath or declaration.”

To learn more:

The USPTO has a specific process for handling patent applications filed without required drawings:

  1. The Office of Patent Application Processing (OPAP) reviews the application to determine if drawings are necessary under 35 U.S.C. 113.
  2. If drawings are required but missing, OPAP issues a Notice of Incomplete Application.
  3. The applicant is given a two-month period to submit the drawings and any required fees.
  4. If compliant drawings are received within this period, the application retains its original filing date.
  5. If drawings are not submitted or are non-compliant, the application may be treated as abandoned.

MPEP 601.01(f) states: ‘If the drawings are received within the two-month period and are acceptable, the USPTO will enter them into the application file and treat the application under 37 CFR 1.53(f) as having been filed on the date the initial submission was received in the USPTO.’

This process ensures that applications are complete and examiners have all necessary information to understand the invention.

To learn more:

During postal service emergencies, the USPTO takes special measures to ensure patent applications are handled appropriately:

  • The USPTO Director may designate the interruption or emergency as a ‘postal service interruption or emergency’ under 35 U.S.C. 21(a).
  • This designation allows for the acceptance of filings that would have been timely filed if not for the postal service interruption or emergency.
  • The USPTO may publish a notice in the Official Gazette and on its website about the designation and any special procedures to be followed.

As stated in MPEP 511: The USPTO will consider on a case-by-case basis whether to waive the date indicated on any certificate of mailing or transmission accompanied by a showing which establishes to the satisfaction of the Director that the delay was due to the emergency.

To learn more:

The USPTO has specific procedures for handling papers that include a Certificate of Mailing or Transmission. According to the MPEP:

“The Mail Center of the Office of Patent Application Processing (OPAP) will continue to date stamp the actual date of receipt of all papers received by mail in the Office. No attempt will be made to retain the envelopes in which the papers are received or to indicate on the papers the postal cancellation date (postmark).”

Key points in the USPTO’s handling process include:

  • The actual receipt date is stamped on all papers
  • The date on the Certificate is used to determine if the paper was filed within the period for reply
  • If the paper is received after the period for reply, but the Certificate date is within the period, the paper is considered timely filed
  • A notation (e.g., “C of Mail 11/10/97”) is made next to the Office Date Stamp to indicate the Certificate date

It’s important to note that while the Certificate date is used to determine timeliness, the actual receipt date is used for all other purposes, including calculating subsequent deadlines.

To learn more:

The USPTO has specific procedures for handling oversized models or exhibits. According to MPEP 608.03(a):

Oversized models or exhibits are not transferred to the File Information Unit (FIU). Instead, they are stored in a permanent location…

Here’s how the USPTO manages these items:

  • Oversized items are stored in a permanent location separate from the File Information Unit.
  • The USPTO may photograph the items if practical, before storage or disposal.
  • A decision is made on retention or return based on the nature and size of the item.
  • If return is requested, the applicant must provide proper postage and handling fees.

It’s important to communicate with the USPTO about any oversized models or exhibits to ensure proper handling and potential return.

To learn more:

The USPTO has specific guidelines for handling offensive language in patent applications. According to MPEP 608:

“If during the course of examination of a patent application, an examiner notes the use of language that could be deemed offensive to any race, religion, sex, ethnic group, or nationality, he or she should object to the use of the language as failing to comply with 37 CFR 1.3 which proscribes the presentation of papers which are lacking in decorum and courtesy.”

Examiners are instructed to object to such language and require its removal before classifying the application for publication or passing it to issue. This policy applies to both text and drawings in the application.

To learn more:

To learn more:

The USPTO handles oaths or declarations with defects as follows:

  • If the oath or declaration does not contain the required averments or information, the USPTO will object to it and require a new oath or declaration.
  • Defects in the wording of an oath or declaration may be corrected by a supplemental paper properly signed and identifying the application.
  • Non-initialed and/or non-dated alterations are treated as not made.

According to MPEP 602.03: ‘If the oath or declaration does not contain the information required by 37 CFR 1.63 or a signature, the Office will object to the oath or declaration and require a new oath or declaration. If the defect cannot be cured by a new oath or declaration, the Office will require reexecution of the declaration by the inventor.’

It’s important to note that while some defects can be corrected, others may require a completely new oath or declaration to be submitted.

To learn more:

How does the USPTO handle new matter introduced in continuation-in-part applications?

Continuation-in-part (CIP) applications are a special case when it comes to new matter. The MPEP 608.04 states:

‘In the case of a continuation-in-part application, any claim directed to matter which was not described in the parent nonprovisional application in the manner provided by the first paragraph of 35 U.S.C. 112 is treated as entitled only to the filing date of the continuation-in-part application.’

This means:

  • New matter can be introduced in a CIP application.
  • Claims based on the new matter will only receive the filing date of the CIP application.
  • Claims fully supported by the parent application can retain the earlier filing date.

Examiners will carefully review CIP applications to determine which claims are entitled to which filing dates, affecting prior art considerations and potentially the validity of the claims.

To learn more:

Tags: new matter

How does the USPTO handle new matter in continuation applications?

The United States Patent and Trademark Office (USPTO) treats new matter in continuation applications similarly to how it handles new matter in original applications. According to MPEP 608.04:

“A continuation application cannot include new matter. Applicant is required to delete the benefit claim or change the relationship (continuation application) to continuation-in-part (CIP) if the application contains subject matter that would have been new matter in the prior-filed application.”

This means that:

  • Continuation applications must be based entirely on the disclosure of the parent application
  • Any new subject matter introduced in a continuation application will be rejected as new matter
  • If new matter is present, the applicant must either remove it or change the application type to a continuation-in-part (CIP)

CIP applications allow for the introduction of new matter, but the new subject matter will only receive the benefit of the CIP filing date, not the earlier parent application date. It’s crucial for applicants to carefully review their continuation applications to ensure they don’t inadvertently introduce new matter, which could jeopardize their priority claim to the parent application.

To learn more:

To learn more:

When multiple correspondence addresses are provided, the USPTO has a specific process for selection. According to 37 CFR 1.33(a):

“If more than one correspondence address is specified, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.”

This means that the USPTO will choose one address for all official communications, with a preference for Customer Number addresses if provided. Applicants should be aware of this to ensure they provide the most appropriate address for correspondence.

To learn more:

When multiple correspondence addresses are specified in a single document, the USPTO has a specific procedure for selecting which address to use. According to MPEP 601.03(b):

“If more than one correspondence address is specified in a single document, the Office will select one of the specified addresses for use as the correspondence address and, if given, will select the address associated with a Customer Number over a typed correspondence address.”

This means that if you provide multiple addresses, the USPTO will choose one, giving preference to a Customer Number address over a typed address. To avoid confusion, it’s best to clearly specify only one correspondence address in your patent application documents.

To learn more:

The USPTO has a specific procedure for handling missing documents from an application file. According to the MPEP:

When a document is missing from an application, Office practice is to call the applicant’s representative and request submission (generally by facsimile) of a copy of the missing document.

This informal approach is the primary method used by the USPTO to address missing documents. However, if this informal method is unsuccessful, the Office may resort to more formal measures:

While the Office will generally treat missing documents in this relatively informal manner (rather than issuing a notice under 37 CFR 1.251), the Office may issue a notice under 37 CFR 1.251 to obtain a copy of a missing document if the Office’s informal attempts to obtain a copy of the document are unsuccessful.

It’s important for applicants and their representatives to promptly respond to such informal requests to avoid more formal procedures and potential delays in application processing.

To learn more:

The USPTO does not officially receive mail on weekends or federal holidays when the office is closed. Any correspondence received on these days is typically stamped with the next business day’s date. For example, if mail is delivered to the USPTO on a Saturday, it will be stamped with the following Monday’s date (or Tuesday if Monday is a holiday). This practice ensures consistency in dating received documents and aligns with the USPTO’s official business hours.

How does the USPTO handle interviews for applications with multiple practitioners of record?

The USPTO has specific guidelines for handling interviews when multiple practitioners are of record for a patent application. MPEP 408 provides guidance on this situation:

‘Where a registered practitioner has been given a power of attorney or authorization of agent, only that practitioner, a practitioner appointed in an associate power of attorney or authorization of agent, or another registered practitioner who has the permission of one of the aforementioned practitioners may conduct an interview.’

This means that when multiple practitioners are of record, any one of them can conduct the interview. However, it’s important to note that clear communication between the practitioners is crucial to ensure consistent representation of the applicant’s interests. The USPTO typically communicates with the practitioner who initiated the interview or the one designated as the primary contact for the application.

For more information on patent examination, visit: patent examination.

For more information on power of attorney, visit: power of attorney.

The USPTO has a specific procedure for handling inquiries from high-level government sources. According to MPEP 203.08(a):

Inquiries referred to in this section such as correspondence from Congress or the White House should immediately be transmitted to the Director of the Office of Governmental Affairs, and a staff member of that office should be notified by phone that such correspondence has been received at 571-272-7300.

This process ensures uniformity in handling these important inquiries and compliance with Department of Commerce directives.

To learn more:

Tags: USPTO

For Continued Prosecution Applications (CPAs) filed under 37 CFR 1.53(d), the USPTO automatically considers information that was considered in the parent application. The MPEP states:

“Information which has been considered by the Office in the parent application of a continued prosecution application (CPA) filed under 37 CFR 1.53(d) will be part of the file before the examiner and need not be resubmitted in the continuing application to have the information considered and listed on the patent.”

This means that applicants do not need to resubmit previously considered information in a CPA. The examiner will have access to and consider this information without any additional action required from the applicant.

To learn more:

The USPTO handles informal drawings in patent applications as follows:

  • If the drawings are informal but otherwise sufficient for examination, the USPTO will accept them provisionally.
  • The drawings will be approved by the Office of Patent Application Processing (OPAP) for publication purposes.
  • Formal drawings will be required if the application is allowed.

According to MPEP 507: ‘If the drawings are informal but otherwise in compliance with 37 CFR 1.121(d), the OPAP will accept the application for purposes of publication and place a ‘Drawing Informalities’ form PTO-948 in the file wrapper.’

The examiner may require formal drawings or corrections in a subsequent office action if necessary for a proper examination or if the application is allowed.

For more information on drawing review, visit: drawing review.

For more information on informal drawings, visit: informal drawings.

For more information on OPAP, visit: OPAP.

How does the USPTO handle inequitable conduct in patent applications?

The USPTO takes inequitable conduct in patent applications very seriously. According to MPEP 410:

“[T]he Office will consider equitable and public policy principles in assessing whether to issue a patent to an applicant who has engaged in inequitable conduct.”

Inequitable conduct typically involves:

  • Failure to disclose material information
  • Submitting false material information
  • Intentional misrepresentation of facts

If inequitable conduct is found, the consequences may include:

  • Rejection of the patent application
  • Invalidation of an issued patent
  • Disciplinary action against registered practitioners

The USPTO may also refer cases of suspected fraud to the U.S. Department of Justice for potential criminal prosecution. It’s crucial for applicants and their representatives to maintain honesty and transparency throughout the patent application process.

For more information on fraud, visit: fraud.

For more information on USPTO, visit: USPTO.

Tags: fraud, USPTO

How does the USPTO handle incorrect or erroneous assignment recordings?

The USPTO has a specific process for handling incorrect or erroneous assignment recordings:

  1. No expungement: The USPTO does not expunge or remove assignment documents once they are recorded.
  2. Corrective documents: Parties can record corrective documents to address errors or provide clarifications.
  3. Maintaining integrity: This approach preserves the integrity of the assignment records.

As stated in MPEP 302: ‘Even if a recorded document is subsequently found to be invalid, the recording will be maintained in the assignment records and the assignment records will not be expunged.’ This policy ensures a complete historical record of all recorded documents.

For more information on USPTO records, visit: USPTO records.

The USPTO has specific rules for handling inconsistent information between an Application Data Sheet (ADS) and other documents:

  1. Generally, the most recent submission will govern.
  2. For foreign priority or domestic benefit claims, the most recent ADS will govern.
  3. Inventorship and inventor names are governed by 37 CFR 1.41 and 1.48.
  4. When submitted simultaneously, the ADS will govern over other documents.

37 CFR 1.76(d)(1) states: “The most recent submission will govern with respect to inconsistencies as between the information provided in an application data sheet, a designation of a correspondence address, or by the inventor’s oath or declaration, except that: (i) The most recent application data sheet will govern with respect to foreign priority (§ 1.55) or domestic benefit (§ 1.78) claims; and (ii) The naming of the inventorship is governed by § 1.41 and changes to inventorship or the names of the inventors is governed by § 1.48.”

If inconsistencies are found, applicants should submit a corrected ADS to ensure accurate information is captured by the Office.

To learn more:

The USPTO has specific rules for handling inconsistencies between the Application Data Sheet (ADS) and other documents, as outlined in MPEP 601.05:

  1. The most recent submission generally governs for inconsistencies between an ADS and other documents.
  2. For foreign priority or domestic benefit claims, the most recent ADS governs.
  3. For inventorship and inventor names, 37 CFR 1.41 and 1.48 govern.
  4. When inconsistent information is supplied simultaneously, the ADS will control over a designation of correspondence address or the inventor’s oath or declaration.
  5. The Office captures bibliographic information from the ADS and generally does not check it against other documents.

If you need to correct inconsistencies, submit a corrected ADS as described in 37 CFR 1.76(c)(1). Note that certain changes, such as inventorship, may require specific forms or petitions in addition to a corrected ADS.

To learn more:

For applications filed before September 16, 2012 (pre-AIA applications), the USPTO has specific guidelines for handling inconsistencies between the Application Data Sheet (ADS) and other documents. According to MPEP 601.05(b):

If an ADS is inconsistent with the information provided in another document that was submitted at the same time or previous to the ADS submission, the ADS will control.

However, there are exceptions to this rule:

  • Inventorship: The ADS does not control if it’s inconsistent with the inventorship set forth in an executed oath or declaration.
  • Correspondence address: A clear direction to use a different address will override the ADS.
  • Small entity status: Any small entity assertion or claim will control over the ADS.

It’s crucial for applicants to ensure consistency across all application documents to avoid potential issues during the examination process.

To learn more:

Tags: ADS, pre-AIA

The USPTO has specific procedures for handling incomplete nonprovisional applications:

  • The Office of Patent Application Processing (OPAP) reviews applications for completeness.
  • If deficiencies are found, OPAP sends a notice to the applicant.
  • The notice specifies the missing elements and provides a time period for correction.
  • Failure to respond may result in abandonment of the application.

MPEP 601.01(a) states: ‘If the application does not contain the specification required by 35 U.S.C. 112 including at least one claim and/or the oath or declaration, or any filing fee, the Office of Patent Application Processing (OPAP) will send a notice identifying the deficiency and setting a two month (not extendable) time period within which the applicant must supply the omission or correction in order to obtain a filing date.’

It’s crucial for applicants to respond promptly to these notices to avoid potential loss of filing date or abandonment of the application.

To learn more:

When dealing with Information Disclosure Statements (IDSs) in Requests for Continued Examination (RCE), the USPTO follows specific guidelines as outlined in the MPEP:

  1. Previously considered information: The MPEP states, “Information which has been considered by the Office in the application before the filing of a RCE will be part of the file before the examiner and need not be resubmitted to have the information considered by the examiner and listed on the patent.”
  2. Previously submitted but not considered information: The MPEP explains, “Information filed in the application in compliance with the content requirements of 37 CFR 1.98 before the filing of a RCE will be considered by the examiner after the filing of the RCE.”

For example, if an applicant filed an IDS after a final Office action that didn’t meet the requirements of 37 CFR 1.97(d)(1) and (d)(2), the examiner would not have considered it. However, after filing an RCE, the examiner will consider this previously submitted IDS without the need for resubmission.

For more details on RCE, refer to MPEP § 706.07(h).

To learn more:

The USPTO has specific procedures for handling hazardous or dangerous materials submitted as exhibits:

  • Such materials are not accepted for retention by the Office.
  • The Office will immediately dispose of these materials upon discovery.
  • Applicants are advised against submitting hazardous or dangerous materials.

According to MPEP 608.03(a): No substances or materials considered hazardous or dangerous to Office personnel, will be accepted.

If an applicant needs to demonstrate properties of hazardous materials, they should consider alternative methods, such as detailed descriptions, simulations, or non-hazardous substitutes.

To learn more:

The USPTO has specific procedures for handling foreign language provisional applications during the screening process. According to the MPEP:

Provisional applications filed in a foreign language are also screened under these provisions. The Office will make an attempt to determine the subject matter of the application, but the applicant may be required to provide at least an English language abstract of the information for screening purposes.

To avoid potential delays in the screening process, the MPEP strongly recommends:

It is strongly recommended that if the applicant is in possession of an English language description of the technology, it should be filed with the provisional application to prevent screening delays.

This recommendation helps ensure that the USPTO can efficiently review the application for national security and property rights issues without language barriers impeding the process.

For more information on patent procedure, visit: patent procedure.

The USPTO has specific rules for handling facsimile transmissions received outside of business hours, as outlined in MPEP 502.01:

Correspondence for which transmission was completed on a Saturday, Sunday, or Federal holiday within the District of Columbia, will be accorded a receipt date of the next succeeding day which is not a Saturday, Sunday, or Federal holiday within the District of Columbia.

This means that if a facsimile transmission is completed during non-business hours, weekends, or federal holidays, the USPTO will assign it a receipt date of the next business day. For example:

  • A fax completed on Friday at 9:05 p.m. Pacific time (12:05 a.m. Saturday Eastern time) would be accorded a receipt date of the following Monday (assuming Monday is not a federal holiday).
  • A fax completed on a federal holiday would be accorded a receipt date of the next business day.

It’s important to note that while the actual transmission may occur outside of business hours, the official receipt date will always be a business day. This can be crucial for meeting deadlines and calculating time-sensitive patent-related actions.

To learn more:

The USPTO has specific rules for dating facsimile transmissions. According to 37 CFR 1.6(a)(3):

Correspondence transmitted by facsimile to the Patent and Trademark Office will be stamped with the date on which the complete transmission is received in the Patent and Trademark Office unless that date is a Saturday, Sunday, or Federal holiday within the District of Columbia, in which case the date stamped will be the next succeeding day which is not a Saturday, Sunday, or Federal holiday within the District of Columbia.

This means that faxed correspondence is generally dated on the day of complete transmission, except for weekends and holidays, where it’s dated the next business day.

When errors are made in the execution of an original assignment document, the USPTO allows for the submission of a ‘substitute statement’ to correct these errors. According to MPEP 323:

“Where errors were made in the execution of the original assignment document … a ‘substitute statement’ may be submitted for recordation.”

The process involves:

  • Preparing a new, correctly executed assignment document.
  • Submitting this as a ‘substitute statement’ along with a copy of the originally recorded papers.
  • Clearly identifying the errors in the original document.
  • Paying the required recording fee.

The USPTO will then record the substitute statement, which effectively replaces the erroneous original assignment document.

For more information on patent assignment, visit: patent assignment.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

The USPTO recognizes and accepts electronic signatures on assignment documents submitted electronically. According to MPEP 302.10:

“The USPTO will accept electronic signatures on documents submitted electronically.”

This means that assignors and assignees can use various forms of electronic signatures, such as:

  • Typed names
  • Digital signatures
  • Scanned images of handwritten signatures

It’s important to ensure that the electronic signature complies with the USPTO’s requirements and is legally binding. The specific requirements for electronic signatures are outlined in MPEP 502.02.

To learn more:

When discrepancies are found in title reports, the USPTO takes specific actions to address them. The MPEP 320 states:

If there are discrepancies between the title report and the instrument(s) recorded in the USPTO or the file contents, the title report is returned to the paralegal with an explanation of the discrepancy. The paralegal then contacts the person who ordered the title report and requests correction.

This process ensures that any issues with ownership or chain of title are resolved before the patent application proceeds further.

For more information on ownership verification, visit: ownership verification.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has specific procedures for handling correspondence with a Certificate of Mailing or Transmission:

  1. All papers received by mail are date stamped with the actual date of receipt, regardless of any Certificate of Mailing.
  2. For papers with a Certificate of Mailing or Transmission, the date on the certificate is used to determine if the paper was filed within the period for reply.
  3. If the paper is received within the period for reply, the actual receipt date is used for all purposes.
  4. If the paper is received after the period for reply, but the certificate date is within the period, the paper is considered timely filed. In this case, a notation is made next to the ‘Office Date’ stamp indicating the certificate date (e.g., ‘C of Mail 11/10/97’).
  5. For facsimile transmissions, the date stamped is the date the complete transmission is received, unless that date is a Saturday, Sunday, or Federal holiday within the District of Columbia, in which case the date stamped will be the next succeeding business day.
  6. For EFS-Web submissions, the receipt date is the date the correspondence is received at the USPTO’s correspondence address when it was officially submitted, which can include weekends and holidays.

The MPEP states: “The date indicated on the Certificate of Mailing or of Transmission will be used by the Office only to determine if the paper was deposited in the United States Postal Service, transmitted by facsimile or transmitted via EFS-Web within the period for reply.”

How does the USPTO handle correspondence when there’s a conflict between customer number and application data sheet?

When there’s a conflict between the correspondence address provided in a customer number and an application data sheet (ADS), the USPTO follows specific rules:

  1. The correspondence address in the ADS takes precedence if filed with the initial application papers.
  2. A customer number provided in a single paper with a clear power of attorney overrides the ADS.
  3. If no power of attorney is filed, the correspondence address in the ADS is used.

The MPEP states:

Where an applicant provides a correspondence address in an application data sheet (ADS) that is different from the address associated with a customer number provided in a single paper (e.g., in a power of attorney or inventor’s oath or declaration), the address in the ADS will be the correspondence address of record. (MPEP 403)

It’s crucial to ensure consistency in your filings to avoid confusion. If you need to change the correspondence address after filing, you should submit a separate change of address request or update your customer number information.

For more information on application data sheet, visit: application data sheet.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO, visit: USPTO.

How does the USPTO handle correspondence submitted in violation of the rules?

The USPTO has specific procedures for handling correspondence submitted in violation of the rules. According to MPEP 501:

‘Correspondence submitted to the U.S. Patent and Trademark Office in violation of the rules as to paying fees, manner of presenting papers, or other formal matters will not be filed.’

However, the USPTO does provide a grace period and notification process:

  • The Office may notify the submitter of the violation and set a period for correction.
  • If the violation is corrected within the set period, the document will be considered as having been filed on the date of receipt of the correction.

It’s crucial for applicants to adhere to USPTO rules to avoid potential delays or non-filing of their correspondence. If a violation occurs, prompt correction based on USPTO notification is essential to maintain the original filing date.

How does the USPTO handle correspondence sent by Priority Mail Express®?

The USPTO treats correspondence sent by Priority Mail Express® (formerly Express Mail) with special consideration. According to MPEP 502:

“Any correspondence received by Priority Mail Express® will be considered filed with the USPTO on the date of deposit with the United States Postal Service.”

This means that the date of deposit with USPS is considered the filing date at the USPTO, which can be crucial for meeting deadlines. However, it’s important to note that:

  • The Priority Mail Express® label number must be placed on the correspondence.
  • The filing date accorded to Priority Mail Express® is only applicable to the specific items deposited with USPS.

Always keep your Priority Mail Express® mailing receipt as proof of the deposit date.

For more information on Priority Mail Express, visit: Priority Mail Express.

For more information on USPS, visit: USPS.

For more information on USPTO correspondence, visit: USPTO correspondence.

The USPTO does not receive or process correspondence on Saturdays, Sundays, or Federal holidays within the District of Columbia, with some exceptions. According to 37 CFR 1.6(a)(1):

The Patent and Trademark Office is not open for the filing of correspondence on any day that is a Saturday, Sunday, or Federal holiday within the District of Columbia. Except for correspondence transmitted by facsimile under paragraph (a)(3) of this section, or filed electronically under paragraph (a)(4) of this section, no correspondence is received in the Office on Saturdays, Sundays, or Federal holidays within the District of Columbia.

When the last day for taking action or paying a fee falls on a weekend or holiday, it’s considered timely if done on the next business day: When the last day for taking any action or paying any fee in the Office falls on a Saturday, Sunday, or a Federal holiday within the District of Columbia, the action or the fee is considered timely if the action is taken or the fee is paid on the next succeeding business day.

How does the USPTO handle correspondence received after official hours?

The USPTO has specific procedures for handling correspondence received outside of official business hours:

  • Correspondence delivered to the USPTO after business hours is considered filed on the next business day.
  • There are exceptions for certain types of time-sensitive filings.

MPEP 502 states: ‘Correspondence placed in the USPTO’s night box before midnight on weekdays (except federal holidays) will receive a filing date of the succeeding business day.’ This means that documents deposited in the night box after business hours but before midnight will be treated as if they were received on the next business day.

For electronic filings, the USPTO’s Electronic Filing System (EFS-Web) is generally available 24/7, allowing for submissions outside of regular business hours. However, the actual filing date may still be affected by the time of submission.

In a Pre-AIA 37 CFR 1.47 application, the USPTO follows specific procedures for handling correspondence. According to MPEP 409.03(j):

‘The Notice of Acceptance under 37 CFR 1.47 should remind the applicant that the nonsigning inventor has access to the application papers. Applicant may petition under 37 CFR 1.14(e) for access restriction. See MPEP § 104.’

This means that:

  • The USPTO will send a Notice of Acceptance to the applicant.
  • The non-signing inventor has the right to access application papers.
  • The applicant can petition for access restriction if necessary.
  • Regular correspondence will be sent to the applicant or their representative.

It’s important to note that while the application is prosecuted by the applicant under 37 CFR 1.47, the non-signing inventor retains certain rights, including access to the application file.

To learn more:

To learn more:

How does the USPTO handle correspondence if no practitioner is of record in a patent application?

When no practitioner is of record in a patent application, the USPTO follows specific procedures for handling correspondence. Here’s what you need to know:

  • Correspondence is sent to the applicant’s correspondence address
  • The address used is the one shown in the application or the Patent Application Locating and Monitoring (PALM) system
  • It’s crucial for applicants to keep their correspondence information up to date

As stated in MPEP 403.01(a): ‘If a practitioner is not of record, correspondence will be sent to the applicant’s correspondence address as shown in the application or the Patent Application Locating and Monitoring (PALM) system.’

This policy ensures that even without a practitioner of record, the USPTO can maintain communication with the applicant. It’s important for applicants to regularly check and update their correspondence information to avoid missing critical communications from the USPTO.

To learn more:

How does the USPTO handle correspondence from multiple patent practitioners?

When multiple patent practitioners are involved in an application, the USPTO has specific rules for handling correspondence. MPEP 403.01(a) states: Where more than one practitioner is of record in an application, the Office will direct correspondence to the practitioner first named in the request for representation unless the request for representation specifies otherwise.

This means:

  • The USPTO will typically communicate with the first-named practitioner.
  • Applicants can specify a different practitioner for correspondence if desired.
  • All practitioners of record have the authority to act on behalf of the applicant.

It’s important for the applicant and all involved practitioners to clearly communicate their roles and preferences for correspondence to ensure smooth communication with the USPTO. For more information on correspondence procedures, visit the USPTO’s MPEP 403 page.

To learn more:

How does the USPTO handle correspondence from multiple attorneys in a patent application?

The USPTO has specific guidelines for handling correspondence from multiple attorneys in a patent application:

  • If multiple attorneys are listed on the Power of Attorney form, the USPTO will direct all correspondence to the first listed attorney.
  • The first listed attorney is considered the ‘correspondence address’ for official communications.
  • As stated in MPEP 403.01(a): ‘If more than one attorney is of record, the Office will direct correspondence to the first listed attorney in the Power of Attorney.’
  • Other listed attorneys can still communicate with the USPTO, but official correspondence will be sent to the designated address.

This approach ensures clear communication channels and prevents confusion in multi-attorney cases.

To learn more:

For juristic entities (e.g., corporations, organizations), the USPTO has specific requirements for correspondence and signatures. According to 37 CFR 1.33(b)(3):

Unless otherwise specified, all papers submitted on behalf of a juristic entity must be signed by a patent practitioner.

This means that:

  • A juristic entity must prosecute a patent application through a registered patent practitioner.
  • All correspondence, amendments, and other papers must be signed by a patent practitioner on behalf of the juristic entity.
  • The juristic entity cannot directly correspond with the USPTO or sign documents without representation by a patent practitioner.

This requirement ensures that juristic entities have proper legal representation in patent matters, which can be complex and have significant legal implications.

To learn more:

How does the USPTO handle correspondence for applications with multiple attorneys or agents?

When an application has multiple attorneys or agents of record, the USPTO follows specific guidelines for correspondence:

  • The USPTO will direct all correspondence to the first named attorney or agent of record, unless otherwise specified.
  • If a customer number is provided, correspondence will be sent to the address associated with that customer number.
  • Applicants can designate one or more attorneys or agents to receive correspondence by filing a power of attorney or including the information in an application data sheet.

As stated in the MPEP:

If applicant provides, in a single paper, a list of patent practitioners and a correspondence address without also filing a clear power of attorney to a patent practitioner, the Office will direct all correspondence to the correspondence address pursuant to 37 CFR 1.33(a). (MPEP 403)

It’s important to clearly designate correspondence preferences to ensure proper communication with the USPTO.

For more information on patent agents, visit: patent agents.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO correspondence, visit: USPTO correspondence.

How does the USPTO handle correspondence for applications with multiple applicants?

The USPTO has specific rules for handling correspondence in applications with multiple applicants:

  • For applications filed on or after September 16, 2012, the USPTO will direct correspondence to the first named applicant, unless a practitioner is appointed.
  • For applications filed before September 16, 2012, correspondence is sent to the first named inventor, unless a practitioner is of record.

As stated in MPEP 403: ‘Where more than one attorney or agent is of record, the Office will direct correspondence to the first named attorney or agent of record, unless otherwise requested.’ This ensures clear communication channels for multi-applicant applications.

For more information on USPTO correspondence, visit: USPTO correspondence.

How does the USPTO handle correspondence during emergency situations?

The USPTO has provisions for handling correspondence during emergency situations, such as severe weather or other unforeseen circumstances:

  • The USPTO may designate certain days as ‘Federal holidays within the District of Columbia’ under specific conditions.
  • This designation affects filing dates and deadlines.

MPEP 502 states: ‘When the entire USPTO is officially closed for business for an entire day due to an emergency situation, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21.’ This means that deadlines falling on such days will be extended to the next business day, similar to federal holidays.

During emergencies, the USPTO typically issues public notices and updates its website to inform stakeholders about any changes to operations or filing procedures. It’s crucial for patent applicants and attorneys to stay informed about such announcements to ensure compliance with modified deadlines and procedures.

How does the USPTO handle correspondence delivered by EXPRESS MAIL?

The USPTO has specific procedures for handling correspondence delivered by EXPRESS MAIL. According to MPEP 502:

“Any correspondence delivered by the ‘Express Mail Post Office to Addressee’ service of the United States Postal Service (USPS) is considered filed or received in the Office on the date of deposit with the USPS.”

This means that the date of deposit with the USPS is considered the filing date at the USPTO, provided that:

  • The correspondence is properly addressed to the USPTO
  • The proper address is on the EXPRESS MAIL mailing label
  • The EXPRESS MAIL mailing label number is placed on the correspondence

It’s important to note that this applies only to the USPS EXPRESS MAIL service and not to similar services provided by private courier companies.

For more information on Express Mail, visit: Express Mail.

For more information on USPTO correspondence, visit: USPTO correspondence.

When the USPTO is notified of the death of a sole patent practitioner of record, they continue to hold correspondence with the deceased practitioner’s office. However, the USPTO also mails a copy of the Office action to the person who originally appointed the practitioner. This ensures that the applicant or owner is informed of ongoing patent matters.

How does the USPTO handle conflicting powers of attorney in a patent application?

When conflicting powers of attorney are submitted in a patent application, the USPTO follows specific procedures to resolve the conflict. According to MPEP 402.10:

Where a written power of attorney is submitted in an application without the signature of one or more inventors or assignees, the power of attorney is not accepted until either (1) the nonsigning inventor or assignee provides a power of attorney consistent with the power of attorney provided by the other parties, or (2) the nonsigning inventor or assignee is removed from the application.

In practice, this means:

  • The USPTO will not accept a power of attorney unless it is signed by all parties or consistent with previously filed powers.
  • If conflicting powers are received, the Office will contact the applicants to resolve the discrepancy.
  • The application may be delayed until the conflict is resolved.
  • In some cases, the nonsigning inventor or assignee may need to be removed from the application for prosecution to proceed.

It’s crucial for applicants to coordinate and agree on representation to avoid such conflicts and potential delays in the patent application process.

To learn more:

How does the USPTO handle conflicting instructions from multiple representatives?

When multiple representatives are authorized to act on behalf of an applicant or assignee, conflicts may arise if they provide contradictory instructions. The USPTO has a clear procedure for handling such situations. According to MPEP 402.04, “Where an applicant is represented by more than one practitioner, the Office will direct all communications to the first named representative (the representative of record) in absence of a request to the contrary or in absence of revocation of power of attorney.” This means that if conflicting instructions are received, the USPTO will generally follow the guidance provided by the representative of record, ensuring a clear line of communication and decision-making.

To learn more:

When the USPTO receives conflicting instructions from multiple assignees or co-inventors regarding a patent application, it follows a specific protocol to ensure fair treatment of all parties. According to MPEP 106, the USPTO will not arbitrate disputes between the parties.

In such cases, the USPTO typically:

  • Suspends action on the application until the conflict is resolved
  • Notifies all parties of the conflicting instructions
  • Advises the parties to resolve the dispute among themselves or through the courts
  • Resumes prosecution only when clear, consistent instructions are received from all interested parties or when a court order is issued

This approach ensures that the USPTO remains neutral and that the rights of all assignees and inventors are protected throughout the patent prosecution process.

The USPTO handles confidentiality in 37 CFR 1.47(a) petitions with care, recognizing the sensitive nature of the information provided. The MPEP 409.03(b) states:

‘Petitions under 37 CFR 1.47 are not available to the public since they are contained in the application file… The petition will be available to the nonsigning inventor upon request.’

This means:

  • Petition documents are kept confidential as part of the non-public application file.
  • The general public cannot access these petitions.
  • The nonsigning inventor has the right to request and view the petition.
  • The USPTO balances the need for transparency with the protection of potentially sensitive information.

Applicants should be aware that while the petition is generally confidential, the nonsigning inventor may still access it, which could affect strategies for presenting information in the petition.

To learn more:

To learn more:

The United States Patent and Trademark Office (USPTO) has specific procedures for maintaining the confidentiality of international applications filed in the U.S. According to MPEP 110, which references 35 U.S.C. 368, International applications filed in the Patent and Trademark Office shall be subject to the provisions of chapter 17. This means that such applications are subject to the same secrecy provisions as regular U.S. patent applications. Additionally, If a license to file in a foreign country is refused or if an international application is ordered to be kept secret and a permit refused, the Patent and Trademark Office when acting as a Receiving Office, International Searching Authority, or International Preliminary Examining Authority, may not disclose the contents of such application to anyone not authorized to receive such disclosure. This ensures that sensitive information in international applications is protected in accordance with U.S. law.

For more information on international applications, visit: international applications.

For more information on USPTO, visit: USPTO.

How does the USPTO handle confidential patent assignment information?

The USPTO generally treats patent assignment records as public information. However, there are provisions for handling confidential information within these records. MPEP 301.01 states:

“Assignments and other documents affecting title to applications, patents, and registrations that are recorded in the USPTO are generally open to public inspection. Only documents that are sealed as provided in 37 CFR 1.14 or otherwise not open to public inspection are not available for public inspection.”

If a document contains sensitive information that should not be publicly disclosed, the parties involved can:

  • Redact confidential information before submitting the document for recordation
  • Request that certain documents be sealed under 37 CFR 1.14
  • Submit separate public and non-public versions of documents when necessary

It’s important to note that the decision to seal documents is at the discretion of the USPTO and is generally limited to specific circumstances outlined in the regulations.

The USPTO provides a specific process for handling confidential license agreements. According to MPEP 313:

“If the document to be recorded is a confidential license agreement, such as a trade secret agreement, the instrument must be submitted with a cover sheet to request redaction of the document. The parties must include all of the information required by 37 CFR 3.31, and additionally state that the document is confidential and identify the item(s) for which redaction is being requested.”

This process allows parties to protect sensitive information while still recording the existence of the license agreement with the USPTO.

The MPEP 608.01(v) outlines the process for handling complaints about trademark misuse in patent applications:

  1. Technology Center Directors should reply to all complaint letters regarding the misuse of marks used in commerce and forward a copy of the complaint letter and reply to the Office of the Deputy Commissioner for Patents who oversees the Office of Petitions.
  2. Where a letter demonstrates the misuse of a mark in a patent application publication, the Office should, where the application is still pending, ensure that the mark is replaced by appropriate generic terminology.

This process ensures that complaints are addressed at a high level within the USPTO and that appropriate action is taken to correct any misuse of trademarks in pending applications. It’s important for applicants to be aware of this process and to use trademarks properly in their applications to avoid such complaints and potential corrections.

To learn more:

After an attorney withdraws from a patent application, the USPTO adjusts its communication process as follows:

  • The Office communicates directly with the applicant or assignee.
  • This direct communication continues until a new registered patent practitioner is appointed.
  • The applicant or assignee who originally appointed the withdrawing attorney becomes the point of contact for all purposes in the application.

According to MPEP 402.06: ‘For applications in which the attorney or agent has withdrawn from representation, the Office will communicate directly with the applicant … until such time as a new attorney or agent is appointed.’

It’s crucial for applicants to stay responsive and consider appointing new representation promptly to ensure smooth prosecution of their patent application.

To learn more:

The USPTO has specific procedures for handling changes in power of attorney and correspondence address. According to MPEP 403:

‘A new power of attorney or change of correspondence address filed in a patent application or patent does not change the correspondence address for any other application or patent.’

Key points to remember:

  • Each application or patent is treated separately.
  • A change in one application doesn’t automatically apply to others, even if filed by the same applicant or assignee.
  • To change multiple applications, you must file separate requests for each one.
  • Using a customer number can simplify this process for multiple applications.

It’s crucial to ensure that any changes are properly filed and recorded to maintain effective communication with the USPTO.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How does the USPTO handle changes in ownership of patents?

The USPTO handles changes in ownership of patents through a process of recording assignments. According to MPEP 301:

“The assignment of a patent, or patent application, is the transfer of the entire right, title and interest therein. An assignment of an application may be made before the application is filed or after it is filed.”

When a change in ownership occurs:

  • The new owner must record the assignment with the USPTO
  • This recording serves as public notice of the transfer
  • It helps maintain clear records of patent ownership

The USPTO maintains these records and updates them as new assignments are recorded.

For more information on assignment recording, visit: assignment recording.

For more information on USPTO procedures, visit: USPTO procedures.

How does the USPTO handle certified copies for international design applications?

For international design applications, the USPTO has a specific process for handling certified copies. According to the MPEP:

‘For international design applications designating the United States, the certified copy requirement is considered to have been met by the filing of the international design application pursuant to 37 CFR 1.55(m).’

This means that if you file an international design application that designates the United States, you don’t need to separately submit a certified copy of the priority document. The filing of the international design application itself fulfills this requirement.

However, it’s important to note that this only applies to international design applications. For other types of patent applications claiming priority to a foreign application, you would still need to ensure that a certified copy is filed or retrievable through the priority document exchange program within the specified time period.

While a prior assignment recorded against an original application is automatically effective for division and continuation applications, the USPTO does not automatically update its assignment records for these new applications. As stated in MPEP 306:

Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

This means that even though the assignment is legally effective, the USPTO’s records won’t show it unless the assignee takes specific action. To ensure the USPTO’s records are up to date, assignees should:

  • File a request for recordation of the assignment for the new application
  • Ensure the request complies with 37 CFR 3.28
  • Pay the required fee as specified in 37 CFR 3.41

How does the USPTO handle assignment documents that contain errors?

The USPTO has procedures in place for handling assignment documents with errors:

  • Minor errors: The USPTO may correct minor errors in assignment documents without requiring a new submission. As stated in MPEP 302: ‘Minor corrections to documents recorded pursuant to 37 CFR 3.11 will be made by the Assignment Division, provided that the corrections do not involve the re-recording of the entire assignment document.’
  • Major errors: For significant errors, a new corrected document must be submitted. The MPEP notes: ‘Other corrections may be made only by the submission of a new document.’
  • Erroneous recording: If an assignment is erroneously recorded, the USPTO will correct its records upon notification.

It’s important to review assignment documents carefully before submission to avoid delays and potential legal issues.

For more information on document correction, visit: document correction.

For more information on USPTO procedures, visit: USPTO procedures.

How does the USPTO handle assignment documents after recording?

After recording an assignment document, the USPTO follows a specific process. According to MPEP 302.01: ‘Assignment documents submitted for recording are scanned and stored in a public database.’

The handling process includes:

  • Scanning the submitted copy of the assignment document
  • Storing the scanned document in a publicly accessible database
  • Retaining the physical copy submitted (not returning it to the sender)
  • Making the recorded information available for public inspection

This process ensures that assignment records are preserved and accessible while maintaining the integrity of the original submissions.

To learn more:

The USPTO treats applications with omitted drawings similarly to those with missing specification pages. According to MPEP 506:

In the event that a page of the specification, or a portion thereof, or a page of the drawings, or a portion thereof, is inadvertently omitted from an application as filed, the application will be not be considered complete and the applicant will be notified to file the omitted portion.

If drawings are omitted, the applicant will be notified and given a time period to submit the missing drawings. However, adding new drawings after the filing date may affect the application’s effective filing date if they introduce new matter. It’s crucial to include all necessary drawings with the initial application to avoid potential issues.

For more information on new matter, visit: new matter.

Tags: new matter

The USPTO has specific procedures for handling applications in which the government may have a property interest. According to the MPEP:

For those applications in which the Government has a property interest (including applications indicating national security classified subject matter), responsibility for notifying the Commissioner for Patents of the need for a Secrecy Order resides with the agency having that interest.

Additionally, the screening process identifies inventions that may be of interest to specific government agencies:

A second purpose for the screening of all applications, with an exception for provisional applications, is to identify inventions in which DOE or NASA might have property rights. See42 U.S.C. 2182,51 U.S.C. 20135, andMPEP § 150.

This process ensures that government agencies are notified of inventions that may fall under their purview and allows them to take appropriate action, such as requesting a Secrecy Order if necessary.

For more information on patent applications, visit: patent applications.

When an application is filed with missing parts, the USPTO follows these procedures:

  1. If the application meets minimum requirements for a filing date, it will be assigned one.
  2. A Notice to File Missing Parts will be issued, detailing the missing items.
  3. Applicants must submit missing items along with any required surcharges within the specified time period.
  4. For applications filed on or after September 16, 2012, the inventor’s oath or declaration can be postponed until payment of the issue fee if a compliant application data sheet is filed.
  5. For applications filed on or after December 18, 2013, filing of claims can be postponed until the expiration of the time period set in the Notice to File Missing Parts.

The MPEP states: ‘The inventor’s oath or declaration, basic filing fee, and search fee and examination fee as set forth in 37 CFR 1.16, may be filed later than the remaining application papers, but if so, they must be accompanied by the required surcharge (if appropriate, see MPEP § 506).’ (MPEP 503)

How does the USPTO handle applications filed before September 16, 2012?

Applications filed before September 16, 2012, are subject to different correspondence rules. As stated in MPEP 403.01(a): For applications filed before September 16, 2012, pre-AIA 37 CFR 1.33(a) applies. This means that for these older applications, the correspondence rules and procedures outlined in pre-AIA 37 CFR 1.33(a) are still in effect. It’s important to check the filing date of your application to determine which set of rules applies.

For more detailed information on pre-AIA rules, you can refer to MPEP 403 which covers correspondence for applications filed before September 16, 2012.

To learn more:

The United States Patent and Trademark Office (USPTO) treats all ‘conditional’ requests for Continued Prosecution Applications (CPAs) as unconditional requests. This is clearly stated in MPEP ¶ 2.35:

“Any ‘conditional’ request for a CPA submitted as a separate paper is treated as an unconditional request for a CPA.”

This means that once a CPA request is filed, even if the applicant intended it to be conditional, the USPTO will process it as a regular CPA. The conditions specified by the applicant are essentially disregarded, and the CPA is established based on the filing of the request alone.

For more information on CPA, visit: CPA.

For more information on Patent Application Process, visit: Patent Application Process.

The USPTO has different fee structures for recording patent and trademark documents. According to MPEP 302.06:

Additionally, for patent documents:

  • Electronic submissions currently have a $0 fee
  • Paper or fax submissions have a fee set in 37 CFR 1.21(h)(2)

It’s important to note that trademark fees may differ and do not have the same $0 electronic submission option as patents. Always check the current USPTO fee schedule for the most up-to-date information.

To learn more:

The USPTO has a specific process to ensure that all applications are cleared from secrecy review before they are issued as patents. According to the MPEP:

All applications are required to be cleared from secrecy review before forwarding to issue. If the L&R code on the general information display does not equal 1, then in an IFW application, a message should be sent to LREVINCOMINGDOCS.

The USPTO uses a system called the Patent Data Portal (PDP) to track the status of applications:

The Patent Data Portal (PDP) System’s general information display discloses the current Licensing and Review status. The indicator “L&R code” displays the current status of the application while the indicators “Third Level Review” and “Secrecy Order” display the historical status of the application.

Specific codes are used to indicate the status of an application:

  • An L&R code of “3” or a “Third Level Review” of “Yes” indicates that the application is/has been considered for security screening.
  • A Secrecy Code of “4” indicates that the application is currently under Secrecy Order.

If an application is under Secrecy Order, special handling is required:

In this case, the application has been converted to a paper application file and there should be no images maintained in the Image File Wrapper system (IFW).

This process ensures that no application is issued as a patent until it has been fully cleared from secrecy review, protecting sensitive information and national security interests.

For more information on patent issuance, visit: patent issuance.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO actively encourages the use of interviews to expedite patent prosecution. According to MPEP § 408, The Office encourages the use of interviews to expedite prosecution. When an examiner believes an interview would advance the application’s progress, they may contact the patent practitioner of record to suggest a telephonic, personal, or video conference interview.

To initiate an interview, applicants should submit an ‘Applicant Initiated Interview Request’ form (PTOL-413A) prior to the interview. This form helps the examiner prepare and focus on the issues to be discussed.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO determines eligible countries for priority claims based on international agreements and reciprocity. MPEP 213.01 states:

The right of priority is recognized only if the foreign application was filed in a country granting similar privileges to United States citizens.

This means the USPTO maintains a list of countries that have established reciprocal rights with the United States. These countries typically include Paris Convention members, PCT contracting states, and nations with bilateral agreements recognizing priority rights.

To learn more:

The USPTO determines the correspondence address based on the most recent information provided. According to MPEP 403.02:

“If, after one patent practitioner is appointed, a second patent practitioner is later added by submission of a new power of attorney appointing both practitioners, correspondence will be mailed to the latest correspondence address of record.”

This means that the USPTO will use the most recently provided correspondence address, regardless of which practitioner it is associated with. This practice is governed by 37 CFR 1.33 and 37 CFR 1.76, which provide regulations on correspondence and application data sheets. It’s crucial for applicants and practitioners to keep the correspondence address up to date to ensure proper communication with the USPTO.

To learn more:

How does the USPTO determine if material is ‘new matter’ in a patent application?

The USPTO determines if material is ‘new matter’ by comparing the content of the application as originally filed with any subsequent amendments or additions. According to MPEP 608.04(a):

In establishing new matter, the examiner must find that the subject matter is unequivocally described in the application as filed.

The process typically involves:

  • Reviewing the original specification, claims, and drawings
  • Comparing any amendments or new submissions to the original disclosure
  • Determining if the new material goes beyond what was explicitly or inherently disclosed
  • Considering whether a person skilled in the art would recognize the added material as being inherently present in the original disclosure

If the examiner finds that the added material is not supported by the original disclosure, it will be rejected as new matter under 35 U.S.C. 132(a) and 37 CFR 1.121(f).

To learn more:

Tags: new matter

How does the USPTO determine if inventors are truly joint inventors?

The U.S. Patent and Trademark Office (USPTO) relies on the information provided by the applicants to determine joint inventorship. According to MPEP 602.09, ‘The specification must contain the names of all joint inventors.’ However, the USPTO does not typically investigate the accuracy of joint inventorship claims unless there is evidence of impropriety. The determination of joint inventorship is based on the 35 U.S.C. 116, which states that inventors may apply for a patent jointly even if:

  • They did not physically work together or at the same time,
  • Each did not make the same type or amount of contribution, or
  • Each did not make a contribution to the subject matter of every claim of the patent.

If disputes arise, they are typically resolved through legal proceedings rather than by the USPTO itself.

To learn more:

The USPTO determines the necessity of drawings in a patent application based on whether they are required to understand the invention. According to MPEP 601.01(f) and 35 U.S.C. 113:

“The applicant shall furnish a drawing where necessary for the understanding of the subject matter sought to be patented.”

Examiners assess the application’s written description to determine if drawings are essential. If the invention can be fully understood without drawings, they may not be deemed necessary. However, for most mechanical, electrical, and design inventions, drawings are typically required to adequately disclose the invention.

To learn more:

To learn more:

The USPTO generally does not make an upfront determination about whether an application qualifies as a continuation-in-part (CIP) unless it becomes necessary in a proceeding. According to the MPEP:

“The Office does not need to make a determination as to whether the requirement of 35 U.S.C. 120 that the earlier nonprovisional application discloses the invention of the second application in the manner provided by 35 U.S.C. 112(a) is met unless the filing date of the earlier nonprovisional application is relied upon in a proceeding before the Office.”

However, examiners may use form paragraph 2.06 to remind applicants of possible CIP status:

“This application repeats a substantial portion of prior Application No. [1], filed [2], and adds disclosure not presented in the prior application. Because this application names the inventor or at least one joint inventor named in the prior application, it may constitute a continuation-in-part of the prior application.”

Ultimately, it’s the applicant’s responsibility to properly claim CIP status and comply with the requirements of 35 U.S.C. 120 and 37 CFR 1.78.

For more information on patent examination, visit: patent examination.

The examiner generally does not examine the certified copy of the foreign priority application except to see that it contains no obvious formal defects and corresponds to the U.S. application. The examiner will consider the merits of the priority claim if:

  • An intervening reference is found with an effective date between the foreign filing date and U.S. filing date
  • Determining if a reference is prior art under the grace period
  • An interference situation is under consideration

If the examiner finds the applicant is not entitled to the priority date, a rejection is made and the applicant must then perfect the claim. [MPEP 216]

The USPTO determines if a prior-filed application provides adequate support for a later-filed application by examining whether the prior-filed application discloses the invention claimed in the later-filed application in sufficient detail. According to MPEP 211.05:

‘To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application); the disclosure of the invention in the prior application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, except for the best mode requirement.’

This means that the prior-filed application must provide a written description of the invention, enable one skilled in the art to make and use the invention, and disclose the best mode (if invented prior to the AIA) for carrying out the invention.

To learn more:

To learn more:

The USPTO determines if a patent application is incomplete by reviewing the submitted materials against the required components for a complete application. According to MPEP 203.06:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

The process typically involves:

  • Initial review by USPTO staff
  • Checking for presence of all required documents and fees
  • Verifying that the application meets minimum requirements for obtaining a filing date
  • Issuing a notice of missing parts if deficiencies are found

For detailed information on the requirements, refer to MPEP 506 and MPEP 601, which provide guidance on completeness criteria and filing procedures.

To learn more:

The USPTO determines if a foreign country qualifies for priority rights based on specific criteria outlined in the MPEP. According to MPEP 213.01:

The right of priority is recognized only if the foreign country in which the original application was filed is recognized at the time of filing the application in the United States.

The USPTO considers several factors:

  • The country must be a member of the Paris Convention for the Protection of Industrial Property or have a bilateral agreement with the United States.
  • The country must grant similar priority rights to U.S. citizens.
  • The country must be recognized by the U.S. Department of State.

The USPTO maintains a list of recognized countries and regional patent offices in MPEP 213.01, which is updated periodically to reflect changes in international relations and treaty memberships.

The USPTO evaluates whether a delay in claiming priority was unintentional based on the totality of the circumstances. According to MPEP 214.02:

The Director may require additional information where there is a question whether the delay was unintentional.

This means that the USPTO may request additional information from the applicant to determine if the delay was truly unintentional. The evaluation process typically involves:

  • Reviewing the explanation provided in the petition
  • Considering the length of the delay
  • Assessing any changes in ownership or responsibility for the application
  • Examining the circumstances surrounding the discovery of the need for a delayed priority claim

The USPTO applies a good faith standard, looking for evidence that the delay was not deliberate and that reasonable steps were taken to correct the issue once it was discovered. It’s important to provide a detailed and honest account of the circumstances leading to the delay when filing the petition.

To learn more:

The USPTO follows a specific process to determine if an error on a cover sheet is typographical in nature. According to MPEP 323.01(a):

“The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.”

This process involves:

  • Reviewing the corrected cover sheet submitted by the requesting party
  • Comparing it to the original cover sheet
  • Examining the originally recorded assignment document or other title-affecting document
  • Assessing whether the error is purely typographical or if it substantively affects the title or assignment

If the error is determined to be typographical and does not affect the title, the Assignment Services Division will record the corrected cover sheet and update the Assignment Historical Database. However, if the error affects the title, different procedures apply, including potential changes to the recordation date.

To learn more:

How does the USPTO determine if a country is eligible for priority right benefits?

The USPTO determines a country’s eligibility for priority right benefits based on specific criteria. As stated in MPEP 213.01:

The United States will recognize claims for right of priority under 35 U.S.C. 119(a)-(d) based on applications filed in countries which have acceded to the Patent Cooperation Treaty (PCT) prior to becoming a Contracting State of that Treaty.

This means that countries that have joined the PCT are generally recognized for priority rights. Additionally, the USPTO considers other factors such as whether the country:

  • Extends similar privileges to U.S. citizens
  • Is a member of the World Trade Organization (WTO)
  • Has a bilateral agreement with the United States

The USPTO maintains a list of countries and organizations that meet these criteria, which is periodically updated to reflect changes in international agreements and relations.

To learn more:

The USPTO determines if a claim in a later-filed application is entitled to the benefit of an earlier filing date by evaluating whether:

  • The subject matter of the claim is disclosed in the earlier-filed application.
  • The disclosure in the earlier-filed application complies with the requirements of 35 U.S.C. 112(a), except for the best mode requirement.
  • The disclosure enables one skilled in the art to make and use the claimed invention without undue experimentation.

As stated in MPEP 211.05:

“A claim in the later-filed application is not entitled to the benefit of the filing date of the prior-filed application if the disclosure of the prior-filed application does not enable one skilled in the art to ‘use’ the claimed invention.”

If the earlier application fails to provide adequate support or enablement for a claim in the later-filed application, that claim will not be entitled to the earlier filing date. This assessment is made on a claim-by-claim basis, and different claims within the same application may have different effective filing dates.

To learn more:

The United States Patent and Trademark Office (USPTO) defines different types of patent applications in the Code of Federal Regulations (CFR) and the Manual of Patent Examining Procedure (MPEP). Specifically:

  • National application, Provisional application, and Nonprovisional application are defined in 37 CFR 1.9(a)
  • International application is defined in 37 CFR 1.9(b)
  • International design application is defined in 37 CFR 1.9(n)

These definitions provide the legal basis for understanding the different types of applications that can be filed with the USPTO. For more detailed explanations and context, refer to MPEP § 201, which provides comprehensive guidance on types and status of applications.

To learn more:

The United States Patent and Trademark Office (USPTO) defines an abandoned patent application through the Manual of Patent Examining Procedure (MPEP) 203.05. According to this section, an abandoned application is defined as:

An abandoned application is, inter alia, one which is removed from the Office docket of pending applications

This removal from the docket can occur for various reasons, including formal abandonment, failure to take appropriate action during prosecution, non-payment of fees, or the expiration of the statutory period for provisional applications.

The term ‘international application’ is defined in 37 CFR 1.9(b). An international application typically refers to a patent application filed under the Patent Cooperation Treaty (PCT), which provides a unified procedure for filing patent applications to protect inventions in its contracting states.

Key points about international applications:

  • They are governed by the Patent Cooperation Treaty.
  • They can lead to national phase entries in multiple countries.
  • They provide a streamlined filing process for seeking patent protection internationally.
  • The specific definition in 37 CFR 1.9(b) should be consulted for precise legal terminology.

International applications are distinct from national applications and offer a pathway for inventors to seek protection in multiple countries through a single filing.

For more information on Patent Cooperation Treaty, visit: Patent Cooperation Treaty.

How does the USPTO define ‘unintentional delay’ for priority claims?

The USPTO does not provide a specific definition of ‘unintentional delay’ in the context of priority claims. However, the interpretation is generally consistent with other areas of patent law where unintentional delay is considered.

According to MPEP 214.02: ‘The Director may require additional information where there is a question whether the delay was unintentional.’

This means that:

  • The delay must not have been deliberate or intentional.
  • The applicant must have taken reasonable care to meet the deadline but failed due to unforeseen circumstances.
  • Once the applicant became aware of the missed deadline, they must have acted promptly to file the petition.

It’s important to note that the USPTO may request additional information if there’s any doubt about the unintentional nature of the delay. Applicants should be prepared to provide a detailed explanation of the circumstances that led to the delay if requested.

To learn more:

The USPTO refers to ‘suspended or excluded practitioners’ in MPEP 105 as “an attorney or agent who has been suspended or excluded from practice by the USPTO.” This typically refers to patent attorneys or agents who have faced disciplinary action and are temporarily or permanently barred from practicing before the USPTO. These individuals are subject to specific restrictions, including the inability to communicate with USPTO employees about patent applications or inspect application materials, unless they are the inventor or applicant.

To learn more:

How does the USPTO define ‘new matter’ in patent applications?

The United States Patent and Trademark Office (USPTO) defines ‘new matter’ as any content added to a patent application after the initial filing date that was not present in the original specification, claims, or drawings. According to MPEP 608.04(a):

“Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.”

This definition is strict and encompasses any additions or modifications that introduce information not explicitly or inherently supported by the original disclosure. New matter can include:

  • Additional text in the specification
  • New or modified claim elements
  • Changes to drawings or the addition of new figures
  • Incorporation of external references not properly incorporated on the filing date

It’s important to note that new matter is prohibited under 35 U.S.C. 132(a), which states that “No amendment shall introduce new matter into the disclosure of the invention.”

To learn more:

Tags: new matter, USPTO

How does the USPTO define ‘material information’ in patent applications?

The USPTO considers information to be material if it affects the patentability of an invention. According to MPEP 410:

“Information is material to patentability when it is not cumulative to information already of record or being made of record in the application, and (1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or (2) It refutes, or is inconsistent with, a position the applicant takes in: (i) Opposing an argument of unpatentability relied on by the Office, or (ii) Asserting an argument of patentability.”

In simpler terms, material information includes any facts that could affect the USPTO’s decision to grant a patent. This may include prior art, conflicting statements, or any other information that could impact the novelty or non-obviousness of the claimed invention.

For more information on prior art, visit: prior art.

For more information on USPTO, visit: USPTO.

Tags: prior art, USPTO

The USPTO has changed its approach to classifying patent drawings. According to MPEP 608.02(i), “the Office no longer considers drawings as formal or informal.” This means that the traditional distinction between formal and informal drawings has been eliminated. Instead, the focus is on whether the drawings are sufficient for publication and examination purposes, regardless of their formal classification.

To learn more:

When an attorney or agent is suspended, the USPTO does not communicate with them. Instead:

  • For sole practitioners: The Office action is mailed to the address of the first named applicant in the application.
  • For multiple practitioners: The Office action is mailed to the first named unsuspended registered practitioner of record and to the first named applicant.

This is outlined in Form Paragraphs 4.07 and 4.08 of MPEP § 407.

The USPTO calculates the 12-month priority period for nonprovisional applications as follows:

  • Start date: The period begins on the filing date of the earliest foreign application for which priority is claimed.
  • End date: The period ends 12 months later, on the same date of the following year.
  • Holiday/weekend adjustment: If the 12-month period ends on a Saturday, Sunday, or federal holiday, it extends to the next business day.

According to MPEP 213.03: “The 12-month priority period ends on the anniversary date of the earliest foreign application. If the anniversary date falls on a Saturday, Sunday, or federal holiday, the 12-month period ends on the next succeeding business day.”

It’s crucial to accurately calculate this period to ensure timely filing of your nonprovisional application and maintain your priority claim.

To learn more:

How does the USPTO assign application numbers to continuation or divisional applications?

The USPTO assigns application numbers to continuation or divisional applications in the same manner as new applications. According to MPEP 503:

A continuation or divisional application (including a continued prosecution application) filed under 37 CFR 1.53(b) is assigned a new application number.

This means:

  • Each continuation or divisional application receives a unique number
  • The number is assigned in the same sequence as other new applications
  • The application number does not indicate its relationship to the parent application

It’s important to reference the parent application in the appropriate sections of the new application to establish the continuity.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on USPTO procedures, visit: USPTO procedures.

When an applicant submits an insufficient payment for fees due on filing a nonprovisional application under 35 U.S.C. 111(a) and has not specified how to apply the payment, the USPTO applies the payment in a specific order. The MPEP outlines this order as follows:

  1. Basic filing fee
  2. Search fee
  3. Examination fee
  4. Excess claims fee (independent claims exceeding three and total claims exceeding twenty)
  5. Application size fee
  6. Non-electronic filing fee (if applicable)

For provisional applications under 35 U.S.C. 111(b), the order is:

  1. Basic filing fee
  2. Application size fee

This information helps applicants understand how their payments will be allocated if they submit an insufficient amount for the required fees.

To learn more:

Tags: patent fees

When the claim for foreign priority and the certified copy of the foreign application are received within the time period set forth in 37 CFR 1.55, and there are no irregularities, the USPTO acknowledges receipt in the next Office action.

According to the MPEP: Assuming that the papers are timely and regular in form and that there are no irregularities in dates, the examiner in the next Office action will advise the applicant that the papers have been received on form PTOL-326 or by use of form paragraph 2.26.

The examiner may use form paragraph 2.26, which states: Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55.

If the foreign priority papers have been filed in a parent application, the examiner will use form paragraph 2.27 to acknowledge this fact.

To learn more:

The USPTO acknowledges receipt of foreign priority claims in several ways:

  1. If the claim is timely and all requirements are met, the examiner will advise the applicant in the next Office action using form PTOL-326 or form paragraph 2.26
  2. For priority documents filed in a parent application, the examiner may use form paragraph 2.27
  3. If there are irregularities, the examiner may use specific form paragraphs to notify the applicant of issues

MPEP 214.03 states: “When the claim for foreign priority and the certified copy of the foreign application are received within the time period set forth in 37 CFR 1.55, if applicable, they are entered into the application file history. Assuming that the papers are timely and regular in form and that there are no irregularities in dates, the examiner in the next Office action will advise the applicant that the papers have been received on form PTOL-326 or by use of form paragraph 2.26.”

The United States Patent and Trademark Office (USPTO) formally acknowledges a Request to Delete a Named Inventor in a Continued Prosecution Application (CPA) through an official response. This acknowledgment serves as confirmation that the request has been received and processed.

The MPEP ¶ 2.32 provides the standard language used by examiners to acknowledge such requests:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

In this acknowledgment:

  • [1] refers to the name(s) of the inventor(s) requested to be deleted
  • [2] indicates the filing date of the CPA

This official response confirms that the USPTO has processed the request and updated the inventorship accordingly.

For more information on CPA, visit: CPA.

For more information on USPTO acknowledgment, visit: USPTO acknowledgment.

For papers that have been scanned into the Image File Wrapper (IFW) system, the USPTO has a specific procedure for ‘returning’ them. According to MPEP 508.02:

“If a paper has been scanned into the IFW, ‘return’ of the paper will be accomplished by the Office closing it in IFW.”

This means that instead of physically returning the paper, the USPTO will electronically close or restrict access to the document within the IFW system. This process maintains the integrity of the digital file while effectively ‘returning’ the document.

To learn more:

How does the title of a patent application affect its classification?

The title of a patent application plays a significant role in its initial classification. According to MPEP 606:

The title of the invention may not exceed 500 characters in length and must be as short and specific as possible.

The title’s impact on classification includes:

  • Initial sorting: The title is often the first piece of information used to categorize the application.
  • Technology field identification: A clear, specific title helps quickly identify the relevant technology field.
  • Examiner assignment: The title can influence which art unit and examiner are assigned to the application.
  • Prior art searches: An accurate title can guide more effective prior art searches.

While the abstract and claims ultimately determine the final classification, a well-crafted title ensures the application starts in the right direction, potentially speeding up the examination process and improving the quality of the initial review.

To learn more:

How does the timing of an IDS submission affect the required certification?

The timing of an Information Disclosure Statement (IDS) submission directly impacts the required certification:

  • IDS filed within three months of filing or before first Office action: No certification required
  • IDS filed after three months of filing but before first Office action on the merits: Certification under 37 CFR 1.97(e) or fee under 37 CFR 1.17(p) required
  • IDS filed after first Office action but before final action, notice of allowance, or action closing prosecution: Certification under 37 CFR 1.97(e) or fee under 37 CFR 1.17(p) required
  • IDS filed after final action, notice of allowance, or action closing prosecution: Both certification under 37 CFR 1.97(e) and fee under 37 CFR 1.17(p) required

As stated in MPEP 609.04(b): “An information disclosure statement shall be considered by the Office if filed by the applicant within any one of the following time periods:” followed by the specific timing requirements. This underscores the importance of timely IDS submission to avoid additional certification or fee requirements.

To learn more:

The September 16, 2012 date is significant for assignment procedures in applications claiming the benefit of a provisional application. For applications filed on or after this date, the assignment rules are more flexible:

  • If the application includes new subject matter not in the provisional application, new assignment papers are not required if the assignee is the original applicant in the later application.
  • For applications filed before this date, new assignment papers are always required if there’s new subject matter, regardless of who the assignee is.

This change aligns with the implementation of the America Invents Act. As stated in MPEP § 306.01: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein.

To learn more:

The right of priority for international design applications is governed by 35 U.S.C. 386. There are two main scenarios:

  1. A U.S. national application can claim priority from a prior international design application that designated at least one country other than the United States.
  2. An international design application designating the United States can claim priority from a prior foreign application, a prior PCT application designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

The MPEP states: Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a) – (d) and 172 with respect to a prior international design application that designates at least one country other than the United States.

To learn more:

The right of priority for international applications filed under the Patent Cooperation Treaty (PCT) operates similarly to national applications, but with some specific provisions and requirements set by the PCT system.

According to MPEP 213.06: “In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.”

Key points about priority in PCT applications include:

  • The priority claim must be made in the PCT Request form or through a later correction.
  • The applicant must file a certified copy of the priority document with the International Bureau within 16 months from the priority date, unless it was previously filed with the receiving Office.
  • If the priority document is issued by the receiving Office, the applicant can request that Office to prepare and transmit the document to the International Bureau.
  • The International Bureau will make the priority document available to designated Offices.
  • For U.S. national stage entry, if the certified copy was submitted during the international phase, it generally satisfies the requirement for the U.S. application.

The MPEP further notes: “If, however, the International Bureau is unable to forward a copy of the certified priority document because the applicant failed to submit a certified copy of the foreign priority document during the international phase, the applicant will need to provide a certified copy of the priority document or have the Office retrieve the priority application in accordance with the priority document exchange program during the national stage to fulfill the requirements of 37 CFR 1.55.”

For more information on certified copy, visit: certified copy.

The right of priority under 35 U.S.C. 386(a) and 386(b) applies to different types of applications. According to MPEP 213.07:

Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.

This means that 35 U.S.C. 386(a) allows a nonprovisional application to claim priority based on a prior international design application.

On the other hand, 35 U.S.C. 386(b) applies differently:

Pursuant to 35 U.S.C. 386(b) and 37 CFR 1.55, an international design application designating the United States may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 and the Hague Agreement and Regulations thereunder with respect to a prior foreign application, international application (PCT) designating at least one country other than the United States, or a prior international design application designating at least one country other than the United States.

Thus, 35 U.S.C. 386(b) allows an international design application designating the United States to claim priority based on various types of prior applications.

The key differences are:

  • 386(a) applies to nonprovisional applications claiming priority to international design applications.
  • 386(b) applies to international design applications claiming priority to foreign applications, PCT applications, or other international design applications.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on right of priority, visit: right of priority.

For international patent applications filed by non-inventor applicants, there are specific requirements outlined in 37 CFR 1.46(b):

If an application entering the national stage under 35 U.S.C. 371, or a nonprovisional international design application, is applied for by a person other than the inventor under paragraph (a) of this section, the assignee, person to whom the inventor is under an obligation to assign the invention, or person who otherwise shows sufficient proprietary interest in the matter must have been identified as the applicant for the United States in the international stage of the international application or as the applicant in the publication of the international registration under Hague Agreement Article 10(3).

This means that for PCT applications entering the U.S. national stage or for international design applications, the non-inventor applicant must have been properly identified as the applicant for the United States during the international phase or in the international registration publication.

To learn more:

The Priority Document Exchange (PDX) program allows for electronic transmission of priority documents between participating foreign intellectual property offices. According to 37 CFR 1.55(i), if the foreign application was filed in a participating office, the requirement for a timely filed certified copy is considered satisfied if the Office receives a copy through the PDX program during the pendency of the application and before the patent is granted.

How does the priority date work in a continuation-in-part application?

In a continuation-in-part (CIP) application, the priority date can vary for different parts of the application. According to MPEP 201.08:

“The disclosure presented in the continuation-in-part application may include subject matter in common with the earlier application and may include additional subject matter not disclosed in the earlier application. Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the earlier nonprovisional application are entitled to the benefit of the filing date of the earlier nonprovisional application.”

This means:

  • Subject matter carried over from the parent application retains the original filing date as its priority date
  • New matter added in the CIP has the filing date of the CIP as its priority date
  • Each claim in a CIP is evaluated individually to determine its effective filing date
  • Claims fully supported by the parent application get the earlier priority date
  • Claims relying on new matter get the later CIP filing date as their priority date

Understanding priority dates in CIPs is crucial for determining patentability and for defending against potential prior art references.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

The priority claim deadline for PCT applications entering the national stage in the U.S. differs from that of regular U.S. patent applications:

  • PCT National Stage Applications: For these applications, the priority claim must be made within the time limit set in the PCT and the Regulations under the PCT.
  • Regular U.S. Applications: The deadline is the later of four months from the actual U.S. filing date or sixteen months from the foreign priority date.

According to MPEP 214.01: “In an application that entered the national stage from an international application after compliance with 35 U.S.C. 371, the claim for priority must be made during the pendency of the application and within the time limit set forth in the PCT and the Regulations under the PCT.”

It’s crucial to understand these differences to ensure timely filing of priority claims in different application types.

To learn more:

The presence of reserved sections like MPEP 404 does not directly affect patent examination. These sections are placeholders and do not contain any substantive information or guidance for examiners. However, their existence may indirectly impact the examination process in the following ways:

  • They maintain consistent numbering in the MPEP, aiding navigation and referencing
  • They allow for future expansion of examination guidelines without major restructuring
  • They serve as potential indicators of areas where the USPTO may develop new policies or procedures

Patent examiners rely on active, non-reserved sections of the MPEP, current USPTO policies, and relevant laws and regulations to conduct examinations.

The presence of new matter in a continuation or divisional application can significantly affect its filing date. If new matter is found, the application may lose the benefit of the earlier filing date for the new subject matter.

According to MPEP ¶ 2.10.01:

“Applicant is required to delete the benefit claim or change the relationship (continuation or divisional application) to continuation-in-part because this application contains the following matter not disclosed in the prior-filed application:”

If the application is changed to a continuation-in-part, the new matter will have the filing date of the current application, while the previously disclosed matter retains the earlier filing date. This can have important implications for determining prior art and patent term.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For patent applications filed before September 16, 2012, the rules for granting power to inspect are slightly different. According to MPEP 104:

“For applications filed prior to September 16, 2012, if an executed oath or declaration pursuant to 37 CFR 1.63 or 1.497 has been filed, no person but the applicant (any one of joint applicants), an attorney or agent of record (if a power of attorney was filed), or an assignee whose assignment is of record will be permitted to have access to the file of any pending application kept in confidence under 35 U.S.C. 122(a), except as provided for under 37 CFR 1.11, 1.14, 41.6, or 42.412.”

This means that for older applications, access is more restricted once an oath or declaration has been filed, limiting it to the applicant, attorney or agent of record, or assignee of record, unless specific exceptions apply.

For more information on application access, visit: application access.

For more information on power to inspect, visit: power to inspect.

For more information on pre-AIA applications, visit: pre-AIA applications.

For applications filed on or after September 16, 2012, the power of attorney from a prior application may have effect in the continuing application under certain conditions. The MPEP states: 37 CFR 1.32(d) provides that a power of attorney from a prior national application for which benefit is claimed under 35 U.S.C. 120, 121, or 365(c) in a continuing application may have effect in the continuing application if a copy of the power of attorney from the prior application is filed in the continuing application unless: (1) The power of attorney was granted by the inventor; and (2) The continuing application names an inventor who was not named as an inventor in the prior application. It’s recommended to file a copy of the power of attorney in the continuing application in all situations to clarify the record.

To learn more:

The USPTO attempts to retrieve foreign applications for design applications through the PDX program where possible. Specifically for Spanish industrial design applications:

The Spanish Patent and Trademark Office deposits certain ES industrial design applications for access by the USPTO via the WIPO DAS. Therefore, when the applicant claims foreign priority to an ES industrial design application and provides the WIPO DAS access code, the USPTO will attempt retrieval via the WIPO DAS.

This means that applicants claiming priority to Spanish industrial design applications should provide the WIPO DAS access code to enable the USPTO to retrieve the application through the WIPO Digital Access Service (DAS).

The Patent Cooperation Treaty (PCT) system interacts with foreign priority claims in several important ways:

1. Priority claims in PCT applications:
– PCT applications can claim priority to earlier foreign applications under the Paris Convention.
– The priority period is 12 months from the earliest priority date.

2. PCT as a basis for priority:
– A PCT application can serve as the basis for a priority claim in a later-filed national or regional application.

3. Effect on time limits:
– The 30-month time limit for entering the national phase is calculated from the priority date (if claimed) or the PCT filing date if no priority is claimed.

4. Restoration of priority rights:
– The PCT system allows for restoration of priority rights if an international application is filed within 14 months of the priority date and the delay was unintentional.

5. Certified copies:
– The PCT system has provisions for providing certified copies of priority documents to designated offices.

As stated in MPEP 213.06: “In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT.”

The PCT system provides a streamlined process for seeking patent protection internationally while preserving priority rights, but applicants must be aware of the specific requirements and time limits within the PCT system.

How does the patent title affect search and classification?

The patent title plays a crucial role in search and classification processes. According to MPEP 606:

“The title of the invention … is used for classifying and searching.”

This means that:

  • A well-crafted title helps examiners and researchers find relevant prior art
  • It aids in properly classifying the invention within the patent system
  • An accurate title can expedite the examination process
  • It helps potential licensees or competitors discover the patent more easily

Therefore, creating a clear, concise, and descriptive title is essential not only for compliance but also for the practical aspects of patent searching and classification.

To learn more:

Tags: prior art

The Patent Law Treaties Implementation Act of 2012 (PLTIA) introduced several changes to nonprovisional application filings, effective December 18, 2013:

  • It amended 35 U.S.C. 111(a) to provide minimal formal requirements for obtaining a filing date.
  • For non-design applications, a filing date is granted when a specification (with or without claims) is received by the USPTO.
  • It allows for the delayed submission of claims and drawings, subject to certain conditions and potential surcharges.
  • It introduced the option to file an application by reference under 35 U.S.C. 111(c).

The MPEP states: Effective for applications filed on or after December 18, 2013, 37 CFR 1.53(b) was amended to implement the changes to 35 U.S.C. 111(a) and 35 U.S.C. 171 by the Patent Law Treaties Implementation Act of 2012 (PLTIA) (Public Law 112-211).

While these changes provide more flexibility in the filing process, it’s important to note that they don’t change the best practices for preparing and filing patent applications. Including a complete specification, claims, and drawings at the time of filing is still recommended to ensure compliance with disclosure requirements.

To learn more:

How does the patent examiner determine if a title change is necessary?

A patent examiner determines if a title change is necessary by evaluating whether the current title accurately reflects the claimed invention. According to MPEP 606.01, the examiner assesses if the title is “descriptive of the invention claimed.” If not, they will require a new title. The examiner considers several factors:

  • Does the title clearly indicate the nature of the invention?
  • Is it specific to the claimed subject matter?
  • Does it avoid overly broad or generic terms?
  • Is it brief yet informative?

If the examiner finds that the title doesn’t meet these criteria, they may request a change to ensure that the title accurately represents the invention as claimed in the application.

To learn more:

The patent examination process involves a back-and-forth between the examiner and the applicant. MPEP 203.03 describes a key part of this process:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action.

The general steps in the examination process are:

  1. The applicant files a nonprovisional application.
  2. The examiner reviews the application and issues an Office Action.
  3. The applicant responds to the Office Action, potentially with amendments.
  4. This process may repeat until the application is either allowed or finally rejected.

Each time the applicant responds with changes, the application becomes an ‘amended’ application as described in MPEP 203.03.

To learn more:

The Patent Cooperation Treaty (PCT) significantly impacts international patent applications. According to MPEP 213.01:

International applications filed under the Patent Cooperation Treaty (PCT) are considered to have been filed in any PCT contracting state of which the United States is one.

This means that a PCT application effectively serves as a placeholder for potential national phase entries in all PCT member countries. It provides applicants with additional time to decide in which countries they want to pursue patent protection, while securing an early filing date.

To learn more:

The Patent Cooperation Treaty (PCT) interacts with foreign priority claims as outlined in MPEP 213. The PCT allows applicants to file a single international patent application that can later enter the national phase in multiple countries.

Key points regarding PCT and foreign priority:

  • PCT applications can claim priority from earlier national or regional applications
  • The priority period for PCT applications is also 12 months from the earliest priority date
  • PCT applications themselves can serve as the basis for priority claims in subsequent national or regional applications

As stated in MPEP 213, “U.S. national applications may claim priority to an international application (PCT) filed in a PCT Receiving Office other than the United States Receiving Office.” This demonstrates the flexibility of the PCT system in international patent protection strategies.

The Patent and Trademark Office (PTO) generally does not directly handle patent ownership disputes. According to MPEP 301:

The Patent and Trademark Office is not the forum for resolving patent ownership disputes. Such disputes are to be settled by the parties involved, outside the Patent and Trademark Office.

If there’s a dispute over ownership, the PTO will typically continue to recognize the owner of record until a court order or other legal document resolving the dispute is presented. Parties involved in ownership disputes should seek legal counsel and resolve the matter through appropriate legal channels.

How does the Paris Convention affect the filing deadline for U.S. nonprovisional applications?

The Paris Convention plays a crucial role in determining the filing deadline for U.S. nonprovisional applications claiming priority to foreign applications. The MPEP explains:

“Under the Paris Convention, the right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design, filed in a country signatory to the Convention.” (MPEP 213.03)

Key points about the Paris Convention’s impact on filing deadlines:

  • It establishes a 12-month priority period for utility patents and plant patents.
  • For design patents, it provides a 6-month priority period.
  • The priority period starts from the filing date of the earliest foreign application.
  • It applies to applications filed in any country that is a member of the Paris Convention.

This international agreement ensures that inventors have a reasonable timeframe to file patent applications in multiple countries while maintaining the priority date of their original filing. It’s crucial for applicants to be aware of these deadlines when planning their international patent strategy.

To learn more:

How does the Paris Convention affect priority claims in US patent applications?

The Paris Convention plays a crucial role in international priority claims for US patent applications. According to MPEP 216:

‘The right of priority is based on the Paris Convention for the Protection of Industrial Property, which is adhered to by the United States.’

The Paris Convention affects US patent applications in the following ways:

  • It allows applicants to claim priority from foreign applications filed in member countries
  • It establishes a 12-month priority period for utility patents and a 6-month period for design patents
  • It ensures that filing an application in one member country does not invalidate the novelty of the invention in other member countries

The implementation of the Paris Convention in US law is found in 35 U.S.C. 119(a)-(d), which outlines the requirements for claiming foreign priority.

For more information on foreign priority, visit: foreign priority.

For more information on international patent applications, visit: international patent applications.

For more information on Paris Convention, visit: Paris Convention.

How does the Paris Convention affect international patent applications designating the United States?

The Paris Convention plays a significant role in international patent applications designating the United States. According to MPEP 211.01(c):

‘International applications, which designate the United States, that are filed on or after November 29, 2000, are subject to the provisions of the Patent Cooperation Treaty (PCT). International applications, which designate the United States, that are filed before November 29, 2000, are subject to the provisions of both the PCT and the Paris Convention for the Protection of Industrial Property.’

This means that for applications filed on or after November 29, 2000, the PCT rules govern, while earlier applications must comply with both PCT and Paris Convention provisions. The Paris Convention ensures certain rights, such as a 12-month priority period, for patent applicants across member countries, facilitating the international protection of inventions.

To learn more:

How does the oath or declaration work in divisional applications?

In divisional applications, the oath or declaration process is simplified to reduce the burden on applicants. According to MPEP 201.06(c):

37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) that contains the subject matter described in the prior nonprovisional application, provided a copy of the executed oath or declaration filed in the prior nonprovisional application is submitted.

Key points about the oath or declaration in divisional applications:

  • A new oath or declaration is not required if the divisional application contains the same subject matter as the parent application.
  • A copy of the executed oath or declaration from the parent application can be submitted.
  • The copy must show the USPTO seal or stamp indicating it was received.
  • If the inventorship changes, a new oath or declaration may be required.

This provision under 37 CFR 1.63(d) streamlines the filing process for divisional applications while ensuring proper inventorship documentation.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

How does the oath or declaration requirement differ for divisional applications?

For divisional applications, the oath or declaration requirement can be simplified under certain conditions. According to MPEP 201.06(c):

“The divisional application may be filed under 37 CFR 1.53(b) using all or part of a copy of the oath or declaration filed in the prior nonprovisional application under 37 CFR 1.63(d), as long as the oath or declaration is still applicable to the subject matter of the divisional application.”

This means that if the original oath or declaration from the parent application still covers the subject matter in the divisional application, it can be reused. However, if new matter is introduced or the inventors change, a new oath or declaration may be required.

For more information on Divisional application, visit: Divisional application.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent filing, visit: patent filing.

The oath or declaration requirements for continuation applications differ significantly depending on whether they were filed before or after September 16, 2012:

  • For applications filed on or after September 16, 2012: The inventor’s oath or declaration must comply with the requirements of 35 U.S.C. 115 as revised effective September 16, 2012. It must state that the inventor (1) is an original inventor of the claimed invention, and (2) authorized the filing of the patent application for the claimed invention. It must also contain an acknowledgment of penalties for willful false statements.
  • For applications filed before September 16, 2012: Applicants could file either a newly executed oath or declaration, or a copy of the oath or declaration from the prior application, along with a statement requesting deletion of names of non-inventors for the continuation application.

The MPEP states:

For applications filed on or after September 16, 2012, to claim the benefit of a prior application under 35 U.S.C. 120, 121, 365(c), or 386(c) applicant must include a reference to the prior application in compliance with 37 CFR 1.78(d)(2) in an application data sheet.

This change reflects the America Invents Act’s modifications to U.S. patent law.

For more information on America Invents Act, visit: America Invents Act.

For more information on continuation application, visit: continuation application.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent application requirements, visit: patent application requirements.

The Manual of Patent Examining Procedure (MPEP) addresses the issue of unavailable joint inventors for applications filed on or after September 16, 2012, in section 409.02. This section provides guidance on how to proceed when a joint inventor is unavailable or unwilling to participate in the patent application process.

Key points from MPEP 409.02 include:

  • Joint inventors must apply for a patent jointly and each must make an inventor’s oath or declaration.
  • If a joint inventor refuses to join or cannot be found after diligent effort, the other joint inventor(s) may proceed with the application.
  • A substitute statement can be executed in lieu of an oath or declaration from the unavailable inventor.

For applications filed before September 16, 2012, different procedures apply, which are covered in MPEP § 409.03 et seq.

To learn more:

To learn more:

The guidance in MPEP 409.03(f) specifically addresses the issue of continuation-in-part (CIP) applications in relation to assignments. According to MPEP 409.03(f):

“An assignment of an application and any ‘reissue, division, or continuation of said application’ does not itself establish an assignment of a continuation-in-part application. In re Gray, 115 USPQ 80 (Comm’r Pat. 1956).”

This means that even if an original application has been assigned, and that assignment includes language covering continuations and divisions, it does not automatically cover a continuation-in-part application. This is because a CIP application, by definition, contains new matter not present in the original application.

When dealing with a CIP application under pre-AIA 37 CFR 1.47(b), applicants need to ensure that the assignment or proof of proprietary interest specifically covers the new matter included in the CIP. A new assignment or demonstration of proprietary interest may be necessary for the portions of the CIP that were not present in the original application.

To learn more:

To learn more:

Tags: pre-AIA

Micro entity status does not automatically carry over to continuation or divisional applications. A new certification is required for each new application:

  1. A new assertion of entitlement to micro entity status is required for any continuation, divisional, or continuation-in-part application.
  2. This applies even if micro entity status was properly claimed in the parent application.
  3. The new certification must be filed in the continuing application.

The MPEP states: The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

It’s important to note that this requirement for a new certification applies specifically to micro entity status. For small entity status, a new assertion is also required, but the rules are slightly different.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

The inventorship requirements for continuation applications differ based on whether they were filed before or after September 16, 2012:

  • For applications filed on or after September 16, 2012: The inventorship is determined by the information provided in the application data sheet (ADS) filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If no ADS is filed, the inventorship is set by the copy of the inventor’s oath or declaration from the earlier-filed application, unless accompanied by a statement signed under 37 CFR 1.33(b) specifying the correct inventorship.
  • For applications filed before September 16, 2012: The inventorship was generally set by the copy of the executed oath or declaration from the prior application, unless accompanied by a statement requesting deletion of the names of persons who are not inventors in the continuation application.

The MPEP states for post-AIA applications:

37 CFR 1.63(d)(2) provides that the inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application.

These changes reflect the America Invents Act’s modifications to U.S. patent law, simplifying the process for correcting inventorship in many cases.

For more information on America Invents Act, visit: America Invents Act.

For more information on continuation application, visit: continuation application.

For more information on inventorship, visit: inventorship.

For more information on patent application requirements, visit: patent application requirements.

The inventorship of an international application entering the national stage under 35 U.S.C. 371 is determined according to 37 CFR 1.41(e), which states:

The inventorship of an international application entering the national stage under 35 U.S.C. 371 is the inventor or joint inventors set forth in the application data sheet in accordance with § 1.76 filed with the initial submission under 35 U.S.C. 371.

This means that applicants can change inventorship as to the U.S. at the time of national stage entry by simply filing an application data sheet naming the inventor or joint inventors with the initial submission under 35 U.S.C. 371.

If no application data sheet is provided, the inventorship is the inventor or joint inventors set forth in the international application, including any changes made under PCT Rule 92bis. It’s important to note that 37 CFR 1.41(e) does not allow naming inventors via the inventor’s oath or declaration if an application data sheet is not provided.

To learn more:

The inventorship of a divisional application must include at least one inventor named in the parent application, but it doesn’t have to be identical. The MPEP states:

The inventorship in the divisional application must include at least one inventor named in the prior-filed application, and the divisional application must claim the benefit of the prior-filed application under 35 U.S.C. 120, 121, 365(c), or 386(c).

If the divisional application is filed with fewer inventors than the parent application, a statement may be filed requesting deletion of the names of the additional inventors. For applications filed on or after September 16, 2012, the statement must be filed with the divisional application and signed by a party set forth in 37 CFR 1.33(b).

To learn more:

The inventorship in a Continued Prosecution Application (CPA) is generally the same as in the prior application, unless a specific request is made to change it. According to 37 CFR 1.53(d)(4):

The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If a change in inventorship is desired, a statement requesting the deletion of the names of non-inventors must be filed with the CPA request. This statement must be signed by a person authorized under 37 CFR 1.33(b). For applications filed on or after September 16, 2012, any request to add an inventor must be in the form of a request under 37 CFR 1.48.

The inventorship in a continuing application can be the same as or different from the prior application, depending on the circumstances:

  1. For applications filed on or after September 16, 2012, the inventorship is determined by the application data sheet or the copy of the oath/declaration from the earlier-filed application.
  2. If the continuing application names a new joint inventor, they must provide a new oath or declaration.

The MPEP states: 37 CFR 1.63(d)(2) provides that the inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application. If an application data sheet is not filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application, the inventorship is the inventorship set forth in the copy of the inventor’s oath or declaration from the earlier-filed application, unless it is accompanied by a statement signed pursuant to 37 CFR 1.33(b) stating the name of each inventor in the continuing application.

For applications filed before September 16, 2012, different rules apply regarding the deletion or addition of inventors in continuing applications.

For more information on application data sheet, visit: application data sheet.

For more information on declaration, visit: declaration.

For more information on inventorship, visit: inventorship.

For more information on oath, visit: oath.

The inventorship in a Continued Prosecution Application (CPA) is directly related to the parent application. As stated in MPEP 201.06(d):

‘The inventorship in a CPA filed under 37 CFR 1.53(d) is the same as in the prior application.’

This means that when you file a CPA, you are essentially continuing the same application with the same inventors. However, it’s important to note that if there are any changes to inventorship required, they must be made through the appropriate procedures, such as filing a request under 37 CFR 1.48. Any such changes should be made promptly to ensure the accuracy of the patent application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on parent application, visit: parent application.

The inventorship in a Continued Prosecution Application (CPA) automatically carries over from the prior application, unless specific steps are taken to change it. As stated in the MPEP:

“The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA. 37 CFR 1.53(d)(4).”

If an inventor needs to be added or deleted, a request under 37 CFR 1.48 must be filed, along with the required fee. The examiner will notify the applicant if there are any inventorship discrepancies in the first Office action.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on patent filing, visit: patent filing.

Incorporation by reference for foreign priority applications is an important safeguard for applicants. Here’s how it works:

  • For applications filed on or after September 21, 2004, a claim under 37 CFR 1.55 for priority of a prior-filed foreign application is considered an incorporation by reference of the prior-filed foreign priority application.
  • This incorporation is subject to the conditions and requirements of 37 CFR 1.57(b).
  • It applies to inadvertently omitted material from the foreign priority application.
  • Applicants can provide an explicit incorporation by reference statement for broader coverage.

The MPEP states: For applications filed on or after September 21, 2004, a claim under 37 CFR 1.55 for priority of a prior-filed foreign application that was present on the filing date of the application is considered an incorporation by reference of the prior-filed foreign priority application as to inadvertently omitted material, subject to the conditions and requirements of 37 CFR 1.57(b). This provision helps protect applicants from accidental omissions in their U.S. applications.

To learn more:

How does the IDS requirement differ for continuation-in-part applications?

For continuation-in-part (CIP) applications, the Information Disclosure Statement (IDS) requirements have some specific considerations. According to MPEP 609.02:

‘For continuation-in-part applications, applicant should submit an information disclosure statement complying with the content requirements of 37 CFR 1.98 at the time of filing of the continuation-in-part application.’

This means that for CIP applications:

  • A new IDS should be submitted with the CIP application filing
  • The IDS should include all information material to patentability of the newly added subject matter
  • Previously cited information from the parent application should be re-cited if it’s still material to the claims in the CIP

It’s important to note that the duty of disclosure extends to the new subject matter introduced in the CIP, so applicants should be thorough in their IDS submissions for these types of applications.

To learn more:

How does the government’s march-in rights affect contractor-owned inventions?

The government’s march-in rights are a significant aspect of federally sponsored research and development contracts. As outlined in MPEP 310:

“The government has the right to require the contractor to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant(s) upon terms that are reasonable under the circumstances, if the contractor fails to take effective steps to achieve practical application of the invention.”

March-in rights allow the government to intervene if:

  • The contractor fails to commercialize the invention within a reasonable time.
  • Action is necessary to alleviate health or safety needs.
  • Action is necessary to meet requirements for public use specified by federal regulations.
  • The contractor has breached agreements specified in 35 U.S.C. 204 regarding U.S. manufacture.

These rights ensure that inventions resulting from federally funded research benefit the public, even if the contractor fails to do so effectively.

For more information on contractor-owned inventions, visit: contractor-owned inventions.

For more information on federally sponsored research, visit: federally sponsored research.

The Government License Rights statement, as required by 35 U.S.C. 202(c)(6) and described in MPEP 310, does not transfer ownership of the patent to the government. Instead, it acknowledges that:

“The government has certain rights in the invention.”

These rights typically include:

  • A non-exclusive, non-transferable, irrevocable, paid-up license to practice or have practiced the invention for or on behalf of the United States throughout the world
  • March-in rights, allowing the government to require the contractor to grant licenses to third parties under certain circumstances
  • The right to receive periodic reports on the utilization of the invention

While the contractor retains ownership and the right to commercialize the invention, they must operate within the framework of these government rights.

How does the filing date of new matter in a CIP application affect patent rights?

n

The filing date of new matter in a continuation-in-part (CIP) application significantly affects patent rights. According to MPEP 201.08:

n

“Matter disclosed in the parent application is entitled to the benefit of the filing date of the parent application. Matter disclosed for the first time in the continuation-in-part application does not receive the benefit of the filing date of the parent application.”

n

This means:

n

    n

  • The new matter in a CIP is treated as having the filing date of the CIP application itself.
  • n

  • This later filing date can impact the assessment of prior art and the determination of patentability for the new matter.
  • n

  • It may affect the patent term for claims based on the new matter.
  • n

  • In some cases, it could make the new matter more vulnerable to challenges based on intervening prior art.
  • n

n

Therefore, inventors and patent attorneys must carefully consider the timing and content of CIP applications to maximize patent protection.

For more information on new matter, visit: new matter.

For more information on patent rights, visit: patent rights.

For more information on prior art, visit: prior art.

The filing date of a divisional application can affect the patent term in several ways:

  1. 20-year term: The 20-year patent term is calculated from the earliest U.S. filing date to which the divisional application claims priority. This means that the term of a patent issued on a divisional application will generally be shorter than that of its parent application.
  2. Patent Term Adjustment (PTA): The divisional application may be eligible for PTA based on delays in its own prosecution, but not for delays in the prosecution of its parent application.
  3. Terminal Disclaimer: If there’s a risk of obviousness-type double patenting, a terminal disclaimer may be required, potentially limiting the term of the divisional patent to that of the parent patent.

The MPEP 201.06(c) does not directly address patent term, but it’s important to consider these factors when filing a divisional application. For more details on patent term, refer to MPEP 2701.

For more information on Divisional application, visit: Divisional application.

For more information on patent term, visit: patent term.

For more information on patent term adjustment, visit: patent term adjustment.

The filing date of a Continued Prosecution Application (CPA) is determined by the date on which a proper request for a CPA is filed. Specifically, the MPEP states:

The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed.

It’s important to note that the CPA request must be on a separate paper. If the request is not on a separate paper, it will not be considered a proper CPA request and will not receive a filing date.

For more information on patent applications, visit: patent applications.

For more information on USPTO procedures, visit: USPTO procedures.

The filing date of a Continued Prosecution Application (CPA) is determined differently from other types of patent applications. For a CPA, the filing date is the date on which a request for a CPA is filed on a separate paper.

The MPEP states: The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed.

This means that unlike regular applications where the filing date is typically the date all required components are received, a CPA’s filing date is based solely on when the CPA request is submitted, provided it meets the necessary requirements.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

The filing of a Continued Prosecution Application (CPA) has significant effects on the prior application:

  • The CPA is considered a request to expressly abandon the prior application as of the filing date of the CPA
  • The prior application is automatically abandoned in favor of the CPA
  • The filing date of the CPA is the date on which the request for the CPA is filed

As stated in the MPEP: The filing date of a continued prosecution application is the date on which a request on a separate paper for an application under this paragraph is filed. An application filed under this paragraph:… (v) Is a request to expressly abandon the prior application as of the filing date of the request for an application under this paragraph.

For more information on patent applications, visit: patent applications.

The filing date of a Continued Prosecution Application (CPA) is important for priority claims and patent term calculations. Key points include:

  • The filing date of a CPA is the date on which the CPA request is received by the USPTO
  • A CPA is automatically considered a specific reference under 35 U.S.C. 120 to the prior application
  • The CPA is entitled to the benefit of the filing date of the prior application
  • Priority claims from the parent application automatically carry over to the CPA

As stated in MPEP 201.06(d): A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. That is, the CPA includes the request for an application under 37 CFR 1.53(d) and the recitation of the application number of the prior application in such request is the ‘specific reference to the earlier filed application’ required by 35 U.S.C. 120.

For more information on benefit claims, visit: benefit claims.

For more information on patent term, visit: patent term.

The filing date of a Continued Prosecution Application (CPA) has important implications for its priority claim. According to MPEP 201.06(d):

The filing date of a CPA is the date on which a request on a separate paper for an application under 37 CFR 1.53(d) is filed. A request for a CPA is not entitled to the benefit of a Certificate of Mailing or Transmission under 37 CFR 1.8.

This means that:

  • The CPA’s filing date is the actual date the USPTO receives the CPA request.
  • This date cannot be backdated using a Certificate of Mailing or Transmission.
  • The CPA automatically receives the benefit of the filing date of the prior application.
  • Any foreign priority or domestic benefit claims made in the prior application are automatically carried forward to the CPA.

It’s crucial to understand that while the CPA maintains the priority claims of the prior application, its actual filing date is the date of receipt by the USPTO, which can affect certain statutory deadlines and prior art considerations.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

How does the filing date of a continuation-in-part application affect patent rights?

The filing date of a continuation-in-part (CIP) application can significantly affect patent rights, particularly for the new matter added. According to MPEP 201.08:

“The effective filing date of a claimed invention in a continuation-in-part application is determined on a claim-by-claim basis and is dependent upon the sufficiency of the disclosure in the parent application(s) to support the claimed invention.”

This means:

  • Claims fully supported by the parent application may benefit from the earlier filing date.
  • Claims relying on newly added matter in the CIP will have the filing date of the CIP as their effective date.
  • The later filing date for new matter can affect patentability if relevant prior art emerges between the parent and CIP filing dates.

It’s crucial to carefully consider the timing and content of a CIP to maximize patent protection and avoid potential issues with prior art.

For more information on effective filing date, visit: effective filing date.

For more information on patent rights, visit: patent rights.

The filing date of a continuation application can significantly affect its patent term. While the continuation application gets the benefit of the earlier filing date for prior art purposes, its actual filing date is used to calculate the patent term. According to MPEP 201.07:

The filing date of a continuation application is the filing date of the parent application.

However, this refers to the priority date for prior art purposes. The actual patent term is calculated from the filing date of the continuation application itself. Here’s how it works:

  • The patent term is generally 20 years from the filing date of the earliest non-provisional application to which priority is claimed.
  • For a continuation application, this means 20 years from the filing date of the parent non-provisional application.
  • Each continuation in a chain reduces the effective patent term.

It’s crucial to consider this when deciding whether to file a continuation or a new application, as it can impact the overall protection period for your invention.

For more information on continuation application, visit: continuation application.

For more information on patent priority, visit: patent priority.

For more information on patent term, visit: patent term.

The filing date of a patent application can affect the prosecution rights of assignees. MPEP 106.01 distinguishes between applications filed before and after September 16, 2012:

  • For applications filed before September 16, 2012: See MPEP § 324 for information on prosecution by the assignee.
  • For applications filed on or after September 16, 2012: See MPEP § 325 for details on prosecution by the assignee.

The MPEP states: “For information pertaining to prosecution by the assignee, see MPEP § 324 (for applications filed before September 16, 2012) and MPEP § 325 (for applications filed on or after September 16, 2012).”

This distinction is important because the America Invents Act, which went into effect on September 16, 2012, introduced changes to patent law that affected assignee rights and procedures.

For more information on America Invents Act, visit: America Invents Act.

For more information on patent law changes, visit: patent law changes.

When dealing with foreign language documents in an Information Disclosure Statement (IDS), the examiner follows specific guidelines as outlined in MPEP 609.05(b):

Foreign language documents cited on an information disclosure statement will be considered in view of the concise explanation submitted and insofar as it is understood on its face, e.g., drawings, chemical formulas, in the same manner that non-English language information in the specification is considered.

Key points for handling foreign language documents:

  • The examiner will consider the concise explanation provided with the document.
  • Visual elements like drawings and chemical formulas will be considered.
  • The document will be treated similarly to non-English information in the specification.
  • If no concise explanation is provided, the examiner may not fully consider the document’s relevance.

To learn more:

To learn more:

How does the Electronic Priority Document Exchange (PDX) program work with the USPTO?

The Electronic Priority Document Exchange (PDX) program is a system that allows participating intellectual property offices to exchange priority documents electronically. According to MPEP 215.01, the USPTO participates in this program, which can simplify the process of submitting certified copies of foreign priority applications.

The MPEP states: The USPTO has agreements with the European Patent Office (EPO) and the Japan Patent Office (JPO) that enable the USPTO to obtain certified copies of foreign applications filed in those offices from their electronic records management systems.

Here’s how the PDX program works with the USPTO:

  • If a foreign application was filed with a participating office (e.g., EPO or JPO), the applicant can request that office to make the certified copy of the priority document available to the USPTO.
  • The applicant must submit a request to retrieve the priority document through the USPTO’s electronic filing system (EFS-Web or Patent Center).
  • The USPTO will then attempt to retrieve the document electronically from the foreign office.
  • If successful, this electronic retrieval satisfies the requirement to file a certified copy of the foreign priority application.

It’s important to note that the applicant is still responsible for ensuring that the certified copy is received by the USPTO within the required time frame, even when using the PDX program.

The effective filing date for claims in a continuation-in-part (CIP) application can vary depending on the content of the claims. According to MPEP 201.08:

The effective filing date of a claimed invention in a continuation-in-part application is determined on a claim-by-claim basis and is dependent upon the sufficiency of the disclosure in the earlier application(s) to support the claimed invention with 35 U.S.C. 112(a) except for the best mode requirement.

This means:

  • Claims that are fully supported by the earlier application(s) get the benefit of the earlier filing date(s).
  • Claims that rely on newly added matter in the CIP have the filing date of the CIP as their effective filing date.

It’s crucial for patent applicants to carefully consider the implications of adding new matter in a CIP, as it can affect the priority date and potentially impact patentability.

To learn more:

To learn more:

The disclosure requirements for claiming the benefit of provisional and nonprovisional applications differ in some aspects:

Provisional Applications (35 U.S.C. 119(e)):

For a nonprovisional application to claim the benefit of a provisional application:

  • The written description and drawings (if any) of the provisional application must adequately support and enable the subject matter claimed in the nonprovisional application.
  • A claim is not required in the provisional application.

Nonprovisional Applications (35 U.S.C. 120, 121, 365(c), or 386(c)):

For continuation and divisional applications:

  • The disclosure must be the same as the prior-filed application.
  • No new matter can be added.

For continuation-in-part applications:

  • New matter may be included.
  • Only claims supported by the prior-filed application are entitled to the earlier filing date.

As stated in MPEP 211.05:

“Under 35 U.S.C. 120, a claim in a U.S. application is entitled to the benefit of the filing date of an earlier filed U.S. application if the subject matter of the claim is disclosed in the manner provided by 35 U.S.C. 112(a) except for the best mode requirement, in the earlier filed application.”

This requirement applies to both provisional and nonprovisional applications, ensuring that the earlier application provides proper support for the claimed invention.

To learn more:

The Digital Access Service (DAS) plays a significant role in international design applications:

  • DAS facilitates the exchange of priority documents between participating offices.
  • For applications filed in DAS-participating offices, the International Bureau can retrieve priority documents directly.
  • This eliminates the need for applicants to submit certified copies in many cases.
  • Applicants should ensure their priority claims are properly recorded in the international registration.

MPEP 213.07 states: Where the foreign application was filed in a participating office, the International Bureau will attempt to obtain the priority document from the participating office. This streamlined process through DAS enhances efficiency in handling priority documents for international design applications.

To learn more:

The death of an inventor can have significant implications for power of attorney in a patent application. According to MPEP 409.01(a):

Unless a power of attorney is coupled with an interest (i.e., a patent practitioner is assignee or part-assignee), the death of an inventor who is an applicant party terminates the power of attorney given by the deceased inventor in an application filed on or after September 16, 2012.

This means that in most cases, when an inventor who is also an applicant dies, any power of attorney they had given is automatically terminated. As a result:

  • If the deceased inventor was the sole inventor-applicant, a new power of attorney is necessary.
  • If all powers of attorney in the application have been terminated due to the inventor’s death, a new power of attorney is required.
  • The new power of attorney must come from the heirs, administrators, executors, or assignees of the deceased inventor.

It’s important for legal representatives and other parties involved in the patent application to be aware of this and take appropriate action to ensure the application can continue to be prosecuted effectively.

To learn more:

How does the copendency requirement affect claiming benefit of a prior application?

The copendency requirement is a critical factor in claiming the benefit of a prior application. MPEP 211.01(b) states: To be entitled to the benefit of the filing date of an earlier-filed application, the later-filed application must be copending with the earlier application.

Copendency means:

  • The later application must be filed before the patenting or abandonment of the prior application.
  • There must be no gap in pendency between the applications in the chain.

If copendency is not maintained, the benefit claim to the earlier application will be lost. This can significantly impact the effective filing date of the later application, potentially affecting its patentability.

For detailed information on copendency, refer to MPEP 211.01(b) and 35 U.S.C. 120.

Provisional and nonprovisional applications have different content requirements. According to MPEP 601:

  • Provisional applications do not require claims or an oath or declaration.
  • Nonprovisional applications must include at least one claim and an oath or declaration.

The MPEP states: ‘A provisional application must also include the cover sheet required by 37 CFR 1.51(c)(1), which may be an application data sheet (37 CFR 1.76), or a cover letter identifying the application as a provisional application. Otherwise, the application will be treated as a nonprovisional application filed under 37 CFR 1.53(b).’

It’s crucial to understand these differences to ensure proper filing and to avoid unintended treatment of your application.

To learn more:

The Certificate of Mailing or Transmission can significantly affect the timeliness of USPTO submissions. According to MPEP 512:

“The date indicated on the Certificate of Mailing or Transmission will be used by the Office as the date of receipt of the paper or fee.”

This means that even if there are delays in postal or electronic transmission, your submission will be considered timely if the certificate date is within the required deadline. However, it’s important to note that the actual mailing or transmission must occur on or before the certificate date. False certificates can lead to serious consequences, including invalidation of the submission and potential disciplinary action.

To learn more:

The Certificate of Mailing or Transmission can affect filing date calculations in several ways:

  1. For timely filing: If a paper with a certificate is received after a deadline but the certificate date is within the deadline, the paper is considered timely filed. The MPEP states: “If the date stated is within the period for reply, the reply in most instances will be considered to be timely.”
  2. For actual receipt date: The USPTO will continue to stamp the actual date of receipt on all papers. According to the MPEP: “The receipt date stamped on all papers will also be the date which is entered on Office records and from which any subsequent periods are calculated.”
  3. For subsequent deadlines: If a paper starts a new period for reply, that period is calculated from the actual receipt date, not the certificate date. For example: “If the last day to reply to a final Office action was November 10, 2014, and applicant deposited a Notice of Appeal with fee in the U.S. mail on November 10, 2014, and so certified, that appeal is timely even if it was not received in the U.S. Patent and Trademark Office until November 12, 2014. Since the date of receipt of the notice of appeal will be used to calculate the time at which the brief is due, the brief was due on January 12, 2015.”

It’s important to note that while the certificate can establish timely filing, it doesn’t change the actual receipt date for other USPTO processing purposes.

For applications filed before the America Invents Act (AIA), the best mode requirement affects benefit claims by requiring that the prior-filed application disclose the best mode contemplated by the inventor for carrying out the invention. According to MPEP 211.05:

‘The disclosure of the prior-filed application must provide adequate support and enablement for the claimed subject matter of the later-filed application in compliance with the requirements of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, except for the best mode requirement.

However, it’s important to note that while the best mode requirement is not applied to benefit claims for applications filed on or after September 16, 2012 (the effective date of the AIA), it still applies to applications filed before this date. For pre-AIA applications, failure to disclose the best mode in the prior-filed application could result in the loss of the benefit claim if it is determined that the best mode was not carried forward to the later-filed application.

To learn more:

The benefit claim process for national stage applications entering from an international application under 35 U.S.C. 371 has some specific timing requirements that differ from regular applications filed under 35 U.S.C. 111(a). The MPEP states:

“If the application is a nonprovisional application entering the national stage from an international application under 35 U.S.C. 371, the reference to the prior application must be made during the pendency of the application and within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f), four months from the date of the initial submission under 35 U.S.C. 371 to enter the national stage, or sixteen months from the filing date of the prior application.”

Key differences for national stage applications include:

  • The time period for submitting the benefit claim starts from the date the national stage commenced or the date of initial submission to enter the national stage.
  • There are three possible deadlines, and the applicant can use the latest of these:
    1. Four months from the date the national stage commenced
    2. Four months from the date of the initial submission to enter the national stage
    3. Sixteen months from the filing date of the prior application

It’s important to carefully track these dates for national stage applications to ensure timely submission of benefit claims.

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on national stage application, visit: national stage application.

The Bayh-Dole Act, as implemented in 37 CFR Part 401, significantly affects government rights in federally funded inventions:

  • It allows contractors (including small businesses and nonprofit organizations) to retain title to inventions made under federally funded research and development contracts.
  • The government receives a nonexclusive, nontransferable, irrevocable, paid-up license to practice the invention.
  • The Act encourages the commercialization of federally funded inventions while protecting the government’s interests.

As stated in the MPEP: ‘The Bayh-Dole Act… provides, in essence, that nonprofit organizations and small business firms may retain title to inventions made under federally funded research and development contracts.’

For more information on Bayh-Dole Act, visit: Bayh-Dole Act.

The Background of the Invention, specifically the Field of Invention part, can relate to the Cooperative Patent Classification (CPC) in the following way:

According to MPEP 608.01(c), “This statement may include a paraphrasing of the applicable Cooperative Patent Classification (CPC) definitions.” This means that when describing the field of the invention, applicants can use the CPC definitions as a guide to accurately and comprehensively describe the technical field to which their invention pertains.

Using CPC definitions can help ensure that the Field of Invention is described in a way that aligns with standardized classification systems, potentially making it easier for patent examiners to understand and classify the invention.

To learn more:

The assignment process for continuations-in-part (CIPs) differs from other application types due to the potential inclusion of new subject matter. The MPEP § 306.01 explains:

If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein. This is similar to the practice with respect to continuations-in-part filed under 35 U.S.C. 120.

In essence:

  • For continuations and divisions that contain only subject matter from the parent application, the original assignment usually remains effective.
  • For CIPs or applications with new subject matter not in the parent or provisional application, new assignment papers are typically required, with the exception noted for applications filed on or after September 16, 2012, where the assignee is the original applicant.

This difference reflects the unique nature of CIPs, which introduce new matter not present in the parent application.

The assignment process for continuation-in-part (CIP) applications claiming benefit of a provisional application differs from standard continuations or divisions:

  • If the CIP includes new subject matter not in the provisional application, new assignment papers are typically required.
  • This requirement is similar to the practice for CIPs filed under 35 U.S.C. 120.
  • An exception exists for applications filed on or after September 16, 2012, where the assignee is the original applicant in the CIP.

MPEP § 306.01 states: If an application claiming the benefit of the earlier filing date of a provisional application includes subject matter that is not common with subject matter of the provisional application, new assignment papers must be recorded for the application claiming the benefit of the provisional application, unless the later application is filed on or after September 16, 2012 and the assignee is the original applicant therein. This is similar to the practice with respect to continuations-in-part filed under 35 U.S.C. 120.

This approach ensures that the assignment covers all subject matter in the CIP, including new material not present in the provisional application.

To learn more:

The assignment of a priority right can significantly impact patent applications. According to MPEP 216:

‘The right of priority is a personal right of the applicant or his successor in title. It may be transferred to the extent and subject to the conditions provided for in the statutes.’

Key points about the assignment of priority rights:

  • Priority rights can be transferred separately from the application itself.
  • The assignment must be executed before filing the later application claiming priority.
  • An assignment of the entire right, title, and interest in an application includes the right of priority.
  • Partial assignments of priority rights are possible but must be clearly documented.

Proper assignment of priority rights is crucial for maintaining the earlier effective filing date, which can be critical for patentability and avoiding prior art rejections.

For more information on effective filing date, visit: effective filing date.

The application filing limit for micro entity status works as follows:

  • An applicant must not have been named as an inventor on more than 4 previously filed patent applications
  • This limit excludes provisional applications, foreign applications, and PCT applications where the basic national fee was not paid
  • Applications filed as a result of previous employment where rights were assigned don’t count towards the limit

MPEP 509.04(a) clarifies: ‘It does not matter how long ago the previous applications were filed or whether the previously filed applications are pending, patented, or abandoned; they are still included when counting to determine whether the application filing limit has been reached.’

The Application Data Sheet (ADS) plays an important role in establishing and changing inventorship in patent applications:

  • The ADS should include inventor information, including legal name, residence, and mailing address of each inventor.
  • The naming of inventorship is governed by 37 CFR 1.41.
  • Changes to inventorship or the names of inventors are governed by 37 CFR 1.48.
  • In case of inconsistencies, the most recent submission will generally govern, except for inventorship issues.

37 CFR 1.76(d)(1) states: “The naming of the inventorship is governed by § 1.41 and changes to inventorship or the names of the inventors is governed by § 1.48.”

It’s important to note that while the ADS is used to provide inventor information, any changes to inventorship must comply with the specific requirements of 37 CFR 1.48, which may require additional documentation beyond just updating the ADS.

To learn more:

The America Invents Act (AIA) significantly affected assignee rights in patent applications, particularly for those filed on or after September 16, 2012. MPEP 106.01 highlights one key change:

‘…for applications filed on or after September 16, 2012, [the assignee] can prosecute the application after becoming the applicant under 37 CFR 1.46.’

This change allows assignees of the entire interest to take a more active role in patent prosecution by becoming the applicant. The AIA aimed to modernize the U.S. patent system and align it more closely with international practices.

For more detailed information on how the AIA affects assignee rights, refer to MPEP § 325 for applications filed on or after September 16, 2012.

The America Invents Act’s (AIA) first-inventor-to-file (FITF) provision has significant implications for perfecting foreign priority claims, especially in cases where the foreign application has a pre-March 16, 2013 filing date. Key points include:

  • If a patent was examined under FITF provisions, but the foreign priority application has a pre-AIA filing date, perfecting the priority claim may require further examination.
  • In such cases, a certificate of correction is not sufficient, and a reissue application is necessary.
  • This situation arises because changing the effective filing date could potentially subject the patent to a different statutory framework.

The MPEP states: In situations where further examination would be required, the petition should not be granted. For example, further examination would be required where grant of the petition would cause the patent to be subject to a different statutory framework, e.g., where the foreign application has a pre-March 16, 2013 filing date in a patent that was examined under the first inventor to file (FITF) provisions of the AIA.

This requirement ensures that patents are not inadvertently subjected to different legal standards without proper examination.

How does the AIA impact power of attorney for applications filed before September 16, 2012?

The America Invents Act (AIA) does not significantly change the power of attorney requirements for applications filed before September 16, 2012. As stated in MPEP 402.02(b):

For applications filed before September 16, 2012, all parties having the right to prosecute the application at the time of filing the power of attorney must act together in appointing a power of attorney.

This means that the pre-AIA rules continue to apply for these older applications. However, it’s important to note that any new applications filed on or after September 16, 2012, are subject to the updated AIA rules regarding power of attorney.

To learn more:

How does the AIA FITF system affect the prior-filed application requirements?

The America Invents Act (AIA) First Inventor to File (FITF) system has introduced some changes to the prior-filed application requirements. The MPEP explains:

“AIA 35 U.S.C. 120, 121, 365(c), and 386(c) require that the prior-filed application to which benefit is claimed must name the inventor or a joint inventor named in the later-filed application as the inventor or a joint inventor.”

Key points to note:

  • The prior application must name at least one common inventor with the later-filed application.
  • This requirement applies to applications filed on or after September 16, 2012.
  • For applications filed before this date, the prior application must name the inventor(s) named in the later-filed application.

These changes ensure that the benefit claim aligns with the FITF system’s focus on the first inventor to file. For more information, refer to MPEP 211.01 and USPTO AIA FITF Guidance.

To learn more:

To learn more:

How does the AIA FITF system affect priority claims in patent applications?

The America Invents Act (AIA) First-Inventor-to-File (FITF) system, which went into effect on March 16, 2013, significantly impacted how priority is determined for patent applications. According to MPEP 210:

The AIA converted the U.S. patent system from a ‘first to invent’ system to a ‘first inventor to file’ system. Specifically, the changes to 35 U.S.C. 102 and 103 in the AIA apply to any patent application subject to the first inventor to file provisions of the AIA.

Key effects of the AIA FITF system on priority claims include:

  • The effective filing date of a claimed invention is crucial for determining prior art.
  • Applications filed on or after March 16, 2013, are subject to FITF provisions.
  • Transitional applications (those with claims to pre-AIA and post-AIA effective filing dates) may be subject to both systems.
  • Priority claims must be carefully evaluated to determine which system applies to each claim.

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

For more information on FITF, visit: FITF.

How does the AIA first-inventor-to-file system affect benefit claims?

The America Invents Act (AIA) introduced the first-inventor-to-file system, which has significant implications for benefit claims. While the MPEP 211.01 doesn’t directly address this, it’s an important consideration for applicants. Here’s how it affects benefit claims:

  • Effective Filing Date: The effective filing date of a claimed invention is crucial under the AIA system. It’s determined by the earliest application in the priority chain that describes the claimed invention.
  • Prior Art: The prior art date is now based on the effective filing date, making proper benefit claims even more critical.
  • Grace Period: The one-year grace period for disclosures by the inventor is now measured from the effective filing date.
  • Continuation and CIP Applications: These applications can still claim benefit to earlier applications, but the effective filing date for each claim is determined individually based on when its subject matter was first disclosed in the application chain.

For more information on the AIA and its impact on patent applications, refer to MPEP 2151 and the USPTO’s AIA FAQ page.

To learn more:

How does the AIA First Inventor to File system affect priority claims?

The America Invents Act (AIA) introduced the First Inventor to File (FITF) system, which has significant implications for priority claims. Under the AIA:

  • Applications filed on or after March 16, 2013, are subject to the FITF provisions.
  • Priority claims can still be made to earlier applications, but the effective filing date is crucial for determining prior art.
  • The effective filing date is the earlier of:
    1. The actual filing date of the application, or
    2. The filing date of the earliest application for which benefit or priority is claimed and which describes the subject matter.

As stated in MPEP 210: “The AIA provides that the right of priority and the benefit of an earlier filing date are available to a claim only if that claim is supported by the prior-filed application to which priority or benefit is claimed.”

This means that each claim in a later-filed application must be fully supported by the prior-filed application to receive its priority date. Applicants must carefully consider the content of their priority applications when making claims in subsequent filings.

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

How does the AIA change the process for applications with deceased or incapacitated inventors?

The America Invents Act (AIA) introduced significant changes to the patent application process, including how applications with deceased or legally incapacitated inventors are handled. According to MPEP 409.01(a):

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign the invention, or who otherwise shows sufficient proprietary interest in the matter, to make the application for patent.”

Key changes under the AIA include:

  • Allowing assignees or those with sufficient proprietary interest to file applications
  • Introduction of the substitute statement to replace inventor oaths in certain circumstances
  • Simplified process for continuing prosecution when an inventor becomes unavailable
  • Removal of the need for heirs or legal representatives to expressly petition to file on behalf of a deceased inventor

These changes streamline the application process and provide more flexibility when dealing with situations involving deceased or incapacitated inventors, making it easier for the remaining inventors or interested parties to pursue patent protection.

To learn more:

How does the AIA change joint inventorship requirements?

The America Invents Act (AIA) introduced significant changes to joint inventorship requirements:

  • Elimination of ‘without deceptive intention’: The AIA removed the requirement that joint inventors make their respective contributions ‘without deceptive intention.’ This simplifies the inventorship determination process.
  • Broader inventorship criteria: The AIA expanded the definition of joint inventorship, allowing for more flexibility in determining who qualifies as a joint inventor.
  • Changes to oath or declaration: The AIA modified the requirements for inventor’s oath or declaration, impacting how joint inventors are identified and verified in patent applications.

As stated in MPEP 602.09: ‘The AIA eliminated the requirement that each joint inventor make their contribution jointly with the other joint inventors.’

To learn more:

How does the AIA affect priority claims for applications filed on or after March 16, 2013?

The America Invents Act (AIA) significantly changed the U.S. patent system, particularly affecting priority claims for applications filed on or after March 16, 2013. According to MPEP 216:

“AIA 35 U.S.C. 100(i)(1)(B) provides that the effective filing date for a claimed invention in a patent or application for patent (other than a reissue application or reissued patent) is the filing date of the earliest application for which the patent or application is entitled to claim a right of foreign priority or domestic benefit.”

This change means that:

  • The effective filing date can now include foreign priority dates, not just domestic benefit dates.
  • The first-to-file system replaced the first-to-invent system for determining priority.
  • Prior art is now determined based on the effective filing date, including foreign priority dates.

These changes have significant implications for inventors and patent practitioners in terms of strategy for filing applications and claiming priority, especially in a global context.

For more information on America Invents Act, visit: America Invents Act.

For more information on effective filing date, visit: effective filing date.

For more information on foreign priority, visit: foreign priority.

The addition of new matter in a continuation-in-part (CIP) application can significantly affect priority claims. Here’s how:

  • Claims that are fully supported by the parent application retain the parent’s filing date.
  • Claims that rely on the new matter added in the CIP receive the filing date of the CIP application.

The MPEP 201.08 states: The disclosure presented in the continuation-in-part application may include subject matter in common with or vary from that of the prior application. This means that each claim in a CIP must be evaluated individually to determine its effective filing date, which can impact prior art considerations and the validity of the patent.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

The abstract and the specification serve different purposes in a patent application. While the specification provides a detailed description of the invention, the abstract offers a brief overview. According to MPEP 608.01(b):

The abstract is a brief narrative of the disclosure as a whole, as concise as the disclosure permits, in a single paragraph preferably not exceeding 150 words, commencing on a separate sheet following the claims.

Key differences include:

  • Length: The abstract is limited to 150 words, while the specification can be much longer
  • Purpose: The abstract provides a quick overview, while the specification offers detailed description
  • Content: The abstract summarizes key points, while the specification includes comprehensive details
  • Legal weight: The specification is part of the patent, while the abstract is not typically used for interpreting the scope of claims

Both elements are crucial, but they serve distinct roles in communicating your invention.

To learn more:

The 6-month rule for foreign filing licenses states that:

  • After 6 months from the filing date of a US application, a foreign filing license is no longer required for that subject matter.
  • This automatic license occurs unless a Secrecy Order has been imposed on the application.
  • The rule is based on 35 U.S.C. 184 and 37 CFR 5.11(e)(2).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

The ‘unintentional’ delay standard is crucial in evaluating petitions for delayed benefit claims. According to MPEP 211.04:

While the Director may require additional information whenever there is a question of whether the delay was unintentional, a person filing a petition to accept a delayed benefit claim more than two years after the date the benefit claim was due is required to provide additional explanation of the circumstances surrounding the delay that establishes that the entire delay was unintentional.

This requirement is in addition to the standard statement of unintentional delay. For further discussion on the ‘unintentional’ delay standard, refer to MPEP § 711.03(c).

For more information on unintentional delay, visit: unintentional delay.

The ‘first foreign application’ rule states that the priority period is calculated from the earliest foreign filing, with some exceptions. This means:

  • Priority can only be claimed to the first application filed for the invention.
  • If multiple foreign applications were filed, only the earliest can serve as the basis for priority.
  • Applications filed in non-recognized countries are disregarded for priority purposes.

The MPEP provides an example: If an inventor has filed an application in France on October 4, 1981, and an identical application in the United Kingdom on March 3, 1982, and then files in the United States on February 2, 1983, the inventor is not entitled to the right of priority at all; the inventor would not be entitled to the benefit of the date of the French application since this application was filed more than twelve months before the U.S. application, and the inventor would not be entitled to the benefit of the date of the United Kingdom application since this application is not the first one filed. (MPEP 213.03)

To learn more:

The ‘Detailed Description’ section of a patent application is closely tied to the enablement requirement, which is a fundamental principle in patent law. According to MPEP 608.01(g):

“This detailed description… must be in such particularity as to enable any person skilled in the pertinent art or science to make and use the invention without involving extensive experimentation”

This statement directly addresses the enablement requirement, which demands that:

  • The description must be detailed enough for a person skilled in the relevant field to make and use the invention.
  • It should not require ‘extensive experimentation’ to implement the invention.
  • The level of detail should be commensurate with the complexity of the technology.

The enablement requirement, codified in 35 U.S.C. § 112(a), ensures that the patent disclosure is sufficient to justify the grant of exclusive rights. A detailed description that fails to meet the enablement requirement can result in rejection of the patent application or invalidation of an issued patent.

For more information on enablement, refer to MPEP § 2164, which provides comprehensive guidance on this crucial aspect of patent law.

To learn more:

Tags: patent law

Taiwan’s unique political status has implications for patent priority claims in US applications. According to MPEP 213.01:

‘Applicants from Taiwan may claim priority under 35 U.S.C. 119(a)-(d) to applications filed in Taiwan which are filed by or on behalf of the governing authority on Taiwan.’

This special provision allows Taiwanese applicants to claim priority despite Taiwan not being officially recognized as a sovereign state by the United States. The MPEP further clarifies:

Applications from Taiwan must meet the following criteria to be eligible for priority claims:

  • The application must be filed by or on behalf of the governing authority on Taiwan
  • The priority claim must be made in accordance with the standard procedures outlined in 35 U.S.C. 119(a)-(d)

This arrangement ensures that inventors and companies in Taiwan can participate in the international patent system and maintain priority rights for their inventions when seeking protection in the United States.

Submitting documents as evidence in a reply to an Office action is distinct from filing an information disclosure statement (IDS). The MPEP clarifies:

“Compliance with the information disclosure rules is not a threshold requirement to have information considered when submitted by applicant to support an argument being made in a reply to an Office action.”

When submitting documents as evidence, applicants don’t need to comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98. However, if the same documents are also listed on an IDS form (e.g., PTO/SB/08), the applicant must comply with IDS rules for those documents to be considered as part of the IDS.

To learn more:

Small entity status does not automatically carry over from a parent application to a continuation application. The MPEP provides clear guidance on this matter:

If small entity status has been established in a parent application and is still proper and desired in a continuation, continuation-in-part, or divisional application filed under 37 CFR 1.53(b), a new assertion as to the continued entitlement to small entity status under 37 CFR 1.27 is required.

This means that applicants must take specific steps to maintain small entity status in a continuation application:

  1. Review Eligibility: Ensure that the applicant still qualifies for small entity status under the current rules.
  2. New Assertion: File a new assertion of entitlement to small entity status in the continuation application.
  3. Timing: This assertion should be made at the time of filing the continuation application or with the first fee payment.

It’s important to note that improperly claiming small entity status can have serious consequences, including the patent being held unenforceable. Therefore, applicants should carefully review their status before making a new assertion in a continuation application.

For micro entity status, the requirements are even more stringent:

The refiling of an application under 37 CFR 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under 37 CFR 1.53(d) (design applications only)), requires a new certification of entitlement to micro entity status in the continuing application.

Applicants should be diligent in properly asserting and maintaining their entity status throughout the patent application process, including when filing continuation applications.

For more information on continuation application, visit: continuation application.

For more information on patent fees, visit: patent fees.

When a power of attorney is revoked, it affects pending applications as follows:

  • The revocation is effective upon receipt in the USPTO.
  • It applies to all pending applications in which the attorney or agent was appointed, unless specifically limited.
  • The Office will not communicate further with the revoked attorney/agent.
  • The applicant must appoint a new representative or correspond directly with the Office.

As stated in MPEP 402.05: ‘A power of attorney may be revoked at any stage in the proceedings of a case.’ This means the revocation can occur at any point during the patent application process.

To learn more:

When a power of attorney is revoked, it’s important to understand its impact on pending amendments in a patent application. According to MPEP 402.05:

Any amendments made in an application after the filing date of the application will not be effective to revoke a power of attorney.

This means that if an applicant submits an amendment to revoke a power of attorney after the application’s filing date, that amendment will not be effective in revoking the power of attorney. To properly revoke a power of attorney, the applicant must follow the specific procedures outlined in the MPEP, such as submitting a separate revocation document or a new power of attorney.

To learn more:

Restriction requirements can affect joint inventorship in patent applications. The MPEP explains:

If an application by joint inventors includes more than one independent and distinct invention, restriction may be required with the possible result of a necessity to change the inventorship named in the application if the elected invention was not the invention of all the originally named inventors.

In such cases:

  • A ‘divisional’ application complying with 35 U.S.C. 120 would be entitled to the benefit of the earlier filing date of the original application.
  • Examiners should remind applicants to correct inventorship under 37 CFR 1.48 if an invention is elected and claims to the invention of one or more inventors are canceled.

This process ensures that the correct inventors are named for each distinct invention in the case of a restriction requirement.

To learn more:

To learn more:

Proper identification of foreign priority applications is particularly important for electronic priority document exchange programs. The MPEP emphasizes this point:

Proper identification of priority applications is essential to establishing accurate and complete relationships among various patent documents, especially in the context of electronic priority document exchange programs

The impact on electronic priority document exchange programs includes:

  • Facilitating accurate matching of priority documents with corresponding applications
  • Ensuring efficient retrieval and processing of priority documents
  • Reducing errors and delays in the priority document exchange process
  • Supporting the integrity of international patent filing systems

Accurate identification helps streamline the electronic exchange process, benefiting both applicants and patent offices involved in international patent procedures.

To learn more:

The PDX system has specific procedures for handling international applications filed under the Patent Cooperation Treaty (PCT). According to MPEP 215.01:

The USPTO will automatically attempt retrieval of international applications filed under the PCT where the receiving office is RO/AU, RO/DK, RO/ES, RO/FI, RO/IB, RO/MA or RO/SE and the applicant has provided the required WIPO DAS access code for the international application to which foreign priority is claimed.

Key points for PCT applications:

  • Automatic retrieval attempts are made for certain PCT applications.
  • Applies to applications filed with receiving offices: RO/AU, RO/DK, RO/ES, RO/FI, RO/IB, RO/MA, or RO/SE.
  • The applicant must provide the WIPO DAS access code for the international application.
  • This process streamlines priority document retrieval for eligible PCT applications.

Applicants should ensure they provide the necessary WIPO DAS access code to facilitate this automatic retrieval process.

To learn more:

PDX for U.S. design applications has specific considerations, as explained in MPEP 215.01:

The USPTO will attempt retrieval of foreign applications to which priority is claimed in a U.S. design application where possible. The Spanish Patent and Trademark Office deposits certain ES industrial design applications for access by the USPTO via the WIPO DAS. Therefore, when the applicant claims foreign priority to an ES industrial design application and provides the WIPO DAS access code, the USPTO will attempt retrieval via the WIPO DAS.

Key points for design applications:

  • The USPTO attempts to retrieve foreign priority documents for design applications where possible.
  • Spanish industrial design applications are accessible through WIPO DAS.
  • Applicants must provide the WIPO DAS access code for Spanish industrial design applications.
  • The USPTO will attempt retrieval via WIPO DAS when the access code is provided.

This process helps streamline the priority document retrieval for design applications, particularly those with Spanish priority.

To learn more:

Paying a small entity fee has significant implications for certifying small entity status. According to MPEP 509.03(a), “Consistent with 37 CFR 1.4(d)(4), the payment of a small entity basic filing or national fee constitutes a certification under 37 CFR 11.18(b).” This means that simply paying the small entity fee, even without a specific written assertion, activates the self-certification requirement. Applicants should be aware that this payment invokes the certification provisions, regardless of whether they are a practitioner or non-practitioner.

To learn more:

Tags: patent fees

For pre-AIA patent applications (filed before September 16, 2012), partial assignees have specific rights and requirements when it comes to patent ownership and prosecution. According to MPEP 324:

A partial assignee is any assignee of record having less than the entire right, title and interest in the application. Where at least one inventor retains an ownership interest together with the partial assignee(s), the combination of all partial assignees and inventors retaining ownership interest is needed to conduct the prosecution of an application.

This means that if there are multiple partial assignees or a combination of partial assignees and inventors, they must act together to prosecute the application. Additionally, when establishing ownership:

  • Each partial assignee must provide a submission under pre-AIA 37 CFR 3.73(b).
  • The extent of each assignee’s interest must be clearly stated.
  • The Office must be able to determine if it has obtained action by all of the right, title, and interest holders.

If the extent of ownership is not clear, the USPTO may refuse to accept the submission as an establishment of ownership interest.

For more information on joint ownership, visit: joint ownership.

For more information on partial assignees, visit: partial assignees.

For more information on pre-AIA applications, visit: pre-AIA applications.

When an application is filed with informal drawings, the Office of Patent Application Processing (OPAP) will review the drawings to determine if they can be used for publication purposes. If the drawings are not acceptable for publication purposes, OPAP will object to the drawings and require corrected drawings within a set time period, usually two months. This objection does not affect the filing date of the application, and applicants can correct the drawings later in the examination process if needed.

How does new matter in a continuation-in-part application affect priority dates?

The introduction of new matter in a continuation-in-part (CIP) application has significant implications for priority dates. According to MPEP 201.08:

“The new matter in a continuation-in-part application is not entitled to the benefit of the filing date of the parent application.”

This means:

  • Subject matter carried over from the parent application retains the parent’s filing date as its priority date
  • New matter introduced in the CIP has the filing date of the CIP as its priority date
  • Different claims within the same CIP application may have different priority dates

This distinction is crucial for determining prior art and potential patent infringement cases. Inventors and patent practitioners must carefully consider the implications of adding new matter when filing a CIP application.

For more information on new matter, visit: new matter.

Tags: new matter

How does new matter in a continuation-in-part affect prior art considerations?

The introduction of new matter in a continuation-in-part (CIP) application significantly affects prior art considerations. According to the MPEP 201.08:

Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the prior-filed application are entitled to the benefit of the filing date of the prior-filed application.

This means:

  • Claims based on new matter have the filing date of the CIP as their effective filing date.
  • Prior art that predates the CIP filing but postdates the parent application can be used against claims based on new matter.
  • Claims fully supported by the parent application retain the earlier effective filing date for prior art purposes.

Patent examiners must carefully analyze each claim to determine its effective filing date and apply the appropriate prior art. Applicants should be aware that introducing new matter may expose some claims to a broader range of prior art, potentially affecting patentability.

For more information on effective filing date, visit: effective filing date.

For more information on new matter, visit: new matter.

For more information on prior art, visit: prior art.

How does new matter in a continuation-in-part affect patent rights?

New matter introduced in a continuation-in-part (CIP) application can significantly affect patent rights. According to MPEP 201.08, “Matter not disclosed in the parent nonprovisional application is entitled only to the filing date of the continuation-in-part application.”

This means:

  • New matter is only entitled to the filing date of the CIP application itself.
  • This later filing date can impact the assessment of prior art for the new matter.
  • Patent term for claims based on new matter may be calculated from the CIP filing date.
  • Different parts of the CIP application may have different priority dates, affecting patentability and enforcement.

It’s crucial for inventors and patent practitioners to carefully consider the implications of adding new matter in a CIP, as it can affect the scope and strength of patent protection.

For more information on new matter, visit: new matter.

For more information on patent rights, visit: patent rights.

The treatment of new matter varies depending on the type of continuing application:

  • Continuation and Divisional Applications: Must not contain any new matter. The disclosure must be the same as the prior application.
  • Continuation-in-Part (CIP) Applications: Can include new matter not disclosed in the parent application.
  • Continued Prosecution Applications (CPAs): Cannot contain new matter.

For continuation and divisional applications, the MPEP states: “The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.”

For CIPs, the MPEP notes: “A continuation-in-part is an application… repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.”

If new matter is found in a continuation or divisional application, the examiner will require the applicant to delete the benefit claim or change the application to a continuation-in-part. For CPAs, any new matter introduced will be required to be canceled.

It’s important to note that claims in a CIP application that rely on new matter will only be entitled to the filing date of the CIP, not the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

How does MPEP 608.04(a) define ‘new matter’ in patent applications?

MPEP 608.04(a) defines new matter as any content added to the specification, claims, or drawings after the application filing date that was not present on the original filing date. Specifically, the MPEP states: “Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.” This definition is crucial for patent applicants and examiners to understand what constitutes acceptable additions or amendments to a patent application after it has been filed.

To learn more:

To learn more:

MPEP 409.03(f) provides guidance on handling patent applications when an inventor is deceased or legally incapacitated. The section states:

‘When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or assignee on compliance with the foregoing provisions.’

This means that in cases of a deceased inventor, the patent can still be issued to their legal representative or assignee, provided they comply with the requirements for proving proprietary interest. For legally incapacitated inventors, similar provisions apply, allowing the legal guardian or other authorized representative to act on behalf of the inventor in patent matters.

It’s important to note that in these situations, additional documentation such as death certificates or court orders establishing legal guardianship may be required to establish the authority of the person acting on behalf of the inventor.

To learn more:

To learn more:

MPEP 402.08 has significant implications for patent attorneys involved in derivation proceedings. The key provision states:

While an application is involved in an interference or derivation proceeding, any power of attorney of or revocation of power of attorney should be forwarded to the Patent Trial and Appeal Board for consideration.

For patent attorneys, this means:

  • Any changes in representation must go through the PTAB, not regular USPTO channels.
  • There may be delays in processing power of attorney changes due to PTAB review.
  • Attorneys must be prepared to justify changes in representation to the PTAB if necessary.
  • The timing of representation changes may be influenced by the ongoing derivation proceeding.

Patent attorneys should be aware of these special procedures to ensure smooth transitions in representation during derivation proceedings.

To learn more:

To learn more:

MPEP 318 provides clear guidance to patent examiners on how to handle assignment documents. The section states:

“Assignment documents submitted for recording should not be placed directly in application or patent files, but should be forwarded to Assignment Division for recording.”

This instruction serves to:

  • Remind examiners not to include assignment documents in the main application file
  • Direct examiners to forward any received assignment documents to the Assignment Division
  • Ensure that the proper procedures for recording assignments are followed
  • Maintain the separation between technical examination and ownership recording

By following this guidance, patent examiners help maintain the integrity of both the application files and the assignment records.

MPEP 310 is closely related to the Bayh-Dole Act, officially known as the Patent and Trademark Law Amendments Act. Here’s how they are connected:

  • The Bayh-Dole Act allows contractors to retain title to inventions made with federal funding.
  • It requires contractors to disclose these inventions and include a statement in patent applications about government support.
  • MPEP 310 provides specific guidance on implementing the Bayh-Dole Act’s requirements, particularly the government license rights statement.
  • The statutory basis for MPEP 310 is 35 U.S.C. 202(c)(6), which is part of the Bayh-Dole Act.

In essence, MPEP 310 serves as a practical guide for patent applicants to comply with the Bayh-Dole Act’s provisions regarding government-funded inventions.

According to MPEP 201.01, original applications are defined as follows:

‘Original applications include applications filed under 35 U.S.C. 111(a) and provisional applications filed under 35 U.S.C. 111(b).’

This definition encompasses two distinct types of applications:

  • Non-provisional applications filed under 35 U.S.C. 111(a)
  • Provisional applications filed under 35 U.S.C. 111(b)

Understanding this distinction is crucial for inventors and patent practitioners when deciding which type of application to file based on their specific needs and circumstances.

For more information on patent filing, visit: patent filing.

MPEP 201.01 provides a clear definition of a national application in the context of U.S. patent law. According to MPEP 201.01:

‘A national application is one that was filed in the United States Patent and Trademark Office (USPTO) under 35 U.S.C. 111(a), an application which entered the national stage from an international application after compliance with 35 U.S.C. 371, or a reissue application filed under 35 U.S.C. 251.’

This definition encompasses three main categories:

  1. Applications filed directly with the USPTO under 35 U.S.C. 111(a)
  2. International applications that have entered the national stage in the U.S. after complying with 35 U.S.C. 371
  3. Reissue applications filed under 35 U.S.C. 251

Understanding this definition is crucial for patent applicants and practitioners to determine the appropriate filing procedures and requirements for their inventions.

For more information on 35 U.S.C. 111(a), visit: 35 U.S.C. 111(a).

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

For more information on USPTO, visit: USPTO.

The MPEP 201 defines a provisional application for patent as follows:

“A provisional application for patent is a U.S. national application filed in the USPTO under 35 U.S.C. 111(b). It allows filing without a formal patent claim, oath or declaration, or any information disclosure (prior art) statement.”

Key features of a provisional application include:

  • It provides the means to establish an early effective filing date in a later filed nonprovisional patent application.
  • It allows the term “Patent Pending” to be applied in connection with the description of the invention.
  • It has a pendency lasting 12 months from the date the provisional application is filed.
  • The 12-month pendency period cannot be extended.

Provisional applications are often used by inventors to quickly secure a filing date while they continue to develop their invention or seek funding.

For more information on 12-month pendency, visit: 12-month pendency.

For more information on early filing date, visit: early filing date.

For more information on provisional application, visit: provisional application.

Limited recognition in international patent applications is addressed in 37 CFR 11.9(c), which states:

An individual not registered under § 11.6 may, if appointed by an applicant, prosecute an international patent application only before the United States International Searching Authority and the United States International Preliminary Examining Authority, provided that the individual has the right to practice before the national office with which the international application is filed as provided in PCT Art. 49, Rule 90 and § 1.455 of this subchapter, or before the International Bureau when the USPTO is acting as Receiving Office pursuant to PCT Rules 83.1bis and 90.1.

This means that unregistered individuals may represent applicants in certain phases of international patent applications under specific conditions. For more detailed information:

  • See MPEP § 1807 for representation in international applications (PCT)
  • See MPEP § 2911 for representation in international design applications

To learn more:

How does licensing affect small entity status?

Licensing can significantly impact small entity status. According to MPEP 509.03:

An applicant or patentee is not considered a small entity if any rights in the invention have been assigned, granted, conveyed, or licensed to an entity that would not qualify for small entity status.

This means:

  • If a small entity licenses rights to a large entity, small entity status is lost.
  • Exclusive licenses generally result in loss of small entity status.
  • Non-exclusive licenses may not affect status if they don’t convey all significant rights.

It’s crucial to review all licensing agreements before claiming small entity status. Any change in licensing that affects status must be reported to the USPTO promptly.

To learn more:

Licensing can significantly impact small entity status for patent fees. The MPEP provides specific guidance on this matter:

Rights conveyed by an applicant or patentee to a Government agency are not considered to be license for purposes of this paragraph. A Government agency includes any agency of the Federal Government or military department of the Government.

This means that licensing to a government agency does not affect small entity status. However, licensing to other entities can impact your status:

  • If you license rights to a large entity, you may lose your small entity status.
  • Exclusive licenses to large entities typically disqualify you from small entity status.
  • Non-exclusive licenses may not affect your status, depending on the terms.

It’s crucial to review any licensing agreements carefully and consult with a patent attorney to determine how they might affect your small entity status.

To learn more:

Tags: patent fees

How does licensing affect small entity status for a business concern?

Licensing can significantly impact a business concern’s eligibility for small entity status. According to MPEP 509.02:

“Rights to an invention are considered as assigned, granted, conveyed, or licensed when they are held by an entity other than the inventor, and they are not qualified for small entity status.”

This means that if a business concern has licensed rights to the invention to any person or entity that does not qualify as a small entity, it may lose its small entity status. Specifically:

  • If the business has licensed rights to a large entity, it cannot claim small entity status.
  • Exclusive licenses to large entities will disqualify the business from small entity status.
  • Non-exclusive licenses may not affect small entity status if they are arms-length agreements.

It’s crucial for businesses to carefully consider the impact of licensing agreements on their small entity status before entering into such arrangements.

To learn more:

How does licensing affect micro entity status eligibility?

Licensing can significantly impact an applicant’s eligibility for micro entity status. According to the MPEP:

“The applicant has not assigned, granted, or conveyed, nor is under an obligation by contract or law to assign, grant, or convey, a license or other ownership interest in the application concerned to an entity that, in the calendar year preceding the calendar year in which the applicable fee is being paid, had a gross income, as defined in section 61(a) of the Internal Revenue Code of 1986, exceeding 3 times the median household income for that preceding calendar year, as most recently reported by the Bureau of the Census.”

This means that if you’ve licensed or are obligated to license your application to a high-income entity (exceeding 3 times the median household income), you may not be eligible for micro entity status. It’s crucial to consider any existing or potential licensing agreements when determining your eligibility.

To learn more:

Tags: micro entity

When an inventor becomes legally incapacitated before filing a patent application and executing the required oath or declaration, a legal representative must be appointed to act on their behalf. According to 37 CFR 1.43 (pre-AIA):

“In case an inventor is insane or otherwise legally incapacitated, the legal representative (guardian, conservator, etc.) of such inventor may make the necessary oath or declaration, and apply for and obtain the patent.”

The legal representative, typically appointed by a court of competent jurisdiction, can then execute the oath or declaration and proceed with the patent application process on behalf of the incapacitated inventor.

To learn more:

How does joint ownership work for patents?

Joint ownership in patents occurs when two or more parties share ownership rights. The MPEP 301 provides guidance on this:

‘In the case of joint owners, each joint owner has the right to make, use, offer for sale, and sell the patented invention without the consent of and without accounting to the other owners.’

This means that each joint owner has full rights to use and profit from the patent independently, without needing permission from the other owners. However, this can lead to complications, especially in licensing or selling the patent, as all joint owners typically need to agree on such actions. It’s often advisable for joint owners to have a written agreement outlining their rights and responsibilities.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

Joint ownership in patents and patent applications occurs when two or more parties share ownership rights. According to MPEP 301:

“Joint inventors are treated as joint owners of the invention unless there is an assignment.”

Key aspects of joint ownership include:

  • Each joint owner has the right to make, use, sell, and license the invention without consent from other owners.
  • Profits do not need to be shared unless there’s a specific agreement.
  • All joint owners must agree to sell or assign the entire patent to a third party.
  • In infringement suits, all joint owners must be joined as plaintiffs.

It’s important for joint owners to have clear agreements in place to avoid potential conflicts and ensure proper management of the patent rights.

For more information on joint inventors, visit: joint inventors.

For more information on joint ownership, visit: joint ownership.

For more information on patent rights, visit: patent rights.

For more information on USPTO, visit: USPTO.

Inventorship in a Continued Prosecution Application (CPA) generally carries over from the prior application, but there are some important considerations:

  • The inventive entity of the CPA is automatically the same as the prior application unless a statement is filed requesting deletion of inventors
  • A statement requesting deletion of inventors must be filed with the CPA request and signed by a person authorized under 37 CFR 1.33(b)
  • New inventors cannot be added simply by naming them in the CPA transmittal letter or a new oath/declaration
  • To add new inventors, a request under 37 CFR 1.48 must be filed, including the required fee

The MPEP states: The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

If an inventor is named in the CPA who was not in the prior application, the examiner will notify the applicant using form paragraph 2.33:

It is noted that [1] identified as a named inventor in the Continued Prosecution Application (CPA) filed under 37 CFR 1.53(d) on [2], but no request under 37 CFR 1.48, as is required, was filed to correct the inventorship.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent applications, visit: patent applications.

In a Continued Prosecution Application (CPA), the inventorship is typically the same as in the prior application. However, if a new inventor needs to be added, a specific process must be followed. According to MPEP ¶ 2.33:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48. Otherwise, the inventorship in the CPA shall be the same as in the prior application.

This means that if you want to add a new inventor to a CPA, you must file a formal request under 37 CFR 1.48, which outlines the procedures for correcting or changing inventorship in patent applications.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Tags: CPA, inventorship

Inventorship in a continuing application depends on the type of continuing application and when it was filed. Key points:

  • For applications filed on or after September 16, 2012, the inventorship is initially the inventor(s) named in the application data sheet
  • For earlier applications, the inventorship carries over from the parent application
  • In a continuation or divisional, the inventorship must include at least one inventor named in the parent application
  • In a continuation-in-part, new inventors can be added to cover new matter
  • Inventorship can be corrected if needed using procedures under 37 CFR 1.48

For CPAs filed on or after September 16, 2012, the MPEP states: The inventorship of a continuing application filed under 35 U.S.C. 111(a) is the inventor or joint inventors specified in the application data sheet filed before or concurrently with the copy of the inventor’s oath or declaration from the earlier-filed application.

If the inventorship needs to be changed, a request under 37 CFR 1.48 must be filed.

For more information on application data sheet, visit: application data sheet.

For more information on continuing applications, visit: continuing applications.

For more information on inventorship, visit: inventorship.

Inventorship is a crucial aspect of continuation applications. According to MPEP 201.07:

The inventorship in the continuation application must include at least one inventor named in the prior-filed application…

This requirement ensures a clear line of continuity between the parent application and the continuation application. Key points to consider:

  • At least one inventor from the parent application must be included in the continuation application.
  • Additional inventors can be added to the continuation application if they contributed to the claimed invention.
  • Inventors from the parent application who did not contribute to the claims in the continuation application can be removed.
  • Changes in inventorship must be properly documented and may require an oath or declaration from new inventors.

For Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), there are additional inventorship requirements:

In addition, a continuation or divisional application may only be filed under 37 CFR 1.53(d) if the prior application is a nonprovisional design application, but not an international design application, that is complete as defined by 37 CFR 1.51(b) (except for the inventor’s oath or declaration if the CPA is filed on or after September 16, 2012), and the prior nonprovisional application contains an application data sheet indicating the name, residence, and mailing address of each inventor.

Always consult with a patent attorney when dealing with inventorship issues in continuation applications to ensure compliance with USPTO requirements.

For more information on application data sheet, visit: application data sheet.

Incorporation by reference can be an important tool in continuation applications, allowing applicants to include material from prior applications. The MPEP provides detailed guidance on this topic:

For applications filed on or after September 21, 2004:

An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are “hereby incorporated by reference.” The statement must appear in the specification.

Additionally, for these applications:

For applications filed on or after September 21, 2004, a claim under 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.78(d) for benefit of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States that was present on the filing date of the continuing application is considered an incorporation by reference of the prior-filed application as to inadvertently omitted material, subject to the conditions and requirements of 37 CFR 1.57(b).

For applications filed before September 21, 2004:

The incorporation by reference statement could appear in the application transmittal letter or in the specification.

It’s important to note that incorporation by reference cannot be used to add new matter to an application after its filing date. The MPEP states:

An incorporation by reference statement added after an application’s filing date is not effective because no new matter can be added to an application after its filing date (see 35 U.S.C. 132(a)).

Proper use of incorporation by reference can help applicants maintain continuity between related applications and potentially recover from certain filing errors.

For more information on 37 cfr 1.57, visit: 37 cfr 1.57.

For more information on continuation application, visit: continuation application.

For more information on incorporation by reference, visit: incorporation by reference.

How does government funding affect small entity status?

Government funding can impact small entity status, particularly for universities and small businesses. The MPEP 509.03 provides guidance:

A small business concern or nonprofit organization is not disqualified as a small entity because of a license to the Federal government pursuant to 35 U.S.C. 202(c)(4).

This means:

  • Receiving government funding does not automatically disqualify an entity from small entity status.
  • The government’s license rights under the Bayh-Dole Act do not negate small entity status.
  • However, other types of government agreements or contracts might affect status.

It’s important to carefully review the terms of any government funding or agreements to determine if they impact small entity eligibility. When in doubt, consult with a patent attorney or the USPTO for clarification.

To learn more:

Filing a new power of attorney typically revokes all prior powers of attorney. According to MPEP 402.05: When an original power of attorney is filed giving power of attorney to attorneys A, B, and C, and the same principal subsequently files another power of attorney, giving power of attorney to D without revoking all prior powers of attorney, the subsequently filed power of attorney will be treated as a revocation of the original power of attorney. This means that the most recently filed power of attorney will control.

To learn more:

In pre-2012 patent applications, filing a new power of attorney can have significant effects on existing powers of attorney. MPEP 402.05(b) outlines several scenarios:

  1. New power of attorney without explicit revocation: “When an original power of attorney is filed giving power of attorney to attorneys A, B, and C, and the same principal subsequently files another power of attorney, giving power of attorney to D without revoking all prior powers of attorney, the subsequently filed power of attorney will be treated as a revocation of the original power of attorney.”
  2. Assignee filing new power of attorney: “If the applicant signed the original power of attorney, and an assignee of the entire interest of the applicant later takes action and files a new power of attorney, the original power of attorney is revoked and replaced by the power of attorney filed by the assignee.”
  3. Change in Customer Number: “If a power of attorney is given to the practitioners associated with a Customer Number, and a (second) power of attorney is later received giving power of attorney to patent practitioners associated with a different Customer Number, the second power of attorney will be processed, with the first Customer Number being replaced with the second.”

In all these cases, the most recently filed power of attorney will control, effectively revoking or replacing the previous ones.

To learn more:

Filing a delayed benefit claim can have significant implications for patent term adjustment (PTA). According to MPEP 211.04:

‘If a benefit claim is submitted later than the time period provided by 37 CFR 1.78, the patent will not be granted the earlier filing date unless a petition under 37 CFR 1.78 is granted. If the petition is granted, the patent term adjustment (PTA) may be reduced.’

This means that if your delayed benefit claim is accepted through a successful petition, it may result in a reduction of your patent’s term adjustment. The reduction in PTA is intended to balance the benefit gained from the earlier filing date against the delay in claiming that benefit.

To learn more:

Filing a Continued Prosecution Application (CPA) has a significant effect on the prior application. According to the MPEP, A request for a CPA expressly abandons the prior application as of the filing date of the request for the CPA. This means that when you file a CPA, the previous application is automatically abandoned in favor of the new CPA. The CPA will use the file wrapper and contents of the prior application, including the specification, drawings, and oath or declaration, and will be assigned the same application number as the prior application.

To learn more:

Filing a Continued Prosecution Application (CPA) includes a waiver of confidentiality for the prior application. The MPEP states:

A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means that if someone is entitled to access information about either the CPA or the prior application, they may also be given access to information about the other related applications in the file. Applicants should be aware of this reduced confidentiality when deciding whether to file a CPA.

Filing a Continued Prosecution Application (CPA) has implications for public access to the application. The MPEP states:

“A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file. 37 CFR 1.53(d)(6).”

This means:

  • The CPA is considered a waiver of confidentiality for the entire application chain
  • Members of the public who have access to one application in the chain may be given similar access to others
  • This increased accessibility applies to both the prior application and any continuing applications

Applicants should be aware of this potential for increased public access when deciding to file a CPA.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

Filing a Continued Prosecution Application (CPA) has implications for the confidentiality of the application under 35 U.S.C. 122:

  • Filing a CPA is construed as a waiver of confidentiality to a certain extent
  • Members of the public entitled to access the prior application may be given similar access to the CPA and other related applications
  • This waiver applies to the entire chain of related applications

The MPEP states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

For more information on 35 U.S.C. 122, visit: 35 U.S.C. 122.

For more information on patent applications, visit: patent applications.

For more information on public access, visit: public access.

Filing a Continued Prosecution Application (CPA) has implications for confidentiality and public access to application information:

  • Filing a CPA is construed as a waiver of confidentiality under 35 U.S.C. 122
  • Members of the public entitled to access the prior application may be given similar access to the CPA
  • This waiver extends to any continuing applications in the chain of CPAs
  • Certified copies of CPAs will include the most recent non-continued prosecution application in the chain

MPEP 201.06(d) states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

For more information on USPTO procedures, visit: USPTO procedures.

Filing a continuation-in-part (CIP) application does not automatically resolve or affect outstanding rejections in the parent application. The MPEP 201.08 clarifies this point:

“The mere filing of a continuation-in-part application does not itself create a presumption that the applicant acquiesces in any rejections which may be outstanding in the copending national nonprovisional application or applications upon which the continuation-in-part application relies for benefit.”

This means:

  • Outstanding rejections in the parent application remain active and must be addressed separately.
  • The applicant is not presumed to agree with or accept these rejections by filing a CIP.
  • The CIP application will be examined independently, though it may face similar rejections if it includes the same claimed subject matter.

Applicants should continue to respond to office actions and address rejections in the parent application if they wish to pursue those claims, even after filing a CIP.

For more information on parent application, visit: parent application.

For more information on patent examination, visit: patent examination.

Filing a continuation or divisional application under 37 CFR 1.53(b) does not automatically abandon the prior application. The status of the prior application depends on the actions taken by the applicant:

  1. The prior application remains pending unless expressly abandoned.
  2. To expressly abandon the prior application, a separate paper must be filed and signed in accordance with 37 CFR 1.138.
  3. If a notice of allowance has been issued in the prior application, it can become abandoned by nonpayment of the issue fee.

The MPEP states: Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application. If the prior nonprovisional application is to be expressly abandoned, such a paper must be signed in accordance with 37 CFR 1.138.

It’s important to note that if the issue fee has been paid in the prior application, a petition to withdraw the application from issue must be filed before it can be abandoned, even if a continuing application has been filed.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

Filing a continuation application under 37 CFR 1.53(b) does not automatically abandon the prior application. The MPEP clearly states:

Under 37 CFR 1.53(b) practice, the prior nonprovisional application is not automatically abandoned upon filing of the continuing application.

However, applicants have several options regarding the status of the prior application:

  1. Express Abandonment: If desired, the prior application can be expressly abandoned. This requires a separate paper signed in accordance with 37 CFR 1.138.
  2. Allowed Applications: If the prior application has received a notice of allowance, it can become abandoned by non-payment of the issue fee.
  3. Continued Prosecution: The prior application can remain pending if the applicant wishes to continue prosecution.

It’s important to note that if an issue fee has been paid in the prior application, special procedures are required:

However, once an issue fee has been paid in the prior application, even if the payment occurs following the filing of a continuing application under 37 CFR 1.53(b), a petition to withdraw the prior nonprovisional application from issue must be filed before the prior nonprovisional application can be abandoned (37 CFR 1.313).

Applicants should carefully consider their strategy for managing multiple related applications when filing a continuation.

For more information on continuation application, visit: continuation application.

For more information on patent prosecution, visit: patent prosecution.

How does employment at an institution of higher education affect micro entity status?

Employment at an institution of higher education can provide a pathway to micro entity status. The MPEP states:

“A micro entity shall also include an applicant who certifies that: (1) The applicant’s employer, from which the applicant obtains the majority of the applicant’s income, is an institution of higher education as defined in section 101(a) of the Higher Education Act of 1965 (20 U.S.C. 1001(a)); or (2) The applicant has assigned, granted, conveyed, or is under an obligation by contract or law, to assign, grant, or convey, a license or other ownership interest in the particular application to such an institution of higher education.” (MPEP 509.04(d))

This means that if you are employed by a qualifying institution of higher education and receive the majority of your income from it, or if you have assigned or are obligated to assign your rights in the application to such an institution, you may be eligible for micro entity status. This provision can be particularly beneficial for academic researchers and inventors.

To learn more:

How does employment affect micro entity status for inventors?

An inventor’s employment can significantly impact their eligibility for micro entity status. The MPEP provides specific guidelines:

“[A]n applicant is not considered to be named on more than four previously filed patent applications if the applicant has assigned, or is under an obligation to assign, all ownership rights in the applications as the result of the applicant’s previous employment.” (MPEP 509.04(a))

This means that if an inventor has previously filed patent applications as part of their job, and they have assigned or are obligated to assign the rights to their employer, these applications don’t count towards the four-application limit for micro entity status. However, it’s crucial to note that:

  • The inventor must not be currently named as an inventor on more than four non-provisional patent applications.
  • The inventor’s current employer must not be considered a non-micro entity.

Inventors should carefully evaluate their employment situation and patent history when determining their eligibility for micro entity status.

To learn more:

Tags: micro entity

Continued Prosecution Application (CPA) practice differs significantly for utility and plant applications compared to design applications. The key difference is:

CPA practice is not available for utility and plant applications filed on or after May 29, 2000.

As stated in the MPEP 201.06(d): “Effective July 14, 2003, CPA practice has been eliminated as to utility and plant applications in view of the eighteen-month publication of applications under 35 U.S.C. 122(b). A request for a CPA filed on or after July 14, 2003 in a utility or plant application is improper and will not be treated as a CPA.”

For utility and plant applications, applicants should instead consider filing:

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on RCE, visit: RCE.

Correcting inventorship can potentially affect the power of attorney in a patent application. The MPEP states:

For applications filed on or after September 16, 2012, 37 CFR 1.32(e) provides that if the power of attorney was granted by the originally named inventive entity, and an added inventor pursuant to 37 CFR 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the 37 CFR 1.48 request.

This means that if a new inventor is added and doesn’t provide a consistent power of attorney, the original power of attorney may be lost. However, the MPEP also notes, This provision does not preclude a practitioner from acting in a representative capacity pursuant to 37 CFR 1.34, if applicable. It’s important to consider this potential consequence when correcting inventorship in applications filed on or after September 16, 2012.

To learn more:

The effect on the date of recordation depends on whether the error affects title to the application or patent. According to MPEP 323.01(a):

  1. Errors that do not affect title: If the typographical error does not affect title, the Assignment Services Division will correct the Assignment Historical Database and allow the recording party to keep the original date of recordation.
  2. Errors that affect title: If the error affects title to the application or patent, the recording party will not keep the original date of recordation. The MPEP states: Rather, the Assignment Services Division will correct its automated records and change the date of recordation to the date the corrected cover sheet was received in the Office.

It’s crucial to ensure accuracy in cover sheets to maintain the earliest possible recordation date, especially for errors that could affect title to the application or patent.

To learn more:

Copendency is a crucial requirement for claiming benefit between nonprovisional applications. The later-filed application must be filed before:

  • The patenting of the prior application
  • The abandonment of the prior application
  • The termination of proceedings in the prior application

As stated in MPEP 211.01(b): When a later-filed application is claiming the benefit of a prior-filed nonprovisional application under 35 U.S.C. 120, 121, 365(c), or 386(c), the later-filed application must be copending with the prior application or with an intermediate nonprovisional application similarly entitled to the benefit of the filing date of the prior application.

If copendency is not maintained, the benefit claim is improper and the later-filed application cannot claim the earlier filing date of the prior application.

To learn more:

Continuity in patent applications refers to the relationship of copendency of the same subject matter in two different applications naming the same inventor or at least one joint inventor in common. The MPEP 211.01(b) states:

“The term ‘continuity’ is used to express the relationship of copendency of the same subject matter in two different applications naming the same inventor or at least one joint inventor in common.”

Continuing applications include:

  • Divisional applications
  • Continuation applications
  • Continuation-in-part applications

It’s important to note that the prior application may disclose more than the later-filed application, or vice versa. In either case, the later-filed application is entitled to the benefit of the filing date of the prior application for the common subject matter disclosed in compliance with 35 U.S.C. 112(a).

To learn more:

Confidentiality in Continued Prosecution Applications (CPAs) is handled differently from standard applications. Filing a CPA includes a waiver of confidentiality to some extent:

  • The CPA is construed to include a waiver of confidentiality under 35 U.S.C. 122
  • This waiver allows public access to both the prior application and any continuing applications filed under 37 CFR 1.53(d)
  • Access is limited to those entitled under 37 CFR 1.14 to obtain information about the applications

The MPEP states: A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means that if someone is entitled to access information about either the prior application or the CPA, they may be given similar access to information about both applications. This is different from the standard confidentiality provisions for pending applications.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Claiming the benefit of an international design application under 35 U.S.C. 386(c) can potentially establish an earlier effective filing date for a nonprovisional application. This is significant because the effective filing date is used to determine which prior art is applicable during examination.

As stated in the MPEP:

“Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.”

By claiming this benefit, the nonprovisional application can potentially use the filing date of the international design application as its effective filing date, provided all requirements are met. This earlier date can be crucial for overcoming prior art references and establishing priority in the field.

For more information on 35 U.S.C. 386(c), visit: 35 U.S.C. 386(c).

For more information on effective filing date, visit: effective filing date.

For more information on prior art, visit: prior art.

How does claiming small entity status affect patent fees?

Claiming small entity status can significantly reduce patent fees. According to MPEP 509.03, “Claiming small entity status allows the payment of certain reduced patent fees pursuant to 35 U.S.C. 41(h)(1).” This means that small entities, such as independent inventors, small businesses, and nonprofit organizations, can pay reduced fees for many patent-related services, typically 50% of the standard fee. However, it’s important to ensure eligibility before claiming this status to avoid potential issues later in the patent process.

To learn more:

Claiming priority for international design applications has some specific provisions, particularly when the application designates the United States. These provisions are outlined in the MPEP and relevant regulations.

According to MPEP 213.07: “Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.”

Key points about priority in international design applications include:

  • The right of priority under 35 U.S.C. 386(a) or (b) applies only to applications filed on or after May 13, 2015.
  • For nonprovisional international design applications, the priority claim must be presented in an application data sheet during the pendency of the application, unless made in accordance with the Hague Agreement and Regulations.
  • The certified copy of the priority document must be furnished within the time period specified in 37 CFR 1.55(g).
  • An international design application designating the U.S. can claim priority to a prior foreign application, PCT application, or another international design application.

The MPEP also notes: “See MPEP § 2920.05(d) for additional information pertaining to the right of priority based upon an international design application.”

These provisions ensure that design patent applicants can properly claim priority to earlier filed applications in the context of the international design registration system.

For more information on design patent, visit: design patent.

For more information on Hague Agreement, visit: Hague Agreement.

Claiming priority to a foreign application generally does not affect the term of a U.S. patent. The patent term is typically calculated from the actual U.S. filing date, not the foreign priority date.

For utility and plant patents:
– The term is 20 years from the earliest U.S. filing date of the application or any U.S. application to which it claims benefit under 35 U.S.C. 120, 121, or 365(c).
– The foreign priority date is not used in this calculation.

For design patents:
– The term is 15 years from the date of grant.
– The filing or priority dates do not affect the term.

It’s important to note that while the foreign priority date doesn’t affect the patent term, it can affect the effective filing date for prior art purposes, which can be crucial for determining patentability.

Patent Term Adjustment (PTA) may be available to extend the term of a utility or plant patent due to delays in prosecution, but this is calculated based on the actual U.S. filing date, not the foreign priority date.

Claiming foreign priority can significantly affect the prior art date in your application:

  • For applications subject to pre-AIA law, the foreign priority date becomes the effective U.S. filing date for prior art purposes under 35 U.S.C. 102(a), (b), and (d)
  • For applications subject to AIA law, the foreign priority date is treated as the effective filing date for prior art purposes under 35 U.S.C. 102(a)(1) and (a)(2)

This means that intervening disclosures between your foreign filing date and your U.S. filing date may not be considered prior art against your application. However, it’s important to note that the claimed subject matter must be fully supported by the foreign application to get the benefit of its filing date. Additionally, the priority claim must be proper and timely made for this benefit to apply.

How does claiming benefit of an international application affect the patent term?

Claiming the benefit of an international application can affect the patent term in specific ways. According to MPEP 211.01(c):

It should be noted that international applications, which designate the United States, are included in the definition of ‘national application’ in pre-AIA 35 U.S.C. 154(a)(2).

This means that for patents subject to the 20-year term provision of pre-AIA 35 U.S.C. 154(a)(2), the 20-year term begins on the international filing date of the international application. However, it’s important to note that the MPEP 2701 provides more detailed information on patent term calculations, including adjustments and extensions that may apply.

To learn more:

To learn more:

Tags: patent term

Claiming the benefit of an earlier filing date for continuing applications (continuation, divisional, and continuation-in-part) is governed by 35 U.S.C. 120 and 37 CFR 1.78. Key points include:

  • The continuing application must be filed before the patenting, abandonment, or termination of proceedings on the prior application.
  • The continuing application must contain a specific reference to the prior application.
  • For applications filed on or after September 16, 2012, the specific reference must be included in an application data sheet (ADS).
  • For applications filed before September 16, 2012, the specific reference must be in the first sentence(s) of the specification or in an ADS.
  • The continuing application must have at least one common inventor with the prior application.

As stated in the MPEP:

A continuation or divisional application that names as inventors the same or fewer than all of the inventors named in the prior application may be filed under this paragraph or paragraph (d) of this section.

It’s important to note that for continuation-in-part applications, any claims that rely on new matter added in the CIP will not be entitled to the benefit of the earlier filing date of the parent application.

For more information on patent application types, visit: patent application types.

Claiming benefit to a prior application can affect the patent term in several ways:

  1. For applications subject to the 20-year term provision:
    • The term begins from the earliest U.S. filing date to which benefit is claimed under 35 U.S.C. 120, 121, or 365(c)
    • Claiming benefit to earlier applications may reduce the effective patent term
  2. For provisional applications:
    • Claiming benefit under 35 U.S.C. 119(e) does not affect the patent term
    • However, claiming benefit to a provisional under 35 U.S.C. 120 (not recommended) could reduce the term

MPEP 211.02 cautions: “Although 35 U.S.C. 120 does not preclude a benefit claim to a provisional application, it is not recommended that applicants claim the benefit to a provisional application under 35 U.S.C. 120 since such a claim could have the effect of reducing the patent term, as the term of a patent issuing from such an application may be measured from the filing date of the provisional application pursuant to 35 U.S.C. 154(a)(2).”

It’s important to carefully consider the implications of benefit claims on patent term when developing a patent strategy, especially for patent families with multiple related applications.

To learn more:

Changing the correspondence address in a patent application does not automatically change a patent practitioner’s address of record with the USPTO. These are two separate matters:

  • The correspondence address is specific to an application or patent
  • The practitioner’s address of record is maintained in the USPTO’s roster of registered practitioners

MPEP 601.03(a) cites 37 CFR 1.33(e), which states: A change of address filed in a patent application or patent does not change the address for a patent practitioner in the roster of patent attorneys and agents.

This means that even if you change the correspondence address for a specific application, you must separately update your address with the Office of Enrollment and Discipline if you want to change your official address of record as a registered practitioner.

Practitioners have an obligation to keep their address current with the USPTO. As noted in MPEP 601.03: Note that the obligation (see 37 CFR 11.11) of a registered attorney or agent to notify the Director of the Office of Enrollment and Discipline of any change of his or her address is separate from the obligation to file a notice of change of address in individual applications.

To learn more:

Changing the correspondence address in a patent application does not affect a patent practitioner’s address in the USPTO roster of patent attorneys and agents. This is explicitly stated in 37 CFR 1.33(e):

A change of address filed in a patent application or patent does not change the address for a patent practitioner in the roster of patent attorneys and agents. See § 11.11 of this title.

This means that practitioners must separately update their contact information in the USPTO roster if they wish to change their official address on record with the USPTO. The change of correspondence address in a specific application or patent is independent of the practitioner’s address in the official roster.

To learn more:

Changing a patent title can have several effects on the application process. As stated in MPEP 606.01, “When the Technology Center (TC) technical support staff prepares the application for issue and sees that the title has been changed, the TC technical support staff will make the required change in the Office computer record systems.” This ensures that the revised title is accurately reflected in all official records and databases, which can impact future searches and classifications of the patent.

To learn more:

How does attorney withdrawal affect the power of attorney in a patent application?

When an attorney withdraws from a patent application, it affects the power of attorney status. According to MPEP 402.06:

“The Office will not remove the names of practitioners who have been granted a power of attorney or authorization of agent from the list of practitioners of record at the request of the practitioner filing the withdrawal.”

This means that even after withdrawal, the attorney’s name may remain on record unless specific actions are taken. However, the withdrawn attorney no longer has the authority to act on behalf of the application. To fully revoke the power of attorney, the applicant must file a revocation and/or new power of attorney. It’s crucial for applicants to update their power of attorney promptly after an attorney’s withdrawal to ensure proper representation and communication with the USPTO.

To learn more:

How does attorney withdrawal affect pending patent applications?

When an attorney withdraws from representation in a pending patent application, it can have several implications:

  • The applicant becomes responsible for prosecuting the application.
  • Official correspondence will be sent directly to the applicant.
  • Deadlines and response periods remain in effect.
  • The applicant may need to find new representation quickly.

According to MPEP 402.06:

“Where an attorney or agent of record withdraws from an application, the Office will communicate directly with the applicant, or with a new registered attorney or agent if a power of attorney is filed.”

It’s important for applicants to act promptly after attorney withdrawal to ensure continuity in their patent prosecution. If a new attorney is hired, a new power of attorney should be filed with the USPTO to ensure proper communication and representation.

To learn more:

For division and continuation applications, a prior assignment recorded against the original application is automatically applied to the new application. This is because the assignment recorded against the original application gives the assignee rights to the subject matter common to both applications.

However, it’s important to note that while the assignment is effective for the new application, the USPTO’s assignment records will not automatically reflect this. As stated in the MPEP: Although the assignment recorded against an original application is applied to the division or continuation application, the Office’s assignment records will only reflect an assignment of a division or continuation application (or any other application) if a request for recordation in compliance with 37 CFR 3.28, accompanied by the required fee (37 CFR 3.41), is filed.

For applications claiming the benefit of a provisional application under 35 U.S.C. 119(e), the assignment process depends on the content of the later application:

  • If the later application includes only subject matter from the provisional application, an assignment recorded against the provisional application will be effective for the later application.
  • If the later application includes new subject matter not in the provisional application, new assignment papers must be recorded for the later application, unless it was filed on or after September 16, 2012, and the assignee is the original applicant.

As stated in MPEP § 306.01: If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

To learn more:

The assignment process for applications claiming benefit of a provisional application is similar to that of continuations and divisions in certain circumstances:

  • When the later application includes only subject matter from the provisional application, the assignment treatment is the same as for continuations and divisions filed under 35 U.S.C. 120.
  • In these cases, an assignment recorded against the provisional application will be effective in the later application.

MPEP § 306.01 states: If an application which claims the benefit of the earlier filing date of a provisional application under 35 U.S.C. 119(e) includes only subject matter which formed a part of the provisional application, an assignment recorded against the provisional application will be effective in the later application, similar to the practice with respect to continuations and divisions filed under 35 U.S.C. 120.

This similarity in treatment simplifies the assignment process when no new subject matter is introduced in the later application.

To learn more:

Assigning ownership rights can significantly affect micro entity status. The MPEP provides the following guidance:

  • An applicant is disqualified from micro entity status if they transfer, or are obligated to transfer, any ownership interest to an entity that exceeds the gross income limit.
  • If an inventor assigns all rights to an employer that exceeds the gross income limit, micro entity status cannot be claimed.
  • Even if rights are later transferred back to the inventor or to another person who doesn’t exceed the gross income limit, micro entity status cannot be regained.

The MPEP states: “Once an assignee or licensee exceeding the gross income limit receives the ownership interest, the 37 CFR 1.29(a)(4) certification requirement can no longer be met – even if the assignee or licensee retransfers rights and no longer holds any ownership interest in the application.

It’s important to note that this applies to both actual transfers and obligations to transfer ownership rights.

To learn more:

How does an international application designating the US affect benefit claims?

An international application designating the United States can be used as a basis for claiming benefit in a nonprovisional application. The MPEP 211.01(b) states:

Any nonprovisional application claiming the benefit of one or more prior-filed copending nonprovisional applications or international applications designating the United States must include a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications.

When claiming benefit from an international application, you must provide:

  • The international application number
  • The international filing date
  • The relationship between the applications

It’s important to note that the international application must designate the United States for it to be eligible as a basis for a benefit claim in a U.S. nonprovisional application.

To learn more:

An international application designating the United States has significant effects on the application process:

  • It is treated as a national application from its international filing date.
  • It follows different rules for restriction practice and unity of invention.
  • It has different notification procedures for incomplete applications.

According to 35 U.S.C. 363: “An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.”

However, as noted in MPEP 201.01: “Treatment of a national application under 35 U.S.C. 111 and a national stage application (a national application which entered the national stage from an international application in which the conditions of 37 CFR 1.9(a)(1) have been satisfied) are similar but not identical.” For example, unity of invention practice applies to national stage applications, while restriction practice applies to applications filed under 35 U.S.C. 111(a).

For more information on international applications, visit: international applications.

An international application designating the United States has significant effects on national patent rights. According to 35 U.S.C. 363:

An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office.

This means that an international application (PCT application) that designates the US is treated similarly to a national application filed under 35 U.S.C. 111. However, there are some differences in treatment between national applications and national stage applications (which enter the national stage from an international application). For example:

  • Restriction practice applies to national applications, while unity of invention practice applies to national stage applications
  • Different notification practices apply to incomplete applications in each case

For detailed information on the examination of international applications in the national stage, refer to MPEP § 1893.03.

For more information on international applications, visit: international applications.

For more information on patent rights, visit: patent rights.

When an examiner encounters a non-compliant amendment under 37 CFR 1.57(b), they follow a specific procedure outlined in the MPEP:

  1. They use a form paragraph stating the non-compliance and the specific reason.
  2. If the amendment introduces new matter, they follow up with additional form paragraphs (7.28 for specification/drawings, 7.31.01 for claims).
  3. For after-final amendments, they issue an advisory action indicating that the amendment raises new issues due to non-compliance.

The MPEP notes, This form paragraph must be followed by form paragraph 7.28, where the amendment is made to the specification and/or drawings and introduces new matter into the disclosure, and/or form paragraph 7.31.01, where the amendment adds new matter to the claims or affects the claims.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

When an applicant submits documents as evidence in a reply to an Office action, the examiner is not required to process these documents as items of information cited in an information disclosure statement. The MPEP clarifies:

“The record should reflect whether the evidence was considered, but listing on a form (e.g., PTO-892 or PTO/SB/08) and appropriate marking of the form by the examiner is not required.”

The examiner should indicate that the teachings relied on by the applicant have been considered, but they do not need to formally list or mark these documents on information disclosure forms.

To learn more:

When a Continued Prosecution Application (CPA) is established, the examiner notifies the applicant in the first Office action of the CPA. According to MPEP ¶ 2.30, the examiner uses a specific form paragraph:

“The request filed on [1] for a Continued Prosecution Application (CPA) under 37 CFR 1.53(d) based on parent Application No. [2] is acceptable and a CPA has been established. An action on the CPA follows.”

This notification is important because:

  • Applicants are not separately notified of the abandonment of the parent application
  • A filing receipt is not normally sent for a CPA

Therefore, this Office action serves as the official notification that the CPA has been properly established.

For more information on design patents, visit: design patents.

For more information on patent examination, visit: patent examination.

When a Continued Prosecution Application (CPA) is accepted, the examiner notifies the applicant in the first Office action of the CPA. This is because, unlike regular applications, applicants do not receive a separate notification about the abandonment of the parent application or a filing receipt for the CPA.

MPEP ¶ 2.30 states: Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established. This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA. This guidance ensures that applicants are properly informed about the status of their CPA.

When an examiner encounters a noncomplying Information Disclosure Statement (IDS), they use specific form paragraphs to notify the applicant. The MPEP 609.05(a) states:

The examiner may use form paragraph 6.49 which is reproduced below to inform applicant that the information has not been considered.

The examiner will typically use form paragraph 6.49 or one of its variants (6.49.01 to 6.49.10) to explain why the IDS was not considered and what specific requirements were not met. This notification allows the applicant to correct the deficiency or file a new IDS that complies with the requirements.

To learn more:

According to MPEP § 201, specifically paragraph 2.30, an examiner notifies an applicant about a Continued Prosecution Application’s (CPA) acceptance in the first Office action of the CPA. The MPEP states:

Use this form paragraph in the first Office action of a CPA to advise the applicant that a request for a CPA is acceptable and that a CPA has been established. This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

This notification is crucial because it confirms the establishment of the CPA and provides important information to the applicant about the status of their application.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent examination, visit: patent examination.

When a Continued Prosecution Application (CPA) request for a design patent application is deemed unacceptable, the examiner uses a specific form paragraph to inform the applicant. According to MPEP ¶ 2.31, the examiner note states:

“Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.”

The form paragraph includes:

  • An acknowledgment of the CPA request receipt
  • The filing date of the paper containing the request
  • The Application Number identified in the CPA request
  • An explanation of why the request is not acceptable
  • A statement that no CPA has been established

This formal communication ensures that the applicant is clearly informed about the status of their CPA request and the reasons for its non-acceptance.

For more information on USPTO procedures, visit: USPTO procedures.

When a Continued Prosecution Application (CPA) request for a design patent application is not compliant with the regulations, the examiner informs the applicant using a specific form paragraph. The MPEP provides guidance on this:

Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.

The form paragraph includes:

  • Acknowledgment of the CPA request receipt
  • The filing date of the paper containing the request
  • The application number identified in the CPA request
  • Explanation of why the request is not acceptable
  • Statement that no CPA has been established

This standardized approach ensures clear communication between the USPTO and the applicant regarding the status of their CPA request.

For more information on USPTO procedures, visit: USPTO procedures.

An examiner can indicate consideration of an IDS in two ways:

  1. By placing their initials adjacent to the citations on the PTO/SB/08 form or its equivalent.
  2. Using an alternative electronic signature method where:
    • Each page of reference citations is stamped with “All references considered except where lined through” along with the examiner’s electronic initials.
    • The final page includes the examiner’s electronic signature.
    • Citations not considered are struck through.

As stated in the MPEP, The initials of the examiner placed adjacent to the citations on the PTO/SB/08 or its equivalent mean that the information has been considered by the examiner to the extent noted above. (MPEP 609.05(b))

To learn more:

When an examiner considers an Information Disclosure Statement (IDS), they indicate their consideration in specific ways:

  1. Traditionally, the examiner places their initials adjacent to the citations on the PTO/SB/08 form or its equivalent.
  2. An alternative electronic signature method may also be used, where:
  • Examiners no longer initial each reference citation considered.
  • Citations not considered are struck through.
  • Each page of reference citations is stamped with the phrase ‘All references considered except where lined through’ along with the examiner’s electronic initials.
  • The final page includes the examiner’s electronic signature.

The MPEP states: Consideration by the examiner of the information submitted in an IDS means nothing more than considering the documents in the same manner as other documents in Office search files are considered by the examiner while conducting a search of the prior art in a proper field of search.

To learn more:

To learn more:

When an Information Disclosure Statement (IDS) does not comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98, the examiner will handle it as follows:

  • The IDS will be placed in the application file, but the information will not be considered.
  • The examiner will write ‘not considered’ on the IDS where none of the information complies with the requirements.
  • If using a PTO/SB/08 form, the examiner will draw a diagonal line or ‘X’ across the form.
  • The examiner will inform the applicant that the information has not been considered and explain why using appropriate form paragraphs.

As stated in the MPEP:

‘If an information disclosure statement does not comply with the requirements based on the time of filing of the IDS as discussed in MPEP § 609.04(b), including the requirements for fees and/or statement under 37 CFR 1.97(e), the IDS will be placed in the application file, but none of the information will be considered by the examiner.’

To learn more:

To learn more:

When an examiner detects new matter in a patent application, they must take specific actions:

  1. Object to amendments introducing new matter using 35 U.S.C. 132(a).
  2. Use Form Paragraph 7.28 to object to new matter added to the specification.
  3. If new matter affects the claims, reject the claims under 35 U.S.C. 112(a).

The MPEP states:

If new matter is added to the claims, or affects the scope of the claims, the claims affected should be rejected under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, on the ground that it recites elements without support in the original disclosure.

To learn more:

To learn more:

Tags: new matter

When an examiner finds an intervening reference (a reference with an effective date between the foreign filing date and the U.S. filing date) and a foreign priority claim is present, the examiner follows these steps:

  1. If the certified copy of the priority papers has not been filed, the examiner rejects the claims that may be unpatentable over the reference without considering the priority date.
  2. The applicant may then argue the rejection or present the foreign papers to overcome the date of the reference.
  3. If the applicant argues the rejection, the examiner may, in the next action:
    • Specifically require the foreign papers to be filed while repeating the rejection if still applicable, or
    • Simply continue the rejection

The MPEP states: “If at the time of making an action the examiner has found such an intervening reference, the examiner simply rejects whatever claims may be considered unpatentable thereover, without paying any attention to the priority date (assuming the certified copy of the priority papers has not yet been filed).” (MPEP 216)

How does an examiner handle a large number of cited references in an IDS?

When an examiner encounters a large number of cited references in an Information Disclosure Statement (IDS), they should:

  • Review each reference to the extent required to form an initial assessment of its relevance.
  • Focus more attention on those references that appear to be most relevant to the claimed invention.
  • Consider the references in light of the detailed explanations provided by the applicant, if any.
  • Document their consideration by initialing each citation, regardless of perceived relevance.

The MPEP 609.05(b) states: ‘In the event that a large number of documents are submitted and applicant’s explanation of relevance is minimal, the examiner may determine that the applicant has not complied with 37 CFR 1.98.’

However, it’s important to note that the examiner should not automatically consider the submission of a large number of references as an attempt to overwhelm the examiner. Each case should be evaluated on its own merits, and the examiner should make a good faith effort to review all cited references.

To learn more:

Patent examiners carefully compare the content of the continuation or divisional application with the prior-filed application to identify any new matter. If they find information not disclosed in the prior application, they will issue a notice to the applicant.

The MPEP ¶ 2.10.01 instructs examiners:

“In bracket 1, provide an example of the matter not disclosed in the prior-filed application.”

This means the examiner must specifically point out the new matter found in the application, allowing the applicant to understand and address the issue.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent examination, visit: patent examination.

An examiner determines if an application qualifies as a continuation under MPEP ¶ 2.05 by assessing the following criteria:

  • The application discloses only subject matter that was previously disclosed in a prior application
  • The application claims only subject matter that was disclosed in the prior application
  • The application names at least one inventor who was also named in the prior application

The MPEP provides specific language for this assessment: “This application discloses and claims only subject matter disclosed in prior Application No. [1], filed [2], and names an inventor or inventors named in the prior application.” (MPEP ¶ 2.05)

If all these criteria are met, the examiner may notify the applicant that the application may constitute a continuation. The examiner will then proceed with the appropriate examination procedures for continuation applications.

For more information on continuation application, visit: continuation application.

For more information on patent examination, visit: patent examination.

Patent examiners use specific criteria to determine if an application may qualify as a continuation-in-part (CIP). According to MPEP ¶ 2.06, an examiner should consider the following:

  • The application repeats a substantial portion of a prior application.
  • The application adds disclosure not presented in the prior application.
  • The application names the inventor or at least one joint inventor named in the prior application.

The MPEP states: Because this application names the inventor or at least one joint inventor named in the prior application, it may constitute a continuation-in-part of the prior application. However, examiners are advised to use this determination cautiously: This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Patent examiners use specific criteria to determine if an application may qualify as a divisional. According to MPEP ¶ 2.01, an examiner looks for the following indicators:

  1. The application claims only subject matter disclosed in a prior application.
  2. The claimed subject matter appears to be independent and distinct from that claimed in the prior application.
  3. At least one inventor from the prior application is named in the current application.

The MPEP provides guidance to examiners:

“This form paragraph should only be used if it appears that the application may be a divisional, but a benefit claim has not been properly established.”

If these conditions are met, but a proper benefit claim hasn’t been made, the examiner may use this paragraph to notify the applicant of the possible divisional status and the need to establish a benefit claim if desired.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

For more information on USPTO, visit: USPTO.

According to MPEP 608.02(w), when an application is ready for issue except for a slight defect in the drawing, the examiner will communicate the necessary changes to the applicant as follows:

  • Prepare a letter to the applicant indicating the change to be made
  • May include a marked-up copy of the drawing showing the addition or alteration
  • Attach the marked-up copy of the drawing to the letter
  • Make the letter and marked-up drawing of record in the application file

This process allows for efficient communication of minor drawing changes without requiring the applicant to submit annotated sheets.

To learn more:

Examiners have several methods to acknowledge the receipt of replacement drawing sheets:

  1. Using Form Paragraph 6.37
  2. Using Form PTOL-324
  3. Using the PTOL-326 Office Action Summary

The MPEP 608.02(h) provides the following example of Form Paragraph 6.37:

“The drawings were received on [1]. These drawings are [2].”

In this form paragraph, the examiner would insert the date of receipt in [1] and either ‘acceptable’ or ‘unacceptable’ in [2]. If the drawings are unacceptable, the examiner must provide an explanation, which may include identifying any drawings not entered due to new matter and explaining necessary corrections for resubmission.

To learn more:

How does an attorney or agent officially withdraw from a patent application?

To officially withdraw from a patent application, an attorney or agent must follow these steps:

  1. Submit a request to withdraw as attorney or agent of record.
  2. The request must be signed by the attorney or agent of record.
  3. Include the application number and filing date.
  4. Provide the names of the inventors and assignee (if applicable).
  5. State the reason for withdrawal.

The MPEP 402.06 states: ‘When an attorney or agent of record in an application withdraws… the Office of Enrollment and Discipline should be notified by the withdrawing attorney or agent.’ This notification ensures proper processing of the withdrawal request.

To learn more:

An assignee can file a substitute statement when an inventor is unavailable or refuses to sign the oath or declaration. The process involves the following steps:

  1. Determine if the assignee has the right to make the application for patent as provided in 37 CFR 1.46.
  2. Prepare the substitute statement following the requirements of 37 CFR 1.64.
  3. Include an explanation of the circumstances that make the inventor unavailable or unwilling to sign.
  4. Provide evidence of the assignment, if not already recorded with the USPTO.

MPEP 604 states: ‘A substitute statement may also be made by an assignee of the entire interest, an applicant under 37 CFR 1.46(b), or a person who otherwise shows sufficient proprietary interest in the matter, provided that the inventor is deceased, legally incapacitated, cannot be found or reached after diligent effort, or has refused to execute the oath or declaration.’

The assignee must ensure that the substitute statement complies with all requirements, including identifying the inventor, stating the relationship to the inventor, and acknowledging that willful false statements are punishable by law.

To learn more:

To establish the right to take action in a patent application filed before September 16, 2012, an assignee must meet the following requirements:

  • The assignee must be of the entire right, title, and interest in the application.
  • A proper documentary evidence of chain of title from the original owner to the assignee must be submitted.
  • The evidence must be recorded in the United States Patent and Trademark Office (USPTO) no later than the date of payment of the issue fee.

As stated in MPEP 324: The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted.

It’s important to note that these requirements are specific to applications filed before September 16, 2012. Different rules may apply for applications filed on or after this date.

For more information on assignee rights, visit: assignee rights.

For more information on chain of title, visit: chain of title.

For more information on documentary evidence, visit: documentary evidence.

For more information on USPTO, visit: USPTO.

To establish ownership and take action in a patent application filed on or after September 16, 2012, an assignee who is not the original applicant must:

  1. File a request to change the applicant under 37 CFR 1.46(c)(2)
  2. File an application data sheet under 37 CFR 1.76 specifying the assignee as the applicant
  3. Submit a statement under 37 CFR 3.73(c) establishing ownership

The 37 CFR 3.73(c) statement must contain either:

  • Documentary evidence of a chain of title from the original owner to the assignee and a statement affirming that the documentary evidence was submitted for recordation, or
  • A statement specifying where such evidence is recorded in the Office (e.g., reel and frame number)

The MPEP states: “The establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted.”

An assignee establishes ownership in a patent application by filing a statement under 37 CFR 3.73(c). According to MPEP 325:

“The statement under 37 CFR 3.73(c) must be filed in the application or patent where ownership must be established and must contain:
(A) documentary evidence of a chain of title from the original owner to the assignee; or
(B) a statement specifying where documentary evidence of a chain of title from the original owner to the assignee is recorded in the assignment records of the Office.”

This statement serves as proof of the assignee’s right to take action in the application.

For more information on assignee ownership, visit: assignee ownership.

For more information on chain of title, visit: chain of title.

How does an assignee become of record in a patent application?

An assignee must become of record in a patent application before they can revoke the power of attorney given by the applicant. According to MPEP 402.07, this process involves:

  1. Filing a statement under 37 CFR 3.73(c)
  2. Complying with the requirements of 37 CFR 3.71

The MPEP states:

“The assignee must become of record as provided in 37 CFR 3.71. After the assignee becomes of record, the assignee is permitted to revoke the power of attorney of the applicant under the provisions of 37 CFR 1.36(a).”

This typically involves submitting documentary evidence of the chain of title from the original owner to the assignee, such as assignment documents. Once the USPTO recognizes the assignee as the owner of record, they can proceed with revoking the existing power of attorney and appointing a new one.

To learn more:

For pre-AIA applications, the Application Data Sheet (ADS) plays a crucial role in establishing priority claims:

1. For domestic priority: MPEP 601.05(b) states, “Providing this information in the application data sheet constitutes the specific reference required by 35 U.S.C. 119(e) or 120.” This means that including domestic priority information in the ADS satisfies the requirement for a specific reference to earlier filed applications.

2. For foreign priority: The MPEP notes, “Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55.”

In both cases, including priority information in the ADS eliminates the need to make these claims elsewhere in the application, such as in the specification.

To learn more:

The Application Data Sheet (ADS) plays a crucial role in naming inventors for patent applications filed on or after September 16, 2012. According to MPEP 601.05(a):

“The naming of the inventors in the application data sheet is the naming of the actual inventors of the subject matter of the application. The inventorship determined from the application data sheet will be used as the inventorship on the patent if the application is granted as a patent.”

This means that the ADS serves as the official document for declaring inventorship. It’s important to note that:

  • The ADS replaces the need for a separate inventor’s oath or declaration for naming inventors
  • Any changes to inventorship after filing must be done through a proper request under 37 CFR 1.48
  • Accuracy in naming inventors is crucial, as incorrect inventorship can affect the validity of the patent

Applicants should ensure that the inventorship information in the ADS is complete and accurate at the time of filing to avoid potential complications later in the patent process.

To learn more:

MPEP 203.03 defines an ‘amended’ application as:

An ‘amended’ nonprovisional application is one that having been acted on by the examiner, has in turn been acted on by the applicant in reply to the examiner’s action. The applicant’s reply may be confined to an election, a traverse of the action taken by the examiner or may include an amendment of the application.

In essence, an application becomes ‘amended’ when the applicant responds to an examiner’s action, whether through election, traversal, or by submitting amendments to the application.

To file an application under pre-AIA 37 CFR 1.47(b), an applicant must demonstrate a proprietary interest in the subject matter of the application. The MPEP outlines three ways to establish this:

  1. Show that the invention has been assigned to the applicant
  2. Provide evidence that the inventor has agreed in writing to assign the invention to the applicant
  3. Otherwise demonstrate a proprietary interest in the subject matter of the application

The MPEP states: “The pre-AIA 37 CFR 1.47(b) applicant must make out a prima facie case (1) that the invention has been assigned to him or her or (2) that the inventor has agreed in writing to assign the invention to him or her or (3) otherwise demonstrate a proprietary interest in the subject matter of the application.”

For more detailed information on demonstrating proprietary interest, refer to MPEP § 409.03(f).

To learn more:

To claim the benefit of a prior application’s filing date for a divisional application, applicants must follow specific procedures outlined in patent law and regulations. The MPEP ¶ 2.01 states:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This means applicants should:

  • Ensure compliance with 35 U.S.C. 120 requirements for continuity and disclosure
  • Follow the procedures outlined in 37 CFR 1.78 for claiming benefit
  • Consult MPEP § 211 for detailed guidance on benefit claims

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the divisional application.

For more information on Divisional application, visit: Divisional application.

In patent applications filed before September 16, 2012, an Application Data Sheet (ADS) can significantly impact the priority claim process. The ADS can be used to:

  • Provide domestic benefit information
  • Include foreign priority information
  • Correct or update priority claims within certain timeframes

According to MPEP 601.05(b): “For applications filed before September 16, 2012, an application data sheet may be used to provide or correct benefit claim information, such as cross-references to one or more prior-filed applications… The benefit claim must be set forth in the ADS in order to be considered properly submitted.”

It’s crucial to note that while the ADS can be used to submit priority information, applicants must still comply with other statutory requirements and deadlines for claiming priority. The ADS provides a centralized location for this information, potentially simplifying the application process and reducing errors in priority claims.

To learn more:

In patent applications filed before September 16, 2012, an Application Data Sheet (ADS) can significantly affect the oath or declaration requirements. Specifically:

  • An ADS can eliminate the need for certain information in the oath or declaration.
  • It allows for the submission of some bibliographic data without an oath or declaration.

The MPEP 601.05(b) states: “If an application data sheet is used in an application filed before September 16, 2012 (in compliance with pre-AIA 37 CFR 1.76) to supply or change the information in 37 CFR 1.63(c), and the oath or declaration under 37 CFR 1.63 refers to the application data sheet, the oath or declaration does not need to be supplemented to include the information supplied in the application data sheet.”

This means that if the oath or declaration references the ADS, it doesn’t need to be updated with information already provided in the ADS, streamlining the application process.

To learn more:

Adding an inventor to a patent application can affect an existing power of attorney under certain circumstances. According to MPEP 402.05(a):

If the power of attorney was granted by the originally named inventive entity and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.

This means that if a new inventor is added to the application and does not provide a power of attorney that matches the existing one, the original power of attorney will be lost when the request to add the inventor is granted. However, this doesn’t prevent a practitioner from acting under 37 CFR 1.34 if applicable.

To learn more:

Adding an inventor to a patent application can potentially affect an existing power of attorney. According to MPEP 402.02(a):

“If the power of attorney was granted by the originally named inventive entity, and an added inventor pursuant to § 1.48 does not provide a power of attorney consistent with the power of attorney granted by the originally named inventive entity, the addition of the inventor results in the loss of that power of attorney upon grant of the § 1.48 request.”

This means that if a new inventor is added to the application and does not provide a power of attorney consistent with the existing one, the original power of attorney will be lost. However, this provision does not preclude a practitioner from acting pursuant to 37 CFR 1.34, if applicable.

It’s important for applicants and practitioners to be aware of this potential consequence when adding inventors to an application, and to take appropriate steps to maintain or reestablish the desired power of attorney.

To learn more:

The rules for acting in a representative capacity differ slightly for applications filed before and after September 16, 2012. According to MPEP 402.04:

For applications filed on or after September 16, 2012:

A patent practitioner acting in a representative capacity must submit papers on behalf of all parties identified as the applicant. They cannot represent only some of the applicant parties.

For applications filed before September 16, 2012:

A patent practitioner may act in a representative capacity on behalf of:

  • The applicant, or
  • The assignee of the entire right who has properly established its right to take action under 37 CFR 3.71 and 3.73

Additionally, for pre-September 16, 2012 applications, a person acting in a representative capacity may sign a document granting access to an application or a change of correspondence address if:

  1. An executed oath or declaration under pre-AIA 37 CFR 1.63 has not been filed, and
  2. The patent practitioner was named in the application transmittal papers.

To learn more:

How does a U.S. national stage application differ from a regular national application?

A U.S. national stage application is derived from an international application, while a regular national application is filed directly with the USPTO. The key differences lie in their origins and the legal provisions governing them.

As stated in MPEP 201.01:

A national application may be a U.S. national application filed under 35 U.S.C. 111(a), or a national stage application under 35 U.S.C. 371 of an international application.

Regular national applications are filed under 35 U.S.C. 111(a), while national stage applications enter the U.S. national phase from an international PCT application under 35 U.S.C. 371. National stage applications must meet specific requirements for entering the national phase, such as time limits and submission of necessary documents.

For more information on national stage application, visit: national stage application.

For more information on patent filing, visit: patent filing.

For more information on USPTO, visit: USPTO.

A title report plays a crucial role in the patent examination process by providing essential ownership information. According to the MPEP Section 320, “The title report is placed in the file wrapper.” This means that:

  • Examiners have access to the most current ownership information
  • It helps ensure that communications are sent to the correct parties
  • It assists in identifying potential issues related to inventorship or ownership

By having accurate ownership information, the examination process can proceed more efficiently and with fewer complications related to ownership disputes or incorrect parties being involved in the process.

For more information on ownership information, visit: ownership information.

For more information on patent examination, visit: patent examination.

For more information on title report, visit: title report.

A terminal disclaimer filed in a parent application can affect a divisional application in specific ways. According to MPEP 201.06:

‘The divisional application must be directed to subject matter described and claimed in the prior nonprovisional application.’

This means that if a terminal disclaimer was filed in the parent application, it may impact the divisional application as follows:

  • Inheritance of Terminal Disclaimer: Generally, a terminal disclaimer filed in the parent application does not automatically apply to the divisional application.
  • Potential Double Patenting: If the claims in the divisional application are not patentably distinct from those in the parent application, a new terminal disclaimer may be required in the divisional to overcome a double patenting rejection.
  • Examination Considerations: Examiners will consider the relationship between the parent and divisional applications when determining if a terminal disclaimer is necessary.

It’s important to consult with a patent attorney or agent to understand the specific implications of terminal disclaimers on your divisional application, as each case can have unique considerations.

To learn more:

A terminal disclaimer filed in a parent application automatically carries over to a Continued Prosecution Application (CPA). The MPEP clearly states:

“A terminal disclaimer filed in the parent application carries over to a CPA. The terminal disclaimer filed in the parent application carries over because the CPA retains the same application number as the parent application, i.e., the application number to which the previously filed terminal disclaimer is directed.”

However, if an applicant does not want the terminal disclaimer to apply to the CPA, they must take specific action:

“If applicant does not want the terminal disclaimer to carry over to the CPA, applicant must file a petition under 37 CFR 1.182 along with the required petition fee, requesting the terminal disclaimer filed in the parent application not be carried over to the CPA.”

It’s important to note that such a petition must be filed and granted before the patent issues to be effective.

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on patent term, visit: patent term.

A substitute application is distinct from a continuing application in several ways. According to MPEP 201.02:

‘A substitute application is an application which is filed to take the place of a prior application and which is identified as such and discloses and claims only subject matter disclosed in the prior application.’

Key differences include:

  • A substitute application replaces the prior application entirely, while a continuing application coexists with the prior application.
  • Substitute applications only claim subject matter from the prior application, whereas continuing applications may introduce new matter (in the case of continuation-in-part applications).
  • The filing of a substitute application typically results in the abandonment of the prior application, which is not necessarily the case with continuing applications.

For more information on patent prosecution, visit: patent prosecution.

For more information on substitute application, visit: substitute application.

A substitute application has a significant impact on the filing date of a patent application. According to MPEP 201.02:

A substitute application does not obtain the benefit of the filing date of the prior application.

This means that if an applicant files a substitute application, it will receive a new filing date based on when it was submitted, rather than inheriting the filing date of the original application it’s replacing. This can have important implications for patent priority and the determination of prior art.

It’s crucial for applicants to understand this distinction, as the filing date can significantly affect the patentability of an invention, especially in fast-moving technological fields.

For more information on patent procedure, visit: patent procedure.

For more information on substitute application, visit: substitute application.

A security interest in a patent or patent application generally does not affect small entity status unless it is defaulted upon. According to 37 CFR 1.27(a)(5):

A security interest does not involve an obligation to transfer rights in the invention for the purposes of paragraphs (a)(1) through (a)(3) of this section unless the security interest is defaulted upon.

This means that an applicant or patentee can take out a loan secured by rights in a patent application or patent without losing small entity status, even if the lender is a large entity. However, if the loan is defaulted upon and the security interest is enforced, resulting in a transfer of rights to a non-small entity, the small entity status would be lost.

In such cases, the USPTO must be notified of the loss of entitlement to small entity status prior to or at the time of paying the earliest of the issue fee or any maintenance fee due after the date on which small entity status is no longer appropriate.

To learn more:

How does a secrecy order affect patent term and maintenance fees?

A secrecy order can have significant impacts on both the patent term and maintenance fees. According to MPEP 120:

“If the application is found to be allowable during the secrecy order period, it will be passed to issue upon the removal or rescission of the secrecy order.”

This means that while under a secrecy order:

  • The patent application’s examination continues, but issuance is delayed.
  • The patent term may be affected, as it typically begins on the issue date.
  • No maintenance fees are due until the patent is issued.

However, the law provides some compensation for these delays. “The term of the patent may be extended for the period of delay due to the secrecy order pursuant to 35 U.S.C. 154(b).” This extension helps to offset the time lost due to the secrecy order, ensuring that inventors don’t lose patent protection time unfairly.

For more information on patent term, visit: patent term.

Tags: patent term

A Secrecy Order significantly impacts the prosecution of a patent application. According to 37 CFR 5.3:

Unless specifically ordered otherwise, action on the application by the Office and prosecution by the applicant will proceed during the time an application is under secrecy order to the point indicated in this section.

Key effects include:

  • Applications under final rejection must be appealed or prosecuted to avoid abandonment, but appeals won’t be set for hearing until the Secrecy Order is removed.
  • Interferences or derivation proceedings won’t be instituted for applications under Secrecy Order.
  • When the application is in condition for allowance, the applicant and the relevant agency will be notified, but no notice of allowance will be issued until the Secrecy Order is removed.
  • International applications under Secrecy Order won’t be transmitted to international authorities or the applicant.

These restrictions ensure that sensitive information remains protected while allowing some progress in the application process.

For more information on international applications, visit: international applications.

For more information on patent prosecution, visit: patent prosecution.

A secrecy order significantly impacts the foreign filing of a patent application. According to MPEP 120:

“The issuance of a secrecy order does not alter the applicant’s right to appeal to the Patent Trial and Appeal Board or to file a civil action under 35 U.S.C. 145 or 146, except that if such appeal or civil action involves national security issues, prior approval of the Commissioner for Patents must be obtained.”

This means:

  • The applicant cannot file the application in foreign countries without permission
  • Foreign filing licenses are not granted while a secrecy order is in effect
  • The applicant must wait for the secrecy order to be lifted before pursuing international patent protection
  • Any attempt to file abroad without authorization could result in abandonment of the U.S. application and other penalties

It’s crucial for inventors to understand these restrictions to maintain their patent rights and avoid legal issues.

For more information on foreign filing license, visit: foreign filing license.

How does a restriction requirement lead to a divisional application?

A restriction requirement often leads to the filing of a divisional application. This process occurs as follows:

  1. An examiner issues a restriction requirement when they believe the original application contains claims to two or more independent or distinct inventions.
  2. The applicant must then elect one invention to pursue in the original application.
  3. The non-elected inventions can be pursued in one or more divisional applications.

As stated in MPEP 201.06:

“The inventions embodied in the claims of a divisional application are generally further characterized as (1) independent inventions or (2) related inventions which are distinct.”

This means that the divisional application allows the applicant to protect inventions that were disclosed but not pursued in the original application due to the restriction requirement.

For more information on Divisional application, visit: Divisional application.

For more information on patent examination, visit: patent examination.

A reissue application differs from a regular patent application in several key ways:

  • Purpose: A reissue application is specifically for correcting defects in an existing, unexpired patent, while a regular application is for obtaining a new patent.
  • Timing: Reissue applications can only be filed for unexpired patents, whereas regular applications are filed before a patent is granted.
  • Scope: Reissue applications are limited to the invention disclosed in the original patent, with some exceptions for broadening reissues.
  • Examination process: The examination of a reissue application focuses on the changes made to correct the defect, in addition to a review of the entire patent.

As stated in MPEP 201.05, “A reissue application is an application for a patent to take the place of an unexpired patent that is defective.” This fundamental difference sets reissue applications apart from regular patent applications. For more detailed information on the reissue process, refer to MPEP Chapter 1400.

To learn more:

A reissue application does not affect the original patent’s term. According to MPEP 201.05, ‘The reissue application is a continuation of the original application and the reissue patent will expire at the same time that the original patent would have expired.’

This means that:

  • The term of the reissue patent remains the same as the original patent.
  • No additional patent term is granted through the reissue process.
  • The expiration date of the reissue patent will be identical to that of the original patent.

It’s important to note that while a reissue doesn’t extend the patent term, it can potentially strengthen or broaden the patent’s claims within the original term, subject to certain limitations such as the two-year rule for broadening reissues.

The patent term is governed by 35 U.S.C. 254, which states: ‘Every reissued patent shall have the same effect and operation in law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such amended form, but in so far as the claims of the original and reissued patents are substantially identical, such surrender shall not affect any action then pending nor abate any cause of action then existing, and the reissued patent, to the extent that its claims are substantially identical with the original patent, shall constitute a continuation thereof and have effect continuously from the date of the original patent.’

To learn more:

While the MPEP 201.02 doesn’t provide detailed definitions, it references 37 CFR 1.9(a) for the definitions of provisional and nonprovisional applications:

  • Provisional Application: A temporary application that establishes an early filing date but does not mature into an issued patent without further action.
  • Nonprovisional Application: A regular patent application that can be examined and potentially result in an issued patent.

Key differences include:

  • Provisional applications have a pendency of 12 months from the filing date.
  • Nonprovisional applications undergo examination, while provisional applications do not.
  • A nonprovisional application must be filed within 12 months of the provisional to claim its filing date benefit.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on patent examination, visit: patent examination.

For more information on patent filing, visit: patent filing.

For more information on provisional application, visit: provisional application.

How does a provisional application affect public disclosure of an invention?

Filing a provisional application does not automatically result in public disclosure of your invention. The MPEP 201.04 states: ‘A provisional application will not be published, and, therefore, no publication fee is required.’

This means that your invention remains confidential when you file a provisional application. However, it’s crucial to understand that:

  • The confidentiality only applies to the USPTO’s handling of your application.
  • If you publicly disclose your invention yourself, it could affect your ability to obtain patents in some countries.
  • The 12-month grace period for filing a nonprovisional application starts from the provisional filing date, not from any public disclosure you might make.

Always consult with a patent attorney before making any public disclosures about your invention, even after filing a provisional application.

For more information on provisional application, visit: provisional application.

For more information on public disclosure, visit: public disclosure.

In pre-AIA patent applications (filed before September 16, 2012), a power of attorney given by the assignee of the entire interest has significant implications for previous powers of attorney. As stated in the MPEP:

A power of attorney by the assignee of the entire interest revokes all powers given by the applicant and prior assignees if the assignee establishes their right to take action as provided in pre-AIA 37 CFR 3.71 and pre-AIA 37 CFR 3.73(b).

This means that when the assignee of the entire interest files a new power of attorney, it effectively cancels all previous powers of attorney given by the applicant or any prior assignees. However, the assignee must properly establish their right to take action in the application according to the relevant regulations.

To learn more:

A plant patent application is a specialized type of patent application designed to protect new varieties of plants. The MPEP 201 states:

A plant application is an application for a plant patent. A plant patent protects a distinct and new variety of plant that is asexually reproduced.

Key differences of plant patent applications include:

  • They are specifically for asexually reproduced plants
  • They protect the entire plant, not just a specific part
  • They have unique requirements for description and claiming

Plant patents are less common than utility or design patents but are crucial for protecting innovations in agriculture and horticulture.

For more information on patent application types, visit: patent application types.

To show ‘sufficient proprietary interest’ for filing a patent application, an individual or entity must demonstrate a significant legal or equitable interest in the invention. According to MPEP 409.05:

Quote: ‘A person who otherwise shows sufficient proprietary interest in the matter may make an application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is appropriate to preserve the rights of the parties.’

To establish sufficient proprietary interest, the applicant must:

  • Provide proof of the relevant facts demonstrating their interest in the invention
  • Show that filing the application is necessary to preserve the rights of all parties involved
  • Submit a petition under 37 CFR 1.46 to the Office of Petitions

The Director of the USPTO will then determine if the evidence sufficiently demonstrates proprietary interest.

To learn more:

Tags: USPTO

According to MPEP 201.01, a PCT (Patent Cooperation Treaty) application can enter the national stage in the United States through the following process:

  1. The applicant must comply with the requirements of 35 U.S.C. 371.
  2. This typically involves submitting the national fee, a copy of the international application (unless previously communicated by the International Bureau), and a translation into English if the international application was filed in another language.
  3. Once these requirements are met, the application is considered a national application under 35 U.S.C. 111(a).

The MPEP states: “An international application enters the national stage when the applicant has fulfilled the requirements of 35 U.S.C. 371.” This process allows inventors to seek patent protection in multiple countries through a single international application.

For more information on 35 U.S.C. 371, visit: 35 U.S.C. 371.

A Patent Cooperation Treaty (PCT) application can become a national application in the United States when certain conditions are met. According to MPEP 201.01:

‘An international application filed under the Patent Cooperation Treaty in which the basic national fee under 35 U.S.C. 41(a)(1)(F) has been paid’ becomes a national application.

This process, known as ‘national stage entry,’ involves the following steps:

  • Filing the appropriate documents with the USPTO
  • Paying the required national fee
  • Providing an English translation if the international application was not filed in English

Once these requirements are fulfilled, the international application effectively becomes a U.S. national application and is processed accordingly.

For more information on national stage entry, visit: national stage entry.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

When a patent examiner encounters an amendment attempting to reference a prior application in a Continued Prosecution Application (CPA), they should not enter the amendment and inform the applicant of this decision.

According to MPEP ¶ 2.34, examiners should use the following language:

“The amendment filed [1] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [2] application of Application No. [3] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

Examiners should fill in the brackets with: [1] the filing date of the amendment, [2] either “continuation” or “divisional”, and [3] the Application Number of the prior nonprovisional application.

For more information on CPA, visit: CPA.

Tags: CPA

When a patent examiner encounters an amendment attempting to refer to a Continued Prosecution Application (CPA) as a continuation or divisional application, they should not enter the amendment. According to MPEP § 201.06(d), examiners are instructed to use Form Paragraph 2.34 to inform the applicant that such amendments will not be entered:

“Use this form paragraph to inform the applicant that an amendment to the first sentence(s) of the specification referring to the CPA as a continuing application of the prior application has not been entered and will not be entered if submitted again.”

The examiner will provide the reason for non-entry, explaining that the CPA request itself serves as the specific reference required by 35 U.S.C. 120, and there is no need to amend the specification to refer back to the prior application.

For more information on CPA, visit: CPA.

Tags: CPA

A national application differs from an international application in several key aspects:

  • Filing Authority: National applications are filed directly with the United States Patent and Trademark Office (USPTO), while international applications are filed under the Patent Cooperation Treaty (PCT).
  • Legal Basis: National applications are filed under 35 U.S.C. 111(a), as stated in MPEP 201.01: ‘A national application may be filed under 35 U.S.C. 111(a) in the U.S. Patent and Trademark Office (USPTO)…’
  • Geographical Scope: National applications are specific to the United States, while international applications can potentially provide patent protection in multiple countries.
  • Examination Process: National applications enter the USPTO examination queue directly, whereas international applications have an international phase before entering national phases in designated countries.

Understanding these differences is crucial for inventors and legal representatives when deciding on their patent filing strategy.

For more information on USPTO, visit: USPTO.

Tags: USPTO

A general authorization allows the USPTO to charge certain fees to your deposit account without requiring specific authorization for each fee. The MPEP states:

A general authorization to charge all fees, or only certain fees, set forth in §§ 1.16 to 1.18 to a deposit account containing sufficient funds may be filed in an individual application, either for the entire pendency of the application or with respect to a particular paper filed.

Key points about general authorizations:

  • They can cover fees under 37 CFR 1.16 and 1.17
  • Fees under 37 CFR 1.19, 1.20, and 1.21 are generally not covered
  • Issue fees (37 CFR 1.18) require a separate authorization after the notice of allowance
  • The authorization should be clear and unambiguous to avoid misinterpretation

Always ensure your deposit account has sufficient funds to cover authorized fees to avoid potential application abandonment or additional expenses.

To learn more:

To designate a domestic representative, a foreign assignee must follow these steps:

  • Prepare a written document signed by the assignee
  • Clearly label the document as ‘Designation of Domestic Representative’
  • Submit the designation as a separate paper from any assignment document
  • Ensure the document is signed in accordance with 37 CFR 1.33(b)

As stated in MPEP 302.04, The designation of domestic representative should always be submitted to the Office as a paper separate from any assignment document. This ensures proper processing and entry into the record of the appropriate application or patent file.

To learn more:

How does a divisional application differ from other continuing applications?

A divisional application is a unique type of continuing application that focuses on a distinct invention separated from a parent application. According to the MPEP:

A divisional application is one filed for an invention which has been disclosed and claimed, but not allowed, in a prior nonprovisional application or international application designating the United States. It is a later application for an independent and distinct invention carved out of a pending application. (MPEP 201.02)

Key differences of a divisional application include:

  • It is filed in response to a restriction requirement in the parent application
  • It claims only subject matter that was disclosed but not claimed in the parent application
  • It does not add new matter
  • It allows the applicant to pursue protection for inventions that were deemed distinct in the original application

Unlike continuations or CIPs, divisional applications are specifically for pursuing separate inventions identified during the examination of the parent application.

To learn more:

Divisional applications and provisional applications are distinct types of patent applications with different purposes and characteristics:

  • Divisional Application: Claims subject matter from a prior non-provisional application that is independent and distinct from the original claims.
  • Provisional Application: A temporary application that establishes a priority date but does not mature into an issued patent.

The MPEP explicitly states in MPEP ¶ 2.01:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.”

This distinction is important because divisional applications claim the benefit under 35 U.S.C. 120, while provisional applications are claimed under 35 U.S.C. 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

A divisional application discloses and claims only subject matter disclosed in the parent application, while a continuation-in-part (CIP) application may include new matter. The MPEP states:

A continuation-in-part application should not be designated as a divisional application. The Court of Appeals for the Federal Circuit has concluded that the protection of the third sentence of 35 U.S.C. 121 does not extend to continuation-in-part applications, stating that ‘the protection afforded by section 121 to applications (or patents issued therefrom) filed as a result of a restriction requirement is limited to divisional applications.’

This means that divisional applications have certain protections against double patenting rejections that CIPs do not have.

To learn more:

A divisional application does not extend the patent term beyond that of the parent application. The term of a patent issuing from a divisional application is calculated from the filing date of the earliest application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c), excluding any benefit claims to provisional applications.

This means that while you can pursue additional patent protection through a divisional application, you don’t get extra time beyond the original 20-year term from the earliest non-provisional filing date.

It’s important to note that patent term adjustments may apply independently to divisional applications based on delays in their own prosecution.

To learn more:

A divisional application’s patent term adjustment (PTA) is calculated independently from its parent application. The MPEP 201.06 provides guidance on this matter:

‘A divisional application will receive its own patent term adjustment under 35 U.S.C. 154(b), which will be calculated based on the prosecution of the divisional application itself.’

Key points to understand:

  • The divisional application’s PTA is based solely on its own prosecution history
  • Any delays or adjustments from the parent application do not affect the divisional’s PTA
  • The PTA calculation starts from the filing date of the divisional application
  • Applicants should monitor the prosecution of the divisional application to ensure accurate PTA calculation

For more information on patent term adjustment, refer to MPEP 2730.

To learn more:

To learn more:

Design patent applications and utility patent applications are distinct types of patent applications, each protecting different aspects of an invention. According to MPEP 201:

‘Design applications are not included in the term ‘nonprovisional’ as used in 37 CFR 1.9. […] Design applications are treated separately in 35 U.S.C. 171-173 and 37 CFR 1.151-1.155.’

Key differences include:

  • Subject Matter: Utility patents protect how an invention works, while design patents protect how it looks.
  • Duration: Utility patents last 20 years from filing, design patents 15 years from grant.
  • Examination Process: Design applications typically have a simpler examination process.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) automatically references the prior application without requiring any specific amendment to the specification.

According to MPEP ¶ 2.34: “As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.”

This means that the act of filing a CPA itself serves as the reference to the prior application, eliminating the need for any additional amendments or references in the specification.

A Continued Prosecution Application (CPA) differs from other types of continuing applications in several ways:

  • CPAs are only available for design applications, not utility applications.
  • Filing a CPA automatically establishes the necessary reference to the prior application under 35 U.S.C. 120, without needing to amend the specification.
  • CPAs are processed differently from other continuing applications, as outlined in MPEP § 201.06(d).

The MPEP states: ‘As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.’ This unique feature distinguishes CPAs from other types of continuing applications, such as continuations or divisionals, which may require explicit references in the specification.

For more information on continuing applications, visit: continuing applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) and a continuation application are both ways to continue prosecution of a patent application, but they have key differences:

  • CPA: Only available for design applications filed before May 29, 2000, and for plant applications. It continues examination of the same application.
  • Continuation: Available for all types of applications and creates a new application that claims priority to the parent application.

The MPEP ¶ 2.34 highlights a crucial distinction in how they reference prior applications:

As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request.

This means that for a CPA, the mere act of filing establishes the reference to the prior application. In contrast, a continuation application typically requires an explicit reference to the parent application in the specification.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

A Continued Prosecution Application (CPA) automatically maintains the priority claim to its parent application without requiring a separate reference. The CPA itself serves as the specific reference required under 35 U.S.C. 120.

The MPEP states: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

This means that filing a CPA automatically establishes a priority claim to the parent application and any earlier applications in the priority chain without additional paperwork.

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent applications, visit: patent applications.

Filing a Continued Prosecution Application (CPA) has specific effects on the status of the prior application:

  • The prior application is abandoned by operation of law upon filing of the CPA.
  • Any appeal in the prior application is dismissed automatically.
  • Any amendment filed with the CPA request is not entered unless it is specifically requested by the applicant.

As stated in the MPEP 201.06(d): ‘The filing of a CPA is not a filing of a new application. Rather, it is a continuation of the pending prior application.’ This means that while the prior application is technically abandoned, its substance continues in the CPA.

It’s important to note that any amendment accompanying the CPA request will be placed in the file but not entered unless the applicant specifically requests it. This allows applicants to submit potential amendments without automatically changing the application’s content.

For more information on CPA, visit: CPA.

Tags: CPA

Filing a Continued Prosecution Application (CPA) has several effects on the examination process:

  • The CPA is treated as a continuation of the prior application for examination purposes
  • Information Disclosure Statements from the prior application are automatically considered in the CPA
  • Affidavits and declarations from the prior application carry over to the CPA
  • A terminal disclaimer filed in the parent application carries over to the CPA
  • For examination priority, CPAs are treated as ‘amended’ applications rather than ‘new’ applications if an Office action was issued in the prior application

MPEP 201.06(d) notes: For examination priority purposes only, the USPTO will treat continuation CPAs as if they were ‘amended’ applications (as of the CPA filing date) and not as ‘new’ applications. This treatment is limited to CPAs in which the prior application has an Office action issued by the examiner.

For more information on design patents, visit: design patents.

For more information on patent prosecution, visit: patent prosecution.

For more information on USPTO procedures, visit: USPTO procedures.

Filing a Continued Prosecution Application (CPA) can impact the examination process and priority. Key points include:

  • CPAs are generally treated as “amended” applications for examination priority purposes
  • This may result in faster first Office actions compared to new applications
  • Preliminary amendments should be filed with the CPA to avoid potential denial of entry
  • Information Disclosure Statements (IDS) from the prior application are automatically considered

As stated in the MPEP:

For examination priority purposes only, the USPTO will treat continuation CPAs as if they were “amended” applications (as of the CPA filing date) and not as “new” applications. This treatment is limited to CPAs in which the prior application has an Office action issued by the examiner.

Applicants can request a three-month suspension of action under 37 CFR 1.103(b) if more time is needed to prepare amendments or an IDS. Affidavits and declarations from the parent application automatically become part of the CPA.

A Continued Prosecution Application (CPA) automatically maintains the benefit claim to earlier applications. The MPEP states:

A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. That is, the CPA includes the request for an application under 37 CFR 1.53(d) and the recitation of the application number of the prior application in such request is the ‘specific reference to the earlier filed application’ required by 35 U.S.C. 120.

This means that filing a CPA automatically establishes a benefit claim to the prior application and any earlier applications in the chain, without the need for a separate statement in the specification or application data sheet. However, if the prior application claimed benefit of earlier applications, those benefit claims must still be present in the prior application.

For more information on continuation applications, visit: continuation applications.

For more information on patent priority, visit: patent priority.

Continued Prosecution Applications (CPAs) automatically carry over certain aspects from the parent application. Specifically:

  • Priority claims under 35 U.S.C. 119(a)-(d) made in the parent application automatically carry over to a CPA.
  • A terminal disclaimer filed in the parent application carries over to a CPA.

The MPEP explains: Priority claims under 35 U.S.C. 119(a)-(d) made in a parent application will automatically carry over to a CPA. A terminal disclaimer filed in the parent application carries over to a CPA.

This automatic carry-over occurs because the CPA retains the same application number as the parent application.

For more information on patent applications, visit: patent applications.

Filing a Continued Prosecution Application (CPA) can affect patent term because it results in a new filing date. While the CPA retains the benefit of the earlier filing date for prior art purposes, the actual filing date of the CPA is used for calculating patent term. The MPEP notes: Applicants will not be permitted to delete such a benefit claim as to certain applications assigned that application number (e.g., for patent term purposes). This means that the patent term for a CPA will generally be shorter than if the original application had been allowed, as the term is calculated from the CPA filing date, not the original application’s filing date.

To learn more:

Tags: CPA, patent term

Filing a Continued Prosecution Application (CPA) can have important implications for both patent term and prior art dates:

Patent Term:

  • A CPA is a continuation of the prior application, so it does not get a new 15-year term from filing
  • The 15-year term for a design patent issuing from a CPA is measured from the filing date of the earliest application in the chain that is subject to the 15-year term

Prior Art Dates:

  • The effective filing date of a CPA for prior art purposes is generally the actual filing date of the CPA
  • However, the CPA can claim the benefit of the prior application’s filing date for subject matter disclosed in the prior application

The MPEP notes: “A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No amendment in an application under this paragraph may delete this specific reference to any prior application.” (37 CFR 1.53(d)(7))

This means the CPA is automatically considered a continuation for benefit claim purposes, which can affect both term and prior art dates.

For more information on benefit claims, visit: benefit claims.

For more information on patent term, visit: patent term.

For more information on prior art, visit: prior art.

The inventorship in a Continued Prosecution Application (CPA) generally remains the same as in the prior application. The MPEP states, The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA. If changes to inventorship are needed, they must be made through a specific request under 37 CFR 1.48.

To learn more:

Tags: CPA, inventorship

Filing a Continued Prosecution Application (CPA) has implications for the confidentiality of the application. As stated in the MPEP:

A CPA is construed to include a waiver of confidentiality by the applicant under 35 U.S.C. 122 to the extent that any member of the public who is entitled under the provisions of 37 CFR 1.14 to obtain access to, copies of, or information concerning either the prior application or any continuing application filed under the provisions of 37 CFR 1.53(d) may be given similar access to, copies of, or similar information concerning, the other application(s) in the application file.

This means:

  • The CPA is treated as a waiver of confidentiality for the prior application
  • Members of the public who have access to the CPA may also be given access to the prior application
  • This applies to all applications in the chain of CPAs

Applicants should consider this loss of confidentiality when deciding whether to file a CPA or a new application under 37 CFR 1.53(b).

For more information on Patent application access, visit: Patent application access.

For more information on public information, visit: public information.

A Continued Prosecution Application (CPA) automatically maintains the benefit claim to the prior application under 35 U.S.C. 120 without requiring a separate statement. Key points include:

  • The CPA request itself serves as the specific reference required by 35 U.S.C. 120
  • No amendment to the specification or application data sheet is needed to maintain the benefit claim
  • The benefit claim extends to all applications in a chain of CPAs

As stated in the MPEP: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on patent applications, visit: patent applications.

A Continued Prosecution Application (CPA) has specific effects on benefit claims and references to prior applications:

  • The CPA request itself serves as the specific reference required by 35 U.S.C. 120
  • No amendment to the specification or application data sheet is required or permitted to reference the prior application
  • A CPA automatically includes a benefit claim to all applications in the chain of CPAs with the same application number

As stated in the MPEP:

A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No amendment in an application under this paragraph may delete this specific reference to any prior application.

This means that applicants cannot selectively delete benefit claims to certain applications in the CPA chain. When referencing a CPA in a later application, the reference incorporates the entire chain of applications with that application number.

A Continued Prosecution Application (CPA) is a unique type of continuing application that has specific limitations. According to MPEP 201.02:

A ‘continued prosecution application’ (CPA) is a continuation or divisional application for an invention disclosed in a prior nonprovisional application filed under 37 CFR 1.53(b) or (d). A CPA can only be filed in a design application.

Key differences of CPAs compared to other continuing applications:

  • Limited to design applications: CPAs can only be filed for design patents, not utility or plant patents.
  • Automatic abandonment: Filing a CPA automatically abandons the prior application.
  • Simplified filing: CPAs can be filed with fewer formalities than other continuing applications.
  • Examination continuation: The examination process continues from where it left off in the parent application.

It’s important to note that CPAs are no longer available for utility or plant applications filed on or after May 29, 2000. For these types of applications, applicants must use other forms of continuing applications, such as RCEs (Requests for Continued Examination).

For more information on continued prosecution application, visit: continued prosecution application.

For more information on continuing applications, visit: continuing applications.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

How does a continuing application claim benefit to a prior-filed international application?

A continuing application can claim benefit to a prior-filed international application that designates the United States. The MPEP 211.01(b) states:

‘A nonprovisional application may claim benefit under 35 U.S.C. 120 to an international application designating the United States only if the international application was filed on or after November 29, 2000.’

To claim this benefit, the following conditions must be met:

  • The international application must designate the United States
  • It must be filed on or after November 29, 2000
  • The benefit claim must be made in accordance with 37 CFR 1.78
  • The continuing application must be filed while the international application is pending before the USPTO or within the time period set in 35 U.S.C. 120, 121, 365(c), or 386(c)

It’s important to note that the benefit claim is to the international application itself, not to its national stage in the United States.

To learn more:

To learn more:

A continuation-in-part (CIP) application and a provisional application are two distinct types of patent applications with different purposes and effects. The key difference is highlighted in MPEP ¶ 2.06, which states:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation-in-part’ of the provisional application.

This means that:

  • A CIP application builds upon a prior non-provisional application, adding new disclosure while claiming the benefit of the earlier filing date for the shared content.
  • A provisional application is a temporary placeholder that establishes a priority date but does not mature into a patent. It cannot be continued or have a CIP.
  • Applications claiming benefit from a provisional application are typically filed as new non-provisional applications, not as CIPs.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

How does a continuation-in-part application affect the priority date?

A continuation-in-part (CIP) application can have different priority dates for different parts of the disclosure. According to MPEP 201.08:

‘The continuation-in-part application may be entitled to the benefit of the filing date of the prior application as to the common subject matter disclosed in compliance with 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph.’

This means:

  • Content shared with the parent application retains the earlier priority date.
  • New matter added in the CIP has the filing date of the CIP as its priority date.
  • Different claims in the CIP may have different priority dates based on their disclosure in the parent or CIP application.

Understanding these priority date implications is crucial for determining patentability and prior art considerations.

For more information on new matter, visit: new matter.

Tags: new matter

A continuation-in-part (CIP) application can have a complex effect on patent term. The MPEP 201.08 states:

‘A continuation-in-part application is entitled to the benefit of the filing date of an earlier nonprovisional application as to common subject matter.’

This has several implications for patent term:

  • 20-year term: The patent term is generally 20 years from the earliest effective U.S. filing date of the first nonprovisional application in the chain.
  • New matter: Claims solely supported by new matter in the CIP do not receive the benefit of the earlier filing date, potentially extending their effective term.
  • Priority claims: The ability to claim priority to earlier applications can affect the starting point of the 20-year term.
  • Patent term adjustment: Delays in prosecution may lead to patent term adjustments, which can extend the term beyond 20 years.

Applicants should carefully consider the impact on patent term when deciding to file a CIP, especially for rapidly evolving technologies where a longer term might be advantageous.

For more information on new matter, visit: new matter.

For more information on patent term, visit: patent term.

For more information on patent term adjustment, visit: patent term adjustment.

A continuation-in-part (CIP) application is a type of continuing application that differs from a regular continuation in its content and priority claims. According to MPEP 201.08:

‘A continuation-in-part is an application filed during the lifetime of an earlier nonprovisional application, repeating some substantial portion or all of the earlier nonprovisional application and adding matter not disclosed in the said earlier nonprovisional application.’

Key differences between CIP and regular continuation applications:

  • New Matter: CIPs include new subject matter not present in the parent application, while regular continuations do not.
  • Priority Date: CIPs have different priority dates for different parts of the disclosure. The new matter gets the CIP’s filing date, while common subject matter retains the parent’s filing date.
  • Examination: CIPs are examined for both the old and new subject matter, potentially requiring additional prior art searches.
  • Term: The patent term for a CIP may be affected by the new subject matter’s later filing date.

CIPs are useful when inventors want to add new improvements or developments to their original invention while maintaining the priority date for the original subject matter.

For more information on continuing applications, visit: continuing applications.

How does a continuation-in-part (CIP) application affect priority claims?

A continuation-in-part (CIP) application introduces new matter not present in the prior application, which affects priority claims as follows:

  • Claims fully supported by the prior application retain the benefit of the earlier filing date.
  • Claims relying on new matter only receive the filing date of the CIP application.
  • As stated in MPEP 211.01(b): “Only the claims of the continuation-in-part application that are disclosed in the manner provided by 35 U.S.C. 112(a) in the prior-filed application are entitled to the benefit of the filing date of the prior-filed application.”

Examiners must analyze each claim individually to determine its effective filing date. This can result in different claims within the same CIP application having different priority dates.

To learn more:

Continuation applications and provisional applications are distinct types of patent applications with different purposes and requirements. A key difference is that a continuation application is based on a prior nonprovisional application, while a provisional application is a standalone filing that can later be used as a priority document.

The MPEP specifically notes:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the provisional application.”

This guidance also applies to continuation applications. Provisional applications serve as temporary placeholders and do not undergo examination, while continuation applications are fully examined and build upon previously filed nonprovisional applications.

To learn more:

While both continuation and continuation-in-part (CIP) applications are types of continuing applications, they have a key difference in terms of their disclosure. According to the MPEP:

The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

The main differences are:

  • Continuation: Contains the same disclosure as the parent application without any new matter.
  • Continuation-in-part (CIP): May include the disclosure from the parent application plus additional new matter.

This distinction is crucial because it affects the priority date for different claims in the application. In a continuation, all claims are entitled to the parent’s filing date. In a CIP, only claims supported by the parent application get the benefit of the earlier filing date; new matter gets the filing date of the CIP.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

A continuation application can have significant implications for the patent term. Here are key points to understand:

  • Patent Term Calculation: The term of a patent stemming from a continuation application is generally calculated from the filing date of the earliest application in the chain to which priority is claimed.
  • 20-Year Term: Under current U.S. law, utility and plant patents have a term of 20 years from the earliest effective U.S. filing date of the application.
  • No Extension of Monopoly: As stated in MPEP 201.07, ‘The filing of a continuation application does not extend the term of the patent to be granted on the continuing application because the term of a patent issuing on a continuation application is measured from the filing date of the earliest application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c).’
  • Patent Term Adjustment: While the base term is not extended, a continuation may be eligible for patent term adjustment due to delays in prosecution, which can effectively extend the term.

It’s important to note that while continuation applications don’t extend the base patent term, they can provide strategic advantages in terms of claim scope and prosecution timing.

To learn more:

A continuation-in-part (CIP) application differs from a regular continuation application in that it adds new disclosure not present in the prior application. While both types of applications repeat substantial portions of a prior application, only a CIP introduces new subject matter.

The MPEP states: This application repeats a substantial portion of prior Application No.[1], filed[2], and adds disclosure not presented in the prior application. (MPEP ¶ 2.06) This additional disclosure is what sets a CIP apart from a standard continuation.

For more information on continuation application, visit: continuation application.

For more information on patent application types, visit: patent application types.

37 CFR 1.63(d) provides a simplified process for submitting an oath or declaration in a divisional application. The MPEP states:

’37 CFR 1.63(d) provides that a newly executed oath or declaration is not required in a continuation or divisional application filed by all or by fewer than all of the inventors named in a prior nonprovisional application containing a signed oath or declaration.’

This means that if the divisional application is filed by the same inventor(s) as the parent application, and there’s no new matter added, the oath or declaration from the parent application can be used for the divisional application. This simplifies the filing process and reduces paperwork.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on oath or declaration, visit: oath or declaration.

37 CFR 1.57(b) is closely tied to priority claims in patent applications. For an amendment to comply with this regulation, the claim for priority or benefit of the prior-filed application must have been present on the filing date of the current application.

The MPEP specifically states that an amendment may not comply with 37 CFR 1.57(b) if the claim for priority/benefit of the prior-filed application was not present on the filing date of the present application. This requirement ensures that the incorporation by reference is based on a properly established relationship between the current application and the prior-filed application.

If the priority claim was not present at filing, the applicant cannot use 37 CFR 1.57(b) to incorporate material from the prior-filed application, even if that material was inadvertently omitted.

For more information on 37 CFR 1.57(b), visit: 37 CFR 1.57(b).

For more information on incorporation by reference, visit: incorporation by reference.

For more information on patent applications, visit: patent applications.

For international applications, 37 CFR 1.57(b)(1) specifies:n

    n

  • Any amendment will only be effective as to the United States and shall have no effect on the international filing date
  • n

  • It cannot be relied upon to accord an international filing date or alter the filing date under PCT Article 11
  • n

  • No request to add omitted material will be acted on prior to national stage entry under 37 CFR 1.491 or filing of a US application claiming benefit of the international application
  • n

35 U.S.C. 365(c) is a crucial provision for claiming the benefit of an international application’s filing date in a subsequent national application. As explained in MPEP 211.01(c):

The first sentence of 35 U.S.C. 365(c) specifically provides that ‘[i]n accordance with the conditions and requirements of section 120,… a national application shall be entitled to the benefit of the filing date of a prior international application designating the United States.’

This provision allows applicants to claim the priority of an international application in a later-filed U.S. national application, provided they meet the conditions set forth in 35 U.S.C. 120. One key condition is timing, as the MPEP notes:

The condition of 35 U.S.C. 120 relating to the time of filing requires the later application to be ‘filed before the patenting or abandonment of or termination of proceedings on the first application….’

This means that the national application must be filed while the international application is still pending to claim its benefit.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on 35 U.S.C. 365(c), visit: 35 U.S.C. 365(c).

35 U.S.C. 365 addresses the right of priority for international applications in two key aspects:

  1. National applications based on international applications
  2. International applications based on foreign applications

The MPEP states:

“35 U.S.C. 365(a) provides that a national application shall be entitled to the right of priority based on a prior international application of whatever origin, which designated any country other than, or in addition to, the United States.”

“35 U.S.C. 365(b) provides that an international application designating the United States shall be entitled to the right of priority of a prior foreign application which may either be another international application or a regularly filed foreign application.”

These provisions ensure that applicants can claim priority based on international applications, enhancing the flexibility of the international patent system.

If an inventor becomes legally incapacitated after signing the oath or declaration, the application can still proceed. According to MPEP 409.01:

If an inventor who executed the oath or declaration becomes legally incapacitated after the application is filed but before the patent issues, no substitute oath or declaration is required.

This means that the previously signed oath or declaration remains valid, and the application can continue through the patent process without requiring additional documentation regarding the inventor’s incapacitation.

To learn more:

Claiming the benefit of a prior application in a continuation is a crucial step that must be done correctly. The MPEP 201.07 provides specific guidance:

If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§1.76(b)(5)). The reference also must identify the relationship of the applications, namely, whether the later-filed application is a continuation, divisional, or continuation-in-part of the prior-filed nonprovisional application, international application, or international design application.

To properly claim the benefit:

  1. Include a reference to the prior application in the Application Data Sheet (ADS)
  2. Specify the application number, filing date, and relationship (continuation) of the applications
  3. Ensure the claim is made within the time period set in 37 CFR 1.78
  4. Pay any required fees

Failure to properly claim benefit can result in loss of the earlier filing date, so it’s crucial to follow these steps carefully.

For more information on continuation application, visit: continuation application.

For more information on patent law, visit: patent law.

USPTO examiners have a specific internal process for obtaining title reports when needed. The MPEP outlines this process:

Examiners may obtain a title report using the PALM Intranet (select “General Information,” insert the appropriate application number, select “Search,” select “Assignments”). The screen resulting from the search may be printed to yield the copy of the title report.

This internal system allows examiners to access ownership information efficiently when required for their examination duties.

USPTO employees are legally obligated to maintain the confidentiality of pending patent applications. According to MPEP 101:

All U.S. Patent and Trademark Office employees are legally obligated to preserve pending applications for patents in confidence until they are published or patented in accordance with 35 U.S.C. 122 and 37 CFR 1.14.

This includes several practices:

  • Not reproducing or copying application documents except for official purposes
  • Properly handling and storing application files
  • Using appropriate envelopes for interoffice mail
  • Being careful during interviews to prevent exposure of other applicants’ files

Violations of these confidentiality requirements can result in suspension, removal, and even criminal penalties.

For more information on USPTO employees, visit: USPTO employees.

USPTO employees are legally obligated to maintain the confidentiality of pending patent applications. The MPEP states:

“All U.S. Patent and Trademark Office employees are legally obligated to preserve pending applications for patents in confidence until they are published or patented in accordance with 35 U.S.C. 122 and 37 CFR 1.14.”

Employees must follow strict procedures to ensure confidentiality, including:

  • Not reproducing or copying application documents except for official purposes
  • Properly handling and storing application files
  • Using appropriate envelopes for interoffice mail
  • Being cautious during interviews to prevent exposure of other applications

Violations of these procedures can result in suspension, removal, or even criminal penalties.

The first inventor to file provisions that took effect on 3/16/2013 require additional statements for certain “transition” applications:

– Transition applications are those filed on or after 3/16/2013 that claim priority to an application filed before 3/16/2013.
– If a transition application ever contained a claim having an effective filing date on or after 3/16/2013, a statement to that effect is required within the later of 4 months from the actual filing date, 4 months from national stage entry, 16 months from the prior application, or the date the claim was first presented.
– This statement requirement does not apply if the application only claims priority to applications filed on or after 3/16/2013, or if the applicants reasonably believe the application never contained such a claim.

See MPEP 210 and MPEP 2159 for more details.

The first inventor to file provisions of the America Invents Act (AIA) have significant implications for priority and benefit claims, particularly for applications filed on or after March 16, 2013. Key points include:

  1. The effective filing date of each claimed invention determines whether an application is subject to examination under AIA or pre-AIA 35 U.S.C. 102 and 103.
  2. Applications that contain or contained at any time a claim with an effective filing date on or after March 16, 2013, are subject to the AIA version of 35 U.S.C. 102 and 103.
  3. Applications that claim priority to or benefit of a pre-AIA application may be subject to additional requirements.

As stated in the MPEP: These provisions apply to any application for patent, and to any patent issuing thereon, that contains or contained at any time— (A) a claim to a claimed invention that has an effective filing date as defined under section 100(i) of title 35, United States Code, that is on or after March 16, 2013; or (B) a specific reference under section 120, 121, or 365(c) of title 35, United States Code, to any patent or application that contains or contained at any time such a claim. (MPEP 210)

For transition applications (those filed on or after March 16, 2013, that claim priority to or benefit of a pre-AIA application), applicants may need to provide a statement regarding the presence of claims with an effective filing date on or after March 16, 2013. This requirement is outlined in 37 CFR 1.55(k) and 1.78(a)(6) and (d)(6).

For more information on effective filing date, visit: effective filing date.

For more information on first inventor to file, visit: first inventor to file.

For more information on pre-AIA, visit: pre-AIA.

For more information on transition applications, visit: transition applications.

Secrecy Orders have significant impacts on foreign filing licenses:

  • A Secrecy Order prevents the granting of a foreign filing license.
  • It overrides the 6-month rule, prohibiting foreign filing even after 6 months.
  • Applications under a Secrecy Order cannot be exported or filed in foreign countries.
  • Violating a Secrecy Order can result in abandonment of the invention and other penalties.

The MPEP states: “Only the imposition of a Secrecy Order will cause revocation of the authority which arises from 35 U.S.C. 184 to file a foreign application 6 months or later after the date of filing of a corresponding U.S. patent application.”

For more information on Secrecy Orders, refer to MPEP 120.

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

How do reissue applications differ from original patent applications?

Reissue applications are distinct from original patent applications in that they are used to correct errors in already-issued patents. The MPEP 201 states, “An application for reissue of a patent is an application for a new patent to correct an error in an unexpired patent as provided in 37 CFR 1.171 through 1.178.”

Key differences include:

  • Purpose: To correct errors in existing patents, not to obtain new patents
  • Timing: Filed after a patent has been issued and while it’s still unexpired
  • Legal basis: Filed under 35 U.S.C. 251 and subject to specific regulations
  • Content: Must include a copy of the original patent and point out the error(s) to be corrected
  • Examination: Focuses on the proposed changes and their impact on patentability

Reissue applications provide a mechanism for patent holders to address issues in their patents, potentially broadening or narrowing claims, or correcting other substantive errors.

For more information on reissue applications, visit: reissue applications.

The requirements for power of attorney in patent applications differ based on the filing date:

  • For applications filed on or after September 16, 2012: Refer to MPEP § 402.02(a) for detailed information and relevant forms.
  • For applications filed before September 16, 2012: Consult MPEP § 402.02(b) for specific details and applicable forms.

The MPEP 601.02 states: “See MPEP § 402.02(a) for detailed information and relevant forms pertaining to appointment of a power of attorney in applications filed on or after September 16, 2012. See MPEP § 402.02(b) for detailed information and relevant forms pertaining to appointment of a power of attorney in applications filed before September 16, 2012.”

This distinction is important as it affects the specific procedures and forms required for appointing a power of attorney.

To learn more:

When multiple assignees seek to take action in a patent matter, each partial assignee must provide a submission under 37 CFR 3.73(c). According to the MPEP:

In each submission, the extent of each assignee’s interest must be set forth so that the Office can determine whether it has obtained action by the entirety of the right, title and interest holders (owners). 37 CFR 3.73(c)(2)(i).

Assignees have two options:

  1. Specify the percentage of ownership interest for each assignee, accounting for 100% of ownership.
  2. Identify all parties (including inventors) who together own the entire right, title, and interest, and state that all identified parties own the entire right, title, and interest.

The MPEP warns: “If the extent of the partial assignee’s ownership interest is not set forth in the submission under 37 CFR 3.73(c), the Office may refuse to accept the submission as an establishment of ownership interest.”

To verify if someone is authorized to conduct business with the USPTO for a patent application filed after September 16, 2012, you can follow these steps:

  • Check if the person is listed as the applicant or an assignee
  • Verify if they are a registered patent practitioner
  • Look for a power of attorney or authorization of agent document
  • Confirm if they are named as an inventor in the application

The USPTO maintains specific rules about who can correspond regarding patent applications. As stated in MPEP 403.01(a):

For applications filed on or after September 16, 2012, … the applicant’s or patent owner’s correspondence address … is the correspondence address of the patent practitioner appointed in a power of attorney or authorization of agent, or if no practitioner is appointed, the correspondence address of the applicant or patent owner.

If you’re unsure, it’s best to contact the USPTO directly for clarification.

To learn more:

Tags: USPTO

To use a Certificate of Mailing or Transmission, you must include a signed certification with your correspondence. The MPEP provides suggested formats for these certificates:

“The following are suggested formats for either a Certificate of Mailing or Certificate of Transmission under 37 CFR 1.8(a). The certification may be included with all correspondence concerning this application or proceeding to establish a date of mailing or transmission under 37 CFR 1.8(a).”

The certificate should include:

  • A statement certifying the date of mailing or transmission
  • The signature of the person making the certification
  • The application number (if known)

It’s important to note that the certificate must be signed by someone with a reasonable basis to expect the correspondence would be mailed or transmitted on or before the date indicated.

To learn more:

How do I update the list of practitioners associated with a Customer Number?

To update the list of practitioners associated with a Customer Number, follow these steps:

  1. Complete the Change of Correspondence Address Form (PTO/SB/122)
  2. Provide the Customer Number and the updated list of registered practitioners
  3. Submit the form to the USPTO

The MPEP 403 specifies:

‘A request to change the correspondence address or list of registered practitioners associated with a Customer Number must be made in writing.’

It’s important to note that:

  • Only registered practitioners can be added to a Customer Number
  • Changes will affect all applications associated with the Customer Number
  • The USPTO recommends using the online Electronic Business Center (EBC) for faster processing

Keeping the practitioner list up-to-date ensures proper communication and representation for all linked patent applications.

For more information on Customer Number, visit: Customer Number.

For more information on USPTO correspondence, visit: USPTO correspondence.

How do I submit supporting documents for electronic assignment submissions?

When submitting assignment documents electronically, you can include supporting documents as follows:

  • Upload supporting documents as separate PDF files along with the main assignment document.
  • Ensure each supporting document is less than 25 MB in size.
  • Include a brief description for each supporting document during the submission process.

According to MPEP 302.10, ‘Supporting documents can be submitted as PDF files via EFS-Web and EPAS.’ This allows for a comprehensive submission of all relevant materials related to the assignment.

To learn more:

To submit color drawings in a utility patent application, you must file a petition under 37 CFR 1.84(a)(2). The petition must include:

  1. The fee set forth in 37 CFR 1.17(h)
  2. One set of color drawings if submitted via the USPTO electronic filing system, or three sets if not submitted electronically
  3. An amendment to the specification inserting the following language as the first paragraph of the brief description of the drawings: ‘The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.’

The petition must explain why color drawings are necessary. Color drawings will only be accepted if the USPTO determines that color is the only practical medium for illustrating the claimed invention.

To learn more:

To submit a large biological sequence listing (over 100MB) on optical discs for a patent application, follow these guidelines:

  • Use read-only optical discs (e.g., CD-R, DVD-R).
  • Ensure the sequence listing is in ASCII text format.
  • Include two copies of the optical disc containing identical sequence listings.
  • Label each disc with the following information:
    • Name of the applicant
    • Title of the invention
    • Application number (if known)
    • Filing date (if known)
    • Disc number (e.g., ‘1 of 2’, ‘2 of 2’)
  • Include a statement in the specification that incorporates the sequence listing by reference.

MPEP 608.05(c) states: “Sequence listings may be submitted […] on read-only optical discs when the sequence listing file size is over 100 megabytes.”

Ensure that the submission complies with the requirements set forth in 37 CFR 1.821-1.825 and follows the specific guidelines for optical disc submissions outlined in MPEP 608.05.

To learn more:

To submit a biological sequence listing for a patent application, follow these steps:

  • Prepare the sequence listing in accordance with 37 CFR 1.821-1.825.
  • Submit the sequence listing as a separate part of the application.
  • If the sequence listing is 100KB or less, you can include it in the specification or submit it as a text file via EFS-Web or PatentCenter.
  • For sequence listings larger than 100KB, submit them on read-only optical discs.
  • Ensure the sequence listing is in ASCII text format.
  • Include a statement that the content of the sequence listing is incorporated by reference in the application.

As stated in MPEP 608.05(c): “Sequence listings may be submitted in electronic form via EFS-Web or PatentCenter as ASCII text files or PDF files up to 100 megabytes, and on read-only optical discs when the sequence listing file size is over 100 megabytes.”

To learn more:

For patent applications filed before July 1, 2022, biological sequence listings should be submitted as follows:

  1. Prepare a “Sequence Listing” as an ASCII plain text file.
  2. Ensure the file complies with 37 CFR 1.821 – 1.824.
  3. Submit the file via the USPTO patent electronic filing system or on a read-only optical disc.

As stated in MPEP 608.05(c): “For applications filed before July 1, 2022, the sequence listing can be a ‘Sequence Listing’ (as an ASCII plain text file in compliance with 37 CFR 1.821 – 1.824) submission must be submitted via the USPTO patent electronic filing system or on read-only optical disc.”

For detailed information, refer to MPEP §§ 2420 et seq.

To learn more:

When filing a patent application, you must specify a correspondence address in one of two ways:

  • In an application data sheet (ADS) under 37 CFR 1.76, or
  • Elsewhere in the application papers in a clearly identifiable manner

As stated in 37 CFR 1.33(a): When filing an application, a correspondence address must be set forth in either an application data sheet (§ 1.76), or elsewhere, in a clearly identifiable manner, in any paper submitted with an application filing.

This address will be used by the USPTO to send all official communications regarding your application.

To learn more:

How do I set up a deposit account with the USPTO?

To set up a deposit account with the USPTO:

  1. Visit the USPTO Deposit Accounts page
  2. Download and complete the Deposit Account Application Form
  3. Submit the form with an initial deposit (minimum $1,000)
  4. Wait for account approval and receive your account number

According to MPEP 509: ‘A deposit account may be established by submitting a completed Deposit Account Application Form with an initial deposit of at least $1,000.’ This account can be used for future fee payments, offering convenience for frequent USPTO transactions.

To learn more:

To revoke a power of attorney in a patent application:

  • The applicant or assignee of the entire interest must submit a revocation signed by them.
  • The revocation should be submitted to the USPTO in writing.
  • It can be done by filing a new power of attorney (Form PTO/AIA/82) and checking the revocation box.
  • Alternatively, you can submit a document specifically revoking the previous power of attorney.

As stated in the MPEP 402: ‘A power of attorney may be revoked at any stage in the proceedings of a case.’ It’s important to note that revoking a power of attorney does not remove attorneys from the list of patent practitioners associated with an application. To do that, you must file a separate request.

For more information on power of attorney, visit: power of attorney.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

How do I retrieve a priority document from a foreign IP office using PDX?

To retrieve a priority document from a foreign IP office using PDX:

  • Ensure the foreign IP office participates in PDX.
  • File an application with the USPTO that claims priority to the foreign application.
  • Submit a Request to Retrieve through EFS-Web or Patent Center.
  • Include the foreign application number, country code, and filing date.
  • The USPTO will attempt to retrieve the document electronically.

According to MPEP 215.01: “The USPTO will attempt to electronically retrieve the priority document through the WIPO DAS […] or through a bilateral PDX agreement.”

To learn more:

To request retrieval of a foreign priority document through the Priority Document Exchange (PDX) program, follow these steps:

  1. Ensure that the foreign application is from a participating office in the PDX program.
  2. File an application data sheet (ADS) including a proper priority claim to the foreign application.
  3. Submit a request for retrieval of the foreign priority document.

The MPEP 215.01 states: “To authorize retrieval of a priority document via PDX, the applicant should submit the request electronically via EFS-Web using the Priority Document Exchange Request form (PTO/SB/38) or as a pre-grant (PGPub) request via Private PAIR.” It’s important to note that the request should be made within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To request deletion of a named inventor in a Continued Prosecution Application (CPA) for design applications, you need to file a proper request with the USPTO. According to MPEP § 201, specifically paragraph 2.32:

In a continued prosecution application (CPA) for a design application (37 CFR 1.53(d)), a request to delete a named inventor from the prior application may be submitted by way of a letter to the examiner or a request for corrected filing receipt. However, it should be noted that this is only available for design applications.

This process is specific to design applications and allows for the correction of inventorship in CPAs.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on USPTO procedures, visit: USPTO procedures.

To request copies of patent assignment records, follow these steps:

  1. For records after May 1, 1957: Contact the USPTO and pay the fee set forth in 37 CFR 1.19.
  2. For records before May 1, 1957: Contact the National Archives and Records Administration (NARA) directly.
  3. For recent records: Check the USPTO website for online availability.

When requesting a copy, the MPEP advises: “An order for a copy of an assignment or other document should identify the reel and frame number where the assignment or document is recorded.” Failure to provide this information may result in additional charges.

How do I request a Customer Number from the USPTO?

To request a Customer Number from the USPTO, follow these steps:

  1. Complete the Customer Number Request Form (PTO/SB/125)
  2. Include the names of registered practitioners associated with the Customer Number
  3. Provide the correspondence address for the Customer Number
  4. Submit the form to the USPTO

According to MPEP 403, ‘A Customer Number may be requested by (A) a registered attorney or agent of record, (B) an assignee of the entire interest of the applicant, or (C) the applicant.’ The USPTO will process the request and assign a unique Customer Number, which can then be used for managing correspondence and access to patent applications.

For more information on USPTO Forms, visit: USPTO Forms.

Tags: USPTO Forms

To record an assignment document with the USPTO, you must:

  • Submit a copy of the original assignment document
  • Include a completed cover sheet (Form PTO-1595 or equivalent)
  • Pay the required recording fee

The cover sheet must contain key information like the names of the parties, description of the interest conveyed, and patent/application numbers affected. As stated in MPEP 302.07: “Each assignment document submitted to the Office for recording must be accompanied by a cover sheet as required by 37 CFR 3.28.”

Documents can be submitted electronically via EPAS, by mail, or by fax. Electronic submission is recommended as it has a $0 fee.

For more information on assignment recording, visit: assignment recording.

For more information on cover sheet, visit: cover sheet.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

To record a security interest in a patent or patent application:

  • Submit the document to be recorded to the USPTO’s Assignment Recordation Branch.
  • Include a cover sheet with the necessary information, as specified in MPEP 313.
  • Pay the required fee.

The MPEP states: Documents other than assignments are recorded in the same manner as assignments. The document and cover sheet should be mailed to the Office of Public Records Document Services Division for recording.

For more information on USPTO, visit: USPTO.

Tags: USPTO

To record a joint research agreement (JRA) with the USPTO, follow these steps:

  1. Prepare the JRA document or an excerpt of it
  2. Complete a cover sheet, clearly identifying the document as a “joint research agreement”
  3. Submit the document and cover sheet to the USPTO

As stated in MPEP 302.07: “If the document submitted for recordation is a joint research agreement or an excerpt of a joint research agreement, the cover sheet must clearly identify the document as a ‘joint research agreement’.”

The cover sheet for a JRA must include:

  • The name of the owner of the application or patent
  • The name of each other party to the joint research agreement
  • The date the joint research agreement was executed

JRAs can be submitted electronically via EPAS, by mail, or by fax, following the same procedures as other assignment documents.

For more information on joint research agreement, visit: joint research agreement.

Recording a government interest in a patent requires special procedures:

  1. Prepare the document establishing the government interest
  2. Complete a patent cover sheet, indicating it relates to a government interest
  3. Submit the document and cover sheet to the USPTO

As stated in MPEP 302.07: “Cover sheets required by 37 CFR 3.28 seeking to record a governmental interest must also (1) indicate that the document relates to a governmental interest and (2) indicate, if applicable, that the document to be recorded is not a document affecting title.”

Key points for government interest recordations:

  • No fee is required if the document doesn’t affect title and is properly identified
  • These documents are recorded in a special Departmental Register
  • Some government documents may be recorded in a Secret Register with restricted access

Government agencies should follow Executive Order 9424 which requires prompt forwarding of government interests in patents for recording.

For more information on patent recordation, visit: patent recordation.

To prove an invention has been assigned in a pre-AIA 37 CFR 1.47(b) application, you must submit the following:

  • A copy of the assignment in English
  • A statement under pre-AIA 37 CFR 3.73(b) by the assignee

According to MPEP 409.03(f):

“If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant. A statement under pre-AIA 37 CFR 3.73(b) by the assignee must also be submitted (see MPEP § 324).”

It’s important to note that the assignment must specifically cover the invention described in the application. General assignments may not be sufficient.

To learn more:

To learn more:

Tags: pre-AIA

To properly use a certificate of mailing for patent correspondence, follow these steps:

  1. Prepare your correspondence.
  2. Attach a certificate of mailing to each piece of correspondence.
  3. Include the required information on the certificate.
  4. Sign and date the certificate.
  5. Mail the correspondence with the attached certificate.

According to MPEP 512:

Each piece of correspondence for which a certificate is filed must include a signed and dated certificate which sets forth the date of deposit or transmission.

Ensure that you follow these guidelines to properly use the certificate of mailing procedure.

To learn more:

For applications filed on or after September 16, 2012, the specific reference to the prior application must be included in an application data sheet (ADS) in compliance with 37 CFR 1.76. For applications filed before September 16, 2012, the reference should be in an ADS and/or in the first sentence(s) of the specification following the title.

The reference must include:

  • The prior application number
  • The filing date
  • The relationship between the applications (continuation, divisional, or continuation-in-part) for nonprovisional applications

For example: “This application is a continuation of Application No. 12/345,678, filed January 1, 2010.”

For provisional applications, only the application number and filing date are required. The relationship should not be specified.

To learn more:

When filing patent correspondence, you should include the following identifying information:

  • Application number (checked for accuracy, including series code and serial number)
  • Art Unit number (copied from most recent Office communication)
  • Filing date
  • Name of the examiner who prepared the most recent Office action
  • Title of invention
  • Confirmation number

As stated in 37 CFR 1.5(a): ‘When correspondence directed to the Patent and Trademark Office concerns a previously filed application for a patent, it must identify on the top page in a conspicuous location, the application number (consisting of the series code and the serial number; e.g., 07/123,456), or the serial number and filing date assigned to that application by the Patent and Trademark Office, or the international application number of the international application, or the international registration number of an international design application.’

According to 37 CFR 3.21, a patent assignment must identify the patent by patent number. For patent applications:

  • National applications: Identify by application number (series code and serial number)
  • International applications designating the US: Identify by international application number
  • International design applications designating the US: Identify by international registration number or US application number

If the assignment is executed before filing but after the application is executed, it must identify the application by inventor name(s) and invention title. For provisional applications not yet filed, identify by inventor name(s) and invention title.

The MPEP suggests including language like: I hereby authorize and request my attorney, (Insert name), of (Insert address), to insert here in parentheses (Application number , filed ) the filing date and application number of said application when known.

For more information on application identification, visit: application identification.

For more information on patent assignment, visit: patent assignment.

For more information on patent identification, visit: patent identification.

To properly identify a patent in an assignment, you must use the patent number. According to 37 CFR 3.21, “An assignment relating to a patent must identify the patent by the patent number.” This ensures that there is no ambiguity about which patent is being assigned.

To learn more:

To properly identify a foreign application when claiming priority, you must provide the following information:

  • Application number
  • Country or intellectual property authority
  • Day, month, and year of filing

As stated in MPEP 214.01: “The claim for priority must be presented in an application data sheet (§ 1.76(b)(6)) and must identify the foreign application to which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.”

For applications filed under 35 U.S.C. 111(a) on or after September 16, 2012, this information must be provided in an application data sheet. For earlier applications, it may be included in the oath or declaration if not provided in an application data sheet.

To learn more:

How do I properly identify a foreign application when claiming priority in a U.S. patent application?

When claiming priority to a foreign application in a U.S. patent application, it’s crucial to provide accurate identification information. According to MPEP 214.01, you must include the following details:

  • The application number of the foreign application
  • The country or intellectual property authority where the foreign application was filed
  • The day, month, and year of filing of the foreign application

The MPEP states: ‘The claim for priority must identify the foreign application for which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.’

Additionally, if you’re submitting a certified copy of the foreign application, ensure that it matches the identification information provided in your priority claim. Accurate identification is essential for establishing your priority rights and avoiding potential issues during examination or litigation.

To properly claim the benefit of a prior application, you must include a specific reference to the prior application. For applications filed on or after September 16, 2012, this reference must be included in an application data sheet (ADS). For applications filed before September 16, 2012, the reference must be in an ADS and/or in the first sentence(s) of the specification following the title.

The MPEP 211.02 states: Both 35 U.S.C. 119(e) and 120 include the requirement that the later-filed application must contain a specific reference to the prior application.

For benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c), the reference must include the relationship (i.e., continuation, divisional, or continuation-in-part) of the applications.

For more information on ADS, visit: ADS.

For more information on divisional, visit: divisional.

For more information on specific reference, visit: specific reference.

How do I mark changes in a corrected Application Data Sheet (ADS) for benefit claims?

When submitting a corrected Application Data Sheet (ADS) to add or correct a benefit claim, it’s crucial to properly mark the changes. According to MPEP 211.02(a):

The corrected ADS must identify the information that is being changed with underlining for insertions and strike-through or brackets for text removed as required by 37 CFR 1.76(c)(2).

To properly mark changes in a corrected ADS:

  • Insertions: Underline new text
  • Deletions: Use strike-through or brackets for removed text
  • Existing information: Include all information from the original ADS, even if unchanged

It’s important to note that the entire benefit claim must be underlined if you’re adding a new benefit claim. This helps the USPTO easily identify and process the changes to your application.

To learn more:

Tags: ADS

When assigning a provisional application before it’s filed, you must use specific identifying information. MPEP 302.03 provides guidance: “If an assignment of a provisional application under § 1.53(c) of this chapter is executed before the provisional application is filed, it must identify the provisional application by the name of each inventor and the title of the invention so that there can be no mistake as to the provisional application intended.” This ensures that the correct provisional application can be associated with the assignment once it’s filed.

To learn more:

When submitting a corrected cover sheet to address an erroneous assignment or name change, follow these instructions from MPEP 323.01(c):

  1. Check the box titled ‘Other’ in the ‘Nature of Conveyance’ section.
  2. Indicate that the submission is to correct an error in a previously recorded document that erroneously affects the identified application(s) or patent(s).
  3. Write the name of the correct owner in both the ‘conveying party’ and ‘receiving party’ boxes.

The MPEP explains the reasoning behind this: The party should also write the name of the correct owner in both the box requesting the name of the conveying party and the box requesting the name and address of the receiving party; this is to make it clear that ownership never changed and that any assignment or name change recorded against the application(s) or patent(s) was erroneous.

To learn more:

To file a foreign priority claim in a U.S. patent application, you must:

  1. File the claim within the specified time limit (see previous FAQ for details).
  2. Present the claim in an application data sheet (ADS) for applications filed on or after September 16, 2012. For applications filed before this date, the claim can be in the ADS or in the oath/declaration.
  3. Identify the foreign application by providing:
    • Application number
    • Country (or intellectual property authority)
    • Filing date (day, month, and year)

This is specified in 37 CFR 1.55(d)(1): The claim for priority must be presented in an application data sheet (§1.76(b)(6)) and must identify the foreign application to which priority is claimed by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.

It’s crucial to provide accurate and complete information to ensure your priority claim is properly recorded and considered.

For international applications entering the national stage in the United States under 35 U.S.C. 371, the process for filing a foreign priority claim is different from regular U.S. applications. According to MPEP 214.01:

“The claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT in an international application entering the national stage under 35 U.S.C. 371, except as provided in paragraph (e) of this section.”

This means that you need to follow the time limits specified in the Patent Cooperation Treaty (PCT) and its regulations when filing a priority claim for an international application entering the U.S. national stage.

For more detailed information on the timing and procedure for claiming priority in national stage applications, you should refer to MPEP § 213.06, which specifically deals with this topic.

To learn more:

Filing a delayed benefit claim in an international application involves specific procedures. The MPEP 211.04 provides guidance on this matter:

“A petition under 37 CFR 1.78 for accepting an unintentionally delayed benefit claim and the petition fee under 37 CFR 1.17(m) are required to add a benefit claim under 35 U.S.C. 120 and 365(c) in an abandoned international application designating the United States, even when the international application did not enter the national stage under 35 U.S.C. 371.”

For international applications not filed with the United States Receiving Office and not a nonprovisional application, the petition may be filed in the earliest nonprovisional application that claims benefit to the international application. As stated in MPEP 211.04:

“If a petition under 37 CFR 1.78(c) or (e) is required in an international application that was not filed with the United States Receiving Office and is not a nonprovisional application, then the petition may be filed in the earliest nonprovisional application that claims benefit under 35 U.S.C. 120, 121, 365(c), or 386(c) to the international application and will be treated as having been filed in the international application.”

To learn more:

To correctly add a new inventor to a Continued Prosecution Application (CPA), you must follow the procedures outlined in 37 CFR 1.48. The MPEP ¶ 2.33 states:

Any request to add an inventor must be in the form of a request under 37 CFR 1.48.

To add a new inventor:

  1. File a request under 37 CFR 1.48 to correct the inventorship.
  2. Include a statement from the new inventor agreeing to the addition.
  3. Pay any required fees.
  4. Provide an oath or declaration from the new inventor.

Failure to follow these steps may result in the inventorship remaining the same as in the prior application.

For more information on CPA, visit: CPA.

Tags: CPA

How do I correct the filing date of a prior-filed application in a benefit claim?

To correct the filing date of a prior-filed application in a benefit claim, you need to follow specific procedures outlined in MPEP 211.02(a). The MPEP states:

“If the prior application is a provisional application, and the filing date of the provisional application in the benefit claim is incorrect, applicant should file a petition under 37 CFR 1.78 to correct the benefit claim. A petition under 37 CFR 1.78 and the petition fee are required to correct the benefit claim because the correction is considered a delayed claim as per 37 CFR 1.78.”

For non-provisional applications, a similar process applies. You must file a petition under 37 CFR 1.78 along with the required fee to correct the filing date in the benefit claim.

To learn more:

To correct or update information in an Application Data Sheet (ADS), follow these guidelines from MPEP 601.05:

  1. Submit a new ADS titled “Supplemental Application Data Sheet”
  2. Include all sections listed in 37 CFR 1.76(b), even if some sections have no changed data
  3. Identify changes with underlining for insertions and strike-through or brackets for text removed
  4. Make changes relative to the most recent filing receipt
  5. Submit the corrected ADS until payment of the issue fee

Note that certain changes, such as inventorship changes, foreign priority and domestic benefit information changes, and correspondence address changes, must comply with specific rules and may require additional forms or petitions.

The USPTO recommends using the corrected Web-based ADS when possible, as it pre-populates with information of record and automatically formats changes.

To learn more:

To correct or add a benefit claim after filing your application, you need to follow specific procedures depending on the timing and circumstances:

  1. If you received a filing receipt with missing or incorrect benefit claim information, you can request a corrected filing receipt. However, the Office will only grant this request if the proper reference to the prior application was included in the original filing or within the time period required by 37 CFR 1.78.
  2. If you’re adding a benefit claim after the time period required by 37 CFR 1.78, you must file a petition and pay the petition fee. The petition must be accompanied by a corrected Application Data Sheet (ADS) for applications filed on or after September 16, 2012, or an amendment to the specification or a supplemental ADS for applications filed before that date.

As stated in MPEP 211.02(a): If a benefit claim is added after the time period required by 37 CFR 1.78, a petition and the petition fee are required.

Depending on the status of your application, you may also need to file:

  • A Request for Continued Examination (RCE) if the application is under final rejection or has been allowed.
  • A reissue application or a request for a certificate of correction if the application has already issued as a patent.

It’s important to note that you cannot add an incorporation by reference statement to a benefit claim after the filing date, as this would be considered new matter.

For more information on ADS, visit: ADS.

For more information on RCE, visit: RCE.

Tags: ADS, RCE

How do I correct an error in my foreign priority claim?

If you need to correct an error in your foreign priority claim, the process depends on the nature of the error and when it’s discovered. According to MPEP 214.01, “Applicant may correct the failure to adequately claim priority to the prior foreign application by amending the specification or submitting a new application data sheet (ADS) identifying the foreign application by application number, country (or intellectual property authority), and filing date.” Here are some key points to remember:

  • If the error is discovered within the time period for filing the priority claim, you can simply submit a corrected ADS or amend the specification.
  • If the error is discovered after the time period has expired, you may need to file a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim.
  • For minor typographical errors, a request for a corrected filing receipt may be sufficient.

Always consult with a patent attorney or agent to determine the best course of action for your specific situation.

How do I correct an error in micro entity status if I underpaid fees?

If you erroneously paid fees as a micro entity when you were not entitled to that status, resulting in an underpayment, you need to take the following steps:

  • Submit a written assertion of small entity status (if eligible) or a written assertion to establish non-small entity status.
  • Pay the fee deficiency, which is the difference between the amount paid and the amount due.

As stated in MPEP 509.04(f): “A written assertion to establish non-small entity status must be accompanied by the difference between the current amount due and the amount previously paid.”

It’s important to correct the error promptly to avoid potential issues with your patent application or granted patent.

To learn more:

Tags: patent fees

If you need to correct an error in an oath or declaration, the process depends on the nature of the error and when it’s discovered. According to MPEP 602:

  • For minor typographical errors, you can submit a supplemental oath or declaration pointing out the error in the original.
  • If the error is substantial, a new oath or declaration may be required.
  • For applications filed on or after September 16, 2012, defects can often be corrected through an application data sheet (ADS).

The MPEP states: ‘Applicant may submit a substitute statement in lieu of an oath or declaration as provided for in 37 CFR 1.64 if the requirements of 37 CFR 1.64 are met.’

It’s important to address any errors promptly to avoid potential issues during patent examination or enforcement.

To learn more:

To correct an error in a recorded assignment document, you need to submit a ‘corrective document’ to the Assignment Division. This document should include:

  1. A copy of the original assignment document with corrections made, initialed, and dated by the party conveying the interest.
  2. A new Recordation Form Cover Sheet (form PTO-1595) identifying the submission as a ‘corrective document’ and indicating the reel and frame number of the incorrectly recorded assignment.

The corrective document will be given a new reel and frame number and recording date. A recording fee is required for each patent application and patent affected.

As stated in the MPEP: “The recording fee set forth in 37 CFR 1.21(h) is required for each patent application and patent against which the corrective document is being recorded.” (MPEP § 323)

To correct a typographical error on a recorded cover sheet for a patent assignment, you need to submit the following to the Assignment Services Division:

  • A copy of the originally recorded assignment document (or other document affecting title)
  • A corrected cover sheet
  • The required fee for each application or patent to be corrected

Additionally, it’s recommended to submit a copy of the original cover sheet to facilitate comparison. When filing the corrected cover sheet, you should:

  • Check the box titled “Other” in the “Nature of Conveyance” area
  • Indicate that the submission is to correct an error in a previously recorded cover sheet
  • Identify the reel and frame numbers (if known)
  • Specify the nature of the correction

As stated in MPEP 323.01(a): “The Office will then compare the corrected cover sheet with the original cover sheet and the originally recorded assignment document (or other document affecting title) to determine whether the correction is typographical in nature.”

To learn more:

To correct a benefit claim in your patent application, follow these steps:

  1. For applications filed on or after September 16, 2012:
    • Submit a corrected Application Data Sheet (ADS) in compliance with 37 CFR 1.76(c)
  2. For applications filed before September 16, 2012:
    • Submit an amendment to the specification (if the benefit claim is in the specification) or
    • Submit a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c)
  3. If the correction is made after the time period set in 37 CFR 1.78:
    • File a petition under 37 CFR 1.78
    • Pay the required petition fee
    • Provide a statement that the entire delay was unintentional

MPEP 211.02(a) states: “If applicant receives a filing receipt with missing or incorrect benefit claim information, applicant may request a corrected filing receipt. The Office will not grant a request for a corrected filing receipt to include a benefit claim unless the proper reference to the prior application is included (i) in an ADS (for applications filed on or after September 16, 2012) or (ii) in the first sentence(s) of the specification or an ADS (for applications filed prior to September 16, 2012) within the time period required by 37 CFR 1.78 with a few exceptions.”

It’s important to review your filing receipt promptly and carefully to avoid the need for a petition and associated fees.

To learn more:

How do I correct a benefit claim in a nonprovisional application after the time period set forth in 37 CFR 1.78?

To correct a benefit claim in a nonprovisional application after the time period set forth in 37 CFR 1.78, you need to file a petition to accept a delayed claim. The MPEP states:

“A petition to accept a delayed claim under 37 CFR 1.78(c) for the benefit of a prior-filed provisional application or under 37 CFR 1.78(e) for the benefit of a prior-filed nonprovisional application must be accompanied by:”

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78(a)(3) to the prior-filed provisional application or the reference required by 35 U.S.C. 120 and 37 CFR 1.78(d)(2) to the prior-filed nonprovisional application, unless previously submitted;
  • The petition fee set forth in 37 CFR 1.17(m); and
  • A statement that the entire delay between the date the benefit claim was due under 37 CFR 1.78(a)(4) or 37 CFR 1.78(d)(3) and the date the benefit claim was filed was unintentional.

The Director may require additional information where there is a question whether the delay was unintentional.

For more detailed information, refer to MPEP 211.02(a).

To learn more:

To claim the benefit of a prior-filed application, you must include a specific reference to the prior-filed application in your current application. The method of including this reference depends on when your application was filed:

  • For applications filed before September 16, 2012: Include the reference in the first sentence(s) of the specification following the title or in an application data sheet (ADS) compliant with pre-AIA 37 CFR 1.76.
  • For applications filed on or after September 16, 2012: Include the reference in an ADS compliant with 37 CFR 1.76.

The MPEP states: If applicant desires to claim the benefit of a prior-filed application under 35 U.S.C. 119(e), 120, 121, 365(c) or 386(c), the instant application must contain, or be amended to contain, a specific reference to the prior-filed application in compliance with 37 CFR 1.78. (MPEP § 211)

For more information on ADS, visit: ADS.

For more information on prior-filed application, visit: prior-filed application.

For more information on specific reference, visit: specific reference.

To claim the benefit of a prior-filed application in a continuation application, you must include a reference to the prior-filed application in the new application. According to 37 CFR 1.78(d)(2):

Any nonprovisional application, international application designating the United States, or international design application designating the United States that claims the benefit of one or more prior-filed nonprovisional applications, international applications designating the United States, or international design applications designating the United States must contain or be amended to contain a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number), international application number and international filing date, or international registration number and filing date under §1.1023.

For nonprovisional applications, this reference must be included in an application data sheet (ADS) as specified in 37 CFR 1.76(b)(5). The reference should also identify the relationship between the applications, stating whether it’s a continuation, divisional, or continuation-in-part.

For more information on continuation application, visit: continuation application.

For more information on patent procedure, visit: patent procedure.

For more information on prior-filed application, visit: prior-filed application.

How do I claim small entity status for a patent application?

To claim small entity status for a patent application, follow these steps:

  • Determine eligibility: Ensure you meet the criteria for small entity status as defined in 37 CFR 1.27(a).
  • Submit a written assertion: Provide a written assertion of entitlement to small entity status. This can be done by:
    • Checking the appropriate box on a patent application transmittal form
    • Submitting a separate paper specifically asserting small entity status
    • Paying small entity fees (which is considered a written assertion)
  • Timing: You can claim small entity status at any time during the pendency of the application or after the patent issues.

As stated in MPEP 509.03, “A small entity status assertion must be filed in each application or patent in which the small entity is desired to claim such status.”

To learn more:

Tags: USPTO fees

Priority to an international design application can be claimed in a U.S. nonprovisional application or in another international design application designating the U.S. MPEP 213.07 states: ‘Pursuant to 35 U.S.C. 386(a) and 37 CFR 1.55, a nonprovisional application may make a claim of foreign priority in accordance with the conditions and requirements of 35 U.S.C. 119(a)-(d) and 172 with respect to a prior international design application that designates at least one country other than the United States.’

The priority claim should be made in an Application Data Sheet (ADS) for nonprovisional applications. For international design applications designating the U.S., the priority claim can be made in accordance with the Hague Agreement and Regulations.

For more information on Hague Agreement, visit: Hague Agreement.

Claiming priority to a provisional application is different from claiming foreign priority. To claim the benefit of a provisional application in a later-filed nonprovisional application:

  • The nonprovisional must be filed within 12 months of the provisional filing date
  • A specific reference to the provisional application must be made in an application data sheet
  • The provisional and nonprovisional must name at least one common inventor
  • The claimed subject matter must be supported by the provisional application

This is known as a domestic benefit claim under 35 U.S.C. 119(e), rather than a foreign priority claim under 35 U.S.C. 119(a)-(d). The requirements are specified in 37 CFR 1.78 rather than 37 CFR 1.55.

To claim priority to an earlier-filed foreign application, the applicant must:

1. File the U.S. application within 12 months of the foreign application’s filing date (6 months for design applications).
2. In the U.S. application, include a claim for priority that identifies the foreign application. For applications filed on/after 9/16/12, this must be in an ADS.
3. File a certified copy of the foreign application, unless it was previously filed or is available to the USPTO via a priority document exchange program.

See MPEP 213216 for the detailed requirements. Some deadlines can be extended on petition if unintentionally delayed.

Claiming priority to a PCT international application can be done in two ways:

  1. In a U.S. national stage application under 35 U.S.C. 371:
    • The priority claim is made in the PCT application
    • No further action is needed when entering the national stage
  2. In a U.S. nonprovisional application under 35 U.S.C. 111(a):
    • File within 12 months of the PCT filing date
    • Make the priority claim in an application data sheet
    • Provide a certified copy of the PCT application (unless already filed with the PCT)

In both cases, the PCT application must designate the United States. The specific requirements are detailed in 37 CFR 1.55(d)(2) and (f)(2) for national stage applications, and 37 CFR 1.55(d)(1) and (f)(1) for applications under 35 U.S.C. 111(a).

For international applications entering the U.S. national stage under 35 U.S.C. 371, the priority claim must be made within the time limit set by the PCT and its regulations. MPEP 213.06 states: ‘In an international application entering the national stage under 35 U.S.C. 371, the claim for priority must be made and a certified copy of the foreign application must be filed within the time limit set forth in the PCT and the Regulations under the PCT.’

If the priority claim was properly made during the international phase, it’s generally not necessary to repeat it upon national stage entry. However, the certified copy of the priority document must be furnished if not previously submitted to the International Bureau or the USPTO.

For more information on national stage application, visit: national stage application.

To claim priority in a nonprovisional international design application:

  • Include a priority claim in the international design application when filed with the International Bureau (IB).
  • The priority claim must specify the application number and filing date of the priority application.
  • File a certified copy of the priority application with the IB or the USPTO, or have it retrieved through the Digital Access Service (DAS).

According to MPEP 213.07: An applicant filing an international design application designating the United States may claim priority to one or more prior foreign applications under the Paris Convention or to a prior provisional application under 35 U.S.C. 119(e).

To learn more:

To learn more:

To claim foreign priority in a U.S. patent application, you must:

1. File the U.S. application within 12 months (6 months for design applications) of the foreign filing date.
2. Submit a claim for priority identifying the foreign application.
3. File a certified copy of the foreign application.

For applications filed on or after September 16, 2012, 37 CFR 1.55(d)(1) requires that the claim for priority be presented in an application data sheet. The claim must identify the foreign application by specifying the application number, country (or intellectual property authority), day, month, and year of its filing.

A certified copy of the foreign application must also be filed within a specified time period, usually within the later of 4 months from the actual U.S. filing date or 16 months from the foreign filing date.

To claim benefit to a non-English language provisional application, you must:

  • File an English translation of the non-English language provisional application
  • Provide a statement that the translation is accurate
  • File both the translation and the statement in the provisional application
  • Confirm in the present application that the translation and statement were filed in the provisional application

According to MPEP ¶ 2.38, “An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3]. See 37 CFR 1.78.”

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP), you need to follow specific procedures. The MPEP ¶ 2.06 states: “Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.”

This means you must:

It’s crucial to properly establish the benefit claim to secure the earlier filing date for the common subject matter.

How do I cite non-English language documents in an IDS?

When citing non-English language documents in an Information Disclosure Statement (IDS), follow these guidelines:

  • Provide a concise explanation of the relevance of the document.
  • Include an English language translation or abstract if available.
  • If a translation is not available, indicate the language of the document.

According to MPEP 609.04(a): “Where the information listed is not in the English language, but was cited in a search report or other action by a foreign patent office in a counterpart foreign application, the requirement for a concise explanation of relevance can be satisfied by submitting an English-language version of the search report or action which indicates the degree of relevance found by the foreign office.”

Properly citing non-English documents ensures the examiner can consider their relevance to your application.

To learn more:

How do I cite a foreign patent document in an Information Disclosure Statement (IDS)?

When citing a foreign patent document in an Information Disclosure Statement (IDS), you need to provide specific information as outlined in MPEP 609. The citation should include:

  • The country or patent office that issued the document
  • The document number
  • The kind code (if known)
  • The name of the patentee or applicant
  • The date of publication of the document
  • The pages, columns, lines, or paragraph numbers where relevant passages or figures appear (if a particular part of the document is being cited)

For example, a proper citation might look like this:

JP 2000-123456 A (SMITH, John) 15 January 2000, paragraphs [0015]-[0020], figure 3

If an English language abstract is available, it should be submitted along with the foreign patent document. As stated in MPEP 609:

“When citing a foreign patent document on an information disclosure statement, applicant should also submit any English-language abstract of that foreign patent document available to applicant.”

By providing complete and accurate citations for foreign patent documents, you ensure that the examiner can easily locate and consider the relevant prior art during the examination process.

To learn more:

Tags: prior art

To change the correspondence address for a patent application, you need to file a properly signed written request with the USPTO. According to MPEP 601.03:

“A written request may be signed by a practitioner of record, the applicant, an assignee of record, or a party who otherwise shows sufficient proprietary interest in the matter, in accordance with 37 CFR 1.33(b).”

The request should clearly state the new correspondence address and include the application number or patent number if already issued. For pending applications, you can use form PTO/AIA/122 or submit a signed letter.

To learn more:

To certify micro entity status, you must file a certification form with the USPTO. The USPTO provides two forms:

  • Form PTO/SB/15A for certifying under the gross income basis
  • Form PTO/SB/15B for certifying under the institution of higher education basis

The certification must be signed by an authorized party as defined in 37 CFR 1.33(b). It should be filed prior to or at the time of paying the first fee as a micro entity.

To cancel a figure in a patent application, you should:

  • Submit an amendment clearly stating which figure(s) are being canceled
  • Update the specification to remove references to the canceled figure(s)
  • Renumber remaining figures if necessary
  • Update figure descriptions in the specification accordingly

The MPEP states: When a figure is canceled, the applicant, in order to avoid confusion, should also cancel (1) any reference to the figure in the specification; and (2) any other figures if their meaning depends upon the canceled figure. (MPEP 608.02(t))

To learn more:

How do I calculate the application size fee for a patent application?

The application size fee is an additional charge for patent applications exceeding a certain number of pages. Here’s how to calculate it:

  1. Count the total number of pages in your application, including specification, claims, abstract, and drawings.
  2. Subtract 100 from the total page count (the first 100 pages are included in the basic filing fee).
  3. If the result is positive, multiply it by the per-page fee.

According to MPEP 607: “The application size fee applies to any application filed under 35 U.S.C. 111 … the number of pages of specification, claims, and drawings (including all pages containing part of one of those items) is more than 100 pages.”

For current fee amounts, refer to the USPTO Fee Schedule. Remember, the application size fee is in addition to the basic filing fee.

To learn more:

If you’ve inadvertently filed a foreign patent application without obtaining a foreign filing license, you can apply for a retroactive license. According to MPEP 140:

‘Petitions for a retroactive license under 35 U.S.C. 184 are decided by the Office of Petitions. The petition must be in the form of a verified statement and should include the following information:’

  • A listing of each of the foreign countries in which the unlicensed patent application material was filed
  • The dates on which the material was filed in each country
  • A verified statement that the subject matter in question was not under a secrecy order at the time it was filed abroad
  • A verified statement that the license has been diligently sought after discovery of the proscribed foreign filing
  • An explanation of why the material was filed abroad through error without the required license first having been obtained

The petition should be submitted to the USPTO as soon as possible after discovering the error. Include all relevant documentation and be prepared to pay any required fees.

For more information on retroactive foreign filing license, visit: retroactive foreign filing license.

For more information on USPTO, visit: USPTO.

To amend your application to include inadvertently omitted material under 37 CFR 1.57(b), you must:

  1. File an amendment to include the omitted material within the time period set by the USPTO
  2. Ensure the amendment is filed before the close of prosecution or abandonment of the application
  3. Supply a copy of the prior-filed application (unless it’s a US application filed under 35 U.S.C. 111)
  4. Provide an English translation if the prior-filed application is in a foreign language
  5. Identify where the omitted material can be found in the prior-filed application

The MPEP states: “The application must be amended to include the inadvertently omitted portion of the specification or drawing(s) within any time period set by the Office, but in no case later than the close of prosecution as defined by 37 CFR 1.114(b), or abandonment of the application, whichever occurs earlier.”

Examiners are required to review and consider e-IDS submissions in the same manner as paper IDS submissions. The MPEP 609.07 provides guidance on this process:

If the e-IDS complies with the requirements of 37 CFR 1.97, examiners must consider the e-IDS and complete the e-IDS form by initialing, signing, and dating the e-IDS form entries.

Examiners can access the electronic list of U.S. patents and patent application publications from their workstations. They are expected to review these references electronically and should not require applicants to submit paper copies of e-IDS references. It’s crucial for applicants to ensure that citation numbers are accurate, as examiners rely on these numbers to retrieve the correct documents for review.

To learn more:

How do dependent claims affect claim interpretation and infringement analysis?

Dependent claims play a crucial role in claim interpretation and infringement analysis:

  • They narrow the scope of the independent claim they depend on by adding additional limitations.
  • Infringement of a dependent claim automatically implies infringement of its parent claim(s).
  • They can provide fallback positions if the independent claim is found invalid or not infringed.

The MPEP 608.01(n) explains:

“A dependent claim includes all the limitations of the claim from which it depends. The dependent claim is construed to include all the limitations of the independent claim plus those of the dependent claim.”

This principle is essential in patent litigation and licensing negotiations. It means that while a dependent claim is narrower in scope, it can provide additional protection and strategic advantages in enforcing patent rights.

To learn more:

Continuation, divisional, and continuation-in-part (CIP) applications are all types of continuing applications, but they have key differences:

  • Continuation application: Discloses and claims only subject matter disclosed in the prior application. No new matter is added.
  • Divisional application: Results from a restriction requirement in the parent application. Claims an independent and distinct invention carved out of the parent application. No new matter is added.
  • Continuation-in-part (CIP) application: Repeats a substantial portion of the prior application and adds matter not disclosed in the prior application (i.e., new matter is added).

As stated in the MPEP regarding continuation-in-part applications:

A continuation-in-part is an application filed during the lifetime of a prior-filed nonprovisional application, international application designating the United States, or international design application designating the United States repeating some substantial portion or all of the prior-filed application and adding matter not disclosed in the prior-filed application.

All three types of applications must claim the benefit of the prior application under 35 U.S.C. 120, 121, 365(c), or 386(c) and comply with other requirements set forth in 37 CFR 1.78.

For more information on continuation application, visit: continuation application.

For more information on continuation-in-part application, visit: continuation-in-part application.

For more information on Divisional application, visit: Divisional application.

For more information on new matter, visit: new matter.

For more information on patent application types, visit: patent application types.

Business mergers can have significant implications for patent ownership. According to MPEP 314:

Documents of merger are also proper links in the chain of title. They may represent a change of entity as well as a change of name.

This means that when businesses merge, it can result in both a change of the legal entity owning the patent and a change in the name associated with the patent ownership. It’s crucial to properly document these changes to maintain a clear chain of title for the patent.

To learn more:

Benefit claims in Continued Prosecution Applications (CPAs) have some unique characteristics:

  • A CPA automatically includes a specific reference under 35 U.S.C. 120 to the prior application
  • No additional amendment to the specification or application data sheet is required to claim benefit
  • A CPA is considered to reference every application in the chain with the same application number
  • Priority claims under 35 U.S.C. 119(a)-(d) from the parent application automatically carry over to the CPA

The MPEP states: A request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. No further amendment to the specification of the CPA nor a reference in the CPA’s application data sheet is required by 35 U.S.C. 120 or 37 CFR 1.78(d) to identify or reference the prior application, as well as any other application assigned the application number of the prior application (e.g., in instances in which a CPA is the last in a chain of CPAs).

It’s important to note that applicants cannot delete benefit claims to certain applications in a chain of CPAs. The MPEP clarifies: Therefore, regardless of whether an application is filed under 37 CFR 1.53(b) or (d), a claim under 35 U.S.C. 120 to the benefit of a CPA is, by operation of 37 CFR 1.53(d)(7) and 37 CFR 1.78(d)(4), a claim to every application assigned the application number of such CPA. In addition, applicants will not be permitted to delete such a benefit claim as to certain applications assigned that application number (e.g., for patent term purposes).

For more information on benefit claims, visit: benefit claims.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Affidavits or declarations filed in a prior application do not automatically become part of a new application. As stated in MPEP ¶ 2.03: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application do not automatically become a part of this application.

To rely on an earlier-filed affidavit or declaration, the applicant must:

  • Make remarks of record in the new application
  • Include a copy of the original affidavit or declaration filed in the prior application

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

The America Invents Act (AIA) introduced changes to assignee prosecution rights for patent applications filed on or after September 16, 2012. According to MPEP 106.01:

[F]or applications filed on or after September 16, 2012, [the assignee of record of the entire interest] can prosecute the application after becoming the applicant under 37 CFR 1.46.

This change allows the assignee of the entire interest to become the applicant and prosecute the application directly. For more detailed information:

  • For applications filed before September 16, 2012, refer to MPEP § 324
  • For applications filed on or after September 16, 2012, refer to MPEP § 325

To learn more:

The America Invents Act (AIA) significantly changed who can be considered a patent applicant for applications filed on or after September 16, 2012. MPEP § 605 outlines these changes:

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign an invention to file and prosecute an application for patent as the applicant, and to permit a person who otherwise shows sufficient proprietary interest in the matter to file and prosecute an application for patent as the applicant on behalf of the inventor.”

Key changes include:

  • Assignees can now be listed as the applicant
  • Persons with sufficient proprietary interest can file on behalf of the inventor
  • The inventor is no longer required to be listed as the applicant

These changes allow for more flexibility in patent application filing and prosecution, particularly benefiting companies and organizations that routinely file patent applications.

To learn more:

How did the ADS format differ for applications filed before September 16, 2012 compared to later applications?

The Application Data Sheet (ADS) format for applications filed before September 16, 2012 (pre-AIA) differed from the format used in later applications. According to MPEP 601.05(b):

For applications filed before September 16, 2012, the Office continued to use the ADS form PTO/SB/14 that was available prior to September 16, 2012.

Key differences in the pre-September 16, 2012 ADS format include:

  • Form number: The pre-AIA ADS used form PTO/SB/14, while post-AIA applications use form PTO/AIA/14.
  • Inventor information: The pre-AIA ADS didn’t require as detailed inventor information as the post-AIA version.
  • Domestic benefit/Foreign priority: The format for claiming these was simpler in the pre-AIA ADS.
  • Assignee information: The pre-AIA ADS had a different section for providing assignee information.
  • Signature requirements: The pre-AIA ADS had different signature requirements compared to the post-AIA version.

It’s important to use the correct ADS form based on your application’s filing date to ensure compliance with USPTO requirements and proper processing of your application.

To learn more:

The Brief Summary of Invention should be concise yet informative. MPEP 608.01(d) provides guidance on the level of detail required: “That is, the subject matter of the invention should be described in one or more clear, concise sentences or paragraphs.” The summary should provide enough information to understand the nature and substance of the invention without delving into excessive technical details. It should focus on the key aspects that distinguish the invention from prior art and align with the claims. The MPEP also notes that “The brief summary, if properly written to set out the exact nature, operation, and purpose of the invention, will be of material assistance in aiding ready understanding of the patent in future searches.” This suggests that while being concise, the summary should be comprehensive enough to facilitate future patent searches and understanding of the invention.

To learn more:

USPTO personnel should use Patent Data Portal to determine the current location or status of an application. For Image File Wrapper (IFW) applications, no location is associated with the file.

As stated in MPEP 102: When it is desired to determine the current location or status of an application, Office personnel should use Patent Data Portal. If the application is an Image File Wrapper (IFW) application, no location is associated with the file.

37 CFR 1.55(i) provides that the requirement for a timely filed certified copy can be satisfied if:

  1. The foreign application was filed in a participating foreign intellectual property office;
  2. The claim for priority is presented in an application data sheet, identifying the foreign application;
  3. The copy of the foreign application is received by the USPTO from the participating foreign intellectual property office, or a certified copy is filed, within the period specified in 37 CFR 1.55(g)(1).

The USPTO website provides information about the priority document exchange program, including participating offices and necessary information for access to foreign applications.

To learn more:

Under 37 CFR 1.55(i), the requirement for a certified copy of the foreign application will be considered satisfied if:

  1. The foreign application was filed in a foreign intellectual property office participating with the USPTO in a bilateral or multilateral priority document exchange agreement;
  2. The claim for priority is presented in an application data sheet, identifying the foreign application and including the information necessary for the participating foreign office to provide the USPTO with access to the foreign application; and
  3. The copy of the foreign application is received by the USPTO from the participating foreign office, or a certified copy is filed, within the time period specified in 37 CFR 1.55(g)(1).

In addition, if the foreign application was not filed in a participating office directly, but a certified copy was filed in an application subsequently filed in a participating office that permits the USPTO to obtain a copy, the applicant must also file a request in a separate document that the USPTO obtain a copy of the foreign application from the participating office. See MPEP 215.01.

While the public cannot request title reports directly, they can obtain patent ownership information through other means. The MPEP notes:

The public can request a certified abstract of title. The fee for this service is set forth at 37 CFR 1.19(b)(4).

Additionally, some assignment records are publicly available. For more information on accessible records, refer to MPEP § 301.01.

To correct or update the name of the applicant after filing:

  1. File a request under 37 CFR 1.46(c)(1) no later than payment of the issue fee
  2. Include an application data sheet (ADS) under 37 CFR 1.76 specifying the correct or updated name of the applicant
  3. Show appropriate markings in the ADS (underlining for additions, strikethrough for deletions)

The MPEP states: Any request to correct or update the name of the applicant after an applicant has been specified under 37 CFR 1.46(b) must include an application data sheet under 37 CFR 1.76 specifying the correct or updated name of the applicant in the applicant information section.

For minor typographical errors detected after payment of the issue fee, either withdraw the application from issue or file a certificate of correction after patent issuance.

To learn more:

If an applicant misses the 12-month deadline for claiming the benefit of a provisional application, they may be able to restore the benefit under certain conditions:

  1. The nonprovisional application must be filed within 14 months of the provisional application’s filing date
  2. A petition under 37 CFR 1.78(b) must be filed in the nonprovisional application
  3. The delay in filing must be unintentional

The MPEP states: “If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

The petition must include:

  • The reference to the provisional application
  • The petition fee
  • A statement that the delay was unintentional

The benefit of a provisional application can be restored if the nonprovisional application is filed within 14 months of the provisional application filing date. To restore the benefit:

  1. File a petition under 37 CFR 1.78(b) in the nonprovisional application
  2. Include the reference to the provisional application in an application data sheet
  3. Pay the petition fee set in 37 CFR 1.17(m)
  4. Provide a statement that the delay in filing was unintentional

As stated in MPEP 211.01(a): “If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

Requesting information about an unpublished patent application requires specific procedures to ensure confidentiality. According to the MPEP:

  • Requests can be made by phone or in person
  • The requester’s identity and right to information must be verified
  • Only certain individuals (applicant, inventor, assignee of record, or attorney/agent of record) may receive detailed information
  • USPTO employees must follow a strict verification process before releasing any information

The MPEP states:

“Except as provided in 35 U.S.C. 122(b), no information concerning pending or abandoned patent applications (except applications which have been published, reissue applications and reexamination proceedings) may be given to the public without appropriate written authorization.”

This ensures that confidential application information is only released to authorized individuals.

For more information on information requests, visit: information requests.

For more information on unpublished applications, visit: unpublished applications.

The process for obtaining copies of assignment records for pending or abandoned applications depends on whether the application is open to the public. The MPEP states:

‘Copies of assignment records relating to pending or abandoned patent applications which are open to the public pursuant to 37 CFR 1.11 or for which copies or access may be supplied pursuant to 37 CFR 1.14 are available to the public.’

For applications that are not open to the public, the process is more restricted:

‘For pending or abandoned applications which are not open to the public pursuant to 37 CFR 1.11 or for which copies or access may not be supplied pursuant to 37 CFR 1.14, information related thereto is only obtainable upon a proper showing of written authority.’

The required written authority varies depending on the application filing date. For applications filed on or after September 16, 2012, it must come from an inventor, applicant, assignee, patent practitioner of record, or someone with written authority from these parties.

Patents and patent applications can be assigned through a written instrument. The MPEP 301 states:

‘Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing.’

This means that patent rights can be transferred from one party to another through a written document. The assignment must be recorded with the USPTO to be effective against subsequent purchasers or mortgagees.

For more information on patent assignment, visit: patent assignment.

For patent applications filed on or after September 16, 2012, joint inventors have more flexibility in executing oaths or declarations. The MPEP states: “For applications filed on or after September 16, 2012, joint inventors may execute separate oaths or declarations in which only the person executing the oath or declaration is identified if an ADS is filed that provides the required inventor information.” This means each inventor can submit their own oath or declaration, naming only themselves, as long as a complete Application Data Sheet (ADS) is filed with all inventor information. However, if such an ADS is not filed, then each oath or declaration must name all of the inventors, as per 37 CFR 1.63(a) and (b).

To learn more:

Joint inventors who are the applicant can appoint a power of attorney in a patent application using Form PTO/AIA/81. This form allows joint inventors to give one or more joint inventor-applicants the power of attorney to sign on behalf of all joint inventor-applicants.

According to the MPEP:

“Form PTO/AIA/81 may be used by joint inventors who are the applicant to give one or more joint inventor-applicants power of attorney to sign on behalf of all joint inventor-applicants. Since powers of attorney must be signed by ‘the applicant,’ all joint inventor-applicants must sign a power of attorney, including the joint inventor(s) who are being given power of attorney.”

For example, if there are four joint inventors (A, B, C, and D) who are all applicants, and they wish to appoint inventor-applicant C as having power of attorney, all four inventors (A, B, C, and D) must sign the power of attorney form appointing C.

It’s important to note that all joint inventor-applicants must sign the power of attorney, even those who are being given the power to act on behalf of the others.

To learn more:

Inventorship in a patent application can be corrected through the following methods:

  1. Filing a request under 37 CFR 1.48 to correct or change inventorship. For applications filed on or after September 16, 2012, this request should include:
    • An application data sheet (ADS) identifying each inventor by their legal name
    • The processing fee set forth in 37 CFR 1.17(i)
    • An oath or declaration for any new inventor who has not yet executed such a document
  2. Filing a continuing application under 37 CFR 1.53 with the correct inventorship

The method chosen may depend on the specific circumstances and timing of the correction. It’s important to note that inventorship corrections should be made promptly once an error is discovered, as timeliness requirements under 37 CFR 1.116 and 37 CFR 1.312 apply.

To learn more:

To learn more:

Tags: inventorship

Inventorship in a Continued Prosecution Application (CPA) for design patents can be corrected by filing a statement requesting the deletion of a named inventor along with the CPA filing. The MPEP states:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This process allows for immediate correction of inventorship when filing a CPA. However, it’s important to note that any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on patent procedure, visit: patent procedure.

Inventors or applicants can qualify for micro entity status through an institution of higher education in two ways:

  1. If the inventor is an employee of an institution of higher education and obtains the majority of their income from that institution.
  2. If the applicant has assigned, granted, conveyed, or is obligated to assign, grant, or convey a license or other ownership interest in the application to an institution of higher education.

MPEP 509.04(b) states: “Under 37 CFR 1.29(d)(2)(i) the applicant must certify that the applicant’s employer, from which the applicant obtains the majority of the applicant’s income, is an institution of higher education. … Under 37 CFR 1.29(d)(2)(ii) the applicant must certify that the applicant has assigned, granted, or conveyed a license or other ownership interest in the subject application (or is obligated to do so) to such an institution of higher education.”

In both cases, the applicant must also meet the small entity requirement.

To learn more:

How can inventors and joint inventors file patent applications after September 16, 2012?

For patent applications filed on or after September 16, 2012, inventors and joint inventors can file applications in the following ways:

  • An inventor or joint inventor may file an application.
  • A legal representative of a deceased or legally incapacitated inventor may file an application.
  • An assignee, obligated assignee, or person who shows sufficient proprietary interest may file an application.

As stated in MPEP 403.01(a): “For applications filed on or after September 16, 2012, a patent practitioner acting in a representative capacity must have authority to act on behalf of the applicant.” This means that patent practitioners must ensure they have proper authorization before acting on behalf of applicants.

To learn more:

A certificate of correction can be used to perfect a foreign priority claim in the following scenarios:

  1. When the priority claim was timely filed but not included on the patent due to failure to submit a certified copy.
  2. When the priority claim was not timely made, but the correction would not require further examination.

To use a certificate of correction, you must:

  • File a request for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.
  • Include a grantable petition under 37 CFR 1.55(e), (f), or (g) as appropriate.
  • Pay the required fee and provide a showing of good and sufficient cause for the delay, if applicable.

The MPEP states: Where the priority claim required under 37 CFR 1.55 was timely filed in the application but was not included on the patent because the requirement under 37 CFR 1.55 for a certified copy was not satisfied, the patent may be corrected to include the priority claim via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, accompanied by a grantable petition under 37 CFR 1.55(f) or, in the case of a design application, a grantable petition under 37 CFR 1.55(g).

The USPTO allows electronic submission of assignment documents through the Electronic Patent Assignment System (EPAS). According to the MPEP:

  • Visit http://epas.uspto.gov for the EPAS system
  • Include an identified application or patent number
  • Complete one online cover sheet for a single transaction

For electronic submissions, the signature must comply with 37 CFR 3.31(a)(7) or 37 CFR 1.4(d)(2). This typically involves an S-signature between forward slashes (e.g., /John Smith/).

The MPEP notes: The fee set in 37 CFR 1.21(h)(1) for recording an electronically submitted document is currently $0. Customers should check the current fee schedule on the Office website before submitting documents for recordation.

The recordation date for electronic submissions is the date the complete transmission is received by the USPTO.

For more information on electronic submission, visit: electronic submission.

For more information on EPAS, visit: EPAS.

For more information on patent assignment, visit: patent assignment.

The USPTO provides an electronic system for submitting assignment documents. According to MPEP 302.10:

“Assignment documents can be submitted electronically via the Office’s Electronic Patent Assignment System (EPAS).”

EPAS allows for convenient and efficient submission of assignment documents directly to the USPTO.

To learn more:

There are three main ways to submit a patent assignment document to the USPTO:

  1. Mail: Documents can be mailed to the address specified in 37 CFR 3.27: Mail Stop Assignment Recordation Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450.
  2. Fax: Documents can be submitted via facsimile, as outlined in MPEP 302.09. However, certain documents cannot be faxed, such as assignments submitted with new applications.
  3. Electronic Submission: Documents can be submitted electronically through the Electronic Patent Assignment System (EPAS) as described in MPEP 302.10.

Each method has specific requirements and limitations, so it’s important to review the relevant MPEP sections or consult the USPTO website for detailed instructions.

The USPTO provides an online database for searching patent assignment records. According to MPEP 301.01, ‘Assignment records, digests, and indexes are available in the public search room of the USPTO.’ To search online:

  • Visit the USPTO Patent Assignment Search page
  • Enter relevant information such as patent number, assignee name, or assignor name
  • Review the search results for the desired assignment information

The MPEP states, ‘The assignment records of patents and applications are open to public inspection and copies of these records may be obtained upon request and payment of the fee set forth in 37 CFR 1.19(b)(3).’

The timeliness requirement for submitting certified copies of foreign applications can be satisfied through the Priority Document Exchange program. According to 37 CFR 1.55(i), the requirement will be considered satisfied if:

  • The foreign application was filed in a participating foreign intellectual property office
  • The claim for priority is presented in an application data sheet with the required information
  • The copy of the foreign application is received by the USPTO from the participating foreign office within the specified time period

The MPEP states, Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Therefore, it’s crucial to verify that the USPTO has received the priority document.

To learn more:

In a continuing application, you can satisfy the requirement for a certified copy of a foreign application without actually filing the certified copy again. According to 37 CFR 1.55(h):

The requirement for a certified copy of the foreign application will be considered satisfied in an application if a prior-filed nonprovisional application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c) contains a certified copy of the foreign application and the prior-filed nonprovisional application is identified as containing a certified copy of the foreign application.

This means that if you have already filed a certified copy in a parent application, you can simply identify that application as containing the certified copy when filing your continuing application. This approach can save time and reduce the paperwork required for perfecting priority claims in continuing applications.

To learn more:

To learn more:

How can I revoke a power of attorney in a patent application filed on or after September 16, 2012?

To revoke a power of attorney in a patent application filed on or after September 16, 2012, you need to follow these steps:

  • Submit a new power of attorney form (PTO/AIA/82) or a revocation form (PTO/AIA/83).
  • The revocation must be signed by the applicant or patent owner.
  • If using form PTO/AIA/82, check the box indicating revocation of all previous powers of attorney.

According to MPEP 402.02(a): “A power of attorney may be revoked only by the applicant or patent owner. An assignee who is not the applicant may revoke a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c).”

It’s important to note that the revocation is not retroactive; it only takes effect when received by the USPTO.

To learn more:

How can I request participation in the priority document exchange program?

To request participation in the priority document exchange (PDX) program, you need to follow specific procedures outlined in MPEP 213.04. Here’s what you need to do:

Applicants may participate in the priority document exchange (PDX) program by requesting that the USPTO retrieve a copy of the foreign application from a participating foreign intellectual property office. Participation in the PDX program is not automatic; a request must be made.

To make a request:

  • Include an authorization to access the priority document in the foreign office’s system
  • Provide sufficient information to identify the foreign application
  • Submit this request within the later of:
    • 16 months from the filing date of the prior foreign application, or
    • 4 months from the actual filing date of the application in which priority is claimed

It’s important to note that the PDX program is only available with participating foreign offices. Always check the current list of participating offices before making a request.

To learn more:

To request expungement of an assignment record, you need to submit a petition to the USPTO. According to MPEP 323.01(d), the petition should:

  • Clearly identify the assignment record document to be expunged
  • State the reason for expungement
  • Include the fee set forth in 37 CFR 1.17(g)
  • Provide a copy of the original assignment record to be expunged (if available)

The petition should be mailed to the Mail Stop Assignment Recordation Services, Director of the USPTO.

To learn more:

Tags: USPTO

To request access to a patent application that is not publicly available, you generally need to file a petition for access. According to 37 CFR 1.14(a)(1)(vii), for applications that are not published, patented, or the subject of a benefit claim in a published application:

A granted petition for access (see paragraph (i)) or a power to inspect (see paragraph (c) of this section) is necessary to obtain the application, or a copy of the application.”

To file a petition for access, you must:

  • Submit the petition with the fee set forth in 37 CFR 1.17(g)
  • Provide a showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access

The petition should be directed to the Office of Patent Legal Administration. The applicant will be given an opportunity to object to the granting of the petition, and the USPTO will make a determination based on the circumstances presented.

For more information on petition for access, visit: petition for access.

How can I request a refund for my USPTO deposit account?

To request a refund for your USPTO deposit account, you need to follow these steps:

  • Submit a written request to the USPTO Office of Finance
  • Include your deposit account number and the amount to be refunded
  • Provide a detailed explanation for the refund request

The MPEP states: “A refund to a deposit account may be made on request to the Office of Finance.” (MPEP 509.01)

It’s important to note that refunds are typically processed for overpayments or erroneous charges. The USPTO will review your request and determine if a refund is warranted based on the circumstances provided in your explanation.

To learn more:

Tags: patent fees

How can I request a corrected patent with a perfected foreign priority claim?

To request a corrected patent with a perfected foreign priority claim after issuance, you need to follow these steps:

  • File a reissue application under 35 U.S.C. 251.
  • Include a petition for an expedited examination of the reissue application.
  • Pay the required fees for both the reissue application and the petition.
  • Submit the necessary documents to perfect the priority claim, such as a certified copy of the foreign application.

As stated in MPEP 216.01: “A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) in an issued patent.” It’s important to note that this process is only available for perfecting priority claims that were timely filed during the pendency of the application.

How can I replenish my USPTO deposit account?

You can replenish your USPTO deposit account through various methods. According to MPEP 509.01, “Deposits to these accounts may be made by electronic funds transfer, credit card, or check.” Here are the options:

  • Electronic Funds Transfer (EFT): This is the preferred method for replenishing deposit accounts.
  • Credit Card: You can use a credit card to add funds to your account.
  • Check: Checks can be mailed to replenish the account balance.

For detailed instructions on each method, visit the USPTO’s Receipts Accounting Policies page.

To learn more:

To regain micro entity status after losing it, you must file a new certification of entitlement to micro entity status. As stated in MPEP 509.04(e):

Once a notification of a loss of entitlement to micro entity status is filed in the application or patent, a new certification of entitlement to micro entity status is required to again obtain micro entity status.

This means you must:

  • Ensure you meet the criteria for micro entity status as defined in 37 CFR 1.29(a) or 1.29(d)
  • File a new certification form (PTO/SB/15A or PTO/SB/15B) in the application or patent
  • Meet all other requirements for micro entity status

To learn more:

Patent assignments can be recorded with the USPTO in two ways:

  1. In the assignment records: This is done as provided in 37 CFR Part 3. Recording provides public notice of the assignment but does not determine its validity.
  2. In the file of a patent application or patent: This may be necessary for the assignee to take action in the application or patent proceeding.

For a patent to issue to an assignee, the assignment must be recorded or filed for recordation in accordance with 37 CFR 3.11.

It’s important to note that recording an assignment in the USPTO’s assignment records does not automatically allow the assignee to take action in a patent proceeding. Additional steps may be required as outlined in MPEP § 325 for applications filed on or after September 16, 2012, or MPEP § 324 for earlier applications.

For more information on patent assignment, visit: patent assignment.

If you want to record a document for additional patents or applications that has already been recorded in the Assignment Division, you must submit a new recordation request. MPEP 315 outlines the required components:

  1. A copy of the original document (which may be the previously recorded papers with the reel and frame numbers stamped by the Assignment Division, or a copy of such papers)
  2. A completed cover sheet (as per 37 CFR 3.31 and MPEP § 302.07)
  3. The appropriate recording fee (as specified in 37 CFR 1.21(h) and 3.41)

Upon receiving these items, the USPTO will assign a new recording date to that submission, update the assignment database, and include the cover sheet and document as part of the official record.

To prove that a joint inventor cannot be found or refuses to sign the patent application, you must provide evidence of your diligent efforts. According to MPEP 409.03(a):

“The application must be accompanied by proof that the nonsigning inventor (1) cannot be found or reached after diligent effort or (2) refuses to execute the application papers.”

For specific guidance on what constitutes acceptable proof, refer to MPEP 409.03(d). This may include documented attempts to contact the inventor, returned mail, or written statements from the unavailable inventor indicating their refusal to sign.

To learn more:

You can petition the USPTO Director to consider correspondence as filed on a particular date if it was returned or refused by the USPS due to a Priority Mail Express® interruption or emergency. The petition process is outlined in 37 CFR 1.10(g) and (h):

  1. File the petition promptly after becoming aware of the return or refusal
  2. Include the original correspondence or a copy showing the Priority Mail Express® mailing label number
  3. Provide a copy of the Priority Mail Express® mailing label showing the “date accepted” (for returned mail)
  4. Include a statement establishing the original deposit attempt and that the correspondence is the original or a true copy
  5. The USPTO may require additional evidence to verify the interruption or emergency

As stated in MPEP 511: “37 CFR 1.10(g) provides a procedure under which applicant may petition the Director to have correspondence that was returned by the USPS due to an interruption or emergency in Priority Mail Express® service considered as filed on a particular date in the Office.”

If your correspondence is affected by a postal emergency, you can petition the Director to consider it filed on a particular date under certain conditions. The process depends on whether your mail was returned, refused, or unable to be deposited. Here’s a summary of the petition requirements based on MPEP 511:

  1. For returned correspondence (37 CFR 1.10(g)):
    • File promptly after becoming aware of the return
    • Include the original or copy of correspondence with Priority Mail Express® label
    • Provide a statement establishing the original deposit
  2. For refused correspondence (37 CFR 1.10(h)):
    • File promptly after becoming aware of the refusal
    • Include the original or copy of correspondence with Priority Mail Express® label
    • Provide a statement establishing the original attempt to deposit
  3. For correspondence unable to be deposited (37 CFR 1.10(i)):
    • File promptly in a manner designated by the Director
    • Include the original or copy of correspondence
    • Provide a statement establishing that the correspondence would have been deposited but for the emergency

For more detailed information on filing these petitions, refer to MPEP § 513, subsections IX-XI.

To learn more:

To petition for access to a confidential patent application, you must file a petition under 37 CFR 1.14(i), which requires:

  1. Payment of the petition fee set forth in 37 CFR 1.17(g)
  2. A showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access

The petition should be filed with the Office of Patent Legal Administration, unless the application is involved in an interference or trial before the Patent Trial and Appeal Board.

You may file the petition either with proof of service upon the applicant, or in duplicate so the USPTO can send a copy to the applicant. The applicant will typically have about 3 weeks to object to the granting of access.

Direct quote: ‘Any petition by a member of the public seeking access to, or copies of, all or part of any pending or abandoned application preserved in confidence pursuant to paragraph (a) of this section, or any related papers, must include: (1) The fee set forth in § 1.17(g); and (2) A showing that access to the application is necessary to carry out an Act of Congress or that special circumstances exist which warrant petitioner being granted access to all or part of the application.’ (37 CFR 1.14(i))

How can I pay patent fees to the USPTO?

The USPTO offers several methods for paying patent fees. According to MPEP 509:

“Fees can be paid: (A) by credit card, (B) by electronic funds transfer (EFT), (C) by check, (D) by money order, (E) by deposit account, or (F) in cash (for hand-carried applications only).”

Here’s a breakdown of these payment methods:

  • Credit Card: Accepted online or by mail/fax using Form PTO-2038
  • Electronic Funds Transfer (EFT): Available through the USPTO’s Electronic Filing System (EFS-Web)
  • Check or Money Order: Made payable to the Director of the USPTO
  • Deposit Account: A pre-established account with the USPTO
  • Cash: Only for in-person payments at the USPTO office

For most applicants, online payment methods (credit card or EFT) are the most convenient and efficient options.

To learn more:

Tags: patent fees

How can I pay fees to the USPTO electronically?

The USPTO offers several electronic payment options for paying fees:

  • Credit or Debit Card: You can pay using major credit or debit cards through the USPTO’s secure online system.
  • Electronic Funds Transfer (EFT): This allows for direct transfer from your bank account to the USPTO.
  • USPTO Deposit Account: Maintain a pre-funded account with the USPTO for easy fee payments.

According to MPEP 509, “The Office accepts the following forms of payment: […] by credit card, by electronic funds transfer (EFT), or by a USPTO deposit account.” Electronic payments are convenient and often processed more quickly than other methods.

To learn more:

Tags: USPTO fees

To obtain status information for a patent application, you can:

  1. Check Patent Center or Private Patent Application Information Retrieval (PAIR) on the USPTO website at www.uspto.gov
  2. Contact the Application Assistance Unit (AAU) for applications in pre-examination or post-examination processing via email at HelpAAU@uspto.gov, phone at 571-272-4000 or toll-free at 888-786-0101, or visit their website

If the application has not been published but is pending or abandoned, the AAU will determine if the requester is authorized to receive status information based on their relationship to the application.

Obtaining copies of patent assignment records depends on when the assignment was recorded. According to MPEP 301.01:

  1. For assignments recorded on or after May 1, 1957:
    • Copies can be obtained from the USPTO upon request and payment of the fee set forth in 37 CFR 1.19.
    • The MPEP states: “Requests for abstracts of title for assignments of patents recorded after May 1, 1957, are provided by the Certification Division upon request and payment of fee required in 37 CFR 1.19.”
  2. For assignments recorded before May 1, 1957:
    • These records are maintained by the National Archives and Records Administration (NARA).
    • Requests should be directed to NARA directly.
    • The MPEP advises: “Requests for copies of pre-1957 records for patents should be directed to the National Archives and Records Administration (NARA). Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.”

When requesting copies, be sure to identify the reel and frame number where the assignment is recorded to avoid extra charges for search time.

To learn more:

There are several ways to obtain a foreign filing license:

  1. File a US patent application, which is considered an implicit petition for a license. The filing receipt will indicate if a license is granted.
  2. File an explicit petition for a license under 37 CFR 5.12(b) if no US application has been filed.
  3. Wait 6 months after filing a US application, at which point a license is no longer required (unless a Secrecy Order has been imposed).

As stated in the MPEP: “There are two ways in which permission to file an application abroad may be obtained: either a petition for a foreign filing license may be granted (37 CFR 5.12) or an applicant may wait 6 months after filing an application in the USPTO (35 U.S.C. 184) at which time a license on that subject matter is no longer required as long as no Secrecy Order has been imposed.”

For more information on foreign filing license, visit: foreign filing license.

For more information on patent procedure, visit: patent procedure.

For more information on USPTO, visit: USPTO.

To obtain a copy of a recorded assignment document from the USPTO, you can request a certified copy. According to MPEP 317:

Certified copies of recorded documents may be ordered from the Assignment Division for a fee.

To request a certified copy:

  • Contact the USPTO Assignment Division
  • Provide the necessary information to identify the document
  • Pay the required fee

The USPTO will then provide you with a certified copy of the requested assignment document. This can be useful for legal or business purposes where an official copy of the recorded assignment is needed.

For more information on Assignment Division, visit: Assignment Division.

For more information on certified copies, visit: certified copies.

For more information on USPTO, visit: USPTO.

There are two ways to make a patent assignment of record with the USPTO:

  1. Record the assignment in the USPTO’s assignment records as provided in 37 CFR Part 3. This provides legal notice to the public but does not determine the validity or effect of the assignment.
  2. Make the assignment of record in the file of a patent application, patent, or other patent proceeding. This may be necessary for the assignee to ‘take action’ in the application or proceeding.

For a patent to issue to an assignee, the assignment must be recorded or filed for recordation in accordance with 37 CFR 3.11.

To make a Freedom of Information Act (FOIA) request for USPTO records:

  1. Submit a written request to the USPTO FOIA Officer:
    • Address: United States Patent and Trademark Office, P.O. Box 1450, Alexandria, Virginia 22313-1450
    • Mark the letter and envelope ‘Freedom of Information Act Request’
  2. Describe the requested records in detail:
    • Include specific information such as dates, titles, names, subjects, etc.
    • Provide any known file designations or descriptions
  3. If requesting records about yourself, follow additional requirements in 37 CFR 102.24
  4. If requesting records about another individual, provide either:
    • A written authorization signed by that individual permitting disclosure
    • Proof that the individual is deceased (e.g., death certificate, obituary)

Direct quote: ‘A request for USPTO records that are not customarily made available to the public as part of USPTO’s regular informational services must be in writing, and shall be processed under FOIA, regardless of whether FOIA is mentioned in the request.’ (37 CFR 102.4(a))

Note: Many USPTO decisions are already available on the FOIA section of the USPTO website at www.uspto.gov/learning-and-resources/ip-policy/electronic-freedom-information-act-e-foia.

To properly incorporate material by reference in a patent application:

  1. Use the root words ‘incorporate’ and ‘reference’ (e.g., ‘incorporate by reference’) to express a clear intent to incorporate.
  2. Clearly identify the referenced patent, application, or publication.
  3. For essential material, only incorporate by reference to a U.S. patent or U.S. patent application publication.
  4. For nonessential material, you may incorporate by reference to U.S. patents, U.S. patent application publications, foreign patents, foreign published applications, prior and concurrently filed commonly owned U.S. applications, or non-patent publications.

As stated in 37 CFR 1.57(c): ‘An incorporation by reference must be set forth in the specification and must: (1) Express a clear intent to incorporate by reference by using the root words ‘incorporat(e)’ and ‘reference’ (e.g., ‘incorporate by reference’); and (2) Clearly identify the referenced patent, application, or publication.’

To learn more:

For oaths or declarations filed after the application filing date, MPEP 602.08(c) provides several acceptable methods for identifying the application:

  • Application number (series code and serial number, e.g., 08/123,456)
  • Serial number and filing date
  • International application number
  • International registration number for design applications
  • Attorney docket number on the original specification
  • Title of the invention from the original specification, with reference to an attached specification
  • Title of the invention from the original specification, with a cover letter identifying the application

The MPEP emphasizes that Absent any statement(s) to the contrary, it will be presumed that the application filed in the USPTO is the application which the inventor(s) executed by signing the oath or declaration. This presumption helps ensure proper association of documents with the correct application.

To learn more:

There are two main ways to obtain a receipt for items filed with the USPTO:

  1. For paper filings: Include a self-addressed postcard with your submission, itemizing all components being filed. The USPTO will stamp the receipt date on the postcard and return it.
  2. For electronic filings via EFS-Web or Patent Center: An Electronic Acknowledgement Receipt is automatically generated and sent to the filer.

The MPEP states: ‘If a submitter desires a receipt for any item (e.g., paper or fee) filed in the USPTO by means other than the USPTO patent electronic filing system, it may be obtained by enclosing with the paper a self-addressed postcard specifically identifying the item.’ (MPEP 503)

According to MPEP 102, when it is desired to determine the current location or status of an application, USPTO personnel should use Patent Data Portal. However, it’s important to note that:

“If the application is an Image File Wrapper (IFW) application, no location is associated with the file.”

For public inquiries about application status, the recommended methods are:

  • Checking Patent Center or Private PAIR on the USPTO website
  • Contacting the Application Assistance Unit (AAU) for pre-examination or post-examination processing applications
  • Calling the Technology Center (TC) to which the application is assigned for information about replies or expected Office actions

The assignment of an application to a TC can be determined from Patent Data Portal.

For more information on USPTO Resources, visit: USPTO Resources.

The USPTO provides several ways to find a registered patent attorney or agent, as mentioned in MPEP 401:

  1. Visit the USPTO website: www.uspto.gov/FindPatentAttorney for a searchable listing of registered practitioners.
  2. Write to the Office of Enrollment and Discipline (OED) to request a list of registered patent practitioners in your area:

    Mail Stop OED, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450

These resources can help you locate a qualified patent professional to assist with your patent application.

To file an unintentionally delayed foreign priority claim, you must submit a petition under 37 CFR 1.55(e). The petition must include:

  1. The priority claim (if not previously submitted)
  2. A certified copy of the foreign application (unless previously submitted or an exception applies)
  3. The petition fee set forth in 37 CFR 1.17(m)
  4. A statement that the entire delay was unintentional

MPEP 214.02 states: “If a claim for foreign priority is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

Filing an interim copy of a foreign application electronically can be done through the USPTO patent electronic filing system. The MPEP provides guidance on how to file different parts of the application:

  • Main parts (Abstract, Drawings, Specification, Claims) and the cover sheet can be filed as a single PDF file.
  • Text-only files (e.g., Sequence Listings, Large Tables) can be filed as .txt files.
  • XML files (e.g., Standard ST.26 Sequence Listing) should be filed on a read-only optical disc.

The MPEP states: If not provided as a single paper document, the main parts of the interim copy of the foreign priority application, i.e., Abstract, Drawings, Specification, Claims, and where applicable, the foreign patent office’s equivalent to a ‘Sequence Listing’ (see MPEP § 2421.01 a ‘Sequence Listing XML’ (see MPEP § 2412), ‘Large Tables’ (see MPEP § 608.05(b)), or a ‘Computer Program Listing Appendix’ (see MPEP § 608.05(a)), along with the separate cover sheet required by 37 CFR 1.55(j), may be filed as a single PDF image file via the USPTO patent electronic filing system.

For more information on electronic filing, refer to MPEP § 502.05.

To learn more:

Filing a delayed benefit claim for a provisional application follows a similar process to other delayed benefit claims. According to MPEP 211.04:

“If the reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 is not submitted within the required time period, a petition for an unintentionally delayed claim may be filed.”

The petition must include:

  • The reference to the prior provisional application
  • A petition fee
  • A statement that the entire delay was unintentional

It’s important to note that as of December 18, 2013, the amendment containing the specific reference to the earlier filed provisional application no longer needs to be submitted during the pendency of the application.

To learn more:

To ensure your corrected assignment documents are considered timely submitted, the USPTO provides two methods as outlined in MPEP 317.02:

  1. Use the certification procedure under 37 CFR 1.8 (see MPEP § 512)
  2. Use the “Priority Mail Express®” procedure under 37 CFR 1.10 (see MPEP § 513)

The MPEP states:

“The certification procedure under 37 CFR 1.8 (see MPEP § 512) or the “Priority Mail Express®” procedure under 37 CFR 1.10 (see MPEP § 513) may be used for resubmissions of returned papers to obtain the benefit of the date of deposit in the United States Postal Service to establish that the papers were returned within the time period specified.”

By using either of these methods, you can establish that your corrected documents were submitted within the specified time period, thus maintaining the original receipt date as the recording date of the document.

To learn more:

When discussing prior art in your patent application, you should focus on objectively describing the state of the art and how your invention improves upon it. The MPEP 608.01(r) provides guidance:

“The applicant may refer to the general state of the art and the advance thereover made by his or her invention”

Additionally, the MPEP clarifies that “Mere comparisons with the prior art are not considered to be disparaging, per se.” This means you can compare your invention to existing technologies, but do so in a factual, non-judgmental manner that focuses on technical differences and improvements.

To learn more:

Tags: prior art

When filing a Continued Prosecution Application (CPA) for a design patent, you can delete a named inventor by including a statement with your CPA filing. The MPEP ¶ 2.32 states:

Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.

This means you should provide a clear statement identifying the inventor(s) to be deleted when submitting your CPA. The USPTO will then acknowledge and process this request, correcting the inventorship accordingly.

For more information on CPA, visit: CPA.

For more information on design patents, visit: design patents.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

When filing a Continued Prosecution Application (CPA) for a design patent, you can request the deletion of a named inventor by submitting a statement with your CPA filing. The MPEP ¶ 2.32 states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This means that you should include a clear statement requesting the deletion of the specific inventor(s) when you file your CPA. The USPTO will then acknowledge this request and correct the inventorship accordingly.

For more information on design patents, visit: design patents.

For more information on patent procedure, visit: patent procedure.

To delete a named inventor in a Continued Prosecution Application (CPA) for design applications, you must submit a statement requesting the deletion along with the CPA filing. The MPEP states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

It’s important to note that this process is specific to CPA filings for design applications. If you need to delete a named inventor after the CPA has been filed, you must follow a different procedure, as outlined in MPEP ¶ 2.32: “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

For more information on patent procedure, visit: patent procedure.

The process for deleting a benefit claim depends on when your application was filed:

  • For applications filed on or after September 16, 2012: File a corrected Application Data Sheet (ADS) in compliance with 37 CFR 1.76(c) that deletes the reference to the prior-filed application.
  • For applications filed prior to September 16, 2012: Amend the specification (if the benefit claim is in the specification) or submit a supplemental ADS in compliance with pre-AIA 37 CFR 1.76(c) to delete references to prior applications.

However, be aware of the following considerations:

  • The examiner will consider whether any new prior art may become available if a benefit claim is deleted.
  • If submitted after final rejection or action, the amendment or ADS will be treated under 37 CFR 1.116.
  • If submitted after the application has been allowed, it will be treated under 37 CFR 1.312.
  • Deleting a benefit claim may affect the publication date of the application.

The MPEP also notes an important caveat:

A cancellation of a benefit claim to a prior application may be considered as a showing that the applicant is intentionally waiving the benefit claim to the prior application in the instant application.

This means that if you later try to reinstate the benefit claim, the USPTO may not accept it as an unintentional delay.

To learn more:

Tags: ADS

To correct the priority claim in an issued patent, you can file a reissue application under 35 U.S.C. 251. The MPEP states:

‘A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) or 35 U.S.C. 120 in the issued patent.’

This process allows you to amend the specification to include the required reference or correct the priority claim itself. However, it’s important to note that the reissue application must be filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f).

To correct inventorship in a nonprovisional patent application, you need to submit a request under 37 CFR 1.48(a). The request should include:

  • A signed application data sheet (ADS) with the correct inventorship information
  • The processing fee set forth in 37 CFR 1.17(i)

As stated in the MPEP, The application data sheet submitted with a request under 37 CFR 1.48(a) must identify the information being changed with underlining for insertions and strike-through or brackets for text removed.

To learn more:

How can I correct information in an Application Data Sheet (ADS) after submission?

To correct information in an Application Data Sheet (ADS) after submission, you must follow specific procedures outlined in the MPEP:

“If an ADS has been previously submitted, the ADS provided with a continuing application, reissue application, or reexamination proceeding should be marked to show the changes from the previously submitted ADS.” (MPEP 601.05(a))

Here’s how to make corrections:

  • Submit a new ADS with clearly marked changes.
  • Use strikethrough for deletions and underlining for insertions.
  • Include all sections of the ADS, not just those being changed.
  • For inventor information changes, comply with 37 CFR 1.48.
  • For benefit claims corrections, see 37 CFR 1.78.

Remember, some changes may require additional forms or fees. Always check the current USPTO guidelines for the most up-to-date requirements.

To learn more:

If your assignment documents or cover sheets are returned by the Assignment Division, you can correct and resubmit them within a specified time period to maintain the original receipt date. The USPTO states:

“Assignment documents and cover sheets, or copies of the same, which are returned by Assignment Division will be stamped with the original date of receipt by the Office and will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

To ensure timely resubmission, you can use either:

It’s important to note that the specified period for resubmission will not be extended, so prompt action is crucial.

To learn more:

To correct an improperly recorded assignment against your patent or application, follow these steps:

  • File a petition under 37 CFR 1.182 to expunge the improper assignment
  • Include evidence that the recorded assignment is improper
  • Pay the required petition fee

As stated in MPEP 323.01(c): ‘The owner of the patent or application may petition to have such an assignment expunged from the assignment records of the Office.’

To learn more:

To correct an improper incorporation by reference in a patent application:

  1. File an amendment to include the material that was improperly incorporated.
  2. Submit a statement that the amendment contains no new matter.
  3. Ensure the correction is made within the time period set by the Office, or no later than the close of prosecution as defined by 37 CFR 1.114(b).

According to 37 CFR 1.57(g): ‘Any insertion of material incorporated by reference into the specification or drawings of an application must be by way of an amendment to the specification or drawings. Such an amendment must be accompanied by a statement that the material being inserted is the material previously incorporated by reference and that the amendment contains no new matter.’

Note that corrections after abandonment require a petition to revive under 37 CFR 1.137, and corrections after patent issuance require a reissue application.

To learn more:

To correct an error in micro entity status, you need to follow the procedure outlined in 37 CFR 1.29(k). This involves:

  • Submitting a separate deficiency payment for each application or patent
  • Providing an itemization of the total deficiency payment
  • Paying the deficiency owed

The MPEP states: 37 CFR 1.29(k) contains provisions for a micro entity that correspond to the provisions of 37 CFR 1.28(c) for a small entity. This means the process is similar to correcting small entity status errors.

To learn more:

How can I correct an error in micro entity status if I’m no longer eligible?

If you discover that you’re no longer eligible for micro entity status, you should promptly notify the USPTO and pay the deficiency in fees. The MPEP states:

“A notification of loss of entitlement to micro entity status must be filed in the application or patent prior to paying, or at the time of paying, any fee after the date on which status as a micro entity is no longer appropriate.” (MPEP 509.04(f))

To correct the error:

  • File a notification of loss of entitlement to micro entity status
  • Pay the deficiency between the micro entity fees paid and the fees that should have been paid
  • Include any required surcharge for the late payment of the fee deficiency

It’s crucial to address this promptly to avoid potential issues with your patent application or granted patent.

To learn more:

To correct an error in a recorded cover sheet, you must follow the procedure outlined in 37 CFR 3.34. Specifically:

  • The error must be apparent when comparing the cover sheet with the recorded document.
  • You must file a corrected cover sheet for recordation.
  • Include a copy of the original document submitted for recording.
  • Pay the required recording fee as set forth in 37 CFR 3.41.

As stated in the MPEP, Any alleged error in a recorded cover sheet will only be corrected if the error is apparent from a comparison with the recorded assignment document. It’s important to carefully review the notice of recordation issued by the Office after recording.

To learn more:

To correct an error in a recorded assignment document at the USPTO, you have two main options:

  • Cover sheet corrections: For errors in the cover sheet data only, you can submit a corrective document identifying the reel and frame number where the assignment is recorded and explaining the correction.
  • Errors in the assignment document: For errors in the actual assignment document, you need to record a corrective document. This can be either a new assignment or other document correcting the original assignment.

As stated in MPEP 323: “The ‘Correction’ box on the Recordation Form Cover Sheet should be checked to indicate that the new submission is to correct an assignment already recorded.”

For more information on assignment correction, visit: assignment correction.

For more information on cover sheet, visit: cover sheet.

For more information on USPTO, visit: USPTO.

If you discover that another party has improperly recorded an assignment or name change against your application or patent, you can correct this error by following the procedure outlined in MPEP 323.01(c):

  1. First, try to contact the party who recorded the erroneous information and request that they record corrective papers.
  2. If unsuccessful, submit the following to the Assignment Services Division:
    • A completed cover sheet identifying the affected application or patent
    • An affidavit or declaration:
      • Identifying yourself as the correct owner
      • Stating that the previously recorded document contained erroneous information
      • Providing the reel and frame number of the incorrectly recorded document
    • The required fee for each application or patent to be corrected

The MPEP advises: The affidavit or declaration should include a summary of the true chain of title to make it clear that the chain of title for the application or patent identified should not be considered altered by the incorrect assignment or name change.

On the corrected cover sheet, check the ‘Other’ box for ‘Nature of Conveyance’ and indicate that you’re correcting an error in a previously recorded document.

To learn more:

To correct a typographical error in a recorded assignment document, you have two main options:

  • Create and record a new document
  • Make corrections to the original document and re-record it

According to MPEP 323.01(b):

If there is an error in the recorded assignment document (or other document affecting title) rather than in the cover sheet, the party responsible for an erroneous document (e.g., the assignor) must either create and record a new document or make corrections to the original document and re-record it.

This means that the assignor (the party transferring the rights) is typically responsible for correcting such errors.

To learn more:

How can I correct a timely submitted benefit claim with errors?

If you’ve submitted a benefit claim within the required time period but it contains errors, you can correct it without filing a petition. According to MPEP 211.02(a):

“A petition under 37 CFR 1.78 and the petition fee would not be required for correcting a timely submitted benefit claim for the following situations: (1) Changing the relationship of the applications (e.g., changing from “continuation” or “divisional” to “continuation-in-part” or from “continuation-in-part” to “continuation” or “divisional”); (2) Changing the filing date of a prior-filed nonprovisional or provisional application; and (3) Changing a benefit claim of a prior-filed provisional application under 35 U.S.C. 120 (e.g., “This application is a continuation of prior-filed provisional application No. —“) to a benefit claim of the same provisional application under 35 U.S.C. 119(e) (e.g., “This application claims the benefit of prior-filed provisional application No. —“) during the pendency of the later-filed application.”

To make these corrections, you should submit a corrected application data sheet (ADS) with the proper markings to show the changes.

To learn more:

If your assignment document is returned by the USPTO Assignment Division, you can correct it as follows:

  • The returned document will be stamped with the original receipt date.
  • It will come with a letter specifying a time period for correction and resubmission.
  • If resubmitted within this period, the original receipt date may be considered the recording date.
  • You can use the certification procedure (37 CFR 1.8) or “Priority Mail Express” (37 CFR 1.10) for resubmission.
  • If not corrected within the specified period, the new submission date will be the recording date.

MPEP 317.02 states: “If the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of receipt of the papers as the date of recording of the document.”

If you receive a filing receipt with missing or incorrect benefit claim information, you can request a corrected filing receipt. However, the Office will only grant such a request if the proper reference to the prior application is included:

  • For applications filed on or after September 16, 2012: in an Application Data Sheet (ADS)
  • For applications filed prior to September 16, 2012: in the first sentence(s) of the specification or an ADS

This reference must be made within the time period required by 37 CFR 1.78, with a few exceptions. As stated in the MPEP:

The Office may notify applicants on or with the filing receipt that a benefit claim may not have been recognized because the benefit claim was improper but applicants are advised that only the benefit claims that are listed on the filing receipt have been recognized by the Office.

It’s crucial to review your filing receipt promptly and carefully to avoid the need for a petition and associated fees.

To learn more:

How can I correct a defective inventor’s oath or declaration after paying the issue fee?

Correcting a defective inventor’s oath or declaration after paying the issue fee requires specific procedures. According to the MPEP:

If an oath or declaration filed after the date the issue fee was paid is defective, applicant must file a petition under 37 CFR 1.313 to withdraw the application from issue and a renewed petition under 37 CFR 1.137 to revive the application.

The process involves:

  1. Filing a petition to withdraw the application from issue under 37 CFR 1.313
  2. Filing a renewed petition to revive the application under 37 CFR 1.137
  3. Submitting a corrected oath or declaration
  4. Paying any required fees

For detailed guidance, refer to MPEP 602.03.

To learn more:

Tags: issue fee

Confirming receipt of your priority document by the USPTO through the Priority Document Exchange (PDX) program is crucial. The MPEP emphasizes this responsibility:

Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Accordingly, applicants are encouraged to check as necessary to confirm receipt by the Office of appropriate documents.

To verify receipt, you can check the Patent Application Information Retrieval (PAIR) system. Priority documents retrieved through PDX will have the document description: Priority documents electronically retrieved by USPTO from a participating IP Office.

If you don’t see this confirmation, you may need to follow up with the USPTO or consider submitting a certified copy directly to ensure your priority claim is properly documented.

To learn more:

When claiming priority to a foreign application filed in a non-English language, you must provide an English translation of the foreign application. The MPEP 213.02 states:

If the foreign application is not in the English language, an English translation of the foreign application is also required. See 37 CFR 1.55(g)(3).

Additionally, you must submit:

  • A statement that the translation is accurate
  • The certified copy of the foreign application

These documents should be filed within the prescribed time period to properly establish the priority claim.

To learn more:

You can check the status of your patent application through several methods:

  • Patent Center: This platform provides information on issued patents, published patent applications, and applications claiming domestic benefit.
  • Private PAIR (Patent Application Information Retrieval): For unpublished applications, applicants or their registered representatives can securely track progress. Note that a Customer Number must be associated with the application for access.
  • Application Assistance Unit (AAU): For general inquiries, you can contact the AAU directly.

As stated in the MPEP: Status information relating to patent applications is available through Patent Center and the Patent Application Information Retrieval (PAIR) system. (MPEP 203.08)

For most up-to-date information, the MPEP recommends: Applicants and other persons seeking status information regarding an application should check Patent Center on the Office website at www.uspto.gov/patents/apply/patent-center.

To learn more:

To find out if the USPTO is officially closed on any particular day, you can:

  • Call 1-800-PTO(786)-9199
  • Call (571) 272-1000

These phone numbers are provided in MPEP 510 for obtaining information about USPTO closures.

To check if the United States Patent and Trademark Office (USPTO) has received your priority document through the Priority Document Exchange (PDX) program, you should monitor your application status. As stated in MPEP 215.02(a):

Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed during the pendency of the application and before the patent is issued. Accordingly, applicants are encouraged to check as necessary to confirm receipt by the Office of appropriate documents.

You can check the status of your priority document in several ways:

  1. Check the Patent Application Information Retrieval (PAIR) system for your application.
  2. Look for the document description: “Priority documents electronically retrieved by USPTO from a participating IP Office.”
  3. Contact the USPTO directly if you’re unsure about the status.

It’s important to verify receipt of the priority document to ensure compliance with the requirements for claiming priority to a foreign application.

For more information on foreign application, visit: foreign application.

For more information on PAIR system, visit: PAIR system.

For more information on PDX, visit: PDX.

For more information on priority document exchange, visit: priority document exchange.

For more information on USPTO, visit: USPTO.

The process for changing the correspondence address in a patent application filed before September 16, 2012, depends on whether an oath or declaration has been filed:

  • Before filing an oath or declaration: The correspondence address can be changed by the party who filed the application, including the inventor(s), any patent practitioner named in the transmittal papers, or the assignee who filed the application.
  • After filing an oath or declaration: The correspondence address can be changed by a patent practitioner of record, an assignee as provided under pre-AIA 37 CFR 3.71(b), or all of the applicants, unless there’s an assignee of the entire interest who has taken action in the application.

As stated in MPEP 601.03(b): “Where a correspondence address has been established on filing of the application or changed pursuant to pre-AIA 37 CFR 1.33(a)(1) (prior to the filing of an executed oath or declaration under pre-AIA 37 CFR 1.63 by any of the inventors), that correspondence address remains in effect upon filing of an executed oath or declaration under pre-AIA 37 CFR 1.63 and can only be subsequently changed pursuant to pre-AIA 37 CFR 1.33(a)(2).”

To learn more:

How can I change the correspondence address for multiple patent applications?

Changing the correspondence address for multiple patent applications can be efficiently done using the USPTO’s Customer Number practice. Here’s how:

  1. Obtain a customer number if you don’t already have one.
  2. Associate your patent applications with the customer number.
  3. Update the address linked to the customer number.

The MPEP explains:

A Customer Number may be used to: … (2) change the correspondence address, fee address, or list of practitioners of record for a plurality of applications or patents through a single request. (MPEP 403)

This process eliminates the need to file separate change of address forms for each application, saving time and reducing the risk of errors. To make changes, use the USPTO’s Electronic Filing System (EFS-Web) or file a written request with the USPTO.

For more information on Customer Number, visit: Customer Number.

The process for challenging an examiner’s new matter rejection depends on where the alleged new matter appears:

  • For amendments to the specification: If the new matter is confined to amendments in the specification, you can file a petition to review the examiner’s requirement for cancellation.
  • For new matter in claims: If the alleged new matter affects the claims, leading to their rejection, the issue becomes appealable and should not be considered on petition.

As stated in MPEP 608.04(c):

“Where the new matter is confined to amendments to the specification, review of the examiner’s requirement for cancelation is by way of petition. But where the alleged new matter is introduced into or affects the claims, thus necessitating their rejection on this ground, the question becomes an appealable one, and should not be considered on petition even though that new matter has been introduced into the specification also.”

This distinction is important because it determines the appropriate procedure for challenging the examiner’s decision.

To learn more:

To authorize the USPTO to retrieve your priority document through the Priority Document Exchange (PDX) program, you need to follow these steps:

  • File a signed Request to Retrieve Electronic Priority Application(s) (PTO/SB/38 form) or an equivalent request.
  • Submit this request before the USPTO sends a notice indicating that the certified copy of the priority document is required.

As stated in MPEP 215.01, Applicants continue to bear the ultimate responsibility for ensuring that the priority document is filed by the time of patent grant as required under 37 CFR 1.55(g). It’s important to note that even if you authorize the USPTO to retrieve the document, you should monitor the process to ensure successful retrieval.

To learn more:

Pre-1957 patent assignment records are maintained by the National Archives and Records Administration (NARA), not the USPTO. According to MPEP 301.01:

“All assignment records from 1837 to April 30, 1957 for patents are now maintained and are open for public inspection in the National Archives Research Room located at the Washington National Records Center Building, 4205 Suitland Road, Suitland, Maryland 20746 and at the Civilian Records Division of the National Archives at College Park, 8601 Adelphi Road, College Park, MD 20740-6001.”

To access these records:

  • Visit the National Archives website at www.archives.gov for information on how to obtain records from these locations.
  • Be prepared to pay fees required by NARA for copies of records.
  • Note that assignment records from before 1837 are not available.

The MPEP advises: “Since these records are maintained by NARA, it is more expeditious to request copies directly from NARA, rather than from the Office, which would then have to route the requests to NARA.”

To learn more:

Tags: NARA

Patent assignment records can be accessed online through the USPTO’s Assignment Search database. The MPEP states: Assignment records that affect the title of patents and patent applications are recorded in the USPTO’s Assignment Recordation Branch. To access these records:

  • Visit the USPTO Assignment Search website
  • Enter the relevant patent or application number, assignee name, or other search criteria
  • Review the search results for assignment information

This online database provides public access to assignment records, allowing for easy verification of patent ownership.

For patent application information not available through Public PAIR, you can submit a request to the USPTO under the Freedom of Information Act (FOIA). Here’s how to proceed:

  1. Submit a written request to the USPTO’s FOIA Officer.
  2. Clearly identify the records you’re seeking.
  3. Explain why you believe the information should be disclosed if it’s not typically available to the public.
  4. Be prepared to pay any applicable fees for search and duplication.
  5. Wait for the USPTO to process your request and respond, which may take several weeks.

Note that certain information may still be withheld if it falls under FOIA exemptions or is protected by other statutes.

Access to unpublished patent application files is generally restricted. According to MPEP 103:

‘Unpublished abandoned applications are not open to public inspection.’

However, there are exceptions:

  • If the application is referenced in a U.S. patent application publication or patent
  • If written authority from the applicant, assignee, or attorney/agent of record is provided
  • If a petition for access is granted

To request access, you may need to file a petition with the USPTO, demonstrating a need or right to access the application.

For more information on Patent application access, visit: Patent application access.

For more information on unpublished applications, visit: unpublished applications.

Access to information about unpublished patent applications is generally restricted. However, according to MPEP 101, there are specific circumstances under which such information may be accessed:

  1. If you are the applicant, an inventor, the assignee of record, or the attorney or agent of record, you may be able to access information about the application.
  2. If the application is identified in a published patent document or in another application as specified in 37 CFR 1.14(a)(1)(i) through (a)(1)(vi), certain status information may be available to the public.
  3. In some cases, a petition for access or a power to inspect may be required to access information about an unpublished application.

It’s important to note that the USPTO has strict procedures for verifying the identity and authority of individuals requesting information about unpublished applications to maintain confidentiality.

For more information on unpublished applications, visit: unpublished applications.

For more information on USPTO procedures, visit: USPTO procedures.

Access to unpublished abandoned patent applications is limited. According to 37 CFR 1.14(a)(1)(iv), the file contents of an unpublished abandoned application may be made available to the public if:

  • The application is identified in a U.S. patent, statutory invention registration, U.S. patent application publication, international publication of an international application, or publication of an international registration designating the U.S.
  • Benefit of the abandoned application is claimed under 35 U.S.C. 119(e), 120, 121, 365, or 386(c) in an application that has been published or patented.

To obtain access, a written request must be submitted along with payment of the appropriate fee set forth in 37 CFR 1.19(b).

Reissue application files are generally open to public inspection. According to 37 CFR 1.11(b):

  • Reissue applications are open to inspection by the general public
  • The filing of reissue applications (except for continued prosecution applications under 37 CFR 1.53(d)) is announced in the Official Gazette
  • The announcement includes details such as filing date, reissue application and original patent numbers, title, inventor name, and examining group

For Image File Wrapper (IFW) reissue applications:

  • Files are open to inspection by the general public through Patent Center via the USPTO website
  • Members of the public can view the entire content of the reissue application file history online

Direct quote: ‘All reissue applications, all applications in which the Office has accepted a request to open the complete application to inspection by the public, and related papers in the application file, are open to inspection by the public, and copies may be furnished upon paying the fee therefor.’ (37 CFR 1.11(b))

Foreign assignees can designate a domestic representative for USPTO correspondence as outlined in 35 U.S.C. 293 and 37 CFR 3.61. The MPEP states:

An assignee of a patent or patent application who is not domiciled in the United States may, by written document signed by such assignee, designate a domestic representative.

Key points for this designation:

  • It should be submitted as a separate paper from any assignment document
  • It should be clearly labeled ‘Designation of Domestic Representative’
  • It will be entered into the record of the appropriate application or patent file
  • It must be signed in accordance with 37 CFR 1.33(b)
  • It should state the name and address of a person residing within the United States

This designation allows for service of process or notice of proceedings affecting the patent or rights under the patent to be served on the designated representative.

For more information on domestic representative, visit: domestic representative.

For more information on foreign assignee, visit: foreign assignee.

For more information on USPTO correspondence, visit: USPTO correspondence.

Applicants can find a new registered patent attorney or agent through resources provided by the USPTO. According to MPEP § 407: “Applicants may obtain a list of registered patent attorneys and agents located in their area by consulting the USPTO website, https://oedci.uspto.gov/OEDCI/, or by calling the Office of Enrollment and Discipline at (571) 272-4097.” These resources allow applicants to search for qualified practitioners who can represent them before the USPTO.

For more information on USPTO Resources, visit: USPTO Resources.

When an applicant’s patent attorney or agent is suspended, they can find a new registered patent attorney or agent by:

  1. Consulting the USPTO website at https://oedci.uspto.gov/OEDCI/
  2. Calling the Office of Enrollment and Discipline at (571) 272-4097

This information is provided in Form Paragraph 4.07 of MPEP § 407.

To ensure successful retrieval of priority documents under PDX, applicants should follow these guidelines from MPEP 215.01:

Applicants are strongly encouraged to cite the foreign application using an acceptable format (see MPEP § 214.04) and use proper and consistent citation format throughout the U.S. application.

Key points for successful retrieval include:

  • Provide proper, complete, and consistent citations of foreign priority applications and filing dates.
  • Use an acceptable format for citing foreign applications (refer to MPEP § 214.04).
  • Ensure the foreign priority claim is complete to prevent retrieval issues.
  • Check the Private Patent Application and Information Retrieval (PAIR) system to confirm successful retrieval.

Remember, a successful retrieval typically takes about one week to complete.

To learn more:

To ensure successful retrieval of foreign applications through PDX, applicants should:

  • Provide proper and consistent citation of the foreign priority application and its filing date
  • Use an acceptable format for citing the foreign application (see MPEP § 214.04)
  • Ensure the foreign priority claim is complete

The MPEP emphasizes the importance of correct citations:

An improper, incomplete, or inconsistent citation of a foreign priority application and/or its filing date will result in a delay or prevent retrieval under the Priority Document Exchange program.

Applicants are encouraged to check the Private PAIR system to confirm successful retrieval of their foreign priority application.

To ensure that references from the international search report are printed on the resulting patent, applicants must provide a separate listing of these references. According to MPEP 609.03:

“In order to have the references printed on such resulting patent, a separate listing, preferably on a PTO/SB/08 form, must be filed within the set period for reply to this Office action.”

This separate listing should be submitted within the set period for reply to the Office action or, if the application is ready for allowance, within ONE MONTH of the mailing date of the Notice of Allowability. It’s important to note that no extension of time will be granted to comply with this requirement if the application is ready for allowance.

To learn more:

Applicants can avoid the need for preliminary amendments in patent applications by following the guidance provided in MPEP 608.04(b):

Applicants can avoid the need to file a preliminary amendment by incorporating any desired amendments into the text of the specification, even where the application is a continuation or divisional application of a prior-filed application.

This approach involves directly including any necessary changes or additions in the original specification text when preparing the application. By doing so, applicants can ensure that all desired content is present from the initial filing, eliminating the need for separate preliminary amendments. This method is recommended for all types of applications, including continuations and divisionals, to streamline the application process and reduce potential processing delays.

To learn more:

The MPEP outlines the process for adding an omitted inventor to a patent application under 35 U.S.C. 116(b):

  1. If a joint inventor refuses to join or cannot be reached, the application can be made by the other inventor(s).
  2. The Director of the USPTO may grant the patent to the applying inventor(s), subject to the omitted inventor’s rights.
  3. The omitted inventor can subsequently join the application.

Additionally, 35 U.S.C. 116(c) allows for correction of errors in naming inventors: Whenever through error a person is named in an application for patent as the inventor, or through an error an inventor is not named in an application, the Director may permit the application to be amended accordingly, under such terms as he prescribes.

To learn more:

To learn more:

To correct or update an inventor’s name in a nonprovisional patent application:

  1. File a request under 37 CFR 1.48(f).
  2. Include an Application Data Sheet (ADS) identifying each inventor by their legal name.
  3. Pay the processing fee set forth in 37 CFR 1.17(i).

According to MPEP § 602.08(b), “Any request to have the name of the inventor or a joint inventor in a nonprovisional application corrected or updated, including correction of a typographical or transliteration error in the spelling of an inventor’s name, must be by way of a request under 37 CFR 1.48(f).

For provisional applications, use 37 CFR 1.48(d) instead. If the error is discovered after the issue fee is paid, either withdraw the application and submit an RCE or file a certificate of correction after the patent issues.

To learn more:

An inventor’s access to their patent application can be restricted, but it requires a specific process. According to MPEP 106, “Any request to prevent the inventor from obtaining access to the file should be filed as a separate paper, 37 CFR 1.4(c), and should be directed to the Office of Petitions.”

If the request is granted, the inventor will be informed that they can only inspect the application if they can show why such inspection is necessary to conserve their rights. It’s important to note that this restriction is temporary. Once the application is published under 35 U.S.C. 122(b), it becomes publicly available, and any previously granted restrictions on the inventor’s access will no longer be in effect.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

Inventors or applicants can control access to their patent application by assignees through explicit consent or denial. As outlined in MPEP 106.01, the applicant has the right to decide whether to grant or deny access to the application, especially in cases involving part interest assignees. This control mechanism allows inventors to protect sensitive information or maintain strategic advantage during the patent prosecution process. Applicants can communicate their consent or denial of access to the USPTO, which will then enforce these preferences regarding application inspection.

To claim the benefit of a prior application’s filing date in a continuation-in-part (CIP) application, inventors must follow specific procedures. As noted in MPEP ¶ 2.06:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

This involves properly referencing the prior application in the CIP application and ensuring that the CIP is filed before the patenting, abandonment, or termination of proceedings on the prior application. It’s crucial to follow the guidelines in MPEP § 211 for claiming domestic benefit.

For more information on domestic benefit, visit: domestic benefit.

While it’s uncommon, there is a process for restricting an inventor’s access to their patent application. According to MPEP 106:

Any request to prevent the inventor from obtaining access to the file should be filed as a separate paper, 37 CFR 1.4(c), and should be directed to the Office of Petitions. If the request is granted, the inventor will be informed that he or she will only be permitted to inspect the application on sufficient showing why such inspection is necessary to conserve his or her rights.

This process requires a specific request and justification. It’s important to note that such restrictions are temporary, as the MPEP also states, Of course, after the application has published pursuant to 35 U.S.C. 122(b), the application will be available to the public and any restriction on the inventor to access his or her application previously granted will no longer be in effect.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

An inventor can be deleted from a Continued Prosecution Application (CPA) for design patents by submitting a statement requesting the deletion at the time of filing the CPA. The MPEP states:

“Receipt is acknowledged of the statement requesting that [1] be deleted as a named inventor which was filed with the Continued Prosecution Application (CPA) on [2]. The inventorship has been corrected as requested.”

This process allows for the correction of inventorship at the time of filing the CPA. However, it’s important to note that if you need to delete an inventor after the CPA has been filed, you must follow a different procedure, as stated in the MPEP: “Any request to delete a named inventor in a CPA filed after the CPA is filed must be accompanied by a request under 37 CFR 1.48.”

For more information on CPA, visit: CPA.

Tags: CPA

An heir of a deceased inventor can file a patent application under certain conditions. The MPEP 409.01(b) states:

If an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or heirs of the deceased inventor.

To file the application, the heir should:

  • Obtain legal recognition as the heir or legal representative
  • File the application on behalf of the deceased inventor
  • Provide documentation proving their status as heir or legal representative
  • Complete the necessary oath or declaration

It’s advisable to consult with a patent attorney to ensure all legal requirements are met.

To learn more:

An attorney or agent who has been given power of attorney can withdraw by submitting a request to the USPTO. According to MPEP 402.06:

nn

“A registered patent attorney or patent agent who has been given a power of attorney pursuant to § 1.32(b) may withdraw as attorney or agent of record upon application to and approval by the Director.”

nn

The request should briefly state the reason(s) for withdrawal. If based on issues like lack of compensation, it’s recommended to cite “irreconcilable differences” to maintain client confidentiality. The withdrawal is effective when approved by the USPTO, not when received.

nn

Practitioners must take steps to protect the client’s interests when withdrawing, such as giving reasonable notice and allowing time to hire new counsel. The Request for Withdrawal As Attorney or Agent form (PTO/AIA/83) can be used.

For more information on patent representation, visit: patent representation.

For more information on power of attorney, visit: power of attorney.

How can an associate power of attorney be given in applications filed before September 16, 2012?

For applications filed before September 16, 2012, an associate power of attorney can be given by a principal attorney or agent to one or more associate attorneys or agents. According to MPEP 402.02(b):

“For applications filed before September 16, 2012, a power of attorney may be given to one or more attorneys or agents. (37 CFR 1.32(c)(1)). A principal attorney or agent may appoint an associate attorney or agent.”

The associate power of attorney must be signed by the principal attorney or agent who was appointed in the application. It’s important to note that the associate power does not have to be approved by the Office and becomes effective upon submission.

To learn more:

The MPEP outlines two ways to make an assignment of record with the USPTO:

  1. Recording in the USPTO assignment records: ‘An assignment can be made of record in the assignment records of the Office as provided for in 37 CFR Part 3. Recordation of the assignment provides legal notice to the public of the assignment.’
  2. Filing in a specific application or patent file: ‘An assignment can be made of record in the file of a patent application, patent, or other patent proceeding (e.g., reexamination proceeding).’

The MPEP notes: ‘Recordation of an assignment in the assignment records of the Office does not, by itself, permit the assignee to take action in the application, patent, or other patent proceeding.’

It’s important to understand the differences between these methods and their respective purposes in patent proceedings.

For applications filed on or after September 16, 2012, an assignee must first become the applicant under 37 CFR 1.46(c) to revoke a previously given power of attorney and/or grant a new one. This is because, as stated in the MPEP, any power of attorney must be signed by the applicant or patent owner. The process involves:

  • The assignee becoming the applicant
  • Revoking the previous power of attorney
  • Granting a new power of attorney

For more details on establishing the right of an assignee to take action, refer to MPEP § 325.

To learn more:

How can an assignee establish the right to take action in a pre-AIA application?

For pre-AIA applications (filed before September 16, 2012), an assignee can establish the right to take action by:

  1. Filing papers in the USPTO demonstrating the chain of title from the inventor to the assignee, or
  2. Specifying in the papers requesting or taking action that action is being taken pursuant to a specific 37 CFR provision.

According to MPEP 324: “The assignee must establish its ownership of the property to the satisfaction of the Director. The chain of title from the inventor to the assignee must be clearly established.” This typically involves submitting assignment documents or other evidence of ownership to the USPTO.

For more information on assignee rights, visit: assignee rights.

For more information on pre-AIA, visit: pre-AIA.

For more information on USPTO procedures, visit: USPTO procedures.

To ensure assignee information appears on an issued patent, the assignee must comply with 37 CFR 3.81(b). This regulation outlines the specific requirements for including assignee data on a patent.

According to MPEP 307, the assignee should:

  • Submit a request for issuance of the application in the name of the assignee
  • Provide the appropriate documentary evidence of ownership (e.g., assignment for patent)
  • Specify the assignee’s name and address

The MPEP states: A request for a patent to be issued to an assignee submitted pursuant to 37 CFR 3.81(b) must state that the document required by 37 CFR 3.81(b) is being submitted to OPAP in order to request that the patent be issued to an assignee.

It’s crucial to follow these steps accurately to ensure the assignee information is properly recorded and appears on the issued patent.

For more information on assignee information, visit: assignee information.

For more information on patent issuance, visit: patent issuance.

An assignee can become the applicant for a patent application by following these steps:

  1. File the application under 37 CFR 1.46
  2. Include an application data sheet (ADS) under 37 CFR 1.76 specifying the assignee as the applicant in the applicant information section
  3. Record documentary evidence of ownership (e.g., assignment) as provided in 37 CFR part 3 no later than the date the issue fee is paid

The MPEP states: If the applicant is the assignee or person to whom the inventor is under an obligation to assign the invention, the documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for an obligated assignee) should be recorded as provided for in 37 CFR part 3 no later than the date the issue fee is paid.

To learn more:

For applications filed on or after September 16, 2012:

  • The other joint inventor(s) may file the application on behalf of themselves and the non-signing inventor.
  • A substitute statement can be filed in lieu of an oath or declaration for the non-signing inventor.

As stated in MPEP § 409.02: “If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the other joint inventor or inventors may make the application for patent on behalf of themselves and the omitted inventor.”

For more information on substitute statement, visit: substitute statement.

How can an applicant revoke a power of attorney?

An applicant can revoke a power of attorney by submitting a new power of attorney (Form AIA/82 for applications filed on or after September 16, 2012, or Form PTO/SB/80 for applications filed before September 16, 2012) or by submitting a revocation signed by the applicant. As stated in the MPEP:

“A power of attorney may be revoked at any stage in the proceedings of a case, and an applicant may appoint a new attorney or agent at any stage in the proceedings of the case by filing a new power of attorney.” (MPEP 402)

It’s important to note that the revocation should be clear and unambiguous, and it should be submitted to the USPTO for proper processing.

For more information on power of attorney, visit: power of attorney.

For more information on revocation, visit: revocation.

How can an applicant revoke a power of attorney in a patent application?

An applicant can revoke a power of attorney in a patent application by submitting a new power of attorney or by filing a revocation signed by the applicant. According to MPEP 601.02:

“A power of attorney may be revoked at any stage in the proceedings of a case, and a power of attorney to a subsidiary prior organization is revoked by a power to a primary organization.”

It’s important to note that:

  • The revocation should be clear and unambiguous
  • A new power of attorney automatically revokes the previous one
  • The revocation should be signed by the applicant or assignee of the entire interest

After revocation, the USPTO will communicate directly with the applicant or the newly appointed attorney/agent.

To learn more:

For patent applications filed before September 16, 2012, an applicant can revoke a power of attorney using Form PTO/SB/81. According to MPEP 402.05(b), “Form PTO/SB/81 may be used to revoke a power of attorney in an application filed before September 16, 2012.” The revocation can be done at any stage of the proceedings by an applicant for patent or an assignee of the entire interest of the applicant.

It’s important to note that fewer than all of the applicants or assignees may revoke the power of attorney only upon showing sufficient cause and paying a petition fee. The patent practitioner will be notified of the revocation, and the notice will be mailed to the correspondence address for the application in effect before the revocation.

To learn more:

How can an applicant revoke a power of attorney filed on or after September 16, 2012?

An applicant can revoke a power of attorney filed on or after September 16, 2012, by following these steps:

  • Submit a new power of attorney (Form AIA/82 or equivalent) that is properly executed by the applicant.
  • File a revocation of the previous power of attorney. This can be done using the revocation form PTO/AIA/82A or by submitting a clear instruction to revoke the previous power of attorney.

According to MPEP 402.02(a):

“The power of attorney may be revoked by filing a revocation of power of attorney. The revocation may be signed by the applicant for patent (all parties identified as the applicant or invention) or the patent owner. A new power of attorney from the applicant for patent (all parties identified as the applicant) or the patent owner may also be filed, which will act as a revocation of the previous power.”

It’s important to note that the new power of attorney must be properly executed by all applicants to be effective in revoking the previous power of attorney.

To learn more:

An applicant can restore the right of priority if the U.S. application is filed after the 12-month deadline (or 6-month deadline for design applications) but within 2 months of the expiration of that period. This can be done through a petition process, provided the delay was unintentional.

According to MPEP 213.03: “As provided in 37 CFR 1.55(c), if the subsequent application has a filing date which is after the expiration of the twelve-month period (or six-month period in the case of a design application), but within two months from the expiration of the period, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.55(c), if the delay in filing the subsequent application within the period was unintentional.”

The petition to restore the right of priority must include:

  • The priority claim identifying the prior foreign application
  • The petition fee
  • A statement that the delay in filing was unintentional

The USPTO may require additional information to establish that the delay was unintentional.

For more information on foreign priority, visit: foreign priority.

For more information on priority restoration, visit: priority restoration.

For more information on unintentional delay, visit: unintentional delay.

When an applicant receives a Notice of Omitted Items for missing specification pages, they have several options to respond:

  • Submit the omitted pages: The applicant can submit the missing pages within the given time period.
  • Assert no omission occurred: If the applicant believes no pages were actually omitted, they can state this in writing.
  • Rely on incorporation by reference: If the application claims priority to a prior-filed application containing the omitted material, the applicant can rely on incorporation by reference.

The MPEP 601.01(d) states:

If applicant contends that the omitted pages were in fact deposited in the USPTO with the application papers, applicant must file a petition to establish the filing date of the omitted pages. Such a petition would normally be granted only if: (A) the USPTO received and date-stamped the pages in question on the date of deposit; or (B) applicant has produced an itemized postcard receipt which specifically lists the omitted pages as having been deposited on the missing parts’ due date.

It’s crucial to respond within the given time period to avoid potential issues with the application’s filing date.

To learn more:

An applicant can request review of a refusal to accord a filing date by filing a petition. The MPEP states:

Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)). Petitioner should provide any arguments that he or she has that the items noted were not missing or that a filing date should be assigned in the absence of such items if they are believed to be unnecessary.

The petition should be marked to the attention of the Office of Petitions. If the applicant believes no defect exists, they may include a request for refund of the petition fee in the petition.

To rely on an affidavit or declaration from a prior application, an applicant must take specific steps. According to MPEP ¶ 2.03:

“Where it is desired to rely on an earlier-filed affidavit or declaration, the applicant should make the remarks of record in this application and include a copy of the original affidavit or declaration filed in the prior application.”

To rely on a prior affidavit or declaration, an applicant should:

  • Make remarks of record in the new application, referencing the prior affidavit or declaration
  • Include a copy of the original affidavit or declaration from the prior application in the new application

This ensures that the examiner is aware of the prior evidence and can consider it in the context of the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

Under pre-AIA 37 CFR 1.47(b), an applicant can prove irreparable damage by providing a statement that demonstrates the necessity of a filing date. According to MPEP 409.03(g):

Irreparable damage may be established by a pre-AIA 37 CFR 1.47(b) applicant by a showing (a statement) that a filing date is necessary to preserve the rights of the party or to prevent irreparable damage.

This statement should explain why obtaining a specific filing date is crucial for preserving the applicant’s rights or preventing significant harm to their interests.

To learn more:

To learn more:

How can an applicant proceed if an inventor is deceased?

If an inventor is deceased, the applicant can proceed with the patent application by filing a petition under 37 CFR 1.47(b). The MPEP states:

“When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or heir of the inventor upon proper intervention.”

To file the petition, the applicant must:

  • Submit the petition fee set forth in 37 CFR 1.17(g)
  • Provide proof of the inventor’s death, such as a death certificate
  • Include an oath or declaration by the legal representative or heir

The legal representative or heir should state their relationship to the deceased inventor and that they are the legal representative or heir.

To learn more:

To learn more:

An applicant or patent owner can revoke a power of attorney in a patent application filed on or after September 16, 2012 by following these steps:

  • Submit a revocation signed by the applicant or patent owner
  • Include a new power of attorney signed by the applicant or patent owner

According to MPEP 601.03(a):

“The revocation and new power of attorney may be combined in a single paper.”

It’s important to note that the revocation must be signed by the applicant or patent owner, not by a practitioner acting on their behalf.

To learn more:

How can an applicant obtain specific information about their patent application status?

While the USPTO limits the information provided over the phone, applicants have other methods to obtain detailed status information. MPEP 203.08 suggests:

“Applicants can obtain more information using the Patent Application Information Retrieval (PAIR) system. PAIR provides customers direct secure access to their own patent application status information, as well as to general patent information publicly available.”

Applicants can use Private PAIR to access confidential application information, including filing dates, office actions, and current status. For applications not yet published, this is the primary method for obtaining detailed status information.

To learn more:

According to MPEP 303, applicants who want information about assignment documents must take specific steps:

  1. Request separately certified copies of assignment documents
  2. Submit the fees required by 37 CFR 1.19

The MPEP states:

“Applicants desiring an indication of assignment documents of record should request separately certified copies of assignment documents and submit the fees required by 37 CFR 1.19.” (MPEP 303)

An applicant can incorporate by reference a prior application in a continuing application by including an explicit statement in the specification of the continuing application. The MPEP states: An applicant may incorporate by reference the prior application by including, in the continuing application-as-filed, an explicit statement that such specifically enumerated prior application or applications are ‘hereby incorporated by reference.’ The statement must appear in the specification. This incorporation by reference can be useful for adding inadvertently omitted material from the prior application without the need for a petition, provided the continuing application is entitled to a filing date.

To learn more:

If a claim for foreign priority is not presented within the required time period under 37 CFR 1.55, it is considered waived. However, the claim may be accepted if the priority claim was unintentionally delayed.

To file a petition for an unintentionally delayed priority claim, the applicant must submit:

  1. The priority claim under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or 386(b) in an application data sheet, identifying the foreign application to which priority is claimed;
  2. A certified copy of the foreign application, unless previously submitted or an exception applies;
  3. The petition fee set in 37 CFR 1.17(m); and
  4. A statement that the entire delay between the date the priority claim was due and the date it was filed was unintentional.

The Director may require additional information if there is a question whether the delay was unintentional. See 37 CFR 1.55(e).

For applications filed on or after September 16, 2012, an applicant can file a continuation or divisional application using a copy of an oath or declaration from a prior application if:

  • The oath or declaration complies with 35 U.S.C. 115 as revised effective September 16, 2012
  • It was executed by or with respect to the inventor in the earlier-filed application
  • A copy of the oath, declaration, or substitute statement showing the signature or an indication it was executed is submitted in the continuing application

As stated in the MPEP: For applications filed on or after September 16, 2012, the filing of a continuing application by all or by fewer than all of the inventors named in a prior application without a newly executed oath or declaration is permitted provided that an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement under 37 CFR 1.64, was executed by or with respect to such inventor and was filed in the earlier-filed application, and a copy of such oath, declaration, or substitute statement showing the signature or an indication thereon that it was executed, is submitted in the continuing application.

It’s important to note that the oath or declaration must meet the current requirements, even if the prior application was filed before September 16, 2012.

For more information on continuation application, visit: continuation application.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

If an applicant believes that the missing drawings were actually submitted with the original application, they can establish prior receipt by following these steps:

  1. File a petition under 37 CFR 1.53(e) within two months of the OPAP notice date
  2. Include the petition fee set forth in 37 CFR 1.17(f)
  3. Provide evidence of the deposit of the drawings with the application papers

The MPEP states: An applicant asserting that the drawing(s) was in fact received by the USPTO with the application papers must, within two months from the date of the OPAP notice, file a petition under 37 CFR 1.53(e) with the petition fee set forth in 37 CFR 1.17(f), along with evidence of such deposit.

If it is determined that the drawings were indeed received with the original application, the petition fee will be refunded.

To learn more:

To ensure that affidavits or declarations from a prior application are considered in a new application, an applicant must take specific steps. According to MPEP ¶ 2.03:

“Where it is desired to rely on an earlier-filed affidavit or declaration, the applicant should make the remarks of record in this application and include a copy of the original affidavit or declaration filed in the prior application.”

To ensure consideration, the applicant should:

  • Explicitly reference the prior affidavit or declaration in the new application
  • Provide a copy of the original affidavit or declaration
  • Explain the relevance of the prior affidavit to the current application

This process helps the examiner understand the context and importance of the previously submitted evidence in relation to the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

If an applicant in a pre-AIA 37 CFR 1.47(b) application doesn’t have an assignment or agreement to assign, they can demonstrate sufficient proprietary interest by:

  • Submitting a legal memorandum
  • Providing an affidavit or declaration of firsthand knowledge
  • Including copies of relevant statutes or court decisions (if non-U.S.)

MPEP 409.03(f) states:

“A proprietary interest obtained other than by assignment or agreement to assign may be demonstrated by an appropriate legal memorandum to the effect that a court of competent jurisdiction (federal, state, or foreign) would by the weight of authority in that jurisdiction award title of the invention to the pre-AIA 37 CFR 1.47(b) applicant.”

The legal memorandum should be prepared by an attorney familiar with the relevant jurisdiction’s laws. Supporting facts should be provided through affidavits or declarations from individuals with firsthand knowledge. For non-U.S. jurisdictions, copies of relevant statutes or court decisions (in English) should be included.

To learn more:

To learn more:

When filing under pre-AIA 37 CFR 1.47(b), the applicant must prove proprietary interest in the invention. MPEP 409.03(f) outlines three ways to demonstrate this:

  1. Show the invention has been assigned to the applicant
  2. Prove the inventor agreed in writing to assign the invention to the applicant
  3. Otherwise demonstrate sufficient proprietary interest

To prove assignment, submit:

  • A copy of the assignment document
  • A statement under pre-AIA 37 CFR 3.73(b) by the assignee

For an agreement to assign, provide a copy of the agreement. For other proprietary interest, submit a legal memorandum explaining how a court would likely award title to the applicant.

The MPEP states: If the application has been assigned, a copy of the assignment (in the English language) must be submitted. The assignment must clearly indicate that the invention described in the pre-AIA 37 CFR 1.47(b) application was assigned to the pre-AIA 37 CFR 1.47(b) applicant.

To learn more:

To learn more:

An applicant can correct or add a priority claim in an international application according to PCT Rule 26bis.1. This is referenced in 37 CFR 1.451(d), which states:

The applicant may correct or add a priority claim in accordance with PCT Rule 26bis.1.

PCT Rule 26bis.1 allows for the correction or addition of a priority claim within 16 months from the priority date or, where the correction or addition would cause a change in the priority date, within 16 months from the priority date as so changed, whichever 16-month period expires first. However, this must be done no later than four months from the international filing date.

To learn more:

If a patent application is missing a required part, the applicant can correct the deficiency as follows:

  • The USPTO will send a Notice of Missing Parts identifying the deficiency
  • The applicant must submit the missing part within the time period specified in the notice (usually two months)
  • A surcharge fee may be required along with the submission of the missing part
  • For certain missing parts, like claims or drawings, a supplemental oath or declaration may be required for applications filed before September 16, 2012

The MPEP states: In such cases where the basic filing fee, the search fee, the examination fee, and the application size fee are paid, but additional fees are required, under 37 CFR 1.16, a notice is mailed by OPAP or the Technology Center (TC), requiring that the balance of the prescribed fee be paid.

It’s important to respond promptly to any Notice of Missing Parts to avoid abandonment of the application. If the applicant believes the part was not actually missing, they can file a petition for review of the Notice.

For more information on missing parts, visit: missing parts.

To claim the benefit of an international application’s filing date, the following conditions must be met according to MPEP 211.01(c):

  • The international application must designate the United States
  • The international application must be entitled to a filing date in accordance with PCT Article 11
  • The later-filed application must be filed during the pendency of the international application (i.e., prior to its abandonment)

The MPEP states:

To claim the benefit of the filing date of an international application, the international application must designate the United States and be entitled to a filing date in accordance with PCT Article 11, and the later-filed application must be filed during the pendency (e.g., prior to the abandonment) of the international application.

This provision is based on 35 U.S.C. 365(c), which allows national applications to benefit from prior international applications designating the United States, subject to the conditions of 35 U.S.C. 120.

To learn more:

When claiming benefit to multiple prior applications, applicants must carefully establish a chain of copendency. The MPEP 211.01(b) provides guidance:

“The reference to the prior applications must identify all of the prior applications and indicate the relationship (i.e., continuation, divisional, or continuation-in-part) between each nonprovisional application in order to establish copendency throughout the entire chain of prior applications.”

Key points to remember:

  • References must be made in each intermediate application in the chain.
  • A specific reference is required for each prior-filed application and cannot be incorporated by reference from a prior application.
  • There is no limit to the number of prior applications through which a chain of copendency may be traced.

It’s crucial to properly reference all prior applications to ensure the desired benefit claims are recognized. Failure to do so may result in the need for a petition under 37 CFR 1.78 and payment of a petition fee.

To learn more:

To claim benefit of an international design application designating the United States, the following requirements must be met:

  • The claim must be made in a nonprovisional application, international application, or international design application filed on or after May 13, 2015
  • The international design application must be entitled to a filing date in accordance with 37 CFR 1.1023
  • The claim must meet the conditions and requirements of 35 U.S.C. 120

MPEP 211.01(d) states: Pursuant to 35 U.S.C. 386(c), in accordance with the conditions and requirements of 35 U.S.C. 120, a nonprovisional application is entitled to the benefit of a prior international design application designating the United States.

It’s important to note that this benefit can only be claimed in applications or patents filed on or after May 13, 2015, as specified in 37 CFR 1.78(j).

To learn more:

An applicant can challenge a new matter rejection through different procedures depending on where the alleged new matter appears:

  1. Specification: If the new matter is confined to amendments in the specification, the challenge is made by way of petition.
  2. Claims: If the alleged new matter is in the claims or affects the claims, the challenge is made through the appeal process.

The MPEP states: Where the new matter is confined to amendments to the specification, review of the examiner’s requirement for cancelation is by way of petition. But where the alleged new matter is introduced into or affects the claims, thus necessitating their rejection on this ground, the question becomes an appealable one, and should not be considered on petition even though that new matter has been introduced into the specification also. (MPEP 608.04(c))

It’s important to note that the applicant bears the burden of showing that the alleged new matter is actually supported by the original disclosure. This often involves pointing to specific parts of the original specification, drawings, or claims that provide implicit or explicit support for the contested subject matter.

To learn more:

Tags: USPTO

To authorize email communications with the USPTO, an applicant must provide a written authorization. According to MPEP 502.03:

‘The written authorization may be submitted via EFS-Web, mail, or fax. It cannot be submitted by email.’

The USPTO provides a sample authorization form:

‘Recognizing that Internet communications are not secure, I hereby authorize the USPTO to communicate with the undersigned and practitioners in accordance with 37 CFR 1.33 and 37 CFR 1.34 concerning any subject matter of this application by video conferencing, instant messaging, or electronic mail. I understand that a copy of these communications will be made of record in the application file.’

To facilitate processing, the USPTO recommends using Form PTO/SB/439, available at www.uspto.gov/patent/patents-forms. This form can be filed via EFS-Web using the document description ‘Internet Communications Authorized’.

To learn more:

An applicant can appeal a refusal to grant a filing date by submitting a petition. The MPEP states:

“Any review of the refusal to grant a filing date as of the date of deposit of the application would be by way of petition, accompanied by the petition fee (37 CFR 1.17(f)).”

When submitting a petition, the applicant should:

  • Provide arguments that the noted items were not missing
  • Explain why a filing date should be assigned even if certain items were absent (if they believe these items were unnecessary)
  • Include a request for a refund of the petition fee if they allege no defect exists

Petitions related to filing dates are decided by the Office of the Deputy Commissioner for Patent Examination Policy. The MPEP advises:

“Any petition under this section should be marked to the attention of the Office of Petitions.”

To learn more:

Registered practitioners can show authorization to conduct an interview in several ways:

  • By being an attorney or agent of record with a power of attorney
  • By having an authorization to act in a representative capacity
  • By completing, signing, and filing an Applicant Initiated Interview Request Form (PTOL-413A)

The MPEP states: Registered practitioners, when acting in a representative capacity, can show authorization to conduct an interview by completing, signing and filing an Applicant Initiated Interview Request Form (PTOL-413A). This method is particularly convenient as it eliminates the need to file a power of attorney or authorization to act in a representative capacity before having an interview.

Alternatively, practitioners can use Form PTO/SB/84, ‘Authorization to Act in a Representative Capacity,’ available on the USPTO website.

For more information on USPTO Forms, visit: USPTO Forms.

Tags: USPTO Forms

A registered patent attorney or agent who has been given a power of attorney can withdraw as attorney or agent of record by following these steps:

  • File an application for withdrawal with the USPTO Director
  • Obtain approval from the Director
  • Provide notice to the client

As stated in 37 CFR 1.36(b): A registered patent attorney or patent agent who has been given a power of attorney pursuant to § 1.32(b) may withdraw as attorney or agent of record upon application to and approval by the Director. The applicant or patent owner will be notified of the withdrawal of the registered patent attorney or patent agent.

It’s important to note that the withdrawal is effective only when approved by the USPTO, not when the request is received.

To learn more:

How can a practitioner become of record in a patent application filed on or after September 16, 2012?

A practitioner can become of record in a patent application filed on or after September 16, 2012, through the following methods:

  • Filing an Application Data Sheet (ADS) that names the practitioner as the representative
  • Filing a power of attorney (POA) signed by the applicant
  • Filing a patent application transmittal letter signed by the applicant and naming the practitioner as a representative
  • Being named as the representative in the oath or declaration

As stated in MPEP 403.01(a): ‘A power of attorney or authorization of agent may be given to a customer number in applications filed on or after September 16, 2012.’ This allows for easier management of multiple practitioners associated with a single customer number.

To learn more:

How can a power of attorney be revoked in a patent application?

A power of attorney can be revoked in a patent application through the following methods:

  • Filing a new power of attorney: This automatically revokes the previous power of attorney.
  • Filing a revocation signed by the applicant or assignee of the entire interest: This explicitly revokes the previous power of attorney.

As stated in MPEP 601.02: ‘A new power of attorney or authorization of agent filed in the application on or after September 16, 2012, automatically revokes any previously filed power of attorney or authorization of agent.’

It’s important to note that the new power of attorney or revocation must be properly executed by the applicant or assignee to be effective.

To learn more:

A person who shows sufficient proprietary interest in an invention can file a patent application as the applicant. According to MPEP § 409.05, such a person must submit a petition including:

  1. The fee set forth in 37 CFR 1.17(g)
  2. A showing of sufficient proprietary interest in the matter
  3. A statement that making the application on behalf of and as agent for the inventor is appropriate to preserve the rights of the parties

The proprietary interest can be demonstrated by a legal memorandum showing that a court would likely award title of the invention to the applicant. Supporting facts and documentation should be provided.

For more information on proprietary interest, visit: proprietary interest.

A registered patent attorney or agent who has been given a power of attorney may withdraw as attorney or agent of record by submitting a request to the USPTO. The process involves:

  1. Filing a request for withdrawal with the USPTO
  2. Obtaining approval from the Director of the USPTO
  3. Notifying the applicant or patent owner of the withdrawal

MPEP 402.06 states: “When filing a request to withdraw as attorney or agent of record, the patent attorney or agent should briefly state the reason(s) for which he or she is withdrawing so that the Office can determine whether to grant the request.”

The practitioner must also take steps to protect the client’s interests, such as giving reasonable notice and allowing time for the client to find new representation.

A patent can be issued to an assignee in two main ways:

  • Before paying the issue fee: The assignee can submit a request for issuance in their name along with the issue fee payment. The assignment must be previously recorded or stated to have been filed for recordation.
  • After paying the issue fee: A request can be submitted after the issue fee payment, but it requires additional steps and fees.

According to MPEP 307, “Normally, for a patent to issue to an assignee (other than an assignee who is the applicant in an application filed on or after September 16, 2012), a request for issuance of the application in the name of the assignee must be filed in the United States Patent and Trademark Office (Office) at a date not later than the day on which the issue fee is paid.”

For more information on issue fee, visit: issue fee.

For more information on patent assignment, visit: patent assignment.

For more information on patent issuance, visit: patent issuance.

A patent application can become formally abandoned through an explicit action by the applicant or their representative. MPEP 203.05 states that an abandoned application includes one that is removed from the Office docket of pending applications: (A) through formal abandonment by the applicant or by the attorney or agent of record. This means the applicant or their legal representative can submit a formal request to abandon the application, effectively ending its prosecution.

How can a legal representative file a patent application for a deceased inventor?

For patent applications filed on or after September 16, 2012, a legal representative can file a patent application for a deceased inventor by following these steps:

  • Submit an Application Data Sheet (ADS) naming the deceased inventor
  • Include a substitute statement in lieu of an inventor’s oath or declaration
  • Provide documentation showing the legal representative’s authority to act on behalf of the deceased inventor’s estate

The MPEP states: If an inventor dies during the prosecution of an application, or before an application is filed, the legally recognized representative of the inventor may make the substitute statement. (MPEP 409.01(a))

It’s important to note that the legal representative must have the authority to act on behalf of the deceased inventor’s estate or other legal entity holding the appropriate rights.

To learn more:

How can a legal representative file a patent application for a deceased inventor after September 16, 2012?

For patent applications filed on or after September 16, 2012, a legal representative can file an application for a deceased inventor by following these steps:

  • File the application normally, listing the deceased inventor
  • Submit an Application Data Sheet (ADS) identifying the legal representative
  • Include a substitute statement in lieu of an inventor’s oath or declaration

According to MPEP 409.01(a): “If an inventor is deceased or under legal incapacity, the legal representative of the inventor may make an application for patent as provided in 37 CFR 1.43.” The legal representative must provide documentation of their authority to act on behalf of the deceased inventor.

To learn more:

A juristic entity (e.g., corporations, universities, or other organizations) can give power of attorney in a patent application through an appropriate official. According to MPEP 402:

‘Where the applicant is a juristic entity (e.g., organizational assignee), a power of attorney must be signed by a person authorized to act on behalf of the applicant.’

The process typically involves:

  • An official with signing authority (e.g., CEO, president, or authorized patent counsel) signs the power of attorney form.
  • The signed form is submitted to the USPTO along with the patent application or separately if done after filing.
  • If requested by the USPTO, documentation may need to be provided to establish the authority of the person signing on behalf of the juristic entity.

It’s important to ensure that the person signing has the actual authority to bind the juristic entity in patent matters.

For more information on juristic entity, visit: juristic entity.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO, visit: USPTO.

How can a joint inventor apply for a patent if another joint inventor is deceased or legally incapacitated?

If a joint inventor is deceased or legally incapacitated, the other joint inventor(s) can still apply for a patent by following these steps:

  • File the application naming the deceased or legally incapacitated inventor
  • Submit a statement identifying the unavailable inventor and their last known address
  • Show that the signing inventor is obligated to assign the patent to the same entity as the unavailable inventor, or has sufficient proprietary interest
  • Submit the oath or declaration by the available inventor(s)

As stated in MPEP 409.01(a): “In the case of a deceased or legally incapacitated joint inventor, the applicant should identify the unavailable inventor on an application data sheet (ADS) or a substitute statement.”

This process allows the patent application to move forward despite the unavailability of one of the joint inventors.

To learn more:

A claim for foreign priority can be perfected after a patent has been issued through two main methods:

  1. Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323
  2. Reissue application

The choice of method depends on the specific circumstances:

  • A Certificate of Correction can be used if the requirements of 37 CFR 1.55 are met and no further examination is required.
  • A reissue application is necessary if the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance, or if further examination would be required.

The MPEP states: “The failure to perfect a claim to foreign priority prior to issuance of the patent may be cured via a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323, provided the requirements of 37 CFR 1.55 are met, or by filing a reissue application.” (MPEP 216.01)

Arbitration awards in patent disputes are binding between the parties involved in the arbitration but do not affect others. According to 35 U.S.C. 294(c):

‘An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person.’

However, if the patent is later found invalid or unenforceable by a court, the arbitration award may be modified upon application by any party to the arbitration.

The rights of nonsigning inventors in pre-AIA 37 CFR 1.47 applications are protected through specific provisions in patent law. According to MPEP 409.03(i):

“The rights of a nonsigning inventor are protected by the fact that the patent resulting from an application filed under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118 must issue to the inventor, and in an application filed under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the inventor has the same rights that he or she would have if he or she had joined in the application.”

This means that:

  • For applications under pre-AIA 37 CFR 1.47(b) and pre-AIA 35 U.S.C. 118, the patent must be issued to the inventor, even if they didn’t sign the application.
  • For applications under pre-AIA 37 CFR 1.47(a) and 35 U.S.C. 116, the nonsigning inventor retains the same rights as if they had joined the application.

These provisions ensure that the nonsigning inventor’s rights to the invention are preserved, regardless of their lack of signature on the original application.

To learn more:

To learn more:

When supplemental oaths or declarations are received after allowance, they are processed as follows:

  • They are placed in the file by the Office of Data Management.
  • Their receipt is not acknowledged to the party filing them.
  • They are not filed or considered as amendments under 37 CFR 1.312.

The MPEP clarifies:

“When received they will be placed in the file by the Office of Data Management, but their receipt will not be acknowledged to the party filing them. They should not be filed or considered as amendments under 37 CFR 1.312, since they make no change in the wording of the papers on file.”

To learn more:

The USPTO handles returned assignment documents as follows:

  • Documents are stamped with the original receipt date.
  • A letter accompanies returned documents explaining the correction needed.
  • If corrected and resubmitted within the specified time, the original receipt date is considered the recording date.
  • Resubmissions can use the certification procedure under 37 CFR 1.8 or the ‘Priority Mail Express®’ procedure under 37 CFR 1.10.
  • If not corrected and resubmitted in time, the new receipt date becomes the recording date.

The MPEP states: The certification procedure under 37 CFR 1.8 or the ‘Priority Mail Express®’ procedure under 37 CFR 1.10 may be used for resubmissions of returned papers to obtain the benefit of the date of deposit in the United States Postal Service to establish that the papers were returned within the time period specified.

For more information on assignment recording, visit: assignment recording.

For more information on document correction, visit: document correction.

For more information on USPTO procedures, visit: USPTO procedures.

Replacement drawings received in utility patent applications after the Notice of Allowability is mailed are handled differently:

Where replacement drawings are received in utility patent applications after the Notice of Allowability was mailed, the replacement drawings are handled by the Office of Data Management. Submission to the examiner is not necessary unless an amendment to the specification accompanies the drawings, such as an amendment where the description of figures is added or canceled.

This process streamlines the handling of late-submitted drawings, ensuring that only necessary reviews are conducted by examiners at this stage of the patent application process.

To learn more:

In a PCT national stage application, the examiner will consider all U.S. patents, U.S. patent application publications, and U.S. pending applications cited in the international search report that are stored electronically in the USPTO’s Image File Wrapper (IFW) system. As stated in MPEP 609.03:

“The examiner will consider other documents cited in the international search report when the Form PCT/DO/EO/903 in the national stage application indicates that both the international search report and the copies of the documents are present in the national stage file.”

The examiner should indicate in the first Office action that the information has been considered. However, these citations will not be printed on the face of the patent unless they are listed on a form that can be easily captured by the Office printing contractor.

To learn more:

The handling of provisional patent applications with missing drawings differs from nonprovisional applications. For provisional applications:

  • The USPTO does not grant petitions under 37 CFR 1.182 to accept omitted drawings and accord a later filing date
  • Applicants are advised to file a new, complete provisional application instead
  • Upon receiving an OPAP notice about missing drawings, applicants have two options:
    1. File a petition under 37 CFR 1.53(e) with evidence to establish prior receipt of the drawings
    2. Accept the application as deposited by not responding to the notice

The MPEP states: The USPTO will not grant petitions under 37 CFR 1.182 to accept omitted drawing(s) and accord an application filing date as of the date of such submission in provisional applications. The applicant should simply file a new completed provisional application.

If the applicant doesn’t respond to the OPAP notice and the provisional application is otherwise complete under 37 CFR 1.51(c), it will be held in the USPTO’s Image File Wrapper (IFW) system and automatically abandoned at the end of its pendency period.

To learn more:

Provisional application benefits are handled differently from other types of priority claims on the bib-data sheet. If an applicant claims benefit under 35 U.S.C. 119(e) to a prior provisional application, the application number of that provisional application should be printed on the bib-data sheet.

However, it’s important to note: If applicant claims benefit under35 U.S.C. 119(e)to a prior provisional application, and states that the provisional application claims the benefit of, or priority to, earlier domestic or foreign application(s), the earlier application(s) should not be reflected on the bib-data sheet because a provisional application is not entitled to the benefit of, or right of priority to, any other application. (MPEP 202)

This is due to the limitation set forth in 35 U.S.C. 111(b)(7), which states that a provisional application cannot claim priority to or benefit from any other application.

Examiners should verify that provisional application data is correctly listed and that no improper benefit claims to earlier applications through a provisional application are included on the bib-data sheet.

For more information on benefit claims, visit: benefit claims.

For more information on patent examination, visit: patent examination.

For more information on provisional application, visit: provisional application.

How are pro se applicants treated in patent applications?

Pro se applicants (individuals who file patent applications without the assistance of a registered patent attorney or agent) are treated with special consideration by the USPTO. The MPEP states:

“While an inventor may prosecute the application, lack of skill in this field usually acts as a liability in affording the maximum protection for the invention disclosed. Applicant is advised to secure the services of a registered patent attorney or agent to prosecute the application, since the value of a patent is largely dependent upon skillful preparation and prosecution.” (MPEP 605)

However, the USPTO recognizes that some inventors choose to file pro se and provides resources to assist them, such as the Pro Se Assistance Program. While pro se applicants are held to the same legal standards as represented applicants, examiners are encouraged to assist pro se applicants in navigating the patent process.

To learn more:

Priority Mail Express® submissions to the USPTO are treated differently in terms of dating. According to 37 CFR 1.6(a)(2):

Correspondence filed in accordance with § 1.10 will be stamped with the date of deposit as Priority Mail Express® with the United States Postal Service.

This means that new patent applications filed using Priority Mail Express® will be stamped with the date they were deposited with USPS, even if that date is a Saturday, Sunday, or federal holiday. The MPEP provides an example:

For example, if a new patent application is deposited in Priority Mail Express® in accordance with 37 CFR 1.10 on a Saturday and the United States Postal Service gives it a date of deposit of Saturday, the Office will accord and stamp the correspondence with the Saturday date.

Preliminary amendments in continuation applications are subject to specific rules and considerations. The MPEP provides guidance on this topic:

Any preliminary amendment that is present on the filing date of an application filed under 37 CFR 1.53(b) is part of the original disclosure.

This means that preliminary amendments submitted with the application are treated as part of the original filing. However, there are important requirements and considerations:

  1. Compliance with 37 CFR 1.121:

    Amendments must be filed in compliance with the requirements of 37 CFR 1.121 (e.g., the amendment must include a complete claim listing whenever a claim is added, canceled, or amended).

  2. Possible Requirement for Substitute Specification:

    The Office may require a substitute specification for preliminary amendments.

  3. Classification and Assignment:

    Applications should be classified and assigned to the proper Technology Center (TC) by taking into consideration the claims that will be before the examiner upon entry of such a preliminary amendment.

  4. New Matter Considerations: If the preliminary amendment introduces new matter, it may affect the application’s status as a continuation. The MPEP advises:

    Where a copy of the oath or declaration from a prior application was filed in a continuation or divisional application, if the examiner determines that new matter is present relative to the prior application, the examiner should so notify the applicant in the next Office action (preferably the first Office action). The examiner should require applicant to delete the benefit claim or redesignate the application as a continuation-in-part.

Applicants should carefully consider the content and timing of preliminary amendments in continuation applications to ensure compliance with USPTO requirements and to maintain the desired relationship with the parent application.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

For Image File Wrapper (IFW) applications, the process of granting power to inspect is different. According to MPEP 104:

“Powers to inspect are not accepted in Image File Wrapper (IFW) applications. IFW applications are available through the Private Patent Application Information Retrieval (PAIR) system, and pro se applicants and attorneys of record have direct access to the IFW through Private PAIR (when a Customer Number is associated with the correspondence address for the application, and the applicant or attorney has access to Private PAIR for the customer number).”

This means that for IFW applications, access is typically granted through the Private PAIR system, eliminating the need for traditional powers to inspect. If access through Private PAIR is not possible, alternative methods for viewing the application may be necessary.

For more information on Patent application access, visit: Patent application access.

For more information on power to inspect, visit: power to inspect.

For more information on Private PAIR, visit: Private PAIR.

When multiple inventors collaborate on an invention, the patent can be issued to them jointly. The MPEP 308 provides guidance on this:

‘If more than one inventor is named in the application, the patent will issue to the inventors jointly.’

This means that all named inventors share ownership of the patent equally, unless they have agreed otherwise or assigned their rights to another party. Each joint inventor has the right to make, use, sell, or license the invention without the consent of the other inventors, subject to any agreements between them.

For more information on joint inventors, visit: joint inventors.

For more information on patent issuance, visit: patent issuance.

How are patent assignment documents filed and stored at the USPTO?

The USPTO has a specific process for filing and storing patent assignment documents. According to MPEP 317:

“All recorded assignments are scanned and stored in an electronic database.”

This means that once an assignment is recorded, it is digitized for easy access and long-term storage. The electronic database allows for efficient retrieval and management of assignment records. Additionally, the MPEP notes:

“The original document is returned to the sender with a notation of the reel and frame numbers.”

This process ensures that the original document is returned to the sender while maintaining a digital copy for USPTO records. The reel and frame numbers serve as reference points for locating the scanned document in the electronic database.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO procedures, visit: USPTO procedures.

Patent applications are initially processed by the USPTO through electronic scanning and loading into the Image File Wrapper (IFW) system. According to MPEP 508, “All applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. Once documents are loaded into the IFW system, examiners, technical support staff, and other Office personnel will perform further processing and examination using the IFW system.”

When all inventors are unavailable or unwilling to sign a patent application, there are still options for filing. According to MPEP § 409.03(b) (for applications filed before September 16, 2012) and MPEP § 409.05 (for applications filed on or after September 16, 2012):

  • An assignee or obligated assignee may file the application as the applicant
  • A person who shows sufficient proprietary interest in the matter may file the application

In such cases, substitute statements would need to be filed in lieu of inventors’ oaths or declarations, along with the necessary petitions and evidence of the applicant’s right to file the application.

For more information on assignee applicant, visit: assignee applicant.

For more information on proprietary interest, visit: proprietary interest.

Patent applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. As stated in the MPEP, All applications are electronically scanned and loaded into the Image File Wrapper (IFW) system upon filing. This digital system allows examiners, technical support staff, and other Office personnel to perform further processing and examination efficiently.

For physical items such as models, exhibits, and specimens, special handling procedures are in place. The MPEP directs readers to MPEP § 608.03 and 608.03(a) for more information on these items.

For more information on image file wrapper, visit: image file wrapper.

For more information on patent application filing, visit: patent application filing.

For more information on USPTO procedures, visit: USPTO procedures.

The USPTO has specific provisions for handling partial assignees in patent issuance:

  1. If one or more assignees, together with one or more inventors, hold the entire right, title, and interest in the application, the patent may issue in the names of both the assignee(s) and the inventor(s).
  2. If multiple assignees hold the entire right, title, and interest to the exclusion of all inventors, the patent may issue in the names of the multiple assignees.

This is outlined in 37 CFR 3.81(c): (1) If one or more assignee, together with one or more inventor, holds the entire right, title, and interest in the application, the patent may issue in the names of the assignee and the inventor. (2) If multiple assignees hold the entire right, title, and interest to the exclusion of all the inventors, the patent may issue in the names of the multiple assignees.

In a pre-AIA 37 CFR 1.47 application, papers filed by an inventor who did not initially join the application are handled as follows:

“Papers filed by an inventor who did not originally join in the application, and papers relating to its pre-AIA 37 CFR 1.47 status, will be placed in the file wrapper.”

This means that any documents submitted by the previously non-signing inventor, as well as any paperwork related to the application’s pre-AIA 37 CFR 1.47 status, are included in the official application file for record-keeping and potential future reference.

To learn more:

To learn more:

Nonprovisional patent applications are assigned for examination through the Patents Service for Time and Application Routing (PSTAR) program. According to MPEP 504, “The Patents Service for Time and Application Routing (PSTAR) program assigns each nonprovisional application to an examiner.” This system ensures that each application is routed to an appropriate examiner based on factors such as the application’s subject matter and the examiner’s expertise.

To learn more:

Non-English language documents submitted in an Information Disclosure Statement (IDS) are handled as follows:

  • They are considered in view of the concise explanation submitted
  • They are understood to the extent possible based on drawings, chemical formulas, etc.
  • Examiners are not required to have the documents translated
  • Examiners indicate consideration in the same manner as English language documents
  • Examiners should not comment on the extent of understanding of the document

The MPEP states:

‘The examiner need not have the information translated unless it appears to be necessary to do so. The examiner will indicate that the non-English language information has been considered in the same manner as consideration is indicated for information submitted in English.’

This approach is supported by case law, as noted in Semiconductor Energy Laboratory Co. v. Samsung Electronics Co., which clarifies that the examiner’s consideration is presumed to extend only to the translated portion and concise statement provided.

To learn more:

To learn more:

Non-English language documents submitted in an IDS are considered as follows:

  • They are reviewed in light of the concise explanation provided (as required by MPEP § 609.04(a), subsection III).
  • They are understood to the extent possible based on their face value, including drawings and chemical formulas.
  • Examiners are not required to have the documents translated unless necessary.
  • Consideration is indicated in the same manner as for English language documents.

The MPEP states: The examiner need not have the information translated unless it appears to be necessary to do so. The examiner will indicate that the non-English language information has been considered in the same manner as consideration is indicated for information submitted in English. (MPEP 609.05(b))

To learn more:

When adding new claims to a patent application, it’s crucial to follow the proper numbering convention. According to MPEP 608.01(j):

“When claims are added, they must be numbered by the applicant consecutively beginning with the number next following the highest numbered claim previously presented (whether entered or not).”

This means that new claims should be numbered sequentially, starting with the number that comes after the highest-numbered claim in the application, regardless of whether that claim was entered or not. This system ensures a clear and consistent numbering scheme throughout the prosecution process.

To learn more:

National security classified patent applications require special handling by the USPTO. The MPEP states that:

National security classified documents filed in the USPTO must be either hand-carried to Licensing and Review or mailed to the Office in compliance with37 CFR 5.1(a)and Executive Order 13526 of December 29, 2009.

However, the USPTO has made provisions for secure electronic filing:

The Office will accept such applications filed with the USPTO via the Department of Defense Secret Internet Protocol Router Network (SIPRNET) and consider them as filed via the USPTO patent electronic filing system for purposes of37 CFR 1.16(t)and37 CFR 1.445(a)(ii).

Applicants filing national security classified applications must also obtain a secrecy order or provide authority to cancel the security markings, as per37 CFR 5.1(d). The USPTO’s Licensing and Review office can provide a list of contacts at the appropriate defense agencies for this purpose.

For more information on classified patent applications, visit: classified patent applications.

Models, exhibits, or specimens are generally not admitted as part of a patent application, but they may be required during the prosecution process. The MPEP states:

“A model, exhibit, or specimen is normally not admitted as part of the application, although it may be required in the prosecution of the application (37 CFR 1.91 and 1.93, MPEP § 608.03).”

Key points regarding models, exhibits, or specimens:

  • They are not typically part of the initial application filing.
  • The USPTO may request them during examination if needed to understand the invention.
  • If required, they must comply with specific rules outlined in 37 CFR 1.91 and 37 CFR 1.93.
  • Detailed guidelines for handling models, exhibits, or specimens can be found in MPEP § 608.03.

Applicants should be prepared to provide models, exhibits, or specimens if requested by the USPTO during the examination process, but should not include them with the initial application unless specifically required.

To learn more:

Models and exhibits received by the U.S. Patent and Trademark Office are handled as follows:

  • They are taken to the Technology Center (TC) assigned to the related application for examination.
  • Their receipt must be properly recorded on an artifact sheet.
  • A label with the application number, filing date, and attorney’s information should be attached for clear identification.

As stated in the MPEP, The Office may return the model, exhibit, or specimen, at any time once it is no longer necessary for the conduct of business before the Office and return of the model or exhibit is appropriate. (MPEP 608.03(a))

To learn more:

Tags: USPTO

The handling of models and exhibits during patent examination is governed by specific procedures outlined in MPEP 608.03(a). Key points include:

  • Models and exhibits are taken to the assigned Technology Center for examination.
  • Receipt must be recorded on an artifact sheet.
  • A label with application number, filing date, and attorney information should be attached for easy identification and return.
  • Models that cannot be conveniently stored in an artifact folder should not be accepted.
  • Models and exhibits may be presented during interviews but should be taken away afterward unless they meet the requirements of 37 CFR 1.91.

The MPEP states: A full description of what was demonstrated or exhibited during the interview must be made of record. This ensures that the examination record is complete, even if the physical model or exhibit is not retained.

To learn more:

How are inventorship disputes resolved in joint inventor situations?

Inventorship disputes in joint inventor situations can be complex and may require legal intervention. While the MPEP 602.09 doesn’t provide a specific resolution process, it emphasizes the importance of proper inventorship:

“The inventors named in a nonprovisional application must execute an oath or declaration… All named inventors must be named in the executed oath or declaration.”

To resolve inventorship disputes:

  • Parties should first attempt to reach an agreement among themselves
  • If unsuccessful, they may need to seek legal counsel
  • The USPTO may require evidence or a court order to make inventorship changes
  • In some cases, the matter may need to be resolved in federal court

It’s crucial to resolve these disputes promptly, as incorrect inventorship can invalidate a patent. If a dispute arises, it’s advisable to consult with a patent attorney to navigate the resolution process properly.

To learn more:

For pre-AIA applications, the resolution of inconsistencies between the Application Data Sheet (ADS) and other documents is governed by specific rules:

1. General rule: MPEP 601.05(b) states, “The latest submitted information will govern notwithstanding whether supplied by an application data sheet, an amendment to the specification, a designation of a correspondence address, or by an oath or declaration under pre-AIA 37 CFR 1.63 or pre-AIA 37 CFR 1.67, except as provided by pre-AIA 37 CFR 1.76(d)(3).”

2. Exception for inventor information: “The oath or declaration under pre-AIA 37 CFR 1.63 or pre-AIA 37 CFR 1.67 governs inconsistencies with the application data sheet in the naming of inventors and setting forth their citizenship.”

3. Correction process: If inconsistencies exist, a supplemental ADS should be submitted to conform the information with the correct data in other documents.

To learn more:

The USPTO has a specific process for handling incomplete patent documents. According to MPEP 317.01:

“Documents not meeting the other requirements for recording, for example, a document submitted without a completed cover sheet or without the required fee, will be returned for correction to the sender where a correspondence address is available.”

This means that if a document is missing essential components like a completed cover sheet or the required fee, the USPTO will return it to the sender for correction, provided that a correspondence address is available.

To learn more:

The USPTO handles improper Continued Prosecution Application (CPA) requests in the following ways:

  1. For utility or plant applications filed on or after July 14, 2003, improper CPA requests are treated as requests for continued examination (RCE) under 37 CFR 1.114 if the application has a filing date on or after June 8, 1995.
  2. If the improper CPA doesn’t satisfy RCE requirements, it’s treated as an improper RCE, and the time period set in the last Office action continues to run.
  3. For applications with a filing date before June 8, 1995, the Office will notify the applicant of the improper CPA by mailing a notice.
  4. If an examiner discovers an improperly processed CPA, they should immediately notify a supervisory applications examiner (SAE) or other technical support staff to correct the application records.
  5. The Office will not convert an improper CPA into an application under 37 CFR 1.53(b) unless there are extenuating circumstances.

As stated in the MPEP: If an examiner discovers that an improper or incomplete CPA has been processed as a proper CPA in error, the examiner should immediately notify a supervisory applications examiner (SAE) or other technical support staff within the TC who will reprocess the CPA and correct the application records as appropriate.

It’s important to note that if the application becomes abandoned due to an improper CPA, the applicant may need to file a petition under 37 CFR 1.137 to revive the application and pay the required fees.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

For more information on USPTO procedures, visit: USPTO procedures.

How are historical patent assignment records maintained?

The USPTO maintains historical patent assignment records separately from more recent records. MPEP 301.01 explains:

‘The historical database of assignments is maintained separate and apart from the database of assignments affecting title recorded since 1980.’

This means that:

  • Records prior to August 1980 are kept in a separate historical database
  • These older records may not be available through the online Patent Assignment Search
  • Accessing historical records may require different procedures or direct contact with the USPTO

For researchers or legal professionals needing access to pre-1980 assignment records, it’s advisable to contact the USPTO’s Patent and Trademark Resource Centers or the Assignment Recordation Branch for assistance.

The USPTO accepts handwritten signatures in patent applications, but they must meet specific requirements:

  • The signature must be personally applied by the signer.
  • It can be in permanent dark ink or its equivalent.
  • The entire signature must be contained within the signature area of the document.

According to MPEP 402.03: A handwritten signature must be personally applied by the signer. See 37 CFR 1.4(d)(1).

It’s important to note that while handwritten signatures are accepted, the USPTO encourages electronic filing and signatures for efficiency and accuracy in processing applications.

To learn more:

Patent examiners verify foreign priority claims through the following steps:

  1. Check that foreign applications listed on the oath, declaration, or application data sheet are properly listed on the bib-data sheet.
  2. Verify the accuracy of the application number, country, and filing date for each foreign application.
  3. Ensure that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) are listed.
  4. Initial the bib-data sheet in the “VERIFIED” space when the information is correct or has been amended to be correct.
  5. Indicate in the Office action and on the bib-data sheet whether the conditions of 35 U.S.C. 119(a)-(d) or (f) have been met.

MPEP 202 states: “The examiner should check this information for accuracy. Should there be an error on the oath or declaration, or application data sheet itself, the examiner should require a new oath or declaration, or application data sheet, where appropriate. A petition for an unintentionally delayed claim for priority may also be required.”

Foreign priority claims are an important aspect of patent applications and are reflected on the bib-data sheet. The examiner should verify that foreign applications listed on the oath, declaration, or application data sheet are correctly listed on the bib-data sheet.

According to the MPEP: A bib-data sheet should include the application number, country (or intellectual property authority), day, month, and year of each foreign application that the U.S. application is claiming the priority of. The examiner should check this information for accuracy. (MPEP 202)

If there are errors:

  • On the oath, declaration, or application data sheet: The examiner should require a new document.
  • On the bib-data sheet itself: The examiner should make corrections directly on the sheet and have the information updated in the Office computer systems.

It’s important to note that only countries qualifying for benefits under 35 U.S.C. 119(a)-(d) should be listed. A list of qualifying countries can be found in MPEP § 213.01.

For more information on foreign applications, visit: foreign applications.

For more information on foreign priority claims, visit: foreign priority claims.

For more information on patent examination, visit: patent examination.

When the entire USPTO is officially closed for business for an entire day due to adverse weather or other causes:

  • The day is considered a “Federal holiday within the District of Columbia” under 35 U.S.C. 21
  • Any action or fee due on such a day may be taken or paid on the next succeeding business day the Office is open

MPEP 510 states: “When the entire USPTO is officially closed for business for an entire day, for reasons due to adverse weather or other causes, the Office will consider each such day a ‘Federal holiday within the District of Columbia’ under 35 U.S.C. 21. Any action or fee due on such a day may be taken, or fee paid, on the next succeeding business day the Office is open.”

To learn more:

Fees for multiple dependent claims are calculated differently from regular dependent claims. According to MPEP 608.01(n):

  • A multiple dependent claim is considered to be that number of dependent claims to which it refers.
  • Any claim depending from a multiple dependent claim is also considered as the number of dependent claims as referred to in the multiple dependent claim from which it depends.
  • If at least one multiple dependent claim is proper, the multiple dependent claim fee set forth in 37 CFR 1.16(j) will be required.

The USPTO uses Form PTO/SB/07 to assist in the computation of fees for multiple dependent claims. This form is placed in the application file by the Office of Patent Application Processing (OPAP) or the Technology Center (TC) technical support staff.

To learn more:

For patents printed after January 1, 2001, the USPTO distinguishes between citations from information disclosure statements and those cited by the examiner. According to the MPEP:

The citations cited by the examiner on a form PTO-892 will be marked with an asterisk.

This distinction allows readers to easily identify which references were provided by the applicant and which were added by the examiner during the examination process.

To learn more:

Errors in small entity status can be excused if they were made in good faith. According to 37 CFR 1.28(c): ‘If status as a small entity is established in good faith, and fees as a small entity are paid in good faith, in any application or patent, and it is later discovered that such status as a small entity was established in error, or that through error the Office was not notified of a loss of entitlement to small entity status as required by § 1.27(g)(2), the error will be excused upon: compliance with the separate submission and itemization requirements of paragraphs (c)(1) and (c)(2) of this section, and the deficiency payment requirement of paragraph (c)(2) of this section.’

To correct the error, you must:

  • Submit a separate deficiency payment for each application or patent
  • Provide an itemized list of the fees paid in error
  • Pay the deficiency owed (difference between the small entity fee paid and the current non-small entity fee)

To learn more:

Errors in prior application data on the bib-data sheet are corrected as follows:

  1. If the error is in the preprinted data: The examiner can have the technical support staff of the Technology Center make corrections in the Patent Data Portal database.
  2. If the error is an applicant error: The examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate.

MPEP 202 states: “Upon entry of the data, a new bib-data sheet should be printed and scanned into the file. If the error was an applicant error, the examiner should require correction via a corrected or supplemental application data sheet or an amendment, as appropriate. See MPEP § 601.05 et seq. and MPEP § 211.02(a). A petition for an unintentionally delayed benefit claim may also be required. See MPEP § 211.04.”

The USPTO has specific rules for dating electronically filed submissions. According to 37 CFR 1.6(a)(4):

Correspondence may be submitted using the Office electronic filing system only in accordance with the Office electronic filing system requirements. Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

The MPEP further clarifies: Similarly, correspondence submitted via the USPTO electronic filing system (EFS-Web) will be accorded a receipt date on the date the correspondence is received at the correspondence address for the Office set forth in 37 CFR 1.1 (i.e., local time in Alexandria, VA), without regard to whether that date is a Saturday, Sunday, or Federal holiday within the District of Columbia.

Electronically filed patent applications receive special treatment for date-stamping at the USPTO. According to MPEP 505, Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

Key points about electronic filing date-stamping:

  • The receipt date is based on the time in Alexandria, VA (USPTO’s location)
  • Electronic submissions can receive a date stamp on any day, including weekends and holidays
  • The electronic filing system (EFS-Web) must be used in accordance with USPTO requirements

For more details on electronic filing, refer to MPEP § 502.05.

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on USPTO, visit: USPTO.

How are drawing errors handled in patent applications?

Drawing errors in patent applications are typically addressed as follows:

  1. Minor errors: The examiner may handle these by annotations or corrections with the concurrence of the applicant.
  2. Substantial errors: These require the applicant to submit corrected drawings.

According to MPEP 608.02:

‘In instances where the drawing is such that the prosecution can be carried on without the corrections, applicant is informed of the reasons why the drawing is objected to on Form PTO-948 or in an examiner’s action, and that the drawing is accepted as filed.’

If corrections are necessary, the examiner will set a time period for submission. Failure to submit corrected drawings may result in abandonment of the application.

To learn more:

Documents that don’t meet other recording requirements, such as missing a completed cover sheet or required fee, are handled differently by the USPTO. According to the MPEP, “Documents not meeting the other requirements for recording, for example, a document submitted without a completed cover sheet or without the required fee, will be returned for correction to the sender where a correspondence address is available.” This means that unlike documents with identification issues, these documents are returned to the sender for correction, provided a correspondence address is available.

Documents submitted as part of an applicant’s reply to an Office action are handled differently from regular Information Disclosure Statements:

  • They do not need to comply with 37 CFR 1.97 and 37 CFR 1.98 to be considered
  • The examiner will consider the portion of the document relied upon as rebuttal evidence
  • The entire document may not necessarily be considered
  • These documents are not processed as items cited in an IDS
  • The record should reflect that the evidence was considered, but listing on forms like PTO-892 or PTO/SB/08 is not required

The MPEP states:

‘To the extent that a document is submitted as evidence directed to an issue of patentability raised in an Office action, and the evidence is timely presented, applicant need not satisfy the requirements of 37 CFR 1.97 and 37 CFR 1.98 in order to have the examiner consider the information contained in the document relied on by applicant.’

This approach allows for efficient consideration of evidence submitted in response to Office actions without the formal IDS requirements.

To learn more:

To learn more:

The Assignment Division of the USPTO handles documents according to specific procedures outlined in MPEP 317. Key aspects include:

  • Documents are numbered, filmed, and indexed into the assignment database.
  • Original documents are returned to the sender or destroyed after filming.
  • Certified copies of recorded documents can be ordered for a fee.
  • The Assignment Division provides searches of the assignment records upon request.

As stated in the MPEP, All documents submitted for recording are numbered, filmed, and indexed into the assignment database. This process ensures proper documentation and accessibility of assignment records.

For more information on Assignment Division, visit: Assignment Division.

For more information on document handling, visit: document handling.

For more information on patent assignments, visit: patent assignments.

For more information on USPTO, visit: USPTO.

The handling of delayed priority claims in design applications has evolved. The MPEP provides the following information:

“Before May 13, 2015, no procedures were established for accepting an unintentionally delayed priority claim in a design application. Effective May 13, 2015, 37 CFR 1.55(e) provides for the filing of a petition for acceptance of an unintentionally delayed priority claim in a design application where the foreign priority claim was not submitted during the pendency of the design application.”

This change allows design patent applicants and holders to rectify unintentionally delayed priority claims, aligning the process more closely with that of utility patents. As with utility patents, a petition under 37 CFR 1.55(e) may be filed along with a request for a certificate of correction after the design patent has been granted.

To learn more:

Delayed benefit claims in international applications have specific procedures. According to MPEP 211.04:

A petition under 37 CFR 1.78 for accepting an unintentionally delayed benefit claim and the petition fee under 37 CFR 1.17(m) are required to add a benefit claim under 35 U.S.C. 120 and 365(c) in an abandoned international application designating the United States, even when the international application did not enter the national stage under 35 U.S.C. 371.

For international applications not filed with the U.S. Receiving Office and not a nonprovisional application, the petition may be filed in the earliest nonprovisional application claiming benefit to the international application. This petition will be treated as if filed in the international application itself.

For more information on international applications, visit: international applications.

For more information on patent procedure, visit: patent procedure.

The USPTO has a process for handling defective property rights statements submitted in response to DOE or NASA review requests. According to MPEP 150:

If the statement submitted during this period is defective, another letter is sent from Licensing and Review detailing the deficiencies and giving applicant another opportunity to respond during this period of informal correspondence.

The process typically involves:

  • Initial review of the submitted statement
  • If defects are found, a letter is sent detailing the deficiencies
  • The applicant is given another opportunity to respond and correct the statement
  • If repeated efforts to correct a defective statement show lack of cooperation, a formal request with a 30-day statutory deadline may be issued

It’s crucial for applicants to address any deficiencies promptly to avoid potential abandonment of their application.

For more information on USPTO procedures, visit: USPTO procedures.

Continued Prosecution Applications (CPAs) and Requests for Continued Examination (RCEs) are both methods to continue prosecution of an application, but they have significant differences:

  • CPAs are only available for design patent applications, while RCEs can be used for utility, plant, and design applications
  • CPAs result in a new application with the same application number, while RCEs continue examination of the same application
  • CPAs can only be filed before payment of the issue fee, abandonment, or termination of proceedings; RCEs can be filed after payment of the issue fee with a petition
  • CPAs automatically abandon the prior application, while RCEs do not

The MPEP states: Effective July 14, 2003, continued prosecution application (CPA) practice was eliminated as to utility and plant applications. Henceforth, applicants who wish to continue examination of the same claimed invention after the prosecution of a utility or plant application is closed should consider filing a request for continued examination (RCE) under 37 CFR 1.114.

It’s important to note that if an improper CPA is filed for a utility or plant application on or after July 14, 2003, it may be treated as an RCE: If a utility or plant application has a filing date on or after June 8, 1995, an improper CPA filed on or after July 14, 2003 is treated as a request for continued examination (RCE) under 37 CFR 1.114.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

For more information on RCE, visit: RCE.

For continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), the front page of a printed patent will include:

  • The application number and filing date of the most recent noncontinued prosecution application
  • All prior applications from which benefit was claimed in the most recent noncontinued prosecution application

Notably, the filing date of the CPA itself is not included. As stated in the MPEP: “The front page of a printed patent issuing on a continued prosecution application (CPA) filed under 37 CFR 1.53(d) will identify the application number and filing date of the most recent noncontinued prosecution application (but not the filing date of the CPA) as well as all prior applications from which benefit was claimed in the most recent noncontinued prosecution application.” (MPEP 202)

The treatment of continuation-in-part (CIP) applications changed significantly after the deletion of 37 CFR 1.62. According to the MPEP: “A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.” This means that CIP applications can no longer be filed under the former File Wrapper Continuing Procedure and must be filed as new applications.

For more information on continuation-in-part application, visit: continuation-in-part application.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications, regardless of the original application’s filing date.

The MPEP specifically states: A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.

This means that applicants seeking to file a CIP application after December 1, 1997, would need to use a different filing procedure, such as filing a new application under 37 CFR 1.53(b).

To learn more:

To learn more:

For continuation-in-part (CIP) applications, the MPEP states: “A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application… will be treated as an improper application.”

This means that after the deletion of 37 CFR 1.62, CIP applications can no longer be filed using the former File Wrapper Continuing Procedure. Applicants seeking to file a CIP application must do so through the standard application process outlined in MPEP 201.06(d).

For more information on continuation-in-part application, visit: continuation-in-part application.

Continuation-in-part (CIP) applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated as improper applications, regardless of the filing date of the original application. The MPEP states:

“A request filed on or after December 1, 1997, under former 37 CFR 1.62 for a continuation-in-part (CIP) application, or for a continuation or divisional of an application having a filing date before June 8, 1995, will be treated as an improper application.”

This change in procedure means that applicants need to file CIP applications using different methods after December 1, 1997, to ensure proper processing and examination.

For continuation or divisional applications filed under 37 CFR 1.53(b) of an application previously accorded status under pre-AIA 37 CFR 1.47, the process is simplified. The MPEP states: In a continuation or divisional application filed under 37 CFR 1.53(b) of an application accorded status under pre-AIA 37 CFR 1.47, if a copy of a declaration from a prior application and a copy of a decision according status under pre-AIA 37 CFR 1.47 are filed as permitted by pre-AIA 37 CFR 1.63(d)(3)(i), the notice will not be repeated.

This means that if the proper documentation from the original application is provided, the USPTO won’t repeat the notification process for nonsigning inventors. This streamlines the application process for related applications.

To learn more:

To learn more:

The treatment of continuation or divisional applications filed under former 37 CFR 1.62 depends on the filing date of the original application:

  • For applications filed on or after June 8, 1995: Requests filed on or after December 1, 1997, are treated as requests for continued examination (RCE) under 37 CFR 1.114.
  • For applications filed before June 8, 1995: Requests filed on or after December 1, 1997, are treated as improper applications.

As stated in the MPEP: A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114, see MPEP 706.07(h), paragraph IV.

To learn more:

The treatment of continuation or divisional applications filed under former 37 CFR 1.62 depends on the filing date of the original application:

  • For applications filed on or after June 8, 1995: “A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114.” This means these applications are now processed under the RCE procedure.
  • For applications filed before June 8, 1995: Requests for continuation or divisional applications filed on or after December 1, 1997, will be treated as improper applications.

For more details on RCE procedures, refer to MPEP 706.07(h), paragraph IV.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on RCE, visit: RCE.

For applications filed on or after June 8, 1995, continuation or divisional applications filed under former 37 CFR 1.62 on or after December 1, 1997, are treated differently. The MPEP states: “A request for a continuation or divisional application filed under former 37 CFR 1.62 on or after December 1, 1997, in an application that was filed on or after June 8, 1995, will be treated as a request for continued examination (RCE) under 37 CFR 1.114.” This means such applications are now processed under the RCE procedure rather than the former File Wrapper Continuing Procedure.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on RCE, visit: RCE.

According to the MPEP, A continuation or divisional application filed under 37 CFR 1.60 on or after December 1, 1997, will automatically be treated as an application filed under 37 CFR 1.53(b). This means that any continuation or divisional application filed after this date is processed under the new regulations, specifically 37 CFR 1.53(b), regardless of whether the applicant intended to file under the old 37 CFR 1.60 procedure.

To learn more:

To learn more:

The USPTO has specific procedures for handling Congressional and other official inquiries to ensure uniformity and compliance with Department of Commerce directives:

  • Inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies are typically processed through specialized offices.
  • The Office of Policy and International Affairs and/or the Office of Governmental Affairs usually handle these inquiries.
  • Specific types of correspondence are directed to appropriate offices for immediate attention.

According to the MPEP: Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs. (MPEP 203.08(a))

For specific types of inquiries:

  • Embassies, Office of the U.S. Trade Representative, Department of State: Contact the Administrator of the Office of Policy and International Affairs at 571-272-9300.
  • Congress or the White House: Contact the Director of the Office of Governmental Affairs at 571-272-7300.

This process ensures uniformity in the handling of contacts from the indicated sources, and also so that compliance with directives of the Department of Commerce is attained.

To learn more:

Congressional and other official inquiries about patent applications are handled through specific channels at the USPTO. According to MPEP 203.08(a):

Correspondence and inquiries from the White House, Members of Congress, embassies, and heads of Executive departments and agencies normally are cleared by the USPTO’s Office of Policy and International Affairs and/or the Office of Governmental Affairs.

This procedure ensures uniformity in handling contacts from these sources and compliance with Department of Commerce directives. Specific instructions are provided for transmitting such inquiries to the appropriate offices within the USPTO.

For more information on USPTO procedures, visit: USPTO procedures.

For utility and design patent applications, as well as related proceedings, color drawings and photographs are handled as follows, according to MPEP 608.02(c):

Except for international applications, color photographs and color drawings in utility and design applications and proceedings will be stored in SCORE and a black and white copy thereof will be stored in IFW along with a SCORE placeholder sheet.

To break this down:

  • Color drawings and photographs are stored in SCORE (Supplemental Content Repository)
  • A black and white copy is stored in IFW (Image File Wrapper)
  • A SCORE placeholder sheet is included in the IFW

This applies to various types of applications and proceedings, including nonprovisional utility and design patent applications, reissue applications, reexamination proceedings, and supplemental examination proceedings.

To learn more:

How are classified documents marked at the USPTO?

Classified documents at the USPTO are marked with specific security classifications. According to MPEP 121:

  • Documents are marked as ‘Secret,’ ‘Confidential,’ or ‘Restricted Data’
  • These markings indicate the level of security required for handling the document
  • Each page of a classified document must bear the appropriate marking

The MPEP states: ‘All papers in the application and contents of the file jacket are marked with the highest level of security to which the application has been assigned.’ This ensures that all parts of the application are treated with the appropriate level of security throughout the examination process.

In the case of a patent application with only one claim, the numbering convention is different. According to MPEP 608.01(j):

“In a single claim case, the claim is not numbered.”

This means that if your patent application contains only one claim, you should not assign a number to that claim. This practice simplifies the presentation of the claim and avoids unnecessary numbering in cases where there’s only one claim to consider.

To learn more:

Black and white photographs and grayscale drawings are handled uniformly across various types of patent applications and proceedings. According to MPEP 608.02(c):

Black and white photographs and grayscale drawings in: (i) provisional applications under 35 U.S.C. 111(b); (ii) nonprovisional utility and design patent applications under 35 U.S.C. 111(a), including reissue utility and design patent applications; (iii) national stage applications under 35 U.S.C. 371; (iv) international applications (PCT); (v) international design applications; (vi) reexamination proceedings for utility patents and design patents; and (vii) supplemental examination proceedings will be stored in SCORE, and a black and white copy will be stored in IFW along with a SCORE placeholder sheet.

In summary, these types of drawings are:

  • Stored in SCORE (Supplemental Content Repository)
  • A black and white copy is stored in IFW (Image File Wrapper)
  • A SCORE placeholder sheet is included in the IFW

To learn more:

Black and white line drawings are handled differently depending on the type of application:

  • For provisional applications, nonprovisional utility patent applications, international applications (PCT), national stage applications, and reexamination proceedings for utility patents, they are converted into TIFF images and stored in IFW (Image File Wrapper).
  • For design applications, including reissue design patent applications, international design applications, and reexamination proceedings for design patents, they are stored in SCORE (Supplemental Content Repository), with a black and white copy stored in IFW along with a SCORE placeholder sheet.

As stated in the MPEP: Black and white line drawings submitted in: (i) provisional applications under 35 U.S.C. 111(b); (ii) nonprovisional utility patent applications under 35 U.S.C. 111(a), including reissue utility patent applications; (iii) international applications (PCT) and national stage applications under 35 U.S.C. 371; and (iv) reexamination proceedings for utility patents will be converted into TIFF images and stored in IFW.

To learn more:

The definition of biological sequences in patent applications depends on the filing date of the application:

  • For applications filed before July 1, 2022: Biological sequences are defined in 37 CFR 1.821(a).
  • For applications filed on or after July 1, 2022: Biological sequences are defined in 37 CFR 1.831(b).

MPEP 608.05(c) states: “Applications disclosing nucleotide and/or amino acid sequences, as defined in 37 CFR 1.821(a) for applications filed before July 1, 2022 or as defined in 37 CFR 1.831(b) for applications filed on or after July 1, 2022, are required to provide the biological sequence information in a sequence listing.”

These definitions typically include specific criteria for nucleotide and amino acid sequences that must be disclosed in the sequence listing.

To learn more:

How are assignments handled when they are not recorded?

When assignments are not recorded, they are still processed by the Assignment Division. According to the MPEP 317:

“All assignments not recorded will be appropriately marked for return to the sender where a correspondence address is available.”

This means that even if an assignment is not officially recorded, the Assignment Division will still handle the document and return it to the sender if possible. It’s important to note that while unrecorded assignments are processed, they do not have the same legal standing as recorded assignments.

For more information on Assignment Division, visit: Assignment Division.

The USPTO makes assignment records accessible to the public in several ways, as described in 37 CFR 1.12:

  1. Separate assignment records for patents and trademarks are maintained and are open to public inspection.
  2. Assignment records, digests, and indexes for patents are available on the USPTO website.
  3. Images of assignment documents recorded from June 1998 onwards are viewable on the Office website.
  4. For earlier records, the public can place an order to view images.

The MPEP notes: ‘The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.’

However, documents relating only to pending unpublished applications are not open to public inspection.

The handling of assignment records for related patent applications, such as divisional, continuation, or continuation-in-part applications, is addressed in MPEP 301.01. The key point is:

If the application on which a patent was granted is a division, continuation, or continuation-in-part of an earlier application, the assignment records of that earlier application will be open to public inspection because copies or access may be supplied to the earlier application pursuant to 37 CFR 1.14.

This policy has several implications:

  • Once a patent is granted on a related application, the assignment records of the parent application become publicly accessible.
  • This applies even if the parent application was previously unpublished or abandoned.
  • The public accessibility extends to all assignment records in the chain of related applications leading to the granted patent.

This approach ensures transparency in the ownership history of patented inventions, allowing interested parties to trace the chain of title through related applications. It’s important for applicants and assignees to be aware of this when considering their IP strategy and the potential disclosure of ownership information for related applications.

For more information on continuation applications, visit: continuation applications.

For more information on public inspection, visit: public inspection.

Assignment records for reissue applications are treated differently from regular patent applications due to their public nature. According to MPEP 301.01:

Assignment records relating to reissue applications are open to public inspection because reissue applications are open to public inspection pursuant to 37 CFR 1.11(b).

This means that once a reissue application is filed, its assignment records become publicly accessible, regardless of whether the original patent’s assignment records were previously confidential. This is because reissue applications are, by nature, related to already-issued patents and are subject to different rules regarding public disclosure.

The public accessibility of reissue application assignment records aligns with the general principle of transparency in the patent system, allowing interested parties to track ownership changes even during the reissue process. This can be particularly important for those monitoring patent rights in specific technological areas or for potential licensees or purchasers of patent rights.

For more information on public inspection, visit: public inspection.

For more information on reissue applications, visit: reissue applications.

The USPTO treats assignment records and application file records as distinct entities. According to MPEP 323.01(d):

Assignment records are recognized as distinct from application file records.

This distinction is important because:

  • Expungement procedures may affect assignment records differently than application file records.
  • Searches in the Assignment Historical Database may yield different results than searches in application files.
  • The process for correcting or modifying information may differ between assignment records and application file records.

Understanding this distinction is crucial for patent attorneys and applicants when managing their intellectual property records and conducting searches in USPTO databases.

To learn more:

Applications with Secrecy Orders are examined in a secure location by examiners with national security clearances under the control of Licensing and Review. As stated in the MPEP, All applications in which a Secrecy Order has been imposed are examined in a secure location by examiners possessing national security clearances under the control of Licensing and Review. This ensures that sensitive information remains protected during the examination process.

For more information on licensing and review, visit: licensing and review.

For more information on patent examination, visit: patent examination.

How are applications under secrecy order handled at the USPTO?

Applications under secrecy order at the USPTO are handled with strict security measures. According to MPEP 121, these applications are:

  • Stored in special safes or in metal cabinets equipped with three-position dial-type combination locks
  • Never removed from these secure storage areas except for processing
  • Processed and examined only by properly cleared personnel

The MPEP states: ‘Applications bearing national security markings must be stored in a safe or in metal cabinets equipped with a bar and a padlock.’ This ensures that access to these sensitive applications is strictly controlled and limited to authorized individuals only.

For more information on patent application handling, visit: patent application handling.

Applications filed under former 37 CFR 1.62 before December 1, 1997, continue to be processed and examined under the procedures set forth in the former regulation. The MPEP clearly states:

“All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.”

This means that the File Wrapper Continuing Procedure remains applicable for these older applications, ensuring consistency in their examination process.

For more information on patent examination, visit: patent examination.

Application numbers for patent applications are assigned by the Office of Patent Application Processing (OPAP) as follows:

n

    n

  • Nonprovisional applications are assigned numbers beginning with the series code ’15’ or ’16’.
  • n

  • Design applications are assigned numbers beginning with the series code ’29’.
  • n

  • Plant applications are assigned numbers beginning with the series code ’16’.
  • n

  • Provisional applications are assigned numbers beginning with the series code ’62’.
  • n

  • Reexamination proceedings are assigned numbers beginning with the series code ’90’.
  • n

n

As stated in the MPEP 503, “The application number includes a two-digit series code and a six-digit serial number.” This system allows for efficient categorization and tracking of different types of patent applications.

For more information on application number, visit: application number.

For more information on patent application types, visit: patent application types.

For more information on series code, visit: series code.

For PCT applications entering the national stage in the United States, the application number assignment process is slightly different. The MPEP states:

‘For PCT applications entering the national stage under 35 U.S.C. 371, the USPTO assigns the national stage application a U.S. application number.’

This means that when an international PCT application transitions to the national stage in the U.S., it receives a new U.S. application number distinct from its international application number. This U.S. application number is used for all subsequent processing and correspondence related to the national stage application.

It’s important to note that this U.S. application number is different from the international application number (PCT/XX/YYYY/######) that was used during the international phase of the PCT application.

For more information on application number, visit: application number.

The USPTO assigns application numbers to patent applications immediately after mail has been opened. According to MPEP 503, application numbers consist of a series code and a serial number. The series codes are assigned based on the type of application and the time period in which it was filed. For example:

  • 01/ – 16/ for nonprovisional applications (utility, plant, and reissue), with different ranges for specific time periods
  • 29/ for design applications
  • 35/ for international design applications
  • 60/, 61/, and 62/ for provisional applications
  • 90/ for ex parte reexamination proceedings
  • 95/ for inter partes reexamination proceedings
  • 96/ for supplemental examination proceedings and resulting ex parte reexamination proceedings

The MPEP notes: “If an application is filed using the USPTO patent electronic filing system, EFS-Web provides an Acknowledgement Receipt that contains a time and date stamp, an application number and a confirmation number.”

It’s important to note that the application number on a filing receipt is the official number, which may differ from any preliminary number provided on a postcard receipt.

For more information on application number, visit: application number.

For more information on patent application types, visit: patent application types.

For more information on serial number, visit: serial number.

For more information on series code, visit: series code.

When patent drawings are found to be unacceptable, the USPTO notifies applicants through the following process:

  1. The examiner advises the applicant in the first Office action about why the drawings are unacceptable.
  2. The examiner may use specific form paragraphs to explain the defects in the drawings.
  3. Applicants are informed that new corrected drawings are required.

The MPEP 608.02(b) states: If the original drawings are unacceptable, applicant will be notified and informed of what the objections are and that new corrected drawings are required.

It’s important to address these issues promptly to avoid delays in the patent application process.

To learn more:

Amendments in Secrecy Order cases are handled differently from regular patent applications. The MPEP states: Any amendments received thereafter are not entered or responded to until such time as the Secrecy Order is rescinded. At such time, amendments which are free from objection will be entered; otherwise they are denied entry. This means that amendments are held in abeyance until the Secrecy Order is lifted, at which point they are reviewed for entry.

For more information on prosecution, visit: prosecution.

Tags: prosecution

Amendments in secrecy order applications require special handling to maintain security. The MPEP 130 states:

In secrecy order cases, all proposed amendments to the specification and claims, and all provisional amendments to the abstract, drawings and claims must be submitted in duplicate for security review.

Key points about handling amendments in secrecy order cases include:

  • Amendments must be submitted in duplicate for security review.
  • One copy of the amendment is placed in the application file.
  • The other copy is forwarded to a defense agency for review.
  • The defense agency determines if the amendment can be entered without breaching national security.

This process ensures that any changes to the application maintain the required level of secrecy.

For more information on classified information, visit: classified information.

For more information on patent prosecution, visit: patent prosecution.

Allowed secrecy order applications require special handling to maintain security while progressing through the patent process. The MPEP 130 provides guidance on this:

When a secrecy order case is allowed, the Office of Patent Application Processing (OPAP) is notified. The notice of allowance and issue fee letters are drafted and reviewed in the Technology Center and may be hand carried to OPAP for mailing.

Key points about handling allowed secrecy order applications:

  • The Office of Patent Application Processing (OPAP) is notified of the allowance.
  • Notice of allowance and issue fee letters are carefully drafted and reviewed.
  • These documents may be hand-carried to OPAP for mailing to ensure security.
  • The application remains under secrecy order even after allowance.
  • Special care is taken to prevent unauthorized disclosure throughout the process.

This careful handling ensures that the application’s classified status is maintained even as it progresses towards issuance.

For more information on classified information, visit: classified information.

For more information on patent issuance, visit: patent issuance.

Affidavits or declarations filed in a prior application do not automatically become part of a new application. As stated in MPEP ¶ 2.03:

“Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132, filed during the prosecution of the prior application do not automatically become a part of this application.”

To rely on an earlier-filed affidavit or declaration, the applicant must:

  • Make remarks of record in the new application
  • Include a copy of the original affidavit or declaration filed in the prior application

This ensures that the examiner can consider the previously submitted evidence in the context of the new application.

For more information on patent prosecution, visit: patent prosecution.

For more information on prior applications, visit: prior applications.

Affidavits or declarations from a prior application do not automatically become part of a continuation or divisional application. The MPEP states: Affidavits or declarations, such as those submitted under 37 CFR 1.130, 1.131 and 1.132 filed during the prosecution of the prior nonprovisional application do not automatically become a part of a continuation or divisional application filed under 37 CFR 1.53(b). Where it is desired to rely on an earlier filed affidavit or declaration, the applicant should make such remarks of record in the 37 CFR 1.53(b) application and include a copy of the original affidavit or declaration filed in the prior nonprovisional application. This ensures that the examiner is aware of and can consider the relevant affidavits or declarations from the prior application.

To learn more:

No, this specific requirement does not apply to all patent applications. The MPEP clearly states:

‘[Editor Note: This MPEP section is not applicable to applications filed on or after September 16, 2012.]’

This means that the requirement to provide the last known address of a nonsigning inventor is only applicable to pre-AIA applications filed before September 16, 2012, under 37 CFR 1.47. For applications filed on or after this date, different rules may apply, and applicants should consult the current USPTO guidelines or seek legal advice.

To learn more:

To learn more:

No, the United States Patent and Trademark Office (USPTO) does not provide advisory opinions on whether an individual or organization qualifies for small entity status. The MPEP 509.03(a) clearly states: “The U.S. Patent and Trademark Office does not give advisory opinions as to whether or not a specific individual or organization qualifies as a small entity.” This policy is based on Congressional intent that the USPTO rely exclusively on self-certification for small entity status. Applicants are responsible for determining their status and making the appropriate self-certification.

To learn more:

Tags: USPTO

No, the USPTO does not determine the legal effect of recorded documents on patent ownership at the time of recordation. The MPEP clearly states:

“The recordation of a document is not a determination of the effect of the document on the chain of title. The determination of what, if any, effect a document has on title will be made by the Office at such times as ownership must be established to permit action to be taken by the purported assignee in connection with a patent or an application.” (MPEP 313)

This means:

  • Recordation is primarily for public notice
  • The USPTO will evaluate ownership when necessary for specific actions
  • Parties should not assume recordation equates to USPTO approval of ownership claims

No, the USPTO does not routinely check the date of execution for inventor’s oaths or declarations. The MPEP states:

The Office does not check the date of execution of the oath or declaration and will not require a newly executed oath or declaration based on an oath or declaration being stale (i.e., when the date of execution is more than three months prior to the filing date of the application) or where the date of execution has been omitted.

However, applicants should be aware that they have a continuing duty of disclosure under 37 CFR 1.56. This means that while the USPTO doesn’t check the execution date, applicants are still responsible for ensuring the information in the oath or declaration remains accurate and up-to-date.

To learn more:

No, the inclusion of prior application information in the patent does not necessarily indicate that the claims are entitled to the benefit of the earlier filing date.

See MPEP 2136.03 and MPEP 2154.01(b) for additional information.

The Certificate of Mailing procedure does not apply to papers mailed from a foreign country. However, the Certificate of Transmission procedure can be used for correspondence transmitted to the USPTO from a foreign country, with some conditions. The MPEP states:

The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.

This means that while you can’t use a Certificate of Mailing for papers sent by postal mail from outside the United States, you can use a Certificate of Transmission for faxes or EFS-Web submissions from foreign countries, as long as the specific type of correspondence is eligible for the certificate procedure.

Yes, submitting a deficiency payment for micro entity fee errors affects your micro entity status. According to 37 CFR 1.29(k)(4):

Any deficiency payment (based on a previous erroneous payment of a micro entity fee) submitted under this paragraph will be treated as a notification of a loss of entitlement to micro entity status under paragraph (i) of this section.

This means that by submitting a deficiency payment, you are effectively notifying the USPTO that you are no longer entitled to micro entity status. After making the deficiency payment, you will need to pay fees at the small entity or non-small entity rate, as applicable, unless you file a new certification of micro entity status.

To learn more:

No, the act of recording a document with the USPTO does not determine its legal effect on patent ownership. The MPEP clearly states:

The recordation of a document is not a determination of the effect of the document on the chain of title.

This means that while the USPTO will record various documents related to patent interests, it does not make any judgments about how these documents affect ownership at the time of recordation. Instead, as the MPEP explains:

The determination of what, if any, effect a document has on title will be made by the Office at such times as ownership must be established to permit action to be taken by the purported assignee in connection with a patent or an application.

For more information on how the USPTO determines ownership when necessary, refer to MPEP § 324 and § 325.

For more information on chain of title, visit: chain of title.

For more information on patent assignment, visit: patent assignment.

Pre-AIA 37 CFR 1.47 does not directly apply to deceased inventors. The MPEP clearly states: Pre-AIA 37 CFR 1.47 should not be considered an alternative to pre-AIA 37 CFR 1.42 or pre-AIA 35 U.S.C. 117 since the language ‘cannot be found or reached after diligent effort’ has no reasonable application to a deceased inventor.

However, pre-AIA 37 CFR 1.47 does apply in cases where a known legal representative of a deceased inventor:

  • Cannot be found or reached after diligent effort, or
  • Refuses to make application

In such situations, the last known address of the legal representative must be provided, as per MPEP § 409.03(e).

To learn more:

To learn more:

No, paying a fee in a non-micro entity amount does not automatically change your entity status. According to MPEP 509.04(e):

Payment of a fee in other than the micro entity amount is not sufficient notification that micro entity status is no longer appropriate.

To properly notify the USPTO of a change in entity status, you must file a separate notification in the application or patent. This notification must be filed prior to or at the time of paying any fee after the date on which micro entity status is no longer appropriate.

To learn more:

No, MPEP ¶ 2.11 does not apply to benefit claims for provisional applications. The MPEP explicitly states:

Do not use this form paragraph for benefit claims under 35 U.S.C. 119(e) to provisional applications.

This means that the copendency requirements and procedures outlined in MPEP ¶ 2.11 are specifically for non-provisional applications claiming benefit under 35 U.S.C. 120, 121, 365(c), or 386(c). Provisional applications have different rules and procedures for claiming benefit, which are covered under 35 U.S.C. 119(e) and other sections of the MPEP.

For more information on benefit claims, visit: benefit claims.

For more information on patent procedure, visit: patent procedure.

Incorporation by reference under 37 CFR 1.57(b) has limited applicability to international patent applications:

  • It is only effective for the United States
  • It does not affect the international filing date
  • It cannot be used to accord an international filing date
  • Requests to add omitted material will not be acted upon before national stage entry

The MPEP states: “Any amendment to an international application pursuant to 37 CFR 1.57(b)(1) will be effective only as to the United States and shall have no effect on the international filing date of the application. The incorporation by reference relief provided in 37 CFR 1.57(b) cannot be relied upon to accord an international filing date to an international application that is not otherwise entitled to a filing date under PCT Article 11, and it cannot be relied upon to alter the international filing date accorded under PCT Article 11.”

No, filing an interim copy does not replace the need for a certified copy of the foreign application. While an interim copy satisfies the timeliness requirement, a certified copy is still required. The MPEP clarifies this point:

Thus, providing an interim copy of a foreign application under 37 CFR 1.55(j) satisfies the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f), but a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate.

In essence, the interim copy allows applicants to meet initial deadlines, but they must still provide a certified copy of the foreign application during the pendency of the U.S. application, unless they file a specific petition.

To learn more:

No, filing an amendment does not change the status of a ‘new’ application. The MPEP 203.01 explicitly states:

An amendment filed prior to the first Office Action does not alter the status of a ‘new’ application.

This means that even if you submit changes or corrections to your application before receiving any feedback from the examiner, your application is still considered ‘new’ in the eyes of the patent office.

To learn more:

No, a mere change of business name does not constitute a change in legal entity for patent purposes. However, it is still an important part of the ownership record. As stated in MPEP 314:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.

This means that while the legal entity remains the same, the name change should be recorded to maintain an accurate chain of title for the patent.

According to MPEP 314, a mere change of business name does not constitute a change in legal entity for patent purposes. The MPEP states:

Although a mere change of name does not constitute a change in legal entity, it is properly a link in the chain of title.

This means that while the legal entity remains the same, documenting the name change is still important for maintaining a clear chain of title for the patent.

To learn more:

Yes, substitute and continuation-in-part (CIP) applications generally require new assignments. As stated in MPEP 306: In the case of a substitute or continuation-in-part application, a prior assignment of the original application is not applied (effective) to the substitute or continuation-in-part application because the assignment recorded against the original application gives the assignee rights to only the subject matter common to both applications.

However, there is an exception for applications filed on or after September 16, 2012: Substitute or continuation-in-part applications require the recordation of a new assignment if they are to be issued to an assignee, unless the substitute or continuation-in-part application is filed on or after September 16, 2012, and the assignee is the original applicant therein.

No, you do not need to submit copies of U.S. patents and patent application publications when filing an e-IDS. The MPEP 609.07 states:

Copies of U.S. patents and U.S. patent application publications cited in the IDS are not required to be submitted by the applicants with the e-IDS.

However, it’s important to note that for foreign patent documents, non-patent literature (NPLs), and unpublished U.S. patent applications not stored in the Office’s Image File Wrapper (IFW) system, you must submit PDF copies using EFS-Web.

To learn more:

To learn more:

Yes, in most cases, you need to submit a replacement sheet when canceling a patent drawing figure. However, there is an exception:

  • If the canceled figure was the only drawing on the sheet, you only need to submit a marked-up copy of the drawing sheet with an annotation showing the cancellation.
  • In all other cases, you must submit a replacement sheet of drawings without the canceled figure.

MPEP 608.02(t) states: “If a drawing figure is canceled, a replacement sheet of drawings must be submitted without the figure (see 37 CFR 1.121(d)). If the canceled drawing figure was the only drawing on the sheet, then only a marked-up copy of the drawing sheet including an annotation showing that the drawing has been cancelled is required.”

To learn more:

Generally, it is not necessary to resubmit prior art cited by the examiner in a parent application when filing a continuing application that claims benefit under 35 U.S.C. 120. The MPEP states:

“The examiner of the continuing application will consider information which has been considered by the Office in the parent application.”

However, if you want the information to be printed on the patent issuing from the continuing application, you should resubmit it. For international applications that designated the U.S., you must submit an information disclosure statement in the continuing application to ensure the examiner considers the documents cited in the international search report and/or international preliminary examination report.

To learn more:

No, you do not need to provide copies of U.S. patent documents when responding to an unlocatable file notice. The MPEP clearly states:

Since the Office can obtain copies of U.S. patent documents (U.S. patent application publications and patents) from its internal databases, the Office is not requiring applicants or patentees to provide copies of U.S. patent application publications and patents that are among the applicant’s or patentee’s record of the correspondence between the Office and the applicant or patentee for the application, patent, or other proceeding.

However, you must provide copies of all other correspondence and documents, including any appendix or information disclosure statement submitted with the application, unless specifically exempted in the notice.

To learn more:

To learn more:

If you filed a translation of the non-English provisional application and a statement of accuracy in the nonprovisional application before November 25, 2005, you do not need to provide them again. The MPEP ¶ 2.38 states in the Examiner Note:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This exception only applies to translations filed in the nonprovisional application before the specified date. For all other cases, the translation and statement must be filed in the provisional application itself.

For more information on non-English language, visit: non-English language.

For more information on provisional application, visit: provisional application.

Whether you need to pay a fee to correct an error in a recorded assignment at the USPTO depends on the type of correction:

  • Cover sheet corrections: No fee is required for submitting a corrective document to fix errors in the cover sheet data.
  • Assignment document corrections: A recording fee is required when submitting a new corrective assignment document.

According to MPEP 323: “The recordation fee set forth in 37 CFR 1.21(h) is required for each application and patent against which the document is recorded.” This fee applies when recording a new corrective document, but not for simple cover sheet corrections.

For more information on USPTO fees, visit: USPTO fees.

Tags: USPTO fees

If you submitted the reference to the prior application within the required time period but in the wrong location, you may not need to file a petition. The MPEP provides guidance on this situation:

If the reference to the prior application was previously submitted within the time period set forth in 37 CFR 1.78 but was not included in the location in the application required by the rule (e.g., if the reference was submitted in an oath or declaration or the application transmittal letter), and the information concerning the benefit claim was recognized by the Office as shown by its inclusion on the first filing receipt, the petition under 37 CFR 1.78 and the petition fee under 37 CFR 1.17(m) are not required. (MPEP § 211)

However, you are still required to submit the reference in compliance with 37 CFR 1.78. This means:

  • For applications filed on or after September 16, 2012: File an ADS in compliance with 37 CFR 1.76 with the reference.
  • For applications filed before September 16, 2012: File either an amendment to the first sentence(s) of the specification or an ADS in compliance with pre-AIA 37 CFR 1.76.

For more information on petition requirements, visit: petition requirements.

Yes, you must assert small entity status separately for each related application. Specifically:

  • Status must be established in each related, continuing, and reissue application
  • Small entity status in one application does not affect the status of any other application or patent
  • A new assertion is required for continuations, divisionals, continuations-in-part, and reissue applications

According to 37 CFR 1.27(c)(4): “Status as a small entity must be specifically established by an assertion in each related, continuing and reissue application in which status is appropriate and desired. Status as a small entity in one application or patent does not affect the status of any other application or patent, regardless of the relationship of the applications or patents. The refiling of an application under § 1.53 as a continuation, divisional, or continuation-in-part application (including a continued prosecution application under § 1.53(d)), or the filing of a reissue application, requires a new assertion as to continued entitlement to small entity status for the continuing or reissue application.”

To learn more:

No, certified copies of patent applications as filed do not include an indication of assignment documents. According to the MPEP 303, “Certified copies of patent applications as filed do not include an indication of assignment documents.” This means that the initial certified copy of a patent application does not contain information about any assignments that may have been recorded.

For more information on assignment documents, visit: assignment documents.

For more information on certified copies, visit: certified copies.

For more information on patent applications, visit: patent applications.

For more information on USPTO, visit: USPTO.

Generally, applicants do not need to provide a separate listing of references cited in the international search report for a PCT national stage application. According to MPEP 609.03:

“There is no requirement that the examiner list the documents on a PTO-892 form and there is no requirement for the applicant to provide a separate listing of the references.”

However, it’s important to note that if the applicant wants these references to be printed on the face of the resulting patent, they must provide a separate listing, preferably on a PTO/SB/08 form, within the set period for reply to the Office action or within one month of the mailing date of the Notice of Allowability.

To learn more:

Can you file a CPA in a provisional application?

No, you cannot file a Continued Prosecution Application (CPA) in a provisional application. The MPEP 201.06(d) clearly states:

A CPA may not be filed in a provisional application.

CPAs are only available for certain types of nonprovisional applications. Specifically, they can be filed in design applications, and in utility and plant applications that were filed before May 29, 2000. Provisional applications have a different purpose and process, and do not allow for the filing of CPAs.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

Yes, video conferencing tools can be used for examiner interviews in patent applications, but there are specific requirements. According to MPEP 502.03:

‘USPTO video conferencing tools may be used to conduct examiner interviews in both published and unpublished applications under the Patent Internet Usage Policy.’

However, several conditions must be met:

  • Authorization by the practitioner is required prior to sending a meeting invite.
  • All video conferencing communications must be hosted by USPTO personnel.
  • Interviews must originate from USPTO links provided by the examiner.
  • Links from non-USPTO video conferencing tools are not acceptable.

The MPEP also states:

‘The practitioner’s participation in the interview is considered consent to the use of the video conferencing tool for the interview.’

It’s important to note that personal devices or non-USPTO tools cannot be used by USPTO employees for official communications.

To learn more:

No, USPTO employees cannot apply for patents while employed. According to 35 U.S.C. 4:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent…’

This restriction extends for one year after their employment at the USPTO ends.

No, third parties cannot file Information Disclosure Statements (IDS) under 37 CFR 1.97 and 37 CFR 1.98. The MPEP clearly states:

Third parties (individuals not covered by 37 CFR 1.56(c)) cannot file information disclosure statements under 37 CFR 1.97 and 37 CFR 1.98.

However, third parties have other options to submit information:

  • For published applications: Submit patents and publications under 37 CFR 1.290.
  • For unpublished applications: File a protest under 37 CFR 1.291 before a notice of allowance is mailed.
  • Provide information to the applicant, who may then submit it to the Office in an IDS.

To learn more:

Tags: prior art, USPTO

Yes, the USPTO may request additional information when considering a petition to restore the right of priority. The MPEP states:

The Director may require additional information where there is a question whether the delay was unintentional.

This means that if the USPTO has doubts about whether the delay in filing was truly unintentional, they may ask for more details or evidence to support your claim. It’s important to be prepared to provide such information if requested to ensure your petition is properly considered.

For more information on unintentional delay, visit: unintentional delay.

No, the USPTO does not release drawings for correction. According to MPEP 608.02(b), which cites 37 CFR 1.85(b):

The Office will not release drawings for purposes of correction. If corrections are necessary, new corrected drawings must be submitted within the time set by the Office.

This means that applicants must submit new, corrected drawings rather than requesting the original drawings for modification. It’s the applicant’s responsibility to prepare and submit corrected drawings that meet the USPTO’s requirements.

To learn more:

Yes, the USPTO can refuse to expunge an improperly recorded assignment. According to MPEP 323.01(c):

‘The Office, however, has consistently taken the position that such a petition will not be granted unless it is apparent that the recording is a ‘clerical error on the part of the Office.”

This means that the USPTO is generally reluctant to expunge recorded assignments unless there’s clear evidence of an error on their part. If the improper recording was due to actions of the parties involved rather than the USPTO, the petition may be denied.

To learn more:

No, the USPTO cannot record a non-English assignment document without an accompanying English translation. MPEP 302.02 clearly states:

The assignment document, if not in the English language, will not be recorded unless accompanied by an English translation signed by the translator.

This policy ensures that all recorded documents are accessible and understandable to USPTO examiners and the public. Attempting to record a non-English document without a translation will result in the document being rejected for recordation.

To learn more:

Can the USPTO independently verify information provided by patent applicants?

Yes, the USPTO has the authority to independently verify information provided by patent applicants. MPEP 410 states:

“The Office is not the guarantor of the accuracy, correctness or completeness of the information supplied by the applicant.”

This means that while the USPTO relies on the information provided by applicants, it may:

  • Conduct its own investigations
  • Request additional information or evidence
  • Consult external sources to verify claims

Applicants should be aware that the USPTO can and may verify any information submitted during the patent application process. It’s crucial to provide accurate and complete information to avoid potential legal issues or loss of patent rights.

For more information on patent application information, visit: patent application information.

No, the USPTO cannot assist in selecting a patent practitioner. According to MPEP 401, “The Office cannot aid in the selection of a patent practitioner.” However, the USPTO does provide resources for finding registered patent attorneys and agents:

  • A listing is available at www.uspto.gov/FindPatentAttorney
  • Applicants can request a list of registered practitioners in their area by writing to the Office of Enrollment and Discipline (OED)

Yes, the USPTO has the authority to extend deadlines during a postal service emergency. This is based on the provisions outlined in MPEP 511 and 35 U.S.C. 21(a).

Specifically, MPEP 511 states:

The Director may designate the interruption or emergency as a ‘postal service interruption or emergency’ under 35 U.S.C. 21(a) and provide for ‘tolling’ of the time for filing correspondence, fees, or other papers for a limited time.

This means that:

  • The USPTO Director can officially recognize the emergency
  • Time limits for filing various patent-related documents can be extended
  • The extension is typically for a specific, limited period
  • Applicants may need to provide evidence that their delay was due to the recognized emergency

It’s important to note that while the USPTO has this authority, each situation is evaluated individually, and extensions are not automatically granted.

To learn more:

No, the USPTO does not determine whether conditions in a conditional assignment have been fulfilled. According to 37 CFR 3.56:

“The Office does not determine whether such conditions have been fulfilled.”

The USPTO treats the submission of a conditional assignment for recordation as an indication that the condition has been met. This policy simplifies the Office’s handling of assignments and places the responsibility on the parties involved to ensure conditions are met before recording.

To learn more:

Yes, the USPTO can destroy models, exhibits, or specimens during patent prosecution under certain circumstances. The MPEP 608.03(a) states:

‘The United States Patent and Trademark Office will not return the model, exhibit, or specimen in the following cases: … (B) Where the model, exhibit, or specimen has been destroyed by a process of examination or has been returned to the applicant prior to the conclusion of prosecution.’

This indicates that some examination processes may result in the destruction of these items. Applicants should be aware that submitting models, exhibits, or specimens might lead to their alteration or destruction during the examination process.

To learn more:

Can the title of a patent application be changed after filing?

Yes, the title of a patent application can be changed after filing. According to MPEP 606:

Where the title is not descriptive of the invention claimed, the examiner should require the substitution of a new title that is clearly indicative of the invention to which the claims are directed.

This means that:

  • The examiner may require a title change if the original title is not sufficiently descriptive.
  • The applicant can voluntarily amend the title during prosecution.
  • Changes to the title can be made by amendment under 37 CFR 1.121(b).
  • The new title must still comply with all requirements, including being brief, technically accurate, and under 500 characters.

It’s important to note that while changes are possible, starting with a strong, accurate title can help avoid unnecessary amendments and ensure efficient processing of the application.

To learn more:

Can the timeliness requirement for priority documents be met through PDX?

Yes, the timeliness requirement for priority documents can be met through the Priority Document Exchange (PDX) program. MPEP 215.02(a) states:

‘If the priority document is retrieved by the USPTO within the time period set in 37 CFR 1.55(g), the applicant need not take any further action to meet the timeliness requirement.’

This means that if the USPTO successfully retrieves the priority document through PDX within the specified time frame (usually the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application), the timeliness requirement is automatically satisfied. However, applicants should still monitor the status to ensure the document is received and be prepared to submit it manually if necessary.

To learn more:

No, the time period for filing a foreign priority claim cannot be extended. As stated in MPEP 214.01: “This time period is not extendable.”

However, if you miss the deadline, there is a possibility to file a petition to accept an unintentionally delayed priority claim. The MPEP states: “If a claim for priority under 35 U.S.C. 119(a)-(d) or (f), 365(a) or (b), or 386(a) or (b) is presented after the time period set in 37 CFR 1.55, the claim may be accepted if it includes the required identification information and is accompanied by a grantable petition to accept the unintentionally delayed claim for priority.”

For more information on unintentionally delayed priority claims, refer to MPEP § 214.02.

To learn more:

Can the specification be omitted when filing a divisional or continuation application?

No, the specification cannot be omitted when filing a divisional or continuation application. However, the process is simplified. According to MPEP 201.06(c):

“A new specification (including the claims) may be submitted in a divisional application filed under 37 CFR 1.53(b). In such a case, the applicant must file a copy of the prior application as filed or a new specification.”

This means that while you must include a specification, you have two options:

  • Submit a copy of the prior application’s specification
  • Submit a new specification tailored to the divisional or continuation application

If you choose to submit a copy of the prior application, it’s important to ensure that it properly supports the claims in the new application. Any new matter introduced in a continuation application may result in a rejection under 35 U.S.C. 112(a).

Remember, the claims are considered part of the specification, so you must include claims with your application, whether you’re using the prior specification or submitting a new one.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

For more information on patent application requirements, visit: patent application requirements.

For more information on USPTO, visit: USPTO.

Yes, the right of priority can be restored if the U.S. application is filed after the 12-month priority period (or 6-month period for design applications), but within 2 months of the expiration of the priority period, if the delay was unintentional.

37 CFR 1.55(c) states: “If the subsequent application has a filing date which is after the expiration of the period set forth in paragraph (b)(1) of this section, but within two months from the expiration of the period set forth in paragraph (b)(1) of this section, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition pursuant to this paragraph, if the delay in filing the subsequent application within the period set forth in paragraph (b)(1) of this section was unintentional.”

To restore the right of priority, the applicant must file a petition including:
1. The priority claim
2. The petition fee
3. A statement that the delay was unintentional

The USPTO may require additional information to determine if the delay was truly unintentional.

Yes, the right of priority can be restored if the filing deadline is missed, but certain conditions must be met:

  • The subsequent application must be filed within two months of the expiration of the priority period.
  • A petition under 37 CFR 1.55(c) must be filed.
  • The delay in filing must be unintentional.

The MPEP states: As provided in 37 CFR 1.55(c), if the subsequent application has a filing date which is after the expiration of the twelve-month period (or six-month period in the case of a design application), but within two months from the expiration of the period, the right of priority in the subsequent application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.55(c), if the delay in filing the subsequent application within the period was unintentional. (MPEP 213.03)

To learn more:

No, the period for resubmitting corrected assignment documents cannot be extended. The MPEP 317.02 is explicit on this point:

“The specified period to resubmit the returned papers will not be extended.”

This strict policy underscores the importance of promptly addressing any issues with returned assignment documents. Failing to meet the specified deadline will result in the loss of the original receipt date as the recording date for the document. Instead, the USPTO will use the date they receive the corrected papers as the new recording date. This change can potentially affect the priority of your assignment and impact your intellectual property rights. Therefore, it’s crucial to carefully review any returned documents and act quickly to make the necessary corrections and resubmit within the given timeframe.

To learn more:

Yes, the original filing date can be preserved for returned patent documents under certain conditions. The MPEP 317.01 states:

“The returned papers, stamped with the original date of receipt by the Office, will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of filing of the papers as the date of recording of the document.”

This means that if you correct and resubmit the returned documents within the specified timeframe, the USPTO will use the original filing date as the recording date for the document.

To learn more:

Yes, the original filing date can be preserved for corrected documents under certain conditions. The MPEP states: “The returned papers, stamped with the original date of receipt by the Office, will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of filing of the papers as the date of recording of the document.” This means that if you correct and resubmit the document within the specified timeframe, the USPTO will use the original filing date as the recording date.

Can the order of joint inventors’ names be changed after filing a patent application?

Yes, the order of joint inventors’ names can be changed after filing a patent application, but it requires a specific process. The MPEP 602.09 states:

“The order of names of joint patentees in the heading of the patent is taken from the order in which the names appear in the application papers unless changed by request.”

To change the order of inventors’ names:

  • Submit a request to the USPTO
  • Provide a statement from all the joint inventors agreeing to the change
  • Pay any required fees

It’s important to note that changing the order doesn’t affect inventorship rights but may impact how the patent is cited in literature. The request should be made before the patent is granted for it to appear in the correct order on the issued patent.

To learn more:

Yes, the inventorship in a Continued Prosecution Application (CPA) can differ from the original application, but only if a proper request is filed and approved.

According to MPEP ¶ 2.33: Otherwise, the inventorship in the CPA shall be the same as in the prior application. This implies that changes to inventorship are possible, but they require specific action.

To change the inventorship, you must file a request under 37 CFR 1.48. This applies whether you’re adding, removing, or changing the order of inventors. Without this formal request, the inventorship will remain the same as in the original application, even if new inventors are listed on the CPA filing documents.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

Yes, the inventorship in a continuation or continuation-in-part (CIP) application can differ from the parent application, but there are specific requirements:

1. For continuation applications: The inventorship must include at least one inventor named in the prior-filed application.

2. For CIP applications: The inventorship can change more significantly due to the addition of new matter.

The MPEP states for continuation applications: “The inventorship in the continuation application must include at least one inventor named in the prior-filed application.”

For CIP applications, the MPEP notes: “A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78. Subject to the same conditions, a continuation-in-part application that has joint inventors may derive from an earlier application that has a sole inventor.”

Any changes in inventorship must be properly documented and may require a request under 37 CFR 1.48.

The inventorship in a Continued Prosecution Application (CPA) generally remains the same as in the prior application, but it can be changed under certain circumstances:

  • The inventorship automatically carries over from the prior application unless a statement is filed requesting deletion of inventors
  • Inventors can be deleted by filing a statement with the CPA request
  • Adding new inventors requires a request under 37 CFR 1.48 after the CPA is filed

The MPEP states: The inventive entity set forth in the prior nonprovisional application automatically carries over into the CPA UNLESS the request for a CPA is accompanied by or includes on filing a statement requesting the deletion of the name or names of the person or persons who are not inventors of the invention being claimed in the CPA.

For more information on patent applications, visit: patent applications.

Yes, for applications filed on or after September 16, 2012 (except reissue applications), the inventor’s oath or declaration can be postponed until the application is in condition for allowance, provided certain conditions are met:

  • An application data sheet (ADS) in compliance with 37 CFR 1.76 must be filed identifying each inventor by their legal name, mailing address, and residence (if different from mailing address)
  • The inventor’s oath or declaration must be filed no later than the date on which the issue fee is paid

The MPEP states: For applications filed on or after September 16, 2012 (except reissue applications), applicant may postpone filing the inventor’s oath or declaration until the application is in condition for allowance if an application data sheet (ADS) in compliance with 37 CFR 1.76 is filed identifying: (1) each inventor by their legal name; and (2) for each inventor, a mailing address where the inventor customarily receives mail, and residence, if the inventor lives at a location which is different from where the inventor customarily receives mail. See 37 CFR 1.53(f)(3).

This provision allows applicants more flexibility in completing the application requirements, but it’s important to ensure the oath or declaration is filed before paying the issue fee to avoid abandonment.

For more information on declaration, visit: declaration.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on patent application requirements, visit: patent application requirements.

Can the inventor’s oath or declaration be submitted after filing the patent application?

Yes, the inventor’s oath or declaration can be submitted after filing the patent application. The MPEP 602.01(a) states:

“The inventor’s oath or declaration may be submitted after the application filing date. If the oath or declaration is filed after the application filing date, it must be accompanied by the surcharge under 37 CFR 1.16(f).”

However, it’s important to note:

  • The application must still name each inventor at the time of filing
  • An application data sheet (ADS) under 37 CFR 1.76 must be submitted with the application filing
  • The oath or declaration should be submitted no later than the date on which the issue fee is paid

Submitting the oath or declaration after filing may incur additional fees and potentially delay the examination process.

To learn more:

Yes, the foreign application may have been filed by and in the name of the assignee or legal representative or agent of the inventor, as applicant.

If the certified copy of the foreign application corresponds with the one identified in the U.S. application and no discrepancies appear, it may be assumed the U.S. application is entitled to claim priority to the foreign application.

If the U.S. application and the certified copy do not name the same inventor or have at least one joint inventor in common, the priority date should be refused until the inconsistency is resolved. [MPEP 216]

Yes, the filing of an inventor’s oath or declaration can be postponed under certain conditions. According to the MPEP:

If an application data sheet has been submitted, applicant may postpone the filing of the inventor’s oath or declaration until the application is in condition for allowance for applications filed on or after September 16, 2012.

This provision allows applicants more flexibility in the timing of submitting the inventor’s oath or declaration. However, it’s important to note that the oath or declaration must be submitted no later than the date on which the issue fee is paid, as required by 35 U.S.C. 115(f).

To learn more:

Yes, for applications filed on or after September 16, 2012 (except reissue applications), the filing of an inventor’s oath or declaration can be postponed. The MPEP states:

For applications filed on or after September 16, 2012 (except reissue applications), applicant may postpone filing the inventor’s oath or declaration until the application is in condition for allowance if an application data sheet (ADS) in compliance with 37 CFR 1.76 is filed identifying: (1) each inventor by their legal name; and (2) for each inventor, a mailing address where the inventor customarily receives mail, and residence, if the inventor lives at a location which is different from where the inventor customarily receives mail.

However, the inventor’s oath or declaration must be filed no later than the date on which the issue fee is paid.

Yes, the filing fee, oath or declaration, and claims can be submitted after the initial filing of a nonprovisional application. However, there are specific rules and time limits for doing so:

  • These items must be submitted within the period specified by the USPTO, usually in a Notice to File Missing Parts.
  • A surcharge may be required for late submission.
  • Failure to submit these items within the specified period may result in the application being abandoned.

The MPEP states: The fee, oath or declaration, and 1 or more claims may be submitted after the filing date of the application, within such period and under such conditions, including the payment of a surcharge, as may be prescribed by the Director.

It’s important to note that while these items can be submitted later, it’s generally best practice to include them with the initial filing to avoid potential issues or delays.

To learn more:

Yes, the patent examiner has the authority to renumber claims in certain circumstances. According to MPEP 608.01(j):

“When the application is ready for allowance, the examiner, if necessary, will renumber the claims consecutively in the order in which they appear or in such order as may have been requested by applicant.”

This means that while the original claim numbering should be preserved throughout most of the prosecution process, the examiner may renumber the claims at the end of the process, typically when preparing the application for allowance. This final renumbering ensures a logical and sequential order of claims in the issued patent.

To learn more:

No, the English translation and accuracy statement for a non-English provisional application cannot be filed in the non-provisional application. They must be filed in the provisional application itself. MPEP ¶ 2.38 is explicit about this requirement:

“An English translation of the non-English language provisional application and a statement that the translation is accurate must be filed in provisional application No.[3].”

However, there is an exception to this rule. The MPEP states:

“Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.”

This means that for applications filed before November 25, 2005, it was acceptable to file these documents in the non-provisional application. For all applications after this date, the translation and statement must be filed in the provisional application, with a confirmation in the non-provisional application that this has been done.

For more information on patent procedure, visit: patent procedure.

Yes, the Director of the USPTO has the authority to grant access to patent applications in certain circumstances. According to MPEP 104:

“Access provided upon the written order of the Director will also become a part of the record of the application.”

Additionally, the MPEP states:

“Where an applicant relied on the applicant’s application as a means to interfere with a competitor’s business or customers, permission to inspect the application may be given the competitor by the Director. Such permission is via petition for access under 37 CFR 1.14(i).”

This means that in special cases, particularly where there may be competitive interests at stake, the Director can authorize access to an application. However, this permission is not of a continuing nature and may be subject to reevaluation based on changing circumstances.

For more information on Patent application access, visit: Patent application access.

For more information on petition for access, visit: petition for access.

No, extensions of time are not permitted for submitting corrected drawings in response to a notice of allowability. The MPEP clearly states:

Extensions of time to provide acceptable drawings in response to a notice of allowability are not permitted.

This strict policy ensures that the patent granting process is not unnecessarily delayed and encourages applicants to submit corrected drawings promptly after receiving the notice of allowability.

To learn more:

Yes, the benefit of a provisional application can be restored even after the 12-month deadline has passed, under certain conditions. The MPEP explains:

“If a nonprovisional application or an international application designating the United States has a filing date which is after the expiration of the twelve-month period but within two months from the expiration of the period, the benefit of the provisional application may be restored under PCT Rule 26bis.3 for an international application, or upon petition under 37 CFR 1.78(b), if the delay in filing the nonprovisional application or the international application was unintentional.”

To restore the benefit, a petition under 37 CFR 1.78(b) must be filed, which requires:

  • A reference to the provisional application
  • The petition fee
  • A statement that the delay was unintentional

The petition must be filed in the subsequent application or, in certain cases, in the earliest nonprovisional application claiming benefit to the international application.

To learn more:

To learn more:

Yes, removing superfluous matter from patent drawings is one of the changes that can be made without requiring annotated sheets from the applicant. MPEP 608.02(w) states:

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: … (C) Removing superfluous matter.

This provision allows examiners to suggest the removal of unnecessary elements from the drawings, helping to improve clarity and focus on the essential aspects of the invention without requiring a formal submission of annotated sheets by the applicant.

To learn more:

Yes, some deficiencies or inaccuracies in an inventor’s oath or declaration can be corrected using an Application Data Sheet (ADS). The MPEP states: “Some deficiencies or inaccuracies can be corrected with an application data sheet (ADS) in accordance with 37 CFR 1.76.” For more detailed information on using an ADS, the MPEP refers to MPEP § 601.05.

To learn more:

Can small entity status be changed during the patent process?

Yes, small entity status can be changed during the patent process. The MPEP 509.03 provides guidance on this: “Once status as a small entity has been established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.” This means that:

  • You can change from small entity to large entity at any time by simply paying the full fee.
  • If you lose small entity status, you must notify the USPTO before or with the next fee payment.
  • Changing from large entity to small entity requires a new certification of entitlement to small entity status.

It’s important to monitor your status throughout the patent process and update the USPTO promptly if changes occur to avoid potential issues.

To learn more:

Can small entity status be changed during the life of a patent?

Yes, small entity status can change during the life of a patent. The MPEP 509.03 provides guidance on this:

Once status as a small entity has been established in an application or patent, fees as a small entity may thereafter be paid in that application or patent without regard to a change in status until the issue fee is due or any maintenance fee is due.

Key points to remember:

  • Status can change due to mergers, acquisitions, or licensing agreements.
  • The USPTO must be notified of any change before paying the issue fee or maintenance fees.
  • If status changes from small to large entity, future fees must be paid at the higher rate.
  • Conversely, if an entity becomes eligible for small entity status, they can claim it for future fee payments.

It’s important to regularly review your entity status and update the USPTO as necessary to ensure compliance and proper fee payment.

To learn more:

No, sequence listings or tables should not be duplicated in both the drawings and the specification of a patent application. The MPEP 608.02(d) clearly states:

If an application filed under 35 U.S.C. 111 or under 35 U.S.C. 371 includes a sequence listing or a table, such a sequence listing or table should not be included in both the drawings and the descriptive portion of the specification.

This requirement helps to avoid redundancy and potential inconsistencies between the drawings and the specification. Applicants should include sequence listings and tables in the appropriate sections of the specification only.

To learn more:

Can security interests in patents be recorded at the USPTO?

Yes, security interests in patents can be recorded at the USPTO. MPEP 313 states:

Other documents relating to interests in patents or applications will be recorded as provided in 37 CFR 3.11(a).

This includes security interests, which are typically recorded to protect the lender’s rights in case of default. Recording a security interest provides public notice of the lender’s claim on the patent asset.

To record a security interest:

  • Submit the document to the USPTO’s Assignment Recordation Branch
  • Pay the required fee
  • Ensure the document meets the requirements outlined in MPEP 302

Recording does not guarantee the validity of the security interest but establishes an official record of the claim.

For more information on security interests, visit: security interests.

Yes, replacement drawings can be rejected if they contain new matter. The MPEP 608.02(h) states that when reviewing replacement drawings, examiners should not overlook “such factors as new matter, the necessity for the replacement sheets and consistency with other sheets.”

If an examiner identifies new matter in the replacement drawings, they may decide not to enter the sheets into the application. In such cases, the examiner must provide a complete and explicit reasoning for the denial of entry. The MPEP instructs examiners to:

“Identify any drawing(s) not entered because they contain new matter and explain the correction(s) necessary to obtain entry upon resubmission.”

Applicants should ensure that replacement drawings only contain information that was supported in the original disclosure to avoid rejection based on new matter.

To learn more:

Yes, according to MPEP 608.02(w), adding two or three reference characters or exponents is one of the changes that can be made to patent drawings without requiring annotated sheets from the applicant. The MPEP states:

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: (A) Adding two or three reference characters or exponents.

This allows for minor additions to improve the clarity of the drawings without necessitating a formal submission from the applicant.

To learn more:

No, recorded assignment documents will not be expunged even if they are subsequently found to be invalid. The USPTO’s policy is to maintain a complete history of claimed interests in property.

As stated in the MPEP: “Office policy regarding recordation of assignment documents is directed toward maintaining a complete history of claimed interests in property and, therefore, recorded assignment documents will not be expunged even if subsequently found to be invalid. See In re Ratny, 24 USPQ2d 1713 (Comm’r Pat. 1992).” (MPEP § 323)

Once a document is recorded with the Assignment Services Division, it will not be removed from the record relating to that application or patent.

Yes, priority can be claimed based on applications filed under bilateral or multilateral treaties. The MPEP states:

Under Article 4A of the Paris Convention for the Protection of Industrial Property, a right of priority may be based on an application for a patent or for the registration of a utility model or an industrial design filed under the national law of a foreign country adhering to the Convention, or on a foreign application filed under a bilateral or multilateral treaty concluded between two or more such countries.

Examples of such treaties include:

  • The Hague Agreement Concerning the International Registration of Industrial Designs
  • The Convention on the Grant of European Patents (European Patent Office)
  • The Patent Cooperation Treaty (PCT)
  • The International Convention for the Protection of New Varieties of Plants (UPOV)

Applications filed in regional patent offices, such as the European Patent Office (EPO) or the African Regional Intellectual Property Organization (ARIPO), can also serve as a basis for priority claims.

To learn more:

Yes, applicants can claim priority under 35 U.S.C. 119(a)-(d) based on applications filed in certain foreign regional patent offices. The MPEP states:

“In addition to the list of recognized countries set forth in subsection I, above, applicants may claim priority under 35 U.S.C. 119(a)-(d) to applications filed in foreign regional patent offices having member states who are members of the Paris Convention.”

The recognized regional patent offices include:

  • African Regional Intellectual Property Organization (ARIPO)
  • Eurasian Patent Office (EAPO)
  • European Patent Office (EPO)
  • Gulf Cooperation Council (GCC) Patent Office
  • African Intellectual Property Organization (OAPI)

These regional patent offices allow applicants to file a single application that can have effect in multiple member states, streamlining the international patent application process.

While the USPTO is responsible for the content and updates of the MPEP, patent professionals can indirectly influence its content. The USPTO often seeks public input on proposed rule changes and updates to examination procedures. Professionals can participate in these public comment periods or engage with professional organizations that provide feedback to the USPTO. However, there is no formal process for directly suggesting content for specific reserved sections like MPEP 312.

Patent practitioners should not rely on information from reserved MPEP sections, as these sections do not contain any official guidance or information. A reserved section, such as MPEP 404, is essentially a placeholder and does not provide any substantive content. Practitioners should instead:

  • Refer to active, non-reserved sections of the MPEP
  • Consult the most recent USPTO guidelines and notices
  • Stay updated on changes to patent laws and regulations
  • Seek guidance from official USPTO sources when needed

It’s important to always use the most current and official information when dealing with patent matters.

While patent attorneys or applicants cannot directly propose content for reserved MPEP sections like 319, they can provide feedback or suggestions to the USPTO regarding patent examination procedures or policies. The USPTO occasionally seeks public input on proposed changes to patent examination practices, which could potentially influence the content added to reserved sections in the future. However, the ultimate decision on what content to include in the MPEP rests with the USPTO.

Generally, no part of a patent specification can be transferred to another application. The Manual of Patent Examining Procedure (MPEP) § 608.01(t) states: “No part of a specification can normally be transferred to another application.” This means that each patent application should contain its own unique specification, tailored to the specific invention being described and claimed.

To learn more:

To learn more:

The USPTO does not grant partial access to assignment documents. According to MPEP 301.01:

The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.

This policy ensures transparency and prevents selective disclosure of information. It’s important to note that this approach can have implications for documents that contain both public and potentially confidential information. For example:

  • If a document covers both a trademark and a patent application, the entire document becomes public.
  • If a document covers multiple patent applications, it becomes public as soon as any one of the applications is published or patented.

This policy underscores the importance of carefully considering what information is included in assignment documents, particularly when dealing with a mix of public and non-public intellectual property rights.

For more information on assignment documents, visit: assignment documents.

For more information on public inspection, visit: public inspection.

For more information on USPTO policy, visit: USPTO policy.

Can one co-inventor revoke a power of attorney in a patent application?

No, a single co-inventor cannot unilaterally revoke a power of attorney in a patent application. The MPEP 402.10 states:

A power of attorney may not be revoked by less than all of the applicants or owners of the entire interest without good and sufficient reason, and the revocation must be approved by the Director.

This means that to revoke a power of attorney, all co-inventors or owners of the entire interest must agree to the revocation. If a single co-inventor wishes to revoke the power of attorney, they must provide a good and sufficient reason, and the revocation must be approved by the Director of the USPTO.

To learn more:

Yes, in some cases, omitting information from a patent application can be considered new matter. This might seem counterintuitive, but the removal of certain information can change the scope or meaning of the invention in a way that wasn’t supported by the original disclosure.

The MPEP provides an example: New matter includes not only the addition of wholly unsupported subject matter, but may also include […] even the omission of a step from a method. (MPEP 608.04(a))

This concept is particularly important in the context of:

  • Changing the scope of the invention
  • Altering the nature of the invention
  • Removing essential features or steps

Applicants should be cautious when making any changes to their application, including deletions, to ensure they don’t inadvertently introduce new matter by omission. If in doubt, it’s advisable to consult with a patent attorney or agent.

To learn more:

Tags: new matter, USPTO

No, objections to drawings in utility or plant applications cannot be held in abeyance. The MPEP section 608.02(f) clearly states:

“Unless applicant is otherwise notified in an Office action, objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action.”

This policy is based on 37 CFR 1.85(a) and ensures that drawing issues are addressed promptly in the patent application process. Applicants must respond to drawing objections in a timely manner to avoid potential abandonment of their application.

To learn more:

To learn more:

Yes, non-US citizens, specifically nonimmigrant aliens residing in the United States, can obtain limited recognition for patent matters under certain conditions. According to MPEP 402.09 and 37 CFR 11.9(b):

A nonimmigrant alien residing in the United States and fulfilling the provisions of paragraphs (d) and (e) of this section may be granted limited recognition if the nonimmigrant alien is authorized by the United States Government to be employed or trained in the United States in the capacity of representing a patent applicant by presenting or prosecuting a patent application.

However, it’s important to note that limited recognition is not granted to non-US citizens residing abroad and automatically expires upon the nonimmigrant alien’s departure from the United States.

To learn more:

No, non-registered representatives should not be contacted for patent application actions, even if they appear to be authorized by the attorney or agent of record. The MPEP clearly states:

In addition, non-registered representatives of the practitioner of record should not be contacted for such actions, even if apparently authorized by the attorney or agent of record.

This restriction helps maintain the integrity of the patent application process and ensures that only qualified, registered practitioners are involved in critical communications.

Yes, new terms can be introduced in patent claims after the initial filing, but certain requirements must be met. According to MPEP 608.01(o):

New claims, including claims first presented after the application filing date where no claims were submitted on filing, and amendments to the claims already in the application should be scrutinized not only for new matter but also for new terminology.

However, if new terms are introduced, the specification should be amended to provide clear support or antecedent basis for these terms. This ensures that the meaning of the terms in the claims can be understood by referring to the description.

To learn more:

No, new matter cannot be introduced into a nonprovisional application through a supplemental oath or declaration. This is explicitly stated in MPEP 603:

37 CFR 1.67(d) contains the provision of former 37 CFR 1.67(b) that no new matter may be introduced into a nonprovisional application after its filing date even if an inventor’s oath or declaration is filed to correct deficiencies or inaccuracies present in the earlier-filed oath or declaration.

This rule is consistent with the general principle in patent law that new matter cannot be added to an application after its filing date. The purpose of a supplemental oath or declaration is to correct deficiencies or inaccuracies in the original filing, not to introduce new subject matter.

To learn more:

No, new matter cannot be added to a divisional application. The divisional application must only contain subject matter disclosed in the parent application. The MPEP clearly states:

Thus the disclosure presented in a divisional application must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

Any attempt to add new matter to a divisional application will be rejected under 35 U.S.C. 112(a) as lacking written description support in the parent application.

To learn more:

Can new matter be added to a continuation application?

No, new matter cannot be added to a continuation application. A continuation application must disclose and claim only subject matter disclosed in the prior application.

As stated in MPEP 201.07: “The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.” This means that all claims in a continuation application must find support in the original disclosure of the parent application.

If an applicant wishes to add new matter, they would need to file a continuation-in-part (CIP) application instead, which allows for the addition of new subject matter while still claiming the benefit of the earlier filing date for the previously disclosed material.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

No, new matter cannot be added in a Continued Prosecution Application (CPA). The MPEP clearly states: No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application. Any attempt to add new matter will be denied entry by the examiner. If an applicant needs to add new matter, they should consider filing a continuation-in-part application under 37 CFR 1.53(b) instead of a CPA.

To learn more:

Tags: CPA, new matter

Can multiple provisional applications be filed for the same invention?

Yes, multiple provisional applications can be filed for the same invention. The MPEP 201.04 does not place restrictions on filing multiple provisionals. In fact, this practice can be beneficial for inventors who are continuously developing their invention.

Each provisional application establishes a potential priority date for the disclosed content. When filing a subsequent nonprovisional application, the applicant can claim the benefit of multiple provisional applications, potentially securing multiple priority dates for different aspects of the invention.

However, it’s important to note that each provisional application must still meet the requirements of 35 U.S.C. 112(a) for the disclosed subject matter to be eligible for the priority date.

For more information on patent priority, visit: patent priority.

Yes, multiple provisional applications can be combined into a single non-provisional application. This is particularly useful when an inventor has made improvements or additions to their invention over time. The MPEP 201.04 states:

A nonprovisional application that was filed within 12 months of an earlier provisional application may claim the benefit of that provisional application.

While this quote doesn’t explicitly mention multiple provisionals, the USPTO allows claiming benefit from multiple provisional applications in a single non-provisional application, provided each provisional is properly referenced and the non-provisional is filed within 12 months of the earliest provisional application.

For more information on Non-provisional application, visit: Non-provisional application.

For more information on patent priority, visit: patent priority.

For more information on provisional application, visit: provisional application.

Yes, multiple inventors can be deleted from a Continued Prosecution Application (CPA) at once. The language in MPEP ¶ 2.32 supports this:

In bracket 1 insert the name or names of the inventor(s) requested to be deleted.

This indicates that the process allows for the deletion of one or more inventors simultaneously. When filing a CPA, applicants can submit a statement requesting the deletion of multiple named inventors who are not inventors of the invention being claimed in the new application.

However, it’s crucial to ensure that all remaining inventors are correctly named and that the inventorship accurately reflects those who contributed to the claimed invention. If the CPA has already been filed, remember that any subsequent inventorship changes must follow the procedures outlined in 37 CFR 1.48.

For more information on CPA, visit: CPA.

Tags: CPA

Generally, the USPTO maintains only one correspondence address for each patent application. As stated in MPEP 403:

‘The Office will direct all notices, official letters, and other communications relating to the application to a single correspondence address.’

However, there are exceptions:

  • Powers of attorney to different practitioners may be present in an application, but only one correspondence address is recognized.
  • In reexamination proceedings, a ‘duplicate copy’ may be sent to a different address.
  • Maintenance fee reminders may be sent to a ‘fee address’ that differs from the correspondence address.

It’s important to note that while multiple addresses may be associated with an application for specific purposes, the USPTO will generally communicate with only one primary correspondence address.

For more information on Correspondence Address, visit: Correspondence Address.

For more information on USPTO, visit: USPTO.

While it’s possible to include multiple correspondence addresses for a single patent application filed after September 16, 2012, the USPTO will ultimately select only one for official use. Here’s what you need to know:

  • Multiple addresses can be provided in the application
  • The USPTO will choose one address as the official correspondence address
  • If a Customer Number is provided, it may be given preference
  • Only the selected address will receive official communications

The MPEP 403.01(a) states:

Pursuant to 37 CFR 1.33(a), if an applicant includes more than one correspondence address (37 CFR 1.33(a) ) in a patent application, the Office will select one of the specified addresses for use as the correspondence address and, if given, may select the address associated with a Customer Number over a typed correspondence address.

To ensure clear communication, it’s best to designate a single, preferred correspondence address for your application. If you need to change this address later, you can file a request with the USPTO.

To learn more:

Yes, multiple attorneys can be appointed in a patent application. According to MPEP 402.02:

More than one attorney, agent, or other party may be appointed as representative of the applicant or owner.

When appointing multiple attorneys:

  • Use the appropriate power of attorney form (PTO/AIA/82 for applications filed on or after September 16, 2012, or PTO/SB/81 for earlier applications).
  • List all attorneys or agents to be appointed.
  • Specify if they are to act independently or as a team.

To learn more:

Can multiple assignees take action in a patent application?

Yes, multiple assignees can take action in a patent application, but there are specific requirements they must meet. The MPEP 325 states:

“Where multiple assignees are named in the statement under 37 CFR 3.73(c) and/or the Form PTO/AIA/96, and they are not named as joint owners in a single statement or form, the statement or form must be modified accordingly.”

This means that:

  • Multiple assignees can be named in a single statement or form if they are joint owners
  • If they are not joint owners, separate statements or forms must be submitted for each assignee
  • Each assignee must establish their right to take action as per 37 CFR 3.71 and 37 CFR 3.73

It’s important to note that the USPTO will not mediate disputes between assignees. If there are conflicting instructions from multiple assignees, the USPTO may suspend action on the application.

For more information on multiple assignees, visit: multiple assignees.

For more information on USPTO procedures, visit: USPTO procedures.

No, modifications cannot be shown in broken lines on figures that show another form of the invention in solid lines. This is based on the principle established in Ex parte Badger, 1901 C.D. 195, 97 OG 1596 (Comm’r Pat. 1901). The MPEP section 608.02(f) states:

“Modifications may not be shown in broken lines on figures which show in solid lines another form of the invention.”

This rule ensures clarity and prevents confusion in patent drawings by keeping different forms of the invention visually distinct.

To learn more:

Yes, models and exhibits can be presented for demonstration purposes during a patent interview. However, there are specific guidelines to follow:

  • The models and exhibits should be taken away by the applicant or their representative at the conclusion of the interview.
  • They are generally not permitted to be admitted as part of the application or patent unless the requirements of 37 CFR 1.91 are satisfied.
  • A full description of what was demonstrated or exhibited during the interview must be made of record, as per 37 CFR 1.133.

The MPEP states, Any model or exhibit that is left with the examiner at the conclusion of the interview, which is not made part of the application or patent, may be disposed of at the discretion of the Office. (MPEP 608.03(a))

To learn more:

Tags: USPTO

Yes, correcting misspelled legends in patent drawings is one of the changes that can be made without requiring annotated sheets from the applicant. According to MPEP 608.02(w):

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: … (H) Correcting misspelled legends.

This provision allows for the correction of minor typographical errors in drawing legends, improving the accuracy of the patent application without the need for a formal submission of annotated sheets by the applicant.

To learn more:

Can limited recognition be granted to Canadian patent agents?

Yes, limited recognition can be granted to Canadian patent agents. According to MPEP 402.01: Canadian patent agents are not authorized to practice before the Office without proper recognition from the OED Director. Canadian patent agents who are registered and in good standing with the Canadian Patent Office may be granted limited recognition to represent a named applicant in a specific application if the named applicant also appoints a registered U.S. practitioner. This provision allows Canadian patent agents to participate in specific applications, but with certain restrictions and requirements.

To learn more:

To learn more:

Yes, joint inventors can use a single non-English oath or declaration under certain circumstances. The MPEP 602.06 states:

“The Office will accept a single non-English language oath or declaration where there are joint inventors, of which only some understand English but all understand the non-English language of the oath or declaration.”

This means that as long as all joint inventors understand the language used in the oath or declaration, even if some also understand English, a single non-English document can be submitted for all inventors.

To learn more:

Can joint inventors file separate patent applications for the same invention?

No, joint inventors cannot file separate patent applications for the same invention. The MPEP 602.09 states: ‘Joint inventors must apply for a patent jointly and each must make the required oath or declaration.’ This means that all joint inventors must be included in a single patent application for their shared invention. Filing separate applications for the same invention could lead to legal complications and potential rejection of the applications. If inventors have made separate improvements to the invention, they may be able to file separate applications for those specific improvements, but not for the jointly invented core invention.

To learn more:

To learn more:

Can international applicants claim micro entity status based on gross income?

Yes, international applicants can claim micro entity status based on gross income, provided they meet the eligibility criteria. The MPEP 509.04(a) clarifies:

“For purposes of micro entity status, the gross income (instead of median household income) is used to determine entitlement to reduced patent fees.”

International applicants must:

  • Calculate their gross income in U.S. dollars
  • Meet the same income threshold as U.S. applicants
  • Certify their eligibility under oath

The USPTO uses the World Bank’s gross national income (GNI) per capita figures for the applicant’s country of residence to determine the income threshold. Applicants should refer to the most recent World Bank data when assessing their eligibility.

To learn more:

Tags: gross income

Yes, individuals granted limited recognition can file certain documents in patent applications. According to the MPEP 402.01:

Persons granted limited recognition are considered practitioners under 37 CFR 11.1 and thus permitted to perform the same patent prosecution functions of registered patent agents and registered patent attorneys when prosecuting a specified patent application or specified patent applications.

Specifically, they can file:

However, it’s important to note that these individuals are still subject to the restrictions expressed in their grant, including temporal, employer, and visa limitations.

To learn more:

No, incorporation by reference under 37 CFR 1.57(b) cannot be used to add material to a granted patent. This provision is only applicable during the application process, before a patent is granted. The MPEP clearly states:

“If, however, an application has been patented, a certificate of correction or a reissue application could not be used to add inadvertently omitted material to that patent via 37 CFR 1.57(b).”

Once a patent has been granted, other mechanisms such as reissue or certificate of correction would need to be considered for making changes or additions to the patent, subject to their own specific requirements and limitations.

Yes, you can use the original stamped document for recording with additional patents. The USPTO allows the use of previously recorded papers that have been stamped with reel and frame numbers by the Assignment Division.

According to MPEP 315: “A copy of the original document (which may consist of the previously recorded papers on which the Assignment Division has stamped the reel and frame numbers at which they are recorded, or a copy of such papers)” can be submitted as part of the recordation process for additional patents or applications.

For more information on additional patents, visit: additional patents.

For more information on Assignment Division, visit: Assignment Division.

It’s generally not recommended to use claims language or legal phraseology in your patent application abstract. The MPEP 608.01(b) explicitly states:

The abstract should avoid using phrases which can be implied, such as, ‘The disclosure concerns,’ ‘The disclosure defined by this invention,’ ‘The disclosure describes,’ etc. Also, legal phraseology often used in patent claims, such as ‘means’ and ‘said,’ should be avoided.

Instead of using claims language, focus on describing the invention in clear, concise terms that a general reader can understand. The abstract should be informative and provide a summary of the technical disclosure, not a legal definition of the invention’s scope.

To learn more:

No, you should not use the “Hold for Pickup” service option when sending Priority Mail Express® to the USPTO. The reasons for this are:

  • The USPTO does not have resources for picking up mail
  • Mail sent using the “Hold for Pickup” service will not reach the Office

Always use the standard Priority Mail Express® Post Office to Addressee service when sending correspondence to the USPTO.

As stated in MPEP 511: “The Office does not have resources for picking up any mail. Therefore mail should NOT be sent using the ‘Hold for Pickup’ service option (whereby the mail is retained at the destination postal facility for retrieval by the addressee). Mail sent using the ‘Hold for pickup’ service will not reach the Office.”

Can I use PDX for retrieving priority documents from all foreign patent offices?

No, PDX is not available for all foreign patent offices. The availability of PDX depends on:

  • Participation in the WIPO Digital Access Service (DAS)
  • Bilateral PDX agreements between the USPTO and specific foreign offices

MPEP 215.01 states: “The USPTO will attempt to electronically retrieve the priority document through the WIPO DAS (if the foreign office is a DAS depositing office) or through a bilateral PDX agreement.”

To use PDX, check if the foreign office participates in WIPO DAS or has a bilateral agreement with the USPTO. The USPTO maintains a list of participating offices on their website.

To learn more:

Tags: WIPO DAS

Can I use my USPTO deposit account for international patent applications?

Yes, you can use your USPTO deposit account for certain fees associated with international patent applications. The MPEP states: “Deposit accounts can be used for payment of any patent process fee except for international phase fees paid to the International Bureau.” (MPEP 509.01)

This means you can use your deposit account for:

  • PCT fees payable to the USPTO as a Receiving Office
  • National stage entry fees for U.S. national applications
  • Other USPTO-related fees for international applications

However, it’s important to note that fees payable directly to the International Bureau of WIPO cannot be charged to your USPTO deposit account. For those fees, you’ll need to use alternative payment methods specified by WIPO.

To learn more:

Yes, you can generally use your own terminology in the detailed description of your patent application. The MPEP 608.01(g) states:

“An applicant is ordinarily permitted to use his or her own terminology, as long as it can be understood.”

However, there are some important considerations:

  • The terminology must be clear and understandable to a person skilled in the relevant field.
  • Consistency is key – use the same terms throughout your application to avoid confusion.
  • If you introduce new or unconventional terms, it’s advisable to provide definitions or explanations.
  • The examiner may require grammatical corrections, but this is not the primary focus of the examination.

Remember, while you have flexibility in your terminology, the ultimate goal is to clearly communicate your invention. If your unique terms hinder understanding, it may be better to use more standard language in the field.

To learn more:

Can I use hole-punched paper for my patent application?

No, you should not use hole-punched paper for your patent application. The USPTO has specific requirements regarding the paper used for patent applications, and hole-punched paper is explicitly prohibited.

As stated in MPEP 501: Holes should not be punched in the paper.

This requirement is in place to ensure that all documents can be properly scanned, stored, and processed by the USPTO without any loss of information or potential damage to the application papers. Using standard, unmarked paper without holes helps maintain the integrity of the document throughout the application process.

Yes, the USPTO allows the use of certain alternative forms for submitting application data, as described in MPEP 601.05:

  1. Patent Law Treaty Model International Forms can be used to present priority or benefit claims, references to previously filed applications, and applicant information.
  2. The Patent Cooperation Treaty Request Form can be used in national stage applications to present benefit claims and applicant information.

However, there are specific requirements and limitations:

  • When using a Patent Cooperation Treaty Request Form in an application under 35 U.S.C. 111, it must be accompanied by a clear indication that treatment as an application under 35 U.S.C. 111 is desired.
  • If there are inconsistencies between an ADS and these forms, the ADS will govern.

While these alternative forms are accepted, the USPTO generally prefers the use of its official ADS form for clarity and consistency in processing.

To learn more:

Yes, you can use email to respond to Office actions from the USPTO, but certain conditions must be met:

  • You must have a written authorization on file for Internet communication.
  • The response must be submitted through the USPTO’s secure email system or the Electronic Filing System (EFS-Web).
  • The email must include all necessary information and attachments as required for the response.

MPEP 502.03 states: “Replies to Office actions may NOT be submitted by email unless specifically authorized.” This means that without proper authorization, email responses to Office actions will not be accepted.

It’s important to note that while email can be used, the USPTO recommends using EFS-Web for most communications, including responses to Office actions, as it provides a more secure and efficient method of submission.

To learn more:

Can I use color drawings in my patent application?

Yes, you can use color drawings in your patent application, but they require special approval. According to MPEP 608.02:

‘Color drawings are permitted in design applications. Where a design application contains color drawings, the application must include the number of sets of color drawings required by 37 CFR 1.84(a)(2)(ii) and the specification must contain the reference required by 37 CFR 1.84(a)(2)(iii).’

For utility patent applications, color drawings are not ordinarily permitted. However, the USPTO will accept color drawings if:

The petition must explain why color drawings are necessary to accurately depict the invention.

To learn more:

No, you cannot use both sides of the paper when submitting assignment documents to the USPTO. For paper or facsimile submissions, only one side of each page may be used.

As stated in 37 CFR 3.24(b): Only one side of each page may be used.

This requirement ensures that all information is clearly visible and can be properly scanned and recorded by the USPTO. Using both sides of the paper could result in missed information or difficulties in processing your document.

To learn more:

Yes, electronic signatures are permitted on e-IDS submissions. The MPEP 609.07 states:

Applicants and registered practitioners are permitted to sign portions of an EFS-Web submission, including an IDS, with an electronic signature. See 37 CFR 1.4(d)(3).

This means that when submitting an e-IDS through the USPTO’s Electronic Filing System-Web (EFS-Web), you can use an electronic signature to sign the submission. This aligns with the USPTO’s broader acceptance of electronic signatures in patent applications and related documents, as outlined in 37 CFR 1.4(d)(3).

To learn more:

Tags: EFS-Web

Yes, you can use an Application Data Sheet (ADS) to correct inventor information in your patent application. The MPEP 601.05(a) states:

If an ADS is filed after the initial filing date of the application, it must identify the information that is being changed (added, deleted, or modified) with underlining for insertions, and strike-through or brackets for text removed.

To correct inventor information:

  • Use a supplemental ADS if filing after the initial application date
  • Clearly mark changes with underlining for additions and strike-through for removals
  • Ensure all inventor information is consistent across all documents
  • Be aware that some changes may require additional forms or fees

For significant changes to inventorship, you may need to file a request under 37 CFR 1.48 along with the ADS.

To learn more:

Yes, you can use a handwritten signature for electronically filed patent documents. The USPTO accepts a graphic representation of a handwritten signature when submitted via the USPTO patent electronic filing system.

According to 37 CFR 1.4(d)(3): “A graphic representation of a handwritten signature as provided for in 37 CFR 1.4(d)(1) will be accepted when submitted via the USPTO patent electronic filing system.”

This allows for the use of traditional handwritten signatures in electronic filings, providing flexibility for applicants and practitioners.

To learn more:

The use of a copy of an oath or declaration in a continuation-in-part (CIP) application depends on the filing date of the CIP application:

  1. For CIP applications filed on or after September 16, 2012:
    • A copy of an oath or declaration from the prior application may be used.
    • However, the oath or declaration must comply with the requirements of 35 U.S.C. 115 and 37 CFR 1.63 or 1.64 in effect for applications filed on or after September 16, 2012.
    • A new oath or declaration may be necessary if the prior application was filed before September 16, 2012.
  2. For CIP applications filed before September 16, 2012:
    • Generally, a new oath or declaration is required.
    • The copy of the oath or declaration from the prior application is typically not sufficient due to the new matter introduced in a CIP.

According to MPEP 602.05(a): For applications filed on or after September 16, 2012, a continuing application, including a continuation-in-part application, may be filed with a copy of an oath or declaration or substitute statement from the prior nonprovisional application, provided that the oath or declaration is in compliance with 37 CFR 1.63 or the substitute statement is in compliance with 37 CFR 1.64.

It’s important to ensure that the oath or declaration covers all the subject matter in the CIP application, including any new matter added.

To learn more:

Yes, you can use a copy of an oath or declaration from a prior application in certain continuing applications. According to MPEP 602.05:

For applications filed on or after September 16, 2012: a continuing application, including a continuation-in-part application, may be filed with a copy of an oath or declaration or substitute statement from the prior nonprovisional application, provided that the oath or declaration is in compliance with 37 CFR 1.63 or the substitute statement is in compliance with 37 CFR 1.64.

For applications filed before September 16, 2012: A continuation or divisional application filed before September 16, 2012 under 37 CFR 1.53(b) (other than a continuation-in-part (CIP)) may be filed with a copy of the oath or declaration from the prior nonprovisional application.

However, it’s important to note that the requirements for oaths and declarations may differ based on the filing date, and a new oath or declaration may be necessary in some cases.

To learn more:

The use of a Certificate of Mailing or Transmission for international patent applications is limited and depends on the specific type of correspondence. According to the MPEP and 37 CFR 1.8(a)(2)(i)(D)-(F), the certificate procedure does not apply to:

  • The filing of an international application for patent
  • The filing of correspondence in an international application before the U.S. Receiving Office, the U.S. International Searching Authority, or the U.S. International Preliminary Examining Authority
  • The filing of a copy of the international application and the basic national fee necessary to enter the national stage

However, the Certificate of Transmission procedure can be used for some correspondence related to international applications if it’s being transmitted to the USPTO and is not otherwise prohibited. The MPEP states:

The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.

It’s crucial to carefully review the specific requirements and limitations for international application correspondence to ensure proper and timely filing.

Yes, you can use a Certificate of Transmission for documents filed electronically through the USPTO’s Electronic Filing System (EFS-Web). The MPEP provides a suggested format for a Certificate of EFS-Web Transmission:

I hereby certify that this correspondence is being transmitted via the U.S. Patent and Trademark Office electronic filing system (EFS-Web) to the USPTO on [Date].

However, it’s important to note that EFS-Web submissions have their own timestamp system. According to 37 CFR 1.6(a)(4):

Correspondence submitted to the Office by way of the Office electronic filing system will be accorded a receipt date, which is the date the correspondence is received at the correspondence address for the Office set forth in § 1.1 when it was officially submitted.

This date can be a Saturday, Sunday, or federal holiday within the District of Columbia. The certificate can provide an additional layer of documentation for your submission date, but the EFS-Web timestamp is generally considered authoritative for determining the receipt date of electronic submissions.

The use of a Certificate of Mailing or Transmission for correspondence from outside the United States depends on the method of transmission. The MPEP clarifies:

“The Certificate of Mailing procedure does not apply to papers mailed in a foreign country. The Certificate of Transmission procedure for both facsimile transmissions and transmissions via EFS-Web, however, also applies to papers transmitted to the Office from a foreign country provided that the correspondence being transmitted is not prohibited from being transmitted by facsimile or via EFS-Web and is not otherwise precluded from receiving the benefits under 37 CFR 1.8.”

Therefore:

  • You cannot use a Certificate of Mailing for papers mailed from outside the U.S.
  • You can use a Certificate of Transmission for facsimile or EFS-Web transmissions from outside the U.S., as long as the correspondence is eligible for this procedure.

It’s important to verify that your specific type of correspondence is eligible for the Certificate of Transmission procedure before using it from outside the United States.

To learn more:

No, the Certificate of Mailing or Transmission cannot be used for all USPTO correspondence. The MPEP 512 specifies certain types of correspondence that are excluded from the certificate practice:

“The Certificate of Mailing or Transmission procedure does not apply to: (A) Relative to Patents and Patent Applications— (1) The filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date…”

The MPEP lists several other exclusions, including certain international application filings, trademark-related filings, and correspondence filed in interference or trial proceedings. It’s crucial to review the full list in MPEP 512 to ensure compliance with USPTO rules.

To learn more:

No, you cannot use a Certificate of Mailing or Transmission for filing a new patent application to establish the application’s filing date. The MPEP explicitly states:

No benefit will be given to a Certificate of Mailing or Certificate of Facsimile Transmission relative to the filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date.

This restriction is also specified in 37 CFR 1.8(a)(2)(i)(A), which excludes “[t]he filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date” from the Certificate of Mailing or Transmission procedure.

However, it’s worth noting that new patent applications can be filed electronically via the USPTO’s Electronic Filing System (EFS-Web), which provides its own timestamp for filing date purposes.

Can I use a certificate of mailing for all USPTO correspondence?

While the certificate of mailing or transmission is a useful tool, it cannot be used for all types of USPTO correspondence. The MPEP 502 provides specific exceptions:

“The certification procedure under 37 CFR 1.8 is not available for: (A) Applications for patent under 35 U.S.C. 111(a), including reissue applications; (B) International applications for patent; (C) International design applications; (D) Requests for reexamination under 35 U.S.C. 302…”

This list continues with several other exceptions. It’s crucial to note that:

  • New patent applications cannot use the certificate of mailing.
  • International applications are excluded from this procedure.
  • Certain time-sensitive documents require different filing methods.

For these excluded items, consider using Priority Mail Express® or electronic filing to ensure timely receipt by the USPTO. Always check the current regulations or consult with a patent professional to determine the appropriate filing method for your specific correspondence.

For more information on Certificate of Mailing, visit: Certificate of Mailing.

For more information on patent applications, visit: patent applications.

For more information on USPTO correspondence, visit: USPTO correspondence.

While certificates of mailing are widely applicable, they cannot be used for all types of patent-related correspondence. MPEP 512 outlines specific exceptions:

The Certificate of Mailing or Transmission procedure does not apply to the filing of a national patent application specification and drawing or other correspondence for the purpose of obtaining an application filing date.

Additionally, you cannot use a certificate of mailing for:

  • Filing of an international application for patent
  • Filing correspondence in an international application before the U.S. Receiving Office
  • Filing a copy of the international application and the basic national fee to enter the national stage under 35 U.S.C. 371

Always check the current USPTO guidelines to ensure you’re using the correct filing method for your specific correspondence.

To learn more:

No, you should not submit original documents for recording patent assignments. The USPTO explicitly states:

“The United States Patent and Trademark Office will accept and record only a copy of an original assignment or other document. See MPEP § 317. The document submitted for recordation will not be returned to the submitter.”

It’s crucial to submit only copies of original documents, as the USPTO will not return the recorded documents. This ensures that you retain your original documents while still complying with the recording requirements.

No, you cannot submit multiple assignment documents with a single cover sheet. MPEP 302.07 clearly states: “A patent cover sheet must identify only one patent, and a separate patent cover sheet must be submitted for each patent as to which the assignment document is to be recorded.”

This requirement ensures that each assignment is properly documented and linked to the correct patent or application. If you have multiple assignments to record, you must prepare and submit a separate cover sheet for each one.

To learn more:

Can I submit color documents via facsimile for patent assignments?

Submitting color documents via facsimile for patent assignments is not recommended. The MPEP 302.09 states:

“Assignments and other documents affecting title to applications, patents, and registrations that include color drawings or color photographs cannot be recorded by facsimile transmission.”

This restriction is due to the limitations of facsimile technology in accurately reproducing color. To ensure the integrity and legibility of color documents:

  • Submit original color documents in person or by mail to the USPTO.
  • Use the Electronic Patent Assignment System (EPAS) for electronic submissions that may include color elements.
  • If color is not essential to the document, consider converting it to black and white before faxing.

Always verify the current USPTO guidelines for document submission, as procedures may be updated over time.

To learn more:

Yes, you can submit assignments and other documents affecting title to the USPTO via fax. The MPEP states: Assignments and other documents affecting title may be submitted to the Office via facsimile (fax). This process allows for direct submission into the automated Patent and Trademark Assignment System.

However, there are specific requirements and limitations:

  • Documents must include an identified application or patent number, one cover sheet for a single transaction, and payment of the recordation fee.
  • Certain documents cannot be submitted via fax, such as assignments submitted with new patent applications or documents with multiple cover sheets.

For the most up-to-date fax number, refer to the USPTO website or MPEP § 1730.

To learn more:

Can I submit assignment documents for multiple patents or applications in one EPAS submission?

Yes, you can submit assignment documents for multiple patents or applications in a single EPAS submission. This feature is particularly useful for bulk assignments or when dealing with related patent families. Here’s how it works:

  • Upload a single assignment document that covers multiple patents or applications.
  • Enter the relevant patent or application numbers during the submission process.
  • EPAS will associate the document with all specified patents or applications.

The MPEP 302.10 does not explicitly mention this capability, but it is a feature of the EPAS system designed to improve efficiency for users handling multiple assignments. Always ensure that the assignment document clearly identifies all patents or applications it covers.

To learn more:

Tags: EPAS

Can I submit an original assignment document for recording at the USPTO?

No, you should not submit the original assignment document for recording. The MPEP 302.01 clearly states: ‘The USPTO will not return documents filed for recording.’ Therefore, it’s crucial to submit a copy of the original document to ensure you retain the original for your records.

Always keep the original assignment document in a safe place and submit a legible copy for recording purposes. This practice protects your original document and complies with USPTO requirements.

To learn more:

Can I submit an Information Disclosure Statement (IDS) after paying the issue fee?

Yes, it is possible to submit an Information Disclosure Statement (IDS) after paying the issue fee, but there are strict requirements and limitations. According to MPEP 609:

“An information disclosure statement filed after payment of the issue fee may not be considered, but may be placed in the file.”

To have an IDS considered after payment of the issue fee:

  • It must be accompanied by a petition under 37 CFR 1.313(c) to withdraw the application from issue.
  • The petition must be granted for the IDS to be considered.
  • The IDS must comply with the requirements of 37 CFR 1.97 and 37 CFR 1.98.

Additionally, the IDS must be accompanied by:

It’s important to note that submitting an IDS after paying the issue fee should be done only when absolutely necessary, as it can delay the issuance of the patent and incur additional fees.

To learn more:

According to MPEP 508.02, submitting additional information after a patent application has been abandoned is generally not possible. The section states:

“After an application is patented or abandoned, any incoming communication which is not to become part of the record will be returned to the sender.”

This means that once an application is abandoned, the USPTO will typically return any new submissions related to that application. However, there are some exceptions:

  • Petitions to revive the abandoned application
  • Requests for continued examination (RCE) in certain circumstances
  • Appeals to the Patent Trial and Appeal Board, if filed within the appropriate timeframe

If you wish to submit additional information after abandonment, you should consult with a patent attorney to determine if any of these options are available in your specific case.

To learn more:

Yes, you can submit a working model of your invention to the USPTO, but it’s generally not required unless specifically requested by the examiner. According to MPEP 608.03(a):

‘Models or exhibits are not required in most patent applications since the description of the invention in the specification and the drawings must be sufficiently full, clear, and complete and capable of being understood to disclose the invention without the aid of a model.’

However, there are situations where a model might be beneficial or required:

  • If the examiner determines that a model is necessary to understand the invention.
  • In applications involving perpetual motion devices, where a working model is required.
  • When you believe a model would substantially improve the understanding of your invention.

If you decide to submit a model, ensure it complies with USPTO size and safety requirements, and follow the proper procedures for submission as outlined in the MPEP.

To learn more:

To learn more:

Can I submit a supplemental ADS after filing my patent application?

Yes, you can submit a supplemental Application Data Sheet (ADS) after filing your patent application. The MPEP 601.05(a) states:

“A supplemental ADS may be submitted in a nonprovisional application under 37 CFR 1.312 after allowance, with a petition under 37 CFR 1.312 if necessary.”

However, there are important considerations:

  • For applications filed on or after September 16, 2012, any changes must be made with markings (underlining for insertions, strike-through for deletions).
  • Some changes, like inventorship or priority claims, may require additional forms or petitions.
  • Late changes may incur fees or require petitions, especially if they’re made after certain time limits.

Always consult the current USPTO guidelines or a patent attorney when making changes to ensure compliance with all requirements.

To learn more:

Can I submit a photocopy or digital scan of my assignment document for USPTO recording?

Yes, you can submit a photocopy or digital scan of your assignment document for USPTO recording, as long as it’s a complete and legible copy. The MPEP 302.01 specifies: ‘The copy of the document to be recorded should be presented to the Office for recordation.’ This means that:

  • Photocopies are acceptable
  • Digital scans saved as PDF files are also acceptable
  • The copy must be clear and readable
  • All pages and attachments must be included

Remember, while you’re submitting a copy, it must accurately represent the original document in its entirety.

Yes, you can submit a patent assignment electronically through the USPTO’s Electronic Patent Assignment System (EPAS). This is the recommended method for several reasons:

  • It’s free – there is no recordation fee for electronic submissions
  • It’s fast – documents are processed more quickly
  • It’s convenient – you can submit 24/7 from anywhere with internet access

As stated in MPEP 302.10: “Assignments and other documents affecting title may be submitted to the Office via the Office’s Electronic Patent Assignment System (EPAS).”

To use EPAS, you’ll need to complete an online cover sheet and upload a copy of the assignment document. The signature on the electronic cover sheet must comply with USPTO regulations for electronic signatures.

For more information and to access EPAS, visit the USPTO EPAS website.

For more information on electronic patent assignment, visit: electronic patent assignment.

For more information on EPAS, visit: EPAS.

Can I submit a handwritten assignment document for recording at the USPTO?

While handwritten assignment documents are not explicitly prohibited, they are generally discouraged and may face challenges in the recording process. The MPEP 302.01 states that “Documents submitted for recording must be legible and capable of being reproduced in legible copies by use of photocopy and standard office copying equipment.” Handwritten documents may not meet this standard, especially if the handwriting is not clear and easily readable. To ensure smooth processing and avoid potential rejection, it’s recommended to submit typed or printed assignment documents that are clearly legible and meet all USPTO requirements.

Yes, you can still submit assignment documents by mail to the USPTO, although electronic submission is strongly encouraged. If you choose to submit by mail, send your documents to:

Mail Stop Assignment Recordation Services
Director of the USPTO
P.O. Box 1450
Alexandria, VA 22313-1450

However, as noted in MPEP 302.10: “The Office strongly encourages electronic filing of assignment documents using EPAS, because assignment documents filed electronically are recorded faster and are less likely to become lost or misplaced.” Therefore, while mail submission is an option, electronic submission through EPAS is preferable for faster and more secure processing.

To learn more:

Can I retroactively claim micro entity status for previously paid fees?

No, you cannot retroactively claim micro entity status for fees that have already been paid. The MPEP clearly states:

“A fee may be paid in the micro entity amount only if it is submitted with, or subsequent to, the submission of a certification of entitlement to micro entity status.” (MPEP 509.04(f))

This means:

  • Micro entity status must be established before or at the time of paying fees at the micro entity rate
  • You cannot request a refund for the difference between standard fees and micro entity fees for payments made before establishing micro entity status
  • Future fees can be paid at the micro entity rate once status is properly established

To benefit from micro entity status, ensure you file the certification before paying any fees you wish to pay at the reduced rate.

To learn more:

Tags: patent fees

Yes, it is possible to restore the right of priority if you miss the 12-month filing deadline (6 months for design applications). As provided in 37 CFR 1.55(c), if the subsequent application is filed within two months from the expiration of the priority period, the right of priority may be restored upon petition. The petition must include:

  • The priority claim (unless previously submitted)
  • The petition fee
  • A statement that the delay in filing was unintentional

The Director may require additional information where there is a question whether the delay was unintentional. Note that while this allows for a valid priority claim, it does not overcome potential prior art issues under pre-AIA 35 U.S.C. 102(b) or (d) in applications subject to pre-AIA law.

Yes, you can request the return of your model, exhibit, or specimen from the USPTO. However, there are specific procedures and timeframes to follow. According to MPEP 608.03(a):

A request for return of the model, exhibit, or specimen should be made within the period set forth in MPEP § 608.03(a).

Here are the key points to remember:

  • Make the request before the application is allowed or within two months after the date of the Notice of Allowance.
  • Include a proper postage paid return address sticker with the request.
  • If the item is not claimed within the specified period, the USPTO may dispose of it at its discretion.

It’s important to act promptly if you wish to have your items returned, as the USPTO is not obligated to store them indefinitely.

To learn more:

Tags: USPTO

No, the USPTO does not allow partial access to patent assignment documents. According to MPEP 301.01:

“The Office will not open only certain parts of an assignment document to public inspection. If such a document contains two or more items, any one of which, if alone, would be open to such inspection, then the entire document will be open.”

This means:

  • If a document covers both a trademark and a patent, it will be entirely available to the public from the beginning.
  • If it covers multiple patent applications, it becomes publicly available as soon as any one of them is published or patented.

The policy ensures transparency and consistency in the handling of assignment documents.

To learn more:

Can I request a certificate of correction for a priority claim after my patent has issued?

Yes, you can request a certificate of correction for a priority claim after your patent has issued, but only under specific circumstances. According to MPEP 213.04: ‘If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’ However, it’s important to note that this correction is only possible if the failure to make the timely claim was through error and without deceptive intent. You’ll need to file a petition for a certificate of correction along with the required fee and evidence supporting your claim.

To learn more:

To learn more:

Yes, in most cases. According to MPEP 401, “An applicant for patent, other than a juristic entity (e.g., organizational assignee), may file and prosecute their own application, and thus act as their own representative (pro se) before the Office.” However, there are important considerations:

  • Juristic entities (e.g., companies) must be represented by a patent practitioner
  • Pro se applicants are subject to the same rules and potential sanctions as represented applicants
  • Lack of familiarity with patent procedures may result in missed opportunities for optimal protection

Can I record an assignment for a pending patent application?

Yes, you can record an assignment for a pending patent application. In fact, the USPTO encourages early recordation of assignments. According to MPEP 302:

An assignment relating to a patent must identify the patent by the patent number. An assignment relating to a national patent application must identify the national patent application by the application number (consisting of the series code and the serial number, e.g., 07/123,456). An assignment relating to an international patent application which designates the United States of America must identify the international application by the international application number (e.g., PCT/US90/01234).

To record an assignment for a pending application:

  • Use the application number to identify the application
  • Ensure all necessary parties have signed the assignment document
  • Submit the assignment document along with the required cover sheet and fee to the USPTO

Early recordation can help establish clear ownership and facilitate future transactions or licensing agreements.

For more information on USPTO procedures, visit: USPTO procedures.

Yes, you can record a trademark license with the USPTO. The process is similar to recording other documents:

  • Submit the license document to the USPTO’s Assignment Recordation Branch
  • Include a cover sheet with the required information
  • Pay the appropriate fee

MPEP 313 mentions: Trademark documents are recorded in the same manner as patent documents, but… requests to record documents for trademarks should be mailed to: Commissioner for Trademarks, 2900 Crystal Drive, Arlington, VA 22202-3514.

Recording a trademark license can provide legal benefits and help maintain clear records of trademark rights and usage agreements.

No, you cannot petition against a new matter rejection in claims. When new matter affects the claims, leading to their rejection, the issue must be addressed through the appeal process, not by petition.

The MPEP 608.04(c) clearly states:

“But where the alleged new matter is introduced into or affects the claims, thus necessitating their rejection on this ground, the question becomes an appealable one, and should not be considered on petition even though that new matter has been introduced into the specification also.”

This means that even if the new matter appears in both the specification and the claims, the claim-related issues must be addressed through an appeal to the Patent Trial and Appeal Board (PTAB), not through the petition process.

To learn more:

Tags: new matter

Can I perfect a foreign priority claim after my patent has been issued?

No, you cannot perfect a foreign priority claim after your patent has been issued if the claim was not timely filed during the pendency of the application. As stated in MPEP 216.01:

“A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) in an issued patent. However, a reissue application cannot be used to perfect a claim for priority benefit under 35 U.S.C. 119(a)-(d) or (f) where the claim for priority benefit was not timely filed during the pendency of the application that issued as the patent for which reissue is sought.”

This means that if you missed the deadline to file the priority claim or the required certified copy of the foreign application during the original patent application process, you cannot use a reissue application to retroactively perfect the claim after the patent has been issued.

Yes, you can perfect a claim for foreign priority after your patent has been issued. There are two main methods:

  1. Certificate of Correction: This is generally the preferred method if the requirements of 37 CFR 1.55 are met and no further examination is required. As stated in the MPEP, Except in certain situations, a certificate of correction can generally be used to perfect a claim to foreign priority where a petition under 37 CFR 1.55(e) to accept an unintentionally delayed priority claim is filed with a request for a certificate of correction in an issued patent.
  2. Reissue Application: This method is necessary in situations where further examination would be required or when the requirements of 35 U.S.C. 119(a)-(d) or (f) were not satisfied in the patented application or its parent prior to issuance.

To learn more:

Can I pay patent fees in foreign currency?

No, the USPTO does not accept foreign currency for patent fee payments. According to MPEP 509: ‘All payments of money required for USPTO fees or services must be made in U.S. dollars and in the form of a cashier’s or certified check, Treasury note, national bank notes, or United States Postal Service money order.’

If you’re an international applicant, you’ll need to arrange for payment in U.S. dollars. Options include:

  • Using an international credit card that can process payments in USD
  • Establishing a U.S. bank account
  • Using a registered U.S. attorney who can make payments on your behalf

It’s advisable to plan ahead for currency conversion to ensure timely payment of USPTO fees.

To learn more:

To learn more:

Tags: USPTO fees

Can I obtain a foreign filing license for an invention not yet filed with the USPTO?

Yes, it is possible to obtain a foreign filing license for an invention that has not yet been filed with the United States Patent and Trademark Office (USPTO). This is known as a petition-based license. According to MPEP 140:

“If no corresponding national or international application has been filed in the United States, the petition for license should be accompanied by a legible copy of the material upon which a foreign patent application is to be based. Where the material upon which the foreign patent application is to be based is a U.S. application, the petition for license should identify the application by its application number, filing date, inventor, and title. Where the material upon which the foreign patent application is to be based is not a U.S. application, a legible copy of the material must be attached to the petition.”

To obtain such a license, you must file a petition with the USPTO, providing details about the invention and the reasons for seeking an early foreign filing license. The USPTO will review the petition and may grant the license if it determines that the invention does not pose a national security risk.

For more information on foreign filing license, visit: foreign filing license.

Yes, you can obtain a foreign filing license for a provisional patent application. According to MPEP 140:

‘U.S. provisional applications are considered as pending applications and are subject to the license requirement specified in 35 U.S.C. 184.’

This means that:

  • Provisional applications require a foreign filing license just like non-provisional applications.
  • The process for obtaining a license is the same as for non-provisional applications.
  • If you plan to file a foreign application based on your provisional application within 6 months, you should request a license when filing the provisional or shortly thereafter.

Remember, the license requirement applies to the subject matter, not the type of application.

For more information on foreign filing license, visit: foreign filing license.

For more information on provisional application, visit: provisional application.

Yes, you can incorporate material by reference in a provisional patent application. The limitations on incorporation by reference that apply to non-provisional applications do not apply to provisional applications or applications relied on only to establish an earlier effective filing date.

As stated in the MPEP: ‘The limitations on the material which may be incorporated by reference in U.S. patent applications which are to issue as U.S. patents do not apply to applications relied on only to establish an earlier effective filing date under 35 U.S.C. 119 or 35 U.S.C. 120.’

However, it’s important to note that the incorporation by reference must still be clear and properly executed to be effective.

To learn more:

No, detailed descriptions of the drawings should not be included in the Brief Description section of a patent application. According to MPEP 608.01(f):

The specification should not normally describe the drawings in detail, but should concentrate on defining the invention.

The Brief Description section should only contain:

  • References to each figure by number
  • A concise explanation of what each figure represents

Detailed descriptions of the drawings and how they relate to the invention should be reserved for the Detailed Description section of the specification.

To learn more:

To learn more:

Tags: drawings

Yes, you can include a copyright or mask work notice in patent drawings, but it must comply with specific requirements. According to 37 CFR 1.84(s) and MPEP 608.01(w):

A copyright or mask work notice may appear in the drawing, but must be placed within the sight of the drawing immediately below the figure representing the copyright or mask work material and be limited to letters having a print size of .32 cm. to .64 cm. (1/8 to 1/4 inches) high.

Additionally, the content of the notice must be limited to only those elements provided for by law, and the authorization language specified in 37 CFR 1.71(e) must be included at the beginning of the specification. If these conditions are met, the notice will not be objected to as extraneous matter under 37 CFR 1.84.

To learn more:

Yes, you can hand-carry certain documents to the USPTO, but there are specific guidelines and limitations. According to MPEP 501:

Patent-related papers may be hand-carried to the Office in Alexandria, VA. Correspondence cannot be hand-carried to the Regional Offices. If the correspondence is hand-carried to the Office, with limited exceptions (see MPEP § 502, subsection III) it must be delivered to:

United States Patent and Trademark Office
Customer Service Window
Randolph Building
401 Dulany Street
Alexandria, VA 22314

For trademark-related papers, there is a separate location:

Trademark-related papers may be filed at the “walk-up” window located in the Trademark Assistance Center, Madison East, Concourse Level, Room C55, 600 Dulany Street, Alexandria, VA 22314.

It’s important to note that while hand-carrying documents is possible, electronic filing is often faster and more efficient for most types of correspondence with the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO submission, visit: USPTO submission.

No, you cannot get your patent application drawings returned. The United States Patent and Trademark Office (USPTO) clearly states in the Manual of Patent Examining Procedure (MPEP) Section 608.02(y) that:

Drawings will not be returned to the applicant.

This policy ensures that the USPTO maintains a complete record of all submitted materials for each patent application. It’s important for applicants to keep copies of all documents, including drawings, submitted to the USPTO.

To learn more:

Yes, you can request a refund if you establish small entity status after paying full fees, but there are strict time limits:

  • You must file an assertion of small entity status and a refund request within 3 months of the date of the full fee payment
  • This 3-month period cannot be extended

According to 37 CFR 1.28(a): “A refund pursuant to § 1.26, based on establishment of small entity status, of a portion of fees timely paid in full prior to establishing status as a small entity may only be obtained if an assertion under § 1.27(c) and a request for a refund of the excess amount are filed within three months of the date of the timely payment of the full fee. The three-month time period is not extendable under § 1.136.”

To learn more:

To learn more:

Generally, the English translation and accuracy statement for a non-English provisional application must be filed in the provisional application itself, not in the nonprovisional application. However, there is an exception:

As noted in the MPEP, Do not use this form paragraph if a translation of the provisional application and a statement that the translation was accurate were filed in the nonprovisional application (the present application) before November 25, 2005.

This means:

  • For applications filed on or after November 25, 2005, the translation and statement must be filed in the provisional application.
  • For applications filed before November 25, 2005, it was acceptable to file these documents in the nonprovisional application.

It’s important to follow the current requirement of filing these documents in the provisional application to ensure proper benefit claim.

For more information on filing requirements, visit: filing requirements.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

The USPTO is not open for filing correspondence on Saturdays, Sundays, or federal holidays within the District of Columbia. However, there are exceptions:

  • Correspondence deposited as Priority Mail Express® with the USPS in accordance with 37 CFR 1.10 is considered filed on the date of deposit, even on weekends or holidays
  • Electronic filing systems may be available 24/7, but the official filing date will be the next business day

MPEP 510 cites 37 CFR 1.6(a)(1): “The Patent and Trademark Office is not open for the filing of correspondence on any day that is a Saturday, Sunday or Federal holiday within the District of Columbia.”

Can I file multiple provisional applications for the same invention?

Yes, you can file multiple provisional applications for the same invention. This practice is sometimes used to establish earlier priority dates for different aspects of an invention as they are developed. The MPEP 201.04 does not explicitly prohibit this practice.

However, it’s important to note:

  • Each provisional application must meet the requirements for disclosure and enablement
  • The 12-month deadline for filing a nonprovisional application starts from the earliest provisional application you wish to claim benefit from
  • When filing the nonprovisional application, you can claim the benefit of multiple provisional applications

For example, the MPEP states:

“A nonprovisional application may claim the benefit of one or more prior provisional applications under 35 U.S.C. 119(e).”

While this strategy can be beneficial, it’s advisable to consult with a patent attorney to ensure proper execution and to avoid potential pitfalls.

To learn more:

Can I file a U.S. nonprovisional application claiming priority to a provisional application after 12 months?

While it’s generally recommended to file within 12 months, there is a limited exception that allows for filing a nonprovisional application claiming priority to a provisional application after the 12-month period. The MPEP explains:

“A nonprovisional application filed not later than twelve months after the date on which the provisional application was filed … will have its filing date restored to the filing date of the provisional application for the purpose of establishing copendency with the provisional application under 35 U.S.C. 119(e).” (MPEP 213.03)

However, this exception comes with strict conditions:

  • The delay in filing must have been unintentional.
  • The nonprovisional application must be filed within 14 months from the provisional filing date.
  • A petition to restore the right of priority must be filed promptly.

It’s important to note that this exception is not automatic and requires a petition process. If granted, it allows the nonprovisional application to claim the benefit of the provisional application’s filing date.

To learn more:

Can I file a provisional application in a language other than English?

Yes, you can file a provisional application in a language other than English. However, there are important considerations:

  • The USPTO accepts provisional applications in any language.
  • An English translation is not required at the time of filing.
  • If a nonprovisional application is later filed claiming benefit of the provisional, an English translation may be required.

The MPEP 201.04 states: “If a provisional application is filed in a language other than English, an English-language translation of the non-English language provisional application will not be required in the provisional application.” However, it’s important to note that if you later file a nonprovisional application claiming benefit of the provisional, you may need to provide an English translation at that time, along with a statement that the translation is accurate.

To learn more:

Can I file a provisional application electronically?

Yes, you can file a provisional application electronically through the USPTO’s Electronic Filing System (EFS-Web). The MPEP 201.04 states:

“Applicants can file provisional applications electronically using EFS-Web or Patent Center.”

Electronic filing offers several advantages, including:

  • Immediate confirmation of receipt
  • Potential for reduced filing fees
  • Faster processing times
  • 24/7 availability

To file electronically, you’ll need to prepare your application documents in the appropriate format and submit them through the USPTO’s EFS-Web system or Patent Center.

For more information on EFS-Web, visit: EFS-Web.

For more information on electronic filing, visit: electronic filing.

For more information on Patent Center, visit: Patent Center.

For more information on provisional application, visit: provisional application.

Can I file a priority claim in a continuing application?

Yes, you can file a priority claim in a continuing application, but there are specific requirements and deadlines to consider. According to MPEP 214.01, “In the case of a continuation or divisional application filed under 35 U.S.C. 111(a), the claim for priority must be made during the pendency of the application and within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.” This means that even in a continuing application, you must adhere to the time limits for filing the priority claim. It’s important to note that the priority claim must be made in each continuing application; a priority claim in a parent application does not automatically carry over to child applications.

Yes, you can file a priority claim in a continuation or divisional application, but there are specific rules you must follow. According to MPEP 214.01:

‘In the case of a continuation or divisional application filed under 35 U.S.C. 111(a), the claim for priority must be made during the pendency of the application and within the four-month period set forth in 37 CFR 1.55(d)(1).’

This means:

  • The priority claim must be made while the continuation or divisional application is still pending (not abandoned or issued).
  • You have a four-month window from the actual filing date of the continuation or divisional application to make the priority claim.
  • The priority claim should refer back to the foreign application through the parent application(s).

It’s important to note that the continuation or divisional application must have copendency with the parent application to maintain the priority chain. Always consult the latest version of the MPEP and consider seeking advice from a patent attorney to ensure compliance with current USPTO rules.

To learn more:

Can I file a priority claim after paying the issue fee for my patent application?

Yes, you can file a priority claim after paying the issue fee for your patent application, but it comes with additional requirements and costs. According to MPEP 213.04:

If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, it must also be accompanied by the processing fee set forth in 37 CFR 1.17(i).

This means that if you file your priority claim after paying the issue fee, you must:

  • Include the priority claim or certified copy of the foreign application
  • Pay the additional processing fee specified in 37 CFR 1.17(i)
  • Ensure the application hasn’t been patented yet

It’s important to note that once the patent is granted, you cannot file a priority claim retroactively. Therefore, it’s always best to file your priority claim as early as possible during the application process to avoid additional fees and potential complications.

To learn more:

No, you cannot file a petition to restore the benefit of a provisional application in the provisional application itself. According to the MPEP:

“A petition to restore the benefit of a provisional application must be filed in the subsequent application.”

This means you must file the petition in the nonprovisional application or the international application designating the United States that is seeking to claim the benefit of the provisional application. This is because the provisional application itself is not examined and automatically expires after 12 months. The petition is a request to restore the right to claim the benefit in a subsequent application, not to extend the life of the provisional application.

For more information on patent procedure, visit: patent procedure.

For more information on provisional application, visit: provisional application.

Can I file a patent application without claims?

While it is possible to file a patent application without claims, it is not recommended and can have significant consequences:

  • No filing date: According to MPEP 601.01, an application must contain “at least one claim pursuant to 35 U.S.C. 112(b)” to be assigned a filing date.
  • Provisional applications: Claims are not required for provisional applications, but these do not mature into patents without a subsequent non-provisional filing.
  • Subsequent submission: If claims are not included in the initial filing, they must be submitted later, which may delay the examination process and incur additional fees.
  • Priority issues: Lack of claims at filing may affect your ability to claim priority or benefit from earlier filing dates in certain situations.

The MPEP states: “To obtain a filing date, applicant must file specification containing a description pursuant to 35 U.S.C. 112(a) and at least one claim pursuant to 35 U.S.C. 112(b).” Therefore, it’s strongly advised to include at least one claim when filing a non-provisional patent application.

To learn more:

Yes, you can file a foreign priority claim after your patent has been granted, but it requires additional steps:

  1. File a petition under 37 CFR 1.55(e) for an unintentionally delayed priority claim
  2. Submit a request for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323
  3. Pay the required petition and certificate of correction fees

MPEP 214.02 states: “Where a priority claim under 37 CFR 1.55(g) was not timely made, 37 CFR 1.55(g) allows the priority claim and the certified copy required under 37 CFR 1.55 to be filed pursuant to a petition under 37 CFR 1.55(e) even if the application is not pending (e.g., a patented application).”

Can I file a divisional-continuation application?

Yes, you can file a divisional-continuation application, which is a hybrid type of continuing application. This type of application combines aspects of both divisional and continuation applications.

According to MPEP 201.06(c): “The disclosure presented in a divisional application must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.” However, a divisional-continuation can include both claims to a distinct invention (like a divisional) and additional claims to the invention disclosed in the parent (like a continuation).

When filing such an application, it’s crucial to:

  • Ensure that the claims are properly grouped
  • Clearly indicate which claims are divisional and which are continuation
  • Comply with all requirements for both divisional and continuation applications

Always consult with a patent attorney or agent to determine the best filing strategy for your specific situation.

For more information on continuing applications, visit: continuing applications.

Can I file a divisional-continuation application after my parent application has been patented?

No, you cannot file a divisional-continuation application after your parent application has been patented. According to MPEP 201.06(c):

“The divisional application must be filed before the patenting or abandonment of or termination of proceedings on the prior application.”

This means that the window for filing a divisional-continuation application closes when the parent application is either:

  • Granted a patent
  • Abandoned
  • Proceedings are terminated

If you wish to pursue additional claims or inventions after your patent has been granted, you may need to consider other options, such as filing a reissue application or a new continuation-in-part application, depending on the specific circumstances and the nature of the new subject matter.

For more information on parent application, visit: parent application.

For more information on patent grant, visit: patent grant.

Can I file a divisional application without a new oath or declaration?

Yes, you can file a divisional application without a new oath or declaration under certain conditions. According to MPEP 201.06(c):

“Under 37 CFR 1.63(d), a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) if: (1) the prior nonprovisional application contained an oath or declaration as prescribed by 37 CFR 1.63 that was executed by or with respect to the inventor and was signed in compliance with 37 CFR 1.64; and (2) the divisional application was filed by all or by fewer than all of the inventors named in the prior application.”

This provision simplifies the filing process for divisional applications, allowing inventors to use the oath or declaration from the original application, provided the specified conditions are met.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on oath, visit: oath.

Yes, it is possible to file a delayed benefit claim in an abandoned application, particularly for provisional applications. The MPEP 211.04 states:

“Effective December 18, 2013, 35 U.S.C. 119(e)(1) no longer requires that the amendment containing the specific reference to the earlier filed provisional application be submitted during the pendency of the application. Therefore, a petition to revive is no longer required to add or correct a benefit claim under 35 U.S.C. 119(e) in an abandoned nonprovisional application filed on or after November 29, 2000.”

This means you can file a petition under 37 CFR 1.78 to accept an unintentionally delayed claim for the benefit of a prior-filed provisional application in the abandoned nonprovisional application. This may be necessary to correct benefit claims in later-filed applications that claim benefit from the abandoned application.

To learn more:

Can I file a certified copy of a foreign application after paying the issue fee?

Yes, you can file a certified copy of a foreign application after paying the issue fee, but there are important considerations. According to MPEP 213.04, “If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.” This means that while you can still file the certified copy, it won’t automatically be included in your patent. You would need to request a certificate of correction after the patent issues to have the priority claim recognized. It’s always best to file the certified copy before paying the issue fee to avoid this additional step and potential complications.

To learn more:

Yes, you can delete a benefit claim, but it’s important to understand the process and potential implications:

  1. For applications filed on or after September 16, 2012, you can delete a benefit claim by filing a corrected Application Data Sheet (ADS) that removes the reference to the prior-filed application.
  2. For applications filed before September 16, 2012, you can delete a benefit claim by amending the specification (if the claim is in the specification) or by submitting a supplemental ADS to delete references to prior applications.

According to MPEP 211.02(a): The examiner should consider whether any new prior art may now be available if a benefit claim is deleted.

Important considerations:

  • Deleting a benefit claim may expose your application to additional prior art, potentially affecting its patentability.
  • If you delete a benefit claim after final rejection or allowance, the amendment will be treated under special rules (37 CFR 1.116 or 1.312, respectively).
  • Deleting a benefit claim may be seen as intentionally waiving the benefit claim. If you later try to reinstate it, the USPTO may not accept it as unintentionally delayed.
  • In a Continued Prosecution Application (CPA), you cannot delete the reference to the prior application with the same application number.

Always carefully consider the implications before deleting a benefit claim, and consult with a patent attorney if you’re unsure about the consequences.

For more information on ADS, visit: ADS.

For more information on CPA, visit: CPA.

For more information on prior art, visit: prior art.

Tags: ADS, CPA, prior art

No, you should avoid making derogatory remarks about prior art in your patent application. The MPEP 608.01(r) states:

“The applicant may refer to the general state of the art and the advance thereover made by his or her invention, but he or she is not permitted to make derogatory remarks concerning the inventions of others.”

This means you can discuss how your invention improves upon existing technology, but you should not disparage or criticize other inventions or inventors.

To learn more:

Tags: prior art

Can I correct micro entity status errors retroactively?

Yes, you can correct micro entity status errors retroactively, but there are specific rules and time limitations to consider. According to MPEP 509.04(f):

“Errors in micro entity status may be rectified by filing a notification of a change in status … and paying the required fee deficiency.”

However, the ability to make retroactive corrections is subject to time constraints:

  • For underpayments: You can correct the error at any time by paying the fee deficiency.
  • For overpayments: You must file a micro entity certification and request a refund within the time period set in 37 CFR 1.29(k), which is generally within three months of the fee payment.

It’s crucial to address any status errors promptly to maintain the validity of your patent application or granted patent and to ensure compliance with USPTO regulations.

To learn more:

Tags: patent fees

No, you cannot correct micro entity status errors for multiple applications or patents in a single submission. The MPEP, citing 37 CFR 1.29(k)(1), states:

Any paper submitted under this paragraph must be limited to the deficiency payment (all fees paid in error) required for a single application or patent. Where more than one application or patent is involved, separate submissions of deficiency payments are required for each application or patent (see § 1.4(b)).

This means you must submit separate deficiency payments and itemizations for each application or patent where micro entity fees were erroneously paid. This requirement ensures clear and accurate processing of fee corrections for each individual case.

To learn more:

Yes, you can correct inventorship by filing a continuing application. The MPEP states:

Correction of inventorship may also be obtained by the filing of a continuing application under 37 CFR 1.53 without the need for filing a request under 37 CFR 1.48, although it should be noted that the requirements for a request under 37 CFR 1.48 filed on or after September 16, 2012 are minimal.

However, it’s important to note that changing inventorship through a continuing application may affect the application’s benefit claim under 35 U.S.C. 120. The MPEP advises, 35 U.S.C. 120 permits a continuing application to claim the benefit of the filing date of a copending, previously filed, parent application provided there is inventorship overlap between the continuing application and the parent application.

To learn more:

Yes, you can correct certain errors in a recorded USPTO assignment document without submitting a new assignment. The process depends on the type of error:

  • For minor typographical errors, use a Corrective Cover Sheet.
  • For more substantial errors, submit a Substitute Statement.

MPEP 323 states: “The ‘corrective document’ or ‘substitute statement’ will not be recorded as a new assignment.” Instead, it will be recorded to correct the original assignment document, maintaining the original recordation date.

For more information on assignment correction, visit: assignment correction.

For more information on substitute statement, visit: substitute statement.

For more information on USPTO, visit: USPTO.

Yes, you can still correct an erroneous assignment even if you cannot contact or get cooperation from the party who filed it. The MPEP 323.01(c) provides guidance for this situation:

The owner should contact the party who recorded the papers with the erroneous information and request that such party record corrective papers. However, if the party cannot be located or is unwilling to file corrective papers, then the true owner must record the necessary papers with the Assignment Services Division to correct the error.

In such cases, you, as the true owner, must submit the required documentation to the USPTO’s Assignment Services Division, including the completed cover sheet, affidavit or declaration, and required fees. This ensures that you can correct the record even without the cooperation of the party who made the error.

To learn more:

Can I correct a timely benefit claim without a petition?

Yes, in certain circumstances, you can correct a timely benefit claim without filing a petition. The MPEP 211.02(a) provides guidance on this:

If an applicant includes a benefit claim in a timely filed application data sheet (ADS), but the benefit claim contains a typographical error or improper application number, the applicant may correct the benefit claim without a petition by submitting a corrected ADS in compliance with 37 CFR 1.76(c) if the correction is made within the time period set forth in 37 CFR 1.78.

To correct a timely benefit claim without a petition:

  • The original benefit claim must have been submitted in a timely filed ADS
  • The correction must be for a typographical error or improper application number
  • Submit a corrected ADS complying with 37 CFR 1.76(c)
  • Make the correction within the time period specified in 37 CFR 1.78

It’s important to note that this option is only available for minor corrections to timely filed benefit claims. For more substantial changes or untimely claims, a petition may still be required.

To learn more:

Tags: ADS

Can I convert my provisional application to a nonprovisional application?

No, you cannot directly convert a provisional application to a nonprovisional application. The MPEP clearly states: A provisional application cannot be converted to a nonprovisional application. Instead, you must file a separate nonprovisional application within 12 months of the provisional application’s filing date. This nonprovisional application can claim the benefit of the provisional application’s filing date. Here’s what you need to know:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date.
  • It must include a specific reference to the provisional application.
  • The nonprovisional application can expand on the content of the provisional application but must support any claims that rely on the provisional filing date.

Remember, if you don’t file a nonprovisional application within 12 months, the provisional application will automatically expire, and you’ll lose the benefit of its filing date.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on Patent Application Process, visit: Patent Application Process.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

Yes, it is possible to claim priority to multiple foreign applications in a U.S. patent application, provided certain conditions are met:

  • Each foreign application must independently meet the requirements for a priority claim
  • The U.S. application must be filed within 12 months of the earliest filed foreign application
  • The claimed subject matter must be supported by each application for which priority is claimed

When claiming multiple priorities, the U.S. application gets the benefit of each prior application only for the subject matter that it supports. This allows applicants to combine priority claims to protect inventions that were developed and disclosed progressively over time in different countries.

Yes, you can claim priority to multiple foreign applications for the same invention, provided they meet certain criteria. The MPEP 213.02 addresses this situation:

Where two or more foreign applications are combined in a single U.S. application, to take advantage of the changes to 35 U.S.C. 103 or to claim both priority and the benefit of the filing date of an earlier application, the claimed subject matter in the U.S. application is entitled only to the earliest date to which it is entitled in any of the included foreign applications.

To claim priority to multiple foreign applications:

  • Each foreign application must be properly identified in the application data sheet (ADS)
  • Certified copies of all foreign applications must be submitted
  • The U.S. application must be filed within 12 months of the earliest filed foreign application

Note: The effective priority date for any claimed subject matter will be the earliest applicable date from the foreign applications.

To learn more:

Yes, under certain conditions, an applicant can claim priority based on an application for an inventor’s certificate. MPEP 213.05 explains: ‘An inventor’s certificate may form the basis for rights of priority under 35 U.S.C. 119(d) only when the country in which it is filed gives to applicants, at their discretion, the right to apply, on the same invention, either for a patent or for an inventor’s certificate.’

To claim priority to an inventor’s certificate, the applicant must file an affidavit or declaration stating that they had the option to file for either a patent or an inventor’s certificate in the foreign country.

For more information on foreign priority, visit: foreign priority.

Can I claim priority to a provisional application filed in a foreign country?

No, you cannot claim priority to a provisional application filed in a foreign country. The MPEP 213.02 states:

‘Note that a foreign filed provisional application is not eligible for priority benefit.’

Priority claims can only be made to non-provisional applications or other types of applications that are recognized under the Paris Convention. Provisional applications are unique to the U.S. patent system and are not recognized as priority documents in foreign countries or under international agreements.

To learn more:

Yes, it is possible to claim priority to a foreign application after your U.S. patent has been issued. According to MPEP 216.01, a claim for priority under 35 U.S.C. 119(a)-(d) or (f) can be made after the patent is granted, subject to certain conditions:

  • The claim must be made within the time period set forth in 37 CFR 1.55(g).
  • A petition to accept an unintentionally delayed claim for priority must be filed.
  • The required fee must be paid.
  • A certified copy of the foreign application must be submitted.

The MPEP states: ‘A claim for priority under 35 U.S.C. 119(a)-(d) or (f) for the benefit of a prior foreign application may be made after the patent issues if the claim is accompanied by a grantable petition to accept an unintentionally delayed claim for priority.’

Yes, you can change the order of inventors’ names in a nonprovisional patent application filed on or after September 16, 2012. According to MPEP 602.01(c)(2):

37 CFR 1.48(f) … allows an applicant to adjust the order of the names of joint inventors (e.g., to control the order of names on a printed patent).

To change the order of inventors’ names, you must:

  • Submit an application data sheet (ADS) in accordance with 37 CFR 1.76 that lists the inventors in the desired order.
  • Pay the processing fee set forth in 37 CFR 1.17(i).

Note that this procedure is not applicable to provisional applications, as they do not become published applications or patents.

To learn more:

Can I change my entity status during the patent application process?

Yes, you can change your entity status during the patent application process. The MPEP 509.03 states:

“Small entity status may be claimed in a pending application at any time before, or concurrently with, the payment of an issue fee.”

This means you can:

  • Change from standard to small entity status
  • Change from small entity to standard status
  • Claim micro entity status if you qualify

To change your status, you must file a new written assertion of the desired status. Keep in mind that if you change to a higher fee status (e.g., from small to standard), you may need to pay any fee deficiencies for previously paid fees at the lower rate.

To learn more:

Tags: USPTO fees

No, you cannot amend the specification to refer to a Continued Prosecution Application (CPA) as a continuation of a prior application. The USPTO explicitly denies such amendments. As stated in MPEP ¶ 2.34:

The amendment filed [date] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [continuation/divisional] application of Application No. [X] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.

This means that the act of filing a CPA automatically establishes the necessary reference to the prior application, making any specification amendment unnecessary and prohibited.

For more information on CPA, visit: CPA.

Tags: CPA

No, you cannot amend the specification of a Continued Prosecution Application (CPA) to reference the prior application. The USPTO explicitly states that such amendments are not necessary and will not be entered.

As per MPEP ¶ 2.34: “Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This policy simplifies the process and ensures consistency across CPA filings.

No, you cannot amend the specification of a Continued Prosecution Application (CPA) to refer to it as a continuation or divisional application. According to MPEP § 201.06(d):

“The amendment filed [date] requesting that the specification be amended to refer to the present Continued Prosecution Application (CPA) as a [continuation/divisional] application of Application No. [X] has not been entered. As set forth in 37 CFR 1.53(d)(7), a request for a CPA is the specific reference required by 35 U.S.C. 120 to every application assigned the application number identified in such request. Thus, there is no need to amend the first sentence(s) of the specification to refer back to the prior application and any such amendment shall be denied entry.”

This means that the CPA request itself serves as the required reference to the prior application, and no additional amendment to the specification is necessary or allowed.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on Divisional application, visit: Divisional application.

Can I add working examples to my patent application after filing?

Adding working examples to a patent application after filing is generally not permitted if they constitute new matter. According to MPEP 608.04:

“An amendment to the claims or the addition of a new claim must be supported by the description of the invention in the application as filed. In re Wright, 866 F.2d 422, 9 USPQ2d 1649 (Fed. Cir. 1989).”

This means that any working examples added after filing must be fully supported by the original disclosure. If the examples contain information not inherently or implicitly present in the original filing, they will be considered new matter and may be rejected.

However, you may be able to add working examples if:

  • They only elaborate on principles already described in the original application
  • They demonstrate results that are inherent to the invention as originally disclosed
  • They do not introduce any new characteristics or properties not previously mentioned

It’s always best to include comprehensive working examples in the initial filing to avoid potential new matter issues later in the prosecution process.

To learn more:

To learn more:

Tags: new matter

The MPEP ¶ 2.32 specifically addresses the process of deleting named inventors when filing a Continued Prosecution Application (CPA) for design patents. However, it does not explicitly mention adding or substituting inventors at the time of CPA filing.

If you need to add or substitute inventors, rather than just delete them, you should follow the general procedures for correction of inventorship outlined in 37 CFR 1.48. This regulation provides the requirements for adding, deleting, or substituting inventors in patent applications.

It’s advisable to consult with a patent attorney or contact the USPTO directly for guidance on the proper procedure for adding or substituting inventors when filing a CPA, as this may require additional documentation or fees beyond a simple deletion request.

For more information on CPA, visit: CPA.

For more information on inventorship, visit: inventorship.

For more information on patent procedure, visit: patent procedure.

When submitting omitted drawings to a patent application, it’s crucial to understand that you cannot add new matter. The MPEP 601.01(f) states:

“If omitted drawing(s) are filed, the application will be given a filing date as of the date of such filing, provided the submitted drawing(s) do not add new matter to the originally filed application.”

This means that the drawings you submit must only illustrate what was already described in the original application’s specification. Adding new features or details not previously disclosed would be considered new matter and could result in the loss of your original filing date or rejection of the added material.

To learn more:

To learn more:

Tags: new matter

The MPEP ¶ 2.32 specifically addresses the deletion of inventors in a Continued Prosecution Application (CPA) for design patents, but it does not directly discuss adding inventors. However, changes to inventorship in patent applications are generally governed by 37 CFR 1.48.

If you need to add an inventor when filing a CPA, it’s advisable to:

  • Include a clear statement requesting the addition of the new inventor
  • Provide the new inventor’s oath or declaration
  • Submit any required fees

For specific guidance on adding inventors to a CPA, it’s recommended to consult with a patent attorney or contact the USPTO directly, as the process may differ from deleting inventors and could require additional documentation.

For more information on patent procedure, visit: patent procedure.

No, you cannot add an incorporation by reference statement when submitting a benefit claim after the initial filing of your application. The MPEP clearly states:

When a benefit claim is submitted after the filing of an application, the reference to the prior application cannot include an incorporation by reference statement specifying of the prior application unless an incorporation by reference statement specifying of the prior application was presented upon filing of the application.

This rule is based on the principle that no new matter can be added to an application after its filing date, as per 35 U.S.C. 132(a). The MPEP cites the case of Dart Indus. v. Banner, 636 F.2d 684, 207 USPQ 273 (C.A.D.C. 1980) to support this position.

Therefore, if you wish to include an incorporation by reference statement for a prior application, it must be present in the application as originally filed. If it wasn’t included at that time, you cannot add it later when submitting a benefit claim.

To learn more:

Yes, it is possible to add a priority claim to a patent after it has been issued, but the process requires filing a reissue application. The MPEP states:

‘A reissue application can be filed to correct the failure to adequately claim priority under 35 U.S.C. 119(a)-(d) or (f) or 35 U.S.C. 120 in the issued patent.’

To add a priority claim, you would need to:

  • File a reissue application under 35 U.S.C. 251
  • Amend the specification to include the required reference
  • Ensure the reissue application is filed within the time period set forth in 35 U.S.C. 119(a)-(d) or (f)

It’s important to note that adding a priority claim may affect the patent’s term and could potentially impact its validity if prior art emerges between the new priority date and the original filing date.

Can I add a benefit claim to a foreign priority application after filing?

Yes, you can add a benefit claim to a foreign priority application after filing, but specific procedures must be followed. According to MPEP 211.02(a):

“In the case of a design application, an original claim under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) to a prior U.S. application or PCT international application designating the United States may be made by the filing of an amendment to the specification within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior application.”

For utility applications, similar time frames apply. However, if you miss these deadlines, you must file a petition under 37 CFR 1.78 along with the petition fee to add the benefit claim. The petition must include:

  • The reference required by 35 U.S.C. 119(e) and 37 CFR 1.78 to the prior-filed application
  • A statement that the entire delay was unintentional
  • The petition fee set forth in 37 CFR 1.17(m)

It’s important to act promptly when adding or correcting benefit claims to avoid potential issues with patentability or patent term.

To learn more:

Yes, you can add a benefit claim after filing your patent application, but there are specific requirements and potential consequences:

  1. If added within the time period set by 37 CFR 1.78, you can submit a corrected Application Data Sheet (ADS) for applications filed on or after September 16, 2012, or an amendment to the specification or supplemental ADS for applications filed before that date.
  2. If added after the time period set by 37 CFR 1.78, you must file a petition under 37 CFR 1.78 and pay the petition fee. The petition must include:
    • The reference to the prior application
    • The petition fee
    • A statement that the entire delay was unintentional
  3. Depending on the application status, you may also need to file:
    • A Request for Continued Examination (RCE) if the application is under final rejection or allowed
    • A reissue application or request for a certificate of correction if the patent has already issued

As stated in MPEP 211.02(a): “When a benefit claim is submitted after the filing of an application, the reference to the prior application cannot include an incorporation by reference statement specifying of the prior application unless an incorporation by reference statement specifying of the prior application was presented upon filing of the application.”

It’s important to note that adding a benefit claim may affect the patent term and could introduce new prior art, so consider these factors carefully before proceeding.

To learn more:

Access to international application files at the USPTO is governed by specific rules. According to MPEP 103:

‘International applications that designate the U.S. and have been published in accordance with PCT Article 21(2) are generally open to public inspection and copying.’

This means:

  • Published international applications designating the U.S. are accessible
  • Access is available after the application’s international publication
  • Unpublished international applications are not open to public inspection

To access these files, you can use the USPTO’s Public PAIR system or visit the USPTO’s Public Search Facility.

For more information on international applications, visit: international applications.

For more information on public inspection, visit: public inspection.

Access to assignment records for unpublished patent applications is restricted. The MPEP states:

“For pending or abandoned applications which are not open to the public pursuant to 37 CFR 1.11 or for which copies or access may not be supplied pursuant to 37 CFR 1.14, information related thereto is only obtainable upon a proper showing of written authority.”

To access these records, you must have written authority from one of the following:

  • An inventor
  • The applicant
  • The assignee or an assignee of an undivided part interest
  • A patent practitioner of record
  • A person with written authority from any of the above

Alternatively, you must show that you are a bona fide prospective or actual purchaser, mortgagee, or licensee of the application.

Access to pending unpublished patent applications is generally restricted. However, according to 37 CFR 1.14(a)(1)(v) and (vi), there are some circumstances where a copy of the file contents or the application as originally filed may be provided:

  • If the benefit of the application is claimed under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) in an application that has been published or patented.
  • If the application is incorporated by reference or otherwise identified in a U.S. patent, statutory invention registration, U.S. patent application publication, international publication of an international application, or publication of an international registration designating the U.S.

In these cases, a written request must be submitted along with payment of the appropriate fee set forth in 37 CFR 1.19(b). The Office will not provide access to the paper file of a pending application, except under specific circumstances outlined in 37 CFR 1.14(c) or (i).

Yes, heirs can apply for a patent on behalf of a deceased inventor under certain circumstances. According to MPEP 409.01(b):

“Application may be made by the heirs of the inventor, as such, if there is no will or the will did not appoint an executor and the estate was under the sum required by state law for the appointment of an administrator.”

In such cases, the heirs should identify themselves as the legal representative of the deceased inventor in the oath or declaration submitted pursuant to pre-AIA 37 CFR 1.63 and 1.64. This allows heirs to proceed with the patent application process when no formal legal representative has been appointed.

To learn more:

Tags: pre-AIA

No, foreign universities do not qualify as ‘institutions of higher education’ for the purpose of establishing micro entity status. This is because the definition is limited to institutions located in U.S. states or territories.

According to MPEP 509.04(b): “As previously stated, foreign universities do not qualify as an ‘institution of higher education’ for purposes of establishing micro entity status.”

Even if a foreign university offers online programs in the U.S., it still doesn’t qualify because the institution itself must be physically located in a U.S. state or territory as defined in the Higher Education Act of 1965.

To learn more:

Tags: patent fees

Can foreign language assignment documents be recorded at the USPTO?

Yes, foreign language assignment documents can be recorded at the USPTO, but they must be accompanied by an English translation. The MPEP 302 states:

“Unless an assignment is in a language other than English, the Office may rely on the assignment document (or a copy thereof) as filed.”

If the assignment is in a foreign language, you must provide:

  • The original foreign language document
  • An English language translation
  • A statement verifying that the translation is accurate

This ensures that the USPTO can properly review and record the assignment, maintaining accurate ownership records for patents and patent applications.

For more information on patent assignment, visit: patent assignment.

For more information on translation requirements, visit: translation requirements.

For more information on USPTO, visit: USPTO.

Yes, foreign applicants can qualify for micro entity status if they meet all the requirements. The USPTO states in MPEP 509.04(a):

Small entities may claim reduced fees regardless of the country in which they are located. There is no restriction requiring that the person, small business concern, or nonprofit organization be located in the United States.

For applicants with income in foreign currency, 37 CFR 1.29(c) specifies: ‘If an applicant’s, inventor’s, joint inventor’s, or entity’s gross income in the preceding calendar year is not in United States dollars, the average currency exchange rate, as reported by the Internal Revenue Service, during that calendar year shall be used to determine whether the applicant’s, inventor’s, joint inventor’s, or entity’s gross income exceeds the threshold specified in paragraph (a)(3) or (4) of this section.’

No, for-profit universities do not qualify as ‘institutions of higher education’ for the purpose of establishing micro entity status. One of the requirements for an institution of higher education under the Higher Education Act of 1965 is that it must be non-profit.

MPEP 509.04(b) states: “One of the requirements for an ‘institution of higher education’ under section 101(a) of the Higher Education Act of 1965 is that the institution be non-profit. Therefore, for-profit universities and colleges do not qualify as an ‘institution of higher education’ for purposes of establishing micro entity status.”

This means that employees or those who have assigned rights to for-profit universities cannot claim micro entity status on this basis.

To learn more:

Tags: patent fees

Yes, filing unnecessary duplicate copies of patent correspondence can potentially cause processing delays at the USPTO. The MPEP 502.04 explicitly states:

When the Office does not require duplicate copies of a paper, the filing of multiple copies may cause a delay in processing by the Office.

This is one of the reasons why the USPTO discourages the submission of duplicate copies unless specifically required. To ensure efficient processing of your patent application or correspondence, it’s best to avoid submitting unnecessary duplicates.

To learn more:

Yes, failure to pay the issue fee can result in an abandoned patent application. MPEP 203.05 explicitly states that an abandoned application includes one removed from the Office docket for failure to pay the issue fee (MPEP § 711 to § 711.05). This means that even if an application has been approved for issuance, if the applicant fails to pay the required issue fee within the specified time frame, the application will be considered abandoned.

For more detailed information on this topic, you can refer to MPEP § 711 to § 711.05.

While the MPEP 602.08(c) provides specific guidelines for identifying patent applications, it does allow for exceptions in certain circumstances. The MPEP states:

Any variance from the above guidelines will only be considered upon the filing of a petition for waiver of the rules under 37 CFR 1.183 accompanied by a petition fee (37 CFR 1.17(f)).

This means that if you need to deviate from the standard identification requirements, you must:

The USPTO will then consider your petition and determine whether to grant an exception to the standard identification requirements. It’s important to note that such exceptions are not automatically granted and should only be sought in unusual circumstances where compliance with the standard requirements is not possible or would cause undue hardship.

To learn more:

Yes, examiners can initiate interview requests with patent practitioners of record. The MPEP encourages this practice to expedite prosecution:

The Office encourages the use of interviews to expedite prosecution. When the examiner believes the progress of the application would be advanced by an interview, the examiner may contact the patent practitioner of record in the application (in accordance with MPEP § 713) and suggest a telephonic, personal, or video conference interview.

This proactive approach by examiners can help clarify issues and potentially speed up the patent application process.

Can electronic copies of assignment documents be submitted for recording?

Yes, electronic copies of assignment documents can be submitted for recording at the USPTO. The MPEP 302.01 states: Any legible copies, including facsimile transmissions and computer generated copies, of original assignment documents will be acceptable for recording.

This means you can submit:

  • Scanned copies of original documents
  • Faxed copies
  • Computer-generated copies

The key requirement is that the electronic copy must be legible. Ensure that all text, signatures, and dates are clearly visible in the electronic copy. You can submit these electronic copies through the USPTO’s Electronic Patent Assignment System (EPAS) for efficient processing.

Can drawings or figures in a patent application introduce new matter?

Yes, drawings or figures can introduce new matter in a patent application. The MPEP 608.04 addresses this issue:

‘In establishing a disclosure, applicant may rely not only on the description and drawing as filed but also on the original claims if their content justifies it.’

This implies that:

  • Original drawings are part of the disclosure and can support claims.
  • However, new or amended drawings can potentially introduce new matter.
  • Changes to drawings that go beyond what was originally disclosed may be rejected as new matter.

For example, adding specific structural details to a figure that weren’t originally disclosed, or introducing new relationships between components, could be considered new matter. Applicants should be cautious when modifying drawings and ensure any changes are fully supported by the original disclosure.

To learn more:

Generally, no. According to MPEP 608.02(i), “Drawings cannot normally be transferred from a first pending application to another as the Office no longer considers drawings as formal or informal.” This means that each application typically requires its own set of drawings that comply with the specific requirements for that application.

To learn more:

Can drawings be amended after the application filing date without introducing new matter?

Amending drawings after the application filing date without introducing new matter is possible, but it requires careful consideration. According to MPEP 608.04(a):

‘An amendment to the drawings, however, which adds a feature not disclosed in the original drawings or specification involves new matter.’

This means that while you can make amendments to drawings, any new features or elements not disclosed in the original application will be considered new matter. Acceptable amendments typically include:

  • Correcting minor errors or inconsistencies
  • Improving clarity or resolution of existing features
  • Adding reference numbers or labels to existing elements

It’s crucial to ensure that any changes to drawings are fully supported by the original disclosure. If significant changes are needed that would introduce new matter, filing a continuation-in-part application may be necessary.

To learn more:

To learn more:

Can drawings be added to a patent application after the filing date?

According to MPEP 608.04(a), adding drawings to a patent application after the filing date is generally considered new matter. The MPEP states: “Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is new matter.” This includes new drawings. However, there are exceptions:

  • If the drawings merely depict what was already described in the original written description, they might be allowable.
  • Drawings may be accepted if they are clearly supported by the original disclosure and do not introduce new information.

It’s crucial to include all necessary drawings with the initial application to avoid potential new matter issues.

To learn more:

To learn more:

No, drawing objections cannot typically be held in abeyance in a patent application. According to 37 CFR 1.85(a):

Unless applicant is otherwise notified in an Office action, objections to the drawings in a utility or plant application will not be held in abeyance, and a request to hold objections to the drawings in abeyance will not be considered a bona fide attempt to advance the application to final action.

This means that applicants must address drawing objections in their response to an Office action. Failing to do so may result in the response being considered incomplete or non-responsive.

To learn more:

Yes, drawing corrections can be made after the application has been allowed. However, such corrections must be approved by the examiner before the application can be processed for issue. If extensive corrections are required, the examiner may require that the corrections be filed with a Request for Continued Examination (RCE) under 37 CFR 1.114.

Yes, adding or reversing directional arrows in patent drawings is one of the changes that can be made without requiring annotated sheets from the applicant. According to MPEP 608.02(w):

As a guide to the examiner, the following corrections are illustrative of those that may be suggested without requiring annotated sheets from the applicant: … (D) Adding or reversing directional arrows.

This provision allows examiners to suggest the addition or modification of directional arrows to improve the clarity and understanding of the drawings without necessitating a formal submission of annotated sheets by the applicant.

To learn more:

No, design patent applications cannot directly claim the benefit of a provisional application. The MPEP clearly states:

“Design applications may not claim the benefit of a provisional application under 35 U.S.C. 119(e).”

This restriction is based on 35 U.S.C. 172. However, there is a potential indirect way to claim some benefit:

If a design patent application claims benefit under 35 U.S.C. 120 to an intermediate nonprovisional utility patent application that directly claims the benefit of a provisional application, the design application cannot claim the benefit of the filing date of the provisional application.

This means that while a design application can’t directly benefit from a provisional application’s filing date, it may indirectly benefit from the disclosure in a nonprovisional utility application that claims priority to a provisional application.

To learn more:

No, design applications cannot claim the benefit of provisional applications under 35 U.S.C. 119(e).

MPEP 211.01(a) explicitly states: Design applications may not claim the benefit of a provisional application under 35 U.S.C. 119(e).

However, it’s important to note that while a design application cannot directly claim benefit of a provisional application, it may be possible to indirectly claim benefit through an intermediate utility application. The MPEP clarifies: Thus, where a design patent application claims benefit under 35 U.S.C. 120 to an intermediate nonprovisional utility patent application that directly claims the benefit of a provisional application, the design application cannot claim the benefit of the filing date of the provisional application.

To learn more:

Copyright notices may be included in patent applications under certain conditions:

  • The notice must be placed adjacent to the copyrighted material
  • The content must be limited to required legal elements
  • An authorization statement must be included in the specification
  • Notices in drawings must comply with 37 CFR 1.84(s)

As stated in 37 CFR 1.71(d): “A copyright or mask work notice may be placed in a design or utility patent application adjacent to copyright and mask work material contained therein. The notice may appear at any appropriate portion of the patent application disclosure. For notices in drawings, see § 1.84(s). The content of the notice must be limited to only those elements provided for by law.”

To learn more:

To learn more:

Generally, the USPTO does not provide copies of models or other physical exhibits. This policy is outlined in 37 CFR 1.95, which states:

Copies of models or other physical exhibits will not ordinarily be furnished by the Office, and any model or exhibit in an application or patent shall not be taken from the Office except in the custody of an employee of the Office specially authorized by the Director.

This means that while the original models or exhibits may be viewed at the USPTO under certain circumstances, obtaining copies or removing them from the Office is highly restricted. Applicants should maintain their own copies or documentation of any models or exhibits submitted as part of their patent application.

To learn more:

To learn more:

Tags: USPTO policy

No, color drawings cannot be submitted by facsimile to the USPTO. This is explicitly stated in MPEP 502.01 and 37 CFR 1.6(d)(4):

Facsimile transmissions are not permitted and, if submitted, will not be accorded a date of receipt in the following situations: … (4) Color drawings submitted under §§ 1.81, 1.83 through 1.85, 1.152, 1.165, 1.173, 1.437, or 1.1026;

The prohibition on faxing color drawings is due to the limitations of facsimile technology in accurately reproducing colors. Submitting color drawings via fax could result in loss of quality or details that are crucial for the proper examination and understanding of the invention.

If you need to submit color drawings for your patent application, you should use other approved methods, such as mailing or electronic filing through the USPTO’s electronic filing system (EFS-Web or Patent Center). Always refer to the most current USPTO guidelines for submitting color drawings to ensure compliance with their requirements.

To learn more:

Expungement of assignment records is extremely rare and does not result in the complete removal of a document from the assignment records. According to MPEP 323.01(d), petitions to expunge are granted only if:

  • Normal corrective procedures are inadequate
  • The integrity of assignment records won’t be affected

Even if granted, “the image of the recorded document will remain in the records of the Assignment Services Division at the same reel and frame number.” However, links to the specific application or patent will be deleted from the Assignment Historical Database. A redacted version of the ‘expunged’ document must be recorded in its place.

Yes, assignment records can be expunged after they have been recorded by the USPTO, but only through a specific petition process. According to MPEP 323.01(d):

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

This means that once an assignment record has been officially recorded, it cannot be simply removed or deleted. A formal petition must be filed, demonstrating that the document was submitted by mistake or is of improper character. The USPTO will then review the petition and make a determination on whether to expunge the record.

To learn more:

Yes, assignment records can be expunged even after a patent has been issued. The MPEP 323.01(d) states: ‘Expungement of any assignment records will be handled in accordance with 37 CFR 1.4(g). This may include expungement of documents recorded prior to, during, or after, prosecution of the application that matured into the patent.’ This means that the USPTO can consider expungement requests for assignment records at any stage, including after the patent has been granted.

To learn more:

Can assignment documents be submitted electronically to the USPTO?

Yes, assignment documents can be submitted electronically to the USPTO. The MPEP 302 states:

‘Assignment documents can be submitted to the Office in paper or electronically.’

The USPTO provides an electronic system for submitting assignment documents, which can be more convenient and efficient than paper submissions. However, it’s important to note that regardless of the submission method, the documents must meet all legal requirements and be properly executed to be considered valid.

For electronic submissions, users can utilize the Electronic Patent Assignment System (EPAS) provided by the USPTO. This system allows for quick and secure submission of assignment documents directly to the USPTO’s database.

For more information on assignment documents, visit: assignment documents.

For more information on electronic submission, visit: electronic submission.

For more information on EPAS, visit: EPAS.

For more information on USPTO, visit: USPTO.

Yes, arbitration awards in patent disputes can be modified under certain circumstances. According to 35 U.S.C. 294(c):

‘The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration.’

If an award is modified, the party requesting the modification must file a notice with the USPTO, as per 37 CFR 1.335(b).

No, an officer of an assignee corporation is not authorized to sign a certification of micro entity status. According to MPEP 509.04(c):

“If any applicant is an assignee or other party under 37 CFR 1.46, and the assignee or other party is a corporation or organization rather than a person, a registered practitioner must sign the certification of micro entity status. An officer of the assignee corporation, for example, is not authorized to sign a certification of micro entity status.”

This means that for corporate assignees, only a registered patent practitioner can sign the micro entity certification.

To learn more:

Can an oath or declaration from a provisional application be used for a nonprovisional application?

No, an oath or declaration from a provisional application cannot be used for a subsequent nonprovisional application. The MPEP 602.05 states:

‘The oath or declaration filed in a provisional application is not sufficient for the purposes of a nonprovisional application filed under 35 U.S.C. 111(a) or a national stage application filed under 35 U.S.C. 371, even if the nonprovisional application claims the benefit of the provisional application under 35 U.S.C. 119(e).’

This means that when converting a provisional application to a nonprovisional application or filing a nonprovisional application claiming priority to a provisional, a new oath or declaration must be submitted. This requirement ensures that the inventors properly declare their inventorship for the nonprovisional application, which may contain additional or modified content compared to the provisional application.

To learn more:

Yes, an oath or declaration can be filed after the application filing date. However, there are important considerations:

  • A surcharge may be required if the oath or declaration is not present on the filing date.
  • The application must be in condition for allowance before the oath or declaration is filed to avoid abandonment.
  • The oath or declaration must still comply with 37 CFR 1.63, even if filed after the application date.

As stated in MPEP 602.01(a): “If an oath or declaration in compliance with 37 CFR 1.63, or a substitute statement in compliance with 37 CFR 1.64, executed by or with respect to each inventor has not been submitted at the time of filing, the Office will send a Notice to File Missing Parts of Nonprovisional Application indicating that the application lacks the oath or declaration and give a period of time within which to file the oath or declaration.”

To learn more:

Can an inventor’s oath or declaration from a parent application be used in a divisional application?

Yes, an inventor’s oath or declaration from a parent application can often be used in a divisional application. According to MPEP 201.06(c):

‘In accordance with 37 CFR 1.63(d), a newly executed oath or declaration is not required in a divisional application filed under 37 CFR 1.53(b) if: (1) the divisional application claims are directed to subject matter disclosed in the prior-filed application; (2) a copy of the inventor’s oath or declaration from the prior-filed application is provided for the divisional application; and (3) the prior-filed application contains a statement by the applicant that any required oath or declaration, including any substitute statement under 37 CFR 1.64 or assignment-statement under pre-AIA 37 CFR 1.63(e), has been filed.’

This provision simplifies the filing process for divisional applications by allowing the reuse of the original oath or declaration, provided certain conditions are met. However, it’s important to ensure that all inventors named in the divisional application are covered by the oath or declaration from the parent application.

For more information on declaration, visit: declaration.

For more information on Divisional application, visit: Divisional application.

For more information on inventor’s oath, visit: inventor’s oath.

For more information on parent application, visit: parent application.

Yes, an inventor’s oath or declaration can be corrected, withdrawn, or replaced after submission. This is provided for in 35 U.S.C. 115(h)(1), which states:

Any person making a statement required under this section may withdraw, replace, or otherwise correct the statement at any time.

Additionally, 37 CFR 1.63(h) provides:

An oath or declaration filed at any time pursuant to 35 U.S.C. 115(h)(1) will be placed in the file record of the application or patent, but may not necessarily be reviewed by the Office.

This means that:

  • Inventors or applicants can submit corrections or replacements to oaths or declarations at any time
  • These corrected or replacement documents will be added to the application file
  • The USPTO may not necessarily review these additional submissions

However, it’s important to note that any request for correction of the named inventorship must comply with 37 CFR 1.48 in an application and 37 CFR 1.324 in a patent. These regulations provide specific procedures for correcting inventorship, which are separate from the process of correcting an oath or declaration.

To learn more:

Generally, an inventor’s oath or declaration should not be amended after signing. The MPEP clearly states:

The wording of an oath or declaration should not be amended, altered or changed in any manner after it has been signed.

If there are issues with the oath or declaration, the proper course of action is typically to submit a new one. As the MPEP notes:

If the wording is not correct or if all of the required affirmations have not been made, or if it has not been properly subscribed to, a new oath or declaration should be submitted.

However, in some cases, minor deficiencies can be corrected without submitting a new oath or declaration. For example, if the oath does not set forth evidence that the notary was acting within their jurisdiction at the time the oath is administered the oath, a certificate of the notary that the oath was taken within their jurisdiction will correct the deficiency.

To learn more:

Can an inventor’s attorney conduct an interview without a power of attorney?

Yes, an inventor’s attorney can conduct an interview without a power of attorney under certain conditions. The MPEP 405 provides guidance on this matter:

Interviews may be granted to an attorney or agent who is not of record in an application if the conditions of 37 CFR 1.33(b)(3) are satisfied.

This means that if the attorney or agent complies with the requirements set forth in 37 CFR 1.33(b)(3), they can conduct an interview even without a formal power of attorney. These requirements typically include providing evidence of their authority to act on behalf of the applicant.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO procedures, visit: USPTO procedures.

While inventors must use their legal names on patent applications, they can include preferred names or nicknames in a specific format. According to the MPEP 602.08(b):

Nicknames should be placed in quotation marks.

For example, if an inventor’s legal name is John Smith but he goes by ‘Jack’, the name on the patent application should be formatted as:

John “Jack” Smith

This approach allows the inventor to include their preferred name while still maintaining the legal requirements for the patent application.

To learn more:

No, an inventor cannot authorize another individual to act as their agent to sign the application oath or declaration on their behalf. The MPEP is clear on this point, stating: “An inventor may not authorize another individual to act as his or her agent to sign the application oath or declaration on his or her behalf.”

This prohibition is supported by legal precedents, as the MPEP cites: “Staeger v. Commissioner, 189 USPQ 272 (D.D.C. 1976), In re Striker, 182 USPQ 507 (Comm’r Pat. 1973).” These cases reinforce the requirement for the inventor’s personal signature on the oath or declaration.

To learn more:

Tags: pre-AIA

Yes, an international application can be used as a basis for priority in a U.S. national application. This is outlined in 35 U.S.C. 365(a), which states:

In accordance with the conditions and requirements of subsections (a) through (d) of section 119, a national application shall be entitled to the right of priority based on a prior filed international application which designated at least one country other than the United States.

It’s important to note that the international application must have designated at least one country other than the United States to be eligible as a basis for priority.

To learn more:

Yes, under 37 CFR 1.55(j), the requirement for a certified copy of the foreign application to be filed within the time limit set forth in 37 CFR 1.55(f) will be considered satisfied if:

  1. A copy of the original foreign application clearly labeled as “Interim Copy,” including the specification, and any drawings or claims upon which it is based, is filed in the Office together with a separate cover sheet identifying the foreign application and stating that the copy is a true copy of the original application as filed; and
  2. The copy of the foreign application and cover sheet are filed within the later of sixteen months from the filing date of the prior foreign application, four months from the actual filing date of an application under 35 U.S.C. 111(a), or four months from the date the national stage commenced under 35 U.S.C. 371(b) or (f) of an international application.

However, a certified copy of the foreign application must still be filed during the pendency of the application, unless filed with a petition under 37 CFR 1.55(e), (f), or (g) as appropriate. See MPEP 215.02(b).

No, an institution of higher education cannot itself claim micro entity status. The micro entity status based on an institution of higher education is intended for inventors who are employees of such institutions or who have assigned rights to them, not for the institutions themselves.

MPEP 509.04(b) clarifies: “Although the 37 CFR 1.29(d) basis for qualifying for micro entity status is referred to as the ‘institution of higher education’ basis, it is not the institution of higher education that can qualify for micro entity status, but rather inventors who are employees of an institution of higher education (see 37 CFR 1.29(d)(2)(i)) or inventors or applicants who have conveyed ownership rights to an institution of higher education (see 37 CFR 1.29(d)(2)(ii)).”

The institution itself cannot logically make the certifications required under the regulations, such as certifying that its employer is an institution of higher education or that it has assigned rights to itself.

To learn more:

Yes, an incomplete patent application can often be corrected, but the process and consequences depend on the specific deficiencies. While MPEP 203.06 doesn’t directly address corrections, it implies that applications lacking essential parts are incomplete:

An application that is not entitled to a filing date (e.g., for lacking some of the essential parts) is termed an incomplete application.

To correct an incomplete application:

  • Identify the missing components
  • Submit the missing parts as soon as possible
  • Pay any required fees
  • Be aware that the filing date may be adjusted to the date when all essential parts are received

It’s important to note that some deficiencies may result in the need to file a new application. Consult with a patent attorney or agent for specific guidance on your situation.

To learn more:

No, an Information Disclosure Statement (IDS) cannot be incorporated into the specification of a patent application. The MPEP clearly states:

The list of information complying with the format requirements of 37 CFR 1.98(a)(1) and the identification requirements of 37 CFR 1.98(b) may not be incorporated into the specification of the application in which it is being supplied, but must be submitted in a separate paper.‘ (MPEP 609.04(a))

The reasons for this requirement include:

  • To easily confirm that the applicant intends to submit an IDS
  • To provide a readily available checklist for the examiner
  • To provide a simple means of communication to the applicant regarding which documents have been considered

The MPEP recommends using form PTO/SB/08, Information Disclosure Statement, to list the documents. This separate submission ensures clear communication and proper processing of the IDS by the USPTO.

To learn more:

No, extensions of time for filing an Information Disclosure Statement (IDS) are not permitted under 37 CFR 1.136(a) or (b). However, if a bona fide attempt is made to comply with the content requirements of 37 CFR 1.98, but part of the required content is inadvertently omitted, additional time may be given to enable full compliance.

As stated in MPEP 609.04(b): No extensions of time for filing an information disclosure statement are permitted under 37 CFR 1.136(a) or (b). If a bona fide attempt is made to comply with the content requirements of 37 CFR 1.98, but part of the required content is inadvertently omitted, additional time may be given to enable full compliance.

To learn more:

No, an examiner’s objection to unlabeled prior art figures cannot be held in abeyance. The MPEP 608.02(g) clearly states that The objection to the drawings will not be held in abeyance.

This means that the applicant must address the objection in their response to the Office action. Failure to correct the labeling of prior art figures as requested may lead to further complications in the patent prosecution process, potentially including abandonment of the application if not addressed in a timely manner.

To learn more:

Can an examiner request copies of cited NPL documents not submitted with an IDS?

Yes, an examiner can request copies of cited Non-Patent Literature (NPL) documents that were not submitted with an Information Disclosure Statement (IDS) under certain circumstances:

  • If the NPL citation is incomplete or illegible, the examiner may request a legible copy.
  • If the NPL document is not readily available to the examiner, they may request a copy from the applicant.
  • The examiner should only request copies of documents that seem particularly relevant to the claimed invention.

According to MPEP 609.05(c): “The examiner may request copies of only those documents cited in the information disclosure statement that are not present in the Office’s files if the examiner believes the documents to be readily available.”

However, it’s important to note that: “The Office should not require copies of U.S. patents and U.S. patent application publications cited in an IDS, unless required by the first sentence of 37 CFR 1.98(d).”

To learn more:

Yes, patent examiners can make a preliminary determination about whether an application might qualify as a continuation-in-part (CIP). The MPEP ¶ 2.06 provides guidance for examiners, stating:

This form paragraph should only be used if it appears that the application may qualify as a continuation-in-part, but no benefit claim has been properly established.

Examiners typically look for the following indicators:

  • Substantial repetition of content from a prior application
  • Addition of new disclosure not present in the prior application
  • At least one common inventor with the prior application

However, it’s important to note that the final determination of an application’s status as a CIP depends on the applicant’s claims and proper benefit claims being established. Examiners may use this paragraph to alert applicants to the possibility of CIP status and the need to properly claim benefit if desired.

Can an attorney withdraw from patent representation without client consent?

While it’s generally preferable to obtain client consent, an attorney can withdraw from patent representation without client consent under certain circumstances. However, they must still follow proper procedures and notify the USPTO. The MPEP 402.06 states:

“The requirements for withdrawal of an attorney or agent are set forth in 37 CFR 1.36. The Office of Enrollment and Discipline (OED) handles withdrawal of entire firms.”

Key points to consider:

  • The attorney must provide notice to the client and the USPTO.
  • Reasons for withdrawal without consent may include ethical conflicts or non-payment of fees.
  • The USPTO may require the attorney to show good cause for withdrawal.
  • The withdrawal should not unduly prejudice the client’s interests.

Attorneys should consult 37 CFR 1.36 and applicable state bar rules when considering withdrawal without client consent.

To learn more:

Can an attorney withdraw from a patent application without the applicant’s consent?

Yes, an attorney can withdraw from a patent application without the applicant’s consent under certain circumstances. However, the withdrawal must be approved by the USPTO. The MPEP 402.06 states:

‘An attorney or agent may withdraw from representing an applicant or assignee in a patent application pending before the USPTO… When appropriate, the Office will require the applicant or assignee to revoke the previous power of attorney and appoint new attorney(s) of record.’

While the applicant’s consent is not explicitly required, the USPTO considers the following factors when deciding whether to approve a withdrawal:

  • The reasons for withdrawal
  • The stage of prosecution
  • The potential impact on the applicant

The USPTO may deny the withdrawal if it would unduly prejudice the applicant or delay the prosecution of the application.

To learn more:

No, an attorney cannot sign an oath or declaration on behalf of an inventor, even if they have been given power of attorney to do so. This rule applies to applications filed before September 16, 2012.

According to MPEP § 602.08(b), “The oath or declaration may not be signed by an attorney on behalf of the inventor, even if the attorney has been given a power of attorney to do so.” This is supported by legal precedents, including:

  • Opinion of Hon. Edward Bates, 10 Op. Atty. Gen. 137 (1861)
  • Staeger v. Commissioner of Patents and Trademarks, 189 USPQ 272 (D.D.C. 1976)
  • In re Striker, 182 USPQ 507 (PTO Solicitor 1973)

These cases affirm that an oath or declaration signed by an attorney on behalf of the inventor is defective unless the attorney has a proprietary interest in the invention.

To learn more:

Tags: declaration, oath

Yes, an attorney or agent of record can formally abandon your patent application. MPEP 203.05 states that an application can be abandoned:

“through formal abandonment by the applicant or by the attorney or agent of record”

This means that your authorized representative has the power to formally abandon your application. However, they should only do so with your consent or under specific circumstances outlined in their agreement with you. It’s important to maintain clear communication with your patent attorney or agent regarding the status and decisions related to your application.

To learn more:

The MPEP provides guidance on this matter. According to MPEP 602, “The language of 35 U.S.C. 115 and 37 CFR 1.66 is such that an attorney in the application is not barred from administering the oath as notary.” However, it’s important to note that this practice may be subject to local laws. The MPEP further states, “If such practice is permissible under the law of the jurisdiction where the oath is administered, then the oath is a valid oath.” Attorneys should be aware of their local jurisdiction’s rules before administering an oath for their client’s patent application.

To learn more:

Tags: oath

Yes, an assignment can serve as an inventor’s oath or declaration under certain conditions. According to 37 CFR 1.63(e):

An assignment may also serve as an oath or declaration required by this section if the assignment as executed: (i) Includes the information and statements required under paragraphs (a) and (b) of this section; and (ii) A copy of the assignment is recorded as provided for in part 3 of this chapter.

This provision implements 35 U.S.C. 115(e). To use an assignment as an oath or declaration:

  • The assignment must include all required information and statements of a standard oath or declaration
  • It must be executed by the inventor who is under the obligation of assignment
  • A copy of the assignment must be recorded with the USPTO

Applicants should use a check-box on the assignment cover sheet to indicate the dual purpose of the document.

To learn more:

Yes, for certain patent applications, an assignment can contain statements required in an oath or declaration. The MPEP 301 states:

‘For applications filed under 35 U.S.C. 111(a), 363, or 385 on or after September 16, 2012, an assignment may contain the statements required to be made in an oath or declaration (‘assignment-statement’), and if the assignment is made of record in the assignment records of the Office, then the assignment may be utilized as the oath or declaration.’

This provision allows for greater flexibility in meeting the oath or declaration requirements, particularly for assigned inventions. However, it’s important to ensure that the assignment contains all the necessary statements and is properly recorded with the USPTO.

For more information on oath or declaration, visit: oath or declaration.

For more information on patent assignment, visit: patent assignment.

Can an assignment be recorded electronically with the USPTO?

Yes, assignments can be recorded electronically with the USPTO. The MPEP 302 states:

“The USPTO provides for the electronic filing of patent assignment documents through the Electronic Patent Assignment System (EPAS).”

Electronic filing offers several advantages:

  • Faster processing times
  • Immediate confirmation of receipt
  • Reduced risk of errors in data entry
  • 24/7 accessibility

To use EPAS, users must have a USPTO.gov account and follow the specific guidelines for electronic submission. For detailed instructions, visit the Electronic Patent Assignment System (EPAS) on the USPTO website.

For more information on electronic filing, visit: electronic filing.

For more information on EPAS, visit: EPAS.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

Generally, an assignee cannot take action in a patent application if the assignment is not yet recorded in the USPTO. However, there is a specific provision for situations where the assignment has been executed but not yet recorded.

According to MPEP 324: If an assignment has not been recorded in the Office, the assignee may take action in a patent application under 37 CFR 3.73(b) by submitting a statement under 37 CFR 3.73(b) which is signed by a party authorized by the assignee.

This means that even if the assignment is not yet recorded, the assignee can still take action by:

  • Submitting a statement under 37 CFR 3.73(b)
  • Ensuring the statement is signed by an authorized party
  • Including a copy of the assignment document with the statement

However, it’s important to note that the assignment must still be recorded in the USPTO no later than the date of payment of the issue fee. Failure to record the assignment by this deadline could result in the loss of assignee rights.

For more information on assignee rights, visit: assignee rights.

Can an assignee revoke power of attorney in all types of patent applications?

An assignee’s ability to revoke power of attorney applies to most, but not all, types of patent applications. According to MPEP 402.07, there are specific scenarios where this is explicitly allowed:

“For applications involved in an interference or derivation proceeding, 37 CFR 41.5(b) or 42.10(e) provides that the assignee of the entire interest in an application or patent involved in the proceeding may act to the exclusion of the inventor. For national stage applications under 35 U.S.C. 371, the assignee may revoke any power of attorney of the applicant in the national stage application filed under 35 U.S.C. 371 and appoint any representative if the assignee has properly made itself of record in the national stage application pursuant to 37 CFR 3.71.”

This means assignees can revoke power of attorney in:

  • Applications involved in interference or derivation proceedings
  • National stage applications under 35 U.S.C. 371

For other types of applications, the general rule applies where the assignee must first become of record and then can revoke the applicant’s power of attorney. It’s important to consult with a patent attorney or agent for specific cases to ensure compliance with USPTO regulations.

To learn more:

In general, an assignee can revoke a power of attorney in most applications. However, there is an exception for certain government-owned applications. The MPEP states:

In applications filed before September 16, 2012, the assignee of record of the entire interest can revoke the power of attorney of the applicant unless an ‘irrevocable’ right to prosecute the application had been given as in some government owned applications.

This implies that in some government-owned applications, an irrevocable right to prosecute may have been granted, which would prevent the assignee from revoking the power of attorney. If you’re dealing with a government-owned application, it’s crucial to check whether such an irrevocable right exists before attempting to revoke a power of attorney.

To learn more:

Can an assignee revoke a power of attorney given by the applicant in a patent application?

Yes, an assignee can revoke a power of attorney given by the applicant in a patent application, provided certain conditions are met. According to MPEP 402.07:

“The assignee of the entire interest can revoke the power of attorney of the applicant and appoint its own patent practitioner.”

This is possible when:

  • The assignee has properly become of record pursuant to 37 CFR 3.71.
  • The application is involved in an interference or derivation proceeding.
  • The application is national stage application filed under 35 U.S.C. 371.

It’s important to note that the assignee must follow proper procedures and file the necessary documents with the USPTO to effectuate this change.

To learn more:

Yes, an assignee of the entire interest in a patent application can grant inspection rights to others. According to MPEP 106.01, the assignee of the entire interest has the same rights as the inventor and may authorize anyone to inspect the application. This authority stems from the assignee’s complete ownership of the patent application.

Yes, an assignee of part interest can file papers in a patent application even if it goes against the wishes of the inventor or other assignees. However, this is subject to the Commissioner’s discretion.

According to MPEP 106.01:

“Furthermore, the assignee of a part interest may prosecute the application to the exclusion of the inventor, and may file papers against the wishes of the inventor.”

This provision allows part interest assignees to protect their rights in the application, but the Commissioner retains authority to manage conflicts between parties.

To learn more:

No, an assignee of a part interest in a patent application cannot prevent other parties from accessing the application. According to MPEP 106, the assignee of a part interest may not control prosecution of the application to the exclusion of the inventor or other assignees. This means that all parties with an interest in the application have the right to access and inspect the application file.

The USPTO recognizes the rights of all interested parties and ensures that no single party can restrict access to the application information. This policy promotes transparency and fairness in the patent examination process.

No, an assignee of a part interest in a patent application cannot inspect the application without the consent of the inventor or other assignees. According to MPEP 106.01, the assignee of a part interest may not have access to the application file wrapper or be granted access to the subject matter of the application without the applicant’s consent. This restriction is in place to protect the interests of all parties involved in the patent application process.

No, an assignee of a part interest alone cannot file a reissue application. According to MPEP 1410, a reissue application must be applied for by all of the inventors, unless the application is accompanied by a petition under 37 CFR 1.182 for waiver of the requirement. Alternatively, the assignee of the entire interest can file the reissue application. An assignee of only a part interest is not entitled to file a reissue application on his or her own.

Can an assignee file a request to correct inventorship in a patent application?

Yes, an assignee can file a request to correct inventorship in a patent application. According to the MPEP, A request to correct or change the inventorship under 37 CFR 1.48(a) filed on or after September 16, 2012 may be signed by a patent practitioner of record or in compliance with 37 CFR 1.33(b), or by the applicant under 37 CFR 1.42. An assignee or obligated assignee who is the applicant may sign the request. This means that if the assignee is listed as the applicant on the application, they have the authority to file and sign the request for inventorship correction. For more details on who qualifies as an applicant, refer to MPEP 605.

To learn more:

Yes, for applications filed on or after September 16, 2012, an assignee can file a patent application as the applicant. According to MPEP § 409.05:

“An assignee or obligated assignee may file a patent application as the applicant. An assignee or obligated assignee doing so should record documentary evidence of ownership (e.g., assignment for an assignee, employment agreement for an obligated assignee) as provided for in 37 CFR part 3 no later than the date the issue fee is paid in the application.”

However, to be the sole applicant, the assignee must have been assigned the entire interest in the application.

For more information on patent applicant, visit: patent applicant.

Yes, an assignee can correct a typographical error in an assignment document, but the process depends on the availability of the assignor. According to MPEP 323.01(b):

If an assignor is not available to correct an original document or execute a new one, the assignee may submit an affidavit or declaration in which the assignee identifies the error and requests correction.

This means that:

  • If the assignor is available, they should make the correction or execute a new document.
  • If the assignor is not available, the assignee can submit an affidavit or declaration to correct the error.

The assignee must also provide a copy of the originally recorded papers, a cover sheet, and pay the required fee for each application or patent to be corrected, as per 37 CFR 3.41.

To learn more:

Yes, an assignee of record of the entire interest in a patent application can control access to it. According to MPEP 106, “The applicant or assignee of record of the entire interest in an application may file an application or intervene in the prosecution of the application, appointing an attorney or agent of his or her own choice.” This means that the assignee can manage the application’s prosecution and potentially limit access to it.

However, it’s important to note that “Such an application filing or intervention, however, does not exclude the inventor from access to the application to see that it is being prosecuted properly, unless the applicant or assignee makes specific request to that effect.” Any request to prevent the inventor’s access must be filed separately and directed to the Office of Petitions.

For more information on assignee rights, visit: assignee rights.

For more information on inventor access, visit: inventor access.

For more information on Office of Petitions, visit: Office of Petitions.

Yes, an assignee can conduct patent prosecution after attorney withdrawal under certain conditions:

  • The assignee must have originally appointed the withdrawing attorney or agent.
  • The assignee becomes recognized by the Office for all purposes in the application.
  • The assignee can sign amendments and other papers related to the prosecution.

The MPEP 402.06 states: ‘If the applicant is the assignee who appointed the withdrawing attorney or agent, the applicant may conduct the prosecution of the application, for example, by signing amendments and other papers related to the prosecution of the application.’

It’s important to note that while assignees can conduct prosecution, they may benefit from seeking new professional representation to navigate the complex patent process effectively.

To learn more:

An assignee’s ability to appoint a power of attorney in a patent application depends on whether the assignee is the applicant. According to the MPEP:

  • An assignee who is the applicant may appoint an effective power of attorney without the need to establish the right to take action under 37 CFR 3.71.
  • An assignee who is not the applicant may sign a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c), which requires compliance with 37 CFR 3.71 and 3.73.

As stated in the MPEP, “An assignee or obligated assignee who is the applicant may appoint an effective power of attorney without the need to establish the right to take action under 37 CFR 3.71.” However, “An assignee who is not the applicant may sign a power of attorney only if the assignee becomes the applicant per 37 CFR 1.46(c) (which requires compliance with 37 CFR 3.71 and 3.73).”

It’s important to note that an assignee who is not an applicant cannot revoke or appoint a power of attorney in a patent application without first becoming the applicant.

To learn more:

Yes, an arbitration award can be modified by a court, and this modification must be reported to the USPTO. The process is outlined in 35 U.S.C. 294(c) and 37 CFR 1.335(b):

  • If a court modifies an arbitration award, the party requesting the modification must file a notice with the USPTO.
  • The notice should be filed for each patent affected by the modification.
  • It must include the patent number, names of the inventor and patent owner, names and addresses of the arbitration parties, and a copy of the court’s order modifying the award.

As stated in 37 CFR 1.335(b): “If an award by an arbitrator pursuant to 35 U.S.C. 294 is modified by a court, the party requesting the modification must file in the Patent and Trademark Office, a notice of the modification for placement in the file of each patent to which the modification applies.”

This ensures that the USPTO’s records reflect the most current status of patent rights affected by arbitration and subsequent court decisions.

Yes, an application data sheet (ADS) can be used to correct certain information in a patent application. According to MPEP 603, deficiencies or inaccuracies due to the failure to meet the requirements of 37 CFR 1.63(b) in an oath or declaration may be corrected with an application data sheet in accordance with 37 CFR 1.76.

For example, an error in an inventor’s mailing address may be corrected with an application data sheet in accordance with 37 CFR 1.76.

However, it’s important to note that not all corrections can be made with an ADS. Specifically, any correction of inventorship must be pursuant to 37 CFR 1.48. This means that inventorship changes require a separate process and cannot be corrected solely through an ADS.

To learn more:

Can an application data sheet (ADS) be used to name the inventors in a patent application filed before September 16, 2012?

Yes, an application data sheet (ADS) can be used to name the inventors in a patent application filed before September 16, 2012. However, it’s important to note that the ADS is not the only way to name inventors, and there are specific rules governing this process.

According to MPEP 601.05(b):

“37 CFR 1.76(b)(1) states that the application data sheet must include the name, residence, and mailing address of each person believed to be an actual inventor. For nonprovisional applications filed before September 16, 2012, the naming of the inventorship is governed by 37 CFR 1.41(a)(1) in effect as of September 15, 2012.”

This means that while an ADS can be used to name inventors, the inventorship is ultimately determined by the rules set forth in 37 CFR 1.41(a)(1). It’s crucial to ensure that the inventor information provided in the ADS is consistent with other application documents, particularly the oath or declaration.

If there are any discrepancies, the oath or declaration will generally take precedence over the ADS for naming inventors in applications filed before September 16, 2012.

To learn more:

Yes, an Application Data Sheet (ADS) can be used to correct or update inventor information. The MPEP 601.05(a) states:

A corrected ADS may be submitted to correct or update information other than the inventorship. A corrected ADS correcting or updating information other than inventorship which is also reflected in the oath or declaration under 37 CFR 1.63 filed in a pending application must be accompanied by a request to correct or update the information under 37 CFR 1.48(c).

To correct inventorship, a request under 37 CFR 1.48(a) is required along with the corrected ADS. It’s important to follow the proper procedures to ensure the changes are accepted by the USPTO.

To learn more:

For applications filed before September 16, 2012 (pre-AIA applications), the Application Data Sheet (ADS) cannot be used to claim small entity status. According to MPEP 601.05(b):

The ADS cannot be used to make a small entity assertion, which must be done in a separate paper.

To claim small entity status in pre-AIA applications, applicants must submit a separate written assertion of entitlement to small entity status. This can be done through:

  • A specific written assertion of entitlement to small entity status
  • Payment of the small entity basic filing fee
  • Submission of a small entity written assertion in a related application

It’s important to note that for applications filed on or after September 16, 2012, the rules regarding small entity status claims have changed, and the ADS can be used for this purpose in those later applications.

To learn more:

Tags: ADS, pre-AIA

Yes, a nonprovisional application can be filed by reference to a previously filed application under certain conditions:

  • The application must be filed on or after December 18, 2013
  • A reference to the previously filed application must be made in an application data sheet
  • The reference must indicate that the specification and any drawings of the new application are replaced by the reference
  • The reference must specify the previously filed application by application number, filing date, and intellectual property authority

The USPTO states: As provided in 35 U.S.C. 111(c), a nonprovisional application filed under 35 U.S.C. 111(a) on or after December 18, 2013, may be filed by a reference to a previously filed application (foreign, international, provisional, or nonprovisional) indicating that the specification and any drawings of the application are replaced by the reference to the previously filed application.

However, the USPTO cautions: Accordingly, to avoid the risk of incorrect filings and the required surcharge, applicants should simply file a copy of the specification and drawings of the previously filed application, if available, instead of relying upon the reference filing provisions.

To learn more:

Yes, according to MPEP ¶ 2.05, an application can potentially be classified as both a continuation and a division. The MPEP states:

“Accordingly, this application may constitute a continuation or division.” (MPEP ¶ 2.05)

This dual classification possibility arises because:

  • A continuation application discloses and claims only subject matter from the prior application
  • A divisional application is filed as a result of a restriction requirement in the prior application
  • In some cases, an application may meet both criteria

The final determination of whether the application is a continuation, division, or both will depend on the specific circumstances of the application and its relationship to the prior application. The examiner will make this determination during the examination process.

For more information on continuation application, visit: continuation application.

For more information on Divisional application, visit: Divisional application.

Yes, an applicant can withdraw their authorization for email communication with the USPTO. According to MPEP 502.03:

‘A written authorization may be withdrawn by filing a signed paper clearly identifying the original authorization.’

The USPTO provides a sample form for withdrawing authorization:

‘The authorization given on______, to the USPTO to communicate with any practitioner of record or acting in a representative capacity in accordance with 37 CFR 1.33 and 37 CFR 1.34 concerning any subject matter of this application via video conferencing, instant messaging, or electronic mail is hereby withdrawn.’

To facilitate processing, the USPTO recommends using Form PTO/SB/439, available at www.uspto.gov/patent/patents-forms. This form can be filed via EFS-Web using the document description ‘Internet Communications Authorization Withdrawn’.

To learn more:

Can an applicant with a license agreement qualify for micro entity status?

Yes, an applicant with a license agreement can potentially qualify for micro entity status, but there are specific conditions that must be met. The MPEP provides guidance on this:

“An applicant is not considered to have been named on a previously filed application if the applicant has assigned, or is under an obligation to assign, all ownership rights in the application as the result of the applicant’s previous employment.” (MPEP 509.04(a))

However, it’s important to note that:

  • The license agreement must not transfer all substantial rights in the invention to a non-micro entity.
  • If the licensee is not a micro entity, the applicant may lose their micro entity status.
  • The applicant must still meet all other micro entity criteria, including income limitations and the four-application limit.

Applicants with license agreements should carefully review the terms of their agreements and consult with a patent attorney to determine if they still qualify for micro entity status.

To learn more:

Tags: micro entity

Yes, an applicant can submit omitted drawings after filing a patent application, but this will affect the application’s filing date. The process involves:

  1. Submitting the omitted drawings within two months of the OPAP notice
  2. Filing a petition under 37 CFR 1.182
  3. Paying the petition fee set forth in 37 CFR 1.17(f)
  4. Accepting the date of submission of the omitted drawings as the new application filing date

The MPEP states: An applicant desiring to submit the omitted drawing(s) in a nonprovisional application and accept the date of such submission as the application filing date must, within two months from the date of the OPAP notice, file any omitted drawing(s) and a petition under 37 CFR 1.182 with the petition fee set forth in 37 CFR 1.17(f), requesting the later filing date.

It’s important to note that for applications filed before September 16, 2012, the omitted drawings must be accompanied by an oath or declaration in compliance with pre-AIA 37 CFR 1.63 and pre-AIA 37 CFR 1.64.

To learn more:

Yes, an applicant can submit missing parts of an application after the filing date, but this may affect the application’s effective filing date. The MPEP 506 states:

Such portion must be filed within the time period set by the Office in the notification by the Office of the omitted portion, or the application will be regarded as abandoned.

It’s important to note that submitting missing parts may result in a later effective filing date for the application, which could have implications for patent term and prior art considerations. Applicants should strive to submit complete applications initially to avoid potential complications.

For more information on effective filing date, visit: effective filing date.

For more information on missing parts, visit: missing parts.

Yes, an applicant can submit a copy of an inventor’s oath or declaration from a prior application under certain conditions. According to MPEP 602.01(a):

An applicant may submit an inventor’s oath or declaration meeting the requirements of 35 U.S.C. 115 and 37 CFR 1.63 or 1.64 in an earlier-filed application, and submit a copy of such oath or declaration in a later-filed application that claims the benefit of the earlier application under 35 U.S.C. 120, 121, 365(c), or 386(c).

However, there are specific requirements for using a copy:

  • The oath or declaration from the earlier application must comply with the current requirements.
  • The copy must be accompanied by a statement requesting its use and confirming that the executed oath or declaration is still accurate.
  • The earlier application must be specifically referenced.

This provision can save time and effort in subsequent related applications, but applicants must ensure all conditions are met for the copy to be accepted.

To learn more:

Can an applicant postpone filing the inventor’s oath or declaration in a patent application?

Yes, an applicant can postpone filing the inventor’s oath or declaration in a patent application under certain conditions. According to MPEP 602.01(a):

“An applicant may postpone filing the inventor’s oath or declaration until the application is otherwise in condition for allowance if the applicant is an assignee or a person to whom the inventor is under an obligation to assign the invention.”

However, it’s important to note that the oath or declaration (or an acceptable substitute statement) must be filed no later than the date on which the issue fee is paid. If not filed by then, the application will be regarded as abandoned.

Note: This postponement option is only available for applications filed on or after September 16, 2012, under the America Invents Act (AIA).

To learn more:

Yes, an applicant can petition for rescission or modification of a Secrecy Order. The MPEP states:

Applicants may petition for rescission or modification of the Secrecy Order. For example, if the applicant believes that certain existing facts or circumstances would render the Secrecy Order ineffectual, they may informally contact the sponsoring agency to discuss these facts or formally petition the Commissioner for Patents to rescind the Order.

The process for petitioning is outlined in 37 CFR 5.4 and 5.5. Key points include:

  • Petitions must be filed in duplicate and recite facts that purport to render the order ineffectual or futile.
  • For modification to permit foreign filing, all countries and disclosees must be identified.
  • Appeals can be made to the Secretary of Commerce if a petition for rescission is denied.

Applicants should carefully consider the reasons for seeking rescission or modification and provide comprehensive information in their petition.

Can an applicant communicate directly with the USPTO if they have a registered patent attorney?

Generally, when an applicant is represented by a registered patent attorney or agent, direct communication between the applicant and the USPTO is discouraged. The USPTO has specific rules regarding this situation:

  • The USPTO will communicate directly with the registered attorney or agent of record.
  • Applicants should channel their communications through their appointed representative.
  • Direct communication from the applicant may not be officially recognized or acted upon by the USPTO.

MPEP 403.01 clearly states: “The Office will not engage in double correspondence with an applicant and a patent practitioner, or with more than one patent practitioner except as deemed necessary by the Director.” This policy ensures clear and efficient communication channels and prevents potential confusion or contradictory instructions. If an applicant wishes to communicate directly, they should first revoke the power of attorney or authorization of agent on record.

To learn more:

Can an applicant claim micro entity status based on income from a foreign country?

Yes, an applicant can claim micro entity status based on income from a foreign country. The MPEP clarifies:

“For purposes of qualifying for micro entity status based on the gross income limit, the gross income in the foreign currency must be converted into United States dollars at the exchange rate in effect on the date the micro entity certification is filed.”

This means that if you’re an applicant from a foreign country, you can still qualify for micro entity status if your income, when converted to U.S. dollars, does not exceed the gross income limit. It’s important to use the correct exchange rate on the date of filing your micro entity certification to ensure accurate calculation.

To learn more:

Tags: micro entity

Yes, an applicant can appoint two patent practitioners for the same application. However, when doing so, it’s important to specify the correspondence address. As stated in the MPEP:

“If the applicant simultaneously appoints two patent practitioners, applicant should indicate with whom correspondence is to be conducted by specifying a correspondence address.”

This ensures clear communication between the USPTO and the applicant’s representatives. For more details, refer to MPEP § 403, MPEP § 403.01(a), and MPEP § 403.01(b).

To learn more:

Yes, an applicant can appeal a secrecy order issued on their patent application. According to MPEP 120, “An appeal to the Secretary of Commerce, as provided by 35 U.S.C. 181, from a secrecy order cannot be taken until after a petition for rescission of the secrecy order has been made and denied.” This means that the applicant must first:

  1. Petition for rescission of the secrecy order
  2. If the petition is denied, then appeal to the Secretary of Commerce

The appeal process is governed by the provisions of 35 U.S.C. 181 and provides a mechanism for applicants to challenge the imposition of a secrecy order.

Can an applicant add examples or expand on the disclosure after filing a patent application?

Generally, applicants are not permitted to add new examples or expand on the disclosure after filing a patent application without risking a new matter rejection. The MPEP 608.04(a) states:

Matter not present on the filing date of the application in the specification, claims, or drawings that is added after the application filing date is usually new matter.

However, there are some limited circumstances where additions might be allowed:

  • Inherent characteristics: Information that is inherently present in the original disclosure may be added.
  • Well-known equivalents: Describing well-known equivalents of elements already disclosed might be acceptable.
  • Correction of obvious errors: Clear mistakes that would be apparent to one skilled in the art can sometimes be corrected.

It’s important to note that any additions must be carefully scrutinized and should not introduce new concepts or expand the scope of the invention beyond what was originally disclosed. Applicants should strive to include all necessary examples and details in the original filing to avoid potential new matter issues later in the prosecution process.

To learn more:

Tags: new matter

Adding drawings to a patent application after the filing date is possible but subject to certain restrictions. The MPEP states: no amendment may introduce new matter into the disclosure of an application after its filing date. However, there are some provisions for adding drawings in specific circumstances:

  • For applications filed on or after September 21, 2004, if drawings were inadvertently omitted and the application claims priority to a prior-filed application containing the drawings, the applicant may submit the omitted drawings by amendment under 37 CFR 1.57(b).
  • For applications filed before December 18, 2013, applicants may submit drawings and potentially accept a later filing date.
  • For applications filed on or after December 18, 2013, drawings can be added without changing the filing date, but they must not introduce new matter.

In all cases, adding drawings after the filing date requires careful consideration to ensure compliance with USPTO rules and avoid introducing new matter.

To learn more:

Yes, an Application Data Sheet (ADS) can be used to correct or update information in patent applications filed before September 16, 2012, but there are specific rules and timeframes to consider:

  • An ADS can be used to correct or update bibliographic data, especially if submitted within one month of the filing date.
  • After the one-month period, corrections may require additional documentation or fees.

According to MPEP 601.05(b): “If an application data sheet is submitted in a patent application under 37 CFR 1.53(b), the application data sheet will be treated as part of the application and will be used to capture the bibliographic data from the application data sheet. Bibliographic data contained in an application data sheet will govern when inconsistent with information provided by another document (e.g., the application transmittal letter).”

This means that the ADS takes precedence over other documents when it comes to bibliographic information. However, for significant changes after the initial filing, applicants may need to submit additional forms or follow specific procedures outlined by the USPTO.

To learn more:

Yes, an Application Data Sheet (ADS) can be used to correct or update information in a patent application. The MPEP 601.05 states:

‘An ADS may be submitted after the initial filing of the application to correct or update information in a previously submitted application data sheet, or in an oath or declaration under 37 CFR 1.63 or 1.67, except that inventorship changes are governed by 37 CFR 1.48, correspondence address changes are governed by 37 CFR 1.33(a), and citizenship changes are governed by 37 CFR 1.63 or 1.67.’

However, it’s important to note that:

  • Some changes, such as inventorship, correspondence address, and citizenship, are governed by specific regulations and may require additional procedures.
  • When submitting a corrected or updated ADS, applicants should clearly identify the information being changed relative to the most recent filing or ADS.
  • For applications filed on or after September 16, 2012, any changes to the ADS must be made in accordance with 37 CFR 1.76(c).

To learn more:

Tags: ADS

Yes, an abandoned application can still be used as a priority document for subsequent applications, provided that the priority claim is made within the specified time limits. The abandoned status of the earlier application does not affect its ability to serve as a basis for priority. For more information on priority claims, refer to MPEP 201 and MPEP 211.

Yes, an abandoned application can be used as prior art, but the extent of its use depends on several factors. Under MPEP 2127, abandoned applications that have been published can be used as prior art as of their publication date for all they teach. Unpublished abandoned applications may be available as prior art under certain circumstances, such as when they are incorporated by reference in a U.S. patent. It’s important to note that the abandonment status itself does not negate the application’s potential as prior art. For specific rules on using abandoned applications as prior art, consult MPEP 2127 and MPEP 901 on prior art.

Amendments can be made when filing a Continued Prosecution Application (CPA), but there are important restrictions and considerations:

  • Any changes must be made as an amendment to the prior application as it existed before filing the CPA
  • No new matter can be introduced in a CPA
  • Preliminary amendments filed with a CPA are generally entered, but could be denied entry if they unduly interfere with examination
  • New specifications filed with a CPA request are treated as substitute specifications and must comply with 37 CFR 1.125

The MPEP states: Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph. No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application.

Regarding preliminary amendments, the MPEP advises: Applicants are also encouraged to file all preliminary amendments at the time of filing a CPA because the entry of any preliminary amendment filed after the filing date of the CPA could be denied under 37 CFR 1.115 if the preliminary amendment unduly interferes with the preparation of a first Office action.

If more time is needed to prepare amendments, applicants can request a three-month suspension of action under 37 CFR 1.103(b) at the time of filing the CPA.

For more information on amendments, visit: amendments.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on patent applications, visit: patent applications.

Generally, amendments to a provisional application are not permitted after the filing date, except for those required to comply with applicable regulations. The MPEP clearly states:

Amendments, other than those required to make the provisional application comply with applicable regulations, are not permitted after the filing date of the provisional application. (MPEP 601.01(b))

This restriction helps maintain the integrity of the provisional application as a snapshot of the invention at the time of filing.

To learn more:

While amendments can be filed with a Continued Prosecution Application (CPA) request, there are important considerations and limitations. The MPEP states:

“Any new change must be made in the form of an amendment to the prior application as it existed prior to the filing of an application under this paragraph. No amendment in an application under this paragraph (a continued prosecution application) may introduce new matter or matter that would have been new matter in the prior application.”

Additionally:

  • Preliminary amendments filed with a CPA are generally entered
  • Applicants are encouraged to file any amendments at the time of filing the CPA to avoid potential delays
  • Any new matter introduced will be required to be canceled
  • Claims relying on new matter may be rejected under 35 U.S.C. 112(a)

The MPEP advises: “Applicants are strongly encouraged to file any preliminary amendment in a CPA at the time the CPA is filed. See 37 CFR 1.115 and MPEP § 714.03(a).”

For more information on continuation application, visit: continuation application.

For more information on design patent, visit: design patent.

For more information on new matter, visit: new matter.

Yes, in certain circumstances, alternative forms can be used instead of an Application Data Sheet (ADS) to provide some of the required information:

  • Patent Law Treaty Model International Forms can be used for certain information.
  • The Patent Cooperation Treaty Request Form can be used in some cases for national stage applications.

37 CFR 1.76(f) states: “The requirement in § 1.55 or § 1.78 for the presentation of a priority or benefit claim under 35 U.S.C. 119, 120, 121, or 365 in an application data sheet will be satisfied by the presentation of such priority or benefit claim in the Patent Law Treaty Model International Request Form.”

However, it’s important to note that if an ADS is also submitted, the information in the ADS will generally govern when inconsistent with these alternative forms. Additionally, an ADS is still required in certain situations, such as when postponing submission of the inventor’s oath or declaration.

To learn more:

Yes, additional correct documents can be recorded after an assignment record is expunged. The MPEP 323.01(d) states:

An additional assignment of the ‘correct’ document may be recorded in addition to the redacted version where the redacted version is incomplete or the original document was not correct.

This provision allows for the recording of accurate and complete information when:

  • The redacted version of the expunged document is incomplete
  • The original document contained errors or inaccuracies

This process ensures that the assignment records contain the most accurate and up-to-date information possible, even after an expungement procedure has been completed.

To learn more:

Yes, adding specific percentages to a broader original disclosure can be considered new matter. The MPEP section 608.04(a) states:

New matter includes not only the addition of wholly unsupported subject matter, but may also include adding specific percentages or compounds after a broader original disclosure, or even the omission of a step from a method.

For guidance on determining whether such additions constitute new matter, the MPEP refers to MPEP § 2163.05. It’s important for applicants to ensure that any specific percentages added are inherently supported by the original disclosure.

To learn more:

Tags: new matter

Can a withdrawn attorney continue to receive Office communications for a patent application?

No, a withdrawn attorney should not continue to receive Office communications for a patent application. The MPEP 402.06 clearly states:

“An attorney or agent withdrawing from an application who wishes to cease receiving copies of communications from the Office must submit a request that the correspondence cease.”

This means that unless the withdrawn attorney explicitly requests to stop receiving communications, they may continue to receive them. However, it’s important to note that the withdrawn attorney is no longer authorized to act on behalf of the application. To ensure proper handling of the application, the withdrawn attorney should request that correspondence cease, and the applicant or new representative should update the correspondence address with the USPTO.

To learn more:

Can a US national application claim benefit of an international application that entered national stage in another country?

Yes, a U.S. national application can claim the benefit of an international application that entered the national stage in another country, as long as certain conditions are met. The MPEP provides guidance on this:

“A U.S. national application may claim benefit under 35 U.S.C. 120 and 365(c) to an international application which designates at least one country other than the United States only if the international application has been accorded an international filing date and meets the requirements of 35 U.S.C. 371(c).”

This means that for a U.S. application to claim benefit from an international application that entered the national stage elsewhere, the international application must:

  • Have an international filing date
  • Designate at least one country other than the United States
  • Meet the requirements of 35 U.S.C. 371(c)

It’s important to note that the benefit claim is made under both 35 U.S.C. 120 (for continuing applications) and 35 U.S.C. 365(c) (for international applications).

To learn more:

Yes, a U.S. applicant can claim priority from a provisional application filed in a foreign country, provided certain conditions are met. The MPEP 213 states:

An applicant may claim the right of priority based on a prior foreign application under the Paris Convention and 35 U.S.C. 119(a)-(d) whether the foreign application is an application for a patent or for the registration of a utility model or an industrial design.

Key points to consider:

  • The foreign country must be a recognized country or regional patent office as listed in MPEP 213.01.
  • The provisional application must be the first filing of the invention in any country.
  • The U.S. application must be filed within 12 months of the foreign provisional filing date.
  • The applicant must comply with all requirements for claiming priority, including submitting a certified copy of the foreign application.

It’s important to note that not all countries have provisional application systems, so the term ‘provisional’ may have different meanings in different jurisdictions. Always consult with a patent attorney or agent for specific advice on international priority claims.

No, a third party or its representative cannot use the provisions of 37 CFR 1.34 to conduct an interview or take other actions not specifically permitted by the rules of practice. MPEP 405 states:

The use of the provisions of 37 CFR 1.34 by a third party or its representative to conduct an interview, or take other action not specifically permitted by the rules of practice in an application for patent, is considered a violation of 37 CFR 11.18 and may result in disciplinary action if done by a practitioner.

This means that attempting to use 37 CFR 1.34 for unauthorized actions could lead to disciplinary consequences for registered practitioners.

Generally, third parties are not permitted to conduct interviews or take actions in patent applications. The MPEP clearly states:

The use of the provisions of 37 CFR 1.34 by a third party or its representative to conduct an interview, or take other action not specifically permitted by the rules of practice in an application for patent, is considered a violation of 37 CFR 11.18 and may result in disciplinary action if done by a practitioner.

This means that only authorized representatives (such as registered attorneys or agents with proper authorization) can conduct interviews or take actions on behalf of the applicant. Third parties attempting to do so may face disciplinary action, especially if they are registered practitioners.

For more information on disciplinary action, visit: disciplinary action.

For more information on patent interviews, visit: patent interviews.

No, a suspended or excluded practitioner cannot inspect patent applications. According to MPEP 105, “Power to inspect given to such an attorney or agent will not be accepted.” This means that the USPTO will not allow suspended or excluded practitioners to access or review patent applications, even if they are given permission by the applicant.

To learn more:

No, a suspended or excluded practitioner is not permitted to receive correspondence from the USPTO regarding patent applications. According to MPEP 407:

A suspended or excluded practitioner is not entitled to receive correspondence from the Office, or have interviews with examiners, in applications or patents.

The USPTO takes the following steps to ensure compliance:

  • Correspondence will be sent to the applicant or assignee at their address of record.
  • If no practitioner is of record, the correspondence will be sent directly to the applicant or assignee.
  • Examiners are instructed not to hold interviews with suspended or excluded practitioners.

For more information on USPTO correspondence, visit: USPTO correspondence.

Yes, supplemental oaths and declarations covering the claims in a patent application can be filed after allowance. The Manual of Patent Examining Procedure (MPEP) states:

“Supplemental oaths and declarations covering the claims in the application may be filed after allowance as a matter of right.”

This means that applicants have the right to submit additional oaths or declarations even after their patent application has been allowed.

To learn more:

Can a substitute statement be filed in a provisional application?

No, a substitute statement cannot be filed in a provisional application. According to MPEP 604:

“A substitute statement is not available for provisional applications because provisional applications do not require an inventor’s oath or declaration.”

Provisional applications have different requirements compared to non-provisional applications. They are primarily used to establish an early filing date and do not require formal claims, oath, or declaration. Therefore, there is no need for a substitute statement in provisional applications.

To learn more:

The qualification of a subsidiary for small entity status depends on several factors. According to the MPEP:

A business concern or organization is affiliates of another concern or organization if, directly or indirectly, either one controls or has the power to control the other, or a third party or parties controls or has the power to control both.

This means that:

  • If a subsidiary is controlled by a large entity, it generally cannot claim small entity status.
  • The control can be direct (e.g., majority ownership) or indirect (e.g., through contractual arrangements).
  • Even if the subsidiary meets the size standards on its own, affiliation with a large entity typically disqualifies it from small entity status.

However, there may be exceptions in complex corporate structures. It’s advisable to consult with a patent attorney to evaluate your specific situation and determine eligibility for small entity status.

To learn more:

Yes, a sole inventor can file a continuation-in-part (CIP) application based on an earlier application with joint inventors, provided certain conditions are met. The MPEP 201.08 states:

“A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78.”

This situation might occur when one of the joint inventors from the original application independently develops additional subject matter. The key requirements are:

  • The CIP must meet all other conditions of 35 U.S.C. 120 and 37 CFR 1.78.
  • The sole inventor must be one of the joint inventors named in the prior application.
  • The CIP should contain new matter not disclosed in the prior application.

It’s important to ensure proper attribution and compliance with all USPTO requirements when filing such a CIP.

For more information on joint inventors, visit: joint inventors.

Can a small business qualify for micro entity status?

Yes, a small business can potentially qualify for micro entity status, but there are specific requirements to meet. The MPEP outlines two main paths for small businesses:

  1. Income-based qualification: If the small business’s income does not exceed three times the median household income in the preceding calendar year, it may qualify.
  2. Institution of higher education qualification: If the small business has assigned, granted, conveyed, or is under obligation to assign, grant, or convey a license or other ownership interest in the application to an institution of higher education.

The MPEP states:

“An applicant that qualifies as a micro entity under either the gross income basis or the institution of higher education basis can file a certification of micro entity status on either basis (but not both).”

It’s important to note that all parties involved (applicants, inventors, and joint inventors) must meet the requirements. For more details, refer to MPEP 509.04.

To learn more:

To learn more:

Yes, a secrecy order can be appealed or reviewed. The MPEP 120 states: “A petition for rescission or modification of the secrecy order may be filed at any time.” Here’s what you need to know about the appeal process:

  • The petition should be filed with the Patent and Trademark Office (PTO)
  • It must include full statements of all facts and circumstances upon which the petition is based
  • The petition will be referred to the appropriate agency for consideration and recommendation
  • Based on the recommendation, the Commissioner for Patents will make the final decision

If the secrecy order is not rescinded, the applicant may seek further review through legal channels, such as filing a claim in the United States Court of Federal Claims.

Can a secrecy order be appealed or challenged?

Yes, a secrecy order can be appealed or challenged. The MPEP 120 states: “A petition for rescission or modification of the secrecy order may be filed by the principal inventor, any of the joint inventors, or the assignee.” This means that:

  • The principal inventor
  • Any joint inventors
  • The assignee of the patent application

can file a petition to challenge or seek modification of a secrecy order. The petition should be directed to the Commissioner for Patents and should include supporting reasons for the requested rescission or modification. It’s important to note that while an appeal is possible, secrecy orders are typically issued for national security reasons, so the process of challenging them can be complex and may require careful consideration of security implications.

Yes, a request for issuance to an assignee can be submitted after the issue fee is paid, but additional requirements apply:

  1. The request must state that the assignment was submitted for recordation before patent issuance.
  2. It must include a request for a certificate of correction under 37 CFR 1.323.
  3. The appropriate fees must be paid, including the certificate of correction fee and a processing fee.

37 CFR 3.81(b) states: Any request for issuance of an application in the name of the assignee submitted after the date of payment of the issue fee, and any request for a patent to be corrected to state the name of the assignee, must state that the assignment was submitted for recordation as set forth in § 3.11 before issuance of the patent, and must include a request for a certificate of correction under § 1.323 of this chapter (accompanied by the fee set forth in § 1.20(a)) and the processing fee set forth in § 1.17(i) of this chapter.

Yes, a reissue application can be used to correct inventorship. The MPEP 201.05 states: ‘A reissue application may also be filed to correct inventorship in the patent. The reissue oath or declaration must state that the applicant believes the original patent to be wholly or partly inoperative or invalid by reason of the incorrect inventorship.’

This means that if the original patent listed incorrect inventors or omitted inventors who should have been included, a reissue application can be filed to rectify this error. However, it’s important to note that:

  • The error in inventorship must have been made without deceptive intent.
  • The reissue application must be accompanied by a proper reissue oath or declaration explaining the error.
  • All current patent owners must consent to the reissue application.

Correcting inventorship through a reissue application is governed by 35 U.S.C. 251 and the procedures outlined in the MPEP.

To learn more:

Yes, registered patent practitioners can file papers in patent applications and reexamination proceedings without being of record. MPEP 405 states:

Papers may be filed in patent applications and reexamination proceedings by registered attorneys or agents not of record under 37 CFR 1.34. Filing of such papers is considered to be a representation that the attorney or agent is authorized to act in a representative capacity on behalf of applicant.

This means that by filing papers, the practitioner is implicitly stating they have authorization to act on behalf of the applicant, even if they are not officially recorded as the attorney or agent of record.

Yes, a reference to a prior application can be added after filing, but there are specific procedures and limitations to be aware of. According to MPEP 211.02:

If an applicant includes a reference to a prior application elsewhere in the application but not in the first sentence(s) of the specification, and the application is otherwise complete, OPAP will mail a ‘Notice to File Missing Parts’ giving the applicant an opportunity to correct the reference to the prior application. If the application is otherwise incomplete, OPAP will mail a Notice to File Missing Parts, and the applicant can amend the specification to include the reference to the prior application in addition to completing the application.

However, it’s important to note that adding a reference to claim priority benefits has strict time limitations. As per MPEP 211.03:

A petition under 37 CFR 1.78 and the petition fee would be required to add or correct a reference to a prior application in an application after expiration of the time period set in 37 CFR 1.78(a)(4), (b)(3), (c)(3), or (e)(4).

Therefore, while it’s possible to add or correct a reference after filing, it’s always best to include the correct reference in the initial filing to avoid potential complications or the need for petitions.

To learn more:

No, a provisional patent application cannot claim priority to or benefit from other applications. The MPEP 201.04 clearly states:

“A provisional application is not entitled to the right of priority under 35 U.S.C. 119, 365(a), or 386(a) or § 1.55, or to the benefit of an earlier filing date under 35 U.S.C. 120, 121, 365(c), or 386(c) or § 1.78 of any other application.”

This means that a provisional application stands alone and cannot claim the filing date of any earlier U.S. or foreign application. However, it’s important to note that while a provisional application cannot claim priority, it can serve as a priority document for later-filed nonprovisional or foreign applications, provided they are filed within 12 months of the provisional application’s filing date.

To learn more:

Yes, a provisional patent application can be converted to a nonprovisional application. According to MPEP 201.04:

“A provisional application filed under paragraph (c) of this section may be converted to a nonprovisional application filed under paragraph (b) of this section and accorded the original filing date of the provisional application.”

However, there are specific requirements and considerations for this conversion:

  • The request for conversion must be accompanied by the fee set forth in 37 CFR 1.17(i)
  • An amendment including at least one claim as prescribed by 35 U.S.C. 112(b) must be submitted
  • The request must be filed before the abandonment of the provisional application or the expiration of 12 months after its filing date
  • Additional fees for nonprovisional applications will be required

It’s important to note that converting a provisional to a nonprovisional application may result in a shorter patent term. Therefore, filing a new nonprovisional application claiming the benefit of the provisional application under 35 U.S.C. 119(e) is often preferable.

To learn more:

Can a provisional application claim the benefit of an earlier application?

No, a provisional application cannot claim the benefit of an earlier-filed application. This is explicitly stated in MPEP 211.01(a):

“A provisional application is not entitled to the benefit of the filing date of an earlier filed application under 35 U.S.C. 119, 120, 121, 365, or 386.”

This means that a provisional application stands on its own and cannot extend its effective filing date by claiming priority to any earlier application, whether it’s another provisional, a nonprovisional, or a foreign application. The purpose of a provisional application is to establish an early filing date for a subsequent nonprovisional application, not to claim priority to earlier filings.

To learn more:

Can a provisional application be used as a prior-filed application for benefit claims?

Yes, a provisional application can be used as a prior-filed application for benefit claims in certain circumstances. According to MPEP 211.01:

‘The prior application may be a provisional application under 35 U.S.C. 111(b) or a nonprovisional application under 35 U.S.C. 111(a).’

However, there are specific requirements and limitations when claiming the benefit of a provisional application:

  • The nonprovisional application must be filed within 12 months of the provisional application’s filing date (or 14 months with a grantable petition under 37 CFR 1.78(b)).
  • The provisional application must adequately support and enable the subject matter of the claims in the nonprovisional application.
  • The specific reference to the provisional application must be included in an application data sheet (ADS) or the first sentence of the specification.

It’s important to note that while a nonprovisional application can claim the benefit of a provisional application, a provisional application cannot claim the benefit of or priority to any other application.

To learn more:

Can a provisional application be published?

No, provisional applications are not published. The MPEP clearly states: ‘A provisional application is not entitled to the right of priority under 35 U.S.C. 119 or 365(a) or 365(b); is not entitled to the benefit of the filing date of a prior application under 35 U.S.C. 119(e) or 120; and will not be published or examined.’ This means:

  • Provisional applications remain confidential
  • They are not made available to the public
  • No patent document is published based solely on a provisional application

For more information on provisional applications, visit the MPEP 201.04 section.

For more information on patent examination, visit: patent examination.

For more information on provisional application, visit: provisional application.

No, provisional applications are not published or made public by the USPTO. According to MPEP 201.04:

A provisional application is not subject to publication and is not published.

This confidentiality can be advantageous for inventors who want to secure a filing date while keeping their invention details private. However, it’s important to note that while the USPTO doesn’t publish provisional applications, the content may become public if referenced in a later-published nonprovisional application claiming its benefit.

For more information on provisional application, visit: provisional application.

Yes, a provisional application can be filed without claims. The MPEP 201.04 states:

A provisional application must also include the filing fee as set forth in 37 CFR 1.16(d) and a cover sheet identifying the application as a provisional application. Otherwise, the application will be treated as a nonprovisional application. The filing date of a provisional application is the date on which a specification as prescribed by 35 U.S.C. 112(a), and any drawing required by 37 CFR 1.81(a) are filed in the United States Patent and Trademark Office. No claims are required.

While claims are not required for a provisional application, it’s important to provide a comprehensive description of the invention to ensure adequate support for any claims in a subsequent nonprovisional application.

For more information on provisional application, visit: provisional application.

Yes, a provisional application can be filed without an oath or declaration. According to MPEP 601.01(b):

Quote: “A provisional application does not require a claim or oath or declaration.”

This is one of the key differences between provisional and nonprovisional applications. The simplified filing requirements for provisional applications make them a useful tool for quickly establishing a priority date. However, it’s important to remember that:

  • A provisional application cannot mature into a patent
  • To claim the benefit of a provisional application, a nonprovisional application must be filed within one year

When filing the subsequent nonprovisional application, an oath or declaration will be required as part of the complete application.

To learn more:

Can a provisional application be filed without an English translation?

Yes, a provisional application can be filed in a language other than English. However, an English translation must be submitted within a specified timeframe. According to MPEP 601.01(b):

‘If the provisional application is filed in a language other than English, an English-language translation of the non-English-language provisional application will not be required in the provisional application.’

It’s important to note that while the translation is not required for the provisional application itself, it will be necessary if you later file a nonprovisional application claiming benefit of the provisional application. The English translation and a statement that the translation is accurate must be submitted in the nonprovisional application.

To learn more:

Can a provisional application be filed in a language other than English?

Yes, a provisional application can be filed in a language other than English. According to MPEP 201.04:

‘A provisional application may be filed in a language other than English.’

However, it’s important to note that while the USPTO allows this, it may have implications for future patent applications. If you later file a nonprovisional application claiming priority to the provisional, you will need to provide an English translation of the provisional application along with a statement that the translation is accurate. This ensures that the examiner can properly determine if the nonprovisional application is entitled to the benefit of the provisional filing date.

For more information on provisional application, visit: provisional application.

For more information on USPTO, visit: USPTO.

Can a provisional application be filed electronically?

Yes, provisional applications can be filed electronically. The MPEP 601.01(b) states:

“A provisional application may be filed electronically using the EFS-Web or Patent Center.”

Electronic filing offers several advantages, including:

  • Immediate confirmation of receipt
  • Potentially lower filing fees
  • Faster processing times

Applicants should ensure they follow the USPTO’s guidelines for electronic filing to ensure proper submission and processing of their provisional application.

To learn more:

Can a provisional application be converted directly into a nonprovisional application?

No, a provisional application cannot be directly converted into a nonprovisional application. The MPEP 201.04 clearly states:

“A provisional application cannot be converted to a nonprovisional application.”

Instead, to claim the benefit of a provisional application, an applicant must file a separate nonprovisional application within 12 months of the provisional filing date. This nonprovisional application must include a specific reference to the provisional application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on provisional application, visit: provisional application.

No, a provisional application cannot be considered a continuation-in-part (CIP). The MPEP explicitly states: An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation-in-part’ of the provisional application. (MPEP ¶ 2.06)

This distinction is important because:

  • Provisional applications are not examined and do not mature into patents.
  • The term ‘continuation-in-part’ is reserved for non-provisional applications that build upon prior non-provisional applications.
  • The relationship between a non-provisional application and a provisional application is described as ‘claiming the benefit of’ the provisional, not as a continuation or CIP.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

No, a provisional application cannot be called a ‘divisional’ application. The MPEP ¶ 2.01 explicitly states:

An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘divisional’ of the prior application.

This means that while an application can claim the benefit of a provisional application’s filing date under 35 U.S.C. 119(e), it is not considered a divisional application. Divisional applications are specifically related to non-provisional applications and involve claiming independent and distinct inventions from a parent application.

For more information on 35 USC 119(e), visit: 35 USC 119(e).

For more information on Divisional application, visit: Divisional application.

For more information on provisional application, visit: provisional application.

No, a provisional application should not be referred to as a ‘continuation’. The MPEP clearly states:

“An application claiming the benefit of a provisional application under 35 U.S.C. 119(e) should not be called a ‘continuation’ of the provisional application.”

This is because provisional applications serve a different purpose than continuation applications. Provisional applications are temporary placeholders that establish a priority date but do not mature into issued patents. Continuations, on the other hand, are full patent applications that build upon previously filed non-provisional applications.

For more information on 35 U.S.C. 119(e), visit: 35 U.S.C. 119(e).

For more information on patent law, visit: patent law.

For more information on provisional application, visit: provisional application.

Can a priority claim be made in a continuation or divisional application?

Yes, a priority claim can be made in a continuation or divisional application. However, there are specific requirements and time limits to consider. According to MPEP 214.01:

“In the case of a continuation or divisional application, the claim for priority must be made during the pendency of the application.”

This means:

  • The priority claim must be filed within the later of four months from the actual filing date of the continuation or divisional application or sixteen months from the filing date of the prior foreign application.
  • If the claim is filed outside this period, it will be considered untimely and require a petition under 37 CFR 1.55(e).
  • The priority claim should reference the parent application if it properly claimed the benefit of the foreign application.

It’s important to note that the continuation or divisional application must be filed within 12 months of the foreign application’s filing date (or 6 months for design applications) to be eligible for priority.

Can a priority claim be corrected after the patent has been issued?

Yes, it is possible to correct a priority claim after a patent has been issued, but the process is more complex and limited compared to correcting a priority claim in a pending application.

According to MPEP 214.02: ‘For a correction of foreign priority claim after issuance of a patent, see MPEP § 216.01.’

To correct a priority claim in an issued patent, the following steps are typically required:

  • File a petition for a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.
  • Pay the required fee.
  • Provide a statement that the error occurred without deceptive intent.
  • Submit evidence to support the correction, such as a certified copy of the priority document.

It’s important to note that the scope for correcting priority claims in issued patents is more limited than in pending applications. The correction must not involve a change that would broaden the scope of the claims of the issued patent.

For more detailed information on correcting foreign priority claims after patent issuance, refer to MPEP § 216.01.

To learn more:

Yes, a pre-AIA 37 CFR 1.47 application can be published as a Statutory Invention Registration, but with a specific condition. According to the MPEP:

“An application filed under pre-AIA 37 CFR 1.47 can be published as a Statutory Invention Registration (provided the request for a Statutory Invention Registration was filed before March 16, 2013).”

It’s important to note that this option is only available for requests filed before March 16, 2013, as the America Invents Act eliminated Statutory Invention Registrations for applications filed on or after that date.

To learn more:

To learn more:

Yes, a Pre-AIA 37 CFR 1.47 application can be converted to a regular application if the previously non-signing inventor later submits an executed oath or declaration. The MPEP 409.03(j) states:

‘If a 37 CFR 1.47 applicant submits an executed oath or declaration of the nonsigning inventor, the executed oath or declaration should be accepted by the Office and the application no longer treated under 37 CFR 1.47.’

This means that once the missing oath or declaration is submitted, the application will be processed as a regular application, removing the special 37 CFR 1.47 status.

To learn more:

To learn more:

The USPTO has specific rules regarding withdrawal for practitioners acting in a representative capacity under 37 CFR 1.34:

  • The USPTO will not approve withdrawal requests from practitioners acting in a representative capacity.
  • These practitioners are responsible for the correspondence they file in the application while acting in a representative capacity.
  • There is no need for these practitioners to obtain the USPTO’s permission to withdraw from representation.

However, it’s important to note that practitioners acting in a representative capacity, like those with power of attorney, remain responsible for compliance with 37 CFR 1.56 (duty of disclosure) and 37 CFR 11.18 (signature and certification requirements) for documents they file.

This distinction ensures that practitioners understand their ongoing responsibilities even when acting in a limited representative capacity.

To learn more:

Can a practitioner act on behalf of an applicant without a power of attorney?

Yes, a practitioner can act on behalf of an applicant without a power of attorney in certain circumstances. According to MPEP 402.04:

‘A practitioner may in some circumstances within the discretion of the Office act without any power of attorney or authorization of agent when it appears necessary to preserve the rights of the applicant.’

This provision allows for urgent action to be taken to protect the applicant’s interests, even if a formal power of attorney is not in place. However, it’s important to note that this is at the discretion of the USPTO and is typically limited to situations where immediate action is necessary to prevent loss of rights.

To learn more:

Generally, a power of attorney must be signed by all applicants or owners of a patent application. However, there are exceptions:

  1. For revocation: A power of attorney signed by less than all applicants/owners may be accepted if accompanied by a petition under 37 CFR 1.36(a) and fee, with a showing of sufficient cause.
  2. For appointment: A power of attorney signed by less than all applicants/owners may be accepted if accompanied by a petition under 37 CFR 1.183 and fee, demonstrating an extraordinary situation where justice requires waiver of the requirement.

MPEP 402.10 states: “The appointment and/or revocation are not accepted until the petition under 37 CFR 1.36(a) or 1.183 is granted. Therefore, the attorney or agent newly appointed by such papers is not permitted to submit any documents (such as an information disclosure statement (IDS)) into the application file until the petition under 37 CFR 1.36(a) or 1.183 is granted.”

Yes, a power of attorney can be revoked. The process for revoking a power of attorney is outlined in MPEP 601.02:

“A power of attorney may be revoked at any stage in the proceedings of a case, and a power of attorney to a subsidiary attorney will not be revoked by appointment of a principal attorney.”

To revoke a power of attorney:

  • The applicant or assignee must submit a signed revocation document to the USPTO.
  • The revocation should clearly state the intent to revoke the previous power of attorney.
  • If appointing a new attorney or agent, a new power of attorney should be submitted along with the revocation.

It’s important to note that revoking a power of attorney does not remove the attorney or agent from the record. To change the correspondence address, a separate request must be made.

To learn more:

Can a power of attorney be revoked in applications filed before September 16, 2012?

Yes, a power of attorney can be revoked in applications filed before September 16, 2012. The MPEP 402.02(b) states:

“A power of attorney may be revoked at any stage in the proceedings of a case.”

The revocation process for pre-September 16, 2012 applications involves the following:

  • The revocation must be in writing.
  • It must be signed by the applicant or the assignee of the entire interest of the applicant.
  • The revocation is not effective until it is accepted by the Office.

It’s important to note that revoking a power of attorney does not automatically grant power to a new attorney. A new power of attorney must be filed to appoint a new representative.

To learn more:

Yes, a power of attorney can be revoked in a patent application. The process for revocation is outlined in MPEP 402:

‘The power of attorney may be revoked at any time. Pursuant to 37 CFR 1.36(a), an applicant may revoke a power of attorney by filing a new power of attorney that is not directed to the patent practitioner(s) of record.’

To revoke a power of attorney:

  • File a new power of attorney form (PTO/AIA/82) with the USPTO.
  • The new form should either name new representative(s) or indicate that the applicant wishes to prosecute the application pro se (without an attorney).
  • Ensure the form is signed by the applicant or, in the case of a juristic entity, by an authorized official.
  • Submit the form through the USPTO’s Electronic Filing System (EFS-Web) or by mail.

It’s important to note that merely filing a new power of attorney automatically revokes the previous one. There’s no need for a separate revocation document unless you want to revoke without appointing a new representative.

For more information on power of attorney, visit: power of attorney.

For more information on pro se, visit: pro se.

For more information on revocation, visit: revocation.

For more information on USPTO, visit: USPTO.

The revocation of a power of attorney must be done in writing and cannot be accomplished through informal means such as telephone or email. The MPEP 402.05 states:

A power of attorney may not be revoked by a telephone call.

While this quote specifically mentions telephone calls, the same principle applies to emails or other informal communications. To properly revoke a power of attorney, applicants must submit a written revocation document or a new power of attorney that complies with the requirements set forth in MPEP 402. This ensures that the revocation is properly documented and effective in the patent application process.

To learn more:

Yes, a power of attorney can be revoked by fewer than all of the applicants, but with certain conditions. According to MPEP 402.05:

‘A power of attorney may be revoked by fewer than all of the applicants (or fewer than all patent owners in a reexamination proceeding or supplemental examination proceeding) if the power was granted by fewer than all of the applicants or patent owners.’

This means:

  • If the original power of attorney was granted by all applicants, it must be revoked by all applicants.
  • If the original power was granted by a subset of applicants, that same subset can revoke it.
  • In cases of joint inventors, careful consideration must be given to who originally granted the power.

To learn more:

No, a power of attorney cannot be partially revoked for specific patent applications. The MPEP 402.05 states:

‘A principal cannot revoke selected powers of the power of attorney while leaving other powers in effect.’

This means that when revoking a power of attorney, it must be revoked in its entirety for all applications and patents to which it was applied. If you wish to maintain representation for certain applications while revoking others, you would need to file a new power of attorney for those specific applications you want to keep under representation.

To learn more:

Can a power of attorney be granted to a foreign patent attorney or agent?

In general, a power of attorney in U.S. patent applications can only be granted to practitioners who are registered to practice before the USPTO. According to MPEP 402.02:

“The Office cannot recognize more than one power of attorney in an application at any given time. However, a registered attorney or agent may be appointed in a representative capacity under 37 CFR 1.34 in addition to any power of attorney that may be in effect.”

While foreign patent attorneys or agents cannot be directly granted power of attorney, they can work with U.S. registered practitioners who can be appointed. Additionally, foreign attorneys can be recognized as representatives under 37 CFR 1.34 for limited purposes, such as filing papers or receiving Office communications.

To learn more:

Can a power of attorney be granted to a foreign attorney or agent for US patent applications?

A power of attorney for US patent applications can only be granted to individuals who are registered to practice before the USPTO. Foreign attorneys or agents who are not registered with the USPTO cannot be granted power of attorney.

According to MPEP 402: “The Office cannot recognize more than one power of attorney or authorization to act in a representative capacity in a particular application or patent at any given time.” This means that only USPTO-registered practitioners can be given power of attorney.

However, foreign attorneys can work with US-registered patent practitioners who can be granted power of attorney. The foreign attorney can then collaborate with the US-registered practitioner to manage the application.

For more information on power of attorney, visit: power of attorney.

Can a power of attorney be filed after the patent application is submitted to the USPTO?

Yes, a power of attorney can be filed after the patent application is submitted to the USPTO. The MPEP 601.02 states:

“A power of attorney may be filed in a provisional application, a nonprovisional application, a reexamination proceeding, or a supplemental examination proceeding.”

This means that you can file a power of attorney at various stages of the patent process, including:

  • At the time of filing the application
  • After the application has been submitted
  • During prosecution of the application
  • Even after the patent has been granted (for reexamination or supplemental examination proceedings)

However, it’s generally advisable to file the power of attorney as early as possible to ensure smooth communication with the USPTO throughout the application process. If you need to file a power of attorney after submission, use the appropriate USPTO form and follow the current filing procedures.

To learn more:

Generally, papers giving or revoking a power of attorney in an application require signatures from all applicants or owners. However, there are exceptions:

  • For revocation: A petition under 37 CFR 1.36(a) with a fee and showing of sufficient cause is required.
  • For appointment: A petition under 37 CFR 1.183 with a fee, demonstrating an extraordinary situation where justice requires waiver of the requirement in 37 CFR 1.32(b)(4), is necessary.

As stated in the MPEP: “Papers giving or revoking a power of attorney in an application generally require signature by all the applicants or owners of the application.”

To learn more:

Yes, a petition under 37 CFR 1.47(a) can be filed for multiple unavailable inventors. The MPEP 409.03(b) states:

‘Where there are joint inventors, each nonsigning inventor must be petitioned for separately, even if more than one nonsigning inventor is unavailable.’

This means that while a single petition can cover multiple unavailable inventors, the petition must address each inventor individually, providing specific information and evidence for each one’s unavailability.

To learn more:

To learn more:

Yes, a petition for an unintentionally delayed priority claim can be filed after a patent issues, but it requires a different procedure. According to MPEP 214.02:

For applications that have issued as patents, a petition filed under 37 CFR 1.55(e) or 1.78(c) and (e) may be filed as a reissue application, a request for certificate of correction under 37 CFR 1.323, or a petition under 37 CFR 1.78(a) and (b) or 1.55(g), as appropriate.

This means that after a patent has issued, the options for correcting a priority claim are:

  • Filing a reissue application
  • Requesting a certificate of correction
  • Filing a petition under specific regulations

The appropriate method depends on the specific circumstances and the type of priority claim being corrected. It’s important to note that each of these options has its own requirements and limitations. For example, a certificate of correction is generally only available for minor errors that are clerical or typographical in nature.

Given the complexity of post-issuance corrections, it’s advisable to consult with a patent attorney or agent to determine the best course of action for your specific situation.

To learn more:

Yes, a person can sign patent documents on behalf of a juristic entity, but there are specific requirements:

According to MPEP 402.03: ‘Papers submitted on behalf of juristic entities must be signed by a person having authority to sign for the juristic entity.’

This means:

  • The signer must have the legal authority to act on behalf of the entity.
  • For corporations, this typically includes officers or agents appointed by the board.
  • For partnerships, a partner may sign.
  • For universities, an authorized official may sign.

It’s crucial to ensure the signer has proper authorization to avoid potential issues with the patent application.

To learn more:

Yes, but with limitations. According to MPEP 104:

“A person acting in a representative capacity under 37 CFR 1.34 may execute a power to inspect an application only if the patent practitioner was named in the application transmittal papers filed under 37 CFR 1.53 or the national stage documents filed under 37 CFR 1.495 and a power of attorney has not been appointed under 37 CFR 1.32.”

This means that a representative can execute a power to inspect only if they were named in the initial application papers and no formal power of attorney has been filed. Once a power of attorney is filed, any previously filed power to inspect by a practitioner without power of attorney becomes ineffective.

For more information on power to inspect, visit: power to inspect.

For more information on representative capacity, visit: representative capacity.

Yes, a patent title report can be updated after its initial preparation. While the MPEP Section 320 doesn’t explicitly state this, it’s implied by the fact that title reports are prepared at various stages of the patent process. Updates may occur:

  • When new assignments are recorded
  • If there are changes in inventorship
  • When errors or omissions in previous reports are discovered
  • At key stages of the patent process, such as before issuance

The Certificates of Correction Branch, responsible for preparing title reports, would likely generate updated reports to reflect any changes in ownership or other relevant information throughout the patent’s lifecycle.

Can a patent title be changed after filing?

Yes, a patent title can be changed after filing. The MPEP 606 states:

“The title may be amended at any time during the prosecution of the application, and in many instances a change in title may be required by the examiner.”

This means that:

  • Applicants can request a title change during prosecution
  • Examiners may require a title change if the original title is inadequate
  • The title can be amended up until the patent is granted

It’s important to note that any changes to the title should still accurately reflect the nature of the invention and comply with all USPTO requirements.

To learn more:

According to MPEP 604, a patent practitioner cannot automatically sign a substitute statement on behalf of a juristic entity. The MPEP states:

Note: a power of attorney to a patent practitioner to prosecute a patent application executed by the juristic entity does not make that practitioner an official of the juristic entity or empower the practitioner to sign the substitute statement.

For a juristic entity, the substitute statement may be signed by:

  • A person in the organization with apparent authority to sign (e.g., an officer)
  • Any person if the statement sets forth that the person is authorized to act on behalf of the juristic entity (e.g., the general counsel)

This ensures that the substitute statement is executed by someone with proper authority within the organization.

To learn more:

No, a patent practitioner acting in a representative capacity cannot represent only some of the applicants in a joint application. According to MPEP 402.04, when a patent practitioner files a paper in an application filed on or after September 16, 2012, they must be submitting the paper on behalf of all parties identified as the applicant.

The MPEP explicitly states: “The provisions of 37 CFR 1.34 in no way convey authority for a patent practitioner to submit papers in an application only on behalf of some of the parties identified as the applicant.”

For example, if there are three joint inventors who disagree about how to proceed with the application, a patent practitioner representing only one inventor cannot file papers to the exclusion of the other joint inventors. Similarly, when there are multiple assignees identified as the applicant, a patent practitioner cannot file papers on behalf of only some of the parties.

To learn more:

Yes, a registered patent practitioner who is not of record can conduct an interview if they have proper authorization from the applicant. According to MPEP 405:

Interviews may be conducted with a registered practitioner who has proper authority from the applicant, or an attorney or agent of record in the form of a power of attorney or authorization to act in a representative capacity, whether or not the practitioner has a copy of the application file.

The practitioner can show authorization by completing, signing, and filing an Applicant Initiated Interview Request Form (PTOL-413A) or using Form/PTO/SB/84, ‘Authorization to Act in a Representative Capacity’.

Can a patent practitioner change the correspondence address without the applicant’s approval?

Generally, a patent practitioner cannot change the correspondence address without the applicant’s approval. The MPEP 601.03 states:

“A patent practitioner acting in a representative capacity whose correspondence address is the correspondence address of record in an application may change the correspondence address in that application to his or her address.”

However, this is subject to important conditions:

  • The practitioner must be acting in a representative capacity.
  • Their address must already be the correspondence address of record.
  • If the practitioner is no longer representing the applicant, they should not change the address.

It’s important to note that the applicant retains the right to revoke the practitioner’s power of attorney and change the correspondence address at any time. Best practice is for practitioners to communicate with applicants before making any changes to ensure proper authorization and maintain a clear chain of communication with the USPTO.

To learn more:

Can a patent practitioner appointed in the Application Data Sheet (ADS) withdraw from representation?

Yes, a patent practitioner appointed in the Application Data Sheet (ADS) can withdraw from representation, but there are specific procedures to follow:

  • The practitioner must submit a request to withdraw.
  • The request must comply with 37 CFR 1.36.
  • The USPTO must approve the withdrawal.

According to MPEP 402.02(a): “A patent practitioner named in the Application Data Sheet may withdraw as attorney or agent of record upon application to and approval by the USPTO.”

It’s important to note that the practitioner remains responsible for the application until the USPTO approves the withdrawal. The applicant should ensure continuous representation to avoid missing important communications from the USPTO.

To learn more:

No, a patent practitioner cannot appoint a substitute to take over their cases after death. The MPEP 406 clearly states: “The patent practitioner may not appoint a ‘substitute’ and any attempt by the patent practitioner to appoint a ‘substitute’ patent practitioner whose power is intended to survive his or her own will not be recognized by the Office.” This means that any arrangements made by a practitioner for a substitute after their death will not be valid in the eyes of the USPTO.

For more information on power of attorney, visit: power of attorney.

For more information on USPTO policy, visit: USPTO policy.

No, a patent practitioner cannot appoint a substitute whose power would survive their own death. The MPEP clearly states: The patent practitioner may not appoint a ‘substitute’ and any attempt by the patent practitioner to appoint a ‘substitute’ patent practitioner whose power is intended to survive his or her own will not be recognized by the Office. (MPEP 406)

Can a patent examiner change the title of my application?

Yes, a patent examiner has the authority to require a change in the title of your application. According to MPEP 606.01, “Where the title is not descriptive of the invention claimed, the examiner should require the substitution of a new title that is clearly indicative of the invention to which the claims are directed.” This means that if the examiner finds your title to be insufficiently descriptive or not accurately reflecting the claimed invention, they can request that you provide a new, more appropriate title.

To learn more:

Yes, a patent examiner can require a change in the title of an invention. According to MPEP 606.01, “Where the title is not descriptive of the invention claimed, the examiner should require the substitution of a new title that is clearly indicative of the invention to which the claims are directed.” This ensures that the title accurately reflects the subject matter of the invention.

To learn more:

Yes, a patent examiner can begin examination if the drawings are defective under 35 U.S.C. 112, but with specific actions:

  1. The examination begins immediately.
  2. The examiner issues a requirement for corrected drawings.
  3. The examiner rejects the claims as not being in compliance with 35 U.S.C. 112(a).

The MPEP states: However, if the drawings do permit reasonable examination and the supervisory patent examiner believes the drawings are of such a character as to render the application defective under 35 U.S.C. 112, examination should begin immediately with a requirement for corrected drawings and a rejection of the claims as not being in compliance with 35 U.S.C. 112(a) being made.

This approach allows the examination process to proceed while addressing the drawing deficiencies.

To learn more:

To learn more:

Yes, a patent can be issued to multiple assignees or a combination of assignees and inventors. According to MPEP 307, there are two scenarios:

  1. Partial assignees and inventors: “If one or more assignee, together with one or more inventor, holds the entire right, title, and interest in the application, the patent may issue in the names of the assignee and the inventor.”
  2. Multiple assignees: “If multiple assignees hold the entire right, title, and interest to the exclusion of all the inventors, the patent may issue in the names of the multiple assignees.”

These provisions allow for flexibility in patent issuance when ownership is shared among multiple parties.

For more information on multiple assignees, visit: multiple assignees.

For more information on partial assignees, visit: partial assignees.

For more information on patent issuance, visit: patent issuance.

Can a patent be issued to an assignee if the assignment is not recorded?

Yes, a patent can be issued to an assignee even if the assignment is not recorded, provided certain conditions are met:

  • The request for issuance of the patent to the assignee must be made under 37 CFR 3.81(b).
  • The request must be submitted no later than the date the issue fee is paid.
  • The request must include clear evidence of the assignment.

According to MPEP 307: “An assignee who otherwise shows sufficient proprietary interest in the matter may also be entitled to such a patent.” This means that even without a recorded assignment, an assignee can still have the patent issued to them if they can demonstrate their proprietary interest.

For more information on assignee rights, visit: assignee rights.

For more information on patent issuance, visit: patent issuance.

For more information on proprietary interest, visit: proprietary interest.

Yes, a patent can be issued to a deceased inventor. The MPEP 308 states:

‘A patent may be issued to the legal representative (executor, administrator, etc.) of a deceased inventor.’

In such cases, the patent is issued to the legal representative acting on behalf of the deceased inventor’s estate. This ensures that the inventor’s rights and the value of their invention are preserved even after their death.

For more information on legal representative, visit: legal representative.

For more information on patent issuance, visit: patent issuance.

Yes, registered attorneys or agents not of record can file papers in patent applications and reexamination proceedings under 37 CFR 1.34. The MPEP states:

Filing of such papers is considered to be a representation that the attorney or agent is authorized to act in a representative capacity on behalf of applicant.

This means that by filing papers, the attorney or agent is implicitly declaring their authority to represent the applicant.

For more information on patent filing, visit: patent filing.

For more information on USPTO procedures, visit: USPTO procedures.

Can a patent assignment be recorded electronically?

Yes, patent assignments can be recorded electronically. The USPTO provides an electronic system for recording assignment documents. According to MPEP 302:

‘Assignment documents can be submitted for recordation via the Office’s Electronic Patent Assignment System (EPAS). See the USPTO website at http://www.uspto.gov/patents-application-process/documenting-patent-ownership/epas-electronic-patent-assignment-system for additional information regarding EPAS.’

Electronic submission through EPAS is often faster and more convenient than paper submissions. However, it’s important to ensure that all necessary information and signatures are included in the electronic submission.

For more information on electronic patent assignment, visit: electronic patent assignment.

For more information on EPAS, visit: EPAS.

For more information on USPTO, visit: USPTO.

Can a patent application under secrecy order be appealed?

Yes, patent applications under secrecy orders can be appealed, but with certain restrictions. MPEP 120 states: ‘Appeals to the Patent Trial and Appeal Board and petitions to the Director under 37 CFR 1.181 are available to the applicant in secrecy order cases, but those actions will not set aside the secrecy order.‘ This means that while you can appeal decisions related to the patentability of your application, such appeals cannot challenge or remove the secrecy order itself. The secrecy order remains in effect regardless of the appeal process.

For more information on patent appeal, visit: patent appeal.

For more information on patent procedure, visit: patent procedure.

For more information on patent trial and appeal board, visit: patent trial and appeal board.

No, patent applications under Secrecy Orders are not issued and cannot be involved in interferences or derivation proceedings. The MPEP states: Secrecy Order cases are examined for patentability as in other cases, but will not be passed to issue; nor will an interference or derivation be instituted where one or more of the conflicting cases is classified or under Secrecy Order. This is further supported by 37 CFR 5.3 and MPEP § 2306.

For more information on patent issuance, visit: patent issuance.

Yes, a patent application can proceed without all inventors’ signatures under certain circumstances. The MPEP 409.03(d) provides guidance on this matter:

If an inventor is deceased, refuses to execute an application, or cannot be found or reached after diligent effort, the application may be made by the other inventor(s) on behalf of themselves and the non-signing inventor.

To proceed without all signatures, the applicant must:

  • File the application on behalf of themselves and the non-signing inventor
  • Provide proof of the inventor’s unavailability or refusal
  • Submit an oath or declaration by the other inventor(s)
  • Include a petition under 37 CFR 1.47

The USPTO will review the evidence and may grant the petition, allowing the application to proceed without the missing signature.

To learn more:

Yes, a patent application filing date can be restored if drawings are filed late, but only under specific conditions:

  1. The applicant must file the drawings within two months of the filing date of the application or the date of a Notice of Incomplete Application, whichever is later.
  2. The late submission must be accompanied by an oath or declaration specifically referencing the late-filed drawings.
  3. The oath or declaration must state that the delay in filing the drawings was unintentional.

According to MPEP 601.01(f): ‘In design applications, drawings are the disclosure. As such, the application will not be given a filing date until the required drawings are filed.’

It’s important to note that for non-design applications, if the drawings are not necessary to understand the subject matter sought to be patented, the application may retain its original filing date even without the drawings.

To learn more:

Tags: drawings

Yes, a US patent application can claim both foreign priority and domestic benefit simultaneously. This is known as a ‘multiple priority claim’ or ‘multiple benefit claim.’ The MPEP 216 states:

‘It is possible for a U.S. application to be entitled to the benefit of an earlier U.S. filing date and also to the right of priority of a foreign application.’

Here’s how it works:

  • The application can claim foreign priority under 35 U.S.C. 119(a)-(d) to a foreign application filed within the past 12 months.
  • At the same time, it can claim domestic benefit under 35 U.S.C. 120 to an earlier US application.
  • The earlier US application can also claim foreign priority to the same foreign application.

This allows the US application to potentially have an effective filing date that is earlier than both its actual filing date and the filing date of the US application it claims benefit from.

For more information on domestic benefit, visit: domestic benefit.

For more information on foreign priority, visit: foreign priority.

No, patent applications that are entitled to a filing date will not be returned to the applicant, even if requested. This applies to applications filed by regular mail, Priority Mail Express, hand-delivery, or through the USPTO patent electronic filing system.

The MPEP clearly states: ‘Applications which are entitled to a filing date, whether filed by regular mail, by Priority Mail Express® under 37 CFR 1.10, by hand-delivery, by the USPTO patent electronic filing system, or otherwise, will not be returned to applicant even if requested.’ (MPEP 503)

Applicants should be careful not to file duplicate applications or applications not intended for filing, as fees paid for such applications are generally not refundable due to a change of purpose.

Once a patent application is filed and given a filing date, it generally cannot be returned or withdrawn. According to MPEP 503:

“Applications which are entitled to a filing date, whether filed by regular mail, by Priority Mail Express® under 37 CFR 1.10, by hand-delivery, by the USPTO patent electronic filing system, or otherwise, will not be returned to applicant even if requested.”

This policy is in place to maintain the integrity of the filing process and prevent potential abuse. Applicants should be careful not to file applications that are not intended to be filed, such as duplicates of already filed applications.

Furthermore, the MPEP cites 37 CFR 1.26(a), which states that a change of purpose after payment of a fee, such as when a party desires to withdraw a patent application for which a fee was paid, does not entitle the party to a refund of such fee.

If an applicant realizes they have filed an application in error or no longer wish to pursue it, they may choose to abandon the application. However, the application will remain on file with the USPTO and any fees paid will not be refunded.

For more information on application abandonment, visit: application abandonment.

For more information on application return, visit: application return.

Can a patent application be filed without drawings?

In most cases, a patent application should include drawings if they are necessary to understand the invention. However, there are situations where an application can be filed without drawings. As stated in MPEP 601.01(f): ‘If the specification includes a sequence listing or large tables, those elements may be submitted as electronic files in ASCII text format.’

For applications that do require drawings, but are filed without them, the USPTO will send a Notice to File Missing Parts. The applicant can then submit the drawings within a specified time period, typically two months, extendable up to seven months with fees. However, it’s important to note that adding new drawings may be considered new matter if they introduce elements not described in the original specification.

Design patent applications, which are based entirely on the visual appearance of an item, always require drawings and cannot be filed without them.

To learn more:

Yes, a patent application can be filed without an oath or declaration initially. According to MPEP 602:

‘An oath or declaration is not required for a provisional application filed under 35 U.S.C. 111(b) and 37 CFR 1.53(c). Oaths or declarations are required for design applications, plant applications, reissue applications, and nonprovisional utility patent applications filed on or after September 16, 2012, but the filing of the oath or declaration may be postponed until after the application is otherwise in condition for allowance.’

However, it’s important to note that while the filing can be postponed, the oath or declaration must be submitted before the application can be allowed. The USPTO will issue a Notice to File Missing Parts if the oath or declaration is missing, giving the applicant a time period to submit it.

To learn more:

Yes, a patent application can be filed on behalf of a deceased inventor under certain circumstances:

  • The application must be filed by the legal representative of the deceased inventor’s estate.
  • The legal representative must submit an oath or declaration and any necessary assignments.
  • The application should be filed as soon as possible after the inventor’s death to avoid potential issues with prior art.

MPEP 409.01 states: “If an inventor dies after an application is filed but before the application is approved for issue as a patent, and this fact is known to the legal representative or the assignee, a petition to change the applicant under 37 CFR 1.46(c)(2) should be filed.”

It’s important to note that the legal representative must act promptly to ensure the application is properly filed and prosecuted in accordance with USPTO regulations.

To learn more:

Can a patent application be filed if the sole inventor is deceased?

Yes, a patent application can be filed even if the sole inventor is deceased. The MPEP 409.03(b) provides guidance on this situation:

“When an inventor dies during the time intervening between the filing of the application and the granting of a patent thereon, the letters patent may be issued to the legal representative or assignee of the deceased inventor.”

In such cases, the legal representative (such as an executor or administrator of the inventor’s estate) can file the application on behalf of the deceased inventor. They must provide proof of their authority to act on behalf of the deceased inventor’s estate, typically in the form of Letters Testamentary or Letters of Administration.

To learn more:

Yes, a patent application can be filed even if one joint inventor refuses to sign, provided certain conditions are met. According to MPEP 409.03(a):

“Pre-AIA 37 CFR 1.47(a) and pre-AIA 35 U.S.C. 116, second paragraph, requires all available joint inventors to file an application ‘on behalf of’ themselves and on behalf of a joint inventor who ‘cannot be found or reached after diligent effort’ or who refuses to ‘join in an application.'”

To file the application, the available joint inventors must make an oath or declaration on their own behalf and on behalf of the nonsigning inventor. Additionally, proof must be provided that the nonsigning inventor refuses to execute the application papers. This process allows the patent application to proceed despite the refusal of one joint inventor to participate.

To learn more:

Yes, a patent application can be assigned before it is filed. This is known as an assignment of future rights. MPEP 301 states:

“An assignment of an application can be made before the application is filed. See 37 CFR 3.21.”

However, it’s important to note that the assignment document should clearly identify the invention and the application to be filed. Once the application is filed, it’s advisable to record the assignment with the USPTO to ensure proper documentation of ownership.

For more information on patent assignment, visit: patent assignment.

For more information on USPTO, visit: USPTO.

Can a patent applicant attend an interview with the USPTO without their practitioner?

While it is generally recommended that a patent practitioner represents the applicant during USPTO interviews, there are circumstances where an applicant may attend without their practitioner. MPEP 408 states:

‘A registered practitioner, not of record, may accompany a registered practitioner of record to attend an interview of an application in which the registered practitioner is not of record. The registered practitioner not of record may not participate in the interview of the application except as authorized by the patent applicant.’

This implies that while the primary responsibility lies with the practitioner of record, applicants have some flexibility in who attends the interview. However, it’s important to note that without proper representation, applicants may miss out on valuable legal insights and negotiation opportunities during the interview process.

For more information on patent applicant, visit: patent applicant.

For more information on patent examination, visit: patent examination.

Yes, according to MPEP 106.01, an assignee of a part interest or a licensee of exclusive right is entitled to inspect the patent application. The MPEP states: ‘an assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.’

This right to inspection is distinct from the right to intervene in or prosecute the application, which is reserved for the assignee of the entire interest.

No, a partial assignee cannot file a patent application as the sole applicant. The MPEP clarifies this point:

Because all parties having any portion of ownership in a patent property must act together as a composite entity in patent matters before the Office, a partial assignee (e.g., a party who owns 50% of the interest) cannot on its own file a patent application as the applicant.

This means that if multiple parties have ownership interests in the invention, they must act together to file the patent application. For more information on joint ownership, see MPEP § 301.

To learn more:

A nonsigning inventor who subsequently joins an application cannot revoke or grant a power of attorney in certain situations. MPEP 402.05(a) explains:

37 CFR 1.64(f) provides that the submission of an oath or declaration by a nonsigning inventor or legal representative in an application filed under 37 CFR 1.43, 1.45 or 1.46 will not permit the nonsigning inventor or legal representative to revoke or grant a power of attorney.

This means that if a nonsigning inventor later submits an oath or declaration in an application filed under specific circumstances (such as joint inventors, deceased or legally incapacitated inventors, or assignee filing), they cannot use this submission to revoke an existing power of attorney or grant a new one.

To learn more:

In a pre-AIA 37 CFR 1.47 application, a nonsigning inventor has limited rights regarding the power of attorney. According to MPEP 402.05(b):

A nonsigning inventor may subsequently join in a pre-AIA 37 CFR 1.47 application by submitting an oath or declaration under pre-AIA 37 CFR 1.63. However, even if the nonsigning inventor joins in the application, he or she cannot revoke or give a power of attorney without agreement of the pre-AIA 37 CFR 1.47 applicant.

This means that while a nonsigning inventor can later join the application by submitting the required oath or declaration, they do not have the authority to unilaterally revoke or grant a power of attorney. Any such action would require the agreement of the original pre-AIA 37 CFR 1.47 applicant.

To learn more:

To learn more:

Yes, a nonsigning inventor can join a pre-AIA 37 CFR 1.47 application. However, there are specific requirements and limitations to this process.

According to MPEP 409.03(i):

“A nonsigning inventor may join in a pre-AIA 37 CFR 1.47 application. To join in the application, the nonsigning inventor must file an appropriate pre-AIA 37 CFR 1.63 oath or declaration.”

It’s important to note that even if the nonsigning inventor joins the application, they have limited powers. The MPEP further states:

“Even if the nonsigning inventor joins in the application, he or she cannot revoke or give a power of attorney without agreement of the 37 CFR 1.47 applicant.”

This means that while the nonsigning inventor can become part of the application, they do not gain full control over it and must still work in agreement with the original applicant.

To learn more:

To learn more:

Can a nonprovisional application claim benefit from a provisional application filed without an English translation?

Yes, a nonprovisional application can claim the benefit of a provisional application filed without an English translation, but there are specific requirements. According to MPEP 601.01(a):

If the provisional application was filed in a language other than English, an English-language translation of the non-English language provisional application will not be required in the provisional application. The English language translation of the provisional application must be filed in the nonprovisional application.

This means that while the provisional application can be filed in a non-English language, the English translation must be submitted with the nonprovisional application that claims benefit from it. It’s crucial to ensure that the translation is accurate and complete to maintain the benefit claim.

For more details, see MPEP 601.01(a) and MPEP 211 on claiming benefit of earlier filing date.

To learn more:

Yes, a nonprovisional application can be entitled to different foreign filing dates for different claims. This can occur in two scenarios:

  1. The application may be found entitled to the filing date of a foreign application for some claims but not for others.
  2. An applicant may rely on two or more different foreign applications and may be entitled to the filing date of one application for certain claims and to another for other claims.

The MPEP states: “A nonprovisional application may be found entitled to the filing date of the foreign application with respect to some claims and not with respect to others. In addition, an applicant may rely on two or more different foreign applications and may be entitled to the filing date of one of them with respect to certain claims and to another with respect to other claims.” (MPEP 216)

Yes, under certain circumstances, a nonprovisional application filed without claims can be converted to a provisional application. This option is available for applications filed under 35 U.S.C. 111(a) on or after June 8, 1995, but it must be done within specific time limits and meet certain requirements.

The MPEP states: “As 37 CFR 1.53(c)(2) permits the conversion of an application filed under 35 U.S.C. 111(a) to an application under 35 U.S.C. 111(b), an applicant in an application, other than for a design patent, filed under 35 U.S.C. 111(a) on or after June 8, 1995, without at least one claim has the alternative of filing a petition under 37 CFR 1.53(c)(2) to convert such application into an application under 35 U.S.C. 111(b), which does not require a claim to be entitled to its date of deposit as a filing date.”

Key points for conversion:

  • The petition must be filed within 12 months of the original application’s filing date.
  • The application must comply with the requirements of 37 CFR 1.53(c)(2).
  • This option is not available for design patent applications.
  • For applications filed on or after December 18, 2013, conversion is unnecessary as claims are not required for a filing date.

To learn more:

Yes, nonprofit organizations can qualify for small entity status under certain conditions. According to 37 CFR 1.27(a)(3), a nonprofit organization that qualifies for small entity status is one that:

  • Has not assigned, granted, conveyed, or licensed any rights in the invention to a non-small entity
  • Is either:
    • A university or other institution of higher education
    • An organization described in section 501(c)(3) of the Internal Revenue Code and exempt from taxation under 501(a)
    • A nonprofit scientific or educational organization qualified under a nonprofit organization statute of a state
    • A foreign organization that would qualify under the above if it were located in the U.S.

It’s important to note that government organizations, whether domestic or foreign, cannot qualify as nonprofit organizations for small entity status purposes.

To learn more:

Yes, a non-signing inventor can later join the patent application. According to 37 CFR 1.64(f):

A nonsigning inventor or legal representative may subsequently join in the application by submitting an oath or declaration under § 1.63.

However, it’s important to note that this subsequent submission does not give the non-signing inventor or legal representative the power to revoke or grant a power of attorney if the application was filed under 37 CFR 1.43, 1.45, or 1.46.

This provision allows for flexibility in cases where an inventor’s circumstances may change after the initial filing of the application.

To learn more:

Tags: declaration, oath

No, a non-practitioner (someone who is not a registered patent attorney or agent) cannot change the correspondence address for a company’s patent application, even if they have the authority to act on behalf of the company. The MPEP states:

If an application is filed by a company to whom the invention has been assigned or to whom there is an obligation to assign the invention, a person (other than a patent practitioner) who has the authority to act on behalf of the company may not change the correspondence address, as all papers signed on behalf of a juristic entity must be signed by a patent practitioner.

This requirement is based on 37 CFR 1.33(b)(3), which specifies that amendments and other papers must be signed by a patent practitioner when submitted on behalf of a juristic entity (such as a company).

To learn more:

To learn more:

Can a non-inventor appoint a power of attorney in a pre-September 16, 2012 application?

Yes, under certain circumstances, a non-inventor can appoint a power of attorney in applications filed before September 16, 2012. The MPEP 402.02(b) states:

If no power of attorney is on file, then a party who is not an inventor, but who has given a proper showing of ownership or of authority to take action for and on behalf of all of the applicant may appoint an attorney or agent to prosecute the application, subject to the same exception noted above.

This means that a non-inventor, such as an assignee or other party with proper authority, can appoint a power of attorney if:

  • No power of attorney is currently on file
  • They provide proper documentation showing ownership or authority to act on behalf of all applicants
  • They follow the same rules that would apply to inventors appointing a power of attorney

It’s important to note that the non-inventor must have the authority to act for all applicants, not just some of them.

To learn more:

Can a non-attorney represent an applicant before the USPTO?

Yes, a non-attorney can represent an applicant before the USPTO under certain circumstances. According to MPEP 402.04, there are specific provisions for non-attorney representation:

  • Patent agents: Registered patent agents who are not attorneys can represent applicants in patent matters before the USPTO.
  • Limited recognition: Individuals granted limited recognition by the USPTO Director can represent applicants in specific patent matters.
  • Pro se representation: Applicants can represent themselves (pro se) in their own patent applications.

However, it’s important to note that “Effective September 16, 2012, any paper submitted on behalf of a juristic entity must be signed by a patent practitioner.” This means that corporations and other non-human entities must be represented by a registered patent practitioner, who may be either a patent attorney or a patent agent.

To learn more:

Tags: USPTO

Yes, a new patent practitioner can be appointed after the death of the previous one. The USPTO explicitly states in Form Paragraph 4.03: A new registered attorney or agent may be appointed. This allows the applicant or patent owner to ensure continued representation in patent matters following the death of their previous practitioner.

Can a national application be converted to an international application?

Yes, a national application can be converted to an international application under certain conditions. The MPEP states: “A national application may be converted to an international application by filing a PCT international application within one year from the earliest U.S. filing date of the national application and including the United States of America as a designated state.” (MPEP 201.01) This conversion allows applicants to seek patent protection internationally while maintaining the priority date of their original national filing. It’s important to note that this conversion must be done within the one-year timeframe to preserve priority rights.

For more information on conversion, visit: conversion.

Tags: conversion

No, a licensee of exclusive right cannot prosecute a patent application. According to MPEP 106.01, only the assignee of record of the entire interest has the right to intervene in the prosecution of an application. The MPEP states:

While it is only the assignee of record of the entire interest who can intervene in the prosecution of an application or interference to the exclusion of the applicant […], an assignee of a part interest or a licensee of exclusive right is entitled to inspect the application.

This means that while a licensee of exclusive right can inspect the application, they cannot prosecute it or exclude the applicant from the prosecution process.

To learn more:

Can a legal representative use an S-signature for patent documents?

Yes, a legal representative can use an S-signature for patent documents, provided they meet the following requirements:

  • The S-signature must be inserted between forward slash marks
  • The signer’s name must be presented in printed or typed form
  • The capacity of the signer must be included with the signature

The MPEP 402.03 states: ‘When an S-signature is employed in a document filed with the Office in connection with a patent or application, it must be accompanied by the printed or typed name of the signer. The number and qualification of persons required to execute a particular document are governed by the statute requiring the document and applicable regulations.’

For legal representatives, it’s crucial to include their capacity (e.g., attorney, agent) along with their S-signature to ensure compliance with USPTO requirements.

To learn more:

Can a legal representative sign the oath or declaration for an unavailable joint inventor?

Yes, in certain circumstances, a legal representative can sign the oath or declaration for an unavailable joint inventor. According to MPEP 409.03(a):

‘If an inventor is deceased or legally incapacitated, the legal representative of the inventor may sign the oath or declaration as the inventor.’

The legal representative must provide proof of their authority to act on behalf of the unavailable inventor. This might include:

  • Death certificate and letters testamentary for a deceased inventor
  • Court order appointing a guardian for a legally incapacitated inventor

It’s important to note that this provision applies only to deceased or legally incapacitated inventors, not to those who are simply unavailable or unwilling to sign.

To learn more:

Yes, a legal representative can sign patent documents on behalf of the inventor under certain circumstances. The MPEP 402.03 states:

Where a power of attorney or authorization of agent is given to a customer number, a practitioner must sign the correspondence if an applicant is to be represented.

This means that if a power of attorney has been granted, the authorized practitioner can sign documents on behalf of the inventor. However, it’s important to note that certain documents, such as the inventor’s oath or declaration, must still be signed by the inventor personally unless specific conditions are met (e.g., the inventor is deceased, legally incapacitated, or cannot be found after diligent effort).

To learn more:

Yes, a legal representative can file a national patent application in certain circumstances. The Manual of Patent Examining Procedure (MPEP) 201.01 states:

‘A national application may be filed under 35 U.S.C. 111(a) in the U.S. Patent and Trademark Office (USPTO) by… (B) the legal representative (35 U.S.C. 117) of a deceased or legally incapacitated inventor.’

This provision allows for the continuity of the patent application process when the inventor is unable to file themselves. The legal representative must be authorized under 35 U.S.C. 117, which typically includes executors, administrators, or other legal representatives of deceased inventors, or guardians or conservators of incapacitated inventors.

For more information on legal representative, visit: legal representative.

For more information on patent filing, visit: patent filing.

Yes, a legal entity can sign patent correspondence, but there are specific requirements. According to MPEP 502.02:

When a document is to be signed by a corporation or another juristic entity, the signature must comply with 37 CFR 1.33(b)(3).

The requirements for a legal entity’s signature include:

  • The name of the person signing
  • Their capacity (e.g., President, CEO, General Counsel)
  • The name of the legal entity

For example, a valid signature for a corporation might look like:

/John Smith, President, XYZ Corporation/

It’s important to note that the person signing must have the authority to bind the legal entity in matters before the USPTO. This ensures that the correspondence is legally binding and properly authorized.

To learn more:

Can a legal entity be listed as an inventor on a patent application?

No, a legal entity such as a corporation or organization cannot be listed as an inventor on a patent application. The MPEP clearly states:

“[T]he inventor, or each individual who is a joint inventor of a claimed invention, in an application for patent (other than a provisional application) must execute an oath or declaration directed to the application, except as provided for in 37 CFR 1.64.” (MPEP 605)

This means that only natural persons can be inventors. However, a legal entity can be an applicant or assignee of a patent application. The distinction is important:

  • Inventors: Must be individuals who contributed to the conception of the invention.
  • Applicants/Assignees: Can be legal entities that own the rights to the patent.

For example, a company’s employees might be listed as inventors, while the company itself is listed as the applicant or assignee.

To learn more:

Tags: legal entity

Can a legal assistant or secretary sign correspondence on behalf of a patent practitioner?

No, a legal assistant or secretary cannot sign correspondence on behalf of a patent practitioner. The MPEP 502.02 clearly states:

‘The signature of a practitioner on correspondence filed with the USPTO must be a handwritten signature or an S-signature personally signed by such practitioner.’

This requirement ensures that the practitioner takes personal responsibility for the content of the correspondence. Delegating this responsibility to support staff is not permitted and could lead to the correspondence being considered unsigned or improperly signed.

To learn more:

Can a juristic entity be an applicant for a patent application?

No, a juristic entity cannot be an applicant for a patent application filed on or after September 16, 2012. The MPEP 605 clearly states: ‘A juristic entity (e.g., organizational assignee) cannot be named as the applicant for a patent application.’ This means that only natural persons, specifically the inventor(s), can be named as applicants. However, a juristic entity can be named as the assignee or applicant for other purposes, such as in an application for a reissue patent to replace an original patent granted on an application filed before September 16, 2012.

To learn more:

Can a juristic entity appoint a power of attorney in a patent application?

Yes, a juristic entity (such as a corporation or organization) can appoint a power of attorney in a patent application. However, there are specific requirements for doing so:

  • The power of attorney must be signed by a person authorized to act on behalf of the juristic entity
  • The person signing must have apparent authority to bind the juristic entity

The MPEP provides guidance on this matter:

A power of attorney from a juristic entity must be signed by a person authorized to act on behalf of the juristic entity. […] A power of attorney to a patent practitioner to prosecute a patent application executed by the applicant or the assignee of the entire interest of the applicant is the power of attorney of the applicant or assignee, not the power of attorney of the practitioner. (MPEP 402.02(a))

It’s important to note that the power of attorney belongs to the juristic entity, not to the practitioner who is appointed.

To learn more:

Can a juristic entity applicant sign a power of attorney form for a patent application?

No, a juristic entity applicant (such as a corporation or organization) cannot directly sign a power of attorney form for a patent application. Instead, the power of attorney must be signed by a person authorized to act on behalf of the juristic entity.

According to MPEP 402.02(a):

“A power of attorney must be signed by the applicant for patent (37 CFR 1.42) or the patent owner (for reissue applications or reexamination proceedings). A power of attorney may only be signed by the applicant for patent (37 CFR 1.42) or the patent owner of record of the entire interest or their representative. An applicant for patent that is the assignee must comply with 37 CFR 3.71 and 3.73 to establish ownership of the application.”

For juristic entity applicants, this typically means that an officer or employee of the organization who has the authority to bind the organization must sign the power of attorney. This could be a CEO, president, or other authorized representative of the company.

It’s important to note that the person signing on behalf of a juristic entity should also provide their title or position within the organization to demonstrate their authority to act on behalf of the applicant.

To learn more:

No, a juristic entity applicant cannot directly sign a change of correspondence address form. According to MPEP 601.03(a):

“A juristic entity (e.g., organizational assignee) must be represented by a patent practitioner even if the juristic entity is the applicant.”

For juristic entity applicants, the following applies:

  • A registered patent practitioner must sign the change of correspondence address form on behalf of the juristic entity
  • The practitioner must be appointed to represent the juristic entity
  • The appointment can be made in an Application Data Sheet (ADS) or a separate power of attorney document

It’s important to note that this requirement is in place to ensure proper legal representation for juristic entities in patent matters.

To learn more:

Can a joint inventor apply for a patent if another joint inventor is unavailable or refuses to join?

Yes, a joint inventor can apply for a patent even if another joint inventor is unavailable or refuses to join the application. The MPEP 409 states: ‘If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the application may be made by the other inventor on behalf of himself or herself and the nonsigning inventor.’

The process involves:

  • Filing the application on behalf of all inventors
  • Submitting a petition under 37 CFR 1.45
  • Providing proof of the unavailability or refusal of the non-signing inventor
  • Including an oath or declaration by the participating inventor(s)

This provision ensures that the patent application process can proceed even when not all joint inventors are available or willing to participate.

For more information on joint inventors, visit: joint inventors.

Yes, a foreign priority claim can be corrected after filing a patent application, but there are specific procedures and time limitations to follow. According to MPEP 214.04:

‘The time period for making a claim for priority under 37 CFR 1.55 is set forth in 37 CFR 1.55(d)… If the claim for priority or the certified copy of the foreign application is filed after the date the issue fee is paid, the patent will not include the priority claim unless corrected by a certificate of correction under 35 U.S.C. 255 and 37 CFR 1.323.’

To correct a foreign priority claim:

  • If before the issue fee is paid: File a corrected Application Data Sheet (ADS) with the proper identification of the foreign application.
  • If after the issue fee is paid: Request a Certificate of Correction under 35 U.S.C. 255 and 37 CFR 1.323.

It’s important to note that corrections must be made within the time period specified in 37 CFR 1.55(d), which is typically within the later of four months from the actual filing date of the application or sixteen months from the filing date of the prior foreign application.

To learn more:

Can a foreign patent agent with limited recognition represent applicants in all USPTO matters?

No, a foreign patent agent with limited recognition cannot represent applicants in all USPTO matters. The MPEP clearly states that A foreign patent agent granted limited recognition may not represent applicants or parties in trademark matters, ex parte or inter partes appeals to the Patent Trial and Appeal Board, petitions to the Director of the USPTO, disciplinary proceedings, or in any other matter before the Office. (MPEP 402.01) Their representation is strictly limited to the presentation and prosecution of patent applications before the USPTO.

To learn more:

Tags: USPTO

Yes, a foreign filing license can be revoked by the USPTO. Key points about revocation include:

  • The USPTO can revoke a license through written notification.
  • Revocation usually occurs if additional review reveals national security concerns.
  • Revocation is effective on the date the notice is mailed.
  • Foreign filings made before revocation are generally not affected.
  • New foreign filings after revocation are not permitted without a new license.

The MPEP states: “Upon written notification from the USPTO, any foreign filing license required by 37 CFR 5.11(a) may be revoked. Ordinarily, revocation indicates that additional review of the licensed subject matter revealed the need for referral of the application to the appropriate defense agencies.”

For more information on foreign filing license, visit: foreign filing license.

For more information on USPTO, visit: USPTO.

Can a foreign filing license be revoked or modified?

Yes, a foreign filing license can be revoked or modified under certain circumstances. The MPEP 140 provides guidance on this:

Licenses for foreign filing may be revoked or modified upon written notification from the Director. Normally, revocation or modification will only affect applications or other materials not already filed abroad.

Key points about revocation or modification of foreign filing licenses:

  • The Director of the USPTO has the authority to revoke or modify licenses.
  • Notification of revocation or modification will be provided in writing.
  • Generally, the revocation or modification only affects future filings, not those already made abroad.
  • In cases of imminent national emergency, revocation may be immediate and may affect filings already made abroad.

If your license is revoked or modified, you should immediately cease any foreign filing activities covered by the license and seek legal counsel to understand the implications and next steps.

For more information on foreign filing license, visit: foreign filing license.

For more information on revocation, visit: revocation.

Yes, a foreign filing license can be denied by the USPTO. According to MPEP 140:

‘If the Director of the USPTO or his or her designee determines that the application contains subject matter that requires a security review under the Invention Secrecy Act (35 U.S.C. 181-188), the petition for license is denied and the applicant is notified in writing.’

Reasons for denial may include:

  • National security concerns
  • Subject matter falling under the Invention Secrecy Act
  • Incomplete or incorrect application for the license

If a license is denied, the applicant will be notified in writing and may have the opportunity to address the issues or appeal the decision.

For more information on foreign filing license, visit: foreign filing license.

Yes, a domestic representative can be changed after the initial designation. While MPEP 302.04 doesn’t explicitly address changing a domestic representative, it states that the designation is made by a written document signed by such assignee. This implies that a new written document can be submitted to change the designation. To change a domestic representative, follow the same process as the initial designation:

  • Prepare a new written document clearly labeled ‘Change of Domestic Representative’
  • Include the new representative’s name and address
  • Submit the document separately from other filings
  • Ensure it’s signed in accordance with 37 CFR 1.33(b)

It’s advisable to explicitly state that this new designation supersedes any previous designations to avoid confusion.

To learn more:

Yes, a divisional or continuation application can claim benefit from multiple prior applications. The MPEP 201.06(c) states:

‘A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (A) a copy of the prior application as filed; and (B) a new specification, claim or claims and drawings, where applicable.’

This provision allows for claiming benefit from multiple prior applications by following the correct procedures. It’s crucial to ensure that the chain of priority is properly maintained and that all necessary documents and declarations are filed.

To learn more:

To learn more:

No, a divisional application cannot include new matter that was not disclosed in the parent application. The MPEP 201.06 clearly states:

‘A divisional application is a later application for an independent or distinct invention, carved out of a prior application and disclosing and claiming only subject matter disclosed in the prior application.’

This means:

  • The divisional application must be limited to the subject matter disclosed in the parent application
  • No new matter can be added to the divisional application
  • The claims in the divisional must be supported by the disclosure of the parent application

If an applicant wishes to add new matter, they should consider filing a continuation-in-part (CIP) application instead of a divisional. For more information on new matter, refer to MPEP 2163.

To learn more:

Yes, a divisional application can claim the benefit of the filing date of the prior application. The MPEP ¶ 2.01 states:

Should applicant desire to claim the benefit of the filing date of the prior application, attention is directed to 35 U.S.C. 120, 37 CFR 1.78, and MPEP § 211 et seq.

To claim this benefit, the applicant must meet the requirements set forth in 35 U.S.C. 120 and 37 CFR 1.78, which include making a proper benefit claim and ensuring the divisional application is filed before the patenting or abandonment of the prior application.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Yes, a divisional application can claim priority to its parent application. This is one of the key benefits of filing a divisional application. According to MPEP 201.06:

‘A divisional application is entitled to the benefit of the filing date of the prior application.’

This means that the divisional application:

  • Retains the priority date of the parent application for the subject matter disclosed in the parent
  • Can claim the benefit under 35 U.S.C. 120 or 365(c)
  • Must include a specific reference to the parent application in its application data sheet (ADS)

It’s important to note that the divisional application must be filed while the parent application is still pending to claim this benefit.

For more information on 35 U.S.C. 120, visit: 35 U.S.C. 120.

For more information on Divisional application, visit: Divisional application.

For more information on patent law, visit: patent law.

Yes, a divisional application can claim priority to a provisional application under certain conditions. According to MPEP 201.06:

‘A divisional application may claim the benefit of a provisional application under 35 U.S.C. 119(e) if the divisional application is filed within twelve months of the provisional application filing date (or an appropriate later date in accordance with 37 CFR 1.78).’

To claim this benefit, the divisional application must:

  • Be filed within 12 months of the provisional application’s filing date (or later if permitted under 37 CFR 1.78)
  • Include a proper reference to the provisional application
  • Have at least one common inventor with the provisional application

To learn more:

To learn more:

Yes, a divisional application can claim the benefit of its parent application’s filing date. According to MPEP 201.06(c):

“A divisional application is entitled to the benefit of the filing date of the prior-filed application if the prior-filed application discloses the invention claimed in the divisional application in the manner provided by the first paragraph of 35 U.S.C. 112.”

This means that as long as the invention claimed in the divisional application was adequately described in the parent application, it can claim the parent’s filing date. This is crucial for establishing priority and avoiding potential prior art issues.

For more information on Divisional application, visit: Divisional application.

Can a divisional application claim benefit from a provisional application?

Yes, a divisional application can claim benefit from a provisional application through its parent application. The MPEP 201.06 states: “A later-filed application may be filed as a continuation, divisional, or continuation-in-part of a prior nonprovisional application or international application designating the United States. Unless the filing date of the earlier nonprovisional application is to be claimed for prior art purposes, there is no need for the later-filed application to be copending with it.” This means that if the parent application claimed benefit from a provisional application, the divisional application can also claim that benefit, extending its effective filing date back to the provisional application’s filing date.

To learn more:

Can a divisional application be filed without a restriction requirement?

While divisional applications are typically filed in response to a restriction requirement, they can be filed voluntarily without one. The MPEP 201.06 states:

“A divisional application is often filed as a result of a restriction requirement made by the examiner.”

However, the use of “often” implies that this is not always the case. Applicants may choose to file a divisional application voluntarily if they:

  • Recognize distinct inventions in their application
  • Want to pursue different claim scopes separately
  • Need to address potential unity of invention issues proactively

It’s important to note that voluntarily filing a divisional application without a restriction requirement may affect the application of the safe harbor provision under 35 U.S.C. 121, which protects against double patenting rejections in certain cases.

For more information on Divisional application, visit: Divisional application.

Can a divisional application be filed after the parent application is abandoned?

Yes, a divisional application can be filed after the parent application is abandoned, as long as certain conditions are met. The MPEP 201.06 states:

“A divisional application may be filed after abandonment of the parent application, provided the parent application is not relied upon for benefit claims under 35 U.S.C. 120, 121, 365(c), or 386(c) in an application whose effective filing date is on or after March 16, 2013.”

This means that you can file a divisional application even if the parent application has been abandoned. However, it’s crucial to note that if you want to claim the benefit of the parent application’s filing date, and the effective filing date of your divisional application is on or after March 16, 2013, the parent application must not have been abandoned at the time of filing the divisional.

It’s important to consult with a patent attorney to ensure compliance with all requirements when filing a divisional application, especially in cases involving abandoned parent applications.

For more information on Divisional application, visit: Divisional application.

For more information on effective filing date, visit: effective filing date.

No, a design patent application cannot be filed as a provisional application. The MPEP 201.01 states:

“Design applications and provisional applications for patent are considered to be distinct types of applications and are treated as separate categories.”

This means that design patent applications must be filed as nonprovisional applications. Provisional applications are only available for utility and plant patents.

For more information on design patent, visit: design patent.

For more information on patent application types, visit: patent application types.

For more information on provisional application, visit: provisional application.

Yes, design patent applications can be filed as continuations or continuations-in-part (CIPs), but with some specific considerations:

1. Continuations: A design application can be a continuation of a prior design application.

2. Continuations-in-part: A design application can be a CIP of a prior design application if it adds new matter.

3. Relationship to Utility Applications: A design application can also be a continuation or CIP of a utility application, provided the drawings in the utility application sufficiently disclose the claimed design.

The MPEP states: “A design application may be considered to be a divisional of a utility application (but not of a provisional application), and is entitled to the filing date thereof if the drawings of the earlier filed utility application show the same article as that in the design application sufficiently to comply with 35 U.S.C. 112(a). However, such a divisional design application may only be filed under the procedure set forth in 37 CFR 1.53(b), and not under 37 CFR 1.53(d).”

It’s important to note that while not explicitly stated for continuations and CIPs, the same principle applies – the earlier application must sufficiently disclose the claimed design.

Can a design application be considered complete without drawings?

No, a design application cannot be considered complete without drawings. The MPEP 601.01 states: “A design application is not entitled to a filing date under 35 U.S.C. 171 unless the application contains a drawing in compliance with 37 CFR 1.152.” This requirement is specific to design applications due to their visual nature. Drawings are essential for depicting the ornamental design for which protection is sought. Without compliant drawings, the application will not be granted a filing date and will not be processed further.

To learn more:

Can a dependent claim refer to more than one preceding claim in a patent application?

Yes, a dependent claim can refer to more than one preceding claim in a patent application, but there are specific rules governing such references. According to MPEP 608.01(n):

‘A claim which depends from a dependent claim should not be separated by any claim which does not also depend from said dependent claim. It should be kept in mind that a dependent claim may refer to any preceding independent claim. In general, applicant’s sequence will not be changed.’

Key points to remember:

  • A dependent claim can refer to multiple preceding claims, but only in the alternative (using ‘or’).
  • Multiple dependent claims must be carefully constructed to avoid improper dependencies.
  • The order of claims should be maintained to ensure clarity and proper dependency structure.

Proper referencing in dependent claims helps maintain a clear and logical claim structure in the patent application.

To learn more:

Yes, a delayed priority claim can be filed after a patent has been granted. The MPEP provides for this possibility:

“Where a priority claim under 37 CFR 1.55(g) was not timely made, 37 CFR 1.55(g) allows the priority claim and the certified copy required under 37 CFR 1.55 to be filed pursuant to a petition under 37 CFR 1.55(e) even if the application is not pending (e.g., a patented application). Thus, a petition under 37 CFR 1.55(e) may be filed along with request for a certificate of correction after patent grant.”

This provision allows patent holders to rectify priority claims even after their patent has been issued, ensuring that important priority rights are not lost due to unintentional delays.

To learn more:

Yes, a delayed priority claim can be accepted after patent issuance, but the process is more complex and requires a certificate of correction. According to MPEP 214.02:

For utility and plant applications filed on or after November 29, 2000, the failure to timely file a priority claim because of an error in a foreign priority claim may be corrected pursuant to 37 CFR 1.55(g). The failure to timely file a priority claim to an earlier filed application may be corrected pursuant to 37 CFR 1.78(c) and (e).

To correct a delayed priority claim after patent issuance:

  • File a petition under 37 CFR 1.55(e) or 37 CFR 1.78(c) and (e), as appropriate.
  • Submit a request for a certificate of correction under 37 CFR 1.323.
  • Pay the required fees for both the petition and the certificate of correction.
  • Provide a statement of unintentional delay covering the entire period of delay.

It’s important to note that the standards for accepting a delayed priority claim after issuance are typically higher, and the USPTO may require a more detailed explanation of the circumstances surrounding the delay.

To learn more:

To learn more:

Yes, delayed benefit claims can be filed for design applications. The MPEP 211.04 provides specific information about this:

“Effective May 13, 2015, 37 CFR 1.78(d)(3) was amended to make the procedures under 37 CFR 1.78(e) to accept an unintentionally delayed benefit claim applicable to design applications where the benefit claim was not submitted during the pendency of the design application. Thus, a petition under 37 CFR 1.78(e) may be filed along with a request for certificate of correction after patent grant.”

This means that for design applications, it’s possible to file a petition for a delayed benefit claim even after the patent has been granted, along with a request for a certificate of correction.

To learn more:

Yes, a delayed benefit claim can be filed for an international application entering the national stage, but specific requirements must be met. The MPEP 211.04 provides guidance on this:

‘For international applications entering the national stage under 35 U.S.C. 371, the claim for priority must be made within the time limit set forth in the PCT and the Regulations under the PCT…However, if an applicant fails to make a proper benefit claim within the later of four months from the actual filing date of the national stage application or sixteen months from the filing date of the prior-filed application, the benefit claim may be accepted if the applicant files a petition under 37 CFR 1.78.’

This means that while there are specific timeframes for filing benefit claims in national stage applications, if these deadlines are missed, a petition under 37 CFR 1.78 can be filed to request acceptance of the delayed benefit claim. The petition must meet all requirements, including demonstrating that the delay was unintentional.

To learn more:

No, a delayed benefit claim cannot be accepted after the patent has issued. The MPEP 211.04 clearly states:

“A petition under 37 CFR 1.78 to accept an unintentionally delayed claim for the benefit of a prior-filed application will not be granted in an issued patent.”

This means that once a patent has been granted, it is no longer possible to add or correct benefit claims through the petition process. The opportunity to make such changes ends when the patent issues.

If an applicant discovers after issuance that a benefit claim was not properly made or was omitted, they may have limited options:

  • Consider filing a reissue application to correct the error, if it qualifies as an error correctable by reissue.
  • In some cases, a certificate of correction might be appropriate, but this is generally limited to typographical or clerical errors.

It’s crucial for applicants to ensure all desired benefit claims are properly made and recorded before the patent issues to avoid complications and potential loss of priority rights.

To learn more:

Can a deceased inventor’s legal representative sign an assignment for a patent application?

Yes, a deceased inventor’s legal representative can sign an assignment for a patent application. According to MPEP 409.01(a):

“The legal representative (executor, administrator, etc.) of a deceased inventor may make an assignment of the deceased inventor’s rights in the application as well as sign the substitute statement. See MPEP § 409.01(b).”

This provision allows the legal representative to manage the deceased inventor’s intellectual property rights, including assigning those rights to other parties. It’s important to note that the legal representative must have proper authority to act on behalf of the deceased inventor’s estate, which typically requires documentation such as letters testamentary or letters of administration.

To learn more:

Can a Customer Number be used for multiple patent applications?

Yes, a Customer Number can be used for multiple patent applications. This is one of the primary benefits of the Customer Number system. The MPEP 403 states:

‘The Customer Number practice permits applicants, attorneys, and agents of record to change their correspondence address for a number of applications with one request.’

This means that:

  • A single Customer Number can be associated with multiple patent applications
  • Changes to the correspondence address or list of registered practitioners can be made once and applied to all linked applications
  • It simplifies portfolio management for applicants and law firms handling multiple patents

Using a Customer Number for multiple applications streamlines communication with the USPTO and helps ensure consistent handling of related patent matters.

For more information on Customer Number, visit: Customer Number.

Can a CPA be filed in a provisional application?

No, a Continued Prosecution Application (CPA) cannot be filed in a provisional application. The MPEP 201.06(d) clearly states:

A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application, but not an international design application, that is complete as defined by 37 CFR 1.51(b), except for the inventor’s oath or declaration if the application is filed on or after September 16, 2012, and the prior application was filed under 35 U.S.C. 111(a).

This means that CPAs are limited to design applications filed under 35 U.S.C. 111(a). Provisional applications, which are filed under 35 U.S.C. 111(b), are not eligible for CPA filing.

To learn more:

To learn more:

No, Continued Prosecution Applications (CPAs) cannot be filed for utility or plant applications. The MPEP clearly states: Effective July 14, 2003, continued prosecution application (CPA) practice was eliminated as to utility and plant applications. For utility and plant applications, applicants should consider filing a request for continued examination (RCE) under 37 CFR 1.114 or a new application under 37 CFR 1.53(b) instead.

To learn more:

Can a CPA be filed as a continuation-in-part application?

No, a Continued Prosecution Application (CPA) cannot be filed as a continuation-in-part application. According to MPEP 201.06(d):

‘A continuation or divisional application (but not a continuation-in-part) may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).’

This means that while you can file a CPA as a continuation or divisional application of a prior design application, you cannot file it as a continuation-in-part. Continuation-in-part applications typically contain new matter not present in the prior application, which is not allowed in a CPA filing.

For more information on CPA, visit: CPA.

For more information on patent application types, visit: patent application types.

Yes, a corporation can file a patent application under pre-AIA 37 CFR 1.47(b). The MPEP explicitly states that “Where a corporation is the pre-AIA 37 CFR 1.47(b) applicant, an officer (President, Vice-President, Secretary, Treasurer, or Chief Executive Officer) thereof should normally sign the necessary oath or declaration.”

Additionally, “A corporation may authorize any person, including an attorney or agent registered to practice before the U.S. Patent and Trademark Office, to sign the application oath or declaration on its behalf.” However, proper authorization or proof of authority may be required in such cases.

To learn more:

No, a copy of the original oath or declaration cannot be used in a continuation or divisional application filed under 37 CFR 1.53(b). A new oath or declaration must be filed.

According to MPEP 602.02: ‘A new oath or declaration in compliance with 37 CFR 1.63 or 1.67 is required in a continuation or divisional application filed under 37 CFR 1.53(b), regardless of whether a copy of the oath or declaration from the prior application is submitted.’

This requirement ensures that the inventors reaffirm their commitment to the claims in the new application, which may differ from those in the parent application.

To learn more:

No, a copy of the foreign patent as issued does not comply with the certified copy requirement. The MPEP states: “A copy of the foreign patent as issued does not comply since the application as filed is required; however, a copy of the printed specification and drawing of the foreign patent is sufficient if the certification indicates that it corresponds to the application as filed.” The key is that the certified copy must represent the application as originally filed, not the patent as eventually issued.

Can a Continued Prosecution Application (CPA) be filed in a provisional application?

No, a Continued Prosecution Application (CPA) cannot be filed in a provisional application. According to MPEP 201.06(d):

“A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application that is complete as defined by 37 CFR 1.51(b).”

This explicitly limits CPA practice to design applications. Provisional applications are not eligible for CPA filings. If an applicant wishes to continue prosecution based on a provisional application, they must file a non-provisional application claiming priority to the provisional application within the appropriate time frame.

For more information on CPA, visit: CPA.

For more information on provisional application, visit: provisional application.

Can a Continued Prosecution Application (CPA) be filed for utility or plant patent applications?

No, a Continued Prosecution Application (CPA) cannot be filed for utility or plant patent applications. According to MPEP 201.06(d):

‘Effective July 14, 2003, CPAs are only available for design applications.’

This means that CPAs are exclusively for design patent applications. For utility or plant patent applications, applicants must use other continuation options such as:

If an applicant attempts to file a CPA for a utility or plant application, the USPTO will process it as a request for continued examination (RCE) under 37 CFR 1.114, if applicable, or will otherwise treat it as an improper application.

To learn more:

Yes, a Continued Prosecution Application (CPA) can be filed for design applications. In fact, as of September 8, 2000, CPAs are only available for design applications. According to MPEP 201.06(d):

‘Effective July 14, 2003, CPA practice has been eliminated as to utility and plant applications. CPAs can only be filed for design applications.’

This means that for utility and plant patent applications, other forms of continuing applications such as RCEs (Request for Continued Examination) or continuation applications under 37 CFR 1.53(b) must be used instead of CPAs.

For more information on continued prosecution application, visit: continued prosecution application.

For more information on CPA, visit: CPA.

For more information on design applications, visit: design applications.

Yes, a continuation-in-part (CIP) application can have different inventors than the parent application, but there must be at least one common inventor. The MPEP provides guidance on this:

“A continuation-in-part application that has a sole inventor may also derive from an earlier application that has joint inventors and discloses only a portion of the subject matter of the later application, subject to the conditions set forth in 35 U.S.C. 120 and 37 CFR 1.78. Subject to the same conditions, a continuation-in-part application that has joint inventors may derive from an earlier application that has a sole inventor.”

This flexibility allows for situations where new inventors contribute to the additional subject matter in the CIP, or where some inventors from the original application are no longer involved in the new developments.

For more information on joint inventors, visit: joint inventors.

Can a continuation-in-part application claim priority to a provisional application?

Yes, a continuation-in-part (CIP) application can claim priority to a provisional application, but with some important considerations. The MPEP 201.08 doesn’t explicitly address this scenario, but it can be inferred from the general rules governing CIP applications and provisional applications.

Key points to understand:

  • Priority claim: A CIP can claim priority to a provisional application for subject matter disclosed in the provisional.
  • New matter: Any new matter added in the CIP will have the filing date of the CIP itself, not the provisional application.
  • One-year deadline: The CIP must be filed within one year of the provisional application’s filing date to claim its benefit.
  • Multiple priorities: A CIP might claim priority to both a provisional and a non-provisional application in some cases.

Inventors should carefully document which parts of their CIP application correspond to the provisional disclosure to ensure proper priority claims.

For more information on new matter, visit: new matter.

For more information on provisional application, visit: provisional application.

Yes, a continuation-in-part (CIP) application can claim benefit from multiple parent applications. The MPEP 201.08 states:

An applicant may in a single application seek to add and claim new matter while also repeating some or all of the subject matter of one or more earlier applications.

This means:

  • A CIP can incorporate subject matter from multiple earlier applications.
  • It can also add new matter not disclosed in any of the earlier applications.
  • The CIP can claim priority to different parent applications for different parts of its disclosure.

Note: The effective filing date for each claim will depend on which parent application(s) provide sufficient support for that claim, as per 35 U.S.C. 112(a). Claims relying on newly added matter will have the CIP’s filing date as their effective date.

To learn more:

To learn more:

Can a continuation-in-part application claim benefit from an international application?

Yes, a continuation-in-part (CIP) application can claim benefit from an international application, but there are specific requirements and limitations. The MPEP 211.01(c) states:

A U.S. national application may claim benefit under 35 U.S.C. 120 and 365(c) to an international application designating the United States only if the international application was filed on or after November 29, 2000.

However, it’s crucial to understand that for a CIP application, the benefit claim is limited to the subject matter that was disclosed in the international application. Any new matter added in the CIP would not receive the benefit of the international application’s filing date. Additionally, the CIP must meet all the requirements of 35 U.S.C. 120, including copendency and specific reference to the earlier application.

To learn more:

To learn more:

No, a continuation-in-part (CIP) application cannot be filed as a continued prosecution application (CPA). The MPEP explicitly states: “A continuation-in-part application CANNOT be filed as a continued prosecution application (CPA) under 37 CFR 1.53(d).”

Continuation-in-part applications may only be filed under 37 CFR 1.53(b). This is an important distinction to remember when considering different types of patent application filings.

A continuation-in-part (CIP) application can claim the benefit of a prior application’s filing date, but with important limitations:

  • Only the subject matter common to both the CIP and the prior application can claim the earlier filing date.
  • New matter introduced in the CIP will have the filing date of the CIP application.
  • Each claim in the CIP is evaluated independently for priority date determination.

MPEP 211.05 states:

A claim in a continuation-in-part application or subsequent application may be entitled to the benefit of the filing date of the prior application if the disclosure of the prior application provides support for the claim in compliance with 35 U.S.C. 112(a), except for the best mode requirement.

This means that applicants must carefully consider the content of their prior applications when filing a CIP to ensure they receive the maximum benefit of earlier filing dates for their claims.

To learn more:

Tags: new matter

Can a continuation-in-part (CIP) application claim benefit to multiple prior applications?

Yes, a continuation-in-part (CIP) application can claim benefit to multiple prior applications, provided certain conditions are met. The MPEP states:

“An applicant may claim the benefit of the filing date of one or more prior applications under 35 U.S.C. 120, 121, 365(c), or 386(c) in a later-filed application … if the later-filed application is filed before the patenting or abandonment of or termination of proceedings on the prior application.”

However, it’s important to note that for a CIP application:

  • New matter in the CIP will only get the benefit of the CIP’s filing date.
  • Matter disclosed in the prior application(s) can claim the earlier filing date(s).
  • Each claim in the CIP is evaluated separately to determine which filing date it is entitled to.

For more details, see MPEP 211.01 and MPEP 201.08.

To learn more:

To learn more:

Can a continuation-in-part (CIP) application claim benefit to a provisional application?

Yes, a continuation-in-part (CIP) application can claim benefit to a provisional application, but there are important considerations regarding the disclosure and priority dates. The MPEP provides guidance on this:

“An applicant may claim the benefit of the filing date of a provisional application in a subsequent nonprovisional application or international application designating the United States if the nonprovisional application or international application designating the United States is filed within 12 months from the filing date of the provisional application.”

However, it’s crucial to understand that:

  • Only the subject matter that was disclosed in the provisional application will receive the benefit of the provisional filing date.
  • New matter added in the CIP will have the filing date of the CIP application itself.
  • The applicant must comply with the requirements of 35 U.S.C. 119(e) and 37 CFR 1.78.

For more details on claiming benefit of provisional applications, see MPEP 211.

To learn more:

No, a continuation application cannot include new matter. As stated in MPEP 201.07:

The disclosure presented in the continuation must not include any subject matter which would constitute new matter if submitted as an amendment to the parent application.

This means that the continuation application must be based entirely on the disclosure of the prior-filed application. Any new subject matter would need to be filed as a continuation-in-part (CIP) application instead of a standard continuation application.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

For more information on patent law, visit: patent law.

Yes, a continuation application can claim the benefit of multiple parent applications, provided certain conditions are met. According to MPEP 201.07:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 111(b) or 365(c) or filed under 35 U.S.C. 120, 121, 365(c), or 386(c) and 37 CFR 1.53(b) or 1.53(d) as a continuation of prior applications, claiming the benefit of those applications under 35 U.S.C. 120, 121, 365(c), or 386(c).’

This means that a continuation application can claim the benefit of:

  • Multiple earlier-filed nonprovisional applications
  • Earlier-filed provisional applications
  • Earlier-filed international applications designating the United States

However, it’s important to note that the continuation must satisfy the requirements for claiming benefit, including proper copendency and cross-referencing of the prior applications.

For more information on continuation application, visit: continuation application.

Can a continuation application claim the benefit of a provisional application?

Yes, a continuation application can claim the benefit of a provisional application, provided certain conditions are met. The MPEP 201.07 states:

‘A continuation application may be filed under 35 U.S.C. 111(a) or 363 while the prior application is pending, or it may be filed as an RCE under 37 CFR 1.114 of the prior application.’

To claim the benefit of a provisional application:

  • The continuation must be filed within 12 months of the provisional filing date
  • The provisional application must provide adequate support for the claims in the continuation
  • A specific reference to the provisional application must be made in the continuation

It’s important to note that while a continuation can claim benefit from a provisional, it must have at least one intervening nonprovisional application in the chain, as continuations are based on nonprovisional applications.

To learn more:

Yes, a continuation application can claim priority to multiple parent applications under certain conditions. According to MPEP 201.07:

‘A continuation application may be filed as a continuation of an earlier application of the same applicant… The continuation application may be filed before the patenting or abandonment of or termination of proceedings on the prior application.’

This means that:

  • The continuation must have at least one common inventor with the parent application(s).
  • The continuation must be filed while at least one of the parent applications is still pending.
  • The continuation cannot introduce new matter beyond what was disclosed in the parent application(s).

When claiming priority to multiple parents, the continuation essentially combines the disclosures of the parent applications, as long as they form a continuous chain of copending applications.

To learn more:

To learn more:

Yes, a continuation application can be filed after the parent application is granted or abandoned, but there are timing restrictions. The MPEP states:

At any time before the patenting, abandonment, or termination of proceedings on an earlier application, an applicant may have recourse to filing a continuation application under 37 CFR 1.53(b) in order to introduce into the application a new set of claims and to establish a right to further examination by the Office.

However, it’s important to note:

  • For standard continuation applications under 37 CFR 1.53(b), they must be filed before the patenting, abandonment, or termination of proceedings on the earlier application.
  • For Continued Prosecution Applications (CPAs) under 37 CFR 1.53(d), which are only available for design applications (excluding international design applications), they must be filed prior to payment of the issue fee unless a petition under 37 CFR 1.313(c) is granted in the prior application.

Always consult with a patent attorney to ensure proper timing and procedures are followed.

For more information on continuation application, visit: continuation application.

For more information on CPA, visit: CPA.

For more information on patent grant, visit: patent grant.

Can a continuation application add new matter to the original disclosure?

No, a continuation application cannot add new matter to the original disclosure. This is a fundamental characteristic of continuation applications.

According to MPEP 201.07:

‘A continuation application is an application for the invention(s) disclosed in a prior-filed copending nonprovisional application, international application designating the United States, or international design application designating the United States.’

This means that the continuation must rely entirely on the disclosure of the parent application. Any attempt to introduce new matter would result in the application being treated as a continuation-in-part (CIP) rather than a true continuation. It’s crucial for inventors and patent practitioners to understand this limitation when considering filing strategy.

For more information on continuation application, visit: continuation application.

For more information on new matter, visit: new matter.

Yes, a company can be listed as the applicant for a patent application, but the rules differ depending on when the application was filed. According to MPEP § 605:

For applications filed on or after September 16, 2012:

“Effective September 16, 2012, the Office revised the rules of practice to permit a person to whom the inventor has assigned or is under an obligation to assign an invention to file and prosecute an application for patent as the applicant.”

This means that a company can be listed as the applicant if:

  • The inventor has assigned the invention to the company
  • The inventor is under an obligation to assign the invention to the company

For applications filed before September 16, 2012:

“For applications filed before September 16, 2012, a person to whom the inventor assigned an invention could file and prosecute an application for patent, but the inventor is considered the applicant.”

In this case, while a company could file and prosecute the application, the inventor would still be considered the applicant.

It’s important to note that regardless of who is listed as the applicant, the true inventor(s) must always be named in the application.

To learn more:

According to MPEP 608.01(m), claims should not refer to figures or tables in the specification unless absolutely necessary. The MPEP states:

Where possible, claims are to be complete in themselves. Incorporation by reference to a specific figure or table ‘is permitted only in exceptional circumstances where there is no practical way to define the invention in words and where it is more concise to incorporate by reference than duplicating a drawing or table into the claim.’

In most cases, the subject matter of figures or tables should be described in words within the claim. Only when it’s impractical to define the invention without reference to a figure or table, and when it’s more concise to incorporate by reference, should such references be used in claims.

To learn more:

Can a Certificate of Correction be used to add or correct a benefit claim after patent grant?

The use of a Certificate of Correction to add or correct a benefit claim after patent grant depends on the type of patent. According to MPEP 211.02(a):

“For utility and plant applications, a Certificate of Correction can be used to correct the failure to adequately claim priority under 35 U.S.C. 119(e) or 120 in the application as filed if the application was filed within the required time period. However, for design applications, an application may be amended to claim priority to or the benefit of a prior-filed application after the application issues as a patent by filing a reissue application.”

This means:

  • For utility and plant patents: A Certificate of Correction can be used to add or correct a benefit claim after patent grant, provided the application was filed within the required time period.
  • For design patents: A Certificate of Correction cannot be used. Instead, a reissue application must be filed to add or correct a benefit claim after patent grant.

It’s important to note that the option to use a Certificate of Correction for utility and plant patents is subject to specific conditions and time limitations. Always consult the current MPEP and seek legal advice if necessary.

To learn more:

Can a Canadian patent agent represent U.S. patent applicants before the USPTO?

Yes, a Canadian patent agent can represent U.S. patent applicants before the USPTO under certain conditions. According to MPEP 402.01:

‘The Canadian Intellectual Property Office and the United States Patent and Trademark Office have agreed on a procedure to allow for the reciprocal recognition of patent agents and attorneys registered to practice before their respective Offices.’

This means that registered Canadian patent agents can apply for and be granted limited recognition to represent U.S. patent applicants before the USPTO. However, this recognition is subject to specific conditions and requirements set by the OED Director.

To learn more:

Tags: USPTO

No, a best mode defect cannot be cured by a later amendment to the patent application. The MPEP 608.01(h) clearly states: If the best mode contemplated by the inventor at the time of filing the application is not disclosed, such defect cannot be cured by submitting an amendment seeking to put into the specification something required to be there when the application was originally filed.

This guidance is based on the case In re Hay, 534 F.2d 917, 189 USPQ 790 (CCPA 1976). The MPEP further advises: Any proposed amendment of this type should be treated as new matter. This means that the best mode must be disclosed at the time of filing, and attempts to add it later will be rejected as new matter.

To learn more:

Tags: new matter

Yes, a ‘rejected’ patent application can still be approved. The term ‘rejected’ in this context does not mean final rejection or denial of the patent. According to MPEP 203.02:

A nonprovisional application which, during its prosecution in the examining group and before allowance, contains an unanswered examiner’s action is designated as a ‘rejected’ application.

This status is part of the normal examination process. The applicant has the opportunity to respond to the examiner’s action, potentially leading to approval. The application remains ‘rejected’ until:

  • The applicant successfully addresses the examiner’s concerns
  • The examiner issues a notice of allowance
  • The application becomes abandoned

With appropriate responses and amendments, a ‘rejected’ application can progress to approval and eventual patent grant.

To learn more:

USPTO employees are generally not permitted to initiate email communications with patent applicants unless there is a written authorization on record. According to MPEP 502.03:

‘USPTO employees are NOT permitted to initiate communications with applicants via Internet email unless there is a written authorization of record in the patent application by the applicant.’

However, if an applicant has provided written authorization for Internet communications:

‘USPTO employees may respond to Internet email and initiate communications with applicants via Internet email.’

It’s important to note that this policy applies to regular patent applications. For reissue applications and reexamination proceedings, which are open to public inspection, additional restrictions apply:

‘USPTO employees are NOT permitted to initiate communications with applicant in a reissue application or a patentee of a reexamination proceeding via Internet email unless written authorization is given by the applicant or patentee.’

To learn more:

Generally, no. MPEP 105 states: “U.S. Patent and Trademark Office (USPTO) employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application.” This prohibition applies to all forms of communication about patent applications with suspended or excluded practitioners.

To learn more:

Yes, there are certain situations where a petition and petition fee are not required to correct a timely submitted benefit claim. According to the MPEP, these situations include:

  • Changing the relationship of the applications (e.g., from “continuation” to “continuation-in-part” or vice versa)
  • Changing the filing date of a prior-filed nonprovisional or provisional application
  • Changing a benefit claim of a prior-filed provisional application from 35 U.S.C. 120 to 35 U.S.C. 119(e) during the pendency of the later-filed application

Additionally, if the benefit claim was included elsewhere in the application (e.g., in an oath, declaration, or transmittal letter) within the required time period and was recognized by the Office as shown on the first filing receipt, a petition is not required. However, the applicant must still submit the benefit claim in the proper format (i.e., in an Application Data Sheet or by amending the specification for applications filed before September 16, 2012).

Note: If the application has already issued as a patent, corrections to benefit claims that would affect the patent term cannot be made by a certificate of correction or in a reissue application.

Yes, there are significant restrictions on contacting patent practitioners who are not of record for a patent application. According to MPEP § 408, Registered attorneys or agents not of record in a patent application (i.e., there is no power of attorney present in the file that appoints the patent practitioner(s)) and acting in a representative capacity under 37 CFR 1.34 should not be contacted for restriction requirements or approval of examiner’s amendments.

This policy is in place to ensure that only properly authorized representatives are involved in making decisions about patent applications. For more information on interviews with patent practitioners not of record, refer to MPEP § 405.

Yes, there are strict restrictions on communicating with unregistered, suspended, or excluded attorneys regarding patent applications. The MPEP clearly states:

Office employees are forbidden from holding either oral or written communication with an unregistered, suspended or excluded attorney or agent regarding an application unless it is one in which said attorney or agent is the applicant.

This rule helps maintain the integrity of the patent application process and ensures that only qualified, registered practitioners are involved in patent-related communications with the USPTO.

Yes, there are exceptions to the requirement for all applicants to sign power of attorney documents. The MPEP provides one specific exception:

“In an application filed under pre-AIA 37 CFR 1.47(a), an assignee of the entire interest of the available inventors (i.e., the applicant) who has signed the declaration may appoint or revoke a power of attorney without a petition under 37 CFR 1.36(a) or 1.183.”

This exception applies to applications filed before the America Invents Act (AIA) under specific circumstances. However, it’s important to note that this exception does not apply in all cases. The MPEP also states:

“However, in applications accepted under pre-AIA 37 CFR 1.47, such a petition under 37 CFR 1.36(a) or 1.183 submitted by a previously nonsigning inventor who has now joined in the application will not be granted.”

For more information on these exceptions, refer to MPEP § 402.07 and MPEP § 409.03(i).

To learn more:

Yes, there are two exceptions to the patent ownership restrictions for USPTO employees:

  1. Inheritance
  2. Bequest

According to 35 U.S.C. 4:

‘Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of… acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office.’

This means that USPTO employees can acquire patents or interests in patents through inheritance or bequest, even during their employment or the one-year period after.

Yes, design patent applications have different requirements for filing priority claims compared to utility patent applications. The main difference is in the time period for filing the claim. As stated in MPEP 214.01:

“The time periods set forth in 37 CFR 1.55(d) do not apply to design applications.”

For design applications, the MPEP further clarifies: “In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).”

This means that for design patent applications, you can file a priority claim at any time while the application is pending, which provides more flexibility compared to utility patent applications.

For more detailed information on priority claims in design applications, you can refer to MPEP § 1504.10 and MPEP § 2920.05(d).

To learn more:

Yes, there can be subject matter restrictions when claiming priority based on inventor’s certificates. The MPEP 213.05 states:

Certain countries which grant both patents and inventor’s certificates issue only inventor’s certificates on certain subject matter, generally pharmaceuticals, foodstuffs, and cosmetics.

This means that for certain types of inventions, some countries may only offer inventor’s certificates and not patents. However, this doesn’t necessarily prevent an applicant from claiming priority in the US. The key requirement is that the option to file for either a patent or an inventor’s certificate must have generally existed in the country for the particular subject matter of the invention, even if it wasn’t available for the specific invention in question.

Applicants must still provide an affidavit or declaration as required by 37 CFR 1.55(l), stating that they had the option to file for either a patent or an inventor’s certificate for the subject matter forming the basis of the priority claim.

To learn more:

Are there any restrictions on paying USPTO fees by credit card?

Yes, there are some restrictions when paying USPTO fees by credit card:

  • There’s a daily limit on credit card transactions.
  • Some types of fees may not be eligible for credit card payment.
  • Only certain credit cards are accepted.

The MPEP 509 states, “The Office will not accept a general authorization to charge all fees, or all fees in a specific case, to a credit card.” Additionally, “Credit Card Payment Form PTO-2038 should be used when paying a patent or trademark fee (or related service fee) by credit card, unless the payment is being made via EFS-Web.” It’s important to check the current USPTO guidelines for any updates to credit card payment policies.

To learn more:

Tags: USPTO fees

Yes, there are limitations on expunging assignment records at the USPTO. The MPEP 323.01(d) provides important guidance:

‘The USPTO will not expunge any assignment records that have been recorded absent a petition pursuant to 37 CFR 1.59.’

This indicates that:

  • Expungement is not an automatic process and requires a formal petition
  • Only recorded assignments can be considered for expungement
  • The petitioner must provide clear evidence of mistake or improper character
  • The USPTO has discretion in granting or denying the petition

Additionally, the USPTO generally will not expunge an assignment record if it has already been relied upon or cited in other documents. This is to maintain the integrity of the public record and prevent confusion in chain of title matters.

To learn more:

Tags: USPTO

Generally, there are no additional fees charged by the USPTO for using the PDX program to exchange priority documents. The MPEP 215.01 does not mention any specific fees for this service. However, it’s important to note:

  • Regular patent application fees still apply.
  • If the PDX retrieval fails and you need to submit a certified copy, standard fees for document submission may apply.
  • Some foreign offices might charge fees for making documents available through PDX.

Always check the most current fee schedule on the USPTO website for the most up-to-date information on patent-related fees.

Yes, there are fees associated with using the Electronic Patent Assignment System (EPAS). According to MPEP 302.10:

“Customers may submit assignments electronically by accessing the Office’s website and paying the required fee by credit card, electronic fund transfer (EFT) or deposit account.”

The specific fee amounts are not mentioned in this section of the MPEP, so it’s advisable to check the current USPTO Fee Schedule for the most up-to-date information on assignment recording fees.

To learn more:

Tags: USPTO fees

Are there any fee reductions or waivers available for USPTO patent fees?

Yes, the USPTO offers fee reductions for certain applicants. According to MPEP 509, “Certain fees may be reduced if the applicant qualifies as a small entity or micro entity.” Here’s a brief overview:

  • Small Entity: Individuals, small businesses, and nonprofit organizations may qualify for a 50% fee reduction.
  • Micro Entity: Certain applicants may qualify for a 75% fee reduction if they meet specific income and filing requirements.

To determine if you qualify and for detailed information on how to claim these statuses, refer to MPEP 509.02 for Small Entity Status and MPEP 509.04 for Micro Entity Status. Always ensure you meet all requirements before claiming a reduced fee status.

To learn more:

Are there any fee reductions available for small entities or micro entities filing patent applications?

Yes, the USPTO offers significant fee reductions for small entities and micro entities. According to MPEP 607:

“Fees for a nonprovisional application for an original patent are reduced by 50% for a small entity and by 75% for a micro entity.”

To qualify for these reductions:

  • Small Entity: Generally includes independent inventors, small businesses with fewer than 500 employees, and nonprofit organizations.
  • Micro Entity: Must meet small entity requirements plus additional criteria related to application filings and income.

To claim these statuses, you must file the appropriate certification with your application. For detailed eligibility requirements and how to claim these statuses, refer to USPTO’s Micro Entity Guidance and Small Entity Status information.

To learn more:

Based on the information provided in MPEP 302.02, there are no exceptions to the USPTO’s English translation requirement for assignments. The MPEP states unequivocally:

The Office will accept and record non-English language documents only if accompanied by an English translation signed by the individual making the translation.

This requirement applies to all non-English assignment documents without exception. The USPTO’s strict adherence to this policy ensures uniformity in the recording process and accessibility of patent ownership information.

To learn more:

Yes, there are exceptions to the standard time limits for filing foreign priority claims, particularly for design patent applications and certain applications filed before November 29, 2000. According to 37 CFR 1.55(d)(1):

The time periods in this paragraph do not apply if the later-filed application is:
(i) An application for a design patent; or
(ii) An application filed under 35 U.S.C. 111(a) before November 29, 2000.

For design patent applications, the MPEP states:

In a design application, a claim for priority may be made at any time during the pendency of the application. See 37 CFR 1.55(g).

This means that for design patent applications, you can file a foreign priority claim at any time while the application is pending, without being restricted by the usual time limits.

For applications filed under 35 U.S.C. 111(a) before November 29, 2000, different rules may apply, and it’s best to consult with a patent attorney or the USPTO directly for guidance on such cases.

It’s important to note that while these exceptions exist, it’s generally advisable to file priority claims as early as possible to ensure they are properly recorded and considered.

While the general rule is that specifications and drawings cannot be transferred between applications, the use of the word “normally” in MPEP § 608.01(t) suggests that there might be rare exceptions. The MPEP states: “No part of a specification can normally be transferred to another application. Similarly, drawings cannot normally be transferred to another application.”

However, the MPEP doesn’t provide specific examples of such exceptions in this section. Applicants should consult with a patent attorney or the USPTO for guidance on any potential exceptions, as these would likely be handled on a case-by-case basis.

To learn more:

To learn more:

Yes, there are certain exceptions to the foreign filing license requirement. According to MPEP 140:

‘A license is not required if the invention was not made in the United States. Also, a license is not required to file an international application in the United States Receiving Office.’

Additionally, the following situations do not require a foreign filing license:

  • Filing applications in countries where no security agreement exists with the United States
  • Filing a PCT application designating only foreign countries
  • Filing a design patent application in a foreign country

However, it’s important to note that these exceptions are subject to specific conditions and may change. Always consult with a patent attorney or the USPTO if you’re unsure about your specific situation.

For more information on USPTO, visit: USPTO.

Tags: USPTO

Yes, there is one exception to the communication ban. According to MPEP 105, USPTO employees may communicate with a suspended or excluded practitioner “unless it is one in which said attorney or agent is an inventor or the applicant.” This means that if the suspended or excluded practitioner is listed as an inventor or is the applicant on a patent application, USPTO employees are allowed to communicate with them regarding that specific application.

To learn more:

Yes, there are exceptions to the benefit claim requirements for design applications. The MPEP specifically notes:

“Examiner Note: 1. Use this form paragraph only for original applications filed under 35 U.S.C. 111(a) on or after November 29, 2000 and for national stage applications under 35 U.S.C. 371. DO NOT use for design applications.”

This note indicates that the standard benefit claim requirements and procedures outlined in this section of the MPEP do not apply to design applications. Design applications have different rules and requirements for claiming benefit of earlier filing dates.

Key points about benefit claims in design applications:

  • Design applications can claim the benefit of an earlier filed design application or an earlier filed provisional application.
  • The rules for claiming benefit in design applications are generally less stringent than those for utility applications.
  • Specific requirements for design application benefit claims can be found in MPEP 1504.20.

It’s important to consult the specific rules and guidelines for design applications when dealing with benefit claims in this context, as they differ from the requirements for utility applications.

Yes, there are exceptions to paying the recording fee at the USPTO. According to MPEP 302.06, no fee is required for certain documents related to Executive Order 9424. Specifically:

No fee is required for each patent application and patent against which a document required by Executive Order 9424 is to be filed if: (1) The document does not affect title and is so identified in the cover sheet (see § 3.31(c)(2)); and (2) The document and cover sheet are either: Faxed or electronically submitted as prescribed by the Director, or mailed to the Office in compliance with § 3.27.

This exception applies to specific government-related documents that do not affect the title of the patent or application.

To learn more:

Tags: USPTO fees

Yes, juristic entities (e.g., organizational assignees) must be represented by a patent practitioner. As stated in MPEP 401:

An applicant who is a juristic entity must be represented by a patent practitioner.

This requirement ensures that organizations have proper legal representation when navigating the complex patent application process. Individual inventors and joint inventors, however, may represent themselves if they choose to do so.

For more information on juristic entity, visit: juristic entity.

For more information on organizational assignee, visit: organizational assignee.

Yes, certain applications are still processed under former 37 CFR 1.62. Specifically, all continuation, divisional, and continuation-in-part (CIP) applications filed under former 37 CFR 1.62 prior to December 1, 1997, continue to be processed and examined under the procedures set forth in that regulation.

The MPEP clarifies this point: All continuation, divisional and CIP applications filed under former 37 CFR 1.62 prior to December 1, 1997, will continue to be processed and examined under the procedures set forth in former 37 CFR 1.62.

For more detailed information on the practice and procedure under former 37 CFR 1.62, the MPEP directs readers to consult MPEP § 201.06(b) in the MPEP 8th Edition, Rev. 1 (February 2003), which is available on the USPTO website.

To learn more:

To learn more:

Yes, the procedures for correcting inventorship and correcting an inventor’s name are the same. According to MPEP 602.01(c)(2):

The procedures for correction of inventorship and for correction to the name of an inventor or to the order of the names of the inventors are not distinct.

Both procedures require:

  • Submitting an application data sheet (ADS) in accordance with 37 CFR 1.76 that identifies each inventor by their legal name in the desired order.
  • Paying the processing fee set forth in 37 CFR 1.17(i).

This unified procedure simplifies the process for applicants when making changes related to inventorship or inventor names in patent applications.

To learn more:

No, supplemental oaths or declarations filed after allowance are not considered amendments under 37 CFR 1.312. The MPEP explicitly states:

“They should not be filed or considered as amendments under 37 CFR 1.312, since they make no change in the wording of the papers on file.”

This means that supplemental oaths or declarations do not alter the content of the application and are treated differently from post-allowance amendments.

To learn more:

To learn more:

No, substitute specifications are not permitted in reissue applications or reexamination proceedings. This is explicitly stated in 37 CFR 1.125(d):

A substitute specification under this section is not permitted in a reissue application or in a reexamination proceeding.

This restriction is important to maintain the integrity of the original patent document in these special proceedings. Applicants and practitioners should be aware of this limitation when considering how to make amendments or changes to the specification in reissue applications or reexamination proceedings.

To learn more:

Reserved sections are relatively common in the MPEP, especially for section numbers that are being held for future use or that previously contained content that was moved. A quick scan of the MPEP Chapter 200 shows several reserved sections, such as:

  • Section 203.07 [Reserved]
  • Sections 204-209 [Reserved]
  • Section 212 [Reserved]

No, provisional patent applications are not examined. The MPEP 504 clearly states: “Provisional applications will not be examined.” Provisional applications serve as a placeholder to establish a priority date and are not subject to substantive examination by the USPTO.

To learn more:

No, provisional patent applications are not examined for patentability. The MPEP explicitly states:

Provisional applications will not be examined for patentability.

This is one of the key differences between provisional and nonprovisional applications. The purpose of a provisional application is to:

  • Establish an early filing date
  • Allow the term ‘Patent Pending’ to be applied
  • Provide a 12-month period to further develop the invention

Since provisional applications are not examined, they do not require formal patent claims or an oath or declaration. This simplifies the filing process and allows inventors to quickly secure a priority date for their invention.

To obtain patent protection, a nonprovisional application must be filed, which will then undergo examination for patentability.

For more information on patent filing, visit: patent filing.

No, provisional patent applications are not assigned to examiners for examination. MPEP 504 explicitly states: “Provisional applications will not be examined.” This is because provisional applications are primarily used to establish a priority date and are not subject to substantive examination.

No, provisional applications are not subject to Department of Energy (DOE) or NASA property rights review. According to MPEP 150:

Provisional applications are not subject to DOE or NASA property rights review.

This means that inventors filing provisional applications do not need to submit property rights statements to DOE or NASA at the time of filing. However, it’s important to note that if a nonprovisional application is later filed claiming priority to the provisional application, and if it relates to atomic energy or aeronautical and space activities, it may then be subject to the relevant property rights review process.

No, provisional applications are not published or made available to the public by the USPTO. The MPEP 201.04 clearly states:

A provisional application is not subject to publication and is not subject to examination other than to review for national security implications.

This means that the contents of a provisional application remain confidential unless and until a corresponding non-provisional application is published or a patent is issued. This confidentiality can be advantageous for inventors who want to maintain secrecy while securing an early filing date.

For more information on provisional application, visit: provisional application.

Provisional applications are not explicitly mentioned as national applications in MPEP 201.01. The section states:

‘National applications include original (nonprovisional) applications, reissue applications, and reexamination proceedings.’

While provisional applications are filed with the USPTO, they are not considered complete patent applications and do not undergo examination. They serve as a placeholder to establish a priority date. For more information on provisional applications, refer to USPTO’s Provisional Application page.

For more information on USPTO, visit: USPTO.

Tags: USPTO

The treatment of preliminary amendments as new matter depends on when they are filed:

  1. Filing date amendments: Preliminary amendments present on the filing date of the application are considered part of the original disclosure and not new matter.
  2. Post-filing amendments: Preliminary amendments filed after the application’s filing date are not part of the original disclosure and may be considered new matter.

The MPEP states: A preliminary amendment present on the filing date of the application (e.g., filed along with the filing of the application) is considered a part of the original disclosure. (MPEP 608.04(b))

For applications filed on or after September 21, 2004, the USPTO automatically treats any preliminary amendment under 37 CFR 1.115(a)(1) present on the filing date as part of the original disclosure.

To avoid potential new matter issues, applicants are encouraged to incorporate desired amendments into the text of the specification rather than submitting separate preliminary amendments.

To learn more:

Tags: new matter

Photographs are generally not permitted in utility and design patent applications, but exceptions exist. According to MPEP 608.01(f):

Photographs, including photocopies of photographs, are not ordinarily permitted in utility and design patent applications. The Office will accept photographs in utility and design patent applications, however, if photographs are the only practicable medium for illustrating the claimed invention.

Examples of acceptable photographs include:

  • Electrophoresis gels
  • Blots (e.g., immunological, western, Southern, and northern)
  • Cell cultures
  • Histological tissue cross sections
  • In vivo imaging
  • Crystalline structures
  • Ornamental effects (in design patent applications)

The photographs must be of sufficient quality to ensure all details are reproducible in the printed patent. If the subject matter can be illustrated by a drawing, the examiner may require a drawing instead of a photograph.

To learn more:

Photographs can be included in patent applications, but there are specific requirements and limitations. According to MPEP 507:

“OPAP may object to and require corrected drawings within a set time period, if the drawings: (F) include photographs of the claimed invention which are capable of illustration by other medium such as ink drawings, and which are illegible after scanning. See 37 CFR 1.84(b)

This means that while photographs are acceptable, they should only be used when the subject matter cannot be accurately depicted in a drawing. Additionally, the photographs must be of sufficient quality to be legible after scanning. If a photograph can be replaced by a clear ink drawing, the USPTO may require such a replacement.

For more information on drawing requirements, visit: drawing requirements.

For more information on patent drawings, visit: patent drawings.

Are patent assignment records publicly accessible after recording at the USPTO?

Yes, patent assignment records become publicly accessible after they are recorded at the USPTO. The MPEP 302.01 states: ‘Assignment documents submitted for recording are scanned and stored in a public database.’

This means:

  • Anyone can access recorded assignment information
  • The public database allows searching for patent ownership details
  • Transparency in patent ownership is maintained

Public accessibility of these records is crucial for maintaining transparency in patent ownership and facilitating due diligence in patent transactions. Interested parties can search and retrieve assignment information through the USPTO’s Assignment Search database.

To learn more:

No, patent applicants are not required to conduct prior art searches before filing a patent application. This is clarified in the MPEP, which states:

An applicant has no duty to conduct a prior art search as a prerequisite to filing an application for patent. See Nordberg, Inc. v. Telsmith, Inc., 82 F.3d 394, 397, 38 USPQ2d 1593, 1595-96 (Fed. Cir. 1996); FMC Corp. v. Hennessy Indus., Inc., 836 F.2d 521, 526 n.6, 5 USPQ2d 1272, 1275-76 n.6 (Fed. Cir. 1987); FMC Corp. v. Manitowoc Co., 835 F.2d 1411, 1415, 5 USPQ2d 1112, 1115 (Fed. Cir. 1987); American Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F.2d 1350, 1362, 220 USPQ 763, 772 (Fed. Cir.), cert. denied, 469 U.S. 821, 224 USPQ 520 (1984).

However, conducting a prior art search can be beneficial for understanding the state of the art and assessing the potential patentability of an invention.

For more information on patent application requirements, visit: patent application requirements.

For more information on prior art search, visit: prior art search.

No, nonsigning inventors are not entitled to a hearing in pre-AIA 37 CFR 1.47 cases. This is explicitly stated in MPEP 409.03(i):

“A nonsigning inventor is not entitled to a hearing (Cogar v. Schuyler, 464 F.2d 747, 173 USPQ 389 (D.C. Cir. 1972))”

This precedent, set by the case of Cogar v. Schuyler, establishes that while nonsigning inventors have certain rights, such as inspecting application papers and making their position of record, they do not have the right to a formal hearing in these cases.

Additionally, the MPEP states:

“While the U.S. Patent and Trademark Office will grant the nonsigning inventor access to the application, inter partes proceedings will not be instituted in a pre-AIA 37 CFR 1.47 case. In re Hough, 108 USPQ 89 (Comm’r Pat. 1955).”

This further emphasizes that while nonsigning inventors have access to application information, they cannot initiate inter partes proceedings, which would include hearings, in pre-AIA 37 CFR 1.47 cases.

To learn more:

To learn more:

For continuation or divisional applications filed before September 16, 2012, a new oath or declaration is generally not required if certain conditions are met. According to pre-AIA 37 CFR 1.63(d):

A newly executed oath or declaration is not required under § 1.51(b)(2) and § 1.53(f) in a continuation or divisional application, provided that:

  • The prior nonprovisional application contained a proper oath or declaration
  • The continuation or divisional application was filed by all or fewer than all inventors named in the prior application
  • The specification and drawings contain no new matter
  • A copy of the executed oath or declaration from the prior application is submitted

However, a new oath or declaration is required if naming an inventor not named in the prior application. The MPEP states: A newly executed oath or declaration must be filed in a continuation or divisional application naming an inventor not named in the prior application.

To learn more:

No, Information Disclosure Statements (IDSs) are not permitted in provisional patent applications. The MPEP clearly states:

Information Disclosure Statements (IDSs) are not permitted in provisional applications filed under 35 U.S.C. 111(b). See 37 CFR 1.51(d).

The reason for this is that provisional applications do not undergo substantive examination. As the MPEP explains:

Since no substantive examination is given in provisional applications, a disclosure of information is unnecessary.

If an IDS is filed with a provisional application, the USPTO will handle it as follows:

Any such statement filed in a provisional application will be returned or destroyed at the option of the Office.

To learn more:

Are handwritten patent applications accepted by the USPTO?

While it is strongly recommended to submit typed or printed applications, the USPTO does accept handwritten patent applications under certain conditions:

  • The handwriting must be legible and in permanent dark ink or its equivalent.
  • The text must be clearly readable and suitable for reproduction.
  • All other formatting requirements (margins, spacing, etc.) must still be followed.

As stated in MPEP 501: All papers that are to become a part of the permanent records of the United States Patent and Trademark Office should be legibly written either by a typewriter or mechanical printer in permanent dark ink or its equivalent in portrait orientation on flexible, strong, smooth, non-shiny, durable, and white paper.

While handwritten applications are technically accepted, it’s important to note that typed or printed applications are preferred for clarity and ease of processing. Handwritten applications may face additional scrutiny and potential delays in processing due to legibility concerns.

English translations of non-English language foreign applications are not always required. However, 37 CFR 1.55(g)(3) specifies three situations where an English translation may be necessary:

“An English language translation of a non-English language foreign application is not required except: (i) When the application is involved in an interference or derivation proceeding; (ii) When necessary to overcome the date of a reference relied upon by the examiner; or (iii) When specifically required by the examiner.”

If a translation is required, it must be filed with a statement certifying that the translation is accurate. This ensures that the USPTO can properly evaluate the priority claim when necessary for examination or proceedings.

To learn more:

Drawings are not always necessary for a patent application, but they are required when essential for understanding the invention. According to the MPEP, 35 U.S.C. 113 (first sentence) in turn provides that an ‘applicant shall furnish a drawing where necessary for the understanding of the subject matter sought to be patented.’ The USPTO has specific practices for determining when drawings might not be necessary, such as for certain process claims, composition applications, and situations where the invention resides solely in the use of a particular material in an otherwise known article or system.

To learn more:

No, CPAs are not available for all types of patent applications. According to MPEP ¶ 2.30, CPAs are primarily used for design patent applications. The MPEP states: “If the request for a CPA in a utility or plant application is improper and the CPA has been treated as an RCE, do not use this form paragraph (use form paragraph 7.42.15 instead).” This indicates that CPAs are not typically used for utility or plant patent applications, and such requests may be treated as Requests for Continued Examination (RCE) instead.

For more information on design patents, visit: design patents.

For more information on plant patents, visit: plant patents.

For more information on utility patents, visit: utility patents.

Generally, copies of U.S. patents and U.S. patent application publications listed in an Information Disclosure Statement (IDS) are not required unless specifically requested by the Office.

According to the MPEP: ‘There is no requirement for a copy of each U.S. patent or U.S. patent application publication listed in an IDS unless required by the Office.‘ (37 CFR 1.98(a)(2))

However, it’s important to note that copies of other types of documents, such as foreign patents and non-patent literature, are typically required. The MPEP specifies that legible copies must be provided for:

  • Each foreign patent
  • Each publication or that portion which caused it to be listed
  • For each cited pending unpublished U.S. application, the application specification including the claims, and any drawings of the application, unless the cited pending U.S. application is stored in the Image File Wrapper (IFW) system
  • All other information or that portion which caused it to be listed

To learn more:

To learn more:

No, Continued Prosecution Applications (CPAs) are not available for all types of patent applications. They are specifically limited to design patent applications. This is evident from the MPEP guidance, which states:

‘Use this form paragraph to inform applicant that a request for a CPA in a design application is not in compliance with 37 CFR 1.53(d)(2) and, therefore, no CPA has been established.’

This statement clearly indicates that CPAs are associated with design applications. For utility and plant patent applications, other continuation options are available, such as:

  • Continuation Applications
  • Divisional Applications
  • Continuation-in-Part Applications

It’s important for inventors and patent practitioners to understand these distinctions to choose the appropriate type of continuing application for their specific situation.

For more information on continuation applications, visit: continuation applications.

For more information on design patents, visit: design patents.

For more information on patent application types, visit: patent application types.

Are continuation applications considered national applications?

Yes, continuation applications are considered national applications. They are a type of nonprovisional application that continues the examination process of a previously filed application.

The MPEP 201.01 states: ‘National applications include original (nonprovisional), reissue, design, plant, and provisional applications.’ While continuation applications are not explicitly mentioned in this list, they fall under the category of nonprovisional applications.

Continuation applications allow applicants to pursue additional claims based on the disclosure of a parent application. They are filed before the parent application is abandoned or patented and claim the benefit of the parent application’s filing date.

For more information on continuation application, visit: continuation application.

For more information on nonprovisional application, visit: nonprovisional application.

For more information on USPTO, visit: USPTO.

Yes, comparisons with prior art are generally allowed in patent applications, as long as they are not derogatory. The MPEP 608.01(r) explicitly states:

“Mere comparisons with the prior art are not considered to be disparaging, per se.”

This means you can compare your invention to existing technologies to highlight improvements or differences. However, ensure that your comparisons are factual, objective, and focus on technical aspects rather than criticizing or disparaging other inventions or inventors.

To learn more:

Color drawings or photographs are generally not allowed in patent applications without special permission. MPEP 507 states:

OPAP may object to and require corrected drawings within a set time period, if the drawings: … (G) contain color drawings or color photographs, but not a petition to accept color drawings/photographs.

If an applicant wishes to include color drawings or photographs, they must file a petition to accept them. It’s important to note that the requirement for a black and white photocopy of color drawings/photographs has been eliminated. Applicants should be prepared to justify the need for color in their drawings or photographs when filing such a petition.

No, color drawings and color photographs are not permitted in international applications. This is explicitly stated in MPEP 608.02(c):

Color drawings and color photographs are not permitted in international applications (see PCT Rule 11.13).

This restriction is based on the PCT Rule 11.13, which sets out the physical requirements for drawings in international applications. Applicants should be aware that only black and white line drawings are acceptable for international applications filed under the Patent Cooperation Treaty (PCT).

To learn more:

To learn more:

No, claims are not required for a provisional patent application to receive a filing date. This is explicitly stated in 35 U.S.C. 111(b)(2), which provides that “[a] claim, as required by subsections (b) through (e) of section 112, shall not be required in a provisional application.”

The MPEP confirms this by stating: “In addition, 35 U.S.C. 111(b)(2) provides that ‘[a] claim, as required by subsections (b) through (e) of section 112, shall not be required in a provisional application.'”

This provision allows inventors to quickly establish a priority date for their invention without the need to draft formal patent claims, which can be a complex and time-consuming process.

To learn more:

No, attorney’s liens against patents or patent applications are not accepted for recording at the USPTO. This is explicitly stated in the MPEP:

“Documents that are not accepted for recording include attorney’s liens against patents or patent applications. See In re Refusal of Assignment Branch to Record Attorney’s Lien, 8 USPQ2d 1446 (Comm’r Pat. 1988).” (MPEP 313)

This decision reflects the USPTO’s policy on recordable documents and helps maintain clarity in the patent ownership records.

The accessibility of assignment records for pending patent applications depends on whether the application has been published. According to MPEP 301.01:

  • For published patent applications, assignment records are publicly available.
  • For unpublished pending applications, assignment records are not open to public inspection.

The MPEP states: “Documents relating only to one or more pending applications for patent which have not been published under 35 U.S.C. 122(b) will not be open to public inspection.”

For unpublished pending applications, access to assignment information requires proper authorization. As per the MPEP:

“For applications filed on or after September 16, 2012, the written authority must be from (A) an inventor, (B) an applicant, (C) the assignee or an assignee of an undivided part interest, (D) a patent practitioner of record, or (E) a person with written authority from (A), (B), or (C) or (D).”

To learn more:

No, applicants are not separately notified when their parent application is abandoned due to the filing of a Continued Prosecution Application (CPA). This is implied in the examiner’s note in MPEP ¶ 2.35:

This notice should be given, since applicant is not notified of the abandonment of the parent nor is a filing receipt normally sent for a CPA.

The establishment of a CPA automatically results in the abandonment of the parent application. Applicants should be aware that by filing a CPA, they are effectively abandoning the parent application in favor of continuing prosecution through the CPA.

For more information on CPA, visit: CPA.

For more information on patent procedure, visit: patent procedure.

Yes, all patent assignment records are publicly accessible. MPEP 301.01 clearly states:

‘The assignment records of patents and applications are open to public inspection.’

This means that anyone can access these records, which include:

  • Assignment documents
  • Digests of assignments
  • Indexes of patent assignments

The public nature of these records ensures transparency in patent ownership and transfers. However, it’s important to note that while the records are public, obtaining copies may require payment of a fee as specified in 37 CFR 1.19(b)(3).

Trademark Law (5)

The mailing address for trademark-related correspondence is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

This address should be used for all trademark-related documents filed on paper, except for certain specific documents as outlined in the regulations.

According to 37 CFR 2.190: In general, trademark documents to be delivered by the USPS must be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.

It’s important to note that many trademark documents can and should be filed electronically through the Trademark Electronic Application System (TEAS).

To learn more:

The mailing address for trademark applications and trademark-related papers filed on paper is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

This address should be used for all trademark-related documents filed on paper, except for:

  • Documents sent to the Assignment Recordation Branch for recordation
  • Requests for copies of trademark documents
  • Certain documents filed under the Madrid Protocol as specified in 37 CFR 2.190(e)

According to 37 CFR 2.190(a): “In general, trademark documents to be delivered by the USPS must be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.”

For trademark-related documents filed on paper, except for certain specific cases, the address is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

According to MPEP 501, which cites 37 CFR 2.190: “All trademark-related documents filed on paper, except documents sent to the Assignment Recordation Branch for recordation; requests for copies of trademark documents; and certain documents filed under the Madrid Protocol as specified in 37 CFR 2.190(e), should be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.”

It’s important to note that many trademark documents can and should be filed electronically through the Trademark Electronic Application System (TEAS).

For more information on trademark correspondence, visit: trademark correspondence.

For correspondence that is not specific to patents or trademarks, such as requests for certified copies or assignment recordation, the general mailing address is:

Director of the United States Patent and Trademark Office
P.O. Box 1450
Alexandria, VA 22313-1450

This address should be used for:

  • Patent and trademark documents sent to the Assignment Division for recordation (Mail Stop Assignment Recordation Services)
  • Requests for certified or uncertified copies of patent and trademark documents (Mail Stop Patent and Trademark Copy Fulfillment Branch)
  • Correspondence for which an address is not otherwise specified in 37 CFR 1.1 or 2.190

MPEP 501 states: “For correspondence for which an address is not otherwise specified in 37 CFR 1.1 or 2.190, should be addressed to: Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450”

Yes, you can hand-carry certain documents to the USPTO, but there are specific guidelines and limitations. According to MPEP 501:

Patent-related papers may be hand-carried to the Office in Alexandria, VA. Correspondence cannot be hand-carried to the Regional Offices. If the correspondence is hand-carried to the Office, with limited exceptions (see MPEP § 502, subsection III) it must be delivered to:

United States Patent and Trademark Office
Customer Service Window
Randolph Building
401 Dulany Street
Alexandria, VA 22314

For trademark-related papers, there is a separate location:

Trademark-related papers may be filed at the “walk-up” window located in the Trademark Assistance Center, Madison East, Concourse Level, Room C55, 600 Dulany Street, Alexandria, VA 22314.

It’s important to note that while hand-carrying documents is possible, electronic filing is often faster and more efficient for most types of correspondence with the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO submission, visit: USPTO submission.

Trademark Procedure (4)

The mailing address for trademark-related correspondence is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

This address should be used for all trademark-related documents filed on paper, except for certain specific documents as outlined in the regulations.

According to 37 CFR 2.190: In general, trademark documents to be delivered by the USPS must be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.

It’s important to note that many trademark documents can and should be filed electronically through the Trademark Electronic Application System (TEAS).

To learn more:

The mailing address for trademark applications and trademark-related papers filed on paper is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

This address should be used for all trademark-related documents filed on paper, except for:

  • Documents sent to the Assignment Recordation Branch for recordation
  • Requests for copies of trademark documents
  • Certain documents filed under the Madrid Protocol as specified in 37 CFR 2.190(e)

According to 37 CFR 2.190(a): “In general, trademark documents to be delivered by the USPS must be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.”

For trademark-related documents filed on paper, except for certain specific cases, the address is:

Commissioner for Trademarks
P.O. Box 1451
Alexandria, VA 22313-1451

According to MPEP 501, which cites 37 CFR 2.190: “All trademark-related documents filed on paper, except documents sent to the Assignment Recordation Branch for recordation; requests for copies of trademark documents; and certain documents filed under the Madrid Protocol as specified in 37 CFR 2.190(e), should be addressed to: Commissioner for Trademarks, P.O. Box 1451, Alexandria, VA 22313-1451.”

It’s important to note that many trademark documents can and should be filed electronically through the Trademark Electronic Application System (TEAS).

For more information on trademark correspondence, visit: trademark correspondence.

Yes, you can hand-carry certain documents to the USPTO, but there are specific guidelines and limitations. According to MPEP 501:

Patent-related papers may be hand-carried to the Office in Alexandria, VA. Correspondence cannot be hand-carried to the Regional Offices. If the correspondence is hand-carried to the Office, with limited exceptions (see MPEP § 502, subsection III) it must be delivered to:

United States Patent and Trademark Office
Customer Service Window
Randolph Building
401 Dulany Street
Alexandria, VA 22314

For trademark-related papers, there is a separate location:

Trademark-related papers may be filed at the “walk-up” window located in the Trademark Assistance Center, Madison East, Concourse Level, Room C55, 600 Dulany Street, Alexandria, VA 22314.

It’s important to note that while hand-carrying documents is possible, electronic filing is often faster and more efficient for most types of correspondence with the USPTO.

For more information on patent office procedures, visit: patent office procedures.

For more information on USPTO submission, visit: USPTO submission.